
Inclusion NCT03868852 0 9 O
Criteria NCT03868852 10 18 O
: NCT03868852 19 20 O

- NCT03868852 24 25 O
Patients NCT03868852 27 35 O
must NCT03868852 36 40 O
be NCT03868852 41 43 O
≥ NCT03868852 44 45 B-Eq_Comparison
3 NCT03868852 46 47 I-Eq_Comparison
and NCT03868852 48 51 B-And
≤ NCT03868852 52 53 B-Eq_Comparison
18 NCT03868852 54 56 I-Eq_Comparison
years NCT03868852 57 62 I-Eq_Comparison
of NCT03868852 63 65 O
age NCT03868852 66 69 B-Age
. NCT03868852 70 71 O

- NCT03868852 75 76 O
The NCT03868852 78 81 O
predicted NCT03868852 82 91 B-Observation
survival NCT03868852 92 100 I-Observation
period NCT03868852 101 107 O
is NCT03868852 108 110 O
more NCT03868852 111 115 B-Eq_Comparison
than NCT03868852 116 120 I-Eq_Comparison
3 NCT03868852 121 122 I-Eq_Comparison
months NCT03868852 123 129 I-Eq_Comparison
. NCT03868852 130 131 O

- NCT03868852 135 136 O
According NCT03868852 138 147 O
to NCT03868852 148 150 O
RECIST NCT03868852 151 157 O
version NCT03868852 158 165 O
1.1 NCT03868852 166 169 O
, NCT03868852 170 171 O
there NCT03868852 172 177 O
is NCT03868852 178 180 O
at NCT03868852 181 183 B-Eq_Comparison
least NCT03868852 184 189 I-Eq_Comparison
one NCT03868852 190 193 I-Eq_Comparison
measurable NCT03868852 194 204 O
lesion NCT03868852 205 211 B-Condition
. NCT03868852 212 213 O

- NCT03868852 217 218 O
Post NCT03868852 220 224 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03868852 225 234 B-Procedure
pathological NCT03868852 235 247 B-Condition
stage NCT03868852 248 253 I-Condition
was NCT03868852 254 257 O
group NCT03868852 258 263 B-Eq_Comparison
II NCT03868852 264 266 I-Eq_Comparison
- NCT03868852 267 268 I-Eq_Comparison
IV NCT03868852 269 271 I-Eq_Comparison
. NCT03868852 272 273 O

- NCT03868852 277 278 O
Patients NCT03868852 280 288 O
have NCT03868852 289 293 O
not NCT03868852 294 297 B-Negation
received NCT03868852 298 306 B-Eq_Comparison
radiotherapy NCT03868852 307 319 B-Procedure
before NCT03868852 320 326 B-Eq_Comparison
, NCT03868852 327 328 O
and NCT03868852 329 332 B-And
can NCT03868852 333 336 B-Assertion___Assertion_Type_Value:hypothetical
accept NCT03868852 337 343 I-Assertion___Assertion_Type_Value:hypothetical
chemotherapy NCT03868852 344 356 B-Procedure
and NCT03868852 357 360 B-Or
surgical NCT03868852 361 369 B-Procedure
treatment NCT03868852 370 379 I-Procedure
. NCT03868852 380 381 O

- NCT03868852 385 386 O
No NCT03868852 388 390 B-Negation
other NCT03868852 391 396 B-Other
anticancer NCT03868852 397 407 B-Procedure
therapy NCT03868852 408 415 I-Procedure
should NCT03868852 416 422 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03868852 423 425 I-Assertion___Assertion_Type_Value:hypothetical
used NCT03868852 426 430 O
during NCT03868852 431 437 B-Temporal_Connection___Temporal_Connection_Type_Value:during
radiotherapy NCT03868852 438 450 B-Procedure
. NCT03868852 451 452 O

- NCT03868852 456 457 O
The NCT03868852 459 462 O
main NCT03868852 463 467 B-Condition
organs NCT03868852 468 474 I-Condition
are NCT03868852 475 478 O
functioning NCT03868852 479 490 O
normally NCT03868852 491 499 O
, NCT03868852 500 501 O
which NCT03868852 502 507 O
meets NCT03868852 508 513 O
the NCT03868852 514 517 B-Criteria_Count
following NCT03868852 518 527 I-Criteria_Count
criteria NCT03868852 528 536 I-Criteria_Count
: NCT03868852 537 538 O

1 NCT03868852 547 548 O
. NCT03868852 548 549 O
Blood NCT03868852 551 556 B-Procedure
routine NCT03868852 557 564 I-Procedure
examination NCT03868852 565 576 I-Procedure
standards NCT03868852 577 586 O
should NCT03868852 587 593 O
be NCT03868852 594 596 O
met NCT03868852 597 600 O
: NCT03868852 601 602 O
( NCT03868852 603 604 O
no NCT03868852 605 607 B-Negation
blood NCT03868852 608 613 B-Procedure
transfusion NCT03868852 614 625 I-Procedure
within NCT03868852 626 632 B-Eq_Comparison
14 NCT03868852 633 635 I-Eq_Comparison
days NCT03868852 636 640 I-Eq_Comparison
) NCT03868852 641 642 O
A NCT03868852 643 644 O
. NCT03868852 645 646 O
HB NCT03868852 648 650 B-Observation
> NCT03868852 651 652 B-Eq_Comparison
90 NCT03868852 653 655 I-Eq_Comparison
g NCT03868852 656 657 I-Eq_Comparison
/ NCT03868852 658 659 I-Eq_Comparison
L NCT03868852 660 661 I-Eq_Comparison
; NCT03868852 661 662 O
B NCT03868852 663 664 O
. NCT03868852 665 666 O
ANC NCT03868852 668 671 B-Observation
> NCT03868852 672 673 B-Eq_Comparison
1.5 NCT03868852 674 677 I-Eq_Comparison
* NCT03868852 678 679 I-Eq_Comparison
109 NCT03868852 680 683 I-Eq_Comparison
/ NCT03868852 684 685 I-Eq_Comparison
L NCT03868852 686 687 I-Eq_Comparison
; NCT03868852 687 688 O
C NCT03868852 689 690 O
. NCT03868852 691 692 O
PLT NCT03868852 694 697 B-Observation
> NCT03868852 698 699 B-Eq_Comparison
80 NCT03868852 700 702 I-Eq_Comparison
* NCT03868852 703 704 I-Eq_Comparison
109 NCT03868852 705 708 I-Eq_Comparison
/ NCT03868852 709 710 I-Eq_Comparison
L NCT03868852 711 712 I-Eq_Comparison

2 NCT03868852 720 721 O
. NCT03868852 721 722 O
Biochemical NCT03868852 724 735 B-Observation
tests NCT03868852 736 741 I-Observation
should NCT03868852 742 748 O
meet NCT03868852 749 753 O
the NCT03868852 754 757 B-Criteria_Count
following NCT03868852 758 767 I-Criteria_Count
criteria NCT03868852 768 776 I-Criteria_Count
: NCT03868852 777 778 O

A NCT03868852 780 781 O
. NCT03868852 782 783 O
BIL NCT03868852 785 788 B-Observation
< NCT03868852 789 790 B-Eq_Comparison
1.25 NCT03868852 791 795 I-Eq_Comparison
times NCT03868852 796 801 I-Eq_Comparison
normal NCT03868852 802 808 I-Eq_Comparison
upper NCT03868852 809 814 I-Eq_Comparison
limit NCT03868852 815 820 I-Eq_Comparison
( NCT03868852 821 822 I-Eq_Comparison
ULN NCT03868852 823 826 I-Eq_Comparison
) NCT03868852 827 828 I-Eq_Comparison
; NCT03868852 829 830 O
B NCT03868852 831 832 O
. NCT03868852 833 834 O
ALT NCT03868852 836 839 B-Observation
and NCT03868852 840 843 B-And
AST NCT03868852 844 847 B-Observation
< NCT03868852 848 849 B-Eq_Comparison
2.5 NCT03868852 850 853 I-Eq_Comparison
ULN NCT03868852 854 857 I-Eq_Comparison
; NCT03868852 857 858 O
C NCT03868852 859 860 O
. NCT03868852 861 862 O
Serum NCT03868852 864 869 B-Observation
Cr NCT03868852 870 872 I-Observation
< NCT03868852 873 874 B-Eq_Comparison
1 NCT03868852 875 876 I-Eq_Comparison
ULN NCT03868852 877 880 I-Eq_Comparison
, NCT03868852 881 882 O
endogenous NCT03868852 883 893 B-Observation
creatinine NCT03868852 894 904 I-Observation
clearance NCT03868852 905 914 I-Observation
> NCT03868852 915 916 B-Eq_Comparison
50 NCT03868852 917 919 I-Eq_Comparison
ml NCT03868852 920 922 I-Eq_Comparison
/ NCT03868852 923 924 I-Eq_Comparison
min NCT03868852 925 928 I-Eq_Comparison

- NCT03868852 931 932 O
Subjects NCT03868852 934 942 O
volunteered NCT03868852 943 954 O
to NCT03868852 955 957 O
participate NCT03868852 958 969 O
in NCT03868852 970 972 O
this NCT03868852 973 977 O
study NCT03868852 978 983 O
, NCT03868852 984 985 O
patients NCT03868852 986 994 O
or NCT03868852 995 997 O
legal NCT03868852 998 1003 O
guardians NCT03868852 1004 1013 O
signed NCT03868852 1014 1020 O
informed NCT03868852 1021 1029 O
consent NCT03868852 1030 1037 O
through NCT03868852 1038 1045 O
patient NCT03868852 1046 1053 O
consent NCT03868852 1054 1061 O
, NCT03868852 1062 1063 O
good NCT03868852 1064 1068 O
compliance NCT03868852 1069 1079 O
, NCT03868852 1080 1081 O
with NCT03868852 1082 1086 O
follow NCT03868852 1087 1093 O
- NCT03868852 1094 1095 O
up NCT03868852 1096 1098 O
. NCT03868852 1099 1100 O

- NCT03868852 1104 1105 O
Doctors NCT03868852 1107 1114 O
believe NCT03868852 1115 1122 O
that NCT03868852 1123 1127 O
treatment NCT03868852 1128 1137 O
can NCT03868852 1138 1141 O
benefit NCT03868852 1142 1149 O
patients NCT03868852 1150 1158 O
. NCT03868852 1159 1160 O


Key NCT03921411 0 3 O
Inclusion NCT03921411 4 13 O
Criteria NCT03921411 14 22 O

- NCT03921411 25 26 O
Male NCT03921411 28 32 O
or NCT03921411 33 35 B-Or
female NCT03921411 36 42 O
subjects NCT03921411 43 51 O
≥ NCT03921411 52 53 B-Eq_Comparison
12 NCT03921411 54 56 I-Eq_Comparison
to NCT03921411 57 59 I-Eq_Comparison
< NCT03921411 60 61 I-Eq_Comparison
18 NCT03921411 62 64 I-Eq_Comparison
years NCT03921411 65 70 I-Eq_Comparison
of NCT03921411 71 73 O
age NCT03921411 74 77 B-Age

- NCT03921411 80 81 O
Chronic NCT03921411 83 90 O
AD NCT03921411 91 93 B-Condition
that NCT03921411 94 98 O
has NCT03921411 99 102 O
been NCT03921411 103 107 O
documented NCT03921411 108 118 O
for NCT03921411 119 122 O
at NCT03921411 123 125 B-Eq_Comparison
least NCT03921411 126 131 I-Eq_Comparison
2 NCT03921411 132 133 I-Eq_Comparison
years NCT03921411 134 139 I-Eq_Comparison

- NCT03921411 142 143 O
Eczema NCT03921411 145 151 B-Observation
Area NCT03921411 152 156 I-Observation
and NCT03921411 157 160 I-Observation
Severity NCT03921411 161 169 I-Observation
Index NCT03921411 170 175 I-Observation
( NCT03921411 176 177 O
EASI NCT03921411 178 182 B-Observation
) NCT03921411 183 184 O
score NCT03921411 185 190 O
≥ NCT03921411 191 192 B-Eq_Comparison
16 NCT03921411 193 195 I-Eq_Comparison

- NCT03921411 199 200 O
IGA NCT03921411 202 205 B-Observation
score NCT03921411 206 211 O
≥ NCT03921411 212 213 B-Eq_Comparison
3 NCT03921411 214 215 I-Eq_Comparison

- NCT03921411 219 220 O
AD NCT03921411 222 224 B-Observation
involvement NCT03921411 225 236 I-Observation
≥ NCT03921411 237 238 B-Eq_Comparison
10 NCT03921411 239 241 I-Eq_Comparison
% NCT03921411 242 243 I-Eq_Comparison
of NCT03921411 244 246 I-Eq_Comparison
Body NCT03921411 247 251 I-Eq_Comparison
Surface NCT03921411 252 259 I-Eq_Comparison
Area NCT03921411 260 264 I-Eq_Comparison
( NCT03921411 265 266 I-Eq_Comparison
BSA NCT03921411 267 270 I-Eq_Comparison
) NCT03921411 271 272 I-Eq_Comparison

- NCT03921411 276 277 O
Documented NCT03921411 279 289 O
recent NCT03921411 290 296 B-Eq_Comparison
history NCT03921411 297 304 B-Eq_Comparison
of NCT03921411 305 307 O
inadequate NCT03921411 308 318 O
response NCT03921411 319 327 O
to NCT03921411 328 330 O
topical NCT03921411 331 338 B-Drug
medications NCT03921411 339 350 I-Drug

- NCT03921411 353 354 O
Women NCT03921411 356 361 O
of NCT03921411 362 364 O
childbearing NCT03921411 365 377 B-Condition
potential NCT03921411 378 387 B-Assertion___Assertion_Type_Value:hypothetical
must NCT03921411 388 392 O
agree NCT03921411 393 398 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921411 399 401 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03921411 402 404 O
strictly NCT03921411 405 413 O
abstinent NCT03921411 414 423 B-Condition
or NCT03921411 424 426 B-Or
to NCT03921411 427 429 O
use NCT03921411 430 433 O
an NCT03921411 434 436 O
effective NCT03921411 437 446 O
and NCT03921411 447 450 O
approved NCT03921411 451 459 O
method NCT03921411 460 466 O
of NCT03921411 467 469 O
contraception NCT03921411 470 483 B-Procedure
throughout NCT03921411 484 494 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03921411 495 498 O
study NCT03921411 499 504 B-Study
and NCT03921411 505 508 B-And
for NCT03921411 509 512 O
12 NCT03921411 513 515 B-Eq_Comparison
weeks NCT03921411 516 521 I-Eq_Comparison
after NCT03921411 522 527 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03921411 528 531 O
last NCT03921411 532 536 B-Eq_Comparison
study NCT03921411 537 542 B-Study
drug NCT03921411 543 547 B-Procedure
injection NCT03921411 548 557 I-Procedure
. NCT03921411 558 559 O

Key NCT03921411 561 564 O
Exclusion NCT03921411 565 574 O
Criteria NCT03921411 575 583 O

- NCT03921411 586 587 O
Body NCT03921411 589 593 B-Observation
weight NCT03921411 594 600 I-Observation
< NCT03921411 601 602 B-Eq_Comparison
30 NCT03921411 603 605 I-Eq_Comparison
kg NCT03921411 606 608 I-Eq_Comparison

- NCT03921411 611 612 O
Cutaneous NCT03921411 614 623 B-Modifier
infection NCT03921411 624 633 B-Condition
within NCT03921411 634 640 B-Eq_Comparison
1 NCT03921411 641 642 I-Eq_Comparison
week NCT03921411 643 647 I-Eq_Comparison
or NCT03921411 648 650 B-Or
any NCT03921411 651 654 O
infection NCT03921411 655 664 B-Condition
requiring NCT03921411 665 674 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03921411 675 684 B-Procedure
with NCT03921411 685 689 O
oral NCT03921411 690 694 B-Modifier
or NCT03921411 695 697 B-Or
parenteral NCT03921411 698 708 B-Modifier
antibiotics NCT03921411 709 720 B-Procedure
, NCT03921411 721 722 O
antivirals NCT03921411 723 733 B-Drug
, NCT03921411 734 735 O
antiparasitics NCT03921411 736 750 B-Drug
, NCT03921411 751 752 O
or NCT03921411 753 755 B-Or
antifungals NCT03921411 756 767 B-Drug
within NCT03921411 768 774 B-Eq_Comparison
1 NCT03921411 775 776 I-Eq_Comparison
week NCT03921411 777 781 I-Eq_Comparison

- NCT03921411 784 785 O
History NCT03921411 787 794 B-Eq_Comparison
of NCT03921411 795 797 O
hypersensitivity NCT03921411 798 814 B-Condition
( NCT03921411 815 816 O
including NCT03921411 817 826 O
anaphylaxis NCT03921411 827 838 B-Condition
) NCT03921411 839 840 O
to NCT03921411 841 843 O
an NCT03921411 844 846 O
immunoglobulin NCT03921411 847 861 B-Drug
product NCT03921411 862 869 I-Drug
( NCT03921411 870 871 O
plasma NCT03921411 872 878 B-Modifier
- NCT03921411 879 880 I-Modifier
derived NCT03921411 881 888 I-Modifier
or NCT03921411 889 891 B-Or
recombinant NCT03921411 892 903 B-Modifier
, NCT03921411 904 905 O
eg NCT03921411 906 908 O
, NCT03921411 909 910 O
monoclonal NCT03921411 911 921 B-Drug
antibody NCT03921411 922 930 I-Drug
) NCT03921411 931 932 O

- NCT03921411 936 937 O
Any NCT03921411 939 942 O
clinically NCT03921411 943 953 O
significant NCT03921411 954 965 O
issue NCT03921411 966 971 B-Condition
, NCT03921411 972 973 O
based NCT03921411 974 979 O
investigator NCT03921411 980 992 O
judgement NCT03921411 993 1002 O

Inclusion NCT03860909 0 9 O
Criteria NCT03860909 10 18 O
: NCT03860909 19 20 O

- NCT03860909 24 25 O
Female NCT03860909 27 33 O
patients NCT03860909 34 42 O
who NCT03860909 43 46 B-And
have NCT03860909 47 51 O
symptoms NCT03860909 52 60 B-Assertion___Assertion_Type_Value:possible
consistent NCT03860909 61 71 O
with NCT03860909 72 76 O
endometriosis NCT03860909 77 90 B-Condition
such NCT03860909 91 95 O
as NCT03860909 96 98 O
pelvic NCT03860909 99 105 B-Modifier
pain NCT03860909 106 110 B-Condition
, NCT03860909 111 112 O
dysmenorrhea NCT03860909 113 125 B-Condition
, NCT03860909 126 127 O
deep NCT03860909 128 132 B-Condition
dyspareunia NCT03860909 133 144 I-Condition
, NCT03860909 145 146 O
and NCT03860909 147 150 B-Or
infertility NCT03860909 151 162 B-Condition

Exclusion NCT03860909 163 172 O
Criteria NCT03860909 173 181 O
: NCT03860909 182 183 O

- NCT03860909 187 188 O
The NCT03860909 190 193 O
common NCT03860909 194 200 O
contraindication NCT03860909 201 217 B-Contraindication
to NCT03860909 218 220 O
MRI NCT03860909 221 224 B-Procedure
, NCT03860909 225 226 O
peacemaker NCT03860909 227 237 B-Procedure
, NCT03860909 238 239 O
metallic NCT03860909 240 248 B-Condition
foreign NCT03860909 249 256 I-Condition
bodies NCT03860909 257 263 I-Condition
, NCT03860909 264 265 O
and NCT03860909 266 269 B-Or
claustrophobia NCT03860909 270 284 B-Condition

Inclusion NCT03924453 0 9 O
Criteria NCT03924453 10 18 O
: NCT03924453 19 20 O

1 NCT03924453 24 25 O
. NCT03924453 25 26 O
Female NCT03924453 28 34 O
( NCT03924453 35 36 O
mandatory NCT03924453 37 46 O
) NCT03924453 47 48 O

2 NCT03924453 52 53 O
. NCT03924453 53 54 O
Not NCT03924453 56 59 B-Negation
currently NCT03924453 60 69 B-Eq_Comparison
pregnant NCT03924453 70 78 B-Condition
or NCT03924453 79 81 B-Or
nursing NCT03924453 82 89 B-Condition
( NCT03924453 90 91 O
mandatory NCT03924453 92 101 O
) NCT03924453 102 103 O

3 NCT03924453 107 108 O
. NCT03924453 108 109 O
Aged NCT03924453 111 115 B-Age
21 NCT03924453 116 118 B-Eq_Comparison
- NCT03924453 119 120 I-Eq_Comparison
45 NCT03924453 121 123 I-Eq_Comparison
( NCT03924453 124 125 O
advanced NCT03924453 126 134 O
age NCT03924453 135 138 O
can NCT03924453 139 142 O
hinder NCT03924453 143 149 O
hormone NCT03924453 150 157 O
levels NCT03924453 158 164 O
) NCT03924453 165 166 O

4 NCT03924453 170 171 O
. NCT03924453 171 172 O
Not NCT03924453 174 177 B-Negation
be NCT03924453 178 180 O
diagnosed NCT03924453 181 190 O
as NCT03924453 191 193 O
sub NCT03924453 194 197 B-Condition
fertile NCT03924453 198 205 I-Condition
( NCT03924453 206 207 O
infertility NCT03924453 208 219 O
causes NCT03924453 220 226 O
inconsistent NCT03924453 227 239 O
hormone NCT03924453 240 247 O
levels NCT03924453 248 254 O
) NCT03924453 255 256 O

5 NCT03924453 260 261 O
. NCT03924453 261 262 O
Not NCT03924453 264 267 B-Negation
have NCT03924453 268 272 O
used NCT03924453 273 277 O
any NCT03924453 278 281 O
form NCT03924453 282 286 O
of NCT03924453 287 289 O
hormonal NCT03924453 290 298 B-Procedure
birth NCT03924453 299 304 I-Procedure
control NCT03924453 305 312 I-Procedure
in NCT03924453 313 315 O
the NCT03924453 316 319 B-Eq_Comparison
past NCT03924453 320 324 I-Eq_Comparison
2 NCT03924453 325 326 I-Eq_Comparison
months NCT03924453 327 333 I-Eq_Comparison
( NCT03924453 334 335 O
mandatory NCT03924453 336 345 O
) NCT03924453 346 347 O

6 NCT03924453 351 352 O
. NCT03924453 352 353 O
Currently NCT03924453 355 364 B-Eq_Comparison
trying NCT03924453 365 371 B-Assertion___Assertion_Type_Value:intention
to NCT03924453 372 374 I-Assertion___Assertion_Type_Value:intention
conceive NCT03924453 375 383 B-Condition
( NCT03924453 384 385 O
ideal NCT03924453 386 391 O
but NCT03924453 392 395 O
not NCT03924453 396 399 O
required NCT03924453 400 408 O
) NCT03924453 409 410 O

7 NCT03924453 414 415 O
. NCT03924453 415 416 O
Currently NCT03924453 418 427 B-Eq_Comparison
reside NCT03924453 428 434 O
in NCT03924453 435 437 O
the NCT03924453 438 441 O
US NCT03924453 442 444 O
( NCT03924453 445 446 O
mandatory NCT03924453 447 456 O
, NCT03924453 457 458 O
this NCT03924453 459 463 O
study NCT03924453 464 469 O
is NCT03924453 470 472 O
for NCT03924453 473 476 O
US NCT03924453 477 479 O
residents NCT03924453 480 489 O
only NCT03924453 490 494 O
) NCT03924453 495 496 O

Exclusion NCT03924453 498 507 O
Criteria NCT03924453 508 516 O
: NCT03924453 517 518 O

1 NCT03924453 522 523 O
. NCT03924453 523 524 O
Male NCT03924453 526 530 O

2 NCT03924453 533 534 O
. NCT03924453 534 535 O
Pregnant NCT03924453 537 545 B-Condition

3 NCT03924453 548 549 O
. NCT03924453 549 550 O
Nursing NCT03924453 552 559 B-Condition

Inclusion NCT03862755 0 9 O
Criteria NCT03862755 10 18 O
: NCT03862755 19 20 O

- NCT03862755 24 25 O
Lung NCT03862755 27 31 B-Procedure
surgical NCT03862755 32 40 I-Procedure
patients NCT03862755 41 49 O
who NCT03862755 50 53 B-And
were NCT03862755 54 58 O
sent NCT03862755 59 63 B-Encounter
to NCT03862755 64 66 O
thoracic NCT03862755 67 75 B-Modifier
post NCT03862755 76 80 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03862755 81 90 B-Procedure
intensive NCT03862755 91 100 O
care NCT03862755 101 105 O
unit NCT03862755 106 110 O
( NCT03862755 111 112 O
ICU NCT03862755 113 116 O
) NCT03862755 117 118 O
ward NCT03862755 119 123 O
right NCT03862755 124 129 O
after NCT03862755 130 135 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03862755 136 143 B-Procedure
and NCT03862755 144 147 B-And
stayed NCT03862755 148 154 B-Encounter
in NCT03862755 155 157 O
ICU NCT03862755 158 161 O
for NCT03862755 162 165 O
at NCT03862755 166 168 B-Eq_Comparison
least NCT03862755 169 174 I-Eq_Comparison
24 NCT03862755 175 177 I-Eq_Comparison
hours NCT03862755 178 183 I-Eq_Comparison
. NCT03862755 184 185 O

Exclusion NCT03862755 187 196 O
Criteria NCT03862755 197 205 O
: NCT03862755 206 207 O

- NCT03862755 211 212 O
Cases NCT03862755 214 219 O
received NCT03862755 220 228 B-Eq_Comparison
inferior NCT03862755 229 237 B-Procedure
vena NCT03862755 238 242 I-Procedure
filter NCT03862755 243 249 I-Procedure
and NCT03862755 250 253 B-Or
anti NCT03862755 254 258 B-Procedure
- NCT03862755 259 260 I-Procedure
coagulation NCT03862755 261 272 I-Procedure
treatment NCT03862755 273 282 I-Procedure
history NCT03862755 283 290 B-Eq_Comparison
. NCT03862755 291 292 O

Inclusion NCT03920514 0 9 O
Criteria NCT03920514 10 18 O
: NCT03920514 19 20 O

- NCT03920514 24 25 O
Mild NCT03920514 27 31 O
male NCT03920514 32 36 B-Condition
infertility NCT03920514 37 48 I-Condition
or NCT03920514 49 51 B-Or
unexplained NCT03920514 52 63 B-Modifier
infertility NCT03920514 64 75 B-Condition

Exclusion NCT03920514 76 85 O
Criteria NCT03920514 86 94 O
: NCT03920514 95 96 O

- NCT03920514 100 101 O
Adanced NCT03920514 103 110 O
male NCT03920514 111 115 B-Modifier
factor NCT03920514 116 122 I-Modifier
endometriosis NCT03920514 123 136 B-Condition
uterine NCT03920514 137 144 B-Condition
abnormality NCT03920514 145 156 I-Condition
sever NCT03920514 157 162 O
semen NCT03920514 163 168 B-Condition
parameters NCT03920514 169 179 I-Condition
i NCT03920514 180 181 O
impairment NCT03920514 182 192 O
according NCT03920514 193 202 O
to NCT03920514 203 205 O
WHO NCT03920514 206 209 O
2010 NCT03920514 210 214 O
non NCT03920514 215 218 B-Condition
ovulatory NCT03920514 219 228 I-Condition
cycles NCT03920514 229 235 I-Condition
bilatral NCT03920514 236 244 B-Modifier
tubal NCT03920514 245 250 B-Condition
block NCT03920514 251 256 I-Condition

Inclusion NCT03865277 0 9 O
Criteria NCT03865277 10 18 O
: NCT03865277 19 20 O

- NCT03865277 24 25 O
Age NCT03865277 27 30 B-Age
: NCT03865277 31 32 O
older NCT03865277 33 38 B-Eq_Comparison
than NCT03865277 39 43 I-Eq_Comparison
18 NCT03865277 44 46 I-Eq_Comparison
years NCT03865277 47 52 I-Eq_Comparison

- NCT03865277 55 56 O
WHO NCT03865277 58 61 O
( NCT03865277 62 63 O
ECOG NCT03865277 64 68 B-Observation
) NCT03865277 69 70 O
performance NCT03865277 71 82 O
status NCT03865277 83 89 O
0 NCT03865277 90 91 B-Eq_Comparison
- NCT03865277 92 93 I-Eq_Comparison
2 NCT03865277 94 95 I-Eq_Comparison

- NCT03865277 99 100 O
Histological NCT03865277 102 114 O
proven NCT03865277 115 121 O
HNSCC NCT03865277 122 127 B-Condition

- NCT03865277 130 131 O
HPV NCT03865277 133 136 B-Condition
negative NCT03865277 137 145 O
tumors NCT03865277 146 152 B-Modifier
or NCT03865277 153 155 B-Or
HPV NCT03865277 156 159 B-Condition
positive NCT03865277 160 168 O
tumors NCT03865277 169 175 B-Modifier

- NCT03865277 178 179 O
Stage NCT03865277 181 186 B-Eq_Comparison
III NCT03865277 187 190 I-Eq_Comparison
, NCT03865277 191 192 O
IVA NCT03865277 193 196 B-Modifier
or NCT03865277 197 199 B-Or
IVB NCT03865277 200 203 B-Modifier
HNSCC NCT03865277 204 209 B-Condition
according NCT03865277 210 219 O
to NCT03865277 220 222 O
UICC NCT03865277 223 227 O
and NCT03865277 228 231 O
AJCC NCT03865277 232 236 O
guidelines NCT03865277 237 247 O

- NCT03865277 250 251 O
Tumor NCT03865277 253 258 B-Condition
classified NCT03865277 259 269 O
as NCT03865277 270 272 O
irresectable NCT03865277 273 285 B-Modifier
or NCT03865277 286 288 B-Or
patient NCT03865277 289 296 O
inoperable NCT03865277 297 307 B-Modifier
or NCT03865277 308 310 B-Or
patient NCT03865277 311 318 O
refused NCT03865277 319 326 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
surgery NCT03865277 327 334 B-Procedure

- NCT03865277 337 338 O
Tumor NCT03865277 340 345 B-Condition
extension NCT03865277 346 355 B-Modifier
and NCT03865277 356 359 B-And
localization NCT03865277 360 372 B-Modifier
suitable NCT03865277 373 381 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865277 382 385 I-Assertion___Assertion_Type_Value:hypothetical
radiochemotherapy NCT03865277 386 403 B-Procedure
with NCT03865277 404 408 O
curative NCT03865277 409 417 O
intent NCT03865277 418 424 O

- NCT03865277 427 428 O
Simultaneous NCT03865277 430 442 B-Modifier
standard NCT03865277 443 451 I-Modifier
chemotherapy NCT03865277 452 464 B-Procedure
with NCT03865277 465 469 O
cisplatin NCT03865277 470 479 B-Drug
applicable NCT03865277 480 490 B-Assertion___Assertion_Type_Value:hypothetical
( NCT03865277 491 492 O
no NCT03865277 493 495 B-Negation
contra NCT03865277 496 502 B-Contraindication
- NCT03865277 503 504 I-Contraindication
indications NCT03865277 505 516 I-Contraindication
) NCT03865277 517 518 O

- NCT03865277 522 523 O
Dental NCT03865277 525 531 B-Procedure
examination NCT03865277 532 543 B-Modifier
and NCT03865277 544 547 B-And
- NCT03865277 548 549 O
treatment NCT03865277 550 559 B-Modifier
before NCT03865277 560 566 B-Temporal_Connection___Temporal_Connection_Type_Value:before
start NCT03865277 567 572 B-Eq_Comparison
of NCT03865277 573 575 O
therapy NCT03865277 576 583 B-Procedure

- NCT03865277 586 587 O
For NCT03865277 589 592 O
women NCT03865277 593 598 O
with NCT03865277 599 603 B-And
childbearing NCT03865277 604 616 B-Condition
potential NCT03865277 617 626 I-Condition
and NCT03865277 627 630 B-Or
men NCT03865277 631 634 O
in NCT03865277 635 637 B-And
reproductive NCT03865277 638 650 B-Condition
ages NCT03865277 651 655 I-Condition
adequate NCT03865277 656 664 O
contraception NCT03865277 665 678 B-Procedure
. NCT03865277 679 680 O

- NCT03865277 684 685 O
Ability NCT03865277 687 694 O
of NCT03865277 695 697 O
subject NCT03865277 698 705 O
to NCT03865277 706 708 O
understand NCT03865277 709 719 O
character NCT03865277 720 729 O
and NCT03865277 730 733 O
individual NCT03865277 734 744 O
consequences NCT03865277 745 757 O
of NCT03865277 758 760 O
the NCT03865277 761 764 O
clinical NCT03865277 765 773 O
trial NCT03865277 774 779 O

- NCT03865277 782 783 O
Written NCT03865277 785 792 O
informed NCT03865277 793 801 O
consent NCT03865277 802 809 O
( NCT03865277 810 811 O
must NCT03865277 812 816 O
be NCT03865277 817 819 O
available NCT03865277 820 829 O
before NCT03865277 830 836 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03865277 837 846 O
in NCT03865277 847 849 O
the NCT03865277 850 853 O
trial NCT03865277 854 859 B-Study
) NCT03865277 860 861 O

Exclusion NCT03865277 863 872 O
Criteria NCT03865277 873 881 O
: NCT03865277 882 883 O

- NCT03865277 887 888 O
Refusal NCT03865277 890 897 O
of NCT03865277 898 900 O
the NCT03865277 901 904 O
patients NCT03865277 905 913 O
to NCT03865277 914 916 O
take NCT03865277 917 921 O
part NCT03865277 922 926 O
in NCT03865277 927 929 O
the NCT03865277 930 933 O
trial NCT03865277 934 939 O

- NCT03865277 942 943 O
Presence NCT03865277 945 953 B-Eq_Comparison
of NCT03865277 954 956 O
distant NCT03865277 957 964 B-Modifier
metastases NCT03865277 965 975 B-Condition
( NCT03865277 976 977 O
UICC NCT03865277 978 982 B-Condition
stage NCT03865277 983 988 B-Eq_Comparison
IVC NCT03865277 989 992 I-Eq_Comparison
) NCT03865277 993 994 O

- NCT03865277 998 999 O
Previous NCT03865277 1001 1009 B-Eq_Comparison
radiotherapy NCT03865277 1010 1022 B-Procedure
in NCT03865277 1023 1025 O
the NCT03865277 1026 1029 O
head NCT03865277 1030 1034 B-Modifier
and NCT03865277 1035 1038 B-Or
neck NCT03865277 1039 1043 B-Modifier
region NCT03865277 1044 1050 O

- NCT03865277 1053 1054 O
Second NCT03865277 1056 1062 B-Eq_Comparison
malignancy NCT03865277 1063 1073 B-Condition
that NCT03865277 1074 1078 O
is NCT03865277 1079 1081 O
likely NCT03865277 1082 1088 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865277 1089 1091 I-Assertion___Assertion_Type_Value:hypothetical
require NCT03865277 1092 1099 O
treatment NCT03865277 1100 1109 B-Procedure
during NCT03865277 1110 1116 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865277 1117 1120 O
trial NCT03865277 1121 1126 B-Study
intervention NCT03865277 1127 1139 I-Study
or NCT03865277 1140 1142 B-Or
follow NCT03865277 1143 1149 B-Encounter
- NCT03865277 1150 1151 I-Encounter
up NCT03865277 1152 1154 I-Encounter
period NCT03865277 1155 1161 O
or NCT03865277 1162 1164 O
that NCT03865277 1165 1169 O
, NCT03865277 1170 1171 O
in NCT03865277 1172 1174 O
the NCT03865277 1175 1178 O
opinion NCT03865277 1179 1186 O
of NCT03865277 1187 1189 O
the NCT03865277 1190 1193 O
physician NCT03865277 1194 1203 O
, NCT03865277 1204 1205 O
has NCT03865277 1206 1209 O
a NCT03865277 1210 1211 O
considerable NCT03865277 1212 1224 O
risk NCT03865277 1225 1229 B-Risk
of NCT03865277 1230 1232 O
recurrence NCT03865277 1233 1243 B-Modifier
or NCT03865277 1244 1246 B-Or
metastases NCT03865277 1247 1257 B-Condition
within NCT03865277 1258 1264 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865277 1265 1268 O
follow NCT03865277 1269 1275 B-Encounter
- NCT03865277 1276 1277 I-Encounter
up NCT03865277 1278 1280 I-Encounter
period NCT03865277 1281 1287 O

- NCT03865277 1290 1291 O
Serious NCT03865277 1293 1300 O
disease NCT03865277 1301 1308 B-Condition
or NCT03865277 1309 1311 B-Or
medical NCT03865277 1312 1319 B-Condition
condition NCT03865277 1320 1329 I-Condition
with NCT03865277 1330 1334 B-And
life NCT03865277 1335 1339 B-Observation
expectancy NCT03865277 1340 1350 I-Observation
of NCT03865277 1351 1353 O
less NCT03865277 1354 1358 B-Eq_Comparison
than NCT03865277 1359 1363 I-Eq_Comparison
one NCT03865277 1364 1367 I-Eq_Comparison
year NCT03865277 1368 1372 I-Eq_Comparison

- NCT03865277 1375 1376 O
Participation NCT03865277 1378 1391 O
in NCT03865277 1392 1394 O
competing NCT03865277 1395 1404 B-Other
interventional NCT03865277 1405 1419 B-Study
trial NCT03865277 1420 1425 I-Study
on NCT03865277 1426 1428 O
cancer NCT03865277 1429 1435 B-Condition
treatment NCT03865277 1436 1445 B-Procedure

- NCT03865277 1448 1449 O
Patients NCT03865277 1451 1459 O
who NCT03865277 1460 1463 O
are NCT03865277 1464 1467 O
not NCT03865277 1468 1471 B-Contraindication
suitable NCT03865277 1472 1480 I-Contraindication
for NCT03865277 1481 1484 O
radiochemotherapy NCT03865277 1485 1502 B-Procedure

- NCT03865277 1505 1506 O
Pregnant NCT03865277 1508 1516 B-Condition
or NCT03865277 1517 1519 B-Or
lactating NCT03865277 1520 1529 B-Condition
women NCT03865277 1530 1535 O

- NCT03865277 1538 1539 O
Patients NCT03865277 1541 1549 O
not NCT03865277 1550 1553 B-Negation
able NCT03865277 1554 1558 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865277 1559 1561 I-Assertion___Assertion_Type_Value:hypothetical
understand NCT03865277 1562 1572 O
the NCT03865277 1573 1576 O
character NCT03865277 1577 1586 O
and NCT03865277 1587 1590 O
individual NCT03865277 1591 1601 O
consequences NCT03865277 1602 1614 B-Risk
of NCT03865277 1615 1617 O
the NCT03865277 1618 1621 O
trial NCT03865277 1622 1627 B-Study

- NCT03865277 1630 1631 O
Nasopharyngeal NCT03865277 1633 1647 B-Condition
Carcinomas NCT03865277 1648 1658 I-Condition

Inclusion NCT03927274 0 9 O
Criteria NCT03927274 10 18 O
: NCT03927274 19 20 O

- NCT03927274 24 25 O
Histologically NCT03927274 27 41 B-Procedure
confirmed NCT03927274 42 51 O
diagnosis NCT03927274 52 61 O
of NCT03927274 62 64 O
supratentorial NCT03927274 65 79 B-Modifier
WHO NCT03927274 80 83 O
Grade NCT03927274 84 89 B-Eq_Comparison
III NCT03927274 90 93 I-Eq_Comparison
or NCT03927274 94 96 I-Eq_Comparison
IV NCT03927274 97 99 I-Eq_Comparison
Glioma NCT03927274 100 106 B-Condition
( NCT03927274 107 108 O
High NCT03927274 109 113 B-Modifier
Grade NCT03927274 114 119 I-Modifier
Glioma NCT03927274 120 126 B-Condition
) NCT03927274 127 128 O
that NCT03927274 129 133 O
has NCT03927274 134 137 B-And
undergone NCT03927274 138 147 B-Eq_Comparison
surgical NCT03927274 148 156 B-Procedure
biopsy NCT03927274 157 163 I-Procedure
or NCT03927274 164 166 B-Or
resection NCT03927274 167 176 B-Procedure
followed NCT03927274 177 185 B-Temporal_Connection___Temporal_Connection_Type_Value:before
by NCT03927274 186 188 I-Temporal_Connection___Temporal_Connection_Type_Value:before
adjuvant NCT03927274 189 197 B-Procedure
chemoradiotherapy NCT03927274 198 215 I-Procedure
, NCT03927274 216 217 O
that NCT03927274 218 222 O
has NCT03927274 223 226 B-And
evidence NCT03927274 227 235 O
of NCT03927274 236 238 O
recurrence NCT03927274 239 249 O
or NCT03927274 250 252 B-Or
progression NCT03927274 253 264 O
based NCT03927274 265 270 O
on NCT03927274 271 273 O
imaging NCT03927274 274 281 B-Procedure
studies NCT03927274 282 289 O
and NCT03927274 290 293 B-And
a NCT03927274 294 295 O
stereotactic NCT03927274 296 308 B-Modifier
biopsy NCT03927274 309 315 B-Procedure
is NCT03927274 316 318 O
indicated NCT03927274 319 328 B-Indication
for NCT03927274 329 332 O
confirmation NCT03927274 333 345 O
of NCT03927274 346 348 O
recurrence NCT03927274 349 359 O
/ NCT03927274 360 361 B-Or
progression NCT03927274 362 373 O
. NCT03927274 374 375 O

- NCT03927274 379 380 O
18 NCT03927274 382 384 B-Eq_Comparison
years NCT03927274 385 390 I-Eq_Comparison
of NCT03927274 391 393 I-Eq_Comparison
age NCT03927274 394 397 I-Eq_Comparison
or NCT03927274 398 400 I-Eq_Comparison
older NCT03927274 401 406 I-Eq_Comparison

- NCT03927274 409 410 O
Karnofsky NCT03927274 412 421 B-Observation
Performance NCT03927274 422 433 I-Observation
Status NCT03927274 434 440 I-Observation
70 NCT03927274 441 443 B-Eq_Comparison
- NCT03927274 444 445 I-Eq_Comparison
100 NCT03927274 446 449 I-Eq_Comparison
; NCT03927274 450 451 O

- NCT03927274 454 455 O
MRI NCT03927274 457 460 B-Procedure
demonstration NCT03927274 461 474 O
of NCT03927274 475 477 O
a NCT03927274 478 479 O
stereotactically NCT03927274 480 496 B-Modifier
accessible NCT03927274 497 507 I-Modifier
enhancing NCT03927274 508 517 I-Modifier
or NCT03927274 518 520 B-Or
predominantly NCT03927274 521 534 B-Modifier
non NCT03927274 535 538 I-Modifier
- NCT03927274 539 540 I-Modifier
enhancing NCT03927274 541 550 I-Modifier
mass NCT03927274 551 555 B-Condition
that NCT03927274 556 560 B-And
does NCT03927274 561 565 O
not NCT03927274 566 569 B-Negation
require NCT03927274 570 577 B-Assertion___Assertion_Type_Value:hypothetical
resection NCT03927274 578 587 B-Procedure
to NCT03927274 588 590 O
relieve NCT03927274 591 598 O
clinically NCT03927274 599 609 O
significant NCT03927274 610 621 O
mass NCT03927274 622 626 B-Condition
effect NCT03927274 627 633 I-Condition
; NCT03927274 633 634 O

- NCT03927274 637 638 O
Participant NCT03927274 640 651 O
understands NCT03927274 652 663 O
the NCT03927274 664 667 O
procedures NCT03927274 668 678 O
and NCT03927274 679 682 O
agrees NCT03927274 683 689 O
to NCT03927274 690 692 O
comply NCT03927274 693 699 O
with NCT03927274 700 704 O
the NCT03927274 705 708 O
study NCT03927274 709 714 O
requirements NCT03927274 715 727 O
by NCT03927274 728 730 O
providing NCT03927274 731 740 O
written NCT03927274 741 748 O
informed NCT03927274 749 757 O
consent NCT03927274 758 765 O

- NCT03927274 768 769 O
Adequate NCT03927274 771 779 O
organ NCT03927274 780 785 B-Condition
function NCT03927274 786 794 I-Condition
as NCT03927274 795 797 O
indicated NCT03927274 798 807 O
in NCT03927274 808 810 O
protocol NCT03927274 811 819 O

Exclusion NCT03927274 820 829 O
Criteria NCT03927274 830 838 O
: NCT03927274 839 840 O

- NCT03927274 844 845 O
Participant NCT03927274 847 858 O
is NCT03927274 859 861 O
mentally NCT03927274 862 870 B-Modifier
or NCT03927274 871 873 B-Or
legally NCT03927274 874 881 B-Modifier
incapacitated NCT03927274 882 895 B-Condition
at NCT03927274 896 898 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03927274 899 902 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03927274 903 907 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03927274 908 910 O
the NCT03927274 911 914 O
study NCT03927274 915 920 B-Study
; NCT03927274 920 921 O

- NCT03927274 924 925 O
Known NCT03927274 927 932 O
HIV NCT03927274 933 936 B-Condition
( NCT03927274 937 938 O
+ NCT03927274 939 940 O
) NCT03927274 941 942 O
or NCT03927274 943 945 B-Or
has NCT03927274 946 949 O
been NCT03927274 950 954 O
diagnosed NCT03927274 955 964 O
with NCT03927274 965 969 O
AIDS NCT03927274 970 974 B-Condition

- NCT03927274 977 978 O
Participation NCT03927274 980 993 O
in NCT03927274 994 996 O
another NCT03927274 997 1004 B-Other
investigational NCT03927274 1005 1020 O
drug NCT03927274 1021 1025 B-Drug
study NCT03927274 1026 1031 B-Study
in NCT03927274 1032 1034 O
the NCT03927274 1035 1038 O
prior NCT03927274 1039 1044 B-Eq_Comparison
4 NCT03927274 1045 1046 I-Eq_Comparison
weeks NCT03927274 1047 1052 I-Eq_Comparison

- NCT03927274 1055 1056 O
Positive NCT03927274 1058 1066 O
pregnancy NCT03927274 1067 1076 B-Observation
test NCT03927274 1077 1081 I-Observation
in NCT03927274 1082 1084 O
a NCT03927274 1085 1086 O
female NCT03927274 1087 1093 O

- NCT03927274 1096 1097 O
Patient NCT03927274 1099 1106 O
, NCT03927274 1107 1108 O
in NCT03927274 1109 1111 O
the NCT03927274 1112 1115 O
opinion NCT03927274 1116 1123 O
of NCT03927274 1124 1126 O
the NCT03927274 1127 1130 O
investigator NCT03927274 1131 1143 O
, NCT03927274 1144 1145 O
is NCT03927274 1146 1148 O
likely NCT03927274 1149 1155 O
to NCT03927274 1156 1158 O
be NCT03927274 1159 1161 O
poorly NCT03927274 1162 1168 O
compliant NCT03927274 1169 1178 O
. NCT03927274 1179 1180 O

- NCT03927274 1184 1185 O
Diffuse NCT03927274 1187 1194 B-Condition
subependymal NCT03927274 1195 1207 I-Condition
or NCT03927274 1208 1210 B-Or
Cerebral NCT03927274 1211 1219 B-Modifier
Spinal NCT03927274 1220 1226 I-Modifier
Fluid NCT03927274 1227 1232 I-Modifier
( NCT03927274 1233 1234 O
CSF NCT03927274 1235 1238 B-Condition
) NCT03927274 1239 1240 O
disease NCT03927274 1241 1248 B-Condition

- NCT03927274 1251 1252 O
Tumors NCT03927274 1254 1260 B-Condition
involving NCT03927274 1261 1270 O
the NCT03927274 1271 1274 O
cerebellum NCT03927274 1275 1285 B-Modifier

- NCT03927274 1288 1289 O
Tumor NCT03927274 1291 1296 B-Condition
enhancement NCT03927274 1297 1308 B-Modifier
involving NCT03927274 1309 1318 I-Modifier
both NCT03927274 1319 1323 I-Modifier
hemispheres NCT03927274 1324 1335 I-Modifier

- NCT03927274 1338 1339 O
Active NCT03927274 1341 1347 B-Eq_Comparison
infection NCT03927274 1348 1357 B-Condition
requiring NCT03927274 1358 1367 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03927274 1368 1377 B-Procedure

- NCT03927274 1380 1381 O
Unexplained NCT03927274 1383 1394 B-Modifier
febrile NCT03927274 1395 1402 B-Condition
illness NCT03927274 1403 1410 I-Condition

- NCT03927274 1413 1414 O
Radiation NCT03927274 1416 1425 B-Procedure
or NCT03927274 1426 1428 B-Or
chemotherapy NCT03927274 1429 1441 B-Procedure
within NCT03927274 1442 1448 B-Eq_Comparison
4 NCT03927274 1449 1450 I-Eq_Comparison
weeks NCT03927274 1451 1456 I-Eq_Comparison
of NCT03927274 1457 1459 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03927274 1460 1470 B-Study

- NCT03927274 1473 1474 O
Systemic NCT03927274 1476 1484 B-Modifier
diseases NCT03927274 1485 1493 B-Condition
associated NCT03927274 1494 1504 O
with NCT03927274 1505 1509 O
unacceptable NCT03927274 1510 1522 O
anesthesia NCT03927274 1523 1533 B-Procedure
or NCT03927274 1534 1536 B-Or
operative NCT03927274 1537 1546 B-Procedure
risk NCT03927274 1547 1551 B-Risk

- NCT03927274 1554 1555 O
Inability NCT03927274 1557 1566 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03927274 1567 1569 O
undergo NCT03927274 1570 1577 O
magnetic NCT03927274 1578 1586 B-Procedure
resonance NCT03927274 1587 1596 I-Procedure
imaging NCT03927274 1597 1604 I-Procedure
( NCT03927274 1605 1606 O
MRI NCT03927274 1607 1610 B-Procedure
) NCT03927274 1611 1612 O

Inclusion NCT03866122 0 9 O
Criteria NCT03866122 10 18 O
: NCT03866122 19 20 O

- NCT03866122 24 25 O
The NCT03866122 27 30 O
subject NCT03866122 31 38 O
is NCT03866122 39 41 O
currently NCT03866122 42 51 B-Eq_Comparison
being NCT03866122 52 57 O
treated NCT03866122 58 65 B-Procedure
at NCT03866122 66 68 O
QECH NCT03866122 69 73 O
in NCT03866122 74 76 O
the NCT03866122 77 80 O
neonatal NCT03866122 81 89 B-Modifier
or NCT03866122 90 92 B-Or
KMC NCT03866122 93 96 B-Modifier
ward NCT03866122 97 101 O
. NCT03866122 102 103 O

- NCT03866122 107 108 O
Study NCT03866122 110 115 O
devices NCT03866122 116 123 O
are NCT03866122 124 127 O
available NCT03866122 128 137 O
for NCT03866122 138 141 O
use NCT03866122 142 145 O
. NCT03866122 146 147 O

- NCT03866122 151 152 O
The NCT03866122 154 157 O
subject NCT03866122 158 165 O
's NCT03866122 165 167 O
caregiver NCT03866122 168 177 B-Family_Member___Family_Member_Type:parent
has NCT03866122 178 181 O
provided NCT03866122 182 190 O
informed NCT03866122 191 199 O
consent NCT03866122 200 207 O
for NCT03866122 208 211 O
their NCT03866122 212 217 O
child NCT03866122 218 223 O
to NCT03866122 224 226 O
participate NCT03866122 227 238 O
. NCT03866122 239 240 O

Exclusion NCT03866122 242 251 O
Criteria NCT03866122 252 260 O
: NCT03866122 261 262 O

- NCT03866122 266 267 O
At NCT03866122 269 271 O
the NCT03866122 272 275 O
clinician NCT03866122 276 285 O
's NCT03866122 285 287 O
discretion NCT03866122 288 298 O
for NCT03866122 299 302 O
any NCT03866122 303 306 O
reason NCT03866122 307 313 O
including NCT03866122 314 323 O
, NCT03866122 324 325 O
but NCT03866122 326 329 O
not NCT03866122 330 333 O
limited NCT03866122 334 341 O
to NCT03866122 342 344 O
: NCT03866122 345 346 O

- NCT03866122 350 351 O
potential NCT03866122 353 362 B-Risk
for NCT03866122 363 366 O
skin NCT03866122 367 371 B-Modifier
irritation NCT03866122 372 382 B-Condition

- NCT03866122 385 386 O
Cough NCT03866122 388 393 B-Condition

- NCT03866122 396 397 O
other NCT03866122 399 404 B-Other
condition NCT03866122 405 414 B-Condition
that NCT03866122 415 419 O
may NCT03866122 420 423 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03866122 424 432 B-Negation
use NCT03866122 433 436 O
of NCT03866122 437 439 O
the NCT03866122 440 443 O
temperature NCT03866122 444 455 B-Procedure
belt NCT03866122 456 460 I-Procedure

- NCT03866122 463 464 O
concurrent NCT03866122 466 476 B-Modifier
treatments NCT03866122 477 487 B-Procedure
that NCT03866122 488 492 O
may NCT03866122 493 496 B-Assertion___Assertion_Type_Value:hypothetical
require NCT03866122 497 504 O
increased NCT03866122 505 514 O
patient NCT03866122 515 522 B-Procedure
care NCT03866122 523 527 I-Procedure

Inclusion NCT03861286 0 9 O
Criteria NCT03861286 10 18 O
: NCT03861286 19 20 O

1 NCT03861286 24 25 O
. NCT03861286 25 26 O
Patients NCT03861286 28 36 O
undergoing NCT03861286 37 47 B-Eq_Comparison
first NCT03861286 48 53 B-Eq_Comparison
time NCT03861286 54 58 I-Eq_Comparison
cardiopulmonary NCT03861286 59 74 B-Procedure
bypass NCT03861286 75 81 I-Procedure
surgery NCT03861286 82 89 I-Procedure
for NCT03861286 90 93 O
correction NCT03861286 94 104 O
of NCT03861286 105 107 O
atrial NCT03861286 108 114 B-Condition
septal NCT03861286 115 121 I-Condition
defects NCT03861286 122 129 I-Condition
or NCT03861286 130 132 B-Or
tissue NCT03861286 133 139 B-Procedure
mitral NCT03861286 140 146 I-Procedure
valve NCT03861286 147 152 I-Procedure
repair NCT03861286 153 159 I-Procedure

2 NCT03861286 162 163 O
. NCT03861286 163 164 O
Receiving NCT03861286 166 175 B-Eq_Comparison
intravenous NCT03861286 176 187 B-Modifier
Heparin NCT03861286 188 195 B-Drug
for NCT03861286 196 199 O
cardiopulmonary NCT03861286 200 215 B-Procedure
bypass NCT03861286 216 222 I-Procedure

Exclusion NCT03861286 223 232 O
Criteria NCT03861286 233 241 O
: NCT03861286 242 243 O

- NCT03861286 247 248 O
Concomitant NCT03861286 250 261 B-Modifier
Aortic NCT03861286 262 268 B-Condition
Stenosis NCT03861286 269 277 I-Condition
which NCT03861286 278 283 O
is NCT03861286 284 286 O
associated NCT03861286 287 297 O
with NCT03861286 298 302 O
an NCT03861286 303 305 O
acquired NCT03861286 306 314 B-Condition
von NCT03861286 315 318 I-Condition
Willebrand NCT03861286 319 329 I-Condition
Syndrome NCT03861286 330 338 I-Condition
( NCT03861286 339 340 O
aVWS NCT03861286 341 345 B-Condition
) NCT03861286 346 347 O

- NCT03861286 351 352 O
Patients NCT03861286 354 362 O
with NCT03861286 363 367 O
a NCT03861286 368 369 O
baseline NCT03861286 370 378 O
platelet NCT03861286 379 387 B-Observation
count NCT03861286 388 393 I-Observation
of NCT03861286 394 396 O
< NCT03861286 397 398 B-Eq_Comparison
100 NCT03861286 399 402 I-Eq_Comparison
x NCT03861286 403 404 I-Eq_Comparison
109 NCT03861286 405 408 I-Eq_Comparison
/ NCT03861286 409 410 I-Eq_Comparison
L NCT03861286 411 412 I-Eq_Comparison

- NCT03861286 415 416 O
Patients NCT03861286 418 426 O
with NCT03861286 427 431 O
a NCT03861286 432 433 O
known NCT03861286 434 439 O
coagulation NCT03861286 440 451 B-Condition
factor NCT03861286 452 458 I-Condition
deficiency NCT03861286 459 469 I-Condition
or NCT03861286 470 472 B-Or
platelet NCT03861286 473 481 B-Condition
function NCT03861286 482 490 I-Condition
disorder NCT03861286 491 499 I-Condition

- NCT03861286 502 503 O
Patients NCT03861286 505 513 O
receiving NCT03861286 514 523 B-Eq_Comparison
heparin NCT03861286 524 531 B-Procedure
therapy NCT03861286 532 539 I-Procedure
prior NCT03861286 540 545 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03861286 546 548 I-Temporal_Connection___Temporal_Connection_Type_Value:before
CPB NCT03861286 549 552 B-Procedure
within NCT03861286 553 559 B-Eq_Comparison
last NCT03861286 560 564 I-Eq_Comparison
7 NCT03861286 565 566 I-Eq_Comparison
days NCT03861286 567 571 I-Eq_Comparison

Inclusion NCT03923933 0 9 O
Criteria NCT03923933 10 18 O
: NCT03923933 19 20 O

- NCT03923933 24 25 O
glomerular NCT03923933 27 37 B-Observation
filtration NCT03923933 38 48 I-Observation
rate NCT03923933 49 53 I-Observation
less NCT03923933 54 58 B-Eq_Comparison
than NCT03923933 59 63 I-Eq_Comparison
30 NCT03923933 64 66 I-Eq_Comparison
ml NCT03923933 67 69 I-Eq_Comparison
/ NCT03923933 70 71 I-Eq_Comparison
min NCT03923933 72 75 I-Eq_Comparison
/ NCT03923933 76 77 I-Eq_Comparison
1.73 NCT03923933 78 82 I-Eq_Comparison
m NCT03923933 83 84 I-Eq_Comparison

- NCT03923933 87 88 O
Without NCT03923933 90 97 B-Negation
replacement NCT03923933 98 109 B-Procedure
therapy NCT03923933 110 117 I-Procedure
( NCT03923933 118 119 O
dialysis NCT03923933 120 128 B-Procedure
or NCT03923933 129 131 B-Or
hemodialysis NCT03923933 132 144 B-Procedure
) NCT03923933 145 146 O

- NCT03923933 150 151 O
Volume NCT03923933 153 159 B-Condition
overload NCT03923933 160 168 I-Condition

- NCT03923933 171 172 O
At NCT03923933 174 176 B-Eq_Comparison
least NCT03923933 177 182 I-Eq_Comparison
100 NCT03923933 183 186 I-Eq_Comparison
ml NCT03923933 187 189 I-Eq_Comparison
per NCT03923933 190 193 I-Eq_Comparison
day NCT03923933 194 197 I-Eq_Comparison
of NCT03923933 198 200 O
residual NCT03923933 201 209 B-Observation
diuresis NCT03923933 210 218 I-Observation

- NCT03923933 221 222 O
Use NCT03923933 224 227 O
of NCT03923933 228 230 O
a NCT03923933 231 232 O
loop NCT03923933 233 237 B-Drug
diuretic NCT03923933 238 246 I-Drug
for NCT03923933 247 250 O
at NCT03923933 251 253 B-Eq_Comparison
least NCT03923933 254 259 I-Eq_Comparison
one NCT03923933 260 263 I-Eq_Comparison
month NCT03923933 264 269 I-Eq_Comparison

Exclusion NCT03923933 270 279 O
Criteria NCT03923933 280 288 O
: NCT03923933 289 290 O

- NCT03923933 294 295 O
Allergies NCT03923933 297 306 B-Allergy
known NCT03923933 307 312 O
to NCT03923933 313 315 O
diuretics NCT03923933 316 325 B-Drug

- NCT03923933 328 329 O
Patients NCT03923933 331 339 O
with NCT03923933 340 344 O
severe NCT03923933 345 351 O
infections NCT03923933 352 362 B-Condition

- NCT03923933 365 366 O
Patients NCT03923933 368 376 O
with NCT03923933 377 381 O
hemodynamic NCT03923933 382 393 B-Condition
instability NCT03923933 394 405 I-Condition

- NCT03923933 408 409 O
Amputees NCT03923933 411 419 B-Condition

- NCT03923933 422 423 O
Patients NCT03923933 425 433 O
with NCT03923933 434 438 O
cognitive NCT03923933 439 448 B-Condition
impairment NCT03923933 449 459 I-Condition

- NCT03923933 462 463 O
Patients NCT03923933 465 473 O
with NCT03923933 474 478 O
acute NCT03923933 479 484 O
renal NCT03923933 485 490 B-Condition
failure NCT03923933 491 498 I-Condition

- NCT03923933 501 502 O
Patients NCT03923933 504 512 O
with NCT03923933 513 517 O
graft NCT03923933 518 523 B-Condition
loss NCT03923933 524 528 I-Condition

Inclusion NCT03865914 0 9 O
Criteria NCT03865914 10 18 O
: NCT03865914 19 20 O

- NCT03865914 24 25 O
Age NCT03865914 27 30 B-Age
≥ NCT03865914 31 32 B-Eq_Comparison
18 NCT03865914 33 35 I-Eq_Comparison
, NCT03865914 36 37 O
male NCT03865914 38 42 O
or NCT03865914 43 45 B-Or
female NCT03865914 46 52 O

- NCT03865914 55 56 O
Clinical NCT03865914 58 66 O
diagnosed NCT03865914 67 76 O
as NCT03865914 77 79 O
type NCT03865914 80 84 B-Modifier
2 NCT03865914 85 86 I-Modifier
diabetes NCT03865914 87 95 B-Condition
mellitus NCT03865914 96 104 I-Condition

- NCT03865914 107 108 O
The NCT03865914 110 113 O
presence NCT03865914 114 122 O
of NCT03865914 123 125 O
renal NCT03865914 126 131 B-Condition
impairment NCT03865914 132 142 I-Condition
including NCT03865914 143 152 O
: NCT03865914 153 154 O
microalbuminuria NCT03865914 155 171 B-Condition
or NCT03865914 172 174 B-Or
overt NCT03865914 175 180 B-Modifier
proteinuria NCT03865914 181 192 B-Condition
or NCT03865914 193 195 B-Or
renal NCT03865914 196 201 B-Modifier
insufficiency NCT03865914 202 215 B-Condition

- NCT03865914 218 219 O
The NCT03865914 221 224 O
renal NCT03865914 225 230 B-Modifier
biopsy NCT03865914 231 237 B-Procedure
was NCT03865914 238 241 O
performed NCT03865914 242 251 O
with NCT03865914 252 256 O
complete NCT03865914 257 265 O
renal NCT03865914 266 271 B-Condition
pathological NCT03865914 272 284 I-Condition
diagnosis NCT03865914 285 294 O

- NCT03865914 297 298 O
Obtaining NCT03865914 300 309 O
the NCT03865914 310 313 O
signed NCT03865914 314 320 O
informed NCT03865914 321 329 O
consent NCT03865914 330 337 O
from NCT03865914 338 342 O
patients NCT03865914 343 351 O

Exclusion NCT03865914 352 361 O
Criteria NCT03865914 362 370 O
: NCT03865914 371 372 O

- NCT03865914 376 377 O
The NCT03865914 379 382 O
history NCT03865914 383 390 B-Eq_Comparison
of NCT03865914 391 393 O
the NCT03865914 394 397 O
disease NCT03865914 398 405 O
was NCT03865914 406 409 O
not NCT03865914 410 413 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
complete NCT03865914 414 422 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation

- NCT03865914 425 426 O
Clinical NCT03865914 428 436 O
diagnosed NCT03865914 437 446 O
as NCT03865914 447 449 O
other NCT03865914 450 455 B-Other
secondary NCT03865914 456 465 B-Modifier
renal NCT03865914 466 471 B-Condition
diseases NCT03865914 472 480 I-Condition

- NCT03865914 483 484 O
Patients NCT03865914 486 494 O
with NCT03865914 495 499 O
hereditary NCT03865914 500 510 B-Modifier
kidney NCT03865914 511 517 B-Condition
disease NCT03865914 518 525 I-Condition

- NCT03865914 528 529 O
Autoimmune NCT03865914 531 541 B-Condition
diseases NCT03865914 542 550 I-Condition

- NCT03865914 553 554 O
Patients NCT03865914 556 564 O
with NCT03865914 565 569 O
malignant NCT03865914 570 579 B-Condition
tumor NCT03865914 580 585 I-Condition
were NCT03865914 586 590 B-And
expected NCT03865914 591 599 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865914 600 602 I-Assertion___Assertion_Type_Value:hypothetical
survive NCT03865914 603 610 B-Death
less NCT03865914 611 615 B-Eq_Comparison
than NCT03865914 616 620 I-Eq_Comparison
6 NCT03865914 621 622 I-Eq_Comparison
months NCT03865914 623 629 I-Eq_Comparison

- NCT03865914 632 633 O
Pregnancy NCT03865914 635 644 B-Condition
and NCT03865914 645 648 B-Or
lactation NCT03865914 649 658 B-Condition

Inclusion NCT03926780 0 9 O
Criteria NCT03926780 10 18 O
: NCT03926780 19 20 O

- NCT03926780 24 25 O
Evidence NCT03926780 27 35 O
of NCT03926780 36 38 O
LV NCT03926780 39 41 B-Condition
thrombus NCT03926780 42 50 I-Condition
as NCT03926780 51 53 O
assessed NCT03926780 54 62 O
by NCT03926780 63 65 O
trans NCT03926780 66 71 B-Procedure
- NCT03926780 72 73 I-Procedure
thoracic NCT03926780 74 82 I-Procedure
echocardiography NCT03926780 83 99 I-Procedure
( NCT03926780 100 101 O
TTE NCT03926780 102 105 B-Procedure
) NCT03926780 106 107 O
. NCT03926780 108 109 O

Exclusion NCT03926780 111 120 O
Criteria NCT03926780 121 129 O
: NCT03926780 130 131 O

- NCT03926780 135 136 O
Creatinine NCT03926780 138 148 B-Observation
clearance NCT03926780 149 158 I-Observation
less NCT03926780 159 163 B-Eq_Comparison
than NCT03926780 164 168 I-Eq_Comparison
50 NCT03926780 169 171 I-Eq_Comparison
ml NCT03926780 172 174 I-Eq_Comparison
/ NCT03926780 175 176 I-Eq_Comparison
min NCT03926780 177 180 I-Eq_Comparison
. NCT03926780 181 182 O

Inclusion NCT03867760 0 9 O
Criteria NCT03867760 10 18 O
: NCT03867760 19 20 O

- NCT03867760 24 25 O
self NCT03867760 27 31 O
- NCT03867760 32 33 O
reporting NCT03867760 34 43 O
moderate NCT03867760 44 52 B-Eq_Comparison
or NCT03867760 53 55 I-Eq_Comparison
higher NCT03867760 56 62 I-Eq_Comparison
pain NCT03867760 63 67 B-Condition
on NCT03867760 68 70 O
average NCT03867760 71 78 O
during NCT03867760 79 85 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867760 86 89 O
last NCT03867760 90 94 B-Eq_Comparison
week NCT03867760 95 99 I-Eq_Comparison
( NCT03867760 100 101 O
> NCT03867760 102 103 B-Eq_Comparison
3 NCT03867760 104 105 I-Eq_Comparison
on NCT03867760 106 108 O
a NCT03867760 109 110 O
0 NCT03867760 111 112 B-Modifier
- NCT03867760 113 114 I-Modifier
10 NCT03867760 115 117 I-Modifier
pain NCT03867760 118 122 B-Observation
intensity NCT03867760 123 132 I-Observation
numeric NCT03867760 133 140 I-Observation
scale NCT03867760 141 146 I-Observation
) NCT03867760 147 148 O

- NCT03867760 152 153 O
self NCT03867760 155 159 O
- NCT03867760 160 161 O
reporting NCT03867760 162 171 O
experiencing NCT03867760 172 184 O
pain NCT03867760 185 189 B-Condition
at NCT03867760 190 192 B-Eq_Comparison
least NCT03867760 193 198 I-Eq_Comparison
half NCT03867760 199 203 I-Eq_Comparison
of NCT03867760 204 206 I-Eq_Comparison
the NCT03867760 207 210 I-Eq_Comparison
days NCT03867760 211 215 I-Eq_Comparison
in NCT03867760 216 218 O
the NCT03867760 219 222 O
past NCT03867760 223 227 B-Eq_Comparison
4 NCT03867760 228 229 I-Eq_Comparison
weeks NCT03867760 230 235 I-Eq_Comparison

- NCT03867760 238 239 O
self NCT03867760 241 245 O
- NCT03867760 246 247 O
reporting NCT03867760 248 257 O
chronic NCT03867760 258 265 O
pain NCT03867760 266 270 B-Condition
related NCT03867760 271 278 O
to NCT03867760 279 281 O
cancer NCT03867760 282 288 B-Condition
or NCT03867760 289 291 B-Or
its NCT03867760 292 295 O
treatment NCT03867760 296 305 B-Procedure

- NCT03867760 308 309 O
completed NCT03867760 311 320 B-Eq_Comparison
active NCT03867760 321 327 B-Eq_Comparison
cancer NCT03867760 328 334 B-Condition
treatment NCT03867760 335 344 B-Procedure
other NCT03867760 345 350 B-Exception
than NCT03867760 351 355 I-Exception
maintenance NCT03867760 356 367 B-Procedure
therapy NCT03867760 368 375 I-Procedure

- NCT03867760 378 379 O
being NCT03867760 381 386 O
> NCT03867760 387 388 B-Eq_Comparison
18 NCT03867760 389 391 I-Eq_Comparison
years NCT03867760 392 397 I-Eq_Comparison
of NCT03867760 398 400 O
age NCT03867760 401 404 B-Age

- NCT03867760 407 408 O
functional NCT03867760 410 420 O
fluency NCT03867760 421 428 O
in NCT03867760 429 431 O
English NCT03867760 432 439 O

- NCT03867760 442 443 O
mentally NCT03867760 445 453 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03867760 454 457 I-Assertion___Assertion_Type_Value:hypothetical
physically NCT03867760 458 468 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03867760 469 473 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03867760 474 476 O
participate NCT03867760 477 488 O
and NCT03867760 489 492 O
complete NCT03867760 493 501 O
surveys NCT03867760 502 509 B-Observation

Exclusion NCT03867760 510 519 O
Criteria NCT03867760 520 528 O
: NCT03867760 529 530 O

• NCT03867760 532 533 O
has NCT03867760 534 537 O
a NCT03867760 538 539 O
psychiatric NCT03867760 540 551 B-Condition
condition NCT03867760 552 561 I-Condition
or NCT03867760 562 564 B-Or
symptoms NCT03867760 565 573 B-Assertion___Assertion_Type_Value:possible
( NCT03867760 574 575 O
i NCT03867760 576 577 O
. NCT03867760 578 579 O
e NCT03867760 580 581 O
. NCT03867760 582 583 O
, NCT03867760 584 585 O
diagnosis NCT03867760 586 595 O
of NCT03867760 596 598 O
paranoid NCT03867760 599 607 B-Condition
schizophrenia NCT03867760 608 621 I-Condition
or NCT03867760 622 624 B-Or
active NCT03867760 625 631 B-Eq_Comparison
paranoid NCT03867760 632 640 B-Condition
delusional NCT03867760 641 651 I-Condition
thoughts NCT03867760 652 660 I-Condition
, NCT03867760 661 662 O
as NCT03867760 663 665 O
determined NCT03867760 666 676 O
via NCT03867760 677 680 O
a NCT03867760 681 682 O
telephone NCT03867760 683 692 B-Modifier
or NCT03867760 693 695 B-Or
in NCT03867760 696 698 B-Modifier
- NCT03867760 699 700 I-Modifier
person NCT03867760 701 707 I-Modifier
screening NCT03867760 708 717 B-Procedure
assessment NCT03867760 718 728 I-Procedure
) NCT03867760 729 730 O
that NCT03867760 731 735 O
would NCT03867760 736 741 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03867760 742 751 O
with NCT03867760 752 756 O
study NCT03867760 757 762 B-Study
participation NCT03867760 763 776 O
. NCT03867760 777 778 O

Exclusion NCT03867760 780 789 O
Criteria NCT03867760 790 798 O
for NCT03867760 799 802 O
Optional NCT03867760 803 811 O
EEG NCT03867760 812 815 O
Measurement NCT03867760 816 827 O
: NCT03867760 828 829 O

- NCT03867760 833 834 O
a NCT03867760 836 837 O
history NCT03867760 838 845 B-Eq_Comparison
of NCT03867760 846 848 O
seizure NCT03867760 849 856 B-Condition
condition NCT03867760 857 866 I-Condition
within NCT03867760 867 873 B-Eq_Comparison
the NCT03867760 874 877 I-Eq_Comparison
last NCT03867760 878 882 I-Eq_Comparison
year NCT03867760 883 887 I-Eq_Comparison

- NCT03867760 890 891 O
a NCT03867760 893 894 O
significant NCT03867760 895 906 O
brain NCT03867760 907 912 B-Modifier
injury NCT03867760 913 919 B-Condition
or NCT03867760 920 922 B-Or
skull NCT03867760 923 928 B-Modifier
defect NCT03867760 929 935 B-Condition

- NCT03867760 938 939 O
a NCT03867760 941 942 O
history NCT03867760 943 950 B-Eq_Comparison
of NCT03867760 951 953 O
brain NCT03867760 954 959 B-Modifier
cancer NCT03867760 960 966 B-Condition
. NCT03867760 967 968 O


Inclusion NCT03928145 0 9 O
Criteria NCT03928145 10 18 O
: NCT03928145 19 20 O

- NCT03928145 24 25 O
Adults NCT03928145 27 33 O
( NCT03928145 34 35 O
age NCT03928145 36 39 B-Age
30 NCT03928145 40 42 B-Eq_Comparison
to NCT03928145 43 45 I-Eq_Comparison
75 NCT03928145 46 48 I-Eq_Comparison
years NCT03928145 49 54 I-Eq_Comparison
) NCT03928145 55 56 O
. NCT03928145 57 58 O

- NCT03928145 62 63 O
Diagnosis NCT03928145 65 74 O
of NCT03928145 75 77 O
primary NCT03928145 78 85 B-Condition
hypertension NCT03928145 86 98 I-Condition
based NCT03928145 99 104 O
on NCT03928145 105 107 O
ABPM NCT03928145 108 112 B-Procedure
( NCT03928145 113 114 O
mean NCT03928145 115 119 B-Eq_Comparison
24 NCT03928145 120 122 I-Eq_Comparison
- NCT03928145 123 124 I-Eq_Comparison
h NCT03928145 125 126 I-Eq_Comparison
systolic NCT03928145 127 135 B-Observation
BP NCT03928145 136 138 I-Observation
≥ NCT03928145 139 140 B-Eq_Comparison
130 NCT03928145 141 144 I-Eq_Comparison
mmHg NCT03928145 145 149 I-Eq_Comparison
or NCT03928145 150 152 B-Or
mean NCT03928145 153 157 B-Eq_Comparison
24 NCT03928145 158 160 I-Eq_Comparison
- NCT03928145 161 162 I-Eq_Comparison
h NCT03928145 163 164 I-Eq_Comparison
diastolic NCT03928145 165 174 B-Observation
BP NCT03928145 175 177 I-Observation
≥ NCT03928145 178 179 B-Eq_Comparison
80 NCT03928145 180 182 I-Eq_Comparison
mmHg NCT03928145 183 187 I-Eq_Comparison
) NCT03928145 188 189 O
. NCT03928145 190 191 O

- NCT03928145 195 196 O
No NCT03928145 198 200 B-Negation
current NCT03928145 201 208 B-Eq_Comparison
use NCT03928145 209 212 O
of NCT03928145 213 215 O
antihypertensive NCT03928145 216 232 B-Drug
medication NCT03928145 233 243 I-Drug
. NCT03928145 244 245 O

Exclusion NCT03928145 247 256 O
Criteria NCT03928145 257 265 O
: NCT03928145 266 267 O

- NCT03928145 271 272 O
Low NCT03928145 274 277 O
life NCT03928145 278 282 B-Observation
expectancy NCT03928145 283 293 I-Observation
. NCT03928145 294 295 O

- NCT03928145 299 300 O
Other NCT03928145 302 307 B-Other
indications NCT03928145 308 319 B-Indication
for NCT03928145 320 323 O
the NCT03928145 324 327 O
use NCT03928145 328 331 O
of NCT03928145 332 334 O
diuretics NCT03928145 335 344 B-Drug
. NCT03928145 345 346 O

- NCT03928145 350 351 O
Intolerance NCT03928145 353 364 B-Condition
or NCT03928145 365 367 B-Or
contraindications NCT03928145 368 385 B-Contraindication
to NCT03928145 386 388 O
the NCT03928145 389 392 O
study NCT03928145 393 398 B-Study
drugs NCT03928145 399 404 B-Drug
. NCT03928145 405 406 O

- NCT03928145 410 411 O
Cardiovascular NCT03928145 413 427 B-Condition
disease NCT03928145 428 435 I-Condition
( NCT03928145 436 437 O
heart NCT03928145 438 443 B-Condition
failure NCT03928145 444 451 I-Condition
, NCT03928145 452 453 O
myocardial NCT03928145 454 464 B-Condition
infarction NCT03928145 465 475 I-Condition
or NCT03928145 476 478 B-Or
stroke NCT03928145 479 485 B-Condition
) NCT03928145 486 487 O
. NCT03928145 488 489 O

- NCT03928145 493 494 O
Secondary NCT03928145 496 505 B-Modifier
hypertension NCT03928145 506 518 B-Condition
. NCT03928145 519 520 O

- NCT03928145 524 525 O
Chronic NCT03928145 527 534 O
kidney NCT03928145 535 541 B-Modifier
disease NCT03928145 542 549 B-Condition
and NCT03928145 550 553 B-Or
/ NCT03928145 554 555 I-Or
or NCT03928145 556 558 I-Or
abnormal NCT03928145 559 567 O
renal NCT03928145 568 573 B-Modifier
function NCT03928145 574 582 B-Condition
( NCT03928145 583 584 O
creatinine NCT03928145 585 595 B-Observation
> NCT03928145 596 597 B-Eq_Comparison
1.5 NCT03928145 598 601 I-Eq_Comparison
mg NCT03928145 602 604 I-Eq_Comparison
/ NCT03928145 605 606 I-Eq_Comparison
dL NCT03928145 607 609 I-Eq_Comparison
) NCT03928145 610 611 O
. NCT03928145 612 613 O

- NCT03928145 617 618 O
Hyperkalemia NCT03928145 620 632 B-Condition
( NCT03928145 633 634 O
serum NCT03928145 635 640 B-Observation
potassium NCT03928145 641 650 I-Observation
> NCT03928145 651 652 B-Eq_Comparison
5.5 NCT03928145 653 656 I-Eq_Comparison
mEq NCT03928145 657 660 I-Eq_Comparison
/ NCT03928145 661 662 I-Eq_Comparison
L NCT03928145 663 664 I-Eq_Comparison
) NCT03928145 665 666 O
. NCT03928145 667 668 O

- NCT03928145 672 673 O
Gout NCT03928145 675 679 B-Condition
. NCT03928145 680 681 O

- NCT03928145 685 686 O
Previous NCT03928145 688 696 B-Eq_Comparison
antihypertensive NCT03928145 697 713 B-Drug
treatment NCT03928145 714 723 B-Procedure
with NCT03928145 724 728 O
more NCT03928145 729 733 B-Eq_Comparison
than NCT03928145 734 738 I-Eq_Comparison
one NCT03928145 739 742 I-Eq_Comparison
drug NCT03928145 743 747 B-Drug
. NCT03928145 748 749 O

- NCT03928145 753 754 O
Systolic NCT03928145 756 764 B-Observation
blood NCT03928145 765 770 I-Observation
pressure NCT03928145 771 779 I-Observation
≥ NCT03928145 780 781 B-Eq_Comparison
160 NCT03928145 782 785 I-Eq_Comparison
mmHg NCT03928145 786 790 I-Eq_Comparison
or NCT03928145 791 793 B-Or
diastolic NCT03928145 794 803 B-Observation
blood NCT03928145 804 809 I-Observation
pressure NCT03928145 810 818 I-Observation
≥ NCT03928145 819 820 B-Eq_Comparison
100 NCT03928145 821 824 I-Eq_Comparison
mmHg NCT03928145 825 829 I-Eq_Comparison
measured NCT03928145 830 838 O
through NCT03928145 839 846 O
office NCT03928145 847 853 O
blood NCT03928145 854 859 O
pressure NCT03928145 860 868 O
. NCT03928145 869 870 O

- NCT03928145 874 875 O
Pregnancy NCT03928145 877 886 B-Condition
or NCT03928145 887 889 B-Or
prospective NCT03928145 890 901 B-Assertion___Assertion_Type_Value:intention
pregnancy NCT03928145 902 911 B-Condition
during NCT03928145 912 918 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928145 919 922 O
study NCT03928145 923 928 B-Study
. NCT03928145 929 930 O

- NCT03928145 934 935 O
Lactating NCT03928145 937 946 B-Condition
women NCT03928145 947 952 O
. NCT03928145 953 954 O

Inclusion NCT03864159 0 9 O
Criteria NCT03864159 10 18 O
: NCT03864159 19 20 O

- NCT03864159 24 25 O
Age NCT03864159 27 30 B-Age
between NCT03864159 31 38 B-Eq_Comparison
18 NCT03864159 39 41 I-Eq_Comparison
to NCT03864159 42 44 I-Eq_Comparison
25 NCT03864159 45 47 I-Eq_Comparison
years NCT03864159 48 53 I-Eq_Comparison

- NCT03864159 56 57 O
Amateur NCT03864159 59 66 B-Observation
basketball NCT03864159 67 77 I-Observation
players NCT03864159 78 85 I-Observation

- NCT03864159 88 89 O
Belong NCT03864159 91 97 O
to NCT03864159 98 100 O
the NCT03864159 101 104 O
Celeste NCT03864159 105 112 O
club NCT03864159 113 117 O

- NCT03864159 120 121 O
Not NCT03864159 123 126 B-Negation
having NCT03864159 127 133 O
any NCT03864159 134 137 O
injury NCT03864159 138 144 B-Condition
to NCT03864159 145 147 O
the NCT03864159 148 151 O
hamstring NCT03864159 152 161 B-Modifier
musculature NCT03864159 162 173 I-Modifier
at NCT03864159 174 176 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864159 177 180 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03864159 181 185 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03864159 186 188 O
the NCT03864159 189 192 O
study NCT03864159 193 198 B-Study

Exclusion NCT03864159 199 208 O
Criteria NCT03864159 209 217 O
: NCT03864159 218 219 O

- NCT03864159 223 224 O
At NCT03864159 226 228 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864159 229 232 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03864159 233 237 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03864159 238 240 O
the NCT03864159 241 244 O
study NCT03864159 245 250 B-Study
they NCT03864159 251 255 O
are NCT03864159 256 259 O
included NCT03864159 260 268 O
in NCT03864159 269 271 O
a NCT03864159 272 273 O
program NCT03864159 274 281 B-Procedure
of NCT03864159 282 284 I-Procedure
individualized NCT03864159 285 299 I-Procedure
strength NCT03864159 300 308 I-Procedure
training NCT03864159 309 317 I-Procedure
in NCT03864159 318 320 O
lower NCT03864159 321 326 B-Modifier
limbs NCT03864159 327 332 I-Modifier

- NCT03864159 335 336 O
Subjects NCT03864159 338 346 O
with NCT03864159 347 351 O
alterations NCT03864159 352 363 B-Condition
in NCT03864159 364 366 O
venous NCT03864159 367 373 B-Modifier
return NCT03864159 374 380 I-Modifier
or NCT03864159 381 383 B-Or
congenital NCT03864159 384 394 B-Modifier
coagulopathies NCT03864159 395 409 B-Condition

- NCT03864159 412 413 O
Subjects NCT03864159 415 423 O
who NCT03864159 424 427 O
present NCT03864159 428 435 O
hypermobility NCT03864159 436 449 B-Condition

- NCT03864159 452 453 O
Not NCT03864159 455 458 O
signed NCT03864159 459 465 O
the NCT03864159 466 469 O
informed NCT03864159 470 478 O
consent NCT03864159 479 486 O
document NCT03864159 487 495 O

Inclusion NCT03865303 0 9 O
Criteria NCT03865303 10 18 O

- NCT03865303 21 22 O
For NCT03865303 24 27 O
EMR NCT03865303 28 31 O
review NCT03865303 32 38 O
all NCT03865303 39 42 O
adults NCT03865303 43 49 O
admitted NCT03865303 50 58 B-Encounter
to NCT03865303 59 61 O
the NCT03865303 62 65 O
hospital NCT03865303 66 74 O
ages NCT03865303 75 79 B-Age
18 NCT03865303 80 82 B-Eq_Comparison
and NCT03865303 83 86 I-Eq_Comparison
older NCT03865303 87 92 I-Eq_Comparison
with NCT03865303 93 97 O
research NCT03865303 98 106 O
authorization NCT03865303 107 120 O

- NCT03865303 123 124 O
For NCT03865303 126 129 O
survey NCT03865303 130 136 O
- NCT03865303 137 138 O
clinicians NCT03865303 139 149 O
including NCT03865303 150 159 O
physicians NCT03865303 160 170 B-Provider
, NCT03865303 171 172 O
advanced NCT03865303 173 181 B-Provider
care NCT03865303 182 186 I-Provider
practitioners NCT03865303 187 200 I-Provider

- NCT03865303 203 204 O
For NCT03865303 206 209 O
focus NCT03865303 210 215 O
groups NCT03865303 216 222 O
and NCT03865303 223 226 O
interviews NCT03865303 227 237 O
- NCT03865303 238 239 O
clinicians NCT03865303 240 250 O
including NCT03865303 251 260 O
physicians NCT03865303 261 271 B-Provider
, NCT03865303 272 273 O
advanced NCT03865303 274 282 B-Provider
care NCT03865303 283 287 I-Provider
practitioners NCT03865303 288 301 I-Provider

Exclusion NCT03865303 302 311 O
Criteria NCT03865303 312 320 O

- NCT03865303 323 324 O
Age NCT03865303 326 329 B-Age
< NCT03865303 330 331 B-Eq_Comparison
18 NCT03865303 332 334 I-Eq_Comparison
years NCT03865303 335 340 I-Eq_Comparison
old NCT03865303 341 344 O

- NCT03865303 347 348 O
No NCT03865303 350 352 O
research NCT03865303 353 361 O
authorization NCT03865303 362 375 O

- NCT03865303 378 379 O
Refusal NCT03865303 381 388 O
to NCT03865303 389 391 O
give NCT03865303 392 396 O
consent NCT03865303 397 404 O

Inclusion NCT03864276 0 9 O
Criteria NCT03864276 10 18 O
: NCT03864276 19 20 O

- NCT03864276 24 25 O
patients NCT03864276 27 35 O
with NCT03864276 36 40 O
liver NCT03864276 41 46 B-Condition
cirrhosis NCT03864276 47 56 I-Condition
who NCT03864276 57 60 B-And
will NCT03864276 61 65 O
undergo NCT03864276 66 73 O
planned NCT03864276 74 81 B-Eq_Comparison
liver NCT03864276 82 87 B-Procedure
transplantation NCT03864276 88 103 I-Procedure

Exclusion NCT03864276 104 113 O
Criteria NCT03864276 114 122 O
: NCT03864276 123 124 O

- NCT03864276 128 129 O
1 NCT03864276 131 132 O
. NCT03864276 132 133 O
emergent NCT03864276 135 143 B-Modifier
liver NCT03864276 144 149 B-Procedure
transplantation NCT03864276 150 165 I-Procedure

- NCT03864276 168 169 O
2 NCT03864276 171 172 O
. NCT03864276 172 173 O
unstable NCT03864276 175 183 O
angina NCT03864276 184 190 B-Condition

- NCT03864276 193 194 O
3 NCT03864276 196 197 O
. NCT03864276 197 198 O
recent NCT03864276 200 206 B-Eq_Comparison
MI NCT03864276 207 209 B-Condition
( NCT03864276 210 211 O
Myocardial NCT03864276 212 222 B-Condition
Infarction NCT03864276 223 233 I-Condition
) NCT03864276 234 235 O

- NCT03864276 239 240 O
4 NCT03864276 242 243 O
. NCT03864276 243 244 O
uncontrolled NCT03864276 246 258 B-Modifier
hypertension NCT03864276 259 271 B-Condition
( NCT03864276 272 273 O
diastolic NCT03864276 274 283 B-Observation
BP NCT03864276 284 286 I-Observation
> NCT03864276 287 288 B-Eq_Comparison
110 NCT03864276 289 292 I-Eq_Comparison
mmHg NCT03864276 293 297 I-Eq_Comparison
) NCT03864276 298 299 O

- NCT03864276 303 304 O
5 NCT03864276 306 307 O
. NCT03864276 307 308 O
implantable NCT03864276 310 321 B-Procedure
cardiac NCT03864276 322 329 I-Procedure
defibrillator NCT03864276 330 343 I-Procedure

- NCT03864276 346 347 O
6 NCT03864276 349 350 O
. NCT03864276 350 351 O
severe NCT03864276 353 359 O
obesity NCT03864276 360 367 B-Condition
( NCT03864276 368 369 O
BMI NCT03864276 370 373 B-Observation
> NCT03864276 374 375 B-Eq_Comparison
30 NCT03864276 376 378 I-Eq_Comparison
kg NCT03864276 379 381 I-Eq_Comparison
/ NCT03864276 382 383 I-Eq_Comparison
m NCT03864276 384 385 I-Eq_Comparison
2 NCT03864276 386 387 I-Eq_Comparison
) NCT03864276 388 389 O

- NCT03864276 393 394 O
7 NCT03864276 396 397 O
. NCT03864276 397 398 O
allergy NCT03864276 400 407 B-Allergy
to NCT03864276 408 410 O
propofol NCT03864276 411 419 B-Drug

Inclusion NCT03869294 0 9 O
Criteria NCT03869294 10 18 O
: NCT03869294 19 20 O

- NCT03869294 24 25 O
1 NCT03869294 27 28 O
. NCT03869294 28 29 O
Histologically NCT03869294 30 44 B-Procedure
confirmed NCT03869294 45 54 O
pancreatic NCT03869294 55 65 B-Condition
adenocarcinoma NCT03869294 66 80 I-Condition
2 NCT03869294 81 82 O
. NCT03869294 82 83 O
Locally NCT03869294 84 91 B-Modifier
advanced NCT03869294 92 100 I-Modifier
or NCT03869294 101 103 B-Or
metastatic NCT03869294 104 114 B-Modifier
PC NCT03869294 115 117 B-Condition
3 NCT03869294 118 119 O
. NCT03869294 119 120 O
Chemotherapy NCT03869294 121 133 B-Procedure
- NCT03869294 134 135 O
naïve NCT03869294 136 141 B-Negation
4 NCT03869294 142 143 O
. NCT03869294 143 144 O
ECOG NCT03869294 145 149 B-Observation
performance NCT03869294 150 161 I-Observation
status NCT03869294 162 168 I-Observation
of NCT03869294 169 171 O
0 NCT03869294 172 173 B-Eq_Comparison
or NCT03869294 174 176 I-Eq_Comparison
1 NCT03869294 177 178 I-Eq_Comparison
5 NCT03869294 179 180 O
. NCT03869294 180 181 O
An NCT03869294 183 185 O
adequate NCT03869294 186 194 O
bone NCT03869294 195 199 B-Modifier
marrow NCT03869294 200 206 I-Modifier
, NCT03869294 207 208 O
liver NCT03869294 209 214 B-Modifier
function NCT03869294 215 223 B-Condition
and NCT03869294 224 227 B-And
kidney NCT03869294 228 234 B-Modifier
function NCT03869294 235 243 B-Condition

Exclusion NCT03869294 244 253 O
Criteria NCT03869294 254 262 O
: NCT03869294 263 264 O

- NCT03869294 268 269 O
1 NCT03869294 271 272 O
. NCT03869294 272 273 O
Age NCT03869294 274 277 B-Age
≥ NCT03869294 278 279 B-Eq_Comparison
80 NCT03869294 280 282 I-Eq_Comparison
years NCT03869294 283 288 I-Eq_Comparison
2 NCT03869294 289 290 O
. NCT03869294 290 291 O
Brain NCT03869294 292 297 B-Modifier
metastasis NCT03869294 298 308 B-Condition
3 NCT03869294 309 310 O
. NCT03869294 310 311 O
With NCT03869294 312 316 O
other NCT03869294 317 322 B-Other
malignancies NCT03869294 323 335 B-Condition
4 NCT03869294 336 337 O
. NCT03869294 337 338 O
Chronic NCT03869294 339 346 O
diarrhea NCT03869294 347 355 B-Condition
, NCT03869294 356 357 O
cardiac NCT03869294 358 365 B-Condition
disease NCT03869294 366 373 I-Condition
, NCT03869294 374 375 O
pregnancy NCT03869294 376 385 B-Condition
or NCT03869294 386 388 B-Or
breast NCT03869294 389 395 B-Condition
feeding NCT03869294 396 403 I-Condition

Inclusion NCT03867305 0 9 O
Criteria NCT03867305 10 18 O
: NCT03867305 19 20 O

- NCT03867305 24 25 O
Patient NCT03867305 27 34 O
requiring NCT03867305 35 44 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03867305 45 46 O
first NCT03867305 47 52 B-Eq_Comparison
total NCT03867305 53 58 B-Procedure
knee NCT03867305 59 63 I-Procedure
prosthesis NCT03867305 64 74 I-Procedure
( NCT03867305 75 76 O
scheduled NCT03867305 77 86 B-Eq_Comparison
between NCT03867305 87 94 I-Eq_Comparison
Tuesday NCT03867305 95 102 I-Eq_Comparison
and NCT03867305 103 106 I-Eq_Comparison
Friday NCT03867305 107 113 I-Eq_Comparison
) NCT03867305 114 115 O
. NCT03867305 116 117 O

- NCT03867305 121 122 O
Patient NCT03867305 124 131 O
that NCT03867305 132 136 O
has NCT03867305 137 140 O
given NCT03867305 141 146 O
his NCT03867305 147 150 O
/ NCT03867305 151 152 O
her NCT03867305 153 156 O
free NCT03867305 157 161 O
and NCT03867305 162 165 O
informed NCT03867305 166 174 O
consent NCT03867305 175 182 O
and NCT03867305 183 186 O
signed NCT03867305 187 193 O
the NCT03867305 194 197 O
consent NCT03867305 198 205 O
form NCT03867305 206 210 O
. NCT03867305 211 212 O

- NCT03867305 216 217 O
The NCT03867305 219 222 O
patient NCT03867305 223 230 O
must NCT03867305 231 235 O
be NCT03867305 236 238 O
a NCT03867305 239 240 O
member NCT03867305 241 247 O
or NCT03867305 248 250 O
beneficiary NCT03867305 251 262 O
of NCT03867305 263 265 O
a NCT03867305 266 267 O
health NCT03867305 268 274 O
insurance NCT03867305 275 284 O
plan NCT03867305 285 289 O

- NCT03867305 292 293 O
The NCT03867305 295 298 O
patient NCT03867305 299 306 O
is NCT03867305 307 309 O
at NCT03867305 310 312 B-Eq_Comparison
least NCT03867305 313 318 I-Eq_Comparison
18 NCT03867305 319 321 I-Eq_Comparison
years NCT03867305 322 327 I-Eq_Comparison
old NCT03867305 328 331 B-Age
( NCT03867305 332 333 O
≥ NCT03867305 334 335 O
) NCT03867305 336 337 O
and NCT03867305 338 341 B-And
under NCT03867305 342 347 B-Eq_Comparison
90 NCT03867305 348 350 I-Eq_Comparison
years NCT03867305 351 356 I-Eq_Comparison
old NCT03867305 357 360 O
( NCT03867305 361 362 O
< NCT03867305 363 364 O
) NCT03867305 365 366 O
. NCT03867305 367 368 O

Exclusion NCT03867305 370 379 O
Criteria NCT03867305 380 388 O
: NCT03867305 389 390 O

- NCT03867305 394 395 O
The NCT03867305 397 400 O
subject NCT03867305 401 408 O
is NCT03867305 409 411 O
in NCT03867305 412 414 O
a NCT03867305 415 416 O
period NCT03867305 417 423 O
of NCT03867305 424 426 O
exclusion NCT03867305 427 436 O
determined NCT03867305 437 447 O
by NCT03867305 448 450 O
a NCT03867305 451 452 O
previous NCT03867305 453 461 B-Eq_Comparison
study NCT03867305 462 467 B-Study
( NCT03867305 468 469 O
therapeutic NCT03867305 470 481 B-Procedure
study NCT03867305 482 487 B-Study
) NCT03867305 488 489 O

- NCT03867305 493 494 O
The NCT03867305 496 499 O
subject NCT03867305 500 507 O
refuses NCT03867305 508 515 O
to NCT03867305 516 518 O
sign NCT03867305 519 523 O
the NCT03867305 524 527 O
consent NCT03867305 528 535 O

- NCT03867305 538 539 O
It NCT03867305 541 543 O
is NCT03867305 544 546 O
impossible NCT03867305 547 557 O
to NCT03867305 558 560 O
give NCT03867305 561 565 O
the NCT03867305 566 569 O
subject NCT03867305 570 577 O
informed NCT03867305 578 586 O
information NCT03867305 587 598 O

- NCT03867305 601 602 O
The NCT03867305 604 607 O
patient NCT03867305 608 615 O
is NCT03867305 616 618 O
under NCT03867305 619 624 B-Observation
safeguard NCT03867305 625 634 I-Observation
of NCT03867305 635 637 I-Observation
justice NCT03867305 638 645 I-Observation
or NCT03867305 646 648 B-Or
state NCT03867305 649 654 B-Observation
guardianship NCT03867305 655 667 I-Observation

- NCT03867305 670 671 O
The NCT03867305 673 676 O
patient NCT03867305 677 684 O
is NCT03867305 685 687 O
pregnant NCT03867305 688 696 B-Condition
or NCT03867305 697 699 B-Or
breastfeeding NCT03867305 700 713 B-Condition

- NCT03867305 716 717 O
The NCT03867305 719 722 O
patient NCT03867305 723 730 O
is NCT03867305 731 733 O
allergic NCT03867305 734 742 B-Allergy
to NCT03867305 743 745 O
latex NCT03867305 746 751 O
bandages NCT03867305 752 760 O
. NCT03867305 761 762 O

- NCT03867305 766 767 O
The NCT03867305 769 772 O
subject NCT03867305 773 780 O
has NCT03867305 781 784 O
contralateral NCT03867305 785 798 B-Condition
amputation NCT03867305 799 809 I-Condition
, NCT03867305 810 811 O
pressure NCT03867305 812 820 B-Condition
ulcers NCT03867305 821 827 I-Condition
, NCT03867305 828 829 O
severe NCT03867305 830 836 O
Obstructive NCT03867305 837 848 B-Condition
Arteriopathy NCT03867305 849 861 I-Condition
of NCT03867305 862 864 O
Lower NCT03867305 865 870 B-Modifier
Limbs NCT03867305 871 876 I-Modifier
, NCT03867305 877 878 O
lymphoedema NCT03867305 879 890 B-Modifier
or NCT03867305 891 893 B-Or
thromboembolic NCT03867305 894 908 B-Condition
event NCT03867305 909 914 I-Condition
of NCT03867305 915 917 O
the NCT03867305 918 921 O
lower NCT03867305 922 927 B-Modifier
limb NCT03867305 928 932 I-Modifier
( NCT03867305 933 934 O
ipsilateral NCT03867305 935 946 B-Modifier
and NCT03867305 947 950 B-Or
/ NCT03867305 951 952 I-Or
or NCT03867305 953 955 I-Or
contralateral NCT03867305 956 969 B-Modifier
/ NCT03867305 970 971 B-Or
superficial NCT03867305 972 983 B-Modifier
or NCT03867305 984 986 B-Or
deep NCT03867305 987 991 B-Modifier
or NCT03867305 992 994 B-Or
detected NCT03867305 995 1003 O
by NCT03867305 1004 1006 O
post NCT03867305 1007 1011 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03867305 1012 1021 B-Procedure
Doppler NCT03867305 1022 1029 B-Procedure
) NCT03867305 1030 1031 O
. NCT03867305 1032 1033 O

- NCT03867305 1037 1038 O
The NCT03867305 1040 1043 O
subject NCT03867305 1044 1051 O
has NCT03867305 1052 1055 O
chronic NCT03867305 1056 1063 O
or NCT03867305 1064 1066 B-Or
active NCT03867305 1067 1073 B-Eq_Comparison
wounds NCT03867305 1074 1080 B-Condition
or NCT03867305 1081 1083 B-Or
any NCT03867305 1084 1087 O
cause NCT03867305 1088 1093 B-Condition
that NCT03867305 1094 1098 O
hinders NCT03867305 1099 1106 B-Assertion___Assertion_Type_Value:hypothetical
normal NCT03867305 1107 1113 O
rehabilitation NCT03867305 1114 1128 B-Procedure
or NCT03867305 1129 1131 B-Or
the NCT03867305 1132 1135 O
application NCT03867305 1136 1147 O
of NCT03867305 1148 1150 O
a NCT03867305 1151 1152 O
bandage NCT03867305 1153 1160 B-Procedure
. NCT03867305 1161 1162 O

- NCT03867305 1166 1167 O
patient NCT03867305 1169 1176 O
with NCT03867305 1177 1181 O
a NCT03867305 1182 1183 O
stroke NCT03867305 1184 1190 B-Condition
/ NCT03867305 1191 1192 B-Or
Disabling NCT03867305 1193 1202 B-Modifier
Neurological NCT03867305 1203 1215 B-Condition
Pathology NCT03867305 1216 1225 I-Condition
, NCT03867305 1226 1227 O
Chronic NCT03867305 1228 1235 O
Immunological NCT03867305 1236 1249 B-Condition
Pathology NCT03867305 1250 1259 I-Condition
/ NCT03867305 1260 1261 B-Or
Systemic NCT03867305 1262 1270 B-Modifier
Disease NCT03867305 1271 1278 B-Condition
. NCT03867305 1279 1280 O

- NCT03867305 1284 1285 O
patient NCT03867305 1287 1294 O
with NCT03867305 1295 1299 O
Hepatic NCT03867305 1300 1307 B-Condition
insufficiency NCT03867305 1308 1321 I-Condition
. NCT03867305 1322 1323 O

- NCT03867305 1327 1328 O
patient NCT03867305 1330 1337 O
with NCT03867305 1338 1342 O
Venous NCT03867305 1343 1349 B-Condition
insufficiency NCT03867305 1350 1363 I-Condition
( NCT03867305 1364 1365 O
stages NCT03867305 1366 1372 B-Eq_Comparison
3 NCT03867305 1373 1374 I-Eq_Comparison
and NCT03867305 1375 1378 I-Eq_Comparison
4 NCT03867305 1379 1380 I-Eq_Comparison
) NCT03867305 1381 1382 O
. NCT03867305 1383 1384 O

- NCT03867305 1388 1389 O
The NCT03867305 1391 1394 O
patient NCT03867305 1395 1402 O
is NCT03867305 1403 1405 O
on NCT03867305 1406 1408 B-Eq_Comparison
dialysis NCT03867305 1409 1417 B-Procedure
. NCT03867305 1418 1419 O

- NCT03867305 1423 1424 O
The NCT03867305 1426 1429 O
subject NCT03867305 1430 1437 O
has NCT03867305 1438 1441 O
cognitive NCT03867305 1442 1451 B-Modifier
or NCT03867305 1452 1454 B-Or
behavioral NCT03867305 1455 1465 B-Modifier
disorders NCT03867305 1466 1475 B-Condition
( NCT03867305 1476 1477 O
Parkinson NCT03867305 1478 1487 B-Condition
's NCT03867305 1487 1489 I-Condition
disease NCT03867305 1490 1497 I-Condition
, NCT03867305 1498 1499 O
cerebellar NCT03867305 1500 1510 B-Condition
syndrome NCT03867305 1511 1519 I-Condition
, NCT03867305 1520 1521 O
opposition NCT03867305 1522 1532 B-Condition
, NCT03867305 1533 1534 O
agitation NCT03867305 1535 1544 B-Condition
, NCT03867305 1545 1546 O
dementia NCT03867305 1547 1555 B-Condition
) NCT03867305 1556 1557 O
. NCT03867305 1558 1559 O

- NCT03867305 1563 1564 O
The NCT03867305 1566 1569 O
subject NCT03867305 1570 1577 O
has NCT03867305 1578 1581 O
a NCT03867305 1582 1583 O
history NCT03867305 1584 1591 B-Eq_Comparison
of NCT03867305 1592 1594 O
knee NCT03867305 1595 1599 B-Procedure
surgery NCT03867305 1600 1607 I-Procedure
. NCT03867305 1608 1609 O

Inclusion NCT03921502 0 9 O
Criteria NCT03921502 10 18 O
: NCT03921502 19 20 O

- NCT03921502 24 25 O
Symptomatic NCT03921502 27 38 B-Assertion___Assertion_Type_Value:possible
choledocholithiasis NCT03921502 39 58 B-Condition
( NCT03921502 59 60 O
choledocholithiasis NCT03921502 61 80 B-Condition
demonstrated NCT03921502 81 93 O
radiologically NCT03921502 94 108 B-Procedure
or NCT03921502 109 111 B-Or
highly NCT03921502 112 118 O
suspected NCT03921502 119 128 B-Assertion___Assertion_Type_Value:possible
by NCT03921502 129 131 O
clinical NCT03921502 132 140 B-Condition
data NCT03921502 141 145 I-Condition
( NCT03921502 146 147 O
acute NCT03921502 148 153 B-Condition
cholangitis NCT03921502 154 165 I-Condition
or NCT03921502 166 168 B-Or
obstructive NCT03921502 169 180 B-Condition
jaundice NCT03921502 181 189 I-Condition
) NCT03921502 190 191 O
, NCT03921502 192 193 O
analytical NCT03921502 194 204 B-Observation
and NCT03921502 205 208 B-Or
imaging NCT03921502 209 216 B-Procedure
according NCT03921502 217 226 O
to NCT03921502 227 229 O
the NCT03921502 230 233 O
criteria NCT03921502 234 242 O
of NCT03921502 243 245 O
high NCT03921502 246 250 O
probability NCT03921502 251 262 O
of NCT03921502 263 265 O
choledocholithiasis NCT03921502 266 285 O
established NCT03921502 286 297 O
in NCT03921502 298 300 O
the NCT03921502 301 304 O
clinical NCT03921502 305 313 O
guidelines NCT03921502 314 324 O
( NCT03921502 325 326 O
ASGE NCT03921502 327 331 O
Guide NCT03921502 332 337 O
) NCT03921502 338 339 O
. NCT03921502 340 341 O

- NCT03921502 345 346 O
Discarded NCT03921502 348 357 O
for NCT03921502 358 361 O
surgical NCT03921502 362 370 O
treatment NCT03921502 371 380 O
due NCT03921502 381 384 O
to NCT03921502 385 387 O
age NCT03921502 388 391 O
, NCT03921502 392 393 O
comorbidity NCT03921502 394 405 O
or NCT03921502 406 408 O
refusal NCT03921502 409 416 O
of NCT03921502 417 419 O
the NCT03921502 420 423 O
patient NCT03921502 424 431 O
. NCT03921502 432 433 O

- NCT03921502 437 438 O
Age NCT03921502 440 443 B-Age
> NCT03921502 444 445 B-Eq_Comparison
75 NCT03921502 446 448 I-Eq_Comparison
years NCT03921502 449 454 I-Eq_Comparison

Exclusion NCT03921502 455 464 O
Criteria NCT03921502 465 473 O
: NCT03921502 474 475 O

- NCT03921502 479 480 O
Charlson NCT03921502 482 490 B-Observation
comorbidity NCT03921502 491 502 I-Observation
scale NCT03921502 503 508 I-Observation
adjusted NCT03921502 509 517 B-Modifier
to NCT03921502 518 520 I-Modifier
age NCT03921502 521 524 I-Modifier
< NCT03921502 525 526 B-Eq_Comparison
4 NCT03921502 527 528 I-Eq_Comparison
. NCT03921502 528 529 O

- NCT03921502 533 534 O
Prior NCT03921502 536 541 B-Eq_Comparison
ERCP NCT03921502 542 546 B-Procedure
. NCT03921502 547 548 O

- NCT03921502 552 553 O
Previous NCT03921502 555 563 B-Eq_Comparison
episodes NCT03921502 564 572 O
of NCT03921502 573 575 O
cholangitis NCT03921502 576 587 B-Condition
, NCT03921502 588 589 O
pancreatitis NCT03921502 590 602 B-Condition
or NCT03921502 603 605 B-Or
lithiasic NCT03921502 606 615 B-Condition
cholecystitis NCT03921502 616 629 I-Condition
. NCT03921502 630 631 O

- NCT03921502 635 636 O
Hepatobiliary NCT03921502 638 651 B-Procedure
surgery NCT03921502 652 659 I-Procedure
or NCT03921502 660 662 B-Or
previous NCT03921502 663 671 B-Eq_Comparison
superior NCT03921502 672 680 B-Condition
digestive NCT03921502 681 690 I-Condition
tract NCT03921502 691 696 I-Condition
. NCT03921502 697 698 O

- NCT03921502 702 703 O
Ascitis NCT03921502 705 712 B-Condition
. NCT03921502 713 714 O

- NCT03921502 718 719 O
Inability NCT03921502 721 730 B-Negation
to NCT03921502 731 733 O
tolerate NCT03921502 734 742 B-Assertion___Assertion_Type_Value:hypothetical
sedation NCT03921502 743 751 B-Procedure
of NCT03921502 752 754 I-Procedure
endoscopy NCT03921502 755 764 I-Procedure
, NCT03921502 765 766 O
perforation NCT03921502 767 778 B-Condition
of NCT03921502 779 781 I-Condition
the NCT03921502 782 785 I-Condition
digestive NCT03921502 786 795 I-Condition
tract NCT03921502 796 801 I-Condition
or NCT03921502 802 804 O
other NCT03921502 805 810 O
contraindication NCT03921502 811 827 B-Contraindication
to NCT03921502 828 830 O
endoscopy NCT03921502 831 840 B-Procedure
. NCT03921502 841 842 O

- NCT03921502 846 847 O
Coagulopathy NCT03921502 849 861 B-Condition
with NCT03921502 862 866 B-And
INR NCT03921502 867 870 B-Observation
( NCT03921502 871 872 O
international NCT03921502 873 886 B-Observation
normalized NCT03921502 887 897 I-Observation
ratio NCT03921502 898 903 I-Observation
) NCT03921502 904 905 O
> NCT03921502 906 907 B-Eq_Comparison
1.5 NCT03921502 908 911 I-Eq_Comparison
not NCT03921502 912 915 O
correctable NCT03921502 916 927 O
or NCT03921502 928 930 O
thrombocytopenia NCT03921502 931 947 B-Condition
< NCT03921502 948 949 B-Eq_Comparison
50000 NCT03921502 950 955 I-Eq_Comparison
/ NCT03921502 956 957 I-Eq_Comparison
mm NCT03921502 958 960 I-Eq_Comparison
3 NCT03921502 961 962 I-Eq_Comparison
not NCT03921502 963 966 O
correctable NCT03921502 967 978 O
. NCT03921502 979 980 O

- NCT03921502 984 985 O
Other NCT03921502 987 992 B-Other
diagnoses NCT03921502 993 1002 B-Condition
at NCT03921502 1003 1005 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03921502 1006 1015 B-Encounter
( NCT03921502 1016 1017 O
acute NCT03921502 1018 1023 B-Condition
cholecystitis NCT03921502 1024 1037 I-Condition
, NCT03921502 1038 1039 O
acute NCT03921502 1040 1045 B-Condition
pancreatitis NCT03921502 1046 1058 I-Condition
, NCT03921502 1059 1060 O
biliopancreatic NCT03921502 1061 1076 B-Condition
neoplasia NCT03921502 1077 1086 I-Condition
) NCT03921502 1087 1088 O
. NCT03921502 1089 1090 O

- NCT03921502 1094 1095 O
Hemodynamic NCT03921502 1097 1108 B-Condition
instability NCT03921502 1109 1120 O
. NCT03921502 1121 1122 O

- NCT03921502 1126 1127 O
Urgent NCT03921502 1129 1135 B-Procedure
procedure NCT03921502 1136 1145 I-Procedure
performed NCT03921502 1146 1155 O
after NCT03921502 1156 1161 O
hours NCT03921502 1162 1167 O

- NCT03921502 1170 1171 O
No NCT03921502 1173 1175 O
availability NCT03921502 1176 1188 O
of NCT03921502 1189 1191 O
expert NCT03921502 1192 1198 O
material NCT03921502 1199 1207 O
/ NCT03921502 1208 1209 O
endoscopist NCT03921502 1210 1221 O
in NCT03921502 1222 1224 O
drainage NCT03921502 1225 1233 O
. NCT03921502 1234 1235 O

- NCT03921502 1239 1240 O
Anatomical NCT03921502 1242 1252 O
impossibility NCT03921502 1253 1266 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03921502 1267 1269 O
performing NCT03921502 1270 1280 O
biliary NCT03921502 1281 1288 B-Procedure
drainage NCT03921502 1289 1297 I-Procedure
( NCT03921502 1298 1299 O
absence NCT03921502 1300 1307 B-Negation
of NCT03921502 1308 1310 O
vesicular NCT03921502 1311 1320 B-Condition
distension NCT03921502 1321 1331 I-Condition
, NCT03921502 1332 1333 O
contact NCT03921502 1334 1341 B-Condition
between NCT03921502 1342 1349 O
gallbladder NCT03921502 1350 1361 B-Modifier
and NCT03921502 1362 1365 B-And
stomach NCT03921502 1366 1373 B-Modifier
or NCT03921502 1374 1376 B-Or
duodenum NCT03921502 1377 1385 B-Modifier
, NCT03921502 1386 1387 O
contact NCT03921502 1388 1395 B-Observation
area NCT03921502 1396 1400 I-Observation
< NCT03921502 1401 1402 B-Eq_Comparison
10 NCT03921502 1403 1405 I-Eq_Comparison
mm NCT03921502 1406 1408 I-Eq_Comparison
) NCT03921502 1409 1410 O
. NCT03921502 1411 1412 O

- NCT03921502 1416 1417 O
Baseline NCT03921502 1419 1427 O
ECOG NCT03921502 1428 1432 B-Observation
( NCT03921502 1433 1434 O
Easthern NCT03921502 1435 1443 B-Observation
Cooperative NCT03921502 1444 1455 I-Observation
Oncology NCT03921502 1456 1464 I-Observation
Group NCT03921502 1465 1470 I-Observation
) NCT03921502 1471 1472 O
> NCT03921502 1473 1474 B-Eq_Comparison
= NCT03921502 1475 1476 I-Eq_Comparison
4 NCT03921502 1477 1478 I-Eq_Comparison

- NCT03921502 1482 1483 O
Expectancy NCT03921502 1485 1495 B-Observation
of NCT03921502 1496 1498 I-Observation
survival NCT03921502 1499 1507 I-Observation
< NCT03921502 1508 1509 B-Eq_Comparison
6 NCT03921502 1510 1511 I-Eq_Comparison
months NCT03921502 1512 1518 I-Eq_Comparison
. NCT03921502 1519 1520 O

- NCT03921502 1524 1525 O
Refusal NCT03921502 1527 1534 O
to NCT03921502 1535 1537 O
participate NCT03921502 1538 1549 O
. NCT03921502 1550 1551 O

- NCT03921502 1555 1556 O
Distance NCT03921502 1558 1566 B-Observation
between NCT03921502 1567 1574 O
the NCT03921502 1575 1578 O
gallbladder NCT03921502 1579 1590 B-Modifier
and NCT03921502 1591 1594 B-And
upper NCT03921502 1595 1600 B-Modifier
digestive NCT03921502 1601 1610 I-Modifier
tract NCT03921502 1611 1616 I-Modifier
> NCT03921502 1617 1618 B-Eq_Comparison
1 NCT03921502 1619 1620 I-Eq_Comparison
cm NCT03921502 1621 1623 I-Eq_Comparison
, NCT03921502 1624 1625 O
scleroatrophic NCT03921502 1626 1640 B-Condition
vesicle NCT03921502 1641 1648 I-Condition
, NCT03921502 1649 1650 O
lack NCT03921502 1651 1655 B-Negation
of NCT03921502 1656 1658 I-Negation
stable NCT03921502 1659 1665 O
acoustic NCT03921502 1666 1674 B-Observation
window NCT03921502 1675 1681 I-Observation
for NCT03921502 1682 1685 O
drainage NCT03921502 1686 1694 B-Procedure

- NCT03921502 1697 1698 O
ERCP NCT03921502 1700 1704 B-Condition
failed NCT03921502 1705 1711 O
( NCT03921502 1712 1713 O
inhability NCT03921502 1714 1724 B-Negation
to NCT03921502 1725 1727 O
dain NCT03921502 1728 1732 B-Condition
common NCT03921502 1733 1739 I-Condition
bile NCT03921502 1740 1744 I-Condition
duct NCT03921502 1745 1749 I-Condition
) NCT03921502 1750 1751 O

Inclusion NCT03869008 0 9 O
Criteria NCT03869008 10 18 O
: NCT03869008 19 20 O

• NCT03869008 22 23 O
Clinical NCT03869008 24 32 O
Diagnosis NCT03869008 33 42 O
of NCT03869008 43 45 O
Primary NCT03869008 46 53 B-Condition
Raynaud NCT03869008 54 61 I-Condition
's NCT03869008 61 63 I-Condition
Phenomenon NCT03869008 64 74 I-Condition

Exclusion NCT03869008 75 84 O
Criteria NCT03869008 85 93 O
: NCT03869008 94 95 O

- NCT03869008 99 100 O
Less NCT03869008 102 106 B-Eq_Comparison
than NCT03869008 107 111 I-Eq_Comparison
18 NCT03869008 112 114 I-Eq_Comparison
years NCT03869008 115 120 I-Eq_Comparison
of NCT03869008 121 123 O
age NCT03869008 124 127 B-Age

- NCT03869008 130 131 O
Pregnant NCT03869008 133 141 B-Condition
women NCT03869008 142 147 O

- NCT03869008 150 151 O
Current NCT03869008 153 160 B-Eq_Comparison
smokers NCT03869008 161 168 B-Condition

- NCT03869008 171 172 O
Have NCT03869008 174 178 O
Digital NCT03869008 179 186 B-Modifier
ulcers NCT03869008 187 193 B-Condition

- NCT03869008 196 197 O
Diagnosed NCT03869008 199 208 O
Pulmonary NCT03869008 209 218 B-Condition
hypertension NCT03869008 219 231 I-Condition

- NCT03869008 234 235 O
Currently NCT03869008 237 246 B-Eq_Comparison
on NCT03869008 247 249 O
vasodilators NCT03869008 250 262 B-Drug
( NCT03869008 263 264 O
i NCT03869008 265 266 O
. NCT03869008 267 268 O
e NCT03869008 269 270 O
. NCT03869008 271 272 O
Phosphodiesterase NCT03869008 274 291 B-Drug
type NCT03869008 292 296 I-Drug
5 NCT03869008 297 298 I-Drug
inhibitors NCT03869008 299 309 I-Drug
, NCT03869008 310 311 O
prostacyclin NCT03869008 312 324 B-Drug
, NCT03869008 325 326 O
nitroglycerine NCT03869008 327 341 B-Drug
, NCT03869008 342 343 O
or NCT03869008 344 346 B-Or
other NCT03869008 347 352 B-Other
nitric NCT03869008 353 359 B-Drug
oxide NCT03869008 360 365 I-Drug
derivatives NCT03869008 366 377 I-Drug
) NCT03869008 378 379 O

- NCT03869008 383 384 O
Currently NCT03869008 386 395 B-Eq_Comparison
on NCT03869008 396 398 O
Calcium NCT03869008 399 406 B-Drug
Channel NCT03869008 407 414 I-Drug
Blockers NCT03869008 415 423 I-Drug

Inclusion NCT03862404 0 9 O
Criteria NCT03862404 10 18 O
: NCT03862404 19 20 O

- NCT03862404 24 25 O
Male NCT03862404 27 31 O
and NCT03862404 32 35 B-Or
Female NCT03862404 36 42 O
, NCT03862404 43 44 O
between NCT03862404 45 52 B-Eq_Comparison
18 NCT03862404 53 55 I-Eq_Comparison
and NCT03862404 56 59 I-Eq_Comparison
80 NCT03862404 60 62 I-Eq_Comparison
years NCT03862404 63 68 I-Eq_Comparison
, NCT03862404 69 70 O
ASA NCT03862404 71 74 B-Observation
1 NCT03862404 75 76 B-Eq_Comparison
- NCT03862404 77 78 I-Eq_Comparison
3 NCT03862404 79 80 I-Eq_Comparison
, NCT03862404 81 82 O
Scheduled NCT03862404 83 92 B-Eq_Comparison
for NCT03862404 93 96 O
open NCT03862404 97 101 B-Modifier
thoracotomy NCT03862404 102 113 B-Procedure

Exclusion NCT03862404 114 123 O
Criteria NCT03862404 124 132 O
: NCT03862404 133 134 O

- NCT03862404 138 139 O
ASA NCT03862404 141 144 B-Observation
> NCT03862404 145 146 B-Eq_Comparison
3 NCT03862404 147 148 I-Eq_Comparison
, NCT03862404 149 150 O
morbid NCT03862404 151 157 B-Condition
obesity NCT03862404 158 165 I-Condition
BMI NCT03862404 166 169 B-Observation
> NCT03862404 170 171 B-Eq_Comparison
40 NCT03862404 172 174 I-Eq_Comparison
, NCT03862404 175 176 O
Previous NCT03862404 177 185 B-Eq_Comparison
cardiac NCT03862404 186 193 B-Modifier
or NCT03862404 194 196 B-Or
ipsilateral NCT03862404 197 208 B-Modifier
thoracic NCT03862404 209 217 B-Procedure
surgery NCT03862404 218 225 I-Procedure
, NCT03862404 226 227 O
Renal NCT03862404 228 233 B-Modifier
or NCT03862404 234 236 B-Or
hepatic NCT03862404 237 244 B-Modifier
failure NCT03862404 245 252 B-Condition
, NCT03862404 253 254 O
anemia NCT03862404 255 261 B-Condition
, NCT03862404 262 263 O
allergy NCT03862404 264 271 B-Allergy
to NCT03862404 272 274 O
local NCT03862404 275 280 B-Procedure
anesthetics NCT03862404 281 292 I-Procedure
, NCT03862404 293 294 O
contraindications NCT03862404 295 312 B-Contraindication
to NCT03862404 313 315 O
receive NCT03862404 316 323 O
regional NCT03862404 324 332 B-Procedure
anesthesia NCT03862404 333 343 I-Procedure
, NCT03862404 344 345 O
patient NCT03862404 346 353 O
refusal NCT03862404 354 361 O
, NCT03862404 362 363 O
reiteration NCT03862404 364 375 B-Observation
due NCT03862404 376 379 O
to NCT03862404 380 382 O
complication NCT03862404 383 395 B-Condition

Inclusion NCT03921632 0 9 O
Criteria NCT03921632 10 18 O
: NCT03921632 19 20 O

- NCT03921632 24 25 O
Patient NCT03921632 27 34 O
of NCT03921632 35 37 O
the NCT03921632 38 41 O
UNC NCT03921632 42 45 O
Center NCT03921632 46 52 O
for NCT03921632 53 56 O
Excellence NCT03921632 57 67 O
for NCT03921632 68 71 O
Eating NCT03921632 72 78 O
Disorders NCT03921632 79 88 O
inpatient NCT03921632 89 98 O
unit NCT03921632 99 103 O
or NCT03921632 104 106 B-Or
outpatient NCT03921632 107 117 O
clinic NCT03921632 118 124 O
. NCT03921632 125 126 O

- NCT03921632 130 131 O
Diagnosis NCT03921632 133 142 O
of NCT03921632 143 145 O
anorexia NCT03921632 146 154 B-Condition
nervosa NCT03921632 155 162 I-Condition
or NCT03921632 163 165 B-Or
bulimia NCT03921632 166 173 B-Condition
nervosa NCT03921632 174 181 I-Condition

- NCT03921632 184 185 O
Aged NCT03921632 187 191 B-Age
13 NCT03921632 192 194 B-Eq_Comparison
- NCT03921632 195 196 I-Eq_Comparison
50 NCT03921632 197 199 I-Eq_Comparison
years NCT03921632 200 205 I-Eq_Comparison

- NCT03921632 208 209 O
English NCT03921632 211 218 O
- NCT03921632 219 220 O
speaking NCT03921632 221 229 O

Exclusion NCT03921632 230 239 O
Criteria NCT03921632 240 248 O
: NCT03921632 249 250 O

- NCT03921632 254 255 O
Decisionally NCT03921632 257 269 B-Condition
impaired NCT03921632 270 278 I-Condition
( NCT03921632 279 280 O
i NCT03921632 281 282 O
. NCT03921632 283 284 O
e NCT03921632 285 286 O
. NCT03921632 287 288 O
, NCT03921632 289 290 O
Incapable NCT03921632 291 300 O
of NCT03921632 301 303 O
providing NCT03921632 304 313 O
informed NCT03921632 314 322 O
consent NCT03921632 323 330 O
in NCT03921632 331 333 O
the NCT03921632 334 337 O
opinion NCT03921632 338 345 O
of NCT03921632 346 348 O
the NCT03921632 349 352 O
primary NCT03921632 353 360 O
care NCT03921632 361 365 O
provider NCT03921632 366 374 O
in NCT03921632 375 377 O
UNC NCT03921632 378 381 O
Center NCT03921632 382 388 O
for NCT03921632 389 392 O
Excellence NCT03921632 393 403 O
for NCT03921632 404 407 O
Eating NCT03921632 408 414 O
Disorders NCT03921632 415 424 O
) NCT03921632 425 426 O

- NCT03921632 430 431 O
Involuntarily NCT03921632 433 446 B-Observation
committed NCT03921632 447 456 I-Observation
to NCT03921632 457 459 O
the NCT03921632 460 463 O
inpatient NCT03921632 464 473 O
service NCT03921632 474 481 O
of NCT03921632 482 484 O
the NCT03921632 485 488 O
UNC NCT03921632 489 492 B-Provider
Department NCT03921632 493 503 I-Provider
of NCT03921632 504 506 I-Provider
Psychiatry NCT03921632 507 517 I-Provider

Inclusion NCT03863314 0 9 O
Criteria NCT03863314 10 18 O
: NCT03863314 19 20 O

- NCT03863314 24 25 O
Greater NCT03863314 27 34 B-Eq_Comparison
than NCT03863314 35 39 I-Eq_Comparison
18 NCT03863314 40 42 I-Eq_Comparison
years NCT03863314 43 48 I-Eq_Comparison
of NCT03863314 49 51 O
age NCT03863314 52 55 B-Age

- NCT03863314 58 59 O
Personnel NCT03863314 61 70 O
working NCT03863314 71 78 O
or NCT03863314 79 81 O
volunteering NCT03863314 82 94 O
at NCT03863314 95 97 O
Lucile NCT03863314 98 104 O
Packard NCT03863314 105 112 O
Children NCT03863314 113 121 O
's NCT03863314 121 123 O
Hospital NCT03863314 124 132 O
( NCT03863314 133 134 O
LPCH NCT03863314 135 139 O
) NCT03863314 140 141 O
or NCT03863314 142 144 B-Or
Stanford NCT03863314 145 153 O
Health NCT03863314 154 160 O
Care NCT03863314 161 165 O
( NCT03863314 166 167 O
SHC NCT03863314 168 171 O
) NCT03863314 172 173 O
facilities NCT03863314 174 184 O

Exclusion NCT03863314 185 194 O
Criteria NCT03863314 195 203 O
: NCT03863314 204 205 O

- NCT03863314 209 210 O
Patients NCT03863314 212 220 O
who NCT03863314 221 224 O
do NCT03863314 225 227 O
not NCT03863314 228 231 O
consent NCT03863314 232 239 O

- NCT03863314 242 243 O
Are NCT03863314 245 248 O
currently NCT03863314 249 258 B-Eq_Comparison
taking NCT03863314 259 265 I-Eq_Comparison
beta NCT03863314 266 270 B-Drug
blockers NCT03863314 271 279 I-Drug
or NCT03863314 280 282 B-Or
other NCT03863314 283 288 B-Other
chronotropic NCT03863314 289 301 B-Drug
heart NCT03863314 302 307 I-Drug
medication NCT03863314 308 318 I-Drug
( NCT03863314 319 320 I-Drug
s NCT03863314 321 322 I-Drug
) NCT03863314 323 324 O

- NCT03863314 328 329 O
Have NCT03863314 331 335 O
a NCT03863314 336 337 O
history NCT03863314 338 345 B-Eq_Comparison
of NCT03863314 346 348 O
severe NCT03863314 349 355 O
motion NCT03863314 356 362 B-Condition
sickness NCT03863314 363 371 I-Condition

- NCT03863314 374 375 O
Currently NCT03863314 377 386 B-Eq_Comparison
have NCT03863314 387 391 O
nausea NCT03863314 392 398 B-Condition

- NCT03863314 401 402 O
Currently NCT03863314 404 413 B-Eq_Comparison
experiencing NCT03863314 414 426 O
seizures NCT03863314 427 435 B-Condition

- NCT03863314 438 439 O
Are NCT03863314 441 444 O
clinically NCT03863314 445 455 O
unstable NCT03863314 456 464 O

Inclusion NCT03868709 0 9 O
Criteria NCT03868709 10 18 O
: NCT03868709 19 20 O

1 NCT03868709 24 25 O
. NCT03868709 25 26 O
Age NCT03868709 28 31 B-Age
of NCT03868709 32 34 O
50 NCT03868709 35 37 B-Eq_Comparison
years NCT03868709 38 43 I-Eq_Comparison
or NCT03868709 44 46 I-Eq_Comparison
over NCT03868709 47 51 I-Eq_Comparison
; NCT03868709 51 52 O

2 NCT03868709 55 56 O
. NCT03868709 56 57 O
Scheduled NCT03868709 59 68 B-Eq_Comparison
to NCT03868709 69 71 I-Eq_Comparison
undergo NCT03868709 72 79 I-Eq_Comparison
open NCT03868709 80 84 B-Modifier
or NCT03868709 85 87 B-Or
laparoscope NCT03868709 88 99 B-Modifier
assisted NCT03868709 100 108 I-Modifier
upper NCT03868709 109 114 B-Modifier
abdominal NCT03868709 115 124 I-Modifier
or NCT03868709 125 127 B-Or
intrathoracic NCT03868709 128 141 B-Modifier
surgery NCT03868709 142 149 B-Procedure
; NCT03868709 149 150 O

3 NCT03868709 153 154 O
. NCT03868709 154 155 O
The NCT03868709 157 160 O
expected NCT03868709 161 169 B-Assertion___Assertion_Type_Value:hypothetical
duration NCT03868709 170 178 O
of NCT03868709 179 181 O
surgery NCT03868709 182 189 B-Procedure
is NCT03868709 190 192 O
2 NCT03868709 193 194 B-Eq_Comparison
hours NCT03868709 195 200 I-Eq_Comparison
or NCT03868709 201 203 I-Eq_Comparison
longer NCT03868709 204 210 I-Eq_Comparison
; NCT03868709 210 211 O

4 NCT03868709 214 215 O
. NCT03868709 215 216 O
Identified NCT03868709 218 228 O
at NCT03868709 229 231 O
high NCT03868709 232 236 O
risk NCT03868709 237 241 B-Risk
of NCT03868709 242 244 O
PPCs NCT03868709 245 249 B-Condition
according NCT03868709 250 259 O
to NCT03868709 260 262 O
the NCT03868709 263 266 O
ARISCAT NCT03868709 267 274 B-Observation
risk NCT03868709 275 279 I-Observation
score NCT03868709 280 285 I-Observation
( NCT03868709 286 287 O
ARISCAT NCT03868709 288 295 B-Observation
predictive NCT03868709 296 306 I-Observation
score NCT03868709 307 312 I-Observation
≥ NCT03868709 313 314 B-Eq_Comparison
45 NCT03868709 315 317 I-Eq_Comparison
) NCT03868709 318 319 O
. NCT03868709 320 321 O

Exclusion NCT03868709 323 332 O
Criteria NCT03868709 333 341 O
: NCT03868709 342 343 O

1 NCT03868709 347 348 O
. NCT03868709 348 349 O
American NCT03868709 351 359 B-Observation
Society NCT03868709 360 367 I-Observation
of NCT03868709 368 370 I-Observation
Anesthesiologists NCT03868709 371 388 I-Observation
( NCT03868709 389 390 O
ASA NCT03868709 391 394 B-Observation
) NCT03868709 395 396 O
physical NCT03868709 397 405 O
classification NCT03868709 406 420 B-Eq_Comparison
≥ NCT03868709 421 422 I-Eq_Comparison
IV NCT03868709 423 425 I-Eq_Comparison
or NCT03868709 426 428 B-Or
the NCT03868709 429 432 O
expected NCT03868709 433 441 B-Observation
survival NCT03868709 442 450 I-Observation
duration NCT03868709 451 459 O
≤ NCT03868709 460 461 B-Eq_Comparison
24 NCT03868709 462 464 I-Eq_Comparison
h NCT03868709 465 466 I-Eq_Comparison
; NCT03868709 466 467 O

2 NCT03868709 470 471 O
. NCT03868709 471 472 O
Pre NCT03868709 474 477 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03868709 478 487 B-Procedure
history NCT03868709 488 495 B-Eq_Comparison
of NCT03868709 496 498 O
prostatic NCT03868709 499 508 B-Condition
hypertrophy NCT03868709 509 520 I-Condition
or NCT03868709 521 523 B-Or
glaucoma NCT03868709 524 532 B-Condition
; NCT03868709 532 533 O

3 NCT03868709 536 537 O
. NCT03868709 537 538 O
History NCT03868709 540 547 B-Eq_Comparison
of NCT03868709 548 550 O
myocardial NCT03868709 551 561 B-Condition
infarction NCT03868709 562 572 I-Condition
, NCT03868709 573 574 O
severe NCT03868709 575 581 O
heart NCT03868709 582 587 B-Condition
dysfunction NCT03868709 588 599 I-Condition
( NCT03868709 600 601 O
New NCT03868709 602 605 B-Observation
York NCT03868709 606 610 I-Observation
Heart NCT03868709 611 616 I-Observation
Association NCT03868709 617 628 I-Observation
functional NCT03868709 629 639 I-Observation
classification NCT03868709 640 654 B-Eq_Comparison
≥ NCT03868709 655 656 I-Eq_Comparison
3 NCT03868709 657 658 I-Eq_Comparison
) NCT03868709 659 660 O
or NCT03868709 661 663 B-Or
tachyarrhythmia NCT03868709 664 679 B-Condition
within NCT03868709 680 686 B-Eq_Comparison
one NCT03868709 687 690 I-Eq_Comparison
year NCT03868709 691 695 I-Eq_Comparison
; NCT03868709 695 696 O

4 NCT03868709 699 700 O
. NCT03868709 700 701 O
Inhalation NCT03868709 703 713 O
of NCT03868709 714 716 O
β NCT03868709 717 718 B-Drug
2 NCT03868709 719 720 I-Drug
- NCT03868709 721 722 I-Drug
receptor NCT03868709 723 731 I-Drug
activator NCT03868709 732 741 I-Drug
, NCT03868709 742 743 O
M NCT03868709 744 745 B-Drug
- NCT03868709 746 747 I-Drug
receptor NCT03868709 748 756 I-Drug
blockers NCT03868709 757 765 I-Drug
and NCT03868709 766 769 B-Or
/ NCT03868709 770 771 I-Or
or NCT03868709 772 774 I-Or
glucocorticoids NCT03868709 775 790 B-Drug
within NCT03868709 791 797 B-Eq_Comparison
one NCT03868709 798 801 I-Eq_Comparison
month NCT03868709 802 807 I-Eq_Comparison
before NCT03868709 808 814 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03868709 815 822 B-Procedure
; NCT03868709 822 823 O

5 NCT03868709 826 827 O
. NCT03868709 827 828 O
Severe NCT03868709 830 836 O
renal NCT03868709 837 842 B-Condition
dysfunction NCT03868709 843 854 I-Condition
( NCT03868709 855 856 O
requirement NCT03868709 857 868 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03868709 869 871 O
renal NCT03868709 872 877 B-Procedure
replacement NCT03868709 878 889 I-Procedure
therapy NCT03868709 890 897 I-Procedure
) NCT03868709 898 899 O
or NCT03868709 900 902 B-Or
severe NCT03868709 903 909 O
hepatic NCT03868709 910 917 B-Condition
dysfunction NCT03868709 918 929 I-Condition
( NCT03868709 930 931 O
Child NCT03868709 932 937 B-Observation
- NCT03868709 938 939 I-Observation
Pugh NCT03868709 940 944 I-Observation
grade NCT03868709 945 950 B-Eq_Comparison
C NCT03868709 951 952 I-Eq_Comparison
) NCT03868709 953 954 O
; NCT03868709 955 956 O

6 NCT03868709 959 960 O
. NCT03868709 960 961 O
History NCT03868709 963 970 B-Eq_Comparison
of NCT03868709 971 973 O
acute NCT03868709 974 979 O
stroke NCT03868709 980 986 B-Condition
within NCT03868709 987 993 B-Eq_Comparison
three NCT03868709 994 999 I-Eq_Comparison
months NCT03868709 1000 1006 I-Eq_Comparison
before NCT03868709 1007 1013 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03868709 1014 1021 B-Procedure
; NCT03868709 1021 1022 O

7 NCT03868709 1025 1026 O
. NCT03868709 1026 1027 O
Refuse NCT03868709 1029 1035 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868709 1036 1038 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03868709 1039 1050 O
in NCT03868709 1051 1053 O
the NCT03868709 1054 1057 O
study NCT03868709 1058 1063 B-Study
or NCT03868709 1064 1066 B-Or
unable NCT03868709 1067 1073 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03868709 1074 1076 O
cooperate NCT03868709 1077 1086 O
with NCT03868709 1087 1091 O
the NCT03868709 1092 1095 O
inhalation NCT03868709 1096 1106 B-Procedure
therapy NCT03868709 1107 1114 I-Procedure
; NCT03868709 1114 1115 O

8 NCT03868709 1118 1119 O
. NCT03868709 1119 1120 O
Participation NCT03868709 1122 1135 O
in NCT03868709 1136 1138 O
other NCT03868709 1139 1144 B-Other
clinical NCT03868709 1145 1153 B-Study
trial NCT03868709 1154 1159 I-Study
during NCT03868709 1160 1166 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868709 1167 1170 O
last NCT03868709 1171 1175 B-Eq_Comparison
month NCT03868709 1176 1181 I-Eq_Comparison
or NCT03868709 1182 1184 B-Or
within NCT03868709 1185 1191 B-Eq_Comparison
the NCT03868709 1192 1195 I-Eq_Comparison
six NCT03868709 1196 1199 I-Eq_Comparison
half NCT03868709 1200 1204 I-Eq_Comparison
- NCT03868709 1205 1206 I-Eq_Comparison
life NCT03868709 1207 1211 I-Eq_Comparison
periods NCT03868709 1212 1219 B-Temporal_Connection___Temporal_Connection_Type_Value:before
of NCT03868709 1220 1222 O
the NCT03868709 1223 1226 O
study NCT03868709 1227 1232 B-Study
drug NCT03868709 1233 1237 B-Drug
used NCT03868709 1238 1242 B-Temporal_Connection___Temporal_Connection_Type_Value:during
in NCT03868709 1243 1245 I-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868709 1246 1249 O
last NCT03868709 1250 1254 B-Eq_Comparison
trial NCT03868709 1255 1260 B-Study
. NCT03868709 1261 1262 O

Inclusion NCT03869684 0 9 O
Criteria NCT03869684 10 18 O
: NCT03869684 19 20 O

- NCT03869684 24 25 O
Must NCT03869684 27 31 O
agree NCT03869684 32 37 O
to NCT03869684 38 40 O
sign NCT03869684 41 45 O
informed NCT03869684 46 54 O
consent NCT03869684 55 62 O
form NCT03869684 63 67 O
, NCT03869684 68 69 O
and NCT03869684 70 73 O
to NCT03869684 74 76 O
comply NCT03869684 77 83 O
with NCT03869684 84 88 O
protocol NCT03869684 89 97 O
requirements NCT03869684 98 110 O
, NCT03869684 111 112 O
including NCT03869684 113 122 O
study NCT03869684 123 128 O
visits NCT03869684 129 135 O
. NCT03869684 136 137 O

- NCT03869684 141 142 O
Must NCT03869684 144 148 O
have NCT03869684 149 153 O
clear NCT03869684 154 159 B-Modifier
optic NCT03869684 160 165 B-Observation
media NCT03869684 166 171 I-Observation
in NCT03869684 172 174 O
the NCT03869684 175 178 O
study NCT03869684 179 184 B-Study
eye NCT03869684 185 188 B-Modifier
that NCT03869684 189 193 O
is NCT03869684 194 196 O
capable NCT03869684 197 204 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03869684 205 207 I-Assertion___Assertion_Type_Value:hypothetical
producing NCT03869684 208 217 O
high NCT03869684 218 222 B-Modifier
- NCT03869684 223 224 I-Modifier
quality NCT03869684 225 232 I-Modifier
fundus NCT03869684 233 239 B-Observation
images NCT03869684 240 246 I-Observation
. NCT03869684 247 248 O

Exclusion NCT03869684 250 259 O
Criteria NCT03869684 260 268 O
: NCT03869684 269 270 O

- NCT03869684 274 275 O
Has NCT03869684 277 280 O
active NCT03869684 281 287 B-Eq_Comparison
CNV NCT03869684 288 291 B-Condition
due NCT03869684 292 295 O
to NCT03869684 296 298 O
causes NCT03869684 299 305 B-Condition
other NCT03869684 306 311 B-Exception
than NCT03869684 312 316 I-Exception
AMD NCT03869684 317 320 B-Condition
in NCT03869684 321 323 O
the NCT03869684 324 327 O
study NCT03869684 328 333 B-Study
eye NCT03869684 334 337 B-Modifier
. NCT03869684 338 339 O

- NCT03869684 343 344 O
Has NCT03869684 346 349 O
retinal NCT03869684 350 357 B-Condition
vascular NCT03869684 358 366 I-Condition
disease NCT03869684 367 374 I-Condition
or NCT03869684 375 377 B-Or
retinal NCT03869684 378 385 B-Condition
degeneration NCT03869684 386 398 I-Condition
other NCT03869684 399 404 B-Exception
than NCT03869684 405 409 I-Exception
AMD NCT03869684 410 413 B-Condition
in NCT03869684 414 416 O
the NCT03869684 417 420 O
study NCT03869684 421 426 B-Study
eye NCT03869684 427 430 B-Modifier
. NCT03869684 431 432 O

- NCT03869684 436 437 O
Has NCT03869684 439 442 O
had NCT03869684 443 446 B-Eq_Comparison
intraocular NCT03869684 447 458 B-Procedure
surgery NCT03869684 459 466 I-Procedure
, NCT03869684 467 468 O
cataract NCT03869684 469 477 B-Procedure
surgery NCT03869684 478 485 I-Procedure
or NCT03869684 486 488 B-Or
LASIK NCT03869684 489 494 B-Procedure
surgery NCT03869684 495 502 I-Procedure
on NCT03869684 503 505 O
the NCT03869684 506 509 O
study NCT03869684 510 515 B-Study
eye NCT03869684 516 519 B-Modifier
within NCT03869684 520 526 B-Eq_Comparison
90 NCT03869684 527 529 I-Eq_Comparison
days NCT03869684 530 534 I-Eq_Comparison
prior NCT03869684 535 540 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03869684 541 543 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03869684 544 547 O
study NCT03869684 548 553 B-Study
. NCT03869684 554 555 O

- NCT03869684 564 565 O
Has NCT03869684 567 570 O
had NCT03869684 571 574 O
yttrium NCT03869684 575 582 B-Procedure
aluminum NCT03869684 583 591 I-Procedure
garnet NCT03869684 592 598 I-Procedure
( NCT03869684 599 600 O
YAG NCT03869684 601 604 B-Procedure
) NCT03869684 605 606 O
laser NCT03869684 607 612 B-Procedure
capsulotomy NCT03869684 613 624 I-Procedure
on NCT03869684 625 627 O
the NCT03869684 628 631 O
study NCT03869684 632 637 B-Study
eye NCT03869684 638 641 B-Modifier
within NCT03869684 642 648 B-Eq_Comparison
30 NCT03869684 649 651 I-Eq_Comparison
days NCT03869684 652 656 I-Eq_Comparison
prior NCT03869684 657 662 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03869684 663 665 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03869684 666 669 O
study NCT03869684 670 675 B-Study
. NCT03869684 676 677 O

- NCT03869684 681 682 O
Has NCT03869684 684 687 O
active NCT03869684 688 694 B-Eq_Comparison
inflammation NCT03869684 695 707 B-Condition
, NCT03869684 708 709 O
infection NCT03869684 710 719 B-Condition
, NCT03869684 720 721 O
or NCT03869684 722 724 B-Or
other NCT03869684 725 730 B-Other
severe NCT03869684 731 737 O
ocular NCT03869684 738 744 B-Condition
disease NCT03869684 745 752 I-Condition
in NCT03869684 753 755 O
either NCT03869684 756 762 B-Modifier
eye NCT03869684 763 766 I-Modifier
. NCT03869684 767 768 O

- NCT03869684 772 773 O
Has NCT03869684 775 778 O
aphakia NCT03869684 779 786 B-Condition
in NCT03869684 787 789 O
the NCT03869684 790 793 O
study NCT03869684 794 799 B-Study
eye NCT03869684 800 803 B-Modifier
. NCT03869684 804 805 O

- NCT03869684 809 810 O
Has NCT03869684 812 815 O
uncontrolled NCT03869684 816 828 B-Modifier
glaucoma NCT03869684 829 837 B-Condition
or NCT03869684 838 840 B-Or
a NCT03869684 841 842 O
history NCT03869684 843 850 B-Eq_Comparison
of NCT03869684 851 853 I-Eq_Comparison
previous NCT03869684 854 862 I-Eq_Comparison
glaucoma NCT03869684 863 871 B-Procedure
filter NCT03869684 872 878 I-Procedure
surgery NCT03869684 879 886 I-Procedure
in NCT03869684 887 889 O
either NCT03869684 890 896 B-Modifier
eye NCT03869684 897 900 I-Modifier
. NCT03869684 901 902 O

- NCT03869684 906 907 O
Is NCT03869684 909 911 O
a NCT03869684 912 913 O
contact NCT03869684 914 921 B-Procedure
lens NCT03869684 922 926 I-Procedure
wearer NCT03869684 927 933 O
and NCT03869684 934 937 B-And
is NCT03869684 938 940 O
unable NCT03869684 941 947 B-Negation
to NCT03869684 948 950 O
discontinue NCT03869684 951 962 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
their NCT03869684 963 968 O
use NCT03869684 969 972 O
in NCT03869684 973 975 O
both NCT03869684 976 980 B-Modifier
eyes NCT03869684 981 985 I-Modifier
for NCT03869684 986 989 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03869684 990 993 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03869684 994 1002 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03869684 1003 1005 O
the NCT03869684 1006 1009 O
study NCT03869684 1010 1015 B-Study
. NCT03869684 1016 1017 O

- NCT03869684 1021 1022 O
Has NCT03869684 1024 1027 O
a NCT03869684 1028 1029 O
serious NCT03869684 1030 1037 O
allergy NCT03869684 1038 1045 B-Allergy
to NCT03869684 1046 1048 O
, NCT03869684 1049 1050 O
or NCT03869684 1051 1053 B-Or
experienced NCT03869684 1054 1065 O
a NCT03869684 1066 1067 O
prior NCT03869684 1068 1073 B-Eq_Comparison
significant NCT03869684 1074 1085 O
adverse NCT03869684 1086 1093 B-Condition
reaction NCT03869684 1094 1102 I-Condition
to NCT03869684 1103 1105 O
fluorescein NCT03869684 1106 1117 B-Procedure
angiography NCT03869684 1118 1129 I-Procedure
( NCT03869684 1130 1131 O
FA NCT03869684 1132 1134 B-Procedure
) NCT03869684 1135 1136 O
or NCT03869684 1137 1139 B-Or
indocyanine NCT03869684 1140 1151 B-Procedure
green NCT03869684 1152 1157 I-Procedure
angiography NCT03869684 1158 1169 I-Procedure
( NCT03869684 1170 1171 O
ICGA NCT03869684 1172 1176 B-Procedure
) NCT03869684 1177 1178 O
. NCT03869684 1179 1180 O

- NCT03869684 1184 1185 O
Has NCT03869684 1187 1190 O
participated NCT03869684 1191 1203 O
in NCT03869684 1204 1206 O
any NCT03869684 1207 1210 O
other NCT03869684 1211 1216 B-Other
clinical NCT03869684 1217 1225 B-Study
trial NCT03869684 1226 1231 I-Study
and NCT03869684 1232 1235 B-Or
/ NCT03869684 1236 1237 I-Or
or NCT03869684 1238 1240 I-Or
has NCT03869684 1241 1244 O
taken NCT03869684 1245 1250 O
any NCT03869684 1251 1254 O
investigational NCT03869684 1255 1270 B-Study
drug NCT03869684 1271 1275 B-Drug
or NCT03869684 1276 1278 B-Or
product NCT03869684 1279 1286 B-Drug
within NCT03869684 1287 1293 B-Eq_Comparison
90 NCT03869684 1294 1296 I-Eq_Comparison
days NCT03869684 1297 1301 I-Eq_Comparison
prior NCT03869684 1302 1307 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03869684 1308 1310 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03869684 1311 1314 O
study NCT03869684 1315 1320 B-Study
. NCT03869684 1321 1322 O

Other NCT03869684 1324 1329 O
protocol NCT03869684 1330 1338 O
- NCT03869684 1339 1340 O
defined NCT03869684 1341 1348 O
inclusion NCT03869684 1349 1358 O
/ NCT03869684 1359 1360 O
exclusion NCT03869684 1361 1370 O
criteria NCT03869684 1371 1379 O
could NCT03869684 1380 1385 O
apply NCT03869684 1386 1391 O
. NCT03869684 1392 1393 O


Inclusion NCT03862807 0 9 O
Criteria NCT03862807 10 18 O
: NCT03862807 19 20 O

- NCT03862807 24 25 O
Received NCT03862807 27 35 B-Eq_Comparison
liver NCT03862807 36 41 B-Procedure
transplant NCT03862807 42 52 I-Procedure
for NCT03862807 53 56 O
treatment NCT03862807 57 66 B-Procedure
of NCT03862807 67 69 O
hATTR NCT03862807 70 75 B-Modifier
amyloidosis NCT03862807 76 87 B-Condition
≥ NCT03862807 88 89 B-Eq_Comparison
12 NCT03862807 90 92 I-Eq_Comparison
months NCT03862807 93 99 I-Eq_Comparison
before NCT03862807 100 106 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03862807 107 112 B-Study
start NCT03862807 113 118 B-Eq_Comparison

- NCT03862807 121 122 O
Has NCT03862807 124 127 O
increase NCT03862807 128 136 O
in NCT03862807 137 139 O
polyneuropathy NCT03862807 140 154 B-Condition
disability NCT03862807 155 165 I-Condition
( NCT03862807 166 167 O
PND NCT03862807 168 171 B-Condition
) NCT03862807 172 173 O
score NCT03862807 174 179 O
after NCT03862807 180 185 B-Temporal_Connection___Temporal_Connection_Type_Value:after
liver NCT03862807 186 191 B-Procedure
transplant NCT03862807 192 202 I-Procedure

- NCT03862807 205 206 O
Has NCT03862807 208 211 O
received NCT03862807 212 220 B-Eq_Comparison
stable NCT03862807 221 227 O
immunosuppressive NCT03862807 228 245 B-Procedure
regimen NCT03862807 246 253 I-Procedure
with NCT03862807 254 258 B-And
≤ NCT03862807 259 260 B-Eq_Comparison
10 NCT03862807 261 263 I-Eq_Comparison
mg NCT03862807 264 266 I-Eq_Comparison
/ NCT03862807 267 268 I-Eq_Comparison
day NCT03862807 269 272 I-Eq_Comparison
of NCT03862807 273 275 O
prednisone NCT03862807 276 286 B-Drug
for NCT03862807 287 290 O
at NCT03862807 291 293 B-Eq_Comparison
least NCT03862807 294 299 I-Eq_Comparison
3 NCT03862807 300 301 I-Eq_Comparison
months NCT03862807 302 308 I-Eq_Comparison
before NCT03862807 309 315 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03862807 316 321 B-Study
start NCT03862807 322 327 B-Eq_Comparison

- NCT03862807 330 331 O
Has NCT03862807 333 336 O
Karnofsky NCT03862807 337 346 B-Observation
Performance NCT03862807 347 358 I-Observation
Status NCT03862807 359 365 I-Observation
( NCT03862807 366 367 O
KPS NCT03862807 368 371 B-Observation
) NCT03862807 372 373 O
of NCT03862807 374 376 O
≥ NCT03862807 377 378 B-Eq_Comparison
70 NCT03862807 379 381 I-Eq_Comparison
% NCT03862807 382 383 I-Eq_Comparison

- NCT03862807 387 388 O
Has NCT03862807 390 393 O
vitamin NCT03862807 394 401 B-Observation
A NCT03862807 402 403 I-Observation
level NCT03862807 404 409 I-Observation
greater NCT03862807 410 417 B-Eq_Comparison
than NCT03862807 418 422 I-Eq_Comparison
or NCT03862807 423 425 I-Eq_Comparison
equal NCT03862807 426 431 I-Eq_Comparison
to NCT03862807 432 434 I-Eq_Comparison
lower NCT03862807 435 440 I-Eq_Comparison
limit NCT03862807 441 446 I-Eq_Comparison
of NCT03862807 447 449 I-Eq_Comparison
normal NCT03862807 450 456 I-Eq_Comparison

Exclusion NCT03862807 457 466 O
Criteria NCT03862807 467 475 O
: NCT03862807 476 477 O

- NCT03862807 481 482 O
Has NCT03862807 484 487 O
previously NCT03862807 488 498 B-Eq_Comparison
received NCT03862807 499 507 I-Eq_Comparison
inotersen NCT03862807 508 517 B-Drug
or NCT03862807 518 520 B-Or
patisiran NCT03862807 521 530 B-Drug

- NCT03862807 533 534 O
Has NCT03862807 536 539 O
clinically NCT03862807 540 550 O
significant NCT03862807 551 562 O
liver NCT03862807 563 568 B-Observation
function NCT03862807 569 577 I-Observation
test NCT03862807 578 582 I-Observation
abnormalities NCT03862807 583 596 O

- NCT03862807 599 600 O
Has NCT03862807 602 605 O
known NCT03862807 606 611 O
portal NCT03862807 612 618 B-Condition
hypertension NCT03862807 619 631 I-Condition
with NCT03862807 632 636 B-And
ascites NCT03862807 637 644 B-Condition

- NCT03862807 647 648 O
Has NCT03862807 650 653 O
estimated NCT03862807 654 663 B-Observation
glomerular NCT03862807 664 674 I-Observation
filtration NCT03862807 675 685 I-Observation
rate NCT03862807 686 690 I-Observation
( NCT03862807 691 692 O
eGFR NCT03862807 693 697 B-Observation
) NCT03862807 698 699 O
≤ NCT03862807 700 701 B-Eq_Comparison
30 NCT03862807 702 704 I-Eq_Comparison
mL NCT03862807 705 707 I-Eq_Comparison
/ NCT03862807 708 709 I-Eq_Comparison
min NCT03862807 710 713 I-Eq_Comparison
/ NCT03862807 714 715 I-Eq_Comparison
1.73 NCT03862807 716 720 I-Eq_Comparison
m^ NCT03862807 721 723 I-Eq_Comparison
2 NCT03862807 724 725 I-Eq_Comparison

- NCT03862807 729 730 O
Has NCT03862807 732 735 O
known NCT03862807 736 741 O
leptomeningeal NCT03862807 742 756 B-Modifier
amyloidosis NCT03862807 757 768 B-Condition

- NCT03862807 771 772 O
Has NCT03862807 774 777 O
infection NCT03862807 778 787 B-Condition
with NCT03862807 788 792 B-And
hepatitis NCT03862807 793 802 B-Condition
B NCT03862807 803 804 I-Condition
, NCT03862807 805 806 O
hepatitis NCT03862807 807 816 B-Condition
C NCT03862807 817 818 I-Condition
or NCT03862807 819 821 B-Or
human NCT03862807 822 827 B-Condition
immunodeficiency NCT03862807 828 844 I-Condition
virus NCT03862807 845 850 I-Condition
( NCT03862807 851 852 O
HIV NCT03862807 853 856 B-Condition
) NCT03862807 857 858 O

- NCT03862807 862 863 O
Has NCT03862807 865 868 O
New NCT03862807 869 872 B-Observation
York NCT03862807 873 877 I-Observation
Heart NCT03862807 878 883 I-Observation
Association NCT03862807 884 895 I-Observation
heart NCT03862807 896 901 I-Observation
failure NCT03862807 902 909 I-Observation
classification NCT03862807 910 924 O
of NCT03862807 925 927 O
> NCT03862807 928 929 B-Eq_Comparison
2 NCT03862807 930 931 I-Eq_Comparison

- NCT03862807 935 936 O
Is NCT03862807 938 940 O
wheelchair NCT03862807 941 951 B-Condition
bound NCT03862807 952 957 I-Condition
or NCT03862807 958 960 B-Or
bedridden NCT03862807 961 970 B-Condition

- NCT03862807 973 974 O
Has NCT03862807 976 979 O
received NCT03862807 980 988 B-Eq_Comparison
organ NCT03862807 989 994 B-Procedure
transplants NCT03862807 995 1006 I-Procedure
other NCT03862807 1007 1012 B-Exception
than NCT03862807 1013 1017 I-Exception
liver NCT03862807 1018 1023 B-Procedure
transplant NCT03862807 1024 1034 I-Procedure

- NCT03862807 1037 1038 O
Will NCT03862807 1040 1044 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03862807 1045 1047 I-Assertion___Assertion_Type_Value:hypothetical
using NCT03862807 1048 1053 O
an NCT03862807 1054 1056 O
other NCT03862807 1057 1062 B-Other
tetramer NCT03862807 1063 1071 B-Procedure
stabilizer NCT03862807 1072 1082 I-Procedure
during NCT03862807 1083 1089 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862807 1090 1093 O
study NCT03862807 1094 1099 B-Study

Inclusion NCT03921112 0 9 O
Criteria NCT03921112 10 18 O
: NCT03921112 19 20 O

- NCT03921112 24 25 O
Mechanically NCT03921112 27 39 B-Procedure
ventilated NCT03921112 40 50 I-Procedure
patients NCT03921112 51 59 O

- NCT03921112 62 63 O
ASA NCT03921112 65 68 B-Observation
I NCT03921112 69 70 B-Eq_Comparison
, NCT03921112 71 72 O
ASA NCT03921112 73 76 B-Observation
II NCT03921112 77 79 B-Eq_Comparison
, NCT03921112 80 81 O
ASA NCT03921112 82 85 B-Observation
III NCT03921112 86 89 B-Eq_Comparison

Exclusion NCT03921112 90 99 O
Criteria NCT03921112 100 108 O
: NCT03921112 109 110 O

- NCT03921112 114 115 O
Patients NCT03921112 117 125 O
or NCT03921112 126 128 O
gurdians NCT03921112 129 137 O
refuse NCT03921112 138 144 O

- NCT03921112 147 148 O
Patients NCT03921112 150 158 O
with NCT03921112 159 163 O
pneumthorax NCT03921112 164 175 B-Condition

- NCT03921112 178 179 O
Patients NCT03921112 181 189 O
with NCT03921112 190 194 O
pleural NCT03921112 195 202 B-Condition
effusion NCT03921112 203 211 I-Condition

- NCT03921112 214 215 O
Patients NCT03921112 217 225 O
with NCT03921112 226 230 O
surgical NCT03921112 231 239 B-Condition
emphysema NCT03921112 240 249 I-Condition

- NCT03921112 252 253 O
Glasco NCT03921112 255 261 B-Observation
coma NCT03921112 262 266 I-Observation
score NCT03921112 267 272 B-Eq_Comparison
more NCT03921112 273 277 I-Eq_Comparison
than NCT03921112 278 282 I-Eq_Comparison
8 NCT03921112 283 284 I-Eq_Comparison

- NCT03921112 288 289 O
Patients NCT03921112 291 299 O
on NCT03921112 300 302 B-Eq_Comparison
high NCT03921112 303 307 O
inotropic NCT03921112 308 317 B-Drug
support NCT03921112 318 325 I-Drug

- NCT03921112 328 329 O
patients NCT03921112 331 339 O
with NCT03921112 340 344 O
diaphragmatic NCT03921112 345 358 B-Condition
paralysis NCT03921112 359 368 I-Condition

Inclusion NCT03934593 0 9 O
Criteria NCT03934593 10 18 O
: NCT03934593 19 20 O

- NCT03934593 24 25 O
Church NCT03934593 27 33 O
eligibility NCT03934593 34 45 O
: NCT03934593 46 47 O
[ NCT03934593 48 49 O
Churches NCT03934593 50 58 O
must NCT03934593 59 63 O
be NCT03934593 64 66 O
predominantly NCT03934593 67 80 O
Hispanics NCT03934593 81 90 O
( NCT03934593 91 92 O
60 NCT03934593 93 95 O
% NCT03934593 96 97 O
) NCT03934593 98 99 O
with NCT03934593 100 104 O
at NCT03934593 105 107 B-Eq_Comparison
least NCT03934593 108 113 I-Eq_Comparison
20 NCT03934593 114 116 I-Eq_Comparison
adult NCT03934593 117 122 I-Eq_Comparison
congregants NCT03934593 123 134 O
with NCT03934593 135 139 B-And
T NCT03934593 140 141 B-Condition
2D NCT03934593 142 144 I-Condition
willing NCT03934593 145 152 O
to NCT03934593 153 155 O
participate NCT03934593 156 167 O
in NCT03934593 168 170 O
the NCT03934593 171 174 O
study NCT03934593 175 180 O
. NCT03934593 181 182 O
The NCT03934593 184 187 O
rationale NCT03934593 188 197 O
for NCT03934593 198 201 O
20 NCT03934593 202 204 O
diabetic NCT03934593 205 213 O
voluntary NCT03934593 214 223 O
participants NCT03934593 224 236 O
per NCT03934593 237 240 O
church NCT03934593 241 247 O
is NCT03934593 248 250 O
based NCT03934593 251 256 O
on NCT03934593 257 259 O
the NCT03934593 260 263 O
Stanford NCT03934593 264 272 O
requirement NCT03934593 273 284 O
of NCT03934593 285 287 O

12 NCT03934593 293 295 O
- NCT03934593 296 297 O
16 NCT03934593 298 300 O
participants NCT03934593 301 313 O
allowed NCT03934593 314 321 O
per NCT03934593 322 325 O
support NCT03934593 326 333 O
group NCT03934593 334 339 O
and NCT03934593 340 343 O
with NCT03934593 344 348 O
an NCT03934593 349 351 O
anticipated NCT03934593 352 363 O
25 NCT03934593 364 366 O
% NCT03934593 367 368 O
attrition NCT03934593 369 378 O
. NCT03934593 379 380 O
] NCT03934593 381 382 O

- NCT03934593 386 387 O
Participants NCT03934593 389 401 O
' NCT03934593 401 402 O
eligibility NCT03934593 403 414 O
: NCT03934593 415 416 O
Participants NCT03934593 417 429 O
will NCT03934593 430 434 O
be NCT03934593 435 437 O
adults NCT03934593 438 444 O
age NCT03934593 445 448 B-Age
21 NCT03934593 449 451 B-Eq_Comparison
and NCT03934593 452 455 I-Eq_Comparison
above NCT03934593 456 461 I-Eq_Comparison
that NCT03934593 462 466 O
have NCT03934593 467 471 B-And
been NCT03934593 472 476 I-And
diagnosed NCT03934593 477 486 O
with NCT03934593 487 491 O
T NCT03934593 492 493 B-Condition
2D NCT03934593 494 496 I-Condition
. NCT03934593 497 498 O

Exclusion NCT03934593 500 509 O
Criteria NCT03934593 510 518 O
: NCT03934593 519 520 O

- NCT03934593 524 525 O
Children NCT03934593 527 535 O
, NCT03934593 536 537 O
adults NCT03934593 538 544 O
under NCT03934593 545 550 B-Eq_Comparison
21 NCT03934593 551 553 I-Eq_Comparison
years NCT03934593 554 559 I-Eq_Comparison
of NCT03934593 560 562 O
age NCT03934593 563 566 B-Age
, NCT03934593 567 568 O
and NCT03934593 569 572 B-And
pregnant NCT03934593 573 581 B-Condition
women NCT03934593 582 587 O

Inclusion NCT03864809 0 9 O
Criteria NCT03864809 10 18 O
: NCT03864809 19 20 O

- NCT03864809 23 24 O
patients NCT03864809 25 33 O
with NCT03864809 34 38 O
Psoriasis NCT03864809 39 48 B-Condition
and NCT03864809 49 52 B-Or
Patients NCT03864809 53 61 O
with NCT03864809 62 66 O
A NCT03864809 67 68 O
topic NCT03864809 69 74 B-Condition
dermatitis NCT03864809 75 85 I-Condition

Exclusion NCT03864809 86 95 O
Criteria NCT03864809 96 104 O
: NCT03864809 105 106 O

- NCT03864809 110 111 O
All NCT03864809 113 116 O
patient NCT03864809 117 124 O
have NCT03864809 125 129 O
another NCT03864809 130 137 B-Other
dermatological NCT03864809 138 152 B-Condition
disease NCT03864809 153 160 I-Condition

Inclusion NCT03928002 0 9 O
Criteria NCT03928002 10 18 O
: NCT03928002 19 20 O

- NCT03928002 24 25 O
Patient NCT03928002 27 34 O
≥ NCT03928002 35 36 B-Eq_Comparison
7 NCT03928002 37 38 I-Eq_Comparison
years NCT03928002 39 44 I-Eq_Comparison
old NCT03928002 45 48 B-Age

- NCT03928002 51 52 O
Patient NCT03928002 54 61 O
affiliated NCT03928002 62 72 O
to NCT03928002 73 75 O
a NCT03928002 76 77 O
social NCT03928002 78 84 O
security NCT03928002 85 93 O
system NCT03928002 94 100 O

- NCT03928002 103 104 O
Giving NCT03928002 106 112 O
their NCT03928002 113 118 O
informed NCT03928002 119 127 O
consent NCT03928002 128 135 O
for NCT03928002 136 139 O
the NCT03928002 140 143 O
study NCT03928002 144 149 O
( NCT03928002 150 151 O
adults NCT03928002 152 158 O
, NCT03928002 159 160 O
parents NCT03928002 161 168 O
of NCT03928002 169 171 O
minors NCT03928002 172 178 O
) NCT03928002 179 180 O

- NCT03928002 184 185 O
Patients NCT03928002 187 195 O
with NCT03928002 196 200 O
PAH NCT03928002 201 204 B-Condition
associated NCT03928002 205 215 O
with NCT03928002 216 220 O
congenital NCT03928002 221 231 B-Condition
heart NCT03928002 232 237 I-Condition
disease NCT03928002 238 245 I-Condition
requiring NCT03928002 246 255 B-Assertion___Assertion_Type_Value:hypothetical
cardiac NCT03928002 256 263 B-Procedure
catheterization NCT03928002 264 279 I-Procedure
and NCT03928002 280 283 B-And
2 NCT03928002 284 285 B-Modifier
D NCT03928002 286 287 I-Modifier
MRI NCT03928002 288 291 B-Procedure
for NCT03928002 292 295 O
the NCT03928002 296 299 O
diagnosis NCT03928002 300 309 O
or NCT03928002 310 312 O
follow NCT03928002 313 319 O
- NCT03928002 320 321 O
up NCT03928002 322 324 O
of NCT03928002 325 327 O
PAH NCT03928002 328 331 B-Condition
associated NCT03928002 332 342 O
with NCT03928002 343 347 O
congenital NCT03928002 348 358 B-Condition
heart NCT03928002 359 364 I-Condition
disease NCT03928002 365 372 I-Condition

Exclusion NCT03928002 373 382 O
Criteria NCT03928002 383 391 O
: NCT03928002 392 393 O

- NCT03928002 397 398 O
➢ NCT03928002 400 401 O
Patient NCT03928002 402 409 O
< NCT03928002 410 411 B-Eq_Comparison
7 NCT03928002 412 413 I-Eq_Comparison
years NCT03928002 414 419 I-Eq_Comparison
old NCT03928002 420 423 B-Age

- NCT03928002 431 432 O
Pregnant NCT03928002 434 442 B-Condition
woman NCT03928002 443 448 O

- NCT03928002 456 457 O
Contraindications NCT03928002 459 476 B-Contraindication
to NCT03928002 477 479 O
MRI NCT03928002 480 483 B-Procedure
( NCT03928002 484 485 O
claustrophobia NCT03928002 486 500 B-Condition
, NCT03928002 501 502 O
intraocular NCT03928002 503 514 B-Modifier
metal NCT03928002 515 520 B-Condition
foreign NCT03928002 521 528 I-Condition
bodies NCT03928002 529 535 I-Condition
, NCT03928002 536 537 O
pacemaker NCT03928002 538 547 B-Procedure
, NCT03928002 548 549 O
neurostimulator NCT03928002 550 565 B-Procedure
, NCT03928002 566 567 O
cochlear NCT03928002 568 576 B-Procedure
implants NCT03928002 577 585 I-Procedure
, NCT03928002 586 587 O
old NCT03928002 588 591 B-Modifier
heart NCT03928002 592 597 B-Procedure
valves NCT03928002 598 604 I-Procedure
) NCT03928002 605 606 O

- NCT03928002 615 616 O
Contraindication NCT03928002 618 634 B-Contraindication
to NCT03928002 635 637 O
gadolinium NCT03928002 638 648 B-Drug
injection NCT03928002 649 658 B-Procedure
( NCT03928002 659 660 O
allergy NCT03928002 661 668 B-Allergy
, NCT03928002 669 670 O
renal NCT03928002 671 676 B-Condition
failure NCT03928002 677 684 I-Condition
with NCT03928002 685 689 B-And
DFG NCT03928002 690 693 B-Observation
< NCT03928002 694 695 B-Eq_Comparison
30 NCT03928002 696 698 I-Eq_Comparison
ml NCT03928002 699 701 I-Eq_Comparison
/ NCT03928002 702 703 I-Eq_Comparison
min NCT03928002 704 707 I-Eq_Comparison
/ NCT03928002 708 709 I-Eq_Comparison
1.73 NCT03928002 710 714 I-Eq_Comparison
m² NCT03928002 715 717 I-Eq_Comparison
) NCT03928002 718 719 O

- NCT03928002 728 729 O
Hemodynamically NCT03928002 731 746 O
unstable NCT03928002 747 755 O
patients NCT03928002 756 764 O

- NCT03928002 772 773 O
Refusal NCT03928002 775 782 O
to NCT03928002 783 785 O
participate NCT03928002 786 797 O

Inclusion NCT03929640 0 9 O
Criteria NCT03929640 10 18 O
: NCT03929640 19 20 O

- NCT03929640 24 25 O
Pregnant NCT03929640 27 35 B-Condition
women NCT03929640 36 41 O
at NCT03929640 42 44 B-Eq_Comparison
least NCT03929640 45 50 I-Eq_Comparison
18 NCT03929640 51 53 I-Eq_Comparison
years NCT03929640 54 59 I-Eq_Comparison
of NCT03929640 60 62 O
age NCT03929640 63 66 B-Age

- NCT03929640 69 70 O
Planned NCT03929640 72 79 B-Eq_Comparison
delivery NCT03929640 80 88 B-Procedure
via NCT03929640 89 92 O
C NCT03929640 93 94 B-Procedure
- NCT03929640 95 96 I-Procedure
section NCT03929640 97 104 I-Procedure

- NCT03929640 107 108 O
Pfannenstiel NCT03929640 110 122 B-Modifier
skin NCT03929640 123 127 B-Procedure
incision NCT03929640 128 136 I-Procedure

- NCT03929640 139 140 O
Lower NCT03929640 142 147 B-Modifier
uterine NCT03929640 148 155 I-Modifier
segment NCT03929640 156 163 I-Modifier
transverse NCT03929640 164 174 I-Modifier
hysterotomy NCT03929640 175 186 B-Procedure

- NCT03929640 189 190 O
English NCT03929640 192 199 O
speaking NCT03929640 200 208 O

Exclusion NCT03929640 209 218 O
Criteria NCT03929640 219 227 O
: NCT03929640 228 229 O

- NCT03929640 233 234 O
Major NCT03929640 236 241 O
intra NCT03929640 242 247 B-Temporal_Connection___Temporal_Connection_Type_Value:during
- NCT03929640 248 249 O
operative NCT03929640 250 259 B-Procedure
or NCT03929640 260 262 B-Or
post NCT03929640 263 267 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03929640 268 269 O
operative NCT03929640 270 279 B-Procedure
complication NCT03929640 280 292 B-Condition
such NCT03929640 293 297 O
that NCT03929640 298 302 O
clinician NCT03929640 303 312 O
recommends NCT03929640 313 323 B-Assertion___Assertion_Type_Value:hypothetical
patient NCT03929640 324 331 O
should NCT03929640 332 338 O
not NCT03929640 339 342 B-Negation
receive NCT03929640 343 350 O
non NCT03929640 351 354 B-Drug
- NCT03929640 355 356 I-Drug
steroidal NCT03929640 357 366 I-Drug
anti NCT03929640 367 371 I-Drug
- NCT03929640 372 373 I-Drug
inflammatory NCT03929640 374 386 I-Drug
drugs NCT03929640 387 392 I-Drug
or NCT03929640 393 395 B-Or
that NCT03929640 396 400 O
patient NCT03929640 401 408 O
requires NCT03929640 409 417 B-Assertion___Assertion_Type_Value:hypothetical
acetaminophen NCT03929640 418 431 B-Drug
to NCT03929640 432 434 O
treat NCT03929640 435 440 O
fever NCT03929640 441 446 B-Condition
( NCT03929640 447 448 O
ie NCT03929640 449 451 O
suspected NCT03929640 452 461 B-Assertion___Assertion_Type_Value:possible
endometritis NCT03929640 462 474 B-Condition
) NCT03929640 475 476 O

- NCT03929640 480 481 O
Unplanned NCT03929640 483 492 B-Modifier
surgery NCT03929640 493 500 B-Procedure
( NCT03929640 501 502 O
hysterectomy NCT03929640 503 515 B-Procedure
, NCT03929640 516 517 O
bowel NCT03929640 518 523 B-Modifier
/ NCT03929640 524 525 B-Or
bladder NCT03929640 526 533 B-Modifier
repair NCT03929640 534 540 B-Procedure
) NCT03929640 541 542 O

- NCT03929640 546 547 O
Allergy NCT03929640 549 556 B-Allergy
or NCT03929640 557 559 B-Or
contraindication NCT03929640 560 576 B-Contraindication
to NCT03929640 577 579 O
study NCT03929640 580 585 B-Study
medication NCT03929640 586 596 B-Drug

- NCT03929640 599 600 O
Non NCT03929640 602 605 B-Negation
- NCT03929640 606 607 O
English NCT03929640 608 615 O
speaking NCT03929640 616 624 O

- NCT03929640 627 628 O
Inability NCT03929640 630 639 O
to NCT03929640 640 642 O
provide NCT03929640 643 650 O
informed NCT03929640 651 659 O
consent NCT03929640 660 667 O

- NCT03929640 670 671 O
History NCT03929640 673 680 B-Eq_Comparison
of NCT03929640 681 683 O
opioid NCT03929640 684 690 B-Modifier
, NCT03929640 691 692 O
other NCT03929640 693 698 B-Other
illicit NCT03929640 699 706 B-Modifier
substance NCT03929640 707 716 B-Condition
, NCT03929640 717 718 O
or NCT03929640 719 721 B-Or
alcohol NCT03929640 722 729 B-Condition
use NCT03929640 730 733 I-Condition
disorder NCT03929640 734 742 I-Condition
either NCT03929640 743 749 O
before NCT03929640 750 756 B-Temporal_Connection___Temporal_Connection_Type_Value:before
or NCT03929640 757 759 B-Or
during NCT03929640 760 766 B-Temporal_Connection___Temporal_Connection_Type_Value:during
pregnancy NCT03929640 767 776 B-Condition

- NCT03929640 779 780 O
Severe NCT03929640 782 788 O
renal NCT03929640 789 794 B-Modifier
or NCT03929640 795 797 B-Or
hepatic NCT03929640 798 805 B-Modifier
impairment NCT03929640 806 816 B-Condition

Inclusion NCT03928340 0 9 O
Criteria NCT03928340 10 18 O
: NCT03928340 19 20 O

- NCT03928340 24 25 O
Diabetic NCT03928340 27 35 B-Condition
pregnant NCT03928340 36 44 B-Condition
patients NCT03928340 45 53 O
with NCT03928340 54 58 B-And
type NCT03928340 59 63 B-Modifier
one NCT03928340 64 67 I-Modifier
diabetes NCT03928340 68 76 B-Condition
and NCT03928340 77 80 B-And
no NCT03928340 81 83 B-Negation
other NCT03928340 84 89 B-Other
chronic NCT03928340 90 97 O
disorders NCT03928340 98 107 B-Condition

- NCT03928340 110 111 O
Patients NCT03928340 113 121 O
on NCT03928340 122 124 B-Eq_Comparison
insulin NCT03928340 125 132 B-Drug
in NCT03928340 133 135 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928340 136 139 O
3 NCT03928340 140 141 B-Eq_Comparison
rd NCT03928340 142 144 I-Eq_Comparison
trimester NCT03928340 145 154 I-Eq_Comparison
of NCT03928340 155 157 O
pregnancy NCT03928340 158 167 B-Condition
( NCT03928340 168 169 O
on NCT03928340 170 172 B-Eq_Comparison
insulin NCT03928340 173 180 B-Drug
therapy NCT03928340 181 188 I-Drug
since NCT03928340 189 194 B-Temporal_Connection___Temporal_Connection_Type_Value:after
start NCT03928340 195 200 B-Eq_Comparison
of NCT03928340 201 203 O
gestation NCT03928340 204 213 B-Condition
) NCT03928340 214 215 O

- NCT03928340 219 220 O
Patients NCT03928340 222 230 O
pregnant NCT03928340 231 239 B-Condition
in NCT03928340 240 242 O
single NCT03928340 243 249 B-Eq_Comparison
living NCT03928340 250 256 B-Death|B-Negation
fetus NCT03928340 257 262 B-Family_Member___Family_Member_Type:child
with NCT03928340 263 267 O
no NCT03928340 268 270 B-Negation
apparent NCT03928340 271 279 B-Assertion___Assertion_Type_Value:possible
congenital NCT03928340 280 290 B-Condition
anomalies NCT03928340 291 300 I-Condition

- NCT03928340 303 304 O
Haemoglobin NCT03928340 306 317 B-Observation
A NCT03928340 318 319 I-Observation
1 NCT03928340 320 321 I-Observation
C NCT03928340 322 323 I-Observation
( NCT03928340 324 325 O
HbA NCT03928340 326 329 B-Observation
1c NCT03928340 330 332 I-Observation
) NCT03928340 333 334 O
level NCT03928340 335 340 O
between NCT03928340 341 348 B-Eq_Comparison
7 NCT03928340 349 350 I-Eq_Comparison
% NCT03928340 351 352 I-Eq_Comparison
to NCT03928340 353 355 I-Eq_Comparison
11 NCT03928340 356 358 I-Eq_Comparison
% NCT03928340 359 360 I-Eq_Comparison

- NCT03928340 364 365 O
All NCT03928340 367 370 O
patients NCT03928340 371 379 O
have NCT03928340 380 384 O
done NCT03928340 385 389 B-Eq_Comparison
a NCT03928340 390 391 O
dating NCT03928340 392 398 O
ultrasound NCT03928340 399 409 B-Procedure
to NCT03928340 410 412 O
confirm NCT03928340 413 420 O
gestational NCT03928340 421 432 B-Observation
age NCT03928340 433 436 I-Observation
, NCT03928340 437 438 O
viability NCT03928340 439 448 O
and NCT03928340 449 452 B-And
rule NCT03928340 453 457 B-Assertion___Assertion_Type_Value:hypothetical
out NCT03928340 458 461 I-Assertion___Assertion_Type_Value:hypothetical
any NCT03928340 462 465 O
abnormality NCT03928340 466 477 B-Condition

Exclusion NCT03928340 478 487 O
Criteria NCT03928340 488 496 O
: NCT03928340 497 498 O

- NCT03928340 502 503 O
Patients NCT03928340 505 513 O
with NCT03928340 514 518 O
type NCT03928340 519 523 B-Modifier
2 NCT03928340 524 525 I-Modifier
or NCT03928340 526 528 B-Or
gestational NCT03928340 529 540 B-Modifier
diabetes NCT03928340 541 549 B-Condition

- NCT03928340 552 553 O
Patients NCT03928340 555 563 O
with NCT03928340 564 568 O
intolerance NCT03928340 569 580 B-Condition
or NCT03928340 581 583 B-Or
hypersensitivity NCT03928340 584 600 B-Condition
to NCT03928340 601 603 O
metformin NCT03928340 604 613 B-Drug

- NCT03928340 616 617 O
Patients NCT03928340 619 627 O
with NCT03928340 628 632 O
congestive NCT03928340 633 643 B-Condition
heart NCT03928340 644 649 I-Condition
failure NCT03928340 650 657 I-Condition
or NCT03928340 658 660 B-Or
a NCT03928340 661 662 O
history NCT03928340 663 670 B-Eq_Comparison
of NCT03928340 671 673 O
congestive NCT03928340 674 684 B-Condition
heart NCT03928340 685 690 I-Condition
failure NCT03928340 691 698 I-Condition

- NCT03928340 701 702 O
Patients NCT03928340 704 712 O
with NCT03928340 713 717 O
renal NCT03928340 718 723 B-Condition
insufficiency NCT03928340 724 737 I-Condition

- NCT03928340 740 741 O
Patients NCT03928340 743 751 O
having NCT03928340 752 758 O
current NCT03928340 759 766 B-Eq_Comparison
significant NCT03928340 767 778 O
gastrointestinal NCT03928340 779 795 B-Condition
problems NCT03928340 796 804 I-Condition
such NCT03928340 805 809 O
as NCT03928340 810 812 O
severe NCT03928340 813 819 O
vomiting NCT03928340 820 828 B-Condition
requiring NCT03928340 829 838 B-Assertion___Assertion_Type_Value:hypothetical
intravenous NCT03928340 839 850 B-Drug
fluids NCT03928340 851 857 I-Drug
or NCT03928340 858 860 B-Or
hospitalization NCT03928340 861 876 B-Encounter

- NCT03928340 879 880 O
Presence NCT03928340 882 890 O
of NCT03928340 891 893 O
acute NCT03928340 894 899 O
or NCT03928340 900 902 O
chronic NCT03928340 903 910 O
metabolic NCT03928340 911 920 B-Condition
acidosis NCT03928340 921 929 I-Condition
, NCT03928340 930 931 O
including NCT03928340 932 941 O
diabetic NCT03928340 942 950 B-Condition
ketoacidosis NCT03928340 951 963 I-Condition
, NCT03928340 964 965 O
a NCT03928340 966 967 O
history NCT03928340 968 975 B-Eq_Comparison
of NCT03928340 976 978 O
diabetic NCT03928340 979 987 B-Condition
ketoacidosis NCT03928340 988 1000 I-Condition
or NCT03928340 1001 1003 B-Or
history NCT03928340 1004 1011 B-Eq_Comparison
of NCT03928340 1012 1014 O
lactic NCT03928340 1015 1021 B-Condition
acidosis NCT03928340 1022 1030 I-Condition

- NCT03928340 1033 1034 O
Patients NCT03928340 1036 1044 O
with NCT03928340 1045 1049 O
liver NCT03928340 1050 1055 B-Modifier
impairment NCT03928340 1056 1066 B-Condition

- NCT03928340 1069 1070 O
Patients NCT03928340 1072 1080 O
with NCT03928340 1081 1085 O
known NCT03928340 1086 1091 O
higher NCT03928340 1092 1098 B-Modifier
order NCT03928340 1099 1104 I-Modifier
pregnancies NCT03928340 1105 1116 B-Condition
( NCT03928340 1117 1118 O
twins NCT03928340 1119 1124 B-Modifier
, NCT03928340 1125 1126 O
triplets NCT03928340 1127 1135 B-Modifier
, NCT03928340 1136 1137 O
etc NCT03928340 1138 1141 O
. NCT03928340 1142 1143 O
) NCT03928340 1144 1145 O

- NCT03928340 1149 1150 O
Patients NCT03928340 1152 1160 O
having NCT03928340 1161 1167 O
a NCT03928340 1168 1169 O
known NCT03928340 1170 1175 O
potentially NCT03928340 1176 1187 B-Assertion___Assertion_Type_Value:hypothetical
fetal NCT03928340 1188 1193 B-Condition
lethal NCT03928340 1194 1200 I-Condition
anomaly NCT03928340 1201 1208 I-Condition

Inclusion NCT03865628 0 9 O
Criteria NCT03865628 10 18 O
: NCT03865628 19 20 O

- NCT03865628 24 25 O
Singleton NCT03865628 27 36 B-Modifier
pregnancy NCT03865628 37 46 B-Condition

- NCT03865628 49 50 O
Estimation NCT03865628 52 62 O
of NCT03865628 63 65 O
the NCT03865628 66 69 O
fetal NCT03865628 70 75 B-Modifier
weight NCT03865628 76 82 B-Observation
less NCT03865628 83 87 B-Eq_Comparison
than NCT03865628 88 92 I-Eq_Comparison
estimation NCT03865628 93 103 I-Eq_Comparison
the NCT03865628 104 107 I-Eq_Comparison
10 NCT03865628 108 110 I-Eq_Comparison
th NCT03865628 111 113 I-Eq_Comparison
percentile NCT03865628 114 124 I-Eq_Comparison

Exclusion NCT03865628 125 134 O
Criteria NCT03865628 135 143 O
: NCT03865628 144 145 O

- NCT03865628 149 150 O
Refusal NCT03865628 152 159 O
of NCT03865628 160 162 O
parents NCT03865628 163 170 O

- NCT03865628 173 174 O
Fetal NCT03865628 176 181 B-Modifier
and NCT03865628 182 185 B-Or
vascular NCT03865628 186 194 B-Modifier
malformations NCT03865628 195 208 B-Condition

- NCT03865628 211 212 O
Fetal NCT03865628 214 219 B-Condition
anemia NCT03865628 220 226 I-Condition

Inclusion NCT03869515 0 9 O
Criteria NCT03869515 10 18 O
: NCT03869515 19 20 O

- NCT03869515 24 25 O
The NCT03869515 27 30 O
chILD NCT03869515 31 36 B-Condition
syndrome NCT03869515 37 45 I-Condition
exists NCT03869515 46 52 O
when NCT03869515 53 57 O
a NCT03869515 58 59 O
child NCT03869515 60 65 B-Family_Member___Family_Member_Type:child
with NCT03869515 66 70 O
DLD NCT03869515 71 74 B-Condition
has NCT03869515 75 78 O
had NCT03869515 79 82 O
the NCT03869515 83 86 O
common NCT03869515 87 93 O
causes NCT03869515 94 100 B-Condition
of NCT03869515 101 103 O
DLD NCT03869515 104 107 B-Condition
excluded NCT03869515 108 116 B-Negation
as NCT03869515 117 119 O
the NCT03869515 120 123 O
primary NCT03869515 124 131 O
diagnosis NCT03869515 132 141 O
and NCT03869515 142 145 B-And
has NCT03869515 146 149 O
at NCT03869515 150 152 B-Eq_Comparison
least NCT03869515 153 158 I-Eq_Comparison
three NCT03869515 159 164 I-Eq_Comparison
of NCT03869515 165 167 B-Criteria_Count
the NCT03869515 168 171 I-Criteria_Count
following NCT03869515 172 181 I-Criteria_Count
four NCT03869515 182 186 B-Eq_Comparison
criteria NCT03869515 187 195 O
: NCT03869515 196 197 O
( NCT03869515 198 199 O
1 NCT03869515 200 201 O
) NCT03869515 202 203 O
respiratory NCT03869515 204 215 B-Condition
symptoms NCT03869515 216 224 B-Assertion___Assertion_Type_Value:possible
( NCT03869515 225 226 O
e NCT03869515 227 228 O
. NCT03869515 229 230 O
g NCT03869515 231 232 O
. NCT03869515 233 234 O
, NCT03869515 235 236 O
cough NCT03869515 237 242 B-Condition
, NCT03869515 243 244 O
rapid NCT03869515 245 250 B-Modifier
and NCT03869515 251 254 B-Or
/ NCT03869515 255 256 I-Or
or NCT03869515 257 259 I-Or
difficult NCT03869515 260 269 B-Modifier
breathing NCT03869515 270 279 B-Condition
, NCT03869515 280 281 O
or NCT03869515 282 284 B-Or
exercise NCT03869515 285 293 B-Condition
intolerance NCT03869515 294 305 I-Condition
) NCT03869515 306 307 O
; NCT03869515 308 309 O
( NCT03869515 310 311 O
2 NCT03869515 312 313 O
) NCT03869515 314 315 O
respiratory NCT03869515 316 327 B-Condition
signs NCT03869515 328 333 B-Assertion___Assertion_Type_Value:possible
( NCT03869515 334 335 O
e NCT03869515 336 337 O
. NCT03869515 338 339 O
g NCT03869515 340 341 O
. NCT03869515 342 343 O
, NCT03869515 344 345 O
resting NCT03869515 346 353 B-Condition
tachypnea NCT03869515 354 363 I-Condition
, NCT03869515 364 365 O
adventitious NCT03869515 366 378 B-Condition
sounds NCT03869515 379 385 I-Condition
, NCT03869515 386 387 O
retractions NCT03869515 388 399 B-Condition
, NCT03869515 400 401 O
digital NCT03869515 402 409 B-Condition
clubbing NCT03869515 410 418 I-Condition
, NCT03869515 419 420 O
failure NCT03869515 421 428 B-Condition
to NCT03869515 429 431 I-Condition
thrive NCT03869515 432 438 I-Condition
, NCT03869515 439 440 O
or NCT03869515 441 443 B-Or
respiratory NCT03869515 444 455 B-Condition
fail NCT03869515 456 460 I-Condition
- NCT03869515 461 462 I-Condition
ure NCT03869515 463 466 I-Condition
) NCT03869515 467 468 O
; NCT03869515 469 470 O
( NCT03869515 471 472 O
3 NCT03869515 473 474 O
) NCT03869515 475 476 O
hypoxemia NCT03869515 477 486 B-Condition
; NCT03869515 486 487 O
and NCT03869515 488 491 O
( NCT03869515 492 493 O
4 NCT03869515 494 495 O
) NCT03869515 496 497 O
diffuse NCT03869515 498 505 B-Condition
abnormalities NCT03869515 506 519 I-Condition
on NCT03869515 520 522 O
CXR NCT03869515 523 526 B-Procedure
or NCT03869515 527 529 B-Or
a NCT03869515 530 531 O
CT NCT03869515 532 534 B-Procedure
scan NCT03869515 535 539 I-Procedure
. NCT03869515 540 541 O

Exclusion NCT03869515 543 552 O
Criteria NCT03869515 553 561 O
: NCT03869515 562 563 O

- NCT03869515 567 568 O
These NCT03869515 570 575 O
include NCT03869515 576 583 O
cystic NCT03869515 584 590 B-Condition
fibrosis NCT03869515 591 599 I-Condition
, NCT03869515 600 601 O
congenital NCT03869515 602 612 B-Modifier
or NCT03869515 613 615 B-Or
acquired NCT03869515 616 624 B-Modifier
immunodeficiency NCT03869515 625 641 B-Condition
, NCT03869515 642 643 O
congenital NCT03869515 644 654 B-Condition
heart NCT03869515 655 660 I-Condition
disease NCT03869515 661 668 I-Condition
, NCT03869515 669 670 O
bronchopulmonary NCT03869515 671 687 B-Condition
dysplasia NCT03869515 688 697 I-Condition
, NCT03869515 698 699 O
pulmonary NCT03869515 700 709 B-Condition
infection NCT03869515 710 719 I-Condition
, NCT03869515 720 721 O
primary NCT03869515 722 729 B-Modifier
ciliary NCT03869515 730 737 I-Modifier
dyskinesia NCT03869515 738 748 B-Condition
presenting NCT03869515 749 759 O
with NCT03869515 760 764 O
newborn NCT03869515 765 772 B-Condition
respiratory NCT03869515 773 784 I-Condition
distress NCT03869515 785 793 I-Condition
and NCT03869515 794 797 B-Or
recurrent NCT03869515 798 807 B-Modifier
aspiration NCT03869515 808 818 B-Condition
. NCT03869515 819 820 O

Inclusion NCT03866070 0 9 O
Criteria NCT03866070 10 18 O
: NCT03866070 19 20 O

- NCT03866070 24 25 O
Female NCT03866070 27 33 O

- NCT03866070 36 37 O
Handball NCT03866070 39 47 B-Observation
players NCT03866070 48 55 I-Observation
federated NCT03866070 56 65 O
in NCT03866070 66 68 O
the NCT03866070 69 72 O
Madrid NCT03866070 73 79 O
Handball NCT03866070 80 88 O
Federation NCT03866070 89 99 O

- NCT03866070 102 103 O
With NCT03866070 105 109 O
an NCT03866070 110 112 O
age NCT03866070 113 116 B-Age
range NCT03866070 117 122 O
between NCT03866070 123 130 B-Eq_Comparison
18 NCT03866070 131 133 I-Eq_Comparison
and NCT03866070 134 137 I-Eq_Comparison
37 NCT03866070 138 140 I-Eq_Comparison
years NCT03866070 141 146 I-Eq_Comparison

- NCT03866070 149 150 O
More NCT03866070 152 156 B-Eq_Comparison
than NCT03866070 157 161 I-Eq_Comparison
2 NCT03866070 162 163 I-Eq_Comparison
years NCT03866070 164 169 I-Eq_Comparison
of NCT03866070 170 172 O
handball NCT03866070 173 181 B-Observation
sports NCT03866070 182 188 I-Observation

- NCT03866070 191 192 O
Currently NCT03866070 194 203 O
participate NCT03866070 204 215 O
in NCT03866070 216 218 O
amateur NCT03866070 219 226 O
competitions NCT03866070 227 239 O
of NCT03866070 240 242 O
First NCT03866070 243 248 O
National NCT03866070 249 257 O
Women NCT03866070 258 263 O
's NCT03866070 263 265 O
category NCT03866070 266 274 O
. NCT03866070 275 276 O

Exclusion NCT03866070 278 287 O
Criteria NCT03866070 288 296 O
: NCT03866070 297 298 O

- NCT03866070 302 303 O
Have NCT03866070 305 309 O
suffered NCT03866070 310 318 B-Eq_Comparison
a NCT03866070 319 320 O
shoulder NCT03866070 321 329 B-Modifier
injury NCT03866070 330 336 B-Condition
in NCT03866070 337 339 O
the NCT03866070 340 343 O
last NCT03866070 344 348 B-Eq_Comparison
six NCT03866070 349 352 I-Eq_Comparison
months NCT03866070 353 359 I-Eq_Comparison

- NCT03866070 362 363 O
Who NCT03866070 365 368 O
are NCT03866070 369 372 O
currently NCT03866070 373 382 B-Eq_Comparison
doing NCT03866070 383 388 O
some NCT03866070 389 393 O
physiotherapy NCT03866070 394 407 B-Procedure
treatment NCT03866070 408 417 I-Procedure

- NCT03866070 420 421 O
Who NCT03866070 423 426 O
fail NCT03866070 427 431 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03866070 432 434 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
participate NCT03866070 435 446 O
in NCT03866070 447 449 O
the NCT03866070 450 453 O
established NCT03866070 454 465 O
intervention NCT03866070 466 478 B-Procedure
and NCT03866070 479 482 B-And
evaluation NCT03866070 483 493 B-Procedure
sessions NCT03866070 494 502 O

- NCT03866070 505 506 O
Refusing NCT03866070 508 516 O
to NCT03866070 517 519 O
sign NCT03866070 520 524 O
the NCT03866070 525 528 O
informed NCT03866070 529 537 O
consent NCT03866070 538 545 O
document NCT03866070 546 554 O
. NCT03866070 555 556 O

Inclusion NCT03926221 0 9 O
Criteria NCT03926221 10 18 O
: NCT03926221 19 20 O

1 NCT03926221 24 25 O
. NCT03926221 25 26 O
Age NCT03926221 28 31 B-Age
between NCT03926221 32 39 B-Eq_Comparison
10 NCT03926221 40 42 I-Eq_Comparison
and NCT03926221 43 46 I-Eq_Comparison
18 NCT03926221 47 49 I-Eq_Comparison
and NCT03926221 50 53 O
living NCT03926221 54 60 O
with NCT03926221 61 65 O
a NCT03926221 66 67 O
parent NCT03926221 68 74 B-Family_Member___Family_Member_Type:parent
or NCT03926221 75 77 O
guardian NCT03926221 78 86 O

2 NCT03926221 89 90 O
. NCT03926221 90 91 O
Lowest NCT03926221 93 99 O
quartile NCT03926221 100 108 O
of NCT03926221 109 111 O
the NCT03926221 112 115 O
widely NCT03926221 116 122 O
used NCT03926221 123 127 O
and NCT03926221 128 131 O
well NCT03926221 132 136 O
- NCT03926221 137 138 O
validated NCT03926221 139 148 O
Children NCT03926221 149 157 B-Observation
's NCT03926221 157 159 I-Observation
Morningness NCT03926221 160 171 I-Observation
- NCT03926221 172 173 I-Observation
Eveningness NCT03926221 174 185 I-Observation
Preferences NCT03926221 186 197 I-Observation
Scale NCT03926221 198 203 I-Observation
( NCT03926221 204 205 O
CMEP NCT03926221 206 210 B-Observation
; NCT03926221 210 211 O
27 NCT03926221 212 214 B-Eq_Comparison
or NCT03926221 215 217 I-Eq_Comparison
lower NCT03926221 218 223 I-Eq_Comparison
) NCT03926221 224 225 O
and NCT03926221 226 229 O

3 NCT03926221 232 233 O
. NCT03926221 233 234 O
Youth NCT03926221 236 241 O
self NCT03926221 242 246 O
- NCT03926221 247 248 O
reported NCT03926221 249 257 O
weekday NCT03926221 258 265 O
sleep NCT03926221 266 271 B-Observation
onset NCT03926221 272 277 I-Observation
time NCT03926221 278 282 I-Observation
for NCT03926221 283 286 O
the NCT03926221 287 290 O
past NCT03926221 291 295 B-Eq_Comparison
month NCT03926221 296 301 I-Eq_Comparison
later NCT03926221 302 307 B-Eq_Comparison
than NCT03926221 308 312 I-Eq_Comparison
10 NCT03926221 313 315 I-Eq_Comparison
: NCT03926221 316 317 I-Eq_Comparison
40 NCT03926221 318 320 I-Eq_Comparison
pm NCT03926221 321 323 I-Eq_Comparison
for NCT03926221 324 327 O
10 NCT03926221 328 330 B-Eq_Comparison
- NCT03926221 331 332 I-Eq_Comparison
to NCT03926221 333 335 I-Eq_Comparison
13 NCT03926221 336 338 I-Eq_Comparison
- NCT03926221 339 340 I-Eq_Comparison
year NCT03926221 341 345 I-Eq_Comparison
- NCT03926221 346 347 O
olds NCT03926221 348 352 B-Age
; NCT03926221 352 353 O
11 NCT03926221 354 356 B-Eq_Comparison
: NCT03926221 357 358 I-Eq_Comparison
00 NCT03926221 359 361 I-Eq_Comparison
pm NCT03926221 362 364 I-Eq_Comparison
for NCT03926221 365 368 O
14 NCT03926221 369 371 B-Eq_Comparison
- NCT03926221 372 373 I-Eq_Comparison
16 NCT03926221 374 376 I-Eq_Comparison
year NCT03926221 377 381 I-Eq_Comparison
olds NCT03926221 382 386 B-Age
, NCT03926221 387 388 O
and NCT03926221 389 392 B-Or
later NCT03926221 393 398 B-Eq_Comparison
than NCT03926221 399 403 I-Eq_Comparison
11 NCT03926221 404 406 I-Eq_Comparison
: NCT03926221 407 408 I-Eq_Comparison
20 NCT03926221 409 411 I-Eq_Comparison
for NCT03926221 412 415 O
17 NCT03926221 416 418 B-Eq_Comparison
- NCT03926221 419 420 I-Eq_Comparison
18 NCT03926221 421 423 I-Eq_Comparison
year NCT03926221 424 428 I-Eq_Comparison
olds NCT03926221 429 433 B-Age
at NCT03926221 434 436 B-Eq_Comparison
least NCT03926221 437 442 I-Eq_Comparison
3 NCT03926221 443 444 I-Eq_Comparison
nights NCT03926221 445 451 I-Eq_Comparison
per NCT03926221 452 455 I-Eq_Comparison
week NCT03926221 456 460 I-Eq_Comparison
; NCT03926221 460 461 O

4 NCT03926221 464 465 O
. NCT03926221 465 466 O
English NCT03926221 468 475 O
language NCT03926221 476 484 O
fluency NCT03926221 485 492 O
; NCT03926221 492 493 O

5 NCT03926221 496 497 O
. NCT03926221 497 498 O
able NCT03926221 500 504 O
and NCT03926221 505 508 O
willing NCT03926221 509 516 O
to NCT03926221 517 519 O
give NCT03926221 520 524 O
informed NCT03926221 525 533 O
assent NCT03926221 534 540 O
; NCT03926221 540 541 O

6 NCT03926221 544 545 O
. NCT03926221 545 546 O
at NCT03926221 548 550 B-Eq_Comparison
least NCT03926221 551 556 I-Eq_Comparison
one NCT03926221 557 560 I-Eq_Comparison
parent NCT03926221 561 567 B-Family_Member___Family_Member_Type:parent
/ NCT03926221 568 569 O
primary NCT03926221 570 577 O
caregiver NCT03926221 578 587 O
who NCT03926221 588 591 O
lives NCT03926221 592 597 O
in NCT03926221 598 600 O
the NCT03926221 601 604 O
same NCT03926221 605 609 O
household NCT03926221 610 619 O
as NCT03926221 620 622 O
the NCT03926221 623 626 O
teen NCT03926221 627 631 O
for NCT03926221 632 635 O
at NCT03926221 636 638 B-Eq_Comparison
least NCT03926221 639 644 I-Eq_Comparison
50 NCT03926221 645 647 I-Eq_Comparison
% NCT03926221 648 649 I-Eq_Comparison
of NCT03926221 650 652 I-Eq_Comparison
the NCT03926221 653 656 I-Eq_Comparison
week NCT03926221 657 661 I-Eq_Comparison
must NCT03926221 662 666 O
participate NCT03926221 667 678 O
in NCT03926221 679 681 O
all NCT03926221 682 685 O
study NCT03926221 686 691 O
sessions NCT03926221 692 700 O
. NCT03926221 701 702 O

Exclusion NCT03926221 704 713 O
Criteria NCT03926221 714 722 O
: NCT03926221 723 724 O

1 NCT03926221 728 729 O
. NCT03926221 729 730 O
An NCT03926221 732 734 O
active NCT03926221 735 741 B-Eq_Comparison
, NCT03926221 742 743 O
progressive NCT03926221 744 755 B-Modifier
physical NCT03926221 756 764 B-Condition
illness NCT03926221 765 772 I-Condition
directly NCT03926221 773 781 O
related NCT03926221 782 789 O
to NCT03926221 790 792 O
the NCT03926221 793 796 O
onset NCT03926221 797 802 B-Eq_Comparison
and NCT03926221 803 806 O
course NCT03926221 807 813 O
of NCT03926221 814 816 O
the NCT03926221 817 820 O
sleep NCT03926221 821 826 B-Condition
disturbance NCT03926221 827 838 I-Condition
; NCT03926221 838 839 O

2 NCT03926221 842 843 O
. NCT03926221 843 844 O
evidence NCT03926221 846 854 O
of NCT03926221 855 857 O
sleep NCT03926221 858 863 B-Condition
apnea NCT03926221 864 869 I-Condition
, NCT03926221 870 871 O
restless NCT03926221 872 880 B-Condition
legs NCT03926221 881 885 I-Condition
or NCT03926221 886 888 B-Or
periodic NCT03926221 889 897 B-Modifier
limb NCT03926221 898 902 B-Condition
movements NCT03926221 903 912 I-Condition
; NCT03926221 912 913 O

3 NCT03926221 916 917 O
. NCT03926221 917 918 O
significantly NCT03926221 920 933 O
impairing NCT03926221 934 943 O
pervasive NCT03926221 944 953 B-Modifier
developmental NCT03926221 954 967 B-Condition
disorder NCT03926221 968 976 I-Condition
; NCT03926221 976 977 O

4 NCT03926221 980 981 O
. NCT03926221 981 982 O
history NCT03926221 984 991 B-Eq_Comparison
of NCT03926221 992 994 O
substance NCT03926221 995 1004 B-Condition
dependence NCT03926221 1005 1015 I-Condition
in NCT03926221 1016 1018 O
the NCT03926221 1019 1022 O
past NCT03926221 1023 1027 B-Eq_Comparison
six NCT03926221 1028 1031 I-Eq_Comparison
months NCT03926221 1032 1038 I-Eq_Comparison
; NCT03926221 1038 1039 O

5 NCT03926221 1042 1043 O
. NCT03926221 1043 1044 O
suicide NCT03926221 1046 1053 B-Condition
risk NCT03926221 1054 1058 B-Risk
; NCT03926221 1058 1059 O
bipolar NCT03926221 1060 1067 B-Condition
disorder NCT03926221 1068 1076 I-Condition
or NCT03926221 1077 1079 B-Or
schizophrenia NCT03926221 1080 1093 B-Condition
or NCT03926221 1094 1096 O
another NCT03926221 1097 1104 B-Other
current NCT03926221 1105 1112 B-Eq_Comparison
Axis NCT03926221 1113 1117 B-Eq_Comparison
I NCT03926221 1118 1119 I-Eq_Comparison
disorder NCT03926221 1120 1128 B-Condition
if NCT03926221 1129 1131 O
there NCT03926221 1132 1137 O
is NCT03926221 1138 1140 O
a NCT03926221 1141 1142 O
significant NCT03926221 1143 1154 O
risk NCT03926221 1155 1159 B-Risk
of NCT03926221 1160 1162 O
harm NCT03926221 1163 1167 B-Condition
and NCT03926221 1168 1171 B-Or
/ NCT03926221 1172 1173 I-Or
or NCT03926221 1174 1176 I-Or
decompensation NCT03926221 1177 1191 B-Condition
if NCT03926221 1192 1194 O
treatment NCT03926221 1195 1204 B-Procedure
of NCT03926221 1205 1207 O
that NCT03926221 1208 1212 O
comorbid NCT03926221 1213 1221 O
condition NCT03926221 1222 1231 O
is NCT03926221 1232 1234 O
delayed NCT03926221 1235 1242 O
as NCT03926221 1243 1245 O
a NCT03926221 1246 1247 O
function NCT03926221 1248 1256 O
of NCT03926221 1257 1259 O
participating NCT03926221 1260 1273 O
in NCT03926221 1274 1276 O
any NCT03926221 1277 1280 O
stage NCT03926221 1281 1286 O
of NCT03926221 1287 1289 O
this NCT03926221 1290 1294 O
study NCT03926221 1295 1300 B-Study
; NCT03926221 1300 1301 O

6 NCT03926221 1304 1305 O
. NCT03926221 1305 1306 O
Participants NCT03926221 1308 1320 O
will NCT03926221 1321 1325 O
not NCT03926221 1326 1329 B-Negation
be NCT03926221 1330 1332 O
excluded NCT03926221 1333 1341 B-Negation
if NCT03926221 1342 1344 O
medications NCT03926221 1345 1356 B-Drug
are NCT03926221 1357 1360 O
stable NCT03926221 1361 1367 O
( NCT03926221 1368 1369 O
> NCT03926221 1370 1371 B-Eq_Comparison
4 NCT03926221 1372 1373 I-Eq_Comparison
weeks NCT03926221 1374 1379 I-Eq_Comparison
) NCT03926221 1380 1381 O
. NCT03926221 1382 1383 O

Inclusion NCT03861611 0 9 O
Criteria NCT03861611 10 18 O
: NCT03861611 19 20 O

- NCT03861611 24 25 O
Men NCT03861611 27 30 O
or NCT03861611 31 33 B-Or
women NCT03861611 34 39 O
age NCT03861611 40 43 B-Age
18 NCT03861611 44 46 B-Eq_Comparison
- NCT03861611 47 48 I-Eq_Comparison
64 NCT03861611 49 51 I-Eq_Comparison
. NCT03861611 51 52 O

- NCT03861611 56 57 O
Present NCT03861611 59 66 O
to NCT03861611 67 69 O
ED NCT03861611 70 72 B-Encounter
primary NCT03861611 73 80 O
for NCT03861611 81 84 O
management NCT03861611 85 95 O
of NCT03861611 96 98 O
Low NCT03861611 99 102 B-Condition
Back NCT03861611 103 107 I-Condition
Pain NCT03861611 108 112 I-Condition
( NCT03861611 113 114 O
LBP NCT03861611 115 118 B-Condition
) NCT03861611 119 120 O

- NCT03861611 124 125 O
Functionally NCT03861611 127 139 B-Modifier
impairing NCT03861611 140 149 I-Modifier
back NCT03861611 150 154 B-Condition
pain NCT03861611 155 159 I-Condition
: NCT03861611 160 161 O
A NCT03861611 162 163 O
baseline NCT03861611 164 172 O
score NCT03861611 173 178 O
of NCT03861611 179 181 O
greater NCT03861611 182 189 B-Eq_Comparison
than NCT03861611 190 194 I-Eq_Comparison
5 NCT03861611 195 196 I-Eq_Comparison
on NCT03861611 197 199 O
the NCT03861611 200 203 O
Roland NCT03861611 204 210 B-Observation
- NCT03861611 211 212 I-Observation
Morris NCT03861611 213 219 I-Observation
Disability NCT03861611 220 230 I-Observation
Questionnaire NCT03861611 231 244 I-Observation

- NCT03861611 247 248 O
Musculoskeletal NCT03861611 250 265 B-Condition
etiology NCT03861611 266 274 I-Condition
of NCT03861611 275 277 O
low NCT03861611 278 281 B-Modifier
back NCT03861611 282 286 I-Modifier
. NCT03861611 287 288 O

- NCT03861611 292 293 O
Non NCT03861611 295 298 B-Negation
- NCT03861611 299 300 O
radicular NCT03861611 301 310 B-Modifier
pain NCT03861611 311 315 B-Condition
. NCT03861611 316 317 O

- NCT03861611 321 322 O
Pain NCT03861611 324 328 B-Condition
duration NCT03861611 329 337 O
< NCT03861611 338 339 B-Eq_Comparison
2 NCT03861611 340 341 I-Eq_Comparison
weeks NCT03861611 342 347 I-Eq_Comparison
( NCT03861611 348 349 O
336 NCT03861611 350 353 B-Eq_Comparison
hours NCT03861611 354 359 I-Eq_Comparison
) NCT03861611 360 361 O
. NCT03861611 362 363 O

- NCT03861611 367 368 O
Non NCT03861611 370 373 B-Negation
- NCT03861611 374 375 O
traumatic NCT03861611 376 385 B-Modifier
LBP NCT03861611 386 389 B-Condition

- NCT03861611 392 393 O
Participant NCT03861611 395 406 O
is NCT03861611 407 409 O
to NCT03861611 410 412 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03861611 413 415 I-Assertion___Assertion_Type_Value:hypothetical
discharged NCT03861611 416 426 B-Encounter
home NCT03861611 427 431 O
. NCT03861611 432 433 O

Exclusion NCT03861611 435 444 O
Criteria NCT03861611 445 453 O
: NCT03861611 454 455 O

- NCT03861611 459 460 O
Flank NCT03861611 462 467 B-Modifier
pain NCT03861611 468 472 B-Condition
, NCT03861611 473 474 O
that NCT03861611 475 479 O
is NCT03861611 480 482 O
pain NCT03861611 483 487 B-Condition
originating NCT03861611 488 499 O
from NCT03861611 500 504 O
tissues NCT03861611 505 512 B-Modifier
lateral NCT03861611 513 520 I-Modifier
to NCT03861611 521 523 I-Modifier
the NCT03861611 524 527 I-Modifier
paraspinal NCT03861611 528 538 I-Modifier
muscles NCT03861611 539 546 I-Modifier
. NCT03861611 547 548 O

- NCT03861611 552 553 O
Not NCT03861611 555 558 B-Negation
available NCT03861611 559 568 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03861611 569 572 O
follow NCT03861611 573 579 B-Encounter
- NCT03861611 580 581 I-Encounter
up NCT03861611 582 584 I-Encounter

- NCT03861611 587 588 O
Pregnant NCT03861611 590 598 B-Condition

- NCT03861611 601 602 O
Chronic NCT03861611 604 611 O
pain NCT03861611 612 616 B-Condition
syndrome NCT03861611 617 625 I-Condition

- NCT03861611 628 629 O
Allergic NCT03861611 631 639 B-Allergy
to NCT03861611 640 642 O
or NCT03861611 643 645 B-Or
intolerant NCT03861611 646 656 B-Condition
of NCT03861611 657 659 O
investigational NCT03861611 660 675 B-Study
medications NCT03861611 676 687 B-Drug

- NCT03861611 690 691 O
Contra NCT03861611 693 699 B-Contraindication
- NCT03861611 700 701 I-Contraindication
indications NCT03861611 702 713 I-Contraindication
to NCT03861611 714 716 O
investigational NCT03861611 717 732 B-Study
medications NCT03861611 733 744 B-Drug

Participant NCT03922932 0 11 O
- NCT03922932 12 13 O
Related NCT03922932 14 21 O
Inclusion NCT03922932 22 31 O
Criteria NCT03922932 32 40 O
: NCT03922932 41 42 O

I NCT03922932 44 45 O
. NCT03922932 46 47 O
All NCT03922932 49 52 O
Diabetics NCT03922932 53 62 B-Condition
( NCT03922932 63 64 O
Groups NCT03922932 65 71 O
A NCT03922932 72 73 O
, NCT03922932 74 75 O
B NCT03922932 76 77 O
, NCT03922932 78 79 O
C NCT03922932 80 81 O
) NCT03922932 82 83 O

- NCT03922932 87 88 O
Type NCT03922932 90 94 B-Modifier
1 NCT03922932 95 96 I-Modifier
diabetes NCT03922932 97 105 B-Condition
of NCT03922932 106 108 O
at NCT03922932 109 111 B-Eq_Comparison
least NCT03922932 112 117 I-Eq_Comparison
5 NCT03922932 118 119 I-Eq_Comparison
years NCT03922932 120 125 I-Eq_Comparison
duration NCT03922932 126 134 O
or NCT03922932 135 137 B-Or

- NCT03922932 140 141 O
Type NCT03922932 143 147 B-Modifier
2 NCT03922932 148 149 I-Modifier
diabetes NCT03922932 150 158 B-Condition
of NCT03922932 159 161 O
any NCT03922932 162 165 O
duration NCT03922932 166 174 O
II NCT03922932 175 177 O
. NCT03922932 178 179 O
Group NCT03922932 181 186 O
B NCT03922932 187 188 O

- NCT03922932 191 192 O
Able NCT03922932 194 198 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03922932 199 201 I-Assertion___Assertion_Type_Value:hypothetical
return NCT03922932 202 208 O
for NCT03922932 209 212 O
follow NCT03922932 213 219 B-Encounter
- NCT03922932 220 221 I-Encounter
up NCT03922932 222 224 I-Encounter
over NCT03922932 225 229 B-Eq_Comparison
3 NCT03922932 230 231 I-Eq_Comparison
years NCT03922932 232 237 I-Eq_Comparison

Participant NCT03922932 238 249 O
- NCT03922932 250 251 O
Related NCT03922932 252 259 O
Exclusion NCT03922932 260 269 O
Criteria NCT03922932 270 278 O
: NCT03922932 279 280 O

I NCT03922932 282 283 O
. NCT03922932 284 285 O
Group NCT03922932 287 292 O
B NCT03922932 293 294 O

- NCT03922932 297 298 O
Significant NCT03922932 300 311 O
medical NCT03922932 312 319 B-Condition
condition NCT03922932 320 329 I-Condition
that NCT03922932 330 334 O
would NCT03922932 335 340 B-Assertion___Assertion_Type_Value:hypothetical
make NCT03922932 341 345 O
long NCT03922932 346 350 O
- NCT03922932 351 352 O
term NCT03922932 353 357 O
follow NCT03922932 358 364 B-Encounter
- NCT03922932 365 366 I-Encounter
up NCT03922932 367 369 I-Encounter
difficult NCT03922932 370 379 B-Negation
II NCT03922932 380 382 O
. NCT03922932 383 384 O
Controls NCT03922932 386 394 O
( NCT03922932 395 396 O
Group NCT03922932 397 402 O
D NCT03922932 403 404 O
) NCT03922932 405 406 O

- NCT03922932 410 411 O
Any NCT03922932 413 416 O
medical NCT03922932 417 424 B-Condition
problems NCT03922932 425 433 I-Condition
associated NCT03922932 434 444 O
with NCT03922932 445 449 O
retinal NCT03922932 450 457 B-Condition
vascular NCT03922932 458 466 I-Condition
abnormalities NCT03922932 467 480 I-Condition
( NCT03922932 481 482 O
i NCT03922932 483 484 O
. NCT03922932 485 486 O
e NCT03922932 487 488 O
. NCT03922932 489 490 O
, NCT03922932 491 492 O
hypertension NCT03922932 493 505 B-Condition
, NCT03922932 506 507 O
systemic NCT03922932 508 516 B-Condition
vasculitis NCT03922932 517 527 I-Condition
, NCT03922932 528 529 O
carotid NCT03922932 530 537 B-Condition
insufficiency NCT03922932 538 551 I-Condition
, NCT03922932 552 553 O
etc NCT03922932 554 557 O
. NCT03922932 558 559 O
) NCT03922932 560 561 O

Eye NCT03922932 563 566 O
- NCT03922932 567 568 O
Related NCT03922932 569 576 O
Inclusion NCT03922932 577 586 O
Criteria NCT03922932 587 595 O
: NCT03922932 596 597 O

I NCT03922932 599 600 O
. NCT03922932 601 602 O
Group NCT03922932 604 609 O
A NCT03922932 610 611 O
: NCT03922932 612 613 O

- NCT03922932 617 618 O
Presence NCT03922932 620 628 O
of NCT03922932 629 631 O
active NCT03922932 632 638 B-Eq_Comparison
neovascularization NCT03922932 639 657 B-Condition
, NCT03922932 658 659 O
with NCT03922932 660 664 B-Assertion___Assertion_Type_Value:hypothetical
or NCT03922932 665 667 I-Assertion___Assertion_Type_Value:hypothetical
without NCT03922932 668 675 I-Assertion___Assertion_Type_Value:hypothetical
prior NCT03922932 676 681 B-Eq_Comparison
treatment NCT03922932 682 691 B-Procedure

- NCT03922932 694 695 O
Presence NCT03922932 697 705 O
of NCT03922932 706 708 O
involuted NCT03922932 709 718 B-Modifier
fibrovascular NCT03922932 719 732 B-Condition
proliferans NCT03922932 733 744 I-Condition

II NCT03922932 745 747 O
. NCT03922932 748 749 O
Group NCT03922932 751 756 O
B NCT03922932 757 758 O
: NCT03922932 759 760 O

- NCT03922932 764 765 O
NPDR NCT03922932 767 771 B-Condition
of NCT03922932 772 774 O
any NCT03922932 775 778 O
severity NCT03922932 779 787 O
as NCT03922932 788 790 O
defined NCT03922932 791 798 O
by NCT03922932 799 801 O
the NCT03922932 802 805 O
International NCT03922932 806 819 B-Observation
Clinical NCT03922932 820 828 I-Observation
Diabetic NCT03922932 829 837 I-Observation
Retinopathy NCT03922932 838 849 I-Observation
Severity NCT03922932 850 858 I-Observation
Scale NCT03922932 859 864 I-Observation

III NCT03922932 865 868 O
. NCT03922932 869 870 O
Groups NCT03922932 872 878 O
C NCT03922932 879 880 O
& NCT03922932 881 882 O
D NCT03922932 883 884 O
: NCT03922932 885 886 O

- NCT03922932 890 891 O
No NCT03922932 893 895 B-Negation
evidence NCT03922932 896 904 O
of NCT03922932 905 907 O
diabetic NCT03922932 908 916 B-Condition
retinopathy NCT03922932 917 928 I-Condition

IV NCT03922932 929 931 O
. NCT03922932 932 933 O
Group NCT03922932 935 940 O
ME NCT03922932 941 943 O
: NCT03922932 944 945 O

- NCT03922932 949 950 O
Presence NCT03922932 952 960 O
of NCT03922932 961 963 O
center NCT03922932 964 970 B-Modifier
- NCT03922932 971 972 I-Modifier
involving NCT03922932 973 982 I-Modifier
macular NCT03922932 983 990 B-Condition
edema NCT03922932 991 996 I-Condition
requiring NCT03922932 997 1006 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03922932 1007 1016 B-Procedure

Eye NCT03922932 1017 1020 O
- NCT03922932 1021 1022 O
Related NCT03922932 1023 1030 O
Exclusion NCT03922932 1031 1040 O
Criteria NCT03922932 1041 1049 O
: NCT03922932 1050 1051 O
( NCT03922932 1052 1053 O
Applies NCT03922932 1054 1061 O
to NCT03922932 1062 1064 O
study NCT03922932 1065 1070 O
eye NCT03922932 1071 1074 O
only NCT03922932 1075 1079 O
. NCT03922932 1080 1081 O
May NCT03922932 1083 1086 O
be NCT03922932 1087 1089 O
present NCT03922932 1090 1097 O
in NCT03922932 1098 1100 O
non NCT03922932 1101 1104 O
- NCT03922932 1105 1106 O
study NCT03922932 1107 1112 O
eye NCT03922932 1113 1116 O
. NCT03922932 1117 1118 O
) NCT03922932 1119 1120 O

- NCT03922932 1124 1125 O
Visual NCT03922932 1127 1133 B-Observation
acuity NCT03922932 1134 1140 I-Observation
worse NCT03922932 1141 1146 B-Eq_Comparison
than NCT03922932 1147 1151 I-Eq_Comparison
20 NCT03922932 1152 1154 I-Eq_Comparison
/ NCT03922932 1155 1156 I-Eq_Comparison
200 NCT03922932 1157 1160 I-Eq_Comparison

- NCT03922932 1164 1165 O
Inability NCT03922932 1167 1176 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03922932 1177 1179 O
maintain NCT03922932 1180 1188 O
stable NCT03922932 1189 1195 O
fixation NCT03922932 1196 1204 O
for NCT03922932 1205 1208 O
OCT NCT03922932 1209 1212 B-Procedure
imaging NCT03922932 1213 1220 I-Procedure

- NCT03922932 1223 1224 O
History NCT03922932 1226 1233 B-Eq_Comparison
of NCT03922932 1234 1236 O
major NCT03922932 1237 1242 O
eye NCT03922932 1243 1246 B-Procedure
surgery NCT03922932 1247 1254 I-Procedure
( NCT03922932 1255 1256 O
vitrectomy NCT03922932 1257 1267 B-Procedure
, NCT03922932 1268 1269 O
cataract NCT03922932 1270 1278 B-Procedure
surgery NCT03922932 1279 1286 I-Procedure
, NCT03922932 1287 1288 O
scleral NCT03922932 1289 1296 B-Procedure
buckle NCT03922932 1297 1303 I-Procedure
, NCT03922932 1304 1305 O
other NCT03922932 1306 1311 B-Other
intraocular NCT03922932 1312 1323 B-Procedure
surgery NCT03922932 1324 1331 I-Procedure
, NCT03922932 1332 1333 O
etc NCT03922932 1334 1337 O
. NCT03922932 1338 1339 O
) NCT03922932 1340 1341 O
within NCT03922932 1342 1348 B-Eq_Comparison
90 NCT03922932 1349 1351 I-Eq_Comparison
days NCT03922932 1352 1356 I-Eq_Comparison
of NCT03922932 1357 1359 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03922932 1360 1370 B-Study

- NCT03922932 1373 1374 O
History NCT03922932 1376 1383 B-Eq_Comparison
of NCT03922932 1384 1386 O
another NCT03922932 1387 1394 B-Other
eye NCT03922932 1395 1398 B-Condition
disease NCT03922932 1399 1406 I-Condition
or NCT03922932 1407 1409 B-Or
condition NCT03922932 1410 1419 B-Condition
that NCT03922932 1420 1424 O
may NCT03922932 1425 1428 B-Assertion___Assertion_Type_Value:hypothetical
alter NCT03922932 1429 1434 O
retinal NCT03922932 1435 1442 B-Condition
perfusion NCT03922932 1443 1452 B-Modifier
, NCT03922932 1453 1454 O
permeability NCT03922932 1455 1467 B-Modifier
, NCT03922932 1468 1469 O
or NCT03922932 1470 1472 B-Or
retinal NCT03922932 1473 1480 B-Modifier
anatomy NCT03922932 1481 1488 I-Modifier

- NCT03922932 1491 1492 O
Substantial NCT03922932 1494 1505 O
media NCT03922932 1506 1511 B-Condition
opacity NCT03922932 1512 1519 I-Condition
( NCT03922932 1520 1521 O
cataract NCT03922932 1522 1530 B-Condition
, NCT03922932 1531 1532 O
corneal NCT03922932 1533 1540 B-Condition
scar NCT03922932 1541 1545 I-Condition
, NCT03922932 1546 1547 O
vitreous NCT03922932 1548 1556 B-Condition
hemorrhage NCT03922932 1557 1567 I-Condition
) NCT03922932 1568 1569 O
that NCT03922932 1570 1574 O
may NCT03922932 1575 1578 O
interfere NCT03922932 1579 1588 O
with NCT03922932 1589 1593 O
study NCT03922932 1594 1599 B-Study
imaging NCT03922932 1600 1607 B-Procedure


Inclusion NCT03923985 0 9 O
Criteria NCT03923985 10 18 O
: NCT03923985 19 20 O

- NCT03923985 24 25 O
Healthy NCT03923985 27 34 B-Condition
women NCT03923985 35 40 O
between NCT03923985 41 48 B-Eq_Comparison
18 NCT03923985 49 51 I-Eq_Comparison
and NCT03923985 52 55 I-Eq_Comparison
45 NCT03923985 56 58 I-Eq_Comparison
years NCT03923985 59 64 I-Eq_Comparison
old NCT03923985 65 68 B-Age

- NCT03923985 71 72 O
Women NCT03923985 74 79 O
without NCT03923985 80 87 B-Negation
current NCT03923985 88 95 B-Eq_Comparison
symptoms NCT03923985 96 104 B-Assertion___Assertion_Type_Value:possible
of NCT03923985 105 107 O
vaginal NCT03923985 108 115 B-Condition
infection NCT03923985 116 125 I-Condition

- NCT03923985 128 129 O
Negative NCT03923985 131 139 O
bacteriological NCT03923985 140 155 B-Modifier
and NCT03923985 156 159 B-And
clinical NCT03923985 160 168 B-Modifier
examination NCT03923985 169 180 B-Procedure

Exclusion NCT03923985 181 190 O
Criteria NCT03923985 191 199 O
: NCT03923985 200 201 O

- NCT03923985 205 206 O
Women NCT03923985 208 213 O
with NCT03923985 214 218 B-And
vaginal NCT03923985 219 226 B-Condition
infection NCT03923985 227 236 I-Condition

- NCT03923985 239 240 O
Women NCT03923985 242 247 O
with NCT03923985 248 252 B-And
undiagnosed NCT03923985 253 264 O
vaginal NCT03923985 265 272 B-Condition
bleeding NCT03923985 273 281 I-Condition

- NCT03923985 284 285 O
Patients NCT03923985 287 295 O
with NCT03923985 296 300 O
endometrial NCT03923985 301 312 B-Condition
hyperplasia NCT03923985 313 324 I-Condition

- NCT03923985 327 328 O
Suspicion NCT03923985 330 339 B-Assertion___Assertion_Type_Value:possible
of NCT03923985 340 342 O
neoplasia NCT03923985 343 352 B-Condition
or NCT03923985 353 355 B-Or
active NCT03923985 356 362 B-Eq_Comparison
neoplasia NCT03923985 363 372 B-Condition

- NCT03923985 375 376 O
Women NCT03923985 378 383 O
with NCT03923985 384 388 B-And
intolerance NCT03923985 389 400 B-Condition
, NCT03923985 401 402 O
allergy NCT03923985 403 410 B-Allergy
or NCT03923985 411 413 B-Or
hypersensitivity NCT03923985 414 430 B-Condition
to NCT03923985 431 433 O
the NCT03923985 434 437 O
components NCT03923985 438 448 O
of NCT03923985 449 451 O
the NCT03923985 452 455 O
probiotic NCT03923985 456 465 B-Drug

- NCT03923985 468 469 O
Women NCT03923985 471 476 O
with NCT03923985 477 481 B-And
immunosuppressive NCT03923985 482 499 B-Condition
disorders NCT03923985 500 509 I-Condition
or NCT03923985 510 512 B-Or
with NCT03923985 513 517 O
HIV NCT03923985 518 521 B-Condition

- NCT03923985 524 525 O
Women NCT03923985 527 532 O
who NCT03923985 533 536 B-And
are NCT03923985 537 540 O
currently NCT03923985 541 550 B-Eq_Comparison
using NCT03923985 551 556 I-Eq_Comparison
probiotics NCT03923985 557 567 B-Drug
by NCT03923985 568 570 O
any NCT03923985 571 574 O
route NCT03923985 575 580 O
of NCT03923985 581 583 O
administration NCT03923985 584 598 O

- NCT03923985 601 602 O
Women NCT03923985 604 609 O
who NCT03923985 610 613 B-And
are NCT03923985 614 617 O
using NCT03923985 618 623 B-Eq_Comparison
some NCT03923985 624 628 O
treatment NCT03923985 629 638 B-Procedure
for NCT03923985 639 642 O
vaginal NCT03923985 643 650 B-Modifier
sepsis NCT03923985 651 657 B-Condition

- NCT03923985 660 661 O
Chronic NCT03923985 663 670 O
decompensated NCT03923985 671 684 B-Modifier
noncommunicable NCT03923985 685 700 B-Condition
diseases NCT03923985 701 709 I-Condition
( NCT03923985 710 711 O
diabetes NCT03923985 712 720 B-Condition
mellitus NCT03923985 721 729 I-Condition
, NCT03923985 730 731 O
heart NCT03923985 732 737 B-Condition
disease NCT03923985 738 745 I-Condition
. NCT03923985 746 747 O
. NCT03923985 748 749 O
. NCT03923985 750 751 O
) NCT03923985 752 753 O

- NCT03923985 757 758 O
Pregnant NCT03923985 760 768 B-Condition
women NCT03923985 769 774 O
or NCT03923985 775 777 B-Or
those NCT03923985 778 783 O
with NCT03923985 784 788 O
precocious NCT03923985 789 799 B-Condition
menopause NCT03923985 800 809 I-Condition

Inclusion NCT03868917 0 9 O
Criteria NCT03868917 10 18 O
: NCT03868917 19 20 O

- NCT03868917 24 25 O
Scheduled NCT03868917 27 36 B-Eq_Comparison
for NCT03868917 37 40 O
elective NCT03868917 41 49 B-Modifier
thoracotomy NCT03868917 50 61 B-Procedure

- NCT03868917 64 65 O
ASA NCT03868917 67 70 B-Observation
status NCT03868917 71 77 O
1 NCT03868917 78 79 B-Eq_Comparison
, NCT03868917 80 81 I-Eq_Comparison
2 NCT03868917 82 83 I-Eq_Comparison

Exclusion NCT03868917 85 94 O
Criteria NCT03868917 95 103 O
: NCT03868917 104 105 O

- NCT03868917 109 110 O
Inability NCT03868917 112 121 O
to NCT03868917 122 124 O
provide NCT03868917 125 132 O
adequate NCT03868917 133 141 O
informed NCT03868917 142 150 O
consent NCT03868917 151 158 O

- NCT03868917 161 162 O
Any NCT03868917 164 167 O
contraindication NCT03868917 168 184 B-Contraindication
to NCT03868917 185 187 O
the NCT03868917 188 191 O
placement NCT03868917 192 201 O
of NCT03868917 202 204 O
thoracic NCT03868917 205 213 B-Procedure
paravertebral NCT03868917 214 227 I-Procedure
catheters NCT03868917 228 237 I-Procedure

- NCT03868917 240 241 O
Unstable NCT03868917 243 251 O
vertebral NCT03868917 252 261 B-Modifier
and NCT03868917 262 265 B-Or
transverse NCT03868917 266 276 B-Modifier
process NCT03868917 277 284 I-Modifier
fractures NCT03868917 285 294 B-Condition

- NCT03868917 297 298 O
Any NCT03868917 300 303 O
chronic NCT03868917 304 311 O
painful NCT03868917 312 319 B-Condition
conditions NCT03868917 320 330 I-Condition
or NCT03868917 331 333 B-Or
pre NCT03868917 334 337 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03868917 338 347 B-Procedure
opioid NCT03868917 348 354 B-Drug
use NCT03868917 355 358 O
Any NCT03868917 359 362 O
chronic NCT03868917 363 370 O
painful NCT03868917 371 378 B-Condition
conditions NCT03868917 379 389 I-Condition
or NCT03868917 390 392 B-Or
pre NCT03868917 393 396 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03868917 397 406 B-Procedure
opioid NCT03868917 407 413 B-Drug
use NCT03868917 414 417 O

- NCT03868917 420 421 O
Coagulation NCT03868917 423 434 B-Condition
abnormalities NCT03868917 435 448 I-Condition
or NCT03868917 449 451 B-Or
expectation NCT03868917 452 463 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868917 464 466 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03868917 467 469 O
on NCT03868917 470 472 B-Eq_Comparison
therapeutic NCT03868917 473 484 B-Drug
anticoagulants NCT03868917 485 499 I-Drug
post NCT03868917 500 504 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operatively NCT03868917 505 516 B-Procedure

- NCT03868917 519 520 O
Allergy NCT03868917 522 529 B-Allergy
to NCT03868917 530 532 O
any NCT03868917 533 536 O
of NCT03868917 537 539 O
the NCT03868917 540 543 O
drugs NCT03868917 544 549 B-Drug
/ NCT03868917 550 551 B-Or
agents NCT03868917 552 558 B-Drug
used NCT03868917 559 563 O
in NCT03868917 564 566 O
study NCT03868917 567 572 B-Study
protocol NCT03868917 573 581 O

- NCT03868917 584 585 O
Altered NCT03868917 587 594 B-Condition
mental NCT03868917 595 601 I-Condition
status NCT03868917 602 608 I-Condition
or NCT03868917 609 611 B-Or
emergency NCT03868917 612 621 B-Modifier
surgery NCT03868917 622 629 B-Procedure

- NCT03868917 632 633 O
Comorbid NCT03868917 635 643 B-Condition
conditions NCT03868917 644 654 I-Condition
such NCT03868917 655 659 O
as NCT03868917 660 662 O
sepsis NCT03868917 663 669 B-Condition
, NCT03868917 670 671 O
unstable NCT03868917 672 680 O
angina NCT03868917 681 687 B-Condition
, NCT03868917 688 689 O
congestive NCT03868917 690 700 B-Condition
heart NCT03868917 701 706 I-Condition
failure NCT03868917 707 714 I-Condition

Inclusion NCT03861299 0 9 O
Criteria NCT03861299 10 18 O
: NCT03861299 19 20 O

1 NCT03861299 24 25 O
. NCT03861299 25 26 O
Age NCT03861299 28 31 B-Age
≥ NCT03861299 32 33 B-Eq_Comparison
18 NCT03861299 34 36 I-Eq_Comparison
years NCT03861299 37 42 I-Eq_Comparison
and NCT03861299 43 46 B-And
≤ NCT03861299 47 48 B-Eq_Comparison
90 NCT03861299 49 51 I-Eq_Comparison
years NCT03861299 52 57 I-Eq_Comparison

2 NCT03861299 60 61 O
. NCT03861299 61 62 O
Tumor NCT03861299 64 69 B-Condition
diagnosed NCT03861299 70 79 O
as NCT03861299 80 82 O
Glioblastoma NCT03861299 83 95 B-Modifier
Multiforme NCT03861299 96 106 I-Modifier
on NCT03861299 107 109 O
MRI NCT03861299 110 113 B-Procedure
with NCT03861299 114 118 O
distinct NCT03861299 119 127 B-Modifier
ring NCT03861299 128 132 I-Modifier
- NCT03861299 133 134 I-Modifier
like NCT03861299 135 139 I-Modifier
pattern NCT03861299 140 147 I-Modifier
of NCT03861299 148 150 O
contrast NCT03861299 151 159 B-Procedure
enhancement NCT03861299 160 171 I-Procedure
with NCT03861299 172 176 O
thick NCT03861299 177 182 B-Modifier
irregular NCT03861299 183 192 I-Modifier
walls NCT03861299 193 198 I-Modifier
and NCT03861299 199 202 B-And
a NCT03861299 203 204 O
core NCT03861299 205 209 B-Modifier
area NCT03861299 210 214 I-Modifier
reduced NCT03861299 215 222 I-Modifier
signal NCT03861299 223 229 I-Modifier
suggestive NCT03861299 230 240 B-Assertion___Assertion_Type_Value:possible
of NCT03861299 241 243 O
tumour NCT03861299 244 250 B-Condition
necrosis NCT03861299 251 259 I-Condition
as NCT03861299 260 262 O
assessed NCT03861299 263 271 O
by NCT03861299 272 274 O
the NCT03861299 275 278 O
surgeon NCT03861299 279 286 B-Provider

3 NCT03861299 289 290 O
. NCT03861299 290 291 O
Tumors NCT03861299 293 299 B-Condition
situated NCT03861299 300 308 O
in NCT03861299 309 311 B-Modifier
or NCT03861299 312 314 I-Modifier
near NCT03861299 315 319 I-Modifier
eloquent NCT03861299 320 328 I-Modifier
areas NCT03861299 329 334 I-Modifier
; NCT03861299 334 335 O
motor NCT03861299 336 341 B-Modifier
cortex NCT03861299 342 348 I-Modifier
, NCT03861299 349 350 O
sensory NCT03861299 351 358 B-Modifier
cortex NCT03861299 359 365 I-Modifier
, NCT03861299 366 367 O
subcortical NCT03861299 368 379 B-Modifier
pyramidal NCT03861299 380 389 I-Modifier
tract NCT03861299 390 395 I-Modifier
or NCT03861299 396 398 B-Or
speech NCT03861299 399 405 B-Modifier
areas NCT03861299 406 411 I-Modifier
as NCT03861299 412 414 O
indicated NCT03861299 415 424 O
on NCT03861299 425 427 O
MRI NCT03861299 428 431 B-Procedure
( NCT03861299 432 433 O
Sawaya NCT03861299 434 440 B-Condition
Grading NCT03861299 441 448 B-Eq_Comparison
II NCT03861299 449 451 I-Eq_Comparison
and NCT03861299 452 455 I-Eq_Comparison
II NCT03861299 456 458 I-Eq_Comparison
) NCT03861299 459 460 O

4 NCT03861299 464 465 O
. NCT03861299 465 466 O
The NCT03861299 468 471 O
tumor NCT03861299 472 477 B-Condition
is NCT03861299 478 480 O
suitable NCT03861299 481 489 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03861299 490 493 I-Assertion___Assertion_Type_Value:hypothetical
resection NCT03861299 494 503 B-Procedure
( NCT03861299 504 505 O
according NCT03861299 506 515 O
to NCT03861299 516 518 O
neurosurgeon NCT03861299 519 531 B-Provider
) NCT03861299 532 533 O

5 NCT03861299 537 538 O
. NCT03861299 538 539 O
Karnofsky NCT03861299 541 550 B-Observation
performance NCT03861299 551 562 I-Observation
scale NCT03861299 563 568 I-Observation
80 NCT03861299 569 571 B-Eq_Comparison
or NCT03861299 572 574 I-Eq_Comparison
more NCT03861299 575 579 I-Eq_Comparison

6 NCT03861299 582 583 O
. NCT03861299 583 584 O
Written NCT03861299 586 593 O
Informed NCT03861299 594 602 O
consent NCT03861299 603 610 O

Exclusion NCT03861299 611 620 O
Criteria NCT03861299 621 629 O
: NCT03861299 630 631 O

1 NCT03861299 635 636 O
. NCT03861299 636 637 O
Tumors NCT03861299 639 645 B-Condition
of NCT03861299 646 648 O
the NCT03861299 649 652 O
cerebellum NCT03861299 653 663 B-Modifier
, NCT03861299 664 665 O
brain NCT03861299 666 671 B-Modifier
stem NCT03861299 672 676 I-Modifier
or NCT03861299 677 679 B-Or
midline NCT03861299 680 687 B-Modifier

2 NCT03861299 690 691 O
. NCT03861299 691 692 O
Multifocal NCT03861299 694 704 B-Modifier
contrast NCT03861299 705 713 I-Modifier
enhancing NCT03861299 714 723 I-Modifier
lesions NCT03861299 724 731 B-Condition

3 NCT03861299 734 735 O
. NCT03861299 735 736 O
Substantial NCT03861299 738 749 O
non NCT03861299 750 753 B-Modifier
- NCT03861299 754 755 I-Modifier
contrast NCT03861299 756 764 I-Modifier
enhancing NCT03861299 765 774 I-Modifier
tumor NCT03861299 775 780 B-Condition
areas NCT03861299 781 786 O
suggesting NCT03861299 787 797 B-Assertion___Assertion_Type_Value:possible
low NCT03861299 798 801 O
grade NCT03861299 802 807 O
gliomas NCT03861299 808 815 B-Condition
with NCT03861299 816 820 O
malignant NCT03861299 821 830 B-Modifier
transformation NCT03861299 831 845 I-Modifier

4 NCT03861299 848 849 O
. NCT03861299 849 850 O
Medical NCT03861299 852 859 B-Condition
reasons NCT03861299 860 867 I-Condition
precluding NCT03861299 868 878 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
MRI NCT03861299 879 882 B-Procedure
( NCT03861299 883 884 O
eg NCT03861299 885 887 O
, NCT03861299 888 889 O
pacemaker NCT03861299 890 899 B-Procedure
) NCT03861299 900 901 O

5 NCT03861299 905 906 O
. NCT03861299 906 907 O
Inability NCT03861299 909 918 O
to NCT03861299 919 921 O
give NCT03861299 922 926 O
consent NCT03861299 927 934 O
because NCT03861299 935 942 O
of NCT03861299 943 945 O
or NCT03861299 946 948 O
language NCT03861299 949 957 B-Condition
barrier NCT03861299 958 965 I-Condition

6 NCT03861299 968 969 O
. NCT03861299 969 970 O
Psychiatric NCT03861299 972 983 B-Condition
history NCT03861299 984 991 B-Eq_Comparison

7 NCT03861299 994 995 O
. NCT03861299 995 996 O
Previous NCT03861299 998 1006 B-Eq_Comparison
brain NCT03861299 1007 1012 B-Modifier
tumour NCT03861299 1013 1019 B-Condition
surgery NCT03861299 1020 1027 B-Procedure

8 NCT03861299 1030 1031 O
. NCT03861299 1031 1032 O
Previous NCT03861299 1034 1042 B-Eq_Comparison
low NCT03861299 1043 1046 O
- NCT03861299 1047 1048 O
grade NCT03861299 1049 1054 O
glioma NCT03861299 1055 1061 B-Condition
. NCT03861299 1062 1063 O

9 NCT03861299 1067 1068 O
. NCT03861299 1068 1069 O
Second NCT03861299 1071 1077 B-Eq_Comparison
primary NCT03861299 1078 1085 B-Modifier
malignancy NCT03861299 1086 1096 B-Condition
within NCT03861299 1097 1103 B-Eq_Comparison
the NCT03861299 1104 1107 I-Eq_Comparison
past NCT03861299 1108 1112 I-Eq_Comparison
5 NCT03861299 1113 1114 I-Eq_Comparison
years NCT03861299 1115 1120 I-Eq_Comparison
with NCT03861299 1121 1125 O
the NCT03861299 1126 1129 O
exception NCT03861299 1130 1139 B-Exception
of NCT03861299 1140 1142 I-Exception
adequately NCT03861299 1143 1153 O
treated NCT03861299 1154 1161 B-Procedure
in NCT03861299 1162 1164 B-Modifier
situ NCT03861299 1165 1169 I-Modifier
carcinoma NCT03861299 1170 1179 B-Condition
of NCT03861299 1180 1182 O
any NCT03861299 1183 1186 B-Modifier
organ NCT03861299 1187 1192 I-Modifier
or NCT03861299 1193 1195 B-Or
basal NCT03861299 1196 1201 B-Modifier
cell NCT03861299 1202 1206 I-Modifier
carcinoma NCT03861299 1207 1216 B-Condition
of NCT03861299 1217 1219 O
the NCT03861299 1220 1223 O
skin NCT03861299 1224 1228 B-Modifier
. NCT03861299 1229 1230 O

10 NCT03861299 1233 1235 O
. NCT03861299 1235 1236 O
Severe NCT03861299 1238 1244 O
aphasia NCT03861299 1245 1252 B-Condition
or NCT03861299 1253 1255 B-Or
dysphasia NCT03861299 1256 1265 B-Condition

Inclusion NCT03866057 0 9 O
criteria NCT03866057 10 18 O
: NCT03866057 19 20 O

- NCT03866057 24 25 O
age NCT03866057 27 30 B-Age
18 NCT03866057 31 33 B-Eq_Comparison
- NCT03866057 34 35 I-Eq_Comparison
90 NCT03866057 36 38 I-Eq_Comparison

- NCT03866057 42 43 O
acute NCT03866057 45 50 O
ischemic NCT03866057 51 59 B-Modifier
or NCT03866057 60 62 B-Or
hemorrhagic NCT03866057 63 74 B-Modifier
stroke NCT03866057 75 81 B-Condition
( NCT03866057 82 83 O
within NCT03866057 84 90 B-Eq_Comparison
30 NCT03866057 91 93 I-Eq_Comparison
days NCT03866057 94 98 I-Eq_Comparison
) NCT03866057 99 100 O

- NCT03866057 104 105 O
consent NCT03866057 107 114 O
to NCT03866057 115 117 O
participate NCT03866057 118 129 O
and NCT03866057 130 133 O
to NCT03866057 134 136 O
anonymous NCT03866057 137 146 O
processing NCT03866057 147 157 O
of NCT03866057 158 160 O
data NCT03866057 161 165 O
. NCT03866057 166 167 O

Additional NCT03866057 169 179 O
inclusion NCT03866057 180 189 O
criteria NCT03866057 190 198 O
for NCT03866057 199 202 O
Sub NCT03866057 203 206 O
- NCT03866057 207 208 O
project NCT03866057 209 216 O
Neurophysiological NCT03866057 217 235 O
Markers NCT03866057 236 243 O
: NCT03866057 244 245 O

- NCT03866057 248 249 O
signing NCT03866057 250 257 O
of NCT03866057 258 260 O
informed NCT03866057 261 269 O
consent NCT03866057 270 277 O
for NCT03866057 278 281 O
the NCT03866057 282 285 O
participation NCT03866057 286 299 O
in NCT03866057 300 302 O
the NCT03866057 303 306 O
sub NCT03866057 307 310 O
- NCT03866057 311 312 O
project NCT03866057 313 320 O
. NCT03866057 321 322 O

Additional NCT03866057 324 334 O
inclusion NCT03866057 335 344 O
criteria NCT03866057 345 353 O
for NCT03866057 354 357 O
Epigenetic NCT03866057 358 368 O
subproject NCT03866057 369 379 O
: NCT03866057 380 381 O

- NCT03866057 384 385 O
signing NCT03866057 386 393 O
of NCT03866057 394 396 O
informed NCT03866057 397 405 O
consent NCT03866057 406 413 O
for NCT03866057 414 417 O
participation NCT03866057 418 431 O
in NCT03866057 432 434 O
the NCT03866057 435 438 O
subproject NCT03866057 439 449 O
. NCT03866057 450 451 O

Exclusion NCT03866057 453 462 O
Criteria NCT03866057 463 471 O
: NCT03866057 472 473 O

- NCT03866057 476 477 O
Stroke NCT03866057 478 484 B-Condition
occurred NCT03866057 485 493 O
more NCT03866057 494 498 B-Eq_Comparison
than NCT03866057 499 503 I-Eq_Comparison
30 NCT03866057 504 506 I-Eq_Comparison
days NCT03866057 507 511 I-Eq_Comparison
after NCT03866057 512 517 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03866057 518 521 O
transfer NCT03866057 522 530 B-Encounter
to NCT03866057 531 533 O
intensive NCT03866057 534 543 O
rehabilitation NCT03866057 544 558 O

Additional NCT03866057 559 569 O
exclusion NCT03866057 570 579 O
criteria NCT03866057 580 588 O
for NCT03866057 589 592 O
Epigenetic NCT03866057 593 603 O
subproject NCT03866057 604 614 O
( NCT03866057 615 616 O
for NCT03866057 617 620 O
retrospective NCT03866057 621 634 O
analysis NCT03866057 635 643 O
) NCT03866057 644 645 O
: NCT03866057 646 647 O

- NCT03866057 651 652 O
history NCT03866057 654 661 B-Eq_Comparison
of NCT03866057 662 664 O
major NCT03866057 665 670 O
psychiatric NCT03866057 671 682 B-Condition
disorder NCT03866057 683 691 I-Condition
or NCT03866057 692 694 B-Or
recent NCT03866057 695 701 B-Eq_Comparison
exacerbation NCT03866057 702 714 B-Condition

- NCT03866057 717 718 O
global NCT03866057 720 726 B-Condition
aphasia NCT03866057 727 734 I-Condition

- NCT03866057 737 738 O
refusal NCT03866057 740 747 O
of NCT03866057 748 750 O
the NCT03866057 751 754 O
patient NCT03866057 755 762 O
to NCT03866057 763 765 O
participate NCT03866057 766 777 O
in NCT03866057 778 780 O
the NCT03866057 781 784 O
study NCT03866057 785 790 O
. NCT03866057 791 792 O

Inclusion NCT03925909 0 9 O
Criteria NCT03925909 10 18 O
: NCT03925909 19 20 O

- NCT03925909 24 25 O
30 NCT03925909 27 29 B-Eq_Comparison
- NCT03925909 30 31 I-Eq_Comparison
60 NCT03925909 32 34 I-Eq_Comparison
years NCT03925909 35 40 I-Eq_Comparison

- NCT03925909 43 44 O
Increased NCT03925909 46 55 O
fasting NCT03925909 56 63 B-Observation
blood NCT03925909 64 69 I-Observation
glucose NCT03925909 70 77 I-Observation
from NCT03925909 78 82 O
6.1 NCT03925909 83 86 B-Eq_Comparison
to NCT03925909 87 89 I-Eq_Comparison
7.0 NCT03925909 90 93 I-Eq_Comparison
mmol NCT03925909 94 98 I-Eq_Comparison
/ NCT03925909 99 100 I-Eq_Comparison
L NCT03925909 101 102 I-Eq_Comparison
or NCT03925909 103 105 B-Or
, NCT03925909 106 107 O

- NCT03925909 111 112 O
Decreased NCT03925909 114 123 O
glucose NCT03925909 124 131 B-Observation
tolerance NCT03925909 132 141 I-Observation
of NCT03925909 142 144 O
7 NCT03925909 145 146 B-Eq_Comparison
, NCT03925909 147 148 I-Eq_Comparison
8 NCT03925909 149 150 I-Eq_Comparison
to NCT03925909 151 153 I-Eq_Comparison
11.1 NCT03925909 154 158 I-Eq_Comparison
mmol NCT03925909 159 163 I-Eq_Comparison
/ NCT03925909 164 165 I-Eq_Comparison
L NCT03925909 166 167 I-Eq_Comparison
or NCT03925909 168 170 B-Or
, NCT03925909 171 172 O

- NCT03925909 176 177 O
Glycated NCT03925909 179 187 B-Modifier
hemoglobin NCT03925909 188 198 B-Observation
with NCT03925909 199 203 O
values NCT03925909 204 210 O
between NCT03925909 211 218 B-Eq_Comparison
5.7 NCT03925909 219 222 I-Eq_Comparison
and NCT03925909 223 226 I-Eq_Comparison
6.4 NCT03925909 227 230 I-Eq_Comparison
% NCT03925909 231 232 I-Eq_Comparison

Exclusion NCT03925909 234 243 O
Criteria NCT03925909 244 252 O
: NCT03925909 253 254 O

- NCT03925909 258 259 O
Use NCT03925909 261 264 B-Eq_Comparison
hypoglycemic NCT03925909 265 277 B-Drug
, NCT03925909 278 279 O
hypolipidemic NCT03925909 280 293 B-Drug
drugs NCT03925909 294 299 O
, NCT03925909 300 301 O

- NCT03925909 305 306 O
Use NCT03925909 308 311 B-Eq_Comparison
dietary NCT03925909 312 319 B-Drug
supplements NCT03925909 320 331 I-Drug
( NCT03925909 332 333 O
vitamins NCT03925909 334 342 B-Drug
, NCT03925909 343 344 O
minerals NCT03925909 345 353 B-Drug
, NCT03925909 354 355 O
bioflavonoids NCT03925909 356 369 B-Drug
, NCT03925909 370 371 O
prebiotics NCT03925909 372 382 B-Drug
, NCT03925909 383 384 O
probiotics NCT03925909 385 395 B-Drug
or NCT03925909 396 398 O
other NCT03925909 399 404 B-Other
bioactive NCT03925909 405 414 B-Drug
compounds NCT03925909 415 424 I-Drug
) NCT03925909 425 426 O
, NCT03925909 427 428 O

- NCT03925909 432 433 O
Exercise NCT03925909 435 443 B-Condition
intensely NCT03925909 444 453 O
( NCT03925909 454 455 O
more NCT03925909 456 460 B-Eq_Comparison
than NCT03925909 461 465 I-Eq_Comparison
10 NCT03925909 466 468 I-Eq_Comparison
hours NCT03925909 469 474 I-Eq_Comparison
per NCT03925909 475 478 I-Eq_Comparison
week NCT03925909 479 483 I-Eq_Comparison
) NCT03925909 484 485 O

- NCT03925909 489 490 O
History NCT03925909 492 499 B-Eq_Comparison
of NCT03925909 500 502 O
cardiovascular NCT03925909 503 517 B-Condition
diseases NCT03925909 518 526 I-Condition
, NCT03925909 527 528 O
diabetes NCT03925909 529 537 B-Condition
mellitus NCT03925909 538 546 I-Condition
, NCT03925909 547 548 O
liver NCT03925909 549 554 B-Modifier
and NCT03925909 555 558 B-Or
kidney NCT03925909 559 565 B-Modifier
disease NCT03925909 566 573 B-Condition
. NCT03925909 574 575 O

Inclusion NCT03866746 0 9 O
Criteria NCT03866746 10 18 O
: NCT03866746 19 20 O

- NCT03866746 24 25 O
older NCT03866746 27 32 B-Eq_Comparison
than NCT03866746 33 37 I-Eq_Comparison
18 NCT03866746 38 40 I-Eq_Comparison
years NCT03866746 41 46 I-Eq_Comparison
old NCT03866746 47 50 B-Age

- NCT03866746 53 54 O
diagnosed NCT03866746 56 65 O
with NCT03866746 66 70 O
DME NCT03866746 71 74 B-Condition
with NCT03866746 75 79 B-And
central NCT03866746 80 87 B-Observation
macular NCT03866746 88 95 I-Observation
thickness NCT03866746 96 105 I-Observation
( NCT03866746 106 107 O
CMT NCT03866746 108 111 B-Observation
) NCT03866746 112 113 O
more NCT03866746 114 118 B-Eq_Comparison
than NCT03866746 119 123 I-Eq_Comparison
250 NCT03866746 124 127 I-Eq_Comparison
µm NCT03866746 128 130 I-Eq_Comparison
measured NCT03866746 131 139 O
by NCT03866746 140 142 O
OCT NCT03866746 143 146 B-Procedure

- NCT03866746 149 150 O
best NCT03866746 152 156 B-Observation
corrected NCT03866746 157 166 I-Observation
visual NCT03866746 167 173 I-Observation
acuity NCT03866746 174 180 I-Observation
( NCT03866746 181 182 O
BCVA NCT03866746 183 187 B-Observation
) NCT03866746 188 189 O
between NCT03866746 190 197 B-Eq_Comparison
20 NCT03866746 198 200 I-Eq_Comparison
/ NCT03866746 201 202 I-Eq_Comparison
400 NCT03866746 203 206 I-Eq_Comparison
and NCT03866746 207 210 I-Eq_Comparison
20 NCT03866746 211 213 I-Eq_Comparison
/ NCT03866746 214 215 I-Eq_Comparison
40 NCT03866746 216 218 I-Eq_Comparison
. NCT03866746 218 219 O

Exclusion NCT03866746 221 230 O
Criteria NCT03866746 231 239 O
: NCT03866746 240 241 O

- NCT03866746 245 246 O
patients NCT03866746 248 256 O
with NCT03866746 257 261 O
intra NCT03866746 262 267 B-Modifier
- NCT03866746 268 269 I-Modifier
ocular NCT03866746 270 276 I-Modifier
surgery NCT03866746 277 284 B-Procedure
as NCT03866746 285 287 O
cataract NCT03866746 288 296 B-Procedure
surgery NCT03866746 297 304 I-Procedure
within NCT03866746 305 311 B-Eq_Comparison
6 NCT03866746 312 313 I-Eq_Comparison
months NCT03866746 314 320 I-Eq_Comparison

- NCT03866746 323 324 O
prior NCT03866746 326 331 B-Eq_Comparison
intravitreal NCT03866746 332 344 B-Procedure
injection NCT03866746 345 354 I-Procedure
of NCT03866746 355 357 O
any NCT03866746 358 361 O
drug NCT03866746 362 366 B-Drug
within NCT03866746 367 373 B-Eq_Comparison
the NCT03866746 374 377 I-Eq_Comparison
preceding NCT03866746 378 387 I-Eq_Comparison
6 NCT03866746 388 389 I-Eq_Comparison
months NCT03866746 390 396 I-Eq_Comparison

- NCT03866746 399 400 O
panretinal NCT03866746 402 412 B-Procedure
photocoagulation NCT03866746 413 429 I-Procedure
( NCT03866746 430 431 O
PRP NCT03866746 432 435 B-Procedure
) NCT03866746 436 437 O
within NCT03866746 438 444 B-Eq_Comparison
the NCT03866746 445 448 I-Eq_Comparison
former NCT03866746 449 455 I-Eq_Comparison
4 NCT03866746 456 457 I-Eq_Comparison
months NCT03866746 458 464 I-Eq_Comparison
. NCT03866746 465 466 O

- NCT03866746 470 471 O
Patients NCT03866746 473 481 O
with NCT03866746 482 486 O
previous NCT03866746 487 495 B-Eq_Comparison
macular NCT03866746 496 503 B-Procedure
laser NCT03866746 504 509 I-Procedure

- NCT03866746 512 513 O
patients NCT03866746 515 523 O
with NCT03866746 524 528 O
vitreo NCT03866746 529 535 B-Condition
- NCT03866746 536 537 I-Condition
macular NCT03866746 538 545 I-Condition
traction NCT03866746 546 554 I-Condition
( NCT03866746 555 556 O
VMT NCT03866746 557 560 B-Condition
) NCT03866746 561 562 O
syndrome NCT03866746 563 571 B-Modifier

- NCT03866746 574 575 O
severe NCT03866746 577 583 O
glaucoma NCT03866746 584 592 B-Condition

- NCT03866746 595 596 O
other NCT03866746 598 603 B-Other
retinal NCT03866746 604 611 B-Condition
vascular NCT03866746 612 620 I-Condition
diseases NCT03866746 621 629 I-Condition

- NCT03866746 632 633 O
conditions NCT03866746 635 645 B-Condition
that NCT03866746 646 650 O
impede NCT03866746 651 657 O
the NCT03866746 658 661 O
OCT NCT03866746 662 665 B-Procedure
interpretation NCT03866746 666 680 B-Modifier

Inclusion NCT03863379 0 9 O
Criteria NCT03863379 10 18 O
: NCT03863379 19 20 O

Persons NCT03863379 22 29 O
with NCT03863379 30 34 O

- NCT03863379 37 38 O
stroke NCT03863379 40 46 B-Condition
/ NCT03863379 47 48 B-Or
cerebrovascular NCT03863379 49 64 B-Condition
disease NCT03863379 65 72 I-Condition

- NCT03863379 75 76 O
traumatic NCT03863379 78 87 B-Condition
brain NCT03863379 88 93 I-Condition
injury NCT03863379 94 100 I-Condition

- NCT03863379 103 104 O
multiple NCT03863379 106 114 B-Condition
sclerosis NCT03863379 115 124 I-Condition

- NCT03863379 127 128 O
spinal NCT03863379 130 136 B-Modifier
cord NCT03863379 137 141 I-Modifier
injuries NCT03863379 142 150 B-Condition
( NCT03863379 151 152 O
including NCT03863379 153 162 O
spinal NCT03863379 163 169 B-Modifier
cord NCT03863379 170 174 I-Modifier
lesions NCT03863379 175 182 B-Condition
i NCT03863379 183 184 O
. NCT03863379 185 186 O
e NCT03863379 187 188 O
. NCT03863379 189 190 O
myelopathies NCT03863379 192 204 B-Condition
etc NCT03863379 205 208 O
. NCT03863379 209 210 O
) NCT03863379 211 212 O

Exclusion NCT03863379 214 223 O
Criteria NCT03863379 224 232 O
: NCT03863379 233 234 O

Persons NCT03863379 236 243 O
with NCT03863379 244 248 O

- NCT03863379 251 252 O
heterotopic NCT03863379 254 265 B-Condition
ossifications NCT03863379 266 279 I-Condition
, NCT03863379 280 281 O

- NCT03863379 285 286 O
chronic NCT03863379 288 295 O
administration NCT03863379 296 310 O
of NCT03863379 311 313 O
drugs NCT03863379 314 319 B-Drug
, NCT03863379 320 321 O
which NCT03863379 322 327 O
promote NCT03863379 328 335 O
fat NCT03863379 336 339 B-Condition
increase NCT03863379 340 348 O

- NCT03863379 351 352 O
chronic NCT03863379 354 361 O
administration NCT03863379 362 376 O
of NCT03863379 377 379 O
drugs NCT03863379 380 385 B-Drug
, NCT03863379 386 387 O
which NCT03863379 388 393 O
promote NCT03863379 394 401 O
bone NCT03863379 402 406 B-Modifier
or NCT03863379 407 409 B-Or
muscle NCT03863379 410 416 B-Modifier
loss NCT03863379 417 421 B-Condition

- NCT03863379 424 425 O
co NCT03863379 427 429 B-Modifier
- NCT03863379 430 431 I-Modifier
existing NCT03863379 432 440 I-Modifier
other NCT03863379 441 446 B-Other
diseases NCT03863379 447 455 B-Condition
such NCT03863379 456 460 O
as NCT03863379 461 463 O
: NCT03863379 464 465 O
endocrinopathies NCT03863379 466 482 B-Condition
, NCT03863379 483 484 O
muscular NCT03863379 485 493 B-Condition
dystrophies NCT03863379 494 505 I-Condition
, NCT03863379 506 507 O
non NCT03863379 508 511 B-Negation
- NCT03863379 512 513 O
alcoholic NCT03863379 514 523 B-Modifier
fatty NCT03863379 524 529 B-Condition
liver NCT03863379 530 535 I-Condition
disease NCT03863379 536 543 I-Condition
. NCT03863379 544 545 O

Inclusion NCT03926832 0 9 O
Criteria NCT03926832 10 18 O
: NCT03926832 19 20 O

- NCT03926832 24 25 O
Subjects NCT03926832 27 35 O
with NCT03926832 36 40 O
a NCT03926832 41 42 O
definite NCT03926832 43 51 O
diagnosis NCT03926832 52 61 O
of NCT03926832 62 64 O
sarcoidosis NCT03926832 65 76 B-Condition
according NCT03926832 77 86 O
to NCT03926832 87 89 O
international NCT03926832 90 103 O
ATS NCT03926832 104 107 O
and NCT03926832 108 111 O
WASOG NCT03926832 112 117 O
guideline NCT03926832 118 127 O

Exclusion NCT03926832 128 137 O
Criteria NCT03926832 138 146 O
: NCT03926832 147 148 O

- NCT03926832 152 153 O
Ongoing NCT03926832 155 162 B-Eq_Comparison
CPAP NCT03926832 163 167 B-Procedure
treatment NCT03926832 168 177 I-Procedure

- NCT03926832 180 181 O
Psychiatric NCT03926832 183 194 B-Condition
disorders NCT03926832 195 204 I-Condition

Inclusion NCT03869476 0 9 O
Criteria NCT03869476 10 18 O
: NCT03869476 19 20 O

- NCT03869476 24 25 O
Adult NCT03869476 27 32 O
( NCT03869476 33 34 O
18 NCT03869476 35 37 B-Eq_Comparison
years NCT03869476 38 43 I-Eq_Comparison
of NCT03869476 44 46 I-Eq_Comparison
age NCT03869476 47 50 I-Eq_Comparison
or NCT03869476 51 53 I-Eq_Comparison
older NCT03869476 54 59 I-Eq_Comparison
) NCT03869476 60 61 O
with NCT03869476 62 66 B-And
the NCT03869476 67 70 O
diagnosis NCT03869476 71 80 O
of NCT03869476 81 83 O
essential NCT03869476 84 93 B-Modifier
thrombocytosis NCT03869476 94 108 B-Condition
, NCT03869476 109 110 O
prefibrotic NCT03869476 111 122 B-Condition
myelofibrosis NCT03869476 123 136 I-Condition
or NCT03869476 137 139 B-Or
overt NCT03869476 140 145 B-Modifier
myelofibrosis NCT03869476 146 159 B-Condition
according NCT03869476 160 169 O
to NCT03869476 170 172 O
WHO NCT03869476 173 176 O
2016 NCT03869476 177 181 O
criteria NCT03869476 182 190 O
; NCT03869476 190 191 O

- NCT03869476 194 195 O
Patient NCT03869476 197 204 O
who NCT03869476 205 208 O
has NCT03869476 209 212 O
not NCT03869476 213 216 B-Negation
received NCT03869476 217 225 B-Eq_Comparison
specific NCT03869476 226 234 O
treatment NCT03869476 235 244 B-Procedure
for NCT03869476 245 248 O
neoplasms NCT03869476 249 258 B-Condition
; NCT03869476 258 259 O

- NCT03869476 262 263 O
Patient NCT03869476 265 272 O
who NCT03869476 273 276 O
has NCT03869476 277 280 O
signed NCT03869476 281 287 O
the NCT03869476 288 291 O
consent NCT03869476 292 299 O
to NCT03869476 300 302 O
participate NCT03869476 303 314 O
in NCT03869476 315 317 O
the NCT03869476 318 321 O
study NCT03869476 322 327 B-Study
; NCT03869476 327 328 O

- NCT03869476 331 332 O
Patient NCT03869476 334 341 O
who NCT03869476 342 345 O
has NCT03869476 346 349 O
consented NCT03869476 350 359 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869476 360 362 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03869476 363 365 O
included NCT03869476 366 374 O
in NCT03869476 375 377 O
the NCT03869476 378 381 O
" NCT03869476 382 383 O
Malignant NCT03869476 383 392 O
Haemopathies NCT03869476 393 405 O
" NCT03869476 405 406 O
collection NCT03869476 407 417 O
at NCT03869476 418 420 O
the NCT03869476 421 424 O
University NCT03869476 425 435 O
Hospital NCT03869476 436 444 O
of NCT03869476 445 447 O
Angers NCT03869476 448 454 O
or NCT03869476 455 457 B-Or
Brest NCT03869476 458 463 O
and NCT03869476 464 467 O
for NCT03869476 468 471 O
whom NCT03869476 472 476 O
the NCT03869476 477 480 O
samples NCT03869476 481 488 O
necessary NCT03869476 489 498 O
for NCT03869476 499 502 O
the NCT03869476 503 506 O
study NCT03869476 507 512 B-Study
are NCT03869476 513 516 O
available NCT03869476 517 526 O
in NCT03869476 527 529 O
the NCT03869476 530 533 O
biocollection NCT03869476 534 547 O
. NCT03869476 548 549 O

Exclusion NCT03869476 551 560 O
Criteria NCT03869476 561 569 O
: NCT03869476 570 571 O

- NCT03869476 575 576 O
Patient NCT03869476 578 585 O
with NCT03869476 586 590 O
another NCT03869476 591 598 B-Other
hematologic NCT03869476 599 610 B-Condition
neoplasm NCT03869476 611 619 I-Condition
or NCT03869476 620 622 B-Or
progressive NCT03869476 623 634 B-Modifier
cancer NCT03869476 635 641 B-Condition
at NCT03869476 642 644 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03869476 645 648 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03869476 649 653 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03869476 654 656 O
diagnosis NCT03869476 657 666 O
; NCT03869476 666 667 O

- NCT03869476 670 671 O
Patient NCT03869476 673 680 O
with NCT03869476 681 685 O
a NCT03869476 686 687 O
diagnosis NCT03869476 688 697 O
of NCT03869476 698 700 O
secondary NCT03869476 701 710 B-Modifier
myelofibrosis NCT03869476 711 724 B-Condition
; NCT03869476 724 725 O

- NCT03869476 728 729 O
Pregnant NCT03869476 731 739 B-Condition
or NCT03869476 740 742 B-Or
breastfeeding NCT03869476 743 756 B-Condition
woman NCT03869476 757 762 O
; NCT03869476 762 763 O

- NCT03869476 766 767 O
Person NCT03869476 769 775 O
prived NCT03869476 776 782 B-Observation
of NCT03869476 783 785 I-Observation
liberty NCT03869476 786 793 I-Observation
by NCT03869476 794 796 O
judicial NCT03869476 797 805 O
or NCT03869476 806 808 O
administrative NCT03869476 809 823 O
decision NCT03869476 824 832 O
; NCT03869476 832 833 O

- NCT03869476 836 837 O
Person NCT03869476 839 845 O
subject NCT03869476 846 853 O
to NCT03869476 854 856 O
a NCT03869476 857 858 O
legal NCT03869476 859 864 B-Observation
protection NCT03869476 865 875 I-Observation
measure NCT03869476 876 883 I-Observation
; NCT03869476 883 884 O

For NCT03920267 0 3 O
more NCT03920267 4 8 O
information NCT03920267 9 20 O
regarding NCT03920267 21 30 O
Bristol NCT03920267 31 38 O
- NCT03920267 39 40 O
Myers NCT03920267 41 46 O
Squibb NCT03920267 47 53 O
Clinical NCT03920267 54 62 O
Trial NCT03920267 63 68 O
participation NCT03920267 69 82 O
, NCT03920267 83 84 O
please NCT03920267 85 91 O

visit NCT03920267 92 97 O
www NCT03920267 98 101 O
. NCT03920267 102 103 O
BMSStudyConnect NCT03920267 104 119 O
. NCT03920267 120 121 O
com NCT03920267 122 125 O

Inclusion NCT03920267 126 135 O
Criteria NCT03920267 136 144 O
: NCT03920267 145 146 O

- NCT03920267 150 151 O
Completion NCT03920267 153 163 O
of NCT03920267 164 166 O
SLE NCT03920267 167 170 O
Study NCT03920267 171 176 O
( NCT03920267 177 178 O
NCT NCT03920267 179 182 O
03252587 NCT03920267 183 191 O
) NCT03920267 192 193 O
through NCT03920267 194 201 O
the NCT03920267 202 205 O
protocol NCT03920267 206 214 O
- NCT03920267 215 216 O
required NCT03920267 217 225 O
treatment NCT03920267 226 235 O
period NCT03920267 236 242 O
, NCT03920267 243 244 O
and NCT03920267 245 248 O
currently NCT03920267 249 258 B-Eq_Comparison
receiving NCT03920267 259 268 I-Eq_Comparison
blinded NCT03920267 269 276 O
study NCT03920267 277 282 B-Study
drug NCT03920267 283 287 B-Drug

- NCT03920267 290 291 O
Women NCT03920267 293 298 O
of NCT03920267 299 301 B-And
childbearing NCT03920267 302 314 B-Condition
potential NCT03920267 315 324 I-Condition
( NCT03920267 325 326 O
WOCBP NCT03920267 327 332 B-Condition
) NCT03920267 333 334 O
must NCT03920267 335 339 O
have NCT03920267 340 344 O
a NCT03920267 345 346 O
negative NCT03920267 347 355 O
urine NCT03920267 356 361 B-Observation
pregnancy NCT03920267 362 371 I-Observation
test NCT03920267 372 376 I-Observation
and NCT03920267 377 380 B-And
must NCT03920267 381 385 O
agree NCT03920267 386 391 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03920267 392 394 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03920267 395 398 O
correctly NCT03920267 399 408 O
a NCT03920267 409 410 O
highly NCT03920267 411 417 O
effective NCT03920267 418 427 O
method NCT03920267 428 434 O
( NCT03920267 435 436 O
s NCT03920267 437 438 O
) NCT03920267 439 440 O
of NCT03920267 441 443 O
contraception NCT03920267 444 457 B-Procedure
for NCT03920267 458 461 O
the NCT03920267 462 465 O
duration NCT03920267 466 474 B-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03920267 475 477 O
treatment NCT03920267 478 487 B-Procedure
with NCT03920267 488 492 O
study NCT03920267 493 498 B-Study
drug NCT03920267 499 503 B-Drug

Exclusion NCT03920267 504 513 O
Criteria NCT03920267 514 522 O
: NCT03920267 523 524 O

- NCT03920267 528 529 O
Any NCT03920267 531 534 O
disease NCT03920267 535 542 B-Condition
or NCT03920267 543 545 B-Or
medical NCT03920267 546 553 B-Condition
condition NCT03920267 554 563 I-Condition
that NCT03920267 564 568 O
, NCT03920267 569 570 O
in NCT03920267 571 573 O
the NCT03920267 574 577 O
opinion NCT03920267 578 585 O
of NCT03920267 586 588 O
the NCT03920267 589 592 O
investigator NCT03920267 593 605 O
, NCT03920267 606 607 O
would NCT03920267 608 613 B-Assertion___Assertion_Type_Value:hypothetical
make NCT03920267 614 618 O
the NCT03920267 619 622 O
subject NCT03920267 623 630 O
unsuitable NCT03920267 631 641 B-Negation
for NCT03920267 642 645 O
this NCT03920267 646 650 O
study NCT03920267 651 656 B-Study
, NCT03920267 657 658 O
would NCT03920267 659 664 O
interfere NCT03920267 665 674 O
with NCT03920267 675 679 O
the NCT03920267 680 683 O
interpretation NCT03920267 684 698 O
of NCT03920267 699 701 O
subject NCT03920267 702 709 O
safety NCT03920267 710 716 O
or NCT03920267 717 719 O
study NCT03920267 720 725 O
results NCT03920267 726 733 O
, NCT03920267 734 735 O
or NCT03920267 736 738 O
considered NCT03920267 739 749 O
unsuitable NCT03920267 750 760 O
by NCT03920267 761 763 O
the NCT03920267 764 767 O
investigator NCT03920267 768 780 O
for NCT03920267 781 784 O
any NCT03920267 785 788 O
other NCT03920267 789 794 O
reason NCT03920267 795 801 O

- NCT03920267 804 805 O
Evidence NCT03920267 807 815 O
of NCT03920267 816 818 O
active NCT03920267 819 825 B-Eq_Comparison
tuberculosis NCT03920267 826 838 B-Condition
( NCT03920267 839 840 O
TB NCT03920267 841 843 B-Condition
) NCT03920267 844 845 O

Other NCT03920267 847 852 O
protocol NCT03920267 853 861 O
defined NCT03920267 862 869 O
inclusion NCT03920267 870 879 O
/ NCT03920267 880 881 O
exclusion NCT03920267 882 891 O
criteria NCT03920267 892 900 O
could NCT03920267 901 906 O
apply NCT03920267 907 912 O

Inclusion NCT03920696 0 9 O
Criteria NCT03920696 10 18 O
: NCT03920696 19 20 O

- NCT03920696 24 25 O
Age NCT03920696 27 30 B-Age
≥ NCT03920696 31 32 B-Eq_Comparison
18 NCT03920696 33 35 I-Eq_Comparison
years NCT03920696 36 41 I-Eq_Comparison

- NCT03920696 44 45 O
Patients NCT03920696 47 55 O
with NCT03920696 56 60 O
Pityriasis NCT03920696 61 71 B-Condition
Lichenoides NCT03920696 72 83 I-Condition
selected NCT03920696 84 92 O
from NCT03920696 93 97 O
histological NCT03920696 98 110 O
coding NCT03920696 111 117 O
OT NCT03920696 118 120 O
0431 NCT03920696 121 125 O
, NCT03920696 126 127 O
seen NCT03920696 128 132 B-Encounter
at NCT03920696 133 135 O
Henri NCT03920696 136 141 O
Mondor NCT03920696 142 148 O
and NCT03920696 149 152 O
with NCT03920696 153 157 O
a NCT03920696 158 159 O
diagnosis NCT03920696 160 169 O
verified NCT03920696 170 178 O
from NCT03920696 179 183 O
medical NCT03920696 184 191 O
records NCT03920696 192 199 O
. NCT03920696 200 201 O

Exclusion NCT03920696 203 212 O
Criteria NCT03920696 213 221 O
: NCT03920696 222 223 O

- NCT03920696 227 228 O
Histological NCT03920696 230 242 O
coding NCT03920696 243 249 O
error NCT03920696 250 255 O

- NCT03920696 258 259 O
Histological NCT03920696 261 273 O
records NCT03920696 274 281 O
of NCT03920696 282 284 O
patients NCT03920696 285 293 O
in NCT03920696 294 296 O
care NCT03920696 297 301 B-Encounter
outside NCT03920696 302 309 B-Other
Henri NCT03920696 310 315 O
Mondor NCT03920696 316 322 O
( NCT03920696 323 324 O
cases NCT03920696 325 330 O
referred NCT03920696 331 339 O
for NCT03920696 340 343 O
histological NCT03920696 344 356 O
expertise NCT03920696 357 366 O
only NCT03920696 367 371 O
but NCT03920696 372 375 O
not NCT03920696 376 379 O
seen NCT03920696 380 384 O
clinically NCT03920696 385 395 O
) NCT03920696 396 397 O

- NCT03920696 401 402 O
Clinical NCT03920696 404 412 B-Condition
lesions NCT03920696 413 420 I-Condition
incompatible NCT03920696 421 433 B-Negation
with NCT03920696 434 438 O
Pityriasis NCT03920696 439 449 B-Condition
Lichenoides NCT03920696 450 461 I-Condition
according NCT03920696 462 471 O
to NCT03920696 472 474 O
classically NCT03920696 475 486 O
published NCT03920696 487 496 O
semiological NCT03920696 497 509 O
data NCT03920696 510 514 O

- NCT03920696 517 518 O
Missing NCT03920696 520 527 O
or NCT03920696 528 530 O
insufficient NCT03920696 531 543 O
medical NCT03920696 544 551 O
records NCT03920696 552 559 O
for NCT03920696 560 563 O
data NCT03920696 564 568 O
exploitation NCT03920696 569 581 O

Inclusion NCT03865186 0 9 O
Criteria NCT03865186 10 18 O
: NCT03865186 19 20 O

- NCT03865186 24 25 O
Clinical NCT03865186 27 35 O
diagnosis NCT03865186 36 45 O
of NCT03865186 46 48 O
schizophrenia NCT03865186 49 62 B-Condition
according NCT03865186 63 72 O
to NCT03865186 73 75 O
DSM NCT03865186 76 79 O
- NCT03865186 80 81 O
IV NCT03865186 82 84 O

- NCT03865186 87 88 O
over NCT03865186 90 94 B-Eq_Comparison
the NCT03865186 95 98 I-Eq_Comparison
age NCT03865186 99 102 I-Eq_Comparison
of NCT03865186 103 105 I-Eq_Comparison
18 NCT03865186 106 108 I-Eq_Comparison

Exclusion NCT03865186 110 119 O
Criteria NCT03865186 120 128 O
: NCT03865186 129 130 O

- NCT03865186 134 135 O
having NCT03865186 137 143 B-Eq_Comparison
cominication NCT03865186 144 156 B-Condition
problems NCT03865186 157 165 I-Condition

- NCT03865186 168 169 O
having NCT03865186 171 177 B-Eq_Comparison
another NCT03865186 178 185 B-Other
psychiatric NCT03865186 186 197 B-Condition
disease NCT03865186 198 205 I-Condition

Inclusion NCT03923140 0 9 O
Criteria NCT03923140 10 18 O
: NCT03923140 19 20 O

- NCT03923140 24 25 O
All NCT03923140 27 30 O
patients NCT03923140 31 39 O
must NCT03923140 40 44 O
meet NCT03923140 45 49 O
the NCT03923140 50 53 O
following NCT03923140 54 63 O
diagnostic NCT03923140 64 74 O
criteria NCT03923140 75 83 O
of NCT03923140 84 86 O
CAPS NCT03923140 87 91 B-Condition
and NCT03923140 92 95 B-And
have NCT03923140 96 100 O
pathogenic NCT03923140 101 111 B-Condition
mutation NCT03923140 112 120 I-Condition
( NCT03923140 121 122 I-Condition
s NCT03923140 123 124 I-Condition
) NCT03923140 125 126 I-Condition
in NCT03923140 127 129 O
NLRP NCT03923140 130 134 B-Modifier
3 NCT03923140 135 136 I-Modifier
gene NCT03923140 137 141 I-Modifier
. NCT03923140 142 143 O

1 NCT03923140 152 153 O
. NCT03923140 153 154 O
Raised NCT03923140 156 162 B-Condition
inflammatory NCT03923140 163 175 I-Condition
markers NCT03923140 176 183 I-Condition
( NCT03923140 184 185 O
CRP NCT03923140 186 189 B-Condition
/ NCT03923140 190 191 B-Or
SAA NCT03923140 192 195 B-Condition
) NCT03923140 196 197 O
( NCT03923140 198 199 O
mandatory NCT03923140 200 209 O
criteria NCT03923140 210 218 O
) NCT03923140 219 220 O

2 NCT03923140 229 230 O
. NCT03923140 230 231 O
≥ NCT03923140 233 234 B-Eq_Comparison
2 NCT03923140 235 236 I-Eq_Comparison
of NCT03923140 237 239 I-Eq_Comparison
6 NCT03923140 240 241 I-Eq_Comparison
CAPS NCT03923140 242 246 B-Condition
typical NCT03923140 247 254 O
signs NCT03923140 255 260 B-Assertion___Assertion_Type_Value:possible
/ NCT03923140 261 262 B-Or
symptoms NCT03923140 263 271 B-Assertion___Assertion_Type_Value:possible
: NCT03923140 272 273 O

1 NCT03923140 287 288 O
. NCT03923140 288 289 O
Urticaria NCT03923140 291 300 B-Condition
- NCT03923140 301 302 I-Condition
like NCT03923140 303 307 I-Condition
rash NCT03923140 308 312 I-Condition
; NCT03923140 312 313 O

2 NCT03923140 326 327 O
. NCT03923140 327 328 O
Cold NCT03923140 330 334 B-Condition
/ NCT03923140 335 336 B-Or
stress NCT03923140 337 343 B-Condition
triggered NCT03923140 344 353 O
episodes NCT03923140 354 362 O
; NCT03923140 362 363 O

3 NCT03923140 376 377 O
. NCT03923140 377 378 O
Sensorineural NCT03923140 380 393 B-Condition
hearing NCT03923140 394 401 I-Condition
loss NCT03923140 402 406 I-Condition
; NCT03923140 406 407 O

4 NCT03923140 420 421 O
. NCT03923140 421 422 O
Musculoskeletal NCT03923140 424 439 B-Condition
symptoms NCT03923140 440 448 B-Assertion___Assertion_Type_Value:possible
( NCT03923140 449 450 O
arthralgia NCT03923140 451 461 B-Condition
/ NCT03923140 462 463 B-Or
arthritis NCT03923140 464 473 B-Condition
/ NCT03923140 474 475 B-Or
myalgia NCT03923140 476 483 B-Condition
) NCT03923140 484 485 O
; NCT03923140 486 487 O

5 NCT03923140 500 501 O
. NCT03923140 501 502 O
Chronic NCT03923140 504 511 O
aseptic NCT03923140 512 519 B-Condition
meningitis NCT03923140 520 530 I-Condition
; NCT03923140 530 531 O

6 NCT03923140 544 545 O
. NCT03923140 545 546 O
Skeletal NCT03923140 548 556 B-Modifier
abnormalities NCT03923140 557 570 B-Condition
( NCT03923140 571 572 O
epiphyseal NCT03923140 573 583 B-Condition
overgrowth NCT03923140 584 594 I-Condition
/ NCT03923140 595 596 B-Or
frontal NCT03923140 597 604 B-Condition
bossing NCT03923140 605 612 I-Condition
) NCT03923140 613 614 O
. NCT03923140 615 616 O

Exclusion NCT03923140 618 627 O
Criteria NCT03923140 628 636 O
: NCT03923140 637 638 O

- NCT03923140 642 643 O
Patients NCT03923140 645 653 O
will NCT03923140 654 658 O
not NCT03923140 659 662 O
be NCT03923140 663 665 O
included NCT03923140 666 674 O
if NCT03923140 675 677 O
meets NCT03923140 678 683 O
any NCT03923140 684 687 O
of NCT03923140 688 690 O
the NCT03923140 691 694 O
following NCT03923140 695 704 O
criteria NCT03923140 705 713 O
: NCT03923140 714 715 O

1 NCT03923140 724 725 O
. NCT03923140 725 726 O
Being NCT03923140 728 733 B-Eq_Comparison
treated NCT03923140 734 741 B-Procedure
with NCT03923140 742 746 O
IL NCT03923140 747 749 B-Drug
- NCT03923140 750 751 I-Drug
1 NCT03923140 752 753 I-Drug
inhibitor NCT03923140 754 763 I-Drug
, NCT03923140 764 765 O
other NCT03923140 766 771 B-Other
biological NCT03923140 772 782 B-Drug
agents NCT03923140 783 789 I-Drug
and NCT03923140 790 793 B-Or
immunosuppressants NCT03923140 794 812 B-Drug

2 NCT03923140 820 821 O
. NCT03923140 821 822 O
Pregnant NCT03923140 824 832 B-Condition
and NCT03923140 833 836 B-Or
lactating NCT03923140 837 846 B-Condition
women NCT03923140 847 852 O

3 NCT03923140 860 861 O
. NCT03923140 861 862 O
Serious NCT03923140 864 871 O
organ NCT03923140 872 877 B-Condition
function NCT03923140 878 886 I-Condition
failure NCT03923140 887 894 I-Condition
, NCT03923140 895 896 O
expected NCT03923140 897 905 B-Observation
life NCT03923140 906 910 I-Observation
time NCT03923140 911 915 I-Observation
less NCT03923140 916 920 B-Eq_Comparison
than NCT03923140 921 925 I-Eq_Comparison
6 NCT03923140 926 927 I-Eq_Comparison
months NCT03923140 928 934 I-Eq_Comparison

Inclusion NCT03925363 0 9 O
Criteria NCT03925363 10 18 O
: NCT03925363 19 20 O

- NCT03925363 24 25 O
Previous NCT03925363 27 35 B-Eq_Comparison
participants NCT03925363 36 48 O
in NCT03925363 49 51 O
healthy NCT03925363 52 59 O
aging NCT03925363 60 65 O
initiative NCT03925363 66 76 O
. NCT03925363 77 78 O

Exclusion NCT03925363 80 89 O
Criteria NCT03925363 90 98 O
: NCT03925363 99 100 O

- NCT03925363 104 105 O
Not NCT03925363 107 110 B-Negation
able NCT03925363 111 115 B-Condition
to NCT03925363 116 118 I-Condition
walk NCT03925363 119 123 I-Condition
or NCT03925363 124 126 B-Or
previous NCT03925363 127 135 B-Eq_Comparison
medical NCT03925363 136 143 O
diagnoses NCT03925363 144 153 B-Condition
that NCT03925363 154 158 O
severely NCT03925363 159 167 O
limits NCT03925363 168 174 B-Negation
the NCT03925363 175 178 O
possibility NCT03925363 179 190 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925363 191 193 O
exercise NCT03925363 194 202 B-Observation
. NCT03925363 203 204 O

Inclusion NCT03921606 0 9 O
Criteria NCT03921606 10 18 O
: NCT03921606 19 20 O

- NCT03921606 24 25 O
aged NCT03921606 27 31 B-Age
18 NCT03921606 32 34 B-Eq_Comparison
years NCT03921606 35 40 I-Eq_Comparison
or NCT03921606 41 43 I-Eq_Comparison
above NCT03921606 44 49 I-Eq_Comparison
, NCT03921606 50 51 O

- NCT03921606 55 56 O
able NCT03921606 58 62 O
to NCT03921606 63 65 O
speak NCT03921606 66 71 O
Cantonese NCT03921606 72 81 O
and NCT03921606 82 85 B-Or
read NCT03921606 86 90 O
Chinese NCT03921606 91 98 O

- NCT03921606 101 102 O
do NCT03921606 104 106 O
not NCT03921606 107 110 B-Negation
intend NCT03921606 111 117 B-Assertion___Assertion_Type_Value:intention
to NCT03921606 118 120 I-Assertion___Assertion_Type_Value:intention
quit NCT03921606 121 125 B-Condition
smoking NCT03921606 126 133 I-Condition
( NCT03921606 134 135 O
pre NCT03921606 136 139 B-Condition
- NCT03921606 140 141 I-Condition
contemplation NCT03921606 142 155 I-Condition
stage NCT03921606 156 161 I-Condition
) NCT03921606 162 163 O
, NCT03921606 164 165 O
but NCT03921606 166 169 B-And
are NCT03921606 170 173 O
willing NCT03921606 174 181 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921606 182 184 I-Assertion___Assertion_Type_Value:hypothetical
promote NCT03921606 185 192 O
their NCT03921606 193 198 O
health NCT03921606 199 205 B-Condition

- NCT03921606 208 209 O
use NCT03921606 211 214 O
a NCT03921606 215 216 O
smartphone NCT03921606 217 227 O
and NCT03921606 228 231 O
can NCT03921606 232 235 O
use NCT03921606 236 239 O
an NCT03921606 240 242 O
instant NCT03921606 243 250 O
messaging NCT03921606 251 260 O
tool NCT03921606 261 265 O
( NCT03921606 266 267 O
e NCT03921606 268 269 O
. NCT03921606 270 271 O
g NCT03921606 272 273 O
. NCT03921606 274 275 O
, NCT03921606 276 277 O
WhatsApp NCT03921606 278 286 O
/ NCT03921606 287 288 O
WeChat NCT03921606 289 295 O
) NCT03921606 296 297 O

- NCT03921606 301 302 O
willing NCT03921606 304 311 O
to NCT03921606 312 314 O
receive NCT03921606 315 322 O
health NCT03921606 323 329 O
promotion NCT03921606 330 339 O
advice NCT03921606 340 346 O
and NCT03921606 347 350 O
interact NCT03921606 351 359 O
with NCT03921606 360 364 O
our NCT03921606 365 368 O
interventionist NCT03921606 369 384 O
via NCT03921606 385 388 O
WhatsApp NCT03921606 389 397 O
/ NCT03921606 398 399 O
WeChat NCT03921606 400 406 O
on NCT03921606 407 409 O
a NCT03921606 410 411 O
smartphone NCT03921606 412 422 O
throughout NCT03921606 423 433 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03921606 434 437 O
study NCT03921606 438 443 B-Study
period NCT03921606 444 450 O

Exclusion NCT03921606 451 460 O
Criteria NCT03921606 461 469 O
: NCT03921606 470 471 O

- NCT03921606 475 476 O
inability NCT03921606 478 487 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921606 488 490 O
give NCT03921606 491 495 O
informed NCT03921606 496 504 O
consent NCT03921606 505 512 O
or NCT03921606 513 515 O
participate NCT03921606 516 527 O
in NCT03921606 528 530 O
our NCT03921606 531 534 O
intervention NCT03921606 535 547 B-Procedure
due NCT03921606 548 551 O
to NCT03921606 552 554 O
impaired NCT03921606 555 563 B-Condition
mental NCT03921606 564 570 I-Condition
status NCT03921606 571 577 I-Condition
, NCT03921606 578 579 O
cognitive NCT03921606 580 589 B-Condition
impairment NCT03921606 590 600 I-Condition
or NCT03921606 601 603 O
communication NCT03921606 604 617 B-Condition
barriers NCT03921606 618 626 I-Condition

- NCT03921606 629 630 O
participate NCT03921606 632 643 O
in NCT03921606 644 646 O
another NCT03921606 647 654 B-Other
smoking NCT03921606 655 662 B-Procedure
cessation NCT03921606 663 672 I-Procedure
programme NCT03921606 673 682 O
or NCT03921606 683 685 O
service NCT03921606 686 693 O

Inclusion NCT03923114 0 9 O
Criteria NCT03923114 10 18 O
: NCT03923114 19 20 O

Patients NCT03923114 22 30 O
with NCT03923114 31 35 O
treatment NCT03923114 36 45 B-Procedure
response NCT03923114 46 54 B-Observation
: NCT03923114 55 56 O

- NCT03923114 60 61 O
Age NCT03923114 63 66 B-Age
≥ NCT03923114 67 68 B-Eq_Comparison
18 NCT03923114 69 71 I-Eq_Comparison
years NCT03923114 72 77 I-Eq_Comparison

- NCT03923114 80 81 O
Subject NCT03923114 83 90 O
is NCT03923114 91 93 O
diagnosed NCT03923114 94 103 O
with NCT03923114 104 108 O
type NCT03923114 109 113 B-Modifier
2 NCT03923114 114 115 I-Modifier
diabetes NCT03923114 116 124 B-Condition

- NCT03923114 127 128 O
Subject NCT03923114 130 137 O
showed NCT03923114 138 144 O
response NCT03923114 145 153 B-Observation
to NCT03923114 154 156 O
GLP NCT03923114 157 160 B-Procedure
- NCT03923114 161 162 I-Procedure
1 NCT03923114 163 164 I-Procedure
RA NCT03923114 165 167 I-Procedure
treatment NCT03923114 168 177 I-Procedure

- NCT03923114 180 181 O
Ability NCT03923114 183 190 O
to NCT03923114 191 193 O
sign NCT03923114 194 198 O
informed NCT03923114 199 207 O
consent NCT03923114 208 215 O

Patients NCT03923114 216 224 O
without NCT03923114 225 232 B-Negation
treatment NCT03923114 233 242 B-Observation
response NCT03923114 243 251 I-Observation
: NCT03923114 252 253 O

- NCT03923114 257 258 O
Age NCT03923114 260 263 B-Age
≥ NCT03923114 264 265 B-Eq_Comparison
18 NCT03923114 266 268 I-Eq_Comparison
years NCT03923114 269 274 I-Eq_Comparison

- NCT03923114 277 278 O
Subject NCT03923114 280 287 O
is NCT03923114 288 290 O
diagnosed NCT03923114 291 300 O
with NCT03923114 301 305 O
type NCT03923114 306 310 B-Modifier
2 NCT03923114 311 312 I-Modifier
diabetes NCT03923114 313 321 B-Condition

- NCT03923114 324 325 O
Subject NCT03923114 327 334 O
showed NCT03923114 335 341 O
no NCT03923114 342 344 B-Negation
response NCT03923114 345 353 B-Observation
to NCT03923114 354 356 O
GLP NCT03923114 357 360 B-Procedure
- NCT03923114 361 362 I-Procedure
1 NCT03923114 363 364 I-Procedure
RA NCT03923114 365 367 I-Procedure
treatment NCT03923114 368 377 I-Procedure

- NCT03923114 380 381 O
Ability NCT03923114 383 390 O
to NCT03923114 391 393 O
sign NCT03923114 394 398 O
informed NCT03923114 399 407 O
consent NCT03923114 408 415 O

Exclusion NCT03923114 416 425 O
Criteria NCT03923114 426 434 O
: NCT03923114 435 436 O

- NCT03923114 440 441 O
Liver NCT03923114 443 448 B-Condition
disease NCT03923114 449 456 I-Condition

- NCT03923114 459 460 O
Renal NCT03923114 462 467 B-Condition
disease NCT03923114 468 475 I-Condition

- NCT03923114 478 479 O
Pregnancy NCT03923114 481 490 B-Condition
or NCT03923114 491 493 B-Or
the NCT03923114 494 497 O
wish NCT03923114 498 502 B-Assertion___Assertion_Type_Value:intention
to NCT03923114 503 505 I-Assertion___Assertion_Type_Value:intention
become NCT03923114 506 512 O
pregnant NCT03923114 513 521 B-Condition
within NCT03923114 522 528 B-Eq_Comparison
6 NCT03923114 529 530 I-Eq_Comparison
months NCT03923114 531 537 I-Eq_Comparison
after NCT03923114 538 543 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03923114 544 547 O
study NCT03923114 548 553 B-Study

- NCT03923114 556 557 O
Breastfeeding NCT03923114 559 572 B-Condition

- NCT03923114 575 576 O
Age NCT03923114 578 581 B-Age
< NCT03923114 582 583 B-Eq_Comparison
18 NCT03923114 584 586 I-Eq_Comparison
years NCT03923114 587 592 I-Eq_Comparison

- NCT03923114 595 596 O
Pituitary NCT03923114 598 607 B-Condition
disorder NCT03923114 608 616 I-Condition

- NCT03923114 619 620 O
Inability NCT03923114 622 631 O
to NCT03923114 632 634 O
sign NCT03923114 635 639 O
informed NCT03923114 640 648 O
consent NCT03923114 649 656 O

- NCT03923114 659 660 O
Exclusion NCT03923114 662 671 O
criteria NCT03923114 672 680 O
for NCT03923114 681 684 O
MR NCT03923114 685 687 O
: NCT03923114 688 689 O

- NCT03923114 698 699 O
Fragments NCT03923114 701 710 B-Modifier
, NCT03923114 711 712 O
clips NCT03923114 713 718 B-Modifier
or NCT03923114 719 721 B-Or
devices NCT03923114 722 729 B-Modifier
in NCT03923114 730 732 O
brain NCT03923114 733 738 B-Condition
, NCT03923114 739 740 O
eyes NCT03923114 741 745 B-Modifier
, NCT03923114 746 747 O
spinal NCT03923114 748 754 B-Modifier
canal NCT03923114 755 760 I-Modifier

- NCT03923114 768 769 O
Implantable NCT03923114 771 782 B-Procedure
defibrillator NCT03923114 783 796 I-Procedure
or NCT03923114 797 799 B-Or
pacemaker NCT03923114 800 809 B-Procedure
( NCT03923114 810 811 O
wires NCT03923114 812 817 O
) NCT03923114 818 819 O

- NCT03923114 828 829 O
Mandibular NCT03923114 831 841 B-Procedure
magnetic NCT03923114 842 850 I-Procedure
implants NCT03923114 851 859 I-Procedure

- NCT03923114 867 868 O
Neurostimulator NCT03923114 870 885 B-Procedure
, NCT03923114 886 887 O
bladder NCT03923114 888 895 B-Procedure
stimulator NCT03923114 896 906 I-Procedure
, NCT03923114 907 908 O
non NCT03923114 909 912 B-Procedure
- NCT03923114 913 914 I-Procedure
removable NCT03923114 915 924 I-Procedure
insulin NCT03923114 925 932 I-Procedure
pump NCT03923114 933 937 I-Procedure

- NCT03923114 945 946 O
Metal NCT03923114 948 953 B-Procedure
tissue NCT03923114 954 960 I-Procedure
- NCT03923114 961 962 I-Procedure
expander NCT03923114 963 971 I-Procedure
in NCT03923114 972 974 O
chest NCT03923114 975 980 B-Modifier

- NCT03923114 988 989 O
Cochlear NCT03923114 991 999 B-Procedure
implant NCT03923114 1000 1007 I-Procedure

- NCT03923114 1015 1016 O
Ossicular NCT03923114 1018 1027 B-Procedure
replacement NCT03923114 1028 1039 I-Procedure
prosthesis NCT03923114 1040 1050 I-Procedure

Inclusion NCT03865420 0 9 O
Criteria NCT03865420 10 18 O
: NCT03865420 19 20 O

- NCT03865420 24 25 O
Men NCT03865420 27 30 O
or NCT03865420 31 33 B-Or
women NCT03865420 34 39 O
of NCT03865420 40 42 O
any NCT03865420 43 46 O
race NCT03865420 47 51 O
or NCT03865420 52 54 O
ethnicity NCT03865420 55 64 O
aged NCT03865420 65 69 B-Age
18 NCT03865420 70 72 B-Eq_Comparison
or NCT03865420 73 75 I-Eq_Comparison
older NCT03865420 76 81 I-Eq_Comparison

- NCT03865420 84 85 O
No NCT03865420 87 89 B-Negation
symptoms NCT03865420 90 98 B-Assertion___Assertion_Type_Value:possible
of NCT03865420 99 101 O
ALS NCT03865420 102 105 B-Condition
or NCT03865420 106 108 B-Or
fronto NCT03865420 109 115 B-Modifier
- NCT03865420 116 117 I-Modifier
temporal NCT03865420 118 126 I-Modifier
dementia NCT03865420 127 135 B-Condition
at NCT03865420 136 138 B-Temporal_Connection___Temporal_Connection_Type_Value:during
enrollment NCT03865420 139 149 B-Study

- NCT03865420 152 153 O
Have NCT03865420 155 159 O
a NCT03865420 160 161 O
first NCT03865420 162 167 B-Family_Member
degree NCT03865420 168 174 I-Family_Member
relative NCT03865420 175 183 I-Family_Member
who NCT03865420 184 187 O
had NCT03865420 188 191 O
an NCT03865420 192 194 O
ALS NCT03865420 195 198 B-Condition
- NCT03865420 199 200 O
spectrum NCT03865420 201 209 O
diagnosis NCT03865420 210 219 O
with NCT03865420 220 224 B-And
a NCT03865420 225 226 O
confirmed NCT03865420 227 236 O
ALS NCT03865420 237 240 B-Condition
- NCT03865420 241 242 I-Condition
spectrum NCT03865420 243 251 I-Condition
gene NCT03865420 252 256 I-Condition
mutation NCT03865420 257 265 I-Condition
; NCT03865420 265 266 O
or NCT03865420 267 269 B-Or
already NCT03865420 270 277 B-Eq_Comparison
have NCT03865420 278 282 O
had NCT03865420 283 286 O
genetic NCT03865420 287 294 B-Procedure
testing NCT03865420 295 302 I-Procedure
and NCT03865420 303 306 B-And
have NCT03865420 307 311 O
tested NCT03865420 312 318 B-Observation
positive NCT03865420 319 327 O
for NCT03865420 328 331 O
an NCT03865420 332 334 O
ALS NCT03865420 335 338 B-Condition
- NCT03865420 339 340 I-Condition
spectrum NCT03865420 341 349 I-Condition
gene NCT03865420 350 354 I-Condition
mutation NCT03865420 355 363 I-Condition
. NCT03865420 364 365 O

- NCT03865420 369 370 O
Willing NCT03865420 372 379 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865420 380 382 I-Assertion___Assertion_Type_Value:hypothetical
undergo NCT03865420 383 390 O
genetic NCT03865420 391 398 B-Procedure
testing NCT03865420 399 406 I-Procedure
with NCT03865420 407 411 O
option NCT03865420 412 418 O
of NCT03865420 419 421 O
whether NCT03865420 422 429 O
or NCT03865420 430 432 O
not NCT03865420 433 436 O
to NCT03865420 437 439 O
learn NCT03865420 440 445 O
results NCT03865420 446 453 O

- NCT03865420 456 457 O
Willing NCT03865420 459 466 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865420 467 469 I-Assertion___Assertion_Type_Value:hypothetical
travel NCT03865420 470 476 O
to NCT03865420 477 479 O
Columbia NCT03865420 480 488 O
University NCT03865420 489 499 O
Irving NCT03865420 500 506 O
Medical NCT03865420 507 514 O
Center NCT03865420 515 521 O
( NCT03865420 522 523 O
CUIMC NCT03865420 524 529 O
) NCT03865420 530 531 O
every NCT03865420 532 537 B-Eq_Comparison
6 NCT03865420 538 539 I-Eq_Comparison
- NCT03865420 540 541 I-Eq_Comparison
24 NCT03865420 542 544 I-Eq_Comparison
months NCT03865420 545 551 I-Eq_Comparison
for NCT03865420 552 555 O
study NCT03865420 556 561 B-Study
procedures NCT03865420 562 572 O

- NCT03865420 575 576 O
Capable NCT03865420 578 585 O
of NCT03865420 586 588 O
providing NCT03865420 589 598 O
informed NCT03865420 599 607 O
consent NCT03865420 608 615 O
and NCT03865420 616 619 O
following NCT03865420 620 629 O
study NCT03865420 630 635 O
procedures NCT03865420 636 646 O
, NCT03865420 647 648 O
or NCT03865420 649 651 O
has NCT03865420 652 655 O
a NCT03865420 656 657 O
legally NCT03865420 658 665 O
authorized NCT03865420 666 676 O
representative NCT03865420 677 691 O
who NCT03865420 692 695 O
is NCT03865420 696 698 O
able NCT03865420 699 703 O
to NCT03865420 704 706 O
consent NCT03865420 707 714 O
for NCT03865420 715 718 O
the NCT03865420 719 722 O
subject NCT03865420 723 730 O
. NCT03865420 731 732 O

Exclusion NCT03865420 734 743 O
Criteria NCT03865420 744 752 O
: NCT03865420 753 754 O

- NCT03865420 758 759 O
Known NCT03865420 761 766 O
HIV NCT03865420 767 770 B-Condition

- NCT03865420 773 774 O
Known NCT03865420 776 781 O
hepatitis NCT03865420 782 791 B-Condition
B NCT03865420 792 793 I-Condition

- NCT03865420 796 797 O
Known NCT03865420 799 804 O
hepatitis NCT03865420 805 814 B-Condition
C NCT03865420 815 816 I-Condition

Inclusion NCT03860324 0 9 O
Criteria NCT03860324 10 18 O
: NCT03860324 19 20 O

- NCT03860324 24 25 O
Surgical NCT03860324 27 35 O
plan NCT03860324 36 40 B-Eq_Comparison
for NCT03860324 41 44 I-Eq_Comparison
total NCT03860324 45 50 B-Procedure
hip NCT03860324 51 54 I-Procedure
replacement NCT03860324 55 66 I-Procedure

- NCT03860324 69 70 O
Signing NCT03860324 72 79 O
of NCT03860324 80 82 O
consent NCT03860324 83 90 O
form NCT03860324 91 95 O
to NCT03860324 96 98 O
participate NCT03860324 99 110 O
in NCT03860324 111 113 O
the NCT03860324 114 117 O
study NCT03860324 118 123 O

Exclusion NCT03860324 124 133 O
Criteria NCT03860324 134 142 O
: NCT03860324 143 144 O

- NCT03860324 148 149 O
Patient NCT03860324 151 158 O
refusal NCT03860324 159 166 O

- NCT03860324 169 170 O
BMI NCT03860324 172 175 B-Observation
> NCT03860324 176 177 B-Eq_Comparison
40 NCT03860324 178 180 I-Eq_Comparison
kg NCT03860324 181 183 I-Eq_Comparison
/ NCT03860324 184 185 I-Eq_Comparison
m NCT03860324 186 187 I-Eq_Comparison
2 NCT03860324 188 189 I-Eq_Comparison

- NCT03860324 192 193 O
Surgical NCT03860324 195 203 O
plan NCT03860324 204 208 B-Eq_Comparison
for NCT03860324 209 212 I-Eq_Comparison
revision NCT03860324 213 221 B-Modifier
of NCT03860324 222 224 O
hip NCT03860324 225 228 B-Procedure
replacement NCT03860324 229 240 I-Procedure

- NCT03860324 243 244 O
Patient NCT03860324 246 253 O
unable NCT03860324 254 260 B-Negation
to NCT03860324 261 263 O
quantify NCT03860324 264 272 O
pain NCT03860324 273 277 B-Condition
level NCT03860324 278 283 O

- NCT03860324 286 287 O
Chronic NCT03860324 289 296 O
kidney NCT03860324 297 303 B-Condition
disease NCT03860324 304 311 I-Condition
with NCT03860324 312 316 B-And
a NCT03860324 317 318 O
Glomerular NCT03860324 319 329 B-Observation
Filtration NCT03860324 330 340 I-Observation
Rate NCT03860324 341 345 I-Observation
< NCT03860324 346 347 B-Eq_Comparison
50 NCT03860324 348 350 I-Eq_Comparison
ml NCT03860324 351 353 I-Eq_Comparison
/ NCT03860324 354 355 I-Eq_Comparison
min NCT03860324 356 359 I-Eq_Comparison

- NCT03860324 362 363 O
Previously NCT03860324 365 375 B-Eq_Comparison
medicated NCT03860324 376 385 B-Procedure
with NCT03860324 386 390 O
opioids NCT03860324 391 398 B-Drug

- NCT03860324 401 402 O
Patient NCT03860324 404 411 O
unable NCT03860324 412 418 B-Negation
to NCT03860324 419 421 O
perform NCT03860324 422 429 O
the NCT03860324 430 433 O
surgery NCT03860324 434 441 B-Procedure
with NCT03860324 442 446 O
spinal NCT03860324 447 453 B-Procedure
block NCT03860324 454 459 I-Procedure

- NCT03860324 462 463 O
Allergy NCT03860324 465 472 B-Allergy
to NCT03860324 473 475 O
local NCT03860324 476 481 B-Procedure
anesthetics NCT03860324 482 493 I-Procedure

- NCT03860324 496 497 O
Infection NCT03860324 499 508 B-Condition
in NCT03860324 509 511 O
the NCT03860324 512 515 O
site NCT03860324 516 520 B-Modifier
of NCT03860324 521 523 O
the NCT03860324 524 527 O
Erector NCT03860324 528 535 B-Modifier
Spinae NCT03860324 536 542 I-Modifier
Plane NCT03860324 543 548 I-Modifier
or NCT03860324 549 551 B-Or
Fascia NCT03860324 552 558 B-Modifier
Iliaca NCT03860324 559 565 I-Modifier
block NCT03860324 566 571 I-Modifier

- NCT03860324 574 575 O
Allergy NCT03860324 577 584 B-Allergy
or NCT03860324 585 587 B-Or
contraindication NCT03860324 588 604 B-Contraindication
to NCT03860324 605 607 O
the NCT03860324 608 611 O
use NCT03860324 612 615 O
of NCT03860324 616 618 O
morphine NCT03860324 619 627 B-Drug

Inclusion NCT03861884 0 9 O
Criteria NCT03861884 10 18 O
: NCT03861884 19 20 O

1 NCT03861884 24 25 O
. NCT03861884 25 26 O
Ability NCT03861884 28 35 O
to NCT03861884 36 38 O
give NCT03861884 39 43 O
informed NCT03861884 44 52 O
consent NCT03861884 53 60 O
. NCT03861884 61 62 O

2 NCT03861884 66 67 O
. NCT03861884 67 68 O
Either NCT03861884 70 76 O
pathological NCT03861884 77 89 B-Procedure
, NCT03861884 90 91 O
genetic NCT03861884 92 99 B-Procedure
or NCT03861884 100 102 B-Or
imaging NCT03861884 103 110 B-Procedure
biomarker NCT03861884 111 120 O
evidence NCT03861884 121 129 O
to NCT03861884 130 132 O
suggest NCT03861884 133 140 O
Fronto NCT03861884 141 147 B-Condition
- NCT03861884 148 149 I-Condition
temporal NCT03861884 150 158 I-Condition
Lobar NCT03861884 159 164 I-Condition
Degeneration NCT03861884 165 177 I-Condition
, NCT03861884 178 179 O
Alzheimer NCT03861884 180 189 B-Condition
's NCT03861884 189 191 I-Condition
Disease NCT03861884 192 199 I-Condition
or NCT03861884 200 202 B-Or
Vascular NCT03861884 203 211 B-Modifier
Cognitive NCT03861884 212 221 B-Condition
Impairment NCT03861884 222 232 I-Condition
, NCT03861884 233 234 O
or NCT03861884 235 237 O
defined NCT03861884 238 245 O
clinical NCT03861884 246 254 O
diagnoses NCT03861884 255 264 O
. NCT03861884 265 266 O

Exclusion NCT03861884 268 277 O
Criteria NCT03861884 278 286 O
: NCT03861884 287 288 O

1 NCT03861884 292 293 O
. NCT03861884 293 294 O
Lack NCT03861884 296 300 B-Condition
of NCT03861884 301 303 I-Condition
mental NCT03861884 304 310 I-Condition
capacity NCT03861884 311 319 I-Condition
to NCT03861884 320 322 O
consent NCT03861884 323 330 O
to NCT03861884 331 333 O
study NCT03861884 334 339 O
involvement NCT03861884 340 351 O
. NCT03861884 352 353 O

2 NCT03861884 357 358 O
. NCT03861884 358 359 O
Not NCT03861884 361 364 B-Negation
speaking NCT03861884 365 373 O
English NCT03861884 374 381 O
before NCT03861884 382 388 B-Temporal_Connection___Temporal_Connection_Type_Value:before
age NCT03861884 389 392 B-Age
5 NCT03861884 393 394 B-Eq_Comparison
years NCT03861884 395 400 I-Eq_Comparison
. NCT03861884 401 402 O

3 NCT03861884 406 407 O
. NCT03861884 407 408 O
Learning NCT03861884 410 418 B-Condition
disability NCT03861884 419 429 I-Condition
. NCT03861884 430 431 O

4 NCT03861884 435 436 O
. NCT03861884 436 437 O
MRI NCT03861884 439 442 B-Procedure
contraindications NCT03861884 443 460 B-Contraindication

Inclusion NCT03929471 0 9 O
Criteria NCT03929471 10 18 O
: NCT03929471 19 20 O

- NCT03929471 24 25 O
Adult NCT03929471 27 32 O
( NCT03929471 33 34 O
> NCT03929471 35 36 B-Eq_Comparison
18 NCT03929471 37 39 I-Eq_Comparison
years NCT03929471 40 45 I-Eq_Comparison
old NCT03929471 46 49 B-Age
) NCT03929471 50 51 O
outpatients NCT03929471 52 63 B-Encounter
on NCT03929471 64 66 B-Eq_Comparison
3 NCT03929471 67 68 B-Eq_Comparison
- NCT03929471 69 70 I-Eq_Comparison
4 NCT03929471 71 72 I-Eq_Comparison
times NCT03929471 73 78 I-Eq_Comparison
per NCT03929471 79 82 I-Eq_Comparison
week NCT03929471 83 87 I-Eq_Comparison
HD NCT03929471 88 90 B-Procedure
sessions NCT03929471 91 99 O
for NCT03929471 100 103 O
at NCT03929471 104 106 B-Eq_Comparison
least NCT03929471 107 112 I-Eq_Comparison
6 NCT03929471 113 114 I-Eq_Comparison
weeks NCT03929471 115 120 I-Eq_Comparison
with NCT03929471 121 125 B-And
a NCT03929471 126 127 O
life NCT03929471 128 132 B-Observation
expectancy NCT03929471 133 143 I-Observation
> NCT03929471 144 145 B-Eq_Comparison
6 NCT03929471 146 147 I-Eq_Comparison
months NCT03929471 148 154 I-Eq_Comparison
. NCT03929471 155 156 O

- NCT03929471 160 161 O
Fluid NCT03929471 163 168 B-Observation
overload NCT03929471 169 177 I-Observation
≥ NCT03929471 178 179 B-Eq_Comparison
1.1 NCT03929471 180 183 I-Eq_Comparison
L NCT03929471 184 185 I-Eq_Comparison
. NCT03929471 186 187 O

- NCT03929471 191 192 O
Medically NCT03929471 194 203 B-Condition
stable NCT03929471 204 210 O
patient NCT03929471 211 218 O
. NCT03929471 219 220 O

- NCT03929471 224 225 O
Minimum NCT03929471 227 234 B-Eq_Comparison
of NCT03929471 235 237 I-Eq_Comparison
3 NCT03929471 238 239 I-Eq_Comparison
hours NCT03929471 240 245 I-Eq_Comparison
of NCT03929471 246 248 O
dialysis NCT03929471 249 257 B-Procedure
per NCT03929471 258 261 O
session NCT03929471 262 269 O
. NCT03929471 270 271 O

Exclusion NCT03929471 273 282 O
Criteria NCT03929471 283 291 O
: NCT03929471 292 293 O

- NCT03929471 297 298 O
Pregnancy NCT03929471 300 309 B-Condition
or NCT03929471 310 312 B-Or
lactation NCT03929471 313 322 B-Condition
. NCT03929471 323 324 O

- NCT03929471 328 329 O
Declined NCT03929471 331 339 O
informed NCT03929471 340 348 O
consent NCT03929471 349 356 O
. NCT03929471 357 358 O

- NCT03929471 367 368 O
Patients NCT03929471 370 378 O
with NCT03929471 379 383 O
cognitive NCT03929471 384 393 B-Condition
dysfunction NCT03929471 394 405 I-Condition
. NCT03929471 406 407 O

- NCT03929471 416 417 O
Severe NCT03929471 419 425 O
life NCT03929471 426 430 B-Modifier
- NCT03929471 431 432 I-Modifier
limiting NCT03929471 433 441 I-Modifier
Comorbidities NCT03929471 442 455 B-Condition
( NCT03929471 456 457 O
malignant NCT03929471 458 467 B-Condition
tumour NCT03929471 468 474 I-Condition
, NCT03929471 475 476 O
tuberculosis NCT03929471 477 489 B-Condition
, NCT03929471 490 491 O
. NCT03929471 492 493 O
. NCT03929471 494 495 O
. NCT03929471 496 497 O
. NCT03929471 498 499 O
) NCT03929471 500 501 O

- NCT03929471 510 511 O
Surgery NCT03929471 513 520 B-Procedure
within NCT03929471 521 527 B-Eq_Comparison
six NCT03929471 528 531 I-Eq_Comparison
weeks NCT03929471 532 537 I-Eq_Comparison
of NCT03929471 538 540 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03929471 541 544 O
study NCT03929471 545 550 B-Study
. NCT03929471 551 552 O

- NCT03929471 561 562 O
Nocturnal NCT03929471 564 573 B-Modifier
dialysis NCT03929471 574 582 B-Procedure
patients NCT03929471 583 591 O
. NCT03929471 592 593 O

- NCT03929471 602 603 O
Patients NCT03929471 605 613 O
expected NCT03929471 614 622 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929471 623 625 O
receive NCT03929471 626 633 O
a NCT03929471 634 635 O
transplant NCT03929471 636 646 B-Procedure
or NCT03929471 647 649 B-Or
move NCT03929471 650 654 B-Observation
to NCT03929471 655 657 O
another NCT03929471 658 665 B-Other
center NCT03929471 666 672 O
within NCT03929471 673 679 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03929471 680 683 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03929471 684 692 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03929471 693 695 O
the NCT03929471 696 699 O
study NCT03929471 700 705 B-Study
. NCT03929471 706 707 O

- NCT03929471 716 717 O
Patients NCT03929471 719 727 O
with NCT03929471 728 732 O
arteriovenous NCT03929471 733 746 B-Condition
fistula NCT03929471 747 754 I-Condition
issues NCT03929471 755 761 O
. NCT03929471 762 763 O

Inclusion NCT03923465 0 9 O
Criteria NCT03923465 10 18 O
: NCT03923465 19 20 O

- NCT03923465 24 25 O
Systemically NCT03923465 27 39 B-Modifier
healthy NCT03923465 40 47 B-Condition

- NCT03923465 50 51 O
Clinical NCT03923465 53 61 O
diagnosis NCT03923465 62 71 O
of NCT03923465 72 74 O
advanced NCT03923465 75 83 O
periodontitis NCT03923465 84 97 B-Condition

- NCT03923465 100 101 O
Having NCT03923465 103 109 O
one NCT03923465 110 113 B-Eq_Comparison
isolated NCT03923465 114 122 B-Condition
intrabony NCT03923465 123 132 I-Condition
defect NCT03923465 133 139 I-Condition
with NCT03923465 140 144 O
probing NCT03923465 145 152 B-Observation
depth NCT03923465 153 158 I-Observation
( NCT03923465 159 160 O
PD NCT03923465 161 163 B-Observation
) NCT03923465 164 165 O
≥ NCT03923465 166 167 B-Eq_Comparison
7 NCT03923465 168 169 I-Eq_Comparison
mm NCT03923465 170 172 I-Eq_Comparison
, NCT03923465 173 174 O
clinical NCT03923465 175 183 B-Observation
attachment NCT03923465 184 194 I-Observation
level NCT03923465 195 200 I-Observation
( NCT03923465 201 202 O
CAL NCT03923465 203 206 B-Observation
) NCT03923465 207 208 O
≥ NCT03923465 209 210 B-Eq_Comparison
8 NCT03923465 211 212 I-Eq_Comparison
mm NCT03923465 213 215 I-Eq_Comparison
and NCT03923465 216 219 B-And
at NCT03923465 220 222 B-Eq_Comparison
least NCT03923465 223 228 I-Eq_Comparison
4 NCT03923465 229 230 I-Eq_Comparison
mm NCT03923465 231 233 I-Eq_Comparison
intrabony NCT03923465 234 243 B-Observation
component NCT03923465 244 253 I-Observation
involving NCT03923465 254 263 O
predominantly NCT03923465 264 277 O
the NCT03923465 278 281 O
interproximal NCT03923465 282 295 O
area NCT03923465 296 300 O
of NCT03923465 301 303 O
the NCT03923465 304 307 O
affected NCT03923465 308 316 O
tooth NCT03923465 317 322 O
. NCT03923465 323 324 O

- NCT03923465 328 329 O
Full NCT03923465 331 335 B-Observation
- NCT03923465 336 337 I-Observation
mouth NCT03923465 338 343 I-Observation
plaque NCT03923465 344 350 I-Observation
score NCT03923465 351 356 I-Observation
( NCT03923465 357 358 O
FMPS NCT03923465 359 363 B-Observation
) NCT03923465 364 365 O
≤ NCT03923465 366 367 B-Eq_Comparison
20 NCT03923465 368 370 I-Eq_Comparison
% NCT03923465 371 372 I-Eq_Comparison
. NCT03923465 373 374 O

- NCT03923465 378 379 O
Full NCT03923465 381 385 B-Observation
- NCT03923465 386 387 I-Observation
mouth NCT03923465 388 393 I-Observation
bleeding NCT03923465 394 402 I-Observation
score NCT03923465 403 408 I-Observation
( NCT03923465 409 410 O
FMBS NCT03923465 411 415 B-Observation
) NCT03923465 416 417 O
≤ NCT03923465 418 419 B-Eq_Comparison
20 NCT03923465 420 422 I-Eq_Comparison
% NCT03923465 423 424 I-Eq_Comparison
. NCT03923465 425 426 O

Exclusion NCT03923465 428 437 O
Criteria NCT03923465 438 446 O
: NCT03923465 447 448 O

- NCT03923465 452 453 O
Smokers NCT03923465 455 462 O

- NCT03923465 465 466 O
Patients NCT03923465 468 476 O
with NCT03923465 477 481 O
known NCT03923465 482 487 O
systemic NCT03923465 488 496 B-Modifier
diseases NCT03923465 497 505 B-Condition
such NCT03923465 506 510 O
as NCT03923465 511 513 O
diabetes NCT03923465 514 522 B-Condition
and NCT03923465 523 526 B-And
cardiovascular NCT03923465 527 541 B-Condition
diseases NCT03923465 542 550 I-Condition
or NCT03923465 551 553 B-Or
using NCT03923465 554 559 B-Eq_Comparison
medications NCT03923465 560 571 B-Drug
that NCT03923465 572 576 O
affect NCT03923465 577 583 O
periodontal NCT03923465 584 595 B-Condition
tissues NCT03923465 596 603 I-Condition
, NCT03923465 604 605 O
pregnant NCT03923465 606 614 B-Condition
or NCT03923465 615 617 B-Or
lactating NCT03923465 618 627 B-Condition
women NCT03923465 628 633 O

- NCT03923465 636 637 O
One NCT03923465 639 642 B-Condition
- NCT03923465 643 644 I-Condition
wall NCT03923465 645 649 I-Condition
intrabony NCT03923465 650 659 I-Condition
defects NCT03923465 660 667 I-Condition

- NCT03923465 670 671 O
Defects NCT03923465 673 680 B-Condition
that NCT03923465 681 685 O
involve NCT03923465 686 693 O
buccal NCT03923465 694 700 B-Modifier
and NCT03923465 701 704 B-Or
lingual NCT03923465 705 712 B-Modifier
sites NCT03923465 713 718 I-Modifier

- NCT03923465 721 722 O
Presence NCT03923465 724 732 O
of NCT03923465 733 735 O
inadequate NCT03923465 736 746 O
endodontic NCT03923465 747 757 B-Procedure
treatment NCT03923465 758 767 I-Procedure
and NCT03923465 768 771 B-Or
/ NCT03923465 772 773 I-Or
or NCT03923465 774 776 I-Or
restoration NCT03923465 777 788 B-Procedure
in NCT03923465 789 791 I-Procedure
the NCT03923465 792 795 I-Procedure
relevant NCT03923465 796 804 I-Procedure
teeth NCT03923465 805 810 I-Procedure
. NCT03923465 811 812 O

Inclusion NCT03926663 0 9 O
Criteria NCT03926663 10 18 O
: NCT03926663 19 20 O

- NCT03926663 24 25 O
Patients NCT03926663 27 35 O
aged NCT03926663 36 40 B-Age
from NCT03926663 41 45 O
18 NCT03926663 46 48 B-Eq_Comparison
- NCT03926663 49 50 I-Eq_Comparison
60 NCT03926663 51 53 I-Eq_Comparison
years NCT03926663 54 59 I-Eq_Comparison

- NCT03926663 62 63 O
ASA NCT03926663 65 68 B-Observation
physical NCT03926663 69 77 O
status NCT03926663 78 84 O
I NCT03926663 85 86 B-Eq_Comparison

- NCT03926663 89 90 O
Undergoing NCT03926663 92 102 B-Eq_Comparison
septoplasty NCT03926663 103 114 B-Procedure

Exclusion NCT03926663 115 124 O
Criteria NCT03926663 125 133 O
: NCT03926663 134 135 O

- NCT03926663 139 140 O
Patients NCT03926663 142 150 O
with NCT03926663 151 155 O
cardiovascular NCT03926663 156 170 B-Condition
disease NCT03926663 171 178 I-Condition
( NCT03926663 179 180 O
congestive NCT03926663 181 191 B-Condition
heart NCT03926663 192 197 I-Condition
failure NCT03926663 198 205 I-Condition
, NCT03926663 206 207 O
coronary NCT03926663 208 216 B-Condition
artery NCT03926663 217 223 I-Condition
disease NCT03926663 224 231 I-Condition
, NCT03926663 232 233 O
hypertension NCT03926663 234 246 B-Condition
. NCT03926663 247 248 O

- NCT03926663 252 253 O
History NCT03926663 255 262 B-Eq_Comparison
of NCT03926663 263 265 O
renal NCT03926663 266 271 B-Modifier
or NCT03926663 272 274 B-Or
hepatic NCT03926663 275 282 B-Modifier
insufficiency NCT03926663 283 296 B-Condition

- NCT03926663 299 300 O
Endocrinal NCT03926663 302 312 B-Condition
Diseases NCT03926663 313 321 I-Condition

Inclusion NCT03868969 0 9 O
Criteria NCT03868969 10 18 O
: NCT03868969 19 20 O

- NCT03868969 24 25 O
clinical NCT03868969 27 35 O
suspicion NCT03868969 36 45 B-Assertion___Assertion_Type_Value:possible
of NCT03868969 46 48 O
urinary NCT03868969 49 56 B-Condition
tract NCT03868969 57 62 I-Condition
infection NCT03868969 63 72 I-Condition
( NCT03868969 73 74 O
UTI NCT03868969 75 78 B-Condition
) NCT03868969 79 80 O
defined NCT03868969 81 88 O
by NCT03868969 89 91 O
the NCT03868969 92 95 O
presence NCT03868969 96 104 O
of NCT03868969 105 107 O
at NCT03868969 108 110 B-Eq_Comparison
least NCT03868969 111 116 I-Eq_Comparison
one NCT03868969 117 120 I-Eq_Comparison
of NCT03868969 121 123 B-Criteria_Count
these NCT03868969 124 129 I-Criteria_Count
signs NCT03868969 130 135 I-Criteria_Count
: NCT03868969 136 137 O
fever NCT03868969 138 143 B-Observation
> NCT03868969 144 145 B-Eq_Comparison
38 NCT03868969 146 148 I-Eq_Comparison
° NCT03868969 149 150 I-Eq_Comparison
C NCT03868969 150 151 I-Eq_Comparison
and NCT03868969 152 155 B-Or
/ NCT03868969 156 157 I-Or
or NCT03868969 158 160 I-Or
sus NCT03868969 161 164 B-Modifier
- NCT03868969 165 166 I-Modifier
pubic NCT03868969 167 172 I-Modifier
pain NCT03868969 173 177 B-Condition
and NCT03868969 178 181 B-Or
/ NCT03868969 182 183 I-Or
or NCT03868969 184 186 I-Or
dysuria NCT03868969 187 194 B-Condition
and NCT03868969 195 198 B-Or
/ NCT03868969 199 200 I-Or
or NCT03868969 201 203 I-Or
pollakiuria NCT03868969 204 215 B-Condition
and NCT03868969 216 219 B-Or
/ NCT03868969 220 221 I-Or
or NCT03868969 222 224 I-Or
urinary NCT03868969 225 232 B-Modifier
burns NCT03868969 233 238 B-Condition
and NCT03868969 239 242 B-Or
/ NCT03868969 243 244 I-Or
or NCT03868969 245 247 I-Or
macroscopic NCT03868969 248 259 B-Modifier
hematuria NCT03868969 260 269 B-Condition
and NCT03868969 270 273 B-Or
/ NCT03868969 274 275 I-Or
or NCT03868969 276 278 I-Or
acute NCT03868969 279 284 O
urinary NCT03868969 285 292 B-Condition
retention NCT03868969 293 302 I-Condition
and NCT03868969 303 306 B-Or
/ NCT03868969 307 308 I-Or
or NCT03868969 309 311 I-Or
pain NCT03868969 312 316 B-Condition
with NCT03868969 317 321 O
the NCT03868969 322 325 O
rectal NCT03868969 326 332 B-Procedure
examination NCT03868969 333 344 I-Procedure
and NCT03868969 345 348 B-Or
/ NCT03868969 349 350 I-Or
or NCT03868969 351 353 I-Or
confusion NCT03868969 354 363 B-Condition

- NCT03868969 366 367 O
And NCT03868969 369 372 B-And
urinary NCT03868969 373 380 B-Observation
analysis NCT03868969 381 389 I-Observation
with NCT03868969 390 394 O
leukocyturia NCT03868969 395 407 B-Condition
> NCT03868969 408 409 B-Eq_Comparison
10 NCT03868969 410 412 I-Eq_Comparison
/ NCT03868969 413 414 I-Eq_Comparison
mm NCT03868969 415 417 I-Eq_Comparison
3 NCT03868969 418 419 I-Eq_Comparison
, NCT03868969 420 421 O
bacteriuria NCT03868969 422 433 B-Condition
> NCT03868969 434 435 B-Eq_Comparison
10 NCT03868969 436 438 I-Eq_Comparison
^ NCT03868969 439 440 I-Eq_Comparison
3 NCT03868969 441 442 I-Eq_Comparison
CFU NCT03868969 443 446 I-Eq_Comparison
/ NCT03868969 447 448 I-Eq_Comparison
mL NCT03868969 449 451 I-Eq_Comparison
with NCT03868969 452 456 B-And
ESBL NCT03868969 457 461 B-Modifier
producing NCT03868969 462 471 I-Modifier
enterobacteriaceae NCT03868969 472 490 B-Condition
and NCT03868969 491 494 B-And
resistance NCT03868969 495 505 B-Condition
associated NCT03868969 506 516 O
with NCT03868969 517 521 O
fluoroquinolones NCT03868969 522 538 B-Drug
( NCT03868969 539 540 O
FQ NCT03868969 541 543 B-Drug
) NCT03868969 544 545 O
and NCT03868969 546 549 B-Or
cotrimoxazole NCT03868969 550 563 B-Drug
( NCT03868969 564 565 O
CTX NCT03868969 566 569 B-Drug
) NCT03868969 570 571 O
but NCT03868969 572 575 B-And
sensitive NCT03868969 576 585 B-Condition
to NCT03868969 586 588 O
fosfomycin NCT03868969 589 599 B-Drug
. NCT03868969 600 601 O

Exclusion NCT03868969 603 612 O
Criteria NCT03868969 613 621 O
: NCT03868969 622 623 O

- NCT03868969 627 628 O
allergy NCT03868969 630 637 B-Allergy
to NCT03868969 638 640 O
fosfomycin NCT03868969 641 651 B-Drug
and NCT03868969 652 655 B-Or
/ NCT03868969 656 657 I-Or
or NCT03868969 658 660 I-Or
trometamol NCT03868969 661 671 B-Drug

- NCT03868969 674 675 O
Presence NCT03868969 677 685 O
of NCT03868969 686 688 O
material NCT03868969 689 697 B-Condition
in NCT03868969 698 700 O
the NCT03868969 701 704 O
urinary NCT03868969 705 712 B-Modifier
tract NCT03868969 713 718 I-Modifier

- NCT03868969 721 722 O
Severe NCT03868969 724 730 O
immunosuppression NCT03868969 731 748 B-Condition

- NCT03868969 751 752 O
Chronic NCT03868969 754 761 O
prostatitis NCT03868969 762 773 B-Condition

- NCT03868969 776 777 O
Prostate NCT03868969 779 787 B-Condition
abscess NCT03868969 788 795 I-Condition

- NCT03868969 798 799 O
Acute NCT03868969 801 806 O
pyelonephritis NCT03868969 807 821 B-Condition

- NCT03868969 824 825 O
Hemodynamic NCT03868969 827 838 B-Condition
instability NCT03868969 839 850 O

- NCT03868969 853 854 O
Chronic NCT03868969 856 863 O
renal NCT03868969 864 869 B-Condition
failure NCT03868969 870 877 I-Condition
( NCT03868969 878 879 O
clearance NCT03868969 880 889 B-Observation
< NCT03868969 890 891 B-Eq_Comparison
60 NCT03868969 892 894 I-Eq_Comparison
mL NCT03868969 895 897 I-Eq_Comparison
/ NCT03868969 898 899 I-Eq_Comparison
min NCT03868969 900 903 I-Eq_Comparison
) NCT03868969 904 905 O

- NCT03868969 909 910 O
Prior NCT03868969 912 917 B-Eq_Comparison
antibiotic NCT03868969 918 928 B-Procedure
therapy NCT03868969 929 936 I-Procedure
, NCT03868969 937 938 O
with NCT03868969 939 943 B-And
an NCT03868969 944 946 O
antibiotic NCT03868969 947 957 B-Drug
sensitive NCT03868969 958 967 B-Condition
on NCT03868969 968 970 O
the NCT03868969 971 974 O
antibiotic NCT03868969 975 985 B-Observation
susceptibility NCT03868969 986 1000 I-Observation
test NCT03868969 1001 1005 I-Observation
except NCT03868969 1006 1012 B-Exception
: NCT03868969 1013 1014 O
amoxicillin NCT03868969 1015 1026 B-Drug
- NCT03868969 1027 1028 B-Or
clavulanic NCT03868969 1029 1039 B-Drug
acid NCT03868969 1040 1044 I-Drug
, NCT03868969 1045 1046 O
cefixime NCT03868969 1047 1055 B-Drug
, NCT03868969 1056 1057 O
nitrofurantoin NCT03868969 1058 1072 B-Drug
. NCT03868969 1073 1074 O

- NCT03868969 1078 1079 O
Co NCT03868969 1081 1083 O
- NCT03868969 1084 1085 O
treatment NCT03868969 1086 1095 B-Procedure
with NCT03868969 1096 1100 O
metoclopramide NCT03868969 1101 1115 B-Drug

Inclusion NCT03866850 0 9 O
Criteria NCT03866850 10 18 O
: NCT03866850 19 20 O

- NCT03866850 24 25 O
Cochlear NCT03866850 27 35 B-Modifier
Nucleus NCT03866850 36 43 I-Modifier
cochlear NCT03866850 44 52 B-Procedure
implant NCT03866850 53 60 I-Procedure
users NCT03866850 61 66 O
or NCT03866850 67 69 B-Or
Advanced NCT03866850 70 78 B-Modifier
Bionics NCT03866850 79 86 I-Modifier
cochlear NCT03866850 87 95 B-Procedure
implant NCT03866850 96 103 I-Procedure
users NCT03866850 104 109 O

- NCT03866850 112 113 O
Native NCT03866850 115 121 O
speakers NCT03866850 122 130 O
of NCT03866850 131 133 O
English NCT03866850 134 141 O

- NCT03866850 144 145 O
Early NCT03866850 147 152 B-Modifier
onset NCT03866850 153 158 B-Eq_Comparison
of NCT03866850 159 161 O
deafness NCT03866850 162 170 B-Condition
( NCT03866850 171 172 O
< NCT03866850 173 174 B-Eq_Comparison
3 NCT03866850 175 176 I-Eq_Comparison
years NCT03866850 177 182 I-Eq_Comparison
of NCT03866850 183 185 O
age NCT03866850 186 189 B-Age
) NCT03866850 190 191 O
; NCT03866850 192 193 O
no NCT03866850 194 196 O
requirement NCT03866850 197 208 O
for NCT03866850 209 212 O
age NCT03866850 213 216 O
at NCT03866850 217 219 O
implantation NCT03866850 220 232 B-Procedure

- NCT03866850 235 236 O
Late NCT03866850 238 242 B-Modifier
onset NCT03866850 243 248 B-Eq_Comparison
of NCT03866850 249 251 O
deafness NCT03866850 252 260 B-Condition
( NCT03866850 261 262 O
> NCT03866850 263 264 B-Eq_Comparison
3 NCT03866850 265 266 I-Eq_Comparison
years NCT03866850 267 272 I-Eq_Comparison
of NCT03866850 273 275 O
age NCT03866850 276 279 B-Age
) NCT03866850 280 281 O
; NCT03866850 282 283 O
matched NCT03866850 284 291 O
in NCT03866850 292 294 O
duration NCT03866850 295 303 O
of NCT03866850 304 306 O
deafness NCT03866850 307 315 O
to NCT03866850 316 318 O
the NCT03866850 319 322 O
early NCT03866850 323 328 O
onset NCT03866850 329 334 O
group NCT03866850 335 340 O

- NCT03866850 343 344 O
Has NCT03866850 346 349 O
had NCT03866850 350 353 O
device NCT03866850 354 360 O
experience NCT03866850 361 371 O
for NCT03866850 372 375 O
at NCT03866850 376 378 O
least NCT03866850 379 384 O
one NCT03866850 385 388 O
year NCT03866850 389 393 O

- NCT03866850 396 397 O
Can NCT03866850 399 402 O
be NCT03866850 403 405 O
child NCT03866850 406 411 O
or NCT03866850 412 414 B-Or
adult NCT03866850 415 420 O
at NCT03866850 421 423 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866850 424 427 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03866850 428 432 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03866850 433 435 O
enrollment NCT03866850 436 446 B-Study

Exclusion NCT03866850 447 456 O
Criteria NCT03866850 457 465 O
: NCT03866850 466 467 O

- NCT03866850 471 472 O
None NCT03866850 474 478 O

Inclusion NCT03860792 0 9 O
Criteria NCT03860792 10 18 O
: NCT03860792 19 20 O

- NCT03860792 24 25 O
Diagnosis NCT03860792 27 36 O
of NCT03860792 37 39 O
AD NCT03860792 40 42 B-Condition
by NCT03860792 43 45 O
current NCT03860792 46 53 O
McKhann NCT03860792 54 61 O
et NCT03860792 62 64 O
al NCT03860792 65 67 O
. NCT03860792 68 69 O
criteria NCT03860792 71 79 O

- NCT03860792 82 83 O
CDR NCT03860792 85 88 B-Observation
global NCT03860792 89 95 I-Observation
score NCT03860792 96 101 I-Observation
of NCT03860792 102 104 O
0.5 NCT03860792 105 108 B-Eq_Comparison
or NCT03860792 109 111 I-Eq_Comparison
1 NCT03860792 112 113 I-Eq_Comparison

- NCT03860792 117 118 O
Agreed NCT03860792 120 126 O
cooperation NCT03860792 127 138 O
from NCT03860792 139 143 O
an NCT03860792 144 146 O
appropriate NCT03860792 147 158 O
study NCT03860792 159 164 O
partner NCT03860792 165 172 O

- NCT03860792 175 176 O
Speaks NCT03860792 178 184 O
English NCT03860792 185 192 O
as NCT03860792 193 195 O
primary NCT03860792 196 203 O
language NCT03860792 204 212 O

- NCT03860792 215 216 O
Age NCT03860792 218 221 B-Age
50 NCT03860792 222 224 B-Eq_Comparison
to NCT03860792 225 227 I-Eq_Comparison
90 NCT03860792 228 230 I-Eq_Comparison

- NCT03860792 234 235 O
No NCT03860792 237 239 B-Negation
medication NCT03860792 240 250 B-Drug
changes NCT03860792 251 258 O
within NCT03860792 259 265 B-Eq_Comparison
the NCT03860792 266 269 I-Eq_Comparison
past NCT03860792 270 274 I-Eq_Comparison
30 NCT03860792 275 277 I-Eq_Comparison
days NCT03860792 278 282 I-Eq_Comparison

Exclusion NCT03860792 283 292 O
Criteria NCT03860792 293 301 O
: NCT03860792 302 303 O

- NCT03860792 307 308 O
Resides NCT03860792 310 317 O
in NCT03860792 318 320 O
a NCT03860792 321 322 O
nursing NCT03860792 323 330 O
home NCT03860792 331 335 O
or NCT03860792 336 338 B-Or
dementia NCT03860792 339 347 O
special NCT03860792 348 355 O
care NCT03860792 356 360 O
unit NCT03860792 361 365 O
, NCT03860792 366 367 O
or NCT03860792 368 370 B-Or
can NCT03860792 371 374 B-Negation
not NCT03860792 374 377 I-Negation
control NCT03860792 378 385 O
diet NCT03860792 386 390 B-Procedure

- NCT03860792 393 394 O
A NCT03860792 396 397 O
potentially NCT03860792 398 409 B-Assertion___Assertion_Type_Value:hypothetical
confounding NCT03860792 410 421 O
serious NCT03860792 422 429 O
medical NCT03860792 430 437 O
risk NCT03860792 438 442 B-Risk
including NCT03860792 443 452 O
insulin NCT03860792 453 460 B-Drug
- NCT03860792 461 462 O
requiring NCT03860792 463 472 B-Assertion___Assertion_Type_Value:hypothetical
diabetes NCT03860792 473 481 B-Condition
, NCT03860792 482 483 O
cancer NCT03860792 484 490 B-Condition
requiring NCT03860792 491 500 B-Assertion___Assertion_Type_Value:hypothetical
chemotherapy NCT03860792 501 513 B-Procedure
or NCT03860792 514 516 B-Or
radiation NCT03860792 517 526 B-Procedure
within NCT03860792 527 533 B-Eq_Comparison
the NCT03860792 534 537 I-Eq_Comparison
past NCT03860792 538 542 I-Eq_Comparison
5 NCT03860792 543 544 I-Eq_Comparison
years NCT03860792 545 550 I-Eq_Comparison
, NCT03860792 551 552 O
or NCT03860792 553 555 B-Or
a NCT03860792 556 557 O
recent NCT03860792 558 564 B-Eq_Comparison
cardiac NCT03860792 565 572 B-Condition
event NCT03860792 573 578 I-Condition
( NCT03860792 579 580 O
i NCT03860792 581 582 O
. NCT03860792 583 584 O
e NCT03860792 585 586 O
. NCT03860792 587 588 O
heart NCT03860792 590 595 B-Condition
attack NCT03860792 596 602 I-Condition
, NCT03860792 603 604 O
angioplasty NCT03860792 605 616 B-Procedure
, NCT03860792 617 618 O
etc NCT03860792 619 622 O
. NCT03860792 623 624 O
) NCT03860792 625 626 O

- NCT03860792 630 631 O
Participating NCT03860792 633 646 B-Eq_Comparison
in NCT03860792 647 649 O
another NCT03860792 650 657 B-Other
clinical NCT03860792 658 666 B-Study
trial NCT03860792 667 672 I-Study
or NCT03860792 673 675 B-Or
using NCT03860792 676 681 B-Eq_Comparison
an NCT03860792 682 684 O
investigational NCT03860792 685 700 B-Study
drug NCT03860792 701 705 B-Drug
or NCT03860792 706 708 B-Or
therapy NCT03860792 709 716 B-Procedure
within NCT03860792 717 723 B-Eq_Comparison
30 NCT03860792 724 726 I-Eq_Comparison
days NCT03860792 727 731 I-Eq_Comparison
of NCT03860792 732 734 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03860792 735 738 O
Screening NCT03860792 739 748 B-Study
Visit NCT03860792 749 754 O

- NCT03860792 757 758 O
A NCT03860792 760 761 O
history NCT03860792 762 769 B-Eq_Comparison
of NCT03860792 770 772 O
renal NCT03860792 773 778 B-Condition
stones NCT03860792 779 785 I-Condition

Inclusion NCT03862261 0 9 O
Criteria NCT03862261 10 18 O
: NCT03862261 19 20 O

- NCT03862261 24 25 O
Children NCT03862261 27 35 O
< NCT03862261 36 37 B-Eq_Comparison
5 NCT03862261 38 39 I-Eq_Comparison
years NCT03862261 40 45 I-Eq_Comparison
old NCT03862261 46 49 B-Age
. NCT03862261 50 51 O

- NCT03862261 55 56 O
Presumptive NCT03862261 58 69 B-Assertion___Assertion_Type_Value:possible
pulmonary NCT03862261 70 79 B-Modifier
or NCT03862261 80 82 B-Or
extra NCT03862261 83 88 B-Modifier
- NCT03862261 89 90 I-Modifier
pulmonary NCT03862261 91 100 I-Modifier
TB NCT03862261 101 103 B-Condition
case NCT03862261 104 108 O
: NCT03862261 109 110 O
symptoms NCT03862261 111 119 B-Assertion___Assertion_Type_Value:possible
or NCT03862261 120 122 B-Or
clinical NCT03862261 123 131 O
signs NCT03862261 132 137 B-Assertion___Assertion_Type_Value:possible
suggestive NCT03862261 138 148 B-Assertion___Assertion_Type_Value:possible
of NCT03862261 149 151 O
active NCT03862261 152 158 B-Eq_Comparison
TB NCT03862261 159 161 B-Condition
disease NCT03862261 162 169 I-Condition
. NCT03862261 170 171 O

- NCT03862261 175 176 O
Other NCT03862261 178 183 B-Other
infectious NCT03862261 184 194 B-Condition
diseases NCT03862261 195 203 I-Condition
are NCT03862261 204 207 O
not NCT03862261 208 211 B-Negation
suspected NCT03862261 212 221 B-Assertion___Assertion_Type_Value:possible
or NCT03862261 222 224 B-Or
have NCT03862261 225 229 O
already NCT03862261 230 237 O
been NCT03862261 238 242 O
ruled NCT03862261 243 248 O
out NCT03862261 249 252 O
. NCT03862261 253 254 O

- NCT03862261 258 259 O
Commitment NCT03862261 261 271 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862261 272 274 I-Assertion___Assertion_Type_Value:hypothetical
take NCT03862261 275 279 O
treatment NCT03862261 280 289 B-Procedure
in NCT03862261 290 292 O
the NCT03862261 293 296 O
clinic NCT03862261 297 303 O
of NCT03862261 304 306 O
enrolment NCT03862261 307 316 O
or NCT03862261 317 319 B-Or
another NCT03862261 320 327 O
INPUT NCT03862261 328 333 O
study NCT03862261 334 339 B-Study
site NCT03862261 340 344 O
. NCT03862261 345 346 O

- NCT03862261 350 351 O
Parental NCT03862261 353 361 B-Family_Member___Family_Member_Type:parent
/ NCT03862261 362 363 O
caregiver NCT03862261 364 373 O
consent NCT03862261 374 381 O
for NCT03862261 382 385 O
the NCT03862261 386 389 O
child NCT03862261 390 395 B-Family_Member___Family_Member_Type:child
to NCT03862261 396 398 O
participate NCT03862261 399 410 O
in NCT03862261 411 413 O
the NCT03862261 414 417 O
study NCT03862261 418 423 B-Study
. NCT03862261 424 425 O

Exclusion NCT03862261 427 436 O
Criteria NCT03862261 437 445 O
: NCT03862261 446 447 O

- NCT03862261 451 452 O
Children NCT03862261 454 462 O
who NCT03862261 463 466 B-And
are NCT03862261 467 470 O
TB NCT03862261 471 473 B-Condition
contacts NCT03862261 474 482 O
but NCT03862261 483 486 B-And
without NCT03862261 487 494 B-Negation
symptoms NCT03862261 495 503 B-Assertion___Assertion_Type_Value:possible
or NCT03862261 504 506 B-Or
signs NCT03862261 507 512 B-Assertion___Assertion_Type_Value:possible
of NCT03862261 513 515 O
active NCT03862261 516 522 B-Eq_Comparison
TB NCT03862261 523 525 B-Condition

Inclusion NCT03865901 0 9 O
Criteria NCT03865901 10 18 O
: NCT03865901 19 20 O

1 NCT03865901 24 25 O
. NCT03865901 25 26 O
Women NCT03865901 28 33 O
18 NCT03865901 34 36 B-Eq_Comparison
years NCT03865901 37 42 I-Eq_Comparison
of NCT03865901 43 45 I-Eq_Comparison
age NCT03865901 46 49 I-Eq_Comparison
or NCT03865901 50 52 I-Eq_Comparison
older NCT03865901 53 58 I-Eq_Comparison
at NCT03865901 59 61 B-Temporal_Connection___Temporal_Connection_Type_Value:during
enrollment NCT03865901 62 72 B-Study

2 NCT03865901 75 76 O
. NCT03865901 76 77 O
Has NCT03865901 79 82 O
an NCT03865901 83 85 O
established NCT03865901 86 97 O
viable NCT03865901 98 104 B-Modifier
singleton NCT03865901 105 114 I-Modifier
pregnancy NCT03865901 115 124 B-Condition

3 NCT03865901 127 128 O
. NCT03865901 128 129 O
Is NCT03865901 131 133 O
recommended NCT03865901 134 145 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865901 146 149 I-Assertion___Assertion_Type_Value:hypothetical
routine NCT03865901 150 157 O
GDM NCT03865901 158 161 B-Procedure
screening NCT03865901 162 171 I-Procedure
between NCT03865901 172 179 B-Eq_Comparison
24 NCT03865901 180 182 I-Eq_Comparison
- NCT03865901 183 184 I-Eq_Comparison
28 NCT03865901 185 187 I-Eq_Comparison
weeks NCT03865901 188 193 I-Eq_Comparison
gestation NCT03865901 194 203 B-Observation

4 NCT03865901 206 207 O
. NCT03865901 207 208 O
Has NCT03865901 210 213 O
confirmed NCT03865901 214 223 O
gestational NCT03865901 224 235 B-Observation
age NCT03865901 236 239 I-Observation
of NCT03865901 240 242 O
24 NCT03865901 243 245 B-Eq_Comparison
- NCT03865901 246 247 I-Eq_Comparison
28 NCT03865901 248 250 I-Eq_Comparison
weeks NCT03865901 251 256 I-Eq_Comparison
at NCT03865901 257 259 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865901 260 263 O
Screening NCT03865901 264 273 B-Study
Visit NCT03865901 274 279 O

5 NCT03865901 282 283 O
. NCT03865901 283 284 O
Is NCT03865901 286 288 O
willing NCT03865901 289 296 O
and NCT03865901 297 300 O
able NCT03865901 301 305 O
to NCT03865901 306 308 O
provide NCT03865901 309 316 O
documentation NCT03865901 317 330 O
of NCT03865901 331 333 O
informed NCT03865901 334 342 O
consent NCT03865901 343 350 O

Exclusion NCT03865901 351 360 O
Criteria NCT03865901 361 369 O
: NCT03865901 370 371 O

1 NCT03865901 375 376 O
. NCT03865901 376 377 O
Has NCT03865901 379 382 O
diabetes NCT03865901 383 391 B-Condition
before NCT03865901 392 398 B-Temporal_Connection___Temporal_Connection_Type_Value:before
pregnancy NCT03865901 399 408 B-Condition
or NCT03865901 409 411 B-Or
has NCT03865901 412 415 O
already NCT03865901 416 423 B-Eq_Comparison
been NCT03865901 424 428 O
diagnosed NCT03865901 429 438 O
with NCT03865901 439 443 O
GDM NCT03865901 444 447 B-Condition

2 NCT03865901 450 451 O
. NCT03865901 451 452 O
Has NCT03865901 454 457 O
contraindications NCT03865901 458 475 B-Contraindication
for NCT03865901 476 479 O
drinking NCT03865901 480 488 B-Modifier
oral NCT03865901 489 493 I-Modifier
glucose NCT03865901 494 501 B-Drug
solution NCT03865901 502 510 O
up NCT03865901 511 513 B-Eq_Comparison
to NCT03865901 514 516 I-Eq_Comparison
100 NCT03865901 517 520 I-Eq_Comparison
g NCT03865901 521 522 I-Eq_Comparison
of NCT03865901 523 525 I-Eq_Comparison
sugar NCT03865901 526 531 I-Eq_Comparison

3 NCT03865901 534 535 B-Eq_Comparison
. NCT03865901 535 536 O
Is NCT03865901 538 540 O
taking NCT03865901 541 547 B-Eq_Comparison
metformin NCT03865901 548 557 B-Drug
for NCT03865901 558 561 O
any NCT03865901 562 565 O
reason NCT03865901 566 572 O

4 NCT03865901 575 576 O
. NCT03865901 576 577 O
Has NCT03865901 579 582 O
any NCT03865901 583 586 O
concomitant NCT03865901 587 598 B-Modifier
illness NCT03865901 599 606 B-Condition
, NCT03865901 607 608 O
disease NCT03865901 609 616 B-Condition
or NCT03865901 617 619 B-Or
condition NCT03865901 620 629 B-Condition
that NCT03865901 630 634 O
, NCT03865901 635 636 O
in NCT03865901 637 639 O
the NCT03865901 640 643 O
clinical NCT03865901 644 652 O
judgment NCT03865901 653 661 O
of NCT03865901 662 664 O
the NCT03865901 665 668 O
investigator NCT03865901 669 681 O
, NCT03865901 682 683 O
is NCT03865901 684 686 O
likely NCT03865901 687 693 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865901 694 696 O
prevent NCT03865901 697 704 O
the NCT03865901 705 708 O
subject NCT03865901 709 716 O
from NCT03865901 717 721 O
complying NCT03865901 722 731 O
with NCT03865901 732 736 O
any NCT03865901 737 740 O
aspect NCT03865901 741 747 O
of NCT03865901 748 750 O
the NCT03865901 751 754 O
protocol NCT03865901 755 763 B-Study
, NCT03865901 764 765 O
or NCT03865901 766 768 B-Or
that NCT03865901 769 773 O
may NCT03865901 774 777 O
put NCT03865901 778 781 O
the NCT03865901 782 785 O
subject NCT03865901 786 793 O
at NCT03865901 794 796 O
unacceptable NCT03865901 797 809 O
risk NCT03865901 810 814 B-Risk

Inclusion NCT03868436 0 9 O
Criteria NCT03868436 10 18 O
: NCT03868436 19 20 O

1 NCT03868436 24 25 O
. NCT03868436 25 26 O
Conscious NCT03868436 28 37 O
adult NCT03868436 38 43 O
patients NCT03868436 44 52 O
: NCT03868436 53 54 O
≥ NCT03868436 55 56 B-Eq_Comparison
18 NCT03868436 57 59 I-Eq_Comparison
years NCT03868436 60 65 I-Eq_Comparison
of NCT03868436 66 68 O
age NCT03868436 69 72 B-Age

2 NCT03868436 75 76 O
. NCT03868436 76 77 O
Moderate NCT03868436 79 87 B-Eq_Comparison
to NCT03868436 88 90 I-Eq_Comparison
severe NCT03868436 91 97 I-Eq_Comparison
pain NCT03868436 98 102 B-Condition
associated NCT03868436 103 113 O
with NCT03868436 114 118 O
trauma NCT03868436 119 125 B-Condition
( NCT03868436 126 127 O
NRS NCT03868436 128 131 B-Observation
0 NCT03868436 132 133 I-Observation
- NCT03868436 134 135 I-Observation
10 NCT03868436 136 138 I-Observation
≥ NCT03868436 139 140 B-Eq_Comparison
4 NCT03868436 141 142 I-Eq_Comparison
) NCT03868436 143 144 O
which NCT03868436 145 150 O
is NCT03868436 151 153 O
unlikely NCT03868436 154 162 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868436 163 165 I-Assertion___Assertion_Type_Value:hypothetical
require NCT03868436 166 173 O
surgery NCT03868436 174 181 B-Procedure
/ NCT03868436 182 183 B-Or
hospitalization NCT03868436 184 199 B-Encounter
, NCT03868436 200 201 O
such NCT03868436 202 206 O
as NCT03868436 207 209 O

- NCT03868436 217 218 O
Musculoskeletal NCT03868436 220 235 B-Modifier
injuries NCT03868436 236 244 B-Condition
and NCT03868436 245 248 B-Or
physical NCT03868436 249 257 B-Modifier
wounds NCT03868436 258 264 B-Condition

- NCT03868436 272 273 O
Fractures NCT03868436 275 284 B-Condition

- NCT03868436 292 293 O
Lacerations NCT03868436 295 306 B-Condition

- NCT03868436 314 315 O
Burns NCT03868436 317 322 B-Condition

- NCT03868436 330 331 O
Dislocations NCT03868436 333 345 O

- NCT03868436 353 354 O
Contusions NCT03868436 356 366 B-Condition

- NCT03868436 374 375 O
Injury NCT03868436 377 383 B-Condition
due NCT03868436 384 387 O
to NCT03868436 388 390 O
foreign NCT03868436 391 398 B-Condition
bodies NCT03868436 399 405 I-Condition

3 NCT03868436 408 409 O
. NCT03868436 409 410 O
Patient NCT03868436 412 419 O
( NCT03868436 420 421 O
and NCT03868436 422 425 O
/ NCT03868436 426 427 O
or NCT03868436 428 430 O
patient NCT03868436 431 438 O
's NCT03868436 438 440 O
authorized NCT03868436 441 451 O
legal NCT03868436 452 457 O
representative NCT03868436 458 472 O
) NCT03868436 473 474 O
should NCT03868436 475 481 O
understand NCT03868436 482 492 O
the NCT03868436 493 496 O
nature NCT03868436 497 503 O
of NCT03868436 504 506 O
the NCT03868436 507 510 O
study NCT03868436 511 516 O
and NCT03868436 517 520 O
provide NCT03868436 521 528 O
written NCT03868436 529 536 O
informed NCT03868436 537 545 O
consent NCT03868436 546 553 O

4 NCT03868436 556 557 O
. NCT03868436 557 558 O
Patient NCT03868436 560 567 O
is NCT03868436 568 570 O
able NCT03868436 571 575 O
to NCT03868436 576 578 O
follow NCT03868436 579 585 O
all NCT03868436 586 589 O
study NCT03868436 590 595 O
requirements NCT03868436 596 608 O
and NCT03868436 609 612 O
procedures NCT03868436 613 623 O
and NCT03868436 624 627 O
complete NCT03868436 628 636 O
required NCT03868436 637 645 O
questionnaires NCT03868436 646 660 O

Exclusion NCT03868436 661 670 O
Criteria NCT03868436 671 679 O
: NCT03868436 680 681 O

1 NCT03868436 685 686 O
. NCT03868436 686 687 O
Multi NCT03868436 689 694 B-Condition
- NCT03868436 695 696 I-Condition
level NCT03868436 697 702 I-Condition
trauma NCT03868436 703 709 I-Condition

2 NCT03868436 712 713 O
. NCT03868436 713 714 O
Women NCT03868436 716 721 O
of NCT03868436 722 724 B-And
child NCT03868436 725 730 B-Condition
bearing NCT03868436 731 738 I-Condition
potential NCT03868436 739 748 I-Condition
who NCT03868436 749 752 B-And
are NCT03868436 753 756 O
pregnant NCT03868436 757 765 B-Condition
or NCT03868436 766 768 B-Or
peri NCT03868436 769 773 B-Condition
partum NCT03868436 774 780 I-Condition
, NCT03868436 781 782 O
including NCT03868436 783 792 O
labour NCT03868436 793 799 B-Condition

3 NCT03868436 802 803 O
. NCT03868436 803 804 O
An NCT03868436 806 808 O
altered NCT03868436 809 816 B-Condition
level NCT03868436 817 822 I-Condition
of NCT03868436 823 825 I-Condition
consciousness NCT03868436 826 839 I-Condition
, NCT03868436 840 841 O
due NCT03868436 842 845 O
to NCT03868436 846 848 O
any NCT03868436 849 852 O
cause NCT03868436 853 858 B-Condition
, NCT03868436 859 860 O
including NCT03868436 861 870 O
head NCT03868436 871 875 B-Modifier
injury NCT03868436 876 882 B-Condition
, NCT03868436 883 884 O
drugs NCT03868436 885 890 B-Drug
, NCT03868436 891 892 O
or NCT03868436 893 895 B-Or
alcohol NCT03868436 896 903 B-Drug

4 NCT03868436 906 907 O
. NCT03868436 907 908 O
Clinically NCT03868436 910 920 O
significant NCT03868436 921 932 O
renal NCT03868436 933 938 B-Condition
impairment NCT03868436 939 949 I-Condition

5 NCT03868436 952 953 O
. NCT03868436 953 954 O
A NCT03868436 956 957 O
history NCT03868436 958 965 B-Eq_Comparison
of NCT03868436 966 968 O
liver NCT03868436 969 974 B-Condition
dysfunction NCT03868436 975 986 I-Condition
after NCT03868436 987 992 B-Temporal_Connection___Temporal_Connection_Type_Value:after
previous NCT03868436 993 1001 B-Eq_Comparison
MEOF NCT03868436 1002 1006 B-Drug
use NCT03868436 1007 1010 O
or NCT03868436 1011 1013 B-Or
other NCT03868436 1014 1019 B-Other
halogenated NCT03868436 1020 1031 B-Drug
anesthetics NCT03868436 1032 1043 I-Drug

6 NCT03868436 1046 1047 O
. NCT03868436 1047 1048 O
Hypersensitivity NCT03868436 1050 1066 B-Condition
to NCT03868436 1067 1069 O
MEOF NCT03868436 1070 1074 B-Drug
or NCT03868436 1075 1077 B-Or
other NCT03868436 1078 1083 B-Other
halogenated NCT03868436 1084 1095 B-Drug
anesthetics NCT03868436 1096 1107 I-Drug
, NCT03868436 1108 1109 O
or NCT03868436 1110 1112 B-Or
to NCT03868436 1113 1115 O
butylated NCT03868436 1116 1125 B-Drug
hydroxytoluene NCT03868436 1126 1140 I-Drug

7 NCT03868436 1143 1144 O
. NCT03868436 1144 1145 O
Known NCT03868436 1147 1152 O
or NCT03868436 1153 1155 B-Or
genetically NCT03868436 1156 1167 B-Modifier
susceptible NCT03868436 1168 1179 I-Modifier
to NCT03868436 1180 1182 I-Modifier
malignant NCT03868436 1183 1192 I-Modifier
hyperthermia NCT03868436 1193 1205 B-Condition
or NCT03868436 1206 1208 B-Or
a NCT03868436 1209 1210 O
history NCT03868436 1211 1218 B-Eq_Comparison
of NCT03868436 1219 1221 O
severe NCT03868436 1222 1228 O
adverse NCT03868436 1229 1236 B-Condition
reactions NCT03868436 1237 1246 I-Condition
in NCT03868436 1247 1249 O
either NCT03868436 1250 1256 O
patient NCT03868436 1257 1264 B-Family_Member___Family_Member_Type:patient
or NCT03868436 1265 1267 B-Or
relatives NCT03868436 1268 1277 B-Family_Member

8 NCT03868436 1280 1281 O
. NCT03868436 1281 1282 O
Exacerbation NCT03868436 1284 1296 O
of NCT03868436 1297 1299 O
an NCT03868436 1300 1302 O
underlying NCT03868436 1303 1313 B-Condition
condition NCT03868436 1314 1323 I-Condition
( NCT03868436 1324 1325 O
i NCT03868436 1326 1327 O
. NCT03868436 1328 1329 O
e NCT03868436 1330 1331 O
. NCT03868436 1332 1333 O
, NCT03868436 1334 1335 O
chronic NCT03868436 1336 1343 O
pain NCT03868436 1344 1348 B-Condition
) NCT03868436 1349 1350 O

9 NCT03868436 1354 1355 O
. NCT03868436 1355 1356 O
Clinically NCT03868436 1358 1368 O
evident NCT03868436 1369 1376 B-Modifier
or NCT03868436 1377 1379 B-Or
potential NCT03868436 1380 1389 B-Assertion___Assertion_Type_Value:hypothetical
hemodynamic NCT03868436 1390 1401 B-Condition
instability NCT03868436 1402 1413 O
as NCT03868436 1414 1416 O
per NCT03868436 1417 1420 O
the NCT03868436 1421 1424 O
opinion NCT03868436 1425 1432 O
of NCT03868436 1433 1435 O
the NCT03868436 1436 1439 O
investigator NCT03868436 1440 1452 O

10 NCT03868436 1454 1456 O
. NCT03868436 1456 1457 O
Clinically NCT03868436 1459 1469 O
evident NCT03868436 1470 1477 O
respiratory NCT03868436 1478 1489 B-Condition
impairment NCT03868436 1490 1500 I-Condition
as NCT03868436 1501 1503 O
per NCT03868436 1504 1507 O
the NCT03868436 1508 1511 O
opinion NCT03868436 1512 1519 O
of NCT03868436 1520 1522 O
the NCT03868436 1523 1526 O
investigator NCT03868436 1527 1539 O

11 NCT03868436 1541 1543 O
. NCT03868436 1543 1544 O
Prior NCT03868436 1546 1551 B-Eq_Comparison
treatment NCT03868436 1552 1561 B-Procedure
with NCT03868436 1562 1566 O
PENTHROX NCT03868436 1567 1575 B-Drug
within NCT03868436 1576 1582 B-Eq_Comparison
3 NCT03868436 1583 1584 I-Eq_Comparison
months NCT03868436 1585 1591 I-Eq_Comparison

Inclusion NCT03929952 0 9 O
Criteria NCT03929952 10 18 O
: NCT03929952 19 20 O

- NCT03929952 24 25 O
Patient NCT03929952 27 34 O
with NCT03929952 35 39 O
a NCT03929952 40 41 O
wifi NCT03929952 42 46 O
connexion NCT03929952 47 56 O
at NCT03929952 57 59 O
home NCT03929952 60 64 O

- NCT03929952 67 68 O
Patient NCT03929952 70 77 O
with NCT03929952 78 82 O
the NCT03929952 83 86 O
ability NCT03929952 87 94 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929952 95 97 I-Assertion___Assertion_Type_Value:hypothetical
modulate NCT03929952 98 106 B-Observation
the NCT03929952 107 110 I-Observation
height NCT03929952 111 117 I-Observation
of NCT03929952 118 120 I-Observation
the NCT03929952 121 124 I-Observation
candle NCT03929952 125 131 I-Observation
by NCT03929952 132 134 O
thinking NCT03929952 135 143 O
in NCT03929952 144 146 O
the NCT03929952 147 150 O
alpha NCT03929952 151 156 B-Observation
synchrony NCT03929952 157 166 I-Observation
test NCT03929952 167 171 I-Observation
. NCT03929952 172 173 O

- NCT03929952 177 178 O
Patient NCT03929952 180 187 O
with NCT03929952 188 192 O
chronic NCT03929952 193 200 B-Condition
low NCT03929952 201 204 I-Condition
back NCT03929952 205 209 I-Condition
pain NCT03929952 210 214 I-Condition
for NCT03929952 215 218 O
more NCT03929952 219 223 B-Eq_Comparison
than NCT03929952 224 228 I-Eq_Comparison
six NCT03929952 229 232 I-Eq_Comparison
months NCT03929952 233 239 I-Eq_Comparison
with NCT03929952 240 244 B-And
a NCT03929952 245 246 O
visual NCT03929952 247 253 B-Observation
analogue NCT03929952 254 262 I-Observation
pain NCT03929952 263 267 I-Observation
scale NCT03929952 268 273 I-Observation
greater NCT03929952 274 281 B-Eq_Comparison
than NCT03929952 282 286 I-Eq_Comparison
5 NCT03929952 287 288 I-Eq_Comparison
impacting NCT03929952 289 298 O
activities NCT03929952 299 309 O
of NCT03929952 310 312 O
daily NCT03929952 313 318 O
living NCT03929952 319 325 O
, NCT03929952 326 327 O
hobbies NCT03929952 328 335 O
and NCT03929952 336 339 O
work NCT03929952 340 344 O

- NCT03929952 347 348 O
Patient NCT03929952 350 357 O
having NCT03929952 358 364 O
given NCT03929952 365 370 O
free NCT03929952 371 375 O
and NCT03929952 376 379 O
informed NCT03929952 380 388 O
consent NCT03929952 389 396 O
and NCT03929952 397 400 O
signed NCT03929952 401 407 O
consent NCT03929952 408 415 O
. NCT03929952 416 417 O

- NCT03929952 421 422 O
Affected NCT03929952 424 432 O
patient NCT03929952 433 440 O
or NCT03929952 441 443 O
beneficiary NCT03929952 444 455 O
of NCT03929952 456 458 O
a NCT03929952 459 460 O
health NCT03929952 461 467 O
insurance NCT03929952 468 477 O
plan NCT03929952 478 482 O
. NCT03929952 483 484 O

- NCT03929952 488 489 O
Patient NCT03929952 491 498 O
who NCT03929952 499 502 O
is NCT03929952 503 505 O
at NCT03929952 506 508 B-Eq_Comparison
least NCT03929952 509 514 I-Eq_Comparison
18 NCT03929952 515 517 I-Eq_Comparison
years NCT03929952 518 523 I-Eq_Comparison
old NCT03929952 524 527 B-Age
( NCT03929952 528 529 O
≥ NCT03929952 530 531 O
) NCT03929952 532 533 O
and NCT03929952 534 537 B-And
younger NCT03929952 538 545 B-Eq_Comparison
than NCT03929952 546 550 I-Eq_Comparison
75 NCT03929952 551 553 I-Eq_Comparison
years NCT03929952 554 559 I-Eq_Comparison
old NCT03929952 560 563 B-Age
( NCT03929952 564 565 O
< NCT03929952 566 567 O
) NCT03929952 568 569 O
. NCT03929952 570 571 O

Exclusion NCT03929952 573 582 O
Criteria NCT03929952 583 591 O
: NCT03929952 592 593 O

- NCT03929952 597 598 O
Pregnant NCT03929952 600 608 B-Condition
or NCT03929952 609 611 B-Or
breastfeeding NCT03929952 612 625 B-Condition
patient NCT03929952 626 633 O

- NCT03929952 636 637 O
Patient NCT03929952 639 646 O
with NCT03929952 647 651 O
a NCT03929952 652 653 O
contraindication NCT03929952 654 670 B-Contraindication
to NCT03929952 671 673 O
performing NCT03929952 674 684 O
a NCT03929952 685 686 O
fMRI NCT03929952 687 691 B-Procedure
scan NCT03929952 692 696 I-Procedure
: NCT03929952 697 698 O
ferromagnetic NCT03929952 699 712 B-Procedure
implant NCT03929952 713 720 I-Procedure
in NCT03929952 721 723 O
the NCT03929952 724 727 O
body NCT03929952 728 732 O
, NCT03929952 733 734 O
piercing NCT03929952 735 743 B-Condition
, NCT03929952 744 745 O
claustrophobia NCT03929952 746 760 B-Condition
, NCT03929952 761 762 O
unable NCT03929952 763 769 B-Condition
to NCT03929952 770 772 I-Condition
remain NCT03929952 773 779 I-Condition
in NCT03929952 780 782 I-Condition
the NCT03929952 783 786 I-Condition
scanner NCT03929952 787 794 I-Condition
stationary NCT03929952 795 805 I-Condition
for NCT03929952 806 809 O
40 NCT03929952 810 812 B-Eq_Comparison
minutes NCT03929952 813 820 I-Eq_Comparison

- NCT03929952 823 824 O
Patient NCT03929952 826 833 O
already NCT03929952 834 841 O
included NCT03929952 842 850 O
in NCT03929952 851 853 O
another NCT03929952 854 861 O
study NCT03929952 862 867 O

- NCT03929952 870 871 O
Patient NCT03929952 873 880 O
in NCT03929952 881 883 O
a NCT03929952 884 885 O
exclusion NCT03929952 886 895 O
period NCT03929952 896 902 O
determined NCT03929952 903 913 O
by NCT03929952 914 916 O
a NCT03929952 917 918 O
previous NCT03929952 919 927 B-Eq_Comparison
study NCT03929952 928 933 B-Study

- NCT03929952 936 937 O
The NCT03929952 939 942 O
subject NCT03929952 943 950 O
is NCT03929952 951 953 O
under NCT03929952 954 959 O
the NCT03929952 960 963 O
protection NCT03929952 964 974 B-Observation
of NCT03929952 975 977 I-Observation
justice NCT03929952 978 985 I-Observation
, NCT03929952 986 987 O
guardianship NCT03929952 988 1000 O
or NCT03929952 1001 1003 O
curatorship NCT03929952 1004 1015 O
. NCT03929952 1016 1017 O

- NCT03929952 1021 1022 O
The NCT03929952 1024 1027 O
subject NCT03929952 1028 1035 O
refuses NCT03929952 1036 1043 O
to NCT03929952 1044 1046 O
sign NCT03929952 1047 1051 O
the NCT03929952 1052 1055 O
consent NCT03929952 1056 1063 O
. NCT03929952 1064 1065 O

- NCT03929952 1069 1070 O
It NCT03929952 1072 1074 O
is NCT03929952 1075 1077 O
not NCT03929952 1078 1081 O
possible NCT03929952 1082 1090 O
to NCT03929952 1091 1093 O
give NCT03929952 1094 1098 O
the NCT03929952 1099 1102 O
subject NCT03929952 1103 1110 O
informed NCT03929952 1111 1119 O
information NCT03929952 1120 1131 O
. NCT03929952 1132 1133 O

Inclusion NCT03868046 0 9 O
Criteria NCT03868046 10 18 O
: NCT03868046 19 20 O

1 NCT03868046 24 25 O
. NCT03868046 25 26 O
Initiation NCT03868046 28 38 B-Eq_Comparison
of NCT03868046 39 41 O
treatment NCT03868046 42 51 B-Procedure
with NCT03868046 52 56 O
a NCT03868046 57 58 O
single NCT03868046 59 65 B-Eq_Comparison
ICI NCT03868046 66 69 B-Procedure
or NCT03868046 70 72 B-Or
a NCT03868046 73 74 O
combination NCT03868046 75 86 B-Eq_Comparison
of NCT03868046 87 89 O
ICIs NCT03868046 90 94 B-Procedure
. NCT03868046 95 96 O

2 NCT03868046 100 101 O
. NCT03868046 101 102 O
Acceptation NCT03868046 104 115 O
of NCT03868046 116 118 O
an NCT03868046 119 121 O
informed NCT03868046 122 130 O
consent NCT03868046 131 138 O
. NCT03868046 139 140 O

Exclusion NCT03868046 142 151 O
Criteria NCT03868046 152 160 O
: NCT03868046 161 162 O

1 NCT03868046 166 167 O
. NCT03868046 167 168 O
Life NCT03868046 170 174 B-Observation
expectancy NCT03868046 175 185 I-Observation
lower NCT03868046 186 191 B-Eq_Comparison
than NCT03868046 192 196 I-Eq_Comparison
3 NCT03868046 197 198 I-Eq_Comparison
months NCT03868046 199 205 I-Eq_Comparison
from NCT03868046 206 210 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03868046 211 214 O
initiation NCT03868046 215 225 B-Eq_Comparison
of NCT03868046 226 228 O
treatment NCT03868046 229 238 B-Procedure
with NCT03868046 239 243 O
ICIs NCT03868046 244 248 B-Procedure
. NCT03868046 249 250 O

2 NCT03868046 254 255 O
. NCT03868046 255 256 O
Proven NCT03868046 258 264 O
hypersensitivity NCT03868046 265 281 B-Condition
or NCT03868046 282 284 B-Or
previous NCT03868046 285 293 O
allergic NCT03868046 294 302 B-Allergy
anaphylactic NCT03868046 303 315 B-Condition
reaction NCT03868046 316 324 I-Condition
induced NCT03868046 325 332 O
by NCT03868046 333 335 O
a NCT03868046 336 337 O
specific NCT03868046 338 346 O
ICI NCT03868046 347 350 B-Procedure
. NCT03868046 351 352 O

3 NCT03868046 356 357 O
. NCT03868046 357 358 O
Active NCT03868046 360 366 B-Eq_Comparison
autoimmune NCT03868046 367 377 B-Condition
disease NCT03868046 378 385 I-Condition
with NCT03868046 386 390 O
severe NCT03868046 391 397 O
involvement NCT03868046 398 409 O
. NCT03868046 410 411 O

4 NCT03868046 415 416 O
. NCT03868046 416 417 O
Eastern NCT03868046 419 426 B-Observation
Cooperative NCT03868046 427 438 I-Observation
Oncology NCT03868046 439 447 I-Observation
Group NCT03868046 448 453 I-Observation
( NCT03868046 454 455 O
ECOG NCT03868046 456 460 B-Observation
) NCT03868046 461 462 O
performance NCT03868046 463 474 O
status NCT03868046 475 481 O
≥ NCT03868046 482 483 B-Eq_Comparison
3 NCT03868046 484 485 I-Eq_Comparison
. NCT03868046 485 486 O

5 NCT03868046 490 491 O
. NCT03868046 491 492 O
Ongoing NCT03868046 494 501 B-Eq_Comparison
immunosuppressive NCT03868046 502 519 B-Procedure
therapy NCT03868046 520 527 I-Procedure
: NCT03868046 528 529 O
prednisone NCT03868046 530 540 B-Drug
at NCT03868046 541 543 O
doses NCT03868046 544 549 O
> NCT03868046 550 551 B-Eq_Comparison
10 NCT03868046 552 554 I-Eq_Comparison
mg NCT03868046 555 557 I-Eq_Comparison
/ NCT03868046 558 559 I-Eq_Comparison
day NCT03868046 560 563 I-Eq_Comparison
or NCT03868046 564 566 O
equivalent NCT03868046 567 577 O
( NCT03868046 578 579 O
> NCT03868046 580 581 B-Eq_Comparison
1.5 NCT03868046 582 585 I-Eq_Comparison
mg NCT03868046 586 588 I-Eq_Comparison
/ NCT03868046 589 590 I-Eq_Comparison
day NCT03868046 591 594 I-Eq_Comparison
of NCT03868046 595 597 O
dexamethasone NCT03868046 598 611 B-Drug
) NCT03868046 612 613 O
, NCT03868046 614 615 O
and NCT03868046 616 619 B-Or
/ NCT03868046 620 621 I-Or
or NCT03868046 622 624 I-Or
any NCT03868046 625 628 O
dose NCT03868046 629 633 O
of NCT03868046 634 636 O
azathioprine NCT03868046 637 649 B-Drug
, NCT03868046 650 651 O
methotrexate NCT03868046 652 664 B-Drug
, NCT03868046 665 666 O
mycophenolate NCT03868046 667 680 B-Drug
, NCT03868046 681 682 O
cyclophosphamide NCT03868046 683 699 B-Drug
, NCT03868046 700 701 O
leflunomide NCT03868046 702 713 B-Drug
, NCT03868046 714 715 O
rituximab NCT03868046 716 725 B-Drug
, NCT03868046 726 727 O
anti NCT03868046 728 732 B-Drug
- NCT03868046 733 734 I-Drug
tumor NCT03868046 735 740 I-Drug
necrosis NCT03868046 741 749 I-Drug
factor NCT03868046 750 756 I-Drug
drugs NCT03868046 757 762 I-Drug
( NCT03868046 763 764 O
infliximab NCT03868046 765 775 B-Drug
, NCT03868046 776 777 O
etanercept NCT03868046 778 788 B-Drug
, NCT03868046 789 790 O
adalimumab NCT03868046 791 801 B-Drug
, NCT03868046 802 803 O
golimumab NCT03868046 804 813 B-Drug
) NCT03868046 814 815 O
, NCT03868046 816 817 O
belimumab NCT03868046 818 827 B-Drug
and NCT03868046 828 831 B-Or
abatacept NCT03868046 832 841 B-Drug
. NCT03868046 842 843 O

Inclusion NCT03864796 0 9 O
Criteria NCT03864796 10 18 O
: NCT03864796 19 20 O

- NCT03864796 24 25 O
newly NCT03864796 27 32 B-Eq_Comparison
diagnosed NCT03864796 33 42 O
primary NCT03864796 43 50 B-Modifier
immune NCT03864796 51 57 I-Modifier
thrombocytopenic NCT03864796 58 74 B-Condition
patients NCT03864796 75 83 O

Exclusion NCT03864796 84 93 O
Criteria NCT03864796 94 102 O
: NCT03864796 103 104 O

- NCT03864796 108 109 O
We NCT03864796 111 113 O
will NCT03864796 114 118 O
exclude NCT03864796 119 126 B-Negation
patients NCT03864796 127 135 O
with NCT03864796 136 140 O
any NCT03864796 141 144 O
other NCT03864796 145 150 B-Other
possible NCT03864796 151 159 B-Assertion___Assertion_Type_Value:possible
cause NCT03864796 160 165 B-Condition
of NCT03864796 166 168 O
thrombocytopenia NCT03864796 169 185 B-Condition
either NCT03864796 186 192 O
immune NCT03864796 193 199 B-Modifier
or NCT03864796 200 202 B-Or
non NCT03864796 203 206 B-Negation
immune NCT03864796 207 213 B-Modifier
as NCT03864796 214 216 O
: NCT03864796 217 218 O

- NCT03864796 222 223 O
Patients NCT03864796 225 233 O
with NCT03864796 234 238 O
diabetes NCT03864796 239 247 B-Condition

- NCT03864796 250 251 O
HCV NCT03864796 253 256 B-Condition

- NCT03864796 259 260 O
other NCT03864796 262 267 B-Other
autoimmune NCT03864796 268 278 B-Condition
disease NCT03864796 279 286 I-Condition
( NCT03864796 287 288 O
as NCT03864796 289 291 O
SLE NCT03864796 292 295 B-Condition
or NCT03864796 296 298 B-Or
RA NCT03864796 299 301 B-Condition
) NCT03864796 302 303 O

- NCT03864796 307 308 O
Chronic NCT03864796 310 317 O
Liver NCT03864796 318 323 B-Modifier
or NCT03864796 324 326 B-Or
kidney NCT03864796 327 333 B-Modifier
disease NCT03864796 334 341 B-Condition

Inclusion NCT03866564 0 9 O
Criteria NCT03866564 10 18 O
: NCT03866564 19 20 O

- NCT03866564 24 25 O
Age NCT03866564 27 30 B-Age
24 NCT03866564 31 33 B-Eq_Comparison
- NCT03866564 34 35 I-Eq_Comparison
55 NCT03866564 36 38 I-Eq_Comparison

- NCT03866564 42 43 O
Former NCT03866564 45 51 B-Eq_Comparison
professional NCT03866564 52 64 B-Observation
football NCT03866564 65 73 I-Observation
play NCT03866564 74 78 I-Observation
from NCT03866564 79 83 O
1960 NCT03866564 84 88 B-Eq_Comparison
to NCT03866564 89 91 I-Eq_Comparison
present NCT03866564 92 99 I-Eq_Comparison
. NCT03866564 100 101 O

- NCT03866564 105 106 O
Prior NCT03866564 108 113 B-Eq_Comparison
completed NCT03866564 114 123 O
the NCT03866564 124 127 O
first NCT03866564 128 133 B-Eq_Comparison
Health NCT03866564 134 140 B-Observation
and NCT03866564 141 144 I-Observation
Wellness NCT03866564 145 153 I-Observation
Questionnaire NCT03866564 154 167 I-Observation
( NCT03866564 168 169 O
Q NCT03866564 170 171 B-Observation
1 NCT03866564 172 173 I-Observation
) NCT03866564 174 175 O

- NCT03866564 179 180 O
" NCT03866564 182 183 O
Healthy NCT03866564 183 190 O
" NCT03866564 190 191 O
subjects NCT03866564 192 200 O
: NCT03866564 201 202 O
ability NCT03866564 203 210 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03866564 211 213 I-Assertion___Assertion_Type_Value:hypothetical
give NCT03866564 214 218 O
informed NCT03866564 219 227 O
consent NCT03866564 228 235 O
, NCT03866564 236 237 O
comply NCT03866564 238 244 O
with NCT03866564 245 249 O
study NCT03866564 250 255 O
procedures NCT03866564 256 266 O
, NCT03866564 267 268 O
and NCT03866564 269 272 O
have NCT03866564 273 277 O
a NCT03866564 278 279 O
Telephone NCT03866564 280 289 B-Observation
- NCT03866564 290 291 I-Observation
Montreal NCT03866564 292 300 I-Observation
Cognitive NCT03866564 301 310 I-Observation
Assessment NCT03866564 311 321 I-Observation
( NCT03866564 322 323 O
T NCT03866564 324 325 B-Observation
- NCT03866564 326 327 I-Observation
MoCA NCT03866564 328 332 I-Observation
) NCT03866564 333 334 O
score NCT03866564 335 340 O
of NCT03866564 341 343 O
> NCT03866564 344 345 B-Eq_Comparison
20 NCT03866564 346 348 I-Eq_Comparison
. NCT03866564 348 349 O

- NCT03866564 353 354 O
" NCT03866564 356 357 O
Afflicted NCT03866564 357 366 O
" NCT03866564 366 367 O
participants NCT03866564 368 380 O
: NCT03866564 381 382 O
must NCT03866564 383 387 O
meet NCT03866564 388 392 O
criteria NCT03866564 393 401 O
for NCT03866564 402 405 O
at NCT03866564 406 408 B-Eq_Comparison
least NCT03866564 409 414 I-Eq_Comparison
one NCT03866564 415 418 I-Eq_Comparison
of NCT03866564 419 421 O
the NCT03866564 422 425 B-Criteria_Count
following NCT03866564 426 435 I-Criteria_Count
subjective NCT03866564 436 446 B-Condition
afflictions NCT03866564 447 458 I-Condition
based NCT03866564 459 464 O
on NCT03866564 465 467 O
Q NCT03866564 468 469 B-Observation
1 NCT03866564 470 471 I-Observation
responses NCT03866564 472 481 O
: NCT03866564 482 483 O
1 NCT03866564 484 485 O
) NCT03866564 486 487 O
Cardiovascular NCT03866564 488 502 B-Condition
Dysfunction NCT03866564 503 514 I-Condition
, NCT03866564 515 516 O
2 NCT03866564 517 518 O
) NCT03866564 519 520 O
Neurocognitive NCT03866564 521 535 B-Condition
Disease NCT03866564 536 543 I-Condition
, NCT03866564 544 545 O
3 NCT03866564 546 547 O
) NCT03866564 548 549 O
Chronic NCT03866564 550 557 O
Pain NCT03866564 558 562 B-Condition
, NCT03866564 563 564 O
and NCT03866564 565 568 O
/ NCT03866564 569 570 O
or NCT03866564 571 573 O
4 NCT03866564 574 575 O
) NCT03866564 576 577 O
Sleep NCT03866564 578 583 B-Condition
Apnea NCT03866564 584 589 I-Condition

- NCT03866564 592 593 O
" NCT03866564 595 596 O
Afflicted NCT03866564 596 605 O
" NCT03866564 605 606 O
participants NCT03866564 607 619 O
must NCT03866564 620 624 O
be NCT03866564 625 627 O
able NCT03866564 628 632 O
to NCT03866564 633 635 O
give NCT03866564 636 640 O
informed NCT03866564 641 649 O
consent NCT03866564 650 657 O
or NCT03866564 658 660 O
have NCT03866564 661 665 O
a NCT03866564 666 667 O
legal NCT03866564 668 673 O
guardian NCT03866564 674 682 O
present NCT03866564 683 690 O
to NCT03866564 691 693 O
provide NCT03866564 694 701 O
informed NCT03866564 702 710 O
consent NCT03866564 711 718 O
( NCT03866564 719 720 O
if NCT03866564 721 723 O
participants NCT03866564 724 736 O
demonstrate NCT03866564 737 748 O
on NCT03866564 749 751 O
T NCT03866564 752 753 B-Observation
- NCT03866564 754 755 I-Observation
MoCA NCT03866564 756 760 I-Observation
score NCT03866564 761 766 B-Eq_Comparison
< NCT03866564 767 768 I-Eq_Comparison
19 NCT03866564 769 771 I-Eq_Comparison
) NCT03866564 772 773 O
and NCT03866564 774 777 O
to NCT03866564 778 780 O
comply NCT03866564 781 787 O
with NCT03866564 788 792 O
study NCT03866564 793 798 O
procedures NCT03866564 799 809 O
. NCT03866564 810 811 O

Exclusion NCT03866564 813 822 O
Criteria NCT03866564 823 831 O
: NCT03866564 832 833 O

- NCT03866564 837 838 O
Prior NCT03866564 840 845 B-Eq_Comparison
metallic NCT03866564 846 854 B-Procedure
device NCT03866564 855 861 I-Procedure
implants NCT03866564 862 870 I-Procedure
such NCT03866564 871 875 O
as NCT03866564 876 878 O
cardiac NCT03866564 879 886 B-Procedure
pacemakers NCT03866564 887 897 I-Procedure
/ NCT03866564 898 899 B-Or
defibrillators NCT03866564 900 914 B-Procedure
or NCT03866564 915 917 B-Or
perfusion NCT03866564 918 927 B-Procedure
pumps NCT03866564 928 933 I-Procedure
that NCT03866564 934 938 O
can NCT03866564 939 942 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03866564 942 945 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
be NCT03866564 946 948 O
removed NCT03866564 949 956 B-Negation
. NCT03866564 957 958 O

- NCT03866564 962 963 O
Ferromagnetic NCT03866564 965 978 B-Procedure
implants NCT03866564 979 987 I-Procedure
or NCT03866564 988 990 B-Or
objects NCT03866564 991 998 B-Procedure
that NCT03866564 999 1003 O
can NCT03866564 1004 1007 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03866564 1007 1010 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
be NCT03866564 1011 1013 O
removed NCT03866564 1014 1021 B-Negation
such NCT03866564 1022 1026 O
as NCT03866564 1027 1029 O
aneurysm NCT03866564 1030 1038 B-Procedure
clips NCT03866564 1039 1044 I-Procedure
, NCT03866564 1045 1046 O
surgical NCT03866564 1047 1055 B-Procedure
clips NCT03866564 1056 1061 I-Procedure
, NCT03866564 1062 1063 O
prostheses NCT03866564 1064 1074 B-Procedure
, NCT03866564 1075 1076 O
artificial NCT03866564 1077 1087 B-Procedure
hearts NCT03866564 1088 1094 I-Procedure
, NCT03866564 1095 1096 O
valves NCT03866564 1097 1103 B-Procedure
with NCT03866564 1104 1108 O
steel NCT03866564 1109 1114 B-Modifier
parts NCT03866564 1115 1120 I-Modifier
, NCT03866564 1121 1122 O
metal NCT03866564 1123 1128 B-Condition
fragments NCT03866564 1129 1138 I-Condition
, NCT03866564 1139 1140 O
shrapnel NCT03866564 1141 1149 B-Condition
, NCT03866564 1150 1151 O
tattoos NCT03866564 1152 1159 B-Condition
near NCT03866564 1160 1164 B-Modifier
the NCT03866564 1165 1168 I-Modifier
eye NCT03866564 1169 1172 I-Modifier
, NCT03866564 1173 1174 O
or NCT03866564 1175 1177 B-Or
steel NCT03866564 1178 1183 B-Procedure
implants NCT03866564 1184 1192 B-Modifier
or NCT03866564 1193 1195 B-Or
jewelry NCT03866564 1196 1203 B-Modifier

- NCT03866564 1206 1207 O
Body NCT03866564 1209 1213 B-Observation
weight NCT03866564 1214 1220 I-Observation
> NCT03866564 1221 1222 B-Eq_Comparison
450 NCT03866564 1223 1226 I-Eq_Comparison
lbs NCT03866564 1227 1230 I-Eq_Comparison

- NCT03866564 1233 1234 O
Inability NCT03866564 1236 1245 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03866564 1246 1248 O
complete NCT03866564 1249 1257 O
the NCT03866564 1258 1261 O
telephone NCT03866564 1262 1271 B-Procedure
screener NCT03866564 1272 1280 I-Procedure

- NCT03866564 1283 1284 O
Low NCT03866564 1286 1289 O
T NCT03866564 1290 1291 B-Observation
- NCT03866564 1292 1293 I-Observation
MoCA NCT03866564 1294 1298 I-Observation
score NCT03866564 1299 1304 O
( NCT03866564 1305 1306 O
< NCT03866564 1307 1308 B-Eq_Comparison
20 NCT03866564 1309 1311 I-Eq_Comparison
) NCT03866564 1312 1313 O
and NCT03866564 1314 1317 O
absence NCT03866564 1318 1325 O
of NCT03866564 1326 1328 O
an NCT03866564 1329 1331 O
available NCT03866564 1332 1341 O
legal NCT03866564 1342 1347 O
guardian NCT03866564 1348 1356 O
who NCT03866564 1357 1360 O
can NCT03866564 1361 1364 O
accompany NCT03866564 1365 1374 O
the NCT03866564 1375 1378 O
participant NCT03866564 1379 1390 O
through NCT03866564 1391 1398 O
all NCT03866564 1399 1402 O
phases NCT03866564 1403 1409 O
of NCT03866564 1410 1412 O
the NCT03866564 1413 1416 O
study NCT03866564 1417 1422 B-Study
. NCT03866564 1423 1424 O

- NCT03866564 1428 1429 O
Significant NCT03866564 1431 1442 O
behavioral NCT03866564 1443 1453 B-Modifier
or NCT03866564 1454 1456 B-Or
functional NCT03866564 1457 1467 B-Modifier
disability NCT03866564 1468 1478 B-Condition
due NCT03866564 1479 1482 O
to NCT03866564 1483 1485 O
cognitive NCT03866564 1486 1495 B-Condition
impairment NCT03866564 1496 1506 I-Condition

Inclusion NCT03923361 0 9 O
Criteria NCT03923361 10 18 O
: NCT03923361 19 20 O

- NCT03923361 24 25 O
Age NCT03923361 27 30 B-Age
18 NCT03923361 31 33 B-Eq_Comparison
- NCT03923361 34 35 I-Eq_Comparison
55 NCT03923361 36 38 I-Eq_Comparison

- NCT03923361 42 43 O
Diagnosis NCT03923361 45 54 O
of NCT03923361 55 57 O
major NCT03923361 58 63 B-Modifier
depressive NCT03923361 64 74 B-Condition
disorder NCT03923361 75 83 I-Condition
or NCT03923361 84 86 B-Or
bipolar NCT03923361 87 94 B-Condition
disorder NCT03923361 95 103 I-Condition

- NCT03923361 106 107 O
Current NCT03923361 109 116 B-Eq_Comparison
moderate NCT03923361 117 125 O
- NCT03923361 126 127 O
to NCT03923361 128 130 B-Or
- NCT03923361 131 132 O
severe NCT03923361 133 139 O
depressive NCT03923361 140 150 B-Condition
episode NCT03923361 151 158 I-Condition

- NCT03923361 161 162 O
Episode NCT03923361 164 171 O
duration NCT03923361 172 180 O
more NCT03923361 181 185 B-Eq_Comparison
than NCT03923361 186 190 I-Eq_Comparison
2 NCT03923361 191 192 I-Eq_Comparison
months NCT03923361 193 199 I-Eq_Comparison
and NCT03923361 200 203 B-And
less NCT03923361 204 208 B-Eq_Comparison
than NCT03923361 209 213 I-Eq_Comparison
5 NCT03923361 214 215 I-Eq_Comparison
years NCT03923361 216 221 I-Eq_Comparison

- NCT03923361 224 225 O
Failure NCT03923361 227 234 O
of NCT03923361 235 237 O
at NCT03923361 238 240 B-Eq_Comparison
least NCT03923361 241 246 I-Eq_Comparison
2 NCT03923361 247 248 I-Eq_Comparison
adequate NCT03923361 249 257 O
antidepressant NCT03923361 258 272 B-Drug
medication NCT03923361 273 283 I-Drug
trials NCT03923361 284 290 O
within NCT03923361 291 297 B-Eq_Comparison
the NCT03923361 298 301 I-Eq_Comparison
past NCT03923361 302 306 I-Eq_Comparison
2 NCT03923361 307 308 I-Eq_Comparison
years NCT03923361 309 314 I-Eq_Comparison

- NCT03923361 317 318 O
Body NCT03923361 320 324 B-Observation
mass NCT03923361 325 329 I-Observation
index NCT03923361 330 335 I-Observation
< NCT03923361 336 337 B-Eq_Comparison
40 NCT03923361 338 340 I-Eq_Comparison

- NCT03923361 344 345 O
16 NCT03923361 347 349 B-Observation
- NCT03923361 350 351 I-Observation
item NCT03923361 352 356 I-Observation
Quick NCT03923361 357 362 I-Observation
Inventory NCT03923361 363 372 I-Observation
of NCT03923361 373 375 I-Observation
Depressive NCT03923361 376 386 I-Observation
Symptomatology NCT03923361 387 401 I-Observation
, NCT03923361 402 403 O
self NCT03923361 404 408 O
- NCT03923361 409 410 O
rated NCT03923361 411 416 O
> NCT03923361 417 418 B-Eq_Comparison
10 NCT03923361 419 421 I-Eq_Comparison

Exclusion NCT03923361 423 432 O
Criteria NCT03923361 433 441 O
: NCT03923361 442 443 O

- NCT03923361 447 448 O
Contraindication NCT03923361 450 466 B-Contraindication
to NCT03923361 467 469 O
propofol NCT03923361 470 478 B-Drug
or NCT03923361 479 481 B-Or
midazolam NCT03923361 482 491 B-Drug

- NCT03923361 494 495 O
Daily NCT03923361 497 502 B-Eq_Comparison
use NCT03923361 503 506 O
of NCT03923361 507 509 O
benzodiazepine NCT03923361 510 524 B-Drug
, NCT03923361 525 526 O
opioid NCT03923361 527 533 B-Drug
, NCT03923361 534 535 O
ACE NCT03923361 536 539 B-Drug
inhibitor NCT03923361 540 549 I-Drug
, NCT03923361 550 551 O
or NCT03923361 552 554 B-Or
ARB NCT03923361 555 558 B-Drug
medication NCT03923361 559 569 I-Drug

- NCT03923361 572 573 O
Symptomatic NCT03923361 575 586 B-Assertion___Assertion_Type_Value:possible
coronary NCT03923361 587 595 B-Condition
artery NCT03923361 596 602 I-Condition
disease NCT03923361 603 610 I-Condition
or NCT03923361 611 613 B-Or
heart NCT03923361 614 619 B-Condition
failure NCT03923361 620 627 I-Condition

- NCT03923361 630 631 O
Poorly NCT03923361 633 639 B-Modifier
controlled NCT03923361 640 650 I-Modifier
hypertension NCT03923361 651 663 B-Condition
or NCT03923361 664 666 B-Or
diabetes NCT03923361 667 675 B-Condition

- NCT03923361 678 679 O
Abnormal NCT03923361 681 689 O
kidney NCT03923361 690 696 B-Modifier
or NCT03923361 697 699 B-Or
liver NCT03923361 700 705 B-Modifier
function NCT03923361 706 714 B-Condition

- NCT03923361 717 718 O
Pregnant NCT03923361 720 728 B-Condition
or NCT03923361 729 731 B-Or
breast NCT03923361 732 738 B-Condition
feeding NCT03923361 739 746 I-Condition

- NCT03923361 749 750 O
Traumatic NCT03923361 752 761 B-Condition
brain NCT03923361 762 767 I-Condition
injury NCT03923361 768 774 I-Condition
or NCT03923361 775 777 B-Or
significant NCT03923361 778 789 O
neurologic NCT03923361 790 800 B-Condition
signs NCT03923361 801 806 B-Assertion___Assertion_Type_Value:possible
( NCT03923361 807 808 O
past NCT03923361 809 813 B-Eq_Comparison
year NCT03923361 814 818 I-Eq_Comparison
) NCT03923361 819 820 O

- NCT03923361 824 825 O
Substance NCT03923361 827 836 B-Condition
use NCT03923361 837 840 I-Condition
disorder NCT03923361 841 849 I-Condition
( NCT03923361 850 851 O
past NCT03923361 852 856 B-Eq_Comparison
year NCT03923361 857 861 I-Eq_Comparison
) NCT03923361 862 863 O

- NCT03923361 867 868 O
Obsessive NCT03923361 870 879 B-Condition
compulsive NCT03923361 880 890 I-Condition
disorder NCT03923361 891 899 I-Condition
( NCT03923361 900 901 O
current NCT03923361 902 909 B-Eq_Comparison
) NCT03923361 910 911 O

- NCT03923361 915 916 O
Post NCT03923361 918 922 B-Condition
- NCT03923361 923 924 I-Condition
traumatic NCT03923361 925 934 I-Condition
stress NCT03923361 935 941 I-Condition
disorder NCT03923361 942 950 I-Condition
( NCT03923361 951 952 O
current NCT03923361 953 960 B-Eq_Comparison
) NCT03923361 961 962 O

- NCT03923361 966 967 O
Schizophrenia NCT03923361 969 982 B-Condition
- NCT03923361 983 984 I-Condition
spectrum NCT03923361 985 993 I-Condition
disorder NCT03923361 994 1002 I-Condition
( NCT03923361 1003 1004 O
lifetime NCT03923361 1005 1013 O
) NCT03923361 1014 1015 O

- NCT03923361 1019 1020 O
Neurocognitive NCT03923361 1022 1036 B-Condition
disorder NCT03923361 1037 1045 I-Condition
( NCT03923361 1046 1047 O
current NCT03923361 1048 1055 B-Eq_Comparison
) NCT03923361 1056 1057 O

- NCT03923361 1061 1062 O
Personality NCT03923361 1064 1075 B-Condition
disorder NCT03923361 1076 1084 I-Condition
as NCT03923361 1085 1087 O
a NCT03923361 1088 1089 O
current NCT03923361 1090 1097 B-Eq_Comparison
focus NCT03923361 1098 1103 O
of NCT03923361 1104 1106 O
treatment NCT03923361 1107 1116 B-Procedure

- NCT03923361 1119 1120 O
ECT NCT03923361 1122 1125 B-Procedure
within NCT03923361 1126 1132 B-Eq_Comparison
the NCT03923361 1133 1136 I-Eq_Comparison
past NCT03923361 1137 1141 I-Eq_Comparison
3 NCT03923361 1142 1143 I-Eq_Comparison
months NCT03923361 1144 1150 I-Eq_Comparison

- NCT03923361 1153 1154 O
Inappropriate NCT03923361 1156 1169 B-Contraindication
for NCT03923361 1170 1173 O
ECT NCT03923361 1174 1177 B-Procedure
, NCT03923361 1178 1179 O
or NCT03923361 1180 1182 B-Or
poor NCT03923361 1183 1187 O
response NCT03923361 1188 1196 O
to NCT03923361 1197 1199 O
ECT NCT03923361 1200 1203 B-Procedure
within NCT03923361 1204 1210 B-Eq_Comparison
the NCT03923361 1211 1214 I-Eq_Comparison
past NCT03923361 1215 1219 I-Eq_Comparison
5 NCT03923361 1220 1221 I-Eq_Comparison
years NCT03923361 1222 1227 I-Eq_Comparison

- NCT03923361 1230 1231 O
Incompetent NCT03923361 1233 1244 O
to NCT03923361 1245 1247 O
provide NCT03923361 1248 1255 O
consent NCT03923361 1256 1263 O

Inclusion NCT03927417 0 9 O
Criteria NCT03927417 10 18 O
: NCT03927417 19 20 O

• NCT03927417 22 23 O
Couples NCT03927417 24 31 O
with NCT03927417 32 36 O
primary NCT03927417 37 44 B-Modifier
/ NCT03927417 45 46 B-Or
secondary NCT03927417 47 56 B-Modifier
infertility NCT03927417 57 68 B-Condition
who NCT03927417 69 72 B-And
are NCT03927417 73 76 O
planned NCT03927417 77 84 B-Eq_Comparison
to NCT03927417 85 87 I-Eq_Comparison
undergo NCT03927417 88 95 I-Eq_Comparison
IVF NCT03927417 96 99 B-Procedure
/ NCT03927417 100 101 B-Or
ICSI NCT03927417 102 106 B-Procedure

treatment NCT03927417 107 116 O
in NCT03927417 117 119 O
one NCT03927417 120 123 O
of NCT03927417 124 126 O
the NCT03927417 127 130 O
above NCT03927417 131 136 O
mentioned NCT03927417 137 146 O
centers NCT03927417 147 154 O
and NCT03927417 155 158 O
who NCT03927417 159 162 O
agree NCT03927417 163 168 O
to NCT03927417 169 171 O
take NCT03927417 172 176 O
part NCT03927417 177 181 O
in NCT03927417 182 184 O
this NCT03927417 185 189 O
study NCT03927417 190 195 O
. NCT03927417 196 197 O

Exclusion NCT03927417 199 208 O
Criteria NCT03927417 209 217 O
: NCT03927417 218 219 O

- NCT03927417 223 224 O
Couples NCT03927417 226 233 O
planned NCT03927417 234 241 B-Eq_Comparison
for NCT03927417 242 245 O
oocyte NCT03927417 246 252 B-Modifier
and NCT03927417 253 256 B-Or
sperm NCT03927417 257 262 B-Modifier
donation NCT03927417 263 271 B-Observation

- NCT03927417 274 275 O
Couples NCT03927417 277 284 O
in NCT03927417 285 287 O
whom NCT03927417 288 292 O
the NCT03927417 293 296 O
female NCT03927417 297 303 O
partner NCT03927417 304 311 O
has NCT03927417 312 315 O
a NCT03927417 316 317 O
history NCT03927417 318 325 B-Eq_Comparison
of NCT03927417 326 328 O
: NCT03927417 329 330 O

- NCT03927417 334 335 O
Chemotherapy NCT03927417 337 349 B-Procedure
or NCT03927417 350 352 B-Or
radiation NCT03927417 353 362 B-Procedure
which NCT03927417 363 368 O
impacts NCT03927417 369 376 O
the NCT03927417 377 380 O
ovarian NCT03927417 381 388 O
reserve NCT03927417 389 396 O

- NCT03927417 399 400 O
Surgery NCT03927417 402 409 B-Procedure
at NCT03927417 410 412 O
the NCT03927417 413 416 O
ovaries NCT03927417 417 424 B-Modifier
/ NCT03927417 425 426 B-Or
adnex NCT03927417 427 432 B-Modifier
region NCT03927417 433 439 I-Modifier

- NCT03927417 442 443 O
Tubal NCT03927417 445 450 B-Procedure
ligation NCT03927417 451 459 I-Procedure

- NCT03927417 462 463 O
Reversal NCT03927417 465 473 B-Procedure
of NCT03927417 474 476 I-Procedure
tubal NCT03927417 477 482 I-Procedure
ligation NCT03927417 483 491 I-Procedure

- NCT03927417 494 495 O
Endometriosis NCT03927417 497 510 B-Condition

- NCT03927417 513 514 O
Couples NCT03927417 516 523 O
in NCT03927417 524 526 O
whom NCT03927417 527 531 O
the NCT03927417 532 535 O
male NCT03927417 536 540 O
partner NCT03927417 541 548 O
has NCT03927417 549 552 O
a NCT03927417 553 554 O
history NCT03927417 555 562 B-Eq_Comparison
of NCT03927417 563 565 O
: NCT03927417 566 567 O

- NCT03927417 571 572 O
Chemotherapy NCT03927417 574 586 B-Procedure
/ NCT03927417 587 588 B-Or
Radiation NCT03927417 589 598 B-Procedure
which NCT03927417 599 604 O
impacts NCT03927417 605 612 O
the NCT03927417 613 616 O
semen NCT03927417 617 622 B-Condition
result NCT03927417 623 629 O

- NCT03927417 632 633 O
Surgery NCT03927417 635 642 B-Procedure
at NCT03927417 643 645 O
the NCT03927417 646 649 O
testicles NCT03927417 650 659 B-Modifier

- NCT03927417 662 663 O
Vasectomy NCT03927417 665 674 B-Procedure

- NCT03927417 677 678 O
Surgery NCT03927417 680 687 B-Procedure
for NCT03927417 688 691 I-Procedure
reversal NCT03927417 692 700 I-Procedure
of NCT03927417 701 703 I-Procedure
vasectomy NCT03927417 704 713 I-Procedure

Inclusion NCT03929432 0 9 O
Criteria NCT03929432 10 18 O
: NCT03929432 19 20 O

- NCT03929432 24 25 O
Presence NCT03929432 27 35 O
of NCT03929432 36 38 O
post NCT03929432 39 43 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03929432 44 45 O
stroke NCT03929432 46 52 B-Condition
aphasia NCT03929432 53 60 B-Condition

- NCT03929432 63 64 O
Single NCT03929432 66 72 B-Eq_Comparison
left NCT03929432 73 77 B-Modifier
hemisphere NCT03929432 78 88 I-Modifier
stroke NCT03929432 89 95 B-Condition
etiology NCT03929432 96 104 B-Modifier

- NCT03929432 107 108 O
At NCT03929432 110 112 B-Eq_Comparison
least NCT03929432 113 118 I-Eq_Comparison
6 NCT03929432 119 120 I-Eq_Comparison
months NCT03929432 121 127 I-Eq_Comparison
post NCT03929432 128 132 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03929432 133 134 O
stroke NCT03929432 135 141 B-Condition

- NCT03929432 144 145 O
Age NCT03929432 147 150 B-Age
range NCT03929432 151 156 O
between NCT03929432 157 164 B-Eq_Comparison
18 NCT03929432 165 167 I-Eq_Comparison
and NCT03929432 168 171 I-Eq_Comparison
80 NCT03929432 172 174 I-Eq_Comparison
years NCT03929432 175 180 I-Eq_Comparison
old NCT03929432 181 184 O

- NCT03929432 187 188 O
Speak NCT03929432 190 195 O
English NCT03929432 196 203 O
as NCT03929432 204 206 O
a NCT03929432 207 208 O
native NCT03929432 209 215 O
language NCT03929432 216 224 O

- NCT03929432 227 228 O
Adequate NCT03929432 230 238 O
hearing NCT03929432 239 246 B-Condition
and NCT03929432 247 250 B-And
vision NCT03929432 251 257 B-Condition
to NCT03929432 258 260 B-Assertion___Assertion_Type_Value:hypothetical
complete NCT03929432 261 269 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03929432 270 273 O
tasks NCT03929432 274 279 B-Observation

Exclusion NCT03929432 280 289 O
Criteria NCT03929432 290 298 O
: NCT03929432 299 300 O

- NCT03929432 304 305 O
Severe NCT03929432 307 313 O
auditory NCT03929432 314 322 B-Condition
comprehension NCT03929432 323 336 I-Condition
deficits NCT03929432 337 345 I-Condition
( NCT03929432 346 347 O
determined NCT03929432 348 358 O
by NCT03929432 359 361 O
pretest NCT03929432 362 369 B-Procedure
) NCT03929432 370 371 O
( NCT03929432 372 373 O
i NCT03929432 374 375 O
. NCT03929432 376 377 O
e NCT03929432 378 379 O
. NCT03929432 380 381 O
, NCT03929432 382 383 O
global NCT03929432 384 390 B-Condition
aphasia NCT03929432 391 398 I-Condition
, NCT03929432 399 400 O
Wernicke NCT03929432 401 409 B-Condition
's NCT03929432 409 411 I-Condition
aphasia NCT03929432 412 419 I-Condition
, NCT03929432 420 421 O
transcortical NCT03929432 422 435 B-Condition
sensory NCT03929432 436 443 I-Condition
aphasia NCT03929432 444 451 I-Condition
) NCT03929432 452 453 O

- NCT03929432 457 458 O
Inability NCT03929432 460 469 O
to NCT03929432 470 472 O
provide NCT03929432 473 480 O
informed NCT03929432 481 489 O
consent NCT03929432 490 497 O

- NCT03929432 500 501 O
Co NCT03929432 503 505 O
- NCT03929432 506 507 O
occurring NCT03929432 508 517 O
history NCT03929432 518 525 B-Eq_Comparison
of NCT03929432 526 528 O
neurological NCT03929432 529 541 B-Modifier
disease NCT03929432 542 549 B-Condition
/ NCT03929432 550 551 B-Or
disorder NCT03929432 552 560 B-Condition
/ NCT03929432 561 562 B-Or
injury NCT03929432 563 569 B-Condition
( NCT03929432 570 571 O
e NCT03929432 572 573 O
. NCT03929432 574 575 O
g NCT03929432 576 577 O
. NCT03929432 578 579 O
, NCT03929432 580 581 O
traumatic NCT03929432 582 591 B-Condition
brain NCT03929432 592 597 I-Condition
injury NCT03929432 598 604 I-Condition
, NCT03929432 605 606 O
right NCT03929432 607 612 B-Modifier
hemisphere NCT03929432 613 623 I-Modifier
stroke NCT03929432 624 630 B-Condition
, NCT03929432 631 632 O
dementia NCT03929432 633 641 B-Condition
) NCT03929432 642 643 O

- NCT03929432 647 648 O
Co NCT03929432 650 652 O
- NCT03929432 653 654 O
occurring NCT03929432 655 664 O
history NCT03929432 665 672 B-Eq_Comparison
of NCT03929432 673 675 O
a NCT03929432 676 677 O
major NCT03929432 678 683 O
mental NCT03929432 684 690 B-Condition
illness NCT03929432 691 698 I-Condition
( NCT03929432 699 700 O
e NCT03929432 701 702 O
. NCT03929432 703 704 O
g NCT03929432 705 706 O
. NCT03929432 707 708 O
, NCT03929432 709 710 O
schizophrenia NCT03929432 711 724 B-Condition
, NCT03929432 725 726 O
drug NCT03929432 727 731 B-Condition
addiction NCT03929432 732 741 I-Condition
, NCT03929432 742 743 O
bipolar NCT03929432 744 751 B-Condition
) NCT03929432 752 753 O

- NCT03929432 757 758 O
Clinical NCT03929432 760 768 O
conditions NCT03929432 769 779 B-Condition
contraindicated NCT03929432 780 795 B-Contraindication
for NCT03929432 796 799 O
MRI NCT03929432 800 803 B-Procedure
or NCT03929432 804 806 B-Or
tDCS NCT03929432 807 811 B-Procedure
( NCT03929432 812 813 O
e NCT03929432 814 815 O
. NCT03929432 816 817 O
g NCT03929432 818 819 O
. NCT03929432 820 821 O
, NCT03929432 822 823 O
implanted NCT03929432 824 833 B-Procedure
electrical NCT03929432 834 844 I-Procedure
devices NCT03929432 845 852 I-Procedure
, NCT03929432 853 854 O
claustrophobia NCT03929432 855 869 B-Condition
, NCT03929432 870 871 O
seizure NCT03929432 872 879 B-Condition
disorder NCT03929432 880 888 I-Condition
) NCT03929432 889 890 O

- NCT03929432 894 895 O
Positive NCT03929432 897 905 O
pregnancy NCT03929432 906 915 B-Observation
test NCT03929432 916 920 I-Observation
( NCT03929432 921 922 O
for NCT03929432 923 926 O
females NCT03929432 927 934 O
) NCT03929432 935 936 O

Inclusion NCT03868982 0 9 O
Criteria NCT03868982 10 18 O
: NCT03868982 19 20 O

- NCT03868982 24 25 O
Diagnosis NCT03868982 27 36 O
of NCT03868982 37 39 O
ARDS NCT03868982 40 44 B-Condition
by NCT03868982 45 47 O
Berlin NCT03868982 48 54 O
definition NCT03868982 55 65 O

- NCT03868982 68 69 O
P NCT03868982 71 72 B-Observation
/ NCT03868982 73 74 I-Observation
F NCT03868982 75 76 I-Observation
ratio NCT03868982 77 82 I-Observation
between NCT03868982 83 90 B-Eq_Comparison
100 NCT03868982 91 94 I-Eq_Comparison
- NCT03868982 95 96 I-Eq_Comparison
300 NCT03868982 97 100 I-Eq_Comparison

- NCT03868982 104 105 O
Completed NCT03868982 107 116 O
the NCT03868982 117 120 O
case NCT03868982 121 125 O
enrollement NCT03868982 126 137 B-Study
within NCT03868982 138 144 B-Eq_Comparison
48 NCT03868982 145 147 I-Eq_Comparison
hours NCT03868982 148 153 I-Eq_Comparison

Exclusion NCT03868982 154 163 O
Criteria NCT03868982 164 172 O
: NCT03868982 173 174 O

- NCT03868982 178 179 O
Less NCT03868982 181 185 B-Eq_Comparison
than NCT03868982 186 190 I-Eq_Comparison
18 NCT03868982 191 193 I-Eq_Comparison
years NCT03868982 194 199 I-Eq_Comparison
old NCT03868982 200 203 B-Age

- NCT03868982 206 207 O
Pregnancy NCT03868982 209 218 B-Condition

- NCT03868982 221 222 O
Participants NCT03868982 224 236 O
with NCT03868982 237 241 O
tracheostomy NCT03868982 242 254 B-Procedure

- NCT03868982 257 258 O
Unable NCT03868982 260 266 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03868982 267 269 O
insert NCT03868982 270 276 O
the NCT03868982 277 280 O
NG NCT03868982 281 283 B-Procedure
- NCT03868982 284 285 I-Procedure
tube NCT03868982 286 290 I-Procedure

Inclusion NCT03934008 0 9 O
Criteria NCT03934008 10 18 O
( NCT03934008 19 20 O
primary NCT03934008 21 28 O
outcome NCT03934008 29 36 O
) NCT03934008 37 38 O
: NCT03934008 39 40 O

- NCT03934008 44 45 O
Patients NCT03934008 47 55 O
0 NCT03934008 56 57 B-Eq_Comparison
- NCT03934008 58 59 I-Eq_Comparison
6 NCT03934008 60 61 I-Eq_Comparison
years NCT03934008 62 67 I-Eq_Comparison
of NCT03934008 68 70 O
age NCT03934008 71 74 B-Age

- NCT03934008 77 78 O
Seen NCT03934008 80 84 B-Encounter
in NCT03934008 85 87 O
the NCT03934008 88 91 O
Rocking NCT03934008 92 99 O
Horse NCT03934008 100 105 O
Community NCT03934008 106 115 O
Center NCT03934008 116 122 O
by NCT03934008 123 125 O
a NCT03934008 126 127 O
pediatric NCT03934008 128 137 B-Provider
provider NCT03934008 138 146 I-Provider
during NCT03934008 147 153 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03934008 154 157 O
baseline NCT03934008 158 166 B-Study
or NCT03934008 167 169 B-Or
study NCT03934008 170 175 B-Study
period NCT03934008 176 182 O

Inclusion NCT03934008 183 192 O
Criteria NCT03934008 193 201 O
( NCT03934008 202 203 O
secondary NCT03934008 204 213 O
parental NCT03934008 214 222 O
health NCT03934008 223 229 O
belief NCT03934008 230 236 O
outcomes NCT03934008 237 245 O
) NCT03934008 246 247 O
: NCT03934008 248 249 O

- NCT03934008 253 254 O
Parents NCT03934008 256 263 B-Family_Member___Family_Member_Type:parent
/ NCT03934008 264 265 O
caregivers NCT03934008 266 276 O
( NCT03934008 277 278 O
1 NCT03934008 279 280 O
) NCT03934008 281 282 O
≥ NCT03934008 283 284 B-Eq_Comparison
18 NCT03934008 285 287 I-Eq_Comparison
years NCT03934008 288 293 I-Eq_Comparison
old NCT03934008 294 297 B-Age

- NCT03934008 300 301 O
Read NCT03934008 303 307 O
English NCT03934008 308 315 O

- NCT03934008 318 319 O
Have NCT03934008 321 325 O
at NCT03934008 326 328 B-Eq_Comparison
least NCT03934008 329 334 I-Eq_Comparison
one NCT03934008 335 338 I-Eq_Comparison
child NCT03934008 339 344 O
≤ NCT03934008 345 346 B-Eq_Comparison
6 NCT03934008 347 348 I-Eq_Comparison
years NCT03934008 349 354 I-Eq_Comparison
of NCT03934008 355 357 O
age NCT03934008 358 361 B-Age

Inclusion NCT03934008 362 371 O
Criteria NCT03934008 372 380 O
( NCT03934008 381 382 O
secondary NCT03934008 383 392 O
provider NCT03934008 393 401 O
outcomes NCT03934008 402 410 O
) NCT03934008 411 412 O
: NCT03934008 413 414 O
All NCT03934008 415 418 O
providers NCT03934008 419 428 O
who NCT03934008 429 432 O
interact NCT03934008 433 441 O
with NCT03934008 442 446 O
pediatric NCT03934008 447 456 O

patients NCT03934008 457 465 O
in NCT03934008 466 468 O
the NCT03934008 469 472 O
Rocking NCT03934008 473 480 O
Horse NCT03934008 481 486 O
Community NCT03934008 487 496 O
Center NCT03934008 497 503 O
who NCT03934008 504 507 O

- NCT03934008 510 511 O
Complete NCT03934008 513 521 O
the NCT03934008 522 525 O
training NCT03934008 526 534 O
and NCT03934008 535 538 O

- NCT03934008 541 542 O
Implement NCT03934008 544 553 O
the NCT03934008 554 557 O
MOTIVE NCT03934008 558 564 O
tool NCT03934008 565 569 O
in NCT03934008 570 572 O
practice NCT03934008 573 581 O

Inclusion NCT03929874 0 9 O
Criteria NCT03929874 10 18 O
: NCT03929874 19 20 O

- NCT03929874 24 25 O
Patients NCT03929874 27 35 O
under NCT03929874 36 41 B-Eq_Comparison
40 NCT03929874 42 44 I-Eq_Comparison
or NCT03929874 45 47 B-Or
over NCT03929874 48 52 B-Eq_Comparison
60 NCT03929874 53 55 I-Eq_Comparison
years NCT03929874 56 61 I-Eq_Comparison
of NCT03929874 62 64 O
age NCT03929874 65 68 B-Age
who NCT03929874 69 72 B-And
require NCT03929874 73 80 B-Assertion___Assertion_Type_Value:hypothetical
spinal NCT03929874 81 87 B-Procedure
anesthesia NCT03929874 88 98 I-Procedure
for NCT03929874 99 102 O
orthopedic NCT03929874 103 113 B-Procedure
surgery NCT03929874 114 121 I-Procedure
, NCT03929874 122 123 O

- NCT03929874 127 128 O
with NCT03929874 130 134 O
ASA NCT03929874 135 138 B-Observation
physical NCT03929874 139 147 O
status NCT03929874 148 154 O
classification NCT03929874 155 169 O
system NCT03929874 170 176 O
I NCT03929874 177 178 B-Eq_Comparison
, NCT03929874 179 180 I-Eq_Comparison
II NCT03929874 181 183 I-Eq_Comparison
, NCT03929874 184 185 I-Eq_Comparison
III NCT03929874 186 189 I-Eq_Comparison

Exclusion NCT03929874 190 199 O
Criteria NCT03929874 200 208 O
: NCT03929874 209 210 O

- NCT03929874 214 215 O
Patients NCT03929874 217 225 O
with NCT03929874 226 230 O
contraindication NCT03929874 231 247 B-Contraindication
to NCT03929874 248 250 O
spinal NCT03929874 251 257 B-Procedure
anesthesia NCT03929874 258 268 I-Procedure
( NCT03929874 269 270 O
coagulopathy NCT03929874 271 283 B-Condition
, NCT03929874 284 285 O
local NCT03929874 286 291 B-Modifier
infection NCT03929874 292 301 B-Condition
, NCT03929874 302 303 O
allergy NCT03929874 304 311 B-Allergy
to NCT03929874 312 314 O
local NCT03929874 315 320 B-Procedure
anesthetic NCT03929874 321 331 I-Procedure
) NCT03929874 332 333 O

- NCT03929874 337 338 O
Patients NCT03929874 340 348 O
with NCT03929874 349 353 O
communication NCT03929874 354 367 B-Condition
difficulties NCT03929874 368 380 I-Condition

- NCT03929874 383 384 O
Patient NCT03929874 386 393 O
who NCT03929874 394 397 O
can NCT03929874 398 401 O
not NCT03929874 402 405 B-Negation
take NCT03929874 406 410 O
a NCT03929874 411 412 O
sitting NCT03929874 413 420 B-Modifier
or NCT03929874 421 423 B-Or
lateral NCT03929874 424 431 B-Modifier
decubitus NCT03929874 432 441 I-Modifier
position NCT03929874 442 450 B-Condition
( NCT03929874 451 452 O
fracture NCT03929874 453 461 B-Condition
) NCT03929874 462 463 O

- NCT03929874 467 468 O
Patients NCT03929874 470 478 O
with NCT03929874 479 483 O
a NCT03929874 484 485 O
history NCT03929874 486 493 B-Eq_Comparison
of NCT03929874 494 496 O
spinal NCT03929874 497 503 B-Procedure
surgery NCT03929874 504 511 I-Procedure

- NCT03929874 514 515 O
Patient NCT03929874 517 524 O
with NCT03929874 525 529 O
anatomical NCT03929874 530 540 B-Condition
abnormality NCT03929874 541 552 I-Condition
of NCT03929874 553 555 O
the NCT03929874 556 559 O
spine NCT03929874 560 565 B-Modifier

Inclusion NCT03931941 0 9 O
Criteria NCT03931941 10 18 O
: NCT03931941 19 20 O

1 NCT03931941 24 25 O
. NCT03931941 25 26 O
≥ NCT03931941 28 29 B-Eq_Comparison
18 NCT03931941 30 32 I-Eq_Comparison
years NCT03931941 33 38 I-Eq_Comparison
old NCT03931941 39 42 B-Age
. NCT03931941 43 44 O

2 NCT03931941 48 49 O
. NCT03931941 49 50 O
Medical NCT03931941 52 59 O
record NCT03931941 60 66 O
documentation NCT03931941 67 80 O
of NCT03931941 81 83 O
either NCT03931941 84 90 O
: NCT03931941 91 92 O
a NCT03931941 93 94 O
) NCT03931941 95 96 O
recurrent NCT03931941 97 106 B-Modifier
CDI NCT03931941 107 110 B-Condition
per NCT03931941 111 114 O
the NCT03931941 115 118 O
study NCT03931941 119 124 O
definition NCT03931941 125 135 O
, NCT03931941 136 137 O
that NCT03931941 138 142 O
includes NCT03931941 143 151 O
at NCT03931941 152 154 B-Eq_Comparison
least NCT03931941 155 160 I-Eq_Comparison
one NCT03931941 161 164 I-Eq_Comparison
recurrence NCT03931941 165 175 O
after NCT03931941 176 181 B-Temporal_Connection___Temporal_Connection_Type_Value:after
a NCT03931941 182 183 O
primary NCT03931941 184 191 O
episode NCT03931941 192 199 O
and NCT03931941 200 203 B-And
has NCT03931941 204 207 O
completed NCT03931941 208 217 O
at NCT03931941 218 220 B-Eq_Comparison
least NCT03931941 221 226 I-Eq_Comparison
one NCT03931941 227 230 I-Eq_Comparison
round NCT03931941 231 236 O
of NCT03931941 237 239 O
standard NCT03931941 240 248 O
- NCT03931941 249 250 O
of NCT03931941 251 253 O
- NCT03931941 254 255 O
care NCT03931941 256 260 O
oral NCT03931941 261 265 B-Procedure
antibiotic NCT03931941 266 276 I-Procedure
therapy NCT03931941 277 284 I-Procedure
, NCT03931941 285 286 O
b NCT03931941 287 288 O
) NCT03931941 289 290 O
or NCT03931941 291 293 B-Or
has NCT03931941 294 297 O
had NCT03931941 298 301 O
at NCT03931941 302 304 B-Eq_Comparison
least NCT03931941 305 310 I-Eq_Comparison
two NCT03931941 311 314 I-Eq_Comparison
episodes NCT03931941 315 323 O
of NCT03931941 324 326 O
severe NCT03931941 327 333 O
CDI NCT03931941 334 337 B-Condition
resulting NCT03931941 338 347 O
in NCT03931941 348 350 O
hospitalization NCT03931941 351 366 B-Encounter
. NCT03931941 367 368 O

3 NCT03931941 372 373 O
. NCT03931941 373 374 O
A NCT03931941 376 377 O
positive NCT03931941 378 386 O
stool NCT03931941 387 392 B-Observation
test NCT03931941 393 397 I-Observation
for NCT03931941 398 401 O
the NCT03931941 402 405 O
presence NCT03931941 406 414 O
of NCT03931941 415 417 O
toxigenic NCT03931941 418 427 B-Organism
C NCT03931941 428 429 I-Organism
. NCT03931941 430 431 I-Organism
difficile NCT03931941 433 442 I-Organism
or NCT03931941 443 445 B-Or
C NCT03931941 446 447 B-Organism
. NCT03931941 448 449 I-Organism
difficile NCT03931941 451 460 I-Organism
toxin NCT03931941 461 466 I-Organism
within NCT03931941 467 473 B-Eq_Comparison
30 NCT03931941 474 476 I-Eq_Comparison
days NCT03931941 477 481 I-Eq_Comparison
prior NCT03931941 482 487 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03931941 488 490 I-Temporal_Connection___Temporal_Connection_Type_Value:before
or NCT03931941 491 493 O
on NCT03931941 494 496 O
the NCT03931941 497 500 O
date NCT03931941 501 505 O
of NCT03931941 506 508 O
enrollment NCT03931941 509 519 B-Study
. NCT03931941 520 521 O

4 NCT03931941 525 526 O
. NCT03931941 526 527 O
Is NCT03931941 529 531 O
currently NCT03931941 532 541 B-Eq_Comparison
taking NCT03931941 542 548 O
or NCT03931941 549 551 B-Or
was NCT03931941 552 555 O
just NCT03931941 556 560 B-Eq_Comparison
prescribed NCT03931941 561 571 O
antibiotics NCT03931941 572 583 B-Drug
to NCT03931941 584 586 O
control NCT03931941 587 594 O
CDI NCT03931941 595 598 B-Condition
related NCT03931941 599 606 O
diarrhea NCT03931941 607 615 B-Condition
at NCT03931941 616 618 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03931941 619 622 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03931941 623 627 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03931941 628 630 O
enrollment NCT03931941 631 641 B-Study
. NCT03931941 642 643 O

[ NCT03931941 646 647 O
Note NCT03931941 648 652 O
: NCT03931941 653 654 O
Subject NCT03931941 655 662 O
's NCT03931941 662 664 O
CDI NCT03931941 665 668 B-Condition
diarrhea NCT03931941 669 677 B-Condition
must NCT03931941 678 682 O
be NCT03931941 683 685 O
controlled NCT03931941 686 696 O
( NCT03931941 697 698 O
< NCT03931941 699 700 B-Eq_Comparison
3 NCT03931941 701 702 I-Eq_Comparison
unformed NCT03931941 703 711 I-Eq_Comparison
/ NCT03931941 712 713 I-Eq_Comparison
loose NCT03931941 714 719 I-Eq_Comparison
stools NCT03931941 720 726 I-Eq_Comparison
/ NCT03931941 727 728 I-Eq_Comparison
day NCT03931941 729 732 I-Eq_Comparison
) NCT03931941 733 734 O
while NCT03931941 735 740 B-Temporal_Connection___Temporal_Connection_Type_Value:during

taking NCT03931941 741 747 B-Eq_Comparison
antibiotics NCT03931941 748 759 B-Drug
during NCT03931941 760 766 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03931941 767 776 B-Study
. NCT03931941 777 778 O
] NCT03931941 779 780 O

Exclusion NCT03931941 782 791 O
Criteria NCT03931941 792 800 O
: NCT03931941 801 802 O

1 NCT03931941 806 807 O
. NCT03931941 807 808 O
Has NCT03931941 810 813 O
continued NCT03931941 814 823 O
CDI NCT03931941 824 827 B-Condition
diarrhea NCT03931941 828 836 B-Condition
despite NCT03931941 837 844 B-And
being NCT03931941 845 850 O
on NCT03931941 851 853 O
a NCT03931941 854 855 O
course NCT03931941 856 862 O
of NCT03931941 863 865 O
antibiotics NCT03931941 866 877 B-Drug
prescribed NCT03931941 878 888 O
for NCT03931941 889 892 O
CDI NCT03931941 893 896 B-Condition
treatment NCT03931941 897 906 O
. NCT03931941 907 908 O

2 NCT03931941 912 913 O
. NCT03931941 913 914 O
Requires NCT03931941 916 924 B-Assertion___Assertion_Type_Value:hypothetical
systemic NCT03931941 925 933 B-Modifier
antibiotic NCT03931941 934 944 B-Procedure
therapy NCT03931941 945 952 I-Procedure
for NCT03931941 953 956 O
a NCT03931941 957 958 O
condition NCT03931941 959 968 B-Condition
other NCT03931941 969 974 B-Exception
than NCT03931941 975 979 I-Exception
CDI NCT03931941 980 983 B-Condition
. NCT03931941 984 985 O

3 NCT03931941 989 990 O
. NCT03931941 990 991 O
Fecal NCT03931941 993 998 B-Procedure
microbiota NCT03931941 999 1009 I-Procedure
transplant NCT03931941 1010 1020 I-Procedure
( NCT03931941 1021 1022 O
FMT NCT03931941 1023 1026 B-Procedure
) NCT03931941 1027 1028 O
within NCT03931941 1029 1035 B-Eq_Comparison
the NCT03931941 1036 1039 I-Eq_Comparison
past NCT03931941 1040 1044 I-Eq_Comparison
6 NCT03931941 1045 1046 I-Eq_Comparison
months NCT03931941 1047 1053 I-Eq_Comparison
. NCT03931941 1054 1055 O

4 NCT03931941 1059 1060 O
. NCT03931941 1060 1061 O
FMT NCT03931941 1063 1066 B-Procedure
with NCT03931941 1067 1071 B-And
an NCT03931941 1072 1074 O
associated NCT03931941 1075 1085 O
serious NCT03931941 1086 1093 O
adverse NCT03931941 1094 1101 B-Observation
event NCT03931941 1102 1107 I-Observation
related NCT03931941 1108 1115 O
to NCT03931941 1116 1118 O
the NCT03931941 1119 1122 O
FMT NCT03931941 1123 1126 B-Procedure
product NCT03931941 1127 1134 O
or NCT03931941 1135 1137 B-Or
procedure NCT03931941 1138 1147 B-Procedure
. NCT03931941 1148 1149 O

5 NCT03931941 1153 1154 O
. NCT03931941 1154 1155 O
Bezlotoxumab NCT03931941 1157 1169 B-Drug
( NCT03931941 1170 1171 O
CDI NCT03931941 1172 1175 B-Condition
monoclonal NCT03931941 1176 1186 B-Drug
antibodies NCT03931941 1187 1197 I-Drug
) NCT03931941 1198 1199 O
if NCT03931941 1200 1202 O
received NCT03931941 1203 1211 B-Eq_Comparison
within NCT03931941 1212 1218 B-Eq_Comparison
the NCT03931941 1219 1222 I-Eq_Comparison
last NCT03931941 1223 1227 I-Eq_Comparison
year NCT03931941 1228 1232 I-Eq_Comparison
. NCT03931941 1233 1234 O

6 NCT03931941 1238 1239 O
. NCT03931941 1239 1240 O
CD NCT03931941 1242 1244 B-Observation
4 NCT03931941 1245 1246 I-Observation
count NCT03931941 1247 1252 I-Observation
< NCT03931941 1253 1254 B-Eq_Comparison
200 NCT03931941 1255 1258 I-Eq_Comparison
/ NCT03931941 1259 1260 I-Eq_Comparison
mm NCT03931941 1261 1263 I-Eq_Comparison
3 NCT03931941 1264 1265 I-Eq_Comparison
during NCT03931941 1266 1272 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03931941 1273 1282 B-Study
. NCT03931941 1283 1284 O

7 NCT03931941 1288 1289 O
. NCT03931941 1289 1290 O
An NCT03931941 1292 1294 O
absolute NCT03931941 1295 1303 B-Observation
neutrophil NCT03931941 1304 1314 I-Observation
count NCT03931941 1315 1320 I-Observation
of NCT03931941 1321 1323 O
< NCT03931941 1324 1325 B-Eq_Comparison
1000 NCT03931941 1326 1330 I-Eq_Comparison
cells NCT03931941 1331 1336 I-Eq_Comparison
/ NCT03931941 1337 1338 I-Eq_Comparison
µL NCT03931941 1339 1341 I-Eq_Comparison
during NCT03931941 1342 1348 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03931941 1349 1358 B-Study
. NCT03931941 1359 1360 O

8 NCT03931941 1364 1365 O
. NCT03931941 1365 1366 O
Pregnant NCT03931941 1368 1376 B-Condition
, NCT03931941 1377 1378 O
breastfeeding NCT03931941 1379 1392 B-Condition
, NCT03931941 1393 1394 O
or NCT03931941 1395 1397 B-Or
intends NCT03931941 1398 1405 B-Assertion___Assertion_Type_Value:intention
to NCT03931941 1406 1408 I-Assertion___Assertion_Type_Value:intention
become NCT03931941 1409 1415 O
pregnant NCT03931941 1416 1424 B-Condition
during NCT03931941 1425 1431 B-Temporal_Connection___Temporal_Connection_Type_Value:during
study NCT03931941 1432 1437 B-Study
participation NCT03931941 1438 1451 O
. NCT03931941 1452 1453 O

Inclusion NCT03869424 0 9 O
Criteria NCT03869424 10 18 O
: NCT03869424 19 20 O

- NCT03869424 24 25 O
healthy NCT03869424 27 34 B-Condition
volunteers NCT03869424 35 45 O

- NCT03869424 48 49 O
fluent NCT03869424 51 57 O
in NCT03869424 58 60 O
German NCT03869424 61 67 O
language NCT03869424 68 76 O

Exclusion NCT03869424 77 86 O
Criteria NCT03869424 87 95 O
: NCT03869424 96 97 O

- NCT03869424 101 102 O
mental NCT03869424 104 110 B-Condition
disorders NCT03869424 111 120 I-Condition

- NCT03869424 123 124 O
allergic NCT03869424 126 134 B-Allergy
to NCT03869424 135 137 O
capsaicin NCT03869424 138 147 B-Drug

- NCT03869424 150 151 O
allergic NCT03869424 153 161 B-Allergy
to NCT03869424 162 164 O
sesame NCT03869424 165 171 B-Drug
oil NCT03869424 172 175 I-Drug

- NCT03869424 178 179 O
intake NCT03869424 181 187 O
of NCT03869424 188 190 O
psychopharmacological NCT03869424 191 212 B-Drug
drugs NCT03869424 213 218 I-Drug
in NCT03869424 219 221 O
the NCT03869424 222 225 O
last NCT03869424 226 230 B-Eq_Comparison
four NCT03869424 231 235 I-Eq_Comparison
weeks NCT03869424 236 241 I-Eq_Comparison

- NCT03869424 244 245 O
intake NCT03869424 247 253 O
of NCT03869424 254 256 O
illegal NCT03869424 257 264 B-Modifier
drugs NCT03869424 265 270 B-Drug
in NCT03869424 271 273 O
the NCT03869424 274 277 O
last NCT03869424 278 282 B-Eq_Comparison
two NCT03869424 283 286 I-Eq_Comparison
weeks NCT03869424 287 292 I-Eq_Comparison

- NCT03869424 295 296 O
consumption NCT03869424 298 309 O
of NCT03869424 310 312 O
alcohol NCT03869424 313 320 B-Drug
in NCT03869424 321 323 O
the NCT03869424 324 327 O
last NCT03869424 328 332 B-Eq_Comparison
twelve NCT03869424 333 339 I-Eq_Comparison
hours NCT03869424 340 345 I-Eq_Comparison

- NCT03869424 348 349 O
students NCT03869424 351 359 O
in NCT03869424 360 362 O
medicine NCT03869424 363 371 O
, NCT03869424 372 373 O
pharmacy NCT03869424 374 382 O
, NCT03869424 383 384 O
or NCT03869424 385 387 O
psychology NCT03869424 388 398 O

- NCT03869424 401 402 O
completed NCT03869424 404 413 O
studies NCT03869424 414 421 O
in NCT03869424 422 424 O
medicine NCT03869424 425 433 O
, NCT03869424 434 435 O
pharmacy NCT03869424 436 444 O
or NCT03869424 445 447 O
psychology NCT03869424 448 458 O

- NCT03869424 461 462 O
current NCT03869424 464 471 B-Eq_Comparison
pregnancy NCT03869424 472 481 B-Condition
or NCT03869424 482 484 B-Or
lactation NCT03869424 485 494 B-Condition

- NCT03869424 497 498 O
cardio NCT03869424 500 506 B-Condition
vascular NCT03869424 507 515 I-Condition
disease NCT03869424 516 523 I-Condition

- NCT03869424 526 527 O
kidney NCT03869424 529 535 B-Condition
disease NCT03869424 536 543 I-Condition

- NCT03869424 546 547 O
liver NCT03869424 549 554 B-Condition
disease NCT03869424 555 562 I-Condition

Inclusion NCT03864055 0 9 O
Criteria NCT03864055 10 18 O
: NCT03864055 19 20 O

- NCT03864055 24 25 O
age NCT03864055 27 30 B-Age
of NCT03864055 31 33 O
18 NCT03864055 34 36 B-Eq_Comparison
years NCT03864055 37 42 I-Eq_Comparison
or NCT03864055 43 45 I-Eq_Comparison
younger NCT03864055 46 53 I-Eq_Comparison

- NCT03864055 56 57 O
both NCT03864055 59 63 O
sexes NCT03864055 64 69 O
are NCT03864055 70 73 O
included NCT03864055 74 82 O

- NCT03864055 85 86 O
a NCT03864055 88 89 O
clinical NCT03864055 90 98 B-Modifier
or NCT03864055 99 101 B-Or
radiological NCT03864055 102 114 B-Procedure
finding NCT03864055 115 122 O
of NCT03864055 123 125 O
mastoiditis NCT03864055 126 137 B-Condition
in NCT03864055 138 140 O
the NCT03864055 141 144 O
patient NCT03864055 145 152 O
's NCT03864055 152 154 O
file NCT03864055 155 159 O

- NCT03864055 162 163 O
Documentation NCT03864055 165 178 O
of NCT03864055 179 181 O
CSVT NCT03864055 182 186 B-Condition
in NCT03864055 187 189 O
an NCT03864055 190 192 O
imaging NCT03864055 193 200 B-Procedure
study NCT03864055 201 206 I-Procedure
, NCT03864055 207 208 O
either NCT03864055 209 215 O
CT NCT03864055 216 218 B-Procedure
or NCT03864055 219 221 B-Or
MRI NCT03864055 222 225 B-Procedure
. NCT03864055 226 227 O

Patient NCT03864055 229 236 O
's NCT03864055 236 238 O
exclusion NCT03864055 239 248 O
criteria NCT03864055 249 257 O

- NCT03864055 260 261 O
age NCT03864055 263 266 B-Age
above NCT03864055 267 272 B-Eq_Comparison
18 NCT03864055 273 275 I-Eq_Comparison
years NCT03864055 276 281 I-Eq_Comparison

- NCT03864055 284 285 O
lack NCT03864055 287 291 B-Negation
of NCT03864055 292 294 I-Negation
a NCT03864055 295 296 O
clinical NCT03864055 297 305 B-Modifier
or NCT03864055 306 308 B-Or
radiological NCT03864055 309 321 B-Procedure
finding NCT03864055 322 329 O
of NCT03864055 330 332 O
mastoiditis NCT03864055 333 344 B-Condition
in NCT03864055 345 347 O
the NCT03864055 348 351 O
patient NCT03864055 352 359 O
's NCT03864055 359 361 O
file NCT03864055 362 366 O

- NCT03864055 369 370 O
Lack NCT03864055 372 376 B-Negation
of NCT03864055 377 379 O
documentation NCT03864055 380 393 O
of NCT03864055 394 396 O
CSVT NCT03864055 397 401 B-Condition
in NCT03864055 402 404 O
an NCT03864055 405 407 O
imaging NCT03864055 408 415 B-Procedure
study NCT03864055 416 421 I-Procedure
, NCT03864055 422 423 O
either NCT03864055 424 430 O
CT NCT03864055 431 433 B-Procedure
or NCT03864055 434 436 B-Or
MRI NCT03864055 437 440 B-Procedure
. NCT03864055 441 442 O

- NCT03864055 446 447 O
previous NCT03864055 449 457 B-Eq_Comparison
unprovoked NCT03864055 458 468 B-Modifier
venous NCT03864055 469 475 B-Condition
thromboembolism NCT03864055 476 491 I-Condition
event NCT03864055 492 497 O
. NCT03864055 498 499 O

Inclusion NCT03866941 0 9 O
Criteria NCT03866941 10 18 O
: NCT03866941 19 20 O

1 NCT03866941 24 25 O
. NCT03866941 25 26 O
All NCT03866941 28 31 O
the NCT03866941 32 35 O
cases NCT03866941 36 41 O
with NCT03866941 42 46 O
the NCT03866941 47 50 O
primary NCT03866941 51 58 O
diagnosis NCT03866941 59 68 O
of NCT03866941 69 71 O
acute NCT03866941 72 77 O
or NCT03866941 78 80 B-Or
chronic NCT03866941 81 88 O
synthetic NCT03866941 89 98 B-Condition
cannabinoids NCT03866941 99 111 I-Condition
toxicity NCT03866941 112 120 I-Condition
will NCT03866941 121 125 O
be NCT03866941 126 128 O
included NCT03866941 129 137 O
in NCT03866941 138 140 O
the NCT03866941 141 144 O
study NCT03866941 145 150 B-Study
. NCT03866941 151 152 O

2 NCT03866941 156 157 O
. NCT03866941 157 158 O
Willing NCT03866941 160 167 O
and NCT03866941 168 171 O
able NCT03866941 172 176 O
to NCT03866941 177 179 O
comply NCT03866941 180 186 O
with NCT03866941 187 191 O
the NCT03866941 192 195 O
study NCT03866941 196 201 O
procedures NCT03866941 202 212 O
and NCT03866941 213 216 O
provide NCT03866941 217 224 O
written NCT03866941 225 232 O
informed NCT03866941 233 241 O
consent NCT03866941 242 249 O
to NCT03866941 250 252 O
participate NCT03866941 253 264 O
in NCT03866941 265 267 O
the NCT03866941 268 271 O
study NCT03866941 272 277 B-Study
. NCT03866941 278 279 O

Exclusion NCT03866941 281 290 O
Criteria NCT03866941 291 299 O
: NCT03866941 300 301 O

- NCT03866941 305 306 O
1 NCT03866941 308 309 O
- NCT03866941 310 311 O
Patients NCT03866941 312 320 O
with NCT03866941 321 325 O
a NCT03866941 326 327 O
history NCT03866941 328 335 B-Eq_Comparison
of NCT03866941 336 338 O
any NCT03866941 339 342 O
chronic NCT03866941 343 350 O
disease NCT03866941 351 358 B-Condition
( NCT03866941 359 360 O
renal NCT03866941 361 366 B-Modifier
and NCT03866941 367 370 B-Or
hepatic NCT03866941 371 378 B-Modifier
) NCT03866941 379 380 O
. NCT03866941 381 382 O
2 NCT03866941 384 385 O
- NCT03866941 386 387 O
Patients NCT03866941 388 396 O
refuse NCT03866941 397 403 O
to NCT03866941 404 406 O
participate NCT03866941 407 418 O
in NCT03866941 419 421 O
the NCT03866941 422 425 O
study NCT03866941 426 431 O
. NCT03866941 432 433 O
3 NCT03866941 435 436 O
- NCT03866941 437 438 O
Abuse NCT03866941 439 444 B-Condition
to NCT03866941 445 447 O
other NCT03866941 448 453 B-Other
drugs NCT03866941 454 459 B-Drug
. NCT03866941 460 461 O

Inclusion NCT03921125 0 9 O
Criteria NCT03921125 10 18 O
: NCT03921125 19 20 O

- NCT03921125 24 25 O
Sample NCT03921125 27 33 O
of NCT03921125 34 36 O
40 NCT03921125 37 39 O
healthy NCT03921125 40 47 O
ASA NCT03921125 48 51 B-Observation
I NCT03921125 52 53 B-Eq_Comparison
or NCT03921125 54 56 I-Eq_Comparison
II NCT03921125 57 59 I-Eq_Comparison
donors NCT03921125 60 66 O
' NCT03921125 66 67 O
candidate NCT03921125 68 77 O
for NCT03921125 78 81 O
right NCT03921125 82 87 B-Modifier
lobe NCT03921125 88 92 I-Modifier
hepatectomy NCT03921125 93 104 B-Procedure
for NCT03921125 105 108 O
living NCT03921125 109 115 B-Modifier
donor NCT03921125 116 121 I-Modifier
liver NCT03921125 122 127 B-Procedure
transplantation NCT03921125 128 143 I-Procedure

Exclusion NCT03921125 144 153 O
Criteria NCT03921125 154 162 O
: NCT03921125 163 164 O

- NCT03921125 168 169 O
Lack NCT03921125 171 175 O
of NCT03921125 176 178 O
consent NCT03921125 179 186 O

Inclusion NCT03869554 0 9 O
Criteria NCT03869554 10 18 O
: NCT03869554 19 20 O

- NCT03869554 24 25 O
Adult NCT03869554 27 32 O
patient NCT03869554 33 40 O
( NCT03869554 41 42 O
> NCT03869554 43 44 B-Eq_Comparison
18 NCT03869554 45 47 I-Eq_Comparison
years NCT03869554 48 53 I-Eq_Comparison
old NCT03869554 54 57 B-Age
) NCT03869554 58 59 O

- NCT03869554 63 64 O
Obtaining NCT03869554 66 75 O
consent NCT03869554 76 83 O
to NCT03869554 84 86 O
participate NCT03869554 87 98 O
in NCT03869554 99 101 O
the NCT03869554 102 105 O
study NCT03869554 106 111 O

- NCT03869554 114 115 O
Patients NCT03869554 117 125 O
whose NCT03869554 126 131 O
clinical NCT03869554 132 140 O
presentation NCT03869554 141 153 O
meets NCT03869554 154 159 O
at NCT03869554 160 162 B-Eq_Comparison
least NCT03869554 163 168 I-Eq_Comparison
one NCT03869554 169 172 I-Eq_Comparison
of NCT03869554 173 175 O
the NCT03869554 176 179 B-Criteria_Count
following NCT03869554 180 189 I-Criteria_Count
criteria NCT03869554 190 198 I-Criteria_Count
: NCT03869554 199 200 O

- NCT03869554 209 210 O
Undetermined NCT03869554 212 224 B-Modifier
nephropathy NCT03869554 225 236 B-Condition
despite NCT03869554 237 244 B-And
renal NCT03869554 245 250 B-Procedure
biopsy NCT03869554 251 257 I-Procedure
, NCT03869554 258 259 O

- NCT03869554 268 269 O
Nephroangiosclerosis NCT03869554 271 291 B-Condition
as NCT03869554 292 294 O
the NCT03869554 295 298 O
predominant NCT03869554 299 310 B-Modifier
lesion NCT03869554 311 317 B-Condition

- NCT03869554 325 326 O
Chronic NCT03869554 328 335 O
tubulointerstitial NCT03869554 336 354 B-Modifier
nephropathy NCT03869554 355 366 B-Condition
, NCT03869554 367 368 O

- NCT03869554 377 378 O
Glomerulosclerosis NCT03869554 380 398 B-Condition
, NCT03869554 399 400 O

- NCT03869554 409 410 O
Segmental NCT03869554 412 421 B-Modifier
and NCT03869554 422 425 B-Or
focal NCT03869554 426 431 B-Modifier
hyalinosis NCT03869554 432 442 B-Condition
. NCT03869554 443 444 O

- NCT03869554 453 454 O
Optically NCT03869554 456 465 O
normal NCT03869554 466 472 O
kidney NCT03869554 473 479 B-Modifier
or NCT03869554 480 482 B-Or
seat NCT03869554 483 487 B-Modifier
of NCT03869554 488 490 I-Modifier
minimal NCT03869554 491 498 I-Modifier
lesions NCT03869554 499 506 B-Condition

Exclusion NCT03869554 507 516 O
Criteria NCT03869554 517 525 O
: NCT03869554 526 527 O

- NCT03869554 531 532 O
Patient NCT03869554 534 541 O
who NCT03869554 542 545 O
has NCT03869554 546 549 O
already NCT03869554 550 557 B-Eq_Comparison
been NCT03869554 558 562 O
screened NCT03869554 563 571 B-Procedure
for NCT03869554 572 575 O
Fabry NCT03869554 576 581 B-Condition
Disease NCT03869554 582 589 I-Condition

- NCT03869554 592 593 O
At NCT03869554 595 597 B-Eq_Comparison
least NCT03869554 598 603 I-Eq_Comparison
one NCT03869554 604 607 I-Eq_Comparison
of NCT03869554 608 610 O
the NCT03869554 611 614 B-Criteria_Count
following NCT03869554 615 624 I-Criteria_Count
criteria NCT03869554 625 633 I-Criteria_Count
: NCT03869554 634 635 O

- NCT03869554 644 645 O
Nephrotic NCT03869554 647 656 B-Condition
syndrome NCT03869554 657 665 I-Condition
and NCT03869554 666 669 B-Or
/ NCT03869554 670 671 I-Or
or NCT03869554 672 674 I-Or
Glomerular NCT03869554 675 685 B-Modifier
nephropathy NCT03869554 686 697 B-Condition

- NCT03869554 705 706 O
Histological NCT03869554 708 720 B-Procedure
diagnosis NCT03869554 721 730 O
of NCT03869554 731 733 O
certain NCT03869554 734 741 O
nephropathies NCT03869554 742 755 B-Condition
( NCT03869554 756 757 O
specific NCT03869554 758 766 O
kidney NCT03869554 767 773 B-Modifier
lesions NCT03869554 774 781 B-Condition
) NCT03869554 782 783 O

Inclusion NCT03860597 0 9 O
Criteria NCT03860597 10 18 O
: NCT03860597 19 20 O

- NCT03860597 24 25 O
diagnosis NCT03860597 27 36 O
of NCT03860597 37 39 O
schizophrenia NCT03860597 40 53 B-Condition
OR NCT03860597 54 56 B-Or
schizoaffective NCT03860597 57 72 B-Condition
- NCT03860597 73 74 I-Condition
depressed NCT03860597 75 84 I-Condition
OR NCT03860597 85 87 B-Or
healthy NCT03860597 88 95 B-Condition
subjects NCT03860597 96 104 O

- NCT03860597 107 108 O
ages NCT03860597 110 114 B-Age
18 NCT03860597 115 117 B-Eq_Comparison
- NCT03860597 118 119 I-Eq_Comparison
50 NCT03860597 120 122 I-Eq_Comparison
for NCT03860597 123 126 O
all NCT03860597 127 130 O
subjects NCT03860597 131 139 O

- NCT03860597 142 143 O
double NCT03860597 145 151 B-Modifier
barrier NCT03860597 152 159 I-Modifier
contraception NCT03860597 160 173 B-Procedure
for NCT03860597 174 177 O
all NCT03860597 178 181 O
subjects NCT03860597 182 190 O

- NCT03860597 193 194 O
not NCT03860597 196 199 B-Negation
pregnant NCT03860597 200 208 B-Condition
for NCT03860597 209 212 O
all NCT03860597 213 216 O
subjects NCT03860597 217 225 O

Exclusion NCT03860597 226 235 O
Criteria NCT03860597 236 244 O
: NCT03860597 245 246 O

- NCT03860597 250 251 O
DSM NCT03860597 253 256 B-Condition
- NCT03860597 257 258 I-Condition
IV NCT03860597 259 261 I-Condition
Axis NCT03860597 262 266 I-Condition
I NCT03860597 267 268 B-Eq_Comparison
or NCT03860597 269 271 I-Eq_Comparison
II NCT03860597 272 274 I-Eq_Comparison
Diagnosis NCT03860597 275 284 O
for NCT03860597 285 288 O
for NCT03860597 289 292 O
healthy NCT03860597 293 300 B-Condition
subjects NCT03860597 301 309 O

- NCT03860597 312 313 O
MEM NCT03860597 315 318 B-Condition
or NCT03860597 319 321 B-Or
amantadine NCT03860597 322 332 B-Drug
for NCT03860597 333 336 O
patients NCT03860597 337 345 O

- NCT03860597 348 349 O
current NCT03860597 351 358 B-Eq_Comparison
substance NCT03860597 359 368 B-Condition
abuse NCT03860597 369 374 I-Condition
for NCT03860597 375 378 O
all NCT03860597 379 382 O
subjects NCT03860597 383 391 O

- NCT03860597 394 395 O
current NCT03860597 397 404 B-Eq_Comparison
recreational NCT03860597 405 417 B-Condition
drug NCT03860597 418 422 I-Condition
use NCT03860597 423 426 I-Condition
for NCT03860597 427 430 O
all NCT03860597 431 434 O
subjects NCT03860597 435 443 O

- NCT03860597 446 447 O
history NCT03860597 449 456 B-Eq_Comparison
of NCT03860597 457 459 O
other NCT03860597 460 465 B-Other
significant NCT03860597 466 477 O
medical NCT03860597 478 485 B-Condition
illness NCT03860597 486 493 I-Condition
( NCT03860597 494 495 O
e NCT03860597 496 497 O
. NCT03860597 498 499 O
g NCT03860597 500 501 O
. NCT03860597 502 503 O
cancer NCT03860597 505 511 B-Condition
, NCT03860597 512 513 O
diabetes NCT03860597 514 522 B-Condition
, NCT03860597 523 524 O
heart NCT03860597 525 530 B-Condition
disease NCT03860597 531 538 I-Condition
, NCT03860597 539 540 O
HIV NCT03860597 541 544 B-Condition
, NCT03860597 545 546 O
seizures NCT03860597 547 555 B-Condition
) NCT03860597 556 557 O
for NCT03860597 558 561 O
all NCT03860597 562 565 O
subjects NCT03860597 566 574 O

- NCT03860597 577 578 O
open NCT03860597 580 584 B-Modifier
head NCT03860597 585 589 I-Modifier
injury NCT03860597 590 596 B-Condition
or NCT03860597 597 599 B-Or
closed NCT03860597 600 606 B-Modifier
head NCT03860597 607 611 I-Modifier
injury NCT03860597 612 618 B-Condition
with NCT03860597 619 623 B-And
loss NCT03860597 624 628 B-Condition
of NCT03860597 629 631 I-Condition
consciousness NCT03860597 632 645 I-Condition
> NCT03860597 646 647 B-Eq_Comparison
1 NCT03860597 648 649 I-Eq_Comparison
min NCT03860597 650 653 I-Eq_Comparison
for NCT03860597 654 657 O
all NCT03860597 658 661 O
subjects NCT03860597 662 670 O

- NCT03860597 673 674 O
hearing NCT03860597 676 683 B-Modifier
or NCT03860597 684 686 B-Or
visual NCT03860597 687 693 B-Modifier
impairment NCT03860597 694 704 B-Condition
for NCT03860597 705 708 O
all NCT03860597 709 712 O
subjects NCT03860597 713 721 O

- NCT03860597 724 725 O
pregnancy NCT03860597 727 736 B-Condition
for NCT03860597 737 740 O
all NCT03860597 741 744 O
subjects NCT03860597 745 753 O

- NCT03860597 756 757 O
dementia NCT03860597 759 767 B-Condition
for NCT03860597 768 771 O
all NCT03860597 772 775 O
subjects NCT03860597 776 784 O

- NCT03860597 787 788 O
mental NCT03860597 790 796 B-Condition
retardation NCT03860597 797 808 I-Condition
for NCT03860597 809 812 O
all NCT03860597 813 816 O
subjects NCT03860597 817 825 O

Inclusion NCT03927885 0 9 O
Criteria NCT03927885 10 18 O
: NCT03927885 19 20 O

- NCT03927885 24 25 O
Patient NCT03927885 27 34 O
with NCT03927885 35 39 O
a NCT03927885 40 41 O
diagnosis NCT03927885 42 51 O
of NCT03927885 52 54 O
advanced NCT03927885 55 63 O
cancer NCT03927885 64 70 B-Condition
( NCT03927885 71 72 O
metastatic NCT03927885 73 83 B-Modifier
or NCT03927885 84 86 B-Or
recurrent NCT03927885 87 96 B-Modifier
incurable NCT03927885 97 106 I-Modifier
solid NCT03927885 107 112 B-Condition
tumors NCT03927885 113 119 I-Condition
) NCT03927885 120 121 O

- NCT03927885 125 126 O
Presence NCT03927885 128 136 O
of NCT03927885 137 139 O
fatigue NCT03927885 140 147 B-Condition
of NCT03927885 148 150 O
> NCT03927885 151 152 B-Eq_Comparison
= NCT03927885 153 154 I-Eq_Comparison
4 NCT03927885 155 156 I-Eq_Comparison
/ NCT03927885 157 158 I-Eq_Comparison
10 NCT03927885 159 161 I-Eq_Comparison
on NCT03927885 162 164 O
Edmonton NCT03927885 165 173 B-Observation
Symptom NCT03927885 174 181 I-Observation
Assessment NCT03927885 182 192 I-Observation
System NCT03927885 193 199 I-Observation
( NCT03927885 200 201 O
ESAS NCT03927885 202 206 B-Observation
) NCT03927885 207 208 O
Fatigue NCT03927885 209 216 O
item NCT03927885 217 221 O
( NCT03927885 222 223 O
0 NCT03927885 224 225 O
- NCT03927885 226 227 O
10 NCT03927885 228 230 O
severity NCT03927885 231 239 O
scale NCT03927885 240 245 O
) NCT03927885 246 247 O

- NCT03927885 251 252 O
Patient NCT03927885 254 261 O
should NCT03927885 262 268 O
describe NCT03927885 269 277 O
fatigue NCT03927885 278 285 B-Condition
as NCT03927885 286 288 O
being NCT03927885 289 294 O
present NCT03927885 295 302 O
for NCT03927885 303 306 O
a NCT03927885 307 308 O
minimum NCT03927885 309 316 B-Eq_Comparison
of NCT03927885 317 319 I-Eq_Comparison
2 NCT03927885 320 321 I-Eq_Comparison
weeks NCT03927885 322 327 I-Eq_Comparison
prior NCT03927885 328 333 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03927885 334 336 O
screening NCT03927885 337 346 B-Study

- NCT03927885 349 350 O
Uncontrolled NCT03927885 352 364 B-Modifier
pain NCT03927885 365 369 B-Condition
; NCT03927885 369 370 O
patient NCT03927885 371 378 O
is NCT03927885 379 381 O
on NCT03927885 382 384 B-Eq_Comparison
opioids NCT03927885 385 392 B-Drug
for NCT03927885 393 396 O
the NCT03927885 397 400 O
treatment NCT03927885 401 410 B-Procedure
of NCT03927885 411 413 O
cancer NCT03927885 414 420 B-Condition
pain NCT03927885 421 425 B-Condition
, NCT03927885 426 427 O
he NCT03927885 428 430 O
/ NCT03927885 431 432 O
she NCT03927885 433 436 O
must NCT03927885 437 441 O
have NCT03927885 442 446 O
had NCT03927885 447 450 O
no NCT03927885 451 453 B-Negation
major NCT03927885 454 459 O
dose NCT03927885 460 464 O
change NCT03927885 465 471 O
( NCT03927885 472 473 O
> NCT03927885 474 475 B-Eq_Comparison
25 NCT03927885 476 478 I-Eq_Comparison
% NCT03927885 479 480 I-Eq_Comparison
) NCT03927885 481 482 O
for NCT03927885 483 486 O
at NCT03927885 487 489 B-Eq_Comparison
least NCT03927885 490 495 I-Eq_Comparison
48 NCT03927885 496 498 I-Eq_Comparison
hours NCT03927885 499 504 I-Eq_Comparison
prior NCT03927885 505 510 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03927885 511 513 O
study NCT03927885 514 519 B-Study
entry NCT03927885 520 525 O
. NCT03927885 526 527 O
Change NCT03927885 529 535 O
in NCT03927885 536 538 O
opioid NCT03927885 539 545 B-Drug
dose NCT03927885 546 550 O
after NCT03927885 551 556 B-Temporal_Connection___Temporal_Connection_Type_Value:after
study NCT03927885 557 562 B-Study
entry NCT03927885 563 568 O
is NCT03927885 569 571 O
allowed NCT03927885 572 579 B-Assertion___Assertion_Type_Value:hypothetical

- NCT03927885 582 583 O
Patient NCT03927885 585 592 O
must NCT03927885 593 597 O
be NCT03927885 598 600 O
willing NCT03927885 601 608 O
to NCT03927885 609 611 O
engage NCT03927885 612 618 O
in NCT03927885 619 621 O
telephone NCT03927885 622 631 O
follow NCT03927885 632 638 O
up NCT03927885 639 641 O
with NCT03927885 642 646 O
research NCT03927885 647 655 O
staff NCT03927885 656 661 O

- NCT03927885 664 665 O
Patient NCT03927885 667 674 O
must NCT03927885 675 679 O
have NCT03927885 680 684 O
telephone NCT03927885 685 694 O
access NCT03927885 695 701 O
to NCT03927885 702 704 O
be NCT03927885 705 707 O
contacted NCT03927885 708 717 O
by NCT03927885 718 720 O
the NCT03927885 721 724 O
research NCT03927885 725 733 O
staff NCT03927885 734 739 O

- NCT03927885 742 743 O
Hemoglobin NCT03927885 745 755 B-Observation
level NCT03927885 756 761 O
of NCT03927885 762 764 O
> NCT03927885 765 766 B-Eq_Comparison
= NCT03927885 767 768 I-Eq_Comparison
9 NCT03927885 769 770 I-Eq_Comparison
g NCT03927885 771 772 I-Eq_Comparison
/ NCT03927885 773 774 I-Eq_Comparison
dL NCT03927885 775 777 I-Eq_Comparison
. NCT03927885 778 779 O
Patient NCT03927885 781 788 O
may NCT03927885 789 792 B-Assertion___Assertion_Type_Value:hypothetical
receive NCT03927885 793 800 O
packed NCT03927885 801 807 B-Procedure
red NCT03927885 808 811 I-Procedure
blood NCT03927885 812 817 I-Procedure
cell NCT03927885 818 822 I-Procedure
( NCT03927885 823 824 O
PRBC NCT03927885 825 829 B-Procedure
) NCT03927885 830 831 O
transfusion NCT03927885 832 843 B-Modifier
so NCT03927885 844 846 B-Assertion___Assertion_Type_Value:hypothetical
as NCT03927885 847 849 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03927885 850 852 I-Assertion___Assertion_Type_Value:hypothetical
have NCT03927885 853 857 O
hemoglobin NCT03927885 858 868 B-Observation
level NCT03927885 869 874 O
of NCT03927885 875 877 O
> NCT03927885 878 879 B-Eq_Comparison
= NCT03927885 880 881 I-Eq_Comparison
9 NCT03927885 882 883 I-Eq_Comparison
g NCT03927885 884 885 I-Eq_Comparison
/ NCT03927885 886 887 I-Eq_Comparison
dL NCT03927885 888 890 I-Eq_Comparison
so NCT03927885 891 893 O
at NCT03927885 894 896 O
participate NCT03927885 897 908 O
in NCT03927885 909 911 O
the NCT03927885 912 915 O
study NCT03927885 916 921 B-Study

Exclusion NCT03927885 922 931 O
Criteria NCT03927885 932 940 O
: NCT03927885 941 942 O

- NCT03927885 946 947 O
Surgery NCT03927885 949 956 B-Procedure
, NCT03927885 957 958 O
or NCT03927885 959 961 B-Or
pain NCT03927885 962 966 B-Procedure
relieving NCT03927885 967 976 I-Procedure
procedures NCT03927885 977 987 I-Procedure
within NCT03927885 988 994 B-Eq_Comparison
2 NCT03927885 995 996 I-Eq_Comparison
weeks NCT03927885 997 1002 I-Eq_Comparison
of NCT03927885 1003 1005 B-Temporal_Connection___Temporal_Connection_Type_Value:after
entry NCT03927885 1006 1011 O
into NCT03927885 1012 1016 O
the NCT03927885 1017 1020 O
study NCT03927885 1021 1026 B-Study
or NCT03927885 1027 1029 B-Or
during NCT03927885 1030 1036 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03927885 1037 1040 O
study NCT03927885 1041 1046 B-Study
period NCT03927885 1047 1053 O

- NCT03927885 1056 1057 O
Patients NCT03927885 1059 1067 O
with NCT03927885 1068 1072 O
history NCT03927885 1073 1080 B-Eq_Comparison
of NCT03927885 1081 1083 O
substance NCT03927885 1084 1093 B-Condition
abuse NCT03927885 1094 1099 I-Condition
( NCT03927885 1100 1101 O
Cut NCT03927885 1102 1105 B-Observation
down NCT03927885 1106 1110 I-Observation
, NCT03927885 1111 1112 I-Observation
Annoyed NCT03927885 1113 1120 I-Observation
, NCT03927885 1121 1122 I-Observation
Guilty NCT03927885 1123 1129 I-Observation
, NCT03927885 1130 1131 I-Observation
Eye NCT03927885 1132 1135 I-Observation
opener NCT03927885 1136 1142 I-Observation
[ NCT03927885 1143 1144 O
CAGE NCT03927885 1145 1149 B-Observation
] NCT03927885 1150 1151 O
> NCT03927885 1152 1153 B-Eq_Comparison
= NCT03927885 1154 1155 I-Eq_Comparison
2 NCT03927885 1156 1157 I-Eq_Comparison
+ NCT03927885 1158 1159 O
) NCT03927885 1160 1161 O
, NCT03927885 1162 1163 O
cognitively NCT03927885 1164 1175 B-Condition
impaired NCT03927885 1176 1184 I-Condition
( NCT03927885 1185 1186 O
MD NCT03927885 1187 1189 B-Condition
Anderson NCT03927885 1190 1198 I-Condition
Symptom NCT03927885 1199 1206 I-Condition
[ NCT03927885 1207 1208 O
MDAS NCT03927885 1209 1213 B-Condition
] NCT03927885 1214 1215 O
> NCT03927885 1216 1217 B-Eq_Comparison
7 NCT03927885 1218 1219 I-Eq_Comparison
) NCT03927885 1220 1221 O

Inclusion NCT03926351 0 9 O
Criteria NCT03926351 10 18 O
: NCT03926351 19 20 O

- NCT03926351 24 25 O
Age NCT03926351 27 30 B-Age
> NCT03926351 31 32 B-Eq_Comparison
50 NCT03926351 33 35 I-Eq_Comparison
years NCT03926351 36 41 I-Eq_Comparison

- NCT03926351 44 45 O
SCD NCT03926351 47 50 B-Condition
or NCT03926351 51 53 B-Or
MCI NCT03926351 54 57 B-Condition

- NCT03926351 60 61 O
No NCT03926351 63 65 B-Negation
evidence NCT03926351 66 74 O
of NCT03926351 75 77 O
neurodegeneration NCT03926351 78 95 B-Condition
( NCT03926351 96 97 O
i NCT03926351 98 99 O
. NCT03926351 100 101 O
e NCT03926351 102 103 O
. NCT03926351 104 105 O
CSF NCT03926351 107 110 B-Observation
phospho NCT03926351 111 118 I-Observation
and NCT03926351 119 122 B-Or
total NCT03926351 123 128 B-Observation
tau NCT03926351 129 132 I-Observation
- NCT03926351 133 134 I-Observation
levels NCT03926351 135 141 I-Observation
below NCT03926351 142 147 B-Eq_Comparison
cut NCT03926351 148 151 I-Eq_Comparison
- NCT03926351 152 153 I-Eq_Comparison
off NCT03926351 154 157 I-Eq_Comparison
) NCT03926351 158 159 O

- NCT03926351 163 164 O
Scandinavian NCT03926351 166 178 O
mother NCT03926351 179 185 O
tongue NCT03926351 186 192 O

- NCT03926351 195 196 O
Completed NCT03926351 198 207 O
2 NCT03926351 208 209 B-Eq_Comparison
- NCT03926351 210 211 I-Eq_Comparison
year NCT03926351 212 216 I-Eq_Comparison
follow NCT03926351 217 223 B-Encounter
- NCT03926351 224 225 I-Encounter
up NCT03926351 226 228 I-Encounter
in NCT03926351 229 231 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926351 232 235 O
DDI NCT03926351 236 239 B-Other
- NCT03926351 240 241 O
study NCT03926351 242 247 B-Study

- NCT03926351 250 251 O
Stable NCT03926351 253 259 O
medication NCT03926351 260 270 B-Drug
for NCT03926351 271 274 O
at NCT03926351 275 277 B-Eq_Comparison
least NCT03926351 278 283 I-Eq_Comparison
3 NCT03926351 284 285 I-Eq_Comparison
months NCT03926351 286 292 I-Eq_Comparison
prior NCT03926351 293 298 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926351 299 301 O
baseline NCT03926351 302 310 B-Study
exam NCT03926351 311 315 O

Exclusion NCT03926351 316 325 O
Criteria NCT03926351 326 334 O
: NCT03926351 335 336 O

- NCT03926351 340 341 O
Dementia NCT03926351 343 351 B-Condition
( NCT03926351 352 353 O
defined NCT03926351 354 361 O
as NCT03926351 362 364 O
MMSE NCT03926351 365 369 B-Observation
< NCT03926351 370 371 B-Eq_Comparison
26 NCT03926351 372 374 I-Eq_Comparison
and NCT03926351 375 378 B-Or
/ NCT03926351 379 380 I-Or
or NCT03926351 381 383 I-Or
CDR NCT03926351 384 387 B-Observation
> NCT03926351 388 389 B-Eq_Comparison
/ NCT03926351 390 391 I-Eq_Comparison
= NCT03926351 392 393 I-Eq_Comparison
1 NCT03926351 394 395 I-Eq_Comparison
) NCT03926351 396 397 O
) NCT03926351 398 399 O

- NCT03926351 403 404 O
Other NCT03926351 406 411 B-Other
dementia NCT03926351 412 420 B-Condition
giving NCT03926351 421 427 O
disease NCT03926351 428 435 O
than NCT03926351 436 440 B-Exception
AD NCT03926351 441 443 B-Condition

- NCT03926351 446 447 O
Other NCT03926351 449 454 B-Other
brain NCT03926351 455 460 B-Condition
disease NCT03926351 461 468 I-Condition

- NCT03926351 471 472 O
Significant NCT03926351 474 485 O
depression NCT03926351 486 496 B-Condition

- NCT03926351 499 500 O
Unstable NCT03926351 502 510 O
coronary NCT03926351 511 519 B-Condition
heart NCT03926351 520 525 I-Condition
disease NCT03926351 526 533 I-Condition
or NCT03926351 534 536 B-Or
heart NCT03926351 537 542 B-Condition
failure NCT03926351 543 550 I-Condition
in NCT03926351 551 553 O
need NCT03926351 554 558 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03926351 559 561 I-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03926351 562 571 B-Procedure

- NCT03926351 574 575 O
Systemic NCT03926351 577 585 B-Modifier
inflammatory NCT03926351 586 598 B-Condition
diseases NCT03926351 599 607 I-Condition

- NCT03926351 610 611 O
Somatic NCT03926351 613 620 B-Condition
disease NCT03926351 621 628 I-Condition
that NCT03926351 629 633 O
might NCT03926351 634 639 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03926351 640 646 O
cognitive NCT03926351 647 656 B-Condition
function NCT03926351 657 665 I-Condition
adversely NCT03926351 666 675 O

- NCT03926351 678 679 O
Usage NCT03926351 681 686 B-Eq_Comparison
of NCT03926351 687 689 O
anticoagulants NCT03926351 690 704 B-Drug

- NCT03926351 707 708 O
Prior NCT03926351 710 715 B-Eq_Comparison
radiation NCT03926351 716 725 B-Procedure
- NCT03926351 726 727 O
or NCT03926351 728 730 B-Or
chemo NCT03926351 731 736 B-Procedure
- NCT03926351 737 738 I-Procedure
therapy NCT03926351 739 746 I-Procedure
possibly NCT03926351 747 755 B-Assertion___Assertion_Type_Value:hypothetical
affecting NCT03926351 756 765 O
CNS NCT03926351 766 769 B-Condition

- NCT03926351 772 773 O
Relevant NCT03926351 775 783 O
cancer NCT03926351 784 790 B-Condition
or NCT03926351 791 793 O
other NCT03926351 794 799 B-Other
serious NCT03926351 800 807 O
disease NCT03926351 808 815 B-Condition
with NCT03926351 816 820 B-And
expected NCT03926351 821 829 B-Observation
survival NCT03926351 830 838 I-Observation
< NCT03926351 839 840 B-Eq_Comparison
5 NCT03926351 841 842 I-Eq_Comparison
years NCT03926351 843 848 I-Eq_Comparison

- NCT03926351 851 852 O
Fish NCT03926351 854 858 B-Drug
meal NCT03926351 859 863 I-Drug
intake NCT03926351 864 870 O
more NCT03926351 871 875 B-Eq_Comparison
than NCT03926351 876 880 I-Eq_Comparison
2 NCT03926351 881 882 I-Eq_Comparison
times NCT03926351 883 888 I-Eq_Comparison
a NCT03926351 889 890 I-Eq_Comparison
week NCT03926351 891 895 I-Eq_Comparison

- NCT03926351 898 899 O
Regularly NCT03926351 901 910 B-Eq_Comparison
intake NCT03926351 911 917 O
of NCT03926351 918 920 O
Omega NCT03926351 921 926 B-Drug
- NCT03926351 927 928 I-Drug
3 NCT03926351 929 930 I-Drug
supplements NCT03926351 931 942 I-Drug
over NCT03926351 943 947 O
the NCT03926351 948 951 O
last NCT03926351 952 956 B-Eq_Comparison
3 NCT03926351 957 958 I-Eq_Comparison
months NCT03926351 959 965 I-Eq_Comparison

Inclusion NCT03862573 0 9 O
Criteria NCT03862573 10 18 O
: NCT03862573 19 20 O

1 NCT03862573 24 25 O
. NCT03862573 25 26 O
Children NCT03862573 28 36 O
age NCT03862573 37 40 B-Age
4 NCT03862573 41 42 B-Eq_Comparison
to NCT03862573 43 45 I-Eq_Comparison
< NCT03862573 46 47 I-Eq_Comparison
17 NCT03862573 48 50 I-Eq_Comparison
years NCT03862573 51 56 I-Eq_Comparison

2 NCT03862573 59 60 O
. NCT03862573 60 61 O
Arriving NCT03862573 63 71 B-Encounter
to NCT03862573 72 74 O
the NCT03862573 75 78 O
UBC NCT03862573 79 82 O
dentistry NCT03862573 83 92 O
clinic NCT03862573 93 99 O
and NCT03862573 100 103 B-And
need NCT03862573 104 108 B-Assertion___Assertion_Type_Value:hypothetical
dental NCT03862573 109 115 B-Procedure
assessment NCT03862573 116 126 B-Modifier
/ NCT03862573 127 128 B-Or
procedures NCT03862573 129 139 B-Modifier

3 NCT03862573 142 143 O
. NCT03862573 143 144 O
Parents NCT03862573 146 153 O
will NCT03862573 154 158 O
sign NCT03862573 159 163 O
a NCT03862573 164 165 O
consent NCT03862573 166 173 O
form NCT03862573 174 178 O
and NCT03862573 179 182 O
children NCT03862573 183 191 O
will NCT03862573 192 196 O
sign NCT03862573 197 201 O
an NCT03862573 202 204 O
assent NCT03862573 205 211 O
form NCT03862573 212 216 O

Exclusion NCT03862573 217 226 O
Criteria NCT03862573 227 235 O
: NCT03862573 236 237 O

1 NCT03862573 241 242 O
. NCT03862573 242 243 O
Children NCT03862573 245 253 O
with NCT03862573 254 258 B-And
conditions NCT03862573 259 269 B-Condition
that NCT03862573 270 274 O
may NCT03862573 275 278 B-Assertion___Assertion_Type_Value:hypothetical
prohibit NCT03862573 279 287 B-Negation
participation NCT03862573 288 301 O
or NCT03862573 302 304 O
evaluation NCT03862573 305 315 O
of NCT03862573 316 318 O
the NCT03862573 319 322 O
procedure NCT03862573 323 332 B-Procedure
( NCT03862573 333 334 O
such NCT03862573 335 339 O
as NCT03862573 340 342 O
developmental NCT03862573 343 356 B-Condition
delay NCT03862573 357 362 I-Condition
, NCT03862573 363 364 O
autism NCT03862573 365 371 B-Condition
, NCT03862573 372 373 O
challenging NCT03862573 374 385 B-Condition
communication NCT03862573 386 399 I-Condition
) NCT03862573 400 401 O

2 NCT03862573 405 406 O
. NCT03862573 406 407 O
Facial NCT03862573 409 415 B-Condition
features NCT03862573 416 424 I-Condition
prohibiting NCT03862573 425 436 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
wearing NCT03862573 437 444 B-Observation
the NCT03862573 445 448 O
VR NCT03862573 449 451 B-Modifier
goggles NCT03862573 452 459 I-Modifier

3 NCT03862573 462 463 O
. NCT03862573 463 464 O
Children NCT03862573 466 474 O
needing NCT03862573 475 482 B-Assertion___Assertion_Type_Value:hypothetical
sedation NCT03862573 483 491 B-Procedure
that NCT03862573 492 496 O
includes NCT03862573 497 505 O
inhalation NCT03862573 506 516 B-Procedure
via NCT03862573 517 520 I-Procedure
a NCT03862573 521 522 I-Procedure
mask NCT03862573 523 527 I-Procedure
( NCT03862573 528 529 O
N NCT03862573 530 531 B-Procedure
2O NCT03862573 532 534 I-Procedure
) NCT03862573 535 536 O
or NCT03862573 537 539 B-Or
IV NCT03862573 540 542 B-Modifier
/ NCT03862573 543 544 B-Or
IM NCT03862573 545 547 B-Modifier
sedation NCT03862573 548 556 B-Procedure

Inclusion NCT03920670 0 9 O
Criteria NCT03920670 10 18 O

- NCT03920670 21 22 O
Age NCT03920670 24 27 B-Age
> NCT03920670 28 29 B-Eq_Comparison
or NCT03920670 30 32 I-Eq_Comparison
= NCT03920670 33 34 I-Eq_Comparison
18 NCT03920670 35 37 I-Eq_Comparison
years NCT03920670 38 43 I-Eq_Comparison
old NCT03920670 44 47 O

- NCT03920670 50 51 O
Patients NCT03920670 53 61 O
willing NCT03920670 62 69 O
to NCT03920670 70 72 O
participate NCT03920670 73 84 O
and NCT03920670 85 88 O
provide NCT03920670 89 96 O
an NCT03920670 97 99 O
informed NCT03920670 100 108 O
consent NCT03920670 109 116 O

- NCT03920670 119 120 O
Patients NCT03920670 122 130 O
undergoing NCT03920670 131 141 B-Eq_Comparison
an NCT03920670 142 144 O
elective NCT03920670 145 153 B-Modifier
surgical NCT03920670 154 162 B-Procedure
procedure NCT03920670 163 172 I-Procedure
that NCT03920670 173 177 O
requires NCT03920670 178 186 B-Assertion___Assertion_Type_Value:hypothetical
use NCT03920670 187 190 O
of NCT03920670 191 193 O
non NCT03920670 194 197 B-Drug
- NCT03920670 198 199 I-Drug
depolarizing NCT03920670 200 212 I-Drug
NMBA NCT03920670 213 217 I-Drug
agents NCT03920670 218 224 I-Drug
administered NCT03920670 225 237 O
intraoperatively NCT03920670 238 254 B-Modifier
. NCT03920670 255 256 O

Exclusion NCT03920670 258 267 O
Criteria NCT03920670 268 276 O

- NCT03920670 279 280 O
Patients NCT03920670 282 290 O
with NCT03920670 291 295 O
unilateral NCT03920670 296 306 B-Condition
disorders NCT03920670 307 316 I-Condition
, NCT03920670 317 318 O
such NCT03920670 319 323 O
as NCT03920670 324 326 O
stroke NCT03920670 327 333 B-Condition
, NCT03920670 334 335 O
carpal NCT03920670 336 342 B-Condition
tunnel NCT03920670 343 349 I-Condition
syndrome NCT03920670 350 358 I-Condition
, NCT03920670 359 360 O
broken NCT03920670 361 367 B-Condition
wrist NCT03920670 368 373 B-Modifier
with NCT03920670 374 378 B-And
nerve NCT03920670 379 384 B-Modifier
damage NCT03920670 385 391 I-Modifier
, NCT03920670 392 393 O
Dupuytren NCT03920670 394 403 B-Condition
contracture NCT03920670 404 415 I-Condition
, NCT03920670 416 417 O
or NCT03920670 418 420 B-Or
any NCT03920670 421 424 O
similar NCT03920670 425 432 O
wrist NCT03920670 433 438 B-Modifier
injury NCT03920670 439 445 B-Condition
. NCT03920670 446 447 O

- NCT03920670 451 452 O
Patients NCT03920670 454 462 O
with NCT03920670 463 467 O
systemic NCT03920670 468 476 B-Modifier
neuromuscular NCT03920670 477 490 B-Condition
diseases NCT03920670 491 499 I-Condition
such NCT03920670 500 504 O
as NCT03920670 505 507 O
myasthenia NCT03920670 508 518 B-Condition
gravis NCT03920670 519 525 I-Condition

- NCT03920670 528 529 O
Patients NCT03920670 531 539 O
with NCT03920670 540 544 O
significant NCT03920670 545 556 O
organ NCT03920670 557 562 B-Condition
dysfunction NCT03920670 563 574 I-Condition
that NCT03920670 575 579 O
can NCT03920670 580 583 B-Assertion___Assertion_Type_Value:hypothetical
significantly NCT03920670 584 597 O
affect NCT03920670 598 604 O
pharmacokinetics NCT03920670 605 621 O
of NCT03920670 622 624 O
neuromuscular NCT03920670 625 638 B-Modifier
blocking NCT03920670 639 647 I-Modifier
and NCT03920670 648 651 B-Or
reversal NCT03920670 652 660 B-Modifier
agents NCT03920670 661 667 B-Drug
, NCT03920670 668 669 O
i NCT03920670 670 671 O
. NCT03920670 672 673 O
e NCT03920670 674 675 O
. NCT03920670 676 677 O
, NCT03920670 678 679 O
severe NCT03920670 680 686 O
renal NCT03920670 687 692 B-Condition
impairment NCT03920670 693 703 I-Condition
or NCT03920670 704 706 B-Or
end NCT03920670 707 710 B-Modifier
- NCT03920670 711 712 I-Modifier
stage NCT03920670 713 718 I-Modifier
liver NCT03920670 719 724 B-Condition
disease NCT03920670 725 732 I-Condition
. NCT03920670 733 734 O

Inclusion NCT03921983 0 9 O
Criteria NCT03921983 10 18 O
: NCT03921983 19 20 O

- NCT03921983 24 25 O
COPD NCT03921983 27 31 B-Condition
diagnostic NCT03921983 32 42 O

- NCT03921983 45 46 O
Both NCT03921983 48 52 O
sex NCT03921983 53 56 O

- NCT03921983 59 60 O
18 NCT03921983 62 64 B-Eq_Comparison
< NCT03921983 65 66 I-Eq_Comparison
Age NCT03921983 67 70 B-Age
< NCT03921983 71 72 B-Eq_Comparison
80 NCT03921983 73 75 I-Eq_Comparison
years NCT03921983 76 81 I-Eq_Comparison
old NCT03921983 82 85 O

- NCT03921983 88 89 O
LTOT NCT03921983 91 95 B-Condition
- NCT03921983 96 97 O
group NCT03921983 98 103 O
: NCT03921983 104 105 O
PaO NCT03921983 106 109 B-Observation
2 NCT03921983 110 111 I-Observation
≥ NCT03921983 112 113 B-Eq_Comparison
65 NCT03921983 114 116 I-Eq_Comparison
mmHg NCT03921983 117 121 I-Eq_Comparison
and NCT03921983 122 125 B-And
SaO NCT03921983 126 129 B-Observation
2 NCT03921983 130 131 I-Observation
≥ NCT03921983 132 133 B-Eq_Comparison
92 NCT03921983 134 136 I-Eq_Comparison
% NCT03921983 137 138 I-Eq_Comparison

- NCT03921983 142 143 O
LTOT NCT03921983 145 149 B-Condition
+ NCT03921983 150 151 O
group NCT03921983 152 157 O
: NCT03921983 158 159 O
long NCT03921983 160 164 O
term NCT03921983 165 169 O
oxygenotherapy NCT03921983 170 184 B-Procedure
prescribed NCT03921983 185 195 O
for NCT03921983 196 199 O
more NCT03921983 200 204 B-Eq_Comparison
than NCT03921983 205 209 I-Eq_Comparison
3 NCT03921983 210 211 I-Eq_Comparison
months NCT03921983 212 218 I-Eq_Comparison
, NCT03921983 219 220 O
with NCT03921983 221 225 O
daily NCT03921983 226 231 B-Eq_Comparison
use NCT03921983 232 235 I-Eq_Comparison
between NCT03921983 236 243 I-Eq_Comparison
12 NCT03921983 244 246 I-Eq_Comparison
and NCT03921983 247 250 I-Eq_Comparison
15 NCT03921983 251 253 I-Eq_Comparison
hours NCT03921983 254 259 I-Eq_Comparison
. NCT03921983 260 261 O

Patients NCT03921983 263 271 O
in NCT03921983 272 274 O
both NCT03921983 275 279 O
groups NCT03921983 280 286 O
will NCT03921983 287 291 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03921983 292 294 I-Assertion___Assertion_Type_Value:hypothetical
matched NCT03921983 295 302 O
for NCT03921983 303 306 O
age NCT03921983 307 310 B-Age
( NCT03921983 311 312 O
± NCT03921983 313 314 B-Eq_Comparison
5 NCT03921983 315 316 I-Eq_Comparison
years NCT03921983 317 322 I-Eq_Comparison
) NCT03921983 323 324 O
, NCT03921983 325 326 O
sex NCT03921983 327 330 B-Observation
and NCT03921983 331 334 B-And
physical NCT03921983 335 343 B-Observation
activity NCT03921983 344 352 I-Observation

estimated NCT03921983 353 362 O
by NCT03921983 363 365 O
GPAQ NCT03921983 366 370 B-Observation
questionnaire NCT03921983 371 384 I-Observation
( NCT03921983 385 386 O
± NCT03921983 387 388 B-Eq_Comparison
15 NCT03921983 389 391 I-Eq_Comparison
% NCT03921983 392 393 I-Eq_Comparison
Mets NCT03921983 394 398 I-Eq_Comparison
. NCT03921983 399 400 I-Eq_Comparison
min NCT03921983 401 404 I-Eq_Comparison
/ NCT03921983 405 406 I-Eq_Comparison
week NCT03921983 407 411 I-Eq_Comparison
) NCT03921983 412 413 O
. NCT03921983 414 415 O

Exclusion NCT03921983 417 426 O
Criteria NCT03921983 427 435 O
: NCT03921983 436 437 O

- NCT03921983 441 442 O
Recent NCT03921983 444 450 B-Eq_Comparison
cardiorespiratory NCT03921983 451 468 B-Condition
exacerbation NCT03921983 469 481 I-Condition
( NCT03921983 482 483 O
< NCT03921983 484 485 B-Eq_Comparison
6 NCT03921983 486 487 I-Eq_Comparison
weeks NCT03921983 488 493 I-Eq_Comparison
) NCT03921983 494 495 O
. NCT03921983 496 497 O

- NCT03921983 501 502 O
Pulmonary NCT03921983 504 513 B-Procedure
rehabilitation NCT03921983 514 528 I-Procedure
program NCT03921983 529 536 O
during NCT03921983 537 543 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03921983 544 547 O
last NCT03921983 548 552 B-Eq_Comparison
2 NCT03921983 553 554 I-Eq_Comparison
months NCT03921983 555 561 I-Eq_Comparison

- NCT03921983 564 565 O
Continuous NCT03921983 567 577 B-Eq_Comparison
LTOT NCT03921983 578 582 B-Procedure
( NCT03921983 583 584 O
24 NCT03921983 585 587 B-Eq_Comparison
hours NCT03921983 588 593 I-Eq_Comparison
) NCT03921983 594 595 O
or NCT03921983 596 598 B-Or
deambulation NCT03921983 599 611 B-Modifier
O NCT03921983 612 613 B-Procedure
2 NCT03921983 614 615 I-Procedure
therapy NCT03921983 616 623 I-Procedure
alone NCT03921983 624 629 O

- NCT03921983 632 633 O
Anticoagulant NCT03921983 635 648 O
drugs NCT03921983 649 654 O

- NCT03921983 657 658 O
Hematocrit NCT03921983 660 670 B-Observation
outside NCT03921983 671 678 O
the NCT03921983 679 682 O
normal NCT03921983 683 689 O
range NCT03921983 690 695 O
( NCT03921983 696 697 O
35 NCT03921983 698 700 B-Eq_Comparison
- NCT03921983 701 702 I-Eq_Comparison
50 NCT03921983 703 705 I-Eq_Comparison
% NCT03921983 706 707 I-Eq_Comparison
) NCT03921983 708 709 O

Inclusion NCT03869359 0 9 O
Criteria NCT03869359 10 18 O
: NCT03869359 19 20 O

- NCT03869359 24 25 O
Adult NCT03869359 27 32 O
patients NCT03869359 33 41 O
with NCT03869359 42 46 B-And
IBS NCT03869359 47 50 B-Condition
according NCT03869359 51 60 O
to NCT03869359 61 63 O
Rome NCT03869359 64 68 O
IV NCT03869359 69 71 O
criteria NCT03869359 72 80 O

Exclusion NCT03869359 81 90 O
Criteria NCT03869359 91 99 O
: NCT03869359 100 101 O

- NCT03869359 105 106 O
allergy NCT03869359 108 115 B-Allergy
or NCT03869359 116 118 B-Or
documented NCT03869359 119 129 O
intolerance NCT03869359 130 141 B-Condition
to NCT03869359 142 144 O
food NCT03869359 145 149 B-Modifier
, NCT03869359 150 151 O

- NCT03869359 155 156 O
severe NCT03869359 158 164 O
cardiovascular NCT03869359 165 179 B-Modifier
, NCT03869359 180 181 O
hepatic NCT03869359 182 189 B-Modifier
, NCT03869359 190 191 O
neurological NCT03869359 192 204 B-Modifier
or NCT03869359 205 207 B-Or
psychiatric NCT03869359 208 219 B-Modifier
disease NCT03869359 220 227 B-Condition

- NCT03869359 230 231 O
serious NCT03869359 233 240 O
gastrointestinal NCT03869359 241 257 B-Condition
disease NCT03869359 258 265 I-Condition
: NCT03869359 266 267 O
including NCT03869359 268 277 O
celiac NCT03869359 278 284 B-Condition
disease NCT03869359 285 292 I-Condition
and NCT03869359 293 296 B-Or
inflammatory NCT03869359 297 309 B-Condition
bowel NCT03869359 310 315 I-Condition
diseases NCT03869359 316 324 I-Condition
( NCT03869359 325 326 O
IBD NCT03869359 327 330 B-Condition
) NCT03869359 331 332 O
, NCT03869359 333 334 O

- NCT03869359 338 339 O
diabetes NCT03869359 341 349 B-Condition

- NCT03869359 352 353 O
bowel NCT03869359 355 360 B-Condition
dysfunction NCT03869359 361 372 I-Condition
related NCT03869359 373 380 O
to NCT03869359 381 383 O
previous NCT03869359 384 392 B-Eq_Comparison
surgery NCT03869359 393 400 B-Procedure

- NCT03869359 403 404 O
pregnant NCT03869359 406 414 B-Condition
or NCT03869359 415 417 B-Or
lactating NCT03869359 418 427 B-Condition
women NCT03869359 428 433 O

- NCT03869359 436 437 O
usage NCT03869359 439 444 O
of NCT03869359 445 447 O
antibiotics NCT03869359 448 459 B-Drug
within NCT03869359 460 466 B-Eq_Comparison
4 NCT03869359 467 468 I-Eq_Comparison
weeks NCT03869359 469 474 I-Eq_Comparison
before NCT03869359 475 481 B-Temporal_Connection___Temporal_Connection_Type_Value:before
inclusion NCT03869359 482 491 B-Study

- NCT03869359 494 495 O
strict NCT03869359 497 503 O
avoidance NCT03869359 504 513 O
of NCT03869359 514 516 O
foods NCT03869359 517 522 O

Inclusion NCT03862664 0 9 O
Criteria NCT03862664 10 18 O
: NCT03862664 19 20 O

- NCT03862664 24 25 O
Excellent NCT03862664 27 36 O
general NCT03862664 37 44 O
physical NCT03862664 45 53 B-Modifier
and NCT03862664 54 57 B-And
mental NCT03862664 58 64 B-Modifier
condition NCT03862664 65 74 B-Condition
, NCT03862664 75 76 O

- NCT03862664 80 81 O
Free NCT03862664 83 87 B-Negation
of NCT03862664 88 90 I-Negation
chronic NCT03862664 91 98 O
disease NCT03862664 99 106 B-Condition
or NCT03862664 107 109 B-Or

- NCT03862664 112 113 O
Previous NCT03862664 115 123 B-Eq_Comparison
major NCT03862664 124 129 O
abdominal NCT03862664 130 139 B-Procedure
surgery NCT03862664 140 147 I-Procedure
, NCT03862664 148 149 O

- NCT03862664 153 154 O
Body NCT03862664 156 160 B-Observation
mass NCT03862664 161 165 I-Observation
index NCT03862664 166 171 I-Observation
( NCT03862664 172 173 O
BMI NCT03862664 174 177 B-Observation
) NCT03862664 178 179 O
< NCT03862664 180 181 B-Eq_Comparison
28 NCT03862664 182 184 I-Eq_Comparison
, NCT03862664 185 186 O

- NCT03862664 190 191 O
ABO NCT03862664 193 196 B-Observation
blood NCT03862664 197 202 I-Observation
group NCT03862664 203 208 O
identical NCT03862664 209 218 O
to NCT03862664 219 221 O
recipients NCT03862664 222 232 O
and NCT03862664 233 236 B-And

- NCT03862664 239 240 O
Negative NCT03862664 242 250 O
for NCT03862664 251 254 O
hepatitis NCT03862664 255 264 B-Condition
B NCT03862664 265 266 B-Modifier
, NCT03862664 267 268 O
C NCT03862664 269 270 B-Modifier
and NCT03862664 271 274 B-Or
human NCT03862664 275 280 B-Condition
immunodeficiency NCT03862664 281 297 I-Condition
viruses NCT03862664 298 305 I-Condition
( NCT03862664 306 307 O
HIV NCT03862664 308 311 B-Condition
) NCT03862664 312 313 O
. NCT03862664 314 315 O

Exclusion NCT03862664 317 326 O
Criteria NCT03862664 327 335 O
: NCT03862664 336 337 O

- NCT03862664 341 342 O
ASA NCT03862664 344 347 B-Observation
physical NCT03862664 348 356 O
status NCT03862664 357 363 O
> NCT03862664 364 365 B-Eq_Comparison
II NCT03862664 366 368 I-Eq_Comparison
, NCT03862664 369 370 O

- NCT03862664 374 375 O
BMI NCT03862664 377 380 B-Observation
> NCT03862664 381 382 B-Eq_Comparison
28 NCT03862664 383 385 I-Eq_Comparison
, NCT03862664 386 387 O

- NCT03862664 391 392 O
Psychiatric NCT03862664 394 405 B-Modifier
or NCT03862664 406 408 B-Or
mental NCT03862664 409 415 B-Modifier
retardation NCT03862664 416 427 B-Condition
, NCT03862664 428 429 O

- NCT03862664 433 434 O
pregnant NCT03862664 436 444 B-Condition
and NCT03862664 445 448 B-Or
nursing NCT03862664 449 456 B-Condition
women NCT03862664 457 462 O
or NCT03862664 463 465 B-Or

- NCT03862664 468 469 O
Patients NCT03862664 471 479 O
with NCT03862664 480 484 O
significant NCT03862664 485 496 O
laboratory NCT03862664 497 507 B-Observation
abnormalities NCT03862664 508 521 O

Inclusion NCT03865732 0 9 O
Criteria NCT03865732 10 18 O
: NCT03865732 19 20 O

- NCT03865732 24 25 O
Molecular NCT03865732 27 36 B-Procedure
confirmation NCT03865732 37 49 O
of NCT03865732 50 52 O
a NCT03865732 53 54 O
pathogenic NCT03865732 55 65 B-Modifier
or NCT03865732 66 68 B-Or
likely NCT03865732 69 75 B-Assertion___Assertion_Type_Value:possible
pathogenic NCT03865732 76 86 B-Modifier
PCDH NCT03865732 87 91 B-Condition
19 NCT03865732 92 94 I-Condition
variant NCT03865732 95 102 I-Condition

- NCT03865732 105 106 O
Failure NCT03865732 108 115 B-Negation
to NCT03865732 116 118 O
control NCT03865732 119 126 O
seizures NCT03865732 127 135 B-Condition
despite NCT03865732 136 143 B-And
2 NCT03865732 144 145 B-Eq_Comparison
or NCT03865732 146 148 I-Eq_Comparison
more NCT03865732 149 153 I-Eq_Comparison
anti NCT03865732 154 158 O
- NCT03865732 159 160 O
seizure NCT03865732 161 168 B-Condition
medications NCT03865732 169 180 B-Drug

- NCT03865732 183 184 O
12 NCT03865732 186 188 B-Eq_Comparison
seizures NCT03865732 189 197 B-Condition
over NCT03865732 198 202 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03865732 203 204 O
12 NCT03865732 205 207 B-Eq_Comparison
- NCT03865732 208 209 I-Eq_Comparison
week NCT03865732 210 214 I-Eq_Comparison
period NCT03865732 215 221 I-Eq_Comparison
of NCT03865732 222 224 O
primary NCT03865732 225 232 B-Condition
seizure NCT03865732 233 240 I-Condition
types NCT03865732 241 246 O
prior NCT03865732 247 252 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865732 253 255 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03865732 256 265 B-Study

- NCT03865732 268 269 O
On NCT03865732 271 273 B-Eq_Comparison
a NCT03865732 274 275 O
stable NCT03865732 276 282 O
regimen NCT03865732 283 290 O
of NCT03865732 291 293 O
anti NCT03865732 294 298 O
- NCT03865732 299 300 O
seizure NCT03865732 301 308 B-Condition
treatments NCT03865732 309 319 B-Procedure
( NCT03865732 320 321 O
Vagus NCT03865732 322 327 B-Procedure
nerve NCT03865732 328 333 I-Procedure
stimulator NCT03865732 334 344 I-Procedure
, NCT03865732 345 346 O
ketogenic NCT03865732 347 356 B-Observation
diet NCT03865732 357 361 I-Observation
, NCT03865732 362 363 O
and NCT03865732 364 367 B-Or
modified NCT03865732 368 376 B-Modifier
Atkins NCT03865732 377 383 B-Observation
diet NCT03865732 384 388 I-Observation
should NCT03865732 389 395 O
be NCT03865732 396 398 O
unchanged NCT03865732 399 408 O
for NCT03865732 409 412 O
3 NCT03865732 413 414 B-Eq_Comparison
months NCT03865732 415 421 I-Eq_Comparison
prior NCT03865732 422 427 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865732 428 430 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03865732 431 440 B-Study
) NCT03865732 441 442 O

Exclusion NCT03865732 444 453 O
Criteria NCT03865732 454 462 O
: NCT03865732 463 464 O

- NCT03865732 468 469 O
Previous NCT03865732 471 479 B-Eq_Comparison
exposure NCT03865732 480 488 O
to NCT03865732 489 491 O
ganaxolone NCT03865732 492 502 B-Drug

- NCT03865732 505 506 O
> NCT03865732 508 509 B-Eq_Comparison
8 NCT03865732 510 511 I-Eq_Comparison
consecutive NCT03865732 512 523 I-Eq_Comparison
weeks NCT03865732 524 529 I-Eq_Comparison
of NCT03865732 530 532 O
seizure NCT03865732 533 540 B-Condition
freedom NCT03865732 541 548 B-Negation
during NCT03865732 549 555 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865732 556 559 O
12 NCT03865732 560 562 B-Eq_Comparison
weeks NCT03865732 563 568 I-Eq_Comparison
prior NCT03865732 569 574 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865732 575 577 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03865732 578 587 B-Study

- NCT03865732 590 591 O
Concurrent NCT03865732 593 603 B-Modifier
use NCT03865732 604 607 O
of NCT03865732 608 610 O
strong NCT03865732 611 617 B-Drug
inducers NCT03865732 618 626 I-Drug
or NCT03865732 627 629 B-Or
inhibitors NCT03865732 630 640 B-Drug
of NCT03865732 641 643 O
CYP NCT03865732 644 647 B-Modifier
3A NCT03865732 648 650 I-Modifier
4 NCT03865732 651 652 I-Modifier
/ NCT03865732 653 654 B-Or
5 NCT03865732 655 656 B-Modifier
/ NCT03865732 657 658 B-Or
7 NCT03865732 659 660 B-Modifier
is NCT03865732 661 663 O
not NCT03865732 664 667 B-Negation
permitted NCT03865732 668 677 O

- NCT03865732 680 681 O
Use NCT03865732 683 686 B-Eq_Comparison
of NCT03865732 687 689 O
tetrahydrocannabinol NCT03865732 690 710 B-Drug
( NCT03865732 711 712 O
THC NCT03865732 713 716 B-Drug
) NCT03865732 717 718 O
or NCT03865732 719 721 B-Or
non NCT03865732 722 725 B-Modifier
- NCT03865732 726 727 I-Modifier
approved NCT03865732 728 736 I-Modifier
cannabidiol NCT03865732 737 748 B-Drug
( NCT03865732 749 750 O
CBD NCT03865732 751 754 B-Drug
) NCT03865732 755 756 O
is NCT03865732 757 759 O
prohibited NCT03865732 760 770 B-Negation
during NCT03865732 771 777 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865732 778 781 O
double NCT03865732 782 788 B-Modifier
- NCT03865732 789 790 I-Modifier
blind NCT03865732 791 796 I-Modifier
phase NCT03865732 797 802 O

- NCT03865732 805 806 O
Exposure NCT03865732 808 816 O
to NCT03865732 817 819 O
any NCT03865732 820 823 O
other NCT03865732 824 829 B-Other
investigational NCT03865732 830 845 B-Study
drug NCT03865732 846 850 B-Drug
within NCT03865732 851 857 B-Eq_Comparison
30 NCT03865732 858 860 I-Eq_Comparison
days NCT03865732 861 865 I-Eq_Comparison
or NCT03865732 866 868 B-Or
fewer NCT03865732 869 874 B-Eq_Comparison
than NCT03865732 875 879 I-Eq_Comparison
5 NCT03865732 880 881 I-Eq_Comparison
half NCT03865732 882 886 I-Eq_Comparison
- NCT03865732 887 888 I-Eq_Comparison
lives NCT03865732 889 894 I-Eq_Comparison
prior NCT03865732 895 900 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865732 901 903 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03865732 904 913 B-Study

Inclusion NCT03929848 0 9 O
Criteria NCT03929848 10 18 O
: NCT03929848 19 20 O

- NCT03929848 24 25 O
patients NCT03929848 27 35 O
who NCT03929848 36 39 O
is NCT03929848 40 42 O
scheduled NCT03929848 43 52 B-Eq_Comparison
for NCT03929848 53 56 O
laryngomicrosurgery NCT03929848 57 76 B-Procedure
due NCT03929848 77 80 O
to NCT03929848 81 83 O
simple NCT03929848 84 90 B-Modifier
vocal NCT03929848 91 96 I-Modifier
cord NCT03929848 97 101 I-Modifier
cyst NCT03929848 102 106 B-Condition
or NCT03929848 107 109 B-Or
nodule NCT03929848 110 116 B-Condition

Exclusion NCT03929848 117 126 O
Criteria NCT03929848 127 135 O
: NCT03929848 136 137 O

- NCT03929848 141 142 O
Who NCT03929848 144 147 O
does NCT03929848 148 152 B-Negation
n't NCT03929848 152 155 I-Negation
agree NCT03929848 156 161 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929848 162 164 I-Assertion___Assertion_Type_Value:hypothetical
enroll NCT03929848 165 171 B-Study

- NCT03929848 174 175 O
do NCT03929848 177 179 O
not NCT03929848 180 183 B-Negation
use NCT03929848 184 187 O
a NCT03929848 188 189 O
reinforced NCT03929848 190 200 B-Procedure
tracheal NCT03929848 201 209 I-Procedure
tube NCT03929848 210 214 I-Procedure
of NCT03929848 215 217 O
internal NCT03929848 218 226 B-Observation
diameter NCT03929848 227 235 I-Observation
of NCT03929848 236 238 O
5.5 NCT03929848 239 242 B-Eq_Comparison
mm NCT03929848 243 245 I-Eq_Comparison
for NCT03929848 246 249 O
male NCT03929848 250 254 O
patient NCT03929848 255 262 O

- NCT03929848 265 266 O
do NCT03929848 268 270 O
not NCT03929848 271 274 B-Negation
use NCT03929848 275 278 O
a NCT03929848 279 280 O
reinforced NCT03929848 281 291 B-Procedure
tracheal NCT03929848 292 300 I-Procedure
tube NCT03929848 301 305 I-Procedure
of NCT03929848 306 308 O
internal NCT03929848 309 317 B-Observation
diameter NCT03929848 318 326 I-Observation
of NCT03929848 327 329 O
5.0 NCT03929848 330 333 B-Eq_Comparison
mm NCT03929848 334 336 I-Eq_Comparison
for NCT03929848 337 340 O
female NCT03929848 341 347 O
patient NCT03929848 348 355 O

Inclusion NCT03926481 0 9 O
Criteria NCT03926481 10 18 O
: NCT03926481 19 20 O

- NCT03926481 24 25 O
English NCT03926481 27 34 O
Speaking NCT03926481 35 43 O

- NCT03926481 46 47 O
Age NCT03926481 49 52 B-Age
≥ NCT03926481 53 54 B-Eq_Comparison
65 NCT03926481 55 57 I-Eq_Comparison
years NCT03926481 58 63 I-Eq_Comparison

- NCT03926481 66 67 O
Body NCT03926481 69 73 O
Composition NCT03926481 74 85 O
Body NCT03926481 86 90 B-Observation
Fat NCT03926481 91 94 I-Observation
> NCT03926481 95 96 B-Eq_Comparison
25 NCT03926481 97 99 I-Eq_Comparison
% NCT03926481 100 101 I-Eq_Comparison
for NCT03926481 102 105 O
Men NCT03926481 106 109 O

- NCT03926481 112 113 O
Body NCT03926481 115 119 O
Composition NCT03926481 120 131 O
Body NCT03926481 132 136 B-Observation
Fat NCT03926481 137 140 I-Observation
> NCT03926481 141 142 B-Eq_Comparison
30 NCT03926481 143 145 I-Eq_Comparison
% NCT03926481 146 147 I-Eq_Comparison
for NCT03926481 148 151 O
Women NCT03926481 152 157 O

- NCT03926481 160 161 O
Participating NCT03926481 163 176 O
in NCT03926481 177 179 O
the NCT03926481 180 183 O
Dartmouth NCT03926481 184 193 O
Hitchcock NCT03926481 194 203 O
Weight NCT03926481 204 210 O
and NCT03926481 211 214 O
Wellness NCT03926481 215 223 O
Center NCT03926481 224 230 O
( NCT03926481 231 232 O
WWC NCT03926481 233 236 O
) NCT03926481 237 238 O
Healthy NCT03926481 239 246 O
Lifestyle NCT03926481 247 256 O
Program NCT03926481 257 264 O
( NCT03926481 265 266 O
HLP NCT03926481 267 270 O
) NCT03926481 271 272 O

- NCT03926481 276 277 O
Willing NCT03926481 279 286 O
and NCT03926481 287 290 O
able NCT03926481 291 295 O
to NCT03926481 296 298 O
give NCT03926481 299 303 O
informed NCT03926481 304 312 O
consent NCT03926481 313 320 O

Exclusion NCT03926481 321 330 O
Criteria NCT03926481 331 339 O
: NCT03926481 340 341 O

- NCT03926481 345 346 O
Unable NCT03926481 348 354 O
to NCT03926481 355 357 O
perform NCT03926481 358 365 O
measures NCT03926481 366 374 O

- NCT03926481 377 378 O
Individuals NCT03926481 380 391 O
unwilling NCT03926481 392 401 O
/ NCT03926481 402 403 O
unable NCT03926481 404 410 O
to NCT03926481 411 413 O
provide NCT03926481 414 421 O
consent NCT03926481 422 429 O

- NCT03926481 432 433 O
Severe NCT03926481 435 441 O
mental NCT03926481 442 448 B-Modifier
or NCT03926481 449 451 B-Or
life NCT03926481 452 456 B-Modifier
- NCT03926481 457 458 I-Modifier
threatening NCT03926481 459 470 I-Modifier
illness NCT03926481 471 478 B-Condition

- NCT03926481 481 482 O
History NCT03926481 484 491 B-Eq_Comparison
of NCT03926481 492 494 O
bariatric NCT03926481 495 504 B-Procedure
surgery NCT03926481 505 512 I-Procedure

Inclusion NCT03927612 0 9 O
Criteria NCT03927612 10 18 O
: NCT03927612 19 20 O

- NCT03927612 24 25 O
Aged NCT03927612 27 31 B-Age
9 NCT03927612 32 33 B-Eq_Comparison
- NCT03927612 34 35 I-Eq_Comparison
12 NCT03927612 36 38 I-Eq_Comparison

- NCT03927612 42 43 O
English NCT03927612 45 52 O
- NCT03927612 53 54 O
speaking NCT03927612 55 63 O

- NCT03927612 66 67 O
Meet NCT03927612 69 73 O
DSM NCT03927612 74 77 O
- NCT03927612 78 79 O
5 NCT03927612 80 81 O
criteria NCT03927612 82 90 O
for NCT03927612 91 94 O
oppositional NCT03927612 95 107 B-Condition
defiant NCT03927612 108 115 I-Condition
disorder NCT03927612 116 124 I-Condition
( NCT03927612 125 126 O
ODD NCT03927612 127 130 B-Condition
) NCT03927612 131 132 O
, NCT03927612 133 134 O
conduct NCT03927612 135 142 B-Condition
disorder NCT03927612 143 151 I-Condition
( NCT03927612 152 153 O
CD NCT03927612 154 156 B-Condition
) NCT03927612 157 158 O
, NCT03927612 159 160 O
or NCT03927612 161 163 B-Or
Other NCT03927612 164 169 B-Other
Specified NCT03927612 170 179 B-Modifier
or NCT03927612 180 182 B-Or
Unspecified NCT03927612 183 194 B-Modifier
Disruptive NCT03927612 195 205 I-Modifier
, NCT03927612 206 207 O
Impulse NCT03927612 208 215 B-Modifier
- NCT03927612 216 217 I-Modifier
Control NCT03927612 218 225 I-Modifier
, NCT03927612 226 227 O
and NCT03927612 228 231 B-Or
Conduct NCT03927612 232 239 B-Modifier
Disorder NCT03927612 240 248 B-Condition

- NCT03927612 251 252 O
Right NCT03927612 254 259 O
- NCT03927612 260 261 O
handed NCT03927612 262 268 O

- NCT03927612 271 272 O
Estimated NCT03927612 274 283 O
full NCT03927612 284 288 B-Observation
- NCT03927612 289 290 I-Observation
scale NCT03927612 291 296 I-Observation
IQ NCT03927612 297 299 I-Observation
greater NCT03927612 300 307 B-Eq_Comparison
than NCT03927612 308 312 I-Eq_Comparison
75 NCT03927612 313 315 I-Eq_Comparison

Exclusion NCT03927612 317 326 O
Criteria NCT03927612 327 335 O
: NCT03927612 336 337 O

- NCT03927612 341 342 O
Bipolar NCT03927612 344 351 B-Condition
disorder NCT03927612 352 360 I-Condition
, NCT03927612 361 362 O
any NCT03927612 363 366 O
disorder NCT03927612 367 375 B-Condition
involving NCT03927612 376 385 O
psychosis NCT03927612 386 395 B-Condition
, NCT03927612 396 397 O
pervasive NCT03927612 398 407 B-Condition
developmental NCT03927612 408 421 I-Condition
disorders NCT03927612 422 431 I-Condition
, NCT03927612 432 433 O
current NCT03927612 434 441 B-Eq_Comparison
or NCT03927612 442 444 B-Or
past NCT03927612 445 449 B-Eq_Comparison
substance NCT03927612 450 459 B-Condition
use NCT03927612 460 463 I-Condition
disorder NCT03927612 464 472 I-Condition
, NCT03927612 473 474 O
or NCT03927612 475 477 B-Or
current NCT03927612 478 485 B-Eq_Comparison
major NCT03927612 486 491 O
depressive NCT03927612 492 502 B-Condition
disorder NCT03927612 503 511 I-Condition

- NCT03927612 514 515 O
History NCT03927612 517 524 B-Eq_Comparison
of NCT03927612 525 527 O
neurological NCT03927612 528 540 B-Condition
problems NCT03927612 541 549 I-Condition
( NCT03927612 550 551 O
e NCT03927612 552 553 O
. NCT03927612 554 555 O
g NCT03927612 556 557 O
. NCT03927612 558 559 O
, NCT03927612 560 561 O
epilepsy NCT03927612 562 570 B-Condition
, NCT03927612 571 572 O
traumatic NCT03927612 573 582 B-Condition
brain NCT03927612 583 588 I-Condition
injury NCT03927612 589 595 I-Condition
) NCT03927612 596 597 O

- NCT03927612 601 602 O
Contraindications NCT03927612 604 621 B-Contraindication
for NCT03927612 622 625 O
MRI NCT03927612 626 629 B-Procedure

Inclusion NCT03928899 0 9 O
Criteria NCT03928899 10 18 O
: NCT03928899 19 20 O

- NCT03928899 24 25 O
singleton NCT03928899 27 36 B-Condition
pregnant NCT03928899 37 45 I-Condition
women NCT03928899 46 51 O

- NCT03928899 54 55 O
in NCT03928899 57 59 O
vertex NCT03928899 60 66 B-Condition
presentation NCT03928899 67 79 I-Condition

- NCT03928899 82 83 O
GDM NCT03928899 85 88 B-Condition
that NCT03928899 89 93 O
is NCT03928899 94 96 O
controlled NCT03928899 97 107 O
with NCT03928899 108 112 O
only NCT03928899 113 117 O
diet NCT03928899 118 122 O
and NCT03928899 123 126 O
exercise NCT03928899 127 135 O

- NCT03928899 138 139 O
at NCT03928899 141 143 O
37 NCT03928899 144 146 B-Eq_Comparison
weeks NCT03928899 147 152 I-Eq_Comparison
0 NCT03928899 153 154 I-Eq_Comparison
days NCT03928899 155 159 I-Eq_Comparison
to NCT03928899 160 162 I-Eq_Comparison
37 NCT03928899 163 165 I-Eq_Comparison
weeks NCT03928899 166 171 I-Eq_Comparison
6 NCT03928899 172 173 I-Eq_Comparison
days NCT03928899 174 178 I-Eq_Comparison
of NCT03928899 179 181 O
gestation NCT03928899 182 191 B-Observation

- NCT03928899 194 195 O
more NCT03928899 197 201 B-Eq_Comparison
than NCT03928899 202 206 I-Eq_Comparison
18 NCT03928899 207 209 I-Eq_Comparison
years NCT03928899 210 215 I-Eq_Comparison
old NCT03928899 216 219 B-Age

- NCT03928899 222 223 O
have NCT03928899 225 229 O
no NCT03928899 230 232 B-Negation
other NCT03928899 233 238 B-Other
contraindications NCT03928899 239 256 B-Contraindication
to NCT03928899 257 259 O
vaginal NCT03928899 260 267 B-Procedure
delivery NCT03928899 268 276 I-Procedure
. NCT03928899 277 278 O

Exclusion NCT03928899 280 289 O
Criteria NCT03928899 290 298 O
: NCT03928899 299 300 O

- NCT03928899 304 305 O
prior NCT03928899 307 312 B-Eq_Comparison
caesarean NCT03928899 313 322 B-Procedure
section NCT03928899 323 330 I-Procedure
or NCT03928899 331 333 B-Or
myomectomy NCT03928899 334 344 B-Procedure

- NCT03928899 347 348 O
any NCT03928899 350 353 O
known NCT03928899 354 359 O
contraindications NCT03928899 360 377 B-Contraindication
to NCT03928899 378 380 O
vaginal NCT03928899 381 388 B-Procedure
delivery NCT03928899 389 397 I-Procedure

- NCT03928899 400 401 O
uncertain NCT03928899 403 412 B-Negation
gestational NCT03928899 413 424 B-Observation
age NCT03928899 425 428 I-Observation

- NCT03928899 431 432 O
non NCT03928899 434 437 B-Condition
reassuring NCT03928899 438 448 I-Condition
foetal NCT03928899 449 455 I-Condition
wellbeing NCT03928899 456 465 I-Condition
necessitating NCT03928899 466 479 B-Assertion___Assertion_Type_Value:hypothetical
delivery NCT03928899 480 488 B-Procedure

- NCT03928899 491 492 O
maternal NCT03928899 494 502 B-Family_Member___Family_Member_Type:mother
pregnancy NCT03928899 503 512 B-Condition
- NCT03928899 513 514 I-Condition
related NCT03928899 515 522 I-Condition
disease NCT03928899 523 530 I-Condition
necessitating NCT03928899 531 544 O
delivery NCT03928899 545 553 B-Procedure
( NCT03928899 554 555 O
any NCT03928899 556 559 O
hypertensive NCT03928899 560 572 B-Condition
disorder NCT03928899 573 581 I-Condition
, NCT03928899 582 583 O
cardiac NCT03928899 584 591 B-Condition
disease NCT03928899 592 599 I-Condition
, NCT03928899 600 601 O
renal NCT03928899 602 607 B-Condition
insufficiency NCT03928899 608 621 I-Condition
, NCT03928899 622 623 O
immune NCT03928899 624 630 B-Condition
diseases NCT03928899 631 639 I-Condition
, NCT03928899 640 641 O
et NCT03928899 642 644 O
al NCT03928899 645 647 O
. NCT03928899 648 649 O
) NCT03928899 650 651 O

- NCT03928899 655 656 O
placenta NCT03928899 658 666 B-Condition
previa NCT03928899 667 673 B-Modifier
, NCT03928899 674 675 O
accreta NCT03928899 676 683 B-Modifier
, NCT03928899 684 685 O
vasa NCT03928899 686 690 B-Modifier
previa NCT03928899 691 697 I-Modifier

- NCT03928899 700 701 O
known NCT03928899 703 708 O
foetal NCT03928899 709 715 B-Condition
anomaly NCT03928899 716 723 I-Condition

- NCT03928899 726 727 O
negative NCT03928899 729 737 B-Negation
reproductive NCT03928899 738 750 B-Condition
history NCT03928899 751 758 I-Condition

- NCT03928899 761 762 O
ruptured NCT03928899 764 772 B-Condition
membranes NCT03928899 773 782 I-Condition
or NCT03928899 783 785 B-Or
known NCT03928899 786 791 O
oligohydramnios NCT03928899 792 807 B-Condition
( NCT03928899 808 809 O
defined NCT03928899 810 817 O
as NCT03928899 818 820 O
AFI NCT03928899 821 824 B-Observation
< NCT03928899 825 826 B-Eq_Comparison
5 NCT03928899 827 828 I-Eq_Comparison
or NCT03928899 829 831 B-Or
MVP NCT03928899 832 835 B-Observation
< NCT03928899 836 837 B-Eq_Comparison
2 NCT03928899 838 839 I-Eq_Comparison
) NCT03928899 840 841 O
before NCT03928899 842 848 B-Temporal_Connection___Temporal_Connection_Type_Value:before

37 NCT03928899 854 856 B-Eq_Comparison
weeks NCT03928899 857 862 I-Eq_Comparison
6 NCT03928899 863 864 I-Eq_Comparison
days NCT03928899 865 869 I-Eq_Comparison
of NCT03928899 870 872 O
gestation NCT03928899 873 882 B-Observation

- NCT03928899 885 886 O
fetal NCT03928899 888 893 B-Condition
growth NCT03928899 894 900 I-Condition
restriction NCT03928899 901 912 I-Condition
, NCT03928899 913 914 O
defined NCT03928899 915 922 O
as NCT03928899 923 925 O
EFW NCT03928899 926 929 B-Observation
< NCT03928899 930 931 B-Eq_Comparison
10 NCT03928899 932 934 I-Eq_Comparison
th NCT03928899 935 937 I-Eq_Comparison
percentile NCT03928899 938 948 I-Eq_Comparison

- NCT03928899 951 952 O
known NCT03928899 954 959 O
HIV NCT03928899 960 963 B-Condition
positivity NCT03928899 964 974 O
because NCT03928899 975 982 O
of NCT03928899 983 985 O
modified NCT03928899 986 994 O
delivery NCT03928899 995 1003 O
plan NCT03928899 1004 1008 O

- NCT03928899 1011 1012 O
signs NCT03928899 1014 1019 B-Assertion___Assertion_Type_Value:possible
of NCT03928899 1020 1022 O
labor NCT03928899 1023 1028 B-Condition
( NCT03928899 1029 1030 O
regular NCT03928899 1031 1038 B-Condition
painful NCT03928899 1039 1046 I-Condition
contractions NCT03928899 1047 1059 I-Condition
with NCT03928899 1060 1064 B-And
cervical NCT03928899 1065 1073 B-Condition
change NCT03928899 1074 1080 I-Condition
) NCT03928899 1081 1082 O
before NCT03928899 1083 1089 B-Temporal_Connection___Temporal_Connection_Type_Value:before
37 NCT03928899 1090 1092 B-Eq_Comparison
weeks NCT03928899 1093 1098 I-Eq_Comparison
6 NCT03928899 1099 1100 I-Eq_Comparison
days NCT03928899 1101 1105 I-Eq_Comparison
of NCT03928899 1106 1108 O
gestation NCT03928899 1109 1118 B-Observation
. NCT03928899 1119 1120 O

Inclusion NCT03864354 0 9 O
Criteria NCT03864354 10 18 O
: NCT03864354 19 20 O

- NCT03864354 24 25 O
18 NCT03864354 27 29 B-Eq_Comparison
years NCT03864354 30 35 I-Eq_Comparison
of NCT03864354 36 38 I-Eq_Comparison
age NCT03864354 39 42 I-Eq_Comparison
or NCT03864354 43 45 I-Eq_Comparison
older NCT03864354 46 51 I-Eq_Comparison

- NCT03864354 54 55 O
previously NCT03864354 57 67 B-Eq_Comparison
diagnosed NCT03864354 68 77 O
with NCT03864354 78 82 O
asthma NCT03864354 83 89 B-Condition

Exclusion NCT03864354 90 99 O
Criteria NCT03864354 100 108 O
: NCT03864354 109 110 O

- NCT03864354 114 115 O
Current NCT03864354 117 124 B-Eq_Comparison
smoker NCT03864354 125 131 B-Condition

- NCT03864354 134 135 O
Diagnosed NCT03864354 137 146 O
with NCT03864354 147 151 O
any NCT03864354 152 155 O
other NCT03864354 156 161 B-Other
respiratory NCT03864354 162 173 B-Condition
disease NCT03864354 174 181 I-Condition
besides NCT03864354 182 189 B-Exception
asthma NCT03864354 190 196 B-Condition

- NCT03864354 199 200 O
Receiving NCT03864354 202 211 B-Eq_Comparison
OMM NCT03864354 212 215 B-Drug
from NCT03864354 216 220 O
a NCT03864354 221 222 O
licensed NCT03864354 223 231 O
physician NCT03864354 232 241 B-Provider
, NCT03864354 242 243 O
chiropractic NCT03864354 244 256 B-Procedure
treatment NCT03864354 257 266 I-Procedure
, NCT03864354 267 268 O
or NCT03864354 269 271 B-Or
massage NCT03864354 272 279 B-Procedure
therapy NCT03864354 280 287 I-Procedure
for NCT03864354 288 291 O
30 NCT03864354 292 294 B-Eq_Comparison
days NCT03864354 295 299 I-Eq_Comparison
prior NCT03864354 300 305 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03864354 306 308 I-Temporal_Connection___Temporal_Connection_Type_Value:before
and NCT03864354 309 312 B-Or
during NCT03864354 313 319 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864354 320 323 O
study NCT03864354 324 329 B-Study

Inclusion NCT03925584 0 9 O
Criteria NCT03925584 10 18 O
: NCT03925584 19 20 O

- NCT03925584 24 25 O
Greater NCT03925584 27 34 B-Eq_Comparison
than NCT03925584 35 39 I-Eq_Comparison
37 NCT03925584 40 42 I-Eq_Comparison
weeks NCT03925584 43 48 I-Eq_Comparison
gestation NCT03925584 49 58 B-Observation
, NCT03925584 59 60 O

- NCT03925584 64 65 O
Between NCT03925584 67 74 B-Eq_Comparison
0 NCT03925584 75 76 I-Eq_Comparison
to NCT03925584 77 79 I-Eq_Comparison
30 NCT03925584 80 82 I-Eq_Comparison
days NCT03925584 83 87 I-Eq_Comparison
of NCT03925584 88 90 O
age NCT03925584 91 94 B-Age

- NCT03925584 97 98 O
24 NCT03925584 100 102 B-Eq_Comparison
hours NCT03925584 103 108 I-Eq_Comparison
post NCT03925584 109 113 B-Temporal_Connection___Temporal_Connection_Type_Value:after
congenital NCT03925584 114 124 B-Modifier
heart NCT03925584 125 130 B-Procedure
surgery NCT03925584 131 138 I-Procedure

- NCT03925584 141 142 O
Receiving NCT03925584 144 153 B-Eq_Comparison
mechanical NCT03925584 154 164 B-Procedure
ventilation NCT03925584 165 176 I-Procedure

- NCT03925584 179 180 O
Background NCT03925584 182 192 B-Observation
noise NCT03925584 193 198 I-Observation
level NCT03925584 199 204 I-Observation
( NCT03925584 205 206 O
at NCT03925584 207 209 O
bedside NCT03925584 210 217 B-Modifier
) NCT03925584 218 219 O
at NCT03925584 220 222 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03925584 223 226 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03925584 227 231 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03925584 232 234 O
music NCT03925584 235 240 B-Procedure
therapy NCT03925584 241 248 I-Procedure
must NCT03925584 249 253 O
be NCT03925584 254 256 O
55 NCT03925584 257 259 B-Eq_Comparison
dB NCT03925584 260 262 I-Eq_Comparison
or NCT03925584 263 265 I-Eq_Comparison
less NCT03925584 266 270 I-Eq_Comparison
. NCT03925584 271 272 O

Exclusion NCT03925584 274 283 O
Criteria NCT03925584 284 292 O
: NCT03925584 293 294 O

- NCT03925584 298 299 O
Hemodynamically NCT03925584 301 316 B-Condition
unstable NCT03925584 317 325 O
or NCT03925584 326 328 B-Or
end NCT03925584 329 332 B-Death|B-Risk
of NCT03925584 333 335 I-Death|I-Risk
life NCT03925584 336 340 I-Death|I-Risk

- NCT03925584 343 344 O
If NCT03925584 346 348 O
patient NCT03925584 349 356 O
is NCT03925584 357 359 O
in NCT03925584 360 362 O
a NCT03925584 363 364 O
closed NCT03925584 365 371 O
Giraffe NCT03925584 372 379 O
bed NCT03925584 380 383 O

- NCT03925584 386 387 O
Evidence NCT03925584 389 397 O
of NCT03925584 398 400 O
hearing NCT03925584 401 408 B-Condition
impairment NCT03925584 409 419 I-Condition

- NCT03925584 422 423 O
Patient NCT03925584 425 432 O
has NCT03925584 433 436 O
known NCT03925584 437 442 O
or NCT03925584 443 445 O
suspected NCT03925584 446 455 B-Assertion___Assertion_Type_Value:possible
active NCT03925584 456 462 B-Eq_Comparison
seizure NCT03925584 463 470 B-Condition
disorder NCT03925584 471 479 I-Condition

Inclusion NCT03862742 0 9 O
Criteria NCT03862742 10 18 O
: NCT03862742 19 20 O

- NCT03862742 24 25 O
≥ NCT03862742 27 28 B-Eq_Comparison
18 NCT03862742 29 31 I-Eq_Comparison
years NCT03862742 32 37 I-Eq_Comparison
of NCT03862742 38 40 O
age NCT03862742 41 44 B-Age

- NCT03862742 47 48 O
Own NCT03862742 50 53 O
an NCT03862742 54 56 O
iOS NCT03862742 57 60 O
or NCT03862742 61 63 O
Android NCT03862742 64 71 O
device NCT03862742 72 78 O

Exclusion NCT03862742 79 88 O
Criteria NCT03862742 89 97 O
: NCT03862742 98 99 O

- NCT03862742 103 104 O
Inability NCT03862742 106 115 O
to NCT03862742 116 118 O
give NCT03862742 119 123 O
informed NCT03862742 124 132 O
consent NCT03862742 133 140 O

- NCT03862742 143 144 O
< NCT03862742 146 147 B-Eq_Comparison
18 NCT03862742 148 150 I-Eq_Comparison
years NCT03862742 151 156 I-Eq_Comparison
of NCT03862742 157 159 O
age NCT03862742 160 163 B-Age

- NCT03862742 166 167 O
Inability NCT03862742 169 178 B-Negation
to NCT03862742 179 181 I-Negation
understand NCT03862742 182 192 I-Negation
written NCT03862742 193 200 O
English NCT03862742 201 208 O
language NCT03862742 209 217 O

- NCT03862742 220 221 O
Hypertensive NCT03862742 223 235 B-Condition
urgency NCT03862742 236 243 B-Modifier
or NCT03862742 244 246 B-Or
emergency NCT03862742 247 256 B-Modifier
as NCT03862742 257 259 O
an NCT03862742 260 262 O
admission NCT03862742 263 272 O
diagnosis NCT03862742 273 282 O

Inclusion NCT03921190 0 9 O
Criteria NCT03921190 10 18 O
: NCT03921190 19 20 O

- NCT03921190 24 25 O
Adult NCT03921190 27 32 O
patients NCT03921190 33 41 O
( NCT03921190 42 43 O
16 NCT03921190 44 46 B-Eq_Comparison
years NCT03921190 47 52 I-Eq_Comparison
old NCT03921190 53 56 I-Eq_Comparison
and NCT03921190 57 60 I-Eq_Comparison
older NCT03921190 61 66 I-Eq_Comparison
) NCT03921190 67 68 O

- NCT03921190 72 73 O
Healthy NCT03921190 75 82 B-Condition
( NCT03921190 83 84 O
American NCT03921190 85 93 B-Observation
Society NCT03921190 94 101 I-Observation
of NCT03921190 102 104 I-Observation
Anaesthesiologists NCT03921190 105 123 I-Observation
( NCT03921190 124 125 O
ASA NCT03921190 126 129 B-Observation
) NCT03921190 130 131 O
category NCT03921190 132 140 B-Eq_Comparison
I NCT03921190 141 142 I-Eq_Comparison
or NCT03921190 143 145 I-Eq_Comparison
II NCT03921190 146 148 I-Eq_Comparison
) NCT03921190 149 150 O

- NCT03921190 154 155 O
A NCT03921190 157 158 O
maxillary NCT03921190 159 168 B-Modifier
posterior NCT03921190 169 178 I-Modifier
tooth NCT03921190 179 184 I-Modifier
( NCT03921190 185 186 O
excluding NCT03921190 187 196 B-Exception
third NCT03921190 197 202 B-Modifier
molars NCT03921190 203 209 I-Modifier
) NCT03921190 210 211 O
referred NCT03921190 212 220 O
for NCT03921190 221 224 O
root NCT03921190 225 229 B-Procedure
canal NCT03921190 230 235 I-Procedure
treatment NCT03921190 236 245 I-Procedure
and NCT03921190 246 249 B-And
diagnosed NCT03921190 250 259 O
with NCT03921190 260 264 O
irreversible NCT03921190 265 277 B-Condition
pulpitis NCT03921190 278 286 I-Condition
and NCT03921190 287 290 B-And
normal NCT03921190 291 297 O
apical NCT03921190 298 304 B-Condition
tissues NCT03921190 305 312 I-Condition

Exclusion NCT03921190 313 322 O
Criteria NCT03921190 323 331 O
: NCT03921190 332 333 O

- NCT03921190 337 338 O
Psychological NCT03921190 340 353 B-Condition
disorders NCT03921190 354 363 I-Condition

- NCT03921190 366 367 O
Intraoral NCT03921190 369 378 B-Modifier
soft NCT03921190 379 383 B-Condition
tissue NCT03921190 384 390 I-Condition
abnormalities NCT03921190 391 404 I-Condition

- NCT03921190 407 408 O
necrotic NCT03921190 410 418 B-Condition
pulp NCT03921190 419 423 I-Condition
with NCT03921190 424 428 B-And
/ NCT03921190 429 430 B-Or
without NCT03921190 431 438 B-Negation
apical NCT03921190 439 445 B-Condition
pathology NCT03921190 446 455 I-Condition

- NCT03921190 458 459 O
tenderness NCT03921190 461 471 B-Condition
to NCT03921190 472 474 O
palpation NCT03921190 475 484 B-Procedure
and NCT03921190 485 488 B-Or
/ NCT03921190 489 490 I-Or
or NCT03921190 491 493 I-Or
percussion NCT03921190 494 504 B-Procedure

- NCT03921190 507 508 O
The NCT03921190 510 513 O
use NCT03921190 514 517 O
of NCT03921190 518 520 O
analgesics NCT03921190 521 531 B-Drug
in NCT03921190 532 534 O
the NCT03921190 535 538 O
preceding NCT03921190 539 548 B-Eq_Comparison
12 NCT03921190 549 551 I-Eq_Comparison
hours NCT03921190 552 557 I-Eq_Comparison
before NCT03921190 558 564 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03921190 565 568 O
appointment NCT03921190 569 580 B-Encounter
. NCT03921190 581 582 O

Inclusion NCT03860064 0 9 O
Criteria NCT03860064 10 18 O
: NCT03860064 19 20 O

- NCT03860064 24 25 O
18 NCT03860064 27 29 B-Eq_Comparison
- NCT03860064 30 31 I-Eq_Comparison
35 NCT03860064 32 34 I-Eq_Comparison
- NCT03860064 35 36 I-Eq_Comparison
year NCT03860064 37 41 I-Eq_Comparison
- NCT03860064 42 43 O
old NCT03860064 44 47 B-Age
women NCT03860064 48 53 O

- NCT03860064 56 57 O
BMI NCT03860064 59 62 B-Observation
: NCT03860064 63 64 O
> NCT03860064 65 66 B-Eq_Comparison
18 NCT03860064 67 69 I-Eq_Comparison
and NCT03860064 70 73 B-And
< NCT03860064 74 75 B-Eq_Comparison
30 NCT03860064 76 78 I-Eq_Comparison
kg NCT03860064 79 81 I-Eq_Comparison
/ NCT03860064 82 83 I-Eq_Comparison
m NCT03860064 84 85 I-Eq_Comparison
2 NCT03860064 86 87 I-Eq_Comparison

- NCT03860064 90 91 O
Normal NCT03860064 93 99 O
female NCT03860064 100 106 B-Modifier
karyotype NCT03860064 107 116 B-Condition

- NCT03860064 119 120 O
Normal NCT03860064 122 128 O
uterus NCT03860064 129 135 B-Condition
and NCT03860064 136 139 B-And
ovaries NCT03860064 140 147 B-Condition
at NCT03860064 148 150 B-Temporal_Connection___Temporal_Connection_Type_Value:during
transvaginal NCT03860064 151 163 B-Procedure
ultrasound NCT03860064 164 174 I-Procedure

Exclusion NCT03860064 175 184 O
Criteria NCT03860064 185 193 O
: NCT03860064 194 195 O

- NCT03860064 199 200 O
> NCT03860064 202 203 B-Eq_Comparison
35 NCT03860064 204 206 I-Eq_Comparison
years NCT03860064 207 212 I-Eq_Comparison

- NCT03860064 215 216 O
PCO NCT03860064 218 221 B-Condition
syndrome NCT03860064 222 230 I-Condition
carriers NCT03860064 231 239 O

- NCT03860064 242 243 O
Null NCT03860064 245 249 B-Modifier
follicle NCT03860064 250 258 B-Condition
aspiration NCT03860064 259 269 I-Condition

- NCT03860064 272 273 O
History NCT03860064 275 282 B-Eq_Comparison
of NCT03860064 283 285 O
chemotherapy NCT03860064 286 298 B-Procedure
or NCT03860064 299 301 B-Or
radiotherapy NCT03860064 302 314 B-Procedure

Inclusion NCT03928379 0 9 O
Criteria NCT03928379 10 18 O
: NCT03928379 19 20 O

- NCT03928379 24 25 O
Have NCT03928379 27 31 O
Type NCT03928379 32 36 B-Modifier
II NCT03928379 37 39 I-Modifier
diabetes NCT03928379 40 48 B-Condition

- NCT03928379 51 52 O
Body NCT03928379 54 58 B-Observation
mass NCT03928379 59 63 I-Observation
index NCT03928379 64 69 I-Observation
( NCT03928379 70 71 O
BMI NCT03928379 72 75 B-Observation
) NCT03928379 76 77 O
of NCT03928379 78 80 O
25 NCT03928379 81 83 B-Eq_Comparison
- NCT03928379 84 85 I-Eq_Comparison
40 NCT03928379 86 88 I-Eq_Comparison
kilograms NCT03928379 89 98 I-Eq_Comparison
per NCT03928379 99 102 I-Eq_Comparison
square NCT03928379 103 109 I-Eq_Comparison
meter NCT03928379 110 115 I-Eq_Comparison
( NCT03928379 116 117 I-Eq_Comparison
kg NCT03928379 118 120 I-Eq_Comparison
/ NCT03928379 121 122 I-Eq_Comparison
m² NCT03928379 123 125 I-Eq_Comparison
) NCT03928379 126 127 I-Eq_Comparison
, NCT03928379 128 129 O
inclusive NCT03928379 130 139 O

- NCT03928379 142 143 O
Have NCT03928379 145 149 O
a NCT03928379 150 151 O
body NCT03928379 152 156 B-Observation
weight NCT03928379 157 163 I-Observation
of NCT03928379 164 166 O
< NCT03928379 167 168 B-Eq_Comparison
150 NCT03928379 169 172 I-Eq_Comparison
kilograms NCT03928379 173 182 I-Eq_Comparison
( NCT03928379 183 184 O
kg NCT03928379 185 187 O
) NCT03928379 188 189 O

- NCT03928379 193 194 O
Have NCT03928379 196 200 O
clinical NCT03928379 201 209 O
lab NCT03928379 210 213 B-Observation
test NCT03928379 214 218 I-Observation
results NCT03928379 219 226 O
within NCT03928379 227 233 B-Eq_Comparison
normal NCT03928379 234 240 I-Eq_Comparison
reference NCT03928379 241 250 I-Eq_Comparison
range NCT03928379 251 256 I-Eq_Comparison
for NCT03928379 257 260 O
the NCT03928379 261 264 O
population NCT03928379 265 275 O
or NCT03928379 276 278 O
investigator NCT03928379 279 291 O
site NCT03928379 292 296 O
, NCT03928379 297 298 O
or NCT03928379 299 301 O
results NCT03928379 302 309 O
with NCT03928379 310 314 O
acceptable NCT03928379 315 325 O
deviations NCT03928379 326 336 O
that NCT03928379 337 341 O
are NCT03928379 342 345 O
judged NCT03928379 346 352 O
to NCT03928379 353 355 O
be NCT03928379 356 358 O
not NCT03928379 359 362 O
clinically NCT03928379 363 373 O
significant NCT03928379 374 385 O
by NCT03928379 386 388 O
the NCT03928379 389 392 O
investigator NCT03928379 393 405 O
; NCT03928379 405 406 O
however NCT03928379 407 414 O
, NCT03928379 415 416 O
should NCT03928379 417 423 O
have NCT03928379 424 428 O
serum NCT03928379 429 434 B-Observation
magnesium NCT03928379 435 444 I-Observation
and NCT03928379 445 448 B-And
potassium NCT03928379 449 458 B-Observation
levels NCT03928379 459 465 I-Observation
, NCT03928379 466 467 O
along NCT03928379 468 473 B-And
with NCT03928379 474 478 I-And
lactate NCT03928379 479 486 B-Observation
dehydrogenase NCT03928379 487 500 I-Observation
, NCT03928379 501 502 O
CK NCT03928379 503 505 B-Observation
values NCT03928379 506 512 O
within NCT03928379 513 519 B-Eq_Comparison
the NCT03928379 520 523 I-Eq_Comparison
normal NCT03928379 524 530 I-Eq_Comparison
range NCT03928379 531 536 I-Eq_Comparison
at NCT03928379 537 539 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03928379 540 549 B-Study
and NCT03928379 550 553 B-And
Day NCT03928379 554 557 B-Study
- NCT03928379 558 559 O
2 NCT03928379 560 561 O
. NCT03928379 561 562 O

Exclusion NCT03928379 564 573 O
Criteria NCT03928379 574 582 O
: NCT03928379 583 584 O

- NCT03928379 588 589 O
Have NCT03928379 591 595 O
Type NCT03928379 596 600 B-Modifier
1 NCT03928379 601 602 I-Modifier
diabetes NCT03928379 603 611 B-Condition
or NCT03928379 612 614 B-Or
latent NCT03928379 615 621 B-Modifier
autoimmune NCT03928379 622 632 I-Modifier
diabetes NCT03928379 633 641 B-Condition
in NCT03928379 642 644 B-Modifier
adults NCT03928379 645 651 I-Modifier

- NCT03928379 654 655 O
Have NCT03928379 657 661 O
uncontrolled NCT03928379 662 674 B-Modifier
diabetes NCT03928379 675 683 B-Condition
defined NCT03928379 684 691 O
as NCT03928379 692 694 O
an NCT03928379 695 697 O
episode NCT03928379 698 705 O
of NCT03928379 706 708 O
ketoacidosis NCT03928379 709 721 B-Condition
or NCT03928379 722 724 B-Or
hyperosmolar NCT03928379 725 737 B-Condition
state NCT03928379 738 743 I-Condition
requiring NCT03928379 744 753 O
hospitalization NCT03928379 754 769 B-Encounter
for NCT03928379 770 773 O
6 NCT03928379 774 775 B-Eq_Comparison
months NCT03928379 776 782 I-Eq_Comparison
prior NCT03928379 783 788 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928379 789 791 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03928379 792 801 B-Study

- NCT03928379 804 805 O
Have NCT03928379 807 811 O
had NCT03928379 812 815 O
an NCT03928379 816 818 O
episode NCT03928379 819 826 O
of NCT03928379 827 829 O
severe NCT03928379 830 836 O
hypoglycemia NCT03928379 837 849 B-Condition
, NCT03928379 850 851 O
defined NCT03928379 852 859 O
by NCT03928379 860 862 O
the NCT03928379 863 866 O
occurrence NCT03928379 867 877 O
of NCT03928379 878 880 O
neuroglycopenic NCT03928379 881 896 B-Condition
symptoms NCT03928379 897 905 B-Assertion___Assertion_Type_Value:possible
requiring NCT03928379 906 915 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03928379 916 919 O
assistance NCT03928379 920 930 B-Observation
of NCT03928379 931 933 I-Observation
another NCT03928379 934 941 I-Observation
person NCT03928379 942 948 I-Observation
for NCT03928379 949 952 O
recovery NCT03928379 953 961 O
, NCT03928379 962 963 O
within NCT03928379 964 970 B-Eq_Comparison
6 NCT03928379 971 972 I-Eq_Comparison
months NCT03928379 973 979 I-Eq_Comparison
prior NCT03928379 980 985 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928379 986 988 O
Visit NCT03928379 989 994 B-Study
1 NCT03928379 995 996 O

- NCT03928379 1000 1001 O
Have NCT03928379 1003 1007 O
an NCT03928379 1008 1010 O
abnormal NCT03928379 1011 1019 O
12 NCT03928379 1020 1022 B-Procedure
- NCT03928379 1023 1024 I-Procedure
lead NCT03928379 1025 1029 I-Procedure
electrocardiogram NCT03928379 1030 1047 I-Procedure
( NCT03928379 1048 1049 O
ECG NCT03928379 1050 1053 B-Procedure
) NCT03928379 1054 1055 O
at NCT03928379 1056 1058 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03928379 1059 1068 B-Study
and NCT03928379 1069 1072 B-Or
/ NCT03928379 1073 1074 I-Or
or NCT03928379 1075 1077 I-Or
Day NCT03928379 1078 1081 B-Study
- NCT03928379 1082 1083 O
2 NCT03928379 1084 1085 O
that NCT03928379 1086 1090 O
, NCT03928379 1091 1092 O
in NCT03928379 1093 1095 O
the NCT03928379 1096 1099 O
opinion NCT03928379 1100 1107 O
of NCT03928379 1108 1110 O
the NCT03928379 1111 1114 O
investigator NCT03928379 1115 1127 O
, NCT03928379 1128 1129 O
increases NCT03928379 1130 1139 O
the NCT03928379 1140 1143 O
risks NCT03928379 1144 1149 B-Risk
associated NCT03928379 1150 1160 O
with NCT03928379 1161 1165 O
participating NCT03928379 1166 1179 O
in NCT03928379 1180 1182 O
the NCT03928379 1183 1186 O
study NCT03928379 1187 1192 B-Study
or NCT03928379 1193 1195 O
may NCT03928379 1196 1199 O
confound NCT03928379 1200 1208 O
ECG NCT03928379 1209 1212 O
data NCT03928379 1213 1217 O
analysis NCT03928379 1218 1226 O

- NCT03928379 1229 1230 O
Have NCT03928379 1232 1236 O
poorly NCT03928379 1237 1243 B-Modifier
controlled NCT03928379 1244 1254 I-Modifier
hypertension NCT03928379 1255 1267 B-Condition
at NCT03928379 1268 1270 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03928379 1271 1280 B-Study
; NCT03928379 1280 1281 O
or NCT03928379 1282 1284 B-Or
a NCT03928379 1285 1286 O
change NCT03928379 1287 1293 O
in NCT03928379 1294 1296 O
antihypertensive NCT03928379 1297 1313 B-Drug
medication NCT03928379 1314 1324 I-Drug
within NCT03928379 1325 1331 B-Eq_Comparison
30 NCT03928379 1332 1334 I-Eq_Comparison
days NCT03928379 1335 1339 I-Eq_Comparison
of NCT03928379 1340 1342 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03928379 1343 1352 B-Study

- NCT03928379 1355 1356 O
Have NCT03928379 1358 1362 O
an NCT03928379 1363 1365 O
estimated NCT03928379 1366 1375 B-Observation
glomerular NCT03928379 1376 1386 I-Observation
filtration NCT03928379 1387 1397 I-Observation
rate NCT03928379 1398 1402 I-Observation
< NCT03928379 1403 1404 B-Eq_Comparison
45 NCT03928379 1405 1407 I-Eq_Comparison
milliliters NCT03928379 1408 1419 I-Eq_Comparison
per NCT03928379 1420 1423 I-Eq_Comparison
minute NCT03928379 1424 1430 I-Eq_Comparison
per NCT03928379 1431 1434 I-Eq_Comparison
1.73 NCT03928379 1435 1439 I-Eq_Comparison
meters NCT03928379 1440 1446 I-Eq_Comparison
squared NCT03928379 1447 1454 I-Eq_Comparison
of NCT03928379 1455 1457 I-Eq_Comparison
body NCT03928379 1458 1462 I-Eq_Comparison
surface NCT03928379 1463 1470 I-Eq_Comparison
area NCT03928379 1471 1475 I-Eq_Comparison
( NCT03928379 1476 1477 I-Eq_Comparison
mL NCT03928379 1478 1480 I-Eq_Comparison
/ NCT03928379 1481 1482 I-Eq_Comparison
min NCT03928379 1483 1486 I-Eq_Comparison
/ NCT03928379 1487 1488 I-Eq_Comparison
1.73 NCT03928379 1489 1493 I-Eq_Comparison
m² NCT03928379 1494 1496 I-Eq_Comparison
) NCT03928379 1497 1498 I-Eq_Comparison

Inclusion NCT03921177 0 9 O
Criteria NCT03921177 10 18 O
: NCT03921177 19 20 O

- NCT03921177 24 25 O
Resident NCT03921177 27 35 O
of NCT03921177 36 38 O
566 NCT03921177 39 42 O
rural NCT03921177 43 48 O
sectors NCT03921177 49 56 O
( NCT03921177 57 58 O
clusters NCT03921177 59 67 O
) NCT03921177 68 69 O
in NCT03921177 70 72 O
Gaibandha NCT03921177 73 82 O
district NCT03921177 83 91 O

- NCT03921177 94 95 O
Recently NCT03921177 97 105 B-Eq_Comparison
- NCT03921177 106 107 O
married NCT03921177 108 115 B-Condition
woman NCT03921177 116 121 O

- NCT03921177 124 125 O
Nulligravid NCT03921177 127 138 B-Condition

Exclusion NCT03921177 139 148 O
Criteria NCT03921177 149 157 O
: NCT03921177 158 159 O

- NCT03921177 163 164 O
Women NCT03921177 166 171 O
with NCT03921177 172 176 B-And
a NCT03921177 177 178 O
history NCT03921177 179 186 B-Eq_Comparison
of NCT03921177 187 189 I-Eq_Comparison
previous NCT03921177 190 198 I-Eq_Comparison
pregnancy NCT03921177 199 208 B-Condition

- NCT03921177 211 212 O
Women NCT03921177 214 219 O
who NCT03921177 220 223 O
refuse NCT03921177 224 230 O
consent NCT03921177 231 238 O
for NCT03921177 239 242 O
participation NCT03921177 243 256 O

Inclusion NCT03927937 0 9 O
Criteria NCT03927937 10 18 O
: NCT03927937 19 20 O

- NCT03927937 24 25 O
Tooth NCT03927937 27 32 O
with NCT03927937 33 37 O
imposible NCT03927937 38 47 O
prognosis NCT03927937 48 57 O

- NCT03927937 60 61 O
Plaque NCT03927937 63 69 B-Observation
index NCT03927937 70 75 I-Observation
score NCT03927937 76 81 I-Observation
less NCT03927937 82 86 B-Eq_Comparison
than NCT03927937 87 91 I-Eq_Comparison
30 NCT03927937 92 94 I-Eq_Comparison
% NCT03927937 95 96 I-Eq_Comparison

- NCT03927937 100 101 O
No NCT03927937 103 105 B-Negation
relevant NCT03927937 106 114 O
systemic NCT03927937 115 123 B-Modifier
disease NCT03927937 124 131 B-Condition

- NCT03927937 134 135 O
Smokers NCT03927937 137 144 B-Observation
( NCT03927937 145 146 O
Less NCT03927937 147 151 B-Eq_Comparison
than NCT03927937 152 156 I-Eq_Comparison
20 NCT03927937 157 159 I-Eq_Comparison
cigars NCT03927937 160 166 I-Eq_Comparison
/ NCT03927937 167 168 I-Eq_Comparison
day NCT03927937 169 172 I-Eq_Comparison
) NCT03927937 173 174 O

Exclusion NCT03927937 176 185 O
Criteria NCT03927937 186 194 O
: NCT03927937 195 196 O

- NCT03927937 200 201 O
Pregnancy NCT03927937 203 212 B-Condition
- NCT03927937 213 214 B-Or
Lactation NCT03927937 215 224 B-Condition

- NCT03927937 227 228 O
Relevant NCT03927937 230 238 O
systemic NCT03927937 239 247 B-Modifier
disease NCT03927937 248 255 B-Condition

Inclusion NCT03926169 0 9 O
Criteria NCT03926169 10 18 O
: NCT03926169 19 20 O

- NCT03926169 24 25 O
Participant NCT03926169 27 38 O
with NCT03926169 39 43 O
moderate NCT03926169 44 52 B-Eq_Comparison
to NCT03926169 53 55 I-Eq_Comparison
severe NCT03926169 56 62 I-Eq_Comparison
Hidradenitis NCT03926169 63 75 B-Condition
Suppurativa NCT03926169 76 87 I-Condition
( NCT03926169 88 89 O
HS NCT03926169 90 92 B-Condition
) NCT03926169 93 94 O
for NCT03926169 95 98 O
at NCT03926169 99 101 B-Eq_Comparison
least NCT03926169 102 107 I-Eq_Comparison
one NCT03926169 108 111 I-Eq_Comparison
year NCT03926169 112 116 I-Eq_Comparison
prior NCT03926169 117 122 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926169 123 125 I-Temporal_Connection___Temporal_Connection_Type_Value:before
Baseline NCT03926169 126 134 B-Study
visit NCT03926169 135 140 O
. NCT03926169 141 142 O

- NCT03926169 146 147 O
HS NCT03926169 149 151 B-Condition
lesions NCT03926169 152 159 I-Condition
present NCT03926169 160 167 O
in NCT03926169 168 170 O
at NCT03926169 171 173 B-Eq_Comparison
least NCT03926169 174 179 I-Eq_Comparison
two NCT03926169 180 183 I-Eq_Comparison
distinct NCT03926169 184 192 I-Eq_Comparison
anatomical NCT03926169 193 203 I-Eq_Comparison
areas NCT03926169 204 209 I-Eq_Comparison
. NCT03926169 210 211 O

- NCT03926169 215 216 O
Draining NCT03926169 218 226 B-Observation
fistula NCT03926169 227 234 I-Observation
count NCT03926169 235 240 I-Observation
of NCT03926169 241 243 O
< NCT03926169 244 245 B-Eq_Comparison
= NCT03926169 246 247 I-Eq_Comparison
20 NCT03926169 248 250 I-Eq_Comparison
at NCT03926169 251 253 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Baseline NCT03926169 254 262 B-Study
visit NCT03926169 263 268 O
. NCT03926169 269 270 O

- NCT03926169 274 275 O
Total NCT03926169 277 282 O
abscesses NCT03926169 283 292 B-Observation
and NCT03926169 293 296 I-Observation
nodule NCT03926169 297 303 I-Observation
count NCT03926169 304 309 I-Observation
( NCT03926169 310 311 O
AN NCT03926169 312 314 B-Observation
count NCT03926169 315 320 I-Observation
) NCT03926169 321 322 O
of NCT03926169 323 325 O
> NCT03926169 326 327 B-Eq_Comparison
= NCT03926169 328 329 I-Eq_Comparison
5 NCT03926169 330 331 I-Eq_Comparison
at NCT03926169 332 334 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Baseline NCT03926169 335 343 B-Study
visit NCT03926169 344 349 O
. NCT03926169 350 351 O

- NCT03926169 355 356 O
Participants NCT03926169 358 370 O
are NCT03926169 371 374 O
required NCT03926169 375 383 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926169 384 386 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03926169 387 390 O
a NCT03926169 391 392 O
daily NCT03926169 393 398 B-Eq_Comparison
antiseptic NCT03926169 399 409 B-Procedure
wash NCT03926169 410 414 I-Procedure
on NCT03926169 415 417 O
their NCT03926169 418 423 O
HS NCT03926169 424 426 B-Condition
lesions NCT03926169 427 434 I-Condition
. NCT03926169 435 436 O

- NCT03926169 440 441 O
Participant NCT03926169 443 454 O
must NCT03926169 455 459 O
have NCT03926169 460 464 O
a NCT03926169 465 466 O
history NCT03926169 467 474 B-Eq_Comparison
of NCT03926169 475 477 O
inadequate NCT03926169 478 488 B-Condition
response NCT03926169 489 497 I-Condition
or NCT03926169 498 500 B-Or
intolerance NCT03926169 501 512 B-Condition
to NCT03926169 513 515 O
an NCT03926169 516 518 O
adequate NCT03926169 519 527 O
trial NCT03926169 528 533 O
of NCT03926169 534 536 O
oral NCT03926169 537 541 B-Drug
antibiotics NCT03926169 542 553 I-Drug
for NCT03926169 554 557 O
treatment NCT03926169 558 567 B-Procedure
of NCT03926169 568 570 O
HS NCT03926169 571 573 B-Condition
. NCT03926169 574 575 O

Exclusion NCT03926169 577 586 O
Criteria NCT03926169 587 595 O
: NCT03926169 596 597 O

- NCT03926169 601 602 O
Participant NCT03926169 604 615 O
has NCT03926169 616 619 O
a NCT03926169 620 621 O
history NCT03926169 622 629 B-Eq_Comparison
of NCT03926169 630 632 O
active NCT03926169 633 639 B-Eq_Comparison
skin NCT03926169 640 644 B-Condition
disease NCT03926169 645 652 I-Condition
other NCT03926169 653 658 B-Exception
than NCT03926169 659 663 I-Exception
HS NCT03926169 664 666 B-Condition
that NCT03926169 667 671 O
could NCT03926169 672 677 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03926169 678 687 O
with NCT03926169 688 692 O
the NCT03926169 693 696 O
assessment NCT03926169 697 707 B-Procedure
of NCT03926169 708 710 O
HS NCT03926169 711 713 B-Condition
. NCT03926169 714 715 O

- NCT03926169 719 720 O
Participant NCT03926169 722 733 O
has NCT03926169 734 737 O
active NCT03926169 738 744 B-Eq_Comparison
tuberculosis NCT03926169 745 757 B-Condition
( NCT03926169 758 759 O
TB NCT03926169 760 762 B-Condition
) NCT03926169 763 764 O
or NCT03926169 765 767 B-Or
concurrent NCT03926169 768 778 O
treatment NCT03926169 779 788 B-Procedure
for NCT03926169 789 792 O
latent NCT03926169 793 799 B-Modifier
TB NCT03926169 800 802 B-Condition
or NCT03926169 803 805 B-Or
evidence NCT03926169 806 814 O
of NCT03926169 815 817 O
hepatitis NCT03926169 818 827 B-Condition
B NCT03926169 828 829 I-Condition
virus NCT03926169 830 835 I-Condition
( NCT03926169 836 837 O
HBV NCT03926169 838 841 B-Condition
) NCT03926169 842 843 O
or NCT03926169 844 846 B-Or
hepatitis NCT03926169 847 856 B-Condition
C NCT03926169 857 858 I-Condition
virus NCT03926169 859 864 I-Condition
( NCT03926169 865 866 O
HCV NCT03926169 867 870 B-Condition
) NCT03926169 871 872 O
or NCT03926169 873 875 B-Or
human NCT03926169 876 881 B-Condition
immuno NCT03926169 882 888 I-Condition
deficiency NCT03926169 889 899 I-Condition
virus NCT03926169 900 905 I-Condition
( NCT03926169 906 907 O
HIV NCT03926169 908 911 B-Condition
) NCT03926169 912 913 O
infection NCT03926169 914 923 B-Condition
. NCT03926169 924 925 O

- NCT03926169 929 930 O
Participant NCT03926169 932 943 O
has NCT03926169 944 947 O
prior NCT03926169 948 953 B-Eq_Comparison
exposure NCT03926169 954 962 O
to NCT03926169 963 965 O
anti NCT03926169 966 970 O
- NCT03926169 971 972 O
interleukin NCT03926169 973 984 B-Condition
- NCT03926169 985 986 I-Condition
1 NCT03926169 987 988 I-Condition
( NCT03926169 989 990 O
anti NCT03926169 991 995 O
- NCT03926169 996 997 O
IL NCT03926169 998 1000 B-Condition
- NCT03926169 1001 1002 I-Condition
1 NCT03926169 1003 1004 I-Condition
) NCT03926169 1005 1006 O
treatment NCT03926169 1007 1016 B-Procedure
within NCT03926169 1017 1023 B-Eq_Comparison
3 NCT03926169 1024 1025 I-Eq_Comparison
months NCT03926169 1026 1032 I-Eq_Comparison
or NCT03926169 1033 1035 B-Or
5 NCT03926169 1036 1037 B-Eq_Comparison
half NCT03926169 1038 1042 I-Eq_Comparison
- NCT03926169 1043 1044 I-Eq_Comparison
lives NCT03926169 1045 1050 I-Eq_Comparison
, NCT03926169 1051 1052 O
whichever NCT03926169 1053 1062 O
is NCT03926169 1063 1065 O
longer NCT03926169 1066 1072 O
, NCT03926169 1073 1074 O
prior NCT03926169 1075 1080 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926169 1081 1083 I-Temporal_Connection___Temporal_Connection_Type_Value:before
baseline NCT03926169 1084 1092 B-Study
. NCT03926169 1093 1094 O

- NCT03926169 1098 1099 O
Participant NCT03926169 1101 1112 O
has NCT03926169 1113 1116 O
received NCT03926169 1117 1125 B-Eq_Comparison
prescription NCT03926169 1126 1138 O
topical NCT03926169 1139 1146 B-Drug
therapies NCT03926169 1147 1156 I-Drug
( NCT03926169 1157 1158 O
including NCT03926169 1159 1168 O
topical NCT03926169 1169 1176 B-Drug
antibiotics NCT03926169 1177 1188 I-Drug
) NCT03926169 1189 1190 O
within NCT03926169 1191 1197 B-Eq_Comparison
14 NCT03926169 1198 1200 I-Eq_Comparison
days NCT03926169 1201 1205 I-Eq_Comparison
prior NCT03926169 1206 1211 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926169 1212 1214 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03926169 1215 1218 O
Baseline NCT03926169 1219 1227 B-Study
visit NCT03926169 1228 1233 O
. NCT03926169 1234 1235 O

- NCT03926169 1239 1240 O
Participant NCT03926169 1242 1253 O
has NCT03926169 1254 1257 O
received NCT03926169 1258 1266 B-Eq_Comparison
systemic NCT03926169 1267 1275 B-Modifier
non NCT03926169 1276 1279 B-Procedure
- NCT03926169 1280 1281 I-Procedure
biologic NCT03926169 1282 1290 I-Procedure
therapies NCT03926169 1291 1300 I-Procedure
that NCT03926169 1301 1305 O
can NCT03926169 1306 1309 O
also NCT03926169 1310 1314 O
be NCT03926169 1315 1317 O
used NCT03926169 1318 1322 O
to NCT03926169 1323 1325 O
treat NCT03926169 1326 1331 O
HS NCT03926169 1332 1334 B-Condition
within NCT03926169 1335 1341 B-Eq_Comparison
4 NCT03926169 1342 1343 I-Eq_Comparison
weeks NCT03926169 1344 1349 I-Eq_Comparison
prior NCT03926169 1350 1355 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926169 1356 1358 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03926169 1359 1362 O
Baseline NCT03926169 1363 1371 B-Study
visit NCT03926169 1372 1377 O
. NCT03926169 1378 1379 O

- NCT03926169 1383 1384 O
Participant NCT03926169 1386 1397 O
has NCT03926169 1398 1401 O
received NCT03926169 1402 1410 B-Eq_Comparison
any NCT03926169 1411 1414 O
systemic NCT03926169 1415 1423 B-Modifier
( NCT03926169 1424 1425 O
including NCT03926169 1426 1435 O
oral NCT03926169 1436 1440 B-Modifier
) NCT03926169 1441 1442 O
antibiotic NCT03926169 1443 1453 B-Drug
treatment NCT03926169 1454 1463 B-Procedure
within NCT03926169 1464 1470 B-Eq_Comparison
4 NCT03926169 1471 1472 I-Eq_Comparison
weeks NCT03926169 1473 1478 I-Eq_Comparison
prior NCT03926169 1479 1484 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926169 1485 1487 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03926169 1488 1491 O
Baseline NCT03926169 1492 1500 B-Study
visit NCT03926169 1501 1506 O
. NCT03926169 1507 1508 O

Inclusion NCT03863691 0 9 O
Criteria NCT03863691 10 18 O
: NCT03863691 19 20 O

- NCT03863691 24 25 O
Common NCT03863691 27 33 O
European NCT03863691 34 42 O
Framework NCT03863691 43 52 O
of NCT03863691 53 55 O
Reference NCT03863691 56 65 O
for NCT03863691 66 69 O
Languages NCT03863691 70 79 O
level NCT03863691 80 85 O
B NCT03863691 86 87 O
2 NCT03863691 88 89 O
in NCT03863691 90 92 O
German NCT03863691 93 99 O
language NCT03863691 100 108 O
. NCT03863691 109 110 O

- NCT03863691 114 115 O
Consent NCT03863691 117 124 O
ability NCT03863691 125 132 O
for NCT03863691 133 136 O
all NCT03863691 137 140 O
relevant NCT03863691 141 149 O
aspects NCT03863691 150 157 O
of NCT03863691 158 160 O
the NCT03863691 161 164 O
experiment NCT03863691 165 175 O
. NCT03863691 176 177 O

Exclusion NCT03863691 179 188 O
Criteria NCT03863691 189 197 O
: NCT03863691 198 199 O

- NCT03863691 203 204 O
Amisulpride NCT03863691 206 217 B-Drug
allergy NCT03863691 218 225 B-Allergy
. NCT03863691 226 227 O

- NCT03863691 231 232 O
Allergy NCT03863691 234 241 B-Allergy
to NCT03863691 242 244 O
other NCT03863691 245 250 O
components NCT03863691 251 261 B-Drug
of NCT03863691 262 264 I-Drug
amisulpride NCT03863691 265 276 I-Drug
/ NCT03863691 277 278 B-Or
placebo NCT03863691 279 286 B-Drug
capsules NCT03863691 287 295 I-Drug
like NCT03863691 296 300 O
lactose NCT03863691 301 308 B-Drug
. NCT03863691 309 310 O

- NCT03863691 314 315 O
Daily NCT03863691 317 322 B-Eq_Comparison
intake NCT03863691 323 329 O
of NCT03863691 330 332 O
other NCT03863691 333 338 B-Other
medication NCT03863691 339 349 B-Drug
including NCT03863691 350 359 O
contraceptives NCT03863691 360 374 B-Drug
. NCT03863691 375 376 O

- NCT03863691 380 381 O
Tendency NCT03863691 383 391 B-Modifier
to NCT03863691 392 394 O
seizures NCT03863691 395 403 B-Condition
. NCT03863691 404 405 O

- NCT03863691 409 410 O
Diagnosis NCT03863691 412 421 O
of NCT03863691 422 424 O
cancer NCT03863691 425 431 B-Condition
especially NCT03863691 432 442 O
pheochromocytoma NCT03863691 443 459 B-Condition
, NCT03863691 460 461 O
prolactinoma NCT03863691 462 474 B-Condition
, NCT03863691 475 476 O
or NCT03863691 477 479 B-Or
breast NCT03863691 480 486 B-Modifier
cancer NCT03863691 487 493 B-Condition
. NCT03863691 494 495 O

- NCT03863691 499 500 O
Kidney NCT03863691 502 508 B-Condition
dysfunction NCT03863691 509 520 I-Condition
: NCT03863691 521 522 O
creatinine NCT03863691 523 533 B-Observation
clearance NCT03863691 534 543 I-Observation
below NCT03863691 544 549 B-Eq_Comparison
10 NCT03863691 550 552 I-Eq_Comparison
ml NCT03863691 553 555 I-Eq_Comparison
per NCT03863691 556 559 I-Eq_Comparison
minute NCT03863691 560 566 I-Eq_Comparison
. NCT03863691 567 568 O

- NCT03863691 572 573 O
High NCT03863691 575 579 O
risk NCT03863691 580 584 B-Risk
for NCT03863691 585 588 O
stroke NCT03863691 589 595 B-Condition
or NCT03863691 596 598 B-Or
thrombosis NCT03863691 599 609 B-Condition
. NCT03863691 610 611 O

- NCT03863691 615 616 O
Known NCT03863691 618 623 O
prolongation NCT03863691 624 636 B-Condition
of NCT03863691 637 639 I-Condition
the NCT03863691 640 643 I-Condition
QT NCT03863691 644 646 I-Condition
interval NCT03863691 647 655 I-Condition
, NCT03863691 656 657 O

- NCT03863691 661 662 O
Any NCT03863691 664 667 O
substantial NCT03863691 668 679 O
medical NCT03863691 680 687 B-Condition
condition NCT03863691 688 697 I-Condition
that NCT03863691 698 702 O
is NCT03863691 703 705 O
capable NCT03863691 706 713 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03863691 714 716 I-Assertion___Assertion_Type_Value:hypothetical
reducing NCT03863691 717 725 O
the NCT03863691 726 729 O
volunteers NCT03863691 730 740 O
ability NCT03863691 741 748 O
to NCT03863691 749 751 O
participate NCT03863691 752 763 O
at NCT03863691 764 766 O
the NCT03863691 767 770 O
study NCT03863691 771 776 B-Study
. NCT03863691 777 778 O

- NCT03863691 782 783 O
Suicidal NCT03863691 785 793 B-Condition
thoughts NCT03863691 794 802 I-Condition
or NCT03863691 803 805 B-Or
suicide NCT03863691 806 813 B-Condition
attempts NCT03863691 814 822 I-Condition
in NCT03863691 823 825 O
the NCT03863691 826 829 O
past NCT03863691 830 834 B-Eq_Comparison
or NCT03863691 835 837 B-Or
at NCT03863691 838 840 O
present NCT03863691 841 848 B-Eq_Comparison
. NCT03863691 849 850 O

- NCT03863691 854 855 O
Substantial NCT03863691 857 868 O
mental NCT03863691 869 875 B-Condition
disorders NCT03863691 876 885 I-Condition
especially NCT03863691 886 896 O
schizophrenia NCT03863691 897 910 B-Condition
, NCT03863691 911 912 O
bipolar NCT03863691 913 920 B-Condition
disorder NCT03863691 921 929 I-Condition
, NCT03863691 930 931 O
drug NCT03863691 932 936 B-Condition
abuse NCT03863691 937 942 I-Condition
, NCT03863691 943 944 O
or NCT03863691 945 947 B-Or
personality NCT03863691 948 959 B-Condition
disorders NCT03863691 960 969 I-Condition
. NCT03863691 970 971 O

- NCT03863691 975 976 O
Pregnancy NCT03863691 978 987 B-Condition
or NCT03863691 988 990 B-Or
breastfeeding NCT03863691 991 1004 B-Condition
. NCT03863691 1005 1006 O

Inclusion NCT03925402 0 9 O
Criteria NCT03925402 10 18 O
: NCT03925402 19 20 O

- NCT03925402 24 25 O
Adults NCT03925402 27 33 O
, NCT03925402 34 35 O
either NCT03925402 36 42 O
sex NCT03925402 43 46 O
, NCT03925402 47 48 O
ages NCT03925402 49 53 B-Age
18 NCT03925402 54 56 B-Eq_Comparison
years NCT03925402 57 62 I-Eq_Comparison
or NCT03925402 63 65 I-Eq_Comparison
above NCT03925402 66 71 I-Eq_Comparison

- NCT03925402 74 75 O
Patients NCT03925402 77 85 O
with NCT03925402 86 90 O
3 NCT03925402 91 92 B-Condition
GCRE NCT03925402 93 97 I-Condition
bacteremia NCT03925402 98 108 I-Condition

- NCT03925402 111 112 O
Patients NCT03925402 114 122 O
admitted NCT03925402 123 131 B-Encounter
to NCT03925402 132 134 O
any NCT03925402 135 138 O
of NCT03925402 139 141 O
the NCT03925402 142 145 O
study NCT03925402 146 151 O
sites NCT03925402 152 157 O

Exclusion NCT03925402 158 167 O
Criteria NCT03925402 168 176 O
: NCT03925402 177 178 O

- NCT03925402 182 183 O
Discontinuation NCT03925402 185 200 O
of NCT03925402 201 203 O
antibiotic NCT03925402 204 214 B-Drug
due NCT03925402 215 218 O
to NCT03925402 219 221 O
transition NCT03925402 222 232 B-Encounter
to NCT03925402 233 235 O
hospice NCT03925402 236 243 O
care NCT03925402 244 248 O

- NCT03925402 251 252 O
Polymicrobial NCT03925402 254 267 B-Condition
bacteremia NCT03925402 268 278 I-Condition

- NCT03925402 281 282 O
Empirical NCT03925402 284 293 B-Drug
antibiotic NCT03925402 294 304 I-Drug
after NCT03925402 305 310 B-Temporal_Connection___Temporal_Connection_Type_Value:after
24 NCT03925402 311 313 B-Eq_Comparison
hours NCT03925402 314 319 I-Eq_Comparison
of NCT03925402 320 322 I-Eq_Comparison
first NCT03925402 323 328 I-Eq_Comparison
evidence NCT03925402 329 337 O
of NCT03925402 338 340 O
bacteremia NCT03925402 341 351 B-Condition

Inclusion NCT03864874 0 9 O
Criteria NCT03864874 10 18 O
: NCT03864874 19 20 O

- NCT03864874 24 25 O
Patient NCT03864874 27 34 O
candidate NCT03864874 35 44 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864874 45 47 I-Assertion___Assertion_Type_Value:hypothetical
pulmonary NCT03864874 48 57 B-Procedure
metastasectomy NCT03864874 58 72 I-Procedure
with NCT03864874 73 77 O
curative NCT03864874 78 86 B-Modifier
intent NCT03864874 87 93 I-Modifier
by NCT03864874 94 96 O
mean NCT03864874 97 101 O
of NCT03864874 102 104 O
both NCT03864874 105 109 O
major NCT03864874 110 115 O
anatomical NCT03864874 116 126 B-Modifier
or NCT03864874 127 129 B-Or
limited NCT03864874 130 137 B-Modifier
resection NCT03864874 138 147 B-Procedure
; NCT03864874 147 148 O

- NCT03864874 151 152 O
Age NCT03864874 154 157 B-Age
> NCT03864874 158 159 B-Eq_Comparison
18 NCT03864874 160 162 I-Eq_Comparison
years NCT03864874 163 168 I-Eq_Comparison
. NCT03864874 169 170 O

Exclusion NCT03864874 172 181 O
Criteria NCT03864874 182 190 O
: NCT03864874 191 192 O

- NCT03864874 196 197 O
Patients NCT03864874 199 207 O
with NCT03864874 208 212 O
widespread NCT03864874 213 223 O
metastatic NCT03864874 224 234 B-Condition
disease NCT03864874 235 242 I-Condition
where NCT03864874 243 248 O
surgical NCT03864874 249 257 B-Procedure
resection NCT03864874 258 267 I-Procedure
is NCT03864874 268 270 B-Assertion___Assertion_Type_Value:hypothetical
performed NCT03864874 271 280 I-Assertion___Assertion_Type_Value:hypothetical
only NCT03864874 281 285 O
for NCT03864874 286 289 O
diagnostic NCT03864874 290 300 O
purposes NCT03864874 301 309 O
; NCT03864874 309 310 O

- NCT03864874 313 314 O
History NCT03864874 316 323 B-Eq_Comparison
of NCT03864874 324 326 I-Eq_Comparison
previous NCT03864874 327 335 I-Eq_Comparison
intrapleural NCT03864874 336 348 B-Procedure
talc NCT03864874 349 353 I-Procedure
injection NCT03864874 354 363 I-Procedure
; NCT03864874 363 364 O

- NCT03864874 367 368 O
Any NCT03864874 370 373 O
anatomical NCT03864874 374 384 B-Modifier
or NCT03864874 385 387 B-Or
pathological NCT03864874 388 400 B-Modifier
condition NCT03864874 401 410 B-Condition
( NCT03864874 411 412 O
eg NCT03864874 413 415 O
. NCT03864874 416 417 O
diffuse NCT03864874 419 426 B-Condition
adhesions NCT03864874 427 436 I-Condition
, NCT03864874 437 438 O
severe NCT03864874 439 445 O
emphysema NCT03864874 446 455 B-Condition
) NCT03864874 456 457 O
that NCT03864874 458 462 O
may NCT03864874 463 466 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03864874 467 476 O
with NCT03864874 477 481 O
execution NCT03864874 482 491 O
of NCT03864874 492 494 O
ultrasonographic NCT03864874 495 511 B-Procedure
investigation NCT03864874 512 525 I-Procedure
; NCT03864874 525 526 O

- NCT03864874 529 530 O
Incomplete NCT03864874 532 542 B-Modifier
lung NCT03864874 543 547 B-Condition
exclusion NCT03864874 548 557 I-Condition
during NCT03864874 558 564 B-Temporal_Connection___Temporal_Connection_Type_Value:during
surgical NCT03864874 565 573 B-Procedure
procedure NCT03864874 574 583 I-Procedure
. NCT03864874 584 585 O

Inclusion NCT03928548 0 9 O
Criteria NCT03928548 10 18 O
: NCT03928548 19 20 O

- NCT03928548 24 25 O
Adult NCT03928548 27 32 O
and NCT03928548 33 36 B-Or
pediatric NCT03928548 37 46 O
acute NCT03928548 47 52 B-Encounter
care NCT03928548 53 57 I-Encounter
patients NCT03928548 58 66 O
at NCT03928548 67 69 O
participating NCT03928548 70 83 O
facility NCT03928548 84 92 O

- NCT03928548 95 96 O
Newly NCT03928548 98 103 B-Eq_Comparison
identified NCT03928548 104 114 I-Eq_Comparison
as NCT03928548 115 117 O
needing NCT03928548 118 125 B-Assertion___Assertion_Type_Value:hypothetical
in NCT03928548 126 128 B-Encounter
- NCT03928548 129 130 I-Encounter
patient NCT03928548 131 138 I-Encounter
nutrition NCT03928548 139 148 B-Procedure
care NCT03928548 149 153 I-Procedure
through NCT03928548 154 161 O
current NCT03928548 162 169 O
facility NCT03928548 170 178 O
policy NCT03928548 179 185 O

- NCT03928548 188 189 O
Receive NCT03928548 191 198 O
initial NCT03928548 199 206 B-Eq_Comparison
nutrition NCT03928548 207 216 B-Procedure
care NCT03928548 217 221 I-Procedure
one NCT03928548 222 225 B-Eq_Comparison
day NCT03928548 226 229 I-Eq_Comparison
before NCT03928548 230 236 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03928548 237 242 B-Study
enrollment NCT03928548 243 253 O
day NCT03928548 254 257 O

- NCT03928548 260 261 O
Patient NCT03928548 263 270 O
is NCT03928548 271 273 O
over NCT03928548 274 278 B-Eq_Comparison
one NCT03928548 279 282 I-Eq_Comparison
month NCT03928548 283 288 I-Eq_Comparison
of NCT03928548 289 291 O
age NCT03928548 292 295 B-Age
, NCT03928548 296 297 O
including NCT03928548 298 307 O
infants NCT03928548 308 315 O
, NCT03928548 316 317 O
children NCT03928548 318 326 O
, NCT03928548 327 328 O
teenagers NCT03928548 329 338 O
and NCT03928548 339 342 B-Or
adult NCT03928548 343 348 O
patients NCT03928548 349 357 O
who NCT03928548 358 361 B-And
are NCT03928548 362 365 B-Eq_Comparison
intubated NCT03928548 366 375 B-Procedure
and NCT03928548 376 379 B-Or
/ NCT03928548 380 381 I-Or
or NCT03928548 382 384 I-Or
sedated NCT03928548 385 392 B-Procedure

- NCT03928548 395 396 O
Patient NCT03928548 398 405 O
, NCT03928548 406 407 O
parent NCT03928548 408 414 B-Family_Member___Family_Member_Type:parent
, NCT03928548 415 416 O
legal NCT03928548 417 422 O
guardian NCT03928548 423 431 O
or NCT03928548 432 434 O
legally NCT03928548 435 442 O
authorized NCT03928548 443 453 O
representative NCT03928548 454 468 O
provide NCT03928548 469 476 O
informed NCT03928548 477 485 O
consent NCT03928548 486 493 O
; NCT03928548 493 494 O
children NCT03928548 495 503 O
7 NCT03928548 504 505 B-Eq_Comparison
and NCT03928548 506 509 I-Eq_Comparison
older NCT03928548 510 515 I-Eq_Comparison
provide NCT03928548 516 523 O
assent NCT03928548 524 530 O

- NCT03928548 533 534 O
Patient NCT03928548 536 543 O
and NCT03928548 544 547 O
/ NCT03928548 548 549 O
or NCT03928548 550 552 O
parent NCT03928548 553 559 O
, NCT03928548 560 561 O
legal NCT03928548 562 567 O
guardian NCT03928548 568 576 O
or NCT03928548 577 579 O
legally NCT03928548 580 587 O
authorized NCT03928548 588 598 O
representative NCT03928548 599 613 O
are NCT03928548 614 617 O
fluent NCT03928548 618 624 O
in NCT03928548 625 627 O
English NCT03928548 628 635 O
or NCT03928548 636 638 B-Or
Spanish NCT03928548 639 646 O

Exclusion NCT03928548 647 656 O
Criteria NCT03928548 657 665 O
: NCT03928548 666 667 O

- NCT03928548 671 672 O
Received NCT03928548 674 682 B-Eq_Comparison
nutrition NCT03928548 683 692 B-Procedure
care NCT03928548 693 697 I-Procedure
previously NCT03928548 698 708 B-Eq_Comparison
during NCT03928548 709 715 B-Temporal_Connection___Temporal_Connection_Type_Value:during
current NCT03928548 716 723 B-Eq_Comparison
admission NCT03928548 724 733 B-Encounter

- NCT03928548 736 737 O
Pregnant NCT03928548 739 747 B-Condition
women NCT03928548 748 753 O

- NCT03928548 756 757 O
Prisoners NCT03928548 759 768 B-Observation

- NCT03928548 771 772 O
Infants NCT03928548 774 781 O
currently NCT03928548 782 791 B-Eq_Comparison
in NCT03928548 792 794 B-Encounter
the NCT03928548 795 798 O
neonatal NCT03928548 799 807 O
intensive NCT03928548 808 817 O
care NCT03928548 818 822 O
unit NCT03928548 823 827 O
( NCT03928548 828 829 O
NICU NCT03928548 830 834 O
) NCT03928548 835 836 O
with NCT03928548 837 841 B-And
a NCT03928548 842 843 O
diagnosis NCT03928548 844 853 O
of NCT03928548 854 856 O
prematurity NCT03928548 857 868 B-Condition

- NCT03928548 871 872 O
Neonates NCT03928548 874 882 O
of NCT03928548 883 885 O
uncertain NCT03928548 886 895 B-Condition
viability NCT03928548 896 905 I-Condition
or NCT03928548 906 908 B-Or
non NCT03928548 909 912 B-Condition
- NCT03928548 913 914 I-Condition
viable NCT03928548 915 921 I-Condition
neonates NCT03928548 922 930 O

- NCT03928548 933 934 O
Patients NCT03928548 936 944 O
receiving NCT03928548 945 954 B-Eq_Comparison
palliative NCT03928548 955 965 O
/ NCT03928548 966 967 B-Or
hospice NCT03928548 968 975 O
care NCT03928548 976 980 B-Encounter

- NCT03928548 983 984 O
Patient NCT03928548 986 993 O
admitted NCT03928548 994 1002 B-Encounter
for NCT03928548 1003 1006 O
long NCT03928548 1007 1011 B-Procedure
- NCT03928548 1012 1013 I-Procedure
term NCT03928548 1014 1018 I-Procedure
acute NCT03928548 1019 1024 I-Procedure
care NCT03928548 1025 1029 I-Procedure
( NCT03928548 1030 1031 O
LTAC NCT03928548 1032 1036 B-Procedure
) NCT03928548 1037 1038 O

Inclusion NCT03923751 0 9 O
Criteria NCT03923751 10 18 O
: NCT03923751 19 20 O

- NCT03923751 24 25 O
All NCT03923751 27 30 O
Polish NCT03923751 31 37 O
hospitals NCT03923751 38 47 O
practising NCT03923751 48 58 O
anesthesiology NCT03923751 59 73 O
and NCT03923751 74 77 O
intensive NCT03923751 78 87 O
care NCT03923751 88 92 O
in NCT03923751 93 95 O
the NCT03923751 96 99 O
national NCT03923751 100 108 O
register NCT03923751 109 117 O
of NCT03923751 118 120 O
medical NCT03923751 121 128 O
practices NCT03923751 129 138 O
( NCT03923751 139 140 O
www NCT03923751 141 144 O
. NCT03923751 145 146 O
rpwdl NCT03923751 147 152 O
. NCT03923751 153 154 O
csioz NCT03923751 155 160 O
. NCT03923751 161 162 O
gov NCT03923751 163 166 O
. NCT03923751 167 168 O
pl NCT03923751 169 171 O
) NCT03923751 172 173 O

Exclusion NCT03923751 175 184 O
Criteria NCT03923751 185 193 O
: NCT03923751 194 195 O

- NCT03923751 199 200 O
Hospitals NCT03923751 202 211 O
and NCT03923751 212 215 O
medical NCT03923751 216 223 O
practices NCT03923751 224 233 O
not NCT03923751 234 237 O
practising NCT03923751 238 248 O
anesthesiology NCT03923751 249 263 O
or NCT03923751 264 266 O
intensive NCT03923751 267 276 O
care NCT03923751 277 281 O

Inclusion NCT03868878 0 9 O
Criteria NCT03868878 10 18 O
: NCT03868878 19 20 O

- NCT03868878 24 25 O
age NCT03868878 27 30 B-Age
greater NCT03868878 31 38 B-Eq_Comparison
than NCT03868878 39 43 I-Eq_Comparison
60 NCT03868878 44 46 I-Eq_Comparison
years NCT03868878 47 52 I-Eq_Comparison
; NCT03868878 52 53 O

- NCT03868878 56 57 O
is NCT03868878 59 61 O
not NCT03868878 62 65 B-Negation
engaged NCT03868878 66 73 O
in NCT03868878 74 76 O
physical NCT03868878 77 85 B-Observation
exercise NCT03868878 86 94 I-Observation
programs NCT03868878 95 103 O
for NCT03868878 104 107 O
at NCT03868878 108 110 B-Eq_Comparison
least NCT03868878 111 116 I-Eq_Comparison
one NCT03868878 117 120 I-Eq_Comparison
year NCT03868878 121 125 I-Eq_Comparison
; NCT03868878 125 126 O

- NCT03868878 129 130 O
do NCT03868878 132 134 O
not NCT03868878 135 138 B-Negation
present NCT03868878 139 146 O
severe NCT03868878 147 153 O
cardiovascular NCT03868878 154 168 B-Condition
disease NCT03868878 169 176 I-Condition
, NCT03868878 177 178 O
kidney NCT03868878 179 185 B-Condition
disease NCT03868878 186 193 I-Condition
, NCT03868878 194 195 O
liver NCT03868878 196 201 B-Condition
disease NCT03868878 202 209 I-Condition
or NCT03868878 210 212 B-Or
limiting NCT03868878 213 221 B-Modifier
cognitive NCT03868878 222 231 I-Modifier
or NCT03868878 232 234 B-Or
neuromuscular NCT03868878 235 248 B-Modifier
disease NCT03868878 249 256 B-Condition
and NCT03868878 257 260 B-And
; NCT03868878 260 261 O

- NCT03868878 264 265 O
does NCT03868878 267 271 O
not NCT03868878 272 275 B-Negation
present NCT03868878 276 283 O
visual NCT03868878 284 290 B-Modifier
or NCT03868878 291 293 B-Or
auditory NCT03868878 294 302 B-Modifier
inability NCT03868878 303 312 B-Condition
. NCT03868878 313 314 O

Exclusion NCT03868878 316 325 O
Criteria NCT03868878 326 334 O
: NCT03868878 335 336 O

- NCT03868878 340 341 O
failing NCT03868878 343 350 B-Negation
to NCT03868878 351 353 O
perform NCT03868878 354 361 O
any NCT03868878 362 365 O
of NCT03868878 366 368 O
the NCT03868878 369 372 O
evaluations NCT03868878 373 384 B-Study
suggested NCT03868878 385 394 O
during NCT03868878 395 401 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868878 402 405 O
intervention NCT03868878 406 418 B-Study
protocol NCT03868878 419 427 O
and NCT03868878 428 431 B-And
; NCT03868878 431 432 O

- NCT03868878 435 436 O
absence NCT03868878 438 445 B-Negation
in NCT03868878 446 448 O
five NCT03868878 449 453 B-Eq_Comparison
or NCT03868878 454 456 I-Eq_Comparison
more NCT03868878 457 461 I-Eq_Comparison
Capoeira NCT03868878 462 470 B-Procedure
training NCT03868878 471 479 I-Procedure
sessions NCT03868878 480 488 I-Procedure
. NCT03868878 489 490 O

Inclusion NCT03929159 0 9 O
Criteria NCT03929159 10 18 O
: NCT03929159 19 20 O

- NCT03929159 24 25 O
Electively NCT03929159 27 37 O
scheduled NCT03929159 38 47 B-Eq_Comparison
for NCT03929159 48 51 O
surgical NCT03929159 52 60 B-Procedure
operation NCT03929159 61 70 I-Procedure
that NCT03929159 71 75 O
require NCT03929159 76 83 O
general NCT03929159 84 91 B-Procedure
anesthesia NCT03929159 92 102 I-Procedure
and NCT03929159 103 106 B-And
expected NCT03929159 107 115 B-Assertion___Assertion_Type_Value:hypothetical
duration NCT03929159 116 124 O
of NCT03929159 125 127 O
hospitalization NCT03929159 128 143 B-Encounter
of NCT03929159 144 146 O
longer NCT03929159 147 153 B-Eq_Comparison
than NCT03929159 154 158 I-Eq_Comparison
one NCT03929159 159 162 I-Eq_Comparison
day NCT03929159 163 166 I-Eq_Comparison
( NCT03929159 167 168 O
for NCT03929159 169 172 O
patients NCT03929159 173 181 O
in NCT03929159 182 184 O
Peri NCT03929159 185 189 B-Procedure
operative NCT03929159 190 199 I-Procedure
Evaluation NCT03929159 200 210 I-Procedure
& NCT03929159 211 212 I-Procedure
Management NCT03929159 213 223 I-Procedure
[ NCT03929159 224 225 O
POEM NCT03929159 226 230 B-Procedure
] NCT03929159 231 232 O
) NCT03929159 233 234 O
or NCT03929159 235 237 B-Or
high NCT03929159 238 242 O
clinical NCT03929159 243 251 O
suspicion NCT03929159 252 261 B-Assertion___Assertion_Type_Value:possible
of NCT03929159 262 264 O
sepsis NCT03929159 265 271 B-Condition
by NCT03929159 272 274 O
the NCT03929159 275 278 O
emergency NCT03929159 279 288 B-Provider
physician NCT03929159 289 298 I-Provider
( NCT03929159 299 300 O
for NCT03929159 301 304 O
patients NCT03929159 305 313 O
in NCT03929159 314 316 O
emergency NCT03929159 317 326 B-Encounter
center NCT03929159 327 333 I-Encounter
) NCT03929159 334 335 O

- NCT03929159 339 340 O
Ability NCT03929159 342 349 O
to NCT03929159 350 352 O
give NCT03929159 353 357 O
informed NCT03929159 358 366 O
consent NCT03929159 367 374 O
. NCT03929159 375 376 O
If NCT03929159 378 380 O
the NCT03929159 381 384 O
patient NCT03929159 385 392 O
is NCT03929159 393 395 O
incapacitated NCT03929159 396 409 O
and NCT03929159 410 413 O
unable NCT03929159 414 420 O
to NCT03929159 421 423 O
give NCT03929159 424 428 O
informed NCT03929159 429 437 O
consent NCT03929159 438 445 O
, NCT03929159 446 447 O
the NCT03929159 448 451 O
next NCT03929159 452 456 O
- NCT03929159 457 458 O
of NCT03929159 459 461 O
- NCT03929159 462 463 O
kin NCT03929159 464 467 O
or NCT03929159 468 470 O
a NCT03929159 471 472 O
person NCT03929159 473 479 O
who NCT03929159 480 483 O
has NCT03929159 484 487 O
the NCT03929159 488 491 O
power NCT03929159 492 497 O
of NCT03929159 498 500 O
attorney NCT03929159 501 509 O
must NCT03929159 510 514 O
be NCT03929159 515 517 O
present NCT03929159 518 525 O
for NCT03929159 526 529 O
informed NCT03929159 530 538 O
consent NCT03929159 539 546 O
. NCT03929159 547 548 O

- NCT03929159 552 553 O
For NCT03929159 555 558 O
patients NCT03929159 559 567 O
in NCT03929159 568 570 O
the NCT03929159 571 574 O
emergency NCT03929159 575 584 B-Encounter
center NCT03929159 585 591 I-Encounter
only NCT03929159 592 596 O
, NCT03929159 597 598 O
two NCT03929159 599 602 B-Eq_Comparison
or NCT03929159 603 605 I-Eq_Comparison
more NCT03929159 606 610 I-Eq_Comparison
of NCT03929159 611 613 O
the NCT03929159 614 617 B-Criteria_Count
following NCT03929159 618 627 I-Criteria_Count
SIRS NCT03929159 628 632 B-Condition
criteria NCT03929159 633 641 O
: NCT03929159 642 643 O

- NCT03929159 652 653 O
Leukocytes NCT03929159 655 665 B-Observation
> NCT03929159 666 667 B-Eq_Comparison
12 NCT03929159 668 670 I-Eq_Comparison
, NCT03929159 671 672 I-Eq_Comparison
000 NCT03929159 673 676 I-Eq_Comparison
/ NCT03929159 677 678 I-Eq_Comparison
mm^ NCT03929159 679 682 I-Eq_Comparison
3 NCT03929159 683 684 I-Eq_Comparison
or NCT03929159 685 687 B-Or
< NCT03929159 688 689 B-Eq_Comparison
4 NCT03929159 690 691 I-Eq_Comparison
, NCT03929159 692 693 I-Eq_Comparison
000 NCT03929159 694 697 I-Eq_Comparison
/ NCT03929159 698 699 I-Eq_Comparison
mm^ NCT03929159 700 703 I-Eq_Comparison
3 NCT03929159 704 705 I-Eq_Comparison
or NCT03929159 706 708 B-Or
> NCT03929159 709 710 B-Eq_Comparison
10 NCT03929159 711 713 I-Eq_Comparison
% NCT03929159 714 715 I-Eq_Comparison
immature NCT03929159 716 724 B-Observation
( NCT03929159 725 726 I-Observation
band NCT03929159 727 731 I-Observation
) NCT03929159 732 733 I-Observation
forms NCT03929159 734 739 I-Observation
, NCT03929159 740 741 O
provided NCT03929159 742 750 O
that NCT03929159 751 755 O
no NCT03929159 756 758 B-Negation
filgrastim NCT03929159 759 769 B-Drug
or NCT03929159 770 772 B-Or
pegfilgrastim NCT03929159 773 786 B-Drug
was NCT03929159 787 790 O
administered NCT03929159 791 803 B-Eq_Comparison
within NCT03929159 804 810 B-Eq_Comparison
30 NCT03929159 811 813 I-Eq_Comparison
days NCT03929159 814 818 I-Eq_Comparison
and NCT03929159 819 822 B-And
no NCT03929159 823 825 B-Negation
leukemia NCT03929159 826 834 B-Condition

- NCT03929159 842 843 O
Heart NCT03929159 845 850 B-Observation
rate NCT03929159 851 855 I-Observation
> NCT03929159 856 857 B-Eq_Comparison
90 NCT03929159 858 860 I-Eq_Comparison
beats NCT03929159 861 866 I-Eq_Comparison
/ NCT03929159 867 868 I-Eq_Comparison
minute NCT03929159 869 875 I-Eq_Comparison
( NCT03929159 876 877 I-Eq_Comparison
min NCT03929159 878 881 I-Eq_Comparison
) NCT03929159 882 883 I-Eq_Comparison

- NCT03929159 892 893 O
Respiratory NCT03929159 895 906 B-Observation
rate NCT03929159 907 911 I-Observation
> NCT03929159 912 913 B-Eq_Comparison
20 NCT03929159 914 916 I-Eq_Comparison
breaths NCT03929159 917 924 I-Eq_Comparison
/ NCT03929159 925 926 I-Eq_Comparison
min NCT03929159 927 930 I-Eq_Comparison
or NCT03929159 931 933 O
partial NCT03929159 934 941 B-Observation
pressure NCT03929159 942 950 I-Observation
of NCT03929159 951 953 I-Observation
carbon NCT03929159 954 960 I-Observation
dioxide NCT03929159 961 968 I-Observation
( NCT03929159 969 970 O
CO NCT03929159 971 973 B-Observation
2 NCT03929159 974 975 I-Observation
) NCT03929159 976 977 O
< NCT03929159 978 979 B-Eq_Comparison
32 NCT03929159 980 982 I-Eq_Comparison
mmHg NCT03929159 983 987 I-Eq_Comparison

- NCT03929159 995 996 O
Oral NCT03929159 998 1002 B-Modifier
temperature NCT03929159 1003 1014 B-Observation
> NCT03929159 1015 1016 B-Eq_Comparison
38 NCT03929159 1017 1019 I-Eq_Comparison
degrees NCT03929159 1020 1027 I-Eq_Comparison
Celsius NCT03929159 1028 1035 I-Eq_Comparison
( NCT03929159 1036 1037 I-Eq_Comparison
C NCT03929159 1038 1039 I-Eq_Comparison
) NCT03929159 1040 1041 I-Eq_Comparison
or NCT03929159 1042 1044 B-Or
< NCT03929159 1045 1046 B-Eq_Comparison
36 NCT03929159 1047 1049 I-Eq_Comparison
degrees NCT03929159 1050 1057 I-Eq_Comparison
C NCT03929159 1058 1059 I-Eq_Comparison
or NCT03929159 1060 1062 B-Or
axillary NCT03929159 1063 1071 B-Modifier
temperature NCT03929159 1072 1083 B-Observation
> NCT03929159 1084 1085 B-Eq_Comparison
37 NCT03929159 1086 1088 I-Eq_Comparison
degrees NCT03929159 1089 1096 I-Eq_Comparison
C NCT03929159 1097 1098 I-Eq_Comparison
or NCT03929159 1099 1101 B-Or
< NCT03929159 1102 1103 B-Eq_Comparison
35 NCT03929159 1104 1106 I-Eq_Comparison
degrees NCT03929159 1107 1114 I-Eq_Comparison
C NCT03929159 1115 1116 I-Eq_Comparison

Exclusion NCT03929159 1117 1126 O
Criteria NCT03929159 1127 1135 O
: NCT03929159 1136 1137 O

- NCT03929159 1141 1142 O
Inability NCT03929159 1144 1153 O
to NCT03929159 1154 1156 O
give NCT03929159 1157 1161 O
informed NCT03929159 1162 1170 O
consent NCT03929159 1171 1178 O
or NCT03929159 1179 1181 O
a NCT03929159 1182 1183 O
person NCT03929159 1184 1190 O
who NCT03929159 1191 1194 O
has NCT03929159 1195 1198 O
power NCT03929159 1199 1204 O
of NCT03929159 1205 1207 O
attorney NCT03929159 1208 1216 O
for NCT03929159 1217 1220 O
medical NCT03929159 1221 1228 O
decision NCT03929159 1229 1237 O
is NCT03929159 1238 1240 O
not NCT03929159 1241 1244 O
available NCT03929159 1245 1254 O

- NCT03929159 1257 1258 O
Being NCT03929159 1260 1265 B-Eq_Comparison
moribund NCT03929159 1266 1274 B-Condition
( NCT03929159 1275 1276 O
for NCT03929159 1277 1280 O
patients NCT03929159 1281 1289 O
in NCT03929159 1290 1292 O
emergency NCT03929159 1293 1302 B-Encounter
center NCT03929159 1303 1309 I-Encounter
) NCT03929159 1310 1311 O
or NCT03929159 1312 1314 O
cancellation NCT03929159 1315 1327 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
of NCT03929159 1328 1330 O
surgery NCT03929159 1331 1338 B-Procedure
( NCT03929159 1339 1340 O
for NCT03929159 1341 1344 O
patients NCT03929159 1345 1353 O
in NCT03929159 1354 1356 O
POEM NCT03929159 1357 1361 B-Procedure
) NCT03929159 1362 1363 O

- NCT03929159 1367 1368 O
Active NCT03929159 1370 1376 B-Eq_Comparison
" NCT03929159 1377 1378 O
Do NCT03929159 1378 1380 B-Observation
Not NCT03929159 1381 1384 I-Observation
Resuscitate NCT03929159 1385 1396 I-Observation
" NCT03929159 1396 1397 O
or NCT03929159 1398 1400 B-Or
" NCT03929159 1401 1402 O
Do NCT03929159 1402 1404 B-Observation
Not NCT03929159 1405 1408 I-Observation
Intubate NCT03929159 1409 1417 I-Observation
" NCT03929159 1417 1418 O
order NCT03929159 1419 1424 O


Inclusion NCT03868358 0 9 O
Criteria NCT03868358 10 18 O
: NCT03868358 19 20 O

- NCT03868358 24 25 O
Patients NCT03868358 27 35 O
met NCT03868358 36 39 O
diagnostic NCT03868358 40 50 O
criteria NCT03868358 51 59 O
for NCT03868358 60 63 O
schizophrenia NCT03868358 64 77 B-Condition
or NCT03868358 78 80 B-Or
schizoaffective NCT03868358 81 96 B-Condition
disorder NCT03868358 97 105 I-Condition
using NCT03868358 106 111 O
the NCT03868358 112 115 O
Structural NCT03868358 116 126 O
Clinical NCT03868358 127 135 O
Interview NCT03868358 136 145 O
for NCT03868358 146 149 O
Diagnostic NCT03868358 150 160 O
and NCT03868358 161 164 O
Statistical NCT03868358 165 176 O
Manual NCT03868358 177 183 O
Diploma NCT03868358 184 191 O
in NCT03868358 192 194 O
Social NCT03868358 195 201 O
Medicine NCT03868358 202 210 O
( NCT03868358 211 212 O
DSM NCT03868358 213 216 O
) NCT03868358 217 218 O
- NCT03868358 219 220 O
IV NCT03868358 221 223 O
( NCT03868358 224 225 O
SCID NCT03868358 226 230 O
, NCT03868358 231 232 O
Version NCT03868358 233 240 O
2.0 NCT03868358 241 244 O
) NCT03868358 245 246 O
. NCT03868358 247 248 O

- NCT03868358 252 253 O
Patients NCT03868358 255 263 O
remain NCT03868358 264 270 O
their NCT03868358 271 276 O
psychotropic NCT03868358 277 289 B-Drug
medication NCT03868358 290 300 I-Drug
at NCT03868358 301 303 O
steady NCT03868358 304 310 O
dosages NCT03868358 311 318 O
for NCT03868358 319 322 O
at NCT03868358 323 325 B-Eq_Comparison
least NCT03868358 326 331 I-Eq_Comparison
4 NCT03868358 332 333 I-Eq_Comparison
weeks NCT03868358 334 339 I-Eq_Comparison
prior NCT03868358 340 345 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03868358 346 348 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03868358 349 354 B-Study
entry NCT03868358 355 360 O
and NCT03868358 361 364 B-And
for NCT03868358 365 368 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868358 369 372 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03868358 373 381 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03868358 382 384 O
the NCT03868358 385 388 O
trial NCT03868358 389 394 B-Study
. NCT03868358 395 396 O

- NCT03868358 400 401 O
Verbal NCT03868358 403 409 B-Observation
intelligence NCT03868358 410 422 I-Observation
quotient NCT03868358 423 431 I-Observation
> NCT03868358 432 433 B-Eq_Comparison
85 NCT03868358 434 436 I-Eq_Comparison
as NCT03868358 437 439 O
measured NCT03868358 440 448 O
by NCT03868358 449 451 O
using NCT03868358 452 457 O
a NCT03868358 458 459 O
Chinese NCT03868358 460 467 B-Modifier
version NCT03868358 468 475 I-Modifier
of NCT03868358 476 478 O
the NCT03868358 479 482 O
National NCT03868358 483 491 B-Observation
Adult NCT03868358 492 497 I-Observation
Reading NCT03868358 498 505 I-Observation
Test NCT03868358 506 510 I-Observation
. NCT03868358 511 512 O

Exclusion NCT03868358 514 523 O
Criteria NCT03868358 524 532 O
: NCT03868358 533 534 O

- NCT03868358 538 539 O
History NCT03868358 541 548 B-Eq_Comparison
of NCT03868358 549 551 O
significant NCT03868358 552 563 O
head NCT03868358 564 568 B-Modifier
trauma NCT03868358 569 575 B-Condition
or NCT03868358 576 578 B-Or
neurological NCT03868358 579 591 B-Condition
disorders NCT03868358 592 601 I-Condition

- NCT03868358 604 605 O
Alcohol NCT03868358 607 614 B-Modifier
or NCT03868358 615 617 B-Or
drug NCT03868358 618 622 B-Modifier
abuse NCT03868358 623 628 B-Condition
Focal NCT03868358 629 634 B-Condition
brain NCT03868358 635 640 I-Condition
lesions NCT03868358 641 648 I-Condition
on NCT03868358 649 651 O
T NCT03868358 652 653 B-Modifier
1 NCT03868358 654 655 I-Modifier
- NCT03868358 656 657 O
or NCT03868358 658 660 B-Or
T NCT03868358 661 662 B-Modifier
2 NCT03868358 663 664 I-Modifier
- NCT03868358 665 666 I-Modifier
weighted NCT03868358 667 675 I-Modifier
fluid NCT03868358 676 681 B-Modifier
- NCT03868358 682 683 I-Modifier
attenuated NCT03868358 684 694 I-Modifier
inversion NCT03868358 695 704 I-Modifier
- NCT03868358 705 706 I-Modifier
recovery NCT03868358 707 715 I-Modifier
magnetic NCT03868358 716 724 B-Procedure
resonance NCT03868358 725 734 I-Procedure
images NCT03868358 735 741 I-Procedure

- NCT03868358 744 745 O
a NCT03868358 747 748 O
prior NCT03868358 749 754 B-Eq_Comparison
history NCT03868358 755 762 I-Eq_Comparison
of NCT03868358 763 765 O
a NCT03868358 766 767 O
seizure NCT03868358 768 775 B-Condition
not NCT03868358 776 779 B-Negation
induced NCT03868358 780 787 O
by NCT03868358 788 790 O
drug NCT03868358 791 795 B-Condition
withdrawal NCT03868358 796 806 I-Condition
, NCT03868358 807 808 O
first NCT03868358 809 814 B-Modifier
degree NCT03868358 815 821 I-Modifier
relative NCT03868358 822 830 B-Family_Member
with NCT03868358 831 835 O
epilepsy NCT03868358 836 844 B-Condition
, NCT03868358 845 846 O
significant NCT03868358 847 858 O
neurological NCT03868358 859 871 B-Condition
illness NCT03868358 872 879 I-Condition
or NCT03868358 880 882 B-Or
head NCT03868358 883 887 B-Modifier
trauma NCT03868358 888 894 B-Condition
, NCT03868358 895 896 O
endocrine NCT03868358 897 906 B-Condition
disease NCT03868358 907 914 I-Condition
, NCT03868358 915 916 O
such NCT03868358 917 921 O
as NCT03868358 922 924 O
thyroid NCT03868358 925 932 B-Condition
disease NCT03868358 933 940 I-Condition
, NCT03868358 941 942 O
significant NCT03868358 943 954 O
unstable NCT03868358 955 963 O
medical NCT03868358 964 971 B-Condition
condition NCT03868358 972 981 I-Condition
, NCT03868358 982 983 O
recent NCT03868358 984 990 B-Eq_Comparison
aggression NCT03868358 991 1001 B-Condition
or NCT03868358 1002 1004 B-Or
other NCT03868358 1005 1010 B-Other
forms NCT03868358 1011 1016 O
of NCT03868358 1017 1019 O
behavioral NCT03868358 1020 1030 B-Condition
dyscontrol NCT03868358 1031 1041 I-Condition

- NCT03868358 1044 1045 O
left NCT03868358 1047 1051 B-Condition
- NCT03868358 1052 1053 I-Condition
handedness NCT03868358 1054 1064 I-Condition
, NCT03868358 1065 1066 O
pregnancy NCT03868358 1067 1076 B-Condition

- NCT03868358 1079 1080 O
estimated NCT03868358 1082 1091 B-Observation
intelligence NCT03868358 1092 1104 I-Observation
quotient NCT03868358 1105 1113 I-Observation
< NCT03868358 1114 1115 B-Eq_Comparison
80 NCT03868358 1116 1118 I-Eq_Comparison

- NCT03868358 1122 1123 O
current NCT03868358 1125 1132 B-Eq_Comparison
alcohol NCT03868358 1133 1140 B-Modifier
or NCT03868358 1141 1143 B-Or
drug NCT03868358 1144 1148 B-Modifier
abuse NCT03868358 1149 1154 B-Condition

- NCT03868358 1157 1158 O
inability NCT03868358 1160 1169 O
to NCT03868358 1170 1172 O
provide NCT03868358 1173 1180 O
informed NCT03868358 1181 1189 O
consent NCT03868358 1190 1197 O
. NCT03868358 1198 1199 O

- NCT03868358 1203 1204 O
Hamilton NCT03868358 1206 1214 B-Observation
Anxiety NCT03868358 1215 1222 I-Observation
Rating NCT03868358 1223 1229 I-Observation
Scale NCT03868358 1230 1235 I-Observation
or NCT03868358 1236 1238 B-Or
the NCT03868358 1239 1242 O
Hamilton NCT03868358 1243 1251 B-Observation
Depression NCT03868358 1252 1262 I-Observation
Rating NCT03868358 1263 1269 I-Observation
Scale NCT03868358 1270 1275 I-Observation
score NCT03868358 1276 1281 B-Eq_Comparison
> NCT03868358 1282 1283 I-Eq_Comparison
10 NCT03868358 1284 1286 I-Eq_Comparison

Inclusion NCT03922113 0 9 O
Criteria NCT03922113 10 18 O
: NCT03922113 19 20 O

- NCT03922113 24 25 O
Collaborative NCT03922113 27 40 O
ICU NCT03922113 41 44 O
patients NCT03922113 45 53 O
with NCT03922113 54 58 O
length NCT03922113 59 65 O
of NCT03922113 66 68 O
stay NCT03922113 69 73 B-Encounter
> NCT03922113 74 75 B-Eq_Comparison
48 NCT03922113 76 78 I-Eq_Comparison
h NCT03922113 79 80 I-Eq_Comparison

- NCT03922113 83 84 O
Surgical NCT03922113 86 94 O
patients NCT03922113 95 103 O
scheduled NCT03922113 104 113 B-Eq_Comparison
for NCT03922113 114 117 O
colorectal NCT03922113 118 128 B-Procedure
surgery NCT03922113 129 136 I-Procedure

- NCT03922113 139 140 O
Healthy NCT03922113 142 149 B-Condition
subjects NCT03922113 150 158 O

Exclusion NCT03922113 159 168 O
Criteria NCT03922113 169 177 O
: NCT03922113 178 179 O

- NCT03922113 183 184 O
a NCT03922113 186 187 O
score NCT03922113 188 193 O
> NCT03922113 194 195 B-Eq_Comparison
1 NCT03922113 196 197 I-Eq_Comparison
or NCT03922113 198 200 B-Or
< NCT03922113 201 202 B-Eq_Comparison
- NCT03922113 203 204 I-Eq_Comparison
1 NCT03922113 205 206 I-Eq_Comparison
on NCT03922113 207 209 O
the NCT03922113 210 213 O
Richmond NCT03922113 214 222 B-Observation
Agitation NCT03922113 223 232 I-Observation
and NCT03922113 233 236 I-Observation
Sedation NCT03922113 237 245 I-Observation
Scale NCT03922113 246 251 I-Observation
( NCT03922113 252 253 O
RASS NCT03922113 254 258 B-Observation
) NCT03922113 259 260 O

- NCT03922113 264 265 O
coma NCT03922113 267 271 B-Condition

- NCT03922113 274 275 O
total NCT03922113 277 282 B-Modifier
hip NCT03922113 283 286 I-Modifier
or NCT03922113 287 289 B-Or
knee NCT03922113 290 294 B-Modifier
arthroplasty NCT03922113 295 307 B-Procedure
in NCT03922113 308 310 O
the NCT03922113 311 314 O
dominant NCT03922113 315 323 B-Modifier
limb NCT03922113 324 328 I-Modifier

- NCT03922113 331 332 O
unauthorized NCT03922113 334 346 B-Condition
support NCT03922113 347 354 I-Condition
on NCT03922113 355 357 O
the NCT03922113 358 361 O
dominant NCT03922113 362 370 B-Modifier
leg NCT03922113 371 374 I-Modifier

- NCT03922113 377 378 O
open NCT03922113 380 384 B-Condition
wound NCT03922113 385 390 I-Condition
located NCT03922113 391 398 O
at NCT03922113 399 401 O
the NCT03922113 402 405 O
ankle NCT03922113 406 411 B-Modifier
's NCT03922113 411 413 I-Modifier
anterior NCT03922113 414 422 I-Modifier
face NCT03922113 423 427 I-Modifier
of NCT03922113 428 430 I-Modifier
the NCT03922113 431 434 I-Modifier
dominant NCT03922113 435 443 I-Modifier
leg NCT03922113 444 447 I-Modifier

- NCT03922113 450 451 O
pre NCT03922113 453 456 B-Eq_Comparison
- NCT03922113 457 458 I-Eq_Comparison
existing NCT03922113 459 467 I-Eq_Comparison
myopathy NCT03922113 468 476 B-Condition
or NCT03922113 477 479 B-Or
polyneuropathy NCT03922113 480 494 B-Condition

- NCT03922113 497 498 O
para NCT03922113 500 504 B-Modifier
- NCT03922113 505 506 O
or NCT03922113 507 509 B-Or
tetraparesis NCT03922113 510 522 B-Condition
, NCT03922113 523 524 O
para NCT03922113 525 529 B-Modifier
- NCT03922113 530 531 O
or NCT03922113 532 534 B-Or
tetraplegia NCT03922113 535 546 B-Condition

- NCT03922113 549 550 O
refusal NCT03922113 552 559 O
. NCT03922113 560 561 O

Inclusion NCT03920930 0 9 O
Criteria NCT03920930 10 18 O
: NCT03920930 19 20 O

• NCT03920930 22 23 O
patients NCT03920930 24 32 O
undergoing NCT03920930 33 43 B-Eq_Comparison
elective NCT03920930 44 52 O
, NCT03920930 53 54 O
primary NCT03920930 55 62 B-Modifier
knee NCT03920930 63 67 B-Procedure
joint NCT03920930 68 73 I-Procedure
replacement NCT03920930 74 85 I-Procedure
in NCT03920930 86 88 O
combined NCT03920930 89 97 O
general NCT03920930 98 105 B-Procedure
anaesthesia NCT03920930 106 117 I-Procedure

Exclusion NCT03920930 118 127 O
Criteria NCT03920930 128 136 O
: NCT03920930 137 138 O

- NCT03920930 142 143 O
heart NCT03920930 145 150 B-Condition
insufficiency NCT03920930 151 164 I-Condition
NYHA NCT03920930 165 169 B-Observation
> NCT03920930 170 171 B-Eq_Comparison
2 NCT03920930 172 173 I-Eq_Comparison

- NCT03920930 177 178 O
liver NCT03920930 180 185 B-Condition
insufficiency NCT03920930 186 199 I-Condition
> NCT03920930 200 201 O
CHILD NCT03920930 202 207 O
B NCT03920930 208 209 O

- NCT03920930 212 213 O
evidence NCT03920930 215 223 O
of NCT03920930 224 226 O
diabetic NCT03920930 227 235 B-Condition
polyneuropathy NCT03920930 236 250 I-Condition

- NCT03920930 253 254 O
severe NCT03920930 256 262 O
adipositas NCT03920930 263 273 B-Condition
BMI NCT03920930 274 277 B-Observation
> NCT03920930 278 279 B-Eq_Comparison
40 NCT03920930 280 282 I-Eq_Comparison

- NCT03920930 286 287 O
patients NCT03920930 289 297 O
< NCT03920930 298 299 B-Eq_Comparison
18 NCT03920930 300 302 I-Eq_Comparison
years NCT03920930 303 308 I-Eq_Comparison

- NCT03920930 311 312 O
pregnancy NCT03920930 314 323 B-Condition

- NCT03920930 326 327 O
in NCT03920930 329 331 O
case NCT03920930 332 336 O
of NCT03920930 337 339 O
police NCT03920930 340 346 B-Observation
custody NCT03920930 347 354 I-Observation

- NCT03920930 357 358 O
participation NCT03920930 360 373 O
in NCT03920930 374 376 O
a NCT03920930 377 378 O
paralleled NCT03920930 379 389 B-Other
interventional NCT03920930 390 404 O
RCT NCT03920930 405 408 B-Study
in NCT03920930 409 411 O
a NCT03920930 412 413 O
time NCT03920930 414 418 O
frame NCT03920930 419 424 O
of NCT03920930 425 427 O
30 NCT03920930 428 430 B-Eq_Comparison
days NCT03920930 431 435 I-Eq_Comparison

- NCT03920930 438 439 O
chronic NCT03920930 441 448 O
opioid NCT03920930 449 455 B-Procedure
therapy NCT03920930 456 463 I-Procedure
> NCT03920930 464 465 B-Eq_Comparison
3 NCT03920930 466 467 I-Eq_Comparison
months NCT03920930 468 474 I-Eq_Comparison
before NCT03920930 475 481 B-Temporal_Connection___Temporal_Connection_Type_Value:before
scheduled NCT03920930 482 491 B-Eq_Comparison
surgery NCT03920930 492 499 B-Procedure

- NCT03920930 502 503 O
allergy NCT03920930 505 512 B-Allergy
against NCT03920930 513 520 O
medication NCT03920930 521 531 B-Drug
required NCT03920930 532 540 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03920930 541 544 I-Assertion___Assertion_Type_Value:hypothetical
surgery NCT03920930 545 552 B-Procedure
or NCT03920930 553 555 B-Or
anaesthesia NCT03920930 556 567 B-Procedure


Inclusion NCT03928015 0 9 O
Criteria NCT03928015 10 18 O
: NCT03928015 19 20 O

1 NCT03928015 24 25 O
. NCT03928015 25 26 O
Male NCT03928015 28 32 O
or NCT03928015 33 35 B-Or
female NCT03928015 36 42 O
, NCT03928015 43 44 O
18 NCT03928015 45 47 B-Eq_Comparison
years NCT03928015 48 53 I-Eq_Comparison
to NCT03928015 54 56 I-Eq_Comparison
65 NCT03928015 57 59 I-Eq_Comparison
years NCT03928015 60 65 I-Eq_Comparison
old NCT03928015 66 69 B-Age
( NCT03928015 70 71 O
inclusive NCT03928015 72 81 O
) NCT03928015 82 83 O

2 NCT03928015 87 88 O
. NCT03928015 88 89 O
Index NCT03928015 91 96 O
admission NCT03928015 97 106 B-Encounter
for NCT03928015 107 110 O
traumatic NCT03928015 111 120 B-Condition
injury NCT03928015 121 127 I-Condition

3 NCT03928015 130 131 O
. NCT03928015 131 132 O
High NCT03928015 134 138 O
initial NCT03928015 139 146 B-Eq_Comparison
morphine NCT03928015 147 155 B-Drug
equivalent NCT03928015 156 166 O
use NCT03928015 167 170 O
≥ NCT03928015 171 172 B-Eq_Comparison
90 NCT03928015 173 175 I-Eq_Comparison
mg NCT03928015 176 178 I-Eq_Comparison
in NCT03928015 179 181 O
the NCT03928015 182 185 O
first NCT03928015 186 191 B-Eq_Comparison
24 NCT03928015 192 194 I-Eq_Comparison
hours NCT03928015 195 200 I-Eq_Comparison
from NCT03928015 201 205 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03928015 206 215 B-Encounter

4 NCT03928015 218 219 O
. NCT03928015 219 220 O
Baseline NCT03928015 222 230 O
pain NCT03928015 231 235 B-Condition
assessed NCT03928015 236 244 O
at NCT03928015 245 247 O
screening NCT03928015 248 257 B-Procedure
of NCT03928015 258 260 O
≥ NCT03928015 261 262 B-Eq_Comparison
5 NCT03928015 263 264 I-Eq_Comparison
on NCT03928015 265 267 O
the NCT03928015 268 271 O
pain NCT03928015 272 276 B-Observation
numeric NCT03928015 277 284 I-Observation
rating NCT03928015 285 291 I-Observation
score NCT03928015 292 297 I-Observation
( NCT03928015 298 299 O
NRS NCT03928015 300 303 B-Observation
) NCT03928015 304 305 O

5 NCT03928015 309 310 O
. NCT03928015 310 311 O
Willing NCT03928015 313 320 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928015 321 323 I-Assertion___Assertion_Type_Value:hypothetical
divulge NCT03928015 324 331 O
habitual NCT03928015 332 340 O
marijuana NCT03928015 341 350 B-Condition
usage NCT03928015 351 356 O
( NCT03928015 357 358 O
yes NCT03928015 359 362 O
or NCT03928015 363 365 O
no NCT03928015 366 368 O
. NCT03928015 369 370 O
Yes NCT03928015 372 375 O
, NCT03928015 376 377 O
habitual NCT03928015 378 386 O
/ NCT03928015 387 388 O
chronic NCT03928015 389 396 O
usage NCT03928015 397 402 O
; NCT03928015 402 403 O
no NCT03928015 404 406 O
, NCT03928015 407 408 O
recreational NCT03928015 409 421 O
, NCT03928015 422 423 O
former NCT03928015 424 430 O
, NCT03928015 431 432 O
or NCT03928015 433 435 O
never NCT03928015 436 441 O
usage NCT03928015 442 447 O
) NCT03928015 448 449 O

Exclusion NCT03928015 455 464 O
Criteria NCT03928015 465 473 O
: NCT03928015 474 475 O

1 NCT03928015 479 480 O
. NCT03928015 480 481 O
Patients NCT03928015 483 491 O
on NCT03928015 492 494 B-Eq_Comparison
a NCT03928015 495 496 O
pain NCT03928015 497 501 B-Procedure
management NCT03928015 502 512 I-Procedure
agreement NCT03928015 513 522 O

2 NCT03928015 525 526 O
. NCT03928015 526 527 O
Patients NCT03928015 529 537 O
who NCT03928015 538 541 O
are NCT03928015 542 545 O
nil NCT03928015 546 549 B-Procedure
per NCT03928015 550 553 I-Procedure
os NCT03928015 554 556 I-Procedure
( NCT03928015 557 558 O
NPO NCT03928015 559 562 B-Procedure
) NCT03928015 563 564 O
at NCT03928015 565 567 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928015 568 571 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03928015 572 576 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03928015 577 579 O
randomization NCT03928015 580 593 B-Study
or NCT03928015 594 596 B-Or
are NCT03928015 597 600 O
expected NCT03928015 601 609 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928015 610 612 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03928015 613 615 O
NPO NCT03928015 616 619 B-Procedure
within NCT03928015 620 626 B-Eq_Comparison
the NCT03928015 627 630 I-Eq_Comparison
next NCT03928015 631 635 I-Eq_Comparison
48 NCT03928015 636 638 I-Eq_Comparison
hours NCT03928015 639 644 I-Eq_Comparison

3 NCT03928015 647 648 O
. NCT03928015 648 649 O
Patients NCT03928015 651 659 O
who NCT03928015 660 663 O
have NCT03928015 664 668 O
received NCT03928015 669 677 B-Eq_Comparison
or NCT03928015 678 680 B-Or
are NCT03928015 681 684 O
expected NCT03928015 685 693 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928015 694 696 I-Assertion___Assertion_Type_Value:hypothetical
receive NCT03928015 697 704 O
neuraxial NCT03928015 705 714 B-Modifier
/ NCT03928015 715 716 B-Or
locoregional NCT03928015 717 729 B-Modifier
blocks NCT03928015 730 736 B-Drug
for NCT03928015 737 740 O
pain NCT03928015 741 745 B-Condition
within NCT03928015 746 752 B-Eq_Comparison
the NCT03928015 753 756 I-Eq_Comparison
next NCT03928015 757 761 I-Eq_Comparison
48 NCT03928015 762 764 I-Eq_Comparison
hours NCT03928015 765 770 I-Eq_Comparison

4 NCT03928015 773 774 O
. NCT03928015 774 775 O
Known NCT03928015 777 782 O
allergy NCT03928015 783 790 B-Allergy
or NCT03928015 791 793 B-Or
previous NCT03928015 794 802 B-Eq_Comparison
hypersensitivity NCT03928015 803 819 B-Condition
reaction NCT03928015 820 828 O
to NCT03928015 829 831 O
dronabinol NCT03928015 832 842 B-Drug
or NCT03928015 843 845 B-Or
sesame NCT03928015 846 852 B-Drug
oil NCT03928015 853 856 I-Drug

5 NCT03928015 859 860 O
. NCT03928015 860 861 O
Patients NCT03928015 863 871 O
prescribed NCT03928015 872 882 B-Eq_Comparison
dronabinol NCT03928015 883 893 B-Drug
between NCT03928015 894 901 B-Temporal_Connection___Temporal_Connection_Type_Value:after
arrival NCT03928015 902 909 B-Encounter
and NCT03928015 910 913 O
prior NCT03928015 914 919 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928015 920 922 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03928015 923 932 B-Study
/ NCT03928015 933 934 B-Or
randomization NCT03928015 935 948 B-Study

6 NCT03928015 951 952 O
. NCT03928015 952 953 O
Pregnancy NCT03928015 955 964 B-Condition
or NCT03928015 965 967 B-Or
breast NCT03928015 968 974 B-Condition
feeding NCT03928015 975 982 I-Condition

7 NCT03928015 985 986 O
. NCT03928015 986 987 O
Incarceration NCT03928015 989 1002 B-Observation


Inclusion NCT03920683 0 9 O
Criteria NCT03920683 10 18 O
: NCT03920683 19 20 O

- NCT03920683 24 25 O
Age NCT03920683 27 30 B-Age
≥ NCT03920683 31 32 B-Eq_Comparison
18 NCT03920683 33 35 I-Eq_Comparison
ans NCT03920683 36 39 O

- NCT03920683 42 43 O
Diabetes NCT03920683 45 53 B-Condition
mellitus NCT03920683 54 62 I-Condition
( NCT03920683 63 64 O
type NCT03920683 65 69 B-Eq_Comparison
1 NCT03920683 70 71 I-Eq_Comparison
or NCT03920683 72 74 I-Eq_Comparison
2 NCT03920683 75 76 I-Eq_Comparison
) NCT03920683 77 78 O

- NCT03920683 82 83 O
Patients NCT03920683 85 93 O
addressed NCT03920683 94 103 O
to NCT03920683 104 106 O
a NCT03920683 107 108 O
one NCT03920683 109 112 B-Eq_Comparison
- NCT03920683 113 114 I-Eq_Comparison
day NCT03920683 115 118 I-Eq_Comparison
hospitalization NCT03920683 119 134 B-Encounter
to NCT03920683 135 137 B-Temporal_Connection___Temporal_Connection_Type_Value:during
assess NCT03920683 138 144 O
cardiovascular NCT03920683 145 159 B-Condition
comorbidities NCT03920683 160 173 I-Condition
, NCT03920683 174 175 O
between NCT03920683 176 183 B-Eq_Comparison
January NCT03920683 184 191 I-Eq_Comparison
2014 NCT03920683 192 196 I-Eq_Comparison
and NCT03920683 197 200 I-Eq_Comparison
May NCT03920683 201 204 I-Eq_Comparison
2017 NCT03920683 205 209 I-Eq_Comparison
, NCT03920683 210 211 O
in NCT03920683 212 214 O
the NCT03920683 215 218 O
diabetes NCT03920683 219 227 O
department NCT03920683 228 238 O
, NCT03920683 239 240 O
in NCT03920683 241 243 O
the NCT03920683 244 247 O
Pitié NCT03920683 248 253 O
- NCT03920683 254 255 O
Salpêtrière NCT03920683 256 267 O
hospital NCT03920683 268 276 O

- NCT03920683 279 280 O
Coronary NCT03920683 282 290 B-Observation
artery NCT03920683 291 297 I-Observation
calcium NCT03920683 298 305 I-Observation
score NCT03920683 306 311 I-Observation
available NCT03920683 312 321 O

- NCT03920683 324 325 O
Toe NCT03920683 327 330 B-Observation
- NCT03920683 331 332 I-Observation
brachial NCT03920683 333 341 I-Observation
index NCT03920683 342 347 I-Observation
available NCT03920683 348 357 O

Exclusion NCT03920683 358 367 O
Criteria NCT03920683 368 376 O
: NCT03920683 377 378 O

- NCT03920683 382 383 O
History NCT03920683 385 392 B-Eq_Comparison
of NCT03920683 393 395 O
coronary NCT03920683 396 404 B-Condition
artery NCT03920683 405 411 I-Condition
disease NCT03920683 412 419 I-Condition

- NCT03920683 422 423 O
History NCT03920683 425 432 B-Eq_Comparison
of NCT03920683 433 435 O
Raynaud NCT03920683 436 443 B-Condition
's NCT03920683 443 445 I-Condition
syndrome NCT03920683 446 454 I-Condition

- NCT03920683 457 458 O
Opposition NCT03920683 460 470 O
of NCT03920683 471 473 O
the NCT03920683 474 477 O
patient NCT03920683 478 485 O

Inclusion NCT03868813 0 9 O
Criteria NCT03868813 10 18 O
: NCT03868813 19 20 O

Health NCT03868813 22 28 O
Coaches NCT03868813 29 36 O
Group NCT03868813 37 42 O
: NCT03868813 43 44 O

( NCT03868813 47 48 O
i NCT03868813 49 50 O
) NCT03868813 51 52 O
age NCT03868813 53 56 B-Age
between NCT03868813 57 64 B-Eq_Comparison
18 NCT03868813 65 67 I-Eq_Comparison
and NCT03868813 68 71 I-Eq_Comparison
80 NCT03868813 72 74 I-Eq_Comparison
years NCT03868813 75 80 I-Eq_Comparison
( NCT03868813 81 82 O
ii NCT03868813 83 85 O
) NCT03868813 86 87 O
fluent NCT03868813 88 94 O
in NCT03868813 95 97 O
English NCT03868813 98 105 O
( NCT03868813 106 107 O
iii NCT03868813 108 111 O
) NCT03868813 112 113 O
work NCT03868813 114 118 O
in NCT03868813 119 121 O
or NCT03868813 122 124 O
carry NCT03868813 125 130 O
expertise NCT03868813 131 140 O
in NCT03868813 141 143 O
physical NCT03868813 144 152 B-Observation
activity NCT03868813 153 161 I-Observation
, NCT03868813 162 163 O
nutrition NCT03868813 164 173 B-Condition
/ NCT03868813 174 175 B-Or
diet NCT03868813 176 180 B-Observation
or NCT03868813 181 183 B-Or
health NCT03868813 184 190 B-Condition
behavior NCT03868813 191 199 I-Condition
. NCT03868813 200 201 O

People NCT03868813 203 209 O
with NCT03868813 210 214 O
Diabetes NCT03868813 215 223 O
Group NCT03868813 224 229 O
( NCT03868813 230 231 O
Patient NCT03868813 232 239 O
/ NCT03868813 240 241 O
Caregiver NCT03868813 242 251 O
Dyads NCT03868813 252 257 O
) NCT03868813 258 259 O
: NCT03868813 260 261 O

( NCT03868813 264 265 O
i NCT03868813 266 267 O
) NCT03868813 268 269 O
age NCT03868813 270 273 B-Age
between NCT03868813 274 281 B-Eq_Comparison
18 NCT03868813 282 284 I-Eq_Comparison
and NCT03868813 285 288 I-Eq_Comparison
80 NCT03868813 289 291 I-Eq_Comparison
years NCT03868813 292 297 I-Eq_Comparison
( NCT03868813 298 299 O
ii NCT03868813 300 302 O
) NCT03868813 303 304 O
fluent NCT03868813 305 311 O
in NCT03868813 312 314 O
English NCT03868813 315 322 O
( NCT03868813 323 324 O
iii NCT03868813 325 328 O
) NCT03868813 329 330 O
have NCT03868813 331 335 O
Type NCT03868813 336 340 B-Modifier
- NCT03868813 341 342 I-Modifier
II NCT03868813 343 345 I-Modifier
diabetes NCT03868813 346 354 B-Condition
. NCT03868813 355 356 O

Exclusion NCT03868813 358 367 O
Criteria NCT03868813 368 376 O
: NCT03868813 377 378 O

None NCT03868813 380 384 O


Inclusion NCT03926650 0 9 O
Criteria NCT03926650 10 18 O
: NCT03926650 19 20 O

- NCT03926650 24 25 O
surgery NCT03926650 27 34 B-Procedure
continues NCT03926650 35 44 O
more NCT03926650 45 49 B-Eq_Comparison
then NCT03926650 50 54 I-Eq_Comparison
1 NCT03926650 55 56 I-Eq_Comparison
hour NCT03926650 57 61 I-Eq_Comparison

- NCT03926650 64 65 O
between NCT03926650 67 74 B-Eq_Comparison
ages NCT03926650 75 79 I-Eq_Comparison
18 NCT03926650 80 82 I-Eq_Comparison
- NCT03926650 83 84 I-Eq_Comparison
65 NCT03926650 85 87 I-Eq_Comparison

- NCT03926650 91 92 O
ASA NCT03926650 94 97 B-Observation
I NCT03926650 98 99 B-Eq_Comparison
, NCT03926650 100 101 I-Eq_Comparison
II NCT03926650 102 104 I-Eq_Comparison
and NCT03926650 105 108 I-Eq_Comparison
III NCT03926650 109 112 I-Eq_Comparison
patients NCT03926650 113 121 O

Exclusion NCT03926650 122 131 O
Criteria NCT03926650 132 140 O
: NCT03926650 141 142 O

- NCT03926650 146 147 O
The NCT03926650 149 152 O
patients NCT03926650 153 161 O
who NCT03926650 162 165 O
has NCT03926650 166 169 O
allergical NCT03926650 170 180 B-Allergy
reactions NCT03926650 181 190 O
of NCT03926650 191 193 O
the NCT03926650 194 197 O
drugs NCT03926650 198 203 B-Drug
used NCT03926650 204 208 O

- NCT03926650 211 212 O
neurological NCT03926650 214 226 B-Modifier
or NCT03926650 227 229 B-Or
neuromuscular NCT03926650 230 243 B-Modifier
diseases NCT03926650 244 252 B-Condition

- NCT03926650 255 256 O
the NCT03926650 258 261 O
patients NCT03926650 262 270 O
who NCT03926650 271 274 O
use NCT03926650 275 278 B-Eq_Comparison
drugs NCT03926650 279 284 B-Drug
effecting NCT03926650 285 294 O
the NCT03926650 295 298 O
neuromuscular NCT03926650 299 312 B-Condition
junction NCT03926650 313 321 I-Condition

- NCT03926650 324 325 O
pregnant NCT03926650 327 335 B-Condition
patients NCT03926650 336 344 O

- NCT03926650 347 348 O
electrolyte NCT03926650 350 361 B-Condition
disregulations NCT03926650 362 376 I-Condition

- NCT03926650 379 380 O
major NCT03926650 382 387 O
organ NCT03926650 388 393 B-Condition
failures NCT03926650 394 402 I-Condition
, NCT03926650 403 404 O
liver NCT03926650 405 410 B-Condition
failure NCT03926650 411 418 I-Condition
, NCT03926650 419 420 O
kidney NCT03926650 421 427 B-Condition
failure NCT03926650 428 435 I-Condition

- NCT03926650 438 439 O
obese NCT03926650 441 446 B-Condition
and NCT03926650 447 450 B-Or
cachectic NCT03926650 451 460 B-Condition
patients NCT03926650 461 469 O

For NCT03869671 0 3 O
all NCT03869671 4 7 O
phases NCT03869671 8 14 O
: NCT03869671 15 16 O

Inclusion NCT03869671 18 27 O
Criteria NCT03869671 28 36 O
: NCT03869671 37 38 O

- NCT03869671 42 43 O
An NCT03869671 45 47 O
adult NCT03869671 48 53 O
PWID NCT03869671 54 58 B-Condition

- NCT03869671 61 62 O
Self NCT03869671 64 68 O
report NCT03869671 69 75 O
of NCT03869671 76 78 O
any NCT03869671 79 82 O
high NCT03869671 83 87 O
risk NCT03869671 88 92 B-Risk
behaviors NCT03869671 93 102 I-Risk
for NCT03869671 103 106 O
HIV NCT03869671 107 110 B-Condition
( NCT03869671 111 112 O
past NCT03869671 113 117 B-Eq_Comparison
- NCT03869671 118 119 I-Eq_Comparison
month NCT03869671 120 125 I-Eq_Comparison
receptive NCT03869671 126 135 B-Modifier
syringe NCT03869671 136 143 B-Condition
sharing NCT03869671 144 151 I-Condition
, NCT03869671 152 153 O
transactional NCT03869671 154 167 B-Condition
sex NCT03869671 168 171 I-Condition
, NCT03869671 172 173 O
condomless NCT03869671 174 184 B-Modifier
sex NCT03869671 185 188 B-Condition
with NCT03869671 189 193 O
an NCT03869671 194 196 O
HIV NCT03869671 197 200 B-Modifier
- NCT03869671 201 202 I-Modifier
infected NCT03869671 203 211 I-Modifier
or NCT03869671 212 214 B-Or
unknown NCT03869671 215 222 B-Modifier
status NCT03869671 223 229 I-Modifier
partner NCT03869671 230 237 I-Modifier
) NCT03869671 238 239 O

Exclusion NCT03869671 241 250 O
Criteria NCT03869671 251 259 O
: NCT03869671 260 261 O

- NCT03869671 265 266 O
Unable NCT03869671 268 274 O
or NCT03869671 275 277 O
unwilling NCT03869671 278 287 O
to NCT03869671 288 290 O
provide NCT03869671 291 298 O
informed NCT03869671 299 307 O
consent NCT03869671 308 315 O

For NCT03869671 316 319 O
Phase NCT03869671 320 325 O
3 NCT03869671 326 327 O
( NCT03869671 328 329 O
the NCT03869671 330 333 O
RCT NCT03869671 334 337 O
pilot NCT03869671 338 343 O
) NCT03869671 344 345 O
: NCT03869671 346 347 O

Inclusion NCT03869671 349 358 O
Criteria NCT03869671 359 367 O
: NCT03869671 368 369 O

- NCT03869671 373 374 O
Clinically NCT03869671 376 386 O
eligible NCT03869671 387 395 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869671 396 399 I-Assertion___Assertion_Type_Value:hypothetical
PrEP NCT03869671 400 404 B-Procedure
( NCT03869671 405 406 O
confirmed NCT03869671 407 416 O
HIV NCT03869671 417 420 B-Condition
- NCT03869671 421 422 O
uninfected NCT03869671 423 433 B-Negation
status NCT03869671 434 440 O
, NCT03869671 441 442 O
adequate NCT03869671 443 451 O
renal NCT03869671 452 457 B-Observation
function NCT03869671 458 466 I-Observation
[ NCT03869671 467 468 O
estimated NCT03869671 469 478 B-Observation
creatinine NCT03869671 479 489 I-Observation
clearance NCT03869671 490 499 I-Observation
≥ NCT03869671 500 501 B-Eq_Comparison
60 NCT03869671 502 504 I-Eq_Comparison
ml NCT03869671 505 507 I-Eq_Comparison
/ NCT03869671 508 509 I-Eq_Comparison
min NCT03869671 510 513 I-Eq_Comparison
] NCT03869671 514 515 O
, NCT03869671 516 517 O
and NCT03869671 518 521 B-And
documented NCT03869671 522 532 O
hepatitis NCT03869671 533 542 B-Condition
B NCT03869671 543 544 I-Condition
virus NCT03869671 545 550 I-Condition
[ NCT03869671 551 552 O
HBV NCT03869671 553 556 B-Condition
] NCT03869671 557 558 O
status NCT03869671 559 565 O
) NCT03869671 566 567 O

Inclusion NCT03921658 0 9 O
Criteria NCT03921658 10 18 O
: NCT03921658 19 20 O

- NCT03921658 24 25 O
Age NCT03921658 27 30 B-Age
≥ NCT03921658 31 32 B-Eq_Comparison
18 NCT03921658 33 35 I-Eq_Comparison

- NCT03921658 39 40 O
Ability NCT03921658 42 49 O
to NCT03921658 50 52 O
read NCT03921658 53 57 O
and NCT03921658 58 61 O
write NCT03921658 62 67 O
in NCT03921658 68 70 O
English NCT03921658 71 78 O

- NCT03921658 81 82 O
women NCT03921658 84 89 O
with NCT03921658 90 94 B-And
newly NCT03921658 95 100 B-Eq_Comparison
diagnosed NCT03921658 101 110 O
with NCT03921658 111 115 O
ovarian NCT03921658 116 123 B-Modifier
, NCT03921658 124 125 O
primary NCT03921658 126 133 B-Modifier
peritoneal NCT03921658 134 144 I-Modifier
, NCT03921658 145 146 O
or NCT03921658 147 149 B-Or
fallopian NCT03921658 150 159 B-Modifier
tube NCT03921658 160 164 I-Modifier
cancer NCT03921658 165 171 B-Condition

- NCT03921658 174 175 O
Treatment NCT03921658 177 186 B-Procedure
plan NCT03921658 187 191 B-Assertion___Assertion_Type_Value:hypothetical
includes NCT03921658 192 200 O
chemotherapy NCT03921658 201 213 B-Procedure

- NCT03921658 216 217 O
Able NCT03921658 219 223 O
to NCT03921658 224 226 O
provide NCT03921658 227 234 O
written NCT03921658 235 242 O
voluntary NCT03921658 243 252 O
consent NCT03921658 253 260 O
before NCT03921658 261 267 O
performance NCT03921658 268 279 O
of NCT03921658 280 282 O
any NCT03921658 283 286 O
study NCT03921658 287 292 O
related NCT03921658 293 300 O
procedure NCT03921658 301 310 O
. NCT03921658 311 312 O

- NCT03921658 316 317 O
Cohort NCT03921658 319 325 O
1 NCT03921658 326 327 O
only NCT03921658 328 332 O
: NCT03921658 333 334 O
within NCT03921658 335 341 B-Eq_Comparison
2 NCT03921658 342 343 I-Eq_Comparison
years NCT03921658 344 349 I-Eq_Comparison
of NCT03921658 350 352 O
completing NCT03921658 353 363 O
initial NCT03921658 364 371 B-Eq_Comparison
chemotherapy NCT03921658 372 384 B-Procedure
treatment NCT03921658 385 394 I-Procedure

- NCT03921658 397 398 O
Cohort NCT03921658 400 406 O
2 NCT03921658 407 408 O
only NCT03921658 409 413 O
: NCT03921658 414 415 O
prior NCT03921658 416 421 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921658 422 424 O
starting NCT03921658 425 433 O
chemotherapy NCT03921658 434 446 B-Procedure

Exclusion NCT03921658 447 456 O
Criteria NCT03921658 457 465 O
: NCT03921658 466 467 O

- NCT03921658 471 472 O
Inability NCT03921658 474 483 O
to NCT03921658 484 486 O
provide NCT03921658 487 494 O
informed NCT03921658 495 503 O
written NCT03921658 504 511 O
consent NCT03921658 512 519 O

- NCT03921658 522 523 O
Previous NCT03921658 525 533 B-Eq_Comparison
exposure NCT03921658 534 542 O
to NCT03921658 543 545 O
chemotherapy NCT03921658 546 558 B-Procedure

- NCT03921658 561 562 O
Life NCT03921658 564 568 B-Observation
expectancy NCT03921658 569 579 I-Observation
< NCT03921658 580 581 B-Eq_Comparison
3 NCT03921658 582 583 I-Eq_Comparison
months NCT03921658 584 590 I-Eq_Comparison
or NCT03921658 591 593 B-Or
in NCT03921658 594 596 O
hospice NCT03921658 597 604 B-Observation
care NCT03921658 605 609 I-Observation
or NCT03921658 610 612 B-Or
nursing NCT03921658 613 620 B-Observation
home NCT03921658 621 625 I-Observation

Inclusion NCT03868800 0 9 O
Criteria NCT03868800 10 18 O
: NCT03868800 19 20 O

- NCT03868800 24 25 O
Estimated NCT03868800 27 36 B-Observation
glomerular NCT03868800 37 47 I-Observation
filtration NCT03868800 48 58 I-Observation
rate NCT03868800 59 63 I-Observation
below NCT03868800 64 69 B-Eq_Comparison
20 NCT03868800 70 72 I-Eq_Comparison
ml NCT03868800 73 75 I-Eq_Comparison
/ NCT03868800 76 77 I-Eq_Comparison
min NCT03868800 78 81 I-Eq_Comparison

- NCT03868800 84 85 O
A NCT03868800 87 88 O
clinical NCT03868800 89 97 O
judgement NCT03868800 98 107 O
made NCT03868800 108 112 O
by NCT03868800 113 115 O
the NCT03868800 116 119 O
contact NCT03868800 120 127 O
nurse NCT03868800 128 133 O
and NCT03868800 134 137 O
the NCT03868800 138 141 O
contact NCT03868800 142 149 O
physician NCT03868800 150 159 O

Exclusion NCT03868800 160 169 O
Criteria NCT03868800 170 178 O
: NCT03868800 179 180 O

- NCT03868800 184 185 O
Conservative NCT03868800 187 199 B-Procedure
care NCT03868800 200 204 I-Procedure

- NCT03868800 207 208 O
A NCT03868800 210 211 O
set NCT03868800 212 215 B-Eq_Comparison
date NCT03868800 216 220 I-Eq_Comparison
for NCT03868800 221 224 O
a NCT03868800 225 226 O
transplantation NCT03868800 227 242 B-Procedure
with NCT03868800 243 247 O
a NCT03868800 248 249 O
living NCT03868800 250 256 B-Modifier
donor NCT03868800 257 262 I-Modifier

- NCT03868800 265 266 O
Not NCT03868800 268 271 B-Negation
able NCT03868800 272 276 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868800 277 279 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03868800 280 291 B-Study
due NCT03868800 292 295 O
to NCT03868800 296 298 O
cognitive NCT03868800 299 308 B-Condition
impairment NCT03868800 309 319 I-Condition

Inclusion NCT03923517 0 9 O
Criteria NCT03923517 10 18 O
: NCT03923517 19 20 O

- NCT03923517 24 25 O
informal NCT03923517 27 35 O
carer NCT03923517 36 41 O
of NCT03923517 42 44 O
a NCT03923517 45 46 O
person NCT03923517 47 53 O
with NCT03923517 54 58 O
YOD NCT03923517 59 62 B-Condition
who NCT03923517 63 66 O
has NCT03923517 67 70 O
been NCT03923517 71 75 O
diagnosed NCT03923517 76 85 O
with NCT03923517 86 90 O
either NCT03923517 91 97 O
Frontal NCT03923517 98 105 B-Condition
Temporal NCT03923517 106 114 I-Condition
Dementia NCT03923517 115 123 I-Condition
( NCT03923517 124 125 O
FTD NCT03923517 126 129 B-Condition
) NCT03923517 130 131 O
or NCT03923517 132 134 B-Or
Alzheimer NCT03923517 135 144 B-Condition
's NCT03923517 144 146 I-Condition
Disease NCT03923517 147 154 I-Condition
( NCT03923517 155 156 O
AD NCT03923517 157 159 B-Condition
) NCT03923517 160 161 O
12 NCT03923517 162 164 B-Eq_Comparison
months NCT03923517 165 171 I-Eq_Comparison
ago NCT03923517 172 175 I-Eq_Comparison
or NCT03923517 176 178 I-Eq_Comparison
less NCT03923517 179 183 I-Eq_Comparison
; NCT03923517 183 184 O

- NCT03923517 187 188 O
the NCT03923517 190 193 O
carer NCT03923517 194 199 O
has NCT03923517 200 203 O
face NCT03923517 204 208 B-Observation
- NCT03923517 209 210 I-Observation
to NCT03923517 211 213 I-Observation
- NCT03923517 214 215 I-Observation
face NCT03923517 216 220 I-Observation
contact NCT03923517 221 228 I-Observation
with NCT03923517 229 233 O
the NCT03923517 234 237 O
person NCT03923517 238 244 O
with NCT03923517 245 249 O
YOD NCT03923517 250 253 B-Condition
at NCT03923517 254 256 B-Eq_Comparison
least NCT03923517 257 262 I-Eq_Comparison
twice NCT03923517 263 268 I-Eq_Comparison
a NCT03923517 269 270 I-Eq_Comparison
weak NCT03923517 271 275 I-Eq_Comparison
; NCT03923517 275 276 O

- NCT03923517 279 280 O
the NCT03923517 282 285 O
carer NCT03923517 286 291 O
has NCT03923517 292 295 O
a NCT03923517 296 297 O
working NCT03923517 298 305 O
computer NCT03923517 306 314 O
and NCT03923517 315 318 O
internet NCT03923517 319 327 O
access NCT03923517 328 334 O
in NCT03923517 335 337 O
his NCT03923517 338 341 O
home NCT03923517 342 346 O
; NCT03923517 346 347 O

- NCT03923517 350 351 O
the NCT03923517 353 356 O
carer NCT03923517 357 362 O
is NCT03923517 363 365 O
available NCT03923517 366 375 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03923517 376 379 O
the NCT03923517 380 383 O
intervention NCT03923517 384 396 B-Study
duration NCT03923517 397 405 O
of NCT03923517 406 408 O
approximately NCT03923517 409 422 O
eight NCT03923517 423 428 B-Eq_Comparison
weeks NCT03923517 429 434 I-Eq_Comparison
; NCT03923517 434 435 O

- NCT03923517 438 439 O
the NCT03923517 441 444 O
carer NCT03923517 445 450 O
is NCT03923517 451 453 O
fluent NCT03923517 454 460 O
in NCT03923517 461 463 O
German NCT03923517 464 470 O
; NCT03923517 470 471 O

- NCT03923517 474 475 O
signed NCT03923517 477 483 O
consent NCT03923517 484 491 O
form NCT03923517 492 496 O
. NCT03923517 497 498 O

Exclusion NCT03923517 500 509 O
Criteria NCT03923517 510 518 O
: NCT03923517 519 520 O

- NCT03923517 524 525 O
the NCT03923517 527 530 O
carer NCT03923517 531 536 O
has NCT03923517 537 540 O
face NCT03923517 541 545 B-Observation
- NCT03923517 546 547 I-Observation
to NCT03923517 548 550 I-Observation
- NCT03923517 551 552 I-Observation
face NCT03923517 553 557 I-Observation
contact NCT03923517 558 565 I-Observation
with NCT03923517 566 570 O
the NCT03923517 571 574 O
person NCT03923517 575 581 O
with NCT03923517 582 586 O
YOD NCT03923517 587 590 B-Condition
less NCT03923517 591 595 B-Eq_Comparison
than NCT03923517 596 600 I-Eq_Comparison
twice NCT03923517 601 606 I-Eq_Comparison
a NCT03923517 607 608 I-Eq_Comparison
week NCT03923517 609 613 I-Eq_Comparison
; NCT03923517 613 614 O

- NCT03923517 617 618 O
the NCT03923517 620 623 O
person NCT03923517 624 630 O
with NCT03923517 631 635 O
YOD NCT03923517 636 639 B-Condition
the NCT03923517 640 643 O
carer NCT03923517 644 649 O
is NCT03923517 650 652 O
caring NCT03923517 653 659 O
for NCT03923517 660 663 O
has NCT03923517 664 667 O
a NCT03923517 668 669 O
different NCT03923517 670 679 B-Other
dementia NCT03923517 680 688 B-Condition
cause NCT03923517 689 694 B-Condition
other NCT03923517 695 700 B-Exception
than NCT03923517 701 705 I-Exception
FTD NCT03923517 706 709 B-Condition
or NCT03923517 710 712 B-Or
AD NCT03923517 713 715 B-Condition
or NCT03923517 716 718 B-Or
the NCT03923517 719 722 O
diagnosis NCT03923517 723 732 O
is NCT03923517 733 735 O
older NCT03923517 736 741 B-Eq_Comparison
than NCT03923517 742 746 I-Eq_Comparison
12 NCT03923517 747 749 I-Eq_Comparison
months NCT03923517 750 756 I-Eq_Comparison
; NCT03923517 756 757 O

- NCT03923517 760 761 O
the NCT03923517 763 766 O
carer NCT03923517 767 772 O
does NCT03923517 773 777 O
not NCT03923517 778 781 O
have NCT03923517 782 786 O
a NCT03923517 787 788 O
working NCT03923517 789 796 O
computer NCT03923517 797 805 O
and NCT03923517 806 809 O
internet NCT03923517 810 818 O
access NCT03923517 819 825 O
at NCT03923517 826 828 O
home NCT03923517 829 833 O
or NCT03923517 834 836 O
is NCT03923517 837 839 O
not NCT03923517 840 843 O
confident NCT03923517 844 853 O
to NCT03923517 854 856 O
use NCT03923517 857 860 O
them NCT03923517 861 865 O
; NCT03923517 865 866 O

- NCT03923517 869 870 O
the NCT03923517 872 875 O
carer NCT03923517 876 881 O
is NCT03923517 882 884 O
not NCT03923517 885 888 B-Negation
available NCT03923517 889 898 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03923517 899 902 O
the NCT03923517 903 906 O
approximately NCT03923517 907 920 O
eight NCT03923517 921 926 B-Eq_Comparison
week NCT03923517 927 931 I-Eq_Comparison
intervention NCT03923517 932 944 B-Study
duration NCT03923517 945 953 O
; NCT03923517 953 954 O

- NCT03923517 957 958 O
the NCT03923517 960 963 O
carer NCT03923517 964 969 O
is NCT03923517 970 972 O
not NCT03923517 973 976 B-Negation
fluent NCT03923517 977 983 O
in NCT03923517 984 986 O
German NCT03923517 987 993 O
; NCT03923517 993 994 O

- NCT03923517 997 998 O
the NCT03923517 1000 1003 O
carer NCT03923517 1004 1009 O
has NCT03923517 1010 1013 O
a NCT03923517 1014 1015 O
significant NCT03923517 1016 1027 O
health NCT03923517 1028 1034 B-Condition
problem NCT03923517 1035 1042 I-Condition
or NCT03923517 1043 1045 B-Or
disability NCT03923517 1046 1056 B-Condition
, NCT03923517 1057 1058 O
which NCT03923517 1059 1064 O
precludes NCT03923517 1065 1074 O
him NCT03923517 1075 1078 O
/ NCT03923517 1079 1080 O
her NCT03923517 1081 1084 O
from NCT03923517 1085 1089 O
participating NCT03923517 1090 1103 O
in NCT03923517 1104 1106 O
the NCT03923517 1107 1110 O
study NCT03923517 1111 1116 O
; NCT03923517 1116 1117 O

- NCT03923517 1120 1121 O
no NCT03923517 1123 1125 O
signed NCT03923517 1126 1132 O
informed NCT03923517 1133 1141 O
consent NCT03923517 1142 1149 O
. NCT03923517 1150 1151 O

Inclusion NCT03866837 0 9 O
Criteria NCT03866837 10 18 O
: NCT03866837 19 20 O

- NCT03866837 24 25 O
vaginal NCT03866837 27 34 B-Procedure
delivery NCT03866837 35 43 I-Procedure

- NCT03866837 46 47 O
an NCT03866837 49 51 O
infant NCT03866837 52 58 B-Family_Member___Family_Member_Type:child
age NCT03866837 59 62 B-Eq_Comparison
of NCT03866837 63 65 I-Eq_Comparison
6 NCT03866837 66 67 I-Eq_Comparison
months NCT03866837 68 74 I-Eq_Comparison
( NCT03866837 75 76 O
± NCT03866837 77 78 B-Eq_Comparison
3 NCT03866837 79 80 I-Eq_Comparison
weeks NCT03866837 81 86 I-Eq_Comparison
) NCT03866837 87 88 O

- NCT03866837 92 93 O
mother NCT03866837 95 101 B-Family_Member___Family_Member_Type:mother
≥ NCT03866837 102 103 B-Eq_Comparison
15 NCT03866837 104 106 I-Eq_Comparison
years NCT03866837 107 112 I-Eq_Comparison
of NCT03866837 113 115 O
age NCT03866837 116 119 B-Age

- NCT03866837 122 123 O
infant NCT03866837 125 131 O
still NCT03866837 132 137 O
breastfeeding NCT03866837 138 151 B-Condition

- NCT03866837 154 155 O
anticipated NCT03866837 157 168 O
residence NCT03866837 169 178 O
in NCT03866837 179 181 O
the NCT03866837 182 185 O
area NCT03866837 186 190 O
for NCT03866837 191 194 O
the NCT03866837 195 198 O
study NCT03866837 199 204 B-Study
duration NCT03866837 205 213 O
. NCT03866837 214 215 O

Exclusion NCT03866837 217 226 O
Criteria NCT03866837 227 235 O
: NCT03866837 236 237 O

- NCT03866837 241 242 O
inability NCT03866837 244 253 O
to NCT03866837 254 256 O
provide NCT03866837 257 264 O
informed NCT03866837 265 273 O
consent NCT03866837 274 281 O

- NCT03866837 284 285 O
hemoglobin NCT03866837 287 297 B-Observation
< NCT03866837 298 299 B-Eq_Comparison
70 NCT03866837 300 302 I-Eq_Comparison
g NCT03866837 303 304 I-Eq_Comparison
/ NCT03866837 305 306 I-Eq_Comparison
L NCT03866837 307 308 I-Eq_Comparison

- NCT03866837 311 312 O
Z NCT03866837 314 315 B-Observation
scores NCT03866837 316 322 I-Observation
for NCT03866837 323 326 I-Observation
weight NCT03866837 327 333 I-Observation
- NCT03866837 334 335 I-Observation
for NCT03866837 336 339 I-Observation
- NCT03866837 340 341 I-Observation
age NCT03866837 342 345 I-Observation
( NCT03866837 346 347 O
WAZ NCT03866837 348 351 B-Observation
) NCT03866837 352 353 O
or NCT03866837 354 356 B-Or
weight NCT03866837 357 363 B-Observation
- NCT03866837 364 365 I-Observation
for NCT03866837 366 369 I-Observation
- NCT03866837 370 371 I-Observation
height NCT03866837 372 378 I-Observation
( NCT03866837 379 380 O
WHZ NCT03866837 381 384 B-Observation
) NCT03866837 385 386 O
< NCT03866837 387 388 B-Eq_Comparison
3 NCT03866837 389 390 I-Eq_Comparison
, NCT03866837 391 392 O

- NCT03866837 396 397 O
any NCT03866837 399 402 O
maternal NCT03866837 403 411 B-Family_Member___Family_Member_Type:mother
or NCT03866837 412 414 B-Or
infant NCT03866837 415 421 B-Family_Member___Family_Member_Type:child
chronic NCT03866837 422 429 O
illness NCT03866837 430 437 B-Condition

- NCT03866837 440 441 O
administration NCT03866837 443 457 O
of NCT03866837 458 460 O
any NCT03866837 461 464 O
infant NCT03866837 465 471 B-Family_Member___Family_Member_Type:child
vitamin NCT03866837 472 479 B-Modifier
or NCT03866837 480 482 B-Or
mineral NCT03866837 483 490 B-Modifier
supplements NCT03866837 491 502 B-Drug
for NCT03866837 503 506 O
the NCT03866837 507 510 O
past NCT03866837 511 515 B-Eq_Comparison
2 NCT03866837 516 517 I-Eq_Comparison
months NCT03866837 518 524 I-Eq_Comparison

- NCT03866837 527 528 O
any NCT03866837 530 533 O
history NCT03866837 534 541 B-Eq_Comparison
of NCT03866837 542 544 O
infant NCT03866837 545 551 B-Family_Member___Family_Member_Type:child
antibiotic NCT03866837 552 562 B-Drug
treatment NCT03866837 563 572 B-Procedure
. NCT03866837 573 574 O

Inclusion NCT03862014 0 9 O
Criteria NCT03862014 10 18 O
: NCT03862014 19 20 O

- NCT03862014 24 25 O
Patients NCT03862014 27 35 O
and NCT03862014 36 39 O
parents NCT03862014 40 47 B-Family_Member
of NCT03862014 48 50 O
the NCT03862014 51 54 O
patients NCT03862014 55 63 O
who NCT03862014 64 67 O
accept NCT03862014 68 74 O
to NCT03862014 75 77 O
participate NCT03862014 78 89 O
and NCT03862014 90 93 O
sign NCT03862014 94 98 O
the NCT03862014 99 102 O
informed NCT03862014 103 111 O
consent NCT03862014 112 119 O

- NCT03862014 122 123 O
Patients NCT03862014 125 133 O
whose NCT03862014 134 139 O
molar NCT03862014 140 145 B-Modifier
teeth NCT03862014 146 151 I-Modifier
are NCT03862014 152 155 O
diagnosed NCT03862014 156 165 O
as NCT03862014 166 168 O
molar NCT03862014 169 174 B-Condition
incisor NCT03862014 175 182 I-Condition
hypomineralization NCT03862014 183 201 I-Condition
by NCT03862014 202 204 O
EAPD NCT03862014 205 209 O

- NCT03862014 212 213 O
Teeth NCT03862014 215 220 B-Modifier
that NCT03862014 221 225 I-Modifier
are NCT03862014 226 229 O
fully NCT03862014 230 235 B-Condition
erupted NCT03862014 236 243 I-Condition

- NCT03862014 246 247 O
Patients NCT03862014 249 257 O
who NCT03862014 258 261 O
have NCT03862014 262 266 O
at NCT03862014 267 269 B-Eq_Comparison
least NCT03862014 270 275 I-Eq_Comparison
two NCT03862014 276 279 I-Eq_Comparison
permanent NCT03862014 280 289 B-Modifier
first NCT03862014 290 295 I-Modifier
molars NCT03862014 296 302 B-Condition
that NCT03862014 303 307 O
need NCT03862014 308 312 B-Assertion___Assertion_Type_Value:hypothetical
fissure NCT03862014 313 320 B-Procedure
sealant NCT03862014 321 328 I-Procedure

- NCT03862014 331 332 O
Teeth NCT03862014 334 339 B-Modifier
that NCT03862014 340 344 O
have NCT03862014 345 349 O
white NCT03862014 350 355 B-Modifier
- NCT03862014 356 357 I-Modifier
yellow NCT03862014 358 364 I-Modifier
- NCT03862014 365 366 I-Modifier
brown NCT03862014 367 372 I-Modifier
discoloration NCT03862014 373 386 B-Condition
that NCT03862014 387 391 O
indicate NCT03862014 392 400 O
high NCT03862014 401 405 O
- NCT03862014 406 407 O
caries NCT03862014 408 414 B-Condition
risk NCT03862014 415 419 B-Risk

Exclusion NCT03862014 420 429 O
Criteria NCT03862014 430 438 O
: NCT03862014 439 440 O

- NCT03862014 444 445 O
Teeth NCT03862014 447 452 B-Modifier
that NCT03862014 453 457 O
are NCT03862014 458 461 O
previously NCT03862014 462 472 B-Eq_Comparison
restored NCT03862014 473 481 B-Procedure
or NCT03862014 482 484 B-Or
have NCT03862014 485 489 O
caries NCT03862014 490 496 B-Condition

- NCT03862014 499 500 O
Patients NCT03862014 502 510 O
who NCT03862014 511 514 O
have NCT03862014 515 519 O
orthodontic NCT03862014 520 531 B-Procedure
treatment NCT03862014 532 541 I-Procedure

- NCT03862014 544 545 O
Patients NCT03862014 547 555 O
who NCT03862014 556 559 O
are NCT03862014 560 563 O
not NCT03862014 564 567 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
cooperative NCT03862014 568 579 O
for NCT03862014 580 583 O
the NCT03862014 584 587 O
dental NCT03862014 588 594 B-Procedure
procedure NCT03862014 595 604 I-Procedure

- NCT03862014 607 608 O
Teeth NCT03862014 610 615 B-Modifier
that NCT03862014 616 620 O
have NCT03862014 621 625 O
dental NCT03862014 626 632 B-Condition
flourosis NCT03862014 633 642 I-Condition
or NCT03862014 643 645 B-Or
enamel NCT03862014 646 652 B-Condition
malformation NCT03862014 653 665 I-Condition
according NCT03862014 666 675 O
to NCT03862014 676 678 O
the NCT03862014 679 682 O
specific NCT03862014 683 691 O
syndromes NCT03862014 692 701 O

Inclusion NCT03868696 0 9 O
Criteria NCT03868696 10 18 O
: NCT03868696 19 20 O

- NCT03868696 24 25 O
Adults NCT03868696 27 33 O
with NCT03868696 34 38 B-And
Colles NCT03868696 39 45 B-Modifier
' NCT03868696 45 46 I-Modifier
type NCT03868696 47 51 I-Modifier
fractures NCT03868696 52 61 B-Condition
of NCT03868696 62 64 O
the NCT03868696 65 68 O
distal NCT03868696 69 75 B-Modifier
radius NCT03868696 76 82 I-Modifier
undergoing NCT03868696 83 93 B-Eq_Comparison
fracture NCT03868696 94 102 B-Procedure
manipulation NCT03868696 103 115 I-Procedure
in NCT03868696 116 118 O
the NCT03868696 119 122 O
ED NCT03868696 123 125 O

- NCT03868696 128 129 O
UDiReCT NCT03868696 131 138 O
Trial NCT03868696 139 144 O
trained NCT03868696 145 152 O
staff NCT03868696 153 158 O
available NCT03868696 159 168 O

Exclusion NCT03868696 169 178 O
Criteria NCT03868696 179 187 O
: NCT03868696 188 189 O

- NCT03868696 193 194 O
Age NCT03868696 196 199 B-Age
under NCT03868696 200 205 B-Eq_Comparison
18 NCT03868696 206 208 I-Eq_Comparison

- NCT03868696 212 213 O
Volar NCT03868696 215 220 B-Modifier
displaced NCT03868696 221 230 I-Modifier
( NCT03868696 231 232 O
Smith NCT03868696 233 238 B-Modifier
's NCT03868696 238 240 I-Modifier
) NCT03868696 241 242 O
type NCT03868696 243 247 O
fractures NCT03868696 248 257 B-Condition
( NCT03868696 258 259 O
well NCT03868696 260 264 O
established NCT03868696 265 276 O
as NCT03868696 277 279 O
being NCT03868696 280 285 O
unstable NCT03868696 286 294 O
and NCT03868696 295 298 B-And
requiring NCT03868696 299 308 B-Assertion___Assertion_Type_Value:hypothetical
surgical NCT03868696 309 317 B-Procedure
treatment NCT03868696 318 327 I-Procedure
) NCT03868696 328 329 O

- NCT03868696 333 334 O
Unable NCT03868696 336 342 O
or NCT03868696 343 345 O
unwilling NCT03868696 346 355 O
to NCT03868696 356 358 O
give NCT03868696 359 363 O
informed NCT03868696 364 372 O
consent NCT03868696 373 380 O

- NCT03868696 383 384 O
Unable NCT03868696 386 392 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03868696 393 395 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
unwilling NCT03868696 396 405 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
to NCT03868696 406 408 O
be NCT03868696 409 411 O
followed NCT03868696 412 420 B-Encounter
up NCT03868696 421 423 I-Encounter
( NCT03868696 424 425 O
e NCT03868696 426 427 O
. NCT03868696 428 429 O
g NCT03868696 430 431 O
. NCT03868696 432 433 O
orthopaedic NCT03868696 435 446 B-Provider
follow NCT03868696 447 453 B-Encounter
up NCT03868696 454 456 I-Encounter
in NCT03868696 457 459 O
another NCT03868696 460 467 B-Other
region NCT03868696 468 474 O
) NCT03868696 475 476 O

- NCT03868696 480 481 O
Major NCT03868696 483 488 O
trauma NCT03868696 489 495 B-Condition
with NCT03868696 496 500 B-And
other NCT03868696 501 506 B-Other
injuries NCT03868696 507 515 B-Condition
and NCT03868696 516 519 B-And
ISS NCT03868696 520 523 B-Observation
( NCT03868696 524 525 O
Injury NCT03868696 526 532 B-Observation
Severity NCT03868696 533 541 I-Observation
Score NCT03868696 542 547 I-Observation
) NCT03868696 548 549 O
> NCT03868696 550 551 B-Eq_Comparison
16 NCT03868696 552 554 I-Eq_Comparison

- NCT03868696 558 559 O
Urgent NCT03868696 561 567 B-Modifier
manipulation NCT03868696 568 580 B-Procedure
required NCT03868696 581 589 B-Assertion___Assertion_Type_Value:hypothetical
due NCT03868696 590 593 O
to NCT03868696 594 596 O
neurovascular NCT03868696 597 610 B-Modifier
or NCT03868696 611 613 B-Or
skin NCT03868696 614 618 B-Modifier
compromise NCT03868696 619 629 B-Condition

- NCT03868696 632 633 O
Open NCT03868696 635 639 B-Modifier
fractures NCT03868696 640 649 B-Condition
or NCT03868696 650 652 B-Or
those NCT03868696 653 658 O
with NCT03868696 659 663 O
associated NCT03868696 664 674 O
nerve NCT03868696 675 680 B-Modifier
or NCT03868696 681 683 B-Or
tendon NCT03868696 684 690 B-Modifier
involvement NCT03868696 691 702 I-Modifier
( NCT03868696 703 704 O
affect NCT03868696 705 711 O
functional NCT03868696 712 722 O
outcome NCT03868696 723 730 O
) NCT03868696 731 732 O

- NCT03868696 736 737 O
Prisoners NCT03868696 739 748 B-Observation

Inclusion NCT03923153 0 9 O
Criteria NCT03923153 10 18 O
: NCT03923153 19 20 O

- NCT03923153 24 25 O
No NCT03923153 27 29 B-Negation
contraindication NCT03923153 30 46 B-Contraindication
for NCT03923153 47 50 O
pulmonary NCT03923153 51 60 B-Procedure
physiotherapy NCT03923153 61 74 I-Procedure

- NCT03923153 77 78 O
Anjina NCT03923153 80 86 B-Condition
patients NCT03923153 87 95 O
who NCT03923153 96 99 O
are NCT03923153 100 103 O
clinically NCT03923153 104 114 O
stable NCT03923153 115 121 O

- NCT03923153 124 125 O
have NCT03923153 127 131 O
no NCT03923153 132 134 B-Negation
other NCT03923153 135 140 B-Other
disease NCT03923153 141 148 B-Condition
that NCT03923153 149 153 O
may NCT03923153 154 157 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03923153 158 164 O
respiratory NCT03923153 165 176 B-Condition
function NCT03923153 177 185 I-Condition

- NCT03923153 188 189 O
Individuals NCT03923153 191 202 O
who NCT03923153 203 206 O
have NCT03923153 207 211 O
the NCT03923153 212 215 O
good NCT03923153 216 220 O
cooperation NCT03923153 221 232 O

Exclusion NCT03923153 233 242 O
Criteria NCT03923153 243 251 O
: NCT03923153 252 253 O

- NCT03923153 257 258 O
Patients NCT03923153 260 268 O
under NCT03923153 269 274 B-Eq_Comparison
the NCT03923153 275 278 I-Eq_Comparison
age NCT03923153 279 282 I-Eq_Comparison
of NCT03923153 283 285 I-Eq_Comparison
18 NCT03923153 286 288 I-Eq_Comparison

- NCT03923153 292 293 O
Pregnancy NCT03923153 295 304 B-Condition

- NCT03923153 307 308 O
Active NCT03923153 310 316 B-Eq_Comparison
infection NCT03923153 317 326 B-Condition

- NCT03923153 329 330 O
Patients NCT03923153 332 340 O
with NCT03923153 341 345 O
known NCT03923153 346 351 O
malignancies NCT03923153 352 364 B-Condition

- NCT03923153 367 368 O
patients NCT03923153 370 378 O
without NCT03923153 379 386 O
consent NCT03923153 387 394 O

- NCT03923153 397 398 O
known NCT03923153 400 405 O
arrhythmia NCT03923153 406 416 B-Condition
, NCT03923153 417 418 O
dilated NCT03923153 419 426 B-Modifier
or NCT03923153 427 429 B-Or
hypertrophic NCT03923153 430 442 B-Modifier
cardiomyopathy NCT03923153 443 457 B-Condition
, NCT03923153 458 459 O
heart NCT03923153 460 465 B-Condition
failure NCT03923153 466 473 I-Condition
( NCT03923153 474 475 O
EF NCT03923153 476 478 B-Observation
< NCT03923153 479 480 B-Eq_Comparison
40 NCT03923153 481 483 I-Eq_Comparison
% NCT03923153 484 485 I-Eq_Comparison
) NCT03923153 486 487 O

Inclusion NCT03932045 0 9 O
Criteria NCT03932045 10 18 O
: NCT03932045 19 20 O

1 NCT03932045 24 25 O
. NCT03932045 25 26 O
Individuals NCT03932045 28 39 O
who NCT03932045 40 43 O
desire NCT03932045 44 50 B-Assertion___Assertion_Type_Value:intention
an NCT03932045 51 53 O
improvement NCT03932045 54 65 O
in NCT03932045 66 68 O
the NCT03932045 69 72 O
appearance NCT03932045 73 83 B-Observation
of NCT03932045 84 86 I-Observation
the NCT03932045 87 90 I-Observation
nasolabial NCT03932045 91 101 I-Observation
fold NCT03932045 102 106 I-Observation
on NCT03932045 107 109 O
both NCT03932045 110 114 O
sides NCT03932045 115 120 O
of NCT03932045 121 123 O
the NCT03932045 124 127 O
face NCT03932045 128 132 O
and NCT03932045 133 136 B-And
who NCT03932045 137 140 O
have NCT03932045 141 145 O
a NCT03932045 146 147 O
score NCT03932045 148 153 B-Eq_Comparison
of NCT03932045 154 156 I-Eq_Comparison
3 NCT03932045 157 158 I-Eq_Comparison
or NCT03932045 159 161 I-Eq_Comparison
4 NCT03932045 162 163 I-Eq_Comparison
on NCT03932045 164 166 O
the NCT03932045 167 170 O
Wrinkle NCT03932045 171 178 B-Observation
Severity NCT03932045 179 187 I-Observation
Rating NCT03932045 188 194 I-Observation
Scale NCT03932045 195 200 I-Observation
( NCT03932045 201 202 O
WSRS NCT03932045 203 207 B-Observation
) NCT03932045 208 209 O

2 NCT03932045 213 214 O
. NCT03932045 214 215 O
Individuals NCT03932045 217 228 O
who NCT03932045 229 232 O
have NCT03932045 233 237 O
consented NCT03932045 238 247 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03932045 248 250 I-Assertion___Assertion_Type_Value:hypothetical
abstain NCT03932045 251 258 B-Negation
from NCT03932045 259 263 I-Negation
any NCT03932045 264 267 O
other NCT03932045 268 273 O
dermatological NCT03932045 274 288 B-Procedure
procedures NCT03932045 289 299 I-Procedure
or NCT03932045 300 302 B-Or
treatments NCT03932045 303 313 B-Procedure
, NCT03932045 314 315 O
including NCT03932045 316 325 O
treatments NCT03932045 326 336 O
for NCT03932045 337 340 O
wrinkle NCT03932045 341 348 B-Procedure
reduction NCT03932045 349 358 I-Procedure
in NCT03932045 359 361 O
the NCT03932045 362 365 O
facial NCT03932045 366 372 O
area NCT03932045 373 377 O
, NCT03932045 378 379 O
during NCT03932045 380 386 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03932045 387 390 O
duration NCT03932045 391 399 O
of NCT03932045 400 402 O
this NCT03932045 403 407 O
study NCT03932045 408 413 B-Study
. NCT03932045 414 415 O

Exclusion NCT03932045 417 426 O
Criteria NCT03932045 427 435 O
: NCT03932045 436 437 O

1 NCT03932045 441 442 O
. NCT03932045 442 443 O
Administered NCT03932045 445 457 B-Eq_Comparison
an NCT03932045 458 460 O
anticoagulant NCT03932045 461 474 B-Drug
( NCT03932045 475 476 O
with NCT03932045 477 481 O
the NCT03932045 482 485 O
exception NCT03932045 486 495 B-Exception
of NCT03932045 496 498 O
low NCT03932045 499 502 B-Eq_Comparison
dosage NCT03932045 503 509 O
aspirin NCT03932045 510 517 B-Drug
( NCT03932045 518 519 O
100 NCT03932045 520 523 B-Eq_Comparison
mg NCT03932045 524 526 I-Eq_Comparison
, NCT03932045 527 528 I-Eq_Comparison
up NCT03932045 529 531 I-Eq_Comparison
to NCT03932045 532 534 I-Eq_Comparison
300 NCT03932045 535 538 I-Eq_Comparison
mg NCT03932045 539 541 I-Eq_Comparison
/ NCT03932045 542 543 I-Eq_Comparison
day NCT03932045 544 547 I-Eq_Comparison
) NCT03932045 548 549 O
) NCT03932045 550 551 O
within NCT03932045 552 558 B-Eq_Comparison
2 NCT03932045 559 560 I-Eq_Comparison
weeks NCT03932045 561 566 I-Eq_Comparison
of NCT03932045 567 569 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03932045 570 573 O
date NCT03932045 574 578 O
of NCT03932045 579 581 O
the NCT03932045 582 585 O
screening NCT03932045 586 595 B-Study

2 NCT03932045 598 599 O
. NCT03932045 599 600 O
Administered NCT03932045 602 614 B-Eq_Comparison
Vitamin NCT03932045 615 622 B-Drug
E NCT03932045 623 624 I-Drug
or NCT03932045 625 627 B-Or
non NCT03932045 628 631 B-Drug
- NCT03932045 632 633 I-Drug
steroidal NCT03932045 634 643 I-Drug
anti NCT03932045 644 648 I-Drug
- NCT03932045 649 650 I-Drug
inflammatory NCT03932045 651 663 I-Drug
drugs NCT03932045 664 669 I-Drug
or NCT03932045 670 672 B-Or
Collagen NCT03932045 673 681 B-Drug
within NCT03932045 682 688 B-Eq_Comparison
1 NCT03932045 689 690 I-Eq_Comparison
week NCT03932045 691 695 I-Eq_Comparison
of NCT03932045 696 698 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03932045 699 702 O
date NCT03932045 703 707 O
of NCT03932045 708 710 O
the NCT03932045 711 714 O
screening NCT03932045 715 724 B-Study
, NCT03932045 725 726 O
or NCT03932045 727 729 O
who NCT03932045 730 733 O
require NCT03932045 734 741 B-Assertion___Assertion_Type_Value:hypothetical
these NCT03932045 742 747 O
during NCT03932045 748 754 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03932045 755 758 O
period NCT03932045 759 765 O
of NCT03932045 766 768 O
the NCT03932045 769 772 O
study NCT03932045 773 778 B-Study

3 NCT03932045 781 782 O
. NCT03932045 782 783 O
History NCT03932045 785 792 B-Eq_Comparison
of NCT03932045 793 795 O
bleeding NCT03932045 796 804 B-Condition
disorder NCT03932045 805 813 I-Condition
in NCT03932045 814 816 O
past NCT03932045 817 821 B-Eq_Comparison
or NCT03932045 822 824 B-Or
present NCT03932045 825 832 B-Eq_Comparison

4 NCT03932045 835 836 O
. NCT03932045 836 837 O
Received NCT03932045 839 847 B-Eq_Comparison
deep NCT03932045 848 852 B-Procedure
- NCT03932045 853 854 I-Procedure
peeling NCT03932045 855 862 I-Procedure
, NCT03932045 863 864 O
skin NCT03932045 865 869 B-Procedure
regeneration NCT03932045 870 882 I-Procedure
, NCT03932045 883 884 O
plastic NCT03932045 885 892 B-Procedure
surgery NCT03932045 893 900 I-Procedure
( NCT03932045 901 902 O
including NCT03932045 903 912 O
botulinum NCT03932045 913 922 B-Procedure
toxin NCT03932045 923 928 I-Procedure
injection NCT03932045 929 938 I-Procedure
) NCT03932045 939 940 O
, NCT03932045 941 942 O
wrinkle NCT03932045 943 950 B-Procedure
improvement NCT03932045 951 962 I-Procedure
or NCT03932045 963 965 B-Or
acne NCT03932045 966 970 B-Procedure
scar NCT03932045 971 975 I-Procedure
treatment NCT03932045 976 985 I-Procedure
in NCT03932045 986 988 O
the NCT03932045 989 992 O
facial NCT03932045 993 999 O
area NCT03932045 1000 1004 O
within NCT03932045 1005 1011 B-Eq_Comparison
24 NCT03932045 1012 1014 I-Eq_Comparison
weeks NCT03932045 1015 1020 I-Eq_Comparison
of NCT03932045 1021 1023 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03932045 1024 1027 O
date NCT03932045 1028 1032 O
of NCT03932045 1033 1035 O
the NCT03932045 1036 1039 O
screening NCT03932045 1040 1049 B-Study

5 NCT03932045 1052 1053 O
. NCT03932045 1053 1054 O
Administered NCT03932045 1056 1068 B-Eq_Comparison
an NCT03932045 1069 1071 O
hyaluronic NCT03932045 1072 1082 B-Drug
acid NCT03932045 1083 1087 I-Drug
filler NCT03932045 1088 1094 I-Drug
within NCT03932045 1095 1101 B-Eq_Comparison
24 NCT03932045 1102 1104 I-Eq_Comparison
weeks NCT03932045 1105 1110 I-Eq_Comparison
of NCT03932045 1111 1113 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03932045 1114 1117 O
date NCT03932045 1118 1122 O
of NCT03932045 1123 1125 O
the NCT03932045 1126 1129 O
screening NCT03932045 1130 1139 B-Study


Inclusion NCT03926533 0 9 O
Criteria NCT03926533 10 18 O
: NCT03926533 19 20 O

- NCT03926533 24 25 O
index NCT03926533 27 32 O
ICU NCT03926533 33 36 O
stay NCT03926533 37 41 B-Encounter
with NCT03926533 42 46 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03926533 47 48 O
diagnosis NCT03926533 49 58 O
of NCT03926533 59 61 O
sepsis NCT03926533 62 68 B-Condition
or NCT03926533 69 71 B-Or
acute NCT03926533 72 77 O
respiratory NCT03926533 78 89 B-Condition
distress NCT03926533 90 98 I-Condition
syndrome NCT03926533 99 107 I-Condition
projected NCT03926533 108 117 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926533 118 120 O
be NCT03926533 121 123 O
discharged NCT03926533 124 134 B-Encounter
alive NCT03926533 135 140 B-Death|B-Negation
as NCT03926533 141 143 O
these NCT03926533 144 149 O
patients NCT03926533 150 158 O
are NCT03926533 159 162 O
at NCT03926533 163 165 O
the NCT03926533 166 169 O
highest NCT03926533 170 177 O
risk NCT03926533 178 182 B-Risk
for NCT03926533 183 186 O
developing NCT03926533 187 197 O
PICS NCT03926533 198 202 B-Condition

Exclusion NCT03926533 203 212 O
Criteria NCT03926533 213 221 O
: NCT03926533 222 223 O

1 NCT03926533 227 228 O
. NCT03926533 228 229 O
no NCT03926533 231 233 O
access NCT03926533 234 240 O
to NCT03926533 241 243 O
computer NCT03926533 244 252 O
, NCT03926533 253 254 O
electronic NCT03926533 255 265 O
device NCT03926533 266 272 O
( NCT03926533 273 274 O
e NCT03926533 275 276 O
. NCT03926533 277 278 O
g NCT03926533 279 280 O
. NCT03926533 281 282 O
, NCT03926533 283 284 O
tablet NCT03926533 285 291 O
, NCT03926533 292 293 O
smartphone NCT03926533 294 304 O
) NCT03926533 305 306 O
, NCT03926533 307 308 O
and NCT03926533 309 312 O
/ NCT03926533 313 314 O
or NCT03926533 315 317 O
internet NCT03926533 318 326 O
connection NCT03926533 327 337 O
for NCT03926533 338 341 O
virtual NCT03926533 342 349 O
clinic NCT03926533 350 356 O
visit NCT03926533 357 362 O
, NCT03926533 363 364 O

2 NCT03926533 368 369 O
. NCT03926533 369 370 O
primary NCT03926533 372 379 B-Encounter
care NCT03926533 380 384 I-Encounter
received NCT03926533 385 393 B-Eq_Comparison
outside NCT03926533 394 401 B-Other
of NCT03926533 402 404 O
VUMC NCT03926533 405 409 O
network NCT03926533 410 417 O
, NCT03926533 418 419 O

3 NCT03926533 423 424 O
. NCT03926533 424 425 O
hospice NCT03926533 427 434 O
care NCT03926533 435 439 O
at NCT03926533 440 442 O
discharge NCT03926533 443 452 B-Encounter
, NCT03926533 453 454 O

4 NCT03926533 458 459 O
. NCT03926533 459 460 O
substance NCT03926533 462 471 B-Condition
abuse NCT03926533 472 477 I-Condition
or NCT03926533 478 480 B-Or
psychiatric NCT03926533 481 492 B-Condition
disorder NCT03926533 493 501 I-Condition
that NCT03926533 502 506 O
prevents NCT03926533 507 515 B-Negation
independent NCT03926533 516 527 B-Condition
living NCT03926533 528 534 I-Condition
, NCT03926533 535 536 O

5 NCT03926533 540 541 O
. NCT03926533 541 542 O
blind NCT03926533 544 549 B-Condition
, NCT03926533 550 551 O
deaf NCT03926533 552 556 B-Condition
, NCT03926533 557 558 O
unable NCT03926533 559 565 B-Negation
to NCT03926533 566 568 O
speak NCT03926533 569 574 O
English NCT03926533 575 582 O
, NCT03926533 583 584 O
or NCT03926533 585 587 B-Or

6 NCT03926533 590 591 O
. NCT03926533 591 592 O
severe NCT03926533 594 600 O
dementia NCT03926533 601 609 B-Condition
prior NCT03926533 610 615 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926533 616 618 I-Temporal_Connection___Temporal_Connection_Type_Value:before
index NCT03926533 619 624 O
hospitalization NCT03926533 625 640 B-Encounter

Inclusion NCT03928977 0 9 O
Criteria NCT03928977 10 18 O
: NCT03928977 19 20 O

- NCT03928977 24 25 O
Patient NCT03928977 27 34 O
admitted NCT03928977 35 43 O
in NCT03928977 44 46 O
for NCT03928977 47 50 O
a NCT03928977 51 52 O
transient NCT03928977 53 62 B-Condition
neurologic NCT03928977 63 73 I-Condition
deficit NCT03928977 74 81 I-Condition
and NCT03928977 82 85 B-And
suspicion NCT03928977 86 95 B-Assertion___Assertion_Type_Value:possible
of NCT03928977 96 98 O
TIA NCT03928977 99 102 B-Condition
of NCT03928977 103 105 O
carotid NCT03928977 106 113 B-Modifier
circulation NCT03928977 114 125 I-Modifier

- NCT03928977 128 129 O
Prescription NCT03928977 131 143 O
for NCT03928977 144 147 O
conventionnal NCT03928977 148 161 O
MRI NCT03928977 162 165 B-Procedure

Exclusion NCT03928977 166 175 O
Criteria NCT03928977 176 184 O
: NCT03928977 185 186 O

- NCT03928977 190 191 O
Contraindication NCT03928977 193 209 B-Contraindication
to NCT03928977 210 212 O
MRI NCT03928977 213 216 B-Procedure

- NCT03928977 219 220 O
Previous NCT03928977 222 230 B-Eq_Comparison
neurological NCT03928977 231 243 B-Condition
disease NCT03928977 244 251 I-Condition
( NCT03928977 252 253 O
with NCT03928977 254 258 B-And
lesions NCT03928977 259 266 B-Condition
) NCT03928977 267 268 O

- NCT03928977 272 273 O
Severe NCT03928977 275 281 O
psychiatric NCT03928977 282 293 B-Condition
disease NCT03928977 294 301 I-Condition

Inclusion NCT03921762 0 9 O
Criteria NCT03921762 10 18 O
: NCT03921762 19 20 O

- NCT03921762 24 25 O
> NCT03921762 27 28 B-Eq_Comparison
50 NCT03921762 29 31 I-Eq_Comparison
years NCT03921762 32 37 I-Eq_Comparison
old NCT03921762 38 41 B-Age

- NCT03921762 44 45 O
Bilateral NCT03921762 47 56 B-Modifier
age NCT03921762 57 60 I-Modifier
- NCT03921762 61 62 I-Modifier
related NCT03921762 63 70 I-Modifier
cataract NCT03921762 71 79 B-Condition

- NCT03921762 82 83 O
Qualify NCT03921762 85 92 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03921762 93 96 I-Assertion___Assertion_Type_Value:hypothetical
bilateral NCT03921762 97 106 B-Procedure
implantation NCT03921762 107 119 I-Procedure
within NCT03921762 120 126 B-Eq_Comparison
1 NCT03921762 127 128 I-Eq_Comparison
month NCT03921762 129 134 I-Eq_Comparison

- NCT03921762 137 138 O
No NCT03921762 140 142 B-Negation
previous NCT03921762 143 151 B-Eq_Comparison
refractive NCT03921762 152 162 B-Modifier
or NCT03921762 163 165 B-Or
ocular NCT03921762 166 172 B-Modifier
surgery NCT03921762 173 180 B-Procedure

- NCT03921762 183 184 O
Available NCT03921762 186 195 O
IOL NCT03921762 196 199 B-Observation
dioptre NCT03921762 200 207 I-Observation
range NCT03921762 208 213 I-Observation
: NCT03921762 214 215 O
18 NCT03921762 216 218 B-Eq_Comparison
to NCT03921762 219 221 I-Eq_Comparison
27 NCT03921762 222 224 I-Eq_Comparison
D NCT03921762 225 226 I-Eq_Comparison

- NCT03921762 229 230 O
Expected NCT03921762 232 240 B-Assertion___Assertion_Type_Value:hypothetical
post NCT03921762 241 245 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03921762 246 255 B-Procedure
astigmatism NCT03921762 256 267 B-Observation
≤ NCT03921762 268 269 B-Eq_Comparison
0.75 NCT03921762 270 274 I-Eq_Comparison
D NCT03921762 275 276 I-Eq_Comparison

Exclusion NCT03921762 277 286 O
Criteria NCT03921762 287 295 O
: NCT03921762 296 297 O

- NCT03921762 301 302 O
Pupil NCT03921762 304 309 B-Observation
> NCT03921762 310 311 B-Eq_Comparison
4 NCT03921762 312 313 I-Eq_Comparison
mm NCT03921762 314 316 I-Eq_Comparison

- NCT03921762 319 320 O
Occupation NCT03921762 322 332 O
requiring NCT03921762 333 342 O
night NCT03921762 343 348 O
- NCT03921762 349 350 O
time NCT03921762 351 355 O
driving NCT03921762 356 363 O
or NCT03921762 364 366 O
any NCT03921762 367 370 O
occupation NCT03921762 371 381 O
incompatible NCT03921762 382 394 O
with NCT03921762 395 399 O
multifocality NCT03921762 400 413 O

- NCT03921762 416 417 O
Acute NCT03921762 419 424 O
or NCT03921762 425 427 B-Or
chronic NCT03921762 428 435 O
disease NCT03921762 436 443 B-Condition
or NCT03921762 444 446 B-Or
illness NCT03921762 447 454 B-Condition
that NCT03921762 455 459 O
would NCT03921762 460 465 B-Assertion___Assertion_Type_Value:hypothetical
increase NCT03921762 466 474 O
risk NCT03921762 475 479 B-Risk
or NCT03921762 480 482 B-Or
confound NCT03921762 483 491 O
study NCT03921762 492 497 B-Study
results NCT03921762 498 505 O
[ NCT03921762 506 507 O
e NCT03921762 508 509 O
. NCT03921762 510 511 O
g NCT03921762 512 513 O
. NCT03921762 514 515 O
diabetes NCT03921762 517 525 B-Condition
mellitus NCT03921762 526 534 I-Condition
( NCT03921762 535 536 O
with NCT03921762 537 541 B-And
retinopathy NCT03921762 542 553 B-Condition
) NCT03921762 554 555 O
, NCT03921762 556 557 O
immunocompromised NCT03921762 558 575 B-Condition
, NCT03921762 576 577 O
glaucoma NCT03921762 578 586 B-Condition
, NCT03921762 587 588 O
epiretinal NCT03921762 589 599 B-Condition
membrane NCT03921762 600 608 I-Condition
, NCT03921762 609 610 O
cornea NCT03921762 611 617 B-Condition
guttata NCT03921762 618 625 I-Condition
, NCT03921762 626 627 O
etc NCT03921762 628 631 O
… NCT03921762 631 632 O
. NCT03921762 633 634 O
] NCT03921762 635 636 O
found NCT03921762 637 642 O
to NCT03921762 643 645 O
be NCT03921762 646 648 O
relevant NCT03921762 649 657 O
by NCT03921762 658 660 O
the NCT03921762 661 664 O
investigators NCT03921762 665 678 O

- NCT03921762 681 682 O
Amblyopia NCT03921762 684 693 B-Condition
, NCT03921762 694 695 O
strabismus NCT03921762 696 706 B-Condition

- NCT03921762 709 710 O
Extremely NCT03921762 712 721 O
shallow NCT03921762 722 729 B-Condition
anterior NCT03921762 730 738 I-Condition
chamber NCT03921762 739 746 I-Condition

- NCT03921762 749 750 O
Capsule NCT03921762 752 759 B-Modifier
or NCT03921762 760 762 B-Or
zonular NCT03921762 763 770 B-Modifier
abnormalities NCT03921762 771 784 B-Condition
that NCT03921762 785 789 O
may NCT03921762 790 793 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03921762 794 800 O
post NCT03921762 801 805 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03921762 806 815 B-Procedure
centration NCT03921762 816 826 B-Modifier
or NCT03921762 827 829 B-Or
tilt NCT03921762 830 834 B-Modifier
of NCT03921762 835 837 O
the NCT03921762 838 841 O
lens NCT03921762 842 846 B-Condition
( NCT03921762 847 848 O
e NCT03921762 849 850 O
. NCT03921762 851 852 O
g NCT03921762 853 854 O
. NCT03921762 855 856 O
pseudoexfoliation NCT03921762 858 875 B-Condition
syndrome NCT03921762 876 884 I-Condition
, NCT03921762 885 886 O
uveitis NCT03921762 887 894 B-Condition
, NCT03921762 895 896 O
Marfan NCT03921762 897 903 B-Condition
's NCT03921762 903 905 I-Condition
syndrome NCT03921762 906 914 I-Condition
) NCT03921762 915 916 O

- NCT03921762 920 921 O
Pupil NCT03921762 923 928 B-Condition
abnormalities NCT03921762 929 942 I-Condition
( NCT03921762 943 944 O
non NCT03921762 945 948 O
- NCT03921762 949 950 O
reactive NCT03921762 951 959 O
, NCT03921762 960 961 O
tonic NCT03921762 962 967 B-Condition
pupils NCT03921762 968 974 I-Condition
, NCT03921762 975 976 O
abnormally NCT03921762 977 987 B-Condition
shaped NCT03921762 988 994 I-Condition
pupils NCT03921762 995 1001 I-Condition
or NCT03921762 1002 1004 B-Or
pupils NCT03921762 1005 1011 B-Condition
that NCT03921762 1012 1016 I-Condition
do NCT03921762 1017 1019 I-Condition
not NCT03921762 1020 1023 I-Condition
dilate NCT03921762 1024 1030 I-Condition
under NCT03921762 1031 1036 B-Modifier
mesopic NCT03921762 1037 1044 I-Modifier
/ NCT03921762 1045 1046 I-Modifier
scotopic NCT03921762 1047 1055 I-Modifier
conditions NCT03921762 1056 1066 I-Modifier
) NCT03921762 1067 1068 O

- NCT03921762 1072 1073 O
Instability NCT03921762 1075 1086 O
to NCT03921762 1087 1089 O
place NCT03921762 1090 1095 B-Procedure
the NCT03921762 1096 1099 I-Procedure
intraocular NCT03921762 1100 1111 I-Procedure
lens NCT03921762 1112 1116 I-Procedure
safely NCT03921762 1117 1123 O
at NCT03921762 1124 1126 O
the NCT03921762 1127 1130 O
location NCT03921762 1131 1139 O
planned NCT03921762 1140 1147 O

- NCT03921762 1150 1151 O
Pregnancy NCT03921762 1153 1162 B-Condition
( NCT03921762 1163 1164 O
pregnancy NCT03921762 1165 1174 B-Observation
test NCT03921762 1175 1179 I-Observation
will NCT03921762 1180 1184 B-Eq_Comparison
be NCT03921762 1185 1187 I-Eq_Comparison
taken NCT03921762 1188 1193 O
pre NCT03921762 1194 1197 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03921762 1198 1199 O
operatively NCT03921762 1200 1211 B-Procedure
in NCT03921762 1212 1214 O
women NCT03921762 1215 1220 O
of NCT03921762 1221 1223 B-And
reproductive NCT03921762 1224 1236 B-Condition
age NCT03921762 1237 1240 I-Condition
) NCT03921762 1241 1242 O

Inclusion NCT03866902 0 9 O
criteria NCT03866902 10 18 O
for NCT03866902 19 22 O
mothers NCT03866902 23 30 B-Family_Member___Family_Member_Type:mother
will NCT03866902 31 35 O
be NCT03866902 36 38 O
: NCT03866902 39 40 O

- NCT03866902 44 45 O
age NCT03866902 47 50 B-Age
18 NCT03866902 51 53 B-Eq_Comparison
years NCT03866902 54 59 I-Eq_Comparison
or NCT03866902 60 62 I-Eq_Comparison
older NCT03866902 63 68 I-Eq_Comparison

- NCT03866902 71 72 O
self NCT03866902 74 78 O
- NCT03866902 79 80 O
identification NCT03866902 81 95 O
as NCT03866902 96 98 O
Hispanic NCT03866902 99 107 O

- NCT03866902 110 111 O
limited NCT03866902 113 120 B-Negation
English NCT03866902 121 128 O
proficiency NCT03866902 129 140 O
; NCT03866902 140 141 O
little NCT03866902 142 148 B-Negation
acculturation NCT03866902 149 162 B-Observation
, NCT03866902 163 164 O
as NCT03866902 165 167 O
measured NCT03866902 168 176 O
by NCT03866902 177 179 O
the NCT03866902 180 183 O
Short NCT03866902 184 189 B-Observation
Acculturation NCT03866902 190 203 I-Observation
Scale NCT03866902 204 209 I-Observation
for NCT03866902 210 213 I-Observation
Hispanics NCT03866902 214 223 I-Observation
with NCT03866902 224 228 O
a NCT03866902 229 230 O
score NCT03866902 231 236 O
from NCT03866902 237 241 O
1.00 NCT03866902 242 246 B-Eq_Comparison
to NCT03866902 247 249 I-Eq_Comparison
2.99 NCT03866902 250 254 I-Eq_Comparison

- NCT03866902 258 259 O
ability NCT03866902 261 268 O
to NCT03866902 269 271 O
understand NCT03866902 272 282 O
spoken NCT03866902 283 289 O
Spanish NCT03866902 290 297 O

- NCT03866902 300 301 O
a NCT03866902 303 304 O
BMI NCT03866902 305 308 B-Observation
> NCT03866902 309 310 B-Eq_Comparison
25 NCT03866902 311 313 I-Eq_Comparison
kg NCT03866902 314 316 I-Eq_Comparison
/ NCT03866902 317 318 I-Eq_Comparison
m² NCT03866902 319 321 I-Eq_Comparison

- NCT03866902 324 325 O
residence NCT03866902 327 336 O
with NCT03866902 337 341 O
the NCT03866902 342 345 B-Family_Member___Family_Member_Type:child
child NCT03866902 346 351 I-Family_Member___Family_Member_Type:child

- NCT03866902 354 355 O
consent NCT03866902 357 364 O
to NCT03866902 365 367 O
join NCT03866902 368 372 O
the NCT03866902 373 376 O
study NCT03866902 377 382 O
and NCT03866902 383 386 O
consent NCT03866902 387 394 O
for NCT03866902 395 398 O
their NCT03866902 399 404 B-Family_Member___Family_Member_Type:child
child NCT03866902 405 410 I-Family_Member___Family_Member_Type:child
to NCT03866902 411 413 O
join NCT03866902 414 418 O
the NCT03866902 419 422 O
study NCT03866902 423 428 B-Study
. NCT03866902 429 430 O

Inclusion NCT03866902 432 441 O
criteria NCT03866902 442 450 O
for NCT03866902 451 454 O
children NCT03866902 455 463 B-Family_Member___Family_Member_Type:child
will NCT03866902 464 468 O
be NCT03866902 469 471 O
: NCT03866902 472 473 O

- NCT03866902 477 478 O
age NCT03866902 480 483 B-Age
3 NCT03866902 484 485 B-Eq_Comparison
- NCT03866902 486 487 I-Eq_Comparison
5 NCT03866902 488 489 I-Eq_Comparison
years NCT03866902 490 495 I-Eq_Comparison

- NCT03866902 498 499 O
ability NCT03866902 501 508 O
to NCT03866902 509 511 O
understand NCT03866902 512 522 O
spoken NCT03866902 523 529 O
Spanish NCT03866902 530 537 O

- NCT03866902 540 541 O
a NCT03866902 543 544 O
BMI NCT03866902 545 548 B-Observation
> NCT03866902 549 550 B-Eq_Comparison
25 NCT03866902 551 553 I-Eq_Comparison
th NCT03866902 554 556 I-Eq_Comparison
percentile NCT03866902 557 567 I-Eq_Comparison
for NCT03866902 568 571 O
age NCT03866902 572 575 B-Modifier
and NCT03866902 576 579 I-Modifier
gender NCT03866902 580 586 I-Modifier

Exclusion NCT03866902 587 596 O
criteria NCT03866902 597 605 O
for NCT03866902 606 609 O
mothers NCT03866902 610 617 B-Family_Member___Family_Member_Type:mother
will NCT03866902 618 622 O
be NCT03866902 623 625 O
: NCT03866902 626 627 O

- NCT03866902 631 632 O
heart NCT03866902 634 639 B-Condition
murmur NCT03866902 640 646 I-Condition

- NCT03866902 649 650 O
congenital NCT03866902 652 662 B-Condition
heart NCT03866902 663 668 I-Condition
disease NCT03866902 669 676 I-Condition

- NCT03866902 679 680 O
family NCT03866902 682 688 B-Family_Member
history NCT03866902 689 696 I-Family_Member
of NCT03866902 697 699 O
sudden NCT03866902 700 706 B-Condition
death NCT03866902 707 712 I-Condition

- NCT03866902 715 716 O
difficulty NCT03866902 718 728 B-Negation
exercising NCT03866902 729 739 B-Observation

- NCT03866902 742 743 O
psychological NCT03866902 745 758 B-Condition
problems NCT03866902 759 767 I-Condition

Inclusion NCT03865199 0 9 O
Criteria NCT03865199 10 18 O
: NCT03865199 19 20 O

- NCT03865199 24 25 O
Women NCT03865199 27 32 O
aged NCT03865199 33 37 B-Age
18 NCT03865199 38 40 B-Eq_Comparison
or NCT03865199 41 43 I-Eq_Comparison
older NCT03865199 44 49 I-Eq_Comparison
undergoing NCT03865199 50 60 B-Eq_Comparison
medical NCT03865199 61 68 B-Modifier
or NCT03865199 69 71 B-Or
surgical NCT03865199 72 80 B-Modifier
abortion NCT03865199 81 89 B-Procedure
at NCT03865199 90 92 O
Planned NCT03865199 93 100 O
Parenthood NCT03865199 101 111 O
of NCT03865199 112 114 O
Illinois NCT03865199 115 123 O
( NCT03865199 124 125 O
PPIL NCT03865199 126 130 O
) NCT03865199 131 132 O
will NCT03865199 133 137 O
be NCT03865199 138 140 O
eligible NCT03865199 141 149 O
for NCT03865199 150 153 O
inclusion NCT03865199 154 163 O
. NCT03865199 164 165 O
Inclusion NCT03865199 167 176 O
criteria NCT03865199 177 185 O
include NCT03865199 186 193 O
having NCT03865199 194 200 O
an NCT03865199 201 203 O
intrauterine NCT03865199 204 216 B-Modifier
pregnancy NCT03865199 217 226 B-Condition
, NCT03865199 227 228 O
having NCT03865199 229 235 O
a NCT03865199 236 237 O
smart NCT03865199 238 243 O
phone NCT03865199 244 249 O
to NCT03865199 250 252 O
be NCT03865199 253 255 O
able NCT03865199 256 260 O
to NCT03865199 261 263 O
follow NCT03865199 264 270 O
- NCT03865199 271 272 O
up NCT03865199 273 275 O
by NCT03865199 276 278 O
text NCT03865199 279 283 O
message NCT03865199 284 291 O
2 NCT03865199 292 293 B-Eq_Comparison
- NCT03865199 294 295 I-Eq_Comparison
4 NCT03865199 296 297 I-Eq_Comparison
weeks NCT03865199 298 303 I-Eq_Comparison
after NCT03865199 304 309 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03865199 310 313 O
clinic NCT03865199 314 320 B-Encounter
appointment NCT03865199 321 332 I-Encounter
, NCT03865199 333 334 O
having NCT03865199 335 341 O
no NCT03865199 342 344 B-Negation
contraindications NCT03865199 345 362 B-Contraindication
to NCT03865199 363 365 O
an NCT03865199 366 368 O
outpatient NCT03865199 369 379 B-Encounter
medication NCT03865199 380 390 B-Modifier
or NCT03865199 391 393 B-Or
surgical NCT03865199 394 402 B-Modifier
abortion NCT03865199 403 411 B-Procedure
that NCT03865199 412 416 O
same NCT03865199 417 421 O
day NCT03865199 422 425 O
, NCT03865199 426 427 O
and NCT03865199 428 431 O
not NCT03865199 432 435 O
meeting NCT03865199 436 443 O
any NCT03865199 444 447 O
exclusion NCT03865199 448 457 O
criteria NCT03865199 458 466 O
. NCT03865199 467 468 O

Exclusion NCT03865199 470 479 O
Criteria NCT03865199 480 488 O
: NCT03865199 489 490 O

- NCT03865199 494 495 O
Exclusion NCT03865199 497 506 O
criteria NCT03865199 507 515 O
will NCT03865199 516 520 O
include NCT03865199 521 528 O
non NCT03865199 529 532 B-Negation
- NCT03865199 533 534 O
English NCT03865199 535 542 O
speaking NCT03865199 543 551 O
, NCT03865199 552 553 O
no NCT03865199 554 556 O
working NCT03865199 557 564 O
telephone NCT03865199 565 574 O
, NCT03865199 575 576 O
and NCT03865199 577 580 O
less NCT03865199 581 585 B-Eq_Comparison
than NCT03865199 586 590 I-Eq_Comparison
5 NCT03865199 591 592 I-Eq_Comparison
th NCT03865199 593 595 I-Eq_Comparison
grade NCT03865199 596 601 I-Eq_Comparison
education NCT03865199 602 611 B-Observation
level NCT03865199 612 617 I-Observation
. NCT03865199 618 619 O

Inclusion NCT03923608 0 9 O
Criteria NCT03923608 10 18 O
: NCT03923608 19 20 O
should NCT03923608 21 27 O
report NCT03923608 28 34 O
the NCT03923608 35 38 O
absence NCT03923608 39 46 B-Negation
of NCT03923608 47 49 O
: NCT03923608 50 51 O

- NCT03923608 55 56 O
anemia NCT03923608 58 64 B-Condition
, NCT03923608 65 66 O

- NCT03923608 70 71 O
diabetes NCT03923608 73 81 B-Condition
, NCT03923608 82 83 O

- NCT03923608 87 88 O
cardiovascular NCT03923608 90 104 B-Condition
disease NCT03923608 105 112 I-Condition
, NCT03923608 113 114 O

- NCT03923608 118 119 O
and NCT03923608 121 124 O
upper NCT03923608 125 130 B-Modifier
limb NCT03923608 131 135 I-Modifier
and NCT03923608 136 139 B-Or
spinal NCT03923608 140 146 B-Modifier
muscular NCT03923608 147 155 I-Modifier
injuries NCT03923608 156 164 B-Condition
in NCT03923608 165 167 O
the NCT03923608 168 171 O
last NCT03923608 172 176 B-Eq_Comparison
six NCT03923608 177 180 I-Eq_Comparison
months NCT03923608 181 187 I-Eq_Comparison

Exclusion NCT03923608 188 197 O
Criteria NCT03923608 198 206 O
: NCT03923608 207 208 O

- NCT03923608 212 213 O
absence NCT03923608 215 222 B-Negation
at NCT03923608 223 225 O
any NCT03923608 226 229 O
study NCT03923608 230 235 B-Study
session NCT03923608 236 243 O
and NCT03923608 244 247 O

- NCT03923608 250 251 O
episode NCT03923608 253 260 O
of NCT03923608 261 263 O
muscle NCT03923608 264 270 B-Modifier
- NCT03923608 271 272 I-Modifier
tendon NCT03923608 273 279 I-Modifier
or NCT03923608 280 282 B-Or
osteoarticular NCT03923608 283 297 B-Modifier
injury NCT03923608 298 304 B-Condition
in NCT03923608 305 307 O
the NCT03923608 308 311 O
upper NCT03923608 312 317 B-Modifier
limbs NCT03923608 318 323 I-Modifier
during NCT03923608 324 330 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923608 331 334 O
study NCT03923608 335 340 B-Study
. NCT03923608 341 342 O

Inclusion NCT03860467 0 9 O
Criteria NCT03860467 10 18 O
: NCT03860467 19 20 O

- NCT03860467 24 25 O
admitted NCT03860467 27 35 B-Encounter
to NCT03860467 36 38 O
the NCT03860467 39 42 O
ICU NCT03860467 43 46 O
at NCT03860467 47 49 O
the NCT03860467 50 53 O
University NCT03860467 54 64 O
Hospital NCT03860467 65 73 O
Basel NCT03860467 74 79 O

- NCT03860467 82 83 O
suffered NCT03860467 85 93 O
from NCT03860467 94 98 O
one NCT03860467 99 102 B-Eq_Comparison
or NCT03860467 103 105 I-Eq_Comparison
more NCT03860467 106 110 I-Eq_Comparison
epileptic NCT03860467 111 120 B-Condition
seizures NCT03860467 121 129 I-Condition
( NCT03860467 130 131 O
detected NCT03860467 132 140 O
clinically NCT03860467 141 151 B-Modifier
and NCT03860467 152 155 B-Or
/ NCT03860467 156 157 I-Or
or NCT03860467 158 160 I-Or
by NCT03860467 161 163 O
EEG NCT03860467 164 167 B-Procedure
) NCT03860467 168 169 O
during NCT03860467 170 176 B-Temporal_Connection___Temporal_Connection_Type_Value:during
their NCT03860467 177 182 O
ICU NCT03860467 183 186 O
- NCT03860467 187 188 O
stay NCT03860467 189 193 B-Encounter

Exclusion NCT03860467 194 203 O
Criteria NCT03860467 204 212 O
: NCT03860467 213 214 O

- NCT03860467 218 219 O
patients NCT03860467 221 229 O
with NCT03860467 230 234 O
epileptic NCT03860467 235 244 B-Condition
seizures NCT03860467 245 253 I-Condition
transforming NCT03860467 254 266 O
into NCT03860467 267 271 O
Status NCT03860467 272 278 B-Condition
epilepticus NCT03860467 279 290 I-Condition
( NCT03860467 291 292 O
SE NCT03860467 293 295 B-Condition
) NCT03860467 296 297 O

Inclusion NCT03924791 0 9 O
Criteria NCT03924791 10 18 O
: NCT03924791 19 20 O

- NCT03924791 24 25 O
Diagnosed NCT03924791 27 36 O
with NCT03924791 37 41 O
sciatica NCT03924791 42 50 B-Condition
by NCT03924791 51 53 O
GP NCT03924791 54 56 B-Provider

- NCT03924791 59 60 O
NRS NCT03924791 62 65 B-Observation
leg NCT03924791 66 69 I-Observation
pain NCT03924791 70 74 I-Observation
of NCT03924791 75 77 O
6 NCT03924791 78 79 B-Eq_Comparison
or NCT03924791 80 82 I-Eq_Comparison
more NCT03924791 83 87 I-Eq_Comparison
on NCT03924791 88 90 O
a NCT03924791 91 92 O
10 NCT03924791 93 95 O
- NCT03924791 96 97 O
point NCT03924791 98 103 O
NRS NCT03924791 104 107 O
scale NCT03924791 108 113 O

- NCT03924791 116 117 O
Minimum NCT03924791 119 126 O
duration NCT03924791 127 135 O
of NCT03924791 136 138 O
symptoms NCT03924791 139 147 B-Assertion___Assertion_Type_Value:possible
of NCT03924791 148 150 O
3 NCT03924791 151 152 B-Eq_Comparison
weeks NCT03924791 153 158 I-Eq_Comparison
and NCT03924791 159 162 O
maximum NCT03924791 163 170 B-Eq_Comparison
duration NCT03924791 171 179 I-Eq_Comparison
of NCT03924791 180 182 I-Eq_Comparison
8 NCT03924791 183 184 I-Eq_Comparison
weeks NCT03924791 185 190 I-Eq_Comparison

Exclusion NCT03924791 191 200 O
Criteria NCT03924791 201 209 O
: NCT03924791 210 211 O

- NCT03924791 215 216 O
Age NCT03924791 218 221 B-Age
under NCT03924791 222 227 B-Eq_Comparison
18 NCT03924791 228 230 I-Eq_Comparison
years NCT03924791 231 236 I-Eq_Comparison

- NCT03924791 239 240 O
Condition NCT03924791 242 251 B-Condition
preventing NCT03924791 252 262 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03924791 263 265 O
receive NCT03924791 266 273 O
transforaminal NCT03924791 274 288 B-Modifier
epidural NCT03924791 289 297 B-Procedure
injection NCT03924791 298 307 I-Procedure

- NCT03924791 310 311 O
Severe NCT03924791 313 319 O
scoliosis NCT03924791 320 329 B-Condition

- NCT03924791 332 333 O
Transforaminal NCT03924791 335 349 B-Modifier
epidural NCT03924791 350 358 B-Procedure
injection NCT03924791 359 368 I-Procedure
received NCT03924791 369 377 B-Eq_Comparison
in NCT03924791 378 380 I-Eq_Comparison
6 NCT03924791 381 382 I-Eq_Comparison
months NCT03924791 383 389 I-Eq_Comparison
before NCT03924791 390 396 B-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03924791 397 410 B-Study
date NCT03924791 411 415 O

- NCT03924791 418 419 O
Surgery NCT03924791 421 428 B-Procedure
for NCT03924791 429 432 O
sciatica NCT03924791 433 441 B-Condition
at NCT03924791 442 444 O
the NCT03924791 445 448 O
same NCT03924791 449 453 B-Modifier
level NCT03924791 454 459 I-Modifier

- NCT03924791 462 463 O
Surgery NCT03924791 465 472 B-Procedure
for NCT03924791 473 476 O
sciatica NCT03924791 477 485 B-Condition
at NCT03924791 486 488 O
another NCT03924791 489 496 B-Modifier
level NCT03924791 497 502 I-Modifier
within NCT03924791 503 509 B-Eq_Comparison
one NCT03924791 510 513 I-Eq_Comparison
year NCT03924791 514 518 I-Eq_Comparison
before NCT03924791 519 525 B-Temporal_Connection___Temporal_Connection_Type_Value:before
inclusion NCT03924791 526 535 B-Study

- NCT03924791 538 539 O
Pregnancy NCT03924791 541 550 B-Condition

Inclusion NCT03920098 0 9 O
Criteria NCT03920098 10 18 O
: NCT03920098 19 20 O

- NCT03920098 24 25 O
Primipara NCT03920098 27 36 B-Condition
( NCT03920098 37 38 O
no NCT03920098 39 41 B-Negation
previous NCT03920098 42 50 B-Eq_Comparison
pregnancies NCT03920098 51 62 B-Condition
) NCT03920098 63 64 O

- NCT03920098 68 69 O
18 NCT03920098 71 73 B-Eq_Comparison
to NCT03920098 74 76 I-Eq_Comparison
25 NCT03920098 77 79 I-Eq_Comparison
years NCT03920098 80 85 I-Eq_Comparison
of NCT03920098 86 88 O
age NCT03920098 89 92 B-Age

- NCT03920098 95 96 O
Gestation NCT03920098 98 107 B-Observation
< NCT03920098 108 109 B-Eq_Comparison
15 NCT03920098 110 112 I-Eq_Comparison
weeks NCT03920098 113 118 I-Eq_Comparison
at NCT03920098 119 121 B-Temporal_Connection___Temporal_Connection_Type_Value:during
first NCT03920098 122 127 B-Eq_Comparison
prenatal NCT03920098 128 136 B-Condition
visit NCT03920098 137 142 B-Encounter

- NCT03920098 145 146 O
No NCT03920098 148 150 B-Negation
intention NCT03920098 151 160 B-Assertion___Assertion_Type_Value:intention
to NCT03920098 161 163 O
move NCT03920098 164 168 B-Observation
outside NCT03920098 169 176 O
the NCT03920098 177 180 O
city NCT03920098 181 185 O
of NCT03920098 186 188 O
Santiago NCT03920098 189 197 O
in NCT03920098 198 200 O
the NCT03920098 201 204 O
next NCT03920098 205 209 B-Eq_Comparison
to NCT03920098 210 212 I-Eq_Comparison
years NCT03920098 213 218 I-Eq_Comparison

Exclusion NCT03920098 219 228 O
Criteria NCT03920098 229 237 O
: NCT03920098 238 239 O

- NCT03920098 243 244 O
Multipara NCT03920098 246 255 B-Condition

- NCT03920098 258 259 O
Pre NCT03920098 261 264 B-Eq_Comparison
- NCT03920098 265 266 I-Eq_Comparison
existing NCT03920098 267 275 I-Eq_Comparison
cancer NCT03920098 276 282 B-Condition
( NCT03920098 283 284 O
except NCT03920098 285 291 B-Exception
non NCT03920098 292 295 B-Modifier
- NCT03920098 296 297 I-Modifier
melanoma NCT03920098 298 306 I-Modifier
skin NCT03920098 307 311 B-Modifier
cancer NCT03920098 312 318 B-Condition
) NCT03920098 319 320 O

- NCT03920098 324 325 O
Family NCT03920098 327 333 B-Family_Member
history NCT03920098 334 341 I-Family_Member
of NCT03920098 342 344 O
breast NCT03920098 345 351 B-Modifier
cancer NCT03920098 352 358 B-Condition
( NCT03920098 359 360 O
one NCT03920098 361 364 B-Eq_Comparison
first NCT03920098 365 370 B-Modifier
- NCT03920098 371 372 I-Modifier
degree NCT03920098 373 379 I-Modifier
female NCT03920098 380 386 B-Family_Member
relative NCT03920098 387 395 I-Family_Member
diagnosed NCT03920098 396 405 O
with NCT03920098 406 410 O
breast NCT03920098 411 417 B-Modifier
cancer NCT03920098 418 424 B-Condition
) NCT03920098 425 426 O

- NCT03920098 430 431 O
High NCT03920098 433 437 O
- NCT03920098 438 439 O
risk NCT03920098 440 444 B-Risk
pregnancy NCT03920098 445 454 B-Condition
according NCT03920098 455 464 O
to NCT03920098 465 467 O
national NCT03920098 468 476 O
guidelines NCT03920098 477 487 O

- NCT03920098 490 491 O
During NCT03920098 493 499 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03920098 500 503 O
follow NCT03920098 504 510 B-Encounter
- NCT03920098 511 512 I-Encounter
up NCT03920098 513 515 I-Encounter
, NCT03920098 516 517 O
pregnant NCT03920098 518 526 B-Condition
women NCT03920098 527 532 O
under NCT03920098 533 538 O
any NCT03920098 539 542 O
treatment NCT03920098 543 552 B-Procedure
that NCT03920098 553 557 O
may NCT03920098 558 561 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03920098 562 568 O
the NCT03920098 569 572 O
levels NCT03920098 573 579 O
of NCT03920098 580 582 O
metabolic NCT03920098 583 592 B-Observation
markers NCT03920098 593 600 I-Observation
will NCT03920098 601 605 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03920098 606 608 I-Assertion___Assertion_Type_Value:hypothetical
excluded NCT03920098 609 617 B-Negation
from NCT03920098 618 622 O
the NCT03920098 623 626 O
analysis NCT03920098 627 635 B-Study

- NCT03920098 638 639 O
Pregnant NCT03920098 641 649 B-Condition
women NCT03920098 650 655 O
with NCT03920098 656 660 B-And
pre NCT03920098 661 664 B-Condition
- NCT03920098 665 666 I-Condition
eclampsia NCT03920098 667 676 I-Condition
or NCT03920098 677 679 B-Or
with NCT03920098 680 684 O
preterm NCT03920098 685 692 B-Condition
birth NCT03920098 693 698 I-Condition
( NCT03920098 699 700 O
less NCT03920098 701 705 B-Eq_Comparison
than NCT03920098 706 710 I-Eq_Comparison
37 NCT03920098 711 713 I-Eq_Comparison
weeks NCT03920098 714 719 I-Eq_Comparison
of NCT03920098 720 722 O
gestational NCT03920098 723 734 B-Observation
age NCT03920098 735 738 I-Observation
) NCT03920098 739 740 O
will NCT03920098 741 745 O
be NCT03920098 746 748 O
also NCT03920098 749 753 O
excluded NCT03920098 754 762 B-Negation

Inclusion NCT03861572 0 9 O
Criteria NCT03861572 10 18 O
: NCT03861572 19 20 O

- NCT03861572 24 25 O
Participants NCT03861572 27 39 O
will NCT03861572 40 44 O
be NCT03861572 45 47 O
male NCT03861572 48 52 O
and NCT03861572 53 56 B-Or
female NCT03861572 57 63 O
subjects NCT03861572 64 72 O
who NCT03861572 73 76 B-And
suffered NCT03861572 77 85 B-Eq_Comparison
total NCT03861572 86 91 B-Modifier
acute NCT03861572 92 97 O
Achilles NCT03861572 98 106 B-Condition
tendon NCT03861572 107 113 I-Condition
rupture NCT03861572 114 121 I-Condition
, NCT03861572 122 123 O
and NCT03861572 124 127 B-And
which NCT03861572 128 133 O
underwent NCT03861572 134 143 B-Eq_Comparison
surgical NCT03861572 144 152 B-Procedure
repair NCT03861572 153 159 I-Procedure
. NCT03861572 160 161 O
In NCT03861572 163 165 O
addition NCT03861572 166 174 O
, NCT03861572 175 176 O
to NCT03861572 177 179 O
participate NCT03861572 180 191 O
in NCT03861572 192 194 O
this NCT03861572 195 199 O
study NCT03861572 200 205 B-Study
all NCT03861572 206 209 O
volunteers NCT03861572 210 220 O
will NCT03861572 221 225 O
need NCT03861572 226 230 O
to NCT03861572 231 233 O
present NCT03861572 234 241 O
medical NCT03861572 242 249 O
and NCT03861572 250 253 O
/ NCT03861572 254 255 O
or NCT03861572 256 258 O
physiotherapeutic NCT03861572 259 276 O
release NCT03861572 277 284 O
for NCT03861572 285 288 O
physical NCT03861572 289 297 O
/ NCT03861572 298 299 O
sports NCT03861572 300 306 O
activities NCT03861572 307 317 O
practice NCT03861572 318 326 O
. NCT03861572 327 328 O

Exclusion NCT03861572 330 339 O
Criteria NCT03861572 340 348 O
: NCT03861572 349 350 O

- NCT03861572 354 355 O
Volunteers NCT03861572 357 367 O
that NCT03861572 368 372 O
did NCT03861572 373 376 O
not NCT03861572 377 380 B-Negation
have NCT03861572 381 385 O
Achilles NCT03861572 386 394 B-Procedure
tendon NCT03861572 395 401 I-Procedure
surgical NCT03861572 402 410 I-Procedure
reconstruction NCT03861572 411 425 I-Procedure
, NCT03861572 426 427 O
that NCT03861572 428 432 O
did NCT03861572 433 436 O
not NCT03861572 437 440 B-Negation
present NCT03861572 441 448 O
medical NCT03861572 449 456 B-Modifier
and NCT03861572 457 460 B-Or
/ NCT03861572 461 462 I-Or
or NCT03861572 463 465 I-Or
physiotherapeutic NCT03861572 466 483 B-Modifier
release NCT03861572 484 491 B-Observation
for NCT03861572 492 495 O
physical NCT03861572 496 504 B-Modifier
/ NCT03861572 505 506 B-Or
sports NCT03861572 507 513 B-Modifier
activities NCT03861572 514 524 I-Modifier
, NCT03861572 525 526 O
who NCT03861572 527 530 B-And
have NCT03861572 531 535 O
participated NCT03861572 536 548 O
in NCT03861572 549 551 O
strength NCT03861572 552 560 B-Procedure
training NCT03861572 561 569 I-Procedure
program NCT03861572 570 577 I-Procedure
for NCT03861572 578 581 O
the NCT03861572 582 585 O
plantar NCT03861572 586 593 B-Modifier
flexors NCT03861572 594 601 I-Modifier
in NCT03861572 602 604 O
the NCT03861572 605 608 O
last NCT03861572 609 613 B-Eq_Comparison
6 NCT03861572 614 615 I-Eq_Comparison
months NCT03861572 616 622 I-Eq_Comparison
, NCT03861572 623 624 O
patients NCT03861572 625 633 O
with NCT03861572 634 638 O
diabetic NCT03861572 639 647 B-Condition
diseases NCT03861572 648 656 I-Condition
, NCT03861572 657 658 O
as NCT03861572 659 661 B-And
well NCT03861572 662 666 I-And
as NCT03861572 667 669 I-And
those NCT03861572 670 675 O
with NCT03861572 676 680 O
difficulty NCT03861572 681 691 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
for NCT03861572 692 695 O
understanding NCT03861572 696 709 O
and NCT03861572 710 713 O
/ NCT03861572 714 715 O
or NCT03861572 716 718 O
executing NCT03861572 719 728 O
the NCT03861572 729 732 O
test NCT03861572 733 737 B-Study
and NCT03861572 738 741 O
training NCT03861572 742 750 O
protocols NCT03861572 751 760 O
in NCT03861572 761 763 O
the NCT03861572 764 767 O
isokinetic NCT03861572 768 778 O
dynamometer NCT03861572 779 790 O
will NCT03861572 791 795 O
be NCT03861572 796 798 O
excluded NCT03861572 799 807 O
. NCT03861572 808 809 O

Inclusion NCT03922529 0 9 O
Criteria NCT03922529 10 18 O
: NCT03922529 19 20 O

- NCT03922529 24 25 O
Age NCT03922529 27 30 B-Age
≥ NCT03922529 31 32 B-Eq_Comparison
70 NCT03922529 33 35 I-Eq_Comparison
year NCT03922529 36 40 I-Eq_Comparison

- NCT03922529 43 44 O
Eligible NCT03922529 46 54 O
cardiovascular NCT03922529 55 69 B-Condition
disease NCT03922529 70 77 I-Condition
( NCT03922529 78 79 O
CVD NCT03922529 80 83 B-Condition
) NCT03922529 84 85 O
diagnosis NCT03922529 86 95 O
( NCT03922529 96 97 O
hospitalization NCT03922529 98 113 B-Encounter
for NCT03922529 114 117 O
Acute NCT03922529 118 123 B-Condition
myocardial NCT03922529 124 134 I-Condition
infarction NCT03922529 135 145 I-Condition
( NCT03922529 146 147 O
AMI NCT03922529 148 151 B-Condition
) NCT03922529 152 153 O
/ NCT03922529 154 155 B-Or
Acute NCT03922529 156 161 B-Condition
coronary NCT03922529 162 170 I-Condition
syndrome NCT03922529 171 179 I-Condition
( NCT03922529 180 181 O
ACS NCT03922529 182 185 B-Condition
) NCT03922529 186 187 O
, NCT03922529 188 189 O
stable NCT03922529 190 196 O
Ischemic NCT03922529 197 205 B-Condition
Heart NCT03922529 206 211 I-Condition
Disease NCT03922529 212 219 I-Condition
, NCT03922529 220 221 O
revascularization NCT03922529 222 239 B-Modifier
Coronary NCT03922529 240 248 B-Procedure
artery NCT03922529 249 255 I-Procedure
bypass NCT03922529 256 262 I-Procedure
graft NCT03922529 263 268 I-Procedure
surgery NCT03922529 269 276 I-Procedure
and NCT03922529 277 280 B-Or
Percutaneous NCT03922529 281 293 B-Procedure
Coronary NCT03922529 294 302 I-Procedure
Intervention NCT03922529 303 315 I-Procedure
[ NCT03922529 316 317 O
CABG NCT03922529 318 322 B-Procedure
, NCT03922529 323 324 O
PCI NCT03922529 325 328 B-Procedure
] NCT03922529 329 330 O
, NCT03922529 331 332 O
valvular NCT03922529 333 341 B-Condition
heart NCT03922529 342 347 I-Condition
disease NCT03922529 348 355 I-Condition
[ NCT03922529 356 357 O
specifically NCT03922529 358 370 O
, NCT03922529 371 372 O
surgical NCT03922529 373 381 B-Modifier
or NCT03922529 382 384 B-Or
percutaneous NCT03922529 385 397 B-Modifier
intervention NCT03922529 398 410 B-Procedure
for NCT03922529 411 414 O
mitral NCT03922529 415 421 B-Condition
regurgitation NCT03922529 422 435 I-Condition
or NCT03922529 436 438 B-Or
aortic NCT03922529 439 445 B-Condition
stenosis NCT03922529 446 454 I-Condition
] NCT03922529 455 456 O
, NCT03922529 457 458 O
or NCT03922529 459 461 B-Or
heart NCT03922529 462 467 B-Condition
failure NCT03922529 468 475 I-Condition
( NCT03922529 476 477 O
HF NCT03922529 478 480 B-Condition
) NCT03922529 481 482 O
) NCT03922529 483 484 O

- NCT03922529 488 489 O
English NCT03922529 491 498 O
speaking NCT03922529 499 507 O

- NCT03922529 510 511 O
able NCT03922529 513 517 O
to NCT03922529 518 520 O
provide NCT03922529 521 528 O
written NCT03922529 529 536 O
informed NCT03922529 537 545 O
consent NCT03922529 546 553 O

- NCT03922529 556 557 O
able NCT03922529 559 563 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03922529 564 566 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03922529 567 569 O
assessed NCT03922529 570 578 O
and NCT03922529 579 582 O
undergo NCT03922529 583 590 O
study NCT03922529 591 596 B-Study
interventions NCT03922529 597 610 O
. NCT03922529 611 612 O

Exclusion NCT03922529 614 623 O
Criteria NCT03922529 624 632 O
: NCT03922529 633 634 O

- NCT03922529 638 639 O
Unstable NCT03922529 641 649 O
medical NCT03922529 650 657 B-Condition
condition NCT03922529 658 667 I-Condition
as NCT03922529 668 670 O
indicated NCT03922529 671 680 O
by NCT03922529 681 683 O
history NCT03922529 684 691 O
, NCT03922529 692 693 O
physical NCT03922529 694 702 B-Procedure
exam NCT03922529 703 707 I-Procedure
, NCT03922529 708 709 O
and NCT03922529 710 713 B-Or
/ NCT03922529 714 715 I-Or
or NCT03922529 716 718 I-Or
laboratory NCT03922529 719 729 B-Observation
findings NCT03922529 730 738 I-Observation

- NCT03922529 741 742 O
Presence NCT03922529 744 752 O
of NCT03922529 753 755 O
non NCT03922529 756 759 B-Exception
- NCT03922529 760 761 O
CVD NCT03922529 762 765 B-Condition
conditions NCT03922529 766 776 B-Condition
likely NCT03922529 777 783 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03922529 784 786 B-Eq_Comparison
be NCT03922529 787 789 I-Eq_Comparison
fatal NCT03922529 790 795 B-Death
within NCT03922529 796 802 B-Eq_Comparison
12 NCT03922529 803 805 I-Eq_Comparison
months NCT03922529 806 812 I-Eq_Comparison
( NCT03922529 813 814 O
e NCT03922529 815 816 O
. NCT03922529 817 818 O
g NCT03922529 819 820 O
. NCT03922529 821 822 O
, NCT03922529 823 824 O
metastatic NCT03922529 825 835 B-Modifier
cancer NCT03922529 836 842 B-Condition
) NCT03922529 843 844 O

- NCT03922529 848 849 O
Severe NCT03922529 851 857 O
cognitive NCT03922529 858 867 B-Condition
impairment NCT03922529 868 878 I-Condition
: NCT03922529 879 880 O
Short NCT03922529 881 886 B-Observation
Blessed NCT03922529 887 894 I-Observation
screening NCT03922529 895 904 I-Observation
with NCT03922529 905 909 O
a NCT03922529 910 911 O
score NCT03922529 912 917 O
of NCT03922529 918 920 O
13 NCT03922529 921 923 B-Eq_Comparison
or NCT03922529 924 926 I-Eq_Comparison
greater NCT03922529 927 934 I-Eq_Comparison
or NCT03922529 935 937 B-Or
can NCT03922529 938 941 O
not NCT03922529 941 944 O
consent NCT03922529 945 952 O
( NCT03922529 953 954 O
as NCT03922529 955 957 O
indicated NCT03922529 958 967 O
by NCT03922529 968 970 O
medical NCT03922529 971 978 O
record NCT03922529 979 985 O
) NCT03922529 986 987 O

- NCT03922529 991 992 O
Long NCT03922529 994 998 B-Procedure
- NCT03922529 999 1000 I-Procedure
term NCT03922529 1001 1005 I-Procedure
care NCT03922529 1006 1010 I-Procedure
resident NCT03922529 1011 1019 O
at NCT03922529 1020 1022 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03922529 1023 1032 B-Encounter
with NCT03922529 1033 1037 B-And
no NCT03922529 1038 1040 B-Negation
plans NCT03922529 1041 1046 B-Assertion___Assertion_Type_Value:intention
to NCT03922529 1047 1049 O
return NCT03922529 1050 1056 O
to NCT03922529 1057 1059 O
independent NCT03922529 1060 1071 B-Observation
living NCT03922529 1072 1078 I-Observation

- NCT03922529 1081 1082 O
anticipates NCT03922529 1084 1095 B-Assertion___Assertion_Type_Value:hypothetical
inability NCT03922529 1096 1105 B-Negation
to NCT03922529 1106 1108 O
return NCT03922529 1109 1115 O
for NCT03922529 1116 1119 O
required NCT03922529 1120 1128 O
reassessments NCT03922529 1129 1142 B-Procedure
at NCT03922529 1143 1145 O
3 NCT03922529 1146 1147 B-Eq_Comparison
, NCT03922529 1148 1149 I-Eq_Comparison
6 NCT03922529 1150 1151 I-Eq_Comparison
and NCT03922529 1152 1155 I-Eq_Comparison
12 NCT03922529 1156 1158 I-Eq_Comparison
months NCT03922529 1159 1165 I-Eq_Comparison

- NCT03922529 1168 1169 O
long NCT03922529 1171 1175 B-Procedure
- NCT03922529 1176 1177 I-Procedure
term NCT03922529 1178 1182 I-Procedure
care NCT03922529 1183 1187 I-Procedure
residents NCT03922529 1188 1197 O
at NCT03922529 1198 1200 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03922529 1201 1210 B-Encounter
with NCT03922529 1211 1215 B-And
no NCT03922529 1216 1218 B-Negation
plans NCT03922529 1219 1224 B-Assertion___Assertion_Type_Value:intention
to NCT03922529 1225 1227 O
return NCT03922529 1228 1234 O
to NCT03922529 1235 1237 O
independent NCT03922529 1238 1249 B-Observation
living NCT03922529 1250 1256 I-Observation
. NCT03922529 1257 1258 O

Inclusion NCT03925948 0 9 O
Criteria NCT03925948 10 18 O
: NCT03925948 19 20 O

- NCT03925948 24 25 O
African NCT03925948 27 34 O
Americans NCT03925948 35 44 O
residing NCT03925948 45 53 O
in NCT03925948 54 56 O
Baltimore NCT03925948 57 66 O
, NCT03925948 67 68 O
Maryland NCT03925948 69 77 O

- NCT03925948 80 81 O
had NCT03925948 83 86 O
uncontrolled NCT03925948 87 99 B-Modifier
diabetes NCT03925948 100 108 B-Condition
( NCT03925948 109 110 O
defined NCT03925948 111 118 O
as NCT03925948 119 121 O
HbA NCT03925948 122 125 B-Observation
1C NCT03925948 126 128 I-Observation
> NCT03925948 129 130 B-Eq_Comparison
7 NCT03925948 131 132 I-Eq_Comparison
% NCT03925948 133 134 I-Eq_Comparison
) NCT03925948 135 136 O

Exclusion NCT03925948 138 147 O
Criteria NCT03925948 148 156 O
: NCT03925948 157 158 O

- NCT03925948 162 163 O
Unable NCT03925948 165 171 O
to NCT03925948 172 174 O
give NCT03925948 175 179 O
informed NCT03925948 180 188 O
consent NCT03925948 189 196 O

- NCT03925948 199 200 O
Physical NCT03925948 202 210 B-Modifier
or NCT03925948 211 213 B-Or
mental NCT03925948 214 220 B-Modifier
health NCT03925948 221 227 B-Condition
conditions NCT03925948 228 238 I-Condition
that NCT03925948 239 243 O
could NCT03925948 244 249 B-Assertion___Assertion_Type_Value:hypothetical
limit NCT03925948 250 255 O
active NCT03925948 256 262 O
participation NCT03925948 263 276 O
in NCT03925948 277 279 O
the NCT03925948 280 283 O
study NCT03925948 284 289 B-Study
( NCT03925948 290 291 O
e NCT03925948 292 293 O
. NCT03925948 294 295 O
g NCT03925948 296 297 O
. NCT03925948 298 299 O
, NCT03925948 300 301 O
blindness NCT03925948 302 311 B-Condition
in NCT03925948 312 314 O
both NCT03925948 315 319 B-Modifier
eyes NCT03925948 320 324 I-Modifier
, NCT03925948 325 326 O
severe NCT03925948 327 333 O
immobility NCT03925948 334 344 B-Condition
, NCT03925948 345 346 O
psychiatric NCT03925948 347 358 B-Condition
diseases NCT03925948 359 367 I-Condition
) NCT03925948 368 369 O

- NCT03925948 373 374 O
Hematological NCT03925948 376 389 B-Condition
condition NCT03925948 390 399 I-Condition
that NCT03925948 400 404 O
would NCT03925948 405 410 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03925948 411 417 O
HbA NCT03925948 418 421 B-Observation
1C NCT03925948 422 424 I-Observation
assay NCT03925948 425 430 I-Observation
, NCT03925948 431 432 O
e NCT03925948 433 434 O
. NCT03925948 435 436 O
g NCT03925948 437 438 O
. NCT03925948 439 440 O
, NCT03925948 441 442 O
hemolytic NCT03925948 443 452 B-Condition
anemia NCT03925948 453 459 I-Condition
, NCT03925948 460 461 O
sickle NCT03925948 462 468 B-Condition
cell NCT03925948 469 473 I-Condition
anemia NCT03925948 474 480 I-Condition

Inclusion NCT03861156 0 9 O
Criteria NCT03861156 10 18 O
: NCT03861156 19 20 O

- NCT03861156 24 25 O
Aged NCT03861156 27 31 B-Age
at NCT03861156 32 34 B-Eq_Comparison
least NCT03861156 35 40 I-Eq_Comparison
18 NCT03861156 41 43 I-Eq_Comparison
years NCT03861156 44 49 I-Eq_Comparison
. NCT03861156 50 51 O

- NCT03861156 55 56 O
Histologically NCT03861156 58 72 B-Modifier
or NCT03861156 73 75 B-Or
cytologically NCT03861156 76 89 B-Procedure
proven NCT03861156 90 96 O
diagnosis NCT03861156 97 106 O
of NCT03861156 107 109 O
NSCLC NCT03861156 110 115 B-Condition
that NCT03861156 116 120 O
is NCT03861156 121 123 O
locally NCT03861156 124 131 B-Modifier
advanced NCT03861156 132 140 I-Modifier
or NCT03861156 141 143 B-Or
metastatic NCT03861156 144 154 B-Modifier
. NCT03861156 155 156 O

- NCT03861156 160 161 O
Radiological NCT03861156 163 175 B-Procedure
documentation NCT03861156 176 189 O
of NCT03861156 190 192 O
disease NCT03861156 193 200 B-Condition
progression NCT03861156 201 212 I-Condition
while NCT03861156 213 218 B-Temporal_Connection___Temporal_Connection_Type_Value:during
on NCT03861156 219 221 O
a NCT03861156 222 223 O
previous NCT03861156 224 232 B-Eq_Comparison
continuous NCT03861156 233 243 B-Modifier
treatment NCT03861156 244 253 B-Procedure
with NCT03861156 254 258 O
an NCT03861156 259 261 O
first NCT03861156 262 267 B-Modifier
or NCT03861156 268 270 B-Or
second NCT03861156 271 277 B-Modifier
generation NCT03861156 278 288 I-Modifier
of NCT03861156 289 291 O
EGFR NCT03861156 292 296 B-Drug
TKI NCT03861156 297 300 I-Drug
e NCT03861156 301 302 O
. NCT03861156 303 304 O
g NCT03861156 305 306 O
. NCT03861156 307 308 O
gefitinib NCT03861156 310 319 B-Drug
or NCT03861156 320 322 B-Or
erlotinib NCT03861156 323 332 B-Drug
. NCT03861156 333 334 O

- NCT03861156 338 339 O
patients NCT03861156 341 349 O
must NCT03861156 350 354 O
also NCT03861156 355 359 O
have NCT03861156 360 364 O
confirmation NCT03861156 365 377 O
of NCT03861156 378 380 O
tumour NCT03861156 381 387 B-Condition
T NCT03861156 388 389 I-Condition
790 NCT03861156 390 393 I-Condition
M NCT03861156 394 395 I-Condition
mutation NCT03861156 396 404 I-Condition
status NCT03861156 405 411 O
( NCT03861156 412 413 O
confirmed NCT03861156 414 423 O
positive NCT03861156 424 432 O
) NCT03861156 433 434 O
after NCT03861156 435 440 B-Temporal_Connection___Temporal_Connection_Type_Value:after
disease NCT03861156 441 448 B-Condition
progression NCT03861156 449 460 I-Condition
on NCT03861156 461 463 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861156 464 467 O
prior NCT03861156 468 473 B-Eq_Comparison
EGFR NCT03861156 474 478 B-Drug
TKI NCT03861156 479 482 I-Drug
. NCT03861156 483 484 O

- NCT03861156 488 489 O
Eastern NCT03861156 491 498 B-Observation
cooperative NCT03861156 499 510 I-Observation
oncology NCT03861156 511 519 I-Observation
group NCT03861156 520 525 I-Observation
performance NCT03861156 526 537 I-Observation
status NCT03861156 538 544 I-Observation
( NCT03861156 545 546 O
ECOG NCT03861156 547 551 B-Observation
PS NCT03861156 552 554 O
) NCT03861156 555 556 O
of NCT03861156 557 559 O
0 NCT03861156 560 561 B-Eq_Comparison
- NCT03861156 562 563 I-Eq_Comparison
1 NCT03861156 564 565 I-Eq_Comparison
. NCT03861156 565 566 O

- NCT03861156 570 571 O
a NCT03861156 573 574 O
minimum NCT03861156 575 582 O
life NCT03861156 583 587 B-Observation
expectancy NCT03861156 588 598 I-Observation
of NCT03861156 599 601 O
12 NCT03861156 602 604 B-Eq_Comparison
weeks NCT03861156 605 610 I-Eq_Comparison
. NCT03861156 611 612 O

- NCT03861156 616 617 O
At NCT03861156 619 621 B-Eq_Comparison
least NCT03861156 622 627 I-Eq_Comparison
one NCT03861156 628 631 I-Eq_Comparison
lesion NCT03861156 632 638 B-Condition
, NCT03861156 639 640 O
not NCT03861156 641 644 B-Negation
previously NCT03861156 645 655 B-Eq_Comparison
irradiated NCT03861156 656 666 B-Procedure
during NCT03861156 667 673 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861156 674 677 O
study NCT03861156 678 683 B-Study
screening NCT03861156 684 693 O
period NCT03861156 694 700 O
, NCT03861156 701 702 O
that NCT03861156 703 707 B-And
can NCT03861156 708 711 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03861156 712 714 I-Assertion___Assertion_Type_Value:hypothetical
accurately NCT03861156 715 725 O
measured NCT03861156 726 734 B-Observation
at NCT03861156 735 737 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03861156 738 746 B-Study
according NCT03861156 747 756 O
to NCT03861156 757 759 O
RECIST NCT03861156 760 766 O
1.1 NCT03861156 767 770 O
. NCT03861156 770 771 O

- NCT03861156 775 776 O
Agree NCT03861156 778 783 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861156 784 786 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03861156 787 790 O
routine NCT03861156 791 798 O
adequate NCT03861156 799 807 O
and NCT03861156 808 811 O
effective NCT03861156 812 821 O
contraceptive NCT03861156 822 835 B-Procedure
measures NCT03861156 836 844 O
during NCT03861156 845 851 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861156 852 855 O
entire NCT03861156 856 862 O
study NCT03861156 863 868 B-Study
period NCT03861156 869 875 O
and NCT03861156 876 879 B-And
within NCT03861156 880 886 B-Eq_Comparison
6 NCT03861156 887 888 I-Eq_Comparison
weeks NCT03861156 889 894 I-Eq_Comparison
after NCT03861156 895 900 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03861156 901 904 O
last NCT03861156 905 909 B-Eq_Comparison
dose NCT03861156 910 914 O
pre NCT03861156 915 918 B-Condition
- NCT03861156 919 920 I-Condition
menopausal NCT03861156 921 931 I-Condition
fertility NCT03861156 932 941 I-Condition
possible NCT03861156 942 950 O
; NCT03861156 950 951 O
Female NCT03861156 952 958 O
patients NCT03861156 959 967 O
need NCT03861156 968 972 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861156 973 975 I-Assertion___Assertion_Type_Value:hypothetical
exclude NCT03861156 976 983 B-Negation
pregnancy NCT03861156 984 993 B-Condition
( NCT03861156 994 995 O
ie NCT03861156 996 998 O
negative NCT03861156 999 1007 O
pregnancy NCT03861156 1008 1017 B-Observation
test NCT03861156 1018 1022 I-Observation
) NCT03861156 1023 1024 O
and NCT03861156 1025 1028 B-Or
in NCT03861156 1029 1031 O
non NCT03861156 1032 1035 B-Negation
- NCT03861156 1036 1037 O
lactation NCT03861156 1038 1047 B-Condition
period NCT03861156 1048 1054 O
. NCT03861156 1055 1056 O

Exclusion NCT03861156 1058 1067 O
Criteria NCT03861156 1068 1076 O
: NCT03861156 1077 1078 O

- NCT03861156 1082 1083 O
Treatment NCT03861156 1085 1094 B-Procedure
with NCT03861156 1095 1099 O
a NCT03861156 1100 1101 O
first NCT03861156 1102 1107 B-Modifier
or NCT03861156 1108 1110 B-Or
second NCT03861156 1111 1117 B-Modifier
generation NCT03861156 1118 1128 I-Modifier
of NCT03861156 1129 1131 O
EGFR NCT03861156 1132 1136 B-Drug
- NCT03861156 1137 1138 I-Drug
TKI NCT03861156 1139 1142 I-Drug
within NCT03861156 1143 1149 B-Eq_Comparison
7 NCT03861156 1150 1151 I-Eq_Comparison
days NCT03861156 1152 1156 I-Eq_Comparison
of NCT03861156 1157 1159 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03861156 1160 1165 B-Study
entry NCT03861156 1166 1171 O
; NCT03861156 1171 1172 O
previous NCT03861156 1173 1181 B-Eq_Comparison
treatment NCT03861156 1182 1191 B-Procedure
with NCT03861156 1192 1196 O
a NCT03861156 1197 1198 O
third NCT03861156 1199 1204 B-Modifier
generation NCT03861156 1205 1215 I-Modifier
of NCT03861156 1216 1218 O
EGFR NCT03861156 1219 1223 B-Drug
- NCT03861156 1224 1225 I-Drug
TKI NCT03861156 1226 1229 I-Drug
. NCT03861156 1230 1231 O

- NCT03861156 1235 1236 O
Unresolved NCT03861156 1238 1248 B-Eq_Comparison
toxicities NCT03861156 1249 1259 B-Condition
from NCT03861156 1260 1264 O
prior NCT03861156 1265 1270 B-Eq_Comparison
therapy NCT03861156 1271 1278 B-Procedure
. NCT03861156 1279 1280 O

- NCT03861156 1284 1285 O
Unstable NCT03861156 1287 1295 O
spinal NCT03861156 1296 1302 B-Condition
cord NCT03861156 1303 1307 I-Condition
compression NCT03861156 1308 1319 I-Condition
/ NCT03861156 1320 1321 B-Or
brain NCT03861156 1322 1327 B-Modifier
metastases NCT03861156 1328 1338 B-Condition
. NCT03861156 1339 1340 O

- NCT03861156 1344 1345 O
Severe NCT03861156 1347 1353 O
/ NCT03861156 1354 1355 B-Or
uncontrolled NCT03861156 1356 1368 B-Modifier
systemic NCT03861156 1369 1377 I-Modifier
diseases NCT03861156 1378 1386 B-Condition
, NCT03861156 1387 1388 O
including NCT03861156 1389 1398 O
uncontrolled NCT03861156 1399 1411 B-Modifier
hypertension NCT03861156 1412 1424 B-Condition
, NCT03861156 1425 1426 O
bleeding NCT03861156 1427 1435 B-Condition
diatheses NCT03861156 1436 1445 I-Condition
or NCT03861156 1446 1448 B-Or
infection NCT03861156 1449 1458 B-Condition
. NCT03861156 1459 1460 O

- NCT03861156 1464 1465 O
QTcF NCT03861156 1467 1471 B-Observation
> NCT03861156 1472 1473 B-Eq_Comparison
470 NCT03861156 1474 1477 I-Eq_Comparison
msec NCT03861156 1478 1482 I-Eq_Comparison
during NCT03861156 1483 1489 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861156 1490 1493 O
screening NCT03861156 1494 1503 B-Study
period NCT03861156 1504 1510 O
. NCT03861156 1511 1512 O

- NCT03861156 1516 1517 O
Severe NCT03861156 1519 1525 O
respiratory NCT03861156 1526 1537 B-Condition
diseases NCT03861156 1538 1546 I-Condition
such NCT03861156 1547 1551 O
as NCT03861156 1552 1554 O
interstitial NCT03861156 1555 1567 B-Condition
lung NCT03861156 1568 1572 I-Condition
disease NCT03861156 1573 1580 I-Condition
, NCT03861156 1581 1582 O
severe NCT03861156 1583 1589 O
asthma NCT03861156 1590 1596 B-Condition
, NCT03861156 1597 1598 O
pulmonary NCT03861156 1599 1608 B-Condition
embolism NCT03861156 1609 1617 I-Condition
, NCT03861156 1618 1619 O
etc NCT03861156 1620 1623 O
. NCT03861156 1624 1625 O

- NCT03861156 1629 1630 O
previous NCT03861156 1632 1640 B-Eq_Comparison
treatment NCT03861156 1641 1650 B-Procedure
with NCT03861156 1651 1655 O
2 NCT03861156 1656 1657 B-Eq_Comparison
or NCT03861156 1658 1660 I-Eq_Comparison
more NCT03861156 1661 1665 I-Eq_Comparison
lines NCT03861156 1666 1671 O
of NCT03861156 1672 1674 O
Chemotherapy NCT03861156 1675 1687 B-Procedure
or NCT03861156 1688 1690 B-Or
immunotherapy NCT03861156 1691 1704 B-Procedure
. NCT03861156 1705 1706 O

Inclusion NCT03924973 0 9 O
Criteria NCT03924973 10 18 O
: NCT03924973 19 20 O

- NCT03924973 24 25 O
Inclusion NCT03924973 27 36 O
in NCT03924973 37 39 O
the NCT03924973 40 43 O
initial NCT03924973 44 51 O
IDEA NCT03924973 52 56 O
trail NCT03924973 57 62 O

- NCT03924973 65 66 O
Requiring NCT03924973 68 77 B-Assertion___Assertion_Type_Value:hypothetical
less NCT03924973 78 82 B-Eq_Comparison
than NCT03924973 83 87 I-Eq_Comparison
40 NCT03924973 88 90 I-Eq_Comparison
minutes NCT03924973 91 98 I-Eq_Comparison
travel NCT03924973 99 105 B-Observation
to NCT03924973 106 108 O
the NCT03924973 109 112 O
assessment NCT03924973 113 123 O
center NCT03924973 124 130 O

Exclusion NCT03924973 131 140 O
Criteria NCT03924973 141 149 O
: NCT03924973 150 151 O

- NCT03924973 155 156 O
Impossibility NCT03924973 158 171 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
of NCT03924973 172 174 O
coming NCT03924973 175 181 B-Observation
in NCT03924973 182 184 I-Observation
for NCT03924973 185 188 O
assessment NCT03924973 189 199 B-Procedure

- NCT03924973 202 203 O
Exclusion NCT03924973 205 214 O
from NCT03924973 215 219 O
IDEA NCT03924973 220 224 O

Inclusion NCT03865745 0 9 O
Criteria NCT03865745 10 18 O
: NCT03865745 19 20 O

1 NCT03865745 24 25 O
. NCT03865745 25 26 O
Age NCT03865745 28 31 B-Age
of NCT03865745 32 34 O
40 NCT03865745 35 37 B-Eq_Comparison
~ NCT03865745 38 39 I-Eq_Comparison
75 NCT03865745 40 42 I-Eq_Comparison
men NCT03865745 43 46 O
and NCT03865745 47 50 B-Or
women NCT03865745 51 56 O

2 NCT03865745 59 60 O
. NCT03865745 60 61 O
Those NCT03865745 63 68 O
who NCT03865745 69 72 O
visited NCT03865745 73 80 B-Encounter
the NCT03865745 81 84 O
menopausal NCT03865745 85 95 O
clinic NCT03865745 96 102 O
with NCT03865745 103 107 B-And
complaints NCT03865745 108 118 O
of NCT03865745 119 121 O
climacteric NCT03865745 122 133 B-Condition
symptoms NCT03865745 134 142 B-Assertion___Assertion_Type_Value:possible
due NCT03865745 143 146 O
to NCT03865745 147 149 O
functional NCT03865745 150 160 O
deterioration NCT03865745 161 174 B-Condition
of NCT03865745 175 177 I-Condition
various NCT03865745 178 185 I-Condition
organs NCT03865745 186 192 I-Condition
such NCT03865745 193 197 O
as NCT03865745 198 200 O
fatigue NCT03865745 201 208 B-Condition
, NCT03865745 209 210 O
helplessness NCT03865745 211 223 B-Condition

3 NCT03865745 226 227 O
. NCT03865745 227 228 O
Those NCT03865745 230 235 O
who NCT03865745 236 239 O
have NCT03865745 240 244 O
agreed NCT03865745 245 251 O
to NCT03865745 252 254 O
voluntarily NCT03865745 255 266 O
decide NCT03865745 267 273 O
to NCT03865745 274 276 O
participate NCT03865745 277 288 O
and NCT03865745 289 292 O
observe NCT03865745 293 300 O
the NCT03865745 301 304 O
instructions NCT03865745 305 317 O
after NCT03865745 318 323 O
hearing NCT03865745 324 331 O
the NCT03865745 332 335 O
detailed NCT03865745 336 344 O
explanation NCT03865745 345 356 O
of NCT03865745 357 359 O
this NCT03865745 360 364 O
human NCT03865745 365 370 O
body NCT03865745 371 375 O
application NCT03865745 376 387 O
test NCT03865745 388 392 O

Exclusion NCT03865745 393 402 O
Criteria NCT03865745 403 411 O
: NCT03865745 412 413 O

1 NCT03865745 417 418 O
. NCT03865745 418 419 O
Those NCT03865745 421 426 O
who NCT03865745 427 430 O
have NCT03865745 431 435 O
suspected NCT03865745 436 445 B-Assertion___Assertion_Type_Value:possible
symptoms NCT03865745 446 454 I-Assertion___Assertion_Type_Value:possible
of NCT03865745 455 457 O
acute NCT03865745 458 463 O
disease NCT03865745 464 471 B-Condition
( NCT03865745 472 473 O
severe NCT03865745 474 480 O
infectious NCT03865745 481 491 B-Condition
disease NCT03865745 492 499 I-Condition
, NCT03865745 500 501 O
severe NCT03865745 502 508 O
trauma NCT03865745 509 515 B-Condition
, NCT03865745 516 517 O
severe NCT03865745 518 524 O
diarrhea NCT03865745 525 533 B-Condition
, NCT03865745 534 535 O
vomiting NCT03865745 536 544 B-Condition
, NCT03865745 545 546 O
etc NCT03865745 547 550 O
. NCT03865745 551 552 O
) NCT03865745 553 554 O

2 NCT03865745 558 559 O
. NCT03865745 559 560 O
Patients NCT03865745 562 570 O
with NCT03865745 571 575 O
a NCT03865745 576 577 O
history NCT03865745 578 585 B-Eq_Comparison
of NCT03865745 586 588 O
antibiotic NCT03865745 589 599 B-Drug
treatment NCT03865745 600 609 B-Procedure
for NCT03865745 610 613 O
more NCT03865745 614 618 B-Eq_Comparison
than NCT03865745 619 623 I-Eq_Comparison
1 NCT03865745 624 625 I-Eq_Comparison
month NCT03865745 626 631 I-Eq_Comparison
within NCT03865745 632 638 B-Eq_Comparison
the NCT03865745 639 642 I-Eq_Comparison
last NCT03865745 643 647 I-Eq_Comparison
6 NCT03865745 648 649 I-Eq_Comparison
months NCT03865745 650 656 I-Eq_Comparison

3 NCT03865745 664 665 O
. NCT03865745 665 666 O
Those NCT03865745 668 673 O
who NCT03865745 674 677 O
have NCT03865745 678 682 O
gastrointestinal NCT03865745 683 699 B-Condition
diseases NCT03865745 700 708 I-Condition
( NCT03865745 709 710 O
inflammatory NCT03865745 711 723 B-Condition
growth NCT03865745 724 730 I-Condition
disease NCT03865745 731 738 I-Condition
, NCT03865745 739 740 O
active NCT03865745 741 747 B-Condition
peptic NCT03865745 748 754 I-Condition
ulcer NCT03865745 755 760 I-Condition
, NCT03865745 761 762 O
etc NCT03865745 763 766 O
. NCT03865745 767 768 O
) NCT03865745 769 770 O
or NCT03865745 771 773 B-Or
gastrointestinal NCT03865745 774 790 B-Procedure
surgery NCT03865745 791 798 I-Procedure
( NCT03865745 799 800 O
except NCT03865745 801 807 B-Exception
for NCT03865745 808 811 O
simple NCT03865745 812 818 B-Modifier
appendectomy NCT03865745 819 831 B-Procedure
or NCT03865745 832 834 B-Or
hernia NCT03865745 835 841 B-Procedure
surgery NCT03865745 842 849 I-Procedure
) NCT03865745 850 851 O

4 NCT03865745 855 856 O
. NCT03865745 856 857 O
Those NCT03865745 859 864 O
taking NCT03865745 865 871 B-Eq_Comparison
health NCT03865745 872 878 B-Drug
functional NCT03865745 879 889 I-Drug
foods NCT03865745 890 895 I-Drug
, NCT03865745 896 897 O
lactic NCT03865745 898 904 B-Drug
acid NCT03865745 905 909 I-Drug
bacteria NCT03865745 910 918 I-Drug
, NCT03865745 919 920 O
and NCT03865745 921 924 B-Or
red NCT03865745 925 928 B-Drug
ginseng NCT03865745 929 936 I-Drug
extracts NCT03865745 937 945 I-Drug
for NCT03865745 946 949 O
the NCT03865745 950 953 O
past NCT03865745 954 958 B-Eq_Comparison
year NCT03865745 959 963 I-Eq_Comparison

5 NCT03865745 966 967 O
. NCT03865745 967 968 O
Those NCT03865745 970 975 O
who NCT03865745 976 979 O
are NCT03865745 980 983 O
currently NCT03865745 984 993 B-Eq_Comparison
participating NCT03865745 994 1007 O
in NCT03865745 1008 1010 O
other NCT03865745 1011 1016 B-Other
clinical NCT03865745 1017 1025 B-Study
studies NCT03865745 1026 1033 I-Study
or NCT03865745 1034 1036 B-Or
human NCT03865745 1037 1042 B-Study
trials NCT03865745 1043 1049 I-Study
, NCT03865745 1050 1051 O
or NCT03865745 1052 1054 B-Or
participating NCT03865745 1055 1068 O
in NCT03865745 1069 1071 O
clinical NCT03865745 1072 1080 B-Study
trials NCT03865745 1081 1087 I-Study
or NCT03865745 1088 1090 B-Or
human NCT03865745 1091 1096 B-Study
application NCT03865745 1097 1108 I-Study
tests NCT03865745 1109 1114 I-Study
within NCT03865745 1115 1121 B-Eq_Comparison
the NCT03865745 1122 1125 I-Eq_Comparison
past NCT03865745 1126 1130 I-Eq_Comparison
month NCT03865745 1131 1136 I-Eq_Comparison


Inclusion NCT03861104 0 9 O
Criteria NCT03861104 10 18 O
: NCT03861104 19 20 O

- NCT03861104 24 25 O
patients NCT03861104 27 35 O
who NCT03861104 36 39 O
will NCT03861104 40 44 B-Eq_Comparison
undergo NCT03861104 45 52 I-Eq_Comparison
septoplasty NCT03861104 53 64 B-Procedure
/ NCT03861104 65 66 B-Or
septorhinoplasty NCT03861104 67 83 B-Procedure
procedures NCT03861104 84 94 I-Procedure

- NCT03861104 97 98 O
patients NCT03861104 100 108 O
who NCT03861104 109 112 O
will NCT03861104 113 117 B-Eq_Comparison
receive NCT03861104 118 125 I-Eq_Comparison
nasal NCT03861104 126 131 B-Procedure
packing NCT03861104 132 139 I-Procedure
at NCT03861104 140 142 B-Temporal_Connection___Temporal_Connection_Type_Value:during
their NCT03861104 143 148 O
septoplasty NCT03861104 149 160 B-Procedure
septorhinoplasty NCT03861104 161 177 I-Procedure
procedures NCT03861104 178 188 I-Procedure

Exclusion NCT03861104 189 198 O
Criteria NCT03861104 199 207 O
: NCT03861104 208 209 O

- NCT03861104 213 214 O
patients NCT03861104 216 224 O
who NCT03861104 225 228 O
will NCT03861104 229 233 O
not NCT03861104 234 237 B-Negation
want NCT03861104 238 242 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861104 243 245 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03861104 246 257 O
to NCT03861104 258 260 O
the NCT03861104 261 264 O
study NCT03861104 265 270 B-Study

- NCT03861104 273 274 O
revision NCT03861104 276 284 B-Modifier
surgeries NCT03861104 285 294 B-Procedure

- NCT03861104 297 298 O
if NCT03861104 300 302 O
the NCT03861104 303 306 O
patient NCT03861104 307 314 O
is NCT03861104 315 317 O
taking NCT03861104 318 324 B-Eq_Comparison
antidepressants NCT03861104 325 340 B-Drug
during NCT03861104 341 347 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861104 348 351 O
last NCT03861104 352 356 B-Eq_Comparison
6 NCT03861104 357 358 I-Eq_Comparison
months NCT03861104 359 365 I-Eq_Comparison

- NCT03861104 368 369 O
if NCT03861104 371 373 O
the NCT03861104 374 377 O
patient NCT03861104 378 385 O
has NCT03861104 386 389 O
a NCT03861104 390 391 O
history NCT03861104 392 399 B-Eq_Comparison
of NCT03861104 400 402 O
a NCT03861104 403 404 O
disease NCT03861104 405 412 B-Condition
that NCT03861104 413 417 O
can NCT03861104 418 421 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03861104 422 428 O
anxiety NCT03861104 429 436 B-Condition
levels NCT03861104 437 443 O

- NCT03861104 446 447 O
if NCT03861104 449 451 O
patient NCT03861104 452 459 O
wants NCT03861104 460 465 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861104 466 468 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03861104 469 471 O
excluded NCT03861104 472 480 B-Negation
from NCT03861104 481 485 O
the NCT03861104 486 489 O
study NCT03861104 490 495 B-Study

Inclusion NCT03861507 0 9 O
Criteria NCT03861507 10 18 O
: NCT03861507 19 20 O

- NCT03861507 24 25 O
Male NCT03861507 27 31 O
, NCT03861507 32 33 O
aged NCT03861507 34 38 B-Age
18 NCT03861507 39 41 B-Eq_Comparison
years NCT03861507 42 47 I-Eq_Comparison
or NCT03861507 48 50 I-Eq_Comparison
older NCT03861507 51 56 I-Eq_Comparison

- NCT03861507 59 60 O
Willing NCT03861507 62 69 O
to NCT03861507 70 72 O
provide NCT03861507 73 80 O
written NCT03861507 81 88 O
consent NCT03861507 89 96 O

- NCT03861507 99 100 O
Pathologically NCT03861507 102 116 B-Procedure
confirmed NCT03861507 117 126 O
prostate NCT03861507 127 135 B-Modifier
cancer NCT03861507 136 142 B-Condition
on NCT03861507 143 145 O
previous NCT03861507 146 154 B-Eq_Comparison
biopsy NCT03861507 155 161 B-Procedure

- NCT03861507 164 165 O
Suitable NCT03861507 167 175 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03861507 176 179 I-Assertion___Assertion_Type_Value:hypothetical
and NCT03861507 180 183 O
consenting NCT03861507 184 194 O
to NCT03861507 195 197 O
high NCT03861507 198 202 B-Modifier
- NCT03861507 203 204 I-Modifier
dose NCT03861507 205 209 I-Modifier
- NCT03861507 210 211 I-Modifier
rate NCT03861507 212 216 I-Modifier
brachytherapy NCT03861507 217 230 B-Procedure
for NCT03861507 231 234 O
treatment NCT03861507 235 244 B-Procedure
as NCT03861507 245 247 O
standard NCT03861507 248 256 O
of NCT03861507 257 259 O
care NCT03861507 260 264 O
. NCT03861507 265 266 O

Exclusion NCT03861507 268 277 O
Criteria NCT03861507 278 286 O
: NCT03861507 287 288 O

- NCT03861507 292 293 O
• NCT03861507 295 296 O
Previous NCT03861507 297 305 B-Eq_Comparison
radiotherapy NCT03861507 306 318 B-Procedure
to NCT03861507 319 321 O
the NCT03861507 322 325 O
prostate NCT03861507 326 334 B-Condition

Inclusion NCT03861312 0 9 O
Criteria NCT03861312 10 18 O
: NCT03861312 19 20 O

- NCT03861312 24 25 O
The NCT03861312 27 30 O
inclusion NCT03861312 31 40 O
criteria NCT03861312 41 49 O
were NCT03861312 50 54 O
as NCT03861312 55 57 O
follows NCT03861312 58 65 O
: NCT03861312 66 67 O
a NCT03861312 68 69 O
) NCT03861312 70 71 O
men NCT03861312 72 75 O
and NCT03861312 76 79 B-Or
women NCT03861312 80 85 O
aged NCT03861312 86 90 B-Age
between NCT03861312 91 98 B-Eq_Comparison
18 NCT03861312 99 101 I-Eq_Comparison
- NCT03861312 102 103 I-Eq_Comparison
and NCT03861312 104 107 I-Eq_Comparison
65 NCT03861312 108 110 I-Eq_Comparison
- NCT03861312 111 112 I-Eq_Comparison
years NCT03861312 113 118 I-Eq_Comparison
b NCT03861312 119 120 O
) NCT03861312 121 122 O
medical NCT03861312 123 130 O
diagnosis NCT03861312 131 140 O
of NCT03861312 141 143 O
Non NCT03861312 144 147 B-Modifier
- NCT03861312 148 149 I-Modifier
Specific NCT03861312 150 158 I-Modifier
Chronic NCT03861312 159 166 O
Neck NCT03861312 167 171 B-Modifier
Pain NCT03861312 172 176 B-Condition
with NCT03861312 177 181 B-And
more NCT03861312 182 186 B-Eq_Comparison
than NCT03861312 187 191 I-Eq_Comparison
6 NCT03861312 192 193 I-Eq_Comparison
months NCT03861312 194 200 I-Eq_Comparison
of NCT03861312 201 203 O
evolution NCT03861312 204 213 O
of NCT03861312 214 216 O
neck NCT03861312 217 221 B-Modifier
pain NCT03861312 222 226 B-Condition
. NCT03861312 227 228 O

Exclusion NCT03861312 230 239 O
Criteria NCT03861312 240 248 O
: NCT03861312 249 250 O

- NCT03861312 254 255 O
Exclusion NCT03861312 257 266 O
criteria NCT03861312 267 275 O
included NCT03861312 276 284 O
the NCT03861312 285 288 O
following NCT03861312 289 298 O
: NCT03861312 299 300 O
a NCT03861312 301 302 O
) NCT03861312 303 304 O
patients NCT03861312 305 313 O
with NCT03861312 314 318 O
rheumatic NCT03861312 319 328 B-Condition
diseases NCT03861312 329 337 I-Condition
, NCT03861312 338 339 O
cervical NCT03861312 340 348 B-Condition
hernia NCT03861312 349 355 I-Condition
, NCT03861312 356 357 O
cervical NCT03861312 358 366 B-Condition
whiplash NCT03861312 367 375 I-Condition
syndrome NCT03861312 376 384 I-Condition
, NCT03861312 385 386 O
neck NCT03861312 387 391 B-Modifier
surgeries NCT03861312 392 401 B-Procedure
or NCT03861312 402 404 B-Or
history NCT03861312 405 412 B-Eq_Comparison
of NCT03861312 413 415 O
arthrodesis NCT03861312 416 427 B-Procedure
, NCT03861312 428 429 O
b NCT03861312 430 431 O
) NCT03861312 432 433 O
systemic NCT03861312 434 442 B-Modifier
diseases NCT03861312 443 451 B-Condition
, NCT03861312 452 453 O
c NCT03861312 454 455 O
) NCT03861312 456 457 O
vision NCT03861312 458 464 B-Modifier
, NCT03861312 465 466 O
hearing NCT03861312 467 474 B-Modifier
or NCT03861312 475 477 B-Or
vestibular NCT03861312 478 488 B-Modifier
problems NCT03861312 489 497 B-Condition
, NCT03861312 498 499 O
d NCT03861312 500 501 O
) NCT03861312 502 503 O
Severe NCT03861312 504 510 O
trauma NCT03861312 511 517 B-Condition
or NCT03861312 518 520 B-Or
traffic NCT03861312 521 528 B-Condition
accident NCT03861312 529 537 I-Condition
which NCT03861312 538 543 O
has NCT03861312 544 547 O
had NCT03861312 548 551 O
an NCT03861312 552 554 O
impact NCT03861312 555 561 O
on NCT03861312 562 564 O
the NCT03861312 565 568 O
cervical NCT03861312 569 577 B-Modifier
area NCT03861312 578 582 I-Modifier
. NCT03861312 583 584 O

Inclusion NCT03923192 0 9 O
Criteria NCT03923192 10 18 O
: NCT03923192 19 20 O

- NCT03923192 24 25 O
Patients NCT03923192 27 35 O
aged NCT03923192 36 40 B-Age
from NCT03923192 41 45 O
15 NCT03923192 46 48 B-Eq_Comparison
to NCT03923192 49 51 I-Eq_Comparison
50 NCT03923192 52 54 I-Eq_Comparison
years NCT03923192 55 60 I-Eq_Comparison
. NCT03923192 61 62 O

- NCT03923192 66 67 O
No NCT03923192 69 71 O
gender NCT03923192 72 78 O
restriction NCT03923192 79 90 O
. NCT03923192 91 92 O

- NCT03923192 96 97 O
Patients NCT03923192 99 107 O
should NCT03923192 108 114 O
have NCT03923192 115 119 O
an NCT03923192 120 122 O
acceptable NCT03923192 123 133 O
oral NCT03923192 134 138 O
hygiene NCT03923192 139 146 O
level NCT03923192 147 152 O
. NCT03923192 153 154 O

- NCT03923192 158 159 O
Patients NCT03923192 161 169 O
must NCT03923192 170 174 O
have NCT03923192 175 179 O
at NCT03923192 180 182 B-Eq_Comparison
least NCT03923192 183 188 I-Eq_Comparison
one NCT03923192 189 192 I-Eq_Comparison
posterior NCT03923192 193 202 B-Modifier
proximal NCT03923192 203 211 I-Modifier
caries NCT03923192 212 218 B-Condition

Exclusion NCT03923192 219 228 O
Criteria NCT03923192 229 237 O
: NCT03923192 238 239 O

- NCT03923192 243 244 O
Patients NCT03923192 246 254 O
with NCT03923192 255 259 O
a NCT03923192 260 261 O
compromised NCT03923192 262 273 B-Condition
medical NCT03923192 274 281 O
history NCT03923192 282 289 B-Eq_Comparison
. NCT03923192 290 291 O

- NCT03923192 295 296 O
Severe NCT03923192 298 304 O
or NCT03923192 305 307 B-Or
active NCT03923192 308 314 B-Eq_Comparison
periodontal NCT03923192 315 326 B-Condition
disease NCT03923192 327 334 I-Condition
. NCT03923192 335 336 O

- NCT03923192 340 341 O
Heavy NCT03923192 343 348 B-Modifier
bruxism NCT03923192 349 356 B-Condition
or NCT03923192 357 359 B-Or
a NCT03923192 360 361 O
traumatic NCT03923192 362 371 B-Modifier
occlusion NCT03923192 372 381 B-Condition
. NCT03923192 382 383 O

- NCT03923192 387 388 O
Acute NCT03923192 390 395 O
or NCT03923192 396 398 B-Or
chronic NCT03923192 399 406 O
dental NCT03923192 407 413 B-Modifier
infection NCT03923192 414 423 B-Condition
. NCT03923192 424 425 O

- NCT03923192 429 430 O
Pregnant NCT03923192 432 440 B-Condition
or NCT03923192 441 443 B-Or
breastfeeding NCT03923192 444 457 B-Condition
women NCT03923192 458 463 O
. NCT03923192 464 465 O

- NCT03923192 469 470 O
Patients NCT03923192 472 480 O
with NCT03923192 481 485 O
posterior NCT03923192 486 495 B-Modifier
restorations NCT03923192 496 508 B-Procedure
on NCT03923192 509 511 O
molars NCT03923192 512 518 B-Modifier
or NCT03923192 519 521 B-Or
premolars NCT03923192 522 531 B-Modifier

Inclusion NCT03922581 0 9 O
Criteria NCT03922581 10 18 O
: NCT03922581 19 20 O

- NCT03922581 24 25 O
ability NCT03922581 27 34 O
to NCT03922581 35 37 O
provide NCT03922581 38 45 O
informed NCT03922581 46 54 O
consent NCT03922581 55 62 O

- NCT03922581 65 66 O
willingness NCT03922581 68 79 O
to NCT03922581 80 82 O
participate NCT03922581 83 94 O
in NCT03922581 95 97 O
study NCT03922581 98 103 O

- NCT03922581 106 107 O
self NCT03922581 109 113 O
- NCT03922581 114 115 O
identity NCT03922581 116 124 O
as NCT03922581 125 127 O
African NCT03922581 128 135 O
American NCT03922581 136 144 O

- NCT03922581 147 148 O
history NCT03922581 150 157 B-Eq_Comparison
of NCT03922581 158 160 O
childhood NCT03922581 161 170 O
and NCT03922581 171 174 B-Or
/ NCT03922581 175 176 I-Or
or NCT03922581 177 179 I-Or
adult NCT03922581 180 185 O
trauma NCT03922581 186 192 B-Condition
exposure NCT03922581 193 201 I-Condition
( NCT03922581 202 203 O
3 NCT03922581 204 205 B-Eq_Comparison
total NCT03922581 206 211 I-Eq_Comparison
criterion NCT03922581 212 221 I-Eq_Comparison
A NCT03922581 222 223 I-Eq_Comparison
traumas NCT03922581 224 231 I-Eq_Comparison
) NCT03922581 232 233 O

- NCT03922581 237 238 O
positive NCT03922581 240 248 O
PTSD NCT03922581 249 253 B-Condition
screen NCT03922581 254 260 O
( NCT03922581 261 262 O
PC NCT03922581 263 265 B-Observation
- NCT03922581 266 267 I-Observation
PTSD NCT03922581 268 272 I-Observation
≥ NCT03922581 273 274 B-Eq_Comparison
3 NCT03922581 275 276 I-Eq_Comparison
) NCT03922581 277 278 O

- NCT03922581 282 283 O
positive NCT03922581 285 293 O
MDD NCT03922581 294 297 B-Condition
screen NCT03922581 298 304 O
( NCT03922581 305 306 O
PHQ NCT03922581 307 310 B-Observation
- NCT03922581 311 312 I-Observation
9 NCT03922581 313 314 I-Observation
≥ NCT03922581 315 316 B-Eq_Comparison
5 NCT03922581 317 318 I-Eq_Comparison
) NCT03922581 319 320 O

Exclusion NCT03922581 322 331 O
Criteria NCT03922581 332 340 O
: NCT03922581 341 342 O

- NCT03922581 346 347 O
presence NCT03922581 349 357 O
of NCT03922581 358 360 O
intellectual NCT03922581 361 373 B-Condition
disability NCT03922581 374 384 I-Condition
, NCT03922581 385 386 O
bipolar NCT03922581 387 394 B-Condition
, NCT03922581 395 396 O
or NCT03922581 397 399 B-Or
psychotic NCT03922581 400 409 B-Condition
disorder NCT03922581 410 418 I-Condition

- NCT03922581 421 422 O
presence NCT03922581 424 432 O
of NCT03922581 433 435 O
current NCT03922581 436 443 B-Eq_Comparison
substance NCT03922581 444 453 B-Condition
use NCT03922581 454 457 I-Condition
disorder NCT03922581 458 466 I-Condition
( NCT03922581 467 468 O
past NCT03922581 469 473 B-Eq_Comparison
1 NCT03922581 474 475 I-Eq_Comparison
month NCT03922581 476 481 I-Eq_Comparison
; NCT03922581 481 482 O
see NCT03922581 483 486 O
cut NCT03922581 487 490 O
off NCT03922581 491 494 O
scores NCT03922581 495 501 O
in NCT03922581 502 504 O
psychological NCT03922581 505 518 O
measures NCT03922581 519 527 O
below NCT03922581 528 533 O
) NCT03922581 534 535 O

- NCT03922581 539 540 O
active NCT03922581 542 548 B-Eq_Comparison
suicidality NCT03922581 549 560 B-Condition

Inclusion NCT03922295 0 9 O
Criteria NCT03922295 10 18 O
: NCT03922295 19 20 O

- NCT03922295 24 25 O
Patients NCT03922295 27 35 O
with NCT03922295 36 40 O
chronic NCT03922295 41 48 B-Condition
suppurative NCT03922295 49 60 I-Condition
otitis NCT03922295 61 67 I-Condition
media NCT03922295 68 73 I-Condition
with NCT03922295 74 78 B-And
total NCT03922295 79 84 B-Modifier
or NCT03922295 85 87 B-Or
subtotal NCT03922295 88 96 B-Modifier
tympanic NCT03922295 97 105 B-Condition
membrane NCT03922295 106 114 I-Condition
perforation NCT03922295 115 126 I-Condition
with NCT03922295 127 131 B-And
limited NCT03922295 132 139 B-Condition
anterior NCT03922295 140 148 I-Condition
remnant NCT03922295 149 156 I-Condition
. NCT03922295 157 158 O

- NCT03922295 162 163 O
dry NCT03922295 165 168 B-Condition
perforation NCT03922295 169 180 I-Condition
for NCT03922295 181 184 O
at NCT03922295 185 187 B-Eq_Comparison
least NCT03922295 188 193 I-Eq_Comparison
3 NCT03922295 194 195 I-Eq_Comparison
months NCT03922295 196 202 I-Eq_Comparison
. NCT03922295 203 204 O

Exclusion NCT03922295 206 215 O
Criteria NCT03922295 216 224 O
: NCT03922295 225 226 O

- NCT03922295 230 231 O
Recurrent NCT03922295 233 242 B-Condition
perforation NCT03922295 243 254 I-Condition
after NCT03922295 255 260 B-Temporal_Connection___Temporal_Connection_Type_Value:during
previous NCT03922295 261 269 B-Eq_Comparison
myringoplasty NCT03922295 270 283 B-Procedure
. NCT03922295 284 285 O

- NCT03922295 289 290 O
Ossicular NCT03922295 292 301 B-Procedure
disruption NCT03922295 302 312 B-Modifier
or NCT03922295 313 315 B-Or
fixation NCT03922295 316 324 B-Modifier
. NCT03922295 325 326 O

- NCT03922295 330 331 O
immune NCT03922295 333 339 B-Condition
- NCT03922295 340 341 I-Condition
compromised NCT03922295 342 353 I-Condition
patients NCT03922295 354 362 O
including NCT03922295 363 372 O
uncontrolled NCT03922295 373 385 B-Modifier
diabetics NCT03922295 386 395 B-Condition
, NCT03922295 396 397 O
chronic NCT03922295 398 405 O
liver NCT03922295 406 411 B-Modifier
and NCT03922295 412 415 B-Or
kidney NCT03922295 416 422 B-Modifier
diseases NCT03922295 423 431 B-Condition
. NCT03922295 432 433 O

Inclusion NCT03920527 0 9 O
Criteria NCT03920527 10 18 O
: NCT03920527 19 20 O
includes NCT03920527 21 29 O
presence NCT03920527 30 38 O
of NCT03920527 39 41 O
all NCT03920527 42 45 O
the NCT03920527 46 49 O
following NCT03920527 50 59 O
: NCT03920527 60 61 O

- NCT03920527 65 66 O
one NCT03920527 68 71 B-Eq_Comparison
or NCT03920527 72 74 I-Eq_Comparison
more NCT03920527 75 79 I-Eq_Comparison
clinical NCT03920527 80 88 B-Condition
symptoms NCT03920527 89 97 I-Condition
( NCT03920527 98 99 O
persistent NCT03920527 100 110 B-Modifier
cough NCT03920527 111 116 B-Condition
, NCT03920527 117 118 O
recurrent NCT03920527 119 128 B-Modifier
hemoptysis NCT03920527 129 139 B-Condition
, NCT03920527 140 141 O
weight NCT03920527 142 148 B-Condition
loss NCT03920527 149 153 I-Condition
, NCT03920527 154 155 O
malaise NCT03920527 156 163 B-Condition
, NCT03920527 164 165 O
fever NCT03920527 166 171 B-Condition
and NCT03920527 172 175 B-Or
dyspnea NCT03920527 176 183 B-Condition
) NCT03920527 184 185 O
for NCT03920527 186 189 O
≥ NCT03920527 190 191 B-Eq_Comparison
3 NCT03920527 192 193 I-Eq_Comparison
months NCT03920527 194 200 I-Eq_Comparison

- NCT03920527 203 204 O
slowly NCT03920527 206 212 B-Modifier
progressive NCT03920527 213 224 I-Modifier
or NCT03920527 225 227 B-Or
persistent NCT03920527 228 238 B-Modifier
radiological NCT03920527 239 251 B-Procedure
findings NCT03920527 252 260 B-Condition
( NCT03920527 261 262 O
one NCT03920527 263 266 B-Eq_Comparison
or NCT03920527 267 269 I-Eq_Comparison
more NCT03920527 270 274 I-Eq_Comparison
cavities NCT03920527 275 283 B-Condition
and NCT03920527 284 287 B-Or
surrounding NCT03920527 288 299 B-Modifier
fibrosis NCT03920527 300 308 B-Condition
, NCT03920527 309 310 O
infiltrates NCT03920527 311 322 B-Condition
, NCT03920527 323 324 O
consolidation NCT03920527 325 338 B-Condition
, NCT03920527 339 340 O
with NCT03920527 341 345 O
or NCT03920527 346 348 O
without NCT03920527 349 356 O
fungal NCT03920527 357 363 B-Condition
ball NCT03920527 364 368 I-Condition
or NCT03920527 369 371 B-Or
progressive NCT03920527 372 383 B-Modifier
pleural NCT03920527 384 391 B-Condition
thickening NCT03920527 392 402 I-Condition
) NCT03920527 403 404 O
on NCT03920527 405 407 O
computed NCT03920527 408 416 B-Procedure
tomography NCT03920527 417 427 I-Procedure
( NCT03920527 428 429 O
CT NCT03920527 430 432 B-Procedure
) NCT03920527 433 434 O
of NCT03920527 435 437 O
the NCT03920527 438 441 O
thorax NCT03920527 442 448 B-Modifier

- NCT03920527 451 452 O
immunological NCT03920527 454 467 B-Modifier
( NCT03920527 468 469 O
A NCT03920527 470 471 B-Organism
. NCT03920527 472 473 I-Organism
fumigatus NCT03920527 474 483 I-Organism
- NCT03920527 484 485 O
specific NCT03920527 486 494 O
IgG NCT03920527 495 498 B-Observation
> NCT03920527 499 500 B-Eq_Comparison
27 NCT03920527 501 503 I-Eq_Comparison
mgA NCT03920527 504 507 I-Eq_Comparison
/ NCT03920527 508 509 I-Eq_Comparison
L NCT03920527 510 511 I-Eq_Comparison
or NCT03920527 512 514 B-Or
positive NCT03920527 515 523 O
Aspergillus NCT03920527 524 535 B-Organism
precipitins NCT03920527 536 547 I-Organism
) NCT03920527 548 549 O
or NCT03920527 550 552 O
microbiological NCT03920527 553 568 B-Observation
evidence NCT03920527 569 577 O
of NCT03920527 578 580 O
Aspergillus NCT03920527 581 592 B-Modifier
infection NCT03920527 593 602 B-Condition
( NCT03920527 603 604 O
growth NCT03920527 605 611 O
of NCT03920527 612 614 O
Aspergillus NCT03920527 615 626 B-Organism
in NCT03920527 627 629 O
respiratory NCT03920527 630 641 B-Observation
secretions NCT03920527 642 652 I-Observation
or NCT03920527 653 655 B-Or
serum NCT03920527 656 661 B-Observation
galactomannan NCT03920527 662 675 I-Observation
index NCT03920527 676 681 I-Observation
> NCT03920527 682 683 B-Eq_Comparison
0.5 NCT03920527 684 687 I-Eq_Comparison
or NCT03920527 688 690 B-Or
BALF NCT03920527 691 695 B-Observation
galactomannan NCT03920527 696 709 I-Observation
index NCT03920527 710 715 I-Observation
> NCT03920527 716 717 B-Eq_Comparison
1 NCT03920527 718 719 I-Eq_Comparison
) NCT03920527 720 721 O
and NCT03920527 722 725 B-And
, NCT03920527 726 727 O

- NCT03920527 731 732 O
exclusion NCT03920527 734 743 B-Negation
of NCT03920527 744 746 O
other NCT03920527 747 752 B-Other
pulmonary NCT03920527 753 762 B-Modifier
disorders NCT03920527 763 772 B-Condition
with NCT03920527 773 777 O
similar NCT03920527 778 785 O
presentation NCT03920527 786 798 O
. NCT03920527 799 800 O

Exclusion NCT03920527 802 811 O
Criteria NCT03920527 812 820 O
: NCT03920527 821 822 O

- NCT03920527 826 827 O
failure NCT03920527 829 836 O
to NCT03920527 837 839 O
provide NCT03920527 840 847 O
informed NCT03920527 848 856 O
consent NCT03920527 857 864 O

- NCT03920527 867 868 O
patients NCT03920527 870 878 O
on NCT03920527 879 881 B-Eq_Comparison
immunosuppressive NCT03920527 882 899 B-Drug
drugs NCT03920527 900 905 I-Drug
, NCT03920527 906 907 O
intake NCT03920527 908 914 O
of NCT03920527 915 917 O
prednisolone NCT03920527 918 930 B-Drug
( NCT03920527 931 932 O
or NCT03920527 933 935 O
equivalent NCT03920527 936 946 O
) NCT03920527 947 948 O
> NCT03920527 949 950 B-Eq_Comparison
10 NCT03920527 951 953 I-Eq_Comparison
mg NCT03920527 954 956 I-Eq_Comparison
for NCT03920527 957 960 O
at NCT03920527 961 963 B-Eq_Comparison
least NCT03920527 964 969 I-Eq_Comparison
3 NCT03920527 970 971 I-Eq_Comparison
weeks NCT03920527 972 977 I-Eq_Comparison
or NCT03920527 978 980 B-Or
a NCT03920527 981 982 O
diagnosis NCT03920527 983 992 O
of NCT03920527 993 995 O
human NCT03920527 996 1001 B-Condition
immunodeficiency NCT03920527 1002 1018 I-Condition
virus NCT03920527 1019 1024 I-Condition
syndrome NCT03920527 1025 1033 I-Condition

- NCT03920527 1036 1037 O
intake NCT03920527 1039 1045 O
antifungal NCT03920527 1046 1056 B-Drug
azoles NCT03920527 1057 1063 I-Drug
for NCT03920527 1064 1067 O
> NCT03920527 1068 1069 B-Eq_Comparison
3 NCT03920527 1070 1071 I-Eq_Comparison
weeks NCT03920527 1072 1077 I-Eq_Comparison
in NCT03920527 1078 1080 O
the NCT03920527 1081 1084 O
preceding NCT03920527 1085 1094 B-Eq_Comparison
six NCT03920527 1095 1098 I-Eq_Comparison
months NCT03920527 1099 1105 I-Eq_Comparison

- NCT03920527 1108 1109 O
subjects NCT03920527 1111 1119 O
with NCT03920527 1120 1124 O
active NCT03920527 1125 1131 B-Eq_Comparison
pulmonary NCT03920527 1132 1141 B-Modifier
infection NCT03920527 1142 1151 B-Condition
due NCT03920527 1152 1155 O
to NCT03920527 1156 1158 O
mycobacterium NCT03920527 1159 1172 B-Organism
tuberculosis NCT03920527 1173 1185 I-Organism
or NCT03920527 1186 1188 B-Or
mycobacteria NCT03920527 1189 1201 B-Organism
other NCT03920527 1202 1207 B-Exception
than NCT03920527 1208 1212 I-Exception
tuberculosis NCT03920527 1213 1225 B-Condition
( NCT03920527 1226 1227 O
MOTT NCT03920527 1228 1232 B-Condition
) NCT03920527 1233 1234 O

- NCT03920527 1238 1239 O
subjects NCT03920527 1241 1249 O
with NCT03920527 1250 1254 O
others NCT03920527 1255 1261 B-Other
forms NCT03920527 1262 1267 O
of NCT03920527 1268 1270 O
pulmonary NCT03920527 1271 1280 B-Modifier
aspergillosis NCT03920527 1281 1294 B-Condition
( NCT03920527 1295 1296 O
allergic NCT03920527 1297 1305 B-Modifier
bronchopulmonary NCT03920527 1306 1322 I-Modifier
aspergillosis NCT03920527 1323 1336 B-Condition
, NCT03920527 1337 1338 O
chronic NCT03920527 1339 1346 O
necrotizing NCT03920527 1347 1358 B-Modifier
aspergillosis NCT03920527 1359 1372 B-Condition
and NCT03920527 1373 1376 B-Or
angio NCT03920527 1377 1382 B-Modifier
- NCT03920527 1383 1384 I-Modifier
invasive NCT03920527 1385 1393 I-Modifier
aspergillosis NCT03920527 1394 1407 B-Condition
) NCT03920527 1408 1409 O

- NCT03920527 1413 1414 O
pregnancy NCT03920527 1416 1425 B-Condition

Inclusion NCT03925311 0 9 O
Criteria NCT03925311 10 18 O
: NCT03925311 19 20 O

Age NCT03925311 22 25 B-Age
20 NCT03925311 26 28 B-Eq_Comparison
- NCT03925311 29 30 I-Eq_Comparison
40 NCT03925311 31 33 I-Eq_Comparison
years NCT03925311 34 39 I-Eq_Comparison
. NCT03925311 40 41 O

Exclusion NCT03925311 43 52 O
Criteria NCT03925311 53 61 O
: NCT03925311 62 63 O

- NCT03925311 67 68 O
Uncorrected NCT03925311 70 81 B-Modifier
uterine NCT03925311 82 89 I-Modifier
anomalies NCT03925311 90 99 B-Condition
, NCT03925311 100 101 O
such NCT03925311 102 106 O
as NCT03925311 107 109 O
septate NCT03925311 110 117 B-Modifier
or NCT03925311 118 120 B-Or
bicornuate NCT03925311 121 131 B-Modifier
uterus NCT03925311 132 138 B-Condition
, NCT03925311 139 140 O
fibroids NCT03925311 141 149 B-Condition
( NCT03925311 150 151 O
submucous NCT03925311 152 161 B-Modifier
/ NCT03925311 162 163 B-Or
intramural NCT03925311 164 174 B-Modifier
) NCT03925311 175 176 O
. NCT03925311 177 178 O

- NCT03925311 182 183 O
Intrauterine NCT03925311 185 197 B-Condition
adhesions NCT03925311 198 207 I-Condition
. NCT03925311 208 209 O

- NCT03925311 213 214 O
Adenomyosis NCT03925311 216 227 B-Condition
. NCT03925311 228 229 O

Inclusion NCT03929315 0 9 O
Criteria NCT03929315 10 18 O
: NCT03929315 19 20 O

- NCT03929315 24 25 O
Pediatric NCT03929315 27 36 O
residents NCT03929315 37 46 O
and NCT03929315 47 50 O
fellows NCT03929315 51 58 O
from NCT03929315 59 63 O
the NCT03929315 64 67 O
Hospital NCT03929315 68 76 O
for NCT03929315 77 80 O
Sick NCT03929315 81 85 O
Children NCT03929315 86 94 O
, NCT03929315 95 96 O
Toronto NCT03929315 97 104 O

Exclusion NCT03929315 105 114 O
Criteria NCT03929315 115 123 O
: NCT03929315 124 125 O

- NCT03929315 129 130 O
Refusal NCT03929315 132 139 O
to NCT03929315 140 142 O
participate NCT03929315 143 154 O
in NCT03929315 155 157 O
study NCT03929315 158 163 O

- NCT03929315 166 167 O
Previous NCT03929315 169 177 B-Eq_Comparison
experience NCT03929315 178 188 O
with NCT03929315 189 193 O
at NCT03929315 194 196 O
most NCT03929315 197 201 O
two NCT03929315 202 205 O
OLV NCT03929315 206 209 O
in NCT03929315 210 212 O
children NCT03929315 213 221 O

- NCT03929315 224 225 O
Previous NCT03929315 227 235 B-Eq_Comparison
experience NCT03929315 236 246 O
with NCT03929315 247 251 O
at NCT03929315 252 254 O
most NCT03929315 255 259 O
two NCT03929315 260 263 O
OLV NCT03929315 264 267 O
in NCT03929315 268 270 O
manikins NCT03929315 271 279 O

Inclusion NCT03865407 0 9 O
Criteria NCT03865407 10 18 O
: NCT03865407 19 20 O

- NCT03865407 24 25 O
Chronic NCT03865407 27 34 O
Kidney NCT03865407 35 41 B-Condition
Disease NCT03865407 42 49 I-Condition
stage NCT03865407 50 55 B-Eq_Comparison
1 NCT03865407 56 57 I-Eq_Comparison
- NCT03865407 58 59 I-Eq_Comparison
5 NCT03865407 60 61 I-Eq_Comparison

- NCT03865407 65 66 O
Hyperuricemic NCT03865407 68 81 B-Condition
( NCT03865407 82 83 O
UA NCT03865407 84 86 B-Observation
> NCT03865407 87 88 B-Eq_Comparison
= NCT03865407 89 90 I-Eq_Comparison
5.5 NCT03865407 91 94 I-Eq_Comparison
mg NCT03865407 95 97 I-Eq_Comparison
/ NCT03865407 98 99 I-Eq_Comparison
dL NCT03865407 100 102 I-Eq_Comparison
) NCT03865407 103 104 O

Exclusion NCT03865407 106 115 O
Criteria NCT03865407 116 124 O
: NCT03865407 125 126 O

- NCT03865407 130 131 O
Contraindication NCT03865407 133 149 B-Contraindication
to NCT03865407 150 152 O
Allopurinol NCT03865407 153 164 B-Drug

- NCT03865407 167 168 O
Elevated NCT03865407 170 178 O
baseline NCT03865407 179 187 O
liver NCT03865407 188 193 B-Observation
function NCT03865407 194 202 I-Observation
tests NCT03865407 203 208 I-Observation

- NCT03865407 211 212 O
Receiving NCT03865407 214 223 B-Eq_Comparison
acute NCT03865407 224 229 O
or NCT03865407 230 232 B-Or
chronic NCT03865407 233 240 O
dialysis NCT03865407 241 249 B-Procedure

- NCT03865407 252 253 O
Primary NCT03865407 255 262 B-Modifier
metabolic NCT03865407 263 272 B-Condition
disorder NCT03865407 273 281 I-Condition

- NCT03865407 284 285 O
Sickle NCT03865407 287 293 B-Condition
cell NCT03865407 294 298 I-Condition
disease NCT03865407 299 306 I-Condition

- NCT03865407 309 310 O
Autosomal NCT03865407 312 321 B-Modifier
Dominant NCT03865407 322 330 I-Modifier
Polycystic NCT03865407 331 341 B-Condition
Kidney NCT03865407 342 348 I-Condition
Disease NCT03865407 349 356 I-Condition

- NCT03865407 359 360 O
Cystinosis NCT03865407 362 372 B-Condition

- NCT03865407 375 376 O
Bartter NCT03865407 378 385 B-Modifier
or NCT03865407 386 388 B-Or
Gitelman NCT03865407 389 397 B-Modifier
Disease NCT03865407 398 405 B-Condition

- NCT03865407 408 409 O
Pregnant NCT03865407 411 419 B-Condition
or NCT03865407 420 422 B-Or
nursing NCT03865407 423 430 B-Condition

Inclusion NCT03924180 0 9 O
Criteria NCT03924180 10 18 O
: NCT03924180 19 20 O

- NCT03924180 24 25 O
Phenylketonuric NCT03924180 27 42 B-Condition
patient NCT03924180 43 50 O
diagnosed NCT03924180 51 60 O
in NCT03924180 61 63 O
neonatal NCT03924180 64 72 B-Procedure
screening NCT03924180 73 82 I-Procedure

- NCT03924180 85 86 O
Patient NCT03924180 88 95 O
with NCT03924180 96 100 O
Phenylalaninemia NCT03924180 101 117 B-Observation
≥ NCT03924180 118 119 B-Eq_Comparison
900 NCT03924180 120 123 I-Eq_Comparison
μmol NCT03924180 124 128 I-Eq_Comparison
/ NCT03924180 129 130 I-Eq_Comparison
L NCT03924180 131 132 I-Eq_Comparison
on NCT03924180 133 135 O
blotter NCT03924180 136 143 O
made NCT03924180 144 148 O
during NCT03924180 149 155 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03924180 156 159 O
screening NCT03924180 160 169 B-Study
period NCT03924180 170 176 O
( NCT03924180 177 178 O
or NCT03924180 179 181 B-Or
average NCT03924180 182 189 O
blotting NCT03924180 190 198 B-Observation
results NCT03924180 199 206 I-Observation
≥ NCT03924180 207 208 B-Eq_Comparison
900 NCT03924180 209 212 I-Eq_Comparison
μmol NCT03924180 213 217 I-Eq_Comparison
/ NCT03924180 218 219 I-Eq_Comparison
L NCT03924180 220 221 I-Eq_Comparison
if NCT03924180 222 224 O
several NCT03924180 225 232 B-Eq_Comparison
blots NCT03924180 233 238 B-Observation
made NCT03924180 239 243 O
during NCT03924180 244 250 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03924180 251 254 O
screening NCT03924180 255 264 B-Study
period NCT03924180 265 271 O
) NCT03924180 272 273 O

- NCT03924180 277 278 O
Untreated NCT03924180 280 289 B-Negation|B-Procedure
patient NCT03924180 290 297 O
: NCT03924180 298 299 O
not NCT03924180 300 303 B-Negation
taking NCT03924180 304 310 B-Eq_Comparison
any NCT03924180 311 314 O
amino NCT03924180 315 320 B-Drug
acid NCT03924180 321 325 I-Drug
supplement NCT03924180 326 336 I-Drug
for NCT03924180 337 340 O
his NCT03924180 341 344 O
PKU NCT03924180 345 348 B-Condition
, NCT03924180 349 350 O
regardless NCT03924180 351 361 O
of NCT03924180 362 364 O
diet NCT03924180 365 369 O

Exclusion NCT03924180 370 379 O
Criteria NCT03924180 380 388 O
: NCT03924180 389 390 O

- NCT03924180 394 395 O
Protected NCT03924180 397 406 O
patient NCT03924180 407 414 O
: NCT03924180 415 416 O
court NCT03924180 417 422 B-Condition
bail NCT03924180 423 427 I-Condition
, NCT03924180 428 429 O
curatorship NCT03924180 430 441 B-Condition
, NCT03924180 442 443 O
guardianship NCT03924180 444 456 B-Condition

- NCT03924180 459 460 O
Patient NCT03924180 462 469 O
with NCT03924180 470 474 O
concomitant NCT03924180 475 486 B-Condition
diseases NCT03924180 487 495 I-Condition
/ NCT03924180 496 497 B-Or
conditions NCT03924180 498 508 B-Condition
that NCT03924180 509 513 O
may NCT03924180 514 517 B-Assertion___Assertion_Type_Value:possible
compromise NCT03924180 518 528 O
the NCT03924180 529 532 O
study NCT03924180 533 538 B-Study
, NCT03924180 539 540 O
at NCT03924180 541 543 O
the NCT03924180 544 547 O
discretion NCT03924180 548 558 O
of NCT03924180 559 561 O
the NCT03924180 562 565 O
investigator NCT03924180 566 578 O

- NCT03924180 581 582 O
Participated NCT03924180 584 596 O
in NCT03924180 597 599 O
a NCT03924180 600 601 O
clinical NCT03924180 602 610 B-Study
trial NCT03924180 611 616 I-Study
or NCT03924180 617 619 B-Or
trial NCT03924180 620 625 B-Study
to NCT03924180 626 628 O
evaluate NCT03924180 629 637 O
PKU NCT03924180 638 641 B-Condition
foods NCT03924180 642 647 O
or NCT03924180 648 650 B-Or
treatments NCT03924180 651 661 B-Procedure
in NCT03924180 662 664 O
the NCT03924180 665 668 O
last NCT03924180 669 673 B-Eq_Comparison
7 NCT03924180 674 675 I-Eq_Comparison
days NCT03924180 676 680 I-Eq_Comparison
prior NCT03924180 681 686 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924180 687 689 O
inclusion NCT03924180 690 699 B-Study
or NCT03924180 700 702 B-Or
planned NCT03924180 703 710 B-Eq_Comparison
during NCT03924180 711 717 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03924180 718 721 O
next NCT03924180 722 726 B-Eq_Comparison
6 NCT03924180 727 728 I-Eq_Comparison
months NCT03924180 729 735 I-Eq_Comparison

- NCT03924180 738 739 O
Participation NCT03924180 741 754 O
in NCT03924180 755 757 O
an NCT03924180 758 760 O
interventional NCT03924180 761 775 O
study NCT03924180 776 781 B-Study
with NCT03924180 782 786 O
health NCT03924180 787 793 B-Drug
products NCT03924180 794 802 I-Drug
during NCT03924180 803 809 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03924180 810 813 O
next NCT03924180 814 818 B-Eq_Comparison
6 NCT03924180 819 820 I-Eq_Comparison
months NCT03924180 821 827 I-Eq_Comparison

- NCT03924180 830 831 O
Pregnancy NCT03924180 833 842 B-Condition
project NCT03924180 843 850 O
within NCT03924180 851 857 B-Eq_Comparison
6 NCT03924180 858 859 I-Eq_Comparison
months NCT03924180 860 866 I-Eq_Comparison
, NCT03924180 867 868 O
pre NCT03924180 869 872 B-Condition
- NCT03924180 873 874 I-Condition
conception NCT03924180 875 885 I-Condition
diet NCT03924180 886 890 I-Condition
, NCT03924180 891 892 O
pregnancy NCT03924180 893 902 B-Condition
or NCT03924180 903 905 B-Or
breastfeeding NCT03924180 906 919 B-Condition

- NCT03924180 922 923 O
Refusal NCT03924180 925 932 O
to NCT03924180 933 935 O
consume NCT03924180 936 943 O
only NCT03924180 944 948 O
validated NCT03924180 949 958 O
complements NCT03924180 959 970 O
for NCT03924180 971 974 O
the NCT03924180 975 978 O
protocol NCT03924180 979 987 O

- NCT03924180 990 991 O
Phenylketonuria NCT03924180 993 1008 B-Condition
undergoing NCT03924180 1009 1019 B-Eq_Comparison
treatment NCT03924180 1020 1029 B-Procedure
with NCT03924180 1030 1034 O
BH NCT03924180 1035 1037 B-Drug
4 NCT03924180 1038 1039 I-Drug

- NCT03924180 1042 1043 O
Allergy NCT03924180 1045 1052 B-Allergy
to NCT03924180 1053 1055 O
the NCT03924180 1056 1059 O
product NCT03924180 1060 1067 B-Drug
under NCT03924180 1068 1073 O
study NCT03924180 1074 1079 B-Study

Inclusion NCT03864861 0 9 O
Criteria NCT03864861 10 18 O
: NCT03864861 19 20 O

- NCT03864861 24 25 O
All NCT03864861 27 30 O
adult NCT03864861 31 36 O
patients NCT03864861 37 45 O
( NCT03864861 46 47 O
aged NCT03864861 48 52 B-Age
≥ NCT03864861 53 54 B-Eq_Comparison
18 NCT03864861 55 57 I-Eq_Comparison
years NCT03864861 58 63 I-Eq_Comparison
) NCT03864861 64 65 O
undergoing NCT03864861 66 76 B-Eq_Comparison
elective NCT03864861 77 85 B-Modifier
bariatric NCT03864861 86 95 B-Procedure
surgery NCT03864861 96 103 I-Procedure
and NCT03864861 104 107 O
by NCT03864861 108 110 O
any NCT03864861 111 114 O
approach NCT03864861 115 123 O
( NCT03864861 124 125 O
Includes NCT03864861 126 134 O
surgery NCT03864861 135 142 B-Procedure
with NCT03864861 143 147 O
laparoscopic NCT03864861 148 160 B-Procedure
, NCT03864861 161 162 O
assisted NCT03864861 163 171 B-Modifier
laparoscopic NCT03864861 172 184 B-Procedure
approach NCT03864861 185 193 I-Procedure
or NCT03864861 194 196 B-Or
open NCT03864861 197 201 B-Procedure
approach NCT03864861 202 210 I-Procedure
) NCT03864861 211 212 O
in NCT03864861 213 215 O
a NCT03864861 216 217 O
participating NCT03864861 218 231 O
hospital NCT03864861 232 240 O
during NCT03864861 241 247 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864861 248 251 O
30 NCT03864861 252 254 B-Eq_Comparison
- NCT03864861 255 256 I-Eq_Comparison
day NCT03864861 257 260 I-Eq_Comparison
cohort NCT03864861 261 267 B-Study
period NCT03864861 268 274 O
with NCT03864861 275 279 B-And
a NCT03864861 280 281 O
planned NCT03864861 282 289 B-Eq_Comparison
overnight NCT03864861 290 299 B-Encounter
stay NCT03864861 300 304 I-Encounter
. NCT03864861 305 306 O

Exclusion NCT03864861 308 317 O
Criteria NCT03864861 318 326 O
: NCT03864861 327 328 O

- NCT03864861 332 333 O
Patients NCT03864861 335 343 O
undergoing NCT03864861 344 354 B-Eq_Comparison
emergency NCT03864861 355 364 B-Modifier
surgery NCT03864861 365 372 B-Procedure

- NCT03864861 380 381 O
Endoscopic NCT03864861 383 393 B-Procedure
procedures NCT03864861 394 404 I-Procedure

- NCT03864861 412 413 O
Patients NCT03864861 415 423 O
under NCT03864861 424 429 B-Eq_Comparison
18 NCT03864861 430 432 I-Eq_Comparison
years NCT03864861 433 438 I-Eq_Comparison
of NCT03864861 439 441 O
age NCT03864861 442 445 B-Age

- NCT03864861 453 454 O
Patients NCT03864861 456 464 O
with NCT03864861 465 469 O
previous NCT03864861 470 478 B-Eq_Comparison
bariatric NCT03864861 479 488 B-Procedure
surgery NCT03864861 489 496 I-Procedure
who NCT03864861 497 500 B-And
undergo NCT03864861 501 508 O
revision NCT03864861 509 517 B-Procedure
surgery NCT03864861 518 525 I-Procedure

- NCT03864861 533 534 O
Patients NCT03864861 536 544 O
who NCT03864861 545 548 O
refuse NCT03864861 549 555 O
to NCT03864861 556 558 O
participate NCT03864861 559 570 O

Inclusion NCT03920540 0 9 O
Criteria NCT03920540 10 18 O
: NCT03920540 19 20 O

- NCT03920540 24 25 O
Patients NCT03920540 27 35 O
diagnosed NCT03920540 36 45 O
with NCT03920540 46 50 O
Hunter NCT03920540 51 57 B-Condition
syndrome NCT03920540 58 66 I-Condition

- NCT03920540 69 70 O
Male NCT03920540 72 76 O
at NCT03920540 77 79 B-And
the NCT03920540 80 83 O
age NCT03920540 84 87 B-Age
of NCT03920540 88 90 O
≥ NCT03920540 91 92 B-Eq_Comparison
5 NCT03920540 93 94 I-Eq_Comparison

- NCT03920540 98 99 O
Adequate NCT03920540 101 109 O
abilities NCT03920540 110 119 O
( NCT03920540 120 121 O
including NCT03920540 122 131 O
6 NCT03920540 132 133 B-Observation
- NCT03920540 134 135 I-Observation
MWT NCT03920540 136 139 I-Observation
) NCT03920540 140 141 O
to NCT03920540 142 144 O
participate NCT03920540 145 156 O
in NCT03920540 157 159 O
this NCT03920540 160 164 O
study NCT03920540 165 170 O
in NCT03920540 171 173 O
the NCT03920540 174 177 O
opinion NCT03920540 178 185 O
of NCT03920540 186 188 O
the NCT03920540 189 192 O
investigator NCT03920540 193 205 O
. NCT03920540 206 207 O

- NCT03920540 211 212 O
Voluntarily NCT03920540 214 225 O
signed NCT03920540 226 232 O
written NCT03920540 233 240 O
informed NCT03920540 241 249 O
consent NCT03920540 250 257 O
to NCT03920540 258 260 O
participation NCT03920540 261 274 O
in NCT03920540 275 277 O
this NCT03920540 278 282 O
study NCT03920540 283 288 O

- NCT03920540 291 292 O
Consent NCT03920540 294 301 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03920540 302 304 I-Assertion___Assertion_Type_Value:hypothetical
contraception NCT03920540 305 318 B-Procedure

Exclusion NCT03920540 319 328 O
Criteria NCT03920540 329 337 O
: NCT03920540 338 339 O

- NCT03920540 343 344 O
Prior NCT03920540 346 351 B-Eq_Comparison
treatment NCT03920540 352 361 B-Procedure
with NCT03920540 362 366 O
iduronate NCT03920540 367 376 B-Drug
- NCT03920540 377 378 I-Drug
2 NCT03920540 379 380 I-Drug
- NCT03920540 381 382 I-Drug
sulfatase NCT03920540 383 392 I-Drug
ERT NCT03920540 393 396 I-Drug

- NCT03920540 399 400 O
History NCT03920540 402 409 B-Eq_Comparison
of NCT03920540 410 412 O
bronchotomy NCT03920540 413 424 B-Procedure
, NCT03920540 425 426 O
bone NCT03920540 427 431 B-Procedure
marrow NCT03920540 432 438 I-Procedure
trasplanation NCT03920540 439 452 I-Procedure
, NCT03920540 453 454 O
or NCT03920540 455 457 B-Or
cord NCT03920540 458 462 B-Procedure
blood NCT03920540 463 468 I-Procedure
transplanation NCT03920540 469 483 I-Procedure
. NCT03920540 484 485 O

- NCT03920540 489 490 O
Known NCT03920540 492 497 O
hypersensitivity NCT03920540 498 514 B-Condition
reactions NCT03920540 515 524 O
to NCT03920540 525 527 O
any NCT03920540 528 531 O
of NCT03920540 532 534 O
the NCT03920540 535 538 O
components NCT03920540 539 549 O
of NCT03920540 550 552 O
the NCT03920540 553 556 O
invetigational NCT03920540 557 571 B-Study
product NCT03920540 572 579 B-Drug

- NCT03920540 582 583 O
Prior NCT03920540 585 590 B-Eq_Comparison
or NCT03920540 591 593 B-Or
planned NCT03920540 594 601 B-Eq_Comparison
administration NCT03920540 602 616 O
of NCT03920540 617 619 O
other NCT03920540 620 625 O
investigational NCT03920540 626 641 B-Study
products NCT03920540 642 650 B-Drug
within NCT03920540 651 657 B-Eq_Comparison
30 NCT03920540 658 660 I-Eq_Comparison
days NCT03920540 661 665 I-Eq_Comparison
before NCT03920540 666 672 B-Temporal_Connection___Temporal_Connection_Type_Value:before
treatment NCT03920540 673 682 B-Procedure
with NCT03920540 683 687 O
the NCT03920540 688 691 O
investigational NCT03920540 692 707 B-Study
product NCT03920540 708 715 B-Drug
in NCT03920540 716 718 O
this NCT03920540 719 723 O
study NCT03920540 724 729 O
or NCT03920540 730 732 O
duirng NCT03920540 733 739 B-Temporal_Connection___Temporal_Connection_Type_Value:during
this NCT03920540 740 744 O
study NCT03920540 745 750 B-Study
. NCT03920540 751 752 O

- NCT03920540 756 757 O
Unable NCT03920540 759 765 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03920540 766 768 O
perform NCT03920540 769 776 O
6 NCT03920540 777 778 B-Observation
- NCT03920540 779 780 I-Observation
MWT NCT03920540 781 784 I-Observation
. NCT03920540 785 786 O

- NCT03920540 790 791 O
Female NCT03920540 793 799 O

Inclusion NCT03925285 0 9 O
Criteria NCT03925285 10 18 O
: NCT03925285 19 20 O

- NCT03925285 24 25 O
Biopsy NCT03925285 27 33 B-Procedure
confirmed NCT03925285 34 43 O
diagnosis NCT03925285 44 53 O
of NCT03925285 54 56 O
SNIP NCT03925285 57 61 B-Condition
and NCT03925285 62 65 B-And
scheduled NCT03925285 66 75 B-Eq_Comparison
to NCT03925285 76 78 O
undergo NCT03925285 79 86 O
surgical NCT03925285 87 95 B-Procedure
resection NCT03925285 96 105 I-Procedure
; NCT03925285 105 106 O

- NCT03925285 109 110 O
Age NCT03925285 112 115 B-Age
≥ NCT03925285 116 117 B-Eq_Comparison
18 NCT03925285 118 120 I-Eq_Comparison
years NCT03925285 121 126 I-Eq_Comparison
; NCT03925285 126 127 O

- NCT03925285 130 131 O
Written NCT03925285 133 140 O
informed NCT03925285 141 149 O
consent NCT03925285 150 157 O
; NCT03925285 157 158 O

- NCT03925285 161 162 O
Mentally NCT03925285 164 172 B-Condition
competent NCT03925285 173 182 I-Condition
person NCT03925285 183 189 O
that NCT03925285 190 194 O
is NCT03925285 195 197 O
able NCT03925285 198 202 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03925285 203 206 I-Assertion___Assertion_Type_Value:hypothetical
willing NCT03925285 207 214 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03925285 215 217 O
comply NCT03925285 218 224 O
with NCT03925285 225 229 O
study NCT03925285 230 235 B-Study
procedures NCT03925285 236 246 B-Procedure
. NCT03925285 247 248 O

Exclusion NCT03925285 250 259 O
Criteria NCT03925285 260 268 O
: NCT03925285 269 270 O

- NCT03925285 274 275 O
Medical NCT03925285 277 284 B-Modifier
or NCT03925285 285 287 B-Or
psychiatric NCT03925285 288 299 B-Modifier
conditions NCT03925285 300 310 B-Condition
that NCT03925285 311 315 O
compromise NCT03925285 316 326 O
the NCT03925285 327 330 O
patient NCT03925285 331 338 O
's NCT03925285 338 340 O
ability NCT03925285 341 348 O
to NCT03925285 349 351 O
give NCT03925285 352 356 O
informed NCT03925285 357 365 O
consent NCT03925285 366 373 O
; NCT03925285 373 374 O

- NCT03925285 377 378 O
Concurrent NCT03925285 380 390 B-Modifier
uncontrolled NCT03925285 391 403 I-Modifier
medical NCT03925285 404 411 B-Condition
conditions NCT03925285 412 422 I-Condition
; NCT03925285 422 423 O

- NCT03925285 426 427 O
Received NCT03925285 429 437 B-Eq_Comparison
an NCT03925285 438 440 O
investigational NCT03925285 441 456 B-Study
drug NCT03925285 457 461 B-Drug
within NCT03925285 462 468 B-Eq_Comparison
30 NCT03925285 469 471 I-Eq_Comparison
days NCT03925285 472 476 I-Eq_Comparison
prior NCT03925285 477 482 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03925285 483 485 O
the NCT03925285 486 489 O
dose NCT03925285 490 494 O
of NCT03925285 495 497 O
bevacizumab NCT03925285 498 509 B-Drug
- NCT03925285 510 511 I-Drug
IRDye NCT03925285 512 517 I-Drug
800 NCT03925285 518 521 I-Drug
CW NCT03925285 522 524 I-Drug
; NCT03925285 524 525 O

- NCT03925285 528 529 O
Tumors NCT03925285 531 537 B-Condition
at NCT03925285 538 540 O
sites NCT03925285 541 546 B-Modifier
of NCT03925285 547 549 O
which NCT03925285 550 555 O
the NCT03925285 556 559 O
surgeon NCT03925285 560 567 O
would NCT03925285 568 573 O
assess NCT03925285 574 580 O
that NCT03925285 581 585 O
in NCT03925285 586 588 B-Procedure
vivo NCT03925285 589 593 I-Procedure
imaging NCT03925285 594 601 I-Procedure
would NCT03925285 602 607 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03925285 608 611 B-Negation
be NCT03925285 612 614 O
feasible NCT03925285 615 623 O
; NCT03925285 623 624 O

- NCT03925285 627 628 O
History NCT03925285 630 637 B-Eq_Comparison
of NCT03925285 638 640 O
myocardial NCT03925285 641 651 B-Condition
infarction NCT03925285 652 662 I-Condition
, NCT03925285 663 664 O
cerebrovascular NCT03925285 665 680 B-Condition
accident NCT03925285 681 689 I-Condition
, NCT03925285 690 691 O
uncontrolled NCT03925285 692 704 B-Modifier
cardiac NCT03925285 705 712 I-Modifier
heart NCT03925285 713 718 B-Condition
failure NCT03925285 719 726 I-Condition
, NCT03925285 727 728 O
significant NCT03925285 729 740 O
liver NCT03925285 741 746 B-Condition
disease NCT03925285 747 754 I-Condition
or NCT03925285 755 757 B-Or
unstable NCT03925285 758 766 B-Condition
angina NCT03925285 767 773 I-Condition
within NCT03925285 774 780 B-Eq_Comparison
6 NCT03925285 781 782 I-Eq_Comparison
months NCT03925285 783 789 I-Eq_Comparison
prior NCT03925285 790 795 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03925285 796 798 O
enrollment NCT03925285 799 809 B-Study
; NCT03925285 809 810 O

- NCT03925285 813 814 O
Inadequately NCT03925285 816 828 B-Modifier
controlled NCT03925285 829 839 I-Modifier
hypertension NCT03925285 840 852 B-Condition
with NCT03925285 853 857 O
or NCT03925285 858 860 O
without NCT03925285 861 868 O
current NCT03925285 869 876 B-Eq_Comparison
antihypertensive NCT03925285 877 893 B-Drug
medications NCT03925285 894 905 I-Drug
; NCT03925285 905 906 O

- NCT03925285 909 910 O
History NCT03925285 912 919 B-Eq_Comparison
of NCT03925285 920 922 O
infusion NCT03925285 923 931 B-Modifier
reactions NCT03925285 932 941 B-Condition
to NCT03925285 942 944 O
bevacizumab NCT03925285 945 956 B-Drug
or NCT03925285 957 959 B-Or
other NCT03925285 960 965 B-Other
monoclonal NCT03925285 966 976 B-Procedure
antibody NCT03925285 977 985 I-Procedure
therapies NCT03925285 986 995 I-Procedure
; NCT03925285 995 996 O

- NCT03925285 999 1000 O
Pregnant NCT03925285 1002 1010 B-Condition
or NCT03925285 1011 1013 B-Or
lactating NCT03925285 1014 1023 B-Condition
women NCT03925285 1024 1029 O
. NCT03925285 1030 1031 O
Documentation NCT03925285 1033 1046 O
of NCT03925285 1047 1049 O
a NCT03925285 1050 1051 O
negative NCT03925285 1052 1060 O
pregnancy NCT03925285 1061 1070 B-Observation
test NCT03925285 1071 1075 I-Observation
must NCT03925285 1076 1080 O
be NCT03925285 1081 1083 O
available NCT03925285 1084 1093 O
for NCT03925285 1094 1097 O
women NCT03925285 1098 1103 O
of NCT03925285 1104 1106 O
childbearing NCT03925285 1107 1119 B-Condition
potential NCT03925285 1120 1129 I-Condition
. NCT03925285 1130 1131 O
Woman NCT03925285 1133 1138 O
of NCT03925285 1139 1141 O
childbearing NCT03925285 1142 1154 B-Condition
potential NCT03925285 1155 1164 I-Condition
are NCT03925285 1165 1168 B-And
premenopausal NCT03925285 1169 1182 B-Condition
women NCT03925285 1183 1188 O
with NCT03925285 1189 1193 B-And
intact NCT03925285 1194 1200 B-Condition
reproductive NCT03925285 1201 1213 I-Condition
organs NCT03925285 1214 1220 I-Condition
and NCT03925285 1221 1224 B-And
women NCT03925285 1225 1230 O
less NCT03925285 1231 1235 B-Eq_Comparison
than NCT03925285 1236 1240 I-Eq_Comparison
two NCT03925285 1241 1244 I-Eq_Comparison
years NCT03925285 1245 1250 I-Eq_Comparison
after NCT03925285 1251 1256 B-Temporal_Connection___Temporal_Connection_Type_Value:after
menopause NCT03925285 1257 1266 B-Condition
; NCT03925285 1266 1267 O

- NCT03925285 1270 1271 O
Lab NCT03925285 1273 1276 B-Observation
values NCT03925285 1277 1283 I-Observation
that NCT03925285 1284 1288 O
in NCT03925285 1289 1291 O
the NCT03925285 1292 1295 O
opinion NCT03925285 1296 1303 O
of NCT03925285 1304 1306 O
the NCT03925285 1307 1310 O
primary NCT03925285 1311 1318 O
surgeon NCT03925285 1319 1326 O
would NCT03925285 1327 1332 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03925285 1333 1340 B-Negation
surgical NCT03925285 1341 1349 B-Procedure
resection NCT03925285 1350 1359 I-Procedure
; NCT03925285 1359 1360 O

- NCT03925285 1363 1364 O
Life NCT03925285 1366 1370 B-Observation
expectancy NCT03925285 1371 1381 I-Observation
< NCT03925285 1382 1383 B-Eq_Comparison
12 NCT03925285 1384 1386 I-Eq_Comparison
weeks NCT03925285 1387 1392 I-Eq_Comparison
; NCT03925285 1392 1393 O

Inclusion NCT03924609 0 9 O
Criteria NCT03924609 10 18 O
: NCT03924609 19 20 O

A NCT03924609 22 23 O
. NCT03924609 24 25 O
Histologically NCT03924609 27 41 B-Procedure
proven NCT03924609 42 48 O
breast NCT03924609 49 55 B-Modifier
cancer NCT03924609 56 62 B-Condition
confirmed NCT03924609 63 72 O
by NCT03924609 73 75 O
biopsy NCT03924609 76 82 B-Procedure
or NCT03924609 83 85 B-Or
pathological NCT03924609 86 98 B-Procedure
examination NCT03924609 99 110 I-Procedure
of NCT03924609 111 113 O
the NCT03924609 114 117 O
resected NCT03924609 118 126 B-Modifier
tumor NCT03924609 127 132 B-Condition
. NCT03924609 133 134 O

B NCT03924609 136 137 O
. NCT03924609 138 139 O
Histologically NCT03924609 141 155 B-Procedure
confirmed NCT03924609 156 165 O
breast NCT03924609 166 172 B-Modifier
cancer NCT03924609 173 179 B-Condition
patients NCT03924609 180 188 O
, NCT03924609 189 190 O
fulfilling NCT03924609 191 201 O
any NCT03924609 202 205 O
of NCT03924609 206 208 O
the NCT03924609 209 212 B-Criteria_Count
following NCT03924609 213 222 I-Criteria_Count
: NCT03924609 223 224 O

1 NCT03924609 228 229 O
. NCT03924609 229 230 O
Multiple NCT03924609 232 240 B-Eq_Comparison
bone NCT03924609 241 245 B-Modifier
metastases NCT03924609 246 256 B-Condition
indicated NCT03924609 257 266 O
by NCT03924609 267 269 O
bone NCT03924609 270 274 B-Procedure
scan NCT03924609 275 279 I-Procedure

2 NCT03924609 282 283 O
. NCT03924609 283 284 O
Bone NCT03924609 286 290 B-Procedure
scan NCT03924609 291 295 I-Procedure
positive NCT03924609 296 304 O
, NCT03924609 305 306 O
and NCT03924609 307 310 B-And
proven NCT03924609 311 317 O
by NCT03924609 318 320 O
other NCT03924609 321 326 B-Other
imaging NCT03924609 327 334 B-Procedure
examinations NCT03924609 335 347 I-Procedure
, NCT03924609 348 349 O
including NCT03924609 350 359 O
computed NCT03924609 360 368 B-Procedure
tomography NCT03924609 369 379 I-Procedure
( NCT03924609 380 381 O
CT NCT03924609 382 384 B-Procedure
) NCT03924609 385 386 O
, NCT03924609 387 388 O
magnetic NCT03924609 389 397 B-Procedure
resonance NCT03924609 398 407 I-Procedure
imaging NCT03924609 408 415 I-Procedure
( NCT03924609 416 417 O
MRI NCT03924609 418 421 B-Procedure
) NCT03924609 422 423 O
and NCT03924609 424 427 B-Or
X NCT03924609 428 429 B-Procedure
- NCT03924609 430 431 I-Procedure
ray NCT03924609 432 435 I-Procedure
. NCT03924609 436 437 O

3 NCT03924609 441 442 O
. NCT03924609 442 443 O
Bone NCT03924609 445 449 B-Procedure
scan NCT03924609 450 454 I-Procedure
positive NCT03924609 455 463 O
, NCT03924609 464 465 O
with NCT03924609 466 470 B-And
clinical NCT03924609 471 479 O
symptoms NCT03924609 480 488 B-Condition
, NCT03924609 489 490 O
including NCT03924609 491 500 O
bone NCT03924609 501 505 B-Modifier
pain NCT03924609 506 510 B-Condition
, NCT03924609 511 512 O
pathologic NCT03924609 513 523 B-Condition
fracture NCT03924609 524 532 I-Condition
, NCT03924609 533 534 O
spinal NCT03924609 535 541 B-Condition
cord NCT03924609 542 546 I-Condition
compression NCT03924609 547 558 I-Condition
and NCT03924609 559 562 O
so NCT03924609 563 565 O
on NCT03924609 566 568 O
. NCT03924609 569 570 O

4 NCT03924609 574 575 O
. NCT03924609 575 576 O
Bone NCT03924609 578 582 B-Modifier
metastases NCT03924609 583 593 B-Condition
indicated NCT03924609 594 603 O
by NCT03924609 604 606 O
PET NCT03924609 607 610 B-Procedure
- NCT03924609 611 612 I-Procedure
CT NCT03924609 613 615 I-Procedure

5 NCT03924609 618 619 O
. NCT03924609 619 620 O
Histologically NCT03924609 622 636 B-Procedure
proven NCT03924609 637 643 O
bone NCT03924609 644 648 B-Modifier
metastases NCT03924609 649 659 B-Condition

Exclusion NCT03924609 660 669 O
Criteria NCT03924609 670 678 O
: NCT03924609 679 680 O

A NCT03924609 682 683 O
. NCT03924609 684 685 O
No NCT03924609 687 689 B-Negation
bone NCT03924609 690 694 B-Modifier
metastases NCT03924609 695 705 B-Condition
confirmed NCT03924609 706 715 O
by NCT03924609 716 718 O
pathological NCT03924609 719 731 B-Procedure
examination NCT03924609 732 743 I-Procedure

B NCT03924609 745 746 O
. NCT03924609 747 748 O
Bone NCT03924609 750 754 B-Modifier
metastases NCT03924609 755 765 B-Condition
secondary NCT03924609 766 775 O
to NCT03924609 776 778 O
other NCT03924609 779 784 B-Other
malignant NCT03924609 785 794 B-Condition
tumor NCT03924609 795 800 I-Condition
other NCT03924609 801 806 B-Exception
than NCT03924609 807 811 I-Exception
breast NCT03924609 812 818 B-Modifier
cancer NCT03924609 819 825 B-Condition

C NCT03924609 827 828 O
. NCT03924609 829 830 O
Secondary NCT03924609 832 841 B-Modifier
primary NCT03924609 842 849 I-Modifier
tumor NCT03924609 850 855 B-Condition


Inclusion NCT03863431 0 9 O
Criteria NCT03863431 10 18 O
: NCT03863431 19 20 O

- NCT03863431 24 25 O
18 NCT03863431 27 29 B-Eq_Comparison
- NCT03863431 30 31 I-Eq_Comparison
40 NCT03863431 32 34 I-Eq_Comparison
years NCT03863431 35 40 I-Eq_Comparison

- NCT03863431 43 44 O
BMI NCT03863431 46 49 B-Observation
= NCT03863431 50 51 B-Eq_Comparison
18.5 NCT03863431 52 56 I-Eq_Comparison
- NCT03863431 57 58 I-Eq_Comparison
29.9 NCT03863431 59 63 I-Eq_Comparison
kg NCT03863431 64 66 I-Eq_Comparison
/ NCT03863431 67 68 I-Eq_Comparison
m NCT03863431 69 70 I-Eq_Comparison
2 NCT03863431 71 72 I-Eq_Comparison

- NCT03863431 75 76 O
Male NCT03863431 78 82 O
or NCT03863431 83 85 B-Or
female NCT03863431 86 92 O

- NCT03863431 95 96 O
Physically NCT03863431 98 108 B-Observation
active NCT03863431 109 115 I-Observation
( NCT03863431 116 117 O
> NCT03863431 118 119 B-Eq_Comparison
3 NCT03863431 120 121 I-Eq_Comparison
x NCT03863431 122 123 O
30 NCT03863431 124 126 B-Eq_Comparison
min NCT03863431 127 130 I-Eq_Comparison
moderate NCT03863431 131 139 I-Eq_Comparison
exercise NCT03863431 140 148 I-Eq_Comparison
per NCT03863431 149 152 I-Eq_Comparison
week NCT03863431 153 157 I-Eq_Comparison
) NCT03863431 158 159 O

- NCT03863431 163 164 O
Non NCT03863431 166 169 B-Negation
- NCT03863431 170 171 O
smoker NCT03863431 172 178 B-Condition
( NCT03863431 179 180 O
including NCT03863431 181 190 O
the NCT03863431 191 194 O
use NCT03863431 195 198 O
of NCT03863431 199 201 O
vaporisers NCT03863431 202 212 B-Drug
and NCT03863431 213 216 B-Or
e NCT03863431 217 218 B-Drug
- NCT03863431 219 220 I-Drug
cigarettes NCT03863431 221 231 I-Drug
) NCT03863431 232 233 O

- NCT03863431 237 238 O
Healthy NCT03863431 240 247 B-Condition
( NCT03863431 248 249 O
determined NCT03863431 250 260 O
by NCT03863431 261 263 O
the NCT03863431 264 267 O
School NCT03863431 268 274 B-Observation
's NCT03863431 274 276 I-Observation
standard NCT03863431 277 285 I-Observation
health NCT03863431 286 292 I-Observation
questionnaire NCT03863431 293 306 I-Observation
) NCT03863431 307 308 O

- NCT03863431 312 313 O
No NCT03863431 315 317 B-Negation
cardiometabolic NCT03863431 318 333 B-Modifier
or NCT03863431 334 336 B-Or
inflammatory NCT03863431 337 349 B-Modifier
illness NCT03863431 350 357 B-Condition

Exclusion NCT03863431 358 367 O
Criteria NCT03863431 368 376 O
: NCT03863431 377 378 O

- NCT03863431 382 383 O
Outside NCT03863431 385 392 O
of NCT03863431 393 395 O
age NCT03863431 396 399 O
- NCT03863431 400 401 O
range NCT03863431 402 407 O

- NCT03863431 410 411 O
Outside NCT03863431 413 420 B-Negation
BMI NCT03863431 421 424 B-Observation
range NCT03863431 425 430 B-Eq_Comparison

- NCT03863431 433 434 O
Inactive NCT03863431 436 444 B-Observation
( NCT03863431 445 446 O
< NCT03863431 447 448 B-Eq_Comparison
3 NCT03863431 449 450 I-Eq_Comparison
x NCT03863431 451 452 O
30 NCT03863431 453 455 B-Eq_Comparison
min NCT03863431 456 459 I-Eq_Comparison
moderate NCT03863431 460 468 I-Eq_Comparison
exercise NCT03863431 469 477 I-Eq_Comparison
per NCT03863431 478 481 I-Eq_Comparison
week NCT03863431 482 486 I-Eq_Comparison
) NCT03863431 487 488 O

- NCT03863431 492 493 O
Smoker NCT03863431 495 501 B-Condition

- NCT03863431 504 505 O
Taking NCT03863431 507 513 B-Eq_Comparison
medication NCT03863431 514 524 B-Drug

- NCT03863431 527 528 O
History NCT03863431 530 537 B-Eq_Comparison
of NCT03863431 538 540 O
cardiometabolic NCT03863431 541 556 B-Modifier
or NCT03863431 557 559 B-Or
inflammatory NCT03863431 560 572 B-Modifier
illness NCT03863431 573 580 B-Condition

- NCT03863431 583 584 O
Vegetarian NCT03863431 586 596 B-Condition
/ NCT03863431 597 598 B-Or
vegan NCT03863431 599 604 B-Condition
( NCT03863431 605 606 O
as NCT03863431 607 609 O
the NCT03863431 610 613 O
high NCT03863431 614 618 O
- NCT03863431 619 620 O
fat NCT03863431 621 624 O
diet NCT03863431 625 629 O
is NCT03863431 630 632 O
based NCT03863431 633 638 O
on NCT03863431 639 641 O
animal NCT03863431 642 648 O
fats NCT03863431 649 653 O
) NCT03863431 654 655 O

- NCT03863431 659 660 O
Other NCT03863431 662 667 B-Other
dietary NCT03863431 668 675 B-Condition
restrictions NCT03863431 676 688 I-Condition
which NCT03863431 689 694 O
prevent NCT03863431 695 702 B-Negation
consumption NCT03863431 703 714 O
of NCT03863431 715 717 O
the NCT03863431 718 721 O
experimental NCT03863431 722 734 B-Procedure
diet NCT03863431 735 739 I-Procedure

- NCT03863431 742 743 O
Consumption NCT03863431 745 756 O
of NCT03863431 757 759 O
probiotics NCT03863431 760 770 B-Drug
within NCT03863431 771 777 B-Eq_Comparison
last NCT03863431 778 782 I-Eq_Comparison
3 NCT03863431 783 784 I-Eq_Comparison
months NCT03863431 785 791 I-Eq_Comparison
( NCT03863431 792 793 O
these NCT03863431 794 799 O
influence NCT03863431 800 809 O
the NCT03863431 810 813 O
gut NCT03863431 814 817 O
microbiota NCT03863431 818 828 O
) NCT03863431 829 830 O

- NCT03863431 834 835 O
Participation NCT03863431 837 850 O
in NCT03863431 851 853 O
another NCT03863431 854 861 B-Other
clinical NCT03863431 862 870 B-Study
trial NCT03863431 871 876 I-Study

- NCT03863431 879 880 O
Those NCT03863431 882 887 O
with NCT03863431 888 892 O
known NCT03863431 893 898 B-Modifier
or NCT03863431 899 901 B-Or
suspected NCT03863431 902 911 B-Assertion___Assertion_Type_Value:possible
food NCT03863431 912 916 B-Condition
intolerances NCT03863431 917 929 I-Condition
, NCT03863431 930 931 O
allergies NCT03863431 932 941 B-Allergy
or NCT03863431 942 944 B-Or
hypersensitivity NCT03863431 945 961 B-Condition

- NCT03863431 964 965 O
Women NCT03863431 967 972 O
who NCT03863431 973 976 B-And
are NCT03863431 977 980 O
known NCT03863431 981 986 O
to NCT03863431 987 989 O
be NCT03863431 990 992 O
pregnant NCT03863431 993 1001 B-Condition
or NCT03863431 1002 1004 B-Or
who NCT03863431 1005 1008 O
are NCT03863431 1009 1012 O
intending NCT03863431 1013 1022 B-Assertion___Assertion_Type_Value:intention
to NCT03863431 1023 1025 I-Assertion___Assertion_Type_Value:intention
become NCT03863431 1026 1032 O
pregnant NCT03863431 1033 1041 B-Condition
over NCT03863431 1042 1046 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863431 1047 1050 I-Temporal_Connection___Temporal_Connection_Type_Value:during
course NCT03863431 1051 1057 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03863431 1058 1060 O
the NCT03863431 1061 1064 O
study NCT03863431 1065 1070 B-Study

Inclusion NCT03928873 0 9 O
Criteria NCT03928873 10 18 O
: NCT03928873 19 20 O

1 NCT03928873 24 25 O
. NCT03928873 25 26 O
Older NCT03928873 28 33 B-Eq_Comparison
than NCT03928873 34 38 I-Eq_Comparison
20 NCT03928873 39 41 I-Eq_Comparison
years NCT03928873 42 47 I-Eq_Comparison
of NCT03928873 48 50 O
age NCT03928873 51 54 B-Age

2 NCT03928873 57 58 O
. NCT03928873 58 59 O
Grade NCT03928873 61 66 B-Eq_Comparison
2 NCT03928873 67 68 I-Eq_Comparison
~ NCT03928873 69 70 I-Eq_Comparison
3 NCT03928873 71 72 I-Eq_Comparison
trigger NCT03928873 73 80 B-Condition
finger NCT03928873 81 87 I-Condition
based NCT03928873 88 93 O
on NCT03928873 94 96 O
the NCT03928873 97 100 O
Quinnell NCT03928873 101 109 O
classification NCT03928873 110 124 O

Exclusion NCT03928873 125 134 O
Criteria NCT03928873 135 143 O
: NCT03928873 144 145 O

1 NCT03928873 149 150 O
. NCT03928873 150 151 O
Previous NCT03928873 153 161 B-Eq_Comparison
treatment NCT03928873 162 171 B-Procedure
by NCT03928873 172 174 O
physical NCT03928873 175 183 B-Procedure
therapy NCT03928873 184 191 I-Procedure
, NCT03928873 192 193 O
local NCT03928873 194 199 B-Procedure
corticosteroid NCT03928873 200 214 I-Procedure
injection NCT03928873 215 224 I-Procedure
, NCT03928873 225 226 O
or NCT03928873 227 229 B-Or
surgical NCT03928873 230 238 O
release NCT03928873 239 246 O
for NCT03928873 247 250 O
trigger NCT03928873 251 258 B-Condition
finger NCT03928873 259 265 I-Condition
before NCT03928873 266 272 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03928873 273 276 O
study NCT03928873 277 282 B-Study

2 NCT03928873 285 286 O
. NCT03928873 286 287 O
The NCT03928873 289 292 O
presence NCT03928873 293 301 O
of NCT03928873 302 304 O
a NCT03928873 305 306 O
musculoskeletal NCT03928873 307 322 B-Condition
disease NCT03928873 323 330 I-Condition
or NCT03928873 331 333 B-Or
previous NCT03928873 334 342 B-Eq_Comparison
nerve NCT03928873 343 348 B-Condition
injuries NCT03928873 349 357 I-Condition
at NCT03928873 358 360 O
the NCT03928873 361 364 O
upper NCT03928873 365 370 B-Modifier
extremities NCT03928873 371 382 I-Modifier

3 NCT03928873 385 386 O
. NCT03928873 386 387 O
Multiple NCT03928873 389 397 B-Condition
trigger NCT03928873 398 405 I-Condition
finger NCT03928873 406 412 I-Condition
; NCT03928873 412 413 O
local NCT03928873 414 419 B-Condition
infection NCT03928873 420 429 I-Condition
; NCT03928873 429 430 O
malignancy NCT03928873 431 441 B-Condition
; NCT03928873 441 442 O
inflammatory NCT03928873 443 455 B-Condition
arthritis NCT03928873 456 465 I-Condition
; NCT03928873 465 466 O
cardiac NCT03928873 467 474 B-Condition
arrhythmia NCT03928873 475 485 I-Condition
or NCT03928873 486 488 B-Or
cardiac NCT03928873 489 496 B-Procedure
pacemaker NCT03928873 497 506 I-Procedure
; NCT03928873 506 507 O
and NCT03928873 508 511 B-Or
pregnancy NCT03928873 512 521 B-Condition
. NCT03928873 522 523 O

Inclusion NCT03862469 0 9 O
Criteria NCT03862469 10 18 O
: NCT03862469 19 20 O

- NCT03862469 24 25 O
Female NCT03862469 27 33 O

- NCT03862469 36 37 O
Aged NCT03862469 39 43 B-Age
18 NCT03862469 44 46 B-Eq_Comparison
- NCT03862469 47 48 I-Eq_Comparison
35 NCT03862469 49 51 I-Eq_Comparison
years NCT03862469 52 57 I-Eq_Comparison
, NCT03862469 58 59 O
established NCT03862469 60 71 O
by NCT03862469 72 74 O
visual NCT03862469 75 81 B-Procedure
inspection NCT03862469 82 92 I-Procedure
of NCT03862469 93 95 O
a NCT03862469 96 97 O
government NCT03862469 98 108 O
- NCT03862469 109 110 O
issued NCT03862469 111 117 O
ID NCT03862469 118 120 O

- NCT03862469 123 124 O
Average NCT03862469 126 133 O
menstrual NCT03862469 134 143 B-Observation
cycle NCT03862469 144 149 I-Observation
21 NCT03862469 150 152 B-Eq_Comparison
- NCT03862469 153 154 I-Eq_Comparison
35 NCT03862469 155 157 I-Eq_Comparison
days NCT03862469 158 162 I-Eq_Comparison

- NCT03862469 165 166 O
Access NCT03862469 168 174 O
to NCT03862469 175 177 O
smartphone NCT03862469 178 188 O
with NCT03862469 189 193 O
working NCT03862469 194 201 O
camera NCT03862469 202 208 O
for NCT03862469 209 212 O
daily NCT03862469 213 218 O
use NCT03862469 219 222 O
of NCT03862469 223 225 O
the NCT03862469 226 229 O
PreMom NCT03862469 230 236 O
application NCT03862469 237 248 O

Exclusion NCT03862469 249 258 O
Criteria NCT03862469 259 267 O
: NCT03862469 268 269 O

- NCT03862469 273 274 O
Lifetime NCT03862469 276 284 O
DSM NCT03862469 285 288 B-Condition
- NCT03862469 289 290 I-Condition
5 NCT03862469 291 292 I-Condition
Axis NCT03862469 293 297 I-Condition
1 NCT03862469 298 299 I-Condition
disorder NCT03862469 300 308 I-Condition
( NCT03862469 309 310 O
except NCT03862469 311 317 B-Exception
anxiety NCT03862469 318 325 B-Condition
and NCT03862469 326 329 B-Or
depression NCT03862469 330 340 B-Condition
) NCT03862469 341 342 O
, NCT03862469 343 344 O
as NCT03862469 345 347 O
documented NCT03862469 348 358 O
in NCT03862469 359 361 O
the NCT03862469 362 365 O
Mental NCT03862469 366 372 B-Procedure
Health NCT03862469 373 379 I-Procedure
Interview NCT03862469 380 389 I-Procedure

- NCT03862469 392 393 O
Current NCT03862469 395 402 B-Eq_Comparison
DSM NCT03862469 403 406 B-Condition
- NCT03862469 407 408 I-Condition
5 NCT03862469 409 410 I-Condition
Axis NCT03862469 411 415 I-Condition
depressive NCT03862469 416 426 I-Condition
or NCT03862469 427 429 B-Or
anxiety NCT03862469 430 437 B-Condition
disorder NCT03862469 438 446 I-Condition
, NCT03862469 447 448 O
as NCT03862469 449 451 O
documented NCT03862469 452 462 O
in NCT03862469 463 465 O
the NCT03862469 466 469 O
Mental NCT03862469 470 476 B-Procedure
Health NCT03862469 477 483 I-Procedure
Interview NCT03862469 484 493 I-Procedure

- NCT03862469 496 497 O
Positive NCT03862469 499 507 O
urine NCT03862469 508 513 B-Observation
drug NCT03862469 514 518 I-Observation
screen NCT03862469 519 525 I-Observation
test NCT03862469 526 530 I-Observation

- NCT03862469 533 534 O
Breath NCT03862469 536 542 B-Observation
alcohol NCT03862469 543 550 I-Observation
concentration NCT03862469 551 564 I-Observation
> NCT03862469 565 566 B-Eq_Comparison
0.00 NCT03862469 567 571 I-Eq_Comparison
% NCT03862469 572 573 I-Eq_Comparison

- NCT03862469 577 578 O
Self NCT03862469 580 584 O
- NCT03862469 585 586 O
reported NCT03862469 587 595 O
smoker NCT03862469 596 602 B-Condition
or NCT03862469 603 605 B-Or
carbon NCT03862469 606 612 B-Observation
monoxide NCT03862469 613 621 I-Observation
concentration NCT03862469 622 635 I-Observation
≥ NCT03862469 636 637 B-Eq_Comparison
6 NCT03862469 638 639 I-Eq_Comparison
ppm NCT03862469 640 643 I-Eq_Comparison

- NCT03862469 646 647 O
Irregular NCT03862469 649 658 B-Condition
menstrual NCT03862469 659 668 I-Condition
cycle NCT03862469 669 674 I-Condition

- NCT03862469 677 678 O
Current NCT03862469 680 687 B-Eq_Comparison
pregnancy NCT03862469 688 697 B-Condition
( NCT03862469 698 699 O
urine NCT03862469 700 705 B-Observation
test NCT03862469 706 710 I-Observation
- NCT03862469 711 712 O
verified NCT03862469 713 721 O
) NCT03862469 722 723 O
or NCT03862469 724 726 B-Or
lactation NCT03862469 727 736 B-Condition
, NCT03862469 737 738 O
or NCT03862469 739 741 B-Or
a NCT03862469 742 743 O
plan NCT03862469 744 748 B-Assertion___Assertion_Type_Value:intention
to NCT03862469 749 751 I-Assertion___Assertion_Type_Value:intention
become NCT03862469 752 758 O
pregnant NCT03862469 759 767 B-Condition

- NCT03862469 770 771 O
Moderate NCT03862469 773 781 B-Eq_Comparison
or NCT03862469 782 784 I-Eq_Comparison
high NCT03862469 785 789 I-Eq_Comparison
suicide NCT03862469 790 797 B-Condition
risk NCT03862469 798 802 B-Risk

- NCT03862469 805 806 O
Shipley NCT03862469 808 815 B-Observation
IQ NCT03862469 816 818 I-Observation
( NCT03862469 819 820 O
vocabulary NCT03862469 821 831 B-Observation
standard NCT03862469 832 840 I-Observation
score NCT03862469 841 846 I-Observation
) NCT03862469 847 848 O
> NCT03862469 849 850 B-Eq_Comparison
80 NCT03862469 851 853 I-Eq_Comparison

- NCT03862469 857 858 O
Prescription NCT03862469 860 872 O
medications NCT03862469 873 884 B-Drug

Inclusion NCT03925259 0 9 O
Criteria NCT03925259 10 18 O
: NCT03925259 19 20 O

- NCT03925259 24 25 O
Long NCT03925259 27 31 O
term NCT03925259 32 36 O
physical NCT03925259 37 45 B-Condition
health NCT03925259 46 52 I-Condition
condition NCT03925259 53 62 I-Condition
and NCT03925259 63 66 B-Or
comorbid NCT03925259 67 75 B-Condition
mental NCT03925259 76 82 I-Condition
health NCT03925259 83 89 I-Condition
problem NCT03925259 90 97 I-Condition

- NCT03925259 100 101 O
Age NCT03925259 103 106 B-Age
16 NCT03925259 107 109 B-Eq_Comparison
+ NCT03925259 110 111 I-Eq_Comparison

- NCT03925259 115 116 O
Referred NCT03925259 118 126 B-Encounter
to NCT03925259 127 129 O
a NCT03925259 130 131 O
psychological NCT03925259 132 145 B-Provider
therapies NCT03925259 146 155 I-Provider
service NCT03925259 156 163 I-Provider

Exclusion NCT03925259 164 173 O
Criteria NCT03925259 174 182 O
: NCT03925259 183 184 O

- NCT03925259 188 189 O
Diagnosis NCT03925259 191 200 O
of NCT03925259 201 203 O
' NCT03925259 204 205 O
medically NCT03925259 205 214 B-Condition
unexplained NCT03925259 215 226 I-Condition
symptoms NCT03925259 227 235 I-Condition
' NCT03925259 235 236 O
including NCT03925259 237 246 O
somatoform NCT03925259 247 257 B-Condition
disorders NCT03925259 258 267 I-Condition
( NCT03925259 268 269 O
e NCT03925259 270 271 O
. NCT03925259 272 273 O
g NCT03925259 274 275 O
. NCT03925259 276 277 O
pain NCT03925259 279 283 B-Condition
disorder NCT03925259 284 292 I-Condition
, NCT03925259 293 294 O
conversion NCT03925259 295 305 B-Condition
disorder NCT03925259 306 314 I-Condition
, NCT03925259 315 316 O
body NCT03925259 317 321 B-Condition
dysmorphic NCT03925259 322 332 I-Condition
disorder NCT03925259 333 341 I-Condition
, NCT03925259 342 343 O
hypochondriasis NCT03925259 344 359 B-Condition
) NCT03925259 360 361 O
and NCT03925259 362 365 O
functional NCT03925259 366 376 B-Condition
somatic NCT03925259 377 384 I-Condition
syndromes NCT03925259 385 394 I-Condition
( NCT03925259 395 396 O
e NCT03925259 397 398 O
. NCT03925259 399 400 O
g NCT03925259 401 402 O
. NCT03925259 403 404 O
irritable NCT03925259 406 415 B-Condition
bowel NCT03925259 416 421 I-Condition
syndrome NCT03925259 422 430 I-Condition
, NCT03925259 431 432 O
chronic NCT03925259 433 440 B-Condition
fatigue NCT03925259 441 448 I-Condition
syndrome NCT03925259 449 457 I-Condition
, NCT03925259 458 459 O
fibromyalgia NCT03925259 460 472 B-Condition
, NCT03925259 473 474 O
non NCT03925259 475 478 B-Modifier
- NCT03925259 479 480 I-Modifier
cardiac NCT03925259 481 488 I-Modifier
chest NCT03925259 489 494 I-Modifier
pain NCT03925259 495 499 B-Condition
, NCT03925259 500 501 O
non NCT03925259 502 505 B-Condition
- NCT03925259 506 507 I-Condition
epileptic NCT03925259 508 517 I-Condition
seizures NCT03925259 518 526 I-Condition
) NCT03925259 527 528 O

- NCT03925259 532 533 O
Mental NCT03925259 535 541 B-Condition
health NCT03925259 542 548 I-Condition
diagnoses NCT03925259 549 558 O
in NCT03925259 559 561 B-Or
addition NCT03925259 562 570 I-Or
to NCT03925259 571 573 I-Or
anxiety NCT03925259 574 581 B-Condition
or NCT03925259 582 584 B-Or
depression NCT03925259 585 595 B-Condition
( NCT03925259 596 597 O
e NCT03925259 598 599 O
. NCT03925259 600 601 O
g NCT03925259 602 603 O
. NCT03925259 604 605 O
personality NCT03925259 607 618 B-Condition
disorder NCT03925259 619 627 I-Condition
, NCT03925259 628 629 O
bipolar NCT03925259 630 637 B-Condition
disorder NCT03925259 638 646 I-Condition
or NCT03925259 647 649 B-Or
psychosis NCT03925259 650 659 B-Condition
) NCT03925259 660 661 O

- NCT03925259 665 666 O
Currently NCT03925259 668 677 B-Eq_Comparison
accesses NCT03925259 678 686 B-Encounter
secondary NCT03925259 687 696 O
care NCT03925259 697 701 O
mental NCT03925259 702 708 B-Provider
health NCT03925259 709 715 I-Provider
services NCT03925259 716 724 I-Provider

- NCT03925259 727 728 O
Significant NCT03925259 730 741 O
current NCT03925259 742 749 B-Eq_Comparison
suicidal NCT03925259 750 758 B-Condition
risk NCT03925259 759 763 B-Risk

- NCT03925259 766 767 O
Current NCT03925259 769 776 B-Eq_Comparison
substance NCT03925259 777 786 B-Condition
misuse NCT03925259 787 793 I-Condition

- NCT03925259 796 797 O
Previous NCT03925259 799 807 B-Eq_Comparison
contact NCT03925259 808 815 B-Encounter
with NCT03925259 816 820 O
mental NCT03925259 821 827 B-Provider
health NCT03925259 828 834 I-Provider
services NCT03925259 835 843 I-Provider
( NCT03925259 844 845 O
defined NCT03925259 846 853 O
as NCT03925259 854 856 O
two NCT03925259 857 860 B-Eq_Comparison
or NCT03925259 861 863 I-Eq_Comparison
more NCT03925259 864 868 I-Eq_Comparison
prior NCT03925259 869 874 B-Eq_Comparison
episodes NCT03925259 875 883 O
of NCT03925259 884 886 O
service NCT03925259 887 894 B-Encounter
contact NCT03925259 895 902 I-Encounter
without NCT03925259 903 910 B-Negation
significant NCT03925259 911 922 O
change NCT03925259 923 929 O
) NCT03925259 930 931 O

- NCT03925259 935 936 O
Inpatient NCT03925259 938 947 B-Encounter
admission NCT03925259 948 957 I-Encounter
for NCT03925259 958 961 O
mental NCT03925259 962 968 B-Condition
health NCT03925259 969 975 I-Condition
difficulties NCT03925259 976 988 I-Condition
within NCT03925259 989 995 B-Eq_Comparison
the NCT03925259 996 999 I-Eq_Comparison
last NCT03925259 1000 1004 I-Eq_Comparison
five NCT03925259 1005 1009 I-Eq_Comparison
years NCT03925259 1010 1015 I-Eq_Comparison

- NCT03925259 1018 1019 O
History NCT03925259 1021 1028 B-Eq_Comparison
of NCT03925259 1029 1031 O
self NCT03925259 1032 1036 B-Condition
- NCT03925259 1037 1038 I-Condition
injury NCT03925259 1039 1045 I-Condition

- NCT03925259 1048 1049 O
A NCT03925259 1051 1052 O
stated NCT03925259 1053 1059 O
reluctance NCT03925259 1060 1070 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03925259 1071 1073 O
engage NCT03925259 1074 1080 O
in NCT03925259 1081 1083 O
psychotherapy NCT03925259 1084 1097 B-Procedure
. NCT03925259 1098 1099 O

Inclusion NCT03864393 0 9 O
Criteria NCT03864393 10 18 O
: NCT03864393 19 20 O

- NCT03864393 24 25 O
18 NCT03864393 27 29 B-Eq_Comparison
years NCT03864393 30 35 I-Eq_Comparison
of NCT03864393 36 38 I-Eq_Comparison
age NCT03864393 39 42 I-Eq_Comparison
or NCT03864393 43 45 I-Eq_Comparison
older NCT03864393 46 51 I-Eq_Comparison

- NCT03864393 54 55 O
diagnosis NCT03864393 57 66 O
of NCT03864393 67 69 O
idiopathic NCT03864393 70 80 B-Modifier
Parkinson NCT03864393 81 90 B-Condition
's NCT03864393 90 92 I-Condition
Disease NCT03864393 93 100 I-Condition
, NCT03864393 101 102 O
mild NCT03864393 103 107 B-Eq_Comparison
to NCT03864393 108 110 I-Eq_Comparison
moderate NCT03864393 111 119 I-Eq_Comparison
( NCT03864393 120 121 O
Hoehn NCT03864393 122 127 B-Observation
and NCT03864393 128 131 I-Observation
Yahr NCT03864393 132 136 I-Observation
score NCT03864393 137 142 I-Observation
less NCT03864393 143 147 B-Eq_Comparison
than NCT03864393 148 152 I-Eq_Comparison
or NCT03864393 153 155 I-Eq_Comparison
equal NCT03864393 156 161 I-Eq_Comparison
to NCT03864393 162 164 I-Eq_Comparison
3 NCT03864393 165 166 I-Eq_Comparison
) NCT03864393 167 168 O

- NCT03864393 172 173 O
speaks NCT03864393 175 181 O
English NCT03864393 182 189 O

- NCT03864393 192 193 O
able NCT03864393 195 199 B-Condition
to NCT03864393 200 202 I-Condition
ambulate NCT03864393 203 211 I-Condition
without NCT03864393 212 219 B-Negation
requiring NCT03864393 220 229 O
an NCT03864393 230 232 O
assistive NCT03864393 233 242 B-Procedure
device NCT03864393 243 249 I-Procedure

Exclusion NCT03864393 250 259 O
Criteria NCT03864393 260 268 O
: NCT03864393 269 270 O

- NCT03864393 274 275 O
neurological NCT03864393 277 289 B-Condition
disease NCT03864393 290 297 I-Condition
diagnosis NCT03864393 298 307 O
other NCT03864393 308 313 B-Exception
than NCT03864393 314 318 I-Exception
PD NCT03864393 319 321 B-Condition

- NCT03864393 324 325 O
uncontrolled NCT03864393 327 339 B-Modifier
cardiovascular NCT03864393 340 354 B-Modifier
, NCT03864393 355 356 O
pulmonary NCT03864393 357 366 B-Modifier
, NCT03864393 367 368 O
neurological NCT03864393 369 381 B-Modifier
, NCT03864393 382 383 O
or NCT03864393 384 386 B-Or
metabolic NCT03864393 387 396 B-Modifier
disease NCT03864393 397 404 B-Condition
which NCT03864393 405 410 O
may NCT03864393 411 414 B-Assertion___Assertion_Type_Value:hypothetical
impact NCT03864393 415 421 O
the NCT03864393 422 425 O
ability NCT03864393 426 433 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864393 434 436 I-Assertion___Assertion_Type_Value:hypothetical
exercise NCT03864393 437 445 B-Observation
or NCT03864393 446 448 B-Or
in NCT03864393 449 451 O
which NCT03864393 452 457 O
exercise NCT03864393 458 466 B-Observation
is NCT03864393 467 469 O
contraindicated NCT03864393 470 485 B-Contraindication

- NCT03864393 488 489 O
any NCT03864393 491 494 O
medications NCT03864393 495 506 B-Drug
, NCT03864393 507 508 O
such NCT03864393 509 513 O
as NCT03864393 514 516 O
beta NCT03864393 517 521 B-Drug
- NCT03864393 522 523 I-Drug
blockers NCT03864393 524 532 I-Drug
, NCT03864393 533 534 O
that NCT03864393 535 539 O
may NCT03864393 540 543 B-Assertion___Assertion_Type_Value:hypothetical
alter NCT03864393 544 549 O
HR NCT03864393 550 552 B-Observation
or NCT03864393 553 555 B-Or
metabolic NCT03864393 556 565 B-Observation
data NCT03864393 566 570 I-Observation

- NCT03864393 573 574 O
cognitive NCT03864393 576 585 B-Modifier
or NCT03864393 586 588 B-Or
psychiatric NCT03864393 589 600 B-Modifier
impairment NCT03864393 601 611 B-Condition
precluding NCT03864393 612 622 O
informed NCT03864393 623 631 O
consent NCT03864393 632 639 O
or NCT03864393 640 642 O
ability NCT03864393 643 650 O
to NCT03864393 651 653 O
following NCT03864393 654 663 O
instructions NCT03864393 664 676 O

- NCT03864393 679 680 O
mini NCT03864393 682 686 B-Observation
- NCT03864393 687 688 I-Observation
Mental NCT03864393 689 695 I-Observation
State NCT03864393 696 701 I-Observation
Examination NCT03864393 702 713 I-Observation
score NCT03864393 714 719 B-Eq_Comparison
< NCT03864393 720 721 I-Eq_Comparison
24 NCT03864393 722 724 I-Eq_Comparison

- NCT03864393 728 729 O
pregnancy NCT03864393 731 740 B-Condition

Inclusion NCT03867929 0 9 O
Criteria NCT03867929 10 18 O
: NCT03867929 19 20 O

- NCT03867929 24 25 O
presence NCT03867929 27 35 B-Eq_Comparison
of NCT03867929 36 38 O
erectile NCT03867929 39 47 B-Condition
dysfunction NCT03867929 48 59 I-Condition

Exclusion NCT03867929 60 69 O
Criteria NCT03867929 70 78 O
: NCT03867929 79 80 O

- NCT03867929 84 85 O
Presence NCT03867929 87 95 B-Eq_Comparison
of NCT03867929 96 98 O
uncontrolled NCT03867929 99 111 B-Modifier
diabetes NCT03867929 112 120 B-Condition
mellitus NCT03867929 121 129 I-Condition
, NCT03867929 130 131 O

- NCT03867929 135 136 O
Presence NCT03867929 138 146 B-Eq_Comparison
of NCT03867929 147 149 O
uncontrolled NCT03867929 150 162 B-Modifier
hypertension NCT03867929 163 175 B-Condition
, NCT03867929 176 177 O

- NCT03867929 181 182 O
Presence NCT03867929 184 192 B-Eq_Comparison
of NCT03867929 193 195 O
uncontrolled NCT03867929 196 208 B-Modifier
lipid NCT03867929 209 214 B-Condition
metabolism NCT03867929 215 225 I-Condition
disorders NCT03867929 226 235 I-Condition
, NCT03867929 236 237 O

- NCT03867929 241 242 O
Presence NCT03867929 244 252 B-Eq_Comparison
of NCT03867929 253 255 O
neurological NCT03867929 256 268 B-Condition
diseases NCT03867929 269 277 I-Condition
, NCT03867929 278 279 O

- NCT03867929 283 284 O
Presence NCT03867929 286 294 B-Eq_Comparison
of NCT03867929 295 297 O
heamatological NCT03867929 298 312 B-Condition
diseases NCT03867929 313 321 I-Condition
, NCT03867929 322 323 O

- NCT03867929 327 328 O
Urinary NCT03867929 330 337 B-Condition
tract NCT03867929 338 343 I-Condition
infection NCT03867929 344 353 I-Condition
, NCT03867929 354 355 O

- NCT03867929 359 360 O
Diagnosis NCT03867929 362 371 O
of NCT03867929 372 374 O
any NCT03867929 375 378 O
malignencies NCT03867929 379 391 B-Condition
, NCT03867929 392 393 O

- NCT03867929 397 398 O
Chronic NCT03867929 400 407 O
kidney NCT03867929 408 414 B-Condition
failure NCT03867929 415 422 I-Condition
, NCT03867929 423 424 O

- NCT03867929 428 429 O
Presence NCT03867929 431 439 B-Eq_Comparison
of NCT03867929 440 442 O
metabolic NCT03867929 443 452 B-Condition
syndrome NCT03867929 453 461 I-Condition
, NCT03867929 462 463 O

- NCT03867929 467 468 O
Presence NCT03867929 470 478 B-Eq_Comparison
of NCT03867929 479 481 O
psychiatric NCT03867929 482 493 B-Condition
diseases NCT03867929 494 502 I-Condition
and NCT03867929 503 506 B-Or
/ NCT03867929 507 508 I-Or
or NCT03867929 509 511 I-Or
medical NCT03867929 512 519 B-Procedure
treatment NCT03867929 520 529 I-Procedure
, NCT03867929 530 531 O

- NCT03867929 535 536 O
Smoking NCT03867929 538 545 B-Condition
, NCT03867929 546 547 O

- NCT03867929 551 552 O
History NCT03867929 554 561 B-Eq_Comparison
of NCT03867929 562 564 O
pelvic NCT03867929 565 571 B-Procedure
surgery NCT03867929 572 579 I-Procedure
, NCT03867929 580 581 O
cardiac NCT03867929 582 589 B-Procedure
surgery NCT03867929 590 597 I-Procedure
and NCT03867929 598 601 B-Or
pelvic NCT03867929 602 608 B-Modifier
radiotherapy NCT03867929 609 621 B-Procedure

Inclusion NCT03922893 0 9 O
Criteria NCT03922893 10 18 O
: NCT03922893 19 20 O

- NCT03922893 24 25 O
Individuals NCT03922893 27 38 O
who NCT03922893 39 42 O
have NCT03922893 43 47 O
undergone NCT03922893 48 57 O
clinical NCT03922893 58 66 B-Modifier
and NCT03922893 67 70 B-Or
/ NCT03922893 71 72 I-Or
or NCT03922893 73 75 I-Or
research NCT03922893 76 84 B-Modifier
genetic NCT03922893 85 92 B-Procedure
evaluation NCT03922893 93 103 I-Procedure
, NCT03922893 104 105 O
found NCT03922893 106 111 O
to NCT03922893 112 114 O
have NCT03922893 115 119 O
or NCT03922893 120 122 O
not NCT03922893 123 126 O
have NCT03922893 127 131 O
a NCT03922893 132 133 O
germline NCT03922893 134 142 B-Condition
genetic NCT03922893 143 150 I-Condition
variant NCT03922893 151 158 I-Condition
( NCT03922893 159 160 O
pathogenic NCT03922893 161 171 B-Modifier
, NCT03922893 172 173 O
likely NCT03922893 174 180 B-Assertion___Assertion_Type_Value:possible
pathogenic NCT03922893 181 191 B-Modifier
, NCT03922893 192 193 O
variant NCT03922893 194 201 O
of NCT03922893 202 204 O
uncertain NCT03922893 205 214 O
/ NCT03922893 215 216 O
unknown NCT03922893 217 224 O
significance NCT03922893 225 237 O
, NCT03922893 238 239 O
likely NCT03922893 240 246 B-Assertion___Assertion_Type_Value:possible
benign NCT03922893 247 253 B-Modifier
) NCT03922893 254 255 O
. NCT03922893 256 257 O

- NCT03922893 261 262 O
Individuals NCT03922893 264 275 O
with NCT03922893 276 280 O
or NCT03922893 281 283 O
without NCT03922893 284 291 O
a NCT03922893 292 293 O
personal NCT03922893 294 302 O
history NCT03922893 303 310 B-Eq_Comparison
of NCT03922893 311 313 O
malignant NCT03922893 314 323 B-Modifier
or NCT03922893 324 326 B-Or
pre NCT03922893 327 330 B-Modifier
- NCT03922893 331 332 I-Modifier
malignant NCT03922893 333 342 I-Modifier
lesions NCT03922893 343 350 B-Condition
who NCT03922893 351 354 O
demonstrate NCT03922893 355 366 O
: NCT03922893 367 368 O
a NCT03922893 369 370 O
) NCT03922893 371 372 O
clinical NCT03922893 373 381 O
findings NCT03922893 382 390 O
suggestive NCT03922893 391 401 B-Assertion___Assertion_Type_Value:possible
of NCT03922893 402 404 O
a NCT03922893 405 406 O
genetic NCT03922893 407 414 B-Condition
cancer NCT03922893 415 421 I-Condition
susceptibility NCT03922893 422 436 I-Condition
syndrome NCT03922893 437 445 I-Condition
including NCT03922893 446 455 B-And
very NCT03922893 456 460 O
early NCT03922893 461 466 B-Modifier
age NCT03922893 467 470 B-Age
at NCT03922893 471 473 O
onset NCT03922893 474 479 B-Eq_Comparison
, NCT03922893 480 481 O
multiple NCT03922893 482 490 B-Modifier
primary NCT03922893 491 498 I-Modifier
malignancies NCT03922893 499 511 B-Condition
, NCT03922893 512 513 O
or NCT03922893 514 516 B-Or
other NCT03922893 517 522 B-Other
features NCT03922893 523 531 B-Condition
; NCT03922893 531 532 O
and NCT03922893 533 536 B-Or
/ NCT03922893 537 538 I-Or
or NCT03922893 539 541 I-Or
b NCT03922893 542 543 O
) NCT03922893 544 545 O
family NCT03922893 546 552 B-Family_Member
histories NCT03922893 553 562 I-Family_Member
suggestive NCT03922893 563 573 B-Assertion___Assertion_Type_Value:possible
of NCT03922893 574 576 O
a NCT03922893 577 578 O
genetic NCT03922893 579 586 B-Condition
cancer NCT03922893 587 593 I-Condition
susceptibility NCT03922893 594 608 I-Condition
syndrome NCT03922893 609 617 I-Condition
, NCT03922893 618 619 O
or NCT03922893 620 622 O
c NCT03922893 623 624 O
) NCT03922893 625 626 O
other NCT03922893 627 632 B-Other
features NCT03922893 633 641 B-Condition
suggesting NCT03922893 642 652 B-Assertion___Assertion_Type_Value:possible
inherited NCT03922893 653 662 O
etiology NCT03922893 663 671 O
of NCT03922893 672 674 O
malignancy NCT03922893 675 685 B-Condition
as NCT03922893 686 688 O
determined NCT03922893 689 699 O
by NCT03922893 700 702 O
the NCT03922893 703 706 O
PI NCT03922893 707 709 O
. NCT03922893 710 711 O

- NCT03922893 715 716 O
Family NCT03922893 718 724 B-Family_Member
members NCT03922893 725 732 I-Family_Member
of NCT03922893 733 735 O
the NCT03922893 736 739 O
above NCT03922893 740 745 O
participants NCT03922893 746 758 O
. NCT03922893 759 760 O
Both NCT03922893 762 766 O
children NCT03922893 767 775 O
( NCT03922893 776 777 O
with NCT03922893 778 782 O
parental NCT03922893 783 791 O
consent NCT03922893 792 799 O
as NCT03922893 800 802 O
age NCT03922893 803 806 O
appropriate NCT03922893 807 818 O
) NCT03922893 819 820 O
and NCT03922893 821 824 B-Or
adults NCT03922893 825 831 O
are NCT03922893 832 835 O
eligible NCT03922893 836 844 O
to NCT03922893 845 847 O
participation NCT03922893 848 861 O
. NCT03922893 862 863 O

- NCT03922893 867 868 O
Individuals NCT03922893 870 881 O
may NCT03922893 882 885 O
or NCT03922893 886 888 O
may NCT03922893 889 892 O
not NCT03922893 893 896 O
be NCT03922893 897 899 O
enrolled NCT03922893 900 908 O
MSK NCT03922893 909 912 O
patients NCT03922893 913 921 O
; NCT03922893 921 922 O
probands NCT03922893 923 931 O
may NCT03922893 932 935 O
be NCT03922893 936 938 O
referred NCT03922893 939 947 O
to NCT03922893 948 950 O
( NCT03922893 951 952 O
or NCT03922893 953 955 O
self NCT03922893 956 960 O
- NCT03922893 961 962 O
referred NCT03922893 963 971 O
to NCT03922893 972 974 O
) NCT03922893 975 976 O
the NCT03922893 977 980 O
study NCT03922893 981 986 O
and NCT03922893 987 990 O
may NCT03922893 991 994 O
be NCT03922893 995 997 O
enrolled NCT03922893 998 1006 O
at NCT03922893 1007 1009 O
discretion NCT03922893 1010 1020 O
of NCT03922893 1021 1023 O
the NCT03922893 1024 1027 O
PI NCT03922893 1028 1030 O
and NCT03922893 1031 1034 O
if NCT03922893 1035 1037 O
able NCT03922893 1038 1042 O
to NCT03922893 1043 1045 O
provide NCT03922893 1046 1053 O
informed NCT03922893 1054 1062 O
consent NCT03922893 1063 1070 O
. NCT03922893 1071 1072 O

- NCT03922893 1076 1077 O
Biospecimens NCT03922893 1079 1091 O
derived NCT03922893 1092 1099 O
from NCT03922893 1100 1104 O
deceased NCT03922893 1105 1113 B-Death
family NCT03922893 1114 1120 B-Family_Member
members NCT03922893 1121 1128 I-Family_Member
may NCT03922893 1129 1132 O
be NCT03922893 1133 1135 O
used NCT03922893 1136 1140 O
for NCT03922893 1141 1144 O
research NCT03922893 1145 1153 O
in NCT03922893 1154 1156 O
this NCT03922893 1157 1161 O
study NCT03922893 1162 1167 O
if NCT03922893 1168 1170 O
consent NCT03922893 1171 1178 O
if NCT03922893 1179 1181 O
provided NCT03922893 1182 1190 O
by NCT03922893 1191 1193 O
the NCT03922893 1194 1197 O
executor NCT03922893 1198 1206 O
of NCT03922893 1207 1209 O
the NCT03922893 1210 1213 O
estate NCT03922893 1214 1220 O
of NCT03922893 1221 1223 O
that NCT03922893 1224 1228 O
individual NCT03922893 1229 1239 O
. NCT03922893 1240 1241 O

Exclusion NCT03922893 1243 1252 O
Criteria NCT03922893 1253 1261 O
: NCT03922893 1262 1263 O

- NCT03922893 1267 1268 O
Patients NCT03922893 1270 1278 O
will NCT03922893 1279 1283 O
be NCT03922893 1284 1286 O
excluded NCT03922893 1287 1295 B-Negation
from NCT03922893 1296 1300 O
this NCT03922893 1301 1305 O
study NCT03922893 1306 1311 B-Study
if NCT03922893 1312 1314 O
he NCT03922893 1315 1317 O
/ NCT03922893 1318 1319 O
she NCT03922893 1320 1323 O
has NCT03922893 1324 1327 O
physical NCT03922893 1328 1336 B-Modifier
, NCT03922893 1337 1338 O
cognitive NCT03922893 1339 1348 B-Modifier
or NCT03922893 1349 1351 B-Or
psychiatric NCT03922893 1352 1363 B-Modifier
conditions NCT03922893 1364 1374 B-Condition
that NCT03922893 1375 1379 O
interfere NCT03922893 1380 1389 O
with NCT03922893 1390 1394 O
ability NCT03922893 1395 1402 O
to NCT03922893 1403 1405 O
give NCT03922893 1406 1410 O
meaningful NCT03922893 1411 1421 O
informed NCT03922893 1422 1430 O
consent NCT03922893 1431 1438 O
. NCT03922893 1439 1440 O

Inclusion NCT03922620 0 9 O
Criteria NCT03922620 10 18 O
: NCT03922620 19 20 O

1 NCT03922620 24 25 O
. NCT03922620 25 26 O
Patients NCT03922620 28 36 O
18 NCT03922620 37 39 B-Eq_Comparison
years NCT03922620 40 45 I-Eq_Comparison
of NCT03922620 46 48 I-Eq_Comparison
age NCT03922620 49 52 I-Eq_Comparison
or NCT03922620 53 55 I-Eq_Comparison
older NCT03922620 56 61 I-Eq_Comparison

2 NCT03922620 64 65 O
. NCT03922620 65 66 O
Patients NCT03922620 68 76 O
undergoing NCT03922620 77 87 B-Eq_Comparison
elective NCT03922620 88 96 O
primary NCT03922620 97 104 B-Modifier
ankle NCT03922620 105 110 I-Modifier
or NCT03922620 111 113 B-Or
hindfoot NCT03922620 114 122 B-Modifier
surgery NCT03922620 123 130 B-Procedure
( NCT03922620 131 132 O
ankle NCT03922620 133 138 B-Procedure
arthrodesis NCT03922620 139 150 I-Procedure
, NCT03922620 151 152 O
subtalar NCT03922620 153 161 B-Procedure
arthrodesis NCT03922620 162 173 I-Procedure
, NCT03922620 174 175 O
triple NCT03922620 176 182 B-Procedure
arthrodesis NCT03922620 183 194 I-Procedure
, NCT03922620 195 196 O
total NCT03922620 197 202 B-Procedure
ankle NCT03922620 203 208 I-Procedure
arthroplasty NCT03922620 209 221 I-Procedure
, NCT03922620 222 223 O
peroneal NCT03922620 224 232 B-Procedure
tendon NCT03922620 233 239 I-Procedure
debridement NCT03922620 240 251 B-Modifier
/ NCT03922620 252 253 B-Or
transfer NCT03922620 254 262 B-Modifier
, NCT03922620 263 264 O
Cavus NCT03922620 265 270 B-Procedure
Reconstruction NCT03922620 271 285 I-Procedure
, NCT03922620 286 287 O
Medial NCT03922620 288 294 B-Procedure
Displacement NCT03922620 295 307 I-Procedure
Calcaneal NCT03922620 308 317 I-Procedure
Osteotomy NCT03922620 318 327 I-Procedure
, NCT03922620 328 329 O
Dwyer NCT03922620 330 335 B-Procedure
Osteotomy NCT03922620 336 345 I-Procedure
) NCT03922620 346 347 O

Exclusion NCT03922620 349 358 O
Criteria NCT03922620 359 367 O
: NCT03922620 368 369 O

1 NCT03922620 373 374 O
. NCT03922620 374 375 O
Patients NCT03922620 377 385 O
who NCT03922620 386 389 O
are NCT03922620 390 393 O
undergoing NCT03922620 394 404 B-Eq_Comparison
revision NCT03922620 405 413 B-Procedure
surgical NCT03922620 414 422 I-Procedure
procedure NCT03922620 423 432 I-Procedure

2 NCT03922620 435 436 O
. NCT03922620 436 437 O
Patients NCT03922620 439 447 O
who NCT03922620 448 451 O
have NCT03922620 452 456 O
taken NCT03922620 457 462 O
opioid NCT03922620 463 469 B-Drug
pain NCT03922620 470 474 I-Drug
medications NCT03922620 475 486 I-Drug
in NCT03922620 487 489 O
the NCT03922620 490 493 O
past NCT03922620 494 498 B-Eq_Comparison
3 NCT03922620 499 500 I-Eq_Comparison
months NCT03922620 501 507 I-Eq_Comparison
prior NCT03922620 508 513 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03922620 514 516 I-Temporal_Connection___Temporal_Connection_Type_Value:before
surgical NCT03922620 517 525 B-Procedure
procedure NCT03922620 526 535 I-Procedure

3 NCT03922620 538 539 O
. NCT03922620 539 540 O
Patients NCT03922620 542 550 O
who NCT03922620 551 554 O
have NCT03922620 555 559 O
allergies NCT03922620 560 569 B-Allergy
to NCT03922620 570 572 O
any NCT03922620 573 576 O
of NCT03922620 577 579 O
the NCT03922620 580 583 O
medications NCT03922620 584 595 B-Drug
or NCT03922620 596 598 O
components NCT03922620 599 609 O
of NCT03922620 610 612 O
medications NCT03922620 613 624 O
investigated NCT03922620 625 637 O
in NCT03922620 638 640 O
the NCT03922620 641 644 O
study NCT03922620 645 650 B-Study

4 NCT03922620 653 654 O
. NCT03922620 654 655 O
Patients NCT03922620 657 665 O
currently NCT03922620 666 675 B-Eq_Comparison
incarcerated NCT03922620 676 688 B-Observation

5 NCT03922620 691 692 O
. NCT03922620 692 693 O
Patients NCT03922620 695 703 O
who NCT03922620 704 707 O
can NCT03922620 708 711 B-Negation
not NCT03922620 711 714 I-Negation
read NCT03922620 715 719 O
and NCT03922620 720 723 O
speak NCT03922620 724 729 O
English NCT03922620 730 737 O

Inclusion NCT03867747 0 9 O
Criteria NCT03867747 10 18 O
: NCT03867747 19 20 O

- NCT03867747 24 25 O
Patients NCT03867747 27 35 O
with NCT03867747 36 40 O
structural NCT03867747 41 51 B-Modifier
heart NCT03867747 52 57 B-Condition
disease NCT03867747 58 65 I-Condition
and NCT03867747 66 69 B-Or
implantable NCT03867747 70 81 B-Procedure
cardioverter NCT03867747 82 94 I-Procedure
defibrillator NCT03867747 95 108 I-Procedure
( NCT03867747 109 110 O
ICD NCT03867747 111 114 B-Procedure
) NCT03867747 115 116 O

- NCT03867747 120 121 O
Age NCT03867747 123 126 B-Age
> NCT03867747 127 128 B-Eq_Comparison
18 NCT03867747 129 131 I-Eq_Comparison
years NCT03867747 132 137 I-Eq_Comparison

- NCT03867747 140 141 O
either NCT03867747 143 149 O

1 NCT03867747 157 158 O
. NCT03867747 158 159 O
Recurring NCT03867747 161 170 B-Modifier
symptomatic NCT03867747 171 182 B-Assertion___Assertion_Type_Value:possible
monomorphic NCT03867747 183 194 B-Condition
ventricular NCT03867747 195 206 I-Condition
tachycardia NCT03867747 207 218 I-Condition
that NCT03867747 219 223 O
requires NCT03867747 224 232 B-Assertion___Assertion_Type_Value:hypothetical
ICD NCT03867747 233 236 B-Procedure
intervention NCT03867747 237 249 I-Procedure
( NCT03867747 250 251 O
e NCT03867747 252 253 O
. NCT03867747 254 255 O
g NCT03867747 256 257 O
. NCT03867747 258 259 O
shock NCT03867747 261 266 B-Modifier
or NCT03867747 267 269 B-Or
anti NCT03867747 270 274 B-Negation
- NCT03867747 275 276 O
tachycardia NCT03867747 277 288 B-Modifier
stimulation NCT03867747 289 300 B-Procedure
) NCT03867747 301 302 O
. NCT03867747 303 304 O
At NCT03867747 306 308 B-Eq_Comparison
least NCT03867747 309 314 I-Eq_Comparison
3 NCT03867747 315 316 I-Eq_Comparison
episodes NCT03867747 317 325 O
within NCT03867747 326 332 B-Eq_Comparison
the NCT03867747 333 336 I-Eq_Comparison
3 NCT03867747 337 338 I-Eq_Comparison
months NCT03867747 339 345 I-Eq_Comparison
prior NCT03867747 346 351 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867747 352 354 I-Temporal_Connection___Temporal_Connection_Type_Value:before
inclusion NCT03867747 355 364 B-Study
or NCT03867747 365 367 B-Or

2 NCT03867747 375 376 O
. NCT03867747 376 377 O
induction NCT03867747 379 388 B-Procedure
of NCT03867747 389 391 O
symptomatic NCT03867747 392 403 B-Assertion___Assertion_Type_Value:possible
monomorphic NCT03867747 404 415 B-Condition
ventricular NCT03867747 416 427 I-Condition
tachycardia NCT03867747 428 439 I-Condition
that NCT03867747 440 444 O
requires NCT03867747 445 453 B-Assertion___Assertion_Type_Value:hypothetical
ICD NCT03867747 454 457 B-Procedure
intervention NCT03867747 458 470 I-Procedure
( NCT03867747 471 472 O
e NCT03867747 473 474 O
. NCT03867747 475 476 O
g NCT03867747 477 478 O
. NCT03867747 479 480 O
shock NCT03867747 482 487 B-Modifier
or NCT03867747 488 490 B-Or
anti NCT03867747 491 495 B-Negation
- NCT03867747 496 497 O
tachycardia NCT03867747 498 509 B-Modifier
stimulation NCT03867747 510 521 B-Procedure
) NCT03867747 522 523 O
. NCT03867747 524 525 O
Induction NCT03867747 527 536 B-Procedure
triggered NCT03867747 537 546 O
by NCT03867747 547 549 O
ICD NCT03867747 550 553 B-Procedure
or NCT03867747 554 556 B-Or
during NCT03867747 557 563 B-Temporal_Connection___Temporal_Connection_Type_Value:during
electrophysiology NCT03867747 564 581 B-Procedure
studies NCT03867747 582 589 I-Procedure
( NCT03867747 590 591 O
EPS NCT03867747 592 595 B-Procedure
) NCT03867747 596 597 O
or NCT03867747 598 600 B-Or
both NCT03867747 601 605 B-Modifier
, NCT03867747 606 607 O
a NCT03867747 608 609 O
) NCT03867747 610 611 O
and NCT03867747 612 615 O
b NCT03867747 616 617 O
) NCT03867747 618 619 O

- NCT03867747 623 624 O
Refractory NCT03867747 626 636 B-Condition
to NCT03867747 637 639 O
antiarrhythmic NCT03867747 640 654 B-Procedure
combination NCT03867747 655 666 I-Procedure
therapy NCT03867747 667 674 I-Procedure

- NCT03867747 677 678 O
Beside NCT03867747 680 686 O
the NCT03867747 687 690 O
cardiac NCT03867747 691 698 B-Condition
conditions NCT03867747 699 709 I-Condition
: NCT03867747 710 711 O
No NCT03867747 712 714 B-Negation
competing NCT03867747 715 724 O
illness NCT03867747 725 732 B-Condition
that NCT03867747 733 737 O
would NCT03867747 738 743 B-Assertion___Assertion_Type_Value:hypothetical
additionally NCT03867747 744 756 O
limit NCT03867747 757 762 O
the NCT03867747 763 766 O
life NCT03867747 767 771 B-Observation
expectancy NCT03867747 772 782 I-Observation
to NCT03867747 783 785 O
less NCT03867747 786 790 B-Eq_Comparison
than NCT03867747 791 795 I-Eq_Comparison
6 NCT03867747 796 797 I-Eq_Comparison
months NCT03867747 798 804 I-Eq_Comparison

- NCT03867747 807 808 O
No NCT03867747 810 812 B-Negation
prior NCT03867747 813 818 B-Eq_Comparison
radiation NCT03867747 819 828 B-Procedure
therapy NCT03867747 829 836 I-Procedure
in NCT03867747 837 839 O
the NCT03867747 840 843 O
thorax NCT03867747 844 850 B-Modifier
area NCT03867747 851 855 I-Modifier

- NCT03867747 858 859 O
No NCT03867747 861 863 B-Negation
pregnancy NCT03867747 864 873 B-Condition
and NCT03867747 874 877 B-And
no NCT03867747 878 880 B-Negation
active NCT03867747 881 887 B-Eq_Comparison
breastfeeding NCT03867747 888 901 B-Condition

- NCT03867747 904 905 O
Ability NCT03867747 907 914 O
to NCT03867747 915 917 O
consent NCT03867747 918 925 O
and NCT03867747 926 929 O
consent NCT03867747 930 937 O
to NCT03867747 938 940 O
study NCT03867747 941 946 O
participation NCT03867747 947 960 O

Exclusion NCT03867747 961 970 O
Criteria NCT03867747 971 979 O
: NCT03867747 980 981 O

- NCT03867747 985 986 O
ICD NCT03867747 988 991 B-Condition
electrode NCT03867747 992 1001 I-Condition
malfunction NCT03867747 1002 1013 I-Condition
of NCT03867747 1014 1016 O
ICD NCT03867747 1017 1020 B-Procedure
readings NCT03867747 1021 1029 O
outside NCT03867747 1030 1037 O
reference NCT03867747 1038 1047 O
range NCT03867747 1048 1053 O

- NCT03867747 1056 1057 O
Lack NCT03867747 1059 1063 B-Negation
of NCT03867747 1064 1066 O
evidence NCT03867747 1067 1075 O
of NCT03867747 1076 1078 O
a NCT03867747 1079 1080 O
myocardial NCT03867747 1081 1091 B-Condition
scar NCT03867747 1092 1096 I-Condition
( NCT03867747 1097 1098 O
Computer NCT03867747 1099 1107 B-Procedure
tomography NCT03867747 1108 1118 I-Procedure
or NCT03867747 1119 1121 B-Or
magnetic NCT03867747 1122 1130 B-Procedure
resonance NCT03867747 1131 1140 I-Procedure
tomography NCT03867747 1141 1151 I-Procedure
for NCT03867747 1152 1155 O
MRI NCT03867747 1156 1159 B-Procedure
- NCT03867747 1160 1161 O
capable NCT03867747 1162 1169 O
ICD NCT03867747 1170 1173 B-Procedure
aggregates NCT03867747 1174 1184 I-Procedure
or NCT03867747 1185 1187 B-Or
electrophysiological NCT03867747 1188 1208 B-Observation
measurement NCT03867747 1209 1220 I-Observation
) NCT03867747 1221 1222 O

- NCT03867747 1226 1227 O
No NCT03867747 1229 1231 B-Negation
possible NCT03867747 1232 1240 B-Assertion___Assertion_Type_Value:hypothetical
induction NCT03867747 1241 1250 B-Procedure
of NCT03867747 1251 1253 O
symptomatic NCT03867747 1254 1265 B-Assertion___Assertion_Type_Value:possible
monomorphic NCT03867747 1266 1277 B-Modifier
ventricular NCT03867747 1278 1289 B-Condition
tachycardia NCT03867747 1290 1301 I-Condition
non NCT03867747 1302 1305 B-Negation
- NCT03867747 1306 1307 O
persistent NCT03867747 1308 1318 B-Modifier
or NCT03867747 1319 1321 B-Or
persistent NCT03867747 1322 1332 B-Modifier
with NCT03867747 1333 1337 O
delivery NCT03867747 1338 1346 O
of NCT03867747 1347 1349 O
ICD NCT03867747 1350 1353 B-Procedure
therapies NCT03867747 1354 1363 I-Procedure
such NCT03867747 1364 1368 O
as NCT03867747 1369 1371 O
antitachycardic NCT03867747 1372 1387 B-Procedure
pacing NCT03867747 1388 1394 I-Procedure
or NCT03867747 1395 1397 B-Or
shock NCT03867747 1398 1403 B-Procedure

- NCT03867747 1406 1407 O
Contraindication NCT03867747 1409 1425 B-Contraindication
to NCT03867747 1426 1428 O
radiosurgery NCT03867747 1429 1441 B-Procedure
( NCT03867747 1442 1443 O
e NCT03867747 1444 1445 O
. NCT03867747 1446 1447 O
g NCT03867747 1448 1449 O
. NCT03867747 1450 1451 O
precise NCT03867747 1453 1460 O
target NCT03867747 1461 1467 B-Observation
volume NCT03867747 1468 1474 I-Observation
definition NCT03867747 1475 1485 I-Observation
not NCT03867747 1486 1489 B-Negation
possible NCT03867747 1490 1498 B-Assertion___Assertion_Type_Value:hypothetical
due NCT03867747 1499 1502 O
to NCT03867747 1503 1505 O
image NCT03867747 1506 1511 B-Observation
artifacts NCT03867747 1512 1521 I-Observation
created NCT03867747 1522 1529 O
from NCT03867747 1530 1534 O
a NCT03867747 1535 1536 O
left NCT03867747 1537 1541 B-Procedure
ventricular NCT03867747 1542 1553 I-Procedure
assist NCT03867747 1554 1560 I-Procedure
device NCT03867747 1561 1567 I-Procedure
[ NCT03867747 1568 1569 O
LVAD NCT03867747 1570 1574 B-Procedure
] NCT03867747 1575 1576 O
) NCT03867747 1577 1578 O

- NCT03867747 1582 1583 O
Inability NCT03867747 1585 1594 O
to NCT03867747 1595 1597 O
consent NCT03867747 1598 1605 O
or NCT03867747 1606 1608 O
missing NCT03867747 1609 1616 O
or NCT03867747 1617 1619 O
withdrawn NCT03867747 1620 1629 O
consent NCT03867747 1630 1637 O

Inclusion NCT03869710 0 9 O
Criteria NCT03869710 10 18 O
: NCT03869710 19 20 O

- NCT03869710 24 25 O
Chronic NCT03869710 27 34 O
neck NCT03869710 35 39 B-Modifier
pain NCT03869710 40 44 B-Condition

- NCT03869710 47 48 O
Chronic NCT03869710 50 57 O
head NCT03869710 58 62 B-Modifier
pain NCT03869710 63 67 B-Condition

Exclusion NCT03869710 68 77 O
Criteria NCT03869710 78 86 O
: NCT03869710 87 88 O

- NCT03869710 92 93 O
previous NCT03869710 95 103 B-Eq_Comparison
surgery NCT03869710 104 111 B-Procedure
of NCT03869710 112 114 O
neck NCT03869710 115 119 B-Modifier
and NCT03869710 120 123 B-Or
head NCT03869710 124 128 B-Modifier

- NCT03869710 131 132 O
Body NCT03869710 134 138 B-Observation
Mass NCT03869710 139 143 I-Observation
Index NCT03869710 144 149 I-Observation
> NCT03869710 150 151 B-Eq_Comparison
39 NCT03869710 152 154 I-Eq_Comparison
, NCT03869710 155 156 I-Eq_Comparison
99 NCT03869710 157 159 I-Eq_Comparison

- NCT03869710 163 164 O
politrauma NCT03869710 166 176 B-Condition
patients NCT03869710 177 185 O

- NCT03869710 188 189 O
pregnancy NCT03869710 191 200 B-Condition

- NCT03869710 203 204 O
neck NCT03869710 206 210 B-Modifier
and NCT03869710 211 214 B-Or
head NCT03869710 215 219 B-Modifier
infections NCT03869710 220 230 B-Condition

Inclusion NCT03860922 0 9 O
Criteria NCT03860922 10 18 O
: NCT03860922 19 20 O

- NCT03860922 24 25 O
patients NCT03860922 27 35 O
in NCT03860922 36 38 O
different NCT03860922 39 48 O
age NCT03860922 49 52 O
groups NCT03860922 53 59 O
and NCT03860922 60 63 O
both NCT03860922 64 68 O
sex NCT03860922 69 72 O
referred NCT03860922 73 81 O
from NCT03860922 82 86 O
orthopedic NCT03860922 87 97 O
outpatient NCT03860922 98 108 B-Encounter
clinic NCT03860922 109 115 O
with NCT03860922 116 120 B-And
chronic NCT03860922 121 128 O
ankle NCT03860922 129 134 B-Modifier
pain NCT03860922 135 139 B-Condition
and NCT03860922 140 143 B-And
suspected NCT03860922 144 153 B-Assertion___Assertion_Type_Value:possible
clinically NCT03860922 154 164 O
to NCT03860922 165 167 O
have NCT03860922 168 172 O
impingement NCT03860922 173 184 B-Condition
syndrome NCT03860922 185 193 I-Condition
. NCT03860922 194 195 O

Exclusion NCT03860922 197 206 O
Criteria NCT03860922 207 215 O
: NCT03860922 216 217 O

1 NCT03860922 221 222 O
. NCT03860922 222 223 O
Inflammatory NCT03860922 225 237 B-Condition
arthritis NCT03860922 238 247 I-Condition
of NCT03860922 248 250 O
ankle NCT03860922 251 256 B-Modifier
joint NCT03860922 257 262 I-Modifier
, NCT03860922 263 264 O
infection NCT03860922 265 274 B-Condition
in NCT03860922 275 277 O
ankle NCT03860922 278 283 B-Modifier
joint NCT03860922 284 289 I-Modifier
, NCT03860922 290 291 O
neoplasm NCT03860922 292 300 B-Modifier
around NCT03860922 301 307 B-Modifier
ankle NCT03860922 308 313 I-Modifier
joint NCT03860922 314 319 I-Modifier
. NCT03860922 320 321 O

2 NCT03860922 325 326 O
. NCT03860922 326 327 O
Patients NCT03860922 329 337 O
with NCT03860922 338 342 O
contraindications NCT03860922 343 360 B-Contraindication
for NCT03860922 361 364 O
MRI NCT03860922 365 368 B-Procedure
, NCT03860922 369 370 O
e NCT03860922 371 372 O
. NCT03860922 373 374 O
g NCT03860922 375 376 O
. NCT03860922 377 378 O
an NCT03860922 380 382 O
implanted NCT03860922 383 392 B-Procedure
magnetic NCT03860922 393 401 I-Procedure
device NCT03860922 402 408 I-Procedure
, NCT03860922 409 410 O
pacemakers NCT03860922 411 421 B-Procedure
or NCT03860922 422 424 B-Or
claustrophobia NCT03860922 425 439 B-Condition
. NCT03860922 440 441 O

Inclusion NCT03926143 0 9 O
Criteria NCT03926143 10 18 O
: NCT03926143 19 20 O

- NCT03926143 24 25 O
Participants NCT03926143 27 39 O
ongoing NCT03926143 40 47 O
in NCT03926143 48 50 O
an NCT03926143 51 53 O
applicable NCT03926143 54 64 O
Bayer NCT03926143 65 70 O
- NCT03926143 71 72 O
sponsored NCT03926143 73 82 O
anetumab NCT03926143 83 91 B-Drug
ravtansine NCT03926143 92 102 I-Drug
parent NCT03926143 103 109 O
study NCT03926143 110 115 B-Study
at NCT03926143 116 118 O
the NCT03926143 119 122 O
time NCT03926143 123 127 O
of NCT03926143 128 130 O
its NCT03926143 131 134 O
planned NCT03926143 135 142 O
study NCT03926143 143 148 O
closure NCT03926143 149 156 O
. NCT03926143 157 158 O

- NCT03926143 162 163 O
For NCT03926143 165 168 O
on NCT03926143 169 171 B-Eq_Comparison
- NCT03926143 172 173 O
treatment NCT03926143 174 183 B-Procedure
participants NCT03926143 184 196 O
: NCT03926143 197 198 O
participant NCT03926143 199 210 O
is NCT03926143 211 213 O
eligible NCT03926143 214 222 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926143 223 225 O
receive NCT03926143 226 233 O
the NCT03926143 234 237 O
next NCT03926143 238 242 O
dose NCT03926143 243 247 O
of NCT03926143 248 250 O
study NCT03926143 251 256 B-Study
intervention NCT03926143 257 269 B-Drug
per NCT03926143 270 273 O
the NCT03926143 274 277 O
parent NCT03926143 278 284 O
study NCT03926143 285 290 O
protocol NCT03926143 291 299 O
. NCT03926143 300 301 O

Exclusion NCT03926143 303 312 O
Criteria NCT03926143 313 321 O
: NCT03926143 322 323 O

- NCT03926143 327 328 O
For NCT03926143 330 333 O
on NCT03926143 334 336 B-Eq_Comparison
- NCT03926143 337 338 O
treatment NCT03926143 339 348 B-Procedure
participants NCT03926143 349 361 O
: NCT03926143 362 363 O
a NCT03926143 364 365 O
positive NCT03926143 366 374 O
serum NCT03926143 375 380 B-Observation
pregnancy NCT03926143 381 390 I-Observation
test NCT03926143 391 395 I-Observation
. NCT03926143 396 397 O

- NCT03926143 401 402 O
For NCT03926143 404 407 O
on NCT03926143 408 410 B-Eq_Comparison
- NCT03926143 411 412 O
treatment NCT03926143 413 422 B-Procedure
participants NCT03926143 423 435 O
: NCT03926143 436 437 O
use NCT03926143 438 441 O
of NCT03926143 442 444 O
one NCT03926143 445 448 B-Eq_Comparison
or NCT03926143 449 451 I-Eq_Comparison
more NCT03926143 452 456 I-Eq_Comparison
of NCT03926143 457 459 O
the NCT03926143 460 463 O
prohibited NCT03926143 464 474 O
medications NCT03926143 475 486 B-Drug
listed NCT03926143 487 493 O
in NCT03926143 494 496 O
the NCT03926143 497 500 O
respective NCT03926143 501 511 O
parent NCT03926143 512 518 O
study NCT03926143 519 524 O
protocol NCT03926143 525 533 O
. NCT03926143 534 535 O

- NCT03926143 539 540 O
Participants NCT03926143 542 554 O
who NCT03926143 555 558 O
are NCT03926143 559 562 O
receiving NCT03926143 563 572 B-Eq_Comparison
standard NCT03926143 573 581 O
- NCT03926143 582 583 O
of NCT03926143 584 586 O
- NCT03926143 587 588 O
care NCT03926143 589 593 O
agent NCT03926143 594 599 B-Drug
( NCT03926143 600 601 I-Drug
s NCT03926143 602 603 I-Drug
) NCT03926143 604 605 I-Drug
but NCT03926143 606 609 B-And
not NCT03926143 610 613 B-Negation
anetumab NCT03926143 614 622 B-Drug
ravtansine NCT03926143 623 633 I-Drug
in NCT03926143 634 636 O
the NCT03926143 637 640 O
parent NCT03926143 641 647 O
study NCT03926143 648 653 O
, NCT03926143 654 655 O
and NCT03926143 656 659 B-And
are NCT03926143 660 663 O
able NCT03926143 664 668 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926143 669 671 I-Assertion___Assertion_Type_Value:hypothetical
receive NCT03926143 672 679 O
standard NCT03926143 680 688 O
- NCT03926143 689 690 O
of NCT03926143 691 693 O
- NCT03926143 694 695 O
care NCT03926143 696 700 O
agent NCT03926143 701 706 B-Drug
outside NCT03926143 707 714 B-Other
of NCT03926143 715 717 O
the NCT03926143 718 721 O
clinical NCT03926143 722 730 O
study NCT03926143 731 736 B-Study
. NCT03926143 737 738 O

Inclusion NCT03926520 0 9 O
Criteria NCT03926520 10 18 O
: NCT03926520 19 20 O

1 NCT03926520 24 25 O
. NCT03926520 25 26 O
Diagnosis NCT03926520 28 37 O
of NCT03926520 38 40 O
Alzheimer NCT03926520 41 50 B-Condition
's NCT03926520 50 52 I-Condition
Dementia NCT03926520 53 61 I-Condition
according NCT03926520 62 71 O
to NCT03926520 72 74 O
NIA NCT03926520 75 78 O
- NCT03926520 79 80 O
AA NCT03926520 81 83 O
Criteria NCT03926520 84 92 O
for NCT03926520 93 96 O
dementia NCT03926520 97 105 O
[ NCT03926520 106 107 O
55 NCT03926520 108 110 O
] NCT03926520 111 112 O

2 NCT03926520 116 117 O
. NCT03926520 117 118 O
MMSE NCT03926520 120 124 B-Observation
< NCT03926520 125 126 B-Eq_Comparison
15 NCT03926520 127 129 I-Eq_Comparison

3 NCT03926520 133 134 O
. NCT03926520 134 135 O
Cohen NCT03926520 137 142 B-Observation
- NCT03926520 143 144 I-Observation
Mansfield NCT03926520 145 154 I-Observation
Agitation NCT03926520 155 164 I-Observation
Inventory NCT03926520 165 174 I-Observation
Short NCT03926520 175 180 I-Observation
Version NCT03926520 181 188 I-Observation
( NCT03926520 189 190 O
CMAI NCT03926520 191 195 B-Observation
) NCT03926520 196 197 O
score NCT03926520 198 203 O
of NCT03926520 204 206 O
≥ NCT03926520 207 208 B-Eq_Comparison
4 NCT03926520 209 210 I-Eq_Comparison
on NCT03926520 211 213 O
at NCT03926520 214 216 B-Eq_Comparison
least NCT03926520 217 222 I-Eq_Comparison
one NCT03926520 223 226 I-Eq_Comparison
item NCT03926520 227 231 I-Eq_Comparison
, NCT03926520 232 233 O
a NCT03926520 234 235 O
score NCT03926520 236 241 O
of NCT03926520 242 244 O
3 NCT03926520 245 246 B-Eq_Comparison
on NCT03926520 247 249 I-Eq_Comparison
at NCT03926520 250 252 I-Eq_Comparison
least NCT03926520 253 258 I-Eq_Comparison
two NCT03926520 259 262 I-Eq_Comparison
items NCT03926520 263 268 I-Eq_Comparison
, NCT03926520 269 270 O
or NCT03926520 271 273 B-Or
a NCT03926520 274 275 O
score NCT03926520 276 281 O
of NCT03926520 282 284 O
2 NCT03926520 285 286 B-Eq_Comparison
on NCT03926520 287 289 I-Eq_Comparison
at NCT03926520 290 292 I-Eq_Comparison
least NCT03926520 293 298 I-Eq_Comparison
three NCT03926520 299 304 I-Eq_Comparison
items NCT03926520 305 310 I-Eq_Comparison
. NCT03926520 311 312 O

4 NCT03926520 316 317 O
. NCT03926520 317 318 O
At NCT03926520 320 322 B-Eq_Comparison
least NCT03926520 323 328 I-Eq_Comparison
one NCT03926520 329 332 I-Eq_Comparison
failed NCT03926520 333 339 O
pharmacological NCT03926520 340 355 B-Drug
intervention NCT03926520 356 368 O
to NCT03926520 369 371 O
manage NCT03926520 372 378 O
behavioral NCT03926520 379 389 B-Condition
symptoms NCT03926520 390 398 B-Assertion___Assertion_Type_Value:possible

5 NCT03926520 401 402 O
. NCT03926520 402 403 O
Medically NCT03926520 405 414 B-Condition
stable NCT03926520 415 421 O
for NCT03926520 422 425 B-Assertion___Assertion_Type_Value:hypothetical
safe NCT03926520 426 430 O
administration NCT03926520 431 445 O
of NCT03926520 446 448 O
ECT NCT03926520 449 452 B-Procedure
verified NCT03926520 453 461 O
by NCT03926520 462 464 O
standard NCT03926520 465 473 B-Procedure
physical NCT03926520 474 482 I-Procedure
examination NCT03926520 483 494 I-Procedure
, NCT03926520 495 496 O
urinalysis NCT03926520 497 507 B-Observation
and NCT03926520 508 511 O
serum NCT03926520 512 517 B-Observation
chemistries NCT03926520 518 529 I-Observation

6 NCT03926520 532 533 O
. NCT03926520 533 534 O
Comprehension NCT03926520 536 549 O
of NCT03926520 550 552 O
English NCT03926520 553 560 O
language NCT03926520 561 569 O

7 NCT03926520 572 573 O
. NCT03926520 573 574 O
Authorized NCT03926520 576 586 O
legal NCT03926520 587 592 O
representative NCT03926520 593 607 O
able NCT03926520 608 612 O
and NCT03926520 613 616 O
willing NCT03926520 617 624 O
to NCT03926520 625 627 O
give NCT03926520 628 632 O
informed NCT03926520 633 641 O
consent NCT03926520 642 649 O

8 NCT03926520 652 653 O
. NCT03926520 653 654 O
Age NCT03926520 656 659 B-Age
55 NCT03926520 660 662 B-Eq_Comparison
- NCT03926520 663 664 I-Eq_Comparison
89 NCT03926520 665 667 I-Eq_Comparison
years NCT03926520 668 673 I-Eq_Comparison
old NCT03926520 674 677 O
( NCT03926520 678 679 O
inclusive NCT03926520 680 689 O
) NCT03926520 690 691 O

Exclusion NCT03926520 693 702 O
Criteria NCT03926520 703 711 O
: NCT03926520 712 713 O

1 NCT03926520 717 718 O
. NCT03926520 718 719 O
Current NCT03926520 721 728 B-Eq_Comparison
diagnosis NCT03926520 729 738 O
of NCT03926520 739 741 O
co NCT03926520 742 744 B-Condition
- NCT03926520 745 746 I-Condition
morbid NCT03926520 747 753 I-Condition
delirium NCT03926520 754 762 I-Condition
, NCT03926520 763 764 O
measured NCT03926520 765 773 O
by NCT03926520 774 776 O
the NCT03926520 777 780 O
Confusion NCT03926520 781 790 B-Observation
Assessment NCT03926520 791 801 I-Observation
Measure NCT03926520 802 809 I-Observation
( NCT03926520 810 811 O
CAM NCT03926520 812 815 B-Observation
) NCT03926520 816 817 O
and NCT03926520 818 821 O
by NCT03926520 822 824 O
clinical NCT03926520 825 833 O
diagnosis NCT03926520 834 843 O

2 NCT03926520 846 847 O
. NCT03926520 847 848 O
Diagnosis NCT03926520 850 859 O
of NCT03926520 860 862 O
Non NCT03926520 863 866 B-Negation
- NCT03926520 867 868 O
AD NCT03926520 869 871 B-Condition
Dementia NCT03926520 872 880 B-Condition

3 NCT03926520 883 884 O
. NCT03926520 884 885 O
Lifetime NCT03926520 887 895 B-Eq_Comparison
or NCT03926520 896 898 B-Or
current NCT03926520 899 906 B-Eq_Comparison
diagnosis NCT03926520 907 916 O
of NCT03926520 917 919 O
Schizophrenia NCT03926520 920 933 B-Condition
, NCT03926520 934 935 O
Bipolar NCT03926520 936 943 B-Condition
Disorder NCT03926520 944 952 I-Condition
or NCT03926520 953 955 B-Or
Schizoaffective NCT03926520 956 971 B-Condition
Disorder NCT03926520 972 980 I-Condition

4 NCT03926520 983 984 O
. NCT03926520 984 985 O
Current NCT03926520 987 994 B-Eq_Comparison
episode NCT03926520 995 1002 O
of NCT03926520 1003 1005 O
Major NCT03926520 1006 1011 B-Modifier
Depressive NCT03926520 1012 1022 B-Condition
Disorder NCT03926520 1023 1031 I-Condition
( NCT03926520 1032 1033 O
MDD NCT03926520 1034 1037 B-Condition
) NCT03926520 1038 1039 O

5 NCT03926520 1043 1044 O
. NCT03926520 1044 1045 O
Active NCT03926520 1047 1053 B-Eq_Comparison
substance NCT03926520 1054 1063 B-Condition
use NCT03926520 1064 1067 I-Condition
disorder NCT03926520 1068 1076 I-Condition
within NCT03926520 1077 1083 B-Eq_Comparison
past NCT03926520 1084 1088 I-Eq_Comparison
6 NCT03926520 1089 1090 I-Eq_Comparison
months NCT03926520 1091 1097 I-Eq_Comparison

6 NCT03926520 1100 1101 O
. NCT03926520 1101 1102 O
Treatment NCT03926520 1104 1113 B-Procedure
with NCT03926520 1114 1118 O
ECT NCT03926520 1119 1122 B-Procedure
or NCT03926520 1123 1125 B-Or
other NCT03926520 1126 1131 O
neurostimulation NCT03926520 1132 1148 B-Procedure
therapies NCT03926520 1149 1158 I-Procedure
( NCT03926520 1159 1160 O
e NCT03926520 1161 1162 O
. NCT03926520 1163 1164 O
g NCT03926520 1165 1166 O
. NCT03926520 1167 1168 O
, NCT03926520 1169 1170 O
TMS NCT03926520 1171 1174 B-Procedure
or NCT03926520 1175 1177 O
vagal NCT03926520 1178 1183 B-Procedure
nerve NCT03926520 1184 1189 I-Procedure
stimulation NCT03926520 1190 1201 I-Procedure
) NCT03926520 1202 1203 O
within NCT03926520 1204 1210 B-Eq_Comparison
the NCT03926520 1211 1214 I-Eq_Comparison
past NCT03926520 1215 1219 I-Eq_Comparison
3 NCT03926520 1220 1221 I-Eq_Comparison
months NCT03926520 1222 1228 I-Eq_Comparison

Inclusion NCT03927820 0 9 O
Criteria NCT03927820 10 18 O
: NCT03927820 19 20 O

- NCT03927820 24 25 O
Adult NCT03927820 27 32 O
patient NCT03927820 33 40 O
admitted NCT03927820 41 49 B-Encounter
to NCT03927820 50 52 O
Vanderbilt NCT03927820 53 63 O
University NCT03927820 64 74 O
Medical NCT03927820 75 82 O
Center NCT03927820 83 89 O
( NCT03927820 90 91 O
VUMC NCT03927820 92 96 O
) NCT03927820 97 98 O
( NCT03927820 99 100 O
excluding NCT03927820 101 110 B-Exception
surgery NCT03927820 111 118 B-Provider
services NCT03927820 119 127 I-Provider
) NCT03927820 128 129 O

- NCT03927820 133 134 O
on NCT03927820 136 138 B-Eq_Comparison
a NCT03927820 139 140 O
long NCT03927820 141 145 B-Drug
acting NCT03927820 146 152 I-Drug
inhaler NCT03927820 153 160 I-Drug
or NCT03927820 161 163 B-Or
prescribed NCT03927820 164 174 O
a NCT03927820 175 176 O
long NCT03927820 177 181 B-Drug
acting NCT03927820 182 188 I-Drug
inhaler NCT03927820 189 196 I-Drug
during NCT03927820 197 203 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03927820 204 213 B-Encounter
. NCT03927820 214 215 O

Exclusion NCT03927820 217 226 O
Criteria NCT03927820 227 235 O
: NCT03927820 236 237 O

- NCT03927820 241 242 O
Diagnosis NCT03927820 244 253 O
of NCT03927820 254 256 O
cystic NCT03927820 257 263 B-Condition
fibrosis NCT03927820 264 272 I-Condition

- NCT03927820 275 276 O
Diagnosis NCT03927820 278 287 O
of NCT03927820 288 290 O
graft NCT03927820 291 296 B-Condition
versus NCT03927820 297 303 I-Condition
host NCT03927820 304 308 I-Condition
disease NCT03927820 309 316 I-Condition
( NCT03927820 317 318 O
GVHD NCT03927820 319 323 B-Condition
) NCT03927820 324 325 O

- NCT03927820 329 330 O
no NCT03927820 332 334 B-Negation
medication NCT03927820 335 345 O
insurance NCT03927820 346 355 O

- NCT03927820 358 359 O
discharge NCT03927820 361 370 B-Encounter
to NCT03927820 371 373 O
any NCT03927820 374 377 O
post NCT03927820 378 382 O
- NCT03927820 383 384 O
acute NCT03927820 385 390 O
care NCT03927820 391 395 O
facility NCT03927820 396 404 O
or NCT03927820 405 407 B-Or
inpatient NCT03927820 408 417 O
hospice NCT03927820 418 425 O

- NCT03927820 428 429 O
death NCT03927820 431 436 B-Death
during NCT03927820 437 443 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospitalization NCT03927820 444 459 B-Encounter

Inclusion NCT03862482 0 9 O
Criteria NCT03862482 10 18 O
: NCT03862482 19 20 O

- NCT03862482 24 25 O
non NCT03862482 27 30 B-Negation
- NCT03862482 31 32 O
smoker NCT03862482 33 39 B-Condition

- NCT03862482 42 43 O
no NCT03862482 45 47 B-Negation
temporomandibular NCT03862482 48 65 B-Condition
joint NCT03862482 66 71 I-Condition
( NCT03862482 72 73 O
TMJ NCT03862482 74 77 B-Condition
) NCT03862482 78 79 O
disorder NCT03862482 80 88 B-Modifier
or NCT03862482 89 91 B-Or
facial NCT03862482 92 98 B-Modifier
pain NCT03862482 99 103 B-Condition

- NCT03862482 106 107 O
having NCT03862482 109 115 O
partcipated NCT03862482 116 127 O
in NCT03862482 128 130 O
the NCT03862482 131 134 O
original NCT03862482 135 143 O
study NCT03862482 144 149 B-Study
( NCT03862482 150 151 O
1993 NCT03862482 152 156 B-Eq_Comparison
- NCT03862482 157 158 I-Eq_Comparison
1996 NCT03862482 159 163 I-Eq_Comparison
) NCT03862482 164 165 O
at NCT03862482 166 168 O
which NCT03862482 169 174 O
time NCT03862482 175 179 O
the NCT03862482 180 183 O
mnimum NCT03862482 184 190 O
participate NCT03862482 191 202 O
age NCT03862482 203 206 B-Age
was NCT03862482 207 210 O
25 NCT03862482 211 213 B-Eq_Comparison
years NCT03862482 214 219 I-Eq_Comparison
and NCT03862482 220 223 B-And
the NCT03862482 224 227 O
maximum NCT03862482 228 235 B-Eq_Comparison
56 NCT03862482 236 238 I-Eq_Comparison
years NCT03862482 239 244 I-Eq_Comparison
. NCT03862482 245 246 O

Exclusion NCT03862482 248 257 O
Criteria NCT03862482 258 266 O
: NCT03862482 267 268 O

- NCT03862482 272 273 O
refusal NCT03862482 275 282 O
to NCT03862482 283 285 O
sign NCT03862482 286 290 O
informed NCT03862482 291 299 O
consent NCT03862482 300 307 O
documents NCT03862482 308 317 O
. NCT03862482 318 319 O

Inclusion NCT03924557 0 9 O
Criteria NCT03924557 10 18 O
: NCT03924557 19 20 O

- NCT03924557 24 25 O
Must NCT03924557 27 31 O
have NCT03924557 32 36 O
a NCT03924557 37 38 O
clinical NCT03924557 39 47 O
diagnosis NCT03924557 48 57 O
of NCT03924557 58 60 O
solid NCT03924557 61 66 B-Modifier
tumor NCT03924557 67 72 I-Modifier
cancer NCT03924557 73 79 B-Condition
and NCT03924557 80 83 O
be NCT03924557 84 86 O
seeking NCT03924557 87 94 B-Assertion___Assertion_Type_Value:intention
treatment NCT03924557 95 104 B-Procedure
and NCT03924557 105 108 B-And
supportive NCT03924557 109 119 B-Procedure
care NCT03924557 120 124 I-Procedure
at NCT03924557 125 127 O
the NCT03924557 128 131 O
UF NCT03924557 132 134 O
Health NCT03924557 135 141 O
Cancer NCT03924557 142 148 O
Center NCT03924557 149 155 O
( NCT03924557 156 157 O
Medical NCT03924557 158 165 O
Plaza NCT03924557 166 171 O
) NCT03924557 172 173 O

- NCT03924557 177 178 O
Patients NCT03924557 180 188 O
must NCT03924557 189 193 O
plan NCT03924557 194 198 B-Eq_Comparison
to NCT03924557 199 201 O
receive NCT03924557 202 209 O
chemotherapy NCT03924557 210 222 B-Procedure
known NCT03924557 223 228 O
to NCT03924557 229 231 O
be NCT03924557 232 234 O
associated NCT03924557 235 245 O
with NCT03924557 246 250 O
the NCT03924557 251 254 O
need NCT03924557 255 259 O
for NCT03924557 260 263 O
supportive NCT03924557 264 274 O
care NCT03924557 275 279 O
within NCT03924557 280 286 B-Eq_Comparison
30 NCT03924557 287 289 I-Eq_Comparison
days NCT03924557 290 294 I-Eq_Comparison
of NCT03924557 295 297 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03924557 298 308 B-Study

- NCT03924557 311 312 O
Life NCT03924557 314 318 B-Observation
expectancy NCT03924557 319 329 I-Observation
must NCT03924557 330 334 O
be NCT03924557 335 337 O
greater NCT03924557 338 345 B-Eq_Comparison
than NCT03924557 346 350 I-Eq_Comparison
6 NCT03924557 351 352 I-Eq_Comparison
months NCT03924557 353 359 I-Eq_Comparison

- NCT03924557 362 363 O
Must NCT03924557 365 369 O
have NCT03924557 370 374 O
Eastern NCT03924557 375 382 B-Observation
Cooperative NCT03924557 383 394 I-Observation
Oncology NCT03924557 395 403 I-Observation
Group NCT03924557 404 409 I-Observation
( NCT03924557 410 411 O
ECOG NCT03924557 412 416 B-Observation
) NCT03924557 417 418 O
performance NCT03924557 419 430 O
status NCT03924557 431 437 O
of NCT03924557 438 440 O
0 NCT03924557 441 442 B-Eq_Comparison
- NCT03924557 443 444 I-Eq_Comparison
2 NCT03924557 445 446 I-Eq_Comparison

- NCT03924557 450 451 O
Written NCT03924557 453 460 O
informed NCT03924557 461 469 O
consent NCT03924557 470 477 O
obtained NCT03924557 478 486 O
from NCT03924557 487 491 O
the NCT03924557 492 495 O
patient NCT03924557 496 503 O

- NCT03924557 506 507 O
The NCT03924557 509 512 O
ability NCT03924557 513 520 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03924557 521 524 O
the NCT03924557 525 528 O
patient NCT03924557 529 536 O
to NCT03924557 537 539 O
comply NCT03924557 540 546 O
with NCT03924557 547 551 O
all NCT03924557 552 555 O
the NCT03924557 556 559 O
study NCT03924557 560 565 B-Study
- NCT03924557 566 567 O
related NCT03924557 568 575 O
procedures NCT03924557 576 586 B-Procedure
. NCT03924557 587 588 O

Exclusion NCT03924557 590 599 O
Criteria NCT03924557 600 608 O
: NCT03924557 609 610 O

- NCT03924557 614 615 O
Patients NCT03924557 617 625 O
unwilling NCT03924557 626 635 O
or NCT03924557 636 638 O
unable NCT03924557 639 645 O
to NCT03924557 646 648 O
provide NCT03924557 649 656 O
voluntary NCT03924557 657 666 O
informed NCT03924557 667 675 O
consent NCT03924557 676 683 O

- NCT03924557 686 687 O
Patients NCT03924557 689 697 O
who NCT03924557 698 701 O
are NCT03924557 702 705 O
unwilling NCT03924557 706 715 O
or NCT03924557 716 718 O
unable NCT03924557 719 725 O
to NCT03924557 726 728 O
comply NCT03924557 729 735 O
with NCT03924557 736 740 O
protocol NCT03924557 741 749 O
requirement NCT03924557 750 761 O
and NCT03924557 762 765 O
/ NCT03924557 766 767 O
or NCT03924557 768 770 O
follow NCT03924557 771 777 O
- NCT03924557 778 779 O
up NCT03924557 780 782 O
procedures NCT03924557 783 793 O

- NCT03924557 796 797 O
Patients NCT03924557 799 807 O
planned NCT03924557 808 815 B-Eq_Comparison
to NCT03924557 816 818 I-Eq_Comparison
undergo NCT03924557 819 826 I-Eq_Comparison
cancer NCT03924557 827 833 B-Condition
therapy NCT03924557 834 841 B-Procedure
other NCT03924557 842 847 B-Exception
than NCT03924557 848 852 I-Exception
chemotherapy NCT03924557 853 865 B-Procedure
( NCT03924557 866 867 O
i NCT03924557 868 869 O
. NCT03924557 870 871 O
e NCT03924557 872 873 O
. NCT03924557 874 875 O
, NCT03924557 876 877 O
radiation NCT03924557 878 887 B-Procedure
, NCT03924557 888 889 O
surgery NCT03924557 890 897 B-Procedure
or NCT03924557 898 900 B-Or
hormonal NCT03924557 901 909 B-Procedure
treatment NCT03924557 910 919 I-Procedure
alone NCT03924557 920 925 O
) NCT03924557 926 927 O

- NCT03924557 931 932 O
Prisoners NCT03924557 934 943 B-Observation
or NCT03924557 944 946 B-Or
patients NCT03924557 947 955 O
who NCT03924557 956 959 O
are NCT03924557 960 963 O
involuntarily NCT03924557 964 977 B-Observation
incarcerated NCT03924557 978 990 I-Observation
. NCT03924557 991 992 O
Patients NCT03924557 994 1002 O
who NCT03924557 1003 1006 O
are NCT03924557 1007 1010 O
compulsorily NCT03924557 1011 1023 O
detained NCT03924557 1024 1032 O
for NCT03924557 1033 1036 O
treatment NCT03924557 1037 1046 B-Procedure
of NCT03924557 1047 1049 O
either NCT03924557 1050 1056 O
a NCT03924557 1057 1058 O
psychiatric NCT03924557 1059 1070 B-Modifier
or NCT03924557 1071 1073 B-Or
physical NCT03924557 1074 1082 B-Modifier
illness NCT03924557 1083 1090 B-Condition
. NCT03924557 1091 1092 O

Inclusion NCT03869879 0 9 O
Criteria NCT03869879 10 18 O
: NCT03869879 19 20 O

- NCT03869879 24 25 O
60 NCT03869879 27 29 B-Eq_Comparison
- NCT03869879 30 31 I-Eq_Comparison
89 NCT03869879 32 34 I-Eq_Comparison
years NCT03869879 35 40 I-Eq_Comparison
old NCT03869879 41 44 B-Age

- NCT03869879 47 48 O
gait NCT03869879 50 54 B-Condition
disturbances NCT03869879 55 67 I-Condition
requiring NCT03869879 68 77 B-Assertion___Assertion_Type_Value:hypothetical
physical NCT03869879 78 86 B-Procedure
therapy NCT03869879 87 94 I-Procedure

Exclusion NCT03869879 95 104 O
Criteria NCT03869879 105 113 O
: NCT03869879 114 115 O

- NCT03869879 119 120 O
unable NCT03869879 122 128 O
to NCT03869879 129 131 O
follow NCT03869879 132 138 O
instructions NCT03869879 139 151 O
( NCT03869879 152 153 O
up NCT03869879 154 156 O
to NCT03869879 157 159 O
the NCT03869879 160 163 O
practitioner NCT03869879 164 176 O
's NCT03869879 176 178 O
judgement NCT03869879 179 188 O
) NCT03869879 189 190 O

Inclusion NCT03867630 0 9 O
Criteria NCT03867630 10 18 O
: NCT03867630 19 20 O

- NCT03867630 24 25 O
20 NCT03867630 27 29 B-Eq_Comparison
to NCT03867630 30 32 I-Eq_Comparison
80 NCT03867630 33 35 I-Eq_Comparison
years NCT03867630 36 41 I-Eq_Comparison
old NCT03867630 42 45 B-Age

- NCT03867630 48 49 O
Patients NCT03867630 51 59 O
with NCT03867630 60 64 O
a NCT03867630 65 66 O
herniated NCT03867630 67 76 B-Condition
disc NCT03867630 77 81 I-Condition
, NCT03867630 82 83 O
spinal NCT03867630 84 90 B-Condition
stenosis NCT03867630 91 99 I-Condition

- NCT03867630 102 103 O
Patients NCT03867630 105 113 O
with NCT03867630 114 118 O
chronic NCT03867630 119 126 O
low NCT03867630 127 130 B-Modifier
back NCT03867630 131 135 I-Modifier
pain NCT03867630 136 140 B-Condition
and NCT03867630 141 144 B-Or
lower NCT03867630 145 150 B-Modifier
extremity NCT03867630 151 160 I-Modifier
pain NCT03867630 161 165 B-Condition
who NCT03867630 166 169 B-And
did NCT03867630 170 173 O
not NCT03867630 174 177 O
respond NCT03867630 178 185 O
to NCT03867630 186 188 O
lumbar NCT03867630 189 195 B-Modifier
epidural NCT03867630 196 204 B-Procedure
steroid NCT03867630 205 212 I-Procedure
injections NCT03867630 213 223 I-Procedure

- NCT03867630 226 227 O
Patients NCT03867630 229 237 O
who NCT03867630 238 241 O
are NCT03867630 242 245 O
performed NCT03867630 246 255 B-Eq_Comparison
percutaneous NCT03867630 256 268 B-Procedure
epidural NCT03867630 269 277 I-Procedure
neuroplasty NCT03867630 278 289 I-Procedure
with NCT03867630 290 294 O
wire NCT03867630 295 299 B-Procedure
type NCT03867630 300 304 I-Procedure
catheter NCT03867630 305 313 I-Procedure
. NCT03867630 314 315 O

Exclusion NCT03867630 317 326 O
Criteria NCT03867630 327 335 O
: NCT03867630 336 337 O

- NCT03867630 341 342 O
Incomplete NCT03867630 344 354 O
medical NCT03867630 355 362 O
record NCT03867630 363 369 O

- NCT03867630 372 373 O
Contraindication NCT03867630 375 391 B-Contraindication
to NCT03867630 392 394 O
percutaneous NCT03867630 395 407 B-Procedure
epidural NCT03867630 408 416 I-Procedure
neuroplasty NCT03867630 417 428 I-Procedure

Inclusion NCT03921138 0 9 O
Criteria NCT03921138 10 18 O
: NCT03921138 19 20 O

- NCT03921138 24 25 O
patients NCT03921138 27 35 O
who NCT03921138 36 39 O
underwent NCT03921138 40 49 B-Eq_Comparison
benign NCT03921138 50 56 B-Modifier
laparoscopic NCT03921138 57 69 B-Procedure
hysterectomy NCT03921138 70 82 I-Procedure
with NCT03921138 83 87 B-And
systematic NCT03921138 88 98 B-Procedure
salpingectomy NCT03921138 99 112 I-Procedure

Exclusion NCT03921138 113 122 O
Criteria NCT03921138 123 131 O
: NCT03921138 132 133 O

- NCT03921138 137 138 O
Hysterectomy NCT03921138 140 152 B-Procedure
in NCT03921138 153 155 O
a NCT03921138 156 157 O
context NCT03921138 158 165 B-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03921138 166 168 I-Temporal_Connection___Temporal_Connection_Type_Value:during
gynecologic NCT03921138 169 180 B-Condition
cancer NCT03921138 181 187 I-Condition

- NCT03921138 190 191 O
Hysterectomy NCT03921138 193 205 B-Procedure
not NCT03921138 206 209 B-Negation
carried NCT03921138 210 217 O
out NCT03921138 218 221 O
using NCT03921138 222 227 O
laparoscopy NCT03921138 228 239 B-Procedure

- NCT03921138 242 243 O
Fimbriated NCT03921138 245 255 B-Condition
end NCT03921138 256 259 I-Condition
missing NCT03921138 260 267 B-Modifier
or NCT03921138 268 270 B-Or
damaged NCT03921138 271 278 B-Modifier
or NCT03921138 279 281 O
impossible NCT03921138 282 292 O
for NCT03921138 293 296 O
pathologist NCT03921138 297 308 O
to NCT03921138 309 311 O
analyze NCT03921138 312 319 O

Inclusion NCT03921840 0 9 O
Criteria NCT03921840 10 18 O
: NCT03921840 19 20 O

- NCT03921840 24 25 O
Intact NCT03921840 27 33 B-Condition
cognition NCT03921840 34 43 I-Condition

- NCT03921840 46 47 O
Poor NCT03921840 49 53 B-Condition
sleep NCT03921840 54 59 I-Condition
quality NCT03921840 60 67 I-Condition

- NCT03921840 70 71 O
Self NCT03921840 73 77 O
- NCT03921840 78 79 O
reported NCT03921840 80 88 O
presence NCT03921840 89 97 O
of NCT03921840 98 100 O
pain NCT03921840 101 105 B-Condition

- NCT03921840 108 109 O
Capacity NCT03921840 111 119 O
for NCT03921840 120 123 O
mild NCT03921840 124 128 O
to NCT03921840 129 131 B-Or
moderate NCT03921840 132 140 O
physical NCT03921840 141 149 B-Observation
activity NCT03921840 150 158 I-Observation
. NCT03921840 159 160 O

Exclusion NCT03921840 162 171 O
Criteria NCT03921840 172 180 O
: NCT03921840 181 182 O

- NCT03921840 186 187 O
Non NCT03921840 189 192 B-Negation
- NCT03921840 193 194 O
ambulatory NCT03921840 195 205 B-Condition
or NCT03921840 206 208 B-Or
have NCT03921840 209 213 O
severely NCT03921840 214 222 O
impaired NCT03921840 223 231 B-Condition
mobility NCT03921840 232 240 I-Condition
, NCT03921840 241 242 O

- NCT03921840 246 247 O
Visual NCT03921840 249 255 B-Modifier
or NCT03921840 256 258 B-Or
hearing NCT03921840 259 266 B-Modifier
impairment NCT03921840 267 277 B-Condition
that NCT03921840 278 282 O
interfered NCT03921840 283 293 O
with NCT03921840 294 298 O
assessments NCT03921840 299 310 O
, NCT03921840 311 312 O
and NCT03921840 313 316 O

- NCT03921840 319 320 O
An NCT03921840 322 324 O
acute NCT03921840 325 330 O
or NCT03921840 331 333 B-Or
a NCT03921840 334 335 O
terminal NCT03921840 336 344 B-Modifier
illness NCT03921840 345 352 B-Condition

- NCT03921840 355 356 O
Neuropathic NCT03921840 358 369 B-Modifier
pain NCT03921840 370 374 B-Condition

Inclusion NCT03860025 0 9 O
Criteria NCT03860025 10 18 O
: NCT03860025 19 20 O

- NCT03860025 24 25 O
patients NCT03860025 27 35 O
with NCT03860025 36 40 O
one NCT03860025 41 44 B-Eq_Comparison
or NCT03860025 45 47 I-Eq_Comparison
more NCT03860025 48 52 I-Eq_Comparison
events NCT03860025 53 59 O
of NCT03860025 60 62 O
hip NCT03860025 63 66 B-Condition
dislocation NCT03860025 67 78 I-Condition
after NCT03860025 79 84 B-Temporal_Connection___Temporal_Connection_Type_Value:after
a NCT03860025 85 86 O
primary NCT03860025 87 94 B-Modifier
THA NCT03860025 95 98 B-Procedure

- NCT03860025 101 102 O
controls NCT03860025 104 112 O
with NCT03860025 113 117 O
a NCT03860025 118 119 O
primary NCT03860025 120 127 B-Modifier
THA NCT03860025 128 131 B-Procedure
without NCT03860025 132 139 B-Negation
events NCT03860025 140 146 O
of NCT03860025 147 149 O
hip NCT03860025 150 153 B-Condition
dislocation NCT03860025 154 165 I-Condition

Exclusion NCT03860025 166 175 O
Criteria NCT03860025 176 184 O
: NCT03860025 185 186 O

- NCT03860025 189 190 O

Inclusion NCT03929276 0 9 O
Criteria NCT03929276 10 18 O
: NCT03929276 19 20 O

- NCT03929276 24 25 O
Subjects NCT03929276 27 35 O
with NCT03929276 36 40 O
adhesive NCT03929276 41 49 B-Condition
capsulitis NCT03929276 50 60 I-Condition
diagnosis NCT03929276 61 70 O
by NCT03929276 71 73 O
physical NCT03929276 74 82 B-Procedure
examination NCT03929276 83 94 I-Procedure
( NCT03929276 95 96 O
Compared NCT03929276 97 105 O
with NCT03929276 106 110 O
intact NCT03929276 111 117 O
side NCT03929276 118 122 O
, NCT03929276 123 124 O
there NCT03929276 125 130 O
is NCT03929276 131 133 O
more NCT03929276 134 138 B-Eq_Comparison
than NCT03929276 139 143 I-Eq_Comparison
25 NCT03929276 144 146 I-Eq_Comparison
% NCT03929276 147 148 I-Eq_Comparison
limitation NCT03929276 149 159 O
in NCT03929276 160 162 O
at NCT03929276 163 165 B-Eq_Comparison
least NCT03929276 166 171 I-Eq_Comparison
two NCT03929276 172 175 I-Eq_Comparison
directions NCT03929276 176 186 I-Eq_Comparison
of NCT03929276 187 189 O
shoulder NCT03929276 190 198 B-Observation
range NCT03929276 199 204 I-Observation
of NCT03929276 205 207 I-Observation
motion NCT03929276 208 214 I-Observation
) NCT03929276 215 216 O

- NCT03929276 220 221 O
Subjects NCT03929276 223 231 O
have NCT03929276 232 236 O
complaints NCT03929276 237 247 B-Condition
for NCT03929276 248 251 O
at NCT03929276 252 254 B-Eq_Comparison
least NCT03929276 255 260 I-Eq_Comparison
1 NCT03929276 261 262 I-Eq_Comparison
month NCT03929276 263 268 I-Eq_Comparison

- NCT03929276 271 272 O
No NCT03929276 274 276 B-Negation
pregnancy NCT03929276 277 286 B-Condition
/ NCT03929276 287 288 B-Or
breastfeeding NCT03929276 289 302 B-Condition

Exclusion NCT03929276 303 312 O
Criteria NCT03929276 313 321 O
: NCT03929276 322 323 O

- NCT03929276 327 328 O
History NCT03929276 330 337 B-Eq_Comparison
of NCT03929276 338 340 O
bilateral NCT03929276 341 350 B-Modifier
adhesive NCT03929276 351 359 B-Condition
capsulitis NCT03929276 360 370 I-Condition

- NCT03929276 373 374 O
History NCT03929276 376 383 B-Eq_Comparison
of NCT03929276 384 386 O
shoulder NCT03929276 387 395 B-Modifier
trauma NCT03929276 396 402 B-Condition
, NCT03929276 403 404 O
fracture NCT03929276 405 413 B-Condition
, NCT03929276 414 415 O
shoulder NCT03929276 416 424 B-Procedure
shoulder NCT03929276 425 433 I-Procedure
surgery NCT03929276 434 441 I-Procedure
, NCT03929276 442 443 O
calcific NCT03929276 444 452 B-Condition
tendinopathy NCT03929276 453 465 I-Condition
, NCT03929276 466 467 O
glenohumeral NCT03929276 468 480 B-Condition
osteoarthritis NCT03929276 481 495 I-Condition
, NCT03929276 496 497 O
inflammatory NCT03929276 498 510 B-Condition
rheumatic NCT03929276 511 520 I-Condition
diseases NCT03929276 521 529 I-Condition
, NCT03929276 530 531 O
tumor NCT03929276 532 537 B-Condition
, NCT03929276 538 539 O
infection NCT03929276 540 549 B-Condition

- NCT03929276 552 553 O
History NCT03929276 555 562 B-Eq_Comparison
of NCT03929276 563 565 O
corticosteroid NCT03929276 566 580 B-Drug
injection NCT03929276 581 590 O
in NCT03929276 591 593 O
the NCT03929276 594 597 O
shoulder NCT03929276 598 606 B-Modifier
during NCT03929276 607 613 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03929276 614 617 O
last NCT03929276 618 622 B-Eq_Comparison
3 NCT03929276 623 624 I-Eq_Comparison
months NCT03929276 625 631 I-Eq_Comparison

- NCT03929276 634 635 O
History NCT03929276 637 644 B-Eq_Comparison
of NCT03929276 645 647 O
recent NCT03929276 648 654 B-Eq_Comparison
lung NCT03929276 655 659 B-Modifier
, NCT03929276 660 661 O
breast NCT03929276 662 668 B-Modifier
or NCT03929276 669 671 B-Or
bypass NCT03929276 672 678 B-Modifier
surgery NCT03929276 679 686 B-Procedure

- NCT03929276 689 690 O
History NCT03929276 692 699 B-Eq_Comparison
of NCT03929276 700 702 O
cervical NCT03929276 703 711 B-Condition
radiculopathy NCT03929276 712 725 I-Condition
/ NCT03929276 726 727 B-Or
brachial NCT03929276 728 736 B-Condition
plexus NCT03929276 737 743 I-Condition
lesion NCT03929276 744 750 I-Condition

- NCT03929276 753 754 O
History NCT03929276 756 763 B-Eq_Comparison
of NCT03929276 764 766 O
neuromuscular NCT03929276 767 780 B-Condition
disease NCT03929276 781 788 I-Condition

- NCT03929276 791 792 O
History NCT03929276 794 801 B-Eq_Comparison
of NCT03929276 802 804 O
physical NCT03929276 805 813 B-Procedure
therapy NCT03929276 814 821 I-Procedure
program NCT03929276 822 829 O
for NCT03929276 830 833 O
the NCT03929276 834 837 O
same NCT03929276 838 842 B-Modifier
shoulder NCT03929276 843 851 I-Modifier
in NCT03929276 852 854 O
the NCT03929276 855 858 O
last NCT03929276 859 863 B-Eq_Comparison
6 NCT03929276 864 865 I-Eq_Comparison
months NCT03929276 866 872 I-Eq_Comparison

Inclusion NCT03862079 0 9 O
Criteria NCT03862079 10 18 O
: NCT03862079 19 20 O

- NCT03862079 24 25 O
Patients NCT03862079 27 35 O
who NCT03862079 36 39 O
are NCT03862079 40 43 O
day NCT03862079 44 47 B-Eq_Comparison
- NCT03862079 48 49 I-Eq_Comparison
10 NCT03862079 50 52 I-Eq_Comparison
pre NCT03862079 53 56 I-Eq_Comparison
- NCT03862079 57 58 I-Eq_Comparison
to NCT03862079 59 61 I-Eq_Comparison
day NCT03862079 62 65 I-Eq_Comparison
+ NCT03862079 66 67 I-Eq_Comparison
30 NCT03862079 68 70 I-Eq_Comparison
post NCT03862079 71 75 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03862079 76 77 O
allogeneic NCT03862079 78 88 B-Procedure
hematopoietic NCT03862079 89 102 I-Procedure
cell NCT03862079 103 107 I-Procedure
transplant NCT03862079 108 118 I-Procedure
( NCT03862079 119 120 O
AHCT NCT03862079 121 125 B-Procedure
) NCT03862079 126 127 O
from NCT03862079 128 132 O
any NCT03862079 133 136 O
donor NCT03862079 137 142 B-Modifier
or NCT03862079 143 145 B-Or
graft NCT03862079 146 151 B-Modifier
source NCT03862079 152 158 I-Modifier
and NCT03862079 159 162 B-And
for NCT03862079 163 166 O
any NCT03862079 167 170 O
conditioning NCT03862079 171 183 B-Procedure
regimen NCT03862079 184 191 I-Procedure

- NCT03862079 194 195 O
Patients NCT03862079 197 205 O
who NCT03862079 206 209 O
have NCT03862079 210 214 O
received NCT03862079 215 223 B-Eq_Comparison
treatment NCT03862079 224 233 B-Procedure
with NCT03862079 234 238 O
meropenem NCT03862079 239 248 B-Drug
or NCT03862079 249 251 B-Or
piperacillin NCT03862079 252 264 B-Drug
- NCT03862079 265 266 I-Drug
tazobactam NCT03862079 267 277 I-Drug
( NCT03862079 278 279 O
pip NCT03862079 280 283 B-Drug
- NCT03862079 284 285 I-Drug
tazo NCT03862079 286 290 I-Drug
) NCT03862079 291 292 O
intravenously NCT03862079 293 306 B-Modifier
( NCT03862079 307 308 O
IV NCT03862079 309 311 B-Modifier
) NCT03862079 312 313 O
( NCT03862079 314 315 O
of NCT03862079 316 318 O
at NCT03862079 319 321 B-Eq_Comparison
least NCT03862079 322 327 I-Eq_Comparison
24 NCT03862079 328 330 I-Eq_Comparison
hours NCT03862079 331 336 I-Eq_Comparison
duration NCT03862079 337 345 I-Eq_Comparison
) NCT03862079 346 347 O
in NCT03862079 348 350 O
past NCT03862079 351 355 B-Eq_Comparison
7 NCT03862079 356 357 I-Eq_Comparison
days NCT03862079 358 362 I-Eq_Comparison

- NCT03862079 365 366 O
Controlled NCT03862079 368 378 B-Modifier
infection NCT03862079 379 388 B-Condition
defined NCT03862079 389 396 O
as NCT03862079 397 399 O
hemodynamically NCT03862079 400 415 B-Condition
stable NCT03862079 416 422 O
and NCT03862079 423 426 B-And
not NCT03862079 427 430 B-Negation
requiring NCT03862079 431 440 B-Assertion___Assertion_Type_Value:hypothetical
supplemental NCT03862079 441 453 B-Observation
oxygen NCT03862079 454 460 I-Observation
of NCT03862079 461 463 O
more NCT03862079 464 468 B-Eq_Comparison
than NCT03862079 469 473 I-Eq_Comparison
2 NCT03862079 474 475 I-Eq_Comparison
liters NCT03862079 476 482 I-Eq_Comparison
via NCT03862079 483 486 I-Eq_Comparison
nasal NCT03862079 487 492 B-Modifier
cannula NCT03862079 493 500 I-Modifier

- NCT03862079 503 504 O
Patients NCT03862079 506 514 O
who NCT03862079 515 518 O
are NCT03862079 519 522 O
able NCT03862079 523 527 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862079 528 530 I-Assertion___Assertion_Type_Value:hypothetical
take NCT03862079 531 535 O
oral NCT03862079 536 540 B-Drug
medications NCT03862079 541 552 I-Drug
in NCT03862079 553 555 O
suspension NCT03862079 556 566 B-Modifier
form NCT03862079 567 571 I-Modifier

- NCT03862079 574 575 O
Patients NCT03862079 577 585 O
who NCT03862079 586 589 O
are NCT03862079 590 593 O
able NCT03862079 594 598 O
to NCT03862079 599 601 O
provide NCT03862079 602 609 O
informed NCT03862079 610 618 O
consent NCT03862079 619 626 O
( NCT03862079 627 628 O
IC NCT03862079 629 631 O
) NCT03862079 632 633 O
and NCT03862079 634 637 O
comply NCT03862079 638 644 O
with NCT03862079 645 649 O
all NCT03862079 650 653 O
study NCT03862079 654 659 O
visits NCT03862079 660 666 O
and NCT03862079 667 670 O
procedures NCT03862079 671 681 O

Exclusion NCT03862079 682 691 O
Criteria NCT03862079 692 700 O
: NCT03862079 701 702 O

- NCT03862079 706 707 O
Patients NCT03862079 709 717 O
who NCT03862079 718 721 O
are NCT03862079 722 725 O
anticipated NCT03862079 726 737 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862079 738 740 I-Assertion___Assertion_Type_Value:hypothetical
require NCT03862079 741 748 O
continued NCT03862079 749 758 O
broad NCT03862079 759 764 B-Modifier
spectrum NCT03862079 765 773 I-Modifier
antibiotics NCT03862079 774 785 B-Drug
with NCT03862079 786 790 B-And
meropenem NCT03862079 791 800 B-Drug
or NCT03862079 801 803 B-Or
pip NCT03862079 804 807 B-Drug
- NCT03862079 808 809 I-Drug
tazo NCT03862079 810 814 I-Drug
IV NCT03862079 815 817 B-Modifier
for NCT03862079 818 821 O
> NCT03862079 822 823 B-Eq_Comparison
96 NCT03862079 824 826 I-Eq_Comparison
hours NCT03862079 827 832 I-Eq_Comparison
post NCT03862079 833 837 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03862079 838 839 O
engraftment NCT03862079 840 851 B-Procedure
such NCT03862079 852 856 O
as NCT03862079 857 859 O
for NCT03862079 860 863 O
known NCT03862079 864 869 O
, NCT03862079 870 871 O
documented NCT03862079 872 882 O
infections NCT03862079 883 893 B-Condition
necessitating NCT03862079 894 907 B-Assertion___Assertion_Type_Value:hypothetical
prolonged NCT03862079 908 917 O
treatment NCT03862079 918 927 B-Procedure

- NCT03862079 930 931 O
Patients NCT03862079 933 941 O
with NCT03862079 942 946 O
a NCT03862079 947 948 O
prior NCT03862079 949 954 B-Eq_Comparison
documented NCT03862079 955 965 O
infection NCT03862079 966 975 B-Condition
with NCT03862079 976 980 O
mycormycetes NCT03862079 981 993 B-Organism

- NCT03862079 996 997 O
Patients NCT03862079 999 1007 O
who NCT03862079 1008 1011 O
are NCT03862079 1012 1015 O
greater NCT03862079 1016 1023 B-Eq_Comparison
than NCT03862079 1024 1028 I-Eq_Comparison
2 NCT03862079 1029 1030 I-Eq_Comparison
days NCT03862079 1031 1035 I-Eq_Comparison
from NCT03862079 1036 1040 B-Temporal_Connection___Temporal_Connection_Type_Value:after
time NCT03862079 1041 1045 O
of NCT03862079 1046 1048 O
neutrophil NCT03862079 1049 1059 B-Procedure
engraftment NCT03862079 1060 1071 I-Procedure
post NCT03862079 1072 1076 B-Temporal_Connection___Temporal_Connection_Type_Value:after
AHCT NCT03862079 1077 1081 B-Procedure

- NCT03862079 1084 1085 O
Patients NCT03862079 1087 1095 O
with NCT03862079 1096 1100 O
active NCT03862079 1101 1107 B-Eq_Comparison
enteric NCT03862079 1108 1115 B-Modifier
infections NCT03862079 1116 1126 B-Condition

- NCT03862079 1129 1130 O
Patients NCT03862079 1132 1140 O
with NCT03862079 1141 1145 O
acute NCT03862079 1146 1151 O
GVHD NCT03862079 1152 1156 B-Condition
> NCT03862079 1157 1158 B-Eq_Comparison
= NCT03862079 1159 1160 I-Eq_Comparison
grade NCT03862079 1161 1166 I-Eq_Comparison
II NCT03862079 1167 1169 I-Eq_Comparison

- NCT03862079 1172 1173 O
Patients NCT03862079 1175 1183 O
unwilling NCT03862079 1184 1193 B-Assertion___Assertion_Type_Value:hypothetical
or NCT03862079 1194 1196 B-Or
unable NCT03862079 1197 1203 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03862079 1204 1206 O
undergo NCT03862079 1207 1214 O
the NCT03862079 1215 1218 O
FMT NCT03862079 1219 1222 B-Procedure
via NCT03862079 1223 1226 O
retention NCT03862079 1227 1236 B-Procedure
enema NCT03862079 1237 1242 I-Procedure
procedure NCT03862079 1243 1252 I-Procedure

- NCT03862079 1255 1256 O
Patients NCT03862079 1258 1266 O
who NCT03862079 1267 1270 O
have NCT03862079 1271 1275 O
received NCT03862079 1276 1284 B-Eq_Comparison
treatment NCT03862079 1285 1294 B-Procedure
with NCT03862079 1295 1299 O
an NCT03862079 1300 1302 O
investigational NCT03862079 1303 1318 B-Study
agent NCT03862079 1319 1324 B-Drug
within NCT03862079 1325 1331 B-Eq_Comparison
2 NCT03862079 1332 1333 I-Eq_Comparison
weeks NCT03862079 1334 1339 I-Eq_Comparison
of NCT03862079 1340 1342 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03862079 1343 1353 B-Study

- NCT03862079 1356 1357 O
Patients NCT03862079 1359 1367 O
unable NCT03862079 1368 1374 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03862079 1375 1377 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
tolerate NCT03862079 1378 1386 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
oral NCT03862079 1387 1391 B-Procedure
decontamination NCT03862079 1392 1407 I-Procedure
regimen NCT03862079 1408 1415 O
of NCT03862079 1416 1418 O
pip NCT03862079 1419 1422 B-Drug
- NCT03862079 1423 1424 I-Drug
tazo NCT03862079 1425 1429 I-Drug
and NCT03862079 1430 1433 B-Or
nystatin NCT03862079 1434 1442 B-Drug
due NCT03862079 1443 1446 O
to NCT03862079 1447 1449 O
prior NCT03862079 1450 1455 B-Eq_Comparison
allergy NCT03862079 1456 1463 B-Allergy
or NCT03862079 1464 1466 B-Or
intolerance NCT03862079 1467 1478 B-Condition
of NCT03862079 1479 1481 O
these NCT03862079 1482 1487 O
medications NCT03862079 1488 1499 O

- NCT03862079 1502 1503 O
Patients NCT03862079 1505 1513 O
with NCT03862079 1514 1518 O
any NCT03862079 1519 1522 O
medical NCT03862079 1523 1530 B-Modifier
or NCT03862079 1531 1533 B-Or
psychological NCT03862079 1534 1547 B-Modifier
condition NCT03862079 1548 1557 B-Condition
that NCT03862079 1558 1562 O
, NCT03862079 1563 1564 O
in NCT03862079 1565 1567 O
the NCT03862079 1568 1571 O
opinion NCT03862079 1572 1579 O
of NCT03862079 1580 1582 O
the NCT03862079 1583 1586 O
investigator NCT03862079 1587 1599 O
, NCT03862079 1600 1601 O
might NCT03862079 1602 1607 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03862079 1608 1617 O
with NCT03862079 1618 1622 O
the NCT03862079 1623 1626 O
subject NCT03862079 1627 1634 O
's NCT03862079 1634 1636 O
participation NCT03862079 1637 1650 O
in NCT03862079 1651 1653 O
the NCT03862079 1654 1657 O
trial NCT03862079 1658 1663 B-Study
, NCT03862079 1664 1665 O
pose NCT03862079 1666 1670 O
any NCT03862079 1671 1674 O
additional NCT03862079 1675 1685 O
risk NCT03862079 1686 1690 B-Risk
for NCT03862079 1691 1694 O
the NCT03862079 1695 1698 O
subject NCT03862079 1699 1706 O
, NCT03862079 1707 1708 O
or NCT03862079 1709 1711 B-Or
confound NCT03862079 1712 1720 O
the NCT03862079 1721 1724 O
assessments NCT03862079 1725 1736 O
of NCT03862079 1737 1739 O
the NCT03862079 1740 1743 O
subject NCT03862079 1744 1751 O

Inclusion NCT03924596 0 9 O
Criteria NCT03924596 10 18 O
: NCT03924596 19 20 O

- NCT03924596 24 25 O
Participants NCT03924596 27 39 O
with NCT03924596 40 44 O
renal NCT03924596 45 50 B-Observation
stones NCT03924596 51 57 I-Observation
equal NCT03924596 58 63 B-Eq_Comparison
or NCT03924596 64 66 I-Eq_Comparison
less NCT03924596 67 71 I-Eq_Comparison
than NCT03924596 72 76 I-Eq_Comparison
10 NCT03924596 77 79 I-Eq_Comparison
mm NCT03924596 80 82 I-Eq_Comparison
in NCT03924596 83 85 O
size NCT03924596 86 90 O

Exclusion NCT03924596 91 100 O
Criteria NCT03924596 101 109 O
: NCT03924596 110 111 O

- NCT03924596 115 116 O
Participants NCT03924596 118 130 O
with NCT03924596 131 135 O
renal NCT03924596 136 141 B-Condition
pathology NCT03924596 142 151 I-Condition
( NCT03924596 152 153 O
Renal NCT03924596 154 159 B-Modifier
anomalies NCT03924596 160 169 B-Condition
, NCT03924596 170 171 O
multiple NCT03924596 172 180 B-Modifier
renal NCT03924596 181 186 I-Modifier
cysts NCT03924596 187 192 B-Condition
, NCT03924596 193 194 O
renal NCT03924596 195 200 B-Modifier
tumors NCT03924596 201 207 B-Condition
) NCT03924596 208 209 O

- NCT03924596 213 214 O
Participants NCT03924596 216 228 O
with NCT03924596 229 233 O
comorbidities NCT03924596 234 247 B-Condition
( NCT03924596 248 249 O
DM NCT03924596 250 252 B-Condition
, NCT03924596 253 254 O
CKD NCT03924596 255 258 B-Condition
) NCT03924596 259 260 O

Inclusion NCT03868124 0 9 O
Criteria NCT03868124 10 18 O
: NCT03868124 19 20 O

- NCT03868124 24 25 O
Diagnosed NCT03868124 27 36 O
with NCT03868124 37 41 O
open NCT03868124 42 46 B-Modifier
- NCT03868124 47 48 I-Modifier
angle NCT03868124 49 54 I-Modifier
glaucoma NCT03868124 55 63 B-Condition
or NCT03868124 64 66 B-Or
ocular NCT03868124 67 73 B-Modifier
hypertension NCT03868124 74 86 B-Condition

- NCT03868124 89 90 O
C NCT03868124 92 93 B-Observation
/ NCT03868124 94 95 I-Observation
D NCT03868124 96 97 I-Observation
ratio NCT03868124 98 103 I-Observation
≤ NCT03868124 104 105 B-Eq_Comparison
0.8 NCT03868124 106 109 I-Eq_Comparison

- NCT03868124 113 114 O
Zero NCT03868124 116 120 B-Eq_Comparison
to NCT03868124 121 123 I-Eq_Comparison
two NCT03868124 124 127 I-Eq_Comparison
pre NCT03868124 128 131 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03868124 132 141 B-Procedure
ocular NCT03868124 142 148 B-Drug
hypotensive NCT03868124 149 160 I-Drug
medications NCT03868124 161 172 I-Drug

Exclusion NCT03868124 173 182 O
Criteria NCT03868124 183 191 O
: NCT03868124 192 193 O

- NCT03868124 197 198 O
Active NCT03868124 200 206 B-Eq_Comparison
corneal NCT03868124 207 214 B-Condition
inflammation NCT03868124 215 227 I-Condition
or NCT03868124 228 230 B-Or
edema NCT03868124 231 236 B-Condition

- NCT03868124 239 240 O
Retinal NCT03868124 242 249 B-Condition
disorders NCT03868124 250 259 I-Condition
not NCT03868124 260 263 B-Exception
associated NCT03868124 264 274 O
with NCT03868124 275 279 O
glaucoma NCT03868124 280 288 B-Condition

Inclusion NCT03869957 0 9 O
Criteria NCT03869957 10 18 O
: NCT03869957 19 20 O

- NCT03869957 24 25 O
Patients NCT03869957 27 35 O
admitted NCT03869957 36 44 B-Encounter
in NCT03869957 45 47 O
the NCT03869957 48 51 O
non NCT03869957 52 55 B-Negation
- NCT03869957 56 57 O
critical NCT03869957 58 66 O
areas NCT03869957 67 72 O
of NCT03869957 73 75 O
the NCT03869957 76 79 O
Instituto NCT03869957 80 89 O
Nacional NCT03869957 90 98 O
de NCT03869957 99 101 O
Ciencias NCT03869957 102 110 O
Médicas NCT03869957 111 118 O
y NCT03869957 119 120 O
Nutrición NCT03869957 121 130 O
Salvador NCT03869957 131 139 O
Zubirán NCT03869957 140 147 O
( NCT03869957 148 149 O
INCMNSZ NCT03869957 150 157 O
) NCT03869957 158 159 O
with NCT03869957 160 164 B-And
a NCT03869957 165 166 O
nutritional NCT03869957 167 178 B-Condition
risk NCT03869957 179 183 B-Risk
between NCT03869957 184 191 B-Eq_Comparison
January NCT03869957 192 199 I-Eq_Comparison
2019 NCT03869957 200 204 I-Eq_Comparison
and NCT03869957 205 208 I-Eq_Comparison
July NCT03869957 209 213 I-Eq_Comparison
2020 NCT03869957 214 218 I-Eq_Comparison
will NCT03869957 219 223 O
be NCT03869957 224 226 O
considered NCT03869957 227 237 O
eligible NCT03869957 238 246 O
. NCT03869957 247 248 O

- NCT03869957 252 253 O
Patients NCT03869957 255 263 O
with NCT03869957 264 268 O
recent NCT03869957 269 275 B-Eq_Comparison
diagnosis NCT03869957 276 285 O
of NCT03869957 286 288 O
IF NCT03869957 289 291 B-Condition
type NCT03869957 292 296 B-Modifier
II NCT03869957 297 299 I-Modifier
( NCT03869957 300 301 O
an NCT03869957 302 304 O
evolution NCT03869957 305 314 O
> NCT03869957 315 316 B-Eq_Comparison
28 NCT03869957 317 319 I-Eq_Comparison
days NCT03869957 320 324 I-Eq_Comparison
) NCT03869957 325 326 O
originate NCT03869957 327 336 O
from NCT03869957 337 341 O
various NCT03869957 342 349 O
gastrointestinal NCT03869957 350 366 B-Modifier
or NCT03869957 367 369 B-Or
systemic NCT03869957 370 378 B-Modifier
diseases NCT03869957 379 387 B-Condition
( NCT03869957 388 389 O
short NCT03869957 390 395 B-Modifier
bowel NCT03869957 396 401 I-Modifier
, NCT03869957 402 403 O
intestinal NCT03869957 404 414 B-Modifier
fistula NCT03869957 415 422 I-Modifier
, NCT03869957 423 424 O
intestinal NCT03869957 425 435 B-Modifier
dysmotility NCT03869957 436 447 I-Modifier
, NCT03869957 448 449 O
mechanical NCT03869957 450 460 B-Modifier
obstruction NCT03869957 461 472 I-Modifier
, NCT03869957 473 474 O
and NCT03869957 475 478 B-Or
extensive NCT03869957 479 488 B-Modifier
small NCT03869957 489 494 I-Modifier
bowel NCT03869957 495 500 I-Modifier
mucosal NCT03869957 501 508 I-Modifier
disease NCT03869957 509 516 B-Condition
) NCT03869957 517 518 O
. NCT03869957 519 520 O

Exclusion NCT03869957 527 536 O
Criteria NCT03869957 537 545 O
: NCT03869957 546 547 O

- NCT03869957 551 552 O
Patients NCT03869957 554 562 O
with NCT03869957 563 567 O
contraindications NCT03869957 568 585 B-Contraindication
for NCT03869957 586 589 O
PN NCT03869957 590 592 B-Procedure

- NCT03869957 595 596 O
Patients NCT03869957 598 606 O
with NCT03869957 607 611 O
known NCT03869957 612 617 O
allergies NCT03869957 618 627 B-Allergy
to NCT03869957 628 630 O
the NCT03869957 631 634 O
components NCT03869957 635 645 O
of NCT03869957 646 648 O
the NCT03869957 649 652 O
PN NCT03869957 653 655 B-Procedure
formula NCT03869957 656 663 O

- NCT03869957 666 667 O
Severe NCT03869957 669 675 O
liver NCT03869957 676 681 B-Modifier
or NCT03869957 682 684 B-Or
renal NCT03869957 685 690 B-Modifier
insufficiency NCT03869957 691 704 B-Condition

- NCT03869957 707 708 O
Uncontrolled NCT03869957 710 722 O
diabetes NCT03869957 723 731 B-Condition
mellitus NCT03869957 732 740 I-Condition

- NCT03869957 743 744 O
Certain NCT03869957 746 753 O
acute NCT03869957 754 759 O
and NCT03869957 760 763 B-Or
life NCT03869957 764 768 B-Death|B-Risk
- NCT03869957 769 770 I-Death|I-Risk
threatening NCT03869957 771 782 I-Death|I-Risk
conditions NCT03869957 783 793 B-Condition

- NCT03869957 796 797 O
Immunological NCT03869957 799 812 B-Condition
diseases NCT03869957 813 821 I-Condition
( NCT03869957 822 823 O
such NCT03869957 824 828 O
as NCT03869957 829 831 O
autoimmune NCT03869957 832 842 B-Condition
diseases NCT03869957 843 851 I-Condition
, NCT03869957 852 853 O
human NCT03869957 854 859 B-Condition
immunodeficiency NCT03869957 860 876 I-Condition
virus NCT03869957 877 882 I-Condition
infection NCT03869957 883 892 I-Condition
, NCT03869957 893 894 O
cancer NCT03869957 895 901 B-Condition
, NCT03869957 902 903 O
etc NCT03869957 904 907 O
. NCT03869957 908 909 O
) NCT03869957 910 911 O

- NCT03869957 915 916 O
Those NCT03869957 918 923 O
that NCT03869957 924 928 O
take NCT03869957 929 933 B-Eq_Comparison
immunosuppressant NCT03869957 934 951 B-Drug
medications NCT03869957 952 963 I-Drug

- NCT03869957 966 967 O
Severe NCT03869957 969 975 O
hemorrhagic NCT03869957 976 987 B-Condition
disorders NCT03869957 988 997 I-Condition

- NCT03869957 1000 1001 O
Pregnant NCT03869957 1003 1011 B-Condition
or NCT03869957 1012 1014 B-Or
lactating NCT03869957 1015 1024 B-Condition


Inclusion NCT03925610 0 9 O
Criteria NCT03925610 10 18 O
: NCT03925610 19 20 O

- NCT03925610 24 25 O
Body NCT03925610 27 31 B-Observation
mass NCT03925610 32 36 I-Observation
index NCT03925610 37 42 I-Observation
( NCT03925610 43 44 O
BMI NCT03925610 45 48 B-Observation
) NCT03925610 49 50 O
equal NCT03925610 51 56 B-Eq_Comparison
or NCT03925610 57 59 I-Eq_Comparison
greater NCT03925610 60 67 I-Eq_Comparison
than NCT03925610 68 72 I-Eq_Comparison
35 NCT03925610 73 75 I-Eq_Comparison
kg NCT03925610 76 78 I-Eq_Comparison
/ NCT03925610 79 80 I-Eq_Comparison
m NCT03925610 81 82 I-Eq_Comparison
2 NCT03925610 83 84 I-Eq_Comparison
. NCT03925610 84 85 O

- NCT03925610 89 90 O
American NCT03925610 92 100 B-Observation
Society NCT03925610 101 108 I-Observation
of NCT03925610 109 111 I-Observation
Anesthesiologists NCT03925610 112 129 I-Observation
( NCT03925610 130 131 O
ASA NCT03925610 132 135 B-Observation
) NCT03925610 136 137 O
physical NCT03925610 138 146 O
status NCT03925610 147 153 B-Eq_Comparison
I NCT03925610 154 155 I-Eq_Comparison
- NCT03925610 156 157 I-Eq_Comparison
III NCT03925610 158 161 I-Eq_Comparison
patients NCT03925610 162 170 O
. NCT03925610 171 172 O

- NCT03925610 176 177 O
Scheduled NCT03925610 179 188 B-Eq_Comparison
to NCT03925610 189 191 I-Eq_Comparison
undergo NCT03925610 192 199 I-Eq_Comparison
laparoscopic NCT03925610 200 212 B-Procedure
roux NCT03925610 213 217 I-Procedure
- NCT03925610 218 219 I-Procedure
en NCT03925610 220 222 I-Procedure
- NCT03925610 223 224 I-Procedure
Y NCT03925610 225 226 I-Procedure
gastric NCT03925610 227 234 I-Procedure
bypass NCT03925610 235 241 I-Procedure
or NCT03925610 242 244 B-Or
gastric NCT03925610 245 252 B-Procedure
sleeve NCT03925610 253 259 I-Procedure
placement NCT03925610 260 269 I-Procedure
surgery NCT03925610 270 277 I-Procedure
for NCT03925610 278 281 O
weight NCT03925610 282 288 B-Condition
loss NCT03925610 289 293 I-Condition
. NCT03925610 294 295 O

Exclusion NCT03925610 297 306 O
Criteria NCT03925610 307 315 O
: NCT03925610 316 317 O

- NCT03925610 321 322 O
Chronic NCT03925610 324 331 B-Condition
obstructive NCT03925610 332 343 I-Condition
pulmonary NCT03925610 344 353 I-Condition
disorder NCT03925610 354 362 I-Condition
( NCT03925610 363 364 O
COPD NCT03925610 365 369 B-Condition
) NCT03925610 370 371 O
. NCT03925610 372 373 O

- NCT03925610 377 378 O
Treatment NCT03925610 380 389 B-Procedure
with NCT03925610 390 394 O
continuous NCT03925610 395 405 B-Procedure
positive NCT03925610 406 414 I-Procedure
airway NCT03925610 415 421 I-Procedure
pressure NCT03925610 422 430 I-Procedure
( NCT03925610 431 432 O
CPAP NCT03925610 433 437 B-Procedure
) NCT03925610 438 439 O
in NCT03925610 440 442 O
the NCT03925610 443 446 O
past NCT03925610 447 451 B-Eq_Comparison
three NCT03925610 452 457 I-Eq_Comparison
months NCT03925610 458 464 I-Eq_Comparison
. NCT03925610 465 466 O

- NCT03925610 470 471 O
Severe NCT03925610 473 479 O
neurological NCT03925610 480 492 B-Modifier
, NCT03925610 493 494 O
cardiopulmonary NCT03925610 495 510 B-Modifier
, NCT03925610 511 512 O
psychiatric NCT03925610 513 524 B-Modifier
, NCT03925610 525 526 O
or NCT03925610 527 529 B-Or
untreated NCT03925610 530 539 B-Negation|B-Procedure
thyroid NCT03925610 540 547 B-Modifier
disorder NCT03925610 548 556 B-Condition
. NCT03925610 557 558 O

- NCT03925610 562 563 O
Chronic NCT03925610 565 572 B-Condition
pain NCT03925610 573 577 I-Condition
condition NCT03925610 578 587 I-Condition
that NCT03925610 588 592 O
was NCT03925610 593 596 O
being NCT03925610 597 602 B-Eq_Comparison
treated NCT03925610 603 610 O
with NCT03925610 611 615 O
opioids NCT03925610 616 623 B-Drug
. NCT03925610 624 625 O

- NCT03925610 629 630 O
Patients NCT03925610 632 640 O
with NCT03925610 641 645 O
a NCT03925610 646 647 O
hematocrit NCT03925610 648 658 B-Observation
lower NCT03925610 659 664 B-Eq_Comparison
than NCT03925610 665 669 I-Eq_Comparison
35 NCT03925610 670 672 I-Eq_Comparison
% NCT03925610 673 674 I-Eq_Comparison
. NCT03925610 675 676 O

Inclusion NCT03863951 0 9 O
Criteria NCT03863951 10 18 O
: NCT03863951 19 20 O

- NCT03863951 24 25 O
diagnosed NCT03863951 27 36 O
with NCT03863951 37 41 O
the NCT03863951 42 45 O
first NCT03863951 46 51 B-Eq_Comparison
ever NCT03863951 52 56 I-Eq_Comparison
acute NCT03863951 57 62 O
ischemic NCT03863951 63 71 B-Modifier
stroke NCT03863951 72 78 B-Condition
occurring NCT03863951 79 88 O
within NCT03863951 89 95 B-Eq_Comparison
2 NCT03863951 96 97 I-Eq_Comparison
weeks NCT03863951 98 103 I-Eq_Comparison
and NCT03863951 104 107 O
were NCT03863951 108 112 O
confirmed NCT03863951 113 122 O
by NCT03863951 123 125 O
CT NCT03863951 126 128 B-Procedure
or NCT03863951 129 131 B-Or
MRI NCT03863951 132 135 B-Procedure
, NCT03863951 136 137 O

- NCT03863951 141 142 O
has NCT03863951 144 147 O
no NCT03863951 148 150 B-Negation
history NCT03863951 151 158 B-Eq_Comparison
of NCT03863951 159 161 O
depression NCT03863951 162 172 B-Condition
or NCT03863951 173 175 B-Or
use NCT03863951 176 179 O
of NCT03863951 180 182 O
antidepressants NCT03863951 183 198 B-Drug
or NCT03863951 199 201 B-Or
antipsychotics NCT03863951 202 216 B-Drug
, NCT03863951 217 218 O

- NCT03863951 222 223 O
were NCT03863951 225 229 O
competent NCT03863951 230 239 O
to NCT03863951 240 242 O
consent NCT03863951 243 250 O
to NCT03863951 251 253 O
take NCT03863951 254 258 O
part NCT03863951 259 263 O
in NCT03863951 264 266 O
this NCT03863951 267 271 O
research NCT03863951 272 280 O
. NCT03863951 281 282 O

Exclusion NCT03863951 284 293 O
Criteria NCT03863951 294 302 O
: NCT03863951 303 304 O

- NCT03863951 308 309 O
significant NCT03863951 311 322 O
acute NCT03863951 323 328 O
or NCT03863951 329 331 B-Or
severe NCT03863951 332 338 O
illness NCT03863951 339 346 B-Condition
such NCT03863951 347 351 O
as NCT03863951 352 354 O
infection NCT03863951 355 364 B-Condition
, NCT03863951 365 366 O
heart NCT03863951 367 372 B-Condition
failure NCT03863951 373 380 I-Condition
and NCT03863951 381 384 B-Or
tumor NCT03863951 385 390 B-Condition
, NCT03863951 391 392 O

- NCT03863951 396 397 O
previous NCT03863951 399 407 B-Eq_Comparison
diagnosis NCT03863951 408 417 O
of NCT03863951 418 420 O
depression NCT03863951 421 431 B-Condition
or NCT03863951 432 434 B-Or
other NCT03863951 435 440 B-Other
mental NCT03863951 441 447 B-Condition
disorder NCT03863951 448 456 I-Condition
or NCT03863951 457 459 B-Or
who NCT03863951 460 463 O
had NCT03863951 464 467 O
recently NCT03863951 468 476 B-Eq_Comparison
accepted NCT03863951 477 485 O
antidepressants NCT03863951 486 501 B-Drug
or NCT03863951 502 504 B-Or
antipsychotics NCT03863951 505 519 B-Drug
, NCT03863951 520 521 O

- NCT03863951 525 526 O
antibiotics NCT03863951 528 539 B-Drug
in NCT03863951 540 542 O
the NCT03863951 543 546 O
last NCT03863951 547 551 B-Eq_Comparison
two NCT03863951 552 555 I-Eq_Comparison
weeks NCT03863951 556 561 I-Eq_Comparison
, NCT03863951 562 563 O

- NCT03863951 567 568 O
severe NCT03863951 570 576 O
aphasia NCT03863951 577 584 B-Condition
or NCT03863951 585 587 B-Or
dysarthria NCT03863951 588 598 B-Condition
, NCT03863951 599 600 O
irritable NCT03863951 601 610 B-Condition
bowel NCT03863951 611 616 I-Condition
syndrome NCT03863951 617 625 I-Condition
, NCT03863951 626 627 O
asthma NCT03863951 628 634 B-Condition
, NCT03863951 635 636 O
and NCT03863951 637 640 B-Or
pregnant NCT03863951 641 649 B-Condition
or NCT03863951 650 652 B-Or
lactating NCT03863951 653 662 B-Condition
women NCT03863951 663 668 O
, NCT03863951 669 670 O

- NCT03863951 674 675 O
a NCT03863951 677 678 O
previous NCT03863951 679 687 B-Eq_Comparison
history NCT03863951 688 695 I-Eq_Comparison
of NCT03863951 696 698 O
neurological NCT03863951 699 711 B-Condition
illness NCT03863951 712 719 I-Condition
including NCT03863951 720 729 O
AD NCT03863951 730 732 B-Condition
and NCT03863951 733 736 B-Or
PD NCT03863951 737 739 B-Condition
, NCT03863951 740 741 O

- NCT03863951 745 746 O
Inflammatory NCT03863951 748 760 B-Condition
bowel NCT03863951 761 766 I-Condition
disease NCT03863951 767 774 I-Condition
, NCT03863951 775 776 O

Inclusion NCT03869372 0 9 O
Criteria NCT03869372 10 18 O
: NCT03869372 19 20 O

- NCT03869372 24 25 O
Adults NCT03869372 27 33 O
between NCT03869372 34 41 B-Eq_Comparison
age NCT03869372 42 45 I-Eq_Comparison
18 NCT03869372 46 48 I-Eq_Comparison
and NCT03869372 49 52 I-Eq_Comparison
75 NCT03869372 53 55 I-Eq_Comparison

- NCT03869372 59 60 O
Participants NCT03869372 62 74 O
without NCT03869372 75 82 B-Negation
a NCT03869372 83 84 O
history NCT03869372 85 92 B-Eq_Comparison
of NCT03869372 93 95 O
gastrointestinal NCT03869372 96 112 B-Condition
disorders NCT03869372 113 122 I-Condition
( NCT03869372 123 124 O
control NCT03869372 125 132 O
group NCT03869372 133 138 O
) NCT03869372 139 140 O

- NCT03869372 144 145 O
Participants NCT03869372 147 159 O
with NCT03869372 160 164 O
functional NCT03869372 165 175 B-Modifier
dyspepsia NCT03869372 176 185 B-Condition
( NCT03869372 186 187 O
FD NCT03869372 188 190 O
group NCT03869372 191 196 O
) NCT03869372 197 198 O

- NCT03869372 202 203 O
Participants NCT03869372 205 217 O
with NCT03869372 218 222 O
moderate NCT03869372 223 231 B-Eq_Comparison
- NCT03869372 232 233 I-Eq_Comparison
to NCT03869372 234 236 I-Eq_Comparison
- NCT03869372 237 238 I-Eq_Comparison
severe NCT03869372 239 245 I-Eq_Comparison
irritable NCT03869372 246 255 B-Condition
bowel NCT03869372 256 261 I-Condition
syndrome NCT03869372 262 270 I-Condition
( NCT03869372 271 272 O
defined NCT03869372 273 280 O
by NCT03869372 281 283 O
IBS NCT03869372 284 287 B-Observation
symptom NCT03869372 288 295 I-Observation
severity NCT03869372 296 304 I-Observation
scores NCT03869372 305 311 I-Observation
( NCT03869372 312 313 O
IBS NCT03869372 314 317 B-Observation
- NCT03869372 318 319 I-Observation
SSS NCT03869372 320 323 I-Observation
) NCT03869372 324 325 O
greater NCT03869372 326 333 B-Eq_Comparison
than NCT03869372 334 338 I-Eq_Comparison
250 NCT03869372 339 342 I-Eq_Comparison
) NCT03869372 343 344 O
( NCT03869372 345 346 O
IBS NCT03869372 347 350 O
group NCT03869372 351 356 O
) NCT03869372 357 358 O

Exclusion NCT03869372 360 369 O
Criteria NCT03869372 370 378 O
: NCT03869372 379 380 O

- NCT03869372 384 385 O
history NCT03869372 387 394 B-Eq_Comparison
of NCT03869372 395 397 O
myocardial NCT03869372 398 408 B-Condition
infarction NCT03869372 409 419 I-Condition
, NCT03869372 420 421 O
supplemental NCT03869372 422 434 B-Procedure
oxygen NCT03869372 435 441 I-Procedure
requirement NCT03869372 442 453 O
, NCT03869372 454 455 O
or NCT03869372 456 458 B-Or
diabetes NCT03869372 459 467 B-Condition

- NCT03869372 470 471 O
history NCT03869372 473 480 B-Eq_Comparison
of NCT03869372 481 483 O
chronic NCT03869372 484 491 O
gastrointestinal NCT03869372 492 508 B-Condition
symptoms NCT03869372 509 517 B-Assertion___Assertion_Type_Value:possible
( NCT03869372 518 519 O
for NCT03869372 520 523 O
healthy NCT03869372 524 531 O
control NCT03869372 532 539 O
population NCT03869372 540 550 O
only NCT03869372 551 555 O
) NCT03869372 556 557 O

- NCT03869372 561 562 O
history NCT03869372 564 571 B-Eq_Comparison
of NCT03869372 572 574 O
gastric NCT03869372 575 582 B-Procedure
surgery NCT03869372 583 590 I-Procedure

- NCT03869372 593 594 O
psychosis NCT03869372 596 605 B-Condition
or NCT03869372 606 608 B-Or
altered NCT03869372 609 616 B-Condition
cognitive NCT03869372 617 626 I-Condition
status NCT03869372 627 633 I-Condition

- NCT03869372 636 637 O
history NCT03869372 639 646 B-Eq_Comparison
of NCT03869372 647 649 O
head NCT03869372 650 654 B-Modifier
injury NCT03869372 655 661 B-Condition
, NCT03869372 662 663 O
metal NCT03869372 664 669 B-Condition
in NCT03869372 670 672 I-Condition
the NCT03869372 673 676 I-Condition
skull NCT03869372 677 682 I-Condition
, NCT03869372 683 684 O
stroke NCT03869372 685 691 B-Condition
, NCT03869372 692 693 O
or NCT03869372 694 696 B-Or
a NCT03869372 697 698 O
history NCT03869372 699 706 B-Eq_Comparison
of NCT03869372 707 709 O
seizures NCT03869372 710 718 B-Condition

- NCT03869372 721 722 O
implantable NCT03869372 724 735 B-Procedure
devices NCT03869372 736 743 I-Procedure
, NCT03869372 744 745 O
such NCT03869372 746 750 O
as NCT03869372 751 753 O
a NCT03869372 754 755 O
pacemaker NCT03869372 756 765 B-Procedure
or NCT03869372 766 768 B-Or
nerve NCT03869372 769 774 B-Procedure
stimulator NCT03869372 775 785 I-Procedure

- NCT03869372 788 789 O
current NCT03869372 791 798 B-Eq_Comparison
use NCT03869372 799 802 O
of NCT03869372 803 805 O
the NCT03869372 806 809 O
following NCT03869372 810 819 O
medications NCT03869372 820 831 B-Drug
or NCT03869372 832 834 B-Or
use NCT03869372 835 838 O
of NCT03869372 839 841 O
substances NCT03869372 842 852 B-Drug
which NCT03869372 853 858 O
are NCT03869372 859 862 O
known NCT03869372 863 868 O
to NCT03869372 869 871 O
lower NCT03869372 872 877 O
the NCT03869372 878 881 O
seizure NCT03869372 882 889 B-Condition
threshold NCT03869372 890 899 B-Modifier
: NCT03869372 900 901 O
amitriptyline NCT03869372 902 915 B-Drug
( NCT03869372 916 917 O
Elavil NCT03869372 918 924 B-Drug
) NCT03869372 925 926 O
, NCT03869372 927 928 O
nortriptyline NCT03869372 929 942 B-Drug
( NCT03869372 943 944 O
Pamelor NCT03869372 945 952 B-Drug
) NCT03869372 953 954 O
, NCT03869372 955 956 O
imipramine NCT03869372 957 967 B-Drug
( NCT03869372 968 969 O
Tofranil NCT03869372 970 978 B-Drug
) NCT03869372 979 980 O
, NCT03869372 981 982 O
doxepin NCT03869372 983 990 B-Drug
( NCT03869372 991 992 O
Sinequan NCT03869372 993 1001 B-Drug
) NCT03869372 1002 1003 O
, NCT03869372 1004 1005 O
clozapine NCT03869372 1006 1015 B-Drug
( NCT03869372 1016 1017 O
Clozaril NCT03869372 1018 1026 B-Drug
) NCT03869372 1027 1028 O
, NCT03869372 1029 1030 O
chlorpromazine NCT03869372 1031 1045 B-Drug
( NCT03869372 1046 1047 O
Thorazine NCT03869372 1048 1057 B-Drug
) NCT03869372 1058 1059 O
, NCT03869372 1060 1061 O
amphetamines NCT03869372 1062 1074 B-Drug
or NCT03869372 1075 1077 B-Or
methamphetamine NCT03869372 1078 1093 B-Drug
, NCT03869372 1094 1095 O
Ecstasy NCT03869372 1096 1103 B-Drug
, NCT03869372 1104 1105 O
Ketamine NCT03869372 1106 1114 B-Drug
, NCT03869372 1115 1116 O
Angel NCT03869372 1117 1122 B-Drug
Dust NCT03869372 1123 1127 I-Drug
/ NCT03869372 1128 1129 B-Or
phencyclidine NCT03869372 1130 1143 B-Drug
( NCT03869372 1144 1145 O
PCP NCT03869372 1146 1149 B-Drug
) NCT03869372 1150 1151 O
, NCT03869372 1152 1153 O
cocaine NCT03869372 1154 1161 B-Drug
, NCT03869372 1162 1163 O
or NCT03869372 1164 1166 B-Or
3 NCT03869372 1167 1168 B-Eq_Comparison
or NCT03869372 1169 1171 I-Eq_Comparison
more NCT03869372 1172 1176 I-Eq_Comparison
alcoholic NCT03869372 1177 1186 B-Drug
drinks NCT03869372 1187 1193 I-Drug
per NCT03869372 1194 1197 O
day NCT03869372 1198 1201 O

- NCT03869372 1204 1205 O
pregnancy NCT03869372 1207 1216 B-Condition

Inclusion NCT03860246 0 9 O
Criteria NCT03860246 10 18 O
: NCT03860246 19 20 O

Nursing NCT03860246 22 29 O
home NCT03860246 30 34 O
residents NCT03860246 35 44 O
with NCT03860246 45 49 O
≥ NCT03860246 50 51 B-Eq_Comparison
2 NCT03860246 52 53 I-Eq_Comparison
of NCT03860246 54 56 O
the NCT03860246 57 60 B-Criteria_Count
following NCT03860246 61 70 I-Criteria_Count
risk NCT03860246 71 75 B-Risk
factors NCT03860246 76 83 I-Risk
for NCT03860246 84 87 O
atrial NCT03860246 88 94 B-Condition
fibrillation NCT03860246 95 107 I-Condition
: NCT03860246 108 109 O

- NCT03860246 113 114 O
age NCT03860246 116 119 B-Age
≥ NCT03860246 120 121 B-Eq_Comparison
75 NCT03860246 122 124 I-Eq_Comparison
years NCT03860246 125 130 I-Eq_Comparison

- NCT03860246 133 134 O
female NCT03860246 136 142 O
sex NCT03860246 143 146 O

- NCT03860246 149 150 O
obstructive NCT03860246 152 163 B-Condition
sleep NCT03860246 164 169 I-Condition
apnea NCT03860246 170 175 I-Condition

- NCT03860246 178 179 O
peripheral NCT03860246 181 191 B-Condition
vascular NCT03860246 192 200 I-Condition
disease NCT03860246 201 208 I-Condition

- NCT03860246 211 212 O
diabetes NCT03860246 214 222 B-Condition
mellitus NCT03860246 223 231 I-Condition

- NCT03860246 234 235 O
obesity NCT03860246 237 244 B-Condition
( NCT03860246 245 246 O
body NCT03860246 247 251 B-Observation
mass NCT03860246 252 256 I-Observation
index NCT03860246 257 262 I-Observation
[ NCT03860246 263 264 O
BMI NCT03860246 265 268 B-Observation
] NCT03860246 269 270 O
> NCT03860246 271 272 B-Eq_Comparison
30 NCT03860246 273 275 I-Eq_Comparison
kg NCT03860246 276 278 I-Eq_Comparison
/ NCT03860246 279 280 I-Eq_Comparison
m NCT03860246 281 282 I-Eq_Comparison
2 NCT03860246 283 284 I-Eq_Comparison
) NCT03860246 285 286 O

- NCT03860246 290 291 O
hypertension NCT03860246 293 305 B-Condition

- NCT03860246 308 309 O
congestive NCT03860246 311 321 B-Condition
heart NCT03860246 322 327 I-Condition
failure NCT03860246 328 335 I-Condition

Exclusion NCT03860246 336 345 O
Criteria NCT03860246 346 354 O
: NCT03860246 355 356 O

- NCT03860246 360 361 O
prior NCT03860246 363 368 B-Eq_Comparison
diagnosis NCT03860246 369 378 O
of NCT03860246 379 381 O
AF NCT03860246 382 384 B-Condition

- NCT03860246 387 388 O
continuous NCT03860246 390 400 B-Modifier
rhythm NCT03860246 401 407 B-Procedure
monitoring NCT03860246 408 418 I-Procedure
over NCT03860246 419 423 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860246 424 427 O
past NCT03860246 428 432 B-Eq_Comparison
year NCT03860246 433 437 I-Eq_Comparison

- NCT03860246 440 441 O
pacemaker NCT03860246 443 452 B-Procedure
or NCT03860246 453 455 B-Or
implantable NCT03860246 456 467 B-Procedure
cardioverter NCT03860246 468 480 I-Procedure
defibrillator NCT03860246 481 494 I-Procedure
in NCT03860246 495 497 B-Modifier
situ NCT03860246 498 502 I-Modifier

Inclusion NCT03865043 0 9 O
criteria NCT03865043 10 18 O
: NCT03865043 19 20 O

- NCT03865043 24 25 O
Patients NCT03865043 27 35 O
undergoing NCT03865043 36 46 B-Eq_Comparison
a NCT03865043 47 48 O
TAVI NCT03865043 49 53 B-Procedure
at NCT03865043 54 56 O
Montpellier NCT03865043 57 68 O
University NCT03865043 69 79 O
Hospital NCT03865043 80 88 O

- NCT03865043 91 92 O
Since NCT03865043 94 99 B-Eq_Comparison
November NCT03865043 100 108 I-Eq_Comparison
2017 NCT03865043 109 113 I-Eq_Comparison

- NCT03865043 117 118 O
With NCT03865043 120 124 O
implantation NCT03865043 125 137 B-Procedure
of NCT03865043 138 140 O
a NCT03865043 141 142 O
COREVALVE NCT03865043 143 152 B-Modifier
or NCT03865043 153 155 B-Or
EDWARDS NCT03865043 156 163 B-Modifier

- NCT03865043 166 167 O
By NCT03865043 169 171 O
femoral NCT03865043 172 179 B-Procedure
approach NCT03865043 180 188 I-Procedure

Exclusion NCT03865043 189 198 O
criteria NCT03865043 199 207 O
: NCT03865043 208 209 O

- NCT03865043 213 214 O
Minor NCT03865043 216 221 O
patient NCT03865043 222 229 O

- NCT03865043 232 233 O
Patient NCT03865043 235 242 O
unable NCT03865043 243 249 O
to NCT03865043 250 252 O
give NCT03865043 253 257 O
consent NCT03865043 258 265 O
for NCT03865043 266 269 O
reasons NCT03865043 270 277 O
of NCT03865043 278 280 O
understanding NCT03865043 281 294 O
or NCT03865043 295 297 O
language NCT03865043 298 306 B-Condition
barrier NCT03865043 307 314 I-Condition

Inclusion NCT03863522 0 9 O
Criteria NCT03863522 10 18 O
: NCT03863522 19 20 O

- NCT03863522 24 25 O
Patient NCT03863522 27 34 O
must NCT03863522 35 39 O
be NCT03863522 40 42 O
female NCT03863522 43 49 O

- NCT03863522 52 53 O
Patient NCT03863522 55 62 O
must NCT03863522 63 67 O
be NCT03863522 68 70 O
18 NCT03863522 71 73 B-Eq_Comparison
years NCT03863522 74 79 I-Eq_Comparison
of NCT03863522 80 82 I-Eq_Comparison
age NCT03863522 83 86 I-Eq_Comparison
or NCT03863522 87 89 I-Eq_Comparison
older NCT03863522 90 95 I-Eq_Comparison

- NCT03863522 98 99 O
Patient NCT03863522 101 108 O
has NCT03863522 109 112 O
been NCT03863522 113 117 O
recommended NCT03863522 118 129 O
for NCT03863522 130 133 O
ultrasound NCT03863522 134 144 B-Procedure
core NCT03863522 145 149 I-Procedure
needle NCT03863522 150 156 I-Procedure
biopsy NCT03863522 157 163 I-Procedure
of NCT03863522 164 166 O
a NCT03863522 167 168 O
suspicious NCT03863522 169 179 B-Assertion___Assertion_Type_Value:possible
breast NCT03863522 180 186 B-Condition
lesion NCT03863522 187 193 I-Condition

Exclusion NCT03863522 194 203 O
Criteria NCT03863522 204 212 O
: NCT03863522 213 214 O

- NCT03863522 218 219 O
Patients NCT03863522 221 229 O
may NCT03863522 230 233 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03863522 234 236 I-Assertion___Assertion_Type_Value:hypothetical
excluded NCT03863522 237 245 B-Negation
for NCT03863522 246 249 O
any NCT03863522 250 253 O
condition NCT03863522 254 263 B-Condition
that NCT03863522 264 268 O
in NCT03863522 269 271 O
the NCT03863522 272 275 O
opinion NCT03863522 276 283 O
of NCT03863522 284 286 O
the NCT03863522 287 290 O
investigator NCT03863522 291 303 O
may NCT03863522 304 307 O
not NCT03863522 308 311 O
make NCT03863522 312 316 O
it NCT03863522 317 319 O
safe NCT03863522 320 324 O
to NCT03863522 325 327 O
take NCT03863522 328 332 O
part NCT03863522 333 337 O
( NCT03863522 338 339 O
e NCT03863522 340 341 O
. NCT03863522 342 343 O
g NCT03863522 344 345 O
. NCT03863522 346 347 O
certain NCT03863522 349 356 O
medicines NCT03863522 357 366 B-Drug
) NCT03863522 367 368 O
. NCT03863522 369 370 O

Inclusion NCT03926975 0 9 O
Criteria NCT03926975 10 18 O
: NCT03926975 19 20 O

- NCT03926975 24 25 O
young NCT03926975 27 32 O
, NCT03926975 33 34 O
normal NCT03926975 35 41 O
individuals NCT03926975 42 53 O

Exclusion NCT03926975 54 63 O
Criteria NCT03926975 64 72 O
: NCT03926975 73 74 O

- NCT03926975 78 79 O
IOP NCT03926975 81 84 B-Observation
> NCT03926975 85 86 B-Eq_Comparison
20 NCT03926975 87 89 I-Eq_Comparison
mm NCT03926975 90 92 I-Eq_Comparison
in NCT03926975 93 95 O
either NCT03926975 96 102 B-Modifier
eye NCT03926975 103 106 I-Modifier
, NCT03926975 107 108 O
and NCT03926975 109 112 O
h NCT03926975 113 114 B-Eq_Comparison
/ NCT03926975 115 116 I-Eq_Comparison
o NCT03926975 117 118 I-Eq_Comparison
ocular NCT03926975 119 125 B-Condition
hypertension NCT03926975 126 138 I-Condition
, NCT03926975 139 140 O
glaucoma NCT03926975 141 149 B-Condition
, NCT03926975 150 151 O
or NCT03926975 152 154 B-Or
ocular NCT03926975 155 161 B-Modifier
surgery NCT03926975 162 169 B-Procedure
that NCT03926975 170 174 O
can NCT03926975 175 178 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03926975 179 185 O
IOP NCT03926975 186 189 B-Observation
. NCT03926975 190 191 O

- NCT03926975 195 196 O
h NCT03926975 198 199 B-Eq_Comparison
/ NCT03926975 200 201 I-Eq_Comparison
o NCT03926975 202 203 I-Eq_Comparison
scleral NCT03926975 204 211 B-Condition
lens NCT03926975 212 216 I-Condition
wear NCT03926975 217 221 O
or NCT03926975 222 224 B-Or
current NCT03926975 225 232 B-Eq_Comparison
scleral NCT03926975 233 240 B-Condition
lens NCT03926975 241 245 I-Condition
wear NCT03926975 246 250 O

Inclusion NCT03869086 0 9 O
Criteria NCT03869086 10 18 O
: NCT03869086 19 20 O

- NCT03869086 24 25 O
BMI NCT03869086 27 30 B-Observation
> NCT03869086 31 32 B-Eq_Comparison
= NCT03869086 33 34 I-Eq_Comparison
25 NCT03869086 35 37 I-Eq_Comparison
kg NCT03869086 38 40 I-Eq_Comparison
/ NCT03869086 41 42 I-Eq_Comparison
m NCT03869086 43 44 I-Eq_Comparison
2 NCT03869086 45 46 I-Eq_Comparison

- NCT03869086 49 50 O
Adults NCT03869086 52 58 O
aged NCT03869086 59 63 B-Age
50 NCT03869086 64 66 B-Eq_Comparison
- NCT03869086 67 68 I-Eq_Comparison
80 NCT03869086 69 71 I-Eq_Comparison
years NCT03869086 72 77 I-Eq_Comparison
old NCT03869086 78 81 O

- NCT03869086 84 85 O
Successful NCT03869086 87 97 B-Modifier
biochemical NCT03869086 98 109 I-Modifier
, NCT03869086 110 111 O
haematological NCT03869086 112 126 B-Modifier
, NCT03869086 127 128 O
and NCT03869086 129 132 B-Or
urinalysis NCT03869086 133 143 B-Modifier
assessment NCT03869086 144 154 B-Procedure
at NCT03869086 155 157 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03869086 158 167 B-Study

Exclusion NCT03869086 168 177 O
Criteria NCT03869086 178 186 O
: NCT03869086 187 188 O

- NCT03869086 192 193 O
Current NCT03869086 195 202 B-Eq_Comparison
smokers NCT03869086 203 210 B-Condition
, NCT03869086 211 212 O
or NCT03869086 213 215 B-Or
ex NCT03869086 216 218 B-Eq_Comparison
- NCT03869086 219 220 O
smokers NCT03869086 221 228 B-Condition
ceasing NCT03869086 229 236 O
< NCT03869086 237 238 B-Eq_Comparison
6 NCT03869086 239 240 I-Eq_Comparison
months NCT03869086 241 247 I-Eq_Comparison
ago NCT03869086 248 251 I-Eq_Comparison

- NCT03869086 254 255 O
existing NCT03869086 257 265 B-Eq_Comparison
or NCT03869086 266 268 B-Or
significant NCT03869086 269 280 O
past NCT03869086 281 285 B-Eq_Comparison
medical NCT03869086 286 293 I-Eq_Comparison
history NCT03869086 294 301 I-Eq_Comparison
of NCT03869086 302 304 O
vascular NCT03869086 305 313 B-Condition
disease NCT03869086 314 321 I-Condition
or NCT03869086 322 324 B-Or
medical NCT03869086 325 332 O
conditions NCT03869086 333 343 B-Condition
likely NCT03869086 344 350 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869086 351 353 I-Assertion___Assertion_Type_Value:hypothetical
affect NCT03869086 354 360 O
the NCT03869086 361 364 O
study NCT03869086 365 370 B-Study
measures NCT03869086 371 379 O

- NCT03869086 382 383 O
Fructose NCT03869086 385 393 B-Modifier
or NCT03869086 394 396 B-Or
lactose NCT03869086 397 404 B-Modifier
intolerant NCT03869086 405 415 B-Condition
subjects NCT03869086 416 424 O
or NCT03869086 425 427 B-Or
known NCT03869086 428 433 O
allergies NCT03869086 434 443 B-Allergy
to NCT03869086 444 446 O
intervention NCT03869086 447 459 B-Study
treatments NCT03869086 460 470 B-Procedure

- NCT03869086 473 474 O
Those NCT03869086 476 481 O
unprepared NCT03869086 482 492 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869086 493 495 I-Assertion___Assertion_Type_Value:hypothetical
adhere NCT03869086 496 502 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03869086 503 505 O
dietary NCT03869086 506 513 B-Procedure
instructions NCT03869086 514 526 I-Procedure

- NCT03869086 529 530 O
Parallel NCT03869086 532 540 O
participation NCT03869086 541 554 O
in NCT03869086 555 557 O
another NCT03869086 558 565 B-Other
research NCT03869086 566 574 B-Study
project NCT03869086 575 582 O
involving NCT03869086 583 592 O
dietary NCT03869086 593 600 B-Procedure
intervention NCT03869086 601 613 I-Procedure
and NCT03869086 614 617 B-Or
/ NCT03869086 618 619 I-Or
or NCT03869086 620 622 I-Or
sampling NCT03869086 623 631 B-Procedure
of NCT03869086 632 634 O
biological NCT03869086 635 645 B-Modifier
fluids NCT03869086 646 652 I-Modifier
/ NCT03869086 653 654 B-Or
material NCT03869086 655 663 B-Modifier

- NCT03869086 666 667 O
Those NCT03869086 669 674 O
on NCT03869086 675 677 B-Eq_Comparison
therapeutic NCT03869086 678 689 B-Procedure
diets NCT03869086 690 695 I-Procedure
or NCT03869086 696 698 B-Or
having NCT03869086 699 705 O
experienced NCT03869086 706 717 B-Eq_Comparison
substantial NCT03869086 718 729 O
weight NCT03869086 730 736 B-Condition
loss NCT03869086 737 741 I-Condition
within NCT03869086 742 748 B-Eq_Comparison
2 NCT03869086 749 750 I-Eq_Comparison
months NCT03869086 751 757 I-Eq_Comparison
of NCT03869086 758 760 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03869086 761 770 B-Study
. NCT03869086 771 772 O

- NCT03869086 776 777 O
Those NCT03869086 779 784 O
taking NCT03869086 785 791 B-Eq_Comparison
flavonoid NCT03869086 792 801 B-Drug
, NCT03869086 802 803 O
nitrate NCT03869086 804 811 B-Drug
/ NCT03869086 812 813 B-Or
nitrite NCT03869086 814 821 B-Drug
containing NCT03869086 822 832 I-Drug
or NCT03869086 833 835 B-Or
fish NCT03869086 836 840 B-Modifier
oil NCT03869086 841 844 I-Modifier
containing NCT03869086 845 855 I-Modifier
supplements NCT03869086 856 867 B-Drug
( NCT03869086 868 869 O
and NCT03869086 870 873 B-And
unwilling NCT03869086 874 883 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869086 884 886 I-Assertion___Assertion_Type_Value:hypothetical
cease NCT03869086 887 892 B-Negation
intake NCT03869086 893 899 O
during NCT03869086 900 906 B-Temporal_Connection___Temporal_Connection_Type_Value:during
, NCT03869086 907 908 O
and NCT03869086 909 912 B-And
1 NCT03869086 913 914 B-Eq_Comparison
month NCT03869086 915 920 I-Eq_Comparison
preceding NCT03869086 921 930 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03869086 931 934 O
trial NCT03869086 935 940 B-Study
) NCT03869086 941 942 O
or NCT03869086 943 945 B-Or
unwilling NCT03869086 946 955 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869086 956 958 I-Assertion___Assertion_Type_Value:hypothetical
maintain NCT03869086 959 967 O
existing NCT03869086 968 976 B-Eq_Comparison
intake NCT03869086 977 983 O
of NCT03869086 984 986 O
other NCT03869086 987 992 B-Other
supplements NCT03869086 993 1004 B-Drug
. NCT03869086 1005 1006 O

- NCT03869086 1010 1011 O
Prescribed NCT03869086 1013 1023 O
hypoglycaemic NCT03869086 1024 1037 B-Drug
, NCT03869086 1038 1039 O
anti NCT03869086 1040 1044 B-Drug
- NCT03869086 1045 1046 I-Drug
hypertensive NCT03869086 1047 1059 I-Drug
, NCT03869086 1060 1061 O
vasodilator NCT03869086 1062 1073 B-Drug
or NCT03869086 1074 1076 B-Or
hormone NCT03869086 1077 1084 B-Procedure
replacement NCT03869086 1085 1096 I-Procedure
therapy NCT03869086 1097 1104 I-Procedure
( NCT03869086 1105 1106 O
HRT NCT03869086 1107 1110 B-Procedure
) NCT03869086 1111 1112 O
medication NCT03869086 1113 1123 B-Drug
. NCT03869086 1124 1125 O

- NCT03869086 1129 1130 O
Unsatisfactory NCT03869086 1132 1146 O
biochemical NCT03869086 1147 1158 B-Modifier
, NCT03869086 1159 1160 O
haematological NCT03869086 1161 1175 B-Modifier
or NCT03869086 1176 1178 B-Or
urinary NCT03869086 1179 1186 B-Modifier
results NCT03869086 1187 1194 B-Observation
or NCT03869086 1195 1197 B-Or
measurements NCT03869086 1198 1210 B-Observation
considered NCT03869086 1211 1221 O
to NCT03869086 1222 1224 O
be NCT03869086 1225 1227 O
counter NCT03869086 1228 1235 O
indicative NCT03869086 1236 1246 O
for NCT03869086 1247 1250 O
the NCT03869086 1251 1254 O
study NCT03869086 1255 1260 B-Study

- NCT03869086 1263 1264 O
Undiagnosed NCT03869086 1266 1277 B-Modifier
hypertension NCT03869086 1278 1290 B-Condition
( NCT03869086 1291 1292 O
elicited NCT03869086 1293 1301 O
at NCT03869086 1302 1304 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03869086 1305 1314 B-Study
; NCT03869086 1314 1315 O
i NCT03869086 1316 1317 O
. NCT03869086 1318 1319 O
e NCT03869086 1320 1321 O
. NCT03869086 1322 1323 O
≥ NCT03869086 1325 1326 B-Eq_Comparison
180 NCT03869086 1327 1330 I-Eq_Comparison
/ NCT03869086 1331 1332 I-Eq_Comparison
110 NCT03869086 1333 1336 I-Eq_Comparison
mmHg NCT03869086 1337 1341 I-Eq_Comparison
) NCT03869086 1342 1343 O
at NCT03869086 1344 1346 O
a NCT03869086 1347 1348 O
level NCT03869086 1349 1354 O
requiring NCT03869086 1355 1364 B-Assertion___Assertion_Type_Value:hypothetical
immediate NCT03869086 1365 1374 O
referral NCT03869086 1375 1383 O
back NCT03869086 1384 1388 O
to NCT03869086 1389 1391 O
general NCT03869086 1392 1399 B-Provider
practitioner NCT03869086 1400 1412 I-Provider
for NCT03869086 1413 1416 O
follow NCT03869086 1417 1423 B-Encounter
- NCT03869086 1424 1425 I-Encounter
up NCT03869086 1426 1428 I-Encounter

Inclusion NCT03921047 0 9 O
Criteria NCT03921047 10 18 O
: NCT03921047 19 20 O

- NCT03921047 24 25 O
Diagnosis NCT03921047 27 36 O
of NCT03921047 37 39 O
AML NCT03921047 40 43 B-Condition
scheduled NCT03921047 44 53 B-Eq_Comparison
to NCT03921047 54 56 O
undergo NCT03921047 57 64 O
HSCT NCT03921047 65 69 B-Procedure
at NCT03921047 70 72 O
University NCT03921047 73 83 O
of NCT03921047 84 86 O
Southern NCT03921047 87 95 O
California NCT03921047 96 106 O
( NCT03921047 107 108 O
USC NCT03921047 109 112 O
) NCT03921047 113 114 O

Exclusion NCT03921047 116 125 O
Criteria NCT03921047 126 134 O
: NCT03921047 135 136 O

- NCT03921047 140 141 O
Inability NCT03921047 143 152 O
to NCT03921047 153 155 O
provide NCT03921047 156 163 O
consent NCT03921047 164 171 O
because NCT03921047 172 179 O
of NCT03921047 180 182 O
severe NCT03921047 183 189 B-Condition
mental NCT03921047 190 196 I-Condition
disorders NCT03921047 197 206 I-Condition

- NCT03921047 209 210 O
Donor NCT03921047 212 217 O
unwilling NCT03921047 218 227 O
to NCT03921047 228 230 O
provide NCT03921047 231 238 O
consent NCT03921047 239 246 O

Inclusion NCT03863249 0 9 O
Criteria NCT03863249 10 18 O
: NCT03863249 19 20 O

1 NCT03863249 24 25 O
. NCT03863249 25 26 O
Subjects NCT03863249 28 36 O
of NCT03863249 37 39 O
40 NCT03863249 40 42 B-Eq_Comparison
- NCT03863249 43 44 I-Eq_Comparison
70 NCT03863249 45 47 I-Eq_Comparison
years NCT03863249 48 53 I-Eq_Comparison
. NCT03863249 54 55 O

2 NCT03863249 59 60 O
. NCT03863249 60 61 O
No NCT03863249 63 65 B-Negation
smokers NCT03863249 66 73 B-Condition
or NCT03863249 74 76 B-Or
smokers NCT03863249 77 84 B-Observation
of NCT03863249 85 87 O
less NCT03863249 88 92 B-Eq_Comparison
than NCT03863249 93 97 I-Eq_Comparison
10 NCT03863249 98 100 I-Eq_Comparison
cigarettes NCT03863249 101 111 I-Eq_Comparison
a NCT03863249 112 113 I-Eq_Comparison
day NCT03863249 114 117 I-Eq_Comparison
. NCT03863249 118 119 O

3 NCT03863249 123 124 O
. NCT03863249 124 125 O
Patients NCT03863249 127 135 O
with NCT03863249 136 140 O
periodontitis NCT03863249 141 154 B-Condition
stages NCT03863249 155 161 B-Eq_Comparison
III NCT03863249 162 165 I-Eq_Comparison
and NCT03863249 166 169 I-Eq_Comparison
IV NCT03863249 170 172 I-Eq_Comparison
grades NCT03863249 173 179 B-Eq_Comparison
A NCT03863249 180 181 I-Eq_Comparison
- NCT03863249 182 183 I-Eq_Comparison
B NCT03863249 184 185 I-Eq_Comparison
. NCT03863249 186 187 O

4 NCT03863249 191 192 O
. NCT03863249 192 193 O
Presence NCT03863249 195 203 O
of NCT03863249 204 206 O
20 NCT03863249 207 209 B-Eq_Comparison
natural NCT03863249 210 217 B-Modifier
teeth NCT03863249 218 223 B-Condition
, NCT03863249 224 225 O
including NCT03863249 226 235 O
at NCT03863249 236 238 B-Eq_Comparison
least NCT03863249 239 244 I-Eq_Comparison
three NCT03863249 245 250 I-Eq_Comparison
molar NCT03863249 251 256 B-Modifier
teeth NCT03863249 257 262 B-Condition
. NCT03863249 263 264 O

5 NCT03863249 268 269 O
. NCT03863249 269 270 O
Presence NCT03863249 272 280 O
of NCT03863249 281 283 O
at NCT03863249 284 286 B-Eq_Comparison
least NCT03863249 287 292 I-Eq_Comparison
4 NCT03863249 293 294 I-Eq_Comparison
sites NCT03863249 295 300 I-Eq_Comparison
with NCT03863249 301 305 O
at NCT03863249 306 308 B-Eq_Comparison
least NCT03863249 309 314 I-Eq_Comparison
6 NCT03863249 315 316 I-Eq_Comparison
mm NCT03863249 317 319 I-Eq_Comparison
probing NCT03863249 320 327 B-Observation
depth NCT03863249 328 333 I-Observation
. NCT03863249 334 335 O

6 NCT03863249 339 340 O
. NCT03863249 340 341 O
Good NCT03863249 343 347 O
general NCT03863249 348 355 B-Condition
health NCT03863249 356 362 I-Condition

Exclusion NCT03863249 363 372 O
Criteria NCT03863249 373 381 O
: NCT03863249 382 383 O

1 NCT03863249 387 388 O
. NCT03863249 388 389 O
Smokers NCT03863249 391 398 B-Observation
of NCT03863249 399 401 O
more NCT03863249 402 406 B-Eq_Comparison
than NCT03863249 407 411 I-Eq_Comparison
10 NCT03863249 412 414 I-Eq_Comparison
cigarettes NCT03863249 415 425 I-Eq_Comparison
a NCT03863249 426 427 I-Eq_Comparison
day NCT03863249 428 431 I-Eq_Comparison
. NCT03863249 432 433 O

2 NCT03863249 437 438 O
. NCT03863249 438 439 O
Patients NCT03863249 441 449 O
who NCT03863249 450 453 O
have NCT03863249 454 458 O
received NCT03863249 459 467 B-Eq_Comparison
periodontal NCT03863249 468 479 B-Procedure
treatment NCT03863249 480 489 I-Procedure
in NCT03863249 490 492 O
the NCT03863249 493 496 O
previous NCT03863249 497 505 B-Eq_Comparison
12 NCT03863249 506 508 I-Eq_Comparison
months NCT03863249 509 515 I-Eq_Comparison
. NCT03863249 516 517 O

3 NCT03863249 521 522 O
. NCT03863249 522 523 O
Patients NCT03863249 525 533 O
who NCT03863249 534 537 O
have NCT03863249 538 542 O
used NCT03863249 543 547 B-Eq_Comparison
antibiotics NCT03863249 548 559 B-Drug
in NCT03863249 560 562 O
the NCT03863249 563 566 O
last NCT03863249 567 571 B-Eq_Comparison
6 NCT03863249 572 573 I-Eq_Comparison
months NCT03863249 574 580 I-Eq_Comparison
. NCT03863249 581 582 O

4 NCT03863249 586 587 O
. NCT03863249 587 588 O
Routine NCT03863249 590 597 O
use NCT03863249 598 601 O
of NCT03863249 602 604 O
oral NCT03863249 605 609 B-Drug
antiseptics NCT03863249 610 621 I-Drug
and NCT03863249 622 625 B-Or
/ NCT03863249 626 627 I-Or
or NCT03863249 628 630 I-Or
during NCT03863249 631 637 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863249 638 641 O
previous NCT03863249 642 650 B-Eq_Comparison
3 NCT03863249 651 652 I-Eq_Comparison
months NCT03863249 653 659 I-Eq_Comparison
. NCT03863249 660 661 O

5 NCT03863249 665 666 O
. NCT03863249 666 667 O
Systemic NCT03863249 669 677 B-Modifier
conditions NCT03863249 678 688 B-Condition
that NCT03863249 689 693 O
required NCT03863249 694 702 O
antibiotic NCT03863249 703 713 B-Drug
premedication NCT03863249 714 727 I-Drug
. NCT03863249 728 729 O

6 NCT03863249 733 734 O
. NCT03863249 734 735 O
Women NCT03863249 737 742 O
pregnant NCT03863249 743 751 B-Condition
or NCT03863249 752 754 B-Or
nursing NCT03863249 755 762 B-Condition
. NCT03863249 763 764 O

7 NCT03863249 768 769 O
. NCT03863249 769 770 O
Medications NCT03863249 772 783 B-Drug
that NCT03863249 784 788 O
could NCT03863249 789 794 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03863249 795 804 O
the NCT03863249 805 808 O
outcome NCT03863249 809 816 O
of NCT03863249 817 819 O
periodontal NCT03863249 820 831 B-Procedure
therapy NCT03863249 832 839 I-Procedure
. NCT03863249 840 841 O

8 NCT03863249 845 846 O
. NCT03863249 846 847 O
Any NCT03863249 849 852 O
known NCT03863249 853 858 O
allergies NCT03863249 859 868 B-Allergy
to NCT03863249 869 871 O
the NCT03863249 872 875 O
test NCT03863249 876 880 B-Study
antimicrobial NCT03863249 881 894 B-Drug
agents NCT03863249 895 901 I-Drug
. NCT03863249 902 903 O

9 NCT03863249 907 908 O
. NCT03863249 908 909 O
Diabetics NCT03863249 911 920 B-Condition
. NCT03863249 921 922 O

Inclusion NCT03923569 0 9 O
Criteria NCT03923569 10 18 O
: NCT03923569 19 20 O

For NCT03923569 22 25 O
all NCT03923569 26 29 O
participants NCT03923569 30 42 O
: NCT03923569 43 44 O

- NCT03923569 48 49 O
age NCT03923569 51 54 B-Age
from NCT03923569 55 59 O
50 NCT03923569 60 62 B-Eq_Comparison
to NCT03923569 63 65 I-Eq_Comparison
75 NCT03923569 66 68 I-Eq_Comparison
years NCT03923569 69 74 I-Eq_Comparison
old NCT03923569 75 78 O

- NCT03923569 81 82 O
affiliated NCT03923569 84 94 O
to NCT03923569 95 97 O
the NCT03923569 98 101 O
French NCT03923569 102 108 O
health NCT03923569 109 115 O
care NCT03923569 116 120 O
system NCT03923569 121 127 O

For NCT03923569 128 131 O
AD NCT03923569 132 134 B-Condition
patients NCT03923569 135 143 O
: NCT03923569 144 145 O

- NCT03923569 149 150 O
meeting NCT03923569 152 159 O
International NCT03923569 160 173 O
Working NCT03923569 174 181 O
Group NCT03923569 182 187 O
( NCT03923569 188 189 O
IWG NCT03923569 190 193 O
) NCT03923569 194 195 O
- NCT03923569 196 197 O
2 NCT03923569 198 199 O
criteria NCT03923569 200 208 O
for NCT03923569 209 212 O
diagnosis NCT03923569 213 222 O

- NCT03923569 225 226 O
Mini NCT03923569 228 232 B-Observation
- NCT03923569 233 234 I-Observation
Mental NCT03923569 235 241 I-Observation
State NCT03923569 242 247 I-Observation
Examination NCT03923569 248 259 I-Observation
( NCT03923569 260 261 O
MMSE NCT03923569 262 266 B-Observation
) NCT03923569 267 268 O
≥ NCT03923569 269 270 B-Eq_Comparison
20 NCT03923569 271 273 I-Eq_Comparison
( NCT03923569 274 275 O
Greco NCT03923569 276 281 O
version NCT03923569 282 289 O
) NCT03923569 290 291 O

For NCT03923569 293 296 O
healthy NCT03923569 297 304 B-Condition
volunteers NCT03923569 305 315 O
: NCT03923569 316 317 O

- NCT03923569 321 322 O
MMSE NCT03923569 324 328 B-Observation
> NCT03923569 329 330 B-Eq_Comparison
25 NCT03923569 331 333 I-Eq_Comparison

- NCT03923569 337 338 O
Dubois NCT03923569 340 346 B-Observation
5 NCT03923569 347 348 I-Observation
words NCT03923569 349 354 I-Observation
test NCT03923569 355 359 I-Observation
≥ NCT03923569 360 361 B-Eq_Comparison
9 NCT03923569 362 363 I-Eq_Comparison

Exclusion NCT03923569 365 374 O
Criteria NCT03923569 375 383 O
: NCT03923569 384 385 O

For NCT03923569 387 390 O
all NCT03923569 391 394 O
participants NCT03923569 395 407 O
: NCT03923569 408 409 O

- NCT03923569 413 414 O
Pregnancy NCT03923569 416 425 B-Condition

- NCT03923569 428 429 O
people NCT03923569 431 437 O
not NCT03923569 438 441 O
able NCT03923569 442 446 O
to NCT03923569 447 449 O
give NCT03923569 450 454 O
consent NCT03923569 455 462 O

- NCT03923569 465 466 O
contraindication NCT03923569 468 484 B-Contraindication
for NCT03923569 485 488 O
MRI NCT03923569 489 492 B-Procedure
( NCT03923569 493 494 O
metallic NCT03923569 495 503 B-Condition
body NCT03923569 504 508 I-Condition
parts NCT03923569 509 514 I-Condition
, NCT03923569 515 516 O
claustrophobia NCT03923569 517 531 B-Condition
) NCT03923569 532 533 O
, NCT03923569 534 535 O

- NCT03923569 539 540 O
aphasia NCT03923569 542 549 B-Condition
, NCT03923569 550 551 O
apraxia NCT03923569 552 559 B-Condition
or NCT03923569 560 562 B-Or
agnosia NCT03923569 563 570 B-Condition

- NCT03923569 573 574 O
neurological NCT03923569 576 588 B-Modifier
( NCT03923569 589 590 O
other NCT03923569 591 596 B-Exception
than NCT03923569 597 601 I-Exception
AD NCT03923569 602 604 B-Condition
) NCT03923569 605 606 O
or NCT03923569 607 609 B-Or
any NCT03923569 610 613 O
other NCT03923569 614 619 B-Other
serious NCT03923569 620 627 O
disease NCT03923569 628 635 B-Condition
( NCT03923569 636 637 O
cancer NCT03923569 638 644 O
, NCT03923569 645 646 O
addiction NCT03923569 647 656 B-Condition
, NCT03923569 657 658 O
systemic NCT03923569 659 667 B-Condition
disease NCT03923569 668 675 I-Condition
) NCT03923569 676 677 O

- NCT03923569 681 682 O
sleep NCT03923569 684 689 O
apnea NCT03923569 690 695 O

- NCT03923569 698 699 O
major NCT03923569 701 706 O
depression NCT03923569 707 717 B-Condition
or NCT03923569 718 720 B-Or
anxiety NCT03923569 721 728 B-Condition
for NCT03923569 729 732 O
more NCT03923569 733 737 B-Eq_Comparison
than NCT03923569 738 742 I-Eq_Comparison
3 NCT03923569 743 744 I-Eq_Comparison
months NCT03923569 745 751 I-Eq_Comparison
( NCT03923569 752 753 O
Beck NCT03923569 754 758 B-Observation
> NCT03923569 759 760 B-Eq_Comparison
10 NCT03923569 761 763 I-Eq_Comparison
) NCT03923569 764 765 O
or NCT03923569 766 768 B-Or
psychiatric NCT03923569 769 780 B-Condition
disease NCT03923569 781 788 I-Condition

- NCT03923569 791 792 O
documented NCT03923569 794 804 O
epilepsy NCT03923569 805 813 B-Condition

- NCT03923569 816 817 O
use NCT03923569 819 822 B-Eq_Comparison
of NCT03923569 823 825 O
neuroleptics NCT03923569 826 838 B-Drug
( NCT03923569 839 840 O
more NCT03923569 841 845 B-Eq_Comparison
than NCT03923569 846 850 I-Eq_Comparison
one NCT03923569 851 854 I-Eq_Comparison
dose NCT03923569 855 859 I-Eq_Comparison
per NCT03923569 860 863 I-Eq_Comparison
day NCT03923569 864 867 I-Eq_Comparison
) NCT03923569 868 869 O

- NCT03923569 873 874 O
use NCT03923569 876 879 B-Eq_Comparison
of NCT03923569 880 882 O
antiepileptics NCT03923569 883 897 B-Drug

- NCT03923569 900 901 O
use NCT03923569 903 906 B-Eq_Comparison
of NCT03923569 907 909 O
benzodiazepines NCT03923569 910 925 B-Drug
at NCT03923569 926 928 O
a NCT03923569 929 930 O
dose NCT03923569 931 935 O
superior NCT03923569 936 944 B-Eq_Comparison
or NCT03923569 945 947 I-Eq_Comparison
equal NCT03923569 948 953 I-Eq_Comparison
to NCT03923569 954 956 I-Eq_Comparison
two NCT03923569 957 960 I-Eq_Comparison
intakes NCT03923569 961 968 I-Eq_Comparison
per NCT03923569 969 972 I-Eq_Comparison
day NCT03923569 973 976 I-Eq_Comparison

- NCT03923569 979 980 O
use NCT03923569 982 985 B-Eq_Comparison
of NCT03923569 986 988 O
antidepressants NCT03923569 989 1004 B-Drug

- NCT03923569 1007 1008 O
restless NCT03923569 1010 1018 B-Condition
leg NCT03923569 1019 1022 I-Condition
syndrome NCT03923569 1023 1031 I-Condition
treated NCT03923569 1032 1039 O
by NCT03923569 1040 1042 O
dopaminergic NCT03923569 1043 1055 B-Drug
agonists NCT03923569 1056 1064 I-Drug
. NCT03923569 1065 1066 O

For NCT03923569 1068 1071 O
AD NCT03923569 1072 1074 B-Condition
patients NCT03923569 1075 1083 O
: NCT03923569 1084 1085 O

- NCT03923569 1089 1090 O
other NCT03923569 1092 1097 B-Other
causes NCT03923569 1098 1104 B-Condition
of NCT03923569 1105 1107 O
dementia NCT03923569 1108 1116 B-Condition

- NCT03923569 1119 1120 O
non NCT03923569 1122 1125 B-Modifier
- NCT03923569 1126 1127 I-Modifier
degenerative NCT03923569 1128 1140 I-Modifier
neurological NCT03923569 1141 1153 I-Modifier
lesions NCT03923569 1154 1161 B-Condition

- NCT03923569 1164 1165 O
white NCT03923569 1167 1172 B-Condition
matter NCT03923569 1173 1179 I-Condition
hypersignals NCT03923569 1180 1192 I-Condition

- NCT03923569 1195 1196 O
acute NCT03923569 1198 1203 O
cognitive NCT03923569 1204 1213 B-Condition
deficits NCT03923569 1214 1222 I-Condition

Inclusion NCT03862118 0 9 O
Criteria NCT03862118 10 18 O
: NCT03862118 19 20 O

- NCT03862118 24 25 O
•Both NCT03862118 27 32 O
sexes NCT03862118 33 38 O
will NCT03862118 39 43 O
be NCT03862118 44 46 O
included NCT03862118 47 55 O
. NCT03862118 56 57 O

- NCT03862118 66 67 O
Age NCT03862118 69 72 B-Age
( NCT03862118 73 74 O
20 NCT03862118 75 77 B-Eq_Comparison
- NCT03862118 78 79 I-Eq_Comparison
50 NCT03862118 80 82 I-Eq_Comparison
) NCT03862118 83 84 O

- NCT03862118 93 94 O
Patient NCT03862118 96 103 O
with NCT03862118 104 108 O
Fitzpatrick NCT03862118 109 120 B-Condition
skin NCT03862118 121 125 I-Condition
types NCT03862118 126 131 B-Eq_Comparison
III NCT03862118 132 135 I-Eq_Comparison
- NCT03862118 136 137 I-Eq_Comparison
IV NCT03862118 138 140 I-Eq_Comparison

Exclusion NCT03862118 141 150 O
Criteria NCT03862118 151 159 O
: NCT03862118 160 161 O

- NCT03862118 165 166 O
• NCT03862118 168 169 O
Patients NCT03862118 170 178 O
with NCT03862118 179 183 O
known NCT03862118 184 189 O
platelet NCT03862118 190 198 B-Condition
dysfunction NCT03862118 199 210 I-Condition
syndrome NCT03862118 211 219 I-Condition
, NCT03862118 220 221 O
critical NCT03862118 222 230 O
thrombocytopenia NCT03862118 231 247 B-Condition
( NCT03862118 248 249 O
< NCT03862118 250 251 B-Eq_Comparison
50 NCT03862118 252 254 I-Eq_Comparison
, NCT03862118 255 256 I-Eq_Comparison
000 NCT03862118 257 260 I-Eq_Comparison
/ NCT03862118 261 262 I-Eq_Comparison
ul NCT03862118 263 265 I-Eq_Comparison
) NCT03862118 266 267 O
, NCT03862118 268 269 O
any NCT03862118 270 273 O
hemodynamic NCT03862118 274 285 B-Condition
instability NCT03862118 286 297 I-Condition
. NCT03862118 298 299 O

- NCT03862118 308 309 O
Patients NCT03862118 311 319 O
with NCT03862118 320 324 O
chronic NCT03862118 325 332 O
medical NCT03862118 333 340 B-Condition
illness NCT03862118 341 348 I-Condition
( NCT03862118 349 350 O
e NCT03862118 351 352 O
. NCT03862118 353 354 O
g NCT03862118 355 356 O
. NCT03862118 357 358 O
diabetes NCT03862118 360 368 B-Condition
, NCT03862118 369 370 O
chronic NCT03862118 371 378 O
infections NCT03862118 379 389 B-Condition
, NCT03862118 390 391 O
and NCT03862118 392 395 B-Or
blood NCT03862118 396 401 B-Modifier
dyscrasias NCT03862118 402 412 B-Condition
) NCT03862118 413 414 O
. NCT03862118 415 416 O

- NCT03862118 425 426 O
Patients NCT03862118 428 436 O
with NCT03862118 437 441 O
local NCT03862118 442 447 B-Modifier
inflammatory NCT03862118 448 460 I-Modifier
skin NCT03862118 461 465 B-Condition
disorders NCT03862118 466 475 I-Condition
or NCT03862118 476 478 B-Or
active NCT03862118 479 485 B-Eq_Comparison
herpes NCT03862118 486 492 B-Condition
infection NCT03862118 493 502 I-Condition
at NCT03862118 503 505 O
the NCT03862118 506 509 O
site NCT03862118 510 514 B-Modifier
of NCT03862118 515 517 O
the NCT03862118 518 521 O
procedure NCT03862118 522 531 B-Procedure
. NCT03862118 532 533 O

- NCT03862118 542 543 O
Patients NCT03862118 545 553 O
on NCT03862118 554 556 B-Eq_Comparison
consistent NCT03862118 557 567 O
use NCT03862118 568 571 O
of NCT03862118 572 574 O
anti NCT03862118 575 579 B-Drug
- NCT03862118 580 581 I-Drug
coagulants NCT03862118 582 592 I-Drug
or NCT03862118 593 595 B-Or
non NCT03862118 596 599 B-Drug
- NCT03862118 600 601 I-Drug
steroidal NCT03862118 602 611 I-Drug
anti NCT03862118 612 616 I-Drug
- NCT03862118 617 618 I-Drug
inflammatory NCT03862118 619 631 I-Drug
drugs NCT03862118 632 637 I-Drug
( NCT03862118 638 639 O
NSAID NCT03862118 640 645 B-Drug
) NCT03862118 646 647 O
within NCT03862118 648 654 B-Eq_Comparison
48 NCT03862118 655 657 I-Eq_Comparison
hours NCT03862118 658 663 I-Eq_Comparison
of NCT03862118 664 666 B-Temporal_Connection___Temporal_Connection_Type_Value:before
procedure NCT03862118 667 676 B-Procedure
. NCT03862118 677 678 O

- NCT03862118 687 688 O
Haemoglobin NCT03862118 690 701 B-Observation
level NCT03862118 702 707 O
< NCT03862118 708 709 B-Eq_Comparison
10 NCT03862118 710 712 I-Eq_Comparison
g NCT03862118 713 714 I-Eq_Comparison
/ NCT03862118 715 716 I-Eq_Comparison
dl NCT03862118 717 719 I-Eq_Comparison
were NCT03862118 720 724 O
also NCT03862118 725 729 O
excluded NCT03862118 730 738 B-Negation
. NCT03862118 739 740 O

- NCT03862118 749 750 O
Patients NCT03862118 752 760 O
with NCT03862118 761 765 O
cancer NCT03862118 766 772 B-Condition
- NCT03862118 773 774 O
especially NCT03862118 775 785 O
hematopoietic NCT03862118 786 799 B-Modifier
or NCT03862118 800 802 B-Or
of NCT03862118 803 805 O
bone NCT03862118 806 810 B-Modifier
. NCT03862118 811 812 O

- NCT03862118 821 822 O
Pregnant NCT03862118 824 832 B-Condition
females NCT03862118 833 840 O
. NCT03862118 841 842 O

- NCT03862118 851 852 O
Patients NCT03862118 854 862 O
with NCT03862118 863 867 O
corticosteroids NCT03862118 868 883 B-Drug
injection NCT03862118 884 893 O
at NCT03862118 894 896 O
treatment NCT03862118 897 906 B-Procedure
site NCT03862118 907 911 O
within NCT03862118 912 918 B-Eq_Comparison
1 NCT03862118 919 920 I-Eq_Comparison
month NCT03862118 921 926 I-Eq_Comparison
or NCT03862118 927 929 B-Or
systemic NCT03862118 930 938 B-Modifier
use NCT03862118 939 942 O
of NCT03862118 943 945 O
corticosteroids NCT03862118 946 961 B-Drug
within NCT03862118 962 968 B-Eq_Comparison
2 NCT03862118 969 970 I-Eq_Comparison
weeks NCT03862118 971 976 I-Eq_Comparison
. NCT03862118 977 978 O

Inclusion NCT03860142 0 9 O
Criteria NCT03860142 10 18 O
: NCT03860142 19 20 O

- NCT03860142 24 25 O
Children NCT03860142 27 35 O
whose NCT03860142 36 41 B-And
age NCT03860142 42 45 B-Age
≥ NCT03860142 46 47 B-Eq_Comparison
24 NCT03860142 48 50 I-Eq_Comparison
months NCT03860142 51 57 I-Eq_Comparison
and NCT03860142 58 61 B-And
≤ NCT03860142 62 63 B-Eq_Comparison
36 NCT03860142 64 66 I-Eq_Comparison
months NCT03860142 67 73 I-Eq_Comparison

- NCT03860142 76 77 O
Full NCT03860142 79 83 B-Modifier
- NCT03860142 84 85 I-Modifier
term NCT03860142 86 90 I-Modifier
or NCT03860142 91 93 B-Or
prematurely NCT03860142 94 105 B-Modifier
born NCT03860142 106 110 B-Birth
( NCT03860142 111 112 O
< NCT03860142 113 114 B-Eq_Comparison
33 NCT03860142 115 117 I-Eq_Comparison
SA NCT03860142 118 120 B-Observation
) NCT03860142 121 122 O
at NCT03860142 123 125 O
Nice NCT03860142 126 130 O
University NCT03860142 131 141 O
Hospital NCT03860142 142 150 O

Exclusion NCT03860142 151 160 O
Criteria NCT03860142 161 169 O
: NCT03860142 170 171 O

- NCT03860142 175 176 O
Children NCT03860142 178 186 O
with NCT03860142 187 191 B-And
congenital NCT03860142 192 202 B-Condition
pathologies NCT03860142 203 214 I-Condition
( NCT03860142 215 216 O
with NCT03860142 217 221 O
malformations NCT03860142 222 235 B-Condition
in NCT03860142 236 238 O
the NCT03860142 239 242 O
oro NCT03860142 243 246 B-Modifier
- NCT03860142 247 248 I-Modifier
facial NCT03860142 249 255 I-Modifier
sphere NCT03860142 256 262 I-Modifier
) NCT03860142 263 264 O

- NCT03860142 268 269 O
Children NCT03860142 271 279 O
with NCT03860142 280 284 B-And
neurological NCT03860142 285 297 B-Modifier
and NCT03860142 298 301 B-Or
developmental NCT03860142 302 315 B-Modifier
pathologies NCT03860142 316 327 B-Condition
unrelated NCT03860142 328 337 B-Exception
to NCT03860142 338 340 I-Exception
prematurity NCT03860142 341 352 B-Condition

- NCT03860142 355 356 O
Children NCT03860142 358 366 O
with NCT03860142 367 371 B-And
ENT NCT03860142 372 375 B-Condition
deformities NCT03860142 376 387 I-Condition

- NCT03860142 390 391 O
Parental NCT03860142 393 401 B-Family_Member___Family_Member_Type:parent
langage NCT03860142 402 409 B-Condition
barrier NCT03860142 410 417 I-Condition

Inclusion NCT03863236 0 9 O
Criteria NCT03863236 10 18 O
: NCT03863236 19 20 O

- NCT03863236 24 25 O
18 NCT03863236 27 29 B-Eq_Comparison
years NCT03863236 30 35 I-Eq_Comparison
or NCT03863236 36 38 I-Eq_Comparison
older NCT03863236 39 44 I-Eq_Comparison

- NCT03863236 47 48 O
Primary NCT03863236 50 57 B-Modifier
colon NCT03863236 58 63 I-Modifier
adenocarcinoma NCT03863236 64 78 B-Condition

- NCT03863236 81 82 O
Curative NCT03863236 84 92 B-Procedure
operation NCT03863236 93 102 I-Procedure
is NCT03863236 103 105 O
possible NCT03863236 106 114 B-Assertion___Assertion_Type_Value:hypothetical

- NCT03863236 117 118 O
Patient NCT03863236 120 127 O
has NCT03863236 128 131 O
a NCT03863236 132 133 O
life NCT03863236 134 138 B-Observation
expectancy NCT03863236 139 149 I-Observation
of NCT03863236 150 152 O
at NCT03863236 153 155 B-Eq_Comparison
least NCT03863236 156 161 I-Eq_Comparison
12 NCT03863236 162 164 I-Eq_Comparison
months NCT03863236 165 171 I-Eq_Comparison

- NCT03863236 174 175 O
Patient NCT03863236 177 184 O
signs NCT03863236 185 190 O
the NCT03863236 191 194 O
informed NCT03863236 195 203 O
consent NCT03863236 204 211 O
and NCT03863236 212 215 O
agrees NCT03863236 216 222 O
to NCT03863236 223 225 O
attend NCT03863236 226 232 O
all NCT03863236 233 236 O
study NCT03863236 237 242 O
visits NCT03863236 243 249 O

Exclusion NCT03863236 250 259 O
Criteria NCT03863236 260 268 O
: NCT03863236 269 270 O

- NCT03863236 274 275 O
Recurrent NCT03863236 277 286 B-Modifier
colon NCT03863236 287 292 B-Condition
adenocarcinoma NCT03863236 293 307 I-Condition

- NCT03863236 310 311 O
Metastatic NCT03863236 313 323 B-Condition
disease NCT03863236 324 331 I-Condition

- NCT03863236 334 335 O
Cancer NCT03863236 337 343 B-Condition
that NCT03863236 344 348 O
will NCT03863236 349 353 B-Assertion___Assertion_Type_Value:hypothetical
require NCT03863236 354 361 I-Assertion___Assertion_Type_Value:hypothetical
multiorgan NCT03863236 362 372 B-Procedure
resection NCT03863236 373 382 I-Procedure

- NCT03863236 385 386 O
Pregnant NCT03863236 388 396 B-Condition
or NCT03863236 397 399 B-Or
suspected NCT03863236 400 409 B-Assertion___Assertion_Type_Value:possible
pregnancy NCT03863236 410 419 B-Condition

- NCT03863236 422 423 O
Patient NCT03863236 425 432 O
with NCT03863236 433 437 O
a NCT03863236 438 439 O
comorbid NCT03863236 440 448 B-Condition
illness NCT03863236 449 456 I-Condition
or NCT03863236 457 459 B-Or
condition NCT03863236 460 469 B-Condition
that NCT03863236 470 474 O
would NCT03863236 475 480 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03863236 481 489 B-Negation
the NCT03863236 490 493 O
use NCT03863236 494 497 O
of NCT03863236 498 500 O
surgery NCT03863236 501 508 B-Procedure
( NCT03863236 509 510 O
ASA NCT03863236 511 514 B-Observation
5 NCT03863236 515 516 B-Eq_Comparison
) NCT03863236 517 518 O
. NCT03863236 519 520 O

- NCT03863236 524 525 O
Patients NCT03863236 527 535 O
with NCT03863236 536 540 O
concurrent NCT03863236 541 551 B-Modifier
or NCT03863236 552 554 B-Or
previous NCT03863236 555 563 B-Eq_Comparison
malignant NCT03863236 564 573 B-Condition
tumors NCT03863236 574 580 I-Condition
within NCT03863236 581 587 B-Eq_Comparison
5 NCT03863236 588 589 I-Eq_Comparison
years NCT03863236 590 595 I-Eq_Comparison
before NCT03863236 596 602 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03863236 603 606 O
study NCT03863236 607 612 B-Study
enrollment NCT03863236 613 623 O

- NCT03863236 626 627 O
Patient NCT03863236 629 636 O
undergoing NCT03863236 637 647 B-Eq_Comparison
emergency NCT03863236 648 657 B-Modifier
procedures NCT03863236 658 668 B-Procedure

- NCT03863236 671 672 O
Dialysis NCT03863236 674 682 B-Procedure

- NCT03863236 685 686 O
Liver NCT03863236 688 693 B-Condition
dysfunction NCT03863236 694 705 I-Condition
, NCT03863236 706 707 O
child NCT03863236 708 713 B-Condition
pugh NCT03863236 714 718 I-Condition
B NCT03863236 719 720 B-Eq_Comparison
or NCT03863236 721 723 I-Eq_Comparison
worse NCT03863236 724 729 I-Eq_Comparison

- NCT03863236 732 733 O
NRS NCT03863236 735 738 B-Observation
score NCT03863236 739 744 B-Eq_Comparison
< NCT03863236 745 746 I-Eq_Comparison
2 NCT03863236 747 748 I-Eq_Comparison
or NCT03863236 749 751 B-Or
> NCT03863236 752 753 B-Eq_Comparison
5 NCT03863236 754 755 I-Eq_Comparison

- NCT03863236 759 760 O
BMI NCT03863236 762 765 B-Observation
under NCT03863236 766 771 B-Eq_Comparison
18.5 NCT03863236 772 776 I-Eq_Comparison

- NCT03863236 780 781 O
Weight NCT03863236 783 789 B-Observation
loss NCT03863236 790 794 I-Observation
15 NCT03863236 795 797 B-Eq_Comparison
% NCT03863236 798 799 I-Eq_Comparison
or NCT03863236 800 802 I-Eq_Comparison
more NCT03863236 803 807 I-Eq_Comparison
past NCT03863236 808 812 B-Eq_Comparison
6 NCT03863236 813 814 I-Eq_Comparison
months NCT03863236 815 821 I-Eq_Comparison

- NCT03863236 824 825 O
Serum NCT03863236 827 832 B-Observation
albumin NCT03863236 833 840 I-Observation
less NCT03863236 841 845 B-Eq_Comparison
than NCT03863236 846 850 I-Eq_Comparison
30 NCT03863236 851 853 I-Eq_Comparison
without NCT03863236 854 861 B-Negation
liver NCT03863236 862 867 B-Modifier
or NCT03863236 868 870 B-Or
renal NCT03863236 871 876 B-Modifier
dysfunction NCT03863236 877 888 B-Condition

- NCT03863236 891 892 O
Chronic NCT03863236 894 901 B-Condition
malnutrition NCT03863236 902 914 I-Condition
: NCT03863236 915 916 O
short NCT03863236 917 922 B-Condition
bowel NCT03863236 923 928 I-Condition
syndrome NCT03863236 929 937 I-Condition
, NCT03863236 938 939 O
previous NCT03863236 940 948 B-Eq_Comparison
gastrectomy NCT03863236 949 960 B-Condition
, NCT03863236 961 962 O
pancreatic NCT03863236 963 973 B-Condition
dysfunction NCT03863236 974 985 I-Condition

- NCT03863236 988 989 O
Language NCT03863236 991 999 B-Condition
barrier NCT03863236 1000 1007 I-Condition
or NCT03863236 1008 1010 O
other NCT03863236 1011 1016 O
reasons NCT03863236 1017 1024 O
why NCT03863236 1025 1028 O
informed NCT03863236 1029 1037 O
consent NCT03863236 1038 1045 O
is NCT03863236 1046 1048 O
not NCT03863236 1049 1052 O
possible NCT03863236 1053 1061 O

Inclusion NCT03920813 0 9 O
Criteria NCT03920813 10 18 O
: NCT03920813 19 20 O

- NCT03920813 24 25 O
Patients NCT03920813 27 35 O
have NCT03920813 36 40 O
been NCT03920813 41 45 O
diagnosed NCT03920813 46 55 O
with NCT03920813 56 60 O
Acute NCT03920813 61 66 B-Condition
Lymphoblastic NCT03920813 67 80 I-Condition
Leukemia NCT03920813 81 89 I-Condition

- NCT03920813 92 93 O
Childhood NCT03920813 95 104 O
patients NCT03920813 105 113 O
who NCT03920813 114 117 B-And
were NCT03920813 118 122 O
undergoing NCT03920813 123 133 B-Eq_Comparison
chemotherapy NCT03920813 134 146 B-Procedure
or NCT03920813 147 149 B-Or
continuous NCT03920813 150 160 O
follow NCT03920813 161 167 B-Encounter
- NCT03920813 168 169 I-Encounter
up NCT03920813 170 172 I-Encounter
after NCT03920813 173 178 B-Temporal_Connection___Temporal_Connection_Type_Value:after
completion NCT03920813 179 189 O
of NCT03920813 190 192 O
chemotherapy NCT03920813 193 205 B-Procedure

- NCT03920813 208 209 O
Patients NCT03920813 211 219 O
received NCT03920813 220 228 B-Eq_Comparison
the NCT03920813 229 232 O
phase NCT03920813 233 238 O
of NCT03920813 239 241 O
maintenance NCT03920813 242 253 B-Procedure
therapy NCT03920813 254 261 I-Procedure
that NCT03920813 262 266 O
included NCT03920813 267 275 O
oral NCT03920813 276 280 B-Modifier
6 NCT03920813 281 282 B-Drug
- NCT03920813 283 284 I-Drug
MP NCT03920813 285 287 I-Drug
( NCT03920813 288 289 O
> NCT03920813 290 291 B-Eq_Comparison
4 NCT03920813 292 293 I-Eq_Comparison
weeks NCT03920813 294 299 I-Eq_Comparison
) NCT03920813 300 301 O
and NCT03920813 302 305 O
completion NCT03920813 306 316 O
of NCT03920813 317 319 O
≥ NCT03920813 320 321 B-Eq_Comparison
6 NCT03920813 322 323 I-Eq_Comparison
months NCT03920813 324 330 I-Eq_Comparison
according NCT03920813 331 340 O
to NCT03920813 341 343 O
the NCT03920813 344 347 O
CCLG NCT03920813 348 352 O
( NCT03920813 353 354 O
Chinese NCT03920813 355 362 O
Children NCT03920813 363 371 O
's NCT03920813 371 373 O
Leukemia NCT03920813 374 382 O
Group NCT03920813 383 388 O
) NCT03920813 389 390 O
protocol NCT03920813 391 399 O
- NCT03920813 400 401 O
ALL NCT03920813 402 405 O
2015 NCT03920813 406 410 O

Exclusion NCT03920813 412 421 O
Criteria NCT03920813 422 430 O
: NCT03920813 431 432 O

- NCT03920813 436 437 O
Patients NCT03920813 439 447 O
with NCT03920813 448 452 O
high NCT03920813 453 457 O
- NCT03920813 458 459 O
risk NCT03920813 460 464 B-Risk
ALL NCT03920813 465 468 B-Condition
( NCT03920813 469 470 O
presence NCT03920813 471 479 O
of NCT03920813 480 482 O
higher NCT03920813 483 489 O
- NCT03920813 490 491 O
risk NCT03920813 492 496 O
features NCT03920813 497 505 O
: NCT03920813 506 507 O
MRD NCT03920813 508 511 B-Observation
≥ NCT03920813 512 513 B-Eq_Comparison
1 NCT03920813 514 515 I-Eq_Comparison
% NCT03920813 516 517 I-Eq_Comparison
at NCT03920813 518 520 O
46 NCT03920813 521 523 O
day NCT03920813 524 527 O
, NCT03920813 528 529 O
or NCT03920813 530 532 B-Or
age NCT03920813 533 536 B-Age
< NCT03920813 537 538 B-Eq_Comparison
6 NCT03920813 539 540 I-Eq_Comparison
month NCT03920813 541 546 I-Eq_Comparison
and NCT03920813 547 550 B-And
white NCT03920813 551 556 B-Observation
blood NCT03920813 557 562 I-Observation
cell NCT03920813 563 567 I-Observation
( NCT03920813 568 569 O
WBC NCT03920813 570 573 B-Observation
) NCT03920813 574 575 O
count NCT03920813 576 581 B-Eq_Comparison
≥ NCT03920813 582 583 I-Eq_Comparison
300 NCT03920813 584 587 I-Eq_Comparison
× NCT03920813 588 589 I-Eq_Comparison
109 NCT03920813 590 593 I-Eq_Comparison
/ NCT03920813 594 595 I-Eq_Comparison
L NCT03920813 596 597 I-Eq_Comparison
with NCT03920813 598 602 O
translocations NCT03920813 603 617 O
t NCT03920813 618 619 O
( NCT03920813 620 621 O
9 NCT03920813 622 623 O
; NCT03920813 624 625 O
22 NCT03920813 626 628 O
) NCT03920813 629 630 O
( NCT03920813 631 632 O
q NCT03920813 633 634 O
34 NCT03920813 635 637 O
; NCT03920813 638 639 O
q NCT03920813 639 640 O
11 NCT03920813 641 643 O
) NCT03920813 644 645 O
[ NCT03920813 646 647 O
BCR NCT03920813 648 651 O
- NCT03920813 652 653 O
ABL NCT03920813 654 657 O
] NCT03920813 658 659 O
, NCT03920813 660 661 O
t NCT03920813 662 663 O
( NCT03920813 664 665 O
4 NCT03920813 666 667 O
; NCT03920813 668 669 O
11 NCT03920813 670 672 O
) NCT03920813 673 674 O
( NCT03920813 675 676 O
q NCT03920813 677 678 O
21 NCT03920813 679 681 O
; NCT03920813 682 683 O
q NCT03920813 683 684 O
23 NCT03920813 685 687 O
) NCT03920813 688 689 O
[ NCT03920813 690 691 O
AF NCT03920813 692 694 O
4 NCT03920813 695 696 O
/ NCT03920813 697 698 O
MLL NCT03920813 699 702 O
] NCT03920813 703 704 O
, NCT03920813 705 706 O
t NCT03920813 707 708 O
( NCT03920813 709 710 O
1 NCT03920813 711 712 O
; NCT03920813 713 714 O
19 NCT03920813 715 717 O
) NCT03920813 718 719 O
( NCT03920813 720 721 O
q NCT03920813 722 723 O
23 NCT03920813 724 726 O
; NCT03920813 727 728 O
p NCT03920813 728 729 O
13 NCT03920813 730 732 O
) NCT03920813 733 734 O
[ NCT03920813 735 736 O
E NCT03920813 737 738 O
2A NCT03920813 739 741 O
- NCT03920813 742 743 O
PBX NCT03920813 744 747 O
1 NCT03920813 748 749 O
] NCT03920813 750 751 O
or NCT03920813 752 754 O
other NCT03920813 755 760 O
MLL NCT03920813 761 764 O
- NCT03920813 765 766 O
rearrangements NCT03920813 767 781 O
) NCT03920813 782 783 O
were NCT03920813 784 788 O
removed NCT03920813 789 796 O

Inclusion NCT03923660 0 9 O
Criteria NCT03923660 10 18 O
: NCT03923660 19 20 O

- NCT03923660 24 25 O
Severe NCT03923660 27 33 O
COPD NCT03923660 34 38 B-Condition
( NCT03923660 39 40 O
FEV NCT03923660 41 44 B-Observation
1 NCT03923660 45 46 I-Observation
[ NCT03923660 47 48 O
forced NCT03923660 49 55 B-Observation
expiratory NCT03923660 56 66 I-Observation
volume NCT03923660 67 73 I-Observation
in NCT03923660 74 76 I-Observation
1 NCT03923660 77 78 I-Observation
second NCT03923660 79 85 I-Observation
] NCT03923660 86 87 O
/ NCT03923660 88 89 B-Or
FVC NCT03923660 90 93 B-Observation
[ NCT03923660 94 95 O
forced NCT03923660 96 102 B-Observation
vital NCT03923660 103 108 I-Observation
capacity NCT03923660 109 117 I-Observation
] NCT03923660 118 119 O
< NCT03923660 120 121 B-Eq_Comparison
70 NCT03923660 122 124 I-Eq_Comparison
% NCT03923660 125 126 I-Eq_Comparison
et NCT03923660 127 129 O
FEV NCT03923660 130 133 B-Observation
1 NCT03923660 134 135 I-Observation
< NCT03923660 136 137 B-Eq_Comparison
50 NCT03923660 138 140 I-Eq_Comparison
% NCT03923660 141 142 I-Eq_Comparison
) NCT03923660 143 144 O

- NCT03923660 148 149 O
Informed NCT03923660 151 159 O
consent NCT03923660 160 167 O

- NCT03923660 170 171 O
Affiliation NCT03923660 173 184 O
to NCT03923660 185 187 O
a NCT03923660 188 189 O
social NCT03923660 190 196 O
security NCT03923660 197 205 O
scheme NCT03923660 206 212 O

Exclusion NCT03923660 213 222 O
Criteria NCT03923660 223 231 O
: NCT03923660 232 233 O

- NCT03923660 237 238 O
Effort NCT03923660 240 246 B-Procedure
oxygen NCT03923660 247 253 I-Procedure
therapy NCT03923660 254 261 I-Procedure

- NCT03923660 264 265 O
Cardiovascular NCT03923660 267 281 B-Modifier
, NCT03923660 282 283 O
neuromuscular NCT03923660 284 297 B-Modifier
or NCT03923660 298 300 B-Or
musculoskeletal NCT03923660 301 316 B-Modifier
disorders NCT03923660 317 326 B-Condition
that NCT03923660 327 331 O
can NCT03923660 332 335 O
provide NCT03923660 336 343 O
significant NCT03923660 344 355 O
dyspnea NCT03923660 356 363 B-Condition
or NCT03923660 364 366 B-Or
limit NCT03923660 367 372 O
exercise NCT03923660 373 381 B-Observation

- NCT03923660 384 385 O
Legal NCT03923660 387 392 B-Condition
incapacity NCT03923660 393 403 I-Condition

- NCT03923660 406 407 O
Low NCT03923660 409 412 O
or NCT03923660 413 415 B-Or
no NCT03923660 416 418 B-Negation
cooperation NCT03923660 419 430 B-Observation
anticipated NCT03923660 431 442 B-Assertion___Assertion_Type_Value:hypothetical

Inclusion NCT03929380 0 9 O
Criteria NCT03929380 10 18 O
: NCT03929380 19 20 O

- NCT03929380 24 25 O
Males NCT03929380 27 32 O
, NCT03929380 33 34 O
with NCT03929380 35 39 B-And
at NCT03929380 40 42 B-Eq_Comparison
least NCT03929380 43 48 I-Eq_Comparison
a NCT03929380 49 50 I-Eq_Comparison
year NCT03929380 51 55 I-Eq_Comparison
of NCT03929380 56 58 O
experience NCT03929380 59 69 O
in NCT03929380 70 72 O
heavylift NCT03929380 73 82 B-Modifier
exercises NCT03929380 83 92 B-Observation
, NCT03929380 93 94 O
age NCT03929380 95 98 B-Age
between NCT03929380 99 106 B-Eq_Comparison
20 NCT03929380 107 109 I-Eq_Comparison
and NCT03929380 110 113 I-Eq_Comparison
35 NCT03929380 114 116 I-Eq_Comparison
years NCT03929380 117 122 I-Eq_Comparison
. NCT03929380 123 124 O

Exclusion NCT03929380 126 135 O
Criteria NCT03929380 136 144 O
: NCT03929380 145 146 O

- NCT03929380 150 151 O


Inclusion NCT03922321 0 9 O
Criteria NCT03922321 10 18 O
: NCT03922321 19 20 O

1 NCT03922321 24 25 O
. NCT03922321 25 26 O
Male NCT03922321 28 32 O
or NCT03922321 33 35 B-Or
female NCT03922321 36 42 O
≥ NCT03922321 43 44 B-Eq_Comparison
18 NCT03922321 45 47 I-Eq_Comparison
years NCT03922321 48 53 I-Eq_Comparison
of NCT03922321 54 56 O
age NCT03922321 57 60 B-Age
. NCT03922321 61 62 O

2 NCT03922321 66 67 O
. NCT03922321 67 68 O
Clinical NCT03922321 70 78 O
diagnosis NCT03922321 79 88 O
of NCT03922321 89 91 O
Graves NCT03922321 92 98 B-Condition
' NCT03922321 98 99 I-Condition
disease NCT03922321 100 107 I-Condition
with NCT03922321 108 112 B-And
hyperthyroidism NCT03922321 113 128 B-Condition
associated NCT03922321 129 139 O
with NCT03922321 140 144 O
active NCT03922321 145 151 B-Eq_Comparison
, NCT03922321 152 153 O
moderate NCT03922321 154 162 O
to NCT03922321 163 165 B-Or
severe NCT03922321 166 172 O
GO NCT03922321 173 175 B-Condition
with NCT03922321 176 180 O
a NCT03922321 181 182 O
Clinical NCT03922321 183 191 B-Observation
Activity NCT03922321 192 200 I-Observation
Score NCT03922321 201 206 I-Observation
( NCT03922321 207 208 O
CAS NCT03922321 209 212 B-Observation
) NCT03922321 213 214 O
≥ NCT03922321 215 216 B-Eq_Comparison
4 NCT03922321 217 218 I-Eq_Comparison
for NCT03922321 219 222 O
the NCT03922321 223 226 O
most NCT03922321 227 231 O
severely NCT03922321 232 240 O
affected NCT03922321 241 249 B-Modifier
eye NCT03922321 250 253 I-Modifier
at NCT03922321 254 256 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03922321 257 266 B-Study
( NCT03922321 267 268 O
on NCT03922321 269 271 O
the NCT03922321 272 275 O
7 NCT03922321 276 277 O
- NCT03922321 278 279 O
item NCT03922321 280 284 O
scale NCT03922321 285 290 O
) NCT03922321 291 292 O
and NCT03922321 293 296 B-And
Baseline NCT03922321 297 305 B-Study
( NCT03922321 306 307 O
on NCT03922321 308 310 O
the NCT03922321 311 314 O
10 NCT03922321 315 317 O
- NCT03922321 318 319 O
item NCT03922321 320 324 O
scale NCT03922321 325 330 O
) NCT03922321 331 332 O
. NCT03922321 333 334 O

3 NCT03922321 338 339 O
. NCT03922321 339 340 O
Onset NCT03922321 342 347 B-Eq_Comparison
of NCT03922321 348 350 O
active NCT03922321 351 357 B-Eq_Comparison
GO NCT03922321 358 360 B-Condition
within NCT03922321 361 367 B-Eq_Comparison
9 NCT03922321 368 369 I-Eq_Comparison
months NCT03922321 370 376 I-Eq_Comparison
of NCT03922321 377 379 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03922321 380 389 B-Study
. NCT03922321 390 391 O

4 NCT03922321 395 396 O
. NCT03922321 396 397 O
Moderate NCT03922321 399 407 O
- NCT03922321 408 409 O
to NCT03922321 410 412 B-Or
- NCT03922321 413 414 O
severe NCT03922321 415 421 O
active NCT03922321 422 428 B-Eq_Comparison
GO NCT03922321 429 431 B-Condition
( NCT03922321 432 433 O
not NCT03922321 434 437 B-Negation
sight NCT03922321 438 443 B-Condition
- NCT03922321 444 445 I-Condition
threatening NCT03922321 446 457 I-Condition
but NCT03922321 458 461 B-And
has NCT03922321 462 465 O
an NCT03922321 466 468 O
appreciable NCT03922321 469 480 O
impact NCT03922321 481 487 O
on NCT03922321 488 490 O
daily NCT03922321 491 496 B-Observation
life NCT03922321 497 501 I-Observation
) NCT03922321 502 503 O
, NCT03922321 504 505 O
usually NCT03922321 506 513 O
associated NCT03922321 514 524 O
with NCT03922321 525 529 O
one NCT03922321 530 533 B-Eq_Comparison
or NCT03922321 534 536 I-Eq_Comparison
more NCT03922321 537 541 I-Eq_Comparison
of NCT03922321 542 544 O
the NCT03922321 545 548 B-Criteria_Count
following NCT03922321 549 558 I-Criteria_Count
: NCT03922321 559 560 O
lid NCT03922321 561 564 B-Observation
retraction NCT03922321 565 575 I-Observation
≥ NCT03922321 576 577 B-Eq_Comparison
2 NCT03922321 578 579 I-Eq_Comparison
mm NCT03922321 580 582 I-Eq_Comparison
, NCT03922321 583 584 O
moderate NCT03922321 585 593 O
or NCT03922321 594 596 B-Or
severe NCT03922321 597 603 O
soft NCT03922321 604 608 B-Condition
tissue NCT03922321 609 615 I-Condition
involvement NCT03922321 616 627 I-Condition
, NCT03922321 628 629 O
proptosis NCT03922321 630 639 B-Observation
≥ NCT03922321 640 641 B-Eq_Comparison
3 NCT03922321 642 643 I-Eq_Comparison
mm NCT03922321 644 646 I-Eq_Comparison
above NCT03922321 647 652 I-Eq_Comparison
normal NCT03922321 653 659 I-Eq_Comparison
for NCT03922321 660 663 O
race NCT03922321 664 668 O
and NCT03922321 669 672 O
gender NCT03922321 673 679 O
, NCT03922321 680 681 O
and NCT03922321 682 685 B-Or
/ NCT03922321 686 687 I-Or
or NCT03922321 688 690 I-Or
inconstant NCT03922321 691 701 B-Modifier
or NCT03922321 702 704 B-Or
constant NCT03922321 705 713 B-Modifier
diplopia NCT03922321 714 722 B-Condition
. NCT03922321 723 724 O

5 NCT03922321 728 729 O
. NCT03922321 729 730 O
Other NCT03922321 732 737 O
, NCT03922321 738 739 O
more NCT03922321 740 744 O
specific NCT03922321 745 753 O
inclusion NCT03922321 754 763 O
criteria NCT03922321 764 772 O
are NCT03922321 773 776 O
defined NCT03922321 777 784 O
in NCT03922321 785 787 O
the NCT03922321 788 791 O
protocol NCT03922321 792 800 O

Exclusion NCT03922321 801 810 O
Criteria NCT03922321 811 819 O
: NCT03922321 820 821 O

1 NCT03922321 825 826 O
. NCT03922321 826 827 O
Use NCT03922321 829 832 O
of NCT03922321 833 835 O
any NCT03922321 836 839 O
steroid NCT03922321 840 847 B-Drug
( NCT03922321 848 849 O
intravenous NCT03922321 850 861 B-Modifier
[ NCT03922321 862 863 O
IV NCT03922321 864 866 B-Modifier
] NCT03922321 867 868 O
or NCT03922321 869 871 B-Or
oral NCT03922321 872 876 B-Modifier
) NCT03922321 877 878 O
with NCT03922321 879 883 O
a NCT03922321 884 885 O
cumulative NCT03922321 886 896 O
dose NCT03922321 897 901 O
equivalent NCT03922321 902 912 O
to NCT03922321 913 915 O
≥ NCT03922321 916 917 B-Eq_Comparison
1 NCT03922321 918 919 I-Eq_Comparison
g NCT03922321 920 921 I-Eq_Comparison
of NCT03922321 922 924 O
methylprednisolone NCT03922321 925 943 B-Drug
for NCT03922321 944 947 O
the NCT03922321 948 951 O
treatment NCT03922321 952 961 O
of NCT03922321 962 964 O
GO NCT03922321 965 967 B-Condition
within NCT03922321 968 974 B-Eq_Comparison
3 NCT03922321 975 976 I-Eq_Comparison
weeks NCT03922321 977 982 I-Eq_Comparison
prior NCT03922321 983 988 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03922321 989 991 O
Screening NCT03922321 992 1001 B-Study
. NCT03922321 1002 1003 O

2 NCT03922321 1007 1008 O
. NCT03922321 1008 1009 O
Use NCT03922321 1011 1014 O
of NCT03922321 1015 1017 O
rituximab NCT03922321 1018 1027 B-Drug
, NCT03922321 1028 1029 O
tocilizumab NCT03922321 1030 1041 B-Drug
, NCT03922321 1042 1043 O
or NCT03922321 1044 1046 B-Or
any NCT03922321 1047 1050 O
monoclonal NCT03922321 1051 1061 B-Drug
antibody NCT03922321 1062 1070 I-Drug
for NCT03922321 1071 1074 O
immunomodulation NCT03922321 1075 1091 B-Condition
within NCT03922321 1092 1098 B-Eq_Comparison
the NCT03922321 1099 1102 I-Eq_Comparison
past NCT03922321 1103 1107 I-Eq_Comparison
9 NCT03922321 1108 1109 I-Eq_Comparison
months NCT03922321 1110 1116 I-Eq_Comparison
prior NCT03922321 1117 1122 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03922321 1123 1125 O
Baseline NCT03922321 1126 1134 B-Study
. NCT03922321 1135 1136 O

3 NCT03922321 1140 1141 O
. NCT03922321 1141 1142 O
Total NCT03922321 1144 1149 B-Observation
IgG NCT03922321 1150 1153 I-Observation
level NCT03922321 1154 1159 I-Observation
< NCT03922321 1160 1161 B-Eq_Comparison
6 NCT03922321 1162 1163 I-Eq_Comparison
g NCT03922321 1164 1165 I-Eq_Comparison
/ NCT03922321 1166 1167 I-Eq_Comparison
L NCT03922321 1168 1169 I-Eq_Comparison
at NCT03922321 1170 1172 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03922321 1173 1182 B-Study
. NCT03922321 1183 1184 O

4 NCT03922321 1188 1189 O
. NCT03922321 1189 1190 O
Absolute NCT03922321 1192 1200 B-Observation
neutrophil NCT03922321 1201 1211 I-Observation
count NCT03922321 1212 1217 I-Observation
< NCT03922321 1218 1219 B-Eq_Comparison
1500 NCT03922321 1220 1224 I-Eq_Comparison
cells NCT03922321 1225 1230 I-Eq_Comparison
/ NCT03922321 1231 1232 I-Eq_Comparison
mm NCT03922321 1233 1235 I-Eq_Comparison
3 NCT03922321 1236 1237 I-Eq_Comparison
at NCT03922321 1238 1240 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03922321 1241 1250 B-Study
. NCT03922321 1251 1252 O

5 NCT03922321 1256 1257 O
. NCT03922321 1257 1258 O
Participants NCT03922321 1260 1272 O
with NCT03922321 1273 1277 O
decreased NCT03922321 1278 1287 O
best NCT03922321 1288 1292 B-Condition
corrected NCT03922321 1293 1302 I-Condition
visual NCT03922321 1303 1309 I-Condition
acuity NCT03922321 1310 1316 I-Condition
due NCT03922321 1317 1320 O
to NCT03922321 1321 1323 O
optic NCT03922321 1324 1329 B-Condition
neuropathy NCT03922321 1330 1340 I-Condition
as NCT03922321 1341 1343 O
defined NCT03922321 1344 1351 O
by NCT03922321 1352 1354 O
a NCT03922321 1355 1356 O
decrease NCT03922321 1357 1365 B-Observation
in NCT03922321 1366 1368 I-Observation
vision NCT03922321 1369 1375 I-Observation
of NCT03922321 1376 1378 O
2 NCT03922321 1379 1380 B-Eq_Comparison
lines NCT03922321 1381 1386 I-Eq_Comparison
on NCT03922321 1387 1389 O
the NCT03922321 1390 1393 O
Snellen NCT03922321 1394 1401 B-Modifier
chart NCT03922321 1402 1407 I-Modifier
, NCT03922321 1408 1409 O
new NCT03922321 1410 1413 B-Eq_Comparison
visual NCT03922321 1414 1420 B-Condition
field NCT03922321 1421 1426 I-Condition
defect NCT03922321 1427 1433 I-Condition
, NCT03922321 1434 1435 O
or NCT03922321 1436 1438 B-Or
color NCT03922321 1439 1444 B-Condition
defect NCT03922321 1445 1451 I-Condition
secondary NCT03922321 1452 1461 O
to NCT03922321 1462 1464 O
optic NCT03922321 1465 1470 B-Condition
nerve NCT03922321 1471 1476 I-Condition
involvement NCT03922321 1477 1488 B-Modifier
within NCT03922321 1489 1495 B-Eq_Comparison
the NCT03922321 1496 1499 I-Eq_Comparison
last NCT03922321 1500 1504 I-Eq_Comparison
6 NCT03922321 1505 1506 I-Eq_Comparison
months NCT03922321 1507 1513 I-Eq_Comparison
at NCT03922321 1514 1516 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03922321 1517 1526 B-Study
. NCT03922321 1527 1528 O

6 NCT03922321 1532 1533 O
. NCT03922321 1533 1534 O
Previous NCT03922321 1536 1544 B-Eq_Comparison
orbital NCT03922321 1545 1552 B-Procedure
irradiation NCT03922321 1553 1564 I-Procedure
or NCT03922321 1565 1567 B-Or
surgery NCT03922321 1568 1575 B-Procedure
for NCT03922321 1576 1579 O
GO NCT03922321 1580 1582 B-Condition
. NCT03922321 1583 1584 O

7 NCT03922321 1588 1589 O
. NCT03922321 1589 1590 O
Other NCT03922321 1592 1597 O
, NCT03922321 1598 1599 O
more NCT03922321 1600 1604 O
specific NCT03922321 1605 1613 O
exclusion NCT03922321 1614 1623 O
criteria NCT03922321 1624 1632 O
are NCT03922321 1633 1636 O
defined NCT03922321 1637 1644 O
in NCT03922321 1645 1647 O
the NCT03922321 1648 1651 O
protocol NCT03922321 1652 1660 O

Inclusion NCT03862235 0 9 O
Criteria NCT03862235 10 18 O
: NCT03862235 19 20 O

- NCT03862235 24 25 O
Anabolic NCT03862235 27 35 B-Drug
androgenic NCT03862235 36 46 I-Drug
steroids NCT03862235 47 55 I-Drug
users NCT03862235 56 61 O
and NCT03862235 62 65 B-Or
Anabolic NCT03862235 66 74 B-Drug
androgenic NCT03862235 75 85 I-Drug
steroids NCT03862235 86 94 I-Drug
nonusers NCT03862235 95 103 B-Negation
groups NCT03862235 104 110 O
had NCT03862235 111 114 O
been NCT03862235 115 119 O
involved NCT03862235 120 128 O
in NCT03862235 129 131 O
strength NCT03862235 132 140 B-Observation
training NCT03862235 141 149 I-Observation
for NCT03862235 150 153 O
at NCT03862235 154 156 B-Eq_Comparison
least NCT03862235 157 162 I-Eq_Comparison
2 NCT03862235 163 164 I-Eq_Comparison
years NCT03862235 165 170 I-Eq_Comparison
; NCT03862235 170 171 O

- NCT03862235 174 175 O
Anabolic NCT03862235 177 185 B-Drug
androgenic NCT03862235 186 196 I-Drug
steroids NCT03862235 197 205 I-Drug
users NCT03862235 206 211 O
should NCT03862235 212 218 O
be NCT03862235 219 221 O
self NCT03862235 222 226 O
- NCT03862235 227 228 O
administering NCT03862235 229 242 O
anabolic NCT03862235 243 251 B-Drug
androgenic NCT03862235 252 262 I-Drug
steroids NCT03862235 263 271 I-Drug
in NCT03862235 272 274 O
periodic NCT03862235 275 283 O
cycles NCT03862235 284 290 O
lasting NCT03862235 291 298 O
from NCT03862235 299 303 O
8 NCT03862235 304 305 B-Eq_Comparison
to NCT03862235 306 308 I-Eq_Comparison
12 NCT03862235 309 311 I-Eq_Comparison
weeks NCT03862235 312 317 I-Eq_Comparison
for NCT03862235 318 321 O
at NCT03862235 322 324 B-Eq_Comparison
least NCT03862235 325 330 I-Eq_Comparison
2 NCT03862235 331 332 I-Eq_Comparison
years NCT03862235 333 338 I-Eq_Comparison
with NCT03862235 339 343 O
2 NCT03862235 344 345 B-Eq_Comparison
- NCT03862235 346 347 I-Eq_Comparison
4 NCT03862235 348 349 I-Eq_Comparison
cycles NCT03862235 350 356 I-Eq_Comparison
per NCT03862235 357 360 I-Eq_Comparison
year NCT03862235 361 365 I-Eq_Comparison
; NCT03862235 365 366 O

- NCT03862235 369 370 O
All NCT03862235 372 375 O
anabolic NCT03862235 376 384 B-Drug
androgenic NCT03862235 385 395 I-Drug
steroids NCT03862235 396 404 I-Drug
users NCT03862235 405 410 O
were NCT03862235 411 415 O
on NCT03862235 416 418 O
a NCT03862235 419 420 O
cycle NCT03862235 421 426 O
over NCT03862235 427 431 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862235 432 435 I-Temporal_Connection___Temporal_Connection_Type_Value:during
course NCT03862235 436 442 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03862235 443 445 O
the NCT03862235 446 449 O
study NCT03862235 450 455 B-Study
; NCT03862235 455 456 O

- NCT03862235 459 460 O
Sedentary NCT03862235 462 471 O
control NCT03862235 472 479 O
group NCT03862235 480 485 O
: NCT03862235 486 487 O
sedentary NCT03862235 488 497 B-Condition
men NCT03862235 498 501 O
without NCT03862235 502 509 B-Negation
cardiovascular NCT03862235 510 524 B-Condition
disease NCT03862235 525 532 I-Condition
. NCT03862235 533 534 O

Exclusion NCT03862235 536 545 O
Criteria NCT03862235 546 554 O
: NCT03862235 555 556 O

- NCT03862235 560 561 O
Smoking NCT03862235 563 570 B-Condition
; NCT03862235 570 571 O

- NCT03862235 574 575 O
Alcohol NCT03862235 577 584 B-Observation
consumption NCT03862235 585 596 I-Observation
; NCT03862235 596 597 O

- NCT03862235 600 601 O
Use NCT03862235 603 606 O
of NCT03862235 607 609 O
diuretics NCT03862235 610 619 B-Drug
and NCT03862235 620 623 B-Or
/ NCT03862235 624 625 I-Or
or NCT03862235 626 628 I-Or
antihypertensive NCT03862235 629 645 B-Drug
medications NCT03862235 646 657 I-Drug
; NCT03862235 657 658 O

- NCT03862235 661 662 O
Liver NCT03862235 664 669 B-Modifier
and NCT03862235 670 673 B-Or
kidney NCT03862235 674 680 B-Modifier
disease NCT03862235 681 688 B-Condition

Inclusion NCT03926598 0 9 O
Criteria NCT03926598 10 18 O
: NCT03926598 19 20 O

- NCT03926598 24 25 O
Existing NCT03926598 27 35 O
patients NCT03926598 36 44 O
of NCT03926598 45 47 O
Children NCT03926598 48 56 O
's NCT03926598 56 58 O
Healthcare NCT03926598 59 69 O
of NCT03926598 70 72 O
Atlanta NCT03926598 73 80 O
( NCT03926598 81 82 O
CHOA NCT03926598 83 87 O
) NCT03926598 88 89 O
with NCT03926598 90 94 B-And
Type NCT03926598 95 99 B-Modifier
2 NCT03926598 100 101 I-Modifier
Diabetes NCT03926598 102 110 B-Condition
that NCT03926598 111 115 O
are NCT03926598 116 119 B-And
12 NCT03926598 120 122 B-Eq_Comparison
or NCT03926598 123 125 I-Eq_Comparison
older NCT03926598 126 131 I-Eq_Comparison
at NCT03926598 132 134 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926598 135 138 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03926598 139 143 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03926598 144 146 O
participation NCT03926598 147 160 B-Study
or NCT03926598 161 163 O
caretakers NCT03926598 164 174 O
of NCT03926598 175 177 O
existing NCT03926598 178 186 O
patients NCT03926598 187 195 O
of NCT03926598 196 198 O
CHOA NCT03926598 199 203 O
with NCT03926598 204 208 O
Type NCT03926598 209 213 B-Modifier
2 NCT03926598 214 215 I-Modifier
Diabetes NCT03926598 216 224 B-Condition

- NCT03926598 227 228 O
Front NCT03926598 230 235 O
desk NCT03926598 236 240 O
staff NCT03926598 241 246 O

- NCT03926598 249 250 O
Nurses NCT03926598 252 258 B-Provider
at NCT03926598 259 261 O
CHOA NCT03926598 262 266 O

- NCT03926598 269 270 O
Certified NCT03926598 272 281 O
Diabetes NCT03926598 282 290 O
Educators NCT03926598 291 300 O
at NCT03926598 301 303 O
CHOA NCT03926598 304 308 O

- NCT03926598 311 312 O
Physicians NCT03926598 314 324 B-Provider
working NCT03926598 325 332 O
at NCT03926598 333 335 O
CHOA NCT03926598 336 340 O

- NCT03926598 343 344 O
Participants NCT03926598 346 358 O
must NCT03926598 359 363 O
also NCT03926598 364 368 O
be NCT03926598 369 371 O
fluent NCT03926598 372 378 O
in NCT03926598 379 381 O
English NCT03926598 382 389 O
, NCT03926598 390 391 O
either NCT03926598 392 398 O
as NCT03926598 399 401 O
a NCT03926598 402 403 O
first NCT03926598 404 409 O
or NCT03926598 410 412 O
secondary NCT03926598 413 422 O
language NCT03926598 423 431 O
, NCT03926598 432 433 O
as NCT03926598 434 436 O
the NCT03926598 437 440 O
Guide NCT03926598 441 446 O
- NCT03926598 447 448 O
To NCT03926598 449 451 O
- NCT03926598 452 453 O
Goals NCT03926598 454 459 O
app NCT03926598 460 463 O
is NCT03926598 464 466 O
in NCT03926598 467 469 O
English NCT03926598 470 477 O
. NCT03926598 478 479 O

Exclusion NCT03926598 481 490 O
Criteria NCT03926598 491 499 O
: NCT03926598 500 501 O

- NCT03926598 505 506 O
Individuals NCT03926598 508 519 O
that NCT03926598 520 524 O
are NCT03926598 525 528 O
using NCT03926598 529 534 B-Eq_Comparison
a NCT03926598 535 536 O
care NCT03926598 537 541 B-Procedure
coordination NCT03926598 542 554 I-Procedure
tool NCT03926598 555 559 I-Procedure
other NCT03926598 560 565 B-Exception
than NCT03926598 566 570 I-Exception
GTG NCT03926598 571 574 B-Procedure
to NCT03926598 575 577 O
translate NCT03926598 578 587 O
ADA NCT03926598 588 591 O
clinical NCT03926598 592 600 O
standards NCT03926598 601 610 O
of NCT03926598 611 613 O
care NCT03926598 614 618 O
for NCT03926598 619 622 O
children NCT03926598 623 631 O
with NCT03926598 632 636 O
T NCT03926598 637 638 B-Condition
2D NCT03926598 639 641 I-Condition
during NCT03926598 642 648 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926598 649 652 O
study NCT03926598 653 658 B-Study
period NCT03926598 659 665 O
will NCT03926598 666 670 O
be NCT03926598 671 673 O
excluded NCT03926598 674 682 B-Negation
from NCT03926598 683 687 O
this NCT03926598 688 692 O
study NCT03926598 693 698 O
in NCT03926598 699 701 B-Assertion___Assertion_Type_Value:hypothetical
order NCT03926598 702 707 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03926598 708 710 I-Assertion___Assertion_Type_Value:hypothetical
avoid NCT03926598 711 716 O
confounding NCT03926598 717 728 O
factors NCT03926598 729 736 O
. NCT03926598 737 738 O
Examples NCT03926598 740 748 O
of NCT03926598 749 751 O
care NCT03926598 752 756 O
coordination NCT03926598 757 769 O
tools NCT03926598 770 775 O
include NCT03926598 776 783 O
products NCT03926598 784 792 O
that NCT03926598 793 797 O
have NCT03926598 798 802 O
the NCT03926598 803 806 O
capabilities NCT03926598 807 819 O
to NCT03926598 820 822 O
send NCT03926598 823 827 O
and NCT03926598 828 831 O
receive NCT03926598 832 839 O
electronic NCT03926598 840 850 O
messages NCT03926598 851 859 O
to NCT03926598 860 862 O
the NCT03926598 863 866 O
care NCT03926598 867 871 O
team NCT03926598 872 876 O
, NCT03926598 877 878 O
receive NCT03926598 879 886 O
and NCT03926598 887 890 O
discuss NCT03926598 891 898 O
care NCT03926598 899 903 O
plans NCT03926598 904 909 O
, NCT03926598 910 911 O
and NCT03926598 912 915 O
create NCT03926598 916 922 O
and NCT03926598 923 926 O
share NCT03926598 927 932 O
health NCT03926598 933 939 O
logs NCT03926598 940 944 O
. NCT03926598 945 946 O

Inclusion NCT03864510 0 9 O
Criteria NCT03864510 10 18 O
: NCT03864510 19 20 O

- NCT03864510 24 25 O
Diabetes NCT03864510 27 35 B-Condition
type NCT03864510 36 40 B-Modifier
2 NCT03864510 41 42 I-Modifier

- NCT03864510 46 47 O
Age NCT03864510 49 52 B-Age
35 NCT03864510 53 55 B-Eq_Comparison
- NCT03864510 56 57 I-Eq_Comparison
75 NCT03864510 58 60 I-Eq_Comparison
year NCT03864510 61 65 I-Eq_Comparison

Exclusion NCT03864510 66 75 O
Criteria NCT03864510 76 84 O
: NCT03864510 85 86 O

- NCT03864510 90 91 O
Contraindication NCT03864510 93 109 B-Contraindication
to NCT03864510 110 112 O
MR NCT03864510 113 115 B-Procedure

- NCT03864510 118 119 O
Alcohol NCT03864510 121 128 B-Condition
dependance NCT03864510 129 139 I-Condition

- NCT03864510 142 143 O
Previously NCT03864510 145 155 B-Eq_Comparison
diagnosed NCT03864510 156 165 O
liver NCT03864510 166 171 B-Condition
cirrhosis NCT03864510 172 181 I-Condition

- NCT03864510 184 185 O
Previously NCT03864510 187 197 B-Eq_Comparison
known NCT03864510 198 203 O
liver NCT03864510 204 209 B-Condition
disease NCT03864510 210 217 I-Condition
( NCT03864510 218 219 O
other NCT03864510 220 225 B-Exception
than NCT03864510 226 230 I-Exception
fatty NCT03864510 231 236 B-Condition
liver NCT03864510 237 242 I-Condition
) NCT03864510 243 244 O

Inclusion NCT03927859 0 9 O
Criteria NCT03927859 10 18 O
: NCT03927859 19 20 O

Only NCT03927859 22 26 O
patients NCT03927859 27 35 O
diagnosed NCT03927859 36 45 O
with NCT03927859 46 50 O
Type NCT03927859 51 55 B-Modifier
I NCT03927859 56 57 I-Modifier
or NCT03927859 58 60 B-Or
Type NCT03927859 61 65 B-Modifier
II NCT03927859 66 68 I-Modifier
Diabetes NCT03927859 69 77 B-Condition
with NCT03927859 78 82 B-And
no NCT03927859 83 85 B-Negation
evidence NCT03927859 86 94 O
in NCT03927859 95 97 O
their NCT03927859 98 103 O
medical NCT03927859 104 111 O
records NCT03927859 112 119 O
of NCT03927859 120 122 O
a NCT03927859 123 124 O
screening NCT03927859 125 134 B-Procedure
within NCT03927859 135 141 B-Eq_Comparison
the NCT03927859 142 145 I-Eq_Comparison
last NCT03927859 146 150 I-Eq_Comparison
2 NCT03927859 151 152 I-Eq_Comparison
years NCT03927859 153 158 I-Eq_Comparison
will NCT03927859 159 163 O
be NCT03927859 164 166 O
included NCT03927859 167 175 O
in NCT03927859 176 178 O
the NCT03927859 179 182 O
study NCT03927859 183 188 B-Study
and NCT03927859 189 192 O
only NCT03927859 193 197 O
individuals NCT03927859 198 209 O
18 NCT03927859 210 212 B-Eq_Comparison
years NCT03927859 213 218 I-Eq_Comparison
of NCT03927859 219 221 I-Eq_Comparison
age NCT03927859 222 225 I-Eq_Comparison
or NCT03927859 226 228 I-Eq_Comparison
older NCT03927859 229 234 I-Eq_Comparison
will NCT03927859 235 239 O
be NCT03927859 240 242 O
included NCT03927859 243 251 O
. NCT03927859 252 253 O

Exclusion NCT03927859 255 264 O
Criteria NCT03927859 265 273 O
: NCT03927859 274 275 O

Patients NCT03927859 277 285 O
screened NCT03927859 286 294 B-Procedure
within NCT03927859 295 301 B-Eq_Comparison
the NCT03927859 302 305 I-Eq_Comparison
last NCT03927859 306 310 I-Eq_Comparison
year NCT03927859 311 315 I-Eq_Comparison
. NCT03927859 316 317 O
In NCT03927859 319 321 O
addition NCT03927859 322 330 O
, NCT03927859 331 332 O
individuals NCT03927859 333 344 O
who NCT03927859 345 348 O
can NCT03927859 349 352 B-Negation
not NCT03927859 352 355 I-Negation
speak NCT03927859 356 361 O
English NCT03927859 362 369 O
will NCT03927859 370 374 O
be NCT03927859 375 377 O
excluded NCT03927859 378 386 B-Negation
from NCT03927859 387 391 O
the NCT03927859 392 395 O
study NCT03927859 396 401 B-Study
to NCT03927859 402 404 O
minimize NCT03927859 405 413 O
additional NCT03927859 414 424 O
workload NCT03927859 425 433 O
placed NCT03927859 434 440 O
on NCT03927859 441 443 O
administrative NCT03927859 444 458 O
staff NCT03927859 459 464 O
. NCT03927859 465 466 O


Inclusion NCT03924375 0 9 O
Criteria NCT03924375 10 18 O
: NCT03924375 19 20 O

- NCT03924375 24 25 O
Gastroscopy NCT03924375 27 38 B-Procedure
can NCT03924375 39 42 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03924375 43 45 I-Assertion___Assertion_Type_Value:hypothetical
performed NCT03924375 46 55 O

- NCT03924375 58 59 O
Serologic NCT03924375 61 70 B-Observation
markers NCT03924375 71 78 I-Observation
including NCT03924375 79 88 O
serum NCT03924375 89 94 B-Observation
pepsinogen NCT03924375 95 105 I-Observation
can NCT03924375 106 109 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03924375 110 112 I-Assertion___Assertion_Type_Value:hypothetical
measured NCT03924375 113 121 O

Exclusion NCT03924375 122 131 O
Criteria NCT03924375 132 140 O
: NCT03924375 141 142 O

- NCT03924375 146 147 O
Age NCT03924375 149 152 B-Age
< NCT03924375 153 154 B-Eq_Comparison
20 NCT03924375 155 157 I-Eq_Comparison
or NCT03924375 158 160 B-Or
> NCT03924375 161 162 B-Eq_Comparison
70 NCT03924375 163 165 I-Eq_Comparison
years NCT03924375 166 171 I-Eq_Comparison

- NCT03924375 174 175 O
Anemia NCT03924375 177 183 B-Condition
( NCT03924375 184 185 O
serum NCT03924375 186 191 B-Observation
hemoglobin NCT03924375 192 202 I-Observation
level NCT03924375 203 208 I-Observation
< NCT03924375 209 210 B-Eq_Comparison
10 NCT03924375 211 213 I-Eq_Comparison
g NCT03924375 214 215 I-Eq_Comparison
/ NCT03924375 216 217 I-Eq_Comparison
dL NCT03924375 218 220 I-Eq_Comparison
) NCT03924375 221 222 O

- NCT03924375 226 227 O
Severe NCT03924375 229 235 O
systemic NCT03924375 236 244 B-Modifier
disease NCT03924375 245 252 B-Condition

- NCT03924375 255 256 O
Advanced NCT03924375 258 266 O
chronic NCT03924375 267 274 O
liver NCT03924375 275 280 B-Condition
disease NCT03924375 281 288 I-Condition

- NCT03924375 291 292 O
Use NCT03924375 294 297 B-Eq_Comparison
of NCT03924375 298 300 O
certain NCT03924375 301 308 O
medications NCT03924375 309 320 B-Drug
, NCT03924375 321 322 O
including NCT03924375 323 332 O
proton NCT03924375 333 339 B-Drug
pump NCT03924375 340 344 I-Drug
inhibitors NCT03924375 345 355 I-Drug
, NCT03924375 356 357 O
H NCT03924375 358 359 B-Drug
2 NCT03924375 360 361 I-Drug
- NCT03924375 362 363 I-Drug
receptor NCT03924375 364 372 I-Drug
antagonists NCT03924375 373 384 I-Drug
, NCT03924375 385 386 O
or NCT03924375 387 389 B-Or
antibiotics NCT03924375 390 401 B-Drug

- NCT03924375 404 405 O
History NCT03924375 407 414 B-Eq_Comparison
of NCT03924375 415 417 O
H NCT03924375 418 419 B-Organism
. NCT03924375 420 421 I-Organism
pylori NCT03924375 423 429 I-Organism
eradication NCT03924375 430 441 B-Condition

- NCT03924375 444 445 O
History NCT03924375 447 454 B-Eq_Comparison
of NCT03924375 455 457 O
gastric NCT03924375 458 465 B-Procedure
surgery NCT03924375 466 473 I-Procedure

- NCT03924375 476 477 O
Recent NCT03924375 479 485 O
history NCT03924375 486 493 B-Eq_Comparison
of NCT03924375 494 496 O
upper NCT03924375 497 502 B-Modifier
gastrointestinal NCT03924375 503 519 I-Modifier
bleeding NCT03924375 520 528 B-Condition

Inclusion NCT03925987 0 9 O
Criteria NCT03925987 10 18 O
: NCT03925987 19 20 O

1 NCT03925987 24 25 O
. NCT03925987 25 26 O
DSM NCT03925987 28 31 O
- NCT03925987 32 33 O
V NCT03925987 34 35 O
diagnosis NCT03925987 36 45 O
of NCT03925987 46 48 O
an NCT03925987 49 51 O
Anxiety NCT03925987 52 59 B-Condition
disorder NCT03925987 60 68 I-Condition
( NCT03925987 69 70 O
Generalized NCT03925987 71 82 B-Condition
Anxiety NCT03925987 83 90 I-Condition
Disorder NCT03925987 91 99 I-Condition
, NCT03925987 100 101 O
Social NCT03925987 102 108 B-Condition
Anxiety NCT03925987 109 116 I-Condition
Disorder NCT03925987 117 125 I-Condition
, NCT03925987 126 127 O
Panic NCT03925987 128 133 B-Condition
Disorder NCT03925987 134 142 I-Condition
, NCT03925987 143 144 O
Agoraphobia NCT03925987 145 156 B-Condition
) NCT03925987 157 158 O

2 NCT03925987 162 163 O
. NCT03925987 163 164 O
Anxiety NCT03925987 166 173 B-Observation
Sensitivity NCT03925987 174 185 I-Observation
Index NCT03925987 186 191 I-Observation
( NCT03925987 192 193 O
ASI NCT03925987 194 197 B-Observation
- NCT03925987 198 199 I-Observation
3 NCT03925987 200 201 I-Observation
) NCT03925987 202 203 O
total NCT03925987 204 209 B-Eq_Comparison
score NCT03925987 210 215 I-Eq_Comparison
> NCT03925987 216 217 I-Eq_Comparison
29 NCT03925987 218 220 I-Eq_Comparison

3 NCT03925987 224 225 O
. NCT03925987 225 226 O
Overall NCT03925987 228 235 B-Observation
Anxiety NCT03925987 236 243 I-Observation
Severity NCT03925987 244 252 I-Observation
and NCT03925987 253 256 I-Observation
Impairment NCT03925987 257 267 I-Observation
Scale NCT03925987 268 273 I-Observation
( NCT03925987 274 275 O
OASIS NCT03925987 276 281 B-Observation
) NCT03925987 282 283 O
score NCT03925987 284 289 B-Eq_Comparison
> NCT03925987 290 291 I-Eq_Comparison
8 NCT03925987 292 293 I-Eq_Comparison

4 NCT03925987 297 298 O
. NCT03925987 298 299 O
Between NCT03925987 301 308 B-Eq_Comparison
18 NCT03925987 309 311 I-Eq_Comparison
- NCT03925987 312 313 I-Eq_Comparison
55 NCT03925987 314 316 I-Eq_Comparison
years NCT03925987 317 322 I-Eq_Comparison
of NCT03925987 323 325 O
age NCT03925987 326 329 B-Age

5 NCT03925987 332 333 O
. NCT03925987 333 334 O
Subject NCT03925987 336 343 O
must NCT03925987 344 348 O
be NCT03925987 349 351 O
" NCT03925987 352 353 O
treatment NCT03925987 353 362 B-Procedure
- NCT03925987 363 364 O
seeking NCT03925987 365 372 B-Assertion___Assertion_Type_Value:intention
" NCT03925987 372 373 O
and NCT03925987 374 377 B-And
willing NCT03925987 378 385 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925987 386 388 I-Assertion___Assertion_Type_Value:hypothetical
enroll NCT03925987 389 395 O
in NCT03925987 396 398 O
the NCT03925987 399 402 O
10 NCT03925987 403 405 B-Eq_Comparison
- NCT03925987 406 407 I-Eq_Comparison
week NCT03925987 408 412 I-Eq_Comparison
group NCT03925987 413 418 O
- NCT03925987 419 420 O
based NCT03925987 421 426 O
Exposure NCT03925987 427 435 B-Procedure
Therapy NCT03925987 436 443 I-Procedure

Exclusion NCT03925987 444 453 O
Criteria NCT03925987 454 462 O
: NCT03925987 463 464 O

1 NCT03925987 468 469 O
. NCT03925987 469 470 O
Comorbid NCT03925987 472 480 O
Bipolar NCT03925987 481 488 B-Condition
Disorder NCT03925987 489 497 I-Condition
, NCT03925987 498 499 O
Schizophrenia NCT03925987 500 513 B-Condition
, NCT03925987 514 515 O
Anorexia NCT03925987 516 524 B-Condition
or NCT03925987 525 527 B-Or
Bulimia NCT03925987 528 535 B-Condition
Nervosa NCT03925987 536 543 I-Condition
, NCT03925987 544 545 O
or NCT03925987 546 548 B-Or
Obsessive NCT03925987 549 558 B-Condition
- NCT03925987 559 560 I-Condition
Compulsive NCT03925987 561 571 I-Condition
Disorder NCT03925987 572 580 I-Condition

2 NCT03925987 583 584 O
. NCT03925987 584 585 O
Current NCT03925987 587 594 B-Eq_Comparison
Substance NCT03925987 595 604 B-Condition
Use NCT03925987 605 608 I-Condition
Disorder NCT03925987 609 617 I-Condition
> NCT03925987 618 619 B-Eq_Comparison
moderate NCT03925987 620 628 I-Eq_Comparison
( NCT03925987 629 630 O
within NCT03925987 631 637 B-Eq_Comparison
the NCT03925987 638 641 I-Eq_Comparison
past NCT03925987 642 646 I-Eq_Comparison
6 NCT03925987 647 648 I-Eq_Comparison
months NCT03925987 649 655 I-Eq_Comparison
) NCT03925987 656 657 O

3 NCT03925987 661 662 O
. NCT03925987 662 663 O
Currently NCT03925987 665 674 B-Eq_Comparison
taking NCT03925987 675 681 I-Eq_Comparison
a NCT03925987 682 683 O
psychotropic NCT03925987 684 696 B-Drug
medication NCT03925987 697 707 I-Drug

4 NCT03925987 710 711 O
. NCT03925987 711 712 O
Currently NCT03925987 714 723 B-Eq_Comparison
receiving NCT03925987 724 733 I-Eq_Comparison
psychotherapy NCT03925987 734 747 B-Procedure
/ NCT03925987 748 749 B-Or
counseling NCT03925987 750 760 B-Procedure
for NCT03925987 761 764 O
anxiety NCT03925987 765 772 B-Condition

5 NCT03925987 775 776 O
. NCT03925987 776 777 O
Currently NCT03925987 779 788 B-Eq_Comparison
being NCT03925987 789 794 O
treated NCT03925987 795 802 O
as NCT03925987 803 805 O
an NCT03925987 806 808 O
inpatient NCT03925987 809 818 B-Encounter

6 NCT03925987 821 822 O
. NCT03925987 822 823 O
Active NCT03925987 825 831 B-Eq_Comparison
suicidal NCT03925987 832 840 B-Condition
ideation NCT03925987 841 849 I-Condition
with NCT03925987 850 854 O
intent NCT03925987 855 861 B-Modifier
or NCT03925987 862 864 B-Or
plan NCT03925987 865 869 B-Modifier

7 NCT03925987 872 873 O
. NCT03925987 873 874 O
History NCT03925987 876 883 B-Eq_Comparison
of NCT03925987 884 886 O
neurological NCT03925987 887 899 B-Modifier
, NCT03925987 900 901 O
cardiovascular NCT03925987 902 916 B-Modifier
or NCT03925987 917 919 B-Or
respiratory NCT03925987 920 931 B-Modifier
problems NCT03925987 932 940 B-Condition
( NCT03925987 941 942 O
e NCT03925987 943 944 O
. NCT03925987 945 946 O
g NCT03925987 947 948 O
. NCT03925987 949 950 O
, NCT03925987 951 952 O
asthma NCT03925987 953 959 B-Condition
, NCT03925987 960 961 O
severe NCT03925987 962 968 O
brain NCT03925987 969 974 B-Modifier
injury NCT03925987 975 981 B-Condition
) NCT03925987 982 983 O

Inclusion NCT03861754 0 9 O
Criteria NCT03861754 10 18 O
: NCT03861754 19 20 O

- NCT03861754 24 25 O
Body NCT03861754 27 31 B-Observation
mass NCT03861754 32 36 I-Observation
Index NCT03861754 37 42 I-Observation
> NCT03861754 43 44 B-Eq_Comparison
30 NCT03861754 45 47 I-Eq_Comparison

- NCT03861754 51 52 O
Age NCT03861754 54 57 B-Age
18 NCT03861754 58 60 B-Eq_Comparison
- NCT03861754 61 62 I-Eq_Comparison
64 NCT03861754 63 65 I-Eq_Comparison

Exclusion NCT03861754 67 76 O
Criteria NCT03861754 77 85 O
: NCT03861754 86 87 O

- NCT03861754 91 92 O
Pregnancy NCT03861754 94 103 B-Condition

- NCT03861754 106 107 O
Health NCT03861754 109 115 B-Condition
reasons NCT03861754 116 123 I-Condition
preventing NCT03861754 124 134 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
exercise NCT03861754 135 143 B-Observation
and NCT03861754 144 147 B-Or
exercise NCT03861754 148 156 B-Procedure
test NCT03861754 157 161 I-Procedure

- NCT03861754 164 165 O
Medication NCT03861754 167 177 B-Drug
preventing NCT03861754 178 188 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
exercise NCT03861754 189 197 B-Observation
and NCT03861754 198 201 B-Or
exercise NCT03861754 202 210 B-Procedure
test NCT03861754 211 215 I-Procedure

- NCT03861754 218 219 O
Previously NCT03861754 221 231 B-Eq_Comparison
diagnosed NCT03861754 232 241 O
diabetes NCT03861754 242 250 B-Condition

Inclusion NCT03868605 0 9 O
Criteria NCT03868605 10 18 O
: NCT03868605 19 20 O

- NCT03868605 24 25 O
age NCT03868605 27 30 B-Age
≥ NCT03868605 31 32 B-Eq_Comparison
18 NCT03868605 33 35 I-Eq_Comparison
years NCT03868605 36 41 I-Eq_Comparison

- NCT03868605 44 45 O
colorectal NCT03868605 47 57 B-Modifier
lesions NCT03868605 58 65 B-Observation
of NCT03868605 66 68 O
10 NCT03868605 69 71 B-Eq_Comparison
- NCT03868605 72 73 I-Eq_Comparison
25 NCT03868605 74 76 I-Eq_Comparison
mm NCT03868605 77 79 I-Eq_Comparison
size NCT03868605 80 84 O
with NCT03868605 85 89 B-And
positive NCT03868605 90 98 O
non NCT03868605 99 102 B-Negation
- NCT03868605 103 104 O
lifting NCT03868605 105 112 B-Modifier
sign NCT03868605 113 117 B-Condition

- NCT03868605 120 121 O
signed NCT03868605 123 129 O
informed NCT03868605 130 138 O
consent NCT03868605 139 146 O
with NCT03868605 147 151 O
the NCT03868605 152 155 O
study NCT03868605 156 161 B-Study
and NCT03868605 162 165 O
with NCT03868605 166 170 O
colonoscopy NCT03868605 171 182 B-Procedure

Exclusion NCT03868605 183 192 O
Criteria NCT03868605 193 201 O
: NCT03868605 202 203 O

- NCT03868605 207 208 O
age NCT03868605 210 213 B-Age
< NCT03868605 214 215 B-Eq_Comparison
18 NCT03868605 216 218 I-Eq_Comparison
years NCT03868605 219 224 I-Eq_Comparison

- NCT03868605 227 228 O
lesions NCT03868605 230 237 B-Observation
> NCT03868605 238 239 B-Eq_Comparison
25 NCT03868605 240 242 I-Eq_Comparison
mm NCT03868605 243 245 I-Eq_Comparison

- NCT03868605 248 249 O
pedunculated NCT03868605 251 263 B-Condition
polyps NCT03868605 264 270 I-Condition

- NCT03868605 273 274 O
colorectal NCT03868605 276 286 B-Condition
stenosis NCT03868605 287 295 I-Condition

- NCT03868605 298 299 O
colonoscopy NCT03868605 301 312 B-Procedure
contraindication NCT03868605 313 329 B-Contraindication

- NCT03868605 332 333 O
severe NCT03868605 335 341 O
acute NCT03868605 342 347 O
inflammatory NCT03868605 348 360 B-Condition
bowel NCT03868605 361 366 I-Condition
disease NCT03868605 367 374 I-Condition

- NCT03868605 377 378 O
severe NCT03868605 380 386 O
comorbidities NCT03868605 387 400 B-Condition

- NCT03868605 403 404 O
patient NCT03868605 406 413 O
not NCT03868605 414 417 O
able NCT03868605 418 422 O
to NCT03868605 423 425 O
sign NCT03868605 426 430 O
the NCT03868605 431 434 O
informed NCT03868605 435 443 O
consent NCT03868605 444 451 O

Inclusion NCT03861117 0 9 O
Criteria NCT03861117 10 18 O
: NCT03861117 19 20 O

- NCT03861117 24 25 O
Patient NCT03861117 27 34 O
18 NCT03861117 35 37 B-Eq_Comparison
years NCT03861117 38 43 I-Eq_Comparison
old NCT03861117 44 47 I-Eq_Comparison
or NCT03861117 48 50 I-Eq_Comparison
more NCT03861117 51 55 I-Eq_Comparison

- NCT03861117 58 59 O
Intubated NCT03861117 61 70 B-Procedure
and NCT03861117 71 74 B-And
ventilated NCT03861117 75 85 B-Procedure
in NCT03861117 86 88 O
intensive NCT03861117 89 98 O
care NCT03861117 99 103 O
unit NCT03861117 104 108 O
for NCT03861117 109 112 O
more NCT03861117 113 117 B-Eq_Comparison
than NCT03861117 118 122 I-Eq_Comparison
24 NCT03861117 123 125 I-Eq_Comparison
hours NCT03861117 126 131 I-Eq_Comparison

- NCT03861117 134 135 O
Patient NCT03861117 137 144 O
ready NCT03861117 145 150 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03861117 151 154 I-Assertion___Assertion_Type_Value:hypothetical
weaning NCT03861117 155 162 B-Procedure
evaluation NCT03861117 163 173 I-Procedure

- NCT03861117 176 177 O
Failure NCT03861117 179 186 O
of NCT03861117 187 189 O
a NCT03861117 190 191 O
first NCT03861117 192 197 B-Eq_Comparison
T NCT03861117 198 199 B-Modifier
- NCT03861117 200 201 I-Modifier
piece NCT03861117 202 207 I-Modifier
SBT NCT03861117 208 211 B-Procedure

Exclusion NCT03861117 212 221 O
Criteria NCT03861117 222 230 O
: NCT03861117 231 232 O

- NCT03861117 236 237 O
Chronic NCT03861117 239 246 O
neuromuscular NCT03861117 247 260 B-Condition
disease NCT03861117 261 268 I-Condition

- NCT03861117 271 272 O
Guillain NCT03861117 274 282 B-Condition
- NCT03861117 283 284 I-Condition
Barré NCT03861117 285 290 I-Condition
Syndrome NCT03861117 291 299 I-Condition

- NCT03861117 302 303 O
Central NCT03861117 305 312 B-Condition
nervous NCT03861117 313 320 I-Condition
system NCT03861117 321 327 I-Condition
disease NCT03861117 328 335 I-Condition
with NCT03861117 336 340 B-And
consciousness NCT03861117 341 354 B-Condition
disorder NCT03861117 355 363 I-Condition

- NCT03861117 366 367 O
Tracheostomy NCT03861117 369 381 B-Procedure

- NCT03861117 384 385 O
Chronic NCT03861117 387 394 O
disease NCT03861117 395 402 B-Condition
with NCT03861117 403 407 B-And
life NCT03861117 408 412 B-Observation
expectancy NCT03861117 413 423 I-Observation
less NCT03861117 424 428 B-Eq_Comparison
than NCT03861117 429 433 I-Eq_Comparison
1 NCT03861117 434 435 I-Eq_Comparison
year NCT03861117 436 440 I-Eq_Comparison

- NCT03861117 443 444 O
Pregnancy NCT03861117 446 455 B-Condition
, NCT03861117 456 457 O
breast NCT03861117 458 464 B-Condition
feeding NCT03861117 465 472 I-Condition

- NCT03861117 475 476 O
Withholding NCT03861117 478 489 B-Assertion___Assertion_Type_Value:hypothetical
life NCT03861117 490 494 B-Procedure
support NCT03861117 495 502 I-Procedure
regarding NCT03861117 503 512 O
a NCT03861117 513 514 O
reintubation NCT03861117 515 527 B-Procedure

- NCT03861117 530 531 O
Prisoner NCT03861117 533 541 B-Observation
or NCT03861117 542 544 B-Or
patient NCT03861117 545 552 O
interned NCT03861117 553 561 B-Encounter
in NCT03861117 562 564 O
psychiatric NCT03861117 565 576 O
hospital NCT03861117 577 585 O

- NCT03861117 588 589 O
Guardianship NCT03861117 591 603 B-Observation

- NCT03861117 606 607 O
Language NCT03861117 609 617 B-Condition
barrier NCT03861117 618 625 I-Condition

- NCT03861117 628 629 O
Lack NCT03861117 631 635 B-Negation
of NCT03861117 636 638 I-Negation
medical NCT03861117 639 646 O
insurance NCT03861117 647 656 O

- NCT03861117 659 660 O
Lack NCT03861117 662 666 O
of NCT03861117 667 669 O
the NCT03861117 670 673 O
patient NCT03861117 674 681 O
's NCT03861117 681 683 O
consent NCT03861117 684 691 O
( NCT03861117 692 693 O
or NCT03861117 694 696 O
of NCT03861117 697 699 O
the NCT03861117 700 703 O
next NCT03861117 704 708 O
of NCT03861117 709 711 O
kin NCT03861117 712 715 O
where NCT03861117 716 721 O
appropriate NCT03861117 722 733 O
) NCT03861117 734 735 O

- NCT03861117 739 740 O
Patient NCT03861117 742 749 O
under NCT03861117 750 755 O
an NCT03861117 756 758 O
exclusion NCT03861117 759 768 O
period NCT03861117 769 775 O
after NCT03861117 776 781 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrollment NCT03861117 782 792 O
in NCT03861117 793 795 O
another NCT03861117 796 803 B-Other
research NCT03861117 804 812 B-Study
study NCT03861117 813 818 I-Study

Inclusion NCT03928470 0 9 O
Criteria NCT03928470 10 18 O
: NCT03928470 19 20 O

1 NCT03928470 24 25 O
. NCT03928470 25 26 O
Male NCT03928470 28 32 O
or NCT03928470 33 35 B-Or
Female NCT03928470 36 42 O
aged NCT03928470 43 47 B-Age
≥ NCT03928470 48 49 B-Eq_Comparison
19 NCT03928470 50 52 I-Eq_Comparison
years NCT03928470 53 58 I-Eq_Comparison

2 NCT03928470 61 62 O
. NCT03928470 62 63 O
Episode NCT03928470 65 72 O
of NCT03928470 73 75 O
heartburn NCT03928470 76 85 B-Condition
for NCT03928470 86 89 O
3 NCT03928470 90 91 B-Eq_Comparison
months NCT03928470 92 98 I-Eq_Comparison
or NCT03928470 99 101 I-Eq_Comparison
more NCT03928470 102 106 I-Eq_Comparison
during NCT03928470 107 113 B-Temporal_Connection___Temporal_Connection_Type_Value:during
prior NCT03928470 114 119 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928470 120 122 I-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03928470 123 136 B-Study
visit NCT03928470 137 142 O
. NCT03928470 143 144 O

3 NCT03928470 148 149 O
. NCT03928470 149 150 O
Episode NCT03928470 152 159 O
of NCT03928470 160 162 O
heartburn NCT03928470 163 172 B-Condition
for NCT03928470 173 176 O
2 NCT03928470 177 178 B-Eq_Comparison
days NCT03928470 179 183 I-Eq_Comparison
or NCT03928470 184 186 I-Eq_Comparison
more NCT03928470 187 191 I-Eq_Comparison
during NCT03928470 192 198 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928470 199 202 O
last NCT03928470 203 207 B-Eq_Comparison
7 NCT03928470 208 209 I-Eq_Comparison
days NCT03928470 210 214 I-Eq_Comparison
prior NCT03928470 215 220 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928470 221 223 I-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03928470 224 237 B-Study
visit NCT03928470 238 243 O
. NCT03928470 244 245 O

4 NCT03928470 249 250 O
. NCT03928470 250 251 O
Grade NCT03928470 253 258 B-Eq_Comparison
N NCT03928470 259 260 I-Eq_Comparison
, NCT03928470 261 262 I-Eq_Comparison
M NCT03928470 263 264 I-Eq_Comparison
by NCT03928470 265 267 O
EGD NCT03928470 268 271 B-Procedure
test NCT03928470 272 276 I-Procedure
. NCT03928470 277 278 O

Exclusion NCT03928470 280 289 O
Criteria NCT03928470 290 298 O
: NCT03928470 299 300 O

1 NCT03928470 304 305 O
. NCT03928470 305 306 O
Surgery NCT03928470 308 315 B-Procedure
history NCT03928470 316 323 B-Eq_Comparison
on NCT03928470 324 326 O
stomach NCT03928470 327 334 B-Modifier
or NCT03928470 335 337 B-Or
esophagus NCT03928470 338 347 B-Modifier

2 NCT03928470 350 351 O
. NCT03928470 351 352 O
Active NCT03928470 354 360 B-Eq_Comparison
medical NCT03928470 361 368 O
history NCT03928470 369 376 O
of NCT03928470 377 379 O
stomach NCT03928470 380 387 B-Modifier
, NCT03928470 388 389 O
esophagus NCT03928470 390 399 B-Modifier
area NCT03928470 400 404 O

3 NCT03928470 407 408 O
. NCT03928470 408 409 O
Other NCT03928470 411 416 B-Other
system NCT03928470 417 423 B-Modifier
disorder NCT03928470 424 432 B-Condition
which NCT03928470 433 438 O
can NCT03928470 439 442 B-Assertion___Assertion_Type_Value:hypothetical
disturb NCT03928470 443 450 O
this NCT03928470 451 455 O
trial NCT03928470 456 461 B-Study

4 NCT03928470 464 465 O
. NCT03928470 465 466 O
Patients NCT03928470 468 476 O
taking NCT03928470 477 483 B-Eq_Comparison
the NCT03928470 484 487 O
contraindication NCT03928470 488 504 B-Contraindication
of NCT03928470 505 507 O
concomitant NCT03928470 508 519 B-Modifier
medications NCT03928470 520 531 B-Drug

5 NCT03928470 534 535 O
. NCT03928470 535 536 O
Clinically NCT03928470 538 548 O
significant NCT03928470 549 560 O
Abnormal NCT03928470 561 569 O
Lab NCT03928470 570 573 B-Observation
test NCT03928470 574 578 I-Observation

6 NCT03928470 581 582 O
. NCT03928470 582 583 O
Pregnant NCT03928470 585 593 B-Condition
woman NCT03928470 594 599 O
, NCT03928470 600 601 O
Breastfeeding NCT03928470 602 615 B-Condition
woman NCT03928470 616 621 O
. NCT03928470 622 623 O

Inclusion NCT03860259 0 9 O
Criteria NCT03860259 10 18 O
: NCT03860259 19 20 O

1 NCT03860259 24 25 O
. NCT03860259 25 26 O
Subject NCT03860259 28 35 O
is NCT03860259 36 38 O
greater NCT03860259 39 46 B-Eq_Comparison
than NCT03860259 47 51 I-Eq_Comparison
18 NCT03860259 52 54 I-Eq_Comparison
years NCT03860259 55 60 I-Eq_Comparison
of NCT03860259 61 63 O
age NCT03860259 64 67 B-Age

2 NCT03860259 70 71 O
. NCT03860259 71 72 O
Subject NCT03860259 74 81 O
is NCT03860259 82 84 O
willing NCT03860259 85 92 O
and NCT03860259 93 96 O
able NCT03860259 97 101 O
to NCT03860259 102 104 O
provide NCT03860259 105 112 O
informed NCT03860259 113 121 O
consent NCT03860259 122 129 O

3 NCT03860259 132 133 O
. NCT03860259 133 134 O
Subject NCT03860259 136 143 O
is NCT03860259 144 146 O
scheduled NCT03860259 147 156 B-Eq_Comparison
to NCT03860259 157 159 O
undergo NCT03860259 160 167 O
elective NCT03860259 168 176 B-Modifier
rotator NCT03860259 177 184 B-Procedure
cuff NCT03860259 185 189 I-Procedure
surgery NCT03860259 190 197 I-Procedure

4 NCT03860259 200 201 O
. NCT03860259 201 202 O
Subject NCT03860259 204 211 O
has NCT03860259 212 215 O
consented NCT03860259 216 225 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860259 226 228 I-Assertion___Assertion_Type_Value:hypothetical
an NCT03860259 229 231 O
interscalene NCT03860259 232 244 B-Procedure
block NCT03860259 245 250 I-Procedure

Exclusion NCT03860259 251 260 O
Criteria NCT03860259 261 269 O
: NCT03860259 270 271 O

1 NCT03860259 275 276 O
. NCT03860259 276 277 O
Opioid NCT03860259 279 285 B-Condition
dependence NCT03860259 286 296 I-Condition

2 NCT03860259 299 300 O
. NCT03860259 300 301 O
Any NCT03860259 303 306 O
subject NCT03860259 307 314 O
diagnosed NCT03860259 315 324 O
with NCT03860259 325 329 O
a NCT03860259 330 331 O
chronic NCT03860259 332 339 O
pain NCT03860259 340 344 B-Condition
condition NCT03860259 345 354 I-Condition
which NCT03860259 355 360 O
daily NCT03860259 361 366 B-Eq_Comparison
opioid NCT03860259 367 373 B-Drug
use NCT03860259 374 377 O
is NCT03860259 378 380 O
needed NCT03860259 381 387 O

3 NCT03860259 390 391 O
. NCT03860259 391 392 O
Anatomical NCT03860259 394 404 B-Condition
malformation NCT03860259 405 417 I-Condition
, NCT03860259 418 419 O
which NCT03860259 420 425 O
in NCT03860259 426 428 O
the NCT03860259 429 432 O
investigator NCT03860259 433 445 O
's NCT03860259 445 447 O
opinion NCT03860259 448 455 O
may NCT03860259 456 459 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03860259 460 469 O
with NCT03860259 470 474 O
the NCT03860259 475 478 O
placement NCT03860259 479 488 O
of NCT03860259 489 491 O
the NCT03860259 492 495 O
nerve NCT03860259 496 501 B-Procedure
block NCT03860259 502 507 I-Procedure

4 NCT03860259 510 511 O
. NCT03860259 511 512 O
Raynaud NCT03860259 514 521 B-Condition
's NCT03860259 521 523 I-Condition
disease NCT03860259 524 531 I-Condition
diagnosis NCT03860259 532 541 O

5 NCT03860259 544 545 O
. NCT03860259 545 546 O
Vasculopathy NCT03860259 548 560 B-Condition

6 NCT03860259 563 564 O
. NCT03860259 564 565 O
Patient NCT03860259 567 574 O
refusal NCT03860259 575 582 O

Inclusion NCT03928288 0 9 O
Criteria NCT03928288 10 18 O
: NCT03928288 19 20 O

- NCT03928288 24 25 O
Female NCT03928288 27 33 O
with NCT03928288 34 38 O
surgically NCT03928288 39 49 B-Procedure
- NCT03928288 50 51 O
confirmed NCT03928288 52 61 O
endometriosis NCT03928288 62 75 B-Condition
, NCT03928288 76 77 O
determined NCT03928288 78 88 O
at NCT03928288 89 91 O
laparoscopy NCT03928288 92 103 B-Procedure
performed NCT03928288 104 113 O
within NCT03928288 114 120 B-Eq_Comparison
3 NCT03928288 121 122 I-Eq_Comparison
y NCT03928288 123 124 I-Eq_Comparison
prior NCT03928288 125 130 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928288 131 133 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03928288 134 139 B-Study
baseline NCT03928288 140 148 O

- NCT03928288 151 152 O
Age NCT03928288 154 157 B-Age
15 NCT03928288 158 160 B-Eq_Comparison
years NCT03928288 161 166 I-Eq_Comparison
to NCT03928288 167 169 I-Eq_Comparison
40 NCT03928288 170 172 I-Eq_Comparison
years NCT03928288 173 178 I-Eq_Comparison

- NCT03928288 181 182 O
Current NCT03928288 184 191 B-Eq_Comparison
use NCT03928288 192 195 O
≥ NCT03928288 196 197 B-Eq_Comparison
2 NCT03928288 198 199 I-Eq_Comparison
months NCT03928288 200 206 I-Eq_Comparison
duration NCT03928288 207 215 O
of NCT03928288 216 218 O
hormonal NCT03928288 219 227 B-Procedure
therapy NCT03928288 228 235 I-Procedure
such NCT03928288 236 240 O
as NCT03928288 241 243 O
combined NCT03928288 244 252 B-Modifier
oral NCT03928288 253 257 B-Procedure
contraceptives NCT03928288 258 272 I-Procedure
, NCT03928288 273 274 O
norethindrone NCT03928288 275 288 B-Drug
acetate NCT03928288 289 296 I-Drug
, NCT03928288 297 298 O
or NCT03928288 299 301 B-Or
levonorgestrel NCT03928288 302 316 B-Procedure
intrauterine NCT03928288 317 329 I-Procedure
device NCT03928288 330 336 I-Procedure

- NCT03928288 339 340 O
Current NCT03928288 342 349 B-Eq_Comparison
pelvic NCT03928288 350 356 B-Modifier
pain NCT03928288 357 361 B-Observation
( NCT03928288 362 363 O
score NCT03928288 364 369 O
≥ NCT03928288 370 371 B-Eq_Comparison
3 NCT03928288 372 373 I-Eq_Comparison
on NCT03928288 374 376 O
Visual NCT03928288 377 383 O
Analog NCT03928288 384 390 O
Scale NCT03928288 391 396 O
, NCT03928288 397 398 O
where NCT03928288 399 404 O
0 NCT03928288 405 406 O
represents NCT03928288 407 417 O
absence NCT03928288 418 425 O
of NCT03928288 426 428 O
pain NCT03928288 429 433 O
and NCT03928288 434 437 O
10 NCT03928288 438 440 O
indicates NCT03928288 441 450 O
unbearable NCT03928288 451 461 O
pain NCT03928288 462 466 O
) NCT03928288 467 468 O
present NCT03928288 469 476 O
for NCT03928288 477 480 O
≥ NCT03928288 481 482 B-Eq_Comparison
14 NCT03928288 483 485 I-Eq_Comparison
days NCT03928288 486 490 I-Eq_Comparison
/ NCT03928288 491 492 I-Eq_Comparison
month NCT03928288 493 498 I-Eq_Comparison
over NCT03928288 499 503 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928288 504 507 O
2 NCT03928288 508 509 B-Eq_Comparison
months NCT03928288 510 516 I-Eq_Comparison
prior NCT03928288 517 522 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928288 523 525 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03928288 526 531 B-Study
enrollment NCT03928288 532 542 O

- NCT03928288 545 546 O
Willingness NCT03928288 548 559 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928288 560 562 O
comply NCT03928288 563 569 O
with NCT03928288 570 574 O
visit NCT03928288 575 580 B-Encounter
schedule NCT03928288 581 589 O
and NCT03928288 590 593 O
protocol NCT03928288 594 602 O

Exclusion NCT03928288 603 612 O
Criteria NCT03928288 613 621 O
: NCT03928288 622 623 O

- NCT03928288 627 628 O
Pre NCT03928288 630 633 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03928288 634 635 O
menarche NCT03928288 636 644 B-Condition
or NCT03928288 645 647 B-Or
post NCT03928288 648 652 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03928288 653 654 O
menopause NCT03928288 655 664 B-Condition

- NCT03928288 667 668 O
Contraindications NCT03928288 670 687 B-Contraindication
to NCT03928288 688 690 O
cabergoline NCT03928288 691 702 B-Drug
( NCT03928288 703 704 O
e NCT03928288 705 706 O
. NCT03928288 707 708 O
g NCT03928288 709 710 O
. NCT03928288 711 712 O
, NCT03928288 713 714 O
cardiac NCT03928288 715 722 B-Condition
valve NCT03928288 723 728 I-Condition
disorder NCT03928288 729 737 I-Condition
; NCT03928288 737 738 O
pulmonary NCT03928288 739 748 B-Modifier
, NCT03928288 749 750 O
pericardial NCT03928288 751 762 B-Modifier
, NCT03928288 763 764 O
retroperitoneal NCT03928288 765 780 B-Modifier
fibrotic NCT03928288 781 789 I-Modifier
disorder NCT03928288 790 798 B-Condition
; NCT03928288 798 799 O
hypersensitivity NCT03928288 800 816 B-Condition
to NCT03928288 817 819 O
ergot NCT03928288 820 825 B-Modifier
derivatives NCT03928288 826 837 I-Modifier
; NCT03928288 837 838 O
uncontrolled NCT03928288 839 851 B-Modifier
hypertension NCT03928288 852 864 B-Condition
) NCT03928288 865 866 O

- NCT03928288 870 871 O
Significant NCT03928288 873 884 O
mental NCT03928288 885 891 B-Modifier
or NCT03928288 892 894 B-Or
chronic NCT03928288 895 902 O
systemic NCT03928288 903 911 B-Modifier
illness NCT03928288 912 919 B-Condition
that NCT03928288 920 924 O
might NCT03928288 925 930 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03928288 931 939 O
pain NCT03928288 940 944 B-Procedure
assessment NCT03928288 945 955 I-Procedure
or NCT03928288 956 958 B-Or
the NCT03928288 959 962 O
ability NCT03928288 963 970 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928288 971 973 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03928288 974 982 O
the NCT03928288 983 986 O
study NCT03928288 987 992 B-Study

- NCT03928288 995 996 O
Pregnant NCT03928288 998 1006 B-Condition
, NCT03928288 1007 1008 O
breastfeeding NCT03928288 1009 1022 B-Condition
, NCT03928288 1023 1024 O
or NCT03928288 1025 1027 B-Or
planning NCT03928288 1028 1036 B-Assertion___Assertion_Type_Value:intention
to NCT03928288 1037 1039 I-Assertion___Assertion_Type_Value:intention
become NCT03928288 1040 1046 I-Assertion___Assertion_Type_Value:intention
pregnant NCT03928288 1047 1055 B-Condition
in NCT03928288 1056 1058 O
the NCT03928288 1059 1062 O
next NCT03928288 1063 1067 B-Eq_Comparison
6 NCT03928288 1068 1069 I-Eq_Comparison
months NCT03928288 1070 1076 I-Eq_Comparison

- NCT03928288 1079 1080 O
Impaired NCT03928288 1082 1090 O
liver NCT03928288 1091 1096 O
function NCT03928288 1097 1105 O
( NCT03928288 1106 1107 O
ALT NCT03928288 1108 1111 O
> NCT03928288 1112 1113 O
2 NCT03928288 1114 1115 O
x NCT03928288 1116 1117 O
normal NCT03928288 1118 1124 O
) NCT03928288 1125 1126 O
or NCT03928288 1127 1129 O
liver NCT03928288 1130 1135 O
disease NCT03928288 1136 1143 O

- NCT03928288 1146 1147 O
Breast NCT03928288 1149 1155 B-Modifier
cancer NCT03928288 1156 1162 B-Condition
, NCT03928288 1163 1164 O
current NCT03928288 1165 1172 B-Eq_Comparison
or NCT03928288 1173 1175 B-Or
previous NCT03928288 1176 1184 B-Eq_Comparison

- NCT03928288 1187 1188 O
Thromboembolic NCT03928288 1190 1204 B-Condition
disease NCT03928288 1205 1212 I-Condition
, NCT03928288 1213 1214 O
current NCT03928288 1215 1222 B-Eq_Comparison
or NCT03928288 1223 1225 B-Or
previous NCT03928288 1226 1234 B-Eq_Comparison

- NCT03928288 1237 1238 O
Use NCT03928288 1240 1243 O
of NCT03928288 1244 1246 O
other NCT03928288 1247 1252 B-Other
drugs NCT03928288 1253 1258 B-Drug
that NCT03928288 1259 1263 O
affect NCT03928288 1264 1270 B-Assertion___Assertion_Type_Value:hypothetical
dopamine NCT03928288 1271 1279 B-Drug
( NCT03928288 1280 1281 O
e NCT03928288 1282 1283 O
. NCT03928288 1284 1285 O
g NCT03928288 1286 1287 O
. NCT03928288 1288 1289 O
, NCT03928288 1290 1291 O
phenothiazines NCT03928288 1292 1306 B-Drug
, NCT03928288 1307 1308 O
metoclopramide NCT03928288 1309 1323 B-Drug
, NCT03928288 1324 1325 O
butyrophenones NCT03928288 1326 1340 B-Drug
) NCT03928288 1341 1342 O

Inclusion NCT03861325 0 9 O
Criteria NCT03861325 10 18 O
: NCT03861325 19 20 O

- NCT03861325 24 25 O
The NCT03861325 27 30 O
patient NCT03861325 31 38 O
or NCT03861325 39 41 O
his NCT03861325 42 45 O
/ NCT03861325 46 47 O
her NCT03861325 48 51 O
representative NCT03861325 52 66 O
has NCT03861325 67 70 O
been NCT03861325 71 75 O
informed NCT03861325 76 84 O
about NCT03861325 85 90 O
the NCT03861325 91 94 O
implementation NCT03861325 95 109 O
of NCT03861325 110 112 O
the NCT03861325 113 116 O
study NCT03861325 117 122 O
, NCT03861325 123 124 O
its NCT03861325 125 128 O
objectives NCT03861325 129 139 O
, NCT03861325 140 141 O
its NCT03861325 142 145 O
constraints NCT03861325 146 157 O
, NCT03861325 158 159 O
the NCT03861325 160 163 O
rights NCT03861325 164 170 O
of NCT03861325 171 173 O
the NCT03861325 174 177 O
patient NCT03861325 178 185 O
and NCT03861325 186 189 O
must NCT03861325 190 194 O
have NCT03861325 195 199 O
received NCT03861325 200 208 O
the NCT03861325 209 212 O
newsletter NCT03861325 213 223 O
and NCT03861325 224 227 O
no NCT03861325 228 230 O
opposition NCT03861325 231 241 O
of NCT03861325 242 244 O
the NCT03861325 245 248 O
study NCT03861325 249 254 O
. NCT03861325 255 256 O

- NCT03861325 260 261 O
The NCT03861325 263 266 O
patient NCT03861325 267 274 O
must NCT03861325 275 279 O
be NCT03861325 280 282 O
an NCT03861325 283 285 O
affiliate NCT03861325 286 295 O
or NCT03861325 296 298 O
beneficiary NCT03861325 299 310 O
of NCT03861325 311 313 O
a NCT03861325 314 315 O
health NCT03861325 316 322 O
insurance NCT03861325 323 332 O
plan NCT03861325 333 337 O
. NCT03861325 338 339 O

- NCT03861325 343 344 O
The NCT03861325 346 349 O
patient NCT03861325 350 357 O
is NCT03861325 358 360 O
at NCT03861325 361 363 B-Eq_Comparison
least NCT03861325 364 369 I-Eq_Comparison
18 NCT03861325 370 372 I-Eq_Comparison
years NCT03861325 373 378 I-Eq_Comparison
old NCT03861325 379 382 B-Age
. NCT03861325 383 384 O

- NCT03861325 388 389 O
The NCT03861325 391 394 O
patient NCT03861325 395 402 O
has NCT03861325 403 406 O
septic NCT03861325 407 413 B-Condition
shock NCT03861325 414 419 I-Condition
as NCT03861325 420 422 O
defined NCT03861325 423 430 O
by NCT03861325 431 433 O
the NCT03861325 434 437 O
3 NCT03861325 438 439 O
rd NCT03861325 440 442 O
International NCT03861325 443 456 O
Conference NCT03861325 457 467 O
for NCT03861325 468 471 O
the NCT03861325 472 475 O
definition NCT03861325 476 486 O
of NCT03861325 487 489 O
sepsis NCT03861325 490 496 O
and NCT03861325 497 500 O
septic NCT03861325 501 507 O
shock NCT03861325 508 513 O

Exclusion NCT03861325 514 523 O
Criteria NCT03861325 524 532 O
: NCT03861325 533 534 O

- NCT03861325 538 539 O
The NCT03861325 541 544 O
patient NCT03861325 545 552 O
is NCT03861325 553 555 O
in NCT03861325 556 558 O
an NCT03861325 559 561 O
exclusion NCT03861325 562 571 O
period NCT03861325 572 578 O
determined NCT03861325 579 589 O
by NCT03861325 590 592 O
a NCT03861325 593 594 O
previous NCT03861325 595 603 B-Eq_Comparison
study NCT03861325 604 609 B-Study

- NCT03861325 612 613 O
The NCT03861325 615 618 O
patient NCT03861325 619 626 O
is NCT03861325 627 629 O
under NCT03861325 630 635 B-Observation
guardianship NCT03861325 636 648 I-Observation
, NCT03861325 649 650 O
under NCT03861325 651 656 B-Observation
guardianship NCT03861325 657 669 I-Observation
, NCT03861325 670 671 O
or NCT03861325 672 674 B-Or
under NCT03861325 675 680 B-Observation
the NCT03861325 681 684 I-Observation
protection NCT03861325 685 695 I-Observation
of NCT03861325 696 698 I-Observation
justice NCT03861325 699 706 I-Observation

- NCT03861325 709 710 O
The NCT03861325 712 715 O
patient NCT03861325 716 723 O
has NCT03861325 724 727 O
already NCT03861325 728 735 O
participated NCT03861325 736 748 O
in NCT03861325 749 751 O
this NCT03861325 752 756 O
study NCT03861325 757 762 O

- NCT03861325 765 766 O
The NCT03861325 768 771 O
patient NCT03861325 772 779 O
or NCT03861325 780 782 O
his NCT03861325 783 786 O
/ NCT03861325 787 788 O
her NCT03861325 789 792 O
representative NCT03861325 793 807 O
refuses NCT03861325 808 815 O
to NCT03861325 816 818 O
participate NCT03861325 819 830 O
in NCT03861325 831 833 O
the NCT03861325 834 837 O
study NCT03861325 838 843 O

- NCT03861325 846 847 O
The NCT03861325 849 852 O
patient NCT03861325 853 860 O
is NCT03861325 861 863 O
pregnant NCT03861325 864 872 B-Condition
, NCT03861325 873 874 O
parturient NCT03861325 875 885 B-Condition
or NCT03861325 886 888 B-Or
is NCT03861325 889 891 O
breastfeeding NCT03861325 892 905 B-Condition

- NCT03861325 908 909 O
The NCT03861325 911 914 O
patient NCT03861325 915 922 O
is NCT03861325 923 925 O
a NCT03861325 926 927 O
minor NCT03861325 928 933 O

- NCT03861325 936 937 O
The NCT03861325 939 942 O
patient NCT03861325 943 950 O
is NCT03861325 951 953 O
in NCT03861325 954 956 O
therapeutic NCT03861325 957 968 B-Condition
limitation NCT03861325 969 979 I-Condition
or NCT03861325 980 982 B-Or
moribund NCT03861325 983 991 B-Condition

- NCT03861325 994 995 O
The NCT03861325 997 1000 O
patient NCT03861325 1001 1008 O
has NCT03861325 1009 1012 B-Eq_Comparison
undergone NCT03861325 1013 1022 I-Eq_Comparison
or NCT03861325 1023 1025 B-Or
is NCT03861325 1026 1028 B-Eq_Comparison
going NCT03861325 1029 1034 I-Eq_Comparison
to NCT03861325 1035 1037 I-Eq_Comparison
have NCT03861325 1038 1042 I-Eq_Comparison
scheduled NCT03861325 1043 1052 B-Modifier
or NCT03861325 1053 1055 B-Or
emergency NCT03861325 1056 1065 B-Encounter
digestive NCT03861325 1066 1075 B-Procedure
surgery NCT03861325 1076 1083 I-Procedure

- NCT03861325 1086 1087 O
The NCT03861325 1089 1092 O
patient NCT03861325 1093 1100 O
is NCT03861325 1101 1103 O
HIV NCT03861325 1104 1107 B-Condition
- NCT03861325 1108 1109 O
positive NCT03861325 1110 1118 O

- NCT03861325 1121 1122 O
The NCT03861325 1124 1127 O
patient NCT03861325 1128 1135 O
has NCT03861325 1136 1139 O
Child NCT03861325 1140 1145 B-Modifier
C NCT03861325 1146 1147 I-Modifier
cirrhosis NCT03861325 1148 1157 B-Condition

- NCT03861325 1160 1161 O
The NCT03861325 1163 1166 O
patient NCT03861325 1167 1174 O
has NCT03861325 1175 1178 O
progressive NCT03861325 1179 1190 B-Modifier
digestive NCT03861325 1191 1200 B-Condition
neoplasia NCT03861325 1201 1210 I-Condition
, NCT03861325 1211 1212 O
digestive NCT03861325 1213 1222 B-Condition
lymphoma NCT03861325 1223 1231 I-Condition
, NCT03861325 1232 1233 O
chronic NCT03861325 1234 1241 O
inflammatory NCT03861325 1242 1254 B-Condition
bowel NCT03861325 1255 1260 I-Condition
disease NCT03861325 1261 1268 I-Condition
( NCT03861325 1269 1270 O
Crohn NCT03861325 1271 1276 B-Condition
's NCT03861325 1276 1278 I-Condition
disease NCT03861325 1279 1286 I-Condition
. NCT03861325 1287 1288 O
. NCT03861325 1289 1290 O
. NCT03861325 1291 1292 O
) NCT03861325 1293 1294 O
. NCT03861325 1295 1296 O

Inclusion NCT03922243 0 9 O
Criteria NCT03922243 10 18 O
: NCT03922243 19 20 O

- NCT03922243 24 25 O
Dental NCT03922243 27 33 B-Procedure
treatment NCT03922243 34 43 I-Procedure
performed NCT03922243 44 53 O
in NCT03922243 54 56 O
the NCT03922243 57 60 O
time NCT03922243 61 65 O
frame NCT03922243 66 71 O

Exclusion NCT03922243 72 81 O
Criteria NCT03922243 82 90 O
: NCT03922243 91 92 O

- NCT03922243 96 97 O
Dental NCT03922243 99 105 B-Procedure
treatment NCT03922243 106 115 I-Procedure
not NCT03922243 116 119 B-Negation
performed NCT03922243 120 129 O

Inclusion NCT03862989 0 9 O
Criteria NCT03862989 10 18 O
: NCT03862989 19 20 O

- NCT03862989 24 25 O
post NCT03862989 27 31 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03862989 32 33 O
myocardial NCT03862989 34 44 B-Condition
infarction NCT03862989 45 55 I-Condition
ventricular NCT03862989 56 67 B-Condition
tachycardia NCT03862989 68 79 I-Condition
diagnosis NCT03862989 80 89 O

- NCT03862989 92 93 O
scheduled NCT03862989 95 104 B-Eq_Comparison
to NCT03862989 105 107 I-Eq_Comparison
undergo NCT03862989 108 115 I-Eq_Comparison
radiofrequency NCT03862989 116 130 B-Procedure
catheter NCT03862989 131 139 I-Procedure
ablation NCT03862989 140 148 I-Procedure
as NCT03862989 149 151 O
either NCT03862989 152 158 O
emergency NCT03862989 159 168 B-Modifier
or NCT03862989 169 171 B-Or
elective NCT03862989 172 180 B-Modifier
case NCT03862989 181 185 O

Exclusion NCT03862989 186 195 O
Criteria NCT03862989 196 204 O
: NCT03862989 205 206 O

- NCT03862989 210 211 O
Unable NCT03862989 213 219 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03862989 220 222 O
perform NCT03862989 223 230 O
pace NCT03862989 231 235 B-Procedure
mapping NCT03862989 236 243 I-Procedure
during NCT03862989 244 250 B-Temporal_Connection___Temporal_Connection_Type_Value:during
ablation NCT03862989 251 259 B-Procedure
procedure NCT03862989 260 269 I-Procedure

- NCT03862989 272 273 O
Unable NCT03862989 275 281 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03862989 282 284 O
terminate NCT03862989 285 294 B-Condition
VT NCT03862989 295 297 I-Condition
thus NCT03862989 298 302 O
unable NCT03862989 303 309 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03862989 310 312 O
provide NCT03862989 313 320 O
data NCT03862989 321 325 O
regarding NCT03862989 326 335 O
successful NCT03862989 336 346 O
ablation NCT03862989 347 355 B-Procedure
lesion NCT03862989 356 362 I-Procedure
sites NCT03862989 363 368 O

- NCT03862989 371 372 O
Intracardiac NCT03862989 374 386 B-Condition
thrombus NCT03862989 387 395 I-Condition

Inclusion NCT03868527 0 9 O
Criteria NCT03868527 10 18 O
: NCT03868527 19 20 O

- NCT03868527 23 24 O
Patients NCT03868527 25 33 O
followed NCT03868527 34 42 B-Encounter
for NCT03868527 43 46 O
hematological NCT03868527 47 60 B-Condition
diseases NCT03868527 61 69 I-Condition
in NCT03868527 70 72 O
Lyon NCT03868527 73 77 O
Sud NCT03868527 78 81 O
Hospital NCT03868527 82 90 O

Exclusion NCT03868527 91 100 O
Criteria NCT03868527 101 109 O
: NCT03868527 110 111 O

- NCT03868527 114 115 O
Patients NCT03868527 116 124 O
who NCT03868527 125 128 O
does NCT03868527 129 133 B-Negation
n't NCT03868527 133 136 I-Negation
have NCT03868527 137 141 I-Negation
hematological NCT03868527 142 155 B-Condition
diseases NCT03868527 156 164 I-Condition

Inclusion NCT03928600 0 9 O
Criteria NCT03928600 10 18 O
: NCT03928600 19 20 O

- NCT03928600 24 25 O
full NCT03928600 27 31 B-Condition
- NCT03928600 32 33 I-Condition
term NCT03928600 34 38 I-Condition
( NCT03928600 39 40 O
≥ NCT03928600 41 42 B-Eq_Comparison
37 NCT03928600 43 45 I-Eq_Comparison
weeks NCT03928600 46 51 I-Eq_Comparison
of NCT03928600 52 54 O
gestation NCT03928600 55 64 B-Observation
) NCT03928600 65 66 O

- NCT03928600 70 71 O
singleton NCT03928600 73 82 B-Condition

- NCT03928600 85 86 O
vertex NCT03928600 88 94 B-Condition
- NCT03928600 95 96 I-Condition
presenting NCT03928600 97 107 I-Condition
gestations NCT03928600 108 118 I-Condition

- NCT03928600 121 122 O
with NCT03928600 124 128 O
no NCT03928600 129 131 B-Negation
contraindication NCT03928600 132 148 B-Contraindication
to NCT03928600 149 151 O
vaginal NCT03928600 152 159 B-Procedure
delivery NCT03928600 160 168 I-Procedure

- NCT03928600 171 172 O
intact NCT03928600 174 180 B-Condition
membranes NCT03928600 181 190 I-Condition

- NCT03928600 193 194 O
Bishop NCT03928600 196 202 B-Observation
score NCT03928600 203 208 I-Observation
< NCT03928600 209 210 B-Eq_Comparison
7 NCT03928600 211 212 I-Eq_Comparison
and NCT03928600 213 216 B-And
cervical NCT03928600 217 225 B-Observation
dilation NCT03928600 226 234 I-Observation
≤ NCT03928600 235 236 B-Eq_Comparison
2 NCT03928600 237 238 I-Eq_Comparison
cm NCT03928600 239 241 I-Eq_Comparison

Exclusion NCT03928600 242 251 O
Criteria NCT03928600 252 260 O
: NCT03928600 261 262 O

- NCT03928600 266 267 O
contraindication NCT03928600 269 285 B-Contraindication
for NCT03928600 286 289 O
misoprostol NCT03928600 290 301 B-Drug

- NCT03928600 304 305 O
history NCT03928600 307 314 B-Eq_Comparison
of NCT03928600 315 317 I-Eq_Comparison
previous NCT03928600 318 326 I-Eq_Comparison
caesarean NCT03928600 327 336 B-Procedure

- NCT03928600 339 340 O
rupture NCT03928600 342 349 B-Condition
of NCT03928600 350 352 I-Condition
membranes NCT03928600 353 362 I-Condition
, NCT03928600 363 364 O

- NCT03928600 368 369 O
fetal NCT03928600 371 376 B-Modifier
or NCT03928600 377 379 B-Or
maternal NCT03928600 380 388 B-Modifier
morbidities NCT03928600 389 400 B-Condition
( NCT03928600 401 402 O
fetal NCT03928600 403 408 B-Condition
major NCT03928600 409 414 I-Condition
abnormalities NCT03928600 415 428 I-Condition
, NCT03928600 429 430 O
FIGO NCT03928600 431 435 O
definition NCT03928600 436 446 O
of NCT03928600 447 449 O
pathological NCT03928600 450 462 B-Modifier
CTG NCT03928600 463 466 B-Condition
, NCT03928600 467 468 O
HELLP NCT03928600 469 474 B-Condition
syndrome NCT03928600 475 483 I-Condition
, NCT03928600 484 485 O
preeclampsia NCT03928600 486 498 B-Condition
or NCT03928600 499 501 B-Or
hypertension NCT03928600 502 514 B-Condition
with NCT03928600 515 519 O
severe NCT03928600 520 526 O
features NCT03928600 527 535 O
, NCT03928600 536 537 O
fetal NCT03928600 538 543 B-Condition
growth NCT03928600 544 550 I-Condition
restriction NCT03928600 551 562 I-Condition
) NCT03928600 563 564 O

Inclusion NCT03920150 0 9 O
Criteria NCT03920150 10 18 O
: NCT03920150 19 20 O

- NCT03920150 24 25 O
vitamin NCT03920150 27 34 B-Condition
D NCT03920150 35 36 I-Condition
deficiency NCT03920150 37 47 I-Condition
by NCT03920150 48 50 O
serum NCT03920150 51 56 B-Observation
level NCT03920150 57 62 I-Observation
< NCT03920150 63 64 B-Eq_Comparison
50 NCT03920150 65 67 I-Eq_Comparison
nmol NCT03920150 68 72 I-Eq_Comparison
/ NCT03920150 73 74 I-Eq_Comparison
l NCT03920150 75 76 I-Eq_Comparison

Exclusion NCT03920150 77 86 O
Criteria NCT03920150 87 95 O
: NCT03920150 96 97 O

- NCT03920150 101 102 O
hypercalcaemia NCT03920150 104 118 B-Condition

Inclusion NCT03866005 0 9 O
Criteria NCT03866005 10 18 O
: NCT03866005 19 20 O

- NCT03866005 24 25 O
Diagnosed NCT03866005 27 36 O
diabetes NCT03866005 37 45 B-Condition
mellitus NCT03866005 46 54 I-Condition
and NCT03866005 55 58 B-And
treatment NCT03866005 59 68 B-Procedure
- NCT03866005 69 70 O
naïve NCT03866005 71 76 B-Negation
CI NCT03866005 77 79 B-Condition
- NCT03866005 80 81 I-Condition
DME NCT03866005 82 85 I-Condition
requiring NCT03866005 86 95 B-Assertion___Assertion_Type_Value:hypothetical
anti NCT03866005 96 100 O
- NCT03866005 101 102 O
VEGF NCT03866005 103 107 B-Condition
therapy NCT03866005 108 115 B-Procedure
per NCT03866005 116 119 O
retinal NCT03866005 120 127 B-Provider
specialist NCT03866005 128 138 I-Provider
's NCT03866005 138 140 O
customary NCT03866005 141 150 O
treatment NCT03866005 151 160 B-Procedure
regimen NCT03866005 161 168 O
will NCT03866005 169 173 O
be NCT03866005 174 176 O
recruited NCT03866005 177 186 O
to NCT03866005 187 189 O
participate NCT03866005 190 201 O
in NCT03866005 202 204 O
the NCT03866005 205 208 O
study NCT03866005 209 214 B-Study
. NCT03866005 215 216 O
CI NCT03866005 218 220 B-Condition
- NCT03866005 221 222 I-Condition
DME NCT03866005 223 226 I-Condition
will NCT03866005 227 231 O
be NCT03866005 232 234 O
defined NCT03866005 235 242 O
as NCT03866005 243 245 O
a NCT03866005 246 247 O
central NCT03866005 248 255 B-Observation
subfield NCT03866005 256 264 I-Observation
thickness NCT03866005 265 274 I-Observation
( NCT03866005 275 276 O
CST NCT03866005 277 280 B-Observation
) NCT03866005 281 282 O
> NCT03866005 283 284 B-Eq_Comparison
300 NCT03866005 285 288 I-Eq_Comparison
microns NCT03866005 289 296 I-Eq_Comparison
on NCT03866005 297 299 O
spectral NCT03866005 300 308 B-Modifier
domain NCT03866005 309 315 I-Modifier
optical NCT03866005 316 323 B-Procedure
coherence NCT03866005 324 333 I-Procedure
tomography NCT03866005 334 344 I-Procedure
( NCT03866005 345 346 O
SD NCT03866005 347 349 B-Procedure
- NCT03866005 350 351 I-Procedure
OCT NCT03866005 352 355 I-Procedure
) NCT03866005 356 357 O
or NCT03866005 358 360 B-Or
CST NCT03866005 361 364 B-Observation
> NCT03866005 365 366 B-Eq_Comparison
250 NCT03866005 367 370 I-Eq_Comparison
microns NCT03866005 371 378 I-Eq_Comparison
with NCT03866005 379 383 B-And
definite NCT03866005 384 392 O
intra NCT03866005 393 398 B-Modifier
- NCT03866005 399 400 I-Modifier
retinal NCT03866005 401 408 I-Modifier
cystic NCT03866005 409 415 B-Condition
fluid NCT03866005 416 421 I-Condition
accumulation NCT03866005 422 434 I-Condition
. NCT03866005 435 436 O
Additional NCT03866005 438 448 O
inclusion NCT03866005 449 458 O
criteria NCT03866005 459 467 O
are NCT03866005 468 471 O
age NCT03866005 472 475 B-Age
> NCT03866005 476 477 B-Eq_Comparison
18 NCT03866005 478 480 I-Eq_Comparison
years NCT03866005 481 486 I-Eq_Comparison
, NCT03866005 487 488 O
and NCT03866005 489 492 O
ability NCT03866005 493 500 O
to NCT03866005 501 503 O
give NCT03866005 504 508 O
informed NCT03866005 509 517 O
consent NCT03866005 518 525 O
. NCT03866005 526 527 O

Exclusion NCT03866005 529 538 O
Criteria NCT03866005 539 547 O
: NCT03866005 548 549 O

- NCT03866005 553 554 O
Age NCT03866005 556 559 B-Age
< NCT03866005 560 561 B-Eq_Comparison
18 NCT03866005 562 564 I-Eq_Comparison
years NCT03866005 565 570 I-Eq_Comparison
, NCT03866005 571 572 O
inability NCT03866005 573 582 O
to NCT03866005 583 585 O
give NCT03866005 586 590 O
informed NCT03866005 591 599 O
consent NCT03866005 600 607 O
, NCT03866005 608 609 O
evidence NCT03866005 610 618 O
of NCT03866005 619 621 O
proliferative NCT03866005 622 635 B-Condition
diabetic NCT03866005 636 644 I-Condition
retinopathy NCT03866005 645 656 I-Condition
, NCT03866005 657 658 O
evidence NCT03866005 659 667 O
of NCT03866005 668 670 O
other NCT03866005 671 676 B-Other
serious NCT03866005 677 684 O
ocular NCT03866005 685 691 B-Condition
disease NCT03866005 692 699 I-Condition
( NCT03866005 700 701 O
age NCT03866005 702 705 B-Modifier
- NCT03866005 706 707 I-Modifier
related NCT03866005 708 715 I-Modifier
macular NCT03866005 716 723 B-Condition
degeneration NCT03866005 724 736 I-Condition
, NCT03866005 737 738 O
glaucoma NCT03866005 739 747 B-Condition
, NCT03866005 748 749 O
significant NCT03866005 750 761 O
media NCT03866005 762 767 B-Condition
opacity NCT03866005 768 775 I-Condition
) NCT03866005 776 777 O
, NCT03866005 778 779 O
history NCT03866005 780 787 B-Eq_Comparison
of NCT03866005 788 790 I-Eq_Comparison
previous NCT03866005 791 799 I-Eq_Comparison
intraocular NCT03866005 800 811 B-Procedure
surgery NCT03866005 812 819 I-Procedure
, NCT03866005 820 821 O
including NCT03866005 822 831 O
macular NCT03866005 832 839 B-Modifier
or NCT03866005 840 842 B-Or
panretinal NCT03866005 843 853 B-Modifier
photocoagulation NCT03866005 854 870 B-Procedure
( NCT03866005 871 872 O
except NCT03866005 873 879 B-Exception
uncomplicated NCT03866005 880 893 B-Modifier
cataract NCT03866005 894 902 I-Modifier
or NCT03866005 903 905 B-Or
keratorefractive NCT03866005 906 922 B-Modifier
surgery NCT03866005 923 930 B-Procedure
more NCT03866005 931 935 B-Eq_Comparison
than NCT03866005 936 940 I-Eq_Comparison
6 NCT03866005 941 942 I-Eq_Comparison
months NCT03866005 943 949 I-Eq_Comparison
prior NCT03866005 950 955 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866005 956 958 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03866005 959 969 B-Study
) NCT03866005 970 971 O
, NCT03866005 972 973 O
pregnant NCT03866005 974 982 B-Condition
and NCT03866005 983 986 B-Or
nursing NCT03866005 987 994 B-Condition
women NCT03866005 995 1000 O
, NCT03866005 1001 1002 O
known NCT03866005 1003 1008 O
sensitivity NCT03866005 1009 1020 B-Condition
to NCT03866005 1021 1023 O
any NCT03866005 1024 1027 O
of NCT03866005 1028 1030 O
the NCT03866005 1031 1034 O
supplement NCT03866005 1035 1045 B-Drug
ingredients NCT03866005 1046 1057 I-Drug
. NCT03866005 1058 1059 O

Inclusion NCT03928080 0 9 O
Criteria NCT03928080 10 18 O
: NCT03928080 19 20 O

- NCT03928080 24 25 O
Aged NCT03928080 27 31 B-Age
18 NCT03928080 32 34 B-Eq_Comparison
and NCT03928080 35 38 I-Eq_Comparison
above NCT03928080 39 44 I-Eq_Comparison
. NCT03928080 45 46 O

- NCT03928080 50 51 O
Having NCT03928080 53 59 O
the NCT03928080 60 63 O
ability NCT03928080 64 71 O
to NCT03928080 72 74 O
learn NCT03928080 75 80 O
the NCT03928080 81 84 O
standard NCT03928080 85 93 O
toothbrushing NCT03928080 94 107 O
method NCT03928080 108 114 O
with NCT03928080 115 119 O
artificial NCT03928080 120 130 O
intelligence NCT03928080 131 143 O
powered NCT03928080 144 151 O
toothbrush NCT03928080 152 162 O
. NCT03928080 163 164 O

- NCT03928080 168 169 O
Ability NCT03928080 171 178 O
and NCT03928080 179 182 O
willingness NCT03928080 183 194 O
to NCT03928080 195 197 O
give NCT03928080 198 202 O
written NCT03928080 203 210 O
informed NCT03928080 211 219 O
consent NCT03928080 220 227 O
. NCT03928080 228 229 O

Exclusion NCT03928080 231 240 O
Criteria NCT03928080 241 249 O
: NCT03928080 250 251 O

- NCT03928080 255 256 O
Edentulous NCT03928080 258 268 B-Condition
mouth NCT03928080 269 274 I-Condition
. NCT03928080 275 276 O

- NCT03928080 280 281 O
Pregnant NCT03928080 283 291 B-Condition
females NCT03928080 292 299 O
. NCT03928080 300 301 O

- NCT03928080 305 306 O
Having NCT03928080 308 314 O
received NCT03928080 315 323 B-Eq_Comparison
professional NCT03928080 324 336 O
periodontal NCT03928080 337 348 B-Procedure
treatment NCT03928080 349 358 I-Procedure
( NCT03928080 359 360 O
other NCT03928080 361 366 B-Exception
than NCT03928080 367 371 I-Exception
supragingival NCT03928080 372 385 B-Procedure
cleaning NCT03928080 386 394 I-Procedure
) NCT03928080 395 396 O
within NCT03928080 397 403 B-Eq_Comparison
the NCT03928080 404 407 I-Eq_Comparison
previous NCT03928080 408 416 I-Eq_Comparison
12 NCT03928080 417 419 I-Eq_Comparison
months NCT03928080 420 426 I-Eq_Comparison
. NCT03928080 427 428 O

- NCT03928080 432 433 O
Having NCT03928080 435 441 O
received NCT03928080 442 450 B-Eq_Comparison
antibiotic NCT03928080 451 461 B-Drug
medication NCT03928080 462 472 I-Drug
within NCT03928080 473 479 B-Eq_Comparison
the NCT03928080 480 483 I-Eq_Comparison
previous NCT03928080 484 492 I-Eq_Comparison
3 NCT03928080 493 494 I-Eq_Comparison
months NCT03928080 495 501 I-Eq_Comparison
. NCT03928080 502 503 O

Inclusion NCT03864094 0 9 O
Criteria NCT03864094 10 18 O
: NCT03864094 19 20 O

- NCT03864094 24 25 O
Healthy NCT03864094 27 34 B-Condition
women NCT03864094 35 40 O

- NCT03864094 43 44 O
Age NCT03864094 46 49 B-Age
18 NCT03864094 50 52 B-Eq_Comparison
- NCT03864094 53 54 I-Eq_Comparison
50 NCT03864094 55 57 I-Eq_Comparison
years NCT03864094 58 63 I-Eq_Comparison

- NCT03864094 66 67 O
Gynecological NCT03864094 69 82 B-Procedure
procedures NCT03864094 83 93 I-Procedure

- NCT03864094 96 97 O
General NCT03864094 99 106 B-Procedure
anesthesia NCT03864094 107 117 I-Procedure

Exclusion NCT03864094 118 127 O
Criteria NCT03864094 128 136 O
: NCT03864094 137 138 O

- NCT03864094 142 143 O
Pre NCT03864094 145 148 B-Eq_Comparison
- NCT03864094 149 150 I-Eq_Comparison
existing NCT03864094 151 159 I-Eq_Comparison
hypertension NCT03864094 160 172 B-Condition

- NCT03864094 175 176 O
Diabetes NCT03864094 178 186 B-Condition
for NCT03864094 187 190 O
several NCT03864094 191 198 B-Eq_Comparison
years NCT03864094 199 204 I-Eq_Comparison

- NCT03864094 207 208 O
Ischemic NCT03864094 210 218 B-Modifier
heart NCT03864094 219 224 B-Condition
disease NCT03864094 225 232 I-Condition

- NCT03864094 235 236 O
Cerebrovascular NCT03864094 238 253 B-Condition
disease NCT03864094 254 261 I-Condition

- NCT03864094 264 265 O
Heart NCT03864094 267 272 B-Condition
valve NCT03864094 273 278 I-Condition
disease NCT03864094 279 286 I-Condition

- NCT03864094 289 290 O
Verified NCT03864094 292 300 O
cardiac NCT03864094 301 308 B-Condition
arrhythmia NCT03864094 309 319 I-Condition

- NCT03864094 322 323 O
Anaemia NCT03864094 325 332 B-Condition

- NCT03864094 335 336 O
Kidney NCT03864094 338 344 B-Modifier
or NCT03864094 345 347 B-Or
hepatic NCT03864094 348 355 B-Modifier
disease NCT03864094 356 363 B-Condition

- NCT03864094 366 367 O
Hypersensitivity NCT03864094 369 385 B-Condition
for NCT03864094 386 389 O
soya NCT03864094 390 394 B-Modifier
, NCT03864094 395 396 O
eggs NCT03864094 397 401 B-Modifier
or NCT03864094 402 404 B-Or
peanuts NCT03864094 405 412 B-Modifier

- NCT03864094 415 416 O
Pregnancy NCT03864094 418 427 B-Condition

- NCT03864094 430 431 O
Poor NCT03864094 433 437 B-Condition
health NCT03864094 438 444 I-Condition
state NCT03864094 445 450 O

- NCT03864094 453 454 O
Illicit NCT03864094 456 463 B-Condition
substance NCT03864094 464 473 I-Condition
use NCT03864094 474 477 O

- NCT03864094 480 481 O
BMI NCT03864094 483 486 B-Observation
< NCT03864094 487 488 B-Eq_Comparison
20 NCT03864094 489 491 I-Eq_Comparison
or NCT03864094 492 494 B-Or
> NCT03864094 495 496 B-Eq_Comparison
35 NCT03864094 497 499 I-Eq_Comparison
kg NCT03864094 500 502 I-Eq_Comparison
/ NCT03864094 503 504 I-Eq_Comparison
m NCT03864094 505 506 I-Eq_Comparison
2 NCT03864094 507 508 I-Eq_Comparison

- NCT03864094 511 512 O
SBP NCT03864094 514 517 B-Observation
> NCT03864094 518 519 B-Eq_Comparison
150 NCT03864094 520 523 I-Eq_Comparison
mmHg NCT03864094 524 528 I-Eq_Comparison

- NCT03864094 531 532 O
HR NCT03864094 534 536 B-Observation
> NCT03864094 537 538 B-Eq_Comparison
100 NCT03864094 539 542 I-Eq_Comparison
beats NCT03864094 543 548 I-Eq_Comparison
/ NCT03864094 549 550 I-Eq_Comparison
min NCT03864094 551 554 I-Eq_Comparison

Inclusion NCT03860870 0 9 O
Criteria NCT03860870 10 18 O
: NCT03860870 19 20 O

- NCT03860870 24 25 O
Healthy NCT03860870 27 34 B-Condition

- NCT03860870 37 38 O
Male NCT03860870 40 44 O

- NCT03860870 47 48 O
18 NCT03860870 50 52 B-Eq_Comparison
- NCT03860870 53 54 I-Eq_Comparison
40 NCT03860870 55 57 I-Eq_Comparison
years NCT03860870 58 63 I-Eq_Comparison
of NCT03860870 64 66 O
age NCT03860870 67 70 B-Age

- NCT03860870 73 74 O
No NCT03860870 76 78 B-Negation
known NCT03860870 79 84 O
contraindications NCT03860870 85 102 B-Contraindication
for NCT03860870 103 106 O
anabolic NCT03860870 107 115 B-Drug
drugs NCT03860870 116 121 I-Drug
( NCT03860870 122 123 O
e NCT03860870 124 125 O
. NCT03860870 126 127 O
g NCT03860870 128 129 O
. NCT03860870 130 131 O
cancer NCT03860870 133 139 B-Condition
) NCT03860870 140 141 O

Exclusion NCT03860870 143 152 O
Criteria NCT03860870 153 161 O
: NCT03860870 162 163 O

- NCT03860870 167 168 O
Abnormal NCT03860870 170 178 O
ECG NCT03860870 179 182 B-Procedure

- NCT03860870 185 186 O
Steroid NCT03860870 188 195 B-Condition
abuse NCT03860870 196 201 I-Condition

- NCT03860870 204 205 O
Ongoing NCT03860870 207 214 B-Eq_Comparison
use NCT03860870 215 218 O
of NCT03860870 219 221 O
prescription NCT03860870 222 234 B-Drug
medication NCT03860870 235 245 I-Drug

- NCT03860870 248 249 O
heavy NCT03860870 251 256 O
resistance NCT03860870 257 267 B-Observation
training NCT03860870 268 276 I-Observation
more NCT03860870 277 281 B-Eq_Comparison
than NCT03860870 282 286 I-Eq_Comparison
2 NCT03860870 287 288 I-Eq_Comparison
times NCT03860870 289 294 I-Eq_Comparison
weekly NCT03860870 295 301 I-Eq_Comparison

- NCT03860870 304 305 O
Disease NCT03860870 307 314 B-Condition
deemed NCT03860870 315 321 O
by NCT03860870 322 324 O
the NCT03860870 325 328 O
MD NCT03860870 329 331 O
to NCT03860870 332 334 O
infer NCT03860870 335 340 O
a NCT03860870 341 342 O
risk NCT03860870 343 347 B-Risk
to NCT03860870 348 350 O
participate NCT03860870 351 362 O
in NCT03860870 363 365 O
the NCT03860870 366 369 O
trial NCT03860870 370 375 B-Study

Inclusion NCT03926247 0 9 O
Criteria NCT03926247 10 18 O
: NCT03926247 19 20 O

- NCT03926247 24 25 O
Mexican NCT03926247 27 34 O
immigrant NCT03926247 35 44 O

- NCT03926247 47 48 O
Residing NCT03926247 50 58 O
in NCT03926247 59 61 O
Bernalillo NCT03926247 62 72 O
County NCT03926247 73 79 O
, NCT03926247 80 81 O
New NCT03926247 82 85 O
Mexico NCT03926247 86 92 O

Exclusion NCT03926247 93 102 O
Criteria NCT03926247 103 111 O
: NCT03926247 112 113 O

- NCT03926247 117 118 O
Severe NCT03926247 120 126 O
cognitive NCT03926247 127 136 B-Condition
functioning NCT03926247 137 148 I-Condition
problems NCT03926247 149 157 I-Condition

- NCT03926247 160 161 O
Imminent NCT03926247 163 171 O
suicide NCT03926247 172 179 B-Condition
risk NCT03926247 180 184 B-Risk

- NCT03926247 187 188 O
Mental NCT03926247 190 196 B-Condition
illness NCT03926247 197 204 I-Condition
that NCT03926247 205 209 O
is NCT03926247 210 212 O
so NCT03926247 213 215 O
severe NCT03926247 216 222 O
as NCT03926247 223 225 O
to NCT03926247 226 228 O
impede NCT03926247 229 235 O
participation NCT03926247 236 249 O
in NCT03926247 250 252 O
a NCT03926247 253 254 O
group NCT03926247 255 260 O
and NCT03926247 261 264 O
that NCT03926247 265 269 O
warrants NCT03926247 270 278 B-Assertion___Assertion_Type_Value:hypothetical
immediate NCT03926247 279 288 O
individual NCT03926247 289 299 O
treatment NCT03926247 300 309 B-Procedure

Inclusion NCT03867071 0 9 O
Criteria NCT03867071 10 18 O
: NCT03867071 19 20 O

- NCT03867071 24 25 O
Patients NCT03867071 27 35 O
between NCT03867071 36 43 B-Eq_Comparison
18 NCT03867071 44 46 I-Eq_Comparison
to NCT03867071 47 49 I-Eq_Comparison
65 NCT03867071 50 52 I-Eq_Comparison
years NCT03867071 53 58 I-Eq_Comparison
old NCT03867071 59 62 B-Age

- NCT03867071 65 66 O
Patient NCT03867071 68 75 O
with NCT03867071 76 80 O
an NCT03867071 81 83 O
ASA NCT03867071 84 87 B-Observation
1 NCT03867071 88 89 B-Eq_Comparison
or NCT03867071 90 92 I-Eq_Comparison
2 NCT03867071 93 94 I-Eq_Comparison
( NCT03867071 95 96 O
ASA NCT03867071 97 100 O
1 NCT03867071 101 102 O
corresponding NCT03867071 103 116 O
to NCT03867071 117 119 O
a NCT03867071 120 121 O
patient NCT03867071 122 129 O
in NCT03867071 130 132 O
perfect NCT03867071 133 140 O
health NCT03867071 141 147 O
and NCT03867071 148 151 O
ASA NCT03867071 152 155 O
2 NCT03867071 156 157 O
to NCT03867071 158 160 O
a NCT03867071 161 162 O
patient NCT03867071 163 170 O
with NCT03867071 171 175 O
moderate NCT03867071 176 184 O
involvement NCT03867071 185 196 O
and NCT03867071 197 200 O
well NCT03867071 201 205 O
controlled NCT03867071 206 216 O
organ NCT03867071 217 222 O
function NCT03867071 223 231 O
) NCT03867071 232 233 O

- NCT03867071 237 238 O
patient NCT03867071 240 247 O
presenting NCT03867071 248 258 O
at NCT03867071 259 261 B-Eq_Comparison
least NCT03867071 262 267 I-Eq_Comparison
one NCT03867071 268 271 I-Eq_Comparison
of NCT03867071 272 274 O
the NCT03867071 275 278 B-Criteria_Count
following NCT03867071 279 288 I-Criteria_Count
fractures NCT03867071 289 298 B-Condition
: NCT03867071 299 300 O
Basin NCT03867071 301 306 B-Modifier
and NCT03867071 307 310 B-Or
/ NCT03867071 311 312 I-Or
or NCT03867071 313 315 I-Or
femur NCT03867071 316 321 B-Modifier
with NCT03867071 322 326 O
surgical NCT03867071 327 335 B-Procedure
indication NCT03867071 336 346 B-Indication
, NCT03867071 347 348 O
associated NCT03867071 349 359 O
or NCT03867071 360 362 O
not NCT03867071 363 366 O
with NCT03867071 367 371 O
other NCT03867071 372 377 B-Other
fractures NCT03867071 378 387 B-Condition
. NCT03867071 388 389 O

- NCT03867071 393 394 O
patient NCT03867071 396 403 O
with NCT03867071 404 408 O
hemoglobin NCT03867071 409 419 B-Observation
between NCT03867071 420 427 B-Eq_Comparison
9 NCT03867071 428 429 I-Eq_Comparison
and NCT03867071 430 433 I-Eq_Comparison
13 NCT03867071 434 436 I-Eq_Comparison
g NCT03867071 437 438 I-Eq_Comparison
/ NCT03867071 439 440 I-Eq_Comparison
dl NCT03867071 441 443 I-Eq_Comparison
at NCT03867071 444 446 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867071 447 450 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03867071 451 455 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03867071 456 458 O
admission NCT03867071 459 468 B-Encounter
on NCT03867071 469 471 O
trauma NCT03867071 472 478 O
department NCT03867071 479 489 O

Exclusion NCT03867071 490 499 O
Criteria NCT03867071 500 508 O
: NCT03867071 509 510 O

- NCT03867071 514 515 O
patient NCT03867071 517 524 O
with NCT03867071 525 529 O
contraindication NCT03867071 530 546 B-Contraindication
to NCT03867071 547 549 O
synthetic NCT03867071 550 559 B-Procedure
erythropoietin NCT03867071 560 574 I-Procedure

- NCT03867071 577 578 O
Patient NCT03867071 580 587 O
with NCT03867071 588 592 O
intravenous NCT03867071 593 604 B-Procedure
iron NCT03867071 605 609 I-Procedure
contraindication NCT03867071 610 626 B-Contraindication

- NCT03867071 629 630 O
pregnant NCT03867071 632 640 B-Condition
patient NCT03867071 641 648 O
or NCT03867071 649 651 B-Or
with NCT03867071 652 656 O
a NCT03867071 657 658 O
risk NCT03867071 659 663 B-Risk
of NCT03867071 664 666 O
pregnancy NCT03867071 667 676 B-Condition

- NCT03867071 679 680 O
patient NCT03867071 682 689 O
who NCT03867071 690 693 O
has NCT03867071 694 697 O
not NCT03867071 698 701 O
given NCT03867071 702 707 O
his NCT03867071 708 711 O
consent NCT03867071 712 719 O
or NCT03867071 720 722 O
does NCT03867071 723 727 O
not NCT03867071 728 731 O
understand NCT03867071 732 742 O
the NCT03867071 743 746 O
protocol NCT03867071 747 755 O

- NCT03867071 758 759 O
Patient NCT03867071 761 768 O
with NCT03867071 769 773 O
hemodynamic NCT03867071 774 785 B-Condition
instability NCT03867071 786 797 O

- NCT03867071 800 801 O
patient NCT03867071 803 810 O
participating NCT03867071 811 824 O
in NCT03867071 825 827 O
another NCT03867071 828 835 B-Other
research NCT03867071 836 844 B-Study
protocol NCT03867071 845 853 I-Study
for NCT03867071 854 857 O
less NCT03867071 858 862 B-Eq_Comparison
than NCT03867071 863 867 I-Eq_Comparison
3 NCT03867071 868 869 I-Eq_Comparison
months NCT03867071 870 876 I-Eq_Comparison
. NCT03867071 877 878 O


Inclusion NCT03869203 0 9 O
Criteria NCT03869203 10 18 O
: NCT03869203 19 20 O

- NCT03869203 24 25 O
1 NCT03869203 27 28 O
. NCT03869203 28 29 O
elective NCT03869203 31 39 B-Modifier
total NCT03869203 40 45 B-Procedure
knee NCT03869203 46 50 I-Procedure
arthroplasty NCT03869203 51 63 I-Procedure
for NCT03869203 64 67 O
degenerative NCT03869203 68 80 B-Modifier
osteoarthritis NCT03869203 81 95 B-Condition

- NCT03869203 98 99 O
2 NCT03869203 101 102 O
. NCT03869203 102 103 O
elective NCT03869203 105 113 B-Modifier
total NCT03869203 114 119 B-Procedure
hip NCT03869203 120 123 I-Procedure
arthroplasty NCT03869203 124 136 I-Procedure
for NCT03869203 137 140 O
osteoarthritis NCT03869203 141 155 B-Condition
of NCT03869203 156 158 O
osteonecrosis NCT03869203 159 172 B-Condition
of NCT03869203 173 175 I-Condition
femoral NCT03869203 176 183 I-Condition
head NCT03869203 184 188 I-Condition

Exclusion NCT03869203 189 198 O
Criteria NCT03869203 199 207 O
: NCT03869203 208 209 O

- NCT03869203 213 214 O
1 NCT03869203 216 217 O
. NCT03869203 217 218 O
ASA NCT03869203 220 223 B-Observation
class NCT03869203 224 229 B-Eq_Comparison
> NCT03869203 230 231 I-Eq_Comparison
3 NCT03869203 232 233 I-Eq_Comparison

- NCT03869203 237 238 O
2 NCT03869203 240 241 O
. NCT03869203 241 242 O
severe NCT03869203 244 250 O
medical NCT03869203 251 258 B-Condition
comorbidities NCT03869203 259 272 I-Condition

- NCT03869203 275 276 O
3 NCT03869203 278 279 O
. NCT03869203 279 280 O
inflammatory NCT03869203 282 294 B-Condition
arthritis NCT03869203 295 304 I-Condition
including NCT03869203 305 314 O
rheumatoid NCT03869203 315 325 B-Condition
arthritis NCT03869203 326 335 I-Condition

- NCT03869203 338 339 O
4 NCT03869203 341 342 O
. NCT03869203 342 343 O
severe NCT03869203 345 351 O
instability NCT03869203 352 363 B-Condition
of NCT03869203 364 366 O
knee NCT03869203 367 371 B-Modifier
or NCT03869203 372 374 B-Or
hip NCT03869203 375 378 B-Modifier

- NCT03869203 381 382 O
5 NCT03869203 384 385 O
. NCT03869203 385 386 O
revision NCT03869203 388 396 B-Modifier
surgery NCT03869203 397 404 B-Procedure

Inclusion NCT03866096 0 9 O
Criteria NCT03866096 10 18 O
: NCT03866096 19 20 O

- NCT03866096 24 25 O
Volleyball NCT03866096 27 37 B-Observation
players NCT03866096 38 45 I-Observation

- NCT03866096 48 49 O
Female NCT03866096 51 57 O

- NCT03866096 60 61 O
From NCT03866096 63 67 O
18 NCT03866096 68 70 B-Eq_Comparison
to NCT03866096 71 73 I-Eq_Comparison
25 NCT03866096 74 76 I-Eq_Comparison
years NCT03866096 77 82 I-Eq_Comparison

- NCT03866096 85 86 O
With NCT03866096 88 92 O
more NCT03866096 93 97 B-Eq_Comparison
than NCT03866096 98 102 I-Eq_Comparison
one NCT03866096 103 106 I-Eq_Comparison
year NCT03866096 107 111 I-Eq_Comparison
of NCT03866096 112 114 O
sports NCT03866096 115 121 B-Observation
practice NCT03866096 122 130 I-Observation

- NCT03866096 133 134 O
Currently NCT03866096 136 145 B-Eq_Comparison
participate NCT03866096 146 157 O
in NCT03866096 158 160 O
amateur NCT03866096 161 168 O
industry NCT03866096 169 177 O
competitions NCT03866096 178 190 O

Exclusion NCT03866096 191 200 O
Criteria NCT03866096 201 209 O
: NCT03866096 210 211 O

- NCT03866096 215 216 O
Present NCT03866096 218 225 O
a NCT03866096 226 227 O
medical NCT03866096 228 235 O
diagnosis NCT03866096 236 245 O
of NCT03866096 246 248 O
musculoskeletal NCT03866096 249 264 B-Modifier
injury NCT03866096 265 271 B-Condition
at NCT03866096 272 274 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866096 275 278 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03866096 279 283 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03866096 284 286 O
beginning NCT03866096 287 296 B-Eq_Comparison
the NCT03866096 297 300 O
study NCT03866096 301 306 B-Study

- NCT03866096 309 310 O
Receive NCT03866096 312 319 B-Eq_Comparison
a NCT03866096 320 321 O
physiotherapy NCT03866096 322 335 B-Procedure
treatment NCT03866096 336 345 I-Procedure
unrelated NCT03866096 346 355 B-Negation
to NCT03866096 356 358 O
the NCT03866096 359 362 O
study NCT03866096 363 368 B-Study

- NCT03866096 371 372 O
Have NCT03866096 374 378 O
suffered NCT03866096 379 387 B-Eq_Comparison
neurological NCT03866096 388 400 B-Condition
pathology NCT03866096 401 410 I-Condition
in NCT03866096 411 413 O
the NCT03866096 414 417 O
last NCT03866096 418 422 B-Eq_Comparison
6 NCT03866096 423 424 I-Eq_Comparison
months NCT03866096 425 431 I-Eq_Comparison

- NCT03866096 434 435 O
Have NCT03866096 437 441 O
some NCT03866096 442 446 O
type NCT03866096 447 451 O
of NCT03866096 452 454 O
auditory NCT03866096 455 463 B-Modifier
or NCT03866096 464 466 B-Or
vestibular NCT03866096 467 477 B-Modifier
disorder NCT03866096 478 486 B-Condition

- NCT03866096 489 490 O
Not NCT03866096 492 495 O
signed NCT03866096 496 502 O
the NCT03866096 503 506 O
informed NCT03866096 507 515 O
consent NCT03866096 516 523 O
. NCT03866096 524 525 O

Inclusion NCT03868176 0 9 O
Criteria NCT03868176 10 18 O
: NCT03868176 19 20 O

- NCT03868176 24 25 O
Patient NCT03868176 27 34 O
with NCT03868176 35 39 O
germ NCT03868176 40 44 B-Modifier
cell NCT03868176 45 49 I-Modifier
tumor NCT03868176 50 55 B-Condition
. NCT03868176 56 57 O

- NCT03868176 61 62 O
Patient NCT03868176 64 71 O
with NCT03868176 72 76 O
a NCT03868176 77 78 O
mobile NCT03868176 79 85 O
phone NCT03868176 86 91 O
. NCT03868176 92 93 O

- NCT03868176 97 98 O
Patient NCT03868176 100 107 O
on NCT03868176 108 110 B-Eq_Comparison
surveillance NCT03868176 111 123 B-Procedure
. NCT03868176 124 125 O

Exclusion NCT03868176 127 136 O
Criteria NCT03868176 137 145 O
: NCT03868176 146 147 O

- NCT03868176 151 152 O
Testicular NCT03868176 154 164 B-Modifier
cancer NCT03868176 165 171 B-Condition
without NCT03868176 172 179 B-Negation
germ NCT03868176 180 184 B-Modifier
cell NCT03868176 185 189 I-Modifier
component NCT03868176 190 199 I-Modifier
. NCT03868176 200 201 O

- NCT03868176 205 206 O
Prior NCT03868176 208 213 B-Eq_Comparison
history NCT03868176 214 221 I-Eq_Comparison
of NCT03868176 222 224 O
other NCT03868176 225 230 B-Other
malignancy NCT03868176 231 241 B-Condition
except NCT03868176 242 248 B-Exception
for NCT03868176 249 252 O
: NCT03868176 253 254 O
cutaneous NCT03868176 255 264 B-Condition
cancers NCT03868176 265 272 I-Condition
excluding NCT03868176 273 282 B-Exception
melanoma NCT03868176 283 291 B-Condition
, NCT03868176 292 293 O
superficial NCT03868176 294 305 B-Modifier
bladder NCT03868176 306 313 I-Modifier
tumor NCT03868176 314 319 B-Condition
, NCT03868176 320 321 O
localized NCT03868176 322 331 B-Modifier
prostate NCT03868176 332 340 I-Modifier
cancer NCT03868176 341 347 B-Condition
with NCT03868176 348 352 B-And
undetectable NCT03868176 353 365 O
PSA NCT03868176 366 369 B-Observation
. NCT03868176 370 371 O

- NCT03868176 375 376 O
Cognitive NCT03868176 378 387 B-Condition
condition NCT03868176 388 397 I-Condition
that NCT03868176 398 402 O
would NCT03868176 403 408 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03868176 409 417 B-Negation
patient NCT03868176 418 425 O
's NCT03868176 425 427 O
understanding NCT03868176 428 441 O
and NCT03868176 442 445 O
completion NCT03868176 446 456 O
of NCT03868176 457 459 O
study NCT03868176 460 465 B-Study
procedures NCT03868176 466 476 B-Procedure
. NCT03868176 477 478 O

Inclusion NCT03861923 0 9 O
Criteria NCT03861923 10 18 O
: NCT03861923 19 20 O

- NCT03861923 24 25 O
Primary NCT03861923 27 34 O
complaint NCT03861923 35 44 O
of NCT03861923 45 47 O
shoulder NCT03861923 48 56 B-Modifier
pain NCT03861923 57 61 B-Condition
and NCT03861923 62 65 B-Or
stiffness NCT03861923 66 75 B-Condition

- NCT03861923 78 79 O
Gradual NCT03861923 81 88 O
onset NCT03861923 89 94 O
of NCT03861923 95 97 O
symptoms NCT03861923 98 106 O

- NCT03861923 109 110 O
Glenohumeral NCT03861923 112 124 B-Observation
passive NCT03861923 125 132 I-Observation
range NCT03861923 133 138 I-Observation
of NCT03861923 139 141 I-Observation
motion NCT03861923 142 148 I-Observation
limited NCT03861923 149 156 O
in NCT03861923 157 159 O
multiple NCT03861923 160 168 B-Modifier
directions NCT03861923 169 179 I-Modifier

- NCT03861923 182 183 O
Glenohumeral NCT03861923 185 197 B-Observation
passive NCT03861923 198 205 I-Observation
range NCT03861923 206 211 I-Observation
of NCT03861923 212 214 I-Observation
motion NCT03861923 215 221 I-Observation
decreases NCT03861923 222 231 O
as NCT03861923 232 234 O
the NCT03861923 235 238 O
humerus NCT03861923 239 246 B-Modifier
is NCT03861923 247 249 O
abducted NCT03861923 250 258 B-Observation
from NCT03861923 259 263 O
45 NCT03861923 264 266 B-Eq_Comparison
degrees NCT03861923 267 274 I-Eq_Comparison
to NCT03861923 275 277 I-Eq_Comparison
90 NCT03861923 278 280 I-Eq_Comparison
degrees NCT03861923 281 288 I-Eq_Comparison

- NCT03861923 291 292 O
Age NCT03861923 294 297 B-Age
18 NCT03861923 298 300 B-Eq_Comparison
to NCT03861923 301 303 I-Eq_Comparison
65 NCT03861923 304 306 I-Eq_Comparison
years NCT03861923 307 312 I-Eq_Comparison

- NCT03861923 315 316 O
Reports NCT03861923 318 325 O
pain NCT03861923 326 330 B-Condition
with NCT03861923 331 335 O
normal NCT03861923 336 342 B-Modifier
activity NCT03861923 343 351 I-Modifier
greater NCT03861923 352 359 B-Eq_Comparison
than NCT03861923 360 364 I-Eq_Comparison
or NCT03861923 365 367 I-Eq_Comparison
equal NCT03861923 368 373 I-Eq_Comparison
to NCT03861923 374 376 I-Eq_Comparison
2 NCT03861923 377 378 I-Eq_Comparison
/ NCT03861923 379 380 I-Eq_Comparison
10 NCT03861923 381 383 I-Eq_Comparison
on NCT03861923 384 386 O
the NCT03861923 387 390 O
numeric NCT03861923 391 398 O
pain NCT03861923 399 403 B-Observation
rating NCT03861923 404 410 I-Observation
scale NCT03861923 411 416 I-Observation

- NCT03861923 419 420 O
Read NCT03861923 422 426 O
and NCT03861923 427 430 O
speak NCT03861923 431 436 O
English NCT03861923 437 444 O

Exclusion NCT03861923 445 454 O
Criteria NCT03861923 455 463 O
: NCT03861923 464 465 O

- NCT03861923 469 470 O
Signs NCT03861923 472 477 B-Assertion___Assertion_Type_Value:possible
or NCT03861923 478 480 I-Assertion___Assertion_Type_Value:possible
symptoms NCT03861923 481 489 I-Assertion___Assertion_Type_Value:possible
of NCT03861923 490 492 O
cervical NCT03861923 493 501 B-Condition
radiculopathy NCT03861923 502 515 I-Condition
, NCT03861923 516 517 O
radiculitis NCT03861923 518 529 B-Condition
, NCT03861923 530 531 O
or NCT03861923 532 534 B-Or
referral NCT03861923 535 543 B-Condition
from NCT03861923 544 548 O
the NCT03861923 549 552 O
cervical NCT03861923 553 561 B-Modifier
spine NCT03861923 562 567 I-Modifier

- NCT03861923 570 571 O
Clinical NCT03861923 573 581 O
evidence NCT03861923 582 590 O
as NCT03861923 591 593 O
determined NCT03861923 594 604 O
in NCT03861923 605 607 O
the NCT03861923 608 611 O
examination NCT03861923 612 623 B-Procedure
of NCT03861923 624 626 O
an NCT03861923 627 629 O
alternative NCT03861923 630 641 B-Other
shoulder NCT03861923 642 650 B-Modifier
diagnosis NCT03861923 651 660 B-Condition

- NCT03861923 663 664 O
Normal NCT03861923 666 672 O
passive NCT03861923 673 680 B-Modifier
shoulder NCT03861923 681 689 I-Modifier
range NCT03861923 690 695 B-Observation
of NCT03861923 696 698 I-Observation
motion NCT03861923 699 705 I-Observation

- NCT03861923 708 709 O
Known NCT03861923 711 716 O
radiographic NCT03861923 717 729 B-Procedure
evidence NCT03861923 730 738 O
of NCT03861923 739 741 O
glenohumeral NCT03861923 742 754 B-Modifier
osteoarthritis NCT03861923 755 769 B-Condition

- NCT03861923 772 773 O
Known NCT03861923 775 780 O
neurologic NCT03861923 781 791 B-Condition
disease NCT03861923 792 799 I-Condition

- NCT03861923 802 803 O
Received NCT03861923 805 813 O
dry NCT03861923 814 817 B-Procedure
needling NCT03861923 818 826 I-Procedure
or NCT03861923 827 829 B-Or
acupuncture NCT03861923 830 841 B-Procedure
within NCT03861923 842 848 B-Eq_Comparison
the NCT03861923 849 852 I-Eq_Comparison
past NCT03861923 853 857 I-Eq_Comparison
6 NCT03861923 858 859 I-Eq_Comparison
months NCT03861923 860 866 I-Eq_Comparison

- NCT03861923 869 870 O
Fear NCT03861923 872 876 B-Condition
of NCT03861923 877 879 I-Condition
needling NCT03861923 880 888 I-Condition

- NCT03861923 891 892 O
Currently NCT03861923 894 903 B-Eq_Comparison
being NCT03861923 904 909 O
treated NCT03861923 910 917 B-Procedure
with NCT03861923 918 922 O
anticoagulant NCT03861923 923 936 B-Drug
medication NCT03861923 937 947 I-Drug

- NCT03861923 950 951 O
Shoulder NCT03861923 953 961 B-Observation
pain NCT03861923 962 966 I-Observation
and NCT03861923 967 970 I-Observation
disability NCT03861923 971 981 I-Observation
index NCT03861923 982 987 I-Observation
( NCT03861923 988 989 O
SPADI NCT03861923 990 995 B-Observation
) NCT03861923 996 997 O
score NCT03861923 998 1003 O
less NCT03861923 1004 1008 B-Eq_Comparison
than NCT03861923 1009 1013 I-Eq_Comparison
10 NCT03861923 1014 1016 I-Eq_Comparison
% NCT03861923 1017 1018 I-Eq_Comparison
or NCT03861923 1019 1021 B-Or
greater NCT03861923 1022 1029 B-Eq_Comparison
than NCT03861923 1030 1034 I-Eq_Comparison
90 NCT03861923 1035 1037 I-Eq_Comparison
% NCT03861923 1038 1039 I-Eq_Comparison

For NCT03869255 0 3 O
community NCT03869255 4 13 O
patients NCT03869255 14 22 O
: NCT03869255 23 24 O

Inclusion NCT03869255 26 35 O
Criteria NCT03869255 36 44 O
: NCT03869255 45 46 O

- NCT03869255 50 51 O
the NCT03869255 53 56 O
selection NCT03869255 57 66 B-Assertion___Assertion_Type_Value:hypothetical
criteria NCT03869255 67 75 I-Assertion___Assertion_Type_Value:hypothetical
for NCT03869255 76 79 O
blood NCT03869255 80 85 B-Observation
donation NCT03869255 86 94 I-Observation

- NCT03869255 97 98 O
age NCT03869255 100 103 B-Age
≥ NCT03869255 104 105 B-Eq_Comparison
18 NCT03869255 106 108 I-Eq_Comparison
years NCT03869255 109 114 I-Eq_Comparison
old NCT03869255 115 118 O

- NCT03869255 121 122 O
No NCT03869255 124 126 O
refusal NCT03869255 127 134 O
of NCT03869255 135 137 O
the NCT03869255 138 141 O
person NCT03869255 142 148 O

Exclusion NCT03869255 149 158 O
Criteria NCT03869255 159 167 O
: NCT03869255 168 169 O

- NCT03869255 173 174 O
None NCT03869255 176 180 O

For NCT03869255 181 184 O
hospitalized NCT03869255 185 197 B-Encounter
patients NCT03869255 198 206 O
: NCT03869255 207 208 O

Inclusion NCT03869255 210 219 O
Criteria NCT03869255 220 228 O
: NCT03869255 229 230 O

- NCT03869255 234 235 O
age NCT03869255 237 240 B-Age
≥ NCT03869255 241 242 B-Eq_Comparison
18 NCT03869255 243 245 I-Eq_Comparison
years NCT03869255 246 251 I-Eq_Comparison
old NCT03869255 252 255 O

- NCT03869255 258 259 O
hospitalization NCT03869255 261 276 B-Encounter
in NCT03869255 277 279 O
one NCT03869255 280 283 O
of NCT03869255 284 286 O
the NCT03869255 287 290 O
services NCT03869255 291 299 O
participating NCT03869255 300 313 O
in NCT03869255 314 316 O
the NCT03869255 317 320 O
study NCT03869255 321 326 B-Study

- NCT03869255 329 330 O
no NCT03869255 332 334 O
refusal NCT03869255 335 342 O
of NCT03869255 343 345 O
the NCT03869255 346 349 O
person NCT03869255 350 356 O

Exclusion NCT03869255 357 366 O
Criteria NCT03869255 367 375 O
: NCT03869255 376 377 O

- NCT03869255 381 382 O
None NCT03869255 384 388 O

Inclusion NCT03869814 0 9 O
Criteria NCT03869814 10 18 O
: NCT03869814 19 20 O

1 NCT03869814 24 25 O
. NCT03869814 25 26 O
Age NCT03869814 28 31 B-Age
greater NCT03869814 32 39 B-Eq_Comparison
than NCT03869814 40 44 I-Eq_Comparison
or NCT03869814 45 47 I-Eq_Comparison
equal NCT03869814 48 53 I-Eq_Comparison
to NCT03869814 54 56 I-Eq_Comparison
21 NCT03869814 57 59 I-Eq_Comparison
years NCT03869814 60 65 I-Eq_Comparison
old NCT03869814 66 69 O

2 NCT03869814 72 73 O
. NCT03869814 73 74 O
Clinical NCT03869814 76 84 O
suspicion NCT03869814 85 94 B-Assertion___Assertion_Type_Value:possible
of NCT03869814 95 97 O
malignancy NCT03869814 98 108 B-Condition
based NCT03869814 109 114 O
on NCT03869814 115 117 O
signs NCT03869814 118 123 B-Assertion___Assertion_Type_Value:possible
, NCT03869814 124 125 O
symptoms NCT03869814 126 134 B-Assertion___Assertion_Type_Value:possible
, NCT03869814 135 136 O
imaging NCT03869814 137 144 B-Procedure
studies NCT03869814 145 152 I-Procedure
, NCT03869814 153 154 O
and NCT03869814 155 158 B-Or
/ NCT03869814 159 160 I-Or
or NCT03869814 161 163 I-Or
non NCT03869814 164 167 B-Negation
- NCT03869814 168 169 O
surgical NCT03869814 170 178 B-Modifier
biopsies NCT03869814 179 187 B-Procedure
of NCT03869814 188 190 O
any NCT03869814 191 194 O
of NCT03869814 195 197 O
the NCT03869814 198 201 O
following NCT03869814 202 211 O
cancer NCT03869814 212 218 B-Condition
types NCT03869814 219 224 O
: NCT03869814 225 226 O
bladder NCT03869814 227 234 B-Modifier
, NCT03869814 235 236 O
breast NCT03869814 237 243 B-Modifier
, NCT03869814 244 245 O
colorectal NCT03869814 246 256 B-Modifier
, NCT03869814 257 258 O
kidney NCT03869814 259 265 B-Modifier
, NCT03869814 266 267 O
liver NCT03869814 268 273 B-Modifier
, NCT03869814 274 275 O
lung NCT03869814 276 280 B-Modifier
, NCT03869814 281 282 O
pancreas NCT03869814 283 291 B-Modifier
or NCT03869814 292 294 B-Or
prostate NCT03869814 295 303 B-Modifier
. NCT03869814 304 305 O

3 NCT03869814 309 310 O
. NCT03869814 310 311 O
Candidate NCT03869814 313 322 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869814 323 326 I-Assertion___Assertion_Type_Value:hypothetical
subsequent NCT03869814 327 337 O
medical NCT03869814 338 345 B-Modifier
and NCT03869814 346 349 B-Or
/ NCT03869814 350 351 I-Or
or NCT03869814 352 354 I-Or
surgical NCT03869814 355 363 B-Modifier
work NCT03869814 364 368 B-Procedure
- NCT03869814 369 370 I-Procedure
up NCT03869814 371 373 I-Procedure
to NCT03869814 374 376 O
complete NCT03869814 377 385 O
organ NCT03869814 386 391 B-Modifier
- NCT03869814 392 393 I-Modifier
specific NCT03869814 394 402 I-Modifier
cancer NCT03869814 403 409 B-Condition
diagnosis NCT03869814 410 419 O
inclusive NCT03869814 420 429 O
of NCT03869814 430 432 O
pathologic NCT03869814 433 443 B-Procedure
staging NCT03869814 444 451 I-Procedure
as NCT03869814 452 454 O
specified NCT03869814 455 464 O
by NCT03869814 465 467 O
the NCT03869814 468 471 O
College NCT03869814 472 479 O
of NCT03869814 480 482 O
American NCT03869814 483 491 O
Pathology NCT03869814 492 501 O
( NCT03869814 502 503 O
CAP NCT03869814 504 507 O
) NCT03869814 508 509 O
. NCT03869814 510 511 O

4 NCT03869814 515 516 O
. NCT03869814 516 517 O
Provision NCT03869814 519 528 O
of NCT03869814 529 531 O
informed NCT03869814 532 540 O
consent NCT03869814 541 548 O
. NCT03869814 549 550 O

Exclusion NCT03869814 552 561 O
Criteria NCT03869814 562 570 O
: NCT03869814 571 572 O

1 NCT03869814 576 577 O
. NCT03869814 577 578 O
Age NCT03869814 580 583 B-Age
less NCT03869814 584 588 B-Eq_Comparison
than NCT03869814 589 593 I-Eq_Comparison
21 NCT03869814 594 596 I-Eq_Comparison
years NCT03869814 597 602 I-Eq_Comparison
old NCT03869814 603 606 O

2 NCT03869814 609 610 O
. NCT03869814 610 611 O
Any NCT03869814 613 616 O
prior NCT03869814 617 622 B-Eq_Comparison
cancer NCT03869814 623 629 B-Condition
diagnosis NCT03869814 630 639 O
, NCT03869814 640 641 O
without NCT03869814 642 649 B-Negation
or NCT03869814 650 652 B-Or
with NCT03869814 653 657 B-And
any NCT03869814 658 661 O
treatment NCT03869814 662 671 B-Procedure
( NCT03869814 672 673 O
e NCT03869814 674 675 O
. NCT03869814 676 677 O
g NCT03869814 678 679 O
. NCT03869814 680 681 O
, NCT03869814 682 683 O
medical NCT03869814 684 691 B-Modifier
, NCT03869814 692 693 O
surgical NCT03869814 694 702 B-Modifier
, NCT03869814 703 704 O
or NCT03869814 705 707 B-Or
radiation NCT03869814 708 717 B-Modifier
oncology NCT03869814 718 726 I-Modifier
) NCT03869814 727 728 O
within NCT03869814 729 735 B-Eq_Comparison
prior NCT03869814 736 741 I-Eq_Comparison
six NCT03869814 742 745 I-Eq_Comparison
months NCT03869814 746 752 I-Eq_Comparison
. NCT03869814 753 754 O

3 NCT03869814 758 759 O
. NCT03869814 759 760 O
Any NCT03869814 762 765 O
surgery NCT03869814 766 773 B-Procedure
, NCT03869814 774 775 O
i NCT03869814 776 777 O
. NCT03869814 778 779 O
e NCT03869814 780 781 O
. NCT03869814 782 783 O
, NCT03869814 784 785 O
invasive NCT03869814 786 794 B-Procedure
procedure NCT03869814 795 804 I-Procedure
performed NCT03869814 805 814 O
in NCT03869814 815 817 O
the NCT03869814 818 821 O
operating NCT03869814 822 831 O
room NCT03869814 832 836 O
with NCT03869814 837 841 O
any NCT03869814 842 845 O
level NCT03869814 846 851 O
of NCT03869814 852 854 O
anesthesia NCT03869814 855 865 B-Procedure
, NCT03869814 866 867 O
within NCT03869814 868 874 B-Eq_Comparison
prior NCT03869814 875 880 I-Eq_Comparison
month NCT03869814 881 886 I-Eq_Comparison
. NCT03869814 887 888 O

4 NCT03869814 892 893 O
. NCT03869814 893 894 O
Any NCT03869814 896 899 O
non NCT03869814 900 903 B-Negation
- NCT03869814 904 905 O
cancer NCT03869814 906 912 B-Condition
systemic NCT03869814 913 921 B-Procedure
therapy NCT03869814 922 929 I-Procedure
associated NCT03869814 930 940 O
with NCT03869814 941 945 O
molecularly NCT03869814 946 957 B-Modifier
targeted NCT03869814 958 966 I-Modifier
immune NCT03869814 967 973 B-Procedure
modulation NCT03869814 974 984 I-Procedure
, NCT03869814 985 986 O
e NCT03869814 987 988 O
. NCT03869814 989 990 O
g NCT03869814 991 992 O
. NCT03869814 993 994 O
, NCT03869814 995 996 O
monoclonal NCT03869814 997 1007 B-Procedure
antibodies NCT03869814 1008 1018 I-Procedure
. NCT03869814 1019 1020 O

5 NCT03869814 1024 1025 O
. NCT03869814 1025 1026 O
Any NCT03869814 1028 1031 O
concurrent NCT03869814 1032 1042 B-Modifier
or NCT03869814 1043 1045 B-Or
prior NCT03869814 1046 1051 B-Eq_Comparison
pregnancy NCT03869814 1052 1061 B-Condition
within NCT03869814 1062 1068 B-Eq_Comparison
previous NCT03869814 1069 1077 I-Eq_Comparison
twelve NCT03869814 1078 1084 I-Eq_Comparison
months NCT03869814 1085 1091 I-Eq_Comparison
. NCT03869814 1092 1093 O

6 NCT03869814 1097 1098 O
. NCT03869814 1098 1099 O
Any NCT03869814 1101 1104 O
history NCT03869814 1105 1112 B-Eq_Comparison
of NCT03869814 1113 1115 O
organ NCT03869814 1116 1121 B-Procedure
tissue NCT03869814 1122 1128 I-Procedure
transplantation NCT03869814 1129 1144 I-Procedure

7 NCT03869814 1147 1148 O
. NCT03869814 1148 1149 O
Any NCT03869814 1151 1154 O
history NCT03869814 1155 1162 B-Eq_Comparison
of NCT03869814 1163 1165 O
blood NCT03869814 1166 1171 B-Procedure
product NCT03869814 1172 1179 I-Procedure
transfusion NCT03869814 1180 1191 I-Procedure
within NCT03869814 1192 1198 B-Eq_Comparison
prior NCT03869814 1199 1204 I-Eq_Comparison
month NCT03869814 1205 1210 I-Eq_Comparison
. NCT03869814 1211 1212 O

8 NCT03869814 1216 1217 O
. NCT03869814 1217 1218 O
Any NCT03869814 1220 1223 O
major NCT03869814 1224 1229 O
trauma NCT03869814 1230 1236 B-Condition
within NCT03869814 1237 1243 B-Eq_Comparison
prior NCT03869814 1244 1249 I-Eq_Comparison
six NCT03869814 1250 1253 I-Eq_Comparison
months NCT03869814 1254 1260 I-Eq_Comparison
, NCT03869814 1261 1262 O
e NCT03869814 1263 1264 O
. NCT03869814 1265 1266 O
g NCT03869814 1267 1268 O
. NCT03869814 1269 1270 O
, NCT03869814 1271 1272 O
burn NCT03869814 1273 1277 B-Condition
injury NCT03869814 1278 1284 I-Condition
, NCT03869814 1285 1286 O
extremity NCT03869814 1287 1296 B-Condition
crush NCT03869814 1297 1302 I-Condition
injury NCT03869814 1303 1309 I-Condition
, NCT03869814 1310 1311 O
motor NCT03869814 1312 1317 B-Condition
vehicle NCT03869814 1318 1325 I-Condition
accident NCT03869814 1326 1334 I-Condition
, NCT03869814 1335 1336 O
etc NCT03869814 1337 1340 O
. NCT03869814 1341 1342 O

9 NCT03869814 1346 1347 O
. NCT03869814 1347 1348 O
Unable NCT03869814 1350 1356 O
to NCT03869814 1357 1359 O
provide NCT03869814 1360 1367 O
informed NCT03869814 1368 1376 O
consent NCT03869814 1377 1384 O
. NCT03869814 1385 1386 O

Inclusion NCT03866031 0 9 O
Criteria NCT03866031 10 18 O
: NCT03866031 19 20 O

1 NCT03866031 24 25 O
. NCT03866031 25 26 O
the NCT03866031 28 31 O
patient NCT03866031 32 39 O
should NCT03866031 40 46 O
be NCT03866031 47 49 O
completely NCT03866031 50 60 O
edentulous NCT03866031 61 71 B-Condition
for NCT03866031 72 75 O
at NCT03866031 76 78 B-Eq_Comparison
least NCT03866031 79 84 I-Eq_Comparison
6 NCT03866031 85 86 I-Eq_Comparison
months NCT03866031 87 93 I-Eq_Comparison
. NCT03866031 94 95 O

2 NCT03866031 99 100 O
. NCT03866031 100 101 O
first NCT03866031 103 108 O
class NCT03866031 109 114 O
jaw NCT03866031 115 118 O
relation NCT03866031 119 127 O
. NCT03866031 128 129 O

3 NCT03866031 133 134 O
. NCT03866031 134 135 O
adequate NCT03866031 137 145 O
bone NCT03866031 146 150 B-Condition
for NCT03866031 151 154 O
an NCT03866031 155 157 O
implant NCT03866031 158 165 B-Observation
length NCT03866031 166 172 I-Observation
of NCT03866031 173 175 O
at NCT03866031 176 178 B-Eq_Comparison
least NCT03866031 179 184 I-Eq_Comparison
10 NCT03866031 185 187 I-Eq_Comparison
mm NCT03866031 188 190 I-Eq_Comparison
and NCT03866031 191 194 B-And
diameter NCT03866031 195 203 B-Modifier
of NCT03866031 204 206 O
at NCT03866031 207 209 B-Eq_Comparison
least NCT03866031 210 215 I-Eq_Comparison
2.75 NCT03866031 216 220 I-Eq_Comparison
mm NCT03866031 221 223 I-Eq_Comparison
. NCT03866031 224 225 O

4 NCT03866031 229 230 O
. NCT03866031 230 231 O
the NCT03866031 233 236 O
patients NCT03866031 237 245 O
should NCT03866031 246 252 O
be NCT03866031 253 255 O
able NCT03866031 256 260 O
to NCT03866031 261 263 O
speak NCT03866031 264 269 O
and NCT03866031 270 273 O
write NCT03866031 274 279 O
in NCT03866031 280 282 O
arabic NCT03866031 283 289 O
. NCT03866031 290 291 O

Exclusion NCT03866031 293 302 O
Criteria NCT03866031 303 311 O
: NCT03866031 312 313 O

1 NCT03866031 316 317 O
) NCT03866031 318 319 O
patients NCT03866031 320 328 O
who NCT03866031 329 332 O
received NCT03866031 333 341 B-Eq_Comparison
radiotherapy NCT03866031 342 354 B-Procedure
to NCT03866031 355 357 O
the NCT03866031 358 361 O
head NCT03866031 362 366 B-Modifier
or NCT03866031 367 369 B-Or
neck NCT03866031 370 374 B-Modifier
region NCT03866031 375 381 O
for NCT03866031 382 385 O
tumors NCT03866031 386 392 B-Condition
. NCT03866031 393 394 O
( NCT03866031 396 397 O
2 NCT03866031 398 399 O
) NCT03866031 400 401 O
a NCT03866031 402 403 O
history NCT03866031 404 411 B-Eq_Comparison
of NCT03866031 412 414 O
chemotherapy NCT03866031 415 427 B-Procedure
. NCT03866031 428 429 O
( NCT03866031 431 432 O
3 NCT03866031 433 434 O
) NCT03866031 435 436 O
patients NCT03866031 437 445 O
on NCT03866031 446 448 B-Eq_Comparison
long NCT03866031 449 453 O
- NCT03866031 454 455 O
term NCT03866031 456 460 O
steroids NCT03866031 461 469 B-Drug
, NCT03866031 470 471 O
or NCT03866031 472 474 B-Or
bisphosphonates NCT03866031 475 490 B-Drug
. NCT03866031 491 492 O
( NCT03866031 494 495 O
4 NCT03866031 496 497 O
) NCT03866031 498 499 O
heavy NCT03866031 500 505 O
smokers NCT03866031 506 513 B-Condition
. NCT03866031 514 515 O

( NCT03866031 518 519 O
5 NCT03866031 520 521 O
) NCT03866031 522 523 O
patients NCT03866031 524 532 O
with NCT03866031 533 537 O
physical NCT03866031 538 546 B-Modifier
and NCT03866031 547 550 B-Or
mental NCT03866031 551 557 B-Modifier
dis NCT03866031 558 561 B-Condition
- NCT03866031 562 563 I-Condition
abilities NCT03866031 564 573 I-Condition
that NCT03866031 574 578 O
interfere NCT03866031 579 588 O
with NCT03866031 589 593 O
the NCT03866031 594 597 O
maintenance NCT03866031 598 609 O
of NCT03866031 610 612 O
implants NCT03866031 613 621 B-Procedure
. NCT03866031 622 623 O

( NCT03866031 626 627 O
6 NCT03866031 628 629 O
) NCT03866031 630 631 O
uncontrolled NCT03866031 632 644 B-Modifier
systematic NCT03866031 645 655 I-Modifier
disease NCT03866031 656 663 B-Condition
that NCT03866031 664 668 O
could NCT03866031 669 674 B-Assertion___Assertion_Type_Value:hypothetical
compromise NCT03866031 675 685 O
implant NCT03866031 686 693 B-Procedure
surgery NCT03866031 694 701 I-Procedure
. NCT03866031 702 703 O
( NCT03866031 705 706 O
7 NCT03866031 707 708 O
) NCT03866031 709 710 O
extreme NCT03866031 711 718 O
bruxism NCT03866031 719 726 B-Condition
. NCT03866031 727 728 O
( NCT03866031 730 731 O
8 NCT03866031 732 733 O
) NCT03866031 734 735 O
infectious NCT03866031 736 746 B-Condition
disease NCT03866031 747 754 I-Condition
. NCT03866031 755 756 O
( NCT03866031 758 759 O
9 NCT03866031 760 761 O
) NCT03866031 762 763 O
temporomandibular NCT03866031 764 781 B-Condition
joint NCT03866031 782 787 I-Condition
dysfunction NCT03866031 788 799 I-Condition
. NCT03866031 800 801 O


Inclusion NCT03867279 0 9 O
Criteria NCT03867279 10 18 O
: NCT03867279 19 20 O

- NCT03867279 24 25 O
From NCT03867279 27 31 O
18 NCT03867279 32 34 B-Eq_Comparison
to NCT03867279 35 37 I-Eq_Comparison
24 NCT03867279 38 40 I-Eq_Comparison
years NCT03867279 41 46 I-Eq_Comparison
old NCT03867279 47 50 B-Age

- NCT03867279 53 54 O
Male NCT03867279 56 60 O

- NCT03867279 63 64 O
That NCT03867279 66 70 O
they NCT03867279 71 75 O
be NCT03867279 76 78 O
weight NCT03867279 79 85 B-Observation
lifters NCT03867279 86 93 I-Observation
with NCT03867279 94 98 O
at NCT03867279 99 101 B-Eq_Comparison
least NCT03867279 102 107 I-Eq_Comparison
one NCT03867279 108 111 I-Eq_Comparison
year NCT03867279 112 116 I-Eq_Comparison
of NCT03867279 117 119 O
experience NCT03867279 120 130 O

- NCT03867279 133 134 O
That NCT03867279 136 140 O
they NCT03867279 141 145 O
do NCT03867279 146 148 O
not NCT03867279 149 152 B-Negation
present NCT03867279 153 160 O
musculoskeletal NCT03867279 161 176 B-Modifier
injury NCT03867279 177 183 B-Condition
or NCT03867279 184 186 B-Or
pathology NCT03867279 187 196 B-Condition
in NCT03867279 197 199 O
the NCT03867279 200 203 O
three NCT03867279 204 209 B-Eq_Comparison
months NCT03867279 210 216 I-Eq_Comparison
prior NCT03867279 217 222 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867279 223 225 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03867279 226 229 O
beginning NCT03867279 230 239 O
of NCT03867279 240 242 O
the NCT03867279 243 246 O
study NCT03867279 247 252 B-Study

Exclusion NCT03867279 253 262 O
Criteria NCT03867279 263 271 O
: NCT03867279 272 273 O

- NCT03867279 277 278 O
Can NCT03867279 280 283 O
not NCT03867279 284 287 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
be NCT03867279 288 290 B-Encounter
present NCT03867279 291 298 I-Encounter
during NCT03867279 299 305 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867279 306 309 O
6 NCT03867279 310 311 B-Eq_Comparison
weeks NCT03867279 312 317 I-Eq_Comparison
of NCT03867279 318 320 O
the NCT03867279 321 324 O
intervention NCT03867279 325 337 B-Study
and NCT03867279 338 341 B-And
the NCT03867279 342 345 O
evaluations NCT03867279 346 357 B-Study
will NCT03867279 358 362 O
be NCT03867279 363 365 O
excluded NCT03867279 366 374 B-Negation

- NCT03867279 377 378 O
Under NCT03867279 380 385 B-Eq_Comparison
pharmacological NCT03867279 386 401 B-Procedure
treatment NCT03867279 402 411 I-Procedure

- NCT03867279 414 415 O
Who NCT03867279 417 420 O
are NCT03867279 421 424 O
performing NCT03867279 425 435 O
another NCT03867279 436 443 B-Other
physiotherapy NCT03867279 444 457 B-Procedure
study NCT03867279 458 463 B-Study

- NCT03867279 466 467 O
Not NCT03867279 469 472 O
sign NCT03867279 473 477 O
the NCT03867279 478 481 O
informed NCT03867279 482 490 O
consent NCT03867279 491 498 O
document NCT03867279 499 507 O
. NCT03867279 508 509 O

Inclusion NCT03927300 0 9 O
Criteria NCT03927300 10 18 O
: NCT03927300 19 20 O

- NCT03927300 24 25 O
Adult NCT03927300 27 32 O
patients NCT03927300 33 41 O
( NCT03927300 42 43 O
≥ NCT03927300 44 45 B-Eq_Comparison
18 NCT03927300 46 48 I-Eq_Comparison
years NCT03927300 49 54 I-Eq_Comparison
) NCT03927300 55 56 O
with NCT03927300 57 61 O
no NCT03927300 62 64 O
age NCT03927300 65 68 O
limit NCT03927300 69 74 O
; NCT03927300 74 75 O

- NCT03927300 78 79 O
Patients NCT03927300 81 89 O
receiving NCT03927300 90 99 B-Eq_Comparison
peritoneal NCT03927300 100 110 B-Procedure
dialysis NCT03927300 111 119 I-Procedure
on NCT03927300 120 122 O
the NCT03927300 123 126 O
investigation NCT03927300 127 140 O
center NCT03927300 141 147 O
between NCT03927300 148 155 B-Eq_Comparison
2012 NCT03927300 156 160 I-Eq_Comparison
and NCT03927300 161 164 I-Eq_Comparison
2014 NCT03927300 165 169 I-Eq_Comparison
( NCT03927300 170 171 O
Group NCT03927300 172 177 O
1 NCT03927300 178 179 O
) NCT03927300 180 181 O
and NCT03927300 182 185 B-And
between NCT03927300 186 193 B-Eq_Comparison
2016 NCT03927300 194 198 I-Eq_Comparison
and NCT03927300 199 202 I-Eq_Comparison
2018 NCT03927300 203 207 I-Eq_Comparison
( NCT03927300 208 209 O
Group NCT03927300 210 215 O
2 NCT03927300 216 217 O
) NCT03927300 218 219 O
; NCT03927300 220 221 O

- NCT03927300 224 225 O
Patient NCT03927300 227 234 O
information NCT03927300 235 246 O
in NCT03927300 247 249 O
this NCT03927300 250 254 O
retrospective NCT03927300 255 268 O
study NCT03927300 269 274 B-Study
; NCT03927300 274 275 O

Exclusion NCT03927300 276 285 O
Criteria NCT03927300 286 294 O
: NCT03927300 295 296 O

- NCT03927300 300 301 O
Patients NCT03927300 303 311 O
who NCT03927300 312 315 O
have NCT03927300 316 320 O
started NCT03927300 321 328 B-Eq_Comparison
a NCT03927300 329 330 O
peritoneal NCT03927300 331 341 B-Procedure
dialysis NCT03927300 342 350 I-Procedure
program NCT03927300 351 358 O
before NCT03927300 359 365 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03927300 366 369 O
periods NCT03927300 370 377 O
of NCT03927300 378 380 O
investigation NCT03927300 381 394 B-Study
; NCT03927300 394 395 O

- NCT03927300 398 399 O
Patients NCT03927300 401 409 O
who NCT03927300 410 413 O
have NCT03927300 414 418 O
been NCT03927300 419 423 O
equipped NCT03927300 424 432 O
with NCT03927300 433 437 O
apTeleCare NCT03927300 438 448 B-Procedure
during NCT03927300 449 455 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03927300 456 459 O
dialysis NCT03927300 460 468 B-Procedure
program NCT03927300 469 476 O
; NCT03927300 476 477 O

- NCT03927300 480 481 O
Subject NCT03927300 483 490 O
under NCT03927300 491 496 B-Observation
guardianship NCT03927300 497 509 I-Observation
, NCT03927300 510 511 O
curators NCT03927300 512 520 O
or NCT03927300 521 523 O
safeguard NCT03927300 524 533 O
of NCT03927300 534 536 O
justice NCT03927300 537 544 O
; NCT03927300 544 545 O

- NCT03927300 548 549 O
Patient NCT03927300 551 558 O
not NCT03927300 559 562 O
affiliated NCT03927300 563 573 O
to NCT03927300 574 576 O
a NCT03927300 577 578 O
French NCT03927300 579 585 O
social NCT03927300 586 592 O
protection NCT03927300 593 603 O
; NCT03927300 603 604 O


Inclusion NCT03863678 0 9 O
Criteria NCT03863678 10 18 O
: NCT03863678 19 20 O

- NCT03863678 24 25 O
First NCT03863678 27 32 B-Eq_Comparison
time NCT03863678 33 37 I-Eq_Comparison
stroke NCT03863678 38 44 B-Condition
, NCT03863678 45 46 O

- NCT03863678 50 51 O
Patients NCT03863678 53 61 O
who NCT03863678 62 65 O
has NCT03863678 66 69 O
spasticity NCT03863678 70 80 B-Condition
due NCT03863678 81 84 O
to NCT03863678 85 87 O
stroke NCT03863678 88 94 B-Condition
, NCT03863678 95 96 O

- NCT03863678 100 101 O
At NCT03863678 103 105 B-Eq_Comparison
least NCT03863678 106 111 I-Eq_Comparison
6 NCT03863678 112 113 I-Eq_Comparison
months NCT03863678 114 120 I-Eq_Comparison
after NCT03863678 121 126 B-Temporal_Connection___Temporal_Connection_Type_Value:after
stroke NCT03863678 127 133 B-Condition
, NCT03863678 134 135 O

- NCT03863678 139 140 O
Individuals NCT03863678 142 153 O
between NCT03863678 154 161 B-Eq_Comparison
the NCT03863678 162 165 I-Eq_Comparison
ages NCT03863678 166 170 I-Eq_Comparison
of NCT03863678 171 173 I-Eq_Comparison
18 NCT03863678 174 176 I-Eq_Comparison
- NCT03863678 177 178 I-Eq_Comparison
75 NCT03863678 179 181 I-Eq_Comparison
will NCT03863678 182 186 O
be NCT03863678 187 189 O
included NCT03863678 190 198 O
in NCT03863678 199 201 O
the NCT03863678 202 205 O
study NCT03863678 206 211 B-Study
. NCT03863678 212 213 O

Exclusion NCT03863678 215 224 O
Criteria NCT03863678 225 233 O
: NCT03863678 234 235 O

- NCT03863678 239 240 O
Any NCT03863678 242 245 O
contraindication NCT03863678 246 262 B-Contraindication
for NCT03863678 263 266 O
dry NCT03863678 267 270 B-Procedure
needling NCT03863678 271 279 I-Procedure
( NCT03863678 280 281 O
eg NCT03863678 282 284 O
, NCT03863678 285 286 O
anticoagulants NCT03863678 287 301 B-Drug
, NCT03863678 302 303 O
infections NCT03863678 304 314 B-Condition
, NCT03863678 315 316 O
bleeding NCT03863678 317 325 B-Condition
, NCT03863678 326 327 O
etc NCT03863678 328 331 O
. NCT03863678 332 333 O
) NCT03863678 334 335 O
, NCT03863678 336 337 O

- NCT03863678 341 342 O
Having NCT03863678 344 350 B-Eq_Comparison
diabetes NCT03863678 351 359 B-Condition
, NCT03863678 360 361 O

- NCT03863678 365 366 O
Having NCT03863678 368 374 B-Eq_Comparison
cardiovascular NCT03863678 375 389 B-Condition
diseases NCT03863678 390 398 I-Condition
, NCT03863678 399 400 O

- NCT03863678 404 405 O
Having NCT03863678 407 413 B-Eq_Comparison
any NCT03863678 414 417 O
other NCT03863678 418 423 B-Other
neurological NCT03863678 424 436 B-Condition
problems NCT03863678 437 445 I-Condition
, NCT03863678 446 447 O

- NCT03863678 451 452 O
Application NCT03863678 454 465 O
of NCT03863678 466 468 O
Botox NCT03863678 469 474 B-Procedure
within NCT03863678 475 481 B-Eq_Comparison
6 NCT03863678 482 483 I-Eq_Comparison
months NCT03863678 484 490 I-Eq_Comparison
prior NCT03863678 491 496 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863678 497 499 O
the NCT03863678 500 503 O
study NCT03863678 504 509 B-Study
, NCT03863678 510 511 O

- NCT03863678 515 516 O
Individuals NCT03863678 518 529 O
included NCT03863678 530 538 O
in NCT03863678 539 541 O
another NCT03863678 542 549 B-Other
treatment NCT03863678 550 559 B-Procedure
program NCT03863678 560 567 I-Procedure
will NCT03863678 568 572 O
not NCT03863678 573 576 B-Negation
be NCT03863678 577 579 O
included NCT03863678 580 588 O
in NCT03863678 589 591 O
the NCT03863678 592 595 O
study NCT03863678 596 601 B-Study
. NCT03863678 602 603 O

Inclusion NCT03862326 0 9 O
Criteria NCT03862326 10 18 O
: NCT03862326 19 20 O

Diaper NCT03862326 22 28 O
grant NCT03862326 29 34 O

- NCT03862326 37 38 O
Urinary NCT03862326 40 47 B-Condition
incontinency NCT03862326 48 60 I-Condition

- NCT03862326 64 65 O
Living NCT03862326 67 73 O
in NCT03862326 74 76 O
own NCT03862326 77 80 O
home NCT03862326 81 85 O
in NCT03862326 86 88 O
Aalborg NCT03862326 89 96 O
Municipality NCT03862326 97 109 O

Exclusion NCT03862326 110 119 O
Criteria NCT03862326 120 128 O
: NCT03862326 129 130 O

- NCT03862326 134 135 O
Dementia NCT03862326 137 145 O

- NCT03862326 149 150 O
Inability NCT03862326 152 161 O
to NCT03862326 162 164 O
transport NCT03862326 165 174 O
herself NCT03862326 175 182 O
to NCT03862326 183 185 O
the NCT03862326 186 189 O
training NCT03862326 190 198 O
facility NCT03862326 199 207 O

- NCT03862326 211 212 O
neurological NCT03862326 214 226 B-Condition
diseases NCT03862326 227 235 I-Condition

- NCT03862326 239 240 O
inability NCT03862326 242 251 B-Negation
to NCT03862326 252 254 O
understand NCT03862326 255 265 O
Danish NCT03862326 266 272 O
or NCT03862326 273 275 O
bring NCT03862326 276 281 O
a NCT03862326 282 283 O
translator NCT03862326 284 294 O


Inclusion NCT03928613 0 9 O
Criteria NCT03928613 10 18 O
: NCT03928613 19 20 O

- NCT03928613 24 25 O
Aged NCT03928613 27 31 B-Age
above NCT03928613 32 37 B-Eq_Comparison
60 NCT03928613 38 40 I-Eq_Comparison

- NCT03928613 44 45 O
Confirmed NCT03928613 47 56 O
literacy NCT03928613 57 65 B-Condition
o NCT03928613 66 67 O
Diagnosed NCT03928613 68 77 O
with NCT03928613 78 82 O
mild NCT03928613 83 87 O
cognitive NCT03928613 88 97 B-Condition
impairment NCT03928613 98 108 I-Condition
by NCT03928613 109 111 O
International NCT03928613 112 125 O
Working NCT03928613 126 133 O
Group NCT03928613 134 139 O
on NCT03928613 140 142 O
Mild NCT03928613 143 147 O
Cognitive NCT03928613 148 157 O
Impairment NCT03928613 158 168 O
and NCT03928613 169 172 B-And
Clinical NCT03928613 173 181 B-Observation
Dementia NCT03928613 182 190 I-Observation
Rating NCT03928613 191 197 I-Observation
( NCT03928613 198 199 O
CDR NCT03928613 200 203 B-Observation
) NCT03928613 204 205 O
of NCT03928613 206 208 O
0 NCT03928613 209 210 B-Eq_Comparison
or NCT03928613 211 213 I-Eq_Comparison
0.5 NCT03928613 214 217 I-Eq_Comparison
. NCT03928613 217 218 O

Exclusion NCT03928613 220 229 O
Criteria NCT03928613 230 238 O
: NCT03928613 239 240 O

- NCT03928613 244 245 O
Evidence NCT03928613 247 255 O
of NCT03928613 256 258 O
delirium NCT03928613 259 267 B-Condition
, NCT03928613 268 269 O
confusion NCT03928613 270 279 B-Condition

- NCT03928613 282 283 O
Any NCT03928613 285 288 O
neurological NCT03928613 289 301 B-Condition
conditions NCT03928613 302 312 I-Condition
causing NCT03928613 313 320 O
cognitive NCT03928613 321 330 B-Condition
decline NCT03928613 331 338 I-Condition
such NCT03928613 339 343 O
as NCT03928613 344 346 O
Parkinson NCT03928613 347 356 B-Condition
's NCT03928613 356 358 I-Condition
disease NCT03928613 359 366 I-Condition
, NCT03928613 367 368 O
brain NCT03928613 369 374 B-Modifier
hemorrhage NCT03928613 375 385 B-Condition
, NCT03928613 386 387 O
brain NCT03928613 388 393 B-Modifier
tumor NCT03928613 394 399 B-Condition
, NCT03928613 400 401 O
normal NCT03928613 402 408 B-Condition
pressure NCT03928613 409 417 I-Condition
hydrocephalus NCT03928613 418 431 I-Condition

- NCT03928613 434 435 O
Evidence NCT03928613 437 445 O
of NCT03928613 446 448 O
severe NCT03928613 449 455 O
cerebrovascular NCT03928613 456 471 B-Condition
pathology NCT03928613 472 481 I-Condition

- NCT03928613 484 485 O
Presence NCT03928613 487 495 O
of NCT03928613 496 498 O
depressive NCT03928613 499 509 B-Condition
symptoms NCT03928613 510 518 B-Assertion___Assertion_Type_Value:possible
that NCT03928613 519 523 O
could NCT03928613 524 529 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03928613 530 539 O
cognitive NCT03928613 540 549 B-Condition
function NCT03928613 550 558 I-Condition

- NCT03928613 561 562 O
Presence NCT03928613 564 572 O
of NCT03928613 573 575 O
medical NCT03928613 576 583 B-Condition
comorbidities NCT03928613 584 597 I-Condition
that NCT03928613 598 602 O
could NCT03928613 603 608 B-Assertion___Assertion_Type_Value:hypothetical
result NCT03928613 609 615 O
in NCT03928613 616 618 O
any NCT03928613 619 622 O
difficulties NCT03928613 623 635 B-Negation
in NCT03928613 636 638 O
study NCT03928613 639 644 B-Study
participation NCT03928613 645 658 O

Inclusion NCT03934346 0 9 O
Criteria NCT03934346 10 18 O
: NCT03934346 19 20 O

- NCT03934346 24 25 O
Apparently NCT03934346 27 37 B-Assertion___Assertion_Type_Value:possible
healthy NCT03934346 38 45 B-Condition
men NCT03934346 46 49 O

- NCT03934346 52 53 O
Body NCT03934346 55 59 B-Observation
mass NCT03934346 60 64 I-Observation
index NCT03934346 65 70 I-Observation
between NCT03934346 71 78 B-Eq_Comparison
18 NCT03934346 79 81 I-Eq_Comparison
and NCT03934346 82 85 I-Eq_Comparison
30 NCT03934346 86 88 I-Eq_Comparison
kg NCT03934346 89 91 I-Eq_Comparison
/ NCT03934346 92 93 I-Eq_Comparison
m NCT03934346 94 95 I-Eq_Comparison
2 NCT03934346 96 97 I-Eq_Comparison

- NCT03934346 100 101 O
Willing NCT03934346 103 110 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03934346 111 113 I-Assertion___Assertion_Type_Value:hypothetical
eat NCT03934346 114 117 B-Observation
only NCT03934346 118 122 O
the NCT03934346 123 126 O
foods NCT03934346 127 132 O
provided NCT03934346 133 141 O
by NCT03934346 142 144 O
the NCT03934346 145 148 O
study NCT03934346 149 154 B-Study
for NCT03934346 155 158 O
a NCT03934346 159 160 O
2 NCT03934346 161 162 B-Eq_Comparison
week NCT03934346 163 167 I-Eq_Comparison
period NCT03934346 168 174 O

Exclusion NCT03934346 175 184 O
Criteria NCT03934346 185 193 O
: NCT03934346 194 195 O

- NCT03934346 199 200 O
Those NCT03934346 202 207 O
reporting NCT03934346 208 217 O
any NCT03934346 218 221 O
chronic NCT03934346 222 229 O
or NCT03934346 230 232 B-Or
acute NCT03934346 233 238 O
diseases NCT03934346 239 247 B-Condition
, NCT03934346 248 249 O
food NCT03934346 250 254 O
allergies NCT03934346 255 264 B-Allergy
, NCT03934346 265 266 O
smoking NCT03934346 267 274 B-Modifier
or NCT03934346 275 277 B-Or
alcohol NCT03934346 278 285 B-Modifier
abuse NCT03934346 286 291 B-Condition

- NCT03934346 294 295 O
Use NCT03934346 297 300 B-Eq_Comparison
of NCT03934346 301 303 O
illicit NCT03934346 304 311 B-Drug
drugs NCT03934346 312 317 I-Drug
; NCT03934346 317 318 O
regular NCT03934346 319 326 O
consumption NCT03934346 327 338 O
of NCT03934346 339 341 O
medications NCT03934346 342 353 B-Drug
, NCT03934346 354 355 O
micronutrient NCT03934346 356 369 B-Drug
supplements NCT03934346 370 381 I-Drug
, NCT03934346 382 383 O
or NCT03934346 384 386 B-Or
both NCT03934346 387 391 O

- NCT03934346 394 395 O
Vegetarians NCT03934346 397 408 B-Condition
, NCT03934346 409 410 O
or NCT03934346 411 413 B-Or
those NCT03934346 414 419 O
unable NCT03934346 420 426 B-Condition
to NCT03934346 427 429 I-Condition
eat NCT03934346 430 433 I-Condition
meat NCT03934346 434 438 I-Condition
, NCT03934346 439 440 O
are NCT03934346 441 444 O
also NCT03934346 445 449 O
excluded NCT03934346 450 458 O
since NCT03934346 459 464 O
the NCT03934346 465 468 O
foods NCT03934346 469 474 O
for NCT03934346 475 478 O
the NCT03934346 479 482 O
study NCT03934346 483 488 O
contain NCT03934346 489 496 O
meat NCT03934346 497 501 O

- NCT03934346 504 505 O
Unable NCT03934346 507 513 B-Negation
to NCT03934346 514 516 O
refrain NCT03934346 517 524 B-Negation
from NCT03934346 525 529 O
taking NCT03934346 530 536 B-Eq_Comparison
medications NCT03934346 537 548 B-Drug
during NCT03934346 549 555 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03934346 556 559 O
study NCT03934346 560 565 B-Study
period NCT03934346 566 572 O

Inclusion NCT03867942 0 9 O
Criteria NCT03867942 10 18 O
: NCT03867942 19 20 O

- NCT03867942 24 25 O
Age NCT03867942 27 30 B-Age
: NCT03867942 31 32 O
19 NCT03867942 33 35 B-Eq_Comparison
~ NCT03867942 36 37 I-Eq_Comparison
45 NCT03867942 38 40 I-Eq_Comparison

- NCT03867942 44 45 O
Body NCT03867942 47 51 B-Observation
weight NCT03867942 52 58 I-Observation
: NCT03867942 59 60 O
55 NCT03867942 61 63 B-Eq_Comparison
kg NCT03867942 64 66 I-Eq_Comparison
or NCT03867942 67 69 I-Eq_Comparison
higher NCT03867942 70 76 I-Eq_Comparison
( NCT03867942 77 78 O
female NCT03867942 79 85 O
: NCT03867942 86 87 O
50 NCT03867942 88 90 B-Eq_Comparison
kg NCT03867942 91 93 I-Eq_Comparison
or NCT03867942 94 96 I-Eq_Comparison
higher NCT03867942 97 103 I-Eq_Comparison
) NCT03867942 104 105 O
and NCT03867942 106 109 B-And
BMI NCT03867942 110 113 B-Observation
18 NCT03867942 114 116 B-Eq_Comparison
~ NCT03867942 117 118 I-Eq_Comparison
27 NCT03867942 119 121 I-Eq_Comparison
kg NCT03867942 122 124 I-Eq_Comparison
/ NCT03867942 125 126 I-Eq_Comparison
m NCT03867942 127 128 I-Eq_Comparison
2 NCT03867942 129 130 I-Eq_Comparison

- NCT03867942 133 134 O
SBP NCT03867942 136 139 B-Observation
90 NCT03867942 140 142 B-Eq_Comparison
~ NCT03867942 143 144 I-Eq_Comparison
150 NCT03867942 145 148 I-Eq_Comparison
mmHg NCT03867942 149 153 I-Eq_Comparison
, NCT03867942 154 155 O
DBP NCT03867942 156 159 B-Observation
60 NCT03867942 160 162 B-Eq_Comparison
- NCT03867942 163 164 I-Eq_Comparison
95 NCT03867942 165 167 I-Eq_Comparison
mmHg NCT03867942 168 172 I-Eq_Comparison

- NCT03867942 175 176 O
Fasting NCT03867942 178 185 B-Modifier
glucose NCT03867942 186 193 B-Observation
70 NCT03867942 194 196 B-Eq_Comparison
~ NCT03867942 197 198 I-Eq_Comparison
120 NCT03867942 199 202 I-Eq_Comparison
mg NCT03867942 203 205 I-Eq_Comparison
/ NCT03867942 206 207 I-Eq_Comparison
dL NCT03867942 208 210 I-Eq_Comparison

- NCT03867942 213 214 O
Infertility NCT03867942 216 227 B-Condition

1 NCT03867942 235 236 O
. NCT03867942 236 237 O
Surgically NCT03867942 239 249 B-Modifier
infertile NCT03867942 250 259 B-Condition

2 NCT03867942 267 268 O
. NCT03867942 268 269 O
To NCT03867942 271 273 O
prevent NCT03867942 274 281 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
pregnancy NCT03867942 282 291 B-Condition
, NCT03867942 292 293 O
participants NCT03867942 294 306 O
who NCT03867942 307 310 O
agreed NCT03867942 311 317 B-Assertion___Assertion_Type_Value:hypothetical
using NCT03867942 318 323 B-Eq_Comparison
2 NCT03867942 324 325 B-Eq_Comparison
or NCT03867942 326 328 I-Eq_Comparison
more NCT03867942 329 333 I-Eq_Comparison
contraceptive NCT03867942 334 347 B-Procedure
methods NCT03867942 348 355 I-Procedure
. NCT03867942 356 357 O
Such NCT03867942 359 363 O
as NCT03867942 364 366 O

- NCT03867942 369 370 O
Barrier NCT03867942 372 379 B-Procedure
methods NCT03867942 380 387 I-Procedure
: NCT03867942 388 389 O
Condom NCT03867942 390 396 B-Procedure
, NCT03867942 397 398 O
Diaphragm NCT03867942 399 408 B-Condition
, NCT03867942 409 410 O
Cervical NCT03867942 411 419 B-Procedure
cap NCT03867942 420 423 I-Procedure
( NCT03867942 424 425 O
Pessary NCT03867942 426 433 B-Procedure
) NCT03867942 434 435 O
, NCT03867942 436 437 O
Spermicide NCT03867942 438 448 B-Procedure

- NCT03867942 451 452 O
Hormonal NCT03867942 454 462 B-Procedure
methods NCT03867942 463 470 I-Procedure
: NCT03867942 471 472 O
Pills NCT03867942 473 478 B-Drug
, NCT03867942 479 480 O
Injection NCT03867942 481 490 B-Procedure
( NCT03867942 491 492 O
Depot NCT03867942 493 498 B-Modifier
) NCT03867942 499 500 O
, NCT03867942 501 502 O
Skin NCT03867942 503 507 B-Procedure
patch NCT03867942 508 513 I-Procedure
, NCT03867942 514 515 O
Hormonal NCT03867942 516 524 B-Procedure
implant NCT03867942 525 532 I-Procedure
( NCT03867942 533 534 O
Implanon NCT03867942 535 543 B-Modifier
) NCT03867942 544 545 O
, NCT03867942 546 547 O
Vaginal NCT03867942 548 555 B-Procedure
ring NCT03867942 556 560 I-Procedure

- NCT03867942 563 564 O
Intrauterine NCT03867942 566 578 B-Procedure
Devices NCT03867942 579 586 I-Procedure
( NCT03867942 587 588 O
IUDs NCT03867942 589 593 B-Procedure
) NCT03867942 594 595 O
: NCT03867942 596 597 O
Cooper NCT03867942 598 604 B-Modifier
IUD NCT03867942 605 608 B-Procedure
( NCT03867942 609 610 O
Loop NCT03867942 611 615 B-Modifier
) NCT03867942 616 617 O
, NCT03867942 618 619 O
Hormonal NCT03867942 620 628 B-Modifier
IUD NCT03867942 629 632 B-Procedure
( NCT03867942 633 634 O
Mirena NCT03867942 635 641 B-Modifier
) NCT03867942 642 643 O

- NCT03867942 647 648 O
Natural NCT03867942 650 657 B-Procedure
methods NCT03867942 658 665 I-Procedure
: NCT03867942 666 667 O
Basic NCT03867942 668 673 B-Modifier
body NCT03867942 674 678 B-Observation
temperature NCT03867942 679 690 I-Observation
, NCT03867942 691 692 O
Ovulation NCT03867942 693 702 B-Condition
period NCT03867942 703 709 I-Condition
, NCT03867942 710 711 O
Coitus NCT03867942 712 718 B-Procedure
interruptus NCT03867942 719 730 I-Procedure
, NCT03867942 731 732 O
Abstinent NCT03867942 733 742 B-Condition

- NCT03867942 745 746 O
People NCT03867942 748 754 O
who NCT03867942 755 758 O
perfectly NCT03867942 759 768 O
understood NCT03867942 769 779 O
clinical NCT03867942 780 788 O
trial NCT03867942 789 794 O
and NCT03867942 795 798 O
independently NCT03867942 799 812 O
decided NCT03867942 813 820 O
to NCT03867942 821 823 O
participate NCT03867942 824 835 O
in NCT03867942 836 838 O
clinical NCT03867942 839 847 O
trial NCT03867942 848 853 O
. NCT03867942 854 855 O

- NCT03867942 859 860 O
People NCT03867942 862 868 O
who NCT03867942 869 872 O
will NCT03867942 873 877 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03867942 878 880 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03867942 881 885 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03867942 886 888 O
collect NCT03867942 889 896 O
blood NCT03867942 897 902 B-Observation
sample NCT03867942 903 909 I-Observation
during NCT03867942 910 916 B-Temporal_Connection___Temporal_Connection_Type_Value:during
clinical NCT03867942 917 925 B-Study
trial NCT03867942 926 931 I-Study
period NCT03867942 932 938 O
. NCT03867942 939 940 O

- NCT03867942 944 945 O
People NCT03867942 947 953 O
who NCT03867942 954 957 O
are NCT03867942 958 961 O
suitable NCT03867942 962 970 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867942 971 973 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03867942 974 985 I-Assertion___Assertion_Type_Value:hypothetical
clinical NCT03867942 986 994 B-Study
trial NCT03867942 995 1000 I-Study
by NCT03867942 1001 1003 O
physical NCT03867942 1004 1012 B-Procedure
examination NCT03867942 1013 1024 I-Procedure
, NCT03867942 1025 1026 O
lab NCT03867942 1027 1030 B-Observation
test NCT03867942 1031 1035 I-Observation
and NCT03867942 1036 1039 B-And
medical NCT03867942 1040 1047 B-Procedure
examination NCT03867942 1048 1059 I-Procedure
by NCT03867942 1060 1062 B-Modifier
interview NCT03867942 1063 1072 I-Modifier
. NCT03867942 1073 1074 O

Exclusion NCT03867942 1076 1085 O
Criteria NCT03867942 1086 1094 O
: NCT03867942 1095 1096 O

- NCT03867942 1100 1101 O
Genetic NCT03867942 1103 1110 B-Condition
problems NCT03867942 1111 1119 I-Condition
such NCT03867942 1120 1124 O
as NCT03867942 1125 1127 O
galactose NCT03867942 1128 1137 B-Condition
intolerance NCT03867942 1138 1149 I-Condition
, NCT03867942 1150 1151 O
Lapp NCT03867942 1152 1156 B-Condition
lacatase NCT03867942 1157 1165 I-Condition
deficiency NCT03867942 1166 1176 I-Condition
, NCT03867942 1177 1178 O
glucose NCT03867942 1179 1186 B-Condition
- NCT03867942 1187 1188 I-Condition
galactose NCT03867942 1189 1198 I-Condition
malabsorption NCT03867942 1199 1212 I-Condition

- NCT03867942 1215 1216 O
Clinically NCT03867942 1218 1228 O
significant NCT03867942 1229 1240 O
disease NCT03867942 1241 1248 B-Condition
such NCT03867942 1249 1253 O
as NCT03867942 1254 1256 O
liver NCT03867942 1257 1262 B-Modifier
, NCT03867942 1263 1264 O
kidney NCT03867942 1265 1271 B-Modifier
, NCT03867942 1272 1273 O
digestive NCT03867942 1274 1283 B-Modifier
, NCT03867942 1284 1285 O
pulmonary NCT03867942 1286 1295 B-Modifier
, NCT03867942 1296 1297 O
endocrine NCT03867942 1298 1307 B-Modifier
system NCT03867942 1308 1314 I-Modifier
, NCT03867942 1315 1316 O
cardiovascular NCT03867942 1317 1331 B-Modifier
disease NCT03867942 1332 1339 B-Condition
etc NCT03867942 1340 1343 O
. NCT03867942 1344 1345 O

- NCT03867942 1349 1350 O
People NCT03867942 1352 1358 O
who NCT03867942 1359 1362 O
have NCT03867942 1363 1367 O
gastrointestinal NCT03867942 1368 1384 B-Condition
disease NCT03867942 1385 1392 I-Condition
or NCT03867942 1393 1395 B-Or
history NCT03867942 1396 1403 B-Eq_Comparison
of NCT03867942 1404 1406 O
surgery NCT03867942 1407 1414 B-Procedure
which NCT03867942 1415 1420 O
would NCT03867942 1421 1426 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03867942 1427 1433 O
absorption NCT03867942 1434 1444 B-Condition
of NCT03867942 1445 1447 O
drug NCT03867942 1448 1452 B-Drug
. NCT03867942 1453 1454 O

- NCT03867942 1458 1459 O
History NCT03867942 1461 1468 B-Eq_Comparison
of NCT03867942 1469 1471 O
clinically NCT03867942 1472 1482 O
significant NCT03867942 1483 1494 O
drug NCT03867942 1495 1499 B-Drug
induced NCT03867942 1500 1507 O
hyper NCT03867942 1508 1513 B-Condition
- NCT03867942 1514 1515 I-Condition
sensitive NCT03867942 1516 1525 I-Condition
reaction NCT03867942 1526 1534 I-Condition
or NCT03867942 1535 1537 B-Or
drug NCT03867942 1538 1542 B-Drug
related NCT03867942 1543 1550 O
muscular NCT03867942 1551 1559 B-Condition
disease NCT03867942 1560 1567 I-Condition

Inclusion NCT03921710 0 9 O
criteria NCT03921710 10 18 O
: NCT03921710 19 20 O

- NCT03921710 24 25 O
< NCT03921710 27 28 B-Eq_Comparison
38 NCT03921710 29 31 I-Eq_Comparison
years NCT03921710 32 37 I-Eq_Comparison

- NCT03921710 40 41 O
PCOS NCT03921710 43 47 B-Condition
patients NCT03921710 48 56 O
with NCT03921710 57 61 B-And
polycystic NCT03921710 62 72 B-Condition
ovarian NCT03921710 73 80 I-Condition
morphology NCT03921710 81 91 I-Condition
: NCT03921710 92 93 O
at NCT03921710 94 96 B-Eq_Comparison
least NCT03921710 97 102 I-Eq_Comparison
25 NCT03921710 103 105 I-Eq_Comparison
follicles NCT03921710 106 115 B-Observation
( NCT03921710 116 117 O
2 NCT03921710 118 119 B-Eq_Comparison
- NCT03921710 120 121 I-Eq_Comparison
9 NCT03921710 122 123 I-Eq_Comparison
mm NCT03921710 124 126 I-Eq_Comparison
) NCT03921710 127 128 O
throughout NCT03921710 129 139 O
the NCT03921710 140 143 O
whole NCT03921710 144 149 O
ovary NCT03921710 150 155 O
and NCT03921710 156 159 O
/ NCT03921710 160 161 O
or NCT03921710 162 164 O
increased NCT03921710 165 174 O
ovarian NCT03921710 175 182 B-Observation
volume NCT03921710 183 189 I-Observation
( NCT03921710 190 191 O
> NCT03921710 192 193 B-Eq_Comparison
10 NCT03921710 194 196 I-Eq_Comparison
ml NCT03921710 197 199 I-Eq_Comparison
) NCT03921710 200 201 O
( NCT03921710 202 203 O
it NCT03921710 204 206 O
is NCT03921710 207 209 O
sufficient NCT03921710 210 220 O
that NCT03921710 221 225 O
1 NCT03921710 226 227 O
ovary NCT03921710 228 233 O
fits NCT03921710 234 238 O
these NCT03921710 239 244 O
criteria NCT03921710 245 253 O
) NCT03921710 254 255 O

- NCT03921710 259 260 O
No NCT03921710 262 264 B-Negation
major NCT03921710 265 270 B-Modifier
uterine NCT03921710 271 278 B-Modifier
or NCT03921710 279 281 B-Or
ovarian NCT03921710 282 289 B-Modifier
abnormalities NCT03921710 290 303 B-Condition

Exclusion NCT03921710 304 313 O
criteria NCT03921710 314 322 O
: NCT03921710 323 324 O

- NCT03921710 328 329 O
High NCT03921710 331 335 O
( NCT03921710 336 337 O
> NCT03921710 338 339 B-Eq_Comparison
grade NCT03921710 340 345 I-Eq_Comparison
2 NCT03921710 346 347 I-Eq_Comparison
) NCT03921710 348 349 O
grade NCT03921710 350 355 O
endometriosis NCT03921710 356 369 B-Condition

- NCT03921710 372 373 O
Cases NCT03921710 375 380 O
with NCT03921710 381 385 O
extremely NCT03921710 386 395 O
poor NCT03921710 396 400 B-Condition
sperm NCT03921710 401 406 I-Condition
( NCT03921710 407 408 O
OAT NCT03921710 409 412 B-Condition
) NCT03921710 413 414 O
such NCT03921710 415 419 O
as NCT03921710 420 422 O
azoospermia NCT03921710 423 434 B-Condition
or NCT03921710 435 437 B-Or
cryptozoospermia NCT03921710 438 454 B-Condition

Inclusion NCT03869749 0 9 O
Criteria NCT03869749 10 18 O
: NCT03869749 19 20 O

- NCT03869749 24 25 O
two NCT03869749 27 30 B-Eq_Comparison
parents NCT03869749 31 38 B-Family_Member___Family_Member_Type:parent
in NCT03869749 39 41 O
the NCT03869749 42 45 O
home NCT03869749 46 50 O

- NCT03869749 53 54 O
an NCT03869749 56 58 O
adolescent NCT03869749 59 69 O
who NCT03869749 70 73 B-And
is NCT03869749 74 76 O
between NCT03869749 77 84 B-Eq_Comparison
14 NCT03869749 85 87 I-Eq_Comparison
and NCT03869749 88 91 I-Eq_Comparison
18 NCT03869749 92 94 I-Eq_Comparison
years NCT03869749 95 100 I-Eq_Comparison
of NCT03869749 101 103 O
age NCT03869749 104 107 B-Age

- NCT03869749 110 111 O
marital NCT03869749 113 120 B-Observation
distress NCT03869749 121 129 I-Observation

- NCT03869749 132 133 O
youth NCT03869749 135 140 O
reports NCT03869749 141 148 O
of NCT03869749 149 151 O
stress NCT03869749 152 158 B-Condition
or NCT03869749 159 161 B-Or
anxiety NCT03869749 162 169 B-Condition

Exclusion NCT03869749 170 179 O
Criteria NCT03869749 180 188 O
: NCT03869749 189 190 O

- NCT03869749 194 195 O
two NCT03869749 197 200 B-Eq_Comparison
parents NCT03869749 201 208 B-Family_Member___Family_Member_Type:parent
in NCT03869749 209 211 O
the NCT03869749 212 215 O
home NCT03869749 216 220 O
, NCT03869749 221 222 O
but NCT03869749 223 226 B-And
they NCT03869749 227 231 O
are NCT03869749 232 235 O
pursuing NCT03869749 236 244 B-Assertion___Assertion_Type_Value:intention
legal NCT03869749 245 250 B-Observation
divorce NCT03869749 251 258 I-Observation
or NCT03869749 259 261 B-Or
separation NCT03869749 262 272 B-Observation

- NCT03869749 275 276 O
parents NCT03869749 278 285 B-Family_Member___Family_Member_Type:parent
are NCT03869749 286 289 O
not NCT03869749 290 293 B-Negation
willing NCT03869749 294 301 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869749 302 304 I-Assertion___Assertion_Type_Value:hypothetical
receive NCT03869749 305 312 O
marital NCT03869749 313 320 B-Modifier
education NCT03869749 321 330 B-Procedure
/ NCT03869749 331 332 B-Or
support NCT03869749 333 340 B-Procedure

- NCT03869749 343 344 O
adolescents NCT03869749 346 357 O
are NCT03869749 358 361 O
clinically NCT03869749 362 372 O
depressed NCT03869749 373 382 B-Condition
or NCT03869749 383 385 B-Or
report NCT03869749 386 392 O
suicidal NCT03869749 393 401 B-Condition
ideation NCT03869749 402 410 I-Condition
at NCT03869749 411 413 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03869749 414 422 B-Study

Inclusion NCT03923075 0 9 O
Criteria NCT03923075 10 18 O
: NCT03923075 19 20 O

- NCT03923075 24 25 O
children NCT03923075 27 35 O
underoing NCT03923075 36 45 B-Eq_Comparison
elective NCT03923075 46 54 O
surgery NCT03923075 55 62 B-Procedure
under NCT03923075 63 68 O
general NCT03923075 69 76 B-Procedure
anaesthsia NCT03923075 77 87 I-Procedure

- NCT03923075 90 91 O
age NCT03923075 93 96 B-Age
4 NCT03923075 97 98 B-Eq_Comparison
- NCT03923075 99 100 I-Eq_Comparison
12 NCT03923075 101 103 I-Eq_Comparison
years NCT03923075 104 109 I-Eq_Comparison
old NCT03923075 110 113 O

- NCT03923075 116 117 O
ASA NCT03923075 119 122 B-Observation
I NCT03923075 123 124 B-Eq_Comparison
- NCT03923075 125 126 I-Eq_Comparison
II NCT03923075 127 129 I-Eq_Comparison

Exclusion NCT03923075 130 139 O
Criteria NCT03923075 140 148 O
: NCT03923075 149 150 O

- NCT03923075 154 155 O
patient NCT03923075 157 164 O
or NCT03923075 165 167 O
parent NCT03923075 168 174 O
refusal NCT03923075 175 182 O

- NCT03923075 185 186 O
Mallampati NCT03923075 188 198 B-Observation
score NCT03923075 199 204 I-Observation
> NCT03923075 205 206 B-Eq_Comparison
3 NCT03923075 207 208 I-Eq_Comparison

- NCT03923075 212 213 O
BMI NCT03923075 215 218 B-Observation
> NCT03923075 219 220 B-Eq_Comparison
35 NCT03923075 221 223 I-Eq_Comparison

- NCT03923075 227 228 O
severe NCT03923075 230 236 O
systemic NCT03923075 237 245 B-Modifier
cardiac NCT03923075 246 253 B-Condition
disease NCT03923075 254 261 I-Condition

- NCT03923075 264 265 O
neuromuscular NCT03923075 267 280 B-Condition
disease NCT03923075 281 288 I-Condition

- NCT03923075 291 292 O
recent NCT03923075 294 300 B-Eq_Comparison
respiratory NCT03923075 301 312 B-Condition
infection NCT03923075 313 322 I-Condition

- NCT03923075 325 326 O
drug NCT03923075 328 332 B-Drug
allergy NCT03923075 333 340 B-Allergy

Inclusion NCT03927079 0 9 O
Criteria NCT03927079 10 18 O
: NCT03927079 19 20 O

- NCT03927079 24 25 O
patients NCT03927079 27 35 O
who NCT03927079 36 39 O
undergo NCT03927079 40 47 O
a NCT03927079 48 49 O
flexible NCT03927079 50 58 O
bronchoscopic NCT03927079 59 72 B-Procedure
lavage NCT03927079 73 79 I-Procedure
and NCT03927079 80 83 B-And
with NCT03927079 84 88 O
a NCT03927079 89 90 O
beta NCT03927079 91 95 B-Drug
lactamines NCT03927079 96 106 I-Drug
treatment NCT03927079 107 116 B-Procedure
as NCT03927079 117 119 O
cephalosporin NCT03927079 120 133 B-Drug
of NCT03927079 134 136 O
3 NCT03927079 137 138 B-Modifier
rd NCT03927079 139 141 I-Modifier
generation NCT03927079 142 152 I-Modifier
( NCT03927079 153 154 O
CEFTRIAXONE NCT03927079 155 166 B-Drug
/ NCT03927079 167 168 B-Or
CEFOTAXIME NCT03927079 169 179 B-Drug
, NCT03927079 180 181 O
CEFTAZIDIME NCT03927079 182 193 B-Drug
) NCT03927079 194 195 O
, NCT03927079 196 197 O
of NCT03927079 198 200 O
4 NCT03927079 201 202 B-Modifier
th NCT03927079 203 205 I-Modifier
generation NCT03927079 206 216 I-Modifier
( NCT03927079 217 218 O
CEFEPIM NCT03927079 219 226 B-Drug
) NCT03927079 227 228 O
, NCT03927079 229 230 O
or NCT03927079 231 233 B-Or
AMOXICILLIN NCT03927079 234 245 B-Drug
- NCT03927079 246 247 I-Drug
CLAVULANIC NCT03927079 248 258 I-Drug
ACID NCT03927079 259 263 I-Drug
, NCT03927079 264 265 O
or NCT03927079 266 268 B-Or
PIPERACILLIN NCT03927079 269 281 B-Drug
- NCT03927079 282 283 I-Drug
TAZOBACTAM NCT03927079 284 294 I-Drug

- NCT03927079 297 298 O
patient NCT03927079 300 307 O
major NCT03927079 308 313 O

- NCT03927079 316 317 O
informed NCT03927079 319 327 O
and NCT03927079 328 331 O
signed NCT03927079 332 338 O
consent NCT03927079 339 346 O
form NCT03927079 347 351 O

Exclusion NCT03927079 352 361 O
Criteria NCT03927079 362 370 O
: NCT03927079 371 372 O

- NCT03927079 376 377 O
patient NCT03927079 379 386 O
under NCT03927079 387 392 B-Eq_Comparison
chronic NCT03927079 393 400 O
dialysis NCT03927079 401 409 B-Procedure

- NCT03927079 412 413 O
patient NCT03927079 415 422 O
placed NCT03927079 423 429 O
under NCT03927079 430 435 O
judicial NCT03927079 436 444 B-Observation
protection NCT03927079 445 455 I-Observation

Inclusion NCT03865524 0 9 O
Criteria NCT03865524 10 18 O
: NCT03865524 19 20 O

- NCT03865524 24 25 O
Men NCT03865524 27 30 O
and NCT03865524 31 34 B-Or
women NCT03865524 35 40 O
over NCT03865524 41 45 B-Eq_Comparison
18 NCT03865524 46 48 I-Eq_Comparison
years NCT03865524 49 54 I-Eq_Comparison
old NCT03865524 55 58 B-Age
. NCT03865524 59 60 O

- NCT03865524 64 65 O
Written NCT03865524 67 74 O
informed NCT03865524 75 83 O
consent NCT03865524 84 91 O
according NCT03865524 92 101 O
to NCT03865524 102 104 O
ICH NCT03865524 105 108 O
/ NCT03865524 109 110 O
GCP NCT03865524 111 114 O
and NCT03865524 115 118 O
Spanish NCT03865524 119 126 O
legislation NCT03865524 127 138 O
, NCT03865524 139 140 O
obtained NCT03865524 141 149 O
before NCT03865524 150 156 B-Temporal_Connection___Temporal_Connection_Type_Value:before
any NCT03865524 157 160 O
study NCT03865524 161 166 B-Study
procedure NCT03865524 167 176 O
. NCT03865524 177 178 O

- NCT03865524 182 183 O
Patient NCT03865524 185 192 O
with NCT03865524 193 197 O
a NCT03865524 198 199 O
BMI NCT03865524 200 203 B-Observation
equal NCT03865524 204 209 B-Eq_Comparison
to NCT03865524 210 212 I-Eq_Comparison
or NCT03865524 213 215 I-Eq_Comparison
greater NCT03865524 216 223 I-Eq_Comparison
than NCT03865524 224 228 I-Eq_Comparison
30 NCT03865524 229 231 I-Eq_Comparison
Kg NCT03865524 232 234 I-Eq_Comparison
/ NCT03865524 235 236 I-Eq_Comparison
m NCT03865524 237 238 I-Eq_Comparison
2 NCT03865524 239 240 I-Eq_Comparison

- NCT03865524 243 244 O
Patients NCT03865524 246 254 O
with NCT03865524 255 259 O
clinical NCT03865524 260 268 B-Modifier
and NCT03865524 269 272 B-Or
radiological NCT03865524 273 285 B-Procedure
criteria NCT03865524 286 294 O
of NCT03865524 295 297 O
knee NCT03865524 298 302 B-Modifier
osteoarthritis NCT03865524 303 317 B-Condition
. NCT03865524 318 319 O

- NCT03865524 323 324 O
Patients NCT03865524 326 334 O
with NCT03865524 335 339 O
indication NCT03865524 340 350 B-Indication
for NCT03865524 351 354 O
primary NCT03865524 355 362 B-Modifier
TKA NCT03865524 363 366 B-Condition
according NCT03865524 367 376 O
to NCT03865524 377 379 O
medical NCT03865524 380 387 O
criteria NCT03865524 388 396 O
. NCT03865524 397 398 O

Exclusion NCT03865524 400 409 O
Criteria NCT03865524 410 418 O
: NCT03865524 419 420 O

- NCT03865524 424 425 O
Pregnancy NCT03865524 427 436 B-Condition
or NCT03865524 437 439 B-Or
lactation NCT03865524 440 449 B-Condition
. NCT03865524 450 451 O

- NCT03865524 455 456 O
Inability NCT03865524 458 467 O
to NCT03865524 468 470 O
give NCT03865524 471 475 O
informed NCT03865524 476 484 O
consent NCT03865524 485 492 O
in NCT03865524 493 495 O
the NCT03865524 496 499 O
absence NCT03865524 500 507 O
of NCT03865524 508 510 O
a NCT03865524 511 512 O
legal NCT03865524 513 518 O
representative NCT03865524 519 533 O
. NCT03865524 534 535 O

- NCT03865524 539 540 O
Subjects NCT03865524 542 550 O
that NCT03865524 551 555 O
are NCT03865524 556 559 O
participating NCT03865524 560 573 B-Eq_Comparison
in NCT03865524 574 576 O
a NCT03865524 577 578 O
study NCT03865524 579 584 B-Study
with NCT03865524 585 589 O
medicines NCT03865524 590 599 B-Drug
or NCT03865524 600 602 B-Or
other NCT03865524 603 608 B-Other
medical NCT03865524 609 616 B-Procedure
devices NCT03865524 617 624 I-Procedure
. NCT03865524 625 626 O

- NCT03865524 630 631 O
Those NCT03865524 633 638 O
who NCT03865524 639 642 O
show NCT03865524 643 647 O
inability NCT03865524 648 657 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865524 658 660 O
follow NCT03865524 661 667 O
the NCT03865524 668 671 O
instructions NCT03865524 672 684 O
or NCT03865524 685 687 O
collaborate NCT03865524 688 699 O
during NCT03865524 700 706 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865524 707 710 O
development NCT03865524 711 722 O
of NCT03865524 723 725 O
the NCT03865524 726 729 O
study NCT03865524 730 735 B-Study
. NCT03865524 736 737 O

- NCT03865524 741 742 O
If NCT03865524 744 746 O
in NCT03865524 747 749 O
the NCT03865524 750 753 O
opinion NCT03865524 754 761 O
of NCT03865524 762 764 O
the NCT03865524 765 768 O
researcher NCT03865524 769 779 O
there NCT03865524 780 785 O
are NCT03865524 786 789 O
findings NCT03865524 790 798 O
in NCT03865524 799 801 O
the NCT03865524 802 805 O
physical NCT03865524 806 814 B-Procedure
examination NCT03865524 815 826 I-Procedure
, NCT03865524 827 828 O
abnormalities NCT03865524 829 842 B-Condition
in NCT03865524 843 845 O
the NCT03865524 846 849 O
results NCT03865524 850 857 O
of NCT03865524 858 860 O
the NCT03865524 861 864 O
clinical NCT03865524 865 873 O
analyzes NCT03865524 874 882 O
or NCT03865524 883 885 B-Or
other NCT03865524 886 891 O
medical NCT03865524 892 899 O
, NCT03865524 900 901 O
social NCT03865524 902 908 B-Modifier
or NCT03865524 909 911 B-Or
psychosocial NCT03865524 912 924 B-Modifier
factors NCT03865524 925 932 B-Condition
that NCT03865524 933 937 O
could NCT03865524 938 943 B-Assertion___Assertion_Type_Value:hypothetical
have NCT03865524 944 948 O
a NCT03865524 949 950 O
negative NCT03865524 951 959 O
influence NCT03865524 960 969 O

- NCT03865524 972 973 O
Having NCT03865524 975 981 O
had NCT03865524 982 985 O
a NCT03865524 986 987 O
previous NCT03865524 988 996 B-Eq_Comparison
surgical NCT03865524 997 1005 B-Procedure
procedure NCT03865524 1006 1015 I-Procedure
on NCT03865524 1016 1018 B-Modifier
or NCT03865524 1019 1021 B-Or
around NCT03865524 1022 1028 B-Modifier
the NCT03865524 1029 1032 I-Modifier
knee NCT03865524 1033 1037 I-Modifier
in NCT03865524 1038 1040 O
the NCT03865524 1041 1044 O
last NCT03865524 1045 1049 B-Eq_Comparison
12 NCT03865524 1050 1052 I-Eq_Comparison
months NCT03865524 1053 1059 I-Eq_Comparison
( NCT03865524 1060 1061 O
such NCT03865524 1062 1066 O
as NCT03865524 1067 1069 O
proximal NCT03865524 1070 1078 B-Procedure
tibial NCT03865524 1079 1085 I-Procedure
osteotomy NCT03865524 1086 1095 I-Procedure
, NCT03865524 1096 1097 O
femoral NCT03865524 1098 1105 B-Procedure
osteotomy NCT03865524 1106 1115 I-Procedure
, NCT03865524 1116 1117 O
open NCT03865524 1118 1122 B-Procedure
reduction NCT03865524 1123 1132 I-Procedure
and NCT03865524 1133 1136 B-Or
internal NCT03865524 1137 1145 B-Procedure
fixation NCT03865524 1146 1154 I-Procedure
for NCT03865524 1155 1158 O
a NCT03865524 1159 1160 O
fracture NCT03865524 1161 1169 B-Condition
, NCT03865524 1170 1171 O
patellectomy NCT03865524 1172 1184 B-Procedure
or NCT03865524 1185 1187 B-Or
patellar NCT03865524 1188 1196 B-Procedure
realignment NCT03865524 1197 1208 I-Procedure
) NCT03865524 1209 1210 O
. NCT03865524 1211 1212 O

- NCT03865524 1216 1217 O
Need NCT03865524 1219 1223 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03865524 1224 1225 O
simultaneous NCT03865524 1226 1238 B-Modifier
bilateral NCT03865524 1239 1248 I-Modifier
TKA NCT03865524 1249 1252 B-Procedure
. NCT03865524 1253 1254 O

- NCT03865524 1258 1259 O
Have NCT03865524 1261 1265 O
a NCT03865524 1266 1267 O
varus NCT03865524 1268 1273 B-Observation
angle NCT03865524 1274 1279 I-Observation
or NCT03865524 1280 1282 B-Or
valgus NCT03865524 1283 1289 B-Observation
≥ NCT03865524 1290 1291 B-Eq_Comparison
15 NCT03865524 1292 1294 I-Eq_Comparison
° NCT03865524 1295 1296 I-Eq_Comparison
. NCT03865524 1297 1298 O

- NCT03865524 1302 1303 O
Total NCT03865524 1305 1310 B-Procedure
revision NCT03865524 1311 1319 I-Procedure
knee NCT03865524 1320 1324 I-Procedure
arthroplasty NCT03865524 1325 1337 I-Procedure
. NCT03865524 1338 1339 O

Inclusion NCT03924284 0 9 O
Criteria NCT03924284 10 18 O
: NCT03924284 19 20 O

- NCT03924284 24 25 O
Nasopharyngeal NCT03924284 27 41 B-Observation
or NCT03924284 42 44 B-Or
saliva NCT03924284 45 51 B-Observation
specimens NCT03924284 52 61 O
of NCT03924284 62 64 O
patients NCT03924284 65 73 O
in NCT03924284 74 76 O
Queen NCT03924284 77 82 O
Mary NCT03924284 83 87 O
Hospital NCT03924284 88 96 O
of NCT03924284 97 99 O
Hong NCT03924284 100 104 O
Kong NCT03924284 105 109 O

- NCT03924284 112 113 O
Tested NCT03924284 115 121 O
for NCT03924284 122 125 O
influenza NCT03924284 126 135 B-Observation
A NCT03924284 136 137 I-Observation
virus NCT03924284 138 143 I-Observation
using NCT03924284 144 149 O
a NCT03924284 150 151 O
commercially NCT03924284 152 164 O
available NCT03924284 165 174 O
assay NCT03924284 175 180 O
or NCT03924284 181 183 O
by NCT03924284 184 186 O
the NCT03924284 187 190 O
Public NCT03924284 191 197 O
Health NCT03924284 198 204 O
Laboratory NCT03924284 205 215 O
Services NCT03924284 216 224 O
Branch NCT03924284 225 231 O
in NCT03924284 232 234 O
Hong NCT03924284 235 239 O
Kong NCT03924284 240 244 O

Exclusion NCT03924284 245 254 O
Criteria NCT03924284 255 263 O
: NCT03924284 264 265 O

- NCT03924284 269 270 O
Insufficient NCT03924284 272 284 O
specimen NCT03924284 285 293 O
volume NCT03924284 294 300 O

Inclusion NCT03864614 0 9 O
Criteria NCT03864614 10 18 O
: NCT03864614 19 20 O

1 NCT03864614 24 25 O
. NCT03864614 25 26 O
Subject NCT03864614 28 35 O
has NCT03864614 36 39 O
a NCT03864614 40 41 O
diagnosis NCT03864614 42 51 O
of NCT03864614 52 54 O
MDD NCT03864614 55 58 B-Condition
as NCT03864614 59 61 O
diagnosed NCT03864614 62 71 O
by NCT03864614 72 74 O
SCID NCT03864614 75 79 O
- NCT03864614 80 81 O
5 NCT03864614 82 83 O
- NCT03864614 84 85 O
CT NCT03864614 86 88 O
, NCT03864614 89 90 O
with NCT03864614 91 95 B-And
symptoms NCT03864614 96 104 O
that NCT03864614 105 109 O
have NCT03864614 110 114 O
been NCT03864614 115 119 O
present NCT03864614 120 127 O
for NCT03864614 128 131 O
at NCT03864614 132 134 B-Eq_Comparison
least NCT03864614 135 140 I-Eq_Comparison
a NCT03864614 141 142 I-Eq_Comparison
4 NCT03864614 143 144 I-Eq_Comparison
- NCT03864614 145 146 I-Eq_Comparison
week NCT03864614 147 151 I-Eq_Comparison
period NCT03864614 152 158 O
. NCT03864614 159 160 O

2 NCT03864614 164 165 O
. NCT03864614 165 166 O
Subject NCT03864614 168 175 O
is NCT03864614 176 178 O
in NCT03864614 179 181 O
good NCT03864614 182 186 B-Condition
physical NCT03864614 187 195 I-Condition
health NCT03864614 196 202 I-Condition
and NCT03864614 203 206 B-And
has NCT03864614 207 210 O
no NCT03864614 211 213 B-Negation
clinically NCT03864614 214 224 O
significant NCT03864614 225 236 O
findings NCT03864614 237 245 B-Condition
, NCT03864614 246 247 O
as NCT03864614 248 250 O
determined NCT03864614 251 261 O
by NCT03864614 262 264 O
the NCT03864614 265 268 O
Investigator NCT03864614 269 281 O
, NCT03864614 282 283 O
on NCT03864614 284 286 O
physical NCT03864614 287 295 B-Procedure
examination NCT03864614 296 307 I-Procedure
, NCT03864614 308 309 O
12 NCT03864614 310 312 B-Procedure
- NCT03864614 313 314 I-Procedure
lead NCT03864614 315 319 I-Procedure
ECG NCT03864614 320 323 I-Procedure
, NCT03864614 324 325 O
or NCT03864614 326 328 B-Or
clinical NCT03864614 329 337 O
laboratory NCT03864614 338 348 B-Observation
tests NCT03864614 349 354 I-Observation
. NCT03864614 355 356 O

Exclusion NCT03864614 358 367 O
Criteria NCT03864614 368 376 O
: NCT03864614 377 378 O

1 NCT03864614 382 383 O
. NCT03864614 383 384 O
Subject NCT03864614 386 393 O
has NCT03864614 394 397 O
attempted NCT03864614 398 407 B-Condition
suicide NCT03864614 408 415 I-Condition
associated NCT03864614 416 426 B-Temporal_Connection___Temporal_Connection_Type_Value:during
with NCT03864614 427 431 I-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864614 432 435 O
current NCT03864614 436 443 B-Eq_Comparison
episode NCT03864614 444 451 O
of NCT03864614 452 454 O
MDD NCT03864614 455 458 B-Condition
. NCT03864614 459 460 O

2 NCT03864614 464 465 O
. NCT03864614 465 466 O
Subject NCT03864614 468 475 O
has NCT03864614 476 479 O
a NCT03864614 480 481 O
medical NCT03864614 482 489 O
history NCT03864614 490 497 B-Eq_Comparison
of NCT03864614 498 500 O
bipolar NCT03864614 501 508 B-Condition
disorder NCT03864614 509 517 I-Condition
, NCT03864614 518 519 O
schizophrenia NCT03864614 520 533 B-Condition
, NCT03864614 534 535 O
and NCT03864614 536 539 B-Or
/ NCT03864614 540 541 I-Or
or NCT03864614 542 544 I-Or
schizoaffective NCT03864614 545 560 B-Condition
disorder NCT03864614 561 569 I-Condition
. NCT03864614 570 571 O

3 NCT03864614 575 576 O
. NCT03864614 576 577 O
Subject NCT03864614 579 586 O
has NCT03864614 587 590 O
had NCT03864614 591 594 B-Eq_Comparison
vagus NCT03864614 595 600 B-Procedure
nerve NCT03864614 601 606 I-Procedure
stimulation NCT03864614 607 618 I-Procedure
, NCT03864614 619 620 O
electroconvulsive NCT03864614 621 638 B-Procedure
therapy NCT03864614 639 646 I-Procedure
, NCT03864614 647 648 O
or NCT03864614 649 651 B-Or
has NCT03864614 652 655 O
taken NCT03864614 656 661 B-Eq_Comparison
ketamine NCT03864614 662 670 B-Drug
( NCT03864614 671 672 O
including NCT03864614 673 682 O
esketamine NCT03864614 683 693 B-Drug
) NCT03864614 694 695 O
within NCT03864614 696 702 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864614 703 706 I-Temporal_Connection___Temporal_Connection_Type_Value:during
current NCT03864614 707 714 B-Eq_Comparison
major NCT03864614 715 720 O
depressive NCT03864614 721 731 B-Condition
episode NCT03864614 732 739 I-Condition
. NCT03864614 740 741 O

Inclusion NCT03925701 0 9 O
Criteria NCT03925701 10 18 O
: NCT03925701 19 20 O

- NCT03925701 24 25 O
NAFLD NCT03925701 27 32 B-Condition
and NCT03925701 33 36 O
type NCT03925701 37 41 B-Condition
2 NCT03925701 42 43 I-Condition
DM NCT03925701 44 46 I-Condition

Exclusion NCT03925701 47 56 O
Criteria NCT03925701 57 65 O
: NCT03925701 66 67 O

- NCT03925701 71 72 O
Viral NCT03925701 74 79 B-Condition
hepatitis NCT03925701 80 89 I-Condition
. NCT03925701 90 91 O

- NCT03925701 95 96 O
Child NCT03925701 98 103 O
score NCT03925701 104 109 O
more NCT03925701 110 114 B-Eq_Comparison
than NCT03925701 115 119 I-Eq_Comparison
6 NCT03925701 120 121 I-Eq_Comparison
. NCT03925701 121 122 O

- NCT03925701 126 127 O
renal NCT03925701 129 134 B-Modifier
impairment NCT03925701 135 145 B-Condition
. NCT03925701 146 147 O

Inclusion NCT03862287 0 9 O
Criteria NCT03862287 10 18 O
: NCT03862287 19 20 O

- NCT03862287 24 25 O
ASA NCT03862287 27 30 B-Observation
I NCT03862287 31 32 B-Eq_Comparison
- NCT03862287 33 34 I-Eq_Comparison
III NCT03862287 35 38 I-Eq_Comparison
male NCT03862287 39 43 O
and NCT03862287 44 47 B-Or
female NCT03862287 48 54 O
patients NCT03862287 55 63 O
aged NCT03862287 64 68 B-Age
between NCT03862287 69 76 B-Eq_Comparison
18 NCT03862287 77 79 I-Eq_Comparison
to NCT03862287 80 82 I-Eq_Comparison
80 NCT03862287 83 85 I-Eq_Comparison
years NCT03862287 86 91 I-Eq_Comparison
old NCT03862287 92 95 O
, NCT03862287 96 97 O
who NCT03862287 98 101 B-And
will NCT03862287 102 106 B-Assertion___Assertion_Type_Value:hypothetical
receive NCT03862287 107 114 I-Assertion___Assertion_Type_Value:hypothetical
spinal NCT03862287 115 121 B-Procedure
anesthesia NCT03862287 122 132 I-Procedure
for NCT03862287 133 136 O
surgeries NCT03862287 137 146 B-Procedure
lasting NCT03862287 147 154 O
less NCT03862287 155 159 B-Eq_Comparison
than NCT03862287 160 164 I-Eq_Comparison
one NCT03862287 165 168 I-Eq_Comparison
hour NCT03862287 169 173 I-Eq_Comparison
. NCT03862287 174 175 O

Exclusion NCT03862287 177 186 O
Criteria NCT03862287 187 195 O
: NCT03862287 196 197 O

- NCT03862287 201 202 O
Patients NCT03862287 204 212 O
younger NCT03862287 213 220 B-Eq_Comparison
than NCT03862287 221 225 I-Eq_Comparison
18 NCT03862287 226 228 I-Eq_Comparison
years NCT03862287 229 234 I-Eq_Comparison
old NCT03862287 235 238 B-Age
. NCT03862287 239 240 O

- NCT03862287 244 245 O
ASA NCT03862287 247 250 B-Observation
physical NCT03862287 251 259 O
status NCT03862287 260 266 O
> NCT03862287 267 268 B-Eq_Comparison
3 NCT03862287 269 270 I-Eq_Comparison
. NCT03862287 270 271 O

- NCT03862287 275 276 O
Immunosuppression NCT03862287 278 295 B-Condition
or NCT03862287 296 298 B-Or
high NCT03862287 299 303 O
risk NCT03862287 304 308 B-Risk
of NCT03862287 309 311 O
infection NCT03862287 312 321 B-Condition
. NCT03862287 322 323 O

- NCT03862287 327 328 O
Contraindications NCT03862287 330 347 B-Contraindication
to NCT03862287 348 350 O
receiving NCT03862287 351 360 O
spinal NCT03862287 361 367 B-Procedure
anesthesia NCT03862287 368 378 I-Procedure
( NCT03862287 379 380 O
e NCT03862287 381 382 O
. NCT03862287 383 384 O
g NCT03862287 385 386 O
. NCT03862287 387 388 O
coagulation NCT03862287 390 401 B-Condition
impairment NCT03862287 402 412 I-Condition
) NCT03862287 413 414 O
. NCT03862287 415 416 O

- NCT03862287 420 421 O
Patients NCT03862287 423 431 O
with NCT03862287 432 436 O
psychosis NCT03862287 437 446 B-Condition

- NCT03862287 449 450 O
Patients NCT03862287 452 460 O
with NCT03862287 461 465 O
preexisting NCT03862287 466 477 B-Eq_Comparison
back NCT03862287 478 482 B-Condition
pain NCT03862287 483 487 I-Condition
. NCT03862287 488 489 O

- NCT03862287 493 494 O
Patients NCT03862287 496 504 O
with NCT03862287 505 509 O
cognitive NCT03862287 510 519 B-Condition
impairment NCT03862287 520 530 I-Condition

- NCT03862287 533 534 O
Allergies NCT03862287 536 545 B-Allergy
to NCT03862287 546 548 O
local NCT03862287 549 554 B-Procedure
anesthetics NCT03862287 555 566 I-Procedure
, NCT03862287 567 568 O
analgesics NCT03862287 569 579 B-Drug
or NCT03862287 580 582 B-Or
any NCT03862287 583 586 O
medication NCT03862287 587 597 B-Drug
used NCT03862287 598 602 O
in NCT03862287 603 605 O
the NCT03862287 606 609 O
study NCT03862287 610 615 B-Study
. NCT03862287 616 617 O

- NCT03862287 621 622 O
Patients NCT03862287 624 632 O
with NCT03862287 633 637 O
chronic NCT03862287 638 645 O
regular NCT03862287 646 653 B-Eq_Comparison
opioid NCT03862287 654 660 B-Drug
usage NCT03862287 661 666 O

- NCT03862287 669 670 O
Presence NCT03862287 672 680 O
of NCT03862287 681 683 O
preexisting NCT03862287 684 695 B-Eq_Comparison
neurological NCT03862287 696 708 B-Condition
symptoms NCT03862287 709 717 B-Assertion___Assertion_Type_Value:possible
. NCT03862287 718 719 O

Inclusion NCT03934034 0 9 O
Criteria NCT03934034 10 18 O
: NCT03934034 19 20 O

1 NCT03934034 24 25 O
. NCT03934034 25 26 O
Clinical NCT03934034 28 36 O
diagnosis NCT03934034 37 46 O
of NCT03934034 47 49 O
NTM NCT03934034 50 53 B-Condition
pulmonary NCT03934034 54 63 I-Condition
disease NCT03934034 64 71 I-Condition
. NCT03934034 72 73 O

2 NCT03934034 77 78 O
. NCT03934034 78 79 O
The NCT03934034 81 84 O
causative NCT03934034 85 94 B-Organism
agent NCT03934034 95 100 I-Organism
of NCT03934034 101 103 O
NTM NCT03934034 104 107 B-Condition
pulmonary NCT03934034 108 117 I-Condition
disease NCT03934034 118 125 I-Condition
includes NCT03934034 126 134 O
: NCT03934034 135 136 O
M NCT03934034 137 138 B-Organism
. NCT03934034 139 140 I-Organism
avium NCT03934034 142 147 I-Organism
complex NCT03934034 148 155 I-Organism
, NCT03934034 156 157 O
or NCT03934034 158 160 B-Or
M NCT03934034 161 162 B-Organism
. NCT03934034 163 164 I-Organism
abscessus NCT03934034 166 175 I-Organism
subspecies NCT03934034 176 186 I-Organism
abscessus NCT03934034 187 196 I-Organism
, NCT03934034 197 198 O
or NCT03934034 199 201 B-Or
M NCT03934034 202 203 B-Organism
. NCT03934034 204 205 I-Organism
abscessus NCT03934034 207 216 I-Organism
subspecies NCT03934034 217 227 I-Organism
massiliense NCT03934034 228 239 I-Organism
, NCT03934034 240 241 O
or NCT03934034 242 244 B-Or
M NCT03934034 245 246 B-Organism
. NCT03934034 247 248 I-Organism
kansasii NCT03934034 250 258 I-Organism
. NCT03934034 259 260 O

3 NCT03934034 264 265 O
. NCT03934034 265 266 O
Patients NCT03934034 268 276 O
who NCT03934034 277 280 O
starts NCT03934034 281 287 O
new NCT03934034 288 291 B-Eq_Comparison
treatment NCT03934034 292 301 B-Procedure
( NCT03934034 302 303 O
those NCT03934034 304 309 O
who NCT03934034 310 313 O
have NCT03934034 314 318 O
previous NCT03934034 319 327 B-Eq_Comparison
history NCT03934034 328 335 I-Eq_Comparison
of NCT03934034 336 338 O
treatment NCT03934034 339 348 B-Procedure
are NCT03934034 349 352 O
eligible NCT03934034 353 361 O
) NCT03934034 362 363 O

Exclusion NCT03934034 365 374 O
Criteria NCT03934034 375 383 O

1 NCT03934034 386 387 O
. NCT03934034 387 388 O
Patients NCT03934034 390 398 O
who NCT03934034 399 402 O
have NCT03934034 403 407 O
been NCT03934034 408 412 O
treated NCT03934034 413 420 B-Procedure
for NCT03934034 421 424 O
more NCT03934034 425 429 B-Eq_Comparison
than NCT03934034 430 434 I-Eq_Comparison
4 NCT03934034 435 436 I-Eq_Comparison
weeks NCT03934034 437 442 I-Eq_Comparison
. NCT03934034 443 444 O

2 NCT03934034 448 449 O
. NCT03934034 449 450 O
The NCT03934034 452 455 O
causative NCT03934034 456 465 B-Organism
agent NCT03934034 466 471 I-Organism
of NCT03934034 472 474 O
NTM NCT03934034 475 478 B-Condition
pulmonary NCT03934034 479 488 I-Condition
disease NCT03934034 489 496 I-Condition
is NCT03934034 497 499 O
none NCT03934034 500 504 B-Negation
of NCT03934034 505 507 I-Negation
M NCT03934034 508 509 B-Organism
. NCT03934034 510 511 I-Organism
avium NCT03934034 513 518 I-Organism
complex NCT03934034 519 526 I-Organism
, NCT03934034 527 528 O
M NCT03934034 529 530 B-Organism
. NCT03934034 531 532 I-Organism
abscessus NCT03934034 534 543 I-Organism
subspecies NCT03934034 544 554 I-Organism
abscessus NCT03934034 555 564 I-Organism
, NCT03934034 565 566 O
M NCT03934034 567 568 B-Organism
. NCT03934034 569 570 I-Organism
abscessus NCT03934034 572 581 I-Organism
subspecies NCT03934034 582 592 I-Organism
massiliense NCT03934034 593 604 I-Organism
, NCT03934034 605 606 O
or NCT03934034 607 609 B-Or
M NCT03934034 610 611 B-Organism
. NCT03934034 612 613 I-Organism
kansasii NCT03934034 615 623 I-Organism
. NCT03934034 624 625 O

Inclusion NCT03922230 0 9 O
Criteria NCT03922230 10 18 O
: NCT03922230 19 20 O

1 NCT03922230 24 25 O
. NCT03922230 25 26 O
Diagnosis NCT03922230 28 37 O
of NCT03922230 38 40 O
esophageal NCT03922230 41 51 B-Modifier
squamous NCT03922230 52 60 B-Condition
cell NCT03922230 61 65 I-Condition
carcinoma NCT03922230 66 75 I-Condition
by NCT03922230 76 78 O
pathological NCT03922230 79 91 B-Procedure
cytology NCT03922230 92 100 I-Procedure
and NCT03922230 101 104 B-And
histology NCT03922230 105 114 B-Procedure
. NCT03922230 115 116 O

2 NCT03922230 120 121 O
. NCT03922230 121 122 O
Clinically NCT03922230 124 134 O
judged NCT03922230 135 141 O
patients NCT03922230 142 150 O
with NCT03922230 151 155 O
p NCT03922230 156 157 B-Modifier
0 NCT03922230 158 159 I-Modifier
~ NCT03922230 160 161 B-Or
pIV NCT03922230 162 165 B-Modifier
initial NCT03922230 166 173 B-Eq_Comparison
treatment NCT03922230 174 183 B-Procedure
. NCT03922230 184 185 O
( NCT03922230 186 187 O
1 NCT03922230 188 189 O
Variable NCT03922230 190 198 O
risk NCT03922230 199 203 B-Risk
factors NCT03922230 204 211 O
are NCT03922230 212 215 O
overeating NCT03922230 216 226 B-Condition
food NCT03922230 227 231 O
( NCT03922230 232 233 O
habits NCT03922230 234 240 O
) NCT03922230 241 242 O
and NCT03922230 243 246 O
family NCT03922230 247 253 B-Family_Member
history NCT03922230 254 261 I-Family_Member
. NCT03922230 262 263 O
2 NCT03922230 265 266 O
Among NCT03922230 267 272 O
all NCT03922230 273 276 O
the NCT03922230 277 280 O
patients NCT03922230 281 289 O
, NCT03922230 290 291 O
the NCT03922230 292 295 O
ratio NCT03922230 296 301 O
of NCT03922230 302 304 O
male NCT03922230 305 309 O
to NCT03922230 310 312 O
female NCT03922230 313 319 O
is NCT03922230 320 322 O
3 NCT03922230 323 324 O
: NCT03922230 325 326 O
1 NCT03922230 327 328 O
, NCT03922230 329 330 O
and NCT03922230 331 334 O
the NCT03922230 335 338 O
age NCT03922230 339 342 B-Age
is NCT03922230 343 345 O
between NCT03922230 346 353 B-Eq_Comparison
50 NCT03922230 354 356 I-Eq_Comparison
and NCT03922230 357 360 I-Eq_Comparison
70 NCT03922230 361 363 I-Eq_Comparison
years NCT03922230 364 369 I-Eq_Comparison
old NCT03922230 370 373 O
. NCT03922230 374 375 O
In NCT03922230 377 379 O
addition NCT03922230 380 388 O
to NCT03922230 389 391 O
eating NCT03922230 392 398 O
too NCT03922230 399 402 O
hot NCT03922230 403 406 O
food NCT03922230 407 411 O
, NCT03922230 412 413 O
other NCT03922230 414 419 O
eating NCT03922230 420 426 O
habits NCT03922230 427 433 O
( NCT03922230 434 435 O
such NCT03922230 436 440 O
as NCT03922230 441 443 O
eating NCT03922230 444 450 O
fresh NCT03922230 451 456 O
fruits NCT03922230 457 463 O
and NCT03922230 464 467 O
vegetables NCT03922230 468 478 O
, NCT03922230 479 480 O
eating NCT03922230 481 487 O
preserved NCT03922230 488 497 O
food NCT03922230 498 502 O
, NCT03922230 503 504 O
etc NCT03922230 505 508 O
. NCT03922230 509 510 O
) NCT03922230 511 512 O
are NCT03922230 513 516 O
consistent NCT03922230 517 527 O
, NCT03922230 528 529 O
other NCT03922230 530 535 O
factors NCT03922230 536 543 B-Condition
( NCT03922230 544 545 O
such NCT03922230 546 550 O
as NCT03922230 551 553 O
BMI NCT03922230 554 557 B-Observation
, NCT03922230 558 559 O
smoking NCT03922230 560 567 B-Condition
, NCT03922230 568 569 O
drinking NCT03922230 570 578 B-Condition
, NCT03922230 579 580 O
etc NCT03922230 581 584 O
. NCT03922230 585 586 O
) NCT03922230 587 588 O
as NCT03922230 589 591 O
much NCT03922230 592 596 O
as NCT03922230 597 599 O
possible NCT03922230 600 608 O
. NCT03922230 609 610 O
3 NCT03922230 612 613 O
In NCT03922230 614 616 O
order NCT03922230 617 622 O
to NCT03922230 623 625 O
rule NCT03922230 626 630 O
out NCT03922230 631 634 O
the NCT03922230 635 638 O
interference NCT03922230 639 651 O
of NCT03922230 652 654 O
other NCT03922230 655 660 O
diseases NCT03922230 661 669 O
, NCT03922230 670 671 O
each NCT03922230 672 676 O
sample NCT03922230 677 683 O
needs NCT03922230 684 689 O
to NCT03922230 690 692 O
be NCT03922230 693 695 O
determined NCT03922230 696 706 O
to NCT03922230 707 709 O
have NCT03922230 710 714 O
no NCT03922230 715 717 B-Negation
history NCT03922230 718 725 B-Eq_Comparison
of NCT03922230 726 728 O
other NCT03922230 729 734 O
diseases NCT03922230 735 743 B-Condition
( NCT03922230 744 745 O
such NCT03922230 746 750 O
as NCT03922230 751 753 O
neurodegenerative NCT03922230 754 771 B-Condition
diseases NCT03922230 772 780 I-Condition
, NCT03922230 781 782 O
leukemia NCT03922230 783 791 B-Condition
) NCT03922230 792 793 O
. NCT03922230 794 795 O
） NCT03922230 796 797 O

3 NCT03922230 800 801 O
. NCT03922230 801 802 O
The NCT03922230 804 807 O
normal NCT03922230 808 814 O
population NCT03922230 815 825 O
comes NCT03922230 826 831 O
from NCT03922230 832 836 O
the NCT03922230 837 840 O
healthy NCT03922230 841 848 O
population NCT03922230 849 859 O
of NCT03922230 860 862 O
Nanfang NCT03922230 863 870 O
Hospital NCT03922230 871 879 O
Health NCT03922230 880 886 O
Center NCT03922230 887 893 O
of NCT03922230 894 896 O
Southern NCT03922230 897 905 O
Medical NCT03922230 906 913 O
University NCT03922230 914 924 O
. NCT03922230 925 926 O

Exclusion NCT03922230 928 937 O
Criteria NCT03922230 938 946 O
: NCT03922230 947 948 O

1 NCT03922230 952 953 O
. NCT03922230 953 954 O
Pre NCT03922230 956 959 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03922230 960 969 B-Procedure
patients NCT03922230 970 978 O
have NCT03922230 979 983 O
received NCT03922230 984 992 B-Eq_Comparison
relevant NCT03922230 993 1001 O
treatment NCT03922230 1002 1011 B-Procedure
, NCT03922230 1012 1013 O
such NCT03922230 1014 1018 O
as NCT03922230 1019 1021 O
radiotherapy NCT03922230 1022 1034 B-Procedure
and NCT03922230 1035 1038 O
chemotherapy NCT03922230 1039 1051 B-Procedure
; NCT03922230 1051 1052 O

2 NCT03922230 1055 1056 O
. NCT03922230 1056 1057 O
The NCT03922230 1059 1062 O
subject NCT03922230 1063 1070 O
has NCT03922230 1071 1074 O
other NCT03922230 1075 1080 O
diseases NCT03922230 1081 1089 B-Condition
, NCT03922230 1090 1091 O
such NCT03922230 1092 1096 O
as NCT03922230 1097 1099 O
tumors NCT03922230 1100 1106 B-Condition
in NCT03922230 1107 1109 O
other NCT03922230 1110 1115 O
parts NCT03922230 1116 1121 O
; NCT03922230 1121 1122 O

3 NCT03922230 1125 1126 O
. NCT03922230 1126 1127 O
Patients NCT03922230 1129 1137 O
do NCT03922230 1138 1140 O
not NCT03922230 1141 1144 O
meet NCT03922230 1145 1149 O
the NCT03922230 1150 1153 O
age NCT03922230 1154 1157 O
; NCT03922230 1157 1158 O

4 NCT03922230 1161 1162 O
. NCT03922230 1162 1163 O
There NCT03922230 1165 1170 O
is NCT03922230 1171 1173 O
no NCT03922230 1174 1176 B-Negation
guarantee NCT03922230 1177 1186 O
that NCT03922230 1187 1191 O
other NCT03922230 1192 1197 O
eating NCT03922230 1198 1204 O
habits NCT03922230 1205 1211 O
( NCT03922230 1212 1213 O
such NCT03922230 1214 1218 O
as NCT03922230 1219 1221 O
eating NCT03922230 1222 1228 O
fresh NCT03922230 1229 1234 O
fruits NCT03922230 1235 1241 O
and NCT03922230 1242 1245 O
vegetables NCT03922230 1246 1256 O
, NCT03922230 1257 1258 O
not NCT03922230 1259 1262 O
eating NCT03922230 1263 1269 O
preserved NCT03922230 1270 1279 O
foods NCT03922230 1280 1285 O
) NCT03922230 1286 1287 O
and NCT03922230 1288 1291 O
other NCT03922230 1292 1297 O
factors NCT03922230 1298 1305 B-Condition
( NCT03922230 1306 1307 O
such NCT03922230 1308 1312 O
as NCT03922230 1313 1315 O
BMI NCT03922230 1316 1319 B-Observation
, NCT03922230 1320 1321 O
smoking NCT03922230 1322 1329 B-Condition
, NCT03922230 1330 1331 O
drinking NCT03922230 1332 1340 B-Condition
, NCT03922230 1341 1342 O
etc NCT03922230 1343 1346 O
. NCT03922230 1347 1348 O
) NCT03922230 1349 1350 O
are NCT03922230 1351 1354 O
basically NCT03922230 1355 1364 O
the NCT03922230 1365 1368 O
same NCT03922230 1369 1373 O
. NCT03922230 1374 1375 O

Inclusion NCT03925519 0 9 O
Criteria NCT03925519 10 18 O
: NCT03925519 19 20 O

- NCT03925519 24 25 O
patients NCT03925519 27 35 O
with NCT03925519 36 40 O
type NCT03925519 41 45 B-Modifier
2 NCT03925519 46 47 I-Modifier
diabetes NCT03925519 48 56 B-Condition
for NCT03925519 57 60 O
more NCT03925519 61 65 B-Eq_Comparison
than NCT03925519 66 70 I-Eq_Comparison
5 NCT03925519 71 72 I-Eq_Comparison
years NCT03925519 73 78 I-Eq_Comparison
. NCT03925519 79 80 O

- NCT03925519 84 85 O
Patients NCT03925519 87 95 O
who NCT03925519 96 99 O
were NCT03925519 100 104 O
diagnosed NCT03925519 105 114 O
according NCT03925519 115 124 O
to NCT03925519 125 127 O
the NCT03925519 128 131 O
criteria NCT03925519 132 140 O
of NCT03925519 141 143 O
the NCT03925519 144 147 O
American NCT03925519 148 156 O
diabetes NCT03925519 157 165 O
association NCT03925519 166 177 O
. NCT03925519 178 179 O

- NCT03925519 183 184 O
Not NCT03925519 186 189 B-Negation
receiving NCT03925519 190 199 B-Eq_Comparison
any NCT03925519 200 203 O
drugs NCT03925519 204 209 B-Drug
affecting NCT03925519 210 219 O
the NCT03925519 220 223 O
data NCT03925519 224 228 O
obtained NCT03925519 229 237 O

- NCT03925519 240 241 O
had NCT03925519 243 246 O
Normal NCT03925519 247 253 O
daily NCT03925519 254 259 B-Eq_Comparison
diets NCT03925519 260 265 B-Observation

- NCT03925519 268 269 O
Not NCT03925519 271 274 B-Negation
participating NCT03925519 275 288 O
in NCT03925519 289 291 O
any NCT03925519 292 295 O
other NCT03925519 296 301 B-Other
exercise NCT03925519 302 310 B-Procedure
programs NCT03925519 311 319 I-Procedure

- NCT03925519 322 323 O
Without NCT03925519 325 332 B-Negation
any NCT03925519 333 336 O
musculoskeletal NCT03925519 337 352 B-Condition
disorders NCT03925519 353 362 I-Condition
affecting NCT03925519 363 372 O
an NCT03925519 373 375 O
exercise NCT03925519 376 384 B-Procedure
program NCT03925519 385 392 I-Procedure

Exclusion NCT03925519 393 402 O
Criteria NCT03925519 403 411 O
: NCT03925519 412 413 O

- NCT03925519 417 418 O
Exclusion NCT03925519 420 429 O
criteria NCT03925519 430 438 O
included NCT03925519 439 447 O
anemia NCT03925519 448 454 B-Condition
, NCT03925519 455 456 O
overt NCT03925519 457 462 O
complications NCT03925519 463 476 B-Condition
of NCT03925519 477 479 O
diabetes NCT03925519 480 488 B-Condition
like NCT03925519 489 493 O
nephropathy NCT03925519 494 505 B-Condition
, NCT03925519 506 507 O
neuropathy NCT03925519 508 518 B-Condition
, NCT03925519 519 520 O
retinopathy NCT03925519 521 532 B-Condition
, NCT03925519 533 534 O
obvious NCT03925519 535 542 O
ischemic NCT03925519 543 551 B-Condition
heart NCT03925519 552 557 I-Condition
disease NCT03925519 558 565 I-Condition
( NCT03925519 566 567 O
angina NCT03925519 568 574 B-Condition
, NCT03925519 575 576 O
myocardial NCT03925519 577 587 B-Condition
infarction NCT03925519 588 598 I-Condition
, NCT03925519 599 600 O
and NCT03925519 601 604 O
lead NCT03925519 605 609 B-Procedure
electrocardiogram NCT03925519 610 627 I-Procedure
abnormalities NCT03925519 628 641 O
) NCT03925519 642 643 O
, NCT03925519 644 645 O
HCV NCT03925519 646 649 B-Condition
, NCT03925519 650 651 O
HBV NCT03925519 652 655 B-Condition
, NCT03925519 656 657 O
chronic NCT03925519 658 665 O
liver NCT03925519 666 671 B-Modifier
and NCT03925519 672 675 B-Or
kidney NCT03925519 676 682 B-Modifier
diseases NCT03925519 683 691 B-Condition
, NCT03925519 692 693 O
hypothyroidism NCT03925519 694 708 B-Condition
, NCT03925519 709 710 O
and NCT03925519 711 714 B-Or
drugs NCT03925519 715 720 B-Drug
( NCT03925519 721 722 O
diuretics NCT03925519 723 732 B-Drug
; NCT03925519 732 733 O
oral NCT03925519 734 738 B-Drug
contraceptives NCT03925519 739 753 I-Drug
) NCT03925519 754 755 O
. NCT03925519 756 757 O

Inclusion NCT03862963 0 9 O
Criteria NCT03862963 10 18 O
: NCT03862963 19 20 O

- NCT03862963 24 25 O
Resident NCT03862963 27 35 O
of NCT03862963 36 38 O
the NCT03862963 39 42 O
Republic NCT03862963 43 51 O
of NCT03862963 52 54 O
Marshall NCT03862963 55 63 O
Islands NCT03862963 64 71 O

- NCT03862963 74 75 O
Aged NCT03862963 77 81 B-Age
18 NCT03862963 82 84 B-Eq_Comparison
- NCT03862963 85 86 I-Eq_Comparison
75 NCT03862963 87 89 I-Eq_Comparison
years NCT03862963 90 95 I-Eq_Comparison

- NCT03862963 98 99 O
HbA NCT03862963 101 104 B-Observation
1c NCT03862963 105 107 I-Observation
≥ NCT03862963 108 109 B-Eq_Comparison
8.0 NCT03862963 110 113 I-Eq_Comparison
% NCT03862963 114 115 I-Eq_Comparison
or NCT03862963 116 118 B-Or
diagnosed NCT03862963 119 128 O
with NCT03862963 129 133 O
T NCT03862963 134 135 B-Condition
2D NCT03862963 136 138 I-Condition
and NCT03862963 139 142 B-And
taking NCT03862963 143 149 B-Eq_Comparison
diabetes NCT03862963 150 158 B-Condition
medication NCT03862963 159 169 B-Drug

- NCT03862963 172 173 O
Medical NCT03862963 175 182 O
clearance NCT03862963 183 192 O
to NCT03862963 193 195 O
participate NCT03862963 196 207 O
from NCT03862963 208 212 O
Diabetes NCT03862963 213 221 O
Wellness NCT03862963 222 230 O
Center NCT03862963 231 237 O
( NCT03862963 238 239 O
DWC NCT03862963 240 243 O
) NCT03862963 244 245 O
physicians NCT03862963 246 256 B-Provider
. NCT03862963 257 258 O

Exclusion NCT03862963 260 269 O
Criteria NCT03862963 270 278 O
: NCT03862963 279 280 O

- NCT03862963 284 285 O
Recent NCT03862963 287 293 B-Eq_Comparison
( NCT03862963 294 295 O
≤ NCT03862963 296 297 B-Eq_Comparison
3 NCT03862963 298 299 I-Eq_Comparison
months NCT03862963 300 306 I-Eq_Comparison
) NCT03862963 307 308 O
change NCT03862963 309 315 O
in NCT03862963 316 318 O
a NCT03862963 319 320 O
diabetes NCT03862963 321 329 B-Condition
- NCT03862963 330 331 O
related NCT03862963 332 339 O
medication NCT03862963 340 350 B-Drug
dosage NCT03862963 351 357 O

- NCT03862963 360 361 O
A NCT03862963 363 364 O
physical NCT03862963 365 373 B-Modifier
or NCT03862963 374 376 B-Or
medical NCT03862963 377 384 B-Modifier
condition NCT03862963 385 394 B-Condition
that NCT03862963 395 399 O
would NCT03862963 400 405 B-Assertion___Assertion_Type_Value:hypothetical
impede NCT03862963 406 412 O
participation NCT03862963 413 426 O
in NCT03862963 427 429 O
the NCT03862963 430 433 O
lifestyle NCT03862963 434 443 B-Procedure
intervention NCT03862963 444 456 I-Procedure
( NCT03862963 457 458 O
e NCT03862963 459 460 O
. NCT03862963 461 462 O
g NCT03862963 463 464 O
. NCT03862963 465 466 O
, NCT03862963 467 468 O
wheel NCT03862963 469 474 B-Condition
- NCT03862963 475 476 I-Condition
chair NCT03862963 477 482 I-Condition
bound NCT03862963 483 488 I-Condition
, NCT03862963 489 490 O
unstable NCT03862963 491 499 O
angina NCT03862963 500 506 B-Condition
) NCT03862963 507 508 O

- NCT03862963 512 513 O
Evidence NCT03862963 515 523 O
of NCT03862963 524 526 O
significant NCT03862963 527 538 O
coronary NCT03862963 539 547 B-Condition
heart NCT03862963 548 553 I-Condition
disease NCT03862963 554 561 I-Condition

- NCT03862963 564 565 O
Previous NCT03862963 567 575 B-Eq_Comparison
participation NCT03862963 576 589 O
in NCT03862963 590 592 O
an NCT03862963 593 595 O
intensive NCT03862963 596 605 O
lifestyle NCT03862963 606 615 B-Procedure
intervention NCT03862963 616 628 I-Procedure

Inclusion NCT03864965 0 9 O
Criteria NCT03864965 10 18 O
: NCT03864965 19 20 O

- NCT03864965 24 25 O
Patients NCT03864965 27 35 O
having NCT03864965 36 42 O
mild NCT03864965 43 47 O
cognitive NCT03864965 48 57 B-Condition
impairment NCT03864965 58 68 I-Condition
( NCT03864965 69 70 O
MCI NCT03864965 71 74 B-Condition
) NCT03864965 75 76 O
or NCT03864965 77 79 B-Or
very NCT03864965 80 84 O
mild NCT03864965 85 89 B-Eq_Comparison
to NCT03864965 90 92 I-Eq_Comparison
mild NCT03864965 93 97 I-Eq_Comparison
dementia NCT03864965 98 106 B-Condition
( NCT03864965 107 108 O
CDR NCT03864965 109 112 B-Observation
0.5 NCT03864965 113 116 B-Eq_Comparison
- NCT03864965 117 118 I-Eq_Comparison
1 NCT03864965 119 120 I-Eq_Comparison
) NCT03864965 121 122 O
. NCT03864965 123 124 O

Exclusion NCT03864965 126 135 O
Criteria NCT03864965 136 144 O
: NCT03864965 145 146 O

- NCT03864965 150 151 O
Patients NCT03864965 153 161 O
with NCT03864965 162 166 O
moderate NCT03864965 167 175 B-Eq_Comparison
to NCT03864965 176 178 I-Eq_Comparison
severe NCT03864965 179 185 I-Eq_Comparison
dementia NCT03864965 186 194 B-Condition
( NCT03864965 195 196 O
CDR NCT03864965 197 200 B-Observation
2 NCT03864965 201 202 B-Eq_Comparison
- NCT03864965 203 204 I-Eq_Comparison
3 NCT03864965 205 206 I-Eq_Comparison
) NCT03864965 207 208 O
. NCT03864965 209 210 O


Inclusion NCT03863444 0 9 O
Criteria NCT03863444 10 18 O
: NCT03863444 19 20 O

- NCT03863444 24 25 O
( NCT03863444 27 28 O
1 NCT03863444 29 30 O
) NCT03863444 31 32 O
gestational NCT03863444 33 44 B-Observation
age NCT03863444 45 48 I-Observation
35 NCT03863444 49 51 B-Eq_Comparison
to NCT03863444 52 54 I-Eq_Comparison
39 NCT03863444 55 57 I-Eq_Comparison
weeks NCT03863444 58 63 I-Eq_Comparison

- NCT03863444 66 67 O
( NCT03863444 69 70 O
2 NCT03863444 71 72 O
) NCT03863444 73 74 O
adults NCT03863444 75 81 O

- NCT03863444 84 85 O
( NCT03863444 87 88 O
3 NCT03863444 89 90 O
) NCT03863444 91 92 O
primipara NCT03863444 93 102 B-Condition
and NCT03863444 103 106 B-And
their NCT03863444 107 112 O
spouses NCT03863444 113 120 B-Family_Member___Family_Member_Type:spouse

- NCT03863444 123 124 O
( NCT03863444 126 127 O
4 NCT03863444 128 129 O
) NCT03863444 130 131 O
having NCT03863444 132 138 B-Eq_Comparison
routine NCT03863444 139 146 O
prenatal NCT03863444 147 155 B-Modifier
visits NCT03863444 156 162 B-Encounter
and NCT03863444 163 166 B-And
plan NCT03863444 167 171 B-Assertion___Assertion_Type_Value:intention
to NCT03863444 172 174 O
have NCT03863444 175 179 O
the NCT03863444 180 183 O
birth NCT03863444 184 189 B-Birth
in NCT03863444 190 192 O
the NCT03863444 193 196 O
medical NCT03863444 197 204 O
center NCT03863444 205 211 O

- NCT03863444 214 215 O
( NCT03863444 217 218 O
5 NCT03863444 219 220 O
) NCT03863444 221 222 O
able NCT03863444 223 227 O
to NCT03863444 228 230 O
communicate NCT03863444 231 242 O
with NCT03863444 243 247 O
Mandarin NCT03863444 248 256 O
or NCT03863444 257 259 B-Or
Taiwanese NCT03863444 260 269 O

- NCT03863444 272 273 O
( NCT03863444 275 276 O
6 NCT03863444 277 278 O
) NCT03863444 279 280 O
willing NCT03863444 281 288 O
to NCT03863444 289 291 O
participate NCT03863444 292 303 O
in NCT03863444 304 306 O
this NCT03863444 307 311 O
study NCT03863444 312 317 O
and NCT03863444 318 321 O
give NCT03863444 322 326 O
written NCT03863444 327 334 O
inform NCT03863444 335 341 O
- NCT03863444 342 343 O
consent NCT03863444 344 351 O
forms NCT03863444 352 357 O

Exclusion NCT03863444 358 367 O
Criteria NCT03863444 368 376 O
: NCT03863444 377 378 O

- NCT03863444 382 383 O
( NCT03863444 385 386 O
1 NCT03863444 387 388 O
) NCT03863444 389 390 O
having NCT03863444 391 397 O
fetus NCT03863444 398 403 B-Condition
with NCT03863444 404 408 O
abnormality NCT03863444 409 420 O

- NCT03863444 423 424 O
( NCT03863444 426 427 O
2 NCT03863444 428 429 O
) NCT03863444 430 431 O
high NCT03863444 432 436 O
- NCT03863444 437 438 O
risk NCT03863444 439 443 B-Risk
pregnancy NCT03863444 444 453 B-Condition

- NCT03863444 456 457 O
( NCT03863444 459 460 O
3 NCT03863444 461 462 O
) NCT03863444 463 464 O
can NCT03863444 465 468 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03863444 468 471 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
room NCT03863444 472 476 B-Observation
- NCT03863444 477 478 I-Observation
in NCT03863444 479 481 I-Observation
due NCT03863444 482 485 O
to NCT03863444 486 488 O
newborn NCT03863444 489 496 B-Family_Member___Family_Member_Type:child
's NCT03863444 496 498 O
medical NCT03863444 499 506 B-Condition
conditions NCT03863444 507 517 I-Condition

Inclusion NCT03920293 0 9 O
Criteria NCT03920293 10 18 O
: NCT03920293 19 20 O

1 NCT03920293 24 25 O
. NCT03920293 25 26 O
Diagnosed NCT03920293 28 37 O
with NCT03920293 38 42 O
Myasthenia NCT03920293 43 53 B-Condition
Gravis NCT03920293 54 60 I-Condition
at NCT03920293 61 63 B-Eq_Comparison
least NCT03920293 64 69 I-Eq_Comparison
6 NCT03920293 70 71 I-Eq_Comparison
months NCT03920293 72 78 I-Eq_Comparison
( NCT03920293 79 80 O
180 NCT03920293 81 84 B-Eq_Comparison
days NCT03920293 85 89 I-Eq_Comparison
) NCT03920293 90 91 O
prior NCT03920293 92 97 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03920293 98 100 O
the NCT03920293 101 104 O
date NCT03920293 105 109 O
of NCT03920293 110 112 O
the NCT03920293 113 116 O
Screening NCT03920293 117 126 B-Study
Visit NCT03920293 127 132 O
as NCT03920293 133 135 O
confirmed NCT03920293 136 145 O
by NCT03920293 146 148 O
specific NCT03920293 149 157 O
criteria NCT03920293 158 166 O
. NCT03920293 167 168 O

2 NCT03920293 172 173 O
. NCT03920293 173 174 O
Myasthenia NCT03920293 176 186 B-Condition
Gravis NCT03920293 187 193 I-Condition
Foundation NCT03920293 194 204 I-Condition
of NCT03920293 205 207 I-Condition
America NCT03920293 208 215 I-Condition
Clinical NCT03920293 216 224 I-Condition
Classification NCT03920293 225 239 I-Condition
Class NCT03920293 240 245 B-Eq_Comparison
II NCT03920293 246 248 I-Eq_Comparison
to NCT03920293 249 251 I-Eq_Comparison
IV NCT03920293 252 254 I-Eq_Comparison
at NCT03920293 255 257 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03920293 258 267 B-Study
. NCT03920293 268 269 O

3 NCT03920293 273 274 O
. NCT03920293 274 275 O
MG NCT03920293 277 279 B-Observation
- NCT03920293 280 281 I-Observation
ADL NCT03920293 282 285 I-Observation
profile NCT03920293 286 293 O
must NCT03920293 294 298 O
be NCT03920293 299 301 O
≥ NCT03920293 302 303 B-Eq_Comparison
6 NCT03920293 304 305 I-Eq_Comparison
at NCT03920293 306 308 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03920293 309 318 B-Study
and NCT03920293 319 322 O
randomization NCT03920293 323 336 O
( NCT03920293 337 338 O
Day NCT03920293 339 342 O
1 NCT03920293 343 344 O
) NCT03920293 345 346 O
. NCT03920293 347 348 O

4 NCT03920293 352 353 O
. NCT03920293 353 354 O
Vaccinated NCT03920293 356 366 B-Immunization
against NCT03920293 367 374 O
meningococcal NCT03920293 375 388 B-Condition
infections NCT03920293 389 399 I-Condition
within NCT03920293 400 406 B-Eq_Comparison
3 NCT03920293 407 408 I-Eq_Comparison
years NCT03920293 409 414 I-Eq_Comparison
prior NCT03920293 415 420 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03920293 421 423 I-Temporal_Connection___Temporal_Connection_Type_Value:before
, NCT03920293 424 425 O
or NCT03920293 426 428 B-Or
at NCT03920293 429 431 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03920293 432 435 O
time NCT03920293 436 440 O
of NCT03920293 441 443 O
, NCT03920293 444 445 O
initiating NCT03920293 446 456 O
study NCT03920293 457 462 B-Study
drug NCT03920293 463 467 B-Drug
to NCT03920293 468 470 O
reduce NCT03920293 471 477 O
the NCT03920293 478 481 O
risk NCT03920293 482 486 B-Risk
of NCT03920293 487 489 O
meningococcal NCT03920293 490 503 B-Modifier
infection NCT03920293 504 513 B-Condition
( NCT03920293 514 515 O
N NCT03920293 516 517 B-Organism
meningitidis NCT03920293 518 530 I-Organism
) NCT03920293 531 532 O
. NCT03920293 533 534 O

Exclusion NCT03920293 536 545 O
Criteria NCT03920293 546 554 O
: NCT03920293 555 556 O

Medical NCT03920293 558 565 B-Condition
Conditions NCT03920293 566 576 I-Condition

1 NCT03920293 579 580 O
. NCT03920293 580 581 O
Any NCT03920293 583 586 O
active NCT03920293 587 593 B-Eq_Comparison
or NCT03920293 594 596 B-Or
untreated NCT03920293 597 606 B-Negation|B-Procedure
thymoma NCT03920293 607 614 B-Condition
. NCT03920293 615 616 O
History NCT03920293 618 625 B-Eq_Comparison
of NCT03920293 626 628 O
thymic NCT03920293 629 635 B-Condition
carcinoma NCT03920293 636 645 I-Condition
or NCT03920293 646 648 B-Or
thymic NCT03920293 649 655 B-Condition
malignancy NCT03920293 656 666 I-Condition
unless NCT03920293 667 673 B-Exception
deemed NCT03920293 674 680 O
cured NCT03920293 681 686 O
by NCT03920293 687 689 O
adequate NCT03920293 690 698 O
treatment NCT03920293 699 708 B-Procedure
with NCT03920293 709 713 B-And
no NCT03920293 714 716 B-Negation
evidence NCT03920293 717 725 O
of NCT03920293 726 728 O
recurrence NCT03920293 729 739 O
for NCT03920293 740 743 O
≥ NCT03920293 744 745 B-Eq_Comparison
5 NCT03920293 746 747 I-Eq_Comparison
years NCT03920293 748 753 I-Eq_Comparison
before NCT03920293 754 760 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03920293 761 770 B-Study
. NCT03920293 771 772 O

2 NCT03920293 776 777 O
. NCT03920293 777 778 O
History NCT03920293 780 787 B-Eq_Comparison
of NCT03920293 788 790 O
thymectomy NCT03920293 791 801 B-Procedure
within NCT03920293 802 808 B-Eq_Comparison
the NCT03920293 809 812 I-Eq_Comparison
12 NCT03920293 813 815 I-Eq_Comparison
months NCT03920293 816 822 I-Eq_Comparison
prior NCT03920293 823 828 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03920293 829 831 O
screening NCT03920293 832 841 B-Study
. NCT03920293 842 843 O

3 NCT03920293 847 848 O
. NCT03920293 848 849 O
History NCT03920293 851 858 B-Eq_Comparison
of NCT03920293 859 861 O
N NCT03920293 862 863 B-Organism
meningitidis NCT03920293 864 876 I-Organism
infection NCT03920293 877 886 B-Condition
. NCT03920293 887 888 O

4 NCT03920293 892 893 O
. NCT03920293 893 894 O
Use NCT03920293 896 899 O
of NCT03920293 900 902 O
the NCT03920293 903 906 O
following NCT03920293 907 916 O
within NCT03920293 917 923 O
the NCT03920293 924 927 O
time NCT03920293 928 932 O
period NCT03920293 933 939 O
specified NCT03920293 940 949 O
below NCT03920293 950 955 O
: NCT03920293 956 957 O

- NCT03920293 966 967 O
IV NCT03920293 969 971 B-Drug
immunoglobulin NCT03920293 972 986 I-Drug
within NCT03920293 987 993 B-Eq_Comparison
4 NCT03920293 994 995 I-Eq_Comparison
weeks NCT03920293 996 1001 I-Eq_Comparison
of NCT03920293 1002 1004 B-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03920293 1005 1018 B-Study

- NCT03920293 1026 1027 O
Use NCT03920293 1029 1032 O
of NCT03920293 1033 1035 O
plasma NCT03920293 1036 1042 B-Procedure
exchange NCT03920293 1043 1051 I-Procedure
within NCT03920293 1052 1058 B-Eq_Comparison
4 NCT03920293 1059 1060 I-Eq_Comparison
weeks NCT03920293 1061 1066 I-Eq_Comparison
of NCT03920293 1067 1069 B-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03920293 1070 1083 B-Study

- NCT03920293 1091 1092 O
Use NCT03920293 1094 1097 O
of NCT03920293 1098 1100 O
rituximab NCT03920293 1101 1110 B-Drug
within NCT03920293 1111 1117 B-Eq_Comparison
6 NCT03920293 1118 1119 I-Eq_Comparison
months NCT03920293 1120 1126 I-Eq_Comparison
of NCT03920293 1127 1129 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03920293 1130 1139 B-Study

5 NCT03920293 1142 1143 O
. NCT03920293 1143 1144 O
Participants NCT03920293 1146 1158 O
who NCT03920293 1159 1162 O
have NCT03920293 1163 1167 O
received NCT03920293 1168 1176 O
previous NCT03920293 1177 1185 B-Eq_Comparison
treatment NCT03920293 1186 1195 B-Procedure
with NCT03920293 1196 1200 O
complement NCT03920293 1201 1211 B-Drug
inhibitors NCT03920293 1212 1222 I-Drug
( NCT03920293 1223 1224 O
for NCT03920293 1225 1228 O
example NCT03920293 1229 1236 O
, NCT03920293 1237 1238 O
eculizumab NCT03920293 1239 1249 B-Drug
) NCT03920293 1250 1251 O
. NCT03920293 1252 1253 O

Inclusion NCT03928457 0 9 O
Criteria NCT03928457 10 18 O
: NCT03928457 19 20 O

- NCT03928457 24 25 O
preterm NCT03928457 27 34 B-Condition
neonates NCT03928457 35 43 O
born NCT03928457 44 48 B-Birth
at NCT03928457 49 51 B-Temporal_Connection___Temporal_Connection_Type_Value:during
26 NCT03928457 52 54 B-Eq_Comparison
to NCT03928457 55 57 I-Eq_Comparison
34 NCT03928457 58 60 I-Eq_Comparison
weeks NCT03928457 61 66 I-Eq_Comparison
of NCT03928457 67 69 O
gestational NCT03928457 70 81 B-Observation
age NCT03928457 82 85 I-Observation

- NCT03928457 88 89 O
signed NCT03928457 91 97 O
written NCT03928457 98 105 O
informed NCT03928457 106 114 O
consent NCT03928457 115 122 O
form NCT03928457 123 127 O

Exclusion NCT03928457 128 137 O
Criteria NCT03928457 138 146 O
: NCT03928457 147 148 O

- NCT03928457 152 153 O
infants NCT03928457 155 162 O
infected NCT03928457 163 171 B-Condition

- NCT03928457 174 175 O
infants NCT03928457 177 184 O
suffering NCT03928457 185 194 O
from NCT03928457 195 199 O
neurological NCT03928457 200 212 B-Condition
disorders NCT03928457 213 222 I-Condition

- NCT03928457 225 226 O
serious NCT03928457 228 235 O
heart NCT03928457 236 241 B-Modifier
, NCT03928457 242 243 O
respiratory NCT03928457 244 255 B-Modifier
, NCT03928457 256 257 O
digestive NCT03928457 258 267 B-Modifier
or NCT03928457 268 270 B-Or
metabolic NCT03928457 271 280 B-Modifier
diseases NCT03928457 281 289 B-Condition

- NCT03928457 292 293 O
infants NCT03928457 295 302 O
born NCT03928457 303 307 B-Birth
from NCT03928457 308 312 O
mothers NCT03928457 313 320 B-Family_Member___Family_Member_Type:mother
aged NCT03928457 321 325 B-Age
less NCT03928457 326 330 B-Eq_Comparison
than NCT03928457 331 335 I-Eq_Comparison
18 NCT03928457 336 338 I-Eq_Comparison
years NCT03928457 339 344 I-Eq_Comparison
old NCT03928457 345 348 O
or NCT03928457 349 351 B-Or
deprived NCT03928457 352 360 B-Observation
of NCT03928457 361 363 I-Observation
their NCT03928457 364 369 I-Observation
parental NCT03928457 370 378 I-Observation
rights NCT03928457 379 385 I-Observation

- NCT03928457 388 389 O
non NCT03928457 391 394 B-Negation
covered NCT03928457 395 402 O
by NCT03928457 403 405 O
national NCT03928457 406 414 O
health NCT03928457 415 421 O
insurance NCT03928457 422 431 O

Inclusion NCT03867825 0 9 O
Criteria NCT03867825 10 18 O
: NCT03867825 19 20 O

- NCT03867825 24 25 O
Newborn NCT03867825 27 34 O
infants NCT03867825 35 42 O

Exclusion NCT03867825 43 52 O
Criteria NCT03867825 53 61 O
: NCT03867825 62 63 O

- NCT03867825 67 68 O
Infants NCT03867825 70 77 O
> NCT03867825 78 79 B-Eq_Comparison
1 NCT03867825 80 81 I-Eq_Comparison
month NCT03867825 82 87 I-Eq_Comparison
of NCT03867825 88 90 O
age NCT03867825 91 94 B-Age

Inclusion NCT03862274 0 9 O
Criteria NCT03862274 10 18 O
: NCT03862274 19 20 O

- NCT03862274 24 25 O
Patients NCT03862274 27 35 O
that NCT03862274 36 40 O
have NCT03862274 41 45 O
a NCT03862274 46 47 O
TPP NCT03862274 48 51 B-Modifier
1 NCT03862274 52 53 I-Modifier
enzyme NCT03862274 54 60 B-Condition
deficiency NCT03862274 61 71 I-Condition

- NCT03862274 74 75 O
Patients NCT03862274 77 85 O
have NCT03862274 86 90 O
confirmed NCT03862274 91 100 O
molecular NCT03862274 101 110 B-Procedure
diagnosis NCT03862274 111 120 O
of NCT03862274 121 123 O
pathogenic NCT03862274 124 134 B-Condition
variants NCT03862274 135 143 I-Condition
in NCT03862274 144 146 O
the NCT03862274 147 150 O
TPP NCT03862274 151 154 B-Modifier
1 NCT03862274 155 156 I-Modifier
gene NCT03862274 157 161 I-Modifier

- NCT03862274 164 165 O
Patients NCT03862274 167 175 O
that NCT03862274 176 180 O
are NCT03862274 181 184 O
enrolled NCT03862274 185 193 O
in NCT03862274 194 196 O
post NCT03862274 197 201 O
- NCT03862274 202 203 O
marketing NCT03862274 204 213 O
studies NCT03862274 214 221 O
will NCT03862274 222 226 O
be NCT03862274 227 229 O
allowed NCT03862274 230 237 O
to NCT03862274 238 240 O
enroll NCT03862274 241 247 O
into NCT03862274 248 252 O
the NCT03862274 253 256 O
current NCT03862274 257 264 O
study NCT03862274 265 270 O

Exclusion NCT03862274 271 280 O
Criteria NCT03862274 281 289 O
: NCT03862274 290 291 O

- NCT03862274 295 296 O
Patients NCT03862274 298 306 O
without NCT03862274 307 314 B-Negation
a NCT03862274 315 316 O
diagnosis NCT03862274 317 326 O
of NCT03862274 327 329 O
CLN NCT03862274 330 333 B-Condition
2 NCT03862274 334 335 I-Condition
and NCT03862274 336 339 B-Or
deficiency NCT03862274 340 350 B-Condition
of NCT03862274 351 353 O
TPP NCT03862274 354 357 B-Modifier
1 NCT03862274 358 359 I-Modifier

- NCT03862274 362 363 O
Patients NCT03862274 365 373 O
that NCT03862274 374 378 O
are NCT03862274 379 382 O
currently NCT03862274 383 392 B-Eq_Comparison
enrolled NCT03862274 393 401 O
as NCT03862274 402 404 O
part NCT03862274 405 409 O
of NCT03862274 410 412 O
a NCT03862274 413 414 O
larger NCT03862274 415 421 O
multi NCT03862274 422 427 O
- NCT03862274 428 429 O
center NCT03862274 430 436 O
clinical NCT03862274 437 445 O
trial NCT03862274 446 451 B-Study

Inclusion NCT03923101 0 9 O
Criteria NCT03923101 10 18 O
: NCT03923101 19 20 O

- NCT03923101 24 25 O
All NCT03923101 27 30 O
Keratoconus NCT03923101 31 42 B-Condition
patients NCT03923101 43 51 O
presenting NCT03923101 52 62 B-Encounter
in NCT03923101 63 65 O
the NCT03923101 66 69 O
department NCT03923101 70 80 O
of NCT03923101 81 83 O
ophthalmology NCT03923101 84 97 O
, NCT03923101 98 99 O
Saarland NCT03923101 100 108 O
University NCT03923101 109 119 O
Medical NCT03923101 120 127 O
Center NCT03923101 128 134 O
, NCT03923101 135 136 O
Homburg NCT03923101 137 144 O
, NCT03923101 145 146 O
Saarland NCT03923101 147 155 O
, NCT03923101 156 157 O
Germany NCT03923101 158 165 O
. NCT03923101 166 167 O

Exclusion NCT03923101 169 178 O
Criteria NCT03923101 179 187 O
: NCT03923101 188 189 O

- NCT03923101 193 194 O
Patients NCT03923101 196 204 O
without NCT03923101 205 212 B-Negation
Keratoconus NCT03923101 213 224 B-Condition
. NCT03923101 225 226 O

Inclusion NCT03929718 0 9 O
Criteria NCT03929718 10 18 O
: NCT03929718 19 20 O

- NCT03929718 24 25 O
diagnosis NCT03929718 27 36 O
of NCT03929718 37 39 O
typical NCT03929718 40 47 B-Modifier
AFL NCT03929718 48 51 B-Condition
confirmed NCT03929718 52 61 O
by NCT03929718 62 64 O
12 NCT03929718 65 67 B-Procedure
- NCT03929718 68 69 I-Procedure
lead NCT03929718 70 74 I-Procedure
ECG NCT03929718 75 78 I-Procedure

- NCT03929718 81 82 O
no NCT03929718 84 86 B-Negation
documented NCT03929718 87 97 O
AF NCT03929718 98 100 B-Condition
on NCT03929718 101 103 O
ECG NCT03929718 104 107 B-Procedure
, NCT03929718 108 109 O
ambulatory NCT03929718 110 120 B-Procedure
monitor NCT03929718 121 128 I-Procedure
, NCT03929718 129 130 O
pacemaker NCT03929718 131 140 B-Procedure
or NCT03929718 141 143 B-Or
ICD NCT03929718 144 147 B-Procedure
at NCT03929718 148 150 O
any NCT03929718 151 154 B-Eq_Comparison
time NCT03929718 155 159 I-Eq_Comparison

- NCT03929718 162 163 O
scheduled NCT03929718 165 174 B-Eq_Comparison
to NCT03929718 175 177 O
undergo NCT03929718 178 185 O
catheter NCT03929718 186 194 B-Procedure
ablation NCT03929718 195 203 I-Procedure
of NCT03929718 204 206 O
the NCT03929718 207 210 O
CTI NCT03929718 211 214 B-Modifier
for NCT03929718 215 218 O
treatment NCT03929718 219 228 B-Procedure
of NCT03929718 229 231 O
AFL NCT03929718 232 235 B-Condition

- NCT03929718 238 239 O
history NCT03929718 241 248 B-Eq_Comparison
of NCT03929718 249 251 O
hypertension NCT03929718 252 264 B-Condition
( NCT03929718 265 266 O
HTN NCT03929718 267 270 B-Condition
) NCT03929718 271 272 O
or NCT03929718 273 275 B-Or
heart NCT03929718 276 281 B-Condition
failure NCT03929718 282 289 I-Condition
( NCT03929718 290 291 O
HF NCT03929718 292 294 B-Condition
) NCT03929718 295 296 O
( NCT03929718 297 298 O
reduced NCT03929718 299 306 B-Modifier
or NCT03929718 307 309 B-Or
preserved NCT03929718 310 319 B-Modifier
systolic NCT03929718 320 328 B-Condition
function NCT03929718 329 337 I-Condition
) NCT03929718 338 339 O

Exclusion NCT03929718 341 350 O
Criteria NCT03929718 351 359 O
: NCT03929718 360 361 O

- NCT03929718 365 366 O
history NCT03929718 368 375 B-Eq_Comparison
of NCT03929718 376 378 O
known NCT03929718 379 384 O
AF NCT03929718 385 387 B-Condition
episodes NCT03929718 388 396 O

- NCT03929718 399 400 O
previous NCT03929718 402 410 B-Eq_Comparison
CTI NCT03929718 411 414 B-Modifier
or NCT03929718 415 417 B-Or
PVI NCT03929718 418 421 B-Modifier
ablation NCT03929718 422 430 B-Procedure
procedure NCT03929718 431 440 I-Procedure

- NCT03929718 443 444 O
other NCT03929718 446 451 B-Other
SVT NCT03929718 452 455 B-Condition
mechanisms NCT03929718 456 466 I-Condition
demonstrated NCT03929718 467 479 O
( NCT03929718 480 481 O
AVNRT NCT03929718 482 487 B-Condition
, NCT03929718 488 489 O
AVRT NCT03929718 490 494 B-Condition
or NCT03929718 495 497 B-Or
accessory NCT03929718 498 507 B-Condition
pathways NCT03929718 508 516 I-Condition
) NCT03929718 517 518 O

- NCT03929718 522 523 O
amiodarone NCT03929718 525 535 B-Drug
usage NCT03929718 536 541 O
within NCT03929718 542 548 B-Eq_Comparison
the NCT03929718 549 552 I-Eq_Comparison
past NCT03929718 553 557 I-Eq_Comparison
3 NCT03929718 558 559 I-Eq_Comparison
months NCT03929718 560 566 I-Eq_Comparison
, NCT03929718 567 568 O

- NCT03929718 572 573 O
unwillingness NCT03929718 575 588 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03929718 589 591 O
participate NCT03929718 592 603 O
or NCT03929718 604 606 O
undergo NCT03929718 607 614 O
insertable NCT03929718 615 625 B-Procedure
monitor NCT03929718 626 633 I-Procedure
implantation NCT03929718 634 646 I-Procedure

- NCT03929718 649 650 O
hyperkalemia NCT03929718 652 664 B-Condition
( NCT03929718 665 666 O
potassium NCT03929718 667 676 B-Observation
> NCT03929718 677 678 B-Eq_Comparison
5.0 NCT03929718 679 682 I-Eq_Comparison
mEq NCT03929718 683 686 I-Eq_Comparison
/ NCT03929718 687 688 I-Eq_Comparison
L NCT03929718 689 690 I-Eq_Comparison
) NCT03929718 691 692 O

- NCT03929718 696 697 O
severe NCT03929718 699 705 O
renal NCT03929718 706 711 B-Condition
disease NCT03929718 712 719 I-Condition
( NCT03929718 720 721 O
Cr NCT03929718 722 724 B-Observation
> NCT03929718 725 726 B-Eq_Comparison
2.5 NCT03929718 727 730 I-Eq_Comparison
mg NCT03929718 731 733 I-Eq_Comparison
/ NCT03929718 734 735 I-Eq_Comparison
dL NCT03929718 736 738 I-Eq_Comparison
[ NCT03929718 739 740 O
men NCT03929718 741 744 O
] NCT03929718 745 746 O
, NCT03929718 747 748 O
> NCT03929718 749 750 B-Eq_Comparison
2.0 NCT03929718 751 754 I-Eq_Comparison
mg NCT03929718 755 757 I-Eq_Comparison
/ NCT03929718 758 759 I-Eq_Comparison
dL NCT03929718 760 762 I-Eq_Comparison
[ NCT03929718 763 764 O
women NCT03929718 765 770 O
, NCT03929718 771 772 O
GFR NCT03929718 773 776 B-Observation
< NCT03929718 777 778 B-Eq_Comparison
30 NCT03929718 779 781 I-Eq_Comparison
mL NCT03929718 782 784 I-Eq_Comparison
/ NCT03929718 785 786 I-Eq_Comparison
min NCT03929718 787 790 I-Eq_Comparison
/ NCT03929718 791 792 I-Eq_Comparison
1.73 NCT03929718 793 797 I-Eq_Comparison
m NCT03929718 798 799 I-Eq_Comparison
2 NCT03929718 800 801 I-Eq_Comparison
) NCT03929718 802 803 O

- NCT03929718 807 808 O
life NCT03929718 810 814 B-Observation
expectancy NCT03929718 815 825 I-Observation
< NCT03929718 826 827 B-Eq_Comparison
18 NCT03929718 828 830 I-Eq_Comparison
months NCT03929718 831 837 I-Eq_Comparison

- NCT03929718 840 841 O
prior NCT03929718 843 848 B-Eq_Comparison
intolerance NCT03929718 849 860 B-Condition
to NCT03929718 861 863 O
treatment NCT03929718 864 873 B-Procedure
with NCT03929718 874 878 O
an NCT03929718 879 881 O
aldosterone NCT03929718 882 893 B-Drug
antagonist NCT03929718 894 904 I-Drug

- NCT03929718 907 908 O
current NCT03929718 910 917 B-Eq_Comparison
treatment NCT03929718 918 927 B-Procedure
with NCT03929718 928 932 O
an NCT03929718 933 935 O
aldosterone NCT03929718 936 947 B-Drug
antagonist NCT03929718 948 958 I-Drug

- NCT03929718 961 962 O
need NCT03929718 964 968 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03929718 969 972 I-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03929718 973 982 B-Procedure
with NCT03929718 983 987 O
a NCT03929718 988 989 O
class NCT03929718 990 995 B-Eq_Comparison
I NCT03929718 996 997 I-Eq_Comparison
or NCT03929718 998 1000 I-Eq_Comparison
III NCT03929718 1001 1004 I-Eq_Comparison
AAD NCT03929718 1005 1008 B-Drug
for NCT03929718 1009 1012 O
another NCT03929718 1013 1020 B-Other
indication NCT03929718 1021 1031 B-Indication

- NCT03929718 1034 1035 O
operative NCT03929718 1037 1046 B-Modifier
AFL NCT03929718 1047 1050 B-Condition
( NCT03929718 1051 1052 O
occurring NCT03929718 1053 1062 O
within NCT03929718 1063 1069 B-Eq_Comparison
30 NCT03929718 1070 1072 I-Eq_Comparison
days NCT03929718 1073 1077 I-Eq_Comparison
of NCT03929718 1078 1080 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03929718 1081 1088 B-Procedure
) NCT03929718 1089 1090 O
that NCT03929718 1091 1095 O
is NCT03929718 1096 1098 O
expected NCT03929718 1099 1107 O
to NCT03929718 1108 1110 O
resolve NCT03929718 1111 1118 O

- NCT03929718 1121 1122 O
presence NCT03929718 1124 1132 O
of NCT03929718 1133 1135 O
a NCT03929718 1136 1137 O
cardiac NCT03929718 1138 1145 B-Procedure
rhythm NCT03929718 1146 1152 I-Procedure
device NCT03929718 1153 1159 I-Procedure
( NCT03929718 1160 1161 O
pacemaker NCT03929718 1162 1171 B-Procedure
or NCT03929718 1172 1174 B-Or
ICD NCT03929718 1175 1178 B-Procedure
) NCT03929718 1179 1180 O
capable NCT03929718 1181 1188 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03929718 1189 1191 O
AF NCT03929718 1192 1194 B-Procedure
monitoring NCT03929718 1195 1205 I-Procedure

- NCT03929718 1208 1209 O
currently NCT03929718 1211 1220 B-Eq_Comparison
pregnant NCT03929718 1221 1229 B-Condition
or NCT03929718 1230 1232 B-Or
nursing NCT03929718 1233 1240 B-Condition
a NCT03929718 1241 1242 I-Condition
child NCT03929718 1243 1248 I-Condition

- NCT03929718 1251 1252 O
unwilling NCT03929718 1254 1263 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03929718 1264 1267 B-Negation
to NCT03929718 1268 1270 O
become NCT03929718 1271 1277 O
pregnant NCT03929718 1278 1286 B-Condition
and NCT03929718 1287 1290 B-And
to NCT03929718 1291 1293 O
use NCT03929718 1294 1297 O
birth NCT03929718 1298 1303 B-Procedure
control NCT03929718 1304 1311 I-Procedure
while NCT03929718 1312 1317 B-Temporal_Connection___Temporal_Connection_Type_Value:during
taking NCT03929718 1318 1324 B-Eq_Comparison
spironolactone NCT03929718 1325 1339 B-Drug

Inclusion NCT03863717 0 9 O
Criteria NCT03863717 10 18 O
: NCT03863717 19 20 O

- NCT03863717 24 25 O
Diagnosis NCT03863717 27 36 O
of NCT03863717 37 39 O
COPD NCT03863717 40 44 B-Condition
confirmed NCT03863717 45 54 O
by NCT03863717 55 57 O
clinical NCT03863717 58 66 B-Observation
examination NCT03863717 67 78 I-Observation
and NCT03863717 79 82 B-And
a NCT03863717 83 84 O
pulmonary NCT03863717 85 94 B-Observation
function NCT03863717 95 103 I-Observation
test NCT03863717 104 108 I-Observation

- NCT03863717 111 112 O
Stable NCT03863717 114 120 O
clinical NCT03863717 121 129 B-Condition
condition NCT03863717 130 139 I-Condition
( NCT03863717 140 141 O
without NCT03863717 142 149 B-Negation
recent NCT03863717 150 156 B-Eq_Comparison
respiratory NCT03863717 157 168 B-Condition
system NCT03863717 169 175 I-Condition
infections NCT03863717 176 186 I-Condition
or NCT03863717 187 189 B-Or
any NCT03863717 190 193 O
exacerbation NCT03863717 194 206 O
of NCT03863717 207 209 O
the NCT03863717 210 213 O
disease NCT03863717 214 221 O
) NCT03863717 222 223 O

- NCT03863717 227 228 O
Patients NCT03863717 230 238 O
must NCT03863717 239 243 O
be NCT03863717 244 246 O
willing NCT03863717 247 254 O
to NCT03863717 255 257 O
re NCT03863717 258 260 O
evaluate NCT03863717 261 269 O
at NCT03863717 270 272 O
the NCT03863717 273 276 O
end NCT03863717 277 280 O
of NCT03863717 281 283 O
the NCT03863717 284 287 O
study NCT03863717 288 293 O

- NCT03863717 296 297 O
Patients NCT03863717 299 307 O
must NCT03863717 308 312 O
be NCT03863717 313 315 O
willing NCT03863717 316 323 O
to NCT03863717 324 326 O
give NCT03863717 327 331 O
written NCT03863717 332 339 O
consent NCT03863717 340 347 O
for NCT03863717 348 351 O
their NCT03863717 352 357 O
participation NCT03863717 358 371 O
in NCT03863717 372 374 O
the NCT03863717 375 378 O
study NCT03863717 379 384 O

Exclusion NCT03863717 385 394 O
Criteria NCT03863717 395 403 O
: NCT03863717 404 405 O

- NCT03863717 409 410 O
Age NCT03863717 412 415 B-Age
< NCT03863717 416 417 B-Eq_Comparison
18 NCT03863717 418 420 I-Eq_Comparison
years NCT03863717 421 426 I-Eq_Comparison
old NCT03863717 427 430 O

- NCT03863717 433 434 O
Unstable NCT03863717 436 444 O
cardiac NCT03863717 445 452 B-Condition
disease NCT03863717 453 460 I-Condition

- NCT03863717 463 464 O
Musculoskeletal NCT03863717 466 481 B-Modifier
and NCT03863717 482 485 B-Or
neurological NCT03863717 486 498 B-Modifier
diseases NCT03863717 499 507 B-Condition
that NCT03863717 508 512 O
could NCT03863717 513 518 O
affect NCT03863717 519 525 O
exercise NCT03863717 526 534 O
performance NCT03863717 535 546 O
or NCT03863717 547 549 O
preclude NCT03863717 550 558 O
exercise NCT03863717 559 567 O

- NCT03863717 570 571 O
Patients NCT03863717 573 581 O
of NCT03863717 582 584 O
COPD NCT03863717 585 589 B-Condition
final NCT03863717 590 595 B-Modifier
stage NCT03863717 596 601 I-Modifier
or NCT03863717 602 604 B-Or
other NCT03863717 605 610 O
serious NCT03863717 611 618 O
disease NCT03863717 619 626 B-Condition
final NCT03863717 627 632 B-Modifier
stage NCT03863717 633 638 I-Modifier

- NCT03863717 641 642 O
Significant NCT03863717 644 655 O
cognitive NCT03863717 656 665 B-Modifier
or NCT03863717 666 668 B-Or
psychiatric NCT03863717 669 680 B-Modifier
impairment NCT03863717 681 691 B-Condition
that NCT03863717 692 696 O
would NCT03863717 697 702 B-Assertion___Assertion_Type_Value:hypothetical
lead NCT03863717 703 707 O
to NCT03863717 708 710 O
an NCT03863717 711 713 O
inability NCT03863717 714 723 B-Condition
to NCT03863717 724 726 I-Condition
follow NCT03863717 727 733 I-Condition
simple NCT03863717 734 740 I-Condition
commands NCT03863717 741 749 I-Condition
in NCT03863717 750 752 O
a NCT03863717 753 754 O
group NCT03863717 755 760 O
setting NCT03863717 761 768 O

Inclusion NCT03926676 0 9 O
Criteria NCT03926676 10 18 O
: NCT03926676 19 20 O

- NCT03926676 24 25 O
patients NCT03926676 27 35 O
with NCT03926676 36 40 O
badly NCT03926676 41 46 B-Modifier
broken NCT03926676 47 53 B-Condition
vital NCT03926676 54 59 I-Condition
teeth NCT03926676 60 65 I-Condition

good NCT03926676 66 70 B-Modifier
oral NCT03926676 71 75 B-Condition
hygiene NCT03926676 76 83 I-Condition
measures NCT03926676 84 92 O

young NCT03926676 93 98 O
adults NCT03926676 99 105 O
males NCT03926676 106 111 O
or NCT03926676 112 114 B-Or
females NCT03926676 115 122 O

cooperative NCT03926676 123 134 O
patients NCT03926676 135 143 O
approving NCT03926676 144 153 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926676 154 156 O
participate NCT03926676 157 168 O
in NCT03926676 169 171 O
the NCT03926676 172 175 O
study NCT03926676 176 181 B-Study

Exclusion NCT03926676 182 191 O
Criteria NCT03926676 192 200 O
: NCT03926676 201 202 O

- NCT03926676 206 207 O
patients NCT03926676 209 217 O
with NCT03926676 218 222 O
compromised NCT03926676 223 234 B-Modifier
medical NCT03926676 235 242 B-Condition
history NCT03926676 243 250 I-Condition

lack NCT03926676 251 255 O
of NCT03926676 256 258 O
compliance NCT03926676 259 269 O

severe NCT03926676 270 276 O
medical NCT03926676 277 284 B-Condition
condition NCT03926676 285 294 I-Condition

severe NCT03926676 295 301 O
or NCT03926676 302 304 B-Or
active NCT03926676 305 311 B-Eq_Comparison
periodontal NCT03926676 312 323 B-Condition
disease NCT03926676 324 331 I-Condition

Inclusion NCT03923595 0 9 O
Criteria NCT03923595 10 18 O
: NCT03923595 19 20 O

- NCT03923595 24 25 O
all NCT03923595 27 30 O
consecutive NCT03923595 31 42 O
patients NCT03923595 43 51 O
from NCT03923595 52 56 O
SERD NCT03923595 57 61 O
of NCT03923595 62 64 O
18 NCT03923595 65 67 B-Eq_Comparison
yrs NCT03923595 68 71 I-Eq_Comparison
or NCT03923595 72 74 I-Eq_Comparison
older NCT03923595 75 80 I-Eq_Comparison
either NCT03923595 81 87 O
naive NCT03923595 88 93 B-Condition
or NCT03923595 94 96 B-Or
previously NCT03923595 97 107 B-Eq_Comparison
treated NCT03923595 108 115 B-Procedure
including NCT03923595 116 125 O
HBsAg NCT03923595 126 131 B-Condition
positive NCT03923595 132 140 O
and NCT03923595 141 144 B-Or
HIV NCT03923595 145 148 B-Condition
positive NCT03923595 149 157 O
. NCT03923595 158 159 O

Exclusion NCT03923595 161 170 O
Criteria NCT03923595 171 179 O
: NCT03923595 180 181 O

- NCT03923595 185 186 O
GFR NCT03923595 188 191 B-Observation
< NCT03923595 192 193 B-Eq_Comparison
50 NCT03923595 194 196 I-Eq_Comparison
ml NCT03923595 197 199 I-Eq_Comparison
/ NCT03923595 200 201 I-Eq_Comparison
min NCT03923595 202 205 I-Eq_Comparison
, NCT03923595 206 207 O
pregnancy NCT03923595 208 217 B-Condition
, NCT03923595 218 219 O
breast NCT03923595 220 226 B-Condition
- NCT03923595 227 228 I-Condition
feeding NCT03923595 229 236 I-Condition
, NCT03923595 237 238 O
cirrhosis NCT03923595 239 248 B-Condition
of NCT03923595 249 251 B-And
CHILD NCT03923595 252 257 B-Condition
- NCT03923595 258 259 I-Condition
PUGH NCT03923595 260 264 I-Condition
- NCT03923595 265 266 I-Condition
TURCOTTE NCT03923595 267 275 I-Condition
B NCT03923595 276 277 B-Eq_Comparison
7 NCT03923595 278 279 I-Eq_Comparison
o NCT03923595 280 281 I-Eq_Comparison
> NCT03923595 282 283 I-Eq_Comparison
. NCT03923595 284 285 O

Inclusion NCT03864549 0 9 O
Criteria NCT03864549 10 18 O
: NCT03864549 19 20 O

- NCT03864549 24 25 O
Pregnant NCT03864549 27 35 B-Condition
women NCT03864549 36 41 O
who NCT03864549 42 45 B-And
were NCT03864549 46 50 O
diagnosed NCT03864549 51 60 O
with NCT03864549 61 65 O
GDM NCT03864549 66 69 B-Condition
from NCT03864549 70 74 B-Temporal_Connection___Temporal_Connection_Type_Value:during
13 NCT03864549 75 77 B-Eq_Comparison
to NCT03864549 78 80 I-Eq_Comparison
32.6 NCT03864549 81 85 I-Eq_Comparison
gestational NCT03864549 86 97 B-Observation
weeks NCT03864549 98 103 O

- NCT03864549 106 107 O
18 NCT03864549 109 111 B-Eq_Comparison
years NCT03864549 112 117 I-Eq_Comparison
old NCT03864549 118 121 I-Eq_Comparison
and NCT03864549 122 125 I-Eq_Comparison
older NCT03864549 126 131 I-Eq_Comparison

- NCT03864549 134 135 O
Singleton NCT03864549 137 146 B-Modifier
pregnancy NCT03864549 147 156 B-Condition

Exclusion NCT03864549 157 166 O
Criteria NCT03864549 167 175 O
: NCT03864549 176 177 O

- NCT03864549 181 182 O
Women NCT03864549 184 189 O
with NCT03864549 190 194 B-And
pre NCT03864549 195 198 B-Modifier
- NCT03864549 199 200 I-Modifier
gestational NCT03864549 201 212 I-Modifier
diabetes NCT03864549 213 221 B-Condition
mellitus NCT03864549 222 230 I-Condition

- NCT03864549 233 234 O
GDM NCT03864549 236 239 B-Condition
diagnosed NCT03864549 240 249 O
≥ NCT03864549 250 251 B-Eq_Comparison
33 NCT03864549 252 254 I-Eq_Comparison
gestational NCT03864549 255 266 B-Observation
weeks NCT03864549 267 272 O

- NCT03864549 275 276 O
Women NCT03864549 278 283 O
using NCT03864549 284 289 B-Eq_Comparison
prophylactic NCT03864549 290 302 B-Procedure
antimicrobial NCT03864549 303 316 I-Procedure
treatment NCT03864549 317 326 I-Procedure

- NCT03864549 329 330 O
Immunocompromised NCT03864549 332 349 B-Condition
women NCT03864549 350 355 O

- NCT03864549 358 359 O
Multiple NCT03864549 361 369 B-Eq_Comparison
pregnancy NCT03864549 370 379 B-Condition

- NCT03864549 382 383 O
Women NCT03864549 385 390 O
taking NCT03864549 391 397 B-Eq_Comparison
oral NCT03864549 398 402 B-Modifier
probiotic NCT03864549 403 412 B-Drug
products NCT03864549 413 421 I-Drug
who NCT03864549 422 425 B-And
refuse NCT03864549 426 432 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864549 433 435 I-Assertion___Assertion_Type_Value:hypothetical
stop NCT03864549 436 440 B-Negation
the NCT03864549 441 444 O
consumption NCT03864549 445 456 O
( NCT03864549 457 458 O
food NCT03864549 459 463 B-Modifier
- NCT03864549 464 465 I-Modifier
containing NCT03864549 466 476 I-Modifier
probiotics NCT03864549 477 487 B-Drug
is NCT03864549 488 490 O
not NCT03864549 491 494 B-Exception
considered NCT03864549 495 505 I-Exception
an NCT03864549 506 508 O
exclusion NCT03864549 509 518 O
criterion NCT03864549 519 528 O
) NCT03864549 529 530 O
. NCT03864549 531 532 O

Inclusion NCT03920917 0 9 O
Criteria NCT03920917 10 18 O
: NCT03920917 19 20 O

- NCT03920917 24 25 O
1 NCT03920917 27 28 O
. NCT03920917 28 29 O
Patient NCT03920917 31 38 O
with NCT03920917 39 43 O
paroxysmal NCT03920917 44 54 B-Condition
atrial NCT03920917 55 61 I-Condition
fibrillation NCT03920917 62 74 I-Condition
who NCT03920917 75 78 B-And
is NCT03920917 79 81 O
scheduled NCT03920917 82 91 B-Eq_Comparison
for NCT03920917 92 95 O
ablation NCT03920917 96 104 B-Procedure
procedure NCT03920917 105 114 I-Procedure
and NCT03920917 115 118 B-And
≥ NCT03920917 119 120 B-Eq_Comparison
20 NCT03920917 121 123 I-Eq_Comparison
and NCT03920917 124 127 B-And
≤ NCT03920917 128 129 B-Eq_Comparison
80 NCT03920917 130 132 I-Eq_Comparison
years NCT03920917 133 138 I-Eq_Comparison
of NCT03920917 139 141 O
age NCT03920917 142 145 B-Age

- NCT03920917 148 149 O
2 NCT03920917 151 152 O
. NCT03920917 152 153 O
Left NCT03920917 155 159 B-Observation
atrium NCT03920917 160 166 I-Observation
size NCT03920917 167 171 I-Observation
< NCT03920917 172 173 B-Eq_Comparison
45 NCT03920917 174 176 I-Eq_Comparison
mm NCT03920917 177 179 I-Eq_Comparison

- NCT03920917 182 183 O
3 NCT03920917 185 186 O
. NCT03920917 186 187 O
paroxysmal NCT03920917 189 199 B-Condition
atrial NCT03920917 200 206 I-Condition
fibrillation NCT03920917 207 219 I-Condition
that NCT03920917 220 224 O
is NCT03920917 225 227 O
recurrence NCT03920917 228 238 O
during NCT03920917 239 245 B-Temporal_Connection___Temporal_Connection_Type_Value:during
antiarrhythmic NCT03920917 246 260 B-Drug
drug NCT03920917 261 265 I-Drug
treatment NCT03920917 266 275 B-Procedure
or NCT03920917 276 278 B-Or
is NCT03920917 279 281 O
not NCT03920917 282 285 B-Negation
able NCT03920917 286 290 O
to NCT03920917 291 293 O
use NCT03920917 294 297 O
an NCT03920917 298 300 O
antiarrhythmic NCT03920917 301 315 B-Drug
drug NCT03920917 316 320 I-Drug
. NCT03920917 321 322 O

- NCT03920917 326 327 O
4 NCT03920917 329 330 O
. NCT03920917 330 331 O
Patient NCT03920917 333 340 O
who NCT03920917 341 344 O
is NCT03920917 345 347 O
indicated NCT03920917 348 357 B-Indication
for NCT03920917 358 361 O
anticoagulation NCT03920917 362 377 B-Procedure
therapy NCT03920917 378 385 I-Procedure
( NCT03920917 386 387 O
for NCT03920917 388 391 O
prevention NCT03920917 392 402 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03920917 403 405 O
cerebral NCT03920917 406 414 B-Condition
infarction NCT03920917 415 425 I-Condition
) NCT03920917 426 427 O

Exclusion NCT03920917 429 438 O
Criteria NCT03920917 439 447 O
: NCT03920917 448 449 O

- NCT03920917 453 454 O
1 NCT03920917 456 457 O
. NCT03920917 457 458 O
Patients NCT03920917 460 468 O
with NCT03920917 469 473 O
persistent NCT03920917 474 484 B-Modifier
or NCT03920917 485 487 B-Or
permanent NCT03920917 488 497 B-Modifier
atrial NCT03920917 498 504 B-Condition
fibrillation NCT03920917 505 517 I-Condition

- NCT03920917 520 521 O
2 NCT03920917 523 524 O
. NCT03920917 524 525 O
Atrial NCT03920917 527 533 B-Condition
fibrillation NCT03920917 534 546 I-Condition
associated NCT03920917 547 557 O
with NCT03920917 558 562 O
severe NCT03920917 563 569 O
cardiac NCT03920917 570 577 B-Condition
malformation NCT03920917 578 590 I-Condition
or NCT03920917 591 593 B-Or
a NCT03920917 594 595 O
structural NCT03920917 596 606 B-Modifier
heart NCT03920917 607 612 B-Condition
disease NCT03920917 613 620 I-Condition
that NCT03920917 621 625 B-And
is NCT03920917 626 628 O
hemodynamically NCT03920917 629 644 B-Condition
affected NCT03920917 645 653 O

- NCT03920917 656 657 O
3 NCT03920917 659 660 O
. NCT03920917 660 661 O
Patients NCT03920917 663 671 O
with NCT03920917 672 676 O
severe NCT03920917 677 683 O
renal NCT03920917 684 689 B-Condition
impairment NCT03920917 690 700 I-Condition
or NCT03920917 701 703 B-Or
CT NCT03920917 704 706 B-Procedure
imaging NCT03920917 707 714 I-Procedure
difficulty NCT03920917 715 725 O
using NCT03920917 726 731 O
contrast NCT03920917 732 740 B-Procedure
media NCT03920917 741 746 I-Procedure

- NCT03920917 749 750 O
4 NCT03920917 752 753 O
. NCT03920917 753 754 O
Patients NCT03920917 756 764 O
with NCT03920917 765 769 O
a NCT03920917 770 771 O
past NCT03920917 772 776 B-Eq_Comparison
history NCT03920917 777 784 I-Eq_Comparison
of NCT03920917 785 787 O
radiofrequency NCT03920917 788 802 B-Procedure
ablation NCT03920917 803 811 I-Procedure
for NCT03920917 812 815 O
atrial NCT03920917 816 822 B-Condition
fibrillation NCT03920917 823 835 I-Condition
or NCT03920917 836 838 B-Or
other NCT03920917 839 844 B-Other
cardiac NCT03920917 845 852 B-Procedure
surgery NCT03920917 853 860 I-Procedure

- NCT03920917 863 864 O
5 NCT03920917 866 867 O
. NCT03920917 867 868 O
Patients NCT03920917 870 878 O
with NCT03920917 879 883 O
active NCT03920917 884 890 B-Eq_Comparison
internal NCT03920917 891 899 B-Condition
bleeding NCT03920917 900 908 I-Condition

- NCT03920917 911 912 O
6 NCT03920917 914 915 O
. NCT03920917 915 916 O
Patients NCT03920917 918 926 O
with NCT03920917 927 931 O
contraindications NCT03920917 932 949 B-Contraindication
for NCT03920917 950 953 O
anticoagulation NCT03920917 954 969 B-Procedure
therapy NCT03920917 970 977 I-Procedure
( NCT03920917 978 979 O
for NCT03920917 980 983 O
prevention NCT03920917 984 994 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03920917 995 997 O
cerebral NCT03920917 998 1006 B-Condition
infarction NCT03920917 1007 1017 I-Condition
) NCT03920917 1018 1019 O
and NCT03920917 1020 1023 B-And
antiarrhythmic NCT03920917 1024 1038 B-Drug
drugs NCT03920917 1039 1044 I-Drug

- NCT03920917 1047 1048 O
7 NCT03920917 1050 1051 O
. NCT03920917 1051 1052 O
Patients NCT03920917 1054 1062 O
with NCT03920917 1063 1067 O
valvular NCT03920917 1068 1076 B-Modifier
atrial NCT03920917 1077 1083 B-Condition
fibrillation NCT03920917 1084 1096 I-Condition
( NCT03920917 1097 1098 O
mitral NCT03920917 1099 1105 B-Condition
stenosis NCT03920917 1106 1114 I-Condition
> NCT03920917 1115 1116 B-Eq_Comparison
grade NCT03920917 1117 1122 I-Eq_Comparison
2 NCT03920917 1123 1124 I-Eq_Comparison
, NCT03920917 1125 1126 O
mechanical NCT03920917 1127 1137 B-Procedure
valve NCT03920917 1138 1143 I-Procedure
, NCT03920917 1144 1145 O
mitral NCT03920917 1146 1152 B-Procedure
valvuloplasty NCT03920917 1153 1166 I-Procedure
) NCT03920917 1167 1168 O

- NCT03920917 1172 1173 O
8 NCT03920917 1175 1176 O
. NCT03920917 1176 1177 O
Patients NCT03920917 1179 1187 O
with NCT03920917 1188 1192 O
a NCT03920917 1193 1194 O
severe NCT03920917 1195 1201 O
comorbid NCT03920917 1202 1210 B-Condition
disease NCT03920917 1211 1218 I-Condition

- NCT03920917 1221 1222 O
9 NCT03920917 1224 1225 O
. NCT03920917 1225 1226 O
Expected NCT03920917 1228 1236 B-Observation
survival NCT03920917 1237 1245 I-Observation
< NCT03920917 1246 1247 B-Eq_Comparison
1 NCT03920917 1248 1249 I-Eq_Comparison
year NCT03920917 1250 1254 I-Eq_Comparison

- NCT03920917 1257 1258 O
10 NCT03920917 1260 1262 O
. NCT03920917 1262 1263 O
Drug NCT03920917 1265 1269 B-Condition
addicts NCT03920917 1270 1277 I-Condition
or NCT03920917 1278 1280 B-Or
alcoholics NCT03920917 1281 1291 B-Condition

- NCT03920917 1294 1295 O
11 NCT03920917 1297 1299 O
. NCT03920917 1299 1300 O
Patients NCT03920917 1302 1310 O
who NCT03920917 1311 1314 O
can NCT03920917 1315 1318 O
not NCT03920917 1318 1321 O
read NCT03920917 1322 1326 O
the NCT03920917 1327 1330 O
consent NCT03920917 1331 1338 O
form NCT03920917 1339 1343 O
( NCT03920917 1344 1345 O
illiterates NCT03920917 1346 1357 B-Condition
, NCT03920917 1358 1359 O
foreigners NCT03920917 1360 1370 O
, NCT03920917 1371 1372 O
etc NCT03920917 1373 1376 O
. NCT03920917 1377 1378 O
) NCT03920917 1379 1380 O

- NCT03920917 1384 1385 O
12 NCT03920917 1387 1389 O
. NCT03920917 1389 1390 O
Other NCT03920917 1392 1397 O
patients NCT03920917 1398 1406 O
who NCT03920917 1407 1410 O
are NCT03920917 1411 1414 O
judged NCT03920917 1415 1421 O
by NCT03920917 1422 1424 O
the NCT03920917 1425 1428 O
principal NCT03920917 1429 1438 O
or NCT03920917 1439 1441 O
sub NCT03920917 1442 1445 O
- NCT03920917 1446 1447 O
investigator NCT03920917 1448 1460 O
to NCT03920917 1461 1463 O
be NCT03920917 1464 1466 O
ineligible NCT03920917 1467 1477 O
for NCT03920917 1478 1481 O
participation NCT03920917 1482 1495 O
in NCT03920917 1496 1498 O
this NCT03920917 1499 1503 O
clinical NCT03920917 1504 1512 O
study NCT03920917 1513 1518 B-Study

Inclusion NCT03865004 0 9 O
Criteria NCT03865004 10 18 O
: NCT03865004 19 20 O
Renal NCT03865004 21 26 B-Condition
colic NCT03865004 27 32 I-Condition
patients NCT03865004 33 41 O
- NCT03865004 42 43 O

Exclusion NCT03865004 45 54 O
Criteria NCT03865004 55 63 O
: NCT03865004 64 65 O
Not NCT03865004 66 69 B-Negation
renal NCT03865004 70 75 B-Condition
colic NCT03865004 76 81 I-Condition
patients NCT03865004 82 90 O

- NCT03865004 92 93 O

Inclusion NCT03864380 0 9 O
Criteria NCT03864380 10 18 O
: NCT03864380 19 20 O

- NCT03864380 24 25 O
Person NCT03864380 27 33 O
registered NCT03864380 34 44 O
at NCT03864380 45 47 O
the NCT03864380 48 51 O
2019 NCT03864380 52 56 O
Paris NCT03864380 57 62 O
Marathon NCT03864380 63 71 O

Exclusion NCT03864380 72 81 O
Criteria NCT03864380 82 90 O
: NCT03864380 91 92 O

- NCT03864380 96 97 O
Ophthalmological NCT03864380 99 115 B-Condition
disorders NCT03864380 116 125 I-Condition
making NCT03864380 126 132 O
access NCT03864380 133 139 B-Observation
to NCT03864380 140 142 O
the NCT03864380 143 146 O
fundus NCT03864380 147 153 B-Modifier
impossible NCT03864380 154 164 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
for NCT03864380 165 168 O
both NCT03864380 169 173 B-Modifier
eyes NCT03864380 174 178 I-Modifier

Inclusion NCT03928938 0 9 O
Criteria NCT03928938 10 18 O
: NCT03928938 19 20 O

1 NCT03928938 24 25 O
. NCT03928938 25 26 O
Signed NCT03928938 28 34 O
informed NCT03928938 35 43 O
consent NCT03928938 44 51 O

2 NCT03928938 54 55 O
. NCT03928938 55 56 O
Advanced NCT03928938 58 66 O
cancers NCT03928938 67 74 B-Condition

3 NCT03928938 77 78 O
. NCT03928938 78 79 O
Immune NCT03928938 81 87 B-Procedure
checkpoint NCT03928938 88 98 I-Procedure
inhibitor NCT03928938 99 108 I-Procedure
therapy NCT03928938 109 116 I-Procedure
initiated NCT03928938 117 126 O
within NCT03928938 127 133 B-Eq_Comparison
+ NCT03928938 134 135 I-Eq_Comparison
/ NCT03928938 136 137 I-Eq_Comparison
- NCT03928938 138 139 I-Eq_Comparison
2 NCT03928938 140 141 I-Eq_Comparison
wks NCT03928938 142 145 I-Eq_Comparison

4 NCT03928938 148 149 O
. NCT03928938 149 150 O
Age NCT03928938 152 155 B-Age
> NCT03928938 156 157 B-Eq_Comparison
18 NCT03928938 158 160 I-Eq_Comparison
y NCT03928938 161 162 I-Eq_Comparison

5 NCT03928938 165 166 O
. NCT03928938 166 167 O
ECOG NCT03928938 169 173 B-Observation
0 NCT03928938 174 175 B-Eq_Comparison
- NCT03928938 176 177 I-Eq_Comparison
3 NCT03928938 178 179 I-Eq_Comparison

6 NCT03928938 183 184 O
. NCT03928938 184 185 O
Patient NCT03928938 187 194 O
compliant NCT03928938 195 204 O
with NCT03928938 205 209 O
the NCT03928938 210 213 O
study NCT03928938 214 219 O
procedures NCT03928938 220 230 O

Exclusion NCT03928938 231 240 O
Criteria NCT03928938 241 249 O
: NCT03928938 250 251 O

1 NCT03928938 255 256 O
. NCT03928938 256 257 O
Immune NCT03928938 259 265 B-Procedure
checkpoint NCT03928938 266 276 I-Procedure
inhibitor NCT03928938 277 286 I-Procedure
therapy NCT03928938 287 294 I-Procedure
initiated NCT03928938 295 304 O
> NCT03928938 305 306 B-Eq_Comparison
2 NCT03928938 307 308 I-Eq_Comparison
wks NCT03928938 309 312 I-Eq_Comparison
ago NCT03928938 313 316 B-Temporal_Connection___Temporal_Connection_Type_Value:before

2 NCT03928938 319 320 O
. NCT03928938 320 321 O
General NCT03928938 323 330 B-Condition
vulnerability NCT03928938 331 344 I-Condition
affecting NCT03928938 345 354 O
the NCT03928938 355 358 O
participation NCT03928938 359 372 O
in NCT03928938 373 375 O
the NCT03928938 376 379 O
trial NCT03928938 380 385 B-Study

3 NCT03928938 388 389 O
. NCT03928938 389 390 O
No NCT03928938 392 394 O
internet NCT03928938 395 403 O
access NCT03928938 404 410 O

Inclusion NCT03863600 0 9 O
Criteria NCT03863600 10 18 O
: NCT03863600 19 20 O

- NCT03863600 24 25 O
Residing NCT03863600 27 35 O
in NCT03863600 36 38 O
rural NCT03863600 39 44 O
village NCT03863600 45 52 O

- NCT03863600 55 56 O
Registered NCT03863600 58 68 O
for NCT03863600 69 72 O
pregnancy NCT03863600 73 82 B-Condition
care NCT03863600 83 87 B-Procedure
at NCT03863600 88 90 O
the NCT03863600 91 94 O
villages NCT03863600 95 103 O
governmental NCT03863600 104 116 O
clinic NCT03863600 117 123 O

- NCT03863600 126 127 O
With NCT03863600 129 133 O
singleton NCT03863600 134 143 B-Modifier
pregnancy NCT03863600 144 153 B-Condition

- NCT03863600 156 157 O
Gave NCT03863600 159 163 B-Eq_Comparison
birth NCT03863600 164 169 B-Birth
the NCT03863600 170 173 O
last NCT03863600 174 178 B-Eq_Comparison
one NCT03863600 179 182 I-Eq_Comparison
to NCT03863600 183 185 I-Eq_Comparison
six NCT03863600 186 189 I-Eq_Comparison
month NCT03863600 190 195 I-Eq_Comparison

Exclusion NCT03863600 196 205 O
Criteria NCT03863600 206 214 O
: NCT03863600 215 216 O

- NCT03863600 220 221 O
Residing NCT03863600 223 231 O
in NCT03863600 232 234 O
urban NCT03863600 235 240 O
areas NCT03863600 241 246 O

- NCT03863600 249 250 O
With NCT03863600 252 256 O
multiple NCT03863600 257 265 B-Eq_Comparison
pregnancy NCT03863600 266 275 B-Condition

- NCT03863600 278 279 O
Not NCT03863600 281 284 B-Negation
registered NCT03863600 285 295 O
for NCT03863600 296 299 O
antenatal NCT03863600 300 309 B-Procedure
care NCT03863600 310 314 I-Procedure
at NCT03863600 315 317 O
the NCT03863600 318 321 O
local NCT03863600 322 327 O
governmental NCT03863600 328 340 O
clinic NCT03863600 341 347 O

Inclusion NCT03922659 0 9 O
Criteria NCT03922659 10 18 O
: NCT03922659 19 20 O

- NCT03922659 24 25 O
Diagnosis NCT03922659 27 36 O
as NCT03922659 37 39 O
heroin NCT03922659 40 46 B-Condition
dependence NCT03922659 47 57 I-Condition
according NCT03922659 58 67 O
to NCT03922659 68 70 O
DSM NCT03922659 71 74 O
- NCT03922659 75 76 O
IV NCT03922659 77 79 O
criteria NCT03922659 80 88 O

- NCT03922659 91 92 O
No NCT03922659 94 96 O
definite NCT03922659 97 105 O
history NCT03922659 106 113 B-Eq_Comparison
of NCT03922659 114 116 O
neurological NCT03922659 117 129 B-Condition
diseases NCT03922659 130 138 I-Condition
and NCT03922659 139 142 B-Or
psychological NCT03922659 143 156 B-Condition
problems NCT03922659 157 165 I-Condition

- NCT03922659 168 169 O
Volunteer NCT03922659 171 180 O
to NCT03922659 181 183 O
participate NCT03922659 184 195 O
the NCT03922659 196 199 O
study NCT03922659 200 205 O
, NCT03922659 206 207 O
cooperate NCT03922659 208 217 O
to NCT03922659 218 220 O
be NCT03922659 221 223 O
followed NCT03922659 224 232 O
up NCT03922659 233 235 O

Exclusion NCT03922659 236 245 O
Criteria NCT03922659 246 254 O
: NCT03922659 255 256 O

- NCT03922659 260 261 O
Acute NCT03922659 263 268 O
withdrawal NCT03922659 269 279 B-Condition
state NCT03922659 280 285 I-Condition
and NCT03922659 286 289 O
CIWA NCT03922659 290 294 B-Observation
score NCT03922659 295 300 O
> NCT03922659 301 302 B-Eq_Comparison
9 NCT03922659 303 304 I-Eq_Comparison

- NCT03922659 308 309 O
With NCT03922659 311 315 O
other NCT03922659 316 321 B-Other
neurological NCT03922659 322 334 B-Condition
diseases NCT03922659 335 343 I-Condition
and NCT03922659 344 347 B-Or
psychological NCT03922659 348 361 B-Condition
problems NCT03922659 362 370 I-Condition

- NCT03922659 373 374 O
With NCT03922659 376 380 O
ever NCT03922659 381 385 B-Eq_Comparison
brain NCT03922659 386 391 B-Modifier
trauma NCT03922659 392 398 B-Condition
and NCT03922659 399 402 B-Or
damage NCT03922659 403 409 B-Condition

- NCT03922659 412 413 O
With NCT03922659 415 419 O
other NCT03922659 420 425 B-Other
psychological NCT03922659 426 439 B-Drug
medications NCT03922659 440 451 I-Drug
or NCT03922659 452 454 B-Or
other NCT03922659 455 460 B-Other
substance NCT03922659 461 470 B-Condition
dependence NCT03922659 471 481 I-Condition

- NCT03922659 484 485 O
With NCT03922659 487 491 O
other NCT03922659 492 497 B-Other
contraindications NCT03922659 498 515 B-Contraindication
to NCT03922659 516 518 O
have NCT03922659 519 523 O
transcranial NCT03922659 524 536 B-Procedure
magnetic NCT03922659 537 545 I-Procedure
stimulation NCT03922659 546 557 I-Procedure

Inclusion NCT03863756 0 9 O
Criteria NCT03863756 10 18 O
: NCT03863756 19 20 O

- NCT03863756 24 25 O
Patients NCT03863756 27 35 O
with NCT03863756 36 40 O
Spondyloarthritis NCT03863756 41 58 B-Condition
( NCT03863756 59 60 O
SpA NCT03863756 61 64 B-Condition
) NCT03863756 65 66 O
meeting NCT03863756 67 74 O
the NCT03863756 75 78 O
criteria NCT03863756 79 87 O
of NCT03863756 88 90 O
Amor NCT03863756 91 95 O
and NCT03863756 96 99 O
/ NCT03863756 100 101 O
or NCT03863756 102 104 O
Assessement NCT03863756 105 116 O
of NCT03863756 117 119 O
spondyloarthritis NCT03863756 120 137 O
International NCT03863756 138 151 O
Society NCT03863756 152 159 O
( NCT03863756 160 161 O
ASAS NCT03863756 162 166 O
) NCT03863756 167 168 O

- NCT03863756 172 173 O
Indication NCT03863756 175 185 B-Indication
of NCT03863756 186 188 O
standard NCT03863756 189 197 B-Procedure
radiography NCT03863756 198 209 I-Procedure
for NCT03863756 210 213 O
the NCT03863756 214 217 O
follow NCT03863756 218 224 B-Encounter
- NCT03863756 225 226 I-Encounter
up NCT03863756 227 229 I-Encounter
of NCT03863756 230 232 O
the NCT03863756 233 236 O
patients NCT03863756 237 245 O
. NCT03863756 246 247 O

Exclusion NCT03863756 249 258 O
Criteria NCT03863756 259 267 O
: NCT03863756 268 269 O

- NCT03863756 273 274 O
the NCT03863756 276 279 O
presence NCT03863756 280 288 O
of NCT03863756 289 291 O
a NCT03863756 292 293 O
contraindication NCT03863756 294 310 B-Contraindication
to NCT03863756 311 313 O
the NCT03863756 314 317 O
performance NCT03863756 318 329 O
of NCT03863756 330 332 O
conventional NCT03863756 333 345 B-Procedure
radiography NCT03863756 346 357 I-Procedure
( NCT03863756 358 359 O
CR NCT03863756 360 362 B-Procedure
) NCT03863756 363 364 O
or NCT03863756 365 367 B-Or
EOS NCT03863756 368 371 B-Procedure
imaging NCT03863756 372 379 I-Procedure

- NCT03863756 382 383 O
any NCT03863756 385 388 O
disease NCT03863756 389 396 B-Condition
affecting NCT03863756 397 406 O
cognition NCT03863756 407 416 B-Observation

- NCT03863756 419 420 O
Patients NCT03863756 422 430 O
who NCT03863756 431 434 O
have NCT03863756 435 439 O
had NCT03863756 440 443 B-Eq_Comparison
surgery NCT03863756 444 451 B-Procedure
on NCT03863756 452 454 O
the NCT03863756 455 458 O
spine NCT03863756 459 464 B-Modifier
and NCT03863756 465 468 B-Or
/ NCT03863756 469 470 I-Or
or NCT03863756 471 473 I-Or
hip NCT03863756 474 477 B-Modifier
. NCT03863756 478 479 O

Inclusion NCT03927651 0 9 O
Criteria NCT03927651 10 18 O
: NCT03927651 19 20 O

- NCT03927651 24 25 O
Patients NCT03927651 27 35 O
attending NCT03927651 36 45 O
a NCT03927651 46 47 O
pre NCT03927651 48 51 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03927651 52 61 B-Procedure
visit NCT03927651 62 67 B-Encounter
at NCT03927651 68 70 O
the NCT03927651 71 74 O
Center NCT03927651 75 81 O
for NCT03927651 82 85 O
Comprehensive NCT03927651 86 99 O
Gynecology NCT03927651 100 110 O
who NCT03927651 111 114 B-And
will NCT03927651 115 119 B-Eq_Comparison
undergo NCT03927651 120 127 O
surgery NCT03927651 128 135 B-Procedure
. NCT03927651 136 137 O

Exclusion NCT03927651 139 148 O
Criteria NCT03927651 149 157 O
: NCT03927651 158 159 O

- NCT03927651 163 164 O
Not NCT03927651 166 169 O
able NCT03927651 170 174 O
to NCT03927651 175 177 O
comprehend NCT03927651 178 188 O
and NCT03927651 189 192 O
sign NCT03927651 193 197 O
a NCT03927651 198 199 O
written NCT03927651 200 207 O
consent NCT03927651 208 215 O

- NCT03927651 218 219 O
Patients NCT03927651 221 229 O
with NCT03927651 230 234 O
a NCT03927651 235 236 O
history NCT03927651 237 244 B-Eq_Comparison
of NCT03927651 245 247 O
allergy NCT03927651 248 255 B-Allergy
to NCT03927651 256 258 O
iodides NCT03927651 259 266 O

- NCT03927651 269 270 O
Patients NCT03927651 272 280 O
history NCT03927651 281 288 B-Eq_Comparison
of NCT03927651 289 291 O
renal NCT03927651 292 297 B-Condition
failure NCT03927651 298 305 I-Condition
or NCT03927651 306 308 B-Or
uremia NCT03927651 309 315 B-Condition
, NCT03927651 316 317 O
and NCT03927651 318 321 B-And
those NCT03927651 322 327 O
on NCT03927651 328 330 B-Eq_Comparison
dialysis NCT03927651 331 339 B-Procedure

Inclusion NCT03927729 0 9 O
Criteria NCT03927729 10 18 O
: NCT03927729 19 20 O

- NCT03927729 24 25 O
Conscious NCT03927729 27 36 B-Condition
patient NCT03927729 37 44 O

- NCT03927729 47 48 O
Age NCT03927729 50 53 B-Age
≥ NCT03927729 54 55 B-Eq_Comparison
18 NCT03927729 56 58 I-Eq_Comparison
years NCT03927729 59 64 I-Eq_Comparison

- NCT03927729 67 68 O
Acute NCT03927729 70 75 O
pain NCT03927729 76 80 B-Condition
of NCT03927729 81 83 O
monotraumatic NCT03927729 84 97 B-Modifier
origin NCT03927729 98 104 I-Modifier

- NCT03927729 107 108 O
Pain NCT03927729 110 114 B-Observation
> NCT03927729 115 116 B-Eq_Comparison
4 NCT03927729 117 118 I-Eq_Comparison
on NCT03927729 119 121 O
a NCT03927729 122 123 O
visual NCT03927729 124 130 O
numerical NCT03927729 131 140 O
scale NCT03927729 141 146 O

Exclusion NCT03927729 147 156 O
Criteria NCT03927729 157 165 O
: NCT03927729 166 167 O

- NCT03927729 171 172 O
State NCT03927729 174 179 B-Condition
of NCT03927729 180 182 I-Condition
shock NCT03927729 183 188 I-Condition
with NCT03927729 189 193 B-And
unstable NCT03927729 194 202 O
hemodynamics NCT03927729 203 215 B-Condition
( NCT03927729 216 217 O
PA NCT03927729 218 220 B-Observation
< NCT03927729 221 222 B-Eq_Comparison
90 NCT03927729 223 225 I-Eq_Comparison
/ NCT03927729 226 227 O
60 NCT03927729 228 230 O
) NCT03927729 231 232 O

- NCT03927729 236 237 O
Suspected NCT03927729 239 248 B-Assertion___Assertion_Type_Value:possible
or NCT03927729 249 251 B-Or
proven NCT03927729 252 258 B-Modifier
trauma NCT03927729 259 265 B-Condition
to NCT03927729 266 268 O
the NCT03927729 269 272 O
chest NCT03927729 273 278 B-Modifier
, NCT03927729 279 280 O
abdomen NCT03927729 281 288 B-Modifier
or NCT03927729 289 291 B-Or
pelvis NCT03927729 292 298 B-Modifier

- NCT03927729 301 302 O
Serious NCT03927729 304 311 O
head NCT03927729 312 316 O
trauma NCT03927729 317 323 O

- NCT03927729 326 327 O
Consciousness NCT03927729 329 342 B-Condition
disorder NCT03927729 343 351 I-Condition
with NCT03927729 352 356 B-And
Glasgow NCT03927729 357 364 B-Observation
score NCT03927729 365 370 I-Observation
< NCT03927729 371 372 B-Eq_Comparison
15 NCT03927729 373 375 I-Eq_Comparison

- NCT03927729 379 380 O
Patient NCT03927729 382 389 O
who NCT03927729 390 393 O
has NCT03927729 394 397 O
already NCT03927729 398 405 B-Eq_Comparison
received NCT03927729 406 414 I-Eq_Comparison
analgesics NCT03927729 415 425 B-Drug
( NCT03927729 426 427 O
with NCT03927729 428 432 O
the NCT03927729 433 436 O
exception NCT03927729 437 446 B-Exception
of NCT03927729 447 449 O
paracetamol NCT03927729 450 461 B-Drug
) NCT03927729 462 463 O

- NCT03927729 467 468 O
Patient NCT03927729 470 477 O
receiving NCT03927729 478 487 B-Eq_Comparison
an NCT03927729 488 490 O
intravenous NCT03927729 491 502 B-Modifier
approach NCT03927729 503 511 O
for NCT03927729 512 515 O
analgesia NCT03927729 516 525 B-Drug

- NCT03927729 528 529 O
Renal NCT03927729 531 536 B-Modifier
or NCT03927729 537 539 B-Or
hepatic NCT03927729 540 547 B-Modifier
disorders NCT03927729 548 557 B-Condition
known NCT03927729 558 563 O

- NCT03927729 566 567 O
Hypersensitivity NCT03927729 569 585 B-Condition
to NCT03927729 586 588 O
fluoridated NCT03927729 589 600 B-Modifier
anesthetics NCT03927729 601 612 I-Modifier
or NCT03927729 613 615 B-Or
history NCT03927729 616 623 B-Eq_Comparison
of NCT03927729 624 626 O
malignant NCT03927729 627 636 B-Condition
hyperthermia NCT03927729 637 649 I-Condition
in NCT03927729 650 652 O
the NCT03927729 653 656 O
patient NCT03927729 657 664 B-Family_Member___Family_Member_Type:patient
or NCT03927729 665 667 B-Or
family NCT03927729 668 674 B-Family_Member

- NCT03927729 677 678 O
Pregnant NCT03927729 680 688 B-Condition
or NCT03927729 689 691 B-Or
nursing NCT03927729 692 699 B-Condition
woman NCT03927729 700 705 O

- NCT03927729 708 709 O
Patient NCT03927729 711 718 O
under NCT03927729 719 724 O
judicial NCT03927729 725 733 B-Observation
protection NCT03927729 734 744 I-Observation

- NCT03927729 747 748 O
Non NCT03927729 750 753 B-Condition
communicating NCT03927729 754 767 I-Condition
patient NCT03927729 768 775 O
or NCT03927729 776 778 B-Or
with NCT03927729 779 783 O
difficulties NCT03927729 784 796 B-Condition
of NCT03927729 797 799 I-Condition
understanding NCT03927729 800 813 I-Condition

Exclusion NCT03927729 814 823 O
Criteria NCT03927729 824 832 O
: NCT03927729 833 834 O

- NCT03927729 838 839 O
Intravenous NCT03927729 841 852 B-Modifier
injection NCT03927729 853 862 I-Modifier
for NCT03927729 863 866 O
analgesia NCT03927729 867 876 B-Drug

Inclusion NCT03866083 0 9 O
Criteria NCT03866083 10 18 O
: NCT03866083 19 20 O

- NCT03866083 23 24 O
Critically NCT03866083 25 35 O
ill NCT03866083 36 39 O
cirrhotics NCT03866083 40 50 B-Condition
with NCT03866083 51 55 B-And
early NCT03866083 56 61 B-Modifier
onset NCT03866083 62 67 I-Modifier
septic NCT03866083 68 74 B-Condition
shock NCT03866083 75 80 I-Condition
( NCT03866083 81 82 O
< NCT03866083 83 84 B-Eq_Comparison
24 NCT03866083 85 87 I-Eq_Comparison
hours NCT03866083 88 93 I-Eq_Comparison
) NCT03866083 94 95 O
with NCT03866083 96 100 B-And
norepinephrine NCT03866083 101 115 B-Drug

of NCT03866083 116 118 O
more NCT03866083 119 123 B-Eq_Comparison
than NCT03866083 124 128 I-Eq_Comparison
10 NCT03866083 129 131 I-Eq_Comparison
ug NCT03866083 132 134 I-Eq_Comparison
/ NCT03866083 135 136 I-Eq_Comparison
min NCT03866083 137 140 I-Eq_Comparison
and NCT03866083 141 144 B-And
lactate NCT03866083 145 152 B-Observation
> NCT03866083 153 154 B-Eq_Comparison
4 NCT03866083 155 156 I-Eq_Comparison
mmol NCT03866083 157 161 I-Eq_Comparison
/ NCT03866083 162 163 I-Eq_Comparison
L NCT03866083 164 165 I-Eq_Comparison
. NCT03866083 166 167 O

Exclusion NCT03866083 169 178 O
Criteria NCT03866083 179 187 O
: NCT03866083 188 189 O

- NCT03866083 193 194 O
Patients NCT03866083 196 204 O
with NCT03866083 205 209 O
age NCT03866083 210 213 B-Age
less NCT03866083 214 218 B-Eq_Comparison
than NCT03866083 219 223 I-Eq_Comparison
18 NCT03866083 224 226 I-Eq_Comparison
years NCT03866083 227 232 I-Eq_Comparison

- NCT03866083 235 236 O
Severe NCT03866083 238 244 O
known NCT03866083 245 250 O
cardiopulmonary NCT03866083 251 266 B-Condition
disease NCT03866083 267 274 I-Condition
( NCT03866083 275 276 O
structural NCT03866083 277 287 B-Modifier
or NCT03866083 288 290 B-Or
valvular NCT03866083 291 299 B-Modifier
heart NCT03866083 300 305 B-Condition
disease NCT03866083 306 313 I-Condition
, NCT03866083 314 315 O
coronary NCT03866083 316 324 B-Condition
artery NCT03866083 325 331 I-Condition
disease NCT03866083 332 339 I-Condition
, NCT03866083 340 341 O
COPD NCT03866083 342 346 B-Condition
) NCT03866083 347 348 O

- NCT03866083 352 353 O
Severe NCT03866083 355 361 O
coagulopathy NCT03866083 362 374 B-Condition
platelets NCT03866083 375 384 B-Observation
< NCT03866083 385 386 B-Eq_Comparison
20 NCT03866083 387 389 I-Eq_Comparison
, NCT03866083 390 391 I-Eq_Comparison
000 NCT03866083 392 395 I-Eq_Comparison
and NCT03866083 396 399 B-And
INR NCT03866083 400 403 B-Observation
> NCT03866083 404 405 B-Eq_Comparison
5 NCT03866083 406 407 I-Eq_Comparison

- NCT03866083 411 412 O
Active NCT03866083 414 420 B-Eq_Comparison
Bleed NCT03866083 421 426 B-Condition
( NCT03866083 427 428 O
Mucosal NCT03866083 429 436 B-Modifier
or NCT03866083 437 439 B-Or
variceal NCT03866083 440 448 B-Modifier
) NCT03866083 449 450 O

- NCT03866083 454 455 O
Pregnancy NCT03866083 457 466 B-Condition

- NCT03866083 469 470 O
Chronic NCT03866083 472 479 O
kidney NCT03866083 480 486 B-Condition
disease NCT03866083 487 494 I-Condition

- NCT03866083 497 498 O
Extremely NCT03866083 500 509 O
moribund NCT03866083 510 518 B-Death|B-Risk
patients NCT03866083 519 527 O
with NCT03866083 528 532 B-And
an NCT03866083 533 535 O
expected NCT03866083 536 544 O
life NCT03866083 545 549 B-Observation
expectancy NCT03866083 550 560 I-Observation
of NCT03866083 561 563 O
less NCT03866083 564 568 B-Eq_Comparison
than NCT03866083 569 573 I-Eq_Comparison
24 NCT03866083 574 576 I-Eq_Comparison
hours NCT03866083 577 582 I-Eq_Comparison

- NCT03866083 585 586 O
Failure NCT03866083 588 595 O
to NCT03866083 596 598 O
give NCT03866083 599 603 O
informed NCT03866083 604 612 O
consent NCT03866083 613 620 O
from NCT03866083 621 625 O
family NCT03866083 626 632 O
members NCT03866083 633 640 O
. NCT03866083 641 642 O

- NCT03866083 646 647 O
Hemodynamic NCT03866083 649 660 B-Condition
instability NCT03866083 661 672 O
requiring NCT03866083 673 682 O
very NCT03866083 683 687 O
high NCT03866083 688 692 O
dose NCT03866083 693 697 O
of NCT03866083 698 700 O
vasopressors NCT03866083 701 713 B-Drug
, NCT03866083 714 715 O
late NCT03866083 716 720 B-Modifier
presentation NCT03866083 721 733 I-Modifier
or NCT03866083 734 736 B-Or
spontaneous NCT03866083 737 748 B-Modifier
reversal NCT03866083 749 757 I-Modifier
of NCT03866083 758 760 O
shock NCT03866083 761 766 B-Condition

- NCT03866083 769 770 O
Patient NCT03866083 772 779 O
enrolled NCT03866083 780 788 O
in NCT03866083 789 791 O
other NCT03866083 792 797 B-Other
clinical NCT03866083 798 806 B-Study
trials NCT03866083 807 813 I-Study

Inclusion NCT03926468 0 9 O
Criteria NCT03926468 10 18 O
: NCT03926468 19 20 O

- NCT03926468 24 25 O
histologically NCT03926468 27 41 O
confirmed NCT03926468 42 51 O
head NCT03926468 52 56 B-Modifier
and NCT03926468 57 60 B-Or
neck NCT03926468 61 65 B-Modifier
squamous NCT03926468 66 74 B-Condition
cell NCT03926468 75 79 I-Condition
carcinoma NCT03926468 80 89 I-Condition
( NCT03926468 90 91 O
HNSCC NCT03926468 92 97 B-Condition
) NCT03926468 98 99 O

- NCT03926468 103 104 O
WHO NCT03926468 106 109 B-Observation
performance NCT03926468 110 121 I-Observation
status NCT03926468 122 128 I-Observation
0 NCT03926468 129 130 B-Eq_Comparison
- NCT03926468 131 132 I-Eq_Comparison
2 NCT03926468 133 134 I-Eq_Comparison

- NCT03926468 138 139 O
clinical NCT03926468 141 149 O
stage NCT03926468 150 155 B-Eq_Comparison
III NCT03926468 156 159 I-Eq_Comparison
patients NCT03926468 160 168 O
with NCT03926468 169 173 O
bulky NCT03926468 174 179 B-Modifier
T NCT03926468 180 181 I-Modifier
3 NCT03926468 182 183 I-Modifier
primary NCT03926468 184 191 I-Modifier
+ NCT03926468 192 193 B-Or
/ NCT03926468 194 195 I-Or
- NCT03926468 196 197 I-Or
neck NCT03926468 198 202 B-Modifier
metastasis NCT03926468 203 213 B-Condition

- NCT03926468 216 217 O
all NCT03926468 219 222 O
stage NCT03926468 223 228 B-Eq_Comparison
IV NCT03926468 229 231 I-Eq_Comparison
patients NCT03926468 232 240 O

- NCT03926468 243 244 O
referral NCT03926468 246 254 O
to NCT03926468 255 257 O
definitive NCT03926468 258 268 O
radiotherapy NCT03926468 269 281 B-Procedure
or NCT03926468 282 284 B-Or
chemoradiotherapy NCT03926468 285 302 B-Procedure
or NCT03926468 303 305 B-Or
multimodality NCT03926468 306 319 B-Procedure
treatment NCT03926468 320 329 I-Procedure

Exclusion NCT03926468 330 339 O
Criteria NCT03926468 340 348 O
: NCT03926468 349 350 O

- NCT03926468 354 355 O
patients NCT03926468 357 365 O
who NCT03926468 366 369 O
are NCT03926468 370 373 O
not NCT03926468 374 377 O
able NCT03926468 378 382 O
to NCT03926468 383 385 O
sign NCT03926468 386 390 O
written NCT03926468 391 398 O
informed NCT03926468 399 407 O
consent NCT03926468 408 415 O

Inclusion NCT03865875 0 9 O
Criteria NCT03865875 10 18 O

- NCT03865875 21 22 O
Adults NCT03865875 24 30 O
age NCT03865875 31 34 B-Age
18 NCT03865875 35 37 B-Eq_Comparison
years NCT03865875 38 43 I-Eq_Comparison
or NCT03865875 44 46 I-Eq_Comparison
older NCT03865875 47 52 I-Eq_Comparison
. NCT03865875 53 54 O

- NCT03865875 58 59 O
Diagnosed NCT03865875 61 70 O
within NCT03865875 71 77 B-Eq_Comparison
8 NCT03865875 78 79 I-Eq_Comparison
weeks NCT03865875 80 85 I-Eq_Comparison
with NCT03865875 86 90 O
upfront NCT03865875 91 98 O
resectable NCT03865875 99 109 B-Modifier
, NCT03865875 110 111 O
borderline NCT03865875 112 122 B-Modifier
resectable NCT03865875 123 133 I-Modifier
, NCT03865875 134 135 O
or NCT03865875 136 138 B-Or
locally NCT03865875 139 146 B-Modifier
advanced NCT03865875 147 155 I-Modifier
unresectable NCT03865875 156 168 I-Modifier
PDAC NCT03865875 169 173 B-Condition
as NCT03865875 174 176 O
defined NCT03865875 177 184 O
by NCT03865875 185 187 O
the NCT03865875 188 191 O
National NCT03865875 192 200 O
Comprehensive NCT03865875 201 214 O
Cancer NCT03865875 215 221 O
Network NCT03865875 222 229 O
( NCT03865875 230 231 O
NCCN NCT03865875 232 236 O
) NCT03865875 237 238 O
. NCT03865875 239 240 O

- NCT03865875 244 245 O
Planning NCT03865875 247 255 B-Assertion___Assertion_Type_Value:intention
to NCT03865875 256 258 O
undergo NCT03865875 259 266 O
TNT NCT03865875 267 270 B-Procedure
at NCT03865875 271 273 O
MGH NCT03865875 274 277 O
. NCT03865875 278 279 O

- NCT03865875 283 284 O
Planning NCT03865875 286 294 B-Assertion___Assertion_Type_Value:intention
to NCT03865875 295 297 O
receive NCT03865875 298 305 O
modified NCT03865875 306 314 B-Modifier
FOLFIRINOX NCT03865875 315 325 B-Drug
for NCT03865875 326 329 O
neoadjuvant NCT03865875 330 341 B-Modifier
chemotherapy NCT03865875 342 354 B-Procedure
. NCT03865875 355 356 O

- NCT03865875 360 361 O
Planning NCT03865875 363 371 B-Assertion___Assertion_Type_Value:intention
to NCT03865875 372 374 O
undergo NCT03865875 375 382 O
surgical NCT03865875 383 391 B-Procedure
resection NCT03865875 392 401 I-Procedure
of NCT03865875 402 404 O
PDAC NCT03865875 405 409 B-Condition
at NCT03865875 410 412 O
MGH NCT03865875 413 416 O
. NCT03865875 417 418 O

- NCT03865875 422 423 O
Verbal NCT03865875 425 431 O
fluency NCT03865875 432 439 O
in NCT03865875 440 442 O
English NCT03865875 443 450 O
. NCT03865875 451 452 O

Exclusion NCT03865875 454 463 O
Criteria NCT03865875 464 472 O

- NCT03865875 475 476 O
Metastatic NCT03865875 478 488 B-Condition
disease NCT03865875 489 496 I-Condition
. NCT03865875 497 498 O

- NCT03865875 502 503 O
Previous NCT03865875 505 513 B-Eq_Comparison
treatment NCT03865875 514 523 B-Procedure
for NCT03865875 524 527 O
pancreas NCT03865875 528 536 B-Modifier
adenocarcinoma NCT03865875 537 551 B-Condition
and NCT03865875 552 555 B-And
no NCT03865875 556 558 B-Negation
prior NCT03865875 559 564 B-Eq_Comparison
therapy NCT03865875 565 572 B-Procedure
for NCT03865875 573 576 O
any NCT03865875 577 580 O
cancer NCT03865875 581 587 B-Condition
within NCT03865875 588 594 B-Eq_Comparison
5 NCT03865875 595 596 I-Eq_Comparison
years NCT03865875 597 602 I-Eq_Comparison
. NCT03865875 603 604 O

- NCT03865875 608 609 O
Known NCT03865875 611 616 O
history NCT03865875 617 624 B-Eq_Comparison
of NCT03865875 625 627 O
cognitive NCT03865875 628 637 B-Modifier
or NCT03865875 638 640 B-Or
psychologic NCT03865875 641 652 B-Modifier
impairment NCT03865875 653 663 B-Condition
. NCT03865875 664 665 O

- NCT03865875 669 670 O
Known NCT03865875 672 677 O
history NCT03865875 678 685 B-Eq_Comparison
of NCT03865875 686 688 O
physical NCT03865875 689 697 B-Condition
impairment NCT03865875 698 708 I-Condition
such NCT03865875 709 713 O
as NCT03865875 714 716 O
immobility NCT03865875 717 727 B-Condition
, NCT03865875 728 729 O
use NCT03865875 730 733 O
of NCT03865875 734 736 O
walking NCT03865875 737 744 B-Procedure
aids NCT03865875 745 749 I-Procedure
, NCT03865875 750 751 O
or NCT03865875 752 754 B-Or
required NCT03865875 755 763 O
wheelchair NCT03865875 764 774 B-Procedure
use NCT03865875 775 778 I-Procedure
. NCT03865875 779 780 O

- NCT03865875 784 785 O
Known NCT03865875 787 792 O
history NCT03865875 793 800 B-Eq_Comparison
of NCT03865875 801 803 O
the NCT03865875 804 807 O
following NCT03865875 808 817 O
orthopedic NCT03865875 818 828 B-Condition
comorbidities NCT03865875 829 842 I-Condition
: NCT03865875 843 844 O
advanced NCT03865875 845 853 O
osteoarthritis NCT03865875 854 868 B-Condition
or NCT03865875 869 871 B-Or
rheumatoid NCT03865875 872 882 B-Modifier
arthritis NCT03865875 883 892 B-Condition
, NCT03865875 893 894 O
mobility NCT03865875 895 903 B-Modifier
- NCT03865875 904 905 I-Modifier
limiting NCT03865875 906 914 I-Modifier
amputations NCT03865875 915 926 B-Condition
, NCT03865875 927 928 O
orthopedic NCT03865875 929 939 B-Modifier
injuries NCT03865875 940 948 B-Condition
, NCT03865875 949 950 O
or NCT03865875 951 953 B-Or
widespread NCT03865875 954 964 O
chronic NCT03865875 965 972 O
pain NCT03865875 973 977 B-Condition
( NCT03865875 978 979 O
e NCT03865875 980 981 O
. NCT03865875 982 983 O
g NCT03865875 984 985 O
. NCT03865875 986 987 O
fibromyalgia NCT03865875 989 1001 B-Condition
) NCT03865875 1002 1003 O
. NCT03865875 1004 1005 O

- NCT03865875 1009 1010 O
Known NCT03865875 1012 1017 O
history NCT03865875 1018 1025 B-Eq_Comparison
of NCT03865875 1026 1028 O
the NCT03865875 1029 1032 O
following NCT03865875 1033 1042 O
pulmonary NCT03865875 1043 1052 B-Modifier
comorbidities NCT03865875 1053 1066 B-Condition
: NCT03865875 1067 1068 O
severe NCT03865875 1069 1075 O
chronic NCT03865875 1076 1083 O
obstructive NCT03865875 1084 1095 B-Condition
pulmonary NCT03865875 1096 1105 I-Condition
disease NCT03865875 1106 1113 I-Condition
( NCT03865875 1114 1115 O
COPD NCT03865875 1116 1120 B-Condition
) NCT03865875 1121 1122 O
defined NCT03865875 1123 1130 O
as NCT03865875 1131 1133 O
FEV NCT03865875 1134 1137 B-Observation
1 NCT03865875 1138 1139 I-Observation
≤ NCT03865875 1140 1141 B-Eq_Comparison
50 NCT03865875 1142 1144 I-Eq_Comparison
% NCT03865875 1145 1146 I-Eq_Comparison
, NCT03865875 1147 1148 O
emphysema NCT03865875 1149 1158 B-Condition
, NCT03865875 1159 1160 O
interstitial NCT03865875 1161 1173 B-Condition
lung NCT03865875 1174 1178 I-Condition
disease NCT03865875 1179 1186 I-Condition
, NCT03865875 1187 1188 O
and NCT03865875 1189 1192 B-Or
/ NCT03865875 1193 1194 I-Or
or NCT03865875 1195 1197 I-Or
use NCT03865875 1198 1201 O
of NCT03865875 1202 1204 O
supplemental NCT03865875 1205 1217 B-Procedure
oxygen NCT03865875 1218 1224 I-Procedure
. NCT03865875 1225 1226 O

- NCT03865875 1230 1231 O
Known NCT03865875 1233 1238 O
history NCT03865875 1239 1246 B-Eq_Comparison
of NCT03865875 1247 1249 O
the NCT03865875 1250 1253 O
following NCT03865875 1254 1263 O
cardiovascular NCT03865875 1264 1278 B-Condition
comorbidities NCT03865875 1279 1292 I-Condition
: NCT03865875 1293 1294 O
uncontrolled NCT03865875 1295 1307 B-Modifier
hypertension NCT03865875 1308 1320 B-Condition
, NCT03865875 1321 1322 O
severe NCT03865875 1323 1329 O
congestive NCT03865875 1330 1340 B-Condition
heart NCT03865875 1341 1346 I-Condition
failure NCT03865875 1347 1354 I-Condition
( NCT03865875 1355 1356 O
NYHA NCT03865875 1357 1361 B-Observation
Class NCT03865875 1362 1367 B-Eq_Comparison
IV NCT03865875 1368 1370 I-Eq_Comparison
) NCT03865875 1371 1372 O
, NCT03865875 1373 1374 O
and NCT03865875 1375 1378 B-Or
/ NCT03865875 1379 1380 I-Or
or NCT03865875 1381 1383 I-Or
myocardial NCT03865875 1384 1394 B-Condition
infarction NCT03865875 1395 1405 I-Condition
within NCT03865875 1406 1412 B-Eq_Comparison
the NCT03865875 1413 1416 I-Eq_Comparison
last NCT03865875 1417 1421 I-Eq_Comparison
6 NCT03865875 1422 1423 I-Eq_Comparison
months NCT03865875 1424 1430 I-Eq_Comparison
. NCT03865875 1431 1432 O

- NCT03865875 1436 1437 O
Inability NCT03865875 1439 1448 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865875 1449 1451 O
tolerate NCT03865875 1452 1460 O
diet NCT03865875 1461 1465 B-Observation
through NCT03865875 1466 1473 O
routine NCT03865875 1474 1481 O
oral NCT03865875 1482 1486 B-Modifier
routes NCT03865875 1487 1493 I-Modifier
and NCT03865875 1494 1497 B-Or
/ NCT03865875 1498 1499 I-Or
or NCT03865875 1500 1502 I-Or
patients NCT03865875 1503 1511 O
with NCT03865875 1512 1516 O
strict NCT03865875 1517 1523 O
nutritional NCT03865875 1524 1535 B-Condition
restrictions NCT03865875 1536 1548 I-Condition
, NCT03865875 1549 1550 O
allergies NCT03865875 1551 1560 B-Allergy
, NCT03865875 1561 1562 O
and NCT03865875 1563 1566 B-Or
/ NCT03865875 1567 1568 I-Or
or NCT03865875 1569 1571 I-Or
dietary NCT03865875 1572 1579 B-Observation
preferences NCT03865875 1580 1591 I-Observation
. NCT03865875 1592 1593 O

Inclusion NCT03934151 0 9 O
Criteria NCT03934151 10 18 O
: NCT03934151 19 20 O

- NCT03934151 24 25 O
Patients NCT03934151 27 35 O
and NCT03934151 36 39 O
/ NCT03934151 40 41 O
or NCT03934151 42 44 O
legal NCT03934151 45 50 O
guardians NCT03934151 51 60 O
exhaustively NCT03934151 61 73 O
informed NCT03934151 74 82 O
by NCT03934151 83 85 O
the NCT03934151 86 89 O
investigator NCT03934151 90 102 O
, NCT03934151 103 104 O
and NCT03934151 105 108 O
who NCT03934151 109 112 O
have NCT03934151 113 117 O
voluntarily NCT03934151 118 129 O
provided NCT03934151 130 138 O
written NCT03934151 139 146 O
informed NCT03934151 147 155 O
consent NCT03934151 156 163 O
or NCT03934151 164 166 O
, NCT03934151 167 168 O
when NCT03934151 169 173 O
unable NCT03934151 174 180 O
to NCT03934151 181 183 O
read NCT03934151 184 188 O
and NCT03934151 189 192 O
/ NCT03934151 193 194 O
or NCT03934151 195 197 O
write NCT03934151 198 203 O
, NCT03934151 204 205 O
verbal NCT03934151 206 212 O
consent NCT03934151 213 220 O
put NCT03934151 221 224 O
into NCT03934151 225 229 O
writing NCT03934151 230 237 O
by NCT03934151 238 240 O
a NCT03934151 241 242 O
third NCT03934151 243 248 O
person NCT03934151 249 255 O

- NCT03934151 258 259 O
Patients NCT03934151 261 269 O
who NCT03934151 270 273 O
underwent NCT03934151 274 283 B-Eq_Comparison
elective NCT03934151 284 292 O
laparoscopic NCT03934151 293 305 B-Modifier
or NCT03934151 306 308 B-Or
video NCT03934151 309 314 B-Modifier
assisted NCT03934151 315 323 I-Modifier
right NCT03934151 324 329 B-Procedure
hemicolectomy NCT03934151 330 343 I-Procedure
at NCT03934151 344 346 O
U NCT03934151 347 348 O
. NCT03934151 349 350 O
O NCT03934151 351 352 O
. NCT03934151 353 354 O
General NCT03934151 356 363 B-Modifier
and NCT03934151 364 367 B-Or
Thoracic NCT03934151 368 376 B-Modifier
Surgery NCT03934151 377 384 B-Procedure
for NCT03934151 385 388 O
malignant NCT03934151 389 398 B-Modifier
or NCT03934151 399 401 B-Or
bening NCT03934151 402 408 B-Modifier
pathology NCT03934151 409 418 B-Condition
. NCT03934151 419 420 O

- NCT03934151 424 425 O
Patients NCT03934151 427 435 O
who NCT03934151 436 439 O
had NCT03934151 440 443 O
prior NCT03934151 444 449 B-Eq_Comparison
chemotherapy NCT03934151 450 462 B-Procedure
and NCT03934151 463 466 B-Or
radiotherapy NCT03934151 467 479 B-Procedure

Exclusion NCT03934151 480 489 O
Criteria NCT03934151 490 498 O
: NCT03934151 499 500 O

- NCT03934151 504 505 O
Patients NCT03934151 507 515 O
operated NCT03934151 516 524 B-Procedure
in NCT03934151 525 527 B-Temporal_Connection___Temporal_Connection_Type_Value:during
emergency NCT03934151 528 537 B-Encounter

- NCT03934151 540 541 O
Pregnant NCT03934151 543 551 B-Condition
women NCT03934151 552 557 O

- NCT03934151 560 561 O
Right NCT03934151 563 568 B-Procedure
laparotomic NCT03934151 569 580 I-Procedure
hemicolectomy NCT03934151 581 594 I-Procedure

- NCT03934151 597 598 O
BMI NCT03934151 600 603 B-Observation
> NCT03934151 604 605 B-Eq_Comparison
35 NCT03934151 606 608 I-Eq_Comparison

Inclusion NCT03925376 0 9 O
Criteria NCT03925376 10 18 O
: NCT03925376 19 20 O

- NCT03925376 24 25 O
Patients NCT03925376 27 35 O
undergoing NCT03925376 36 46 B-Eq_Comparison
redo NCT03925376 47 51 O
cardiac NCT03925376 52 59 B-Procedure
surgery NCT03925376 60 67 I-Procedure

Exclusion NCT03925376 68 77 O
Criteria NCT03925376 78 86 O
: NCT03925376 87 88 O

- NCT03925376 92 93 O
Age NCT03925376 95 98 B-Age
< NCT03925376 99 100 B-Eq_Comparison
18 NCT03925376 101 103 I-Eq_Comparison
years NCT03925376 104 109 I-Eq_Comparison
; NCT03925376 109 110 O

- NCT03925376 113 114 O
Patients NCT03925376 116 124 O
with NCT03925376 125 129 O
a NCT03925376 130 131 O
DNR NCT03925376 132 135 B-Observation
order NCT03925376 136 141 I-Observation
or NCT03925376 142 144 B-Or
" NCT03925376 145 146 B-Observation
do NCT03925376 146 148 I-Observation
not NCT03925376 149 152 I-Observation
escalate NCT03925376 153 161 I-Observation
care NCT03925376 162 166 I-Observation
" NCT03925376 166 167 I-Observation
order NCT03925376 168 173 I-Observation
. NCT03925376 174 175 O

Inclusion NCT03868865 0 9 O
Criteria NCT03868865 10 18 O
: NCT03868865 19 20 O

- NCT03868865 24 25 O
curative NCT03868865 27 35 B-Condition
malignancy NCT03868865 36 46 I-Condition
( NCT03868865 47 48 O
breast NCT03868865 49 55 B-Modifier
cancer NCT03868865 56 62 B-Condition
of NCT03868865 63 65 O
TNM NCT03868865 66 69 O
( NCT03868865 70 71 O
T NCT03868865 72 73 O
: NCT03868865 74 75 O
primary NCT03868865 76 83 O
tumor NCT03868865 84 89 O
, NCT03868865 90 91 O
N NCT03868865 92 93 O
: NCT03868865 94 95 O
regional NCT03868865 96 104 O
nodes NCT03868865 105 110 O
, NCT03868865 111 112 O
M NCT03868865 113 114 O
: NCT03868865 115 116 O
metastasis NCT03868865 117 127 O
) NCT03868865 128 129 O
staging NCT03868865 130 137 B-Eq_Comparison
I NCT03868865 138 139 I-Eq_Comparison
- NCT03868865 140 141 I-Eq_Comparison
III NCT03868865 142 145 I-Eq_Comparison
) NCT03868865 146 147 O

- NCT03868865 151 152 O
receiving NCT03868865 154 163 B-Eq_Comparison
chemotherapy NCT03868865 164 176 B-Procedure

- NCT03868865 179 180 O
at NCT03868865 182 184 B-Eq_Comparison
least NCT03868865 185 190 I-Eq_Comparison
18 NCT03868865 191 193 I-Eq_Comparison
years NCT03868865 194 199 I-Eq_Comparison
old NCT03868865 200 203 B-Age

- NCT03868865 206 207 O
written NCT03868865 209 216 O
informed NCT03868865 217 225 O
consent NCT03868865 226 233 O

- NCT03868865 236 237 O
willing NCT03868865 239 246 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03868865 247 250 B-And
physically NCT03868865 251 261 O
/ NCT03868865 262 263 O
mentally NCT03868865 264 272 O
able NCT03868865 273 277 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868865 278 280 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03868865 281 292 O
in NCT03868865 293 295 O
a NCT03868865 296 297 O
six NCT03868865 298 301 B-Eq_Comparison
hours NCT03868865 302 307 I-Eq_Comparison
day NCT03868865 308 311 I-Eq_Comparison
care NCT03868865 312 316 B-Observation
clinic NCT03868865 317 323 I-Observation
program NCT03868865 324 331 I-Observation
eleven NCT03868865 332 338 B-Eq_Comparison
times NCT03868865 339 344 I-Eq_Comparison
during NCT03868865 345 351 B-Temporal_Connection___Temporal_Connection_Type_Value:during
chemotherapy NCT03868865 352 364 B-Procedure
. NCT03868865 365 366 O

Exclusion NCT03868865 368 377 O
Criteria NCT03868865 378 386 O
: NCT03868865 387 388 O

- NCT03868865 392 393 O
insufficient NCT03868865 395 407 B-Negation
knowledge NCT03868865 408 417 O
of NCT03868865 418 420 O
the NCT03868865 421 424 O
German NCT03868865 425 431 O
language NCT03868865 432 440 O

- NCT03868865 443 444 O
physical NCT03868865 446 454 B-Modifier
or NCT03868865 455 457 B-Or
mental NCT03868865 458 464 B-Modifier
disabilities NCT03868865 465 477 B-Condition
resulting NCT03868865 478 487 O
in NCT03868865 488 490 O
ineligibility NCT03868865 491 504 O
for NCT03868865 505 508 O
participation NCT03868865 509 522 O
in NCT03868865 523 525 O
the NCT03868865 526 529 O
program NCT03868865 530 537 O
or NCT03868865 538 540 O
filling NCT03868865 541 548 O
out NCT03868865 549 552 O
the NCT03868865 553 556 O
questionnaires NCT03868865 557 571 O
. NCT03868865 572 573 O


Inclusion NCT03867526 0 9 O
Criteria NCT03867526 10 18 O
: NCT03867526 19 20 O

- NCT03867526 24 25 O
Informed NCT03867526 27 35 O
consent NCT03867526 36 43 O
will NCT03867526 44 48 O
be NCT03867526 49 51 O
obtained NCT03867526 52 60 O
from NCT03867526 61 65 O
the NCT03867526 66 69 O
patient NCT03867526 70 77 O
or NCT03867526 78 80 O
the NCT03867526 81 84 O
parents NCT03867526 85 92 B-Family_Member___Family_Member_Type:parent
before NCT03867526 93 99 B-Temporal_Connection___Temporal_Connection_Type_Value:before
any NCT03867526 100 103 O
study NCT03867526 104 109 B-Study
related NCT03867526 110 117 O
procedures NCT03867526 118 128 B-Procedure
. NCT03867526 129 130 O

- NCT03867526 134 135 O
Patients NCT03867526 137 145 O
of NCT03867526 146 148 O
both NCT03867526 149 153 O
genders NCT03867526 154 161 O
older NCT03867526 162 167 B-Eq_Comparison
than NCT03867526 168 172 I-Eq_Comparison
6 NCT03867526 173 174 I-Eq_Comparison
months NCT03867526 175 181 I-Eq_Comparison
and NCT03867526 182 185 B-And
younger NCT03867526 186 193 B-Eq_Comparison
than NCT03867526 194 198 I-Eq_Comparison
80 NCT03867526 199 201 I-Eq_Comparison
years NCT03867526 202 207 I-Eq_Comparison

- NCT03867526 210 211 O
The NCT03867526 213 216 O
patient NCT03867526 217 224 O
has NCT03867526 225 228 O
a NCT03867526 229 230 O
diagnosis NCT03867526 231 240 O
of NCT03867526 241 243 O
Wilson NCT03867526 244 250 B-Condition
dis NCT03867526 251 254 I-Condition
- NCT03867526 255 256 I-Condition
ease NCT03867526 257 261 I-Condition

Exclusion NCT03867526 262 271 O
Criteria NCT03867526 272 280 O
: NCT03867526 281 282 O

- NCT03867526 286 287 O
No NCT03867526 289 291 O
Informed NCT03867526 292 300 O
consent NCT03867526 301 308 O
from NCT03867526 309 313 O
the NCT03867526 314 317 O
patient NCT03867526 318 325 O
or NCT03867526 326 328 O
the NCT03867526 329 332 O
parents NCT03867526 333 340 B-Family_Member___Family_Member_Type:parent
before NCT03867526 341 347 B-Temporal_Connection___Temporal_Connection_Type_Value:before
any NCT03867526 348 351 O
study NCT03867526 352 357 B-Study
related NCT03867526 358 365 O
procedures NCT03867526 366 376 B-Procedure

- NCT03867526 379 380 O
Patients NCT03867526 382 390 O
of NCT03867526 391 393 O
both NCT03867526 394 398 O
genders NCT03867526 399 406 O
younger NCT03867526 407 414 B-Eq_Comparison
than NCT03867526 415 419 I-Eq_Comparison
6 NCT03867526 420 421 I-Eq_Comparison
months NCT03867526 422 428 I-Eq_Comparison
and NCT03867526 429 432 B-And
older NCT03867526 433 438 B-Eq_Comparison
than NCT03867526 439 443 I-Eq_Comparison
80 NCT03867526 444 446 I-Eq_Comparison
years NCT03867526 447 452 I-Eq_Comparison

- NCT03867526 455 456 O
No NCT03867526 458 460 B-Negation
diagnosis NCT03867526 461 470 O
of NCT03867526 471 473 O
Wilson NCT03867526 474 480 B-Condition
disease NCT03867526 481 488 I-Condition

Inclusion NCT03867552 0 9 O
Criteria NCT03867552 10 18 O
: NCT03867552 19 20 O

- NCT03867552 24 25 O
Woman NCT03867552 27 32 O
≥ NCT03867552 33 34 B-Eq_Comparison
18 NCT03867552 35 37 I-Eq_Comparison
years NCT03867552 38 43 I-Eq_Comparison
old NCT03867552 44 47 B-Age

- NCT03867552 50 51 O
undergoing NCT03867552 53 63 B-Eq_Comparison
laparoscopic NCT03867552 64 76 B-Procedure
surgery NCT03867552 77 84 I-Procedure
for NCT03867552 85 88 O
endometriosis NCT03867552 89 102 B-Condition
, NCT03867552 103 104 O
uterine NCT03867552 105 112 B-Condition
myoma NCT03867552 113 118 I-Condition
's NCT03867552 118 120 I-Condition
, NCT03867552 121 122 O
hysterectomy NCT03867552 123 135 B-Procedure
or NCT03867552 136 138 B-Or
colpopexy NCT03867552 139 148 B-Procedure
. NCT03867552 149 150 O

Exclusion NCT03867552 152 161 O
Criteria NCT03867552 162 170 O
: NCT03867552 171 172 O

- NCT03867552 176 177 O
Women NCT03867552 179 184 O
< NCT03867552 185 186 B-Eq_Comparison
18 NCT03867552 187 189 I-Eq_Comparison
years NCT03867552 190 195 I-Eq_Comparison
old NCT03867552 196 199 B-Age

- NCT03867552 202 203 O
Males NCT03867552 205 210 O

- NCT03867552 213 214 O
Pregnancy NCT03867552 216 225 B-Condition

- NCT03867552 228 229 O
Conditions NCT03867552 231 241 B-Condition
associated NCT03867552 242 252 O
with NCT03867552 253 257 O
chronic NCT03867552 258 265 O
pain NCT03867552 266 270 B-Condition
, NCT03867552 271 272 O
such NCT03867552 273 277 O
as NCT03867552 278 280 O
peripheral NCT03867552 281 291 B-Condition
neuropathy NCT03867552 292 302 I-Condition
, NCT03867552 303 304 O
pathology NCT03867552 305 314 B-Condition
of NCT03867552 315 317 O
the NCT03867552 318 321 O
vertebral NCT03867552 322 331 B-Modifier
column NCT03867552 332 338 I-Modifier
and NCT03867552 339 342 B-Or
osteo NCT03867552 343 348 B-Condition
- NCT03867552 349 350 I-Condition
articular NCT03867552 351 360 I-Condition
disease NCT03867552 361 368 I-Condition
. NCT03867552 369 370 O

- NCT03867552 374 375 O
Conditions NCT03867552 377 387 B-Condition
causing NCT03867552 388 395 O
acute NCT03867552 396 401 O
pain NCT03867552 402 406 B-Condition
e NCT03867552 407 408 O
. NCT03867552 409 410 O
g NCT03867552 411 412 O
. NCT03867552 413 414 O
abdominal NCT03867552 416 425 B-Modifier
trauma NCT03867552 426 432 B-Condition

Inclusion NCT03868241 0 9 O
Criteria NCT03868241 10 18 O
: NCT03868241 19 20 O

- NCT03868241 24 25 O
All NCT03868241 27 30 O
patients NCT03868241 31 39 O
admitted NCT03868241 40 48 B-Encounter
to NCT03868241 49 51 O
the NCT03868241 52 55 O
intensive NCT03868241 56 65 O
care NCT03868241 66 70 O
unit NCT03868241 71 75 O
which NCT03868241 76 81 O
will NCT03868241 82 86 B-Assertion___Assertion_Type_Value:hypothetical
require NCT03868241 87 94 I-Assertion___Assertion_Type_Value:hypothetical
simultaneous NCT03868241 95 107 O
insertion NCT03868241 108 117 B-Procedure
of NCT03868241 118 120 I-Procedure
all NCT03868241 121 124 I-Procedure
three NCT03868241 125 130 I-Procedure
devices NCT03868241 131 138 I-Procedure
( NCT03868241 139 140 O
endotracheal NCT03868241 141 153 B-Procedure
tube NCT03868241 154 158 I-Procedure
, NCT03868241 159 160 O
central NCT03868241 161 168 B-Procedure
venous NCT03868241 169 175 I-Procedure
catheter NCT03868241 176 184 I-Procedure
and NCT03868241 185 188 B-Or
urinary NCT03868241 189 196 B-Procedure
catheter NCT03868241 197 205 I-Procedure
) NCT03868241 206 207 O
due NCT03868241 208 211 O
to NCT03868241 212 214 O
illness NCT03868241 215 222 B-Condition
severity NCT03868241 223 231 O
as NCT03868241 232 234 O
defined NCT03868241 235 242 O
by NCT03868241 243 245 O
the NCT03868241 246 249 O
attending NCT03868241 250 259 B-Provider
physician NCT03868241 260 269 I-Provider
. NCT03868241 270 271 O

Exclusion NCT03868241 273 282 O
Criteria NCT03868241 283 291 O
: NCT03868241 292 293 O

- NCT03868241 297 298 O
Patients NCT03868241 300 308 O
admitted NCT03868241 309 317 B-Encounter
to NCT03868241 318 320 O
the NCT03868241 321 324 O
intensive NCT03868241 325 334 O
care NCT03868241 335 339 O
unit NCT03868241 340 344 O
for NCT03868241 345 348 O
more NCT03868241 349 353 B-Eq_Comparison
than NCT03868241 354 358 I-Eq_Comparison
48 NCT03868241 359 361 I-Eq_Comparison
hours NCT03868241 362 367 I-Eq_Comparison
or NCT03868241 368 370 B-Or
admitted NCT03868241 371 379 B-Encounter
in NCT03868241 380 382 O
the NCT03868241 383 386 O
hospital NCT03868241 387 395 O
for NCT03868241 396 399 O
more NCT03868241 400 404 B-Eq_Comparison
than NCT03868241 405 409 I-Eq_Comparison
seven NCT03868241 410 415 I-Eq_Comparison
days NCT03868241 416 420 I-Eq_Comparison

- NCT03868241 423 424 O
Presence NCT03868241 426 434 O
of NCT03868241 435 437 O
any NCT03868241 438 441 O
of NCT03868241 442 444 O
the NCT03868241 445 448 O
invasive NCT03868241 449 457 B-Procedure
devices NCT03868241 458 465 I-Procedure
( NCT03868241 466 467 O
endotracheal NCT03868241 468 480 B-Procedure
tube NCT03868241 481 485 I-Procedure
, NCT03868241 486 487 O
central NCT03868241 488 495 B-Procedure
venous NCT03868241 496 502 I-Procedure
catheter NCT03868241 503 511 I-Procedure
or NCT03868241 512 514 B-Or
urinary NCT03868241 515 522 B-Procedure
catheters NCT03868241 523 532 I-Procedure
) NCT03868241 533 534 O
before NCT03868241 535 541 B-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03868241 542 555 B-Study
and NCT03868241 556 559 B-And
absence NCT03868241 560 567 B-Negation
of NCT03868241 568 570 O
the NCT03868241 571 574 O
intention NCT03868241 575 584 B-Assertion___Assertion_Type_Value:intention
to NCT03868241 585 587 O
exchange NCT03868241 588 596 O
the NCT03868241 597 600 O
devices NCT03868241 601 608 O
; NCT03868241 608 609 O

- NCT03868241 612 613 O
Previous NCT03868241 615 623 B-Eq_Comparison
use NCT03868241 624 627 O
of NCT03868241 628 630 O
any NCT03868241 631 634 O
type NCT03868241 635 639 O
of NCT03868241 640 642 O
coated NCT03868241 643 649 B-Procedure
devices NCT03868241 650 657 I-Procedure
; NCT03868241 657 658 O

- NCT03868241 661 662 O
Age NCT03868241 664 667 B-Age
< NCT03868241 668 669 B-Eq_Comparison
18 NCT03868241 670 672 I-Eq_Comparison
years NCT03868241 673 678 I-Eq_Comparison
; NCT03868241 678 679 O

- NCT03868241 682 683 O
Known NCT03868241 685 690 O
pregnancy NCT03868241 691 700 B-Condition

- NCT03868241 703 704 O
Known NCT03868241 706 711 O
allergy NCT03868241 712 719 B-Allergy
to NCT03868241 720 722 O
gold NCT03868241 723 727 O
, NCT03868241 728 729 O
silver NCT03868241 730 736 O
and NCT03868241 737 740 B-Or
palladium NCT03868241 741 750 O
; NCT03868241 750 751 O

- NCT03868241 754 755 O
Suspected NCT03868241 757 766 B-Assertion___Assertion_Type_Value:possible
or NCT03868241 767 769 B-Or
confirmed NCT03868241 770 779 B-Modifier
brain NCT03868241 780 785 B-Modifier
death NCT03868241 786 791 B-Death
; NCT03868241 791 792 O

- NCT03868241 795 796 O
Previously NCT03868241 798 808 B-Eq_Comparison
enrolled NCT03868241 809 817 O
in NCT03868241 818 820 O
the NCT03868241 821 824 O
study NCT03868241 825 830 B-Study

Newly NCT03868241 831 836 O
added NCT03868241 837 842 O
exclusion NCT03868241 843 852 O
criteria NCT03868241 853 861 O
in NCT03868241 862 864 O
version NCT03868241 865 872 O
2.0 NCT03868241 873 876 O
: NCT03868241 877 878 O

- NCT03868241 882 883 O
Severe NCT03868241 885 891 O
chronic NCT03868241 892 899 O
pulmonary NCT03868241 900 909 B-Condition
obstructive NCT03868241 910 921 I-Condition
disease NCT03868241 922 929 I-Condition
which NCT03868241 930 935 O
may NCT03868241 936 939 B-Assertion___Assertion_Type_Value:hypothetical
limit NCT03868241 940 945 O
catheter NCT03868241 946 954 B-Procedure
site NCT03868241 955 959 I-Procedure
selection NCT03868241 960 969 O

- NCT03868241 972 973 O
Previous NCT03868241 975 983 B-Eq_Comparison
irradiation NCT03868241 984 995 B-Procedure
and NCT03868241 996 999 B-Or
/ NCT03868241 1000 1001 I-Or
or NCT03868241 1002 1004 I-Or
thrombosis NCT03868241 1005 1015 B-Condition
in NCT03868241 1016 1018 O
site NCT03868241 1019 1023 B-Modifier
selected NCT03868241 1024 1032 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03868241 1033 1036 I-Assertion___Assertion_Type_Value:hypothetical
catheter NCT03868241 1037 1045 B-Procedure
insertion NCT03868241 1046 1055 I-Procedure

Inclusion NCT03867682 0 9 O
Criteria NCT03867682 10 18 O
: NCT03867682 19 20 O

1 NCT03867682 24 25 O
. NCT03867682 25 26 O
Refractory NCT03867682 28 38 B-Modifier
or NCT03867682 39 41 B-Or
relapsed NCT03867682 42 50 B-Modifier
AML NCT03867682 51 54 B-Condition
which NCT03867682 55 60 O
will NCT03867682 61 65 O
include NCT03867682 66 73 O
: NCT03867682 74 75 O

1 NCT03867682 84 85 O
. NCT03867682 85 86 O
Refractory NCT03867682 88 98 B-Condition
disease NCT03867682 99 106 I-Condition
will NCT03867682 107 111 O
be NCT03867682 112 114 O
defined NCT03867682 115 122 O
as NCT03867682 123 125 O
at NCT03867682 126 128 B-Eq_Comparison
least NCT03867682 129 134 I-Eq_Comparison
1 NCT03867682 135 136 I-Eq_Comparison
prior NCT03867682 137 142 B-Eq_Comparison
treatment NCT03867682 143 152 B-Procedure
with NCT03867682 153 157 B-And
no NCT03867682 158 160 B-Negation
remission NCT03867682 161 170 B-Condition
. NCT03867682 171 172 O

2 NCT03867682 181 182 O
. NCT03867682 182 183 O
Relapsed NCT03867682 185 193 B-Condition
disease NCT03867682 194 201 I-Condition
will NCT03867682 202 206 O
be NCT03867682 207 209 O
defined NCT03867682 210 217 O
as NCT03867682 218 220 O
5 NCT03867682 221 222 B-Eq_Comparison
% NCT03867682 223 224 I-Eq_Comparison
or NCT03867682 225 227 I-Eq_Comparison
more NCT03867682 228 232 I-Eq_Comparison
blasts NCT03867682 233 239 B-Observation
in NCT03867682 240 242 I-Observation
bone NCT03867682 243 247 I-Observation
marrow NCT03867682 248 254 I-Observation
seen NCT03867682 255 259 O
after NCT03867682 260 265 B-Temporal_Connection___Temporal_Connection_Type_Value:after
remission NCT03867682 266 275 B-Condition
. NCT03867682 276 277 O

3 NCT03867682 286 287 O
. NCT03867682 287 288 O
Patients NCT03867682 290 298 O
with NCT03867682 299 303 O
AML NCT03867682 304 307 B-Condition
arising NCT03867682 308 315 O
from NCT03867682 316 320 O
myelodysplastic NCT03867682 321 336 B-Condition
syndromes NCT03867682 337 346 I-Condition
( NCT03867682 347 348 O
including NCT03867682 349 358 O
CMML NCT03867682 359 363 B-Condition
) NCT03867682 364 365 O
or NCT03867682 366 368 B-Or
myeloproliferative NCT03867682 369 387 B-Condition
neoplasms NCT03867682 388 397 I-Condition
( NCT03867682 398 399 O
secondary NCT03867682 400 409 B-Modifier
AML NCT03867682 410 413 B-Condition
, NCT03867682 414 415 O
ts NCT03867682 416 418 B-Condition
- NCT03867682 419 420 I-Condition
AML NCT03867682 421 424 I-Condition
) NCT03867682 425 426 O
are NCT03867682 427 430 O
also NCT03867682 431 435 O
eligible NCT03867682 436 444 O
. NCT03867682 445 446 O

2 NCT03867682 450 451 O
. NCT03867682 451 452 O
Circulating NCT03867682 454 465 B-Observation
blast NCT03867682 466 471 I-Observation
count NCT03867682 472 477 I-Observation
≤ NCT03867682 478 479 B-Eq_Comparison
200 NCT03867682 480 483 I-Eq_Comparison
/ NCT03867682 484 485 I-Eq_Comparison
μL NCT03867682 486 488 I-Eq_Comparison
within NCT03867682 489 495 B-Eq_Comparison
10 NCT03867682 496 498 I-Eq_Comparison
days NCT03867682 499 503 I-Eq_Comparison
prior NCT03867682 504 509 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867682 510 512 I-Temporal_Connection___Temporal_Connection_Type_Value:before
first NCT03867682 513 518 B-Eq_Comparison
cycle NCT03867682 519 524 O
of NCT03867682 525 527 O
treatment NCT03867682 528 537 B-Procedure
. NCT03867682 538 539 O
Hydroxyurea NCT03867682 541 552 B-Drug
should NCT03867682 553 559 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03867682 560 562 I-Assertion___Assertion_Type_Value:hypothetical
used NCT03867682 563 567 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03867682 568 570 O
keep NCT03867682 571 575 O
the NCT03867682 576 579 O
peripheral NCT03867682 580 590 B-Observation
blast NCT03867682 591 596 I-Observation
count NCT03867682 597 602 I-Observation
≤ NCT03867682 603 604 B-Eq_Comparison
200 NCT03867682 605 608 I-Eq_Comparison
/ NCT03867682 609 610 I-Eq_Comparison
μL NCT03867682 611 613 I-Eq_Comparison
until NCT03867682 614 619 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03867682 620 623 O
first NCT03867682 624 629 B-Eq_Comparison
day NCT03867682 630 633 I-Eq_Comparison
of NCT03867682 634 636 O
protocol NCT03867682 637 645 O
treatment NCT03867682 646 655 B-Procedure
, NCT03867682 656 657 O
to NCT03867682 658 660 O
the NCT03867682 661 664 O
extent NCT03867682 665 671 O
that NCT03867682 672 676 O
this NCT03867682 677 681 O
is NCT03867682 682 684 O
possible NCT03867682 685 693 O

3 NCT03867682 696 697 O
. NCT03867682 697 698 O
ECOG NCT03867682 700 704 B-Observation
≤ NCT03867682 705 706 B-Eq_Comparison
2 NCT03867682 707 708 I-Eq_Comparison

4 NCT03867682 712 713 O
. NCT03867682 713 714 O
Estimated NCT03867682 716 725 B-Observation
creatinine NCT03867682 726 736 I-Observation
clearance NCT03867682 737 746 I-Observation
≥ NCT03867682 747 748 B-Eq_Comparison
50 NCT03867682 749 751 I-Eq_Comparison
mL NCT03867682 752 754 I-Eq_Comparison
/ NCT03867682 755 756 I-Eq_Comparison
min NCT03867682 757 760 I-Eq_Comparison

5 NCT03867682 763 764 O
. NCT03867682 764 765 O
AST NCT03867682 767 770 B-Observation
and NCT03867682 771 774 B-And
ALT NCT03867682 775 778 B-Observation
≤ NCT03867682 779 780 B-Eq_Comparison
3.0 NCT03867682 781 784 I-Eq_Comparison
x NCT03867682 785 786 I-Eq_Comparison
ULN NCT03867682 787 790 I-Eq_Comparison

6 NCT03867682 793 794 O
. NCT03867682 794 795 O
Bilirubin NCT03867682 797 806 B-Observation
≤ NCT03867682 807 808 B-Eq_Comparison
3.0 NCT03867682 809 812 I-Eq_Comparison
x NCT03867682 813 814 I-Eq_Comparison
ULN NCT03867682 815 818 I-Eq_Comparison

Exclusion NCT03867682 819 828 O
Criteria NCT03867682 829 837 O
: NCT03867682 838 839 O

1 NCT03867682 843 844 O
. NCT03867682 844 845 O
Active NCT03867682 847 853 B-Eq_Comparison
CNS NCT03867682 854 857 B-Modifier
Leukemia NCT03867682 858 866 B-Condition
. NCT03867682 867 868 O

2 NCT03867682 872 873 O
. NCT03867682 873 874 O
Known NCT03867682 876 881 O
HIV NCT03867682 882 885 B-Condition
infection NCT03867682 886 895 I-Condition
or NCT03867682 896 898 B-Or
known NCT03867682 899 904 O
hepatitis NCT03867682 905 914 B-Modifier
B NCT03867682 915 916 I-Modifier
or NCT03867682 917 919 B-Or
hepatitis NCT03867682 920 929 B-Modifier
C NCT03867682 930 931 I-Modifier
infection NCT03867682 932 941 B-Condition
( NCT03867682 942 943 O
with NCT03867682 944 948 O
a NCT03867682 949 950 O
detectable NCT03867682 951 961 O
viral NCT03867682 962 967 B-Observation
load NCT03867682 968 972 I-Observation
) NCT03867682 973 974 O
. NCT03867682 975 976 O

3 NCT03867682 980 981 O
. NCT03867682 981 982 O
Participant NCT03867682 984 995 O
has NCT03867682 996 999 O
received NCT03867682 1000 1008 B-Eq_Comparison
strong NCT03867682 1009 1015 O
and NCT03867682 1016 1019 B-Or
/ NCT03867682 1020 1021 I-Or
or NCT03867682 1022 1024 I-Or
moderate NCT03867682 1025 1033 O
CYP NCT03867682 1034 1037 B-Drug
3A NCT03867682 1038 1040 I-Drug
inducers NCT03867682 1041 1049 I-Drug
within NCT03867682 1050 1056 B-Eq_Comparison
7 NCT03867682 1057 1058 I-Eq_Comparison
days NCT03867682 1059 1063 I-Eq_Comparison
prior NCT03867682 1064 1069 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867682 1070 1072 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03867682 1073 1076 O
initiation NCT03867682 1077 1087 B-Eq_Comparison
of NCT03867682 1088 1090 O
study NCT03867682 1091 1096 B-Study
treatment NCT03867682 1097 1106 B-Procedure
. NCT03867682 1107 1108 O

4 NCT03867682 1112 1113 O
. NCT03867682 1113 1114 O
Have NCT03867682 1116 1120 O
received NCT03867682 1121 1129 B-Eq_Comparison
prior NCT03867682 1130 1135 I-Eq_Comparison
radiation NCT03867682 1136 1145 B-Procedure
to NCT03867682 1146 1148 O
maximally NCT03867682 1149 1158 B-Modifier
tolerated NCT03867682 1159 1168 I-Modifier
levels NCT03867682 1169 1175 I-Modifier
to NCT03867682 1176 1178 O
any NCT03867682 1179 1182 O
critical NCT03867682 1183 1191 O
normal NCT03867682 1192 1198 O
organ NCT03867682 1199 1204 B-Modifier
. NCT03867682 1205 1206 O

5 NCT03867682 1210 1211 O
. NCT03867682 1211 1212 O
Clinically NCT03867682 1214 1224 O
significant NCT03867682 1225 1236 O
cardiac NCT03867682 1237 1244 B-Condition
disease NCT03867682 1245 1252 I-Condition
. NCT03867682 1253 1254 O

6 NCT03867682 1258 1259 O
. NCT03867682 1259 1260 O
Active NCT03867682 1262 1268 B-Eq_Comparison
, NCT03867682 1269 1270 O
uncontrolled NCT03867682 1271 1283 B-Modifier
serious NCT03867682 1284 1291 O
infection NCT03867682 1292 1301 B-Condition
. NCT03867682 1302 1303 O

7 NCT03867682 1307 1308 O
. NCT03867682 1308 1309 O
Have NCT03867682 1311 1315 O
other NCT03867682 1316 1321 B-Other
non NCT03867682 1322 1325 B-Negation
- NCT03867682 1326 1327 O
myeloid NCT03867682 1328 1335 B-Modifier
malignancy NCT03867682 1336 1346 B-Condition
within NCT03867682 1347 1353 B-Eq_Comparison
2 NCT03867682 1354 1355 I-Eq_Comparison
years NCT03867682 1356 1361 I-Eq_Comparison
of NCT03867682 1362 1364 B-Temporal_Connection___Temporal_Connection_Type_Value:before
entry NCT03867682 1365 1370 B-Study
( NCT03867682 1371 1372 O
with NCT03867682 1373 1377 O
exceptions NCT03867682 1378 1388 O
) NCT03867682 1389 1390 O
. NCT03867682 1391 1392 O

8 NCT03867682 1396 1397 O
. NCT03867682 1397 1398 O
Psychiatric NCT03867682 1400 1411 B-Condition
disorder NCT03867682 1412 1420 I-Condition
that NCT03867682 1421 1425 O
would NCT03867682 1426 1431 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03867682 1432 1440 B-Negation
study NCT03867682 1441 1446 B-Study
participation NCT03867682 1447 1460 O

9 NCT03867682 1463 1464 O
. NCT03867682 1464 1465 O
Previous NCT03867682 1467 1475 B-Eq_Comparison
solid NCT03867682 1476 1481 B-Modifier
organ NCT03867682 1482 1487 B-Procedure
transplant NCT03867682 1488 1498 I-Procedure
( NCT03867682 1499 1500 O
prior NCT03867682 1501 1506 B-Eq_Comparison
treatment NCT03867682 1507 1516 B-Procedure
with NCT03867682 1517 1521 O
SCT NCT03867682 1522 1525 B-Procedure
is NCT03867682 1526 1528 O
allowed NCT03867682 1529 1536 O
but NCT03867682 1537 1540 B-And
not NCT03867682 1541 1544 B-Negation
if NCT03867682 1545 1547 O
patient NCT03867682 1548 1555 O
has NCT03867682 1556 1559 O
GVHD NCT03867682 1560 1564 B-Condition
or NCT03867682 1565 1567 B-Or
is NCT03867682 1568 1570 O
still NCT03867682 1571 1576 O
receiving NCT03867682 1577 1586 B-Eq_Comparison
immunosuppression NCT03867682 1587 1604 B-Procedure
/ NCT03867682 1605 1606 B-Or
GVHD NCT03867682 1607 1611 B-Procedure
therapy NCT03867682 1612 1619 I-Procedure
) NCT03867682 1620 1621 O
. NCT03867682 1622 1623 O

Inclusion NCT03868137 0 9 O
Criteria NCT03868137 10 18 O
: NCT03868137 19 20 O

- NCT03868137 24 25 O
Age NCT03868137 27 30 B-Age
≥ NCT03868137 31 32 B-Eq_Comparison
18 NCT03868137 33 35 I-Eq_Comparison

- NCT03868137 39 40 O
Female NCT03868137 42 48 O

- NCT03868137 51 52 O
Able NCT03868137 54 58 O
to NCT03868137 59 61 O
provide NCT03868137 62 69 O
informed NCT03868137 70 78 O
consent NCT03868137 79 86 O

- NCT03868137 89 90 O
English NCT03868137 92 99 O
speaking NCT03868137 100 108 O

- NCT03868137 111 112 O
Able NCT03868137 114 118 O
to NCT03868137 119 121 O
provide NCT03868137 122 129 O
telephone NCT03868137 130 139 O
and NCT03868137 140 143 O
address NCT03868137 144 151 O
contact NCT03868137 152 159 O
information NCT03868137 160 171 O

- NCT03868137 174 175 O
Able NCT03868137 177 181 O
and NCT03868137 182 185 O
willing NCT03868137 186 193 O
to NCT03868137 194 196 O
receive NCT03868137 197 204 O
HIPAA NCT03868137 205 210 O
compliant NCT03868137 211 220 O
telephone NCT03868137 221 230 O
texts NCT03868137 231 236 O
and NCT03868137 237 240 O
phone NCT03868137 241 246 O
messages NCT03868137 247 255 O

- NCT03868137 258 259 O
Stable NCT03868137 261 267 O
( NCT03868137 268 269 O
the NCT03868137 270 273 O
same NCT03868137 274 278 O
) NCT03868137 279 280 O
address NCT03868137 281 288 O
and NCT03868137 289 292 O
phone NCT03868137 293 298 O
number NCT03868137 299 305 O
within NCT03868137 306 312 B-Eq_Comparison
the NCT03868137 313 316 I-Eq_Comparison
last NCT03868137 317 321 I-Eq_Comparison
6 NCT03868137 322 323 I-Eq_Comparison
months NCT03868137 324 330 I-Eq_Comparison
. NCT03868137 331 332 O

Exclusion NCT03868137 334 343 O
Criteria NCT03868137 344 352 O
: NCT03868137 353 354 O

- NCT03868137 358 359 O
Contraindications NCT03868137 361 378 B-Contraindication
to NCT03868137 379 381 O
IUD NCT03868137 382 385 B-Procedure
insertion NCT03868137 386 395 I-Procedure
( NCT03868137 396 397 O
active NCT03868137 398 404 B-Eq_Comparison
pelvic NCT03868137 405 411 B-Modifier
infection NCT03868137 412 421 B-Condition
, NCT03868137 422 423 O
current NCT03868137 424 431 B-Eq_Comparison
pregnancy NCT03868137 432 441 B-Condition
) NCT03868137 442 443 O

- NCT03868137 447 448 O
Contraindications NCT03868137 450 467 B-Contraindication
to NCT03868137 468 470 O
NSAIDs NCT03868137 471 477 B-Drug
( NCT03868137 478 479 O
allergy NCT03868137 480 487 B-Allergy
, NCT03868137 488 489 O
history NCT03868137 490 497 B-Eq_Comparison
of NCT03868137 498 500 O
asthma NCT03868137 501 507 B-Condition
, NCT03868137 508 509 O
history NCT03868137 510 517 B-Eq_Comparison
of NCT03868137 518 520 O
aspirin NCT03868137 521 528 B-Drug
allergy NCT03868137 529 536 B-Allergy
, NCT03868137 537 538 O
history NCT03868137 539 546 B-Eq_Comparison
of NCT03868137 547 549 O
kidney NCT03868137 550 556 B-Condition
disease NCT03868137 557 564 I-Condition
, NCT03868137 565 566 O
history NCT03868137 567 574 B-Eq_Comparison
of NCT03868137 575 577 O
stomach NCT03868137 578 585 B-Modifier
ulcer NCT03868137 586 591 B-Condition
, NCT03868137 592 593 O
history NCT03868137 594 601 B-Eq_Comparison
of NCT03868137 602 604 O
active NCT03868137 605 611 B-Eq_Comparison
GI NCT03868137 612 614 B-Modifier
bleeding NCT03868137 615 623 B-Condition
, NCT03868137 624 625 O
history NCT03868137 626 633 B-Eq_Comparison
of NCT03868137 634 636 O
liver NCT03868137 637 642 B-Condition
disease NCT03868137 643 650 I-Condition
) NCT03868137 651 652 O

- NCT03868137 656 657 O
Not NCT03868137 659 662 B-Negation
undergoing NCT03868137 663 673 B-Eq_Comparison
any NCT03868137 674 677 O
other NCT03868137 678 683 B-Other
concurrent NCT03868137 684 694 B-Modifier
office NCT03868137 695 701 I-Modifier
procedures NCT03868137 702 712 B-Procedure

Inclusion NCT03865979 0 9 O
Criteria NCT03865979 10 18 O
: NCT03865979 19 20 O

- NCT03865979 24 25 O
Subjects NCT03865979 27 35 O
with NCT03865979 36 40 O
stroke NCT03865979 41 47 B-Condition
symptoms NCT03865979 48 56 B-Assertion___Assertion_Type_Value:possible
who NCT03865979 57 60 B-And
undergo NCT03865979 61 68 O
CT NCT03865979 69 71 B-Procedure
brain NCT03865979 72 77 I-Procedure
imaging NCT03865979 78 85 I-Procedure
. NCT03865979 86 87 O

Exclusion NCT03865979 89 98 O
Criteria NCT03865979 99 107 O
: NCT03865979 108 109 O

- NCT03865979 113 114 O
Subjects NCT03865979 116 124 O
with NCT03865979 125 129 O
poor NCT03865979 130 134 B-Modifier
or NCT03865979 135 137 B-Or
incomplete NCT03865979 138 148 B-Modifier
CT NCT03865979 149 151 B-Procedure
brain NCT03865979 152 157 I-Procedure
imaging NCT03865979 158 165 I-Procedure
. NCT03865979 166 167 O

Inclusion NCT03861377 0 9 O
Criteria NCT03861377 10 18 O
: NCT03861377 19 20 O

- NCT03861377 24 25 O
Gynecological NCT03861377 27 40 B-Procedure
procedure NCT03861377 41 50 I-Procedure

- NCT03861377 53 54 O
Age NCT03861377 56 59 B-Age
18 NCT03861377 60 62 B-Eq_Comparison
- NCT03861377 63 64 I-Eq_Comparison
50 NCT03861377 65 67 I-Eq_Comparison
years NCT03861377 68 73 I-Eq_Comparison

- NCT03861377 76 77 O
General NCT03861377 79 86 B-Procedure
anesthesia NCT03861377 87 97 I-Procedure
planned NCT03861377 98 105 B-Eq_Comparison

- NCT03861377 108 109 O
Systolic NCT03861377 111 119 B-Observation
blood NCT03861377 120 125 I-Observation
pressure NCT03861377 126 134 I-Observation
< NCT03861377 135 136 B-Eq_Comparison
150 NCT03861377 137 140 I-Eq_Comparison
mmHg NCT03861377 141 145 I-Eq_Comparison
, NCT03861377 146 147 O
HR NCT03861377 148 150 B-Observation
< NCT03861377 151 152 B-Eq_Comparison
100 NCT03861377 153 156 I-Eq_Comparison
beats NCT03861377 157 162 I-Eq_Comparison
/ NCT03861377 163 164 I-Eq_Comparison
min NCT03861377 165 168 I-Eq_Comparison

Exclusion NCT03861377 169 178 O
Criteria NCT03861377 179 187 O
: NCT03861377 188 189 O

- NCT03861377 193 194 O
Pre NCT03861377 196 199 B-Eq_Comparison
- NCT03861377 200 201 I-Eq_Comparison
existing NCT03861377 202 210 I-Eq_Comparison
hypertension NCT03861377 211 223 B-Condition

- NCT03861377 226 227 O
Diabetes NCT03861377 229 237 B-Condition

- NCT03861377 240 241 O
Ischemic NCT03861377 243 251 B-Modifier
heart NCT03861377 252 257 B-Condition
disease NCT03861377 258 265 I-Condition
or NCT03861377 266 268 B-Or
cerebrovascular NCT03861377 269 284 B-Condition
disease NCT03861377 285 292 I-Condition

- NCT03861377 295 296 O
Heart NCT03861377 298 303 B-Condition
valve NCT03861377 304 309 I-Condition
disease NCT03861377 310 317 I-Condition

- NCT03861377 320 321 O
Verified NCT03861377 323 331 O
cardiac NCT03861377 332 339 B-Condition
arrhythmia NCT03861377 340 350 I-Condition
other NCT03861377 351 356 B-Exception
than NCT03861377 357 361 I-Exception
extrasystoles NCT03861377 362 375 B-Condition

- NCT03861377 378 379 O
Verified NCT03861377 381 389 O
anaemia NCT03861377 390 397 B-Condition
with NCT03861377 398 402 B-And
hemoglobin NCT03861377 403 413 B-Observation
level NCT03861377 414 419 O
below NCT03861377 420 425 B-Eq_Comparison
9.0 NCT03861377 426 429 I-Eq_Comparison
gr NCT03861377 430 432 I-Eq_Comparison
/ NCT03861377 433 434 I-Eq_Comparison
dl NCT03861377 435 437 I-Eq_Comparison
. NCT03861377 438 439 O

- NCT03861377 443 444 O
Kidney NCT03861377 446 452 B-Modifier
or NCT03861377 453 455 B-Or
hepatic NCT03861377 456 463 B-Modifier
disease NCT03861377 464 471 B-Condition

- NCT03861377 474 475 O
Hypersensitivity NCT03861377 477 493 B-Condition
for NCT03861377 494 497 O
propofol NCT03861377 498 506 B-Drug
, NCT03861377 507 508 O
soya NCT03861377 509 513 B-Modifier
, NCT03861377 514 515 O
eggs NCT03861377 516 520 B-Modifier
or NCT03861377 521 523 B-Or
peanuts NCT03861377 524 531 B-Modifier

- NCT03861377 534 535 O
Pregnancy NCT03861377 537 546 B-Condition

- NCT03861377 549 550 O
Poor NCT03861377 552 556 B-Condition
health NCT03861377 557 563 I-Condition
state NCT03861377 564 569 O

- NCT03861377 572 573 O
Illicit NCT03861377 575 582 B-Condition
substance NCT03861377 583 592 I-Condition
use NCT03861377 593 596 I-Condition

- NCT03861377 599 600 O
BMI NCT03861377 602 605 B-Observation
< NCT03861377 606 607 B-Eq_Comparison
20 NCT03861377 608 610 I-Eq_Comparison
or NCT03861377 611 613 B-Or
> NCT03861377 614 615 B-Eq_Comparison
35 NCT03861377 616 618 I-Eq_Comparison
kg NCT03861377 619 621 I-Eq_Comparison
/ NCT03861377 622 623 I-Eq_Comparison
m NCT03861377 624 625 I-Eq_Comparison
2 NCT03861377 626 627 I-Eq_Comparison

Inclusion NCT03920423 0 9 O
Criteria NCT03920423 10 18 O
: NCT03920423 19 20 O

- NCT03920423 24 25 O
requirement NCT03920423 27 38 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03920423 39 41 I-Assertion___Assertion_Type_Value:hypothetical
radial NCT03920423 42 48 B-Procedure
arterial NCT03920423 49 57 I-Procedure
catheterization NCT03920423 58 73 I-Procedure
during NCT03920423 74 80 B-Temporal_Connection___Temporal_Connection_Type_Value:during
peri NCT03920423 81 85 O
operative NCT03920423 86 95 B-Procedure
period NCT03920423 96 102 O

- NCT03920423 105 106 O
within NCT03920423 108 114 O
cardiac NCT03920423 115 122 B-Condition
- NCT03920423 123 124 I-Condition
vascular NCT03920423 125 133 I-Condition
disease NCT03920423 134 141 I-Condition

- NCT03920423 144 145 O
written NCT03920423 147 154 O
consent NCT03920423 155 162 O

Exclusion NCT03920423 163 172 O
Criteria NCT03920423 173 181 O
: NCT03920423 182 183 O

- NCT03920423 187 188 O
contraindication NCT03920423 190 206 B-Contraindication
to NCT03920423 207 209 O
radial NCT03920423 210 216 B-Procedure
arterial NCT03920423 217 225 I-Procedure
catheterization NCT03920423 226 241 I-Procedure

- NCT03920423 244 245 O
abnormal NCT03920423 247 255 B-Condition
artery NCT03920423 256 262 I-Condition
evaluated NCT03920423 263 272 O
by NCT03920423 273 275 O
ultrasonography NCT03920423 276 291 B-Procedure

Inclusion NCT03869489 0 9 O
Criteria NCT03869489 10 18 O
: NCT03869489 19 20 O

- NCT03869489 24 25 O
Normal NCT03869489 27 33 O
hearing NCT03869489 34 41 B-Condition
and NCT03869489 42 45 B-And
vision NCT03869489 46 52 B-Condition

Exclusion NCT03869489 53 62 O
Criteria NCT03869489 63 71 O
: NCT03869489 72 73 O

- NCT03869489 77 78 O
Left NCT03869489 80 84 B-Condition
- NCT03869489 85 86 I-Condition
handedness NCT03869489 87 97 I-Condition

- NCT03869489 100 101 O
History NCT03869489 103 110 B-Eq_Comparison
of NCT03869489 111 113 O
seizure NCT03869489 114 121 B-Condition
, NCT03869489 122 123 O
head NCT03869489 124 128 B-Modifier
injury NCT03869489 129 135 B-Condition
( NCT03869489 136 137 O
including NCT03869489 138 147 O
neurosurgery NCT03869489 148 160 B-Procedure
) NCT03869489 161 162 O
, NCT03869489 163 164 O
brain NCT03869489 165 170 B-Modifier
injury NCT03869489 171 177 B-Condition
, NCT03869489 178 179 O
diagnosis NCT03869489 180 189 O
or NCT03869489 190 192 B-Or
a NCT03869489 193 194 O
neurological NCT03869489 195 207 B-Modifier
or NCT03869489 208 210 B-Or
psychiatric NCT03869489 211 222 B-Modifier
disorder NCT03869489 223 231 B-Condition
, NCT03869489 232 233 O
metal NCT03869489 234 239 B-Condition
in NCT03869489 240 242 I-Condition
the NCT03869489 243 246 I-Condition
head NCT03869489 247 251 I-Condition
, NCT03869489 252 253 O
sensitive NCT03869489 254 263 B-Condition
scalp NCT03869489 264 269 I-Condition

- NCT03869489 272 273 O
History NCT03869489 275 282 B-Eq_Comparison
of NCT03869489 283 285 O
anxiolytic NCT03869489 286 296 B-Drug
and NCT03869489 297 300 B-Or
/ NCT03869489 301 302 I-Or
or NCT03869489 303 305 I-Or
antidepressant NCT03869489 306 320 B-Drug
medications NCT03869489 321 332 I-Drug

- NCT03869489 335 336 O
Participation NCT03869489 338 351 O
in NCT03869489 352 354 O
Experiment NCT03869489 355 365 B-Study
# NCT03869489 366 367 O
1 NCT03869489 368 369 O
or NCT03869489 370 372 B-Or
Experiment NCT03869489 373 383 B-Study
# NCT03869489 384 385 O
2 NCT03869489 386 387 O
of NCT03869489 388 390 O
the NCT03869489 391 394 O
larger NCT03869489 395 401 O
study NCT03869489 402 407 B-Study

Inclusion NCT03920579 0 9 O
Criteria NCT03920579 10 18 O
: NCT03920579 19 20 O

1 NCT03920579 24 25 O
. NCT03920579 25 26 O
Healthy NCT03920579 28 35 B-Condition
volunteers NCT03920579 36 46 O
aged NCT03920579 47 51 B-Age
between NCT03920579 52 59 B-Eq_Comparison
≥ NCT03920579 60 61 I-Eq_Comparison
20 NCT03920579 62 64 I-Eq_Comparison
and NCT03920579 65 68 I-Eq_Comparison
≤ NCT03920579 69 70 I-Eq_Comparison
45 NCT03920579 71 73 I-Eq_Comparison
years NCT03920579 74 79 I-Eq_Comparison
old NCT03920579 80 83 O

2 NCT03920579 86 87 O
. NCT03920579 87 88 O
Weight NCT03920579 90 96 B-Observation
≥ NCT03920579 97 98 B-Eq_Comparison
50 NCT03920579 99 101 I-Eq_Comparison
kg NCT03920579 102 104 I-Eq_Comparison
, NCT03920579 105 106 O
with NCT03920579 107 111 O
calculated NCT03920579 112 122 O
body NCT03920579 123 127 B-Observation
mass NCT03920579 128 132 I-Observation
index NCT03920579 133 138 I-Observation
( NCT03920579 139 140 O
BMI NCT03920579 141 144 B-Observation
) NCT03920579 145 146 O
of NCT03920579 147 149 O
≥ NCT03920579 150 151 B-Eq_Comparison
18.5 NCT03920579 152 156 I-Eq_Comparison
and NCT03920579 157 160 B-And
≤ NCT03920579 161 162 B-Eq_Comparison
27.0 NCT03920579 163 167 I-Eq_Comparison
kg NCT03920579 168 170 I-Eq_Comparison
/ NCT03920579 171 172 I-Eq_Comparison
m NCT03920579 173 174 I-Eq_Comparison
2 NCT03920579 175 176 I-Eq_Comparison

3 NCT03920579 179 180 O
. NCT03920579 180 181 O
Those NCT03920579 183 188 O
who NCT03920579 189 192 O
have NCT03920579 193 197 O
no NCT03920579 198 200 B-Negation
congenital NCT03920579 201 211 B-Condition
chronic NCT03920579 212 219 I-Condition
disease NCT03920579 220 227 I-Condition
or NCT03920579 228 230 B-Or
chronic NCT03920579 231 238 B-Condition
disease NCT03920579 239 246 I-Condition
requiring NCT03920579 247 256 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03920579 257 266 B-Procedure
and NCT03920579 267 270 B-And
who NCT03920579 271 274 O
have NCT03920579 275 279 O
no NCT03920579 280 282 B-Negation
pathological NCT03920579 283 295 B-Condition
symptoms NCT03920579 296 304 B-Assertion___Assertion_Type_Value:possible
or NCT03920579 305 307 B-Or
findings NCT03920579 308 316 B-Modifier

4 NCT03920579 319 320 O
. NCT03920579 320 321 O
Those NCT03920579 323 328 O
who NCT03920579 329 332 O
are NCT03920579 333 336 O
judged NCT03920579 337 343 O
to NCT03920579 344 346 O
be NCT03920579 347 349 O
eligible NCT03920579 350 358 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03920579 359 362 O
clinical NCT03920579 363 371 O
trials NCT03920579 372 378 O
based NCT03920579 379 384 O
on NCT03920579 385 387 O
laboratory NCT03920579 388 398 B-Observation
and NCT03920579 399 402 B-And
ECG NCT03920579 403 406 B-Observation
results NCT03920579 407 414 O
during NCT03920579 415 421 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03920579 422 431 B-Study
tests NCT03920579 432 437 O

5 NCT03920579 440 441 O
. NCT03920579 441 442 O
Those NCT03920579 444 449 O
who NCT03920579 450 453 O
voluntarily NCT03920579 454 465 O
decide NCT03920579 466 472 O
to NCT03920579 473 475 O
participate NCT03920579 476 487 O
and NCT03920579 488 491 O
agree NCT03920579 492 497 O
to NCT03920579 498 500 O
comply NCT03920579 501 507 O
with NCT03920579 508 512 O
the NCT03920579 513 516 O
cautions NCT03920579 517 525 O
after NCT03920579 526 531 O
hearing NCT03920579 532 539 O
and NCT03920579 540 543 O
fully NCT03920579 544 549 O
understanding NCT03920579 550 563 O
the NCT03920579 564 567 O
detailed NCT03920579 568 576 O
description NCT03920579 577 588 O
of NCT03920579 589 591 O
this NCT03920579 592 596 O
clinical NCT03920579 597 605 O
trial NCT03920579 606 611 O

Exclusion NCT03920579 612 621 O
Criteria NCT03920579 622 630 O
: NCT03920579 631 632 O

1 NCT03920579 636 637 O
. NCT03920579 637 638 O
History NCT03920579 640 647 B-Eq_Comparison
of NCT03920579 648 650 O
presence NCT03920579 651 659 O
of NCT03920579 660 662 O
hepatobiliary NCT03920579 663 676 B-Modifier
, NCT03920579 677 678 O
renal NCT03920579 679 684 B-Modifier
, NCT03920579 685 686 O
cardiovascular NCT03920579 687 701 B-Modifier
, NCT03920579 702 703 O
endocrine NCT03920579 704 713 B-Modifier
, NCT03920579 714 715 O
respiratory NCT03920579 716 727 B-Modifier
, NCT03920579 728 729 O
gastrointestinal NCT03920579 730 746 B-Modifier
, NCT03920579 747 748 O
hematological NCT03920579 749 762 B-Modifier
, NCT03920579 763 764 O
neurologic NCT03920579 765 775 B-Modifier
, NCT03920579 776 777 O
psychiatric NCT03920579 778 789 B-Modifier
or NCT03920579 790 792 B-Or
musculoskeletal NCT03920579 793 808 B-Modifier
disorders NCT03920579 809 818 B-Condition
affecting NCT03920579 819 828 B-Assertion___Assertion_Type_Value:hypothetical
absorption NCT03920579 829 839 B-Modifier
, NCT03920579 840 841 O
distribution NCT03920579 842 854 B-Modifier
, NCT03920579 855 856 O
metabolism NCT03920579 857 867 B-Modifier
and NCT03920579 868 871 O
excretion NCT03920579 872 881 B-Modifier
of NCT03920579 882 884 O
the NCT03920579 885 888 O
drug NCT03920579 889 893 B-Drug

2 NCT03920579 896 897 O
. NCT03920579 897 898 O
Genetic NCT03920579 900 907 B-Condition
problems NCT03920579 908 916 I-Condition
such NCT03920579 917 921 O
as NCT03920579 922 924 O
galactose NCT03920579 925 934 B-Condition
intolerance NCT03920579 935 946 I-Condition
, NCT03920579 947 948 O
Lapp NCT03920579 949 953 B-Condition
lactose NCT03920579 954 961 I-Condition
deficiency NCT03920579 962 972 I-Condition
or NCT03920579 973 975 B-Or
glucose NCT03920579 976 983 B-Condition
- NCT03920579 984 985 I-Condition
galactose NCT03920579 986 995 I-Condition
malabsorption NCT03920579 996 1009 I-Condition

3 NCT03920579 1012 1013 O
. NCT03920579 1013 1014 O
Those NCT03920579 1016 1021 O
who NCT03920579 1022 1025 O
are NCT03920579 1026 1029 O
deemed NCT03920579 1030 1036 O
unfit NCT03920579 1037 1042 O
by NCT03920579 1043 1045 O
the NCT03920579 1046 1049 O
investigators NCT03920579 1050 1063 O
to NCT03920579 1064 1066 O
participate NCT03920579 1067 1078 O
in NCT03920579 1079 1081 O
the NCT03920579 1082 1085 O
clinical NCT03920579 1086 1094 O
trial NCT03920579 1095 1100 O
for NCT03920579 1101 1104 O
other NCT03920579 1105 1110 O
reasons NCT03920579 1111 1118 O
including NCT03920579 1119 1128 O
the NCT03920579 1129 1132 O
results NCT03920579 1133 1140 O
of NCT03920579 1141 1143 O
laboratory NCT03920579 1144 1154 O
tests NCT03920579 1155 1160 O

Inclusion NCT03861988 0 9 O
Criteria NCT03861988 10 18 O
: NCT03861988 19 20 O

- NCT03861988 24 25 O
Patient NCT03861988 27 34 O
presenting NCT03861988 35 45 B-Eq_Comparison
for NCT03861988 46 49 O
primary NCT03861988 50 57 B-Modifier
total NCT03861988 58 63 B-Procedure
joint NCT03861988 64 69 I-Procedure
arthroplasty NCT03861988 70 82 I-Procedure

- NCT03861988 85 86 O
Major NCT03861988 88 93 O
Depressive NCT03861988 94 104 B-Condition
Disorder NCT03861988 105 113 I-Condition

Exclusion NCT03861988 114 123 O
Criteria NCT03861988 124 132 O
: NCT03861988 133 134 O

- NCT03861988 138 139 O
Pregnant NCT03861988 141 149 B-Condition
of NCT03861988 150 152 O
breastfeeding NCT03861988 153 166 B-Condition
women NCT03861988 167 172 O

Inclusion NCT03861676 0 9 O
Criteria NCT03861676 10 18 O
: NCT03861676 19 20 O

- NCT03861676 24 25 O
Adenocarcinoma NCT03861676 27 41 B-Condition
of NCT03861676 42 44 O
the NCT03861676 45 48 O
prostate NCT03861676 49 57 B-Modifier

- NCT03861676 60 61 O
Performance NCT03861676 63 74 B-Observation
Status NCT03861676 75 81 I-Observation
< NCT03861676 82 83 B-Eq_Comparison
2 NCT03861676 84 85 I-Eq_Comparison

- NCT03861676 89 90 O
Clinical NCT03861676 92 100 O
stages NCT03861676 101 107 O
( NCT03861676 108 109 O
not NCT03861676 110 113 B-Negation
radiographic NCT03861676 114 126 B-Modifier
stage NCT03861676 127 132 I-Modifier
) NCT03861676 133 134 O
T NCT03861676 135 136 B-Eq_Comparison
1c NCT03861676 137 139 I-Eq_Comparison
- NCT03861676 140 141 I-Eq_Comparison
T NCT03861676 142 143 I-Eq_Comparison
2a NCT03861676 144 146 I-Eq_Comparison
, NCT03861676 147 148 I-Eq_Comparison
Nx NCT03861676 149 151 I-Eq_Comparison
or NCT03861676 152 154 B-Or
N NCT03861676 155 156 B-Eq_Comparison
0 NCT03861676 157 158 I-Eq_Comparison
, NCT03861676 159 160 I-Eq_Comparison
Mx NCT03861676 161 163 I-Eq_Comparison
or NCT03861676 164 166 B-Or
M NCT03861676 167 168 B-Eq_Comparison
0 NCT03861676 169 170 I-Eq_Comparison

- NCT03861676 173 174 O
Gleason NCT03861676 176 183 B-Observation
6 NCT03861676 184 185 B-Eq_Comparison
- NCT03861676 186 187 I-Eq_Comparison
7 NCT03861676 188 189 I-Eq_Comparison
cancer NCT03861676 190 196 B-Condition

- NCT03861676 199 200 O
Prostate NCT03861676 202 210 B-Observation
volume NCT03861676 211 217 I-Observation
< NCT03861676 218 219 B-Eq_Comparison
60 NCT03861676 220 222 I-Eq_Comparison
cc NCT03861676 223 225 I-Eq_Comparison
( NCT03861676 226 227 O
if NCT03861676 228 230 O
MRI NCT03861676 231 234 B-Procedure
and NCT03861676 235 238 B-And
TRUS NCT03861676 239 243 B-Procedure
have NCT03861676 244 248 O
conflicting NCT03861676 249 260 O
values NCT03861676 261 267 O
, NCT03861676 268 269 O
then NCT03861676 270 274 O
MRI NCT03861676 275 278 B-Procedure
value NCT03861676 279 284 O
will NCT03861676 285 289 O
be NCT03861676 290 292 O
utilized NCT03861676 293 301 O
) NCT03861676 302 303 O

- NCT03861676 307 308 O
International NCT03861676 310 323 B-Observation
Prostate NCT03861676 324 332 I-Observation
symptom NCT03861676 333 340 I-Observation
score NCT03861676 341 346 I-Observation
( NCT03861676 347 348 O
IPSS NCT03861676 349 353 B-Observation
) NCT03861676 354 355 O
20 NCT03861676 356 358 B-Eq_Comparison
or NCT03861676 359 361 I-Eq_Comparison
less NCT03861676 362 366 I-Eq_Comparison

- NCT03861676 369 370 O
Ability NCT03861676 372 379 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861676 380 382 I-Assertion___Assertion_Type_Value:hypothetical
undergo NCT03861676 383 390 O
DCF NCT03861676 391 394 B-Procedure
- NCT03861676 395 396 I-Procedure
Pyl NCT03861676 397 400 I-Procedure
PSMA NCT03861676 401 405 I-Procedure
PET NCT03861676 406 409 I-Procedure
as NCT03861676 410 412 O
part NCT03861676 413 417 O
of NCT03861676 418 420 O
pre NCT03861676 421 424 B-Temporal_Connection___Temporal_Connection_Type_Value:before
treatment NCT03861676 425 434 B-Procedure
staging NCT03861676 435 442 O

- NCT03861676 445 446 O
Signed NCT03861676 448 454 O
study NCT03861676 455 460 O
- NCT03861676 461 462 O
specific NCT03861676 463 471 O
consent NCT03861676 472 479 O
form NCT03861676 480 484 O
prior NCT03861676 485 490 O
to NCT03861676 491 493 O
registration NCT03861676 494 506 O

Exclusion NCT03861676 507 516 O
Criteria NCT03861676 517 525 O
: NCT03861676 526 527 O

- NCT03861676 531 532 O
Prior NCT03861676 534 539 B-Eq_Comparison
history NCT03861676 540 547 I-Eq_Comparison
of NCT03861676 548 550 O
pelvic NCT03861676 551 557 B-Modifier
radiation NCT03861676 558 567 B-Procedure
therapy NCT03861676 568 575 I-Procedure

- NCT03861676 578 579 O
Major NCT03861676 581 586 O
medical NCT03861676 587 594 B-Modifier
or NCT03861676 595 597 B-Or
psychiatric NCT03861676 598 609 B-Modifier
illness NCT03861676 610 617 B-Condition
which NCT03861676 618 623 O
, NCT03861676 624 625 O
in NCT03861676 626 628 O
the NCT03861676 629 632 O
investigator NCT03861676 633 645 O
's NCT03861676 645 647 O
opinion NCT03861676 648 655 O
, NCT03861676 656 657 O
would NCT03861676 658 663 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03861676 664 671 B-Negation
completion NCT03861676 672 682 O
of NCT03861676 683 685 O
treatment NCT03861676 686 695 B-Procedure
and NCT03861676 696 699 B-And
would NCT03861676 700 705 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03861676 706 715 O
with NCT03861676 716 720 O
follow NCT03861676 721 727 B-Encounter
up NCT03861676 728 730 I-Encounter
. NCT03861676 731 732 O

- NCT03861676 736 737 O
Implanted NCT03861676 739 748 B-Procedure
device NCT03861676 749 755 B-Modifier
or NCT03861676 756 758 B-Or
apparatus NCT03861676 759 768 B-Modifier
which NCT03861676 769 774 O
obstruct NCT03861676 775 783 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
visibility NCT03861676 784 794 O
of NCT03861676 795 797 O
the NCT03861676 798 801 O
implanted NCT03861676 802 811 B-Modifier
sources NCT03861676 812 819 I-Modifier
on NCT03861676 820 822 O
fluoroscopy NCT03861676 823 834 B-Procedure

- NCT03861676 837 838 O
Metallic NCT03861676 840 848 B-Procedure
implants NCT03861676 849 857 I-Procedure
, NCT03861676 858 859 O
claustrophobia NCT03861676 860 874 B-Condition
not NCT03861676 875 878 B-Negation
amenable NCT03861676 879 887 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861676 888 890 O
medication NCT03861676 891 901 B-Drug
, NCT03861676 902 903 O
or NCT03861676 904 906 B-Or
known NCT03861676 907 912 O
contraindications NCT03861676 913 930 B-Contraindication
to NCT03861676 931 933 O
undergoing NCT03861676 934 944 O
MR NCT03861676 945 947 B-Procedure
scanning NCT03861676 948 956 I-Procedure

- NCT03861676 959 960 O
History NCT03861676 962 969 B-Eq_Comparison
of NCT03861676 970 972 O
other NCT03861676 973 978 B-Other
malignancy NCT03861676 979 989 B-Condition
diagnosed NCT03861676 990 999 O
within NCT03861676 1000 1006 B-Eq_Comparison
the NCT03861676 1007 1010 I-Eq_Comparison
past NCT03861676 1011 1015 I-Eq_Comparison
3 NCT03861676 1016 1017 I-Eq_Comparison
years NCT03861676 1018 1023 I-Eq_Comparison

Inclusion NCT03865329 0 9 O
Criteria NCT03865329 10 18 O

- NCT03865329 21 22 O
COPD NCT03865329 24 28 B-Condition
related NCT03865329 29 36 O
hospitalization NCT03865329 37 52 B-Encounter
and NCT03865329 53 56 B-And
eligible NCT03865329 57 65 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865329 66 69 O
PR NCT03865329 70 72 B-Procedure

- NCT03865329 75 76 O
Exclusion NCT03865329 78 87 O
Criteria NCT03865329 88 96 O

- NCT03865329 99 100 O
Inability NCT03865329 102 111 B-Condition
to NCT03865329 112 114 I-Condition
walk NCT03865329 115 119 I-Condition
( NCT03865329 120 121 O
orthopedic NCT03865329 122 132 B-Modifier
- NCT03865329 133 134 B-Or
neurologic NCT03865329 135 145 B-Modifier
problems NCT03865329 146 154 B-Condition
or NCT03865329 155 157 B-Or
confined NCT03865329 158 166 B-Condition
to NCT03865329 167 169 I-Condition
bed NCT03865329 170 173 I-Condition
) NCT03865329 174 175 O

Inclusion NCT03929575 0 9 O
Criteria NCT03929575 10 18 O
: NCT03929575 19 20 O

- NCT03929575 24 25 O
Body NCT03929575 27 31 B-Observation
Mass NCT03929575 32 36 I-Observation
Index NCT03929575 37 42 I-Observation
between NCT03929575 43 50 B-Eq_Comparison
18.5 NCT03929575 51 55 I-Eq_Comparison
and NCT03929575 56 59 I-Eq_Comparison
35 NCT03929575 60 62 I-Eq_Comparison
kg NCT03929575 63 65 I-Eq_Comparison
/ NCT03929575 66 67 I-Eq_Comparison
m^ NCT03929575 68 70 I-Eq_Comparison
2 NCT03929575 71 72 I-Eq_Comparison

- NCT03929575 76 77 O
Non NCT03929575 79 82 B-Negation
- NCT03929575 83 84 O
smoking NCT03929575 85 92 B-Condition
( NCT03929575 93 94 O
assessed NCT03929575 95 103 O
by NCT03929575 104 106 O
Health NCT03929575 107 113 B-Observation
History NCT03929575 114 121 I-Observation
Questionnaire NCT03929575 122 135 I-Observation
) NCT03929575 136 137 O

- NCT03929575 141 142 O
English NCT03929575 144 151 O
- NCT03929575 152 153 O
speaking NCT03929575 154 162 O

- NCT03929575 165 166 O
Regular NCT03929575 168 175 O
participation NCT03929575 176 189 O
in NCT03929575 190 192 O
physical NCT03929575 193 201 B-Observation
activity NCT03929575 202 210 I-Observation
( NCT03929575 211 212 O
> NCT03929575 213 214 B-Eq_Comparison
4 NCT03929575 215 216 I-Eq_Comparison
hours NCT03929575 217 222 I-Eq_Comparison
per NCT03929575 223 226 I-Eq_Comparison
week NCT03929575 227 231 I-Eq_Comparison
) NCT03929575 232 233 O

Exclusion NCT03929575 235 244 O
Criteria NCT03929575 245 253 O
: NCT03929575 254 255 O

- NCT03929575 259 260 O
Medical NCT03929575 262 269 O
conditions NCT03929575 270 280 B-Condition
that NCT03929575 281 285 O
prohibit NCT03929575 286 294 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
physical NCT03929575 295 303 B-Observation
activity NCT03929575 304 312 I-Observation
( NCT03929575 313 314 O
assessed NCT03929575 315 323 O
by NCT03929575 324 326 O
Health NCT03929575 327 333 B-Observation
History NCT03929575 334 341 I-Observation
Questionnaire NCT03929575 342 355 I-Observation
) NCT03929575 356 357 O

- NCT03929575 361 362 O
Pregnant NCT03929575 364 372 B-Condition
women NCT03929575 373 378 O
or NCT03929575 379 381 B-Or
women NCT03929575 382 387 O
expecting NCT03929575 388 397 B-Assertion___Assertion_Type_Value:intention
/ NCT03929575 398 399 B-Or
trying NCT03929575 400 406 B-Assertion___Assertion_Type_Value:intention
to NCT03929575 407 409 O
become NCT03929575 410 416 O
pregnant NCT03929575 417 425 B-Condition

- NCT03929575 428 429 O
BMI NCT03929575 431 434 B-Observation
greater NCT03929575 435 442 B-Eq_Comparison
than NCT03929575 443 447 I-Eq_Comparison
or NCT03929575 448 450 I-Eq_Comparison
equal NCT03929575 451 456 I-Eq_Comparison
to NCT03929575 457 459 I-Eq_Comparison
35 NCT03929575 460 462 I-Eq_Comparison
kg NCT03929575 463 465 I-Eq_Comparison
/ NCT03929575 466 467 I-Eq_Comparison
m^ NCT03929575 468 470 I-Eq_Comparison
2 NCT03929575 471 472 I-Eq_Comparison

- NCT03929575 476 477 O
Current NCT03929575 479 486 B-Eq_Comparison
smoker NCT03929575 487 493 B-Condition
( NCT03929575 494 495 O
assessed NCT03929575 496 504 O
by NCT03929575 505 507 O
Health NCT03929575 508 514 B-Observation
History NCT03929575 515 522 I-Observation
Questionnaire NCT03929575 523 536 I-Observation
) NCT03929575 537 538 O

Inclusion NCT03924414 0 9 O
Criteria NCT03924414 10 18 O
: NCT03924414 19 20 O

- NCT03924414 24 25 O
Men NCT03924414 27 30 O
and NCT03924414 31 34 B-Or
women NCT03924414 35 40 O
age NCT03924414 41 44 B-Age
65 NCT03924414 45 47 B-Eq_Comparison
years NCT03924414 48 53 I-Eq_Comparison
or NCT03924414 54 56 I-Eq_Comparison
older NCT03924414 57 62 I-Eq_Comparison

- NCT03924414 65 66 O
Current NCT03924414 68 75 B-Eq_Comparison
PD NCT03924414 76 78 B-Condition
diagnosis NCT03924414 79 88 O
with NCT03924414 89 93 B-And
symptoms NCT03924414 94 102 O
severity NCT03924414 103 111 O
at NCT03924414 112 114 O
Hoehn NCT03924414 115 120 B-Condition
& NCT03924414 121 122 I-Condition
Yahr NCT03924414 123 127 I-Condition
( NCT03924414 128 129 O
H&Y NCT03924414 130 133 B-Condition
) NCT03924414 134 135 O
stage NCT03924414 136 141 B-Eq_Comparison
1 NCT03924414 142 143 I-Eq_Comparison
- NCT03924414 144 145 I-Eq_Comparison
4 NCT03924414 146 147 I-Eq_Comparison
based NCT03924414 148 153 O
on NCT03924414 154 156 O
an NCT03924414 157 159 O
expert NCT03924414 160 166 O
assessment NCT03924414 167 177 O
( NCT03924414 178 179 O
movement NCT03924414 180 188 B-Condition
disorders NCT03924414 189 198 I-Condition
neurologist NCT03924414 199 210 B-Provider
report NCT03924414 211 217 O
or NCT03924414 218 220 B-Or
telemedicine NCT03924414 221 233 B-Procedure
evaluation NCT03924414 234 244 I-Procedure
) NCT03924414 245 246 O

- NCT03924414 250 251 O
Willing NCT03924414 253 260 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03924414 261 264 B-And
able NCT03924414 265 269 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924414 270 272 O
continue NCT03924414 273 281 O
in NCT03924414 282 284 O
follow NCT03924414 285 291 B-Encounter
- NCT03924414 292 293 I-Encounter
up NCT03924414 294 296 I-Encounter
for NCT03924414 297 300 O
at NCT03924414 301 303 B-Eq_Comparison
least NCT03924414 304 309 I-Eq_Comparison
2 NCT03924414 310 311 I-Eq_Comparison
years NCT03924414 312 317 I-Eq_Comparison

- NCT03924414 320 321 O
Willing NCT03924414 323 330 O
and NCT03924414 331 334 O
able NCT03924414 335 339 O
to NCT03924414 340 342 O
provide NCT03924414 343 350 O
informed NCT03924414 351 359 O
consent NCT03924414 360 367 O

Exclusion NCT03924414 368 377 O
Criteria NCT03924414 378 386 O
: NCT03924414 387 388 O

- NCT03924414 392 393 O
History NCT03924414 395 402 B-Eq_Comparison
of NCT03924414 403 405 O
hip NCT03924414 406 409 B-Modifier
fracture NCT03924414 410 418 B-Condition

- NCT03924414 421 422 O
Any NCT03924414 424 427 O
use NCT03924414 428 431 O
of NCT03924414 432 434 O
a NCT03924414 435 436 O
bisphosphonate NCT03924414 437 451 B-Drug
drug NCT03924414 452 456 I-Drug
within NCT03924414 457 463 B-Eq_Comparison
the NCT03924414 464 467 I-Eq_Comparison
last NCT03924414 468 472 I-Eq_Comparison
12 NCT03924414 473 475 I-Eq_Comparison
months NCT03924414 476 482 I-Eq_Comparison

- NCT03924414 485 486 O
Use NCT03924414 488 491 O
of NCT03924414 492 494 O
any NCT03924414 495 498 O
other NCT03924414 499 504 B-Other
osteoporosis NCT03924414 505 517 B-Procedure
treatment NCT03924414 518 527 I-Procedure
( NCT03924414 528 529 O
such NCT03924414 530 534 O
as NCT03924414 535 537 O
SERMs NCT03924414 538 543 B-Drug
and NCT03924414 544 547 B-Or
denosumab NCT03924414 548 557 B-Drug
) NCT03924414 558 559 O
within NCT03924414 560 566 B-Eq_Comparison
the NCT03924414 567 570 I-Eq_Comparison
last NCT03924414 571 575 I-Eq_Comparison
6 NCT03924414 576 577 I-Eq_Comparison
months NCT03924414 578 584 I-Eq_Comparison

- NCT03924414 592 593 O
Tooth NCT03924414 595 600 B-Procedure
extraction NCT03924414 601 611 I-Procedure
or NCT03924414 612 614 B-Or
invasive NCT03924414 615 623 B-Modifier
dental NCT03924414 624 630 B-Procedure
procedures NCT03924414 631 641 I-Procedure
within NCT03924414 642 648 B-Eq_Comparison
the NCT03924414 649 652 I-Eq_Comparison
past NCT03924414 653 657 I-Eq_Comparison
30 NCT03924414 658 660 I-Eq_Comparison
days NCT03924414 661 665 I-Eq_Comparison
or NCT03924414 666 668 O
planned NCT03924414 669 676 B-Eq_Comparison
/ NCT03924414 677 678 B-Or
scheduled NCT03924414 679 688 B-Eq_Comparison
extraction NCT03924414 689 699 B-Procedure
/ NCT03924414 700 701 B-Or
procedure NCT03924414 702 711 B-Procedure
in NCT03924414 712 714 O
the NCT03924414 715 718 O
next NCT03924414 719 723 B-Eq_Comparison
12 NCT03924414 724 726 I-Eq_Comparison
months NCT03924414 727 733 I-Eq_Comparison

- NCT03924414 736 737 O
Non NCT03924414 739 742 B-Condition
- NCT03924414 743 744 I-Condition
ambulatory NCT03924414 745 755 I-Condition
, NCT03924414 756 757 O
i NCT03924414 758 759 O
. NCT03924414 760 761 O
e NCT03924414 762 763 O
. NCT03924414 764 765 O
, NCT03924414 766 767 O
unable NCT03924414 768 774 B-Condition
to NCT03924414 775 777 I-Condition
walk NCT03924414 778 782 I-Condition
without NCT03924414 783 790 O
assistance NCT03924414 791 801 O
of NCT03924414 802 804 O
another NCT03924414 805 812 O
person NCT03924414 813 819 O
. NCT03924414 820 821 O

- NCT03924414 825 826 O
Undergoing NCT03924414 828 838 B-Eq_Comparison
kidney NCT03924414 839 845 B-Procedure
dialysis NCT03924414 846 854 I-Procedure

- NCT03924414 857 858 O
A NCT03924414 860 861 O
diagnosis NCT03924414 862 871 O
of NCT03924414 872 874 O
multiple NCT03924414 875 883 B-Condition
myeloma NCT03924414 884 891 I-Condition
or NCT03924414 892 894 B-Or
Paget NCT03924414 895 900 B-Condition
's NCT03924414 900 902 I-Condition
disease NCT03924414 903 910 I-Condition

- NCT03924414 913 914 O
Unable NCT03924414 916 922 B-Negation
to NCT03924414 923 925 O
speak NCT03924414 926 931 O
or NCT03924414 932 934 O
read NCT03924414 935 939 O
English NCT03924414 940 947 O
sufficiently NCT03924414 948 960 O
to NCT03924414 961 963 O
complete NCT03924414 964 972 O
informed NCT03924414 973 981 O
consent NCT03924414 982 989 O

- NCT03924414 992 993 O
Any NCT03924414 995 998 O
other NCT03924414 999 1004 B-Other
criteria NCT03924414 1005 1013 B-Condition
, NCT03924414 1014 1015 O
which NCT03924414 1016 1021 O
would NCT03924414 1022 1027 O
make NCT03924414 1028 1032 O
the NCT03924414 1033 1036 O
patient NCT03924414 1037 1044 O
unsuitable NCT03924414 1045 1055 O
to NCT03924414 1056 1058 O
participate NCT03924414 1059 1070 O
in NCT03924414 1071 1073 O
this NCT03924414 1074 1078 O
study NCT03924414 1079 1084 O
as NCT03924414 1085 1087 O
determined NCT03924414 1088 1098 O
by NCT03924414 1099 1101 O
the NCT03924414 1102 1105 O
study NCT03924414 1106 1111 O
staff NCT03924414 1112 1117 O
( NCT03924414 1118 1119 O
e NCT03924414 1120 1121 O
. NCT03924414 1122 1123 O
g NCT03924414 1124 1125 O
. NCT03924414 1126 1127 O
, NCT03924414 1128 1129 O
an NCT03924414 1130 1132 O
uncontrolled NCT03924414 1133 1145 O
drug NCT03924414 1146 1150 B-Modifier
and NCT03924414 1151 1154 B-Or
/ NCT03924414 1155 1156 I-Or
or NCT03924414 1157 1159 I-Or
alcohol NCT03924414 1160 1167 B-Modifier
addiction NCT03924414 1168 1177 B-Condition
) NCT03924414 1178 1179 O


Inclusion NCT03928795 0 9 O
Criteria NCT03928795 10 18 O
: NCT03928795 19 20 O

- NCT03928795 24 25 O
Monofetal NCT03928795 27 36 B-Modifier
pregnancy NCT03928795 37 46 B-Condition

- NCT03928795 49 50 O
Age NCT03928795 52 55 B-Age
over NCT03928795 56 60 B-Eq_Comparison
18 NCT03928795 61 63 I-Eq_Comparison
years NCT03928795 64 69 I-Eq_Comparison
old NCT03928795 70 73 O

- NCT03928795 76 77 O
Term NCT03928795 79 83 B-Condition
Pregnancy NCT03928795 84 93 I-Condition
≥ NCT03928795 94 95 B-Eq_Comparison
37 NCT03928795 96 98 I-Eq_Comparison
SA NCT03928795 99 101 I-Eq_Comparison

- NCT03928795 104 105 O
Indication NCT03928795 107 117 B-Indication
for NCT03928795 118 121 O
Elective NCT03928795 122 130 B-Modifier
caesarean NCT03928795 131 140 B-Procedure
section NCT03928795 141 148 I-Procedure

Exclusion NCT03928795 149 158 O
Criteria NCT03928795 159 167 O
: NCT03928795 168 169 O

- NCT03928795 173 174 O
- NCT03928795 176 177 O
Fetal NCT03928795 178 183 B-Modifier
pathology NCT03928795 184 193 B-Condition
known NCT03928795 194 199 O
prenatally NCT03928795 200 210 O
like NCT03928795 211 215 O
intrauterine NCT03928795 216 228 B-Modifier
severe NCT03928795 229 235 O
growth NCT03928795 236 242 B-Condition
retardation NCT03928795 243 254 I-Condition
with NCT03928795 255 259 B-And
Doppler NCT03928795 260 267 B-Condition
abnormalities NCT03928795 268 281 O
, NCT03928795 282 283 O
fetal NCT03928795 284 289 B-Modifier
malformation NCT03928795 290 302 B-Condition
or NCT03928795 303 305 B-Or
a NCT03928795 306 307 O
known NCT03928795 308 313 O
fetal NCT03928795 314 319 B-Modifier
genetic NCT03928795 320 327 B-Condition
defect NCT03928795 328 334 I-Condition
. NCT03928795 335 336 O

- NCT03928795 340 341 O
Anomaly NCT03928795 343 350 B-Condition
of NCT03928795 351 353 O
placental NCT03928795 354 363 B-Modifier
adhesion NCT03928795 364 372 I-Modifier
. NCT03928795 373 374 O

- NCT03928795 378 379 O
Caesarean NCT03928795 381 390 B-Procedure
in NCT03928795 391 393 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03928795 394 395 I-Temporal_Connection___Temporal_Connection_Type_Value:during
context NCT03928795 396 403 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03928795 404 406 O
medical NCT03928795 407 414 B-Modifier
or NCT03928795 415 417 B-Or
obstetric NCT03928795 418 427 B-Modifier
emergency NCT03928795 428 437 B-Observation
. NCT03928795 438 439 O

- NCT03928795 443 444 O
Caesarean NCT03928795 446 455 B-Procedure
section NCT03928795 456 463 I-Procedure
performed NCT03928795 464 473 O
under NCT03928795 474 479 O
general NCT03928795 480 487 B-Procedure
anesthesia NCT03928795 488 498 I-Procedure
following NCT03928795 499 508 B-Temporal_Connection___Temporal_Connection_Type_Value:after
failure NCT03928795 509 516 O
of NCT03928795 517 519 O
locoregional NCT03928795 520 532 B-Modifier
anesthesia NCT03928795 533 543 B-Procedure
. NCT03928795 544 545 O

- NCT03928795 549 550 O
Refusal NCT03928795 552 559 O
of NCT03928795 560 562 O
the NCT03928795 563 566 O
woman NCT03928795 567 572 O
to NCT03928795 573 575 O
participate NCT03928795 576 587 O
in NCT03928795 588 590 O
the NCT03928795 591 594 O
study NCT03928795 595 600 B-Study
. NCT03928795 601 602 O

- NCT03928795 606 607 O
Impossibility NCT03928795 609 622 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03928795 623 625 B-Or
failure NCT03928795 626 633 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03928795 634 636 O
study NCT03928795 637 642 O
the NCT03928795 643 646 O
neonatal NCT03928795 647 655 B-Modifier
acid NCT03928795 656 660 B-Observation
- NCT03928795 661 662 I-Observation
base NCT03928795 663 667 I-Observation
balance NCT03928795 668 675 I-Observation
on NCT03928795 676 678 O
the NCT03928795 679 682 O
umbilical NCT03928795 683 692 B-Modifier
cord NCT03928795 693 697 I-Modifier
. NCT03928795 698 699 O

Inclusion NCT03925103 0 9 O
Criteria NCT03925103 10 18 O
: NCT03925103 19 20 O

- NCT03925103 24 25 O
Clinical NCT03925103 27 35 O
NSCLC NCT03925103 36 41 O
early NCT03925103 42 47 O
stage NCT03925103 48 53 O
( NCT03925103 54 55 O
stage NCT03925103 56 61 O
I NCT03925103 62 63 O
- NCT03925103 64 65 O
II NCT03925103 66 68 O
) NCT03925103 69 70 O
. NCT03925103 71 72 O

- NCT03925103 76 77 O
Both NCT03925103 79 83 O
forced NCT03925103 84 90 B-Observation
expiratory NCT03925103 91 101 I-Observation
volume NCT03925103 102 108 I-Observation
in NCT03925103 109 111 I-Observation
one NCT03925103 112 115 I-Observation
second NCT03925103 116 122 I-Observation
( NCT03925103 123 124 O
FEV NCT03925103 125 128 B-Observation
1 NCT03925103 129 130 I-Observation
) NCT03925103 131 132 O
and NCT03925103 133 136 B-And
diffusion NCT03925103 137 146 B-Observation
capacity NCT03925103 147 155 I-Observation
of NCT03925103 156 158 I-Observation
carbon NCT03925103 159 165 I-Observation
monoxide NCT03925103 166 174 I-Observation
( NCT03925103 175 176 O
DLCO NCT03925103 177 181 B-Observation
) NCT03925103 182 183 O
> NCT03925103 184 185 B-Eq_Comparison
60 NCT03925103 186 188 I-Eq_Comparison
% NCT03925103 189 190 I-Eq_Comparison

- NCT03925103 194 195 O
Both NCT03925103 197 201 O
predicted NCT03925103 202 211 B-Modifier
post NCT03925103 212 216 I-Modifier
operative NCT03925103 217 226 I-Modifier
( NCT03925103 227 228 O
PPO NCT03925103 229 232 B-Modifier
) NCT03925103 233 234 O
FEV NCT03925103 235 238 B-Observation
1 NCT03925103 239 240 I-Observation
and NCT03925103 241 244 B-And
PPO NCT03925103 245 248 B-Modifier
DLCO NCT03925103 249 253 B-Observation
> NCT03925103 254 255 B-Eq_Comparison
35 NCT03925103 256 258 I-Eq_Comparison
% NCT03925103 259 260 O

- NCT03925103 264 265 O
American NCT03925103 267 275 B-Observation
Society NCT03925103 276 283 I-Observation
of NCT03925103 284 286 I-Observation
Anesthesia NCT03925103 287 297 I-Observation
( NCT03925103 298 299 O
ASA NCT03925103 300 303 B-Observation
) NCT03925103 304 305 O
score NCT03925103 306 311 B-Eq_Comparison
< NCT03925103 312 313 I-Eq_Comparison
= NCT03925103 314 315 I-Eq_Comparison
2 NCT03925103 316 317 I-Eq_Comparison

- NCT03925103 321 322 O
Body NCT03925103 324 328 B-Observation
mass NCT03925103 329 333 I-Observation
index NCT03925103 334 339 I-Observation
( NCT03925103 340 341 O
BMI NCT03925103 342 345 B-Observation
) NCT03925103 346 347 O
> NCT03925103 348 349 B-Eq_Comparison
18 NCT03925103 350 352 I-Eq_Comparison
< NCT03925103 353 354 B-Eq_Comparison
28 NCT03925103 355 357 I-Eq_Comparison

Exclusion NCT03925103 359 368 O
Criteria NCT03925103 369 377 O
: NCT03925103 378 379 O

- NCT03925103 383 384 O
Clinical NCT03925103 386 394 O
NSCLC NCT03925103 395 400 B-Condition
stage NCT03925103 401 406 B-Eq_Comparison
> NCT03925103 407 408 I-Eq_Comparison
II NCT03925103 409 411 I-Eq_Comparison

- NCT03925103 414 415 O
History NCT03925103 417 424 B-Eq_Comparison
of NCT03925103 425 427 O
Neoadjuvant NCT03925103 428 439 B-Procedure
chemotherapy NCT03925103 440 452 I-Procedure
or NCT03925103 453 455 B-Or
radiotherapy NCT03925103 456 468 B-Procedure

- NCT03925103 471 472 O
Radiologic NCT03925103 474 484 B-Procedure
evidence NCT03925103 485 493 O
of NCT03925103 494 496 O
extensive NCT03925103 497 506 O
pleural NCT03925103 507 514 B-Condition
adhesions NCT03925103 515 524 I-Condition
. NCT03925103 525 526 O

- NCT03925103 530 531 O
Age NCT03925103 533 536 B-Age
< NCT03925103 537 538 B-Eq_Comparison
18 NCT03925103 539 541 I-Eq_Comparison
or NCT03925103 542 544 B-Or
> NCT03925103 545 546 B-Eq_Comparison
80 NCT03925103 547 549 I-Eq_Comparison
years NCT03925103 550 555 I-Eq_Comparison
. NCT03925103 556 557 O

- NCT03925103 561 562 O
Patients NCT03925103 564 572 O
with NCT03925103 573 577 O
previous NCT03925103 578 586 B-Eq_Comparison
pleurodesis NCT03925103 587 598 B-Procedure
or NCT03925103 599 601 B-Or
thoracotomy NCT03925103 602 613 B-Procedure
in NCT03925103 614 616 O
the NCT03925103 617 620 O
affected NCT03925103 621 629 B-Modifier
hemithorax NCT03925103 630 640 I-Modifier
. NCT03925103 641 642 O

- NCT03925103 646 647 O
Patients NCT03925103 649 657 O
who NCT03925103 658 661 O
will NCT03925103 662 666 B-Eq_Comparison
undergo NCT03925103 667 674 I-Eq_Comparison
surgical NCT03925103 675 683 B-Procedure
lung NCT03925103 684 688 I-Procedure
resection NCT03925103 689 698 I-Procedure
other NCT03925103 699 704 B-Exception
than NCT03925103 705 709 I-Exception
lobectomy NCT03925103 710 719 B-Procedure
. NCT03925103 720 721 O

- NCT03925103 725 726 O
Patients NCT03925103 728 736 O
with NCT03925103 737 741 O
severe NCT03925103 742 748 O
comorbidity NCT03925103 749 760 B-Condition
contraindicating NCT03925103 761 777 B-Contraindication
lobectomy NCT03925103 778 787 B-Procedure
. NCT03925103 788 789 O

- NCT03925103 793 794 O
Patients NCT03925103 796 804 O
refusal NCT03925103 805 812 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03925103 813 815 B-Or
noncompliance NCT03925103 816 829 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03925103 830 832 O
general NCT03925103 833 840 B-Procedure
surgery NCT03925103 841 848 I-Procedure
and NCT03925103 849 852 B-Or
one NCT03925103 853 856 B-Modifier
- NCT03925103 857 858 I-Modifier
lung NCT03925103 859 863 I-Modifier
ventilation NCT03925103 864 875 B-Procedure
. NCT03925103 876 877 O

Inclusion NCT03867656 0 9 O
Criteria NCT03867656 10 18 O
: NCT03867656 19 20 O

- NCT03867656 24 25 O
Male NCT03867656 27 31 O

- NCT03867656 34 35 O
Age NCT03867656 37 40 B-Age
25 NCT03867656 41 43 B-Eq_Comparison
to NCT03867656 44 46 I-Eq_Comparison
65 NCT03867656 47 49 I-Eq_Comparison
years NCT03867656 50 55 I-Eq_Comparison
old NCT03867656 56 59 O
. NCT03867656 60 61 O

- NCT03867656 65 66 O
Type NCT03867656 68 72 B-Modifier
2 NCT03867656 73 74 I-Modifier
diabetes NCT03867656 75 83 B-Condition
. NCT03867656 84 85 O

- NCT03867656 89 90 O
In NCT03867656 92 94 O
Metformin NCT03867656 95 104 B-Drug
or NCT03867656 105 107 B-Or
sulfonylureas NCT03867656 108 121 B-Drug

Exclusion NCT03867656 122 131 O
Criteria NCT03867656 132 140 O
: NCT03867656 141 142 O

- NCT03867656 146 147 O
Treatment NCT03867656 149 158 B-Procedure
with NCT03867656 159 163 O
other NCT03867656 164 169 B-Other
antidiabetics NCT03867656 170 183 B-Drug

- NCT03867656 186 187 O
Osteopososis NCT03867656 189 201 B-Condition
or NCT03867656 202 204 B-Or
gastrointestinal NCT03867656 205 221 B-Modifier
disease NCT03867656 222 229 B-Condition

- NCT03867656 232 233 O
Smoking NCT03867656 235 242 B-Condition

- NCT03867656 245 246 O
Long NCT03867656 248 252 O
term NCT03867656 253 257 O
steroid NCT03867656 258 265 B-Drug
treatment NCT03867656 266 275 B-Procedure

- NCT03867656 278 279 O
Weight NCT03867656 281 287 B-Observation
change NCT03867656 288 294 O
more NCT03867656 295 299 B-Eq_Comparison
than NCT03867656 300 304 I-Eq_Comparison
3 NCT03867656 305 306 I-Eq_Comparison
kg NCT03867656 307 309 I-Eq_Comparison
within NCT03867656 310 316 B-Eq_Comparison
the NCT03867656 317 320 I-Eq_Comparison
last NCT03867656 321 325 I-Eq_Comparison
3 NCT03867656 326 327 I-Eq_Comparison
months NCT03867656 328 334 I-Eq_Comparison
. NCT03867656 335 336 O

- NCT03867656 340 341 O
Overweight NCT03867656 343 353 B-Condition
or NCT03867656 354 356 B-Or
intestinal NCT03867656 357 367 B-Modifier
surgery NCT03867656 368 375 B-Procedure

Inclusion NCT03925467 0 9 O
Criteria NCT03925467 10 18 O
: NCT03925467 19 20 O

Patients NCT03925467 22 30 O
meet NCT03925467 31 35 O
at NCT03925467 36 38 B-Eq_Comparison
least NCT03925467 39 44 I-Eq_Comparison
three NCT03925467 45 50 I-Eq_Comparison
out NCT03925467 51 54 B-Criteria_Count
of NCT03925467 55 57 I-Criteria_Count
the NCT03925467 58 61 I-Criteria_Count
following NCT03925467 62 71 I-Criteria_Count
six NCT03925467 72 75 B-Eq_Comparison
conditions NCT03925467 76 86 O
: NCT03925467 87 88 O

- NCT03925467 92 93 O
Any NCT03925467 95 98 O
gender NCT03925467 99 105 O
aged NCT03925467 106 110 B-Age
50 NCT03925467 111 113 B-Eq_Comparison
years NCT03925467 114 119 I-Eq_Comparison
or NCT03925467 120 122 I-Eq_Comparison
above NCT03925467 123 128 I-Eq_Comparison
; NCT03925467 128 129 O

- NCT03925467 132 133 O
Have NCT03925467 135 139 O
less NCT03925467 140 144 B-Eq_Comparison
than NCT03925467 145 149 I-Eq_Comparison
30 NCT03925467 150 152 I-Eq_Comparison
mins NCT03925467 153 157 I-Eq_Comparison
of NCT03925467 158 160 O
morning NCT03925467 161 168 B-Observation
stiffness NCT03925467 169 178 I-Observation
; NCT03925467 178 179 O

- NCT03925467 182 183 O
Crepitus NCT03925467 185 193 B-Condition
on NCT03925467 194 196 I-Condition
active NCT03925467 197 203 I-Condition
motion NCT03925467 204 210 I-Condition
; NCT03925467 210 211 O

- NCT03925467 214 215 O
Bony NCT03925467 217 221 B-Condition
tenderness NCT03925467 222 232 I-Condition
; NCT03925467 232 233 O

- NCT03925467 236 237 O
Bony NCT03925467 239 243 B-Condition
enlargement NCT03925467 244 255 I-Condition
; NCT03925467 255 256 O

- NCT03925467 259 260 O
No NCT03925467 262 264 B-Negation
palpable NCT03925467 265 273 B-Condition
warmth NCT03925467 274 280 I-Condition
. NCT03925467 281 282 O

Exclusion NCT03925467 284 293 O
Criteria NCT03925467 294 302 O
: NCT03925467 303 304 O

- NCT03925467 308 309 O
Subjects NCT03925467 311 319 O
who NCT03925467 320 323 O
are NCT03925467 324 327 O
unable NCT03925467 328 334 B-Condition
to NCT03925467 335 337 I-Condition
walk NCT03925467 338 342 I-Condition
. NCT03925467 343 344 O

- NCT03925467 348 349 O
Malignancy NCT03925467 351 361 B-Condition
, NCT03925467 362 363 O

- NCT03925467 367 368 O
Any NCT03925467 370 373 O
acute NCT03925467 374 379 O
medical NCT03925467 380 387 B-Condition
condition NCT03925467 388 397 I-Condition
, NCT03925467 398 399 O

- NCT03925467 403 404 O
Poorly NCT03925467 406 412 B-Modifier
controlled NCT03925467 413 423 I-Modifier
diabetes NCT03925467 424 432 B-Condition
or NCT03925467 433 435 B-Or
hypertension NCT03925467 436 448 B-Condition
, NCT03925467 449 450 O

- NCT03925467 454 455 O
A NCT03925467 457 458 O
motor NCT03925467 459 464 B-Modifier
or NCT03925467 465 467 B-Or
sensory NCT03925467 468 475 B-Modifier
nerve NCT03925467 476 481 B-Condition
defect NCT03925467 482 488 I-Condition
, NCT03925467 489 490 O

- NCT03925467 494 495 O
Blood NCT03925467 497 502 O
clotting NCT03925467 503 511 O
disease NCT03925467 512 519 O
, NCT03925467 520 521 O

- NCT03925467 525 526 O
Mental NCT03925467 528 534 B-Condition
illness NCT03925467 535 542 I-Condition
, NCT03925467 543 544 O

- NCT03925467 548 549 O
Dementia NCT03925467 551 559 B-Condition
, NCT03925467 560 561 O

- NCT03925467 565 566 O
Mental NCT03925467 568 574 B-Condition
retardation NCT03925467 575 586 I-Condition
or NCT03925467 587 589 O
other NCT03925467 590 595 O
abnormal NCT03925467 596 604 O
person NCT03925467 605 611 O
on NCT03925467 612 614 O
the NCT03925467 615 618 O
organic NCT03925467 619 626 O
mind NCT03925467 627 631 O
. NCT03925467 632 633 O

- NCT03925467 637 638 O
Subjects NCT03925467 640 648 O
with NCT03925467 649 653 O
intra NCT03925467 654 659 B-Modifier
- NCT03925467 660 661 I-Modifier
articular NCT03925467 662 671 I-Modifier
solid NCT03925467 672 677 I-Modifier
or NCT03925467 678 680 B-Or
hyaluronic NCT03925467 681 691 B-Modifier
acid NCT03925467 692 696 I-Modifier
injection NCT03925467 697 706 B-Procedure
in NCT03925467 707 709 O
the NCT03925467 710 713 O
past NCT03925467 714 718 B-Eq_Comparison
3 NCT03925467 719 720 I-Eq_Comparison
months NCT03925467 721 727 I-Eq_Comparison
. NCT03925467 728 729 O

- NCT03925467 733 734 O
Knee NCT03925467 736 740 B-Modifier
surgery NCT03925467 741 748 B-Procedure
, NCT03925467 749 750 O

- NCT03925467 754 755 O
Knee NCT03925467 757 761 B-Modifier
trauma NCT03925467 762 768 B-Condition
, NCT03925467 769 770 O

- NCT03925467 774 775 O
Congenital NCT03925467 777 787 B-Modifier
knee NCT03925467 788 792 I-Modifier
deformation NCT03925467 793 804 B-Condition
, NCT03925467 805 806 O

- NCT03925467 810 811 O
Severe NCT03925467 813 819 O
knee NCT03925467 820 824 B-Modifier
varus NCT03925467 825 830 B-Condition
or NCT03925467 831 833 B-Or
valgus NCT03925467 834 840 B-Condition
deformation NCT03925467 841 852 I-Condition
, NCT03925467 853 854 O

- NCT03925467 858 859 O
Endocrine NCT03925467 861 870 B-Modifier
, NCT03925467 871 872 O
metabolic NCT03925467 873 882 B-Modifier
, NCT03925467 883 884 O
infectious NCT03925467 885 895 B-Modifier
, NCT03925467 896 897 O
inflammatory NCT03925467 898 910 B-Modifier
, NCT03925467 911 912 O
secondary NCT03925467 913 922 B-Modifier
degenerative NCT03925467 923 935 I-Modifier
knee NCT03925467 936 940 I-Modifier
arthritis NCT03925467 941 950 B-Condition
caused NCT03925467 951 957 O
by NCT03925467 958 960 O
problems NCT03925467 961 969 O
with NCT03925467 970 974 O
rheumatic NCT03925467 975 984 B-Condition
immune NCT03925467 985 991 I-Condition
diseases NCT03925467 992 1000 I-Condition
. NCT03925467 1001 1002 O

- NCT03925467 1006 1007 O
Subjects NCT03925467 1009 1017 O
who NCT03925467 1018 1021 O
are NCT03925467 1022 1025 O
hypersensitive NCT03925467 1026 1040 B-Condition
to NCT03925467 1041 1043 O
needles NCT03925467 1044 1051 B-Modifier
. NCT03925467 1052 1053 O

- NCT03925467 1057 1058 O
Subjects NCT03925467 1060 1068 O
who NCT03925467 1069 1072 O
are NCT03925467 1073 1076 O
unwilling NCT03925467 1077 1086 O
to NCT03925467 1087 1089 O
cooperate NCT03925467 1090 1099 O
or NCT03925467 1100 1102 O
sign NCT03925467 1103 1107 O
the NCT03925467 1108 1111 O
subject NCT03925467 1112 1119 O
consent NCT03925467 1120 1127 O
. NCT03925467 1128 1129 O

Inclusion NCT03923088 0 9 O
Criteria NCT03923088 10 18 O
: NCT03923088 19 20 O

- NCT03923088 24 25 O
Children NCT03923088 27 35 O
: NCT03923088 36 37 O
6 NCT03923088 38 39 B-Eq_Comparison
to NCT03923088 40 42 I-Eq_Comparison
9 NCT03923088 43 44 I-Eq_Comparison
years NCT03923088 45 50 I-Eq_Comparison
old NCT03923088 51 54 B-Age
children NCT03923088 55 63 O
. NCT03923088 64 65 O
Teeth NCT03923088 67 72 O
: NCT03923088 73 74 O
tooth NCT03923088 75 80 O
requiring NCT03923088 81 90 B-Assertion___Assertion_Type_Value:hypothetical
dental NCT03923088 91 97 B-Procedure
treatment NCT03923088 98 107 I-Procedure

Exclusion NCT03923088 108 117 O
Criteria NCT03923088 118 126 O
: NCT03923088 127 128 O

- NCT03923088 132 133 O
Children NCT03923088 135 143 O
having NCT03923088 144 150 B-And
allergy NCT03923088 151 158 B-Allergy
to NCT03923088 159 161 O
local NCT03923088 162 167 B-Procedure
anaesthesia NCT03923088 168 179 I-Procedure
or NCT03923088 180 182 B-Or
systemic NCT03923088 183 191 B-Modifier
problem NCT03923088 192 199 B-Condition
. NCT03923088 200 201 O
Refusal NCT03923088 203 210 O
of NCT03923088 211 213 O
participation NCT03923088 214 227 O
Mentally NCT03923088 228 236 B-Condition
ill NCT03923088 237 240 I-Condition
or NCT03923088 241 243 B-Or
mentally NCT03923088 244 252 B-Condition
retarded NCT03923088 253 261 I-Condition
children NCT03923088 262 270 O

Inclusion NCT03924531 0 9 O
Criteria NCT03924531 10 18 O
: NCT03924531 19 20 O

- NCT03924531 24 25 O
over NCT03924531 27 31 B-Eq_Comparison
21 NCT03924531 32 34 I-Eq_Comparison
years NCT03924531 35 40 I-Eq_Comparison
of NCT03924531 41 43 O
age NCT03924531 44 47 B-Age

- NCT03924531 50 51 O
able NCT03924531 53 57 O
to NCT03924531 58 60 O
understand NCT03924531 61 71 O
and NCT03924531 72 75 O
speak NCT03924531 76 81 O
English NCT03924531 82 89 O

- NCT03924531 92 93 O
self NCT03924531 95 99 O
- NCT03924531 100 101 O
report NCT03924531 102 108 O
of NCT03924531 109 111 O
having NCT03924531 112 118 O
difficulty NCT03924531 119 129 B-Negation
with NCT03924531 130 134 O
a NCT03924531 135 136 O
healthy NCT03924531 137 144 B-Observation
diet NCT03924531 145 149 I-Observation
and NCT03924531 150 153 B-And
engaging NCT03924531 154 162 O
in NCT03924531 163 165 O
regular NCT03924531 166 173 B-Observation
physical NCT03924531 174 182 I-Observation
activity NCT03924531 183 191 I-Observation
. NCT03924531 192 193 O

Exclusion NCT03924531 195 204 O
Criteria NCT03924531 205 213 O
: NCT03924531 214 215 O

- NCT03924531 219 220 O
On NCT03924531 222 224 O
chemotherapy NCT03924531 225 237 B-Procedure
for NCT03924531 238 241 O
cancer NCT03924531 242 248 B-Procedure
treatment NCT03924531 249 258 I-Procedure

- NCT03924531 261 262 O
Current NCT03924531 264 271 B-Eq_Comparison
substance NCT03924531 272 281 B-Condition
abuse NCT03924531 282 287 I-Condition
disorder NCT03924531 288 296 I-Condition
( NCT03924531 297 298 O
i NCT03924531 299 300 O
. NCT03924531 301 302 O
e NCT03924531 303 304 O
. NCT03924531 305 306 O
, NCT03924531 307 308 O
drugs NCT03924531 309 314 B-Drug
, NCT03924531 315 316 O
alcohol NCT03924531 317 324 B-Drug
) NCT03924531 325 326 O
. NCT03924531 327 328 O

- NCT03924531 332 333 O
Current NCT03924531 335 342 B-Eq_Comparison
diagnoses NCT03924531 343 352 O
of NCT03924531 353 355 O
Post NCT03924531 356 360 B-Condition
- NCT03924531 361 362 I-Condition
traumatic NCT03924531 363 372 I-Condition
stress NCT03924531 373 379 I-Condition
disorders NCT03924531 380 389 I-Condition
, NCT03924531 390 391 O
severe NCT03924531 392 398 O
anxiety NCT03924531 399 406 B-Condition
, NCT03924531 407 408 O
or NCT03924531 409 411 B-Or
severe NCT03924531 412 418 O
depression NCT03924531 419 429 B-Condition
. NCT03924531 430 431 O

- NCT03924531 435 436 O
On NCT03924531 438 440 B-Eq_Comparison
hemodialysis NCT03924531 441 453 B-Procedure
. NCT03924531 454 455 O

- NCT03924531 459 460 O
Pregnant NCT03924531 462 470 B-Condition
. NCT03924531 471 472 O
( NCT03924531 474 475 O
Pregnant NCT03924531 476 484 B-Condition
women NCT03924531 485 490 O
may NCT03924531 491 494 B-Assertion___Assertion_Type_Value:hypothetical
develop NCT03924531 495 502 O
Preeclampsia NCT03924531 503 515 B-Condition
, NCT03924531 516 517 O
which NCT03924531 518 523 O
is NCT03924531 524 526 O
a NCT03924531 527 528 O
pregnancy NCT03924531 529 538 B-Condition
complication NCT03924531 539 551 I-Condition
characterized NCT03924531 552 565 O
by NCT03924531 566 568 O
high NCT03924531 569 573 B-Condition
blood NCT03924531 574 579 I-Condition
pressure NCT03924531 580 588 I-Condition
) NCT03924531 589 590 O

Inclusion NCT03925142 0 9 O
Criteria NCT03925142 10 18 O
: NCT03925142 19 20 O

- NCT03925142 24 25 O
Male NCT03925142 27 31 O
or NCT03925142 32 34 B-Or
female NCT03925142 35 41 O

- NCT03925142 44 45 O
30 NCT03925142 47 49 B-Eq_Comparison
- NCT03925142 50 51 I-Eq_Comparison
69 NCT03925142 52 54 I-Eq_Comparison
years NCT03925142 55 60 I-Eq_Comparison
old NCT03925142 61 64 B-Age

- NCT03925142 67 68 O
BMI NCT03925142 70 73 B-Observation
25 NCT03925142 74 76 B-Eq_Comparison
- NCT03925142 77 78 I-Eq_Comparison
37 NCT03925142 79 81 I-Eq_Comparison
kg NCT03925142 82 84 I-Eq_Comparison
/ NCT03925142 85 86 I-Eq_Comparison
m NCT03925142 87 88 I-Eq_Comparison
2 NCT03925142 89 90 I-Eq_Comparison

- NCT03925142 93 94 O
Total NCT03925142 96 101 B-Observation
cholesterol NCT03925142 102 113 I-Observation
< NCT03925142 114 115 B-Eq_Comparison
260 NCT03925142 116 119 I-Eq_Comparison
mg NCT03925142 120 122 I-Eq_Comparison
/ NCT03925142 123 124 I-Eq_Comparison
dL NCT03925142 125 127 I-Eq_Comparison

- NCT03925142 130 131 O
Low NCT03925142 133 136 B-Observation
- NCT03925142 137 138 I-Observation
density NCT03925142 139 146 I-Observation
lipoprotein NCT03925142 147 158 I-Observation
cholesterol NCT03925142 159 170 I-Observation
< NCT03925142 171 172 B-Eq_Comparison
190 NCT03925142 173 176 I-Eq_Comparison
mg NCT03925142 177 179 I-Eq_Comparison
/ NCT03925142 180 181 I-Eq_Comparison
dL NCT03925142 182 184 I-Eq_Comparison

- NCT03925142 187 188 O
Glucose NCT03925142 190 197 B-Observation
< NCT03925142 198 199 B-Eq_Comparison
110 NCT03925142 200 203 I-Eq_Comparison
mg NCT03925142 204 206 I-Eq_Comparison
/ NCT03925142 207 208 I-Eq_Comparison
dL NCT03925142 209 211 I-Eq_Comparison

- NCT03925142 214 215 O
Systolic NCT03925142 217 225 B-Modifier
/ NCT03925142 226 227 B-Or
diastolic NCT03925142 228 237 B-Modifier
blood NCT03925142 238 243 B-Observation
pressure NCT03925142 244 252 I-Observation
< NCT03925142 253 254 B-Eq_Comparison
140 NCT03925142 255 258 I-Eq_Comparison
/ NCT03925142 259 260 I-Eq_Comparison
90 NCT03925142 261 263 I-Eq_Comparison

- NCT03925142 267 268 O
Body NCT03925142 270 274 B-Observation
weight NCT03925142 275 281 I-Observation
stable NCT03925142 282 288 O
for NCT03925142 289 292 O
3 NCT03925142 293 294 B-Eq_Comparison
months NCT03925142 295 301 I-Eq_Comparison
prior NCT03925142 302 307 I-Eq_Comparison
( NCT03925142 308 309 O
± NCT03925142 310 311 B-Eq_Comparison
3 NCT03925142 312 313 I-Eq_Comparison
kg NCT03925142 314 316 I-Eq_Comparison
) NCT03925142 317 318 O

- NCT03925142 322 323 O
Stable NCT03925142 325 331 O
physical NCT03925142 332 340 B-Observation
activity NCT03925142 341 349 I-Observation
regimen NCT03925142 350 357 O
3 NCT03925142 358 359 B-Eq_Comparison
months NCT03925142 360 366 I-Eq_Comparison
prior NCT03925142 367 372 I-Eq_Comparison

- NCT03925142 375 376 O
Medication NCT03925142 378 388 B-Drug
use NCT03925142 389 392 O
stable NCT03925142 393 399 O
for NCT03925142 400 403 O
6 NCT03925142 404 405 B-Eq_Comparison
months NCT03925142 406 412 I-Eq_Comparison
prior NCT03925142 413 418 I-Eq_Comparison

- NCT03925142 421 422 O
Non NCT03925142 424 427 B-Negation
- NCT03925142 428 429 O
smoking NCT03925142 430 437 B-Condition

- NCT03925142 440 441 O
Not NCT03925142 443 446 B-Negation
drinking NCT03925142 447 455 B-Observation
more NCT03925142 456 460 B-Eq_Comparison
than NCT03925142 461 465 I-Eq_Comparison
2 NCT03925142 466 467 I-Eq_Comparison
alcoholic NCT03925142 468 477 I-Eq_Comparison
drinks NCT03925142 478 484 I-Eq_Comparison
per NCT03925142 485 488 I-Eq_Comparison
day NCT03925142 489 492 I-Eq_Comparison

- NCT03925142 495 496 O
Non NCT03925142 498 501 B-Negation
- NCT03925142 502 503 O
diabetic NCT03925142 504 512 B-Condition

- NCT03925142 515 516 O
Not NCT03925142 518 521 B-Negation
lactose NCT03925142 522 529 B-Condition
- NCT03925142 530 531 I-Condition
intolerant NCT03925142 532 542 I-Condition

- NCT03925142 545 546 O
Not NCT03925142 548 551 B-Negation
acutely NCT03925142 552 559 O
ill NCT03925142 560 563 B-Condition

- NCT03925142 566 567 O
Non NCT03925142 569 572 B-Negation
- NCT03925142 573 574 O
pregnant NCT03925142 575 583 B-Condition
and NCT03925142 584 587 B-And
not NCT03925142 588 591 B-Negation
lactating NCT03925142 592 601 B-Condition
. NCT03925142 602 603 O

- NCT03925142 607 608 O
Participants NCT03925142 610 622 O
must NCT03925142 623 627 O
be NCT03925142 628 630 O
willing NCT03925142 631 638 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03925142 639 642 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03925142 643 647 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03925142 648 650 O
consume NCT03925142 651 658 O
the NCT03925142 659 662 O
prescribed NCT03925142 663 673 O
diets NCT03925142 674 679 B-Procedure
( NCT03925142 680 681 O
lacto NCT03925142 682 687 B-Modifier
- NCT03925142 688 689 I-Modifier
ovo NCT03925142 690 693 I-Modifier
vegetarian NCT03925142 694 704 I-Modifier
and NCT03925142 705 708 B-Or
omnivorous NCT03925142 709 719 B-Modifier
) NCT03925142 720 721 O
. NCT03925142 722 723 O

Exclusion NCT03925142 725 734 O
Criteria NCT03925142 735 743 O
: NCT03925142 744 745 O

- NCT03925142 749 750 O
< NCT03925142 752 753 B-Eq_Comparison
30 NCT03925142 754 756 I-Eq_Comparison
or NCT03925142 757 759 B-Or
> NCT03925142 760 761 B-Eq_Comparison
69 NCT03925142 762 764 I-Eq_Comparison
years NCT03925142 765 770 I-Eq_Comparison
old NCT03925142 771 774 B-Age

- NCT03925142 777 778 O
BMI NCT03925142 780 783 B-Observation
< NCT03925142 784 785 B-Eq_Comparison
25.0 NCT03925142 786 790 I-Eq_Comparison
or NCT03925142 791 793 B-Or
> NCT03925142 794 795 B-Eq_Comparison
37 NCT03925142 796 798 I-Eq_Comparison
kg NCT03925142 799 801 I-Eq_Comparison
/ NCT03925142 802 803 I-Eq_Comparison
m NCT03925142 804 805 I-Eq_Comparison
2 NCT03925142 806 807 I-Eq_Comparison

- NCT03925142 810 811 O
Fasting NCT03925142 813 820 B-Modifier
serum NCT03925142 821 826 B-Observation
total NCT03925142 827 832 I-Observation
cholesterol NCT03925142 833 844 I-Observation
> NCT03925142 845 846 B-Eq_Comparison
260 NCT03925142 847 850 I-Eq_Comparison
mg NCT03925142 851 853 I-Eq_Comparison
/ NCT03925142 854 855 I-Eq_Comparison
dL NCT03925142 856 858 I-Eq_Comparison

- NCT03925142 861 862 O
Low NCT03925142 864 867 B-Observation
- NCT03925142 868 869 I-Observation
density NCT03925142 870 877 I-Observation
lipoprotein NCT03925142 878 889 I-Observation
cholesterol NCT03925142 890 901 I-Observation
> NCT03925142 902 903 B-Eq_Comparison
189 NCT03925142 904 907 I-Eq_Comparison
mg NCT03925142 908 910 I-Eq_Comparison
/ NCT03925142 911 912 I-Eq_Comparison
dL NCT03925142 913 915 I-Eq_Comparison

- NCT03925142 918 919 O
Glucose NCT03925142 921 928 B-Observation
> NCT03925142 929 930 B-Eq_Comparison
110 NCT03925142 931 934 I-Eq_Comparison
mg NCT03925142 935 937 I-Eq_Comparison
/ NCT03925142 938 939 I-Eq_Comparison
dL NCT03925142 940 942 I-Eq_Comparison

- NCT03925142 945 946 O
Systolic NCT03925142 948 956 B-Modifier
/ NCT03925142 957 958 B-Or
diastolic NCT03925142 959 968 B-Modifier
blood NCT03925142 969 974 B-Observation
pressure NCT03925142 975 983 I-Observation
> NCT03925142 984 985 B-Eq_Comparison
140 NCT03925142 986 989 I-Eq_Comparison
/ NCT03925142 990 991 I-Eq_Comparison
90 NCT03925142 992 994 I-Eq_Comparison

- NCT03925142 998 999 O
Body NCT03925142 1001 1005 B-Observation
weight NCT03925142 1006 1012 I-Observation
stable NCT03925142 1013 1019 O
for NCT03925142 1020 1023 O
< NCT03925142 1024 1025 B-Eq_Comparison
3 NCT03925142 1026 1027 I-Eq_Comparison
months NCT03925142 1028 1034 I-Eq_Comparison
prior NCT03925142 1035 1040 I-Eq_Comparison
( NCT03925142 1041 1042 O
± NCT03925142 1043 1044 B-Eq_Comparison
3 NCT03925142 1045 1046 I-Eq_Comparison
kg NCT03925142 1047 1049 I-Eq_Comparison
) NCT03925142 1050 1051 O

- NCT03925142 1055 1056 O
Stable NCT03925142 1058 1064 O
physical NCT03925142 1065 1073 B-Observation
activity NCT03925142 1074 1082 I-Observation
regimen NCT03925142 1083 1090 O
< NCT03925142 1091 1092 B-Eq_Comparison
3 NCT03925142 1093 1094 I-Eq_Comparison
months NCT03925142 1095 1101 I-Eq_Comparison
prior NCT03925142 1102 1107 I-Eq_Comparison

- NCT03925142 1110 1111 O
Medication NCT03925142 1113 1123 B-Drug
use NCT03925142 1124 1127 O
unstable NCT03925142 1128 1136 O
for NCT03925142 1137 1140 O
6 NCT03925142 1141 1142 B-Eq_Comparison
months NCT03925142 1143 1149 I-Eq_Comparison
prior NCT03925142 1150 1155 I-Eq_Comparison
and NCT03925142 1156 1159 B-And
using NCT03925142 1160 1165 B-Eq_Comparison
medications NCT03925142 1166 1177 B-Drug

- NCT03925142 1180 1181 O
Smoking NCT03925142 1183 1190 O

- NCT03925142 1193 1194 O
Drinking NCT03925142 1196 1204 B-Observation
more NCT03925142 1205 1209 B-Eq_Comparison
than NCT03925142 1210 1214 I-Eq_Comparison
2 NCT03925142 1215 1216 I-Eq_Comparison
alcoholic NCT03925142 1217 1226 I-Eq_Comparison
drinks NCT03925142 1227 1233 I-Eq_Comparison
per NCT03925142 1234 1237 I-Eq_Comparison
day NCT03925142 1238 1241 I-Eq_Comparison

- NCT03925142 1244 1245 O
Diabetic NCT03925142 1247 1255 B-Condition

- NCT03925142 1258 1259 O
Have NCT03925142 1261 1265 O
renal NCT03925142 1266 1271 B-Condition
failure NCT03925142 1272 1279 I-Condition

- NCT03925142 1282 1283 O
Have NCT03925142 1285 1289 O
liver NCT03925142 1290 1295 B-Condition
failure NCT03925142 1296 1303 I-Condition

- NCT03925142 1306 1307 O
Have NCT03925142 1309 1313 O
cardiovascular NCT03925142 1314 1328 B-Condition
events NCT03925142 1329 1335 I-Condition
( NCT03925142 1336 1337 O
myocardial NCT03925142 1338 1348 B-Condition
infarction NCT03925142 1349 1359 I-Condition
or NCT03925142 1360 1362 B-Or
stroke NCT03925142 1363 1369 B-Condition
) NCT03925142 1370 1371 O
during NCT03925142 1372 1378 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03925142 1379 1382 O
6 NCT03925142 1383 1384 B-Eq_Comparison
months NCT03925142 1385 1391 I-Eq_Comparison
prior NCT03925142 1392 1397 I-Eq_Comparison
to NCT03925142 1398 1400 O
the NCT03925142 1401 1404 O
study NCT03925142 1405 1410 B-Study

- NCT03925142 1413 1414 O
Pregnant NCT03925142 1416 1424 B-Condition
or NCT03925142 1425 1427 B-Or
lactating NCT03925142 1428 1437 B-Condition

Inclusion NCT03930524 0 9 O
Criteria NCT03930524 10 18 O
: NCT03930524 19 20 O

- NCT03930524 24 25 O
Incoming NCT03930524 27 35 O
college NCT03930524 36 43 O
students NCT03930524 44 52 O
aged NCT03930524 53 57 B-Age
18 NCT03930524 58 60 B-Eq_Comparison
- NCT03930524 61 62 I-Eq_Comparison
21 NCT03930524 63 65 I-Eq_Comparison
at NCT03930524 66 68 O
the NCT03930524 69 72 O
University NCT03930524 73 83 O
of NCT03930524 84 86 O
Minnesota NCT03930524 87 96 O
will NCT03930524 97 101 O
be NCT03930524 102 104 O
eligible NCT03930524 105 113 O
and NCT03930524 114 117 O
randomly NCT03930524 118 126 O
selected NCT03930524 127 135 O
for NCT03930524 136 139 O
participation NCT03930524 140 153 O
. NCT03930524 154 155 O

Exclusion NCT03930524 157 166 O
Criteria NCT03930524 167 175 O
: NCT03930524 176 177 O

- NCT03930524 181 182 O
None NCT03930524 184 188 O

Inclusion NCT03866018 0 9 O
Criteria NCT03866018 10 18 O
: NCT03866018 19 20 O

- NCT03866018 24 25 O
Male NCT03866018 27 31 O
or NCT03866018 32 34 B-Or
Female NCT03866018 35 41 O
≥ NCT03866018 42 43 B-Eq_Comparison
60 NCT03866018 44 46 I-Eq_Comparison
years NCT03866018 47 52 I-Eq_Comparison
old NCT03866018 53 56 B-Age

- NCT03866018 59 60 O
MMSE NCT03866018 62 66 B-Observation
score NCT03866018 67 72 O
between NCT03866018 73 80 B-Eq_Comparison
4 NCT03866018 81 82 I-Eq_Comparison
and NCT03866018 83 86 I-Eq_Comparison
26 NCT03866018 87 89 I-Eq_Comparison
/ NCT03866018 90 91 I-Eq_Comparison
30 NCT03866018 92 94 I-Eq_Comparison

- NCT03866018 98 99 O
Diagnosis NCT03866018 101 110 O
of NCT03866018 111 113 O
minor NCT03866018 114 119 B-Eq_Comparison
to NCT03866018 120 122 I-Eq_Comparison
major NCT03866018 123 128 I-Eq_Comparison
NeuroCognitive NCT03866018 129 143 B-Condition
Disorder NCT03866018 144 152 I-Condition
of NCT03866018 153 155 O
the NCT03866018 156 159 O
Alzheimer NCT03866018 160 169 B-Condition
type NCT03866018 170 174 O
or NCT03866018 175 177 B-Or
multiple NCT03866018 178 186 B-Eq_Comparison
etiology NCT03866018 187 195 B-Condition
; NCT03866018 195 196 O

- NCT03866018 199 200 O
Subject NCT03866018 202 209 O
without NCT03866018 210 217 B-Negation
a NCT03866018 218 219 O
major NCT03866018 220 225 O
hearing NCT03866018 226 233 B-Modifier
or NCT03866018 234 236 B-Or
visual NCT03866018 237 243 B-Modifier
impairment NCT03866018 244 254 B-Condition
; NCT03866018 254 255 O

- NCT03866018 258 259 O
Subject NCT03866018 261 268 O
not NCT03866018 269 272 B-Negation
presenting NCT03866018 273 283 O
any NCT03866018 284 287 O
contraindications NCT03866018 288 305 B-Contraindication
to NCT03866018 306 308 O
the NCT03866018 309 312 O
practice NCT03866018 313 321 O
of NCT03866018 322 324 O
adapted NCT03866018 325 332 O
physical NCT03866018 333 341 B-Observation
activity NCT03866018 342 350 I-Observation
; NCT03866018 350 351 O

- NCT03866018 354 355 O
Subject NCT03866018 357 364 O
affiliated NCT03866018 365 375 O
to NCT03866018 376 378 O
Social NCT03866018 379 385 O
Security NCT03866018 386 394 O
System NCT03866018 395 401 O
; NCT03866018 401 402 O

- NCT03866018 405 406 O
Signing NCT03866018 408 415 O
informed NCT03866018 416 424 O
consent NCT03866018 425 432 O

Exclusion NCT03866018 433 442 O
Criteria NCT03866018 443 451 O
: NCT03866018 452 453 O

- NCT03866018 457 458 O
< NCT03866018 460 461 B-Eq_Comparison
60 NCT03866018 462 464 I-Eq_Comparison
years NCT03866018 465 470 I-Eq_Comparison

- NCT03866018 473 474 O
Medical NCT03866018 476 483 O
indications NCT03866018 484 495 O
: NCT03866018 496 497 O
Recent NCT03866018 498 504 B-Eq_Comparison
or NCT03866018 505 507 B-Or
unstable NCT03866018 508 516 O
cardiovascular NCT03866018 517 531 B-Condition
events NCT03866018 532 538 I-Condition
: NCT03866018 539 540 O
ECG NCT03866018 541 544 B-Procedure
changes NCT03866018 545 552 O
, NCT03866018 553 554 O
unstable NCT03866018 555 563 O
angina NCT03866018 564 570 B-Condition
, NCT03866018 571 572 O
uncontrolled NCT03866018 573 585 B-Modifier
arrhythmia NCT03866018 586 596 B-Condition
, NCT03866018 597 598 O
3 NCT03866018 599 600 B-Modifier
rd NCT03866018 601 603 I-Modifier
degree NCT03866018 604 610 I-Modifier
BAV NCT03866018 611 614 B-Condition
, NCT03866018 615 616 O
acute NCT03866018 617 622 O
heart NCT03866018 623 628 B-Condition
failure NCT03866018 629 636 I-Condition
. NCT03866018 637 638 O

- NCT03866018 642 643 O
MMSE NCT03866018 645 649 B-Observation
score NCT03866018 650 655 B-Eq_Comparison
< NCT03866018 656 657 I-Eq_Comparison
4 NCT03866018 658 659 I-Eq_Comparison

- NCT03866018 663 664 O
Subject NCT03866018 666 673 O
already NCT03866018 674 681 B-Eq_Comparison
engaged NCT03866018 682 689 O
in NCT03866018 690 692 O
appropriate NCT03866018 693 704 O
physical NCT03866018 705 713 B-Observation
activity NCT03866018 714 722 I-Observation

- NCT03866018 725 726 O
Subject NCT03866018 728 735 O
with NCT03866018 736 740 O
a NCT03866018 741 742 O
perceptual NCT03866018 743 753 B-Condition
disorder NCT03866018 754 762 I-Condition
( NCT03866018 763 764 O
AMD NCT03866018 765 768 B-Condition
, NCT03866018 769 770 O
deafness NCT03866018 771 779 B-Condition
. NCT03866018 780 781 O
. NCT03866018 782 783 O
. NCT03866018 784 785 O
) NCT03866018 786 787 O

- NCT03866018 791 792 O
Subject NCT03866018 794 801 O
with NCT03866018 802 806 O
a NCT03866018 807 808 O
motor NCT03866018 809 814 B-Condition
disability NCT03866018 815 825 I-Condition

- NCT03866018 828 829 O
Subject NCT03866018 831 838 O
under NCT03866018 839 844 B-Observation
guardianship NCT03866018 845 857 I-Observation
, NCT03866018 858 859 O
curatorship NCT03866018 860 871 B-Observation
or NCT03866018 872 874 B-Or
safeguard NCT03866018 875 884 B-Observation
of NCT03866018 885 887 I-Observation
justice NCT03866018 888 895 I-Observation

- NCT03866018 898 899 O
Persons NCT03866018 901 908 O
deprived NCT03866018 909 917 B-Observation
of NCT03866018 918 920 I-Observation
their NCT03866018 921 926 I-Observation
liberty NCT03866018 927 934 I-Observation
( NCT03866018 935 936 O
administrative NCT03866018 937 951 B-Modifier
or NCT03866018 952 954 B-Or
judicial NCT03866018 955 963 B-Modifier
) NCT03866018 964 965 O

Inclusion NCT03867643 0 9 O
Criteria NCT03867643 10 18 O
: NCT03867643 19 20 O

- NCT03867643 24 25 O
Children NCT03867643 27 35 O
who NCT03867643 36 39 O
are NCT03867643 40 43 O
6 NCT03867643 44 45 B-Eq_Comparison
- NCT03867643 46 47 I-Eq_Comparison
12 NCT03867643 48 50 I-Eq_Comparison
years NCT03867643 51 56 I-Eq_Comparison
old NCT03867643 57 60 B-Age
, NCT03867643 61 62 O
in NCT03867643 63 65 O
Chongqing NCT03867643 66 75 O

- NCT03867643 78 79 O
After NCT03867643 81 86 B-Temporal_Connection___Temporal_Connection_Type_Value:after
birth NCT03867643 87 92 B-Birth
, NCT03867643 93 94 O
three NCT03867643 95 100 B-Eq_Comparison
injections NCT03867643 101 111 B-Procedure
of NCT03867643 112 114 O
Hep NCT03867643 115 118 B-Drug
B NCT03867643 119 120 I-Drug
were NCT03867643 121 125 O
inoculated NCT03867643 126 136 O
in NCT03867643 137 139 O
time NCT03867643 140 144 O
according NCT03867643 145 154 O
to NCT03867643 155 157 O
the NCT03867643 158 161 O
procedure NCT03867643 162 171 O
of NCT03867643 172 174 O
0 NCT03867643 175 176 B-Eq_Comparison
, NCT03867643 177 178 I-Eq_Comparison
1 NCT03867643 179 180 I-Eq_Comparison
and NCT03867643 181 184 I-Eq_Comparison
6 NCT03867643 185 186 I-Eq_Comparison
months NCT03867643 187 193 I-Eq_Comparison
( NCT03867643 194 195 O
The NCT03867643 196 199 O
vaccination NCT03867643 200 211 O
certificate NCT03867643 212 223 O
record NCT03867643 224 230 O
） NCT03867643 230 231 O

- NCT03867643 234 235 O
No NCT03867643 237 239 B-Negation
HBV NCT03867643 240 243 B-Immunization
booster NCT03867643 244 251 I-Immunization
vaccine NCT03867643 252 259 I-Immunization
given NCT03867643 260 265 O
since NCT03867643 266 271 B-Temporal_Connection___Temporal_Connection_Type_Value:after
primary NCT03867643 272 279 B-Modifier
HBV NCT03867643 280 283 B-Immunization
immunization NCT03867643 284 296 I-Immunization

- NCT03867643 299 300 O
Children NCT03867643 302 310 O
or NCT03867643 311 313 B-Or
guardian NCT03867643 314 322 B-Family_Member___Family_Member_Type:parent
knew NCT03867643 323 327 O
and NCT03867643 328 331 O
agreed NCT03867643 332 338 O
to NCT03867643 339 341 O
accept NCT03867643 342 348 O
the NCT03867643 349 352 O
study NCT03867643 353 358 B-Study

- NCT03867643 361 362 O
Follow NCT03867643 364 370 B-Encounter
- NCT03867643 371 372 I-Encounter
up NCT03867643 373 375 I-Encounter
study NCT03867643 376 381 B-Study
and NCT03867643 382 385 B-And
blood NCT03867643 386 391 B-Observation
collection NCT03867643 392 402 I-Observation
after NCT03867643 403 408 B-Temporal_Connection___Temporal_Connection_Type_Value:after
vaccination NCT03867643 409 420 B-Immunization
can NCT03867643 421 424 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03867643 425 427 I-Assertion___Assertion_Type_Value:hypothetical
accepted NCT03867643 428 436 O

Exclusion NCT03867643 437 446 O
Criteria NCT03867643 447 455 O
: NCT03867643 456 457 O

- NCT03867643 461 462 O
Unwilling NCT03867643 464 473 O
or NCT03867643 474 476 O
impossible NCT03867643 477 487 O
to NCT03867643 488 490 O
participate NCT03867643 491 502 O
in NCT03867643 503 505 O
this NCT03867643 506 510 O
research NCT03867643 511 519 O
project NCT03867643 520 527 O
; NCT03867643 527 528 O

- NCT03867643 531 532 O
Have NCT03867643 534 538 O
a NCT03867643 539 540 O
history NCT03867643 541 548 B-Eq_Comparison
of NCT03867643 549 551 O
allergy NCT03867643 552 559 B-Allergy
or NCT03867643 560 562 B-Or
have NCT03867643 563 567 O
had NCT03867643 568 571 O
a NCT03867643 572 573 O
serious NCT03867643 574 581 O
vaccine NCT03867643 582 589 B-Immunization
reaction NCT03867643 590 598 B-Condition

- NCT03867643 601 602 O
Have NCT03867643 604 608 O
immune NCT03867643 609 615 B-Condition
impairment NCT03867643 616 626 I-Condition
diseases NCT03867643 627 635 I-Condition
and NCT03867643 636 639 B-Or
appear NCT03867643 640 646 B-Assertion___Assertion_Type_Value:possible
immune NCT03867643 647 653 B-Condition
impairment NCT03867643 654 664 I-Condition
; NCT03867643 664 665 O

- NCT03867643 668 669 O
Immunosuppressive NCT03867643 671 688 B-Procedure
treatment NCT03867643 689 698 I-Procedure
, NCT03867643 699 700 O
receive NCT03867643 701 708 O
any NCT03867643 709 712 O
injection NCT03867643 713 722 B-Modifier
or NCT03867643 723 725 B-Or
oral NCT03867643 726 730 B-Modifier
administration NCT03867643 731 745 I-Modifier
of NCT03867643 746 748 O
cortisone NCT03867643 749 758 B-Drug
or NCT03867643 759 761 B-Or
cancer NCT03867643 762 768 B-Condition
chemotherapy NCT03867643 769 781 B-Procedure
; NCT03867643 781 782 O

- NCT03867643 785 786 O
Any NCT03867643 788 791 O
kind NCT03867643 792 796 O
of NCT03867643 797 799 O
vaccine NCT03867643 800 807 B-Immunization
or NCT03867643 808 810 B-Or
any NCT03867643 811 814 O
kind NCT03867643 815 819 O
of NCT03867643 820 822 O
observation NCT03867643 823 834 B-Study
drug NCT03867643 835 839 B-Drug
has NCT03867643 840 843 O
been NCT03867643 844 848 O
vaccinated NCT03867643 849 859 B-Immunization
in NCT03867643 860 862 O
the NCT03867643 863 866 O
past NCT03867643 867 871 B-Eq_Comparison
four NCT03867643 872 876 I-Eq_Comparison
weeks NCT03867643 877 882 I-Eq_Comparison
; NCT03867643 882 883 O

- NCT03867643 886 887 O
Any NCT03867643 889 892 O
acute NCT03867643 893 898 O
disease NCT03867643 899 906 B-Condition
or NCT03867643 907 909 B-Or
other NCT03867643 910 915 B-Other
infection NCT03867643 916 925 B-Condition
requiring NCT03867643 926 935 O
antibiotic NCT03867643 936 946 B-Drug
or NCT03867643 947 949 B-Or
antiviral NCT03867643 950 959 B-Drug
treatment NCT03867643 960 969 B-Procedure
in NCT03867643 970 972 O
the NCT03867643 973 976 O
past NCT03867643 977 981 B-Eq_Comparison
four NCT03867643 982 986 I-Eq_Comparison
weeks NCT03867643 987 992 I-Eq_Comparison
; NCT03867643 992 993 O

- NCT03867643 996 997 O
Fever NCT03867643 999 1004 B-Condition
symptoms NCT03867643 1005 1013 B-Assertion___Assertion_Type_Value:possible
occurred NCT03867643 1014 1022 O
in NCT03867643 1023 1025 O
the NCT03867643 1026 1029 O
past NCT03867643 1030 1034 B-Eq_Comparison
week NCT03867643 1035 1039 I-Eq_Comparison
( NCT03867643 1040 1041 O
axillary NCT03867643 1042 1050 B-Modifier
temperature NCT03867643 1051 1062 B-Observation
≥ NCT03867643 1063 1064 B-Eq_Comparison
38 NCT03867643 1065 1067 I-Eq_Comparison
℃ NCT03867643 1068 1069 I-Eq_Comparison
) NCT03867643 1070 1071 O

- NCT03867643 1075 1076 O
Blood NCT03867643 1078 1083 B-Procedure
transfusion NCT03867643 1084 1095 I-Procedure
experience NCT03867643 1096 1106 O
; NCT03867643 1106 1107 O

- NCT03867643 1110 1111 O
Has NCT03867643 1113 1116 O
a NCT03867643 1117 1118 O
history NCT03867643 1119 1126 B-Eq_Comparison
of NCT03867643 1127 1129 O
more NCT03867643 1130 1134 O
serious NCT03867643 1135 1142 O
infectious NCT03867643 1143 1153 B-Condition
diseases NCT03867643 1154 1162 I-Condition
( NCT03867643 1163 1164 O
five NCT03867643 1165 1169 O
types NCT03867643 1170 1175 O
of NCT03867643 1176 1178 O
hepatitis NCT03867643 1179 1188 B-Condition
, NCT03867643 1189 1190 O
AIDS NCT03867643 1191 1195 B-Condition
, NCT03867643 1196 1197 O
syphilis NCT03867643 1198 1206 B-Condition
, NCT03867643 1207 1208 O
gonorrhea NCT03867643 1209 1218 B-Condition
, NCT03867643 1219 1220 O
etc NCT03867643 1221 1224 O
. NCT03867643 1225 1226 O
) NCT03867643 1228 1229 O
; NCT03867643 1230 1231 O

- NCT03867643 1234 1235 O
Hepatitis NCT03867643 1237 1246 B-Condition
B NCT03867643 1247 1248 I-Condition
infection NCT03867643 1249 1258 B-Modifier
or NCT03867643 1259 1261 B-Or
carriers NCT03867643 1262 1270 B-Modifier
( NCT03867643 1271 1272 O
lineal NCT03867643 1273 1279 O
relationship NCT03867643 1280 1292 O
) NCT03867643 1293 1294 O
; NCT03867643 1295 1296 O

- NCT03867643 1299 1300 O
Abnormal NCT03867643 1302 1310 O
physical NCT03867643 1311 1319 B-Procedure
examination NCT03867643 1320 1331 I-Procedure

Inclusion NCT03864692 0 9 O
Criteria NCT03864692 10 18 O
: NCT03864692 19 20 O

- NCT03864692 24 25 O
singleton NCT03864692 27 36 B-Modifier
parturient NCT03864692 37 47 B-Condition

- NCT03864692 50 51 O
planned NCT03864692 53 60 B-Eq_Comparison
for NCT03864692 61 64 O
elective NCT03864692 65 73 B-Modifier
LSCS NCT03864692 74 78 B-Procedure
under NCT03864692 79 84 O
spinal NCT03864692 85 91 B-Procedure
anesthesia NCT03864692 92 102 I-Procedure

Exclusion NCT03864692 103 112 O
Criteria NCT03864692 113 121 O
: NCT03864692 122 123 O

- NCT03864692 127 128 O
gestational NCT03864692 130 141 B-Observation
age NCT03864692 142 145 I-Observation
< NCT03864692 146 147 B-Eq_Comparison
36 NCT03864692 148 150 I-Eq_Comparison
weeks NCT03864692 151 156 I-Eq_Comparison

- NCT03864692 159 160 O
emergency NCT03864692 162 171 O
cases NCT03864692 172 177 O

- NCT03864692 180 181 O
placenta NCT03864692 183 191 B-Condition
previa NCT03864692 192 198 I-Condition
, NCT03864692 199 200 O
pre NCT03864692 201 204 B-Condition
- NCT03864692 205 206 I-Condition
eclampsia NCT03864692 207 216 I-Condition

- NCT03864692 219 220 O
BMI NCT03864692 222 225 B-Observation
> NCT03864692 226 227 B-Eq_Comparison
40 NCT03864692 228 230 I-Eq_Comparison

- NCT03864692 234 235 O
Reynauld NCT03864692 237 245 B-Condition
disease NCT03864692 246 253 I-Condition

- NCT03864692 256 257 O
patient NCT03864692 259 266 O
refusal NCT03864692 267 274 O

- NCT03864692 277 278 O
cardiovascular NCT03864692 280 294 B-Condition
disease NCT03864692 295 302 I-Condition

Inclusion NCT03921216 0 9 O
Criteria NCT03921216 10 18 O
: NCT03921216 19 20 O

Diabetic NCT03921216 22 30 B-Condition
nephropathy NCT03921216 31 42 I-Condition
, NCT03921216 43 44 O
because NCT03921216 45 52 O
of NCT03921216 53 55 O
type NCT03921216 56 60 B-Modifier
2 NCT03921216 61 62 I-Modifier
diabetes NCT03921216 63 71 B-Condition
, NCT03921216 72 73 O
undergoing NCT03921216 74 84 B-Eq_Comparison
hemodialysis NCT03921216 85 97 B-Procedure
and NCT03921216 98 101 B-And
subjects NCT03921216 102 110 O
with NCT03921216 111 115 O
chronic NCT03921216 116 123 O
kidney NCT03921216 124 130 B-Condition
disease NCT03921216 131 138 I-Condition
of NCT03921216 139 141 O
other NCT03921216 142 147 B-Other
causes NCT03921216 148 154 B-Condition
undergoing NCT03921216 155 165 B-Eq_Comparison
hemodialysis NCT03921216 166 178 B-Procedure
. NCT03921216 179 180 O

Exclusion NCT03921216 182 191 O
Criteria NCT03921216 192 200 O
: NCT03921216 201 202 O

- NCT03921216 206 207 O
Active NCT03921216 209 215 B-Eq_Comparison
infection NCT03921216 216 225 B-Condition
that NCT03921216 226 230 O
increases NCT03921216 231 240 O
the NCT03921216 241 244 O
risk NCT03921216 245 249 B-Risk
of NCT03921216 250 252 O
secondary NCT03921216 253 262 B-Modifier
infection NCT03921216 263 272 B-Condition
in NCT03921216 273 275 O
the NCT03921216 276 279 O
skin NCT03921216 280 284 B-Modifier
where NCT03921216 285 290 B-And
the NCT03921216 291 294 O
vesicles NCT03921216 295 303 B-Condition
containing NCT03921216 304 314 I-Condition
interstitial NCT03921216 315 327 I-Condition
fluid NCT03921216 328 333 I-Condition
have NCT03921216 334 338 O
been NCT03921216 339 343 O
emptied NCT03921216 344 351 B-Modifier
of NCT03921216 352 354 I-Modifier
interstitial NCT03921216 355 367 I-Modifier
fluid NCT03921216 368 373 I-Modifier
with NCT03921216 374 378 O
a NCT03921216 379 380 O
fine NCT03921216 381 385 B-Procedure
needle NCT03921216 386 392 I-Procedure
and NCT03921216 393 396 B-And
the NCT03921216 397 400 O
bladder NCT03921216 401 408 B-Condition
roof NCT03921216 409 413 I-Condition
is NCT03921216 414 416 O
intact NCT03921216 417 423 O
. NCT03921216 424 425 O

- NCT03921216 429 430 O
Treatment NCT03921216 432 441 B-Procedure
with NCT03921216 442 446 O
Warfarin NCT03921216 447 455 B-Drug
due NCT03921216 456 459 O
to NCT03921216 460 462 O
increased NCT03921216 463 472 O
risk NCT03921216 473 477 B-Risk
of NCT03921216 478 480 O
Calciphylaxis NCT03921216 481 494 B-Condition
( NCT03921216 495 496 O
calcific NCT03921216 497 505 B-Condition
uremic NCT03921216 506 512 I-Condition
arteriolopathy NCT03921216 513 527 I-Condition
, NCT03921216 528 529 O
CUA NCT03921216 530 533 B-Condition
) NCT03921216 534 535 O


Inclusion NCT03863652 0 9 O
Criteria NCT03863652 10 18 O
: NCT03863652 19 20 O

- NCT03863652 24 25 O
Patients NCT03863652 27 35 O
≥ NCT03863652 36 37 B-Eq_Comparison
18 NCT03863652 38 40 I-Eq_Comparison
years NCT03863652 41 46 I-Eq_Comparison
old NCT03863652 47 50 B-Age
requiring NCT03863652 51 60 B-Assertion___Assertion_Type_Value:hypothetical
PCI NCT03863652 61 64 B-Procedure

- NCT03863652 67 68 O
Patients NCT03863652 70 78 O
who NCT03863652 79 82 O
are NCT03863652 83 86 O
palpable NCT03863652 87 95 B-Condition
distal NCT03863652 96 102 I-Condition
radial NCT03863652 103 109 I-Condition
arter NCT03863652 110 115 I-Condition

- NCT03863652 118 119 O
The NCT03863652 121 124 O
decision NCT03863652 125 133 O
to NCT03863652 134 136 O
participate NCT03863652 137 148 O
voluntarily NCT03863652 149 160 O
in NCT03863652 161 163 O
this NCT03863652 164 168 O
study NCT03863652 169 174 O
and NCT03863652 175 178 O
the NCT03863652 179 182 O
written NCT03863652 183 190 O
consent NCT03863652 191 198 O
of NCT03863652 199 201 O
the NCT03863652 202 205 O
patient NCT03863652 206 213 O

Exclusion NCT03863652 214 223 O
Criteria NCT03863652 224 232 O
: NCT03863652 233 234 O

- NCT03863652 238 239 O
Patients NCT03863652 241 249 O
who NCT03863652 250 253 O
are NCT03863652 254 257 O
not NCT03863652 258 261 B-Negation
palpable NCT03863652 262 270 B-Condition
distal NCT03863652 271 277 I-Condition
radial NCT03863652 278 284 I-Condition
artery NCT03863652 285 291 I-Condition

- NCT03863652 294 295 O
Female NCT03863652 297 303 O
of NCT03863652 304 306 B-And
childbearing NCT03863652 307 319 B-Condition
potential NCT03863652 320 329 I-Condition
, NCT03863652 330 331 O
who NCT03863652 332 335 B-And
possibly NCT03863652 336 344 B-Assertion___Assertion_Type_Value:intention
plans NCT03863652 345 350 I-Assertion___Assertion_Type_Value:intention
to NCT03863652 351 353 O
become NCT03863652 354 360 O
pregnant NCT03863652 361 369 B-Condition
any NCT03863652 370 373 B-Eq_Comparison
time NCT03863652 374 378 I-Eq_Comparison
after NCT03863652 379 384 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrollment NCT03863652 385 395 O
into NCT03863652 396 400 O
this NCT03863652 401 405 O
study NCT03863652 406 411 B-Study
. NCT03863652 412 413 O

- NCT03863652 417 418 O
Patients NCT03863652 420 428 O
who NCT03863652 429 432 O
are NCT03863652 433 436 O
not NCT03863652 437 440 O
appropriate NCT03863652 441 452 O
for NCT03863652 453 456 O
this NCT03863652 457 461 O
study NCT03863652 462 467 O

Inclusion NCT03926572 0 9 O
Criteria NCT03926572 10 18 O
: NCT03926572 19 20 O

- NCT03926572 24 25 O
Adult NCT03926572 27 32 O
patients NCT03926572 33 41 O
over NCT03926572 42 46 B-Eq_Comparison
18 NCT03926572 47 49 I-Eq_Comparison
years NCT03926572 50 55 I-Eq_Comparison

- NCT03926572 58 59 O
Diagnosis NCT03926572 61 70 O
of NCT03926572 71 73 O
Pulmonary NCT03926572 74 83 B-Condition
arterial NCT03926572 84 92 I-Condition
hypertension NCT03926572 93 105 I-Condition
or NCT03926572 106 108 B-Or
non NCT03926572 109 112 B-Modifier
- NCT03926572 113 114 I-Modifier
operable NCT03926572 115 123 I-Modifier
chronic NCT03926572 124 131 I-Modifier
thromboembolic NCT03926572 132 146 B-Condition
pulmonary NCT03926572 147 156 I-Condition
hypertension NCT03926572 157 169 I-Condition
established NCT03926572 170 181 O
by NCT03926572 182 184 O
right NCT03926572 185 190 B-Procedure
cardiac NCT03926572 191 198 I-Procedure
catheterization NCT03926572 199 214 I-Procedure
prior NCT03926572 215 220 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926572 221 223 O
inclusion NCT03926572 224 233 O
in NCT03926572 234 236 O
the NCT03926572 237 240 O
study NCT03926572 241 246 B-Study

- NCT03926572 249 250 O
Patients NCT03926572 252 260 O
admitted NCT03926572 261 269 B-Encounter
in NCT03926572 270 272 O
intensive NCT03926572 273 282 O
care NCT03926572 283 287 O
unit NCT03926572 288 292 O
for NCT03926572 293 296 O
acute NCT03926572 297 302 O
decompensation NCT03926572 303 317 B-Modifier
of NCT03926572 318 320 O
pulmonary NCT03926572 321 330 B-Condition
hypertension NCT03926572 331 343 I-Condition
requiring NCT03926572 344 353 O
intravenous NCT03926572 354 365 B-Modifier
diuretic NCT03926572 366 374 B-Procedure
therapy NCT03926572 375 382 I-Procedure
± NCT03926572 383 384 B-Or
use NCT03926572 385 388 O
of NCT03926572 389 391 O
inotropes NCT03926572 392 401 B-Drug
or NCT03926572 402 404 B-Or
vasopressors NCT03926572 405 417 B-Drug
. NCT03926572 418 419 O

- NCT03926572 423 424 O
Patients NCT03926572 426 434 O
must NCT03926572 435 439 O
have NCT03926572 440 444 O
given NCT03926572 445 450 O
their NCT03926572 451 456 O
written NCT03926572 457 464 O
informed NCT03926572 465 473 O
consent NCT03926572 474 481 O
to NCT03926572 482 484 O
participate NCT03926572 485 496 O
in NCT03926572 497 499 O
the NCT03926572 500 503 O
study NCT03926572 504 509 B-Study
after NCT03926572 510 515 O
having NCT03926572 516 522 O
received NCT03926572 523 531 O
adequate NCT03926572 532 540 O
previous NCT03926572 541 549 O
information NCT03926572 550 561 O
and NCT03926572 562 565 O
prior NCT03926572 566 571 O
to NCT03926572 572 574 O
any NCT03926572 575 578 O
study NCT03926572 579 584 B-Study
- NCT03926572 585 586 O
specific NCT03926572 587 595 O
procedures NCT03926572 596 606 B-Procedure

Exclusion NCT03926572 607 616 O
Criteria NCT03926572 617 625 O
: NCT03926572 626 627 O

- NCT03926572 631 632 O
Patients NCT03926572 634 642 O
with NCT03926572 643 647 O
post NCT03926572 648 652 B-Modifier
- NCT03926572 653 654 I-Modifier
capillary NCT03926572 655 664 I-Modifier
pulmonary NCT03926572 665 674 B-Condition
hypertension NCT03926572 675 687 I-Condition

- NCT03926572 690 691 O
Patients NCT03926572 693 701 O
with NCT03926572 702 706 O
pulmonary NCT03926572 707 716 B-Condition
hypertension NCT03926572 717 729 I-Condition
associated NCT03926572 730 740 O
with NCT03926572 741 745 O
chronic NCT03926572 746 753 O
respiratory NCT03926572 754 765 B-Condition
disease NCT03926572 766 773 I-Condition

- NCT03926572 776 777 O
Patients NCT03926572 779 787 O
with NCT03926572 788 792 O
pulmonary NCT03926572 793 802 B-Condition
hypertension NCT03926572 803 815 I-Condition
with NCT03926572 816 820 O
unclear NCT03926572 821 828 B-Modifier
/ NCT03926572 829 830 O
or NCT03926572 831 833 B-Or
multifactorial NCT03926572 834 848 B-Modifier
mechanisms NCT03926572 849 859 I-Modifier

- NCT03926572 862 863 O
Patients NCT03926572 865 873 O
with NCT03926572 874 878 O
operable NCT03926572 879 887 B-Modifier
chronic NCT03926572 888 895 I-Modifier
thromboembolic NCT03926572 896 910 I-Modifier
pulmonary NCT03926572 911 920 B-Condition
hypertension NCT03926572 921 933 I-Condition

- NCT03926572 936 937 O
Shock NCT03926572 939 944 B-Condition
due NCT03926572 945 948 O
to NCT03926572 949 951 O
another NCT03926572 952 959 B-Other
cause NCT03926572 960 965 B-Condition
than NCT03926572 966 970 B-Exception
acute NCT03926572 971 976 O
decompensation NCT03926572 977 991 B-Modifier
of NCT03926572 992 994 O
pulmonary NCT03926572 995 1004 B-Condition
hypertension NCT03926572 1005 1017 I-Condition

- NCT03926572 1020 1021 O
Pregnant NCT03926572 1023 1031 B-Condition
women NCT03926572 1032 1037 O
, NCT03926572 1038 1039 O
or NCT03926572 1040 1042 B-Or
breast NCT03926572 1043 1049 B-Condition
feeding NCT03926572 1050 1057 I-Condition
women NCT03926572 1058 1063 O

- NCT03926572 1066 1067 O
Adult NCT03926572 1069 1074 O
protected NCT03926572 1075 1084 B-Observation
person NCT03926572 1085 1091 I-Observation

- NCT03926572 1094 1095 O
Person NCT03926572 1097 1103 O
deprived NCT03926572 1104 1112 B-Observation
of NCT03926572 1113 1115 I-Observation
liberty NCT03926572 1116 1123 I-Observation

- NCT03926572 1126 1127 O
Person NCT03926572 1129 1135 O
admitted NCT03926572 1136 1144 O
without NCT03926572 1145 1152 O
consent NCT03926572 1153 1160 O

- NCT03926572 1163 1164 O
Pregnant NCT03926572 1166 1174 B-Condition
or NCT03926572 1175 1177 B-Or
breastfeeding NCT03926572 1178 1191 B-Condition
women NCT03926572 1192 1197 O

Inclusion NCT03869606 0 9 O
Criteria NCT03869606 10 18 O
: NCT03869606 19 20 O

- NCT03869606 24 25 O
Patients NCT03869606 27 35 O
11 NCT03869606 36 38 B-Eq_Comparison
to NCT03869606 39 41 I-Eq_Comparison
no NCT03869606 42 44 I-Eq_Comparison
older NCT03869606 45 50 I-Eq_Comparison
than NCT03869606 51 55 I-Eq_Comparison
17 NCT03869606 56 58 I-Eq_Comparison
years NCT03869606 59 64 I-Eq_Comparison
of NCT03869606 65 67 O
age NCT03869606 68 71 B-Age

Exclusion NCT03869606 72 81 O
Criteria NCT03869606 82 90 O
: NCT03869606 91 92 O

- NCT03869606 96 97 O
severed NCT03869606 99 106 O
developmental NCT03869606 107 120 B-Condition
delay NCT03869606 121 126 I-Condition
, NCT03869606 127 128 O

- NCT03869606 132 133 O
orthopedic NCT03869606 135 145 B-Procedure
patients NCT03869606 146 154 O
with NCT03869606 155 159 B-And
leg NCT03869606 160 163 B-Modifier
injuries NCT03869606 164 172 B-Condition

- NCT03869606 175 176 O
injury NCT03869606 178 184 B-Condition
that NCT03869606 185 189 O
would NCT03869606 190 195 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03869606 196 203 B-Negation
passive NCT03869606 204 211 B-Modifier
leg NCT03869606 212 215 I-Modifier
elevation NCT03869606 216 225 B-Procedure
. NCT03869606 226 227 O

- NCT03869606 231 232 O
severe NCT03869606 234 240 O
aortic NCT03869606 241 247 B-Condition
insufficiency NCT03869606 248 261 I-Condition
, NCT03869606 262 263 O

- NCT03869606 267 268 O
severe NCT03869606 270 276 O
anatomic NCT03869606 277 285 B-Condition
abnormalities NCT03869606 286 299 I-Condition
of NCT03869606 300 302 O
the NCT03869606 303 306 O
thoracic NCT03869606 307 315 B-Modifier
aorta NCT03869606 316 321 I-Modifier

- NCT03869606 324 325 O
patients NCT03869606 327 335 O
with NCT03869606 336 340 O
external NCT03869606 341 349 B-Procedure
cardiac NCT03869606 350 357 I-Procedure
pacemakers NCT03869606 358 368 I-Procedure
. NCT03869606 369 370 O
close NCT03869606 372 377 O

Inclusion NCT03864198 0 9 O
Criteria NCT03864198 10 18 O
: NCT03864198 19 20 O

- NCT03864198 24 25 O
male NCT03864198 27 31 O
18 NCT03864198 32 34 B-Eq_Comparison
- NCT03864198 35 36 I-Eq_Comparison
50 NCT03864198 37 39 I-Eq_Comparison
years NCT03864198 40 45 I-Eq_Comparison

- NCT03864198 48 49 O
oligozoospermia NCT03864198 51 66 B-Condition
: NCT03864198 67 68 O
< NCT03864198 69 70 B-Eq_Comparison
5 NCT03864198 71 72 I-Eq_Comparison
million NCT03864198 73 80 I-Eq_Comparison
spermatozoa NCT03864198 81 92 I-Eq_Comparison
/ NCT03864198 93 94 I-Eq_Comparison
mL NCT03864198 95 97 I-Eq_Comparison
; NCT03864198 97 98 O

- NCT03864198 101 102 O
asthenozoospermia NCT03864198 104 121 B-Condition
: NCT03864198 122 123 O
< NCT03864198 124 125 B-Eq_Comparison
32 NCT03864198 126 128 I-Eq_Comparison
% NCT03864198 129 130 I-Eq_Comparison
progressive NCT03864198 131 142 B-Observation
motile NCT03864198 143 149 I-Observation
spermatozoa NCT03864198 150 161 I-Observation
; NCT03864198 161 162 O

- NCT03864198 165 166 O
teratozoospermia NCT03864198 168 184 B-Condition
: NCT03864198 185 186 O
< NCT03864198 187 188 B-Eq_Comparison
4 NCT03864198 189 190 I-Eq_Comparison
% NCT03864198 191 192 I-Eq_Comparison
normal NCT03864198 193 199 O
forms NCT03864198 200 205 B-Observation
. NCT03864198 206 207 O

Exclusion NCT03864198 209 218 O
Criteria NCT03864198 219 227 O
: NCT03864198 228 229 O

- NCT03864198 233 234 O
azoospermia NCT03864198 236 247 B-Condition

- NCT03864198 250 251 O
smoke NCT03864198 253 258 B-Condition

- NCT03864198 261 262 O
use NCT03864198 264 267 B-Eq_Comparison
drugs NCT03864198 268 273 B-Drug

- NCT03864198 276 277 O
use NCT03864198 279 282 B-Eq_Comparison
drugs NCT03864198 283 288 B-Drug
with NCT03864198 289 293 B-And
proven NCT03864198 294 300 O
fertility NCT03864198 301 310 B-Condition
toxicity NCT03864198 311 319 I-Condition

- NCT03864198 322 323 O
exposition NCT03864198 325 335 O
to NCT03864198 336 338 O
any NCT03864198 339 342 O
environmental NCT03864198 343 356 B-Modifier
or NCT03864198 357 359 B-Or
occupational NCT03864198 360 372 B-Modifier
toxic NCT03864198 373 378 I-Modifier
substances NCT03864198 379 389 B-Drug

- NCT03864198 392 393 O
exposition NCT03864198 395 405 O
to NCT03864198 406 408 O
radiation NCT03864198 409 418 B-Procedure
or NCT03864198 419 421 B-Or
heat NCT03864198 422 426 B-Modifier

- NCT03864198 429 430 O
orchitis NCT03864198 432 440 B-Condition
secondary NCT03864198 441 450 B-Modifier
to NCT03864198 451 453 O
mumps NCT03864198 454 459 B-Condition

- NCT03864198 462 463 O
sexually NCT03864198 465 473 B-Condition
transmitted NCT03864198 474 485 I-Condition
diseases NCT03864198 486 494 I-Condition

- NCT03864198 497 498 O
history NCT03864198 500 507 B-Eq_Comparison
of NCT03864198 508 510 O
cryptorchidism NCT03864198 511 525 B-Condition

- NCT03864198 528 529 O
previous NCT03864198 531 539 B-Eq_Comparison
testicular NCT03864198 540 550 B-Procedure
torsion NCT03864198 551 558 I-Procedure

- NCT03864198 561 562 O
genitourinary NCT03864198 564 577 B-Condition
anomalies NCT03864198 578 587 I-Condition

- NCT03864198 590 591 O
alterations NCT03864198 593 604 B-Procedure
of NCT03864198 605 607 O
the NCT03864198 608 611 O
epididymis NCT03864198 612 622 B-Modifier
or NCT03864198 623 625 B-Or
deferens NCT03864198 626 634 B-Modifier

- NCT03864198 637 638 O
inguinal NCT03864198 640 648 B-Procedure
surgery NCT03864198 649 656 I-Procedure

Inclusion NCT03863847 0 9 O
Criteria NCT03863847 10 18 O
: NCT03863847 19 20 O

- NCT03863847 24 25 O
Patients NCT03863847 27 35 O
suffering NCT03863847 36 45 O
from NCT03863847 46 50 O
chronic NCT03863847 51 58 O
pain NCT03863847 59 63 B-Condition
due NCT03863847 64 67 O
to NCT03863847 68 70 O
tennis NCT03863847 71 77 B-Condition
elbow NCT03863847 78 83 I-Condition
for NCT03863847 84 87 O
at NCT03863847 88 90 B-Eq_Comparison
least NCT03863847 91 96 I-Eq_Comparison
3 NCT03863847 97 98 I-Eq_Comparison
months NCT03863847 99 105 I-Eq_Comparison

- NCT03863847 108 109 O
A NCT03863847 111 112 O
clinical NCT03863847 113 121 O
diagnosis NCT03863847 122 131 O
of NCT03863847 132 134 O
chronic NCT03863847 135 142 O
lateral NCT03863847 143 150 B-Condition
epicondylalgia NCT03863847 151 165 I-Condition
, NCT03863847 166 167 O

- NCT03863847 171 172 O
Pain NCT03863847 174 178 B-Condition
associated NCT03863847 179 189 O
with NCT03863847 190 194 O
functional NCT03863847 195 205 B-Observation
activities NCT03863847 206 216 I-Observation
such NCT03863847 217 221 O
as NCT03863847 222 224 O
gripping NCT03863847 225 233 B-Observation
and NCT03863847 234 237 B-Or
pain NCT03863847 238 242 B-Condition
with NCT03863847 243 247 O
resisted NCT03863847 248 256 B-Observation
contraction NCT03863847 257 268 I-Observation
of NCT03863847 269 271 O
the NCT03863847 272 275 O
wrist NCT03863847 276 281 B-Modifier
extensors NCT03863847 282 291 I-Modifier
or NCT03863847 292 294 B-Or
extensor NCT03863847 295 303 B-Modifier
carpi NCT03863847 304 309 I-Modifier
radialis NCT03863847 310 318 B-Condition
brevis NCT03863847 319 325 I-Condition
, NCT03863847 326 327 O
or NCT03863847 328 330 B-Or
with NCT03863847 331 335 O
passive NCT03863847 336 343 B-Observation
stretching NCT03863847 344 354 I-Observation
of NCT03863847 355 357 O
the NCT03863847 358 361 O
wrist NCT03863847 362 367 B-Modifier
extensors NCT03863847 368 377 I-Modifier
. NCT03863847 378 379 O

Exclusion NCT03863847 381 390 O
Criteria NCT03863847 391 399 O
: NCT03863847 400 401 O

- NCT03863847 405 406 O
Clinical NCT03863847 408 416 O
diagnosis NCT03863847 417 426 O
of NCT03863847 427 429 O
chronic NCT03863847 430 437 O
lateral NCT03863847 438 445 B-Condition
epicondylalgia NCT03863847 446 460 I-Condition
on NCT03863847 461 463 O
both NCT03863847 464 468 B-Modifier
sides NCT03863847 469 474 I-Modifier
, NCT03863847 475 476 O
cervicothoracic NCT03863847 477 492 B-Modifier
spinal NCT03863847 493 499 I-Modifier
pathology NCT03863847 500 509 B-Condition
, NCT03863847 510 511 O
other NCT03863847 512 517 B-Other
upper NCT03863847 518 523 B-Modifier
limb NCT03863847 524 528 I-Modifier
musculoskeletal NCT03863847 529 544 B-Condition
disorders NCT03863847 545 554 I-Condition
or NCT03863847 555 557 B-Or
neurological NCT03863847 558 570 B-Condition
disorders NCT03863847 571 580 I-Condition

- NCT03863847 583 584 O
Pregnancy NCT03863847 586 595 B-Condition

- NCT03863847 598 599 O
Drug NCT03863847 601 605 B-Condition
addiction NCT03863847 606 615 I-Condition
defined NCT03863847 616 623 O
as NCT03863847 624 626 O
the NCT03863847 627 630 O
use NCT03863847 631 634 O
of NCT03863847 635 637 O
cannabis NCT03863847 638 646 B-Drug
, NCT03863847 647 648 O
opioids NCT03863847 649 656 B-Drug
or NCT03863847 657 659 B-Or
other NCT03863847 660 665 B-Other
drugs NCT03863847 666 671 B-Drug

- NCT03863847 674 675 O
Previous NCT03863847 677 685 B-Eq_Comparison
or NCT03863847 686 688 B-Or
current NCT03863847 689 696 B-Eq_Comparison
neurologic NCT03863847 697 707 B-Modifier
, NCT03863847 708 709 O
musculoskeletal NCT03863847 710 725 B-Modifier
or NCT03863847 726 728 B-Or
mental NCT03863847 729 735 B-Modifier
illnesses NCT03863847 736 745 B-Condition
defined NCT03863847 746 753 O
as NCT03863847 754 756 O
an NCT03863847 757 759 O
on NCT03863847 760 762 B-Eq_Comparison
- NCT03863847 763 764 I-Eq_Comparison
going NCT03863847 765 770 I-Eq_Comparison
systemic NCT03863847 771 779 B-Modifier
condition NCT03863847 780 789 B-Condition

- NCT03863847 792 793 O
Lack NCT03863847 795 799 B-Negation
of NCT03863847 800 802 O
ability NCT03863847 803 810 B-Condition
to NCT03863847 811 813 I-Condition
cooperate NCT03863847 814 823 I-Condition

- NCT03863847 826 827 O
Current NCT03863847 829 836 B-Eq_Comparison
use NCT03863847 837 840 O
of NCT03863847 841 843 O
medications NCT03863847 844 855 B-Drug
that NCT03863847 856 860 O
may NCT03863847 861 864 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03863847 865 871 O
the NCT03863847 872 875 O
trial NCT03863847 876 881 B-Study
e NCT03863847 882 883 O
. NCT03863847 884 885 O
g NCT03863847 886 887 O
. NCT03863847 888 889 O
analgesics NCT03863847 891 901 B-Drug
, NCT03863847 902 903 O
anti NCT03863847 904 908 B-Drug
- NCT03863847 909 910 I-Drug
inflammatory NCT03863847 911 923 I-Drug
drugs NCT03863847 924 929 I-Drug

- NCT03863847 932 933 O
Consumption NCT03863847 935 946 O
of NCT03863847 947 949 O
alcohol NCT03863847 950 957 B-Drug
, NCT03863847 958 959 O
caffeine NCT03863847 960 968 B-Drug
, NCT03863847 969 970 O
nicotine NCT03863847 971 979 B-Drug
or NCT03863847 980 982 B-Or
painkillers NCT03863847 983 994 B-Drug
throughout NCT03863847 995 1005 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863847 1006 1009 O
study NCT03863847 1010 1015 B-Study
period NCT03863847 1016 1022 O

- NCT03863847 1025 1026 O
Past NCT03863847 1028 1032 B-Eq_Comparison
history NCT03863847 1033 1040 I-Eq_Comparison
of NCT03863847 1041 1043 O
chronic NCT03863847 1044 1051 O
pain NCT03863847 1052 1056 B-Condition
, NCT03863847 1057 1058 O
neurological NCT03863847 1059 1071 B-Modifier
or NCT03863847 1072 1074 B-Or
psychiatric NCT03863847 1075 1086 B-Modifier
conditions NCT03863847 1087 1097 B-Condition

- NCT03863847 1100 1101 O
Participation NCT03863847 1103 1116 O
in NCT03863847 1117 1119 O
other NCT03863847 1120 1125 B-Other
pain NCT03863847 1126 1130 B-Condition
trials NCT03863847 1131 1137 B-Study
throughout NCT03863847 1138 1148 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863847 1149 1152 O
study NCT03863847 1153 1158 B-Study
period NCT03863847 1159 1165 O
and NCT03863847 1166 1169 B-Or
one NCT03863847 1170 1173 B-Eq_Comparison
month NCT03863847 1174 1179 I-Eq_Comparison
prior NCT03863847 1180 1185 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863847 1186 1188 I-Temporal_Connection___Temporal_Connection_Type_Value:before
participation NCT03863847 1189 1202 B-Study

- NCT03863847 1205 1206 O
Participation NCT03863847 1208 1221 O
in NCT03863847 1222 1224 O
more NCT03863847 1225 1229 B-Eq_Comparison
than NCT03863847 1230 1234 I-Eq_Comparison
two NCT03863847 1235 1238 I-Eq_Comparison
sessions NCT03863847 1239 1247 O
of NCT03863847 1248 1250 O
muscle NCT03863847 1251 1257 B-Observation
training NCT03863847 1258 1266 I-Observation
exercises NCT03863847 1267 1276 B-Eq_Comparison
per NCT03863847 1277 1280 I-Eq_Comparison
week NCT03863847 1281 1285 I-Eq_Comparison
involving NCT03863847 1286 1295 O
the NCT03863847 1296 1299 O
upper NCT03863847 1300 1305 B-Modifier
limb NCT03863847 1306 1310 I-Modifier
and NCT03863847 1311 1314 B-Or
/ NCT03863847 1315 1316 I-Or
or NCT03863847 1317 1319 I-Or
lower NCT03863847 1320 1325 B-Modifier
back NCT03863847 1326 1330 I-Modifier

- NCT03863847 1333 1334 O
Evidence NCT03863847 1336 1344 O
of NCT03863847 1345 1347 O
other NCT03863847 1348 1353 B-Other
sources NCT03863847 1354 1361 O
of NCT03863847 1362 1364 O
elbow NCT03863847 1365 1370 B-Modifier
pain NCT03863847 1371 1375 B-Condition
such NCT03863847 1376 1380 O
as NCT03863847 1381 1383 O
exacerbation NCT03863847 1384 1396 O
of NCT03863847 1397 1399 O
pain NCT03863847 1400 1404 B-Condition
with NCT03863847 1405 1409 O
neck NCT03863847 1410 1414 B-Observation
movement NCT03863847 1415 1423 I-Observation
or NCT03863847 1424 1426 B-Or
manual NCT03863847 1427 1433 B-Modifier
examination NCT03863847 1434 1445 B-Procedure

- NCT03863847 1448 1449 O
Sensory NCT03863847 1451 1458 B-Condition
disturbances NCT03863847 1459 1471 I-Condition

- NCT03863847 1474 1475 O
History NCT03863847 1477 1484 B-Eq_Comparison
of NCT03863847 1485 1487 O
fractures NCT03863847 1488 1497 B-Condition

- NCT03863847 1500 1501 O
Elbow NCT03863847 1503 1508 B-Procedure
surgery NCT03863847 1509 1516 I-Procedure

- NCT03863847 1519 1520 O
Contraindications NCT03863847 1522 1539 B-Contraindication
to NCT03863847 1540 1542 O
the NCT03863847 1543 1546 O
use NCT03863847 1547 1550 O
of NCT03863847 1551 1553 O
TMS NCT03863847 1554 1557 B-Procedure

Inclusion NCT03926130 0 9 O
Criteria NCT03926130 10 18 O
: NCT03926130 19 20 O

- NCT03926130 24 25 O
Diagnosis NCT03926130 27 36 O
of NCT03926130 37 39 O
CD NCT03926130 40 42 B-Condition
for NCT03926130 43 46 O
at NCT03926130 47 49 B-Eq_Comparison
least NCT03926130 50 55 I-Eq_Comparison
3 NCT03926130 56 57 I-Eq_Comparison
months NCT03926130 58 64 I-Eq_Comparison
prior NCT03926130 65 70 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926130 71 73 I-Temporal_Connection___Temporal_Connection_Type_Value:before
baseline NCT03926130 74 82 B-Study

- NCT03926130 85 86 O
Confirmed NCT03926130 88 97 O
diagnosis NCT03926130 98 107 O
of NCT03926130 108 110 O
moderate NCT03926130 111 119 O
to NCT03926130 120 122 B-Or
severe NCT03926130 123 129 O
CD NCT03926130 130 132 B-Condition
as NCT03926130 133 135 O
assessed NCT03926130 136 144 O
by NCT03926130 145 147 O
SF NCT03926130 148 150 B-Observation
, NCT03926130 151 152 O
AP NCT03926130 153 155 B-Observation
score NCT03926130 156 161 I-Observation
, NCT03926130 162 163 O
and NCT03926130 164 167 B-Or
SES NCT03926130 168 171 B-Observation
- NCT03926130 172 173 I-Observation
CD NCT03926130 174 176 I-Observation

- NCT03926130 179 180 O
Demonstrated NCT03926130 182 194 O
intolerance NCT03926130 195 206 B-Condition
, NCT03926130 207 208 O
loss NCT03926130 209 213 B-Condition
of NCT03926130 214 216 I-Condition
response NCT03926130 217 225 I-Condition
or NCT03926130 226 228 B-Or
inadequate NCT03926130 229 239 B-Condition
response NCT03926130 240 248 I-Condition
to NCT03926130 249 251 O
conventional NCT03926130 252 264 B-Modifier
or NCT03926130 265 267 B-Or
to NCT03926130 268 270 O
biologic NCT03926130 271 279 B-Modifier
therapy NCT03926130 280 287 B-Procedure
for NCT03926130 288 291 O
CD NCT03926130 292 294 B-Condition

- NCT03926130 297 298 O
If NCT03926130 300 302 O
female NCT03926130 303 309 O
, NCT03926130 310 311 O
subject NCT03926130 312 319 O
must NCT03926130 320 324 O
meet NCT03926130 325 329 O
the NCT03926130 330 333 O
contraception NCT03926130 334 347 B-Procedure
recommendations NCT03926130 348 363 B-Assertion___Assertion_Type_Value:hypothetical

Exclusion NCT03926130 364 373 O
Criteria NCT03926130 374 382 O
: NCT03926130 383 384 O

- NCT03926130 388 389 O
Have NCT03926130 391 395 O
a NCT03926130 396 397 O
current NCT03926130 398 405 B-Eq_Comparison
diagnosis NCT03926130 406 415 O
of NCT03926130 416 418 O
ulcerative NCT03926130 419 429 B-Condition
colitis NCT03926130 430 437 I-Condition
, NCT03926130 438 439 O
inflammatory NCT03926130 440 452 B-Condition
bowel NCT03926130 453 458 I-Condition
disease NCT03926130 459 466 I-Condition
- NCT03926130 467 468 I-Condition
unclassified NCT03926130 469 481 I-Condition
( NCT03926130 482 483 O
IBD NCT03926130 484 487 B-Condition
- NCT03926130 488 489 I-Condition
U NCT03926130 490 491 I-Condition
) NCT03926130 492 493 O
( NCT03926130 494 495 O
formerly NCT03926130 496 504 O
known NCT03926130 505 510 O
as NCT03926130 511 513 O
indeterminate NCT03926130 514 527 B-Condition
colitis NCT03926130 528 535 I-Condition
) NCT03926130 536 537 O
, NCT03926130 538 539 O
abdominal NCT03926130 540 549 B-Modifier
or NCT03926130 550 552 B-Or
perianal NCT03926130 553 561 B-Modifier
abscess NCT03926130 562 569 B-Condition
or NCT03926130 570 572 B-Or
short NCT03926130 573 578 B-Condition
bowel NCT03926130 579 584 I-Condition
syndrome NCT03926130 585 593 I-Condition

- NCT03926130 596 597 O
Have NCT03926130 599 603 O
a NCT03926130 604 605 O
stoma NCT03926130 606 611 B-Procedure
or NCT03926130 612 614 B-Or
ostomy NCT03926130 615 621 B-Procedure

- NCT03926130 624 625 O
Have NCT03926130 627 631 O
had NCT03926130 632 635 O
a NCT03926130 636 637 O
bowel NCT03926130 638 643 B-Procedure
resection NCT03926130 644 653 I-Procedure
within NCT03926130 654 660 B-Eq_Comparison
6 NCT03926130 661 662 I-Eq_Comparison
months NCT03926130 663 669 I-Eq_Comparison
, NCT03926130 670 671 O
or NCT03926130 672 674 B-Or
any NCT03926130 675 678 O
kind NCT03926130 679 683 O
of NCT03926130 684 686 O
intra NCT03926130 687 692 B-Modifier
- NCT03926130 693 694 I-Modifier
abdominal NCT03926130 695 704 I-Modifier
or NCT03926130 705 707 B-Or
extra NCT03926130 708 713 B-Modifier
abdominal NCT03926130 714 723 I-Modifier
surgery NCT03926130 724 731 B-Procedure
within NCT03926130 732 738 B-Eq_Comparison
3 NCT03926130 739 740 I-Eq_Comparison
months NCT03926130 741 747 I-Eq_Comparison
of NCT03926130 748 750 B-Temporal_Connection___Temporal_Connection_Type_Value:before
baseline NCT03926130 751 759 B-Study

- NCT03926130 762 763 O
Have NCT03926130 765 769 O
ever NCT03926130 770 774 O
received NCT03926130 775 783 B-Eq_Comparison
any NCT03926130 784 787 O
monoclonal NCT03926130 788 798 B-Procedure
antibodies NCT03926130 799 809 I-Procedure
binding NCT03926130 810 817 I-Procedure
IL NCT03926130 818 820 I-Procedure
- NCT03926130 821 822 I-Procedure
23 NCT03926130 823 825 I-Procedure

Inclusion NCT03868280 0 9 O
Criteria NCT03868280 10 18 O
: NCT03868280 19 20 O

- NCT03868280 24 25 O
Mid NCT03868280 27 30 B-Modifier
shaft NCT03868280 31 36 I-Modifier
or NCT03868280 37 39 B-Or
subtrochanteric NCT03868280 40 55 B-Modifier
femur NCT03868280 56 61 I-Modifier
fracture NCT03868280 62 70 B-Condition
appropriate NCT03868280 71 82 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03868280 83 86 O
antegrade NCT03868280 87 96 B-Procedure
fixation NCT03868280 97 105 I-Procedure

- NCT03868280 108 109 O
Surgeon NCT03868280 111 118 B-Provider
agreement NCT03868280 119 128 O
for NCT03868280 129 132 O
participation NCT03868280 133 146 O
in NCT03868280 147 149 O
study NCT03868280 150 155 B-Study

- NCT03868280 158 159 O
Ability NCT03868280 161 168 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868280 169 171 I-Assertion___Assertion_Type_Value:hypothetical
obtain NCT03868280 172 178 O
peri NCT03868280 179 183 B-Procedure
operative NCT03868280 184 193 I-Procedure
imaging NCT03868280 194 201 I-Procedure
( NCT03868280 202 203 O
CT NCT03868280 204 206 B-Procedure
scans NCT03868280 207 212 I-Procedure
) NCT03868280 213 214 O

- NCT03868280 218 219 O
Provision NCT03868280 221 230 O
of NCT03868280 231 233 O
informed NCT03868280 234 242 O
consent NCT03868280 243 250 O

Exclusion NCT03868280 251 260 O
Criteria NCT03868280 261 269 O
: NCT03868280 270 271 O

- NCT03868280 275 276 O
Inability NCT03868280 278 287 O
to NCT03868280 288 290 O
provide NCT03868280 291 298 O
informed NCT03868280 299 307 O
consent NCT03868280 308 315 O
( NCT03868280 316 317 O
e NCT03868280 318 319 O
. NCT03868280 320 321 O
g NCT03868280 322 323 O
. NCT03868280 324 325 O
cognitive NCT03868280 327 336 B-Condition
disability NCT03868280 337 347 I-Condition
, NCT03868280 348 349 O
language NCT03868280 350 358 B-Condition
barrier NCT03868280 359 366 I-Condition
) NCT03868280 367 368 O

- NCT03868280 372 373 O
Bilateral NCT03868280 375 384 B-Modifier
Femoral NCT03868280 385 392 I-Modifier
Fractures NCT03868280 393 402 B-Condition

- NCT03868280 405 406 O
Inability NCT03868280 408 417 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03868280 418 420 B-Or
lack NCT03868280 421 425 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
of NCT03868280 426 428 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
willingness NCT03868280 429 440 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
to NCT03868280 441 443 O
attend NCT03868280 444 450 O
follow NCT03868280 451 457 B-Encounter
up NCT03868280 458 460 I-Encounter

- NCT03868280 463 464 O
Ipsilateral NCT03868280 466 477 B-Modifier
tibial NCT03868280 478 484 B-Condition
fracture NCT03868280 485 493 I-Condition

- NCT03868280 496 497 O
Ipsilateral NCT03868280 499 510 B-Modifier
femoral NCT03868280 511 518 I-Modifier
neck NCT03868280 519 523 I-Modifier
fracture NCT03868280 524 532 B-Condition

- NCT03868280 535 536 O
Ipsilateral NCT03868280 538 549 B-Modifier
acetabular NCT03868280 550 560 I-Modifier
fracture NCT03868280 561 569 B-Condition

- NCT03868280 572 573 O
Pregnant NCT03868280 575 583 B-Condition
or NCT03868280 584 586 B-Or
breastfeeding NCT03868280 587 600 B-Condition

- NCT03868280 603 604 O
Contraindications NCT03868280 606 623 B-Contraindication
to NCT03868280 624 626 O
CT NCT03868280 627 629 B-Procedure
imaging NCT03868280 630 637 I-Procedure
including NCT03868280 638 647 O
impaired NCT03868280 648 656 B-Condition
kidney NCT03868280 657 663 I-Condition
/ NCT03868280 664 665 B-Or
liver NCT03868280 666 671 B-Condition
function NCT03868280 672 680 I-Condition
, NCT03868280 681 682 O
or NCT03868280 683 685 B-Or
lack NCT03868280 686 690 O
of NCT03868280 691 693 O
timely NCT03868280 694 700 O
availability NCT03868280 701 713 O

- NCT03868280 716 717 O
Periprosthetic NCT03868280 719 733 B-Modifier
fracture NCT03868280 734 742 B-Condition

- NCT03868280 745 746 O
Pathologic NCT03868280 748 758 B-Modifier
fracture NCT03868280 759 767 B-Condition

- NCT03868280 770 771 O
Significant NCT03868280 773 784 O
delirium NCT03868280 785 793 B-Condition
or NCT03868280 794 796 B-Or
dementia NCT03868280 797 805 B-Condition

Inclusion NCT03921944 0 9 O
Criteria NCT03921944 10 18 O
: NCT03921944 19 20 O

- NCT03921944 24 25 O
age NCT03921944 27 30 B-Age
> NCT03921944 31 32 B-Eq_Comparison
45 NCT03921944 33 35 I-Eq_Comparison
yrs NCT03921944 36 39 I-Eq_Comparison

- NCT03921944 42 43 O
primary NCT03921944 45 52 B-Modifier
diagnosis NCT03921944 53 62 O
of NCT03921944 63 65 O
osteoarthritis NCT03921944 66 80 B-Condition
of NCT03921944 81 83 O
the NCT03921944 84 87 O
shoulder NCT03921944 88 96 B-Modifier

- NCT03921944 99 100 O
total NCT03921944 102 107 B-Procedure
shoulder NCT03921944 108 116 I-Procedure
replacement NCT03921944 117 128 I-Procedure
performed NCT03921944 129 138 O
by NCT03921944 139 141 O
Dr NCT03921944 142 144 B-Provider
. NCT03921944 145 146 I-Provider
Armstrong NCT03921944 148 157 I-Provider

- NCT03921944 160 161 O
administered NCT03921944 163 175 B-Eq_Comparison
a NCT03921944 176 177 O
local NCT03921944 178 183 B-Procedure
anesthetic NCT03921944 184 194 I-Procedure
mixture NCT03921944 195 202 O
and NCT03921944 203 206 B-And
not NCT03921944 207 210 B-Negation
regional NCT03921944 211 219 B-Procedure
anesthesia NCT03921944 220 230 I-Procedure

- NCT03921944 233 234 O
all NCT03921944 236 239 O
genders NCT03921944 240 247 O

- NCT03921944 250 251 O
Fluent NCT03921944 253 259 O
in NCT03921944 260 262 O
written NCT03921944 263 270 O
and NCT03921944 271 274 O
spoken NCT03921944 275 281 O
English NCT03921944 282 289 O

- NCT03921944 292 293 O
Patients NCT03921944 295 303 O
capable NCT03921944 304 311 O
of NCT03921944 312 314 O
giving NCT03921944 315 321 O
informed NCT03921944 322 330 O
consent NCT03921944 331 338 O

Exclusion NCT03921944 339 348 O
Criteria NCT03921944 349 357 O
: NCT03921944 358 359 O

- NCT03921944 363 364 O
Known NCT03921944 366 371 O
contraindications NCT03921944 372 389 B-Contraindication
to NCT03921944 390 392 O
CT NCT03921944 393 395 B-Procedure
/ NCT03921944 396 397 B-Or
EMG NCT03921944 398 401 B-Procedure

- NCT03921944 404 405 O
Inability NCT03921944 407 416 O
to NCT03921944 417 419 O
provide NCT03921944 420 427 O
informed NCT03921944 428 436 O
consent NCT03921944 437 444 O

- NCT03921944 447 448 O
History NCT03921944 450 457 B-Eq_Comparison
of NCT03921944 458 460 O
recent NCT03921944 461 467 B-Eq_Comparison
trauma NCT03921944 468 474 B-Condition
to NCT03921944 475 477 O
the NCT03921944 478 481 O
shoulder NCT03921944 482 490 B-Modifier

- NCT03921944 493 494 O
Atypical NCT03921944 496 504 B-Modifier
shoulder NCT03921944 505 513 I-Modifier
pain NCT03921944 514 518 B-Condition

- NCT03921944 521 522 O
Other NCT03921944 524 529 O
suspected NCT03921944 530 539 B-Assertion___Assertion_Type_Value:possible
shoulder NCT03921944 540 548 B-Modifier
pathology NCT03921944 549 558 B-Condition
( NCT03921944 559 560 O
i NCT03921944 561 562 O
. NCT03921944 563 564 O
e NCT03921944 565 566 O
. NCT03921944 567 568 O
tumor NCT03921944 570 575 B-Condition
, NCT03921944 576 577 O
infection NCT03921944 578 587 B-Condition
) NCT03921944 588 589 O

- NCT03921944 593 594 O
Pregnancy NCT03921944 596 605 B-Condition

- NCT03921944 608 609 O
Bilateral NCT03921944 611 620 B-Modifier
total NCT03921944 621 626 B-Procedure
shoulder NCT03921944 627 635 I-Procedure
arthroplasty NCT03921944 636 648 I-Procedure

Inclusion NCT03923959 0 9 O
Criteria NCT03923959 10 18 O
: NCT03923959 19 20 O

1 NCT03923959 24 25 O
. NCT03923959 25 26 O
Provision NCT03923959 28 37 O
of NCT03923959 38 40 O
written NCT03923959 41 48 O
informed NCT03923959 49 57 O
consent NCT03923959 58 65 O

2 NCT03923959 68 69 O
. NCT03923959 69 70 O
Age NCT03923959 72 75 B-Age
> NCT03923959 76 77 B-Eq_Comparison
or NCT03923959 78 80 I-Eq_Comparison
= NCT03923959 81 82 I-Eq_Comparison
to NCT03923959 83 85 I-Eq_Comparison
65 NCT03923959 86 88 I-Eq_Comparison
years NCT03923959 89 94 I-Eq_Comparison

3 NCT03923959 97 98 O
. NCT03923959 98 99 O
Hip NCT03923959 101 104 B-Modifier
fracture NCT03923959 105 113 B-Condition
location NCT03923959 114 122 O
within NCT03923959 123 129 O
the NCT03923959 130 133 O
femoral NCT03923959 134 141 B-Modifier
neck NCT03923959 142 146 I-Modifier
, NCT03923959 147 148 O
intertrochanteric NCT03923959 149 166 B-Modifier
, NCT03923959 167 168 O
and NCT03923959 169 172 O
subtrochanteric NCT03923959 173 188 B-Modifier
regions NCT03923959 189 196 O

4 NCT03923959 199 200 O
. NCT03923959 200 201 O
Indication NCT03923959 203 213 B-Indication
for NCT03923959 214 217 O
one NCT03923959 218 221 B-Eq_Comparison
of NCT03923959 222 224 O
the NCT03923959 225 228 B-Criteria_Count
following NCT03923959 229 238 I-Criteria_Count
surgical NCT03923959 239 247 B-Procedure
interventions NCT03923959 248 261 I-Procedure
: NCT03923959 262 263 O
hemiarthroplasty NCT03923959 264 280 B-Procedure
, NCT03923959 281 282 O
total NCT03923959 283 288 B-Procedure
hip NCT03923959 289 292 I-Procedure
replacement NCT03923959 293 304 I-Procedure
, NCT03923959 305 306 O
sliding NCT03923959 307 314 B-Modifier
plate NCT03923959 315 320 I-Modifier
and NCT03923959 321 324 B-Or
screw NCT03923959 325 330 B-Modifier
fixation NCT03923959 331 339 B-Procedure
, NCT03923959 340 341 O
or NCT03923959 342 344 B-Or
intramedullary NCT03923959 345 359 B-Modifier
fixation NCT03923959 360 368 B-Procedure

Exclusion NCT03923959 369 378 O
Criteria NCT03923959 379 387 O
: NCT03923959 388 389 O

1 NCT03923959 393 394 O
. NCT03923959 394 395 O
Indication NCT03923959 397 407 B-Indication
for NCT03923959 408 411 O
closed NCT03923959 412 418 B-Procedure
reduction NCT03923959 419 428 I-Procedure
or NCT03923959 429 431 B-Or
percutaneous NCT03923959 432 444 B-Procedure
screw NCT03923959 445 450 I-Procedure

2 NCT03923959 453 454 O
. NCT03923959 454 455 O
Allergy NCT03923959 457 464 B-Allergy
to NCT03923959 465 467 O
TXA NCT03923959 468 471 B-Drug

3 NCT03923959 474 475 O
. NCT03923959 475 476 O
Cerebrovascular NCT03923959 478 493 B-Condition
accident NCT03923959 494 502 I-Condition
/ NCT03923959 503 504 B-Or
stroke NCT03923959 505 511 B-Condition
, NCT03923959 512 513 O
active NCT03923959 514 520 B-Eq_Comparison
coronary NCT03923959 521 529 B-Condition
disease NCT03923959 530 537 I-Condition
/ NCT03923959 538 539 B-Or
myocardial NCT03923959 540 550 B-Condition
infarction NCT03923959 551 561 I-Condition
, NCT03923959 562 563 O
or NCT03923959 564 566 B-Or
deep NCT03923959 567 571 B-Condition
vein NCT03923959 572 576 I-Condition
thrombosis NCT03923959 577 587 I-Condition
/ NCT03923959 588 589 B-Or
pulmonary NCT03923959 590 599 B-Condition
emboli NCT03923959 600 606 I-Condition
within NCT03923959 607 613 B-Eq_Comparison
one NCT03923959 614 617 I-Eq_Comparison
( NCT03923959 618 619 I-Eq_Comparison
1 NCT03923959 620 621 I-Eq_Comparison
) NCT03923959 622 623 I-Eq_Comparison
month NCT03923959 624 629 I-Eq_Comparison
of NCT03923959 630 632 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923959 633 636 O
fracture NCT03923959 637 645 B-Condition

4 NCT03923959 648 649 O
. NCT03923959 649 650 O
Presence NCT03923959 652 660 O
of NCT03923959 661 663 O
hypercoaguable NCT03923959 664 678 B-Condition
disorder NCT03923959 679 687 I-Condition

Inclusion NCT03861494 0 9 O
Criteria NCT03861494 10 18 O
: NCT03861494 19 20 O

- NCT03861494 24 25 O
patients NCT03861494 27 35 O
hospitalized NCT03861494 36 48 B-Encounter
with NCT03861494 49 53 B-And
primary NCT03861494 54 61 O
diagnosis NCT03861494 62 71 O
of NCT03861494 72 74 O
acute NCT03861494 75 80 O
or NCT03861494 81 83 B-Or
subacute NCT03861494 84 92 O
ischemic NCT03861494 93 101 B-Condition
cerebral NCT03861494 102 110 I-Condition
infarction NCT03861494 111 121 I-Condition

- NCT03861494 124 125 O
18 NCT03861494 127 129 B-Eq_Comparison
years NCT03861494 130 135 I-Eq_Comparison
of NCT03861494 136 138 I-Eq_Comparison
age NCT03861494 139 142 I-Eq_Comparison
or NCT03861494 143 145 I-Eq_Comparison
older NCT03861494 146 151 I-Eq_Comparison

- NCT03861494 154 155 O
English NCT03861494 157 164 O
speaking NCT03861494 165 173 O

- NCT03861494 176 177 O
admitted NCT03861494 179 187 B-Encounter
to NCT03861494 188 190 O
hospital NCT03861494 191 199 O
Sunday NCT03861494 200 206 B-Eq_Comparison
through NCT03861494 207 214 I-Eq_Comparison
Thursday NCT03861494 215 223 I-Eq_Comparison

- NCT03861494 226 227 O
patient NCT03861494 229 236 O
or NCT03861494 237 239 O
responsible NCT03861494 240 251 O
primary NCT03861494 252 259 O
caregiver NCT03861494 260 269 O
able NCT03861494 270 274 O
to NCT03861494 275 277 O
understand NCT03861494 278 288 O
and NCT03861494 289 292 O
provide NCT03861494 293 300 O
informed NCT03861494 301 309 O
consent NCT03861494 310 317 O

- NCT03861494 320 321 O
prognosis NCT03861494 323 332 B-Observation
for NCT03861494 333 336 I-Observation
survival NCT03861494 337 345 I-Observation
greater NCT03861494 346 353 B-Eq_Comparison
than NCT03861494 354 358 I-Eq_Comparison
6 NCT03861494 359 360 I-Eq_Comparison
months NCT03861494 361 367 I-Eq_Comparison

- NCT03861494 370 371 O
one NCT03861494 373 376 B-Eq_Comparison
or NCT03861494 377 379 I-Eq_Comparison
more NCT03861494 380 384 I-Eq_Comparison
vascular NCT03861494 385 393 B-Condition
risk NCT03861494 394 398 B-Risk
factors NCT03861494 399 406 I-Risk
( NCT03861494 407 408 O
HTN NCT03861494 409 412 B-Condition
, NCT03861494 413 414 O
DLP NCT03861494 415 418 B-Condition
, NCT03861494 419 420 O
current NCT03861494 421 428 B-Condition
smoker NCT03861494 429 435 I-Condition
, NCT03861494 436 437 O
DM NCT03861494 438 440 B-Condition
, NCT03861494 441 442 O
obesity NCT03861494 443 450 B-Condition
) NCT03861494 451 452 O

- NCT03861494 456 457 O
live NCT03861494 459 463 O
in NCT03861494 464 466 O
NWA NCT03861494 467 470 O
area NCT03861494 471 475 O
( NCT03861494 476 477 O
Benton NCT03861494 478 484 O
, NCT03861494 485 486 O
Boone NCT03861494 487 492 O
, NCT03861494 493 494 O
Carroll NCT03861494 495 502 O
, NCT03861494 503 504 O
Madison NCT03861494 505 512 O
, NCT03861494 513 514 O
and NCT03861494 515 518 O
Washington NCT03861494 519 529 O
counties NCT03861494 530 538 O
) NCT03861494 539 540 O
, NCT03861494 541 542 O

- NCT03861494 546 547 O
have NCT03861494 549 553 O
a NCT03861494 554 555 O
working NCT03861494 556 563 O
phone NCT03861494 564 569 O
. NCT03861494 570 571 O

Exclusion NCT03861494 573 582 O
Criteria NCT03861494 583 591 O
: NCT03861494 592 593 O

- NCT03861494 597 598 O
admitted NCT03861494 600 608 B-Encounter
with NCT03861494 609 613 B-And
transient NCT03861494 614 623 B-Condition
ischemic NCT03861494 624 632 I-Condition
attack NCT03861494 633 639 I-Condition

- NCT03861494 642 643 O
admitted NCT03861494 645 653 B-Encounter
with NCT03861494 654 658 B-And
an NCT03861494 659 661 O
intracerebral NCT03861494 662 675 B-Condition
hemorrhage NCT03861494 676 686 I-Condition

- NCT03861494 689 690 O
experience NCT03861494 692 702 O
an NCT03861494 703 705 O
in NCT03861494 706 708 O
- NCT03861494 709 710 O
hospital NCT03861494 711 719 O
ischemic NCT03861494 720 728 B-Condition
cerebral NCT03861494 729 737 I-Condition
infarction NCT03861494 738 748 I-Condition

- NCT03861494 751 752 O
hospital NCT03861494 754 762 O
to NCT03861494 763 765 O
hospital NCT03861494 766 774 O
transfer NCT03861494 775 783 B-Encounter
patients NCT03861494 784 792 O

- NCT03861494 795 796 O
nursing NCT03861494 798 805 O
home NCT03861494 806 810 O
as NCT03861494 811 813 O
primary NCT03861494 814 821 O
residence NCT03861494 822 831 O
before NCT03861494 832 838 B-Temporal_Connection___Temporal_Connection_Type_Value:before
or NCT03861494 839 841 B-Or
after NCT03861494 842 847 B-Temporal_Connection___Temporal_Connection_Type_Value:after
discharge NCT03861494 848 857 B-Encounter

- NCT03861494 860 861 O
hospice NCT03861494 863 870 O

- NCT03861494 873 874 O
inability NCT03861494 876 885 B-Condition
to NCT03861494 886 888 I-Condition
comply NCT03861494 889 895 I-Condition
with NCT03861494 896 900 O
post NCT03861494 901 905 B-Temporal_Connection___Temporal_Connection_Type_Value:after
discharge NCT03861494 906 915 B-Encounter
follow NCT03861494 916 922 B-Encounter
up NCT03861494 923 925 I-Encounter

Inclusion NCT03869411 0 9 O
Criteria NCT03869411 10 18 O
: NCT03869411 19 20 O

- NCT03869411 24 25 O
Diabetes NCT03869411 27 35 O
group NCT03869411 36 41 O
: NCT03869411 42 43 O
1 NCT03869411 44 45 O
) NCT03869411 46 47 O
Age NCT03869411 48 51 B-Age
between NCT03869411 52 59 B-Eq_Comparison
30 NCT03869411 60 62 I-Eq_Comparison
- NCT03869411 63 64 I-Eq_Comparison
70 NCT03869411 65 67 I-Eq_Comparison
years NCT03869411 68 73 I-Eq_Comparison
of NCT03869411 74 76 O
old NCT03869411 77 80 O
, NCT03869411 81 82 O
2 NCT03869411 83 84 O
) NCT03869411 85 86 O
type NCT03869411 87 91 B-Modifier
2 NCT03869411 92 93 I-Modifier
diabetes NCT03869411 94 102 B-Condition
. NCT03869411 103 104 O

- NCT03869411 108 109 O
Healthy NCT03869411 111 118 B-Condition
control NCT03869411 119 126 O
group NCT03869411 127 132 O
: NCT03869411 133 134 O
1 NCT03869411 135 136 O
) NCT03869411 137 138 O
Age NCT03869411 139 142 B-Age
between NCT03869411 143 150 B-Eq_Comparison
30 NCT03869411 151 153 I-Eq_Comparison
- NCT03869411 154 155 I-Eq_Comparison
70 NCT03869411 156 158 I-Eq_Comparison
years NCT03869411 159 164 I-Eq_Comparison
of NCT03869411 165 167 O
old NCT03869411 168 171 O
, NCT03869411 172 173 O
2 NCT03869411 174 175 O
) NCT03869411 176 177 O
without NCT03869411 178 185 B-Negation
diabetes NCT03869411 186 194 B-Condition

Exclusion NCT03869411 195 204 O
Criteria NCT03869411 205 213 O
: NCT03869411 214 215 O

- NCT03869411 219 220 O
history NCT03869411 222 229 B-Eq_Comparison
of NCT03869411 230 232 O
moderate NCT03869411 233 241 B-Eq_Comparison
- NCT03869411 242 243 I-Eq_Comparison
severe NCT03869411 244 250 I-Eq_Comparison
somatic NCT03869411 251 258 B-Modifier
or NCT03869411 259 261 B-Or
autonomic NCT03869411 262 271 B-Modifier
neuropathy NCT03869411 272 282 B-Condition
, NCT03869411 283 284 O
cardiovascular NCT03869411 285 299 B-Condition
disease NCT03869411 300 307 I-Condition
, NCT03869411 308 309 O
preproliferative NCT03869411 310 326 B-Modifier
or NCT03869411 327 329 B-Or
proliferative NCT03869411 330 343 B-Modifier
retinopathy NCT03869411 344 355 B-Condition
, NCT03869411 356 357 O
and NCT03869411 358 361 B-Or
chronic NCT03869411 362 369 O
renal NCT03869411 370 375 B-Condition
failure NCT03869411 376 383 I-Condition

- NCT03869411 386 387 O
unable NCT03869411 389 395 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03869411 396 398 O
perform NCT03869411 399 406 O
the NCT03869411 407 410 O
programs NCT03869411 411 419 B-Procedure
or NCT03869411 420 422 B-Or
assessments NCT03869411 423 434 B-Procedure

- NCT03869411 437 438 O
other NCT03869411 440 445 B-Other
systematic NCT03869411 446 456 B-Modifier
diseases NCT03869411 457 465 B-Condition

Inclusion NCT03921931 0 9 O
Criteria NCT03921931 10 18 O
: NCT03921931 19 20 O

- NCT03921931 24 25 O
men NCT03921931 27 30 O
and NCT03921931 31 34 B-Or
women NCT03921931 35 40 O
aged NCT03921931 41 45 B-Age
over NCT03921931 46 50 B-Eq_Comparison
18 NCT03921931 51 53 I-Eq_Comparison
years NCT03921931 54 59 I-Eq_Comparison

- NCT03921931 62 63 O
signed NCT03921931 65 71 O
informed NCT03921931 72 80 O
consent NCT03921931 81 88 O
form NCT03921931 89 93 O

- NCT03921931 96 97 O
ametropia NCT03921931 99 108 B-Observation
below NCT03921931 109 114 B-Eq_Comparison
3 NCT03921931 115 116 I-Eq_Comparison
diopters NCT03921931 117 125 I-Eq_Comparison

- NCT03921931 128 129 O
ability NCT03921931 131 138 O
and NCT03921931 139 142 O
willingness NCT03921931 143 154 O
to NCT03921931 155 157 O
follow NCT03921931 158 164 O
instructions NCT03921931 165 177 O

for NCT03921931 178 181 O
healthy NCT03921931 182 189 B-Observation
volunteers NCT03921931 190 200 O
: NCT03921931 201 202 O

- NCT03921931 206 207 O
normal NCT03921931 209 215 O
ophthalmologic NCT03921931 216 230 B-Observation
findings NCT03921931 231 239 I-Observation

for NCT03921931 240 243 O
primary NCT03921931 244 251 B-Modifier
open NCT03921931 252 256 I-Modifier
angle NCT03921931 257 262 I-Modifier
glaucoma NCT03921931 263 271 B-Condition
patients NCT03921931 272 280 O
( NCT03921931 281 282 O
POAG NCT03921931 283 287 B-Condition
) NCT03921931 288 289 O
: NCT03921931 290 291 O

- NCT03921931 295 296 O
diagnosed NCT03921931 298 307 O
POAG NCT03921931 308 312 B-Condition

- NCT03921931 315 316 O
MD NCT03921931 318 320 B-Observation
< NCT03921931 321 322 B-Eq_Comparison
= NCT03921931 323 324 I-Eq_Comparison
10 NCT03921931 325 327 I-Eq_Comparison
dB NCT03921931 328 330 I-Eq_Comparison

for NCT03921931 331 334 O
age NCT03921931 335 338 B-Modifier
- NCT03921931 339 340 I-Modifier
related NCT03921931 341 348 I-Modifier
macular NCT03921931 349 356 B-Condition
degeneration NCT03921931 357 369 I-Condition
( NCT03921931 370 371 O
AMD NCT03921931 372 375 B-Condition
) NCT03921931 376 377 O
: NCT03921931 378 379 O

- NCT03921931 383 384 O
diagnosed NCT03921931 386 395 O
dry NCT03921931 396 399 B-Modifier
AMD NCT03921931 400 403 B-Condition

- NCT03921931 406 407 O
diagnosed NCT03921931 409 418 O
stage NCT03921931 419 424 B-Eq_Comparison
II NCT03921931 425 427 I-Eq_Comparison
or NCT03921931 428 430 B-Or
stage NCT03921931 431 436 B-Eq_Comparison
III NCT03921931 437 440 I-Eq_Comparison
AMD NCT03921931 441 444 B-Condition

Exclusion NCT03921931 445 454 O
Criteria NCT03921931 455 463 O
: NCT03921931 464 465 O

- NCT03921931 469 470 O
Presence NCT03921931 472 480 O
of NCT03921931 481 483 O
any NCT03921931 484 487 O
abnormalities NCT03921931 488 501 B-Condition
preventing NCT03921931 502 512 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
reliable NCT03921931 513 521 O
measurements NCT03921931 522 534 B-Observation

- NCT03921931 537 538 O
Ocular NCT03921931 540 546 B-Condition
inflammation NCT03921931 547 559 I-Condition
and NCT03921931 560 563 B-Or
ocular NCT03921931 564 570 B-Condition
disease NCT03921931 571 578 I-Condition
interfering NCT03921931 579 590 O
with NCT03921931 591 595 O
the NCT03921931 596 599 O
study NCT03921931 600 605 O
aims NCT03921931 606 610 O

- NCT03921931 613 614 O
Use NCT03921931 616 619 O
of NCT03921931 620 622 O
photosensitizing NCT03921931 623 639 B-Drug
medication NCT03921931 640 650 I-Drug
( NCT03921931 651 652 O
phototoxic NCT03921931 653 663 B-Drug
drugs NCT03921931 664 669 I-Drug
, NCT03921931 670 671 O
photoallergic NCT03921931 672 685 B-Drug
drugs NCT03921931 686 691 I-Drug
) NCT03921931 692 693 O
in NCT03921931 694 696 O
the NCT03921931 697 700 O
3 NCT03921931 701 702 B-Eq_Comparison
months NCT03921931 703 709 I-Eq_Comparison
preceding NCT03921931 710 719 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03921931 720 723 O
study NCT03921931 724 729 B-Study

- NCT03921931 732 733 O
Presence NCT03921931 735 743 O
of NCT03921931 744 746 O
any NCT03921931 747 750 O
condition NCT03921931 751 760 B-Condition
with NCT03921931 761 765 O
the NCT03921931 766 769 O
possibility NCT03921931 770 781 B-Assertion___Assertion_Type_Value:possible
of NCT03921931 782 784 I-Assertion___Assertion_Type_Value:possible
causing NCT03921931 785 792 O
photosensitivity NCT03921931 793 809 B-Condition
, NCT03921931 810 811 O
including NCT03921931 812 821 O
systemic NCT03921931 822 830 B-Condition
lupus NCT03921931 831 836 I-Condition
erythematosus NCT03921931 837 850 I-Condition
SLE NCT03921931 851 854 B-Condition
, NCT03921931 855 856 O
Porphyria NCT03921931 857 866 B-Condition
, NCT03921931 867 868 O
Vitiligo NCT03921931 869 877 B-Condition
, NCT03921931 878 879 O
Xeroderma NCT03921931 880 889 B-Condition
Pigmentosum NCT03921931 890 901 I-Condition
and NCT03921931 902 905 B-Or
Albinism NCT03921931 906 914 B-Condition

- NCT03921931 917 918 O
Presence NCT03921931 920 928 O
of NCT03921931 929 931 O
any NCT03921931 932 935 O
form NCT03921931 936 940 O
of NCT03921931 941 943 O
epilepsy NCT03921931 944 952 B-Condition

- NCT03921931 955 956 O
Ocular NCT03921931 958 964 B-Procedure
surgery NCT03921931 965 972 I-Procedure
in NCT03921931 973 975 O
the NCT03921931 976 979 O
3 NCT03921931 980 981 B-Eq_Comparison
months NCT03921931 982 988 I-Eq_Comparison
preceding NCT03921931 989 998 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03921931 999 1002 O
study NCT03921931 1003 1008 B-Study

- NCT03921931 1011 1012 O
Pregnancy NCT03921931 1014 1023 B-Condition
, NCT03921931 1024 1025 O
planned NCT03921931 1026 1033 B-Assertion___Assertion_Type_Value:intention
pregnancy NCT03921931 1034 1043 B-Condition
or NCT03921931 1044 1046 B-Or
lactating NCT03921931 1047 1056 B-Condition

- NCT03921931 1059 1060 O
Any NCT03921931 1062 1065 O
medical NCT03921931 1066 1073 O
or NCT03921931 1074 1076 O
surgical NCT03921931 1077 1085 B-Procedure
history NCT03921931 1086 1093 B-Eq_Comparison
, NCT03921931 1094 1095 O
disorder NCT03921931 1096 1104 B-Condition
or NCT03921931 1105 1107 B-Or
disease NCT03921931 1108 1115 B-Condition
such NCT03921931 1116 1120 O
as NCT03921931 1121 1123 O
acute NCT03921931 1124 1129 O
or NCT03921931 1130 1132 B-Or
chronic NCT03921931 1133 1140 O
severe NCT03921931 1141 1147 O
organic NCT03921931 1148 1155 B-Condition
disease NCT03921931 1156 1163 I-Condition

Inclusion NCT03867773 0 9 O
Criteria NCT03867773 10 18 O
: NCT03867773 19 20 O

- NCT03867773 24 25 O
Male NCT03867773 27 31 O
or NCT03867773 32 34 B-Or
female NCT03867773 35 41 O
; NCT03867773 41 42 O

- NCT03867773 45 46 O
body NCT03867773 48 52 B-Observation
mass NCT03867773 53 57 I-Observation
index NCT03867773 58 63 I-Observation
( NCT03867773 64 65 O
BMI NCT03867773 66 69 B-Observation
) NCT03867773 70 71 O
between NCT03867773 72 79 B-Eq_Comparison
30.0 NCT03867773 80 84 I-Eq_Comparison
and NCT03867773 85 88 I-Eq_Comparison
49.9 NCT03867773 89 93 I-Eq_Comparison
kg NCT03867773 94 96 I-Eq_Comparison
/ NCT03867773 97 98 I-Eq_Comparison
m NCT03867773 99 100 I-Eq_Comparison
2 NCT03867773 101 102 I-Eq_Comparison
; NCT03867773 102 103 O

- NCT03867773 106 107 O
age NCT03867773 109 112 B-Age
between NCT03867773 113 120 B-Eq_Comparison
18 NCT03867773 121 123 I-Eq_Comparison
and NCT03867773 124 127 I-Eq_Comparison
65 NCT03867773 128 130 I-Eq_Comparison
years NCT03867773 131 136 I-Eq_Comparison
; NCT03867773 136 137 O
sedentary NCT03867773 138 147 B-Observation
( NCT03867773 148 149 O
light NCT03867773 150 155 B-Observation
exercise NCT03867773 156 164 I-Observation
less NCT03867773 165 169 B-Eq_Comparison
than NCT03867773 170 174 I-Eq_Comparison
1 NCT03867773 175 176 I-Eq_Comparison
h NCT03867773 177 178 I-Eq_Comparison
per NCT03867773 179 182 I-Eq_Comparison
week NCT03867773 183 187 I-Eq_Comparison
) NCT03867773 188 189 O
or NCT03867773 190 192 B-Or
moderately NCT03867773 193 203 B-Observation
active NCT03867773 204 210 I-Observation
( NCT03867773 211 212 O
moderate NCT03867773 213 221 B-Observation
exercise NCT03867773 222 230 I-Observation
1 NCT03867773 231 232 B-Eq_Comparison
to NCT03867773 233 235 I-Eq_Comparison
2 NCT03867773 236 237 I-Eq_Comparison
h NCT03867773 238 239 I-Eq_Comparison
per NCT03867773 240 243 I-Eq_Comparison
week NCT03867773 244 248 I-Eq_Comparison
) NCT03867773 249 250 O
; NCT03867773 251 252 O

- NCT03867773 255 256 O
weight NCT03867773 258 264 B-Observation
stable NCT03867773 265 271 O
for NCT03867773 272 275 O
> NCT03867773 276 277 B-Eq_Comparison
3 NCT03867773 278 279 I-Eq_Comparison
months NCT03867773 280 286 I-Eq_Comparison
prior NCT03867773 287 292 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867773 293 295 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03867773 296 299 O
beginning NCT03867773 300 309 O
of NCT03867773 310 312 O
the NCT03867773 313 316 O
study NCT03867773 317 322 B-Study
( NCT03867773 323 324 O
gain NCT03867773 325 329 B-Eq_Comparison
or NCT03867773 330 332 I-Eq_Comparison
loss NCT03867773 333 337 I-Eq_Comparison
< NCT03867773 338 339 I-Eq_Comparison
4 NCT03867773 340 341 I-Eq_Comparison
kg NCT03867773 342 344 I-Eq_Comparison
) NCT03867773 345 346 O
; NCT03867773 347 348 O

- NCT03867773 351 352 O
able NCT03867773 354 358 O
to NCT03867773 359 361 O
give NCT03867773 362 366 O
written NCT03867773 367 374 O
informed NCT03867773 375 383 O
consent NCT03867773 384 391 O

Exclusion NCT03867773 392 401 O
Criteria NCT03867773 402 410 O
: NCT03867773 411 412 O

- NCT03867773 416 417 O
Smoker NCT03867773 419 425 B-Condition
; NCT03867773 425 426 O
diabetic NCT03867773 427 435 B-Condition
; NCT03867773 435 436 O

- NCT03867773 439 440 O
history NCT03867773 442 449 B-Eq_Comparison
of NCT03867773 450 452 O
alcohol NCT03867773 453 460 B-Condition
dependance NCT03867773 461 471 I-Condition
( NCT03867773 472 473 O
score NCT03867773 474 479 B-Eq_Comparison
> NCT03867773 480 481 I-Eq_Comparison
20 NCT03867773 482 484 I-Eq_Comparison
from NCT03867773 485 489 O
Alcohol NCT03867773 490 497 B-Observation
and NCT03867773 498 501 I-Observation
Health NCT03867773 502 508 I-Observation
Questionnaire NCT03867773 509 522 I-Observation
8 NCT03867773 523 524 I-Observation
) NCT03867773 525 526 O
; NCT03867773 527 528 O

- NCT03867773 531 532 O
taking NCT03867773 534 540 B-Eq_Comparison
weight NCT03867773 541 547 B-Drug
loss NCT03867773 548 552 I-Drug
medications NCT03867773 553 564 I-Drug
; NCT03867773 564 565 O

- NCT03867773 568 569 O
taking NCT03867773 571 577 B-Eq_Comparison
medication NCT03867773 578 588 B-Drug
that NCT03867773 589 593 O
requires NCT03867773 594 602 O
eating NCT03867773 603 609 B-Observation
food NCT03867773 610 614 I-Observation
before NCT03867773 615 621 B-Temporal_Connection___Temporal_Connection_Type_Value:before
( NCT03867773 622 623 O
or NCT03867773 624 626 O
with NCT03867773 627 631 O
) NCT03867773 632 633 O
the NCT03867773 634 637 O
medication NCT03867773 638 648 O
; NCT03867773 648 649 O
history NCT03867773 650 657 B-Eq_Comparison
of NCT03867773 658 660 O
eating NCT03867773 661 667 B-Condition
disorders NCT03867773 668 677 I-Condition
; NCT03867773 677 678 O

- NCT03867773 681 682 O
night NCT03867773 684 689 O
- NCT03867773 690 691 O
shift NCT03867773 692 697 O
workers NCT03867773 698 705 O
; NCT03867773 705 706 O

- NCT03867773 709 710 O
perimenopausal NCT03867773 712 726 B-Condition
; NCT03867773 726 727 O

- NCT03867773 730 731 O
pregnant NCT03867773 733 741 B-Condition
women NCT03867773 742 747 O

Inclusion NCT03921476 0 9 O
Criteria NCT03921476 10 18 O
: NCT03921476 19 20 O

Female NCT03921476 22 28 O
subjects NCT03921476 29 37 O
between NCT03921476 38 45 B-Eq_Comparison
18 NCT03921476 46 48 I-Eq_Comparison
and NCT03921476 49 52 I-Eq_Comparison
65 NCT03921476 53 55 I-Eq_Comparison
years NCT03921476 56 61 I-Eq_Comparison
of NCT03921476 62 64 O
age NCT03921476 65 68 B-Age
currently NCT03921476 69 78 B-Eq_Comparison
taking NCT03921476 79 85 B-Eq_Comparison
spironolactone NCT03921476 86 100 B-Drug
for NCT03921476 101 104 O
a NCT03921476 105 106 O
diagnosis NCT03921476 107 116 O
of NCT03921476 117 119 O
acne NCT03921476 120 124 B-Condition
vulgaris NCT03921476 125 133 I-Condition

OR NCT03921476 134 136 B-Or

Female NCT03921476 137 143 O
subjects NCT03921476 144 152 O
between NCT03921476 153 160 B-Eq_Comparison
18 NCT03921476 161 163 I-Eq_Comparison
and NCT03921476 164 167 I-Eq_Comparison
65 NCT03921476 168 170 I-Eq_Comparison
years NCT03921476 171 176 I-Eq_Comparison
of NCT03921476 177 179 O
age NCT03921476 180 183 B-Age
currently NCT03921476 184 193 B-Eq_Comparison
taking NCT03921476 194 200 B-Eq_Comparison
oral NCT03921476 201 205 B-Drug
antibiotics NCT03921476 206 217 I-Drug
for NCT03921476 218 221 O
a NCT03921476 222 223 O
diagnosis NCT03921476 224 233 O
of NCT03921476 234 236 O
acne NCT03921476 237 241 B-Condition
vulgaris NCT03921476 242 250 I-Condition

AND NCT03921476 251 254 B-And
Subjects NCT03921476 255 263 O
able NCT03921476 264 268 O
to NCT03921476 269 271 O
complete NCT03921476 272 280 O
an NCT03921476 281 283 O
online NCT03921476 284 290 O
survey NCT03921476 291 297 O
in NCT03921476 298 300 O
English NCT03921476 301 308 O

Exclusion NCT03921476 309 318 O
Criteria NCT03921476 319 327 O
: NCT03921476 328 329 O

Subjects NCT03921476 331 339 O
less NCT03921476 340 344 B-Eq_Comparison
than NCT03921476 345 349 I-Eq_Comparison
18 NCT03921476 350 352 I-Eq_Comparison
years NCT03921476 353 358 I-Eq_Comparison
of NCT03921476 359 361 O
age NCT03921476 362 365 B-Age
or NCT03921476 366 368 B-Or
older NCT03921476 369 374 B-Eq_Comparison
than NCT03921476 375 379 I-Eq_Comparison
65 NCT03921476 380 382 I-Eq_Comparison
years NCT03921476 383 388 I-Eq_Comparison
of NCT03921476 389 391 O
age NCT03921476 392 395 B-Age
Subjects NCT03921476 396 404 O
that NCT03921476 405 409 O
have NCT03921476 410 414 O
ever NCT03921476 415 419 O
been NCT03921476 420 424 O
diagnosed NCT03921476 425 434 O
with NCT03921476 435 439 O
any NCT03921476 440 443 O
mood NCT03921476 444 448 B-Condition
disorder NCT03921476 449 457 I-Condition
by NCT03921476 458 460 O
a NCT03921476 461 462 O
clinician NCT03921476 463 472 O
prior NCT03921476 473 478 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921476 479 481 O
starting NCT03921476 482 490 O
spironolactone NCT03921476 491 505 B-Drug
( NCT03921476 506 507 O
history NCT03921476 508 515 B-Eq_Comparison
of NCT03921476 516 518 O
mood NCT03921476 519 523 B-Condition
disorder NCT03921476 524 532 I-Condition
or NCT03921476 533 535 B-Or
current NCT03921476 536 543 B-Eq_Comparison
mood NCT03921476 544 548 B-Condition
disorder NCT03921476 549 557 I-Condition
) NCT03921476 558 559 O
Subjects NCT03921476 560 568 O
taking NCT03921476 569 575 B-Eq_Comparison
hormonal NCT03921476 576 584 B-Drug
contraception NCT03921476 585 598 I-Drug
( NCT03921476 599 600 O
including NCT03921476 601 610 O
but NCT03921476 611 614 O
not NCT03921476 615 618 O
limited NCT03921476 619 626 O
to NCT03921476 627 629 O
oral NCT03921476 630 634 B-Drug
contraceptive NCT03921476 635 648 I-Drug
pills NCT03921476 649 654 I-Drug
) NCT03921476 655 656 O
for NCT03921476 657 660 O
a NCT03921476 661 662 O
duration NCT03921476 663 671 O
of NCT03921476 672 674 O
less NCT03921476 675 679 B-Eq_Comparison
than NCT03921476 680 684 I-Eq_Comparison
6 NCT03921476 685 686 I-Eq_Comparison
months NCT03921476 687 693 I-Eq_Comparison
Subjects NCT03921476 694 702 O
that NCT03921476 703 707 O
have NCT03921476 708 712 O
ever NCT03921476 713 717 O
been NCT03921476 718 722 O
diagnosed NCT03921476 723 732 O
with NCT03921476 733 737 O
any NCT03921476 738 741 O
type NCT03921476 742 746 O
of NCT03921476 747 749 O
sexual NCT03921476 750 756 B-Condition
dysfunction NCT03921476 757 768 I-Condition
prior NCT03921476 769 774 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921476 775 777 O
starting NCT03921476 778 786 O
spironolactone NCT03921476 787 801 B-Drug
Subjects NCT03921476 802 810 O
not NCT03921476 811 814 B-Negation
able NCT03921476 815 819 O
to NCT03921476 820 822 O
complete NCT03921476 823 831 O
an NCT03921476 832 834 O
online NCT03921476 835 841 O
survey NCT03921476 842 848 O
in NCT03921476 849 851 O
English NCT03921476 852 859 O
Subjects NCT03921476 860 868 O
taking NCT03921476 869 875 B-Eq_Comparison
oral NCT03921476 876 880 B-Drug
isotretinoin NCT03921476 881 893 I-Drug
for NCT03921476 894 897 O
a NCT03921476 898 899 O
diagnosis NCT03921476 900 909 O
of NCT03921476 910 912 O
acne NCT03921476 913 917 B-Condition
Subjects NCT03921476 918 926 O
that NCT03921476 927 931 O
are NCT03921476 932 935 O
currently NCT03921476 936 945 B-Eq_Comparison
pregnant NCT03921476 946 954 B-Condition


Inclusion NCT03865550 0 9 O
Criteria NCT03865550 10 18 O
: NCT03865550 19 20 O

- NCT03865550 24 25 O
18 NCT03865550 27 29 B-Eq_Comparison
- NCT03865550 30 31 I-Eq_Comparison
85 NCT03865550 32 34 I-Eq_Comparison
years NCT03865550 35 40 I-Eq_Comparison
of NCT03865550 41 43 O
age NCT03865550 44 47 B-Age

- NCT03865550 50 51 O
ASA NCT03865550 53 56 B-Observation
I NCT03865550 57 58 B-Eq_Comparison
- NCT03865550 59 60 I-Eq_Comparison
IV NCT03865550 61 63 I-Eq_Comparison

- NCT03865550 66 67 O
Undergoing NCT03865550 69 79 B-Eq_Comparison
primary NCT03865550 80 87 B-Modifier
unilateral NCT03865550 88 98 I-Modifier
elective NCT03865550 99 107 I-Modifier
total NCT03865550 108 113 B-Procedure
knee NCT03865550 114 118 I-Procedure
arthroplasty NCT03865550 119 131 I-Procedure
with NCT03865550 132 136 O
spinal NCT03865550 137 143 B-Procedure
anesthesia NCT03865550 144 154 I-Procedure

Exclusion NCT03865550 155 164 O
Criteria NCT03865550 165 173 O
: NCT03865550 174 175 O

- NCT03865550 179 180 O
BMI NCT03865550 182 185 B-Observation
over NCT03865550 186 190 B-Eq_Comparison
40 NCT03865550 191 193 I-Eq_Comparison
* NCT03865550 194 195 O

- NCT03865550 199 200 O
Contraindication NCT03865550 202 218 B-Contraindication
or NCT03865550 219 221 B-Or
allergy NCT03865550 222 229 B-Allergy
to NCT03865550 230 232 O
opioid NCT03865550 233 239 B-Drug
pain NCT03865550 240 244 I-Drug
medication NCT03865550 245 255 I-Drug
or NCT03865550 256 258 B-Or
ketamine NCT03865550 259 267 B-Drug
* NCT03865550 268 269 O

- NCT03865550 273 274 O
Daily NCT03865550 276 281 B-Eq_Comparison
opioid NCT03865550 282 288 B-Drug
use NCT03865550 289 292 O
for NCT03865550 293 296 O
pain NCT03865550 297 301 B-Condition
control NCT03865550 302 309 O
before NCT03865550 310 316 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03865550 317 324 B-Procedure
in NCT03865550 325 327 B-Eq_Comparison
excess NCT03865550 328 334 I-Eq_Comparison
of NCT03865550 335 337 I-Eq_Comparison
systemic NCT03865550 338 346 I-Eq_Comparison
morphine NCT03865550 347 355 I-Eq_Comparison
equivalent NCT03865550 356 366 I-Eq_Comparison
to NCT03865550 367 369 I-Eq_Comparison
10 NCT03865550 370 372 I-Eq_Comparison
mg NCT03865550 373 375 I-Eq_Comparison
* NCT03865550 376 377 O

- NCT03865550 381 382 O
Ejection NCT03865550 384 392 B-Observation
fraction NCT03865550 393 401 I-Observation
( NCT03865550 402 403 O
EF NCT03865550 404 406 B-Observation
) NCT03865550 407 408 O
less NCT03865550 409 413 B-Eq_Comparison
than NCT03865550 414 418 I-Eq_Comparison
30 NCT03865550 419 421 I-Eq_Comparison
% NCT03865550 422 423 I-Eq_Comparison

- NCT03865550 427 428 O
Creatinine NCT03865550 430 440 B-Observation
clearance NCT03865550 441 450 I-Observation
less NCT03865550 451 455 B-Eq_Comparison
than NCT03865550 456 460 I-Eq_Comparison
30 NCT03865550 461 463 I-Eq_Comparison
mL NCT03865550 464 466 I-Eq_Comparison
/ NCT03865550 467 468 I-Eq_Comparison
min NCT03865550 469 472 I-Eq_Comparison
* NCT03865550 473 474 O

- NCT03865550 478 479 O
History NCT03865550 481 488 B-Eq_Comparison
of NCT03865550 489 491 O
chronic NCT03865550 492 499 O
liver NCT03865550 500 505 B-Condition
failure NCT03865550 506 513 I-Condition

- NCT03865550 516 517 O
Desire NCT03865550 519 525 B-Assertion___Assertion_Type_Value:intention
for NCT03865550 526 529 I-Assertion___Assertion_Type_Value:intention
nerve NCT03865550 530 535 B-Procedure
block NCT03865550 536 541 I-Procedure
or NCT03865550 542 544 B-Or
general NCT03865550 545 552 B-Procedure
anesthesia NCT03865550 553 563 I-Procedure

- NCT03865550 566 567 O
Any NCT03865550 569 572 O
neurologic NCT03865550 573 583 B-Modifier
or NCT03865550 584 586 B-Or
psychiatric NCT03865550 587 598 B-Modifier
disorder NCT03865550 599 607 B-Condition
( NCT03865550 608 609 O
including NCT03865550 610 619 O
bipolar NCT03865550 620 627 B-Condition
disorder NCT03865550 628 636 I-Condition
, NCT03865550 637 638 O
post NCT03865550 639 643 B-Condition
traumatic NCT03865550 644 653 I-Condition
stress NCT03865550 654 660 I-Condition
disorder NCT03865550 661 669 I-Condition
, NCT03865550 670 671 O
schizophrenia NCT03865550 672 685 B-Condition
) NCT03865550 686 687 O

- NCT03865550 691 692 O
Prior NCT03865550 694 699 B-Eq_Comparison
surgery NCT03865550 700 707 B-Procedure
on NCT03865550 708 710 O
ipsilateral NCT03865550 711 722 B-Modifier
knee NCT03865550 723 727 I-Modifier
within NCT03865550 728 734 B-Eq_Comparison
the NCT03865550 735 738 I-Eq_Comparison
last NCT03865550 739 743 I-Eq_Comparison
6 NCT03865550 744 745 I-Eq_Comparison
months NCT03865550 746 752 I-Eq_Comparison

- NCT03865550 755 756 O
Alcohol NCT03865550 758 765 B-Condition
abuse NCT03865550 766 771 I-Condition

Inclusion NCT03927118 0 9 O
Criteria NCT03927118 10 18 O

Patients NCT03927118 19 27 O
who NCT03927118 28 31 O
underwent NCT03927118 32 41 B-Eq_Comparison
first NCT03927118 42 47 I-Eq_Comparison
time NCT03927118 48 52 I-Eq_Comparison
intravitreal NCT03927118 53 65 B-Procedure
injection NCT03927118 66 75 I-Procedure

Exclusion NCT03927118 76 85 O
Criteria NCT03927118 86 94 O

Previously NCT03927118 95 105 B-Eq_Comparison
received NCT03927118 106 114 I-Eq_Comparison
any NCT03927118 115 118 O
surgery NCT03927118 119 126 B-Procedure

Proliferative NCT03927118 127 140 B-Condition
diabetic NCT03927118 141 149 I-Condition
retinopathy NCT03927118 150 161 I-Condition

Glaucoma NCT03927118 162 170 B-Condition
or NCT03927118 171 173 B-Or
glaucoma NCT03927118 174 182 B-Condition
suspicion NCT03927118 183 192 B-Assertion___Assertion_Type_Value:possible

Optic NCT03927118 193 198 B-Condition
disc NCT03927118 199 203 I-Condition
fatigue NCT03927118 204 211 I-Condition

Optic NCT03927118 212 217 B-Condition
disc NCT03927118 218 222 I-Condition
edema NCT03927118 223 228 I-Condition

Uveitis NCT03927118 229 236 B-Condition
and NCT03927118 237 240 B-Or
media NCT03927118 241 246 B-Condition
opacity NCT03927118 247 254 I-Condition

Blurred NCT03927118 255 262 B-Condition
of NCT03927118 263 265 I-Condition
image NCT03927118 266 271 I-Condition
clarity NCT03927118 272 279 I-Condition

Inclusion NCT03922256 0 9 O

- NCT03922256 12 13 O
Age NCT03922256 15 18 B-Age
> NCT03922256 19 20 B-Eq_Comparison
18 NCT03922256 21 23 I-Eq_Comparison
years NCT03922256 24 29 I-Eq_Comparison
; NCT03922256 29 30 O

- NCT03922256 33 34 O
Unilateral NCT03922256 36 46 B-Modifier
fracture NCT03922256 47 55 B-Condition
of NCT03922256 56 58 O
distal NCT03922256 59 65 B-Modifier
radius NCT03922256 66 72 I-Modifier
without NCT03922256 73 80 I-Modifier
misalignment NCT03922256 81 93 I-Modifier
( NCT03922256 94 95 O
dorsal NCT03922256 96 102 B-Observation
angulation NCT03922256 103 113 I-Observation
< NCT03922256 114 115 B-Eq_Comparison
10 NCT03922256 116 118 I-Eq_Comparison
° NCT03922256 119 120 I-Eq_Comparison
, NCT03922256 121 122 O
axial NCT03922256 123 128 B-Observation
radial NCT03922256 129 135 I-Observation
shortening NCT03922256 136 146 I-Observation
< NCT03922256 147 148 B-Eq_Comparison
5 NCT03922256 149 150 I-Eq_Comparison
mm NCT03922256 151 153 I-Eq_Comparison
) NCT03922256 154 155 O
, NCT03922256 156 157 O
< NCT03922256 158 159 B-Eq_Comparison
2 NCT03922256 160 161 I-Eq_Comparison
mm NCT03922256 162 164 I-Eq_Comparison
intraarticular NCT03922256 165 179 B-Observation
stepoff NCT03922256 180 187 I-Observation
; NCT03922256 187 188 O

- NCT03922256 191 192 O
Independent NCT03922256 194 205 B-Condition
in NCT03922256 206 208 O
activities NCT03922256 209 219 O
of NCT03922256 220 222 O
daily NCT03922256 223 228 O
living NCT03922256 229 235 O
; NCT03922256 235 236 O

- NCT03922256 239 240 O
Capable NCT03922256 242 249 O
and NCT03922256 250 253 O
willing NCT03922256 254 261 O
of NCT03922256 262 264 O
signing NCT03922256 265 272 O
informed NCT03922256 273 281 O
consent NCT03922256 282 289 O
. NCT03922256 290 291 O

Exclusion NCT03922256 293 302 O

- NCT03922256 305 306 O
Children NCT03922256 308 316 O
under NCT03922256 317 322 B-Eq_Comparison
the NCT03922256 323 326 I-Eq_Comparison
age NCT03922256 327 330 I-Eq_Comparison
of NCT03922256 331 333 I-Eq_Comparison
18 NCT03922256 334 336 I-Eq_Comparison
; NCT03922256 337 338 O

- NCT03922256 341 342 O
Fracture NCT03922256 344 352 B-Condition
of NCT03922256 353 355 O
the NCT03922256 356 359 O
contralateral NCT03922256 360 373 B-Modifier
arm NCT03922256 374 377 I-Modifier
; NCT03922256 377 378 O

- NCT03922256 381 382 O
Other NCT03922256 384 389 O
fractures NCT03922256 390 399 B-Condition
of NCT03922256 400 402 O
the NCT03922256 403 406 O
ipsilateral NCT03922256 407 418 B-Modifier
arm NCT03922256 419 422 I-Modifier
; NCT03922256 422 423 O

- NCT03922256 426 427 O
Open NCT03922256 429 433 B-Modifier
fractures NCT03922256 434 443 B-Condition
; NCT03922256 443 444 O

- NCT03922256 447 448 O
Fractures NCT03922256 450 459 B-Condition
that NCT03922256 460 464 O
require NCT03922256 465 472 B-Assertion___Assertion_Type_Value:hypothetical
reduction NCT03922256 473 482 B-Procedure
. NCT03922256 483 484 O

Inclusion NCT03864224 0 9 O
Criteria NCT03864224 10 18 O
: NCT03864224 19 20 O

- NCT03864224 24 25 O
Patients NCT03864224 27 35 O
must NCT03864224 36 40 O
have NCT03864224 41 45 O
persistent NCT03864224 46 56 B-Modifier
low NCT03864224 57 60 I-Modifier
back NCT03864224 61 65 I-Modifier
pain NCT03864224 66 70 B-Condition
of NCT03864224 71 73 O
at NCT03864224 74 76 B-Eq_Comparison
least NCT03864224 77 82 I-Eq_Comparison
1 NCT03864224 83 84 I-Eq_Comparison
month NCT03864224 85 90 I-Eq_Comparison
's NCT03864224 90 92 O
duration NCT03864224 93 101 O
. NCT03864224 102 103 O

Exclusion NCT03864224 105 114 O
Criteria NCT03864224 115 123 O
: NCT03864224 124 125 O

- NCT03864224 129 130 O
Participating NCT03864224 132 145 O
currently NCT03864224 146 155 B-Eq_Comparison
in NCT03864224 156 158 O
a NCT03864224 159 160 O
supervised NCT03864224 161 171 O
exercise NCT03864224 172 180 B-Modifier
or NCT03864224 181 183 B-Or
rehabilitation NCT03864224 184 198 B-Modifier
program NCT03864224 199 206 B-Procedure
or NCT03864224 207 209 B-Or
enrolled NCT03864224 210 218 O
in NCT03864224 219 221 O
another NCT03864224 222 229 B-Other
interventional NCT03864224 230 244 O
clinical NCT03864224 245 253 B-Study
trial NCT03864224 254 259 I-Study
. NCT03864224 260 261 O

- NCT03864224 265 266 O
Patients NCT03864224 268 276 O
with NCT03864224 277 281 O
nerve NCT03864224 282 287 B-Condition
root NCT03864224 288 292 I-Condition
involvement NCT03864224 293 304 I-Condition
, NCT03864224 305 306 O
suspected NCT03864224 307 316 B-Assertion___Assertion_Type_Value:possible
serious NCT03864224 317 324 O
pathology NCT03864224 325 334 B-Condition
, NCT03864224 335 336 O
unstable NCT03864224 337 345 O
trauma NCT03864224 346 352 B-Condition
to NCT03864224 353 355 O
the NCT03864224 356 359 O
spine NCT03864224 360 365 B-Modifier
, NCT03864224 366 367 O
aspects NCT03864224 368 375 O
of NCT03864224 376 378 O
pregnancy NCT03864224 379 388 B-Condition
or NCT03864224 389 391 B-Or
other NCT03864224 392 397 B-Other
conditions NCT03864224 398 408 B-Condition
that NCT03864224 409 413 O
would NCT03864224 414 419 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03864224 420 427 B-Negation
participation NCT03864224 428 441 O
or NCT03864224 442 444 O
disallow NCT03864224 445 453 O
trial NCT03864224 454 459 B-Study
completion NCT03864224 460 470 O
within NCT03864224 471 477 O
the NCT03864224 478 481 O
prescribed NCT03864224 482 492 O
time NCT03864224 493 497 O
period NCT03864224 498 504 O
. NCT03864224 505 506 O

- NCT03864224 510 511 O
Persons NCT03864224 513 520 O
with NCT03864224 521 525 O
conditions NCT03864224 526 536 B-Condition
that NCT03864224 537 541 O
require NCT03864224 542 549 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03864224 550 551 O
specialist NCT03864224 552 562 B-Provider
consult NCT03864224 563 570 I-Provider
are NCT03864224 571 574 O
suspected NCT03864224 575 584 B-Assertion___Assertion_Type_Value:possible
of NCT03864224 585 587 O
needing NCT03864224 588 595 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03864224 596 597 O
specialist NCT03864224 598 608 B-Provider
consult NCT03864224 609 616 I-Provider
, NCT03864224 617 618 O
or NCT03864224 619 621 B-Or
have NCT03864224 622 626 O
conditions NCT03864224 627 637 B-Condition
that NCT03864224 638 642 O
would NCT03864224 643 648 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03864224 649 651 O
aggravated NCT03864224 652 662 O
or NCT03864224 663 665 B-Or
worsened NCT03864224 666 674 O
if NCT03864224 675 677 O
treated NCT03864224 678 685 B-Procedure
by NCT03864224 686 688 O
the NCT03864224 689 692 O
interventions NCT03864224 693 706 B-Procedure
in NCT03864224 707 709 O
this NCT03864224 710 714 O
study NCT03864224 715 720 B-Study
. NCT03864224 721 722 O

Inclusion NCT03867708 0 9 O
Criteria NCT03867708 10 18 O
: NCT03867708 19 20 O

- NCT03867708 24 25 O
Patients NCT03867708 27 35 O
with NCT03867708 36 40 O
suitable NCT03867708 41 49 O
indication NCT03867708 50 60 B-Indication
for NCT03867708 61 64 O
ASD NCT03867708 65 68 B-Condition
closure NCT03867708 69 76 B-Procedure
according NCT03867708 77 86 O
to NCT03867708 87 89 O
recent NCT03867708 90 96 O
guidelines NCT03867708 97 107 O
: NCT03867708 108 109 O

1 NCT03867708 118 119 O
. NCT03867708 119 120 O
Impaired NCT03867708 122 130 B-Condition
functional NCT03867708 131 141 I-Condition
capacity NCT03867708 142 150 I-Condition
. NCT03867708 151 152 O

2 NCT03867708 161 162 O
. NCT03867708 162 163 O
Right NCT03867708 165 170 B-Modifier
atrial NCT03867708 171 177 I-Modifier
and NCT03867708 178 181 B-Or
/ NCT03867708 182 183 I-Or
or NCT03867708 184 186 I-Or
RV NCT03867708 187 189 B-Modifier
enlargement NCT03867708 190 201 B-Condition
. NCT03867708 202 203 O

3 NCT03867708 212 213 O
. NCT03867708 213 214 O
Left NCT03867708 216 220 B-Modifier
- NCT03867708 221 222 I-Modifier
to NCT03867708 223 225 I-Modifier
- NCT03867708 226 227 I-Modifier
right NCT03867708 228 233 I-Modifier
shunt NCT03867708 234 239 B-Condition
with NCT03867708 240 244 B-And
[ NCT03867708 245 246 O
Qp NCT03867708 247 249 B-Observation
: NCT03867708 250 251 I-Observation
Qs NCT03867708 252 254 I-Observation
] NCT03867708 255 256 O
≥ NCT03867708 257 258 B-Eq_Comparison
1.5 NCT03867708 259 262 I-Eq_Comparison
: NCT03867708 263 264 I-Eq_Comparison
1 NCT03867708 265 266 I-Eq_Comparison
. NCT03867708 266 267 O

4 NCT03867708 276 277 O
. NCT03867708 277 278 O
Paradoxical NCT03867708 280 291 B-Condition
embolism NCT03867708 292 300 I-Condition
. NCT03867708 301 302 O

- NCT03867708 306 307 O
Patients NCT03867708 309 317 O
with NCT03867708 318 322 O
isolated NCT03867708 323 331 B-Modifier
secundum NCT03867708 332 340 I-Modifier
ASD NCT03867708 341 344 B-Condition
with NCT03867708 345 349 B-And
sufficient NCT03867708 350 360 O
rims NCT03867708 361 365 B-Observation
suitable NCT03867708 366 374 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03867708 375 378 I-Assertion___Assertion_Type_Value:hypothetical
device NCT03867708 379 385 B-Procedure
closure NCT03867708 386 393 I-Procedure
. NCT03867708 394 395 O

Exclusion NCT03867708 397 406 O
Criteria NCT03867708 407 415 O
: NCT03867708 416 417 O

- NCT03867708 421 422 O
Small NCT03867708 424 429 B-Modifier
ASD NCT03867708 430 433 B-Condition
with NCT03867708 434 438 B-And
Qp NCT03867708 439 441 B-Observation
/ NCT03867708 442 443 I-Observation
Qs NCT03867708 444 446 I-Observation
< NCT03867708 447 448 B-Eq_Comparison
1.5 NCT03867708 449 452 I-Eq_Comparison
: NCT03867708 453 454 I-Eq_Comparison
1 NCT03867708 455 456 I-Eq_Comparison
or NCT03867708 457 459 B-Or
no NCT03867708 460 462 B-Negation
signs NCT03867708 463 468 B-Assertion___Assertion_Type_Value:possible
of NCT03867708 469 471 O
RV NCT03867708 472 474 B-Condition
volume NCT03867708 475 481 I-Condition
overload NCT03867708 482 490 I-Condition

- NCT03867708 493 494 O
A NCT03867708 496 497 O
single NCT03867708 498 504 B-Eq_Comparison
defect NCT03867708 505 511 B-Observation
too NCT03867708 512 515 B-Modifier
large NCT03867708 516 521 I-Modifier
for NCT03867708 522 525 O
closure NCT03867708 526 533 B-Procedure
( NCT03867708 534 535 O
> NCT03867708 536 537 B-Eq_Comparison
38 NCT03867708 538 540 I-Eq_Comparison
mm NCT03867708 541 543 I-Eq_Comparison
) NCT03867708 544 545 O

- NCT03867708 549 550 O
Multiple NCT03867708 552 560 B-Eq_Comparison
ASDs NCT03867708 561 565 B-Condition
unsuitable NCT03867708 566 576 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
for NCT03867708 577 580 O
percutaneous NCT03867708 581 593 B-Procedure
closure NCT03867708 594 601 I-Procedure
. NCT03867708 602 603 O

- NCT03867708 607 608 O
Anterior NCT03867708 610 618 B-Modifier
, NCT03867708 619 620 O
posterior NCT03867708 621 630 B-Modifier
, NCT03867708 631 632 O
superior NCT03867708 633 641 B-Modifier
, NCT03867708 642 643 O
or NCT03867708 644 646 B-Or
inferior NCT03867708 647 655 B-Modifier
rim NCT03867708 656 659 B-Observation
< NCT03867708 660 661 B-Eq_Comparison
5 NCT03867708 662 663 I-Eq_Comparison
mm NCT03867708 664 666 I-Eq_Comparison
. NCT03867708 667 668 O

- NCT03867708 672 673 O
Abnormal NCT03867708 675 683 O
pulmonary NCT03867708 684 693 B-Condition
venous NCT03867708 694 700 I-Condition
drainage NCT03867708 701 709 I-Condition
. NCT03867708 710 711 O

- NCT03867708 715 716 O
Associated NCT03867708 718 728 O
structural NCT03867708 729 739 B-Modifier
heart NCT03867708 740 745 B-Condition
disease NCT03867708 746 753 I-Condition
requiring NCT03867708 754 763 B-Assertion___Assertion_Type_Value:hypothetical
cardiac NCT03867708 764 771 B-Procedure
surgery NCT03867708 772 779 I-Procedure
. NCT03867708 780 781 O

- NCT03867708 785 786 O
ASD NCT03867708 788 791 B-Condition
with NCT03867708 792 796 B-And
severe NCT03867708 797 803 O
pulmonary NCT03867708 804 813 B-Condition
arterial NCT03867708 814 822 I-Condition
hypertension NCT03867708 823 835 I-Condition
and NCT03867708 836 839 B-And
bidirectional NCT03867708 840 853 B-Modifier
or NCT03867708 854 856 B-Or
right NCT03867708 857 862 B-Modifier
- NCT03867708 863 864 I-Modifier
to NCT03867708 865 867 I-Modifier
- NCT03867708 868 869 I-Modifier
left NCT03867708 870 874 I-Modifier
shunting NCT03867708 875 883 B-Condition
. NCT03867708 884 885 O

- NCT03867708 889 890 O
Intracardiac NCT03867708 892 904 B-Condition
thrombi NCT03867708 905 912 I-Condition
diagnosed NCT03867708 913 922 O
by NCT03867708 923 925 O
echocardiography NCT03867708 926 942 B-Procedure
. NCT03867708 943 944 O

Inclusion NCT03921580 0 9 O
Criteria NCT03921580 10 18 O
: NCT03921580 19 20 O

- NCT03921580 24 25 O
Men NCT03921580 27 30 O
and NCT03921580 31 34 B-Or
women NCT03921580 35 40 O
from NCT03921580 41 45 O
18 NCT03921580 46 48 B-Eq_Comparison
to NCT03921580 49 51 I-Eq_Comparison
65 NCT03921580 52 54 I-Eq_Comparison
years NCT03921580 55 60 I-Eq_Comparison
old NCT03921580 61 64 B-Age
. NCT03921580 65 66 O

- NCT03921580 70 71 O
Body NCT03921580 73 77 B-Observation
Mass NCT03921580 78 82 I-Observation
Index NCT03921580 83 88 I-Observation
( NCT03921580 89 90 O
BMI NCT03921580 91 94 B-Observation
) NCT03921580 95 96 O
≥ NCT03921580 97 98 B-Eq_Comparison
25 NCT03921580 99 101 I-Eq_Comparison
and NCT03921580 102 105 B-And
< NCT03921580 106 107 B-Eq_Comparison
30 NCT03921580 108 110 I-Eq_Comparison
kg NCT03921580 111 113 I-Eq_Comparison
/ NCT03921580 114 115 I-Eq_Comparison
m NCT03921580 116 117 I-Eq_Comparison
2 NCT03921580 118 119 I-Eq_Comparison
. NCT03921580 119 120 O

- NCT03921580 124 125 O
Adequate NCT03921580 127 135 O
cultural NCT03921580 136 144 O
level NCT03921580 145 150 O
and NCT03921580 151 154 O
understanding NCT03921580 155 168 O
for NCT03921580 169 172 O
the NCT03921580 173 176 O
clinical NCT03921580 177 185 O
trial NCT03921580 186 191 O
. NCT03921580 192 193 O

- NCT03921580 197 198 O
Signed NCT03921580 200 206 O
informed NCT03921580 207 215 O
consent NCT03921580 216 223 O

Exclusion NCT03921580 224 233 O
Criteria NCT03921580 234 242 O
: NCT03921580 243 244 O

- NCT03921580 248 249 O
Subjects NCT03921580 251 259 O
with NCT03921580 260 264 O
BMI NCT03921580 265 268 B-Observation
≥ NCT03921580 269 270 B-Eq_Comparison
30 NCT03921580 271 273 I-Eq_Comparison
or NCT03921580 274 276 B-Or
< NCT03921580 277 278 B-Eq_Comparison
25 NCT03921580 279 281 I-Eq_Comparison
kg NCT03921580 282 284 I-Eq_Comparison
/ NCT03921580 285 286 I-Eq_Comparison
m NCT03921580 287 288 I-Eq_Comparison
2 NCT03921580 289 290 I-Eq_Comparison

- NCT03921580 293 294 O
Subjects NCT03921580 296 304 O
diagnosed NCT03921580 305 314 O
with NCT03921580 315 319 O
Diabetes NCT03921580 320 328 B-Condition
Mellitus NCT03921580 329 337 I-Condition
. NCT03921580 338 339 O

- NCT03921580 343 344 O
Subjects NCT03921580 346 354 O
with NCT03921580 355 359 O
dyslipidemia NCT03921580 360 372 B-Condition
on NCT03921580 373 375 B-Eq_Comparison
pharmacological NCT03921580 376 391 B-Procedure
treatment NCT03921580 392 401 I-Procedure

- NCT03921580 404 405 O
Subjects NCT03921580 407 415 O
with NCT03921580 416 420 O
hypertension NCT03921580 421 433 B-Condition
on NCT03921580 434 436 B-Eq_Comparison
pharmacological NCT03921580 437 452 B-Procedure
treatment NCT03921580 453 462 I-Procedure

- NCT03921580 465 466 O
Subjects NCT03921580 468 476 O
with NCT03921580 477 481 O
established NCT03921580 482 493 O
diagnosis NCT03921580 494 503 O
of NCT03921580 504 506 O
eating NCT03921580 507 513 B-Condition
disorder NCT03921580 514 522 I-Condition

- NCT03921580 525 526 O
Smokers NCT03921580 528 535 O
or NCT03921580 536 538 O
those NCT03921580 539 544 O
subjects NCT03921580 545 553 O
with NCT03921580 554 558 O
high NCT03921580 559 563 O
alcohol NCT03921580 564 571 B-Observation
consumption NCT03921580 572 583 I-Observation
( NCT03921580 584 585 O
> NCT03921580 586 587 B-Eq_Comparison
2 NCT03921580 588 589 I-Eq_Comparison
- NCT03921580 590 591 I-Eq_Comparison
3 NCT03921580 592 593 I-Eq_Comparison
servings NCT03921580 594 602 I-Eq_Comparison
/ NCT03921580 603 604 I-Eq_Comparison
day NCT03921580 605 608 I-Eq_Comparison
in NCT03921580 609 611 O
men NCT03921580 612 615 O
and NCT03921580 616 619 B-Or
> NCT03921580 620 621 B-Eq_Comparison
1 NCT03921580 622 623 I-Eq_Comparison
serving NCT03921580 624 631 I-Eq_Comparison
/ NCT03921580 632 633 I-Eq_Comparison
day NCT03921580 634 637 I-Eq_Comparison
in NCT03921580 638 640 O
women NCT03921580 641 646 O
( NCT03921580 647 648 O
1 NCT03921580 649 650 O
serving NCT03921580 651 658 O
= NCT03921580 659 660 O
1 NCT03921580 661 662 O
glass NCT03921580 663 668 O
of NCT03921580 669 671 O
wine NCT03921580 672 676 O
or NCT03921580 677 679 O
1 NCT03921580 680 681 O
bottle NCT03921580 682 688 O
of NCT03921580 689 691 O
beer NCT03921580 692 696 O
) NCT03921580 697 698 O

- NCT03921580 702 703 O
Subjects NCT03921580 705 713 O
under NCT03921580 714 719 O
pharmacological NCT03921580 720 735 B-Procedure
treatment NCT03921580 736 745 I-Procedure
( NCT03921580 746 747 O
except NCT03921580 748 754 B-Exception
oral NCT03921580 755 759 B-Drug
contraceptives NCT03921580 760 774 I-Drug
) NCT03921580 775 776 O

- NCT03921580 780 781 O
Subjects NCT03921580 783 791 O
with NCT03921580 792 796 O
large NCT03921580 797 802 O
weight NCT03921580 803 809 B-Observation
fluctuations NCT03921580 810 822 O
of NCT03921580 823 825 O
more NCT03921580 826 830 B-Eq_Comparison
than NCT03921580 831 835 I-Eq_Comparison
4 NCT03921580 836 837 I-Eq_Comparison
kg NCT03921580 838 840 I-Eq_Comparison
or NCT03921580 841 843 B-Or
who NCT03921580 844 847 O
have NCT03921580 848 852 O
undergone NCT03921580 853 862 B-Eq_Comparison
in NCT03921580 863 865 O
six NCT03921580 866 869 B-Eq_Comparison
months NCT03921580 870 876 I-Eq_Comparison
a NCT03921580 877 878 O
weight NCT03921580 879 885 B-Procedure
loss NCT03921580 886 890 I-Procedure
diet NCT03921580 891 895 I-Procedure

- NCT03921580 898 899 O
Subjects NCT03921580 901 909 O
with NCT03921580 910 914 O
sensory NCT03921580 915 922 O
problems NCT03921580 923 931 O

- NCT03921580 934 935 O
Subjects NCT03921580 937 945 O
with NCT03921580 946 950 O
gastrointestinal NCT03921580 951 967 B-Condition
diseases NCT03921580 968 976 I-Condition
that NCT03921580 977 981 O
affect NCT03921580 982 988 O
the NCT03921580 989 992 O
digestion NCT03921580 993 1002 B-Condition
or NCT03921580 1003 1005 B-Or
absorption NCT03921580 1006 1016 B-Condition
of NCT03921580 1017 1019 I-Condition
nutrients NCT03921580 1020 1029 I-Condition

- NCT03921580 1032 1033 O
Pregnant NCT03921580 1035 1043 B-Condition
or NCT03921580 1044 1046 B-Or
breastfeeding NCT03921580 1047 1060 B-Condition
women NCT03921580 1061 1066 O

- NCT03921580 1069 1070 O
Women NCT03921580 1072 1077 O
with NCT03921580 1078 1082 B-And
menstrual NCT03921580 1083 1092 B-Condition
irregularities NCT03921580 1093 1107 I-Condition
( NCT03921580 1108 1109 O
absence NCT03921580 1110 1117 B-Condition
of NCT03921580 1118 1120 I-Condition
menstrual NCT03921580 1121 1130 I-Condition
cycle NCT03921580 1131 1136 I-Condition
at NCT03921580 1137 1139 B-Eq_Comparison
least NCT03921580 1140 1145 I-Eq_Comparison
2 NCT03921580 1146 1147 I-Eq_Comparison
months NCT03921580 1148 1154 I-Eq_Comparison
) NCT03921580 1155 1156 O

- NCT03921580 1160 1161 O
Subjects NCT03921580 1163 1171 O
with NCT03921580 1172 1176 O
intense NCT03921580 1177 1184 O
physical NCT03921580 1185 1193 B-Observation
activity NCT03921580 1194 1202 I-Observation
. NCT03921580 1203 1204 O

- NCT03921580 1208 1209 O
Subjects NCT03921580 1211 1219 O
with NCT03921580 1220 1224 O
food NCT03921580 1225 1229 O
allergies NCT03921580 1230 1239 B-Allergy
to NCT03921580 1240 1242 O
meals NCT03921580 1243 1248 O
included NCT03921580 1249 1257 O
in NCT03921580 1258 1260 O
breakfast NCT03921580 1261 1270 O
, NCT03921580 1271 1272 O
study NCT03921580 1273 1278 B-Study
product NCT03921580 1279 1286 B-Drug
or NCT03921580 1287 1289 O
lunch NCT03921580 1290 1295 O
or NCT03921580 1296 1298 O
that NCT03921580 1299 1303 O
reject NCT03921580 1304 1310 O
their NCT03921580 1311 1316 O
consumption NCT03921580 1317 1328 O

- NCT03921580 1331 1332 O
Subjects NCT03921580 1334 1342 O
with NCT03921580 1343 1347 O
a NCT03921580 1348 1349 O
diagnosis NCT03921580 1350 1359 O
of NCT03921580 1360 1362 O
celiac NCT03921580 1363 1369 B-Condition
disease NCT03921580 1370 1377 I-Condition
or NCT03921580 1378 1380 B-Or
a NCT03921580 1381 1382 O
gluten NCT03921580 1383 1389 B-Condition
intolerance NCT03921580 1390 1401 I-Condition

Inclusion NCT03925766 0 9 O
Criteria NCT03925766 10 18 O
: NCT03925766 19 20 O

- NCT03925766 24 25 O
Patient NCT03925766 27 34 O
with NCT03925766 35 39 O
altered NCT03925766 40 47 B-Modifier
Roux NCT03925766 48 52 B-Procedure
en NCT03925766 53 55 I-Procedure
Y NCT03925766 56 57 I-Procedure
Gastric NCT03925766 58 65 I-Procedure
Bypass NCT03925766 66 72 I-Procedure
anatomy NCT03925766 73 80 O

Exclusion NCT03925766 81 90 O
Criteria NCT03925766 91 99 O
: NCT03925766 100 101 O

- NCT03925766 105 106 O
Patients NCT03925766 108 116 O
without NCT03925766 117 124 B-Negation
Roux NCT03925766 125 129 B-Procedure
en NCT03925766 130 132 I-Procedure
Y NCT03925766 133 134 I-Procedure
Gastric NCT03925766 135 142 I-Procedure
Bypass NCT03925766 143 149 I-Procedure
anatomy NCT03925766 150 157 O

Inclusion NCT03923049 0 9 O
Criteria NCT03923049 10 18 O
: NCT03923049 19 20 O

1 NCT03923049 23 24 O
. NCT03923049 24 25 O
Subjects NCT03923049 26 34 O
older NCT03923049 35 40 B-Eq_Comparison
than NCT03923049 41 45 I-Eq_Comparison
18 NCT03923049 46 48 I-Eq_Comparison
years NCT03923049 49 54 I-Eq_Comparison
of NCT03923049 55 57 O
age NCT03923049 58 61 B-Age
with NCT03923049 62 66 B-And
high NCT03923049 67 71 O
suspicion NCT03923049 72 81 B-Assertion___Assertion_Type_Value:possible
of NCT03923049 82 84 O
cardiac NCT03923049 85 92 B-Condition
sarcoidosis NCT03923049 93 104 I-Condition
and NCT03923049 105 108 B-Or
/ NCT03923049 109 110 I-Or
or NCT03923049 111 113 I-Or

biopsy NCT03923049 114 120 B-Procedure
proven NCT03923049 121 127 O
extracardiac NCT03923049 128 140 B-Condition
sarcoidosis NCT03923049 141 152 I-Condition
and NCT03923049 153 156 B-Or
/ NCT03923049 157 158 I-Or
or NCT03923049 159 161 I-Or
positive NCT03923049 162 170 O
HRS NCT03923049 171 174 B-Condition
criteria NCT03923049 175 183 O
will NCT03923049 184 188 O
be NCT03923049 189 191 O
enrolled NCT03923049 192 200 O
. NCT03923049 201 202 O

Exclusion NCT03923049 204 213 O
Criteria NCT03923049 214 222 O
: NCT03923049 223 224 O

1 NCT03923049 228 229 O
. NCT03923049 229 230 O
Coronary NCT03923049 232 240 B-Condition
artery NCT03923049 241 247 I-Condition
disease NCT03923049 248 255 I-Condition

2 NCT03923049 258 259 O
. NCT03923049 259 260 O
Insulin NCT03923049 262 269 B-Modifier
dependent NCT03923049 270 279 I-Modifier
diabetes NCT03923049 280 288 B-Condition

3 NCT03923049 291 292 O
. NCT03923049 292 293 O
Claustrophobia NCT03923049 295 309 B-Condition

4 NCT03923049 312 313 O
. NCT03923049 313 314 O
Pregnancy NCT03923049 316 325 B-Condition
/ NCT03923049 326 327 B-Or
nursing NCT03923049 328 335 B-Condition

5 NCT03923049 338 339 O
. NCT03923049 339 340 O
Presence NCT03923049 342 350 O
of NCT03923049 351 353 O
pacemaker NCT03923049 354 363 B-Procedure
or NCT03923049 364 366 B-Or
automatic NCT03923049 367 376 B-Procedure
implantable NCT03923049 377 388 I-Procedure
cardioverter NCT03923049 389 401 I-Procedure
- NCT03923049 402 403 I-Procedure
defibrillator NCT03923049 404 417 I-Procedure

6 NCT03923049 420 421 O
. NCT03923049 421 422 O
Impaired NCT03923049 424 432 B-Condition
renal NCT03923049 433 438 I-Condition
function NCT03923049 439 447 I-Condition
( NCT03923049 448 449 O
estimated NCT03923049 450 459 B-Observation
glomerular NCT03923049 460 470 I-Observation
filtration NCT03923049 471 481 I-Observation
rate NCT03923049 482 486 I-Observation
< NCT03923049 487 488 B-Eq_Comparison
45 NCT03923049 489 491 I-Eq_Comparison
ml NCT03923049 492 494 I-Eq_Comparison
/ NCT03923049 495 496 I-Eq_Comparison
min NCT03923049 497 500 I-Eq_Comparison
/ NCT03923049 501 502 I-Eq_Comparison
1.73 NCT03923049 503 507 I-Eq_Comparison
m NCT03923049 508 509 I-Eq_Comparison
2 NCT03923049 510 511 I-Eq_Comparison
) NCT03923049 512 513 O
will NCT03923049 514 518 O
be NCT03923049 519 521 O
excluded NCT03923049 522 530 O
. NCT03923049 531 532 O

7 NCT03923049 536 537 O
. NCT03923049 537 538 O
Inability NCT03923049 540 549 B-Negation
to NCT03923049 550 552 O
undergo NCT03923049 553 560 B-Assertion___Assertion_Type_Value:hypothetical
PET NCT03923049 561 564 B-Procedure
/ NCT03923049 565 566 B-Or
MRI NCT03923049 567 570 B-Procedure
due NCT03923049 571 574 O
to NCT03923049 575 577 O
any NCT03923049 578 581 O
other NCT03923049 582 587 O
condition NCT03923049 588 597 B-Condition
. NCT03923049 598 599 O

Inclusion NCT03926962 0 9 O
Criteria NCT03926962 10 18 O
: NCT03926962 19 20 O

- NCT03926962 24 25 O
BMI NCT03926962 27 30 B-Observation
: NCT03926962 31 32 O
18 NCT03926962 33 35 B-Eq_Comparison
- NCT03926962 36 37 I-Eq_Comparison
30 NCT03926962 38 40 I-Eq_Comparison
kg NCT03926962 41 43 I-Eq_Comparison
/ NCT03926962 44 45 I-Eq_Comparison
m NCT03926962 46 47 I-Eq_Comparison
2 NCT03926962 48 49 I-Eq_Comparison
( NCT03926962 50 51 O
Body NCT03926962 52 56 B-Observation
Mass NCT03926962 57 61 I-Observation
Index NCT03926962 62 67 I-Observation
[ NCT03926962 68 69 O
BMI NCT03926962 70 73 B-Observation
] NCT03926962 74 75 O
[ NCT03926962 76 77 O
kg NCT03926962 78 80 O
/ NCT03926962 81 82 O
m NCT03926962 83 84 O
2 NCT03926962 85 86 O
] NCT03926962 87 88 O
= NCT03926962 89 90 O
Body NCT03926962 91 95 O
weight NCT03926962 96 102 O
[ NCT03926962 103 104 O
kg NCT03926962 105 107 O
] NCT03926962 108 109 O
Height NCT03926962 110 116 O
2 NCT03926962 117 118 O
[ NCT03926962 119 120 O
m NCT03926962 121 122 O
2 NCT03926962 123 124 O
] NCT03926962 125 126 O
) NCT03926962 127 128 O

- NCT03926962 132 133 O
Ability NCT03926962 135 142 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03926962 143 146 B-And
willingness NCT03926962 147 158 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926962 159 161 I-Assertion___Assertion_Type_Value:hypothetical
abstain NCT03926962 162 169 B-Negation
from NCT03926962 170 174 O
alcohol NCT03926962 175 182 B-Drug
, NCT03926962 183 184 O
methylxanthine NCT03926962 185 199 B-Drug
- NCT03926962 200 201 O
containing NCT03926962 202 212 O
beverages NCT03926962 213 222 O
or NCT03926962 223 225 O
food NCT03926962 226 230 O
( NCT03926962 231 232 O
coffee NCT03926962 233 239 O
, NCT03926962 240 241 O
tea NCT03926962 242 245 O
, NCT03926962 246 247 O
cola NCT03926962 248 252 O
, NCT03926962 253 254 O
chocolate NCT03926962 255 264 O
, NCT03926962 265 266 O
" NCT03926962 267 268 O
powerdrinks NCT03926962 268 279 O
" NCT03926962 279 280 O
) NCT03926962 281 282 O
, NCT03926962 283 284 O
grapefruit NCT03926962 285 295 O
( NCT03926962 296 297 O
juice NCT03926962 298 303 O
) NCT03926962 304 305 O
from NCT03926962 306 310 O
48 NCT03926962 311 313 B-Eq_Comparison
h NCT03926962 314 315 I-Eq_Comparison
prior NCT03926962 316 321 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926962 322 324 I-Temporal_Connection___Temporal_Connection_Type_Value:before
entry NCT03926962 325 330 B-Study
in NCT03926962 331 333 O
the NCT03926962 334 337 O
clinical NCT03926962 338 346 O
research NCT03926962 347 355 O
center NCT03926962 356 362 O
until NCT03926962 363 368 B-Temporal_Connection___Temporal_Connection_Type_Value:before
discharge NCT03926962 369 378 B-Encounter

- NCT03926962 381 382 O
Medical NCT03926962 384 391 O
history NCT03926962 392 399 B-Eq_Comparison
without NCT03926962 400 407 B-Negation
major NCT03926962 408 413 B-Modifier
pathology NCT03926962 414 423 B-Condition

Exclusion NCT03926962 424 433 O
Criteria NCT03926962 434 442 O
: NCT03926962 443 444 O

- NCT03926962 448 449 O
Evidence NCT03926962 451 459 O
of NCT03926962 460 462 O
clinically NCT03926962 463 473 O
relevant NCT03926962 474 482 B-Modifier
pathology NCT03926962 483 492 B-Condition

- NCT03926962 495 496 O
Mental NCT03926962 498 504 B-Condition
handicap NCT03926962 505 513 I-Condition

- NCT03926962 516 517 O
History NCT03926962 519 526 B-Eq_Comparison
of NCT03926962 527 529 O
relevant NCT03926962 530 538 O
drug NCT03926962 539 543 O
and NCT03926962 544 547 B-Or
/ NCT03926962 548 549 I-Or
or NCT03926962 550 552 I-Or
food NCT03926962 553 557 O
allergies NCT03926962 558 567 B-Allergy

- NCT03926962 570 571 O
Regular NCT03926962 573 580 O
/ NCT03926962 581 582 O
routine NCT03926962 583 590 B-Eq_Comparison
treatment NCT03926962 591 600 B-Procedure
with NCT03926962 601 605 O
non NCT03926962 606 609 B-Negation
- NCT03926962 610 611 O
topical NCT03926962 612 619 B-Drug
medications NCT03926962 620 631 I-Drug
within NCT03926962 632 638 B-Eq_Comparison
30 NCT03926962 639 641 I-Eq_Comparison
days NCT03926962 642 646 I-Eq_Comparison
prior NCT03926962 647 652 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926962 653 655 I-Temporal_Connection___Temporal_Connection_Type_Value:before
entry NCT03926962 656 661 B-Study
into NCT03926962 662 666 O
the NCT03926962 667 670 O
clinical NCT03926962 671 679 O
research NCT03926962 680 688 O
center NCT03926962 689 695 O

- NCT03926962 698 699 O
Smoking NCT03926962 701 708 B-Condition
within NCT03926962 709 715 B-Eq_Comparison
60 NCT03926962 716 718 I-Eq_Comparison
days NCT03926962 719 723 I-Eq_Comparison
prior NCT03926962 724 729 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926962 730 732 I-Temporal_Connection___Temporal_Connection_Type_Value:before
drug NCT03926962 733 737 B-Procedure
administration NCT03926962 738 752 I-Procedure
and NCT03926962 753 756 B-And
through NCT03926962 757 764 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926962 765 768 O
follow NCT03926962 769 775 B-Encounter
- NCT03926962 776 777 I-Encounter
up NCT03926962 778 780 I-Encounter
visit NCT03926962 781 786 I-Encounter

- NCT03926962 789 790 O
History NCT03926962 792 799 B-Eq_Comparison
of NCT03926962 800 802 O
alcohol NCT03926962 803 810 B-Condition
abuse NCT03926962 811 816 I-Condition
or NCT03926962 817 819 B-Or
drug NCT03926962 820 824 B-Condition
addiction NCT03926962 825 834 I-Condition
( NCT03926962 835 836 O
including NCT03926962 837 846 O
soft NCT03926962 847 851 B-Condition
drugs NCT03926962 852 857 I-Condition
like NCT03926962 858 862 O
cannabis NCT03926962 863 871 B-Condition
products NCT03926962 872 880 O
) NCT03926962 881 882 O

Inclusion NCT03860701 0 9 O
Criteria NCT03860701 10 18 O
: NCT03860701 19 20 O

- NCT03860701 24 25 O
Patients NCT03860701 27 35 O
with NCT03860701 36 40 O
NEC NCT03860701 41 44 B-Condition
( NCT03860701 45 46 O
stages NCT03860701 47 53 B-Eq_Comparison
I NCT03860701 54 55 I-Eq_Comparison
- NCT03860701 56 57 I-Eq_Comparison
III NCT03860701 58 61 I-Eq_Comparison
Bell NCT03860701 62 66 O
's NCT03860701 66 68 O
Classification NCT03860701 69 83 O
) NCT03860701 84 85 O

- NCT03860701 89 90 O
Weight NCT03860701 92 98 B-Observation
greater NCT03860701 99 106 B-Eq_Comparison
or NCT03860701 107 109 I-Eq_Comparison
equal NCT03860701 110 115 I-Eq_Comparison
to NCT03860701 116 118 I-Eq_Comparison
750 NCT03860701 119 122 I-Eq_Comparison
g NCT03860701 123 124 I-Eq_Comparison
. NCT03860701 125 126 I-Eq_Comparison

- NCT03860701 130 131 O
Gestational NCT03860701 133 144 B-Observation
age NCT03860701 145 148 I-Observation
< NCT03860701 149 150 B-Eq_Comparison
36 NCT03860701 151 153 I-Eq_Comparison
weeks NCT03860701 154 159 I-Eq_Comparison
. NCT03860701 160 161 O

- NCT03860701 165 166 O
Patients NCT03860701 168 176 O
whose NCT03860701 177 182 O
parents NCT03860701 183 190 O
consent NCT03860701 191 198 O
to NCT03860701 199 201 O
participate NCT03860701 202 213 O
in NCT03860701 214 216 O
the NCT03860701 217 220 O
study NCT03860701 221 226 O
. NCT03860701 227 228 O

Exclusion NCT03860701 230 239 O
Criteria NCT03860701 240 248 O
: NCT03860701 249 250 O

- NCT03860701 254 255 O
Patients NCT03860701 257 265 O
with NCT03860701 266 270 O
major NCT03860701 271 276 O
congenital NCT03860701 277 287 B-Condition
anomalies NCT03860701 288 297 I-Condition

- NCT03860701 300 301 O
No NCT03860701 303 305 B-Negation
antecedent NCT03860701 306 316 B-Condition
of NCT03860701 317 319 O
limb NCT03860701 320 324 B-Modifier
ischemia NCT03860701 325 333 B-Condition
/ NCT03860701 334 335 B-Or
limb NCT03860701 336 340 B-Modifier
thrombotic NCT03860701 341 351 B-Condition
events NCT03860701 352 358 I-Condition
. NCT03860701 359 360 O

- NCT03860701 364 365 O
No NCT03860701 367 369 B-Negation
antecedent NCT03860701 370 380 B-Condition
diagnosis NCT03860701 381 390 O
of NCT03860701 391 393 O
occlusive NCT03860701 394 403 B-Modifier
arterial NCT03860701 404 412 I-Modifier
or NCT03860701 413 415 B-Or
venous NCT03860701 416 422 B-Modifier
thrombosis NCT03860701 423 433 B-Condition

- NCT03860701 436 437 O
Hemodynamic NCT03860701 439 450 B-Condition
instability NCT03860701 451 462 O

Inclusion NCT03922152 0 9 O
Criteria NCT03922152 10 18 O
: NCT03922152 19 20 O

- NCT03922152 24 25 O
histologically NCT03922152 27 41 O
proven NCT03922152 42 48 O
advanced NCT03922152 49 57 O
esophageal NCT03922152 58 68 B-Modifier
cancer NCT03922152 69 75 B-Condition

- NCT03922152 78 79 O
excluded NCT03922152 81 89 B-Negation
from NCT03922152 90 94 O
curative NCT03922152 95 103 B-Procedure
therapy NCT03922152 104 111 I-Procedure
because NCT03922152 112 119 O
of NCT03922152 120 122 O
disease NCT03922152 123 130 O
stage NCT03922152 131 136 O
and NCT03922152 137 140 B-Or
/ NCT03922152 141 142 I-Or
or NCT03922152 143 145 I-Or
presence NCT03922152 146 154 O
of NCT03922152 155 157 O
multiple NCT03922152 158 166 B-Eq_Comparison
comorbidities NCT03922152 167 180 B-Condition
and NCT03922152 181 184 B-Or
/ NCT03922152 185 186 I-Or
or NCT03922152 187 189 I-Or
poor NCT03922152 190 194 B-Condition
performance NCT03922152 195 206 I-Condition
status NCT03922152 207 213 I-Condition

- NCT03922152 216 217 O
age NCT03922152 219 222 B-Age
> NCT03922152 223 224 B-Eq_Comparison
18 NCT03922152 225 227 I-Eq_Comparison
years NCT03922152 228 233 I-Eq_Comparison

- NCT03922152 236 237 O
Eastern NCT03922152 239 246 B-Observation
Cooperative NCT03922152 247 258 I-Observation
Oncology NCT03922152 259 267 I-Observation
Group NCT03922152 268 273 I-Observation
( NCT03922152 274 275 O
ECOG NCT03922152 276 280 B-Observation
) NCT03922152 281 282 O
< NCT03922152 283 284 B-Eq_Comparison
3 NCT03922152 285 286 I-Eq_Comparison

Exclusion NCT03922152 288 297 O
Criteria NCT03922152 298 306 O
: NCT03922152 307 308 O

- NCT03922152 312 313 O
prior NCT03922152 315 320 B-Eq_Comparison
radiotherapy NCT03922152 321 333 B-Procedure
to NCT03922152 334 336 O
the NCT03922152 337 340 O
same NCT03922152 341 345 B-Modifier
region NCT03922152 346 352 I-Modifier

Inclusion NCT03865706 0 9 O
Criteria NCT03865706 10 18 O
: NCT03865706 19 20 O

1 NCT03865706 24 25 O
. NCT03865706 25 26 O
Hospitalized NCT03865706 28 40 B-Encounter
in NCT03865706 41 43 O
an NCT03865706 44 46 O
eligible NCT03865706 47 55 B-Assertion___Assertion_Type_Value:hypothetical
medical NCT03865706 56 63 O
ICU NCT03865706 64 67 O

2 NCT03865706 70 71 O
. NCT03865706 71 72 O
Age NCT03865706 74 77 B-Age
≥ NCT03865706 78 79 B-Eq_Comparison
18 NCT03865706 80 82 I-Eq_Comparison
years NCT03865706 83 88 I-Eq_Comparison
old NCT03865706 89 92 O
at NCT03865706 93 95 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865706 96 99 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03865706 100 104 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03865706 105 107 O
hospitalization NCT03865706 108 123 B-Encounter

3 NCT03865706 126 127 O
. NCT03865706 127 128 O
With NCT03865706 130 134 O
sepsis NCT03865706 135 141 B-Condition
as NCT03865706 142 144 O
defined NCT03865706 145 152 O
by NCT03865706 153 155 O
the NCT03865706 156 159 O
Sepsis NCT03865706 160 166 O
- NCT03865706 167 168 O
3 NCT03865706 169 170 O
( NCT03865706 171 172 O
2016 NCT03865706 173 177 O
) NCT03865706 178 179 O
consensus NCT03865706 180 189 O
as NCT03865706 190 192 O
a NCT03865706 193 194 O
known NCT03865706 195 200 B-Modifier
or NCT03865706 201 203 B-Or
suspected NCT03865706 204 213 B-Assertion___Assertion_Type_Value:possible
infection NCT03865706 214 223 B-Condition
with NCT03865706 224 228 B-And
a NCT03865706 229 230 O
SOFA NCT03865706 231 235 B-Observation
score NCT03865706 236 241 I-Observation
of NCT03865706 242 244 O
≥ NCT03865706 245 246 B-Eq_Comparison
2 NCT03865706 247 248 I-Eq_Comparison
points NCT03865706 249 255 I-Eq_Comparison
above NCT03865706 256 261 I-Eq_Comparison
baseline NCT03865706 262 270 I-Eq_Comparison

4 NCT03865706 273 274 O
. NCT03865706 274 275 O
Received NCT03865706 277 285 B-Eq_Comparison
broad NCT03865706 286 291 B-Modifier
- NCT03865706 292 293 I-Modifier
spectrum NCT03865706 294 302 I-Modifier
antibiotics NCT03865706 303 314 B-Drug
within NCT03865706 315 321 B-Eq_Comparison
the NCT03865706 322 325 I-Eq_Comparison
last NCT03865706 326 330 I-Eq_Comparison
24 NCT03865706 331 333 I-Eq_Comparison
hours NCT03865706 334 339 I-Eq_Comparison
or NCT03865706 340 342 B-Or
ordered NCT03865706 343 350 O
and NCT03865706 351 354 O
pending NCT03865706 355 362 B-Assertion___Assertion_Type_Value:hypothetical
administration NCT03865706 363 377 I-Assertion___Assertion_Type_Value:hypothetical

5 NCT03865706 380 381 O
. NCT03865706 381 382 O
Able NCT03865706 384 388 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865706 389 391 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03865706 392 400 O
enrollment NCT03865706 401 411 B-Study
within NCT03865706 412 418 B-Eq_Comparison
4 NCT03865706 419 420 I-Eq_Comparison
hours NCT03865706 421 426 I-Eq_Comparison
of NCT03865706 427 429 B-Temporal_Connection___Temporal_Connection_Type_Value:after
ICU NCT03865706 430 433 O
admission NCT03865706 434 443 B-Encounter
for NCT03865706 444 447 O
administration NCT03865706 448 462 O
of NCT03865706 463 465 O
the NCT03865706 466 469 O
intervention NCT03865706 470 482 B-Study
within NCT03865706 483 489 B-Eq_Comparison
6 NCT03865706 490 491 I-Eq_Comparison
hours NCT03865706 492 497 I-Eq_Comparison
of NCT03865706 498 500 B-Temporal_Connection___Temporal_Connection_Type_Value:after
ICU NCT03865706 501 504 O
admission NCT03865706 505 514 B-Encounter

Exclusion NCT03865706 515 524 O
Criteria NCT03865706 525 533 O
: NCT03865706 534 535 O

1 NCT03865706 539 540 O
. NCT03865706 540 541 O
Inability NCT03865706 543 552 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865706 553 555 O
receive NCT03865706 556 563 O
oral NCT03865706 564 568 B-Modifier
or NCT03865706 569 571 B-Or
enteric NCT03865706 572 579 B-Modifier
fluids NCT03865706 580 586 B-Procedure

2 NCT03865706 589 590 O
. NCT03865706 590 591 O
Inulin NCT03865706 593 599 B-Drug
allergy NCT03865706 600 607 B-Allergy

3 NCT03865706 610 611 O
. NCT03865706 611 612 O
Hyponatremia NCT03865706 614 626 B-Condition
( NCT03865706 627 628 O
serum NCT03865706 629 634 B-Observation
sodium NCT03865706 635 641 I-Observation
≤ NCT03865706 642 643 B-Eq_Comparison
128 NCT03865706 644 647 I-Eq_Comparison
mEq NCT03865706 648 651 I-Eq_Comparison
/ NCT03865706 652 653 I-Eq_Comparison
L NCT03865706 654 655 I-Eq_Comparison
) NCT03865706 656 657 O

4 NCT03865706 661 662 O
. NCT03865706 662 663 O
Immunosuppression NCT03865706 665 682 B-Condition
, NCT03865706 683 684 O
defined NCT03865706 685 692 O
as NCT03865706 693 695 O
history NCT03865706 696 703 B-Eq_Comparison
of NCT03865706 704 706 O
solid NCT03865706 707 712 B-Procedure
organ NCT03865706 713 718 I-Procedure
transplant NCT03865706 719 729 I-Procedure
or NCT03865706 730 732 B-Or
as NCT03865706 733 735 O
receipt NCT03865706 736 743 B-Eq_Comparison
of NCT03865706 744 746 O
ablative NCT03865706 747 755 B-Procedure
chemotherapy NCT03865706 756 768 I-Procedure
, NCT03865706 769 770 O
steroids NCT03865706 771 779 B-Drug
at NCT03865706 780 782 O
the NCT03865706 783 786 O
equivalent NCT03865706 787 797 O
of NCT03865706 798 800 O
≥ NCT03865706 801 802 B-Eq_Comparison
5 NCT03865706 803 804 I-Eq_Comparison
mg NCT03865706 805 807 I-Eq_Comparison
/ NCT03865706 808 809 I-Eq_Comparison
day NCT03865706 810 813 I-Eq_Comparison
prednisone NCT03865706 814 824 B-Drug
, NCT03865706 825 826 O
antimetabolites NCT03865706 827 842 B-Drug
, NCT03865706 843 844 O
anti NCT03865706 845 849 B-Drug
- NCT03865706 850 851 I-Drug
TNFα NCT03865706 852 856 I-Drug
agents NCT03865706 857 863 I-Drug
, NCT03865706 864 865 O
calcineurin NCT03865706 866 877 B-Drug
inhibitors NCT03865706 878 888 I-Drug
, NCT03865706 889 890 O
or NCT03865706 891 893 B-Or
mycophenolate NCT03865706 894 907 B-Drug

5 NCT03865706 910 911 O
. NCT03865706 911 912 O
Surgery NCT03865706 914 921 B-Procedure
involving NCT03865706 922 931 O
the NCT03865706 932 935 O
intestinal NCT03865706 936 946 B-Modifier
lumen NCT03865706 947 952 I-Modifier
within NCT03865706 953 959 B-Eq_Comparison
30 NCT03865706 960 962 I-Eq_Comparison
days NCT03865706 963 967 I-Eq_Comparison
or NCT03865706 968 970 B-Or
known NCT03865706 971 976 O
intestinal NCT03865706 977 987 B-Condition
strictures NCT03865706 988 998 I-Condition

6 NCT03865706 1001 1002 O
. NCT03865706 1002 1003 O
Do NCT03865706 1005 1007 B-Observation
Not NCT03865706 1008 1011 I-Observation
Resuscitate NCT03865706 1012 1023 I-Observation
( NCT03865706 1024 1025 O
DNR NCT03865706 1026 1029 B-Observation
) NCT03865706 1030 1031 O
or NCT03865706 1032 1034 B-Or
Do NCT03865706 1035 1037 B-Observation
Not NCT03865706 1038 1041 I-Observation
Intubate NCT03865706 1042 1050 I-Observation
( NCT03865706 1051 1052 O
DNI NCT03865706 1053 1056 B-Observation
) NCT03865706 1057 1058 O
status NCT03865706 1059 1065 O
, NCT03865706 1066 1067 O
or NCT03865706 1068 1070 B-Or
" NCT03865706 1071 1072 O
no NCT03865706 1072 1074 B-Observation
escalation NCT03865706 1075 1085 I-Observation
of NCT03865706 1086 1088 I-Observation
care NCT03865706 1089 1093 I-Observation
" NCT03865706 1093 1094 O
orders NCT03865706 1095 1101 O

7 NCT03865706 1104 1105 O
. NCT03865706 1105 1106 O
Lack NCT03865706 1108 1112 O
capacity NCT03865706 1113 1121 O
for NCT03865706 1122 1125 O
consent NCT03865706 1126 1133 O
and NCT03865706 1134 1137 O
no NCT03865706 1138 1140 O
appropriate NCT03865706 1141 1152 O
Legally NCT03865706 1153 1160 O
Authorized NCT03865706 1161 1171 O
Representative NCT03865706 1172 1186 O
( NCT03865706 1187 1188 O
LAR NCT03865706 1189 1192 O
) NCT03865706 1193 1194 O


Inclusion NCT03924882 0 9 O
Criteria NCT03924882 10 18 O
: NCT03924882 19 20 O

1 NCT03924882 24 25 O
. NCT03924882 25 26 O
Female NCT03924882 28 34 O
, NCT03924882 35 36 O
age NCT03924882 37 40 B-Age
≥ NCT03924882 41 42 B-Eq_Comparison
18 NCT03924882 43 45 I-Eq_Comparison
years NCT03924882 46 51 I-Eq_Comparison
and NCT03924882 52 55 B-And
≤ NCT03924882 56 57 B-Eq_Comparison
70 NCT03924882 58 60 I-Eq_Comparison
years NCT03924882 61 66 I-Eq_Comparison
, NCT03924882 67 68 O
signed NCT03924882 69 75 O
informed NCT03924882 76 84 O
consent NCT03924882 85 92 O
. NCT03924882 93 94 O

2 NCT03924882 98 99 O
. NCT03924882 99 100 O
Histologically NCT03924882 102 116 B-Procedure
or NCT03924882 117 119 B-Or
pathologically NCT03924882 120 134 B-Procedure
confirmed NCT03924882 135 144 O
diagnosis NCT03924882 145 154 O
of NCT03924882 155 157 O
epithelial NCT03924882 158 168 B-Condition
carcinoma NCT03924882 169 178 I-Condition
of NCT03924882 179 181 O
the NCT03924882 182 185 O
ovary NCT03924882 186 191 B-Modifier
. NCT03924882 192 193 O

3 NCT03924882 197 198 O
. NCT03924882 198 199 O
Platinum NCT03924882 201 209 B-Modifier
resistant NCT03924882 210 219 I-Modifier
ovarian NCT03924882 220 227 I-Modifier
cancer NCT03924882 228 234 B-Condition
( NCT03924882 235 236 O
defined NCT03924882 237 244 O
as NCT03924882 245 247 O
relapsing NCT03924882 248 257 O
within NCT03924882 258 264 B-Eq_Comparison
6 NCT03924882 265 266 I-Eq_Comparison
months NCT03924882 267 273 I-Eq_Comparison
after NCT03924882 274 279 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03924882 280 283 O
last NCT03924882 284 288 B-Eq_Comparison
administration NCT03924882 289 303 O
of NCT03924882 304 306 O
platinum NCT03924882 307 315 B-Modifier
- NCT03924882 316 317 I-Modifier
based NCT03924882 318 323 I-Modifier
chemotherapy NCT03924882 324 336 B-Procedure
) NCT03924882 337 338 O
OR NCT03924882 339 341 B-Or
platinum NCT03924882 342 350 B-Modifier
refractory NCT03924882 351 361 I-Modifier
ovarian NCT03924882 362 369 I-Modifier
cancer NCT03924882 370 376 B-Condition
( NCT03924882 377 378 O
defined NCT03924882 379 386 O
as NCT03924882 387 389 O
progressing NCT03924882 390 401 O
while NCT03924882 402 407 B-Temporal_Connection___Temporal_Connection_Type_Value:during
on NCT03924882 408 410 I-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03924882 411 412 O
platinum NCT03924882 413 421 B-Modifier
- NCT03924882 422 423 I-Modifier
based NCT03924882 424 429 I-Modifier
chemotherapy NCT03924882 430 442 B-Procedure
) NCT03924882 443 444 O

4 NCT03924882 448 449 O
. NCT03924882 449 450 O
At NCT03924882 452 454 B-Eq_Comparison
least NCT03924882 455 460 I-Eq_Comparison
treated NCT03924882 461 468 I-Eq_Comparison
with NCT03924882 469 473 I-Eq_Comparison
one NCT03924882 474 477 I-Eq_Comparison
line NCT03924882 478 482 O
of NCT03924882 483 485 O
platinum NCT03924882 486 494 B-Modifier
- NCT03924882 495 496 I-Modifier
based NCT03924882 497 502 I-Modifier
chemotherapy NCT03924882 503 515 B-Procedure

5 NCT03924882 518 519 O
. NCT03924882 519 520 O
Eastern NCT03924882 522 529 B-Observation
Cooperative NCT03924882 530 541 I-Observation
Oncology NCT03924882 542 550 I-Observation
Group NCT03924882 551 556 I-Observation
( NCT03924882 557 558 O
ECOG NCT03924882 559 563 B-Observation
) NCT03924882 564 565 O
performance NCT03924882 566 577 O
status NCT03924882 578 584 O
0 NCT03924882 585 586 B-Eq_Comparison
- NCT03924882 587 588 I-Eq_Comparison
2 NCT03924882 589 590 I-Eq_Comparison

6 NCT03924882 594 595 O
. NCT03924882 595 596 O
Measurable NCT03924882 598 608 B-Observation
disease NCT03924882 609 616 I-Observation
according NCT03924882 617 626 O
to NCT03924882 627 629 O
Response NCT03924882 630 638 O
Evaluation NCT03924882 639 649 O
Criteria NCT03924882 650 658 O
in NCT03924882 659 661 O
Solid NCT03924882 662 667 O
Tumors NCT03924882 668 674 O
( NCT03924882 675 676 O
RECIST NCT03924882 677 683 O
) NCT03924882 684 685 O
1.1 NCT03924882 686 689 O
version NCT03924882 690 697 O
or NCT03924882 698 700 O
CA NCT03924882 701 703 B-Observation
125 NCT03924882 704 707 I-Observation

7 NCT03924882 715 716 O
. NCT03924882 716 717 O
Patients NCT03924882 719 727 O
must NCT03924882 728 732 O
have NCT03924882 733 737 O
a NCT03924882 738 739 O
life NCT03924882 740 744 B-Observation
expectancy NCT03924882 745 755 I-Observation
of NCT03924882 756 758 O
at NCT03924882 759 761 B-Eq_Comparison
least NCT03924882 762 767 I-Eq_Comparison
3 NCT03924882 768 769 I-Eq_Comparison
months NCT03924882 770 776 I-Eq_Comparison
. NCT03924882 777 778 O

8 NCT03924882 782 783 O
. NCT03924882 783 784 O
Patients NCT03924882 786 794 O
must NCT03924882 795 799 O
have NCT03924882 800 804 O
adequate NCT03924882 805 813 O
organ NCT03924882 814 819 B-Condition
function NCT03924882 820 828 I-Condition
. NCT03924882 829 830 O

Exclusion NCT03924882 832 841 O
Criteria NCT03924882 842 850 O
: NCT03924882 851 852 O

1 NCT03924882 856 857 O
. NCT03924882 857 858 O
Had NCT03924882 860 863 O
prior NCT03924882 864 869 B-Eq_Comparison
exposure NCT03924882 870 878 O
to NCT03924882 879 881 O
anlotinib NCT03924882 882 891 B-Drug
or NCT03924882 892 894 B-Or
has NCT03924882 895 898 O
known NCT03924882 899 904 O
allegies NCT03924882 905 913 B-Allergy
to NCT03924882 914 916 O
any NCT03924882 917 920 O
of NCT03924882 921 923 O
the NCT03924882 924 927 O
excipients NCT03924882 928 938 O
, NCT03924882 939 940 O
Inadequately NCT03924882 941 953 B-Modifier
controlled NCT03924882 954 964 I-Modifier
hypertension NCT03924882 965 977 B-Condition

2 NCT03924882 980 981 O
. NCT03924882 981 982 O
History NCT03924882 984 991 B-Eq_Comparison
of NCT03924882 992 994 O
myocardial NCT03924882 995 1005 B-Condition
infarction NCT03924882 1006 1016 I-Condition
, NCT03924882 1017 1018 O
or NCT03924882 1019 1021 B-Or
unstable NCT03924882 1022 1030 O
angina NCT03924882 1031 1037 B-Condition
, NCT03924882 1038 1039 O
or NCT03924882 1040 1042 B-Or
New NCT03924882 1043 1046 B-Observation
York NCT03924882 1047 1051 I-Observation
Heart NCT03924882 1052 1057 I-Observation
Association NCT03924882 1058 1069 I-Observation
( NCT03924882 1070 1071 O
NYHA NCT03924882 1072 1076 B-Observation
) NCT03924882 1077 1078 O
Grade NCT03924882 1079 1084 B-Eq_Comparison
III NCT03924882 1085 1088 I-Eq_Comparison
- NCT03924882 1089 1090 I-Eq_Comparison
IV NCT03924882 1091 1093 I-Eq_Comparison
within NCT03924882 1094 1100 B-Eq_Comparison
6 NCT03924882 1101 1102 I-Eq_Comparison
months NCT03924882 1103 1109 I-Eq_Comparison
prior NCT03924882 1110 1115 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924882 1116 1118 I-Temporal_Connection___Temporal_Connection_Type_Value:before
Day NCT03924882 1119 1122 B-Study
1 NCT03924882 1123 1124 O
. NCT03924882 1124 1125 O

3 NCT03924882 1129 1130 O
. NCT03924882 1130 1131 O
History NCT03924882 1133 1140 B-Eq_Comparison
of NCT03924882 1141 1143 O
abdominal NCT03924882 1144 1153 B-Condition
fistula NCT03924882 1154 1161 I-Condition
or NCT03924882 1162 1164 B-Or
gastrointestinal NCT03924882 1165 1181 B-Condition
perforation NCT03924882 1182 1193 I-Condition
within NCT03924882 1194 1200 B-Eq_Comparison
28 NCT03924882 1201 1203 I-Eq_Comparison
days NCT03924882 1204 1208 I-Eq_Comparison
prior NCT03924882 1209 1214 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924882 1215 1217 I-Temporal_Connection___Temporal_Connection_Type_Value:before
Day NCT03924882 1218 1221 B-Study
1 NCT03924882 1222 1223 O

4 NCT03924882 1227 1228 O
. NCT03924882 1228 1229 O
Major NCT03924882 1231 1236 O
surgical NCT03924882 1237 1245 B-Procedure
procedure NCT03924882 1246 1255 I-Procedure
within NCT03924882 1256 1262 B-Eq_Comparison
28 NCT03924882 1263 1265 I-Eq_Comparison
days NCT03924882 1266 1270 I-Eq_Comparison
prior NCT03924882 1271 1276 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924882 1277 1279 I-Temporal_Connection___Temporal_Connection_Type_Value:before
Day NCT03924882 1280 1283 B-Study
1 NCT03924882 1284 1285 O
, NCT03924882 1286 1287 O
Serious NCT03924882 1288 1295 O
, NCT03924882 1296 1297 O
non NCT03924882 1298 1301 B-Negation
- NCT03924882 1302 1303 O
healing NCT03924882 1304 1311 B-Modifier
wound NCT03924882 1312 1317 B-Condition
, NCT03924882 1318 1319 O
active NCT03924882 1320 1326 B-Eq_Comparison
ulcer NCT03924882 1327 1332 B-Condition
, NCT03924882 1333 1334 O
bowel NCT03924882 1335 1340 B-Condition
obstruction NCT03924882 1341 1352 I-Condition
within NCT03924882 1353 1359 B-Eq_Comparison
28 NCT03924882 1360 1362 I-Eq_Comparison
days NCT03924882 1363 1367 I-Eq_Comparison
prior NCT03924882 1368 1373 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924882 1374 1376 I-Temporal_Connection___Temporal_Connection_Type_Value:before
Day NCT03924882 1377 1380 B-Study
1 NCT03924882 1381 1382 O

5 NCT03924882 1386 1387 O
. NCT03924882 1387 1388 O
Symptomatic NCT03924882 1390 1401 B-Assertion___Assertion_Type_Value:possible
central NCT03924882 1402 1409 B-Modifier
nervous NCT03924882 1410 1417 I-Modifier
system NCT03924882 1418 1424 I-Modifier
( NCT03924882 1425 1426 O
CNS NCT03924882 1427 1430 B-Modifier
) NCT03924882 1431 1432 O
metastasis NCT03924882 1433 1443 B-Condition


Inclusion NCT03864913 0 9 O
Criteria NCT03864913 10 18 O
: NCT03864913 19 20 O

- NCT03864913 24 25 O
Testosterone NCT03864913 27 39 B-Condition
naive NCT03864913 40 45 I-Condition

- NCT03864913 48 49 O
Transgender NCT03864913 51 62 O
male NCT03864913 63 67 O

- NCT03864913 70 71 O
14 NCT03864913 73 75 B-Eq_Comparison
- NCT03864913 76 77 I-Eq_Comparison
19 NCT03864913 78 80 I-Eq_Comparison
years NCT03864913 81 86 I-Eq_Comparison
old NCT03864913 87 90 B-Age

Exclusion NCT03864913 91 100 O
Criteria NCT03864913 101 109 O
: NCT03864913 110 111 O

- NCT03864913 115 116 O
Transgender NCT03864913 118 129 O
males NCT03864913 130 135 O
who NCT03864913 136 139 B-And
have NCT03864913 140 144 O
received NCT03864913 145 153 B-Eq_Comparison
testosterone NCT03864913 154 166 B-Procedure
therapy NCT03864913 167 174 I-Procedure
in NCT03864913 175 177 O
the NCT03864913 178 181 O
past NCT03864913 182 186 B-Eq_Comparison

Inclusion NCT03923023 0 9 O
Criteria NCT03923023 10 18 O
: NCT03923023 19 20 O

- NCT03923023 24 25 O
Pregnant NCT03923023 27 35 B-Condition
women NCT03923023 36 41 O
who NCT03923023 42 45 B-And
seek NCT03923023 46 50 B-Assertion___Assertion_Type_Value:intention
Antenatal NCT03923023 51 60 B-Provider
care NCT03923023 61 65 I-Provider
services NCT03923023 66 74 I-Provider
and NCT03923023 75 78 B-And
plan NCT03923023 79 83 B-Assertion___Assertion_Type_Value:intention
to NCT03923023 84 86 I-Assertion___Assertion_Type_Value:intention
deliver NCT03923023 87 94 B-Procedure
in NCT03923023 95 97 O
the NCT03923023 98 101 O
selected NCT03923023 102 110 O
health NCT03923023 111 117 O
facilities NCT03923023 118 128 O

- NCT03923023 131 132 O
Women NCT03923023 134 139 O
who NCT03923023 140 143 O
reside NCT03923023 144 150 O
within NCT03923023 151 157 O
the NCT03923023 158 161 O
larger NCT03923023 162 168 O
catchment NCT03923023 169 178 O
area NCT03923023 179 183 O
of NCT03923023 184 186 O
the NCT03923023 187 190 O
selected NCT03923023 191 199 O
3 NCT03923023 200 201 B-Eq_Comparison
health NCT03923023 202 208 O
facilities NCT03923023 209 219 O

Exclusion NCT03923023 220 229 O
Criteria NCT03923023 230 238 O
: NCT03923023 239 240 O

- NCT03923023 244 245 O
Women NCT03923023 247 252 O
who NCT03923023 253 256 O
reside NCT03923023 257 263 O
outside NCT03923023 264 271 B-Other
the NCT03923023 272 275 O
larger NCT03923023 276 282 O
catchment NCT03923023 283 292 O
area NCT03923023 293 297 O
of NCT03923023 298 300 O
the NCT03923023 301 304 O
health NCT03923023 305 311 O
facilities NCT03923023 312 322 O

- NCT03923023 325 326 O
Women NCT03923023 328 333 O
who NCT03923023 334 337 B-And
have NCT03923023 338 342 O
not NCT03923023 343 346 B-Negation
sought NCT03923023 347 353 B-Assertion___Assertion_Type_Value:intention
antenatal NCT03923023 354 363 B-Provider
care NCT03923023 364 368 I-Provider
services NCT03923023 369 377 I-Provider
in NCT03923023 378 380 O
the NCT03923023 381 384 O
3 NCT03923023 385 386 B-Eq_Comparison
health NCT03923023 387 393 O
facilities NCT03923023 394 404 O
and NCT03923023 405 408 O
have NCT03923023 409 413 O
come NCT03923023 414 418 O
to NCT03923023 419 421 O
only NCT03923023 422 426 O
deliver NCT03923023 427 434 O
there NCT03923023 435 440 O

Inclusion NCT03860454 0 9 O
Criteria NCT03860454 10 18 O
: NCT03860454 19 20 O

- NCT03860454 24 25 O
LMNA NCT03860454 27 31 B-Condition
+ NCT03860454 32 33 O
cases NCT03860454 34 39 O
with NCT03860454 40 44 B-And
pathogenic NCT03860454 45 55 B-Condition
LMNA NCT03860454 56 60 I-Condition
mutations NCT03860454 61 70 I-Condition
for NCT03860454 71 74 O
LMNA NCT03860454 75 79 B-Condition
+ NCT03860454 80 81 O
and NCT03860454 82 85 B-Or
heart NCT03860454 86 91 B-Observation
myocardial NCT03860454 92 102 I-Observation
samples NCT03860454 103 110 I-Observation
from NCT03860454 111 115 O
the NCT03860454 116 119 O
explanted NCT03860454 120 129 B-Modifier
hearts NCT03860454 130 136 I-Modifier
of NCT03860454 137 139 O
LMNA NCT03860454 140 144 B-Condition
+ NCT03860454 145 146 O
patients NCT03860454 147 155 O
who NCT03860454 156 159 B-And
are NCT03860454 160 163 O
scheduled NCT03860454 164 173 B-Eq_Comparison
to NCT03860454 174 176 I-Eq_Comparison
undergo NCT03860454 177 184 I-Eq_Comparison
clinically NCT03860454 185 195 O
indicated NCT03860454 196 205 B-Indication
heart NCT03860454 206 211 B-Procedure
transplantation NCT03860454 212 227 I-Procedure
at NCT03860454 228 230 O
the NCT03860454 231 234 O
Papworth NCT03860454 235 243 O
Hospital NCT03860454 244 252 O
NHS NCT03860454 253 256 O
Trust NCT03860454 257 262 O
. NCT03860454 263 264 O

- NCT03860454 268 269 O
DCMWT NCT03860454 271 276 B-Condition
cases NCT03860454 277 282 O
: NCT03860454 283 284 O
patients NCT03860454 285 293 O
with NCT03860454 294 298 O
heart NCT03860454 299 304 B-Condition
muscle NCT03860454 305 311 I-Condition
failure NCT03860454 312 319 I-Condition
but NCT03860454 320 323 B-And
with NCT03860454 324 328 O
wild NCT03860454 329 333 B-Modifier
- NCT03860454 334 335 I-Modifier
type NCT03860454 336 340 I-Modifier
lamin NCT03860454 341 346 B-Condition
gene NCT03860454 347 351 I-Condition
. NCT03860454 352 353 O
Heart NCT03860454 355 360 B-Observation
myocardial NCT03860454 361 371 I-Observation
samples NCT03860454 372 379 I-Observation
from NCT03860454 380 384 O
the NCT03860454 385 388 O
explanted NCT03860454 389 398 B-Modifier
hearts NCT03860454 399 405 I-Modifier
of NCT03860454 406 408 O
DCMWT NCT03860454 409 414 B-Condition
patients NCT03860454 415 423 O
who NCT03860454 424 427 B-And
are NCT03860454 428 431 O
scheduled NCT03860454 432 441 B-Eq_Comparison
to NCT03860454 442 444 O
undergo NCT03860454 445 452 O
clinically NCT03860454 453 463 O
indicated NCT03860454 464 473 B-Indication
heart NCT03860454 474 479 B-Procedure
transplantation NCT03860454 480 495 I-Procedure
at NCT03860454 496 498 O
the NCT03860454 499 502 O
Papworth NCT03860454 503 511 O
Hospital NCT03860454 512 520 O
NHS NCT03860454 521 524 O
Trust NCT03860454 525 530 O
. NCT03860454 531 532 O

- NCT03860454 536 537 O
HV NCT03860454 539 541 O
( NCT03860454 542 543 O
controls NCT03860454 544 552 O
) NCT03860454 553 554 O
: NCT03860454 555 556 O
matched NCT03860454 557 564 O
to NCT03860454 565 567 O
cases NCT03860454 568 573 O
. NCT03860454 574 575 O

Exclusion NCT03860454 577 586 O
Criteria NCT03860454 587 595 O
: NCT03860454 596 597 O

- NCT03860454 601 602 O
Needle NCT03860454 604 610 B-Condition
- NCT03860454 611 612 I-Condition
phobia NCT03860454 613 619 I-Condition
that NCT03860454 620 624 O
would NCT03860454 625 630 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03860454 631 639 B-Negation
blood NCT03860454 640 645 B-Procedure
- NCT03860454 646 647 I-Procedure
letting NCT03860454 648 655 I-Procedure

- NCT03860454 658 659 O
Participants NCT03860454 661 673 O
unwilling NCT03860454 674 683 O
to NCT03860454 684 686 O
consent NCT03860454 687 694 O

- NCT03860454 697 698 O
Patients NCT03860454 700 708 O
that NCT03860454 709 713 O
have NCT03860454 714 718 O
a NCT03860454 719 720 O
conventional NCT03860454 721 733 O
contraindication NCT03860454 734 750 B-Contraindication
for NCT03860454 751 754 O
cardiac NCT03860454 755 762 B-Procedure
magnetic NCT03860454 763 771 I-Procedure
resonance NCT03860454 772 781 I-Procedure
imaging NCT03860454 782 789 I-Procedure
( NCT03860454 790 791 O
MRI NCT03860454 792 795 B-Procedure
) NCT03860454 796 797 O
. NCT03860454 798 799 O

- NCT03860454 803 804 O
Patients NCT03860454 806 814 O
that NCT03860454 815 819 O
have NCT03860454 820 824 O
had NCT03860454 825 828 O
a NCT03860454 829 830 O
blood NCT03860454 831 836 B-Procedure
transfusion NCT03860454 837 848 I-Procedure
within NCT03860454 849 855 B-Eq_Comparison
the NCT03860454 856 859 I-Eq_Comparison
last NCT03860454 860 864 I-Eq_Comparison
month NCT03860454 865 870 I-Eq_Comparison
and NCT03860454 871 874 B-Or
patients NCT03860454 875 883 O
having NCT03860454 884 890 B-Eq_Comparison
haemodialysis NCT03860454 891 904 B-Procedure
will NCT03860454 905 909 O
be NCT03860454 910 912 O
excluded NCT03860454 913 921 B-Negation
. NCT03860454 922 923 O

Inclusion NCT03865693 0 9 O
Criteria NCT03865693 10 18 O
: NCT03865693 19 20 O

- NCT03865693 24 25 O
Burn NCT03865693 27 31 B-Condition
patients NCT03865693 32 40 O

- NCT03865693 43 44 O
severe NCT03865693 46 52 O
neuropatic NCT03865693 53 63 B-Modifier
pain NCT03865693 64 68 B-Condition
rated NCT03865693 69 74 O
at NCT03865693 75 77 B-Eq_Comparison
least NCT03865693 78 83 I-Eq_Comparison
5 NCT03865693 84 85 I-Eq_Comparison
on NCT03865693 86 88 O
the NCT03865693 89 92 O
10 NCT03865693 93 95 B-Observation
- NCT03865693 96 97 I-Observation
point NCT03865693 98 103 I-Observation
numerical NCT03865693 104 113 I-Observation
rating NCT03865693 114 120 I-Observation
scale NCT03865693 121 126 I-Observation
( NCT03865693 127 128 O
NRS NCT03865693 129 132 B-Observation
) NCT03865693 133 134 O

Exclusion NCT03865693 136 145 O
Criteria NCT03865693 146 154 O
: NCT03865693 155 156 O

- NCT03865693 160 161 O
cardiac NCT03865693 163 170 B-Condition
arrest NCT03865693 171 177 I-Condition
history NCT03865693 178 185 B-Eq_Comparison

- NCT03865693 188 189 O
history NCT03865693 191 198 B-Eq_Comparison
of NCT03865693 199 201 O
neurologi NCT03865693 202 211 B-Condition
disease NCT03865693 212 219 I-Condition
or NCT03865693 220 222 B-Or
brain NCT03865693 223 228 B-Procedure
surgery NCT03865693 229 236 I-Procedure

- NCT03865693 239 240 O
unstable NCT03865693 242 250 O
heart NCT03865693 251 256 B-Condition
disease NCT03865693 257 264 I-Condition
or NCT03865693 265 267 B-Or
presence NCT03865693 268 276 O
of NCT03865693 277 279 O
a NCT03865693 280 281 O
cardiac NCT03865693 282 289 B-Procedure
pacemaker NCT03865693 290 299 I-Procedure

- NCT03865693 302 303 O
pain NCT03865693 305 309 B-Condition
resulting NCT03865693 310 319 O
from NCT03865693 320 324 O
other NCT03865693 325 330 B-Other
causes NCT03865693 331 337 B-Condition
like NCT03865693 338 342 O
as NCT03865693 343 345 O
neuromuscular NCT03865693 346 359 B-Condition
diseases NCT03865693 360 368 I-Condition

- NCT03865693 371 372 O
psychiatric NCT03865693 374 385 B-Condition
disorder NCT03865693 386 394 I-Condition

- NCT03865693 397 398 O
diabetes NCT03865693 400 408 B-Condition
mellitus NCT03865693 409 417 I-Condition

- NCT03865693 420 421 O
abnormal NCT03865693 423 431 O
renal NCT03865693 432 437 B-Condition
function NCT03865693 438 446 I-Condition

- NCT03865693 449 450 O
contraindication NCT03865693 452 468 B-Contraindication
for NCT03865693 469 472 O
MRI NCT03865693 473 476 B-Procedure
, NCT03865693 477 478 O
or NCT03865693 479 481 B-Or
pregnancy NCT03865693 482 491 B-Condition
. NCT03865693 492 493 O

Inclusion NCT03861741 0 9 O
Criteria NCT03861741 10 18 O
: NCT03861741 19 20 O

1 NCT03861741 24 25 O
. NCT03861741 25 26 O
NS NCT03861741 28 30 B-Condition
- NCT03861741 31 32 I-Condition
TAD NCT03861741 33 36 I-Condition
probands NCT03861741 37 45 O
operated NCT03861741 46 54 B-Procedure
on NCT03861741 55 57 O
( NCT03861741 58 59 O
n NCT03861741 60 61 O
= NCT03861741 62 63 O
16 NCT03861741 64 66 O
) NCT03861741 67 68 O
. NCT03861741 69 70 O

2 NCT03861741 74 75 O
. NCT03861741 75 76 O
FDR NCT03861741 78 81 B-Condition
and NCT03861741 82 85 B-Or
SDR NCT03861741 86 89 B-Condition
, NCT03861741 90 91 O
aged NCT03861741 92 96 B-Age
16 NCT03861741 97 99 B-Eq_Comparison
and NCT03861741 100 103 I-Eq_Comparison
above NCT03861741 104 109 I-Eq_Comparison
: NCT03861741 110 111 O

1 NCT03861741 120 121 O
. NCT03861741 121 122 O
At NCT03861741 124 126 B-Eq_Comparison
least NCT03861741 127 132 I-Eq_Comparison
two NCT03861741 133 136 I-Eq_Comparison
relatives NCT03861741 137 146 B-Family_Member
willing NCT03861741 147 154 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861741 155 157 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03861741 158 169 O
in NCT03861741 170 172 O
the NCT03861741 173 176 O
screening NCT03861741 177 186 B-Study
programme NCT03861741 187 196 O
. NCT03861741 197 198 O

2 NCT03861741 207 208 O
. NCT03861741 208 209 O
Relatives NCT03861741 211 220 O
able NCT03861741 221 225 O
to NCT03861741 226 228 O
understand NCT03861741 229 239 O
English NCT03861741 240 247 O
. NCT03861741 248 249 O

Exclusion NCT03861741 251 260 O
Criteria NCT03861741 261 269 O
: NCT03861741 270 271 O

1 NCT03861741 275 276 O
. NCT03861741 276 277 O
Probands NCT03861741 279 287 O
with NCT03861741 288 292 O
syndromic NCT03861741 293 302 B-Condition
aortopathies NCT03861741 303 315 I-Condition
, NCT03861741 316 317 O
including NCT03861741 318 327 O
Marfan NCT03861741 328 334 B-Condition
Syndrome NCT03861741 335 343 I-Condition
, NCT03861741 344 345 O
Loeys NCT03861741 346 351 B-Condition
- NCT03861741 352 353 I-Condition
Dietz NCT03861741 354 359 I-Condition
Syndrome NCT03861741 360 368 I-Condition
, NCT03861741 369 370 O
Ehlers NCT03861741 371 377 B-Condition
- NCT03861741 378 379 I-Condition
Danlos NCT03861741 380 386 I-Condition
Syndrome NCT03861741 387 395 I-Condition
, NCT03861741 396 397 O
Shprintzen NCT03861741 398 408 B-Condition
- NCT03861741 409 410 I-Condition
Goldberg NCT03861741 411 419 I-Condition
syndrome NCT03861741 420 428 I-Condition
, NCT03861741 429 430 O
aneurysm NCT03861741 431 439 B-Condition
- NCT03861741 440 441 I-Condition
osteoarthritis NCT03861741 442 456 I-Condition
syndrome NCT03861741 457 465 I-Condition
, NCT03861741 466 467 O
arterial NCT03861741 468 476 B-Condition
tortuosity NCT03861741 477 487 I-Condition
syndrome NCT03861741 488 496 I-Condition
, NCT03861741 497 498 O
and NCT03861741 499 502 B-Or
cutis NCT03861741 503 508 B-Condition
laxa NCT03861741 509 513 I-Condition
syndrome NCT03861741 514 522 I-Condition
. NCT03861741 523 524 O

2 NCT03861741 528 529 O
. NCT03861741 529 530 O
Probands NCT03861741 532 540 O
with NCT03861741 541 545 O
aortic NCT03861741 546 552 B-Condition
lesions NCT03861741 553 560 I-Condition
associated NCT03861741 561 571 O
with NCT03861741 572 576 O
trauma NCT03861741 577 583 B-Condition
and NCT03861741 584 587 B-Or
infections NCT03861741 588 598 B-Condition
. NCT03861741 599 600 O

3 NCT03861741 604 605 O
. NCT03861741 605 606 O
Probands NCT03861741 608 616 O
/ NCT03861741 617 618 O
relatives NCT03861741 619 628 O
unable NCT03861741 629 635 O
to NCT03861741 636 638 O
give NCT03861741 639 643 O
informed NCT03861741 644 652 O
consent NCT03861741 653 660 O

Inclusion NCT03922451 0 9 O
Criteria NCT03922451 10 18 O
: NCT03922451 19 20 O

- NCT03922451 24 25 O
supported NCT03922451 27 36 B-Eq_Comparison
on NCT03922451 37 39 O
ECMO NCT03922451 40 44 B-Procedure

- NCT03922451 47 48 O
receive NCT03922451 50 57 B-Eq_Comparison
piperacillin NCT03922451 58 70 B-Drug
- NCT03922451 71 72 I-Drug
tazobactam NCT03922451 73 83 I-Drug
or NCT03922451 84 86 B-Or
cefazolin NCT03922451 87 96 B-Drug
as NCT03922451 97 99 O
part NCT03922451 100 104 O
of NCT03922451 105 107 O
routine NCT03922451 108 115 B-Procedure
care NCT03922451 116 120 I-Procedure
or NCT03922451 121 123 B-Or
infection NCT03922451 124 133 B-Procedure
management NCT03922451 134 144 I-Procedure

Exclusion NCT03922451 145 154 O
Criteria NCT03922451 155 163 O
: NCT03922451 164 165 O

- NCT03922451 169 170 O
> NCT03922451 172 173 B-Eq_Comparison
= NCT03922451 174 175 I-Eq_Comparison
18 NCT03922451 176 178 I-Eq_Comparison
years NCT03922451 179 184 I-Eq_Comparison

- NCT03922451 187 188 O
No NCT03922451 190 192 O
Consent NCT03922451 193 200 O
provided NCT03922451 201 209 O

Inclusion NCT03862183 0 9 O
Criteria NCT03862183 10 18 O
: NCT03862183 19 20 O

1 NCT03862183 24 25 O
. NCT03862183 25 26 O
Outpatients NCT03862183 28 39 B-Encounter
from NCT03862183 40 44 O
departments NCT03862183 45 56 O
of NCT03862183 57 59 O
Cardiology NCT03862183 60 70 B-Provider
, NCT03862183 71 72 O
Endocrinology NCT03862183 73 86 B-Provider
, NCT03862183 87 88 O
Nephrology NCT03862183 89 99 B-Provider
, NCT03862183 100 101 O
Neurology NCT03862183 102 111 B-Provider
, NCT03862183 112 113 O
Geriatrics NCT03862183 114 124 B-Provider
or NCT03862183 125 127 B-Or
General NCT03862183 128 135 B-Provider
Internal NCT03862183 136 144 I-Provider
Medicine NCT03862183 145 153 I-Provider
. NCT03862183 154 155 O

2 NCT03862183 159 160 O
. NCT03862183 160 161 O
Diagnosed NCT03862183 163 172 O
as NCT03862183 173 175 O
hypertension NCT03862183 176 188 B-Condition
. NCT03862183 189 190 O
Diagnostic NCT03862183 192 202 O
criteria NCT03862183 203 211 O
: NCT03862183 212 213 O
1 NCT03862183 214 215 O
) NCT03862183 216 217 O
The NCT03862183 218 221 O
office NCT03862183 222 228 O
BP NCT03862183 229 231 B-Observation
measured NCT03862183 232 240 O
at NCT03862183 241 243 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862183 244 247 I-Temporal_Connection___Temporal_Connection_Type_Value:during
day NCT03862183 248 251 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03862183 252 254 O
visit NCT03862183 255 260 B-Encounter
and NCT03862183 261 264 O
at NCT03862183 265 267 B-Eq_Comparison
least NCT03862183 268 273 I-Eq_Comparison
one NCT03862183 274 277 I-Eq_Comparison
time NCT03862183 278 282 I-Eq_Comparison
before NCT03862183 283 289 B-Temporal_Connection___Temporal_Connection_Type_Value:before
that NCT03862183 290 294 O
day NCT03862183 295 298 O
were NCT03862183 299 303 O
above NCT03862183 304 309 B-Eq_Comparison
the NCT03862183 310 313 I-Eq_Comparison
cut NCT03862183 314 317 I-Eq_Comparison
- NCT03862183 318 319 I-Eq_Comparison
off NCT03862183 320 323 I-Eq_Comparison
values NCT03862183 324 330 I-Eq_Comparison
( NCT03862183 331 332 O
≥ NCT03862183 333 334 B-Eq_Comparison
140 NCT03862183 335 338 I-Eq_Comparison
mmHg NCT03862183 339 343 I-Eq_Comparison
SBP NCT03862183 344 347 B-Observation
and NCT03862183 348 351 B-Or
/ NCT03862183 352 353 I-Or
or NCT03862183 354 356 I-Or
≥ NCT03862183 357 358 B-Eq_Comparison
90 NCT03862183 359 361 I-Eq_Comparison
mmHg NCT03862183 362 366 I-Eq_Comparison
DBP NCT03862183 367 370 B-Observation
) NCT03862183 371 372 O
; NCT03862183 373 374 O
2 NCT03862183 375 376 O
) NCT03862183 377 378 O
for NCT03862183 379 382 O
patients NCT03862183 383 391 O
with NCT03862183 392 396 O
normal NCT03862183 397 403 O
BP NCT03862183 404 406 B-Observation
at NCT03862183 407 409 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862183 410 413 I-Temporal_Connection___Temporal_Connection_Type_Value:during
day NCT03862183 414 417 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03862183 418 420 O
visit NCT03862183 421 426 B-Encounter
, NCT03862183 427 428 O
they NCT03862183 429 433 O
should NCT03862183 434 440 O
have NCT03862183 441 445 O
already NCT03862183 446 453 O
been NCT03862183 454 458 O
given NCT03862183 459 464 B-Eq_Comparison
pre NCT03862183 465 468 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03862183 469 470 O
treatment NCT03862183 471 480 B-Procedure
with NCT03862183 481 485 O
antihypertensive NCT03862183 486 502 B-Drug
drugs NCT03862183 503 508 I-Drug
≥ NCT03862183 509 510 B-Eq_Comparison
2 NCT03862183 511 512 I-Eq_Comparison
weeks NCT03862183 513 518 I-Eq_Comparison
. NCT03862183 519 520 O

3 NCT03862183 524 525 O
. NCT03862183 525 526 O
Voluntary NCT03862183 528 537 O
participation NCT03862183 538 551 O
. NCT03862183 552 553 O

Exclusion NCT03862183 555 564 O
Criteria NCT03862183 565 573 O
: NCT03862183 574 575 O

1 NCT03862183 579 580 O
. NCT03862183 580 581 O
Patients NCT03862183 583 591 O
aged NCT03862183 592 596 B-Age
< NCT03862183 597 598 B-Eq_Comparison
18 NCT03862183 599 601 I-Eq_Comparison
years NCT03862183 602 607 I-Eq_Comparison
old NCT03862183 608 611 O
. NCT03862183 612 613 O

2 NCT03862183 617 618 O
. NCT03862183 618 619 O
Patients NCT03862183 621 629 O
without NCT03862183 630 637 B-Negation
a NCT03862183 638 639 O
definite NCT03862183 640 648 O
diagnosis NCT03862183 649 658 O
of NCT03862183 659 661 O
hypertension NCT03862183 662 674 B-Condition
( NCT03862183 675 676 O
for NCT03862183 677 680 O
instance NCT03862183 681 689 O
, NCT03862183 690 691 O
if NCT03862183 692 694 O
the NCT03862183 695 698 O
patient NCT03862183 699 706 O
has NCT03862183 707 710 O
been NCT03862183 711 715 O
taking NCT03862183 716 722 B-Eq_Comparison
antihypertensive NCT03862183 723 739 B-Drug
drugs NCT03862183 740 745 I-Drug
irregularly NCT03862183 746 757 O
, NCT03862183 758 759 O
it NCT03862183 760 762 O
is NCT03862183 763 765 O
difficult NCT03862183 766 775 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862183 776 778 I-Assertion___Assertion_Type_Value:hypothetical
confirm NCT03862183 779 786 O
the NCT03862183 787 790 O
diagnosis NCT03862183 791 800 O
of NCT03862183 801 803 O
hypertension NCT03862183 804 816 B-Condition
） NCT03862183 816 817 O
. NCT03862183 818 819 O

3 NCT03862183 823 824 O
. NCT03862183 824 825 O
Patients NCT03862183 827 835 O
with NCT03862183 836 840 O
a NCT03862183 841 842 O
definite NCT03862183 843 851 O
diagnosis NCT03862183 852 861 O
of NCT03862183 862 864 O
secondary NCT03862183 865 874 B-Modifier
hypertension NCT03862183 875 887 B-Condition
. NCT03862183 888 889 O

4 NCT03862183 893 894 O
. NCT03862183 894 895 O
Patients NCT03862183 897 905 O
are NCT03862183 906 909 O
diagnosed NCT03862183 910 919 O
dyslipidemia NCT03862183 920 932 B-Condition
with NCT03862183 933 937 O
clear NCT03862183 938 943 O
cause NCT03862183 944 949 B-Condition
, NCT03862183 950 951 O
such NCT03862183 952 956 O
as NCT03862183 957 959 O
nephrotic NCT03862183 960 969 B-Condition
syndrome NCT03862183 970 978 I-Condition
, NCT03862183 979 980 O
severe NCT03862183 981 987 O
hypothyroidism NCT03862183 988 1002 B-Condition
, NCT03862183 1003 1004 O
terminal NCT03862183 1005 1013 B-Eq_Comparison
stage NCT03862183 1014 1019 I-Eq_Comparison
of NCT03862183 1020 1022 O
malignancy NCT03862183 1023 1033 B-Condition
, NCT03862183 1034 1035 O
etc NCT03862183 1036 1039 O
. NCT03862183 1040 1041 O

5 NCT03862183 1045 1046 O
. NCT03862183 1046 1047 O
Patients NCT03862183 1049 1057 O
are NCT03862183 1058 1061 O
diagnosed NCT03862183 1062 1071 O
end NCT03862183 1072 1075 B-Eq_Comparison
- NCT03862183 1076 1077 I-Eq_Comparison
stage NCT03862183 1078 1083 I-Eq_Comparison
renal NCT03862183 1084 1089 B-Condition
disease NCT03862183 1090 1097 I-Condition
, NCT03862183 1098 1099 O
hemodialysis NCT03862183 1100 1112 B-Procedure
, NCT03862183 1113 1114 O
and NCT03862183 1115 1118 B-Or
peritoneal NCT03862183 1119 1129 B-Procedure
dialysis NCT03862183 1130 1138 I-Procedure
patients NCT03862183 1139 1147 O
. NCT03862183 1148 1149 O

6 NCT03862183 1153 1154 O
. NCT03862183 1154 1155 O
Patients NCT03862183 1157 1165 O
diagnosed NCT03862183 1166 1175 O
with NCT03862183 1176 1180 O
mental NCT03862183 1181 1187 B-Condition
abnormalities NCT03862183 1188 1201 I-Condition
who NCT03862183 1202 1205 B-And
are NCT03862183 1206 1209 O
unable NCT03862183 1210 1216 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03862183 1217 1219 O
complete NCT03862183 1220 1228 O
the NCT03862183 1229 1232 O
questionnaire NCT03862183 1233 1246 B-Observation
. NCT03862183 1247 1248 O

7 NCT03862183 1252 1253 O
. NCT03862183 1253 1254 O
Patients NCT03862183 1256 1264 O
have NCT03862183 1265 1269 O
once NCT03862183 1270 1274 O
participated NCT03862183 1275 1287 B-Eq_Comparison
in NCT03862183 1288 1290 O
this NCT03862183 1291 1295 O
research NCT03862183 1296 1304 B-Study
during NCT03862183 1305 1311 B-Temporal_Connection___Temporal_Connection_Type_Value:during
this NCT03862183 1312 1316 O
study NCT03862183 1317 1322 B-Study
cycle NCT03862183 1323 1328 O
( NCT03862183 1329 1330 O
to NCT03862183 1331 1333 O
avoid NCT03862183 1334 1339 O
repeated NCT03862183 1340 1348 O
participation NCT03862183 1349 1362 O
） NCT03862183 1362 1363 O
. NCT03862183 1364 1365 O

Inclusion NCT03924830 0 9 O
Criteria NCT03924830 10 18 O
: NCT03924830 19 20 O

- NCT03924830 24 25 O
All NCT03924830 27 30 O
patients NCT03924830 31 39 O
must NCT03924830 40 44 O
have NCT03924830 45 49 O
at NCT03924830 50 52 O
only NCT03924830 53 57 B-Eq_Comparison
20 NCT03924830 58 60 I-Eq_Comparison
teeth NCT03924830 61 66 B-Condition
in NCT03924830 67 69 I-Condition
function NCT03924830 70 78 I-Condition
, NCT03924830 79 80 O
must NCT03924830 81 85 O
have NCT03924830 86 90 O
at NCT03924830 91 93 O
only NCT03924830 94 98 B-Eq_Comparison
3 NCT03924830 99 100 I-Eq_Comparison
carious NCT03924830 101 108 B-Modifier
occlusal NCT03924830 109 117 I-Modifier
or NCT03924830 118 120 B-Or
proximo NCT03924830 121 128 B-Modifier
- NCT03924830 129 130 I-Modifier
occlusal NCT03924830 131 139 I-Modifier
lesions NCT03924830 140 147 B-Condition
, NCT03924830 148 149 O
or NCT03924830 150 152 B-Or
old NCT03924830 153 156 B-Modifier
restorations NCT03924830 157 169 B-Condition
that NCT03924830 170 174 O
need NCT03924830 175 179 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924830 180 182 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03924830 183 185 I-Assertion___Assertion_Type_Value:hypothetical
changed NCT03924830 186 193 O
, NCT03924830 194 195 O
in NCT03924830 196 198 O
different NCT03924830 199 208 B-Modifier
teeth NCT03924830 209 214 I-Modifier
. NCT03924830 215 216 O
Those NCT03924830 218 223 O
lesions NCT03924830 224 231 B-Condition
must NCT03924830 232 236 O
be NCT03924830 237 239 O
more NCT03924830 240 244 B-Eq_Comparison
than NCT03924830 245 249 I-Eq_Comparison
2 NCT03924830 250 251 I-Eq_Comparison
mm NCT03924830 252 254 I-Eq_Comparison
deep NCT03924830 255 259 B-Observation
, NCT03924830 260 261 O
should NCT03924830 262 268 O
have NCT03924830 269 273 O
exposed NCT03924830 274 281 B-Condition
dentin NCT03924830 282 288 I-Condition
, NCT03924830 289 290 O
and NCT03924830 291 294 B-And
must NCT03924830 295 299 O
have NCT03924830 300 304 O
at NCT03924830 305 307 O
only NCT03924830 308 312 B-Eq_Comparison
50 NCT03924830 313 315 I-Eq_Comparison
% NCT03924830 316 317 I-Eq_Comparison
of NCT03924830 318 320 O
margins NCT03924830 321 328 B-Observation
in NCT03924830 329 331 I-Observation
enamel NCT03924830 332 338 I-Observation
. NCT03924830 339 340 O
Teeth NCT03924830 342 347 B-Modifier
should NCT03924830 348 354 O
not NCT03924830 355 358 B-Negation
present NCT03924830 359 366 O
periodontal NCT03924830 367 378 B-Condition
mobility NCT03924830 379 387 I-Condition
. NCT03924830 388 389 O

Exclusion NCT03924830 391 400 O
Criteria NCT03924830 401 409 O
: NCT03924830 410 411 O

- NCT03924830 415 416 O
Volunteers NCT03924830 418 428 O
with NCT03924830 429 433 O
periodontal NCT03924830 434 445 B-Condition
disease NCT03924830 446 453 I-Condition
; NCT03924830 453 454 O
with NCT03924830 455 459 B-Or
gingival NCT03924830 460 468 B-Condition
bleeding NCT03924830 469 477 I-Condition
; NCT03924830 477 478 O
use NCT03924830 479 482 O
of NCT03924830 483 485 O
anti NCT03924830 486 490 B-Drug
- NCT03924830 491 492 I-Drug
inflammatory NCT03924830 493 505 I-Drug
drugs NCT03924830 506 511 I-Drug
in NCT03924830 512 514 O
the NCT03924830 515 518 O
last NCT03924830 519 523 B-Eq_Comparison
30 NCT03924830 524 526 I-Eq_Comparison
days NCT03924830 527 531 I-Eq_Comparison
. NCT03924830 532 533 O

Inclusion NCT03924518 0 9 O
Criteria NCT03924518 10 18 O
( NCT03924518 19 20 O
Only NCT03924518 21 25 O
patients NCT03924518 26 34 O
who NCT03924518 35 38 O
fully NCT03924518 39 44 O
meet NCT03924518 45 49 O
the NCT03924518 50 53 O
following NCT03924518 54 63 O
criteria NCT03924518 64 72 O
are NCT03924518 73 76 O
eligible NCT03924518 77 85 O
to NCT03924518 86 88 O

participate NCT03924518 89 100 O
in NCT03924518 101 103 O
the NCT03924518 104 107 O
trial NCT03924518 108 113 O
) NCT03924518 114 115 O
: NCT03924518 116 117 O

- NCT03924518 121 122 O
Meets NCT03924518 124 129 O
the NCT03924518 130 133 O
diagnostic NCT03924518 134 144 O
criteria NCT03924518 145 153 O
for NCT03924518 154 157 O
sepsis NCT03924518 158 164 B-Condition
- NCT03924518 165 166 O
3 NCT03924518 167 168 B-Eq_Comparison
developed NCT03924518 169 178 O
by NCT03924518 179 181 O
the NCT03924518 182 185 O
American NCT03924518 186 194 O
Society NCT03924518 195 202 O
of NCT03924518 203 205 O
Critical NCT03924518 206 214 O
Care NCT03924518 215 219 O
Medicine NCT03924518 220 228 O
( NCT03924518 229 230 O
SCCM NCT03924518 231 235 O
) NCT03924518 236 237 O
/ NCT03924518 238 239 O
European NCT03924518 240 248 O
Critical NCT03924518 249 257 O
Care NCT03924518 258 262 O
Medicine NCT03924518 263 271 O
Association NCT03924518 272 283 O
( NCT03924518 284 285 O
ESICM NCT03924518 286 291 O
) NCT03924518 292 293 O

- NCT03924518 297 298 O
Age NCT03924518 300 303 B-Age
≥ NCT03924518 304 305 B-Eq_Comparison
18 NCT03924518 306 308 I-Eq_Comparison
years NCT03924518 309 314 I-Eq_Comparison
old NCT03924518 315 318 O
and NCT03924518 319 322 B-And
age NCT03924518 323 326 B-Age
≤ NCT03924518 327 328 B-Eq_Comparison
80 NCT03924518 329 331 I-Eq_Comparison
years NCT03924518 332 337 I-Eq_Comparison
old NCT03924518 338 341 O
. NCT03924518 342 343 O

- NCT03924518 347 348 O
Procalcitonin NCT03924518 350 363 B-Observation
≥ NCT03924518 364 365 B-Eq_Comparison
2 NCT03924518 366 367 I-Eq_Comparison
ng NCT03924518 368 370 I-Eq_Comparison
/ NCT03924518 371 372 I-Eq_Comparison
ml NCT03924518 373 375 I-Eq_Comparison

Exclusion NCT03924518 376 385 O
Criteria NCT03924518 386 394 O
: NCT03924518 395 396 O

- NCT03924518 400 401 O
Age NCT03924518 403 406 B-Age
< NCT03924518 407 408 B-Eq_Comparison
18 NCT03924518 409 411 I-Eq_Comparison
years NCT03924518 412 417 I-Eq_Comparison
, NCT03924518 418 419 O
or NCT03924518 420 422 B-Or
age NCT03924518 423 426 B-Age
> NCT03924518 427 428 B-Eq_Comparison
80 NCT03924518 429 431 I-Eq_Comparison
years NCT03924518 432 437 I-Eq_Comparison
. NCT03924518 438 439 O

- NCT03924518 443 444 O
Pregnancy NCT03924518 446 455 B-Condition
or NCT03924518 456 458 B-Or
lactating NCT03924518 459 468 B-Condition

- NCT03924518 471 472 O
A NCT03924518 474 475 O
solid NCT03924518 476 481 B-Modifier
- NCT03924518 482 483 I-Modifier
organ NCT03924518 484 489 I-Modifier
or NCT03924518 490 492 B-Or
bone NCT03924518 493 497 B-Modifier
marrow NCT03924518 498 504 I-Modifier
transplant NCT03924518 505 515 B-Procedure
patients NCT03924518 516 524 O
. NCT03924518 525 526 O

- NCT03924518 530 531 O
Patients NCT03924518 533 541 O
with NCT03924518 542 546 O
myocardial NCT03924518 547 557 B-Condition
infarction NCT03924518 558 568 I-Condition
within NCT03924518 569 575 B-Eq_Comparison
the NCT03924518 576 579 I-Eq_Comparison
past NCT03924518 580 584 I-Eq_Comparison
3 NCT03924518 585 586 I-Eq_Comparison
months NCT03924518 587 593 I-Eq_Comparison
. NCT03924518 594 595 O

- NCT03924518 599 600 O
Advanced NCT03924518 602 610 O
pulmonary NCT03924518 611 620 B-Condition
fibrosis NCT03924518 621 629 I-Condition
. NCT03924518 630 631 O

- NCT03924518 635 636 O
Patients NCT03924518 638 646 O
with NCT03924518 647 651 O
cardiopulmonary NCT03924518 652 667 B-Procedure
resuscitation NCT03924518 668 681 I-Procedure
before NCT03924518 682 688 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03924518 689 699 B-Study
. NCT03924518 700 701 O

- NCT03924518 705 706 O
HIV NCT03924518 708 711 B-Condition
- NCT03924518 712 713 O
positive NCT03924518 714 722 O
patients NCT03924518 723 731 O
. NCT03924518 732 733 O

- NCT03924518 737 738 O
granulocyte NCT03924518 740 751 B-Condition
- NCT03924518 752 753 I-Condition
deficient NCT03924518 754 763 I-Condition
patients NCT03924518 764 772 O
. NCT03924518 773 774 O

- NCT03924518 778 779 O
blood NCT03924518 781 786 B-Modifier
/ NCT03924518 787 788 B-Or
lymphatic NCT03924518 789 798 B-Modifier
system NCT03924518 799 805 I-Modifier
tumors NCT03924518 806 812 B-Condition
are NCT03924518 813 816 O
not NCT03924518 817 820 B-Negation
remission NCT03924518 821 830 B-Modifier
. NCT03924518 831 832 O

- NCT03924518 836 837 O
patients NCT03924518 839 847 O
with NCT03924518 848 852 O
limited NCT03924518 853 860 B-Observation
care NCT03924518 861 865 I-Observation
( NCT03924518 866 867 O
lack NCT03924518 868 872 B-Negation
of NCT03924518 873 875 I-Negation
commitment NCT03924518 876 886 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924518 887 889 I-Assertion___Assertion_Type_Value:hypothetical
full NCT03924518 890 894 O
, NCT03924518 895 896 O
aggressive NCT03924518 897 907 O
life NCT03924518 908 912 B-Procedure
support NCT03924518 913 920 I-Procedure
) NCT03924518 921 922 O
. NCT03924518 923 924 O

- NCT03924518 928 929 O
patients NCT03924518 931 939 O
with NCT03924518 940 944 O
long NCT03924518 945 949 O
- NCT03924518 950 951 O
term NCT03924518 952 956 O
use NCT03924518 957 960 O
of NCT03924518 961 963 O
immunosuppressive NCT03924518 964 981 B-Drug
drugs NCT03924518 982 987 I-Drug
or NCT03924518 988 990 B-Or
with NCT03924518 991 995 O
immunodeficiency NCT03924518 996 1012 B-Condition
. NCT03924518 1013 1014 O

- NCT03924518 1018 1019 O
patients NCT03924518 1021 1029 O
with NCT03924518 1030 1034 O
advanced NCT03924518 1035 1043 O
tumors NCT03924518 1044 1050 B-Condition
. NCT03924518 1051 1052 O

- NCT03924518 1056 1057 O
patients NCT03924518 1059 1067 O
combined NCT03924518 1068 1076 O
with NCT03924518 1077 1081 O
non NCT03924518 1082 1085 B-Negation
- NCT03924518 1086 1087 O
infectious NCT03924518 1088 1098 B-Condition
factors NCT03924518 1099 1106 I-Condition
leading NCT03924518 1107 1114 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924518 1115 1117 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03924518 1118 1121 O
death NCT03924518 1122 1127 B-Death
( NCT03924518 1128 1129 O
uncontrollable NCT03924518 1130 1144 O
major NCT03924518 1145 1150 O
bleeding NCT03924518 1151 1159 B-Condition
, NCT03924518 1160 1161 O
brain NCT03924518 1162 1167 B-Condition
hernia NCT03924518 1168 1174 B-Condition
, NCT03924518 1175 1176 O
etc NCT03924518 1177 1180 O
. NCT03924518 1181 1182 O
) NCT03924518 1183 1184 O
. NCT03924518 1185 1186 O

- NCT03924518 1190 1191 O
surgically NCT03924518 1193 1203 O
unresolved NCT03924518 1204 1214 B-Eq_Comparison
infection NCT03924518 1215 1224 B-Condition
sources NCT03924518 1225 1232 O
( NCT03924518 1233 1234 O
such NCT03924518 1235 1239 O
as NCT03924518 1240 1242 O
some NCT03924518 1243 1247 O
intraperitoneal NCT03924518 1248 1263 B-Condition
infection NCT03924518 1264 1273 I-Condition
etc NCT03924518 1274 1277 O
. NCT03924518 1278 1279 O
) NCT03924518 1280 1281 O

- NCT03924518 1285 1286 O
patients NCT03924518 1288 1296 O
allergic NCT03924518 1297 1305 B-Allergy
to NCT03924518 1306 1308 O
granisetron NCT03924518 1309 1320 O
. NCT03924518 1321 1322 O

- NCT03924518 1326 1327 O
patients NCT03924518 1329 1337 O
with NCT03924518 1338 1342 O
intestinal NCT03924518 1343 1353 B-Condition
obstruction NCT03924518 1354 1365 I-Condition
. NCT03924518 1366 1367 O

Inclusion NCT03865836 0 9 O
Criteria NCT03865836 10 18 O
: NCT03865836 19 20 O

1 NCT03865836 24 25 O
. NCT03865836 25 26 O
Subject NCT03865836 28 35 O
must NCT03865836 36 40 O
have NCT03865836 41 45 O
a NCT03865836 46 47 O
diagnosis NCT03865836 48 57 O
of NCT03865836 58 60 O
LOPD NCT03865836 61 65 B-Condition
based NCT03865836 66 71 O
on NCT03865836 72 74 O
documentation NCT03865836 75 88 O
of NCT03865836 89 91 O
one NCT03865836 92 95 B-Eq_Comparison
of NCT03865836 96 98 O
the NCT03865836 99 102 B-Criteria_Count
following NCT03865836 103 112 I-Criteria_Count
: NCT03865836 113 114 O

1 NCT03865836 123 124 O
. NCT03865836 124 125 O
deficiency NCT03865836 127 137 B-Condition
of NCT03865836 138 140 O
GAA NCT03865836 141 144 B-Modifier
enzyme NCT03865836 145 151 I-Modifier

2 NCT03865836 159 160 O
. NCT03865836 160 161 O
GAA NCT03865836 163 166 B-Procedure
genotyping NCT03865836 167 177 I-Procedure

2 NCT03865836 180 181 O
. NCT03865836 181 182 O
Subject NCT03865836 184 191 O
must NCT03865836 192 196 O
provide NCT03865836 197 204 O
signed NCT03865836 205 211 O
informed NCT03865836 212 220 O
consent NCT03865836 221 228 O
prior NCT03865836 229 234 O
to NCT03865836 235 237 O
any NCT03865836 238 241 O
study NCT03865836 242 247 B-Study
- NCT03865836 248 249 O
related NCT03865836 250 257 O
procedures NCT03865836 258 268 B-Procedure
being NCT03865836 269 274 O
performed NCT03865836 275 284 O
. NCT03865836 285 286 O

Exclusion NCT03865836 288 297 O
Criteria NCT03865836 298 306 O
: NCT03865836 307 308 O

1 NCT03865836 312 313 O
. NCT03865836 313 314 O
Subject NCT03865836 316 323 O
is NCT03865836 324 326 O
eligible NCT03865836 327 335 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865836 336 339 I-Assertion___Assertion_Type_Value:hypothetical
enrollment NCT03865836 340 350 O
in NCT03865836 351 353 O
an NCT03865836 354 356 O
ongoing NCT03865836 357 364 B-Eq_Comparison
clinical NCT03865836 365 373 B-Study
trial NCT03865836 374 379 I-Study
using NCT03865836 380 385 O
ATB NCT03865836 386 389 B-Drug
200 NCT03865836 390 393 I-Drug
/ NCT03865836 394 395 B-Or
AT NCT03865836 396 398 B-Drug
2221 NCT03865836 399 403 I-Drug
. NCT03865836 403 404 O

2 NCT03865836 408 409 O
. NCT03865836 409 410 O
Subject NCT03865836 412 419 O
, NCT03865836 420 421 O
if NCT03865836 422 424 O
female NCT03865836 425 431 O
, NCT03865836 432 433 O
is NCT03865836 434 436 O
pregnant NCT03865836 437 445 B-Condition
or NCT03865836 446 448 B-Or
breastfeeding NCT03865836 449 462 B-Condition
at NCT03865836 463 465 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03865836 466 475 B-Study
. NCT03865836 476 477 O

3 NCT03865836 481 482 O
. NCT03865836 482 483 O
Subject NCT03865836 485 492 O
, NCT03865836 493 494 O
whether NCT03865836 495 502 O
male NCT03865836 503 507 O
or NCT03865836 508 510 B-Or
female NCT03865836 511 517 O
, NCT03865836 518 519 O
is NCT03865836 520 522 O
planning NCT03865836 523 531 B-Assertion___Assertion_Type_Value:intention
to NCT03865836 532 534 O
conceive NCT03865836 535 543 B-Condition
a NCT03865836 544 545 I-Condition
child NCT03865836 546 551 I-Condition
during NCT03865836 552 558 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865836 559 562 O
study NCT03865836 563 568 B-Study
. NCT03865836 569 570 O

Inclusion NCT03920033 0 9 O
Criteria NCT03920033 10 18 O
: NCT03920033 19 20 O

- NCT03920033 24 25 O
Pathologically NCT03920033 27 41 B-Procedure
confirmed NCT03920033 42 51 O
intermediate NCT03920033 52 64 O
- NCT03920033 65 66 O
or NCT03920033 67 69 B-Or
high NCT03920033 70 74 O
- NCT03920033 75 76 O
risk NCT03920033 77 81 B-Risk
prostate NCT03920033 82 90 B-Modifier
cancer NCT03920033 91 97 B-Condition

- NCT03920033 100 101 O
Biochemical NCT03920033 103 114 O
recurrence NCT03920033 115 125 O
after NCT03920033 126 131 B-Temporal_Connection___Temporal_Connection_Type_Value:after
radical NCT03920033 132 139 B-Procedure
prostatectomy NCT03920033 140 153 I-Procedure
( NCT03920033 154 155 O
Definition NCT03920033 156 166 O
: NCT03920033 167 168 O
Serial NCT03920033 169 175 O
elevation NCT03920033 176 185 O
of NCT03920033 186 188 O
PSA NCT03920033 189 192 B-Observation
over NCT03920033 193 197 B-Eq_Comparison
0.2 NCT03920033 198 201 I-Eq_Comparison
ng NCT03920033 202 204 I-Eq_Comparison
/ NCT03920033 205 206 I-Eq_Comparison
mL NCT03920033 207 209 I-Eq_Comparison
and NCT03920033 210 213 B-And
< NCT03920033 214 215 B-Eq_Comparison
= NCT03920033 216 217 I-Eq_Comparison
1.0 NCT03920033 218 221 I-Eq_Comparison
ng NCT03920033 222 224 I-Eq_Comparison
/ NCT03920033 225 226 I-Eq_Comparison
mL NCT03920033 227 229 I-Eq_Comparison
) NCT03920033 230 231 O

- NCT03920033 235 236 O
ECOG NCT03920033 238 242 B-Observation
performance NCT03920033 243 254 I-Observation
status NCT03920033 255 261 I-Observation
0 NCT03920033 262 263 B-Eq_Comparison
- NCT03920033 264 265 I-Eq_Comparison
1 NCT03920033 266 267 I-Eq_Comparison

- NCT03920033 271 272 O
Appropriate NCT03920033 274 285 O
values NCT03920033 286 292 O
of NCT03920033 293 295 O
blood NCT03920033 296 301 O
tests NCT03920033 302 307 O
within NCT03920033 308 314 B-Eq_Comparison
6 NCT03920033 315 316 I-Eq_Comparison
months NCT03920033 317 323 I-Eq_Comparison
after NCT03920033 324 329 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrollment NCT03920033 330 340 B-Study
Absolute NCT03920033 341 349 B-Observation
neutrophil NCT03920033 350 360 I-Observation
count NCT03920033 361 366 I-Observation
( NCT03920033 367 368 O
ANC NCT03920033 369 372 B-Observation
) NCT03920033 373 374 O
≥ NCT03920033 375 376 B-Eq_Comparison
1500 NCT03920033 377 381 I-Eq_Comparison
cells NCT03920033 382 387 I-Eq_Comparison
/ NCT03920033 388 389 I-Eq_Comparison
mm NCT03920033 390 392 I-Eq_Comparison
3 NCT03920033 393 394 I-Eq_Comparison
Platelets NCT03920033 395 404 B-Observation
≥ NCT03920033 405 406 B-Eq_Comparison
50 NCT03920033 407 409 I-Eq_Comparison
, NCT03920033 410 411 I-Eq_Comparison
000 NCT03920033 412 415 I-Eq_Comparison
cells NCT03920033 416 421 I-Eq_Comparison
/ NCT03920033 422 423 I-Eq_Comparison
mm NCT03920033 424 426 I-Eq_Comparison
3 NCT03920033 427 428 I-Eq_Comparison
Hemoglobin NCT03920033 429 439 B-Observation
≥ NCT03920033 440 441 B-Eq_Comparison
8.0 NCT03920033 442 445 I-Eq_Comparison
g NCT03920033 446 447 I-Eq_Comparison
/ NCT03920033 448 449 I-Eq_Comparison
dl NCT03920033 450 452 I-Eq_Comparison

- NCT03920033 455 456 O
Appropriate NCT03920033 458 469 O
values NCT03920033 470 476 O
of NCT03920033 477 479 O
kidney NCT03920033 480 486 B-Observation
function NCT03920033 487 495 I-Observation
within NCT03920033 496 502 B-Eq_Comparison
6 NCT03920033 503 504 I-Eq_Comparison
months NCT03920033 505 511 I-Eq_Comparison
after NCT03920033 512 517 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrollment NCT03920033 518 528 B-Study
Creatinine NCT03920033 529 539 B-Observation
< NCT03920033 540 541 B-Eq_Comparison
2.0 NCT03920033 542 545 I-Eq_Comparison
ng NCT03920033 546 548 I-Eq_Comparison
/ NCT03920033 549 550 I-Eq_Comparison
dL NCT03920033 551 553 I-Eq_Comparison

- NCT03920033 556 557 O
Appropriate NCT03920033 559 570 O
values NCT03920033 571 577 O
of NCT03920033 578 580 O
liver NCT03920033 581 586 B-Observation
function NCT03920033 587 595 I-Observation
within NCT03920033 596 602 B-Eq_Comparison
6 NCT03920033 603 604 I-Eq_Comparison
months NCT03920033 605 611 I-Eq_Comparison
after NCT03920033 612 617 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrollment NCT03920033 618 628 B-Study
total NCT03920033 629 634 B-Observation
bilirubin NCT03920033 635 644 I-Observation
< NCT03920033 645 646 B-Eq_Comparison
1.5 NCT03920033 647 650 I-Eq_Comparison
X NCT03920033 651 652 I-Eq_Comparison
maximum NCT03920033 653 660 I-Eq_Comparison
normal NCT03920033 661 667 I-Eq_Comparison
value NCT03920033 668 673 I-Eq_Comparison
alanine NCT03920033 674 681 B-Observation
aminotransferase NCT03920033 682 698 I-Observation
or NCT03920033 699 701 B-Or
aspartate NCT03920033 702 711 B-Observation
aminotransferase NCT03920033 712 728 I-Observation
< NCT03920033 729 730 B-Eq_Comparison
2.5 NCT03920033 731 734 I-Eq_Comparison
X NCT03920033 735 736 I-Eq_Comparison
maximum NCT03920033 737 744 I-Eq_Comparison
normal NCT03920033 745 751 I-Eq_Comparison
value NCT03920033 752 757 I-Eq_Comparison

Exclusion NCT03920033 758 767 O
Criteria NCT03920033 768 776 O
: NCT03920033 777 778 O

- NCT03920033 782 783 O
Clinically NCT03920033 785 795 O
gross NCT03920033 796 801 B-Modifier
recurrent NCT03920033 802 811 I-Modifier
tumor NCT03920033 812 817 B-Condition

- NCT03920033 820 821 O
Presence NCT03920033 823 831 B-Eq_Comparison
of NCT03920033 832 834 O
distant NCT03920033 835 842 B-Modifier
metastasis NCT03920033 843 853 B-Condition

- NCT03920033 856 857 O
Presence NCT03920033 859 867 B-Eq_Comparison
of NCT03920033 868 870 O
pelvic NCT03920033 871 877 B-Modifier
LN NCT03920033 878 880 I-Modifier
metastasis NCT03920033 881 891 B-Condition

- NCT03920033 894 895 O
History NCT03920033 897 904 B-Eq_Comparison
of NCT03920033 905 907 O
pelvic NCT03920033 908 914 B-Modifier
irradiation NCT03920033 915 926 B-Procedure

- NCT03920033 929 930 O
History NCT03920033 932 939 B-Eq_Comparison
of NCT03920033 940 942 O
cryotherapy NCT03920033 943 954 B-Procedure
or NCT03920033 955 957 B-Or
brachytherapy NCT03920033 958 971 B-Procedure
for NCT03920033 972 975 O
prostate NCT03920033 976 984 B-Modifier
cancer NCT03920033 985 991 B-Condition

- NCT03920033 994 995 O
Double NCT03920033 997 1003 B-Eq_Comparison
primary NCT03920033 1004 1011 B-Modifier
cancer NCT03920033 1012 1018 B-Condition
other NCT03920033 1019 1024 B-Exception
than NCT03920033 1025 1029 I-Exception
skin NCT03920033 1030 1034 B-Modifier
/ NCT03920033 1035 1036 B-Or
thyroid NCT03920033 1037 1044 B-Modifier
cancer NCT03920033 1045 1051 B-Condition

- NCT03920033 1054 1055 O
Combined NCT03920033 1057 1065 O
serious NCT03920033 1066 1073 O
morbidity NCT03920033 1074 1083 B-Condition


Inclusion NCT03860116 0 9 O
Criteria NCT03860116 10 18 O
: NCT03860116 19 20 O

- NCT03860116 24 25 O
1 NCT03860116 27 28 O
. NCT03860116 28 29 O
diagnosed NCT03860116 31 40 O
as NCT03860116 41 43 O
HIV NCT03860116 44 47 B-Condition
positive NCT03860116 48 56 O
; NCT03860116 56 57 O

- NCT03860116 60 61 O
2 NCT03860116 63 64 O
. NCT03860116 64 65 O
initiate NCT03860116 67 75 B-Eq_Comparison
antiretroviral NCT03860116 76 90 B-Procedure
therapy NCT03860116 91 98 I-Procedure
on NCT03860116 99 101 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860116 102 105 I-Temporal_Connection___Temporal_Connection_Type_Value:during
day NCT03860116 106 109 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03860116 110 112 O
recruitment NCT03860116 113 124 B-Study
; NCT03860116 124 125 O

- NCT03860116 128 129 O
3 NCT03860116 131 132 O
. NCT03860116 132 133 O
was NCT03860116 135 138 O
infected NCT03860116 139 147 B-Condition
through NCT03860116 148 155 O
male NCT03860116 156 160 B-Observation
same NCT03860116 161 165 I-Observation
- NCT03860116 166 167 I-Observation
sex NCT03860116 168 171 I-Observation
behavior NCT03860116 172 180 I-Observation
; NCT03860116 180 181 O

- NCT03860116 184 185 O
4 NCT03860116 187 188 O
. NCT03860116 188 189 O
has NCT03860116 191 194 O
access NCT03860116 195 201 O
to NCT03860116 202 204 O
internet NCT03860116 205 213 O
on NCT03860116 214 216 O
a NCT03860116 217 218 O
personal NCT03860116 219 227 O
mobile NCT03860116 228 234 O
phone NCT03860116 235 240 O
; NCT03860116 240 241 O

- NCT03860116 244 245 O
5 NCT03860116 247 248 O
. NCT03860116 248 249 O
has NCT03860116 251 254 O
a NCT03860116 255 256 O
Wechat NCT03860116 257 263 O
account NCT03860116 264 271 O
and NCT03860116 272 275 O
use NCT03860116 276 279 O
it NCT03860116 280 282 O
daily NCT03860116 283 288 O
; NCT03860116 288 289 O

- NCT03860116 292 293 O
6 NCT03860116 295 296 O
. NCT03860116 296 297 O
willing NCT03860116 299 306 O
to NCT03860116 307 309 O
provide NCT03860116 310 317 O
written NCT03860116 318 325 O
informed NCT03860116 326 334 O
consent NCT03860116 335 342 O
; NCT03860116 342 343 O

Exclusion NCT03860116 344 353 O
Criteria NCT03860116 354 362 O
: NCT03860116 363 364 O

- NCT03860116 368 369 O
1 NCT03860116 371 372 O
. NCT03860116 372 373 O
under NCT03860116 375 380 O
severe NCT03860116 381 387 O
physical NCT03860116 388 396 B-Modifier
or NCT03860116 397 399 B-Or
mental NCT03860116 400 406 B-Modifier
condition NCT03860116 407 416 B-Condition
which NCT03860116 417 422 O
precludes NCT03860116 423 432 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
study NCT03860116 433 438 B-Study
participation NCT03860116 439 452 O
; NCT03860116 452 453 O

- NCT03860116 456 457 O
2 NCT03860116 459 460 O
. NCT03860116 460 461 O
being NCT03860116 463 468 B-Eq_Comparison
an NCT03860116 469 471 O
inpatient NCT03860116 472 481 B-Encounter
of NCT03860116 482 484 O
the NCT03860116 485 488 O
hospital NCT03860116 489 497 O
; NCT03860116 497 498 O

Inclusion NCT03867500 0 9 O
criteria NCT03867500 10 18 O
: NCT03867500 19 20 O

- NCT03867500 24 25 O
Women NCT03867500 27 32 O
and NCT03867500 33 36 B-Or
Men NCT03867500 37 40 O
( NCT03867500 41 42 O
Women NCT03867500 43 48 O
premenopausal NCT03867500 49 62 B-Condition
) NCT03867500 63 64 O

- NCT03867500 68 69 O
BMI NCT03867500 71 74 B-Observation
29 NCT03867500 75 77 B-Eq_Comparison
- NCT03867500 78 79 I-Eq_Comparison
37 NCT03867500 80 82 I-Eq_Comparison

- NCT03867500 86 87 O
Weight NCT03867500 89 95 B-Observation
stable NCT03867500 96 102 O

- NCT03867500 105 106 O
Not NCT03867500 108 111 B-Negation
pregnant NCT03867500 112 120 B-Condition
/ NCT03867500 121 122 B-Or
nursing NCT03867500 123 130 B-Condition

Exclusion NCT03867500 131 140 O
criteria NCT03867500 141 149 O
: NCT03867500 150 151 O

- NCT03867500 155 156 O
Ischemic NCT03867500 158 166 B-Condition
heart NCT03867500 167 172 I-Condition
disease NCT03867500 173 180 I-Condition

- NCT03867500 183 184 O
Atherosclerotic NCT03867500 186 201 B-Condition
valvular NCT03867500 202 210 I-Condition
disease NCT03867500 211 218 I-Condition

- NCT03867500 221 222 O
Smokers NCT03867500 224 231 B-Observation
( NCT03867500 232 233 O
> NCT03867500 234 235 B-Eq_Comparison
20 NCT03867500 236 238 I-Eq_Comparison
cigarettes NCT03867500 239 249 I-Eq_Comparison
per NCT03867500 250 253 I-Eq_Comparison
week NCT03867500 254 258 I-Eq_Comparison
) NCT03867500 259 260 O

- NCT03867500 264 265 O
Bilateral NCT03867500 267 276 B-Modifier
oophorectomy NCT03867500 277 289 B-Procedure

- NCT03867500 292 293 O
Concomitant NCT03867500 295 306 B-Modifier
use NCT03867500 307 310 O
of NCT03867500 311 313 O
medications NCT03867500 314 325 B-Drug
that NCT03867500 326 330 O
can NCT03867500 331 334 B-Assertion___Assertion_Type_Value:hypothetical
alter NCT03867500 335 340 O
serum NCT03867500 341 346 B-Observation
lipid NCT03867500 347 352 I-Observation
profile NCT03867500 353 360 I-Observation
: NCT03867500 361 362 O

- NCT03867500 371 372 O
High NCT03867500 374 378 O
dose NCT03867500 379 383 O
fish NCT03867500 384 388 B-Drug
oil NCT03867500 389 392 I-Drug
( NCT03867500 393 394 O
> NCT03867500 395 396 B-Eq_Comparison
3 NCT03867500 397 398 I-Eq_Comparison
g NCT03867500 399 400 I-Eq_Comparison
per NCT03867500 401 404 I-Eq_Comparison
day NCT03867500 405 408 I-Eq_Comparison
) NCT03867500 409 410 O
, NCT03867500 411 412 O

- NCT03867500 421 422 O
STATINS NCT03867500 424 431 B-Drug
( NCT03867500 432 433 O
if NCT03867500 434 436 O
yes NCT03867500 437 440 O
hold NCT03867500 441 445 B-Eq_Comparison
for NCT03867500 446 449 I-Eq_Comparison
6 NCT03867500 450 451 I-Eq_Comparison
weeks NCT03867500 452 457 I-Eq_Comparison
and NCT03867500 458 461 O
receive NCT03867500 462 469 O
PCP NCT03867500 470 473 B-Provider
's NCT03867500 473 475 O
approval NCT03867500 476 484 B-Observation
) NCT03867500 485 486 O
, NCT03867500 487 488 O

- NCT03867500 497 498 O
Niacin NCT03867500 500 506 B-Drug

- NCT03867500 514 515 O
Fibrates NCT03867500 517 525 B-Drug

- NCT03867500 533 534 O
thiazolidinediones NCT03867500 536 554 B-Drug

- NCT03867500 562 563 O
Beta NCT03867500 565 569 B-Drug
- NCT03867500 570 571 I-Drug
blockers NCT03867500 572 580 I-Drug

- NCT03867500 588 589 O
Atypical NCT03867500 591 599 B-Modifier
antipsychotics NCT03867500 600 614 B-Drug

- NCT03867500 617 618 O
Lidocaine NCT03867500 620 629 B-Drug
or NCT03867500 630 632 B-Or
Niacin NCT03867500 633 639 B-Drug
/ NCT03867500 640 641 B-Or
Niaspan NCT03867500 642 649 B-Drug
allergy NCT03867500 650 657 B-Allergy

- NCT03867500 660 661 O
Subjects NCT03867500 663 671 O
with NCT03867500 672 676 O
1.5 NCT03867500 677 680 B-Eq_Comparison
times NCT03867500 681 686 I-Eq_Comparison
upper NCT03867500 687 692 I-Eq_Comparison
limit NCT03867500 693 698 I-Eq_Comparison
of NCT03867500 699 701 I-Eq_Comparison
normal NCT03867500 702 708 I-Eq_Comparison
of NCT03867500 709 711 O
serum NCT03867500 712 717 B-Observation
creatinine NCT03867500 718 728 I-Observation
, NCT03867500 729 730 O
Alkaline NCT03867500 731 739 B-Observation
phosphatase NCT03867500 740 751 I-Observation
, NCT03867500 752 753 O
Aspartate NCT03867500 754 763 B-Observation
aminotransferase NCT03867500 764 780 I-Observation
( NCT03867500 781 782 O
AST NCT03867500 783 786 B-Observation
) NCT03867500 787 788 O
, NCT03867500 789 790 O
Alanine NCT03867500 791 798 B-Observation
aminotransferase NCT03867500 799 815 I-Observation
( NCT03867500 816 817 O
ALT NCT03867500 818 821 B-Observation
) NCT03867500 822 823 O
unless NCT03867500 824 830 B-Exception
participant NCT03867500 831 842 O
has NCT03867500 843 846 O
fatty NCT03867500 847 852 B-Condition
liver NCT03867500 853 858 I-Condition
disease NCT03867500 859 866 I-Condition
, NCT03867500 867 868 O
Total NCT03867500 869 874 B-Observation
bilirubin NCT03867500 875 884 I-Observation
( NCT03867500 885 886 O
unless NCT03867500 887 893 B-Exception
the NCT03867500 894 897 O
patient NCT03867500 898 905 O
has NCT03867500 906 909 O
documented NCT03867500 910 920 O
Gilbert NCT03867500 921 928 B-Condition
's NCT03867500 928 930 I-Condition
syndrome NCT03867500 931 939 I-Condition
) NCT03867500 940 941 O

key NCT03867201 0 3 O
inclusion NCT03867201 4 13 O
Criteria NCT03867201 14 22 O
: NCT03867201 23 24 O

1 NCT03867201 28 29 O
. NCT03867201 29 30 O
History NCT03867201 32 39 B-Eq_Comparison
of NCT03867201 40 42 O
at NCT03867201 43 45 B-Eq_Comparison
least NCT03867201 46 51 I-Eq_Comparison
5 NCT03867201 52 53 I-Eq_Comparison
attacks NCT03867201 54 61 O
of NCT03867201 62 64 O
migraine NCT03867201 65 73 B-Condition

2 NCT03867201 76 77 O
. NCT03867201 77 78 O
≥ NCT03867201 80 81 B-Eq_Comparison
15 NCT03867201 82 84 I-Eq_Comparison
headache NCT03867201 85 93 B-Condition
days NCT03867201 94 98 O
of NCT03867201 99 101 B-And
which NCT03867201 102 107 I-And
≥ NCT03867201 108 109 B-Eq_Comparison
8 NCT03867201 110 111 I-Eq_Comparison
headache NCT03867201 112 120 B-Condition
days NCT03867201 121 125 O
meet NCT03867201 126 130 O
criteria NCT03867201 131 139 O
as NCT03867201 140 142 O
migraine NCT03867201 143 151 B-Condition
days NCT03867201 152 156 B-Eq_Comparison
during NCT03867201 157 163 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867201 164 167 O
baseline NCT03867201 168 176 B-Study
period NCT03867201 177 183 O

3 NCT03867201 186 187 O
. NCT03867201 187 188 O
> NCT03867201 190 191 B-Eq_Comparison
= NCT03867201 192 193 I-Eq_Comparison
80 NCT03867201 194 196 I-Eq_Comparison
% NCT03867201 197 198 I-Eq_Comparison
diary NCT03867201 199 204 B-Observation
compliance NCT03867201 205 215 I-Observation
during NCT03867201 216 222 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867201 223 226 O
baseline NCT03867201 227 235 B-Study
period NCT03867201 236 242 O

Key NCT03867201 243 246 O
exclusion NCT03867201 247 256 O
Criteria NCT03867201 257 265 O
: NCT03867201 266 267 O

1 NCT03867201 271 272 O
. NCT03867201 272 273 O
Older NCT03867201 275 280 B-Eq_Comparison
than NCT03867201 281 285 I-Eq_Comparison
50 NCT03867201 286 288 I-Eq_Comparison
years NCT03867201 289 294 I-Eq_Comparison
of NCT03867201 295 297 O
age NCT03867201 298 301 B-Age
at NCT03867201 302 304 B-Temporal_Connection___Temporal_Connection_Type_Value:during
migraine NCT03867201 305 313 B-Condition
onset NCT03867201 314 319 B-Eq_Comparison

2 NCT03867201 322 323 O
. NCT03867201 323 324 O
History NCT03867201 326 333 B-Eq_Comparison
of NCT03867201 334 336 O
cluster NCT03867201 337 344 B-Modifier
or NCT03867201 345 347 B-Or
hemiplegic NCT03867201 348 358 B-Modifier
headache NCT03867201 359 367 B-Condition

3 NCT03867201 370 371 O
. NCT03867201 371 372 O
Evidence NCT03867201 374 382 O
of NCT03867201 383 385 O
seizure NCT03867201 386 393 B-Condition
or NCT03867201 394 396 B-Or
major NCT03867201 397 402 O
psychiatric NCT03867201 403 414 B-Condition
disorder NCT03867201 415 423 I-Condition

4 NCT03867201 426 427 O
. NCT03867201 427 428 O
Cardiac NCT03867201 430 437 B-Modifier
or NCT03867201 438 440 B-Or
active NCT03867201 441 447 B-Eq_Comparison
hepatic NCT03867201 448 455 B-Condition
disease NCT03867201 456 463 I-Condition

5 NCT03867201 466 467 O
. NCT03867201 467 468 O
Pregnant NCT03867201 470 478 B-Condition
or NCT03867201 479 481 B-Or
nursing NCT03867201 482 489 B-Condition

Inclusion NCT03866707 0 9 O
Criteria NCT03866707 10 18 O
: NCT03866707 19 20 O

- NCT03866707 24 25 O
Childhood NCT03866707 27 36 O
cancer NCT03866707 37 43 B-Condition
survivors NCT03866707 44 53 O
age NCT03866707 54 57 B-Age
1 NCT03866707 58 59 B-Eq_Comparison
- NCT03866707 60 61 I-Eq_Comparison
18 NCT03866707 62 64 I-Eq_Comparison
years NCT03866707 65 70 I-Eq_Comparison
old NCT03866707 71 74 O
who NCT03866707 75 78 B-And
received NCT03866707 79 87 B-Eq_Comparison
intensive NCT03866707 88 97 O
treatment NCT03866707 98 107 B-Procedure
which NCT03866707 108 113 O
included NCT03866707 114 122 O
anthracycline NCT03866707 123 136 B-Drug
and NCT03866707 137 140 B-Or
/ NCT03866707 141 142 I-Or
or NCT03866707 143 145 I-Or
alkylating NCT03866707 146 156 B-Drug
agent NCT03866707 157 162 I-Drug
chemotherapy NCT03866707 163 175 B-Procedure
. NCT03866707 176 177 O

- NCT03866707 181 182 O
Diseases NCT03866707 184 192 B-Condition
which NCT03866707 193 198 O
will NCT03866707 199 203 O
be NCT03866707 204 206 O
eligible NCT03866707 207 215 O
include NCT03866707 216 223 O
, NCT03866707 224 225 O
high NCT03866707 226 230 O
risk NCT03866707 231 235 B-Risk
or NCT03866707 236 238 B-Or
very NCT03866707 239 243 O
high NCT03866707 244 248 O
risk NCT03866707 249 253 B-Risk
acute NCT03866707 254 259 O
lymphoblastic NCT03866707 260 273 B-Condition
leukemia NCT03866707 274 282 I-Condition
, NCT03866707 283 284 O
acute NCT03866707 285 290 O
myeloid NCT03866707 291 298 B-Condition
leukemia NCT03866707 299 307 I-Condition
, NCT03866707 308 309 O
Hodgkin NCT03866707 310 317 B-Condition
lymphoma NCT03866707 318 326 I-Condition
, NCT03866707 327 328 O
non NCT03866707 329 332 B-Negation
- NCT03866707 333 334 O
Hodgkin NCT03866707 335 342 B-Modifier
lymphoma NCT03866707 343 351 B-Condition
, NCT03866707 352 353 O
sarcomas NCT03866707 354 362 B-Condition
. NCT03866707 363 364 O

Healthy NCT03866707 366 373 B-Condition
controls NCT03866707 374 382 O
: NCT03866707 383 384 O

• NCT03866707 386 387 O
Healthy NCT03866707 388 395 B-Condition
controls NCT03866707 396 404 O
are NCT03866707 405 408 O
defined NCT03866707 409 416 O
as NCT03866707 417 419 O
children NCT03866707 420 428 O
ages NCT03866707 429 433 B-Age
1 NCT03866707 434 435 B-Eq_Comparison
- NCT03866707 436 437 I-Eq_Comparison
18 NCT03866707 438 440 I-Eq_Comparison
years NCT03866707 441 446 I-Eq_Comparison
old NCT03866707 447 450 O
who NCT03866707 451 454 B-And
are NCT03866707 455 458 O
free NCT03866707 459 463 B-Negation
from NCT03866707 464 468 I-Negation
diseases NCT03866707 469 477 B-Condition
or NCT03866707 478 480 B-Or
medical NCT03866707 481 488 B-Condition
conditions NCT03866707 489 499 I-Condition
that NCT03866707 500 504 O
might NCT03866707 505 510 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03866707 511 513 I-Assertion___Assertion_Type_Value:hypothetical
affected NCT03866707 514 522 O
by NCT03866707 523 525 O
or NCT03866707 526 528 B-Or
have NCT03866707 529 533 O
an NCT03866707 534 536 O
impact NCT03866707 537 543 O
on NCT03866707 544 546 O
this NCT03866707 547 551 O
research NCT03866707 552 560 O
study NCT03866707 561 566 B-Study
. NCT03866707 567 568 O
Healthy NCT03866707 570 577 B-Condition
controls NCT03866707 578 586 O
will NCT03866707 587 591 O
be NCT03866707 592 594 O
matched NCT03866707 595 602 O
with NCT03866707 603 607 O
patients NCT03866707 608 616 O
for NCT03866707 617 620 O
age NCT03866707 621 624 O
, NCT03866707 625 626 O
sex NCT03866707 627 630 O
, NCT03866707 631 632 O
ethnicity NCT03866707 633 642 O
, NCT03866707 643 644 O
geographic NCT03866707 645 655 O
region NCT03866707 656 662 O
, NCT03866707 663 664 O
and NCT03866707 665 668 O
tanner NCT03866707 669 675 O
stage NCT03866707 676 681 O
, NCT03866707 682 683 O
since NCT03866707 684 689 O
it NCT03866707 690 692 O
is NCT03866707 693 695 O
known NCT03866707 696 701 O
that NCT03866707 702 706 O
these NCT03866707 707 712 O
factors NCT03866707 713 720 O
can NCT03866707 721 724 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03866707 725 731 O
the NCT03866707 732 735 O
epigenetic NCT03866707 736 746 B-Observation
signature NCT03866707 747 756 I-Observation
of NCT03866707 757 759 O
an NCT03866707 760 762 O
individual NCT03866707 763 773 O
. NCT03866707 774 775 O
Controls NCT03866707 777 785 O
will NCT03866707 786 790 O
already NCT03866707 791 798 O
be NCT03866707 799 801 O
having NCT03866707 802 808 O
blood NCT03866707 809 814 B-Observation
drawn NCT03866707 815 820 O
as NCT03866707 821 823 O
part NCT03866707 824 828 O
of NCT03866707 829 831 O
their NCT03866707 832 837 O
routine NCT03866707 838 845 B-Procedure
care NCT03866707 846 850 I-Procedure
. NCT03866707 851 852 O

Exclusion NCT03866707 854 863 O
Criteria NCT03866707 864 872 O
: NCT03866707 873 874 O

Cancer NCT03866707 876 882 B-Condition
survivors NCT03866707 883 892 O
: NCT03866707 893 894 O

• NCT03866707 896 897 O
Patients NCT03866707 898 906 O
who NCT03866707 907 910 O
have NCT03866707 911 915 O
received NCT03866707 916 924 B-Eq_Comparison
a NCT03866707 925 926 O
bone NCT03866707 927 931 B-Procedure
marrow NCT03866707 932 938 I-Procedure
transplant NCT03866707 939 949 I-Procedure
will NCT03866707 950 954 O
not NCT03866707 955 958 B-Negation
be NCT03866707 959 961 O
eligible NCT03866707 962 970 O
. NCT03866707 971 972 O

Healthy NCT03866707 974 981 B-Condition
controls NCT03866707 982 990 O
: NCT03866707 991 992 O

• NCT03866707 994 995 O
Age NCT03866707 996 999 O
, NCT03866707 1000 1001 O
sex NCT03866707 1002 1005 O
, NCT03866707 1006 1007 O
ethnicity NCT03866707 1008 1017 O
, NCT03866707 1018 1019 O
geographic NCT03866707 1020 1030 O
region NCT03866707 1031 1037 O
, NCT03866707 1038 1039 O
and NCT03866707 1040 1043 O
tanner NCT03866707 1044 1050 O
stage NCT03866707 1051 1056 O
matched NCT03866707 1057 1064 O
controls NCT03866707 1065 1073 O
with NCT03866707 1074 1078 O
any NCT03866707 1079 1082 O
acute NCT03866707 1083 1088 O
or NCT03866707 1089 1091 B-Or
chronic NCT03866707 1092 1099 O
disease NCT03866707 1100 1107 B-Condition
will NCT03866707 1108 1112 O
be NCT03866707 1113 1115 O
excluded NCT03866707 1116 1124 B-Negation
. NCT03866707 1125 1126 O


Inclusion NCT03866226 0 9 O
Criteria NCT03866226 10 18 O
: NCT03866226 19 20 O

1 NCT03866226 24 25 O
. NCT03866226 25 26 O
Signed NCT03866226 28 34 O
written NCT03866226 35 42 O
informed NCT03866226 43 51 O
consent NCT03866226 52 59 O

2 NCT03866226 62 63 O
. NCT03866226 63 64 O
Age NCT03866226 66 69 B-Age
18 NCT03866226 70 72 B-Eq_Comparison
- NCT03866226 73 74 I-Eq_Comparison
80 NCT03866226 75 77 I-Eq_Comparison
years NCT03866226 78 83 I-Eq_Comparison

3 NCT03866226 86 87 O
. NCT03866226 87 88 O
Capable NCT03866226 90 97 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03866226 98 100 I-Assertion___Assertion_Type_Value:hypothetical
understanding NCT03866226 101 114 O
the NCT03866226 115 118 O
test NCT03866226 119 123 B-Procedure
and NCT03866226 124 127 B-And
cooperating NCT03866226 128 139 O
with NCT03866226 140 144 O
the NCT03866226 145 148 O
questionnaire NCT03866226 149 162 B-Observation
. NCT03866226 163 164 O

Exclusion NCT03866226 166 175 O
Criteria NCT03866226 176 184 O
: NCT03866226 185 186 O

1 NCT03866226 190 191 O
. NCT03866226 191 192 O
History NCT03866226 194 201 B-Eq_Comparison
of NCT03866226 202 204 O
psychosis NCT03866226 205 214 B-Condition
, NCT03866226 215 216 O
including NCT03866226 217 226 O
schizophrenia NCT03866226 227 240 B-Condition
, NCT03866226 241 242 O
bipolar NCT03866226 243 250 B-Condition
disorder NCT03866226 251 259 I-Condition
, NCT03866226 260 261 O
depression NCT03866226 262 272 B-Condition
, NCT03866226 273 274 O
anxiety NCT03866226 275 282 B-Condition
, NCT03866226 283 284 O
obsessive NCT03866226 285 294 B-Condition
- NCT03866226 295 296 I-Condition
compulsive NCT03866226 297 307 I-Condition
disorder NCT03866226 308 316 I-Condition
, NCT03866226 317 318 O
phobia NCT03866226 319 325 B-Condition
, NCT03866226 326 327 O
somatoform NCT03866226 328 338 B-Condition
disorder NCT03866226 339 347 I-Condition
, NCT03866226 348 349 O
stress NCT03866226 350 356 B-Condition
- NCT03866226 357 358 I-Condition
related NCT03866226 359 366 I-Condition
disorders NCT03866226 367 376 I-Condition

2 NCT03866226 379 380 O
. NCT03866226 380 381 O
History NCT03866226 383 390 B-Eq_Comparison
of NCT03866226 391 393 O
insomnia NCT03866226 394 402 B-Condition
, NCT03866226 403 404 O
currently NCT03866226 405 414 B-Eq_Comparison
with NCT03866226 415 419 O
medication NCT03866226 420 430 B-Drug

3 NCT03866226 433 434 O
. NCT03866226 434 435 O
History NCT03866226 437 444 B-Eq_Comparison
of NCT03866226 445 447 O
obstructive NCT03866226 448 459 B-Condition
sleep NCT03866226 460 465 I-Condition
apnea NCT03866226 466 471 I-Condition
( NCT03866226 472 473 O
OSA NCT03866226 474 477 B-Condition
) NCT03866226 478 479 O

4 NCT03866226 483 484 O
. NCT03866226 484 485 O
History NCT03866226 487 494 B-Eq_Comparison
of NCT03866226 495 497 O
other NCT03866226 498 503 B-Other
sleep NCT03866226 504 509 B-Condition
disorders NCT03866226 510 519 I-Condition
, NCT03866226 520 521 O
including NCT03866226 522 531 O
narcolepsy NCT03866226 532 542 B-Condition
/ NCT03866226 543 544 B-Or
hypersomnias NCT03866226 545 557 B-Condition
, NCT03866226 558 559 O
circadian NCT03866226 560 569 B-Condition
rhythm NCT03866226 570 576 I-Condition
sleep NCT03866226 577 582 I-Condition
disorder NCT03866226 583 591 I-Condition
, NCT03866226 592 593 O
parasomnias NCT03866226 594 605 B-Condition
, NCT03866226 606 607 O
sleep NCT03866226 608 613 B-Modifier
- NCT03866226 614 615 I-Modifier
related NCT03866226 616 623 I-Modifier
dyskinesia NCT03866226 624 634 B-Condition

5 NCT03866226 637 638 O
. NCT03866226 638 639 O
History NCT03866226 641 648 B-Eq_Comparison
of NCT03866226 649 651 O
heart NCT03866226 652 657 B-Condition
failure NCT03866226 658 665 I-Condition
, NCT03866226 666 667 O
that NCT03866226 668 672 O
is NCT03866226 673 675 O
New NCT03866226 676 679 B-Observation
York NCT03866226 680 684 I-Observation
heart NCT03866226 685 690 I-Observation
association NCT03866226 691 702 I-Observation
( NCT03866226 703 704 O
NYHA NCT03866226 705 709 B-Observation
) NCT03866226 710 711 O
Class NCT03866226 712 717 B-Eq_Comparison
Ⅲ NCT03866226 718 719 I-Eq_Comparison
- NCT03866226 720 721 I-Eq_Comparison
Ⅳ NCT03866226 722 723 I-Eq_Comparison

6 NCT03866226 726 727 O
. NCT03866226 727 728 O
History NCT03866226 730 737 B-Eq_Comparison
of NCT03866226 738 740 O
atrial NCT03866226 741 747 B-Condition
fibrillation NCT03866226 748 760 I-Condition
and NCT03866226 761 764 B-Or
frequent NCT03866226 765 773 O
atrial NCT03866226 774 780 B-Modifier
or NCT03866226 781 783 B-Or
ventricular NCT03866226 784 795 B-Modifier
extrasystoles NCT03866226 796 809 B-Condition

7 NCT03866226 812 813 O
. NCT03866226 813 814 O
Ongoing NCT03866226 816 823 B-Eq_Comparison
substance NCT03866226 824 833 B-Modifier
or NCT03866226 834 836 B-Or
alcohol NCT03866226 837 844 B-Modifier
abuse NCT03866226 845 850 B-Condition

8 NCT03866226 853 854 O
. NCT03866226 854 855 O
Currently NCT03866226 857 866 B-Eq_Comparison
receiving NCT03866226 867 876 I-Eq_Comparison
sedative NCT03866226 877 885 B-Drug
hypnotic NCT03866226 886 894 I-Drug
medication NCT03866226 895 905 I-Drug
within NCT03866226 906 912 B-Eq_Comparison
1 NCT03866226 913 914 I-Eq_Comparison
week NCT03866226 915 919 I-Eq_Comparison

9 NCT03866226 922 923 O
. NCT03866226 923 924 O
Pregnant NCT03866226 926 934 B-Condition
women NCT03866226 935 940 O

10 NCT03866226 942 944 O
. NCT03866226 944 945 O
Ongoing NCT03866226 947 954 B-Eq_Comparison
involvement NCT03866226 955 966 O
in NCT03866226 967 969 O
night NCT03866226 970 975 B-Observation
- NCT03866226 976 977 I-Observation
shift NCT03866226 978 983 I-Observation
work NCT03866226 984 988 I-Observation
( NCT03866226 989 990 O
22 NCT03866226 991 993 B-Eq_Comparison
: NCT03866226 994 995 I-Eq_Comparison
00 NCT03866226 996 998 I-Eq_Comparison
- NCT03866226 999 1000 I-Eq_Comparison
6 NCT03866226 1001 1002 I-Eq_Comparison
: NCT03866226 1003 1004 I-Eq_Comparison
00 NCT03866226 1005 1007 I-Eq_Comparison
) NCT03866226 1008 1009 O
within NCT03866226 1010 1016 B-Eq_Comparison
1 NCT03866226 1017 1018 I-Eq_Comparison
week NCT03866226 1019 1023 I-Eq_Comparison

11 NCT03866226 1025 1027 O
. NCT03866226 1027 1028 O
Ongoing NCT03866226 1030 1037 O
need NCT03866226 1038 1042 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03866226 1043 1045 I-Assertion___Assertion_Type_Value:hypothetical
care NCT03866226 1046 1050 B-Procedure
of NCT03866226 1051 1053 O
families NCT03866226 1054 1062 B-Family_Member
at NCT03866226 1063 1065 I-Family_Member
home NCT03866226 1066 1070 I-Family_Member
that NCT03866226 1071 1075 O
wake NCT03866226 1076 1080 B-Condition
during NCT03866226 1081 1087 I-Condition
the NCT03866226 1088 1091 I-Condition
night NCT03866226 1092 1097 I-Condition
within NCT03866226 1098 1104 B-Eq_Comparison
1 NCT03866226 1105 1106 I-Eq_Comparison
week NCT03866226 1107 1111 I-Eq_Comparison

12 NCT03866226 1113 1115 O
. NCT03866226 1115 1116 O
Incomprehensible NCT03866226 1118 1134 O
or NCT03866226 1135 1137 O
unwilling NCT03866226 1138 1147 O
to NCT03866226 1148 1150 O
fill NCT03866226 1151 1155 O
in NCT03866226 1156 1158 O
informed NCT03866226 1159 1167 O
consent NCT03866226 1168 1175 O
or NCT03866226 1176 1178 O
questionnaire NCT03866226 1179 1192 O

Inclusion NCT03868787 0 9 O
Criteria NCT03868787 10 18 O
: NCT03868787 19 20 O

1 NCT03868787 24 25 O
. NCT03868787 25 26 O
Women NCT03868787 28 33 O
≥ NCT03868787 34 35 B-Eq_Comparison
18 NCT03868787 36 38 I-Eq_Comparison
years NCT03868787 39 44 I-Eq_Comparison
of NCT03868787 45 47 O
age NCT03868787 48 51 B-Age

2 NCT03868787 54 55 O
. NCT03868787 55 56 O
Gestational NCT03868787 58 69 B-Observation
age NCT03868787 70 73 I-Observation
between NCT03868787 74 81 B-Eq_Comparison
14 NCT03868787 82 84 I-Eq_Comparison
weeks NCT03868787 85 90 I-Eq_Comparison
and NCT03868787 91 94 I-Eq_Comparison
23 NCT03868787 95 97 I-Eq_Comparison
weeks NCT03868787 98 103 I-Eq_Comparison
6 NCT03868787 104 105 I-Eq_Comparison
days NCT03868787 106 110 I-Eq_Comparison

3 NCT03868787 113 114 O
. NCT03868787 114 115 O
Willing NCT03868787 117 124 O
and NCT03868787 125 128 O
able NCT03868787 129 133 O
to NCT03868787 134 136 O
sign NCT03868787 137 141 O
an NCT03868787 142 144 O
informed NCT03868787 145 153 O
consent NCT03868787 154 161 O
in NCT03868787 162 164 O
English NCT03868787 165 172 O

4 NCT03868787 175 176 O
. NCT03868787 176 177 O
No NCT03868787 179 181 B-Negation
contraindications NCT03868787 182 199 B-Contraindication
to NCT03868787 200 202 O
TENS NCT03868787 203 207 B-Procedure

Exclusion NCT03868787 208 217 O
Criteria NCT03868787 218 226 O
: NCT03868787 227 228 O

1 NCT03868787 232 233 O
. NCT03868787 233 234 O
Incarceration NCT03868787 236 249 B-Observation

2 NCT03868787 252 253 O
. NCT03868787 253 254 O
Preterm NCT03868787 256 263 B-Condition
Premature NCT03868787 264 273 I-Condition
Rupture NCT03868787 274 281 I-Condition
of NCT03868787 282 284 O
Membranes NCT03868787 285 294 B-Modifier
or NCT03868787 295 297 B-Or
evidence NCT03868787 298 306 O
of NCT03868787 307 309 O
intra NCT03868787 310 315 B-Modifier
- NCT03868787 316 317 I-Modifier
amniotic NCT03868787 318 326 I-Modifier
infection NCT03868787 327 336 B-Condition

3 NCT03868787 339 340 O
. NCT03868787 340 341 O
Presence NCT03868787 343 351 O
of NCT03868787 352 354 O
implanted NCT03868787 355 364 B-Procedure
cardiac NCT03868787 365 372 I-Procedure
device NCT03868787 373 379 I-Procedure

4 NCT03868787 382 383 O
. NCT03868787 383 384 O
Lack NCT03868787 386 390 B-Negation
of NCT03868787 391 393 O
sensation NCT03868787 394 403 B-Condition
to NCT03868787 404 406 I-Condition
touch NCT03868787 407 412 I-Condition
on NCT03868787 413 415 O
area NCT03868787 416 420 B-Modifier
of NCT03868787 421 423 O
electrode NCT03868787 424 433 B-Procedure
placement NCT03868787 434 443 I-Procedure

5 NCT03868787 446 447 O
. NCT03868787 447 448 O
Prior NCT03868787 450 455 B-Eq_Comparison
TENS NCT03868787 456 460 B-Procedure
use NCT03868787 461 464 O

6 NCT03868787 467 468 O
. NCT03868787 468 469 O
Opioid NCT03868787 471 477 B-Condition
dependence NCT03868787 478 488 I-Condition

Inclusion NCT03924297 0 9 O
Criteria NCT03924297 10 18 O
: NCT03924297 19 20 O

- NCT03924297 24 25 O
Patients NCT03924297 27 35 O
who NCT03924297 36 39 O
have NCT03924297 40 44 O
seen NCT03924297 45 49 B-Encounter
the NCT03924297 50 53 O
study NCT03924297 54 59 O
PI NCT03924297 60 62 O
( NCT03924297 63 64 O
Remy NCT03924297 65 69 B-Provider
Coeytaux NCT03924297 70 78 I-Provider
, NCT03924297 79 80 I-Provider
MD NCT03924297 81 83 I-Provider
, NCT03924297 84 85 I-Provider
PhD NCT03924297 86 89 I-Provider
) NCT03924297 90 91 O
for NCT03924297 92 95 O
an NCT03924297 96 98 O
integrative NCT03924297 99 110 O
medicine NCT03924297 111 119 O
consultation NCT03924297 120 132 O
between NCT03924297 133 140 B-Eq_Comparison
September NCT03924297 141 150 I-Eq_Comparison
1 NCT03924297 151 152 I-Eq_Comparison
, NCT03924297 153 154 I-Eq_Comparison
2018 NCT03924297 155 159 I-Eq_Comparison
and NCT03924297 160 163 I-Eq_Comparison
April NCT03924297 164 169 I-Eq_Comparison
30 NCT03924297 170 172 I-Eq_Comparison
, NCT03924297 173 174 I-Eq_Comparison
2019 NCT03924297 175 179 I-Eq_Comparison
and NCT03924297 180 183 B-And
who NCT03924297 184 187 O
report NCT03924297 188 194 O
having NCT03924297 195 201 O
been NCT03924297 202 206 O
diagnoses NCT03924297 207 216 O
with NCT03924297 217 221 O
PTSD NCT03924297 222 226 B-Condition
or NCT03924297 227 229 B-Or
who NCT03924297 230 233 O
believe NCT03924297 234 241 O
they NCT03924297 242 246 O
may NCT03924297 247 250 B-Assertion___Assertion_Type_Value:possible
have NCT03924297 251 255 O
PTSD NCT03924297 256 260 B-Condition
or NCT03924297 261 263 B-Or
PTSD NCT03924297 264 268 B-Condition
- NCT03924297 269 270 O
related NCT03924297 271 278 O
symptoms NCT03924297 279 287 B-Assertion___Assertion_Type_Value:possible
are NCT03924297 288 291 O
eligible NCT03924297 292 300 O
to NCT03924297 301 303 O
participate NCT03924297 304 315 O
. NCT03924297 316 317 O

Exclusion NCT03924297 319 328 O
Criteria NCT03924297 329 337 O
: NCT03924297 338 339 O

- NCT03924297 343 344 O
No NCT03924297 346 348 O
exclusion NCT03924297 349 358 O
criteria NCT03924297 359 367 O

Inclusion NCT03868254 0 9 O
Criteria NCT03868254 10 18 O
: NCT03868254 19 20 O

- NCT03868254 24 25 O
Eye NCT03868254 27 30 B-Modifier
treated NCT03868254 31 38 B-Procedure
with NCT03868254 39 43 O
XEN NCT03868254 44 47 B-Modifier
45 NCT03868254 48 50 I-Modifier
Gel NCT03868254 51 54 B-Procedure
Stent NCT03868254 55 60 I-Procedure
for NCT03868254 61 64 O
primary NCT03868254 65 72 B-Modifier
open NCT03868254 73 77 I-Modifier
angle NCT03868254 78 83 I-Modifier
glaucoma NCT03868254 84 92 B-Condition
as NCT03868254 93 95 O
a NCT03868254 96 97 O
standalone NCT03868254 98 108 O
procedure NCT03868254 109 118 O
or NCT03868254 119 121 B-Or
in NCT03868254 122 124 B-Modifier
combination NCT03868254 125 136 I-Modifier
with NCT03868254 137 141 O
phacoemulsification NCT03868254 142 161 B-Procedure

- NCT03868254 164 165 O
XEN NCT03868254 167 170 B-Modifier
45 NCT03868254 171 173 I-Modifier
Gel NCT03868254 174 177 B-Procedure
Stent NCT03868254 178 183 I-Procedure
was NCT03868254 184 187 O
implanted NCT03868254 188 197 O
between NCT03868254 198 205 B-Eq_Comparison
1 NCT03868254 206 207 I-Eq_Comparison
January NCT03868254 208 215 I-Eq_Comparison
2014 NCT03868254 216 220 I-Eq_Comparison
and NCT03868254 221 224 I-Eq_Comparison
1 NCT03868254 225 226 I-Eq_Comparison
October NCT03868254 227 234 I-Eq_Comparison
2015 NCT03868254 235 239 I-Eq_Comparison

Exclusion NCT03868254 241 250 O
Criteria NCT03868254 251 259 O

- NCT03868254 262 263 O
None NCT03868254 265 269 O

Inclusion NCT03868033 0 9 O
Criteria NCT03868033 10 18 O
: NCT03868033 19 20 O

1 NCT03868033 24 25 O
. NCT03868033 25 26 O
Postmenopausal NCT03868033 28 42 B-Condition
women NCT03868033 43 48 O

2 NCT03868033 51 52 O
. NCT03868033 52 53 O
Men NCT03868033 55 58 O
> NCT03868033 59 60 B-Eq_Comparison
50 NCT03868033 61 63 I-Eq_Comparison
- NCT03868033 64 65 I-Eq_Comparison
year NCT03868033 66 70 I-Eq_Comparison
- NCT03868033 71 72 O
old NCT03868033 73 76 B-Age

3 NCT03868033 79 80 O
. NCT03868033 80 81 O
After NCT03868033 83 88 B-Eq_Comparison
Denosumab NCT03868033 89 98 B-Drug
treatment NCT03868033 99 108 B-Procedure
≥ NCT03868033 109 110 B-Eq_Comparison
2 NCT03868033 111 112 I-Eq_Comparison
years NCT03868033 113 118 I-Eq_Comparison
due NCT03868033 119 122 O
to NCT03868033 123 125 O
osteoporosis NCT03868033 126 138 B-Condition

Exclusion NCT03868033 139 148 O
Criteria NCT03868033 149 157 O
: NCT03868033 158 159 O

1 NCT03868033 163 164 O
. NCT03868033 164 165 O
secondary NCT03868033 167 176 B-Modifier
osteoporosis NCT03868033 177 189 B-Condition

2 NCT03868033 192 193 O
. NCT03868033 193 194 O
metabolic NCT03868033 196 205 B-Condition
bone NCT03868033 206 210 I-Condition
disease NCT03868033 211 218 I-Condition

3 NCT03868033 221 222 O
. NCT03868033 222 223 O
cancer NCT03868033 225 231 B-Condition
history NCT03868033 232 239 B-Eq_Comparison

4 NCT03868033 242 243 O
. NCT03868033 243 244 O
continuous NCT03868033 246 256 B-Eq_Comparison
steroid NCT03868033 257 264 B-Procedure
therapy NCT03868033 265 272 I-Procedure

5 NCT03868033 275 276 O
. NCT03868033 276 277 O
hormone NCT03868033 279 286 B-Procedure
replacement NCT03868033 287 298 I-Procedure
therapy NCT03868033 299 306 I-Procedure

6 NCT03868033 309 310 O
. NCT03868033 310 311 O
ever NCT03868033 313 317 B-Eq_Comparison
used NCT03868033 318 322 O
any NCT03868033 323 326 O
other NCT03868033 327 332 B-Other
kind NCT03868033 333 337 O
of NCT03868033 338 340 O
anti NCT03868033 341 345 B-Procedure
- NCT03868033 346 347 I-Procedure
resorptive NCT03868033 348 358 I-Procedure
treatment NCT03868033 359 368 I-Procedure

6 NCT03868033 371 372 O
. NCT03868033 372 373 O
estimated NCT03868033 375 384 B-Observation
Glomerular NCT03868033 385 395 I-Observation
filtration NCT03868033 396 406 I-Observation
rate NCT03868033 407 411 I-Observation
< NCT03868033 412 413 B-Eq_Comparison
35 NCT03868033 414 416 I-Eq_Comparison
mL NCT03868033 417 419 I-Eq_Comparison
/ NCT03868033 420 421 I-Eq_Comparison
min NCT03868033 422 425 I-Eq_Comparison

7 NCT03868033 429 430 O
. NCT03868033 430 431 O
allergy NCT03868033 433 440 B-Allergy
to NCT03868033 441 443 O
Zoledronic NCT03868033 444 454 B-Drug
acid NCT03868033 455 459 I-Drug

8 NCT03868033 462 463 O
. NCT03868033 463 464 O
hypocalcaemia NCT03868033 466 479 B-Condition

9 NCT03868033 483 484 O
. NCT03868033 484 485 O
any NCT03868033 487 490 O
contraindications NCT03868033 491 508 B-Contraindication
to NCT03868033 509 511 O
use NCT03868033 512 515 O
Zoledronic NCT03868033 516 526 B-Drug
acid NCT03868033 527 531 I-Drug


Inclusion NCT03865355 0 9 O
Criteria NCT03865355 10 18 O
: NCT03865355 19 20 O

1 NCT03865355 24 25 O
. NCT03865355 25 26 O
All NCT03865355 28 31 O
patients NCT03865355 32 40 O
with NCT03865355 41 45 O
suspected NCT03865355 46 55 B-Assertion___Assertion_Type_Value:possible
newly NCT03865355 56 61 B-Eq_Comparison
diagnosed NCT03865355 62 71 O
glioma NCT03865355 72 78 B-Condition
( NCT03865355 79 80 O
grade NCT03865355 81 86 B-Eq_Comparison
I NCT03865355 87 88 I-Eq_Comparison
, NCT03865355 89 90 I-Eq_Comparison
II NCT03865355 91 93 I-Eq_Comparison
, NCT03865355 94 95 I-Eq_Comparison
III NCT03865355 96 99 I-Eq_Comparison
or NCT03865355 100 102 B-Or
glioblastoma NCT03865355 103 115 B-Condition
) NCT03865355 116 117 O
with NCT03865355 118 122 B-And
planned NCT03865355 123 130 B-Eq_Comparison
surgical NCT03865355 131 139 B-Procedure
intervention NCT03865355 140 152 I-Procedure
( NCT03865355 153 154 O
resection NCT03865355 155 164 B-Procedure
or NCT03865355 165 167 B-Or
biopsy NCT03865355 168 174 B-Procedure
) NCT03865355 175 176 O
. NCT03865355 177 178 O

2 NCT03865355 182 183 O
. NCT03865355 183 184 O
Patient NCT03865355 186 193 O
aged NCT03865355 194 198 B-Age
18 NCT03865355 199 201 B-Eq_Comparison
years NCT03865355 202 207 I-Eq_Comparison
or NCT03865355 208 210 I-Eq_Comparison
older NCT03865355 211 216 I-Eq_Comparison

3 NCT03865355 219 220 O
. NCT03865355 220 221 O
Patients NCT03865355 223 231 O
have NCT03865355 232 236 O
to NCT03865355 237 239 O
be NCT03865355 240 242 O
able NCT03865355 243 247 O
to NCT03865355 248 250 O
give NCT03865355 251 255 O
informed NCT03865355 256 264 O
consent NCT03865355 265 272 O

Exclusion NCT03865355 273 282 O
Criteria NCT03865355 283 291 O
: NCT03865355 292 293 O

1 NCT03865355 297 298 O
. NCT03865355 298 299 O
Prior NCT03865355 301 306 B-Eq_Comparison
Radiotherapy NCT03865355 307 319 B-Procedure
to NCT03865355 320 322 O
the NCT03865355 323 326 O
central NCT03865355 327 334 B-Modifier
nervous NCT03865355 335 342 I-Modifier
system NCT03865355 343 349 I-Modifier

2 NCT03865355 352 353 O
. NCT03865355 353 354 O
Prior NCT03865355 356 361 B-Eq_Comparison
Chemotherapy NCT03865355 362 374 B-Procedure
within NCT03865355 375 381 B-Eq_Comparison
the NCT03865355 382 385 I-Eq_Comparison
last NCT03865355 386 390 I-Eq_Comparison
5 NCT03865355 391 392 I-Eq_Comparison
years NCT03865355 393 398 I-Eq_Comparison

3 NCT03865355 401 402 O
. NCT03865355 402 403 O
Any NCT03865355 405 408 O
prior NCT03865355 409 414 B-Eq_Comparison
central NCT03865355 415 422 B-Modifier
nervous NCT03865355 423 430 I-Modifier
system NCT03865355 431 437 I-Modifier
malignancy NCT03865355 438 448 B-Condition

4 NCT03865355 451 452 O
. NCT03865355 452 453 O
Any NCT03865355 455 458 O
surgery NCT03865355 459 466 B-Procedure
during NCT03865355 467 473 B-Temporal_Connection___Temporal_Connection_Type_Value:during
last NCT03865355 474 478 B-Eq_Comparison
6 NCT03865355 479 480 I-Eq_Comparison
month NCT03865355 481 486 I-Eq_Comparison

Inclusion NCT03928626 0 9 O
Criteria NCT03928626 10 18 O
: NCT03928626 19 20 O

1 NCT03928626 24 25 O
. NCT03928626 25 26 O
Adults NCT03928626 28 34 O
ages NCT03928626 35 39 B-Age
18 NCT03928626 40 42 B-Eq_Comparison
- NCT03928626 43 44 I-Eq_Comparison
25 NCT03928626 45 47 I-Eq_Comparison

2 NCT03928626 51 52 O
. NCT03928626 52 53 O
Capability NCT03928626 55 65 O
of NCT03928626 66 68 O
performing NCT03928626 69 79 O
the NCT03928626 80 83 O
experimental NCT03928626 84 96 O
tasks NCT03928626 97 102 O
( NCT03928626 103 104 O
e NCT03928626 105 106 O
. NCT03928626 107 108 O
g NCT03928626 109 110 O
. NCT03928626 111 112 O
, NCT03928626 113 114 O
can NCT03928626 115 118 O
read NCT03928626 119 123 O
, NCT03928626 124 125 O
able NCT03928626 126 130 O
to NCT03928626 131 133 O
use NCT03928626 134 137 O
computers NCT03928626 138 147 O
) NCT03928626 148 149 O

3 NCT03928626 153 154 O
. NCT03928626 154 155 O
Native NCT03928626 157 163 O
or NCT03928626 164 166 O
fluent NCT03928626 167 173 O
speaker NCT03928626 174 181 O
of NCT03928626 182 184 O
English NCT03928626 185 192 O

4 NCT03928626 195 196 O
. NCT03928626 196 197 O
Provides NCT03928626 199 207 O
informed NCT03928626 208 216 O
consent NCT03928626 217 224 O

5 NCT03928626 227 228 O
. NCT03928626 228 229 O
Normal NCT03928626 231 237 O
or NCT03928626 238 240 B-Or
corrected NCT03928626 241 250 O
- NCT03928626 251 252 O
to NCT03928626 253 255 O
- NCT03928626 256 257 O
normal NCT03928626 258 264 O
vision NCT03928626 265 271 B-Condition

6 NCT03928626 274 275 O
. NCT03928626 275 276 O
Willing NCT03928626 278 285 O
to NCT03928626 286 288 O
commit NCT03928626 289 295 O
to NCT03928626 296 298 O
the NCT03928626 299 302 O
full NCT03928626 303 307 O
length NCT03928626 308 314 O
of NCT03928626 315 317 O
the NCT03928626 318 321 O
protocol NCT03928626 322 330 O

7 NCT03928626 333 334 O
. NCT03928626 334 335 O
Heavy NCT03928626 337 342 B-Condition
drinking NCT03928626 343 351 I-Condition
or NCT03928626 352 354 B-Or
binge NCT03928626 355 360 B-Condition
- NCT03928626 361 362 I-Condition
drinking NCT03928626 363 371 I-Condition

Exclusion NCT03928626 372 381 O
Criteria NCT03928626 382 390 O
. NCT03928626 391 392 O

1 NCT03928626 396 397 O
. NCT03928626 397 398 O
Present NCT03928626 400 407 B-Eq_Comparison
DSM NCT03928626 408 411 B-Condition
disorders NCT03928626 412 421 I-Condition
, NCT03928626 422 423 O
apart NCT03928626 424 429 B-Exception
from NCT03928626 430 434 I-Exception
alcohol NCT03928626 435 442 B-Condition
use NCT03928626 443 446 I-Condition
disorders NCT03928626 447 456 I-Condition

2 NCT03928626 459 460 O
. NCT03928626 460 461 O
Reports NCT03928626 463 470 O
of NCT03928626 471 473 O
neurological NCT03928626 474 486 B-Modifier
or NCT03928626 487 489 B-Or
systemic NCT03928626 490 498 B-Modifier
disorders NCT03928626 499 508 B-Condition
that NCT03928626 509 513 O
can NCT03928626 514 517 B-Assertion___Assertion_Type_Value:hypothetical
cause NCT03928626 518 523 O
cognitive NCT03928626 524 533 B-Condition
impairment NCT03928626 534 544 I-Condition

3 NCT03928626 547 548 O
. NCT03928626 548 549 O
Minor NCT03928626 551 556 O
cognitive NCT03928626 557 566 B-Condition
impairment NCT03928626 567 577 I-Condition
evidenced NCT03928626 578 587 O
by NCT03928626 588 590 O
an NCT03928626 591 593 O
inability NCT03928626 594 603 B-Condition
to NCT03928626 604 606 I-Condition
correctly NCT03928626 607 616 I-Condition
understand NCT03928626 617 627 I-Condition
study NCT03928626 628 633 B-Study
information NCT03928626 634 645 O

4 NCT03928626 648 649 O
. NCT03928626 649 650 O
Reports NCT03928626 652 659 O
entirely NCT03928626 660 668 O
no NCT03928626 669 671 B-Negation
interest NCT03928626 672 680 B-Assertion___Assertion_Type_Value:intention
in NCT03928626 681 683 O
reducing NCT03928626 684 692 O
the NCT03928626 693 696 O
amount NCT03928626 697 703 O
of NCT03928626 704 706 O
drinking NCT03928626 707 715 B-Condition
( NCT03928626 716 717 O
Alcohol NCT03928626 718 725 B-Observation
Contemplation NCT03928626 726 739 I-Observation
Ladder NCT03928626 740 746 I-Observation
score NCT03928626 747 752 I-Observation
of NCT03928626 753 755 O
9 NCT03928626 756 757 B-Eq_Comparison
or NCT03928626 758 760 I-Eq_Comparison
10 NCT03928626 761 763 I-Eq_Comparison
) NCT03928626 764 765 O
. NCT03928626 766 767 O

Inclusion NCT03929614 0 9 O
Criteria NCT03929614 10 18 O
: NCT03929614 19 20 O

- NCT03929614 24 25 O
AIS NCT03929614 27 30 B-Condition
. NCT03929614 31 32 O

- NCT03929614 36 37 O
10 NCT03929614 39 41 B-Eq_Comparison
- NCT03929614 42 43 I-Eq_Comparison
16 NCT03929614 44 46 I-Eq_Comparison
years NCT03929614 47 52 I-Eq_Comparison
old NCT03929614 53 56 B-Age
, NCT03929614 57 58 O
with NCT03929614 59 63 B-And
brace NCT03929614 64 69 B-Procedure
treatment NCT03929614 70 79 I-Procedure
. NCT03929614 80 81 O

- NCT03929614 85 86 O
Ability NCT03929614 88 95 O
to NCT03929614 96 98 O
read NCT03929614 99 103 O
and NCT03929614 104 107 O
understand NCT03929614 108 118 O
English NCT03929614 119 126 O
or NCT03929614 127 129 B-Or
French NCT03929614 130 136 O
. NCT03929614 137 138 O

- NCT03929614 142 143 O
Physical NCT03929614 145 153 O
and NCT03929614 154 157 O
mental NCT03929614 158 164 O
ability NCT03929614 165 172 O
to NCT03929614 173 175 O
adhere NCT03929614 176 182 O
to NCT03929614 183 185 O
bracing NCT03929614 186 193 O
protocol NCT03929614 194 202 O
. NCT03929614 203 204 O

Exclusion NCT03929614 206 215 O
Criteria NCT03929614 216 224 O
: NCT03929614 225 226 O

- NCT03929614 230 231 O
Diagnosis NCT03929614 233 242 O
of NCT03929614 243 245 O
other NCT03929614 246 251 B-Other
musculoskeletal NCT03929614 252 267 B-Modifier
or NCT03929614 268 270 B-Or
developmental NCT03929614 271 284 B-Modifier
illness NCT03929614 285 292 B-Condition
that NCT03929614 293 297 O
might NCT03929614 298 303 B-Assertion___Assertion_Type_Value:possible
be NCT03929614 304 306 I-Assertion___Assertion_Type_Value:possible
responsible NCT03929614 307 318 O
for NCT03929614 319 322 O
the NCT03929614 323 326 O
spinal NCT03929614 327 333 B-Condition
curvature NCT03929614 334 343 I-Condition
. NCT03929614 344 345 O

- NCT03929614 349 350 O
Patients NCT03929614 352 360 O
with NCT03929614 361 365 O
symptom NCT03929614 366 373 B-Assertion___Assertion_Type_Value:possible
of NCT03929614 374 376 O
a NCT03929614 377 378 O
neurological NCT03929614 379 391 B-Condition
disorder NCT03929614 392 400 I-Condition
. NCT03929614 401 402 O

- NCT03929614 406 407 O
Patients NCT03929614 409 417 O
with NCT03929614 418 422 O
any NCT03929614 423 426 O
other NCT03929614 427 432 O
disorder NCT03929614 433 441 B-Condition
of NCT03929614 442 444 I-Condition
the NCT03929614 445 448 I-Condition
musculoskeletal NCT03929614 449 464 I-Condition
system NCT03929614 465 471 I-Condition
affecting NCT03929614 472 481 O
the NCT03929614 482 485 O
lower NCT03929614 486 491 B-Modifier
limbs NCT03929614 492 497 I-Modifier
, NCT03929614 498 499 O

Inclusion NCT03926611 0 9 O
Criteria NCT03926611 10 18 O
: NCT03926611 19 20 O

- NCT03926611 24 25 O
Male NCT03926611 27 31 O
and NCT03926611 32 35 B-Or
female NCT03926611 36 42 O
subjects NCT03926611 43 51 O
aged NCT03926611 52 56 B-Age
≥ NCT03926611 57 58 B-Eq_Comparison
18 NCT03926611 59 61 I-Eq_Comparison
years NCT03926611 62 67 I-Eq_Comparison
of NCT03926611 68 70 O
age NCT03926611 71 74 O

- NCT03926611 77 78 O
CSU NCT03926611 80 83 B-Condition
diagnosis NCT03926611 84 93 O
for NCT03926611 94 97 O
≥ NCT03926611 98 99 B-Eq_Comparison
6 NCT03926611 100 101 I-Eq_Comparison
months NCT03926611 102 108 I-Eq_Comparison
prior NCT03926611 109 114 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926611 115 117 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03926611 118 127 B-Study

- NCT03926611 130 131 O
Presence NCT03926611 133 141 O
of NCT03926611 142 144 O
itch NCT03926611 145 149 B-Condition
and NCT03926611 150 153 B-And
hives NCT03926611 154 159 B-Condition
for NCT03926611 160 163 O
≥ NCT03926611 164 165 B-Eq_Comparison
6 NCT03926611 166 167 I-Eq_Comparison
consecutive NCT03926611 168 179 I-Eq_Comparison
weeks NCT03926611 180 185 I-Eq_Comparison
prior NCT03926611 186 191 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926611 192 194 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03926611 195 204 B-Study
in NCT03926611 205 207 B-And
spite NCT03926611 208 213 I-And
of NCT03926611 214 216 I-And
use NCT03926611 217 220 O
of NCT03926611 221 223 O
non NCT03926611 224 227 B-Negation
- NCT03926611 228 229 O
sedating NCT03926611 230 238 B-Modifier
H NCT03926611 239 240 B-Drug
1 NCT03926611 241 242 I-Drug
- NCT03926611 243 244 I-Drug
antihistamines NCT03926611 245 259 I-Drug
according NCT03926611 260 269 O
to NCT03926611 270 272 O
local NCT03926611 273 278 O
Treatment NCT03926611 279 288 O
guidelines NCT03926611 289 299 O
during NCT03926611 300 306 O
this NCT03926611 307 311 O
time NCT03926611 312 316 O
period NCT03926611 317 323 O

- NCT03926611 326 327 O
UAS NCT03926611 329 332 B-Observation
7 NCT03926611 333 334 I-Observation
score NCT03926611 335 340 I-Observation
( NCT03926611 341 342 O
range NCT03926611 343 348 O
0 NCT03926611 349 350 B-Eq_Comparison
- NCT03926611 351 352 I-Eq_Comparison
42 NCT03926611 353 355 I-Eq_Comparison
) NCT03926611 356 357 O
≥ NCT03926611 358 359 B-Eq_Comparison
16 NCT03926611 360 362 I-Eq_Comparison
and NCT03926611 363 366 B-And
HSS NCT03926611 367 370 B-Observation
7 NCT03926611 371 372 I-Observation
score NCT03926611 373 378 I-Observation
( NCT03926611 379 380 O
range NCT03926611 381 386 O
0 NCT03926611 387 388 B-Eq_Comparison
- NCT03926611 389 390 I-Eq_Comparison
21 NCT03926611 391 393 I-Eq_Comparison
) NCT03926611 394 395 O
≥ NCT03926611 396 397 B-Eq_Comparison
8 NCT03926611 398 399 I-Eq_Comparison
during NCT03926611 400 406 B-Temporal_Connection___Temporal_Connection_Type_Value:during
7 NCT03926611 407 408 B-Eq_Comparison
days NCT03926611 409 413 I-Eq_Comparison
prior NCT03926611 414 419 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926611 420 422 I-Temporal_Connection___Temporal_Connection_Type_Value:before
randomization NCT03926611 423 436 B-Study
( NCT03926611 437 438 O
Day NCT03926611 439 442 O
1 NCT03926611 443 444 O
) NCT03926611 445 446 O

- NCT03926611 450 451 O
Willing NCT03926611 453 460 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03926611 461 464 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03926611 465 469 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03926611 470 472 O
complete NCT03926611 473 481 O
an NCT03926611 482 484 O
Urticaria NCT03926611 485 494 B-Procedure
Participant NCT03926611 495 506 I-Procedure
Daily NCT03926611 507 512 I-Procedure
eDiary NCT03926611 513 519 I-Procedure
( NCT03926611 520 521 O
UPDD NCT03926611 522 526 B-Procedure
) NCT03926611 527 528 O
for NCT03926611 529 532 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03926611 533 536 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03926611 537 545 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03926611 546 548 O
the NCT03926611 549 552 O
study NCT03926611 553 558 B-Study

Exclusion NCT03926611 559 568 O
Criteria NCT03926611 569 577 O
: NCT03926611 578 579 O

- NCT03926611 583 584 O
Hypersensitivity NCT03926611 586 602 B-Condition
to NCT03926611 603 605 O
any NCT03926611 606 609 O
of NCT03926611 610 612 O
the NCT03926611 613 616 O
study NCT03926611 617 622 B-Study
treatments NCT03926611 623 633 B-Procedure

- NCT03926611 636 637 O
Clearly NCT03926611 639 646 O
defined NCT03926611 647 654 O
predominant NCT03926611 655 666 B-Modifier
or NCT03926611 667 669 B-Or
sole NCT03926611 670 674 B-Modifier
trigger NCT03926611 675 682 I-Modifier
of NCT03926611 683 685 O
their NCT03926611 686 691 O
chronic NCT03926611 692 699 O
urticaria NCT03926611 700 709 B-Condition
( NCT03926611 710 711 O
chronic NCT03926611 712 719 O
inducible NCT03926611 720 729 B-Condition
urticaria NCT03926611 730 739 I-Condition
) NCT03926611 740 741 O

- NCT03926611 745 746 O
Other NCT03926611 748 753 B-Other
diseases NCT03926611 754 762 B-Condition
with NCT03926611 763 767 O
symptoms NCT03926611 768 776 B-Assertion___Assertion_Type_Value:possible
of NCT03926611 777 779 O
urticaria NCT03926611 780 789 B-Condition
or NCT03926611 790 792 B-Or
angioedema NCT03926611 793 803 B-Condition

- NCT03926611 806 807 O
Other NCT03926611 809 814 B-Other
skin NCT03926611 815 819 B-Condition
disease NCT03926611 820 827 I-Condition
associated NCT03926611 828 838 O
with NCT03926611 839 843 O
chronic NCT03926611 844 851 O
itching NCT03926611 852 859 B-Condition
that NCT03926611 860 864 O
might NCT03926611 865 870 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03926611 871 880 O
in NCT03926611 881 883 O
the NCT03926611 884 887 O
investigators NCT03926611 888 901 O
opinion NCT03926611 902 909 O
the NCT03926611 910 913 O
study NCT03926611 914 919 B-Study
evaluations NCT03926611 920 931 O
and NCT03926611 932 935 O
results NCT03926611 936 943 O
, NCT03926611 944 945 O

- NCT03926611 949 950 O
Known NCT03926611 952 957 O
or NCT03926611 958 960 O
suspected NCT03926611 961 970 B-Assertion___Assertion_Type_Value:possible
history NCT03926611 971 978 B-Eq_Comparison
of NCT03926611 979 981 O
an NCT03926611 982 984 O
ongoing NCT03926611 985 992 B-Eq_Comparison
, NCT03926611 993 994 O
chronic NCT03926611 995 1002 O
or NCT03926611 1003 1005 B-Or
recurrent NCT03926611 1006 1015 B-Modifier
infectious NCT03926611 1016 1026 B-Condition
disease NCT03926611 1027 1034 I-Condition
including NCT03926611 1035 1044 O
but NCT03926611 1045 1048 O
not NCT03926611 1049 1052 O
limited NCT03926611 1053 1060 O
to NCT03926611 1061 1063 O
opportunistic NCT03926611 1064 1077 B-Condition
infections NCT03926611 1078 1088 I-Condition
( NCT03926611 1089 1090 O
eg NCT03926611 1091 1093 O
tuberculosis NCT03926611 1094 1106 B-Condition
, NCT03926611 1107 1108 O
atypical NCT03926611 1109 1117 B-Modifier
mycobacterioses NCT03926611 1118 1133 B-Condition
, NCT03926611 1134 1135 O
listeriosis NCT03926611 1136 1147 B-Condition
or NCT03926611 1148 1150 B-Or
aspergillosis NCT03926611 1151 1164 B-Condition
) NCT03926611 1165 1166 O
, NCT03926611 1167 1168 O
HIV NCT03926611 1169 1172 B-Condition
, NCT03926611 1173 1174 O
Hepatitis NCT03926611 1175 1184 B-Condition
B NCT03926611 1185 1186 B-Modifier
/ NCT03926611 1187 1188 B-Or
C NCT03926611 1189 1190 B-Modifier
. NCT03926611 1191 1192 O

- NCT03926611 1196 1197 O
Pregnant NCT03926611 1199 1207 B-Condition
or NCT03926611 1208 1210 B-Or
nursing NCT03926611 1211 1218 B-Condition
( NCT03926611 1219 1220 O
lactating NCT03926611 1221 1230 B-Condition
) NCT03926611 1231 1232 O
women NCT03926611 1233 1238 O

- NCT03926611 1241 1242 O
Women NCT03926611 1244 1249 O
of NCT03926611 1250 1252 B-And
child NCT03926611 1253 1258 B-Condition
- NCT03926611 1259 1260 I-Condition
bearing NCT03926611 1261 1268 I-Condition
potential NCT03926611 1269 1278 I-Condition
not NCT03926611 1279 1282 B-Negation
using NCT03926611 1283 1288 B-Eq_Comparison
highly NCT03926611 1289 1295 O
effective NCT03926611 1296 1305 O
methods NCT03926611 1306 1313 O
of NCT03926611 1314 1316 O
contraception NCT03926611 1317 1330 B-Procedure

Other NCT03926611 1331 1336 O
protocol NCT03926611 1337 1345 O
- NCT03926611 1346 1347 O
defined NCT03926611 1348 1355 O
inclusion NCT03926611 1356 1365 O
/ NCT03926611 1366 1367 O
exclusion NCT03926611 1368 1377 O
criteria NCT03926611 1378 1386 O
may NCT03926611 1387 1390 O
apply NCT03926611 1391 1396 O
. NCT03926611 1397 1398 O

Inclusion NCT03920085 0 9 O
Criteria NCT03920085 10 18 O
: NCT03920085 19 20 O

- NCT03920085 24 25 O
Participants NCT03920085 27 39 O
must NCT03920085 40 44 O
be NCT03920085 45 47 O
enrolled NCT03920085 48 56 O
in NCT03920085 57 59 O
LifeScan NCT03920085 60 68 O
Patient NCT03920085 69 76 O
Registry NCT03920085 77 85 O
. NCT03920085 86 87 O

- NCT03920085 91 92 O
Participants NCT03920085 94 106 O
must NCT03920085 107 111 O
have NCT03920085 112 116 O
read NCT03920085 117 121 O
the NCT03920085 122 125 O
Information NCT03920085 126 137 O
sheet NCT03920085 138 143 O
and NCT03920085 144 147 O
signed NCT03920085 148 154 O
an NCT03920085 155 157 O
informedconsent NCT03920085 158 173 O
form NCT03920085 174 178 O
> NCT03920085 179 180 O
prior NCT03920085 181 186 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03920085 187 189 O
study NCT03920085 190 195 B-Study
participation NCT03920085 196 209 O
. NCT03920085 210 211 O

- NCT03920085 215 216 O
Participants NCT03920085 218 230 O
must NCT03920085 231 235 O
be NCT03920085 236 238 O
16 NCT03920085 239 241 B-Eq_Comparison
years NCT03920085 242 247 I-Eq_Comparison
or NCT03920085 248 250 I-Eq_Comparison
older NCT03920085 251 256 I-Eq_Comparison
. NCT03920085 257 258 O

- NCT03920085 262 263 O
Participants NCT03920085 265 277 O
must NCT03920085 278 282 O
be NCT03920085 283 285 O
diagnosed NCT03920085 286 295 O
with NCT03920085 296 300 O
Diabetes NCT03920085 301 309 B-Condition

Exclusion NCT03920085 310 319 O
Criteria NCT03920085 320 328 O
: NCT03920085 329 330 O

> NCT03920085 333 334 O
Participants NCT03920085 335 347 O
not NCT03920085 348 351 O
enrolled NCT03920085 352 360 O
in NCT03920085 361 363 O
the NCT03920085 364 367 O
LifeScan NCT03920085 368 376 O
Patient NCT03920085 377 384 O
Registry NCT03920085 385 393 O

Inclusion NCT03922009 0 9 O
Criteria NCT03922009 10 18 O
: NCT03922009 19 20 O

1 NCT03922009 24 25 O
. NCT03922009 25 26 O
population NCT03922009 28 38 O
: NCT03922009 39 40 O
acceptance NCT03922009 41 51 O
of NCT03922009 52 54 O
lower NCT03922009 55 60 B-Condition
extremity NCT03922009 61 70 I-Condition
fractures NCT03922009 71 80 I-Condition
in NCT03922009 81 83 O
patients NCT03922009 84 92 O
with NCT03922009 93 97 B-And
spinal NCT03922009 98 104 B-Procedure
anesthesia NCT03922009 105 115 I-Procedure
. NCT03922009 116 117 O

2 NCT03922009 121 122 O
. NCT03922009 122 123 O
Anesthesia NCT03922009 125 135 B-Condition
classification NCT03922009 136 150 I-Condition
( NCT03922009 151 152 O
ASA NCT03922009 153 156 B-Observation
) NCT03922009 157 158 O
: NCT03922009 159 160 O
I NCT03922009 161 162 B-Eq_Comparison
- NCT03922009 163 164 I-Eq_Comparison
III NCT03922009 165 168 I-Eq_Comparison
. NCT03922009 169 170 O

3 NCT03922009 174 175 O
. NCT03922009 175 176 O
Age NCT03922009 178 181 B-Age
: NCT03922009 182 183 O
20 NCT03922009 184 186 B-Eq_Comparison
years NCT03922009 187 192 I-Eq_Comparison
old NCT03922009 193 196 I-Eq_Comparison
to NCT03922009 197 199 I-Eq_Comparison
70 NCT03922009 200 202 I-Eq_Comparison
years NCT03922009 203 208 I-Eq_Comparison
of NCT03922009 209 211 O
age NCT03922009 212 215 O
. NCT03922009 216 217 O

Exclusion NCT03922009 219 228 O
Criteria NCT03922009 229 237 O
: NCT03922009 238 239 O

1 NCT03922009 243 244 O
. NCT03922009 244 245 O
Mental NCT03922009 247 253 B-Condition
illness NCT03922009 254 261 I-Condition
and NCT03922009 262 265 B-And
taking NCT03922009 266 272 B-Eq_Comparison
related NCT03922009 273 280 O
drugs NCT03922009 281 286 B-Drug
. NCT03922009 287 288 O

2 NCT03922009 292 293 O
. NCT03922009 293 294 O
Visually NCT03922009 296 304 B-Condition
impaired NCT03922009 305 313 I-Condition
and NCT03922009 314 317 B-And
hearing NCT03922009 318 325 B-Condition
impaired NCT03922009 326 334 I-Condition
. NCT03922009 335 336 O

3 NCT03922009 340 341 O
. NCT03922009 341 342 O
Being NCT03922009 344 349 O
unable NCT03922009 350 356 B-Condition
to NCT03922009 357 359 I-Condition
communicate NCT03922009 360 371 I-Condition
or NCT03922009 372 374 B-Or
illiterate NCT03922009 375 385 B-Condition
. NCT03922009 386 387 O

4 NCT03922009 391 392 O
. NCT03922009 392 393 O
The NCT03922009 395 398 O
condition NCT03922009 399 408 B-Condition
changes NCT03922009 409 416 O
or NCT03922009 417 419 B-Or
is NCT03922009 420 422 O
critical NCT03922009 423 431 O
, NCT03922009 432 433 O
and NCT03922009 434 437 B-Or
the NCT03922009 438 441 O
intensive NCT03922009 442 451 O
care NCT03922009 452 456 O
unit NCT03922009 457 461 O
is NCT03922009 462 464 O
admitted NCT03922009 465 473 B-Encounter
after NCT03922009 474 479 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03922009 480 483 O
operation NCT03922009 484 493 B-Procedure
. NCT03922009 494 495 O

5 NCT03922009 499 500 O
. NCT03922009 500 501 O
Contact NCT03922009 503 510 B-Condition
isolation NCT03922009 511 520 I-Condition
. NCT03922009 521 522 O

6 NCT03922009 526 527 O
. NCT03922009 527 528 O
Trauma NCT03922009 530 536 B-Condition
of NCT03922009 537 539 O
the NCT03922009 540 543 O
head NCT03922009 544 548 B-Modifier
and NCT03922009 549 552 B-Or
wounds NCT03922009 553 559 B-Condition
on NCT03922009 560 562 O
the NCT03922009 563 566 O
head NCT03922009 567 571 B-Modifier
. NCT03922009 572 573 O

7 NCT03922009 577 578 O
. NCT03922009 578 579 O
History NCT03922009 581 588 B-Eq_Comparison
of NCT03922009 589 591 O
motion NCT03922009 592 598 B-Condition
sickness NCT03922009 599 607 I-Condition
and NCT03922009 608 611 B-Or
vertigo NCT03922009 612 619 B-Condition
. NCT03922009 620 621 O

Inclusion NCT03864991 0 9 O
Criteria NCT03864991 10 18 O
: NCT03864991 19 20 O

- NCT03864991 24 25 O
Patient NCT03864991 27 34 O
diagnosed NCT03864991 35 44 O
with NCT03864991 45 49 O
T NCT03864991 50 51 B-Condition
1D NCT03864991 52 54 I-Condition
> NCT03864991 55 56 B-Eq_Comparison
6 NCT03864991 57 58 I-Eq_Comparison
months NCT03864991 59 65 I-Eq_Comparison

- NCT03864991 68 69 O
Patient NCT03864991 71 78 O
's NCT03864991 78 80 O
age NCT03864991 81 84 B-Age
≥ NCT03864991 85 86 B-Eq_Comparison
15 NCT03864991 87 89 I-Eq_Comparison
years NCT03864991 90 95 I-Eq_Comparison

- NCT03864991 98 99 O
Patient NCT03864991 101 108 O
or NCT03864991 109 111 O
any NCT03864991 112 115 O
one NCT03864991 116 119 O
of NCT03864991 120 122 O
the NCT03864991 123 126 O
family NCT03864991 127 133 B-Family_Member
member NCT03864991 134 140 I-Family_Member
like NCT03864991 141 145 O
father NCT03864991 146 152 B-Family_Member___Family_Member_Type:father
, NCT03864991 153 154 O
mother NCT03864991 155 161 B-Family_Member___Family_Member_Type:parent
or NCT03864991 162 164 B-Or
sibling NCT03864991 165 172 B-Family_Member___Family_Member_Type:sibling
using NCT03864991 173 178 B-Eq_Comparison
smart NCT03864991 179 184 O
phone NCT03864991 185 190 O
. NCT03864991 191 192 O

- NCT03864991 196 197 O
Patient NCT03864991 199 206 O
or NCT03864991 207 209 O
any NCT03864991 210 213 O
one NCT03864991 214 217 O
of NCT03864991 218 220 O
the NCT03864991 221 224 O
family NCT03864991 225 231 B-Family_Member
member NCT03864991 232 238 I-Family_Member
know NCT03864991 239 243 O
how NCT03864991 244 247 O
to NCT03864991 248 250 O
use NCT03864991 251 254 O
( NCT03864991 255 256 O
receive NCT03864991 257 264 O
calls NCT03864991 265 270 O
or NCT03864991 271 273 O
read NCT03864991 274 278 O
text NCT03864991 279 283 O
message NCT03864991 284 291 O
) NCT03864991 292 293 O
a NCT03864991 294 295 O
smart NCT03864991 296 301 O
phone NCT03864991 302 307 O
. NCT03864991 308 309 O

Exclusion NCT03864991 311 320 O
Criteria NCT03864991 321 329 O
: NCT03864991 330 331 O

- NCT03864991 335 336 O
Patient NCT03864991 338 345 O
on NCT03864991 346 348 B-Eq_Comparison
insulin NCT03864991 349 356 B-Drug
pump NCT03864991 357 361 B-Modifier

- NCT03864991 364 365 O
Pregnant NCT03864991 367 375 B-Condition
females NCT03864991 376 383 O
, NCT03864991 384 385 O

- NCT03864991 389 390 O
Patient NCT03864991 392 399 O
with NCT03864991 400 404 O
neurodevelopmental NCT03864991 405 423 B-Condition
delay NCT03864991 424 429 I-Condition
or NCT03864991 430 432 B-Or
thalassemia NCT03864991 433 444 B-Condition

- NCT03864991 447 448 O
Patient NCT03864991 450 457 O
currently NCT03864991 458 467 B-Eq_Comparison
using NCT03864991 468 473 O
any NCT03864991 474 477 O
kind NCT03864991 478 482 O
of NCT03864991 483 485 O
authentic NCT03864991 486 495 O
e NCT03864991 496 497 B-Procedure
- NCT03864991 498 499 I-Procedure
device NCT03864991 500 506 I-Procedure
for NCT03864991 507 510 O
step NCT03864991 511 515 B-Observation
count NCT03864991 516 521 I-Observation
or NCT03864991 522 524 B-Or
physical NCT03864991 525 533 B-Observation
activity NCT03864991 534 542 I-Observation
. NCT03864991 543 544 O

Inclusion NCT03861624 0 9 O
Criteria NCT03861624 10 18 O
: NCT03861624 19 20 O

1 NCT03861624 24 25 O
. NCT03861624 25 26 O
Skeletal NCT03861624 28 36 B-Condition
maturity NCT03861624 37 45 I-Condition

2 NCT03861624 48 49 O
. NCT03861624 49 50 O
AO NCT03861624 52 54 B-Eq_Comparison
/ NCT03861624 55 56 I-Eq_Comparison
OTA NCT03861624 57 60 I-Eq_Comparison
42 NCT03861624 61 63 I-Eq_Comparison
open NCT03861624 64 68 B-Modifier
tibia NCT03861624 69 74 I-Modifier
fractures NCT03861624 75 84 B-Condition

3 NCT03861624 87 88 O
. NCT03861624 88 89 O
Wound NCT03861624 91 96 B-Condition
primarily NCT03861624 97 106 B-Modifier
closeable NCT03861624 107 116 I-Modifier
( NCT03861624 117 118 O
no NCT03861624 119 121 B-Negation
flap NCT03861624 122 126 B-Modifier
or NCT03861624 127 129 B-Or
delay NCT03861624 130 135 B-Modifier
in NCT03861624 136 138 O
closure NCT03861624 139 146 B-Procedure
due NCT03861624 147 150 O
to NCT03861624 151 153 O
contamination NCT03861624 154 167 B-Condition
needed NCT03861624 168 174 O
) NCT03861624 175 176 O

4 NCT03861624 180 181 O
. NCT03861624 181 182 O
Palpable NCT03861624 184 192 B-Modifier
pedal NCT03861624 193 198 B-Observation
pulses NCT03861624 199 205 I-Observation
( NCT03861624 206 207 O
no NCT03861624 208 210 B-Negation
vascular NCT03861624 211 219 B-Condition
injury NCT03861624 220 226 I-Condition
sustained NCT03861624 227 236 O
) NCT03861624 237 238 O

5 NCT03861624 242 243 O
. NCT03861624 243 244 O
Presentation NCT03861624 246 258 O
within NCT03861624 259 265 B-Eq_Comparison
24 NCT03861624 266 268 I-Eq_Comparison
hours NCT03861624 269 274 I-Eq_Comparison
from NCT03861624 275 279 B-Temporal_Connection___Temporal_Connection_Type_Value:after
injury NCT03861624 280 286 B-Condition

Exclusion NCT03861624 287 296 O
Criteria NCT03861624 297 305 O
: NCT03861624 306 307 O

1 NCT03861624 311 312 O
. NCT03861624 312 313 O
Current NCT03861624 315 322 B-Eq_Comparison
injury NCT03861624 323 329 B-Condition
is NCT03861624 330 332 O
a NCT03861624 333 334 O
pathologic NCT03861624 335 345 B-Modifier
fracture NCT03861624 346 354 B-Condition

2 NCT03861624 357 358 O
. NCT03861624 358 359 O
Sustained NCT03861624 361 370 O
bilateral NCT03861624 371 380 B-Modifier
tibia NCT03861624 381 386 I-Modifier
fracture NCT03861624 387 395 B-Condition

3 NCT03861624 398 399 O
. NCT03861624 399 400 O
Sustained NCT03861624 402 411 O
comminuted NCT03861624 412 422 B-Modifier
femur NCT03861624 423 428 I-Modifier
fracture NCT03861624 429 437 B-Condition

4 NCT03861624 440 441 O
. NCT03861624 441 442 O
Sustained NCT03861624 444 453 O
severe NCT03861624 454 460 O
Traumatic NCT03861624 461 470 B-Condition
Brain NCT03861624 471 476 I-Condition
Injury NCT03861624 477 483 I-Condition
( NCT03861624 484 485 O
GCS NCT03861624 486 489 B-Observation
< NCT03861624 490 491 B-Eq_Comparison
12 NCT03861624 492 494 I-Eq_Comparison
) NCT03861624 495 496 O
* NCT03861624 497 498 O
* NCT03861624 499 500 O
* NCT03861624 501 502 O

5 NCT03861624 506 507 O
. NCT03861624 507 508 O
Sustained NCT03861624 510 519 O
severe NCT03861624 520 526 O
spinal NCT03861624 527 533 B-Modifier
cord NCT03861624 534 538 I-Modifier
injury NCT03861624 539 545 B-Condition
( NCT03861624 546 547 O
lower NCT03861624 548 553 B-Modifier
extremity NCT03861624 554 563 I-Modifier
paresis NCT03861624 564 571 B-Condition
/ NCT03861624 572 573 B-Or
paralysis NCT03861624 574 583 B-Condition
) NCT03861624 584 585 O

6 NCT03861624 589 590 O
. NCT03861624 590 591 O
Sustained NCT03861624 593 602 O
severe NCT03861624 603 609 O
burns NCT03861624 610 615 B-Condition
( NCT03861624 616 617 O
> NCT03861624 618 619 B-Eq_Comparison
10 NCT03861624 620 622 I-Eq_Comparison
% NCT03861624 623 624 I-Eq_Comparison
total NCT03861624 625 630 B-Observation
body NCT03861624 631 635 I-Observation
surface NCT03861624 636 643 I-Observation
area NCT03861624 644 648 I-Observation
( NCT03861624 649 650 O
TBSA NCT03861624 651 655 B-Observation
) NCT03861624 656 657 O
or NCT03861624 658 660 B-Or
> NCT03861624 661 662 B-Eq_Comparison
5 NCT03861624 663 664 I-Eq_Comparison
% NCT03861624 665 666 I-Eq_Comparison
TBSA NCT03861624 667 671 B-Observation
with NCT03861624 672 676 B-And
full NCT03861624 677 681 B-Modifier
thickness NCT03861624 682 691 I-Modifier
or NCT03861624 692 694 B-Or
circumferential NCT03861624 695 710 B-Modifier
injury NCT03861624 711 717 B-Condition
) NCT03861624 718 719 O

7 NCT03861624 723 724 O
. NCT03861624 724 725 O
Prior NCT03861624 727 732 B-Eq_Comparison
ipsilateral NCT03861624 733 744 B-Modifier
leg NCT03861624 745 748 I-Modifier
injury NCT03861624 749 755 B-Condition
requiring NCT03861624 756 765 B-Assertion___Assertion_Type_Value:hypothetical
surgery NCT03861624 766 773 B-Procedure

8 NCT03861624 776 777 O
. NCT03861624 777 778 O
Prior NCT03861624 780 785 B-Eq_Comparison
or NCT03861624 786 788 B-Or
current NCT03861624 789 796 B-Eq_Comparison
lower NCT03861624 797 802 B-Modifier
limb NCT03861624 803 807 I-Modifier
deformity NCT03861624 808 817 B-Condition
or NCT03861624 818 820 B-Or
abnormality NCT03861624 821 832 B-Condition

9 NCT03861624 835 836 O
. NCT03861624 836 837 O
Unable NCT03861624 839 845 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03861624 846 848 O
complete NCT03861624 849 857 O
follow NCT03861624 858 864 B-Encounter
- NCT03861624 865 866 I-Encounter
up NCT03861624 867 869 I-Encounter
visits NCT03861624 870 876 I-Encounter

Inclusion NCT03862898 0 9 O
Criteria NCT03862898 10 18 O
: NCT03862898 19 20 O

- NCT03862898 24 25 O
patients NCT03862898 27 35 O
with NCT03862898 36 40 O
lumbar NCT03862898 41 47 B-Modifier
pain NCT03862898 48 52 B-Condition
present NCT03862898 53 60 O
for NCT03862898 61 64 O
more NCT03862898 65 69 B-Eq_Comparison
than NCT03862898 70 74 I-Eq_Comparison
12 NCT03862898 75 77 I-Eq_Comparison
weeks NCT03862898 78 83 I-Eq_Comparison
, NCT03862898 84 85 O

- NCT03862898 89 90 O
pain NCT03862898 92 96 B-Condition
during NCT03862898 97 103 B-Temporal_Connection___Temporal_Connection_Type_Value:during
changing NCT03862898 104 112 B-Observation
of NCT03862898 113 115 I-Observation
the NCT03862898 116 119 I-Observation
position NCT03862898 120 128 I-Observation
, NCT03862898 129 130 O

- NCT03862898 134 135 O
radicular NCT03862898 137 146 B-Modifier
pain NCT03862898 147 151 B-Condition
. NCT03862898 152 153 O

Exclusion NCT03862898 155 164 O
Criteria NCT03862898 165 173 O
: NCT03862898 174 175 O

- NCT03862898 179 180 O
Cauda NCT03862898 182 187 B-Condition
equina NCT03862898 188 194 I-Condition
syndrome NCT03862898 195 203 I-Condition
, NCT03862898 204 205 O

- NCT03862898 209 210 O
ankylosing NCT03862898 212 222 B-Condition
spondylitis NCT03862898 223 234 I-Condition
, NCT03862898 235 236 O

- NCT03862898 240 241 O
thoracic NCT03862898 243 251 B-Condition
deformities NCT03862898 252 263 I-Condition
( NCT03862898 264 265 O
pectus NCT03862898 266 272 B-Condition
carinatum NCT03862898 273 282 I-Condition
, NCT03862898 283 284 O
excavatum NCT03862898 285 294 B-Condition
) NCT03862898 295 296 O
, NCT03862898 297 298 O

- NCT03862898 302 303 O
spina NCT03862898 305 310 B-Condition
bifida NCT03862898 311 317 I-Condition
, NCT03862898 318 319 O

- NCT03862898 323 324 O
fractures NCT03862898 326 335 B-Condition
, NCT03862898 336 337 O

- NCT03862898 341 342 O
post NCT03862898 344 348 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03862898 349 350 O
operative NCT03862898 351 360 B-Procedure
spinal NCT03862898 361 367 B-Condition
conditions NCT03862898 368 378 I-Condition
, NCT03862898 379 380 O

- NCT03862898 384 385 O
diabetes NCT03862898 387 395 B-Condition
, NCT03862898 396 397 O

- NCT03862898 401 402 O
inflammatory NCT03862898 404 416 B-Condition
processes NCT03862898 417 426 I-Condition
, NCT03862898 427 428 O

- NCT03862898 432 433 O
tumors NCT03862898 435 441 B-Condition
, NCT03862898 442 443 O

- NCT03862898 447 448 O
pregnancy NCT03862898 450 459 B-Condition
. NCT03862898 460 461 O

Inclusion NCT03866499 0 9 O
Criteria NCT03866499 10 18 O
: NCT03866499 19 20 O

- NCT03866499 24 25 O
Histologically NCT03866499 27 41 B-Procedure
or NCT03866499 42 44 B-Or
cytologically NCT03866499 45 58 B-Procedure
confirmed NCT03866499 59 68 O
non NCT03866499 69 72 B-Negation
- NCT03866499 73 74 O
small NCT03866499 75 80 B-Modifier
cell NCT03866499 81 85 I-Modifier
lung NCT03866499 86 90 I-Modifier
cancer NCT03866499 91 97 B-Condition
. NCT03866499 98 99 O

- NCT03866499 103 104 O
The NCT03866499 106 109 O
ECOG NCT03866499 110 114 B-Observation
score NCT03866499 115 120 O
of NCT03866499 121 123 O
performance NCT03866499 124 135 O
status NCT03866499 136 142 O
is NCT03866499 143 145 O
0 NCT03866499 146 147 B-Eq_Comparison
- NCT03866499 148 149 I-Eq_Comparison
1 NCT03866499 150 151 I-Eq_Comparison
. NCT03866499 151 152 O

- NCT03866499 156 157 O
Locally NCT03866499 159 166 B-Modifier
advanced NCT03866499 167 175 I-Modifier
or NCT03866499 176 178 B-Or
recurrent NCT03866499 179 188 B-Modifier
metastatic NCT03866499 189 199 I-Modifier
NSCLC NCT03866499 200 205 B-Condition
that NCT03866499 206 210 O
has NCT03866499 211 214 O
never NCT03866499 215 220 B-Negation
received NCT03866499 221 229 B-Eq_Comparison
systemic NCT03866499 230 238 B-Procedure
treatment NCT03866499 239 248 I-Procedure
. NCT03866499 249 250 O

- NCT03866499 254 255 O
According NCT03866499 257 266 O
to NCT03866499 267 269 O
RECIST NCT03866499 270 276 O
1.1 NCT03866499 277 280 O
criteria NCT03866499 281 289 O
, NCT03866499 290 291 O
there NCT03866499 292 297 O
is NCT03866499 298 300 O
at NCT03866499 301 303 B-Eq_Comparison
least NCT03866499 304 309 I-Eq_Comparison
1 NCT03866499 310 311 I-Eq_Comparison
measurable NCT03866499 312 322 O
lesion NCT03866499 323 329 B-Condition
that NCT03866499 330 334 O
has NCT03866499 335 338 O
not NCT03866499 339 342 B-Negation
been NCT03866499 343 347 O
previously NCT03866499 348 358 B-Eq_Comparison
irradiated NCT03866499 359 369 B-Procedure
. NCT03866499 370 371 O

- NCT03866499 375 376 O
Prior NCT03866499 378 383 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866499 384 386 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03866499 387 397 B-Study
, NCT03866499 398 399 O
a NCT03866499 400 401 O
central NCT03866499 402 409 O
laboratory NCT03866499 410 420 B-Observation
testing NCT03866499 421 428 I-Observation
report NCT03866499 429 435 O
has NCT03866499 436 439 O
confirmed NCT03866499 440 449 O
that NCT03866499 450 454 O
the NCT03866499 455 458 O
tumor NCT03866499 459 464 B-Condition
has NCT03866499 465 468 O
one NCT03866499 469 472 B-Eq_Comparison
of NCT03866499 473 475 I-Eq_Comparison
two NCT03866499 476 479 I-Eq_Comparison
common NCT03866499 480 486 B-Condition
EGFR NCT03866499 487 491 I-Condition
mutations NCT03866499 492 501 I-Condition
positive NCT03866499 502 510 O
that NCT03866499 511 515 O
are NCT03866499 516 519 O
sensitive NCT03866499 520 529 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03866499 530 532 I-Assertion___Assertion_Type_Value:hypothetical
EGFR NCT03866499 533 537 B-Procedure
- NCT03866499 538 539 I-Procedure
TKI NCT03866499 540 543 I-Procedure
therapy NCT03866499 544 551 I-Procedure
, NCT03866499 552 553 O
accompanied NCT03866499 554 565 O
with NCT03866499 566 570 B-And
or NCT03866499 571 573 B-Or
not NCT03866499 574 577 B-Negation
accompanied NCT03866499 578 589 O
with NCT03866499 590 594 O
other NCT03866499 595 600 B-Other
EGFR NCT03866499 601 605 B-Condition
mutation NCT03866499 606 614 I-Condition
, NCT03866499 615 616 O
with NCT03866499 617 621 O
the NCT03866499 622 625 O
exception NCT03866499 626 635 B-Exception
of NCT03866499 636 638 O
exon NCT03866499 639 643 B-Condition
20 NCT03866499 644 646 I-Condition
insertion NCT03866499 647 656 I-Condition
. NCT03866499 657 658 O

Exclusion NCT03866499 660 669 O
Criteria NCT03866499 670 678 O
: NCT03866499 679 680 O

- NCT03866499 684 685 O
Previously NCT03866499 687 697 B-Eq_Comparison
received NCT03866499 698 706 I-Eq_Comparison
systemic NCT03866499 707 715 B-Modifier
treatment NCT03866499 716 725 B-Procedure
for NCT03866499 726 729 O
locally NCT03866499 730 737 B-Modifier
advanced NCT03866499 738 746 I-Modifier
or NCT03866499 747 749 B-Or
recurrent NCT03866499 750 759 B-Modifier
metastatic NCT03866499 760 770 I-Modifier
cancer NCT03866499 771 777 B-Condition
. NCT03866499 778 779 O

- NCT03866499 783 784 O
Primary NCT03866499 786 793 B-Modifier
T NCT03866499 794 795 B-Condition
790 NCT03866499 796 799 I-Condition
M NCT03866499 800 801 I-Condition
mutation NCT03866499 802 810 I-Condition
- NCT03866499 811 812 O
positive NCT03866499 813 821 O
patient NCT03866499 822 829 O
. NCT03866499 830 831 O

- NCT03866499 835 836 O
Previous NCT03866499 838 846 B-Eq_Comparison
interstitial NCT03866499 847 859 B-Condition
lung NCT03866499 860 864 I-Condition
disease NCT03866499 865 872 I-Condition
, NCT03866499 873 874 O
drug NCT03866499 875 879 B-Drug
- NCT03866499 880 881 O
induced NCT03866499 882 889 O
interstitial NCT03866499 890 902 B-Condition
lung NCT03866499 903 907 I-Condition
disease NCT03866499 908 915 I-Condition
, NCT03866499 916 917 O
radiation NCT03866499 918 927 B-Condition
pneumonia NCT03866499 928 937 I-Condition
requiring NCT03866499 938 947 B-Assertion___Assertion_Type_Value:hypothetical
hormonal NCT03866499 948 956 B-Procedure
therapy NCT03866499 957 964 I-Procedure
, NCT03866499 965 966 O
or NCT03866499 967 969 B-Or
any NCT03866499 970 973 O
clinically NCT03866499 974 984 O
proven NCT03866499 985 991 O
active NCT03866499 992 998 B-Eq_Comparison
interstitial NCT03866499 999 1011 B-Condition
lung NCT03866499 1012 1016 I-Condition
disease NCT03866499 1017 1024 I-Condition
. NCT03866499 1025 1026 O

- NCT03866499 1030 1031 O
Known NCT03866499 1033 1038 O
active NCT03866499 1039 1045 B-Eq_Comparison
infections NCT03866499 1046 1056 B-Condition
such NCT03866499 1057 1061 O
as NCT03866499 1062 1064 O
hepatitis NCT03866499 1065 1074 B-Condition
B NCT03866499 1075 1076 I-Condition
, NCT03866499 1077 1078 O
hepatitis NCT03866499 1079 1088 B-Condition
C NCT03866499 1089 1090 I-Condition
, NCT03866499 1091 1092 O
and NCT03866499 1093 1096 B-Or
human NCT03866499 1097 1102 B-Condition
immunodeficiency NCT03866499 1103 1119 I-Condition
virus NCT03866499 1120 1125 I-Condition
. NCT03866499 1126 1127 O

- NCT03866499 1131 1132 O
Local NCT03866499 1134 1139 B-Modifier
radiation NCT03866499 1140 1149 B-Procedure
therapy NCT03866499 1150 1157 I-Procedure
is NCT03866499 1158 1160 O
carried NCT03866499 1161 1168 B-Eq_Comparison
out NCT03866499 1169 1172 I-Eq_Comparison
within NCT03866499 1173 1179 B-Eq_Comparison
1 NCT03866499 1180 1181 I-Eq_Comparison
week NCT03866499 1182 1186 I-Eq_Comparison
; NCT03866499 1186 1187 O
more NCT03866499 1188 1192 B-Eq_Comparison
than NCT03866499 1193 1197 I-Eq_Comparison
30 NCT03866499 1198 1200 I-Eq_Comparison
% NCT03866499 1201 1202 I-Eq_Comparison
bone NCT03866499 1203 1207 B-Procedure
marrow NCT03866499 1208 1214 I-Procedure
radiation NCT03866499 1215 1224 I-Procedure
therapy NCT03866499 1225 1232 I-Procedure
or NCT03866499 1233 1235 B-Or
extensive NCT03866499 1236 1245 O
radiation NCT03866499 1246 1255 B-Procedure
therapy NCT03866499 1256 1263 I-Procedure
is NCT03866499 1264 1266 O
performed NCT03866499 1267 1276 O
within NCT03866499 1277 1283 B-Eq_Comparison
4 NCT03866499 1284 1285 I-Eq_Comparison
weeks NCT03866499 1286 1291 I-Eq_Comparison
. NCT03866499 1292 1293 O

- NCT03866499 1297 1298 O
≤ NCT03866499 1300 1301 B-Eq_Comparison
4 NCT03866499 1302 1303 I-Eq_Comparison
weeks NCT03866499 1304 1309 I-Eq_Comparison
from NCT03866499 1310 1314 B-Temporal_Connection___Temporal_Connection_Type_Value:after
major NCT03866499 1315 1320 O
surgery NCT03866499 1321 1328 B-Procedure
or NCT03866499 1329 1331 B-Or
≤ NCT03866499 1332 1333 B-Eq_Comparison
2 NCT03866499 1334 1335 I-Eq_Comparison
weeks NCT03866499 1336 1341 I-Eq_Comparison
from NCT03866499 1342 1346 B-Temporal_Connection___Temporal_Connection_Type_Value:after
minor NCT03866499 1347 1352 O
surgery NCT03866499 1353 1360 B-Procedure
. NCT03866499 1361 1362 O

Inclusion NCT03923829 0 9 O
Criteria NCT03923829 10 18 O
: NCT03923829 19 20 O

- NCT03923829 24 25 O
Controlled NCT03923829 27 37 B-Modifier
Type NCT03923829 38 42 I-Modifier
- NCT03923829 43 44 I-Modifier
2 NCT03923829 45 46 I-Modifier
diabetes NCT03923829 47 55 B-Condition
mellitus NCT03923829 56 64 I-Condition

- NCT03923829 67 68 O
Stage NCT03923829 70 75 B-Eq_Comparison
- NCT03923829 76 77 I-Eq_Comparison
II NCT03923829 78 80 I-Eq_Comparison
& NCT03923829 81 82 I-Eq_Comparison
III NCT03923829 82 85 I-Eq_Comparison
periodontitis NCT03923829 86 99 B-Condition

- NCT03923829 102 103 O
At NCT03923829 105 107 B-Eq_Comparison
least NCT03923829 108 113 I-Eq_Comparison
2 NCT03923829 114 115 I-Eq_Comparison
sites NCT03923829 116 121 I-Eq_Comparison
with NCT03923829 122 126 O
clinical NCT03923829 127 135 O
attachment NCT03923829 136 146 B-Observation
loss NCT03923829 147 151 I-Observation
3 NCT03923829 152 153 B-Eq_Comparison
or NCT03923829 154 156 I-Eq_Comparison
4 NCT03923829 157 158 I-Eq_Comparison
mm NCT03923829 159 161 I-Eq_Comparison
to NCT03923829 162 164 I-Eq_Comparison
≥ NCT03923829 165 166 I-Eq_Comparison
5 NCT03923829 167 168 I-Eq_Comparison
mm NCT03923829 169 171 I-Eq_Comparison
and NCT03923829 172 175 B-And
radiographic NCT03923829 176 188 B-Procedure
bone NCT03923829 189 193 B-Observation
loss NCT03923829 194 198 I-Observation
15 NCT03923829 199 201 B-Eq_Comparison
% NCT03923829 202 203 I-Eq_Comparison
Extending NCT03923829 204 213 B-Modifier
to NCT03923829 214 216 I-Modifier
mid NCT03923829 217 220 I-Modifier
- NCT03923829 221 222 I-Modifier
third NCT03923829 223 228 I-Modifier
of NCT03923829 229 231 I-Modifier
root NCT03923829 232 236 I-Modifier
and NCT03923829 237 240 I-Modifier
beyond NCT03923829 241 247 I-Modifier
. NCT03923829 248 249 O

- NCT03923829 253 254 O
Probing NCT03923829 256 263 B-Observation
depth NCT03923829 264 269 I-Observation
from NCT03923829 270 274 O
≤ NCT03923829 275 276 B-Eq_Comparison
5 NCT03923829 277 278 I-Eq_Comparison
mm NCT03923829 279 281 I-Eq_Comparison
to NCT03923829 282 284 I-Eq_Comparison
≥ NCT03923829 285 286 I-Eq_Comparison
6 NCT03923829 287 288 I-Eq_Comparison
mm NCT03923829 289 291 I-Eq_Comparison

Exclusion NCT03923829 292 301 O
Criteria NCT03923829 302 310 O
: NCT03923829 311 312 O

- NCT03923829 316 317 O
Any NCT03923829 319 322 O
periodontal NCT03923829 323 334 B-Procedure
or NCT03923829 335 337 B-Or
Antibiotic NCT03923829 338 348 B-Drug
treatment NCT03923829 349 358 B-Procedure
during NCT03923829 359 365 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923829 366 369 O
last NCT03923829 370 374 B-Eq_Comparison
six NCT03923829 375 378 I-Eq_Comparison
months NCT03923829 379 385 I-Eq_Comparison
. NCT03923829 386 387 O

- NCT03923829 391 392 O
Receiving NCT03923829 394 403 B-Eq_Comparison
trace NCT03923829 404 409 B-Drug
element NCT03923829 410 417 I-Drug
supplements NCT03923829 418 429 I-Drug
in NCT03923829 430 432 O
the NCT03923829 433 436 O
previous NCT03923829 437 445 B-Eq_Comparison
three NCT03923829 446 451 I-Eq_Comparison
months NCT03923829 452 458 I-Eq_Comparison

- NCT03923829 461 462 O
Pregnant NCT03923829 464 472 B-Condition
or NCT03923829 473 475 B-Or
lactating NCT03923829 476 485 B-Condition
females NCT03923829 486 493 O

- NCT03923829 496 497 O
Gastric NCT03923829 499 506 B-Modifier
or NCT03923829 507 509 B-Or
diuretic NCT03923829 510 518 B-Modifier
treatment NCT03923829 519 528 B-Procedure

- NCT03923829 531 532 O
Acute NCT03923829 534 539 O
renal NCT03923829 540 545 B-Condition
failure NCT03923829 546 553 I-Condition

- NCT03923829 556 557 O
smoking NCT03923829 559 566 B-Condition

Inclusion NCT03929068 0 9 O
Criteria NCT03929068 10 18 O
: NCT03929068 19 20 O

- NCT03929068 24 25 O
Diagnosis NCT03929068 27 36 O
of NCT03929068 37 39 O
ALS NCT03929068 40 43 B-Condition
or NCT03929068 44 46 B-Or
PLS NCT03929068 47 50 B-Condition

- NCT03929068 53 54 O
Age NCT03929068 56 59 B-Age
greater NCT03929068 60 67 B-Eq_Comparison
than NCT03929068 68 72 I-Eq_Comparison
18 NCT03929068 73 75 I-Eq_Comparison
years NCT03929068 76 81 I-Eq_Comparison

- NCT03929068 84 85 O
Clinically NCT03929068 87 97 O
significant NCT03929068 98 109 O
spasticity NCT03929068 110 120 B-Condition
. NCT03929068 121 122 O

Exclusion NCT03929068 124 133 O
Criteria NCT03929068 134 142 O
: NCT03929068 143 144 O

- NCT03929068 148 149 O
Individuals NCT03929068 151 162 O
currently NCT03929068 163 172 B-Eq_Comparison
taking NCT03929068 173 179 I-Eq_Comparison
carbidopa NCT03929068 180 189 B-Drug
- NCT03929068 190 191 I-Drug
levodopa NCT03929068 192 200 I-Drug
or NCT03929068 201 203 B-Or
with NCT03929068 204 208 O
known NCT03929068 209 214 O
hypersensitivity NCT03929068 215 231 B-Condition
of NCT03929068 232 234 O
any NCT03929068 235 238 O
component NCT03929068 239 248 O
of NCT03929068 249 251 O
carbidopa NCT03929068 252 261 B-Drug
- NCT03929068 262 263 I-Drug
levodopa NCT03929068 264 272 I-Drug

- NCT03929068 275 276 O
Narrow NCT03929068 278 284 B-Condition
- NCT03929068 285 286 I-Condition
angle NCT03929068 287 292 I-Condition
glaucoma NCT03929068 293 301 I-Condition

- NCT03929068 304 305 O
Current NCT03929068 307 314 B-Eq_Comparison
use NCT03929068 315 318 I-Eq_Comparison
of NCT03929068 319 321 O
a NCT03929068 322 323 O
non NCT03929068 324 327 B-Drug
- NCT03929068 328 329 I-Drug
selective NCT03929068 330 339 I-Drug
monoamine NCT03929068 340 349 I-Drug
oxidase NCT03929068 350 357 I-Drug
inhibitor NCT03929068 358 367 I-Drug
( NCT03929068 368 369 O
MAOI NCT03929068 370 374 B-Drug
) NCT03929068 375 376 O

- NCT03929068 380 381 O
History NCT03929068 383 390 B-Eq_Comparison
of NCT03929068 391 393 O
malignant NCT03929068 394 403 B-Condition
melanoma NCT03929068 404 412 I-Condition
or NCT03929068 413 415 B-Or
suspicious NCT03929068 416 426 O
skin NCT03929068 427 431 B-Condition
lesions NCT03929068 432 439 I-Condition

- NCT03929068 442 443 O
History NCT03929068 445 452 B-Eq_Comparison
of NCT03929068 453 455 O
depression NCT03929068 456 466 B-Condition
, NCT03929068 467 468 O
suicidal NCT03929068 469 477 B-Condition
ideation NCT03929068 478 486 I-Condition
, NCT03929068 487 488 O
or NCT03929068 489 491 B-Or
psychosis NCT03929068 492 501 B-Condition

- NCT03929068 504 505 O
History NCT03929068 507 514 B-Eq_Comparison
of NCT03929068 515 517 O
myocardial NCT03929068 518 528 B-Condition
infarction NCT03929068 529 539 I-Condition
, NCT03929068 540 541 O
ventricular NCT03929068 542 553 B-Condition
arrhythmia NCT03929068 554 564 I-Condition
, NCT03929068 565 566 O
or NCT03929068 567 569 B-Or
severe NCT03929068 570 576 O
cardiopulmonary NCT03929068 577 592 B-Condition
disease NCT03929068 593 600 I-Condition

- NCT03929068 603 604 O
Uncontrolled NCT03929068 606 618 B-Modifier
hypertension NCT03929068 619 631 B-Condition

- NCT03929068 634 635 O
Asthma NCT03929068 637 643 B-Condition

- NCT03929068 646 647 O
Renal NCT03929068 649 654 B-Condition
disease NCT03929068 655 662 I-Condition

- NCT03929068 665 666 O
Hepatic NCT03929068 668 675 B-Condition
disease NCT03929068 676 683 I-Condition

- NCT03929068 686 687 O
Endocrine NCT03929068 689 698 B-Condition
disease NCT03929068 699 706 I-Condition

- NCT03929068 709 710 O
History NCT03929068 712 719 B-Eq_Comparison
of NCT03929068 720 722 O
peptic NCT03929068 723 729 B-Condition
ulcer NCT03929068 730 735 I-Condition

- NCT03929068 738 739 O
Pregnant NCT03929068 741 749 O
and NCT03929068 750 753 O
/ NCT03929068 754 755 O
or NCT03929068 756 758 O
breastfeeding NCT03929068 759 772 O

- NCT03929068 775 776 O
Current NCT03929068 778 785 B-Eq_Comparison
participation NCT03929068 786 799 O
in NCT03929068 800 802 O
another NCT03929068 803 810 B-Other
interventional NCT03929068 811 825 O
study NCT03929068 826 831 B-Study

Inclusion NCT03860038 0 9 O
criteria NCT03860038 10 18 O
: NCT03860038 19 20 O

1 NCT03860038 24 25 O
. NCT03860038 25 26 O
Age NCT03860038 28 31 B-Age
≥ NCT03860038 32 33 B-Eq_Comparison
18 NCT03860038 34 36 I-Eq_Comparison
, NCT03860038 37 38 O
male NCT03860038 39 43 O
or NCT03860038 44 46 B-Or
female NCT03860038 47 53 O
; NCT03860038 53 54 O

2 NCT03860038 57 58 O
. NCT03860038 58 59 O
Subject NCT03860038 61 68 O
must NCT03860038 69 73 O
have NCT03860038 74 78 O
had NCT03860038 79 82 O
documented NCT03860038 83 93 O
MM NCT03860038 94 96 B-Condition
; NCT03860038 96 97 O

3 NCT03860038 100 101 O
. NCT03860038 101 102 O
At NCT03860038 104 106 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03860038 107 116 B-Study
phase NCT03860038 117 122 O
, NCT03860038 123 124 O
subject NCT03860038 125 132 O
must NCT03860038 133 137 O
have NCT03860038 138 142 O
measurable NCT03860038 143 153 B-Assertion___Assertion_Type_Value:hypothetical
disease NCT03860038 154 161 B-Condition
; NCT03860038 161 162 O

4 NCT03860038 165 166 O
. NCT03860038 166 167 O
Subject NCT03860038 169 176 O
is NCT03860038 177 179 O
in NCT03860038 180 182 O
a NCT03860038 183 184 O
state NCT03860038 185 190 O
of NCT03860038 191 193 O
progressive NCT03860038 194 205 B-Condition
disease NCT03860038 206 213 I-Condition
( NCT03860038 214 215 O
PD NCT03860038 216 218 B-Condition
) NCT03860038 219 220 O
; NCT03860038 221 222 O

5 NCT03860038 225 226 O
. NCT03860038 226 227 O
Subject NCT03860038 229 236 O
must NCT03860038 237 241 O
have NCT03860038 242 246 O
life NCT03860038 247 251 B-Observation
expectancy NCT03860038 252 262 I-Observation
of NCT03860038 263 265 O
no NCT03860038 266 268 B-Eq_Comparison
less NCT03860038 269 273 I-Eq_Comparison
than NCT03860038 274 278 I-Eq_Comparison
6 NCT03860038 279 280 I-Eq_Comparison
months NCT03860038 281 287 I-Eq_Comparison
; NCT03860038 287 288 O

6 NCT03860038 291 292 O
. NCT03860038 292 293 O
Subject NCT03860038 295 302 O
must NCT03860038 303 307 O
have NCT03860038 308 312 O
an NCT03860038 313 315 O
ECOG NCT03860038 316 320 B-Observation
( NCT03860038 321 322 O
Eastern NCT03860038 323 330 B-Observation
Cooperative NCT03860038 331 342 I-Observation
Oncology NCT03860038 343 351 I-Observation
Group NCT03860038 352 357 I-Observation
) NCT03860038 358 359 O
performance NCT03860038 360 371 O
status NCT03860038 372 378 O
score NCT03860038 379 384 O
of NCT03860038 385 387 O
0 NCT03860038 388 389 B-Eq_Comparison
~ NCT03860038 390 391 I-Eq_Comparison
2 NCT03860038 392 393 I-Eq_Comparison
; NCT03860038 394 395 O

Exclusion NCT03860038 396 405 O
criteria NCT03860038 406 414 O
: NCT03860038 415 416 O

1 NCT03860038 420 421 O
. NCT03860038 421 422 O
Subject NCT03860038 424 431 O
has NCT03860038 432 435 O
received NCT03860038 436 444 O
anti NCT03860038 445 449 B-Drug
- NCT03860038 450 451 I-Drug
CD NCT03860038 452 454 I-Drug
38 NCT03860038 455 457 I-Drug
monoclonal NCT03860038 458 468 I-Drug
antibody NCT03860038 469 477 I-Drug
treatment NCT03860038 478 487 B-Procedure
previously NCT03860038 488 498 B-Eq_Comparison
; NCT03860038 498 499 O

2 NCT03860038 502 503 O
. NCT03860038 503 504 O
Subject NCT03860038 506 513 O
has NCT03860038 514 517 O
received NCT03860038 518 526 O
CAR NCT03860038 527 530 B-Procedure
- NCT03860038 531 532 I-Procedure
T NCT03860038 533 534 I-Procedure
cell NCT03860038 535 539 I-Procedure
therapy NCT03860038 540 547 I-Procedure
previously NCT03860038 548 558 B-Eq_Comparison
; NCT03860038 558 559 O

3 NCT03860038 562 563 O
. NCT03860038 563 564 O
Subject NCT03860038 566 573 O
has NCT03860038 574 577 O
previously NCT03860038 578 588 B-Eq_Comparison
received NCT03860038 589 597 O
allogenic NCT03860038 598 607 B-Modifier
stem NCT03860038 608 612 B-Procedure
cell NCT03860038 613 617 I-Procedure
transplant NCT03860038 618 628 I-Procedure
, NCT03860038 629 630 O
or NCT03860038 631 633 B-Or
subject NCT03860038 634 641 O
has NCT03860038 642 645 O
received NCT03860038 646 654 O
autologous NCT03860038 655 665 B-Modifier
stem NCT03860038 666 670 B-Procedure
cell NCT03860038 671 675 I-Procedure
transplant NCT03860038 676 686 I-Procedure
within NCT03860038 687 693 B-Eq_Comparison
3 NCT03860038 694 695 I-Eq_Comparison
months NCT03860038 696 702 I-Eq_Comparison
before NCT03860038 703 709 B-Temporal_Connection___Temporal_Connection_Type_Value:before
administration NCT03860038 710 724 O
of NCT03860038 725 727 O
the NCT03860038 728 731 O
study NCT03860038 732 737 B-Study
agent NCT03860038 738 743 B-Drug
; NCT03860038 743 744 O

4 NCT03860038 747 748 O
. NCT03860038 748 749 O
Primary NCT03860038 751 758 B-Modifier
refractory NCT03860038 759 769 I-Modifier
multiple NCT03860038 770 778 B-Condition
myeloma NCT03860038 779 786 I-Condition
( NCT03860038 787 788 O
subject NCT03860038 789 796 O
failed NCT03860038 797 803 O
to NCT03860038 804 806 O
generate NCT03860038 807 815 O
any NCT03860038 816 819 O
minimal NCT03860038 820 827 O
response NCT03860038 828 836 O
or NCT03860038 837 839 O
any NCT03860038 840 843 O
degree NCT03860038 844 850 O
of NCT03860038 851 853 O
response NCT03860038 854 862 O
to NCT03860038 863 865 O
any NCT03860038 866 869 O
therapy NCT03860038 870 877 B-Procedure
) NCT03860038 878 879 O
; NCT03860038 880 881 O

5 NCT03860038 884 885 O
. NCT03860038 885 886 O
Subject NCT03860038 888 895 O
has NCT03860038 896 899 O
received NCT03860038 900 908 O
anti NCT03860038 909 913 B-Procedure
- NCT03860038 914 915 I-Procedure
myeloma NCT03860038 916 923 I-Procedure
treatment NCT03860038 924 933 I-Procedure
( NCT03860038 934 935 O
radiotherapy NCT03860038 936 948 B-Procedure
is NCT03860038 949 951 O
excluded NCT03860038 952 960 B-Exception
) NCT03860038 961 962 O
within NCT03860038 963 969 B-Eq_Comparison
4 NCT03860038 970 971 I-Eq_Comparison
weeks NCT03860038 972 977 I-Eq_Comparison
or NCT03860038 978 980 B-Or
5 NCT03860038 981 982 B-Eq_Comparison
PK NCT03860038 983 985 I-Eq_Comparison
half NCT03860038 986 990 I-Eq_Comparison
- NCT03860038 991 992 I-Eq_Comparison
lives NCT03860038 993 998 I-Eq_Comparison
of NCT03860038 999 1001 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03860038 1002 1005 O
treatment NCT03860038 1006 1015 B-Procedure
, NCT03860038 1016 1017 O
whichever NCT03860038 1018 1027 O
longer NCT03860038 1028 1034 O
, NCT03860038 1035 1036 O
before NCT03860038 1037 1043 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03860038 1044 1047 O
first NCT03860038 1048 1053 B-Eq_Comparison
study NCT03860038 1054 1059 B-Study
agent NCT03860038 1060 1065 B-Drug
administration NCT03860038 1066 1080 O
. NCT03860038 1081 1082 O

Inclusion NCT03928158 0 9 O
Criteria NCT03928158 10 18 O
: NCT03928158 19 20 O

1 NCT03928158 24 25 O
. NCT03928158 25 26 O
Moderate NCT03928158 28 36 O
/ NCT03928158 37 38 B-Or
severe NCT03928158 39 45 O
hypertensive NCT03928158 46 58 B-Modifier
left NCT03928158 59 63 I-Modifier
ventricular NCT03928158 64 75 I-Modifier
( NCT03928158 76 77 O
LV NCT03928158 78 80 B-Modifier
) NCT03928158 81 82 O
hypertrophy NCT03928158 83 94 B-Condition
( NCT03928158 95 96 O
LVMi NCT03928158 97 101 B-Observation
≥ NCT03928158 102 103 B-Eq_Comparison
109 NCT03928158 104 107 I-Eq_Comparison
g NCT03928158 108 109 I-Eq_Comparison
/ NCT03928158 110 111 I-Eq_Comparison
m² NCT03928158 112 114 I-Eq_Comparison
in NCT03928158 115 117 O
women NCT03928158 118 123 O
and NCT03928158 124 127 B-Or
≥ NCT03928158 128 129 B-Eq_Comparison
132 NCT03928158 130 133 I-Eq_Comparison
g NCT03928158 134 135 I-Eq_Comparison
/ NCT03928158 136 137 I-Eq_Comparison
m² NCT03928158 138 140 I-Eq_Comparison
in NCT03928158 141 143 O
men NCT03928158 144 147 O
) NCT03928158 148 149 O
; NCT03928158 150 151 O

2 NCT03928158 154 155 O
. NCT03928158 155 156 O
New NCT03928158 158 161 B-Observation
York NCT03928158 162 166 I-Observation
Heart NCT03928158 167 172 I-Observation
Association NCT03928158 173 184 I-Observation
( NCT03928158 185 186 O
NYHA NCT03928158 187 191 B-Observation
) NCT03928158 192 193 O
class NCT03928158 194 199 B-Eq_Comparison
II NCT03928158 200 202 I-Eq_Comparison
- NCT03928158 203 204 I-Eq_Comparison
III NCT03928158 205 208 I-Eq_Comparison
heart NCT03928158 209 214 B-Condition
failure NCT03928158 215 222 I-Condition
; NCT03928158 222 223 O

3 NCT03928158 226 227 O
. NCT03928158 227 228 O
Left NCT03928158 230 234 B-Observation
ventricular NCT03928158 235 246 I-Observation
ejection NCT03928158 247 255 I-Observation
fraction NCT03928158 256 264 I-Observation
> NCT03928158 265 266 B-Eq_Comparison
50 NCT03928158 267 269 I-Eq_Comparison
% NCT03928158 270 271 I-Eq_Comparison
; NCT03928158 272 273 O

4 NCT03928158 276 277 O
. NCT03928158 277 278 O
Increased NCT03928158 280 289 O
LV NCT03928158 290 292 B-Observation
filling NCT03928158 293 300 I-Observation
pressures NCT03928158 301 310 I-Observation
assessed NCT03928158 311 319 O
at NCT03928158 320 322 O
rest NCT03928158 323 327 B-Modifier
or NCT03928158 328 330 B-Or
at NCT03928158 331 333 O
peak NCT03928158 334 338 B-Modifier
exercise NCT03928158 339 347 I-Modifier
by NCT03928158 348 350 O
echocardiography NCT03928158 351 367 B-Procedure

5 NCT03928158 370 371 O
. NCT03928158 371 372 O
Body NCT03928158 374 378 B-Observation
mass NCT03928158 379 383 I-Observation
index NCT03928158 384 389 I-Observation
( NCT03928158 390 391 O
BMI NCT03928158 392 395 B-Observation
) NCT03928158 396 397 O
> NCT03928158 398 399 B-Eq_Comparison
30 NCT03928158 400 402 I-Eq_Comparison
kg NCT03928158 403 405 I-Eq_Comparison
/ NCT03928158 406 407 I-Eq_Comparison
m² NCT03928158 408 410 I-Eq_Comparison

6 NCT03928158 413 414 O
. NCT03928158 414 415 O
Signed NCT03928158 417 423 O
and NCT03928158 424 427 O
data NCT03928158 428 432 O
informed NCT03928158 433 441 O
consent NCT03928158 442 449 O

Exclusion NCT03928158 450 459 O
Criteria NCT03928158 460 468 O
: NCT03928158 469 470 O

1 NCT03928158 474 475 O
. NCT03928158 475 476 O
Age NCT03928158 478 481 B-Age
≤ NCT03928158 482 483 B-Eq_Comparison
18 NCT03928158 484 486 I-Eq_Comparison
years NCT03928158 487 492 I-Eq_Comparison
; NCT03928158 492 493 O

2 NCT03928158 496 497 O
. NCT03928158 497 498 O
Evidence NCT03928158 500 508 O
of NCT03928158 509 511 O
myocardial NCT03928158 512 522 B-Condition
ischemia NCT03928158 523 531 I-Condition
during NCT03928158 532 538 O
stress NCT03928158 539 545 B-Procedure
echocardiography NCT03928158 546 562 I-Procedure
; NCT03928158 562 563 O

3 NCT03928158 566 567 O
. NCT03928158 567 568 O
Chronic NCT03928158 570 577 O
atrial NCT03928158 578 584 B-Condition
flutter NCT03928158 585 592 I-Condition
or NCT03928158 593 595 B-Or
atrial NCT03928158 596 602 B-Condition
fibrillation NCT03928158 603 615 I-Condition
; NCT03928158 615 616 O

4 NCT03928158 619 620 O
. NCT03928158 620 621 O
Alternative NCT03928158 623 634 B-Other
cause NCT03928158 635 640 B-Condition
of NCT03928158 641 643 O
left NCT03928158 644 648 B-Condition
ventricular NCT03928158 649 660 I-Condition
hypertrophy NCT03928158 661 672 I-Condition
and NCT03928158 673 676 B-Or
impaired NCT03928158 677 685 B-Condition
diastolic NCT03928158 686 695 I-Condition
function NCT03928158 696 704 I-Condition
( NCT03928158 705 706 O
hypertrophic NCT03928158 707 719 B-Modifier
/ NCT03928158 720 721 B-Or
restictive NCT03928158 722 732 B-Modifier
cardiomyopathy NCT03928158 733 747 B-Condition
, NCT03928158 748 749 O
aortic NCT03928158 750 756 B-Condition
stenosis NCT03928158 757 765 I-Condition
, NCT03928158 766 767 O
constrictive NCT03928158 768 780 B-Condition
pericarditis NCT03928158 781 793 I-Condition
and NCT03928158 794 797 O
etc NCT03928158 798 801 O
. NCT03928158 802 803 O
) NCT03928158 804 805 O
; NCT03928158 806 807 O

5 NCT03928158 810 811 O
. NCT03928158 811 812 O
NYHA NCT03928158 814 818 B-Observation
classification NCT03928158 819 833 B-Eq_Comparison
I NCT03928158 834 835 I-Eq_Comparison
or NCT03928158 836 838 B-Or
decompensated NCT03928158 839 852 B-Modifier
heart NCT03928158 853 858 B-Condition
failure NCT03928158 859 866 I-Condition
at NCT03928158 867 869 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03928158 870 879 B-Study
; NCT03928158 879 880 O

6 NCT03928158 883 884 O
. NCT03928158 884 885 O
Systolic NCT03928158 887 895 B-Observation
blood NCT03928158 896 901 I-Observation
pressure NCT03928158 902 910 I-Observation
< NCT03928158 911 912 B-Eq_Comparison
110 NCT03928158 913 916 I-Eq_Comparison
mmHg NCT03928158 917 921 I-Eq_Comparison
or NCT03928158 922 924 B-Or
> NCT03928158 925 926 B-Eq_Comparison
180 NCT03928158 927 930 I-Eq_Comparison
mmHg NCT03928158 931 935 I-Eq_Comparison
; NCT03928158 935 936 O

7 NCT03928158 939 940 O
. NCT03928158 940 941 O
Diastolic NCT03928158 943 952 B-Observation
blood NCT03928158 953 958 I-Observation
pressure NCT03928158 959 967 I-Observation
< NCT03928158 968 969 B-Eq_Comparison
40 NCT03928158 970 972 I-Eq_Comparison
mmHg NCT03928158 973 977 I-Eq_Comparison
or NCT03928158 978 980 B-Or
> NCT03928158 981 982 B-Eq_Comparison
100 NCT03928158 983 986 I-Eq_Comparison
mmHg NCT03928158 987 991 I-Eq_Comparison
; NCT03928158 991 992 O

8 NCT03928158 995 996 O
. NCT03928158 996 997 O
Anemia NCT03928158 999 1005 B-Condition
( NCT03928158 1006 1007 O
Hb NCT03928158 1008 1010 B-Observation
< NCT03928158 1011 1012 B-Eq_Comparison
100 NCT03928158 1013 1016 I-Eq_Comparison
g NCT03928158 1017 1018 I-Eq_Comparison
/ NCT03928158 1019 1020 I-Eq_Comparison
l NCT03928158 1021 1022 I-Eq_Comparison
) NCT03928158 1023 1024 O
; NCT03928158 1025 1026 O

9 NCT03928158 1029 1030 O
. NCT03928158 1030 1031 O
Significant NCT03928158 1033 1044 O
left NCT03928158 1045 1049 B-Modifier
sided NCT03928158 1050 1055 I-Modifier
structural NCT03928158 1056 1066 B-Condition
valve NCT03928158 1067 1072 I-Condition
disease NCT03928158 1073 1080 I-Condition
; NCT03928158 1080 1081 O

10 NCT03928158 1083 1085 O
. NCT03928158 1085 1086 O
Secondary NCT03928158 1088 1097 B-Modifier
hypertension NCT03928158 1098 1110 B-Condition
; NCT03928158 1110 1111 O

11 NCT03928158 1113 1115 O
. NCT03928158 1115 1116 O
Dyspnea NCT03928158 1118 1125 B-Condition
due NCT03928158 1126 1129 O
to NCT03928158 1130 1132 O
non NCT03928158 1133 1136 B-Modifier
- NCT03928158 1137 1138 I-Modifier
cardiac NCT03928158 1139 1146 I-Modifier
causes NCT03928158 1147 1153 B-Condition
such NCT03928158 1154 1158 O
as NCT03928158 1159 1161 O
pulmonary NCT03928158 1162 1171 B-Condition
disease NCT03928158 1172 1179 I-Condition
, NCT03928158 1180 1181 O
anemia NCT03928158 1182 1188 B-Condition
, NCT03928158 1189 1190 O
severe NCT03928158 1191 1197 O
obesity NCT03928158 1198 1205 B-Condition
, NCT03928158 1206 1207 O
primary NCT03928158 1208 1215 B-Condition
valvular NCT03928158 1216 1224 I-Condition
, NCT03928158 1225 1226 O
or NCT03928158 1227 1229 B-Or
myocardial NCT03928158 1230 1240 B-Condition
diseases NCT03928158 1241 1249 I-Condition
; NCT03928158 1249 1250 O

12 NCT03928158 1252 1254 O
. NCT03928158 1254 1255 O
Myocardial NCT03928158 1257 1267 B-Condition
infarction NCT03928158 1268 1278 I-Condition
or NCT03928158 1279 1281 B-Or
myocardial NCT03928158 1282 1292 B-Procedure
revascularization NCT03928158 1293 1310 I-Procedure
within NCT03928158 1311 1317 B-Eq_Comparison
the NCT03928158 1318 1321 I-Eq_Comparison
last NCT03928158 1322 1326 I-Eq_Comparison
3 NCT03928158 1327 1328 I-Eq_Comparison
months NCT03928158 1329 1335 I-Eq_Comparison
of NCT03928158 1336 1338 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03928158 1339 1348 B-Study
; NCT03928158 1348 1349 O

13 NCT03928158 1351 1353 O
. NCT03928158 1353 1354 O
Stroke NCT03928158 1356 1362 B-Condition
or NCT03928158 1363 1365 B-Or
TIA NCT03928158 1366 1369 B-Condition
within NCT03928158 1370 1376 B-Eq_Comparison
the NCT03928158 1377 1380 I-Eq_Comparison
last NCT03928158 1381 1385 I-Eq_Comparison
3 NCT03928158 1386 1387 I-Eq_Comparison
months NCT03928158 1388 1394 I-Eq_Comparison
of NCT03928158 1395 1397 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03928158 1398 1407 B-Study
; NCT03928158 1407 1408 O

14 NCT03928158 1410 1412 O
. NCT03928158 1412 1413 O
Autoimmunic NCT03928158 1415 1426 B-Modifier
and NCT03928158 1427 1430 B-Or
oncological NCT03928158 1431 1442 B-Modifier
diseases NCT03928158 1443 1451 B-Condition
; NCT03928158 1451 1452 O

15 NCT03928158 1454 1456 O
. NCT03928158 1456 1457 O
Impaired NCT03928158 1459 1467 B-Condition
renal NCT03928158 1468 1473 I-Condition
function NCT03928158 1474 1482 I-Condition
, NCT03928158 1483 1484 O
defined NCT03928158 1485 1492 O
as NCT03928158 1493 1495 O
eGFR NCT03928158 1496 1500 B-Observation
< NCT03928158 1501 1502 B-Eq_Comparison
30 NCT03928158 1503 1505 I-Eq_Comparison
ml NCT03928158 1506 1508 I-Eq_Comparison
/ NCT03928158 1509 1510 I-Eq_Comparison
min NCT03928158 1511 1514 I-Eq_Comparison
/ NCT03928158 1515 1516 I-Eq_Comparison
1.73 NCT03928158 1517 1521 I-Eq_Comparison
m² NCT03928158 1522 1524 I-Eq_Comparison
; NCT03928158 1524 1525 O

16 NCT03928158 1527 1529 O
. NCT03928158 1529 1530 O
Impaired NCT03928158 1532 1540 B-Condition
liver NCT03928158 1541 1546 I-Condition
function NCT03928158 1547 1555 I-Condition
; NCT03928158 1555 1556 O

17 NCT03928158 1558 1560 O
. NCT03928158 1560 1561 O
Potassium NCT03928158 1563 1572 B-Observation
concentration NCT03928158 1573 1586 I-Observation
> NCT03928158 1587 1588 B-Eq_Comparison
5.2 NCT03928158 1589 1592 I-Eq_Comparison
mmol NCT03928158 1593 1597 I-Eq_Comparison
/ NCT03928158 1598 1599 I-Eq_Comparison
L NCT03928158 1600 1601 I-Eq_Comparison
. NCT03928158 1602 1603 O

Inclusion NCT03923556 0 9 O
Criteria NCT03923556 10 18 O
: NCT03923556 19 20 O

- NCT03923556 24 25 O
At NCT03923556 27 29 B-Eq_Comparison
least NCT03923556 30 35 I-Eq_Comparison
18 NCT03923556 36 38 I-Eq_Comparison
years NCT03923556 39 44 I-Eq_Comparison
or NCT03923556 45 47 I-Eq_Comparison
older NCT03923556 48 53 I-Eq_Comparison

- NCT03923556 56 57 O
Diagnosed NCT03923556 59 68 O
with NCT03923556 69 73 O
severe NCT03923556 74 80 O
kidney NCT03923556 81 87 B-Condition
dysfunction NCT03923556 88 99 I-Condition
( NCT03923556 100 101 O
defined NCT03923556 102 109 O
by NCT03923556 110 112 O
plasma NCT03923556 113 119 B-Observation
creatinine NCT03923556 120 130 I-Observation
clearance NCT03923556 131 140 I-Observation
< NCT03923556 141 142 B-Eq_Comparison
30 NCT03923556 143 145 I-Eq_Comparison
mL NCT03923556 146 148 I-Eq_Comparison
/ NCT03923556 149 150 I-Eq_Comparison
min NCT03923556 151 154 I-Eq_Comparison
) NCT03923556 155 156 O

- NCT03923556 160 161 O
Planning NCT03923556 163 171 B-Assertion___Assertion_Type_Value:intention
on NCT03923556 172 174 O
kidney NCT03923556 175 181 B-Procedure
transplantation NCT03923556 182 197 I-Procedure
surgery NCT03923556 198 205 I-Procedure
at NCT03923556 206 208 O
the NCT03923556 209 212 O
University NCT03923556 213 223 O
of NCT03923556 224 226 O
Colorado NCT03923556 227 235 O
Hospital NCT03923556 236 244 O
. NCT03923556 245 246 O

Exclusion NCT03923556 248 257 O
Criteria NCT03923556 258 266 O
: NCT03923556 267 268 O

- NCT03923556 272 273 O
Patients NCT03923556 275 283 O
unable NCT03923556 284 290 O
to NCT03923556 291 293 O
sign NCT03923556 294 298 O
the NCT03923556 299 302 O
informed NCT03923556 303 311 O
consent NCT03923556 312 319 O

- NCT03923556 322 323 O
Pregnant NCT03923556 325 333 B-Condition
women NCT03923556 334 339 O

- NCT03923556 342 343 O
Body NCT03923556 345 349 B-Observation
Mass NCT03923556 350 354 I-Observation
Index NCT03923556 355 360 I-Observation
( NCT03923556 361 362 O
BMI NCT03923556 363 366 B-Observation
) NCT03923556 367 368 O
> NCT03923556 369 370 B-Eq_Comparison
40 NCT03923556 371 373 I-Eq_Comparison
kg NCT03923556 374 376 I-Eq_Comparison
/ NCT03923556 377 378 I-Eq_Comparison
m NCT03923556 379 380 I-Eq_Comparison
2 NCT03923556 381 382 I-Eq_Comparison

- NCT03923556 385 386 O
Pre NCT03923556 388 391 B-Eq_Comparison
- NCT03923556 392 393 I-Eq_Comparison
existing NCT03923556 394 402 I-Eq_Comparison
oxygen NCT03923556 403 409 B-Modifier
or NCT03923556 410 412 B-Or
ventilatory NCT03923556 413 424 B-Modifier
dependency NCT03923556 425 435 B-Condition
( NCT03923556 436 437 O
24 NCT03923556 438 440 B-Eq_Comparison
h NCT03923556 441 442 I-Eq_Comparison
use NCT03923556 443 446 O
of NCT03923556 447 449 O
oxygen NCT03923556 450 456 B-Procedure
or NCT03923556 457 459 B-Or
other NCT03923556 460 465 B-Other
noninvasive NCT03923556 466 477 B-Modifier
or NCT03923556 478 480 B-Or
invasive NCT03923556 481 489 B-Modifier
ventilatory NCT03923556 490 501 B-Procedure
support NCT03923556 502 509 I-Procedure
) NCT03923556 510 511 O

- NCT03923556 515 516 O
Patients NCT03923556 518 526 O
with NCT03923556 527 531 O
any NCT03923556 532 535 O
pulmonary NCT03923556 536 545 B-Modifier
, NCT03923556 546 547 O
neuromuscular NCT03923556 548 561 B-Modifier
or NCT03923556 562 564 B-Or
other NCT03923556 565 570 B-Other
disease NCT03923556 571 578 B-Condition
that NCT03923556 579 583 O
severely NCT03923556 584 592 O
limits NCT03923556 593 599 O
their NCT03923556 600 605 O
respiratory NCT03923556 606 617 B-Condition
functional NCT03923556 618 628 I-Condition
status NCT03923556 629 635 O
( NCT03923556 636 637 O
e NCT03923556 638 639 O
. NCT03923556 640 641 O
g NCT03923556 642 643 O
. NCT03923556 644 645 O
unable NCT03923556 647 653 B-Negation
to NCT03923556 654 656 O
achieve NCT03923556 657 664 O
4 NCT03923556 665 666 B-Eq_Comparison
Metabolic NCT03923556 667 676 B-Observation
Equivalent NCT03923556 677 687 I-Observation
of NCT03923556 688 690 I-Observation
Tasks NCT03923556 691 696 I-Observation
, NCT03923556 697 698 O
METs NCT03923556 699 703 B-Observation
, NCT03923556 704 705 O
such NCT03923556 706 710 O
as NCT03923556 711 713 O
climbing NCT03923556 714 722 B-Observation
up NCT03923556 723 725 I-Observation
1 NCT03923556 726 727 I-Observation
flight NCT03923556 728 734 I-Observation
of NCT03923556 735 737 I-Observation
stairs NCT03923556 738 744 I-Observation
) NCT03923556 745 746 O

- NCT03923556 750 751 O
Presence NCT03923556 753 761 O
of NCT03923556 762 764 O
any NCT03923556 765 768 O
contraindication NCT03923556 769 785 B-Contraindication
for NCT03923556 786 789 O
any NCT03923556 790 793 O
of NCT03923556 794 796 O
the NCT03923556 797 800 O
study NCT03923556 801 806 B-Study
- NCT03923556 807 808 O
related NCT03923556 809 816 O
medications NCT03923556 817 828 B-Drug
or NCT03923556 829 831 B-Or
interventions NCT03923556 832 845 B-Procedure
. NCT03923556 846 847 O

Inclusion NCT03862391 0 9 O
Criteria NCT03862391 10 18 O
: NCT03862391 19 20 O

- NCT03862391 24 25 O
ASA NCT03862391 27 30 B-Observation
physical NCT03862391 31 39 O
status NCT03862391 40 46 O
1 NCT03862391 47 48 B-Eq_Comparison
and NCT03862391 49 52 I-Eq_Comparison
2 NCT03862391 53 54 I-Eq_Comparison
, NCT03862391 55 56 O
underwent NCT03862391 57 66 B-Eq_Comparison
gynicological NCT03862391 67 80 B-Procedure
laparotomic NCT03862391 81 92 I-Procedure
surgery NCT03862391 93 100 I-Procedure
under NCT03862391 101 106 O
general NCT03862391 107 114 B-Procedure
anesthesia NCT03862391 115 125 I-Procedure
, NCT03862391 126 127 O
followed NCT03862391 128 136 B-Encounter
up NCT03862391 137 139 I-Encounter
in NCT03862391 140 142 O
PACU NCT03862391 143 147 O
( NCT03862391 148 149 O
post NCT03862391 150 154 O
operative NCT03862391 155 164 O
care NCT03862391 165 169 O
unit NCT03862391 170 174 O
) NCT03862391 175 176 O

Exclusion NCT03862391 178 187 O
Criteria NCT03862391 188 196 O
: NCT03862391 197 198 O

- NCT03862391 202 203 O
ASA NCT03862391 205 208 B-Observation
3 NCT03862391 209 210 B-Eq_Comparison
or NCT03862391 211 213 I-Eq_Comparison
4 NCT03862391 214 215 I-Eq_Comparison
, NCT03862391 216 217 O
mental NCT03862391 218 224 B-Condition
retardation NCT03862391 225 236 I-Condition
, NCT03862391 237 238 O
psychiatric NCT03862391 239 250 B-Condition
disease NCT03862391 251 258 I-Condition
, NCT03862391 259 260 O
history NCT03862391 261 268 B-Eq_Comparison
of NCT03862391 269 271 O
malignant NCT03862391 272 281 B-Condition
hyperthermia NCT03862391 282 294 I-Condition
in NCT03862391 295 297 O
patient NCT03862391 298 305 B-Family_Member___Family_Member_Type:patient
or NCT03862391 306 308 B-Or
her NCT03862391 309 312 O
family NCT03862391 313 319 B-Family_Member
, NCT03862391 320 321 O
neurological NCT03862391 322 334 B-Condition
disease NCT03862391 335 342 I-Condition
, NCT03862391 343 344 O
morbid NCT03862391 345 351 B-Condition
obesity NCT03862391 352 359 I-Condition
, NCT03862391 360 361 O
history NCT03862391 362 369 B-Eq_Comparison
of NCT03862391 370 372 O
asthma NCT03862391 373 379 B-Condition
and NCT03862391 380 383 B-And
follow NCT03862391 384 390 B-Encounter
- NCT03862391 391 392 I-Encounter
up NCT03862391 393 395 I-Encounter
in NCT03862391 396 398 O
the NCT03862391 399 402 O
intensive NCT03862391 403 412 O
care NCT03862391 413 417 O
unit NCT03862391 418 422 O
. NCT03862391 423 424 O

Inclusion NCT03922438 0 9 O
Criteria NCT03922438 10 18 O
: NCT03922438 19 20 O

- NCT03922438 24 25 O
Non NCT03922438 27 30 B-Negation
syndromic NCT03922438 31 40 B-Condition
patients NCT03922438 41 49 O

- NCT03922438 52 53 O
Medically NCT03922438 55 64 O
fit NCT03922438 65 68 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03922438 69 72 I-Assertion___Assertion_Type_Value:hypothetical
Surgery NCT03922438 73 80 B-Procedure

- NCT03922438 83 84 O
Patient NCT03922438 86 93 O
with NCT03922438 94 98 O
Primary NCT03922438 99 106 B-Modifier
, NCT03922438 107 108 O
complete NCT03922438 109 117 B-Modifier
cleft NCT03922438 118 123 B-Condition
lip NCT03922438 124 127 I-Condition

- NCT03922438 130 131 O
Patient NCT03922438 133 140 O
's NCT03922438 140 142 O
age NCT03922438 143 146 B-Age
younger NCT03922438 147 154 B-Eq_Comparison
than NCT03922438 155 159 I-Eq_Comparison
six NCT03922438 160 163 I-Eq_Comparison
months NCT03922438 164 170 I-Eq_Comparison

Exclusion NCT03922438 171 180 O
Criteria NCT03922438 181 189 O
: NCT03922438 190 191 O

- NCT03922438 195 196 O
Patient NCT03922438 198 205 O
with NCT03922438 206 210 O
syndromic NCT03922438 211 220 B-Modifier
cleft NCT03922438 221 226 B-Condition
lip NCT03922438 227 230 I-Condition

- NCT03922438 233 234 O
Previous NCT03922438 236 244 B-Eq_Comparison
operated NCT03922438 245 253 B-Procedure
cases NCT03922438 254 259 O

- NCT03922438 262 263 O
Incomplete NCT03922438 265 275 B-Modifier
cleft NCT03922438 276 281 B-Condition
lip NCT03922438 282 285 I-Condition

- NCT03922438 288 289 O
Patient NCT03922438 291 298 O
older NCT03922438 299 304 B-Eq_Comparison
than NCT03922438 305 309 I-Eq_Comparison
six NCT03922438 310 313 I-Eq_Comparison
months NCT03922438 314 320 I-Eq_Comparison

- NCT03922438 323 324 O
Patients NCT03922438 326 334 O
with NCT03922438 335 339 O
any NCT03922438 340 343 O
systemic NCT03922438 344 352 B-Modifier
condition NCT03922438 353 362 B-Condition

Inclusion NCT03867721 0 9 O
Criteria NCT03867721 10 18 O
: NCT03867721 19 20 O

- NCT03867721 24 25 O
All NCT03867721 27 30 O
individuals NCT03867721 31 42 O
affected NCT03867721 43 51 O
by NCT03867721 52 54 O
NMDs NCT03867721 55 59 B-Condition
attending NCT03867721 60 69 B-Encounter
our NCT03867721 70 73 O
Centre NCT03867721 74 80 O
for NCT03867721 81 84 O
Home NCT03867721 85 89 O
Mechanical NCT03867721 90 100 O
Ventilation NCT03867721 101 112 O
between NCT03867721 113 120 B-Eq_Comparison
January NCT03867721 121 128 I-Eq_Comparison
2015 NCT03867721 129 133 I-Eq_Comparison
and NCT03867721 134 137 I-Eq_Comparison
December NCT03867721 138 146 I-Eq_Comparison
2018 NCT03867721 147 151 I-Eq_Comparison
who NCT03867721 152 155 B-And
required NCT03867721 156 164 O
daytime NCT03867721 165 172 B-Modifier
MPV NCT03867721 173 176 B-Procedure
as NCT03867721 177 179 B-And
an NCT03867721 180 182 I-And
extension NCT03867721 183 192 I-And
of NCT03867721 193 195 I-And
nocturnal NCT03867721 196 205 B-Modifier
NIV NCT03867721 206 209 B-Procedure

Exclusion NCT03867721 210 219 O
Criteria NCT03867721 220 228 O
: NCT03867721 229 230 O

- NCT03867721 234 235 O
Patients NCT03867721 237 245 O
with NCT03867721 246 250 O
no NCT03867721 251 253 B-Negation
need NCT03867721 254 258 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03867721 259 262 I-Assertion___Assertion_Type_Value:hypothetical
daytime NCT03867721 263 270 B-Modifier
ventilation NCT03867721 271 282 B-Procedure

- NCT03867721 285 286 O
patients NCT03867721 288 296 O
with NCT03867721 297 301 O
ineffective NCT03867721 302 313 B-Modifier
NIV NCT03867721 314 317 B-Procedure
during NCT03867721 318 324 B-Temporal_Connection___Temporal_Connection_Type_Value:during
sleep NCT03867721 325 330 B-Observation
as NCT03867721 331 333 O
assessed NCT03867721 334 342 O
by NCT03867721 343 345 O
the NCT03867721 346 349 O
measurement NCT03867721 350 361 O
of NCT03867721 362 364 O
TcCO NCT03867721 365 369 B-Observation
2 NCT03867721 370 371 I-Observation
> NCT03867721 372 373 B-Eq_Comparison
49 NCT03867721 374 376 I-Eq_Comparison
mmHg NCT03867721 377 381 I-Eq_Comparison
( NCT03867721 382 383 O
S NCT03867721 384 385 O
) NCT03867721 386 387 O

- NCT03867721 391 392 O
patients NCT03867721 394 402 O
with NCT03867721 403 407 O
uncontrollable NCT03867721 408 422 B-Modifier
oral NCT03867721 423 427 B-Condition
leaks NCT03867721 428 433 I-Condition
with NCT03867721 434 438 O
MPV NCT03867721 439 442 B-Procedure
or NCT03867721 443 445 B-Or
episode NCT03867721 446 453 O
of NCT03867721 454 456 O
acute NCT03867721 457 462 O
respiratory NCT03867721 463 474 B-Condition
infection NCT03867721 475 484 I-Condition
during NCT03867721 485 491 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867721 492 495 O
trials NCT03867721 496 502 B-Study

Inclusion NCT03862378 0 9 O
Criteria NCT03862378 10 18 O
: NCT03862378 19 20 O

- NCT03862378 24 25 O
Planned NCT03862378 27 34 B-Eq_Comparison
surgery NCT03862378 35 42 B-Procedure
for NCT03862378 43 46 O
gastric NCT03862378 47 54 B-Modifier
or NCT03862378 55 57 B-Or
colorectal NCT03862378 58 68 B-Modifier
cancer NCT03862378 69 75 B-Condition
with NCT03862378 76 80 O
primary NCT03862378 81 88 B-Modifier
anastomosis NCT03862378 89 100 B-Procedure
. NCT03862378 101 102 O

- NCT03862378 106 107 O
Inform NCT03862378 109 115 O
consent NCT03862378 116 123 O
signed NCT03862378 124 130 O
before NCT03862378 131 137 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03862378 138 145 B-Procedure
. NCT03862378 146 147 O

Exclusion NCT03862378 149 158 O
Criteria NCT03862378 159 167 O
: NCT03862378 168 169 O

- NCT03862378 173 174 O
No NCT03862378 176 178 B-Negation
drainage NCT03862378 179 187 B-Procedure
tube NCT03862378 188 192 I-Procedure
placed NCT03862378 193 199 O
. NCT03862378 200 201 O

Key NCT03926637 0 3 O
Inclusion NCT03926637 4 13 O
Criteria NCT03926637 14 22 O
: NCT03926637 23 24 O

- NCT03926637 28 29 O
Ability NCT03926637 31 38 O
to NCT03926637 39 41 O
understand NCT03926637 42 52 O
the NCT03926637 53 56 O
purpose NCT03926637 57 64 O
and NCT03926637 65 68 O
risks NCT03926637 69 74 O
of NCT03926637 75 77 O
the NCT03926637 78 81 O
study NCT03926637 82 87 O
and NCT03926637 88 91 O
provide NCT03926637 92 99 O
signed NCT03926637 100 106 O
and NCT03926637 107 110 O
dated NCT03926637 111 116 O
informed NCT03926637 117 125 O
consent NCT03926637 126 133 O
and NCT03926637 134 137 O
authorization NCT03926637 138 151 O
to NCT03926637 152 154 O
use NCT03926637 155 158 O
confidential NCT03926637 159 171 O
health NCT03926637 172 178 O
information NCT03926637 179 190 O
in NCT03926637 191 193 O
accordance NCT03926637 194 204 O
with NCT03926637 205 209 O
applicable NCT03926637 210 220 O
participant NCT03926637 221 232 O
privacy NCT03926637 233 240 O
regulations NCT03926637 241 252 O

- NCT03926637 255 256 O
Diagnosis NCT03926637 258 267 O
of NCT03926637 268 270 O
MS NCT03926637 271 273 B-Condition
, NCT03926637 274 275 O
including NCT03926637 276 285 O
Clinically NCT03926637 286 296 B-Condition
Isolated NCT03926637 297 305 I-Condition
Syndrome NCT03926637 306 314 I-Condition

- NCT03926637 317 318 O
Ability NCT03926637 320 327 O
to NCT03926637 328 330 O
understand NCT03926637 331 341 O
the NCT03926637 342 345 O
audio NCT03926637 346 351 O
and NCT03926637 352 355 O
visual NCT03926637 356 362 O
instructions NCT03926637 363 375 O
for NCT03926637 376 379 O
the NCT03926637 380 383 O
test NCT03926637 384 388 O
modules NCT03926637 389 396 O

- NCT03926637 399 400 O
Visual NCT03926637 402 408 B-Condition
function NCT03926637 409 417 I-Condition
, NCT03926637 418 419 O
based NCT03926637 420 425 O
on NCT03926637 426 428 O
the NCT03926637 429 432 O
investigator NCT03926637 433 445 O
's NCT03926637 445 447 O
clinical NCT03926637 448 456 O
judgement NCT03926637 457 466 O
that NCT03926637 467 471 O
does NCT03926637 472 476 O
not NCT03926637 477 480 B-Negation
preclude NCT03926637 481 489 O
an NCT03926637 490 492 O
ability NCT03926637 493 500 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926637 501 503 I-Assertion___Assertion_Type_Value:hypothetical
interact NCT03926637 504 512 O
with NCT03926637 513 517 O
the NCT03926637 518 521 O
Multiple NCT03926637 522 530 B-Observation
Sclerosis NCT03926637 531 540 I-Observation
Performance NCT03926637 541 552 I-Observation
Test NCT03926637 553 557 I-Observation
( NCT03926637 558 559 O
MSPT NCT03926637 560 564 B-Observation
) NCT03926637 565 566 O
. NCT03926637 567 568 O

Key NCT03926637 570 573 O
Exclusion NCT03926637 574 583 O
Criteria NCT03926637 584 592 O
: NCT03926637 593 594 O

- NCT03926637 598 599 O
Unable NCT03926637 601 607 O
or NCT03926637 608 610 O
unwilling NCT03926637 611 620 O
to NCT03926637 621 623 O
provide NCT03926637 624 631 O
informed NCT03926637 632 640 O
consent NCT03926637 641 648 O

- NCT03926637 651 652 O
Participants NCT03926637 654 666 O
younger NCT03926637 667 674 B-Eq_Comparison
than NCT03926637 675 679 I-Eq_Comparison
18 NCT03926637 680 682 I-Eq_Comparison
years NCT03926637 683 688 I-Eq_Comparison
of NCT03926637 689 691 O
age NCT03926637 692 695 B-Age
, NCT03926637 696 697 O
unless NCT03926637 698 704 O
their NCT03926637 705 710 O
parent NCT03926637 711 717 O
or NCT03926637 718 720 O
legal NCT03926637 721 726 O
guardian NCT03926637 727 735 O
provides NCT03926637 736 744 O
the NCT03926637 745 748 O
required NCT03926637 749 757 O
signed NCT03926637 758 764 O
and NCT03926637 765 768 O
dated NCT03926637 769 774 O
informed NCT03926637 775 783 O
consent NCT03926637 784 791 O
and NCT03926637 792 795 O
authorization NCT03926637 796 809 O
to NCT03926637 810 812 O
use NCT03926637 813 816 O
confidential NCT03926637 817 829 O
health NCT03926637 830 836 O
information NCT03926637 837 848 O
and NCT03926637 849 852 O
the NCT03926637 853 856 O
participant NCT03926637 857 868 O
provides NCT03926637 869 877 O
assent NCT03926637 878 884 O
in NCT03926637 885 887 O
accordance NCT03926637 888 898 O
with NCT03926637 899 903 O
national NCT03926637 904 912 O
and NCT03926637 913 916 O
local NCT03926637 917 922 O
subject NCT03926637 923 930 O
privacy NCT03926637 931 938 O
regulations NCT03926637 939 950 O

NOTE NCT03926637 951 955 O
: NCT03926637 956 957 O
Other NCT03926637 958 963 O
protocol NCT03926637 964 972 O
defined NCT03926637 973 980 O
Inclusion NCT03926637 981 990 O
/ NCT03926637 991 992 O
Exclusion NCT03926637 993 1002 O
criteria NCT03926637 1003 1011 O
may NCT03926637 1012 1015 O
apply NCT03926637 1016 1021 O
. NCT03926637 1022 1023 O

Inclusion NCT03927755 0 9 O
Criteria NCT03927755 10 18 O
: NCT03927755 19 20 O

- NCT03927755 24 25 O
Physicians NCT03927755 27 37 B-Provider
with NCT03927755 38 42 O
experience NCT03927755 43 53 O
in NCT03927755 54 56 O
bedside NCT03927755 57 64 B-Modifier
cardiac NCT03927755 65 72 B-Procedure
ultrasound NCT03927755 73 83 I-Procedure

Exclusion NCT03927755 84 93 O
Criteria NCT03927755 94 102 O
: NCT03927755 103 104 O

- NCT03927755 108 109 O
Unwilling NCT03927755 111 120 O
to NCT03927755 121 123 O
consent NCT03927755 124 131 O
to NCT03927755 132 134 O
study NCT03927755 135 140 B-Study

- NCT03927755 143 144 O
Appropriate NCT03927755 146 157 O
ultrasound NCT03927755 158 168 B-Procedure
equipment NCT03927755 169 178 O
not NCT03927755 179 182 O
available NCT03927755 183 192 O

Inclusion NCT03925077 0 9 O
Criteria NCT03925077 10 18 O
: NCT03925077 19 20 O

1 NCT03925077 24 25 O
. NCT03925077 25 26 O
demonstrate NCT03925077 28 39 O
readiness NCT03925077 40 49 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925077 50 52 O
physical NCT03925077 53 61 B-Observation
activity NCT03925077 62 70 I-Observation
by NCT03925077 71 73 O
completing NCT03925077 74 84 O
the NCT03925077 85 88 O
online NCT03925077 89 95 O
Physical NCT03925077 96 104 B-Observation
Activity NCT03925077 105 113 I-Observation
Readiness NCT03925077 114 123 I-Observation
Questionnaire NCT03925077 124 137 I-Observation
( NCT03925077 138 139 O
PAR NCT03925077 140 143 B-Observation
- NCT03925077 144 145 I-Observation
Q NCT03925077 146 147 I-Observation
) NCT03925077 148 149 O
; NCT03925077 150 151 O

2 NCT03925077 154 155 O
. NCT03925077 155 156 O
have NCT03925077 158 162 O
a NCT03925077 163 164 O
SCI NCT03925077 165 168 B-Condition
resulting NCT03925077 169 178 O
in NCT03925077 179 181 O
incomplete NCT03925077 182 192 B-Modifier
or NCT03925077 193 195 B-Or
complete NCT03925077 196 204 B-Modifier
( NCT03925077 205 206 O
C NCT03925077 207 208 B-Eq_Comparison
5 NCT03925077 209 210 I-Eq_Comparison
and NCT03925077 211 214 I-Eq_Comparison
below NCT03925077 215 220 I-Eq_Comparison
) NCT03925077 221 222 O
paraplegia NCT03925077 223 233 B-Condition
or NCT03925077 234 236 B-Or
tetraplegia NCT03925077 237 248 B-Condition
; NCT03925077 248 249 O

3 NCT03925077 252 253 O
. NCT03925077 253 254 O
have NCT03925077 256 260 O
broadband NCT03925077 261 270 O
internet NCT03925077 271 279 O
access NCT03925077 280 286 O
; NCT03925077 286 287 O

4 NCT03925077 290 291 O
. NCT03925077 291 292 O
between NCT03925077 294 301 O
the NCT03925077 302 305 O
ages NCT03925077 306 310 B-Age
of NCT03925077 311 313 O
18 NCT03925077 314 316 B-Eq_Comparison
to NCT03925077 317 319 I-Eq_Comparison
65 NCT03925077 320 322 I-Eq_Comparison
years NCT03925077 323 328 I-Eq_Comparison
; NCT03925077 328 329 O

5 NCT03925077 332 333 O
. NCT03925077 333 334 O
have NCT03925077 336 340 O
the NCT03925077 341 344 O
ability NCT03925077 345 352 O
to NCT03925077 353 355 O
converse NCT03925077 356 364 O
and NCT03925077 365 368 O
read NCT03925077 369 373 O
English NCT03925077 374 381 O
. NCT03925077 382 383 O

Exclusion NCT03925077 385 394 O
Criteria NCT03925077 395 403 O
: NCT03925077 404 405 O

1 NCT03925077 409 410 O
. NCT03925077 410 411 O
significant NCT03925077 413 424 O
visual NCT03925077 425 431 B-Condition
impairment NCT03925077 432 442 I-Condition
that NCT03925077 443 447 O
prevents NCT03925077 448 456 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
seeing NCT03925077 457 463 O
a NCT03925077 464 465 O
computer NCT03925077 466 474 O
screen NCT03925077 475 481 O
to NCT03925077 482 484 O
follow NCT03925077 485 491 O
a NCT03925077 492 493 O
home NCT03925077 494 498 B-Procedure
exercise NCT03925077 499 507 I-Procedure
program NCT03925077 508 515 I-Procedure
; NCT03925077 515 516 O

2 NCT03925077 519 520 O
. NCT03925077 520 521 O
active NCT03925077 523 529 B-Eq_Comparison
pressure NCT03925077 530 538 B-Condition
ulcer NCT03925077 539 544 I-Condition
; NCT03925077 544 545 O

3 NCT03925077 548 549 O
. NCT03925077 549 550 O
any NCT03925077 552 555 O
contraindications NCT03925077 556 573 B-Contraindication
to NCT03925077 574 576 O
exercise NCT03925077 577 585 B-Observation
based NCT03925077 586 591 O
on NCT03925077 592 594 O
the NCT03925077 595 598 O
American NCT03925077 599 607 O
College NCT03925077 608 615 O
of NCT03925077 616 618 O
Sports NCT03925077 619 625 O
Medicine NCT03925077 626 634 O
guidelines NCT03925077 635 645 O
; NCT03925077 645 646 O

4 NCT03925077 649 650 O
. NCT03925077 650 651 O
significant NCT03925077 653 664 O
hearing NCT03925077 665 672 B-Condition
impairment NCT03925077 673 683 I-Condition
impeding NCT03925077 684 692 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
ability NCT03925077 693 700 B-Condition
to NCT03925077 701 703 I-Condition
hear NCT03925077 704 708 I-Condition
music NCT03925077 709 714 O
to NCT03925077 715 717 O
engage NCT03925077 718 724 B-Observation
in NCT03925077 725 727 I-Observation
exercise NCT03925077 728 736 I-Observation
. NCT03925077 737 738 O

Inclusion NCT03923998 0 9 O
Criteria NCT03923998 10 18 O
: NCT03923998 19 20 O

1 NCT03923998 24 25 O
. NCT03923998 25 26 O
Histologically NCT03923998 28 42 B-Procedure
confirmed NCT03923998 43 52 O
stage NCT03923998 53 58 B-Eq_Comparison
IVa NCT03923998 59 62 I-Eq_Comparison
squamous NCT03923998 63 71 B-Condition
cell NCT03923998 72 76 I-Condition
carcinoma NCT03923998 77 86 I-Condition
of NCT03923998 87 89 O
the NCT03923998 90 93 O
oral NCT03923998 94 98 B-Modifier
cavity NCT03923998 99 105 I-Modifier
. NCT03923998 106 107 O

2 NCT03923998 111 112 O
. NCT03923998 112 113 O
Surgically NCT03923998 115 125 B-Procedure
resectable NCT03923998 126 136 B-Assertion___Assertion_Type_Value:hypothetical
oral NCT03923998 137 141 B-Modifier
squamous NCT03923998 142 150 B-Condition
carcinoma NCT03923998 151 160 I-Condition
with NCT03923998 161 165 O
invasion NCT03923998 166 174 B-Modifier
of NCT03923998 175 177 I-Modifier
mandible NCT03923998 178 186 I-Modifier
or NCT03923998 187 189 B-Or
maxilla NCT03923998 190 197 B-Modifier
. NCT03923998 198 199 O

3 NCT03923998 203 204 O
. NCT03923998 204 205 O
Newly NCT03923998 207 212 B-Eq_Comparison
diagnosed NCT03923998 213 222 O
or NCT03923998 223 225 B-Or
previously NCT03923998 226 236 B-Eq_Comparison
untreated NCT03923998 237 246 B-Negation|B-Procedure
squamous NCT03923998 247 255 B-Condition
cell NCT03923998 256 260 I-Condition
carcinoma NCT03923998 261 270 I-Condition
of NCT03923998 271 273 O
the NCT03923998 274 277 O
oral NCT03923998 278 282 B-Modifier
cavity NCT03923998 283 289 I-Modifier
. NCT03923998 290 291 O

Exclusion NCT03923998 293 302 O
Criteria NCT03923998 303 311 O
: NCT03923998 312 313 O

1 NCT03923998 317 318 O
. NCT03923998 318 319 O
Patients NCT03923998 321 329 O
with NCT03923998 330 334 O
distant NCT03923998 335 342 B-Condition
metastases NCT03923998 343 353 I-Condition
. NCT03923998 354 355 O

2 NCT03923998 359 360 O
. NCT03923998 360 361 O
Patients NCT03923998 363 371 O
with NCT03923998 372 376 O
contraindication NCT03923998 377 393 B-Contraindication
to NCT03923998 394 396 O
radiotherapy NCT03923998 397 409 B-Procedure
. NCT03923998 410 411 O

3 NCT03923998 415 416 O
. NCT03923998 416 417 O
Patients NCT03923998 419 427 O
with NCT03923998 428 432 O
vascular NCT03923998 433 441 B-Condition
disorders NCT03923998 442 451 I-Condition
or NCT03923998 452 454 B-Or
ischemic NCT03923998 455 463 B-Condition
heart NCT03923998 464 469 I-Condition
disease NCT03923998 470 477 I-Condition
. NCT03923998 478 479 O
- NCT03923998 481 482 O

Inclusion NCT03928535 0 9 O
Criteria NCT03928535 10 18 O
: NCT03928535 19 20 O

- NCT03928535 24 25 O
Clinical NCT03928535 27 35 O
diagnosis NCT03928535 36 45 O
of NCT03928535 46 48 O
AECOPD NCT03928535 49 55 B-Condition

- NCT03928535 58 59 O
Extubation NCT03928535 61 71 B-Procedure
must NCT03928535 72 76 O
be NCT03928535 77 79 O
performed NCT03928535 80 89 O
after NCT03928535 90 95 B-Temporal_Connection___Temporal_Connection_Type_Value:after
48 NCT03928535 96 98 B-Eq_Comparison
hours NCT03928535 99 104 I-Eq_Comparison
of NCT03928535 105 107 O
invasive NCT03928535 108 116 B-Modifier
ventilation NCT03928535 117 128 B-Procedure

- NCT03928535 131 132 O
Must NCT03928535 134 138 O
be NCT03928535 139 141 O
treated NCT03928535 142 149 O
sequentially NCT03928535 150 162 O
with NCT03928535 163 167 O
HFNC NCT03928535 168 172 B-Procedure
or NCT03928535 173 175 B-Or
NIV NCT03928535 176 179 B-Procedure
after NCT03928535 180 185 B-Temporal_Connection___Temporal_Connection_Type_Value:after
extubation NCT03928535 186 196 B-Procedure

- NCT03928535 199 200 O
PaCO NCT03928535 202 206 B-Observation
2 NCT03928535 207 208 I-Observation
≥ NCT03928535 209 210 B-Eq_Comparison
50 NCT03928535 211 213 I-Eq_Comparison
mmHg NCT03928535 214 218 I-Eq_Comparison
when NCT03928535 219 223 B-Temporal_Connection___Temporal_Connection_Type_Value:during
extubation NCT03928535 224 234 B-Procedure

- NCT03928535 237 238 O
Positive NCT03928535 240 248 B-Observation
End NCT03928535 249 252 I-Observation
Expiratory NCT03928535 253 263 I-Observation
Pressure NCT03928535 264 272 I-Observation
( NCT03928535 273 274 O
PEEP NCT03928535 275 279 B-Observation
) NCT03928535 280 281 O
≤ NCT03928535 282 283 B-Eq_Comparison
8 NCT03928535 284 285 I-Eq_Comparison
cmH NCT03928535 286 289 I-Eq_Comparison
2O NCT03928535 290 292 I-Eq_Comparison
( NCT03928535 293 294 O
1 NCT03928535 295 296 O
cmH NCT03928535 297 300 O
2O NCT03928535 301 303 O
= NCT03928535 304 305 O
0.098 NCT03928535 306 311 O
kPa NCT03928535 312 315 O
) NCT03928535 316 317 O
when NCT03928535 318 322 B-Temporal_Connection___Temporal_Connection_Type_Value:during
extubation NCT03928535 323 333 B-Procedure

Exclusion NCT03928535 334 343 O
Criteria NCT03928535 344 352 O
: NCT03928535 353 354 O

- NCT03928535 358 359 O
Do NCT03928535 361 363 B-Observation
- NCT03928535 364 365 I-Observation
not NCT03928535 366 369 I-Observation
- NCT03928535 370 371 I-Observation
intubate NCT03928535 372 380 I-Observation

- NCT03928535 383 384 O
Tracheostomies NCT03928535 386 400 B-Procedure

- NCT03928535 403 404 O
Accidental NCT03928535 406 416 B-Modifier
extubation NCT03928535 417 427 B-Procedure

- NCT03928535 430 431 O
Self NCT03928535 433 437 B-Modifier
- NCT03928535 438 439 O
extubation NCT03928535 440 450 B-Procedure

Inclusion NCT03864744 0 9 O
Criteria NCT03864744 10 18 O
: NCT03864744 19 20 O

- NCT03864744 24 25 O
Subject NCT03864744 27 34 O
scheduled NCT03864744 35 44 B-Eq_Comparison
for NCT03864744 45 48 O
total NCT03864744 49 54 B-Procedure
pancreatectomy NCT03864744 55 69 I-Procedure
or NCT03864744 70 72 B-Or
pancreaticoduodenectomy NCT03864744 73 96 B-Procedure

- NCT03864744 99 100 O
Informed NCT03864744 102 110 O
consent NCT03864744 111 118 O
signed NCT03864744 119 125 O
prior NCT03864744 126 131 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03864744 132 134 I-Temporal_Connection___Temporal_Connection_Type_Value:before
any NCT03864744 135 138 O
study NCT03864744 139 144 B-Study
- NCT03864744 145 146 O
related NCT03864744 147 154 O
procedure NCT03864744 155 164 B-Procedure

Exclusion NCT03864744 165 174 O
Criteria NCT03864744 175 183 O
: NCT03864744 184 185 O

- NCT03864744 189 190 O
Known NCT03864744 192 197 O
liver NCT03864744 198 203 B-Condition
disease NCT03864744 204 211 I-Condition
before NCT03864744 212 218 B-Temporal_Connection___Temporal_Connection_Type_Value:before
total NCT03864744 219 224 B-Procedure
pancreatectomy NCT03864744 225 239 I-Procedure
or NCT03864744 240 242 B-Or
pancreaticoduodenectomy NCT03864744 243 266 B-Procedure
( NCT03864744 267 268 O
excluding NCT03864744 269 278 B-Exception
NAFLD NCT03864744 279 284 B-Condition
) NCT03864744 285 286 O

- NCT03864744 290 291 O
Severe NCT03864744 293 299 O
co NCT03864744 300 302 B-Condition
- NCT03864744 303 304 I-Condition
morbid NCT03864744 305 311 I-Condition
disease NCT03864744 312 319 I-Condition
( NCT03864744 320 321 O
besides NCT03864744 322 329 B-Exception
from NCT03864744 330 334 O
the NCT03864744 335 338 O
indication NCT03864744 339 349 B-Indication
for NCT03864744 350 353 O
the NCT03864744 354 357 O
pancreas NCT03864744 358 366 B-Procedure
surgery NCT03864744 367 374 I-Procedure
) NCT03864744 375 376 O

- NCT03864744 380 381 O
Pregnancy NCT03864744 383 392 B-Condition

- NCT03864744 395 396 O
Any NCT03864744 398 401 O
condition NCT03864744 402 411 B-Condition
that NCT03864744 412 416 O
the NCT03864744 417 420 O
investigator NCT03864744 421 433 O
feels NCT03864744 434 439 O
would NCT03864744 440 445 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03864744 446 455 O
with NCT03864744 456 460 O
the NCT03864744 461 464 O
safety NCT03864744 465 471 O
of NCT03864744 472 474 O
the NCT03864744 475 478 O
trial NCT03864744 479 484 B-Study
participation NCT03864744 485 498 O
or NCT03864744 499 501 O
the NCT03864744 502 505 O
safety NCT03864744 506 512 O
of NCT03864744 513 515 O
the NCT03864744 516 519 O
subject NCT03864744 520 527 O

- NCT03864744 530 531 O
Metastatic NCT03864744 533 543 B-Condition
disease NCT03864744 544 551 I-Condition

Percutaneous NCT03864744 552 564 B-Modifier
liver NCT03864744 565 570 B-Procedure
biopsy NCT03864744 571 577 I-Procedure
exclusion NCT03864744 578 587 O
criteria NCT03864744 588 596 O
( NCT03864744 597 598 O
to NCT03864744 599 601 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03864744 602 604 I-Assertion___Assertion_Type_Value:hypothetical
evaluated NCT03864744 605 614 B-Procedure
before NCT03864744 615 621 B-Temporal_Connection___Temporal_Connection_Type_Value:before
last NCT03864744 622 626 B-Eq_Comparison
visit NCT03864744 627 632 B-Encounter
) NCT03864744 633 634 O

- NCT03864744 638 639 O
MR NCT03864744 641 643 B-Procedure
spectroscopy NCT03864744 644 656 I-Procedure
demonstrating NCT03864744 657 670 O
lipid NCT03864744 671 676 B-Observation
content NCT03864744 677 684 I-Observation
< NCT03864744 685 686 B-Eq_Comparison
2 NCT03864744 687 688 I-Eq_Comparison
% NCT03864744 689 690 I-Eq_Comparison

- NCT03864744 694 695 O
Haemoglobin NCT03864744 697 708 B-Observation
< NCT03864744 709 710 B-Eq_Comparison
6 NCT03864744 711 712 I-Eq_Comparison
mmol NCT03864744 713 717 I-Eq_Comparison
/ NCT03864744 718 719 I-Eq_Comparison
L NCT03864744 720 721 I-Eq_Comparison

- NCT03864744 724 725 O
INR NCT03864744 727 730 B-Observation
> NCT03864744 731 732 B-Eq_Comparison
1.5 NCT03864744 733 736 I-Eq_Comparison

- NCT03864744 740 741 O
Trombocytes NCT03864744 743 754 B-Observation
< NCT03864744 755 756 B-Eq_Comparison
40 NCT03864744 757 759 I-Eq_Comparison
× NCT03864744 760 761 I-Eq_Comparison
109 NCT03864744 762 765 I-Eq_Comparison
/ NCT03864744 766 767 I-Eq_Comparison
L NCT03864744 768 769 I-Eq_Comparison

- NCT03864744 772 773 O
Skin NCT03864744 775 779 B-Modifier
infection NCT03864744 780 789 B-Condition
in NCT03864744 790 792 O
area NCT03864744 793 797 B-Modifier
where NCT03864744 798 803 O
biopsy NCT03864744 804 810 B-Procedure
will NCT03864744 811 815 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03864744 816 818 I-Assertion___Assertion_Type_Value:hypothetical
sampled NCT03864744 819 826 O

Inclusion NCT03926429 0 9 O
Criteria NCT03926429 10 18 O
: NCT03926429 19 20 O

- NCT03926429 24 25 O
reactive NCT03926429 27 35 O
arthritis NCT03926429 36 45 B-Condition
diagnosed NCT03926429 46 55 O
in NCT03926429 56 58 O
one NCT03926429 59 62 O
of NCT03926429 63 65 O
the NCT03926429 66 69 O
two NCT03926429 70 73 O
rheumatology NCT03926429 74 86 O
departments NCT03926429 87 98 O
from NCT03926429 99 103 O
Centre NCT03926429 104 110 O
Hospitalier NCT03926429 111 122 O
Lyon NCT03926429 123 127 O
Sud NCT03926429 128 131 O
or NCT03926429 132 134 B-Or
Besançon NCT03926429 135 143 O

Exclusion NCT03926429 144 153 O
Criteria NCT03926429 154 162 O
: NCT03926429 163 164 O

- NCT03926429 168 169 O
presence NCT03926429 171 179 O
of NCT03926429 180 182 O
other NCT03926429 183 188 B-Other
known NCT03926429 189 194 O
causes NCT03926429 195 201 B-Condition
of NCT03926429 202 204 O
arthritis NCT03926429 205 214 B-Condition
, NCT03926429 215 216 O
such NCT03926429 217 221 O
as NCT03926429 222 224 O
other NCT03926429 225 230 B-Other
defined NCT03926429 231 238 O
spondyloarthritides NCT03926429 239 258 B-Condition
, NCT03926429 259 260 O
septic NCT03926429 261 267 B-Modifier
arthritis NCT03926429 268 277 B-Condition
, NCT03926429 278 279 O
Lyme NCT03926429 280 284 B-Condition
disease NCT03926429 285 292 I-Condition
, NCT03926429 293 294 O
microcrystalline NCT03926429 295 311 B-Modifier
arthritis NCT03926429 312 321 B-Condition
or NCT03926429 322 324 B-Or
rheumatoid NCT03926429 325 335 B-Modifier
arthritis NCT03926429 336 345 B-Condition

Inclusion NCT03866772 0 9 O
Criteria NCT03866772 10 18 O
: NCT03866772 19 20 O

- NCT03866772 24 25 O
unfavourable NCT03866772 27 39 B-Condition
cervix NCT03866772 40 46 I-Condition
( NCT03866772 47 48 O
Bishop NCT03866772 49 55 B-Observation
score NCT03866772 56 61 I-Observation
≤ NCT03866772 62 63 B-Eq_Comparison
4 NCT03866772 64 65 I-Eq_Comparison
) NCT03866772 66 67 O
, NCT03866772 68 69 O

- NCT03866772 73 74 O
indication NCT03866772 76 86 B-Indication
for NCT03866772 87 90 O
induction NCT03866772 91 100 B-Procedure
of NCT03866772 101 103 I-Procedure
labor NCT03866772 104 109 I-Procedure
( NCT03866772 110 111 O
medical NCT03866772 112 119 B-Modifier
or NCT03866772 120 122 B-Or
obstetrical NCT03866772 123 134 B-Modifier
) NCT03866772 135 136 O
, NCT03866772 137 138 O

- NCT03866772 142 143 O
37 NCT03866772 145 147 B-Eq_Comparison
completed NCT03866772 148 157 O
gestational NCT03866772 158 169 B-Observation
weeks NCT03866772 170 175 O
, NCT03866772 176 177 O

- NCT03866772 181 182 O
vertex NCT03866772 184 190 B-Condition
presentation NCT03866772 191 203 I-Condition
, NCT03866772 204 205 O

- NCT03866772 209 210 O
singleton NCT03866772 212 221 B-Modifier
pregnancy NCT03866772 222 231 B-Condition

- NCT03866772 234 235 O
intact NCT03866772 237 243 B-Condition
membranes NCT03866772 244 253 I-Condition
. NCT03866772 254 255 O

Exclusion NCT03866772 257 266 O
Criteria NCT03866772 267 275 O
: NCT03866772 276 277 O

- NCT03866772 281 282 O
previous NCT03866772 284 292 B-Eq_Comparison
cesarean NCT03866772 293 301 B-Procedure
delivery NCT03866772 302 310 I-Procedure

- NCT03866772 313 314 O
previous NCT03866772 316 324 B-Eq_Comparison
uterine NCT03866772 325 332 B-Procedure
surgery NCT03866772 333 340 I-Procedure
( NCT03866772 341 342 O
eg NCT03866772 343 345 O
: NCT03866772 346 347 O
myomectomy NCT03866772 348 358 B-Procedure
) NCT03866772 359 360 O

- NCT03866772 364 365 O
noncephalic NCT03866772 367 378 B-Condition
presentation NCT03866772 379 391 I-Condition

- NCT03866772 394 395 O
multiple NCT03866772 397 405 B-Eq_Comparison
pregnancy NCT03866772 406 415 B-Condition

- NCT03866772 418 419 O
pre NCT03866772 421 424 B-Condition
- NCT03866772 425 426 I-Condition
eclampsia NCT03866772 427 436 I-Condition
with NCT03866772 437 441 O
severe NCT03866772 442 448 O
features NCT03866772 449 457 B-Modifier

- NCT03866772 460 461 O
oligohydramnios NCT03866772 463 478 B-Condition
( NCT03866772 479 480 O
Maximal NCT03866772 481 488 B-Observation
vertical NCT03866772 489 497 I-Observation
pocket NCT03866772 498 504 I-Observation
≤ NCT03866772 505 506 B-Eq_Comparison
2 NCT03866772 507 508 I-Eq_Comparison
) NCT03866772 509 510 O

- NCT03866772 514 515 O
estimated NCT03866772 517 526 B-Modifier
fetal NCT03866772 527 532 B-Family_Member___Family_Member_Type:child
weight NCT03866772 533 539 B-Observation
< NCT03866772 540 541 B-Eq_Comparison
10 NCT03866772 542 544 I-Eq_Comparison
% NCT03866772 545 546 I-Eq_Comparison
percentile NCT03866772 547 557 I-Eq_Comparison

- NCT03866772 560 561 O
any NCT03866772 563 566 O
contraindication NCT03866772 567 583 B-Contraindication
to NCT03866772 584 586 O
Vaginal NCT03866772 587 594 B-Procedure
delivery NCT03866772 595 603 I-Procedure

Inclusion NCT03926858 0 9 O
Criteria NCT03926858 10 18 O
: NCT03926858 19 20 O

- NCT03926858 24 25 O
18 NCT03926858 27 29 B-Eq_Comparison
years NCT03926858 30 35 I-Eq_Comparison
or NCT03926858 36 38 I-Eq_Comparison
older NCT03926858 39 44 I-Eq_Comparison

- NCT03926858 47 48 O
Undergoing NCT03926858 50 60 B-Eq_Comparison
general NCT03926858 61 68 B-Modifier
or NCT03926858 69 71 B-Or
regional NCT03926858 72 80 B-Modifier
anesthesia NCT03926858 81 91 B-Procedure

- NCT03926858 94 95 O
Hospitalized NCT03926858 97 109 B-Encounter
for NCT03926858 110 113 O
at NCT03926858 114 116 B-Eq_Comparison
least NCT03926858 117 122 I-Eq_Comparison
24 NCT03926858 123 125 I-Eq_Comparison
hours NCT03926858 126 131 I-Eq_Comparison
after NCT03926858 132 137 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03926858 138 145 B-Procedure

- NCT03926858 148 149 O
Able NCT03926858 151 155 O
to NCT03926858 156 158 O
give NCT03926858 159 163 O
informed NCT03926858 164 172 O
consent NCT03926858 173 180 O

- NCT03926858 183 184 O
Able NCT03926858 186 190 O
to NCT03926858 191 193 O
read NCT03926858 194 198 O
and NCT03926858 199 202 O
write NCT03926858 203 208 O

Exclusion NCT03926858 209 218 O
Criteria NCT03926858 219 227 O
: NCT03926858 228 229 O

- NCT03926858 233 234 O
Existing NCT03926858 236 244 B-Eq_Comparison
diagnoses NCT03926858 245 254 O
of NCT03926858 255 257 O
psychiatric NCT03926858 258 269 B-Modifier
or NCT03926858 270 272 B-Or
neurologic NCT03926858 273 283 B-Modifier
pathology NCT03926858 284 293 B-Condition

- NCT03926858 296 297 O
A NCT03926858 299 300 O
history NCT03926858 301 308 B-Eq_Comparison
of NCT03926858 309 311 O
substance NCT03926858 312 321 B-Condition
abuse NCT03926858 322 327 I-Condition

- NCT03926858 330 331 O
Admitted NCT03926858 333 341 B-Encounter
to NCT03926858 342 344 O
ICU NCT03926858 345 348 O
after NCT03926858 349 354 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03926858 355 362 B-Procedure

Inclusion NCT03867409 0 9 O
Criteria NCT03867409 10 18 O
: NCT03867409 19 20 O

- NCT03867409 24 25 O
reside NCT03867409 27 33 O
within NCT03867409 34 40 O
the NCT03867409 41 44 O
United NCT03867409 45 51 O
States NCT03867409 52 58 O
but NCT03867409 59 62 B-Exception
outside NCT03867409 63 70 I-Exception
of NCT03867409 71 73 O
Florida NCT03867409 74 81 O

- NCT03867409 84 85 O
speak NCT03867409 87 92 O
English NCT03867409 93 100 O

- NCT03867409 103 104 O
are NCT03867409 106 109 O
of NCT03867409 110 112 O
either NCT03867409 113 119 O
black NCT03867409 120 125 O
or NCT03867409 126 128 B-Or
white NCT03867409 129 134 O
racial NCT03867409 135 141 O
background NCT03867409 142 152 O
. NCT03867409 153 154 O

- NCT03867409 158 159 O
are NCT03867409 161 164 O
out NCT03867409 165 168 O
- NCT03867409 169 170 O
of NCT03867409 171 173 O
- NCT03867409 174 175 O
guidelines NCT03867409 176 186 O
for NCT03867409 187 190 O
colorectal NCT03867409 191 201 B-Procedure
cancer NCT03867409 202 208 I-Procedure
screening NCT03867409 209 218 I-Procedure
( NCT03867409 219 220 O
> NCT03867409 221 222 B-Eq_Comparison
10 NCT03867409 223 225 I-Eq_Comparison
years NCT03867409 226 231 I-Eq_Comparison
for NCT03867409 232 235 O
colonoscopy NCT03867409 236 247 B-Procedure
, NCT03867409 248 249 O
> NCT03867409 250 251 B-Eq_Comparison
3 NCT03867409 252 253 I-Eq_Comparison
years NCT03867409 254 259 I-Eq_Comparison
for NCT03867409 260 263 O
Cologuard NCT03867409 264 273 B-Procedure
, NCT03867409 274 275 O
> NCT03867409 276 277 B-Eq_Comparison
1 NCT03867409 278 279 I-Eq_Comparison
year NCT03867409 280 284 I-Eq_Comparison
for NCT03867409 285 288 O
fecal NCT03867409 289 294 B-Procedure
immunochemical NCT03867409 295 309 I-Procedure
test NCT03867409 310 314 I-Procedure
) NCT03867409 315 316 O

Exclusion NCT03867409 318 327 O
Criteria NCT03867409 328 336 O
: NCT03867409 337 338 O

- NCT03867409 342 343 O
does NCT03867409 345 349 O
not NCT03867409 350 353 O
meet NCT03867409 354 358 O
the NCT03867409 359 362 O
above NCT03867409 363 368 O
criteria NCT03867409 369 377 O

Inclusion NCT03920384 0 9 O
Criteria NCT03920384 10 18 O
: NCT03920384 19 20 O

- NCT03920384 24 25 O
Are NCT03920384 27 30 O
aged NCT03920384 31 35 B-Age
16 NCT03920384 36 38 B-Eq_Comparison
or NCT03920384 39 41 I-Eq_Comparison
over NCT03920384 42 46 I-Eq_Comparison

- NCT03920384 49 50 O
Are NCT03920384 52 55 O
competent NCT03920384 56 65 O
and NCT03920384 66 69 O
willing NCT03920384 70 77 O
to NCT03920384 78 80 O
provide NCT03920384 81 88 O
written NCT03920384 89 96 O
, NCT03920384 97 98 O
informed NCT03920384 99 107 O
consent NCT03920384 108 115 O

- NCT03920384 118 119 O
Are NCT03920384 121 124 O
experiencing NCT03920384 125 137 B-Eq_Comparison
delusions NCT03920384 138 147 B-Condition
( NCT03920384 148 149 O
A NCT03920384 150 151 O
score NCT03920384 152 157 B-Eq_Comparison
of NCT03920384 158 160 I-Eq_Comparison
≥ NCT03920384 161 162 I-Eq_Comparison
3 NCT03920384 163 164 I-Eq_Comparison
on NCT03920384 165 167 O
PANSS NCT03920384 168 173 B-Observation
item NCT03920384 174 178 O
P NCT03920384 179 180 B-Modifier
1 NCT03920384 181 182 I-Modifier
, NCT03920384 183 184 O
P NCT03920384 185 186 B-Modifier
5 NCT03920384 187 188 I-Modifier
or NCT03920384 189 191 B-Or
P NCT03920384 192 193 B-Modifier
6 NCT03920384 194 195 I-Modifier
) NCT03920384 196 197 O

Exclusion NCT03920384 199 208 O
Criteria NCT03920384 209 217 O
: NCT03920384 218 219 O

- NCT03920384 223 224 O
Significant NCT03920384 226 237 O
developmental NCT03920384 238 251 B-Condition
disability NCT03920384 252 262 I-Condition

- NCT03920384 265 266 O
Currently NCT03920384 268 277 B-Eq_Comparison
receiving NCT03920384 278 287 I-Eq_Comparison
or NCT03920384 288 290 B-Or
have NCT03920384 291 295 O
received NCT03920384 296 304 B-Eq_Comparison
CBTp NCT03920384 305 309 B-Procedure
in NCT03920384 310 312 O
the NCT03920384 313 316 O
last NCT03920384 317 321 B-Eq_Comparison
6 NCT03920384 322 323 I-Eq_Comparison
months NCT03920384 324 330 I-Eq_Comparison

- NCT03920384 333 334 O
Significant NCT03920384 336 347 O
difficulty NCT03920384 348 358 B-Negation
with NCT03920384 359 363 O
the NCT03920384 364 367 O
English NCT03920384 368 375 O
language NCT03920384 376 384 O

Inclusion NCT03924115 0 9 O
Criteria NCT03924115 10 18 O
: NCT03924115 19 20 O

- NCT03924115 24 25 O
People NCT03924115 27 33 O
under NCT03924115 34 39 B-Eq_Comparison
treatment NCT03924115 40 49 B-Procedure
for NCT03924115 50 53 O
hypertension NCT03924115 54 66 B-Condition

- NCT03924115 69 70 O
Both NCT03924115 72 76 O
sexes NCT03924115 77 82 O

- NCT03924115 85 86 O
Older NCT03924115 88 93 B-Eq_Comparison
than NCT03924115 94 98 I-Eq_Comparison
60 NCT03924115 99 101 I-Eq_Comparison
years NCT03924115 102 107 I-Eq_Comparison

- NCT03924115 110 111 O
Autovalent NCT03924115 113 123 B-Condition

- NCT03924115 126 127 O
read NCT03924115 129 133 O
and NCT03924115 134 137 O
write NCT03924115 138 143 O

Exclusion NCT03924115 144 153 O
Criteria NCT03924115 154 162 O
: NCT03924115 163 164 O

- NCT03924115 168 169 O
Under NCT03924115 171 176 B-Eq_Comparison
treatment NCT03924115 177 186 B-Procedure
for NCT03924115 187 190 O
severe NCT03924115 191 197 O
psychiatric NCT03924115 198 209 B-Condition
pathology NCT03924115 210 219 I-Condition

- NCT03924115 222 223 O
Mental NCT03924115 225 231 B-Condition
retardation NCT03924115 232 243 I-Condition
. NCT03924115 244 245 O

Inclusion NCT03860714 0 9 O
Criteria NCT03860714 10 18 O
: NCT03860714 19 20 O

- NCT03860714 24 25 O
Non NCT03860714 27 30 B-Negation
- NCT03860714 31 32 O
cardiac NCT03860714 33 40 B-Modifier
surgery NCT03860714 41 48 B-Procedure
patients NCT03860714 49 57 O
; NCT03860714 57 58 O

- NCT03860714 66 67 O
Age NCT03860714 69 72 B-Age
is NCT03860714 73 75 O
greater NCT03860714 76 83 B-Eq_Comparison
than NCT03860714 84 88 I-Eq_Comparison
or NCT03860714 89 91 I-Eq_Comparison
equal NCT03860714 92 97 I-Eq_Comparison
to NCT03860714 98 100 I-Eq_Comparison
60 NCT03860714 101 103 I-Eq_Comparison
years NCT03860714 104 109 I-Eq_Comparison
old NCT03860714 110 113 O
; NCT03860714 113 114 O
③ NCT03860714 115 116 O
Han NCT03860714 117 120 O
Nationality NCT03860714 121 132 O
, NCT03860714 133 134 O
mother NCT03860714 135 141 O
tongue NCT03860714 142 148 O
is NCT03860714 149 151 O
chinese NCT03860714 152 159 O
; NCT03860714 159 160 O
④ NCT03860714 161 162 O
The NCT03860714 163 166 O
MMSE NCT03860714 167 171 B-Observation
score NCT03860714 172 177 O
: NCT03860714 178 179 O
Illiteracy NCT03860714 180 190 O
is NCT03860714 191 193 O
greater NCT03860714 194 201 B-Eq_Comparison
than NCT03860714 202 206 I-Eq_Comparison
or NCT03860714 207 209 I-Eq_Comparison
equal NCT03860714 210 215 I-Eq_Comparison
to NCT03860714 216 218 I-Eq_Comparison
17 NCT03860714 219 221 I-Eq_Comparison
points NCT03860714 222 228 I-Eq_Comparison
, NCT03860714 229 230 O
primary NCT03860714 231 238 B-Observation
school NCT03860714 239 245 I-Observation
is NCT03860714 246 248 O
greater NCT03860714 249 256 B-Eq_Comparison
than NCT03860714 257 261 I-Eq_Comparison
or NCT03860714 262 264 I-Eq_Comparison
equal NCT03860714 265 270 I-Eq_Comparison
to NCT03860714 271 273 I-Eq_Comparison
20 NCT03860714 274 276 I-Eq_Comparison
points NCT03860714 277 283 I-Eq_Comparison
, NCT03860714 284 285 O
higher NCT03860714 286 292 B-Observation
secondary NCT03860714 293 302 I-Observation
school NCT03860714 303 309 I-Observation
is NCT03860714 310 312 O
more NCT03860714 313 317 B-Eq_Comparison
than NCT03860714 318 322 I-Eq_Comparison
24 NCT03860714 323 325 I-Eq_Comparison
points NCT03860714 326 332 I-Eq_Comparison
; NCT03860714 332 333 O
⑤The NCT03860714 334 338 O
people NCT03860714 339 345 O
signed NCT03860714 346 352 O
informed NCT03860714 353 361 O
consent NCT03860714 362 369 O
. NCT03860714 370 371 O

Exclusion NCT03860714 373 382 O
Criteria NCT03860714 383 391 O
: NCT03860714 392 393 O

- NCT03860714 397 398 O
The NCT03860714 400 403 O
diagnosis NCT03860714 404 413 O
of NCT03860714 414 416 O
pre NCT03860714 417 420 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03860714 421 430 B-Procedure
delirium NCT03860714 431 439 B-Condition
； NCT03860714 439 440 O

- NCT03860714 448 449 O
The NCT03860714 451 454 O
diagnosis NCT03860714 455 464 O
Unstable NCT03860714 465 473 O
hypertension NCT03860714 474 486 B-Condition
( NCT03860714 487 488 O
Such NCT03860714 489 493 O
as NCT03860714 494 496 O
: NCT03860714 497 498 O
pheochromocytoma NCT03860714 499 515 B-Condition
or NCT03860714 516 518 B-Or
aortic NCT03860714 519 525 B-Condition
dissection NCT03860714 526 536 I-Condition
） NCT03860714 536 537 O
； NCT03860714 537 538 O
③ NCT03860714 539 540 O
Severe NCT03860714 541 547 O
chronic NCT03860714 548 555 O
obstructive NCT03860714 556 567 B-Condition
pulmonary NCT03860714 568 577 I-Condition
disease NCT03860714 578 585 I-Condition
or NCT03860714 586 588 B-Or
congestive NCT03860714 589 599 B-Condition
heart NCT03860714 600 605 I-Condition
failure NCT03860714 606 613 I-Condition
； NCT03860714 613 614 O
④ NCT03860714 615 616 O
Severe NCT03860714 617 623 O
liver NCT03860714 624 629 B-Modifier
and NCT03860714 630 633 B-Or
kidney NCT03860714 634 640 B-Modifier
dysfunction NCT03860714 641 652 B-Condition
; NCT03860714 652 653 O

Inclusion NCT03864263 0 9 O
Criteria NCT03864263 10 18 O
: NCT03864263 19 20 O

- NCT03864263 24 25 O
The NCT03864263 27 30 O
father NCT03864263 31 37 B-Family_Member___Family_Member_Type:father
or NCT03864263 38 40 B-Or
( NCT03864263 41 42 I-Or
and NCT03864263 43 46 I-Or
) NCT03864263 47 48 I-Or
mother NCT03864263 49 55 B-Family_Member___Family_Member_Type:mother
is NCT03864263 56 58 O
HBV NCT03864263 59 62 B-Condition
- NCT03864263 63 64 I-Condition
infected NCT03864263 65 73 I-Condition
( NCT03864263 74 75 O
pre NCT03864263 76 79 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03864263 80 81 O
pregnancy NCT03864263 82 91 B-Condition
or NCT03864263 92 94 B-Or
present NCT03864263 95 102 B-Eq_Comparison
) NCT03864263 103 104 O
； NCT03864263 105 106 O

- NCT03864263 109 110 O
Children NCT03864263 112 120 B-Family_Member___Family_Member_Type:child
is NCT03864263 121 123 O
vaccinated NCT03864263 124 134 O
with NCT03864263 135 139 O
hepatitis NCT03864263 140 149 B-Immunization
B NCT03864263 150 151 I-Immunization
vaccine NCT03864263 152 159 I-Immunization
after NCT03864263 160 165 B-Temporal_Connection___Temporal_Connection_Type_Value:after
birth NCT03864263 166 171 B-Birth
; NCT03864263 171 172 O

Exclusion NCT03864263 173 182 O
Criteria NCT03864263 183 191 O
: NCT03864263 192 193 O

- NCT03864263 197 198 O
Children NCT03864263 200 208 B-Family_Member___Family_Member_Type:child
with NCT03864263 209 213 O
HBV NCT03864263 214 217 B-Condition
infection NCT03864263 218 227 I-Condition
; NCT03864263 227 228 O

- NCT03864263 231 232 O
Participants NCT03864263 234 246 O
agreed NCT03864263 247 253 O
to NCT03864263 254 256 O
undergo NCT03864263 257 264 O
clinical NCT03864263 265 273 O
follow NCT03864263 274 280 O
- NCT03864263 281 282 O
up NCT03864263 283 285 O
studies NCT03864263 286 293 O
. NCT03864263 294 295 O

Inclusion NCT03930121 0 9 O
Criteria NCT03930121 10 18 O
: NCT03930121 19 20 O

- NCT03930121 24 25 O
left NCT03930121 27 31 B-Modifier
- NCT03930121 32 33 I-Modifier
hemisphere NCT03930121 34 44 I-Modifier
cortical NCT03930121 45 53 I-Modifier
or NCT03930121 54 56 B-Or
subcortical NCT03930121 57 68 B-Modifier
stroke NCT03930121 69 75 B-Condition
with NCT03930121 76 80 B-And
first NCT03930121 81 86 B-Eq_Comparison
- NCT03930121 87 88 I-Eq_Comparison
ever NCT03930121 89 93 I-Eq_Comparison
aphasic NCT03930121 94 101 B-Condition
symptoms NCT03930121 102 110 B-Assertion___Assertion_Type_Value:possible

- NCT03930121 113 114 O
at NCT03930121 116 118 B-Eq_Comparison
least NCT03930121 119 124 I-Eq_Comparison
6 NCT03930121 125 126 I-Eq_Comparison
months NCT03930121 127 133 I-Eq_Comparison
post NCT03930121 134 138 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03930121 139 140 O
onset NCT03930121 141 146 B-Eq_Comparison
of NCT03930121 147 149 O
stroke NCT03930121 150 156 B-Condition
; NCT03930121 156 157 O

- NCT03930121 160 161 O
aphasia NCT03930121 163 170 B-Condition
, NCT03930121 171 172 O
as NCT03930121 173 175 O
determined NCT03930121 176 186 O
by NCT03930121 187 189 O
the NCT03930121 190 193 O
Aachen NCT03930121 194 200 B-Observation
Aphasia NCT03930121 201 208 I-Observation
Test NCT03930121 209 213 I-Observation
( NCT03930121 214 215 O
AAT NCT03930121 216 219 B-Observation
) NCT03930121 220 221 O
; NCT03930121 222 223 O

- NCT03930121 226 227 O
13 NCT03930121 229 231 B-Eq_Comparison
moderate NCT03930121 232 240 O
- NCT03930121 241 242 O
to NCT03930121 243 245 B-Or
- NCT03930121 246 247 O
severe NCT03930121 248 254 O
word NCT03930121 255 259 B-Condition
finding NCT03930121 260 267 I-Condition
difficulties NCT03930121 268 280 I-Condition
( NCT03930121 281 282 O
maximum NCT03930121 283 290 B-Eq_Comparison
of NCT03930121 291 293 I-Eq_Comparison
60 NCT03930121 294 296 I-Eq_Comparison
% NCT03930121 297 298 I-Eq_Comparison
correct NCT03930121 299 306 O
items NCT03930121 307 312 O
on NCT03930121 313 315 O
a NCT03930121 316 317 O
computerized NCT03930121 318 330 B-Observation
naming NCT03930121 331 337 I-Observation
task NCT03930121 338 342 I-Observation
at NCT03930121 343 345 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03930121 346 354 B-Study
) NCT03930121 355 356 O
; NCT03930121 357 358 O

- NCT03930121 361 362 O
at NCT03930121 364 366 B-Eq_Comparison
least NCT03930121 367 372 I-Eq_Comparison
1 NCT03930121 373 374 I-Eq_Comparison
correct NCT03930121 375 382 I-Eq_Comparison
reaction NCT03930121 383 391 I-Eq_Comparison
on NCT03930121 392 394 O
the NCT03930121 395 398 O
first NCT03930121 399 404 O
part NCT03930121 405 409 O
of NCT03930121 410 412 O
the NCT03930121 413 416 O
AAT NCT03930121 417 420 B-Observation
subscale NCT03930121 421 429 I-Observation
Token NCT03930121 430 435 I-Observation
Test NCT03930121 436 440 I-Observation
( NCT03930121 441 442 O
ensuring NCT03930121 443 451 O
basic NCT03930121 452 457 O
comprehension NCT03930121 458 471 O
skills NCT03930121 472 478 O
) NCT03930121 479 480 O
; NCT03930121 481 482 O

- NCT03930121 485 486 O
at NCT03930121 488 490 B-Eq_Comparison
least NCT03930121 491 496 I-Eq_Comparison
1 NCT03930121 497 498 I-Eq_Comparison
point NCT03930121 499 504 I-Eq_Comparison
on NCT03930121 505 507 O
the NCT03930121 508 511 O
communicative NCT03930121 512 525 O
task NCT03930121 526 530 O
of NCT03930121 531 533 O
the NCT03930121 534 537 O
AAT NCT03930121 538 541 B-Observation
subscale NCT03930121 542 550 I-Observation
Spontaneous NCT03930121 551 562 I-Observation
Speech NCT03930121 563 569 I-Observation
( NCT03930121 570 571 O
ensuring NCT03930121 572 580 O
basic NCT03930121 581 586 O
communication NCT03930121 587 600 O
abilities NCT03930121 601 610 O
) NCT03930121 611 612 O
; NCT03930121 613 614 O

- NCT03930121 617 618 O
German NCT03930121 620 626 O
as NCT03930121 627 629 O
first NCT03930121 630 635 O
language NCT03930121 636 644 O
; NCT03930121 644 645 O

- NCT03930121 648 649 O
intact NCT03930121 651 657 B-Modifier
left NCT03930121 658 662 B-Condition
- NCT03930121 663 664 I-Condition
hemisphere NCT03930121 665 675 I-Condition
" NCT03930121 676 677 I-Condition
hand NCT03930121 677 681 I-Condition
knob NCT03930121 682 686 I-Condition
" NCT03930121 686 687 I-Condition
without NCT03930121 688 695 B-Negation
right NCT03930121 696 701 B-Modifier
prefrontal NCT03930121 702 712 B-Condition
lesions NCT03930121 713 720 I-Condition
for NCT03930121 721 724 B-Assertion___Assertion_Type_Value:hypothetical
placement NCT03930121 725 734 B-Procedure
of NCT03930121 735 737 I-Procedure
tDCS NCT03930121 738 742 I-Procedure
electrodes NCT03930121 743 753 I-Procedure
, NCT03930121 754 755 O
as NCT03930121 756 758 O
confirmed NCT03930121 759 768 O
by NCT03930121 769 771 O
magnetic NCT03930121 772 780 B-Procedure
resonance NCT03930121 781 790 I-Procedure
imaging NCT03930121 791 798 I-Procedure
or NCT03930121 799 801 B-Or
computer NCT03930121 802 810 B-Procedure
tomography NCT03930121 811 821 I-Procedure
scans NCT03930121 822 827 I-Procedure
. NCT03930121 828 829 O

Exclusion NCT03930121 831 840 O
Criteria NCT03930121 841 849 O
: NCT03930121 850 851 O

- NCT03930121 855 856 O
contraindications NCT03930121 858 875 B-Contraindication
for NCT03930121 876 879 O
tDCS NCT03930121 880 884 B-Procedure
( NCT03930121 885 886 O
e NCT03930121 887 888 O
. NCT03930121 889 890 O
g NCT03930121 891 892 O
. NCT03930121 893 894 O
, NCT03930121 895 896 O
cardiac NCT03930121 897 904 B-Condition
pacemaker NCT03930121 905 914 I-Condition
, NCT03930121 915 916 O
history NCT03930121 917 924 B-Eq_Comparison
of NCT03930121 925 927 O
seizures NCT03930121 928 936 B-Condition
, NCT03930121 937 938 O
implanted NCT03930121 939 948 B-Condition
metal NCT03930121 949 954 I-Condition
inside NCT03930121 955 961 I-Condition
the NCT03930121 962 965 I-Condition
head NCT03930121 966 970 I-Condition
) NCT03930121 971 972 O
; NCT03930121 973 974 O

- NCT03930121 977 978 O
more NCT03930121 980 984 B-Eq_Comparison
than NCT03930121 985 989 I-Eq_Comparison
one NCT03930121 990 993 I-Eq_Comparison
clinically NCT03930121 994 1004 B-Modifier
apparent NCT03930121 1005 1013 I-Modifier
stroke NCT03930121 1014 1020 B-Condition
with NCT03930121 1021 1025 B-And
aphasic NCT03930121 1026 1033 B-Condition
symptoms NCT03930121 1034 1042 B-Assertion___Assertion_Type_Value:possible
; NCT03930121 1042 1043 O

- NCT03930121 1046 1047 O
other NCT03930121 1049 1054 O
severe NCT03930121 1055 1061 O
neurological NCT03930121 1062 1074 B-Condition
diseases NCT03930121 1075 1083 I-Condition
( NCT03930121 1084 1085 O
e NCT03930121 1086 1087 O
. NCT03930121 1088 1089 O
g NCT03930121 1090 1091 O
. NCT03930121 1092 1093 O
, NCT03930121 1094 1095 O
epilepsy NCT03930121 1096 1104 B-Condition
, NCT03930121 1105 1106 O
brain NCT03930121 1107 1112 B-Condition
tumor NCT03930121 1113 1118 I-Condition
, NCT03930121 1119 1120 O
and NCT03930121 1121 1124 B-And
subdural NCT03930121 1125 1133 B-Condition
hematoma NCT03930121 1134 1142 I-Condition
) NCT03930121 1143 1144 O
; NCT03930121 1145 1146 O

- NCT03930121 1149 1150 O
history NCT03930121 1152 1159 B-Eq_Comparison
of NCT03930121 1160 1162 O
severe NCT03930121 1163 1169 O
alcohol NCT03930121 1170 1177 B-Modifier
or NCT03930121 1178 1180 B-Or
drug NCT03930121 1181 1185 B-Modifier
abuse NCT03930121 1186 1191 B-Condition
; NCT03930121 1191 1192 O

- NCT03930121 1195 1196 O
current NCT03930121 1198 1205 B-Eq_Comparison
severe NCT03930121 1206 1212 O
depression NCT03930121 1213 1223 B-Condition
; NCT03930121 1223 1224 O

- NCT03930121 1227 1228 O
current NCT03930121 1230 1237 B-Eq_Comparison
psychosis NCT03930121 1238 1247 B-Condition
or NCT03930121 1248 1250 B-Or
other NCT03930121 1251 1256 O
relevant NCT03930121 1257 1265 O
psychiatric NCT03930121 1266 1277 B-Condition
condition NCT03930121 1278 1287 I-Condition
; NCT03930121 1287 1288 O

- NCT03930121 1291 1292 O
very NCT03930121 1294 1298 O
severe NCT03930121 1299 1305 O
apraxia NCT03930121 1306 1313 B-Condition
of NCT03930121 1314 1316 I-Condition
speech NCT03930121 1317 1323 I-Condition
, NCT03930121 1324 1325 O
as NCT03930121 1326 1328 O
revealed NCT03930121 1329 1337 O
by NCT03930121 1338 1340 O
Hierarchical NCT03930121 1341 1353 B-Observation
Word NCT03930121 1354 1358 I-Observation
Lists NCT03930121 1359 1364 I-Observation
; NCT03930121 1364 1365 O

- NCT03930121 1368 1369 O
severe NCT03930121 1371 1377 O
non NCT03930121 1378 1381 B-Condition
- NCT03930121 1382 1383 I-Condition
verbal NCT03930121 1384 1390 I-Condition
cognitive NCT03930121 1391 1400 I-Condition
deficits NCT03930121 1401 1409 I-Condition
, NCT03930121 1410 1411 O
as NCT03930121 1412 1414 O
indicated NCT03930121 1415 1424 O
by NCT03930121 1425 1427 O
the NCT03930121 1428 1431 O
Corsi NCT03930121 1432 1437 B-Observation
Block NCT03930121 1438 1443 I-Observation
- NCT03930121 1444 1445 I-Observation
Tapping NCT03930121 1446 1453 I-Observation
Task NCT03930121 1454 1458 I-Observation
; NCT03930121 1458 1459 O

- NCT03930121 1462 1463 O
severe NCT03930121 1465 1471 O
uncontrolled NCT03930121 1472 1484 B-Modifier
medical NCT03930121 1485 1492 B-Condition
problems NCT03930121 1493 1501 I-Condition
; NCT03930121 1501 1502 O

- NCT03930121 1505 1506 O
severely NCT03930121 1508 1516 O
impaired NCT03930121 1517 1525 B-Condition
vision NCT03930121 1526 1532 B-Modifier
or NCT03930121 1533 1535 B-Or
hearing NCT03930121 1536 1543 B-Modifier
that NCT03930121 1544 1548 O
prevents NCT03930121 1549 1557 O
patients NCT03930121 1558 1566 O
from NCT03930121 1567 1571 O
engaging NCT03930121 1572 1580 O
in NCT03930121 1581 1583 O
intensive NCT03930121 1584 1593 O
SLT NCT03930121 1594 1597 O
; NCT03930121 1597 1598 O

- NCT03930121 1601 1602 O
changes NCT03930121 1604 1611 O
in NCT03930121 1612 1614 O
centrally NCT03930121 1615 1624 B-Drug
active NCT03930121 1625 1631 I-Drug
drugs NCT03930121 1632 1637 I-Drug
within NCT03930121 1638 1644 B-Eq_Comparison
2 NCT03930121 1645 1646 I-Eq_Comparison
weeks NCT03930121 1647 1652 I-Eq_Comparison
prior NCT03930121 1653 1658 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03930121 1659 1661 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03930121 1662 1667 B-Study
inclusion NCT03930121 1668 1677 O
. NCT03930121 1678 1679 O

Inclusion NCT03924505 0 9 O
Criteria NCT03924505 10 18 O
: NCT03924505 19 20 O

- NCT03924505 24 25 O
SSPs NCT03924505 27 31 B-Condition
that NCT03924505 32 36 O
participate NCT03924505 37 48 O
in NCT03924505 49 51 O
the NCT03924505 52 55 O
on NCT03924505 56 58 O
- NCT03924505 59 60 O
line NCT03924505 61 65 O
screening NCT03924505 66 75 B-Study
survey NCT03924505 76 82 O
and NCT03924505 83 86 B-And
fall NCT03924505 87 91 O
into NCT03924505 92 96 O
the NCT03924505 97 100 O
implementation NCT03924505 101 115 B-Modifier
phase NCT03924505 116 121 I-Modifier
of NCT03924505 122 124 O
the NCT03924505 125 128 O
EPIS NCT03924505 129 133 B-Condition
continuum NCT03924505 134 143 I-Condition
will NCT03924505 144 148 O
be NCT03924505 149 151 O
recruited NCT03924505 152 161 O
into NCT03924505 162 166 O
the NCT03924505 167 170 O
study NCT03924505 171 176 O
. NCT03924505 177 178 O

Exclusion NCT03924505 180 189 O
Criteria NCT03924505 190 198 O
: NCT03924505 199 200 O

- NCT03924505 203 204 O

Inclusion NCT03860610 0 9 O
Criteria NCT03860610 10 18 O
: NCT03860610 19 20 O

- NCT03860610 24 25 O
Patients NCT03860610 27 35 O
with NCT03860610 36 40 O
an NCT03860610 41 43 O
unilateral NCT03860610 44 54 B-Modifier
THA NCT03860610 55 58 B-Procedure
or NCT03860610 59 61 B-Or
TKA NCT03860610 62 65 B-Procedure
, NCT03860610 66 67 O
which NCT03860610 68 73 O
they NCT03860610 74 78 O
received NCT03860610 79 87 B-Eq_Comparison
for NCT03860610 88 91 O
the NCT03860610 92 95 O
treatment NCT03860610 96 105 B-Procedure
of NCT03860610 106 108 O
osteoarthritis NCT03860610 109 123 B-Condition
( NCT03860610 124 125 O
Patient NCT03860610 126 133 O
groups NCT03860610 134 140 O
1 NCT03860610 141 142 O
+ NCT03860610 143 144 O
2 NCT03860610 145 146 O
) NCT03860610 147 148 O

- NCT03860610 152 153 O
Patients NCT03860610 155 163 O
diagnosed NCT03860610 164 173 O
with NCT03860610 174 178 O
unilateral NCT03860610 179 189 B-Modifier
OA NCT03860610 190 192 B-Condition
of NCT03860610 193 195 O
the NCT03860610 196 199 O
knee NCT03860610 200 204 B-Modifier
or NCT03860610 205 207 B-Or
hip NCT03860610 208 211 B-Modifier
planned NCT03860610 212 219 B-Eq_Comparison
for NCT03860610 220 223 O
a NCT03860610 224 225 O
treatment NCT03860610 226 235 B-Procedure
with NCT03860610 236 240 O
THA NCT03860610 241 244 B-Procedure
or NCT03860610 245 247 B-Or
TKA NCT03860610 248 251 B-Procedure
( NCT03860610 252 253 O
Patient NCT03860610 254 261 O
groups NCT03860610 262 268 O
3 NCT03860610 269 270 O
+ NCT03860610 271 272 O
4 NCT03860610 273 274 O
) NCT03860610 275 276 O

- NCT03860610 280 281 O
Age NCT03860610 283 286 B-Age
≥ NCT03860610 287 288 B-Eq_Comparison
30 NCT03860610 289 291 I-Eq_Comparison
years NCT03860610 292 297 I-Eq_Comparison
( NCT03860610 298 299 O
Healthy NCT03860610 300 307 B-Condition
control NCT03860610 308 315 O
group NCT03860610 316 321 O
) NCT03860610 322 323 O

Exclusion NCT03860610 325 334 O
Criteria NCT03860610 335 343 O
: NCT03860610 344 345 O

- NCT03860610 349 350 O
Body NCT03860610 352 356 B-Observation
mass NCT03860610 357 361 I-Observation
index NCT03860610 362 367 I-Observation
> NCT03860610 368 369 B-Eq_Comparison
35 NCT03860610 370 372 I-Eq_Comparison
kg NCT03860610 373 375 I-Eq_Comparison
/ NCT03860610 376 377 I-Eq_Comparison
m NCT03860610 378 379 I-Eq_Comparison
2 NCT03860610 380 381 I-Eq_Comparison

- NCT03860610 384 385 O
Use NCT03860610 387 390 O
of NCT03860610 391 393 O
walking NCT03860610 394 401 B-Procedure
aids NCT03860610 402 406 I-Procedure

- NCT03860610 409 410 O
Neuromuscular NCT03860610 412 425 B-Condition
disorders NCT03860610 426 435 I-Condition
affecting NCT03860610 436 445 O
gait NCT03860610 446 450 B-Condition

- NCT03860610 453 454 O
Inability NCT03860610 456 465 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03860610 466 468 O
follow NCT03860610 469 475 O
procedures NCT03860610 476 486 B-Procedure
due NCT03860610 487 490 O
to NCT03860610 491 493 O
psychological NCT03860610 494 507 B-Condition
disorders NCT03860610 508 517 I-Condition
or NCT03860610 518 520 B-Or
dementia NCT03860610 521 529 B-Condition

- NCT03860610 532 533 O
Diagnosed NCT03860610 535 544 O
hip NCT03860610 545 548 B-Modifier
or NCT03860610 549 551 O
knee NCT03860610 552 556 B-Modifier
OA NCT03860610 557 559 B-Condition
( NCT03860610 560 561 O
Healthy NCT03860610 562 569 B-Condition
control NCT03860610 570 577 O
group NCT03860610 578 583 O
) NCT03860610 584 585 O

- NCT03860610 589 590 O
Current NCT03860610 592 599 B-Eq_Comparison
pain NCT03860610 600 604 B-Condition
in NCT03860610 605 607 O
the NCT03860610 608 611 O
lower NCT03860610 612 617 B-Modifier
extremities NCT03860610 618 629 I-Modifier
or NCT03860610 630 632 B-Or
lower NCT03860610 633 638 B-Modifier
back NCT03860610 639 643 I-Modifier
( NCT03860610 644 645 O
Healthy NCT03860610 646 653 B-Condition
control NCT03860610 654 661 O
group NCT03860610 662 667 O
) NCT03860610 668 669 O

- NCT03860610 673 674 O
Rheumatoid NCT03860610 676 686 B-Condition
Arthritis NCT03860610 687 696 I-Condition
( NCT03860610 697 698 O
Healthy NCT03860610 699 706 B-Condition
control NCT03860610 707 714 O
group NCT03860610 715 720 O
) NCT03860610 721 722 O

- NCT03860610 726 727 O
Previous NCT03860610 729 737 B-Eq_Comparison
corrective NCT03860610 738 748 B-Procedure
osteotomy NCT03860610 749 758 I-Procedure
( NCT03860610 759 760 O
Healthy NCT03860610 761 768 B-Condition
control NCT03860610 769 776 O
group NCT03860610 777 782 O
) NCT03860610 783 784 O

- NCT03860610 788 789 O
Regular NCT03860610 791 798 O
intake NCT03860610 799 805 O
of NCT03860610 806 808 O
pain NCT03860610 809 813 B-Drug
medication NCT03860610 814 824 I-Drug
( NCT03860610 825 826 O
more NCT03860610 827 831 B-Eq_Comparison
than NCT03860610 832 836 I-Eq_Comparison
4 NCT03860610 837 838 I-Eq_Comparison
times NCT03860610 839 844 I-Eq_Comparison
per NCT03860610 845 848 I-Eq_Comparison
week NCT03860610 849 853 I-Eq_Comparison
) NCT03860610 854 855 O
( NCT03860610 856 857 O
Healthy NCT03860610 858 865 B-Condition
control NCT03860610 866 873 O
group NCT03860610 874 879 O
) NCT03860610 880 881 O

Inclusion NCT03868449 0 9 O
Criteria NCT03868449 10 18 O
: NCT03868449 19 20 O

- NCT03868449 24 25 O
patients NCT03868449 27 35 O
with NCT03868449 36 40 O
common NCT03868449 41 47 B-Modifier
hand NCT03868449 48 52 I-Modifier
conditions NCT03868449 53 63 B-Condition

Exclusion NCT03868449 64 73 O
Criteria NCT03868449 74 82 O
: NCT03868449 83 84 O

- NCT03868449 87 88 O

Inclusion NCT03926156 0 9 O
Criteria NCT03926156 10 18 O
: NCT03926156 19 20 O

1 NCT03926156 24 25 O
. NCT03926156 25 26 O
Provision NCT03926156 28 37 O
of NCT03926156 38 40 O
signed NCT03926156 41 47 O
and NCT03926156 48 51 O
dated NCT03926156 52 57 O
informed NCT03926156 58 66 O
consent NCT03926156 67 74 O
form NCT03926156 75 79 O

2 NCT03926156 82 83 O
. NCT03926156 83 84 O
Stated NCT03926156 86 92 O
willingness NCT03926156 93 104 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926156 105 107 O
comply NCT03926156 108 114 O
with NCT03926156 115 119 O
all NCT03926156 120 123 O
study NCT03926156 124 129 B-Study
procedures NCT03926156 130 140 B-Procedure
and NCT03926156 141 144 O
availability NCT03926156 145 157 O
for NCT03926156 158 161 O
the NCT03926156 162 165 O
duration NCT03926156 166 174 O
of NCT03926156 175 177 O
the NCT03926156 178 181 O
study NCT03926156 182 187 O

3 NCT03926156 190 191 O
. NCT03926156 191 192 O
Men NCT03926156 194 197 O
and NCT03926156 198 201 B-Or
women NCT03926156 202 207 O
≥ NCT03926156 208 209 B-Eq_Comparison
18 NCT03926156 210 212 I-Eq_Comparison
year NCT03926156 213 217 I-Eq_Comparison
- NCT03926156 218 219 I-Eq_Comparison
old NCT03926156 220 223 I-Eq_Comparison

4 NCT03926156 226 227 O
. NCT03926156 227 228 O
Diagnosed NCT03926156 230 239 O
with NCT03926156 240 244 O
moderate NCT03926156 245 253 B-Eq_Comparison
to NCT03926156 254 256 I-Eq_Comparison
severe NCT03926156 257 263 I-Eq_Comparison
mitral NCT03926156 264 270 B-Condition
stenosis NCT03926156 271 279 I-Condition
who NCT03926156 280 283 B-And
have NCT03926156 284 288 O
a NCT03926156 289 290 O
history NCT03926156 291 298 B-Eq_Comparison
of NCT03926156 299 301 O
AF NCT03926156 302 304 B-Condition
of NCT03926156 305 307 O
any NCT03926156 308 311 O
duration NCT03926156 312 320 O
documented NCT03926156 321 331 O
by NCT03926156 332 334 O
any NCT03926156 335 338 O
electrical NCT03926156 339 349 B-Procedure
tracing NCT03926156 350 357 I-Procedure
within NCT03926156 358 364 O
the NCT03926156 365 368 O
prior NCT03926156 369 374 B-Eq_Comparison
12 NCT03926156 375 377 I-Eq_Comparison
months NCT03926156 378 384 I-Eq_Comparison
and NCT03926156 385 388 B-And
for NCT03926156 389 392 O
which NCT03926156 393 398 O
anticoagulation NCT03926156 399 414 B-Procedure
is NCT03926156 415 417 O
indicated NCT03926156 418 427 B-Indication
and NCT03926156 428 431 O
planned NCT03926156 432 439 B-Eq_Comparison
for NCT03926156 440 443 I-Eq_Comparison
the NCT03926156 444 447 O
duration NCT03926156 448 456 B-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03926156 457 459 O
the NCT03926156 460 463 O
study NCT03926156 464 469 B-Study
. NCT03926156 470 471 O

5 NCT03926156 475 476 O
. NCT03926156 476 477 O
Ability NCT03926156 479 486 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926156 487 489 I-Assertion___Assertion_Type_Value:hypothetical
take NCT03926156 490 494 O
oral NCT03926156 495 499 B-Procedure
medication NCT03926156 500 510 I-Procedure
and NCT03926156 511 514 B-And
be NCT03926156 515 517 O
willing NCT03926156 518 525 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926156 526 528 I-Assertion___Assertion_Type_Value:hypothetical
adhere NCT03926156 529 535 O
to NCT03926156 536 538 O
the NCT03926156 539 542 O
rivaroxaban NCT03926156 543 554 B-Drug
regimen NCT03926156 555 562 O

Exclusion NCT03926156 563 572 O
Criteria NCT03926156 573 581 O
: NCT03926156 582 583 O

1 NCT03926156 587 588 O
. NCT03926156 588 589 O
Left NCT03926156 591 595 B-Modifier
atrial NCT03926156 596 602 I-Modifier
clot NCT03926156 603 607 B-Condition

2 NCT03926156 610 611 O
. NCT03926156 611 612 O
Severe NCT03926156 614 620 O
renal NCT03926156 621 626 B-Condition
dysfunction NCT03926156 627 638 I-Condition
( NCT03926156 639 640 O
creatinine NCT03926156 641 651 B-Observation
clearance NCT03926156 652 661 I-Observation
[ NCT03926156 662 663 O
CrCl NCT03926156 664 668 B-Observation
] NCT03926156 669 670 O
< NCT03926156 671 672 B-Eq_Comparison
15 NCT03926156 673 675 I-Eq_Comparison
mL NCT03926156 676 678 I-Eq_Comparison
/ NCT03926156 679 680 I-Eq_Comparison
min NCT03926156 681 684 I-Eq_Comparison
) NCT03926156 685 686 O
, NCT03926156 687 688 O
subjects NCT03926156 689 697 O
with NCT03926156 698 702 O

3 NCT03926156 705 706 O
. NCT03926156 706 707 O
A NCT03926156 709 710 O
condition NCT03926156 711 720 B-Condition
associated NCT03926156 721 731 O
with NCT03926156 732 736 O
a NCT03926156 737 738 O
high NCT03926156 739 743 O
risk NCT03926156 744 748 B-Risk
of NCT03926156 749 751 O
bleeding NCT03926156 752 760 B-Condition

4 NCT03926156 763 764 O
. NCT03926156 764 765 O
Allergic NCT03926156 767 775 B-Allergy
to NCT03926156 776 778 O
rivaroxabn NCT03926156 779 789 B-Drug
/ NCT03926156 790 791 B-Or
warfarin NCT03926156 792 800 B-Drug

Inclusion NCT03924167 0 9 O
Criteria NCT03924167 10 18 O
: NCT03924167 19 20 O

Inclusion NCT03924167 22 31 O
Criteria NCT03924167 32 40 O
for NCT03924167 41 44 O
community NCT03924167 45 54 O
health NCT03924167 55 61 O
representatives NCT03924167 62 77 O
( NCT03924167 78 79 O
CHR NCT03924167 80 83 B-Condition
) NCT03924167 84 85 O
s NCT03924167 86 87 O
. NCT03924167 88 89 O
> NCT03924167 91 92 B-Eq_Comparison
> NCT03924167 93 94 I-Eq_Comparison
18 NCT03924167 95 97 I-Eq_Comparison
years NCT03924167 98 103 I-Eq_Comparison
of NCT03924167 104 106 O
age NCT03924167 107 110 B-Age
or NCT03924167 111 113 O
older NCT03924167 114 119 O

- NCT03924167 122 123 O
have NCT03924167 125 129 O
at NCT03924167 130 132 B-Eq_Comparison
least NCT03924167 133 138 I-Eq_Comparison
a NCT03924167 139 140 O
high NCT03924167 141 145 B-Observation
school NCT03924167 146 152 I-Observation
degree NCT03924167 153 159 I-Observation

- NCT03924167 162 163 O
have NCT03924167 165 169 O
experience NCT03924167 170 180 O
and NCT03924167 181 184 O
/ NCT03924167 185 186 O
or NCT03924167 187 189 O
interest NCT03924167 190 198 O
in NCT03924167 199 201 O
working NCT03924167 202 209 O
with NCT03924167 210 214 O
tribal NCT03924167 215 221 O
children NCT03924167 222 230 O
and NCT03924167 231 234 O
families NCT03924167 235 243 O
. NCT03924167 244 245 O

Exclusion NCT03924167 247 256 O
criteria NCT03924167 257 265 O
: NCT03924167 266 267 O

- NCT03924167 271 272 O
having NCT03924167 274 280 O
less NCT03924167 281 285 B-Eq_Comparison
than NCT03924167 286 290 I-Eq_Comparison
a NCT03924167 291 292 O
high NCT03924167 293 297 B-Observation
school NCT03924167 298 304 I-Observation
degree NCT03924167 305 311 I-Observation

- NCT03924167 314 315 O
not NCT03924167 317 320 O
having NCT03924167 321 327 O
experience NCT03924167 328 338 O
with NCT03924167 339 343 O
tribal NCT03924167 344 350 O
families NCT03924167 351 359 O

Inclusion NCT03924167 360 369 O
criteria NCT03924167 370 378 O
for NCT03924167 379 382 O
families NCT03924167 383 391 O

- NCT03924167 394 395 O
includes NCT03924167 397 405 O
written NCT03924167 406 413 O
consent NCT03924167 414 421 O
for NCT03924167 422 425 O
adults NCT03924167 426 432 O
and NCT03924167 433 436 O
assent NCT03924167 437 443 O
for NCT03924167 444 447 O
children NCT03924167 448 456 O
ages NCT03924167 457 461 B-Age
12 NCT03924167 462 464 B-Eq_Comparison
- NCT03924167 465 466 I-Eq_Comparison
17 NCT03924167 467 469 I-Eq_Comparison
. NCT03924167 469 470 O

- NCT03924167 474 475 O
at NCT03924167 477 479 B-Eq_Comparison
least NCT03924167 480 485 I-Eq_Comparison
one NCT03924167 486 489 I-Eq_Comparison
parent NCT03924167 490 496 O
/ NCT03924167 497 498 O
caregiver NCT03924167 499 508 O
who NCT03924167 509 512 O
is NCT03924167 513 515 O
a NCT03924167 516 517 O
member NCT03924167 518 524 O
of NCT03924167 525 527 O
the NCT03924167 528 531 O
focal NCT03924167 532 537 O
tribe NCT03924167 538 543 O
and NCT03924167 544 547 O
at NCT03924167 548 550 O
least NCT03924167 551 556 O
one NCT03924167 557 560 O
child NCT03924167 561 566 O
, NCT03924167 567 568 O
aged NCT03924167 569 573 B-Age
12 NCT03924167 574 576 B-Eq_Comparison
- NCT03924167 577 578 I-Eq_Comparison
18 NCT03924167 579 581 I-Eq_Comparison
living NCT03924167 582 588 O
in NCT03924167 589 591 O
the NCT03924167 592 595 O
household NCT03924167 596 605 O

Exclusion NCT03924167 606 615 O
Criteria NCT03924167 616 624 O
: NCT03924167 625 626 O

- NCT03924167 630 631 O
current NCT03924167 633 640 B-Eq_Comparison
protective NCT03924167 641 651 B-Observation
order NCT03924167 652 657 I-Observation

- NCT03924167 660 661 O
current NCT03924167 663 670 B-Eq_Comparison
intimate NCT03924167 671 679 B-Condition
partner NCT03924167 680 687 I-Condition
violence NCT03924167 688 696 I-Condition
( NCT03924167 697 698 O
IPV NCT03924167 699 702 B-Condition
) NCT03924167 703 704 O
record NCT03924167 705 711 O
will NCT03924167 712 716 O
be NCT03924167 717 719 O
excluded NCT03924167 720 728 B-Negation
. NCT03924167 729 730 O

Inclusion NCT03864016 0 9 O
Criteria NCT03864016 10 18 O
: NCT03864016 19 20 O

- NCT03864016 24 25 O
Person NCT03864016 27 33 O
who NCT03864016 34 37 O
has NCT03864016 38 41 O
given NCT03864016 42 47 O
written NCT03864016 48 55 O
consent NCT03864016 56 63 O

- NCT03864016 66 67 O
Adult NCT03864016 69 74 O
patient NCT03864016 75 82 O

- NCT03864016 85 86 O
Patient NCT03864016 88 95 O
undergoing NCT03864016 96 106 B-Eq_Comparison
coronary NCT03864016 107 115 B-Procedure
artery NCT03864016 116 122 I-Procedure
bypass NCT03864016 123 129 I-Procedure
surgery NCT03864016 130 137 I-Procedure
with NCT03864016 138 142 O
CEC NCT03864016 143 146 B-Procedure
, NCT03864016 147 148 O
with NCT03864016 149 153 B-And
or NCT03864016 154 156 B-Or
without NCT03864016 157 164 B-Negation
valve NCT03864016 165 170 B-Procedure
surgery NCT03864016 171 178 I-Procedure
, NCT03864016 179 180 O
by NCT03864016 181 183 O
sternotomy NCT03864016 184 194 B-Procedure
. NCT03864016 195 196 O

- NCT03864016 200 201 O
ASA NCT03864016 203 206 B-Observation
< NCT03864016 207 208 B-Eq_Comparison
4 NCT03864016 209 210 I-Eq_Comparison
. NCT03864016 210 211 O

Exclusion NCT03864016 213 222 O
Criteria NCT03864016 223 231 O
: NCT03864016 232 233 O

- NCT03864016 237 238 O
Person NCT03864016 240 246 O
not NCT03864016 247 250 B-Negation
affiliated NCT03864016 251 261 O
to NCT03864016 262 264 O
the NCT03864016 265 268 O
national NCT03864016 269 277 O
health NCT03864016 278 284 O
insurance NCT03864016 285 294 O
system NCT03864016 295 301 O

- NCT03864016 304 305 O
Person NCT03864016 307 313 O
subject NCT03864016 314 321 O
to NCT03864016 322 324 O
legal NCT03864016 325 330 B-Observation
protection NCT03864016 331 341 I-Observation
( NCT03864016 342 343 O
curatorship NCT03864016 344 355 B-Observation
, NCT03864016 356 357 O
guardianship NCT03864016 358 370 B-Observation
) NCT03864016 371 372 O

- NCT03864016 376 377 O
Person NCT03864016 379 385 O
who NCT03864016 386 389 O
has NCT03864016 390 393 O
been NCT03864016 394 398 O
deemed NCT03864016 399 405 O
mentally NCT03864016 406 414 B-Condition
incompetent NCT03864016 415 426 I-Condition

- NCT03864016 429 430 O
Pregnant NCT03864016 432 440 B-Condition
, NCT03864016 441 442 O
parturient NCT03864016 443 453 B-Condition
or NCT03864016 454 456 B-Or
breastfeeding NCT03864016 457 470 B-Condition
woman NCT03864016 471 476 O

- NCT03864016 479 480 O
Adult NCT03864016 482 487 O
unable NCT03864016 488 494 O
or NCT03864016 495 497 O
unwilling NCT03864016 498 507 O
to NCT03864016 508 510 O
provide NCT03864016 511 518 O
consent NCT03864016 519 526 O

- NCT03864016 529 530 O
Patient NCT03864016 532 539 O
with NCT03864016 540 544 O
pre NCT03864016 545 548 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03864016 549 558 B-Procedure
cognitive NCT03864016 559 568 B-Condition
dysfunction NCT03864016 569 580 I-Condition
( NCT03864016 581 582 O
MMS NCT03864016 583 586 B-Observation
< NCT03864016 587 588 B-Eq_Comparison
13 NCT03864016 589 591 I-Eq_Comparison
) NCT03864016 592 593 O
( NCT03864016 594 595 O
APPENDIX NCT03864016 596 604 O
6 NCT03864016 605 606 O
) NCT03864016 607 608 O
, NCT03864016 609 610 O

- NCT03864016 614 615 O
Patient NCT03864016 617 624 O
with NCT03864016 625 629 O
morphine NCT03864016 630 638 B-Drug
intolerance NCT03864016 639 650 B-Condition
, NCT03864016 651 652 O

- NCT03864016 656 657 O
Patient NCT03864016 659 666 O
on NCT03864016 667 669 B-Eq_Comparison
long NCT03864016 670 674 O
- NCT03864016 675 676 O
term NCT03864016 677 681 O
opioid NCT03864016 682 688 B-Drug
treatment NCT03864016 689 698 B-Procedure
, NCT03864016 699 700 O

- NCT03864016 704 705 O
Emergency NCT03864016 707 716 B-Modifier
surgery NCT03864016 717 724 B-Procedure
, NCT03864016 725 726 O

- NCT03864016 730 731 O
Eye NCT03864016 733 736 B-Condition
disease NCT03864016 737 744 I-Condition
, NCT03864016 745 746 O
corneal NCT03864016 747 754 B-Modifier
injury NCT03864016 755 761 B-Condition
, NCT03864016 762 763 O
or NCT03864016 764 766 B-Or
wearing NCT03864016 767 774 B-Modifier
contact NCT03864016 775 782 B-Procedure
lenses NCT03864016 783 789 I-Procedure
, NCT03864016 790 791 O
a NCT03864016 792 793 O
neurological NCT03864016 794 806 B-Condition
disease NCT03864016 807 814 I-Condition
that NCT03864016 815 819 O
can NCT03864016 820 823 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03864016 824 833 O
the NCT03864016 834 837 O
pupillary NCT03864016 838 847 B-Condition
reflex NCT03864016 848 854 I-Condition
, NCT03864016 855 856 O

- NCT03864016 860 861 O
Refusal NCT03864016 863 870 O
to NCT03864016 871 873 O
participate NCT03864016 874 885 O

Inclusion NCT03863470 0 9 O
Criteria NCT03863470 10 18 O
: NCT03863470 19 20 O

- NCT03863470 24 25 O
Age NCT03863470 27 30 B-Age
≥ NCT03863470 31 32 B-Eq_Comparison
18 NCT03863470 33 35 I-Eq_Comparison
years NCT03863470 36 41 I-Eq_Comparison
old NCT03863470 42 45 O
; NCT03863470 45 46 O
AND NCT03863470 47 50 B-And

- NCT03863470 53 54 O
Admission NCT03863470 56 65 B-Encounter
to NCT03863470 66 68 O
1 NCT03863470 69 70 O
of NCT03863470 71 73 O
12 NCT03863470 74 76 O
participating NCT03863470 77 90 O
ICUs NCT03863470 91 95 O
; NCT03863470 95 96 O
AND NCT03863470 97 100 B-And

- NCT03863470 103 104 O
Continuous NCT03863470 106 116 B-Modifier
mechanical NCT03863470 117 127 B-Procedure
ventilation NCT03863470 128 139 I-Procedure
for NCT03863470 140 143 O
≥ NCT03863470 144 145 B-Eq_Comparison
48 NCT03863470 146 148 I-Eq_Comparison
hours NCT03863470 149 154 I-Eq_Comparison
( NCT03863470 155 156 O
without NCT03863470 157 164 B-Modifier
interruption NCT03863470 165 177 I-Modifier
) NCT03863470 178 179 O
; NCT03863470 180 181 O
AND NCT03863470 182 185 B-And

- NCT03863470 188 189 O
Baseline NCT03863470 191 199 O
independent NCT03863470 200 211 B-Condition
ambulatory NCT03863470 212 222 I-Condition
status NCT03863470 223 229 O

Exclusion NCT03863470 230 239 O
Criteria NCT03863470 240 248 O
: NCT03863470 249 250 O

- NCT03863470 254 255 O
Admitting NCT03863470 257 266 O
diagnosis NCT03863470 267 276 O
of NCT03863470 277 279 O
any NCT03863470 280 283 O
of NCT03863470 284 286 O
the NCT03863470 287 290 B-Criteria_Count
following NCT03863470 291 300 I-Criteria_Count
conditions NCT03863470 301 311 I-Criteria_Count
: NCT03863470 312 313 O

- NCT03863470 322 323 O
Cardiopulmonary NCT03863470 325 340 B-Condition
arrest NCT03863470 341 347 I-Condition

- NCT03863470 355 356 O
Raised NCT03863470 358 364 O
intracranial NCT03863470 365 377 B-Condition
pressure NCT03863470 378 386 I-Condition

- NCT03863470 394 395 O
Acute NCT03863470 397 402 O
neurological NCT03863470 403 415 B-Modifier
admission NCT03863470 416 425 O
diagnosis NCT03863470 426 435 B-Condition

- NCT03863470 443 444 O
Subarachnoid NCT03863470 446 458 B-Condition
hemorrhage NCT03863470 459 469 I-Condition

- NCT03863470 477 478 O
Ischemic NCT03863470 480 488 B-Modifier
stroke NCT03863470 489 495 B-Condition

Inclusion NCT03864289 0 9 O
Criteria NCT03864289 10 18 O
: NCT03864289 19 20 O

- NCT03864289 24 25 O
Children NCT03864289 27 35 O
with NCT03864289 36 40 B-And
ASD NCT03864289 41 44 B-Condition
or NCT03864289 45 47 B-Or
high NCT03864289 48 52 O
risk NCT03864289 53 57 B-Risk
for NCT03864289 58 61 O
autism NCT03864289 62 68 B-Condition
; NCT03864289 68 69 O

- NCT03864289 72 73 O
Han NCT03864289 75 78 O
ethic NCT03864289 79 84 O
; NCT03864289 84 85 O

- NCT03864289 88 89 O
Parents NCT03864289 91 98 B-Family_Member___Family_Member_Type:parent
were NCT03864289 99 103 O
at NCT03864289 104 106 B-Eq_Comparison
least NCT03864289 107 112 I-Eq_Comparison
middle NCT03864289 113 119 B-Observation
school NCT03864289 120 126 I-Observation
educated NCT03864289 127 135 I-Observation
, NCT03864289 136 137 O
and NCT03864289 138 141 B-And
agreed NCT03864289 142 148 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864289 149 151 I-Assertion___Assertion_Type_Value:hypothetical
do NCT03864289 152 154 O
at NCT03864289 155 157 B-Eq_Comparison
least NCT03864289 158 163 I-Eq_Comparison
20 NCT03864289 164 166 I-Eq_Comparison
hours NCT03864289 167 172 I-Eq_Comparison
per NCT03864289 173 176 I-Eq_Comparison
week NCT03864289 177 181 I-Eq_Comparison
of NCT03864289 182 184 O
planned NCT03864289 185 192 B-Eq_Comparison
practice NCT03864289 193 201 B-Observation
activities NCT03864289 202 212 I-Observation
with NCT03864289 213 217 O
the NCT03864289 218 221 O
child NCT03864289 222 227 O
in NCT03864289 228 230 O
daily NCT03864289 231 236 O
life NCT03864289 237 241 O
. NCT03864289 242 243 O

Exclusion NCT03864289 245 254 O
Criteria NCT03864289 255 263 O
: NCT03864289 264 265 O

- NCT03864289 269 270 O
Children NCT03864289 272 280 O
with NCT03864289 281 285 B-And
Syndromic NCT03864289 286 295 B-Modifier
ASD NCT03864289 296 299 B-Condition
caused NCT03864289 300 306 O
by NCT03864289 307 309 O
known NCT03864289 310 315 O
genetic NCT03864289 316 323 B-Condition
defects NCT03864289 324 331 I-Condition
or NCT03864289 332 334 B-Or
inherited NCT03864289 335 344 B-Modifier
metabolic NCT03864289 345 354 B-Condition
diseases NCT03864289 355 363 I-Condition
, NCT03864289 364 365 O
such NCT03864289 366 370 O
as NCT03864289 371 373 O
Rett NCT03864289 374 378 B-Condition
Syndrome NCT03864289 379 387 I-Condition
, NCT03864289 388 389 O
Fragile NCT03864289 390 397 B-Condition
X NCT03864289 398 399 I-Condition
Syndrome NCT03864289 400 408 I-Condition
, NCT03864289 409 410 O
Angelman NCT03864289 411 419 B-Condition
Syndrome NCT03864289 420 428 I-Condition
, NCT03864289 429 430 O
Prader NCT03864289 431 437 B-Condition
- NCT03864289 438 439 I-Condition
Willi NCT03864289 440 445 I-Condition
Syndrome NCT03864289 446 454 I-Condition
, NCT03864289 455 456 O
tuberous NCT03864289 457 465 B-Condition
sclerosis NCT03864289 466 475 I-Condition
; NCT03864289 475 476 O

- NCT03864289 479 480 O
Visual NCT03864289 482 488 B-Modifier
, NCT03864289 489 490 O
auditory NCT03864289 491 499 B-Modifier
and NCT03864289 500 503 B-Or
physical NCT03864289 504 512 B-Modifier
disabilities NCT03864289 513 525 B-Condition
; NCT03864289 525 526 O

- NCT03864289 529 530 O
Complication NCT03864289 532 544 O
with NCT03864289 545 549 O
other NCT03864289 550 555 B-Other
serious NCT03864289 556 563 O
chronic NCT03864289 564 571 B-Condition
diseases NCT03864289 572 580 I-Condition
, NCT03864289 581 582 O
such NCT03864289 583 587 O
as NCT03864289 588 590 O
liver NCT03864289 591 596 B-Modifier
and NCT03864289 597 600 B-Or
kidney NCT03864289 601 607 B-Modifier
failure NCT03864289 608 615 B-Condition
, NCT03864289 616 617 O
connective NCT03864289 618 628 B-Condition
tissue NCT03864289 629 635 I-Condition
diseases NCT03864289 636 644 I-Condition
, NCT03864289 645 646 O
tumors NCT03864289 647 653 B-Condition
. NCT03864289 654 655 O

Inclusion NCT03865095 0 9 O
Criteria NCT03865095 10 18 O
: NCT03865095 19 20 O

- NCT03865095 24 25 O
age NCT03865095 27 30 B-Age
≥ NCT03865095 31 32 B-Eq_Comparison
18 NCT03865095 33 35 I-Eq_Comparison
years NCT03865095 36 41 I-Eq_Comparison

- NCT03865095 44 45 O
mechanical NCT03865095 47 57 B-Procedure
ventilation NCT03865095 58 69 I-Procedure
expected NCT03865095 70 78 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865095 79 82 O
at NCT03865095 83 85 B-Eq_Comparison
least NCT03865095 86 91 I-Eq_Comparison
48 NCT03865095 92 94 I-Eq_Comparison
hours NCT03865095 95 100 I-Eq_Comparison

Exclusion NCT03865095 101 110 O
Criteria NCT03865095 111 119 O
: NCT03865095 120 121 O

- NCT03865095 125 126 O
Clinical NCT03865095 128 136 B-Observation
Frailty NCT03865095 137 144 I-Observation
Score NCT03865095 145 150 I-Observation
above NCT03865095 151 156 B-Eq_Comparison
7 NCT03865095 157 158 I-Eq_Comparison
prior NCT03865095 159 164 B-Eq_Comparison
admission NCT03865095 165 174 B-Encounter

- NCT03865095 177 178 O
neuromuscular NCT03865095 180 193 B-Condition
disease NCT03865095 194 201 I-Condition
in NCT03865095 202 204 O
previous NCT03865095 205 213 B-Eq_Comparison
medical NCT03865095 214 221 I-Eq_Comparison
history NCT03865095 222 229 I-Eq_Comparison

- NCT03865095 232 233 O
amputated NCT03865095 235 244 B-Condition
lower NCT03865095 245 250 B-Modifier
extremities NCT03865095 251 262 I-Modifier

- NCT03865095 265 266 O
trauma NCT03865095 268 274 B-Condition
of NCT03865095 275 277 O
lower NCT03865095 278 283 B-Modifier
extremities NCT03865095 284 295 I-Modifier
involving NCT03865095 296 305 I-Modifier
tights NCT03865095 306 312 I-Modifier

- NCT03865095 315 316 O
age NCT03865095 318 321 B-Age
under NCT03865095 322 327 B-Eq_Comparison
18 NCT03865095 328 330 I-Eq_Comparison
years NCT03865095 331 336 I-Eq_Comparison

- NCT03865095 339 340 O
inability NCT03865095 342 351 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865095 352 354 O
perform NCT03865095 355 362 O
ultrasound NCT03865095 363 373 B-Procedure
examination NCT03865095 374 385 I-Procedure

- NCT03865095 388 389 O
death NCT03865095 391 396 B-Death
or NCT03865095 397 399 B-Or
discharge NCT03865095 400 409 B-Encounter
prior NCT03865095 410 415 B-Temporal_Connection___Temporal_Connection_Type_Value:before
completion NCT03865095 416 426 O
of NCT03865095 427 429 O
protocol NCT03865095 430 438 B-Study

- NCT03865095 441 442 O
full NCT03865095 444 448 B-Procedure
verticalization NCT03865095 449 464 I-Procedure
prior NCT03865095 465 470 B-Temporal_Connection___Temporal_Connection_Type_Value:before
completion NCT03865095 471 481 O
of NCT03865095 482 484 O
protocol NCT03865095 485 493 B-Study

Inclusion NCT03861819 0 9 O
Criteria NCT03861819 10 18 O
: NCT03861819 19 20 O

- NCT03861819 24 25 O
Ages NCT03861819 27 31 B-Age
18 NCT03861819 32 34 B-Eq_Comparison
- NCT03861819 35 36 I-Eq_Comparison
59 NCT03861819 37 39 I-Eq_Comparison

- NCT03861819 43 44 O
Histologically NCT03861819 46 60 B-Procedure
confirmed NCT03861819 61 70 O
nonalcoholic NCT03861819 71 83 B-Modifier
steatohepatitis NCT03861819 84 99 B-Condition
and NCT03861819 100 103 B-Or
fibrosis NCT03861819 104 112 B-Condition
( NCT03861819 113 114 O
stage NCT03861819 115 120 B-Eq_Comparison
1 NCT03861819 121 122 I-Eq_Comparison
- NCT03861819 123 124 I-Eq_Comparison
3 NCT03861819 125 126 I-Eq_Comparison
) NCT03861819 127 128 O
from NCT03861819 129 133 O
liver NCT03861819 134 139 B-Procedure
biopsy NCT03861819 140 146 I-Procedure

- NCT03861819 149 150 O
Able NCT03861819 152 156 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861819 157 159 I-Assertion___Assertion_Type_Value:hypothetical
row NCT03861819 160 163 O
on NCT03861819 164 166 O
an NCT03861819 167 169 O
indoor NCT03861819 170 176 B-Observation
rowing NCT03861819 177 183 I-Observation
apparatus NCT03861819 184 193 I-Observation

- NCT03861819 196 197 O
Not NCT03861819 199 202 B-Negation
participating NCT03861819 203 216 O
in NCT03861819 217 219 O
regular NCT03861819 220 227 O
physical NCT03861819 228 236 B-Observation
exercise NCT03861819 237 245 I-Observation
( NCT03861819 246 247 O
more NCT03861819 248 252 B-Eq_Comparison
than NCT03861819 253 257 I-Eq_Comparison
60 NCT03861819 258 260 I-Eq_Comparison
minutes NCT03861819 261 268 I-Eq_Comparison
of NCT03861819 269 271 O
moderate NCT03861819 272 280 O
intensity NCT03861819 281 290 O
or NCT03861819 291 293 B-Or
30 NCT03861819 294 296 B-Eq_Comparison
minutes NCT03861819 297 304 I-Eq_Comparison
of NCT03861819 305 307 O
vigorous NCT03861819 308 316 O
intensity NCT03861819 317 326 O
exercise NCT03861819 327 335 B-Observation
per NCT03861819 336 339 B-Eq_Comparison
week NCT03861819 340 344 I-Eq_Comparison
) NCT03861819 345 346 O

- NCT03861819 350 351 O
Not NCT03861819 353 356 B-Negation
actively NCT03861819 357 365 O
trying NCT03861819 366 372 B-Assertion___Assertion_Type_Value:intention
to NCT03861819 373 375 I-Assertion___Assertion_Type_Value:intention
lose NCT03861819 376 380 B-Condition
weight NCT03861819 381 387 I-Condition
through NCT03861819 388 395 O
a NCT03861819 396 397 O
dietary NCT03861819 398 405 B-Observation
approach NCT03861819 406 414 I-Observation

- NCT03861819 417 418 O
No NCT03861819 420 422 B-Negation
absolute NCT03861819 423 431 O
contra NCT03861819 432 438 B-Contraindication
- NCT03861819 439 440 I-Contraindication
indications NCT03861819 441 452 I-Contraindication
to NCT03861819 453 455 O
exercise NCT03861819 456 464 B-Observation
: NCT03861819 465 466 O
recent NCT03861819 467 473 B-Eq_Comparison
( NCT03861819 474 475 O
< NCT03861819 476 477 B-Eq_Comparison
6 NCT03861819 478 479 I-Eq_Comparison
months NCT03861819 480 486 I-Eq_Comparison
) NCT03861819 487 488 O
acute NCT03861819 489 494 O
cardiac NCT03861819 495 502 B-Condition
event NCT03861819 503 508 I-Condition
unstable NCT03861819 509 517 O
angina NCT03861819 518 524 B-Condition
, NCT03861819 525 526 O
uncontrolled NCT03861819 527 539 B-Modifier
dysrhythmias NCT03861819 540 552 B-Condition
causing NCT03861819 553 560 O
symptoms NCT03861819 561 569 B-Assertion___Assertion_Type_Value:possible
or NCT03861819 570 572 B-Or
hemodynamic NCT03861819 573 584 B-Modifier
compromise NCT03861819 585 595 B-Condition
, NCT03861819 596 597 O
symptomatic NCT03861819 598 609 B-Assertion___Assertion_Type_Value:possible
aortic NCT03861819 610 616 B-Condition
stenosis NCT03861819 617 625 I-Condition
, NCT03861819 626 627 O
uncontrolled NCT03861819 628 640 B-Modifier
symptomatic NCT03861819 641 652 B-Assertion___Assertion_Type_Value:possible
heart NCT03861819 653 658 B-Condition
failure NCT03861819 659 666 I-Condition
, NCT03861819 667 668 O
acute NCT03861819 669 674 O
pulmonary NCT03861819 675 684 B-Condition
embolus NCT03861819 685 692 I-Condition
, NCT03861819 693 694 O
acute NCT03861819 695 700 O
myocarditis NCT03861819 701 712 B-Condition
or NCT03861819 713 715 B-Or
pericarditis NCT03861819 716 728 B-Condition
, NCT03861819 729 730 O
suspected NCT03861819 731 740 B-Assertion___Assertion_Type_Value:possible
or NCT03861819 741 743 B-Or
known NCT03861819 744 749 O
dissecting NCT03861819 750 760 B-Condition
aneurism NCT03861819 761 769 I-Condition
and NCT03861819 770 773 B-Or
acute NCT03861819 774 779 O
systemic NCT03861819 780 788 B-Modifier
infection NCT03861819 789 798 B-Condition

- NCT03861819 801 802 O
No NCT03861819 804 806 B-Negation
other NCT03861819 807 812 B-Other
form NCT03861819 813 817 O
of NCT03861819 818 820 O
chronic NCT03861819 821 828 O
liver NCT03861819 829 834 B-Condition
disease NCT03861819 835 842 I-Condition
( NCT03861819 843 844 O
as NCT03861819 845 847 O
confirmed NCT03861819 848 857 O
by NCT03861819 858 860 O
serology NCT03861819 861 869 B-Procedure
and NCT03861819 870 873 B-Or
histology NCT03861819 874 883 B-Procedure
) NCT03861819 884 885 O

- NCT03861819 889 890 O
No NCT03861819 892 894 B-Negation
liver NCT03861819 895 900 B-Condition
cirrhosis NCT03861819 901 910 I-Condition
( NCT03861819 911 912 O
stage NCT03861819 913 918 B-Eq_Comparison
4 NCT03861819 919 920 I-Eq_Comparison
fibrosis NCT03861819 921 929 B-Condition
on NCT03861819 930 932 O
liver NCT03861819 933 938 B-Procedure
biopsy NCT03861819 939 945 I-Procedure
) NCT03861819 946 947 O
or NCT03861819 948 950 B-Or
a NCT03861819 951 952 O
clinical NCT03861819 953 961 O
diagnosis NCT03861819 962 971 O
of NCT03861819 972 974 O
cirrhosis NCT03861819 975 984 B-Condition
as NCT03861819 985 987 O
ascertained NCT03861819 988 999 O
by NCT03861819 1000 1002 O
a NCT03861819 1003 1004 O
hepatologist NCT03861819 1005 1017 B-Provider

- NCT03861819 1020 1021 O
No NCT03861819 1023 1025 B-Negation
coronary NCT03861819 1026 1034 B-Condition
artery NCT03861819 1035 1041 I-Condition
disease NCT03861819 1042 1049 I-Condition
or NCT03861819 1050 1052 B-Or
chronic NCT03861819 1053 1060 O
obstructive NCT03861819 1061 1072 B-Condition
pulmonary NCT03861819 1073 1082 I-Condition
disease NCT03861819 1083 1090 I-Condition
. NCT03861819 1091 1092 O

- NCT03861819 1096 1097 O
No NCT03861819 1099 1101 B-Negation
diagnosis NCT03861819 1102 1111 O
of NCT03861819 1112 1114 O
malignancy NCT03861819 1115 1125 B-Condition
( NCT03861819 1126 1127 O
except NCT03861819 1128 1134 B-Exception
non NCT03861819 1135 1138 B-Negation
- NCT03861819 1139 1140 O
melanoma NCT03861819 1141 1149 B-Modifier
skin NCT03861819 1150 1154 B-Modifier
cancer NCT03861819 1155 1161 B-Condition
) NCT03861819 1162 1163 O

- NCT03861819 1167 1168 O
No NCT03861819 1170 1172 B-Negation
past NCT03861819 1173 1177 B-Eq_Comparison
or NCT03861819 1178 1180 B-Or
present NCT03861819 1181 1188 B-Eq_Comparison
history NCT03861819 1189 1196 I-Eq_Comparison
of NCT03861819 1197 1199 O
portal NCT03861819 1200 1206 B-Condition
hypertension NCT03861819 1207 1219 I-Condition
( NCT03861819 1220 1221 O
esophageal NCT03861819 1222 1232 B-Modifier
varices NCT03861819 1233 1240 B-Condition
, NCT03861819 1241 1242 O
ascites NCT03861819 1243 1250 B-Condition
, NCT03861819 1251 1252 O
hepatic NCT03861819 1253 1260 B-Condition
encephalopathy NCT03861819 1261 1275 I-Condition
) NCT03861819 1276 1277 O

- NCT03861819 1281 1282 O
No NCT03861819 1284 1286 B-Negation
use NCT03861819 1287 1290 O
of NCT03861819 1291 1293 O
immunosuppression NCT03861819 1294 1311 B-Drug
or NCT03861819 1312 1314 B-Or
chronic NCT03861819 1315 1322 O
nonsteroidal NCT03861819 1323 1335 B-Drug
anti NCT03861819 1336 1340 I-Drug
- NCT03861819 1341 1342 I-Drug
inflammatory NCT03861819 1343 1355 I-Drug
medication NCT03861819 1356 1366 I-Drug

- NCT03861819 1369 1370 O
No NCT03861819 1372 1374 B-Eq_Comparison
more NCT03861819 1375 1379 I-Eq_Comparison
than NCT03861819 1380 1384 I-Eq_Comparison
14 NCT03861819 1385 1387 I-Eq_Comparison
drinks NCT03861819 1388 1394 I-Eq_Comparison
per NCT03861819 1395 1398 I-Eq_Comparison
week NCT03861819 1399 1403 I-Eq_Comparison
( NCT03861819 1404 1405 O
if NCT03861819 1406 1408 O
male NCT03861819 1409 1413 O
) NCT03861819 1414 1415 O
or NCT03861819 1416 1418 B-Or
7 NCT03861819 1419 1420 B-Eq_Comparison
drinks NCT03861819 1421 1427 I-Eq_Comparison
a NCT03861819 1428 1429 I-Eq_Comparison
week NCT03861819 1430 1434 I-Eq_Comparison
( NCT03861819 1435 1436 O
if NCT03861819 1437 1439 O
female NCT03861819 1440 1446 O
) NCT03861819 1447 1448 O
in NCT03861819 1449 1451 O
the NCT03861819 1452 1455 O
last NCT03861819 1456 1460 B-Eq_Comparison
2 NCT03861819 1461 1462 I-Eq_Comparison
years NCT03861819 1463 1468 I-Eq_Comparison

- NCT03861819 1471 1472 O
Cognitively NCT03861819 1474 1485 O
able NCT03861819 1486 1490 O
to NCT03861819 1491 1493 O
provide NCT03861819 1494 1501 O
consent NCT03861819 1502 1509 O

- NCT03861819 1512 1513 O
Able NCT03861819 1515 1519 O
to NCT03861819 1520 1522 O
read NCT03861819 1523 1527 O
, NCT03861819 1528 1529 O
write NCT03861819 1530 1535 O
, NCT03861819 1536 1537 O
and NCT03861819 1538 1541 O
understand NCT03861819 1542 1552 O
English NCT03861819 1553 1560 O

- NCT03861819 1563 1564 O
Transportation NCT03861819 1566 1580 O
to NCT03861819 1581 1583 O
the NCT03861819 1584 1587 O
exercise NCT03861819 1588 1596 O
and NCT03861819 1597 1600 O
testing NCT03861819 1601 1608 O
facility NCT03861819 1609 1617 O

Inclusion NCT03867461 0 9 O
Criteria NCT03867461 10 18 O
: NCT03867461 19 20 O

- NCT03867461 24 25 O
Adults NCT03867461 27 33 O
determined NCT03867461 34 44 O
to NCT03867461 45 47 O
be NCT03867461 48 50 O
candidates NCT03867461 51 61 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03867461 62 65 I-Assertion___Assertion_Type_Value:hypothetical
venous NCT03867461 66 72 B-Procedure
sinus NCT03867461 73 78 I-Procedure
stenting NCT03867461 79 87 I-Procedure

Inclusion NCT03866655 0 9 O
Criteria NCT03866655 10 18 O
: NCT03866655 19 20 O

- NCT03866655 24 25 O
female NCT03866655 27 33 O

- NCT03866655 36 37 O
adult NCT03866655 39 44 O
( NCT03866655 45 46 O
age NCT03866655 47 50 B-Age
18 NCT03866655 51 53 B-Eq_Comparison
years NCT03866655 54 59 I-Eq_Comparison
or NCT03866655 60 62 I-Eq_Comparison
over NCT03866655 63 67 I-Eq_Comparison
) NCT03866655 68 69 O

- NCT03866655 73 74 O
newly NCT03866655 76 81 B-Eq_Comparison
diagnosed NCT03866655 82 91 O

- NCT03866655 94 95 O
early NCT03866655 97 102 B-Modifier
breast NCT03866655 103 109 I-Modifier
cancer NCT03866655 110 116 B-Condition

- NCT03866655 119 120 O
first NCT03866655 122 127 B-Eq_Comparison
primary NCT03866655 128 135 B-Modifier
cancer NCT03866655 136 142 B-Condition
diagnosis NCT03866655 143 152 O

- NCT03866655 155 156 O
under NCT03866655 158 163 B-Eq_Comparison
treatment NCT03866655 164 173 B-Procedure
at NCT03866655 174 176 O
one NCT03866655 177 180 O
of NCT03866655 181 183 O
the NCT03866655 184 187 O
participating NCT03866655 188 201 O
sites NCT03866655 202 207 O
. NCT03866655 208 209 O

Exclusion NCT03866655 211 220 O
Criteria NCT03866655 221 229 O
: NCT03866655 230 231 O

- NCT03866655 235 236 O
have NCT03866655 238 242 O
started NCT03866655 243 250 B-Eq_Comparison
anti NCT03866655 251 255 O
- NCT03866655 256 257 O
cancer NCT03866655 258 264 B-Condition
treatment NCT03866655 265 274 B-Procedure

- NCT03866655 277 278 O
private NCT03866655 280 287 O
patients NCT03866655 288 296 O

- NCT03866655 299 300 O
unable NCT03866655 302 308 B-Negation
to NCT03866655 309 311 O
read NCT03866655 312 316 O
or NCT03866655 317 319 O
write NCT03866655 320 325 O
in NCT03866655 326 328 O
English NCT03866655 329 336 O

- NCT03866655 339 340 O
significant NCT03866655 342 353 O
cognitive NCT03866655 354 363 B-Condition
impairment NCT03866655 364 374 I-Condition

- NCT03866655 377 378 O
poor NCT03866655 380 384 B-Condition
mental NCT03866655 385 391 I-Condition
health NCT03866655 392 398 I-Condition

- NCT03866655 401 402 O
do NCT03866655 404 406 O
not NCT03866655 407 410 O
have NCT03866655 411 415 O
access NCT03866655 416 422 O
to NCT03866655 423 425 O
the NCT03866655 426 429 O
internet NCT03866655 430 438 O

- NCT03866655 441 442 O
confirmed NCT03866655 444 453 O
metastatic NCT03866655 454 464 B-Condition
disease NCT03866655 465 472 I-Condition

Inclusion NCT03861195 0 9 O
Criteria NCT03861195 10 18 O
: NCT03861195 19 20 O

- NCT03861195 24 25 O
age NCT03861195 27 30 B-Age
≥ NCT03861195 31 32 B-Eq_Comparison
18 NCT03861195 33 35 I-Eq_Comparison
years NCT03861195 36 41 I-Eq_Comparison

- NCT03861195 44 45 O
BMI NCT03861195 47 50 B-Observation
≤ NCT03861195 51 52 B-Eq_Comparison
40 NCT03861195 53 55 I-Eq_Comparison
kg NCT03861195 56 58 I-Eq_Comparison
/ NCT03861195 59 60 I-Eq_Comparison
m NCT03861195 61 62 I-Eq_Comparison
2 NCT03861195 63 64 I-Eq_Comparison

- NCT03861195 67 68 O
indication NCT03861195 70 80 B-Indication
for NCT03861195 81 84 O
hysterectomy NCT03861195 85 97 B-Procedure
for NCT03861195 98 101 O
benign NCT03861195 102 108 B-Condition
disease NCT03861195 109 116 I-Condition
or NCT03861195 117 119 B-Or
prophylactic NCT03861195 120 132 B-Procedure
surgery NCT03861195 133 140 I-Procedure
due NCT03861195 141 144 O
to NCT03861195 145 147 O
hereditary NCT03861195 148 158 B-Modifier
cancer NCT03861195 159 165 B-Condition

- NCT03861195 168 169 O
indication NCT03861195 171 181 B-Indication
for NCT03861195 182 185 O
radical NCT03861195 186 193 B-Procedure
hysterectomy NCT03861195 194 206 I-Procedure
and NCT03861195 207 210 B-Or
/ NCT03861195 211 212 I-Or
or NCT03861195 213 215 I-Or
pelvic NCT03861195 216 222 B-Modifier
- NCT03861195 223 224 O
/ NCT03861195 225 226 B-Or
para NCT03861195 227 231 B-Modifier
- NCT03861195 232 233 I-Modifier
aortic NCT03861195 234 240 I-Modifier
( NCT03861195 241 242 O
sentinel NCT03861195 243 251 B-Modifier
- NCT03861195 252 253 I-Modifier
node NCT03861195 254 258 I-Modifier
) NCT03861195 259 260 O
lymphadenectomy NCT03861195 261 276 B-Procedure
for NCT03861195 277 280 O
cervical NCT03861195 281 289 B-Modifier
cancer NCT03861195 290 296 B-Condition

- NCT03861195 299 300 O
indication NCT03861195 302 312 B-Indication
for NCT03861195 313 316 O
modified NCT03861195 317 325 B-Modifier
radical NCT03861195 326 333 I-Modifier
hysterectomy NCT03861195 334 346 B-Procedure
and NCT03861195 347 350 B-Or
/ NCT03861195 351 352 I-Or
or NCT03861195 353 355 I-Or
pelvic NCT03861195 356 362 B-Modifier
- NCT03861195 363 364 O
/ NCT03861195 365 366 B-Or
para NCT03861195 367 371 B-Modifier
- NCT03861195 372 373 I-Modifier
aortic NCT03861195 374 380 I-Modifier
( NCT03861195 381 382 O
sentinel NCT03861195 383 391 B-Modifier
- NCT03861195 392 393 I-Modifier
node NCT03861195 394 398 I-Modifier
) NCT03861195 399 400 O
lymphadenectomy NCT03861195 401 416 B-Procedure
for NCT03861195 417 420 O
endometrial NCT03861195 421 432 B-Modifier
cancer NCT03861195 433 439 B-Condition

- NCT03861195 442 443 O
size NCT03861195 445 449 B-Observation
of NCT03861195 450 452 O
uterus NCT03861195 453 459 B-Modifier
and NCT03861195 460 463 B-Or
vagina NCT03861195 464 470 B-Modifier
allows NCT03861195 471 477 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03861195 478 481 I-Assertion___Assertion_Type_Value:hypothetical
retrieval NCT03861195 482 491 B-Procedure
by NCT03861195 492 494 O
the NCT03861195 495 498 O
vaginal NCT03861195 499 506 B-Modifier
route NCT03861195 507 512 I-Modifier
in NCT03861195 513 515 O
cancer NCT03861195 516 522 B-Condition
patients NCT03861195 523 531 O

- NCT03861195 534 535 O
written NCT03861195 537 544 O
informed NCT03861195 545 553 O
consent NCT03861195 554 561 O

Exclusion NCT03861195 562 571 O
Criteria NCT03861195 572 580 O
: NCT03861195 581 582 O

- NCT03861195 586 587 O
known NCT03861195 589 594 O
extensive NCT03861195 595 604 O
intra NCT03861195 605 610 B-Modifier
- NCT03861195 611 612 I-Modifier
abdominal NCT03861195 613 622 I-Modifier
adhesions NCT03861195 623 632 B-Condition

- NCT03861195 635 636 O
anaesthesiological NCT03861195 638 656 B-Modifier
contraindications NCT03861195 657 674 B-Contraindication
to NCT03861195 675 677 O
laparoscopy NCT03861195 678 689 B-Procedure

- NCT03861195 692 693 O
women NCT03861195 695 700 O
with NCT03861195 701 705 B-And
pacemaker NCT03861195 706 715 B-Procedure
or NCT03861195 716 718 B-Or
other NCT03861195 719 724 B-Other
implants NCT03861195 725 733 B-Procedure
where NCT03861195 734 739 B-And
electrosurgery NCT03861195 740 754 B-Procedure
is NCT03861195 755 757 O
to NCT03861195 758 760 B-Contraindication
be NCT03861195 761 763 I-Contraindication
avoided NCT03861195 764 771 I-Contraindication

- NCT03861195 774 775 O
women NCT03861195 777 782 O
with NCT03861195 783 787 B-And
known NCT03861195 788 793 O
defects NCT03861195 794 801 B-Condition
of NCT03861195 802 804 I-Condition
the NCT03861195 805 808 I-Condition
hemostasis NCT03861195 809 819 I-Condition

- NCT03861195 822 823 O
pregnancy NCT03861195 825 834 B-Condition

- NCT03861195 837 838 O
other NCT03861195 840 845 B-Other
internal NCT03861195 846 854 B-Modifier
or NCT03861195 855 857 B-Or
anatomical NCT03861195 858 868 B-Modifier
criteria NCT03861195 869 877 B-Condition
that NCT03861195 878 882 O
preclude NCT03861195 883 891 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
a NCT03861195 892 893 O
minimal NCT03861195 894 901 B-Procedure
invasive NCT03861195 902 910 I-Procedure
approach NCT03861195 911 919 I-Procedure

- NCT03861195 922 923 O
inability NCT03861195 925 934 O
to NCT03861195 935 937 O
understand NCT03861195 938 948 O
patient NCT03861195 949 956 O
information NCT03861195 957 968 O

Inclusion NCT03864003 0 9 O
Criteria NCT03864003 10 18 O
: NCT03864003 19 20 O

- NCT03864003 24 25 O
Bilateral NCT03864003 27 36 B-Modifier
hearing NCT03864003 37 44 B-Condition
loss NCT03864003 45 49 I-Condition
within NCT03864003 50 56 O
the NCT03864003 57 60 O
fitting NCT03864003 61 68 O
range NCT03864003 69 74 O
of NCT03864003 75 77 O
study NCT03864003 78 83 B-Study
hearing NCT03864003 84 91 B-Procedure
aids NCT03864003 92 96 I-Procedure

Exclusion NCT03864003 97 106 O
Criteria NCT03864003 107 115 O
: NCT03864003 116 117 O

- NCT03864003 121 122 O
Medically NCT03864003 124 133 O
unqualified NCT03864003 134 145 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03864003 146 148 O
receive NCT03864003 149 156 O
hearing NCT03864003 157 164 B-Procedure
aids NCT03864003 165 169 I-Procedure

- NCT03864003 172 173 O
Current NCT03864003 175 182 B-Eq_Comparison
hearing NCT03864003 183 190 B-Procedure
aid NCT03864003 191 194 I-Procedure
user NCT03864003 195 199 O

- NCT03864003 202 203 O
Cognitively NCT03864003 205 216 B-Condition
impaired NCT03864003 217 225 I-Condition

Inclusion NCT03867838 0 9 O
Criteria NCT03867838 10 18 O
: NCT03867838 19 20 O

- NCT03867838 24 25 O
greater NCT03867838 27 34 B-Eq_Comparison
than NCT03867838 35 39 I-Eq_Comparison
6 NCT03867838 40 41 I-Eq_Comparison
months NCT03867838 42 48 I-Eq_Comparison
post NCT03867838 49 53 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03867838 54 55 O
stroke NCT03867838 56 62 B-Condition

- NCT03867838 65 66 O
passive NCT03867838 68 75 B-Observation
abduction NCT03867838 76 85 I-Observation
to NCT03867838 86 88 O
90 NCT03867838 89 91 B-Eq_Comparison
degrees NCT03867838 92 99 I-Eq_Comparison
at NCT03867838 100 102 O
shoulder NCT03867838 103 111 B-Modifier

- NCT03867838 114 115 O
reduced NCT03867838 117 124 O
active NCT03867838 125 131 B-Eq_Comparison
( NCT03867838 132 133 O
retro NCT03867838 134 139 B-Modifier
) NCT03867838 140 141 O
flexion NCT03867838 142 149 B-Condition
/ NCT03867838 150 151 B-Or
extension NCT03867838 152 161 B-Condition
at NCT03867838 162 164 O
shoulder NCT03867838 165 173 B-Modifier
when NCT03867838 174 178 O
abducted NCT03867838 179 187 B-Observation
to NCT03867838 188 190 O
90 NCT03867838 191 193 B-Eq_Comparison
degrees NCT03867838 194 201 I-Eq_Comparison

- NCT03867838 204 205 O
reduced NCT03867838 207 214 O
active NCT03867838 215 221 B-Eq_Comparison
flexion NCT03867838 222 229 B-Condition
/ NCT03867838 230 231 B-Or
extension NCT03867838 232 241 B-Condition
at NCT03867838 242 244 O
elbow NCT03867838 245 250 B-Modifier

Exclusion NCT03867838 251 260 O
Criteria NCT03867838 261 269 O
: NCT03867838 270 271 O

- NCT03867838 275 276 O
unable NCT03867838 278 284 O
to NCT03867838 285 287 O
give NCT03867838 288 292 O
informed NCT03867838 293 301 O
consent NCT03867838 302 309 O

- NCT03867838 312 313 O
unable NCT03867838 315 321 O
to NCT03867838 322 324 O
comprehend NCT03867838 325 335 O
and NCT03867838 336 339 O
follow NCT03867838 340 346 O
instructions NCT03867838 347 359 O

- NCT03867838 362 363 O
have NCT03867838 365 369 O
a NCT03867838 370 371 O
condition NCT03867838 372 381 B-Condition
( NCT03867838 382 383 O
other NCT03867838 384 389 B-Exception
than NCT03867838 390 394 I-Exception
stroke NCT03867838 395 401 B-Condition
) NCT03867838 402 403 O
affecting NCT03867838 404 413 O
sensorimotor NCT03867838 414 426 B-Condition
function NCT03867838 427 435 I-Condition

- NCT03867838 438 439 O
show NCT03867838 441 445 O
evidence NCT03867838 446 454 O
of NCT03867838 455 457 O
unilateral NCT03867838 458 468 B-Modifier
spatial NCT03867838 469 476 B-Condition
neglect NCT03867838 477 484 I-Condition

- NCT03867838 487 488 O
unable NCT03867838 490 496 B-Negation
to NCT03867838 497 499 O
sit NCT03867838 500 503 B-Condition
in NCT03867838 504 506 B-Modifier
a NCT03867838 507 508 I-Modifier
chair NCT03867838 509 514 I-Modifier
without NCT03867838 515 522 B-Negation
armrests NCT03867838 523 531 B-Modifier
for NCT03867838 532 535 O
2 NCT03867838 536 537 B-Eq_Comparison
hours NCT03867838 538 543 I-Eq_Comparison

Inclusion NCT03861559 0 9 O
Criteria NCT03861559 10 18 O
: NCT03861559 19 20 O

- NCT03861559 24 25 O
Has NCT03861559 27 30 O
a NCT03861559 31 32 O
2 NCT03861559 33 34 B-Eq_Comparison
- NCT03861559 35 36 I-Eq_Comparison
year NCT03861559 37 41 I-Eq_Comparison
history NCT03861559 42 49 I-Eq_Comparison
of NCT03861559 50 52 O
seasonal NCT03861559 53 61 O
allergic NCT03861559 62 70 B-Condition
rhinitis NCT03861559 71 79 I-Condition

- NCT03861559 82 83 O
Has NCT03861559 85 88 O
a NCT03861559 89 90 O
positive NCT03861559 91 99 O
skin NCT03861559 100 104 B-Observation
test NCT03861559 105 109 I-Observation
response NCT03861559 110 118 O
to NCT03861559 119 121 O
a NCT03861559 122 123 O
local NCT03861559 124 129 O
seasonal NCT03861559 130 138 O
allergen NCT03861559 139 147 B-Drug
( NCT03861559 148 149 O
current NCT03861559 150 157 B-Eq_Comparison
, NCT03861559 158 159 O
or NCT03861559 160 162 B-Or
performed NCT03861559 163 172 O
in NCT03861559 173 175 O
investigator NCT03861559 176 188 O
's NCT03861559 188 190 O
office NCT03861559 191 197 O
within NCT03861559 198 204 B-Eq_Comparison
the NCT03861559 205 208 I-Eq_Comparison
past NCT03861559 209 213 I-Eq_Comparison
year NCT03861559 214 218 I-Eq_Comparison
) NCT03861559 219 220 O

- NCT03861559 224 225 O
Is NCT03861559 227 229 O
in NCT03861559 230 232 O
good NCT03861559 233 237 B-Condition
health NCT03861559 238 244 I-Condition
and NCT03861559 245 248 B-And
free NCT03861559 249 253 B-Negation
of NCT03861559 254 256 I-Negation
any NCT03861559 257 260 O
unstable NCT03861559 261 269 O
, NCT03861559 270 271 O
clinically NCT03861559 272 282 O
- NCT03861559 283 284 O
significant NCT03861559 285 296 O
disease NCT03861559 297 304 B-Condition
, NCT03861559 305 306 O
other NCT03861559 307 312 B-Exception
than NCT03861559 313 317 I-Exception
allergic NCT03861559 318 326 B-Condition
rhinitis NCT03861559 327 335 I-Condition
, NCT03861559 336 337 O
that NCT03861559 338 342 O
would NCT03861559 343 348 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03861559 349 358 O
with NCT03861559 359 363 O
the NCT03861559 364 367 O
study NCT03861559 368 373 B-Study
schedule NCT03861559 374 382 O
or NCT03861559 383 385 O
evaluation NCT03861559 386 396 O
of NCT03861559 397 399 O
seasonal NCT03861559 400 408 O
allergic NCT03861559 409 417 B-Condition
rhinitis NCT03861559 418 426 I-Condition

Exclusion NCT03861559 427 436 O
Criteria NCT03861559 437 445 O
: NCT03861559 446 447 O

- NCT03861559 451 452 O
Women NCT03861559 454 459 O
who NCT03861559 460 463 B-And
are NCT03861559 464 467 O
pregnant NCT03861559 468 476 B-Condition
or NCT03861559 477 479 B-Or
breastfeeding NCT03861559 480 493 B-Condition

- NCT03861559 496 497 O
Women NCT03861559 499 504 O
of NCT03861559 505 507 B-And
childbearing NCT03861559 508 520 B-Condition
potential NCT03861559 521 530 I-Condition
who NCT03861559 531 534 B-And
are NCT03861559 535 538 O
not NCT03861559 539 542 B-Negation
using NCT03861559 543 548 B-Eq_Comparison
an NCT03861559 549 551 O
acceptable NCT03861559 552 562 O
form NCT03861559 563 567 O
of NCT03861559 568 570 O
birth NCT03861559 571 576 B-Procedure
control NCT03861559 577 584 I-Procedure

- NCT03861559 587 588 O
Has NCT03861559 590 593 O
asthma NCT03861559 594 600 B-Condition
that NCT03861559 601 605 O
requires NCT03861559 606 614 B-Assertion___Assertion_Type_Value:hypothetical
therapy NCT03861559 615 622 B-Procedure
with NCT03861559 623 627 O
inhaled NCT03861559 628 635 B-Modifier
or NCT03861559 636 638 B-Or
systemic NCT03861559 639 647 B-Modifier
corticosteroids NCT03861559 648 663 B-Drug
, NCT03861559 664 665 O
cromolyn NCT03861559 666 674 B-Drug
, NCT03861559 675 676 O
or NCT03861559 677 679 B-Or
nedocromil NCT03861559 680 690 B-Drug

- NCT03861559 693 694 O
Has NCT03861559 696 699 O
significant NCT03861559 700 711 O
renal NCT03861559 712 717 B-Modifier
, NCT03861559 718 719 O
hepatic NCT03861559 720 727 B-Modifier
, NCT03861559 728 729 O
neurologic NCT03861559 730 740 B-Modifier
, NCT03861559 741 742 O
cardiovascular NCT03861559 743 757 B-Modifier
, NCT03861559 758 759 O
hematologic NCT03861559 760 771 B-Modifier
, NCT03861559 772 773 O
metabolic NCT03861559 774 783 B-Modifier
, NCT03861559 784 785 O
cerebrovascular NCT03861559 786 801 B-Modifier
, NCT03861559 802 803 O
respiratory NCT03861559 804 815 B-Modifier
, NCT03861559 816 817 O
gastrointestinal NCT03861559 818 834 B-Modifier
, NCT03861559 835 836 O
or NCT03861559 837 839 B-Or
other NCT03861559 840 845 B-Other
significant NCT03861559 846 857 O
medical NCT03861559 858 865 B-Condition
illness NCT03861559 866 873 I-Condition
or NCT03861559 874 876 B-Or
disorder NCT03861559 877 885 B-Condition
which NCT03861559 886 891 O
, NCT03861559 892 893 O
in NCT03861559 894 896 O
the NCT03861559 897 900 O
judgment NCT03861559 901 909 O
of NCT03861559 910 912 O
the NCT03861559 913 916 O
investigator NCT03861559 917 929 O
, NCT03861559 930 931 O
could NCT03861559 932 937 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03861559 938 947 O
with NCT03861559 948 952 O
the NCT03861559 953 956 O
study NCT03861559 957 962 B-Study
, NCT03861559 963 964 O
or NCT03861559 965 967 B-Or
required NCT03861559 968 976 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03861559 977 986 B-Procedure
which NCT03861559 987 992 O
might NCT03861559 993 998 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03861559 999 1008 O
with NCT03861559 1009 1013 O
the NCT03861559 1014 1017 O
study NCT03861559 1018 1023 B-Study

- NCT03861559 1026 1027 O
Is NCT03861559 1029 1031 O
on NCT03861559 1032 1034 B-Eq_Comparison
immunotherapy NCT03861559 1035 1048 B-Procedure
with NCT03861559 1049 1053 O
the NCT03861559 1054 1057 O
exception NCT03861559 1058 1067 B-Exception
of NCT03861559 1068 1070 O
maintenance NCT03861559 1071 1082 B-Procedure
therapy NCT03861559 1083 1090 I-Procedure

- NCT03861559 1093 1094 O
Has NCT03861559 1096 1099 O
a NCT03861559 1100 1101 O
clinically NCT03861559 1102 1112 O
significant NCT03861559 1113 1124 O
upper NCT03861559 1125 1130 B-Modifier
respiratory NCT03861559 1131 1142 I-Modifier
or NCT03861559 1143 1145 B-Or
sinus NCT03861559 1146 1151 B-Modifier
infection NCT03861559 1152 1161 B-Condition

- NCT03861559 1164 1165 O
Has NCT03861559 1167 1170 O
used NCT03861559 1171 1175 B-Eq_Comparison
an NCT03861559 1176 1178 O
investigational NCT03861559 1179 1194 B-Study
drug NCT03861559 1195 1199 B-Drug
within NCT03861559 1200 1206 B-Eq_Comparison
the NCT03861559 1207 1210 I-Eq_Comparison
previous NCT03861559 1211 1219 I-Eq_Comparison
30 NCT03861559 1220 1222 I-Eq_Comparison
days NCT03861559 1223 1227 I-Eq_Comparison

- NCT03861559 1230 1231 O
Has NCT03861559 1233 1236 O
nasal NCT03861559 1237 1242 B-Modifier
structural NCT03861559 1243 1253 I-Modifier
abnormalities NCT03861559 1254 1267 B-Condition
, NCT03861559 1268 1269 O
including NCT03861559 1270 1279 O
large NCT03861559 1280 1285 B-Modifier
nasal NCT03861559 1286 1291 B-Condition
polyps NCT03861559 1292 1298 I-Condition
and NCT03861559 1299 1302 B-Or
marked NCT03861559 1303 1309 O
septal NCT03861559 1310 1316 B-Condition
deviation NCT03861559 1317 1326 I-Condition
, NCT03861559 1327 1328 O
that NCT03861559 1329 1333 O
significantly NCT03861559 1334 1347 O
interfere NCT03861559 1348 1357 O
with NCT03861559 1358 1362 O
nasal NCT03861559 1363 1368 B-Condition
air NCT03861559 1369 1372 I-Condition
flow NCT03861559 1373 1377 I-Condition

- NCT03861559 1380 1381 O
Has NCT03861559 1383 1386 O
a NCT03861559 1387 1388 O
history NCT03861559 1389 1396 B-Eq_Comparison
of NCT03861559 1397 1399 O
multiple NCT03861559 1400 1408 B-Eq_Comparison
drug NCT03861559 1409 1413 B-Drug
allergies NCT03861559 1414 1423 B-Allergy
or NCT03861559 1424 1426 B-Or
an NCT03861559 1427 1429 O
allergy NCT03861559 1430 1437 B-Allergy
to NCT03861559 1438 1440 O
antihistamines NCT03861559 1441 1455 B-Drug
or NCT03861559 1456 1458 B-Or
corticoids NCT03861559 1459 1469 B-Drug

- NCT03861559 1472 1473 O
Has NCT03861559 1475 1478 O
dependence NCT03861559 1479 1489 O
upon NCT03861559 1490 1494 O
nasal NCT03861559 1495 1500 B-Modifier
, NCT03861559 1501 1502 O
oral NCT03861559 1503 1507 B-Modifier
or NCT03861559 1508 1510 B-Or
ocular NCT03861559 1511 1517 B-Modifier
decongestants NCT03861559 1518 1531 B-Drug
, NCT03861559 1532 1533 O
or NCT03861559 1534 1536 B-Or
nasal NCT03861559 1537 1542 B-Drug
topical NCT03861559 1543 1550 I-Drug
antihistamines NCT03861559 1551 1565 I-Drug
, NCT03861559 1566 1567 O
in NCT03861559 1568 1570 O
the NCT03861559 1571 1574 O
opinion NCT03861559 1575 1582 O
of NCT03861559 1583 1585 O
the NCT03861559 1586 1589 O
investigator NCT03861559 1590 1602 O

- NCT03861559 1605 1606 O
Has NCT03861559 1608 1611 O
rhinitis NCT03861559 1612 1620 B-Condition
medicamentosa NCT03861559 1621 1634 I-Condition

- NCT03861559 1637 1638 O
Is NCT03861559 1640 1642 O
using NCT03861559 1643 1648 B-Eq_Comparison
of NCT03861559 1649 1651 O
any NCT03861559 1652 1655 O
chronic NCT03861559 1656 1663 O
medication NCT03861559 1664 1674 B-Drug
which NCT03861559 1675 1680 O
could NCT03861559 1681 1686 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03861559 1687 1693 O
the NCT03861559 1694 1697 O
course NCT03861559 1698 1704 O
of NCT03861559 1705 1707 O
seasonal NCT03861559 1708 1716 O
allergic NCT03861559 1717 1725 B-Condition
rhinitis NCT03861559 1726 1734 I-Condition

Inclusion NCT03869580 0 9 O
Criteria NCT03869580 10 18 O
: NCT03869580 19 20 O

- NCT03869580 24 25 O
Patients NCT03869580 27 35 O
with NCT03869580 36 40 O
a NCT03869580 41 42 O
double NCT03869580 43 49 B-Procedure
- NCT03869580 50 51 I-Procedure
J NCT03869580 52 53 I-Procedure
stent NCT03869580 54 59 I-Procedure
placement NCT03869580 60 69 B-Modifier
or NCT03869580 70 72 B-Or
change NCT03869580 73 79 B-Modifier
in NCT03869580 80 82 O
the NCT03869580 83 86 O
hospital NCT03869580 87 95 O

Exclusion NCT03869580 96 105 O
Criteria NCT03869580 106 114 O
: NCT03869580 115 116 O

- NCT03869580 120 121 O
renal NCT03869580 123 128 B-Modifier
transplants NCT03869580 129 140 B-Procedure
less NCT03869580 141 145 B-Eq_Comparison
than NCT03869580 146 150 I-Eq_Comparison
one NCT03869580 151 154 I-Eq_Comparison
year NCT03869580 155 159 I-Eq_Comparison
old NCT03869580 160 163 O

1 NCT03866044 1 2 O
. NCT03866044 2 3 O
Parkinson NCT03866044 5 14 B-Condition
's NCT03866044 14 16 I-Condition
Disease NCT03866044 17 24 I-Condition
( NCT03866044 25 26 O
PD NCT03866044 27 29 B-Condition
) NCT03866044 30 31 O
group NCT03866044 32 37 O
Inclusion NCT03866044 38 47 O
criteria NCT03866044 48 56 O
: NCT03866044 57 58 O

- NCT03866044 67 68 O
Aged NCT03866044 70 74 B-Age
18 NCT03866044 75 77 B-Eq_Comparison
or NCT03866044 78 80 I-Eq_Comparison
more NCT03866044 81 85 I-Eq_Comparison
. NCT03866044 86 87 O

- NCT03866044 96 97 O
Clinically NCT03866044 99 109 O
established NCT03866044 110 121 B-Modifier
or NCT03866044 122 124 B-Or
probable NCT03866044 125 133 B-Assertion___Assertion_Type_Value:possible
PD NCT03866044 134 136 B-Condition
according NCT03866044 137 146 O
to NCT03866044 147 149 O
the NCT03866044 150 153 O
Movement NCT03866044 154 162 O
Disorder NCT03866044 163 171 O
Society NCT03866044 172 179 O
Clinical NCT03866044 180 188 O
Diagnostic NCT03866044 189 199 O
Criteria NCT03866044 200 208 O
for NCT03866044 209 212 O
Parkinson NCT03866044 213 222 O
's NCT03866044 222 224 O
Disease NCT03866044 225 232 O

- NCT03866044 240 241 O
Signed NCT03866044 243 249 O
informed NCT03866044 250 258 O
consent NCT03866044 259 266 O
Exclusion NCT03866044 267 276 O
criteria NCT03866044 277 285 O
: NCT03866044 286 287 O

- NCT03866044 296 297 O
Pregnancy NCT03866044 299 308 B-Condition
or NCT03866044 309 311 B-Or
breastfeeding NCT03866044 312 325 B-Condition

- NCT03866044 333 334 O
History NCT03866044 336 343 B-Eq_Comparison
of NCT03866044 344 346 O
other NCT03866044 347 352 B-Other
neurologic NCT03866044 353 363 B-Modifier
or NCT03866044 364 366 B-Or
psychiatric NCT03866044 367 378 B-Modifier
disease NCT03866044 379 386 B-Condition

- NCT03866044 394 395 O
Pacemaker NCT03866044 397 406 B-Procedure
or NCT03866044 407 409 B-Or
other NCT03866044 410 415 B-Other
implanted NCT03866044 416 425 B-Procedure
electronic NCT03866044 426 436 I-Procedure
devices NCT03866044 437 444 I-Procedure

- NCT03866044 452 453 O
Claustrophobia NCT03866044 455 469 B-Condition

2 NCT03866044 472 473 O
. NCT03866044 473 474 O
Healthy NCT03866044 476 483 B-Condition
participants NCT03866044 484 496 O
age NCT03866044 497 500 O
- NCT03866044 501 502 O
and NCT03866044 503 506 O
sex NCT03866044 507 510 O
- NCT03866044 511 512 O
matched NCT03866044 513 520 O
to NCT03866044 521 523 O
the NCT03866044 524 527 O
PD NCT03866044 528 530 B-Condition
group NCT03866044 531 536 O
: NCT03866044 537 538 O

Inclusion NCT03866044 540 549 O
criteria NCT03866044 550 558 O
: NCT03866044 559 560 O

- NCT03866044 564 565 O
Age NCT03866044 567 570 O
- NCT03866044 571 572 O
and NCT03866044 573 576 O
sex NCT03866044 577 580 O
- NCT03866044 581 582 O
matched NCT03866044 583 590 O
to NCT03866044 591 593 O
PD NCT03866044 594 596 B-Condition
group NCT03866044 597 602 O
( NCT03866044 603 604 O
aged NCT03866044 605 609 B-Age
18 NCT03866044 610 612 B-Eq_Comparison
or NCT03866044 613 615 I-Eq_Comparison
more NCT03866044 616 620 I-Eq_Comparison
) NCT03866044 621 622 O

- NCT03866044 626 627 O
Signed NCT03866044 629 635 O
informed NCT03866044 636 644 O
consent NCT03866044 645 652 O

Exclusion NCT03866044 653 662 O
criteria NCT03866044 663 671 O
: NCT03866044 672 673 O

- NCT03866044 677 678 O
Pregnancy NCT03866044 680 689 B-Condition
or NCT03866044 690 692 B-Or
breastfeeding NCT03866044 693 706 B-Condition

- NCT03866044 709 710 O
History NCT03866044 712 719 B-Eq_Comparison
of NCT03866044 720 722 O
neurologic NCT03866044 723 733 B-Modifier
or NCT03866044 734 736 B-Or
psychiatric NCT03866044 737 748 B-Modifier
disease NCT03866044 749 756 B-Condition

- NCT03866044 759 760 O
Pacemaker NCT03866044 762 771 B-Procedure
or NCT03866044 772 774 B-Or
other NCT03866044 775 780 B-Other
implanted NCT03866044 781 790 B-Procedure
electronic NCT03866044 791 801 I-Procedure
devices NCT03866044 802 809 I-Procedure

- NCT03866044 812 813 O
Claustrophobia NCT03866044 815 829 B-Condition

Inclusion NCT03868345 0 9 O
Criteria NCT03868345 10 18 O
: NCT03868345 19 20 O

1 NCT03868345 24 25 O
. NCT03868345 25 26 O
male NCT03868345 28 32 O
or NCT03868345 33 35 B-Or
female NCT03868345 36 42 O
, NCT03868345 43 44 O
age NCT03868345 45 48 B-Age
21 NCT03868345 49 51 B-Eq_Comparison
or NCT03868345 52 54 I-Eq_Comparison
older NCT03868345 55 60 I-Eq_Comparison
, NCT03868345 61 62 O

2 NCT03868345 66 67 O
. NCT03868345 67 68 O
diagnosed NCT03868345 70 79 O
with NCT03868345 80 84 O
definite NCT03868345 85 93 B-Modifier
, NCT03868345 94 95 O
probable NCT03868345 96 104 B-Assertion___Assertion_Type_Value:possible
, NCT03868345 105 106 O
or NCT03868345 107 109 B-Or
possible NCT03868345 110 118 B-Assertion___Assertion_Type_Value:possible
ALS NCT03868345 119 122 B-Condition
according NCT03868345 123 132 O
to NCT03868345 133 135 O
the NCT03868345 136 139 O
modified NCT03868345 140 148 O
El NCT03868345 149 151 O
Escorial NCT03868345 152 160 O
Criteria NCT03868345 161 169 O
, NCT03868345 170 171 O

3 NCT03868345 175 176 O
. NCT03868345 176 177 O
a NCT03868345 179 180 O
score NCT03868345 181 186 B-Eq_Comparison
of NCT03868345 187 189 I-Eq_Comparison
2 NCT03868345 190 191 I-Eq_Comparison
or NCT03868345 192 194 I-Eq_Comparison
greater NCT03868345 195 202 I-Eq_Comparison
on NCT03868345 203 205 O
the NCT03868345 206 209 O
speech NCT03868345 210 216 B-Observation
question NCT03868345 217 225 I-Observation
of NCT03868345 226 228 I-Observation
the NCT03868345 229 232 I-Observation
ALSFRS NCT03868345 233 239 I-Observation
- NCT03868345 240 241 I-Observation
R NCT03868345 242 243 I-Observation
( NCT03868345 244 245 O
i NCT03868345 246 247 O
. NCT03868345 248 249 O
e NCT03868345 250 251 O
. NCT03868345 252 253 O
speech NCT03868345 255 261 B-Condition
is NCT03868345 262 264 O
intelligible NCT03868345 265 277 B-Modifier
with NCT03868345 278 282 O
occasional NCT03868345 283 293 B-Modifier
repetition NCT03868345 294 304 I-Modifier
) NCT03868345 305 306 O
, NCT03868345 307 308 O

4 NCT03868345 312 313 O
. NCT03868345 313 314 O
continuous NCT03868345 316 326 O
internet NCT03868345 327 335 O
access NCT03868345 336 342 O
at NCT03868345 343 345 O
home NCT03868345 346 350 O
, NCT03868345 351 352 O

5 NCT03868345 356 357 O
. NCT03868345 357 358 O
willingness NCT03868345 360 371 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03868345 372 375 I-Assertion___Assertion_Type_Value:hypothetical
medical NCT03868345 376 383 I-Assertion___Assertion_Type_Value:hypothetical
ability NCT03868345 384 391 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03868345 392 394 O
comply NCT03868345 395 401 O
with NCT03868345 402 406 O
scheduled NCT03868345 407 416 B-Eq_Comparison
visits NCT03868345 417 423 B-Encounter
and NCT03868345 424 427 B-And
study NCT03868345 428 433 B-Study
procedures NCT03868345 434 444 B-Procedure
, NCT03868345 445 446 O

6 NCT03868345 450 451 O
. NCT03868345 451 452 O
ability NCT03868345 454 461 O
to NCT03868345 462 464 O
understand NCT03868345 465 475 O
the NCT03868345 476 479 O
purpose NCT03868345 480 487 O
and NCT03868345 488 491 O
risks NCT03868345 492 497 O
of NCT03868345 498 500 O
the NCT03868345 501 504 O
study NCT03868345 505 510 O
and NCT03868345 511 514 O
provide NCT03868345 515 522 O
signed NCT03868345 523 529 O
and NCT03868345 530 533 O
dated NCT03868345 534 539 O
informed NCT03868345 540 548 O
consent NCT03868345 549 556 O
and NCT03868345 557 560 O
authorization NCT03868345 561 574 O
to NCT03868345 575 577 O
use NCT03868345 578 581 O
protected NCT03868345 582 591 O
health NCT03868345 592 598 O
information NCT03868345 599 610 O
( NCT03868345 611 612 O
PHI NCT03868345 613 616 O
) NCT03868345 617 618 O
in NCT03868345 619 621 O
accordance NCT03868345 622 632 O
with NCT03868345 633 637 O
national NCT03868345 638 646 O
and NCT03868345 647 650 O
local NCT03868345 651 656 O
subject NCT03868345 657 664 O
privacy NCT03868345 665 672 O
regulations NCT03868345 673 684 O
, NCT03868345 685 686 O

7 NCT03868345 690 691 O
. NCT03868345 691 692 O
geographic NCT03868345 694 704 O
accessibility NCT03868345 705 718 O
to NCT03868345 719 721 O
study NCT03868345 722 727 O
site NCT03868345 728 732 O
, NCT03868345 733 734 O

8 NCT03868345 738 739 O
. NCT03868345 739 740 O
for NCT03868345 742 745 O
the NCT03868345 746 749 O
25 NCT03868345 750 752 O
participants NCT03868345 753 765 O
in NCT03868345 766 768 O
Group NCT03868345 769 774 O
1 NCT03868345 775 776 O
, NCT03868345 777 778 O
NO NCT03868345 779 781 B-Negation
noted NCT03868345 782 787 O
symptoms NCT03868345 788 796 B-Assertion___Assertion_Type_Value:possible
of NCT03868345 797 799 O
frontotemporal NCT03868345 800 814 B-Condition
cognitive NCT03868345 815 824 I-Condition
dysfunction NCT03868345 825 836 I-Condition
, NCT03868345 837 838 O
and NCT03868345 839 842 B-And

9 NCT03868345 845 846 O
. NCT03868345 846 847 O
for NCT03868345 849 852 O
the NCT03868345 853 856 O
25 NCT03868345 857 859 O
participants NCT03868345 860 872 O
in NCT03868345 873 875 O
Group NCT03868345 876 881 O
2 NCT03868345 882 883 O
, NCT03868345 884 885 O
MUST NCT03868345 886 890 O
have NCT03868345 891 895 O
cognitive NCT03868345 896 905 B-Condition
symptoms NCT03868345 906 914 B-Assertion___Assertion_Type_Value:possible
as NCT03868345 915 917 O
noted NCT03868345 918 923 O
either NCT03868345 924 930 O
by NCT03868345 931 933 O
themselves NCT03868345 934 944 O
or NCT03868345 945 947 O
a NCT03868345 948 949 O
caregiver NCT03868345 950 959 O
. NCT03868345 960 961 O

Exclusion NCT03868345 963 972 O
Criteria NCT03868345 973 981 O
: NCT03868345 982 983 O

1 NCT03868345 987 988 O
. NCT03868345 988 989 O
unwilling NCT03868345 991 1000 O
or NCT03868345 1001 1003 O
unable NCT03868345 1004 1010 O
to NCT03868345 1011 1013 O
comply NCT03868345 1014 1020 O
with NCT03868345 1021 1025 O
the NCT03868345 1026 1029 O
requirements NCT03868345 1030 1042 O
of NCT03868345 1043 1045 O
this NCT03868345 1046 1050 O
protocol NCT03868345 1051 1059 O
, NCT03868345 1060 1061 O
including NCT03868345 1062 1071 O
the NCT03868345 1072 1075 O
presence NCT03868345 1076 1084 O
of NCT03868345 1085 1087 O
any NCT03868345 1088 1091 O
condition NCT03868345 1092 1101 B-Condition
( NCT03868345 1102 1103 O
physical NCT03868345 1104 1112 B-Modifier
, NCT03868345 1113 1114 O
mental NCT03868345 1115 1121 B-Modifier
, NCT03868345 1122 1123 O
or NCT03868345 1124 1126 B-Or
social NCT03868345 1127 1133 B-Modifier
) NCT03868345 1134 1135 O
that NCT03868345 1136 1140 O
is NCT03868345 1141 1143 O
likely NCT03868345 1144 1150 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868345 1151 1153 O
affect NCT03868345 1154 1160 O
the NCT03868345 1161 1164 O
participant NCT03868345 1165 1176 O
's NCT03868345 1176 1178 O
ability NCT03868345 1179 1186 O
to NCT03868345 1187 1189 O
comply NCT03868345 1190 1196 O
with NCT03868345 1197 1201 O
the NCT03868345 1202 1205 O
protocol NCT03868345 1206 1214 O
, NCT03868345 1215 1216 O
and NCT03868345 1217 1220 O

2 NCT03868345 1223 1224 O
. NCT03868345 1224 1225 O
any NCT03868345 1227 1230 O
other NCT03868345 1231 1236 O
reasons NCT03868345 1237 1244 O
that NCT03868345 1245 1249 O
, NCT03868345 1250 1251 O
in NCT03868345 1252 1254 O
the NCT03868345 1255 1258 O
opinion NCT03868345 1259 1266 O
of NCT03868345 1267 1269 O
the NCT03868345 1270 1273 O
PI NCT03868345 1274 1276 O
, NCT03868345 1277 1278 O
cause NCT03868345 1279 1284 O
the NCT03868345 1285 1288 O
candidate NCT03868345 1289 1298 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868345 1299 1301 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03868345 1302 1304 O
deemed NCT03868345 1305 1311 O
unsuitable NCT03868345 1312 1322 B-Negation
for NCT03868345 1323 1326 O
entry NCT03868345 1327 1332 O
into NCT03868345 1333 1337 O
the NCT03868345 1338 1341 O
study NCT03868345 1342 1347 B-Study
. NCT03868345 1348 1349 O

Inclusion NCT03860545 0 9 O
Criteria NCT03860545 10 18 O
: NCT03860545 19 20 O

- NCT03860545 24 25 O
a NCT03860545 27 28 O
planned NCT03860545 29 36 B-Eq_Comparison
operation NCT03860545 37 46 O
of NCT03860545 47 49 O
coronary NCT03860545 50 58 B-Procedure
artery NCT03860545 59 65 I-Procedure
bypass NCT03860545 66 72 I-Procedure
grafting NCT03860545 73 81 I-Procedure
with NCT03860545 82 86 O
the NCT03860545 87 90 O
use NCT03860545 91 94 O
of NCT03860545 95 97 O
cardiopulmonary NCT03860545 98 113 B-Procedure
bypass NCT03860545 114 120 I-Procedure

Exclusion NCT03860545 121 130 O
Criteria NCT03860545 131 139 O
: NCT03860545 140 141 O

- NCT03860545 145 146 O
emergency NCT03860545 148 157 B-Encounter
operations NCT03860545 158 168 B-Procedure
or NCT03860545 169 171 B-Or
re NCT03860545 172 174 B-Procedure
- NCT03860545 175 176 I-Procedure
operations NCT03860545 177 187 I-Procedure
; NCT03860545 187 188 O

- NCT03860545 191 192 O
a NCT03860545 194 195 O
known NCT03860545 196 201 O
pathology NCT03860545 202 211 B-Condition
of NCT03860545 212 214 I-Condition
the NCT03860545 215 218 I-Condition
urinary NCT03860545 219 226 I-Condition
tract NCT03860545 227 232 I-Condition
or NCT03860545 233 235 B-Or
renal NCT03860545 236 241 B-Condition
failure NCT03860545 242 249 I-Condition
; NCT03860545 249 250 O

- NCT03860545 253 254 O
chronic NCT03860545 256 263 O
use NCT03860545 264 267 O
of NCT03860545 268 270 O
the NCT03860545 271 274 O
following NCT03860545 275 284 O
medications NCT03860545 285 296 B-Drug
: NCT03860545 297 298 O
iron NCT03860545 299 303 B-Drug
, NCT03860545 304 305 O
non NCT03860545 306 309 B-Drug
- NCT03860545 310 311 I-Drug
steroidal NCT03860545 312 321 I-Drug
anti NCT03860545 322 326 I-Drug
- NCT03860545 327 328 I-Drug
inflammatory NCT03860545 329 341 I-Drug
drugs NCT03860545 342 347 I-Drug
( NCT03860545 348 349 O
NSAIDs NCT03860545 350 356 B-Drug
) NCT03860545 357 358 O
, NCT03860545 359 360 O
immunosuppression NCT03860545 361 378 B-Drug
, NCT03860545 379 380 O
or NCT03860545 381 383 O
steroids NCT03860545 384 392 B-Drug
in NCT03860545 393 395 O
the NCT03860545 396 399 O
pre NCT03860545 400 403 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03860545 404 413 B-Procedure
period NCT03860545 414 420 O
; NCT03860545 420 421 O

- NCT03860545 424 425 O
polycythemia NCT03860545 427 439 B-Condition
, NCT03860545 440 441 O
porphyria NCT03860545 442 451 B-Condition
or NCT03860545 452 454 B-Or
pathological NCT03860545 455 467 B-Condition
hemoglobin NCT03860545 468 478 I-Condition
species NCT03860545 479 486 I-Condition
in NCT03860545 487 489 I-Condition
anamnesis NCT03860545 490 499 I-Condition
; NCT03860545 499 500 O

- NCT03860545 503 504 O
pre NCT03860545 506 509 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03860545 510 519 B-Procedure
signs NCT03860545 520 525 B-Assertion___Assertion_Type_Value:possible
of NCT03860545 526 528 I-Assertion___Assertion_Type_Value:possible
hepatic NCT03860545 529 536 B-Condition
failure NCT03860545 537 544 I-Condition
; NCT03860545 544 545 O

- NCT03860545 548 549 O
active NCT03860545 551 557 B-Eq_Comparison
autoimmune NCT03860545 558 568 B-Modifier
or NCT03860545 569 571 B-Or
neoplastic NCT03860545 572 582 B-Modifier
diseases NCT03860545 583 591 B-Condition
, NCT03860545 592 593 O
active NCT03860545 594 600 B-Eq_Comparison
infection NCT03860545 601 610 B-Condition
; NCT03860545 610 611 O

- NCT03860545 614 615 O
anticipated NCT03860545 617 628 B-Assertion___Assertion_Type_Value:hypothetical
significant NCT03860545 629 640 O
bleeding NCT03860545 641 649 B-Condition
( NCT03860545 650 651 O
anti NCT03860545 652 656 B-Drug
- NCT03860545 657 658 I-Drug
platelet NCT03860545 659 667 I-Drug
agents NCT03860545 668 674 I-Drug
) NCT03860545 675 676 O
, NCT03860545 677 678 O
suggesting NCT03860545 679 689 B-Assertion___Assertion_Type_Value:possible
the NCT03860545 690 693 O
use NCT03860545 694 697 O
of NCT03860545 698 700 O
blood NCT03860545 701 706 B-Drug
- NCT03860545 707 708 I-Drug
derived NCT03860545 709 716 I-Drug
products NCT03860545 717 725 I-Drug
during NCT03860545 726 732 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860545 733 736 O
operation NCT03860545 737 746 B-Procedure
and NCT03860545 747 750 O
afterward NCT03860545 751 760 O

- NCT03860545 763 764 O
acute NCT03860545 766 771 B-Condition
myocardial NCT03860545 772 782 I-Condition
infarction NCT03860545 783 793 I-Condition
after NCT03860545 794 799 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operation NCT03860545 800 809 B-Procedure

Inclusion NCT03927404 0 9 O
Criteria NCT03927404 10 18 O
: NCT03927404 19 20 O

- NCT03927404 24 25 O
1 NCT03927404 27 28 O
. NCT03927404 28 29 O
Ages NCT03927404 31 35 B-Age
of NCT03927404 36 38 O
18 NCT03927404 39 41 B-Eq_Comparison
and NCT03927404 42 45 I-Eq_Comparison
above NCT03927404 46 51 I-Eq_Comparison

- NCT03927404 54 55 O
2 NCT03927404 57 58 O
. NCT03927404 58 59 O
Unilateral NCT03927404 61 71 B-Modifier
transtibial NCT03927404 72 83 I-Modifier
or NCT03927404 84 86 B-Or
transfemoral NCT03927404 87 99 B-Modifier
amputee NCT03927404 100 107 B-Condition

- NCT03927404 110 111 O
3 NCT03927404 113 114 O
. NCT03927404 114 115 O
Ambulate NCT03927404 117 125 B-Condition
at NCT03927404 126 128 O
a NCT03927404 129 130 O
K NCT03927404 131 132 B-Eq_Comparison
2 NCT03927404 133 134 I-Eq_Comparison
level NCT03927404 135 140 I-Eq_Comparison
or NCT03927404 141 143 I-Eq_Comparison
higher NCT03927404 144 150 I-Eq_Comparison

- NCT03927404 153 154 O
4 NCT03927404 156 157 O
. NCT03927404 157 158 O
At NCT03927404 159 161 B-Eq_Comparison
least NCT03927404 162 167 I-Eq_Comparison
3 NCT03927404 168 169 I-Eq_Comparison
months NCT03927404 170 176 I-Eq_Comparison
post NCT03927404 177 181 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03927404 182 183 O
amputation NCT03927404 184 194 B-Procedure
per NCT03927404 195 198 O
physician NCT03927404 199 208 O
discretion NCT03927404 209 219 O

- NCT03927404 222 223 O
5 NCT03927404 225 226 O
. NCT03927404 226 227 O
Residual NCT03927404 228 236 B-Observation
limb NCT03927404 237 241 I-Observation
length NCT03927404 242 248 I-Observation
greater NCT03927404 249 256 B-Eq_Comparison
than NCT03927404 257 261 I-Eq_Comparison
6.5 NCT03927404 262 265 I-Eq_Comparison
inches NCT03927404 266 272 I-Eq_Comparison
in NCT03927404 273 275 O
length NCT03927404 276 282 O

- NCT03927404 285 286 O
6 NCT03927404 288 289 O
. NCT03927404 289 290 O
Able NCT03927404 291 295 O
to NCT03927404 296 298 O
follow NCT03927404 299 305 O
directions NCT03927404 306 316 O
and NCT03927404 317 320 O
give NCT03927404 321 325 O
informed NCT03927404 326 334 O
consent NCT03927404 335 342 O
on NCT03927404 343 345 O
their NCT03927404 346 351 O
own NCT03927404 352 355 O

- NCT03927404 358 359 O
7 NCT03927404 361 362 O
. NCT03927404 362 363 O
Must NCT03927404 364 368 O
be NCT03927404 369 371 O
able NCT03927404 372 376 B-Condition
to NCT03927404 377 379 I-Condition
ambulate NCT03927404 380 388 I-Condition
without NCT03927404 389 396 O
assistance NCT03927404 397 407 O

Exclusion NCT03927404 408 417 O
Criteria NCT03927404 418 426 O
: NCT03927404 427 428 O

- NCT03927404 432 433 O
1 NCT03927404 435 436 O
. NCT03927404 436 437 O
Conditions NCT03927404 439 449 B-Condition
that NCT03927404 450 454 O
prevent NCT03927404 455 462 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
wearing NCT03927404 463 470 B-Condition
a NCT03927404 471 472 I-Condition
prosthetic NCT03927404 473 483 I-Condition
socket NCT03927404 484 490 I-Condition

- NCT03927404 493 494 O
2 NCT03927404 496 497 O
. NCT03927404 497 498 O
Cognitive NCT03927404 500 509 B-Condition
deficits NCT03927404 510 518 I-Condition
or NCT03927404 519 521 B-Or
mental NCT03927404 522 528 B-Condition
health NCT03927404 529 535 I-Condition
problems NCT03927404 536 544 I-Condition
that NCT03927404 545 549 O
would NCT03927404 550 555 O
limit NCT03927404 556 561 O
ability NCT03927404 562 569 O
to NCT03927404 570 572 O
consent NCT03927404 573 580 O
and NCT03927404 581 584 O
participate NCT03927404 585 596 O
fully NCT03927404 597 602 O
in NCT03927404 603 605 O
the NCT03927404 606 609 O
study NCT03927404 610 615 O
protocol NCT03927404 616 624 O

- NCT03927404 627 628 O
3 NCT03927404 630 631 O
. NCT03927404 631 632 O
Women NCT03927404 633 638 O
who NCT03927404 639 642 B-And
are NCT03927404 643 646 O
pregnant NCT03927404 647 655 B-Condition
or NCT03927404 656 658 B-Or
who NCT03927404 659 662 O
plan NCT03927404 663 667 B-Assertion___Assertion_Type_Value:intention
to NCT03927404 668 670 I-Assertion___Assertion_Type_Value:intention
become NCT03927404 671 677 O
pregnant NCT03927404 678 686 B-Condition
in NCT03927404 687 689 O
the NCT03927404 690 693 O
near NCT03927404 694 698 B-Eq_Comparison
future NCT03927404 699 705 I-Eq_Comparison

Inclusion NCT03924921 0 9 O
Criteria NCT03924921 10 18 O
: NCT03924921 19 20 O

- NCT03924921 24 25 O
Being NCT03924921 27 32 O
older NCT03924921 33 38 B-Eq_Comparison
than NCT03924921 39 43 I-Eq_Comparison
18 NCT03924921 44 46 I-Eq_Comparison
; NCT03924921 47 48 O

- NCT03924921 51 52 O
have NCT03924921 54 58 O
a NCT03924921 59 60 O
diagnosis NCT03924921 61 70 O
of NCT03924921 71 73 O
HIV NCT03924921 74 77 B-Condition
; NCT03924921 77 78 O

- NCT03924921 81 82 O
present NCT03924921 84 91 O
at NCT03924921 92 94 B-Eq_Comparison
least NCT03924921 95 100 I-Eq_Comparison
one NCT03924921 101 104 I-Eq_Comparison
of NCT03924921 105 107 O
the NCT03924921 108 111 B-Criteria_Count
following NCT03924921 112 121 I-Criteria_Count
symptoms NCT03924921 122 130 I-Criteria_Count
during NCT03924921 131 137 O
the NCT03924921 138 141 O
preceding NCT03924921 142 151 B-Eq_Comparison
two NCT03924921 152 155 I-Eq_Comparison
weeks NCT03924921 156 161 I-Eq_Comparison
: NCT03924921 162 163 O
sleep NCT03924921 164 169 B-Condition
problems NCT03924921 170 178 I-Condition
, NCT03924921 179 180 O
fatigue NCT03924921 181 188 B-Condition
, NCT03924921 189 190 O
pain NCT03924921 191 195 B-Condition
, NCT03924921 196 197 O
anxiety NCT03924921 198 205 B-Condition
or NCT03924921 206 208 B-Or
symptoms NCT03924921 209 217 B-Assertion___Assertion_Type_Value:possible
of NCT03924921 218 220 O
depression NCT03924921 221 231 B-Condition
; NCT03924921 231 232 O

- NCT03924921 235 236 O
understand NCT03924921 238 248 O
and NCT03924921 249 252 O
speak NCT03924921 253 258 O
French NCT03924921 259 265 O
and NCT03924921 266 269 O
; NCT03924921 269 270 O

- NCT03924921 273 274 O
be NCT03924921 276 278 O
able NCT03924921 279 283 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924921 284 286 I-Assertion___Assertion_Type_Value:hypothetical
follow NCT03924921 287 293 O
the NCT03924921 294 297 O
instructions NCT03924921 298 310 O
to NCT03924921 311 313 O
learn NCT03924921 314 319 O
the NCT03924921 320 323 O
relaxation NCT03924921 324 334 B-Procedure
technique NCT03924921 335 344 I-Procedure
. NCT03924921 345 346 O

Exclusion NCT03924921 348 357 O
Criteria NCT03924921 358 366 O
: NCT03924921 367 368 O

- NCT03924921 371 372 O

Inclusion NCT03860493 0 9 O
Criteria NCT03860493 10 18 O
: NCT03860493 19 20 O

1 NCT03860493 24 25 O
. NCT03860493 25 26 O
Patients NCT03860493 28 36 O
of NCT03860493 37 39 O
both NCT03860493 40 44 O
genders NCT03860493 45 52 O

2 NCT03860493 55 56 O
. NCT03860493 56 57 O
Minimum NCT03860493 59 66 O
age NCT03860493 67 70 B-Age
: NCT03860493 71 72 O
18 NCT03860493 73 75 B-Eq_Comparison
years NCT03860493 76 81 I-Eq_Comparison
old NCT03860493 82 85 O

3 NCT03860493 88 89 O
. NCT03860493 89 90 O
Spoken NCT03860493 92 98 O
and NCT03860493 99 102 O
written NCT03860493 103 110 O
command NCT03860493 111 118 O
of NCT03860493 119 121 O
the NCT03860493 122 125 O
language NCT03860493 126 134 O
spoken NCT03860493 135 141 O
in NCT03860493 142 144 O
the NCT03860493 145 148 O
country NCT03860493 149 156 O
's NCT03860493 156 158 O
center NCT03860493 159 165 O

4 NCT03860493 168 169 O
. NCT03860493 169 170 O
Ability NCT03860493 172 179 O
to NCT03860493 180 182 O
understand NCT03860493 183 193 O
and NCT03860493 194 197 O
follow NCT03860493 198 204 O
the NCT03860493 205 208 O
study NCT03860493 209 214 O
procedures NCT03860493 215 225 O
and NCT03860493 226 229 O
sign NCT03860493 230 234 O
the NCT03860493 235 238 O
informed NCT03860493 239 247 O
consent NCT03860493 248 255 O

5 NCT03860493 258 259 O
. NCT03860493 259 260 O
open NCT03860493 262 266 B-Modifier
surgical NCT03860493 267 275 B-Procedure
porcedures NCT03860493 276 286 I-Procedure

Exclusion NCT03860493 287 296 O
Criteria NCT03860493 297 305 O
: NCT03860493 306 307 O

1 NCT03860493 311 312 O
. NCT03860493 312 313 O
Known NCT03860493 315 320 O
allergies NCT03860493 321 330 B-Allergy
to NCT03860493 331 333 O
iodides NCT03860493 334 341 B-Drug

2 NCT03860493 344 345 O
. NCT03860493 345 346 O
Known NCT03860493 348 353 O
history NCT03860493 354 361 B-Eq_Comparison
of NCT03860493 362 364 O
coagulopathy NCT03860493 365 377 B-Condition

3 NCT03860493 380 381 O
. NCT03860493 381 382 O
Women NCT03860493 384 389 O
who NCT03860493 390 393 B-And
are NCT03860493 394 397 O
pregnant NCT03860493 398 406 B-Condition
or NCT03860493 407 409 B-Or
breastfeeding NCT03860493 410 423 B-Condition
, NCT03860493 424 425 O
or NCT03860493 426 428 B-Or
for NCT03860493 429 432 O
whom NCT03860493 433 437 O
possibility NCT03860493 438 449 B-Assertion___Assertion_Type_Value:possible
of NCT03860493 450 452 O
pregnancy NCT03860493 453 462 B-Condition
was NCT03860493 463 466 O
not NCT03860493 467 470 O
ruled NCT03860493 471 476 O
out NCT03860493 477 480 O

Inclusion NCT03929991 0 9 O
Criteria NCT03929991 10 18 O
: NCT03929991 19 20 O

- NCT03929991 24 25 O
All NCT03929991 27 30 O
pregnant NCT03929991 31 39 B-Condition
women NCT03929991 40 45 O
undergoing NCT03929991 46 56 B-Eq_Comparison
a NCT03929991 57 58 O
C NCT03929991 59 60 B-Procedure
/ NCT03929991 61 62 I-Procedure
S NCT03929991 63 64 I-Procedure
in NCT03929991 65 67 O
on NCT03929991 68 70 O
the NCT03929991 71 74 O
hospitals NCT03929991 75 84 O
during NCT03929991 85 91 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03929991 92 95 O
study NCT03929991 96 101 B-Study
period NCT03929991 102 108 O
will NCT03929991 109 113 O
be NCT03929991 114 116 O
eligible NCT03929991 117 125 O
to NCT03929991 126 128 O
participate NCT03929991 129 140 O
in NCT03929991 141 143 O
this NCT03929991 144 148 O
study NCT03929991 149 154 O
. NCT03929991 155 156 O

Exclusion NCT03929991 158 167 O
Criteria NCT03929991 168 176 O
: NCT03929991 177 178 O

The NCT03929991 180 183 O
following NCT03929991 184 193 O
conditions NCT03929991 194 204 O
will NCT03929991 205 209 O
not NCT03929991 210 213 O
be NCT03929991 214 216 O
considered NCT03929991 217 227 O
as NCT03929991 228 230 O
outcome NCT03929991 231 238 O
, NCT03929991 239 240 O
unless NCT03929991 241 247 O
they NCT03929991 248 252 O
present NCT03929991 253 260 O
with NCT03929991 261 265 O

systemic NCT03929991 266 274 B-Modifier
repercussion NCT03929991 275 287 B-Condition
due NCT03929991 288 291 O
to NCT03929991 292 294 O
infection NCT03929991 295 304 B-Condition
. NCT03929991 305 306 O
For NCT03929991 308 311 O
example NCT03929991 312 319 O
: NCT03929991 320 321 O

- NCT03929991 325 326 O
Vaginosis NCT03929991 328 337 B-Condition
, NCT03929991 338 339 O
candidiasis NCT03929991 340 351 B-Condition

- NCT03929991 354 355 O
Lower NCT03929991 357 362 B-Modifier
tract NCT03929991 363 368 I-Modifier
urinary NCT03929991 369 376 I-Modifier
infection NCT03929991 377 386 B-Condition

- NCT03929991 389 390 O
Fungal NCT03929991 392 398 B-Modifier
infections NCT03929991 399 409 B-Condition
of NCT03929991 410 412 O
the NCT03929991 413 416 O
skin NCT03929991 417 421 B-Modifier
( NCT03929991 422 423 O
athlete NCT03929991 424 431 B-Condition
's NCT03929991 431 433 I-Condition
foot NCT03929991 434 438 I-Condition
, NCT03929991 439 440 O
jockitch NCT03929991 441 449 B-Condition
, NCT03929991 450 451 O
ringworm NCT03929991 452 460 B-Condition
, NCT03929991 461 462 O
and NCT03929991 463 466 O
yeast NCT03929991 467 472 B-Condition
infections NCT03929991 473 483 I-Condition
) NCT03929991 484 485 O

- NCT03929991 489 490 O
Otitis NCT03929991 492 498 B-Condition

- NCT03929991 501 502 O
Pharyngitis NCT03929991 504 515 B-Condition

- NCT03929991 518 519 O
Herpes NCT03929991 521 527 B-Condition
simplex NCT03929991 528 535 I-Condition
, NCT03929991 536 537 O
Herpes NCT03929991 538 544 B-Condition
Zoster NCT03929991 545 551 I-Condition
( NCT03929991 552 553 O
Shingles NCT03929991 554 562 B-Condition
) NCT03929991 563 564 O

- NCT03929991 568 569 O
Uncomplicated NCT03929991 571 584 B-Modifier
chronic NCT03929991 585 592 B-Condition
infection NCT03929991 593 602 I-Condition

- NCT03929991 605 606 O
Sexually NCT03929991 608 616 B-Condition
transmitted NCT03929991 617 628 I-Condition
infections NCT03929991 629 639 I-Condition
( NCT03929991 640 641 O
Gonorrhoea NCT03929991 642 652 B-Condition
, NCT03929991 653 654 O
Syphilis NCT03929991 655 663 B-Condition
, NCT03929991 664 665 O
Trichomonas NCT03929991 666 677 B-Condition
, NCT03929991 678 679 O
Chlamydia NCT03929991 680 689 B-Condition
, NCT03929991 690 691 O
Hepatitis NCT03929991 692 701 B-Condition
, NCT03929991 702 703 O
HIV NCT03929991 704 707 B-Condition
) NCT03929991 708 709 O

- NCT03929991 713 714 O
Tuberculosis NCT03929991 716 728 B-Condition

- NCT03929991 731 732 O
Bacterial NCT03929991 734 743 B-Condition
colonization NCT03929991 744 756 I-Condition
( NCT03929991 757 758 O
presence NCT03929991 759 767 O
of NCT03929991 768 770 O
microorganisms NCT03929991 771 785 B-Organism
without NCT03929991 786 793 B-Negation
clinical NCT03929991 794 802 B-Condition
signs NCT03929991 803 808 I-Condition
/ NCT03929991 809 810 I-Condition
symptoms NCT03929991 811 819 I-Condition
) NCT03929991 820 821 O

- NCT03929991 825 826 O
Known NCT03929991 828 833 O
vaginal NCT03929991 834 841 B-Modifier
, NCT03929991 842 843 O
urethral NCT03929991 844 852 B-Modifier
and NCT03929991 853 856 B-Or
/ NCT03929991 857 858 I-Or
or NCT03929991 859 861 I-Or
rectal NCT03929991 862 868 B-Modifier
GBS NCT03929991 869 872 B-Condition
colonization NCT03929991 873 885 I-Condition

- NCT03929991 888 889 O
Asymptomatic NCT03929991 891 903 B-Condition
bacteriuria NCT03929991 904 915 I-Condition

- NCT03929991 918 919 O
Known NCT03929991 921 926 O
oropharyngeal NCT03929991 927 940 B-Condition
colonization NCT03929991 941 953 I-Condition

- NCT03929991 956 957 O
Non NCT03929991 959 962 B-Modifier
- NCT03929991 963 964 I-Modifier
infectious NCT03929991 965 975 I-Modifier
hypothermia NCT03929991 976 987 B-Condition
/ NCT03929991 988 989 B-Or
hyperthermia NCT03929991 990 1002 B-Condition
( NCT03929991 1003 1004 O
e NCT03929991 1005 1006 O
. NCT03929991 1007 1008 O
g NCT03929991 1009 1010 O
. NCT03929991 1011 1012 O
related NCT03929991 1014 1021 O
to NCT03929991 1022 1024 O
epidural NCT03929991 1025 1033 B-Procedure
, NCT03929991 1034 1035 O
thyroid NCT03929991 1036 1043 B-Condition
storm NCT03929991 1044 1049 I-Condition
, NCT03929991 1050 1051 O
prostaglandin NCT03929991 1052 1065 B-Drug
administration NCT03929991 1066 1080 O
) NCT03929991 1081 1082 O
during NCT03929991 1083 1089 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospital NCT03929991 1090 1098 B-Encounter
stay NCT03929991 1099 1103 I-Encounter

Inclusion NCT03862924 0 9 O
Criteria NCT03862924 10 18 O
: NCT03862924 19 20 O

- NCT03862924 24 25 O
diagnosed NCT03862924 27 36 O
with NCT03862924 37 41 O
and NCT03862924 42 45 O
engaged NCT03862924 46 53 O
in NCT03862924 54 56 O
care NCT03862924 57 61 O
for NCT03862924 62 65 O
HIV NCT03862924 66 69 B-Condition
( NCT03862924 70 71 O
defined NCT03862924 72 79 O
as NCT03862924 80 82 O
at NCT03862924 83 85 B-Eq_Comparison
least NCT03862924 86 91 I-Eq_Comparison
one NCT03862924 92 95 I-Eq_Comparison
HIV NCT03862924 96 99 O
clinic NCT03862924 100 106 O
medical NCT03862924 107 114 B-Encounter
appointment NCT03862924 115 126 I-Encounter
within NCT03862924 127 133 B-Eq_Comparison
the NCT03862924 134 137 I-Eq_Comparison
past NCT03862924 138 142 I-Eq_Comparison
six NCT03862924 143 146 I-Eq_Comparison
month NCT03862924 147 152 I-Eq_Comparison
period NCT03862924 153 159 I-Eq_Comparison
) NCT03862924 160 161 O

- NCT03862924 165 166 O
at NCT03862924 168 170 B-Eq_Comparison
least NCT03862924 171 176 I-Eq_Comparison
18 NCT03862924 177 179 I-Eq_Comparison
years NCT03862924 180 185 I-Eq_Comparison
of NCT03862924 186 188 O
age NCT03862924 189 192 B-Age

- NCT03862924 195 196 O
smoke NCT03862924 198 203 B-Observation
at NCT03862924 204 206 B-Eq_Comparison
least NCT03862924 207 212 I-Eq_Comparison
5 NCT03862924 213 214 I-Eq_Comparison
cigarettes NCT03862924 215 225 I-Eq_Comparison
per NCT03862924 226 229 I-Eq_Comparison
day NCT03862924 230 233 I-Eq_Comparison
for NCT03862924 234 237 O
longer NCT03862924 238 244 B-Eq_Comparison
than NCT03862924 245 249 I-Eq_Comparison
one NCT03862924 250 253 I-Eq_Comparison
year NCT03862924 254 258 I-Eq_Comparison

- NCT03862924 261 262 O
exhaled NCT03862924 264 271 B-Observation
carbon NCT03862924 272 278 I-Observation
monoxide NCT03862924 279 287 I-Observation
( NCT03862924 288 289 O
CO NCT03862924 290 292 B-Observation
) NCT03862924 293 294 O
level NCT03862924 295 300 O
greater NCT03862924 301 308 B-Eq_Comparison
than NCT03862924 309 313 I-Eq_Comparison
5 NCT03862924 314 315 I-Eq_Comparison
at NCT03862924 316 318 O
BL NCT03862924 319 321 B-Modifier

Exclusion NCT03862924 322 331 O
Criteria NCT03862924 332 340 O
: NCT03862924 341 342 O

- NCT03862924 346 347 O
intention NCT03862924 349 358 B-Assertion___Assertion_Type_Value:intention
to NCT03862924 359 361 I-Assertion___Assertion_Type_Value:intention
quit NCT03862924 362 366 B-Condition
smoking NCT03862924 367 374 I-Condition
in NCT03862924 375 377 O
the NCT03862924 378 381 O
next NCT03862924 382 386 B-Eq_Comparison
30 NCT03862924 387 389 I-Eq_Comparison
days NCT03862924 390 394 I-Eq_Comparison

- NCT03862924 397 398 O
currently NCT03862924 400 409 B-Eq_Comparison
using NCT03862924 410 415 I-Eq_Comparison
pharmacotherapy NCT03862924 416 431 B-Procedure
for NCT03862924 432 435 O
smoking NCT03862924 436 443 B-Procedure
cessation NCT03862924 444 453 I-Procedure

- NCT03862924 456 457 O
currently NCT03862924 459 468 B-Eq_Comparison
using NCT03862924 469 474 I-Eq_Comparison
electronic NCT03862924 475 485 B-Modifier
cigarettes NCT03862924 486 496 B-Drug
more NCT03862924 497 501 B-Eq_Comparison
than NCT03862924 502 506 I-Eq_Comparison
2 NCT03862924 507 508 I-Eq_Comparison
days NCT03862924 509 513 I-Eq_Comparison
/ NCT03862924 514 515 I-Eq_Comparison
week NCT03862924 516 520 I-Eq_Comparison

- NCT03862924 523 524 O
unstable NCT03862924 526 534 O
medical NCT03862924 535 542 B-Modifier
or NCT03862924 543 545 B-Or
psychiatric NCT03862924 546 557 B-Modifier
condition NCT03862924 558 567 B-Condition
( NCT03862924 568 569 O
defined NCT03862924 570 577 O
as NCT03862924 578 580 O
hospitalization NCT03862924 581 596 B-Encounter
) NCT03862924 597 598 O

- NCT03862924 602 603 O
medical NCT03862924 605 612 O
contraindications NCT03862924 613 630 B-Contraindication
to NCT03862924 631 633 O
nicotine NCT03862924 634 642 B-Drug
( NCT03862924 643 644 O
unstable NCT03862924 645 653 O
angina NCT03862924 654 660 B-Condition
, NCT03862924 661 662 O
uncontrolled NCT03862924 663 675 B-Modifier
hypertension NCT03862924 676 688 B-Condition
, NCT03862924 689 690 O
or NCT03862924 691 693 B-Or
recent NCT03862924 694 700 B-Eq_Comparison
cardiovascular NCT03862924 701 715 B-Condition
event NCT03862924 716 721 I-Condition
, NCT03862924 722 723 O
including NCT03862924 724 733 O
hospitalization NCT03862924 734 749 B-Encounter
) NCT03862924 750 751 O

- NCT03862924 755 756 O
psychotic NCT03862924 758 767 B-Condition
symptoms NCT03862924 768 776 B-Assertion___Assertion_Type_Value:possible

- NCT03862924 779 780 O
substance NCT03862924 782 791 B-Condition
use NCT03862924 792 795 I-Condition
disorder NCT03862924 796 804 I-Condition
other NCT03862924 805 810 B-Exception
than NCT03862924 811 815 I-Exception
nicotine NCT03862924 816 824 B-Condition
dependence NCT03862924 825 835 I-Condition

- NCT03862924 838 839 O
past NCT03862924 841 845 B-Eq_Comparison
- NCT03862924 846 847 I-Eq_Comparison
month NCT03862924 848 853 I-Eq_Comparison
suicidal NCT03862924 854 862 B-Condition
ideation NCT03862924 863 871 I-Condition
or NCT03862924 872 874 B-Or
past NCT03862924 875 879 B-Eq_Comparison
- NCT03862924 880 881 I-Eq_Comparison
year NCT03862924 882 886 I-Eq_Comparison
suicide NCT03862924 887 894 B-Condition
attempt NCT03862924 895 902 I-Condition

- NCT03862924 905 906 O
pregnant NCT03862924 908 916 B-Condition
or NCT03862924 917 919 B-Or
nursing NCT03862924 920 927 B-Condition
. NCT03862924 928 929 O

Inclusion NCT03922919 0 9 O
Criteria NCT03922919 10 18 O
: NCT03922919 19 20 O

- NCT03922919 24 25 O
Age NCT03922919 27 30 B-Age
≥ NCT03922919 31 32 B-Eq_Comparison
18 NCT03922919 33 35 I-Eq_Comparison
years NCT03922919 36 41 I-Eq_Comparison
old NCT03922919 42 45 O

- NCT03922919 48 49 O
Indication NCT03922919 51 61 B-Indication
for NCT03922919 62 65 O
antibiotic NCT03922919 66 76 B-Drug
treatment NCT03922919 77 86 B-Procedure
with NCT03922919 87 91 O
a NCT03922919 92 93 O
3 NCT03922919 94 95 B-Modifier
rd NCT03922919 96 98 I-Modifier
generation NCT03922919 99 109 I-Modifier
injectable NCT03922919 110 120 I-Modifier
cephalosporin NCT03922919 121 134 B-Drug
( NCT03922919 135 136 O
cefotaxime NCT03922919 137 147 B-Drug
or NCT03922919 148 150 B-Or
ceftriaxone NCT03922919 151 162 B-Drug
) NCT03922919 163 164 O

- NCT03922919 168 169 O
Signed NCT03922919 171 177 O
Informed NCT03922919 178 186 O
Consent NCT03922919 187 194 O

Exclusion NCT03922919 195 204 O
Criteria NCT03922919 205 213 O
: NCT03922919 214 215 O

- NCT03922919 219 220 O
Hypersensitivity NCT03922919 222 238 B-Condition
to NCT03922919 239 241 O
ceftriaxone NCT03922919 242 253 B-Drug
or NCT03922919 254 256 B-Or
cefotaxime NCT03922919 257 267 B-Drug
, NCT03922919 268 269 O
to NCT03922919 270 272 O
another NCT03922919 273 280 B-Other
cephalosporin NCT03922919 281 294 B-Drug
or NCT03922919 295 297 O
to NCT03922919 298 300 O
any NCT03922919 301 304 O
of NCT03922919 305 307 O
the NCT03922919 308 311 O
excipients NCT03922919 312 322 O
of NCT03922919 323 325 O
the NCT03922919 326 329 O
specialities NCT03922919 330 342 O
concerned NCT03922919 343 352 O
. NCT03922919 353 354 O

- NCT03922919 358 359 O
History NCT03922919 361 368 B-Eq_Comparison
of NCT03922919 369 371 O
severe NCT03922919 372 378 O
hypersensitivity NCT03922919 379 395 B-Condition
( NCT03922919 396 397 O
e NCT03922919 398 399 O
. NCT03922919 400 401 O
g NCT03922919 402 403 O
. NCT03922919 404 405 O
, NCT03922919 406 407 O
anaphylactic NCT03922919 408 420 B-Condition
reaction NCT03922919 421 429 I-Condition
) NCT03922919 430 431 O
to NCT03922919 432 434 O
another NCT03922919 435 442 B-Other
class NCT03922919 443 448 O
of NCT03922919 449 451 O
antibacterial NCT03922919 452 465 B-Drug
agent NCT03922919 466 471 I-Drug
of NCT03922919 472 474 O
the NCT03922919 475 478 O
beta NCT03922919 479 483 B-Modifier
- NCT03922919 484 485 I-Modifier
lactam NCT03922919 486 492 I-Modifier
family NCT03922919 493 499 O
( NCT03922919 500 501 O
penicillins NCT03922919 502 513 B-Drug
, NCT03922919 514 515 O
monobactams NCT03922919 516 527 B-Drug
and NCT03922919 528 531 B-Or
carbapenes NCT03922919 532 542 B-Drug
) NCT03922919 543 544 O

- NCT03922919 548 549 O
Subcutaneous NCT03922919 551 563 B-Modifier
administration NCT03922919 564 578 O
of NCT03922919 579 581 O
ceftriaxone NCT03922919 582 593 B-Drug

- NCT03922919 596 597 O
Pregnant NCT03922919 599 607 B-Condition
and NCT03922919 608 611 B-Or
breastfeeding NCT03922919 612 625 B-Condition
woman NCT03922919 626 631 O

- NCT03922919 634 635 O
Suspicion NCT03922919 637 646 B-Assertion___Assertion_Type_Value:possible
of NCT03922919 647 649 O
Pseudomonas NCT03922919 650 661 B-Condition
infection NCT03922919 662 671 I-Condition
or NCT03922919 672 674 B-Or
documented NCT03922919 675 685 O
Pseudomonas NCT03922919 686 697 B-Condition
infection NCT03922919 698 707 I-Condition
requiring NCT03922919 708 717 B-Assertion___Assertion_Type_Value:hypothetical
ceftazidime NCT03922919 718 729 B-Drug
treatment NCT03922919 730 739 B-Procedure

- NCT03922919 742 743 O
Suspicion NCT03922919 745 754 B-Assertion___Assertion_Type_Value:possible
of NCT03922919 755 757 O
group NCT03922919 758 763 B-Eq_Comparison
III NCT03922919 764 767 I-Eq_Comparison
enterobacteriaceae NCT03922919 768 786 B-Condition
infection NCT03922919 787 796 I-Condition
or NCT03922919 797 799 B-Or
group NCT03922919 800 805 B-Eq_Comparison
III NCT03922919 806 809 I-Eq_Comparison
enterobacteriaceae NCT03922919 810 828 B-Condition
infection NCT03922919 829 838 I-Condition
requiring NCT03922919 839 848 O
cefepime NCT03922919 849 857 B-Drug
treatment NCT03922919 858 867 B-Procedure

Inclusion NCT03869346 0 9 O
Criteria NCT03869346 10 18 O
: NCT03869346 19 20 O

- NCT03869346 24 25 O
American NCT03869346 27 35 B-Observation
Society NCT03869346 36 43 I-Observation
of NCT03869346 44 46 I-Observation
Anesthesiologists NCT03869346 47 64 I-Observation
Grade NCT03869346 65 70 B-Eq_Comparison
Ⅰ NCT03869346 71 72 I-Eq_Comparison
- NCT03869346 73 74 I-Eq_Comparison
II NCT03869346 75 77 I-Eq_Comparison
, NCT03869346 78 79 O
Patients NCT03869346 80 88 O
undergo NCT03869346 89 96 B-Eq_Comparison
elective NCT03869346 97 105 B-Modifier
surgery NCT03869346 106 113 B-Procedure
for NCT03869346 114 117 O
benign NCT03869346 118 124 B-Modifier
Reproductive NCT03869346 125 137 B-Condition
diseases NCT03869346 138 146 I-Condition
( NCT03869346 147 148 O
including NCT03869346 149 158 O
laparoscopic NCT03869346 159 171 B-Procedure
ovarian NCT03869346 172 179 I-Procedure
cyst NCT03869346 180 184 I-Procedure
removal NCT03869346 185 192 I-Procedure
, NCT03869346 193 194 O
laparoscopic NCT03869346 195 207 B-Procedure
tubal NCT03869346 208 213 I-Procedure
ligation NCT03869346 214 222 I-Procedure
, NCT03869346 223 224 O
laparoscopic NCT03869346 225 237 B-Procedure
tubal NCT03869346 238 243 I-Procedure
drainage NCT03869346 244 252 I-Procedure
, NCT03869346 253 254 O
laparoscopic NCT03869346 255 267 B-Procedure
salpingoplasty NCT03869346 268 282 I-Procedure
, NCT03869346 283 284 O
etc NCT03869346 285 288 O
. NCT03869346 289 290 O
) NCT03869346 291 292 O
or NCT03869346 293 295 B-Or
breast NCT03869346 296 302 B-Condition
disease NCT03869346 303 310 I-Condition
. NCT03869346 311 312 O

- NCT03869346 316 317 O
Aged NCT03869346 319 323 B-Age
18 NCT03869346 324 326 B-Eq_Comparison
- NCT03869346 327 328 I-Eq_Comparison
45 NCT03869346 329 331 I-Eq_Comparison
years NCT03869346 332 337 I-Eq_Comparison

- NCT03869346 340 341 O
Body NCT03869346 343 347 B-Observation
Mass NCT03869346 348 352 I-Observation
Index NCT03869346 353 358 I-Observation
18 NCT03869346 359 361 B-Eq_Comparison
- NCT03869346 362 363 I-Eq_Comparison
25 NCT03869346 364 366 I-Eq_Comparison
kg NCT03869346 367 369 I-Eq_Comparison
/ NCT03869346 370 371 I-Eq_Comparison
m NCT03869346 372 373 I-Eq_Comparison
2 NCT03869346 374 375 I-Eq_Comparison
, NCT03869346 376 377 O
body NCT03869346 378 382 B-Observation
weight NCT03869346 383 389 I-Observation
40 NCT03869346 390 392 B-Eq_Comparison
- NCT03869346 393 394 I-Eq_Comparison
65 NCT03869346 395 397 I-Eq_Comparison
kilograms NCT03869346 398 407 I-Eq_Comparison

- NCT03869346 410 411 O
Agreed NCT03869346 413 419 O
to NCT03869346 420 422 O
participate NCT03869346 423 434 O
the NCT03869346 435 438 O
research NCT03869346 439 447 O

Exclusion NCT03869346 448 457 O
Criteria NCT03869346 458 466 O
: NCT03869346 467 468 O

- NCT03869346 472 473 O
Difficult NCT03869346 475 484 B-Condition
airway NCT03869346 485 491 I-Condition

- NCT03869346 494 495 O
upper NCT03869346 497 502 B-Condition
respiratory NCT03869346 503 514 I-Condition
tract NCT03869346 515 520 I-Condition
infection NCT03869346 521 530 I-Condition
within NCT03869346 531 537 B-Eq_Comparison
2 NCT03869346 538 539 I-Eq_Comparison
weeks NCT03869346 540 545 I-Eq_Comparison

- NCT03869346 548 549 O
history NCT03869346 551 558 B-Eq_Comparison
of NCT03869346 559 561 O
allergy NCT03869346 562 569 B-Allergy
or NCT03869346 570 572 B-Or
long NCT03869346 573 577 O
- NCT03869346 578 579 O
term NCT03869346 580 584 O
use NCT03869346 585 588 O
of NCT03869346 589 591 O
propofol NCT03869346 592 600 B-Drug
and NCT03869346 601 604 B-Or
opioids NCT03869346 605 612 B-Drug

- NCT03869346 615 616 O
self NCT03869346 618 622 B-Observation
- NCT03869346 623 624 I-Observation
rating NCT03869346 625 631 I-Observation
anxiety NCT03869346 632 639 I-Observation
scale NCT03869346 640 645 I-Observation
before NCT03869346 646 652 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operation NCT03869346 653 662 B-Procedure
indicates NCT03869346 663 672 O
anxiety NCT03869346 673 680 B-Condition

- NCT03869346 683 684 O
pregnancy NCT03869346 686 695 B-Condition
or NCT03869346 696 698 B-Or
lactation NCT03869346 699 708 B-Condition
. NCT03869346 709 710 O

Inclusion NCT03869918 0 9 O
Criteria NCT03869918 10 18 O
: NCT03869918 19 20 O

1 NCT03869918 24 25 O
. NCT03869918 25 26 O
female NCT03869918 28 34 O

2 NCT03869918 37 38 O
. NCT03869918 38 39 O
age NCT03869918 41 44 B-Age
60 NCT03869918 45 47 B-Eq_Comparison
+ NCT03869918 48 49 I-Eq_Comparison
years NCT03869918 50 55 I-Eq_Comparison

3 NCT03869918 58 59 O
. NCT03869918 59 60 O
community NCT03869918 62 71 O
dwelling NCT03869918 72 80 O

4 NCT03869918 83 84 O
. NCT03869918 84 85 O
Moderate NCT03869918 87 95 B-Eq_Comparison
to NCT03869918 96 98 I-Eq_Comparison
severe NCT03869918 99 105 I-Eq_Comparison
UUI NCT03869918 106 109 B-Condition
( NCT03869918 110 111 O
as NCT03869918 112 114 O
measured NCT03869918 115 123 O
by NCT03869918 124 126 O
International NCT03869918 127 140 B-Observation
Consultation NCT03869918 141 153 I-Observation
on NCT03869918 154 156 I-Observation
Incontinence NCT03869918 157 169 I-Observation
Questionnaire NCT03869918 170 183 I-Observation
Short NCT03869918 184 189 I-Observation
Form NCT03869918 190 194 I-Observation
) NCT03869918 195 196 O

5 NCT03869918 200 201 O
. NCT03869918 201 202 O
low NCT03869918 204 207 O
physical NCT03869918 208 216 B-Observation
activity NCT03869918 217 225 I-Observation
( NCT03869918 226 227 O
Physical NCT03869918 228 236 B-Observation
Activity NCT03869918 237 245 I-Observation
Staging NCT03869918 246 253 I-Observation
questionnaire NCT03869918 254 267 I-Observation
) NCT03869918 268 269 O

6 NCT03869918 273 274 O
. NCT03869918 274 275 O
cognitively NCT03869918 277 288 B-Condition
able NCT03869918 289 293 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869918 294 296 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03869918 297 305 O
the NCT03869918 306 309 O
study NCT03869918 310 315 B-Study
( NCT03869918 316 317 O
in NCT03869918 318 320 O
opinion NCT03869918 321 328 O
of NCT03869918 329 331 O
the NCT03869918 332 335 O
referring NCT03869918 336 345 O
provider NCT03869918 346 354 O
) NCT03869918 355 356 O
Women NCT03869918 357 362 O
currently NCT03869918 363 372 B-Eq_Comparison
on NCT03869918 373 375 O
anti NCT03869918 376 380 B-Drug
- NCT03869918 381 382 I-Drug
cholinergic NCT03869918 383 394 I-Drug
medication NCT03869918 395 405 I-Drug
for NCT03869918 406 409 O
urinary NCT03869918 410 417 B-Condition
incontinence NCT03869918 418 430 I-Condition
will NCT03869918 431 435 O
be NCT03869918 436 438 O
allowed NCT03869918 439 446 O
if NCT03869918 447 449 O
they NCT03869918 450 454 O
meet NCT03869918 455 459 O
the NCT03869918 460 463 O
above NCT03869918 464 469 O
criteria NCT03869918 470 478 O
. NCT03869918 479 480 O

Exclusion NCT03869918 482 491 O
Criteria NCT03869918 492 500 O
: NCT03869918 501 502 O

1 NCT03869918 506 507 O
. NCT03869918 507 508 O
cognitive NCT03869918 510 519 B-Condition
impairment NCT03869918 520 530 I-Condition
( NCT03869918 531 532 O
in NCT03869918 533 535 O
opinion NCT03869918 536 543 O
of NCT03869918 544 546 O
the NCT03869918 547 550 O
referring NCT03869918 551 560 O
provider NCT03869918 561 569 O
) NCT03869918 570 571 O

2 NCT03869918 575 576 O
. NCT03869918 576 577 O
unable NCT03869918 579 585 O
to NCT03869918 586 588 O
provide NCT03869918 589 596 O
informed NCT03869918 597 605 O
consent NCT03869918 606 613 O
or NCT03869918 614 616 O
communicate NCT03869918 617 628 O
in NCT03869918 629 631 O
English NCT03869918 632 639 O

3 NCT03869918 642 643 O
. NCT03869918 643 644 O
desire NCT03869918 646 652 B-Assertion___Assertion_Type_Value:intention
for NCT03869918 653 656 I-Assertion___Assertion_Type_Value:intention
surgical NCT03869918 657 665 B-Procedure
management NCT03869918 666 676 I-Procedure

4 NCT03869918 679 680 O
. NCT03869918 680 681 O
osteoporosis NCT03869918 683 695 B-Condition

5 NCT03869918 698 699 O
. NCT03869918 699 700 O
lack NCT03869918 702 706 O
of NCT03869918 707 709 O
medical NCT03869918 710 717 O
clearance NCT03869918 718 727 O
from NCT03869918 728 732 O
the NCT03869918 733 736 O
physician NCT03869918 737 746 B-Provider
. NCT03869918 747 748 O

Inclusion NCT03923426 0 9 O
Criteria NCT03923426 10 18 O
: NCT03923426 19 20 O

1 NCT03923426 24 25 O
. NCT03923426 25 26 O
Hospitalized NCT03923426 28 40 B-Encounter
patient NCT03923426 41 48 O
≥ NCT03923426 49 50 B-Eq_Comparison
18 NCT03923426 51 53 I-Eq_Comparison
years NCT03923426 54 59 I-Eq_Comparison
old NCT03923426 60 63 B-Age
or NCT03923426 64 66 B-Or
considered NCT03923426 67 77 O
an NCT03923426 78 80 O
adult NCT03923426 81 86 O
in NCT03923426 87 89 O
accordance NCT03923426 90 100 O
with NCT03923426 101 105 O
the NCT03923426 106 109 O
age NCT03923426 110 113 O
of NCT03923426 114 116 O
majority NCT03923426 117 125 O
in NCT03923426 126 128 O
the NCT03923426 129 132 O
participant NCT03923426 133 144 O
's NCT03923426 144 146 O
country NCT03923426 147 154 O
of NCT03923426 155 157 O
residence NCT03923426 158 167 O
at NCT03923426 168 170 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923426 171 174 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03923426 175 179 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03923426 180 182 O
treatment NCT03923426 183 192 B-Procedure
with NCT03923426 193 197 O
ceftazidime NCT03923426 198 209 B-Drug
- NCT03923426 210 211 I-Drug
avibactam NCT03923426 212 221 I-Drug
. NCT03923426 222 223 O

2 NCT03923426 227 228 O
. NCT03923426 228 229 O
Patient NCT03923426 231 238 O
received NCT03923426 239 247 B-Eq_Comparison
≥ NCT03923426 248 249 B-Eq_Comparison
1 NCT03923426 250 251 I-Eq_Comparison
dose NCT03923426 252 256 O
of NCT03923426 257 259 O
ceftazidime NCT03923426 260 271 B-Drug
- NCT03923426 272 273 I-Drug
avibactam NCT03923426 274 283 I-Drug
in NCT03923426 284 286 O
routine NCT03923426 287 294 O
practice NCT03923426 295 303 O
at NCT03923426 304 306 O
participating NCT03923426 307 320 O
site NCT03923426 321 325 O
since NCT03923426 326 331 B-Eq_Comparison
01 NCT03923426 332 334 I-Eq_Comparison
January NCT03923426 335 342 I-Eq_Comparison
, NCT03923426 343 344 I-Eq_Comparison
2018 NCT03923426 345 349 I-Eq_Comparison
onwards NCT03923426 350 357 O
or NCT03923426 358 360 B-Or
since NCT03923426 361 366 O
the NCT03923426 367 370 O
date NCT03923426 371 375 O
of NCT03923426 376 378 O
launch NCT03923426 379 385 O
in NCT03923426 386 388 O
the NCT03923426 389 392 O
country NCT03923426 393 400 O
if NCT03923426 401 403 O
it NCT03923426 404 406 O
is NCT03923426 407 409 O
after NCT03923426 410 415 B-Temporal_Connection___Temporal_Connection_Type_Value:after
01 NCT03923426 416 418 B-Eq_Comparison
January NCT03923426 419 426 I-Eq_Comparison
, NCT03923426 427 428 I-Eq_Comparison
2018 NCT03923426 429 433 I-Eq_Comparison
. NCT03923426 433 434 O

3 NCT03923426 438 439 O
. NCT03923426 439 440 O
Patient NCT03923426 442 449 O
underwent NCT03923426 450 459 B-Eq_Comparison
microbiologic NCT03923426 460 473 B-Observation
sampling NCT03923426 474 482 I-Observation
≤ NCT03923426 483 484 B-Eq_Comparison
5 NCT03923426 485 486 I-Eq_Comparison
days NCT03923426 487 491 I-Eq_Comparison
before NCT03923426 492 498 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923426 499 502 O
initiation NCT03923426 503 513 B-Eq_Comparison
of NCT03923426 514 516 O
ceftazidime NCT03923426 517 528 B-Drug
- NCT03923426 529 530 I-Drug
avibactam NCT03923426 531 540 I-Drug
( NCT03923426 541 542 O
irrespective NCT03923426 543 555 O
of NCT03923426 556 558 O
results NCT03923426 559 566 O
and NCT03923426 567 570 O
actual NCT03923426 571 577 O
bacteriological NCT03923426 578 593 O
identification NCT03923426 594 608 O
) NCT03923426 609 610 O
. NCT03923426 611 612 O

4 NCT03923426 616 617 O
. NCT03923426 617 618 O
Patient NCT03923426 620 627 O
has NCT03923426 628 631 O
all NCT03923426 632 635 O
required NCT03923426 636 644 O
essential NCT03923426 645 654 O
data NCT03923426 655 659 O
elements NCT03923426 660 668 O
which NCT03923426 669 674 O
include NCT03923426 675 682 O
: NCT03923426 683 684 O

1 NCT03923426 693 694 O
. NCT03923426 694 695 O
Start NCT03923426 697 702 O
and NCT03923426 703 706 O
stop NCT03923426 707 711 O
dates NCT03923426 712 717 O
of NCT03923426 718 720 O
ceftazidime NCT03923426 721 732 B-Drug
- NCT03923426 733 734 I-Drug
avibactam NCT03923426 735 744 I-Drug
, NCT03923426 745 746 O

2 NCT03923426 755 756 O
. NCT03923426 756 757 O
Start NCT03923426 759 764 O
and NCT03923426 765 768 O
stop NCT03923426 769 773 O
dates NCT03923426 774 779 O
of NCT03923426 780 782 O
prior NCT03923426 783 788 B-Eq_Comparison
antibiotic NCT03923426 789 799 B-Procedure
therapy NCT03923426 800 807 I-Procedure
used NCT03923426 808 812 O
for NCT03923426 813 816 O
the NCT03923426 817 820 O
index NCT03923426 821 826 O
infection NCT03923426 827 836 B-Condition
, NCT03923426 837 838 O

3 NCT03923426 847 848 O
. NCT03923426 848 849 O
Type NCT03923426 851 855 O
of NCT03923426 856 858 O
combined NCT03923426 859 867 O
antibiotic NCT03923426 868 878 B-Procedure
therapy NCT03923426 879 886 I-Procedure
( NCT03923426 887 888 O
if NCT03923426 889 891 O
applicable NCT03923426 892 902 O
) NCT03923426 903 904 O
and NCT03923426 905 908 B-And
start NCT03923426 909 914 O
and NCT03923426 915 918 O
stop NCT03923426 919 923 O
dates NCT03923426 924 929 O
of NCT03923426 930 932 O
any NCT03923426 933 936 O
antibiotic NCT03923426 937 947 B-Drug
combined NCT03923426 948 956 B-And
with NCT03923426 957 961 I-And
ceftazidime NCT03923426 962 973 B-Drug
- NCT03923426 974 975 I-Drug
avibactam NCT03923426 976 985 I-Drug
. NCT03923426 986 987 O

5 NCT03923426 991 992 O
. NCT03923426 992 993 O
Evidence NCT03923426 995 1003 O
of NCT03923426 1004 1006 O
a NCT03923426 1007 1008 O
personally NCT03923426 1009 1019 O
signed NCT03923426 1020 1026 O
and NCT03923426 1027 1030 O
dated NCT03923426 1031 1036 O
informed NCT03923426 1037 1045 O
consent NCT03923426 1046 1053 O
document NCT03923426 1054 1062 O
indicating NCT03923426 1063 1073 O
that NCT03923426 1074 1078 O
the NCT03923426 1079 1082 O
patient NCT03923426 1083 1090 O
( NCT03923426 1091 1092 O
or NCT03923426 1093 1095 O
a NCT03923426 1096 1097 O
legally NCT03923426 1098 1105 O
acceptable NCT03923426 1106 1116 O
representative NCT03923426 1117 1131 O
) NCT03923426 1132 1133 O
has NCT03923426 1134 1137 O
been NCT03923426 1138 1142 O
informed NCT03923426 1143 1151 O
of NCT03923426 1152 1154 O
all NCT03923426 1155 1158 O
pertinent NCT03923426 1159 1168 O
aspects NCT03923426 1169 1176 O
of NCT03923426 1177 1179 O
the NCT03923426 1180 1183 O
study NCT03923426 1184 1189 O
where NCT03923426 1190 1195 O
required NCT03923426 1196 1204 O
by NCT03923426 1205 1207 O
local NCT03923426 1208 1213 O
regulations NCT03923426 1214 1225 O
. NCT03923426 1226 1227 O

Exclusion NCT03923426 1229 1238 O
Criteria NCT03923426 1239 1247 O
: NCT03923426 1248 1249 O

Patients NCT03923426 1251 1259 O
must NCT03923426 1260 1264 O
not NCT03923426 1265 1268 O
meet NCT03923426 1269 1273 O
any NCT03923426 1274 1277 O
of NCT03923426 1278 1280 O
the NCT03923426 1281 1284 O
following NCT03923426 1285 1294 O
exclusion NCT03923426 1295 1304 O
criteria NCT03923426 1305 1313 O
to NCT03923426 1314 1316 O
be NCT03923426 1317 1319 O
eligible NCT03923426 1320 1328 O
: NCT03923426 1329 1330 O

1 NCT03923426 1334 1335 O
. NCT03923426 1335 1336 O
The NCT03923426 1338 1341 O
patient NCT03923426 1342 1349 O
is NCT03923426 1350 1352 O
enrolled NCT03923426 1353 1361 O
in NCT03923426 1362 1364 O
any NCT03923426 1365 1368 B-Other
clinical NCT03923426 1369 1377 B-Study
trial NCT03923426 1378 1383 I-Study
of NCT03923426 1384 1386 O
an NCT03923426 1387 1389 O
investigational NCT03923426 1390 1405 B-Drug
product NCT03923426 1406 1413 I-Drug
. NCT03923426 1414 1415 O
Patients NCT03923426 1417 1425 O
who NCT03923426 1426 1429 O
are NCT03923426 1430 1433 O
enrolled NCT03923426 1434 1442 O
in NCT03923426 1443 1445 O
non NCT03923426 1446 1449 O
- NCT03923426 1450 1451 O
interventional NCT03923426 1452 1466 O
studies NCT03923426 1467 1474 O
( NCT03923426 1475 1476 O
NISs NCT03923426 1477 1481 O
) NCT03923426 1482 1483 O
( NCT03923426 1484 1485 O
e NCT03923426 1486 1487 O
. NCT03923426 1488 1489 O
g NCT03923426 1490 1491 O
. NCT03923426 1492 1493 O
registries NCT03923426 1495 1505 O
) NCT03923426 1506 1507 O
are NCT03923426 1508 1511 O
eligible NCT03923426 1512 1520 O
for NCT03923426 1521 1524 O
inclusion NCT03923426 1525 1534 O
. NCT03923426 1535 1536 O

2 NCT03923426 1540 1541 O
. NCT03923426 1541 1542 O
The NCT03923426 1544 1547 O
patient NCT03923426 1548 1555 O
has NCT03923426 1556 1559 O
received NCT03923426 1560 1568 B-Eq_Comparison
ceftazidime NCT03923426 1569 1580 B-Drug
- NCT03923426 1581 1582 I-Drug
avibactam NCT03923426 1583 1592 I-Drug
in NCT03923426 1593 1595 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03923426 1596 1597 O
compassionate NCT03923426 1598 1611 B-Procedure
care NCT03923426 1612 1616 I-Procedure
program NCT03923426 1617 1624 I-Procedure
setting NCT03923426 1625 1632 O
. NCT03923426 1633 1634 O

3 NCT03923426 1638 1639 O
. NCT03923426 1639 1640 O
The NCT03923426 1642 1645 O
patient NCT03923426 1646 1653 O
was NCT03923426 1654 1657 O
exposed NCT03923426 1658 1665 B-Eq_Comparison
to NCT03923426 1666 1668 O
ceftazidime NCT03923426 1669 1680 B-Drug
- NCT03923426 1681 1682 I-Drug
avibactam NCT03923426 1683 1692 I-Drug
before NCT03923426 1693 1699 B-Temporal_Connection___Temporal_Connection_Type_Value:before
use NCT03923426 1700 1703 O
for NCT03923426 1704 1707 O
the NCT03923426 1708 1711 O
index NCT03923426 1712 1717 O
infection NCT03923426 1718 1727 B-Condition
. NCT03923426 1728 1729 O

Inclusion NCT03924011 0 9 O
Criteria NCT03924011 10 18 O
: NCT03924011 19 20 O

- NCT03924011 24 25 O
Informed NCT03924011 27 35 O
Consent NCT03924011 36 43 O
as NCT03924011 44 46 O
documented NCT03924011 47 57 O
by NCT03924011 58 60 O
signature NCT03924011 61 70 O

- NCT03924011 73 74 O
Diagnosis NCT03924011 76 85 O
of NCT03924011 86 88 O
non NCT03924011 89 92 B-Modifier
- NCT03924011 93 94 I-Modifier
invasive NCT03924011 95 103 I-Modifier
( NCT03924011 104 105 O
stage NCT03924011 106 111 B-Eq_Comparison
0 NCT03924011 112 113 I-Eq_Comparison
) NCT03924011 114 115 O
or NCT03924011 116 118 B-Or
invasive NCT03924011 119 127 B-Modifier
( NCT03924011 128 129 O
stage NCT03924011 130 135 B-Eq_Comparison
1 NCT03924011 136 137 I-Eq_Comparison
, NCT03924011 138 139 I-Eq_Comparison
2 NCT03924011 140 141 I-Eq_Comparison
and NCT03924011 142 145 I-Eq_Comparison
3 NCT03924011 146 147 I-Eq_Comparison
A NCT03924011 148 149 I-Eq_Comparison
) NCT03924011 150 151 O
breast NCT03924011 152 158 B-Condition
adenocarcinoma NCT03924011 159 173 I-Condition

- NCT03924011 176 177 O
Treatment NCT03924011 179 188 B-Procedure
with NCT03924011 189 193 O
primary NCT03924011 194 201 B-Modifier
breast NCT03924011 202 208 B-Procedure
- NCT03924011 209 210 I-Procedure
sparing NCT03924011 211 218 I-Procedure
surgery NCT03924011 219 226 I-Procedure
( NCT03924011 227 228 O
lumpectomy NCT03924011 229 239 B-Procedure
) NCT03924011 240 241 O
and NCT03924011 242 245 B-Or
/ NCT03924011 246 247 I-Or
or NCT03924011 248 250 I-Or
neoadjuvant NCT03924011 251 262 B-Modifier
( NCT03924011 263 264 O
pre NCT03924011 265 268 B-Modifier
operative NCT03924011 269 278 I-Modifier
) NCT03924011 279 280 O
or NCT03924011 281 283 O
adjuvant NCT03924011 284 292 B-Modifier
( NCT03924011 293 294 O
post NCT03924011 295 299 B-Modifier
operative NCT03924011 300 309 I-Modifier
) NCT03924011 310 311 O
chemotherapy NCT03924011 312 324 B-Procedure
or NCT03924011 325 327 B-Or
hormonal NCT03924011 328 336 B-Procedure
therapy NCT03924011 337 344 I-Procedure

- NCT03924011 347 348 O
Scheduled NCT03924011 350 359 B-Eq_Comparison
for NCT03924011 360 363 O
post NCT03924011 364 368 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03924011 369 378 B-Procedure
radiotherapy NCT03924011 379 391 B-Procedure
at NCT03924011 392 394 O
Ziekenhuis NCT03924011 395 405 O
Oost NCT03924011 406 410 O
- NCT03924011 411 412 O
Limburg NCT03924011 413 420 O
, NCT03924011 421 422 O
Genk NCT03924011 423 427 O
: NCT03924011 428 429 O

- NCT03924011 433 434 O
Hypofractionated NCT03924011 436 452 B-Procedure
radiotherapy NCT03924011 453 465 I-Procedure
regimen NCT03924011 466 473 O
( NCT03924011 474 475 O
i NCT03924011 476 477 O
. NCT03924011 478 479 O
e NCT03924011 480 481 O
. NCT03924011 482 483 O
16 NCT03924011 485 487 B-Eq_Comparison
daily NCT03924011 488 493 I-Eq_Comparison
fractions NCT03924011 494 503 O
of NCT03924011 504 506 O
2.66 NCT03924011 507 511 B-Procedure
Gray NCT03924011 512 516 I-Procedure
to NCT03924011 517 519 O
the NCT03924011 520 523 O
whole NCT03924011 524 529 B-Modifier
breast NCT03924011 530 536 I-Modifier
followed NCT03924011 537 545 B-Temporal_Connection___Temporal_Connection_Type_Value:before
by NCT03924011 546 548 I-Temporal_Connection___Temporal_Connection_Type_Value:before
a NCT03924011 549 550 O
boost NCT03924011 551 556 O
of NCT03924011 557 559 O
5 NCT03924011 560 561 B-Eq_Comparison
fractions NCT03924011 562 571 O
of NCT03924011 572 574 O
2.66 NCT03924011 575 579 B-Procedure
Gray NCT03924011 580 584 I-Procedure
to NCT03924011 585 587 O
the NCT03924011 588 591 O
tumor NCT03924011 592 597 B-Modifier
bed NCT03924011 598 601 I-Modifier
, NCT03924011 602 603 O
5 NCT03924011 604 605 B-Eq_Comparison
x NCT03924011 606 607 I-Eq_Comparison
/ NCT03924011 608 609 I-Eq_Comparison
week NCT03924011 610 614 I-Eq_Comparison
) NCT03924011 615 616 O

Exclusion NCT03924011 622 631 O
Criteria NCT03924011 632 640 O
: NCT03924011 641 642 O

- NCT03924011 646 647 O
Scheduled NCT03924011 649 658 B-Eq_Comparison
for NCT03924011 659 662 O
post NCT03924011 663 667 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03924011 668 677 B-Procedure
radiotherapy NCT03924011 678 690 B-Procedure
at NCT03924011 691 693 O
Jessa NCT03924011 694 699 O
Hospital NCT03924011 700 708 O
, NCT03924011 709 710 O
Hasselt NCT03924011 711 718 O
, NCT03924011 719 720 O
Belgium NCT03924011 721 728 O

- NCT03924011 731 732 O
Previous NCT03924011 734 742 B-Eq_Comparison
irradiation NCT03924011 743 754 B-Procedure
to NCT03924011 755 757 O
the NCT03924011 758 761 O
same NCT03924011 762 766 B-Modifier
breast NCT03924011 767 773 I-Modifier

- NCT03924011 776 777 O
Metastatic NCT03924011 779 789 O
disease NCT03924011 790 797 O

- NCT03924011 800 801 O
Concurrent NCT03924011 803 813 O
chemotherapy NCT03924011 814 826 B-Procedure

- NCT03924011 829 830 O
Required NCT03924011 832 840 B-Assertion___Assertion_Type_Value:hypothetical
use NCT03924011 841 844 O
of NCT03924011 845 847 O
bolus NCT03924011 848 853 B-Procedure
material NCT03924011 854 862 O
to NCT03924011 863 865 O
deliver NCT03924011 866 873 O
radiotherapy NCT03924011 874 886 B-Procedure
( NCT03924011 887 888 O
i NCT03924011 889 890 O
. NCT03924011 891 892 O
e NCT03924011 893 894 O
material NCT03924011 895 903 O
placed NCT03924011 904 910 O
on NCT03924011 911 913 O
the NCT03924011 914 917 O
to NCT03924011 918 920 O
- NCT03924011 921 922 O
be NCT03924011 923 925 O
- NCT03924011 926 927 O
irradiated NCT03924011 928 938 O
zone NCT03924011 939 943 O
to NCT03924011 944 946 O
modulate NCT03924011 947 955 O
the NCT03924011 956 959 O
delivered NCT03924011 960 969 O
dose NCT03924011 970 974 O
in NCT03924011 975 977 O
order NCT03924011 978 983 O
to NCT03924011 984 986 O
ensure NCT03924011 987 993 O
an NCT03924011 994 996 O
optimal NCT03924011 997 1004 O
distribution NCT03924011 1005 1017 O
of NCT03924011 1018 1020 O
the NCT03924011 1021 1024 O
radiation NCT03924011 1025 1034 O
dose NCT03924011 1035 1039 O
; NCT03924011 1039 1040 O
mostly NCT03924011 1041 1047 O
used NCT03924011 1048 1052 O
for NCT03924011 1053 1056 O
treatment NCT03924011 1057 1066 O
of NCT03924011 1067 1069 O
superficial NCT03924011 1070 1081 O
tumors NCT03924011 1082 1088 O
) NCT03924011 1089 1090 O

- NCT03924011 1094 1095 O
Known NCT03924011 1097 1102 O
or NCT03924011 1103 1105 O
suspected NCT03924011 1106 1115 B-Assertion___Assertion_Type_Value:possible
non NCT03924011 1116 1119 B-Condition
- NCT03924011 1120 1121 I-Condition
compliance NCT03924011 1122 1132 I-Condition
, NCT03924011 1133 1134 O
drug NCT03924011 1135 1139 B-Modifier
or NCT03924011 1140 1142 B-Or
alcohol NCT03924011 1143 1150 B-Modifier
abuse NCT03924011 1151 1156 B-Condition

- NCT03924011 1159 1160 O
Inability NCT03924011 1162 1171 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03924011 1172 1174 O
follow NCT03924011 1175 1181 O
the NCT03924011 1182 1185 O
procedures NCT03924011 1186 1196 B-Procedure
of NCT03924011 1197 1199 O
the NCT03924011 1200 1203 O
study NCT03924011 1204 1209 B-Study
, NCT03924011 1210 1211 O
e NCT03924011 1212 1213 O
. NCT03924011 1214 1215 O
g NCT03924011 1216 1217 O
. NCT03924011 1218 1219 O
due NCT03924011 1221 1224 O
to NCT03924011 1225 1227 O
language NCT03924011 1228 1236 B-Condition
problems NCT03924011 1237 1245 I-Condition
, NCT03924011 1246 1247 O
psyschological NCT03924011 1248 1262 B-Condition
disorders NCT03924011 1263 1272 I-Condition
, NCT03924011 1273 1274 O
dementia NCT03924011 1275 1283 B-Condition
, NCT03924011 1284 1285 O
etc NCT03924011 1286 1289 O
. NCT03924011 1290 1291 O
of NCT03924011 1293 1295 O
the NCT03924011 1296 1299 O
participant NCT03924011 1300 1311 O

- NCT03924011 1314 1315 O
Seizure NCT03924011 1317 1324 B-Condition

- NCT03924011 1327 1328 O
Disorders NCT03924011 1330 1339 B-Condition
triggered NCT03924011 1340 1349 O
by NCT03924011 1350 1352 O
lighttake NCT03924011 1353 1362 O
anticoagulants NCT03924011 1363 1377 B-Drug

- NCT03924011 1380 1381 O
Hemorrhagic NCT03924011 1383 1394 B-Condition
diatheses NCT03924011 1395 1404 I-Condition

- NCT03924011 1407 1408 O
Pregnancy NCT03924011 1410 1419 B-Condition

- NCT03924011 1422 1423 O
Suspected NCT03924011 1425 1434 B-Assertion___Assertion_Type_Value:possible
of NCT03924011 1435 1437 O
carrying NCT03924011 1438 1446 O
serious NCT03924011 1447 1454 O
infectious NCT03924011 1455 1465 B-Condition
disease NCT03924011 1466 1473 I-Condition

- NCT03924011 1476 1477 O
HIV NCT03924011 1479 1482 B-Condition
positive NCT03924011 1483 1491 O
history NCT03924011 1492 1499 B-Eq_Comparison


Inclusion NCT03869827 0 9 O
Criteria NCT03869827 10 18 O
: NCT03869827 19 20 O

- NCT03869827 24 25 O
All NCT03869827 27 30 O
birth NCT03869827 31 36 B-Birth
between NCT03869827 37 44 B-Eq_Comparison
24 NCT03869827 45 47 I-Eq_Comparison
+ NCT03869827 48 49 I-Eq_Comparison
0 NCT03869827 50 51 I-Eq_Comparison
weeks NCT03869827 52 57 I-Eq_Comparison
of NCT03869827 58 60 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03869827 61 71 B-Condition
and NCT03869827 72 75 B-And
36 NCT03869827 76 78 B-Eq_Comparison
+ NCT03869827 79 80 I-Eq_Comparison
6 NCT03869827 81 82 I-Eq_Comparison
weeks NCT03869827 83 88 I-Eq_Comparison
of NCT03869827 89 91 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03869827 92 102 B-Condition

- NCT03869827 105 106 O
with NCT03869827 108 112 O
isolated NCT03869827 113 121 B-Modifier
intrauterine NCT03869827 122 134 B-Condition
growth NCT03869827 135 141 I-Condition
restriction NCT03869827 142 153 I-Condition
at NCT03869827 154 156 O
the NCT03869827 157 160 O
maternity NCT03869827 161 170 O
ward NCT03869827 171 175 O
of NCT03869827 176 178 O
the NCT03869827 179 182 O
hospital NCT03869827 183 191 O
Femme NCT03869827 192 197 O
- NCT03869827 198 199 O
Mère NCT03869827 200 204 O
- NCT03869827 205 206 O
Enfant NCT03869827 207 213 O

- NCT03869827 216 217 O
from NCT03869827 219 223 O
1 NCT03869827 224 225 B-Eq_Comparison
st NCT03869827 226 228 I-Eq_Comparison
of NCT03869827 229 231 I-Eq_Comparison
january NCT03869827 232 239 I-Eq_Comparison
2011 NCT03869827 240 244 I-Eq_Comparison
to NCT03869827 245 247 I-Eq_Comparison
31 NCT03869827 248 250 I-Eq_Comparison
december NCT03869827 251 259 I-Eq_Comparison
2016 NCT03869827 260 264 I-Eq_Comparison
. NCT03869827 264 265 O

Inclusion NCT03869827 267 276 O
Criteria NCT03869827 277 285 O
for NCT03869827 286 289 O
control NCT03869827 290 297 O
group NCT03869827 298 303 O
: NCT03869827 304 305 O

- NCT03869827 309 310 O
All NCT03869827 312 315 O
birth NCT03869827 316 321 B-Birth
between NCT03869827 322 329 B-Eq_Comparison
24 NCT03869827 330 332 I-Eq_Comparison
+ NCT03869827 333 334 I-Eq_Comparison
0 NCT03869827 335 336 I-Eq_Comparison
weeks NCT03869827 337 342 I-Eq_Comparison
of NCT03869827 343 345 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03869827 346 356 B-Condition
and NCT03869827 357 360 B-And
36 NCT03869827 361 363 B-Eq_Comparison
+ NCT03869827 364 365 I-Eq_Comparison
6 NCT03869827 366 367 I-Eq_Comparison
weeks NCT03869827 368 373 I-Eq_Comparison
of NCT03869827 374 376 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03869827 377 387 B-Condition

- NCT03869827 390 391 O
without NCT03869827 393 400 B-Negation
isolated NCT03869827 401 409 B-Modifier
intrauterine NCT03869827 410 422 B-Condition
growth NCT03869827 423 429 I-Condition
restriction NCT03869827 430 441 I-Condition
at NCT03869827 442 444 O
the NCT03869827 445 448 O
maternity NCT03869827 449 458 O
ward NCT03869827 459 463 O
of NCT03869827 464 466 O
the NCT03869827 467 470 O
hospital NCT03869827 471 479 O
Femme NCT03869827 480 485 O
- NCT03869827 486 487 O
Mère NCT03869827 488 492 O
- NCT03869827 493 494 O
Enfant NCT03869827 495 501 O

- NCT03869827 504 505 O
from NCT03869827 507 511 O
1 NCT03869827 512 513 B-Eq_Comparison
st NCT03869827 514 516 I-Eq_Comparison
of NCT03869827 517 519 I-Eq_Comparison
january NCT03869827 520 527 I-Eq_Comparison
2011 NCT03869827 528 532 I-Eq_Comparison
to NCT03869827 533 535 I-Eq_Comparison
31 NCT03869827 536 538 I-Eq_Comparison
december NCT03869827 539 547 I-Eq_Comparison
2016 NCT03869827 548 552 I-Eq_Comparison
. NCT03869827 552 553 O

Exclusion NCT03869827 555 564 O
Criteria NCT03869827 565 573 O
: NCT03869827 574 575 O

- NCT03869827 579 580 O
Infants NCT03869827 582 589 O
born NCT03869827 590 594 B-Birth
out NCT03869827 595 598 B-Negation
of NCT03869827 599 601 I-Negation
the NCT03869827 602 605 O
hospital NCT03869827 606 614 O
and NCT03869827 615 618 B-And
secondarily NCT03869827 619 630 B-Encounter
hospitalized NCT03869827 631 643 I-Encounter
in NCT03869827 644 646 O
our NCT03869827 647 650 O
department NCT03869827 651 661 O

- NCT03869827 664 665 O
unaccompanied NCT03869827 667 680 B-Modifier
pregnancies NCT03869827 681 692 B-Condition

- NCT03869827 695 696 O
multiple NCT03869827 698 706 B-Eq_Comparison
pregnancies NCT03869827 707 718 B-Condition

- NCT03869827 721 722 O
children NCT03869827 724 732 O
with NCT03869827 733 737 B-And
malformations NCT03869827 738 751 B-Condition
or NCT03869827 752 754 B-Or
genetic NCT03869827 755 762 B-Condition
abnormalities NCT03869827 763 776 I-Condition
, NCT03869827 777 778 O

- NCT03869827 782 783 O
medical NCT03869827 785 792 B-Procedure
termination NCT03869827 793 804 I-Procedure
of NCT03869827 805 807 I-Procedure
pregnancy NCT03869827 808 817 I-Procedure

- NCT03869827 820 821 O
fetal NCT03869827 823 828 O
deaths NCT03869827 829 835 B-Death
in NCT03869827 836 838 B-Modifier
utero NCT03869827 839 844 I-Modifier

Inclusion NCT03864133 0 9 O
Criteria NCT03864133 10 18 O
: NCT03864133 19 20 O

- NCT03864133 24 25 O
Adults NCT03864133 27 33 O
age NCT03864133 34 37 B-Age
55 NCT03864133 38 40 B-Eq_Comparison
- NCT03864133 41 42 I-Eq_Comparison
90 NCT03864133 43 45 I-Eq_Comparison
years NCT03864133 46 51 I-Eq_Comparison
with NCT03864133 52 56 B-And
visual NCT03864133 57 63 B-Modifier
significant NCT03864133 64 75 O
cataracts NCT03864133 76 85 B-Condition
in NCT03864133 86 88 O
one NCT03864133 89 92 B-Modifier
or NCT03864133 93 95 B-Or
both NCT03864133 96 100 B-Modifier
eyes NCT03864133 101 105 I-Modifier
. NCT03864133 106 107 O

- NCT03864133 111 112 O
Healthy NCT03864133 114 121 B-Condition
individuals NCT03864133 122 133 O
able NCT03864133 134 138 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864133 139 141 I-Assertion___Assertion_Type_Value:hypothetical
tolerate NCT03864133 142 150 O
outpatient NCT03864133 151 161 B-Encounter
cataract NCT03864133 162 170 B-Procedure
surgery NCT03864133 171 178 I-Procedure
under NCT03864133 179 184 O
local NCT03864133 185 190 B-Procedure
anesthesia NCT03864133 191 201 I-Procedure
via NCT03864133 202 205 O
either NCT03864133 206 212 O
phacoemulsification NCT03864133 213 232 B-Procedure
and NCT03864133 233 236 B-Or
/ NCT03864133 237 238 I-Or
or NCT03864133 239 241 I-Or
femtosecond NCT03864133 242 253 B-Modifier
assisted NCT03864133 254 262 I-Modifier
cataract NCT03864133 263 271 B-Procedure
surgery NCT03864133 272 279 I-Procedure
. NCT03864133 280 281 O
Well NCT03864133 283 287 O
- NCT03864133 288 289 O
controlled NCT03864133 290 300 O
diabetes NCT03864133 301 309 B-Condition
, NCT03864133 310 311 O
hypertension NCT03864133 312 324 B-Condition
will NCT03864133 325 329 O
be NCT03864133 330 332 O
included NCT03864133 333 341 O
. NCT03864133 342 343 O

- NCT03864133 347 348 O
Females NCT03864133 350 357 O
of NCT03864133 358 360 O
childbearing NCT03864133 361 373 B-Condition
potential NCT03864133 374 383 B-Assertion___Assertion_Type_Value:hypothetical
must NCT03864133 384 388 O
agree NCT03864133 389 394 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864133 395 397 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03864133 398 401 O
a NCT03864133 402 403 O
reliable NCT03864133 404 412 O
method NCT03864133 413 419 O
of NCT03864133 420 422 O
birth NCT03864133 423 428 B-Procedure
control NCT03864133 429 436 I-Procedure
while NCT03864133 437 442 B-Temporal_Connection___Temporal_Connection_Type_Value:during
participating NCT03864133 443 456 O
in NCT03864133 457 459 O
this NCT03864133 460 464 O
study NCT03864133 465 470 B-Study
. NCT03864133 471 472 O
Reliable NCT03864133 474 482 O
methods NCT03864133 483 490 O
of NCT03864133 491 493 O
birth NCT03864133 494 499 B-Procedure
control NCT03864133 500 507 I-Procedure
are NCT03864133 508 511 O
: NCT03864133 512 513 O
abstinence NCT03864133 514 524 B-Condition
, NCT03864133 525 526 O
oral NCT03864133 527 531 B-Drug
contraceptives NCT03864133 532 546 I-Drug
, NCT03864133 547 548 O
intrauterine NCT03864133 549 561 B-Procedure
device NCT03864133 562 568 I-Procedure
( NCT03864133 569 570 O
IUD NCT03864133 571 574 B-Procedure
) NCT03864133 575 576 O
, NCT03864133 577 578 O
DepoProvera NCT03864133 579 590 B-Procedure
, NCT03864133 591 592 O
tubal NCT03864133 593 598 B-Procedure
ligation NCT03864133 599 607 I-Procedure
or NCT03864133 608 610 B-Or
vasectomy NCT03864133 611 620 B-Procedure
of NCT03864133 621 623 O
the NCT03864133 624 627 O
partner NCT03864133 628 635 O
( NCT03864133 636 637 O
with NCT03864133 638 642 B-And
confirmed NCT03864133 643 652 O
negative NCT03864133 653 661 O
sperm NCT03864133 662 667 B-Observation
counts NCT03864133 668 674 I-Observation
) NCT03864133 675 676 O
in NCT03864133 677 679 B-And
monogamous NCT03864133 680 690 B-Condition
relationship NCT03864133 691 703 I-Condition
( NCT03864133 704 705 O
same NCT03864133 706 710 O
partner NCT03864133 711 718 O
) NCT03864133 719 720 O
. NCT03864133 721 722 O
An NCT03864133 724 726 O
acceptable NCT03864133 727 737 O
, NCT03864133 738 739 O
although NCT03864133 740 748 O
less NCT03864133 749 753 O
reliable NCT03864133 754 762 O
, NCT03864133 763 764 O
method NCT03864133 765 771 O
involves NCT03864133 772 780 O
the NCT03864133 781 784 O
careful NCT03864133 785 792 O
use NCT03864133 793 796 O
of NCT03864133 797 799 O
condoms NCT03864133 800 807 B-Procedure
and NCT03864133 808 811 B-Or
spermicidal NCT03864133 812 823 B-Procedure
foam NCT03864133 824 828 B-Modifier
or NCT03864133 829 831 B-Or
gel NCT03864133 832 835 B-Modifier
and NCT03864133 836 839 B-Or
/ NCT03864133 840 841 I-Or
or NCT03864133 842 844 I-Or
cervical NCT03864133 845 853 B-Procedure
cap NCT03864133 854 857 B-Modifier
or NCT03864133 858 860 B-Or
sponge NCT03864133 861 867 B-Modifier
. NCT03864133 868 869 O
A NCT03864133 871 872 O
pregnancy NCT03864133 873 882 B-Observation
test NCT03864133 883 887 I-Observation
is NCT03864133 888 890 B-Assertion___Assertion_Type_Value:hypothetical
required NCT03864133 891 899 I-Assertion___Assertion_Type_Value:hypothetical
at NCT03864133 900 902 B-Eq_Comparison
least NCT03864133 903 908 I-Eq_Comparison
10 NCT03864133 909 911 I-Eq_Comparison
days NCT03864133 912 916 I-Eq_Comparison
from NCT03864133 917 921 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03864133 922 925 O
last NCT03864133 926 930 B-Eq_Comparison
normal NCT03864133 931 937 O
menstrual NCT03864133 938 947 B-Condition
period NCT03864133 948 954 I-Condition
, NCT03864133 955 956 O
if NCT03864133 957 959 O
the NCT03864133 960 963 O
patient NCT03864133 964 971 O
is NCT03864133 972 974 O
a NCT03864133 975 976 O
sexually NCT03864133 977 985 B-Condition
active NCT03864133 986 992 I-Condition
female NCT03864133 993 999 O
of NCT03864133 1000 1002 B-And
childbearing NCT03864133 1003 1015 B-Condition
potential NCT03864133 1016 1025 I-Condition
. NCT03864133 1026 1027 O

Exclusion NCT03864133 1029 1038 O
Criteria NCT03864133 1039 1047 O
: NCT03864133 1048 1049 O

- NCT03864133 1053 1054 O
Allergy NCT03864133 1056 1063 B-Allergy
to NCT03864133 1064 1066 O
Phenylephrine NCT03864133 1067 1080 B-Drug
or NCT03864133 1081 1083 B-Or
NSAIDs NCT03864133 1084 1090 B-Drug
. NCT03864133 1091 1092 O

- NCT03864133 1096 1097 O
Inability NCT03864133 1099 1108 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03864133 1109 1111 O
sit NCT03864133 1112 1115 B-Observation
steady NCT03864133 1116 1122 B-Modifier
and NCT03864133 1123 1126 B-And
upright NCT03864133 1127 1134 B-Modifier
for NCT03864133 1135 1138 O
the NCT03864133 1139 1142 O
Optical NCT03864133 1143 1150 B-Procedure
Coherence NCT03864133 1151 1160 I-Procedure
Tomography NCT03864133 1161 1171 I-Procedure
( NCT03864133 1172 1173 O
OCT NCT03864133 1174 1177 B-Procedure
) NCT03864133 1178 1179 O
. NCT03864133 1180 1181 O

- NCT03864133 1185 1186 O
Complications NCT03864133 1188 1201 B-Condition
during NCT03864133 1202 1208 B-Temporal_Connection___Temporal_Connection_Type_Value:during
surgery NCT03864133 1209 1216 B-Procedure
, NCT03864133 1217 1218 O
including NCT03864133 1219 1228 O
posterior NCT03864133 1229 1238 B-Modifier
capsular NCT03864133 1239 1247 B-Condition
rupture NCT03864133 1248 1255 I-Condition
, NCT03864133 1256 1257 O
vitreous NCT03864133 1258 1266 B-Condition
loss NCT03864133 1267 1271 I-Condition
, NCT03864133 1272 1273 O
zonular NCT03864133 1274 1281 B-Procedure
dialysis NCT03864133 1282 1290 I-Procedure
, NCT03864133 1291 1292 O
or NCT03864133 1293 1295 B-Or
iris NCT03864133 1296 1300 B-Modifier
trauma NCT03864133 1301 1307 B-Condition
. NCT03864133 1308 1309 O

- NCT03864133 1313 1314 O
Macular NCT03864133 1316 1323 B-Observation
thickness NCT03864133 1324 1333 I-Observation
above NCT03864133 1334 1339 B-Eq_Comparison
300 NCT03864133 1340 1343 I-Eq_Comparison
microns NCT03864133 1344 1351 I-Eq_Comparison
at NCT03864133 1352 1354 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03864133 1355 1363 B-Study

- NCT03864133 1366 1367 O
Currently NCT03864133 1369 1378 B-Eq_Comparison
taking NCT03864133 1379 1385 I-Eq_Comparison
a NCT03864133 1386 1387 O
prostaglandin NCT03864133 1388 1401 B-Drug
analogue NCT03864133 1402 1410 I-Drug

- NCT03864133 1413 1414 O
Presence NCT03864133 1416 1424 O
of NCT03864133 1425 1427 O
an NCT03864133 1428 1430 O
epiretinal NCT03864133 1431 1441 B-Condition
membrane NCT03864133 1442 1450 I-Condition
on NCT03864133 1451 1453 O
the NCT03864133 1454 1457 O
pre NCT03864133 1458 1461 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03864133 1462 1471 I-Temporal_Connection___Temporal_Connection_Type_Value:before
OCT NCT03864133 1472 1475 B-Procedure
. NCT03864133 1476 1477 O

- NCT03864133 1481 1482 O
Retained NCT03864133 1484 1492 B-Modifier
lens NCT03864133 1493 1497 B-Condition
fragment NCT03864133 1498 1506 I-Condition
post NCT03864133 1507 1511 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03864133 1512 1513 O
operatively NCT03864133 1514 1525 B-Procedure
. NCT03864133 1526 1527 O

- NCT03864133 1531 1532 O
Inability NCT03864133 1534 1543 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03864133 1544 1546 O
return NCT03864133 1547 1553 O
for NCT03864133 1554 1557 O
follow NCT03864133 1558 1564 O
appointments NCT03864133 1565 1577 B-Encounter

- NCT03864133 1580 1581 O
Female NCT03864133 1583 1589 O
patients NCT03864133 1590 1598 O
who NCT03864133 1599 1602 B-And
are NCT03864133 1603 1606 O
pregnant NCT03864133 1607 1615 B-Condition
, NCT03864133 1616 1617 O
lactating NCT03864133 1618 1627 B-Condition
or NCT03864133 1628 1630 B-Or
planning NCT03864133 1631 1639 B-Assertion___Assertion_Type_Value:intention
to NCT03864133 1640 1642 I-Assertion___Assertion_Type_Value:intention
become NCT03864133 1643 1649 I-Assertion___Assertion_Type_Value:intention
pregnant NCT03864133 1650 1658 B-Condition
during NCT03864133 1659 1665 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864133 1666 1669 O
course NCT03864133 1670 1676 O
of NCT03864133 1677 1679 O
treatment NCT03864133 1680 1689 B-Procedure
. NCT03864133 1690 1691 O

Inclusion NCT03860363 0 9 O
Criteria NCT03860363 10 18 O
: NCT03860363 19 20 O

- NCT03860363 24 25 O
Adult NCT03860363 27 32 O
( NCT03860363 33 34 O
age NCT03860363 35 38 B-Age
≥ NCT03860363 39 40 B-Eq_Comparison
18 NCT03860363 41 43 I-Eq_Comparison
) NCT03860363 44 45 O

- NCT03860363 49 50 O
Patient NCT03860363 52 59 O
undergoing NCT03860363 60 70 B-Eq_Comparison
non NCT03860363 71 74 B-Negation
- NCT03860363 75 76 O
emergent NCT03860363 77 85 B-Modifier
cardiac NCT03860363 86 93 B-Procedure
surgery NCT03860363 94 101 I-Procedure

- NCT03860363 104 105 O
Anticipated NCT03860363 107 118 B-Assertion___Assertion_Type_Value:possible
requirement NCT03860363 119 130 O
for NCT03860363 131 134 O
mediastinal NCT03860363 135 146 B-Procedure
chest NCT03860363 147 152 I-Procedure
tube NCT03860363 153 157 I-Procedure
drainage NCT03860363 158 166 I-Procedure

Exclusion NCT03860363 167 176 O
Criteria NCT03860363 177 185 O
: NCT03860363 186 187 O

- NCT03860363 191 192 O
Emergency NCT03860363 194 203 B-Modifier
surgery NCT03860363 204 211 B-Procedure

- NCT03860363 214 215 O
Re NCT03860363 217 219 B-Modifier
- NCT03860363 220 221 I-Modifier
do NCT03860363 222 224 I-Modifier
surgery NCT03860363 225 232 B-Procedure

- NCT03860363 235 236 O
Prior NCT03860363 238 243 B-Eq_Comparison
cardiac NCT03860363 244 251 B-Procedure
surgery NCT03860363 252 259 I-Procedure

- NCT03860363 262 263 O
Congenital NCT03860363 265 275 B-Modifier
cardiac NCT03860363 276 283 B-Condition
disease NCT03860363 284 291 I-Condition
or NCT03860363 292 294 B-Or
deformation NCT03860363 295 306 B-Condition

- NCT03860363 309 310 O
Transplant NCT03860363 312 322 B-Procedure
surgery NCT03860363 323 330 I-Procedure

- NCT03860363 333 334 O
Ventricular NCT03860363 336 347 B-Procedure
Assist NCT03860363 348 354 I-Procedure
Device NCT03860363 355 361 I-Procedure
Surgery NCT03860363 362 369 I-Procedure

- NCT03860363 372 373 O
Suspected NCT03860363 375 384 B-Assertion___Assertion_Type_Value:possible
pulmonary NCT03860363 385 394 B-Condition
air NCT03860363 395 398 I-Condition
leak NCT03860363 399 403 I-Condition

- NCT03860363 406 407 O
Atrial NCT03860363 409 415 B-Condition
fibrillation NCT03860363 416 428 I-Condition

- NCT03860363 431 432 O
In NCT03860363 434 436 O
the NCT03860363 437 440 O
opinion NCT03860363 441 448 O
of NCT03860363 449 451 O
the NCT03860363 452 455 O
investigator NCT03860363 456 468 O
the NCT03860363 469 472 O
patient NCT03860363 473 480 O
is NCT03860363 481 483 O
unsuitable NCT03860363 484 494 O
for NCT03860363 495 498 O
the NCT03860363 499 502 O
study NCT03860363 503 508 O
for NCT03860363 509 512 O
any NCT03860363 513 516 O
other NCT03860363 517 522 O
legitimate NCT03860363 523 533 O
reason NCT03860363 534 540 O
including NCT03860363 541 550 O
incarceration NCT03860363 551 564 O
, NCT03860363 565 566 O
pre NCT03860363 567 570 B-Eq_Comparison
- NCT03860363 571 572 I-Eq_Comparison
existing NCT03860363 573 581 I-Eq_Comparison
medical NCT03860363 582 589 B-Modifier
or NCT03860363 590 592 O
psychiatric NCT03860363 593 604 B-Modifier
condition NCT03860363 605 614 B-Condition
, NCT03860363 615 616 O
or NCT03860363 617 619 B-Or
interfering NCT03860363 620 631 O
medications NCT03860363 632 643 B-Drug

- NCT03860363 646 647 O
Known NCT03860363 649 654 O
previous NCT03860363 655 663 B-Eq_Comparison
or NCT03860363 664 666 B-Or
concurrent NCT03860363 667 677 B-Modifier
enrollment NCT03860363 678 688 O
in NCT03860363 689 691 O
a NCT03860363 692 693 O
clinical NCT03860363 694 702 B-Study
trial NCT03860363 703 708 I-Study
that NCT03860363 709 713 O
, NCT03860363 714 715 O
in NCT03860363 716 718 O
the NCT03860363 719 722 O
opinion NCT03860363 723 730 O
of NCT03860363 731 733 O
the NCT03860363 734 737 O
investigator NCT03860363 738 750 O
, NCT03860363 751 752 O
might NCT03860363 753 758 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03860363 759 768 O
with NCT03860363 769 773 O
the NCT03860363 774 777 O
objectives NCT03860363 778 788 O
of NCT03860363 789 791 O
this NCT03860363 792 796 O
clinical NCT03860363 797 805 B-Study
trial NCT03860363 806 811 I-Study

- NCT03860363 814 815 O
Pregnancy NCT03860363 817 826 B-Condition

Inclusion NCT03927469 0 9 O
Criteria NCT03927469 10 18 O
: NCT03927469 19 20 O

- NCT03927469 24 25 O
Being NCT03927469 27 32 O
hospitalized NCT03927469 33 45 B-Encounter
in NCT03927469 46 48 O
the NCT03927469 49 52 O
hospital NCT03927469 53 61 O
between NCT03927469 62 69 B-Eq_Comparison
January NCT03927469 70 77 I-Eq_Comparison
2015 NCT03927469 78 82 I-Eq_Comparison
and NCT03927469 83 86 I-Eq_Comparison
July NCT03927469 87 91 I-Eq_Comparison
2018 NCT03927469 92 96 I-Eq_Comparison
, NCT03927469 97 98 O
according NCT03927469 99 108 O
to NCT03927469 109 111 O
ICD NCT03927469 112 115 O
10 NCT03927469 116 118 O
code NCT03927469 119 123 O
; NCT03927469 123 124 O
hemiplegia NCT03927469 125 135 B-Condition
( NCT03927469 136 137 O
G NCT03927469 138 139 O
81 NCT03927469 140 142 O
) NCT03927469 143 144 O
, NCT03927469 145 146 O
flaccid NCT03927469 147 154 B-Condition
hemiplegia NCT03927469 155 165 I-Condition
( NCT03927469 166 167 O
G NCT03927469 168 169 O
81.0 NCT03927469 170 174 O
) NCT03927469 175 176 O
, NCT03927469 177 178 O
hemiplegia NCT03927469 179 189 B-Condition
, NCT03927469 190 191 I-Condition
unspecified NCT03927469 192 203 I-Condition
( NCT03927469 204 205 O
G NCT03927469 206 207 O
81.9 NCT03927469 208 212 O
) NCT03927469 213 214 O
, NCT03927469 215 216 O
Spastic NCT03927469 217 224 B-Condition
hemiplegia NCT03927469 225 235 I-Condition
( NCT03927469 236 237 O
G NCT03927469 238 239 O
81.1 NCT03927469 240 244 O
) NCT03927469 245 246 O

- NCT03927469 250 251 O
Being NCT03927469 253 258 O
ischemic NCT03927469 259 267 B-Modifier
or NCT03927469 268 270 B-Or
hemorrhagic NCT03927469 271 282 B-Modifier
stroke NCT03927469 283 289 B-Condition

Exclusion NCT03927469 290 299 O
Criteria NCT03927469 300 308 O
: NCT03927469 309 310 O

- NCT03927469 314 315 O
Being NCT03927469 317 322 O
hemiplegic NCT03927469 323 333 B-Condition
due NCT03927469 334 337 O
to NCT03927469 338 340 O
trauma NCT03927469 341 347 B-Condition
, NCT03927469 348 349 O
cancer NCT03927469 350 356 B-Condition
and NCT03927469 357 360 B-Or
intracranial NCT03927469 361 373 B-Procedure
operation NCT03927469 374 383 I-Procedure

Inclusion NCT03863535 0 9 O
Criteria NCT03863535 10 18 O
: NCT03863535 19 20 O

Type NCT03863535 22 26 B-Modifier
II NCT03863535 27 29 I-Modifier
diabetic NCT03863535 30 38 B-Condition
patients NCT03863535 39 47 O
, NCT03863535 48 49 O
18 NCT03863535 50 52 B-Eq_Comparison
years NCT03863535 53 58 I-Eq_Comparison
and NCT03863535 59 62 I-Eq_Comparison
older NCT03863535 63 68 I-Eq_Comparison
, NCT03863535 69 70 O
were NCT03863535 71 75 O
included NCT03863535 76 84 O
if NCT03863535 85 87 O
the NCT03863535 88 91 O
participants NCT03863535 92 104 O
had NCT03863535 105 108 O
: NCT03863535 109 110 O

1 NCT03863535 114 115 O
. NCT03863535 115 116 O
severe NCT03863535 118 124 O
non NCT03863535 125 128 B-Negation
- NCT03863535 129 130 O
PDR NCT03863535 131 134 B-Condition
in NCT03863535 135 137 O
either NCT03863535 138 144 B-Modifier
eyes NCT03863535 145 149 I-Modifier
with NCT03863535 150 154 B-And
/ NCT03863535 155 156 B-Or
without NCT03863535 157 164 B-Negation
diabetic NCT03863535 165 173 B-Condition
macular NCT03863535 174 181 I-Condition
edema NCT03863535 182 187 I-Condition
; NCT03863535 187 188 O

2 NCT03863535 191 192 O
. NCT03863535 192 193 O
ETDRS NCT03863535 195 200 B-Modifier
letters NCT03863535 201 208 I-Modifier
- NCT03863535 209 210 I-Modifier
measured NCT03863535 211 219 I-Modifier
best NCT03863535 220 224 B-Observation
- NCT03863535 225 226 I-Observation
corrected NCT03863535 227 236 I-Observation
visual NCT03863535 237 243 I-Observation
acuity NCT03863535 244 250 I-Observation
( NCT03863535 251 252 O
BCVA NCT03863535 253 257 B-Observation
) NCT03863535 258 259 O
ranging NCT03863535 260 267 O
from NCT03863535 268 272 O
20 NCT03863535 273 275 B-Eq_Comparison
/ NCT03863535 276 277 I-Eq_Comparison
40 NCT03863535 278 280 I-Eq_Comparison
to NCT03863535 281 283 I-Eq_Comparison
20 NCT03863535 284 286 I-Eq_Comparison
/ NCT03863535 287 288 I-Eq_Comparison
320 NCT03863535 289 292 I-Eq_Comparison
Snellen NCT03863535 293 300 B-Modifier
equivalent NCT03863535 301 311 I-Modifier
; NCT03863535 311 312 O

3 NCT03863535 320 321 O
. NCT03863535 321 322 O
no NCT03863535 324 326 B-Negation
previous NCT03863535 327 335 B-Eq_Comparison
treatment NCT03863535 336 345 B-Procedure
( NCT03863535 346 347 O
of NCT03863535 348 350 O
any NCT03863535 351 354 O
type NCT03863535 355 359 O
) NCT03863535 360 361 O
in NCT03863535 362 364 O
either NCT03863535 365 371 B-Modifier
eye NCT03863535 372 375 I-Modifier
. NCT03863535 376 377 O

Exclusion NCT03863535 379 388 O
Criteria NCT03863535 389 397 O
: NCT03863535 398 399 O

1 NCT03863535 403 404 O
. NCT03863535 404 405 O
history NCT03863535 407 414 B-Eq_Comparison
of NCT03863535 415 417 I-Eq_Comparison
prior NCT03863535 418 423 I-Eq_Comparison
laser NCT03863535 424 429 B-Procedure
treatment NCT03863535 430 439 I-Procedure
or NCT03863535 440 442 B-Or
vitrectomy NCT03863535 443 453 B-Procedure
in NCT03863535 454 456 O
the NCT03863535 457 460 O
study NCT03863535 461 466 B-Study
eye NCT03863535 467 470 B-Modifier
; NCT03863535 470 471 O

2 NCT03863535 474 475 O
. NCT03863535 475 476 O
history NCT03863535 478 485 B-Eq_Comparison
of NCT03863535 486 488 O
thromboembolic NCT03863535 489 503 B-Condition
event NCT03863535 504 509 I-Condition
- NCT03863535 510 511 O
including NCT03863535 512 521 O
myocardial NCT03863535 522 532 B-Condition
infarction NCT03863535 533 543 I-Condition
or NCT03863535 544 546 B-Or
cerebral NCT03863535 547 555 B-Condition
vascular NCT03863535 556 564 I-Condition
accident NCT03863535 565 573 I-Condition
; NCT03863535 573 574 O

3 NCT03863535 577 578 O
. NCT03863535 578 579 O
major NCT03863535 581 586 O
surgery NCT03863535 587 594 B-Procedure
within NCT03863535 595 601 B-Eq_Comparison
the NCT03863535 602 605 I-Eq_Comparison
prior NCT03863535 606 611 I-Eq_Comparison
6 NCT03863535 612 613 I-Eq_Comparison
months NCT03863535 614 620 I-Eq_Comparison
or NCT03863535 621 623 B-Or
planned NCT03863535 624 631 B-Eq_Comparison
within NCT03863535 632 638 I-Eq_Comparison
the NCT03863535 639 642 I-Eq_Comparison
next NCT03863535 643 647 I-Eq_Comparison
28 NCT03863535 648 650 I-Eq_Comparison
days NCT03863535 651 655 I-Eq_Comparison
; NCT03863535 655 656 O

4 NCT03863535 659 660 O
. NCT03863535 660 661 O
history NCT03863535 663 670 B-Eq_Comparison
of NCT03863535 671 673 O
glaucoma NCT03863535 674 682 B-Condition
or NCT03863535 683 685 B-Or
ocular NCT03863535 686 692 B-Modifier
hypertension NCT03863535 693 705 B-Condition
; NCT03863535 705 706 O

5 NCT03863535 709 710 O
. NCT03863535 710 711 O
loss NCT03863535 713 717 B-Condition
of NCT03863535 718 720 I-Condition
vision NCT03863535 721 727 I-Condition
as NCT03863535 728 730 O
a NCT03863535 731 732 O
result NCT03863535 733 739 O
of NCT03863535 740 742 O
other NCT03863535 743 748 B-Other
causes NCT03863535 749 755 B-Condition
; NCT03863535 755 756 O

6 NCT03863535 759 760 O
. NCT03863535 760 761 O
history NCT03863535 763 770 B-Eq_Comparison
of NCT03863535 771 773 O
systemic NCT03863535 774 782 B-Modifier
corticosteroid NCT03863535 783 797 B-Procedure
therapy NCT03863535 798 805 I-Procedure
within NCT03863535 806 812 B-Eq_Comparison
the NCT03863535 813 816 I-Eq_Comparison
last NCT03863535 817 821 I-Eq_Comparison
3 NCT03863535 822 823 I-Eq_Comparison
months NCT03863535 824 830 I-Eq_Comparison
; NCT03863535 830 831 O

7 NCT03863535 834 835 O
. NCT03863535 835 836 O
severe NCT03863535 838 844 O
systemic NCT03863535 845 853 B-Modifier
disease NCT03863535 854 861 B-Condition
other NCT03863535 862 867 B-Exception
than NCT03863535 868 872 I-Exception
diabetes NCT03863535 873 881 B-Condition
mellitus NCT03863535 882 890 I-Condition
; NCT03863535 890 891 O

8 NCT03863535 894 895 O
. NCT03863535 895 896 O
known NCT03863535 898 903 O
coagulation NCT03863535 904 915 B-Condition
abnormalities NCT03863535 916 929 O
or NCT03863535 930 932 B-Or
current NCT03863535 933 940 B-Eq_Comparison
use NCT03863535 941 944 O
of NCT03863535 945 947 O
anticoagulative NCT03863535 948 963 B-Drug
medication NCT03863535 964 974 I-Drug
other NCT03863535 975 980 B-Exception
than NCT03863535 981 985 I-Exception
aspirin NCT03863535 986 993 B-Drug

9 NCT03863535 996 997 O
. NCT03863535 997 998 O
any NCT03863535 1000 1003 O
condition NCT03863535 1004 1013 B-Condition
that NCT03863535 1014 1018 O
could NCT03863535 1019 1024 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03863535 1025 1031 O
followup NCT03863535 1032 1040 B-Encounter
or NCT03863535 1041 1043 B-Or
documentation NCT03863535 1044 1057 B-Observation
( NCT03863535 1058 1059 O
including NCT03863535 1060 1069 O
preretinal NCT03863535 1070 1080 B-Modifier
or NCT03863535 1081 1083 B-Or
vitreous NCT03863535 1084 1092 B-Modifier
hemorrhage NCT03863535 1093 1103 B-Condition
) NCT03863535 1104 1105 O
. NCT03863535 1106 1107 O


Inclusion NCT03929679 0 9 O
Criteria NCT03929679 10 18 O
: NCT03929679 19 20 O

- NCT03929679 24 25 O
Signed NCT03929679 27 33 O
informed NCT03929679 34 42 O
consent NCT03929679 43 50 O
obtained NCT03929679 51 59 O
before NCT03929679 60 66 O
any NCT03929679 67 70 O
study NCT03929679 71 76 O
- NCT03929679 77 78 O
related NCT03929679 79 86 O
activities NCT03929679 87 97 O
( NCT03929679 98 99 O
study NCT03929679 100 105 O
- NCT03929679 106 107 O
related NCT03929679 108 115 O
activities NCT03929679 116 126 O
are NCT03929679 127 130 O
any NCT03929679 131 134 O
procedures NCT03929679 135 145 O
related NCT03929679 146 153 O
to NCT03929679 154 156 O
recording NCT03929679 157 166 O
of NCT03929679 167 169 O
data NCT03929679 170 174 O
according NCT03929679 175 184 O
to NCT03929679 185 187 O
protocol NCT03929679 188 196 O
) NCT03929679 197 198 O

- NCT03929679 202 203 O
The NCT03929679 205 208 O
decision NCT03929679 209 217 O
to NCT03929679 218 220 O
initiate NCT03929679 221 229 O
treatment NCT03929679 230 239 O
with NCT03929679 240 244 O
commercially NCT03929679 245 257 O
available NCT03929679 258 267 O
semaglutide NCT03929679 268 279 O
has NCT03929679 280 283 O
been NCT03929679 284 288 O
made NCT03929679 289 293 O
by NCT03929679 294 296 O
the NCT03929679 297 300 O
patient NCT03929679 301 308 O
/ NCT03929679 309 310 O
Legally NCT03929679 311 318 O
Acceptable NCT03929679 319 329 O
Representative NCT03929679 330 344 O
and NCT03929679 345 348 O
the NCT03929679 349 352 O
treating NCT03929679 353 361 O
physician NCT03929679 362 371 O
before NCT03929679 372 378 O
and NCT03929679 379 382 O
independently NCT03929679 383 396 O
from NCT03929679 397 401 O
the NCT03929679 402 405 O
decision NCT03929679 406 414 O
to NCT03929679 415 417 O
include NCT03929679 418 425 O
the NCT03929679 426 429 O
patient NCT03929679 430 437 O
in NCT03929679 438 440 O
this NCT03929679 441 445 O
study NCT03929679 446 451 O

- NCT03929679 454 455 O
Male NCT03929679 457 461 O
or NCT03929679 462 464 B-Or
female NCT03929679 465 471 O
, NCT03929679 472 473 O
age NCT03929679 474 477 B-Age
greater NCT03929679 478 485 B-Eq_Comparison
than NCT03929679 486 490 I-Eq_Comparison
or NCT03929679 491 493 I-Eq_Comparison
equal NCT03929679 494 499 I-Eq_Comparison
to NCT03929679 500 502 I-Eq_Comparison
18 NCT03929679 503 505 I-Eq_Comparison
years NCT03929679 506 511 I-Eq_Comparison
at NCT03929679 512 514 O
the NCT03929679 515 518 O
time NCT03929679 519 523 O
of NCT03929679 524 526 O
signing NCT03929679 527 534 O
informed NCT03929679 535 543 O
consent NCT03929679 544 551 O

- NCT03929679 554 555 O
Diagnosed NCT03929679 557 566 O
with NCT03929679 567 571 O
type NCT03929679 572 576 B-Modifier
2 NCT03929679 577 578 I-Modifier
diabetes NCT03929679 579 587 B-Condition
at NCT03929679 588 590 B-Eq_Comparison
least NCT03929679 591 596 I-Eq_Comparison
12 NCT03929679 597 599 I-Eq_Comparison
weeks NCT03929679 600 605 I-Eq_Comparison
prior NCT03929679 606 611 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03929679 612 614 I-Temporal_Connection___Temporal_Connection_Type_Value:before
inclusion NCT03929679 615 624 B-Study

- NCT03929679 627 628 O
Available NCT03929679 630 639 O
and NCT03929679 640 643 O
documented NCT03929679 644 654 O
haemoglobin NCT03929679 655 666 B-Observation
A NCT03929679 667 668 I-Observation
1c NCT03929679 669 671 I-Observation
( NCT03929679 672 673 O
HbA NCT03929679 674 677 B-Observation
1c NCT03929679 678 680 I-Observation
) NCT03929679 681 682 O
value NCT03929679 683 688 O
less NCT03929679 689 693 B-Eq_Comparison
than NCT03929679 694 698 I-Eq_Comparison
or NCT03929679 699 701 I-Eq_Comparison
equal NCT03929679 702 707 I-Eq_Comparison
to NCT03929679 708 710 I-Eq_Comparison
12 NCT03929679 711 713 I-Eq_Comparison
weeks NCT03929679 714 719 I-Eq_Comparison
prior NCT03929679 720 725 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03929679 726 728 I-Temporal_Connection___Temporal_Connection_Type_Value:before
initiation NCT03929679 729 739 B-Eq_Comparison
of NCT03929679 740 742 O
semaglutide NCT03929679 743 754 B-Drug
treatment NCT03929679 755 764 B-Procedure

Exclusion NCT03929679 765 774 O
Criteria NCT03929679 775 783 O
: NCT03929679 784 785 O

- NCT03929679 789 790 O
Previous NCT03929679 792 800 B-Eq_Comparison
participation NCT03929679 801 814 O
in NCT03929679 815 817 O
this NCT03929679 818 822 O
study NCT03929679 823 828 B-Study
. NCT03929679 829 830 O
Participation NCT03929679 832 845 O
is NCT03929679 846 848 O
defined NCT03929679 849 856 O
as NCT03929679 857 859 O
having NCT03929679 860 866 O
given NCT03929679 867 872 O
informed NCT03929679 873 881 O
consent NCT03929679 882 889 O
in NCT03929679 890 892 O
this NCT03929679 893 897 O
study NCT03929679 898 903 O

- NCT03929679 906 907 O
Mental NCT03929679 909 915 B-Condition
incapacity NCT03929679 916 926 I-Condition
, NCT03929679 927 928 O
unwillingness NCT03929679 929 942 O
or NCT03929679 943 945 B-Or
language NCT03929679 946 954 B-Condition
barriers NCT03929679 955 963 I-Condition
precluding NCT03929679 964 974 O
adequate NCT03929679 975 983 O
understanding NCT03929679 984 997 O
or NCT03929679 998 1000 O
cooperation NCT03929679 1001 1012 O

- NCT03929679 1015 1016 O
Treatment NCT03929679 1018 1027 B-Procedure
with NCT03929679 1028 1032 O
any NCT03929679 1033 1036 O
investigational NCT03929679 1037 1052 B-Study
drug NCT03929679 1053 1057 B-Drug
within NCT03929679 1058 1064 B-Eq_Comparison
90 NCT03929679 1065 1067 I-Eq_Comparison
days NCT03929679 1068 1072 I-Eq_Comparison
prior NCT03929679 1073 1078 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03929679 1079 1081 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03929679 1082 1091 O
into NCT03929679 1092 1096 O
the NCT03929679 1097 1100 O
study NCT03929679 1101 1106 B-Study

- NCT03929679 1109 1110 O
Hypersensitivity NCT03929679 1112 1128 B-Condition
to NCT03929679 1129 1131 O
semaglutide NCT03929679 1132 1143 B-Drug
or NCT03929679 1144 1146 O
to NCT03929679 1147 1149 O
any NCT03929679 1150 1153 O
of NCT03929679 1154 1156 O
the NCT03929679 1157 1160 O
excipients NCT03929679 1161 1171 O

Inclusion NCT03865498 0 9 O
Criteria NCT03865498 10 18 O
: NCT03865498 19 20 O

- NCT03865498 24 25 O
18 NCT03865498 27 29 B-Eq_Comparison
years NCT03865498 30 35 I-Eq_Comparison
of NCT03865498 36 38 I-Eq_Comparison
age NCT03865498 39 42 I-Eq_Comparison
or NCT03865498 43 45 I-Eq_Comparison
older NCT03865498 46 51 I-Eq_Comparison

- NCT03865498 54 55 O
Black NCT03865498 57 62 O
or NCT03865498 63 65 B-Or
Hispanic NCT03865498 66 74 O
, NCT03865498 75 76 O
living NCT03865498 77 83 O
in NCT03865498 84 86 O
the NCT03865498 87 90 O
U NCT03865498 91 92 O
. NCT03865498 93 94 O
S NCT03865498 95 96 O
. NCT03865498 97 98 O
including NCT03865498 100 109 O
the NCT03865498 110 113 O
U NCT03865498 114 115 O
. NCT03865498 116 117 O
S NCT03865498 118 119 O
. NCT03865498 120 121 O
territories NCT03865498 123 134 O

- NCT03865498 137 138 O
a NCT03865498 140 141 O
dementia NCT03865498 142 150 B-Condition
caregiver NCT03865498 151 160 B-Family_Member___Family_Member_Type:parent
with NCT03865498 161 165 O
any NCT03865498 166 169 O
duration NCT03865498 170 178 O
, NCT03865498 179 180 O
able NCT03865498 181 185 O
to NCT03865498 186 188 O
speak NCT03865498 189 194 O
English NCT03865498 195 202 O
or NCT03865498 203 205 B-Or
Spanish NCT03865498 206 213 O
/ NCT03865498 214 215 O
bilingual NCT03865498 216 225 O

- NCT03865498 228 229 O
must NCT03865498 231 235 O
agree NCT03865498 236 241 O
to NCT03865498 242 244 O
terms NCT03865498 245 250 O
of NCT03865498 251 253 O
conditions NCT03865498 254 264 O
of NCT03865498 265 267 O
use NCT03865498 268 271 O
and NCT03865498 272 275 O
privacy NCT03865498 276 283 O
policy NCT03865498 284 290 O
and NCT03865498 291 294 O
rules NCT03865498 295 300 O
of NCT03865498 301 303 O
one NCT03865498 304 307 O
of NCT03865498 308 310 O
the NCT03865498 311 314 O
two NCT03865498 315 318 O
dementia NCT03865498 319 327 O
caregiver NCT03865498 328 337 O
network NCT03865498 338 345 O
( NCT03865498 346 347 O
Hispanic NCT03865498 348 356 O
@dcnh NCT03865498 357 362 O
, NCT03865498 363 364 O
Black NCT03865498 365 370 O
@dcnaab NCT03865498 371 378 O
) NCT03865498 379 380 O
, NCT03865498 381 382 O
the NCT03865498 383 386 O
Twitter NCT03865498 387 394 O
user NCT03865498 395 399 O
agreement NCT03865498 400 409 O
of NCT03865498 410 412 O
the NCT03865498 413 416 O
terms NCT03865498 417 422 O
of NCT03865498 423 425 O
service NCT03865498 426 433 O
, NCT03865498 434 435 O
Twitter NCT03865498 436 443 O
privacy NCT03865498 444 451 O
policy NCT03865498 452 458 O
and NCT03865498 459 462 O
Twitter NCT03865498 463 470 O
rules NCT03865498 471 476 O
including NCT03865498 477 486 O
intellectual NCT03865498 487 499 O
property NCT03865498 500 508 O
, NCT03865498 509 510 O
violence NCT03865498 511 519 B-Condition
, NCT03865498 520 521 O
misconduct NCT03865498 522 532 B-Condition
, NCT03865498 533 534 O
abuse NCT03865498 535 540 B-Condition
behavior NCT03865498 541 549 I-Condition
, NCT03865498 550 551 O
private NCT03865498 552 559 O
information NCT03865498 560 571 O
and NCT03865498 572 575 O
spam NCT03865498 576 580 O
and NCT03865498 581 584 O
security NCT03865498 585 593 O

- NCT03865498 596 597 O
use NCT03865498 599 602 O
a NCT03865498 603 604 O
smartphone NCT03865498 605 615 O
or NCT03865498 616 618 O
a NCT03865498 619 620 O
feature NCT03865498 621 628 O
phone NCT03865498 629 634 O
( NCT03865498 635 636 O
i NCT03865498 637 638 O
. NCT03865498 639 640 O
e NCT03865498 641 642 O
. NCT03865498 643 644 O
, NCT03865498 645 646 O
a NCT03865498 647 648 O
cell NCT03865498 649 653 O
phone NCT03865498 654 659 O
with NCT03865498 660 664 O
text NCT03865498 665 669 O
messaging NCT03865498 670 679 O
) NCT03865498 680 681 O

Exclusion NCT03865498 683 692 O
Criteria NCT03865498 693 701 O
: NCT03865498 702 703 O

- NCT03865498 707 708 O
do NCT03865498 710 712 O
not NCT03865498 713 716 O
have NCT03865498 717 721 O
de NCT03865498 722 724 O
- NCT03865498 725 726 O
identified NCT03865498 727 737 O
Twitter NCT03865498 738 745 O
account NCT03865498 746 753 O
, NCT03865498 754 755 O
children NCT03865498 756 764 O
, NCT03865498 765 766 O
not NCT03865498 767 770 B-Negation
a NCT03865498 771 772 O
dementia NCT03865498 773 781 B-Condition
family NCT03865498 782 788 B-Family_Member___Family_Member_Type:parent
caregiver NCT03865498 789 798 I-Family_Member___Family_Member_Type:parent

Inclusion NCT03869281 0 9 O
Criteria NCT03869281 10 18 O
( NCT03869281 19 20 O
PTA NCT03869281 21 24 O
group NCT03869281 25 30 O
) NCT03869281 31 32 O

- NCT03869281 36 37 O
T NCT03869281 39 40 B-Condition
1D NCT03869281 41 43 I-Condition
patients NCT03869281 44 52 O
who NCT03869281 53 56 B-And
received NCT03869281 57 65 B-Eq_Comparison
their NCT03869281 66 71 O
first NCT03869281 72 77 B-Eq_Comparison
PTA NCT03869281 78 81 B-Procedure
, NCT03869281 82 83 O
or NCT03869281 84 86 B-Or
second NCT03869281 87 93 B-Eq_Comparison
PTA NCT03869281 94 97 B-Procedure
only NCT03869281 98 102 B-And
if NCT03869281 103 105 I-And
their NCT03869281 106 111 O
first NCT03869281 112 117 B-Eq_Comparison
graft NCT03869281 118 123 B-Procedure
was NCT03869281 124 127 O
explanted NCT03869281 128 137 O
within NCT03869281 138 144 B-Eq_Comparison
a NCT03869281 145 146 I-Eq_Comparison
week NCT03869281 147 151 I-Eq_Comparison
, NCT03869281 152 153 O
between NCT03869281 154 161 B-Eq_Comparison
2 NCT03869281 162 163 I-Eq_Comparison
January NCT03869281 164 171 I-Eq_Comparison
2005 NCT03869281 172 176 I-Eq_Comparison
and NCT03869281 177 180 I-Eq_Comparison
31 NCT03869281 181 183 I-Eq_Comparison
December NCT03869281 184 192 I-Eq_Comparison
2017 NCT03869281 193 197 I-Eq_Comparison

- NCT03869281 201 202 O
age NCT03869281 204 207 B-Age
≥ NCT03869281 208 209 B-Eq_Comparison
18 NCT03869281 210 212 I-Eq_Comparison
and NCT03869281 213 216 B-And
< NCT03869281 217 218 B-Eq_Comparison
65 NCT03869281 219 221 I-Eq_Comparison
years NCT03869281 222 227 I-Eq_Comparison

- NCT03869281 230 231 O
willingness NCT03869281 233 244 O
to NCT03869281 245 247 O
participate NCT03869281 248 259 O
in NCT03869281 260 262 O
this NCT03869281 263 267 O
observational NCT03869281 268 281 O
study NCT03869281 282 287 O

Inclusion NCT03869281 288 297 O
Criteria NCT03869281 298 306 O
( NCT03869281 307 308 O
control NCT03869281 309 316 O
group NCT03869281 317 322 O
) NCT03869281 323 324 O

- NCT03869281 328 329 O
Type NCT03869281 331 335 B-Modifier
1 NCT03869281 336 337 I-Modifier
diabetes NCT03869281 338 346 B-Condition

- NCT03869281 349 350 O
age NCT03869281 352 355 B-Age
≥ NCT03869281 356 357 B-Eq_Comparison
18 NCT03869281 358 360 I-Eq_Comparison
years NCT03869281 361 366 I-Eq_Comparison
and NCT03869281 367 370 B-And
< NCT03869281 371 372 B-Eq_Comparison
65 NCT03869281 373 375 I-Eq_Comparison
years NCT03869281 376 381 I-Eq_Comparison

- NCT03869281 384 385 O
willingness NCT03869281 387 398 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869281 399 401 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03869281 402 413 O
in NCT03869281 414 416 O
this NCT03869281 417 421 O
observational NCT03869281 422 435 O
study NCT03869281 436 441 B-Study

- NCT03869281 444 445 O
minimum NCT03869281 447 454 O
disease NCT03869281 455 462 B-Condition
duration NCT03869281 463 471 O
of NCT03869281 472 474 O
5 NCT03869281 475 476 B-Eq_Comparison
years NCT03869281 477 482 I-Eq_Comparison

- NCT03869281 485 486 O
brittle NCT03869281 488 495 B-Condition
diabetes NCT03869281 496 504 I-Condition
, NCT03869281 505 506 O
as NCT03869281 507 509 O
defined NCT03869281 510 517 O
by NCT03869281 518 520 O
the NCT03869281 521 524 O
occurrence NCT03869281 525 535 O
of NCT03869281 536 538 O
frequent NCT03869281 539 547 B-Modifier
acute NCT03869281 548 553 O
complications NCT03869281 554 567 B-Condition
( NCT03869281 568 569 O
ketoacidosis NCT03869281 570 582 B-Condition
or NCT03869281 583 585 B-Or
severe NCT03869281 586 592 O
hypoglycaemic NCT03869281 593 606 B-Condition
episodes NCT03869281 607 615 O
requiring NCT03869281 616 625 O
third NCT03869281 626 631 B-Procedure
- NCT03869281 632 633 I-Procedure
part NCT03869281 634 638 I-Procedure
assistance NCT03869281 639 649 I-Procedure
or NCT03869281 650 652 B-Or
unawareness NCT03869281 653 664 B-Condition
despite NCT03869281 665 672 B-And
well NCT03869281 673 677 O
- NCT03869281 678 679 O
conducted NCT03869281 680 689 O
intensive NCT03869281 690 699 O
insulin NCT03869281 700 707 B-Procedure
therapy NCT03869281 708 715 I-Procedure
) NCT03869281 716 717 O

- NCT03869281 721 722 O
presence NCT03869281 724 732 O
of NCT03869281 733 735 O
at NCT03869281 736 738 B-Eq_Comparison
least NCT03869281 739 744 I-Eq_Comparison
one NCT03869281 745 748 I-Eq_Comparison
diabetes NCT03869281 749 757 B-Condition
- NCT03869281 758 759 O
related NCT03869281 760 767 O
complication NCT03869281 768 780 B-Condition
( NCT03869281 781 782 O
either NCT03869281 783 789 O
neuropathy NCT03869281 790 800 B-Condition
, NCT03869281 801 802 O
retinopathy NCT03869281 803 814 B-Condition
, NCT03869281 815 816 O
subclinical NCT03869281 817 828 B-Modifier
nephropathy NCT03869281 829 840 B-Condition
) NCT03869281 841 842 O
. NCT03869281 843 844 O

Exclusion NCT03869281 846 855 O
Criteria NCT03869281 856 864 O
( NCT03869281 865 866 O
both NCT03869281 867 871 O
groups NCT03869281 872 878 O
) NCT03869281 879 880 O

- NCT03869281 884 885 O
conditions NCT03869281 887 897 B-Condition
other NCT03869281 898 903 B-Exception
than NCT03869281 904 908 I-Exception
T NCT03869281 909 910 B-Condition
1D NCT03869281 911 913 I-Condition
known NCT03869281 914 919 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869281 920 922 I-Assertion___Assertion_Type_Value:hypothetical
affect NCT03869281 923 929 O
bone NCT03869281 930 934 B-Condition
health NCT03869281 935 941 I-Condition
( NCT03869281 942 943 O
i NCT03869281 944 945 O
. NCT03869281 946 947 O
e NCT03869281 948 949 O
. NCT03869281 950 951 O
, NCT03869281 952 953 O
non NCT03869281 954 957 B-Negation
- NCT03869281 958 959 O
compensated NCT03869281 960 971 B-Modifier
hypothyroidism NCT03869281 972 986 B-Condition
, NCT03869281 987 988 O
hyperthyroidism NCT03869281 989 1004 B-Condition
, NCT03869281 1005 1006 O
hyperparathyroidism NCT03869281 1007 1026 B-Condition
, NCT03869281 1027 1028 O
inflammatory NCT03869281 1029 1041 B-Condition
bowel NCT03869281 1042 1047 I-Condition
disease NCT03869281 1048 1055 I-Condition
, NCT03869281 1056 1057 O
malignancy NCT03869281 1058 1068 B-Condition
, NCT03869281 1069 1070 O
rheumatoid NCT03869281 1071 1081 B-Condition
arthritis NCT03869281 1082 1091 I-Condition
, NCT03869281 1092 1093 O
hypogonadism NCT03869281 1094 1106 B-Condition
, NCT03869281 1107 1108 O
severe NCT03869281 1109 1115 O
chronic NCT03869281 1116 1123 O
obstructive NCT03869281 1124 1135 B-Condition
pulmonary NCT03869281 1136 1145 I-Condition
disease NCT03869281 1146 1153 I-Condition
, NCT03869281 1154 1155 O
hepatic NCT03869281 1156 1163 B-Condition
insufficiency NCT03869281 1164 1177 I-Condition
, NCT03869281 1178 1179 O
alcohol NCT03869281 1180 1187 B-Observation
intake NCT03869281 1188 1194 I-Observation
≥ NCT03869281 1195 1196 B-Eq_Comparison
3 NCT03869281 1197 1198 I-Eq_Comparison
units NCT03869281 1199 1204 I-Eq_Comparison
/ NCT03869281 1205 1206 I-Eq_Comparison
day NCT03869281 1207 1210 I-Eq_Comparison
) NCT03869281 1211 1212 O
, NCT03869281 1213 1214 O

- NCT03869281 1218 1219 O
use NCT03869281 1221 1224 B-Eq_Comparison
of NCT03869281 1225 1227 O
drugs NCT03869281 1228 1233 B-Drug
that NCT03869281 1234 1238 O
can NCT03869281 1239 1242 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03869281 1243 1249 O
bone NCT03869281 1250 1254 B-Condition
metabolism NCT03869281 1255 1265 I-Condition
( NCT03869281 1266 1267 O
e NCT03869281 1268 1269 O
. NCT03869281 1270 1271 O
g NCT03869281 1272 1273 O
. NCT03869281 1274 1275 O
, NCT03869281 1276 1277 O
bisphosphonates NCT03869281 1278 1293 B-Drug
, NCT03869281 1294 1295 O
anticonvulsants NCT03869281 1296 1311 B-Drug
, NCT03869281 1312 1313 O
hormone NCT03869281 1314 1321 B-Procedure
replacement NCT03869281 1322 1333 I-Procedure
therapy NCT03869281 1334 1341 I-Procedure
) NCT03869281 1342 1343 O
other NCT03869281 1344 1349 B-Exception
than NCT03869281 1350 1354 I-Exception
glucocorticoids NCT03869281 1355 1370 B-Drug
and NCT03869281 1371 1374 B-Or
immunosuppressants NCT03869281 1375 1393 B-Drug

- NCT03869281 1396 1397 O
recipients NCT03869281 1399 1409 O
of NCT03869281 1410 1412 O
simultaneous NCT03869281 1413 1425 B-Modifier
pancreas NCT03869281 1426 1434 B-Procedure
kidney NCT03869281 1435 1441 I-Procedure
transplantation NCT03869281 1442 1457 I-Procedure
, NCT03869281 1458 1459 O
pancreatic NCT03869281 1460 1470 B-Procedure
islet NCT03869281 1471 1476 I-Procedure
transplantation NCT03869281 1477 1492 I-Procedure
, NCT03869281 1493 1494 O
multiple NCT03869281 1495 1503 B-Modifier
PTAs NCT03869281 1504 1508 B-Procedure
, NCT03869281 1509 1510 O
other NCT03869281 1511 1516 B-Other
transplants NCT03869281 1517 1528 B-Procedure

- NCT03869281 1531 1532 O
BMI NCT03869281 1534 1537 B-Observation
< NCT03869281 1538 1539 B-Eq_Comparison
18.5 NCT03869281 1540 1544 I-Eq_Comparison
or NCT03869281 1545 1547 B-Or
≥ NCT03869281 1548 1549 B-Eq_Comparison
30 NCT03869281 1550 1552 I-Eq_Comparison
kg NCT03869281 1553 1555 I-Eq_Comparison
/ NCT03869281 1556 1557 I-Eq_Comparison
m NCT03869281 1558 1559 I-Eq_Comparison
2 NCT03869281 1560 1561 I-Eq_Comparison

Inclusion NCT03866317 0 9 O
Criteria NCT03866317 10 18 O
: NCT03866317 19 20 O

1 NCT03866317 24 25 O
. NCT03866317 25 26 O
Male NCT03866317 28 32 O
or NCT03866317 33 35 B-Or
female NCT03866317 36 42 O
subject NCT03866317 43 50 O
18 NCT03866317 51 53 B-Eq_Comparison
years NCT03866317 54 59 I-Eq_Comparison
of NCT03866317 60 62 I-Eq_Comparison
age NCT03866317 63 66 I-Eq_Comparison
or NCT03866317 67 69 I-Eq_Comparison
older NCT03866317 70 75 I-Eq_Comparison

2 NCT03866317 78 79 O
. NCT03866317 79 80 O
Subjects NCT03866317 82 90 O
with NCT03866317 91 95 O
moderate NCT03866317 96 104 B-Eq_Comparison
to NCT03866317 105 107 I-Eq_Comparison
severe NCT03866317 108 114 I-Eq_Comparison
DLE NCT03866317 115 118 B-Condition
with NCT03866317 119 123 B-And
at NCT03866317 124 126 B-Eq_Comparison
least NCT03866317 127 132 I-Eq_Comparison
one NCT03866317 133 136 I-Eq_Comparison
active NCT03866317 137 143 B-Eq_Comparison
discoid NCT03866317 144 151 B-Modifier
target NCT03866317 152 158 I-Modifier
lesion NCT03866317 159 165 B-Observation
( NCT03866317 166 167 O
0.5 NCT03866317 168 171 B-Eq_Comparison
- NCT03866317 172 173 I-Eq_Comparison
1.0 NCT03866317 174 177 I-Eq_Comparison
cm NCT03866317 178 180 I-Eq_Comparison
2 NCT03866317 181 182 I-Eq_Comparison
) NCT03866317 183 184 O
, NCT03866317 185 186 O
with NCT03866317 187 191 B-And
CLASI NCT03866317 192 197 B-Observation
≥ NCT03866317 198 199 B-Eq_Comparison
5 NCT03866317 200 201 I-Eq_Comparison
. NCT03866317 201 202 O

3 NCT03866317 206 207 O
. NCT03866317 207 208 O
Willingness NCT03866317 210 221 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03866317 222 224 O
subject NCT03866317 225 232 O
to NCT03866317 233 235 O
follow NCT03866317 236 242 O
all NCT03866317 243 246 O
study NCT03866317 247 252 B-Study
procedures NCT03866317 253 263 B-Procedure

4 NCT03866317 266 267 O
. NCT03866317 267 268 O
Willingness NCT03866317 270 281 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03866317 282 284 I-Assertion___Assertion_Type_Value:hypothetical
avoid NCT03866317 285 290 B-Negation
excessive NCT03866317 291 300 O
exposure NCT03866317 301 309 O
of NCT03866317 310 312 O
diseased NCT03866317 313 321 B-Condition
areas NCT03866317 322 327 O
to NCT03866317 328 330 O
natural NCT03866317 331 338 B-Modifier
or NCT03866317 339 341 B-Or
artificial NCT03866317 342 352 B-Modifier
sunlight NCT03866317 353 361 I-Modifier

Exclusion NCT03866317 362 371 O
Criteria NCT03866317 372 380 O
: NCT03866317 381 382 O

1 NCT03866317 386 387 O
. NCT03866317 387 388 O
Pregnancy NCT03866317 390 399 B-Condition
or NCT03866317 400 402 B-Or
breast NCT03866317 403 409 B-Condition
feeding NCT03866317 410 417 I-Condition

2 NCT03866317 420 421 O
. NCT03866317 421 422 O
Any NCT03866317 424 427 O
condition NCT03866317 428 437 B-Condition
or NCT03866317 438 440 B-Or
therapy NCT03866317 441 448 B-Procedure
that NCT03866317 449 453 O
in NCT03866317 454 456 O
the NCT03866317 457 460 O
investigator NCT03866317 461 473 O
's NCT03866317 473 475 O
opinion NCT03866317 476 483 O
may NCT03866317 484 487 B-Assertion___Assertion_Type_Value:hypothetical
pose NCT03866317 488 492 O
a NCT03866317 493 494 O
risk NCT03866317 495 499 B-Risk
to NCT03866317 500 502 O
the NCT03866317 503 506 O
subject NCT03866317 507 514 O
or NCT03866317 515 517 B-Or
that NCT03866317 518 522 O
could NCT03866317 523 528 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03866317 529 538 O
with NCT03866317 539 543 O
any NCT03866317 544 547 O
evaluation NCT03866317 548 558 O
in NCT03866317 559 561 O
the NCT03866317 562 565 O
study NCT03866317 566 571 B-Study

3 NCT03866317 574 575 O
. NCT03866317 575 576 O
Systemic NCT03866317 578 586 B-Modifier
Lupus NCT03866317 587 592 B-Condition
Erythematosus NCT03866317 593 606 I-Condition
( NCT03866317 607 608 O
SLE NCT03866317 609 612 B-Condition
) NCT03866317 613 614 O
as NCT03866317 615 617 O
defined NCT03866317 618 625 O
by NCT03866317 626 628 O
ACR NCT03866317 629 632 O
criteria NCT03866317 633 641 O

4 NCT03866317 644 645 O
. NCT03866317 645 646 O
Known NCT03866317 648 653 O
hypersensitivity NCT03866317 654 670 B-Condition
to NCT03866317 671 673 O
any NCT03866317 674 677 O
of NCT03866317 678 680 O
the NCT03866317 681 684 O
constituents NCT03866317 685 697 O
or NCT03866317 698 700 B-Or
excipients NCT03866317 701 711 O
of NCT03866317 712 714 O
the NCT03866317 715 718 O
investigational NCT03866317 719 734 B-Study
product NCT03866317 735 742 B-Drug

5 NCT03866317 745 746 O
. NCT03866317 746 747 O
Use NCT03866317 749 752 B-Eq_Comparison
of NCT03866317 753 755 O
any NCT03866317 756 759 O
prescription NCT03866317 760 772 B-Modifier
or NCT03866317 773 775 B-Or
non NCT03866317 776 779 B-Negation
- NCT03866317 780 781 O
prescription NCT03866317 782 794 B-Modifier
medication NCT03866317 795 805 B-Drug
that NCT03866317 806 810 O
could NCT03866317 811 816 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03866317 817 826 O
with NCT03866317 827 831 O
efficacy NCT03866317 832 840 B-Procedure
evaluations NCT03866317 841 852 I-Procedure
in NCT03866317 853 855 O
the NCT03866317 856 859 O
study NCT03866317 860 865 B-Study

6 NCT03866317 868 869 O
. NCT03866317 869 870 O
Change NCT03866317 872 878 O
in NCT03866317 879 881 O
use NCT03866317 882 885 O
of NCT03866317 886 888 O
systemic NCT03866317 889 897 B-Modifier
DLE NCT03866317 898 901 B-Procedure
therapy NCT03866317 902 909 I-Procedure
, NCT03866317 910 911 O
e NCT03866317 912 913 O
. NCT03866317 914 915 O
g NCT03866317 916 917 O
. NCT03866317 918 919 O
systemic NCT03866317 921 929 B-Drug
corticosteroids NCT03866317 930 945 I-Drug
, NCT03866317 946 947 O
cyclosporine NCT03866317 948 960 B-Drug
A NCT03866317 961 962 I-Drug
, NCT03866317 963 964 O
azathioprine NCT03866317 965 977 B-Drug
, NCT03866317 978 979 O
mycophenolate NCT03866317 980 993 B-Drug
mofetil NCT03866317 994 1001 I-Drug
, NCT03866317 1002 1003 O
in NCT03866317 1004 1006 O
the NCT03866317 1007 1010 O
past NCT03866317 1011 1015 B-Eq_Comparison
1 NCT03866317 1016 1017 I-Eq_Comparison
month NCT03866317 1018 1023 I-Eq_Comparison
. NCT03866317 1024 1025 O

7 NCT03866317 1029 1030 O
. NCT03866317 1030 1031 O
Use NCT03866317 1033 1036 B-Eq_Comparison
of NCT03866317 1037 1039 O
systemic NCT03866317 1040 1048 B-Modifier
pain NCT03866317 1049 1053 B-Condition
medications NCT03866317 1054 1065 B-Drug
, NCT03866317 1066 1067 O
e NCT03866317 1068 1069 O
. NCT03866317 1070 1071 O
g NCT03866317 1072 1073 O
. NCT03866317 1074 1075 O
oxycodone NCT03866317 1077 1086 B-Drug
in NCT03866317 1087 1089 O
the NCT03866317 1090 1093 O
past NCT03866317 1094 1098 B-Eq_Comparison
2 NCT03866317 1099 1100 I-Eq_Comparison
weeks NCT03866317 1101 1106 I-Eq_Comparison

8 NCT03866317 1109 1110 O
. NCT03866317 1110 1111 O
Participation NCT03866317 1113 1126 O
in NCT03866317 1127 1129 O
another NCT03866317 1130 1137 B-Other
clinical NCT03866317 1138 1146 O
research NCT03866317 1147 1155 O
study NCT03866317 1156 1161 B-Study
with NCT03866317 1162 1166 B-And
an NCT03866317 1167 1169 O
investigational NCT03866317 1170 1185 B-Study
drug NCT03866317 1186 1190 B-Drug
within NCT03866317 1191 1197 B-Eq_Comparison
4 NCT03866317 1198 1199 I-Eq_Comparison
weeks NCT03866317 1200 1205 I-Eq_Comparison
before NCT03866317 1206 1212 B-Temporal_Connection___Temporal_Connection_Type_Value:before
this NCT03866317 1213 1217 O
study NCT03866317 1218 1223 B-Study

9 NCT03866317 1226 1227 O
. NCT03866317 1227 1228 O
Use NCT03866317 1230 1233 B-Eq_Comparison
of NCT03866317 1234 1236 O
immune NCT03866317 1237 1243 B-Drug
- NCT03866317 1244 1245 I-Drug
suppressant NCT03866317 1246 1257 I-Drug
or NCT03866317 1258 1260 B-Or
other NCT03866317 1261 1266 B-Other
biological NCT03866317 1267 1277 B-Procedure
treatment NCT03866317 1278 1287 I-Procedure

10 NCT03866317 1289 1291 O
. NCT03866317 1291 1292 O
Starting NCT03866317 1294 1302 B-Eq_Comparison
antimalarial NCT03866317 1303 1315 B-Drug
medicine NCT03866317 1316 1324 I-Drug
after NCT03866317 1325 1330 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrolling NCT03866317 1331 1340 O
in NCT03866317 1341 1343 O
the NCT03866317 1344 1347 O
study NCT03866317 1348 1353 B-Study
. NCT03866317 1354 1355 O
Subjects NCT03866317 1357 1365 O
who NCT03866317 1366 1369 O
are NCT03866317 1370 1373 O
already NCT03866317 1374 1381 B-Eq_Comparison
on NCT03866317 1382 1384 O
a NCT03866317 1385 1386 O
stable NCT03866317 1387 1393 O
dose NCT03866317 1394 1398 O
of NCT03866317 1399 1401 O
antimalarial NCT03866317 1402 1414 B-Drug
before NCT03866317 1415 1421 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03866317 1422 1432 B-Study
, NCT03866317 1433 1434 O
may NCT03866317 1435 1438 O
continue NCT03866317 1439 1447 O
the NCT03866317 1448 1451 O
same NCT03866317 1452 1456 O
dose NCT03866317 1457 1461 O
. NCT03866317 1462 1463 O

11 NCT03866317 1466 1468 O
. NCT03866317 1468 1469 O
An NCT03866317 1471 1473 O
ongoing NCT03866317 1474 1481 B-Eq_Comparison
infection NCT03866317 1482 1491 B-Condition
. NCT03866317 1492 1493 O

Inclusion NCT03924206 0 9 O
Criteria NCT03924206 10 18 O
: NCT03924206 19 20 O

- NCT03924206 23 24 O
All NCT03924206 25 28 O
surgical NCT03924206 29 37 B-Procedure
procedures NCT03924206 38 48 I-Procedure
with NCT03924206 49 53 O
a NCT03924206 54 55 O
planned NCT03924206 56 63 B-Eq_Comparison
duration NCT03924206 64 72 O
of NCT03924206 73 75 O
more NCT03924206 76 80 B-Eq_Comparison
than NCT03924206 81 85 I-Eq_Comparison
1 NCT03924206 86 87 I-Eq_Comparison
hour NCT03924206 88 92 I-Eq_Comparison

Exclusion NCT03924206 93 102 O
Criteria NCT03924206 103 111 O
: NCT03924206 112 113 O

- NCT03924206 117 118 O
Patients NCT03924206 120 128 O
with NCT03924206 129 133 O
a NCT03924206 134 135 O
contraindication NCT03924206 136 152 B-Contraindication
for NCT03924206 153 156 O
electrocautery NCT03924206 157 171 B-Procedure
use NCT03924206 172 175 O

- NCT03924206 178 179 O
Patients NCT03924206 181 189 O
with NCT03924206 190 194 O
Pacemaker NCT03924206 195 204 B-Procedure
or NCT03924206 205 207 B-Or
implantable NCT03924206 208 219 B-Procedure
cardioverter NCT03924206 220 232 I-Procedure
- NCT03924206 233 234 I-Procedure
defibrillator NCT03924206 235 248 I-Procedure
( NCT03924206 249 250 O
ICD NCT03924206 251 254 B-Procedure
) NCT03924206 255 256 O

- NCT03924206 260 261 O
Patients NCT03924206 263 271 O
with NCT03924206 272 276 O
an NCT03924206 277 279 O
implanted NCT03924206 280 289 B-Procedure
neurostimulator NCT03924206 290 305 I-Procedure
device NCT03924206 306 312 I-Procedure

Inclusion NCT03926377 0 9 O
Criteria NCT03926377 10 18 O
: NCT03926377 19 20 O

- NCT03926377 24 25 O
patients NCT03926377 27 35 O
presenting NCT03926377 36 46 O
a NCT03926377 47 48 O
multi NCT03926377 49 54 B-Modifier
- NCT03926377 55 56 I-Modifier
bullous NCT03926377 57 64 I-Modifier
pemphigoid NCT03926377 65 75 B-Condition
newly NCT03926377 76 81 O
diagnosed NCT03926377 82 91 O
or NCT03926377 92 94 O
relapsed NCT03926377 95 103 O
more NCT03926377 104 108 B-Eq_Comparison
than NCT03926377 109 113 I-Eq_Comparison
3 NCT03926377 114 115 I-Eq_Comparison
months NCT03926377 116 122 I-Eq_Comparison
after NCT03926377 123 128 B-Temporal_Connection___Temporal_Connection_Type_Value:after
stopping NCT03926377 129 137 O
corticosteroids NCT03926377 138 153 B-Drug
and NCT03926377 154 157 B-And
treated NCT03926377 158 165 B-Procedure
according NCT03926377 166 175 O
to NCT03926377 176 178 O
the NCT03926377 179 182 O
national NCT03926377 183 191 O
protocol NCT03926377 192 200 O
for NCT03926377 201 204 O
diagnosis NCT03926377 205 214 O
and NCT03926377 215 218 O
care NCT03926377 219 223 O
issued NCT03926377 224 230 O
by NCT03926377 231 233 O
the NCT03926377 234 237 O
reference NCT03926377 238 247 O
center NCT03926377 248 254 O
for NCT03926377 255 258 O
autoimmune NCT03926377 259 269 O
bullous NCT03926377 270 277 O
diseases NCT03926377 278 286 O
of NCT03926377 287 289 O
April NCT03926377 290 295 O
2016 NCT03926377 296 300 O

- NCT03926377 304 305 O
patients NCT03926377 307 315 O
having NCT03926377 316 322 O
received NCT03926377 323 331 B-Eq_Comparison
written NCT03926377 332 339 O
and NCT03926377 340 343 O
oral NCT03926377 344 348 O
information NCT03926377 349 360 O
and NCT03926377 361 364 O
signed NCT03926377 365 371 O
informed NCT03926377 372 380 O
consent NCT03926377 381 388 O

- NCT03926377 391 392 O
patients NCT03926377 394 402 O
covered NCT03926377 403 410 O
by NCT03926377 411 413 O
national NCT03926377 414 422 O
health NCT03926377 423 429 O
insurance NCT03926377 430 439 O

Exclusion NCT03926377 440 449 O
Criteria NCT03926377 450 458 O
: NCT03926377 459 460 O

- NCT03926377 464 465 O
Patients NCT03926377 467 475 O
under NCT03926377 476 481 O
tutorship NCT03926377 482 491 O
or NCT03926377 492 494 O
curatorship NCT03926377 495 506 O
or NCT03926377 507 509 O
inability NCT03926377 510 519 O
to NCT03926377 520 522 O
give NCT03926377 523 527 O
informed NCT03926377 528 536 O
consent NCT03926377 537 544 O

- NCT03926377 547 548 O
Patients NCT03926377 550 558 O
receiving NCT03926377 559 568 B-Eq_Comparison
an NCT03926377 569 571 O
anti NCT03926377 572 576 B-Drug
- NCT03926377 577 578 I-Drug
osteoporotic NCT03926377 579 591 I-Drug
treatment NCT03926377 592 601 B-Procedure

- NCT03926377 604 605 O
Patients NCT03926377 607 615 O
requiring NCT03926377 616 625 B-Assertion___Assertion_Type_Value:hypothetical
an NCT03926377 626 628 O
anti NCT03926377 629 633 B-Drug
- NCT03926377 634 635 I-Drug
osteoporotic NCT03926377 636 648 I-Drug
baseline NCT03926377 649 657 O
treatment NCT03926377 658 667 B-Procedure
( NCT03926377 668 669 O
T NCT03926377 670 671 B-Observation
- NCT03926377 672 673 I-Observation
score NCT03926377 674 679 I-Observation
⩽ NCT03926377 680 681 B-Eq_Comparison
- NCT03926377 682 683 I-Eq_Comparison
3 NCT03926377 684 685 I-Eq_Comparison
DS NCT03926377 686 688 I-Eq_Comparison
on NCT03926377 689 691 O
at NCT03926377 692 694 B-Eq_Comparison
least NCT03926377 695 700 I-Eq_Comparison
1 NCT03926377 701 702 I-Eq_Comparison
site NCT03926377 703 707 I-Eq_Comparison
or NCT03926377 708 710 B-Or
FRAX NCT03926377 711 715 B-Observation
score NCT03926377 716 721 I-Observation
above NCT03926377 722 727 B-Eq_Comparison
the NCT03926377 728 731 I-Eq_Comparison
therapeutic NCT03926377 732 743 I-Eq_Comparison
intervention NCT03926377 744 756 I-Eq_Comparison
threshold NCT03926377 757 766 I-Eq_Comparison
) NCT03926377 767 768 O

- NCT03926377 776 777 O
Patients NCT03926377 779 787 O
with NCT03926377 788 792 O
one NCT03926377 793 796 B-Eq_Comparison
or NCT03926377 797 799 I-Eq_Comparison
more NCT03926377 800 804 I-Eq_Comparison
major NCT03926377 805 810 O
risk NCT03926377 811 815 B-Risk
factors NCT03926377 816 823 O
for NCT03926377 824 827 O
osteoporosis NCT03926377 828 840 B-Condition

- NCT03926377 843 844 O
Patients NCT03926377 846 854 O
who NCT03926377 855 858 O
have NCT03926377 859 863 O
received NCT03926377 864 872 B-Eq_Comparison
topical NCT03926377 873 880 B-Drug
corticosteroids NCT03926377 881 896 I-Drug
in NCT03926377 897 899 O
less NCT03926377 900 904 B-Eq_Comparison
than NCT03926377 905 909 I-Eq_Comparison
3 NCT03926377 910 911 I-Eq_Comparison
months NCT03926377 912 918 I-Eq_Comparison


Inclusion NCT03925181 0 9 O
Criteria NCT03925181 10 18 O
for NCT03925181 19 22 O
Patients NCT03925181 23 31 O
: NCT03925181 32 33 O

- NCT03925181 37 38 O
Spent NCT03925181 40 45 B-Encounter
more NCT03925181 46 50 B-Eq_Comparison
than NCT03925181 51 55 I-Eq_Comparison
4 NCT03925181 56 57 I-Eq_Comparison
days NCT03925181 58 62 I-Eq_Comparison
in NCT03925181 63 65 O
the NCT03925181 66 69 O
ICU NCT03925181 70 73 O
, NCT03925181 74 75 O

- NCT03925181 79 80 O
Were NCT03925181 82 86 O
discharged NCT03925181 87 97 B-Encounter
into NCT03925181 98 102 O
the NCT03925181 103 106 O
community NCT03925181 107 116 O
within NCT03925181 117 123 B-Eq_Comparison
4 NCT03925181 124 125 I-Eq_Comparison
months NCT03925181 126 132 I-Eq_Comparison
of NCT03925181 133 135 B-Temporal_Connection___Temporal_Connection_Type_Value:after
transfer NCT03925181 136 144 B-Encounter
out NCT03925181 145 148 I-Encounter
of NCT03925181 149 151 I-Encounter
the NCT03925181 152 155 I-Encounter
ICU NCT03925181 156 159 I-Encounter
( NCT03925181 160 161 O
excluding NCT03925181 162 171 B-Exception
patients NCT03925181 172 180 O
who NCT03925181 181 184 O
were NCT03925181 185 189 O
in NCT03925181 190 192 O
hospital NCT03925181 193 201 B-Encounter
long NCT03925181 202 206 B-Eq_Comparison
- NCT03925181 207 208 I-Eq_Comparison
term NCT03925181 209 213 I-Eq_Comparison
) NCT03925181 214 215 O

- NCT03925181 219 220 O
Speaks NCT03925181 222 228 O
English NCT03925181 229 236 O

- NCT03925181 239 240 O
Has NCT03925181 242 245 O
a NCT03925181 246 247 O
fixed NCT03925181 248 253 O
address NCT03925181 254 261 O

- NCT03925181 264 265 O
Does NCT03925181 267 271 O
not NCT03925181 272 275 B-Negation
have NCT03925181 276 280 O
pre NCT03925181 281 284 B-Eq_Comparison
- NCT03925181 285 286 I-Eq_Comparison
existing NCT03925181 287 295 I-Eq_Comparison
psychiatric NCT03925181 296 307 B-Condition
diagnoses NCT03925181 308 317 O
documented NCT03925181 318 328 O
in NCT03925181 329 331 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03925181 332 335 O
ICU NCT03925181 336 339 O
transfer NCT03925181 340 348 B-Encounter
summary NCT03925181 349 356 O

- NCT03925181 359 360 O
Lives NCT03925181 362 367 B-Observation
within NCT03925181 368 374 O
or NCT03925181 375 377 O
surrounding NCT03925181 378 389 O
Calgary NCT03925181 390 397 O
. NCT03925181 398 399 O

Inclusion NCT03925181 401 410 O
Criteria NCT03925181 411 419 O
for NCT03925181 420 423 O
Caregivers NCT03925181 424 434 O
: NCT03925181 435 436 O

- NCT03925181 440 441 O
Caregiver NCT03925181 443 452 O
of NCT03925181 453 455 O
an NCT03925181 456 458 O
ICU NCT03925181 459 462 O
survivor NCT03925181 463 471 O
participant NCT03925181 472 483 O
meeting NCT03925181 484 491 O
criteria NCT03925181 492 500 O
above NCT03925181 501 506 O

- NCT03925181 509 510 O
Speaks NCT03925181 512 518 O
English NCT03925181 519 526 O

- NCT03925181 529 530 O
Has NCT03925181 532 535 O
a NCT03925181 536 537 O
fixed NCT03925181 538 543 O
address NCT03925181 544 551 O

- NCT03925181 554 555 O
Lives NCT03925181 557 562 B-Observation
within NCT03925181 563 569 O
or NCT03925181 570 572 O
surrounding NCT03925181 573 584 O
Calgary NCT03925181 585 592 O
. NCT03925181 593 594 O

Exclusion NCT03925181 596 605 O
Criteria NCT03925181 606 614 O
for NCT03925181 615 618 O
Patients NCT03925181 619 627 O
: NCT03925181 628 629 O

- NCT03925181 632 633 O
Long NCT03925181 634 638 B-Eq_Comparison
- NCT03925181 639 640 I-Eq_Comparison
term NCT03925181 641 645 I-Eq_Comparison
hospital NCT03925181 646 654 B-Encounter
stay NCT03925181 655 659 O

Excluding NCT03925181 660 669 O
Criteria NCT03925181 670 678 O
for NCT03925181 679 682 O
Caregivers NCT03925181 683 693 O
: NCT03925181 694 695 O

- NCT03925181 698 699 O
None NCT03925181 700 704 O

Inclusion NCT03866252 0 9 O
Criteria NCT03866252 10 18 O
: NCT03866252 19 20 O

- NCT03866252 24 25 O
Major NCT03866252 27 32 O
Depressive NCT03866252 33 43 B-Condition
Disorder NCT03866252 44 52 I-Condition
according NCT03866252 53 62 O
to NCT03866252 63 65 O
Diagnostic NCT03866252 66 76 O
and NCT03866252 77 80 O
Statistical NCT03866252 81 92 O
Manual NCT03866252 93 99 O
of NCT03866252 100 102 O
Mental NCT03866252 103 109 O
Disorders NCT03866252 110 119 O
( NCT03866252 120 121 O
DSM NCT03866252 122 125 O
- NCT03866252 126 127 O
V NCT03866252 128 129 O
) NCT03866252 130 131 O

- NCT03866252 135 136 O
> NCT03866252 138 139 B-Eq_Comparison
25 NCT03866252 140 142 I-Eq_Comparison
years NCT03866252 143 148 I-Eq_Comparison

- NCT03866252 151 152 O
Sufficient NCT03866252 154 164 O
understanding NCT03866252 165 178 O
of NCT03866252 179 181 O
the NCT03866252 182 185 O
German NCT03866252 186 192 O
language NCT03866252 193 201 O

Exclusion NCT03866252 202 211 O
Criteria NCT03866252 212 220 O
: NCT03866252 221 222 O

- NCT03866252 226 227 O
< NCT03866252 229 230 B-Eq_Comparison
25 NCT03866252 231 233 I-Eq_Comparison
years NCT03866252 234 239 I-Eq_Comparison

- NCT03866252 242 243 O
Concomitant NCT03866252 245 256 O
diagnosis NCT03866252 257 266 O
of NCT03866252 267 269 O
past NCT03866252 270 274 B-Eq_Comparison
or NCT03866252 275 277 B-Or
present NCT03866252 278 285 B-Eq_Comparison
psychotic NCT03866252 286 295 B-Condition
disorder NCT03866252 296 304 I-Condition

- NCT03866252 307 308 O
Concomitant NCT03866252 310 321 O
diagnosis NCT03866252 322 331 O
of NCT03866252 332 334 O
past NCT03866252 335 339 B-Eq_Comparison
or NCT03866252 340 342 B-Or
present NCT03866252 343 350 B-Eq_Comparison
bipolar NCT03866252 351 358 B-Condition
disorder NCT03866252 359 367 I-Condition

- NCT03866252 370 371 O
First NCT03866252 373 378 B-Family_Member
degree NCT03866252 379 385 I-Family_Member
relative NCT03866252 386 394 I-Family_Member
with NCT03866252 395 399 O
a NCT03866252 400 401 O
psychotic NCT03866252 402 411 B-Condition
disorder NCT03866252 412 420 I-Condition

- NCT03866252 423 424 O
Unable NCT03866252 426 432 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03866252 433 435 B-Or
unwilling NCT03866252 436 445 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03866252 446 448 O
discontinue NCT03866252 449 460 B-Negation
antidepressant NCT03866252 461 475 B-Drug
medication NCT03866252 476 486 I-Drug

- NCT03866252 489 490 O
Pregnancy NCT03866252 492 501 B-Condition
or NCT03866252 502 504 B-Or
breastfeeding NCT03866252 505 518 B-Condition

- NCT03866252 521 522 O
Known NCT03866252 524 529 O
hypersensitivity NCT03866252 530 546 B-Condition
to NCT03866252 547 549 O
LSD NCT03866252 550 553 B-Drug

- NCT03866252 556 557 O
Somatic NCT03866252 559 566 B-Condition
disorders NCT03866252 567 576 I-Condition
including NCT03866252 577 586 O
central NCT03866252 587 594 B-Condition
nervous NCT03866252 595 602 I-Condition
system NCT03866252 603 609 I-Condition
( NCT03866252 610 611 O
CNS NCT03866252 612 615 B-Condition
) NCT03866252 616 617 O
involvement NCT03866252 618 629 B-Modifier

- NCT03866252 632 633 O
Known NCT03866252 635 640 O
or NCT03866252 641 643 B-Or
suspected NCT03866252 644 653 B-Assertion___Assertion_Type_Value:possible
non NCT03866252 654 657 B-Negation
- NCT03866252 658 659 O
compliance NCT03866252 660 670 B-Modifier
, NCT03866252 671 672 O
drug NCT03866252 673 677 B-Modifier
or NCT03866252 678 680 B-Or
alcohol NCT03866252 681 688 B-Modifier
abuse NCT03866252 689 694 B-Condition

- NCT03866252 697 698 O
Metal NCT03866252 700 705 B-Procedure
implants NCT03866252 706 714 I-Procedure

- NCT03866252 717 718 O
Weight NCT03866252 720 726 B-Observation
< NCT03866252 727 728 B-Eq_Comparison
42 NCT03866252 729 731 I-Eq_Comparison
kg NCT03866252 732 734 I-Eq_Comparison

- NCT03866252 737 738 O
Suicide NCT03866252 740 747 B-Condition
risk NCT03866252 748 752 B-Risk
or NCT03866252 753 755 B-Or
very NCT03866252 756 760 O
likely NCT03866252 761 767 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03866252 768 770 I-Assertion___Assertion_Type_Value:hypothetical
require NCT03866252 771 778 O
psychiatric NCT03866252 779 790 B-Condition
hospitalisation NCT03866252 791 806 B-Encounter

Inclusion NCT03929289 0 9 O
Criteria NCT03929289 10 18 O
: NCT03929289 19 20 O

- NCT03929289 24 25 O
Male NCT03929289 27 31 O
or NCT03929289 32 34 B-Or
female NCT03929289 35 41 O

- NCT03929289 44 45 O
Aged NCT03929289 47 51 B-Age
18 NCT03929289 52 54 B-Eq_Comparison
to NCT03929289 55 57 I-Eq_Comparison
35 NCT03929289 58 60 I-Eq_Comparison
years NCT03929289 61 66 I-Eq_Comparison
old NCT03929289 67 70 O

- NCT03929289 73 74 O
Signed NCT03929289 76 82 O
written NCT03929289 83 90 O
informed NCT03929289 91 99 O
consent NCT03929289 100 107 O

- NCT03929289 110 111 O
Insurance NCT03929289 113 122 O
coverage NCT03929289 123 131 O

Exclusion NCT03929289 132 141 O
Criteria NCT03929289 142 150 O
: NCT03929289 151 152 O

- NCT03929289 156 157 O
Neurological NCT03929289 159 171 B-Modifier
or NCT03929289 172 174 B-Or
psychiatric NCT03929289 175 186 B-Modifier
or NCT03929289 187 189 B-Or
ophthalmological NCT03929289 190 206 B-Modifier
disorder NCT03929289 207 215 B-Condition

- NCT03929289 218 219 O
Non NCT03929289 221 224 B-Negation
- NCT03929289 225 226 O
stabilized NCT03929289 227 237 O
medical NCT03929289 238 245 B-Condition
condition NCT03929289 246 255 I-Condition

- NCT03929289 258 259 O
Ongoing NCT03929289 261 268 B-Eq_Comparison
treatment NCT03929289 269 278 B-Procedure
with NCT03929289 279 283 O
drugs NCT03929289 284 289 B-Drug
that NCT03929289 290 294 O
affect NCT03929289 295 301 O
the NCT03929289 302 305 O
central NCT03929289 306 313 B-Condition
nervous NCT03929289 314 321 I-Condition
system NCT03929289 322 328 I-Condition

- NCT03929289 336 337 O
Uncorrected NCT03929289 339 350 B-Modifier
visual NCT03929289 351 357 B-Condition
inadequacy NCT03929289 358 368 I-Condition

- NCT03929289 376 377 O
No NCT03929289 379 381 B-Negation
fluency NCT03929289 382 389 O
in NCT03929289 390 392 O
French NCT03929289 393 399 O
reading NCT03929289 400 407 O

- NCT03929289 415 416 O
Pregnant NCT03929289 418 426 B-Condition
and NCT03929289 427 430 B-Or
/ NCT03929289 431 432 I-Or
or NCT03929289 433 435 I-Or
breastfeeding NCT03929289 436 449 B-Condition
woman NCT03929289 450 455 O
, NCT03929289 456 457 O
this NCT03929289 458 462 O
exclusion NCT03929289 463 472 O
criterion NCT03929289 473 482 O
will NCT03929289 483 487 O
be NCT03929289 488 490 O
sought NCT03929289 491 497 O
by NCT03929289 498 500 O
questioning NCT03929289 501 512 O
the NCT03929289 513 516 O
subject NCT03929289 517 524 O

- NCT03929289 532 533 O
Subject NCT03929289 535 542 O
commonly NCT03929289 543 551 O
in NCT03929289 552 554 O
care NCT03929289 555 559 O
in NCT03929289 560 562 O
a NCT03929289 563 564 O
health NCT03929289 565 571 O
or NCT03929289 572 574 O
social NCT03929289 575 581 O
facility NCT03929289 582 590 O
for NCT03929289 591 594 O
purposes NCT03929289 595 603 O
other NCT03929289 604 609 O
than NCT03929289 610 614 O
that NCT03929289 615 619 O
of NCT03929289 620 622 O
research NCT03929289 623 631 O

- NCT03929289 639 640 O
Subject NCT03929289 642 649 O
under NCT03929289 650 655 B-Observation
guardianship NCT03929289 656 668 I-Observation

- NCT03929289 676 677 O
Subject NCT03929289 679 686 O
deprived NCT03929289 687 695 B-Observation
of NCT03929289 696 698 I-Observation
liberty NCT03929289 699 706 I-Observation
by NCT03929289 707 709 O
a NCT03929289 710 711 O
judicial NCT03929289 712 720 O
or NCT03929289 721 723 O
administrative NCT03929289 724 738 O
decision NCT03929289 739 747 O

- NCT03929289 755 756 O
Incompatibility NCT03929289 758 773 B-Contraindication
with NCT03929289 774 778 O
the NCT03929289 779 782 O
Magnetic NCT03929289 783 791 B-Procedure
Resonance NCT03929289 792 801 I-Procedure
Imaging NCT03929289 802 809 I-Procedure
( NCT03929289 810 811 O
MRI NCT03929289 812 815 B-Procedure
) NCT03929289 816 817 O
examination NCT03929289 818 829 O
determined NCT03929289 830 840 O
by NCT03929289 841 843 O
answering NCT03929289 844 853 O
the NCT03929289 854 857 O
following NCT03929289 858 867 O
questions NCT03929289 868 877 O
: NCT03929289 878 879 O

- NCT03929289 883 884 O
Carrier NCT03929289 886 893 O
of NCT03929289 894 896 O
a NCT03929289 897 898 O
neurological NCT03929289 899 911 B-Procedure
stimulator NCT03929289 912 922 I-Procedure
, NCT03929289 923 924 O
cardiac NCT03929289 925 932 B-Condition
( NCT03929289 933 934 O
battery NCT03929289 935 942 B-Modifier
) NCT03929289 943 944 O
or NCT03929289 945 947 B-Or
defibrillator NCT03929289 948 961 B-Procedure

- NCT03929289 964 965 O
Carrier NCT03929289 967 974 O
of NCT03929289 975 977 O
a NCT03929289 978 979 O
cardiac NCT03929289 980 987 B-Modifier
prosthesis NCT03929289 988 998 B-Procedure
( NCT03929289 999 1000 O
valve NCT03929289 1001 1006 B-Procedure
, NCT03929289 1007 1008 O
stent NCT03929289 1009 1014 B-Procedure
. NCT03929289 1015 1016 O
. NCT03929289 1017 1018 O
. NCT03929289 1019 1020 O
) NCT03929289 1021 1022 O
or NCT03929289 1023 1025 B-Or
vascular NCT03929289 1026 1034 B-Modifier

- NCT03929289 1037 1038 O
Holder NCT03929289 1040 1046 O
of NCT03929289 1047 1049 O
intracranial NCT03929289 1050 1062 B-Procedure
clips NCT03929289 1063 1068 B-Modifier
or NCT03929289 1069 1071 B-Or
clamps NCT03929289 1072 1078 B-Modifier
( NCT03929289 1079 1080 O
staples NCT03929289 1081 1088 B-Procedure
) NCT03929289 1089 1090 O

- NCT03929289 1094 1095 O
Carrier NCT03929289 1097 1104 O
of NCT03929289 1105 1107 O
a NCT03929289 1108 1109 O
cerebrospinal NCT03929289 1110 1123 B-Procedure
fluid NCT03929289 1124 1129 I-Procedure
bypass NCT03929289 1130 1136 I-Procedure

- NCT03929289 1139 1140 O
Presence NCT03929289 1142 1150 O
of NCT03929289 1151 1153 O
metal NCT03929289 1154 1159 B-Procedure
chips NCT03929289 1160 1165 I-Procedure
in NCT03929289 1166 1168 B-Modifier
the NCT03929289 1169 1172 I-Modifier
eyes NCT03929289 1173 1177 I-Modifier

- NCT03929289 1180 1181 O
Metal NCT03929289 1183 1188 B-Procedure
prosthesis NCT03929289 1189 1199 I-Procedure
carrier NCT03929289 1200 1207 O
( NCT03929289 1208 1209 O
teeth NCT03929289 1210 1215 B-Modifier
, NCT03929289 1216 1217 O
knees NCT03929289 1218 1223 B-Modifier
) NCT03929289 1224 1225 O

- NCT03929289 1229 1230 O
Pump NCT03929289 1232 1236 B-Procedure
carrier NCT03929289 1237 1244 I-Procedure
or NCT03929289 1245 1247 B-Or
infusion NCT03929289 1248 1256 B-Procedure
system NCT03929289 1257 1263 I-Procedure

- NCT03929289 1266 1267 O
Presence NCT03929289 1269 1277 O
of NCT03929289 1278 1280 O
metal NCT03929289 1281 1286 B-Procedure
tattoo NCT03929289 1287 1293 I-Procedure
near NCT03929289 1294 1298 B-Modifier
the NCT03929289 1299 1302 I-Modifier
head NCT03929289 1303 1307 I-Modifier

- NCT03929289 1310 1311 O
Presence NCT03929289 1313 1321 O
of NCT03929289 1322 1324 O
permanent NCT03929289 1325 1334 B-Procedure
makeup NCT03929289 1335 1341 I-Procedure

- NCT03929289 1344 1345 O
Claustrophobia NCT03929289 1347 1361 B-Condition
or NCT03929289 1362 1364 B-Or
respiratory NCT03929289 1365 1376 B-Condition
disorders NCT03929289 1377 1386 I-Condition

Inclusion NCT03926793 0 9 O
Criteria NCT03926793 10 18 O
: NCT03926793 19 20 O

1 NCT03926793 24 25 O
. NCT03926793 25 26 O
Adult NCT03926793 28 33 O
( NCT03926793 34 35 O
males NCT03926793 36 41 O
and NCT03926793 42 45 B-Or
females NCT03926793 46 53 O
) NCT03926793 54 55 O
aged NCT03926793 56 60 B-Age
18 NCT03926793 61 63 B-Eq_Comparison
to NCT03926793 64 66 I-Eq_Comparison
75 NCT03926793 67 69 I-Eq_Comparison
years NCT03926793 70 75 I-Eq_Comparison
( NCT03926793 76 77 O
inclusive NCT03926793 78 87 O
) NCT03926793 88 89 O
with NCT03926793 90 94 B-And
pulmonary NCT03926793 95 104 B-Condition
arterial NCT03926793 105 113 I-Condition
hypertension NCT03926793 114 126 I-Condition
( NCT03926793 127 128 O
PAH NCT03926793 129 132 B-Condition
) NCT03926793 133 134 O

2 NCT03926793 138 139 O
. NCT03926793 139 140 O
A NCT03926793 142 143 O
current NCT03926793 144 151 B-Eq_Comparison
diagnosis NCT03926793 152 161 O
of NCT03926793 162 164 O
symptomatic NCT03926793 165 176 B-Assertion___Assertion_Type_Value:possible
PAH NCT03926793 177 180 B-Condition
classified NCT03926793 181 191 O
by NCT03926793 192 194 O
one NCT03926793 195 198 B-Eq_Comparison
of NCT03926793 199 201 O
the NCT03926793 202 205 B-Criteria_Count
following NCT03926793 206 215 I-Criteria_Count
: NCT03926793 216 217 O

1 NCT03926793 226 227 O
. NCT03926793 227 228 O
Idiopathic NCT03926793 230 240 B-Condition
( NCT03926793 241 242 O
IPAH NCT03926793 243 247 B-Condition
) NCT03926793 248 249 O
or NCT03926793 250 252 B-Or
heritable NCT03926793 253 262 B-Modifier
pulmonary NCT03926793 263 272 B-Condition
arterial NCT03926793 273 281 I-Condition
hypertension NCT03926793 282 294 I-Condition
( NCT03926793 295 296 O
HPAH NCT03926793 297 301 B-Condition
) NCT03926793 302 303 O

2 NCT03926793 312 313 O
. NCT03926793 313 314 O
PAH NCT03926793 316 319 B-Condition
associated NCT03926793 320 330 O
with NCT03926793 331 335 O
one NCT03926793 336 339 B-Eq_Comparison
of NCT03926793 340 342 O
the NCT03926793 343 346 B-Criteria_Count
following NCT03926793 347 356 I-Criteria_Count
connective NCT03926793 357 367 B-Condition
tissue NCT03926793 368 374 I-Condition
diseases NCT03926793 375 383 I-Condition
( NCT03926793 384 385 O
CTDs NCT03926793 386 390 B-Condition
) NCT03926793 391 392 O
: NCT03926793 393 394 O

limited NCT03926793 406 413 B-Condition
scleroderma NCT03926793 414 425 I-Condition
, NCT03926793 426 427 O
mixed NCT03926793 428 433 B-Condition
connective NCT03926793 434 444 I-Condition
tissue NCT03926793 445 451 I-Condition
disease NCT03926793 452 459 I-Condition
or NCT03926793 460 462 B-Or
overlap NCT03926793 463 470 B-Condition
syndrome NCT03926793 471 479 I-Condition
, NCT03926793 480 481 O
or NCT03926793 482 484 B-Or
systemic NCT03926793 485 493 B-Modifier
lupus NCT03926793 494 499 B-Condition
erythematosus NCT03926793 500 513 I-Condition

3 NCT03926793 521 522 O
. NCT03926793 522 523 O
PAH NCT03926793 525 528 B-Condition
associated NCT03926793 529 539 O
with NCT03926793 540 544 O
anorexigen NCT03926793 545 555 B-Drug
or NCT03926793 556 558 B-Or
methamphetamine NCT03926793 559 574 B-Drug
use NCT03926793 575 578 O

3 NCT03926793 581 582 O
. NCT03926793 582 583 O
World NCT03926793 585 590 B-Condition
Health NCT03926793 591 597 I-Condition
Organization NCT03926793 598 610 I-Condition
( NCT03926793 611 612 O
WHO NCT03926793 613 616 B-Condition
) NCT03926793 617 618 O
/ NCT03926793 619 620 B-Or
New NCT03926793 621 624 B-Observation
York NCT03926793 625 629 I-Observation
Heart NCT03926793 630 635 I-Observation
Association NCT03926793 636 647 I-Observation
( NCT03926793 648 649 O
NYHA NCT03926793 650 654 B-Observation
) NCT03926793 655 656 O
functional NCT03926793 657 667 O
class NCT03926793 668 673 B-Eq_Comparison
II NCT03926793 674 676 I-Eq_Comparison
- NCT03926793 677 678 I-Eq_Comparison
IV NCT03926793 679 681 I-Eq_Comparison
symptomatology NCT03926793 682 696 O

Exclusion NCT03926793 697 706 O
Criteria NCT03926793 707 715 O
: NCT03926793 716 717 O

1 NCT03926793 721 722 O
. NCT03926793 722 723 O
Clinically NCT03926793 725 735 O
significant NCT03926793 736 747 O
systemic NCT03926793 748 756 B-Condition
hypertension NCT03926793 757 769 I-Condition
or NCT03926793 770 772 B-Or
hypotension NCT03926793 773 784 B-Condition

2 NCT03926793 787 788 O
. NCT03926793 788 789 O
History NCT03926793 791 798 B-Eq_Comparison
of NCT03926793 799 801 O
left NCT03926793 802 806 B-Modifier
- NCT03926793 807 808 I-Modifier
sided NCT03926793 809 814 I-Modifier
heart NCT03926793 815 820 B-Condition
disease NCT03926793 821 828 I-Condition
and NCT03926793 829 832 B-Or
/ NCT03926793 833 834 I-Or
or NCT03926793 835 837 I-Or
clinically NCT03926793 838 848 O
significant NCT03926793 849 860 O
cardiac NCT03926793 861 868 B-Condition
disease NCT03926793 869 876 I-Condition

3 NCT03926793 879 880 O
. NCT03926793 880 881 O
History NCT03926793 883 890 B-Eq_Comparison
of NCT03926793 891 893 O
decompensated NCT03926793 894 907 B-Modifier
right NCT03926793 908 913 B-Condition
heart NCT03926793 914 919 I-Condition
failure NCT03926793 920 927 I-Condition
within NCT03926793 928 934 B-Eq_Comparison
30 NCT03926793 935 937 I-Eq_Comparison
days NCT03926793 938 942 I-Eq_Comparison
of NCT03926793 943 945 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03926793 946 955 B-Study
( NCT03926793 956 957 O
e NCT03926793 958 959 O
. NCT03926793 960 961 O
g NCT03926793 962 963 O
. NCT03926793 964 965 O
, NCT03926793 966 967 O
hospitalization NCT03926793 968 983 B-Encounter
for NCT03926793 984 987 O
PAH NCT03926793 988 991 B-Condition
or NCT03926793 992 994 B-Or
the NCT03926793 995 998 O
need NCT03926793 999 1003 O
to NCT03926793 1004 1006 O
add NCT03926793 1007 1010 O
an NCT03926793 1011 1013 O
additional NCT03926793 1014 1024 B-Other
PAH NCT03926793 1025 1028 B-Condition
medication NCT03926793 1029 1039 B-Drug
) NCT03926793 1040 1041 O

Inclusion NCT03868735 0 9 O
Criteria NCT03868735 10 18 O
: NCT03868735 19 20 O

- NCT03868735 24 25 O
Orally NCT03868735 27 33 B-Modifier
intubated NCT03868735 34 43 B-Procedure
patient NCT03868735 44 51 O
with NCT03868735 52 56 O
endotracheal NCT03868735 57 69 B-Procedure
tube NCT03868735 70 74 I-Procedure

- NCT03868735 77 78 O
Mechanically NCT03868735 80 92 B-Procedure
ventilated NCT03868735 93 103 I-Procedure
less NCT03868735 104 108 B-Eq_Comparison
than NCT03868735 109 113 I-Eq_Comparison
24 NCT03868735 114 116 I-Eq_Comparison
hours NCT03868735 117 122 I-Eq_Comparison
prior NCT03868735 123 128 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03868735 129 131 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03868735 132 142 B-Study

Exclusion NCT03868735 143 152 O
Criteria NCT03868735 153 161 O
: NCT03868735 162 163 O

- NCT03868735 167 168 O
Less NCT03868735 170 174 B-Eq_Comparison
than NCT03868735 175 179 I-Eq_Comparison
18 NCT03868735 180 182 I-Eq_Comparison
years NCT03868735 183 188 I-Eq_Comparison
old NCT03868735 189 192 B-Age

- NCT03868735 195 196 O
Tracheostomy NCT03868735 198 210 B-Procedure
tube NCT03868735 211 215 I-Procedure

- NCT03868735 218 219 O
Extracorporeal NCT03868735 221 235 B-Procedure
membrane NCT03868735 236 244 I-Procedure
oxygenation NCT03868735 245 256 I-Procedure

- NCT03868735 259 260 O
Transfer NCT03868735 262 270 B-Encounter
from NCT03868735 271 275 O
outside NCT03868735 276 283 B-Other
hospital NCT03868735 284 292 O
with NCT03868735 293 297 B-Temporal_Connection___Temporal_Connection_Type_Value:during
more NCT03868735 298 302 B-Eq_Comparison
than NCT03868735 303 307 I-Eq_Comparison
24 NCT03868735 308 310 I-Eq_Comparison
hours NCT03868735 311 316 I-Eq_Comparison
of NCT03868735 317 319 O
mechanical NCT03868735 320 330 B-Procedure
ventilation NCT03868735 331 342 I-Procedure

Inclusion NCT03860974 0 9 O
Criteria NCT03860974 10 18 O
: NCT03860974 19 20 O

- NCT03860974 24 25 O
undergoing NCT03860974 27 37 B-Eq_Comparison
unilateral NCT03860974 38 48 B-Modifier
or NCT03860974 49 51 B-Or
bilateral NCT03860974 52 61 B-Modifier
breast NCT03860974 62 68 B-Procedure
surgery NCT03860974 69 76 I-Procedure
with NCT03860974 77 81 B-And
at NCT03860974 82 84 B-Eq_Comparison
least NCT03860974 85 90 I-Eq_Comparison
moderate NCT03860974 91 99 I-Eq_Comparison
post NCT03860974 100 104 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03860974 105 114 B-Procedure
pain NCT03860974 115 119 B-Observation
anticipated NCT03860974 120 131 B-Assertion___Assertion_Type_Value:hypothetical

- NCT03860974 134 135 O
analgesic NCT03860974 137 146 B-Drug
plan NCT03860974 147 151 B-Eq_Comparison
includes NCT03860974 152 160 O
a NCT03860974 161 162 O
single NCT03860974 163 169 B-Procedure
- NCT03860974 170 171 I-Procedure
injection NCT03860974 172 181 I-Procedure
peripheral NCT03860974 182 192 I-Procedure
nerve NCT03860974 193 198 I-Procedure
block NCT03860974 199 204 I-Procedure
( NCT03860974 205 206 O
s NCT03860974 207 208 O
) NCT03860974 209 210 O

- NCT03860974 214 215 O
age NCT03860974 217 220 B-Age
18 NCT03860974 221 223 B-Eq_Comparison
years NCT03860974 224 229 I-Eq_Comparison
or NCT03860974 230 232 I-Eq_Comparison
older NCT03860974 233 238 I-Eq_Comparison

Exclusion NCT03860974 239 248 O
Criteria NCT03860974 249 257 O
: NCT03860974 258 259 O

- NCT03860974 263 264 O
morbid NCT03860974 266 272 B-Condition
obesity NCT03860974 273 280 I-Condition
as NCT03860974 281 283 O
defined NCT03860974 284 291 O
by NCT03860974 292 294 O
a NCT03860974 295 296 O
body NCT03860974 297 301 B-Observation
mass NCT03860974 302 306 I-Observation
index NCT03860974 307 312 I-Observation
> NCT03860974 313 314 B-Eq_Comparison
40 NCT03860974 315 317 I-Eq_Comparison
( NCT03860974 318 319 O
BMI NCT03860974 320 323 O
= NCT03860974 324 325 O
weight NCT03860974 326 332 O
in NCT03860974 333 335 O
kg NCT03860974 336 338 O
/ NCT03860974 339 340 O
[ NCT03860974 341 342 O
height NCT03860974 343 349 O
in NCT03860974 350 352 O
meters NCT03860974 353 359 O
] NCT03860974 360 361 O
2 NCT03860974 362 363 O
) NCT03860974 364 365 O

- NCT03860974 369 370 O
renal NCT03860974 372 377 B-Condition
insufficiency NCT03860974 378 391 I-Condition
( NCT03860974 392 393 O
pre NCT03860974 394 397 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03860974 398 407 B-Procedure
creatinine NCT03860974 408 418 B-Observation
> NCT03860974 419 420 B-Eq_Comparison
1.5 NCT03860974 421 424 I-Eq_Comparison
mg NCT03860974 425 427 I-Eq_Comparison
/ NCT03860974 428 429 I-Eq_Comparison
dL NCT03860974 430 432 I-Eq_Comparison
) NCT03860974 433 434 O

- NCT03860974 438 439 O
chronic NCT03860974 441 448 O
opioid NCT03860974 449 455 B-Drug
use NCT03860974 456 459 O
( NCT03860974 460 461 O
daily NCT03860974 462 467 B-Eq_Comparison
use NCT03860974 468 471 O
within NCT03860974 472 478 B-Eq_Comparison
the NCT03860974 479 482 I-Eq_Comparison
2 NCT03860974 483 484 I-Eq_Comparison
weeks NCT03860974 485 490 I-Eq_Comparison
prior NCT03860974 491 496 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03860974 497 499 I-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03860974 500 507 B-Procedure
and NCT03860974 508 511 O
duration NCT03860974 512 520 O
of NCT03860974 521 523 O
use NCT03860974 524 527 O
> NCT03860974 528 529 B-Eq_Comparison
4 NCT03860974 530 531 I-Eq_Comparison
weeks NCT03860974 532 537 I-Eq_Comparison
) NCT03860974 538 539 O

- NCT03860974 543 544 O
history NCT03860974 546 553 B-Eq_Comparison
of NCT03860974 554 556 O
opioid NCT03860974 557 563 B-Condition
abuse NCT03860974 564 569 I-Condition

- NCT03860974 572 573 O
any NCT03860974 575 578 O
comorbidity NCT03860974 579 590 B-Condition
which NCT03860974 591 596 O
results NCT03860974 597 604 O
in NCT03860974 605 607 O
moderate NCT03860974 608 616 O
or NCT03860974 617 619 B-Or
severe NCT03860974 620 626 O
functional NCT03860974 627 637 B-Condition
limitation NCT03860974 638 648 I-Condition
inability NCT03860974 649 658 I-Condition
to NCT03860974 659 661 I-Condition
communicate NCT03860974 662 673 I-Condition
with NCT03860974 674 678 O
the NCT03860974 679 682 O
investigators NCT03860974 683 696 O
or NCT03860974 697 699 O
hospital NCT03860974 700 708 O
staff NCT03860974 709 714 O

- NCT03860974 717 718 O
pregnancy NCT03860974 720 729 B-Condition

- NCT03860974 732 733 O
planned NCT03860974 735 742 B-Eq_Comparison
regional NCT03860974 743 751 B-Drug
analgesic NCT03860974 752 761 I-Drug
with NCT03860974 762 766 B-And
perineural NCT03860974 767 777 B-Procedure
catheter NCT03860974 778 786 I-Procedure
placement NCT03860974 787 796 I-Procedure

- NCT03860974 799 800 O
incarceration NCT03860974 802 815 B-Observation


Inclusion NCT03867396 0 9 O
Criteria NCT03867396 10 18 O
* NCT03867396 19 20 O
: NCT03867396 21 22 O

- NCT03867396 26 27 O
An NCT03867396 29 31 O
Advanced NCT03867396 32 40 B-Procedure
Bionics NCT03867396 41 48 I-Procedure
cochlear NCT03867396 49 57 I-Procedure
implant NCT03867396 58 65 I-Procedure
recipient NCT03867396 66 75 O
with NCT03867396 76 80 O
at NCT03867396 81 83 B-Eq_Comparison
least NCT03867396 84 89 I-Eq_Comparison
12 NCT03867396 90 92 I-Eq_Comparison
months NCT03867396 93 99 I-Eq_Comparison
of NCT03867396 100 102 O
listening NCT03867396 103 112 O
experience NCT03867396 113 123 O

- NCT03867396 126 127 O
Low NCT03867396 129 132 B-Observation
frequency NCT03867396 133 142 I-Observation
Pure NCT03867396 143 147 I-Observation
Tone NCT03867396 148 152 I-Observation
Audiometry NCT03867396 153 163 I-Observation
( NCT03867396 164 165 O
PTA NCT03867396 166 169 B-Observation
) NCT03867396 170 171 O

Exclusion NCT03867396 173 182 O
Criteria NCT03867396 183 191 O
* NCT03867396 192 193 O
: NCT03867396 194 195 O

- NCT03867396 199 200 O
Non NCT03867396 202 205 B-Negation
- NCT03867396 206 207 O
English NCT03867396 208 215 O
speakers NCT03867396 216 224 O

- NCT03867396 232 233 O
Additional NCT03867396 235 245 O
Inclusion NCT03867396 246 255 O
and NCT03867396 256 259 O
Exclusion NCT03867396 260 269 O
criteria NCT03867396 270 278 O
apply NCT03867396 279 284 O

Inclusion NCT03928197 0 9 O
Criteria NCT03928197 10 18 O
: NCT03928197 19 20 O

- NCT03928197 24 25 O
Age NCT03928197 27 30 B-Age
between NCT03928197 31 38 B-Eq_Comparison
25 NCT03928197 39 41 I-Eq_Comparison
years NCT03928197 42 47 I-Eq_Comparison
and NCT03928197 48 51 I-Eq_Comparison
60 NCT03928197 52 54 I-Eq_Comparison
years NCT03928197 55 60 I-Eq_Comparison

- NCT03928197 63 64 O
For NCT03928197 66 69 O
the NCT03928197 70 73 O
volunteers NCT03928197 74 84 O
with NCT03928197 85 89 O
venous NCT03928197 90 96 B-Condition
insuffiency NCT03928197 97 108 I-Condition
: NCT03928197 109 110 O
clearly NCT03928197 111 118 B-Modifier
visual NCT03928197 119 125 I-Modifier
venous NCT03928197 126 132 B-Condition
insufficiency NCT03928197 133 146 I-Condition
( NCT03928197 147 148 O
CEAP NCT03928197 149 153 B-Condition
1 NCT03928197 154 155 B-Eq_Comparison
and NCT03928197 156 159 I-Eq_Comparison
2 NCT03928197 160 161 I-Eq_Comparison
) NCT03928197 162 163 O

- NCT03928197 167 168 O
BMI NCT03928197 170 173 B-Observation
between NCT03928197 174 181 B-Eq_Comparison
24 NCT03928197 182 184 I-Eq_Comparison
and NCT03928197 185 188 I-Eq_Comparison
30 NCT03928197 189 191 I-Eq_Comparison

Exclusion NCT03928197 193 202 O
Criteria NCT03928197 203 211 O
: NCT03928197 212 213 O

- NCT03928197 217 218 O
Volunteers NCT03928197 220 230 O
using NCT03928197 231 236 B-Eq_Comparison
medication NCT03928197 237 247 B-Drug
( NCT03928197 248 249 O
exception NCT03928197 250 259 B-Exception
for NCT03928197 260 263 O
contraception NCT03928197 264 277 B-Drug
) NCT03928197 278 279 O

- NCT03928197 283 284 O
Volunteers NCT03928197 286 296 O
having NCT03928197 297 303 B-Eq_Comparison
comorbidities NCT03928197 304 317 B-Condition

- NCT03928197 320 321 O
Pregnant NCT03928197 323 331 B-Condition
women NCT03928197 332 337 O

- NCT03928197 340 341 O
Women NCT03928197 343 348 O
who NCT03928197 349 352 B-And
menstruate NCT03928197 353 363 B-Condition
on NCT03928197 364 366 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928197 367 370 O
test NCT03928197 371 375 B-Study
date NCT03928197 376 380 I-Study

- NCT03928197 383 384 O
Volunteers NCT03928197 386 396 O
with NCT03928197 397 401 O
an NCT03928197 402 404 O
implanted NCT03928197 405 414 B-Procedure
elektronical NCT03928197 415 427 I-Procedure
device NCT03928197 428 434 I-Procedure
( NCT03928197 435 436 O
IPG NCT03928197 437 440 B-Procedure
, NCT03928197 441 442 O
Pacemaker NCT03928197 443 452 B-Procedure
) NCT03928197 453 454 O


Inclusion NCT03928990 0 9 O
Criteria NCT03928990 10 18 O
: NCT03928990 19 20 O

- NCT03928990 24 25 O
Patients NCT03928990 27 35 O
aged NCT03928990 36 40 B-Age
18 NCT03928990 41 43 B-Eq_Comparison
to NCT03928990 44 46 I-Eq_Comparison
80 NCT03928990 47 49 I-Eq_Comparison
years NCT03928990 50 55 I-Eq_Comparison
old NCT03928990 56 59 O

- NCT03928990 62 63 O
Multiple NCT03928990 65 73 B-Condition
sclerosis NCT03928990 74 83 I-Condition
according NCT03928990 84 93 O
to NCT03928990 94 96 O
McDonald NCT03928990 97 105 O
criteria NCT03928990 106 114 O
; NCT03928990 115 116 O

- NCT03928990 119 120 O
Expanded NCT03928990 122 130 B-Observation
Disability NCT03928990 131 141 I-Observation
Status NCT03928990 142 148 I-Observation
Scale NCT03928990 149 154 I-Observation
( NCT03928990 155 156 O
EDSS NCT03928990 157 161 B-Observation
) NCT03928990 162 163 O
between NCT03928990 164 171 B-Eq_Comparison
0 NCT03928990 172 173 I-Eq_Comparison
and NCT03928990 174 177 I-Eq_Comparison
6.5 NCT03928990 178 181 I-Eq_Comparison
; NCT03928990 182 183 O

- NCT03928990 186 187 O
Patient NCT03928990 189 196 O
able NCT03928990 197 201 B-Condition
to NCT03928990 202 204 I-Condition
move NCT03928990 205 209 I-Condition
with NCT03928990 210 214 O
or NCT03928990 215 217 O
without NCT03928990 218 225 O
mechanical NCT03928990 226 236 B-Procedure
assistance NCT03928990 237 247 I-Procedure
. NCT03928990 248 249 O

Exclusion NCT03928990 251 260 O
Criteria NCT03928990 261 269 O
: NCT03928990 270 271 O

- NCT03928990 275 276 O
Deterioration NCT03928990 278 291 O
of NCT03928990 292 294 O
neurological NCT03928990 295 307 B-Condition
symptomatology NCT03928990 308 322 I-Condition
within NCT03928990 323 329 B-Eq_Comparison
60 NCT03928990 330 332 I-Eq_Comparison
day NCT03928990 333 336 I-Eq_Comparison
before NCT03928990 337 343 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03928990 344 354 B-Study
; NCT03928990 355 356 O

- NCT03928990 359 360 O
Changes NCT03928990 362 369 O
brought NCT03928990 370 377 O
to NCT03928990 378 380 O
the NCT03928990 381 384 O
multiple NCT03928990 385 393 B-Condition
sclerosis NCT03928990 394 403 I-Condition
treatment NCT03928990 404 413 B-Procedure
within NCT03928990 414 420 B-Eq_Comparison
6 NCT03928990 421 422 I-Eq_Comparison
months NCT03928990 423 429 I-Eq_Comparison
before NCT03928990 430 436 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03928990 437 447 B-Study
; NCT03928990 448 449 O

- NCT03928990 452 453 O
Introduction NCT03928990 455 467 B-Eq_Comparison
of NCT03928990 468 470 O
a NCT03928990 471 472 O
treatment NCT03928990 473 482 B-Procedure
acting NCT03928990 483 489 O
on NCT03928990 490 492 O
spasticity NCT03928990 493 503 B-Condition
or NCT03928990 504 506 B-Or
fatigue NCT03928990 507 514 B-Condition
within NCT03928990 515 521 B-Eq_Comparison
30 NCT03928990 522 524 I-Eq_Comparison
day NCT03928990 525 528 I-Eq_Comparison
before NCT03928990 529 535 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03928990 536 546 B-Study

- NCT03928990 549 550 O
Changes NCT03928990 552 559 O
brought NCT03928990 560 567 O
to NCT03928990 568 570 O
reeducation NCT03928990 571 582 B-Procedure
protocol NCT03928990 583 591 I-Procedure
throughout NCT03928990 592 602 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928990 603 606 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03928990 607 615 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03928990 616 618 O
the NCT03928990 619 622 O
study NCT03928990 623 628 B-Study

- NCT03928990 631 632 O
Patient NCT03928990 634 641 O
unable NCT03928990 642 648 B-Negation
to NCT03928990 649 651 O
provide NCT03928990 652 659 O
an NCT03928990 660 662 O
effort NCT03928990 663 669 O
equivalent NCT03928990 670 680 O
to NCT03928990 681 683 O
3 NCT03928990 684 685 B-Eq_Comparison
times NCT03928990 686 691 I-Eq_Comparison
the NCT03928990 692 695 O
resting NCT03928990 696 703 B-Observation
metabolic NCT03928990 704 713 I-Observation
value NCT03928990 714 719 I-Observation
= NCT03928990 720 721 O
3 NCT03928990 722 723 B-Eq_Comparison
Metabolic NCT03928990 724 733 B-Observation
Equivalent NCT03928990 734 744 I-Observation
of NCT03928990 745 747 I-Observation
Task NCT03928990 748 752 I-Observation
( NCT03928990 753 754 O
METs NCT03928990 755 759 B-Observation
) NCT03928990 760 761 O
. NCT03928990 762 763 O

Inclusion NCT03921398 0 9 O
Criteria NCT03921398 10 18 O
( NCT03921398 19 20 O
ESRD NCT03921398 21 25 B-Condition
group NCT03921398 26 31 O
) NCT03921398 32 33 O
: NCT03921398 34 35 O

- NCT03921398 39 40 O
Age NCT03921398 42 45 B-Age
≥ NCT03921398 46 47 B-Eq_Comparison
18 NCT03921398 48 50 I-Eq_Comparison
years NCT03921398 51 56 I-Eq_Comparison
, NCT03921398 57 58 O

- NCT03921398 62 63 O
History NCT03921398 65 72 B-Eq_Comparison
of NCT03921398 73 75 O
biopsy NCT03921398 76 82 O
- NCT03921398 83 84 O
proven NCT03921398 85 91 O
lupus NCT03921398 92 97 B-Condition
nephritis NCT03921398 98 107 I-Condition

- NCT03921398 110 111 O
All NCT03921398 113 116 O
classes NCT03921398 117 124 O
of NCT03921398 125 127 O
lupus NCT03921398 128 133 B-Condition
nephritis NCT03921398 134 143 I-Condition

- NCT03921398 146 147 O
Written NCT03921398 149 156 O
informed NCT03921398 157 165 O
consent NCT03921398 166 173 O

- NCT03921398 176 177 O
Affiliation NCT03921398 179 190 O
to NCT03921398 191 193 O
a NCT03921398 194 195 O
social NCT03921398 196 202 O
security NCT03921398 203 211 O
regime NCT03921398 212 218 O

Exclusion NCT03921398 219 228 O
Criteria NCT03921398 229 237 O
( NCT03921398 238 239 O
ESRD NCT03921398 240 244 B-Condition
group NCT03921398 245 250 O
) NCT03921398 251 252 O
: NCT03921398 253 254 O

- NCT03921398 258 259 O
Past NCT03921398 261 265 B-Eq_Comparison
- NCT03921398 266 267 I-Eq_Comparison
history NCT03921398 268 275 I-Eq_Comparison
of NCT03921398 276 278 O
kidney NCT03921398 279 285 B-Modifier
transplantation NCT03921398 286 301 B-Procedure

- NCT03921398 304 305 O
Active NCT03921398 307 313 B-Eq_Comparison
infection NCT03921398 314 323 B-Condition

- NCT03921398 326 327 O
Active NCT03921398 329 335 B-Eq_Comparison
allergy NCT03921398 336 343 B-Allergy
( NCT03921398 344 345 O
such NCT03921398 346 350 O
as NCT03921398 351 353 O
hay NCT03921398 354 357 B-Condition
fever NCT03921398 358 363 I-Condition
) NCT03921398 364 365 O

- NCT03921398 369 370 O
Pregnant NCT03921398 372 380 B-Condition
or NCT03921398 381 383 B-Or
breastfeeding NCT03921398 384 397 B-Condition
women NCT03921398 398 403 O

- NCT03921398 406 407 O
Protected NCT03921398 409 418 O
adults NCT03921398 419 425 O
( NCT03921398 426 427 O
individuals NCT03921398 428 439 O
under NCT03921398 440 445 B-Observation
guardianship NCT03921398 446 458 I-Observation
by NCT03921398 459 461 O
court NCT03921398 462 467 O
order NCT03921398 468 473 O
) NCT03921398 474 475 O

Inclusion NCT03921398 477 486 O
criteria NCT03921398 487 495 O
( NCT03921398 496 497 O
non NCT03921398 498 501 B-Negation
ESRD NCT03921398 502 506 B-Condition
group NCT03921398 507 512 O
) NCT03921398 513 514 O
: NCT03921398 515 516 O

- NCT03921398 520 521 O
Age NCT03921398 523 526 B-Age
≥ NCT03921398 527 528 B-Eq_Comparison
18 NCT03921398 529 531 I-Eq_Comparison
years NCT03921398 532 537 I-Eq_Comparison
, NCT03921398 538 539 O

- NCT03921398 543 544 O
Biopsy NCT03921398 546 552 B-Procedure
proven NCT03921398 553 559 O
ACTIVE NCT03921398 560 566 B-Eq_Comparison
lupus NCT03921398 567 572 B-Condition
nephritis NCT03921398 573 582 I-Condition

- NCT03921398 585 586 O
First NCT03921398 588 593 B-Eq_Comparison
event NCT03921398 594 599 O
of NCT03921398 600 602 O
lupus NCT03921398 603 608 B-Condition
nephritis NCT03921398 609 618 I-Condition

- NCT03921398 621 622 O
No NCT03921398 624 626 B-Negation
immunosuppressive NCT03921398 627 644 B-Procedure
therapy NCT03921398 645 652 I-Procedure
( NCT03921398 653 654 O
including NCT03921398 655 664 O
corticosteroids NCT03921398 665 680 B-Drug
) NCT03921398 681 682 O

- NCT03921398 686 687 O
Written NCT03921398 689 696 O
informed NCT03921398 697 705 O
consent NCT03921398 706 713 O

- NCT03921398 716 717 O
Affiliation NCT03921398 719 730 O
to NCT03921398 731 733 O
a NCT03921398 734 735 O
social NCT03921398 736 742 O
security NCT03921398 743 751 O
regime NCT03921398 752 758 O

Exclusion NCT03921398 759 768 O
criteria NCT03921398 769 777 O
( NCT03921398 778 779 O
non NCT03921398 780 783 B-Negation
ESRD NCT03921398 784 788 B-Condition
group NCT03921398 789 794 O
) NCT03921398 795 796 O
: NCT03921398 797 798 O

- NCT03921398 802 803 O
Immunosuppressive NCT03921398 805 822 B-Procedure
treatment NCT03921398 823 832 I-Procedure

- NCT03921398 835 836 O
Relapse NCT03921398 838 845 B-Condition
of NCT03921398 846 848 O
lupus NCT03921398 849 854 B-Condition
nephritis NCT03921398 855 864 I-Condition
under NCT03921398 865 870 B-Temporal_Connection___Temporal_Connection_Type_Value:during
treatment NCT03921398 871 880 B-Procedure

- NCT03921398 883 884 O
Pregnant NCT03921398 886 894 B-Condition
or NCT03921398 895 897 B-Or
breastfeeding NCT03921398 898 911 B-Condition
women NCT03921398 912 917 O

- NCT03921398 920 921 O
Protected NCT03921398 923 932 B-Observation
adults NCT03921398 933 939 O
( NCT03921398 940 941 O
individuals NCT03921398 942 953 O
under NCT03921398 954 959 B-Observation
guardianship NCT03921398 960 972 I-Observation
by NCT03921398 973 975 O
court NCT03921398 976 981 O
order NCT03921398 982 987 O
) NCT03921398 988 989 O

Inclusion NCT03869528 0 9 O
Criteria NCT03869528 10 18 O
: NCT03869528 19 20 O

- NCT03869528 24 25 O
All NCT03869528 27 30 O
adults NCT03869528 31 37 O
≥ NCT03869528 38 39 B-Eq_Comparison
18 NCT03869528 40 42 I-Eq_Comparison
yrs NCT03869528 43 46 I-Eq_Comparison
of NCT03869528 47 49 O
age NCT03869528 50 53 B-Age
undergoing NCT03869528 54 64 B-Eq_Comparison
flexible NCT03869528 65 73 B-Modifier
bronchoscopy NCT03869528 74 86 B-Procedure

Exclusion NCT03869528 87 96 O
Criteria NCT03869528 97 105 O
: NCT03869528 106 107 O

- NCT03869528 111 112 O
Uncontrolled NCT03869528 114 126 B-Modifier
hypertension NCT03869528 127 139 B-Condition
Systolic NCT03869528 140 148 B-Observation
Blood NCT03869528 149 154 I-Observation
Pressure NCT03869528 155 163 I-Observation
> NCT03869528 164 165 B-Eq_Comparison
180 NCT03869528 166 169 I-Eq_Comparison
mm NCT03869528 170 172 I-Eq_Comparison
Hg NCT03869528 173 175 I-Eq_Comparison

- NCT03869528 178 179 O
Symptomatic NCT03869528 181 192 B-Assertion___Assertion_Type_Value:possible
coronary NCT03869528 193 201 B-Condition
artery NCT03869528 202 208 I-Condition
disease NCT03869528 209 216 I-Condition

- NCT03869528 219 220 O
Pregnancy NCT03869528 222 231 B-Condition

- NCT03869528 234 235 O
Not NCT03869528 237 240 O
giving NCT03869528 241 247 O
informed NCT03869528 248 256 O
consent NCT03869528 257 264 O
for NCT03869528 265 268 O
the NCT03869528 269 272 O
procedure NCT03869528 273 282 O

- NCT03869528 285 286 O
Hypoxemia NCT03869528 288 297 B-Condition
( NCT03869528 298 299 O
oxygen NCT03869528 300 306 B-Observation
saturation NCT03869528 307 317 I-Observation
[ NCT03869528 318 319 O
by NCT03869528 320 322 O
pulse NCT03869528 323 328 B-Procedure
oximetry NCT03869528 329 337 I-Procedure
] NCT03869528 338 339 O
< NCT03869528 340 341 B-Eq_Comparison
92 NCT03869528 342 344 I-Eq_Comparison
% NCT03869528 345 346 I-Eq_Comparison
with NCT03869528 347 351 B-And
Fio NCT03869528 352 355 B-Observation
2 NCT03869528 356 357 I-Observation
of NCT03869528 358 360 O
≥ NCT03869528 361 362 B-Eq_Comparison
0.3 NCT03869528 363 366 I-Eq_Comparison

- NCT03869528 370 371 O
Bronchoscopy NCT03869528 373 385 B-Procedure
performed NCT03869528 386 395 O
through NCT03869528 396 403 O
an NCT03869528 404 406 O
artificial NCT03869528 407 417 B-Procedure
airway NCT03869528 418 424 I-Procedure

Inclusion NCT03867045 0 9 O
Criteria NCT03867045 10 18 O
: NCT03867045 19 20 O

Patients NCT03867045 22 30 O
> NCT03867045 31 32 B-Eq_Comparison
18 NCT03867045 33 35 I-Eq_Comparison
years NCT03867045 36 41 I-Eq_Comparison
of NCT03867045 42 44 O
age NCT03867045 45 48 B-Age
Patients NCT03867045 49 57 O
planning NCT03867045 58 66 B-Assertion___Assertion_Type_Value:intention
to NCT03867045 67 69 O
start NCT03867045 70 75 B-Eq_Comparison
treatment NCT03867045 76 85 B-Procedure
with NCT03867045 86 90 O
cabozantinib NCT03867045 91 103 B-Procedure
therapy NCT03867045 104 111 I-Procedure
for NCT03867045 112 115 O
renal NCT03867045 116 121 B-Modifier
cancer NCT03867045 122 128 B-Condition
. NCT03867045 129 130 O

Technology NCT03867045 132 142 O
requirement NCT03867045 143 154 O
: NCT03867045 155 156 O
The NCT03867045 157 160 O
patient NCT03867045 161 168 O
will NCT03867045 169 173 O
need NCT03867045 174 178 O
to NCT03867045 179 181 O
have NCT03867045 182 186 O
home NCT03867045 187 191 O
wireless NCT03867045 192 200 O
internet NCT03867045 201 209 O
access NCT03867045 210 216 O
for NCT03867045 217 220 O
use NCT03867045 221 224 O
of NCT03867045 225 227 O
the NCT03867045 228 231 O
software NCT03867045 232 240 O
and NCT03867045 241 244 O
technology NCT03867045 245 255 O
in NCT03867045 256 258 O
this NCT03867045 259 263 O
study NCT03867045 264 269 O
. NCT03867045 270 271 O
The NCT03867045 273 276 O
patient NCT03867045 277 284 O
will NCT03867045 285 289 O
need NCT03867045 290 294 O
to NCT03867045 295 297 O
already NCT03867045 298 305 O
have NCT03867045 306 310 O
or NCT03867045 311 313 O
be NCT03867045 314 316 O
willing NCT03867045 317 324 O
to NCT03867045 325 327 O
set NCT03867045 328 331 O
up NCT03867045 332 334 O
a NCT03867045 335 336 O
Duke NCT03867045 337 341 O
MyChart NCT03867045 342 349 O
account NCT03867045 350 357 O
. NCT03867045 358 359 O

Exclusion NCT03867045 361 370 O
Criteria NCT03867045 371 379 O
: NCT03867045 380 381 O

Non NCT03867045 383 386 B-Negation
- NCT03867045 387 388 O
English NCT03867045 389 396 O
Speaking NCT03867045 397 405 O
. NCT03867045 406 407 O
Any NCT03867045 409 412 O
patient NCT03867045 413 420 O
who NCT03867045 421 424 O
is NCT03867045 425 427 O
not NCT03867045 428 431 O
able NCT03867045 432 436 O
to NCT03867045 437 439 O
comprehend NCT03867045 440 450 O
and NCT03867045 451 454 O
operate NCT03867045 455 462 O
the NCT03867045 463 466 O
technology NCT03867045 467 477 O
at NCT03867045 478 480 O
the NCT03867045 481 484 O
discretion NCT03867045 485 495 O
of NCT03867045 496 498 O
the NCT03867045 499 502 O
enrolling NCT03867045 503 512 O
provider NCT03867045 513 521 O
. NCT03867045 522 523 O


Inclusion NCT03929939 0 9 O
Criteria NCT03929939 10 18 O
: NCT03929939 19 20 O

1 NCT03929939 24 25 O
. NCT03929939 25 26 O
Be NCT03929939 28 30 O
either NCT03929939 31 37 O
a NCT03929939 38 39 O
female NCT03929939 40 46 O
veteran NCT03929939 47 54 B-Observation
with NCT03929939 55 59 B-And
a NCT03929939 60 61 O
current NCT03929939 62 69 B-Eq_Comparison
diagnosis NCT03929939 70 79 O
of NCT03929939 80 82 O
PTSD NCT03929939 83 87 B-Condition
( NCT03929939 88 89 O
for NCT03929939 90 93 O
the NCT03929939 94 97 O
PTSD NCT03929939 98 102 B-Condition
group NCT03929939 103 108 O
) NCT03929939 109 110 O
or NCT03929939 111 113 B-Or
a NCT03929939 114 115 O
female NCT03929939 116 122 O
non NCT03929939 123 126 B-Negation
- NCT03929939 127 128 O
veteran NCT03929939 129 136 B-Observation
without NCT03929939 137 144 B-Negation
a NCT03929939 145 146 O
current NCT03929939 147 154 B-Eq_Comparison
diagnosis NCT03929939 155 164 O
of NCT03929939 165 167 O
PTSD NCT03929939 168 172 B-Condition
( NCT03929939 173 174 O
for NCT03929939 175 178 O
the NCT03929939 179 182 O
non NCT03929939 183 186 B-Negation
- NCT03929939 187 188 O
PTSD NCT03929939 189 193 B-Condition
control NCT03929939 194 201 O
group NCT03929939 202 207 O
) NCT03929939 208 209 O
. NCT03929939 210 211 O

2 NCT03929939 215 216 O
. NCT03929939 216 217 O
Be NCT03929939 219 221 O
between NCT03929939 222 229 O
the NCT03929939 230 233 O
ages NCT03929939 234 238 B-Age
of NCT03929939 239 241 O
18 NCT03929939 242 244 B-Eq_Comparison
- NCT03929939 245 246 I-Eq_Comparison
65 NCT03929939 247 249 I-Eq_Comparison
. NCT03929939 249 250 O

3 NCT03929939 254 255 O
. NCT03929939 255 256 O
Sedentary NCT03929939 258 267 B-Condition
( NCT03929939 268 269 O
exercises NCT03929939 270 279 B-Observation
less NCT03929939 280 284 B-Eq_Comparison
than NCT03929939 285 289 I-Eq_Comparison
three NCT03929939 290 295 I-Eq_Comparison
times NCT03929939 296 301 I-Eq_Comparison
a NCT03929939 302 303 I-Eq_Comparison
week NCT03929939 304 308 I-Eq_Comparison
for NCT03929939 309 312 O
thirty NCT03929939 313 319 B-Eq_Comparison
minutes NCT03929939 320 327 I-Eq_Comparison
or NCT03929939 328 330 I-Eq_Comparison
less NCT03929939 331 335 I-Eq_Comparison
) NCT03929939 336 337 O
. NCT03929939 338 339 O

Exclusion NCT03929939 341 350 O
Criteria NCT03929939 351 359 O
: NCT03929939 360 361 O

1 NCT03929939 365 366 O
. NCT03929939 366 367 O
Any NCT03929939 369 372 O
evidence NCT03929939 373 381 O
of NCT03929939 382 384 O
cardiopulmonary NCT03929939 385 400 B-Modifier
and NCT03929939 401 404 B-Or
neurological NCT03929939 405 417 B-Modifier
diseases NCT03929939 418 426 B-Condition
by NCT03929939 427 429 O
history NCT03929939 430 437 O
or NCT03929939 438 440 O
by NCT03929939 441 443 O
physical NCT03929939 444 452 B-Procedure
examination NCT03929939 453 464 I-Procedure
. NCT03929939 465 466 O

2 NCT03929939 470 471 O
. NCT03929939 471 472 O
Chronic NCT03929939 474 481 O
kidney NCT03929939 482 488 B-Condition
disease NCT03929939 489 496 I-Condition
( NCT03929939 497 498 O
serum NCT03929939 499 504 B-Observation
creatinine NCT03929939 505 515 I-Observation
> NCT03929939 516 517 B-Eq_Comparison
1.5 NCT03929939 518 521 I-Eq_Comparison
mg NCT03929939 522 524 I-Eq_Comparison
/ NCT03929939 525 526 I-Eq_Comparison
dL NCT03929939 527 529 I-Eq_Comparison
) NCT03929939 530 531 O
. NCT03929939 532 533 O

3 NCT03929939 537 538 O
. NCT03929939 538 539 O
Peripheral NCT03929939 541 551 B-Condition
vascular NCT03929939 552 560 I-Condition
disease NCT03929939 561 568 I-Condition
. NCT03929939 569 570 O

4 NCT03929939 574 575 O
. NCT03929939 575 576 O
Peripheral NCT03929939 578 588 B-Condition
neuropathy NCT03929939 589 599 I-Condition
. NCT03929939 600 601 O

5 NCT03929939 605 606 O
. NCT03929939 606 607 O
Current NCT03929939 609 616 B-Eq_Comparison
substance NCT03929939 617 626 B-Condition
use NCT03929939 627 630 I-Condition
disorder NCT03929939 631 639 I-Condition
other NCT03929939 640 645 B-Exception
than NCT03929939 646 650 I-Exception
tobacco NCT03929939 651 658 B-Drug
related NCT03929939 659 666 O
. NCT03929939 667 668 O

6 NCT03929939 672 673 O
. NCT03929939 673 674 O
Endurance NCT03929939 676 685 B-Condition
- NCT03929939 686 687 I-Condition
trained NCT03929939 688 695 I-Condition
athletes NCT03929939 696 704 I-Condition
due NCT03929939 705 708 O
to NCT03929939 709 711 O
the NCT03929939 712 715 O
effects NCT03929939 716 723 O
of NCT03929939 724 726 O
exercise NCT03929939 727 735 B-Procedure
training NCT03929939 736 744 I-Procedure
on NCT03929939 745 747 O
sympathetic NCT03929939 748 759 B-Condition
neural NCT03929939 760 766 I-Condition
control NCT03929939 767 774 I-Condition
and NCT03929939 775 778 B-Or
cardiac NCT03929939 779 786 B-Condition
- NCT03929939 787 788 I-Condition
vascular NCT03929939 789 797 I-Condition
function NCT03929939 798 806 I-Condition
. NCT03929939 807 808 O

7 NCT03929939 812 813 O
. NCT03929939 813 814 O
Current NCT03929939 816 823 B-Eq_Comparison
pregnancy NCT03929939 824 833 B-Condition
. NCT03929939 834 835 O

Inclusion NCT03926494 0 9 O
Criteria NCT03926494 10 18 O
: NCT03926494 19 20 O

- NCT03926494 24 25 O
All NCT03926494 27 30 O
comatose NCT03926494 31 39 B-Condition
patients NCT03926494 40 48 O
( NCT03926494 49 50 O
Glasgow NCT03926494 51 58 B-Observation
coma NCT03926494 59 63 I-Observation
score NCT03926494 64 69 I-Observation
< NCT03926494 70 71 B-Eq_Comparison
8 NCT03926494 72 73 I-Eq_Comparison
) NCT03926494 74 75 O
due NCT03926494 76 79 O
to NCT03926494 80 82 O
carbon NCT03926494 83 89 B-Condition
monoxide NCT03926494 90 98 I-Condition
poisoning NCT03926494 99 108 I-Condition
, NCT03926494 109 110 O
treated NCT03926494 111 118 O
by NCT03926494 119 121 O
hyperbaric NCT03926494 122 132 B-Procedure
oxygen NCT03926494 133 139 I-Procedure
therapy NCT03926494 140 147 I-Procedure
in NCT03926494 148 150 O
a NCT03926494 151 152 O
tertiary NCT03926494 153 161 O
hospital NCT03926494 162 170 O
in NCT03926494 171 173 O
Île NCT03926494 174 177 O
de NCT03926494 178 180 O
France NCT03926494 181 187 O
area NCT03926494 188 192 O
; NCT03926494 192 193 O

- NCT03926494 196 197 O
Aged NCT03926494 199 203 B-Age
≥ NCT03926494 204 205 B-Eq_Comparison
18 NCT03926494 206 208 I-Eq_Comparison
years NCT03926494 209 214 I-Eq_Comparison
; NCT03926494 214 215 O

- NCT03926494 218 219 O
Hospitalized NCT03926494 221 233 B-Encounter
in NCT03926494 234 236 O
hyperbaric NCT03926494 237 247 O
medicine NCT03926494 248 256 O
unity NCT03926494 257 262 O
of NCT03926494 263 265 O
Raymond NCT03926494 266 273 O
Poincaré NCT03926494 274 282 O
hospital NCT03926494 283 291 O
in NCT03926494 292 294 O
Garches NCT03926494 295 302 O
. NCT03926494 303 304 O

Exclusion NCT03926494 306 315 O
Criteria NCT03926494 316 324 O
: NCT03926494 325 326 O

- NCT03926494 330 331 O
Pregnant NCT03926494 333 341 B-Condition
woman NCT03926494 342 347 O
; NCT03926494 347 348 O

- NCT03926494 351 352 O
Patient NCT03926494 354 361 O
present NCT03926494 362 369 O
clinical NCT03926494 370 378 O
signes NCT03926494 379 385 B-Assertion___Assertion_Type_Value:possible
of NCT03926494 386 388 O
stroke NCT03926494 389 395 B-Condition
and NCT03926494 396 399 B-And
without NCT03926494 400 407 B-Negation
CO NCT03926494 408 410 B-Condition
detection NCT03926494 411 420 I-Condition
. NCT03926494 421 422 O

In NCT03926494 424 426 O
case NCT03926494 427 431 O
of NCT03926494 432 434 O
unusable NCT03926494 435 443 O
data NCT03926494 444 448 O
, NCT03926494 449 450 O
patient NCT03926494 451 458 O
will NCT03926494 459 463 O
be NCT03926494 464 466 O
excluded NCT03926494 467 475 O
from NCT03926494 476 480 O
study NCT03926494 481 486 O
. NCT03926494 487 488 O

Inclusion NCT03928756 0 9 O
Criteria NCT03928756 10 18 O
: NCT03928756 19 20 O

1 NCT03928756 24 25 O
. NCT03928756 25 26 O
Have NCT03928756 28 32 O
an NCT03928756 33 35 O
iPhone NCT03928756 36 42 O
smartphone NCT03928756 43 53 O
on NCT03928756 54 56 O
which NCT03928756 57 62 O
the NCT03928756 63 66 O
app NCT03928756 67 70 O
can NCT03928756 71 74 O
be NCT03928756 75 77 O
downloaded NCT03928756 78 88 O

2 NCT03928756 91 92 O
. NCT03928756 92 93 O
Self NCT03928756 95 99 O
- NCT03928756 100 101 O
reported NCT03928756 102 110 O
past NCT03928756 111 115 B-Eq_Comparison
- NCT03928756 116 117 I-Eq_Comparison
month NCT03928756 118 123 I-Eq_Comparison
binge NCT03928756 124 129 B-Condition
drinking NCT03928756 130 138 I-Condition
( NCT03928756 139 140 O
4 NCT03928756 141 142 B-Eq_Comparison
/ NCT03928756 143 144 I-Eq_Comparison
5 NCT03928756 145 146 I-Eq_Comparison
or NCT03928756 147 149 I-Eq_Comparison
more NCT03928756 150 154 I-Eq_Comparison
drinks NCT03928756 155 161 B-Observation
on NCT03928756 162 164 O
one NCT03928756 165 168 B-Eq_Comparison
occasion NCT03928756 169 177 I-Eq_Comparison
, NCT03928756 178 179 O
tailored NCT03928756 180 188 O
by NCT03928756 189 191 O
sex NCT03928756 192 195 B-Condition
) NCT03928756 196 197 O
OR NCT03928756 198 200 B-Or
any NCT03928756 201 204 O
past NCT03928756 205 209 B-Eq_Comparison
- NCT03928756 210 211 I-Eq_Comparison
month NCT03928756 212 217 I-Eq_Comparison
marijuana NCT03928756 218 227 B-Condition
use NCT03928756 228 231 I-Condition
without NCT03928756 232 239 B-Negation
a NCT03928756 240 241 O
medical NCT03928756 242 249 B-Observation
marijuana NCT03928756 250 259 I-Observation
card NCT03928756 260 264 I-Observation

3 NCT03928756 267 268 O
. NCT03928756 268 269 O
Meet NCT03928756 271 275 O
study NCT03928756 276 281 O
verification NCT03928756 282 294 O
criteria NCT03928756 295 303 O
( NCT03928756 304 305 O
i NCT03928756 306 307 O
. NCT03928756 308 309 O
e NCT03928756 310 311 O
. NCT03928756 312 313 O
, NCT03928756 314 315 O
use NCT03928756 316 319 O
of NCT03928756 320 322 O
CAPTCHA NCT03928756 323 330 O
, NCT03928756 331 332 O
IP NCT03928756 333 335 O
address NCT03928756 336 343 O
checks NCT03928756 344 350 O
, NCT03928756 351 352 O
social NCT03928756 353 359 O
media NCT03928756 360 365 O
checks NCT03928756 366 372 O
) NCT03928756 373 374 O
. NCT03928756 375 376 O

Exclusion NCT03928756 378 387 O
Criteria NCT03928756 388 396 O
: NCT03928756 397 398 O

1 NCT03928756 401 402 O
. NCT03928756 402 403 O
Unable NCT03928756 405 411 B-Negation
to NCT03928756 412 414 O
understand NCT03928756 415 425 O
English NCT03928756 426 433 O

Inclusion NCT03868657 0 9 O
Criteria NCT03868657 10 18 O
: NCT03868657 19 20 O

- NCT03868657 24 25 O
Healthy NCT03868657 27 34 O
men NCT03868657 35 38 O
and NCT03868657 39 42 B-Or
women NCT03868657 43 48 O

- NCT03868657 51 52 O
Age NCT03868657 54 57 B-Age
≥ NCT03868657 58 59 B-Eq_Comparison
20 NCT03868657 60 62 I-Eq_Comparison
and NCT03868657 63 66 I-Eq_Comparison
≤ NCT03868657 67 68 I-Eq_Comparison
40 NCT03868657 69 71 I-Eq_Comparison
years NCT03868657 72 77 I-Eq_Comparison

- NCT03868657 80 81 O
BMI NCT03868657 83 86 B-Observation
≥ NCT03868657 87 88 B-Eq_Comparison
18 NCT03868657 89 91 I-Eq_Comparison
, NCT03868657 92 93 I-Eq_Comparison
5 NCT03868657 94 95 I-Eq_Comparison
and NCT03868657 96 99 I-Eq_Comparison
≤ NCT03868657 100 101 I-Eq_Comparison
27 NCT03868657 102 104 I-Eq_Comparison
, NCT03868657 105 106 I-Eq_Comparison
5 NCT03868657 107 108 I-Eq_Comparison

Exclusion NCT03868657 110 119 O
Criteria NCT03868657 120 128 O
: NCT03868657 129 130 O

- NCT03868657 134 135 O
Chronic NCT03868657 137 144 B-Condition
diseases NCT03868657 145 153 I-Condition
( NCT03868657 154 155 O
cardiac NCT03868657 156 163 B-Modifier
, NCT03868657 164 165 O
metabolic NCT03868657 166 175 B-Modifier
, NCT03868657 176 177 O
liver NCT03868657 178 183 B-Modifier
) NCT03868657 184 185 O
including NCT03868657 186 195 O
a NCT03868657 196 197 O
family NCT03868657 198 204 B-Family_Member
history NCT03868657 205 212 I-Family_Member
of NCT03868657 213 215 O
congenital NCT03868657 216 226 B-Condition
Long NCT03868657 227 231 I-Condition
QT NCT03868657 232 234 I-Condition
syndrome NCT03868657 235 243 I-Condition
. NCT03868657 244 245 O

- NCT03868657 249 250 O
QTc NCT03868657 252 255 B-Observation
values NCT03868657 256 262 O
> NCT03868657 263 264 B-Eq_Comparison
440 NCT03868657 265 268 I-Eq_Comparison
ms NCT03868657 269 271 I-Eq_Comparison
( NCT03868657 272 273 O
men NCT03868657 274 277 O
) NCT03868657 278 279 O
and NCT03868657 280 283 B-And
> NCT03868657 284 285 B-Eq_Comparison
450 NCT03868657 286 289 I-Eq_Comparison
ms NCT03868657 290 292 I-Eq_Comparison
( NCT03868657 293 294 O
women NCT03868657 295 300 O
) NCT03868657 301 302 O

- NCT03868657 306 307 O
Clinical NCT03868657 309 317 B-Modifier
important NCT03868657 318 327 I-Modifier
and NCT03868657 328 331 B-Or
/ NCT03868657 332 333 I-Or
or NCT03868657 334 336 I-Or
symptomatic NCT03868657 337 348 B-Assertion___Assertion_Type_Value:possible
bradycardia NCT03868657 349 360 B-Condition

- NCT03868657 363 364 O
Regular NCT03868657 366 373 B-Eq_Comparison
medication NCT03868657 374 384 B-Drug
( NCT03868657 385 386 O
contraceptive NCT03868657 387 400 B-Drug
pills NCT03868657 401 406 I-Drug
allowed NCT03868657 407 414 B-Exception
) NCT03868657 415 416 O

- NCT03868657 420 421 O
Pregnancy NCT03868657 423 432 B-Condition
and NCT03868657 433 436 B-Or
breastfeeding NCT03868657 437 450 B-Condition

Inclusion NCT03862846 0 9 O
Criteria NCT03862846 10 18 O
: NCT03862846 19 20 O

- NCT03862846 24 25 O
Subjects NCT03862846 27 35 O
must NCT03862846 36 40 O
give NCT03862846 41 45 O
written NCT03862846 46 53 O
, NCT03862846 54 55 O
signed NCT03862846 56 62 O
and NCT03862846 63 66 O
dated NCT03862846 67 72 O
informed NCT03862846 73 81 O
consent NCT03862846 82 89 O

- NCT03862846 92 93 O
Confirmed NCT03862846 95 104 O
diagnosis NCT03862846 105 114 O
of NCT03862846 115 117 O
PMM NCT03862846 118 121 B-Condition
according NCT03862846 122 131 O
to NCT03862846 132 134 O
the NCT03862846 135 138 O
2016 NCT03862846 139 143 O
Rome NCT03862846 144 148 O
Consensus NCT03862846 149 158 O
recommendations NCT03862846 159 174 O

- NCT03862846 177 178 O
Confirmed NCT03862846 180 189 O
mitochondrial NCT03862846 190 203 B-Condition
mutation NCT03862846 204 212 I-Condition
with NCT03862846 213 217 B-And
evidence NCT03862846 218 226 O
of NCT03862846 227 229 O
myopathy NCT03862846 230 238 B-Condition

- NCT03862846 241 242 O
Able NCT03862846 244 248 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862846 249 251 I-Assertion___Assertion_Type_Value:hypothetical
remain NCT03862846 252 258 O
on NCT03862846 259 261 O
stable NCT03862846 262 268 O
medication NCT03862846 269 279 B-Drug
throughout NCT03862846 280 290 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862846 291 294 O
study NCT03862846 295 300 B-Study

Exclusion NCT03862846 301 310 O
Criteria NCT03862846 311 319 O
: NCT03862846 320 321 O

- NCT03862846 325 326 O
Documented NCT03862846 328 338 O
evidence NCT03862846 339 347 O
of NCT03862846 348 350 O
ongoing NCT03862846 351 358 B-Eq_Comparison
rhabdomyolysis NCT03862846 359 373 B-Condition

- NCT03862846 376 377 O
Subjects NCT03862846 379 387 O
with NCT03862846 388 392 O
motor NCT03862846 393 398 B-Condition
abnormalities NCT03862846 399 412 I-Condition
other NCT03862846 413 418 B-Exception
than NCT03862846 419 423 I-Exception
related NCT03862846 424 431 O
to NCT03862846 432 434 O
mitochondrial NCT03862846 435 448 B-Condition
disease NCT03862846 449 456 I-Condition

- NCT03862846 459 460 O
Treatment NCT03862846 462 471 B-Procedure
with NCT03862846 472 476 O
an NCT03862846 477 479 O
investigational NCT03862846 480 495 B-Study
drug NCT03862846 496 500 B-Drug
within NCT03862846 501 507 B-Eq_Comparison
3 NCT03862846 508 509 I-Eq_Comparison
months NCT03862846 510 516 I-Eq_Comparison
prior NCT03862846 517 522 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862846 523 525 I-Temporal_Connection___Temporal_Connection_Type_Value:before
Day NCT03862846 526 529 B-Study
1 NCT03862846 530 531 O

- NCT03862846 535 536 O
Hospitalised NCT03862846 538 550 B-Encounter
within NCT03862846 551 557 B-Eq_Comparison
3 NCT03862846 558 559 I-Eq_Comparison
months NCT03862846 560 566 I-Eq_Comparison
prior NCT03862846 567 572 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862846 573 575 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03862846 576 585 B-Study
for NCT03862846 586 589 O
any NCT03862846 590 593 O
major NCT03862846 594 599 O
medical NCT03862846 600 607 B-Condition
condition NCT03862846 608 617 I-Condition

- NCT03862846 620 621 O
Pregnant NCT03862846 623 631 B-Condition
or NCT03862846 632 634 B-Or
nursing NCT03862846 635 642 B-Condition
females NCT03862846 643 650 O

Inclusion NCT03860766 0 9 O
Criteria NCT03860766 10 18 O
: NCT03860766 19 20 O

- NCT03860766 24 25 O
Handball NCT03860766 27 35 B-Observation
players NCT03860766 36 43 I-Observation
; NCT03860766 43 44 O

- NCT03860766 47 48 O
Healthy NCT03860766 50 57 B-Condition
; NCT03860766 57 58 O

- NCT03860766 61 62 O
Participation NCT03860766 64 77 O
of NCT03860766 78 80 O
at NCT03860766 81 83 B-Eq_Comparison
least NCT03860766 84 89 I-Eq_Comparison
one NCT03860766 90 93 I-Eq_Comparison
official NCT03860766 94 102 B-Observation
match NCT03860766 103 108 I-Observation
in NCT03860766 109 111 O
the NCT03860766 112 115 O
last NCT03860766 116 120 B-Eq_Comparison
year NCT03860766 121 125 I-Eq_Comparison
and NCT03860766 126 129 B-And
attend NCT03860766 130 136 O
70 NCT03860766 137 139 B-Eq_Comparison
% NCT03860766 140 141 I-Eq_Comparison
of NCT03860766 142 144 O
the NCT03860766 145 148 O
team NCT03860766 149 153 B-Observation
's NCT03860766 153 155 I-Observation
activities NCT03860766 156 166 I-Observation
during NCT03860766 167 173 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860766 174 177 O
current NCT03860766 178 185 B-Eq_Comparison
season NCT03860766 186 192 O
. NCT03860766 193 194 O

Exclusion NCT03860766 196 205 O
Criteria NCT03860766 206 214 O
: NCT03860766 215 216 O

- NCT03860766 220 221 O
musculoskeletal NCT03860766 223 238 B-Modifier
injury NCT03860766 239 245 B-Condition
in NCT03860766 246 248 O
the NCT03860766 249 252 O
last NCT03860766 253 257 B-Eq_Comparison
three NCT03860766 258 263 I-Eq_Comparison
months NCT03860766 264 270 I-Eq_Comparison
; NCT03860766 270 271 O

- NCT03860766 274 275 O
cardiovascular NCT03860766 277 291 B-Condition
diseases NCT03860766 292 300 I-Condition
; NCT03860766 300 301 O

- NCT03860766 304 305 O
use NCT03860766 307 310 O
of NCT03860766 311 313 O
anabolic NCT03860766 314 322 B-Modifier
, NCT03860766 323 324 O
anti NCT03860766 325 329 B-Modifier
- NCT03860766 330 331 I-Modifier
inflammatory NCT03860766 332 344 I-Modifier
and NCT03860766 345 348 B-Or
analgesic NCT03860766 349 358 B-Modifier
drugs NCT03860766 359 364 B-Drug
72 NCT03860766 365 367 B-Eq_Comparison
hours NCT03860766 368 373 I-Eq_Comparison
before NCT03860766 374 380 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03860766 381 384 O
evaluations NCT03860766 385 396 B-Study
; NCT03860766 396 397 O

- NCT03860766 400 401 O
use NCT03860766 403 406 O
of NCT03860766 407 409 O
alcohol NCT03860766 410 417 B-Drug
and NCT03860766 418 421 B-Or
illicit NCT03860766 422 429 B-Drug
drugs NCT03860766 430 435 I-Drug
during NCT03860766 436 442 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860766 443 446 O
collection NCT03860766 447 457 B-Study
period NCT03860766 458 464 I-Study
; NCT03860766 464 465 O

Inclusion NCT03860220 0 9 O
Criteria NCT03860220 10 18 O
: NCT03860220 19 20 O

- NCT03860220 24 25 O
145 NCT03860220 27 30 B-Eq_Comparison
mmHg NCT03860220 31 35 I-Eq_Comparison
≤ NCT03860220 36 37 I-Eq_Comparison
msSBP NCT03860220 38 43 B-Observation
≤ NCT03860220 44 45 B-Eq_Comparison
190 NCT03860220 46 49 I-Eq_Comparison
mmHg NCT03860220 50 54 I-Eq_Comparison

- NCT03860220 57 58 O
Triglycerides NCT03860220 60 73 B-Observation
< NCT03860220 74 75 B-Eq_Comparison
500 NCT03860220 76 79 I-Eq_Comparison
mg NCT03860220 80 82 I-Eq_Comparison
/ NCT03860220 83 84 I-Eq_Comparison
dL NCT03860220 85 87 I-Eq_Comparison

- NCT03860220 90 91 O
LDL NCT03860220 93 96 B-Observation
- NCT03860220 97 98 I-Observation
C NCT03860220 99 100 I-Observation
≤ NCT03860220 101 102 B-Eq_Comparison
250 NCT03860220 103 106 I-Eq_Comparison
mg NCT03860220 107 109 I-Eq_Comparison
/ NCT03860220 110 111 I-Eq_Comparison
dL NCT03860220 112 114 I-Eq_Comparison

Exclusion NCT03860220 115 124 O
Criteria NCT03860220 125 133 O
: NCT03860220 134 135 O

- NCT03860220 139 140 O
sSBP NCT03860220 142 146 B-Observation
≥ NCT03860220 147 148 B-Eq_Comparison
20 NCT03860220 149 151 I-Eq_Comparison
mmHg NCT03860220 152 156 I-Eq_Comparison
and NCT03860220 157 160 B-And
sDBP NCT03860220 161 165 B-Observation
≥ NCT03860220 166 167 B-Eq_Comparison
10 NCT03860220 168 170 I-Eq_Comparison
mmHg NCT03860220 171 175 I-Eq_Comparison

- NCT03860220 178 179 O
symptomatic NCT03860220 181 192 B-Assertion___Assertion_Type_Value:possible
orthostatic NCT03860220 193 204 B-Modifier
hypotension NCT03860220 205 216 B-Condition
and NCT03860220 217 220 B-Or
secondary NCT03860220 221 230 B-Modifier
/ NCT03860220 231 232 B-Or
iatrogenic NCT03860220 233 243 B-Modifier
hypertension NCT03860220 244 256 B-Condition
and NCT03860220 257 260 B-Or
dyslipidemia NCT03860220 261 273 B-Condition

- NCT03860220 276 277 O
history NCT03860220 279 286 B-Eq_Comparison
of NCT03860220 287 289 O
moderate NCT03860220 290 298 B-Eq_Comparison
to NCT03860220 299 301 I-Eq_Comparison
severe NCT03860220 302 308 I-Eq_Comparison
cerebral NCT03860220 309 317 B-Condition
ischemia NCT03860220 318 326 I-Condition
, NCT03860220 327 328 O
cerebral NCT03860220 329 337 B-Condition
hemorrhage NCT03860220 338 348 I-Condition
, NCT03860220 349 350 O
transient NCT03860220 351 360 B-Condition
ischemic NCT03860220 361 369 I-Condition
attack NCT03860220 370 376 I-Condition
, NCT03860220 377 378 O
myocardial NCT03860220 379 389 B-Condition
infarction NCT03860220 390 400 I-Condition
, NCT03860220 401 402 O
or NCT03860220 403 405 B-Or
unstable NCT03860220 406 414 O
angina NCT03860220 415 421 B-Condition
in NCT03860220 422 424 O
the NCT03860220 425 428 O
past NCT03860220 429 433 B-Eq_Comparison
6 NCT03860220 434 435 I-Eq_Comparison
months NCT03860220 436 442 I-Eq_Comparison
; NCT03860220 442 443 O
severe NCT03860220 444 450 O
heart NCT03860220 451 456 B-Condition
failure NCT03860220 457 464 I-Condition
( NCT03860220 465 466 O
New NCT03860220 467 470 B-Observation
York NCT03860220 471 475 I-Observation
Heart NCT03860220 476 481 I-Observation
Association NCT03860220 482 493 I-Observation
functional NCT03860220 494 504 O
class NCT03860220 505 510 B-Eq_Comparison
III NCT03860220 511 514 I-Eq_Comparison
and NCT03860220 515 518 I-Eq_Comparison
IV NCT03860220 519 521 I-Eq_Comparison
) NCT03860220 522 523 O

- NCT03860220 527 528 O
hypersensitivity NCT03860220 530 546 B-Condition
to NCT03860220 547 549 O
telmisartan NCT03860220 550 561 B-Drug
or NCT03860220 562 564 B-Or
rosuvastatin NCT03860220 565 577 B-Drug

- NCT03860220 580 581 O
history NCT03860220 583 590 B-Eq_Comparison
of NCT03860220 591 593 O
angioedema NCT03860220 594 604 B-Condition
after NCT03860220 605 610 B-Temporal_Connection___Temporal_Connection_Type_Value:after
treatment NCT03860220 611 620 B-Procedure
with NCT03860220 621 625 O
angiotensin NCT03860220 626 637 B-Drug
- NCT03860220 638 639 I-Drug
converting NCT03860220 640 650 I-Drug
enzyme NCT03860220 651 657 I-Drug
inhibitors NCT03860220 658 668 I-Drug
or NCT03860220 669 671 B-Or
ARBs NCT03860220 672 676 B-Drug
; NCT03860220 676 677 O
creatinine NCT03860220 678 688 B-Observation
phosphokinase NCT03860220 689 702 I-Observation
levels NCT03860220 703 709 O
≥ NCT03860220 710 711 B-Eq_Comparison
3 NCT03860220 712 713 I-Eq_Comparison
times NCT03860220 714 719 I-Eq_Comparison
the NCT03860220 720 723 I-Eq_Comparison
upper NCT03860220 724 729 I-Eq_Comparison
limit NCT03860220 730 735 I-Eq_Comparison
of NCT03860220 736 738 I-Eq_Comparison
normal NCT03860220 739 745 I-Eq_Comparison

- NCT03860220 748 749 O
estimated NCT03860220 751 760 B-Observation
glomerular NCT03860220 761 771 I-Observation
filtration NCT03860220 772 782 I-Observation
rate NCT03860220 783 787 I-Observation
≤ NCT03860220 788 789 B-Eq_Comparison
30 NCT03860220 790 792 I-Eq_Comparison
mL NCT03860220 793 795 I-Eq_Comparison
/ NCT03860220 796 797 I-Eq_Comparison
min NCT03860220 798 801 I-Eq_Comparison
; NCT03860220 801 802 O
aspartate NCT03860220 803 812 B-Observation
aminotransferase NCT03860220 813 829 I-Observation
and NCT03860220 830 833 B-Or
alanine NCT03860220 834 841 B-Observation
aminotransferase NCT03860220 842 858 I-Observation
levels NCT03860220 859 865 O
≥ NCT03860220 866 867 B-Eq_Comparison
3 NCT03860220 868 869 I-Eq_Comparison
times NCT03860220 870 875 I-Eq_Comparison
the NCT03860220 876 879 I-Eq_Comparison
upper NCT03860220 880 885 I-Eq_Comparison
limit NCT03860220 886 891 I-Eq_Comparison
of NCT03860220 892 894 I-Eq_Comparison
normal NCT03860220 895 901 I-Eq_Comparison

- NCT03860220 904 905 O
potassium NCT03860220 907 916 B-Observation
levels NCT03860220 917 923 O
> NCT03860220 924 925 B-Eq_Comparison
5.5 NCT03860220 926 929 I-Eq_Comparison
mmol NCT03860220 930 934 I-Eq_Comparison
/ NCT03860220 935 936 I-Eq_Comparison
L NCT03860220 937 938 I-Eq_Comparison
; NCT03860220 938 939 O
or NCT03860220 940 942 B-Or
any NCT03860220 943 946 O
diseases NCT03860220 947 955 B-Condition
that NCT03860220 956 960 O
could NCT03860220 961 966 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03860220 967 973 O
the NCT03860220 974 977 O
results NCT03860220 978 985 O
of NCT03860220 986 988 O
the NCT03860220 989 992 O
study NCT03860220 993 998 B-Study
. NCT03860220 999 1000 O

Inclusion NCT03867422 0 9 O
Criteria NCT03867422 10 18 O
: NCT03867422 19 20 O

- NCT03867422 24 25 O
more NCT03867422 27 31 B-Eq_Comparison
or NCT03867422 32 34 I-Eq_Comparison
equal NCT03867422 35 40 I-Eq_Comparison
18 NCT03867422 41 43 I-Eq_Comparison
years NCT03867422 44 49 I-Eq_Comparison
- NCT03867422 50 51 O
old NCT03867422 52 55 B-Age
and NCT03867422 56 59 B-And
less NCT03867422 60 64 B-Eq_Comparison
or NCT03867422 65 67 I-Eq_Comparison
equal NCT03867422 68 73 I-Eq_Comparison
45 NCT03867422 74 76 I-Eq_Comparison
years NCT03867422 77 82 I-Eq_Comparison
- NCT03867422 83 84 O
old NCT03867422 85 88 B-Age

- NCT03867422 91 92 O
no NCT03867422 94 96 B-Negation
known NCT03867422 97 102 O
hearing NCT03867422 103 110 B-Condition
problem NCT03867422 111 118 I-Condition

Exclusion NCT03867422 119 128 O
Criteria NCT03867422 129 137 O
: NCT03867422 138 139 O

- NCT03867422 143 144 O
professional NCT03867422 146 158 B-Observation
musician NCT03867422 159 167 I-Observation

- NCT03867422 170 171 O
history NCT03867422 173 180 B-Eq_Comparison
of NCT03867422 181 183 O
neurologic NCT03867422 184 194 B-Modifier
, NCT03867422 195 196 O
psychiatric NCT03867422 197 208 B-Modifier
or NCT03867422 209 211 O
cadiologic NCT03867422 212 222 B-Modifier
disease NCT03867422 223 230 B-Condition

- NCT03867422 233 234 O
treatment NCT03867422 236 245 B-Procedure
which NCT03867422 246 251 O
could NCT03867422 252 257 B-Assertion___Assertion_Type_Value:hypothetical
impact NCT03867422 258 264 O
parameters NCT03867422 265 275 B-Observation
of NCT03867422 276 278 O
brain NCT03867422 279 284 B-Modifier
tissue NCT03867422 285 291 I-Modifier
pulsatility NCT03867422 292 303 I-Modifier
and NCT03867422 304 307 O
peripheral NCT03867422 308 318 B-Modifier
nervous NCT03867422 319 326 I-Modifier
system NCT03867422 327 333 I-Modifier

- NCT03867422 336 337 O
opposition NCT03867422 339 349 O
to NCT03867422 350 352 O
use NCT03867422 353 356 O
the NCT03867422 357 360 O
data NCT03867422 361 365 O

Inclusion NCT03866720 0 9 O
Criteria NCT03866720 10 18 O
: NCT03866720 19 20 O

- NCT03866720 24 25 O
Body NCT03866720 27 31 B-Observation
mass NCT03866720 32 36 I-Observation
index NCT03866720 37 42 I-Observation
18.5 NCT03866720 43 47 B-Eq_Comparison
- NCT03866720 48 49 I-Eq_Comparison
29.9 NCT03866720 50 54 I-Eq_Comparison
kg NCT03866720 55 57 I-Eq_Comparison
∙ NCT03866720 58 59 I-Eq_Comparison
m NCT03866720 60 61 I-Eq_Comparison
- NCT03866720 62 63 I-Eq_Comparison
2 NCT03866720 64 65 I-Eq_Comparison

- NCT03866720 69 70 O
Age NCT03866720 72 75 B-Age
18 NCT03866720 76 78 B-Eq_Comparison
- NCT03866720 79 80 I-Eq_Comparison
65 NCT03866720 81 83 I-Eq_Comparison
years NCT03866720 84 89 I-Eq_Comparison

- NCT03866720 92 93 O
Able NCT03866720 95 99 O
and NCT03866720 100 103 O
willing NCT03866720 104 111 O
to NCT03866720 112 114 O
provide NCT03866720 115 122 O
informed NCT03866720 123 131 O
consent NCT03866720 132 139 O
and NCT03866720 140 143 O
safely NCT03866720 144 150 O
comply NCT03866720 151 157 O
with NCT03866720 158 162 O
study NCT03866720 163 168 B-Study
procedures NCT03866720 169 179 B-Procedure

- NCT03866720 182 183 O
Females NCT03866720 185 192 O
to NCT03866720 193 195 B-Assertion___Assertion_Type_Value:hypothetical
maintain NCT03866720 196 204 I-Assertion___Assertion_Type_Value:hypothetical
record NCT03866720 205 211 O
of NCT03866720 212 214 O
regular NCT03866720 215 222 O
menstrual NCT03866720 223 232 B-Procedure
cycle NCT03866720 233 238 I-Procedure
phase NCT03866720 239 244 I-Procedure
or NCT03866720 245 247 B-Or
contraceptive NCT03866720 248 261 B-Procedure
use NCT03866720 262 265 O

- NCT03866720 268 269 O
No NCT03866720 271 273 B-Negation
anticipated NCT03866720 274 285 B-Assertion___Assertion_Type_Value:hypothetical
changes NCT03866720 286 293 O
in NCT03866720 294 296 O
diet NCT03866720 297 301 B-Observation
/ NCT03866720 302 303 B-Or
physical NCT03866720 304 312 B-Observation
activity NCT03866720 313 321 I-Observation
during NCT03866720 322 328 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866720 329 332 O
study NCT03866720 333 338 B-Study
( NCT03866720 339 340 O
e NCT03866720 341 342 O
. NCT03866720 343 344 O
g NCT03866720 345 346 O
. NCT03866720 347 348 O
holidays NCT03866720 350 358 O
or NCT03866720 359 361 O
diet NCT03866720 362 366 B-Observation
plans NCT03866720 367 372 B-Assertion___Assertion_Type_Value:intention
) NCT03866720 373 374 O

- NCT03866720 378 379 O
Inclusive NCT03866720 381 390 O
to NCT03866720 391 393 O
all NCT03866720 394 397 O
breakfast NCT03866720 398 407 O
habits NCT03866720 408 414 O
( NCT03866720 415 416 O
e NCT03866720 417 418 O
. NCT03866720 419 420 O
g NCT03866720 421 422 O
. NCT03866720 423 424 O
regular NCT03866720 426 433 O
skipper NCT03866720 434 441 O
/ NCT03866720 442 443 O
consumer NCT03866720 444 452 O
) NCT03866720 453 454 O

Exclusion NCT03866720 456 465 O
Criteria NCT03866720 466 474 O
: NCT03866720 475 476 O

- NCT03866720 480 481 O
Any NCT03866720 483 486 O
reported NCT03866720 487 495 O
condition NCT03866720 496 505 B-Condition
or NCT03866720 506 508 B-Or
behaviour NCT03866720 509 518 B-Condition
deemed NCT03866720 519 525 O
either NCT03866720 526 532 O
to NCT03866720 533 535 O
pose NCT03866720 536 540 O
undue NCT03866720 541 546 O
personal NCT03866720 547 555 O
risk NCT03866720 556 560 B-Risk
to NCT03866720 561 563 O
the NCT03866720 564 567 O
participant NCT03866720 568 579 O
or NCT03866720 580 582 B-Or
introduce NCT03866720 583 592 O
bias NCT03866720 593 597 O

- NCT03866720 600 601 O
Any NCT03866720 603 606 O
diagnosed NCT03866720 607 616 O
metabolic NCT03866720 617 626 B-Condition
disease NCT03866720 627 634 I-Condition
( NCT03866720 635 636 O
e NCT03866720 637 638 O
. NCT03866720 639 640 O
g NCT03866720 641 642 O
. NCT03866720 643 644 O
type NCT03866720 646 650 B-Modifier
1 NCT03866720 651 652 I-Modifier
or NCT03866720 653 655 B-Or
type NCT03866720 656 660 B-Modifier
2 NCT03866720 661 662 I-Modifier
diabetes NCT03866720 663 671 B-Condition
) NCT03866720 672 673 O

- NCT03866720 677 678 O
Any NCT03866720 680 683 O
reported NCT03866720 684 692 O
use NCT03866720 693 696 O
of NCT03866720 697 699 O
substances NCT03866720 700 710 B-Drug
which NCT03866720 711 716 O
may NCT03866720 717 720 B-Assertion___Assertion_Type_Value:hypothetical
pose NCT03866720 721 725 O
undue NCT03866720 726 731 O
personal NCT03866720 732 740 O
risk NCT03866720 741 745 B-Risk
to NCT03866720 746 748 O
the NCT03866720 749 752 O
participants NCT03866720 753 765 O
or NCT03866720 766 768 B-Or
introduce NCT03866720 769 778 O
bias NCT03866720 779 783 O
into NCT03866720 784 788 O
the NCT03866720 789 792 O
experiment NCT03866720 793 803 B-Study
( NCT03866720 804 805 O
e NCT03866720 806 807 O
. NCT03866720 808 809 O
g NCT03866720 810 811 O
. NCT03866720 812 813 O
smoking NCT03866720 815 822 B-Condition
/ NCT03866720 823 824 B-Or
substance NCT03866720 825 834 B-Condition
abuse NCT03866720 835 840 I-Condition
) NCT03866720 841 842 O

- NCT03866720 846 847 O
Lifestyle NCT03866720 849 858 O
not NCT03866720 859 862 B-Negation
conforming NCT03866720 863 873 O
to NCT03866720 874 876 O
standard NCT03866720 877 885 O
sleep NCT03866720 886 891 B-Condition
- NCT03866720 892 893 I-Condition
wake NCT03866720 894 898 I-Condition
cycle NCT03866720 899 904 I-Condition
( NCT03866720 905 906 O
e NCT03866720 907 908 O
. NCT03866720 909 910 O
g NCT03866720 911 912 O
. NCT03866720 913 914 O
shift NCT03866720 916 921 B-Observation
worker NCT03866720 922 928 I-Observation
) NCT03866720 929 930 O

- NCT03866720 934 935 O
Any NCT03866720 937 940 O
reported NCT03866720 941 949 O
recent NCT03866720 950 956 B-Eq_Comparison
( NCT03866720 957 958 O
< NCT03866720 959 960 B-Eq_Comparison
6 NCT03866720 961 962 I-Eq_Comparison
months NCT03866720 963 969 I-Eq_Comparison
) NCT03866720 970 971 O
change NCT03866720 972 978 O
in NCT03866720 979 981 O
body NCT03866720 982 986 B-Observation
mass NCT03866720 987 991 I-Observation
( NCT03866720 992 993 O
± NCT03866720 994 995 B-Eq_Comparison
3 NCT03866720 996 997 I-Eq_Comparison
% NCT03866720 998 999 I-Eq_Comparison
) NCT03866720 1000 1001 O

Inclusion NCT03862534 0 9 O
Criteria NCT03862534 10 18 O
: NCT03862534 19 20 O

- NCT03862534 24 25 O
Age NCT03862534 27 30 B-Age
≥ NCT03862534 31 32 B-Eq_Comparison
18 NCT03862534 33 35 I-Eq_Comparison
years NCT03862534 36 41 I-Eq_Comparison

- NCT03862534 44 45 O
No NCT03862534 47 49 B-Negation
systemic NCT03862534 50 58 B-Modifier
diseases NCT03862534 59 67 B-Condition
or NCT03862534 68 70 B-Or
pregnancy NCT03862534 71 80 B-Condition
. NCT03862534 81 82 O

- NCT03862534 86 87 O
Self NCT03862534 89 93 O
- NCT03862534 94 95 O
reported NCT03862534 96 104 O
smoking NCT03862534 105 112 B-Observation
≤ NCT03862534 113 114 B-Eq_Comparison
10 NCT03862534 115 117 I-Eq_Comparison
cigarettes NCT03862534 118 128 I-Eq_Comparison
/ NCT03862534 129 130 I-Eq_Comparison
day NCT03862534 131 134 I-Eq_Comparison
. NCT03862534 135 136 O

- NCT03862534 140 141 O
Full NCT03862534 143 147 B-Observation
- NCT03862534 148 149 I-Observation
mouth NCT03862534 150 155 I-Observation
plaque NCT03862534 156 162 I-Observation
score NCT03862534 163 168 I-Observation
( NCT03862534 169 170 O
FMPS NCT03862534 171 175 B-Observation
) NCT03862534 176 177 O
and NCT03862534 178 181 B-And
full NCT03862534 182 186 B-Observation
- NCT03862534 187 188 I-Observation
mouth NCT03862534 189 194 I-Observation
bleeding NCT03862534 195 203 I-Observation
score NCT03862534 204 209 I-Observation
( NCT03862534 210 211 O
FMBS NCT03862534 212 216 B-Observation
) NCT03862534 217 218 O
≤ NCT03862534 219 220 B-Eq_Comparison
10 NCT03862534 221 223 I-Eq_Comparison
% NCT03862534 224 225 I-Eq_Comparison
( NCT03862534 226 227 O
measured NCT03862534 228 236 O
at NCT03862534 237 239 O
four NCT03862534 240 244 B-Eq_Comparison
sites NCT03862534 245 250 I-Eq_Comparison
per NCT03862534 251 254 I-Eq_Comparison
tooth NCT03862534 255 260 I-Eq_Comparison
) NCT03862534 261 262 O
. NCT03862534 263 264 O

- NCT03862534 268 269 O
Presence NCT03862534 271 279 O
of NCT03862534 280 282 O
single NCT03862534 283 289 B-Eq_Comparison
RT NCT03862534 290 292 B-Modifier
1 NCT03862534 293 294 I-Modifier
buccal NCT03862534 295 301 I-Modifier
gingival NCT03862534 302 310 B-Observation
recessions NCT03862534 311 321 I-Observation
≥ NCT03862534 322 323 B-Eq_Comparison
2 NCT03862534 324 325 I-Eq_Comparison
mm NCT03862534 326 328 I-Eq_Comparison
of NCT03862534 329 331 O
depth NCT03862534 332 337 O
located NCT03862534 338 345 O
in NCT03862534 346 348 O
the NCT03862534 349 352 O
anterior NCT03862534 353 361 B-Modifier
area NCT03862534 362 366 I-Modifier
of NCT03862534 367 369 O
the NCT03862534 370 373 O
upper NCT03862534 374 379 B-Modifier
jaw NCT03862534 380 383 I-Modifier
( NCT03862534 384 385 O
central NCT03862534 386 393 B-Modifier
and NCT03862534 394 397 B-Or
lateral NCT03862534 398 405 B-Modifier
incisors NCT03862534 406 414 I-Modifier
, NCT03862534 415 416 O
canine NCT03862534 417 423 B-Modifier
, NCT03862534 424 425 O
first NCT03862534 426 431 B-Modifier
and NCT03862534 432 435 I-Modifier
second NCT03862534 436 442 I-Modifier
pre NCT03862534 443 446 I-Modifier
- NCT03862534 447 448 I-Modifier
molars NCT03862534 449 455 I-Modifier
, NCT03862534 456 457 O
first NCT03862534 458 463 B-Modifier
molar NCT03862534 464 469 I-Modifier
) NCT03862534 470 471 O
and NCT03862534 472 475 O
associated NCT03862534 476 486 O
with NCT03862534 487 491 O
aesthetic NCT03862534 492 501 B-Condition
complains NCT03862534 502 511 I-Condition
and NCT03862534 512 515 O
or NCT03862534 516 518 B-Or
dental NCT03862534 519 525 B-Condition
sensitivity NCT03862534 526 537 I-Condition
. NCT03862534 538 539 O

- NCT03862534 543 544 O
Presence NCT03862534 546 554 O
of NCT03862534 555 557 O
NCCL NCT03862534 558 562 B-Condition
associated NCT03862534 563 573 O
with NCT03862534 574 578 O
recession NCT03862534 579 588 B-Condition

- NCT03862534 591 592 O
No NCT03862534 594 596 B-Negation
history NCT03862534 597 604 B-Eq_Comparison
of NCT03862534 605 607 O
mucogingival NCT03862534 608 620 B-Modifier
or NCT03862534 621 623 B-Or
periodontal NCT03862534 624 635 B-Modifier
surgery NCT03862534 636 643 B-Procedure
at NCT03862534 644 646 O
experimental NCT03862534 647 659 B-Modifier
sites NCT03862534 660 665 I-Modifier
. NCT03862534 666 667 O

Exclusion NCT03862534 669 678 O
Criteria NCT03862534 679 687 O
: NCT03862534 688 689 O

- NCT03862534 693 694 O
Prosthetic NCT03862534 696 706 B-Condition
crown NCT03862534 707 712 I-Condition
at NCT03862534 713 715 O
experimental NCT03862534 716 728 B-Modifier
teeth NCT03862534 729 734 I-Modifier
. NCT03862534 735 736 O

- NCT03862534 740 741 O
Gingival NCT03862534 743 751 B-Condition
recessions NCT03862534 752 762 I-Condition
presenting NCT03862534 763 773 O
minimal NCT03862534 774 781 O
amount NCT03862534 782 788 O
( NCT03862534 789 790 O
< NCT03862534 791 792 B-Eq_Comparison
1 NCT03862534 793 794 I-Eq_Comparison
mm NCT03862534 795 797 I-Eq_Comparison
) NCT03862534 798 799 O
of NCT03862534 800 802 O
apico NCT03862534 803 808 B-Observation
- NCT03862534 809 810 I-Observation
coronal NCT03862534 811 818 I-Observation
keratinized NCT03862534 819 830 I-Observation
tissue NCT03862534 831 837 I-Observation
( NCT03862534 838 839 O
KT NCT03862534 840 842 B-Observation
) NCT03862534 843 844 O
extension NCT03862534 845 854 O
apical NCT03862534 855 861 B-Modifier
to NCT03862534 862 864 I-Modifier
recession NCT03862534 865 874 I-Modifier
area NCT03862534 875 879 I-Modifier
. NCT03862534 880 881 O

Inclusion NCT03924726 0 9 O
Criteria NCT03924726 10 18 O
: NCT03924726 19 20 O

- NCT03924726 24 25 O
Aged NCT03924726 27 31 B-Age
18 NCT03924726 32 34 B-Eq_Comparison
years NCT03924726 35 40 I-Eq_Comparison
and NCT03924726 41 44 I-Eq_Comparison
above NCT03924726 45 50 I-Eq_Comparison
at NCT03924726 51 53 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03924726 54 57 I-Temporal_Connection___Temporal_Connection_Type_Value:during
start NCT03924726 58 63 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03924726 64 66 O
the NCT03924726 67 70 O
treatment NCT03924726 71 80 B-Study
. NCT03924726 81 82 O

- NCT03924726 86 87 O
Molar NCT03924726 89 94 B-Condition
relationship NCT03924726 95 107 I-Condition
either NCT03924726 108 114 O
Class NCT03924726 115 120 B-Eq_Comparison
I NCT03924726 121 122 I-Eq_Comparison
, NCT03924726 123 124 O
< NCT03924726 125 126 B-Eq_Comparison
½ NCT03924726 127 128 I-Eq_Comparison
unit NCT03924726 129 133 I-Eq_Comparison
Class NCT03924726 134 139 I-Eq_Comparison
II NCT03924726 140 142 I-Eq_Comparison
or NCT03924726 143 145 B-Or
Class NCT03924726 146 151 B-Eq_Comparison
III NCT03924726 152 155 I-Eq_Comparison
. NCT03924726 156 157 O

- NCT03924726 161 162 O
Extraction NCT03924726 164 174 B-Procedure
of NCT03924726 175 177 I-Procedure
all NCT03924726 178 181 I-Procedure
four NCT03924726 182 186 I-Procedure
first NCT03924726 187 192 I-Procedure
premolar NCT03924726 193 201 I-Procedure
teeth NCT03924726 202 207 I-Procedure
as NCT03924726 208 210 O
part NCT03924726 211 215 O
of NCT03924726 216 218 O
orthodontic NCT03924726 219 230 B-Procedure
treatment NCT03924726 231 240 I-Procedure
. NCT03924726 241 242 O

- NCT03924726 246 247 O
Maximum NCT03924726 249 256 B-Procedure
anchorage NCT03924726 257 266 I-Procedure
required NCT03924726 267 275 O
using NCT03924726 276 281 O
mini NCT03924726 282 286 B-Procedure
- NCT03924726 287 288 I-Procedure
implant NCT03924726 289 296 I-Procedure
. NCT03924726 297 298 O

- NCT03924726 302 303 O
No NCT03924726 305 307 B-Negation
systemic NCT03924726 308 316 B-Condition
disease NCT03924726 317 324 I-Condition
. NCT03924726 325 326 O

- NCT03924726 330 331 O
Good NCT03924726 333 337 O
oral NCT03924726 338 342 O
hygiene NCT03924726 343 350 O
. NCT03924726 351 352 O

- NCT03924726 356 357 O
No NCT03924726 359 361 B-Negation
periodontal NCT03924726 362 373 B-Condition
disease NCT03924726 374 381 I-Condition
. NCT03924726 382 383 O

Exclusion NCT03924726 385 394 O
Criteria NCT03924726 395 403 O
: NCT03924726 404 405 O

- NCT03924726 409 410 O
Significant NCT03924726 412 423 O
vertical NCT03924726 424 432 B-Condition
skeletal NCT03924726 433 441 I-Condition
discrepancies NCT03924726 442 455 I-Condition
. NCT03924726 456 457 O

- NCT03924726 461 462 O
Systemic NCT03924726 464 472 B-Condition
diseases NCT03924726 473 481 I-Condition
requiring NCT03924726 482 491 B-Assertion___Assertion_Type_Value:hypothetical
long NCT03924726 492 496 O
- NCT03924726 497 498 O
term NCT03924726 499 503 O
antibiotic NCT03924726 504 514 B-Drug
use NCT03924726 515 518 O
, NCT03924726 519 520 O
phenytoin NCT03924726 521 530 B-Drug
, NCT03924726 531 532 O
cyclosporin NCT03924726 533 544 B-Drug
, NCT03924726 545 546 O
anti NCT03924726 547 551 B-Drug
- NCT03924726 552 553 I-Drug
inflammatory NCT03924726 554 566 I-Drug
drugs NCT03924726 567 572 I-Drug
, NCT03924726 573 574 O
bisphosphonates NCT03924726 575 590 B-Drug
, NCT03924726 591 592 O
systemic NCT03924726 593 601 B-Drug
corticosteroids NCT03924726 602 617 I-Drug
or NCT03924726 618 620 B-Or
calcium NCT03924726 621 628 B-Drug
channel NCT03924726 629 636 I-Drug
blockers NCT03924726 637 645 I-Drug
. NCT03924726 646 647 O

- NCT03924726 651 652 O
Poor NCT03924726 654 658 B-Condition
oral NCT03924726 659 663 I-Condition
hygiene NCT03924726 664 671 I-Condition
. NCT03924726 672 673 O

- NCT03924726 677 678 O
Active NCT03924726 680 686 B-Eq_Comparison
periodontal NCT03924726 687 698 B-Condition
disease NCT03924726 699 706 I-Condition
. NCT03924726 707 708 O


Inclusion NCT03921697 0 9 O
Criteria NCT03921697 10 18 O
: NCT03921697 19 20 O

- NCT03921697 24 25 O
Idiopathic NCT03921697 27 37 B-Modifier
Parkinson NCT03921697 38 47 B-Condition
's NCT03921697 47 49 I-Condition
disease NCT03921697 50 57 I-Condition
diagnosed NCT03921697 58 67 O
by NCT03921697 68 70 O
a NCT03921697 71 72 O
neurologist NCT03921697 73 84 B-Provider

- NCT03921697 87 88 O
Ability NCT03921697 90 97 O
to NCT03921697 98 100 O
sign NCT03921697 101 105 O
informed NCT03921697 106 114 O
consent NCT03921697 115 122 O

Exclusion NCT03921697 123 132 O
Criteria NCT03921697 133 141 O
: NCT03921697 142 143 O

- NCT03921697 147 148 O
Inability NCT03921697 150 159 O
to NCT03921697 160 162 O
sign NCT03921697 163 167 O
informed NCT03921697 168 176 O
consent NCT03921697 177 184 O

- NCT03921697 187 188 O
Inability NCT03921697 190 199 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03921697 200 202 O
fill NCT03921697 203 207 O
out NCT03921697 208 211 O
questionnaires NCT03921697 212 226 B-Observation
( NCT03921697 227 228 O
i NCT03921697 229 230 O
. NCT03921697 231 232 O
e NCT03921697 233 234 O
. NCT03921697 235 236 O
due NCT03921697 238 241 O
to NCT03921697 242 244 O
poor NCT03921697 245 249 B-Condition
vision NCT03921697 250 256 I-Condition
, NCT03921697 257 258 O
inability NCT03921697 259 268 B-Condition
to NCT03921697 269 271 I-Condition
read NCT03921697 272 276 I-Condition
, NCT03921697 277 278 O
etc NCT03921697 279 282 O
) NCT03921697 283 284 O

- NCT03921697 288 289 O
Presence NCT03921697 291 299 O
of NCT03921697 300 302 O
psychiatric NCT03921697 303 314 B-Condition
diseases NCT03921697 315 323 I-Condition
( NCT03921697 324 325 O
episode NCT03921697 326 333 O
or NCT03921697 334 336 O
any NCT03921697 337 340 O
form NCT03921697 341 345 O
of NCT03921697 346 348 O
psychosis NCT03921697 349 358 B-Condition
, NCT03921697 359 360 O
diagnosed NCT03921697 361 370 O
by NCT03921697 371 373 O
a NCT03921697 374 375 O
psychiatrist NCT03921697 376 388 B-Provider
in NCT03921697 389 391 O
the NCT03921697 392 395 O
last NCT03921697 396 400 B-Eq_Comparison
year NCT03921697 401 405 I-Eq_Comparison
) NCT03921697 406 407 O
. NCT03921697 408 409 O

- NCT03921697 413 414 O
Age NCT03921697 416 419 B-Age
under NCT03921697 420 425 B-Eq_Comparison
18 NCT03921697 426 428 I-Eq_Comparison
yrs NCT03921697 429 432 I-Eq_Comparison
old NCT03921697 433 436 I-Eq_Comparison

Inclusion NCT03927339 0 9 O
Criteria NCT03927339 10 18 O
: NCT03927339 19 20 O

- NCT03927339 24 25 O
: NCT03927339 27 28 O
knee NCT03927339 29 33 B-Modifier
OA NCT03927339 34 36 B-Condition
with NCT03927339 37 41 B-And
obesity NCT03927339 42 49 B-Condition
; NCT03927339 49 50 O
sedentary NCT03927339 51 60 B-Condition
with NCT03927339 61 65 B-And
no NCT03927339 66 68 B-Negation
previous NCT03927339 69 77 B-Eq_Comparison
education NCT03927339 78 87 B-Observation
; NCT03927339 88 89 O
ability NCT03927339 90 97 O
to NCT03927339 98 100 O
understand NCT03927339 101 111 O
and NCT03927339 112 115 O
follow NCT03927339 116 122 O
commands NCT03927339 123 131 O
; NCT03927339 131 132 O
and NCT03927339 133 136 O
ability NCT03927339 137 144 B-Condition
to NCT03927339 145 147 I-Condition
walk NCT03927339 148 152 I-Condition
independently NCT03927339 153 166 O
. NCT03927339 167 168 O

Exclusion NCT03927339 170 179 O
Criteria NCT03927339 180 188 O
: NCT03927339 189 190 O

- NCT03927339 194 195 O
Medical NCT03927339 197 204 B-Condition
conditions NCT03927339 205 215 I-Condition
contraindicating NCT03927339 216 232 B-Contraindication
moderate NCT03927339 233 241 O
aerobic NCT03927339 242 249 B-Observation
exercising NCT03927339 250 260 I-Observation
( NCT03927339 261 262 O
as NCT03927339 263 265 O
determined NCT03927339 266 276 O
through NCT03927339 277 284 O
prescreening NCT03927339 285 297 O
questions NCT03927339 298 307 O
, NCT03927339 308 309 O
i NCT03927339 310 311 O
. NCT03927339 312 313 O
e NCT03927339 314 315 O
. NCT03927339 316 317 O
, NCT03927339 318 319 O
cardiac NCT03927339 320 327 B-Modifier
or NCT03927339 328 330 B-Or
coronary NCT03927339 331 339 B-Modifier
artery NCT03927339 340 346 B-Condition
disease NCT03927339 347 354 I-Condition
as NCT03927339 355 357 O
ischemic NCT03927339 358 366 B-Condition
cardiomyopathy NCT03927339 367 381 I-Condition
, NCT03927339 382 383 O
chronic NCT03927339 384 391 B-Condition
lung NCT03927339 392 396 I-Condition
disease NCT03927339 397 404 I-Condition
, NCT03927339 405 406 O
asthma NCT03927339 407 413 B-Condition
, NCT03927339 414 415 O
uncontrolled NCT03927339 416 428 B-Modifier
hypertension NCT03927339 429 441 B-Condition
) NCT03927339 442 443 O
, NCT03927339 444 445 O
inability NCT03927339 446 455 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03927339 456 458 O
exercise NCT03927339 459 467 B-Observation
via NCT03927339 468 471 I-Observation
treadmill NCT03927339 472 481 I-Observation
( NCT03927339 482 483 O
i NCT03927339 484 485 O
. NCT03927339 486 487 O
e NCT03927339 488 489 O
. NCT03927339 490 491 O
no NCT03927339 493 495 B-Negation
neuromuscular NCT03927339 496 509 B-Modifier
or NCT03927339 510 512 B-Or
lower NCT03927339 513 518 B-Modifier
extremity NCT03927339 519 528 I-Modifier
conditions NCT03927339 529 539 B-Condition
or NCT03927339 540 542 B-Or
any NCT03927339 543 546 O
other NCT03927339 547 552 O
medical NCT03927339 553 560 O
contraindication NCT03927339 561 577 B-Contraindication
that NCT03927339 578 582 O
could NCT03927339 583 588 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03927339 589 596 B-Negation
them NCT03927339 597 601 O
from NCT03927339 602 606 O
floor NCT03927339 607 612 B-Observation
walking NCT03927339 613 620 I-Observation
as NCT03927339 621 623 O
upset NCT03927339 624 629 O
affecting NCT03927339 630 639 O
movement NCT03927339 640 648 B-Condition
of NCT03927339 649 651 O
the NCT03927339 652 655 O
pelvic NCT03927339 656 662 B-Modifier
arch NCT03927339 663 667 I-Modifier
or NCT03927339 668 670 B-Or
pace NCT03927339 671 675 B-Modifier
, NCT03927339 676 677 O
story NCT03927339 678 683 O
of NCT03927339 684 686 O
previous NCT03927339 687 695 B-Eq_Comparison
hip NCT03927339 696 699 B-Modifier
or NCT03927339 700 702 B-Or
knee NCT03927339 703 707 B-Modifier
operating NCT03927339 708 717 B-Procedure
room NCT03927339 718 722 O
, NCT03927339 723 724 O
periarticular NCT03927339 725 738 B-Modifier
fractures NCT03927339 739 748 B-Condition
, NCT03927339 749 750 O
or NCT03927339 751 753 O
lower NCT03927339 754 759 B-Modifier
limb NCT03927339 760 764 I-Modifier
injuries NCT03927339 765 773 B-Condition
) NCT03927339 774 775 O
. NCT03927339 776 777 O
History NCT03927339 778 785 B-Eq_Comparison
of NCT03927339 786 788 O
recent NCT03927339 789 795 B-Eq_Comparison
reefer NCT03927339 796 802 B-Condition
transmission NCT03927339 803 815 I-Condition
or NCT03927339 816 818 B-Or
acute NCT03927339 819 824 O
joint NCT03927339 825 830 B-Condition
lighting NCT03927339 831 839 I-Condition
. NCT03927339 840 841 O
History NCT03927339 842 849 B-Eq_Comparison
of NCT03927339 850 852 O
recent NCT03927339 853 859 B-Eq_Comparison
joint NCT03927339 860 865 B-Procedure
injection NCT03927339 866 875 I-Procedure
( NCT03927339 876 877 O
steroid NCT03927339 878 885 B-Drug
, NCT03927339 886 887 O
hyaluronic NCT03927339 888 898 B-Drug
acid NCT03927339 899 903 I-Drug
, NCT03927339 904 905 O
etc NCT03927339 906 909 O
. NCT03927339 910 911 O
) NCT03927339 912 913 O
within NCT03927339 914 920 B-Eq_Comparison
6 NCT03927339 921 922 I-Eq_Comparison
calendar NCT03927339 923 931 I-Eq_Comparison
week NCT03927339 932 936 I-Eq_Comparison
of NCT03927339 937 939 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03927339 940 945 B-Study
. NCT03927339 946 947 O
Ingestion NCT03927339 949 958 O
of NCT03927339 959 961 O
antioxidant NCT03927339 962 973 B-Drug
supplementation NCT03927339 974 989 I-Drug
and NCT03927339 990 993 B-Or
the NCT03927339 994 997 O
use NCT03927339 998 1001 O
of NCT03927339 1002 1004 O
psychotropic NCT03927339 1005 1017 B-Drug
agents NCT03927339 1018 1024 I-Drug
. NCT03927339 1025 1026 O

Inclusion NCT03924336 0 9 O
Criteria NCT03924336 10 18 O
: NCT03924336 19 20 O

- NCT03924336 24 25 O
Stage NCT03924336 27 32 B-Eq_Comparison
III NCT03924336 33 36 I-Eq_Comparison
periodontitis NCT03924336 37 50 B-Condition
patient NCT03924336 51 58 O
having NCT03924336 59 65 B-And
at NCT03924336 66 68 B-Eq_Comparison
least NCT03924336 69 74 I-Eq_Comparison
one NCT03924336 75 78 I-Eq_Comparison
tooth NCT03924336 79 84 I-Eq_Comparison
with NCT03924336 85 89 O
2 NCT03924336 90 91 B-Modifier
- NCT03924336 92 93 I-Modifier
wall NCT03924336 94 98 I-Modifier
, NCT03924336 99 100 O
3 NCT03924336 101 102 B-Modifier
- NCT03924336 103 104 I-Modifier
wall NCT03924336 105 109 I-Modifier
, NCT03924336 110 111 O
or NCT03924336 112 114 B-Or
combined NCT03924336 115 123 O
2 NCT03924336 124 125 B-Modifier
- NCT03924336 126 127 I-Modifier
to NCT03924336 128 130 I-Modifier
3 NCT03924336 131 132 I-Modifier
- NCT03924336 133 134 I-Modifier
wall NCT03924336 135 139 I-Modifier
intraosseous NCT03924336 140 152 B-Observation
defect NCT03924336 153 159 I-Observation
≥ NCT03924336 160 161 B-Eq_Comparison
3 NCT03924336 162 163 I-Eq_Comparison
mm NCT03924336 164 166 I-Eq_Comparison
in NCT03924336 167 169 O
depth NCT03924336 170 175 O
( NCT03924336 176 177 O
assessed NCT03924336 178 186 O
by NCT03924336 187 189 O
bone NCT03924336 190 194 B-Procedure
sounding NCT03924336 195 203 I-Procedure
, NCT03924336 204 205 O
radiographic NCT03924336 206 218 B-Procedure
examination NCT03924336 219 230 I-Procedure
) NCT03924336 231 232 O
with NCT03924336 233 237 B-And
clinical NCT03924336 238 246 B-Observation
attachment NCT03924336 247 257 I-Observation
level NCT03924336 258 263 I-Observation
( NCT03924336 264 265 O
CAL NCT03924336 266 269 B-Observation
) NCT03924336 270 271 O
≥ NCT03924336 272 273 B-Eq_Comparison
5 NCT03924336 274 275 I-Eq_Comparison
mm NCT03924336 276 278 I-Eq_Comparison
and NCT03924336 279 282 B-And
pocket NCT03924336 283 289 B-Observation
depth NCT03924336 290 295 I-Observation
( NCT03924336 296 297 O
PD NCT03924336 298 300 B-Observation
) NCT03924336 301 302 O
≥ NCT03924336 303 304 B-Eq_Comparison
6 NCT03924336 305 306 I-Eq_Comparison
mm NCT03924336 307 309 I-Eq_Comparison
. NCT03924336 310 311 O

- NCT03924336 315 316 O
Defect NCT03924336 318 324 B-Condition
not NCT03924336 325 328 B-Negation
extending NCT03924336 329 338 O
to NCT03924336 339 341 O
a NCT03924336 342 343 O
root NCT03924336 344 348 B-Modifier
furcation NCT03924336 349 358 I-Modifier
area NCT03924336 359 363 I-Modifier

- NCT03924336 366 367 O
Vital NCT03924336 369 374 O
teeth NCT03924336 375 380 O

- NCT03924336 383 384 O
Non NCT03924336 386 389 B-Negation
- NCT03924336 390 391 O
smokers NCT03924336 392 399 B-Condition
. NCT03924336 400 401 O

- NCT03924336 405 406 O
No NCT03924336 408 410 B-Negation
history NCT03924336 411 418 B-Eq_Comparison
of NCT03924336 419 421 O
intake NCT03924336 422 428 O
of NCT03924336 429 431 O
antibiotics NCT03924336 432 443 B-Drug
or NCT03924336 444 446 B-Or
other NCT03924336 447 452 O
medications NCT03924336 453 464 B-Drug
affecting NCT03924336 465 474 O
the NCT03924336 475 478 O
periodontium NCT03924336 479 491 B-Condition
in NCT03924336 492 494 O
the NCT03924336 495 498 O
previous NCT03924336 499 507 B-Eq_Comparison
6 NCT03924336 508 509 I-Eq_Comparison
months NCT03924336 510 516 I-Eq_Comparison
. NCT03924336 517 518 O

- NCT03924336 522 523 O
No NCT03924336 525 527 B-Negation
periodontal NCT03924336 528 539 B-Procedure
therapy NCT03924336 540 547 I-Procedure
carried NCT03924336 548 555 O
out NCT03924336 556 559 O
in NCT03924336 560 562 O
the NCT03924336 563 566 O
past NCT03924336 567 571 B-Eq_Comparison
6 NCT03924336 572 573 I-Eq_Comparison
months NCT03924336 574 580 I-Eq_Comparison
. NCT03924336 581 582 O

- NCT03924336 586 587 O
Able NCT03924336 589 593 O
to NCT03924336 594 596 O
sign NCT03924336 597 601 O
an NCT03924336 602 604 O
informed NCT03924336 605 613 O
consent NCT03924336 614 621 O
form NCT03924336 622 626 O
. NCT03924336 627 628 O

- NCT03924336 632 633 O
Patients NCT03924336 635 643 O
age NCT03924336 644 647 B-Age
between NCT03924336 648 655 B-Eq_Comparison
25 NCT03924336 656 658 I-Eq_Comparison
and NCT03924336 659 662 I-Eq_Comparison
50 NCT03924336 663 665 I-Eq_Comparison
years NCT03924336 666 671 I-Eq_Comparison
old NCT03924336 672 675 O
. NCT03924336 676 677 O

- NCT03924336 681 682 O
Patients NCT03924336 684 692 O
who NCT03924336 693 696 O
are NCT03924336 697 700 O
cooperative NCT03924336 701 712 O
, NCT03924336 713 714 O
motivated NCT03924336 715 724 O
, NCT03924336 725 726 O
and NCT03924336 727 730 O
hygiene NCT03924336 731 738 O
conscious NCT03924336 739 748 O
. NCT03924336 749 750 O

- NCT03924336 754 755 O
Systemically NCT03924336 757 769 O
free NCT03924336 770 774 O
according NCT03924336 775 784 O
to NCT03924336 785 787 O
Cornell NCT03924336 788 795 O
Medical NCT03924336 796 803 O
Index NCT03924336 804 809 O
( NCT03924336 810 811 O
Broadbent NCT03924336 812 821 O
, NCT03924336 822 823 O
1951 NCT03924336 824 828 O
) NCT03924336 829 830 O
. NCT03924336 831 832 O

Exclusion NCT03924336 834 843 O
Criteria NCT03924336 844 852 O
: NCT03924336 853 854 O

- NCT03924336 858 859 O
Pregnancy NCT03924336 861 870 B-Condition
or NCT03924336 871 873 B-Or
breast NCT03924336 874 880 B-Condition
feeding NCT03924336 881 888 I-Condition

- NCT03924336 891 892 O
The NCT03924336 894 897 O
presence NCT03924336 898 906 O
of NCT03924336 907 909 O
an NCT03924336 910 912 O
orthodontic NCT03924336 913 924 B-Condition
appliance NCT03924336 925 934 I-Condition

- NCT03924336 937 938 O
Teeth NCT03924336 940 945 B-Condition
mobility NCT03924336 946 954 I-Condition
greater NCT03924336 955 962 B-Eq_Comparison
than NCT03924336 963 967 I-Eq_Comparison
grade NCT03924336 968 973 I-Eq_Comparison
I NCT03924336 974 975 I-Eq_Comparison

Inclusion NCT03864497 0 9 O
Criteria NCT03864497 10 18 O
: NCT03864497 19 20 O

• NCT03864497 22 23 O
Liver NCT03864497 24 29 B-Procedure
transplantation NCT03864497 30 45 I-Procedure
candidates NCT03864497 46 56 B-Assertion___Assertion_Type_Value:hypothetical
with NCT03864497 57 61 O
one NCT03864497 62 65 O
or NCT03864497 66 68 O
more NCT03864497 69 73 O
of NCT03864497 74 76 O
the NCT03864497 77 80 O
following NCT03864497 81 90 O
: NCT03864497 91 92 O

- NCT03864497 96 97 O
inability NCT03864497 99 108 B-Negation
to NCT03864497 109 111 O
perform NCT03864497 112 119 O
> NCT03864497 120 121 B-Eq_Comparison
4 NCT03864497 122 123 I-Eq_Comparison
METs NCT03864497 124 128 B-Observation
by NCT03864497 129 131 O
history NCT03864497 132 139 B-Eq_Comparison

- NCT03864497 142 143 O
insulin NCT03864497 145 152 B-Modifier
- NCT03864497 153 154 I-Modifier
treated NCT03864497 155 162 I-Modifier
diabetes NCT03864497 163 171 B-Condition
mellitus NCT03864497 172 180 I-Condition

- NCT03864497 183 184 O
serum NCT03864497 186 191 B-Observation
creatinine NCT03864497 192 202 I-Observation
> NCT03864497 203 204 B-Eq_Comparison
152 NCT03864497 205 208 I-Eq_Comparison
μmol NCT03864497 209 213 I-Eq_Comparison
/ NCT03864497 214 215 I-Eq_Comparison
l NCT03864497 216 217 I-Eq_Comparison

- NCT03864497 220 221 O
history NCT03864497 223 230 B-Eq_Comparison
of NCT03864497 231 233 O
MI NCT03864497 234 236 B-Condition
, NCT03864497 237 238 O
PCI NCT03864497 239 242 B-Procedure
or NCT03864497 243 245 B-Or
CABG NCT03864497 246 250 B-Procedure

- NCT03864497 253 254 O
stable NCT03864497 256 262 B-Condition
angina NCT03864497 263 269 I-Condition

- NCT03864497 272 273 O
cerebrovascular NCT03864497 275 290 B-Condition
disease NCT03864497 291 298 I-Condition

- NCT03864497 301 302 O
peripheral NCT03864497 304 314 B-Condition
vascular NCT03864497 315 323 I-Condition
disease NCT03864497 324 331 I-Condition

Exclusion NCT03864497 332 341 O
Criteria NCT03864497 342 350 O
: NCT03864497 351 352 O

- NCT03864497 356 357 O
Age NCT03864497 359 362 B-Age
< NCT03864497 363 364 B-Eq_Comparison
18 NCT03864497 365 367 I-Eq_Comparison
years NCT03864497 368 373 I-Eq_Comparison

- NCT03864497 376 377 O
Pregnancy NCT03864497 379 388 B-Condition

- NCT03864497 391 392 O
Contraindication NCT03864497 394 410 B-Contraindication
to NCT03864497 411 413 O
liver NCT03864497 414 419 B-Procedure
transplantation NCT03864497 420 435 I-Procedure

Inclusion NCT03926273 0 9 O
Criteria NCT03926273 10 18 O
: NCT03926273 19 20 O

- NCT03926273 24 25 O
All NCT03926273 27 30 O
participants NCT03926273 31 43 O
were NCT03926273 44 48 O
included NCT03926273 49 57 O
if NCT03926273 58 60 O
their NCT03926273 61 66 O
age NCT03926273 67 70 B-Age
more NCT03926273 71 75 B-Eq_Comparison
than NCT03926273 76 80 I-Eq_Comparison
or NCT03926273 81 83 I-Eq_Comparison
equal NCT03926273 84 89 I-Eq_Comparison
to NCT03926273 90 92 I-Eq_Comparison
18 NCT03926273 93 95 I-Eq_Comparison
years NCT03926273 96 101 I-Eq_Comparison
. NCT03926273 102 103 O
Body NCT03926273 105 109 B-Observation
mass NCT03926273 110 114 I-Observation
index NCT03926273 115 120 I-Observation
< NCT03926273 121 122 B-Eq_Comparison
30 NCT03926273 123 125 I-Eq_Comparison
kg NCT03926273 126 128 I-Eq_Comparison
/ NCT03926273 129 130 I-Eq_Comparison
m NCT03926273 131 132 I-Eq_Comparison
2 NCT03926273 133 134 I-Eq_Comparison
, NCT03926273 135 136 O
total NCT03926273 137 142 B-Observation
cholesterol NCT03926273 143 154 I-Observation
< NCT03926273 155 156 B-Eq_Comparison
200 NCT03926273 157 160 I-Eq_Comparison
mg NCT03926273 161 163 I-Eq_Comparison
/ NCT03926273 164 165 I-Eq_Comparison
dl NCT03926273 166 168 I-Eq_Comparison
, NCT03926273 169 170 O
serum NCT03926273 171 176 B-Observation
triglycerides NCT03926273 177 190 I-Observation
< NCT03926273 191 192 B-Eq_Comparison
200 NCT03926273 193 196 I-Eq_Comparison
mg NCT03926273 197 199 I-Eq_Comparison
/ NCT03926273 200 201 I-Eq_Comparison
dl NCT03926273 202 204 I-Eq_Comparison
and NCT03926273 205 208 B-And
random NCT03926273 209 215 B-Modifier
blood NCT03926273 216 221 B-Observation
glucose NCT03926273 222 229 I-Observation
level NCT03926273 230 235 I-Observation
< NCT03926273 236 237 B-Eq_Comparison
126 NCT03926273 238 241 I-Eq_Comparison
mg NCT03926273 242 244 I-Eq_Comparison
/ NCT03926273 245 246 I-Eq_Comparison
dl NCT03926273 247 249 I-Eq_Comparison
. NCT03926273 250 251 O

Exclusion NCT03926273 253 262 O
Criteria NCT03926273 263 271 O
: NCT03926273 272 273 O

- NCT03926273 277 278 O
Participants NCT03926273 280 292 O
had NCT03926273 293 296 O
acute NCT03926273 297 302 O
or NCT03926273 303 305 B-Or
chronic NCT03926273 306 313 O
metabolic NCT03926273 314 323 B-Condition
disorders NCT03926273 324 333 I-Condition
( NCT03926273 334 335 O
liver NCT03926273 336 341 B-Modifier
, NCT03926273 342 343 O
kidney NCT03926273 344 350 B-Modifier
, NCT03926273 351 352 O
thyroid NCT03926273 353 360 B-Modifier
, NCT03926273 361 362 O
endocrine NCT03926273 363 372 B-Modifier
or NCT03926273 373 375 B-Or
gastrointestinal NCT03926273 376 392 B-Modifier
disorders NCT03926273 393 402 B-Condition
) NCT03926273 403 404 O
. NCT03926273 405 406 O

- NCT03926273 410 411 O
Females NCT03926273 413 420 O
with NCT03926273 421 425 B-And
irregular NCT03926273 426 435 B-Condition
menstrual NCT03926273 436 445 I-Condition
cycle NCT03926273 446 451 I-Condition
or NCT03926273 452 454 B-Or
on NCT03926273 455 457 B-Eq_Comparison
estrogen NCT03926273 458 466 B-Procedure
therapy NCT03926273 467 474 I-Procedure
( NCT03926273 475 476 O
7 NCT03926273 477 478 O
) NCT03926273 479 480 O
. NCT03926273 481 482 O

- NCT03926273 486 487 O
Participants NCT03926273 489 501 O
with NCT03926273 502 506 O
organic NCT03926273 507 514 B-Modifier
cerebral NCT03926273 515 523 B-Condition
lesion NCT03926273 524 530 I-Condition
that NCT03926273 531 535 O
was NCT03926273 536 539 O
detected NCT03926273 540 548 O
on NCT03926273 549 551 O
cranial NCT03926273 552 559 B-Modifier
computed NCT03926273 560 568 B-Procedure
tomography NCT03926273 569 579 I-Procedure
( NCT03926273 580 581 O
CT NCT03926273 582 584 B-Procedure
) NCT03926273 585 586 O
or NCT03926273 587 589 B-Or
cranial NCT03926273 590 597 B-Modifier
magnetic NCT03926273 598 606 B-Procedure
resonance NCT03926273 607 616 I-Procedure
imaging NCT03926273 617 624 I-Procedure
( NCT03926273 625 626 O
MRI NCT03926273 627 630 B-Procedure
) NCT03926273 631 632 O
. NCT03926273 633 634 O

Inclusion NCT03863626 0 9 O
Criteria NCT03863626 10 18 O
: NCT03863626 19 20 O

- NCT03863626 24 25 O
Age NCT03863626 27 30 B-Age
more NCT03863626 31 35 B-Eq_Comparison
than NCT03863626 36 40 I-Eq_Comparison
18 NCT03863626 41 43 I-Eq_Comparison
years NCT03863626 44 49 I-Eq_Comparison
. NCT03863626 50 51 O

- NCT03863626 55 56 O
Chronic NCT03863626 58 65 O
heart NCT03863626 66 71 B-Condition
failure NCT03863626 72 79 I-Condition
prior NCT03863626 80 85 B-Eq_Comparison
diagnosis NCT03863626 86 95 O
, NCT03863626 96 97 O
based NCT03863626 98 103 O
on NCT03863626 104 106 O
signs NCT03863626 107 112 B-Assertion___Assertion_Type_Value:possible
and NCT03863626 113 116 B-Or
or NCT03863626 117 119 I-Or
symptoms NCT03863626 120 128 B-Assertion___Assertion_Type_Value:possible
of NCT03863626 129 131 O
heart NCT03863626 132 137 B-Condition
failure NCT03863626 138 145 I-Condition
, NCT03863626 146 147 O
presenting NCT03863626 148 158 O
with NCT03863626 159 163 O
acute NCT03863626 164 169 O
decompensation NCT03863626 170 184 B-Condition
as NCT03863626 185 187 O
judged NCT03863626 188 194 O
by NCT03863626 195 197 O
the NCT03863626 198 201 O
physician NCT03863626 202 211 B-Provider
to NCT03863626 212 214 O
require NCT03863626 215 222 B-Assertion___Assertion_Type_Value:hypothetical
hospitalization NCT03863626 223 238 B-Encounter
for NCT03863626 239 242 O
IV NCT03863626 243 245 B-Drug
diuretics NCT03863626 246 255 I-Drug

Exclusion NCT03863626 256 265 O
Criteria NCT03863626 266 274 O
: NCT03863626 275 276 O

- NCT03863626 280 281 O
Refusal NCT03863626 283 290 O
to NCT03863626 291 293 O
participate NCT03863626 294 305 O
in NCT03863626 306 308 O
the NCT03863626 309 312 O
study NCT03863626 313 318 O
. NCT03863626 319 320 O

- NCT03863626 324 325 O
Allergy NCT03863626 327 334 B-Allergy
to NCT03863626 335 337 O
IV NCT03863626 338 340 B-Drug
frusemide NCT03863626 341 350 I-Drug
. NCT03863626 351 352 O

- NCT03863626 356 357 O
Severe NCT03863626 359 365 O
renal NCT03863626 366 371 B-Condition
impairment NCT03863626 372 382 I-Condition
defined NCT03863626 383 390 O
as NCT03863626 391 393 O
eGFR NCT03863626 394 398 B-Observation
< NCT03863626 399 400 B-Eq_Comparison
30 NCT03863626 401 403 I-Eq_Comparison
ml NCT03863626 404 406 I-Eq_Comparison
/ NCT03863626 407 408 I-Eq_Comparison
m NCT03863626 409 410 I-Eq_Comparison
. NCT03863626 411 412 O

- NCT03863626 416 417 O
Cardiogenic NCT03863626 419 430 B-Condition
shock NCT03863626 431 436 I-Condition
or NCT03863626 437 439 B-Or
hemodynamic NCT03863626 440 451 B-Condition
instability NCT03863626 452 463 O
judged NCT03863626 464 470 O
by NCT03863626 471 473 O
the NCT03863626 474 477 O
treating NCT03863626 478 486 O
physician NCT03863626 487 496 O
to NCT03863626 497 499 O
be NCT03863626 500 502 O
unsuitable NCT03863626 503 513 O
to NCT03863626 514 516 O
participate NCT03863626 517 528 O
. NCT03863626 529 530 O

Inclusion NCT03923764 0 9 O
Criteria NCT03923764 10 18 O
: NCT03923764 19 20 O

- NCT03923764 24 25 O
Diagnosed NCT03923764 27 36 O
with NCT03923764 37 41 O
COPD NCT03923764 42 46 B-Condition

- NCT03923764 49 50 O
Participating NCT03923764 52 65 O
in NCT03923764 66 68 O
ongoing NCT03923764 69 76 B-Eq_Comparison
lung NCT03923764 77 81 B-Procedure
rehabilitating NCT03923764 82 96 I-Procedure
programme NCT03923764 97 106 O
at NCT03923764 107 109 O
Hvidovre NCT03923764 110 118 O
and NCT03923764 119 122 B-Or
Bispebjerg NCT03923764 123 133 O
Hospital NCT03923764 134 142 O

- NCT03923764 145 146 O
over NCT03923764 148 152 B-Eq_Comparison
18 NCT03923764 153 155 I-Eq_Comparison
years NCT03923764 156 161 I-Eq_Comparison

Exclusion NCT03923764 162 171 O
Criteria NCT03923764 172 180 O
: NCT03923764 181 182 O

- NCT03923764 186 187 O
Plasma NCT03923764 189 195 B-Observation
creatinin NCT03923764 196 205 I-Observation
over NCT03923764 206 210 B-Eq_Comparison
200 NCT03923764 211 214 I-Eq_Comparison
mikrog NCT03923764 215 221 I-Eq_Comparison
/ NCT03923764 222 223 I-Eq_Comparison
l NCT03923764 224 225 I-Eq_Comparison

- NCT03923764 228 229 O
dementia NCT03923764 231 239 B-Condition

- NCT03923764 242 243 O
unable NCT03923764 245 251 B-Negation
to NCT03923764 252 254 O
read NCT03923764 255 259 O
or NCT03923764 260 262 O
speak NCT03923764 263 268 O
danish NCT03923764 269 275 O

Inclusion NCT03860337 0 9 O
Criteria NCT03860337 10 18 O
: NCT03860337 19 20 O

- NCT03860337 23 24 O

Exclusion NCT03860337 26 35 O
Criteria NCT03860337 36 44 O
: NCT03860337 45 46 O

- NCT03860337 50 51 O
pregnant NCT03860337 53 61 B-Condition
or NCT03860337 62 64 B-Or
lactating NCT03860337 65 74 B-Condition
. NCT03860337 75 76 O

Inclusion NCT03864653 0 9 O
Criteria NCT03864653 10 18 O
: NCT03864653 19 20 O

- NCT03864653 24 25 O
Currently NCT03864653 27 36 B-Eq_Comparison
enrolled NCT03864653 37 45 O
within NCT03864653 46 52 O
the NCT03864653 53 56 O
" NCT03864653 57 58 O
Getting NCT03864653 58 65 O
Off NCT03864653 66 69 O
" NCT03864653 69 70 O
( NCT03864653 71 72 O
AKA NCT03864653 73 76 O
, NCT03864653 77 78 O
" NCT03864653 79 80 O
Friends NCT03864653 80 87 O
Getting NCT03864653 88 95 O
Off NCT03864653 96 99 O
" NCT03864653 99 100 O
) NCT03864653 101 102 O
outpatient NCT03864653 103 113 B-Encounter
methamphetamine NCT03864653 114 129 B-Drug
treatment NCT03864653 130 139 B-Procedure
program NCT03864653 140 147 I-Procedure
at NCT03864653 148 150 O
Friends NCT03864653 151 158 O
Community NCT03864653 159 168 O
Center NCT03864653 169 175 O
, NCT03864653 176 177 O
Los NCT03864653 178 181 O
Angeles NCT03864653 182 189 O
, NCT03864653 190 191 O
CA NCT03864653 192 194 O
, NCT03864653 195 196 O
USA NCT03864653 197 200 O
. NCT03864653 201 202 O

- NCT03864653 206 207 O
and NCT03864653 209 212 B-And
; NCT03864653 212 213 O
within NCT03864653 214 220 B-Eq_Comparison
two NCT03864653 221 224 I-Eq_Comparison
weeks NCT03864653 225 230 I-Eq_Comparison
of NCT03864653 231 233 B-Temporal_Connection___Temporal_Connection_Type_Value:before
initial NCT03864653 234 241 B-Eq_Comparison
enrollment NCT03864653 242 252 B-Study
into NCT03864653 253 257 O
the NCT03864653 258 261 O
" NCT03864653 262 263 O
Getting NCT03864653 263 270 O
Off NCT03864653 271 274 O
" NCT03864653 274 275 O
program NCT03864653 276 283 B-Procedure
. NCT03864653 284 285 O

Exclusion NCT03864653 287 296 O
Criteria NCT03864653 297 305 O
: NCT03864653 306 307 O

- NCT03864653 311 312 O
Not NCT03864653 314 317 B-Negation
currently NCT03864653 318 327 B-Eq_Comparison
enrolled NCT03864653 328 336 B-Study
within NCT03864653 337 343 O
the NCT03864653 344 347 O
" NCT03864653 348 349 O
Getting NCT03864653 349 356 O
Off NCT03864653 357 360 O
" NCT03864653 360 361 O
program NCT03864653 362 369 B-Procedure
. NCT03864653 370 371 O

- NCT03864653 375 376 O
or NCT03864653 378 380 B-Or
; NCT03864653 380 381 O
more NCT03864653 382 386 B-Eq_Comparison
than NCT03864653 387 391 I-Eq_Comparison
two NCT03864653 392 395 I-Eq_Comparison
weeks NCT03864653 396 401 I-Eq_Comparison
post NCT03864653 402 406 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03864653 407 408 O
enrollment NCT03864653 409 419 B-Study
in NCT03864653 420 422 O
the NCT03864653 423 426 O
" NCT03864653 427 428 O
Getting NCT03864653 428 435 O
Off NCT03864653 436 439 O
" NCT03864653 439 440 O
program NCT03864653 441 448 B-Procedure
. NCT03864653 449 450 O

Subject NCT03927781 0 7 O
Population NCT03927781 8 18 O
Undergoing NCT03927781 19 29 B-Eq_Comparison
elective NCT03927781 30 38 B-Modifier
ureteroscopy NCT03927781 39 51 B-Procedure
with NCT03927781 52 56 O
stent NCT03927781 57 62 B-Procedure
placement NCT03927781 63 72 I-Procedure
by NCT03927781 73 75 O
Dr NCT03927781 76 78 B-Provider
. NCT03927781 79 80 I-Provider
Murray NCT03927781 82 88 I-Provider
at NCT03927781 89 91 O
University NCT03927781 92 102 O
of NCT03927781 103 105 O
Missouri NCT03927781 106 114 O
Hospital NCT03927781 115 123 O
and NCT03927781 124 127 O
affiliated NCT03927781 128 138 O
facilities NCT03927781 139 149 O

Subject NCT03927781 150 157 O
Inclusion NCT03927781 158 167 O

Age NCT03927781 168 171 B-Age
> NCT03927781 172 173 B-Eq_Comparison
= NCT03927781 174 175 I-Eq_Comparison
18 NCT03927781 176 178 I-Eq_Comparison
years NCT03927781 179 184 I-Eq_Comparison

Subject NCT03927781 185 192 O
Exclusion NCT03927781 193 202 O

- NCT03927781 205 206 O
Renal NCT03927781 208 213 B-Condition
insufficiency NCT03927781 214 227 I-Condition
( NCT03927781 228 229 O
eGFR NCT03927781 230 234 B-Observation
< NCT03927781 235 236 B-Eq_Comparison
30 NCT03927781 237 239 I-Eq_Comparison
mL NCT03927781 240 242 I-Eq_Comparison
/ NCT03927781 243 244 I-Eq_Comparison
minute NCT03927781 245 251 I-Eq_Comparison
/ NCT03927781 252 253 I-Eq_Comparison
1.73 NCT03927781 254 258 I-Eq_Comparison
m NCT03927781 259 260 I-Eq_Comparison
2 NCT03927781 261 262 I-Eq_Comparison
) NCT03927781 263 264 O

- NCT03927781 268 269 O
Chronic NCT03927781 271 278 O
indwelling NCT03927781 279 289 B-Modifier
ureteral NCT03927781 290 298 B-Procedure
stent NCT03927781 299 304 I-Procedure

- NCT03927781 307 308 O
Chronic NCT03927781 310 317 O
opioid NCT03927781 318 324 B-Condition
use NCT03927781 325 328 I-Condition

- NCT03927781 331 332 O
History NCT03927781 334 341 B-Eq_Comparison
of NCT03927781 342 344 O
opioid NCT03927781 345 351 B-Condition
abuse NCT03927781 352 357 I-Condition

- NCT03927781 360 361 O
Chronic NCT03927781 363 370 O
gabapentinoid NCT03927781 371 384 B-Drug
use NCT03927781 385 388 O

- NCT03927781 391 392 O
Plan NCT03927781 394 398 B-Eq_Comparison
for NCT03927781 399 402 O
inpatient NCT03927781 403 412 B-Encounter
hospitalization NCT03927781 413 428 I-Encounter

- NCT03927781 431 432 O
Pregnancy NCT03927781 434 443 B-Condition

- NCT03927781 446 447 O
Inability NCT03927781 449 458 B-Negation
of NCT03927781 459 461 O
the NCT03927781 462 465 O
patient NCT03927781 466 473 O
to NCT03927781 474 476 O
consent NCT03927781 477 484 O
for NCT03927781 485 488 O
themselves NCT03927781 489 499 O
in NCT03927781 500 502 O
English NCT03927781 503 510 O

- NCT03927781 513 514 O
Allergy NCT03927781 516 523 B-Allergy
to NCT03927781 524 526 O
gabapentinoid NCT03927781 527 540 B-Drug

- NCT03927781 543 544 O
Liver NCT03927781 546 551 B-Condition
failure NCT03927781 552 559 I-Condition
or NCT03927781 560 562 B-Or
hepatic NCT03927781 563 570 B-Condition
dysfunction NCT03927781 571 582 I-Condition


Inclusion NCT03861845 0 9 O
Criteria NCT03861845 10 18 O
: NCT03861845 19 20 O

- NCT03861845 24 25 O
18 NCT03861845 27 29 B-Eq_Comparison
years NCT03861845 30 35 I-Eq_Comparison
of NCT03861845 36 38 I-Eq_Comparison
age NCT03861845 39 42 I-Eq_Comparison
or NCT03861845 43 45 I-Eq_Comparison
older NCT03861845 46 51 I-Eq_Comparison

- NCT03861845 54 55 O
speak NCT03861845 57 62 O
English NCT03861845 63 70 O

- NCT03861845 73 74 O
be NCT03861845 76 78 O
prescribed NCT03861845 79 89 O
to NCT03861845 90 92 O
take NCT03861845 93 97 O
two NCT03861845 98 101 B-Eq_Comparison
or NCT03861845 102 104 I-Eq_Comparison
more NCT03861845 105 109 I-Eq_Comparison
medications NCT03861845 110 121 B-Drug
per NCT03861845 122 125 O
day NCT03861845 126 129 B-Eq_Comparison
, NCT03861845 130 131 O
and NCT03861845 132 135 B-And
manage NCT03861845 136 142 B-Assertion___Assertion_Type_Value:hypothetical
their NCT03861845 143 148 I-Assertion___Assertion_Type_Value:hypothetical
own NCT03861845 149 152 O
medications NCT03861845 153 164 B-Drug
. NCT03861845 165 166 O

Exclusion NCT03861845 168 177 O
Criteria NCT03861845 178 186 O
: NCT03861845 187 188 O

- NCT03861845 192 193 O
have NCT03861845 195 199 O
a NCT03861845 200 201 O
significant NCT03861845 202 213 O
cognitive NCT03861845 214 223 B-Condition
impairment NCT03861845 224 234 I-Condition

- NCT03861845 237 238 O
unwilling NCT03861845 240 249 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03861845 250 252 O
use NCT03861845 253 256 O
a NCT03861845 257 258 O
novel NCT03861845 259 264 B-Procedure
pillbox NCT03861845 265 272 I-Procedure

- NCT03861845 275 276 O
unable NCT03861845 278 284 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03861845 285 287 O
meet NCT03861845 288 292 O
with NCT03861845 293 297 O
the NCT03861845 298 301 O
research NCT03861845 302 310 B-Study
team NCT03861845 311 315 I-Study

Inclusion NCT03927534 0 9 O
Criteria NCT03927534 10 18 O
: NCT03927534 19 20 O

- NCT03927534 24 25 O
Age NCT03927534 27 30 B-Age
between NCT03927534 31 38 B-Eq_Comparison
45 NCT03927534 39 41 I-Eq_Comparison
- NCT03927534 42 43 I-Eq_Comparison
75 NCT03927534 44 46 I-Eq_Comparison
years NCT03927534 47 52 I-Eq_Comparison

- NCT03927534 55 56 O
Have NCT03927534 58 62 O
overweight NCT03927534 63 73 B-Condition
or NCT03927534 74 76 B-Or
obesity NCT03927534 77 84 B-Condition
condition NCT03927534 85 94 O
based NCT03927534 95 100 O
in NCT03927534 101 103 O
BMI NCT03927534 104 107 B-Observation
( NCT03927534 108 109 O
Body NCT03927534 110 114 B-Observation
Mass NCT03927534 115 119 I-Observation
Index NCT03927534 120 125 I-Observation
) NCT03927534 126 127 O
. NCT03927534 128 129 O
Individuals NCT03927534 131 142 O
with NCT03927534 143 147 O
BMI NCT03927534 148 151 B-Observation
of NCT03927534 152 154 O
25 NCT03927534 155 157 B-Eq_Comparison
or NCT03927534 158 160 I-Eq_Comparison
more NCT03927534 161 165 I-Eq_Comparison
. NCT03927534 166 167 O

- NCT03927534 171 172 O
Have NCT03927534 174 178 O
two NCT03927534 179 182 B-Eq_Comparison
of NCT03927534 183 185 B-Criteria_Count
these NCT03927534 186 191 I-Criteria_Count
three NCT03927534 192 197 B-Eq_Comparison
risk NCT03927534 198 202 B-Risk
: NCT03927534 203 204 O
sedentary NCT03927534 205 214 B-Condition
lifestyle NCT03927534 215 224 I-Condition
, NCT03927534 225 226 O
poor NCT03927534 227 231 B-Condition
diet NCT03927534 232 236 I-Condition
and NCT03927534 237 240 B-Or
binge NCT03927534 241 246 B-Condition
episodes NCT03927534 247 255 I-Condition
. NCT03927534 256 257 O

- NCT03927534 261 262 O
Ability NCT03927534 264 271 O
to NCT03927534 272 274 O
understand NCT03927534 275 285 O
oral NCT03927534 286 290 O
and NCT03927534 291 294 O
written NCT03927534 295 302 O
Spanish NCT03927534 303 310 O
. NCT03927534 311 312 O

- NCT03927534 316 317 O
Willingness NCT03927534 319 330 O
to NCT03927534 331 333 O
participate NCT03927534 334 345 O
in NCT03927534 346 348 O
the NCT03927534 349 352 O
study NCT03927534 353 358 O
and NCT03927534 359 362 O
signing NCT03927534 363 370 O
informed NCT03927534 371 379 O
consent NCT03927534 380 387 O
. NCT03927534 388 389 O

Exclusion NCT03927534 391 400 O
Criteria NCT03927534 401 409 O
: NCT03927534 410 411 O

- NCT03927534 415 416 O
Any NCT03927534 418 421 O
diagnosis NCT03927534 422 431 O
of NCT03927534 432 434 O
a NCT03927534 435 436 O
disease NCT03927534 437 444 B-Condition
that NCT03927534 445 449 O
may NCT03927534 450 453 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03927534 454 460 O
the NCT03927534 461 464 O
central NCT03927534 465 472 B-Condition
nervous NCT03927534 473 480 I-Condition
system NCT03927534 481 487 I-Condition
( NCT03927534 488 489 O
brain NCT03927534 490 495 B-Modifier
condition NCT03927534 496 505 B-Condition
, NCT03927534 506 507 O
traumatic NCT03927534 508 517 B-Condition
brain NCT03927534 518 523 I-Condition
injury NCT03927534 524 530 I-Condition
, NCT03927534 531 532 O
dementia NCT03927534 533 541 B-Condition
, NCT03927534 542 543 O
etc NCT03927534 544 547 O
) NCT03927534 548 549 O
. NCT03927534 550 551 O

- NCT03927534 555 556 O
Other NCT03927534 558 563 O
psychiatric NCT03927534 564 575 B-Condition
diagnoses NCT03927534 576 585 I-Condition
or NCT03927534 586 588 B-Or
acute NCT03927534 589 594 O
psychiatric NCT03927534 595 606 B-Condition
illness NCT03927534 607 614 I-Condition
( NCT03927534 615 616 O
substance NCT03927534 617 626 B-Condition
dependence NCT03927534 627 637 B-Modifier
or NCT03927534 638 640 B-Or
abuse NCT03927534 641 646 B-Modifier
, NCT03927534 647 648 O
history NCT03927534 649 656 B-Eq_Comparison
of NCT03927534 657 659 O
schizophrenia NCT03927534 660 673 B-Condition
or NCT03927534 674 676 O
other NCT03927534 677 682 B-Other
psychotic NCT03927534 683 692 B-Condition
disorders NCT03927534 693 702 I-Condition
, NCT03927534 703 704 O
etc NCT03927534 705 708 O
. NCT03927534 709 710 O
) NCT03927534 711 712 O
, NCT03927534 713 714 O
except NCT03927534 715 721 B-Exception
for NCT03927534 722 725 I-Exception
anxiety NCT03927534 726 733 B-Condition
disorder NCT03927534 734 742 I-Condition
or NCT03927534 743 745 B-Or
personality NCT03927534 746 757 B-Condition
disorders NCT03927534 758 767 I-Condition
. NCT03927534 768 769 O

- NCT03927534 773 774 O
Presence NCT03927534 776 784 O
of NCT03927534 785 787 O
delusional NCT03927534 788 798 B-Condition
ideas NCT03927534 799 804 I-Condition
or NCT03927534 805 807 B-Or
hallucinations NCT03927534 808 822 B-Condition
whether NCT03927534 823 830 O
consistent NCT03927534 831 841 O
or NCT03927534 842 844 O
not NCT03927534 845 848 O
with NCT03927534 849 853 O
mood NCT03927534 854 858 O
. NCT03927534 859 860 O

- NCT03927534 864 865 O
Suicide NCT03927534 867 874 B-Condition
risk NCT03927534 875 879 B-Risk
. NCT03927534 880 881 O

Inclusion NCT03868761 0 9 O
Criteria NCT03868761 10 18 O
: NCT03868761 19 20 O

1 NCT03868761 24 25 O
. NCT03868761 25 26 O
Males NCT03868761 28 33 O
& NCT03868761 34 35 B-Or
females NCT03868761 36 43 O
aged NCT03868761 44 48 B-Age
13 NCT03868761 49 51 B-Eq_Comparison
- NCT03868761 52 53 I-Eq_Comparison
17 NCT03868761 54 56 I-Eq_Comparison
years NCT03868761 57 62 I-Eq_Comparison
directly NCT03868761 63 71 O
impacted NCT03868761 72 80 O
by NCT03868761 81 83 O
the NCT03868761 84 87 O
2017 NCT03868761 88 92 O
wildfires NCT03868761 93 102 O
having NCT03868761 103 109 O
lost NCT03868761 110 114 B-Observation
their NCT03868761 115 120 I-Observation
home NCT03868761 121 125 I-Observation
or NCT03868761 126 128 B-Or
been NCT03868761 129 133 O
temporarily NCT03868761 134 145 B-Observation
displaced NCT03868761 146 155 I-Observation

2 NCT03868761 158 159 O
. NCT03868761 159 160 O
Screen NCT03868761 162 168 O
positive NCT03868761 169 177 O
for NCT03868761 178 181 O
PTSD NCT03868761 182 186 B-Condition
( NCT03868761 187 188 O
Child NCT03868761 189 194 B-Observation
Trauma NCT03868761 195 201 I-Observation
Screening NCT03868761 202 211 I-Observation
Questionnaire NCT03868761 212 225 I-Observation
= NCT03868761 226 227 B-Eq_Comparison
5 NCT03868761 228 229 I-Eq_Comparison
or NCT03868761 230 232 I-Eq_Comparison
higher NCT03868761 233 239 I-Eq_Comparison
) NCT03868761 240 241 O

3 NCT03868761 245 246 O
. NCT03868761 246 247 O
Have NCT03868761 249 253 O
regular NCT03868761 254 261 O
access NCT03868761 262 268 O
to NCT03868761 269 271 O
a NCT03868761 272 273 O
smart NCT03868761 274 279 O
phone NCT03868761 280 285 O
and NCT03868761 286 289 O
a NCT03868761 290 291 O
computer NCT03868761 292 300 O

4 NCT03868761 303 304 O
. NCT03868761 304 305 O
Have NCT03868761 307 311 O
a NCT03868761 312 313 O
personal NCT03868761 314 322 O
email NCT03868761 323 328 O
address NCT03868761 329 336 O

5 NCT03868761 339 340 O
. NCT03868761 340 341 O
Speak NCT03868761 343 348 O
and NCT03868761 349 352 O
read NCT03868761 353 357 O
English NCT03868761 358 365 O
fluently NCT03868761 366 374 O

6 NCT03868761 377 378 O
. NCT03868761 378 379 O
Have NCT03868761 381 385 O
parental NCT03868761 386 394 O
consent NCT03868761 395 402 O

Exclusion NCT03868761 403 412 O
Criteria NCT03868761 413 421 O
: NCT03868761 422 423 O

1 NCT03868761 427 428 O
. NCT03868761 428 429 O
A NCT03868761 431 432 O
positive NCT03868761 433 441 O
self NCT03868761 442 446 O
- NCT03868761 447 448 O
reported NCT03868761 449 457 O
history NCT03868761 458 465 B-Eq_Comparison
of NCT03868761 466 468 O
psychosis NCT03868761 469 478 B-Condition
, NCT03868761 479 480 O
bipolar NCT03868761 481 488 B-Condition
, NCT03868761 489 490 O
or NCT03868761 491 493 B-Or
schizophrenia NCT03868761 494 507 B-Condition

2 NCT03868761 510 511 O
. NCT03868761 511 512 O
Serious NCT03868761 514 521 O
self NCT03868761 522 526 O
- NCT03868761 527 528 O
reported NCT03868761 529 537 O
physical NCT03868761 538 546 B-Condition
health NCT03868761 547 553 I-Condition
concerns NCT03868761 554 562 I-Condition
necessitating NCT03868761 563 576 B-Assertion___Assertion_Type_Value:hypothetical
surgery NCT03868761 577 584 B-Procedure
or NCT03868761 585 587 B-Or
with NCT03868761 588 592 O
prognosis NCT03868761 593 602 B-Observation
< NCT03868761 603 604 B-Eq_Comparison
6 NCT03868761 605 606 I-Eq_Comparison
months NCT03868761 607 613 I-Eq_Comparison

3 NCT03868761 621 622 O
. NCT03868761 622 623 O
A NCT03868761 625 626 O
positive NCT03868761 627 635 O
screen NCT03868761 636 642 O
for NCT03868761 643 646 O
a NCT03868761 647 648 O
current NCT03868761 649 656 B-Eq_Comparison
Substance NCT03868761 657 666 B-Condition
User NCT03868761 667 671 I-Condition
Disorder NCT03868761 672 680 I-Condition
( NCT03868761 681 682 O
CRAFFT NCT03868761 683 689 B-Observation
= NCT03868761 690 691 B-Eq_Comparison
2 NCT03868761 692 693 I-Eq_Comparison
or NCT03868761 694 696 I-Eq_Comparison
higher NCT03868761 697 703 I-Eq_Comparison
) NCT03868761 704 705 O

4 NCT03868761 709 710 O
. NCT03868761 710 711 O
Current NCT03868761 713 720 B-Eq_Comparison
self NCT03868761 721 725 O
- NCT03868761 726 727 O
reported NCT03868761 728 736 O
suicidal NCT03868761 737 745 B-Condition
ideation NCT03868761 746 754 I-Condition

5 NCT03868761 757 758 O
. NCT03868761 758 759 O
Self NCT03868761 761 765 O
- NCT03868761 766 767 O
reported NCT03868761 768 776 O
pregnancy NCT03868761 777 786 B-Condition

6 NCT03868761 789 790 O
. NCT03868761 790 791 O
Self NCT03868761 793 797 O
- NCT03868761 798 799 O
reported NCT03868761 800 808 O
less NCT03868761 809 813 B-Eq_Comparison
than NCT03868761 814 818 I-Eq_Comparison
four NCT03868761 819 823 I-Eq_Comparison
weeks NCT03868761 824 829 I-Eq_Comparison
of NCT03868761 830 832 O
stable NCT03868761 833 839 O
prescription NCT03868761 840 852 O
medication NCT03868761 853 863 B-Drug
for NCT03868761 864 867 O
anxiety NCT03868761 868 875 B-Condition
, NCT03868761 876 877 O
anti NCT03868761 878 882 B-Drug
- NCT03868761 883 884 I-Drug
depressant NCT03868761 885 895 I-Drug
, NCT03868761 896 897 O
and NCT03868761 898 901 B-Or
sleep NCT03868761 902 907 B-Condition
promoting NCT03868761 908 917 O
medications NCT03868761 918 929 B-Drug
prior NCT03868761 930 935 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03868761 936 938 O
the NCT03868761 939 942 O
screening NCT03868761 943 952 B-Study
assessment NCT03868761 953 963 B-Procedure


Inclusion NCT03928405 0 9 O
Criteria NCT03928405 10 18 O
: NCT03928405 19 20 O

- NCT03928405 24 25 O
Having NCT03928405 27 33 O
mild NCT03928405 34 38 O
or NCT03928405 39 41 B-Or
moderate NCT03928405 42 50 O
severity NCT03928405 51 59 O
of NCT03928405 60 62 O
AD NCT03928405 63 65 B-Condition

- NCT03928405 68 69 O
Lack NCT03928405 71 75 B-Negation
of NCT03928405 76 78 O
communication NCT03928405 79 92 B-Condition
difficulties NCT03928405 93 105 B-Modifier
or NCT03928405 106 108 B-Or
problems NCT03928405 109 117 B-Modifier

- NCT03928405 120 121 O
Volunteering NCT03928405 123 135 O
to NCT03928405 136 138 O
participate NCT03928405 139 150 O
in NCT03928405 151 153 O
the NCT03928405 154 157 O
study NCT03928405 158 163 B-Study

- NCT03928405 166 167 O
Cerebrovascular NCT03928405 169 184 B-Condition
event NCT03928405 185 190 I-Condition
, NCT03928405 191 192 O

- NCT03928405 196 197 O
Having NCT03928405 199 205 O
disturbing NCT03928405 206 216 O
the NCT03928405 217 220 O
balance NCT03928405 221 228 B-Condition
and NCT03928405 229 232 B-Or
coordination NCT03928405 233 245 B-Condition
of NCT03928405 246 248 O
neurological NCT03928405 249 261 B-Condition
disease NCT03928405 262 269 I-Condition
such NCT03928405 270 274 O
as NCT03928405 275 277 O
Parkinson NCT03928405 278 287 B-Condition
, NCT03928405 288 289 O
MS NCT03928405 290 292 B-Condition
, NCT03928405 293 294 O

- NCT03928405 298 299 O
Mini NCT03928405 301 305 B-Observation
Mental NCT03928405 306 312 I-Observation
Test NCT03928405 313 317 I-Observation
Score NCT03928405 318 323 I-Observation
, NCT03928405 324 325 O
18 NCT03928405 326 328 B-Eq_Comparison
to NCT03928405 329 331 I-Eq_Comparison
24 NCT03928405 332 334 I-Eq_Comparison
points NCT03928405 335 341 O
from NCT03928405 342 346 O
being NCT03928405 347 352 O
scored NCT03928405 353 359 O

- NCT03928405 362 363 O
being NCT03928405 365 370 O
65 NCT03928405 371 373 B-Eq_Comparison
- NCT03928405 374 375 I-Eq_Comparison
80 NCT03928405 376 378 I-Eq_Comparison
aged NCT03928405 379 383 B-Age
. NCT03928405 384 385 O

Exclusion NCT03928405 387 396 O
Criteria NCT03928405 397 405 O
: NCT03928405 406 407 O

- NCT03928405 411 412 O
Patients NCT03928405 414 422 O
diagnosed NCT03928405 423 432 O
with NCT03928405 433 437 O
dementia NCT03928405 438 446 B-Condition
( NCT03928405 447 448 O
infection NCT03928405 449 458 B-Condition
, NCT03928405 459 460 O
vascular NCT03928405 461 469 B-Condition
, NCT03928405 470 471 O
hematological NCT03928405 472 485 B-Condition
diseases NCT03928405 486 494 I-Condition
) NCT03928405 495 496 O
, NCT03928405 497 498 O
patients NCT03928405 499 507 O
who NCT03928405 508 511 O
could NCT03928405 512 517 O
not NCT03928405 518 521 B-Negation
be NCT03928405 522 524 O
contacted NCT03928405 525 534 B-Observation
during NCT03928405 535 541 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928405 542 545 O
follow NCT03928405 546 552 B-Study
- NCT03928405 553 554 I-Study
up NCT03928405 555 557 I-Study
period NCT03928405 558 564 I-Study
or NCT03928405 565 567 B-Or
who NCT03928405 568 571 O
did NCT03928405 572 575 O
not NCT03928405 576 579 B-Negation
come NCT03928405 580 584 O
to NCT03928405 585 587 O
control NCT03928405 588 595 B-Modifier
, NCT03928405 596 597 O
cardiac NCT03928405 598 605 B-Modifier
and NCT03928405 606 609 B-Or
cerebrovascular NCT03928405 610 625 B-Modifier
event NCT03928405 626 631 B-Condition
, NCT03928405 632 633 O

- NCT03928405 637 638 O
Endocrine NCT03928405 640 649 B-Condition
disorder NCT03928405 650 658 I-Condition
, NCT03928405 659 660 O
fluid NCT03928405 661 666 B-Condition
- NCT03928405 667 668 I-Condition
electrolyte NCT03928405 669 680 I-Condition
imbalance NCT03928405 681 690 I-Condition
and NCT03928405 691 694 B-Or
infection NCT03928405 695 704 B-Condition

- NCT03928405 707 708 O
Patients NCT03928405 710 718 O
with NCT03928405 719 723 O
malignancy NCT03928405 724 734 B-Condition
and NCT03928405 735 738 B-Or
malignancy NCT03928405 739 749 B-Condition
, NCT03928405 750 751 O
chemotherapy NCT03928405 752 764 B-Procedure
and NCT03928405 765 768 B-Or
radiotherapy NCT03928405 769 781 B-Procedure
, NCT03928405 782 783 O

- NCT03928405 787 788 O
Patients NCT03928405 790 798 O
with NCT03928405 799 803 O
delirium NCT03928405 804 812 B-Condition
or NCT03928405 813 815 B-Or
depression NCT03928405 816 826 B-Condition

- NCT03928405 829 830 O
Those NCT03928405 832 837 O
with NCT03928405 838 842 O
protective NCT03928405 843 853 B-Condition
sensation NCT03928405 854 863 I-Condition
loss NCT03928405 864 868 I-Condition
( NCT03928405 869 870 O
those NCT03928405 871 876 O
with NCT03928405 877 881 O
Semmes NCT03928405 882 888 B-Observation
- NCT03928405 889 890 I-Observation
Weinstein NCT03928405 891 900 I-Observation
Monofilament NCT03928405 901 913 I-Observation
Thickness NCT03928405 914 923 I-Observation
4.56 NCT03928405 924 928 B-Eq_Comparison
and NCT03928405 929 932 I-Eq_Comparison
above NCT03928405 933 938 I-Eq_Comparison
) NCT03928405 939 940 O

- NCT03928405 944 945 O
patients NCT03928405 947 955 O
with NCT03928405 956 960 O
lower NCT03928405 961 966 B-Modifier
or NCT03928405 967 969 B-Or
upper NCT03928405 970 975 B-Modifier
extremity NCT03928405 976 985 I-Modifier
amputations NCT03928405 986 997 B-Procedure
at NCT03928405 998 1000 O
any NCT03928405 1001 1004 O
level NCT03928405 1005 1010 O

Inclusion NCT03863769 0 9 O
Criteria NCT03863769 10 18 O
: NCT03863769 19 20 O

- NCT03863769 24 25 O
Age NCT03863769 27 30 B-Age
greater NCT03863769 31 38 B-Eq_Comparison
than NCT03863769 39 43 I-Eq_Comparison
48 NCT03863769 44 46 I-Eq_Comparison
years NCT03863769 47 52 I-Eq_Comparison
old NCT03863769 53 56 O

- NCT03863769 59 60 O
Patient NCT03863769 62 69 O
has NCT03863769 70 73 O
leg NCT03863769 74 77 B-Modifier
or NCT03863769 78 80 B-Or
buttock NCT03863769 81 88 B-Modifier
pain NCT03863769 89 93 B-Condition
while NCT03863769 94 99 O
walking NCT03863769 100 107 B-Observation

- NCT03863769 110 111 O
Patient NCT03863769 113 120 O
feels NCT03863769 121 126 O
relief NCT03863769 127 133 O
of NCT03863769 134 136 O
symptoms NCT03863769 137 145 O
with NCT03863769 146 150 O
bending NCT03863769 151 158 O
( NCT03863769 159 160 O
flexing NCT03863769 161 168 O
) NCT03863769 169 170 O
forward NCT03863769 171 178 O

- NCT03863769 181 182 O
Patient NCT03863769 184 191 O
feels NCT03863769 192 197 O
relief NCT03863769 198 204 O
when NCT03863769 205 209 O
using NCT03863769 210 215 O
a NCT03863769 216 217 O
shopping NCT03863769 218 226 O
cart NCT03863769 227 231 O
of NCT03863769 232 234 O
bicycle NCT03863769 235 242 O

- NCT03863769 245 246 O
Patient NCT03863769 248 255 O
has NCT03863769 256 259 O
motor NCT03863769 260 265 B-Modifier
or NCT03863769 266 268 B-Or
sensory NCT03863769 269 276 B-Modifier
disturbance NCT03863769 277 288 B-Condition
while NCT03863769 289 294 O
walking NCT03863769 295 302 B-Observation

- NCT03863769 305 306 O
Patient NCT03863769 308 315 O
has NCT03863769 316 319 O
normal NCT03863769 320 326 O
and NCT03863769 327 330 B-And
symmetrical NCT03863769 331 342 B-Modifier
foot NCT03863769 343 347 B-Observation
pulses NCT03863769 348 354 I-Observation

- NCT03863769 357 358 O
Patient NCT03863769 360 367 O
has NCT03863769 368 371 O
lower NCT03863769 372 377 B-Modifier
extremity NCT03863769 378 387 I-Modifier
weakness NCT03863769 388 396 B-Condition

- NCT03863769 399 400 O
Patient NCT03863769 402 409 O
has NCT03863769 410 413 O
low NCT03863769 414 417 B-Modifier
back NCT03863769 418 422 I-Modifier
pain NCT03863769 423 427 B-Condition

- NCT03863769 430 431 O
Duration NCT03863769 433 441 O
of NCT03863769 442 444 O
symptoms NCT03863769 445 453 O
and NCT03863769 454 457 O
signs NCT03863769 458 463 O
for NCT03863769 464 467 O
more NCT03863769 468 472 B-Eq_Comparison
than NCT03863769 473 477 I-Eq_Comparison
1 NCT03863769 478 479 I-Eq_Comparison
month NCT03863769 480 485 I-Eq_Comparison

- NCT03863769 488 489 O
Able NCT03863769 491 495 B-Condition
to NCT03863769 496 498 I-Condition
stand NCT03863769 499 504 B-Modifier
and NCT03863769 505 508 B-And
walk NCT03863769 509 513 B-Modifier
without NCT03863769 514 521 B-Negation
assistive NCT03863769 522 531 B-Procedure
devices NCT03863769 532 539 I-Procedure
for NCT03863769 540 543 O
at NCT03863769 544 546 B-Eq_Comparison
least NCT03863769 547 552 I-Eq_Comparison
20 NCT03863769 553 555 I-Eq_Comparison
minutes NCT03863769 556 563 I-Eq_Comparison

- NCT03863769 566 567 O
Able NCT03863769 569 573 O
to NCT03863769 574 576 O
give NCT03863769 577 581 O
written NCT03863769 582 589 O
informed NCT03863769 590 598 O
consent NCT03863769 599 606 O
and NCT03863769 607 610 O
complete NCT03863769 611 619 O
interviews NCT03863769 620 630 O
and NCT03863769 631 634 O
questionnaires NCT03863769 635 649 O
in NCT03863769 650 652 O
English NCT03863769 653 660 O

Exclusion NCT03863769 661 670 O
Criteria NCT03863769 671 679 O
: NCT03863769 680 681 O

- NCT03863769 685 686 O
Complicated NCT03863769 688 699 O
spinal NCT03863769 700 706 B-Modifier
pain NCT03863769 707 711 B-Condition
due NCT03863769 712 715 O
to NCT03863769 716 718 O
fracture NCT03863769 719 727 B-Condition
, NCT03863769 728 729 O
tumor NCT03863769 730 735 B-Condition
, NCT03863769 736 737 O
infection NCT03863769 738 747 B-Condition
, NCT03863769 748 749 O
or NCT03863769 750 752 B-Or
severe NCT03863769 753 759 O
spondyloarthropathy NCT03863769 760 779 B-Condition

- NCT03863769 782 783 O
Has NCT03863769 785 788 O
other NCT03863769 789 794 B-Other
severe NCT03863769 795 801 O
co NCT03863769 802 804 B-Condition
- NCT03863769 805 806 I-Condition
morbidities NCT03863769 807 818 I-Condition
, NCT03863769 819 820 O
including NCT03863769 821 830 O
progressive NCT03863769 831 842 B-Modifier
neurological NCT03863769 843 855 B-Condition
deficit NCT03863769 856 863 I-Condition

- NCT03863769 866 867 O
Other NCT03863769 869 874 B-Other
serious NCT03863769 875 882 O
pathologies NCT03863769 883 894 B-Condition
of NCT03863769 895 897 O
the NCT03863769 898 901 O
locomotor NCT03863769 902 911 B-Modifier
system NCT03863769 912 918 I-Modifier

- NCT03863769 921 922 O
No NCT03863769 924 926 O
correspondence NCT03863769 927 941 O
availability NCT03863769 942 954 O
through NCT03863769 955 962 O
email NCT03863769 963 968 O

- NCT03863769 971 972 O
Inability NCT03863769 974 983 B-Negation
to NCT03863769 984 986 O
read NCT03863769 987 991 O
/ NCT03863769 992 993 O
comprehend NCT03863769 994 1004 O
English NCT03863769 1005 1012 O

- NCT03863769 1015 1016 O
Compensation NCT03863769 1018 1030 O
or NCT03863769 1031 1033 O
seeking NCT03863769 1034 1041 O
compensation NCT03863769 1042 1054 O
from NCT03863769 1055 1059 O
a NCT03863769 1060 1061 O
third NCT03863769 1062 1067 O
- NCT03863769 1068 1069 O
party NCT03863769 1070 1075 O
liability NCT03863769 1076 1085 O
or NCT03863769 1086 1088 O
workers NCT03863769 1089 1096 O
' NCT03863769 1096 1097 O
compensation NCT03863769 1098 1110 O

- NCT03863769 1113 1114 O
Previous NCT03863769 1116 1124 B-Eq_Comparison
spinal NCT03863769 1125 1131 B-Procedure
manipulation NCT03863769 1132 1144 I-Procedure
within NCT03863769 1145 1151 B-Eq_Comparison
the NCT03863769 1152 1155 I-Eq_Comparison
past NCT03863769 1156 1160 I-Eq_Comparison
month NCT03863769 1161 1166 I-Eq_Comparison

Inclusion NCT03926234 0 9 O
Criteria NCT03926234 10 18 O
: NCT03926234 19 20 O

- NCT03926234 24 25 O
Patients NCT03926234 27 35 O
, NCT03926234 36 37 O
older NCT03926234 38 43 B-Eq_Comparison
than NCT03926234 44 48 I-Eq_Comparison
14 NCT03926234 49 51 I-Eq_Comparison
years NCT03926234 52 57 I-Eq_Comparison
and NCT03926234 58 61 B-And
admitted NCT03926234 62 70 B-Encounter
to NCT03926234 71 73 O
the NCT03926234 74 77 O
ED NCT03926234 78 80 O
, NCT03926234 81 82 O
were NCT03926234 83 87 O
eligible NCT03926234 88 96 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03926234 97 100 I-Assertion___Assertion_Type_Value:hypothetical
this NCT03926234 101 105 O
study NCT03926234 106 111 B-Study
. NCT03926234 112 113 O

Exclusion NCT03926234 115 124 O
Criteria NCT03926234 125 133 O
: NCT03926234 134 135 O

- NCT03926234 139 140 O
Gynecologic NCT03926234 142 153 B-Modifier
and NCT03926234 154 157 B-Or
obstetric NCT03926234 158 167 B-Modifier
emergencies NCT03926234 168 179 B-Condition

- NCT03926234 182 183 O
Patients NCT03926234 185 193 O
, NCT03926234 194 195 O
who NCT03926234 196 199 O
left NCT03926234 200 204 B-Observation
against NCT03926234 205 212 I-Observation
medical NCT03926234 213 220 I-Observation
advice NCT03926234 221 227 I-Observation
or NCT03926234 228 230 O
had NCT03926234 231 234 O
n't NCT03926234 234 237 O
been NCT03926234 238 242 O
aided NCT03926234 243 248 O
by NCT03926234 249 251 O
a NCT03926234 252 253 O
doctor NCT03926234 254 260 O

Inclusion NCT03867994 0 9 O
Criteria NCT03867994 10 18 O
: NCT03867994 19 20 O

- NCT03867994 24 25 O
Patients NCT03867994 27 35 O
aged NCT03867994 36 40 B-Age
between NCT03867994 41 48 B-Eq_Comparison
18 NCT03867994 49 51 I-Eq_Comparison
and NCT03867994 52 55 I-Eq_Comparison
70 NCT03867994 56 58 I-Eq_Comparison
years NCT03867994 59 64 I-Eq_Comparison
. NCT03867994 65 66 O

- NCT03867994 70 71 O
Serum NCT03867994 73 78 B-Observation
creatinine NCT03867994 79 89 I-Observation
≤ NCT03867994 90 91 B-Eq_Comparison
1.5 NCT03867994 92 95 I-Eq_Comparison
mg NCT03867994 96 98 I-Eq_Comparison
/ NCT03867994 99 100 I-Eq_Comparison
dL NCT03867994 101 103 I-Eq_Comparison
. NCT03867994 104 105 O

- NCT03867994 109 110 O
Using NCT03867994 112 117 B-Eq_Comparison
a NCT03867994 118 119 O
moderate NCT03867994 120 128 B-Eq_Comparison
dose NCT03867994 129 133 O
of NCT03867994 134 136 O
atorvastatin NCT03867994 137 149 B-Drug
( NCT03867994 150 151 O
40 NCT03867994 152 154 B-Eq_Comparison
mg NCT03867994 155 157 I-Eq_Comparison
or NCT03867994 158 160 B-Or
equivalent NCT03867994 161 171 O
dose NCT03867994 172 176 O
of NCT03867994 177 179 O
other NCT03867994 180 185 B-Other
statins NCT03867994 186 193 B-Drug
) NCT03867994 194 195 O
. NCT03867994 196 197 O

- NCT03867994 201 202 O
Moderate NCT03867994 204 212 B-Eq_Comparison
to NCT03867994 213 215 I-Eq_Comparison
high NCT03867994 216 220 I-Eq_Comparison
- NCT03867994 221 222 O
risk NCT03867994 223 227 B-Risk
for NCT03867994 228 231 O
CIN NCT03867994 232 235 B-Condition
. NCT03867994 236 237 O

Exclusion NCT03867994 239 248 O
Criteria NCT03867994 249 257 O
: NCT03867994 258 259 O

- NCT03867994 263 264 O
Patients NCT03867994 266 274 O
suffering NCT03867994 275 284 B-Eq_Comparison
from NCT03867994 285 289 O
ST NCT03867994 290 292 B-Modifier
- NCT03867994 293 294 I-Modifier
segment NCT03867994 295 302 I-Modifier
elevation NCT03867994 303 312 I-Modifier
myocardial NCT03867994 313 323 B-Condition
infarction NCT03867994 324 334 I-Condition
( NCT03867994 335 336 O
STEMI NCT03867994 337 342 B-Condition
) NCT03867994 343 344 O

- NCT03867994 348 349 O
Patients NCT03867994 351 359 O
need NCT03867994 360 364 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03867994 365 368 I-Assertion___Assertion_Type_Value:hypothetical
immediate NCT03867994 369 378 O
cardiac NCT03867994 379 386 B-Procedure
catheterization NCT03867994 387 402 I-Procedure

- NCT03867994 405 406 O
Elevated NCT03867994 408 416 O
liver NCT03867994 417 422 B-Condition
enzymes NCT03867994 423 430 I-Condition
( NCT03867994 431 432 O
Aspartate NCT03867994 433 442 B-Observation
aminotransferase NCT03867994 443 459 I-Observation
( NCT03867994 460 461 O
AST NCT03867994 462 465 B-Observation
) NCT03867994 466 467 O
and NCT03867994 468 471 B-Or
Alanine NCT03867994 472 479 B-Observation
aminotransferase NCT03867994 480 496 I-Observation
( NCT03867994 497 498 O
ALT NCT03867994 499 502 B-Observation
) NCT03867994 503 504 O
three NCT03867994 505 510 B-Eq_Comparison
times NCT03867994 511 516 I-Eq_Comparison
the NCT03867994 517 520 I-Eq_Comparison
upper NCT03867994 521 526 I-Eq_Comparison
limit NCT03867994 527 532 I-Eq_Comparison
of NCT03867994 533 535 I-Eq_Comparison
normal NCT03867994 536 542 I-Eq_Comparison
) NCT03867994 543 544 O
. NCT03867994 545 546 O

- NCT03867994 550 551 O
Active NCT03867994 553 559 B-Eq_Comparison
infection NCT03867994 560 569 B-Condition
. NCT03867994 570 571 O

- NCT03867994 575 576 O
Any NCT03867994 578 581 O
contraindication NCT03867994 582 598 B-Contraindication
to NCT03867994 599 601 O
carvedilol NCT03867994 602 612 B-Drug
, NCT03867994 613 614 O
or NCT03867994 615 617 B-Or
atorvastatin NCT03867994 618 630 B-Drug
. NCT03867994 631 632 O

- NCT03867994 636 637 O
Patients NCT03867994 639 647 O
on NCT03867994 648 650 B-Eq_Comparison
regular NCT03867994 651 658 O
use NCT03867994 659 662 O
of NCT03867994 663 665 O
vitamins NCT03867994 666 674 B-Drug
, NCT03867994 675 676 O
minerals NCT03867994 677 685 B-Drug
. NCT03867994 686 687 O

- NCT03867994 691 692 O
Using NCT03867994 694 699 B-Eq_Comparison
medication NCT03867994 700 710 B-Drug
with NCT03867994 711 715 O
antioxidant NCT03867994 716 727 B-Modifier
properties NCT03867994 728 738 I-Modifier
e NCT03867994 739 740 O
. NCT03867994 741 742 O
g NCT03867994 743 744 O
. NCT03867994 745 746 O
, NCT03867994 747 748 O
beta NCT03867994 749 753 B-Drug
- NCT03867994 754 755 I-Drug
carotene NCT03867994 756 764 I-Drug
, NCT03867994 765 766 O
vitamin NCT03867994 767 774 B-Drug
E NCT03867994 775 776 I-Drug
, NCT03867994 777 778 O
vitamin NCT03867994 779 786 B-Drug
C NCT03867994 787 788 I-Drug
, NCT03867994 789 790 O
selenium NCT03867994 791 799 B-Drug
, NCT03867994 800 801 O
theophylline NCT03867994 802 814 B-Drug
or NCT03867994 815 817 B-Or
N NCT03867994 818 819 B-Drug
- NCT03867994 820 821 I-Drug
acetyl NCT03867994 822 828 I-Drug
cysteine NCT03867994 829 837 I-Drug
7 NCT03867994 838 839 B-Eq_Comparison
days NCT03867994 840 844 I-Eq_Comparison
prior NCT03867994 845 850 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867994 851 853 I-Temporal_Connection___Temporal_Connection_Type_Value:before
CC NCT03867994 854 856 B-Procedure
. NCT03867994 857 858 O

- NCT03867994 862 863 O
Hemodynamically NCT03867994 865 880 B-Condition
unstable NCT03867994 881 889 O
patients NCT03867994 890 898 O
( NCT03867994 899 900 O
defined NCT03867994 901 908 O
as NCT03867994 909 911 O
abnormal NCT03867994 912 920 O
or NCT03867994 921 923 B-Or
unstable NCT03867994 924 932 O
blood NCT03867994 933 938 B-Observation
pressure NCT03867994 939 947 I-Observation
, NCT03867994 948 949 O
especially NCT03867994 950 960 O
hypotension NCT03867994 961 972 B-Condition
( NCT03867994 973 974 O
blood NCT03867994 975 980 B-Observation
pressure NCT03867994 981 989 I-Observation
less NCT03867994 990 994 B-Eq_Comparison
than NCT03867994 995 999 I-Eq_Comparison
90 NCT03867994 1000 1002 I-Eq_Comparison
/ NCT03867994 1003 1004 I-Eq_Comparison
60 NCT03867994 1005 1007 I-Eq_Comparison
mm NCT03867994 1008 1010 I-Eq_Comparison
Hg NCT03867994 1011 1013 I-Eq_Comparison
) NCT03867994 1014 1015 O
. NCT03867994 1016 1017 O

- NCT03867994 1021 1022 O
Patients NCT03867994 1024 1032 O
who NCT03867994 1033 1036 O
required NCT03867994 1037 1045 B-Assertion___Assertion_Type_Value:hypothetical
dialysis NCT03867994 1046 1054 B-Procedure
. NCT03867994 1055 1056 O

- NCT03867994 1060 1061 O
Pregnancy NCT03867994 1063 1072 B-Condition
. NCT03867994 1073 1074 O

- NCT03867994 1078 1079 O
Using NCT03867994 1081 1086 O
of NCT03867994 1087 1089 O
carvedilol NCT03867994 1090 1100 B-Drug
in NCT03867994 1101 1103 O
the NCT03867994 1104 1107 O
past NCT03867994 1108 1112 B-Eq_Comparison
three NCT03867994 1113 1118 I-Eq_Comparison
months NCT03867994 1119 1125 I-Eq_Comparison
. NCT03867994 1126 1127 O

- NCT03867994 1131 1132 O
Using NCT03867994 1134 1139 O
a NCT03867994 1140 1141 O
nephrotoxic NCT03867994 1142 1153 B-Drug
agent NCT03867994 1154 1159 I-Drug
in NCT03867994 1160 1162 O
the NCT03867994 1163 1166 O
past NCT03867994 1167 1171 B-Eq_Comparison
48 NCT03867994 1172 1174 I-Eq_Comparison
hours NCT03867994 1175 1180 I-Eq_Comparison
or NCT03867994 1181 1183 B-Or
exposure NCT03867994 1184 1192 O
to NCT03867994 1193 1195 O
a NCT03867994 1196 1197 O
contrast NCT03867994 1198 1206 B-Procedure
agent NCT03867994 1207 1212 I-Procedure
in NCT03867994 1213 1215 O
the NCT03867994 1216 1219 O
past NCT03867994 1220 1224 B-Eq_Comparison
7 NCT03867994 1225 1226 I-Eq_Comparison
days NCT03867994 1227 1231 I-Eq_Comparison
prior NCT03867994 1232 1237 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867994 1238 1240 I-Temporal_Connection___Temporal_Connection_Type_Value:before
cardiac NCT03867994 1241 1248 B-Procedure
catheterization NCT03867994 1249 1264 I-Procedure
. NCT03867994 1265 1266 O

Inclusion NCT03863925 0 9 O
Criteria NCT03863925 10 18 O
: NCT03863925 19 20 O

- NCT03863925 24 25 O
Age NCT03863925 27 30 B-Age
between NCT03863925 31 38 B-Eq_Comparison
20 NCT03863925 39 41 I-Eq_Comparison
years NCT03863925 42 47 I-Eq_Comparison
old NCT03863925 48 51 I-Eq_Comparison
and NCT03863925 52 55 I-Eq_Comparison
65 NCT03863925 56 58 I-Eq_Comparison
years NCT03863925 59 64 I-Eq_Comparison
old NCT03863925 65 68 I-Eq_Comparison

- NCT03863925 71 72 O
Diagnosis NCT03863925 74 83 O
of NCT03863925 84 86 O
major NCT03863925 87 92 B-Modifier
depressive NCT03863925 93 103 B-Condition
disorder NCT03863925 104 112 I-Condition
, NCT03863925 113 114 O
bipolar NCT03863925 115 122 B-Condition
disorder NCT03863925 123 131 I-Condition
, NCT03863925 132 133 O
and NCT03863925 134 137 B-Or
schizophrenia NCT03863925 138 151 B-Condition
, NCT03863925 152 153 O
compatible NCT03863925 154 164 O
with NCT03863925 165 169 O
SCID NCT03863925 170 174 O
for NCT03863925 175 178 O
DSM NCT03863925 179 182 O
- NCT03863925 183 184 O
5 NCT03863925 185 186 O
, NCT03863925 187 188 O
with NCT03863925 189 193 B-And
clinical NCT03863925 194 202 O
necessity NCT03863925 203 212 B-Eq_Comparison
of NCT03863925 213 215 I-Eq_Comparison
ECT NCT03863925 216 219 B-Procedure
under NCT03863925 220 225 O
a NCT03863925 226 227 O
psychiatrist NCT03863925 228 240 O
's NCT03863925 240 242 O
evaluation NCT03863925 243 253 O
and NCT03863925 254 257 O
decision NCT03863925 258 266 O

- NCT03863925 269 270 O
Patients NCT03863925 272 280 O
with NCT03863925 281 285 O
adequate NCT03863925 286 294 B-Condition
visual NCT03863925 295 301 I-Condition
acuity NCT03863925 302 308 I-Condition
and NCT03863925 309 312 B-And
auditory NCT03863925 313 321 B-Condition
acuity NCT03863925 322 328 I-Condition
without NCT03863925 329 336 O
or NCT03863925 337 339 O
with NCT03863925 340 344 O
correction NCT03863925 345 355 O

- NCT03863925 358 359 O
Patients NCT03863925 361 369 O
or NCT03863925 370 372 O
patients NCT03863925 373 381 O
' NCT03863925 381 382 O
legal NCT03863925 383 388 O
representative NCT03863925 389 403 O
signing NCT03863925 404 411 O
up NCT03863925 412 414 O
the NCT03863925 415 418 O
informed NCT03863925 419 427 O
consent NCT03863925 428 435 O

Exclusion NCT03863925 436 445 O
Criteria NCT03863925 446 454 O
: NCT03863925 455 456 O

- NCT03863925 460 461 O
Patients NCT03863925 463 471 O
already NCT03863925 472 479 O
diagnosed NCT03863925 480 489 O
with NCT03863925 490 494 O
neurocognitive NCT03863925 495 509 B-Condition
disorder NCT03863925 510 518 I-Condition

- NCT03863925 521 522 O
Patients NCT03863925 524 532 O
with NCT03863925 533 537 O
contraindications NCT03863925 538 555 B-Contraindication
to NCT03863925 556 558 O
ECT NCT03863925 559 562 B-Procedure
, NCT03863925 563 564 O
including NCT03863925 565 574 O
myocardial NCT03863925 575 585 B-Condition
infarction NCT03863925 586 596 I-Condition
, NCT03863925 597 598 O
cerebrovascular NCT03863925 599 614 B-Condition
disease NCT03863925 615 622 I-Condition
, NCT03863925 623 624 O
elevated NCT03863925 625 633 B-Condition
intracranial NCT03863925 634 646 I-Condition
pressure NCT03863925 647 655 I-Condition
, NCT03863925 656 657 O
intracranial NCT03863925 658 670 B-Condition
angiomas NCT03863925 671 679 I-Condition
, NCT03863925 680 681 O
untreated NCT03863925 682 691 B-Negation|B-Procedure
bony NCT03863925 692 696 B-Condition
fractures NCT03863925 697 706 I-Condition
, NCT03863925 707 708 O
cervical NCT03863925 709 717 B-Condition
spine NCT03863925 718 723 I-Condition
injury NCT03863925 724 730 I-Condition
, NCT03863925 731 732 O
pheochromocytoma NCT03863925 733 749 B-Condition
, NCT03863925 750 751 O
heart NCT03863925 752 757 B-Condition
failure NCT03863925 758 765 I-Condition
, NCT03863925 766 767 O
sever NCT03863925 768 773 O
valvular NCT03863925 774 782 B-Condition
disease NCT03863925 783 790 I-Condition
, NCT03863925 791 792 O
deep NCT03863925 793 797 B-Condition
vein NCT03863925 798 802 I-Condition
thrombosis NCT03863925 803 813 I-Condition
, NCT03863925 814 815 O
etc NCT03863925 816 819 O
. NCT03863925 820 821 O

- NCT03863925 825 826 O
Patients NCT03863925 828 836 O
with NCT03863925 837 841 O
untreated NCT03863925 842 851 B-Negation|B-Procedure
substance NCT03863925 852 861 B-Condition
abuse NCT03863925 862 867 I-Condition
, NCT03863925 868 869 O
including NCT03863925 870 879 O
alcohol NCT03863925 880 887 B-Drug
and NCT03863925 888 891 B-Or
illegal NCT03863925 892 899 B-Drug
drugs NCT03863925 900 905 I-Drug

- NCT03863925 908 909 O
Patients NCT03863925 911 919 O
with NCT03863925 920 924 O
unspecified NCT03863925 925 936 B-Modifier
psychiatric NCT03863925 937 948 B-Condition
disorders NCT03863925 949 958 I-Condition

- NCT03863925 961 962 O
Patients NCT03863925 964 972 O
unable NCT03863925 973 979 O
to NCT03863925 980 982 O
cooperate NCT03863925 983 992 O

Inclusion NCT03869021 0 9 O
Criteria NCT03869021 10 18 O
: NCT03869021 19 20 O

1 NCT03869021 24 25 O
. NCT03869021 25 26 O
Patients NCT03869021 28 36 O
free NCT03869021 37 41 B-Negation
from NCT03869021 42 46 I-Negation
any NCT03869021 47 50 O
disease NCT03869021 51 58 B-Condition
affecting NCT03869021 59 68 B-Modifier
bone NCT03869021 69 73 I-Modifier
formation NCT03869021 74 83 I-Modifier
of NCT03869021 84 86 O
both NCT03869021 87 91 O
sexes NCT03869021 92 97 O
was NCT03869021 98 101 O
included NCT03869021 102 110 O
in NCT03869021 111 113 O
the NCT03869021 114 117 O
study NCT03869021 118 123 O
. NCT03869021 124 125 O

2 NCT03869021 129 130 O
. NCT03869021 130 131 O
Patients NCT03869021 133 141 O
younger NCT03869021 142 149 B-Eq_Comparison
than NCT03869021 150 154 I-Eq_Comparison
25 NCT03869021 155 157 I-Eq_Comparison
years NCT03869021 158 163 I-Eq_Comparison
old NCT03869021 164 167 B-Age
. NCT03869021 168 169 O

3 NCT03869021 173 174 O
. NCT03869021 174 175 O
Patients NCT03869021 177 185 O
included NCT03869021 186 194 O
in NCT03869021 195 197 O
the NCT03869021 198 201 O
study NCT03869021 202 207 O
were NCT03869021 208 212 O
hemifacial NCT03869021 213 223 B-Condition
microsomia NCT03869021 224 234 I-Condition

4 NCT03869021 237 238 O
. NCT03869021 238 239 O
Distraction NCT03869021 241 252 B-Observation
range NCT03869021 253 258 I-Observation
was NCT03869021 259 262 O
between NCT03869021 263 270 O
15 NCT03869021 271 273 B-Eq_Comparison
- NCT03869021 274 275 I-Eq_Comparison
20 NCT03869021 276 278 I-Eq_Comparison
mm NCT03869021 279 281 I-Eq_Comparison
. NCT03869021 282 283 O

Exclusion NCT03869021 285 294 O
Criteria NCT03869021 295 303 O
: NCT03869021 304 305 O

1 NCT03869021 309 310 O
. NCT03869021 310 311 O
The NCT03869021 313 316 O
presence NCT03869021 317 325 B-Eq_Comparison
of NCT03869021 326 328 O
uncontrolled NCT03869021 329 341 B-Modifier
systemic NCT03869021 342 350 I-Modifier
disease NCT03869021 351 358 B-Condition
. NCT03869021 359 360 O

2 NCT03869021 364 365 O
. NCT03869021 365 366 O
Previous NCT03869021 368 376 B-Eq_Comparison
radiotherapy NCT03869021 377 389 B-Procedure
on NCT03869021 390 392 O
head NCT03869021 393 397 B-Modifier
and NCT03869021 398 401 B-Or
neck NCT03869021 402 406 B-Modifier
region NCT03869021 407 413 I-Modifier
. NCT03869021 414 415 O

3 NCT03869021 419 420 O
. NCT03869021 420 421 O
Chemotherapy NCT03869021 423 435 B-Procedure
within NCT03869021 436 442 B-Eq_Comparison
the NCT03869021 443 446 I-Eq_Comparison
past NCT03869021 447 451 I-Eq_Comparison
12 NCT03869021 452 454 I-Eq_Comparison
- NCT03869021 455 456 I-Eq_Comparison
month NCT03869021 457 462 I-Eq_Comparison
period NCT03869021 463 469 O
. NCT03869021 470 471 O

4 NCT03869021 475 476 O
. NCT03869021 476 477 O
An NCT03869021 479 481 O
active NCT03869021 482 488 B-Eq_Comparison
infection NCT03869021 489 498 B-Condition
at NCT03869021 499 501 O
the NCT03869021 502 505 O
distraction NCT03869021 506 517 B-Modifier
site NCT03869021 518 522 I-Modifier
. NCT03869021 523 524 O

Inclusion NCT03868904 0 9 O
Criteria NCT03868904 10 18 O
: NCT03868904 19 20 O

- NCT03868904 24 25 O
Participant NCT03868904 27 38 O
in NCT03868904 39 41 O
TransMedics NCT03868904 42 53 O
OCS NCT03868904 54 57 O
Lung NCT03868904 58 62 O
System NCT03868904 63 69 O
INSPIRE NCT03868904 70 77 O
trial NCT03868904 78 83 B-Study

Exclusion NCT03868904 84 93 O
Criteria NCT03868904 94 102 O
: NCT03868904 103 104 O

- NCT03868904 108 109 O
None NCT03868904 111 115 O

Inclusion NCT03863873 0 9 O
Criteria NCT03863873 10 18 O
: NCT03863873 19 20 O

- NCT03863873 24 25 O
Patients NCT03863873 27 35 O
with NCT03863873 36 40 O
mild NCT03863873 41 45 B-Eq_Comparison
- NCT03863873 46 47 I-Eq_Comparison
to NCT03863873 48 50 I-Eq_Comparison
- NCT03863873 51 52 I-Eq_Comparison
moderate NCT03863873 53 61 I-Eq_Comparison
idiopathic NCT03863873 62 72 B-Modifier
CTS NCT03863873 73 76 B-Condition
with NCT03863873 77 81 O
clinical NCT03863873 82 90 B-Condition
manifestations NCT03863873 91 105 I-Condition
failed NCT03863873 106 112 O
to NCT03863873 113 115 O
respond NCT03863873 116 123 O
to NCT03863873 124 126 O
conservative NCT03863873 127 139 B-Procedure
treatment NCT03863873 140 149 I-Procedure
( NCT03863873 150 151 O
such NCT03863873 152 156 O
as NCT03863873 157 159 O
splint NCT03863873 160 166 B-Procedure
, NCT03863873 167 168 O
medications NCT03863873 169 180 B-Drug
, NCT03863873 181 182 O
Physical NCT03863873 183 191 B-Procedure
therapy NCT03863873 192 199 I-Procedure
) NCT03863873 200 201 O
for NCT03863873 202 205 O
at NCT03863873 206 208 B-Eq_Comparison
least NCT03863873 209 214 I-Eq_Comparison
3 NCT03863873 215 216 I-Eq_Comparison
months NCT03863873 217 223 I-Eq_Comparison
and NCT03863873 224 227 B-And
they NCT03863873 228 232 O
were NCT03863873 233 237 O
diagnosed NCT03863873 238 247 O
by NCT03863873 248 250 O
electrophysiological NCT03863873 251 271 B-Procedure
study NCT03863873 272 277 I-Procedure
and NCT03863873 278 281 B-Or
musculoskeletal NCT03863873 282 297 B-Modifier
ultrasound NCT03863873 298 308 B-Procedure
. NCT03863873 309 310 O

Exclusion NCT03863873 312 321 O
Criteria NCT03863873 322 330 O
: NCT03863873 331 332 O

- NCT03863873 336 337 O
Diabetes NCT03863873 339 347 B-Condition

- NCT03863873 350 351 O
Hypothyroidism NCT03863873 353 367 B-Condition

- NCT03863873 370 371 O
Rheumatoid NCT03863873 373 383 B-Condition
arthritis NCT03863873 384 393 I-Condition

- NCT03863873 396 397 O
Previous NCT03863873 399 407 B-Eq_Comparison
carpal NCT03863873 408 414 B-Procedure
tunnel NCT03863873 415 421 I-Procedure
decompressive NCT03863873 422 435 I-Procedure
surgery NCT03863873 436 443 I-Procedure

- NCT03863873 446 447 O
Cervical NCT03863873 449 457 B-Condition
radiculopathy NCT03863873 458 471 I-Condition
, NCT03863873 472 473 O
polyneuropathy NCT03863873 474 488 B-Condition
, NCT03863873 489 490 O
brachial NCT03863873 491 499 B-Condition
plexopathy NCT03863873 500 510 I-Condition
, NCT03863873 511 512 O
traumatic NCT03863873 513 522 B-Condition
nerve NCT03863873 523 528 I-Condition
injury NCT03863873 529 535 I-Condition
, NCT03863873 536 537 O
thoracic NCT03863873 538 546 B-Condition
outlet NCT03863873 547 553 I-Condition
syndrome NCT03863873 554 562 I-Condition

- NCT03863873 565 566 O
Previous NCT03863873 568 576 B-Eq_Comparison
corticosteroid NCT03863873 577 591 B-Procedure
injection NCT03863873 592 601 I-Procedure
into NCT03863873 602 606 O
the NCT03863873 607 610 O
carpal NCT03863873 611 617 B-Modifier
tunnel NCT03863873 618 624 I-Modifier
in NCT03863873 625 627 O
the NCT03863873 628 631 O
preceding NCT03863873 632 641 B-Eq_Comparison
4 NCT03863873 642 643 I-Eq_Comparison
weeks NCT03863873 644 649 I-Eq_Comparison

- NCT03863873 652 653 O
Anemia NCT03863873 655 661 B-Condition
( NCT03863873 662 663 O
hemoglobin NCT03863873 664 674 B-Observation
< NCT03863873 675 676 B-Eq_Comparison
10 NCT03863873 677 679 I-Eq_Comparison
gm NCT03863873 680 682 I-Eq_Comparison
% NCT03863873 683 684 I-Eq_Comparison
) NCT03863873 685 686 O

- NCT03863873 690 691 O
Coagulopathy NCT03863873 693 705 B-Condition

- NCT03863873 708 709 O
Pregnancy NCT03863873 711 720 B-Condition

Inclusion NCT03868618 0 9 O
Criteria NCT03868618 10 18 O
: NCT03868618 19 20 O

- NCT03868618 24 25 O
Body NCT03868618 27 31 B-Observation
mass NCT03868618 32 36 I-Observation
index NCT03868618 37 42 I-Observation
( NCT03868618 43 44 O
BMI NCT03868618 45 48 B-Observation
) NCT03868618 49 50 O
limitations NCT03868618 51 62 B-Modifier

- NCT03868618 65 66 O
Likely NCT03868618 68 74 B-Assertion___Assertion_Type_Value:possible
suffer NCT03868618 75 81 O
from NCT03868618 82 86 O
moderate NCT03868618 87 95 B-Eq_Comparison
to NCT03868618 96 98 I-Eq_Comparison
severe NCT03868618 99 105 I-Eq_Comparison
OSA NCT03868618 106 109 B-Condition
based NCT03868618 110 115 O
on NCT03868618 116 118 O
history NCT03868618 119 126 B-Eq_Comparison
and NCT03868618 127 130 B-Or
physical NCT03868618 131 139 B-Procedure

- NCT03868618 142 143 O
Has NCT03868618 145 148 O
either NCT03868618 149 155 O
not NCT03868618 156 159 B-Negation
tolerated NCT03868618 160 169 B-Assertion___Assertion_Type_Value:hypothetical
, NCT03868618 170 171 O
has NCT03868618 172 175 O
failed NCT03868618 176 182 O
or NCT03868618 183 185 O
refused NCT03868618 186 193 O
positive NCT03868618 194 202 B-Procedure
airway NCT03868618 203 209 I-Procedure
pressure NCT03868618 210 218 I-Procedure
( NCT03868618 219 220 O
PAP NCT03868618 221 224 B-Procedure
) NCT03868618 225 226 O
treatments NCT03868618 227 237 B-Procedure

- NCT03868618 240 241 O
Willing NCT03868618 243 250 O
and NCT03868618 251 254 O
capable NCT03868618 255 262 O
of NCT03868618 263 265 O
providing NCT03868618 266 275 O
informed NCT03868618 276 284 O
consent NCT03868618 285 292 O

Exclusion NCT03868618 293 302 O
Criteria NCT03868618 303 311 O
: NCT03868618 312 313 O

- NCT03868618 317 318 O
Inadequately NCT03868618 320 332 B-Modifier
treated NCT03868618 333 340 B-Procedure
sleep NCT03868618 341 346 B-Condition
disorders NCT03868618 347 356 I-Condition
other NCT03868618 357 362 B-Exception
than NCT03868618 363 367 I-Exception
OSA NCT03868618 368 371 B-Condition

- NCT03868618 374 375 O
Significant NCT03868618 377 388 O
co NCT03868618 389 391 B-Condition
- NCT03868618 392 393 I-Condition
morbidities NCT03868618 394 405 I-Condition
that NCT03868618 406 410 O
contraindicates NCT03868618 411 426 B-Contraindication
surgery NCT03868618 427 434 B-Procedure
or NCT03868618 435 437 B-Or
general NCT03868618 438 445 B-Procedure
anesthesia NCT03868618 446 456 I-Procedure

Inclusion NCT03867604 0 9 O
Criteria NCT03867604 10 18 O
: NCT03867604 19 20 O

- NCT03867604 24 25 O
20 NCT03867604 27 29 B-Eq_Comparison
- NCT03867604 30 31 I-Eq_Comparison
70 NCT03867604 32 34 I-Eq_Comparison
years NCT03867604 35 40 I-Eq_Comparison
old NCT03867604 41 44 B-Age

- NCT03867604 47 48 O
diagnosed NCT03867604 50 59 O
as NCT03867604 60 62 O
a NCT03867604 63 64 O
myofascial NCT03867604 65 75 B-Condition
pain NCT03867604 76 80 I-Condition
syndrome NCT03867604 81 89 I-Condition
at NCT03867604 90 92 O
upper NCT03867604 93 98 B-Modifier
trapezium NCT03867604 99 108 I-Modifier
muscle NCT03867604 109 115 I-Modifier

- NCT03867604 118 119 O
trigger NCT03867604 121 128 B-Condition
point NCT03867604 129 134 I-Condition

- NCT03867604 137 138 O
taut NCT03867604 140 144 B-Condition
band NCT03867604 145 149 I-Condition

- NCT03867604 152 153 O
refer NCT03867604 155 160 O
pain NCT03867604 161 165 B-Condition
while NCT03867604 166 171 B-Temporal_Connection___Temporal_Connection_Type_Value:during
taut NCT03867604 172 176 B-Condition
band NCT03867604 177 181 I-Condition
irritation NCT03867604 182 192 I-Condition

Exclusion NCT03867604 193 202 O
Criteria NCT03867604 203 211 O
: NCT03867604 212 213 O

- NCT03867604 217 218 O
Cognitive NCT03867604 220 229 B-Condition
impairment NCT03867604 230 240 I-Condition
. NCT03867604 241 242 O

- NCT03867604 246 247 O
Post NCT03867604 249 253 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operation NCT03867604 254 263 B-Procedure
at NCT03867604 264 266 O
neck NCT03867604 267 271 B-Modifier
and NCT03867604 272 275 B-Or
shoulder NCT03867604 276 284 B-Modifier
. NCT03867604 285 286 O

- NCT03867604 290 291 O
Nerve NCT03867604 293 298 B-Condition
compression NCT03867604 299 310 I-Condition
at NCT03867604 311 313 O
cervical NCT03867604 314 322 B-Modifier
region NCT03867604 323 329 I-Modifier
. NCT03867604 330 331 O

- NCT03867604 335 336 O
Could NCT03867604 338 343 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03867604 344 347 B-Negation
receive NCT03867604 348 355 O
injection NCT03867604 356 365 B-Procedure
therapy NCT03867604 366 373 I-Procedure
, NCT03867604 374 375 O
history NCT03867604 376 383 B-Eq_Comparison
of NCT03867604 384 386 O
fainting NCT03867604 387 395 B-Condition
during NCT03867604 396 402 B-Temporal_Connection___Temporal_Connection_Type_Value:during
needling NCT03867604 403 411 B-Procedure

Inclusion NCT03926455 0 9 O
Criteria NCT03926455 10 18 O
: NCT03926455 19 20 O

- NCT03926455 24 25 O
Healthy NCT03926455 27 34 O
adult NCT03926455 35 40 O
men NCT03926455 41 44 O
or NCT03926455 45 47 B-Or
women NCT03926455 48 53 O
who NCT03926455 54 57 B-And
are NCT03926455 58 61 O
not NCT03926455 62 65 B-Negation
pregnant NCT03926455 66 74 B-Condition
or NCT03926455 75 77 O
planning NCT03926455 78 86 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926455 87 89 I-Assertion___Assertion_Type_Value:hypothetical
become NCT03926455 90 96 O
pregnant NCT03926455 97 105 B-Condition
during NCT03926455 106 112 B-Temporal_Connection___Temporal_Connection_Type_Value:during
study NCT03926455 113 118 B-Study
duration NCT03926455 119 127 O
aged NCT03926455 128 132 B-Age
18 NCT03926455 133 135 B-Eq_Comparison
to NCT03926455 136 138 I-Eq_Comparison
55 NCT03926455 139 141 I-Eq_Comparison
years NCT03926455 142 147 I-Eq_Comparison
. NCT03926455 148 149 O

- NCT03926455 153 154 O
Clinical NCT03926455 156 164 O
laboratory NCT03926455 165 175 B-Observation
parameters NCT03926455 176 186 I-Observation
within NCT03926455 187 193 O
normal NCT03926455 194 200 O
laboratory NCT03926455 201 211 O
limits NCT03926455 212 218 O
or NCT03926455 219 221 O
not NCT03926455 222 225 O
found NCT03926455 226 231 O
to NCT03926455 232 234 O
be NCT03926455 235 237 O
clinically NCT03926455 238 248 O
significant NCT03926455 249 260 O
by NCT03926455 261 263 O
the NCT03926455 264 267 O
PI NCT03926455 268 270 O

Exclusion NCT03926455 271 280 O
Criteria NCT03926455 281 289 O
: NCT03926455 290 291 O

- NCT03926455 295 296 O
Relevant NCT03926455 298 306 O
history NCT03926455 307 314 B-Eq_Comparison
of NCT03926455 315 317 O
physical NCT03926455 318 326 B-Modifier
or NCT03926455 327 329 B-Or
psychiatric NCT03926455 330 341 B-Modifier
illness NCT03926455 342 349 B-Condition
or NCT03926455 350 352 B-Or
medical NCT03926455 353 360 B-Condition
disorder NCT03926455 361 369 I-Condition
that NCT03926455 370 374 O
required NCT03926455 375 383 O
treatment NCT03926455 384 393 B-Procedure
. NCT03926455 394 395 O

- NCT03926455 399 400 O
Known NCT03926455 402 407 B-Modifier
or NCT03926455 408 410 B-Or
suspected NCT03926455 411 420 B-Assertion___Assertion_Type_Value:hypothetical
hypersensitivity NCT03926455 421 437 B-Condition
to NCT03926455 438 440 O
investigational NCT03926455 441 456 B-Study
product NCT03926455 457 464 B-Drug

- NCT03926455 467 468 O
Immunocompromised NCT03926455 470 487 B-Condition
subjects NCT03926455 488 496 O

- NCT03926455 499 500 O
Previous NCT03926455 502 510 B-Eq_Comparison
Typhoid NCT03926455 511 518 B-Procedure
vaccination NCT03926455 519 530 I-Procedure
or NCT03926455 531 533 B-Or
elevated NCT03926455 534 542 O
anti NCT03926455 543 547 B-Observation
- NCT03926455 548 549 I-Observation
Vi NCT03926455 550 552 I-Observation
antibodies NCT03926455 553 563 I-Observation
at NCT03926455 564 566 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03926455 567 576 B-Study

- NCT03926455 579 580 O
Known NCT03926455 582 587 O
history NCT03926455 588 595 B-Eq_Comparison
of NCT03926455 596 598 O
Typhoid NCT03926455 599 606 B-Condition
infection NCT03926455 607 616 I-Condition
in NCT03926455 617 619 O
the NCT03926455 620 623 O
previous NCT03926455 624 632 B-Eq_Comparison
6 NCT03926455 633 634 I-Eq_Comparison
months NCT03926455 635 641 I-Eq_Comparison

- NCT03926455 644 645 O
Positive NCT03926455 647 655 O
HIV NCT03926455 656 659 B-Condition
, NCT03926455 660 661 O
HBsAg NCT03926455 662 667 B-Condition
, NCT03926455 668 669 O
or NCT03926455 670 672 B-Or
HCV NCT03926455 673 676 B-Condition
screen NCT03926455 677 683 O

- NCT03926455 686 687 O
Any NCT03926455 689 692 O
other NCT03926455 693 698 O
condition NCT03926455 699 708 B-Condition
or NCT03926455 709 711 B-Or
abnormality NCT03926455 712 723 B-Condition
that NCT03926455 724 728 O
, NCT03926455 729 730 O
in NCT03926455 731 733 O
the NCT03926455 734 737 O
opinion NCT03926455 738 745 O
of NCT03926455 746 748 O
the NCT03926455 749 752 O
Investigator NCT03926455 753 765 O
, NCT03926455 766 767 O
may NCT03926455 768 771 B-Assertion___Assertion_Type_Value:hypothetical
compromise NCT03926455 772 782 O
the NCT03926455 783 786 O
safety NCT03926455 787 793 B-Observation
of NCT03926455 794 796 O
the NCT03926455 797 800 O
patients NCT03926455 801 809 O

Inclusion NCT03865173 0 9 O
Criteria NCT03865173 10 18 O
: NCT03865173 19 20 O

- NCT03865173 24 25 O
Patient NCT03865173 27 34 O
being NCT03865173 35 40 O
over NCT03865173 41 45 B-Eq_Comparison
18 NCT03865173 46 48 I-Eq_Comparison
years NCT03865173 49 54 I-Eq_Comparison
of NCT03865173 55 57 O
age NCT03865173 58 61 B-Age
living NCT03865173 62 68 O
in NCT03865173 69 71 O
metropolitan NCT03865173 72 84 O
France NCT03865173 85 91 O
; NCT03865173 91 92 O

- NCT03865173 95 96 O
Patient NCT03865173 98 105 O
with NCT03865173 106 110 O
recent NCT03865173 111 117 B-Eq_Comparison
stroke NCT03865173 118 124 B-Condition
( NCT03865173 125 126 O
not NCT03865173 127 130 B-Negation
before NCT03865173 131 137 B-Eq_Comparison
2019 NCT03865173 138 142 I-Eq_Comparison
) NCT03865173 143 144 O
whose NCT03865173 145 150 O
diagnosis NCT03865173 151 160 O
confirmed NCT03865173 161 170 O
by NCT03865173 171 173 O
a NCT03865173 174 175 O
neuro NCT03865173 176 181 B-Provider
- NCT03865173 182 183 I-Provider
vascular NCT03865173 184 192 I-Provider
physician NCT03865173 193 202 I-Provider
; NCT03865173 202 203 O

- NCT03865173 206 207 O
Patient NCT03865173 209 216 O
managed NCT03865173 217 224 B-Procedure
for NCT03865173 225 228 O
stroke NCT03865173 229 235 B-Condition
in NCT03865173 236 238 O
one NCT03865173 239 242 O
of NCT03865173 243 245 O
the NCT03865173 246 249 O
13 NCT03865173 250 252 O
participating NCT03865173 253 266 O
hospitals NCT03865173 267 276 O
of NCT03865173 277 279 O
the NCT03865173 280 283 O
Aquitaine NCT03865173 284 293 O
region NCT03865173 294 300 O
; NCT03865173 300 301 O

- NCT03865173 304 305 O
Patient NCT03865173 307 314 O
giving NCT03865173 315 321 O
consent NCT03865173 322 329 O
to NCT03865173 330 332 O
participate NCT03865173 333 344 O
to NCT03865173 345 347 O
PAPASéPA NCT03865173 348 356 O
; NCT03865173 356 357 O

- NCT03865173 360 361 O
Patient NCT03865173 363 370 O
to NCT03865173 371 373 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03865173 374 376 I-Assertion___Assertion_Type_Value:hypothetical
alive NCT03865173 377 382 B-Death|B-Negation
at NCT03865173 383 385 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865173 386 389 I-Temporal_Connection___Temporal_Connection_Type_Value:during
end NCT03865173 390 393 B-Eq_Comparison
of NCT03865173 394 396 O
the NCT03865173 397 400 O
acute NCT03865173 401 406 B-Modifier
management NCT03865173 407 417 I-Modifier
hospital NCT03865173 418 426 B-Encounter
stay NCT03865173 427 431 I-Encounter

Exclusion NCT03865173 432 441 O
Criteria NCT03865173 442 450 O
: NCT03865173 451 452 O

- NCT03865173 456 457 O
Patient NCT03865173 459 466 O
refuse NCT03865173 467 473 O
to NCT03865173 474 476 O
participate NCT03865173 477 488 O
to NCT03865173 489 491 O
PAPASéPA NCT03865173 492 500 O

- NCT03865173 503 504 O
Patient NCT03865173 506 513 O
died NCT03865173 514 518 B-Death
during NCT03865173 519 525 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865173 526 529 O
initial NCT03865173 530 537 B-Eq_Comparison
stay NCT03865173 538 542 B-Encounter

Inclusion NCT03864562 0 9 O
Criteria NCT03864562 10 18 O
: NCT03864562 19 20 O

- NCT03864562 24 25 O
White NCT03864562 27 32 O
European NCT03864562 33 41 O
or NCT03864562 42 44 B-Or
black NCT03864562 45 50 O
African NCT03864562 51 58 O
/ NCT03864562 59 60 B-Or
Caribbean NCT03864562 61 70 O
heritage NCT03864562 71 79 O

- NCT03864562 82 83 O
BMI NCT03864562 85 88 B-Observation
> NCT03864562 89 90 B-Eq_Comparison
18 NCT03864562 91 93 I-Eq_Comparison
kg NCT03864562 94 96 I-Eq_Comparison
/ NCT03864562 97 98 I-Eq_Comparison
m NCT03864562 99 100 I-Eq_Comparison
2 NCT03864562 101 102 I-Eq_Comparison

- NCT03864562 105 106 O
Ability NCT03864562 108 115 O
to NCT03864562 116 118 O
give NCT03864562 119 123 O
written NCT03864562 124 131 O
informed NCT03864562 132 140 O
consent NCT03864562 141 148 O

- NCT03864562 151 152 O
English NCT03864562 154 161 O
speaking NCT03864562 162 170 O

Exclusion NCT03864562 171 180 O
Criteria NCT03864562 181 189 O
: NCT03864562 190 191 O

- NCT03864562 195 196 O
Any NCT03864562 198 201 O
significant NCT03864562 202 213 O
medical NCT03864562 214 221 B-Condition
condition NCT03864562 222 231 I-Condition

- NCT03864562 234 235 O
Uncontrolled NCT03864562 237 249 B-Modifier
hypertension NCT03864562 250 262 B-Condition

- NCT03864562 265 266 O
Alcohol NCT03864562 268 275 B-Observation
consumption NCT03864562 276 287 I-Observation
> NCT03864562 288 289 O
14 NCT03864562 290 292 B-Eq_Comparison
units NCT03864562 293 298 I-Eq_Comparison
/ NCT03864562 299 300 I-Eq_Comparison
week NCT03864562 301 305 I-Eq_Comparison

- NCT03864562 308 309 O
Random NCT03864562 311 317 B-Modifier
blood NCT03864562 318 323 B-Observation
Glucose NCT03864562 324 331 I-Observation
concentration NCT03864562 332 345 I-Observation
above NCT03864562 346 351 B-Eq_Comparison
7.8 NCT03864562 352 355 I-Eq_Comparison
mmol NCT03864562 356 360 I-Eq_Comparison
/ NCT03864562 361 362 I-Eq_Comparison
l NCT03864562 363 364 I-Eq_Comparison

- NCT03864562 367 368 O
Hemoglobin NCT03864562 370 380 B-Observation
A NCT03864562 381 382 I-Observation
1c NCT03864562 383 385 I-Observation
( NCT03864562 386 387 O
HbA NCT03864562 388 391 B-Observation
1c NCT03864562 392 394 I-Observation
) NCT03864562 395 396 O
> NCT03864562 397 398 O
47 NCT03864562 399 401 B-Eq_Comparison
mmol NCT03864562 402 406 I-Eq_Comparison
/ NCT03864562 407 408 I-Eq_Comparison
mol NCT03864562 409 412 I-Eq_Comparison
( NCT03864562 413 414 O
> NCT03864562 415 416 B-Eq_Comparison
6.4 NCT03864562 417 420 I-Eq_Comparison
% NCT03864562 421 422 I-Eq_Comparison
) NCT03864562 423 424 O

- NCT03864562 428 429 O
Use NCT03864562 431 434 B-Eq_Comparison
of NCT03864562 435 437 O
regular NCT03864562 438 445 O
medication NCT03864562 446 456 B-Drug
, NCT03864562 457 458 O
( NCT03864562 459 460 O
oral NCT03864562 461 465 B-Drug
contraceptive NCT03864562 466 479 I-Drug
pill NCT03864562 480 484 I-Drug
or NCT03864562 485 487 B-Or
antihypertensive NCT03864562 488 504 B-Drug
medication NCT03864562 505 515 I-Drug
are NCT03864562 516 519 O
acceptable NCT03864562 520 530 B-Exception
if NCT03864562 531 533 I-Exception
use NCT03864562 534 537 O
has NCT03864562 538 541 O
been NCT03864562 542 546 O
for NCT03864562 547 550 O
> NCT03864562 551 552 B-Eq_Comparison
6 NCT03864562 553 554 I-Eq_Comparison
months NCT03864562 555 561 I-Eq_Comparison
) NCT03864562 562 563 O

- NCT03864562 567 568 O
History NCT03864562 570 577 B-Eq_Comparison
of NCT03864562 578 580 O
Irritable NCT03864562 581 590 B-Condition
Bowel NCT03864562 591 596 I-Condition
Syndrome NCT03864562 597 605 I-Condition
, NCT03864562 606 607 O
food NCT03864562 608 612 B-Condition
intolerances NCT03864562 613 625 I-Condition
or NCT03864562 626 628 B-Or
any NCT03864562 629 632 O
gastrointestinal NCT03864562 633 649 B-Condition
disorders NCT03864562 650 659 I-Condition

- NCT03864562 662 663 O
Previous NCT03864562 665 673 B-Eq_Comparison
bariatric NCT03864562 674 683 B-Procedure
surgery NCT03864562 684 691 I-Procedure
, NCT03864562 692 693 O
or NCT03864562 694 696 B-Or
gastrointestinal NCT03864562 697 713 B-Procedure
surgery NCT03864562 714 721 I-Procedure
which NCT03864562 722 727 O
may NCT03864562 728 731 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03864562 732 738 O
normal NCT03864562 739 745 O
function NCT03864562 746 754 B-Condition
( NCT03864562 755 756 O
e NCT03864562 757 758 O
. NCT03864562 759 760 O
g NCT03864562 761 762 O
. NCT03864562 763 764 O
bowel NCT03864562 766 771 B-Procedure
resection NCT03864562 772 781 I-Procedure
) NCT03864562 782 783 O

Inclusion NCT03865459 0 9 O
Criteria NCT03865459 10 18 O
: NCT03865459 19 20 O

- NCT03865459 24 25 O
age NCT03865459 27 30 B-Age
> NCT03865459 31 32 B-Eq_Comparison
18 NCT03865459 33 35 I-Eq_Comparison
years NCT03865459 36 41 I-Eq_Comparison

- NCT03865459 44 45 O
female NCT03865459 47 53 O
gender NCT03865459 54 60 O

- NCT03865459 63 64 O
rigid NCT03865459 66 71 B-Modifier
cystoscopy NCT03865459 72 82 B-Procedure
for NCT03865459 83 86 O
the NCT03865459 87 90 O
first NCT03865459 91 96 B-Eq_Comparison
time NCT03865459 97 101 I-Eq_Comparison

Exclusion NCT03865459 102 111 O
Criteria NCT03865459 112 120 O
: NCT03865459 121 122 O

- NCT03865459 126 127 O
presence NCT03865459 129 137 O
of NCT03865459 138 140 O
any NCT03865459 141 144 O
contraindication NCT03865459 145 161 B-Contraindication
for NCT03865459 162 165 O
cystoscopy NCT03865459 166 176 B-Procedure
( NCT03865459 177 178 O
such NCT03865459 179 183 O
as NCT03865459 184 186 O
lidocaine NCT03865459 187 196 B-Drug
allergy NCT03865459 197 204 B-Allergy
, NCT03865459 205 206 O
urinary NCT03865459 207 214 B-Condition
tract NCT03865459 215 220 I-Condition
infection NCT03865459 221 230 I-Condition
, NCT03865459 231 232 O
and NCT03865459 233 236 B-Or
urethra NCT03865459 237 244 B-Modifier
- NCT03865459 245 246 O
related NCT03865459 247 254 O
anatomical NCT03865459 255 265 B-Condition
disorders NCT03865459 266 275 I-Condition
) NCT03865459 276 277 O

- NCT03865459 281 282 O
any NCT03865459 284 287 O
analgesic NCT03865459 288 297 B-Drug
used NCT03865459 298 302 O
24 NCT03865459 303 305 B-Eq_Comparison
hours NCT03865459 306 311 I-Eq_Comparison
before NCT03865459 312 318 B-Temporal_Connection___Temporal_Connection_Type_Value:before
cystoscopy NCT03865459 319 329 B-Procedure

- NCT03865459 332 333 O
manipulations NCT03865459 335 348 B-Procedure
such NCT03865459 349 353 O
as NCT03865459 354 356 O
Double NCT03865459 357 363 B-Procedure
- NCT03865459 364 365 I-Procedure
J NCT03865459 366 367 I-Procedure
stent NCT03865459 368 373 I-Procedure
placement NCT03865459 374 383 B-Modifier
or NCT03865459 384 386 B-Or
removal NCT03865459 387 394 B-Modifier
, NCT03865459 395 396 O
and NCT03865459 397 400 B-Or
/ NCT03865459 401 402 I-Or
or NCT03865459 403 405 I-Or
bladder NCT03865459 406 413 B-Modifier
biopsy NCT03865459 414 420 B-Procedure
. NCT03865459 421 422 O

Inclusion NCT03925753 0 9 O
Criteria NCT03925753 10 18 O
: NCT03925753 19 20 O

- NCT03925753 24 25 O
Both NCT03925753 27 31 O
sexes NCT03925753 32 37 O
aged NCT03925753 38 42 B-Age
between NCT03925753 43 50 O
20 NCT03925753 51 53 B-Eq_Comparison
- NCT03925753 54 55 I-Eq_Comparison
90 NCT03925753 56 58 I-Eq_Comparison
years NCT03925753 59 64 I-Eq_Comparison
. NCT03925753 65 66 O

- NCT03925753 70 71 O
Received NCT03925753 73 81 B-Eq_Comparison
stable NCT03925753 82 88 O
hemodialysis NCT03925753 89 101 B-Procedure
at NCT03925753 102 104 B-Eq_Comparison
least NCT03925753 105 110 I-Eq_Comparison
3 NCT03925753 111 112 I-Eq_Comparison
months NCT03925753 113 119 I-Eq_Comparison
. NCT03925753 120 121 O

- NCT03925753 125 126 O
Written NCT03925753 128 135 O
informed NCT03925753 136 144 O
consent NCT03925753 145 152 O
. NCT03925753 153 154 O

Exclusion NCT03925753 156 165 O
Criteria NCT03925753 166 174 O
: NCT03925753 175 176 O

- NCT03925753 180 181 O
patients NCT03925753 183 191 O
with NCT03925753 192 196 O
severe NCT03925753 197 203 O
infections NCT03925753 204 214 B-Condition
, NCT03925753 215 216 O
severe NCT03925753 217 223 O
heart NCT03925753 224 229 B-Condition
disease NCT03925753 230 237 I-Condition
and NCT03925753 238 241 B-Or
liver NCT03925753 242 247 B-Condition
disease NCT03925753 248 255 I-Condition
, NCT03925753 256 257 O
malignancy NCT03925753 258 268 B-Condition
, NCT03925753 269 270 O
autoimmune NCT03925753 271 281 B-Condition
disorders NCT03925753 282 291 I-Condition
, NCT03925753 292 293 O
severe NCT03925753 294 300 O
malnutrition NCT03925753 301 313 B-Condition
, NCT03925753 314 315 O
or NCT03925753 316 318 B-Or
clinical NCT03925753 319 327 O
conditions NCT03925753 328 338 B-Condition
requiring NCT03925753 339 348 O
oral NCT03925753 349 353 B-Procedure
nutrition NCT03925753 354 363 I-Procedure
supplements NCT03925753 364 375 I-Procedure
; NCT03925753 375 376 O

- NCT03925753 379 380 O
Inability NCT03925753 382 391 O
to NCT03925753 392 394 O
follow NCT03925753 395 401 O
protocol NCT03925753 402 410 O
. NCT03925753 411 412 O

- NCT03925753 416 417 O
Pregnancy NCT03925753 419 428 B-Condition
or NCT03925753 429 431 B-Or
wishing NCT03925753 432 439 B-Assertion___Assertion_Type_Value:intention
/ NCT03925753 440 441 B-Or
trying NCT03925753 442 448 B-Assertion___Assertion_Type_Value:intention
to NCT03925753 449 451 O
get NCT03925753 452 455 O
pregnant NCT03925753 456 464 B-Condition

Inclusion NCT03863327 0 9 O
Criteria NCT03863327 10 18 O
: NCT03863327 19 20 O

- NCT03863327 24 25 O
Recorded NCT03863327 27 35 B-Eq_Comparison
EKG NCT03863327 36 39 B-Procedure
prior NCT03863327 40 45 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863327 46 48 I-Temporal_Connection___Temporal_Connection_Type_Value:before
cardiac NCT03863327 49 56 B-Procedure
catheterization NCT03863327 57 72 I-Procedure

Exclusion NCT03863327 73 82 O
Criteria NCT03863327 83 91 O
: NCT03863327 92 93 O

- NCT03863327 97 98 O
Absence NCT03863327 100 107 B-Negation
of NCT03863327 108 110 O
documented NCT03863327 111 121 O
EKG NCT03863327 122 125 B-Procedure
prior NCT03863327 126 131 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863327 132 134 I-Temporal_Connection___Temporal_Connection_Type_Value:before
cardiac NCT03863327 135 142 B-Procedure
catheterization NCT03863327 143 158 I-Procedure

Inclusion NCT03866590 0 9 O
Criteria NCT03866590 10 18 O
: NCT03866590 19 20 O

- NCT03866590 24 25 O
Informed NCT03866590 27 35 O
consent NCT03866590 36 43 O
is NCT03866590 44 46 O
obtained NCT03866590 47 55 O
from NCT03866590 56 60 O
the NCT03866590 61 64 O
participant NCT03866590 65 76 O
or NCT03866590 77 79 O
its NCT03866590 80 83 O
legal NCT03866590 84 89 O
representatives NCT03866590 90 105 O

- NCT03866590 108 109 O
The NCT03866590 111 114 O
participant NCT03866590 115 126 O
is NCT03866590 127 129 O
older NCT03866590 130 135 B-Eq_Comparison
than NCT03866590 136 140 I-Eq_Comparison
14 NCT03866590 141 143 I-Eq_Comparison
years NCT03866590 144 149 I-Eq_Comparison
and NCT03866590 150 153 B-And
younger NCT03866590 154 161 B-Eq_Comparison
than NCT03866590 162 166 I-Eq_Comparison
25 NCT03866590 167 169 I-Eq_Comparison
years NCT03866590 170 175 I-Eq_Comparison
old NCT03866590 176 179 B-Age

- NCT03866590 182 183 O
The NCT03866590 185 188 O
patient NCT03866590 189 196 O
exhibits NCT03866590 197 205 O
chronic NCT03866590 206 213 O
anaemia NCT03866590 214 221 B-Condition
or NCT03866590 222 224 B-Or
cholelithiasis NCT03866590 225 239 B-Condition
or NCT03866590 240 242 B-Or
cholecystitis NCT03866590 243 256 B-Condition
of NCT03866590 257 259 O
undetermined NCT03866590 260 272 B-Modifier
aetiology NCT03866590 273 282 I-Modifier
or NCT03866590 283 285 B-Or
The NCT03866590 286 289 O
patient NCT03866590 290 297 O
has NCT03866590 298 301 O
a NCT03866590 302 303 O
high NCT03866590 304 308 O
- NCT03866590 309 310 O
grade NCT03866590 311 316 O
PKD NCT03866590 317 320 B-Condition
suspicion NCT03866590 321 330 B-Assertion___Assertion_Type_Value:possible
due NCT03866590 331 334 O
to NCT03866590 335 337 O
any NCT03866590 338 341 O
clinical NCT03866590 342 350 O
item NCT03866590 351 355 O
or NCT03866590 356 358 B-Or
The NCT03866590 359 362 O
patient NCT03866590 363 370 O
is NCT03866590 371 373 O
diagnosed NCT03866590 374 383 O
biochemically NCT03866590 384 397 B-Procedure
and NCT03866590 398 401 B-Or
/ NCT03866590 402 403 I-Or
or NCT03866590 404 406 I-Or
genetically NCT03866590 407 418 B-Procedure
with NCT03866590 419 423 O
PKD NCT03866590 424 427 B-Condition

Exclusion NCT03866590 428 437 O
Criteria NCT03866590 438 446 O
: NCT03866590 447 448 O

- NCT03866590 452 453 O
Inability NCT03866590 455 464 O
to NCT03866590 465 467 O
provide NCT03866590 468 475 O
informed NCT03866590 476 484 O
consent NCT03866590 485 492 O

- NCT03866590 495 496 O
The NCT03866590 498 501 O
patient NCT03866590 502 509 O
does NCT03866590 510 514 O
not NCT03866590 515 518 B-Negation
suffer NCT03866590 519 525 O
from NCT03866590 526 530 O
chronic NCT03866590 531 538 O
anaemia NCT03866590 539 546 B-Condition
or NCT03866590 547 549 B-Or
cholelithiasis NCT03866590 550 564 B-Condition
or NCT03866590 565 567 B-Or
cholecystitis NCT03866590 568 581 B-Condition

- NCT03866590 584 585 O
The NCT03866590 587 590 O
aetiology NCT03866590 591 600 O
of NCT03866590 601 603 O
chronic NCT03866590 604 611 O
anaemia NCT03866590 612 619 B-Condition
or NCT03866590 620 622 B-Or
cholelithiasis NCT03866590 623 637 B-Condition
or NCT03866590 638 640 B-Or
cholecystitis NCT03866590 641 654 B-Condition
is NCT03866590 655 657 O
determined NCT03866590 658 668 O
and NCT03866590 669 672 O
is NCT03866590 673 675 O
not NCT03866590 676 679 B-Negation
due NCT03866590 680 683 O
to NCT03866590 684 686 O
PKD NCT03866590 687 690 B-Condition

- NCT03866590 693 694 O
The NCT03866590 696 699 O
participant NCT03866590 700 711 O
is NCT03866590 712 714 O
younger NCT03866590 715 722 B-Eq_Comparison
than NCT03866590 723 727 I-Eq_Comparison
14 NCT03866590 728 730 I-Eq_Comparison
years NCT03866590 731 736 I-Eq_Comparison
or NCT03866590 737 739 B-Or
older NCT03866590 740 745 B-Eq_Comparison
than NCT03866590 746 750 I-Eq_Comparison
25 NCT03866590 751 753 I-Eq_Comparison
years NCT03866590 754 759 I-Eq_Comparison
old NCT03866590 760 763 B-Age

- NCT03866590 766 767 O
Previously NCT03866590 769 779 B-Eq_Comparison
enrolled NCT03866590 780 788 O
in NCT03866590 789 791 O
the NCT03866590 792 795 O
study NCT03866590 796 801 B-Study

Inclusion NCT03924232 0 9 O
Criteria NCT03924232 10 18 O
: NCT03924232 19 20 O

- NCT03924232 24 25 O
All NCT03924232 27 30 O
patients NCT03924232 31 39 O
aged NCT03924232 40 44 B-Age
18 NCT03924232 45 47 B-Eq_Comparison
or NCT03924232 48 50 I-Eq_Comparison
older NCT03924232 51 56 I-Eq_Comparison
and NCT03924232 57 60 B-And
with NCT03924232 61 65 O
a NCT03924232 66 67 O
recent NCT03924232 68 74 B-Eq_Comparison
( NCT03924232 75 76 O
< NCT03924232 77 78 B-Eq_Comparison
48 NCT03924232 79 81 I-Eq_Comparison
h NCT03924232 82 83 I-Eq_Comparison
) NCT03924232 84 85 O
ICU NCT03924232 86 89 O
entry NCT03924232 90 95 B-Encounter
requiring NCT03924232 96 105 O
mechanical NCT03924232 106 116 B-Procedure
ventilation NCT03924232 117 128 I-Procedure
for NCT03924232 129 132 O
at NCT03924232 133 135 B-Eq_Comparison
least NCT03924232 136 141 I-Eq_Comparison
3 NCT03924232 142 143 I-Eq_Comparison
days NCT03924232 144 148 I-Eq_Comparison
will NCT03924232 149 153 O
be NCT03924232 154 156 O
considered NCT03924232 157 167 O
for NCT03924232 168 171 O
enrolment NCT03924232 172 181 O

Exclusion NCT03924232 182 191 O
Criteria NCT03924232 192 200 O
: NCT03924232 201 202 O

- NCT03924232 206 207 O
not NCT03924232 209 212 B-Negation
intubated NCT03924232 213 222 B-Procedure
patients NCT03924232 223 231 O

- NCT03924232 234 235 O
patients NCT03924232 237 245 O
with NCT03924232 246 250 O
an NCT03924232 251 253 O
ICU NCT03924232 254 257 O
prevision NCT03924232 258 267 O
of NCT03924232 268 270 O
stay NCT03924232 271 275 B-Encounter
less NCT03924232 276 280 B-Eq_Comparison
than NCT03924232 281 285 I-Eq_Comparison
3 NCT03924232 286 287 I-Eq_Comparison
days NCT03924232 288 292 I-Eq_Comparison

Inclusion NCT03864029 0 9 O
Criteria NCT03864029 10 18 O
: NCT03864029 19 20 O

- NCT03864029 24 25 O
Willing NCT03864029 27 34 O
and NCT03864029 35 38 O
able NCT03864029 39 43 O
to NCT03864029 44 46 O
provide NCT03864029 47 54 O
informed NCT03864029 55 63 O
consent NCT03864029 64 71 O
( NCT03864029 72 73 O
unless NCT03864029 74 80 O
exemption NCT03864029 81 90 O
of NCT03864029 91 93 O
obtaining NCT03864029 94 103 O
consent NCT03864029 104 111 O
is NCT03864029 112 114 O
obtained NCT03864029 115 123 O
as NCT03864029 124 126 O
per NCT03864029 127 130 O
local NCT03864029 131 136 O
regulation NCT03864029 137 147 O
) NCT03864029 148 149 O
. NCT03864029 150 151 O
Assent NCT03864029 153 159 O
( NCT03864029 160 161 O
if NCT03864029 162 164 O
required NCT03864029 165 173 O
defined NCT03864029 174 181 O
by NCT03864029 182 184 O
local NCT03864029 185 190 O
regulation NCT03864029 191 201 O
and NCT03864029 202 205 O
requirement NCT03864029 206 217 O
) NCT03864029 218 219 O
should NCT03864029 220 226 O
also NCT03864029 227 231 O
be NCT03864029 232 234 O
obtained NCT03864029 235 243 O
from NCT03864029 244 248 O
the NCT03864029 249 252 O
subject NCT03864029 253 260 O
and NCT03864029 261 264 O
the NCT03864029 265 268 O
legal NCT03864029 269 274 O
authorized NCT03864029 275 285 O
representative NCT03864029 286 300 O
. NCT03864029 301 302 O

- NCT03864029 306 307 O
Diagnosed NCT03864029 309 318 O
with NCT03864029 319 323 O
BH NCT03864029 324 326 B-Condition
4 NCT03864029 327 328 I-Condition
deficiency NCT03864029 329 339 I-Condition
per NCT03864029 340 343 O
local NCT03864029 344 349 O
practice NCT03864029 350 358 O
. NCT03864029 359 360 O

- NCT03864029 364 365 O
KUVAN NCT03864029 367 372 B-Drug
® NCT03864029 372 373 O
was NCT03864029 374 377 O
taken NCT03864029 378 383 O
at NCT03864029 384 386 B-Eq_Comparison
least NCT03864029 387 392 I-Eq_Comparison
1 NCT03864029 393 394 I-Eq_Comparison
dose NCT03864029 395 399 I-Eq_Comparison
to NCT03864029 400 402 O
treat NCT03864029 403 408 O
HPA NCT03864029 409 412 B-Condition
caused NCT03864029 413 419 O
by NCT03864029 420 422 O
BH NCT03864029 423 425 B-Condition
4 NCT03864029 426 427 I-Condition
deficiency NCT03864029 428 438 I-Condition
during NCT03864029 439 445 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864029 446 449 O
period NCT03864029 450 456 O
of NCT03864029 457 459 O
observation NCT03864029 460 471 B-Study
. NCT03864029 472 473 O

- NCT03864029 477 478 O
Baseline NCT03864029 480 488 O
Phe NCT03864029 489 492 B-Observation
concentration NCT03864029 493 506 I-Observation
≥ NCT03864029 507 508 B-Eq_Comparison
450 NCT03864029 509 512 I-Eq_Comparison
µmol NCT03864029 513 517 I-Eq_Comparison
/ NCT03864029 518 519 I-Eq_Comparison
L NCT03864029 520 521 I-Eq_Comparison

Exclusion NCT03864029 522 531 O
Criteria NCT03864029 532 540 O
: NCT03864029 541 542 O

- NCT03864029 546 547 O
Subject NCT03864029 549 556 O
diagnosed NCT03864029 557 566 O
to NCT03864029 567 569 O
have NCT03864029 570 574 O
Phenylketonuria NCT03864029 575 590 B-Condition
( NCT03864029 591 592 O
PKU NCT03864029 593 596 B-Condition
) NCT03864029 597 598 O

- NCT03864029 602 603 O
Has NCT03864029 605 608 O
any NCT03864029 609 612 O
condition NCT03864029 613 622 B-Condition
that NCT03864029 623 627 O
, NCT03864029 628 629 O
in NCT03864029 630 632 O
the NCT03864029 633 636 O
view NCT03864029 637 641 O
of NCT03864029 642 644 O
the NCT03864029 645 648 O
Investigator NCT03864029 649 661 O
, NCT03864029 662 663 O
the NCT03864029 664 667 O
medical NCT03864029 668 675 O
record NCT03864029 676 682 O
of NCT03864029 683 685 O
the NCT03864029 686 689 O
subject NCT03864029 690 697 O
in NCT03864029 698 700 O
the NCT03864029 701 704 O
duration NCT03864029 705 713 O
of NCT03864029 714 716 O
observation NCT03864029 717 728 O
is NCT03864029 729 731 O
not NCT03864029 732 735 B-Negation
reliable NCT03864029 736 744 O
, NCT03864029 745 746 O
or NCT03864029 747 749 O
not NCT03864029 750 753 O
accessible NCT03864029 754 764 O
. NCT03864029 765 766 O

Inclusion NCT03929978 0 9 O
Criteria NCT03929978 10 18 O
: NCT03929978 19 20 O

- NCT03929978 24 25 O
Inclusion NCT03929978 27 36 O
criteria NCT03929978 37 45 O
and NCT03929978 46 49 O
justification NCT03929978 50 63 O
hereof NCT03929978 64 70 O
: NCT03929978 71 72 O

1 NCT03929978 81 82 O
. NCT03929978 82 83 O
Have NCT03929978 85 89 O
a NCT03929978 90 91 O
colostomy NCT03929978 92 101 B-Procedure
, NCT03929978 102 103 O
ileostomy NCT03929978 104 113 B-Procedure
( NCT03929978 114 115 O
jejunostomy NCT03929978 116 127 B-Procedure
) NCT03929978 128 129 O
, NCT03929978 130 131 O
loop NCT03929978 132 136 B-Procedure
stoma NCT03929978 137 142 I-Procedure
, NCT03929978 143 144 O
or NCT03929978 145 147 O
two NCT03929978 148 151 B-Eq_Comparison
stomas NCT03929978 152 158 B-Procedure
placed NCT03929978 159 165 O
closely NCT03929978 166 173 O
together NCT03929978 174 182 O

2 NCT03929978 190 191 O
. NCT03929978 191 192 O
Have NCT03929978 194 198 O
given NCT03929978 199 204 O
written NCT03929978 205 212 O
informed NCT03929978 213 221 O
consent NCT03929978 222 229 O
( NCT03929978 230 231 O
the NCT03929978 232 235 O
legal NCT03929978 236 241 O
authorized NCT03929978 242 252 O
representative NCT03929978 253 267 O
of NCT03929978 268 270 O
the NCT03929978 271 274 O
subject NCT03929978 275 282 O
) NCT03929978 283 284 O

Exclusion NCT03929978 286 295 O
Criteria NCT03929978 296 304 O
: NCT03929978 305 306 O

- NCT03929978 310 311 O
The NCT03929978 313 316 O
subjects NCT03929978 317 325 O
are NCT03929978 326 329 O
not NCT03929978 330 333 O
allowed NCT03929978 334 341 O
to NCT03929978 342 344 O
participate NCT03929978 345 356 O
in NCT03929978 357 359 O
case NCT03929978 360 364 O
they NCT03929978 365 369 O
: NCT03929978 370 371 O

Are NCT03929978 373 376 O
currently NCT03929978 377 386 B-Eq_Comparison
suffering NCT03929978 387 396 O
from NCT03929978 397 401 O
peristomal NCT03929978 402 412 B-Condition
skin NCT03929978 413 417 I-Condition
problems NCT03929978 418 426 I-Condition
i NCT03929978 427 428 O
. NCT03929978 429 430 O
e NCT03929978 431 432 O
. NCT03929978 433 434 O
bleeding NCT03929978 436 444 B-Condition
and NCT03929978 445 448 B-Or
/ NCT03929978 449 450 I-Or
or NCT03929978 451 453 I-Or
broken NCT03929978 454 460 B-Condition
skin NCT03929978 461 465 I-Condition

( NCT03929978 467 468 O
assessed NCT03929978 469 477 O
by NCT03929978 478 480 O
the NCT03929978 481 484 O
investigator NCT03929978 485 497 O
) NCT03929978 498 499 O

Inclusion NCT03928782 0 9 O
Criteria NCT03928782 10 18 O
: NCT03928782 19 20 O

- NCT03928782 24 25 O
subjects NCT03928782 27 35 O
who NCT03928782 36 39 O
suffer NCT03928782 40 46 O
from NCT03928782 47 51 O
acute NCT03928782 52 57 O
leukemic NCT03928782 58 66 B-Condition
subjects NCT03928782 67 75 O
who NCT03928782 76 79 O
accept NCT03928782 80 86 B-Assertion___Assertion_Type_Value:hypothetical
chemotherapy NCT03928782 87 99 B-Procedure
within NCT03928782 100 106 B-Eq_Comparison
one NCT03928782 107 110 I-Eq_Comparison
month NCT03928782 111 116 I-Eq_Comparison
and NCT03928782 117 120 B-And
will NCT03928782 121 125 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03928782 126 128 I-Assertion___Assertion_Type_Value:hypothetical
pre NCT03928782 129 132 B-Procedure
treated NCT03928782 133 140 I-Procedure
by NCT03928782 141 143 O
whole NCT03928782 144 149 B-Procedure
- NCT03928782 150 151 I-Procedure
body NCT03928782 152 156 I-Procedure
irradiation NCT03928782 157 168 I-Procedure
peripheral NCT03928782 169 179 B-Modifier
blood NCT03928782 180 185 I-Modifier
cells NCT03928782 186 191 I-Modifier
of NCT03928782 192 194 O
subjects NCT03928782 195 203 O
are NCT03928782 204 207 O
approximate NCT03928782 208 219 O
to NCT03928782 220 222 O
those NCT03928782 223 228 O
of NCT03928782 229 231 O
healthy NCT03928782 232 239 O
person NCT03928782 240 246 O
aged NCT03928782 247 251 B-Age
between NCT03928782 252 259 B-Eq_Comparison
18 NCT03928782 260 262 I-Eq_Comparison
and NCT03928782 263 266 I-Eq_Comparison
50 NCT03928782 267 269 I-Eq_Comparison
years NCT03928782 270 275 I-Eq_Comparison
old NCT03928782 276 279 O
subjects NCT03928782 280 288 O
who NCT03928782 289 292 O
are NCT03928782 293 296 O
competent NCT03928782 297 306 O
to NCT03928782 307 309 O
give NCT03928782 310 314 O
written NCT03928782 315 322 O
informed NCT03928782 323 331 O
consent NCT03928782 332 339 O
subjects NCT03928782 340 348 O
without NCT03928782 349 356 O
other NCT03928782 357 362 O
systemic NCT03928782 363 371 O
diseases NCT03928782 372 380 O

Exclusion NCT03928782 381 390 O
Criteria NCT03928782 391 399 O
: NCT03928782 400 401 O

- NCT03928782 405 406 O
subjects NCT03928782 408 416 O
who NCT03928782 417 420 O
suffer NCT03928782 421 427 O
from NCT03928782 428 432 O
serious NCT03928782 433 440 O
other NCT03928782 441 446 B-Other
systemic NCT03928782 447 455 B-Modifier
diseases NCT03928782 456 464 B-Condition
subjects NCT03928782 465 473 O
who NCT03928782 474 477 O
are NCT03928782 478 481 O
unwilling NCT03928782 482 491 O
or NCT03928782 492 494 O
unable NCT03928782 495 501 O
to NCT03928782 502 504 O
cooperate NCT03928782 505 514 O
with NCT03928782 515 519 O
this NCT03928782 520 524 O
clinical NCT03928782 525 533 O
study NCT03928782 534 539 B-Study
other NCT03928782 540 545 O
serious NCT03928782 546 553 O
cases NCT03928782 554 559 B-Condition
that NCT03928782 560 564 O
probably NCT03928782 565 573 B-Assertion___Assertion_Type_Value:hypothetical
hinder NCT03928782 574 580 O
this NCT03928782 581 585 O
clinical NCT03928782 586 594 O
study NCT03928782 595 600 B-Study

Inclusion NCT03922568 0 9 O
Criteria NCT03922568 10 18 O
: NCT03922568 19 20 O

- NCT03922568 24 25 O
Full NCT03922568 27 31 B-Modifier
Term NCT03922568 32 36 I-Modifier
Delivery NCT03922568 37 45 B-Condition

- NCT03922568 48 49 O
ICSI NCT03922568 51 55 B-Procedure
cases NCT03922568 56 61 O
using NCT03922568 62 67 B-Eq_Comparison
DGC NCT03922568 68 71 B-Procedure
for NCT03922568 72 75 I-Procedure
sperm NCT03922568 76 81 I-Procedure
selection NCT03922568 82 91 I-Procedure

- NCT03922568 94 95 O
ICSI NCT03922568 97 101 B-Procedure
cases NCT03922568 102 107 O
using NCT03922568 108 113 B-Eq_Comparison
MACS NCT03922568 114 118 B-Procedure
for NCT03922568 119 122 I-Procedure
sperm NCT03922568 123 128 I-Procedure
selection NCT03922568 129 138 I-Procedure

- NCT03922568 141 142 O
ICSI NCT03922568 144 148 B-Procedure
cases NCT03922568 149 154 O
using NCT03922568 155 160 B-Eq_Comparison
PICSI NCT03922568 161 166 B-Procedure
dishes NCT03922568 167 173 I-Procedure
for NCT03922568 174 177 I-Procedure
sperm NCT03922568 178 183 I-Procedure
selection NCT03922568 184 193 I-Procedure

- NCT03922568 196 197 O
Fresh NCT03922568 199 204 B-Procedure
blastocyst NCT03922568 205 215 I-Procedure
stage NCT03922568 216 221 I-Procedure
embryo NCT03922568 222 228 I-Procedure
transfer NCT03922568 229 237 I-Procedure
at NCT03922568 238 240 O

- NCT03922568 243 244 O
Fresh NCT03922568 246 251 B-Condition
ejaculate NCT03922568 252 261 I-Condition

Exclusion NCT03922568 262 271 O
Criteria NCT03922568 272 280 O
: NCT03922568 281 282 O

- NCT03922568 286 287 O
Frozen NCT03922568 289 295 B-Procedure
sperm NCT03922568 296 301 I-Procedure

- NCT03922568 304 305 O
Frozen NCT03922568 307 313 B-Procedure
Embryo NCT03922568 314 320 I-Procedure
transfer NCT03922568 321 329 I-Procedure

- NCT03922568 332 333 O
Fresh NCT03922568 335 340 B-Procedure
cleavage NCT03922568 341 349 I-Procedure
stage NCT03922568 350 355 I-Procedure
embryo NCT03922568 356 362 I-Procedure
transfer NCT03922568 363 371 I-Procedure

- NCT03922568 374 375 O
Vanishing NCT03922568 377 386 B-Condition
Twin NCT03922568 387 391 I-Condition
Syndrome NCT03922568 392 400 I-Condition

- NCT03922568 403 404 O
Fetal NCT03922568 406 411 B-Procedure
Reduction NCT03922568 412 421 I-Procedure

- NCT03922568 424 425 O
Preimlantation NCT03922568 427 441 O
genetically NCT03922568 442 453 B-Procedure
screened NCT03922568 454 462 I-Procedure
embryo NCT03922568 463 469 I-Procedure
transfer NCT03922568 470 478 I-Procedure

Inclusion NCT03923400 0 9 O
Criteria NCT03923400 10 18 O
: NCT03923400 19 20 O

- NCT03923400 24 25 O
Any NCT03923400 27 30 O
kind NCT03923400 31 35 O
of NCT03923400 36 38 O
primary NCT03923400 39 46 B-Modifier
mesenchymal NCT03923400 47 58 B-Condition
tumor NCT03923400 59 64 I-Condition
of NCT03923400 65 67 O
the NCT03923400 68 71 O
gastrointestinal NCT03923400 72 88 B-Modifier
tract NCT03923400 89 94 I-Modifier
with NCT03923400 95 99 O
a NCT03923400 100 101 O
histomorphological NCT03923400 102 120 B-Modifier
and NCT03923400 121 124 B-Or
immunohistochemical NCT03923400 125 144 B-Modifier
( NCT03923400 145 146 O
CD NCT03923400 147 149 B-Condition
117 NCT03923400 150 153 I-Condition
( NCT03923400 154 155 O
+ NCT03923400 156 157 O
) NCT03923400 158 159 O
and NCT03923400 160 163 B-Or
/ NCT03923400 164 165 I-Or
or NCT03923400 166 168 I-Or
DOG NCT03923400 169 172 B-Condition
1 NCT03923400 173 174 I-Condition
( NCT03923400 175 176 O
+ NCT03923400 177 178 O
) NCT03923400 179 180 O
) NCT03923400 181 182 O
profile NCT03923400 183 190 B-Condition
consistent NCT03923400 191 201 O
with NCT03923400 202 206 O
GIST NCT03923400 207 211 B-Condition
. NCT03923400 212 213 O

Exclusion NCT03923400 215 224 O
Criteria NCT03923400 225 233 O
: NCT03923400 234 235 O

- NCT03923400 238 239 O

Inclusion NCT03922594 0 9 O
Criteria NCT03922594 10 18 O
: NCT03922594 19 20 O

- NCT03922594 24 25 O
All NCT03922594 27 30 O
infants NCT03922594 31 38 O
or NCT03922594 39 41 B-Or
fetuses NCT03922594 42 49 O
with NCT03922594 50 54 B-And
microcephaly NCT03922594 55 67 B-Condition
, NCT03922594 68 69 O
( NCT03922594 70 71 O
defined NCT03922594 72 79 O
as NCT03922594 80 82 O
head NCT03922594 83 87 B-Observation
circumference NCT03922594 88 101 I-Observation
≤ NCT03922594 102 103 B-Eq_Comparison
- NCT03922594 104 105 I-Eq_Comparison
3 NCT03922594 106 107 I-Eq_Comparison
SD NCT03922594 108 110 I-Eq_Comparison
according NCT03922594 111 120 O
to NCT03922594 121 123 O
INTERGROWTH NCT03922594 124 135 O
standards NCT03922594 136 145 O
for NCT03922594 146 149 O
gestational NCT03922594 150 161 O
age NCT03922594 162 165 O
and NCT03922594 166 169 O
sex NCT03922594 170 173 O
, NCT03922594 174 175 O
detected NCT03922594 176 184 O
during NCT03922594 185 191 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03922594 192 195 O
mother NCT03922594 196 202 B-Family_Member___Family_Member_Type:mother
's NCT03922594 202 204 I-Family_Member___Family_Member_Type:mother
pregnancy NCT03922594 205 214 B-Condition
, NCT03922594 215 216 O
or NCT03922594 217 219 B-Or
at NCT03922594 220 222 O
the NCT03922594 223 226 O
end NCT03922594 227 230 O
of NCT03922594 231 233 O
the NCT03922594 234 237 O
mother NCT03922594 238 244 B-Family_Member___Family_Member_Type:mother
's NCT03922594 244 246 I-Family_Member___Family_Member_Type:mother
pregnancy NCT03922594 247 256 B-Condition
at NCT03922594 257 259 O
one NCT03922594 260 263 O
of NCT03922594 264 266 O
the NCT03922594 267 270 O
participating NCT03922594 271 284 O
maternities NCT03922594 285 296 O
) NCT03922594 297 298 O

- NCT03922594 302 303 O
and NCT03922594 305 308 O
with NCT03922594 309 313 O
abnormal NCT03922594 314 322 O
ultrasound NCT03922594 323 333 B-Procedure
and NCT03922594 334 337 B-Or
/ NCT03922594 338 339 I-Or
or NCT03922594 340 342 I-Or
clinical NCT03922594 343 351 B-Observation
examination NCT03922594 352 363 I-Observation
findings NCT03922594 364 372 I-Observation
for NCT03922594 373 376 O
newborns NCT03922594 377 385 O
. NCT03922594 386 387 O

Exclusion NCT03922594 389 398 O
Criteria NCT03922594 399 407 O
: NCT03922594 408 409 O

- NCT03922594 413 414 O
Infants NCT03922594 416 423 O
/ NCT03922594 424 425 O
fetuses NCT03922594 426 433 O
with NCT03922594 434 438 B-And
microcephaly NCT03922594 439 451 B-Condition
whose NCT03922594 452 457 O
mothers NCT03922594 458 465 B-Family_Member___Family_Member_Type:mother
are NCT03922594 466 469 O
under NCT03922594 470 475 B-Eq_Comparison
the NCT03922594 476 479 I-Eq_Comparison
age NCT03922594 480 483 I-Eq_Comparison
of NCT03922594 484 486 I-Eq_Comparison
18 NCT03922594 487 489 I-Eq_Comparison
years NCT03922594 490 495 I-Eq_Comparison
, NCT03922594 496 497 O

- NCT03922594 501 502 O
or NCT03922594 504 506 O
inability NCT03922594 507 516 O
or NCT03922594 517 519 O
refusal NCT03922594 520 527 O
of NCT03922594 528 530 O
mothers NCT03922594 531 538 O
/ NCT03922594 539 540 O
guardians NCT03922594 541 550 O
to NCT03922594 551 553 O
give NCT03922594 554 558 O
informed NCT03922594 559 567 O
consent NCT03922594 568 575 O
. NCT03922594 576 577 O

Inclusion NCT03863821 0 9 O
Criteria NCT03863821 10 18 O
: NCT03863821 19 20 O

- NCT03863821 24 25 O
Mild NCT03863821 27 31 O
COPD NCT03863821 32 36 B-Condition
with NCT03863821 37 41 B-And
performed NCT03863821 42 51 O
pulmonary NCT03863821 52 61 B-Observation
function NCT03863821 62 70 I-Observation
test NCT03863821 71 75 I-Observation

Exclusion NCT03863821 76 85 O
Criteria NCT03863821 86 94 O
: NCT03863821 95 96 O

- NCT03863821 100 101 O
Left NCT03863821 103 107 B-Modifier
- NCT03863821 108 109 I-Modifier
side NCT03863821 110 114 I-Modifier
heart NCT03863821 115 120 B-Condition
failure NCT03863821 121 128 I-Condition

- NCT03863821 131 132 O
COPD NCT03863821 134 138 B-Condition
exacerbation NCT03863821 139 151 O
within NCT03863821 152 158 B-Eq_Comparison
3 NCT03863821 159 160 I-Eq_Comparison
month NCT03863821 161 166 I-Eq_Comparison

- NCT03863821 169 170 O
Diagnosed NCT03863821 172 181 O
neuromuscular NCT03863821 182 195 B-Condition
disease NCT03863821 196 203 I-Condition

- NCT03863821 206 207 O
Unable NCT03863821 209 215 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03863821 216 218 O
perform NCT03863821 219 226 O
6 NCT03863821 227 228 B-Observation
- NCT03863821 229 230 I-Observation
MWT NCT03863821 231 234 I-Observation

Inclusion NCT03866512 0 9 O
Criteria NCT03866512 10 18 O
: NCT03866512 19 20 O

- NCT03866512 24 25 O
Males NCT03866512 27 32 O
and NCT03866512 33 36 B-Or
females NCT03866512 37 44 O
18 NCT03866512 45 47 B-Eq_Comparison
- NCT03866512 48 49 I-Eq_Comparison
40 NCT03866512 50 52 I-Eq_Comparison
years NCT03866512 53 58 I-Eq_Comparison
of NCT03866512 59 61 O
age NCT03866512 62 65 B-Age

- NCT03866512 68 69 O
Body NCT03866512 71 75 B-Observation
mass NCT03866512 76 80 I-Observation
index NCT03866512 81 86 I-Observation
between NCT03866512 87 94 B-Eq_Comparison
18 NCT03866512 95 97 I-Eq_Comparison
and NCT03866512 98 101 I-Eq_Comparison
27 NCT03866512 102 104 I-Eq_Comparison

Exclusion NCT03866512 106 115 O
Criteria NCT03866512 116 124 O
: NCT03866512 125 126 O

- NCT03866512 130 131 O
Any NCT03866512 133 136 O
diagnosed NCT03866512 137 146 O
metabolic NCT03866512 147 156 B-Condition
impairment NCT03866512 157 167 I-Condition
( NCT03866512 168 169 O
e NCT03866512 170 171 O
. NCT03866512 172 173 O
g NCT03866512 174 175 O
. NCT03866512 176 177 O
type NCT03866512 179 183 B-Modifier
1 NCT03866512 184 185 I-Modifier
or NCT03866512 186 188 B-Or
2 NCT03866512 189 190 B-Modifier
diabetes NCT03866512 191 199 B-Condition
) NCT03866512 200 201 O

- NCT03866512 205 206 O
Any NCT03866512 208 211 O
diagnosed NCT03866512 212 221 O
cardiovascular NCT03866512 222 236 B-Condition
disease NCT03866512 237 244 I-Condition

- NCT03866512 247 248 O
Hypertension NCT03866512 250 262 B-Condition
( NCT03866512 263 264 O
≥ NCT03866512 265 266 B-Eq_Comparison
140 NCT03866512 267 270 I-Eq_Comparison
mmHg NCT03866512 271 275 I-Eq_Comparison
systolic NCT03866512 276 284 B-Observation
and NCT03866512 285 288 B-Or
/ NCT03866512 289 290 I-Or
or NCT03866512 291 293 I-Or
≥ NCT03866512 294 295 B-Eq_Comparison
90 NCT03866512 296 298 I-Eq_Comparison
mmHg NCT03866512 299 303 I-Eq_Comparison
diastolic NCT03866512 304 313 B-Observation
) NCT03866512 314 315 O

- NCT03866512 319 320 O
Chronic NCT03866512 322 329 O
use NCT03866512 330 333 O
of NCT03866512 334 336 O
any NCT03866512 337 340 O
prescribed NCT03866512 341 351 B-Modifier
or NCT03866512 352 354 B-Or
over NCT03866512 355 359 B-Modifier
the NCT03866512 360 363 I-Modifier
counter NCT03866512 364 371 I-Modifier
pharmaceuticals NCT03866512 372 387 B-Drug
( NCT03866512 388 389 O
excluding NCT03866512 390 399 B-Exception
oral NCT03866512 400 404 B-Drug
contraceptives NCT03866512 405 419 I-Drug
and NCT03866512 420 423 B-Or
contraceptive NCT03866512 424 437 B-Procedure
devices NCT03866512 438 445 I-Procedure
) NCT03866512 446 447 O

- NCT03866512 451 452 O
Regular NCT03866512 454 461 B-Eq_Comparison
use NCT03866512 462 465 O
of NCT03866512 466 468 O
nutritional NCT03866512 469 480 B-Drug
supplements NCT03866512 481 492 I-Drug

- NCT03866512 495 496 O
Metallic NCT03866512 498 506 B-Procedure
implants NCT03866512 507 515 I-Procedure

- NCT03866512 518 519 O
A NCT03866512 521 522 O
personal NCT03866512 523 531 B-Family_Member___Family_Member_Type:patient
or NCT03866512 532 534 B-Or
family NCT03866512 535 541 B-Family_Member
history NCT03866512 542 549 I-Family_Member
of NCT03866512 550 552 O
thrombosis NCT03866512 553 563 B-Condition
, NCT03866512 564 565 O
epilepsy NCT03866512 566 574 B-Condition
, NCT03866512 575 576 O
seizures NCT03866512 577 585 B-Condition
or NCT03866512 586 588 B-Or
schizophrenia NCT03866512 589 602 B-Condition

- NCT03866512 605 606 O
Any NCT03866512 608 611 O
previous NCT03866512 612 620 B-Eq_Comparison
motor NCT03866512 621 626 B-Condition
disorders NCT03866512 627 636 I-Condition

- NCT03866512 639 640 O
Any NCT03866512 642 645 O
known NCT03866512 646 651 O
disorders NCT03866512 652 661 B-Condition
in NCT03866512 662 664 I-Condition
lipid NCT03866512 665 670 I-Condition
metabolism NCT03866512 671 681 I-Condition

- NCT03866512 684 685 O
Any NCT03866512 687 690 O
known NCT03866512 691 696 O
disorders NCT03866512 697 706 B-Condition
in NCT03866512 707 709 I-Condition
muscle NCT03866512 710 716 I-Condition
metabolism NCT03866512 717 727 I-Condition

- NCT03866512 730 731 O
Known NCT03866512 733 738 O
allergy NCT03866512 739 746 B-Allergy
for NCT03866512 747 750 O
Acipimox NCT03866512 751 759 B-Drug
, NCT03866512 760 761 O
beta NCT03866512 762 766 B-Drug
agonist NCT03866512 767 774 I-Drug
, NCT03866512 775 776 O
or NCT03866512 777 779 B-Or
other NCT03866512 780 785 B-Other
substances NCT03866512 786 796 B-Drug
in NCT03866512 797 799 I-Drug
the NCT03866512 800 803 I-Drug
tablets NCT03866512 804 811 I-Drug

- NCT03866512 814 815 O
Known NCT03866512 817 822 O
sensitivity NCT03866512 823 834 B-Condition
for NCT03866512 835 838 O
sympathomimetic NCT03866512 839 854 B-Drug
drugs NCT03866512 855 860 I-Drug

- NCT03866512 863 864 O
Known NCT03866512 866 871 O
hypokalaemia NCT03866512 872 884 B-Condition

- NCT03866512 887 888 O
Presence NCT03866512 890 898 B-Eq_Comparison
of NCT03866512 899 901 O
an NCT03866512 902 904 O
ulcer NCT03866512 905 910 B-Condition
in NCT03866512 911 913 O
the NCT03866512 914 917 O
stomach NCT03866512 918 925 B-Modifier
or NCT03866512 926 928 B-Or
gut NCT03866512 929 932 B-Modifier
and NCT03866512 933 936 B-Or
/ NCT03866512 937 938 I-Or
or NCT03866512 939 941 I-Or
strong NCT03866512 942 948 O
history NCT03866512 949 956 B-Eq_Comparison
of NCT03866512 957 959 O
indigestion NCT03866512 960 971 B-Condition

- NCT03866512 974 975 O
Known NCT03866512 977 982 O
severe NCT03866512 983 989 O
kidney NCT03866512 990 996 B-Condition
problems NCT03866512 997 1005 I-Condition

- NCT03866512 1008 1009 O
Pregnancy NCT03866512 1011 1020 B-Condition

- NCT03866512 1023 1024 O
Unable NCT03866512 1026 1032 O
to NCT03866512 1033 1035 O
give NCT03866512 1036 1040 O
consent NCT03866512 1041 1048 O

Inclusion NCT03866135 0 9 O
Criteria NCT03866135 10 18 O
: NCT03866135 19 20 O

- NCT03866135 24 25 O
Patients NCT03866135 27 35 O
diagnosed NCT03866135 36 45 O
as NCT03866135 46 48 O
AS NCT03866135 49 51 B-Condition
according NCT03866135 52 61 O
to NCT03866135 62 64 O
the NCT03866135 65 68 O
modified NCT03866135 69 77 O
New NCT03866135 78 81 O
York NCT03866135 82 86 O
diagnostic NCT03866135 87 97 O
criteria NCT03866135 98 106 O
were NCT03866135 107 111 O
included NCT03866135 112 120 O

Exclusion NCT03866135 121 130 O
Criteria NCT03866135 131 139 O
: NCT03866135 140 141 O

- NCT03866135 145 146 O
Patients NCT03866135 148 156 O
previously NCT03866135 157 167 B-Eq_Comparison
diagnosed NCT03866135 168 177 O
with NCT03866135 178 182 O
OP NCT03866135 183 185 B-Condition
, NCT03866135 186 187 O

- NCT03866135 191 192 O
Patients NCT03866135 194 202 O
previously NCT03866135 203 213 B-Eq_Comparison
treated NCT03866135 214 221 O
with NCT03866135 222 226 O
OP NCT03866135 227 229 B-Condition
, NCT03866135 230 231 O

- NCT03866135 235 236 O
Patients NCT03866135 238 246 O
with NCT03866135 247 251 B-Eq_Comparison
bone NCT03866135 252 256 B-Condition
fractures NCT03866135 257 266 I-Condition
previously NCT03866135 267 277 B-Eq_Comparison
associated NCT03866135 278 288 O
with NCT03866135 289 293 O
OP NCT03866135 294 296 B-Condition
, NCT03866135 297 298 O

- NCT03866135 302 303 O
Those NCT03866135 305 310 O
using NCT03866135 311 316 B-Eq_Comparison
drugs NCT03866135 317 322 B-Drug
that NCT03866135 323 327 O
affect NCT03866135 328 334 O
bone NCT03866135 335 339 B-Condition
metabolism NCT03866135 340 350 I-Condition
, NCT03866135 351 352 O
metabolic NCT03866135 353 362 B-Condition
bone NCT03866135 363 367 I-Condition
diseases NCT03866135 368 376 I-Condition
( NCT03866135 377 378 O
Paget NCT03866135 379 384 B-Condition
's NCT03866135 384 386 I-Condition
disease NCT03866135 387 394 I-Condition
, NCT03866135 395 396 O
osteomalacia NCT03866135 397 409 B-Condition
, NCT03866135 410 411 O
hyperparathyroidism NCT03866135 412 431 B-Condition
) NCT03866135 432 433 O
, NCT03866135 434 435 O

- NCT03866135 439 440 O
Diabetes NCT03866135 442 450 B-Condition
mellitus NCT03866135 451 459 I-Condition
, NCT03866135 460 461 O

- NCT03866135 465 466 O
Hypothyroidism NCT03866135 468 482 B-Condition
, NCT03866135 483 484 O
hyperthyroidism NCT03866135 485 500 B-Condition
, NCT03866135 501 502 O

- NCT03866135 506 507 O
Patients NCT03866135 509 517 O
with NCT03866135 518 522 O
kidney NCT03866135 523 529 B-Modifier
, NCT03866135 530 531 O
liver NCT03866135 532 537 B-Modifier
and NCT03866135 538 541 B-Or
intestinal NCT03866135 542 552 B-Modifier
diseases NCT03866135 553 561 B-Condition
, NCT03866135 562 563 O

- NCT03866135 567 568 O
Those NCT03866135 570 575 O
using NCT03866135 576 581 B-Eq_Comparison
corticosteroids NCT03866135 582 597 B-Drug


Inclusion NCT03863275 0 9 O
Criteria NCT03863275 10 18 O
: NCT03863275 19 20 O

- NCT03863275 24 25 O
Boys NCT03863275 27 31 O
and NCT03863275 32 35 B-Or
girls NCT03863275 36 41 O
from NCT03863275 42 46 O
7 NCT03863275 47 48 B-Eq_Comparison
to NCT03863275 49 51 I-Eq_Comparison
12 NCT03863275 52 54 I-Eq_Comparison
years NCT03863275 55 60 I-Eq_Comparison
old NCT03863275 61 64 B-Age
with NCT03863275 65 69 B-And
class NCT03863275 70 75 B-Eq_Comparison
II NCT03863275 76 78 I-Eq_Comparison
skeletal NCT03863275 79 87 B-Condition
classification NCT03863275 88 102 I-Condition
attending NCT03863275 103 112 B-Encounter
a NCT03863275 113 114 O
consultation NCT03863275 115 127 O
in NCT03863275 128 130 O
the NCT03863275 131 134 O
dental NCT03863275 135 141 O
clinic NCT03863275 142 148 O
of NCT03863275 149 151 O
the NCT03863275 152 155 O
UNICIEO NCT03863275 156 163 O
foundation NCT03863275 164 174 O
, NCT03863275 175 176 O
to NCT03863275 177 179 B-Eq_Comparison
be NCT03863275 180 182 I-Eq_Comparison
fitted NCT03863275 183 189 O
with NCT03863275 190 194 O
myofunctional NCT03863275 195 208 B-Procedure
apparatus NCT03863275 209 218 I-Procedure
type NCT03863275 219 223 B-Modifier
Sn NCT03863275 224 226 I-Modifier
1 NCT03863275 227 228 I-Modifier

Exclusion NCT03863275 229 238 O
Criteria NCT03863275 239 247 O
: NCT03863275 248 249 O

- NCT03863275 253 254 O
Patients NCT03863275 256 264 O
who NCT03863275 265 268 O
have NCT03863275 269 273 O
had NCT03863275 274 277 O
previous NCT03863275 278 286 B-Eq_Comparison
orthopedic NCT03863275 287 297 B-Procedure
treatment NCT03863275 298 307 I-Procedure

- NCT03863275 310 311 O
Patients NCT03863275 313 321 O
with NCT03863275 322 326 O
signs NCT03863275 327 332 B-Assertion___Assertion_Type_Value:possible
of NCT03863275 333 335 O
condyle NCT03863275 336 343 B-Modifier
injuries NCT03863275 344 352 B-Condition

- NCT03863275 355 356 O
Patients NCT03863275 358 366 O
of NCT03863275 367 369 O
Pierre NCT03863275 370 376 B-Provider
Robin NCT03863275 377 382 I-Provider
or NCT03863275 383 385 B-Or
any NCT03863275 386 389 O
form NCT03863275 390 394 O
of NCT03863275 395 397 O
cleft NCT03863275 398 403 B-Condition

- NCT03863275 406 407 O
Patients NCT03863275 409 417 O
with NCT03863275 418 422 O
syndromes NCT03863275 423 432 B-Condition
that NCT03863275 433 437 O
associate NCT03863275 438 447 O
craniofacial NCT03863275 448 460 B-Condition
anomalies NCT03863275 461 470 I-Condition
and NCT03863275 471 474 B-Or
muscle NCT03863275 475 481 B-Condition
alterations NCT03863275 482 493 I-Condition
. NCT03863275 494 495 O

Inclusion NCT03925818 0 9 O
Criteria NCT03925818 10 18 O
: NCT03925818 19 20 O

- NCT03925818 23 24 O
Positive NCT03925818 25 33 O
for NCT03925818 34 37 O
H NCT03925818 38 39 B-Organism
. NCT03925818 40 41 I-Organism
pylori NCT03925818 43 49 I-Organism
infection NCT03925818 50 59 B-Condition

Exclusion NCT03925818 60 69 O
Criteria NCT03925818 70 78 O
: NCT03925818 79 80 O

- NCT03925818 84 85 O
Presence NCT03925818 87 95 O
of NCT03925818 96 98 O
malignancy NCT03925818 99 109 B-Condition

- NCT03925818 112 113 O
Pregnancy NCT03925818 115 124 B-Condition
or NCT03925818 125 127 B-Or
lactation NCT03925818 128 137 B-Condition

- NCT03925818 140 141 O
Clinically NCT03925818 143 153 O
significant NCT03925818 154 165 O
diseases NCT03925818 166 174 B-Condition

- NCT03925818 177 178 O
History NCT03925818 180 187 B-Eq_Comparison
of NCT03925818 188 190 O
drug NCT03925818 191 195 B-Modifier
or NCT03925818 196 198 B-Or
alcohol NCT03925818 199 206 B-Modifier
abuse NCT03925818 207 212 B-Condition

- NCT03925818 215 216 O
Allergy NCT03925818 218 225 B-Allergy
to NCT03925818 226 228 O
pantoprazole NCT03925818 229 241 B-Drug
or NCT03925818 242 244 B-Or
to NCT03925818 245 247 O
any NCT03925818 248 251 O
component NCT03925818 252 261 B-Drug
of NCT03925818 262 264 O
regimens NCT03925818 265 273 O
used NCT03925818 274 278 O
in NCT03925818 279 281 O
the NCT03925818 282 285 O
study NCT03925818 286 291 B-Study

- NCT03925818 294 295 O
Use NCT03925818 297 300 O
of NCT03925818 301 303 O
anti NCT03925818 304 308 B-Drug
- NCT03925818 309 310 I-Drug
secretory NCT03925818 311 320 I-Drug
drugs NCT03925818 321 326 I-Drug
, NCT03925818 327 328 O
antibiotics NCT03925818 329 340 B-Drug
or NCT03925818 341 343 B-Or
probiotics NCT03925818 344 354 B-Drug
4 NCT03925818 355 356 B-Eq_Comparison
weeks NCT03925818 357 362 I-Eq_Comparison
preceding NCT03925818 363 372 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03925818 373 376 O
enrollment NCT03925818 377 387 B-Study
. NCT03925818 388 389 O

Inclusion NCT03932929 0 9 O
Criteria NCT03932929 10 18 O
: NCT03932929 19 20 O

- NCT03932929 24 25 O
over NCT03932929 27 31 B-Eq_Comparison
18 NCT03932929 32 34 I-Eq_Comparison
years NCT03932929 35 40 I-Eq_Comparison
old NCT03932929 41 44 B-Age

- NCT03932929 47 48 O
good NCT03932929 50 54 B-Condition
oral NCT03932929 55 59 I-Condition
hygiene NCT03932929 60 67 I-Condition

- NCT03932929 70 71 O
available NCT03932929 73 82 O
for NCT03932929 83 86 O
recall NCT03932929 87 93 O

- NCT03932929 96 97 O
at NCT03932929 99 101 B-Eq_Comparison
least NCT03932929 102 107 I-Eq_Comparison
20 NCT03932929 108 110 I-Eq_Comparison
teeth NCT03932929 111 116 B-Condition
under NCT03932929 117 122 I-Condition
occlusion NCT03932929 123 132 I-Condition

- NCT03932929 135 136 O
the NCT03932929 138 141 O
presence NCT03932929 142 150 O
of NCT03932929 151 153 O
at NCT03932929 154 156 B-Eq_Comparison
least NCT03932929 157 162 I-Eq_Comparison
three NCT03932929 163 168 I-Eq_Comparison
non NCT03932929 169 172 B-Negation
- NCT03932929 173 174 O
carious NCT03932929 175 182 B-Modifier
cervical NCT03932929 183 191 B-Condition
lesions NCT03932929 192 199 I-Condition

Exclusion NCT03932929 200 209 O
Criteria NCT03932929 210 218 O
: NCT03932929 219 220 O

- NCT03932929 224 225 O
poor NCT03932929 227 231 B-Condition
oral NCT03932929 232 236 I-Condition
hygiene NCT03932929 237 244 I-Condition

- NCT03932929 247 248 O
bruxism NCT03932929 250 257 B-Condition
habits NCT03932929 258 264 I-Condition

- NCT03932929 267 268 O
severe NCT03932929 270 276 O
or NCT03932929 277 279 B-Or
chronic NCT03932929 280 287 O
periodontitis NCT03932929 288 301 B-Condition

- NCT03932929 304 305 O
If NCT03932929 307 309 O
the NCT03932929 310 313 O
teeth NCT03932929 314 319 O
selected NCT03932929 320 328 O
for NCT03932929 329 332 O
study NCT03932929 333 338 O
, NCT03932929 339 340 O
were NCT03932929 341 345 O
nonvital NCT03932929 346 354 O
, NCT03932929 355 356 O
or NCT03932929 357 359 O
had NCT03932929 360 363 O
any NCT03932929 364 367 O
restorations NCT03932929 368 380 O
on NCT03932929 381 383 O
other NCT03932929 384 389 O
surfaces NCT03932929 390 398 O
were NCT03932929 399 403 O
not NCT03932929 404 407 O
included NCT03932929 408 416 O
. NCT03932929 417 418 O

Inclusion NCT03867188 0 9 O
Criteria NCT03867188 10 18 O
: NCT03867188 19 20 O

- NCT03867188 24 25 O
Patients NCT03867188 27 35 O
with NCT03867188 36 40 O
a NCT03867188 41 42 O
soft NCT03867188 43 47 B-Modifier
tissue NCT03867188 48 54 I-Modifier
sarcoma NCT03867188 55 62 B-Condition
of NCT03867188 63 65 O
the NCT03867188 66 69 O
thigh NCT03867188 70 75 B-Modifier

- NCT03867188 78 79 O
Must NCT03867188 81 85 O
have NCT03867188 86 90 O
sufficient NCT03867188 91 101 O
health NCT03867188 102 108 B-Condition
to NCT03867188 109 111 B-Assertion___Assertion_Type_Value:hypothetical
withstand NCT03867188 112 121 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03867188 122 125 O
physical NCT03867188 126 134 O
demands NCT03867188 135 142 O
of NCT03867188 143 145 O
surgery NCT03867188 146 153 B-Procedure

- NCT03867188 156 157 O
≥ NCT03867188 159 160 B-Eq_Comparison
18 NCT03867188 161 163 I-Eq_Comparison
years NCT03867188 164 169 I-Eq_Comparison
old NCT03867188 170 173 I-Eq_Comparison

- NCT03867188 176 177 O
ECOG NCT03867188 179 183 B-Observation
performance NCT03867188 184 195 I-Observation
status NCT03867188 196 202 I-Observation
of NCT03867188 203 205 O
≤ NCT03867188 206 207 B-Eq_Comparison
2 NCT03867188 208 209 I-Eq_Comparison

- NCT03867188 213 214 O
Ability NCT03867188 216 223 O
to NCT03867188 224 226 O
understand NCT03867188 227 237 O
and NCT03867188 238 241 O
the NCT03867188 242 245 O
willingness NCT03867188 246 257 O
to NCT03867188 258 260 O
sign NCT03867188 261 265 O
an NCT03867188 266 268 O
IRB NCT03867188 269 272 O
- NCT03867188 273 274 O
approved NCT03867188 275 283 O
informed NCT03867188 284 292 O
consent NCT03867188 293 300 O
document NCT03867188 301 309 O
( NCT03867188 310 311 O
either NCT03867188 312 318 O
directly NCT03867188 319 327 O
or NCT03867188 328 330 O
via NCT03867188 331 334 O
a NCT03867188 335 336 O
legally NCT03867188 337 344 O
authorized NCT03867188 345 355 O
representative NCT03867188 356 370 O
) NCT03867188 371 372 O

Exclusion NCT03867188 374 383 O
Criteria NCT03867188 384 392 O
: NCT03867188 393 394 O

- NCT03867188 398 399 O
History NCT03867188 401 408 B-Eq_Comparison
of NCT03867188 409 411 O
clinically NCT03867188 412 422 O
significant NCT03867188 423 434 O
medical NCT03867188 435 442 B-Condition
conditions NCT03867188 443 453 I-Condition
including NCT03867188 454 463 O
: NCT03867188 464 465 O
Cardiovascular NCT03867188 466 480 O
: NCT03867188 481 482 O
Atrial NCT03867188 483 489 B-Condition
Fibrillation NCT03867188 490 502 I-Condition
, NCT03867188 503 504 O
Ventricular NCT03867188 505 516 B-Condition
Fibrillation NCT03867188 517 529 I-Condition
, NCT03867188 530 531 O
Significant NCT03867188 532 543 O
Coronary NCT03867188 544 552 B-Condition
Artery NCT03867188 553 559 I-Condition
Disease NCT03867188 560 567 I-Condition
. NCT03867188 568 569 O
Hepatic NCT03867188 571 578 O
: NCT03867188 579 580 O
Viral NCT03867188 581 586 B-Modifier
or NCT03867188 587 589 B-Or
Autoimmune NCT03867188 590 600 B-Modifier
Hepatitis NCT03867188 601 610 B-Condition
, NCT03867188 611 612 O
Cirrhosis NCT03867188 613 622 B-Condition
of NCT03867188 623 625 O
the NCT03867188 626 629 O
Liver NCT03867188 630 635 B-Modifier
, NCT03867188 636 637 O
Liver NCT03867188 638 643 B-Modifier
Metabolism NCT03867188 644 654 B-Condition
Disorders NCT03867188 655 664 I-Condition
. NCT03867188 665 666 O
Renal NCT03867188 668 673 O
: NCT03867188 674 675 O
Any NCT03867188 676 679 O
form NCT03867188 680 684 O
of NCT03867188 685 687 O
renal NCT03867188 688 693 B-Condition
impairment NCT03867188 694 704 I-Condition
. NCT03867188 705 706 O
EXPAREL NCT03867188 708 715 B-Drug
® NCT03867188 715 716 O
is NCT03867188 717 719 O
cleared NCT03867188 720 727 O
by NCT03867188 728 730 O
the NCT03867188 731 734 O
kidneys NCT03867188 735 742 O
, NCT03867188 743 744 O
thus NCT03867188 745 749 O
any NCT03867188 750 753 O
form NCT03867188 754 758 O
of NCT03867188 759 761 O
renal NCT03867188 762 767 B-Condition
impairment NCT03867188 768 778 I-Condition
could NCT03867188 779 784 B-Assertion___Assertion_Type_Value:hypothetical
lead NCT03867188 785 789 O
to NCT03867188 790 792 O
an NCT03867188 793 795 O
adverse NCT03867188 796 803 B-Condition
reaction NCT03867188 804 812 I-Condition
. NCT03867188 813 814 O

- NCT03867188 818 819 O
Medical NCT03867188 821 828 B-Condition
condition NCT03867188 829 838 I-Condition
( NCT03867188 839 840 O
s NCT03867188 841 842 O
) NCT03867188 843 844 O
or NCT03867188 845 847 B-Or
concurrent NCT03867188 848 858 B-Modifier
surgery NCT03867188 859 866 B-Procedure
that NCT03867188 867 871 O
may NCT03867188 872 875 B-Assertion___Assertion_Type_Value:hypothetical
have NCT03867188 876 880 I-Assertion___Assertion_Type_Value:hypothetical
required NCT03867188 881 889 O
analgesic NCT03867188 890 899 B-Procedure
treatment NCT03867188 900 909 I-Procedure
in NCT03867188 910 912 O
the NCT03867188 913 916 O
post NCT03867188 917 921 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03867188 922 931 B-Procedure
period NCT03867188 932 938 O
for NCT03867188 939 942 O
pain NCT03867188 943 947 B-Condition
that NCT03867188 948 952 O
was NCT03867188 953 956 O
not NCT03867188 957 960 B-Negation
strictly NCT03867188 961 969 O
related NCT03867188 970 977 O
to NCT03867188 978 980 O
the NCT03867188 981 984 O
study NCT03867188 985 990 B-Study
surgery NCT03867188 991 998 B-Procedure
. NCT03867188 999 1000 O

- NCT03867188 1004 1005 O
Any NCT03867188 1007 1010 O
clinically NCT03867188 1011 1021 O
significant NCT03867188 1022 1033 O
event NCT03867188 1034 1039 B-Observation
or NCT03867188 1040 1042 B-Or
condition NCT03867188 1043 1052 B-Condition
discovered NCT03867188 1053 1063 O
during NCT03867188 1064 1070 B-Temporal_Connection___Temporal_Connection_Type_Value:during
surgery NCT03867188 1071 1078 B-Procedure
that NCT03867188 1079 1083 O
may NCT03867188 1084 1087 O
have NCT03867188 1088 1092 O
complicated NCT03867188 1093 1104 O
the NCT03867188 1105 1108 O
patient NCT03867188 1109 1116 O
's NCT03867188 1116 1118 O
post NCT03867188 1119 1123 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgical NCT03867188 1124 1132 B-Procedure
course NCT03867188 1133 1139 O
such NCT03867188 1140 1144 O
as NCT03867188 1145 1147 O
vascular NCT03867188 1148 1156 B-Modifier
or NCT03867188 1157 1159 B-Or
nerve NCT03867188 1160 1165 B-Modifier
involvement NCT03867188 1166 1177 B-Condition
that NCT03867188 1178 1182 O
was NCT03867188 1183 1186 O
unknown NCT03867188 1187 1194 O
before NCT03867188 1195 1201 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03867188 1202 1209 B-Procedure
. NCT03867188 1210 1211 O

- NCT03867188 1215 1216 O
History NCT03867188 1218 1225 B-Eq_Comparison
of NCT03867188 1226 1228 O
allergic NCT03867188 1229 1237 B-Allergy
reactions NCT03867188 1238 1247 I-Allergy
attributed NCT03867188 1248 1258 O
to NCT03867188 1259 1261 O
compounds NCT03867188 1262 1271 O
of NCT03867188 1272 1274 O
similar NCT03867188 1275 1282 O
chemical NCT03867188 1283 1291 O
or NCT03867188 1292 1294 O
biologic NCT03867188 1295 1303 O
composition NCT03867188 1304 1315 O
to NCT03867188 1316 1318 O
liposomal NCT03867188 1319 1328 B-Drug
bupivacaine NCT03867188 1329 1340 I-Drug
. NCT03867188 1341 1342 O

- NCT03867188 1346 1347 O
Pregnant NCT03867188 1349 1357 B-Condition
women NCT03867188 1358 1363 O
are NCT03867188 1364 1367 O
excluded NCT03867188 1368 1376 B-Negation
from NCT03867188 1377 1381 O
this NCT03867188 1382 1386 O
study NCT03867188 1387 1392 B-Study
because NCT03867188 1393 1400 O
EXPAREL NCT03867188 1401 1408 B-Drug
has NCT03867188 1409 1412 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03867188 1413 1416 I-Assertion___Assertion_Type_Value:hypothetical
potential NCT03867188 1417 1426 I-Assertion___Assertion_Type_Value:hypothetical
for NCT03867188 1427 1430 O
teratogenic NCT03867188 1431 1442 B-Modifier
or NCT03867188 1443 1445 B-Or
abortifacient NCT03867188 1446 1459 B-Modifier
effects NCT03867188 1460 1467 B-Condition
. NCT03867188 1468 1469 O
Because NCT03867188 1471 1478 O
there NCT03867188 1479 1484 O
is NCT03867188 1485 1487 O
an NCT03867188 1488 1490 O
unknown NCT03867188 1491 1498 O
but NCT03867188 1499 1502 O
potential NCT03867188 1503 1512 B-Assertion___Assertion_Type_Value:hypothetical
risk NCT03867188 1513 1517 B-Risk
for NCT03867188 1518 1521 O
adverse NCT03867188 1522 1529 B-Condition
events NCT03867188 1530 1536 I-Condition
in NCT03867188 1537 1539 O
nursing NCT03867188 1540 1547 B-Condition
infants NCT03867188 1548 1555 B-Family_Member___Family_Member_Type:child
secondary NCT03867188 1556 1565 O
to NCT03867188 1566 1568 O
treatment NCT03867188 1569 1578 B-Procedure
of NCT03867188 1579 1581 O
the NCT03867188 1582 1585 O
mother NCT03867188 1586 1592 B-Family_Member___Family_Member_Type:mother
with NCT03867188 1593 1597 O
EXPAREL NCT03867188 1598 1605 B-Drug
, NCT03867188 1606 1607 O
breastfeeding NCT03867188 1608 1621 B-Condition
should NCT03867188 1622 1628 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03867188 1629 1631 I-Assertion___Assertion_Type_Value:hypothetical
discontinued NCT03867188 1632 1644 B-Negation
if NCT03867188 1645 1647 O
the NCT03867188 1648 1651 O
mother NCT03867188 1652 1658 B-Family_Member___Family_Member_Type:mother
is NCT03867188 1659 1661 O
treated NCT03867188 1662 1669 B-Procedure
with NCT03867188 1670 1674 O
EXPAREL NCT03867188 1675 1682 B-Drug
. NCT03867188 1683 1684 O

Inclusion NCT03925272 0 9 O
Criteria NCT03925272 10 18 O
: NCT03925272 19 20 O

- NCT03925272 24 25 O
unprotected NCT03925272 27 38 B-Modifier
adults NCT03925272 39 45 O
with NCT03925272 46 50 O
social NCT03925272 51 57 O
security NCT03925272 58 66 O
who NCT03925272 67 70 O
have NCT03925272 71 75 O
attested NCT03925272 76 84 O
their NCT03925272 85 90 O
consent NCT03925272 91 98 O
after NCT03925272 99 104 O
receiving NCT03925272 105 114 O
any NCT03925272 115 118 O
relevant NCT03925272 119 127 O
information NCT03925272 128 139 O
about NCT03925272 140 145 O
the NCT03925272 146 149 O
study NCT03925272 150 155 O

- NCT03925272 158 159 O
subjects NCT03925272 161 169 O
whose NCT03925272 170 175 O
ethno NCT03925272 176 181 O
- NCT03925272 182 183 O
geographical NCT03925272 184 196 O
origin NCT03925272 197 203 O
of NCT03925272 204 206 O
both NCT03925272 207 211 O
parents NCT03925272 212 219 B-Family_Member___Family_Member_Type:parent
is NCT03925272 220 222 O
known NCT03925272 223 228 O

- NCT03925272 231 232 O
subjects NCT03925272 234 242 O
for NCT03925272 243 246 O
whom NCT03925272 247 251 O
data NCT03925272 252 256 O
on NCT03925272 257 259 O
principal NCT03925272 260 269 B-Modifier
vaccinations NCT03925272 270 282 B-Immunization
( NCT03925272 283 284 O
diphtheria NCT03925272 285 295 B-Condition
, NCT03925272 296 297 O
tetanus NCT03925272 298 305 B-Condition
, NCT03925272 306 307 O
poliomyelitis NCT03925272 308 321 B-Condition
, NCT03925272 322 323 O
hepatitis NCT03925272 324 333 B-Condition
B NCT03925272 334 335 I-Condition
, NCT03925272 336 337 O
possibly NCT03925272 338 346 B-Assertion___Assertion_Type_Value:hypothetical
tuberculosis NCT03925272 347 359 B-Condition
) NCT03925272 360 361 O
are NCT03925272 362 365 O
documented NCT03925272 366 376 O

- NCT03925272 379 380 O
subjects NCT03925272 382 390 O
who NCT03925272 391 394 O
consented NCT03925272 395 404 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925272 405 407 I-Assertion___Assertion_Type_Value:hypothetical
carry NCT03925272 408 413 O
out NCT03925272 414 417 O
serological NCT03925272 418 429 B-Observation
tests NCT03925272 430 435 I-Observation
HIV NCT03925272 436 439 B-Condition
, NCT03925272 440 441 O
HCV NCT03925272 442 445 B-Condition
, NCT03925272 446 447 O
HBV NCT03925272 448 451 B-Condition

Exclusion NCT03925272 452 461 O
Criteria NCT03925272 462 470 O
: NCT03925272 471 472 O

- NCT03925272 476 477 O
Any NCT03925272 479 482 O
conditions NCT03925272 483 493 B-Condition
that NCT03925272 494 498 O
would NCT03925272 499 504 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03925272 505 508 B-Negation
allow NCT03925272 509 514 O
participation NCT03925272 515 528 O
in NCT03925272 529 531 O
the NCT03925272 532 535 O
present NCT03925272 536 543 O
study NCT03925272 544 549 B-Study
, NCT03925272 550 551 O
on NCT03925272 552 554 O
the NCT03925272 555 558 O
opinion NCT03925272 559 566 O
of NCT03925272 567 569 O
the NCT03925272 570 573 O
investigator NCT03925272 574 586 O
( NCT03925272 587 588 O
documenting NCT03925272 589 600 O
) NCT03925272 601 602 O
, NCT03925272 603 604 O
ie NCT03925272 605 607 O
any NCT03925272 608 611 O
acute NCT03925272 612 617 O
or NCT03925272 618 620 B-Or
chronic NCT03925272 621 628 O
pathology NCT03925272 629 638 B-Condition
that NCT03925272 639 643 O
may NCT03925272 644 647 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03925272 648 657 O
with NCT03925272 658 662 O
the NCT03925272 663 666 O
immune NCT03925272 667 673 B-Condition
system NCT03925272 674 680 I-Condition
, NCT03925272 681 682 O
such NCT03925272 683 687 O
as NCT03925272 688 690 O
progressive NCT03925272 691 702 B-Modifier
or NCT03925272 703 705 B-Or
chronic NCT03925272 706 713 O
pathology NCT03925272 714 723 B-Condition
severe NCT03925272 724 730 O
or NCT03925272 731 733 B-Or
uncontrolled NCT03925272 734 746 B-Modifier
by NCT03925272 747 749 O
current NCT03925272 750 757 B-Eq_Comparison
treatments NCT03925272 758 768 B-Procedure
or NCT03925272 769 771 B-Or
a NCT03925272 772 773 O
pathology NCT03925272 774 783 B-Condition
requiring NCT03925272 784 793 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03925272 794 797 O
administration NCT03925272 798 812 O
of NCT03925272 813 815 O
immune NCT03925272 816 822 B-Drug
impact NCT03925272 823 829 I-Drug
drugs NCT03925272 830 835 I-Drug
: NCT03925272 836 837 O
long NCT03925272 838 842 O
- NCT03925272 843 844 O
term NCT03925272 845 849 O
anti NCT03925272 850 854 B-Drug
- NCT03925272 855 856 I-Drug
inflammatory NCT03925272 857 869 I-Drug
, NCT03925272 870 871 O
immunosuppressive NCT03925272 872 889 B-Drug
, NCT03925272 890 891 O
etc NCT03925272 892 895 O

- NCT03925272 898 899 O
Pregnant NCT03925272 901 909 B-Condition
or NCT03925272 910 912 B-Or
lactating NCT03925272 913 922 B-Condition
women NCT03925272 923 928 O

- NCT03925272 931 932 O
For NCT03925272 934 937 O
the NCT03925272 938 941 O
realization NCT03925272 942 953 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03925272 954 956 I-Assertion___Assertion_Type_Value:hypothetical
skin NCT03925272 957 961 B-Modifier
biopsies NCT03925272 962 970 B-Procedure
: NCT03925272 971 972 O
allergy NCT03925272 973 980 B-Allergy
to NCT03925272 981 983 O
local NCT03925272 984 989 B-Drug
anesthetics NCT03925272 990 1001 I-Drug
, NCT03925272 1002 1003 O
cardiac NCT03925272 1004 1011 B-Condition
valvulopathy NCT03925272 1012 1024 I-Condition

- NCT03925272 1027 1028 O
For NCT03925272 1030 1033 O
the NCT03925272 1034 1037 O
realization NCT03925272 1038 1049 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03925272 1050 1052 I-Assertion___Assertion_Type_Value:hypothetical
Tubertest NCT03925272 1053 1062 B-Observation
: NCT03925272 1063 1064 O
Subject NCT03925272 1065 1072 O
presenting NCT03925272 1073 1083 O
a NCT03925272 1084 1085 O
contraindication NCT03925272 1086 1102 B-Contraindication
to NCT03925272 1103 1105 O
tuberculin NCT03925272 1106 1116 B-Drug

Inclusion NCT03922841 0 9 O
Criteria NCT03922841 10 18 O
: NCT03922841 19 20 O

- NCT03922841 24 25 O
The NCT03922841 27 30 O
subject NCT03922841 31 38 O
must NCT03922841 39 43 O
meet NCT03922841 44 48 O
all NCT03922841 49 52 O
of NCT03922841 53 55 O
the NCT03922841 56 59 O
following NCT03922841 60 69 O
inclusion NCT03922841 70 79 O
criteria NCT03922841 80 88 O
to NCT03922841 89 91 O
participate NCT03922841 92 103 O
in NCT03922841 104 106 O
this NCT03922841 107 111 O
study NCT03922841 112 117 O
. NCT03922841 118 119 O

1 NCT03922841 128 129 O
. NCT03922841 129 130 O
Evidence NCT03922841 132 140 O
of NCT03922841 141 143 O
pleural NCT03922841 144 151 B-Condition
disease NCT03922841 152 159 I-Condition
on NCT03922841 160 162 O
chest NCT03922841 163 168 B-Procedure
radiograph NCT03922841 169 179 I-Procedure
or NCT03922841 180 182 B-Or
bedside NCT03922841 183 190 B-Procedure
ultrasound NCT03922841 191 201 I-Procedure
or NCT03922841 202 204 B-Or
Computed NCT03922841 205 213 B-Procedure
Tomography NCT03922841 214 224 I-Procedure
regardless NCT03922841 225 235 O
of NCT03922841 236 238 O
underlying NCT03922841 239 249 O
aetiology NCT03922841 250 259 O

2 NCT03922841 267 268 O
. NCT03922841 268 269 O
No NCT03922841 271 273 O
age NCT03922841 274 277 O
or NCT03922841 278 280 O
gender NCT03922841 281 287 O
restrictions NCT03922841 288 300 O

3 NCT03922841 308 309 O
. NCT03922841 309 310 O
Ability NCT03922841 312 319 O
to NCT03922841 320 322 O
provide NCT03922841 323 330 O
informed NCT03922841 331 339 O
consent NCT03922841 340 347 O

Exclusion NCT03922841 348 357 O
Criteria NCT03922841 358 366 O
: NCT03922841 367 368 O

- NCT03922841 372 373 O
Subjects NCT03922841 375 383 O
who NCT03922841 384 387 O
no NCT03922841 388 390 B-Negation
radiographic NCT03922841 391 403 B-Procedure
evidence NCT03922841 404 412 O
of NCT03922841 413 415 O
pleural NCT03922841 416 423 B-Condition
disease NCT03922841 424 431 I-Condition
or NCT03922841 432 434 O
who NCT03922841 435 438 O
are NCT03922841 439 442 O
unwilling NCT03922841 443 452 O
/ NCT03922841 453 454 O
unable NCT03922841 455 461 O
to NCT03922841 462 464 O
provide NCT03922841 465 472 O
informed NCT03922841 473 481 O
consent NCT03922841 482 489 O

Inclusion NCT03864484 0 9 O
Criteria NCT03864484 10 18 O
: NCT03864484 19 20 O

- NCT03864484 24 25 O
40 NCT03864484 27 29 B-Eq_Comparison
years NCT03864484 30 35 I-Eq_Comparison
and NCT03864484 36 39 I-Eq_Comparison
older NCT03864484 40 45 I-Eq_Comparison

- NCT03864484 48 49 O
Males NCT03864484 51 56 O
and NCT03864484 57 60 B-Or
females NCT03864484 61 68 O

- NCT03864484 71 72 O
Center NCT03864484 74 80 B-Observation
for NCT03864484 81 84 I-Observation
Epidemiologic NCT03864484 85 98 I-Observation
Studies NCT03864484 99 106 I-Observation
Depression NCT03864484 107 117 I-Observation
Scale NCT03864484 118 123 I-Observation
score NCT03864484 124 129 B-Eq_Comparison
≥ NCT03864484 130 131 I-Eq_Comparison
16 NCT03864484 132 134 I-Eq_Comparison

- NCT03864484 138 139 O
Mini NCT03864484 141 145 B-Observation
Mental NCT03864484 146 152 I-Observation
State NCT03864484 153 158 I-Observation
Examination NCT03864484 159 170 I-Observation
score NCT03864484 171 176 I-Observation
≥ NCT03864484 177 178 B-Eq_Comparison
24 NCT03864484 179 181 I-Eq_Comparison

- NCT03864484 185 186 O
First NCT03864484 188 193 B-Eq_Comparison
stroke NCT03864484 194 200 B-Condition

- NCT03864484 203 204 O
Native NCT03864484 206 212 O
language NCT03864484 213 221 O
is NCT03864484 222 224 O
Japanese NCT03864484 225 233 O

- NCT03864484 236 237 O
Written NCT03864484 239 246 O
informed NCT03864484 247 255 O
consent NCT03864484 256 263 O
prior NCT03864484 264 269 O
to NCT03864484 270 272 O
participation NCT03864484 273 286 O

Exclusion NCT03864484 287 296 O
Criteria NCT03864484 297 305 O
: NCT03864484 306 307 O

- NCT03864484 311 312 O
Major NCT03864484 314 319 O
depressive NCT03864484 320 330 B-Condition
disorder NCT03864484 331 339 I-Condition
before NCT03864484 340 346 B-Temporal_Connection___Temporal_Connection_Type_Value:before
onset NCT03864484 347 352 B-Eq_Comparison
of NCT03864484 353 355 O
stroke NCT03864484 356 362 B-Condition

- NCT03864484 365 366 O
Bilateral NCT03864484 368 377 B-Modifier
hemiplegia NCT03864484 378 388 B-Condition

- NCT03864484 391 392 O
Vision NCT03864484 394 400 B-Modifier
or NCT03864484 401 403 B-Or
hearing NCT03864484 404 411 B-Modifier
deficits NCT03864484 412 420 B-Condition
that NCT03864484 421 425 O
negatively NCT03864484 426 436 O
impact NCT03864484 437 443 O
everyday NCT03864484 444 452 B-Observation
life NCT03864484 453 457 I-Observation

- NCT03864484 460 461 O
Severe NCT03864484 463 469 O
aphasia NCT03864484 470 477 B-Condition

- NCT03864484 480 481 O
Severe NCT03864484 483 489 O
unilateral NCT03864484 490 500 B-Modifier
spatial NCT03864484 501 508 B-Condition
neglect NCT03864484 509 516 I-Condition

- NCT03864484 519 520 O
Diagnosis NCT03864484 522 531 O
of NCT03864484 532 534 O
neurodegenerative NCT03864484 535 552 B-Condition
disease NCT03864484 553 560 I-Condition
such NCT03864484 561 565 O
as NCT03864484 566 568 O
Parkinson NCT03864484 569 578 B-Condition
's NCT03864484 578 580 I-Condition
disease NCT03864484 581 588 I-Condition
or NCT03864484 589 591 B-Or
multiple NCT03864484 592 600 B-Modifier
system NCT03864484 601 607 I-Modifier
atrophy NCT03864484 608 615 B-Condition

- NCT03864484 618 619 O
Current NCT03864484 621 628 B-Eq_Comparison
life NCT03864484 629 633 B-Death|B-Risk
- NCT03864484 634 635 I-Death|I-Risk
threatening NCT03864484 636 647 I-Death|I-Risk
severe NCT03864484 648 654 O
organ NCT03864484 655 660 B-Condition
failure NCT03864484 661 668 I-Condition
, NCT03864484 669 670 O
musculoskeletal NCT03864484 671 686 B-Condition
disorders NCT03864484 687 696 I-Condition
, NCT03864484 697 698 O
or NCT03864484 699 701 B-Or
cancer NCT03864484 702 708 B-Condition

Cystic NCT03921060 0 6 B-Condition
Fibrosis NCT03921060 7 15 I-Condition
Main NCT03921060 16 20 O
Study NCT03921060 21 26 O
Inclusion NCT03921060 27 36 O
Criteria NCT03921060 37 45 O
: NCT03921060 46 47 O

- NCT03921060 51 52 O
Must NCT03921060 54 58 O
have NCT03921060 59 63 O
CF NCT03921060 64 66 B-Condition
diagnosis NCT03921060 67 76 O
confirmed NCT03921060 77 86 O
by NCT03921060 87 89 O
sweat NCT03921060 90 95 B-Observation
test NCT03921060 96 100 I-Observation
or NCT03921060 101 103 B-Or
genotype NCT03921060 104 112 B-Procedure
analysis NCT03921060 113 121 I-Procedure

- NCT03921060 124 125 O
Subjects NCT03921060 127 135 O
( NCT03921060 136 137 O
and NCT03921060 138 141 O
parents NCT03921060 142 149 O
/ NCT03921060 150 151 O
legal NCT03921060 152 157 O
guardians NCT03921060 158 167 O
as NCT03921060 168 170 O
applicable NCT03921060 171 181 O
) NCT03921060 182 183 O
must NCT03921060 184 188 O
have NCT03921060 189 193 O
the NCT03921060 194 197 O
ability NCT03921060 198 205 O
to NCT03921060 206 208 O
read NCT03921060 209 213 O
and NCT03921060 214 217 O
write NCT03921060 218 223 O
in NCT03921060 224 226 O
English NCT03921060 227 234 O

Sub NCT03921060 235 238 O
- NCT03921060 239 240 O
study NCT03921060 241 246 O
Exclusion NCT03921060 247 256 O
Criteria NCT03921060 257 265 O
: NCT03921060 266 267 O

- NCT03921060 271 272 O
No NCT03921060 274 276 B-Negation
CF NCT03921060 277 279 B-Condition
diagnosis NCT03921060 280 289 O

- NCT03921060 292 293 O
Men NCT03921060 295 298 O
or NCT03921060 299 301 B-Or
women NCT03921060 302 307 O
without NCT03921060 308 315 B-Negation
osteoporosis NCT03921060 316 328 B-Condition

- NCT03921060 331 332 O
Less NCT03921060 334 338 B-Eq_Comparison
than NCT03921060 339 343 I-Eq_Comparison
18 NCT03921060 344 346 I-Eq_Comparison
years NCT03921060 347 352 I-Eq_Comparison
of NCT03921060 353 355 O
age NCT03921060 356 359 B-Age

- NCT03921060 362 363 O
Unwilling NCT03921060 365 374 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921060 375 377 O
return NCT03921060 378 384 O
annually NCT03921060 385 393 O
for NCT03921060 394 397 O
study NCT03921060 398 403 B-Study
visits NCT03921060 404 410 O
for NCT03921060 411 414 O
up NCT03921060 415 417 B-Eq_Comparison
to NCT03921060 418 420 I-Eq_Comparison
5 NCT03921060 421 422 I-Eq_Comparison
years NCT03921060 423 428 I-Eq_Comparison

- NCT03921060 431 432 O
Unwilling NCT03921060 434 443 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03921060 444 447 B-Or
/ NCT03921060 448 449 I-Or
or NCT03921060 450 452 I-Or
medically NCT03921060 453 462 O
unable NCT03921060 463 469 B-Negation
to NCT03921060 470 472 O
take NCT03921060 473 477 O
denosumab NCT03921060 478 487 B-Drug

Inclusion NCT03922386 0 9 O
Criteria NCT03922386 10 18 O
: NCT03922386 19 20 O

1 NCT03922386 24 25 O
. NCT03922386 25 26 O
Any NCT03922386 28 31 O
subject NCT03922386 32 39 O
newly NCT03922386 40 45 O
implanted NCT03922386 46 55 O
according NCT03922386 56 65 O
to NCT03922386 66 68 O
the NCT03922386 69 72 O
most NCT03922386 73 77 O
recent NCT03922386 78 84 O
guidelines NCT03922386 85 95 O
from NCT03922386 96 100 O
the NCT03922386 101 104 O
European NCT03922386 105 113 O
Society NCT03922386 114 121 O
of NCT03922386 122 124 O
Cardiology NCT03922386 125 135 O
( NCT03922386 136 137 O
ESC NCT03922386 138 141 O
) NCT03922386 142 143 O
for NCT03922386 144 147 O
less NCT03922386 148 152 B-Eq_Comparison
than NCT03922386 153 157 I-Eq_Comparison
10 NCT03922386 158 160 I-Eq_Comparison
days NCT03922386 161 165 I-Eq_Comparison
with NCT03922386 166 170 O
: NCT03922386 171 172 O

- NCT03922386 181 182 O
a NCT03922386 184 185 O
Single NCT03922386 186 192 B-Modifier
Chamber NCT03922386 193 200 I-Modifier
( NCT03922386 201 202 O
SR NCT03922386 203 205 B-Modifier
) NCT03922386 206 207 O
or NCT03922386 208 210 B-Or
a NCT03922386 211 212 O
Dual NCT03922386 213 217 B-Modifier
Chamber NCT03922386 218 225 I-Modifier
( NCT03922386 226 227 O
DR NCT03922386 228 230 B-Modifier
) NCT03922386 231 232 O
pacemaker NCT03922386 233 242 B-Procedure
from NCT03922386 243 247 O
Microport NCT03922386 248 257 O
CRM NCT03922386 258 261 O
S NCT03922386 262 263 O
. NCT03922386 264 265 O
r NCT03922386 266 267 O
. NCT03922386 268 269 O
l NCT03922386 270 271 O
. NCT03922386 272 273 O

- NCT03922386 282 283 O
any NCT03922386 285 288 O
right NCT03922386 289 294 B-Modifier
atrial NCT03922386 295 301 I-Modifier
and NCT03922386 302 305 B-Or
/ NCT03922386 306 307 I-Or
or NCT03922386 308 310 I-Or
right NCT03922386 311 316 B-Modifier
ventricular NCT03922386 317 328 I-Modifier
XFINE NCT03922386 329 334 B-Procedure
lead NCT03922386 335 339 I-Procedure

2 NCT03922386 342 343 O
. NCT03922386 343 344 O
Have NCT03922386 346 350 O
reviewed NCT03922386 351 359 O
, NCT03922386 360 361 O
signed NCT03922386 362 368 O
and NCT03922386 369 372 O
dated NCT03922386 373 378 O
the NCT03922386 379 382 O
informed NCT03922386 383 391 O
consent NCT03922386 392 399 O

Exclusion NCT03922386 400 409 O
Criteria NCT03922386 410 418 O
: NCT03922386 419 420 O

1 NCT03922386 424 425 O
. NCT03922386 425 426 O
Included NCT03922386 428 436 O
in NCT03922386 437 439 O
another NCT03922386 440 447 B-Other
clinical NCT03922386 448 456 O
study NCT03922386 457 462 B-Study
that NCT03922386 463 467 O
could NCT03922386 468 473 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03922386 474 482 O
the NCT03922386 483 486 O
results NCT03922386 487 494 O
of NCT03922386 495 497 O
this NCT03922386 498 502 O
study NCT03922386 503 508 B-Study
such NCT03922386 509 513 O
as NCT03922386 514 516 O
studies NCT03922386 517 524 B-Study
involving NCT03922386 525 534 O
intra NCT03922386 535 540 B-Procedure
- NCT03922386 541 542 I-Procedure
cardiac NCT03922386 543 550 I-Procedure
device NCT03922386 551 557 I-Procedure

2 NCT03922386 560 561 O
. NCT03922386 561 562 O
Contraindication NCT03922386 564 580 B-Contraindication
to NCT03922386 581 583 O
a NCT03922386 584 585 O
maximum NCT03922386 586 593 B-Eq_Comparison
single NCT03922386 594 600 I-Eq_Comparison
dose NCT03922386 601 605 I-Eq_Comparison
of NCT03922386 606 608 I-Eq_Comparison
310 NCT03922386 609 612 I-Eq_Comparison
µg NCT03922386 613 615 I-Eq_Comparison
Dexamethasone NCT03922386 616 629 B-Drug
Sodium NCT03922386 630 636 I-Drug
Phosphate NCT03922386 637 646 I-Drug
( NCT03922386 647 648 O
DSP NCT03922386 649 652 B-Drug
) NCT03922386 653 654 O

3 NCT03922386 658 659 O
. NCT03922386 659 660 O
Tricuspid NCT03922386 662 671 B-Condition
valvular NCT03922386 672 680 I-Condition
disease NCT03922386 681 688 I-Condition
or NCT03922386 689 691 B-Or
tricuspid NCT03922386 692 701 B-Procedure
replacement NCT03922386 702 713 I-Procedure
heart NCT03922386 714 719 I-Procedure
valve NCT03922386 720 725 I-Procedure
( NCT03922386 726 727 O
mechanical NCT03922386 728 738 B-Modifier
or NCT03922386 739 741 B-Or
tissue NCT03922386 742 748 B-Modifier
) NCT03922386 749 750 O
only NCT03922386 751 755 O
for NCT03922386 756 759 O
subject NCT03922386 760 767 O
with NCT03922386 768 772 O
DR NCT03922386 773 775 B-Procedure
pacemaker NCT03922386 776 785 I-Procedure

4 NCT03922386 788 789 O
. NCT03922386 789 790 O
Active NCT03922386 792 798 B-Eq_Comparison
myocarditis NCT03922386 799 810 B-Condition
, NCT03922386 811 812 O
pocket NCT03922386 813 819 B-Modifier
and NCT03922386 820 823 B-Or
/ NCT03922386 824 825 I-Or
or NCT03922386 826 828 I-Or
lead NCT03922386 829 833 B-Modifier
infection NCT03922386 834 843 B-Condition

5 NCT03922386 846 847 O
. NCT03922386 847 848 O
Age NCT03922386 850 853 B-Age
less NCT03922386 854 858 B-Eq_Comparison
than NCT03922386 859 863 I-Eq_Comparison
18 NCT03922386 864 866 I-Eq_Comparison
years NCT03922386 867 872 I-Eq_Comparison
old NCT03922386 873 876 O
or NCT03922386 877 879 O
under NCT03922386 880 885 O
guardianship NCT03922386 886 898 O
or NCT03922386 899 901 O
kept NCT03922386 902 906 O
in NCT03922386 907 909 O
detention NCT03922386 910 919 O

6 NCT03922386 922 923 O
. NCT03922386 923 924 O
Life NCT03922386 926 930 B-Observation
expectancy NCT03922386 931 941 I-Observation
less NCT03922386 942 946 B-Eq_Comparison
than NCT03922386 947 951 I-Eq_Comparison
1 NCT03922386 952 953 I-Eq_Comparison
year NCT03922386 954 958 I-Eq_Comparison

7 NCT03922386 961 962 O
. NCT03922386 962 963 O
Known NCT03922386 965 970 O
pregnancy NCT03922386 971 980 B-Condition
, NCT03922386 981 982 O
women NCT03922386 983 988 O
breastfeeding NCT03922386 989 1002 B-Condition
or NCT03922386 1003 1005 B-Or
in NCT03922386 1006 1008 O
childbearing NCT03922386 1009 1021 O
age NCT03922386 1022 1025 O
without NCT03922386 1026 1033 B-Negation
an NCT03922386 1034 1036 O
adequate NCT03922386 1037 1045 O
contraceptive NCT03922386 1046 1059 B-Procedure
method NCT03922386 1060 1066 I-Procedure

8 NCT03922386 1069 1070 O
. NCT03922386 1070 1071 O
Be NCT03922386 1073 1075 O
unavailable NCT03922386 1076 1087 O
for NCT03922386 1088 1091 O
the NCT03922386 1092 1095 O
scheduled NCT03922386 1096 1105 O
follow NCT03922386 1106 1112 O
- NCT03922386 1113 1114 O
up NCT03922386 1115 1117 O
associated NCT03922386 1118 1128 O
with NCT03922386 1129 1133 O
this NCT03922386 1134 1138 O
clinical NCT03922386 1139 1147 O
study NCT03922386 1148 1153 O
or NCT03922386 1154 1156 O
refusal NCT03922386 1157 1164 O
to NCT03922386 1165 1167 O
cooperate NCT03922386 1168 1177 O

Inclusion NCT03867916 0 9 O
Criteria NCT03867916 10 18 O
: NCT03867916 19 20 O

- NCT03867916 24 25 O
FOR NCT03867916 27 30 O
INTERVIEWS NCT03867916 31 41 O
AND NCT03867916 42 45 O
FOCUS NCT03867916 46 51 O
GROUPS NCT03867916 52 58 O
: NCT03867916 59 60 O
Cancer NCT03867916 61 67 B-Condition
patients NCT03867916 68 76 O
: NCT03867916 77 78 O
Self NCT03867916 79 83 O
- NCT03867916 84 85 O
identifies NCT03867916 86 96 O
as NCT03867916 97 99 O
Asian NCT03867916 100 105 O
American NCT03867916 106 114 O
, NCT03867916 115 116 O
lives NCT03867916 117 122 O
in NCT03867916 123 125 O
San NCT03867916 126 129 O
Francisco NCT03867916 130 139 O
, NCT03867916 140 141 O
speaks NCT03867916 142 148 O
English NCT03867916 149 156 O
, NCT03867916 157 158 O
Mandarin NCT03867916 159 167 O
, NCT03867916 168 169 O
Cantonese NCT03867916 170 179 O
, NCT03867916 180 181 O
or NCT03867916 182 184 B-Or
Vietnamese NCT03867916 185 195 O
, NCT03867916 196 197 O
has NCT03867916 198 201 O
a NCT03867916 202 203 O
history NCT03867916 204 211 B-Eq_Comparison
of NCT03867916 212 214 O
cancer NCT03867916 215 221 B-Condition
of NCT03867916 222 224 O
any NCT03867916 225 228 O
kind NCT03867916 229 233 O

- NCT03867916 236 237 O
FOR NCT03867916 239 242 O
INTERVIEWS NCT03867916 243 253 O
AND NCT03867916 254 257 O
FOCUS NCT03867916 258 263 O
GROUPS NCT03867916 264 270 O
: NCT03867916 271 272 O
Caregivers NCT03867916 273 283 O
: NCT03867916 284 285 O
any NCT03867916 286 289 O
person NCT03867916 290 296 O
who NCT03867916 297 300 O
has NCT03867916 301 304 O
provided NCT03867916 305 313 O
care NCT03867916 314 318 O
to NCT03867916 319 321 O
an NCT03867916 322 324 O
Asian NCT03867916 325 330 O
American NCT03867916 331 339 O
cancer NCT03867916 340 346 B-Condition
patient NCT03867916 347 354 O

- NCT03867916 357 358 O
FOR NCT03867916 360 363 O
INTERVIEWS NCT03867916 364 374 O
AND NCT03867916 375 378 O
FOCUS NCT03867916 379 384 O
GROUPS NCT03867916 385 391 O
: NCT03867916 392 393 O
Health NCT03867916 394 400 O
professionals NCT03867916 401 414 O
: NCT03867916 415 416 O
physicians NCT03867916 417 427 B-Provider
and NCT03867916 428 431 O
other NCT03867916 432 437 O
health NCT03867916 438 444 B-Provider
professionals NCT03867916 445 458 I-Provider
who NCT03867916 459 462 O
provide NCT03867916 463 470 O
care NCT03867916 471 475 O
to NCT03867916 476 478 O
Asian NCT03867916 479 484 O
American NCT03867916 485 493 O
patients NCT03867916 494 502 O
with NCT03867916 503 507 B-And
cancer NCT03867916 508 514 B-Condition

- NCT03867916 517 518 O
FOR NCT03867916 520 523 O
PILOT NCT03867916 524 529 O
AND NCT03867916 530 533 O
FULL NCT03867916 534 538 O
IMPLEMENTATION NCT03867916 539 553 O
: NCT03867916 554 555 O
Self NCT03867916 556 560 O
- NCT03867916 561 562 O
identifies NCT03867916 563 573 O
as NCT03867916 574 576 O
Asian NCT03867916 577 582 O
American NCT03867916 583 591 O
, NCT03867916 592 593 O
lives NCT03867916 594 599 O
in NCT03867916 600 602 O
San NCT03867916 603 606 O
Francisco NCT03867916 607 616 O
, NCT03867916 617 618 O
speaks NCT03867916 619 625 O
English NCT03867916 626 633 O
, NCT03867916 634 635 O
Mandarin NCT03867916 636 644 O
, NCT03867916 645 646 O
Cantonese NCT03867916 647 656 O
, NCT03867916 657 658 O
or NCT03867916 659 661 B-Or
Vietnamese NCT03867916 662 672 O
, NCT03867916 673 674 O
has NCT03867916 675 678 O
stage NCT03867916 679 684 B-Eq_Comparison
I NCT03867916 685 686 I-Eq_Comparison
- NCT03867916 687 688 I-Eq_Comparison
III NCT03867916 689 692 I-Eq_Comparison
colorectal NCT03867916 693 703 B-Modifier
, NCT03867916 704 705 O
lung NCT03867916 706 710 B-Modifier
, NCT03867916 711 712 O
or NCT03867916 713 715 B-Or
liver NCT03867916 716 721 B-Modifier
cancer NCT03867916 722 728 B-Condition
, NCT03867916 729 730 O
has NCT03867916 731 734 O
not NCT03867916 735 738 B-Negation
yet NCT03867916 739 742 O
undergone NCT03867916 743 752 B-Eq_Comparison
treatment NCT03867916 753 762 B-Procedure

- NCT03867916 765 766 O
FOR NCT03867916 768 771 O
PILOT NCT03867916 772 777 O
AND NCT03867916 778 781 O
FULL NCT03867916 782 786 O
IMPLEMENTATION NCT03867916 787 801 O
: NCT03867916 802 803 O
Is NCT03867916 804 806 O
willing NCT03867916 807 814 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867916 815 817 I-Assertion___Assertion_Type_Value:hypothetical
stay NCT03867916 818 822 O
in NCT03867916 823 825 O
the NCT03867916 826 829 O
study NCT03867916 830 835 B-Study
for NCT03867916 836 839 O
six NCT03867916 840 843 B-Eq_Comparison
months NCT03867916 844 850 I-Eq_Comparison

Exclusion NCT03867916 851 860 O
Criteria NCT03867916 861 869 O
: NCT03867916 870 871 O

- NCT03867916 875 876 O
Any NCT03867916 878 881 O
medical NCT03867916 882 889 B-Modifier
or NCT03867916 890 892 B-Or
psychological NCT03867916 893 906 B-Modifier
conditions NCT03867916 907 917 B-Condition
precluding NCT03867916 918 928 O
informed NCT03867916 929 937 O
consent NCT03867916 938 945 O

Inclusion NCT03864757 0 9 O
Criteria NCT03864757 10 18 O
: NCT03864757 19 20 O

- NCT03864757 24 25 O
Male NCT03864757 27 31 O
and NCT03864757 32 35 B-Or
female NCT03864757 36 42 O
patients NCT03864757 43 51 O
between NCT03864757 52 59 B-Eq_Comparison
18 NCT03864757 60 62 I-Eq_Comparison
and NCT03864757 63 66 I-Eq_Comparison
80 NCT03864757 67 69 I-Eq_Comparison
years NCT03864757 70 75 I-Eq_Comparison

- NCT03864757 78 79 O
Diagnosed NCT03864757 81 90 O
with NCT03864757 91 95 O
permanent NCT03864757 96 105 B-Modifier
UVFP NCT03864757 106 110 B-Condition
and NCT03864757 111 114 B-And
insufficient NCT03864757 115 127 B-Modifier
glottal NCT03864757 128 135 B-Condition
closure NCT03864757 136 143 I-Condition
and NCT03864757 144 147 B-And
planned NCT03864757 148 155 B-Eq_Comparison
type NCT03864757 156 160 B-Modifier
I NCT03864757 161 162 I-Modifier
thyroplasty NCT03864757 163 174 B-Procedure
with NCT03864757 175 179 O
conventional NCT03864757 180 192 B-Procedure
implant NCT03864757 193 200 I-Procedure

- NCT03864757 203 204 O
Ability NCT03864757 206 213 O
to NCT03864757 214 216 O
co NCT03864757 217 219 O
- NCT03864757 220 221 O
operate NCT03864757 222 229 O
with NCT03864757 230 234 O
the NCT03864757 235 238 O
investigator NCT03864757 239 251 O
and NCT03864757 252 255 O
to NCT03864757 256 258 O
comply NCT03864757 259 265 O
with NCT03864757 266 270 O
the NCT03864757 271 274 O
requirements NCT03864757 275 287 O
of NCT03864757 288 290 O
the NCT03864757 291 294 O
entire NCT03864757 295 301 O
study NCT03864757 302 307 O

Exclusion NCT03864757 308 317 O
Criteria NCT03864757 318 326 O
: NCT03864757 327 328 O

- NCT03864757 332 333 O
Any NCT03864757 335 338 O
other NCT03864757 339 344 B-Other
significant NCT03864757 345 356 O
disease NCT03864757 357 364 B-Condition
or NCT03864757 365 367 B-Or
disorder NCT03864757 368 376 B-Condition
which NCT03864757 377 382 O
, NCT03864757 383 384 O
in NCT03864757 385 387 O
the NCT03864757 388 391 O
opinion NCT03864757 392 399 O
of NCT03864757 400 402 O
the NCT03864757 403 406 O
investigator NCT03864757 407 419 O
, NCT03864757 420 421 O
may NCT03864757 422 425 B-Assertion___Assertion_Type_Value:hypothetical
either NCT03864757 426 432 O
put NCT03864757 433 436 O
the NCT03864757 437 440 O
participant NCT03864757 441 452 O
at NCT03864757 453 455 O
risk NCT03864757 456 460 B-Risk
because NCT03864757 461 468 O
of NCT03864757 469 471 O
participation NCT03864757 472 485 O
in NCT03864757 486 488 O
the NCT03864757 489 492 O
clinical NCT03864757 493 501 O
investigation NCT03864757 502 515 O
may NCT03864757 516 519 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03864757 520 529 O
the NCT03864757 530 533 O
result NCT03864757 534 540 O
of NCT03864757 541 543 O
the NCT03864757 544 547 O
clinical NCT03864757 548 556 O
investigation NCT03864757 557 570 O
, NCT03864757 571 572 O
or NCT03864757 573 575 O
the NCT03864757 576 579 O
participant NCT03864757 580 591 O
's NCT03864757 591 593 O
ability NCT03864757 594 601 O
to NCT03864757 602 604 O
participate NCT03864757 605 616 O
in NCT03864757 617 619 O
the NCT03864757 620 623 O
clinical NCT03864757 624 632 O
investigation NCT03864757 633 646 B-Study

- NCT03864757 649 650 O
Scheduled NCT03864757 652 661 B-Eq_Comparison
elective NCT03864757 662 670 B-Modifier
surgery NCT03864757 671 678 B-Procedure
or NCT03864757 679 681 B-Or
other NCT03864757 682 687 B-Other
procedures NCT03864757 688 698 B-Procedure
requiring NCT03864757 699 708 O
general NCT03864757 709 716 B-Procedure
anaesthesia NCT03864757 717 728 I-Procedure
during NCT03864757 729 735 B-Temporal_Connection___Temporal_Connection_Type_Value:during
clinical NCT03864757 736 744 O
investigation NCT03864757 745 758 B-Study

- NCT03864757 761 762 O
Had NCT03864757 764 767 O
medialization NCT03864757 768 781 B-Procedure
thyroplasty NCT03864757 782 793 I-Procedure
before NCT03864757 794 800 B-Eq_Comparison

- NCT03864757 803 804 O
Had NCT03864757 806 809 O
injection NCT03864757 810 819 B-Modifier
medialization NCT03864757 820 833 B-Procedure
laryngoplasty NCT03864757 834 847 I-Procedure
in NCT03864757 848 850 O
the NCT03864757 851 854 O
past NCT03864757 855 859 B-Eq_Comparison
two NCT03864757 860 863 I-Eq_Comparison
years NCT03864757 864 869 I-Eq_Comparison
. NCT03864757 870 871 O

- NCT03864757 875 876 O
Presence NCT03864757 878 886 O
of NCT03864757 887 889 O
structural NCT03864757 890 900 B-Modifier
vocal NCT03864757 901 906 I-Modifier
fold NCT03864757 907 911 I-Modifier
lesions NCT03864757 912 919 B-Condition
such NCT03864757 920 924 O
as NCT03864757 925 927 O
polyp NCT03864757 928 933 B-Condition
or NCT03864757 934 936 B-Or
nodules NCT03864757 937 944 B-Condition

- NCT03864757 947 948 O
Status NCT03864757 950 956 O
post NCT03864757 957 961 B-Temporal_Connection___Temporal_Connection_Type_Value:after
total NCT03864757 962 967 B-Procedure
cordectomy NCT03864757 968 978 I-Procedure

- NCT03864757 981 982 O
Previous NCT03864757 984 992 B-Eq_Comparison
laryngeal NCT03864757 993 1002 B-Procedure
framework NCT03864757 1003 1012 I-Procedure
surgery NCT03864757 1013 1020 I-Procedure
( NCT03864757 1021 1022 O
any NCT03864757 1023 1026 O
type NCT03864757 1027 1031 O
of NCT03864757 1032 1034 O
thyroplasty NCT03864757 1035 1046 B-Procedure
, NCT03864757 1047 1048 O
arytenoid NCT03864757 1049 1058 B-Procedure
adduction NCT03864757 1059 1068 I-Procedure
) NCT03864757 1069 1070 O

- NCT03864757 1074 1075 O
Significant NCT03864757 1077 1088 O
non NCT03864757 1089 1092 B-Negation
- NCT03864757 1093 1094 O
laryngeal NCT03864757 1095 1104 B-Modifier
speech NCT03864757 1105 1111 B-Modifier
abnormality NCT03864757 1112 1123 B-Condition
( NCT03864757 1124 1125 O
severe NCT03864757 1126 1132 O
dysarthria NCT03864757 1133 1143 B-Condition
determined NCT03864757 1144 1154 O
by NCT03864757 1155 1157 O
a NCT03864757 1158 1159 O
panel NCT03864757 1160 1165 O
of NCT03864757 1166 1168 O
trained NCT03864757 1169 1176 O
speech NCT03864757 1177 1183 B-Provider
therapists NCT03864757 1184 1194 I-Provider
) NCT03864757 1195 1196 O

- NCT03864757 1200 1201 O
Severe NCT03864757 1203 1209 O
coagulopathy NCT03864757 1210 1222 B-Condition

Inclusion NCT03865121 0 9 O
criteria NCT03865121 10 18 O
: NCT03865121 19 20 O

- NCT03865121 24 25 O
Subjects NCT03865121 27 35 O
over NCT03865121 36 40 B-Eq_Comparison
60 NCT03865121 41 43 I-Eq_Comparison
years NCT03865121 44 49 I-Eq_Comparison
of NCT03865121 50 52 O
age NCT03865121 53 56 B-Age
with NCT03865121 57 61 B-And
a NCT03865121 62 63 O
clinical NCT03865121 64 72 O
diagnosis NCT03865121 73 82 O
of NCT03865121 83 85 O
Parkinson NCT03865121 86 95 B-Condition
's NCT03865121 95 97 I-Condition
disease NCT03865121 98 105 I-Condition

- NCT03865121 108 109 O
Stages NCT03865121 111 117 O
of NCT03865121 118 120 O
the NCT03865121 121 124 O
disease NCT03865121 125 132 O
2 NCT03865121 133 134 B-Eq_Comparison
- NCT03865121 135 136 I-Eq_Comparison
3 NCT03865121 137 138 I-Eq_Comparison
of NCT03865121 139 141 O
Hoehn NCT03865121 142 147 B-Modifier
and NCT03865121 148 151 I-Modifier
Yahr NCT03865121 152 156 I-Modifier

- NCT03865121 159 160 O
Not NCT03865121 162 165 B-Negation
exposed NCT03865121 166 173 B-Condition
to NCT03865121 174 176 I-Condition
tobacco NCT03865121 177 184 I-Condition
during NCT03865121 185 191 B-Temporal_Connection___Temporal_Connection_Type_Value:during
any NCT03865121 192 195 B-Eq_Comparison
stage NCT03865121 196 201 I-Eq_Comparison
of NCT03865121 202 204 I-Eq_Comparison
their NCT03865121 205 210 I-Eq_Comparison
life NCT03865121 211 215 I-Eq_Comparison

- NCT03865121 218 219 O
No NCT03865121 221 223 B-Negation
history NCT03865121 224 231 B-Eq_Comparison
of NCT03865121 232 234 O
lung NCT03865121 235 239 B-Condition
diseases NCT03865121 240 248 I-Condition

- NCT03865121 251 252 O
No NCT03865121 254 256 B-Negation
laboratory NCT03865121 257 267 B-Observation
abnormalities NCT03865121 268 281 O

- NCT03865121 284 285 O
No NCT03865121 287 289 B-Negation
history NCT03865121 290 297 B-Eq_Comparison
of NCT03865121 298 300 O
adverse NCT03865121 301 308 B-Condition
reactions NCT03865121 309 318 I-Condition
to NCT03865121 319 321 O
nicotine NCT03865121 322 330 B-Drug

- NCT03865121 333 334 O
Able NCT03865121 336 340 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865121 341 343 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03865121 344 347 O
nicotine NCT03865121 348 356 B-Drug
nasal NCT03865121 357 362 I-Drug
spray NCT03865121 363 368 I-Drug

- NCT03865121 371 372 O
Residents NCT03865121 374 383 O
of NCT03865121 384 386 O
Mexico NCT03865121 387 393 O
City NCT03865121 394 398 O
able NCT03865121 399 403 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865121 404 406 I-Assertion___Assertion_Type_Value:hypothetical
attend NCT03865121 407 413 O
for NCT03865121 414 417 O
evaluations NCT03865121 418 429 B-Study

- NCT03865121 432 433 O
Under NCT03865121 435 440 B-Eq_Comparison
current NCT03865121 441 448 I-Eq_Comparison
treatment NCT03865121 449 458 B-Procedure
with NCT03865121 459 463 O
levodopa NCT03865121 464 472 B-Drug
at NCT03865121 473 475 O
a NCT03865121 476 477 O
stable NCT03865121 478 484 O
dose NCT03865121 485 489 O

- NCT03865121 492 493 O
Not NCT03865121 495 498 B-Negation
currently NCT03865121 499 508 B-Eq_Comparison
receiving NCT03865121 509 518 I-Eq_Comparison
a NCT03865121 519 520 O
monoamine NCT03865121 521 530 B-Drug
oxidase NCT03865121 531 538 I-Drug
inhibitor NCT03865121 539 548 I-Drug
treatment NCT03865121 549 558 B-Procedure

Exclusion NCT03865121 559 568 O
Criteria NCT03865121 569 577 O

- NCT03865121 580 581 O
Unable NCT03865121 583 589 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865121 590 592 O
complete NCT03865121 593 601 O
follow NCT03865121 602 608 B-Encounter
- NCT03865121 609 610 I-Encounter
up NCT03865121 611 613 I-Encounter
protocol NCT03865121 614 622 O

- NCT03865121 625 626 O
Drug NCT03865121 628 632 B-Drug
adverse NCT03865121 633 640 B-Condition
reaction NCT03865121 641 649 I-Condition

- NCT03865121 652 653 O
Death NCT03865121 655 660 B-Death

Inclusion NCT03860168 0 9 O
Criteria NCT03860168 10 18 O
for NCT03860168 19 22 O
Participating NCT03860168 23 36 O
Units NCT03860168 37 42 O
: NCT03860168 43 44 O

- NCT03860168 48 49 O
Participating NCT03860168 51 64 O
PICUs NCT03860168 65 70 O
must NCT03860168 71 75 O
be NCT03860168 76 78 O
a NCT03860168 79 80 O
separate NCT03860168 81 89 O
physical NCT03860168 90 98 O
space NCT03860168 99 104 O
dedicated NCT03860168 105 114 O
to NCT03860168 115 117 O
the NCT03860168 118 121 O
care NCT03860168 122 126 O
of NCT03860168 127 129 O
critically NCT03860168 130 140 B-Condition
ill NCT03860168 141 144 I-Condition
infants NCT03860168 145 152 O
and NCT03860168 153 156 B-Or
children NCT03860168 157 165 O
, NCT03860168 166 167 O
with NCT03860168 168 172 B-And
the NCT03860168 173 176 O
ability NCT03860168 177 184 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860168 185 187 I-Assertion___Assertion_Type_Value:hypothetical
provide NCT03860168 188 195 O
mechanical NCT03860168 196 206 B-Procedure
ventilation NCT03860168 207 218 I-Procedure
. NCT03860168 219 220 O

- NCT03860168 224 225 O
Not NCT03860168 227 230 O
implemented NCT03860168 231 242 O
a NCT03860168 243 244 O
PICU NCT03860168 245 249 O
mobility NCT03860168 250 258 O
protocol NCT03860168 259 267 O
and NCT03860168 268 271 O
would NCT03860168 272 277 O
commit NCT03860168 278 284 O
to NCT03860168 285 287 O
not NCT03860168 288 291 O
implementing NCT03860168 292 304 O
a NCT03860168 305 306 O
mobility NCT03860168 307 315 O
protocol NCT03860168 316 324 O
until NCT03860168 325 330 O
the NCT03860168 331 334 O
randomized NCT03860168 335 345 O
time NCT03860168 346 350 O
of NCT03860168 351 353 O
unit NCT03860168 354 358 O
implementation NCT03860168 359 373 O
. NCT03860168 374 375 O

Inclusion NCT03860168 377 386 O
Criteria NCT03860168 387 395 O
for NCT03860168 396 399 O
Patients NCT03860168 400 408 O
: NCT03860168 409 410 O

All NCT03860168 412 415 O
patients NCT03860168 416 424 O
admitted NCT03860168 425 433 B-Encounter
to NCT03860168 434 436 O
the NCT03860168 437 440 O
PICUs NCT03860168 441 446 O
regardless NCT03860168 447 457 O
of NCT03860168 458 460 O
length NCT03860168 461 467 O
of NCT03860168 468 470 O
stay NCT03860168 471 475 O
will NCT03860168 476 480 O
receive NCT03860168 481 488 O
the NCT03860168 489 492 O
unit NCT03860168 493 497 O
- NCT03860168 498 499 O
based NCT03860168 500 505 O
PICU NCT03860168 506 510 O
Up NCT03860168 511 513 O
! NCT03860168 513 514 O
intervention NCT03860168 515 527 B-Procedure
, NCT03860168 528 529 O
which NCT03860168 530 535 O
includes NCT03860168 536 544 O
criteria NCT03860168 545 553 O
for NCT03860168 554 557 O
no NCT03860168 558 560 B-Negation
mobilization NCT03860168 561 573 B-Procedure
based NCT03860168 574 579 O
on NCT03860168 580 582 O
specific NCT03860168 583 591 O
clinical NCT03860168 592 600 B-Condition
factors NCT03860168 601 608 I-Condition
( NCT03860168 609 610 O
i NCT03860168 611 612 O
. NCT03860168 613 614 O
e NCT03860168 615 616 O
. NCT03860168 617 618 O
open NCT03860168 620 624 B-Condition
chest NCT03860168 625 630 I-Condition
, NCT03860168 631 632 O
surgeon NCT03860168 633 640 B-Condition
request NCT03860168 641 648 I-Condition
) NCT03860168 649 650 O
. NCT03860168 651 652 O
10 NCT03860168 653 655 O
For NCT03860168 656 659 O
inclusion NCT03860168 660 669 O
in NCT03860168 670 672 O
data NCT03860168 673 677 O
analysis NCT03860168 678 686 O
, NCT03860168 687 688 O

patients NCT03860168 690 698 O
will NCT03860168 699 703 O
be NCT03860168 704 706 O
eligible NCT03860168 707 715 O
if NCT03860168 716 718 O

- NCT03860168 721 722 O
Admitted NCT03860168 724 732 B-Encounter
to NCT03860168 733 735 O
the NCT03860168 736 739 O
participating NCT03860168 740 753 O
PICU NCT03860168 754 758 O
≥ NCT03860168 759 760 B-Eq_Comparison
3 NCT03860168 761 762 I-Eq_Comparison
days NCT03860168 763 767 I-Eq_Comparison
. NCT03860168 768 769 O

Exclusion NCT03860168 771 780 O
Criteria NCT03860168 781 789 O
for NCT03860168 790 793 O
Patients NCT03860168 794 802 O
: NCT03860168 803 804 O

- NCT03860168 808 809 O
Patients NCT03860168 811 819 O
with NCT03860168 820 824 O
an NCT03860168 825 827 O
active NCT03860168 828 834 B-Eq_Comparison
do NCT03860168 835 837 B-Observation
- NCT03860168 838 839 I-Observation
not NCT03860168 840 843 I-Observation
- NCT03860168 844 845 I-Observation
resuscitate NCT03860168 846 857 I-Observation
( NCT03860168 858 859 O
DNR NCT03860168 860 863 B-Observation
) NCT03860168 864 865 O
order NCT03860168 866 871 O
will NCT03860168 872 876 O
be NCT03860168 877 879 O
excluded NCT03860168 880 888 B-Negation
. NCT03860168 889 890 O


Inclusion NCT03862443 0 9 O
Criteria NCT03862443 10 18 O
for NCT03862443 19 22 O
Parent NCT03862443 23 29 O
/ NCT03862443 30 31 O
Caregiver NCT03862443 32 41 O
: NCT03862443 42 43 O

- NCT03862443 47 48 O
Provide NCT03862443 50 57 O
signed NCT03862443 58 64 O
and NCT03862443 65 68 O
dated NCT03862443 69 74 O
informed NCT03862443 75 83 O
consent NCT03862443 84 91 O
form NCT03862443 92 96 O
in NCT03862443 97 99 O
English NCT03862443 100 107 O
or NCT03862443 108 110 B-Or
Spanish NCT03862443 111 118 O
. NCT03862443 119 120 O

- NCT03862443 124 125 O
Agree NCT03862443 127 132 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862443 133 135 O
comply NCT03862443 136 142 O
with NCT03862443 143 147 O
all NCT03862443 148 151 O
study NCT03862443 152 157 B-Study
procedures NCT03862443 158 168 O
and NCT03862443 169 172 O
be NCT03862443 173 175 B-Assertion___Assertion_Type_Value:hypothetical
available NCT03862443 176 185 I-Assertion___Assertion_Type_Value:hypothetical
for NCT03862443 186 189 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862443 190 193 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03862443 194 202 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03862443 203 205 O
the NCT03862443 206 209 O
study NCT03862443 210 215 B-Study
visit NCT03862443 216 221 O
. NCT03862443 222 223 O

- NCT03862443 227 228 O
Male NCT03862443 230 234 O
or NCT03862443 235 237 B-Or
female NCT03862443 238 244 O
, NCT03862443 245 246 O
aged NCT03862443 247 251 B-Age
18 NCT03862443 252 254 B-Eq_Comparison
and NCT03862443 255 258 I-Eq_Comparison
older NCT03862443 259 264 I-Eq_Comparison
. NCT03862443 265 266 O

- NCT03862443 270 271 O
Speak NCT03862443 273 278 O
, NCT03862443 279 280 O
read NCT03862443 281 285 O
, NCT03862443 286 287 O
and NCT03862443 288 291 O
write NCT03862443 292 297 O
either NCT03862443 298 304 O
English NCT03862443 305 312 O
or NCT03862443 313 315 B-Or
Spanish NCT03862443 316 323 O
. NCT03862443 324 325 O

- NCT03862443 329 330 O
Be NCT03862443 332 334 O
a NCT03862443 335 336 O
parent NCT03862443 337 343 B-Family_Member___Family_Member_Type:parent
or NCT03862443 344 346 B-Or
caregiver NCT03862443 347 356 B-Family_Member___Family_Member_Type:parent
of NCT03862443 357 359 O
a NCT03862443 360 361 O
child NCT03862443 362 367 B-Family_Member___Family_Member_Type:child
at NCT03862443 368 370 B-Eq_Comparison
least NCT03862443 371 376 I-Eq_Comparison
6 NCT03862443 377 378 I-Eq_Comparison
months NCT03862443 379 385 I-Eq_Comparison
old NCT03862443 386 389 B-Age
but NCT03862443 390 393 B-And
less NCT03862443 394 398 B-Eq_Comparison
than NCT03862443 399 403 I-Eq_Comparison
3.5 NCT03862443 404 407 I-Eq_Comparison
years NCT03862443 408 413 I-Eq_Comparison
( NCT03862443 414 415 O
42 NCT03862443 416 418 B-Eq_Comparison
months NCT03862443 419 425 I-Eq_Comparison
) NCT03862443 426 427 O
, NCT03862443 428 429 O
with NCT03862443 430 434 B-And
at NCT03862443 435 437 B-Eq_Comparison
least NCT03862443 438 443 I-Eq_Comparison
2 NCT03862443 444 445 I-Eq_Comparison
fully NCT03862443 446 451 B-Modifier
erupted NCT03862443 452 459 I-Modifier
teeth NCT03862443 460 465 B-Condition
and NCT03862443 466 469 O
enrolled NCT03862443 470 478 O
in NCT03862443 479 481 O
, NCT03862443 482 483 O
or NCT03862443 484 486 O
waitlisted NCT03862443 487 497 O
for NCT03862443 498 501 O
, NCT03862443 502 503 O
one NCT03862443 504 507 O
of NCT03862443 508 510 O
the NCT03862443 511 514 O
three NCT03862443 515 520 O
participating NCT03862443 521 534 O
Los NCT03862443 535 538 O
Angeles NCT03862443 539 546 O
County NCT03862443 547 553 O
EHS NCT03862443 554 557 O
home NCT03862443 558 562 O
visit NCT03862443 563 568 O
programs NCT03862443 569 577 O
. NCT03862443 578 579 O

- NCT03862443 583 584 O
Not NCT03862443 586 589 B-Negation
be NCT03862443 590 592 O
planning NCT03862443 593 601 B-Assertion___Assertion_Type_Value:intention
to NCT03862443 602 604 I-Assertion___Assertion_Type_Value:intention
move NCT03862443 605 609 B-Observation
residence NCT03862443 610 619 O
for NCT03862443 620 623 O
the NCT03862443 624 627 O
next NCT03862443 628 632 B-Eq_Comparison
6 NCT03862443 633 634 I-Eq_Comparison
months NCT03862443 635 641 I-Eq_Comparison
outside NCT03862443 642 649 B-Negation
the NCT03862443 650 653 O
greater NCT03862443 654 661 O
Los NCT03862443 662 665 O
Angeles NCT03862443 666 673 O
area NCT03862443 674 678 O
. NCT03862443 679 680 O

- NCT03862443 684 685 O
Own NCT03862443 687 690 O
a NCT03862443 691 692 O
smartphone NCT03862443 693 703 O
with NCT03862443 704 708 O
the NCT03862443 709 712 O
Google NCT03862443 713 719 O
Play NCT03862443 720 724 O
or NCT03862443 725 727 O
iTunes NCT03862443 728 734 O
store NCT03862443 735 740 O
and NCT03862443 741 744 O
be NCT03862443 745 747 O
willing NCT03862443 748 755 O
to NCT03862443 756 758 O
download NCT03862443 759 767 O
the NCT03862443 768 771 O
smart NCT03862443 772 777 O
powered NCT03862443 778 785 O
TB NCT03862443 786 788 O
app NCT03862443 789 792 O

- NCT03862443 795 796 O
Be NCT03862443 798 800 O
willing NCT03862443 801 808 O
to NCT03862443 809 811 O
be NCT03862443 812 814 O
contacted NCT03862443 815 824 O
via NCT03862443 825 828 O
text NCT03862443 829 833 O
- NCT03862443 834 835 O
messaging NCT03862443 836 845 O
( NCT03862443 846 847 O
SMS NCT03862443 848 851 O
) NCT03862443 852 853 O
for NCT03862443 854 857 O
study NCT03862443 858 863 B-Study
related NCT03862443 864 871 O
notifications NCT03862443 872 885 O
, NCT03862443 886 887 O
such NCT03862443 888 892 O
as NCT03862443 893 895 O
incentives NCT03862443 896 906 O
earned NCT03862443 907 913 O
or NCT03862443 914 916 O
reminders NCT03862443 917 926 O
to NCT03862443 927 929 O
sync NCT03862443 930 934 O
the NCT03862443 935 938 O
TB NCT03862443 939 941 O

Exclusion NCT03862443 942 951 O
Criteria NCT03862443 952 960 O
: NCT03862443 961 962 O

- NCT03862443 966 967 O
Known NCT03862443 969 974 O
allergic NCT03862443 975 983 B-Allergy
reaction NCT03862443 984 992 O
to NCT03862443 993 995 O
components NCT03862443 996 1006 O
of NCT03862443 1007 1009 O
the NCT03862443 1010 1013 O
study NCT03862443 1014 1019 B-Study
product NCT03862443 1020 1027 B-Drug
( NCT03862443 1028 1029 I-Drug
s NCT03862443 1030 1031 I-Drug
) NCT03862443 1032 1033 I-Drug
. NCT03862443 1034 1035 O

- NCT03862443 1039 1040 O
Uncooperative NCT03862443 1042 1055 B-Condition
or NCT03862443 1056 1058 B-Or
behaviorally NCT03862443 1059 1071 B-Condition
unsuited NCT03862443 1072 1080 I-Condition
( NCT03862443 1081 1082 O
assessed NCT03862443 1083 1091 O
during NCT03862443 1092 1098 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03862443 1099 1100 O
TB NCT03862443 1101 1103 B-Procedure
prophylaxis NCT03862443 1104 1115 I-Procedure
at NCT03862443 1116 1118 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862443 1119 1122 O
initial NCT03862443 1123 1130 B-Eq_Comparison
baseline NCT03862443 1131 1139 B-Study
study NCT03862443 1140 1145 I-Study
visit NCT03862443 1146 1151 O
) NCT03862443 1152 1153 O
. NCT03862443 1154 1155 O

- NCT03862443 1159 1160 O
A NCT03862443 1162 1163 O
sibling NCT03862443 1164 1171 B-Family_Member___Family_Member_Type:sibling
of NCT03862443 1172 1174 O
a NCT03862443 1175 1176 O
child NCT03862443 1177 1182 B-Family_Member___Family_Member_Type:child
already NCT03862443 1183 1190 O
enrolled NCT03862443 1191 1199 O
in NCT03862443 1200 1202 O
the NCT03862443 1203 1206 O
study NCT03862443 1207 1212 B-Study
( NCT03862443 1213 1214 O
the NCT03862443 1215 1218 O
family NCT03862443 1219 1225 O
's NCT03862443 1225 1227 O
oldest NCT03862443 1228 1234 O
child NCT03862443 1235 1240 O
in NCT03862443 1241 1243 O
the NCT03862443 1244 1247 O
eligible NCT03862443 1248 1256 O
age NCT03862443 1257 1260 O
range NCT03862443 1261 1266 O
will NCT03862443 1267 1271 O
be NCT03862443 1272 1274 O
the NCT03862443 1275 1278 O
study NCT03862443 1279 1284 O
child NCT03862443 1285 1290 O
) NCT03862443 1291 1292 O
. NCT03862443 1293 1294 O

- NCT03862443 1298 1299 O
Enrolled NCT03862443 1301 1309 O
in NCT03862443 1310 1312 O
foster NCT03862443 1313 1319 B-Observation
care NCT03862443 1320 1324 I-Observation
. NCT03862443 1325 1326 O

- NCT03862443 1330 1331 O
Anything NCT03862443 1333 1341 B-Condition
else NCT03862443 1342 1346 I-Condition
that NCT03862443 1347 1351 O
would NCT03862443 1352 1357 B-Assertion___Assertion_Type_Value:hypothetical
place NCT03862443 1358 1363 O
him NCT03862443 1364 1367 O
/ NCT03862443 1368 1369 O
her NCT03862443 1370 1373 O
at NCT03862443 1374 1376 O
increased NCT03862443 1377 1386 O
health NCT03862443 1387 1393 O
risk NCT03862443 1394 1398 B-Risk
or NCT03862443 1399 1401 B-Or
preclude NCT03862443 1402 1410 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
the NCT03862443 1411 1414 O
individual NCT03862443 1415 1425 O
's NCT03862443 1425 1427 O
full NCT03862443 1428 1432 O
compliance NCT03862443 1433 1443 O
with NCT03862443 1444 1448 O
or NCT03862443 1449 1451 O
completion NCT03862443 1452 1462 O
of NCT03862443 1463 1465 O
the NCT03862443 1466 1469 O
study NCT03862443 1470 1475 B-Study
. NCT03862443 1476 1477 O

Inclusion NCT03868319 0 9 O
Criteria NCT03868319 10 18 O
: NCT03868319 19 20 O

- NCT03868319 24 25 O
scheduled NCT03868319 27 36 B-Eq_Comparison
for NCT03868319 37 40 O
elective NCT03868319 41 49 B-Modifier
RARC NCT03868319 50 54 B-Procedure

Exclusion NCT03868319 55 64 O
Criteria NCT03868319 65 73 O
: NCT03868319 74 75 O

- NCT03868319 79 80 O
history NCT03868319 82 89 B-Eq_Comparison
of NCT03868319 90 92 O
lung NCT03868319 93 97 B-Modifier
surgery NCT03868319 98 105 B-Procedure

- NCT03868319 108 109 O
patients NCT03868319 111 119 O
' NCT03868319 119 120 O
refusal NCT03868319 121 128 O
or NCT03868319 129 131 O
inability NCT03868319 132 141 O
to NCT03868319 142 144 O
give NCT03868319 145 149 O
informed NCT03868319 150 158 O
consent NCT03868319 159 166 O

Inclusion NCT03861910 0 9 O
Criteria NCT03861910 10 18 O
: NCT03861910 19 20 O

- NCT03861910 24 25 O
age NCT03861910 27 30 B-Age
1 NCT03861910 31 32 B-Eq_Comparison
- NCT03861910 33 34 I-Eq_Comparison
12 NCT03861910 35 37 I-Eq_Comparison
months NCT03861910 38 44 I-Eq_Comparison

- NCT03861910 47 48 O
IgE NCT03861910 50 53 B-Modifier
- NCT03861910 54 55 I-Modifier
mediated NCT03861910 56 64 I-Modifier
CMA NCT03861910 65 68 B-Condition

Exclusion NCT03861910 69 78 O
Criteria NCT03861910 79 87 O
: NCT03861910 88 89 O

- NCT03861910 93 94 O
cow NCT03861910 96 99 B-Drug
's NCT03861910 99 101 I-Drug
milk NCT03861910 102 106 I-Drug
protein NCT03861910 107 114 I-Drug
- NCT03861910 115 116 O
induced NCT03861910 117 124 O
anaphylaxis NCT03861910 125 136 B-Condition
, NCT03861910 137 138 O

- NCT03861910 142 143 O
food NCT03861910 145 149 B-Drug
protein NCT03861910 150 157 I-Drug
induced NCT03861910 158 165 O
enterocolitis NCT03861910 166 179 B-Condition
syndrome NCT03861910 180 188 I-Condition
, NCT03861910 189 190 O

- NCT03861910 194 195 O
other NCT03861910 197 202 B-Other
food NCT03861910 203 207 O
allergies NCT03861910 208 217 B-Allergy
, NCT03861910 218 219 O

- NCT03861910 223 224 O
other NCT03861910 226 231 B-Other
allergic NCT03861910 232 240 B-Condition
diseases NCT03861910 241 249 I-Condition
, NCT03861910 250 251 O

- NCT03861910 255 256 O
non NCT03861910 258 261 B-Negation
- NCT03861910 262 263 O
CMA NCT03861910 264 267 B-Modifier
- NCT03861910 268 269 I-Modifier
related NCT03861910 270 277 I-Modifier
atopic NCT03861910 278 284 B-Condition
eczema NCT03861910 285 291 I-Condition
, NCT03861910 292 293 O

- NCT03861910 297 298 O
eosinophilic NCT03861910 300 312 B-Condition
disorders NCT03861910 313 322 I-Condition
of NCT03861910 323 325 O
the NCT03861910 326 329 O
gastrointestinal NCT03861910 330 346 B-Modifier
tract NCT03861910 347 352 I-Modifier
, NCT03861910 353 354 O

- NCT03861910 358 359 O
chronic NCT03861910 361 368 O
systemic NCT03861910 369 377 B-Modifier
diseases NCT03861910 378 386 B-Condition
, NCT03861910 387 388 O

- NCT03861910 392 393 O
congenital NCT03861910 395 405 B-Modifier
cardiac NCT03861910 406 413 B-Condition
defects NCT03861910 414 421 I-Condition
, NCT03861910 422 423 O

- NCT03861910 427 428 O
active NCT03861910 430 436 B-Eq_Comparison
tuberculosis NCT03861910 437 449 B-Condition
, NCT03861910 450 451 O

- NCT03861910 455 456 O
autoimmune NCT03861910 458 468 B-Condition
diseases NCT03861910 469 477 I-Condition
, NCT03861910 478 479 O

- NCT03861910 483 484 O
immunodeficiency NCT03861910 486 502 B-Condition
, NCT03861910 503 504 O

- NCT03861910 508 509 O
chronic NCT03861910 511 518 O
inflammatory NCT03861910 519 531 B-Condition
bowel NCT03861910 532 537 I-Condition
diseases NCT03861910 538 546 I-Condition
, NCT03861910 547 548 O

- NCT03861910 552 553 O
celiac NCT03861910 555 561 B-Condition
disease NCT03861910 562 569 I-Condition
, NCT03861910 570 571 O

- NCT03861910 575 576 O
cystic NCT03861910 578 584 B-Condition
fibrosis NCT03861910 585 593 I-Condition
, NCT03861910 594 595 O

- NCT03861910 599 600 O
metabolic NCT03861910 602 611 B-Condition
diseases NCT03861910 612 620 I-Condition
, NCT03861910 621 622 O

- NCT03861910 626 627 O
malignancy NCT03861910 629 639 B-Condition
, NCT03861910 640 641 O

- NCT03861910 645 646 O
chronic NCT03861910 648 655 O
pulmonary NCT03861910 656 665 B-Condition
diseases NCT03861910 666 674 I-Condition
, NCT03861910 675 676 O

- NCT03861910 680 681 O
malformations NCT03861910 683 696 B-Condition
of NCT03861910 697 699 O
the NCT03861910 700 703 O
gastrointestinal NCT03861910 704 720 B-Modifier
and NCT03861910 721 724 B-Or
/ NCT03861910 725 726 I-Or
or NCT03861910 727 729 I-Or
respiratory NCT03861910 730 741 B-Modifier
tract NCT03861910 742 747 I-Modifier
, NCT03861910 748 749 O

- NCT03861910 753 754 O
administration NCT03861910 756 770 O
of NCT03861910 771 773 O
prebiotics NCT03861910 774 784 B-Drug
or NCT03861910 785 787 B-Or
probiotics NCT03861910 788 798 B-Drug
during NCT03861910 799 805 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03861910 806 809 O
4 NCT03861910 810 811 B-Eq_Comparison
weeks NCT03861910 812 817 I-Eq_Comparison
before NCT03861910 818 824 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03861910 825 834 B-Study
. NCT03861910 835 836 O

Inclusion NCT03865758 0 9 O
Criteria NCT03865758 10 18 O
: NCT03865758 19 20 O

- NCT03865758 24 25 O
Probable NCT03865758 27 35 B-Assertion___Assertion_Type_Value:possible
dementia NCT03865758 36 44 B-Condition
indicated NCT03865758 45 54 O
by NCT03865758 55 57 O
prior NCT03865758 58 63 B-Eq_Comparison
diagnosis NCT03865758 64 73 O
and NCT03865758 74 77 B-Or
/ NCT03865758 78 79 I-Or
or NCT03865758 80 82 I-Or
a NCT03865758 83 84 O
score NCT03865758 85 90 O
of NCT03865758 91 93 O
23 NCT03865758 94 96 B-Eq_Comparison
or NCT03865758 97 99 I-Eq_Comparison
less NCT03865758 100 104 I-Eq_Comparison
on NCT03865758 105 107 O
the NCT03865758 108 111 O
Brief NCT03865758 112 117 B-Observation
Alzheimer NCT03865758 118 127 I-Observation
Screen NCT03865758 128 134 I-Observation
. NCT03865758 135 136 O

Exclusion NCT03865758 138 147 O
Criteria NCT03865758 148 156 O
: NCT03865758 157 158 O

- NCT03865758 162 163 O
No NCT03865758 165 167 B-Negation
evidence NCT03865758 168 176 O
of NCT03865758 177 179 O
dementia NCT03865758 180 188 B-Condition

Inclusion NCT03924362 0 9 O
Criteria NCT03924362 10 18 O
: NCT03924362 19 20 O

All NCT03924362 22 25 O
subjects NCT03924362 26 34 O
with NCT03924362 35 39 O
a NCT03924362 40 41 O
clinical NCT03924362 42 50 O
diagnosis NCT03924362 51 60 O
of NCT03924362 61 63 O
struvite NCT03924362 64 72 B-Condition
calculi NCT03924362 73 80 I-Condition
will NCT03924362 81 85 O
potentially NCT03924362 86 97 O
be NCT03924362 98 100 O
included NCT03924362 101 109 O
. NCT03924362 110 111 O

Specific NCT03924362 113 121 O
inclusion NCT03924362 122 131 O
criteria NCT03924362 132 140 O
include NCT03924362 141 148 O
the NCT03924362 149 152 O
following NCT03924362 153 162 O
: NCT03924362 163 164 O

1 NCT03924362 168 169 O
. NCT03924362 169 170 O
Age NCT03924362 172 175 B-Age
> NCT03924362 176 177 B-Eq_Comparison
18 NCT03924362 178 180 I-Eq_Comparison
years NCT03924362 181 186 I-Eq_Comparison

2 NCT03924362 189 190 O
. NCT03924362 190 191 O
Any NCT03924362 193 196 O
patient NCT03924362 197 204 O
with NCT03924362 205 209 O
bilateral NCT03924362 210 219 B-Condition
stone NCT03924362 220 225 I-Condition
burden NCT03924362 226 232 I-Condition
eligible NCT03924362 233 241 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03924362 242 245 B-And
appropriate NCT03924362 246 257 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03924362 258 261 O
PCNL NCT03924362 262 266 B-Procedure
procedure NCT03924362 267 276 I-Procedure

3 NCT03924362 279 280 O
. NCT03924362 280 281 O
Medically NCT03924362 283 292 O
fit NCT03924362 293 296 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03924362 297 300 I-Assertion___Assertion_Type_Value:hypothetical
definitive NCT03924362 301 311 O
surgical NCT03924362 312 320 B-Procedure
management NCT03924362 321 331 I-Procedure
of NCT03924362 332 334 O
stone NCT03924362 335 340 B-Condition
. NCT03924362 341 342 O

Exclusion NCT03924362 344 353 O
Criteria NCT03924362 354 362 O
: NCT03924362 363 364 O

Patients NCT03924362 366 374 O
with NCT03924362 375 379 O
any NCT03924362 380 383 O
of NCT03924362 384 386 O
the NCT03924362 387 390 O
following NCT03924362 391 400 O
characteristics NCT03924362 401 416 O
will NCT03924362 417 421 O
not NCT03924362 422 425 B-Negation
be NCT03924362 426 428 O
eligible NCT03924362 429 437 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03924362 438 441 O
the NCT03924362 442 445 O
present NCT03924362 446 453 O

study NCT03924362 454 459 B-Study
: NCT03924362 460 461 O

1 NCT03924362 465 466 O
. NCT03924362 466 467 O
Those NCT03924362 469 474 O
with NCT03924362 475 479 O
medical NCT03924362 480 487 B-Condition
comorbidities NCT03924362 488 501 I-Condition
preventing NCT03924362 502 512 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
them NCT03924362 513 517 O
from NCT03924362 518 522 O
safely NCT03924362 523 529 O
undergoing NCT03924362 530 540 O
definitive NCT03924362 541 551 O
surgical NCT03924362 552 560 B-Procedure
therapy NCT03924362 561 568 I-Procedure
. NCT03924362 569 570 O

2 NCT03924362 574 575 O
. NCT03924362 575 576 O
Patients NCT03924362 578 586 O
who NCT03924362 587 590 O
are NCT03924362 591 594 O
unable NCT03924362 595 601 O
to NCT03924362 602 604 O
provide NCT03924362 605 612 O
informed NCT03924362 613 621 O
consent NCT03924362 622 629 O
. NCT03924362 630 631 O

3 NCT03924362 635 636 O
. NCT03924362 636 637 O
Patients NCT03924362 639 647 O
who NCT03924362 648 651 O
are NCT03924362 652 655 O
planned NCT03924362 656 663 B-Eq_Comparison
for NCT03924362 664 667 O
alternative NCT03924362 668 679 B-Other
procedures NCT03924362 680 690 B-Procedure
( NCT03924362 691 692 O
ureteroscopy NCT03924362 693 705 B-Procedure
, NCT03924362 706 707 O
extracorporeal NCT03924362 708 722 B-Procedure
shock NCT03924362 723 728 I-Procedure
wave NCT03924362 729 733 I-Procedure
lithotripsy NCT03924362 734 745 I-Procedure
) NCT03924362 746 747 O

4 NCT03924362 751 752 O
. NCT03924362 752 753 O
Anyone NCT03924362 755 761 O
who NCT03924362 762 765 O
is NCT03924362 766 768 O
unable NCT03924362 769 775 O
to NCT03924362 776 778 O
give NCT03924362 779 783 O
their NCT03924362 784 789 O
informed NCT03924362 790 798 O
consent NCT03924362 799 806 O

5 NCT03924362 809 810 O
. NCT03924362 810 811 O
Anyone NCT03924362 813 819 O
under NCT03924362 820 825 B-Eq_Comparison
the NCT03924362 826 829 I-Eq_Comparison
age NCT03924362 830 833 I-Eq_Comparison
of NCT03924362 834 836 I-Eq_Comparison
19 NCT03924362 837 839 I-Eq_Comparison

6 NCT03924362 843 844 O
. NCT03924362 844 845 O
Anyone NCT03924362 847 853 O
who NCT03924362 854 857 O
, NCT03924362 858 859 O
in NCT03924362 860 862 O
the NCT03924362 863 866 O
opinion NCT03924362 867 874 O
of NCT03924362 875 877 O
the NCT03924362 878 881 O
PI NCT03924362 882 884 O
, NCT03924362 885 886 O
is NCT03924362 887 889 O
unfit NCT03924362 890 895 O
or NCT03924362 896 898 O
unsuitable NCT03924362 899 909 O
to NCT03924362 910 912 O
participate NCT03924362 913 924 O
in NCT03924362 925 927 O
the NCT03924362 928 931 O
study NCT03924362 932 937 B-Study

Inclusion NCT03868384 0 9 O
Criteria NCT03868384 10 18 O
: NCT03868384 19 20 O

- NCT03868384 24 25 O
Patients NCT03868384 27 35 O
with NCT03868384 36 40 O
hypertension NCT03868384 41 53 B-Condition
and NCT03868384 54 57 B-And
taking NCT03868384 58 64 B-Eq_Comparison
antihypertensive NCT03868384 65 81 B-Drug
drugs NCT03868384 82 87 I-Drug
more NCT03868384 88 92 B-Eq_Comparison
than NCT03868384 93 97 I-Eq_Comparison
1 NCT03868384 98 99 I-Eq_Comparison
year NCT03868384 100 104 I-Eq_Comparison

Exclusion NCT03868384 105 114 O
Criteria NCT03868384 115 123 O
: NCT03868384 124 125 O

- NCT03868384 129 130 O
Secondary NCT03868384 132 141 B-Modifier
hypertension NCT03868384 142 154 B-Condition

- NCT03868384 157 158 O
Hypertensive NCT03868384 160 172 B-Condition
emergency NCT03868384 173 182 B-Encounter
and NCT03868384 183 186 B-Or
urgency NCT03868384 187 194 B-Encounter

- NCT03868384 197 198 O
Severe NCT03868384 200 206 O
heart NCT03868384 207 212 B-Condition
failure NCT03868384 213 220 I-Condition
( NCT03868384 221 222 O
NYHA NCT03868384 223 227 B-Observation
III NCT03868384 228 231 B-Eq_Comparison
and NCT03868384 232 235 I-Eq_Comparison
IV NCT03868384 236 238 I-Eq_Comparison
) NCT03868384 239 240 O

- NCT03868384 244 245 O
Angina NCT03868384 247 253 B-Condition
with NCT03868384 254 258 O
6 NCT03868384 259 260 B-Eq_Comparison
months NCT03868384 261 267 I-Eq_Comparison

- NCT03868384 270 271 O
Myocardial NCT03868384 273 283 B-Condition
infarction NCT03868384 284 294 I-Condition
within NCT03868384 295 301 B-Eq_Comparison
6 NCT03868384 302 303 I-Eq_Comparison
months NCT03868384 304 310 I-Eq_Comparison

- NCT03868384 313 314 O
Peripheral NCT03868384 316 326 B-Condition
artery NCT03868384 327 333 I-Condition
disease NCT03868384 334 341 I-Condition
within NCT03868384 342 348 B-Eq_Comparison
6 NCT03868384 349 350 I-Eq_Comparison
months NCT03868384 351 357 I-Eq_Comparison

- NCT03868384 360 361 O
Significant NCT03868384 363 374 O
arrhythmia NCT03868384 375 385 B-Condition
( NCT03868384 386 387 O
i NCT03868384 388 389 O
. NCT03868384 390 391 O
e NCT03868384 392 393 O
. NCT03868384 394 395 O
ventricular NCT03868384 397 408 B-Condition
tachycardia NCT03868384 409 420 I-Condition
and NCT03868384 421 424 B-Or
fibrillation NCT03868384 425 437 B-Condition
, NCT03868384 438 439 O
atrial NCT03868384 440 446 B-Condition
fibrillation NCT03868384 447 459 I-Condition
, NCT03868384 460 461 O
atrial NCT03868384 462 468 B-Condition
flutter NCT03868384 469 476 I-Condition
) NCT03868384 477 478 O

- NCT03868384 482 483 O
Pregnancy NCT03868384 485 494 B-Condition

- NCT03868384 497 498 O
Night NCT03868384 500 505 B-Observation
labor NCT03868384 506 511 I-Observation
, NCT03868384 512 513 O
shift NCT03868384 514 519 B-Observation
worker NCT03868384 520 526 I-Observation

- NCT03868384 529 530 O
Those NCT03868384 532 537 O
who NCT03868384 538 541 O
are NCT03868384 542 545 O
currently NCT03868384 546 555 B-Eq_Comparison
participating NCT03868384 556 569 O
in NCT03868384 570 572 O
other NCT03868384 573 578 B-Other
clinical NCT03868384 579 587 O
studies NCT03868384 588 595 B-Study

- NCT03868384 598 599 O
Those NCT03868384 601 606 O
who NCT03868384 607 610 O
have NCT03868384 611 615 O
taken NCT03868384 616 621 B-Eq_Comparison
other NCT03868384 622 627 B-Other
clinical NCT03868384 628 636 B-Study
trial NCT03868384 637 642 I-Study
drugs NCT03868384 643 648 B-Drug
within NCT03868384 649 655 B-Eq_Comparison
the NCT03868384 656 659 I-Eq_Comparison
past NCT03868384 660 664 I-Eq_Comparison
month NCT03868384 665 670 I-Eq_Comparison

- NCT03868384 673 674 O
According NCT03868384 676 685 O
to NCT03868384 686 688 O
the NCT03868384 689 692 O
opinion NCT03868384 693 700 O
of NCT03868384 701 703 O
the NCT03868384 704 707 O
researcher NCT03868384 708 718 O
, NCT03868384 719 720 O
those NCT03868384 721 726 O
who NCT03868384 727 730 O
have NCT03868384 731 735 O
or NCT03868384 736 738 O
may NCT03868384 739 742 B-Assertion___Assertion_Type_Value:possible
have NCT03868384 743 747 I-Assertion___Assertion_Type_Value:possible
a NCT03868384 748 749 O
disease NCT03868384 750 757 B-Condition
that NCT03868384 758 762 O
may NCT03868384 763 766 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03868384 767 776 O
with NCT03868384 777 781 O
the NCT03868384 782 785 O
completion NCT03868384 786 796 O
of NCT03868384 797 799 O
the NCT03868384 800 803 O
study NCT03868384 804 809 B-Study

- NCT03868384 812 813 O
History NCT03868384 815 822 B-Eq_Comparison
of NCT03868384 823 825 O
drug NCT03868384 826 830 B-Modifier
or NCT03868384 831 833 B-Or
alcohol NCT03868384 834 841 B-Modifier
dependence NCT03868384 842 852 B-Condition
within NCT03868384 853 859 B-Eq_Comparison
6 NCT03868384 860 861 I-Eq_Comparison
months NCT03868384 862 868 I-Eq_Comparison

Inclusion NCT03920332 0 9 O
Criteria NCT03920332 10 18 O
: NCT03920332 19 20 O

- NCT03920332 24 25 O
Inherited NCT03920332 27 36 B-Condition
fibrinogen NCT03920332 37 47 I-Condition
disorders NCT03920332 48 57 I-Condition
( NCT03920332 58 59 O
hypofibrinogenemia NCT03920332 60 78 B-Condition
, NCT03920332 79 80 O
dysfibrinogenemia NCT03920332 81 98 B-Condition
, NCT03920332 99 100 O
hypodysfibrinogenemia NCT03920332 101 122 B-Condition
) NCT03920332 123 124 O

- NCT03920332 128 129 O
At NCT03920332 131 133 B-Eq_Comparison
lest NCT03920332 134 138 I-Eq_Comparison
one NCT03920332 139 142 I-Eq_Comparison
past NCT03920332 143 147 I-Eq_Comparison
pregnancy NCT03920332 148 157 B-Condition

- NCT03920332 160 161 O
Adult NCT03920332 163 168 O

Exclusion NCT03920332 169 178 O
Criteria NCT03920332 179 187 O
: NCT03920332 188 189 O

- NCT03920332 193 194 O
No NCT03920332 196 198 B-Negation
past NCT03920332 199 203 B-Eq_Comparison
pregnancy NCT03920332 204 213 B-Condition

- NCT03920332 216 217 O
Not NCT03920332 219 222 B-Negation
confirmed NCT03920332 223 232 O
fibrinogen NCT03920332 233 243 B-Condition
disorder NCT03920332 244 252 I-Condition

Inclusion NCT03866213 0 9 O
Criteria NCT03866213 10 18 O
: NCT03866213 19 20 O

- NCT03866213 24 25 O
The NCT03866213 27 30 O
patient NCT03866213 31 38 O
is NCT03866213 39 41 O
currently NCT03866213 42 51 B-Eq_Comparison
being NCT03866213 52 57 O
treated NCT03866213 58 65 B-Procedure
at NCT03866213 66 68 O
Queen NCT03866213 69 74 O
Elizabeth NCT03866213 75 84 O
Central NCT03866213 85 92 O
Hospital NCT03866213 93 101 O
or NCT03866213 102 104 B-Or
Kamuzu NCT03866213 105 111 O
Central NCT03866213 112 119 O
Hospital NCT03866213 120 128 O
in NCT03866213 129 131 O
the NCT03866213 132 135 O
neonatal NCT03866213 136 144 O
ward NCT03866213 145 149 O
. NCT03866213 150 151 O

- NCT03866213 155 156 O
The NCT03866213 158 161 O
patient NCT03866213 162 169 O
is NCT03866213 170 172 O
less NCT03866213 173 177 B-Eq_Comparison
than NCT03866213 178 182 I-Eq_Comparison
28 NCT03866213 183 185 I-Eq_Comparison
days NCT03866213 186 190 I-Eq_Comparison
old NCT03866213 191 194 B-Age
( NCT03866213 195 196 O
neonate NCT03866213 197 204 O
) NCT03866213 205 206 O
. NCT03866213 207 208 O

- NCT03866213 212 213 O
The NCT03866213 215 218 O
patient NCT03866213 219 226 O
is NCT03866213 227 229 O
deemed NCT03866213 230 236 O
to NCT03866213 237 239 O
be NCT03866213 240 242 O
at NCT03866213 243 245 O
risk NCT03866213 246 250 B-Risk
for NCT03866213 251 254 O
jaundice NCT03866213 255 263 B-Condition
or NCT03866213 264 266 B-Or
the NCT03866213 267 270 O
patient NCT03866213 271 278 O
is NCT03866213 279 281 O
undergoing NCT03866213 282 292 B-Eq_Comparison
blue NCT03866213 293 297 B-Modifier
light NCT03866213 298 303 I-Modifier
phototherapy NCT03866213 304 316 B-Procedure
for NCT03866213 317 320 O
treatment NCT03866213 321 330 B-Procedure
of NCT03866213 331 333 O
jaundice NCT03866213 334 342 B-Condition
. NCT03866213 343 344 O

- NCT03866213 348 349 O
The NCT03866213 351 354 O
patient NCT03866213 355 362 O
's NCT03866213 362 364 O
parent NCT03866213 365 371 B-Family_Member___Family_Member_Type:parent
or NCT03866213 372 374 O
guardian NCT03866213 375 383 O
has NCT03866213 384 387 O
provided NCT03866213 388 396 O
informed NCT03866213 397 405 O
consent NCT03866213 406 413 O
for NCT03866213 414 417 O
their NCT03866213 418 423 O
child NCT03866213 424 429 B-Family_Member___Family_Member_Type:child
to NCT03866213 430 432 O
participate NCT03866213 433 444 O
. NCT03866213 445 446 O

Exclusion NCT03866213 448 457 O
Criteria NCT03866213 458 466 O
: NCT03866213 467 468 O

- NCT03866213 472 473 O
Parent NCT03866213 475 481 O
or NCT03866213 482 484 O
guardian NCT03866213 485 493 O
is NCT03866213 494 496 O
unable NCT03866213 497 503 O
or NCT03866213 504 506 O
unwilling NCT03866213 507 516 O
to NCT03866213 517 519 O
provide NCT03866213 520 527 O
informed NCT03866213 528 536 O
consent NCT03866213 537 544 O
. NCT03866213 545 546 O

- NCT03866213 550 551 O
The NCT03866213 553 556 O
patient NCT03866213 557 564 O
is NCT03866213 565 567 O
unable NCT03866213 568 574 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03866213 575 577 O
receive NCT03866213 578 585 O
a NCT03866213 586 587 O
blood NCT03866213 588 593 B-Observation
draw NCT03866213 594 598 I-Observation
/ NCT03866213 599 600 B-Or
heel NCT03866213 601 605 B-Observation
stick NCT03866213 606 611 I-Observation
as NCT03866213 612 614 O
determined NCT03866213 615 625 O
by NCT03866213 626 628 O
their NCT03866213 629 634 O
clinician NCT03866213 635 644 O
. NCT03866213 645 646 O

Inclusion NCT03862612 0 9 O
Criteria NCT03862612 10 18 O
: NCT03862612 19 20 O

- NCT03862612 24 25 O
Male NCT03862612 27 31 O
and NCT03862612 32 35 B-Or
Female NCT03862612 36 42 O
participants NCT03862612 43 55 O
providing NCT03862612 56 65 O
written NCT03862612 66 73 O
informed NCT03862612 74 82 O
consent NCT03862612 83 90 O
, NCT03862612 91 92 O

- NCT03862612 96 97 O
ASA NCT03862612 99 102 B-Observation
grade NCT03862612 103 108 B-Eq_Comparison
1 NCT03862612 109 110 I-Eq_Comparison
- NCT03862612 111 112 I-Eq_Comparison
4 NCT03862612 113 114 I-Eq_Comparison
, NCT03862612 115 116 O

- NCT03862612 120 121 O
aged NCT03862612 123 127 B-Age
over NCT03862612 128 132 B-Eq_Comparison
18 NCT03862612 133 135 I-Eq_Comparison

- NCT03862612 139 140 O
undergoing NCT03862612 142 152 B-Eq_Comparison
a NCT03862612 153 154 O
VATS NCT03862612 155 159 B-Procedure
procedure NCT03862612 160 169 I-Procedure
under NCT03862612 170 175 O
General NCT03862612 176 183 B-Procedure
Anaesthesia NCT03862612 184 195 I-Procedure

Exclusion NCT03862612 196 205 O
Criteria NCT03862612 206 214 O
: NCT03862612 215 216 O

- NCT03862612 220 221 O
Absence NCT03862612 223 230 O
of NCT03862612 231 233 O
informed NCT03862612 234 242 O
written NCT03862612 243 250 O
consent NCT03862612 251 258 O
, NCT03862612 259 260 O

- NCT03862612 264 265 O
pre NCT03862612 267 270 B-Eq_Comparison
existing NCT03862612 271 279 I-Eq_Comparison
infection NCT03862612 280 289 B-Condition
at NCT03862612 290 292 O
block NCT03862612 293 298 B-Modifier
site NCT03862612 299 303 I-Modifier
, NCT03862612 304 305 O
- NCT03862612 306 307 O

- NCT03862612 311 312 O
severe NCT03862612 314 320 O
coagulopathy NCT03862612 321 333 B-Condition
, NCT03862612 334 335 O

- NCT03862612 339 340 O
allergy NCT03862612 342 349 B-Allergy
to NCT03862612 350 352 O
local NCT03862612 353 358 B-Procedure
anaesthesia NCT03862612 359 370 I-Procedure
, NCT03862612 371 372 O

- NCT03862612 376 377 O
pre NCT03862612 379 382 B-Eq_Comparison
existing NCT03862612 383 391 I-Eq_Comparison
neurological NCT03862612 392 404 B-Condition
deficit NCT03862612 405 412 I-Condition
, NCT03862612 413 414 O

- NCT03862612 418 419 O
previous NCT03862612 421 429 B-Eq_Comparison
history NCT03862612 430 437 I-Eq_Comparison
of NCT03862612 438 440 O
opiate NCT03862612 441 447 B-Condition
abuse NCT03862612 448 453 I-Condition
, NCT03862612 454 455 O

- NCT03862612 459 460 O
pre NCT03862612 462 465 B-Eq_Comparison
existing NCT03862612 466 474 I-Eq_Comparison
chronic NCT03862612 475 482 O
pain NCT03862612 483 487 B-Condition
condition NCT03862612 488 497 I-Condition
, NCT03862612 498 499 O

- NCT03862612 503 504 O
pre NCT03862612 506 509 B-Eq_Comparison
- NCT03862612 510 511 I-Eq_Comparison
existing NCT03862612 512 520 I-Eq_Comparison
dementia NCT03862612 521 529 B-Condition
[ NCT03862612 530 531 O
because NCT03862612 532 539 O
of NCT03862612 540 542 O
need NCT03862612 543 547 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862612 548 550 I-Assertion___Assertion_Type_Value:hypothetical
co NCT03862612 551 553 O
- NCT03862612 554 555 O
operate NCT03862612 556 563 O
in NCT03862612 564 566 O
completing NCT03862612 567 577 O
QoR NCT03862612 578 581 B-Observation
- NCT03862612 582 583 I-Observation
15 NCT03862612 584 586 I-Observation
score NCT03862612 587 592 I-Observation
day NCT03862612 593 596 B-Eq_Comparison
after NCT03862612 597 602 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03862612 603 610 B-Procedure
] NCT03862612 611 612 O
. NCT03862612 613 614 O

Inclusion NCT03923686 0 9 O
Criteria NCT03923686 10 18 O
: NCT03923686 19 20 O

- NCT03923686 24 25 O
walled NCT03923686 27 33 B-Condition
- NCT03923686 34 35 I-Condition
off NCT03923686 36 39 I-Condition
pancreatic NCT03923686 40 50 I-Condition
necrosis NCT03923686 51 59 I-Condition
( NCT03923686 60 61 O
WON NCT03923686 62 65 B-Condition
) NCT03923686 66 67 O
indicated NCT03923686 68 77 B-Indication
for NCT03923686 78 81 O
endoscopical NCT03923686 82 94 B-Procedure
drainage NCT03923686 95 103 I-Procedure

- NCT03923686 106 107 O
signed NCT03923686 109 115 O
informed NCT03923686 116 124 O
consent NCT03923686 125 132 O
form NCT03923686 133 137 O

Exclusion NCT03923686 138 147 O
Criteria NCT03923686 148 156 O
: NCT03923686 157 158 O

- NCT03923686 162 163 O
patient NCT03923686 165 172 O
disagreement NCT03923686 173 185 O
with NCT03923686 186 190 O
the NCT03923686 191 194 O
study NCT03923686 195 200 O

- NCT03923686 203 204 O
types NCT03923686 206 211 O
of NCT03923686 212 214 O
collections NCT03923686 215 226 B-Condition
other NCT03923686 227 232 B-Exception
than NCT03923686 233 237 I-Exception
WON NCT03923686 238 241 B-Condition

- NCT03923686 244 245 O
drainage NCT03923686 247 255 B-Procedure
with NCT03923686 256 260 O
stents NCT03923686 261 267 B-Procedure
other NCT03923686 268 273 B-Exception
than NCT03923686 274 278 I-Exception
LAMS NCT03923686 279 283 B-Procedure

- NCT03923686 286 287 O
previous NCT03923686 289 297 B-Eq_Comparison
attempts NCT03923686 298 306 O
at NCT03923686 307 309 O
drainage NCT03923686 310 318 B-Procedure
of NCT03923686 319 321 O
WON NCT03923686 322 325 B-Condition

- NCT03923686 328 329 O
severe NCT03923686 331 337 O
coagulopathy NCT03923686 338 350 B-Condition
or NCT03923686 351 353 B-Or
thrombocytopenia NCT03923686 354 370 B-Condition

Inclusion NCT03925441 0 9 O
Criteria NCT03925441 10 18 O
: NCT03925441 19 20 O

- NCT03925441 24 25 O
Children NCT03925441 27 35 O
and NCT03925441 36 39 B-Or
adolescents NCT03925441 40 51 O
who NCT03925441 52 55 B-And
are NCT03925441 56 59 O
diagnosed NCT03925441 60 69 O
with NCT03925441 70 74 O
pediatric NCT03925441 75 84 B-Modifier
chronic NCT03925441 85 92 I-Modifier
severe NCT03925441 93 99 O
plaque NCT03925441 100 106 B-Condition
psoriasis NCT03925441 107 116 I-Condition
. NCT03925441 117 118 O

- NCT03925441 122 123 O
Prior NCT03925441 125 130 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03925441 131 133 O
participating NCT03925441 134 147 O
in NCT03925441 148 150 O
the NCT03925441 151 154 O
study NCT03925441 155 160 B-Study
, NCT03925441 161 162 O
adalimumab NCT03925441 163 173 B-Drug
treatment NCT03925441 174 183 B-Procedure
was NCT03925441 184 187 O
determined NCT03925441 188 198 O
according NCT03925441 199 208 O
to NCT03925441 209 211 O
clinical NCT03925441 212 220 O
judgement NCT03925441 221 230 O
of NCT03925441 231 233 O
the NCT03925441 234 237 O
physician NCT03925441 238 247 O
. NCT03925441 248 249 O

- NCT03925441 253 254 O
Participants NCT03925441 256 268 O
( NCT03925441 269 270 O
or NCT03925441 271 273 O
legal NCT03925441 274 279 O
representative NCT03925441 280 294 O
) NCT03925441 295 296 O
who NCT03925441 297 300 O
voluntarily NCT03925441 301 312 O
agreed NCT03925441 313 319 O
to NCT03925441 320 322 O
participate NCT03925441 323 334 O
in NCT03925441 335 337 O
this NCT03925441 338 342 O
study NCT03925441 343 348 O
and NCT03925441 349 352 O
signed NCT03925441 353 359 O
informed NCT03925441 360 368 O
consent NCT03925441 369 376 O
. NCT03925441 377 378 O

Exclusion NCT03925441 380 389 O
Criteria NCT03925441 390 398 O
: NCT03925441 399 400 O

- NCT03925441 404 405 O
Participants NCT03925441 407 419 O
with NCT03925441 420 424 O
contraindication NCT03925441 425 441 B-Contraindication
to NCT03925441 442 444 O
adalimumab NCT03925441 445 455 B-Drug
as NCT03925441 456 458 O
listed NCT03925441 459 465 O
in NCT03925441 466 468 O
the NCT03925441 469 472 O
approved NCT03925441 473 481 O
Korean NCT03925441 482 488 O
label NCT03925441 489 494 O
. NCT03925441 495 496 O

- NCT03925441 500 501 O
Participants NCT03925441 503 515 O
with NCT03925441 516 520 O
prior NCT03925441 521 526 B-Eq_Comparison
treatment NCT03925441 527 536 B-Procedure
with NCT03925441 537 541 O
adalimumab NCT03925441 542 552 B-Drug
. NCT03925441 553 554 O

Inclusion NCT03867266 0 9 O
criteria NCT03867266 10 18 O
: NCT03867266 19 20 O

- NCT03867266 24 25 O
paroxysmal NCT03867266 27 37 B-Modifier
, NCT03867266 38 39 O
persistent NCT03867266 40 50 B-Modifier
and NCT03867266 51 54 B-Or
/ NCT03867266 55 56 I-Or
or NCT03867266 57 59 I-Or
long NCT03867266 60 64 B-Modifier
standing NCT03867266 65 73 I-Modifier
atrial NCT03867266 74 80 B-Condition
flutter NCT03867266 81 88 I-Condition
even NCT03867266 89 93 O
in NCT03867266 94 96 O
the NCT03867266 97 100 O
presence NCT03867266 101 109 O
of NCT03867266 110 112 O
structural NCT03867266 113 123 B-Modifier
heart NCT03867266 124 129 B-Condition
disease NCT03867266 130 137 I-Condition

- NCT03867266 140 141 O
Informed NCT03867266 143 151 O
consent NCT03867266 152 159 O
form NCT03867266 160 164 O

- NCT03867266 167 168 O
Age NCT03867266 170 173 B-Age
equal NCT03867266 174 179 B-Eq_Comparison
or NCT03867266 180 182 I-Eq_Comparison
above NCT03867266 183 188 I-Eq_Comparison
18 NCT03867266 189 191 I-Eq_Comparison
years NCT03867266 192 197 I-Eq_Comparison

- NCT03867266 200 201 O
Skilled NCT03867266 203 210 O
and NCT03867266 211 214 O
willing NCT03867266 215 222 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867266 223 225 I-Assertion___Assertion_Type_Value:hypothetical
comply NCT03867266 226 232 O
with NCT03867266 233 237 O
all NCT03867266 238 241 O
tests NCT03867266 242 247 B-Procedure
and NCT03867266 248 251 B-And
follow NCT03867266 252 258 B-Encounter
up NCT03867266 259 261 I-Encounter
requirements NCT03867266 262 274 O

- NCT03867266 277 278 O
Patients NCT03867266 280 288 O
that NCT03867266 289 293 O
, NCT03867266 294 295 O
in NCT03867266 296 298 O
the NCT03867266 299 302 O
context NCT03867266 303 310 O
of NCT03867266 311 313 O
ablation NCT03867266 314 322 B-Procedure
for NCT03867266 323 326 O
fibrillation NCT03867266 327 339 B-Condition
atrial NCT03867266 340 346 I-Condition
, NCT03867266 347 348 O
should NCT03867266 349 355 B-Assertion___Assertion_Type_Value:hypothetical
also NCT03867266 356 360 O
undergo NCT03867266 361 368 O
to NCT03867266 369 371 O
typical NCT03867266 372 379 B-Modifier
flutter NCT03867266 380 387 B-Procedure
ablation NCT03867266 388 396 I-Procedure
: NCT03867266 397 398 O
in NCT03867266 399 401 O
this NCT03867266 402 406 O
case NCT03867266 407 411 O
the NCT03867266 412 415 O
data NCT03867266 416 420 O
collected NCT03867266 421 430 O
will NCT03867266 431 435 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03867266 436 438 I-Assertion___Assertion_Type_Value:hypothetical
those NCT03867266 439 444 O
related NCT03867266 445 452 O
to NCT03867266 453 455 O
typical NCT03867266 456 463 O
flutter NCT03867266 464 471 B-Procedure
ablation NCT03867266 472 480 I-Procedure
. NCT03867266 481 482 O

Exclusion NCT03867266 484 493 O
Criteria NCT03867266 494 502 O
: NCT03867266 503 504 O

- NCT03867266 508 509 O
Previous NCT03867266 511 519 B-Eq_Comparison
ablation NCT03867266 520 528 B-Procedure
for NCT03867266 529 532 O
atrial NCT03867266 533 539 B-Condition
flutter NCT03867266 540 547 I-Condition

- NCT03867266 550 551 O
Atrial NCT03867266 553 559 B-Condition
flutter NCT03867266 560 567 I-Condition
secondary NCT03867266 568 577 B-Modifier
to NCT03867266 578 580 O
electrolyte NCT03867266 581 592 B-Condition
imbalance NCT03867266 593 602 I-Condition
, NCT03867266 603 604 O
thyroid NCT03867266 605 612 B-Condition
disease NCT03867266 613 620 I-Condition
or NCT03867266 621 623 B-Or
to NCT03867266 624 626 O
a NCT03867266 627 628 O
reversible NCT03867266 629 639 B-Modifier
or NCT03867266 640 642 B-Or
non NCT03867266 643 646 B-Negation
- NCT03867266 647 648 O
cardiac NCT03867266 649 656 B-Modifier
cause NCT03867266 657 662 B-Condition

- NCT03867266 665 666 O
severe NCT03867266 668 674 O
anemia NCT03867266 675 681 B-Condition
, NCT03867266 682 683 O

- NCT03867266 687 688 O
sepsis NCT03867266 690 696 B-Condition
in NCT03867266 697 699 B-Eq_Comparison
progress NCT03867266 700 708 I-Eq_Comparison

- NCT03867266 711 712 O
Bypass NCT03867266 714 720 B-Procedure
procedure NCT03867266 721 730 I-Procedure
with NCT03867266 731 735 O
coronary NCT03867266 736 744 B-Modifier
arterial NCT03867266 745 753 I-Modifier
artery NCT03867266 754 760 I-Modifier
in NCT03867266 761 763 O
the NCT03867266 764 767 O
last NCT03867266 768 772 B-Eq_Comparison
three NCT03867266 773 778 I-Eq_Comparison
months NCT03867266 779 785 I-Eq_Comparison

- NCT03867266 788 789 O
Pending NCT03867266 791 798 B-Eq_Comparison
cardiac NCT03867266 799 806 B-Procedure
transplantation NCT03867266 807 822 I-Procedure
or NCT03867266 823 825 B-Or
other NCT03867266 826 831 B-Other
cardiac NCT03867266 832 839 B-Procedure
surgery NCT03867266 840 847 I-Procedure

- NCT03867266 850 851 O
Pregnant NCT03867266 853 861 B-Condition
or NCT03867266 862 864 B-Or
breastfeeding NCT03867266 865 878 B-Condition
women NCT03867266 879 884 O

- NCT03867266 887 888 O
Acute NCT03867266 890 895 O
disease NCT03867266 896 903 B-Condition
or NCT03867266 904 906 B-Or
active NCT03867266 907 913 B-Eq_Comparison
systemic NCT03867266 914 922 B-Modifier
infection NCT03867266 923 932 B-Condition
or NCT03867266 933 935 B-Or
sepsis NCT03867266 936 942 B-Condition

- NCT03867266 945 946 O
Documented NCT03867266 948 958 O
left NCT03867266 959 963 B-Modifier
atrial NCT03867266 964 970 B-Condition
thrombus NCT03867266 971 979 I-Condition

- NCT03867266 982 983 O
Unstable NCT03867266 985 993 O
angina NCT03867266 994 1000 B-Condition

- NCT03867266 1003 1004 O
Uncontrolled NCT03867266 1006 1018 B-Modifier
heart NCT03867266 1019 1024 B-Condition
failure NCT03867266 1025 1032 I-Condition

- NCT03867266 1035 1036 O
Life NCT03867266 1038 1042 B-Observation
expectancy NCT03867266 1043 1053 I-Observation
of NCT03867266 1054 1056 O
less NCT03867266 1057 1061 B-Eq_Comparison
than NCT03867266 1062 1066 I-Eq_Comparison
12 NCT03867266 1067 1069 I-Eq_Comparison
months NCT03867266 1070 1076 I-Eq_Comparison

- NCT03867266 1079 1080 O
Registration NCT03867266 1082 1094 O
in NCT03867266 1095 1097 O
any NCT03867266 1098 1101 O
other NCT03867266 1102 1107 B-Other
study NCT03867266 1108 1113 B-Study
evaluating NCT03867266 1114 1124 O
another NCT03867266 1125 1132 B-Other
device NCT03867266 1133 1139 B-Procedure
or NCT03867266 1140 1142 B-Or
medication NCT03867266 1143 1153 B-Drug

- NCT03867266 1156 1157 O
Presence NCT03867266 1159 1167 O
of NCT03867266 1168 1170 O
intramural NCT03867266 1171 1181 B-Condition
thrombi NCT03867266 1182 1189 I-Condition
, NCT03867266 1190 1191 O
tumor NCT03867266 1192 1197 B-Condition
or NCT03867266 1198 1200 B-Or
other NCT03867266 1201 1206 B-Other
anomalies NCT03867266 1207 1216 B-Condition
that NCT03867266 1217 1221 O
preclude NCT03867266 1222 1230 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
the NCT03867266 1231 1234 O
introduction NCT03867266 1235 1247 O
of NCT03867266 1248 1250 O
the NCT03867266 1251 1254 O
catheter NCT03867266 1255 1263 B-Procedure
into NCT03867266 1264 1268 O
the NCT03867266 1269 1272 O
vein NCT03867266 1273 1277 B-Modifier
system NCT03867266 1278 1284 I-Modifier

Inclusion NCT03867539 0 9 O
Criteria NCT03867539 10 18 O
: NCT03867539 19 20 O

- NCT03867539 24 25 O
carpal NCT03867539 27 33 B-Condition
tunnel NCT03867539 34 40 I-Condition
syndrome NCT03867539 41 49 I-Condition
diagnosed NCT03867539 50 59 O
either NCT03867539 60 66 O
by NCT03867539 67 69 O
physical NCT03867539 70 78 B-Procedure
exam NCT03867539 79 83 I-Procedure
or NCT03867539 84 86 B-Or
EMG NCT03867539 87 90 B-Procedure

- NCT03867539 93 94 O
age NCT03867539 96 99 B-Age
> NCT03867539 100 101 B-Eq_Comparison
18 NCT03867539 102 104 I-Eq_Comparison
. NCT03867539 104 105 O

Exclusion NCT03867539 107 116 O
Criteria NCT03867539 117 125 O
: NCT03867539 126 127 O

- NCT03867539 131 132 O
allergy NCT03867539 134 141 B-Allergy
to NCT03867539 142 144 O
bupivacaine NCT03867539 145 156 B-Drug

- NCT03867539 159 160 O
pre NCT03867539 162 165 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03867539 166 167 O
operative NCT03867539 168 177 B-Procedure
opioid NCT03867539 178 184 B-Drug
usage NCT03867539 185 190 O
within NCT03867539 191 197 B-Eq_Comparison
the NCT03867539 198 201 I-Eq_Comparison
last NCT03867539 202 206 I-Eq_Comparison
six NCT03867539 207 210 I-Eq_Comparison
months NCT03867539 211 217 I-Eq_Comparison

- NCT03867539 220 221 O
patients NCT03867539 223 231 O
allergic NCT03867539 232 240 B-Allergy
to NCT03867539 241 243 O
Percocet NCT03867539 244 252 B-Drug
or NCT03867539 253 255 B-Or
acetaminophen NCT03867539 256 269 B-Drug

- NCT03867539 272 273 O
patients NCT03867539 275 283 O
taking NCT03867539 284 290 B-Eq_Comparison
tricyclic NCT03867539 291 300 B-Drug
antidepressants NCT03867539 301 316 I-Drug
( NCT03867539 317 318 O
interaction NCT03867539 319 330 O
with NCT03867539 331 335 O
bupivacaine NCT03867539 336 347 B-Drug
) NCT03867539 348 349 O

- NCT03867539 353 354 O
vulnerable NCT03867539 356 366 B-Observation
populations NCT03867539 367 378 I-Observation
( NCT03867539 379 380 O
prisoners NCT03867539 381 390 B-Observation
or NCT03867539 391 393 B-Or
pregnant NCT03867539 394 402 B-Condition
women NCT03867539 403 408 O
) NCT03867539 409 410 O

Inclusion NCT03867981 0 9 O
Criteria NCT03867981 10 18 O
: NCT03867981 19 20 O

- NCT03867981 24 25 O
Age NCT03867981 27 30 B-Age
18 NCT03867981 31 33 B-Eq_Comparison
- NCT03867981 34 35 I-Eq_Comparison
70 NCT03867981 36 38 I-Eq_Comparison

- NCT03867981 42 43 O
BMI NCT03867981 45 48 B-Observation
: NCT03867981 49 50 O
25 NCT03867981 51 53 B-Eq_Comparison
- NCT03867981 54 55 I-Eq_Comparison
45 NCT03867981 56 58 I-Eq_Comparison
kg NCT03867981 59 61 I-Eq_Comparison
/ NCT03867981 62 63 I-Eq_Comparison
m NCT03867981 64 65 I-Eq_Comparison
2 NCT03867981 66 67 I-Eq_Comparison

- NCT03867981 70 71 O
Regular NCT03867981 73 80 O
internet NCT03867981 81 89 O
access NCT03867981 90 96 O

Exclusion NCT03867981 97 106 O
Criteria NCT03867981 107 115 O
: NCT03867981 116 117 O

- NCT03867981 121 122 O
Currently NCT03867981 124 133 B-Eq_Comparison
pregnant NCT03867981 134 142 B-Condition
, NCT03867981 143 144 O
< NCT03867981 145 146 B-Eq_Comparison
6 NCT03867981 147 148 I-Eq_Comparison
months NCT03867981 149 155 I-Eq_Comparison
post NCT03867981 156 160 B-Condition
- NCT03867981 161 162 I-Condition
partum NCT03867981 163 169 I-Condition
, NCT03867981 170 171 O
nursing NCT03867981 172 179 B-Condition
, NCT03867981 180 181 O
or NCT03867981 182 184 B-Or
planning NCT03867981 185 193 B-Assertion___Assertion_Type_Value:intention
to NCT03867981 194 196 I-Assertion___Assertion_Type_Value:intention
become NCT03867981 197 203 I-Assertion___Assertion_Type_Value:intention
pregnant NCT03867981 204 212 B-Condition
within NCT03867981 213 219 B-Eq_Comparison
the NCT03867981 220 223 I-Eq_Comparison
next NCT03867981 224 228 I-Eq_Comparison
12 NCT03867981 229 231 I-Eq_Comparison
months NCT03867981 232 238 I-Eq_Comparison
. NCT03867981 239 240 O

- NCT03867981 244 245 O
Current NCT03867981 247 254 B-Eq_Comparison
enrollment NCT03867981 255 265 O
in NCT03867981 266 268 O
a NCT03867981 269 270 O
commercial NCT03867981 271 281 B-Modifier
weight NCT03867981 282 288 B-Procedure
loss NCT03867981 289 293 I-Procedure
program NCT03867981 294 301 I-Procedure
or NCT03867981 302 304 B-Or
other NCT03867981 305 310 B-Other
weight NCT03867981 311 317 B-Procedure
loss NCT03867981 318 322 I-Procedure
research NCT03867981 323 331 O
study NCT03867981 332 337 B-Study

- NCT03867981 340 341 O
Currently NCT03867981 343 352 B-Eq_Comparison
taking NCT03867981 353 359 O
weight NCT03867981 360 366 B-Procedure
loss NCT03867981 367 371 I-Procedure
medications NCT03867981 372 383 B-Drug

- NCT03867981 386 387 O
Previously NCT03867981 389 399 B-Eq_Comparison
had NCT03867981 400 403 O
bariatric NCT03867981 404 413 B-Procedure
surgery NCT03867981 414 421 I-Procedure

- NCT03867981 424 425 O
Inability NCT03867981 427 436 B-Condition
to NCT03867981 437 439 I-Condition
walk NCT03867981 440 444 I-Condition
2 NCT03867981 445 446 B-Modifier
blocks NCT03867981 447 453 I-Modifier
without NCT03867981 454 461 I-Modifier
stopping NCT03867981 462 470 I-Modifier

- NCT03867981 473 474 O
Any NCT03867981 476 479 O
medical NCT03867981 480 487 B-Condition
condition NCT03867981 488 497 I-Condition
for NCT03867981 498 501 O
which NCT03867981 502 507 O
weight NCT03867981 508 514 B-Procedure
loss NCT03867981 515 519 I-Procedure
, NCT03867981 520 521 O
dietary NCT03867981 522 529 B-Procedure
restriction NCT03867981 530 541 I-Procedure
, NCT03867981 542 543 O
or NCT03867981 544 546 B-Or
physical NCT03867981 547 555 B-Observation
activity NCT03867981 556 564 I-Observation
is NCT03867981 565 567 O
contraindicated NCT03867981 568 583 B-Contraindication

Inclusion NCT03865134 0 9 O
Criteria NCT03865134 10 18 O
: NCT03865134 19 20 O

- NCT03865134 24 25 O
Age NCT03865134 27 30 B-Age
range NCT03865134 31 36 O
between NCT03865134 37 44 B-Eq_Comparison
2 NCT03865134 45 46 I-Eq_Comparison
- NCT03865134 47 48 I-Eq_Comparison
6 NCT03865134 49 50 I-Eq_Comparison
years NCT03865134 51 56 I-Eq_Comparison
of NCT03865134 57 59 O
age NCT03865134 60 63 O

- NCT03865134 66 67 O
Gestational NCT03865134 69 80 B-Observation
age NCT03865134 81 84 I-Observation
range NCT03865134 85 90 O
26 NCT03865134 91 93 B-Eq_Comparison
- NCT03865134 94 95 I-Eq_Comparison
34 NCT03865134 96 98 I-Eq_Comparison
. NCT03865134 98 99 O
be NCT03865134 101 103 O
between NCT03865134 104 111 B-Eq_Comparison
weeks NCT03865134 112 117 I-Eq_Comparison

- NCT03865134 120 121 O
To NCT03865134 123 125 O
be NCT03865134 126 128 O
diagnosed NCT03865134 129 138 O
with NCT03865134 139 143 O
retinopathy NCT03865134 144 155 B-Condition
of NCT03865134 156 158 I-Condition
prematurity NCT03865134 159 170 I-Condition

- NCT03865134 173 174 O
Neurological NCT03865134 176 188 B-Modifier
, NCT03865134 189 190 O
hereditary NCT03865134 191 201 B-Modifier
and NCT03865134 202 205 B-Or
not NCT03865134 206 209 B-Negation
having NCT03865134 210 216 O
metabolic NCT03865134 217 226 B-Modifier
disease NCT03865134 227 234 B-Condition

- NCT03865134 237 238 O
Compliance NCT03865134 240 250 B-Assertion___Assertion_Type_Value:hypothetical
with NCT03865134 251 255 I-Assertion___Assertion_Type_Value:hypothetical
visual NCT03865134 256 262 B-Procedure
examinations NCT03865134 263 275 I-Procedure
and NCT03865134 276 279 B-Or
physiotherapy NCT03865134 280 293 B-Procedure
evaluations NCT03865134 294 305 I-Procedure

- NCT03865134 308 309 O
To NCT03865134 311 313 O
be NCT03865134 314 316 O
children NCT03865134 317 325 O
and NCT03865134 326 329 O
parents NCT03865134 330 337 O
who NCT03865134 338 341 O
agree NCT03865134 342 347 O
to NCT03865134 348 350 O
participate NCT03865134 351 362 O
in NCT03865134 363 365 O
the NCT03865134 366 369 O
study NCT03865134 370 375 O

Exclusion NCT03865134 376 385 O
Criteria NCT03865134 386 394 O
: NCT03865134 395 396 O

- NCT03865134 400 401 O
To NCT03865134 403 405 O
be NCT03865134 406 408 O
a NCT03865134 409 410 O
child NCT03865134 411 416 O
who NCT03865134 417 420 B-And
does NCT03865134 421 425 O
not NCT03865134 426 429 B-Negation
comply NCT03865134 430 436 B-Assertion___Assertion_Type_Value:hypothetical
with NCT03865134 437 441 I-Assertion___Assertion_Type_Value:hypothetical
Optical NCT03865134 442 449 B-Procedure
Kohlerans NCT03865134 450 459 I-Procedure
Tomography NCT03865134 460 470 I-Procedure
( NCT03865134 471 472 O
OCT NCT03865134 473 476 B-Procedure
) NCT03865134 477 478 O

- NCT03865134 482 483 O
Not NCT03865134 485 488 B-Negation
participating NCT03865134 489 502 B-Eq_Comparison
in NCT03865134 503 505 O
one NCT03865134 506 509 B-Eq_Comparison
or NCT03865134 510 512 I-Eq_Comparison
more NCT03865134 513 517 I-Eq_Comparison
of NCT03865134 518 520 O
the NCT03865134 521 524 O
eye NCT03865134 525 528 B-Procedure
examination NCT03865134 529 540 I-Procedure
or NCT03865134 541 543 B-Or
physiotherapy NCT03865134 544 557 B-Procedure
assessments NCT03865134 558 569 I-Procedure

- NCT03865134 572 573 O
Being NCT03865134 575 580 O
children NCT03865134 581 589 O
and NCT03865134 590 593 B-Or
parents NCT03865134 594 601 B-Family_Member___Family_Member_Type:parent
who NCT03865134 602 605 O
do NCT03865134 606 608 O
not NCT03865134 609 612 B-Negation
agree NCT03865134 613 618 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03865134 619 621 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03865134 622 633 O
in NCT03865134 634 636 O
the NCT03865134 637 640 O
study NCT03865134 641 646 B-Study

Inclusion NCT03861975 0 9 O
Criteria NCT03861975 10 18 O
: NCT03861975 19 20 O

- NCT03861975 24 25 O
Participants NCT03861975 27 39 O
must NCT03861975 40 44 O
have NCT03861975 45 49 O
histologically NCT03861975 50 64 B-Modifier
or NCT03861975 65 67 B-Or
cytologically NCT03861975 68 81 B-Procedure
confirmed NCT03861975 82 91 O
invasive NCT03861975 92 100 B-Modifier
or NCT03861975 101 103 B-Or
in NCT03861975 104 106 B-Modifier
- NCT03861975 107 108 I-Modifier
situ NCT03861975 109 113 I-Modifier
carcinoma NCT03861975 114 123 B-Condition
of NCT03861975 124 126 O
the NCT03861975 127 130 O
breast NCT03861975 131 137 B-Modifier
and NCT03861975 138 141 B-And
will NCT03861975 142 146 B-Eq_Comparison
undergo NCT03861975 147 154 I-Eq_Comparison
unilateral NCT03861975 155 165 B-Modifier
breast NCT03861975 166 172 I-Modifier
cancer NCT03861975 173 179 B-Condition
surgery NCT03861975 180 187 B-Procedure

- NCT03861975 190 191 O
Willingness NCT03861975 193 204 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861975 205 207 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03861975 208 216 O
SEI NCT03861975 217 220 B-Observation
- NCT03861975 221 222 I-Observation
BCLE NCT03861975 223 227 I-Observation
Questionnaire NCT03861975 228 241 I-Observation

- NCT03861975 244 245 O
Age NCT03861975 247 250 B-Age
> NCT03861975 251 252 B-Eq_Comparison
18 NCT03861975 253 255 I-Eq_Comparison
years NCT03861975 256 261 I-Eq_Comparison
. NCT03861975 262 263 O

- NCT03861975 267 268 O
Ability NCT03861975 270 277 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861975 278 280 I-Assertion___Assertion_Type_Value:hypothetical
understand NCT03861975 281 291 I-Assertion___Assertion_Type_Value:hypothetical
and NCT03861975 292 295 B-And
the NCT03861975 296 299 O
willingness NCT03861975 300 311 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861975 312 314 O
verbally NCT03861975 315 323 O
consent NCT03861975 324 331 O
to NCT03861975 332 334 O
the NCT03861975 335 338 O
trial NCT03861975 339 344 B-Study

Exclusion NCT03861975 345 354 O
Criteria NCT03861975 355 363 O
: NCT03861975 364 365 O

- NCT03861975 369 370 O
History NCT03861975 372 379 B-Eq_Comparison
of NCT03861975 380 382 O
primary NCT03861975 383 390 B-Modifier
lymphedema NCT03861975 391 401 B-Condition
. NCT03861975 402 403 O

- NCT03861975 407 408 O
Any NCT03861975 410 413 O
patient NCT03861975 414 421 O
with NCT03861975 422 426 O
a NCT03861975 427 428 O
current NCT03861975 429 436 B-Eq_Comparison
case NCT03861975 437 441 O
of NCT03861975 442 444 O
cellulitis NCT03861975 445 455 B-Condition
. NCT03861975 456 457 O

- NCT03861975 461 462 O
Participants NCT03861975 464 476 O
with NCT03861975 477 481 O
known NCT03861975 482 487 O
brain NCT03861975 488 493 B-Modifier
metastases NCT03861975 494 504 B-Condition
should NCT03861975 505 511 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03861975 512 514 I-Assertion___Assertion_Type_Value:hypothetical
excluded NCT03861975 515 523 B-Negation
from NCT03861975 524 528 O
this NCT03861975 529 533 O
clinical NCT03861975 534 542 B-Study
trial NCT03861975 543 548 I-Study
because NCT03861975 549 556 O
of NCT03861975 557 559 O
their NCT03861975 560 565 O
poor NCT03861975 566 570 B-Condition
prognosis NCT03861975 571 580 I-Condition
and NCT03861975 581 584 B-And
because NCT03861975 585 592 O
they NCT03861975 593 597 O
often NCT03861975 598 603 B-Assertion___Assertion_Type_Value:hypothetical
develop NCT03861975 604 611 I-Assertion___Assertion_Type_Value:hypothetical
progressive NCT03861975 612 623 B-Modifier
neurologic NCT03861975 624 634 B-Condition
dysfunction NCT03861975 635 646 I-Condition
that NCT03861975 647 651 O
would NCT03861975 652 657 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03861975 658 666 O
the NCT03861975 667 670 O
evaluation NCT03861975 671 681 B-Procedure
of NCT03861975 682 684 O
neurologic NCT03861975 685 695 B-Modifier
and NCT03861975 696 699 B-Or
other NCT03861975 700 705 B-Other
adverse NCT03861975 706 713 B-Condition
events NCT03861975 714 720 I-Condition
. NCT03861975 721 722 O

- NCT03861975 726 727 O
Uncontrolled NCT03861975 729 741 B-Modifier
intercurrent NCT03861975 742 754 B-Condition
illness NCT03861975 755 762 I-Condition
including NCT03861975 763 772 O
, NCT03861975 773 774 O
but NCT03861975 775 778 O
not NCT03861975 779 782 O
limited NCT03861975 783 790 O
to NCT03861975 791 793 O
, NCT03861975 794 795 O
ongoing NCT03861975 796 803 B-Eq_Comparison
or NCT03861975 804 806 B-Or
active NCT03861975 807 813 B-Eq_Comparison
infection NCT03861975 814 823 B-Condition
, NCT03861975 824 825 O
symptomatic NCT03861975 826 837 B-Assertion___Assertion_Type_Value:possible
congestive NCT03861975 838 848 B-Condition
heart NCT03861975 849 854 I-Condition
failure NCT03861975 855 862 I-Condition
, NCT03861975 863 864 O
unstable NCT03861975 865 873 O
angina NCT03861975 874 880 B-Condition
pectoris NCT03861975 881 889 I-Condition
, NCT03861975 890 891 O
cardiac NCT03861975 892 899 B-Condition
arrhythmia NCT03861975 900 910 I-Condition
, NCT03861975 911 912 O
or NCT03861975 913 915 B-Or
psychiatric NCT03861975 916 927 B-Modifier
illness NCT03861975 928 935 B-Condition
/ NCT03861975 936 937 B-Or
social NCT03861975 938 944 B-Observation
situations NCT03861975 945 955 I-Observation
that NCT03861975 956 960 O
would NCT03861975 961 966 B-Assertion___Assertion_Type_Value:hypothetical
limit NCT03861975 967 972 O
compliance NCT03861975 973 983 O
with NCT03861975 984 988 O
study NCT03861975 989 994 B-Study
requirements NCT03861975 995 1007 O
. NCT03861975 1008 1009 O

- NCT03861975 1013 1014 O
Participants NCT03861975 1016 1028 O
unable NCT03861975 1029 1035 B-Negation
to NCT03861975 1036 1038 O
abduct NCT03861975 1039 1045 B-Condition
upper NCT03861975 1046 1051 B-Modifier
- NCT03861975 1052 1053 I-Modifier
extremity NCT03861975 1054 1063 I-Modifier
perpendicular NCT03861975 1064 1077 I-Modifier
to NCT03861975 1078 1080 I-Modifier
body NCT03861975 1081 1085 I-Modifier
or NCT03861975 1086 1088 B-Or
to NCT03861975 1089 1091 O
stand NCT03861975 1092 1097 B-Observation
comfortably NCT03861975 1098 1109 O
without NCT03861975 1110 1117 O
aid NCT03861975 1118 1121 O
for NCT03861975 1122 1125 O
several NCT03861975 1126 1133 B-Eq_Comparison
minutes NCT03861975 1134 1141 I-Eq_Comparison
, NCT03861975 1142 1143 O
both NCT03861975 1144 1148 O
of NCT03861975 1149 1151 O
which NCT03861975 1152 1157 O
are NCT03861975 1158 1161 O
necessary NCT03861975 1162 1171 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861975 1172 1174 I-Assertion___Assertion_Type_Value:hypothetical
perform NCT03861975 1175 1182 O
a NCT03861975 1183 1184 O
LymphaTech NCT03861975 1185 1195 B-Procedure
Scan NCT03861975 1196 1200 I-Procedure

Inclusion NCT03865953 0 9 O
Criteria NCT03865953 10 18 O
: NCT03865953 19 20 O

1 NCT03865953 24 25 O
. NCT03865953 25 26 O
Clinical NCT03865953 28 36 O
diagnosis NCT03865953 37 46 O
of NCT03865953 47 49 O
post NCT03865953 50 54 B-Condition
herpetic NCT03865953 55 63 I-Condition
neuralgia NCT03865953 64 73 I-Condition
, NCT03865953 74 75 O
with NCT03865953 76 80 B-And
pain NCT03865953 81 85 B-Condition
persisting NCT03865953 86 96 O
for NCT03865953 97 100 O
at NCT03865953 101 103 B-Eq_Comparison
least NCT03865953 104 109 I-Eq_Comparison
3 NCT03865953 110 111 I-Eq_Comparison
months NCT03865953 112 118 I-Eq_Comparison
after NCT03865953 119 124 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03865953 125 128 O
onset NCT03865953 129 134 B-Eq_Comparison
of NCT03865953 135 137 O
herpes NCT03865953 138 144 B-Condition
zoster NCT03865953 145 151 I-Condition
rash NCT03865953 152 156 I-Condition
OR NCT03865953 157 159 B-Or

2 NCT03865953 162 163 O
. NCT03865953 163 164 O
Clinical NCT03865953 166 174 O
diagnosis NCT03865953 175 184 O
of NCT03865953 185 187 O
distal NCT03865953 188 194 B-Modifier
painful NCT03865953 195 202 I-Modifier
polyneuropathy NCT03865953 203 217 B-Condition
due NCT03865953 218 221 O
to NCT03865953 222 224 O
Type NCT03865953 225 229 B-Modifier
I NCT03865953 230 231 I-Modifier
or NCT03865953 232 234 B-Or
Type NCT03865953 235 239 B-Modifier
II NCT03865953 240 242 I-Modifier
diabetes NCT03865953 243 251 B-Condition
mellitus NCT03865953 252 260 I-Condition
with NCT03865953 261 265 B-And
: NCT03865953 266 267 O

1 NCT03865953 276 277 O
. NCT03865953 277 278 O
symmetrical NCT03865953 280 291 B-Modifier
, NCT03865953 292 293 O
bilateral NCT03865953 294 303 B-Modifier
pain NCT03865953 304 308 B-Condition
in NCT03865953 309 311 O
the NCT03865953 312 315 O
lower NCT03865953 316 321 B-Modifier
extremities NCT03865953 322 333 I-Modifier
for NCT03865953 334 337 O
at NCT03865953 338 340 B-Eq_Comparison
least NCT03865953 341 346 I-Eq_Comparison
3 NCT03865953 347 348 I-Eq_Comparison
months NCT03865953 349 355 I-Eq_Comparison
and NCT03865953 356 359 B-And

2 NCT03865953 367 368 O
. NCT03865953 368 369 O
diabetes NCT03865953 371 379 B-Condition
under NCT03865953 380 385 O
control NCT03865953 386 393 O
for NCT03865953 394 397 O
at NCT03865953 398 400 B-Eq_Comparison
least NCT03865953 401 406 I-Eq_Comparison
3 NCT03865953 407 408 I-Eq_Comparison
months NCT03865953 409 415 I-Eq_Comparison
prior NCT03865953 416 421 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865953 422 424 I-Temporal_Connection___Temporal_Connection_Type_Value:before
randomisation NCT03865953 425 438 B-Study
, NCT03865953 439 440 O
as NCT03865953 441 443 O
indicated NCT03865953 444 453 O
by NCT03865953 454 456 O
a NCT03865953 457 458 O
glycated NCT03865953 459 467 B-Observation
haemoglobin NCT03865953 468 479 I-Observation
level NCT03865953 480 485 I-Observation
( NCT03865953 486 487 O
HbA NCT03865953 488 491 B-Observation
1c NCT03865953 492 494 I-Observation
) NCT03865953 495 496 O
of NCT03865953 497 499 O
≤ NCT03865953 500 501 B-Eq_Comparison
11 NCT03865953 502 504 I-Eq_Comparison
% NCT03865953 505 506 I-Eq_Comparison
( NCT03865953 507 508 O
97 NCT03865953 509 511 B-Eq_Comparison
mmol NCT03865953 512 516 I-Eq_Comparison
/ NCT03865953 517 518 I-Eq_Comparison
mol NCT03865953 519 522 I-Eq_Comparison
) NCT03865953 523 524 O
and NCT03865953 525 528 B-And
on NCT03865953 529 531 O
a NCT03865953 532 533 O
stable NCT03865953 534 540 O
dose NCT03865953 541 545 O
of NCT03865953 546 548 O
insulin NCT03865953 549 556 B-Drug
or NCT03865953 557 559 B-Or
oral NCT03865953 560 564 B-Modifier
diabetic NCT03865953 565 573 B-Condition
medication NCT03865953 574 584 B-Drug
for NCT03865953 585 588 O
3 NCT03865953 589 590 B-Eq_Comparison
months NCT03865953 591 597 I-Eq_Comparison
prior NCT03865953 598 603 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865953 604 606 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03865953 607 616 B-Study
, NCT03865953 617 618 O
and NCT03865953 619 622 B-And

3 NCT03865953 630 631 O
. NCT03865953 631 632 O
no NCT03865953 634 636 B-Negation
change NCT03865953 637 643 O
in NCT03865953 644 646 O
diabetic NCT03865953 647 655 B-Condition
medication NCT03865953 656 666 B-Drug
planned NCT03865953 667 674 B-Eq_Comparison
for NCT03865953 675 678 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865953 679 682 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03865953 683 691 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03865953 692 694 O
the NCT03865953 695 698 O
study NCT03865953 699 704 B-Study

3 NCT03865953 707 708 O
. NCT03865953 708 709 O
Positive NCT03865953 711 719 O
sensory NCT03865953 720 727 B-Condition
symptoms NCT03865953 728 736 I-Condition
( NCT03865953 737 738 O
mechanical NCT03865953 739 749 B-Modifier
or NCT03865953 750 752 B-Or
thermal NCT03865953 753 760 B-Modifier
) NCT03865953 761 762 O
associated NCT03865953 763 773 O
with NCT03865953 774 778 O
neuropathic NCT03865953 779 790 B-Modifier
pain NCT03865953 791 795 B-Condition
, NCT03865953 796 797 O
confirmed NCT03865953 798 807 O
by NCT03865953 808 810 O
: NCT03865953 811 812 O

1 NCT03865953 821 822 O
. NCT03865953 822 823 O
painDETECT NCT03865953 825 835 B-Observation
questionnaire NCT03865953 836 849 I-Observation
( NCT03865953 850 851 O
PD NCT03865953 852 854 B-Observation
- NCT03865953 855 856 I-Observation
Q NCT03865953 857 858 I-Observation
) NCT03865953 859 860 O
and NCT03865953 861 864 B-And

2 NCT03865953 872 873 O
. NCT03865953 873 874 O
Clinical NCT03865953 876 884 O
assessment NCT03865953 885 895 B-Procedure
, NCT03865953 896 897 O
showing NCT03865953 898 905 O
signs NCT03865953 906 911 B-Assertion___Assertion_Type_Value:possible
of NCT03865953 912 914 I-Assertion___Assertion_Type_Value:possible
neuropathic NCT03865953 915 926 B-Modifier
pain NCT03865953 927 931 B-Condition
in NCT03865953 932 934 B-And
either NCT03865953 935 941 O
a NCT03865953 942 943 O
dermatomal NCT03865953 944 954 B-Modifier
( NCT03865953 955 956 O
PHN NCT03865953 957 960 B-Condition
) NCT03865953 961 962 O
or NCT03865953 963 965 B-Or
distal NCT03865953 966 972 B-Modifier
symmetrical NCT03865953 973 984 B-Condition
distribution NCT03865953 985 997 I-Condition
( NCT03865953 998 999 O
DPN NCT03865953 1000 1003 B-Condition
) NCT03865953 1004 1005 O

8 NCT03865953 1008 1009 O
. NCT03865953 1009 1010 O
An NCT03865953 1012 1014 O
average NCT03865953 1015 1022 O
daily NCT03865953 1023 1028 B-Eq_Comparison
pain NCT03865953 1029 1033 B-Observation
score NCT03865953 1034 1039 I-Observation
on NCT03865953 1040 1042 O
the NCT03865953 1043 1046 O
NPRS NCT03865953 1047 1051 B-Observation
of NCT03865953 1052 1054 O
at NCT03865953 1055 1057 B-Eq_Comparison
least NCT03865953 1058 1063 I-Eq_Comparison
4 NCT03865953 1064 1065 I-Eq_Comparison
and NCT03865953 1066 1069 B-And
no NCT03865953 1070 1072 B-Negation
more NCT03865953 1073 1077 B-Eq_Comparison
than NCT03865953 1078 1082 I-Eq_Comparison
8 NCT03865953 1083 1084 I-Eq_Comparison
in NCT03865953 1085 1087 O
the NCT03865953 1088 1091 O
last NCT03865953 1092 1096 O
five NCT03865953 1097 1101 O
diary NCT03865953 1102 1107 O
entries NCT03865953 1108 1115 O
before NCT03865953 1116 1122 B-Temporal_Connection___Temporal_Connection_Type_Value:before
randomisation NCT03865953 1123 1136 B-Study

Exclusion NCT03865953 1137 1146 O
Criteria NCT03865953 1147 1155 O
: NCT03865953 1156 1157 O

1 NCT03865953 1161 1162 O
. NCT03865953 1162 1163 O
Presence NCT03865953 1165 1173 O
of NCT03865953 1174 1176 O
moderate NCT03865953 1177 1185 B-Eq_Comparison
to NCT03865953 1186 1188 I-Eq_Comparison
severe NCT03865953 1189 1195 I-Eq_Comparison
pain NCT03865953 1196 1200 B-Condition
from NCT03865953 1201 1205 O
other NCT03865953 1206 1211 B-Other
causes NCT03865953 1212 1218 B-Condition
that NCT03865953 1219 1223 O
may NCT03865953 1224 1227 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03865953 1228 1236 O
assessment NCT03865953 1237 1247 B-Study
or NCT03865953 1248 1250 O
self NCT03865953 1251 1255 O
- NCT03865953 1256 1257 O
evaluation NCT03865953 1258 1268 O
of NCT03865953 1269 1271 O
NP NCT03865953 1272 1274 O
. NCT03865953 1275 1276 O

2 NCT03865953 1280 1281 O
. NCT03865953 1281 1282 O
Subjects NCT03865953 1284 1292 O
with NCT03865953 1293 1297 O
both NCT03865953 1298 1302 O
DPN NCT03865953 1303 1306 B-Condition
and NCT03865953 1307 1310 B-And
PHN NCT03865953 1311 1314 B-Condition


Inclusion NCT03861078 0 9 O
Criteria NCT03861078 10 18 O
- NCT03861078 19 20 O
- NCT03861078 21 22 O
Participants NCT03861078 23 35 O
must NCT03861078 36 40 O
be NCT03861078 41 43 O
: NCT03861078 44 45 O

- NCT03861078 49 50 O
Healthy NCT03861078 52 59 B-Condition
( NCT03861078 60 61 O
determined NCT03861078 62 72 O
by NCT03861078 73 75 O
self NCT03861078 76 80 O
- NCT03861078 81 82 O
report NCT03861078 83 89 O
) NCT03861078 90 91 O

- NCT03861078 95 96 O
Between NCT03861078 98 105 O
the NCT03861078 106 109 O
ages NCT03861078 110 114 B-Age
of NCT03861078 115 117 O
18 NCT03861078 118 120 B-Eq_Comparison
- NCT03861078 121 122 I-Eq_Comparison
55 NCT03861078 123 125 I-Eq_Comparison
years NCT03861078 126 131 I-Eq_Comparison
old NCT03861078 132 135 O

- NCT03861078 138 139 O
Current NCT03861078 141 148 B-Eq_Comparison
cigarette NCT03861078 149 158 B-Condition
smokers NCT03861078 159 166 I-Condition

- NCT03861078 169 170 O
Wiling NCT03861078 172 178 O
to NCT03861078 179 181 O
provide NCT03861078 182 189 O
informed NCT03861078 190 198 O
consent NCT03861078 199 206 O

- NCT03861078 209 210 O
Able NCT03861078 212 216 O
to NCT03861078 217 219 O
attend NCT03861078 220 226 O
the NCT03861078 227 230 O
lab NCT03861078 231 234 O
session NCT03861078 235 242 O
and NCT03861078 243 246 O
abstain NCT03861078 247 254 O
from NCT03861078 255 259 O
tobacco NCT03861078 260 267 O
/ NCT03861078 268 269 O
nicotine NCT03861078 270 278 O
products NCT03861078 279 287 O
as NCT03861078 288 290 O
required NCT03861078 291 299 O

- NCT03861078 302 303 O
Agree NCT03861078 305 310 O
to NCT03861078 311 313 O
use NCT03861078 314 317 O
designated NCT03861078 318 328 O
products NCT03861078 329 337 O
according NCT03861078 338 347 O
to NCT03861078 348 350 O
the NCT03861078 351 354 O
study NCT03861078 355 360 O
protocol NCT03861078 361 369 O

Exclusion NCT03861078 370 379 O
Criteria NCT03861078 380 388 O
: NCT03861078 389 390 O

- NCT03861078 394 395 O
Women NCT03861078 397 402 O
if NCT03861078 403 405 O
they NCT03861078 406 410 O
are NCT03861078 411 414 O
breast NCT03861078 415 421 B-Condition
- NCT03861078 422 423 I-Condition
feeding NCT03861078 424 431 I-Condition
or NCT03861078 432 434 B-Or
test NCT03861078 435 439 B-Observation
positive NCT03861078 440 448 O
for NCT03861078 449 452 O
pregnancy NCT03861078 453 462 B-Condition
( NCT03861078 463 464 O
by NCT03861078 465 467 O
urinalysis NCT03861078 468 478 B-Observation
) NCT03861078 479 480 O
at NCT03861078 481 483 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03861078 484 493 B-Study
. NCT03861078 494 495 O

- NCT03861078 499 500 O
Individuals NCT03861078 502 513 O
who NCT03861078 514 517 O
weigh NCT03861078 518 523 B-Observation
less NCT03861078 524 528 B-Eq_Comparison
than NCT03861078 529 533 I-Eq_Comparison
110 NCT03861078 534 537 I-Eq_Comparison
pounds NCT03861078 538 544 I-Eq_Comparison
. NCT03861078 545 546 O

Some NCT03861078 548 552 O
study NCT03861078 553 558 O
details NCT03861078 559 566 O
about NCT03861078 567 572 O
the NCT03861078 573 576 O
eligibility NCT03861078 577 588 O
criteria NCT03861078 589 597 O
are NCT03861078 598 601 O
purposely NCT03861078 602 611 O
omitted NCT03861078 612 619 O
at NCT03861078 620 622 O
this NCT03861078 623 627 O
time NCT03861078 628 632 O
to NCT03861078 633 635 O
preserve NCT03861078 636 644 O
scientific NCT03861078 645 655 O
integrity NCT03861078 656 665 O
. NCT03861078 666 667 O
Full NCT03861078 669 673 O
details NCT03861078 674 681 O
will NCT03861078 682 686 O
be NCT03861078 687 689 O
posted NCT03861078 690 696 O
at NCT03861078 697 699 O
the NCT03861078 700 703 O
conclusion NCT03861078 704 714 O
of NCT03861078 715 717 O
the NCT03861078 718 721 O
study NCT03861078 722 727 O
. NCT03861078 728 729 O


Inclusion NCT03860233 0 9 O
Criteria NCT03860233 10 18 O
: NCT03860233 19 20 O

- NCT03860233 24 25 O
Men NCT03860233 27 30 O
or NCT03860233 31 33 B-Or
women NCT03860233 34 39 O
18 NCT03860233 40 42 B-Eq_Comparison
years NCT03860233 43 48 I-Eq_Comparison
of NCT03860233 49 51 I-Eq_Comparison
age NCT03860233 52 55 I-Eq_Comparison
or NCT03860233 56 58 I-Eq_Comparison
older NCT03860233 59 64 I-Eq_Comparison
. NCT03860233 65 66 O

Exclusion NCT03860233 68 77 O
Criteria NCT03860233 78 86 O
: NCT03860233 87 88 O

- NCT03860233 92 93 O
subjects NCT03860233 95 103 O
not NCT03860233 104 107 B-Negation
willing NCT03860233 108 115 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860233 116 118 I-Assertion___Assertion_Type_Value:hypothetical
or NCT03860233 119 121 B-Or
otherwise NCT03860233 122 131 O
unable NCT03860233 132 138 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03860233 139 141 O
use NCT03860233 142 145 O
CPAP NCT03860233 146 150 B-Procedure
for NCT03860233 151 154 O
treatment NCT03860233 155 164 B-Procedure
of NCT03860233 165 167 O
OSA NCT03860233 168 171 B-Condition
. NCT03860233 172 173 O

- NCT03860233 177 178 O
Presence NCT03860233 180 188 O
of NCT03860233 189 191 O
other NCT03860233 192 197 B-Other
sleep NCT03860233 198 203 B-Condition
disorders NCT03860233 204 213 I-Condition

- NCT03860233 216 217 O
Pregnant NCT03860233 219 227 B-Condition
or NCT03860233 228 230 B-Or
breastfeeding NCT03860233 231 244 B-Condition
women NCT03860233 245 250 O

- NCT03860233 253 254 O
Women NCT03860233 256 261 O
of NCT03860233 262 264 B-And
child NCT03860233 265 270 B-Condition
- NCT03860233 271 272 I-Condition
bearing NCT03860233 273 280 I-Condition
age NCT03860233 281 284 I-Condition
( NCT03860233 285 286 O
WOCBA NCT03860233 287 292 B-Condition
) NCT03860233 293 294 O
not NCT03860233 295 298 B-Negation
willing NCT03860233 299 306 B-Assertion___Assertion_Type_Value:hypothetical
or NCT03860233 307 309 B-Or
unable NCT03860233 310 316 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03860233 317 319 O
use NCT03860233 320 323 O
an NCT03860233 324 326 O
accepted NCT03860233 327 335 O
method NCT03860233 336 342 B-Procedure
to NCT03860233 343 345 O
avoid NCT03860233 346 351 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
pregnancy NCT03860233 352 361 B-Condition
for NCT03860233 362 365 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860233 366 369 I-Temporal_Connection___Temporal_Connection_Type_Value:during
entire NCT03860233 370 376 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03860233 377 385 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03860233 386 388 O
the NCT03860233 389 392 O
study NCT03860233 393 398 B-Study

- NCT03860233 401 402 O
Prisoners NCT03860233 404 413 B-Observation
or NCT03860233 414 416 B-Or
subjects NCT03860233 417 425 O
who NCT03860233 426 429 O
are NCT03860233 430 433 O
involuntarily NCT03860233 434 447 B-Observation
incarcerated NCT03860233 448 460 I-Observation

- NCT03860233 463 464 O
Subjects NCT03860233 466 474 O
who NCT03860233 475 478 O
are NCT03860233 479 482 O
compulsorily NCT03860233 483 495 B-Observation
detain NCT03860233 496 502 I-Observation
or NCT03860233 503 505 B-Or
treatment NCT03860233 506 515 B-Procedure
of NCT03860233 516 518 O
either NCT03860233 519 525 O
a NCT03860233 526 527 O
psychiatric NCT03860233 528 539 B-Modifier
or NCT03860233 540 542 B-Or
physical NCT03860233 543 551 B-Modifier
( NCT03860233 552 553 O
i NCT03860233 554 555 O
. NCT03860233 556 557 O
e NCT03860233 558 559 O
. NCT03860233 560 561 O
infectious NCT03860233 563 573 B-Condition
disease NCT03860233 574 581 I-Condition
) NCT03860233 582 583 O
illness NCT03860233 584 591 B-Condition

- NCT03860233 594 595 O
Patients NCT03860233 597 605 O
unable NCT03860233 606 612 O
to NCT03860233 613 615 O
give NCT03860233 616 620 O
consent NCT03860233 621 628 O
because NCT03860233 629 636 O
of NCT03860233 637 639 O
a NCT03860233 640 641 O
language NCT03860233 642 650 B-Condition
barrier NCT03860233 651 658 I-Condition
, NCT03860233 659 660 O
or NCT03860233 661 663 O
other NCT03860233 664 669 O
reason NCT03860233 670 676 O
. NCT03860233 677 678 O

Inclusion NCT03866538 0 9 O
Criteria NCT03866538 10 18 O

- NCT03866538 21 22 O
Patients NCT03866538 24 32 O
will NCT03866538 33 37 O
be NCT03866538 38 40 O
recruited NCT03866538 41 50 O
from NCT03866538 51 55 O
the NCT03866538 56 59 O
Division NCT03866538 60 68 O
of NCT03866538 69 71 O
Gastroenterology NCT03866538 72 88 O
and NCT03866538 89 92 O
Hepatology NCT03866538 93 103 O
and NCT03866538 104 107 O
the NCT03866538 108 111 O
Mayo NCT03866538 112 116 O
Clinic NCT03866538 117 123 O
in NCT03866538 124 126 O
Rochester NCT03866538 127 136 O
, NCT03866538 137 138 O
MN NCT03866538 139 141 O
. NCT03866538 142 143 O

- NCT03866538 147 148 O
Adult NCT03866538 150 155 O
patients NCT03866538 156 164 O
with NCT03866538 165 169 B-And
immune NCT03866538 170 176 B-Condition
mediated NCT03866538 177 185 I-Condition
enteropathies NCT03866538 186 199 I-Condition
who NCT03866538 200 203 B-And
have NCT03866538 204 208 O
had NCT03866538 209 212 O
improvement NCT03866538 213 224 B-Assertion___Assertion_Type_Value:hypothetical
in NCT03866538 225 227 I-Assertion___Assertion_Type_Value:hypothetical
symptoms NCT03866538 228 236 I-Assertion___Assertion_Type_Value:hypothetical
and NCT03866538 237 240 B-Or
histology NCT03866538 241 250 B-Procedure
on NCT03866538 251 253 B-Eq_Comparison
oral NCT03866538 254 258 B-Procedure
budesonide NCT03866538 259 269 I-Procedure
therapy NCT03866538 270 277 I-Procedure
. NCT03866538 278 279 O

Exclusion NCT03866538 281 290 O
Criteria NCT03866538 291 299 O

- NCT03866538 302 303 O
Age NCT03866538 305 308 B-Age
< NCT03866538 309 310 B-Eq_Comparison
18 NCT03866538 311 313 I-Eq_Comparison
years NCT03866538 314 319 I-Eq_Comparison

- NCT03866538 322 323 O
Positive NCT03866538 325 333 O
stool NCT03866538 334 339 B-Observation
gluten NCT03866538 340 346 I-Observation
testing NCT03866538 347 354 I-Observation
in NCT03866538 355 357 O
patients NCT03866538 358 366 O
with NCT03866538 367 371 B-And
refractory NCT03866538 372 382 B-Condition
celiac NCT03866538 383 389 I-Condition
disease NCT03866538 390 397 I-Condition

- NCT03866538 400 401 O
Small NCT03866538 403 408 B-Condition
bowel NCT03866538 409 414 I-Condition
malignancy NCT03866538 415 425 I-Condition
or NCT03866538 426 428 B-Or
history NCT03866538 429 436 B-Eq_Comparison
of NCT03866538 437 439 O
small NCT03866538 440 445 B-Condition
bowel NCT03866538 446 451 I-Condition
malignancy NCT03866538 452 462 I-Condition

- NCT03866538 465 466 O
Refractory NCT03866538 468 478 B-Condition
celiac NCT03866538 479 485 I-Condition
disease NCT03866538 486 493 I-Condition
type NCT03866538 494 498 B-Modifier
2 NCT03866538 499 500 I-Modifier

- NCT03866538 504 505 O
Post NCT03866538 507 511 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03866538 512 513 O
transplant NCT03866538 514 524 B-Procedure
lymphoproliferative NCT03866538 525 544 B-Condition
disorder NCT03866538 545 553 I-Condition
associated NCT03866538 554 564 O
enteropathy NCT03866538 565 576 B-Condition

- NCT03866538 579 580 O
No NCT03866538 582 584 B-Negation
prior NCT03866538 585 590 B-Eq_Comparison
improvement NCT03866538 591 602 B-Assertion___Assertion_Type_Value:hypothetical
in NCT03866538 603 605 I-Assertion___Assertion_Type_Value:hypothetical
symptoms NCT03866538 606 614 I-Assertion___Assertion_Type_Value:hypothetical
and NCT03866538 615 618 B-Or
histology NCT03866538 619 628 B-Procedure
with NCT03866538 629 633 B-And
budesonide NCT03866538 634 644 B-Procedure
therapy NCT03866538 645 652 I-Procedure

- NCT03866538 655 656 O
Discontinuation NCT03866538 658 673 B-Negation
of NCT03866538 674 676 O
budesonide NCT03866538 677 687 B-Procedure
therapy NCT03866538 688 695 I-Procedure
prior NCT03866538 696 701 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866538 702 704 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03866538 705 708 O
trial NCT03866538 709 714 B-Study

- NCT03866538 717 718 O
Other NCT03866538 720 725 B-Other
concurrent NCT03866538 726 736 B-Modifier
systemic NCT03866538 737 745 I-Modifier
corticosteroids NCT03866538 746 761 B-Drug

- NCT03866538 764 765 O
Other NCT03866538 767 772 B-Other
immune NCT03866538 773 779 B-Drug
mediating NCT03866538 780 789 I-Drug
medications NCT03866538 790 801 I-Drug
, NCT03866538 802 803 O
for NCT03866538 804 807 O
example NCT03866538 808 815 O
but NCT03866538 816 819 O
not NCT03866538 820 823 O
limited NCT03866538 824 831 O
to NCT03866538 832 834 O
azathioprine NCT03866538 835 847 B-Drug
, NCT03866538 848 849 O
6 NCT03866538 850 851 B-Drug
- NCT03866538 852 853 I-Drug
mercaptopurine NCT03866538 854 868 I-Drug
, NCT03866538 869 870 O
cyclosporine NCT03866538 871 883 B-Drug
, NCT03866538 884 885 O
methotrexate NCT03866538 886 898 B-Drug
, NCT03866538 899 900 O
anti NCT03866538 901 905 B-Drug
- NCT03866538 906 907 I-Drug
TNF NCT03866538 908 911 I-Drug
monoclonal NCT03866538 912 922 I-Drug
antibodies NCT03866538 923 933 I-Drug
, NCT03866538 934 935 O
alpha NCT03866538 936 941 B-Drug
- NCT03866538 942 943 I-Drug
4 NCT03866538 944 945 I-Drug
beta NCT03866538 946 950 I-Drug
- NCT03866538 951 952 I-Drug
7 NCT03866538 953 954 I-Drug
integrin NCT03866538 955 963 I-Drug
inhibiting NCT03866538 964 974 I-Drug
monoclonal NCT03866538 975 985 I-Drug
antibody NCT03866538 986 994 I-Drug
, NCT03866538 995 996 O
interleukin NCT03866538 997 1008 B-Drug
12 NCT03866538 1009 1011 I-Drug
/ NCT03866538 1012 1013 I-Drug
23 NCT03866538 1014 1016 I-Drug
inhibiting NCT03866538 1017 1027 I-Drug
monoclonal NCT03866538 1028 1038 I-Drug
antibody NCT03866538 1039 1047 I-Drug
, NCT03866538 1048 1049 O
JAK NCT03866538 1050 1053 B-Drug
inhibitors NCT03866538 1054 1064 I-Drug
. NCT03866538 1065 1066 O


Inclusion NCT03927287 0 9 O
Criteria NCT03927287 10 18 O
: NCT03927287 19 20 O

For NCT03927287 22 25 O
the NCT03927287 26 29 O
two NCT03927287 30 33 O
retrospective NCT03927287 34 47 O
cohorts NCT03927287 48 55 O
: NCT03927287 56 57 O

1 NCT03927287 61 62 O
. NCT03927287 62 63 O
All NCT03927287 65 68 O
patients NCT03927287 69 77 O
that NCT03927287 78 82 O
older NCT03927287 83 88 B-Eq_Comparison
than NCT03927287 89 93 I-Eq_Comparison
18 NCT03927287 94 96 I-Eq_Comparison
treated NCT03927287 97 104 B-Procedure
for NCT03927287 105 108 O
localized NCT03927287 109 118 B-Modifier
adenocarcinoma NCT03927287 119 133 B-Condition
of NCT03927287 134 136 O
the NCT03927287 137 140 O
prostate NCT03927287 141 149 B-Modifier
between NCT03927287 150 157 B-Eq_Comparison
2000 NCT03927287 158 162 I-Eq_Comparison
and NCT03927287 163 166 I-Eq_Comparison
2017 NCT03927287 167 171 I-Eq_Comparison
with NCT03927287 172 176 O
either NCT03927287 177 183 O
radical NCT03927287 184 191 B-Procedure
prostatectomy NCT03927287 192 205 I-Procedure
or NCT03927287 206 208 B-Or
radiotherapy NCT03927287 209 221 B-Procedure

2 NCT03927287 224 225 O
. NCT03927287 225 226 O
All NCT03927287 228 231 O
treated NCT03927287 232 239 O
patients NCT03927287 240 248 O
had NCT03927287 249 252 O
a NCT03927287 253 254 O
rising NCT03927287 255 261 O
post NCT03927287 262 266 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03927287 267 268 O
treatment NCT03927287 269 278 B-Procedure
PSA NCT03927287 279 282 B-Observation
, NCT03927287 283 284 O
with NCT03927287 285 289 B-And
at NCT03927287 290 292 B-Eq_Comparison
least NCT03927287 293 298 I-Eq_Comparison
one NCT03927287 299 302 I-Eq_Comparison
post NCT03927287 303 307 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03927287 308 309 O
treatment NCT03927287 310 319 B-Procedure
free NCT03927287 320 324 O
PSA NCT03927287 325 328 B-Observation
blood NCT03927287 329 334 I-Observation
test NCT03927287 335 339 I-Observation
. NCT03927287 340 341 O

For NCT03927287 343 346 O
the NCT03927287 347 350 O
biobank NCT03927287 351 358 O
validation NCT03927287 359 369 O
cohort NCT03927287 370 376 O
: NCT03927287 377 378 O

1 NCT03927287 381 382 O
. NCT03927287 382 383 O
All NCT03927287 385 388 O
patients NCT03927287 389 397 O
treated NCT03927287 398 405 O
with NCT03927287 406 410 O
radical NCT03927287 411 418 B-Procedure
prostatectomy NCT03927287 419 432 I-Procedure
for NCT03927287 433 436 O
localized NCT03927287 437 446 B-Modifier
prostate NCT03927287 447 455 I-Modifier
cancer NCT03927287 456 462 B-Condition
between NCT03927287 463 470 B-Eq_Comparison
2000 NCT03927287 471 475 I-Eq_Comparison
and NCT03927287 476 479 I-Eq_Comparison
2017 NCT03927287 480 484 I-Eq_Comparison
who NCT03927287 485 488 B-And
had NCT03927287 489 492 O
biobank NCT03927287 493 500 B-Observation
samples NCT03927287 501 508 I-Observation
taken NCT03927287 509 514 B-Eq_Comparison
when NCT03927287 515 519 B-Temporal_Connection___Temporal_Connection_Type_Value:during
developing NCT03927287 520 530 O
biochemical NCT03927287 531 542 B-Condition
recurrence NCT03927287 543 553 I-Condition
. NCT03927287 554 555 O

Exclusion NCT03927287 557 566 O
Criteria NCT03927287 567 575 O
: NCT03927287 576 577 O

1 NCT03927287 581 582 O
. NCT03927287 582 583 O
Patients NCT03927287 585 593 O
that NCT03927287 594 598 O
were NCT03927287 599 603 O
younger NCT03927287 604 611 B-Eq_Comparison
than NCT03927287 612 616 I-Eq_Comparison
18 NCT03927287 617 619 I-Eq_Comparison
, NCT03927287 620 621 O

2 NCT03927287 625 626 O
. NCT03927287 626 627 O
Patients NCT03927287 629 637 O
with NCT03927287 638 642 O
prostate NCT03927287 643 651 B-Modifier
cancer NCT03927287 652 658 B-Condition
other NCT03927287 659 664 B-Exception
than NCT03927287 665 669 I-Exception
adenocarcinoma NCT03927287 670 684 B-Condition
, NCT03927287 685 686 O
such NCT03927287 687 691 O
as NCT03927287 692 694 O
small NCT03927287 695 700 B-Modifier
cell NCT03927287 701 705 I-Modifier
and NCT03927287 706 709 B-Or
neuroendocrine NCT03927287 710 724 B-Modifier
cancer NCT03927287 725 731 B-Condition

3 NCT03927287 734 735 O
. NCT03927287 735 736 O
Patients NCT03927287 738 746 O
with NCT03927287 747 751 O
prostate NCT03927287 752 760 B-Modifier
adenocarcinoma NCT03927287 761 775 B-Condition
that NCT03927287 776 780 B-And
did NCT03927287 781 784 O
not NCT03927287 785 788 B-Negation
develop NCT03927287 789 796 O
biochemical NCT03927287 797 808 B-Condition
recurrence NCT03927287 809 819 I-Condition
. NCT03927287 820 821 O

4 NCT03927287 825 826 O
. NCT03927287 826 827 O
In NCT03927287 829 831 O
the NCT03927287 832 835 O
retrospective NCT03927287 836 849 O
cohorts NCT03927287 850 857 O
- NCT03927287 858 859 O
patients NCT03927287 860 868 O
that NCT03927287 869 873 O
did NCT03927287 874 877 O
not NCT03927287 878 881 B-Negation
have NCT03927287 882 886 O
at NCT03927287 887 889 B-Eq_Comparison
least NCT03927287 890 895 I-Eq_Comparison
one NCT03927287 896 899 I-Eq_Comparison
post NCT03927287 900 904 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03927287 905 906 O
treatment NCT03927287 907 916 B-Procedure
free NCT03927287 917 921 O
PSA NCT03927287 922 925 B-Observation
blood NCT03927287 926 931 I-Observation
test NCT03927287 932 936 I-Observation
. NCT03927287 937 938 O

Key NCT03926195 0 3 O
Inclusion NCT03926195 4 13 O
Criteria NCT03926195 14 22 O
: NCT03926195 23 24 O

- NCT03926195 28 29 O
Male NCT03926195 31 35 O
participants NCT03926195 36 48 O
who NCT03926195 49 52 B-And
are NCT03926195 53 56 O
between NCT03926195 57 64 B-Eq_Comparison
the NCT03926195 65 68 I-Eq_Comparison
ages NCT03926195 69 73 I-Eq_Comparison
of NCT03926195 74 76 I-Eq_Comparison
21 NCT03926195 77 79 I-Eq_Comparison
and NCT03926195 80 83 I-Eq_Comparison
65 NCT03926195 84 86 I-Eq_Comparison
years NCT03926195 87 92 I-Eq_Comparison
( NCT03926195 93 94 O
inclusive NCT03926195 95 104 O
) NCT03926195 105 106 O
on NCT03926195 107 109 O
the NCT03926195 110 113 O
day NCT03926195 114 117 O
of NCT03926195 118 120 O
signing NCT03926195 121 128 O
informed NCT03926195 129 137 O
consent NCT03926195 138 145 O

- NCT03926195 148 149 O
Diagnosis NCT03926195 151 160 O
of NCT03926195 161 163 O
active NCT03926195 164 170 B-Eq_Comparison
rheumatoid NCT03926195 171 181 B-Condition
arthritis NCT03926195 182 191 I-Condition
, NCT03926195 192 193 O
psoriatic NCT03926195 194 203 B-Condition
arthritis NCT03926195 204 213 I-Condition
, NCT03926195 214 215 O
ankylosing NCT03926195 216 226 B-Condition
spondylitis NCT03926195 227 238 I-Condition
or NCT03926195 239 241 B-Or
, NCT03926195 242 243 O
non NCT03926195 244 247 B-Modifier
- NCT03926195 248 249 I-Modifier
radiographic NCT03926195 250 262 I-Modifier
axial NCT03926195 263 268 B-Condition
spondyloarthritis NCT03926195 269 286 I-Condition
for NCT03926195 287 290 O
at NCT03926195 291 293 B-Eq_Comparison
least NCT03926195 294 299 I-Eq_Comparison
12 NCT03926195 300 302 I-Eq_Comparison
weeks NCT03926195 303 308 I-Eq_Comparison
prior NCT03926195 309 314 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926195 315 317 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03926195 318 327 B-Study
, NCT03926195 328 329 O
meeting NCT03926195 330 337 O
the NCT03926195 338 341 O
corresponding NCT03926195 342 355 O
specific NCT03926195 356 364 O
disease NCT03926195 365 372 O
classification NCT03926195 373 387 O
criteria NCT03926195 388 396 O
as NCT03926195 397 399 O
specified NCT03926195 400 409 O
in NCT03926195 410 412 O
the NCT03926195 413 416 O
protocol NCT03926195 417 425 O

Key NCT03926195 426 429 O
Exclusion NCT03926195 430 439 O
Criteria NCT03926195 440 448 O
: NCT03926195 449 450 O

- NCT03926195 454 455 O
Previously NCT03926195 457 467 B-Eq_Comparison
documented NCT03926195 468 478 O
problems NCT03926195 479 487 B-Condition
with NCT03926195 488 492 I-Condition
male NCT03926195 493 497 I-Condition
reproductive NCT03926195 498 510 I-Condition
health NCT03926195 511 517 I-Condition

- NCT03926195 520 521 O
Prior NCT03926195 523 528 B-Eq_Comparison
diagnosis NCT03926195 529 538 O
of NCT03926195 539 541 O
male NCT03926195 542 546 B-Condition
infertility NCT03926195 547 558 I-Condition

- NCT03926195 561 562 O
Use NCT03926195 564 567 B-Eq_Comparison
of NCT03926195 568 570 O
any NCT03926195 571 574 O
prohibited NCT03926195 575 585 B-Modifier
concomitant NCT03926195 586 597 I-Modifier
medication NCT03926195 598 608 B-Drug
as NCT03926195 609 611 O
outlined NCT03926195 612 620 O
by NCT03926195 621 623 O
protocol NCT03926195 624 632 O

Note NCT03926195 633 637 O
: NCT03926195 638 639 O
Other NCT03926195 640 645 O
protocol NCT03926195 646 654 O
- NCT03926195 655 656 O
defined NCT03926195 657 664 O
Inclusion NCT03926195 665 674 O
/ NCT03926195 675 676 O
Exclusion NCT03926195 677 686 O
criteria NCT03926195 687 695 O
may NCT03926195 696 699 O
apply NCT03926195 700 705 O
. NCT03926195 706 707 O

Inclusion NCT03922958 0 9 O
Criteria NCT03922958 10 18 O
: NCT03922958 19 20 O

- NCT03922958 24 25 O
All NCT03922958 27 30 O
adults NCT03922958 31 37 O
undergoing NCT03922958 38 48 B-Eq_Comparison
cardiac NCT03922958 49 56 B-Procedure
surgery NCT03922958 57 64 I-Procedure
with NCT03922958 65 69 O
CPB NCT03922958 70 73 B-Procedure
will NCT03922958 74 78 O
be NCT03922958 79 81 O
considered NCT03922958 82 92 O
for NCT03922958 93 96 O
enrollment NCT03922958 97 107 O
. NCT03922958 108 109 O

Exclusion NCT03922958 111 120 O
Criteria NCT03922958 121 129 O
: NCT03922958 130 131 O

- NCT03922958 135 136 O
Factors NCT03922958 138 145 B-Condition
that NCT03922958 146 150 O
affect NCT03922958 151 157 O
immune NCT03922958 158 164 B-Condition
function NCT03922958 165 173 I-Condition
or NCT03922958 174 176 B-Or
AKI NCT03922958 177 180 B-Condition
assessment NCT03922958 181 191 O
are NCT03922958 192 195 O
the NCT03922958 196 199 O
basis NCT03922958 200 205 O
for NCT03922958 206 209 O
exclusion NCT03922958 210 219 O
criteria NCT03922958 220 228 O
: NCT03922958 229 230 O

- NCT03922958 239 240 O
Concurrent NCT03922958 242 252 O
disease NCT03922958 253 260 B-Condition
associated NCT03922958 261 271 O
with NCT03922958 272 276 O
immunosuppression NCT03922958 277 294 B-Condition
including NCT03922958 295 304 O
malignancy NCT03922958 305 315 B-Condition
, NCT03922958 316 317 O
chronic NCT03922958 318 325 B-Condition
infection NCT03922958 326 335 I-Condition
( NCT03922958 336 337 O
e NCT03922958 338 339 O
. NCT03922958 340 341 O
g NCT03922958 342 343 O
. NCT03922958 344 345 O
, NCT03922958 346 347 O
HIV NCT03922958 348 351 B-Condition
, NCT03922958 352 353 O
Hepatitis NCT03922958 354 363 B-Condition
C NCT03922958 364 365 I-Condition
) NCT03922958 366 367 O
, NCT03922958 368 369 O
organ NCT03922958 370 375 B-Procedure
transplant NCT03922958 376 386 I-Procedure
and NCT03922958 387 390 B-Or
immunosuppressant NCT03922958 391 408 B-Drug
medications NCT03922958 409 420 I-Drug

- NCT03922958 428 429 O
Documented NCT03922958 431 441 O
acute NCT03922958 442 447 B-Condition
infection NCT03922958 448 457 I-Condition
with NCT03922958 458 462 O
the NCT03922958 463 466 B-Eq_Comparison
past NCT03922958 467 471 I-Eq_Comparison
1 NCT03922958 472 473 I-Eq_Comparison
month NCT03922958 474 479 I-Eq_Comparison
( NCT03922958 480 481 O
e NCT03922958 482 483 O
. NCT03922958 484 485 O
g NCT03922958 486 487 O
. NCT03922958 488 489 O
, NCT03922958 490 491 O
pneumonia NCT03922958 492 501 B-Condition
, NCT03922958 502 503 O
urinary NCT03922958 504 511 B-Condition
tract NCT03922958 512 517 I-Condition
infection NCT03922958 518 527 I-Condition
) NCT03922958 528 529 O

- NCT03922958 538 539 O
Prednisone NCT03922958 541 551 B-Drug
or NCT03922958 552 554 B-Or
other NCT03922958 555 560 O
steroid NCT03922958 561 568 B-Drug
use NCT03922958 569 572 O
currently NCT03922958 573 582 B-Eq_Comparison
or NCT03922958 583 585 B-Or
within NCT03922958 586 592 B-Eq_Comparison
the NCT03922958 593 596 I-Eq_Comparison
past NCT03922958 597 601 I-Eq_Comparison
one NCT03922958 602 605 I-Eq_Comparison
month NCT03922958 606 611 I-Eq_Comparison

- NCT03922958 619 620 O
AKI NCT03922958 622 625 B-Condition
at NCT03922958 626 628 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03922958 629 632 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03922958 633 637 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03922958 638 640 O
surgery NCT03922958 641 648 B-Procedure

- NCT03922958 656 657 O
ESRD NCT03922958 659 663 B-Condition
requiring NCT03922958 664 673 B-Assertion___Assertion_Type_Value:hypothetical
renal NCT03922958 674 679 B-Procedure
replacement NCT03922958 680 691 I-Procedure
therapy NCT03922958 692 699 I-Procedure

- NCT03922958 707 708 O
Estimated NCT03922958 710 719 O
GFR NCT03922958 720 723 B-Observation
< NCT03922958 724 725 B-Eq_Comparison
45 NCT03922958 726 728 I-Eq_Comparison
mL NCT03922958 729 731 I-Eq_Comparison
/ NCT03922958 732 733 I-Eq_Comparison
min NCT03922958 734 737 I-Eq_Comparison
( NCT03922958 738 739 O
as NCT03922958 740 742 O
judged NCT03922958 743 749 O
by NCT03922958 750 752 O
the NCT03922958 753 756 O
Chronic NCT03922958 757 764 O
Kidney NCT03922958 765 771 O
Disease NCT03922958 772 779 O
Epidemiology NCT03922958 780 792 O
Collaboration NCT03922958 793 806 O
( NCT03922958 807 808 O
CKD NCT03922958 809 812 O
- NCT03922958 813 814 O
EPI NCT03922958 815 818 O
) NCT03922958 819 820 O
equation NCT03922958 821 829 O

Inclusion NCT03864731 0 9 O
Criteria NCT03864731 10 18 O
: NCT03864731 19 20 O

- NCT03864731 24 25 O
Unilateral NCT03864731 27 37 B-Modifier
and NCT03864731 38 41 B-Or
/ NCT03864731 42 43 I-Or
or NCT03864731 44 46 I-Or
bilateral NCT03864731 47 56 B-Modifier
conductive NCT03864731 57 67 B-Condition
hearing NCT03864731 68 75 I-Condition
loss NCT03864731 76 80 I-Condition
( NCT03864731 81 82 O
CHL NCT03864731 83 86 B-Condition
) NCT03864731 87 88 O

- NCT03864731 92 93 O
Conductive NCT03864731 95 105 B-Modifier
hearing NCT03864731 106 113 B-Condition
loss NCT03864731 114 118 I-Condition
> NCT03864731 119 120 B-Eq_Comparison
10 NCT03864731 121 123 I-Eq_Comparison
decibel NCT03864731 124 131 I-Eq_Comparison
on NCT03864731 132 134 O
average NCT03864731 135 142 O

- NCT03864731 145 146 O
Subjective NCT03864731 148 158 O
benefit NCT03864731 159 166 O
from NCT03864731 167 171 O
the NCT03864731 172 175 O
device NCT03864731 176 182 O

- NCT03864731 185 186 O
Subjects NCT03864731 188 196 O
aged NCT03864731 197 201 B-Age
13 NCT03864731 202 204 B-Eq_Comparison
years NCT03864731 205 210 I-Eq_Comparison
or NCT03864731 211 213 I-Eq_Comparison
older NCT03864731 214 219 I-Eq_Comparison

- NCT03864731 222 223 O
Capable NCT03864731 225 232 O
of NCT03864731 233 235 O
the NCT03864731 236 239 O
German NCT03864731 240 246 O
language NCT03864731 247 255 O

- NCT03864731 258 259 O
Willingness NCT03864731 261 272 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03864731 273 276 I-Assertion___Assertion_Type_Value:hypothetical
ability NCT03864731 277 284 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03864731 285 287 O
perform NCT03864731 288 295 O
all NCT03864731 296 299 O
tests NCT03864731 300 305 B-Observation
required NCT03864731 306 314 O
for NCT03864731 315 318 O
the NCT03864731 319 322 O
study NCT03864731 323 328 B-Study

- NCT03864731 331 332 O
Signed NCT03864731 334 340 O
, NCT03864731 341 342 O
and NCT03864731 343 346 O
dated NCT03864731 347 352 O
informed NCT03864731 353 361 O
consent NCT03864731 362 369 O
before NCT03864731 370 376 O
the NCT03864731 377 380 O
start NCT03864731 381 386 O
of NCT03864731 387 389 O
any NCT03864731 390 393 O
study NCT03864731 394 399 B-Study
specific NCT03864731 400 408 O
procedure NCT03864731 409 418 B-Procedure

Exclusion NCT03864731 419 428 O
Criteria NCT03864731 429 437 O
: NCT03864731 438 439 O

- NCT03864731 443 444 O
Pregnancy NCT03864731 446 455 B-Condition
or NCT03864731 456 458 B-Or
breastfeeding NCT03864731 459 472 B-Condition

- NCT03864731 475 476 O
Patient NCT03864731 478 485 O
uses NCT03864731 486 490 O
a NCT03864731 491 492 O
hearing NCT03864731 493 500 B-Condition
aid NCT03864731 501 504 I-Condition
or NCT03864731 505 507 B-Or
plans NCT03864731 508 513 B-Assertion___Assertion_Type_Value:intention
to NCT03864731 514 516 O
acquire NCT03864731 517 524 O
a NCT03864731 525 526 O
hearing NCT03864731 527 534 B-Condition
aid NCT03864731 535 538 I-Condition

- NCT03864731 541 542 O
Patient NCT03864731 544 551 O
is NCT03864731 552 554 O
intolerant NCT03864731 555 565 O
of NCT03864731 566 568 O
the NCT03864731 569 572 O
materials NCT03864731 573 582 O
as NCT03864731 583 585 O
described NCT03864731 586 595 O
by NCT03864731 596 598 O
Manufacturer NCT03864731 599 611 O

- NCT03864731 614 615 O
Patient NCT03864731 617 624 O
presents NCT03864731 625 633 O
with NCT03864731 634 638 O
a NCT03864731 639 640 O
skin NCT03864731 641 645 B-Modifier
or NCT03864731 646 648 B-Or
scalp NCT03864731 649 654 B-Modifier
condition NCT03864731 655 664 B-Condition
that NCT03864731 665 669 O
may NCT03864731 670 673 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03864731 674 682 B-Negation
the NCT03864731 683 686 O
attachment NCT03864731 687 697 B-Procedure
of NCT03864731 698 700 I-Procedure
the NCT03864731 701 704 I-Procedure
adhesive NCT03864731 705 713 I-Procedure
adapter NCT03864731 714 721 I-Procedure
. NCT03864731 722 723 O

- NCT03864731 727 728 O
Patient NCT03864731 730 737 O
can NCT03864731 738 741 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03864731 741 744 I-Assertion___Assertion_Type_Value:hypothetical
perform NCT03864731 745 752 O
the NCT03864731 753 756 O
audiological NCT03864731 757 769 B-Procedure
tests NCT03864731 770 775 I-Procedure
or NCT03864731 776 778 B-Or
is NCT03864731 779 781 O
unable NCT03864731 782 788 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03864731 789 791 O
fill NCT03864731 792 796 O
out NCT03864731 797 800 O
the NCT03864731 801 804 O
questionnaires NCT03864731 805 819 B-Observation
. NCT03864731 820 821 O

- NCT03864731 825 826 O
Patient NCT03864731 828 835 O
presents NCT03864731 836 844 O
with NCT03864731 845 849 O
retrocochlear NCT03864731 850 863 B-Condition
, NCT03864731 864 865 O
or NCT03864731 866 868 B-Or
central NCT03864731 869 876 B-Modifier
auditory NCT03864731 877 885 B-Condition
disorder NCT03864731 886 894 I-Condition
. NCT03864731 895 896 O

- NCT03864731 900 901 O
any NCT03864731 903 906 O
physical NCT03864731 907 915 B-Modifier
, NCT03864731 916 917 O
psychological NCT03864731 918 931 B-Modifier
, NCT03864731 932 933 O
or NCT03864731 934 936 B-Or
emotional NCT03864731 937 946 B-Modifier
disorder NCT03864731 947 955 B-Condition
that NCT03864731 956 960 O
would NCT03864731 961 966 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03864731 967 976 O
with NCT03864731 977 981 O
the NCT03864731 982 985 O
ability NCT03864731 986 993 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864731 994 996 I-Assertion___Assertion_Type_Value:hypothetical
perform NCT03864731 997 1004 O
on NCT03864731 1005 1007 O
test NCT03864731 1008 1012 B-Observation
and NCT03864731 1013 1016 B-Or
rehabilitation NCT03864731 1017 1031 B-Procedure
procedures NCT03864731 1032 1042 I-Procedure

Inclusion NCT03869307 0 9 O
Criteria NCT03869307 10 18 O
: NCT03869307 19 20 O

- NCT03869307 24 25 O
Men NCT03869307 27 30 O
and NCT03869307 31 34 B-Or
women NCT03869307 35 40 O
aged NCT03869307 41 45 B-Age
18 NCT03869307 46 48 B-Eq_Comparison
- NCT03869307 49 50 I-Eq_Comparison
65 NCT03869307 51 53 I-Eq_Comparison

- NCT03869307 57 58 O
Generalized NCT03869307 60 71 B-Modifier
HSD NCT03869307 72 75 B-Condition
( NCT03869307 76 77 O
G NCT03869307 78 79 B-Condition
- NCT03869307 80 81 I-Condition
HSD NCT03869307 82 85 I-Condition
) NCT03869307 86 87 O
defined NCT03869307 88 95 O
with NCT03869307 96 100 O
Beighton NCT03869307 101 109 B-Observation
score NCT03869307 110 115 I-Observation
cut NCT03869307 116 119 O
- NCT03869307 120 121 O
off NCT03869307 122 125 O
≥ NCT03869307 126 127 B-Eq_Comparison
5 NCT03869307 128 129 I-Eq_Comparison
for NCT03869307 130 133 O
women NCT03869307 134 139 O
up NCT03869307 140 142 B-Eq_Comparison
to NCT03869307 143 145 I-Eq_Comparison
the NCT03869307 146 149 I-Eq_Comparison
age NCT03869307 150 153 I-Eq_Comparison
of NCT03869307 154 156 I-Eq_Comparison
50 NCT03869307 157 159 I-Eq_Comparison
years NCT03869307 160 165 I-Eq_Comparison
and NCT03869307 166 169 B-Or
≥ NCT03869307 170 171 B-Eq_Comparison
4 NCT03869307 172 173 I-Eq_Comparison
for NCT03869307 174 177 O
those NCT03869307 178 183 O
above NCT03869307 184 189 B-Eq_Comparison
50 NCT03869307 190 192 I-Eq_Comparison
years NCT03869307 193 198 I-Eq_Comparison
and NCT03869307 199 202 B-Or
all NCT03869307 203 206 O
men NCT03869307 207 210 O
, NCT03869307 211 212 O
or NCT03869307 213 215 B-Or
Historical NCT03869307 216 226 B-Modifier
HSD NCT03869307 227 230 B-Condition
( NCT03869307 231 232 O
H NCT03869307 233 234 B-Condition
- NCT03869307 235 236 I-Condition
HSD NCT03869307 237 240 I-Condition
) NCT03869307 241 242 O
if NCT03869307 243 245 O
the NCT03869307 246 249 O
Beighton NCT03869307 250 258 B-Observation
score NCT03869307 259 264 I-Observation
was NCT03869307 265 268 O
1 NCT03869307 269 270 B-Eq_Comparison
point NCT03869307 271 276 I-Eq_Comparison
below NCT03869307 277 282 I-Eq_Comparison
the NCT03869307 283 286 I-Eq_Comparison
age NCT03869307 287 290 I-Eq_Comparison
and NCT03869307 291 294 I-Eq_Comparison
sex NCT03869307 295 298 I-Eq_Comparison
- NCT03869307 299 300 I-Eq_Comparison
specific NCT03869307 301 309 I-Eq_Comparison
cut NCT03869307 310 313 I-Eq_Comparison
- NCT03869307 314 315 I-Eq_Comparison
off NCT03869307 316 319 I-Eq_Comparison
AND NCT03869307 320 323 B-And
the NCT03869307 324 327 O
five NCT03869307 328 332 B-Observation
- NCT03869307 333 334 I-Observation
part NCT03869307 335 339 I-Observation
questionnaire NCT03869307 340 353 I-Observation
( NCT03869307 354 355 O
5 NCT03869307 356 357 B-Observation
PQ NCT03869307 358 360 I-Observation
) NCT03869307 361 362 O
was NCT03869307 363 366 O
positive NCT03869307 367 375 O
( NCT03869307 376 377 O
= NCT03869307 378 379 O
at NCT03869307 380 382 B-Eq_Comparison
least NCT03869307 383 388 I-Eq_Comparison
two NCT03869307 389 392 I-Eq_Comparison
positive NCT03869307 393 401 I-Eq_Comparison
items NCT03869307 402 407 I-Eq_Comparison
) NCT03869307 408 409 O
. NCT03869307 410 411 O

- NCT03869307 415 416 O
Present NCT03869307 418 425 O
with NCT03869307 426 430 O
one NCT03869307 431 434 B-Eq_Comparison
or NCT03869307 435 437 I-Eq_Comparison
more NCT03869307 438 442 I-Eq_Comparison
secondary NCT03869307 443 452 B-Modifier
symptomatic NCT03869307 453 464 B-Assertion___Assertion_Type_Value:possible
musculoskeletal NCT03869307 465 480 B-Condition
manifestations NCT03869307 481 495 I-Condition
, NCT03869307 496 497 O
defined NCT03869307 498 505 O
as NCT03869307 506 508 O
either NCT03869307 509 515 O

1 NCT03869307 523 524 O
. NCT03869307 524 525 O
musculoskeletal NCT03869307 527 542 B-Modifier
pain NCT03869307 543 547 B-Condition
in NCT03869307 548 550 O
minimum NCT03869307 551 558 B-Eq_Comparison
one NCT03869307 559 562 I-Eq_Comparison
shoulder NCT03869307 563 571 B-Modifier
for NCT03869307 572 575 O
at NCT03869307 576 578 B-Eq_Comparison
least NCT03869307 579 584 I-Eq_Comparison
three NCT03869307 585 590 I-Eq_Comparison
months NCT03869307 591 597 I-Eq_Comparison
and NCT03869307 598 601 B-Or
/ NCT03869307 602 603 I-Or
or NCT03869307 604 606 I-Or

2 NCT03869307 614 615 O
. NCT03869307 615 616 O
recurrent NCT03869307 618 627 B-Modifier
joint NCT03869307 628 633 I-Modifier
dislocations NCT03869307 634 646 B-Condition
or NCT03869307 647 649 B-Or
joint NCT03869307 650 655 B-Modifier
instability NCT03869307 656 667 B-Condition
without NCT03869307 668 675 B-Negation
a NCT03869307 676 677 O
reported NCT03869307 678 686 O
history NCT03869307 687 694 B-Eq_Comparison
of NCT03869307 695 697 O
trauma NCT03869307 698 704 B-Condition
defined NCT03869307 705 712 O
as NCT03869307 713 715 O
either NCT03869307 716 722 O
a NCT03869307 723 724 O
) NCT03869307 725 726 O
minimum NCT03869307 727 734 B-Eq_Comparison
three NCT03869307 735 740 I-Eq_Comparison
atraumatic NCT03869307 741 751 B-Modifier
dislocations NCT03869307 752 764 B-Condition
in NCT03869307 765 767 O
same NCT03869307 768 772 B-Modifier
shoulder NCT03869307 773 781 I-Modifier
, NCT03869307 782 783 O
b NCT03869307 784 785 O
) NCT03869307 786 787 O
minimum NCT03869307 788 795 B-Eq_Comparison
two NCT03869307 796 799 I-Eq_Comparison
atraumatic NCT03869307 800 810 B-Modifier
dislocations NCT03869307 811 823 B-Condition
in NCT03869307 824 826 O
two NCT03869307 827 830 B-Modifier
different NCT03869307 831 840 I-Modifier
joints NCT03869307 841 847 I-Modifier
( NCT03869307 848 849 O
minimum NCT03869307 850 857 B-Eq_Comparison
one NCT03869307 858 861 I-Eq_Comparison
in NCT03869307 862 864 O
the NCT03869307 865 868 O
shoulder NCT03869307 869 877 B-Modifier
) NCT03869307 878 879 O
occurring NCT03869307 880 889 O
at NCT03869307 890 892 O
different NCT03869307 893 902 O
times NCT03869307 903 908 O
, NCT03869307 909 910 O
or NCT03869307 911 913 B-Or
c NCT03869307 914 915 O
) NCT03869307 916 917 O
medical NCT03869307 918 925 O
confirmation NCT03869307 926 938 O
of NCT03869307 939 941 O
joint NCT03869307 942 947 B-Modifier
instability NCT03869307 948 959 B-Condition
in NCT03869307 960 962 O
minimum NCT03869307 963 970 B-Eq_Comparison
two NCT03869307 971 974 I-Eq_Comparison
joints NCT03869307 975 981 I-Eq_Comparison
( NCT03869307 982 983 O
minimum NCT03869307 984 991 B-Eq_Comparison
one NCT03869307 992 995 I-Eq_Comparison
in NCT03869307 996 998 B-Modifier
the NCT03869307 999 1002 I-Modifier
shoulder NCT03869307 1003 1011 I-Modifier
) NCT03869307 1012 1013 O
not NCT03869307 1014 1017 B-Negation
related NCT03869307 1018 1025 O
to NCT03869307 1026 1028 O
trauma NCT03869307 1029 1035 B-Condition
. NCT03869307 1036 1037 O

Exclusion NCT03869307 1039 1048 O
Criteria NCT03869307 1049 1057 O
: NCT03869307 1058 1059 O

- NCT03869307 1063 1064 O
Clinically NCT03869307 1066 1076 O
suspected NCT03869307 1077 1086 B-Assertion___Assertion_Type_Value:possible
referred NCT03869307 1087 1095 O
pain NCT03869307 1096 1100 B-Condition
from NCT03869307 1101 1105 O
the NCT03869307 1106 1109 O
cervical NCT03869307 1110 1118 B-Modifier
spine NCT03869307 1119 1124 I-Modifier

- NCT03869307 1127 1128 O
Systemic NCT03869307 1130 1138 B-Modifier
inflammatory NCT03869307 1139 1151 B-Condition
rheumatic NCT03869307 1152 1161 I-Condition
diseases NCT03869307 1162 1170 I-Condition

- NCT03869307 1173 1174 O
Connective NCT03869307 1176 1186 B-Condition
tissue NCT03869307 1187 1193 I-Condition
diseases NCT03869307 1194 1202 I-Condition
( NCT03869307 1203 1204 O
e NCT03869307 1205 1206 O
. NCT03869307 1207 1208 O
g NCT03869307 1209 1210 O
. NCT03869307 1211 1212 O
Marfans NCT03869307 1214 1221 B-Condition
, NCT03869307 1222 1223 O
Stickler NCT03869307 1224 1232 B-Condition
's NCT03869307 1232 1234 I-Condition
or NCT03869307 1235 1237 B-Or
Loeys NCT03869307 1238 1243 B-Condition
Dietz NCT03869307 1244 1249 I-Condition
syndromes NCT03869307 1250 1259 I-Condition
, NCT03869307 1260 1261 O
Ehlers NCT03869307 1262 1268 B-Condition
- NCT03869307 1269 1270 I-Condition
Danlos NCT03869307 1271 1277 I-Condition
Syndromes NCT03869307 1278 1287 I-Condition
except NCT03869307 1288 1294 B-Exception
hypermobile NCT03869307 1295 1306 B-Modifier
type NCT03869307 1307 1311 I-Modifier
) NCT03869307 1312 1313 O

- NCT03869307 1317 1318 O
Neurological NCT03869307 1320 1332 B-Condition
diseases NCT03869307 1333 1341 I-Condition

- NCT03869307 1344 1345 O
Pregnancy NCT03869307 1347 1356 B-Condition
or NCT03869307 1357 1359 B-Or
childbirth NCT03869307 1360 1370 B-Condition
within NCT03869307 1371 1377 B-Eq_Comparison
the NCT03869307 1378 1381 I-Eq_Comparison
past NCT03869307 1382 1386 I-Eq_Comparison
year NCT03869307 1387 1391 I-Eq_Comparison
or NCT03869307 1392 1394 B-Or
planning NCT03869307 1395 1403 B-Assertion___Assertion_Type_Value:intention
to NCT03869307 1404 1406 I-Assertion___Assertion_Type_Value:intention
get NCT03869307 1407 1410 O
pregnant NCT03869307 1411 1419 B-Condition
during NCT03869307 1420 1426 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03869307 1427 1430 O
study NCT03869307 1431 1436 B-Study
period NCT03869307 1437 1443 O

- NCT03869307 1446 1447 O
Shoulder NCT03869307 1449 1457 B-Modifier
surgery NCT03869307 1458 1465 B-Procedure
within NCT03869307 1466 1472 B-Eq_Comparison
the NCT03869307 1473 1476 I-Eq_Comparison
past NCT03869307 1477 1481 I-Eq_Comparison
year NCT03869307 1482 1486 I-Eq_Comparison

- NCT03869307 1489 1490 O
Steroid NCT03869307 1492 1499 B-Procedure
injection NCT03869307 1500 1509 I-Procedure
in NCT03869307 1510 1512 O
the NCT03869307 1513 1516 O
affected NCT03869307 1517 1525 B-Modifier
shoulder NCT03869307 1526 1534 I-Modifier
within NCT03869307 1535 1541 B-Eq_Comparison
three NCT03869307 1542 1547 I-Eq_Comparison
months NCT03869307 1548 1554 I-Eq_Comparison

- NCT03869307 1557 1558 O
Inability NCT03869307 1560 1569 B-Negation
to NCT03869307 1570 1572 O
speak NCT03869307 1573 1578 O
and NCT03869307 1579 1582 O
understand NCT03869307 1583 1593 O
Danish NCT03869307 1594 1600 O
. NCT03869307 1601 1602 O

- NCT03869307 1606 1607 O
Unable NCT03869307 1609 1615 O
to NCT03869307 1616 1618 O
comply NCT03869307 1619 1625 O
with NCT03869307 1626 1630 O
protocol NCT03869307 1631 1639 O

Inclusion NCT03860688 0 9 O
Criteria NCT03860688 10 18 O
: NCT03860688 19 20 O

- NCT03860688 24 25 O
Men NCT03860688 27 30 O
and NCT03860688 31 34 B-Or
women NCT03860688 35 40 O
, NCT03860688 41 42 O
aged NCT03860688 43 47 B-Age
18 NCT03860688 48 50 B-Eq_Comparison
to NCT03860688 51 53 I-Eq_Comparison
60 NCT03860688 54 56 I-Eq_Comparison
years NCT03860688 57 62 I-Eq_Comparison
. NCT03860688 63 64 O

- NCT03860688 68 69 O
Body NCT03860688 71 75 B-Observation
mass NCT03860688 76 80 I-Observation
index NCT03860688 81 86 I-Observation
20 NCT03860688 87 89 B-Eq_Comparison
to NCT03860688 90 92 I-Eq_Comparison
27 NCT03860688 93 95 I-Eq_Comparison
kg NCT03860688 96 98 I-Eq_Comparison
/ NCT03860688 99 100 I-Eq_Comparison
m NCT03860688 101 102 I-Eq_Comparison
2 NCT03860688 103 104 I-Eq_Comparison

Exclusion NCT03860688 105 114 O
Criteria NCT03860688 115 123 O
: NCT03860688 124 125 O

1 NCT03860688 129 130 O
. NCT03860688 130 131 O
Patients NCT03860688 133 141 O
with NCT03860688 142 146 O
active NCT03860688 147 153 B-Eq_Comparison
inflammatory NCT03860688 154 166 B-Condition
bowel NCT03860688 167 172 I-Condition
disease NCT03860688 173 180 I-Condition

2 NCT03860688 183 184 O
. NCT03860688 184 185 O
Patients NCT03860688 187 195 O
with NCT03860688 196 200 O
pre NCT03860688 201 204 B-Eq_Comparison
- NCT03860688 205 206 I-Eq_Comparison
existing NCT03860688 207 215 I-Eq_Comparison
Celiac NCT03860688 216 222 B-Condition
disease NCT03860688 223 230 I-Condition
, NCT03860688 231 232 O
exocrine NCT03860688 233 241 B-Condition
pancreatic NCT03860688 242 252 I-Condition
insufficiency NCT03860688 253 266 I-Condition
or NCT03860688 267 269 B-Or
small NCT03860688 270 275 B-Condition
bowel NCT03860688 276 281 I-Condition
malabsorption NCT03860688 282 295 I-Condition

3 NCT03860688 298 299 O
. NCT03860688 299 300 O
Patients NCT03860688 302 310 O
with NCT03860688 311 315 O
active NCT03860688 316 322 B-Eq_Comparison
bowel NCT03860688 323 328 B-Condition
malignancy NCT03860688 329 339 I-Condition

4 NCT03860688 342 343 O
. NCT03860688 343 344 O
Patients NCT03860688 346 354 O
with NCT03860688 355 359 O
diabetes NCT03860688 360 368 B-Condition
mellitus NCT03860688 369 377 I-Condition
or NCT03860688 378 380 B-Or
known NCT03860688 381 386 B-Modifier
/ NCT03860688 387 388 B-Or
suspected NCT03860688 389 398 B-Assertion___Assertion_Type_Value:possible
motility NCT03860688 399 407 B-Condition
disorders NCT03860688 408 417 I-Condition
of NCT03860688 418 420 O
the NCT03860688 421 424 O
gut NCT03860688 425 428 B-Modifier

5 NCT03860688 431 432 O
. NCT03860688 432 433 O
Patients NCT03860688 435 443 O
with NCT03860688 444 448 O
decompensated NCT03860688 449 462 B-Modifier
liver NCT03860688 463 468 B-Condition
disease NCT03860688 469 476 I-Condition

6 NCT03860688 479 480 O
. NCT03860688 480 481 O
Patients NCT03860688 483 491 O
on NCT03860688 492 494 B-Eq_Comparison
ezetimibe NCT03860688 495 504 B-Drug
or NCT03860688 505 507 B-Or
bile NCT03860688 508 512 B-Drug
acid NCT03860688 513 517 I-Drug
sequestrants NCT03860688 518 530 I-Drug

7 NCT03860688 533 534 O
. NCT03860688 534 535 O
Patients NCT03860688 537 545 O
who NCT03860688 546 549 O
are NCT03860688 550 553 B-Eq_Comparison
pregnant NCT03860688 554 562 B-Condition
or NCT03860688 563 565 B-Or
breastfeeding NCT03860688 566 579 B-Condition
. NCT03860688 580 581 O

8 NCT03860688 585 586 O
. NCT03860688 586 587 O
Patients NCT03860688 589 597 O
with NCT03860688 598 602 O
renal NCT03860688 603 608 B-Condition
disease NCT03860688 609 616 I-Condition
. NCT03860688 617 618 O

9 NCT03860688 622 623 O
. NCT03860688 623 624 O
Patients NCT03860688 626 634 O
on NCT03860688 635 637 B-Eq_Comparison
benzodiazepine NCT03860688 638 652 B-Drug
. NCT03860688 653 654 O

10 NCT03860688 657 659 O
. NCT03860688 659 660 O
Unstable NCT03860688 662 670 O
cardiac NCT03860688 671 678 B-Modifier
or NCT03860688 679 681 B-Or
respiratory NCT03860688 682 693 B-Modifier
disease NCT03860688 694 701 B-Condition

11 NCT03860688 703 705 O
. NCT03860688 705 706 O
Any NCT03860688 708 711 O
changes NCT03860688 712 719 O
to NCT03860688 720 722 O
medication NCT03860688 723 733 B-Drug
in NCT03860688 734 736 O
the NCT03860688 737 740 O
preceding NCT03860688 741 750 B-Eq_Comparison
month NCT03860688 751 756 I-Eq_Comparison

12 NCT03860688 758 760 O
. NCT03860688 760 761 O
Patients NCT03860688 763 771 O
with NCT03860688 772 776 O
hypersensitive NCT03860688 777 791 B-Condition
to NCT03860688 792 794 O
Revestive NCT03860688 795 804 B-Drug
or NCT03860688 805 807 B-Or
any NCT03860688 808 811 O
ingredient NCT03860688 812 822 O
, NCT03860688 823 824 O
active NCT03860688 825 831 B-Eq_Comparison
or NCT03860688 832 834 B-Or
a NCT03860688 835 836 O
history NCT03860688 837 844 B-Eq_Comparison
of NCT03860688 845 847 O
the NCT03860688 848 851 O
drug NCT03860688 852 856 O
within NCT03860688 857 863 B-Eq_Comparison
the NCT03860688 864 867 I-Eq_Comparison
last NCT03860688 868 872 I-Eq_Comparison
5 NCT03860688 873 874 I-Eq_Comparison
years NCT03860688 875 880 I-Eq_Comparison

13 NCT03860688 882 884 O
. NCT03860688 884 885 O
Patients NCT03860688 887 895 O
with NCT03860688 896 900 O
GI NCT03860688 901 903 B-Condition
malignancy NCT03860688 904 914 I-Condition
( NCT03860688 915 916 O
GI NCT03860688 917 919 B-Modifier
tract NCT03860688 920 925 I-Modifier
, NCT03860688 926 927 O
hepatobiliary NCT03860688 928 941 B-Modifier
, NCT03860688 942 943 O
pancreatic NCT03860688 944 954 B-Modifier
) NCT03860688 955 956 O

Inclusion NCT03924466 0 9 O
Criteria NCT03924466 10 18 O
: NCT03924466 19 20 O

Patients NCT03924466 22 30 O
will NCT03924466 31 35 O
only NCT03924466 36 40 O
be NCT03924466 41 43 O
included NCT03924466 44 52 O
in NCT03924466 53 55 O
the NCT03924466 56 59 O
study NCT03924466 60 65 O
if NCT03924466 66 68 O
they NCT03924466 69 73 O
meet NCT03924466 74 78 O
all NCT03924466 79 82 O
of NCT03924466 83 85 O
the NCT03924466 86 89 B-Criteria_Count
following NCT03924466 90 99 I-Criteria_Count
criteria NCT03924466 100 108 I-Criteria_Count
: NCT03924466 109 110 O

- NCT03924466 114 115 O
Patient NCT03924466 117 124 O
who NCT03924466 125 128 O
has NCT03924466 129 132 O
given NCT03924466 133 138 O
informed NCT03924466 139 147 O
consent NCT03924466 148 155 O

- NCT03924466 158 159 O
Patient NCT03924466 161 168 O
with NCT03924466 169 173 O
age NCT03924466 174 177 B-Age
18 NCT03924466 178 180 B-Eq_Comparison
years NCT03924466 181 186 I-Eq_Comparison
or NCT03924466 187 189 I-Eq_Comparison
older NCT03924466 190 195 I-Eq_Comparison

- NCT03924466 198 199 O
Patient NCT03924466 201 208 O
with NCT03924466 209 213 O
locally NCT03924466 214 221 B-Modifier
or NCT03924466 222 224 B-Or
distantly NCT03924466 225 234 B-Modifier
advanced NCT03924466 235 243 I-Modifier
breast NCT03924466 244 250 I-Modifier
carcinoma NCT03924466 251 260 B-Condition
, NCT03924466 261 262 O
with NCT03924466 263 267 B-And
at NCT03924466 268 270 B-Eq_Comparison
least NCT03924466 271 276 I-Eq_Comparison
1 NCT03924466 277 278 I-Eq_Comparison
lesion NCT03924466 279 285 B-Observation
of NCT03924466 286 288 O
at NCT03924466 289 291 B-Eq_Comparison
least NCT03924466 292 297 I-Eq_Comparison
12 NCT03924466 298 300 I-Eq_Comparison
mm NCT03924466 301 303 I-Eq_Comparison
maximal NCT03924466 304 311 B-Modifier
diameter NCT03924466 312 320 I-Modifier
. NCT03924466 321 322 O
For NCT03924466 324 327 O
lymph NCT03924466 328 333 B-Modifier
node NCT03924466 334 338 I-Modifier
metastases NCT03924466 339 349 B-Observation
, NCT03924466 350 351 O
the NCT03924466 352 355 O
largest NCT03924466 356 363 B-Modifier
diameter NCT03924466 364 372 I-Modifier
should NCT03924466 373 379 O
be NCT03924466 380 382 O
at NCT03924466 383 385 B-Eq_Comparison
least NCT03924466 386 391 I-Eq_Comparison
15 NCT03924466 392 394 I-Eq_Comparison
mm NCT03924466 395 397 I-Eq_Comparison
and NCT03924466 398 401 B-And
the NCT03924466 402 405 O
short NCT03924466 406 411 B-Observation
axis NCT03924466 412 416 I-Observation
at NCT03924466 417 419 B-Eq_Comparison
least NCT03924466 420 425 I-Eq_Comparison
12 NCT03924466 426 428 I-Eq_Comparison
mm NCT03924466 429 431 I-Eq_Comparison
. NCT03924466 432 433 O

Exclusion NCT03924466 435 444 O
Criteria NCT03924466 445 453 O
: NCT03924466 454 455 O

Patients NCT03924466 457 465 O
will NCT03924466 466 470 O
not NCT03924466 471 474 B-Negation
be NCT03924466 475 477 O
included NCT03924466 478 486 O
in NCT03924466 487 489 O
the NCT03924466 490 493 O
study NCT03924466 494 499 B-Study
if NCT03924466 500 502 O
one NCT03924466 503 506 O
or NCT03924466 507 509 O
more NCT03924466 510 514 O
of NCT03924466 515 517 O
the NCT03924466 518 521 O
following NCT03924466 522 531 O
criteria NCT03924466 532 540 O

applies NCT03924466 541 548 O
: NCT03924466 549 550 O

- NCT03924466 554 555 O
Patient NCT03924466 557 564 O
is NCT03924466 565 567 B-Eq_Comparison
pregnant NCT03924466 568 576 B-Condition

- NCT03924466 579 580 O
Patient NCT03924466 582 589 O
is NCT03924466 590 592 B-Eq_Comparison
breast NCT03924466 593 599 B-Condition
feeding NCT03924466 600 607 I-Condition

- NCT03924466 610 611 O
Patient NCT03924466 613 620 O
with NCT03924466 621 625 O
recent NCT03924466 626 632 B-Eq_Comparison
( NCT03924466 633 634 O
< NCT03924466 635 636 B-Eq_Comparison
1 NCT03924466 637 638 I-Eq_Comparison
week NCT03924466 639 643 I-Eq_Comparison
) NCT03924466 644 645 O
gastrointestinal NCT03924466 646 662 B-Condition
disorders NCT03924466 663 672 I-Condition
with NCT03924466 673 677 O
diarrhea NCT03924466 678 686 B-Condition
as NCT03924466 687 689 O
major NCT03924466 690 695 O
symptom NCT03924466 696 703 O

- NCT03924466 706 707 O
Patient NCT03924466 709 716 O
with NCT03924466 717 721 O
any NCT03924466 722 725 O
serious NCT03924466 726 733 O
active NCT03924466 734 740 B-Eq_Comparison
infection NCT03924466 741 750 B-Condition

- NCT03924466 753 754 O
Patient NCT03924466 756 763 O
who NCT03924466 764 767 O
has NCT03924466 768 771 O
any NCT03924466 772 775 O
other NCT03924466 776 781 B-Other
life NCT03924466 782 786 B-Death|B-Risk
- NCT03924466 787 788 I-Death|I-Risk
threatening NCT03924466 789 800 I-Death|I-Risk
illness NCT03924466 801 808 B-Condition
or NCT03924466 809 811 B-Or
organ NCT03924466 812 817 B-Modifier
system NCT03924466 818 824 I-Modifier
dysfunction NCT03924466 825 836 B-Condition
, NCT03924466 837 838 O
which NCT03924466 839 844 O
in NCT03924466 845 847 O
the NCT03924466 848 851 O
opinion NCT03924466 852 859 O
of NCT03924466 860 862 O
the NCT03924466 863 866 O
investigator NCT03924466 867 879 O
would NCT03924466 880 885 O
either NCT03924466 886 892 O
compromise NCT03924466 893 903 O
patient NCT03924466 904 911 O
safety NCT03924466 912 918 O
or NCT03924466 919 921 O
interfere NCT03924466 922 931 O
with NCT03924466 932 936 O
the NCT03924466 937 940 O
evaluation NCT03924466 941 951 O
of NCT03924466 952 954 O
the NCT03924466 955 958 O
test NCT03924466 959 963 B-Study
radiopharmaceutical NCT03924466 964 983 B-Procedure

- NCT03924466 986 987 O
Patient NCT03924466 989 996 O
who NCT03924466 997 1000 O
can NCT03924466 1001 1004 B-Negation
not NCT03924466 1004 1007 I-Negation
communicate NCT03924466 1008 1019 B-Condition
reliably NCT03924466 1020 1028 O
with NCT03924466 1029 1033 O
the NCT03924466 1034 1037 O
investigator NCT03924466 1038 1050 O

- NCT03924466 1053 1054 O
Patient NCT03924466 1056 1063 O
who NCT03924466 1064 1067 O
is NCT03924466 1068 1070 O
unlikely NCT03924466 1071 1079 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924466 1080 1082 O
cooperate NCT03924466 1083 1092 O
with NCT03924466 1093 1097 O
the NCT03924466 1098 1101 O
requirements NCT03924466 1102 1114 O
of NCT03924466 1115 1117 O
the NCT03924466 1118 1121 O
study NCT03924466 1122 1127 B-Study

- NCT03924466 1130 1131 O
Patient NCT03924466 1133 1140 O
who NCT03924466 1141 1144 O
is NCT03924466 1145 1147 O
unwilling NCT03924466 1148 1157 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03924466 1158 1161 B-Or
/ NCT03924466 1162 1163 I-Or
or NCT03924466 1164 1166 I-Or
unable NCT03924466 1167 1173 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924466 1174 1176 O
give NCT03924466 1177 1181 O
informed NCT03924466 1182 1190 O
consent NCT03924466 1191 1198 O

- NCT03924466 1201 1202 O
Patient NCT03924466 1204 1211 O
at NCT03924466 1212 1214 O
increased NCT03924466 1215 1224 O
risk NCT03924466 1225 1229 B-Risk
of NCT03924466 1230 1232 O
death NCT03924466 1233 1238 B-Death
from NCT03924466 1239 1243 O
a NCT03924466 1244 1245 O
pre NCT03924466 1246 1249 B-Eq_Comparison
- NCT03924466 1250 1251 I-Eq_Comparison
existing NCT03924466 1252 1260 I-Eq_Comparison
concurrent NCT03924466 1261 1271 B-Modifier
illness NCT03924466 1272 1279 B-Condition

- NCT03924466 1282 1283 O
Patient NCT03924466 1285 1292 O
who NCT03924466 1293 1296 O
participated NCT03924466 1297 1309 O
already NCT03924466 1310 1317 O
in NCT03924466 1318 1320 O
this NCT03924466 1321 1325 O
study NCT03924466 1326 1331 O
. NCT03924466 1332 1333 O

Inclusion NCT03869567 0 9 O
Criteria NCT03869567 10 18 O
: NCT03869567 19 20 O

- NCT03869567 24 25 O
all NCT03869567 27 30 O
patients NCT03869567 31 39 O
with NCT03869567 40 44 O
cerebral NCT03869567 45 53 B-Condition
thrombectomy NCT03869567 54 66 I-Condition

- NCT03869567 69 70 O
Adults NCT03869567 72 78 O

- NCT03869567 81 82 O
Patients NCT03869567 84 92 O
able NCT03869567 93 97 O
to NCT03869567 98 100 O
express NCT03869567 101 108 O
consent NCT03869567 109 116 O

- NCT03869567 119 120 O
Signed NCT03869567 122 128 O
written NCT03869567 129 136 O
informed NCT03869567 137 145 O
consent NCT03869567 146 153 O
form NCT03869567 154 158 O

- NCT03869567 161 162 O
Covered NCT03869567 164 171 O
by NCT03869567 172 174 O
national NCT03869567 175 183 O
health NCT03869567 184 190 O
insurance NCT03869567 191 200 O

Exclusion NCT03869567 201 210 O
Criteria NCT03869567 211 219 O
: NCT03869567 220 221 O

- NCT03869567 225 226 O
minors NCT03869567 228 234 O

- NCT03869567 237 238 O
pregnancy NCT03869567 240 249 B-Condition
or NCT03869567 250 252 B-Or
beast NCT03869567 253 258 B-Condition
feeding NCT03869567 259 266 I-Condition

- NCT03869567 269 270 O
patient NCT03869567 272 279 O
deprived NCT03869567 280 288 B-Observation
of NCT03869567 289 291 I-Observation
liberty NCT03869567 292 299 I-Observation
by NCT03869567 300 302 O
administrative NCT03869567 303 317 O
or NCT03869567 318 320 O
judicial NCT03869567 321 329 O
decision NCT03869567 330 338 O
or NCT03869567 339 341 B-Or
placed NCT03869567 342 348 O
under NCT03869567 349 354 O
judicial NCT03869567 355 363 B-Observation
protection NCT03869567 364 374 I-Observation
( NCT03869567 375 376 O
guardianship NCT03869567 377 389 O
or NCT03869567 390 392 O
supervision NCT03869567 393 404 O
) NCT03869567 405 406 O

- NCT03869567 410 411 O
obstruction NCT03869567 413 424 O
to NCT03869567 425 427 O
participate NCT03869567 428 439 O

- NCT03869567 442 443 O
non NCT03869567 445 448 B-Negation
covered NCT03869567 449 456 O
by NCT03869567 457 459 O
national NCT03869567 460 468 O
health NCT03869567 469 475 O
insurance NCT03869567 476 485 O

Inclusion NCT03863418 0 9 O
Criteria NCT03863418 10 18 O
: NCT03863418 19 20 O

- NCT03863418 24 25 O
Children NCT03863418 27 35 O
aged NCT03863418 36 40 B-Age
6 NCT03863418 41 42 B-Eq_Comparison
- NCT03863418 43 44 I-Eq_Comparison
36 NCT03863418 45 47 I-Eq_Comparison
months NCT03863418 48 54 I-Eq_Comparison

- NCT03863418 57 58 O
diagnosis NCT03863418 60 69 O
of NCT03863418 70 72 O
Atopic NCT03863418 73 79 B-Condition
Dermatitis NCT03863418 80 90 I-Condition
according NCT03863418 91 100 O
to NCT03863418 101 103 O
SCORAD NCT03863418 104 110 B-Observation
index NCT03863418 111 116 I-Observation

Exclusion NCT03863418 117 126 O
Criteria NCT03863418 127 135 O

- NCT03863418 138 139 O
Age NCT03863418 141 144 B-Age
< NCT03863418 145 146 B-Eq_Comparison
6 NCT03863418 147 148 I-Eq_Comparison
months NCT03863418 149 155 I-Eq_Comparison

- NCT03863418 158 159 O
age NCT03863418 161 164 B-Age
> NCT03863418 165 166 B-Eq_Comparison
36 NCT03863418 167 169 I-Eq_Comparison
months NCT03863418 170 176 I-Eq_Comparison
, NCT03863418 177 178 O

- NCT03863418 182 183 O
skin NCT03863418 185 189 B-Modifier
infections NCT03863418 190 200 B-Condition
, NCT03863418 201 202 O

- NCT03863418 206 207 O
ichthyosis NCT03863418 209 219 B-Condition
, NCT03863418 220 221 O

- NCT03863418 225 226 O
food NCT03863418 228 232 O
allergies NCT03863418 233 242 B-Allergy
, NCT03863418 243 244 O

- NCT03863418 248 249 O
other NCT03863418 251 256 B-Other
allergic NCT03863418 257 265 B-Condition
diseases NCT03863418 266 274 I-Condition
, NCT03863418 275 276 O

- NCT03863418 280 281 O
chronic NCT03863418 283 290 O
systemic NCT03863418 291 299 B-Modifier
diseases NCT03863418 300 308 B-Condition
, NCT03863418 309 310 O

- NCT03863418 314 315 O
congenital NCT03863418 317 327 B-Condition
cardiac NCT03863418 328 335 I-Condition
defects NCT03863418 336 343 I-Condition
, NCT03863418 344 345 O

- NCT03863418 349 350 O
active NCT03863418 352 358 B-Eq_Comparison
tuberculosis NCT03863418 359 371 B-Condition
, NCT03863418 372 373 O

- NCT03863418 377 378 O
autoimmune NCT03863418 380 390 B-Condition
diseases NCT03863418 391 399 I-Condition
, NCT03863418 400 401 O

- NCT03863418 405 406 O
immunodeficiency NCT03863418 408 424 B-Condition
, NCT03863418 425 426 O

- NCT03863418 430 431 O
chronic NCT03863418 433 440 O
inflammatory NCT03863418 441 453 B-Condition
bowel NCT03863418 454 459 I-Condition
diseases NCT03863418 460 468 I-Condition
, NCT03863418 469 470 O

- NCT03863418 474 475 O
celiac NCT03863418 477 483 B-Condition
disease NCT03863418 484 491 I-Condition
, NCT03863418 492 493 O

- NCT03863418 497 498 O
cystic NCT03863418 500 506 B-Condition
fibrosis NCT03863418 507 515 I-Condition
, NCT03863418 516 517 O

- NCT03863418 521 522 O
metabolic NCT03863418 524 533 B-Condition
diseases NCT03863418 534 542 I-Condition
, NCT03863418 543 544 O

- NCT03863418 548 549 O
malignancy NCT03863418 551 561 B-Condition
, NCT03863418 562 563 O

- NCT03863418 567 568 O
chronic NCT03863418 570 577 O
pulmonary NCT03863418 578 587 B-Condition
diseases NCT03863418 588 596 I-Condition
, NCT03863418 597 598 O

- NCT03863418 602 603 O
malformations NCT03863418 605 618 B-Condition
of NCT03863418 619 621 O
the NCT03863418 622 625 O
gastrointestinal NCT03863418 626 642 B-Modifier
and NCT03863418 643 646 B-Or
/ NCT03863418 647 648 I-Or
or NCT03863418 649 651 I-Or
respiratory NCT03863418 652 663 B-Modifier
tract NCT03863418 664 669 I-Modifier
, NCT03863418 670 671 O

- NCT03863418 675 676 O
administration NCT03863418 678 692 O
of NCT03863418 693 695 O
prebiotics NCT03863418 696 706 B-Drug
/ NCT03863418 707 708 B-Or
probiotics NCT03863418 709 719 B-Drug
/ NCT03863418 720 721 B-Or
symbiotic NCT03863418 722 731 B-Modifier
/ NCT03863418 732 733 B-Or
systemic NCT03863418 734 742 B-Modifier
immunomodulators NCT03863418 743 759 B-Drug
during NCT03863418 760 766 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863418 767 770 O
4 NCT03863418 771 772 B-Eq_Comparison
weeks NCT03863418 773 778 I-Eq_Comparison
before NCT03863418 779 785 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03863418 786 795 B-Study
, NCT03863418 796 797 O

- NCT03863418 801 802 O
treatments NCT03863418 804 814 B-Procedure
with NCT03863418 815 819 O
topical NCT03863418 820 827 B-Drug
immunomodulators NCT03863418 828 844 I-Drug
( NCT03863418 845 846 O
Tacrolimus NCT03863418 847 857 B-Drug
or NCT03863418 858 860 B-Or
Pimecrolimus NCT03863418 861 873 B-Drug
) NCT03863418 874 875 O
over NCT03863418 876 880 B-Eq_Comparison
the NCT03863418 881 884 I-Eq_Comparison
three NCT03863418 885 890 I-Eq_Comparison
months NCT03863418 891 897 I-Eq_Comparison
prior NCT03863418 898 903 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863418 904 906 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03863418 907 916 B-Study
; NCT03863418 916 917 O

- NCT03863418 920 921 O
use NCT03863418 923 926 O
of NCT03863418 927 929 O
corticosteroids NCT03863418 930 945 B-Drug
or NCT03863418 946 948 B-Or
calcineurin NCT03863418 949 960 B-Drug
antagonists NCT03863418 961 972 I-Drug
or NCT03863418 973 975 B-Or
phototherapy NCT03863418 976 988 B-Procedure
in NCT03863418 989 991 O
the NCT03863418 992 995 O
previous NCT03863418 996 1004 B-Eq_Comparison
4 NCT03863418 1005 1006 I-Eq_Comparison
weeks NCT03863418 1007 1012 I-Eq_Comparison
, NCT03863418 1013 1014 O

- NCT03863418 1018 1019 O
use NCT03863418 1021 1024 O
of NCT03863418 1025 1027 O
systemic NCT03863418 1028 1036 B-Modifier
antibiotics NCT03863418 1037 1048 B-Drug
or NCT03863418 1049 1051 B-Or
anti NCT03863418 1052 1056 O
- NCT03863418 1057 1058 O
mycotic NCT03863418 1059 1066 B-Condition
drugs NCT03863418 1067 1072 B-Drug
during NCT03863418 1073 1079 B-Temporal_Connection___Temporal_Connection_Type_Value:during
4 NCT03863418 1080 1081 B-Eq_Comparison
weeks NCT03863418 1082 1087 I-Eq_Comparison
before NCT03863418 1088 1094 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03863418 1095 1100 B-Study
entry NCT03863418 1101 1106 O
; NCT03863418 1106 1107 O

- NCT03863418 1110 1111 O
investigator NCT03863418 1113 1125 O
's NCT03863418 1125 1127 O
uncertainty NCT03863418 1128 1139 O
about NCT03863418 1140 1145 O
the NCT03863418 1146 1149 O
willingness NCT03863418 1150 1161 O
or NCT03863418 1162 1164 O
ability NCT03863418 1165 1172 O
of NCT03863418 1173 1175 O
the NCT03863418 1176 1179 O
subject NCT03863418 1180 1187 O
to NCT03863418 1188 1190 O
comply NCT03863418 1191 1197 O
with NCT03863418 1198 1202 O
the NCT03863418 1203 1206 O
protocol NCT03863418 1207 1215 O
requirements NCT03863418 1216 1228 O
; NCT03863418 1228 1229 O

- NCT03863418 1232 1233 O
participation NCT03863418 1235 1248 O
in NCT03863418 1249 1251 O
any NCT03863418 1252 1255 O
other NCT03863418 1256 1261 B-Other
studies NCT03863418 1262 1269 B-Study
involving NCT03863418 1270 1279 O
investigational NCT03863418 1280 1295 B-Study
or NCT03863418 1296 1298 B-Or
marketed NCT03863418 1299 1307 B-Modifier
products NCT03863418 1308 1316 B-Drug
concomitantly NCT03863418 1317 1330 B-Modifier
or NCT03863418 1331 1333 B-Or
within NCT03863418 1334 1340 B-Eq_Comparison
two NCT03863418 1341 1344 I-Eq_Comparison
weeks NCT03863418 1345 1350 I-Eq_Comparison
prior NCT03863418 1351 1356 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863418 1357 1359 I-Temporal_Connection___Temporal_Connection_Type_Value:before
entry NCT03863418 1360 1365 O
into NCT03863418 1366 1370 O
the NCT03863418 1371 1374 O
study NCT03863418 1375 1380 B-Study
; NCT03863418 1380 1381 O

- NCT03863418 1384 1385 O
hypersensitivity NCT03863418 1387 1403 B-Condition
to NCT03863418 1404 1406 O
components NCT03863418 1407 1417 O
contained NCT03863418 1418 1427 O
in NCT03863418 1428 1430 O
study NCT03863418 1431 1436 B-Study
product NCT03863418 1437 1444 B-Drug
. NCT03863418 1445 1446 O

Inclusion NCT03924908 0 9 O
Criteria NCT03924908 10 18 O
: NCT03924908 19 20 O

- NCT03924908 24 25 O
Burn NCT03924908 27 31 B-Condition
patient NCT03924908 32 39 O
treated NCT03924908 40 47 B-Procedure
as NCT03924908 48 50 B-Temporal_Connection___Temporal_Connection_Type_Value:during
outpatient NCT03924908 51 61 B-Encounter

- NCT03924908 64 65 O
Burn NCT03924908 67 71 B-Observation
surface NCT03924908 72 79 I-Observation
area NCT03924908 80 84 I-Observation
> NCT03924908 85 86 B-Eq_Comparison
or NCT03924908 87 89 I-Eq_Comparison
= NCT03924908 90 91 I-Eq_Comparison
5 NCT03924908 92 93 I-Eq_Comparison
% NCT03924908 94 95 I-Eq_Comparison
of NCT03924908 96 98 O
the NCT03924908 99 102 O
total NCT03924908 103 108 O
body NCT03924908 109 113 O
surface NCT03924908 114 121 O
area NCT03924908 122 126 O

- NCT03924908 129 130 O
mainly NCT03924908 132 138 O
2 NCT03924908 139 140 B-Condition
nd NCT03924908 141 143 I-Condition
degree NCT03924908 144 150 I-Condition
burn NCT03924908 151 155 I-Condition

Exclusion NCT03924908 156 165 O
Criteria NCT03924908 166 174 O
: NCT03924908 175 176 O

- NCT03924908 180 181 O
Psychiatric NCT03924908 183 194 B-Condition
antecedents NCT03924908 195 206 I-Condition

- NCT03924908 209 210 O
Claustrophobia NCT03924908 212 226 B-Condition

- NCT03924908 229 230 O
Heavy NCT03924908 232 237 B-Condition
hearing NCT03924908 238 245 I-Condition

- NCT03924908 248 249 O
Visual NCT03924908 251 257 B-Condition
impairment NCT03924908 258 268 I-Condition

- NCT03924908 271 272 O
Face NCT03924908 274 278 B-Modifier
burn NCT03924908 279 283 B-Condition

- NCT03924908 286 287 O
Conjunctivitis NCT03924908 289 303 B-Condition

- NCT03924908 306 307 O
Consent NCT03924908 309 316 O
not NCT03924908 317 320 O
obtained NCT03924908 321 329 O

Inclusion NCT03922282 0 9 O
Criteria NCT03922282 10 18 O
: NCT03922282 19 20 O

- NCT03922282 24 25 O
Subject NCT03922282 27 34 O
who NCT03922282 35 38 O
will NCT03922282 39 43 B-Eq_Comparison
have NCT03922282 44 48 I-Eq_Comparison
thyroid NCT03922282 49 56 B-Procedure
surgery NCT03922282 57 64 I-Procedure

Exclusion NCT03922282 65 74 O
Criteria NCT03922282 75 83 O
: NCT03922282 84 85 O

- NCT03922282 89 90 O
Subject NCT03922282 92 99 O
who NCT03922282 100 103 O
underwent NCT03922282 104 113 B-Eq_Comparison
thyroid NCT03922282 114 121 B-Procedure
surgery NCT03922282 122 129 I-Procedure

- NCT03922282 132 133 O
Subject NCT03922282 135 142 O
who NCT03922282 143 146 O
underwent NCT03922282 147 156 B-Eq_Comparison
any NCT03922282 157 160 O
radiotherapy NCT03922282 161 173 B-Procedure
on NCT03922282 174 176 O
neck NCT03922282 177 181 B-Modifier

- NCT03922282 184 185 O
Subject NCT03922282 187 194 O
who NCT03922282 195 198 O
need NCT03922282 199 203 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03922282 204 206 O
neck NCT03922282 207 211 B-Modifier
dissection NCT03922282 212 222 B-Procedure

- NCT03922282 225 226 O
Subject NCT03922282 228 235 O
under NCT03922282 236 241 B-Eq_Comparison
18 NCT03922282 242 244 I-Eq_Comparison
years NCT03922282 245 250 I-Eq_Comparison
or NCT03922282 251 253 B-Or
over NCT03922282 254 258 B-Eq_Comparison
70 NCT03922282 259 261 I-Eq_Comparison
years NCT03922282 262 267 I-Eq_Comparison

- NCT03922282 270 271 O
Bad NCT03922282 273 276 O
general NCT03922282 277 284 B-Condition
condition NCT03922282 285 294 I-Condition

- NCT03922282 297 298 O
High NCT03922282 300 304 O
American NCT03922282 305 313 B-Observation
Society NCT03922282 314 321 I-Observation
of NCT03922282 322 324 I-Observation
Anesthesiologists NCT03922282 325 342 I-Observation
( NCT03922282 343 344 O
ASA NCT03922282 345 348 B-Observation
) NCT03922282 349 350 O
score NCT03922282 351 356 O
( NCT03922282 357 358 O
over NCT03922282 359 363 B-Eq_Comparison
3 NCT03922282 364 365 I-Eq_Comparison
) NCT03922282 366 367 O

- NCT03922282 371 372 O
Breast NCT03922282 374 380 B-Condition
feeder NCT03922282 381 387 I-Condition
or NCT03922282 388 390 B-Or
pregnancy NCT03922282 391 400 B-Condition

- NCT03922282 403 404 O
Subject NCT03922282 406 413 O
who NCT03922282 414 417 O
disagree NCT03922282 418 426 O
to NCT03922282 427 429 O
do NCT03922282 430 432 O
this NCT03922282 433 437 O
trial NCT03922282 438 443 O

Inclusion NCT03925168 0 9 O
Criteria NCT03925168 10 18 O
: NCT03925168 19 20 O

- NCT03925168 24 25 O
English NCT03925168 27 34 O
- NCT03925168 35 36 O
speaking NCT03925168 37 45 O
, NCT03925168 46 47 O
adult NCT03925168 48 53 O
( NCT03925168 54 55 O
21 NCT03925168 56 58 B-Eq_Comparison
+ NCT03925168 59 60 I-Eq_Comparison
) NCT03925168 61 62 O
hemodialysis NCT03925168 63 75 B-Procedure
patients NCT03925168 76 84 O
who NCT03925168 85 88 B-And
receive NCT03925168 89 96 B-Eq_Comparison
dialysis NCT03925168 97 105 B-Procedure
at NCT03925168 106 108 O
the NCT03925168 109 112 O
one NCT03925168 113 116 O
of NCT03925168 117 119 O
the NCT03925168 120 123 O
two NCT03925168 124 127 O
outpatient NCT03925168 128 138 O
dialysis NCT03925168 139 147 O
centers NCT03925168 148 155 O

Exclusion NCT03925168 156 165 O
Criteria NCT03925168 166 174 O
: NCT03925168 175 176 O

- NCT03925168 180 181 O
do NCT03925168 183 185 O
not NCT03925168 186 189 B-Negation
speak NCT03925168 190 195 O
English NCT03925168 196 203 O
, NCT03925168 204 205 O
deafness NCT03925168 206 214 B-Condition

Inclusion NCT03923218 0 9 O
Criteria NCT03923218 10 18 O
for NCT03923218 19 22 O
chronic NCT03923218 23 30 B-Condition
periodontitis NCT03923218 31 44 I-Condition
groups NCT03923218 45 51 O
: NCT03923218 52 53 O

- NCT03923218 57 58 O
Clinical NCT03923218 60 68 B-Observation
attachment NCT03923218 69 79 I-Observation
loss NCT03923218 80 84 I-Observation
≥ NCT03923218 85 86 B-Eq_Comparison
5 NCT03923218 87 88 I-Eq_Comparison
mm NCT03923218 89 91 I-Eq_Comparison

- NCT03923218 94 95 O
Probing NCT03923218 97 104 B-Observation
depth NCT03923218 105 110 I-Observation
≥ NCT03923218 111 112 B-Eq_Comparison
5 NCT03923218 113 114 I-Eq_Comparison
mm NCT03923218 115 117 I-Eq_Comparison

- NCT03923218 120 121 O
Bone NCT03923218 123 127 B-Observation
loss NCT03923218 128 132 I-Observation
affecting NCT03923218 133 142 O
> NCT03923218 143 144 B-Eq_Comparison
30 NCT03923218 145 147 I-Eq_Comparison
% NCT03923218 148 149 I-Eq_Comparison
of NCT03923218 150 152 O
the NCT03923218 153 156 O
existing NCT03923218 157 165 O
teeth NCT03923218 166 171 B-Modifier
on NCT03923218 172 174 O
clinical NCT03923218 175 183 B-Modifier
and NCT03923218 184 187 B-Or
radiographic NCT03923218 188 200 B-Modifier
examination NCT03923218 201 212 B-Procedure

- NCT03923218 215 216 O
gingival NCT03923218 218 226 B-Observation
index NCT03923218 227 232 I-Observation
( NCT03923218 233 234 O
GI NCT03923218 235 237 B-Observation
) NCT03923218 238 239 O
score NCT03923218 240 245 O
> NCT03923218 246 247 B-Eq_Comparison
1 NCT03923218 248 249 I-Eq_Comparison

Inclusion NCT03923218 251 260 O
criteria NCT03923218 261 269 O
for NCT03923218 270 273 O
control NCT03923218 274 281 O
group NCT03923218 282 287 O
: NCT03923218 288 289 O

- NCT03923218 293 294 O
full NCT03923218 296 300 B-Modifier
- NCT03923218 301 302 I-Modifier
mouth NCT03923218 303 308 I-Modifier
PD NCT03923218 309 311 B-Observation
was NCT03923218 312 315 O
≤ NCT03923218 316 317 B-Eq_Comparison
3 NCT03923218 318 319 I-Eq_Comparison
mm NCT03923218 320 322 I-Eq_Comparison
, NCT03923218 323 324 O

- NCT03923218 328 329 O
Gingival NCT03923218 331 339 B-Observation
index NCT03923218 340 345 I-Observation
< NCT03923218 346 347 B-Eq_Comparison
1 NCT03923218 348 349 I-Eq_Comparison

- NCT03923218 353 354 O
there NCT03923218 356 361 O
was NCT03923218 362 365 O
no NCT03923218 366 368 B-Negation
indication NCT03923218 369 379 O
of NCT03923218 380 382 O
Attachment NCT03923218 383 393 B-Condition
Loss NCT03923218 394 398 I-Condition
or NCT03923218 399 401 B-Or
no NCT03923218 402 404 B-Negation
radiographic NCT03923218 405 417 B-Procedure
evidence NCT03923218 418 426 I-Procedure
of NCT03923218 427 429 O
alveolar NCT03923218 430 438 B-Condition
bone NCT03923218 439 443 I-Condition
loss NCT03923218 444 448 I-Condition
in NCT03923218 449 451 O
control NCT03923218 452 459 O
group NCT03923218 460 465 O
. NCT03923218 466 467 O

- NCT03923218 471 472 O
Non NCT03923218 474 477 B-Negation
- NCT03923218 478 479 O
smokers NCT03923218 480 487 B-Condition
. NCT03923218 488 489 O

Smoking NCT03923218 491 498 B-Condition
criteria NCT03923218 499 507 O
for NCT03923218 508 511 O
groups NCT03923218 512 518 O
: NCT03923218 519 520 O

- NCT03923218 524 525 O
patients NCT03923218 527 535 O
smoked NCT03923218 536 542 B-Observation
more NCT03923218 543 547 B-Eq_Comparison
than NCT03923218 548 552 I-Eq_Comparison
10 NCT03923218 553 555 I-Eq_Comparison
cigarettes NCT03923218 556 566 I-Eq_Comparison
in NCT03923218 567 569 I-Eq_Comparison
a NCT03923218 570 571 I-Eq_Comparison
day NCT03923218 572 575 I-Eq_Comparison

- NCT03923218 578 579 O
smoking NCT03923218 581 588 B-Condition
for NCT03923218 589 592 O
3 NCT03923218 593 594 B-Eq_Comparison
or NCT03923218 595 597 I-Eq_Comparison
more NCT03923218 598 602 I-Eq_Comparison
years NCT03923218 603 608 I-Eq_Comparison
, NCT03923218 609 610 O

Exclusion NCT03923218 612 621 O
Criteria NCT03923218 622 630 O
: NCT03923218 631 632 O

- NCT03923218 636 637 O
systemic NCT03923218 639 647 B-Modifier
condition NCT03923218 648 657 B-Condition
( NCT03923218 658 659 O
diabetes NCT03923218 660 668 B-Condition
, NCT03923218 669 670 O
cardiovascular NCT03923218 671 685 B-Condition
disease NCT03923218 686 693 I-Condition
, NCT03923218 694 695 O
immunologic NCT03923218 696 707 B-Condition
disorders NCT03923218 708 717 I-Condition
, NCT03923218 718 719 O
hepatitis NCT03923218 720 729 B-Condition
, NCT03923218 730 731 O
e NCT03923218 732 733 O
. NCT03923218 734 735 O
g NCT03923218 736 737 O
. NCT03923218 738 739 O
) NCT03923218 740 741 O

- NCT03923218 745 746 O
pregnancy NCT03923218 748 757 B-Condition
, NCT03923218 758 759 O
lactation NCT03923218 760 769 B-Condition
or NCT03923218 770 772 B-Or
menopause NCT03923218 773 782 B-Condition
term NCT03923218 783 787 O
, NCT03923218 788 789 O

- NCT03923218 793 794 O
antibiotic NCT03923218 796 806 B-Drug
treatment NCT03923218 807 816 B-Procedure
or NCT03923218 817 819 B-Or
non NCT03923218 820 823 B-Drug
- NCT03923218 824 825 I-Drug
steroidal NCT03923218 826 835 I-Drug
anti NCT03923218 836 840 I-Drug
- NCT03923218 841 842 I-Drug
inflammatory NCT03923218 843 855 I-Drug
medications NCT03923218 856 867 I-Drug
within NCT03923218 868 874 B-Eq_Comparison
the NCT03923218 875 878 I-Eq_Comparison
last NCT03923218 879 883 I-Eq_Comparison
3 NCT03923218 884 885 I-Eq_Comparison
months NCT03923218 886 892 I-Eq_Comparison
before NCT03923218 893 899 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923218 900 903 O
study NCT03923218 904 909 B-Study
, NCT03923218 910 911 O

- NCT03923218 915 916 O
non NCT03923218 918 921 B-Modifier
- NCT03923218 922 923 I-Modifier
surgical NCT03923218 924 932 I-Modifier
periodontal NCT03923218 933 944 B-Procedure
treatment NCT03923218 945 954 I-Procedure
during NCT03923218 955 961 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923218 962 965 O
last NCT03923218 966 970 B-Eq_Comparison
6 NCT03923218 971 972 I-Eq_Comparison
months NCT03923218 973 979 I-Eq_Comparison
before NCT03923218 980 986 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923218 987 990 O
study NCT03923218 991 996 B-Study
, NCT03923218 997 998 O

- NCT03923218 1002 1003 O
treatment NCT03923218 1005 1014 B-Procedure
with NCT03923218 1015 1019 O
Vitamin NCT03923218 1020 1027 B-Drug
D NCT03923218 1028 1029 I-Drug
supplementation NCT03923218 1030 1045 I-Drug
before NCT03923218 1046 1052 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923218 1053 1056 O
study NCT03923218 1057 1062 B-Study

Inclusion NCT03928587 0 9 O
Criteria NCT03928587 10 18 O
: NCT03928587 19 20 O

1 NCT03928587 24 25 O
. NCT03928587 25 26 O
Healthy NCT03928587 28 35 B-Condition
children NCT03928587 36 44 O
with NCT03928587 45 49 B-And
absence NCT03928587 50 57 B-Negation
of NCT03928587 58 60 I-Negation
severe NCT03928587 61 67 O
chronic NCT03928587 68 75 O
disease NCT03928587 76 83 B-Condition

2 NCT03928587 86 87 O
. NCT03928587 87 88 O
Age NCT03928587 90 93 B-Age
5 NCT03928587 94 95 B-Eq_Comparison
- NCT03928587 96 97 I-Eq_Comparison
8 NCT03928587 98 99 I-Eq_Comparison
years NCT03928587 100 105 I-Eq_Comparison
, NCT03928587 106 107 O
both NCT03928587 108 112 O
inclusive NCT03928587 113 122 O
, NCT03928587 123 124 O
at NCT03928587 125 127 O
inclusion NCT03928587 128 137 O

3 NCT03928587 140 141 O
. NCT03928587 141 142 O
Ability NCT03928587 144 151 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928587 152 154 I-Assertion___Assertion_Type_Value:hypothetical
cooperate NCT03928587 155 164 O
at NCT03928587 165 167 O
dental NCT03928587 168 174 B-Procedure
examination NCT03928587 175 186 I-Procedure

4 NCT03928587 189 190 O
. NCT03928587 190 191 O
Ability NCT03928587 193 200 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928587 201 203 I-Assertion___Assertion_Type_Value:hypothetical
cooperate NCT03928587 204 213 O
to NCT03928587 214 216 O
a NCT03928587 217 218 O
daily NCT03928587 219 224 B-Eq_Comparison
intake NCT03928587 225 231 O
of NCT03928587 232 234 O
a NCT03928587 235 236 O
lozenge NCT03928587 237 244 B-Drug

5 NCT03928587 247 248 O
. NCT03928587 248 249 O
Parents NCT03928587 251 258 O
/ NCT03928587 259 260 O
legal NCT03928587 261 266 O
guarding NCT03928587 267 275 O
provided NCT03928587 276 284 O
voluntary NCT03928587 285 294 O
written NCT03928587 295 302 O
informed NCT03928587 303 311 O
consent NCT03928587 312 319 O

Exclusion NCT03928587 320 329 O
Criteria NCT03928587 330 338 O
: NCT03928587 339 340 O

1 NCT03928587 344 345 O
. NCT03928587 345 346 O
Children NCT03928587 348 356 O
with NCT03928587 357 361 B-And
severe NCT03928587 362 368 O
medical NCT03928587 369 376 B-Condition
conditions NCT03928587 377 387 I-Condition

2 NCT03928587 390 391 O
. NCT03928587 391 392 O
Mentally NCT03928587 394 402 B-Modifier
or NCT03928587 403 405 B-Or
physically NCT03928587 406 416 B-Modifier
disabled NCT03928587 417 425 B-Condition
children NCT03928587 426 434 O

3 NCT03928587 437 438 O
. NCT03928587 438 439 O
Children NCT03928587 441 449 O
of NCT03928587 450 452 O
parents NCT03928587 453 460 B-Family_Member___Family_Member_Type:parent
with NCT03928587 461 465 O
language NCT03928587 466 474 O
barriers NCT03928587 475 483 O
and NCT03928587 484 487 O
not NCT03928587 488 491 O
able NCT03928587 492 496 O
to NCT03928587 497 499 O
give NCT03928587 500 504 O
written NCT03928587 505 512 O
informed NCT03928587 513 521 O
consent NCT03928587 522 529 O

Inclusion NCT03868930 0 9 O
Criteria NCT03868930 10 18 O
: NCT03868930 19 20 O

- NCT03868930 24 25 O
Post NCT03868930 27 31 B-Modifier
- NCT03868930 32 33 I-Modifier
9 NCT03868930 34 35 I-Modifier
/ NCT03868930 36 37 I-Modifier
11 NCT03868930 38 40 I-Modifier
Veterans NCT03868930 41 49 B-Observation
who NCT03868930 50 53 B-And
report NCT03868930 54 60 O
some NCT03868930 61 65 O
reintegration NCT03868930 66 79 B-Modifier
, NCT03868930 80 81 O
readjustment NCT03868930 82 94 B-Modifier
, NCT03868930 95 96 O
or NCT03868930 97 99 B-Or
anger NCT03868930 100 105 B-Modifier
difficulty NCT03868930 106 116 B-Condition

- NCT03868930 124 125 O
i NCT03868930 127 128 O
. NCT03868930 129 130 O
e NCT03868930 131 132 O
. NCT03868930 133 134 O
, NCT03868930 135 136 O
Veterans NCT03868930 137 145 B-Observation
who NCT03868930 146 149 B-And
report NCT03868930 150 156 O
" NCT03868930 157 158 O
some NCT03868930 158 162 B-Modifier
difficulty NCT03868930 163 173 I-Modifier
" NCT03868930 173 174 O
( NCT03868930 175 176 O
Likert NCT03868930 177 183 O
rating NCT03868930 184 190 O
) NCT03868930 191 192 O
on NCT03868930 193 195 O
at NCT03868930 196 198 B-Eq_Comparison
least NCT03868930 199 204 I-Eq_Comparison
one NCT03868930 205 208 I-Eq_Comparison
of NCT03868930 209 211 O
the NCT03868930 212 215 O
primary NCT03868930 216 223 B-Observation
measures NCT03868930 224 232 I-Observation
: NCT03868930 233 234 O
M NCT03868930 235 236 B-Observation
2CQ NCT03868930 237 240 I-Observation
; NCT03868930 240 241 O
PDRI NCT03868930 242 246 B-Observation
; NCT03868930 246 247 O
STAXI NCT03868930 248 253 B-Observation
- NCT03868930 254 255 I-Observation
2 NCT03868930 256 257 I-Observation

- NCT03868930 261 262 O
18 NCT03868930 264 266 B-Eq_Comparison
- NCT03868930 267 268 I-Eq_Comparison
65 NCT03868930 269 271 I-Eq_Comparison
years NCT03868930 272 277 I-Eq_Comparison
old NCT03868930 278 281 B-Age
( NCT03868930 282 283 O
to NCT03868930 284 286 O
avoid NCT03868930 287 292 O
outcomes NCT03868930 293 301 O
being NCT03868930 302 307 O
affected NCT03868930 308 316 O
by NCT03868930 317 319 O
aging NCT03868930 320 325 O
) NCT03868930 326 327 O

- NCT03868930 331 332 O
English NCT03868930 334 341 O
- NCT03868930 342 343 O
speaking NCT03868930 344 352 O
( NCT03868930 353 354 O
sessions NCT03868930 355 363 O
will NCT03868930 364 368 O
be NCT03868930 369 371 O
conducted NCT03868930 372 381 O
in NCT03868930 382 384 O
English NCT03868930 385 392 O
) NCT03868930 393 394 O

- NCT03868930 398 399 O
Agreeing NCT03868930 401 409 O
to NCT03868930 410 412 O
participate NCT03868930 413 424 O

- NCT03868930 432 433 O
i NCT03868930 435 436 O
. NCT03868930 437 438 O
e NCT03868930 439 440 O
. NCT03868930 441 442 O
, NCT03868930 443 444 O
completion NCT03868930 445 455 O
of NCT03868930 456 458 O
ICF NCT03868930 459 462 B-Observation
/ NCT03868930 463 464 B-Or
HIPAA NCT03868930 465 470 B-Observation

Exclusion NCT03868930 471 480 O
Criteria NCT03868930 481 489 O
: NCT03868930 490 491 O

- NCT03868930 495 496 O
schizophreniform NCT03868930 498 514 B-Condition
disorder NCT03868930 515 523 I-Condition
/ NCT03868930 524 525 B-Or
active NCT03868930 526 532 B-Eq_Comparison
psychosis NCT03868930 533 542 B-Condition

- NCT03868930 545 546 O
bipolar NCT03868930 548 555 B-Condition
disorder NCT03868930 556 564 I-Condition

- NCT03868930 567 568 O
active NCT03868930 570 576 B-Eq_Comparison
suicidality NCT03868930 577 588 B-Condition
/ NCT03868930 589 590 B-Or
homicidality NCT03868930 591 603 B-Condition
requiring NCT03868930 604 613 B-Assertion___Assertion_Type_Value:hypothetical
crisis NCT03868930 614 620 B-Procedure
intervention NCT03868930 621 633 I-Procedure

- NCT03868930 636 637 O
other NCT03868930 639 644 B-Other
severe NCT03868930 645 651 O
psychiatric NCT03868930 652 663 B-Condition
disorders NCT03868930 664 673 I-Condition
prohibiting NCT03868930 674 685 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
appropriate NCT03868930 686 697 O
group NCT03868930 698 703 B-Procedure
participation NCT03868930 704 717 I-Procedure

- NCT03868930 720 721 O
neurological NCT03868930 723 735 B-Condition
diagnosis NCT03868930 736 745 O
prohibiting NCT03868930 746 757 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
appropriate NCT03868930 758 769 O
group NCT03868930 770 775 B-Procedure
participation NCT03868930 776 789 I-Procedure
( NCT03868930 790 791 O
excluding NCT03868930 792 801 B-Exception
TBI NCT03868930 802 805 B-Condition
) NCT03868930 806 807 O

- NCT03868930 811 812 O
current NCT03868930 814 821 B-Eq_Comparison
substance NCT03868930 822 831 B-Condition
dependence NCT03868930 832 842 I-Condition

- NCT03868930 845 846 O
current NCT03868930 848 855 B-Eq_Comparison
participation NCT03868930 856 869 O
in NCT03868930 870 872 O
any NCT03868930 873 876 O
other NCT03868930 877 882 B-Other
form NCT03868930 883 887 O
of NCT03868930 888 890 O
active NCT03868930 891 897 B-Eq_Comparison
behavioral NCT03868930 898 908 B-Procedure
therapy NCT03868930 909 916 I-Procedure
at NCT03868930 917 919 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868930 920 923 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03868930 924 928 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03868930 929 931 O
enrollment NCT03868930 932 942 B-Study

- NCT03868930 950 951 O
e NCT03868930 953 954 O
. NCT03868930 955 956 O
g NCT03868930 957 958 O
. NCT03868930 959 960 O
, NCT03868930 961 962 O
Cognitive NCT03868930 963 972 B-Procedure
Processing NCT03868930 973 983 I-Procedure
Therapy NCT03868930 984 991 I-Procedure
, NCT03868930 992 993 O
cognitive NCT03868930 994 1003 B-Procedure
rehabilitation NCT03868930 1004 1018 I-Procedure
for NCT03868930 1019 1022 O
mTBI NCT03868930 1023 1027 B-Condition
, NCT03868930 1028 1029 O
or NCT03868930 1030 1032 B-Or
other NCT03868930 1033 1038 B-Other
psychotherapy NCT03868930 1039 1052 B-Procedure

Inclusion NCT03926026 0 9 O
Criteria NCT03926026 10 18 O
: NCT03926026 19 20 O

- NCT03926026 24 25 O
history NCT03926026 27 34 B-Eq_Comparison
of NCT03926026 35 37 O
blepharitis NCT03926026 38 49 B-Condition
and NCT03926026 50 53 B-And
meet NCT03926026 54 58 O
qualifying NCT03926026 59 69 O
criteria NCT03926026 70 78 O
for NCT03926026 79 82 O
an NCT03926026 83 85 O
acute NCT03926026 86 91 O
exacerbation NCT03926026 92 104 O
of NCT03926026 105 107 O
blepharitis NCT03926026 108 119 B-Condition
in NCT03926026 120 122 O
both NCT03926026 123 127 B-Modifier
eyes NCT03926026 128 132 I-Modifier
at NCT03926026 133 135 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03926026 136 145 B-Study
and NCT03926026 146 149 B-And
Baseline NCT03926026 150 158 B-Study
/ NCT03926026 159 160 O
Day NCT03926026 161 164 O
1 NCT03926026 165 166 O
Visits NCT03926026 167 173 O

- NCT03926026 176 177 O
have NCT03926026 179 183 O
a NCT03926026 184 185 O
qualifying NCT03926026 186 196 O
best NCT03926026 197 201 B-Condition
- NCT03926026 202 203 I-Condition
corrected NCT03926026 204 213 I-Condition
visual NCT03926026 214 220 I-Condition
acuity NCT03926026 221 227 I-Condition

Exclusion NCT03926026 228 237 O
Criteria NCT03926026 238 246 O
: NCT03926026 247 248 O

- NCT03926026 252 253 O
abnormality NCT03926026 255 266 B-Condition
of NCT03926026 267 269 O
the NCT03926026 270 273 O
eyelids NCT03926026 274 281 B-Modifier
or NCT03926026 282 284 B-Or
lashes NCT03926026 285 291 B-Modifier
( NCT03926026 292 293 O
other NCT03926026 294 299 B-Exception
than NCT03926026 300 304 I-Exception
blepharitis NCT03926026 305 316 B-Condition
) NCT03926026 317 318 O
, NCT03926026 319 320 O
or NCT03926026 321 323 O
previous NCT03926026 324 332 B-Eq_Comparison
eyelid NCT03926026 333 339 B-Modifier
surgery NCT03926026 340 347 B-Procedure

- NCT03926026 350 351 O
IOP NCT03926026 353 356 B-Observation
> NCT03926026 357 358 B-Eq_Comparison
21 NCT03926026 359 361 I-Eq_Comparison
mmHg NCT03926026 362 366 I-Eq_Comparison
at NCT03926026 367 369 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03926026 370 379 B-Study
or NCT03926026 380 382 B-Or
Baseline NCT03926026 383 391 B-Study
/ NCT03926026 392 393 O
Day NCT03926026 394 397 O
1 NCT03926026 398 399 O
Visits NCT03926026 400 406 O

- NCT03926026 409 410 O
use NCT03926026 412 415 O
of NCT03926026 416 418 O
steroids NCT03926026 419 427 B-Drug
in NCT03926026 428 430 O
the NCT03926026 431 434 O
past NCT03926026 435 439 B-Eq_Comparison
30 NCT03926026 440 442 I-Eq_Comparison
days NCT03926026 443 447 I-Eq_Comparison
or NCT03926026 448 450 B-Or
retinoids NCT03926026 451 460 B-Drug
in NCT03926026 461 463 O
the NCT03926026 464 467 O
past NCT03926026 468 472 B-Eq_Comparison
12 NCT03926026 473 475 I-Eq_Comparison
months NCT03926026 476 482 I-Eq_Comparison

- NCT03926026 485 486 O
uncontrolled NCT03926026 488 500 B-Modifier
systemic NCT03926026 501 509 B-Condition
disease NCT03926026 510 517 I-Condition

Inclusion NCT03928860 0 9 O
Criteria NCT03928860 10 18 O
: NCT03928860 19 20 O

- NCT03928860 24 25 O
Patients NCT03928860 27 35 O
with NCT03928860 36 40 O
at NCT03928860 41 43 B-Eq_Comparison
least NCT03928860 44 49 I-Eq_Comparison
3 NCT03928860 50 51 I-Eq_Comparison
months NCT03928860 52 58 I-Eq_Comparison
of NCT03928860 59 61 O
clinical NCT03928860 62 70 O
onset NCT03928860 71 76 B-Eq_Comparison
of NCT03928860 77 79 O
peripheral NCT03928860 80 90 B-Condition
vascular NCT03928860 91 99 I-Condition
disease NCT03928860 100 107 I-Condition

- NCT03928860 110 111 O
Patients NCT03928860 113 121 O
with NCT03928860 122 126 O
ABI NCT03928860 127 130 B-Observation
between NCT03928860 131 138 O
0.4 NCT03928860 139 142 B-Eq_Comparison
- NCT03928860 143 144 I-Eq_Comparison
1.4 NCT03928860 145 148 I-Eq_Comparison

- NCT03928860 152 153 O
Patients NCT03928860 155 163 O
up NCT03928860 164 166 B-Eq_Comparison
to NCT03928860 167 169 I-Eq_Comparison
Stage NCT03928860 170 175 I-Eq_Comparison
2 NCT03928860 176 177 I-Eq_Comparison
b NCT03928860 178 179 I-Eq_Comparison
according NCT03928860 180 189 O
to NCT03928860 190 192 O
the NCT03928860 193 196 O
Fontaine NCT03928860 197 205 B-Condition
classification NCT03928860 206 220 I-Condition
system NCT03928860 221 227 I-Condition

Exclusion NCT03928860 228 237 O
Criteria NCT03928860 238 246 O
: NCT03928860 247 248 O

- NCT03928860 252 253 O
Patients NCT03928860 255 263 O
undergoing NCT03928860 264 274 B-Eq_Comparison
vascular NCT03928860 275 283 B-Modifier
or NCT03928860 284 286 B-Or
endovascular NCT03928860 287 299 B-Modifier
surgery NCT03928860 300 307 B-Procedure
in NCT03928860 308 310 O
the NCT03928860 311 314 O
last NCT03928860 315 319 B-Eq_Comparison
3 NCT03928860 320 321 I-Eq_Comparison
months NCT03928860 322 328 I-Eq_Comparison

- NCT03928860 331 332 O
Patients NCT03928860 334 342 O
with NCT03928860 343 347 O
unstable NCT03928860 348 356 B-Condition
angina NCT03928860 357 363 I-Condition

- NCT03928860 366 367 O
Patients NCT03928860 369 377 O
with NCT03928860 378 382 O
myocardial NCT03928860 383 393 B-Condition
infarction NCT03928860 394 404 I-Condition
( NCT03928860 405 406 O
MI NCT03928860 407 409 B-Condition
) NCT03928860 410 411 O

- NCT03928860 415 416 O
Patients NCT03928860 418 426 O
with NCT03928860 427 431 O
stroke NCT03928860 432 438 B-Condition

- NCT03928860 441 442 O
Patients NCT03928860 444 452 O
with NCT03928860 453 457 O
heart NCT03928860 458 463 B-Condition
failure NCT03928860 464 471 I-Condition

- NCT03928860 474 475 O
Patients NCT03928860 477 485 O
with NCT03928860 486 490 O
significant NCT03928860 491 502 O
liver NCT03928860 503 508 B-Modifier
or NCT03928860 509 511 B-Or
renal NCT03928860 512 517 B-Modifier
failure NCT03928860 518 525 B-Condition
( NCT03928860 526 527 O
ie NCT03928860 528 530 O
, NCT03928860 531 532 O
dialysis NCT03928860 533 541 B-Procedure
) NCT03928860 542 543 O

- NCT03928860 547 548 O
Acute NCT03928860 550 555 O
infectious NCT03928860 556 566 B-Condition
diseases NCT03928860 567 575 I-Condition

- NCT03928860 578 579 O
Patients NCT03928860 581 589 O
with NCT03928860 590 594 O
neoplasia NCT03928860 595 604 B-Condition

Inclusion NCT03864068 0 9 O
Criteria NCT03864068 10 18 O
: NCT03864068 19 20 O

- NCT03864068 24 25 O
Women NCT03864068 27 32 O
with NCT03864068 33 37 B-And
chronic NCT03864068 38 45 O
anovulation NCT03864068 46 57 B-Condition
or NCT03864068 58 60 B-Or
oligomenorrhea NCT03864068 61 75 B-Condition
defined NCT03864068 76 83 O
as NCT03864068 84 86 O
spontaneous NCT03864068 87 98 B-Condition
intermenstrual NCT03864068 99 113 I-Condition
periods NCT03864068 114 121 I-Condition
of NCT03864068 122 124 O
greater NCT03864068 125 132 B-Eq_Comparison
than NCT03864068 133 137 I-Eq_Comparison
or NCT03864068 138 140 I-Eq_Comparison
equal NCT03864068 141 146 I-Eq_Comparison
to NCT03864068 147 149 I-Eq_Comparison
45 NCT03864068 150 152 I-Eq_Comparison
days NCT03864068 153 157 I-Eq_Comparison
or NCT03864068 158 160 B-Or
a NCT03864068 161 162 O
total NCT03864068 163 168 O
of NCT03864068 169 171 O
less NCT03864068 172 176 B-Eq_Comparison
than NCT03864068 177 181 I-Eq_Comparison
or NCT03864068 182 184 I-Eq_Comparison
equal NCT03864068 185 190 I-Eq_Comparison
to NCT03864068 191 193 I-Eq_Comparison
8 NCT03864068 194 195 I-Eq_Comparison
menses NCT03864068 196 202 B-Observation
per NCT03864068 203 206 O
year NCT03864068 207 211 O
. NCT03864068 212 213 O

- NCT03864068 217 218 O
Women NCT03864068 220 225 O
with NCT03864068 226 230 B-And
Hyperandrogenism NCT03864068 231 247 B-Condition
defined NCT03864068 248 255 O
as NCT03864068 256 258 O
a NCT03864068 259 260 O
total NCT03864068 261 266 B-Observation
testosterone NCT03864068 267 279 I-Observation
greater NCT03864068 280 287 B-Eq_Comparison
than NCT03864068 288 292 I-Eq_Comparison
50 NCT03864068 293 295 I-Eq_Comparison
ng NCT03864068 296 298 I-Eq_Comparison
/ NCT03864068 299 300 I-Eq_Comparison
dL NCT03864068 301 303 I-Eq_Comparison
or NCT03864068 304 306 B-Or
a NCT03864068 307 308 O
free NCT03864068 309 313 B-Observation
androgen NCT03864068 314 322 I-Observation
index NCT03864068 323 328 I-Observation
greater NCT03864068 329 336 B-Eq_Comparison
than NCT03864068 337 341 I-Eq_Comparison
10 NCT03864068 342 344 I-Eq_Comparison
. NCT03864068 344 345 O

- NCT03864068 349 350 O
Women NCT03864068 352 357 O
with NCT03864068 358 362 B-And
Polycystic NCT03864068 363 373 B-Condition
Ovaries NCT03864068 374 381 I-Condition
on NCT03864068 382 384 O
Ultrasound NCT03864068 385 395 B-Procedure
defined NCT03864068 396 403 O
as NCT03864068 404 406 O
either NCT03864068 407 413 B-Eq_Comparison
12 NCT03864068 414 416 I-Eq_Comparison
or NCT03864068 417 419 I-Eq_Comparison
more NCT03864068 420 424 I-Eq_Comparison
follicles NCT03864068 425 434 B-Observation
measuring NCT03864068 435 444 I-Observation
2 NCT03864068 445 446 B-Eq_Comparison
- NCT03864068 447 448 I-Eq_Comparison
9 NCT03864068 449 450 I-Eq_Comparison
mm NCT03864068 451 453 I-Eq_Comparison
in NCT03864068 454 456 O
diameter NCT03864068 457 465 B-Modifier
or NCT03864068 466 468 B-Or
increased NCT03864068 469 478 O
ovarian NCT03864068 479 486 B-Observation
volume NCT03864068 487 493 I-Observation
greater NCT03864068 494 501 B-Eq_Comparison
than NCT03864068 502 506 I-Eq_Comparison
10 NCT03864068 507 509 I-Eq_Comparison
cm NCT03864068 510 512 I-Eq_Comparison
. NCT03864068 513 514 O

Exclusion NCT03864068 516 525 O
Criteria NCT03864068 526 534 O
: NCT03864068 535 536 O

- NCT03864068 540 541 O
Women NCT03864068 543 548 O
with NCT03864068 549 553 B-And
Hyperprolactinemia NCT03864068 554 572 B-Condition
defined NCT03864068 573 580 O
as NCT03864068 581 583 O
2 NCT03864068 584 585 B-Eq_Comparison
prolactin NCT03864068 586 595 B-Observation
levels NCT03864068 596 602 I-Observation
at NCT03864068 603 605 B-Eq_Comparison
least NCT03864068 606 611 I-Eq_Comparison
one NCT03864068 612 615 I-Eq_Comparison
week NCT03864068 616 620 I-Eq_Comparison
apart NCT03864068 621 626 O
greater NCT03864068 627 634 B-Eq_Comparison
than NCT03864068 635 639 I-Eq_Comparison
30 NCT03864068 640 642 I-Eq_Comparison
ng NCT03864068 643 645 I-Eq_Comparison
/ NCT03864068 646 647 I-Eq_Comparison
mL NCT03864068 648 650 I-Eq_Comparison
. NCT03864068 651 652 O

- NCT03864068 656 657 O
Women NCT03864068 659 664 O
with NCT03864068 665 669 B-And
known NCT03864068 670 675 O
21 NCT03864068 676 678 B-Condition
- NCT03864068 679 680 I-Condition
hydroxylase NCT03864068 681 692 I-Condition
deficiency NCT03864068 693 703 I-Condition
or NCT03864068 704 706 B-Or
other NCT03864068 707 712 B-Other
enzyme NCT03864068 713 719 B-Condition
deficiency NCT03864068 720 730 I-Condition
leading NCT03864068 731 738 O
to NCT03864068 739 741 O
the NCT03864068 742 745 O
congenital NCT03864068 746 756 B-Condition
adrenal NCT03864068 757 764 I-Condition
hyperplasia NCT03864068 765 776 I-Condition
. NCT03864068 777 778 O

- NCT03864068 782 783 O
Women NCT03864068 785 790 O
with NCT03864068 791 795 B-And
elevated NCT03864068 796 804 O
FSH NCT03864068 805 808 B-Observation
levels NCT03864068 809 815 I-Observation
greater NCT03864068 816 823 B-Eq_Comparison
than NCT03864068 824 828 I-Eq_Comparison
10 NCT03864068 829 831 I-Eq_Comparison
mIU NCT03864068 832 835 I-Eq_Comparison
/ NCT03864068 836 837 I-Eq_Comparison
mL NCT03864068 838 840 I-Eq_Comparison
. NCT03864068 841 842 I-Eq_Comparison

- NCT03864068 846 847 O
Women NCT03864068 849 854 O
with NCT03864068 855 859 B-And
uncorrected NCT03864068 860 871 B-Modifier
thyroid NCT03864068 872 879 B-Condition
disease NCT03864068 880 887 I-Condition
as NCT03864068 888 890 O
per NCT03864068 891 894 O
ASRM NCT03864068 895 899 O
guidelines NCT03864068 900 910 O
for NCT03864068 911 914 O
nonpregnant NCT03864068 915 926 O
subjects NCT03864068 927 935 O
( NCT03864068 936 937 O
TSH NCT03864068 938 941 B-Observation
less NCT03864068 942 946 B-Eq_Comparison
than NCT03864068 947 951 I-Eq_Comparison
0.45 NCT03864068 952 956 I-Eq_Comparison
mIU NCT03864068 957 960 I-Eq_Comparison
/ NCT03864068 961 962 I-Eq_Comparison
mL NCT03864068 963 965 I-Eq_Comparison
or NCT03864068 966 968 B-Or
greater NCT03864068 969 976 B-Eq_Comparison
than NCT03864068 977 981 I-Eq_Comparison
4.5 NCT03864068 982 985 I-Eq_Comparison
MIU NCT03864068 986 989 I-Eq_Comparison
/ NCT03864068 990 991 I-Eq_Comparison
mL NCT03864068 992 994 I-Eq_Comparison
) NCT03864068 995 996 O
. NCT03864068 997 998 O

- NCT03864068 1002 1003 O
Women NCT03864068 1005 1010 O
with NCT03864068 1011 1015 B-And
a NCT03864068 1016 1017 O
suspected NCT03864068 1018 1027 B-Assertion___Assertion_Type_Value:possible
adrenal NCT03864068 1028 1035 B-Modifier
or NCT03864068 1036 1038 B-Or
ovarian NCT03864068 1039 1046 B-Modifier
tumor NCT03864068 1047 1052 B-Condition
secreting NCT03864068 1053 1062 B-Modifier
androgens NCT03864068 1063 1072 I-Modifier

- NCT03864068 1075 1076 O
Women NCT03864068 1078 1083 O
with NCT03864068 1084 1088 B-And
Cushing NCT03864068 1089 1096 B-Condition
's NCT03864068 1096 1098 I-Condition
syndrome NCT03864068 1099 1107 I-Condition

- NCT03864068 1110 1111 O
Women NCT03864068 1113 1118 O
on NCT03864068 1119 1121 B-Eq_Comparison
confounding NCT03864068 1122 1133 O
medications NCT03864068 1134 1145 B-Drug
which NCT03864068 1146 1151 O
affect NCT03864068 1152 1158 B-Assertion___Assertion_Type_Value:hypothetical
ovarian NCT03864068 1159 1166 B-Condition
function NCT03864068 1167 1175 I-Condition
including NCT03864068 1176 1185 O
metformin NCT03864068 1186 1195 B-Drug
, NCT03864068 1196 1197 O
hormonal NCT03864068 1198 1206 B-Drug
contraceptives NCT03864068 1207 1221 I-Drug
or NCT03864068 1222 1224 B-Or
other NCT03864068 1225 1230 B-Other
medications NCT03864068 1231 1242 B-Drug
for NCT03864068 1243 1246 O
type NCT03864068 1247 1251 B-Modifier
2 NCT03864068 1252 1253 I-Modifier
diabetes NCT03864068 1254 1262 B-Condition

- NCT03864068 1265 1266 O
Women NCT03864068 1268 1273 O
with NCT03864068 1274 1278 B-And
medical NCT03864068 1279 1286 B-Condition
conditions NCT03864068 1287 1297 I-Condition
that NCT03864068 1298 1302 O
are NCT03864068 1303 1306 O
contraindications NCT03864068 1307 1324 B-Contraindication
to NCT03864068 1325 1327 O
OTC NCT03864068 1328 1331 B-Drug
inositol NCT03864068 1332 1340 I-Drug
or NCT03864068 1341 1343 B-Or
previous NCT03864068 1344 1352 B-Eq_Comparison
allergic NCT03864068 1353 1361 B-Allergy
reactions NCT03864068 1362 1371 O
to NCT03864068 1372 1374 O
the NCT03864068 1375 1378 O
supplement NCT03864068 1379 1389 B-Drug
or NCT03864068 1390 1392 B-Or
to NCT03864068 1393 1395 O
the NCT03864068 1396 1399 O
placebo NCT03864068 1400 1407 B-Drug
maltodextrin NCT03864068 1408 1420 I-Drug
or NCT03864068 1421 1423 B-Or
inulin NCT03864068 1424 1430 B-Drug
. NCT03864068 1431 1432 O

Inclusion NCT03920553 0 9 O
Criteria NCT03920553 10 18 O
: NCT03920553 19 20 O

- NCT03920553 24 25 O
No NCT03920553 27 29 B-Negation
systemic NCT03920553 30 38 B-Modifier
disease NCT03920553 39 46 B-Condition
, NCT03920553 47 48 O

- NCT03920553 52 53 O
the NCT03920553 55 58 O
presence NCT03920553 59 67 O
of NCT03920553 68 70 O
high NCT03920553 71 75 B-Condition
labial NCT03920553 76 82 I-Condition
frenulum NCT03920553 83 91 I-Condition
attachment NCT03920553 92 102 I-Condition
diagnosed NCT03920553 103 112 O
according NCT03920553 113 122 O
to NCT03920553 123 125 O
Mirko NCT03920553 126 131 O
et NCT03920553 132 134 O
al NCT03920553 135 137 O
. NCT03920553 138 139 O
, NCT03920553 140 141 O
- NCT03920553 142 143 O
periodontally NCT03920553 144 157 B-Observation
healthy NCT03920553 158 165 I-Observation
or NCT03920553 166 168 B-Or
a NCT03920553 169 170 O
requirement NCT03920553 171 182 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03920553 183 186 I-Assertion___Assertion_Type_Value:hypothetical
periodontal NCT03920553 187 198 B-Procedure
treatment NCT03920553 199 208 I-Procedure
that NCT03920553 209 213 O
would NCT03920553 214 219 B-Assertion___Assertion_Type_Value:hypothetical
only NCT03920553 220 224 O
require NCT03920553 225 232 O
removing NCT03920553 233 241 B-Procedure
of NCT03920553 242 244 I-Procedure
dental NCT03920553 245 251 I-Procedure
plaque NCT03920553 252 258 I-Procedure
, NCT03920553 259 260 O

- NCT03920553 264 265 O
full NCT03920553 267 271 B-Observation
mouth NCT03920553 272 277 I-Observation
plaque NCT03920553 278 284 I-Observation
score NCT03920553 285 290 I-Observation
< NCT03920553 291 292 B-Eq_Comparison
15 NCT03920553 293 295 I-Eq_Comparison
% NCT03920553 296 297 I-Eq_Comparison
, NCT03920553 298 299 O
probing NCT03920553 300 307 B-Observation
pocket NCT03920553 308 314 I-Observation
depth NCT03920553 315 320 I-Observation
< NCT03920553 321 322 B-Eq_Comparison
3 NCT03920553 323 324 I-Eq_Comparison
mm NCT03920553 325 327 I-Eq_Comparison
in NCT03920553 328 330 O
all NCT03920553 331 334 O
teeth NCT03920553 335 340 O

- NCT03920553 343 344 O
no NCT03920553 346 348 B-Negation
history NCT03920553 349 356 B-Eq_Comparison
of NCT03920553 357 359 O
periodontal NCT03920553 360 371 B-Procedure
surgery NCT03920553 372 379 I-Procedure
. NCT03920553 380 381 O

Exclusion NCT03920553 383 392 O
Criteria NCT03920553 393 401 O
: NCT03920553 402 403 O

- NCT03920553 407 408 O
not NCT03920553 410 413 B-Negation
meet NCT03920553 414 418 O
the NCT03920553 419 422 O
optimal NCT03920553 423 430 O
level NCT03920553 431 436 O
of NCT03920553 437 439 O
oral NCT03920553 440 444 B-Observation
hygiene NCT03920553 445 452 I-Observation
, NCT03920553 453 454 O

- NCT03920553 458 459 O
had NCT03920553 461 464 O
any NCT03920553 465 468 O
condition NCT03920553 469 478 B-Condition
that NCT03920553 479 483 O
could NCT03920553 484 489 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03920553 490 496 O
wound NCT03920553 497 502 B-Condition
healing NCT03920553 503 510 I-Condition
, NCT03920553 511 512 O

- NCT03920553 516 517 O
were NCT03920553 519 523 B-Eq_Comparison
pregnant NCT03920553 524 532 B-Condition
or NCT03920553 533 535 B-Or
lactating NCT03920553 536 545 B-Condition
, NCT03920553 546 547 O

- NCT03920553 551 552 O
were NCT03920553 554 558 B-Eq_Comparison
cigarette NCT03920553 559 568 B-Condition
smokers NCT03920553 569 576 I-Condition
or NCT03920553 577 579 B-Or
were NCT03920553 580 584 B-Eq_Comparison
takiing NCT03920553 585 592 I-Eq_Comparison
any NCT03920553 593 596 O
medication NCT03920553 597 607 B-Drug
that NCT03920553 608 612 O
might NCT03920553 613 618 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03920553 619 625 O
the NCT03920553 626 629 O
outcome NCT03920553 630 637 O
of NCT03920553 638 640 O
the NCT03920553 641 644 O
study NCT03920553 645 650 B-Study
, NCT03920553 651 652 O

Inclusion NCT03924934 0 9 O
Criteria NCT03924934 10 18 O
: NCT03924934 19 20 O

Category NCT03924934 22 30 O
1 NCT03924934 31 32 O
: NCT03924934 33 34 O
Patients NCT03924934 35 43 O
who NCT03924934 44 47 O
live NCT03924934 48 52 O
at NCT03924934 53 55 O
home NCT03924934 56 60 O
and NCT03924934 61 64 O
meet NCT03924934 65 69 O
the NCT03924934 70 73 O
following NCT03924934 74 83 O
criteria NCT03924934 84 92 O
: NCT03924934 93 94 O

- NCT03924934 98 99 O
CDC NCT03924934 101 104 O
- NCT03924934 105 106 O
defined NCT03924934 107 114 O
CRE NCT03924934 115 118 B-Organism
isolated NCT03924934 119 127 I-Organism
during NCT03924934 128 134 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospitalization NCT03924934 135 150 B-Encounter
or NCT03924934 151 153 B-Or
outpatient NCT03924934 154 164 B-Encounter
visit NCT03924934 165 170 I-Encounter

- NCT03924934 173 174 O
Home NCT03924934 176 180 O
origin NCT03924934 181 187 O

- NCT03924934 190 191 O
First NCT03924934 193 198 B-Eq_Comparison
positive NCT03924934 199 207 O
CRE NCT03924934 208 211 B-Organism
culture NCT03924934 212 219 I-Organism
within NCT03924934 220 226 B-Eq_Comparison
48 NCT03924934 227 229 I-Eq_Comparison
hours NCT03924934 230 235 I-Eq_Comparison
of NCT03924934 236 238 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03924934 239 248 B-Encounter
( NCT03924934 249 250 O
in NCT03924934 251 253 O
case NCT03924934 254 258 O
of NCT03924934 259 261 O
hospitalization NCT03924934 262 277 B-Encounter
) NCT03924934 278 279 O

Category NCT03924934 281 289 O
2 NCT03924934 290 291 O
: NCT03924934 292 293 O
Hospitalized NCT03924934 294 306 B-Encounter
patients NCT03924934 307 315 O
with NCT03924934 316 320 B-And
CDC NCT03924934 321 324 O
- NCT03924934 325 326 O
defined NCT03924934 327 334 O
CRE NCT03924934 335 338 B-Organism
isolated NCT03924934 339 347 I-Organism
during NCT03924934 348 354 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospitalization NCT03924934 355 370 B-Encounter
who NCT03924934 371 374 B-And
are NCT03924934 375 378 O
not NCT03924934 379 382 B-Negation
discharged NCT03924934 383 393 B-Encounter
home NCT03924934 394 398 O
and NCT03924934 399 402 O
who NCT03924934 403 406 O
meet NCT03924934 407 411 O
any NCT03924934 412 415 O
of NCT03924934 416 418 O
the NCT03924934 419 422 B-Criteria_Count
following NCT03924934 423 432 I-Criteria_Count
criteria NCT03924934 433 441 I-Criteria_Count
: NCT03924934 442 443 O

- NCT03924934 447 448 O
Admitted NCT03924934 450 458 B-Encounter
from NCT03924934 459 463 O
other NCT03924934 464 469 B-Other
care NCT03924934 470 474 O
facility NCT03924934 475 483 O
( NCT03924934 484 485 O
not NCT03924934 486 489 O
home NCT03924934 490 494 O
origin NCT03924934 495 501 O
) NCT03924934 502 503 O

- NCT03924934 507 508 O
Do NCT03924934 510 512 O
not NCT03924934 513 516 B-Negation
have NCT03924934 517 521 O
first NCT03924934 522 527 B-Eq_Comparison
positive NCT03924934 528 536 O
CRE NCT03924934 537 540 B-Organism
culture NCT03924934 541 548 I-Organism
within NCT03924934 549 555 B-Eq_Comparison
48 NCT03924934 556 558 I-Eq_Comparison
hours NCT03924934 559 564 I-Eq_Comparison
of NCT03924934 565 567 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03924934 568 577 B-Encounter

Category NCT03924934 578 586 O
3 NCT03924934 587 588 O
: NCT03924934 589 590 O
Patients NCT03924934 591 599 O
with NCT03924934 600 604 O
CDC NCT03924934 605 608 O
- NCT03924934 609 610 O
defined NCT03924934 611 618 O
CRE NCT03924934 619 622 B-Organism
isolated NCT03924934 623 631 I-Organism
during NCT03924934 632 638 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospitalization NCT03924934 639 654 B-Encounter
or NCT03924934 655 657 B-Or
outpatient NCT03924934 658 668 B-Encounter
visit NCT03924934 669 674 I-Encounter
who NCT03924934 675 678 B-And
are NCT03924934 679 682 O
discharged NCT03924934 683 693 B-Encounter
home NCT03924934 694 698 O
and NCT03924934 699 702 O
who NCT03924934 703 706 O
meet NCT03924934 707 711 O
any NCT03924934 712 715 O
of NCT03924934 716 718 O
the NCT03924934 719 722 O
following NCT03924934 723 732 O
criteria NCT03924934 733 741 O
: NCT03924934 742 743 O

- NCT03924934 747 748 O
Admitted NCT03924934 750 758 B-Encounter
from NCT03924934 759 763 O
other NCT03924934 764 769 B-Other
care NCT03924934 770 774 O
facility NCT03924934 775 783 O
( NCT03924934 784 785 O
not NCT03924934 786 789 O
home NCT03924934 790 794 O
origin NCT03924934 795 801 O
) NCT03924934 802 803 O

- NCT03924934 807 808 O
Do NCT03924934 810 812 O
not NCT03924934 813 816 B-Negation
have NCT03924934 817 821 O
first NCT03924934 822 827 B-Eq_Comparison
positive NCT03924934 828 836 O
CRE NCT03924934 837 840 B-Organism
culture NCT03924934 841 848 I-Organism
within NCT03924934 849 855 B-Eq_Comparison
48 NCT03924934 856 858 I-Eq_Comparison
hours NCT03924934 859 864 I-Eq_Comparison
of NCT03924934 865 867 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03924934 868 877 B-Encounter
( NCT03924934 878 879 O
in NCT03924934 880 882 O
case NCT03924934 883 887 O
of NCT03924934 888 890 O
hospitalization NCT03924934 891 906 B-Encounter
) NCT03924934 907 908 O

Category NCT03924934 910 918 O
4 NCT03924934 919 920 O
: NCT03924934 921 922 O
Participants NCT03924934 923 935 O
who NCT03924934 936 939 O
meet NCT03924934 940 944 O
the NCT03924934 945 948 O
following NCT03924934 949 958 O
criteria NCT03924934 959 967 O
: NCT03924934 968 969 O

• NCT03924934 971 972 O
Community NCT03924934 973 982 O
contact NCT03924934 983 990 O
of NCT03924934 991 993 O
a NCT03924934 994 995 O
participant NCT03924934 996 1007 O
in NCT03924934 1008 1010 O
Category NCT03924934 1011 1019 O
1 NCT03924934 1020 1021 O
and NCT03924934 1022 1025 O
/ NCT03924934 1026 1027 O
or NCT03924934 1028 1030 O
3 NCT03924934 1031 1032 O
. NCT03924934 1032 1033 O

Exclusion NCT03924934 1035 1044 O
Criteria NCT03924934 1045 1053 O
: NCT03924934 1054 1055 O

In NCT03924934 1057 1059 O
all NCT03924934 1060 1063 O
categories NCT03924934 1064 1074 O
, NCT03924934 1075 1076 O
participants NCT03924934 1077 1089 O
who NCT03924934 1090 1093 O
meet NCT03924934 1094 1098 O
the NCT03924934 1099 1102 O
following NCT03924934 1103 1112 O
criteria NCT03924934 1113 1121 O
will NCT03924934 1122 1126 O
be NCT03924934 1127 1129 O
excluded NCT03924934 1130 1138 O
: NCT03924934 1139 1140 O

• NCT03924934 1142 1143 O
Age NCT03924934 1144 1147 B-Age
< NCT03924934 1148 1149 B-Eq_Comparison
18 NCT03924934 1150 1152 I-Eq_Comparison
years NCT03924934 1153 1158 I-Eq_Comparison

In NCT03924934 1159 1161 O
category NCT03924934 1162 1170 O
1 NCT03924934 1171 1172 O
, NCT03924934 1173 1174 O
the NCT03924934 1175 1178 O
following NCT03924934 1179 1188 O
are NCT03924934 1189 1192 O
exclusionary NCT03924934 1193 1205 O
: NCT03924934 1206 1207 O

- NCT03924934 1211 1212 O
pre NCT03924934 1214 1217 B-Eq_Comparison
- NCT03924934 1218 1219 I-Eq_Comparison
existing NCT03924934 1220 1228 I-Eq_Comparison
renal NCT03924934 1229 1234 B-Condition
failure NCT03924934 1235 1242 I-Condition

- NCT03924934 1245 1246 O
pre NCT03924934 1248 1251 B-Eq_Comparison
- NCT03924934 1252 1253 I-Eq_Comparison
existing NCT03924934 1254 1262 I-Eq_Comparison
liver NCT03924934 1263 1268 B-Condition
disease NCT03924934 1269 1276 I-Condition

- NCT03924934 1279 1280 O
immunocompromised NCT03924934 1282 1299 B-Condition

- NCT03924934 1302 1303 O
history NCT03924934 1305 1312 B-Eq_Comparison
of NCT03924934 1313 1315 O
malignancy NCT03924934 1316 1326 B-Condition

- NCT03924934 1329 1330 O
pregnancy NCT03924934 1332 1341 B-Condition

In NCT03924934 1342 1344 O
addition NCT03924934 1345 1353 O
, NCT03924934 1354 1355 O
in NCT03924934 1356 1358 O
category NCT03924934 1359 1367 O
1 NCT03924934 1368 1369 O
, NCT03924934 1370 1371 O
3 NCT03924934 1372 1373 O
and NCT03924934 1374 1377 O
4 NCT03924934 1378 1379 O
, NCT03924934 1380 1381 O
who NCT03924934 1382 1385 O
meet NCT03924934 1386 1390 O
the NCT03924934 1391 1394 O
following NCT03924934 1395 1404 O
criteria NCT03924934 1405 1413 O
will NCT03924934 1414 1418 O
be NCT03924934 1419 1421 O
excluded NCT03924934 1422 1430 O
: NCT03924934 1431 1432 O

• NCT03924934 1434 1435 O
Unable NCT03924934 1436 1442 O
to NCT03924934 1443 1445 O
provide NCT03924934 1446 1453 O
informed NCT03924934 1454 1462 O
consent NCT03924934 1463 1470 O


Inclusion NCT03863015 0 9 O
Criteria NCT03863015 10 18 O
: NCT03863015 19 20 O

Each NCT03863015 22 26 O
of NCT03863015 27 29 O
the NCT03863015 30 33 O
following NCT03863015 34 43 O
criteria NCT03863015 44 52 O
must NCT03863015 53 57 O
be NCT03863015 58 60 O
fulfilled NCT03863015 61 70 O
for NCT03863015 71 74 O
a NCT03863015 75 76 O
subject NCT03863015 77 84 O
to NCT03863015 85 87 O
be NCT03863015 88 90 O
eligible NCT03863015 91 99 O
: NCT03863015 100 101 O

1 NCT03863015 105 106 O
. NCT03863015 106 107 O
Age NCT03863015 109 112 B-Age
≥ NCT03863015 113 114 B-Eq_Comparison
18 NCT03863015 115 117 I-Eq_Comparison
years NCT03863015 118 123 I-Eq_Comparison

2 NCT03863015 126 127 O
. NCT03863015 127 128 O
OHCA NCT03863015 130 134 B-Condition
of NCT03863015 135 137 O
a NCT03863015 138 139 O
presumed NCT03863015 140 148 O
cardiac NCT03863015 149 156 B-Condition
cause NCT03863015 157 162 I-Condition

3 NCT03863015 165 166 O
. NCT03863015 166 167 O
Unconsciousness NCT03863015 169 184 B-Condition
upon NCT03863015 185 189 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03863015 190 199 B-Encounter
, NCT03863015 200 201 O
i NCT03863015 202 203 O
. NCT03863015 204 205 O
e NCT03863015 206 207 O
. NCT03863015 208 209 O
a NCT03863015 211 212 O
GCS NCT03863015 213 216 B-Observation
< NCT03863015 217 218 B-Eq_Comparison
9 NCT03863015 219 220 I-Eq_Comparison

4 NCT03863015 224 225 O
. NCT03863015 225 226 O
Sustained NCT03863015 228 237 O
ROSC NCT03863015 238 242 B-Condition
for NCT03863015 243 246 O
more NCT03863015 247 251 B-Eq_Comparison
than NCT03863015 252 256 I-Eq_Comparison
20 NCT03863015 257 259 I-Eq_Comparison
minutes NCT03863015 260 267 I-Eq_Comparison

Exclusion NCT03863015 268 277 O
Criteria NCT03863015 278 286 O
: NCT03863015 287 288 O

None NCT03863015 290 294 O
of NCT03863015 295 297 O
the NCT03863015 298 301 O
following NCT03863015 302 311 O
criteria NCT03863015 312 320 O
must NCT03863015 321 325 O
be NCT03863015 326 328 O
fulfilled NCT03863015 329 338 O
for NCT03863015 339 342 O
a NCT03863015 343 344 O
subject NCT03863015 345 352 O
to NCT03863015 353 355 O
be NCT03863015 356 358 O
eligible NCT03863015 359 367 O
: NCT03863015 368 369 O

1 NCT03863015 373 374 O
. NCT03863015 374 375 O
Consciousness NCT03863015 377 390 B-Condition
upon NCT03863015 391 395 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03863015 396 405 B-Encounter
, NCT03863015 406 407 O
i NCT03863015 408 409 O
. NCT03863015 410 411 O
e NCT03863015 412 413 O
. NCT03863015 414 415 O
a NCT03863015 417 418 O
GCS NCT03863015 419 422 B-Observation
≥ NCT03863015 423 424 B-Eq_Comparison
9 NCT03863015 425 426 I-Eq_Comparison

2 NCT03863015 430 431 O
. NCT03863015 431 432 O
Presumed NCT03863015 434 442 O
non NCT03863015 443 446 B-Negation
- NCT03863015 447 448 O
cardiac NCT03863015 449 456 B-Modifier
cause NCT03863015 457 462 O
of NCT03863015 463 465 O
arrest NCT03863015 466 472 B-Condition

3 NCT03863015 475 476 O
. NCT03863015 476 477 O
Unwitnessed NCT03863015 479 490 B-Condition
asystole NCT03863015 491 499 I-Condition

4 NCT03863015 502 503 O
. NCT03863015 503 504 O
Suspected NCT03863015 506 515 B-Assertion___Assertion_Type_Value:possible
or NCT03863015 516 518 B-Or
confirmed NCT03863015 519 528 B-Modifier
intracranial NCT03863015 529 541 B-Condition
bleeding NCT03863015 542 550 I-Condition
or NCT03863015 551 553 B-Or
stroke NCT03863015 554 560 B-Condition

5 NCT03863015 563 564 O
. NCT03863015 564 565 O
Pregnancy NCT03863015 567 576 B-Condition
, NCT03863015 577 578 O
or NCT03863015 579 581 B-Or
females NCT03863015 582 589 O
in NCT03863015 590 592 O
fertile NCT03863015 593 600 B-Condition
age NCT03863015 601 604 I-Condition
, NCT03863015 605 606 O
unless NCT03863015 607 613 B-Or
a NCT03863015 614 615 O
negative NCT03863015 616 624 O
serum NCT03863015 625 630 B-Observation
HCG NCT03863015 631 634 I-Observation
can NCT03863015 635 638 B-Assertion___Assertion_Type_Value:hypothetical
rule NCT03863015 639 643 I-Assertion___Assertion_Type_Value:hypothetical
out NCT03863015 644 647 I-Assertion___Assertion_Type_Value:hypothetical
pregnancy NCT03863015 648 657 B-Condition
within NCT03863015 658 664 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863015 665 668 O
inclusion NCT03863015 669 678 B-Study
window NCT03863015 679 685 I-Study
. NCT03863015 686 687 O

6 NCT03863015 691 692 O
. NCT03863015 692 693 O
Temperature NCT03863015 695 706 B-Observation
on NCT03863015 707 709 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03863015 710 719 B-Encounter
< NCT03863015 720 721 B-Eq_Comparison
30 NCT03863015 722 724 I-Eq_Comparison
° NCT03863015 725 726 I-Eq_Comparison
C NCT03863015 726 727 I-Eq_Comparison

7 NCT03863015 730 731 O
. NCT03863015 731 732 O
Persistent NCT03863015 734 744 B-Modifier
cardiogenic NCT03863015 745 756 B-Condition
shock NCT03863015 757 762 I-Condition
* NCT03863015 763 764 O
that NCT03863015 765 769 O
is NCT03863015 770 772 O
not NCT03863015 773 776 B-Negation
reversed NCT03863015 777 785 B-Modifier
within NCT03863015 786 792 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863015 793 796 O
inclusion NCT03863015 797 806 B-Study
window NCT03863015 807 813 I-Study

8 NCT03863015 816 817 O
. NCT03863015 817 818 O
Known NCT03863015 820 825 O
disease NCT03863015 826 833 B-Condition
making NCT03863015 834 840 O
180 NCT03863015 841 844 B-Eq_Comparison
day NCT03863015 845 848 I-Eq_Comparison
survival NCT03863015 849 857 B-Death|B-Risk
unlikely NCT03863015 858 866 I-Death|I-Risk

9 NCT03863015 869 870 O
. NCT03863015 870 871 O
Known NCT03863015 873 878 O
limitations NCT03863015 879 890 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
in NCT03863015 891 893 O
therapy NCT03863015 894 901 B-Procedure

10 NCT03863015 903 905 O
. NCT03863015 905 906 O
Known NCT03863015 908 913 O
pre NCT03863015 914 917 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03863015 918 919 O
arrest NCT03863015 920 926 B-Condition
Cerebral NCT03863015 927 935 B-Observation
Performance NCT03863015 936 947 I-Observation
Category NCT03863015 948 956 I-Observation
of NCT03863015 957 959 O
3 NCT03863015 960 961 B-Eq_Comparison
to NCT03863015 962 964 I-Eq_Comparison
4 NCT03863015 965 966 I-Eq_Comparison

11 NCT03863015 969 971 O
. NCT03863015 971 972 O
> NCT03863015 974 975 B-Eq_Comparison
240 NCT03863015 976 979 I-Eq_Comparison
minutes NCT03863015 980 987 I-Eq_Comparison
from NCT03863015 988 992 B-Temporal_Connection___Temporal_Connection_Type_Value:after
ROSC NCT03863015 993 997 B-Observation
to NCT03863015 998 1000 O
randomization NCT03863015 1001 1014 B-Study

Inclusion NCT03869801 0 9 O
Criteria NCT03869801 10 18 O
: NCT03869801 19 20 O

- NCT03869801 24 25 O
Elective NCT03869801 27 35 B-Modifier
laparoscopic NCT03869801 36 48 B-Procedure
Cholecystectomy NCT03869801 49 64 I-Procedure
, NCT03869801 65 66 O
ASA NCT03869801 67 70 B-Observation
status NCT03869801 71 77 O
1 NCT03869801 78 79 B-Eq_Comparison
- NCT03869801 80 81 I-Eq_Comparison
2 NCT03869801 82 83 I-Eq_Comparison

Exclusion NCT03869801 85 94 O
Criteria NCT03869801 95 103 O
: NCT03869801 104 105 O

- NCT03869801 109 110 O
Patient NCT03869801 112 119 O
refusal NCT03869801 120 127 O
Contraindications NCT03869801 128 145 B-Contraindication
to NCT03869801 146 148 O
regional NCT03869801 149 157 B-Procedure
anesthesia NCT03869801 158 168 I-Procedure
Known NCT03869801 169 174 O
allergy NCT03869801 175 182 B-Allergy
to NCT03869801 183 185 O
local NCT03869801 186 191 B-Drug
anesthetics NCT03869801 192 203 I-Drug
Bleeding NCT03869801 204 212 B-Condition
diathesis NCT03869801 213 222 B-Condition
Use NCT03869801 223 226 O
of NCT03869801 227 229 O
any NCT03869801 230 233 O
anti NCT03869801 234 238 B-Drug
- NCT03869801 239 240 I-Drug
coagulants NCT03869801 241 251 I-Drug
Inability NCT03869801 252 261 O
to NCT03869801 262 264 O
provide NCT03869801 265 272 O
informed NCT03869801 273 281 O
consent NCT03869801 282 289 O
Severe NCT03869801 290 296 O
kidney NCT03869801 297 303 B-Modifier
or NCT03869801 304 306 B-Or
liver NCT03869801 307 312 B-Modifier
disease NCT03869801 313 320 B-Condition
Inability NCT03869801 321 330 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03869801 331 333 O
operate NCT03869801 334 341 B-Procedure
PCA NCT03869801 342 345 I-Procedure
system NCT03869801 346 352 O
Patient NCT03869801 353 360 O
with NCT03869801 361 365 O
psychiatric NCT03869801 366 377 B-Condition
disorders NCT03869801 378 387 I-Condition

Inclusion NCT03860311 0 9 O
Criteria NCT03860311 10 18 O
: NCT03860311 19 20 O

- NCT03860311 24 25 O
Age NCT03860311 27 30 B-Age
8 NCT03860311 31 32 B-Eq_Comparison
yr NCT03860311 33 35 I-Eq_Comparison
- NCT03860311 36 37 I-Eq_Comparison
18 NCT03860311 38 40 I-Eq_Comparison
yrs NCT03860311 41 44 I-Eq_Comparison

- NCT03860311 47 48 O
Female NCT03860311 50 56 O

- NCT03860311 59 60 O
Likely NCT03860311 62 68 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860311 69 71 I-Assertion___Assertion_Type_Value:hypothetical
have NCT03860311 72 76 O
order NCT03860311 77 82 O
placed NCT03860311 83 89 O
for NCT03860311 90 93 O
transabdominal NCT03860311 94 108 B-Procedure
pelvic NCT03860311 109 115 I-Procedure
ultrasound NCT03860311 116 126 I-Procedure
/ NCT03860311 127 128 B-Or
ovarian NCT03860311 129 136 B-Modifier
ultrasound NCT03860311 137 147 B-Procedure

- NCT03860311 150 151 O
No NCT03860311 153 155 B-Negation
history NCT03860311 156 163 B-Eq_Comparison
of NCT03860311 164 166 O
pelvic NCT03860311 167 173 B-Modifier
or NCT03860311 174 176 B-Or
bladder NCT03860311 177 184 B-Modifier
reconstructive NCT03860311 185 199 B-Procedure
surgery NCT03860311 200 207 I-Procedure

Exclusion NCT03860311 208 217 O
Criteria NCT03860311 218 226 O
: NCT03860311 227 228 O

- NCT03860311 232 233 O
Pregnancy NCT03860311 235 244 B-Condition
( NCT03860311 245 246 O
known NCT03860311 247 252 O
) NCT03860311 253 254 O

- NCT03860311 258 259 O
Critically NCT03860311 261 271 O
ill NCT03860311 272 275 B-Condition
patients NCT03860311 276 284 O

- NCT03860311 287 288 O
Patients NCT03860311 290 298 O
with NCT03860311 299 303 O
known NCT03860311 304 309 O
renal NCT03860311 310 315 B-Modifier
or NCT03860311 316 318 B-Or
genitourinary NCT03860311 319 332 B-Modifier
structural NCT03860311 333 343 I-Modifier
abnormalities NCT03860311 344 357 B-Condition
or NCT03860311 358 360 B-Or
prior NCT03860311 361 366 B-Eq_Comparison
pelvic NCT03860311 367 373 B-Modifier
/ NCT03860311 374 375 B-Or
genitourinary NCT03860311 376 389 B-Modifier
surgery NCT03860311 390 397 B-Procedure

- NCT03860311 400 401 O
Chronic NCT03860311 403 410 O
renal NCT03860311 411 416 B-Condition
disease NCT03860311 417 424 I-Condition

- NCT03860311 427 428 O
Patients NCT03860311 430 438 O
presenting NCT03860311 439 449 O
outside NCT03860311 450 457 B-Negation
the NCT03860311 458 461 O
defined NCT03860311 462 469 B-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03860311 470 479 B-Procedure
windows NCT03860311 480 487 O

Inclusion NCT03862209 0 9 O
Criteria NCT03862209 10 18 O
: NCT03862209 19 20 O

Adults NCT03862209 22 28 O
( NCT03862209 29 30 O
ages NCT03862209 31 35 B-Age
18 NCT03862209 36 38 B-Eq_Comparison
- NCT03862209 39 40 I-Eq_Comparison
65 NCT03862209 41 43 I-Eq_Comparison
) NCT03862209 44 45 O
, NCT03862209 46 47 O
current NCT03862209 48 55 O
service NCT03862209 56 63 O
users NCT03862209 64 69 O
, NCT03862209 70 71 O
with NCT03862209 72 76 B-And
severe NCT03862209 77 83 O
and NCT03862209 84 87 B-Or
enduring NCT03862209 88 96 B-Modifier
mental NCT03862209 97 103 B-Condition
ill NCT03862209 104 107 I-Condition
- NCT03862209 108 109 I-Condition
health NCT03862209 110 116 I-Condition
, NCT03862209 117 118 O
which NCT03862209 119 124 O
, NCT03862209 125 126 O
for NCT03862209 127 130 O
clinical NCT03862209 131 139 O
purposes NCT03862209 140 148 O
, NCT03862209 149 150 O
typically NCT03862209 151 160 O
relates NCT03862209 161 168 O
to NCT03862209 169 171 O
diagnostic NCT03862209 172 182 O
categories NCT03862209 183 193 O
of NCT03862209 194 196 O
bipolar NCT03862209 197 204 B-Condition
disorder NCT03862209 205 213 I-Condition
, NCT03862209 214 215 O
severe NCT03862209 216 222 O
depression NCT03862209 223 233 B-Condition
, NCT03862209 234 235 O
or NCT03862209 236 238 B-Or
schizophrenia NCT03862209 239 252 B-Condition
. NCT03862209 253 254 O
We NCT03862209 256 258 O
use NCT03862209 259 262 O
the NCT03862209 263 266 O
following NCT03862209 267 276 O
definition NCT03862209 277 287 O
for NCT03862209 288 291 O
SMI NCT03862209 292 295 B-Condition
: NCT03862209 296 297 O

- NCT03862209 301 302 O
Presence NCT03862209 304 312 O
of NCT03862209 313 315 O
a NCT03862209 316 317 O
psychiatric NCT03862209 318 329 B-Condition
disorder NCT03862209 330 338 I-Condition
that NCT03862209 339 343 O
requires NCT03862209 344 352 B-Assertion___Assertion_Type_Value:hypothetical
care NCT03862209 353 357 B-Procedure
and NCT03862209 358 361 B-And
treatment NCT03862209 362 371 B-Procedure
( NCT03862209 372 373 O
so NCT03862209 374 376 O
, NCT03862209 377 378 O
they NCT03862209 379 383 O
are NCT03862209 384 387 O
NOT NCT03862209 388 391 B-Negation
in NCT03862209 392 394 O
symptom NCT03862209 395 402 B-Modifier
remission NCT03862209 403 412 I-Modifier
) NCT03862209 413 414 O

- NCT03862209 418 419 O
Has NCT03862209 421 424 O
severe NCT03862209 425 431 O
limitations NCT03862209 432 443 B-Condition
in NCT03862209 444 446 O
social NCT03862209 447 453 B-Modifier
and NCT03862209 454 457 B-And
community NCT03862209 458 467 B-Modifier
functioning NCT03862209 468 479 I-Modifier
( NCT03862209 480 481 O
i NCT03862209 482 483 O
. NCT03862209 484 485 O
e NCT03862209 486 487 O
. NCT03862209 488 489 O
they NCT03862209 491 495 O
are NCT03862209 496 499 O
not NCT03862209 500 503 B-Negation
in NCT03862209 504 506 O
functional NCT03862209 507 517 B-Modifier
remission NCT03862209 518 527 I-Modifier
) NCT03862209 528 529 O

- NCT03862209 533 534 O
These NCT03862209 536 541 O
problems NCT03862209 542 550 B-Condition
are NCT03862209 551 554 O
not NCT03862209 555 558 B-Negation
transient NCT03862209 559 568 B-Modifier
( NCT03862209 569 570 O
e NCT03862209 571 572 O
. NCT03862209 573 574 O
g NCT03862209 575 576 O
. NCT03862209 577 578 O
temporary NCT03862209 580 589 B-Modifier
, NCT03862209 590 591 O
one NCT03862209 592 595 B-Modifier
- NCT03862209 596 597 I-Modifier
off NCT03862209 598 601 I-Modifier
) NCT03862209 602 603 O
in NCT03862209 604 606 O
nature NCT03862209 607 613 O
( NCT03862209 614 615 O
They NCT03862209 616 620 O
are NCT03862209 621 624 O
systematic NCT03862209 625 635 B-Modifier
and NCT03862209 636 639 B-And
long NCT03862209 640 644 O
- NCT03862209 645 646 O
term NCT03862209 647 651 O
) NCT03862209 652 653 O

- NCT03862209 657 658 O
Coordinated NCT03862209 660 671 B-Procedure
care NCT03862209 672 676 I-Procedure
provided NCT03862209 677 685 O
by NCT03862209 686 688 O
care NCT03862209 689 693 B-Provider
networks NCT03862209 694 702 I-Provider
or NCT03862209 703 705 B-Or
teams NCT03862209 706 711 B-Provider
is NCT03862209 712 714 O
needed NCT03862209 715 721 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862209 722 724 I-Assertion___Assertion_Type_Value:hypothetical
implement NCT03862209 725 734 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03862209 735 738 O
treatment NCT03862209 739 748 B-Procedure
plan NCT03862209 749 753 B-Eq_Comparison

Exclusion NCT03862209 754 763 O
Criteria NCT03862209 764 772 O
: NCT03862209 773 774 O

Exclusion NCT03862209 776 785 O
criteria NCT03862209 786 794 O
at NCT03862209 795 797 O
the NCT03862209 798 801 O
patient NCT03862209 802 809 O
level NCT03862209 810 815 O
includes NCT03862209 816 824 O
patients NCT03862209 825 833 O
who NCT03862209 834 837 O
do NCT03862209 838 840 O
not NCT03862209 841 844 O
consent NCT03862209 845 852 O
to NCT03862209 853 855 O
their NCT03862209 856 861 O
data NCT03862209 862 866 O
being NCT03862209 867 872 O
collected NCT03862209 873 882 O
who NCT03862209 883 886 O
are NCT03862209 887 890 O
part NCT03862209 891 895 O
of NCT03862209 896 898 O
the NCT03862209 899 902 O
intervention NCT03862209 903 915 O
or NCT03862209 916 918 O
control NCT03862209 919 926 O
conditions NCT03862209 927 937 O
, NCT03862209 938 939 O
those NCT03862209 940 945 O
who NCT03862209 946 949 O
are NCT03862209 950 953 O
under NCT03862209 954 959 B-Eq_Comparison
the NCT03862209 960 963 I-Eq_Comparison
age NCT03862209 964 967 I-Eq_Comparison
of NCT03862209 968 970 I-Eq_Comparison
18 NCT03862209 971 973 I-Eq_Comparison
at NCT03862209 974 976 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862209 977 980 I-Temporal_Connection___Temporal_Connection_Type_Value:during
start NCT03862209 981 986 B-Eq_Comparison
of NCT03862209 987 989 O
the NCT03862209 990 993 O
study NCT03862209 994 999 B-Study
. NCT03862209 1000 1001 O


Inclusion NCT03863938 0 9 O
Criteria NCT03863938 10 18 O
: NCT03863938 19 20 O

- NCT03863938 24 25 O
Healthy NCT03863938 27 34 B-Condition
adult NCT03863938 35 40 O
males NCT03863938 41 46 O
aged NCT03863938 47 51 B-Age
≥ NCT03863938 52 53 B-Eq_Comparison
19 NCT03863938 54 56 I-Eq_Comparison
years NCT03863938 57 62 I-Eq_Comparison
and NCT03863938 63 66 B-And
≤ NCT03863938 67 68 B-Eq_Comparison
50 NCT03863938 69 71 I-Eq_Comparison
years NCT03863938 72 77 I-Eq_Comparison

- NCT03863938 80 81 O
Body NCT03863938 83 87 B-Observation
weight NCT03863938 88 94 I-Observation
of NCT03863938 95 97 O
≥ NCT03863938 98 99 B-Eq_Comparison
55.0 NCT03863938 100 104 I-Eq_Comparison
kg NCT03863938 105 107 I-Eq_Comparison
and NCT03863938 108 111 B-And
≤ NCT03863938 112 113 B-Eq_Comparison
90.0 NCT03863938 114 118 I-Eq_Comparison
kg NCT03863938 119 121 I-Eq_Comparison
, NCT03863938 122 123 O
with NCT03863938 124 128 B-And
body NCT03863938 129 133 B-Observation
mass NCT03863938 134 138 I-Observation
index NCT03863938 139 144 I-Observation
( NCT03863938 145 146 O
BMI NCT03863938 147 150 B-Observation
) NCT03863938 151 152 O
of NCT03863938 153 155 O
≥ NCT03863938 156 157 B-Eq_Comparison
18.0 NCT03863938 158 162 I-Eq_Comparison
kg NCT03863938 163 165 I-Eq_Comparison
/ NCT03863938 166 167 I-Eq_Comparison
m NCT03863938 168 169 I-Eq_Comparison
2 NCT03863938 170 171 I-Eq_Comparison
and NCT03863938 172 175 B-And
≤ NCT03863938 176 177 B-Eq_Comparison
27.0 NCT03863938 178 182 I-Eq_Comparison
kg NCT03863938 183 185 I-Eq_Comparison
/ NCT03863938 186 187 I-Eq_Comparison
m NCT03863938 188 189 I-Eq_Comparison
2 NCT03863938 190 191 I-Eq_Comparison
at NCT03863938 192 194 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863938 195 198 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03863938 199 203 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03863938 204 206 O
screening NCT03863938 207 216 B-Study

- NCT03863938 219 220 O
Helicobacter NCT03863938 222 234 B-Organism
pylori NCT03863938 235 241 I-Organism
negative NCT03863938 242 250 O

Exclusion NCT03863938 251 260 O
Criteria NCT03863938 261 269 O
: NCT03863938 270 271 O

- NCT03863938 275 276 O
Presence NCT03863938 278 286 B-Eq_Comparison
or NCT03863938 287 289 B-Or
history NCT03863938 290 297 B-Eq_Comparison
of NCT03863938 298 300 O
clinically NCT03863938 301 311 O
significant NCT03863938 312 323 O
diseases NCT03863938 324 332 B-Condition

- NCT03863938 335 336 O
Presence NCT03863938 338 346 B-Eq_Comparison
or NCT03863938 347 349 B-Or
history NCT03863938 350 357 B-Eq_Comparison
of NCT03863938 358 360 O
gastrointestinal NCT03863938 361 377 B-Condition
disorder NCT03863938 378 386 I-Condition
( NCT03863938 387 388 O
gastric NCT03863938 389 396 B-Condition
ulcer NCT03863938 397 402 I-Condition
, NCT03863938 403 404 O
GERD NCT03863938 405 409 B-Condition
, NCT03863938 410 411 O
Crohn NCT03863938 412 417 B-Condition
's NCT03863938 417 419 I-Condition
disease NCT03863938 420 427 I-Condition
, NCT03863938 428 429 O
etc NCT03863938 430 433 O
. NCT03863938 434 435 O
) NCT03863938 436 437 O

- NCT03863938 441 442 O
Hypersensitivity NCT03863938 444 460 B-Condition
to NCT03863938 461 463 O
drugs NCT03863938 464 469 B-Drug
containing NCT03863938 470 480 O
study NCT03863938 481 486 B-Study
drug NCT03863938 487 491 B-Drug
or NCT03863938 492 494 B-Or
proton NCT03863938 495 501 B-Drug
pump NCT03863938 502 506 I-Drug
inhibitor NCT03863938 507 516 I-Drug
and NCT03863938 517 520 B-Or
other NCT03863938 521 526 B-Other
drugs NCT03863938 527 532 B-Drug
( NCT03863938 533 534 O
aspirin NCT03863938 535 542 B-Drug
, NCT03863938 543 544 O
antibiotics NCT03863938 545 556 B-Drug
, NCT03863938 557 558 O
etc NCT03863938 559 562 O
. NCT03863938 563 564 O
) NCT03863938 565 566 O
or NCT03863938 567 569 B-Or
history NCT03863938 570 577 B-Eq_Comparison
of NCT03863938 578 580 O
clinically NCT03863938 581 591 O
significant NCT03863938 592 603 O
hypersensitivity NCT03863938 604 620 B-Condition

- NCT03863938 623 624 O
Serologic NCT03863938 626 635 B-Observation
test NCT03863938 636 640 I-Observation
positive NCT03863938 641 649 O

- NCT03863938 652 653 O
Abnormal NCT03863938 655 663 O
obstacle NCT03863938 664 672 O
to NCT03863938 673 675 O
insertion NCT03863938 676 685 B-Procedure
and NCT03863938 686 689 B-And
maintenance NCT03863938 690 701 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03863938 702 704 O
pH NCT03863938 705 707 B-Procedure
meter NCT03863938 708 713 I-Procedure
catheter NCT03863938 714 722 I-Procedure

- NCT03863938 725 726 O
History NCT03863938 728 735 B-Eq_Comparison
of NCT03863938 736 738 O
drug NCT03863938 739 743 B-Condition
abuse NCT03863938 744 749 I-Condition

- NCT03863938 752 753 O
Excessive NCT03863938 755 764 O
caffeine NCT03863938 765 773 B-Drug
intake NCT03863938 774 780 O
or NCT03863938 781 783 B-Or
persistent NCT03863938 784 794 B-Modifier
alcohol NCT03863938 795 802 B-Drug
intake NCT03863938 803 809 O

- NCT03863938 812 813 O
Not NCT03863938 815 818 B-Negation
use NCT03863938 819 822 O
of NCT03863938 823 825 O
a NCT03863938 826 827 O
medically NCT03863938 828 837 O
acceptable NCT03863938 838 848 O
method NCT03863938 849 855 O
of NCT03863938 856 858 O
contraception NCT03863938 859 872 B-Procedure

Inclusion NCT03921099 0 9 O
Criteria NCT03921099 10 18 O
: NCT03921099 19 20 O

- NCT03921099 24 25 O
Adults NCT03921099 27 33 O
who NCT03921099 34 37 B-And
are NCT03921099 38 41 O
critically NCT03921099 42 52 O
ill NCT03921099 53 56 B-Condition
and NCT03921099 57 60 B-And
with NCT03921099 61 65 O
MRSA NCT03921099 66 70 B-Modifier
infection NCT03921099 71 80 B-Condition
suspection NCT03921099 81 91 B-Assertion___Assertion_Type_Value:possible
. NCT03921099 92 93 O

Exclusion NCT03921099 95 104 O
Criteria NCT03921099 105 113 O
: NCT03921099 114 115 O

1 NCT03921099 119 120 O
. NCT03921099 120 121 O
Pregnancy NCT03921099 123 132 B-Condition
or NCT03921099 133 135 B-Or
breast NCT03921099 136 142 B-Condition
feeding NCT03921099 143 150 I-Condition
. NCT03921099 151 152 O

2 NCT03921099 156 157 O
. NCT03921099 157 158 O
Known NCT03921099 160 165 O
allergy NCT03921099 166 173 B-Allergy
to NCT03921099 174 176 O
either NCT03921099 177 183 O
vancomycin NCT03921099 184 194 B-Drug
or NCT03921099 195 197 B-Or
ascorbic NCT03921099 198 206 B-Drug
acid NCT03921099 207 211 I-Drug
. NCT03921099 212 213 O

3 NCT03921099 217 218 O
. NCT03921099 218 219 O
Base NCT03921099 221 225 O
line NCT03921099 226 230 O
serum NCT03921099 231 236 B-Observation
creatinine NCT03921099 237 247 I-Observation
≥ NCT03921099 248 249 B-Eq_Comparison
2 NCT03921099 250 251 I-Eq_Comparison
mg NCT03921099 252 254 I-Eq_Comparison
/ NCT03921099 255 256 I-Eq_Comparison
dl NCT03921099 257 259 I-Eq_Comparison
. NCT03921099 260 261 O

4 NCT03921099 265 266 O
. NCT03921099 266 267 O
Patients NCT03921099 269 277 O
receiving NCT03921099 278 287 O
other NCT03921099 288 293 O
nephrotoxic NCT03921099 294 305 B-Drug
drug NCT03921099 306 310 I-Drug
( NCT03921099 311 312 O
e NCT03921099 313 314 O
. NCT03921099 315 316 O
g NCT03921099 317 318 O
. NCT03921099 319 320 O
, NCT03921099 321 322 O
aminoglycosides NCT03921099 323 338 B-Drug
, NCT03921099 339 340 O
amphotericin NCT03921099 341 353 B-Drug
B NCT03921099 354 355 I-Drug
, NCT03921099 356 357 O
cisplatin NCT03921099 358 367 B-Drug
or NCT03921099 368 370 B-Or
calcinurine NCT03921099 371 382 B-Drug
inhibitors NCT03921099 383 393 I-Drug
) NCT03921099 394 395 O
. NCT03921099 396 397 O

5 NCT03921099 401 402 O
. NCT03921099 402 403 O
Anticepated NCT03921099 405 416 B-Assertion___Assertion_Type_Value:hypothetical
administration NCT03921099 417 431 O
of NCT03921099 432 434 O
contrast NCT03921099 435 443 B-Drug
medium NCT03921099 444 450 I-Drug
within NCT03921099 451 457 B-Eq_Comparison
7 NCT03921099 458 459 I-Eq_Comparison
days NCT03921099 460 464 I-Eq_Comparison
. NCT03921099 465 466 O

6 NCT03921099 470 471 O
. NCT03921099 471 472 O
Patients NCT03921099 474 482 O
suffering NCT03921099 483 492 O
from NCT03921099 493 497 O
some NCT03921099 498 502 O
underlying NCT03921099 503 513 O
diseases NCT03921099 514 522 B-Condition
( NCT03921099 523 524 O
e NCT03921099 525 526 O
. NCT03921099 527 528 O
g NCT03921099 529 530 O
. NCT03921099 531 532 O
, NCT03921099 533 534 O
cancer NCT03921099 535 541 B-Condition
, NCT03921099 542 543 O
HIV NCT03921099 544 547 B-Condition
infection NCT03921099 548 557 I-Condition
, NCT03921099 558 559 O
systemic NCT03921099 560 568 B-Condition
lupus NCT03921099 569 574 I-Condition
erythematoses NCT03921099 575 588 I-Condition
, NCT03921099 589 590 O
or NCT03921099 591 593 B-Or
urinary NCT03921099 594 601 B-Condition
tract NCT03921099 602 607 I-Condition
stones NCT03921099 608 614 I-Condition
) NCT03921099 615 616 O
. NCT03921099 617 618 O

7 NCT03921099 622 623 O
. NCT03921099 623 624 O
Unlikelyhood NCT03921099 626 638 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03921099 639 641 O
receiving NCT03921099 642 651 O
the NCT03921099 652 655 O
study NCT03921099 656 661 O
medications NCT03921099 662 673 B-Drug
for NCT03921099 674 677 O
at NCT03921099 678 680 B-Eq_Comparison
least NCT03921099 681 686 I-Eq_Comparison
72 NCT03921099 687 689 I-Eq_Comparison
hours NCT03921099 690 695 I-Eq_Comparison

Inclusion NCT03863860 0 9 O
Criteria NCT03863860 10 18 O
: NCT03863860 19 20 O

1 NCT03863860 24 25 O
. NCT03863860 25 26 O
Histologically NCT03863860 28 42 B-Procedure
diagnosed NCT03863860 43 52 O
high NCT03863860 53 57 O
- NCT03863860 58 59 O
grade NCT03863860 60 65 O
serous NCT03863860 66 72 B-Modifier
or NCT03863860 73 75 B-Or
endometrioid NCT03863860 76 88 B-Modifier
ovarian NCT03863860 89 96 I-Modifier
cancer NCT03863860 97 103 B-Condition
( NCT03863860 104 105 O
including NCT03863860 106 115 O
primary NCT03863860 116 123 B-Modifier
peritoneal NCT03863860 124 134 I-Modifier
and NCT03863860 135 138 B-Or
fallopian NCT03863860 139 148 B-Modifier
tube NCT03863860 149 153 I-Modifier
cancer NCT03863860 154 160 B-Condition
) NCT03863860 161 162 O

2 NCT03863860 166 167 O
. NCT03863860 167 168 O
Completion NCT03863860 170 180 O
of NCT03863860 181 183 O
≥ NCT03863860 184 185 B-Eq_Comparison
2 NCT03863860 186 187 I-Eq_Comparison
previous NCT03863860 188 196 B-Eq_Comparison
platinum NCT03863860 197 205 B-Procedure
- NCT03863860 206 207 I-Procedure
containing NCT03863860 208 218 I-Procedure
regimens NCT03863860 219 227 I-Procedure

3 NCT03863860 230 231 O
. NCT03863860 231 232 O
Complete NCT03863860 234 242 B-Condition
response NCT03863860 243 251 I-Condition
( NCT03863860 252 253 O
CR NCT03863860 254 256 B-Condition
) NCT03863860 257 258 O
or NCT03863860 259 261 B-Or
partial NCT03863860 262 269 B-Condition
response NCT03863860 270 278 I-Condition
( NCT03863860 279 280 O
PR NCT03863860 281 283 B-Condition
) NCT03863860 284 285 O
achieved NCT03863860 286 294 O
with NCT03863860 295 299 O
last NCT03863860 300 304 B-Eq_Comparison
platinum NCT03863860 305 313 B-Modifier
- NCT03863860 314 315 I-Modifier
based NCT03863860 316 321 I-Modifier
chemotherapy NCT03863860 322 334 B-Procedure
regimen NCT03863860 335 342 I-Procedure
as NCT03863860 343 345 O
determined NCT03863860 346 356 O
by NCT03863860 357 359 O
investigator NCT03863860 360 372 O

4 NCT03863860 375 376 O
. NCT03863860 376 377 O
Ability NCT03863860 379 386 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03863860 387 389 I-Assertion___Assertion_Type_Value:hypothetical
be NCT03863860 390 392 O
randomized NCT03863860 393 403 O
≤ NCT03863860 404 405 B-Eq_Comparison
8 NCT03863860 406 407 I-Eq_Comparison
weeks NCT03863860 408 413 I-Eq_Comparison
after NCT03863860 414 419 B-Temporal_Connection___Temporal_Connection_Type_Value:after
last NCT03863860 420 424 B-Eq_Comparison
dose NCT03863860 425 429 O
of NCT03863860 430 432 O
platinum NCT03863860 433 441 B-Procedure

Exclusion NCT03863860 442 451 O
Criteria NCT03863860 452 460 O
: NCT03863860 461 462 O

1 NCT03863860 466 467 O
. NCT03863860 467 468 O
Prior NCT03863860 470 475 B-Eq_Comparison
treatment NCT03863860 476 485 B-Procedure
with NCT03863860 486 490 O
a NCT03863860 491 492 O
poly NCT03863860 493 497 B-Drug
( NCT03863860 498 499 I-Drug
ADP NCT03863860 500 503 I-Drug
- NCT03863860 504 505 I-Drug
ribose NCT03863860 506 512 I-Drug
) NCT03863860 513 514 I-Drug
polymerase NCT03863860 515 525 I-Drug
( NCT03863860 526 527 O
PARP NCT03863860 528 532 B-Drug
) NCT03863860 533 534 O
inhibitor NCT03863860 535 544 B-Modifier

2 NCT03863860 547 548 O
. NCT03863860 548 549 O
Patients NCT03863860 551 559 O
who NCT03863860 560 563 O
have NCT03863860 564 568 O
received NCT03863860 569 577 O
other NCT03863860 578 583 B-Other
study NCT03863860 584 589 B-Study
drug NCT03863860 590 594 B-Drug
treatment NCT03863860 595 604 B-Procedure
within NCT03863860 605 611 B-Eq_Comparison
4 NCT03863860 612 613 I-Eq_Comparison
weeks NCT03863860 614 619 I-Eq_Comparison
prior NCT03863860 620 625 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863860 626 628 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03863860 629 632 O
first NCT03863860 633 638 B-Eq_Comparison
administration NCT03863860 639 653 O
( NCT03863860 654 655 B-Eq_Comparison
< NCT03863860 656 657 I-Eq_Comparison
5 NCT03863860 658 659 I-Eq_Comparison
elimination NCT03863860 660 671 I-Eq_Comparison
half NCT03863860 672 676 I-Eq_Comparison
- NCT03863860 677 678 I-Eq_Comparison
lives NCT03863860 679 684 I-Eq_Comparison
of NCT03863860 685 687 O
the NCT03863860 688 691 O
study NCT03863860 692 697 B-Study
drug NCT03863860 698 702 B-Drug
molecular NCT03863860 703 712 B-Modifier
targeted NCT03863860 713 721 I-Modifier
anti NCT03863860 722 726 O
- NCT03863860 727 728 O
cancer NCT03863860 729 735 B-Condition
drugs NCT03863860 736 741 B-Drug
) NCT03863860 742 743 O
. NCT03863860 744 745 O

3 NCT03863860 749 750 O
. NCT03863860 750 751 O
Patients NCT03863860 753 761 O
with NCT03863860 762 766 O
clinical NCT03863860 767 775 O
symptoms NCT03863860 776 784 B-Assertion___Assertion_Type_Value:possible
of NCT03863860 785 787 O
cancer NCT03863860 788 794 B-Condition
ascites NCT03863860 795 802 I-Condition
, NCT03863860 803 804 O
pleural NCT03863860 805 812 B-Condition
effusion NCT03863860 813 821 I-Condition
, NCT03863860 822 823 O
who NCT03863860 824 827 B-And
need NCT03863860 828 832 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03863860 833 835 O
drainage NCT03863860 836 844 B-Procedure
, NCT03863860 845 846 O
or NCT03863860 847 849 B-Or
who NCT03863860 850 853 O
have NCT03863860 854 858 O
undergone NCT03863860 859 868 B-Eq_Comparison
ascites NCT03863860 869 876 B-Procedure
drainage NCT03863860 877 885 I-Procedure
within NCT03863860 886 892 B-Eq_Comparison
2 NCT03863860 893 894 I-Eq_Comparison
months NCT03863860 895 901 I-Eq_Comparison
prior NCT03863860 902 907 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863860 908 910 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03863860 911 914 O
first NCT03863860 915 920 B-Eq_Comparison
administration NCT03863860 921 935 B-Drug
. NCT03863860 936 937 O

Inclusion NCT03863509 0 9 O
Criteria NCT03863509 10 18 O
: NCT03863509 19 20 O

- NCT03863509 24 25 O
able NCT03863509 27 31 O
to NCT03863509 32 34 O
read NCT03863509 35 39 O
and NCT03863509 40 43 O
write NCT03863509 44 49 O
English NCT03863509 50 57 O

- NCT03863509 60 61 O
no NCT03863509 63 65 B-Negation
plans NCT03863509 66 71 B-Assertion___Assertion_Type_Value:intention
to NCT03863509 72 74 O
quit NCT03863509 75 79 B-Negation
smoking NCT03863509 80 87 B-Condition
and NCT03863509 88 91 B-Or
/ NCT03863509 92 93 I-Or
or NCT03863509 94 96 I-Or
e NCT03863509 97 98 B-Drug
- NCT03863509 99 100 I-Drug
cig NCT03863509 101 104 I-Drug
use NCT03863509 105 108 O
in NCT03863509 109 111 O
the NCT03863509 112 115 O
next NCT03863509 116 120 B-Eq_Comparison
month NCT03863509 121 126 I-Eq_Comparison

- NCT03863509 129 130 O
not NCT03863509 132 135 B-Negation
using NCT03863509 136 141 B-Eq_Comparison
cigars NCT03863509 142 148 B-Drug
/ NCT03863509 149 150 B-Or
smokeless NCT03863509 151 160 B-Drug
/ NCT03863509 161 162 B-Or
snus NCT03863509 163 167 B-Drug
tobacco NCT03863509 168 175 I-Drug
> NCT03863509 176 177 B-Eq_Comparison
/ NCT03863509 178 179 I-Eq_Comparison
= NCT03863509 180 181 I-Eq_Comparison
1 NCT03863509 182 183 I-Eq_Comparison
time NCT03863509 184 188 I-Eq_Comparison
per NCT03863509 189 192 I-Eq_Comparison
week NCT03863509 193 197 I-Eq_Comparison

- NCT03863509 200 201 O
having NCT03863509 203 209 O
a NCT03863509 210 211 O
stable NCT03863509 212 218 O
pattern NCT03863509 219 226 O
of NCT03863509 227 229 O
current NCT03863509 230 237 B-Eq_Comparison
product NCT03863509 238 245 B-Drug
use NCT03863509 246 249 I-Drug

- NCT03863509 252 253 O
able NCT03863509 255 259 B-Observation
to NCT03863509 260 262 I-Observation
walk NCT03863509 263 267 I-Observation
at NCT03863509 268 270 B-Eq_Comparison
least NCT03863509 271 276 I-Eq_Comparison
2 NCT03863509 277 278 I-Eq_Comparison
blocks NCT03863509 279 285 I-Eq_Comparison
without NCT03863509 286 293 B-Negation
assistance NCT03863509 294 304 B-Modifier
or NCT03863509 305 307 B-Or
stopping NCT03863509 308 316 B-Modifier

- NCT03863509 319 320 O
Specific NCT03863509 322 330 O
to NCT03863509 331 333 O
Exclusive NCT03863509 334 343 O
Smokers NCT03863509 344 351 B-Condition
: NCT03863509 352 353 O

- NCT03863509 362 363 O
smokes NCT03863509 365 371 B-Condition
daily NCT03863509 372 377 B-Eq_Comparison

- NCT03863509 385 386 O
> NCT03863509 388 389 O
/ NCT03863509 390 391 B-Eq_Comparison
= NCT03863509 392 393 I-Eq_Comparison
5 NCT03863509 394 395 I-Eq_Comparison
cigs NCT03863509 396 400 I-Eq_Comparison
/ NCT03863509 401 402 I-Eq_Comparison
day NCT03863509 403 406 I-Eq_Comparison
for NCT03863509 407 410 O
last NCT03863509 411 415 B-Eq_Comparison
6 NCT03863509 416 417 I-Eq_Comparison
months NCT03863509 418 424 I-Eq_Comparison

- NCT03863509 432 433 O
< NCT03863509 435 436 B-Eq_Comparison
3 NCT03863509 437 438 I-Eq_Comparison
uses NCT03863509 439 443 O
E NCT03863509 444 445 B-Observation
- NCT03863509 446 447 I-Observation
cigs NCT03863509 448 452 I-Observation
in NCT03863509 453 455 O
lifetime NCT03863509 456 464 B-Eq_Comparison

- NCT03863509 472 473 O
> NCT03863509 475 476 B-Eq_Comparison
/ NCT03863509 477 478 I-Eq_Comparison
= NCT03863509 479 480 I-Eq_Comparison
5 NCT03863509 481 482 I-Eq_Comparison
ppm NCT03863509 483 486 I-Eq_Comparison
carbon NCT03863509 487 493 B-Observation
monoxide NCT03863509 494 502 I-Observation
( NCT03863509 503 504 O
CO NCT03863509 505 507 B-Observation
) NCT03863509 508 509 O

- NCT03863509 518 519 O
Cotinine NCT03863509 521 529 B-Observation
> NCT03863509 530 531 B-Eq_Comparison
100 NCT03863509 532 535 I-Eq_Comparison
ng NCT03863509 536 538 I-Eq_Comparison
/ NCT03863509 539 540 I-Eq_Comparison
ml NCT03863509 541 543 I-Eq_Comparison

- NCT03863509 546 547 O
Specific NCT03863509 549 557 O
to NCT03863509 558 560 O
Exclusive NCT03863509 561 570 O
E NCT03863509 571 572 B-Drug
- NCT03863509 573 574 I-Drug
cig NCT03863509 575 578 I-Drug
users NCT03863509 579 584 O
: NCT03863509 585 586 O

- NCT03863509 595 596 O
< NCT03863509 598 599 B-Eq_Comparison
/ NCT03863509 600 601 I-Eq_Comparison
= NCT03863509 602 603 I-Eq_Comparison
2 NCT03863509 604 605 I-Eq_Comparison
days NCT03863509 606 610 I-Eq_Comparison
per NCT03863509 611 614 I-Eq_Comparison
month NCT03863509 615 620 I-Eq_Comparison
cigarette NCT03863509 621 630 B-Drug
use NCT03863509 631 634 O
for NCT03863509 635 638 O
last NCT03863509 639 643 B-Eq_Comparison
6 NCT03863509 644 645 I-Eq_Comparison
months NCT03863509 646 652 I-Eq_Comparison

- NCT03863509 660 661 O
> NCT03863509 663 664 B-Eq_Comparison
/ NCT03863509 665 666 I-Eq_Comparison
= NCT03863509 667 668 I-Eq_Comparison
5 NCT03863509 669 670 I-Eq_Comparison
days NCT03863509 671 675 I-Eq_Comparison
per NCT03863509 676 679 I-Eq_Comparison
week NCT03863509 680 684 I-Eq_Comparison
E NCT03863509 685 686 B-Drug
- NCT03863509 687 688 I-Drug
cig NCT03863509 689 692 I-Drug
use NCT03863509 693 696 O
for NCT03863509 697 700 O
last NCT03863509 701 705 B-Eq_Comparison
3 NCT03863509 706 707 I-Eq_Comparison
months NCT03863509 708 714 I-Eq_Comparison

- NCT03863509 722 723 O
< NCT03863509 725 726 B-Eq_Comparison
/ NCT03863509 727 728 I-Eq_Comparison
= NCT03863509 729 730 I-Eq_Comparison
4 NCT03863509 731 732 I-Eq_Comparison
ppm NCT03863509 733 736 I-Eq_Comparison
CO NCT03863509 737 739 B-Observation

- NCT03863509 747 748 O
Cotinine NCT03863509 750 758 B-Observation
> NCT03863509 759 760 B-Eq_Comparison
100 NCT03863509 761 764 I-Eq_Comparison
ng NCT03863509 765 767 I-Eq_Comparison
/ NCT03863509 768 769 I-Eq_Comparison
ml NCT03863509 770 772 I-Eq_Comparison

- NCT03863509 775 776 O
Specific NCT03863509 778 786 O
to NCT03863509 787 789 O
Dual NCT03863509 790 794 O
users NCT03863509 795 800 O

- NCT03863509 808 809 O
> NCT03863509 811 812 B-Eq_Comparison
/ NCT03863509 813 814 I-Eq_Comparison
= NCT03863509 815 816 I-Eq_Comparison
5 NCT03863509 817 818 I-Eq_Comparison
cigs NCT03863509 819 823 I-Eq_Comparison
/ NCT03863509 824 825 I-Eq_Comparison
day NCT03863509 826 829 I-Eq_Comparison
for NCT03863509 830 833 O
last NCT03863509 834 838 B-Eq_Comparison
6 NCT03863509 839 840 I-Eq_Comparison
months NCT03863509 841 847 I-Eq_Comparison

- NCT03863509 855 856 O
> NCT03863509 858 859 B-Eq_Comparison
/ NCT03863509 860 861 I-Eq_Comparison
= NCT03863509 862 863 I-Eq_Comparison
5 NCT03863509 864 865 I-Eq_Comparison
days NCT03863509 866 870 I-Eq_Comparison
per NCT03863509 871 874 I-Eq_Comparison
week NCT03863509 875 879 I-Eq_Comparison
E NCT03863509 880 881 B-Drug
- NCT03863509 882 883 I-Drug
cig NCT03863509 884 887 I-Drug
use NCT03863509 888 891 O
for NCT03863509 892 895 O
last NCT03863509 896 900 B-Eq_Comparison
3 NCT03863509 901 902 I-Eq_Comparison
months NCT03863509 903 909 I-Eq_Comparison

- NCT03863509 917 918 O
> NCT03863509 920 921 B-Eq_Comparison
/ NCT03863509 922 923 I-Eq_Comparison
= NCT03863509 924 925 I-Eq_Comparison
5 NCT03863509 926 927 I-Eq_Comparison
ppm NCT03863509 928 931 I-Eq_Comparison
CO NCT03863509 932 934 B-Observation

- NCT03863509 942 943 O
Continine NCT03863509 945 954 B-Observation
> NCT03863509 955 956 B-Eq_Comparison
100 NCT03863509 957 960 I-Eq_Comparison
ng NCT03863509 961 963 I-Eq_Comparison
/ NCT03863509 964 965 I-Eq_Comparison
ml NCT03863509 966 968 I-Eq_Comparison

- NCT03863509 971 972 O
Specific NCT03863509 974 982 O
to NCT03863509 983 985 O
Never NCT03863509 986 991 O
- NCT03863509 992 993 O
users NCT03863509 994 999 O

- NCT03863509 1007 1008 O
< NCT03863509 1010 1011 B-Eq_Comparison
100 NCT03863509 1012 1015 I-Eq_Comparison
cigarettes NCT03863509 1016 1026 B-Drug
in NCT03863509 1027 1029 O
a NCT03863509 1030 1031 O
lifetime NCT03863509 1032 1040 B-Eq_Comparison
, NCT03863509 1041 1042 O
none NCT03863509 1043 1047 B-Eq_Comparison
for NCT03863509 1048 1051 O
> NCT03863509 1052 1053 B-Eq_Comparison
5 NCT03863509 1054 1055 I-Eq_Comparison
years NCT03863509 1056 1061 I-Eq_Comparison

- NCT03863509 1069 1070 O
< NCT03863509 1072 1073 B-Eq_Comparison
3 NCT03863509 1074 1075 I-Eq_Comparison
E NCT03863509 1076 1077 B-Drug
- NCT03863509 1078 1079 I-Drug
cig NCT03863509 1080 1083 I-Drug
uses NCT03863509 1084 1088 O
in NCT03863509 1089 1091 O
a NCT03863509 1092 1093 O
lifetime NCT03863509 1094 1102 B-Eq_Comparison

- NCT03863509 1110 1111 O
< NCT03863509 1113 1114 B-Eq_Comparison
/ NCT03863509 1115 1116 I-Eq_Comparison
= NCT03863509 1117 1118 I-Eq_Comparison
4 NCT03863509 1119 1120 I-Eq_Comparison
ppm NCT03863509 1121 1124 I-Eq_Comparison
CO NCT03863509 1125 1127 B-Observation

- NCT03863509 1135 1136 O
Continine NCT03863509 1138 1147 B-Observation
< NCT03863509 1148 1149 B-Eq_Comparison
100 NCT03863509 1150 1153 I-Eq_Comparison
ng NCT03863509 1154 1156 I-Eq_Comparison
/ NCT03863509 1157 1158 I-Eq_Comparison
ml NCT03863509 1159 1161 I-Eq_Comparison

Exclusion NCT03863509 1162 1171 O
Criteria NCT03863509 1172 1180 O
: NCT03863509 1181 1182 O

- NCT03863509 1186 1187 O
current NCT03863509 1189 1196 B-Eq_Comparison
use NCT03863509 1197 1200 O
of NCT03863509 1201 1203 O
a NCT03863509 1204 1205 O
smoking NCT03863509 1206 1213 B-Drug
cessation NCT03863509 1214 1223 I-Drug
medication NCT03863509 1224 1234 I-Drug

- NCT03863509 1237 1238 O
women NCT03863509 1240 1245 O
who NCT03863509 1246 1249 B-And
are NCT03863509 1250 1253 O
pregnant NCT03863509 1254 1262 B-Condition
or NCT03863509 1263 1265 B-Or
plan NCT03863509 1266 1270 B-Assertion___Assertion_Type_Value:intention
to NCT03863509 1271 1273 I-Assertion___Assertion_Type_Value:intention
get NCT03863509 1274 1277 O
pregnant NCT03863509 1278 1286 B-Condition
in NCT03863509 1287 1289 O
the NCT03863509 1290 1293 O
coming NCT03863509 1294 1300 B-Eq_Comparison
month NCT03863509 1301 1306 I-Eq_Comparison

- NCT03863509 1309 1310 O
women NCT03863509 1312 1317 O
who NCT03863509 1318 1321 B-And
might NCT03863509 1322 1327 B-Assertion___Assertion_Type_Value:possible
be NCT03863509 1328 1330 I-Assertion___Assertion_Type_Value:possible
pregnant NCT03863509 1331 1339 B-Condition

- NCT03863509 1342 1343 O
incarcerated NCT03863509 1345 1357 B-Observation
individuals NCT03863509 1358 1369 O

- NCT03863509 1372 1373 O
history NCT03863509 1375 1382 B-Eq_Comparison
of NCT03863509 1383 1385 O
sarcoidosis NCT03863509 1386 1397 B-Condition
in NCT03863509 1398 1400 O
past NCT03863509 1401 1405 B-Eq_Comparison
5 NCT03863509 1406 1407 I-Eq_Comparison
years NCT03863509 1408 1413 I-Eq_Comparison
, NCT03863509 1414 1415 O
or NCT03863509 1416 1418 B-Or
active NCT03863509 1419 1425 B-Eq_Comparison
interstitial NCT03863509 1426 1438 B-Modifier
lung NCT03863509 1439 1443 I-Modifier
/ NCT03863509 1444 1445 B-Or
pulmonary NCT03863509 1446 1455 B-Modifier
fibrosis NCT03863509 1456 1464 B-Condition

Inclusion NCT03921749 0 9 O
Criteria NCT03921749 10 18 O
: NCT03921749 19 20 O

- NCT03921749 24 25 O
people NCT03921749 27 33 O
aged NCT03921749 34 38 B-Age
45 NCT03921749 39 41 B-Eq_Comparison
years NCT03921749 42 47 I-Eq_Comparison
or NCT03921749 48 50 I-Eq_Comparison
more NCT03921749 51 55 I-Eq_Comparison

- NCT03921749 58 59 O
subjects NCT03921749 61 69 O
diagnosed NCT03921749 70 79 O
with NCT03921749 80 84 O
knee NCT03921749 85 89 B-Modifier
OA NCT03921749 90 92 B-Condition
according NCT03921749 93 102 O
to NCT03921749 103 105 O
the NCT03921749 106 109 O
clinical NCT03921749 110 118 O
criteria NCT03921749 119 127 O
of NCT03921749 128 130 O
the NCT03921749 131 134 O
American NCT03921749 135 143 O
College NCT03921749 144 151 O
of NCT03921749 152 154 O
Rheumatology NCT03921749 155 167 O

- NCT03921749 170 171 O
subjects NCT03921749 173 181 O
diagnosed NCT03921749 182 191 O
with NCT03921749 192 196 O
grade NCT03921749 197 202 B-Eq_Comparison
II NCT03921749 203 205 I-Eq_Comparison
or NCT03921749 206 208 I-Eq_Comparison
III NCT03921749 209 212 I-Eq_Comparison
OA NCT03921749 213 215 B-Condition
during NCT03921749 216 222 B-Temporal_Connection___Temporal_Connection_Type_Value:during
radiologicalexamination NCT03921749 223 246 B-Procedure
as NCT03921749 247 249 O
defined NCT03921749 250 257 O
by NCT03921749 258 260 O
the NCT03921749 261 264 O
radiological NCT03921749 265 277 O
classification NCT03921749 278 292 O
of NCT03921749 293 295 O
Kellgren NCT03921749 296 304 O
and NCT03921749 305 308 O
Lawrence NCT03921749 309 317 O
( NCT03921749 318 319 O
K NCT03921749 320 321 O
- NCT03921749 322 323 O
L NCT03921749 324 325 O
) NCT03921749 326 327 O
scale NCT03921749 328 333 O
for NCT03921749 334 337 O
knee NCT03921749 338 342 O
OA NCT03921749 343 345 O

- NCT03921749 348 349 O
subjects NCT03921749 351 359 O
with NCT03921749 360 364 O
tenderness NCT03921749 365 375 B-Condition
in NCT03921749 376 378 O
the NCT03921749 379 382 O
medial NCT03921749 383 389 B-Modifier
tibial NCT03921749 390 396 I-Modifier
plateau NCT03921749 397 404 I-Modifier
area NCT03921749 405 409 I-Modifier

- NCT03921749 412 413 O
subjects NCT03921749 415 423 O
who NCT03921749 424 427 O
had NCT03921749 428 431 O
pain NCT03921749 432 436 B-Condition
on NCT03921749 437 439 O
one NCT03921749 440 443 B-Modifier
side NCT03921749 444 448 I-Modifier
of NCT03921749 449 451 I-Modifier
the NCT03921749 452 455 I-Modifier
knee NCT03921749 456 460 I-Modifier
. NCT03921749 461 462 O

Exclusion NCT03921749 464 473 O
Criteria NCT03921749 474 482 O
: NCT03921749 483 484 O

- NCT03921749 488 489 O
patients NCT03921749 491 499 O
with NCT03921749 500 504 O
a NCT03921749 505 506 O
history NCT03921749 507 514 B-Eq_Comparison
of NCT03921749 515 517 O
spinal NCT03921749 518 524 B-Condition
stenosis NCT03921749 525 533 I-Condition
, NCT03921749 534 535 O
evidence NCT03921749 536 544 O
of NCT03921749 545 547 O
neurologic NCT03921749 548 558 B-Condition
disease NCT03921749 559 566 I-Condition
by NCT03921749 567 569 O
history NCT03921749 570 577 B-Eq_Comparison
or NCT03921749 578 580 O
physical NCT03921749 581 589 B-Procedure
examination NCT03921749 590 601 I-Procedure
, NCT03921749 602 603 O
or NCT03921749 604 606 B-Or
secondary NCT03921749 607 616 O
causes NCT03921749 617 623 O
of NCT03921749 624 626 O
arthritis NCT03921749 627 636 B-Condition
( NCT03921749 637 638 O
inflammatory NCT03921749 639 651 B-Modifier
or NCT03921749 652 654 B-Or
metabolic NCT03921749 655 664 B-Modifier
) NCT03921749 665 666 O

- NCT03921749 670 671 O
those NCT03921749 673 678 O
who NCT03921749 679 682 O
had NCT03921749 683 686 O
a NCT03921749 687 688 O
surgical NCT03921749 689 697 B-Procedure
intervention NCT03921749 698 710 I-Procedure
or NCT03921749 711 713 B-Or
intra NCT03921749 714 719 B-Procedure
- NCT03921749 720 721 I-Procedure
articular NCT03921749 722 731 I-Procedure
injection NCT03921749 732 741 I-Procedure
in NCT03921749 742 744 O
the NCT03921749 745 748 O
affected NCT03921749 749 757 B-Modifier
knee NCT03921749 758 762 I-Modifier
in NCT03921749 763 765 O
the NCT03921749 766 769 O
previous NCT03921749 770 778 B-Eq_Comparison
6 NCT03921749 779 780 I-Eq_Comparison
months NCT03921749 781 787 I-Eq_Comparison

- NCT03921749 790 791 O
any NCT03921749 793 796 O
contraindication NCT03921749 797 813 B-Contraindication
to NCT03921749 814 816 O
extracorporeal NCT03921749 817 831 B-Procedure
shock NCT03921749 832 837 I-Procedure
wave NCT03921749 838 842 I-Procedure
( NCT03921749 843 844 O
pregnancy NCT03921749 845 854 B-Condition
, NCT03921749 855 856 O
cancer NCT03921749 857 863 B-Condition
, NCT03921749 864 865 O
coagulation NCT03921749 866 877 B-Condition
disorders NCT03921749 878 887 I-Condition
, NCT03921749 888 889 O
inflammatory NCT03921749 890 902 B-Condition
disease NCT03921749 903 910 I-Condition
, NCT03921749 911 912 O
pacemakers NCT03921749 913 923 B-Procedure
, NCT03921749 924 925 O
or NCT03921749 926 928 O
other NCT03921749 929 934 B-Other
electronic NCT03921749 935 945 B-Procedure
implants NCT03921749 946 954 I-Procedure
) NCT03921749 955 956 O
. NCT03921749 957 958 O

Inclusion NCT03922087 0 9 O
Criteria NCT03922087 10 18 O
: NCT03922087 19 20 O

- NCT03922087 24 25 O
Pregnant NCT03922087 27 35 B-Condition
women NCT03922087 36 41 O
who NCT03922087 42 45 B-And
have NCT03922087 46 50 O
plan NCT03922087 51 55 B-Assertion___Assertion_Type_Value:intention
to NCT03922087 56 58 I-Assertion___Assertion_Type_Value:intention
delivery NCT03922087 59 67 B-Condition
and NCT03922087 68 71 O
participate NCT03922087 72 83 O
in NCT03922087 84 86 O
child NCT03922087 87 92 O
care NCT03922087 93 97 O
in NCT03922087 98 100 O
Huizhou NCT03922087 101 108 O
hospital NCT03922087 109 117 O
; NCT03922087 117 118 O

- NCT03922087 121 122 O
Pregnant NCT03922087 124 132 B-Condition
women NCT03922087 133 138 O
who NCT03922087 139 142 B-And
have NCT03922087 143 147 O
resided NCT03922087 148 155 B-Observation
in NCT03922087 156 158 O
Huizhou NCT03922087 159 166 O
for NCT03922087 167 170 O
at NCT03922087 171 173 B-Eq_Comparison
least NCT03922087 174 179 I-Eq_Comparison
3 NCT03922087 180 181 I-Eq_Comparison
years NCT03922087 182 187 I-Eq_Comparison
; NCT03922087 187 188 O

- NCT03922087 191 192 O
Pregnant NCT03922087 194 202 B-Condition
women NCT03922087 203 208 O
who NCT03922087 209 212 B-And
are NCT03922087 213 216 O
consent NCT03922087 217 224 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03922087 225 228 I-Assertion___Assertion_Type_Value:hypothetical
specimens NCT03922087 229 238 O
and NCT03922087 239 242 O
data NCT03922087 243 247 O
collection NCT03922087 248 258 O
and NCT03922087 259 262 O
follow NCT03922087 263 269 B-Encounter
- NCT03922087 270 271 I-Encounter
ups NCT03922087 272 275 I-Encounter
for NCT03922087 276 279 O
both NCT03922087 280 284 O
mother NCT03922087 285 291 B-Family_Member___Family_Member_Type:mother
and NCT03922087 292 295 B-And
infant NCT03922087 296 302 B-Family_Member___Family_Member_Type:child
. NCT03922087 303 304 O

Exclusion NCT03922087 306 315 O
Criteria NCT03922087 316 324 O
: NCT03922087 325 326 O

- NCT03922087 330 331 O
Pregnant NCT03922087 333 341 B-Condition
women NCT03922087 342 347 O
who NCT03922087 348 351 B-And
are NCT03922087 352 355 O
with NCT03922087 356 360 O
gestational NCT03922087 361 372 B-Observation
age NCT03922087 373 376 I-Observation
more NCT03922087 377 381 B-Eq_Comparison
than NCT03922087 382 386 I-Eq_Comparison
24 NCT03922087 387 389 I-Eq_Comparison
weeks NCT03922087 390 395 I-Eq_Comparison
; NCT03922087 396 397 O

- NCT03922087 400 401 O
Pregnant NCT03922087 403 411 B-Condition
women NCT03922087 412 417 O
who NCT03922087 418 421 O
refuse NCT03922087 422 428 O
to NCT03922087 429 431 O
participate NCT03922087 432 443 O
or NCT03922087 444 446 O
be NCT03922087 447 449 O
unwilling NCT03922087 450 459 O
to NCT03922087 460 462 O
sign NCT03922087 463 467 O
informed NCT03922087 468 476 O
consent NCT03922087 477 484 O
; NCT03922087 484 485 O

- NCT03922087 488 489 O
Pregnant NCT03922087 491 499 B-Condition
women NCT03922087 500 505 O
who NCT03922087 506 509 B-And
are NCT03922087 510 513 O
mentally NCT03922087 514 522 B-Condition
incapacitated NCT03922087 523 536 I-Condition
and NCT03922087 537 540 O
need NCT03922087 541 545 O
guardians NCT03922087 546 555 O
. NCT03922087 556 557 O

Inclusion NCT03923894 0 9 O
Criteria NCT03923894 10 18 O
: NCT03923894 19 20 O

- NCT03923894 24 25 O
Adult NCT03923894 27 32 O
men NCT03923894 33 36 O
and NCT03923894 37 40 B-Or
women NCT03923894 41 46 O
over NCT03923894 47 51 B-Eq_Comparison
50 NCT03923894 52 54 I-Eq_Comparison
years NCT03923894 55 60 I-Eq_Comparison

- NCT03923894 63 64 O
After NCT03923894 66 71 O
fully NCT03923894 72 77 O
hearing NCT03923894 78 85 O
and NCT03923894 86 89 O
fully NCT03923894 90 95 O
understanding NCT03923894 96 109 O
this NCT03923894 110 114 O
clinical NCT03923894 115 123 O
trials NCT03923894 124 130 O
, NCT03923894 131 132 O
those NCT03923894 133 138 O
who NCT03923894 139 142 O
agree NCT03923894 143 148 O
to NCT03923894 149 151 O
voluntarily NCT03923894 152 163 O
decide NCT03923894 164 170 O
to NCT03923894 171 173 O
participate NCT03923894 174 185 O
and NCT03923894 186 189 O
to NCT03923894 190 192 O
comply NCT03923894 193 199 O
with NCT03923894 200 204 O
the NCT03923894 205 208 O
notice NCT03923894 209 215 O

Exclusion NCT03923894 216 225 O
Criteria NCT03923894 226 234 O
: NCT03923894 235 236 O

- NCT03923894 240 241 O
If NCT03923894 243 245 O
screening NCT03923894 246 255 B-Study
shows NCT03923894 256 261 B-Temporal_Connection___Temporal_Connection_Type_Value:during
that NCT03923894 262 266 O
the NCT03923894 267 270 O
white NCT03923894 271 276 B-Observation
blood NCT03923894 277 282 I-Observation
cell NCT03923894 283 287 I-Observation
( NCT03923894 288 289 O
WBC NCT03923894 290 293 B-Observation
) NCT03923894 294 295 O
is NCT03923894 296 298 O
less NCT03923894 299 303 B-Eq_Comparison
than NCT03923894 304 308 I-Eq_Comparison
3000 NCT03923894 309 313 I-Eq_Comparison
/ NCT03923894 314 315 I-Eq_Comparison
㎕ NCT03923894 316 317 I-Eq_Comparison
or NCT03923894 318 320 B-Or
more NCT03923894 321 325 B-Eq_Comparison
than NCT03923894 326 330 I-Eq_Comparison
8000 NCT03923894 331 335 I-Eq_Comparison
/ NCT03923894 336 337 I-Eq_Comparison
㎕ NCT03923894 338 339 I-Eq_Comparison

- NCT03923894 342 343 O
Those NCT03923894 345 350 O
who NCT03923894 351 354 O
received NCT03923894 355 363 B-Eq_Comparison
influenza NCT03923894 364 373 B-Immunization
vaccination NCT03923894 374 385 I-Immunization
within NCT03923894 386 392 B-Eq_Comparison
3 NCT03923894 393 394 I-Eq_Comparison
months NCT03923894 395 401 I-Eq_Comparison
before NCT03923894 402 408 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923894 409 412 O
screening NCT03923894 413 422 B-Study

- NCT03923894 425 426 O
Those NCT03923894 428 433 O
who NCT03923894 434 437 O
have NCT03923894 438 442 O
a NCT03923894 443 444 O
body NCT03923894 445 449 B-Observation
mass NCT03923894 450 454 I-Observation
index NCT03923894 455 460 I-Observation
( NCT03923894 461 462 O
BMI NCT03923894 463 466 B-Observation
) NCT03923894 467 468 O
of NCT03923894 469 471 O
less NCT03923894 472 476 B-Eq_Comparison
than NCT03923894 477 481 I-Eq_Comparison
18.5 NCT03923894 482 486 I-Eq_Comparison
kg NCT03923894 487 489 I-Eq_Comparison
/ NCT03923894 490 491 I-Eq_Comparison
m NCT03923894 492 493 I-Eq_Comparison
2 NCT03923894 494 495 I-Eq_Comparison
or NCT03923894 496 498 B-Or
greater NCT03923894 499 506 B-Eq_Comparison
than NCT03923894 507 511 I-Eq_Comparison
35 NCT03923894 512 514 I-Eq_Comparison
kg NCT03923894 515 517 I-Eq_Comparison
/ NCT03923894 518 519 I-Eq_Comparison
m NCT03923894 520 521 I-Eq_Comparison
2 NCT03923894 522 523 I-Eq_Comparison
at NCT03923894 524 526 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923894 527 530 O
screening NCT03923894 531 540 B-Study

- NCT03923894 543 544 O
Those NCT03923894 546 551 O
who NCT03923894 552 555 O
have NCT03923894 556 560 O
a NCT03923894 561 562 O
clinically NCT03923894 563 573 O
significant NCT03923894 574 585 O
acute NCT03923894 586 591 O
or NCT03923894 592 594 B-Or
chronic NCT03923894 595 602 O
cardiovascular NCT03923894 603 617 B-Condition
system NCT03923894 618 624 I-Condition
, NCT03923894 625 626 O
endocrine NCT03923894 627 636 B-Condition
system NCT03923894 637 643 I-Condition
, NCT03923894 644 645 O
immune NCT03923894 646 652 B-Condition
system NCT03923894 653 659 I-Condition
, NCT03923894 660 661 O
respiratory NCT03923894 662 673 B-Condition
system NCT03923894 674 680 I-Condition
, NCT03923894 681 682 O
liver NCT03923894 683 688 B-Condition
biliary NCT03923894 689 696 I-Condition
system NCT03923894 697 703 I-Condition
, NCT03923894 704 705 O
kidney NCT03923894 706 712 B-Modifier
and NCT03923894 713 716 B-Or
urinary NCT03923894 717 724 B-Modifier
system NCT03923894 725 731 B-Condition
, NCT03923894 732 733 O
neuropsychiatry NCT03923894 734 749 B-Condition
, NCT03923894 750 751 O
musculoskeletal NCT03923894 752 767 B-Condition
system NCT03923894 768 774 I-Condition
, NCT03923894 775 776 O
inflammatory NCT03923894 777 789 B-Condition
and NCT03923894 790 793 B-Or
hematologic NCT03923894 794 805 B-Condition

- NCT03923894 808 809 O
Those NCT03923894 811 816 O
who NCT03923894 817 820 O
take NCT03923894 821 825 B-Eq_Comparison
a NCT03923894 826 827 O
medication NCT03923894 828 838 B-Drug
or NCT03923894 839 841 B-Or
health NCT03923894 842 848 B-Drug
function NCT03923894 849 857 I-Drug
food NCT03923894 858 862 I-Drug
that NCT03923894 863 867 O
affects NCT03923894 868 875 O
your NCT03923894 876 880 O
promotion NCT03923894 881 890 B-Condition
of NCT03923894 891 893 I-Condition
immunity NCT03923894 894 902 I-Condition
within NCT03923894 903 909 B-Eq_Comparison
1 NCT03923894 910 911 I-Eq_Comparison
month NCT03923894 912 917 I-Eq_Comparison
prior NCT03923894 918 923 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03923894 924 926 O
the NCT03923894 927 930 O
screening NCT03923894 931 940 B-Study

- NCT03923894 943 944 O
Those NCT03923894 946 951 O
who NCT03923894 952 955 O
have NCT03923894 956 960 O
received NCT03923894 961 969 B-Eq_Comparison
antipsychotic NCT03923894 970 983 B-Drug
medication NCT03923894 984 994 I-Drug
within NCT03923894 995 1001 B-Eq_Comparison
3 NCT03923894 1002 1003 I-Eq_Comparison
months NCT03923894 1004 1010 I-Eq_Comparison
before NCT03923894 1011 1017 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03923894 1018 1027 B-Study

- NCT03923894 1030 1031 O
Those NCT03923894 1033 1038 O
who NCT03923894 1039 1042 O
alcoholic NCT03923894 1043 1052 B-Modifier
or NCT03923894 1053 1055 B-Or
drug NCT03923894 1056 1060 B-Modifier
abuse NCT03923894 1061 1066 B-Condition
suspected NCT03923894 1067 1076 B-Assertion___Assertion_Type_Value:possible

- NCT03923894 1079 1080 O
Those NCT03923894 1082 1087 O
who NCT03923894 1088 1091 O
participated NCT03923894 1092 1104 B-Observation
in NCT03923894 1105 1107 I-Observation
other NCT03923894 1108 1113 I-Observation
clinical NCT03923894 1114 1122 I-Observation
trials NCT03923894 1123 1129 I-Observation
within NCT03923894 1130 1136 B-Eq_Comparison
3 NCT03923894 1137 1138 I-Eq_Comparison
months NCT03923894 1139 1145 I-Eq_Comparison
before NCT03923894 1146 1152 B-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03923894 1153 1162 B-Study

- NCT03923894 1165 1166 O
Laboratory NCT03923894 1168 1178 O
test NCT03923894 1179 1183 O
by NCT03923894 1184 1186 O
show NCT03923894 1187 1191 O
the NCT03923894 1192 1195 O
following NCT03923894 1196 1205 O
results NCT03923894 1206 1213 O

- NCT03923894 1221 1222 O
Aspartate NCT03923894 1224 1233 B-Observation
Transaminase NCT03923894 1234 1246 I-Observation
( NCT03923894 1247 1248 O
AST NCT03923894 1249 1252 B-Observation
) NCT03923894 1253 1254 O
, NCT03923894 1255 1256 O
Alanine NCT03923894 1257 1264 B-Observation
Transaminase NCT03923894 1265 1277 I-Observation
( NCT03923894 1278 1279 O
ALT NCT03923894 1280 1283 B-Observation
) NCT03923894 1284 1285 O
> NCT03923894 1286 1287 B-Eq_Comparison
Reference NCT03923894 1288 1297 I-Eq_Comparison
range NCT03923894 1298 1303 I-Eq_Comparison
3 NCT03923894 1304 1305 I-Eq_Comparison
times NCT03923894 1306 1311 I-Eq_Comparison
upper NCT03923894 1312 1317 I-Eq_Comparison
limit NCT03923894 1318 1323 I-Eq_Comparison

- NCT03923894 1331 1332 O
Serum NCT03923894 1334 1339 B-Observation
Creatinine NCT03923894 1340 1350 I-Observation
> NCT03923894 1351 1352 B-Eq_Comparison
2.0 NCT03923894 1353 1356 I-Eq_Comparison
mg NCT03923894 1357 1359 I-Eq_Comparison
/ NCT03923894 1360 1361 I-Eq_Comparison
dL NCT03923894 1362 1364 I-Eq_Comparison

- NCT03923894 1367 1368 O
Pregnancy NCT03923894 1370 1379 B-Condition
or NCT03923894 1380 1382 B-Or
breast NCT03923894 1383 1389 B-Condition
feeding NCT03923894 1390 1397 I-Condition

- NCT03923894 1400 1401 O
Those NCT03923894 1403 1408 O
who NCT03923894 1409 1412 O
does NCT03923894 1413 1417 B-Negation
n't NCT03923894 1417 1420 I-Negation
accept NCT03923894 1421 1427 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03923894 1428 1431 O
implementation NCT03923894 1432 1446 O
of NCT03923894 1447 1449 O
appropriate NCT03923894 1450 1461 O
contraception NCT03923894 1462 1475 B-Drug
of NCT03923894 1476 1478 O
a NCT03923894 1479 1480 O
childbearing NCT03923894 1481 1493 B-Condition
woman NCT03923894 1494 1499 O

- NCT03923894 1502 1503 O
Principal NCT03923894 1505 1514 O
Investigator NCT03923894 1515 1527 O
judged NCT03923894 1528 1534 O
inappropriate NCT03923894 1535 1548 O
for NCT03923894 1549 1552 O
participation NCT03923894 1553 1566 O
in NCT03923894 1567 1569 O
study NCT03923894 1570 1575 O
because NCT03923894 1576 1583 O
of NCT03923894 1584 1586 O
Laboratory NCT03923894 1587 1597 O
test NCT03923894 1598 1602 O
result NCT03923894 1603 1609 O
, NCT03923894 1610 1611 O
etc NCT03923894 1612 1615 O
. NCT03923894 1616 1617 O


Inclusion NCT03862547 0 9 O
Criteria NCT03862547 10 18 O
: NCT03862547 19 20 O

- NCT03862547 24 25 O
men NCT03862547 27 30 O
with NCT03862547 31 35 B-And
DE NCT03862547 36 38 B-Condition
and NCT03862547 39 42 B-And
metabolic NCT03862547 43 52 B-Condition
syndrome NCT03862547 53 61 I-Condition

Exclusion NCT03862547 62 71 O
Criteria NCT03862547 72 80 O
: NCT03862547 81 82 O

- NCT03862547 86 87 O
men NCT03862547 89 92 O
with NCT03862547 93 97 B-And
DE NCT03862547 98 100 B-Condition
without NCT03862547 101 108 B-Negation
metabolic NCT03862547 109 118 B-Condition
syndrome NCT03862547 119 127 I-Condition

Inclusion NCT03864718 0 9 O
Criteria NCT03864718 10 18 O
: NCT03864718 19 20 O

- NCT03864718 24 25 O
complex NCT03864718 27 34 B-Modifier
anal NCT03864718 35 39 B-Condition
fistula NCT03864718 40 47 I-Condition
according NCT03864718 48 57 O
to NCT03864718 58 60 O
Parks NCT03864718 61 66 O
classification NCT03864718 67 81 O

Exclusion NCT03864718 82 91 O
Criteria NCT03864718 92 100 O
: NCT03864718 101 102 O

- NCT03864718 106 107 O
Non NCT03864718 109 112 B-Negation
cryptoglandular NCT03864718 113 128 B-Condition
fistulas NCT03864718 129 137 I-Condition

- NCT03864718 140 141 O
acute NCT03864718 143 148 O
sepsis NCT03864718 149 155 B-Condition

- NCT03864718 158 159 O
inflammatory NCT03864718 161 173 B-Condition
bowel NCT03864718 174 179 I-Condition
diseases NCT03864718 180 188 I-Condition

- NCT03864718 191 192 O
simple NCT03864718 194 200 B-Condition
fistulas NCT03864718 201 209 I-Condition
( NCT03864718 210 211 O
defined NCT03864718 212 219 O
as NCT03864718 220 222 O
subcutaneous NCT03864718 223 235 B-Modifier
, NCT03864718 236 237 O
intersphincteric NCT03864718 238 254 B-Modifier
and NCT03864718 255 258 B-Or
low NCT03864718 259 262 B-Modifier
transsphincteric NCT03864718 263 279 I-Modifier
fistula NCT03864718 280 287 B-Condition
) NCT03864718 288 289 O

- NCT03864718 293 294 O
pregnant NCT03864718 296 304 B-Condition
patients NCT03864718 305 313 O

- NCT03864718 316 317 O
ASA NCT03864718 319 322 B-Observation
IV NCT03864718 323 325 B-Eq_Comparison

- NCT03864718 328 329 O
patients NCT03864718 331 339 B-Age
< NCT03864718 340 341 B-Eq_Comparison
18 NCT03864718 342 344 I-Eq_Comparison

- NCT03864718 348 349 O
immunocompromised NCT03864718 351 368 B-Condition

- NCT03864718 371 372 O
patients NCT03864718 374 382 O
who NCT03864718 383 386 O
refused NCT03864718 387 394 O
consent NCT03864718 395 402 O
. NCT03864718 403 404 O

Inclusion NCT03928171 0 9 O
Criteria NCT03928171 10 18 O
: NCT03928171 19 20 O

- NCT03928171 24 25 O
Adults NCT03928171 27 33 O
( NCT03928171 34 35 O
≥ NCT03928171 36 37 B-Eq_Comparison
18 NCT03928171 38 40 I-Eq_Comparison
years NCT03928171 41 46 I-Eq_Comparison
old NCT03928171 47 50 B-Age
) NCT03928171 51 52 O

- NCT03928171 56 57 O
Scheduled NCT03928171 59 68 B-Eq_Comparison
for NCT03928171 69 72 O
robot NCT03928171 73 78 B-Modifier
- NCT03928171 79 80 I-Modifier
assisted NCT03928171 81 89 I-Modifier
colorectal NCT03928171 90 100 I-Modifier
laparoscopic NCT03928171 101 113 B-Procedure
surgery NCT03928171 114 121 I-Procedure

Exclusion NCT03928171 122 131 O
Criteria NCT03928171 132 140 O
: NCT03928171 141 142 O

- NCT03928171 146 147 O
Severe NCT03928171 149 155 O
liver NCT03928171 156 161 B-Modifier
- NCT03928171 162 163 O
or NCT03928171 164 166 B-Or
renal NCT03928171 167 172 B-Modifier
disease NCT03928171 173 180 B-Condition

- NCT03928171 183 184 O
Pregnancy NCT03928171 186 195 B-Condition
or NCT03928171 196 198 B-Or
lactation NCT03928171 199 208 B-Condition

- NCT03928171 211 212 O
Planned NCT03928171 214 221 B-Eq_Comparison
diagnostics NCT03928171 222 233 B-Procedure
or NCT03928171 234 236 B-Or
treatment NCT03928171 237 246 B-Procedure
with NCT03928171 247 251 O
radioactive NCT03928171 252 263 B-Procedure
iodine NCT03928171 264 270 I-Procedure
< NCT03928171 271 272 B-Eq_Comparison
1 NCT03928171 273 274 I-Eq_Comparison
week NCT03928171 275 279 I-Eq_Comparison
after NCT03928171 280 285 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03928171 286 293 B-Procedure

- NCT03928171 296 297 O
BMI NCT03928171 299 302 B-Observation
> NCT03928171 303 304 B-Eq_Comparison
35 NCT03928171 305 307 I-Eq_Comparison
kg NCT03928171 308 310 I-Eq_Comparison
/ NCT03928171 311 312 I-Eq_Comparison
m NCT03928171 313 314 I-Eq_Comparison
2 NCT03928171 315 316 I-Eq_Comparison

- NCT03928171 319 320 O
Known NCT03928171 322 327 O
or NCT03928171 328 330 O
suspected NCT03928171 331 340 B-Assertion___Assertion_Type_Value:possible
hypersensitivity NCT03928171 341 357 B-Condition
to NCT03928171 358 360 O
indocyanine NCT03928171 361 372 B-Modifier
green NCT03928171 373 378 I-Modifier
, NCT03928171 379 380 O
sodium NCT03928171 381 387 B-Modifier
iodide NCT03928171 388 394 I-Modifier
or NCT03928171 395 397 O
iodine NCT03928171 398 404 B-Modifier

- NCT03928171 407 408 O
Hyperthyroidism NCT03928171 410 425 B-Condition
or NCT03928171 426 428 B-Or
thyroid NCT03928171 429 436 B-Condition
adenomas NCT03928171 437 445 I-Condition

- NCT03928171 448 449 O
Use NCT03928171 451 454 B-Eq_Comparison
of NCT03928171 455 457 O
medication NCT03928171 458 468 B-Drug
interfering NCT03928171 469 480 O
with NCT03928171 481 485 O
ICG NCT03928171 486 489 B-Condition
absorption NCT03928171 490 500 I-Condition
as NCT03928171 501 503 O
listed NCT03928171 504 510 O
in NCT03928171 511 513 O
the NCT03928171 514 517 O
summary NCT03928171 518 525 O
of NCT03928171 526 528 O
product NCT03928171 529 536 O
characteristics NCT03928171 537 552 O
. NCT03928171 553 554 O

Inclusion NCT03862066 0 9 O
Criteria NCT03862066 10 18 O
: NCT03862066 19 20 O

- NCT03862066 24 25 O
Newly NCT03862066 27 32 B-Eq_Comparison
diagnosed NCT03862066 33 42 O
histologically NCT03862066 43 57 B-Procedure
proven NCT03862066 58 64 O
locoregional NCT03862066 65 77 B-Modifier
oral NCT03862066 78 82 I-Modifier
squamous NCT03862066 83 91 I-Modifier
cell NCT03862066 92 96 I-Modifier
carcinoma NCT03862066 97 106 B-Condition
( NCT03862066 107 108 O
OSCC NCT03862066 109 113 B-Condition
) NCT03862066 114 115 O
without NCT03862066 116 123 B-Negation
evidence NCT03862066 124 132 O
of NCT03862066 133 135 O
distant NCT03862066 136 143 B-Modifier
metastases NCT03862066 144 154 B-Condition
. NCT03862066 155 156 O
OSCC NCT03862066 158 162 B-Condition
includes NCT03862066 163 171 O
the NCT03862066 172 175 O
subsites NCT03862066 176 184 B-Modifier
of NCT03862066 185 187 I-Modifier
oral NCT03862066 188 192 I-Modifier
tongue NCT03862066 193 199 I-Modifier
, NCT03862066 200 201 O
floor NCT03862066 202 207 B-Modifier
of NCT03862066 208 210 I-Modifier
mouth NCT03862066 211 216 I-Modifier
, NCT03862066 217 218 O
gingiva NCT03862066 219 226 B-Modifier
, NCT03862066 227 228 O
retromolar NCT03862066 229 239 B-Modifier
trigone NCT03862066 240 247 I-Modifier
and NCT03862066 248 251 B-Or
buccal NCT03862066 252 258 B-Modifier
mucosa NCT03862066 259 265 I-Modifier
OR NCT03862066 266 268 B-Or
Recurrent NCT03862066 269 278 B-Modifier
or NCT03862066 279 281 B-Or
persistent NCT03862066 282 292 B-Modifier
histologically NCT03862066 293 307 B-Procedure
proven NCT03862066 308 314 O
locoregional NCT03862066 315 327 B-Modifier
OSCC NCT03862066 328 332 B-Condition
that NCT03862066 333 337 O
was NCT03862066 338 341 O
initially NCT03862066 342 351 B-Eq_Comparison
treated NCT03862066 352 359 B-Procedure
with NCT03862066 360 364 O
surgery NCT03862066 365 372 B-Procedure
alone NCT03862066 373 378 O
. NCT03862066 379 380 O

- NCT03862066 384 385 O
must NCT03862066 387 391 O
be NCT03862066 392 394 O
eligible NCT03862066 395 403 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03862066 404 407 I-Assertion___Assertion_Type_Value:hypothetical
surgical NCT03862066 408 416 B-Procedure
resection NCT03862066 417 426 I-Procedure

- NCT03862066 429 430 O
greater NCT03862066 432 439 B-Eq_Comparison
than NCT03862066 440 444 I-Eq_Comparison
18 NCT03862066 445 447 I-Eq_Comparison
years NCT03862066 448 453 I-Eq_Comparison
of NCT03862066 454 456 O
age NCT03862066 457 460 B-Age

Exclusion NCT03862066 461 470 O
Criteria NCT03862066 471 479 O
: NCT03862066 480 481 O

- NCT03862066 485 486 O
prior NCT03862066 488 493 B-Eq_Comparison
immunotherapy NCT03862066 494 507 B-Procedure
or NCT03862066 508 510 B-Or
treatment NCT03862066 511 520 B-Procedure
with NCT03862066 521 525 O
another NCT03862066 526 533 B-Other
anti NCT03862066 534 538 B-Drug
PD NCT03862066 539 541 I-Drug
- NCT03862066 542 543 I-Drug
1 NCT03862066 544 545 I-Drug
agent NCT03862066 546 551 I-Drug
besides NCT03862066 552 559 B-Exception
nivolumab NCT03862066 560 569 B-Drug

- NCT03862066 572 573 O
prior NCT03862066 575 580 B-Eq_Comparison
chemotherapy NCT03862066 581 593 B-Procedure
including NCT03862066 594 603 O
cetuximab NCT03862066 604 613 B-Drug
or NCT03862066 614 616 B-Or
radiation NCT03862066 617 626 B-Procedure
therapy NCT03862066 627 634 I-Procedure

- NCT03862066 637 638 O
concomitant NCT03862066 640 651 B-Modifier
malignancies NCT03862066 652 664 B-Condition
except NCT03862066 665 671 B-Exception
cutaneous NCT03862066 672 681 B-Modifier
squamous NCT03862066 682 690 I-Modifier
cell NCT03862066 691 695 I-Modifier
carcinoma NCT03862066 696 705 B-Condition
or NCT03862066 706 708 B-Or
basal NCT03862066 709 714 B-Modifier
cell NCT03862066 715 719 I-Modifier
carcinoma NCT03862066 720 729 B-Condition

- NCT03862066 732 733 O
unresectable NCT03862066 735 747 B-Modifier
primary NCT03862066 748 755 I-Modifier
tumor NCT03862066 756 761 B-Condition
or NCT03862066 762 764 B-Or
regional NCT03862066 765 773 B-Condition
disease NCT03862066 774 781 I-Condition
or NCT03862066 782 784 B-Or
distant NCT03862066 785 792 B-Modifier
metastases NCT03862066 793 803 B-Condition


Inclusion NCT03862248 0 9 O
Criteria NCT03862248 10 18 O
: NCT03862248 19 20 O

- NCT03862248 24 25 O
All NCT03862248 27 30 O
newly NCT03862248 31 36 O
registered NCT03862248 37 47 O
patients NCT03862248 48 56 O
with NCT03862248 57 61 O
smear NCT03862248 62 67 B-Modifier
- NCT03862248 68 69 O
positive NCT03862248 70 78 O
recurrent NCT03862248 79 88 B-Modifier
pulmonary NCT03862248 89 98 I-Modifier
TB NCT03862248 99 101 B-Condition

- NCT03862248 104 105 O
Adults NCT03862248 107 113 O
as NCT03862248 114 116 B-Or
well NCT03862248 117 121 I-Or
as NCT03862248 122 124 I-Or
children NCT03862248 125 133 O
( NCT03862248 134 135 O
no NCT03862248 136 138 O
age NCT03862248 139 142 O
limit NCT03862248 143 148 O
) NCT03862248 149 150 O

- NCT03862248 154 155 O
Able NCT03862248 157 161 O
and NCT03862248 162 165 O
willing NCT03862248 166 173 O
to NCT03862248 174 176 O
provide NCT03862248 177 184 O
written NCT03862248 185 192 O
informed NCT03862248 193 201 O
consent NCT03862248 202 209 O

Exclusion NCT03862248 210 219 O
Criteria NCT03862248 220 228 O
: NCT03862248 229 230 O

- NCT03862248 234 235 O
Patients NCT03862248 237 245 O
transferred NCT03862248 246 257 B-Encounter
to NCT03862248 258 260 O
a NCT03862248 261 262 O
health NCT03862248 263 269 O
facility NCT03862248 270 278 O
not NCT03862248 279 282 B-Negation
supported NCT03862248 283 292 B-Assertion___Assertion_Type_Value:hypothetical
by NCT03862248 293 295 I-Assertion___Assertion_Type_Value:hypothetical
Damien NCT03862248 296 302 O
Foundation NCT03862248 303 313 O
will NCT03862248 314 318 O
be NCT03862248 319 321 O
excluded NCT03862248 322 330 O
. NCT03862248 331 332 O
This NCT03862248 334 338 O
includes NCT03862248 339 347 O
patients NCT03862248 348 356 O
diagnosed NCT03862248 357 366 O
with NCT03862248 367 371 O
HIV NCT03862248 372 375 B-Condition
/ NCT03862248 376 377 B-Or
TB NCT03862248 378 380 B-Condition
- NCT03862248 381 382 O
coinfection NCT03862248 383 394 B-Condition
. NCT03862248 395 396 O

Inclusion NCT03863158 0 9 O
Criteria NCT03863158 10 18 O
: NCT03863158 19 20 O

- NCT03863158 24 25 O
Patients NCT03863158 27 35 O
presenting NCT03863158 36 46 O
acute NCT03863158 47 52 O
myocardial NCT03863158 53 63 B-Condition
infarction NCT03863158 64 74 I-Condition
with NCT03863158 75 79 B-And
hemodynamic NCT03863158 80 91 B-Condition
stability NCT03863158 92 101 O
at NCT03863158 102 104 O
the NCT03863158 105 108 O
diagnosis NCT03863158 109 118 O

- NCT03863158 121 122 O
Patients NCT03863158 124 132 O
undergoing NCT03863158 133 143 B-Eq_Comparison
coronary NCT03863158 144 152 B-Procedure
artery NCT03863158 153 159 I-Procedure
bypass NCT03863158 160 166 I-Procedure
in NCT03863158 167 169 O
Dijon NCT03863158 170 175 O
University NCT03863158 176 186 O
hospital NCT03863158 187 195 O

Exclusion NCT03863158 196 205 O
Criteria NCT03863158 206 214 O
: NCT03863158 215 216 O

- NCT03863158 220 221 O
Patients NCT03863158 223 231 O
with NCT03863158 232 236 O
Acute NCT03863158 237 242 O
pulmonary NCT03863158 243 252 B-Condition
oedema NCT03863158 253 259 I-Condition

- NCT03863158 262 263 O
Patients NCT03863158 265 273 O
with NCT03863158 274 278 O
cardiorespiratory NCT03863158 279 296 B-Condition
arrest NCT03863158 297 303 I-Condition
before NCT03863158 304 310 B-Temporal_Connection___Temporal_Connection_Type_Value:before
coronary NCT03863158 311 319 B-Procedure
angiography NCT03863158 320 331 I-Procedure

- NCT03863158 334 335 O
hemodynamically NCT03863158 337 352 B-Condition
unstable NCT03863158 353 361 O
patient NCT03863158 362 369 O
at NCT03863158 370 372 O
diagnosis NCT03863158 373 382 O

- NCT03863158 385 386 O
patients NCT03863158 388 396 O
requiring NCT03863158 397 406 B-Assertion___Assertion_Type_Value:hypothetical
combined NCT03863158 407 415 B-Modifier
surgery NCT03863158 416 423 B-Procedure

- NCT03863158 426 427 O
patients NCT03863158 429 437 O
with NCT03863158 438 442 O
unstable NCT03863158 443 451 O
angina NCT03863158 452 458 B-Condition

Inclusion NCT03925714 0 9 O
Criteria NCT03925714 10 18 O
: NCT03925714 19 20 O

- NCT03925714 24 25 O
Prediabetic NCT03925714 27 38 B-Condition
subjects NCT03925714 39 47 O
. NCT03925714 48 49 O

Exclusion NCT03925714 51 60 O
Criteria NCT03925714 61 69 O
: NCT03925714 70 71 O

- NCT03925714 75 76 O
Confirmed NCT03925714 78 87 O
diabetes NCT03925714 88 96 B-Condition
. NCT03925714 97 98 O

- NCT03925714 102 103 O
Hepatic NCT03925714 105 112 B-Modifier
or NCT03925714 113 115 B-Or
renal NCT03925714 116 121 B-Modifier
impairment NCT03925714 122 132 B-Condition
. NCT03925714 133 134 O

Inclusion NCT03862001 0 9 O
Criteria NCT03862001 10 18 O
: NCT03862001 19 20 O

- NCT03862001 24 25 O
age NCT03862001 27 30 B-Age
55 NCT03862001 31 33 B-Eq_Comparison
- NCT03862001 34 35 I-Eq_Comparison
80 NCT03862001 36 38 I-Eq_Comparison

- NCT03862001 42 43 O
smoked NCT03862001 45 51 B-Observation
at NCT03862001 52 54 B-Eq_Comparison
least NCT03862001 55 60 I-Eq_Comparison
30 NCT03862001 61 63 I-Eq_Comparison
pack NCT03862001 64 68 I-Eq_Comparison
- NCT03862001 69 70 I-Eq_Comparison
years NCT03862001 71 76 I-Eq_Comparison
in NCT03862001 77 79 I-Eq_Comparison
lifetime NCT03862001 80 88 I-Eq_Comparison

- NCT03862001 91 92 O
if NCT03862001 94 96 O
former NCT03862001 97 103 B-Eq_Comparison
smoker NCT03862001 104 110 B-Condition
, NCT03862001 111 112 O
quit NCT03862001 113 117 B-Negation
smoking NCT03862001 118 125 B-Condition
within NCT03862001 126 132 B-Eq_Comparison
the NCT03862001 133 136 I-Eq_Comparison
last NCT03862001 137 141 I-Eq_Comparison
15 NCT03862001 142 144 I-Eq_Comparison
years NCT03862001 145 150 I-Eq_Comparison

- NCT03862001 153 154 O
English NCT03862001 156 163 O
speaker NCT03862001 164 171 O

- NCT03862001 174 175 O
no NCT03862001 177 179 B-Negation
prior NCT03862001 180 185 B-Eq_Comparison
history NCT03862001 186 193 I-Eq_Comparison
of NCT03862001 194 196 O
lung NCT03862001 197 201 B-Modifier
cancer NCT03862001 202 208 B-Condition

- NCT03862001 211 212 O
did NCT03862001 214 217 O
not NCT03862001 218 221 B-Negation
have NCT03862001 222 226 O
a NCT03862001 227 228 O
lung NCT03862001 229 233 B-Modifier
cancer NCT03862001 234 240 B-Condition
screening NCT03862001 241 250 B-Procedure
test NCT03862001 251 255 I-Procedure
within NCT03862001 256 262 B-Eq_Comparison
the NCT03862001 263 266 I-Eq_Comparison
last NCT03862001 267 271 I-Eq_Comparison
year NCT03862001 272 276 I-Eq_Comparison

- NCT03862001 279 280 O
PCP NCT03862001 282 285 O
does NCT03862001 286 290 O
not NCT03862001 291 294 O
object NCT03862001 295 301 O
to NCT03862001 302 304 O
patient NCT03862001 305 312 O
's NCT03862001 312 314 O
participation NCT03862001 315 328 O

- NCT03862001 331 332 O
have NCT03862001 334 338 O
a NCT03862001 339 340 O
scheduled NCT03862001 341 350 B-Eq_Comparison
visit NCT03862001 351 356 B-Encounter
at NCT03862001 357 359 O
University NCT03862001 360 370 O
of NCT03862001 371 373 O
California NCT03862001 374 384 O
, NCT03862001 385 386 O
San NCT03862001 387 390 O
Francisco NCT03862001 391 400 O
( NCT03862001 401 402 O
UCSF NCT03862001 403 407 O
) NCT03862001 408 409 O
internal NCT03862001 410 418 O
medicine NCT03862001 419 427 O
clinics NCT03862001 428 435 O
. NCT03862001 436 437 O

Exclusion NCT03862001 439 448 O
Criteria NCT03862001 449 457 O
: NCT03862001 458 459 O

- NCT03862001 463 464 O
speaking NCT03862001 466 474 O
a NCT03862001 475 476 O
language NCT03862001 477 485 O
other NCT03862001 486 491 B-Negation
than NCT03862001 492 496 I-Negation
English NCT03862001 497 504 O

- NCT03862001 507 508 O
has NCT03862001 510 513 O
a NCT03862001 514 515 O
history NCT03862001 516 523 B-Eq_Comparison
of NCT03862001 524 526 O
lung NCT03862001 527 531 B-Modifier
cancer NCT03862001 532 538 B-Condition

- NCT03862001 541 542 O
had NCT03862001 544 547 B-Eq_Comparison
a NCT03862001 548 549 O
lung NCT03862001 550 554 B-Modifier
cancer NCT03862001 555 561 B-Condition
screening NCT03862001 562 571 B-Procedure
test NCT03862001 572 576 I-Procedure
within NCT03862001 577 583 B-Eq_Comparison
the NCT03862001 584 587 I-Eq_Comparison
last NCT03862001 588 592 I-Eq_Comparison
year NCT03862001 593 597 I-Eq_Comparison

- NCT03862001 600 601 O
PCP NCT03862001 603 606 O
objects NCT03862001 607 614 O
to NCT03862001 615 617 O
patient NCT03862001 618 625 O
's NCT03862001 625 627 O
participation NCT03862001 628 641 O
. NCT03862001 642 643 O

Inclusion NCT03864341 0 9 O
Criteria NCT03864341 10 18 O
: NCT03864341 19 20 O

- NCT03864341 24 25 O
Be NCT03864341 27 29 O
a NCT03864341 30 31 O
patient NCT03864341 32 39 O
in NCT03864341 40 42 O
the NCT03864341 43 46 O
Bellevue NCT03864341 47 55 O
Hospital NCT03864341 56 64 O
Center NCT03864341 65 71 O
ED NCT03864341 72 74 O
. NCT03864341 75 76 O

- NCT03864341 80 81 O
Be NCT03864341 83 85 O
≥ NCT03864341 86 87 B-Eq_Comparison
18 NCT03864341 88 90 I-Eq_Comparison
years NCT03864341 91 96 I-Eq_Comparison
old NCT03864341 97 100 B-Age
. NCT03864341 101 102 O

- NCT03864341 106 107 O
Screen NCT03864341 109 115 O
positive NCT03864341 116 124 O
for NCT03864341 125 128 O
homelessness NCT03864341 129 141 B-Condition
risk NCT03864341 142 146 B-Risk
using NCT03864341 147 152 O
a NCT03864341 153 154 O
homelessness NCT03864341 155 167 B-Observation
risk NCT03864341 168 172 I-Observation
screening NCT03864341 173 182 I-Observation
tool NCT03864341 183 187 I-Observation
( NCT03864341 188 189 O
HRST NCT03864341 190 194 B-Observation
) NCT03864341 195 196 O
. NCT03864341 197 198 O

- NCT03864341 202 203 O
Screen NCT03864341 205 211 O
positive NCT03864341 212 220 O
for NCT03864341 221 224 O
unhealthy NCT03864341 225 234 O
alcohol NCT03864341 235 242 B-Modifier
or NCT03864341 243 245 B-Or
drug NCT03864341 246 250 B-Modifier
use NCT03864341 251 254 B-Condition
. NCT03864341 255 256 O

- NCT03864341 260 261 O
Able NCT03864341 263 267 O
to NCT03864341 268 270 O
provide NCT03864341 271 278 O
consent NCT03864341 279 286 O
. NCT03864341 287 288 O

Exclusion NCT03864341 290 299 O
Criteria NCT03864341 300 308 O
: NCT03864341 309 310 O

- NCT03864341 314 315 O
Medically NCT03864341 317 326 B-Modifier
( NCT03864341 327 328 O
e NCT03864341 329 330 O
. NCT03864341 331 332 O
g NCT03864341 333 334 O
. NCT03864341 335 336 O
, NCT03864341 337 338 O
critically NCT03864341 339 349 B-Condition
ill NCT03864341 350 353 I-Condition
) NCT03864341 354 355 O
or NCT03864341 356 358 B-Or
psychiatrically NCT03864341 359 374 B-Modifier
unstable NCT03864341 375 383 B-Condition
. NCT03864341 384 385 O

- NCT03864341 389 390 O
Unable NCT03864341 392 398 O
to NCT03864341 399 401 O
provide NCT03864341 402 409 O
informed NCT03864341 410 418 O
consent NCT03864341 419 426 O
for NCT03864341 427 430 O
other NCT03864341 431 436 O
reason NCT03864341 437 443 O
( NCT03864341 444 445 O
e NCT03864341 446 447 O
. NCT03864341 448 449 O
g NCT03864341 450 451 O
. NCT03864341 452 453 O
, NCT03864341 454 455 O
cognitive NCT03864341 456 465 B-Condition
deficit NCT03864341 466 473 I-Condition
, NCT03864341 474 475 O
profound NCT03864341 476 484 B-Condition
intoxication NCT03864341 485 497 I-Condition
) NCT03864341 498 499 O
. NCT03864341 500 501 O

- NCT03864341 505 506 O
Incarcerated NCT03864341 508 520 B-Observation
or NCT03864341 521 523 B-Or
in NCT03864341 524 526 O
police NCT03864341 527 533 B-Observation
custody NCT03864341 534 541 I-Observation
. NCT03864341 542 543 O

- NCT03864341 547 548 O
Unable NCT03864341 550 556 B-Negation
to NCT03864341 557 559 O
understand NCT03864341 560 570 O
and NCT03864341 571 574 O
speak NCT03864341 575 580 O
English NCT03864341 581 588 O
. NCT03864341 589 590 O

- NCT03864341 594 595 O
Lives NCT03864341 597 602 O
outside NCT03864341 603 610 B-Negation
NYC NCT03864341 611 614 O
and NCT03864341 615 618 B-Or
/ NCT03864341 619 620 I-Or
or NCT03864341 621 623 I-Or
can NCT03864341 624 627 B-Negation
not NCT03864341 627 630 I-Negation
give NCT03864341 631 635 O
a NCT03864341 636 637 O
NYC NCT03864341 638 641 O
ZIP NCT03864341 642 645 O
code NCT03864341 646 650 O
. NCT03864341 651 652 O

- NCT03864341 656 657 O
Already NCT03864341 659 666 O
homeless NCT03864341 667 675 B-Condition
( NCT03864341 676 677 O
residing NCT03864341 678 686 O
in NCT03864341 687 689 O
a NCT03864341 690 691 O
shelter NCT03864341 692 699 O
or NCT03864341 700 702 B-Or
on NCT03864341 703 705 O
the NCT03864341 706 709 O
streets NCT03864341 710 717 O
) NCT03864341 718 719 O
. NCT03864341 720 721 O

- NCT03864341 725 726 O
Does NCT03864341 728 732 O
not NCT03864341 733 736 O
have NCT03864341 737 741 O
a NCT03864341 742 743 O
telephone NCT03864341 744 753 O
where NCT03864341 754 759 O
can NCT03864341 760 763 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03864341 764 766 I-Assertion___Assertion_Type_Value:hypothetical
reached NCT03864341 767 774 O
for NCT03864341 775 778 O
follow NCT03864341 779 785 B-Encounter
- NCT03864341 786 787 I-Encounter
up NCT03864341 788 790 I-Encounter
. NCT03864341 791 792 O

- NCT03864341 796 797 O
Has NCT03864341 799 802 O
already NCT03864341 803 810 B-Eq_Comparison
received NCT03864341 811 819 I-Eq_Comparison
specialized NCT03864341 820 831 O
peer NCT03864341 832 836 B-Modifier
navigator NCT03864341 837 846 I-Modifier
/ NCT03864341 847 848 B-Or
addiction NCT03864341 849 858 B-Modifier
social NCT03864341 859 865 B-Procedure
worker NCT03864341 866 872 I-Procedure
services NCT03864341 873 881 I-Procedure
during NCT03864341 882 888 B-Temporal_Connection___Temporal_Connection_Type_Value:during
current NCT03864341 889 896 O
ED NCT03864341 897 899 B-Encounter
visit NCT03864341 900 905 I-Encounter
. NCT03864341 906 907 O

- NCT03864341 911 912 O
Has NCT03864341 914 917 O
already NCT03864341 918 925 B-Eq_Comparison
participated NCT03864341 926 938 I-Eq_Comparison
in NCT03864341 939 941 O
the NCT03864341 942 945 O
study NCT03864341 946 951 B-Study
. NCT03864341 952 953 O

Inclusion NCT03928028 0 9 O
Criteria NCT03928028 10 18 O
: NCT03928028 19 20 O
Adolescents NCT03928028 21 32 O

1 NCT03928028 35 36 O
. NCT03928028 36 37 O
Age NCT03928028 39 42 B-Age
12 NCT03928028 43 45 B-Eq_Comparison
- NCT03928028 46 47 I-Eq_Comparison
18 NCT03928028 48 50 I-Eq_Comparison

2 NCT03928028 54 55 O
. NCT03928028 55 56 O
Currently NCT03928028 58 67 B-Eq_Comparison
meets NCT03928028 68 73 O
Diagnostic NCT03928028 74 84 O
and NCT03928028 85 88 O
Statistical NCT03928028 89 100 O
Manual NCT03928028 101 107 O
- NCT03928028 108 109 O
5 NCT03928028 110 111 O
criteria NCT03928028 112 120 O
for NCT03928028 121 124 O
Anorexia NCT03928028 125 133 B-Condition
Nervosa NCT03928028 134 141 I-Condition

3 NCT03928028 144 145 O
. NCT03928028 145 146 O
Medically NCT03928028 148 157 O
stable NCT03928028 158 164 B-Condition
for NCT03928028 165 168 B-Assertion___Assertion_Type_Value:hypothetical
outpatient NCT03928028 169 179 B-Encounter
treatment NCT03928028 180 189 B-Procedure

4 NCT03928028 192 193 O
. NCT03928028 193 194 O
Fluent NCT03928028 196 202 O
in NCT03928028 203 205 O
English NCT03928028 206 213 O

5 NCT03928028 216 217 O
. NCT03928028 217 218 O
No NCT03928028 220 222 B-Negation
co NCT03928028 223 225 B-Condition
- NCT03928028 226 227 I-Condition
morbid NCT03928028 228 234 I-Condition
condition NCT03928028 235 244 I-Condition
that NCT03928028 245 249 O
would NCT03928028 250 255 O
exclude NCT03928028 256 263 O
participation NCT03928028 264 277 O

6 NCT03928028 280 281 O
. NCT03928028 281 282 O
Medical NCT03928028 284 291 O
clearance NCT03928028 292 301 O
from NCT03928028 302 306 O
primary NCT03928028 307 314 O
care NCT03928028 315 319 O
physician NCT03928028 320 329 O
and NCT03928028 330 333 O
permission NCT03928028 334 344 O
to NCT03928028 345 347 O
speak NCT03928028 348 353 O
to NCT03928028 354 356 O
Primary NCT03928028 357 364 O
Care NCT03928028 365 369 O
Physician NCT03928028 370 379 O
about NCT03928028 380 385 O
clinical NCT03928028 386 394 O
issues NCT03928028 395 401 O

7 NCT03928028 404 405 O
. NCT03928028 405 406 O
Biological NCT03928028 408 418 O
parent NCT03928028 419 425 B-Family_Member___Family_Member_Type:parent
or NCT03928028 426 428 O
primary NCT03928028 429 436 O
caregiver NCT03928028 437 446 O
willing NCT03928028 447 454 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928028 455 457 I-Assertion___Assertion_Type_Value:hypothetical
engage NCT03928028 458 464 O
in NCT03928028 465 467 O
treatment NCT03928028 468 477 B-Procedure
and NCT03928028 478 481 O
who NCT03928028 482 485 O
live NCT03928028 486 490 O
with NCT03928028 491 495 O
the NCT03928028 496 499 O
adolescent NCT03928028 500 510 O

Inclusion NCT03928028 511 520 O
Criteria NCT03928028 521 529 O
: NCT03928028 530 531 O
Parents NCT03928028 532 539 B-Family_Member___Family_Member_Type:parent

1 NCT03928028 542 543 O
. NCT03928028 543 544 O
Age NCT03928028 546 549 B-Age
> NCT03928028 550 551 B-Eq_Comparison
18 NCT03928028 552 554 I-Eq_Comparison

2 NCT03928028 558 559 O
. NCT03928028 559 560 O
Child NCT03928028 562 567 O
with NCT03928028 568 572 B-And
a NCT03928028 573 574 O
diagnoses NCT03928028 575 584 O
of NCT03928028 585 587 O
AN NCT03928028 588 590 B-Condition

3 NCT03928028 593 594 O
. NCT03928028 594 595 O
Both NCT03928028 597 601 O
parents NCT03928028 602 609 O
willing NCT03928028 610 617 O
to NCT03928028 618 620 O
participate NCT03928028 621 632 O

4 NCT03928028 635 636 O
. NCT03928028 636 637 O
Fluent NCT03928028 639 645 O
in NCT03928028 646 648 O
English NCT03928028 649 656 O

5 NCT03928028 659 660 O
. NCT03928028 660 661 O
No NCT03928028 663 665 B-Negation
co NCT03928028 666 668 B-Condition
- NCT03928028 669 670 I-Condition
morbid NCT03928028 671 677 I-Condition
condition NCT03928028 678 687 I-Condition
that NCT03928028 688 692 O
would NCT03928028 693 698 O
exclude NCT03928028 699 706 O
participation NCT03928028 707 720 O

Exclusion NCT03928028 721 730 O
Criteria NCT03928028 731 739 O
: NCT03928028 740 741 O
Adolescent NCT03928028 742 752 O

1 NCT03928028 755 756 O
. NCT03928028 756 757 O
Adolescent NCT03928028 759 769 O
outside NCT03928028 770 777 B-Negation
age NCT03928028 778 781 B-Age
range NCT03928028 782 787 B-Eq_Comparison

2 NCT03928028 790 791 O
. NCT03928028 791 792 O
Adolescent NCT03928028 794 804 O
adopted NCT03928028 805 812 B-Condition

3 NCT03928028 815 816 O
. NCT03928028 816 817 O
Pregnant NCT03928028 819 827 B-Condition
adolescent NCT03928028 828 838 O

4 NCT03928028 841 842 O
. NCT03928028 842 843 O
Presence NCT03928028 845 853 O
of NCT03928028 854 856 O
: NCT03928028 857 858 O
pervasive NCT03928028 859 868 O
developmental NCT03928028 869 882 B-Condition
disability NCT03928028 883 893 I-Condition
, NCT03928028 894 895 O
psychosis NCT03928028 896 905 B-Condition
, NCT03928028 906 907 O
bipolar NCT03928028 908 915 B-Condition
disorder NCT03928028 916 924 I-Condition
, NCT03928028 925 926 O
substance NCT03928028 927 936 B-Condition
abuse NCT03928028 937 942 I-Condition
, NCT03928028 943 944 O
autism NCT03928028 945 951 B-Condition
spectrum NCT03928028 952 960 I-Condition
disorder NCT03928028 961 969 I-Condition
, NCT03928028 970 971 O
or NCT03928028 972 974 B-Or
intellectual NCT03928028 975 987 B-Condition
disability NCT03928028 988 998 I-Condition

5 NCT03928028 1001 1002 O
. NCT03928028 1002 1003 O
Presence NCT03928028 1005 1013 O
of NCT03928028 1014 1016 O
: NCT03928028 1017 1018 O
a NCT03928028 1019 1020 O
brain NCT03928028 1021 1026 B-Modifier
disorder NCT03928028 1027 1035 B-Condition
or NCT03928028 1036 1038 B-Or
injury NCT03928028 1039 1045 B-Condition
( NCT03928028 1046 1047 O
such NCT03928028 1048 1052 O
as NCT03928028 1053 1055 O
TBI NCT03928028 1056 1059 B-Condition
) NCT03928028 1060 1061 O
that NCT03928028 1062 1066 O
could NCT03928028 1067 1072 B-Assertion___Assertion_Type_Value:hypothetical
impact NCT03928028 1073 1079 O
the NCT03928028 1080 1083 O
ability NCT03928028 1084 1091 O
to NCT03928028 1092 1094 O
engage NCT03928028 1095 1101 O
in NCT03928028 1102 1104 O
treatment NCT03928028 1105 1114 B-Procedure

6 NCT03928028 1117 1118 O
. NCT03928028 1118 1119 O
Use NCT03928028 1121 1124 B-Eq_Comparison
of NCT03928028 1125 1127 O
anti NCT03928028 1128 1132 B-Drug
- NCT03928028 1133 1134 I-Drug
psychotic NCT03928028 1135 1144 I-Drug
medication NCT03928028 1145 1155 I-Drug

7 NCT03928028 1158 1159 O
. NCT03928028 1159 1160 O
Concurrent NCT03928028 1162 1172 B-Eq_Comparison
psychosocial NCT03928028 1173 1185 B-Procedure
therapy NCT03928028 1186 1193 I-Procedure

Exclusion NCT03928028 1194 1203 O
Criteria NCT03928028 1204 1212 O
: NCT03928028 1213 1214 O
Parents NCT03928028 1215 1222 B-Family_Member___Family_Member_Type:parent

1 NCT03928028 1225 1226 O
. NCT03928028 1226 1227 O
Presence NCT03928028 1229 1237 O
of NCT03928028 1238 1240 O
: NCT03928028 1241 1242 O
pervasive NCT03928028 1243 1252 O
developmental NCT03928028 1253 1266 B-Condition
disability NCT03928028 1267 1277 I-Condition
, NCT03928028 1278 1279 O
psychosis NCT03928028 1280 1289 B-Condition
, NCT03928028 1290 1291 O
bipolar NCT03928028 1292 1299 B-Condition
disorder NCT03928028 1300 1308 I-Condition
, NCT03928028 1309 1310 O
substance NCT03928028 1311 1320 B-Condition
abuse NCT03928028 1321 1326 I-Condition
, NCT03928028 1327 1328 O
autism NCT03928028 1329 1335 B-Condition
spectrum NCT03928028 1336 1344 I-Condition
disorder NCT03928028 1345 1353 I-Condition
, NCT03928028 1354 1355 O
or NCT03928028 1356 1358 B-Or
intellectual NCT03928028 1359 1371 B-Condition
disability NCT03928028 1372 1382 I-Condition
. NCT03928028 1383 1384 O

2 NCT03928028 1388 1389 O
. NCT03928028 1389 1390 O
Presence NCT03928028 1392 1400 O
of NCT03928028 1401 1403 O
: NCT03928028 1404 1405 O
a NCT03928028 1406 1407 O
brain NCT03928028 1408 1413 B-Modifier
disorder NCT03928028 1414 1422 B-Condition
or NCT03928028 1423 1425 B-Or
injury NCT03928028 1426 1432 B-Condition
( NCT03928028 1433 1434 O
such NCT03928028 1435 1439 O
as NCT03928028 1440 1442 O
TBI NCT03928028 1443 1446 B-Condition
) NCT03928028 1447 1448 O
that NCT03928028 1449 1453 O
could NCT03928028 1454 1459 B-Assertion___Assertion_Type_Value:hypothetical
impact NCT03928028 1460 1466 O
the NCT03928028 1467 1470 O
ability NCT03928028 1471 1478 O
to NCT03928028 1479 1481 O
engage NCT03928028 1482 1488 O
in NCT03928028 1489 1491 O
treatment NCT03928028 1492 1501 B-Procedure

3 NCT03928028 1504 1505 O
. NCT03928028 1505 1506 O
Use NCT03928028 1508 1511 B-Eq_Comparison
of NCT03928028 1512 1514 O
anti NCT03928028 1515 1519 B-Drug
- NCT03928028 1520 1521 I-Drug
psychotic NCT03928028 1522 1531 I-Drug
medication NCT03928028 1532 1542 I-Drug

Inclusion NCT03922516 0 9 O
Criteria NCT03922516 10 18 O
: NCT03922516 19 20 O

- NCT03922516 24 25 O
all NCT03922516 27 30 O
patients NCT03922516 31 39 O
who NCT03922516 40 43 O
are NCT03922516 44 47 O
assigned NCT03922516 48 56 O
to NCT03922516 57 59 O
a NCT03922516 60 61 O
clinically NCT03922516 62 72 O
indicated NCT03922516 73 82 B-Indication
chest NCT03922516 83 88 B-Modifier
X NCT03922516 89 90 B-Procedure
- NCT03922516 91 92 I-Procedure
ray NCT03922516 93 96 I-Procedure
by NCT03922516 97 99 O
the NCT03922516 100 103 O
emergency NCT03922516 104 113 O
department NCT03922516 114 124 O
of NCT03922516 125 127 O
Vienna NCT03922516 128 134 O
General NCT03922516 135 142 O
Hospital NCT03922516 143 151 O

- NCT03922516 154 155 O
ability NCT03922516 157 164 O
to NCT03922516 165 167 O
provide NCT03922516 168 175 O
informed NCT03922516 176 184 O
consent NCT03922516 185 192 O

- NCT03922516 195 196 O
informed NCT03922516 198 206 O
consent NCT03922516 207 214 O
after NCT03922516 215 220 O
detailed NCT03922516 221 229 O
patient NCT03922516 230 237 O
briefing NCT03922516 238 246 O

Exclusion NCT03922516 247 256 O
Criteria NCT03922516 257 265 O
: NCT03922516 266 267 O

- NCT03922516 271 272 O
the NCT03922516 274 277 O
emergency NCT03922516 278 287 O
departments NCT03922516 288 299 O
assessment NCT03922516 300 310 B-Procedure
of NCT03922516 311 313 O
a NCT03922516 314 315 O
critical NCT03922516 316 324 O
clinical NCT03922516 325 333 B-Condition
condition NCT03922516 334 343 I-Condition
oppose NCT03922516 344 350 B-Assertion___Assertion_Type_Value:hypothetical
an NCT03922516 351 353 O
examination NCT03922516 354 365 B-Procedure
with NCT03922516 366 370 O
both NCT03922516 371 375 B-Modifier
modalities NCT03922516 376 386 I-Modifier
( NCT03922516 387 388 O
ULDCT NCT03922516 389 394 B-Procedure
of NCT03922516 395 397 O
the NCT03922516 398 401 O
chest NCT03922516 402 407 B-Modifier
, NCT03922516 408 409 O
chest NCT03922516 410 415 B-Modifier
X NCT03922516 416 417 B-Procedure
- NCT03922516 418 419 I-Procedure
ray NCT03922516 420 423 I-Procedure
) NCT03922516 424 425 O

- NCT03922516 429 430 O
assigned NCT03922516 432 440 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03922516 441 443 O
chest NCT03922516 444 449 B-Modifier
X NCT03922516 450 451 B-Procedure
- NCT03922516 452 453 I-Procedure
ray NCT03922516 454 457 I-Procedure
as NCT03922516 458 460 O
follow NCT03922516 461 467 O
- NCT03922516 468 469 O
up NCT03922516 470 472 O

- NCT03922516 475 476 O
women NCT03922516 478 483 O
with NCT03922516 484 488 B-And
positive NCT03922516 489 497 O
ß NCT03922516 498 499 B-Observation
- NCT03922516 500 501 I-Observation
HCG NCT03922516 502 505 I-Observation
- NCT03922516 506 507 I-Observation
test NCT03922516 508 512 I-Observation

Inclusion NCT03867019 0 9 O
Criteria NCT03867019 10 18 O
: NCT03867019 19 20 O

Subjects NCT03867019 22 30 O
with NCT03867019 31 35 O
BPPV NCT03867019 36 40 B-Condition
- NCT03867019 41 42 O
Patients NCT03867019 43 51 O
diagnosed NCT03867019 52 61 O
with NCT03867019 62 66 O
BPPV NCT03867019 67 71 B-Condition
, NCT03867019 72 73 O
who NCT03867019 74 77 O
meet NCT03867019 78 82 O
the NCT03867019 83 86 B-Criteria_Count
following NCT03867019 87 96 I-Criteria_Count
criteria NCT03867019 97 105 I-Criteria_Count
: NCT03867019 106 107 O

1 NCT03867019 111 112 O
. NCT03867019 112 113 O
Main NCT03867019 115 119 O
complain NCT03867019 120 128 O
of NCT03867019 129 131 O
spinning NCT03867019 132 140 B-Condition
sensation NCT03867019 141 150 I-Condition
( NCT03867019 151 152 O
Vertigo NCT03867019 153 160 B-Condition
) NCT03867019 161 162 O
when NCT03867019 163 167 O
changes NCT03867019 168 175 O
are NCT03867019 176 179 O
made NCT03867019 180 184 O
in NCT03867019 185 187 O
head NCT03867019 188 192 O
position NCT03867019 193 201 O
relative NCT03867019 202 210 O
to NCT03867019 211 213 O
gravity NCT03867019 214 221 O
( NCT03867019 222 223 O
such NCT03867019 224 228 O
as NCT03867019 229 231 O
when NCT03867019 232 236 O
moving NCT03867019 237 243 O
from NCT03867019 244 248 O
sitting NCT03867019 249 256 O
to NCT03867019 257 259 O
lying NCT03867019 260 265 O
down NCT03867019 266 270 O
or NCT03867019 271 273 O
rolling NCT03867019 274 281 O
in NCT03867019 282 284 O
bed NCT03867019 285 288 O
, NCT03867019 289 290 O
bending NCT03867019 291 298 O
over NCT03867019 299 303 O
etc NCT03867019 304 307 O
. NCT03867019 308 309 O
) NCT03867019 310 311 O

2 NCT03867019 315 316 O
. NCT03867019 316 317 O
Positive NCT03867019 319 327 O
Dix NCT03867019 328 331 B-Observation
- NCT03867019 332 333 I-Observation
Hallpike NCT03867019 334 342 I-Observation
/ NCT03867019 343 344 I-Observation
Supine NCT03867019 345 351 I-Observation
Roll NCT03867019 352 356 I-Observation
Test NCT03867019 357 361 I-Observation
, NCT03867019 362 363 O
confirmed NCT03867019 364 373 O
by NCT03867019 374 376 O
presence NCT03867019 377 385 O
of NCT03867019 386 388 O
nystagmus NCT03867019 389 398 B-Condition
. NCT03867019 399 400 O

Subjects NCT03867019 402 410 O
without NCT03867019 411 418 B-Negation
BPPV NCT03867019 419 423 B-Condition
( NCT03867019 424 425 O
Control NCT03867019 426 433 O
group NCT03867019 434 439 O
) NCT03867019 440 441 O
: NCT03867019 442 443 O

Subjects NCT03867019 445 453 O
who NCT03867019 454 457 O
do NCT03867019 458 460 O
not NCT03867019 461 464 B-Negation
suffer NCT03867019 465 471 O
from NCT03867019 472 476 O
dizziness NCT03867019 477 486 B-Condition
/ NCT03867019 487 488 O
spinning NCT03867019 489 497 B-Condition
sensation NCT03867019 498 507 I-Condition
( NCT03867019 508 509 O
Vertigo NCT03867019 510 517 B-Condition
) NCT03867019 518 519 O
. NCT03867019 520 521 O

Exclusion NCT03867019 523 532 O
Criteria NCT03867019 533 541 O
: NCT03867019 542 543 O

- NCT03867019 547 548 O
Suffering NCT03867019 550 559 O
from NCT03867019 560 564 O
pain NCT03867019 565 569 B-Condition
in NCT03867019 570 572 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867019 573 576 I-Temporal_Connection___Temporal_Connection_Type_Value:during
day NCT03867019 577 580 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03867019 581 583 I-Temporal_Connection___Temporal_Connection_Type_Value:during
assessment NCT03867019 584 594 B-Study
. NCT03867019 595 596 O

- NCT03867019 600 601 O
Postural NCT03867019 603 611 B-Modifier
Hypotension NCT03867019 612 623 B-Condition
. NCT03867019 624 625 O

- NCT03867019 629 630 O
Familial NCT03867019 632 640 B-Condition
Dysautonomia NCT03867019 641 653 I-Condition
. NCT03867019 654 655 O

- NCT03867019 659 660 O
Diabetic NCT03867019 662 670 B-Condition
Neuropathy NCT03867019 671 681 I-Condition
. NCT03867019 682 683 O

- NCT03867019 687 688 O
History NCT03867019 690 697 B-Eq_Comparison
of NCT03867019 698 700 O
Whiplash NCT03867019 701 709 B-Condition
or NCT03867019 710 712 B-Or
Traumatic NCT03867019 713 722 B-Condition
Brain NCT03867019 723 728 I-Condition
Injury NCT03867019 729 735 I-Condition
( NCT03867019 736 737 O
TBI NCT03867019 738 741 B-Condition
) NCT03867019 742 743 O
in NCT03867019 744 746 O
the NCT03867019 747 750 O
last NCT03867019 751 755 B-Eq_Comparison
year NCT03867019 756 760 I-Eq_Comparison
. NCT03867019 761 762 O

- NCT03867019 766 767 O
History NCT03867019 769 776 B-Eq_Comparison
of NCT03867019 777 779 O
Stroke NCT03867019 780 786 B-Condition
( NCT03867019 787 788 O
CVA NCT03867019 789 792 B-Condition
) NCT03867019 793 794 O
, NCT03867019 795 796 O
Multiple NCT03867019 797 805 B-Condition
Sclerosis NCT03867019 806 815 I-Condition
( NCT03867019 816 817 O
MS NCT03867019 818 820 B-Condition
) NCT03867019 821 822 O
or NCT03867019 823 825 B-Or
Central NCT03867019 826 833 B-Condition
Positional NCT03867019 834 844 I-Condition
Vertigo NCT03867019 845 852 I-Condition
. NCT03867019 853 854 O

- NCT03867019 858 859 O
Coronary NCT03867019 861 869 B-Condition
Heart NCT03867019 870 875 I-Condition
Disease NCT03867019 876 883 I-Condition
( NCT03867019 884 885 O
CHD NCT03867019 886 889 B-Condition
) NCT03867019 890 891 O
, NCT03867019 892 893 O
Cardiac NCT03867019 894 901 B-Condition
Heart NCT03867019 902 907 I-Condition
Failure NCT03867019 908 915 I-Condition
( NCT03867019 916 917 O
CHF NCT03867019 918 921 B-Condition
) NCT03867019 922 923 O
, NCT03867019 924 925 O
Cardiac NCT03867019 926 933 B-Condition
arrhythmias NCT03867019 934 945 I-Condition
, NCT03867019 946 947 O
Vertebrobasilar NCT03867019 948 963 B-Condition
Insufficiency NCT03867019 964 977 I-Condition
( NCT03867019 978 979 O
VBI NCT03867019 980 983 B-Condition
) NCT03867019 984 985 O
. NCT03867019 986 987 O

- NCT03867019 991 992 O
Under NCT03867019 994 999 O
treatment NCT03867019 1000 1009 B-Procedure
of NCT03867019 1010 1012 O
Beta NCT03867019 1013 1017 B-Drug
- NCT03867019 1018 1019 I-Drug
Blockers NCT03867019 1020 1028 I-Drug
. NCT03867019 1029 1030 O

- NCT03867019 1034 1035 O
Anxiety NCT03867019 1037 1044 B-Condition
Disorders NCT03867019 1045 1054 I-Condition
. NCT03867019 1055 1056 O

- NCT03867019 1060 1061 O
Vestibular NCT03867019 1063 1073 B-Condition
Migraine NCT03867019 1074 1082 I-Condition
, NCT03867019 1083 1084 O
Vestibular NCT03867019 1085 1095 B-Condition
Neuritis NCT03867019 1096 1104 I-Condition
, NCT03867019 1105 1106 O
Menier NCT03867019 1107 1113 B-Condition
's NCT03867019 1113 1115 I-Condition
Disease NCT03867019 1116 1123 I-Condition
, NCT03867019 1124 1125 O
Perilymphatic NCT03867019 1126 1139 B-Condition
Fistula NCT03867019 1140 1147 I-Condition
, NCT03867019 1148 1149 O
Superior NCT03867019 1150 1158 B-Condition
Canal NCT03867019 1159 1164 I-Condition
Dehiscence NCT03867019 1165 1175 I-Condition
Syndrome NCT03867019 1176 1184 I-Condition
. NCT03867019 1185 1186 O

- NCT03867019 1190 1191 O
Medical NCT03867019 1193 1200 B-Condition
conditions NCT03867019 1201 1211 I-Condition
with NCT03867019 1212 1216 O
high NCT03867019 1217 1221 O
risk NCT03867019 1222 1226 B-Risk
of NCT03867019 1227 1229 O
subluxation NCT03867019 1230 1241 B-Condition
/ NCT03867019 1242 1243 B-Or
dislocation NCT03867019 1244 1255 B-Condition
of NCT03867019 1256 1258 O
the NCT03867019 1259 1262 O
Atlanto NCT03867019 1263 1270 B-Modifier
- NCT03867019 1271 1272 I-Modifier
axial NCT03867019 1273 1278 I-Modifier
joint NCT03867019 1279 1284 I-Modifier
. NCT03867019 1285 1286 O

- NCT03867019 1290 1291 O
Health NCT03867019 1293 1299 B-Provider
professionals NCT03867019 1300 1313 I-Provider
who NCT03867019 1314 1317 O
are NCT03867019 1318 1321 O
specialized NCT03867019 1322 1333 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867019 1334 1336 I-Assertion___Assertion_Type_Value:hypothetical
treat NCT03867019 1337 1342 B-Procedure
Vestibular NCT03867019 1343 1353 B-Condition
disorders NCT03867019 1354 1363 I-Condition
( NCT03867019 1364 1365 O
such NCT03867019 1366 1370 O
as NCT03867019 1371 1373 O
Vestibular NCT03867019 1374 1384 B-Provider
physiotherapists NCT03867019 1385 1401 I-Provider
) NCT03867019 1402 1403 O

Inclusion NCT03920891 0 9 O
Criteria NCT03920891 10 18 O
: NCT03920891 19 20 O

- NCT03920891 24 25 O
1 NCT03920891 27 28 O
. NCT03920891 28 29 O
Patient NCT03920891 31 38 O
with NCT03920891 39 43 O
hemodynamic NCT03920891 44 55 B-Modifier
corrected NCT03920891 56 65 I-Modifier
valvular NCT03920891 66 74 I-Modifier
atrial NCT03920891 75 81 B-Condition
fibrillation NCT03920891 82 94 I-Condition
who NCT03920891 95 98 B-And
is NCT03920891 99 101 O
scheduled NCT03920891 102 111 B-Eq_Comparison
for NCT03920891 112 115 O
ablation NCT03920891 116 124 B-Procedure
procedure NCT03920891 125 134 I-Procedure
and NCT03920891 135 138 B-And
≥ NCT03920891 139 140 B-Eq_Comparison
20 NCT03920891 141 143 I-Eq_Comparison
and NCT03920891 144 147 B-And
≤ NCT03920891 148 149 B-Eq_Comparison
80 NCT03920891 150 152 I-Eq_Comparison
years NCT03920891 153 158 I-Eq_Comparison
of NCT03920891 159 161 O
age NCT03920891 162 165 B-Age

- NCT03920891 168 169 O
2 NCT03920891 171 172 O
. NCT03920891 172 173 O
Left NCT03920891 175 179 B-Observation
atrium NCT03920891 180 186 I-Observation
size NCT03920891 187 191 I-Observation
< NCT03920891 192 193 B-Eq_Comparison
50 NCT03920891 194 196 I-Eq_Comparison
mm NCT03920891 197 199 I-Eq_Comparison

- NCT03920891 202 203 O
3 NCT03920891 205 206 O
. NCT03920891 206 207 O
paroxysmal NCT03920891 209 219 B-Modifier
atrial NCT03920891 220 226 B-Condition
fibrillation NCT03920891 227 239 I-Condition
that NCT03920891 240 244 O
is NCT03920891 245 247 O
recurrence NCT03920891 248 258 O
during NCT03920891 259 265 B-Temporal_Connection___Temporal_Connection_Type_Value:during
antiarrhythmic NCT03920891 266 280 B-Drug
drug NCT03920891 281 285 I-Drug
treatment NCT03920891 286 295 B-Procedure
or NCT03920891 296 298 B-Or
is NCT03920891 299 301 O
not NCT03920891 302 305 B-Negation
able NCT03920891 306 310 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03920891 311 313 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03920891 314 317 O
an NCT03920891 318 320 O
antiarrhythmic NCT03920891 321 335 B-Drug
drug NCT03920891 336 340 I-Drug
. NCT03920891 341 342 O

- NCT03920891 346 347 O
4 NCT03920891 349 350 O
. NCT03920891 350 351 O
Patient NCT03920891 353 360 O
who NCT03920891 361 364 O
is NCT03920891 365 367 O
indicated NCT03920891 368 377 B-Indication
for NCT03920891 378 381 O
anticoagulation NCT03920891 382 397 B-Procedure
therapy NCT03920891 398 405 I-Procedure
( NCT03920891 406 407 O
for NCT03920891 408 411 O
prevention NCT03920891 412 422 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03920891 423 425 I-Assertion___Assertion_Type_Value:hypothetical
cerebral NCT03920891 426 434 B-Condition
infarction NCT03920891 435 445 I-Condition
) NCT03920891 446 447 O

Exclusion NCT03920891 449 458 O
Criteria NCT03920891 459 467 O
: NCT03920891 468 469 O

- NCT03920891 473 474 O
1 NCT03920891 476 477 O
. NCT03920891 477 478 O
Patients NCT03920891 480 488 O
with NCT03920891 489 493 O
permanent NCT03920891 494 503 B-Modifier
atrial NCT03920891 504 510 B-Condition
fibrillation NCT03920891 511 523 I-Condition

- NCT03920891 526 527 O
2 NCT03920891 529 530 O
. NCT03920891 530 531 O
Atrial NCT03920891 533 539 B-Condition
fibrillation NCT03920891 540 552 I-Condition
associated NCT03920891 553 563 O
with NCT03920891 564 568 O
severe NCT03920891 569 575 O
cardiac NCT03920891 576 583 B-Condition
malformation NCT03920891 584 596 I-Condition
or NCT03920891 597 599 B-Or
a NCT03920891 600 601 O
structural NCT03920891 602 612 B-Modifier
heart NCT03920891 613 618 B-Condition
disease NCT03920891 619 626 I-Condition
that NCT03920891 627 631 O
is NCT03920891 632 634 O
hemodynamically NCT03920891 635 650 B-Modifier
affected NCT03920891 651 659 O

- NCT03920891 662 663 O
3 NCT03920891 665 666 O
. NCT03920891 666 667 O
Patients NCT03920891 669 677 O
with NCT03920891 678 682 O
severe NCT03920891 683 689 O
renal NCT03920891 690 695 B-Modifier
impairment NCT03920891 696 706 B-Condition
or NCT03920891 707 709 B-Or
CT NCT03920891 710 712 B-Procedure
imaging NCT03920891 713 720 I-Procedure
difficulty NCT03920891 721 731 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
using NCT03920891 732 737 O
contrast NCT03920891 738 746 B-Procedure
media NCT03920891 747 752 I-Procedure

- NCT03920891 755 756 O
4 NCT03920891 758 759 O
. NCT03920891 759 760 O
Patients NCT03920891 762 770 O
with NCT03920891 771 775 O
a NCT03920891 776 777 O
past NCT03920891 778 782 B-Eq_Comparison
history NCT03920891 783 790 I-Eq_Comparison
of NCT03920891 791 793 O
radiofrequency NCT03920891 794 808 B-Procedure
ablation NCT03920891 809 817 I-Procedure
for NCT03920891 818 821 O
atrial NCT03920891 822 828 B-Condition
fibrillation NCT03920891 829 841 I-Condition
or NCT03920891 842 844 B-Or
other NCT03920891 845 850 B-Other
cardiac NCT03920891 851 858 B-Modifier
surgery NCT03920891 859 866 B-Procedure

- NCT03920891 869 870 O
5 NCT03920891 872 873 O
. NCT03920891 873 874 O
Patients NCT03920891 876 884 O
with NCT03920891 885 889 O
active NCT03920891 890 896 B-Eq_Comparison
internal NCT03920891 897 905 B-Modifier
bleeding NCT03920891 906 914 B-Condition

- NCT03920891 917 918 O
6 NCT03920891 920 921 O
. NCT03920891 921 922 O
Patients NCT03920891 924 932 O
with NCT03920891 933 937 O
contraindications NCT03920891 938 955 B-Contraindication
for NCT03920891 956 959 O
anticoagulation NCT03920891 960 975 B-Procedure
therapy NCT03920891 976 983 I-Procedure
( NCT03920891 984 985 O
for NCT03920891 986 989 O
prevention NCT03920891 990 1000 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03920891 1001 1003 I-Assertion___Assertion_Type_Value:hypothetical
cerebral NCT03920891 1004 1012 B-Condition
infarction NCT03920891 1013 1023 I-Condition
) NCT03920891 1024 1025 O
and NCT03920891 1026 1029 B-Or
antiarrhythmic NCT03920891 1030 1044 B-Drug
drugs NCT03920891 1045 1050 I-Drug

- NCT03920891 1053 1054 O
7 NCT03920891 1056 1057 O
. NCT03920891 1057 1058 O
Patients NCT03920891 1060 1068 O
with NCT03920891 1069 1073 O
non NCT03920891 1074 1077 B-Modifier
- NCT03920891 1078 1079 I-Modifier
valvular NCT03920891 1080 1088 I-Modifier
atrial NCT03920891 1089 1095 B-Condition
fibrillation NCT03920891 1096 1108 I-Condition

- NCT03920891 1111 1112 O
8 NCT03920891 1114 1115 O
. NCT03920891 1115 1116 O
Patients NCT03920891 1118 1126 O
with NCT03920891 1127 1131 O
a NCT03920891 1132 1133 O
severe NCT03920891 1134 1140 O
comorbid NCT03920891 1141 1149 B-Condition
disease NCT03920891 1150 1157 I-Condition

- NCT03920891 1160 1161 O
9 NCT03920891 1163 1164 O
. NCT03920891 1164 1165 O
Expected NCT03920891 1167 1175 B-Observation
survival NCT03920891 1176 1184 I-Observation
< NCT03920891 1185 1186 B-Eq_Comparison
1 NCT03920891 1187 1188 I-Eq_Comparison
year NCT03920891 1189 1193 I-Eq_Comparison

- NCT03920891 1196 1197 O
10 NCT03920891 1199 1201 O
. NCT03920891 1201 1202 O
Drug NCT03920891 1204 1208 B-Condition
addicts NCT03920891 1209 1216 I-Condition
or NCT03920891 1217 1219 B-Or
alcoholics NCT03920891 1220 1230 B-Condition

- NCT03920891 1233 1234 O
11 NCT03920891 1236 1238 O
. NCT03920891 1238 1239 O
Patients NCT03920891 1241 1249 O
who NCT03920891 1250 1253 O
can NCT03920891 1254 1257 O
not NCT03920891 1257 1260 O
read NCT03920891 1261 1265 O
the NCT03920891 1266 1269 O
consent NCT03920891 1270 1277 O
form NCT03920891 1278 1282 O
( NCT03920891 1283 1284 O
illiterates NCT03920891 1285 1296 B-Condition
, NCT03920891 1297 1298 O
foreigners NCT03920891 1299 1309 O
, NCT03920891 1310 1311 O
etc NCT03920891 1312 1315 O
. NCT03920891 1316 1317 O
) NCT03920891 1318 1319 O

- NCT03920891 1323 1324 O
12 NCT03920891 1326 1328 O
. NCT03920891 1328 1329 O
Other NCT03920891 1331 1336 O
patients NCT03920891 1337 1345 O
who NCT03920891 1346 1349 O
are NCT03920891 1350 1353 O
judged NCT03920891 1354 1360 O
by NCT03920891 1361 1363 O
the NCT03920891 1364 1367 O
principal NCT03920891 1368 1377 O
or NCT03920891 1378 1380 O
sub NCT03920891 1381 1384 O
- NCT03920891 1385 1386 O
investigator NCT03920891 1387 1399 O
to NCT03920891 1400 1402 O
be NCT03920891 1403 1405 O
ineligible NCT03920891 1406 1416 O
for NCT03920891 1417 1420 O
participation NCT03920891 1421 1434 O
in NCT03920891 1435 1437 O
this NCT03920891 1438 1442 O
clinical NCT03920891 1443 1451 O
study NCT03920891 1452 1457 O

Inclusion NCT03921203 0 9 O
Criteria NCT03921203 10 18 O
: NCT03921203 19 20 O

- NCT03921203 24 25 O
Over NCT03921203 27 31 B-Eq_Comparison
18 NCT03921203 32 34 I-Eq_Comparison
years NCT03921203 35 40 I-Eq_Comparison
. NCT03921203 41 42 O

- NCT03921203 46 47 O
For NCT03921203 49 52 O
the NCT03921203 53 56 O
T NCT03921203 57 58 B-Condition
2D NCT03921203 59 61 I-Condition
study NCT03921203 62 67 O
group NCT03921203 68 73 O
: NCT03921203 74 75 O
Diagnosed NCT03921203 76 85 O
with NCT03921203 86 90 O
type NCT03921203 91 95 B-Modifier
2 NCT03921203 96 97 I-Modifier
diabetes NCT03921203 98 106 B-Condition
. NCT03921203 107 108 O

Exclusion NCT03921203 110 119 O
Criteria NCT03921203 120 128 O
: NCT03921203 129 130 O

For NCT03921203 132 135 O
subjects NCT03921203 136 144 O
with NCT03921203 145 149 O
type NCT03921203 150 154 B-Modifier
2 NCT03921203 155 156 I-Modifier
diabetes NCT03921203 157 165 B-Condition
: NCT03921203 166 167 O

- NCT03921203 171 172 O
Systemic NCT03921203 174 182 B-Modifier
inflammatory NCT03921203 183 195 B-Condition
disease NCT03921203 196 203 I-Condition
that NCT03921203 204 208 O
requires NCT03921203 209 217 B-Assertion___Assertion_Type_Value:hypothetical
active NCT03921203 218 224 B-Eq_Comparison
treatment NCT03921203 225 234 B-Procedure

- NCT03921203 237 238 O
Thyroid NCT03921203 240 247 B-Condition
disease NCT03921203 248 255 I-Condition
that NCT03921203 256 260 O
requires NCT03921203 261 269 B-Assertion___Assertion_Type_Value:hypothetical
active NCT03921203 270 276 B-Eq_Comparison
treatment NCT03921203 277 286 B-Procedure

- NCT03921203 289 290 O
Skin NCT03921203 292 296 B-Condition
disease NCT03921203 297 304 I-Condition
that NCT03921203 305 309 O
requires NCT03921203 310 318 B-Assertion___Assertion_Type_Value:hypothetical
active NCT03921203 319 325 B-Eq_Comparison
treatment NCT03921203 326 335 B-Procedure
and NCT03921203 336 339 B-And
causes NCT03921203 340 346 O
significant NCT03921203 347 358 O
changes NCT03921203 359 366 B-Condition
in NCT03921203 367 369 I-Condition
the NCT03921203 370 373 I-Condition
area NCT03921203 374 378 I-Condition
of NCT03921203 379 381 I-Condition
the NCT03921203 382 385 I-Condition
skin NCT03921203 386 390 I-Condition
that NCT03921203 391 395 O
is NCT03921203 396 398 O
to NCT03921203 399 401 O
be NCT03921203 402 404 O
investigated NCT03921203 405 417 O

- NCT03921203 420 421 O
Treatment NCT03921203 423 432 B-Procedure
with NCT03921203 433 437 O
oral NCT03921203 438 442 B-Drug
glucocorticoids NCT03921203 443 458 I-Drug

- NCT03921203 461 462 O
Levels NCT03921203 464 470 O
of NCT03921203 471 473 O
SR NCT03921203 474 476 B-Observation
, NCT03921203 477 478 O
TSH NCT03921203 479 482 B-Observation
, NCT03921203 483 484 O
T NCT03921203 485 486 B-Observation
4 NCT03921203 487 488 I-Observation
or NCT03921203 489 491 B-Or
Hemoglobin NCT03921203 492 502 B-Observation
in NCT03921203 503 505 O
the NCT03921203 506 509 O
blood NCT03921203 510 515 O
pronouncedly NCT03921203 516 528 O
outside NCT03921203 529 536 O
the NCT03921203 537 540 O
reference NCT03921203 541 550 O
range NCT03921203 551 556 O

- NCT03921203 559 560 O
Pregnancy NCT03921203 562 571 B-Condition

For NCT03921203 572 575 O
healthy NCT03921203 576 583 O
controls NCT03921203 584 592 O
: NCT03921203 593 594 O

- NCT03921203 598 599 O
Registered NCT03921203 601 611 O
disease NCT03921203 612 619 B-Condition
in NCT03921203 620 622 O
the NCT03921203 623 626 O
health NCT03921203 627 633 O
declaration NCT03921203 634 645 O
that NCT03921203 646 650 O
requires NCT03921203 651 659 B-Assertion___Assertion_Type_Value:hypothetical
continuous NCT03921203 660 670 B-Eq_Comparison
systemic NCT03921203 671 679 B-Modifier
treatment NCT03921203 680 689 B-Procedure
. NCT03921203 690 691 O
Exception NCT03921203 693 702 B-Exception
to NCT03921203 703 705 O
the NCT03921203 706 709 O
above NCT03921203 710 715 O
: NCT03921203 716 717 O
well NCT03921203 718 722 O
controlled NCT03921203 723 733 B-Modifier
hypertension NCT03921203 734 746 B-Condition
in NCT03921203 747 749 O
which NCT03921203 750 755 O
case NCT03921203 756 760 O
the NCT03921203 761 764 O
subject NCT03921203 765 772 O
should NCT03921203 773 779 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03921203 780 783 B-Negation
have NCT03921203 784 788 O
treatment NCT03921203 789 798 B-Procedure
with NCT03921203 799 803 O
more NCT03921203 804 808 B-Eq_Comparison
than NCT03921203 809 813 I-Eq_Comparison
one NCT03921203 814 817 I-Eq_Comparison
antihypertensive NCT03921203 818 834 B-Drug
drug NCT03921203 835 839 I-Drug
, NCT03921203 840 841 O
the NCT03921203 842 845 O
drug NCT03921203 846 850 O
must NCT03921203 851 855 O
not NCT03921203 856 859 B-Negation
be NCT03921203 860 862 O
an NCT03921203 863 865 O
alpha NCT03921203 866 871 B-Drug
- NCT03921203 872 873 I-Drug
blocker NCT03921203 874 881 I-Drug
or NCT03921203 882 884 B-Or
beta NCT03921203 885 889 B-Drug
- NCT03921203 890 891 I-Drug
blocker NCT03921203 892 899 I-Drug
or NCT03921203 900 902 B-Or
thiazide NCT03921203 903 911 B-Drug
diuretic NCT03921203 912 920 I-Drug

- NCT03921203 923 924 O
Skin NCT03921203 926 930 B-Condition
disease NCT03921203 931 938 I-Condition
that NCT03921203 939 943 O
requires NCT03921203 944 952 B-Assertion___Assertion_Type_Value:hypothetical
active NCT03921203 953 959 B-Eq_Comparison
treatment NCT03921203 960 969 B-Procedure
and NCT03921203 970 973 B-And
causes NCT03921203 974 980 O
significant NCT03921203 981 992 O
changes NCT03921203 993 1000 B-Condition
in NCT03921203 1001 1003 I-Condition
the NCT03921203 1004 1007 I-Condition
area NCT03921203 1008 1012 I-Condition
of NCT03921203 1013 1015 I-Condition
the NCT03921203 1016 1019 I-Condition
skin NCT03921203 1020 1024 I-Condition
that NCT03921203 1025 1029 O
is NCT03921203 1030 1032 O
to NCT03921203 1033 1035 O
be NCT03921203 1036 1038 O
investigated NCT03921203 1039 1051 O

- NCT03921203 1054 1055 O
Blood NCT03921203 1057 1062 B-Observation
pressure NCT03921203 1063 1071 I-Observation
pronouncedly NCT03921203 1072 1084 O
above NCT03921203 1085 1090 B-Eq_Comparison
140 NCT03921203 1091 1094 I-Eq_Comparison
/ NCT03921203 1095 1096 I-Eq_Comparison
90 NCT03921203 1097 1099 I-Eq_Comparison

- NCT03921203 1103 1104 O
Blood NCT03921203 1106 1111 B-Observation
test NCT03921203 1112 1116 I-Observation
results NCT03921203 1117 1124 O
pronouncedly NCT03921203 1125 1137 O
outside NCT03921203 1138 1145 O
the NCT03921203 1146 1149 O
reference NCT03921203 1150 1159 O
range NCT03921203 1160 1165 O

- NCT03921203 1168 1169 O
Pregnancy NCT03921203 1171 1180 B-Condition

Inclusion NCT03926299 0 9 O
criteria NCT03926299 10 18 O
: NCT03926299 19 20 O

- NCT03926299 24 25 O
Diagnosis NCT03926299 27 36 O
of NCT03926299 37 39 O
vulvar NCT03926299 40 46 B-Condition
lichen NCT03926299 47 53 I-Condition
sclerosus NCT03926299 54 63 I-Condition

- NCT03926299 66 67 O
Clinical NCT03926299 69 77 O
LS NCT03926299 78 80 B-Observation
score NCT03926299 81 86 I-Observation
≥ NCT03926299 87 88 B-Eq_Comparison
4 NCT03926299 89 90 I-Eq_Comparison

Exclusion NCT03926299 92 101 O
criteria NCT03926299 102 110 O
: NCT03926299 111 112 O

- NCT03926299 116 117 O
Concomitant NCT03926299 119 130 B-Modifier
steroid NCT03926299 131 138 B-Drug
, NCT03926299 139 140 O
calcineurin NCT03926299 141 152 B-Drug
inhibitor NCT03926299 153 162 I-Drug
or NCT03926299 163 165 B-Or
any NCT03926299 166 169 O
other NCT03926299 170 175 B-Other
topical NCT03926299 176 183 B-Modifier
or NCT03926299 184 186 B-Or
systemic NCT03926299 187 195 B-Modifier
treatment NCT03926299 196 205 B-Procedure
for NCT03926299 206 209 O
LS NCT03926299 210 212 B-Condition

- NCT03926299 215 216 O
< NCT03926299 218 219 B-Eq_Comparison
3 NCT03926299 220 221 I-Eq_Comparison
months NCT03926299 222 228 I-Eq_Comparison
since NCT03926299 229 234 B-Temporal_Connection___Temporal_Connection_Type_Value:after
start NCT03926299 235 240 B-Eq_Comparison
of NCT03926299 241 243 O
vaginal NCT03926299 244 251 B-Modifier
estrogen NCT03926299 252 260 B-Procedure
treatment NCT03926299 261 270 I-Procedure

- NCT03926299 273 274 O
Malignant NCT03926299 276 285 B-Condition
disease NCT03926299 286 293 I-Condition
as NCT03926299 294 296 O
the NCT03926299 297 300 O
cause NCT03926299 301 306 O
of NCT03926299 307 309 O
the NCT03926299 310 313 O
vulval NCT03926299 314 320 B-Condition
symptoms NCT03926299 321 329 B-Assertion___Assertion_Type_Value:possible

- NCT03926299 332 333 O
BMI NCT03926299 335 338 B-Observation
> NCT03926299 339 340 B-Eq_Comparison
35 NCT03926299 341 343 I-Eq_Comparison
kg NCT03926299 344 346 I-Eq_Comparison
/ NCT03926299 347 348 I-Eq_Comparison
m² NCT03926299 349 351 I-Eq_Comparison

- NCT03926299 354 355 O
Acute NCT03926299 357 362 O
infection NCT03926299 363 372 B-Condition
( NCT03926299 373 374 O
fungal NCT03926299 375 381 B-Modifier
, NCT03926299 382 383 O
bacterial NCT03926299 384 393 B-Modifier
, NCT03926299 394 395 O
viral NCT03926299 396 401 B-Modifier
) NCT03926299 402 403 O
of NCT03926299 404 406 O
the NCT03926299 407 410 O
vulva NCT03926299 411 416 B-Modifier
, NCT03926299 417 418 O
vagina NCT03926299 419 425 B-Modifier
or NCT03926299 426 428 B-Or
bladder NCT03926299 429 436 B-Modifier

- NCT03926299 439 440 O
Presence NCT03926299 442 450 O
of NCT03926299 451 453 O
contraindications NCT03926299 454 471 B-Contraindication
for NCT03926299 472 475 O
the NCT03926299 476 479 O
laser NCT03926299 480 485 B-Procedure
treatment NCT03926299 486 495 I-Procedure
or NCT03926299 496 498 B-Or
topical NCT03926299 499 506 B-Drug
steroid NCT03926299 507 514 I-Drug
treatment NCT03926299 515 524 B-Procedure

Inclusion NCT03926910 0 9 O
Criteria NCT03926910 10 18 O
: NCT03926910 19 20 O

- NCT03926910 24 25 O
Over NCT03926910 27 31 B-Eq_Comparison
18 NCT03926910 32 34 I-Eq_Comparison
years NCT03926910 35 40 I-Eq_Comparison
old NCT03926910 41 44 B-Age
, NCT03926910 45 46 O

- NCT03926910 50 51 O
Programmed NCT03926910 53 63 B-Eq_Comparison
for NCT03926910 64 67 O
cardiac NCT03926910 68 75 B-Procedure
surgery NCT03926910 76 83 I-Procedure
with NCT03926910 84 88 B-And
the NCT03926910 89 92 O
need NCT03926910 93 97 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03926910 98 101 I-Assertion___Assertion_Type_Value:hypothetical
invasive NCT03926910 102 110 B-Procedure
hemodynamic NCT03926910 111 122 I-Procedure
monitoring NCT03926910 123 133 I-Procedure
( NCT03926910 134 135 O
pulmonary NCT03926910 136 145 B-Procedure
artery NCT03926910 146 152 I-Procedure
catheter NCT03926910 153 161 I-Procedure
) NCT03926910 162 163 O
according NCT03926910 164 173 O
to NCT03926910 174 176 O
the NCT03926910 177 180 O
recommendations NCT03926910 181 196 O
: NCT03926910 197 198 O

- NCT03926910 207 208 O
Euroscore NCT03926910 210 219 O
with NCT03926910 220 224 O
predicted NCT03926910 225 234 B-Observation
mortality NCT03926910 235 244 I-Observation
> NCT03926910 245 246 B-Eq_Comparison
10 NCT03926910 247 249 I-Eq_Comparison
% NCT03926910 250 251 I-Eq_Comparison

- NCT03926910 260 261 O
Left NCT03926910 263 267 B-Observation
ventricular NCT03926910 268 279 I-Observation
ejection NCT03926910 280 288 I-Observation
fraction NCT03926910 289 297 I-Observation
( NCT03926910 298 299 O
LVEF NCT03926910 300 304 B-Observation
) NCT03926910 305 306 O
< NCT03926910 307 308 B-Eq_Comparison
40 NCT03926910 309 311 I-Eq_Comparison
% NCT03926910 312 313 I-Eq_Comparison

- NCT03926910 322 323 O
Left NCT03926910 325 329 B-Observation
ventricular NCT03926910 330 341 I-Observation
ejection NCT03926910 342 350 I-Observation
fraction NCT03926910 351 359 I-Observation
( NCT03926910 360 361 O
LVEF NCT03926910 362 366 B-Observation
) NCT03926910 367 368 O
< NCT03926910 369 370 B-Eq_Comparison
50 NCT03926910 371 373 I-Eq_Comparison
% NCT03926910 374 375 I-Eq_Comparison
for NCT03926910 376 379 B-And
mitral NCT03926910 380 386 B-Condition
insufficiency NCT03926910 387 400 I-Condition

- NCT03926910 408 409 O
pulmonary NCT03926910 411 420 B-Condition
artery NCT03926910 421 427 I-Condition
hypertension NCT03926910 428 440 I-Condition
( NCT03926910 441 442 O
PAH NCT03926910 443 446 B-Condition
) NCT03926910 447 448 O
> NCT03926910 449 450 B-Eq_Comparison
50 NCT03926910 451 453 I-Eq_Comparison
mmHg NCT03926910 454 458 I-Eq_Comparison

- NCT03926910 466 467 O
Tricuspid NCT03926910 469 478 B-Condition
insufficiency NCT03926910 479 492 I-Condition
> NCT03926910 493 494 B-Eq_Comparison
3.4 NCT03926910 495 498 I-Eq_Comparison
m NCT03926910 499 500 I-Eq_Comparison
/ NCT03926910 501 502 I-Eq_Comparison
s NCT03926910 503 504 I-Eq_Comparison

- NCT03926910 512 513 O
Tricuspid NCT03926910 515 524 B-Observation
annular NCT03926910 525 532 I-Observation
plane NCT03926910 533 538 I-Observation
systolic NCT03926910 539 547 I-Observation
excursion NCT03926910 548 557 I-Observation
( NCT03926910 558 559 O
TAPSE NCT03926910 560 565 B-Observation
) NCT03926910 566 567 O
< NCT03926910 568 569 B-Eq_Comparison
16 NCT03926910 570 572 I-Eq_Comparison
mm NCT03926910 573 575 I-Eq_Comparison

- NCT03926910 583 584 O
Dilatation NCT03926910 586 596 B-Condition
of NCT03926910 597 599 I-Condition
the NCT03926910 600 603 I-Condition
inferior NCT03926910 604 612 I-Condition
vena NCT03926910 613 617 I-Condition
cava NCT03926910 618 622 I-Condition
under NCT03926910 623 628 I-Condition
respiratory NCT03926910 629 640 I-Condition
collapse NCT03926910 641 649 I-Condition

- NCT03926910 652 653 O
Sinus NCT03926910 655 660 B-Condition
rhythm NCT03926910 661 667 I-Condition
in NCT03926910 668 670 O
immediate NCT03926910 671 680 O
post NCT03926910 681 685 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03926910 686 695 B-Procedure
period NCT03926910 696 702 O
, NCT03926910 703 704 O

- NCT03926910 708 709 O
Sedated NCT03926910 711 718 B-Procedure
with NCT03926910 719 723 O
mechanical NCT03926910 724 734 B-Procedure
ventilation NCT03926910 735 746 I-Procedure
, NCT03926910 747 748 O

- NCT03926910 752 753 O
Having NCT03926910 755 761 O
given NCT03926910 762 767 O
their NCT03926910 768 773 O
written NCT03926910 774 781 O
participation NCT03926910 782 795 O
consent NCT03926910 796 803 O
in NCT03926910 804 806 O
accordance NCT03926910 807 817 O
with NCT03926910 818 822 O
the NCT03926910 823 826 O
regulations NCT03926910 827 838 O
, NCT03926910 839 840 O

- NCT03926910 844 845 O
Benefiting NCT03926910 847 857 O
from NCT03926910 858 862 O
a NCT03926910 863 864 O
social NCT03926910 865 871 O
security NCT03926910 872 880 O

Exclusion NCT03926910 881 890 O
Criteria NCT03926910 891 899 O
: NCT03926910 900 901 O

- NCT03926910 905 906 O
Pregnant NCT03926910 908 916 B-Condition
or NCT03926910 917 919 B-Or
lactating NCT03926910 920 929 B-Condition
women NCT03926910 930 935 O
, NCT03926910 936 937 O

- NCT03926910 941 942 O
Patient NCT03926910 944 951 O
under NCT03926910 952 957 B-Observation
guardianship NCT03926910 958 970 I-Observation
, NCT03926910 971 972 O
Under NCT03926910 973 978 O
curatorship NCT03926910 979 990 O
or NCT03926910 991 993 O
court NCT03926910 994 999 O
of NCT03926910 1000 1002 O
justice NCT03926910 1003 1010 O
, NCT03926910 1011 1012 O

- NCT03926910 1016 1017 O
Discomfort NCT03926910 1019 1029 B-Condition
to NCT03926910 1030 1032 I-Condition
communication NCT03926910 1033 1046 I-Condition
or NCT03926910 1047 1049 B-Or
neuropsychic NCT03926910 1050 1062 B-Condition
disorders NCT03926910 1063 1072 I-Condition
, NCT03926910 1073 1074 O
Inability NCT03926910 1075 1084 B-Negation
to NCT03926910 1085 1087 O
understand NCT03926910 1088 1098 O
, NCT03926910 1099 1100 O
to NCT03926910 1101 1103 O
read NCT03926910 1104 1108 O
or NCT03926910 1109 1111 O
to NCT03926910 1112 1114 O
write NCT03926910 1115 1120 O
the NCT03926910 1121 1124 O
French NCT03926910 1125 1131 O
language NCT03926910 1132 1140 O
, NCT03926910 1141 1142 O

- NCT03926910 1146 1147 O
Patients NCT03926910 1149 1157 O
for NCT03926910 1158 1161 O
whom NCT03926910 1162 1166 O
a NCT03926910 1167 1168 O
fluids NCT03926910 1169 1175 B-Condition
overload NCT03926910 1176 1184 I-Condition
seems NCT03926910 1185 1190 B-Assertion___Assertion_Type_Value:hypothetical
obvious NCT03926910 1191 1198 O
to NCT03926910 1199 1201 O
the NCT03926910 1202 1205 O
intensivist NCT03926910 1206 1217 O
and NCT03926910 1218 1221 B-And
for NCT03926910 1222 1225 O
whom NCT03926910 1226 1230 O
a NCT03926910 1231 1232 O
crystalloids NCT03926910 1233 1245 B-Procedure
filling NCT03926910 1246 1253 I-Procedure
would NCT03926910 1254 1259 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03926910 1260 1262 I-Assertion___Assertion_Type_Value:hypothetical
contraindicated NCT03926910 1263 1278 B-Contraindication
, NCT03926910 1279 1280 O

- NCT03926910 1284 1285 O
Patients NCT03926910 1287 1295 O
for NCT03926910 1296 1299 O
whom NCT03926910 1300 1304 O
respiratory NCT03926910 1305 1316 O
changes NCT03926910 1317 1324 O
in NCT03926910 1325 1327 O
pulse NCT03926910 1328 1333 B-Observation
pressure NCT03926910 1334 1342 I-Observation
( NCT03926910 1343 1344 O
ΔPP NCT03926910 1345 1348 B-Observation
) NCT03926910 1349 1350 O
measurement NCT03926910 1351 1362 O
is NCT03926910 1363 1365 O
not NCT03926910 1366 1369 B-Negation
validated NCT03926910 1370 1379 B-Assertion___Assertion_Type_Value:hypothetical
: NCT03926910 1380 1381 O
patients NCT03926910 1382 1390 O
with NCT03926910 1391 1395 O
spontaneous NCT03926910 1396 1407 B-Condition
ventilation NCT03926910 1408 1419 I-Condition
, NCT03926910 1420 1421 O
atrial NCT03926910 1422 1428 B-Condition
fibrillation NCT03926910 1429 1441 I-Condition
, NCT03926910 1442 1443 O
non NCT03926910 1444 1447 B-Condition
- NCT03926910 1448 1449 I-Condition
sedated NCT03926910 1450 1457 I-Condition

Inclusion NCT03866824 0 9 O
Criteria NCT03866824 10 18 O
: NCT03866824 19 20 O

Men NCT03866824 22 25 O
and NCT03866824 26 29 B-Or
women NCT03866824 30 35 O
aged NCT03866824 36 40 B-Age
20 NCT03866824 41 43 B-Eq_Comparison
to NCT03866824 44 46 I-Eq_Comparison
80 NCT03866824 47 49 I-Eq_Comparison

- NCT03866824 53 54 O
MDD NCT03866824 56 59 B-Condition
diagnosis NCT03866824 60 69 O
objected NCT03866824 70 78 O
to NCT03866824 79 81 O
MRI NCT03866824 82 85 B-Procedure
( NCT03866824 86 87 O
grade NCT03866824 88 93 B-Eq_Comparison
II NCT03866824 94 96 I-Eq_Comparison
/ NCT03866824 97 98 I-Eq_Comparison
III NCT03866824 99 102 I-Eq_Comparison
) NCT03866824 103 104 O

- NCT03866824 108 109 O
Joint NCT03866824 111 116 B-Modifier
pain NCT03866824 117 121 B-Condition
for NCT03866824 122 125 O
more NCT03866824 126 130 B-Eq_Comparison
than NCT03866824 131 135 I-Eq_Comparison
3 NCT03866824 136 137 I-Eq_Comparison
month NCT03866824 138 143 I-Eq_Comparison

- NCT03866824 146 147 O
Absence NCT03866824 149 156 B-Negation
of NCT03866824 157 159 O
bone NCT03866824 160 164 B-Modifier
lesion NCT03866824 165 171 B-Condition
or NCT03866824 172 174 B-Or
moderate NCT03866824 175 183 O
knee NCT03866824 184 188 B-Modifier
osteoarthritis NCT03866824 189 203 B-Condition
stage NCT03866824 204 209 B-Eq_Comparison
< NCT03866824 210 211 I-Eq_Comparison
2 NCT03866824 212 213 I-Eq_Comparison
on NCT03866824 214 216 O
the NCT03866824 217 220 O
Kellgren NCT03866824 221 229 B-Observation
Laurence NCT03866824 230 238 I-Observation
scale NCT03866824 239 244 I-Observation
( NCT03866824 245 246 O
objectified NCT03866824 247 258 O
on NCT03866824 259 261 O
radiography NCT03866824 262 273 B-Procedure
in NCT03866824 274 276 O
schuss NCT03866824 277 283 B-Modifier
) NCT03866824 284 285 O
in NCT03866824 286 288 O
the NCT03866824 289 292 O
6 NCT03866824 293 294 B-Eq_Comparison
months NCT03866824 295 301 I-Eq_Comparison
prior NCT03866824 302 307 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866824 308 310 I-Temporal_Connection___Temporal_Connection_Type_Value:before
inclusion NCT03866824 311 320 B-Study

- NCT03866824 323 324 O
Axial NCT03866824 326 331 B-Observation
deformity NCT03866824 332 341 I-Observation
of NCT03866824 342 344 O
the NCT03866824 345 348 O
lower NCT03866824 349 354 B-Modifier
limbs NCT03866824 355 360 I-Modifier
less NCT03866824 361 365 B-Eq_Comparison
than NCT03866824 366 370 I-Eq_Comparison
or NCT03866824 371 373 I-Eq_Comparison
equal NCT03866824 374 379 I-Eq_Comparison
to NCT03866824 380 382 I-Eq_Comparison
5 NCT03866824 383 384 I-Eq_Comparison
° NCT03866824 385 386 I-Eq_Comparison

- NCT03866824 389 390 O
Signed NCT03866824 392 398 O
consent NCT03866824 399 406 O
signed NCT03866824 407 413 O
by NCT03866824 414 416 O
the NCT03866824 417 420 O
patient NCT03866824 421 428 O

- NCT03866824 431 432 O
Ability NCT03866824 434 441 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03866824 442 444 I-Assertion___Assertion_Type_Value:hypothetical
perform NCT03866824 445 452 O
procedures NCT03866824 453 463 B-Procedure
as NCT03866824 464 466 O
part NCT03866824 467 471 O
of NCT03866824 472 474 O
the NCT03866824 475 478 O
follow NCT03866824 479 485 B-Encounter
- NCT03866824 486 487 I-Encounter
up NCT03866824 488 490 I-Encounter
( NCT03866824 491 492 O
walk NCT03866824 493 497 B-Observation
50 NCT03866824 498 500 B-Eq_Comparison
steps NCT03866824 501 506 I-Eq_Comparison
on NCT03866824 507 509 O
a NCT03866824 510 511 O
flat NCT03866824 512 516 B-Modifier
surface NCT03866824 517 524 I-Modifier
and NCT03866824 525 528 B-Or
up NCT03866824 529 531 B-Modifier
/ NCT03866824 532 533 B-Or
down NCT03866824 534 538 B-Modifier
stairs NCT03866824 539 545 I-Modifier
) NCT03866824 546 547 O
. NCT03866824 548 549 O

- NCT03866824 553 554 O
Be NCT03866824 556 558 O
affiliated NCT03866824 559 569 O
to NCT03866824 570 572 O
a NCT03866824 573 574 O
health NCT03866824 575 581 O
insurance NCT03866824 582 591 O
scheme NCT03866824 592 598 O

Exclusion NCT03866824 599 608 O
Criteria NCT03866824 609 617 O
: NCT03866824 618 619 O

- NCT03866824 623 624 O
Axial NCT03866824 626 631 B-Observation
deformity NCT03866824 632 641 I-Observation
> NCT03866824 642 643 B-Eq_Comparison
5 NCT03866824 644 645 I-Eq_Comparison
° NCT03866824 646 647 I-Eq_Comparison

- NCT03866824 650 651 O
Ligament NCT03866824 653 661 B-Condition
instability NCT03866824 662 673 O

- NCT03866824 676 677 O
Major NCT03866824 679 684 O
injuries NCT03866824 685 693 B-Condition
or NCT03866824 694 696 B-Or
surgery NCT03866824 697 704 B-Procedure
of NCT03866824 705 707 O
the NCT03866824 708 711 O
target NCT03866824 712 718 B-Modifier
knee NCT03866824 719 723 I-Modifier
or NCT03866824 724 726 B-Or
lateral NCT03866824 727 734 B-Modifier
contralateral NCT03866824 735 748 I-Modifier
knee NCT03866824 749 753 I-Modifier
in NCT03866824 754 756 O
the NCT03866824 757 760 O
12 NCT03866824 761 763 B-Eq_Comparison
months NCT03866824 764 770 I-Eq_Comparison
preceding NCT03866824 771 780 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03866824 781 784 O
inclusion NCT03866824 785 794 B-Study
visit NCT03866824 795 800 O

- NCT03866824 803 804 O
Ligament NCT03866824 806 814 B-Procedure
reconstruction NCT03866824 815 829 I-Procedure
in NCT03866824 830 832 O
the NCT03866824 833 836 O
12 NCT03866824 837 839 B-Eq_Comparison
months NCT03866824 840 846 I-Eq_Comparison
prior NCT03866824 847 852 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866824 853 855 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03866824 856 859 O
inclusion NCT03866824 860 869 B-Study
visit NCT03866824 870 875 O

- NCT03866824 878 879 O
Need NCT03866824 881 885 O
a NCT03866824 886 887 O
cane NCT03866824 888 892 B-Modifier
or NCT03866824 893 895 B-Or
assistance NCT03866824 896 906 B-Modifier
to NCT03866824 907 909 O
move NCT03866824 910 914 B-Condition

- NCT03866824 917 918 O
BMI NCT03866824 920 923 B-Observation
> NCT03866824 924 925 B-Eq_Comparison
35 NCT03866824 926 928 I-Eq_Comparison

- NCT03866824 932 933 O
Thrombocytopenia NCT03866824 935 951 B-Condition
< NCT03866824 952 953 B-Eq_Comparison
150 NCT03866824 954 957 I-Eq_Comparison
G NCT03866824 958 959 I-Eq_Comparison
/ NCT03866824 960 961 I-Eq_Comparison
L NCT03866824 962 963 I-Eq_Comparison

- NCT03866824 966 967 O
Thrombocytosis NCT03866824 969 983 B-Condition
> NCT03866824 984 985 B-Eq_Comparison
450 NCT03866824 986 989 I-Eq_Comparison
G NCT03866824 990 991 I-Eq_Comparison
/ NCT03866824 992 993 I-Eq_Comparison
L NCT03866824 994 995 I-Eq_Comparison

Inclusion NCT03863561 0 9 O
Criteria NCT03863561 10 18 O
: NCT03863561 19 20 O

- NCT03863561 24 25 O
Diagnosis NCT03863561 27 36 O
of NCT03863561 37 39 O
type NCT03863561 40 44 B-Modifier
1 NCT03863561 45 46 I-Modifier
or NCT03863561 47 49 B-Or
type NCT03863561 50 54 B-Modifier
2 NCT03863561 55 56 I-Modifier
diabetes NCT03863561 57 65 B-Condition

- NCT03863561 68 69 O
Age NCT03863561 71 74 B-Age
≥ NCT03863561 75 76 B-Eq_Comparison
18 NCT03863561 77 79 I-Eq_Comparison
years NCT03863561 80 85 I-Eq_Comparison

- NCT03863561 88 89 O
Ability NCT03863561 91 98 O
to NCT03863561 99 101 O
read NCT03863561 102 106 O
English NCT03863561 107 114 O

- NCT03863561 117 118 O
Duration NCT03863561 120 128 O
of NCT03863561 129 131 O
diabetes NCT03863561 132 140 B-Condition
≥ NCT03863561 141 142 B-Eq_Comparison
6 NCT03863561 143 144 I-Eq_Comparison
months NCT03863561 145 151 I-Eq_Comparison
( NCT03863561 152 153 O
DSME NCT03863561 154 158 O
cohort NCT03863561 159 165 O
only NCT03863561 166 170 O
) NCT03863561 171 172 O

- NCT03863561 176 177 O
A NCT03863561 179 180 B-Observation
1C NCT03863561 181 183 I-Observation
≥ NCT03863561 184 185 B-Eq_Comparison
8.0 NCT03863561 186 189 I-Eq_Comparison
% NCT03863561 190 191 I-Eq_Comparison
( NCT03863561 192 193 O
DSME NCT03863561 194 198 O
cohort NCT03863561 199 205 O
only NCT03863561 206 210 O
) NCT03863561 211 212 O

Exclusion NCT03863561 214 223 O
Criteria NCT03863561 224 232 O
: NCT03863561 233 234 O

- NCT03863561 237 238 O

Inclusion NCT03864367 0 9 O
Criteria NCT03864367 10 18 O
: NCT03864367 19 20 O

- NCT03864367 24 25 O
55 NCT03864367 27 29 B-Eq_Comparison
and NCT03864367 30 33 I-Eq_Comparison
older NCT03864367 34 39 I-Eq_Comparison

- NCT03864367 42 43 O
distal NCT03864367 45 51 B-Modifier
femur NCT03864367 52 57 I-Modifier
fracture NCT03864367 58 66 B-Condition

- NCT03864367 69 70 O
able NCT03864367 72 76 B-Condition
to NCT03864367 77 79 I-Condition
walk NCT03864367 80 84 I-Condition
prior NCT03864367 85 90 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03864367 91 93 I-Temporal_Connection___Temporal_Connection_Type_Value:before
fracture NCT03864367 94 102 B-Condition

Exclusion NCT03864367 103 112 O
Criteria NCT03864367 113 121 O
: NCT03864367 122 123 O

- NCT03864367 127 128 O
patients NCT03864367 130 138 O
unable NCT03864367 139 145 B-Condition
to NCT03864367 146 148 I-Condition
walk NCT03864367 149 153 I-Condition
without NCT03864367 154 161 B-Negation
any NCT03864367 162 165 O
assistive NCT03864367 166 175 B-Procedure
devices NCT03864367 176 183 I-Procedure
post NCT03864367 184 188 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03864367 189 190 O
injury NCT03864367 191 197 B-Condition

- NCT03864367 200 201 O
patients NCT03864367 203 211 O
too NCT03864367 212 215 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
medically NCT03864367 216 225 B-Condition
unstable NCT03864367 226 234 O
to NCT03864367 235 237 O
participate NCT03864367 238 249 O
in NCT03864367 250 252 O
physical NCT03864367 253 261 B-Procedure
therapy NCT03864367 262 269 I-Procedure

Inclusion NCT03863639 0 9 O
Criteria NCT03863639 10 18 O
: NCT03863639 19 20 O
Severe NCT03863639 21 27 O
Pre NCT03863639 28 31 B-Condition
- NCT03863639 32 33 I-Condition
Eclampsia NCT03863639 34 43 I-Condition
defined NCT03863639 44 51 O
by NCT03863639 52 54 O

- NCT03863639 57 58 O
Symptoms NCT03863639 60 68 B-Assertion___Assertion_Type_Value:possible
of NCT03863639 69 71 O
central NCT03863639 72 79 B-Condition
nervous NCT03863639 80 87 I-Condition
system NCT03863639 88 94 I-Condition
dysfunction NCT03863639 95 106 I-Condition
( NCT03863639 107 108 O
New NCT03863639 109 112 B-Eq_Comparison
onset NCT03863639 113 118 I-Eq_Comparison
cerebral NCT03863639 119 127 B-Modifier
or NCT03863639 128 130 B-Or
visual NCT03863639 131 137 B-Modifier
disturbance NCT03863639 138 149 B-Condition
, NCT03863639 150 151 O
such NCT03863639 152 156 O
as NCT03863639 157 159 O
: NCT03863639 160 161 O
Photopsia NCT03863639 162 171 B-Condition
, NCT03863639 172 173 O
scotomata NCT03863639 174 183 B-Condition
, NCT03863639 184 185 O
cortical NCT03863639 186 194 B-Condition
blindness NCT03863639 195 204 I-Condition
, NCT03863639 205 206 O
retinal NCT03863639 207 214 B-Condition
vasospasm NCT03863639 215 224 I-Condition
) NCT03863639 225 226 O

- NCT03863639 230 231 O
Severe NCT03863639 233 239 O
headache NCT03863639 240 248 B-Condition
( NCT03863639 249 250 O
ie NCT03863639 251 253 O
, NCT03863639 254 255 O
incapacitating NCT03863639 256 270 B-Condition
, NCT03863639 271 272 O
" NCT03863639 273 274 O
the NCT03863639 274 277 O
worst NCT03863639 278 283 O
headache NCT03863639 284 292 B-Condition
I NCT03863639 293 294 O
've NCT03863639 294 297 O
ever NCT03863639 298 302 O
had NCT03863639 303 306 O
" NCT03863639 306 307 O
) NCT03863639 308 309 O
or NCT03863639 310 312 B-Or
headache NCT03863639 313 321 B-Condition
that NCT03863639 322 326 O
persists NCT03863639 327 335 B-Modifier
and NCT03863639 336 339 B-And
progresses NCT03863639 340 350 B-Modifier
despite NCT03863639 351 358 O
analgesic NCT03863639 359 368 B-Procedure
therapy NCT03863639 369 376 I-Procedure

- NCT03863639 379 380 O
Altered NCT03863639 382 389 B-Condition
mental NCT03863639 390 396 I-Condition
status NCT03863639 397 403 I-Condition

- NCT03863639 406 407 O
Hepatic NCT03863639 409 416 B-Condition
abnormality NCT03863639 417 428 O
( NCT03863639 429 430 O
Severe NCT03863639 431 437 O
persistent NCT03863639 438 448 B-Modifier
right NCT03863639 449 454 I-Modifier
upper NCT03863639 455 460 B-Modifier
quadrant NCT03863639 461 469 I-Modifier
or NCT03863639 470 472 B-Or
epigastric NCT03863639 473 483 B-Modifier
pain NCT03863639 484 488 B-Condition
unresponsive NCT03863639 489 501 O
to NCT03863639 502 504 O
medication NCT03863639 505 515 B-Drug
and NCT03863639 516 519 B-And
not NCT03863639 520 523 B-Negation
accounted NCT03863639 524 533 O
for NCT03863639 534 537 O
by NCT03863639 538 540 O
an NCT03863639 541 543 O
alternative NCT03863639 544 555 B-Other
diagnosis NCT03863639 556 565 B-Condition
or NCT03863639 566 568 B-Or
serum NCT03863639 569 574 B-Observation
transaminase NCT03863639 575 587 I-Observation
concentration NCT03863639 588 601 I-Observation
≥ NCT03863639 602 603 B-Eq_Comparison
twice NCT03863639 604 609 I-Eq_Comparison
normal NCT03863639 610 616 I-Eq_Comparison
, NCT03863639 617 618 O
or NCT03863639 619 621 O
both NCT03863639 622 626 O
) NCT03863639 627 628 O

- NCT03863639 632 633 O
Severe NCT03863639 635 641 O
blood NCT03863639 642 647 B-Observation
pressure NCT03863639 648 656 I-Observation
elevation NCT03863639 657 666 O
( NCT03863639 667 668 O
Systolic NCT03863639 669 677 B-Observation
blood NCT03863639 678 683 I-Observation
pressure NCT03863639 684 692 I-Observation
≥ NCT03863639 693 694 B-Eq_Comparison
160 NCT03863639 695 698 I-Eq_Comparison
mmHg NCT03863639 699 703 I-Eq_Comparison
or NCT03863639 704 706 B-Or
diastolic NCT03863639 707 716 B-Observation
blood NCT03863639 717 722 I-Observation
pressure NCT03863639 723 731 I-Observation
≥ NCT03863639 732 733 B-Eq_Comparison
110 NCT03863639 734 737 I-Eq_Comparison
mmHg NCT03863639 738 742 I-Eq_Comparison
on NCT03863639 743 745 O
two NCT03863639 746 749 B-Eq_Comparison
occasions NCT03863639 750 759 I-Eq_Comparison
at NCT03863639 760 762 B-Eq_Comparison
least NCT03863639 763 768 I-Eq_Comparison
four NCT03863639 769 773 I-Eq_Comparison
hours NCT03863639 774 779 I-Eq_Comparison
apart NCT03863639 780 785 I-Eq_Comparison
while NCT03863639 786 791 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863639 792 795 I-Temporal_Connection___Temporal_Connection_Type_Value:during
patient NCT03863639 796 803 I-Temporal_Connection___Temporal_Connection_Type_Value:during
is NCT03863639 804 806 I-Temporal_Connection___Temporal_Connection_Type_Value:during
on NCT03863639 807 809 I-Temporal_Connection___Temporal_Connection_Type_Value:during
bedrest NCT03863639 810 817 B-Encounter
( NCT03863639 818 819 O
unless NCT03863639 820 826 B-Exception
the NCT03863639 827 830 O
patient NCT03863639 831 838 O
is NCT03863639 839 841 O
on NCT03863639 842 844 O
antihypertensive NCT03863639 845 861 B-Procedure
therapy NCT03863639 862 869 I-Procedure
) NCT03863639 870 871 O
) NCT03863639 872 873 O

- NCT03863639 877 878 O
Thrombocytopenia NCT03863639 880 896 B-Condition
( NCT03863639 897 898 O
< NCT03863639 899 900 B-Eq_Comparison
100 NCT03863639 901 904 I-Eq_Comparison
, NCT03863639 905 906 I-Eq_Comparison
000 NCT03863639 907 910 I-Eq_Comparison
platelets NCT03863639 911 920 I-Eq_Comparison
/ NCT03863639 921 922 I-Eq_Comparison
microL NCT03863639 923 929 I-Eq_Comparison
) NCT03863639 930 931 O

- NCT03863639 935 936 O
Renal NCT03863639 938 943 B-Condition
abnormality NCT03863639 944 955 O
( NCT03863639 956 957 O
Progressive NCT03863639 958 969 B-Condition
renal NCT03863639 970 975 I-Condition
insufficiency NCT03863639 976 989 I-Condition
( NCT03863639 990 991 O
serum NCT03863639 992 997 B-Observation
creatinine NCT03863639 998 1008 I-Observation
> NCT03863639 1009 1010 B-Eq_Comparison
1.1 NCT03863639 1011 1014 I-Eq_Comparison
mg NCT03863639 1015 1017 I-Eq_Comparison
/ NCT03863639 1018 1019 I-Eq_Comparison
dL NCT03863639 1020 1022 I-Eq_Comparison
or NCT03863639 1023 1025 B-Or
doubling NCT03863639 1026 1034 B-Eq_Comparison
of NCT03863639 1035 1037 O
serum NCT03863639 1038 1043 B-Observation
creatinine NCT03863639 1044 1054 I-Observation
concentration NCT03863639 1055 1068 I-Observation
in NCT03863639 1069 1071 B-And
the NCT03863639 1072 1075 I-And
absence NCT03863639 1076 1083 B-Negation
of NCT03863639 1084 1086 O
other NCT03863639 1087 1092 B-Other
renal NCT03863639 1093 1098 B-Condition
disease NCT03863639 1099 1106 I-Condition
) NCT03863639 1107 1108 O
) NCT03863639 1109 1110 O

- NCT03863639 1114 1115 O
Pulmonary NCT03863639 1117 1126 B-Condition
edema NCT03863639 1127 1132 I-Condition

15 NCT03863639 1138 1140 O
English NCT03863639 1141 1148 O
- NCT03863639 1149 1150 O
speaking NCT03863639 1151 1159 O
pregnant NCT03863639 1160 1168 B-Condition
controls NCT03863639 1169 1177 O
with NCT03863639 1178 1182 B-And
uncomplicated NCT03863639 1183 1196 B-Modifier
pregnancy NCT03863639 1197 1206 B-Condition
matched NCT03863639 1207 1214 O
by NCT03863639 1215 1217 O
age NCT03863639 1218 1221 O
and NCT03863639 1222 1225 O
gestational NCT03863639 1226 1237 B-Observation
age NCT03863639 1238 1241 I-Observation
will NCT03863639 1242 1246 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03863639 1247 1249 I-Assertion___Assertion_Type_Value:hypothetical
enrolled NCT03863639 1250 1258 B-Study
from NCT03863639 1259 1263 O
the NCT03863639 1264 1267 O
antenatal NCT03863639 1268 1277 O
clinic NCT03863639 1278 1284 O
or NCT03863639 1285 1287 B-Or
the NCT03863639 1288 1291 O
labor NCT03863639 1292 1297 O
ward NCT03863639 1298 1302 O
. NCT03863639 1303 1304 O

Exclusion NCT03863639 1306 1315 O
Criteria NCT03863639 1316 1324 O
: NCT03863639 1325 1326 O

- NCT03863639 1330 1331 O
History NCT03863639 1333 1340 B-Eq_Comparison
of NCT03863639 1341 1343 O
symptomatic NCT03863639 1344 1355 B-Assertion___Assertion_Type_Value:possible
cerebrovascular NCT03863639 1356 1371 B-Condition
disease NCT03863639 1372 1379 I-Condition
with NCT03863639 1380 1384 B-And
substantial NCT03863639 1385 1396 O
residual NCT03863639 1397 1405 B-Condition
deficit NCT03863639 1406 1413 I-Condition

- NCT03863639 1416 1417 O
History NCT03863639 1419 1426 B-Eq_Comparison
of NCT03863639 1427 1429 O
alcoholism NCT03863639 1430 1440 B-Condition

- NCT03863639 1443 1444 O
History NCT03863639 1446 1453 B-Eq_Comparison
of NCT03863639 1454 1456 O
psychiatric NCT03863639 1457 1468 B-Condition
illness NCT03863639 1469 1476 I-Condition

- NCT03863639 1479 1480 O
History NCT03863639 1482 1489 B-Eq_Comparison
of NCT03863639 1490 1492 O
claustrophobia NCT03863639 1493 1507 B-Condition

- NCT03863639 1510 1511 O
Renal NCT03863639 1513 1518 B-Condition
failure NCT03863639 1519 1526 I-Condition
( NCT03863639 1527 1528 O
creatinine NCT03863639 1529 1539 B-Observation
> NCT03863639 1540 1541 B-Eq_Comparison
2.0 NCT03863639 1542 1545 I-Eq_Comparison
mg NCT03863639 1546 1548 I-Eq_Comparison
/ NCT03863639 1549 1550 I-Eq_Comparison
dl NCT03863639 1551 1553 I-Eq_Comparison
) NCT03863639 1554 1555 O

- NCT03863639 1559 1560 O
Patients NCT03863639 1562 1570 O
with NCT03863639 1571 1575 O
less NCT03863639 1576 1580 B-Eq_Comparison
than NCT03863639 1581 1585 I-Eq_Comparison
a NCT03863639 1586 1587 I-Eq_Comparison
7 NCT03863639 1588 1589 I-Eq_Comparison
th NCT03863639 1590 1592 I-Eq_Comparison
grade NCT03863639 1593 1598 I-Eq_Comparison
education NCT03863639 1599 1608 B-Observation
or NCT03863639 1609 1611 B-Or
unable NCT03863639 1612 1618 B-Condition
to NCT03863639 1619 1621 I-Condition
read NCT03863639 1622 1626 I-Condition
and NCT03863639 1627 1630 O
thus NCT03863639 1631 1635 O
unable NCT03863639 1636 1642 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
complete NCT03863639 1643 1651 O
the NCT03863639 1652 1655 O
neuropsychological NCT03863639 1656 1674 B-Procedure
testing NCT03863639 1675 1682 I-Procedure

- NCT03863639 1685 1686 O
Patients NCT03863639 1688 1696 O
with NCT03863639 1697 1701 O
bodily NCT03863639 1702 1708 B-Procedure
implants NCT03863639 1709 1717 I-Procedure
unsafe NCT03863639 1718 1724 B-Contraindication
for NCT03863639 1725 1728 O
MRI NCT03863639 1729 1732 B-Procedure
use NCT03863639 1733 1736 O

Inclusion NCT03868631 0 9 O
Criteria NCT03868631 10 18 O
: NCT03868631 19 20 O

- NCT03868631 24 25 O
non NCT03868631 27 30 B-Negation
- NCT03868631 31 32 O
smoking NCT03868631 33 40 B-Condition

- NCT03868631 43 44 O
body NCT03868631 46 50 B-Observation
mass NCT03868631 51 55 I-Observation
index NCT03868631 56 61 I-Observation
( NCT03868631 62 63 O
BMI NCT03868631 64 67 B-Observation
) NCT03868631 68 69 O
18.5 NCT03868631 70 74 B-Eq_Comparison
- NCT03868631 75 76 I-Eq_Comparison
24.9 NCT03868631 77 81 I-Eq_Comparison

- NCT03868631 85 86 O
recreationally NCT03868631 88 102 B-Observation
active NCT03868631 103 109 B-Eq_Comparison

Exclusion NCT03868631 110 119 O
Criteria NCT03868631 120 128 O
: NCT03868631 129 130 O

- NCT03868631 134 135 O
participated NCT03868631 137 149 O
in NCT03868631 150 152 O
structured NCT03868631 153 163 B-Modifier
weight NCT03868631 164 170 B-Observation
training NCT03868631 171 179 I-Observation
during NCT03868631 180 186 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868631 187 190 O
previous NCT03868631 191 199 B-Eq_Comparison
12 NCT03868631 200 202 I-Eq_Comparison
month NCT03868631 203 208 I-Eq_Comparison

- NCT03868631 211 212 O
vegetarian NCT03868631 214 224 B-Condition
or NCT03868631 225 227 B-Or
vegan NCT03868631 228 233 B-Condition

- NCT03868631 236 237 O
presence NCT03868631 239 247 O
of NCT03868631 248 250 O
chronic NCT03868631 251 258 O
disease NCT03868631 259 266 B-Condition

- NCT03868631 269 270 O
pregnant NCT03868631 272 280 B-Condition
, NCT03868631 281 282 O
postpartum NCT03868631 283 293 B-Condition
up NCT03868631 294 296 B-Eq_Comparison
to NCT03868631 297 299 I-Eq_Comparison
six NCT03868631 300 303 I-Eq_Comparison
months NCT03868631 304 310 I-Eq_Comparison
, NCT03868631 311 312 O
lactating NCT03868631 313 322 B-Condition
, NCT03868631 323 324 O
or NCT03868631 325 327 B-Or
intention NCT03868631 328 337 B-Assertion___Assertion_Type_Value:intention
to NCT03868631 338 340 I-Assertion___Assertion_Type_Value:intention
become NCT03868631 341 347 O
pregnant NCT03868631 348 356 B-Condition

- NCT03868631 359 360 O
allergy NCT03868631 362 369 B-Allergy
to NCT03868631 370 372 O
whey NCT03868631 373 377 O
or NCT03868631 378 380 B-Or
soy NCT03868631 381 384 O

- NCT03868631 387 388 O
changes NCT03868631 390 397 O
in NCT03868631 398 400 O
body NCT03868631 401 405 B-Observation
weight NCT03868631 406 412 I-Observation
more NCT03868631 413 417 B-Eq_Comparison
than NCT03868631 418 422 I-Eq_Comparison
10 NCT03868631 423 425 I-Eq_Comparison
pounds NCT03868631 426 432 I-Eq_Comparison
in NCT03868631 433 435 O
the NCT03868631 436 439 O
past NCT03868631 440 444 B-Eq_Comparison
three NCT03868631 445 450 I-Eq_Comparison
months NCT03868631 451 457 I-Eq_Comparison

Inclusion NCT03925961 0 9 O
Criteria NCT03925961 10 18 O
: NCT03925961 19 20 O

- NCT03925961 24 25 O
General NCT03925961 27 34 O
surgical NCT03925961 35 43 O
patients NCT03925961 44 52 O
who NCT03925961 53 56 O
will NCT03925961 57 61 B-Eq_Comparison
undergo NCT03925961 62 69 I-Eq_Comparison
same NCT03925961 70 74 B-Modifier
- NCT03925961 75 76 I-Modifier
day NCT03925961 77 80 I-Modifier
laparoscopic NCT03925961 81 93 B-Procedure
ventral NCT03925961 94 101 I-Procedure
hernia NCT03925961 102 108 I-Procedure
, NCT03925961 109 110 O
inguinal NCT03925961 111 119 B-Procedure
hernia NCT03925961 120 126 I-Procedure
, NCT03925961 127 128 O
and NCT03925961 129 132 B-Or
gallbladder NCT03925961 133 144 B-Procedure
surgery NCT03925961 145 152 I-Procedure
at NCT03925961 153 155 O
Howard NCT03925961 156 162 O
County NCT03925961 163 169 O
General NCT03925961 170 177 O
Hospital NCT03925961 178 186 O
with NCT03925961 187 191 O
the NCT03925961 192 195 O
general NCT03925961 196 203 B-Provider
surgery NCT03925961 204 211 I-Provider
practice NCT03925961 212 220 I-Provider
at NCT03925961 221 223 O
Johns NCT03925961 224 229 O
Hopkins NCT03925961 230 237 O
Community NCT03925961 238 247 O
Physicians NCT03925961 248 258 O
. NCT03925961 259 260 O

Exclusion NCT03925961 262 271 O
Criteria NCT03925961 272 280 O
: NCT03925961 281 282 O

- NCT03925961 286 287 O
Patients NCT03925961 289 297 O
less NCT03925961 298 302 B-Eq_Comparison
than NCT03925961 303 307 I-Eq_Comparison
18 NCT03925961 308 310 I-Eq_Comparison
years NCT03925961 311 316 I-Eq_Comparison
of NCT03925961 317 319 O
age NCT03925961 320 323 B-Age

- NCT03925961 326 327 O
Adults NCT03925961 329 335 O
who NCT03925961 336 339 O
lack NCT03925961 340 344 O
the NCT03925961 345 348 O
capacity NCT03925961 349 357 O
to NCT03925961 358 360 O
consent NCT03925961 361 368 O

- NCT03925961 371 372 O
Pregnant NCT03925961 374 382 B-Condition
women NCT03925961 383 388 O

- NCT03925961 391 392 O
Prisoners NCT03925961 394 403 B-Observation

- NCT03925961 406 407 O
Non NCT03925961 409 412 B-Negation
- NCT03925961 413 414 O
English NCT03925961 415 422 O
speakers NCT03925961 423 431 O
. NCT03925961 432 433 O

Inclusion NCT03923231 0 9 O
Criteria NCT03923231 10 18 O
: NCT03923231 19 20 O

1 NCT03923231 24 25 O
. NCT03923231 25 26 O
Evidence NCT03923231 28 36 O
of NCT03923231 37 39 O
a NCT03923231 40 41 O
personally NCT03923231 42 52 O
signed NCT03923231 53 59 O
and NCT03923231 60 63 O
dated NCT03923231 64 69 O
informed NCT03923231 70 78 O
consent NCT03923231 79 86 O
document NCT03923231 87 95 O
indicating NCT03923231 96 106 O
that NCT03923231 107 111 O
the NCT03923231 112 115 O
participant NCT03923231 116 127 O
( NCT03923231 128 129 O
or NCT03923231 130 132 O
a NCT03923231 133 134 O
legal NCT03923231 135 140 O
representative NCT03923231 141 155 O
) NCT03923231 156 157 O
has NCT03923231 158 161 O
been NCT03923231 162 166 O
informed NCT03923231 167 175 O
of NCT03923231 176 178 O
all NCT03923231 179 182 O
pertinent NCT03923231 183 192 O
aspects NCT03923231 193 200 O
of NCT03923231 201 203 O
the NCT03923231 204 207 O
study NCT03923231 208 213 O
. NCT03923231 214 215 O

2 NCT03923231 219 220 O
. NCT03923231 220 221 O
In NCT03923231 223 225 O
a NCT03923231 226 227 O
child NCT03923231 228 233 O
aged NCT03923231 234 238 B-Age
≥ NCT03923231 239 240 B-Eq_Comparison
7 NCT03923231 241 242 I-Eq_Comparison
years NCT03923231 243 248 I-Eq_Comparison
( NCT03923231 249 250 O
South NCT03923231 251 256 O
Africa NCT03923231 257 263 O
) NCT03923231 264 265 O
or NCT03923231 266 268 B-Or
aged NCT03923231 269 273 B-Age
≥ NCT03923231 274 275 B-Eq_Comparison
8 NCT03923231 276 277 I-Eq_Comparison
years NCT03923231 278 283 I-Eq_Comparison
( NCT03923231 284 285 O
Uganda NCT03923231 286 292 O
) NCT03923231 293 294 O
, NCT03923231 295 296 O
evidence NCT03923231 297 305 O
of NCT03923231 306 308 O
assent NCT03923231 309 315 O
to NCT03923231 316 318 O
participate NCT03923231 319 330 O

3 NCT03923231 333 334 O
. NCT03923231 334 335 O
Participants NCT03923231 337 349 O
who NCT03923231 350 353 O
are NCT03923231 354 357 O
willing NCT03923231 358 365 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03923231 366 369 B-And
able NCT03923231 370 374 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03923231 375 377 O
comply NCT03923231 378 384 O
with NCT03923231 385 389 O
scheduled NCT03923231 390 399 B-Eq_Comparison
visits NCT03923231 400 406 B-Encounter
, NCT03923231 407 408 O
laboratory NCT03923231 409 419 B-Observation
tests NCT03923231 420 425 I-Observation
, NCT03923231 426 427 O
and NCT03923231 428 431 B-And
other NCT03923231 432 437 O
study NCT03923231 438 443 B-Study
procedures NCT03923231 444 454 O
. NCT03923231 455 456 O

4 NCT03923231 460 461 O
. NCT03923231 461 462 O
HIV NCT03923231 464 467 B-Condition
- NCT03923231 468 469 I-Condition
infected NCT03923231 470 478 I-Condition
, NCT03923231 479 480 O
receiving NCT03923231 481 490 B-Eq_Comparison
ATV NCT03923231 491 494 B-Drug
- NCT03923231 495 496 O
based NCT03923231 497 502 O
ART NCT03923231 503 506 B-Procedure
treatment NCT03923231 507 516 I-Procedure
OR NCT03923231 517 519 B-Or
HIV NCT03923231 520 523 B-Condition
- NCT03923231 524 525 I-Condition
infected NCT03923231 526 534 I-Condition
receiving NCT03923231 535 544 B-Eq_Comparison
second NCT03923231 545 551 B-Modifier
- NCT03923231 552 553 I-Modifier
line NCT03923231 554 558 I-Modifier
ART NCT03923231 559 562 B-Procedure
with NCT03923231 563 567 B-And
concurrent NCT03923231 568 578 O
rifamycin NCT03923231 579 588 B-Drug
- NCT03923231 589 590 O
based NCT03923231 591 596 O
TB NCT03923231 597 599 B-Condition
treatment NCT03923231 600 609 B-Procedure

5 NCT03923231 612 613 O
. NCT03923231 613 614 O
Participant NCT03923231 616 627 O
is NCT03923231 628 630 O
within NCT03923231 631 637 O
one NCT03923231 638 641 O
of NCT03923231 642 644 O
the NCT03923231 645 648 O
target NCT03923231 649 655 O
populations NCT03923231 656 667 O
: NCT03923231 668 669 O

1 NCT03923231 678 679 O
. NCT03923231 679 680 O
Pregnant NCT03923231 682 690 B-Condition
( NCT03923231 691 692 O
> NCT03923231 693 694 B-Eq_Comparison
20 NCT03923231 695 697 I-Eq_Comparison
weeks NCT03923231 698 703 I-Eq_Comparison
) NCT03923231 704 705 O

2 NCT03923231 714 715 O
. NCT03923231 715 716 O
Body NCT03923231 718 722 B-Observation
mass NCT03923231 723 727 I-Observation
index NCT03923231 728 733 I-Observation
> NCT03923231 734 735 B-Eq_Comparison
30 NCT03923231 736 738 I-Eq_Comparison
or NCT03923231 739 741 B-Or
< NCT03923231 742 743 B-Eq_Comparison
18.5 NCT03923231 744 748 I-Eq_Comparison
Kg NCT03923231 749 751 I-Eq_Comparison
/ NCT03923231 752 753 I-Eq_Comparison
m NCT03923231 754 755 I-Eq_Comparison
2 NCT03923231 756 757 I-Eq_Comparison

3 NCT03923231 765 766 O
. NCT03923231 766 767 O
Child NCT03923231 769 774 O
or NCT03923231 775 777 B-Or
adolescent NCT03923231 778 788 O
aged NCT03923231 789 793 B-Age
< NCT03923231 794 795 B-Eq_Comparison
18 NCT03923231 796 798 I-Eq_Comparison
years NCT03923231 799 804 I-Eq_Comparison

Exclusion NCT03923231 805 814 O
Criteria NCT03923231 815 823 O
: NCT03923231 824 825 O

1 NCT03923231 829 830 O
. NCT03923231 830 831 O
Medical NCT03923231 833 840 B-Modifier
, NCT03923231 841 842 O
psychiatric NCT03923231 843 854 B-Modifier
or NCT03923231 855 857 B-Or
obstetric NCT03923231 858 867 B-Modifier
condition NCT03923231 868 877 B-Condition
that NCT03923231 878 882 O
might NCT03923231 883 888 O
affect NCT03923231 889 895 O
participation NCT03923231 896 909 O
in NCT03923231 910 912 O
the NCT03923231 913 916 O
stuy NCT03923231 917 921 B-Study
based NCT03923231 922 927 O
on NCT03923231 928 930 O
investigator NCT03923231 931 943 O
judgement NCT03923231 944 953 O

2 NCT03923231 956 957 O
. NCT03923231 957 958 O
Dissent NCT03923231 960 967 O
from NCT03923231 968 972 O
a NCT03923231 973 974 O
minor NCT03923231 975 980 O

3 NCT03923231 983 984 O
. NCT03923231 984 985 O
For NCT03923231 987 990 O
pregnant NCT03923231 991 999 B-Condition
women NCT03923231 1000 1005 O
in NCT03923231 1006 1008 B-And
Uganda NCT03923231 1009 1015 O
, NCT03923231 1016 1017 O
where NCT03923231 1018 1023 B-And
the NCT03923231 1024 1027 O
husband NCT03923231 1028 1035 B-Family_Member___Family_Member_Type:spouse
is NCT03923231 1036 1038 O
reasonably NCT03923231 1039 1049 O
involved NCT03923231 1050 1058 O
, NCT03923231 1059 1060 O
paternal NCT03923231 1061 1069 O
objection NCT03923231 1070 1079 O

Inclusion NCT03868267 0 9 O
Criteria NCT03868267 10 18 O
: NCT03868267 19 20 O

- NCT03868267 24 25 O
adult NCT03868267 27 32 O
patients NCT03868267 33 41 O
( NCT03868267 42 43 O
≥ NCT03868267 44 45 B-Eq_Comparison
18 NCT03868267 46 48 I-Eq_Comparison
years NCT03868267 49 54 I-Eq_Comparison
of NCT03868267 55 57 O
age NCT03868267 58 61 B-Age
) NCT03868267 62 63 O
who NCT03868267 64 67 B-And
are NCT03868267 68 71 O
undergoing NCT03868267 72 82 B-Eq_Comparison
esophago NCT03868267 83 91 B-Procedure
- NCT03868267 92 93 I-Procedure
gastro NCT03868267 94 100 I-Procedure
duodenoscopy NCT03868267 101 113 I-Procedure
( NCT03868267 114 115 O
EGD NCT03868267 116 119 B-Procedure
) NCT03868267 120 121 O
for NCT03868267 122 125 O
any NCT03868267 126 129 O
reason NCT03868267 130 136 O
and NCT03868267 137 140 B-And
are NCT03868267 141 144 O
consenting NCT03868267 145 155 O
to NCT03868267 156 158 O
be NCT03868267 159 161 O
enrolled NCT03868267 162 170 O
in NCT03868267 171 173 O
the NCT03868267 174 177 O
study NCT03868267 178 183 B-Study
during NCT03868267 184 190 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868267 191 194 O
study NCT03868267 195 200 B-Study
period NCT03868267 201 207 O
. NCT03868267 208 209 O

Exclusion NCT03868267 211 220 O
Criteria NCT03868267 221 229 O
: NCT03868267 230 231 O

- NCT03868267 235 236 O
the NCT03868267 238 241 O
patients NCT03868267 242 250 O
who NCT03868267 251 254 O
can NCT03868267 255 258 B-Negation
not NCT03868267 258 261 I-Negation
speak NCT03868267 262 267 O
English NCT03868267 268 275 O
in NCT03868267 276 278 O
Canada NCT03868267 279 285 O
, NCT03868267 286 287 O
who NCT03868267 288 291 B-And
can NCT03868267 292 295 B-Negation
not NCT03868267 295 298 I-Negation
speak NCT03868267 299 304 O
Japanese NCT03868267 305 313 O
in NCT03868267 314 316 O
Japan NCT03868267 317 322 O
, NCT03868267 323 324 O
and NCT03868267 325 328 B-Or
can NCT03868267 329 332 B-Negation
not NCT03868267 332 335 I-Negation
speak NCT03868267 336 341 O
Persian NCT03868267 342 349 O
in NCT03868267 350 352 O
Iran NCT03868267 353 357 O
. NCT03868267 358 359 O

Patient NCT03869541 0 7 O
participants NCT03869541 8 20 O
: NCT03869541 21 22 O

Inclusion NCT03869541 24 33 O
Criteria NCT03869541 34 42 O
: NCT03869541 43 44 O

- NCT03869541 48 49 O
Patients NCT03869541 51 59 O
admitted NCT03869541 60 68 B-Encounter
to NCT03869541 69 71 O
the NCT03869541 72 75 O
ICU NCT03869541 76 79 O
who NCT03869541 80 83 B-And
are NCT03869541 84 87 O
receiving NCT03869541 88 97 B-Eq_Comparison
vasoactive NCT03869541 98 108 B-Drug
drugs NCT03869541 109 114 I-Drug
. NCT03869541 115 116 O

- NCT03869541 120 121 O
Age NCT03869541 123 126 B-Age
greater NCT03869541 127 134 B-Eq_Comparison
than NCT03869541 135 139 I-Eq_Comparison
or NCT03869541 140 142 I-Eq_Comparison
equal NCT03869541 143 148 I-Eq_Comparison
to NCT03869541 149 151 I-Eq_Comparison
18 NCT03869541 152 154 I-Eq_Comparison
years NCT03869541 155 160 I-Eq_Comparison
old NCT03869541 161 164 O
. NCT03869541 165 166 O

- NCT03869541 170 171 O
Expected NCT03869541 173 181 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869541 182 184 I-Assertion___Assertion_Type_Value:hypothetical
remain NCT03869541 185 191 O
admitted NCT03869541 192 200 B-Encounter
to NCT03869541 201 203 O
the NCT03869541 204 207 O
ICU NCT03869541 208 211 O
for NCT03869541 212 215 O
at NCT03869541 216 218 B-Eq_Comparison
least NCT03869541 219 224 I-Eq_Comparison
24 NCT03869541 225 227 I-Eq_Comparison
hours NCT03869541 228 233 I-Eq_Comparison
post NCT03869541 234 238 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03869541 239 240 O
enrolment NCT03869541 241 250 B-Study
. NCT03869541 251 252 O

Exclusion NCT03869541 254 263 O
Criteria NCT03869541 264 272 O
: NCT03869541 273 274 O

- NCT03869541 278 279 O
Any NCT03869541 281 284 O
patient NCT03869541 285 292 O
who NCT03869541 293 296 O
is NCT03869541 297 299 O
expected NCT03869541 300 308 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869541 309 311 I-Assertion___Assertion_Type_Value:hypothetical
die NCT03869541 312 315 B-Death
imminently NCT03869541 316 326 B-Modifier
, NCT03869541 327 328 O
as NCT03869541 329 331 O
per NCT03869541 332 335 O
clinical NCT03869541 336 344 O
opinion NCT03869541 345 352 O
. NCT03869541 353 354 O

- NCT03869541 358 359 O
Any NCT03869541 361 364 O
patient NCT03869541 365 372 O
where NCT03869541 373 378 O
mobilization NCT03869541 379 391 B-Procedure
is NCT03869541 392 394 O
contraindicated NCT03869541 395 410 B-Contraindication
by NCT03869541 411 413 O
the NCT03869541 414 417 O
nature NCT03869541 418 424 O
of NCT03869541 425 427 O
their NCT03869541 428 433 O
existing NCT03869541 434 442 B-Eq_Comparison
injuries NCT03869541 443 451 B-Condition
. NCT03869541 452 453 O

- NCT03869541 457 458 O
Where NCT03869541 460 465 O
it NCT03869541 466 468 O
is NCT03869541 469 471 O
clear NCT03869541 472 477 O
from NCT03869541 478 482 O
the NCT03869541 483 486 O
medical NCT03869541 487 494 O
records NCT03869541 495 502 O
that NCT03869541 503 507 O
participants NCT03869541 508 520 O
are NCT03869541 521 524 O
prisoners NCT03869541 525 534 B-Observation
or NCT03869541 535 537 B-Or
offenders NCT03869541 538 547 O
on NCT03869541 548 550 B-Observation
probation NCT03869541 551 560 I-Observation
. NCT03869541 561 562 O

- NCT03869541 566 567 O
Patients NCT03869541 569 577 O
with NCT03869541 578 582 O
neuromuscular NCT03869541 583 596 B-Condition
disease NCT03869541 597 604 I-Condition
or NCT03869541 605 607 B-Or
acute NCT03869541 608 613 O
brain NCT03869541 614 619 B-Modifier
injury NCT03869541 620 626 B-Condition
or NCT03869541 627 629 B-Or
spinal NCT03869541 630 636 B-Modifier
cord NCT03869541 637 641 I-Modifier
injury NCT03869541 642 648 B-Condition
. NCT03869541 649 650 O

- NCT03869541 654 655 O
If NCT03869541 657 659 O
the NCT03869541 660 663 O
patient NCT03869541 664 671 O
and NCT03869541 672 675 O
/ NCT03869541 676 677 O
or NCT03869541 678 680 O
their NCT03869541 681 686 O
consultee NCT03869541 687 696 O
is NCT03869541 697 699 O
unable NCT03869541 700 706 B-Negation
to NCT03869541 707 709 O
speak NCT03869541 710 715 O
English NCT03869541 716 723 O
. NCT03869541 724 725 O

Clinicians NCT03869541 727 737 O
participating NCT03869541 738 751 O
in NCT03869541 752 754 O
a NCT03869541 755 756 O
survey NCT03869541 757 763 O
on NCT03869541 764 766 O
hypothetical NCT03869541 767 779 O
randomization NCT03869541 780 793 O
of NCT03869541 794 796 O
patient NCT03869541 797 804 O
participants NCT03869541 805 817 O
: NCT03869541 818 819 O

Inclusion NCT03869541 821 830 O
criteria NCT03869541 831 839 O
: NCT03869541 840 841 O

- NCT03869541 845 846 O
Clinicians NCT03869541 848 858 O
who NCT03869541 859 862 O
work NCT03869541 863 867 O
in NCT03869541 868 870 O
the NCT03869541 871 874 O
intensive NCT03869541 875 884 O
care NCT03869541 885 889 O
unit NCT03869541 890 894 O
where NCT03869541 895 900 O
a NCT03869541 901 902 O
patient NCT03869541 903 910 O
participant NCT03869541 911 922 O
has NCT03869541 923 926 B-Eq_Comparison
been NCT03869541 927 931 I-Eq_Comparison
admitted NCT03869541 932 940 B-Encounter
. NCT03869541 941 942 O

Exclusion NCT03869541 944 953 O
criteria NCT03869541 954 962 O
: NCT03869541 963 964 O

- NCT03869541 968 969 O
None NCT03869541 971 975 O
. NCT03869541 976 977 O

Clinician NCT03869541 979 988 O
participants NCT03869541 989 1001 O
in NCT03869541 1002 1004 O
the NCT03869541 1005 1008 O
survey NCT03869541 1009 1015 O
on NCT03869541 1016 1018 O
the NCT03869541 1019 1022 O
feasibility NCT03869541 1023 1034 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03869541 1035 1037 O
the NCT03869541 1038 1041 O
ICU NCT03869541 1042 1045 O
physical NCT03869541 1046 1054 B-Procedure
rehabilitation NCT03869541 1055 1069 I-Procedure
adverse NCT03869541 1070 1077 O
event NCT03869541 1078 1083 O
tool NCT03869541 1084 1088 O
: NCT03869541 1089 1090 O

Inclusion NCT03869541 1092 1101 O
criteria NCT03869541 1102 1110 O
: NCT03869541 1111 1112 O

- NCT03869541 1116 1117 O
An NCT03869541 1119 1121 O
ICU NCT03869541 1122 1125 O
clinician NCT03869541 1126 1135 O
at NCT03869541 1136 1138 O
the NCT03869541 1139 1142 O
research NCT03869541 1143 1151 O
site NCT03869541 1152 1156 O
. NCT03869541 1157 1158 O

- NCT03869541 1162 1163 O
Has NCT03869541 1165 1168 O
used NCT03869541 1169 1173 O
the NCT03869541 1174 1177 O
ICU NCT03869541 1178 1181 O
physical NCT03869541 1182 1190 B-Observation
rehabilitation NCT03869541 1191 1205 I-Observation
adverse NCT03869541 1206 1213 I-Observation
event NCT03869541 1214 1219 I-Observation
tool NCT03869541 1220 1224 I-Observation
as NCT03869541 1225 1227 O
part NCT03869541 1228 1232 O
of NCT03869541 1233 1235 O
this NCT03869541 1236 1240 O
research NCT03869541 1241 1249 O
study NCT03869541 1250 1255 B-Study
. NCT03869541 1256 1257 O

Exclusion NCT03869541 1259 1268 O
criteria NCT03869541 1269 1277 O
: NCT03869541 1278 1279 O

- NCT03869541 1283 1284 O
None NCT03869541 1286 1290 O
. NCT03869541 1291 1292 O


Inclusion NCT03923543 0 9 O
Criteria NCT03923543 10 18 O
: NCT03923543 19 20 O

- NCT03923543 24 25 O
newborn NCT03923543 27 34 O
to NCT03923543 35 37 B-Eq_Comparison
be NCT03923543 38 40 I-Eq_Comparison
operated NCT03923543 41 49 B-Procedure
with NCT03923543 50 54 B-And
the NCT03923543 55 58 O
diagnosis NCT03923543 59 68 O
of NCT03923543 69 71 O
congenital NCT03923543 72 82 B-Condition
heart NCT03923543 83 88 I-Condition
disease NCT03923543 89 96 I-Condition

Exclusion NCT03923543 97 106 O
Criteria NCT03923543 107 115 O
: NCT03923543 116 117 O

- NCT03923543 121 122 O
age NCT03923543 124 127 B-Age
older NCT03923543 128 133 B-Eq_Comparison
than NCT03923543 134 138 I-Eq_Comparison
1 NCT03923543 139 140 I-Eq_Comparison
month NCT03923543 141 146 I-Eq_Comparison
not NCT03923543 147 150 B-Negation
to NCT03923543 151 153 B-Eq_Comparison
be NCT03923543 154 156 I-Eq_Comparison
operated NCT03923543 157 165 B-Procedure

Inclusion NCT03865862 0 9 O
Criteria NCT03865862 10 18 O
: NCT03865862 19 20 O

- NCT03865862 24 25 O
Volleyball NCT03865862 27 37 B-Observation
players NCT03865862 38 45 I-Observation

- NCT03865862 48 49 O
Federated NCT03865862 51 60 O
that NCT03865862 61 65 O
at NCT03865862 66 68 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865862 69 72 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03865862 73 77 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03865862 78 80 O
the NCT03865862 81 84 O
study NCT03865862 85 90 B-Study
compete NCT03865862 91 98 O
in NCT03865862 99 101 O
clubs NCT03865862 102 107 O
of NCT03865862 108 110 O
the NCT03865862 111 114 O
Community NCT03865862 115 124 O
of NCT03865862 125 127 O
Madrid NCT03865862 128 134 O

- NCT03865862 137 138 O
Over NCT03865862 140 144 B-Eq_Comparison
18 NCT03865862 145 147 I-Eq_Comparison
years NCT03865862 148 153 I-Eq_Comparison
old NCT03865862 154 157 B-Age
. NCT03865862 158 159 O

Exclusion NCT03865862 161 170 O
Criteria NCT03865862 171 179 O
: NCT03865862 180 181 O

- NCT03865862 185 186 O
Present NCT03865862 188 195 O
a NCT03865862 196 197 O
medical NCT03865862 198 205 O
diagnosis NCT03865862 206 215 O
of NCT03865862 216 218 O
injury NCT03865862 219 225 B-Condition
or NCT03865862 226 228 B-Or
illness NCT03865862 229 236 B-Condition

- NCT03865862 239 240 O
Have NCT03865862 242 246 O
suffered NCT03865862 247 255 O
a NCT03865862 256 257 O
knee NCT03865862 258 262 B-Modifier
injury NCT03865862 263 269 B-Condition
in NCT03865862 270 272 O
the NCT03865862 273 276 O
6 NCT03865862 277 278 B-Eq_Comparison
months NCT03865862 279 285 I-Eq_Comparison
prior NCT03865862 286 291 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865862 292 294 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03865862 295 298 O
study NCT03865862 299 304 B-Study

- NCT03865862 307 308 O
Doing NCT03865862 310 315 O
some NCT03865862 316 320 O
pharmacological NCT03865862 321 336 B-Drug
or NCT03865862 337 339 B-Or
physiotherapy NCT03865862 340 353 B-Procedure
treatment NCT03865862 354 363 I-Procedure
external NCT03865862 364 372 B-Other
to NCT03865862 373 375 I-Other
the NCT03865862 376 379 O
study NCT03865862 380 385 B-Study

- NCT03865862 388 389 O
Not NCT03865862 391 394 O
signed NCT03865862 395 401 O
the NCT03865862 402 405 O
informed NCT03865862 406 414 O
consent NCT03865862 415 422 O
document NCT03865862 423 431 O
. NCT03865862 432 433 O

Inclusion NCT03864887 0 9 O
Criteria NCT03864887 10 18 O
: NCT03864887 19 20 O

- NCT03864887 24 25 O
Patients NCT03864887 27 35 O
who NCT03864887 36 39 O
have NCT03864887 40 44 O
had NCT03864887 45 48 B-Eq_Comparison
brain NCT03864887 49 54 B-Condition
death NCT03864887 55 60 I-Condition
or NCT03864887 61 63 B-Or
serious NCT03864887 64 71 O
brain NCT03864887 72 77 B-Modifier
trauma NCT03864887 78 84 B-Condition
. NCT03864887 85 86 O

- NCT03864887 90 91 O
Healthy NCT03864887 93 100 B-Condition
people NCT03864887 101 107 O
who NCT03864887 108 111 B-And
are NCT03864887 112 115 O
interested NCT03864887 116 126 B-Assertion___Assertion_Type_Value:hypothetical
in NCT03864887 127 129 I-Assertion___Assertion_Type_Value:hypothetical
optical NCT03864887 130 137 B-Procedure
assessment NCT03864887 138 148 I-Procedure
of NCT03864887 149 151 O
hemodynamic NCT03864887 152 163 B-Observation
parameters NCT03864887 164 174 I-Observation

Exclusion NCT03864887 175 184 O
Criteria NCT03864887 185 193 O
: NCT03864887 194 195 O

- NCT03864887 199 200 O
Patients NCT03864887 202 210 O
who NCT03864887 211 214 O
are NCT03864887 215 218 O
in NCT03864887 219 221 O
pregnancy NCT03864887 222 231 B-Condition
or NCT03864887 232 234 B-Or
have NCT03864887 235 239 O
plan NCT03864887 240 244 B-Assertion___Assertion_Type_Value:intention
to NCT03864887 245 247 I-Assertion___Assertion_Type_Value:intention
conception NCT03864887 248 258 B-Condition
. NCT03864887 259 260 O

- NCT03864887 264 265 O
Patients NCT03864887 267 275 O
who NCT03864887 276 279 O
have NCT03864887 280 284 O
vertebra NCT03864887 285 293 B-Procedure
surgery NCT03864887 294 301 I-Procedure
or NCT03864887 302 304 B-Or
have NCT03864887 305 309 O
plan NCT03864887 310 314 B-Assertion___Assertion_Type_Value:intention
of NCT03864887 315 317 I-Assertion___Assertion_Type_Value:intention
surgery NCT03864887 318 325 B-Procedure
. NCT03864887 326 327 O

- NCT03864887 331 332 O
Patients NCT03864887 334 342 O
who NCT03864887 343 346 O
are NCT03864887 347 350 O
inappropriate NCT03864887 351 364 O
to NCT03864887 365 367 O
join NCT03864887 368 372 O
this NCT03864887 373 377 O
trial NCT03864887 378 383 O
judged NCT03864887 384 390 O
by NCT03864887 391 393 O
the NCT03864887 394 397 O
radiologists NCT03864887 398 410 O
or NCT03864887 411 413 O
specialists NCT03864887 414 425 O
. NCT03864887 426 427 O

- NCT03864887 436 437 O
AIDS NCT03864887 439 443 B-Condition
, NCT03864887 444 445 O
Active NCT03864887 446 452 B-Eq_Comparison
Hepatitis NCT03864887 453 462 B-Condition
, NCT03864887 463 464 O
Tuberculosis NCT03864887 465 477 B-Condition
, NCT03864887 478 479 O
Syphilis NCT03864887 480 488 B-Condition

- NCT03864887 496 497 O
Patients NCT03864887 499 507 O
who NCT03864887 508 511 O
regularly NCT03864887 512 521 B-Eq_Comparison
take NCT03864887 522 526 I-Eq_Comparison
anticoagulants NCT03864887 527 541 B-Drug
, NCT03864887 542 543 O
antiplatelet NCT03864887 544 556 B-Drug
drugs NCT03864887 557 562 I-Drug

Resident NCT03861429 0 8 O
Inclusion NCT03861429 9 18 O
Criteria NCT03861429 19 27 O
: NCT03861429 28 29 O

- NCT03861429 33 34 O
Identified NCT03861429 36 46 O
as NCT03861429 47 49 O
having NCT03861429 50 56 O
Alzheimer NCT03861429 57 66 B-Condition
's NCT03861429 66 68 I-Condition
or NCT03861429 69 71 B-Or
related NCT03861429 72 79 O
dementia NCT03861429 80 88 B-Condition

- NCT03861429 91 92 O
Mild NCT03861429 94 98 B-Eq_Comparison
to NCT03861429 99 101 I-Eq_Comparison
moderate NCT03861429 102 110 I-Eq_Comparison
cognitive NCT03861429 111 120 B-Condition
impairment NCT03861429 121 131 I-Condition
( NCT03861429 132 133 O
BIMS NCT03861429 134 138 B-Observation
= NCT03861429 139 140 B-Eq_Comparison
8 NCT03861429 141 142 I-Eq_Comparison
- NCT03861429 143 144 I-Eq_Comparison
15 NCT03861429 145 147 I-Eq_Comparison
, NCT03861429 148 149 O
( NCT03861429 150 151 O
MDS NCT03861429 152 155 O
C NCT03861429 156 157 O
0500 NCT03861429 158 162 O
) NCT03861429 163 164 O
( NCT03861429 165 166 O
nursing NCT03861429 167 174 O
home NCT03861429 175 179 O
residents NCT03861429 180 189 O
only NCT03861429 190 194 O
) NCT03861429 195 196 O

- NCT03861429 200 201 O
Makes NCT03861429 203 208 B-Observation
Self NCT03861429 209 213 I-Observation
Understood NCT03861429 214 224 I-Observation
= NCT03861429 225 226 B-Eq_Comparison
< NCT03861429 227 228 I-Eq_Comparison
1 NCT03861429 229 230 I-Eq_Comparison
( NCT03861429 231 232 O
MDS NCT03861429 233 236 O
B NCT03861429 237 238 O
0700 NCT03861429 239 243 O
) NCT03861429 244 245 O
/ NCT03861429 246 247 O
present NCT03861429 248 255 O
in NCT03861429 256 258 O
medical NCT03861429 259 266 O
record NCT03861429 267 273 O

- NCT03861429 276 277 O
Understood NCT03861429 279 289 B-Observation
By NCT03861429 290 292 I-Observation
Others NCT03861429 293 299 I-Observation
= NCT03861429 300 301 B-Eq_Comparison
< NCT03861429 302 303 I-Eq_Comparison
1 NCT03861429 304 305 I-Eq_Comparison
( NCT03861429 306 307 O
MDS NCT03861429 308 311 O
B NCT03861429 312 313 O
0800 NCT03861429 314 318 O
) NCT03861429 319 320 O
/ NCT03861429 321 322 O
present NCT03861429 323 330 O
in NCT03861429 331 333 O
medical NCT03861429 334 341 O
record NCT03861429 342 348 O

- NCT03861429 351 352 O
Reside NCT03861429 354 360 B-Encounter
at NCT03861429 361 363 O
the NCT03861429 364 367 O
facility NCT03861429 368 376 O
at NCT03861429 377 379 B-Eq_Comparison
least NCT03861429 380 385 I-Eq_Comparison
2 NCT03861429 386 387 I-Eq_Comparison
weeks NCT03861429 388 393 I-Eq_Comparison
identified NCT03861429 394 404 O
as NCT03861429 405 407 O
a NCT03861429 408 409 O
long NCT03861429 410 414 B-Observation
- NCT03861429 415 416 I-Observation
term NCT03861429 417 421 I-Observation
resident NCT03861429 422 430 I-Observation

- NCT03861429 433 434 O
Age NCT03861429 436 439 B-Age
> NCT03861429 440 441 B-Eq_Comparison
65 NCT03861429 442 444 I-Eq_Comparison
years NCT03861429 445 450 I-Eq_Comparison

- NCT03861429 453 454 O
Speaks NCT03861429 456 462 O
English NCT03861429 463 470 O

Family NCT03861429 471 477 O
Inclusion NCT03861429 478 487 O
Criteria NCT03861429 488 496 O
: NCT03861429 497 498 O

- NCT03861429 502 503 O
Speaks NCT03861429 505 511 O
English NCT03861429 512 519 O

- NCT03861429 522 523 O
Willing NCT03861429 525 532 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03861429 533 536 I-Assertion___Assertion_Type_Value:hypothetical
able NCT03861429 537 541 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861429 542 544 I-Assertion___Assertion_Type_Value:hypothetical
watch NCT03861429 545 550 O
the NCT03861429 551 554 O
videos NCT03861429 555 561 O

- NCT03861429 564 565 O
Willing NCT03861429 567 574 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861429 575 577 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03861429 578 586 O
short NCT03861429 587 592 B-Observation
surveys NCT03861429 593 600 I-Observation
. NCT03861429 601 602 O
Being NCT03861429 604 609 O
unable NCT03861429 610 616 O
to NCT03861429 617 619 O
attend NCT03861429 620 626 O
care NCT03861429 627 631 O
conference NCT03861429 632 642 O
to NCT03861429 643 645 O
view NCT03861429 646 650 O
the NCT03861429 651 654 O
video NCT03861429 655 660 O
( NCT03861429 661 662 O
e NCT03861429 663 664 O
. NCT03861429 665 666 O
g NCT03861429 667 668 O
. NCT03861429 669 670 O
due NCT03861429 672 675 O
to NCT03861429 676 678 O
distance NCT03861429 679 687 O
) NCT03861429 688 689 O
will NCT03861429 690 694 O
not NCT03861429 695 698 O
exclude NCT03861429 699 706 O
family NCT03861429 707 713 O
from NCT03861429 714 718 O
participating NCT03861429 719 732 O
. NCT03861429 733 734 O

Staff NCT03861429 736 741 O
Inclusion NCT03861429 742 751 O
Criteria NCT03861429 752 760 O
: NCT03861429 761 762 O

- NCT03861429 766 767 O
Speaks NCT03861429 769 775 O
English NCT03861429 776 783 O

- NCT03861429 786 787 O
Willing NCT03861429 789 796 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861429 797 799 I-Assertion___Assertion_Type_Value:hypothetical
watch NCT03861429 800 805 O
the NCT03861429 806 809 O
videos NCT03861429 810 816 O

- NCT03861429 819 820 O
Willing NCT03861429 822 829 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861429 830 832 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03861429 833 841 O
short NCT03861429 842 847 O
surveys NCT03861429 848 855 O

Resident NCT03861429 856 864 O
Exclusion NCT03861429 865 874 O
Criteria NCT03861429 875 883 O
: NCT03861429 884 885 O

- NCT03861429 889 890 O
Limited NCT03861429 892 899 O
communication NCT03861429 900 913 B-Condition
capacity NCT03861429 914 922 I-Condition
( NCT03861429 923 924 O
e NCT03861429 925 926 O
. NCT03861429 927 928 O
g NCT03861429 929 930 O
. NCT03861429 931 932 O
aphasia NCT03861429 934 941 B-Condition
) NCT03861429 942 943 O

- NCT03861429 947 948 O
Comatose NCT03861429 950 958 B-Condition

- NCT03861429 961 962 O
Cognitively NCT03861429 964 975 B-Condition
intact NCT03861429 976 982 I-Condition

- NCT03861429 985 986 O
Severe NCT03861429 988 994 O
cognitive NCT03861429 995 1004 B-Condition
impairment NCT03861429 1005 1015 I-Condition

Inclusion NCT03922906 0 9 O
Criteria NCT03922906 10 18 O
: NCT03922906 19 20 O

1 NCT03922906 24 25 O
. NCT03922906 25 26 O
Subjects NCT03922906 28 36 O
with NCT03922906 37 41 O
history NCT03922906 42 49 B-Eq_Comparison
of NCT03922906 50 52 O
inadequate NCT03922906 53 63 B-Condition
bowel NCT03922906 64 69 I-Condition
preparation NCT03922906 70 81 I-Condition
. NCT03922906 82 83 O

2 NCT03922906 87 88 O
. NCT03922906 88 89 O
Subjects NCT03922906 91 99 O
in NCT03922906 100 102 O
the NCT03922906 103 106 O
age NCT03922906 107 110 B-Age
range NCT03922906 111 116 O
of NCT03922906 117 119 O
22 NCT03922906 120 122 B-Eq_Comparison
- NCT03922906 123 124 I-Eq_Comparison
75 NCT03922906 125 127 I-Eq_Comparison
years NCT03922906 128 133 I-Eq_Comparison
inclusive NCT03922906 134 143 O

3 NCT03922906 146 147 O
. NCT03922906 147 148 O
Subjects NCT03922906 150 158 O
with NCT03922906 159 163 O
BodyMass NCT03922906 164 172 B-Observation
Index NCT03922906 173 178 I-Observation
( NCT03922906 179 180 O
BMI NCT03922906 181 184 B-Observation
) NCT03922906 185 186 O
within NCT03922906 187 193 O
the NCT03922906 194 197 O
range NCT03922906 198 203 O
of NCT03922906 204 206 O
18.5 NCT03922906 207 211 B-Eq_Comparison
- NCT03922906 212 213 I-Eq_Comparison
35 NCT03922906 214 216 I-Eq_Comparison
inclusive NCT03922906 217 226 O

4 NCT03922906 229 230 O
. NCT03922906 230 231 O
Subject NCT03922906 233 240 O
has NCT03922906 241 244 O
signed NCT03922906 245 251 O
the NCT03922906 252 255 O
informed NCT03922906 256 264 O
consent NCT03922906 265 272 O

Exclusion NCT03922906 273 282 O
Criteria NCT03922906 283 291 O
: NCT03922906 292 293 O

1 NCT03922906 297 298 O
. NCT03922906 298 299 O
Patients NCT03922906 301 309 O
with NCT03922906 310 314 O
active NCT03922906 315 321 B-Eq_Comparison
Inflammatory NCT03922906 322 334 B-Condition
Bowel NCT03922906 335 340 I-Condition
Disease NCT03922906 341 348 I-Condition

2 NCT03922906 351 352 O
. NCT03922906 352 353 O
Patients NCT03922906 355 363 O
with NCT03922906 364 368 O
previous NCT03922906 369 377 B-Eq_Comparison
history NCT03922906 378 385 I-Eq_Comparison
of NCT03922906 386 388 O
acute NCT03922906 389 394 O
diverticulitis NCT03922906 395 409 B-Condition
disease NCT03922906 410 417 I-Condition
or NCT03922906 418 420 B-Or
with NCT03922906 421 425 O
prior NCT03922906 426 431 B-Eq_Comparison
incomplete NCT03922906 432 442 B-Modifier
colonoscopy NCT03922906 443 454 B-Procedure
due NCT03922906 455 458 O
to NCT03922906 459 461 O
diverticular NCT03922906 462 474 B-Condition
disease NCT03922906 475 482 I-Condition

3 NCT03922906 485 486 O
. NCT03922906 486 487 O
Patients NCT03922906 489 497 O
with NCT03922906 498 502 O
known NCT03922906 503 508 O
bowel NCT03922906 509 514 B-Condition
obstruction NCT03922906 515 526 I-Condition
/ NCT03922906 527 528 B-Or
strictures NCT03922906 529 539 B-Condition

4 NCT03922906 542 543 O
. NCT03922906 543 544 O
History NCT03922906 546 553 B-Eq_Comparison
of NCT03922906 554 556 I-Eq_Comparison
prior NCT03922906 557 562 I-Eq_Comparison
surgery NCT03922906 563 570 B-Procedure
to NCT03922906 571 573 O
colon NCT03922906 574 579 B-Modifier
and NCT03922906 580 583 B-Or
/ NCT03922906 584 585 I-Or
or NCT03922906 586 588 I-Or
rectum NCT03922906 589 595 B-Modifier

5 NCT03922906 598 599 O
. NCT03922906 599 600 O
ASA NCT03922906 602 605 B-Observation
≥ NCT03922906 606 607 B-Eq_Comparison
III NCT03922906 608 611 I-Eq_Comparison

6 NCT03922906 614 615 O
. NCT03922906 615 616 O
Renal NCT03922906 618 623 B-Condition
insufficiency NCT03922906 624 637 I-Condition
( NCT03922906 638 639 O
Creatinine NCT03922906 640 650 B-Observation
≥ NCT03922906 651 652 B-Eq_Comparison
1.5 NCT03922906 653 656 I-Eq_Comparison
mg NCT03922906 657 659 I-Eq_Comparison
/ NCT03922906 660 661 I-Eq_Comparison
dL NCT03922906 662 664 I-Eq_Comparison
) NCT03922906 665 666 O
( NCT03922906 667 668 O
based NCT03922906 669 674 O
on NCT03922906 675 677 O
medical NCT03922906 678 685 O
history NCT03922906 686 693 O
) NCT03922906 694 695 O

7 NCT03922906 699 700 O
. NCT03922906 700 701 O
Abnormal NCT03922906 703 711 O
Liver NCT03922906 712 717 B-Condition
enzymes NCT03922906 718 725 I-Condition
( NCT03922906 726 727 O
ALT NCT03922906 728 731 B-Observation
/ NCT03922906 732 733 B-Or
AST NCT03922906 734 737 B-Observation
≥ NCT03922906 738 739 B-Eq_Comparison
2 NCT03922906 740 741 I-Eq_Comparison
times NCT03922906 742 747 I-Eq_Comparison
upper NCT03922906 748 753 I-Eq_Comparison
limits NCT03922906 754 760 I-Eq_Comparison
of NCT03922906 761 763 I-Eq_Comparison
normal NCT03922906 764 770 I-Eq_Comparison
) NCT03922906 771 772 O
( NCT03922906 773 774 O
based NCT03922906 775 780 O
on NCT03922906 781 783 O
medical NCT03922906 784 791 O
history NCT03922906 792 799 O
) NCT03922906 800 801 O

8 NCT03922906 805 806 O
. NCT03922906 806 807 O
Patients NCT03922906 809 817 O
taking NCT03922906 818 824 B-Eq_Comparison
anticoagulants NCT03922906 825 839 B-Drug
drugs NCT03922906 840 845 I-Drug
( NCT03922906 846 847 O
excluding NCT03922906 848 857 B-Exception
aspirin NCT03922906 858 865 B-Drug
) NCT03922906 866 867 O
or NCT03922906 868 870 B-Or
dual NCT03922906 871 875 B-Modifier
antiplatelet NCT03922906 876 888 B-Procedure
therapy NCT03922906 889 896 I-Procedure

9 NCT03922906 899 900 O
. NCT03922906 900 901 O
Patients NCT03922906 903 911 O
with NCT03922906 912 916 O
known NCT03922906 917 922 O
coagulation NCT03922906 923 934 B-Condition
disorder NCT03922906 935 943 I-Condition
( NCT03922906 944 945 O
INR NCT03922906 946 949 B-Observation
> NCT03922906 950 951 B-Eq_Comparison
1.5 NCT03922906 952 955 I-Eq_Comparison
) NCT03922906 956 957 O
. NCT03922906 958 959 O

10 NCT03922906 962 964 O
. NCT03922906 964 965 O
Patients NCT03922906 967 975 O
at NCT03922906 976 978 O
risk NCT03922906 979 983 B-Risk
of NCT03922906 984 986 O
hypokalemia NCT03922906 987 998 B-Condition
or NCT03922906 999 1001 B-Or
hyponatremia NCT03922906 1002 1014 B-Condition

11 NCT03922906 1016 1018 O
. NCT03922906 1018 1019 O
Patients NCT03922906 1021 1029 O
with NCT03922906 1030 1034 O
congestive NCT03922906 1035 1045 B-Condition
cardiac NCT03922906 1046 1053 I-Condition
failure NCT03922906 1054 1061 I-Condition

12 NCT03922906 1063 1065 O
. NCT03922906 1065 1066 O
Pregnancy NCT03922906 1068 1077 B-Condition
( NCT03922906 1078 1079 O
as NCT03922906 1080 1082 O
stated NCT03922906 1083 1089 O
by NCT03922906 1090 1092 O
patient NCT03922906 1093 1100 O
) NCT03922906 1101 1102 O
or NCT03922906 1103 1105 B-Or
breast NCT03922906 1106 1112 B-Condition
feeding NCT03922906 1113 1120 I-Condition

13 NCT03922906 1122 1124 O
. NCT03922906 1124 1125 O
Patients NCT03922906 1127 1135 O
with NCT03922906 1136 1140 O
altered NCT03922906 1141 1148 B-Condition
mental NCT03922906 1149 1155 I-Condition
status NCT03922906 1156 1162 I-Condition
/ NCT03922906 1163 1164 O
inability NCT03922906 1165 1174 O
to NCT03922906 1175 1177 O
provide NCT03922906 1178 1185 O
informed NCT03922906 1186 1194 O
consent NCT03922906 1195 1202 O

14 NCT03922906 1204 1206 O
. NCT03922906 1206 1207 O
Patients NCT03922906 1209 1217 O
who NCT03922906 1218 1221 O
have NCT03922906 1222 1226 O
participated NCT03922906 1227 1239 O
in NCT03922906 1240 1242 O
another NCT03922906 1243 1250 B-Other
interventional NCT03922906 1251 1265 O
clinical NCT03922906 1266 1274 O
study NCT03922906 1275 1280 B-Study
in NCT03922906 1281 1283 O
the NCT03922906 1284 1287 O
last NCT03922906 1288 1292 B-Eq_Comparison
2 NCT03922906 1293 1294 I-Eq_Comparison
months NCT03922906 1295 1301 I-Eq_Comparison

Inclusion NCT03934554 0 9 O
Criteria NCT03934554 10 18 O
: NCT03934554 19 20 O

- NCT03934554 24 25 O
Dialysis NCT03934554 27 35 B-Procedure
or NCT03934554 36 38 B-Or
non NCT03934554 39 42 B-Negation
- NCT03934554 43 44 O
dialysis NCT03934554 45 53 B-Procedure
patients NCT03934554 54 62 O
with NCT03934554 63 67 B-And
chronic NCT03934554 68 75 B-Condition
renal NCT03934554 76 81 I-Condition
insufficiency NCT03934554 82 95 I-Condition
with NCT03934554 96 100 B-And
a NCT03934554 101 102 O
GFR NCT03934554 103 106 B-Observation
< NCT03934554 107 108 B-Eq_Comparison
20 NCT03934554 109 111 I-Eq_Comparison
ml NCT03934554 112 114 I-Eq_Comparison
/ NCT03934554 115 116 I-Eq_Comparison
min NCT03934554 117 120 I-Eq_Comparison
eligible NCT03934554 121 129 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03934554 130 133 O
transplant NCT03934554 134 144 B-Procedure

- NCT03934554 147 148 O
Patient NCT03934554 150 157 O
wishing NCT03934554 158 165 B-Assertion___Assertion_Type_Value:intention
to NCT03934554 166 168 I-Assertion___Assertion_Type_Value:intention
start NCT03934554 169 174 O
the NCT03934554 175 178 O
registration NCT03934554 179 191 O
process NCT03934554 192 199 O
at NCT03934554 200 202 O
the NCT03934554 203 206 O
transplant NCT03934554 207 217 B-Procedure

- NCT03934554 220 221 O
Patient NCT03934554 223 230 O
giving NCT03934554 231 237 O
consent NCT03934554 238 245 O
for NCT03934554 246 249 O
the NCT03934554 250 253 O
transmission NCT03934554 254 266 O
of NCT03934554 267 269 O
his NCT03934554 270 273 O
data NCT03934554 274 278 O
via NCT03934554 279 282 O
an NCT03934554 283 285 O
electronic NCT03934554 286 296 O
platform NCT03934554 297 305 O

Exclusion NCT03934554 306 315 O
Criteria NCT03934554 316 324 O
: NCT03934554 325 326 O

- NCT03934554 330 331 O
Patient NCT03934554 333 340 O
already NCT03934554 341 348 O
enrolled NCT03934554 349 357 O

- NCT03934554 360 361 O
Patient NCT03934554 363 370 O
having NCT03934554 371 377 B-Eq_Comparison
a NCT03934554 378 379 O
pathology NCT03934554 380 389 B-Condition
with NCT03934554 390 394 B-And
a NCT03934554 395 396 O
life NCT03934554 397 401 B-Observation
expectancy NCT03934554 402 412 I-Observation
of NCT03934554 413 415 O
less NCT03934554 416 420 B-Eq_Comparison
than NCT03934554 421 425 I-Eq_Comparison
two NCT03934554 426 429 I-Eq_Comparison
years NCT03934554 430 435 I-Eq_Comparison

- NCT03934554 438 439 O
Patient NCT03934554 441 448 O
with NCT03934554 449 453 O
serious NCT03934554 454 461 O
psychiatric NCT03934554 462 473 B-Condition
disorders NCT03934554 474 483 I-Condition
, NCT03934554 484 485 O
or NCT03934554 486 488 B-Or
dementia NCT03934554 489 497 B-Condition
. NCT03934554 498 499 O

Inclusion NCT03922607 0 9 O
Criteria NCT03922607 10 18 O
: NCT03922607 19 20 O

- NCT03922607 24 25 O
Volunteer NCT03922607 27 36 O
should NCT03922607 37 43 O
be NCT03922607 44 46 O
between NCT03922607 47 54 B-Eq_Comparison
18 NCT03922607 55 57 I-Eq_Comparison
and NCT03922607 58 61 I-Eq_Comparison
55 NCT03922607 62 64 I-Eq_Comparison
years NCT03922607 65 70 I-Eq_Comparison
of NCT03922607 71 73 O
age NCT03922607 74 77 B-Age
and NCT03922607 78 81 B-And
in NCT03922607 82 84 O
general NCT03922607 85 92 B-Condition
good NCT03922607 93 97 I-Condition
health NCT03922607 98 104 I-Condition
for NCT03922607 105 108 O
Substudy NCT03922607 109 117 O
1 NCT03922607 118 119 O
and NCT03922607 120 123 B-And
participant NCT03922607 124 135 O
with NCT03922607 136 140 O
moderate NCT03922607 141 149 B-Eq_Comparison
to NCT03922607 150 152 I-Eq_Comparison
severe NCT03922607 153 159 I-Eq_Comparison
chronic NCT03922607 160 167 O
plaque NCT03922607 168 174 B-Condition
psoriasis NCT03922607 175 184 I-Condition
between NCT03922607 185 192 B-Eq_Comparison
18 NCT03922607 193 195 I-Eq_Comparison
and NCT03922607 196 199 I-Eq_Comparison
75 NCT03922607 200 202 I-Eq_Comparison
years NCT03922607 203 208 I-Eq_Comparison
of NCT03922607 209 211 O
age NCT03922607 212 215 B-Age
for NCT03922607 216 219 O
Substudy NCT03922607 220 228 O
2 NCT03922607 229 230 O
at NCT03922607 231 233 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03922607 234 237 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03922607 238 242 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03922607 243 245 O
enrollment NCT03922607 246 256 B-Study
. NCT03922607 257 258 O

- NCT03922607 262 263 O
Participant NCT03922607 265 276 O
should NCT03922607 277 283 O
meet NCT03922607 284 288 O
the NCT03922607 289 292 O
laboratory NCT03922607 293 303 O
assessments NCT03922607 304 315 O
as NCT03922607 316 318 O
mentioned NCT03922607 319 328 O
in NCT03922607 329 331 O
the NCT03922607 332 335 O
protocol NCT03922607 336 344 O
. NCT03922607 345 346 O

Exclusion NCT03922607 348 357 O
Criteria NCT03922607 358 366 O
: NCT03922607 367 368 O

- NCT03922607 372 373 O
Participant NCT03922607 375 386 O
has NCT03922607 387 390 O
a NCT03922607 391 392 O
history NCT03922607 393 400 B-Eq_Comparison
of NCT03922607 401 403 O
epilepsy NCT03922607 404 412 B-Condition
, NCT03922607 413 414 O
any NCT03922607 415 418 O
significant NCT03922607 419 430 O
cardiac NCT03922607 431 438 B-Modifier
, NCT03922607 439 440 O
respiratory NCT03922607 441 452 B-Modifier
, NCT03922607 453 454 O
renal NCT03922607 455 460 B-Modifier
, NCT03922607 461 462 O
hepatic NCT03922607 463 470 B-Modifier
, NCT03922607 471 472 O
gastrointestinal NCT03922607 473 489 B-Modifier
, NCT03922607 490 491 O
opthalmologic NCT03922607 492 505 B-Modifier
, NCT03922607 506 507 O
hematologic NCT03922607 508 519 B-Modifier
, NCT03922607 520 521 O
or NCT03922607 522 524 B-Or
psychiatric NCT03922607 525 536 B-Modifier
disease NCT03922607 537 544 B-Condition
or NCT03922607 545 547 B-Or
disorder NCT03922607 548 556 B-Condition
, NCT03922607 557 558 O
or NCT03922607 559 561 B-Or
any NCT03922607 562 565 O
uncontrolled NCT03922607 566 578 B-Modifier
medical NCT03922607 579 586 B-Condition
illness NCT03922607 587 594 I-Condition
. NCT03922607 595 596 O

Inclusion NCT03866811 0 9 O
Criteria NCT03866811 10 18 O
: NCT03866811 19 20 O

- NCT03866811 24 25 O
female NCT03866811 27 33 O
emergency NCT03866811 34 43 B-Encounter
department NCT03866811 44 54 I-Encounter
patient NCT03866811 55 62 O

- NCT03866811 65 66 O
age NCT03866811 68 71 B-Age
14 NCT03866811 72 74 B-Eq_Comparison
- NCT03866811 75 76 I-Eq_Comparison
19 NCT03866811 77 79 I-Eq_Comparison
years NCT03866811 80 85 I-Eq_Comparison

- NCT03866811 88 89 O
sexually NCT03866811 91 99 B-Condition
active NCT03866811 100 106 I-Condition
with NCT03866811 107 111 B-Modifier
males NCT03866811 112 117 I-Modifier
in NCT03866811 118 120 O
the NCT03866811 121 124 O
past NCT03866811 125 129 B-Eq_Comparison
3 NCT03866811 130 131 I-Eq_Comparison
months NCT03866811 132 138 I-Eq_Comparison

Exclusion NCT03866811 139 148 O
Criteria NCT03866811 149 157 O
: NCT03866811 158 159 O

- NCT03866811 163 164 O
currently NCT03866811 166 175 B-Eq_Comparison
using NCT03866811 176 181 I-Eq_Comparison
any NCT03866811 182 185 O
effective NCT03866811 186 195 O
form NCT03866811 196 200 O
of NCT03866811 201 203 O
contraception NCT03866811 204 217 B-Procedure

- NCT03866811 220 221 O
do NCT03866811 223 225 O
not NCT03866811 226 229 O
own NCT03866811 230 233 O
a NCT03866811 234 235 O
mobile NCT03866811 236 242 O
phone NCT03866811 243 248 O
with NCT03866811 249 253 O
texting NCT03866811 254 261 O

- NCT03866811 264 265 O
are NCT03866811 267 270 B-Eq_Comparison
pregnant NCT03866811 271 279 B-Condition

- NCT03866811 282 283 O
are NCT03866811 285 288 B-Eq_Comparison
too NCT03866811 289 292 O
ill NCT03866811 293 296 B-Condition
for NCT03866811 297 300 O
participation NCT03866811 301 314 O
per NCT03866811 315 318 O
the NCT03866811 319 322 O
attending NCT03866811 323 332 B-Provider
physician NCT03866811 333 342 I-Provider

- NCT03866811 345 346 O
are NCT03866811 348 351 B-Eq_Comparison
cognitively NCT03866811 352 363 B-Condition
impaired NCT03866811 364 372 I-Condition

- NCT03866811 375 376 O
do NCT03866811 378 380 O
not NCT03866811 381 384 B-Negation
live NCT03866811 385 389 O
locally NCT03866811 390 397 O

- NCT03866811 400 401 O
do NCT03866811 403 405 O
not NCT03866811 406 409 B-Negation
speak NCT03866811 410 415 O
English NCT03866811 416 423 O

- NCT03866811 426 427 O
want NCT03866811 429 433 B-Assertion___Assertion_Type_Value:intention
to NCT03866811 434 436 I-Assertion___Assertion_Type_Value:intention
" NCT03866811 437 438 O
become NCT03866811 438 444 O
pregnant NCT03866811 445 453 B-Condition
in NCT03866811 454 456 O
the NCT03866811 457 460 O
next NCT03866811 461 465 B-Eq_Comparison
year NCT03866811 466 470 I-Eq_Comparison
" NCT03866811 470 471 O

Inclusion NCT03864939 0 9 O
Criteria NCT03864939 10 18 O
: NCT03864939 19 20 O

- NCT03864939 24 25 O
patients NCT03864939 27 35 O
with NCT03864939 36 40 O
localized NCT03864939 41 50 B-Modifier
prostate NCT03864939 51 59 I-Modifier
cancer NCT03864939 60 66 B-Condition

- NCT03864939 69 70 O
indication NCT03864939 72 82 B-Indication
for NCT03864939 83 86 O
radical NCT03864939 87 94 B-Procedure
prostatectomy NCT03864939 95 108 I-Procedure

- NCT03864939 111 112 O
no NCT03864939 114 116 B-Negation
other NCT03864939 117 122 B-Other
treatment NCT03864939 123 132 B-Procedure
of NCT03864939 133 135 O
prostate NCT03864939 136 144 B-Modifier
cancer NCT03864939 145 151 B-Condition

- NCT03864939 154 155 O
availability NCT03864939 157 169 O
to NCT03864939 170 172 O
informed NCT03864939 173 181 O
consent NCT03864939 182 189 O

Exclusion NCT03864939 190 199 O
Criteria NCT03864939 200 208 O
: NCT03864939 209 210 O

- NCT03864939 214 215 O
pre NCT03864939 217 220 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03864939 221 230 B-Procedure
incontinence NCT03864939 231 243 B-Condition
( NCT03864939 244 245 O
24 NCT03864939 246 248 B-Observation
hrs NCT03864939 249 252 I-Observation
pad NCT03864939 253 256 I-Observation
- NCT03864939 257 258 I-Observation
test NCT03864939 259 263 I-Observation
) NCT03864939 264 265 O

- NCT03864939 269 270 O
pre NCT03864939 272 275 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03864939 276 285 B-Procedure
erectile NCT03864939 286 294 B-Condition
dysfunction NCT03864939 295 306 I-Condition
( NCT03864939 307 308 O
IIEF NCT03864939 309 313 B-Observation
- NCT03864939 314 315 O
5 NCT03864939 316 317 B-Eq_Comparison
< NCT03864939 318 319 I-Eq_Comparison
20 NCT03864939 320 322 I-Eq_Comparison
) NCT03864939 323 324 O

- NCT03864939 328 329 O
metastasized NCT03864939 331 343 B-Modifier
or NCT03864939 344 346 B-Or
locally NCT03864939 347 354 B-Modifier
advanced NCT03864939 355 363 I-Modifier
prostate NCT03864939 364 372 O
cancer NCT03864939 373 379 B-Condition
in NCT03864939 380 382 O
pre NCT03864939 383 386 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03864939 387 396 B-Procedure
assessment NCT03864939 397 407 B-Observation

- NCT03864939 410 411 O
previous NCT03864939 413 421 B-Eq_Comparison
radiation NCT03864939 422 431 B-Procedure
of NCT03864939 432 434 O
pelvis NCT03864939 435 441 B-Modifier

- NCT03864939 444 445 O
previous NCT03864939 447 455 B-Eq_Comparison
prostate NCT03864939 456 464 B-Modifier
cancer NCT03864939 465 471 B-Condition
therapy NCT03864939 472 479 B-Procedure

- NCT03864939 482 483 O
psychiatric NCT03864939 485 496 B-Condition
disease NCT03864939 497 504 I-Condition

- NCT03864939 507 508 O
participation NCT03864939 510 523 O
at NCT03864939 524 526 O
another NCT03864939 527 534 B-Other
study NCT03864939 535 540 B-Study

Inclusion NCT03925688 0 9 O
Criteria NCT03925688 10 18 O
: NCT03925688 19 20 O

- NCT03925688 24 25 O
Have NCT03925688 27 31 O
a NCT03925688 32 33 O
previous NCT03925688 34 42 B-Eq_Comparison
history NCT03925688 43 50 I-Eq_Comparison
of NCT03925688 51 53 O
elbow NCT03925688 54 59 B-Modifier
joint NCT03925688 60 65 I-Modifier
fracture NCT03925688 66 74 B-Condition
or NCT03925688 75 77 B-Or
dislocation NCT03925688 78 89 B-Condition
that NCT03925688 90 94 O
conform NCT03925688 95 102 O
to NCT03925688 103 105 O
its NCT03925688 106 109 O
manifestations NCT03925688 110 124 O
and NCT03925688 125 128 O
signs NCT03925688 129 134 O
. NCT03925688 135 136 O
And NCT03925688 138 141 O
it NCT03925688 142 144 O
is NCT03925688 145 147 O
diagnosed NCT03925688 148 157 O
by NCT03925688 158 160 O
X NCT03925688 161 162 B-Procedure
- NCT03925688 163 164 I-Procedure
ray NCT03925688 165 168 I-Procedure
test NCT03925688 169 173 I-Procedure
. NCT03925688 174 175 O
HO NCT03925688 177 179 O
must NCT03925688 180 184 O
accord NCT03925688 185 191 O
with NCT03925688 192 196 O
the NCT03925688 197 200 O
relative NCT03925688 201 209 O
diagnostic NCT03925688 210 220 O
criteria NCT03925688 221 229 O
5 NCT03925688 230 231 O
and NCT03925688 232 235 O
have NCT03925688 236 240 O
imaging NCT03925688 241 248 B-Procedure
evidences NCT03925688 249 258 O
of NCT03925688 259 261 O
heterotopic NCT03925688 262 273 B-Condition
ossification NCT03925688 274 286 I-Condition
. NCT03925688 287 288 O

- NCT03925688 292 293 O
Have NCT03925688 295 299 O
complete NCT03925688 300 308 O
clinical NCT03925688 309 317 O
and NCT03925688 318 321 O
imaging NCT03925688 322 329 B-Procedure
dates NCT03925688 330 335 O
. NCT03925688 336 337 O

- NCT03925688 341 342 O
The NCT03925688 344 347 O
age NCT03925688 348 351 B-Age
> NCT03925688 352 353 B-Eq_Comparison
18 NCT03925688 354 356 I-Eq_Comparison
and NCT03925688 357 360 O
no NCT03925688 361 363 O
gender NCT03925688 364 370 O
limitation NCT03925688 371 381 O
. NCT03925688 382 383 O

- NCT03925688 387 388 O
The NCT03925688 390 393 O
patient NCT03925688 394 401 O
is NCT03925688 402 404 O
being NCT03925688 405 410 O
a NCT03925688 411 412 O
relatively NCT03925688 413 423 O
stable NCT03925688 424 430 O
physical NCT03925688 431 439 B-Modifier
and NCT03925688 440 443 B-And
mental NCT03925688 444 450 B-Modifier
state NCT03925688 451 456 B-Condition
without NCT03925688 457 464 B-Negation
acute NCT03925688 465 470 O
injection NCT03925688 471 480 B-Procedure
or NCT03925688 481 483 B-Or
diseases NCT03925688 484 492 B-Condition
. NCT03925688 493 494 O

Exclusion NCT03925688 496 505 O
Criteria NCT03925688 506 514 O
: NCT03925688 515 516 O

- NCT03925688 520 521 O
Have NCT03925688 523 527 O
a NCT03925688 528 529 O
history NCT03925688 530 537 B-Eq_Comparison
of NCT03925688 538 540 O
diabetes NCT03925688 541 549 B-Condition
mellitus NCT03925688 550 558 I-Condition
or NCT03925688 559 561 B-Or
impaired NCT03925688 562 570 B-Condition
blood NCT03925688 571 576 I-Condition
glucose NCT03925688 577 584 I-Condition
, NCT03925688 585 586 O
metabolic NCT03925688 587 596 B-Condition
syndrome NCT03925688 597 605 I-Condition
and NCT03925688 606 609 B-Or
gout NCT03925688 610 614 B-Condition
or NCT03925688 615 617 B-Or
renal NCT03925688 618 623 B-Modifier
dysfunction NCT03925688 624 635 B-Condition
( NCT03925688 636 637 O
creatinine NCT03925688 638 648 B-Observation
≥ NCT03925688 649 650 B-Eq_Comparison
1.5 NCT03925688 651 654 I-Eq_Comparison
mg NCT03925688 655 657 I-Eq_Comparison
/ NCT03925688 658 659 I-Eq_Comparison
dL NCT03925688 660 662 I-Eq_Comparison
) NCT03925688 663 664 O
that NCT03925688 665 669 O
apparently NCT03925688 670 680 B-Assertion___Assertion_Type_Value:possible
influence NCT03925688 681 690 O
glucose NCT03925688 691 698 B-Modifier
, NCT03925688 699 700 O
lipid NCT03925688 701 706 B-Modifier
and NCT03925688 707 710 B-Or
protein NCT03925688 711 718 B-Modifier
metabolic NCT03925688 719 728 B-Condition
of NCT03925688 729 731 O
the NCT03925688 732 735 O
body NCT03925688 736 740 B-Modifier
. NCT03925688 741 742 O

- NCT03925688 746 747 O
Have NCT03925688 749 753 O
a NCT03925688 754 755 O
history NCT03925688 756 763 B-Eq_Comparison
of NCT03925688 764 766 O
taking NCT03925688 767 773 O
drugs NCT03925688 774 779 B-Drug
that NCT03925688 780 784 O
can NCT03925688 785 788 O
influence NCT03925688 789 798 O
uric NCT03925688 799 803 B-Condition
acid NCT03925688 804 808 I-Condition
metabolic NCT03925688 809 818 I-Condition
including NCT03925688 819 828 O
gout NCT03925688 829 833 B-Condition
suppressant NCT03925688 834 845 B-Drug
, NCT03925688 846 847 O
diuretic NCT03925688 848 856 B-Drug
, NCT03925688 857 858 O
small NCT03925688 859 864 O
- NCT03925688 865 866 O
dose NCT03925688 867 871 O
aspirin NCT03925688 872 879 B-Drug
( NCT03925688 880 881 O
75 NCT03925688 882 884 B-Eq_Comparison
~ NCT03925688 885 886 I-Eq_Comparison
300 NCT03925688 887 890 I-Eq_Comparison
mg NCT03925688 891 893 I-Eq_Comparison
/ NCT03925688 894 895 I-Eq_Comparison
d NCT03925688 896 897 I-Eq_Comparison
) NCT03925688 898 899 O
or NCT03925688 900 902 B-Or
large NCT03925688 903 908 O
- NCT03925688 909 910 O
dose NCT03925688 911 915 O
aspirin NCT03925688 916 923 B-Drug
( NCT03925688 924 925 O
> NCT03925688 926 927 B-Eq_Comparison
3 NCT03925688 928 929 I-Eq_Comparison
g NCT03925688 930 931 I-Eq_Comparison
/ NCT03925688 932 933 I-Eq_Comparison
d NCT03925688 934 935 I-Eq_Comparison
) NCT03925688 936 937 O
, NCT03925688 938 939 O
anti NCT03925688 940 944 O
- NCT03925688 945 946 O
tuberculosis NCT03925688 947 959 B-Condition
drugs NCT03925688 960 965 B-Drug
, NCT03925688 966 967 O
immunosuppressor NCT03925688 968 984 B-Drug
, NCT03925688 985 986 O
nicotinic NCT03925688 987 996 B-Drug
acid NCT03925688 997 1001 I-Drug
and NCT03925688 1002 1005 O
anti NCT03925688 1006 1010 O
- NCT03925688 1011 1012 O
tumor NCT03925688 1013 1018 B-Condition
drugs NCT03925688 1019 1024 B-Drug
such NCT03925688 1025 1029 O
as NCT03925688 1030 1032 O
cyclophosphamide NCT03925688 1033 1049 B-Drug
and NCT03925688 1050 1053 O
so NCT03925688 1054 1056 O
on NCT03925688 1057 1059 O
. NCT03925688 1060 1061 O

Inclusion NCT03925675 0 9 O
Criteria NCT03925675 10 18 O
: NCT03925675 19 20 O

1 NCT03925675 24 25 O
. NCT03925675 25 26 O
Patients NCT03925675 28 36 O
evaluated NCT03925675 37 46 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03925675 47 50 I-Assertion___Assertion_Type_Value:hypothetical
residual NCT03925675 51 59 B-Modifier
or NCT03925675 60 62 B-Or
recurrent NCT03925675 63 72 B-Modifier
gliomas NCT03925675 73 80 B-Condition
after NCT03925675 81 86 B-Temporal_Connection___Temporal_Connection_Type_Value:after
initial NCT03925675 87 94 B-Eq_Comparison
tumor NCT03925675 95 100 B-Condition
surgery NCT03925675 101 108 B-Procedure
, NCT03925675 109 110 O
external NCT03925675 111 119 B-Procedure
beam NCT03925675 120 124 I-Procedure
radiation NCT03925675 125 134 I-Procedure
and NCT03925675 135 138 B-Or
/ NCT03925675 139 140 I-Or
or NCT03925675 141 143 I-Or
chemotherapy NCT03925675 144 156 B-Procedure
with NCT03925675 157 161 O
temozolamide NCT03925675 162 174 B-Drug
. NCT03925675 175 176 O

2 NCT03925675 180 181 O
. NCT03925675 181 182 O
Male NCT03925675 184 188 O
and NCT03925675 189 192 B-Or
female NCT03925675 193 199 O

3 NCT03925675 202 203 O
. NCT03925675 203 204 O
Ages NCT03925675 206 210 B-Age
18 NCT03925675 211 213 B-Eq_Comparison
to NCT03925675 214 216 I-Eq_Comparison
70 NCT03925675 217 219 I-Eq_Comparison

Exclusion NCT03925675 221 230 O
Criteria NCT03925675 231 239 O
: NCT03925675 240 241 O

1 NCT03925675 245 246 O
. NCT03925675 246 247 O
Patient NCT03925675 249 256 O
diagnosis NCT03925675 257 266 O
with NCT03925675 267 271 O
glioma NCT03925675 272 278 B-Condition
but NCT03925675 279 282 O
before NCT03925675 283 289 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03925675 290 297 B-Procedure
, NCT03925675 298 299 O
external NCT03925675 300 308 B-Procedure
beam NCT03925675 309 313 I-Procedure
radiation NCT03925675 314 323 I-Procedure
and NCT03925675 324 327 B-Or
/ NCT03925675 328 329 I-Or
or NCT03925675 330 332 I-Or
chemotherapy NCT03925675 333 345 B-Procedure
with NCT03925675 346 350 O
temozolamide NCT03925675 351 363 B-Drug
. NCT03925675 364 365 O

2 NCT03925675 369 370 O
. NCT03925675 370 371 O
Women NCT03925675 373 378 O
who NCT03925675 379 382 O
were NCT03925675 383 387 B-Eq_Comparison
pregnant NCT03925675 388 396 B-Condition
, NCT03925675 397 398 O
breast NCT03925675 399 405 B-Condition
feeding NCT03925675 406 413 I-Condition
, NCT03925675 414 415 O
or NCT03925675 416 418 B-Or
possibly NCT03925675 419 427 B-Assertion___Assertion_Type_Value:possible
pregnant NCT03925675 428 436 B-Condition
. NCT03925675 437 438 O

3 NCT03925675 442 443 O
. NCT03925675 443 444 O
Patients NCT03925675 446 454 O
with NCT03925675 455 459 O
hepatic NCT03925675 460 467 B-Modifier
or NCT03925675 468 470 B-Or
renal NCT03925675 471 476 B-Modifier
dysfunction NCT03925675 477 488 B-Condition
. NCT03925675 489 490 O

4 NCT03925675 494 495 O
. NCT03925675 495 496 O
Patients NCT03925675 498 506 O
with NCT03925675 507 511 O
MRI NCT03925675 512 515 B-Procedure
contraindications NCT03925675 516 533 B-Contraindication
( NCT03925675 534 535 O
i NCT03925675 536 537 O
. NCT03925675 538 539 O
e NCT03925675 540 541 O
. NCT03925675 542 543 O
pacemakers NCT03925675 545 555 B-Procedure
, NCT03925675 556 557 O
non NCT03925675 558 561 B-Procedure
- NCT03925675 562 563 I-Procedure
MR NCT03925675 564 566 I-Procedure
compatible NCT03925675 567 577 I-Procedure
devices NCT03925675 578 585 I-Procedure
) NCT03925675 586 587 O
. NCT03925675 588 589 O

5 NCT03925675 593 594 O
. NCT03925675 594 595 O
Patients NCT03925675 597 605 O
with NCT03925675 606 610 O
a NCT03925675 611 612 O
history NCT03925675 613 620 B-Eq_Comparison
of NCT03925675 621 623 O
drug NCT03925675 624 628 B-Drug
hypersensitivity NCT03925675 629 645 B-Condition
to NCT03925675 646 648 O
18 NCT03925675 649 651 B-Drug
F NCT03925675 652 653 I-Drug
- NCT03925675 654 655 I-Drug
Fluciclovine NCT03925675 656 668 I-Drug
. NCT03925675 669 670 O

Inclusion NCT03864432 0 9 O
Criteria NCT03864432 10 18 O
: NCT03864432 19 20 O

- NCT03864432 24 25 O
Healthy NCT03864432 27 34 B-Condition
male NCT03864432 35 39 O
and NCT03864432 40 43 B-Or
female NCT03864432 44 50 O
subjects NCT03864432 51 59 O
( NCT03864432 60 61 O
aged NCT03864432 62 66 B-Age
19 NCT03864432 67 69 B-Eq_Comparison
~ NCT03864432 70 71 I-Eq_Comparison
45 NCT03864432 72 74 I-Eq_Comparison
years NCT03864432 75 80 I-Eq_Comparison
at NCT03864432 81 83 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864432 84 87 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03864432 88 92 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03864432 93 95 O
screening NCT03864432 96 105 B-Study
) NCT03864432 106 107 O

- NCT03864432 111 112 O
Subjects NCT03864432 114 122 O
weighing NCT03864432 123 131 B-Observation
between NCT03864432 132 139 B-Eq_Comparison
50 NCT03864432 140 142 I-Eq_Comparison
kg NCT03864432 143 145 I-Eq_Comparison
( NCT03864432 146 147 I-Eq_Comparison
inclusive NCT03864432 148 157 I-Eq_Comparison
) NCT03864432 158 159 I-Eq_Comparison
and NCT03864432 160 163 I-Eq_Comparison
90 NCT03864432 164 166 I-Eq_Comparison
kg NCT03864432 167 169 I-Eq_Comparison
( NCT03864432 170 171 O
exclusive NCT03864432 172 181 O
) NCT03864432 182 183 O
, NCT03864432 184 185 O
and NCT03864432 186 189 B-And
having NCT03864432 190 196 O
a NCT03864432 197 198 O
body NCT03864432 199 203 B-Observation
mass NCT03864432 204 208 I-Observation
index NCT03864432 209 214 I-Observation
( NCT03864432 215 216 O
BMI NCT03864432 217 220 B-Observation
) NCT03864432 221 222 O
of NCT03864432 223 225 O
17.1 NCT03864432 226 230 B-Eq_Comparison
～ NCT03864432 231 232 I-Eq_Comparison
25.8 NCT03864432 233 237 I-Eq_Comparison
( NCT03864432 238 239 O
inclusive NCT03864432 240 249 O
of NCT03864432 250 252 O
limits NCT03864432 253 259 O
) NCT03864432 260 261 O
. NCT03864432 262 263 O

- NCT03864432 267 268 O
Subjects NCT03864432 270 278 O
with NCT03864432 279 283 O
a NCT03864432 284 285 O
fasting NCT03864432 286 293 B-Observation
plasma NCT03864432 294 300 I-Observation
glucose NCT03864432 301 308 I-Observation
( NCT03864432 309 310 O
FPG NCT03864432 311 314 B-Observation
) NCT03864432 315 316 O
of NCT03864432 317 319 O
70 NCT03864432 320 322 B-Eq_Comparison
～ NCT03864432 323 324 I-Eq_Comparison
110 NCT03864432 325 328 I-Eq_Comparison
mg NCT03864432 329 331 I-Eq_Comparison
/ NCT03864432 332 333 I-Eq_Comparison
dL NCT03864432 334 336 I-Eq_Comparison
( NCT03864432 337 338 O
inclusive NCT03864432 339 348 O
of NCT03864432 349 351 O
limits NCT03864432 352 358 O
) NCT03864432 359 360 O
at NCT03864432 361 363 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864432 364 367 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03864432 368 372 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03864432 373 375 O
screening NCT03864432 376 385 B-Study

- NCT03864432 388 389 O
Subjects NCT03864432 391 399 O
who NCT03864432 400 403 O
are NCT03864432 404 407 O
willing NCT03864432 408 415 O
to NCT03864432 416 418 O
participate NCT03864432 419 430 O
in NCT03864432 431 433 O
the NCT03864432 434 437 O
entire NCT03864432 438 444 O
study NCT03864432 445 450 O
cycle NCT03864432 451 456 O
and NCT03864432 457 460 O
comply NCT03864432 461 467 O
with NCT03864432 468 472 O
the NCT03864432 473 476 O
study NCT03864432 477 482 O
protocol NCT03864432 483 491 O
( NCT03864432 492 493 O
including NCT03864432 494 503 O
contraception NCT03864432 504 517 O
) NCT03864432 518 519 O
. NCT03864432 520 521 O
Subjects NCT03864432 523 531 O
who NCT03864432 532 535 O
can NCT03864432 536 539 O
sign NCT03864432 540 544 O
the NCT03864432 545 548 O
written NCT03864432 549 556 O
Informed NCT03864432 557 565 O
Consent NCT03864432 566 573 O
Form NCT03864432 574 578 O
after NCT03864432 579 584 O
being NCT03864432 585 590 O
informed NCT03864432 591 599 O
of NCT03864432 600 602 O
the NCT03864432 603 606 O
study NCT03864432 607 612 O
procedures NCT03864432 613 623 O
. NCT03864432 624 625 O

Exclusion NCT03864432 627 636 O
Criteria NCT03864432 637 645 O
: NCT03864432 646 647 O

- NCT03864432 651 652 O
Those NCT03864432 654 659 O
with NCT03864432 660 664 O
a NCT03864432 665 666 O
history NCT03864432 667 674 B-Eq_Comparison
of NCT03864432 675 677 O
allergies NCT03864432 678 687 B-Allergy
including NCT03864432 688 697 O
drug NCT03864432 698 702 B-Drug
allergies NCT03864432 703 712 B-Allergy
( NCT03864432 713 714 O
aspirin NCT03864432 715 722 B-Drug
, NCT03864432 723 724 O
antibiotics NCT03864432 725 736 B-Drug
, NCT03864432 737 738 O
etc NCT03864432 739 742 O
. NCT03864432 743 744 O
) NCT03864432 745 746 O
, NCT03864432 747 748 O
or NCT03864432 749 751 B-Or
other NCT03864432 752 757 B-Other
clinically NCT03864432 758 768 O
significant NCT03864432 769 780 O
allergies NCT03864432 781 790 B-Allergy
. NCT03864432 791 792 O

- NCT03864432 796 797 O
Those NCT03864432 799 804 O
with NCT03864432 805 809 O
diseases NCT03864432 810 818 B-Condition
of NCT03864432 819 821 O
the NCT03864432 822 825 O
liver NCT03864432 826 831 B-Modifier
( NCT03864432 832 833 O
including NCT03864432 834 843 O
carriers NCT03864432 844 852 O
of NCT03864432 853 855 O
hepatitis NCT03864432 856 865 B-Condition
virus NCT03864432 866 871 I-Condition
) NCT03864432 872 873 O
, NCT03864432 874 875 O
kidney NCT03864432 876 882 B-Modifier
, NCT03864432 883 884 O
respiratory NCT03864432 885 896 B-Modifier
system NCT03864432 897 903 I-Modifier
, NCT03864432 904 905 O
endocrine NCT03864432 906 915 B-Modifier
system NCT03864432 916 922 I-Modifier
, NCT03864432 923 924 O
nervous NCT03864432 925 932 B-Modifier
system NCT03864432 933 939 I-Modifier
or NCT03864432 940 942 B-Or
immune NCT03864432 943 949 B-Modifier
system NCT03864432 950 956 I-Modifier
. NCT03864432 957 958 O
Those NCT03864432 960 965 O
with NCT03864432 966 970 O
a NCT03864432 971 972 O
medical NCT03864432 973 980 O
history NCT03864432 981 988 B-Eq_Comparison
of NCT03864432 989 991 O
hematology NCT03864432 992 1002 B-Modifier
/ NCT03864432 1003 1004 B-Or
oncology NCT03864432 1005 1013 B-Modifier
, NCT03864432 1014 1015 O
psychiatry NCT03864432 1016 1026 B-Modifier
or NCT03864432 1027 1029 B-Or
cardiovascular NCT03864432 1030 1044 B-Modifier
diseases NCT03864432 1045 1053 B-Condition
. NCT03864432 1054 1055 O

- NCT03864432 1059 1060 O
Those NCT03864432 1062 1067 O
with NCT03864432 1068 1072 O
a NCT03864432 1073 1074 O
medical NCT03864432 1075 1082 O
history NCT03864432 1083 1090 B-Eq_Comparison
of NCT03864432 1091 1093 O
gastrointestinal NCT03864432 1094 1110 B-Condition
diseases NCT03864432 1111 1119 I-Condition
( NCT03864432 1120 1121 O
ulcers NCT03864432 1122 1128 B-Condition
, NCT03864432 1129 1130 O
Crohn NCT03864432 1131 1136 B-Condition
's NCT03864432 1136 1138 I-Condition
disease NCT03864432 1139 1146 I-Condition
, NCT03864432 1147 1148 O
etc NCT03864432 1149 1152 O
. NCT03864432 1153 1154 O
) NCT03864432 1155 1156 O
or NCT03864432 1157 1159 B-Or
surgery NCT03864432 1160 1167 B-Procedure
( NCT03864432 1168 1169 O
excluding NCT03864432 1170 1179 B-Exception
simple NCT03864432 1180 1186 B-Modifier
appendectomy NCT03864432 1187 1199 B-Procedure
or NCT03864432 1200 1202 B-Or
hernia NCT03864432 1203 1209 B-Procedure
repair NCT03864432 1210 1216 I-Procedure
) NCT03864432 1217 1218 O
, NCT03864432 1219 1220 O
and NCT03864432 1221 1224 O
these NCT03864432 1225 1230 O
situations NCT03864432 1231 1241 O
can NCT03864432 1242 1245 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03864432 1246 1252 O
the NCT03864432 1253 1256 O
absorption NCT03864432 1257 1267 B-Condition
of NCT03864432 1268 1270 O
the NCT03864432 1271 1274 O
study NCT03864432 1275 1280 B-Study
drug NCT03864432 1281 1285 B-Drug
. NCT03864432 1286 1287 O

Inclusion NCT03861065 0 9 O
Criteria NCT03861065 10 18 O
: NCT03861065 19 20 O

- NCT03861065 24 25 O
Patients NCT03861065 27 35 O
with NCT03861065 36 40 O
high NCT03861065 41 45 O
risk NCT03861065 46 50 B-Risk
class NCT03861065 51 56 B-Eq_Comparison
II NCT03861065 57 59 I-Eq_Comparison
, NCT03861065 60 61 I-Eq_Comparison
class NCT03861065 62 67 I-Eq_Comparison
III NCT03861065 68 71 I-Eq_Comparison
, NCT03861065 72 73 O
class NCT03861065 74 79 B-Eq_Comparison
IV NCT03861065 80 82 I-Eq_Comparison
abdominal NCT03861065 83 92 B-Modifier
wounds NCT03861065 93 99 B-Condition

- NCT03861065 102 103 O
Undergoing NCT03861065 105 115 B-Eq_Comparison
laparotomy NCT03861065 116 126 B-Procedure
for NCT03861065 127 130 O
gynecologic NCT03861065 131 142 B-Condition
related NCT03861065 143 150 I-Condition
disorders NCT03861065 151 160 I-Condition

- NCT03861065 163 164 O
Patients NCT03861065 166 174 O
undergoing NCT03861065 175 185 B-Eq_Comparison
laparotomy NCT03861065 186 196 B-Procedure
for NCT03861065 197 200 O
both NCT03861065 201 205 O
benign NCT03861065 206 212 B-Modifier
and NCT03861065 213 216 B-Or
malignant NCT03861065 217 226 B-Modifier
diagnoses NCT03861065 227 236 B-Condition
will NCT03861065 237 241 O
be NCT03861065 242 244 O
included NCT03861065 245 253 O
in NCT03861065 254 256 O
this NCT03861065 257 261 O
study NCT03861065 262 267 B-Study

Exclusion NCT03861065 268 277 O
Criteria NCT03861065 278 286 O
: NCT03861065 287 288 O

- NCT03861065 292 293 O
Pregnancy NCT03861065 295 304 B-Condition

- NCT03861065 307 308 O
Allergy NCT03861065 310 317 B-Allergy
to NCT03861065 318 320 O
triclosan NCT03861065 321 330 B-Drug

- NCT03861065 333 334 O
Patients NCT03861065 336 344 O
undergoing NCT03861065 345 355 B-Eq_Comparison
HIPEC NCT03861065 356 361 B-Procedure

Inclusion NCT03928366 0 9 O
Criteria NCT03928366 10 18 O
: NCT03928366 19 20 O

- NCT03928366 24 25 O
Healthy NCT03928366 27 34 B-Condition
adult NCT03928366 35 40 O
volunteers NCT03928366 41 51 O
( NCT03928366 52 53 O
ASA NCT03928366 54 57 B-Observation
1 NCT03928366 58 59 B-Eq_Comparison
physical NCT03928366 60 68 O
state NCT03928366 69 74 O
) NCT03928366 75 76 O
who NCT03928366 77 80 O
agree NCT03928366 81 86 O
to NCT03928366 87 89 O
participate NCT03928366 90 101 O
voluntarily NCT03928366 102 113 O
in NCT03928366 114 116 O
the NCT03928366 117 120 O
study NCT03928366 121 126 B-Study
, NCT03928366 127 128 O
previous NCT03928366 129 137 B-Eq_Comparison
information NCT03928366 138 149 O
about NCT03928366 150 155 O
it NCT03928366 156 158 O
by NCT03928366 159 161 O
the NCT03928366 162 165 O
Principal NCT03928366 166 175 O
Investigators NCT03928366 176 189 O
( NCT03928366 190 191 O
IP NCT03928366 192 194 O
) NCT03928366 195 196 O
. NCT03928366 197 198 O

Exclusion NCT03928366 200 209 O
Criteria NCT03928366 210 218 O
: NCT03928366 219 220 O

- NCT03928366 224 225 O
Psychological NCT03928366 227 240 B-Modifier
, NCT03928366 241 242 O
psychiatric NCT03928366 243 254 B-Modifier
or NCT03928366 255 257 B-Or
neurological NCT03928366 258 270 B-Modifier
disorders NCT03928366 271 280 B-Condition
. NCT03928366 281 282 O
Consumption NCT03928366 284 295 O
of NCT03928366 296 298 O
drugs NCT03928366 299 304 B-Drug
. NCT03928366 305 306 O
Alterations NCT03928366 308 319 B-Condition
cutaneous NCT03928366 320 329 B-Modifier
or NCT03928366 330 332 B-Or
anatomical NCT03928366 333 343 B-Modifier
cranial NCT03928366 344 351 I-Modifier
. NCT03928366 352 353 O
Idiomatic NCT03928366 355 364 B-Modifier
or NCT03928366 365 367 B-Or
communication NCT03928366 368 381 B-Modifier
barrier NCT03928366 382 389 B-Condition
. NCT03928366 390 391 O
Allergy NCT03928366 393 400 B-Allergy
to NCT03928366 401 403 O
propofol NCT03928366 404 412 B-Drug
, NCT03928366 413 414 O
remifentanil NCT03928366 415 427 B-Drug
or NCT03928366 428 430 O
to NCT03928366 431 433 O
some NCT03928366 434 438 O
of NCT03928366 439 441 O
its NCT03928366 442 445 O
excipients NCT03928366 446 456 O
. NCT03928366 457 458 O
Body NCT03928366 460 464 B-Observation
mass NCT03928366 465 469 I-Observation
index NCT03928366 470 475 I-Observation
( NCT03928366 476 477 O
BMI NCT03928366 478 481 B-Observation
) NCT03928366 482 483 O
< NCT03928366 484 485 B-Eq_Comparison
18 NCT03928366 486 488 I-Eq_Comparison
or NCT03928366 489 491 B-Or
> NCT03928366 492 493 B-Eq_Comparison
30 NCT03928366 494 496 I-Eq_Comparison
kg NCT03928366 497 499 I-Eq_Comparison
/ NCT03928366 500 501 I-Eq_Comparison
m NCT03928366 502 503 I-Eq_Comparison
2 NCT03928366 504 505 I-Eq_Comparison
. NCT03928366 505 506 O
Pregnancy NCT03928366 508 517 B-Condition
. NCT03928366 518 519 O
Airway NCT03928366 521 527 B-Modifier
or NCT03928366 528 530 B-Or
ventilation NCT03928366 531 542 B-Modifier
criteria NCT03928366 543 551 O
hard NCT03928366 552 556 B-Condition
. NCT03928366 557 558 O
Absence NCT03928366 560 567 B-Negation
of NCT03928366 568 570 O
accompanying NCT03928366 571 583 O
adult NCT03928366 584 589 B-Family_Member___Family_Member_Type:parent
at NCT03928366 590 592 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928366 593 596 O
end NCT03928366 597 600 O
of NCT03928366 601 603 O
the NCT03928366 604 607 O
study NCT03928366 608 613 B-Study
. NCT03928366 614 615 O

Inclusion NCT03920787 0 9 O
Criteria NCT03920787 10 18 O
: NCT03920787 19 20 O

- NCT03920787 24 25 O
8 NCT03920787 27 28 B-Eq_Comparison
- NCT03920787 29 30 I-Eq_Comparison
18 NCT03920787 31 33 I-Eq_Comparison
years NCT03920787 34 39 I-Eq_Comparison
old NCT03920787 40 43 B-Age

- NCT03920787 46 47 O
overweight NCT03920787 49 59 B-Condition
or NCT03920787 60 62 B-Or
obesity NCT03920787 63 70 B-Condition

- NCT03920787 73 74 O
basal NCT03920787 76 81 B-Drug
insulin NCT03920787 82 89 I-Drug
≥ NCT03920787 90 91 B-Eq_Comparison
20 NCT03920787 92 94 I-Eq_Comparison
uU NCT03920787 95 97 I-Eq_Comparison
/ NCT03920787 98 99 I-Eq_Comparison
ml NCT03920787 100 102 I-Eq_Comparison

Exclusion NCT03920787 103 112 O
Criteria NCT03920787 113 121 O
: NCT03920787 122 123 O

- NCT03920787 127 128 O
pubertal NCT03920787 130 138 B-Condition
delay NCT03920787 139 144 I-Condition

- NCT03920787 147 148 O
hypogonadism NCT03920787 150 162 B-Condition

- NCT03920787 165 166 O
hypothyroidism NCT03920787 168 182 B-Condition
or NCT03920787 183 185 B-Or
hyperthyroidism NCT03920787 186 201 B-Condition

- NCT03920787 204 205 O
obesity NCT03920787 207 214 B-Condition
- NCT03920787 215 216 O
related NCT03920787 217 224 O
genetic NCT03920787 225 232 B-Condition
diseases NCT03920787 233 241 I-Condition

Inclusion NCT03868150 0 9 O
Criteria NCT03868150 10 18 O
: NCT03868150 19 20 O

- NCT03868150 24 25 O
Patients NCT03868150 27 35 O
scheduled NCT03868150 36 45 B-Eq_Comparison
for NCT03868150 46 49 O
first NCT03868150 50 55 B-Eq_Comparison
- NCT03868150 56 57 I-Eq_Comparison
time NCT03868150 58 62 I-Eq_Comparison
non NCT03868150 63 66 B-Negation
- NCT03868150 67 68 O
emergent NCT03868150 69 77 B-Modifier
open NCT03868150 78 82 B-Procedure
- NCT03868150 83 84 I-Procedure
heart NCT03868150 85 90 I-Procedure
surgery NCT03868150 91 98 I-Procedure
for NCT03868150 99 102 O
coronary NCT03868150 103 111 B-Procedure
artery NCT03868150 112 118 I-Procedure
bypass NCT03868150 119 125 I-Procedure
graft NCT03868150 126 131 I-Procedure
( NCT03868150 132 133 O
CABG NCT03868150 134 138 B-Procedure
) NCT03868150 139 140 O
revascularization NCT03868150 141 158 B-Modifier
, NCT03868150 159 160 O
valvular NCT03868150 161 169 B-Procedure
repair NCT03868150 170 176 B-Modifier
or NCT03868150 177 179 B-Or
replacement NCT03868150 180 191 B-Modifier
, NCT03868150 192 193 O
combined NCT03868150 194 202 B-Modifier
CABG NCT03868150 203 207 B-Procedure
with NCT03868150 208 212 B-And
valve NCT03868150 213 218 B-Procedure
repair NCT03868150 219 225 B-Modifier
or NCT03868150 226 228 B-Or
replacement NCT03868150 229 240 B-Modifier
, NCT03868150 241 242 O
or NCT03868150 243 245 B-Or
valve NCT03868150 246 251 B-Procedure
sparing NCT03868150 252 259 I-Procedure
aortic NCT03868150 260 266 I-Procedure
root NCT03868150 267 271 I-Procedure
repair NCT03868150 272 278 I-Procedure

- NCT03868150 281 282 O
Normal NCT03868150 284 290 O
sinus NCT03868150 291 296 B-Condition
rhythm NCT03868150 297 303 I-Condition

- NCT03868150 306 307 O
No NCT03868150 309 311 B-Negation
documented NCT03868150 312 322 O
history NCT03868150 323 330 B-Eq_Comparison
of NCT03868150 331 333 O
atrial NCT03868150 334 340 B-Condition
fibrillation NCT03868150 341 353 I-Condition

Exclusion NCT03868150 354 363 O
Criteria NCT03868150 364 372 O
: NCT03868150 373 374 O

- NCT03868150 378 379 O
Prior NCT03868150 381 386 B-Eq_Comparison
surgical NCT03868150 387 395 B-Procedure
procedures NCT03868150 396 406 I-Procedure
involving NCT03868150 407 416 O
heart NCT03868150 417 422 B-Procedure
surgery NCT03868150 423 430 I-Procedure
and NCT03868150 431 434 B-Or
cardiopulmonary NCT03868150 435 450 B-Procedure
bypass NCT03868150 451 457 I-Procedure

- NCT03868150 460 461 O
Any NCT03868150 463 466 O
prior NCT03868150 467 472 B-Eq_Comparison
documented NCT03868150 473 483 O
history NCT03868150 484 491 B-Eq_Comparison
of NCT03868150 492 494 O
atrial NCT03868150 495 501 B-Condition
fibrillation NCT03868150 502 514 I-Condition
, NCT03868150 515 516 O
atrial NCT03868150 517 523 B-Condition
flutter NCT03868150 524 531 I-Condition
or NCT03868150 532 534 B-Or
atrial NCT03868150 535 541 B-Condition
tachycardia NCT03868150 542 553 I-Condition
lasting NCT03868150 554 561 O
longer NCT03868150 562 568 B-Eq_Comparison
than NCT03868150 569 573 I-Eq_Comparison
30 NCT03868150 574 576 I-Eq_Comparison
seconds NCT03868150 577 584 I-Eq_Comparison

- NCT03868150 587 588 O
Prior NCT03868150 590 595 B-Eq_Comparison
history NCT03868150 596 603 I-Eq_Comparison
of NCT03868150 604 606 O
Amiodarone NCT03868150 607 617 B-Drug
treatment NCT03868150 618 627 B-Procedure
for NCT03868150 628 631 O
the NCT03868150 632 635 O
management NCT03868150 636 646 O
of NCT03868150 647 649 O
supraventricular NCT03868150 650 666 B-Modifier
tachy NCT03868150 667 672 B-Condition
- NCT03868150 673 674 I-Condition
arrhythmias NCT03868150 675 686 I-Condition

- NCT03868150 689 690 O
Patients NCT03868150 692 700 O
requiring NCT03868150 701 710 B-Assertion___Assertion_Type_Value:hypothetical
surgical NCT03868150 711 719 B-Procedure
treatment NCT03868150 720 729 I-Procedure
of NCT03868150 730 732 O
atrial NCT03868150 733 739 B-Condition
arrhythmias NCT03868150 740 751 I-Condition
such NCT03868150 752 756 O
as NCT03868150 757 759 O
pulmonary NCT03868150 760 769 B-Procedure
vein NCT03868150 770 774 I-Procedure
isolation NCT03868150 775 784 I-Procedure
or NCT03868150 785 787 B-Or
Maze NCT03868150 788 792 B-Procedure
procedure NCT03868150 793 802 I-Procedure
. NCT03868150 803 804 O

Inclusion NCT03921593 0 9 O
Criteria NCT03921593 10 18 O
: NCT03921593 19 20 O

- NCT03921593 24 25 O
Willing NCT03921593 27 34 O
and NCT03921593 35 38 O
able NCT03921593 39 43 O
to NCT03921593 44 46 O
give NCT03921593 47 51 O
informed NCT03921593 52 60 O
consent NCT03921593 61 68 O
for NCT03921593 69 72 O
participation NCT03921593 73 86 O
in NCT03921593 87 89 O
the NCT03921593 90 93 O
study NCT03921593 94 99 O

- NCT03921593 102 103 O
Insulin NCT03921593 105 112 B-Modifier
Dependent NCT03921593 113 122 I-Modifier
Diabetic NCT03921593 123 131 B-Condition
Patients NCT03921593 132 140 O

- NCT03921593 143 144 O
Active NCT03921593 146 152 B-Eq_Comparison
on NCT03921593 153 155 O
Pancreas NCT03921593 156 164 B-Observation
Transplant NCT03921593 165 175 I-Observation
Wait NCT03921593 176 180 I-Observation
List NCT03921593 181 185 I-Observation

Exclusion NCT03921593 186 195 O
Criteria NCT03921593 196 204 O
: NCT03921593 205 206 O

- NCT03921593 210 211 O
Not NCT03921593 213 216 B-Negation
fluent NCT03921593 217 223 O
in NCT03921593 224 226 O
English NCT03921593 227 234 O

Inclusion NCT03921853 0 9 O
Criteria NCT03921853 10 18 O
: NCT03921853 19 20 O

Inclusion NCT03921853 22 31 O
Criteria NCT03921853 32 40 O
: NCT03921853 41 42 O

- NCT03921853 46 47 O
Older NCT03921853 49 54 B-Eq_Comparison
than NCT03921853 55 59 I-Eq_Comparison
18 NCT03921853 60 62 I-Eq_Comparison
and NCT03921853 63 66 O
younger NCT03921853 67 74 O
and NCT03921853 75 78 B-And
≤ NCT03921853 79 80 B-Eq_Comparison
65 NCT03921853 81 83 I-Eq_Comparison
years NCT03921853 84 89 I-Eq_Comparison
of NCT03921853 90 92 O
age NCT03921853 93 96 B-Age
. NCT03921853 97 98 O

- NCT03921853 102 103 O
With NCT03921853 105 109 O
risk NCT03921853 110 114 B-Risk
factors NCT03921853 115 122 O
to NCT03921853 123 125 O
Metabolic NCT03921853 126 135 B-Condition
syndrome NCT03921853 136 144 I-Condition

- NCT03921853 147 148 O
With NCT03921853 150 154 O
obesity NCT03921853 155 162 B-Condition
and NCT03921853 163 166 B-And
morbid NCT03921853 167 173 B-Condition
obesity NCT03921853 174 181 I-Condition
condition NCT03921853 182 191 O

- NCT03921853 194 195 O
Medical NCT03921853 197 204 O
authorization NCT03921853 205 218 O
by NCT03921853 219 221 O
a NCT03921853 222 223 O
physician NCT03921853 224 233 O
. NCT03921853 234 235 O

Exclusion NCT03921853 237 246 O
Criteria NCT03921853 247 255 O
: NCT03921853 256 257 O

- NCT03921853 261 262 O
Physical NCT03921853 264 272 B-Condition
limitations NCT03921853 273 284 I-Condition
( NCT03921853 285 286 O
e NCT03921853 287 288 O
. NCT03921853 289 290 O
g NCT03921853 291 292 O
. NCT03921853 293 294 O
, NCT03921853 295 296 O
restricting NCT03921853 297 308 B-Modifier
injuries NCT03921853 309 317 B-Condition
of NCT03921853 318 320 O
the NCT03921853 321 324 O
musculoskeletal NCT03921853 325 340 B-Modifier
system NCT03921853 341 347 I-Modifier
, NCT03921853 348 349 O
or NCT03921853 350 352 O
dependent NCT03921853 353 362 B-Observation
of NCT03921853 363 365 I-Observation
a NCT03921853 366 367 I-Observation
third NCT03921853 368 373 I-Observation
person NCT03921853 374 380 I-Observation
) NCT03921853 381 382 O
. NCT03921853 383 384 O

- NCT03921853 388 389 O
Exercise NCT03921853 391 399 B-Observation
- NCT03921853 400 401 O
related NCT03921853 402 409 O
dyspnoea NCT03921853 410 418 B-Condition
or NCT03921853 419 421 B-Or
respiratory NCT03921853 422 433 B-Condition
alterations NCT03921853 434 445 O
. NCT03921853 446 447 O

- NCT03921853 451 452 O
Chronic NCT03921853 454 461 O
heart NCT03921853 462 467 B-Condition
disease NCT03921853 468 475 I-Condition
with NCT03921853 476 480 O
any NCT03921853 481 484 O
worsening NCT03921853 485 494 O
in NCT03921853 495 497 O
the NCT03921853 498 501 O
last NCT03921853 502 506 B-Eq_Comparison
month NCT03921853 507 512 I-Eq_Comparison
. NCT03921853 513 514 O

- NCT03921853 518 519 O
Adherence NCT03921853 521 530 B-Observation
rate NCT03921853 531 535 I-Observation
of NCT03921853 536 538 O
less NCT03921853 539 543 B-Eq_Comparison
than NCT03921853 544 548 I-Eq_Comparison
80 NCT03921853 549 551 I-Eq_Comparison
% NCT03921853 552 553 I-Eq_Comparison
of NCT03921853 554 556 O
the NCT03921853 557 560 O
total NCT03921853 561 566 O
interventions NCT03921853 567 580 O
. NCT03921853 581 582 O

Inclusion NCT03923920 0 9 O
Criteria NCT03923920 10 18 O
: NCT03923920 19 20 O

- NCT03923920 24 25 O
Age NCT03923920 27 30 B-Age
≥ NCT03923920 31 32 B-Eq_Comparison
50 NCT03923920 33 35 I-Eq_Comparison
years NCT03923920 36 41 I-Eq_Comparison

- NCT03923920 44 45 O
Undergoing NCT03923920 47 57 B-Eq_Comparison
surgical NCT03923920 58 66 B-Procedure
intervention NCT03923920 67 79 I-Procedure
for NCT03923920 80 83 O
non NCT03923920 84 87 B-Negation
- NCT03923920 88 89 O
congenital NCT03923920 90 100 B-Modifier
spinal NCT03923920 101 107 B-Condition
stenosis NCT03923920 108 116 I-Condition
and NCT03923920 117 120 B-Or
/ NCT03923920 121 122 I-Or
or NCT03923920 123 125 I-Or
spondyloarthropathy NCT03923920 126 145 B-Condition

- NCT03923920 148 149 O
Able NCT03923920 151 155 O
to NCT03923920 156 158 O
consent NCT03923920 159 166 O

Exclusion NCT03923920 167 176 O
Criteria NCT03923920 177 185 O
: NCT03923920 186 187 O

- NCT03923920 191 192 O
History NCT03923920 194 201 B-Eq_Comparison
of NCT03923920 202 204 O
congenital NCT03923920 205 215 B-Condition
spinal NCT03923920 216 222 I-Condition
stenosis NCT03923920 223 231 I-Condition
or NCT03923920 232 234 B-Or
congenital NCT03923920 235 245 B-Condition
spondyloarthropathy NCT03923920 246 265 I-Condition

Inclusion NCT03922269 0 9 O
Criteria NCT03922269 10 18 O
: NCT03922269 19 20 O

- NCT03922269 24 25 O
Participant NCT03922269 27 38 O
self NCT03922269 39 43 O
- NCT03922269 44 45 O
identifies NCT03922269 46 56 O
as NCT03922269 57 59 O
transgender NCT03922269 60 71 O
and NCT03922269 72 75 B-Or
/ NCT03922269 76 77 I-Or
or NCT03922269 78 80 I-Or
has NCT03922269 81 84 O
a NCT03922269 85 86 O
current NCT03922269 87 94 B-Eq_Comparison
gender NCT03922269 95 101 B-Observation
identity NCT03922269 102 110 I-Observation
which NCT03922269 111 116 B-And
differs NCT03922269 117 124 B-Negation
from NCT03922269 125 129 O
gender NCT03922269 130 136 B-Observation
assigned NCT03922269 137 145 O
at NCT03922269 146 148 B-Temporal_Connection___Temporal_Connection_Type_Value:during
birth NCT03922269 149 154 B-Birth
( NCT03922269 155 156 O
includes NCT03922269 157 165 O
all NCT03922269 166 169 O
gender NCT03922269 170 176 O
diverse NCT03922269 177 184 O
people NCT03922269 185 191 O
) NCT03922269 192 193 O

- NCT03922269 197 198 O
Age NCT03922269 200 203 B-Age
> NCT03922269 204 205 B-Eq_Comparison
18 NCT03922269 206 208 I-Eq_Comparison
years NCT03922269 209 214 I-Eq_Comparison

- NCT03922269 217 218 O
HIV NCT03922269 220 223 B-Condition
infection NCT03922269 224 233 I-Condition
diagnosis NCT03922269 234 243 O
at NCT03922269 244 246 O
any NCT03922269 247 250 O
time NCT03922269 251 255 O
before NCT03922269 256 262 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03922269 263 268 B-Study
consent NCT03922269 269 276 O

- NCT03922269 279 280 O
Having NCT03922269 282 288 O
been NCT03922269 289 293 O
prescribed NCT03922269 294 304 O
antiretroviral NCT03922269 305 319 B-Procedure
therapy NCT03922269 320 327 I-Procedure
at NCT03922269 328 330 O
any NCT03922269 331 334 O
time NCT03922269 335 339 O
( NCT03922269 340 341 O
including NCT03922269 342 351 O
people NCT03922269 352 358 O
for NCT03922269 359 362 O
who NCT03922269 363 366 O
antiretroviral NCT03922269 367 381 B-Procedure
therapy NCT03922269 382 389 I-Procedure
initiation NCT03922269 390 400 O
is NCT03922269 401 403 O
planned NCT03922269 404 411 B-Eq_Comparison
after NCT03922269 412 417 B-Temporal_Connection___Temporal_Connection_Type_Value:after
study NCT03922269 418 423 B-Study
enrolment NCT03922269 424 433 O
) NCT03922269 434 435 O

- NCT03922269 439 440 O
Willing NCT03922269 442 449 O
to NCT03922269 450 452 O
sign NCT03922269 453 457 O
an NCT03922269 458 460 O
informed NCT03922269 461 469 O
consent NCT03922269 470 477 O
and NCT03922269 478 481 O
take NCT03922269 482 486 O
part NCT03922269 487 491 O
in NCT03922269 492 494 O
the NCT03922269 495 498 O
study NCT03922269 499 504 O

Exclusion NCT03922269 505 514 O
Criteria NCT03922269 515 523 O
: NCT03922269 524 525 O

- NCT03922269 529 530 O
Age NCT03922269 532 535 B-Age
< NCT03922269 536 537 B-Eq_Comparison
18 NCT03922269 538 540 I-Eq_Comparison
years NCT03922269 541 546 I-Eq_Comparison

- NCT03922269 549 550 O
Unable NCT03922269 552 558 O
to NCT03922269 559 561 O
take NCT03922269 562 566 O
part NCT03922269 567 571 O
in NCT03922269 572 574 O
the NCT03922269 575 578 O
study NCT03922269 579 584 O
according NCT03922269 585 594 O
to NCT03922269 595 597 O
the NCT03922269 598 601 O
Investigator NCT03922269 602 614 O
opinion NCT03922269 615 622 O
( NCT03922269 623 624 O
example NCT03922269 625 632 O
: NCT03922269 633 634 O
unable NCT03922269 635 641 O
to NCT03922269 642 644 O
understand NCT03922269 645 655 O
the NCT03922269 656 659 O
study NCT03922269 660 665 O
information NCT03922269 666 677 O
leaflet NCT03922269 678 685 O
, NCT03922269 686 687 O
unable NCT03922269 688 694 O
to NCT03922269 695 697 O
provide NCT03922269 698 705 O
written NCT03922269 706 713 O
consent NCT03922269 714 721 O
, NCT03922269 722 723 O
etc NCT03922269 724 727 O
. NCT03922269 728 729 O
) NCT03922269 730 731 O

Inclusion NCT03869398 0 9 O
Criteria NCT03869398 10 18 O
: NCT03869398 19 20 O

- NCT03869398 24 25 O
All NCT03869398 27 30 O
patients NCT03869398 31 39 O
, NCT03869398 40 41 O
age NCT03869398 42 45 B-Age
> NCT03869398 46 47 B-Eq_Comparison
18 NCT03869398 48 50 I-Eq_Comparison
, NCT03869398 51 52 O
undergoing NCT03869398 53 63 B-Eq_Comparison
total NCT03869398 64 69 B-Procedure
thyroidectomy NCT03869398 70 83 I-Procedure
are NCT03869398 84 87 O
eligible NCT03869398 88 96 O
. NCT03869398 97 98 O

Exclusion NCT03869398 100 109 O
Criteria NCT03869398 110 118 O
: NCT03869398 119 120 O

- NCT03869398 124 125 O
partial NCT03869398 127 134 B-Procedure
thyroidectomy NCT03869398 135 148 I-Procedure
, NCT03869398 149 150 O
lobectomy NCT03869398 151 160 B-Procedure
, NCT03869398 161 162 O
or NCT03869398 163 165 B-Or
concurrent NCT03869398 166 176 B-Modifier
parathyroidectomy NCT03869398 177 194 B-Procedure
. NCT03869398 195 196 O

Inclusion NCT03866265 0 9 O
Criteria NCT03866265 10 18 O
: NCT03866265 19 20 O

- NCT03866265 24 25 O
The NCT03866265 27 30 O
selection NCT03866265 31 40 O
criteria NCT03866265 41 49 O
of NCT03866265 50 52 O
the NCT03866265 53 56 O
subjects NCT03866265 57 65 O
will NCT03866265 66 70 O
be NCT03866265 71 73 O
as NCT03866265 74 76 O
follows NCT03866265 77 84 O
: NCT03866265 85 86 O

1 NCT03866265 95 96 O
. NCT03866265 96 97 O
they NCT03866265 99 103 O
need NCT03866265 104 108 O
to NCT03866265 109 111 O
be NCT03866265 112 114 O
off NCT03866265 115 118 B-Negation
medication NCT03866265 119 129 B-Drug
and NCT03866265 130 133 B-And
off NCT03866265 134 137 B-Negation
intake NCT03866265 138 144 O
of NCT03866265 145 147 O
dietary NCT03866265 148 155 B-Drug
supplements NCT03866265 156 167 I-Drug

2 NCT03866265 175 176 O
. NCT03866265 176 177 O
they NCT03866265 179 183 O
need NCT03866265 184 188 O
to NCT03866265 189 191 O
have NCT03866265 192 196 O
no NCT03866265 197 199 B-Negation
blood NCT03866265 200 205 B-Condition
clotting NCT03866265 206 214 I-Condition
disorders NCT03866265 215 224 I-Condition
or NCT03866265 225 227 B-Or
dyslipidaemia NCT03866265 228 241 B-Condition
and NCT03866265 242 245 B-And

Exclusion NCT03866265 246 255 O
Criteria NCT03866265 256 264 O
: NCT03866265 265 266 O

Subjects NCT03866265 268 276 O
with NCT03866265 277 281 O
clotting NCT03866265 282 290 B-Condition
disorders NCT03866265 291 300 I-Condition
, NCT03866265 301 302 O
dyslipidemia NCT03866265 303 315 B-Condition
or NCT03866265 316 318 B-Or
being NCT03866265 319 324 O
on NCT03866265 325 327 B-Eq_Comparison
medication NCT03866265 328 338 B-Drug
( NCT03866265 339 340 O
i NCT03866265 341 342 O
. NCT03866265 343 344 O
e NCT03866265 345 346 O
. NCT03866265 347 348 O
statins NCT03866265 350 357 B-Drug
) NCT03866265 358 359 O
or NCT03866265 360 362 B-Or
other NCT03866265 363 368 B-Other
supplements NCT03866265 369 380 B-Drug
during NCT03866265 381 387 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866265 388 391 O
study NCT03866265 392 397 B-Study
will NCT03866265 398 402 O
be NCT03866265 403 405 O
excluded NCT03866265 406 414 B-Negation
. NCT03866265 415 416 O


Inclusion NCT03863912 0 9 O
Criteria NCT03863912 10 18 O
: NCT03863912 19 20 O

- NCT03863912 24 25 O
planned NCT03863912 27 34 B-Eq_Comparison
6 NCT03863912 35 36 I-Eq_Comparison
cycles NCT03863912 37 43 I-Eq_Comparison
of NCT03863912 44 46 O
chemotherapy NCT03863912 47 59 B-Procedure
with NCT03863912 60 64 O
carboplatin NCT03863912 65 76 B-Drug
/ NCT03863912 77 78 B-Or
paclitaxel NCT03863912 79 89 B-Drug
or NCT03863912 90 92 B-Or
carboplatin NCT03863912 93 104 B-Drug
/ NCT03863912 105 106 B-Or
pegylated NCT03863912 107 116 B-Drug
liposomal NCT03863912 117 126 I-Drug
doxorubicin NCT03863912 127 138 I-Drug

- NCT03863912 141 142 O
Age NCT03863912 144 147 B-Age
> NCT03863912 148 149 B-Eq_Comparison
18 NCT03863912 150 152 I-Eq_Comparison
years NCT03863912 153 158 I-Eq_Comparison

Exclusion NCT03863912 159 168 O
Criteria NCT03863912 169 177 O
: NCT03863912 178 179 O

- NCT03863912 183 184 O
inadequate NCT03863912 186 196 B-Negation
knowledge NCT03863912 197 206 O
of NCT03863912 207 209 O
the NCT03863912 210 213 O
German NCT03863912 214 220 O
language NCT03863912 221 229 O

Inclusion NCT03921307 0 9 O
Criteria NCT03921307 10 18 O
: NCT03921307 19 20 O

- NCT03921307 24 25 O
Healthy NCT03921307 27 34 B-Condition
periodontal NCT03921307 35 46 I-Condition
tissue NCT03921307 47 53 I-Condition
Adequate NCT03921307 54 62 O
root NCT03921307 63 67 B-Procedure
canal NCT03921307 68 73 I-Procedure
treatment NCT03921307 74 83 I-Procedure

Exclusion NCT03921307 84 93 O
Criteria NCT03921307 94 102 O
: NCT03921307 103 104 O

- NCT03921307 108 109 O
Parafunctional NCT03921307 111 125 B-Condition
habits NCT03921307 126 132 I-Condition

Inclusion NCT03920449 0 9 O
Criteria NCT03920449 10 18 O
: NCT03920449 19 20 O

- NCT03920449 24 25 O
Chronic NCT03920449 27 34 O
anal NCT03920449 35 39 B-Condition
fissure NCT03920449 40 47 I-Condition
lasting NCT03920449 48 55 O
more NCT03920449 56 60 B-Eq_Comparison
than NCT03920449 61 65 I-Eq_Comparison
6 NCT03920449 66 67 I-Eq_Comparison
weeks NCT03920449 68 73 I-Eq_Comparison

Exclusion NCT03920449 74 83 O
Criteria NCT03920449 84 92 O
: NCT03920449 93 94 O

- NCT03920449 98 99 O
Pregnant NCT03920449 101 109 B-Condition

- NCT03920449 112 113 O
cardiovascular NCT03920449 115 129 B-Condition
disease NCT03920449 130 137 I-Condition
or NCT03920449 138 140 B-Or
heart NCT03920449 141 146 B-Condition
failure NCT03920449 147 154 I-Condition

- NCT03920449 157 158 O
on NCT03920449 160 162 B-Eq_Comparison
antihypertensive NCT03920449 163 179 B-Drug
medications NCT03920449 180 191 I-Drug

- NCT03920449 194 195 O
recurrent NCT03920449 197 206 O
anal NCT03920449 207 211 B-Condition
fissure NCT03920449 212 219 I-Condition
after NCT03920449 220 225 B-Temporal_Connection___Temporal_Connection_Type_Value:after
previous NCT03920449 226 234 B-Eq_Comparison
sphincterotomy NCT03920449 235 249 B-Procedure

- NCT03920449 252 253 O
prior NCT03920449 255 260 B-Eq_Comparison
history NCT03920449 261 268 I-Eq_Comparison
of NCT03920449 269 271 O
anal NCT03920449 272 276 B-Modifier
surgery NCT03920449 277 284 B-Procedure

- NCT03920449 287 288 O
other NCT03920449 290 295 B-Other
benign NCT03920449 296 302 B-Modifier
anorectal NCT03920449 303 312 B-Condition
diseases NCT03920449 313 321 I-Condition

- NCT03920449 324 325 O
with NCT03920449 327 331 O
inflammatory NCT03920449 332 344 B-Condition
bowel NCT03920449 345 350 I-Condition
diseases NCT03920449 351 359 I-Condition

Inclusion NCT03930901 0 9 O
Criteria NCT03930901 10 18 O
: NCT03930901 19 20 O

- NCT03930901 24 25 O
Grade NCT03930901 27 32 O
2 NCT03930901 33 34 O
- NCT03930901 35 36 O
6 NCT03930901 37 38 O

- NCT03930901 42 43 O
Orang NCT03930901 45 50 O
Asli NCT03930901 51 55 O
ethnicity NCT03930901 56 65 O

- NCT03930901 68 69 O
Schools NCT03930901 71 78 O
exclusively NCT03930901 79 90 O
for NCT03930901 91 94 O
Orang NCT03930901 95 100 O
Asli NCT03930901 101 105 O

Exclusion NCT03930901 106 115 O
Criteria NCT03930901 116 124 O
: NCT03930901 125 126 O

- NCT03930901 130 131 O
Grade NCT03930901 133 138 O
1 NCT03930901 139 140 O

- NCT03930901 144 145 O
Chronic NCT03930901 147 154 O
sever NCT03930901 155 160 B-Condition
diseases NCT03930901 161 169 I-Condition

- NCT03930901 172 173 O
no NCT03930901 175 177 O
consent NCT03930901 178 185 O

- NCT03930901 188 189 O
schools NCT03930901 191 198 O
for NCT03930901 199 202 O
mixed NCT03930901 203 208 O
population NCT03930901 209 219 O
groups NCT03930901 220 226 O

Inclusion NCT03860012 0 9 O
Criteria NCT03860012 10 18 O
: NCT03860012 19 20 O

1 NCT03860012 24 25 O
. NCT03860012 25 26 O
inflammatory NCT03860012 28 40 B-Condition
bowel NCT03860012 41 46 I-Condition
disease NCT03860012 47 54 I-Condition

2 NCT03860012 57 58 O
. NCT03860012 58 59 O
on NCT03860012 61 63 B-Eq_Comparison
methotrexate NCT03860012 64 76 B-Drug
at NCT03860012 77 79 O
appropriate NCT03860012 80 91 O
dosing NCT03860012 92 98 O

3 NCT03860012 101 102 O
. NCT03860012 102 103 O
normal NCT03860012 105 111 O
folate NCT03860012 112 118 B-Observation
levels NCT03860012 119 125 I-Observation
at NCT03860012 126 128 O
onset NCT03860012 129 134 B-Eq_Comparison
of NCT03860012 135 137 O
study NCT03860012 138 143 B-Study

4 NCT03860012 146 147 O
. NCT03860012 147 148 O
treatment NCT03860012 150 159 B-Procedure
with NCT03860012 160 164 O
folic NCT03860012 165 170 B-Drug
acid NCT03860012 171 175 I-Drug

5 NCT03860012 178 179 O
. NCT03860012 179 180 O
ages NCT03860012 182 186 B-Age
2 NCT03860012 187 188 B-Eq_Comparison
- NCT03860012 189 190 I-Eq_Comparison
21 NCT03860012 191 193 I-Eq_Comparison
years NCT03860012 194 199 I-Eq_Comparison

Exclusion NCT03860012 200 209 O
Criteria NCT03860012 210 218 O
: NCT03860012 219 220 O

1 NCT03860012 224 225 O
. NCT03860012 225 226 O
abnormal NCT03860012 228 236 O
folate NCT03860012 237 243 B-Observation
levels NCT03860012 244 250 I-Observation

2 NCT03860012 253 254 O
. NCT03860012 254 255 O
age NCT03860012 257 260 B-Age
> NCT03860012 261 262 B-Eq_Comparison
21 NCT03860012 263 265 I-Eq_Comparison
or NCT03860012 266 268 B-Or
less NCT03860012 269 273 B-Eq_Comparison
than NCT03860012 274 278 I-Eq_Comparison
2 NCT03860012 279 280 I-Eq_Comparison

Inclusion NCT03929198 0 9 O
Criteria NCT03929198 10 18 O
: NCT03929198 19 20 O

- NCT03929198 24 25 O
Dysfunctional NCT03929198 27 40 B-Condition
lipids NCT03929198 41 47 I-Condition
, NCT03929198 48 49 O
blood NCT03929198 50 55 B-Observation
pressure NCT03929198 56 64 I-Observation
and NCT03929198 65 68 B-And
glycemic NCT03929198 69 77 B-Condition
control NCT03929198 78 85 I-Condition
determined NCT03929198 86 96 O
at NCT03929198 97 99 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03929198 100 101 O
screening NCT03929198 102 111 B-Study
visit NCT03929198 112 117 O
: NCT03929198 118 119 O

- NCT03929198 128 129 O
Triglycerides NCT03929198 131 144 B-Observation
> NCT03929198 145 146 B-Eq_Comparison
150 NCT03929198 147 150 I-Eq_Comparison
mg NCT03929198 151 153 I-Eq_Comparison
/ NCT03929198 154 155 I-Eq_Comparison
dL NCT03929198 156 158 I-Eq_Comparison
OR NCT03929198 159 161 B-Or
HDL NCT03929198 162 165 B-Observation
< NCT03929198 166 167 B-Eq_Comparison
50 NCT03929198 168 170 I-Eq_Comparison
in NCT03929198 171 173 O
females NCT03929198 174 181 O
, NCT03929198 182 183 O
< NCT03929198 184 185 B-Eq_Comparison
40 NCT03929198 186 188 I-Eq_Comparison
mg NCT03929198 189 191 I-Eq_Comparison
/ NCT03929198 192 193 I-Eq_Comparison
dL NCT03929198 194 196 I-Eq_Comparison
in NCT03929198 197 199 O
males NCT03929198 200 205 O

- NCT03929198 213 214 O
Systolic NCT03929198 216 224 B-Observation
blood NCT03929198 225 230 I-Observation
pressure NCT03929198 231 239 I-Observation
≥ NCT03929198 240 241 B-Eq_Comparison
130 NCT03929198 242 245 I-Eq_Comparison
mmHg NCT03929198 246 250 I-Eq_Comparison
OR NCT03929198 251 253 B-Or
diastolic NCT03929198 254 263 B-Observation
blood NCT03929198 264 269 I-Observation
pressure NCT03929198 270 278 I-Observation
≥ NCT03929198 279 280 B-Eq_Comparison
80 NCT03929198 281 283 I-Eq_Comparison
mmHg NCT03929198 284 288 I-Eq_Comparison
( NCT03929198 289 290 O
or NCT03929198 291 293 B-Or
on NCT03929198 294 296 B-Eq_Comparison
hypertension NCT03929198 297 309 B-Condition
medication NCT03929198 310 320 B-Drug
) NCT03929198 321 322 O

- NCT03929198 331 332 O
HbA NCT03929198 334 337 B-Observation
1c NCT03929198 338 340 I-Observation
≥ NCT03929198 341 342 B-Eq_Comparison
5.7 NCT03929198 343 346 I-Eq_Comparison
% NCT03929198 347 348 I-Eq_Comparison
or NCT03929198 349 351 I-Eq_Comparison
higher NCT03929198 352 358 I-Eq_Comparison

- NCT03929198 361 362 O
No NCT03929198 364 366 B-Negation
diagnosis NCT03929198 367 376 O
or NCT03929198 377 379 O
treatment NCT03929198 380 389 B-Procedure
for NCT03929198 390 393 O
cancer NCT03929198 394 400 B-Condition
in NCT03929198 401 403 O
the NCT03929198 404 407 O
past NCT03929198 408 412 B-Eq_Comparison
year NCT03929198 413 417 I-Eq_Comparison

- NCT03929198 420 421 O
No NCT03929198 423 425 B-Negation
diagnosis NCT03929198 426 435 O
of NCT03929198 436 438 O
mild NCT03929198 439 443 B-Condition
cognitive NCT03929198 444 453 I-Condition
impairment NCT03929198 454 464 I-Condition
or NCT03929198 465 467 B-Or
dementia NCT03929198 468 476 B-Condition
in NCT03929198 477 479 O
the NCT03929198 480 483 O
past NCT03929198 484 488 B-Eq_Comparison
year NCT03929198 489 493 I-Eq_Comparison

- NCT03929198 496 497 O
Ability NCT03929198 499 506 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929198 507 509 I-Assertion___Assertion_Type_Value:hypothetical
perform NCT03929198 510 517 O
daily NCT03929198 518 523 B-Eq_Comparison
exercise NCT03929198 524 532 B-Observation
, NCT03929198 533 534 O
including NCT03929198 535 544 O
aerobic NCT03929198 545 552 B-Observation
activity NCT03929198 553 561 I-Observation
and NCT03929198 562 565 O
resistance NCT03929198 566 576 B-Observation
exercise NCT03929198 577 585 I-Observation

- NCT03929198 588 589 O
Non NCT03929198 591 594 B-Negation
- NCT03929198 595 596 O
smoker NCT03929198 597 603 B-Condition
in NCT03929198 604 606 O
the NCT03929198 607 610 O
past NCT03929198 611 615 B-Eq_Comparison
year NCT03929198 616 620 I-Eq_Comparison

Exclusion NCT03929198 621 630 O
Criteria NCT03929198 631 639 O
: NCT03929198 640 641 O

- NCT03929198 645 646 O
Positive NCT03929198 648 656 O
exercise NCT03929198 657 665 B-Observation
stress NCT03929198 666 672 I-Observation
test NCT03929198 673 677 I-Observation

Inclusion NCT03868683 0 9 O
Criteria NCT03868683 10 18 O
: NCT03868683 19 20 O

- NCT03868683 24 25 O
Chinese NCT03868683 27 34 O
ethnicity NCT03868683 35 44 O

- NCT03868683 47 48 O
Age NCT03868683 50 53 B-Age
≥ NCT03868683 54 55 B-Eq_Comparison
21 NCT03868683 56 58 I-Eq_Comparison
and NCT03868683 59 62 B-And
≤ NCT03868683 63 64 B-Eq_Comparison
60 NCT03868683 65 67 I-Eq_Comparison
years NCT03868683 68 73 I-Eq_Comparison

- NCT03868683 76 77 O
Body NCT03868683 79 83 B-Observation
mass NCT03868683 84 88 I-Observation
index NCT03868683 89 94 I-Observation
between NCT03868683 95 102 B-Eq_Comparison
18.5 NCT03868683 103 107 I-Eq_Comparison
to NCT03868683 108 110 I-Eq_Comparison
25 NCT03868683 111 113 I-Eq_Comparison
kg NCT03868683 114 116 I-Eq_Comparison
/ NCT03868683 117 118 I-Eq_Comparison
m NCT03868683 119 120 I-Eq_Comparison
2 NCT03868683 121 122 I-Eq_Comparison

- NCT03868683 125 126 O
Normal NCT03868683 128 134 O
blood NCT03868683 135 140 B-Observation
pressure NCT03868683 141 149 I-Observation
< NCT03868683 150 151 B-Eq_Comparison
140 NCT03868683 152 155 I-Eq_Comparison
/ NCT03868683 156 157 I-Eq_Comparison
90 NCT03868683 158 160 I-Eq_Comparison
mmHg NCT03868683 161 165 I-Eq_Comparison

- NCT03868683 168 169 O
Fasting NCT03868683 171 178 B-Modifier
blood NCT03868683 179 184 B-Observation
glucose NCT03868683 185 192 I-Observation
< NCT03868683 193 194 B-Eq_Comparison
6.0 NCT03868683 195 198 I-Eq_Comparison
mmol NCT03868683 199 203 I-Eq_Comparison
/ NCT03868683 204 205 I-Eq_Comparison
L NCT03868683 206 207 I-Eq_Comparison

- NCT03868683 210 211 O
In NCT03868683 213 215 O
general NCT03868683 216 223 O
good NCT03868683 224 228 B-Condition
health NCT03868683 229 235 I-Condition

Exclusion NCT03868683 236 245 O
Criteria NCT03868683 246 254 O
: NCT03868683 255 256 O

- NCT03868683 260 261 O
Current NCT03868683 263 270 B-Eq_Comparison
Smoker NCT03868683 271 277 B-Condition

- NCT03868683 280 281 O
have NCT03868683 283 287 O
any NCT03868683 288 291 O
metabolic NCT03868683 292 301 B-Condition
diseases NCT03868683 302 310 I-Condition
( NCT03868683 311 312 O
such NCT03868683 313 317 O
as NCT03868683 318 320 O
diabetes NCT03868683 321 329 B-Condition
, NCT03868683 330 331 O
hypertension NCT03868683 332 344 B-Condition
etc NCT03868683 345 348 O
) NCT03868683 349 350 O

- NCT03868683 354 355 O
have NCT03868683 357 361 O
known NCT03868683 362 367 O
glucose NCT03868683 368 375 B-Condition
- NCT03868683 376 377 I-Condition
6 NCT03868683 378 379 I-Condition
- NCT03868683 380 381 I-Condition
phosphate NCT03868683 382 391 I-Condition
dehydrogenase NCT03868683 392 405 I-Condition
deficiency NCT03868683 406 416 I-Condition
( NCT03868683 417 418 O
G NCT03868683 419 420 B-Condition
6PD NCT03868683 421 424 I-Condition
deficiency NCT03868683 425 435 I-Condition
) NCT03868683 436 437 O

- NCT03868683 441 442 O
having NCT03868683 444 450 O
medical NCT03868683 451 458 B-Condition
conditions NCT03868683 459 469 I-Condition
and NCT03868683 470 473 B-Or
/ NCT03868683 474 475 I-Or
or NCT03868683 476 478 I-Or
taking NCT03868683 479 485 B-Eq_Comparison
medications NCT03868683 486 497 B-Drug
known NCT03868683 498 503 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868683 504 506 I-Assertion___Assertion_Type_Value:hypothetical
affect NCT03868683 507 513 O
glycaemia NCT03868683 514 523 B-Condition
( NCT03868683 524 525 O
glucocorticoids NCT03868683 526 541 B-Drug
, NCT03868683 542 543 O
thyroid NCT03868683 544 551 B-Drug
hormones NCT03868683 552 560 I-Drug
, NCT03868683 561 562 O
thiazide NCT03868683 563 571 B-Drug
diuretics NCT03868683 572 581 I-Drug
) NCT03868683 582 583 O

- NCT03868683 587 588 O
have NCT03868683 590 594 O
intolerances NCT03868683 595 607 B-Condition
or NCT03868683 608 610 B-Or
allergies NCT03868683 611 620 B-Allergy
to NCT03868683 621 623 O
any NCT03868683 624 627 O
foods NCT03868683 628 633 O

- NCT03868683 636 637 O
partake NCT03868683 639 646 O
in NCT03868683 647 649 O
sports NCT03868683 650 656 B-Observation
at NCT03868683 657 659 O
the NCT03868683 660 663 O
competitive NCT03868683 664 675 B-Modifier
and NCT03868683 676 679 B-Or
/ NCT03868683 680 681 I-Or
or NCT03868683 682 684 I-Or
endurance NCT03868683 685 694 B-Modifier
levels NCT03868683 695 701 O

- NCT03868683 704 705 O
intentionally NCT03868683 707 720 O
restrict NCT03868683 721 729 B-Negation
food NCT03868683 730 734 B-Condition
intake NCT03868683 735 741 I-Condition

Inclusion NCT03867058 0 9 O
Criteria NCT03867058 10 18 O
: NCT03867058 19 20 O

- NCT03867058 24 25 O
Native NCT03867058 27 33 O
speakers NCT03867058 34 42 O
of NCT03867058 43 45 O
English NCT03867058 46 53 O

- NCT03867058 56 57 O
Cochlear NCT03867058 59 67 B-Procedure
Nucleus NCT03867058 68 75 I-Procedure
cochlear NCT03867058 76 84 I-Procedure
implant NCT03867058 85 92 I-Procedure
users NCT03867058 93 98 O
or NCT03867058 99 101 B-Or
Advanced NCT03867058 102 110 B-Procedure
Bionics NCT03867058 111 118 I-Procedure
users NCT03867058 119 124 O

- NCT03867058 127 128 O
Postlingually NCT03867058 130 143 B-Modifier
deafened NCT03867058 144 152 B-Condition

- NCT03867058 155 156 O
Has NCT03867058 158 161 O
had NCT03867058 162 165 O
device NCT03867058 166 172 B-Procedure
experience NCT03867058 173 183 O
for NCT03867058 184 187 O
at NCT03867058 188 190 B-Eq_Comparison
least NCT03867058 191 196 I-Eq_Comparison
one NCT03867058 197 200 I-Eq_Comparison
year NCT03867058 201 205 I-Eq_Comparison

- NCT03867058 208 209 O
Can NCT03867058 211 214 O
be NCT03867058 215 217 O
child NCT03867058 218 223 O
or NCT03867058 224 226 B-Or
adult NCT03867058 227 232 O
at NCT03867058 233 235 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867058 236 239 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03867058 240 244 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03867058 245 247 O
enrollment NCT03867058 248 258 B-Study

Exclusion NCT03867058 259 268 O
Criteria NCT03867058 269 277 O
: NCT03867058 278 279 O

- NCT03867058 283 284 O
None NCT03867058 286 290 O

Inclusion NCT03862937 0 9 O
Criteria NCT03862937 10 18 O
: NCT03862937 19 20 O

- NCT03862937 24 25 O
Be NCT03862937 27 29 O
60 NCT03862937 30 32 B-Eq_Comparison
or NCT03862937 33 35 I-Eq_Comparison
older NCT03862937 36 41 I-Eq_Comparison
, NCT03862937 42 43 O
and NCT03862937 44 47 O
in NCT03862937 48 50 O
the NCT03862937 51 54 O
case NCT03862937 55 59 O
of NCT03862937 60 62 O
women NCT03862937 63 68 O
, NCT03862937 69 70 O
they NCT03862937 71 75 O
must NCT03862937 76 80 O
be NCT03862937 81 83 O
postmenopausal NCT03862937 84 98 B-Condition
( NCT03862937 99 100 O
interruption NCT03862937 101 113 B-Negation
of NCT03862937 114 116 O
menstruation NCT03862937 117 129 B-Condition
for NCT03862937 130 133 O
more NCT03862937 134 138 B-Eq_Comparison
than NCT03862937 139 143 I-Eq_Comparison
one NCT03862937 144 147 I-Eq_Comparison
year NCT03862937 148 152 I-Eq_Comparison
) NCT03862937 153 154 O
. NCT03862937 155 156 O

- NCT03862937 160 161 O
Have NCT03862937 163 167 O
not NCT03862937 168 171 B-Negation
participated NCT03862937 172 184 O
in NCT03862937 185 187 O
any NCT03862937 188 191 O
systematic NCT03862937 192 202 B-Modifier
exercise NCT03862937 203 211 B-Procedure
program NCT03862937 212 219 I-Procedure
for NCT03862937 220 223 O
at NCT03862937 224 226 B-Eq_Comparison
least NCT03862937 227 232 I-Eq_Comparison
six NCT03862937 233 236 I-Eq_Comparison
months NCT03862937 237 243 I-Eq_Comparison
prior NCT03862937 244 249 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862937 250 252 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03862937 253 256 O
start NCT03862937 257 262 O
of NCT03862937 263 265 O
this NCT03862937 266 270 O
project NCT03862937 271 278 B-Study
. NCT03862937 279 280 O

- NCT03862937 284 285 O
To NCT03862937 287 289 O
have NCT03862937 290 294 O
a NCT03862937 295 296 O
body NCT03862937 297 301 B-Observation
mass NCT03862937 302 306 I-Observation
index NCT03862937 307 312 I-Observation
( NCT03862937 313 314 O
BMI NCT03862937 315 318 B-Observation
) NCT03862937 319 320 O
between NCT03862937 321 328 B-Eq_Comparison
22 NCT03862937 329 331 I-Eq_Comparison
and NCT03862937 332 335 I-Eq_Comparison
30 NCT03862937 336 338 I-Eq_Comparison
kg NCT03862937 339 341 I-Eq_Comparison
/ NCT03862937 342 343 I-Eq_Comparison
m NCT03862937 344 345 I-Eq_Comparison
2 NCT03862937 346 347 I-Eq_Comparison
. NCT03862937 347 348 O

- NCT03862937 352 353 O
Are NCT03862937 355 358 O
not NCT03862937 359 362 B-Negation
cardiopathic NCT03862937 363 375 B-Condition
, NCT03862937 376 377 O
diabetic NCT03862937 378 386 B-Condition
or NCT03862937 387 389 B-Or
have NCT03862937 390 394 O
any NCT03862937 395 398 O
other NCT03862937 399 404 B-Other
metabolic NCT03862937 405 414 B-Condition
disease NCT03862937 415 422 I-Condition
. NCT03862937 423 424 O

- NCT03862937 428 429 O
Do NCT03862937 431 433 O
not NCT03862937 434 437 B-Negation
present NCT03862937 438 445 O
joint NCT03862937 446 451 B-Condition
problems NCT03862937 452 460 I-Condition
or NCT03862937 461 463 B-Or
any NCT03862937 464 467 O
other NCT03862937 468 473 B-Other
injury NCT03862937 474 480 B-Condition
that NCT03862937 481 485 O
prevents NCT03862937 486 494 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
the NCT03862937 495 498 O
proper NCT03862937 499 505 O
execution NCT03862937 506 515 O
of NCT03862937 516 518 O
the NCT03862937 519 522 O
exercises NCT03862937 523 532 B-Observation
of NCT03862937 533 535 O
the NCT03862937 536 539 O
training NCT03862937 540 548 B-Procedure
routine NCT03862937 549 556 I-Procedure
. NCT03862937 557 558 O

- NCT03862937 562 563 O
Non NCT03862937 565 568 B-Negation
- NCT03862937 569 570 O
smoker NCT03862937 571 577 B-Condition
or NCT03862937 578 580 B-Or
have NCT03862937 581 585 O
quit NCT03862937 586 590 B-Condition
smoking NCT03862937 591 598 I-Condition
for NCT03862937 599 602 O
at NCT03862937 603 605 B-Eq_Comparison
least NCT03862937 606 611 I-Eq_Comparison
five NCT03862937 612 616 I-Eq_Comparison
years NCT03862937 617 622 I-Eq_Comparison
ago NCT03862937 623 626 I-Eq_Comparison
. NCT03862937 627 628 O

- NCT03862937 632 633 O
Release NCT03862937 635 642 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03862937 643 645 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03862937 646 649 O
doctor NCT03862937 650 656 O
( NCT03862937 657 658 O
medical NCT03862937 659 666 O
certificate NCT03862937 667 678 O
) NCT03862937 679 680 O
to NCT03862937 681 683 O
perform NCT03862937 684 691 O
the NCT03862937 692 695 O
physical NCT03862937 696 704 B-Observation
exercises NCT03862937 705 714 I-Observation
. NCT03862937 715 716 O

Exclusion NCT03862937 718 727 O
Criteria NCT03862937 728 736 O
: NCT03862937 737 738 O

- NCT03862937 742 743 O
Do NCT03862937 745 747 O
not NCT03862937 748 751 B-Negation
participate NCT03862937 752 763 O
in NCT03862937 764 766 O
at NCT03862937 767 769 B-Eq_Comparison
least NCT03862937 770 775 I-Eq_Comparison
20 NCT03862937 776 778 I-Eq_Comparison
training NCT03862937 779 787 B-Procedure
sessions NCT03862937 788 796 I-Procedure
or NCT03862937 797 799 B-Or
miss NCT03862937 800 804 B-Negation
more NCT03862937 805 809 B-Eq_Comparison
than NCT03862937 810 814 I-Eq_Comparison
three NCT03862937 815 820 I-Eq_Comparison
consecutive NCT03862937 821 832 I-Eq_Comparison
training NCT03862937 833 841 B-Procedure
sessions NCT03862937 842 850 I-Procedure
. NCT03862937 851 852 O

Inclusion NCT03927482 0 9 O
Criteria NCT03927482 10 18 O
: NCT03927482 19 20 O

- NCT03927482 24 25 O
Currently NCT03927482 27 36 B-Eq_Comparison
enrolled NCT03927482 37 45 O
community NCT03927482 46 55 O
college NCT03927482 56 63 O
student NCT03927482 64 71 O

- NCT03927482 74 75 O
At NCT03927482 77 79 B-Eq_Comparison
least NCT03927482 80 85 I-Eq_Comparison
2 NCT03927482 86 87 I-Eq_Comparison
heavy NCT03927482 88 93 B-Condition
drinking NCT03927482 94 102 I-Condition
episodes NCT03927482 103 111 O
in NCT03927482 112 114 O
past NCT03927482 115 119 B-Eq_Comparison
2 NCT03927482 120 121 I-Eq_Comparison
weeks NCT03927482 122 127 I-Eq_Comparison
at NCT03927482 128 130 B-Temporal_Connection___Temporal_Connection_Type_Value:during
recruitment NCT03927482 131 142 B-Study

- NCT03927482 145 146 O
Own NCT03927482 148 151 O
smart NCT03927482 152 157 O
phone NCT03927482 158 163 O

Exclusion NCT03927482 164 173 O
Criteria NCT03927482 174 182 O
: NCT03927482 183 184 O

- NCT03927482 188 189 O
Alcohol NCT03927482 191 198 B-Condition
abuse NCT03927482 199 204 I-Condition
disorder NCT03927482 205 213 I-Condition
or NCT03927482 214 216 B-Or
currently NCT03927482 217 226 B-Eq_Comparison
in NCT03927482 227 229 O
treatment NCT03927482 230 239 B-Procedure
for NCT03927482 240 243 O
alcohol NCT03927482 244 251 B-Condition
- NCT03927482 252 253 I-Condition
related NCT03927482 254 261 I-Condition
problems NCT03927482 262 270 I-Condition

Inclusion NCT03929497 0 9 O
Criteria NCT03929497 10 18 O
: NCT03929497 19 20 O

- NCT03929497 24 25 O
The NCT03929497 27 30 O
patient NCT03929497 31 38 O
completed NCT03929497 39 48 O
Study NCT03929497 49 54 B-Study
17972 NCT03929497 55 60 O
A NCT03929497 61 62 O
. NCT03929497 63 64 O

- NCT03929497 68 69 O
The NCT03929497 71 74 O
patient NCT03929497 75 82 O
and NCT03929497 83 86 O
the NCT03929497 87 90 O
patient NCT03929497 91 98 O
's NCT03929497 98 100 O
caregiver NCT03929497 101 110 O
or NCT03929497 111 113 O
identified NCT03929497 114 124 O
responsible NCT03929497 125 136 O
person NCT03929497 137 143 O
is NCT03929497 144 146 O
able NCT03929497 147 151 O
to NCT03929497 152 154 O
read NCT03929497 155 159 O
and NCT03929497 160 163 O
understand NCT03929497 164 174 O
the NCT03929497 175 178 O
Informed NCT03929497 179 187 O
Consent NCT03929497 188 195 O
Form NCT03929497 196 200 O
. NCT03929497 201 202 O

- NCT03929497 206 207 O
The NCT03929497 209 212 O
patient NCT03929497 213 220 O
has NCT03929497 221 224 O
signed NCT03929497 225 231 O
the NCT03929497 232 235 O
Informed NCT03929497 236 244 O
Consent NCT03929497 245 252 O
Form NCT03929497 253 257 O
specific NCT03929497 258 266 O
for NCT03929497 267 270 O
Study NCT03929497 271 276 B-Study
17972 NCT03929497 277 282 O
B NCT03929497 283 284 O
. NCT03929497 285 286 O

- NCT03929497 290 291 O
The NCT03929497 293 296 O
patient NCT03929497 297 304 O
can NCT03929497 305 308 B-Assertion___Assertion_Type_Value:hypothetical
potentially NCT03929497 309 320 I-Assertion___Assertion_Type_Value:hypothetical
benefit NCT03929497 321 328 O
from NCT03929497 329 333 O
24 NCT03929497 334 336 B-Eq_Comparison
weeks NCT03929497 337 342 I-Eq_Comparison
of NCT03929497 343 345 O
treatment NCT03929497 346 355 B-Procedure
with NCT03929497 356 360 O
Lu NCT03929497 361 363 B-Drug
AF NCT03929497 364 366 I-Drug
11167 NCT03929497 367 372 I-Drug
according NCT03929497 373 382 O
to NCT03929497 383 385 O
the NCT03929497 386 389 O
investigator NCT03929497 390 402 O
's NCT03929497 402 404 O
clinical NCT03929497 405 413 O
judgment NCT03929497 414 422 O
. NCT03929497 423 424 O

Exclusion NCT03929497 426 435 O
Criteria NCT03929497 436 444 O
: NCT03929497 445 446 O

- NCT03929497 450 451 O
The NCT03929497 453 456 O
patient NCT03929497 457 464 O
has NCT03929497 465 468 O
any NCT03929497 469 472 O
current NCT03929497 473 480 B-Eq_Comparison
primary NCT03929497 481 488 B-Modifier
psychiatric NCT03929497 489 500 B-Condition
disorder NCT03929497 501 509 I-Condition
other NCT03929497 510 515 B-Exception
than NCT03929497 516 520 I-Exception
schizophrenia NCT03929497 521 534 B-Condition
diagnosed NCT03929497 535 544 O
during NCT03929497 545 551 B-Temporal_Connection___Temporal_Connection_Type_Value:during
study NCT03929497 552 557 B-Study
17972 NCT03929497 558 563 O
A NCT03929497 564 565 O

- NCT03929497 568 569 O
The NCT03929497 571 574 O
patient NCT03929497 575 582 O
, NCT03929497 583 584 O
in NCT03929497 585 587 O
the NCT03929497 588 591 O
opinion NCT03929497 592 599 O
of NCT03929497 600 602 O
the NCT03929497 603 606 O
investigator NCT03929497 607 619 O
, NCT03929497 620 621 O
is NCT03929497 622 624 O
at NCT03929497 625 627 O
significant NCT03929497 628 639 O
risk NCT03929497 640 644 B-Risk
of NCT03929497 645 647 O
suicide NCT03929497 648 655 B-Condition

Other NCT03929497 656 661 O
in NCT03929497 662 664 O
- NCT03929497 665 666 O
and NCT03929497 667 670 O
exclusion NCT03929497 671 680 O
criteria NCT03929497 681 689 O
may NCT03929497 690 693 O
apply NCT03929497 694 699 O

Inclusion NCT03865641 0 9 O
Criteria NCT03865641 10 18 O
: NCT03865641 19 20 O

- NCT03865641 24 25 O
The NCT03865641 27 30 O
patients NCT03865641 31 39 O
' NCT03865641 39 40 O
burn NCT03865641 41 45 B-Condition
scars NCT03865641 46 51 I-Condition
had NCT03865641 52 55 O
re NCT03865641 56 58 B-Modifier
- NCT03865641 59 60 I-Modifier
epithelialized NCT03865641 61 75 I-Modifier
after NCT03865641 76 81 B-Temporal_Connection___Temporal_Connection_Type_Value:after
aseptic NCT03865641 82 89 B-Procedure
care NCT03865641 90 94 I-Procedure
or NCT03865641 95 97 B-Or
skin NCT03865641 98 102 B-Procedure
graft NCT03865641 103 108 I-Procedure
. NCT03865641 109 110 O
We NCT03865641 112 114 O
included NCT03865641 115 123 O
patients NCT03865641 124 132 O
aged NCT03865641 133 137 B-Age
≥ NCT03865641 138 139 B-Eq_Comparison
18 NCT03865641 140 142 I-Eq_Comparison
years NCT03865641 143 148 I-Eq_Comparison
with NCT03865641 149 153 B-And
a NCT03865641 154 155 O
deep NCT03865641 156 160 B-Modifier
partial NCT03865641 161 168 I-Modifier
- NCT03865641 169 170 I-Modifier
thickness NCT03865641 171 180 I-Modifier
( NCT03865641 181 182 O
second NCT03865641 183 189 B-Modifier
- NCT03865641 190 191 I-Modifier
degree NCT03865641 192 198 I-Modifier
) NCT03865641 199 200 O
burn NCT03865641 201 205 B-Condition
or NCT03865641 206 208 B-Or
a NCT03865641 209 210 O
full NCT03865641 211 215 B-Modifier
thickness NCT03865641 216 225 I-Modifier
( NCT03865641 226 227 O
third NCT03865641 228 233 B-Modifier
- NCT03865641 234 235 I-Modifier
degree NCT03865641 236 242 I-Modifier
) NCT03865641 243 244 O
burn NCT03865641 245 249 B-Condition
to NCT03865641 250 252 O
their NCT03865641 253 258 O
hands NCT03865641 259 264 B-Modifier
, NCT03865641 265 266 O
with NCT03865641 267 271 B-And
joint NCT03865641 272 277 B-Condition
contracture NCT03865641 278 289 I-Condition
( NCT03865641 290 291 O
hand NCT03865641 292 296 B-Modifier
and NCT03865641 297 300 B-Or
wrist NCT03865641 301 306 B-Modifier
) NCT03865641 307 308 O
, NCT03865641 309 310 O
having NCT03865641 311 317 B-And
been NCT03865641 318 322 I-And
transferred NCT03865641 323 334 B-Encounter
to NCT03865641 335 337 O
the NCT03865641 338 341 O
rehabilitation NCT03865641 342 356 O
department NCT03865641 357 367 O
after NCT03865641 368 373 B-Temporal_Connection___Temporal_Connection_Type_Value:after
acute NCT03865641 374 379 O
burn NCT03865641 380 384 B-Condition
treatment NCT03865641 385 394 B-Procedure
, NCT03865641 395 396 O
and NCT03865641 397 400 O
less NCT03865641 401 405 B-Eq_Comparison
than NCT03865641 406 410 I-Eq_Comparison
6 NCT03865641 411 412 I-Eq_Comparison
months NCT03865641 413 419 I-Eq_Comparison
since NCT03865641 420 425 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03865641 426 429 O
onset NCT03865641 430 435 B-Eq_Comparison
of NCT03865641 436 438 O
the NCT03865641 439 442 O
burn NCT03865641 443 447 B-Modifier
injury NCT03865641 448 454 B-Condition
. NCT03865641 455 456 O

Exclusion NCT03865641 458 467 O
Criteria NCT03865641 468 476 O
: NCT03865641 477 478 O

- NCT03865641 482 483 O
patients NCT03865641 485 493 O
who NCT03865641 494 497 O
had NCT03865641 498 501 O
fourth NCT03865641 502 508 B-Modifier
- NCT03865641 509 510 I-Modifier
degree NCT03865641 511 517 I-Modifier
burns NCT03865641 518 523 B-Condition
( NCT03865641 524 525 O
involving NCT03865641 526 535 O
muscles NCT03865641 536 543 B-Modifier
, NCT03865641 544 545 O
tendons NCT03865641 546 553 B-Modifier
, NCT03865641 554 555 O
and NCT03865641 556 559 B-Or
bone NCT03865641 560 564 B-Modifier
injuries NCT03865641 565 573 B-Condition
) NCT03865641 574 575 O
, NCT03865641 576 577 O
musculoskeletal NCT03865641 578 593 B-Condition
diseases NCT03865641 594 602 I-Condition
( NCT03865641 603 604 O
fracture NCT03865641 605 613 B-Condition
, NCT03865641 614 615 O
amputation NCT03865641 616 626 B-Condition
, NCT03865641 627 628 O
rheumatoid NCT03865641 629 639 B-Condition
arthritis NCT03865641 640 649 I-Condition
, NCT03865641 650 651 O
and NCT03865641 652 655 B-Or
degenerative NCT03865641 656 668 B-Condition
joint NCT03865641 669 674 I-Condition
diseases NCT03865641 675 683 I-Condition
) NCT03865641 684 685 O
in NCT03865641 686 688 O
the NCT03865641 689 692 O
burned NCT03865641 693 699 B-Modifier
hand NCT03865641 700 704 I-Modifier
, NCT03865641 705 706 O
or NCT03865641 707 709 B-Or
neurological NCT03865641 710 722 B-Condition
diseases NCT03865641 723 731 I-Condition
( NCT03865641 732 733 O
such NCT03865641 734 738 O
as NCT03865641 739 741 O
peripheral NCT03865641 742 752 B-Condition
nerve NCT03865641 753 758 I-Condition
disorders NCT03865641 759 768 I-Condition
) NCT03865641 769 770 O
, NCT03865641 771 772 O
preexisting NCT03865641 773 784 B-Eq_Comparison
physical NCT03865641 785 793 B-Modifier
and NCT03865641 794 797 B-Or
psychologic NCT03865641 798 809 B-Modifier
disability NCT03865641 810 820 B-Condition
( NCT03865641 821 822 O
severe NCT03865641 823 829 O
aphasia NCT03865641 830 837 B-Condition
and NCT03865641 838 841 B-Or
cognitive NCT03865641 842 851 B-Condition
impairment NCT03865641 852 862 I-Condition
that NCT03865641 863 867 O
could NCT03865641 868 873 B-Assertion___Assertion_Type_Value:hypothetical
influence NCT03865641 874 883 O
the NCT03865641 884 887 O
intervention NCT03865641 888 900 B-Study
) NCT03865641 901 902 O
, NCT03865641 903 904 O
and NCT03865641 905 908 B-Or
severe NCT03865641 909 915 O
pain NCT03865641 916 920 B-Condition
impeding NCT03865641 921 929 O
hand NCT03865641 930 934 B-Procedure
rehabilitation NCT03865641 935 949 I-Procedure
. NCT03865641 950 951 O

Inclusion NCT03928522 0 9 O
Criteria NCT03928522 10 18 O
: NCT03928522 19 20 O

- NCT03928522 24 25 O
Age NCT03928522 27 30 B-Age
over NCT03928522 31 35 B-Eq_Comparison
18 NCT03928522 36 38 I-Eq_Comparison

- NCT03928522 42 43 O
Total NCT03928522 45 50 B-Procedure
knee NCT03928522 51 55 I-Procedure
arthroplasty NCT03928522 56 68 I-Procedure
for NCT03928522 69 72 O
primary NCT03928522 73 80 B-Modifier
osteoarthritis NCT03928522 81 95 B-Condition
performed NCT03928522 96 105 O
by NCT03928522 106 108 O
Dr NCT03928522 109 111 B-Provider
. NCT03928522 112 113 I-Provider
Rick NCT03928522 115 119 I-Provider
Wright NCT03928522 120 126 I-Provider
. NCT03928522 127 128 O

- NCT03928522 132 133 O
Primary NCT03928522 135 142 O
diagnosis NCT03928522 143 152 O
of NCT03928522 153 155 O
knee NCT03928522 156 160 B-Modifier
osteoarthritis NCT03928522 161 175 B-Condition

- NCT03928522 183 184 O
Exclusion NCT03928522 186 195 O
Criteria NCT03928522 196 204 O
: NCT03928522 205 206 O

- NCT03928522 210 211 O
Diminished NCT03928522 213 223 B-Condition
mental NCT03928522 224 230 I-Condition
capacity NCT03928522 231 239 I-Condition

- NCT03928522 242 243 O
Vancomycin NCT03928522 245 255 B-Drug
allergy NCT03928522 256 263 B-Allergy

- NCT03928522 266 267 O
Tobramycin NCT03928522 269 279 B-Drug
allergy NCT03928522 280 287 B-Allergy

- NCT03928522 290 291 O
Patient NCT03928522 293 300 O
history NCT03928522 301 308 B-Eq_Comparison
requiring NCT03928522 309 318 B-Assertion___Assertion_Type_Value:hypothetical
IV NCT03928522 319 321 O
administration NCT03928522 322 336 O
of NCT03928522 337 339 O
vancomycin NCT03928522 340 350 B-Drug
or NCT03928522 351 353 B-Or
tobramycin NCT03928522 354 364 B-Drug
peri NCT03928522 365 369 B-Temporal_Connection___Temporal_Connection_Type_Value:during
operatively NCT03928522 370 381 B-Procedure

- NCT03928522 384 385 O
Chronic NCT03928522 387 394 O
kidney NCT03928522 395 401 B-Condition
disease NCT03928522 402 409 I-Condition
stage NCT03928522 410 415 B-Eq_Comparison
III NCT03928522 416 419 I-Eq_Comparison
and NCT03928522 420 423 I-Eq_Comparison
stage NCT03928522 424 429 I-Eq_Comparison
IV NCT03928522 430 432 I-Eq_Comparison

Inclusion NCT03866603 0 9 O
Criteria NCT03866603 10 18 O
: NCT03866603 19 20 O

- NCT03866603 24 25 O
Informed NCT03866603 27 35 O
consent NCT03866603 36 43 O
is NCT03866603 44 46 O
obtained NCT03866603 47 55 O
from NCT03866603 56 60 O
the NCT03866603 61 64 O
participant NCT03866603 65 76 O
. NCT03866603 77 78 O

- NCT03866603 82 83 O
The NCT03866603 85 88 O
participant NCT03866603 89 100 O
is NCT03866603 101 103 O
clinically NCT03866603 104 114 O
diagnosed NCT03866603 115 124 O
with NCT03866603 125 129 O
Parkinson NCT03866603 130 139 B-Condition
's NCT03866603 139 141 I-Condition
disease NCT03866603 142 149 I-Condition
or NCT03866603 150 152 B-Or
the NCT03866603 153 156 O
individual NCT03866603 157 167 O
is NCT03866603 168 170 O
a NCT03866603 171 172 O
family NCT03866603 173 179 B-Family_Member
member NCT03866603 180 186 I-Family_Member
of NCT03866603 187 189 O
a NCT03866603 190 191 O
participant NCT03866603 192 203 O
with NCT03866603 204 208 O
LRRK NCT03866603 209 213 B-Modifier
2 NCT03866603 214 215 I-Modifier
parkinsonism NCT03866603 216 228 B-Condition
or NCT03866603 229 231 B-Or
is NCT03866603 232 234 O
a NCT03866603 235 236 O
member NCT03866603 237 243 O
of NCT03866603 244 246 O
a NCT03866603 247 248 O
high NCT03866603 249 253 O
risk NCT03866603 254 258 B-Risk
population NCT03866603 259 269 O
with NCT03866603 270 274 O
an NCT03866603 275 277 O
early NCT03866603 278 283 B-Modifier
PD NCT03866603 284 286 B-Condition
onset NCT03866603 287 292 B-Eq_Comparison
. NCT03866603 293 294 O

- NCT03866603 298 299 O
The NCT03866603 301 304 O
participant NCT03866603 305 316 O
is NCT03866603 317 319 O
equal NCT03866603 320 325 B-Eq_Comparison
to NCT03866603 326 328 I-Eq_Comparison
or NCT03866603 329 331 I-Eq_Comparison
older NCT03866603 332 337 I-Eq_Comparison
than NCT03866603 338 342 I-Eq_Comparison
18 NCT03866603 343 345 I-Eq_Comparison
years NCT03866603 346 351 I-Eq_Comparison
old NCT03866603 352 355 B-Age
. NCT03866603 356 357 O

Exclusion NCT03866603 359 368 O
Criteria NCT03866603 369 377 O
: NCT03866603 378 379 O

- NCT03866603 383 384 O
Inability NCT03866603 386 395 O
to NCT03866603 396 398 O
provide NCT03866603 399 406 O
informed NCT03866603 407 415 O
consent NCT03866603 416 423 O
. NCT03866603 424 425 O

- NCT03866603 429 430 O
The NCT03866603 432 435 O
participant NCT03866603 436 447 O
is NCT03866603 448 450 O
not NCT03866603 451 454 B-Negation
suffering NCT03866603 455 464 O
from NCT03866603 465 469 O
Parkinson NCT03866603 470 479 B-Condition
's NCT03866603 479 481 I-Condition
disease NCT03866603 482 489 I-Condition
or NCT03866603 490 492 B-Or
the NCT03866603 493 496 O
individual NCT03866603 497 507 O
is NCT03866603 508 510 O
not NCT03866603 511 514 B-Negation
a NCT03866603 515 516 O
family NCT03866603 517 523 B-Family_Member
member NCT03866603 524 530 I-Family_Member
of NCT03866603 531 533 O
a NCT03866603 534 535 O
participant NCT03866603 536 547 O
with NCT03866603 548 552 O
LRRK NCT03866603 553 557 B-Modifier
2 NCT03866603 558 559 I-Modifier
parkinsonism NCT03866603 560 572 B-Condition
or NCT03866603 573 575 B-Or
is NCT03866603 576 578 O
not NCT03866603 579 582 B-Negation
a NCT03866603 583 584 O
member NCT03866603 585 591 O
of NCT03866603 592 594 O
a NCT03866603 595 596 O
high NCT03866603 597 601 O
risk NCT03866603 602 606 B-Risk
population NCT03866603 607 617 O
. NCT03866603 618 619 O

- NCT03866603 623 624 O
The NCT03866603 626 629 O
participant NCT03866603 630 641 O
is NCT03866603 642 644 O
younger NCT03866603 645 652 B-Eq_Comparison
than NCT03866603 653 657 I-Eq_Comparison
18 NCT03866603 658 660 I-Eq_Comparison
years NCT03866603 661 666 I-Eq_Comparison
old NCT03866603 667 670 B-Age
. NCT03866603 671 672 O

- NCT03866603 676 677 O
Previously NCT03866603 679 689 B-Eq_Comparison
enrolled NCT03866603 690 698 O
in NCT03866603 699 701 O
the NCT03866603 702 705 O
study NCT03866603 706 711 B-Study
. NCT03866603 712 713 O

- NCT03866603 717 718 O
Participant NCT03866603 720 731 O
in NCT03866603 732 734 B-Observation
custody NCT03866603 735 742 I-Observation
. NCT03866603 743 744 O

Inclusion NCT03866200 0 9 O
Criteria NCT03866200 10 18 O
: NCT03866200 19 20 O

- NCT03866200 24 25 O
The NCT03866200 27 30 O
diagnosis NCT03866200 31 40 O
of NCT03866200 41 43 O
pseudoachondroplasia NCT03866200 44 64 B-Condition
is NCT03866200 65 67 O
based NCT03866200 68 73 O
on NCT03866200 74 76 O
clinical NCT03866200 77 85 B-Procedure
assessment NCT03866200 86 96 I-Procedure
either NCT03866200 97 103 O
in NCT03866200 104 106 B-Modifier
person NCT03866200 107 113 I-Modifier
or NCT03866200 114 116 B-Or
by NCT03866200 117 119 O
photographic NCT03866200 120 132 B-Modifier
review NCT03866200 133 139 I-Modifier
by NCT03866200 140 142 O
skeletal NCT03866200 143 151 B-Provider
dysplasia NCT03866200 152 161 I-Provider
specialist NCT03866200 162 172 I-Provider
( NCT03866200 173 174 O
JTH NCT03866200 175 178 O
) NCT03866200 179 180 O
, NCT03866200 181 182 O

- NCT03866200 186 187 O
Healthy NCT03866200 189 196 B-Condition
beyond NCT03866200 197 203 B-Exception
pseudoachondroplasia NCT03866200 204 224 B-Condition
associated NCT03866200 225 235 O
complications NCT03866200 236 249 B-Condition
, NCT03866200 250 251 O

Exclusion NCT03866200 253 262 O
Criteria NCT03866200 263 271 O
: NCT03866200 272 273 O

- NCT03866200 277 278 O
Current NCT03866200 280 287 B-Eq_Comparison
use NCT03866200 288 291 O
of NCT03866200 292 294 O
resveratrol NCT03866200 295 306 B-Drug

- NCT03866200 309 310 O
Current NCT03866200 312 319 B-Eq_Comparison
use NCT03866200 320 323 O
of NCT03866200 324 326 O
blood NCT03866200 327 332 B-Drug
thinners NCT03866200 333 341 I-Drug
, NCT03866200 342 343 O
lovastatin NCT03866200 344 354 B-Drug
, NCT03866200 355 356 O
ketoconazole NCT03866200 357 369 B-Drug
, NCT03866200 370 371 O
itraconazole NCT03866200 372 384 B-Drug
, NCT03866200 385 386 O
fexofenadine NCT03866200 387 399 B-Drug
and NCT03866200 400 403 B-Or
triazolam NCT03866200 404 413 B-Drug
. NCT03866200 414 415 O

- NCT03866200 419 420 O
Other NCT03866200 422 427 B-Other
non NCT03866200 428 431 B-Negation
- NCT03866200 432 433 O
pseudoachondroplasia NCT03866200 434 454 B-Condition
related NCT03866200 455 462 O
health NCT03866200 463 469 B-Condition
conditions NCT03866200 470 480 I-Condition
, NCT03866200 481 482 O
e NCT03866200 483 484 O
. NCT03866200 485 486 O
g NCT03866200 487 488 O
. NCT03866200 489 490 O
cancers NCT03866200 492 499 B-Condition
. NCT03866200 500 501 O

- NCT03866200 505 506 O
Pregnancy NCT03866200 508 517 B-Condition
or NCT03866200 518 520 B-Or
breastfeeding NCT03866200 521 534 B-Condition
. NCT03866200 535 536 O
Women NCT03866200 538 543 O
must NCT03866200 544 548 O
use NCT03866200 549 552 O
adequate NCT03866200 553 561 O
contraception NCT03866200 562 575 B-Procedure
during NCT03866200 576 582 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866200 583 586 O
study NCT03866200 587 592 B-Study
. NCT03866200 593 594 O

- NCT03866200 598 599 O
Participation NCT03866200 601 614 O
in NCT03866200 615 617 O
another NCT03866200 618 625 B-Other
clinical NCT03866200 626 634 O
study NCT03866200 635 640 B-Study
and NCT03866200 641 644 B-Or
/ NCT03866200 645 646 I-Or
or NCT03866200 647 649 I-Or
using NCT03866200 650 655 B-Eq_Comparison
investigational NCT03866200 656 671 B-Drug
agents NCT03866200 672 678 I-Drug
. NCT03866200 679 680 O

- NCT03866200 684 685 O
Use NCT03866200 687 690 B-Eq_Comparison
of NCT03866200 691 693 O
Non NCT03866200 694 697 B-Drug
- NCT03866200 698 699 I-Drug
steroid NCT03866200 700 707 I-Drug
anti NCT03866200 708 712 I-Drug
- NCT03866200 713 714 I-Drug
inflammatory NCT03866200 715 727 I-Drug
( NCT03866200 728 729 O
NSAIDs NCT03866200 730 736 B-Drug
) NCT03866200 737 738 O
or NCT03866200 739 741 B-Or
aspirin NCT03866200 742 749 B-Drug
. NCT03866200 750 751 O

- NCT03866200 755 756 O
Current NCT03866200 758 765 B-Eq_Comparison
use NCT03866200 766 769 O
of NCT03866200 770 772 O
Alfentanil NCT03866200 773 783 B-Drug
, NCT03866200 784 785 O
Cyclosporine NCT03866200 786 798 B-Drug
, NCT03866200 799 800 O
Dihydroergotamine NCT03866200 801 818 B-Drug
, NCT03866200 819 820 O
Dofetilide NCT03866200 821 831 B-Drug
, NCT03866200 832 833 O
Ergotamine NCT03866200 834 844 B-Drug
, NCT03866200 845 846 O
Fentanyl NCT03866200 847 855 B-Drug
, NCT03866200 856 857 O
Flibanserin NCT03866200 858 869 B-Drug
, NCT03866200 870 871 O
Oxycodone NCT03866200 872 881 B-Drug
, NCT03866200 882 883 O
Pimavanserin NCT03866200 884 896 B-Drug
, NCT03866200 897 898 O
Pimozide NCT03866200 899 907 B-Drug
, NCT03866200 908 909 O
Quinidine NCT03866200 910 919 B-Drug
, NCT03866200 920 921 O
Saquinavir NCT03866200 922 932 B-Drug
, NCT03866200 933 934 O
Sirolimus NCT03866200 935 944 B-Drug
, NCT03866200 945 946 O
Tacrolimus NCT03866200 947 957 B-Drug
, NCT03866200 958 959 O
Temsirolimus NCT03866200 960 972 B-Drug
, NCT03866200 973 974 O
Theophylline NCT03866200 975 987 B-Drug
, NCT03866200 988 989 O
Tizanidine NCT03866200 990 1000 B-Drug
, NCT03866200 1001 1002 O
Thioridazine NCT03866200 1003 1015 B-Drug
, NCT03866200 1016 1017 O
Fosphenytoin NCT03866200 1018 1030 B-Drug
, NCT03866200 1031 1032 O
Phenytoin NCT03866200 1033 1042 B-Drug
or NCT03866200 1043 1045 B-Or
Warfarin NCT03866200 1046 1054 B-Drug
. NCT03866200 1055 1056 O

- NCT03866200 1060 1061 O
Baseline NCT03866200 1063 1071 O
level NCT03866200 1072 1077 O
of NCT03866200 1078 1080 O
pain NCT03866200 1081 1085 B-Condition
of NCT03866200 1086 1088 O
2 NCT03866200 1089 1090 B-Eq_Comparison
or NCT03866200 1091 1093 I-Eq_Comparison
higher NCT03866200 1094 1100 I-Eq_Comparison
on NCT03866200 1101 1103 O
10 NCT03866200 1104 1106 B-Modifier
point NCT03866200 1107 1112 I-Modifier
scale NCT03866200 1113 1118 I-Modifier
. NCT03866200 1119 1120 O

- NCT03866200 1124 1125 O
Platelet NCT03866200 1127 1135 B-Observation
count NCT03866200 1136 1141 I-Observation
below NCT03866200 1142 1147 B-Eq_Comparison
50 NCT03866200 1148 1150 I-Eq_Comparison
, NCT03866200 1151 1152 I-Eq_Comparison
000 NCT03866200 1153 1156 I-Eq_Comparison
per NCT03866200 1157 1160 I-Eq_Comparison
ul NCT03866200 1161 1163 I-Eq_Comparison
on NCT03866200 1164 1166 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03866200 1167 1175 B-Study
complete NCT03866200 1176 1184 B-Observation
blood NCT03866200 1185 1190 I-Observation
count NCT03866200 1191 1196 I-Observation
( NCT03866200 1197 1198 O
CBC NCT03866200 1199 1202 B-Observation
) NCT03866200 1203 1204 O
. NCT03866200 1205 1206 O

Inclusion NCT03929055 0 9 O
Criteria NCT03929055 10 18 O
: NCT03929055 19 20 O

- NCT03929055 24 25 O
patient NCT03929055 27 34 O
with NCT03929055 35 39 O
acute NCT03929055 40 45 B-Condition
respiratory NCT03929055 46 57 I-Condition
failure NCT03929055 58 65 I-Condition
, NCT03929055 66 67 O
not NCT03929055 68 71 B-Negation
intubated NCT03929055 72 81 B-Procedure
, NCT03929055 82 83 O
who NCT03929055 84 87 B-And
require NCT03929055 88 95 B-Assertion___Assertion_Type_Value:hypothetical
non NCT03929055 96 99 B-Modifier
invasive NCT03929055 100 108 I-Modifier
mechanical NCT03929055 109 119 B-Procedure
ventilation NCT03929055 120 131 I-Procedure

Exclusion NCT03929055 132 141 O
Criteria NCT03929055 142 150 O
: NCT03929055 151 152 O

- NCT03929055 156 157 O
patients NCT03929055 159 167 O
in NCT03929055 168 170 O
which NCT03929055 171 176 O
it NCT03929055 177 179 O
is NCT03929055 180 182 O
not NCT03929055 183 186 B-Negation
possible NCT03929055 187 195 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929055 196 198 O
place NCT03929055 199 204 O
the NCT03929055 205 208 O
esophageal NCT03929055 209 219 B-Modifier
catheter NCT03929055 220 228 B-Procedure
or NCT03929055 229 231 B-Or
it NCT03929055 232 234 O
is NCT03929055 235 237 O
not NCT03929055 238 241 B-Negation
possible NCT03929055 242 250 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929055 251 253 O
detect NCT03929055 254 260 O
the NCT03929055 261 264 O
diaphragm NCT03929055 265 274 B-Condition
by NCT03929055 275 277 O
ultrasound NCT03929055 278 288 B-Procedure
or NCT03929055 289 291 B-Or
it NCT03929055 292 294 O
is NCT03929055 295 297 O
not NCT03929055 298 301 B-Negation
possible NCT03929055 302 310 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929055 311 313 O
apply NCT03929055 314 319 O
the NCT03929055 320 323 O
nasal NCT03929055 324 329 B-Procedure
cannula NCT03929055 330 337 I-Procedure
device NCT03929055 338 344 I-Procedure

Inclusion NCT03862352 0 9 O
Criteria NCT03862352 10 18 O
: NCT03862352 19 20 O

- NCT03862352 24 25 O
Any NCT03862352 27 30 O
coronary NCT03862352 31 39 B-Procedure
artery NCT03862352 40 46 I-Procedure
perforation NCT03862352 47 58 I-Procedure
during NCT03862352 59 65 B-Temporal_Connection___Temporal_Connection_Type_Value:during
percutaneous NCT03862352 66 78 B-Procedure
coronary NCT03862352 79 87 I-Procedure
intervention NCT03862352 88 100 I-Procedure

Exclusion NCT03862352 101 110 O
Criteria NCT03862352 111 119 O
: NCT03862352 120 121 O

- NCT03862352 125 126 O
Nil NCT03862352 128 131 O

Inclusion NCT03923504 0 9 O
Criteria NCT03923504 10 18 O
: NCT03923504 19 20 O

- NCT03923504 24 25 O
Ability NCT03923504 27 34 O
to NCT03923504 35 37 O
read NCT03923504 38 42 O
and NCT03923504 43 46 O
understand NCT03923504 47 57 O
and NCT03923504 58 61 O
willing NCT03923504 62 69 O
to NCT03923504 70 72 O
sign NCT03923504 73 77 O
a NCT03923504 78 79 O
written NCT03923504 80 87 O
informed NCT03923504 88 96 O
consent NCT03923504 97 104 O
form NCT03923504 105 109 O
. NCT03923504 110 111 O

- NCT03923504 115 116 O
Diagnosis NCT03923504 118 127 O
of NCT03923504 128 130 O
stage NCT03923504 131 136 B-Eq_Comparison
I NCT03923504 137 138 I-Eq_Comparison
- NCT03923504 139 140 I-Eq_Comparison
IV NCT03923504 141 143 I-Eq_Comparison
non NCT03923504 144 147 B-Modifier
- NCT03923504 148 149 O
or NCT03923504 150 152 B-Or
Hodgkin NCT03923504 153 160 B-Modifier
lymphoma NCT03923504 161 169 B-Condition
and NCT03923504 170 173 B-And
expect NCT03923504 174 180 B-Assertion___Assertion_Type_Value:intention
to NCT03923504 181 183 I-Assertion___Assertion_Type_Value:intention
receive NCT03923504 184 191 O
an NCT03923504 192 194 O
anthracycline NCT03923504 195 208 B-Drug
based NCT03923504 209 214 O
chemotherapeutic NCT03923504 215 231 B-Drug
regimen NCT03923504 232 239 I-Drug
. NCT03923504 240 241 O

- NCT03923504 245 246 O
Capacity NCT03923504 248 256 B-Observation
to NCT03923504 257 259 I-Observation
walk NCT03923504 260 264 I-Observation
at NCT03923504 265 267 B-Eq_Comparison
least NCT03923504 268 273 I-Eq_Comparison
2 NCT03923504 274 275 I-Eq_Comparison
city NCT03923504 276 280 I-Eq_Comparison
blocks NCT03923504 281 287 I-Eq_Comparison
on NCT03923504 288 290 O
a NCT03923504 291 292 O
flat NCT03923504 293 297 O
surface NCT03923504 298 305 O

Exclusion NCT03923504 306 315 O
Criteria NCT03923504 316 324 O
: NCT03923504 325 326 O

- NCT03923504 330 331 O
Contraindications NCT03923504 333 350 B-Contraindication
for NCT03923504 351 354 O
MRI NCT03923504 355 358 B-Procedure

- NCT03923504 361 362 O
Contraindications NCT03923504 364 381 B-Contraindication
for NCT03923504 382 385 O
exercise NCT03923504 386 394 B-Observation
training NCT03923504 395 403 B-Modifier
or NCT03923504 404 406 B-Or
testing NCT03923504 407 414 B-Modifier

- NCT03923504 417 418 O
Active NCT03923504 420 426 B-Eq_Comparison
Pregnancy NCT03923504 427 436 B-Condition

- NCT03923504 439 440 O
Subjects NCT03923504 442 450 O
with NCT03923504 451 455 O
claustrophobia NCT03923504 456 470 B-Condition

- NCT03923504 473 474 O
Inability NCT03923504 476 485 O
to NCT03923504 486 488 O
provide NCT03923504 489 496 O
informed NCT03923504 497 505 O
consent NCT03923504 506 513 O

Inclusion NCT03920462 0 9 O
Criteria NCT03920462 10 18 O
: NCT03920462 19 20 O

- NCT03920462 24 25 O
Capacity NCT03920462 27 35 O
to NCT03920462 36 38 O
ride NCT03920462 39 43 O
a NCT03920462 44 45 O
bike NCT03920462 46 50 O

- NCT03920462 53 54 O
Volunteer NCT03920462 56 65 O
without NCT03920462 66 73 B-Negation
a NCT03920462 74 75 O
contraindication NCT03920462 76 92 B-Contraindication
to NCT03920462 93 95 O
moderate NCT03920462 96 104 O
physical NCT03920462 105 113 B-Observation
activity NCT03920462 114 122 I-Observation
or NCT03920462 123 125 B-Or
cycling NCT03920462 126 133 B-Observation
( NCT03920462 134 135 O
acute NCT03920462 136 141 O
coronary NCT03920462 142 150 B-Condition
artery NCT03920462 151 157 I-Condition
disease NCT03920462 158 165 I-Condition
less NCT03920462 166 170 B-Eq_Comparison
than NCT03920462 171 175 I-Eq_Comparison
2 NCT03920462 176 177 I-Eq_Comparison
years NCT03920462 178 183 I-Eq_Comparison
old NCT03920462 184 187 O
, NCT03920462 188 189 O
musculoskeletal NCT03920462 190 205 B-Modifier
problem NCT03920462 206 213 B-Condition
of NCT03920462 214 216 O
the NCT03920462 217 220 O
spine NCT03920462 221 226 B-Modifier
or NCT03920462 227 229 B-Or
lower NCT03920462 230 235 B-Modifier
limbs NCT03920462 236 241 I-Modifier
incompatible NCT03920462 242 254 B-Negation
with NCT03920462 255 259 O
cycling NCT03920462 260 267 B-Observation
) NCT03920462 268 269 O
. NCT03920462 270 271 O

- NCT03920462 275 276 O
weight NCT03920462 278 284 B-Observation
< NCT03920462 285 286 B-Eq_Comparison
125 NCT03920462 287 290 I-Eq_Comparison
kg NCT03920462 291 293 I-Eq_Comparison

- NCT03920462 296 297 O
volunteer NCT03920462 299 308 O
available NCT03920462 309 318 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03920462 319 322 I-Assertion___Assertion_Type_Value:hypothetical
an NCT03920462 323 325 O
intervention NCT03920462 326 338 B-Procedure
of NCT03920462 339 341 O
2 NCT03920462 342 343 B-Eq_Comparison
- NCT03920462 344 345 I-Eq_Comparison
3 NCT03920462 346 347 I-Eq_Comparison
hours NCT03920462 348 353 I-Eq_Comparison
twice NCT03920462 354 359 I-Eq_Comparison
a NCT03920462 360 361 I-Eq_Comparison
week NCT03920462 362 366 I-Eq_Comparison
during NCT03920462 367 373 B-Temporal_Connection___Temporal_Connection_Type_Value:during
1 NCT03920462 374 375 B-Eq_Comparison
month NCT03920462 376 381 I-Eq_Comparison
. NCT03920462 382 383 O

Exclusion NCT03920462 385 394 O
Criteria NCT03920462 395 403 O
: NCT03920462 404 405 O

- NCT03920462 409 410 O
Person NCT03920462 412 418 O
deprived NCT03920462 419 427 B-Observation
of NCT03920462 428 430 I-Observation
liberty NCT03920462 431 438 I-Observation
or NCT03920462 439 441 B-Or
legal NCT03920462 442 447 B-Observation
protection NCT03920462 448 458 I-Observation
measure NCT03920462 459 466 O

Inclusion NCT03925155 0 9 O
Criteria NCT03925155 10 18 O
: NCT03925155 19 20 O

- NCT03925155 24 25 O
Females NCT03925155 27 34 O
aged NCT03925155 35 39 B-Age
18 NCT03925155 40 42 B-Eq_Comparison
- NCT03925155 43 44 I-Eq_Comparison
50 NCT03925155 45 47 I-Eq_Comparison
years NCT03925155 48 53 I-Eq_Comparison

- NCT03925155 56 57 O
The NCT03925155 59 62 O
study NCT03925155 63 68 O
will NCT03925155 69 73 O
be NCT03925155 74 76 O
offered NCT03925155 77 84 O
to NCT03925155 85 87 O
women NCT03925155 88 93 O
at NCT03925155 94 96 B-And
> NCT03925155 97 98 B-Eq_Comparison
24 NCT03925155 99 101 I-Eq_Comparison
weeks NCT03925155 102 107 I-Eq_Comparison
gestation NCT03925155 108 117 B-Observation
who NCT03925155 118 121 B-And
are NCT03925155 122 125 O
undergoing NCT03925155 126 136 B-Eq_Comparison
nonemergent NCT03925155 137 148 B-Modifier
cesarean NCT03925155 149 157 B-Procedure
delivery NCT03925155 158 166 I-Procedure
with NCT03925155 167 171 B-And
ruptured NCT03925155 172 180 B-Condition
amniotic NCT03925155 181 189 I-Condition
membranes NCT03925155 190 199 I-Condition
. NCT03925155 200 201 O

- NCT03925155 205 206 O
All NCT03925155 208 211 O
patients NCT03925155 212 220 O
undergoing NCT03925155 221 231 B-Eq_Comparison
cesarean NCT03925155 232 240 B-Procedure
delivery NCT03925155 241 249 I-Procedure
with NCT03925155 250 254 B-And
ruptured NCT03925155 255 263 B-Condition
amniotic NCT03925155 264 272 I-Condition
membranes NCT03925155 273 282 I-Condition
. NCT03925155 283 284 O

Exclusion NCT03925155 286 295 O
Criteria NCT03925155 296 304 O
: NCT03925155 305 306 O

- NCT03925155 310 311 O
Minors NCT03925155 313 319 O

- NCT03925155 322 323 O
Emergent NCT03925155 325 333 B-Modifier
cesarean NCT03925155 334 342 B-Procedure
delivery NCT03925155 343 351 I-Procedure
. NCT03925155 352 353 O

- NCT03925155 357 358 O
No NCT03925155 360 362 B-Negation
ruptured NCT03925155 363 371 B-Condition
membranes NCT03925155 372 381 I-Condition
. NCT03925155 382 383 O

- NCT03925155 387 388 O
Allergy NCT03925155 390 397 B-Allergy
to NCT03925155 398 400 O
chlorhexidine NCT03925155 401 414 B-Drug
or NCT03925155 415 417 B-Or
povidone NCT03925155 418 426 B-Drug
- NCT03925155 427 428 I-Drug
iodine NCT03925155 429 435 I-Drug
. NCT03925155 436 437 O

Inclusion NCT03868891 0 9 O
Criteria NCT03868891 10 18 O
: NCT03868891 19 20 O

- NCT03868891 24 25 O
6 NCT03868891 27 28 B-Eq_Comparison
- NCT03868891 29 30 I-Eq_Comparison
17 NCT03868891 31 33 I-Eq_Comparison
years NCT03868891 34 39 I-Eq_Comparison
old NCT03868891 40 43 B-Age

- NCT03868891 46 47 O
Otherwise NCT03868891 49 58 O
healthy NCT03868891 59 66 B-Condition

- NCT03868891 69 70 O
Currently NCT03868891 72 81 B-Eq_Comparison
have NCT03868891 82 86 O
unilateral NCT03868891 87 97 B-Modifier
or NCT03868891 98 100 B-Or
bilateral NCT03868891 101 110 B-Modifier
ventilation NCT03868891 111 122 B-Procedure
tube NCT03868891 123 127 I-Procedure
( NCT03868891 128 129 O
s NCT03868891 130 131 O
) NCT03868891 132 133 O
( NCT03868891 134 135 O
VTs NCT03868891 136 139 B-Procedure
) NCT03868891 140 141 O
inserted NCT03868891 142 150 B-Modifier
for NCT03868891 151 154 O
otitis NCT03868891 155 161 B-Condition
media NCT03868891 162 167 I-Condition
with NCT03868891 168 172 I-Condition
effusion NCT03868891 173 181 I-Condition
( NCT03868891 182 183 O
OME NCT03868891 184 187 B-Condition
) NCT03868891 188 189 O
or NCT03868891 190 192 B-Or
tympanic NCT03868891 193 201 B-Condition
membrane NCT03868891 202 210 I-Condition
retraction NCT03868891 211 221 I-Condition
/ NCT03868891 222 223 B-Or
retraction NCT03868891 224 234 B-Condition
pocket NCT03868891 235 241 I-Condition
( NCT03868891 242 243 O
TM NCT03868891 244 246 B-Condition
- NCT03868891 247 248 I-Condition
R NCT03868891 249 250 I-Condition
/ NCT03868891 251 252 I-Condition
RP NCT03868891 253 255 I-Condition
) NCT03868891 256 257 O
or NCT03868891 258 260 B-Or
a NCT03868891 261 262 O
TM NCT03868891 263 265 B-Condition
perforation NCT03868891 266 277 I-Condition
after NCT03868891 278 283 B-Temporal_Connection___Temporal_Connection_Type_Value:after
extrusion NCT03868891 284 293 B-Procedure
of NCT03868891 294 296 I-Procedure
a NCT03868891 297 298 I-Procedure
VT NCT03868891 299 301 I-Procedure

- NCT03868891 304 305 O
History NCT03868891 307 314 B-Eq_Comparison
of NCT03868891 315 317 O
at NCT03868891 318 320 B-Eq_Comparison
least NCT03868891 321 326 I-Eq_Comparison
2 NCT03868891 327 328 I-Eq_Comparison
sets NCT03868891 329 333 I-Eq_Comparison
of NCT03868891 334 336 O
VT NCT03868891 337 339 B-Procedure
insertions NCT03868891 340 350 I-Procedure
in NCT03868891 351 353 O
the NCT03868891 354 357 O
past NCT03868891 358 362 B-Eq_Comparison

- NCT03868891 365 366 O
Eustachian NCT03868891 368 378 B-Observation
tube NCT03868891 379 383 I-Observation
( NCT03868891 384 385 O
ET NCT03868891 386 388 B-Observation
) NCT03868891 389 390 O
function NCT03868891 391 399 B-Modifier
( NCT03868891 400 401 O
ETF NCT03868891 402 405 B-Observation
) NCT03868891 406 407 O
tests NCT03868891 408 413 O
showing NCT03868891 414 421 O
an NCT03868891 422 424 O
active NCT03868891 425 431 B-Eq_Comparison
muscular NCT03868891 432 440 B-Modifier
pattern NCT03868891 441 448 I-Modifier
of NCT03868891 449 451 O
Eustachian NCT03868891 452 462 B-Condition
tube NCT03868891 463 467 I-Condition
dysfunction NCT03868891 468 479 I-Condition

- NCT03868891 482 483 O
Tubomanometry NCT03868891 485 498 B-Observation
test NCT03868891 499 503 I-Observation
results NCT03868891 504 511 O
showing NCT03868891 512 519 O
evidence NCT03868891 520 528 O
of NCT03868891 529 531 O
velopharyngeal NCT03868891 532 546 B-Condition
dysfunction NCT03868891 547 558 I-Condition
during NCT03868891 559 565 B-Temporal_Connection___Temporal_Connection_Type_Value:during
swallowing NCT03868891 566 576 B-Observation

- NCT03868891 579 580 O
Cleft NCT03868891 582 587 B-Condition
palate NCT03868891 588 594 I-Condition
( NCT03868891 595 596 O
CP NCT03868891 597 599 B-Condition
) NCT03868891 600 601 O
cohort NCT03868891 602 608 O
: NCT03868891 609 610 O
non NCT03868891 611 614 B-Negation
- NCT03868891 615 616 O
syndromic NCT03868891 617 626 B-Condition
; NCT03868891 626 627 O
prior NCT03868891 628 633 B-Eq_Comparison
Furlow NCT03868891 634 640 B-Procedure
palatoplasty NCT03868891 641 653 I-Procedure
without NCT03868891 654 661 B-Negation
complications NCT03868891 662 675 B-Condition
or NCT03868891 676 678 B-Or
need NCT03868891 679 683 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03868891 684 687 I-Assertion___Assertion_Type_Value:hypothetical
revision NCT03868891 688 696 B-Procedure

- NCT03868891 699 700 O
Non NCT03868891 702 705 B-Negation
- NCT03868891 706 707 O
CP NCT03868891 708 710 B-Condition
cohort NCT03868891 711 717 O
: NCT03868891 718 719 O
have NCT03868891 720 724 O
had NCT03868891 725 728 O
prior NCT03868891 729 734 B-Eq_Comparison
adenoidectomy NCT03868891 735 748 B-Procedure

Exclusion NCT03868891 749 758 O
Criteria NCT03868891 759 767 O
: NCT03868891 768 769 O

- NCT03868891 773 774 O
Concurrent NCT03868891 776 786 B-Eq_Comparison
or NCT03868891 787 789 B-Or
past NCT03868891 790 794 B-Eq_Comparison
diagnosis NCT03868891 795 804 O
of NCT03868891 805 807 O
cancer NCT03868891 808 814 B-Condition
or NCT03868891 815 817 B-Or
history NCT03868891 818 825 B-Eq_Comparison
of NCT03868891 826 828 O
radiation NCT03868891 829 838 B-Procedure

- NCT03868891 841 842 O
Have NCT03868891 844 848 B-Eq_Comparison
or NCT03868891 849 851 B-Or
had NCT03868891 852 855 B-Eq_Comparison
vestibular NCT03868891 856 866 B-Condition
pathology NCT03868891 867 876 I-Condition
, NCT03868891 877 878 O
cranial NCT03868891 879 886 B-Modifier
base NCT03868891 887 891 I-Modifier
surgery NCT03868891 892 899 B-Procedure
or NCT03868891 900 902 B-Or
ossicular NCT03868891 903 912 B-Modifier
chain NCT03868891 913 918 B-Procedure
reconstruction NCT03868891 919 933 I-Procedure

- NCT03868891 936 937 O
Craniofacial NCT03868891 939 951 B-Condition
dysmorphology NCT03868891 952 965 I-Condition
( NCT03868891 966 967 O
other NCT03868891 968 973 B-Exception
than NCT03868891 974 978 I-Exception
non NCT03868891 979 982 B-Negation
- NCT03868891 983 984 O
syndromic NCT03868891 985 994 B-Modifier
CP NCT03868891 995 997 B-Condition
with NCT03868891 998 1002 B-And
or NCT03868891 1003 1005 B-Or
without NCT03868891 1006 1013 B-Negation
cleft NCT03868891 1014 1019 B-Condition
lip NCT03868891 1020 1023 I-Condition
in NCT03868891 1024 1026 O
the NCT03868891 1027 1030 O
CP NCT03868891 1031 1033 B-Condition
cohort NCT03868891 1034 1040 O
) NCT03868891 1041 1042 O
or NCT03868891 1043 1045 B-Or
other NCT03868891 1046 1051 B-Other
syndrome NCT03868891 1052 1060 B-Condition

- NCT03868891 1063 1064 O
A NCT03868891 1066 1067 O
non NCT03868891 1068 1071 B-Negation
- NCT03868891 1072 1073 O
patent NCT03868891 1074 1080 B-Modifier
nasal NCT03868891 1081 1086 B-Condition
cavity NCT03868891 1087 1093 I-Condition

- NCT03868891 1096 1097 O
Patulous NCT03868891 1099 1107 B-Condition
ET NCT03868891 1108 1110 I-Condition
or NCT03868891 1111 1113 B-Or
pathologically NCT03868891 1114 1128 B-Condition
low NCT03868891 1129 1132 I-Condition
ET NCT03868891 1133 1135 I-Condition
opening NCT03868891 1136 1143 B-Modifier
or NCT03868891 1144 1146 B-Or
closing NCT03868891 1147 1154 B-Modifier
pressures NCT03868891 1155 1164 I-Modifier

- NCT03868891 1167 1168 O
Pregnancy NCT03868891 1170 1179 B-Condition

- NCT03868891 1182 1183 O
Unable NCT03868891 1185 1191 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03868891 1192 1194 B-Or
unwilling NCT03868891 1195 1204 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03868891 1205 1207 O
perform NCT03868891 1208 1215 O
the NCT03868891 1216 1219 O
tests NCT03868891 1220 1225 B-Observation
and NCT03868891 1226 1229 B-Or
exercises NCT03868891 1230 1239 B-Observation
outlined NCT03868891 1240 1248 O
in NCT03868891 1249 1251 O
the NCT03868891 1252 1255 O
study NCT03868891 1256 1261 B-Study

Inclusion NCT03860428 0 9 O
Criteria NCT03860428 10 18 O
: NCT03860428 19 20 O

- NCT03860428 24 25 O
Gestational NCT03860428 27 38 B-Observation
age NCT03860428 39 42 I-Observation
< NCT03860428 43 44 B-Eq_Comparison
32 NCT03860428 45 47 I-Eq_Comparison
weeks NCT03860428 48 53 I-Eq_Comparison

- NCT03860428 56 57 O
Birthweight NCT03860428 59 70 B-Observation
< NCT03860428 71 72 B-Eq_Comparison
1500 NCT03860428 73 77 I-Eq_Comparison
g NCT03860428 78 79 I-Eq_Comparison

- NCT03860428 82 83 O
Age NCT03860428 85 88 B-Age
less NCT03860428 89 93 B-Eq_Comparison
than NCT03860428 94 98 I-Eq_Comparison
72 NCT03860428 99 101 I-Eq_Comparison
hours NCT03860428 102 107 I-Eq_Comparison

- NCT03860428 110 111 O
PDA NCT03860428 113 116 B-Condition
diameter NCT03860428 117 125 B-Observation
> NCT03860428 126 127 B-Eq_Comparison
1.5 NCT03860428 128 131 I-Eq_Comparison
mm NCT03860428 132 134 I-Eq_Comparison

- NCT03860428 137 138 O
Signed NCT03860428 140 146 O
informed NCT03860428 147 155 O
consent NCT03860428 156 163 O
obtained NCT03860428 164 172 O
from NCT03860428 173 177 O
both NCT03860428 178 182 O
parents NCT03860428 183 190 O

Exclusion NCT03860428 191 200 O
Criteria NCT03860428 201 209 O
: NCT03860428 210 211 O

- NCT03860428 215 216 O
Birthweight NCT03860428 218 229 B-Observation
≥ NCT03860428 230 231 B-Eq_Comparison
1500 NCT03860428 232 236 I-Eq_Comparison
g NCT03860428 237 238 I-Eq_Comparison
and NCT03860428 239 242 B-Or
/ NCT03860428 243 244 I-Or
or NCT03860428 245 247 I-Or
gestation NCT03860428 248 257 B-Observation
age NCT03860428 258 261 I-Observation
≥ NCT03860428 262 263 B-Eq_Comparison
32 NCT03860428 264 266 I-Eq_Comparison
weeks NCT03860428 267 272 I-Eq_Comparison

- NCT03860428 275 276 O
Lack NCT03860428 278 282 O
of NCT03860428 283 285 O
informed NCT03860428 286 294 O
consent NCT03860428 295 302 O
of NCT03860428 303 305 O
the NCT03860428 306 309 O
parents NCT03860428 310 317 O

- NCT03860428 320 321 O
Congenital NCT03860428 323 333 B-Condition
heart NCT03860428 334 339 I-Condition
defect NCT03860428 340 346 I-Condition
, NCT03860428 347 348 O
other NCT03860428 349 354 B-Exception
than NCT03860428 355 359 I-Exception
PDA NCT03860428 360 363 B-Condition
and NCT03860428 364 367 B-Or
/ NCT03860428 368 369 I-Or
or NCT03860428 370 372 I-Or
patent NCT03860428 373 379 B-Condition
foramen NCT03860428 380 387 I-Condition
ovale NCT03860428 388 393 I-Condition
( NCT03860428 394 395 O
PFO NCT03860428 396 399 B-Condition
) NCT03860428 400 401 O

- NCT03860428 405 406 O
The NCT03860428 408 411 O
presence NCT03860428 412 420 O
of NCT03860428 421 423 O
a NCT03860428 424 425 O
clinically NCT03860428 426 436 O
apparent NCT03860428 437 445 O
hemorrhagic NCT03860428 446 457 B-Condition
syndrome NCT03860428 458 466 I-Condition

- NCT03860428 469 470 O
Any NCT03860428 472 475 O
intraventricular NCT03860428 476 492 B-Condition
hemorrhage NCT03860428 493 503 I-Condition
( NCT03860428 504 505 O
IVH NCT03860428 506 509 B-Condition
) NCT03860428 510 511 O
in NCT03860428 512 514 B-Eq_Comparison
the NCT03860428 515 518 I-Eq_Comparison
first NCT03860428 519 524 I-Eq_Comparison
48 NCT03860428 525 527 I-Eq_Comparison
hours NCT03860428 528 533 I-Eq_Comparison
or NCT03860428 534 536 B-Or
IVH NCT03860428 537 540 B-Condition
grade NCT03860428 541 546 B-Eq_Comparison
3 NCT03860428 547 548 I-Eq_Comparison
- NCT03860428 549 550 I-Eq_Comparison
4 NCT03860428 551 552 I-Eq_Comparison

- NCT03860428 556 557 O
A NCT03860428 559 560 O
platelet NCT03860428 561 569 B-Observation
count NCT03860428 570 575 I-Observation
of NCT03860428 576 578 O
< NCT03860428 579 580 B-Eq_Comparison
50 NCT03860428 581 583 I-Eq_Comparison
, NCT03860428 584 585 I-Eq_Comparison
000 NCT03860428 586 589 I-Eq_Comparison
/ NCT03860428 590 591 I-Eq_Comparison
mm NCT03860428 592 594 I-Eq_Comparison
3 NCT03860428 595 596 I-Eq_Comparison

- NCT03860428 599 600 O
A NCT03860428 602 603 O
serum NCT03860428 604 609 B-Observation
creatinine NCT03860428 610 620 I-Observation
concentration NCT03860428 621 634 I-Observation
of NCT03860428 635 637 O
> NCT03860428 638 639 B-Eq_Comparison
110 NCT03860428 640 643 I-Eq_Comparison
μmol NCT03860428 644 648 I-Eq_Comparison
/ NCT03860428 649 650 I-Eq_Comparison
L NCT03860428 651 652 I-Eq_Comparison

- NCT03860428 655 656 O
Oliguria NCT03860428 658 666 B-Observation
< NCT03860428 667 668 B-Eq_Comparison
1 NCT03860428 669 670 I-Eq_Comparison
ml NCT03860428 671 673 I-Eq_Comparison
/ NCT03860428 674 675 I-Eq_Comparison
kg NCT03860428 676 678 I-Eq_Comparison
/ NCT03860428 679 680 I-Eq_Comparison
h NCT03860428 681 682 I-Eq_Comparison

- NCT03860428 685 686 O
Suspected NCT03860428 688 697 B-Assertion___Assertion_Type_Value:possible
/ NCT03860428 698 699 B-Or
apparent NCT03860428 700 708 B-Assertion___Assertion_Type_Value:possible
NEC NCT03860428 709 712 B-Condition

- NCT03860428 715 716 O
Suspected NCT03860428 718 727 B-Assertion___Assertion_Type_Value:possible
/ NCT03860428 728 729 B-Or
apparent NCT03860428 730 738 B-Assertion___Assertion_Type_Value:possible
lung NCT03860428 739 743 B-Modifier
hypoplasia NCT03860428 744 754 B-Condition

Inclusion NCT03920345 0 9 O
Criteria NCT03920345 10 18 O
: NCT03920345 19 20 O

Subject NCT03920345 22 29 O
age NCT03920345 30 33 B-Age
18 NCT03920345 34 36 B-Eq_Comparison
- NCT03920345 37 38 I-Eq_Comparison
85 NCT03920345 39 41 I-Eq_Comparison
years NCT03920345 42 47 I-Eq_Comparison
; NCT03920345 47 48 O

- NCT03920345 51 52 O
SIJ NCT03920345 54 57 B-Condition
arthropathy NCT03920345 58 69 I-Condition
and NCT03920345 70 73 B-Or
chronic NCT03920345 74 81 B-Condition
lower NCT03920345 82 87 I-Condition
back NCT03920345 88 92 I-Condition
pain NCT03920345 93 97 I-Condition
( NCT03920345 98 99 O
CLBP NCT03920345 100 104 B-Condition
) NCT03920345 105 106 O
; NCT03920345 107 108 O

- NCT03920345 111 112 O
Patient NCT03920345 114 121 O
to NCT03920345 122 124 O
undergo NCT03920345 125 132 B-Eq_Comparison
endoscopic NCT03920345 133 143 B-Procedure
electrothermic NCT03920345 144 158 I-Procedure
ablation NCT03920345 159 167 I-Procedure
of NCT03920345 168 170 B-And
spinal NCT03920345 171 177 B-Condition
levels NCT03920345 178 184 I-Condition
S NCT03920345 185 186 B-Eq_Comparison
1 NCT03920345 187 188 I-Eq_Comparison
- NCT03920345 189 190 I-Eq_Comparison
S NCT03920345 191 192 I-Eq_Comparison
3 NCT03920345 193 194 I-Eq_Comparison
. NCT03920345 194 195 O
The NCT03920345 197 200 O
L NCT03920345 201 202 B-Modifier
4 NCT03920345 203 204 I-Modifier
- NCT03920345 205 206 I-Modifier
L NCT03920345 207 208 I-Modifier
5 NCT03920345 209 210 I-Modifier
and NCT03920345 211 214 B-Or
/ NCT03920345 215 216 I-Or
or NCT03920345 217 219 I-Or
L NCT03920345 220 221 B-Modifier
5 NCT03920345 222 223 I-Modifier
- NCT03920345 224 225 I-Modifier
S NCT03920345 226 227 I-Modifier
1 NCT03920345 228 229 I-Modifier
facet NCT03920345 230 235 B-Procedure
joint NCT03920345 236 241 I-Procedure
can NCT03920345 242 245 O
be NCT03920345 246 248 O
included NCT03920345 249 257 O
in NCT03920345 258 260 O
the NCT03920345 261 264 O
ablation NCT03920345 265 273 B-Procedure
per NCT03920345 274 277 O
doctor NCT03920345 278 284 O
discretion NCT03920345 285 295 O
. NCT03920345 296 297 O

- NCT03920345 301 302 O
Correct NCT03920345 304 311 O
spinal NCT03920345 312 318 B-Condition
levels NCT03920345 319 325 I-Condition
( NCT03920345 326 327 O
ranging NCT03920345 328 335 O
L NCT03920345 336 337 B-Eq_Comparison
4 NCT03920345 338 339 I-Eq_Comparison
- NCT03920345 340 341 I-Eq_Comparison
S NCT03920345 342 343 I-Eq_Comparison
3 NCT03920345 344 345 I-Eq_Comparison
) NCT03920345 346 347 O
to NCT03920345 348 350 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03920345 351 353 I-Assertion___Assertion_Type_Value:hypothetical
treated NCT03920345 354 361 B-Procedure
have NCT03920345 362 366 O
been NCT03920345 367 371 O
confirmed NCT03920345 372 381 O
by NCT03920345 382 384 O
1 NCT03920345 385 386 O
) NCT03920345 387 388 O
diagnostic NCT03920345 389 399 B-Procedure
SIJ NCT03920345 400 403 I-Procedure
injection NCT03920345 404 413 I-Procedure
, NCT03920345 414 415 O
followed NCT03920345 416 424 B-Temporal_Connection___Temporal_Connection_Type_Value:before
by NCT03920345 425 427 O
2 NCT03920345 428 429 O
) NCT03920345 430 431 O
diagnostic NCT03920345 432 442 B-Condition
Medial NCT03920345 443 449 B-Modifier
/ NCT03920345 450 451 B-Or
Lateral NCT03920345 452 459 B-Modifier
Branch NCT03920345 460 466 O
Block NCT03920345 467 472 O
at NCT03920345 473 475 O
the NCT03920345 476 479 O
applicable NCT03920345 480 490 O
levels NCT03920345 491 497 O
. NCT03920345 498 499 O

- NCT03920345 503 504 O
The NCT03920345 506 509 O
subject NCT03920345 510 517 O
is NCT03920345 518 520 O
likely NCT03920345 521 527 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03920345 528 530 I-Assertion___Assertion_Type_Value:hypothetical
follow NCT03920345 531 537 B-Observation
standard NCT03920345 538 546 I-Observation
of NCT03920345 547 549 I-Observation
care NCT03920345 550 554 I-Observation
post NCT03920345 555 559 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03920345 560 561 O
operative NCT03920345 562 571 B-Procedure
follow NCT03920345 572 578 O
- NCT03920345 579 580 O
up NCT03920345 581 583 O
for NCT03920345 584 587 O
at NCT03920345 588 590 B-Eq_Comparison
least NCT03920345 591 596 I-Eq_Comparison
24 NCT03920345 597 599 I-Eq_Comparison
months NCT03920345 600 606 I-Eq_Comparison
. NCT03920345 607 608 O

Exclusion NCT03920345 610 619 O
Criteria NCT03920345 620 628 O
: NCT03920345 629 630 O

Patients NCT03920345 632 640 O
receiving NCT03920345 641 650 B-Eq_Comparison
additional NCT03920345 651 661 O
invasive NCT03920345 662 670 B-Procedure
back NCT03920345 671 675 I-Procedure
surgery NCT03920345 676 683 I-Procedure
after NCT03920345 684 689 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03920345 690 693 O
study NCT03920345 694 699 B-Study
treatment NCT03920345 700 709 O
. NCT03920345 710 711 O

- NCT03920345 715 716 O
Inability NCT03920345 718 727 B-Negation
to NCT03920345 728 730 B-Assertion___Assertion_Type_Value:hypothetical
complete NCT03920345 731 739 I-Assertion___Assertion_Type_Value:hypothetical
follow NCT03920345 740 746 O
- NCT03920345 747 748 O
up NCT03920345 749 751 O
visits NCT03920345 752 758 B-Encounter
or NCT03920345 759 761 O
required NCT03920345 762 770 O
questionnaires NCT03920345 771 785 O
. NCT03920345 786 787 O

- NCT03920345 791 792 O
Non NCT03920345 794 797 O
- NCT03920345 798 799 O
compliant NCT03920345 800 809 O
patients NCT03920345 810 818 O

- NCT03920345 821 822 O
Difficult NCT03920345 824 833 B-Modifier
or NCT03920345 834 836 B-Or
impossible NCT03920345 837 847 B-Modifier
communication NCT03920345 848 861 B-Condition
with NCT03920345 862 866 O
the NCT03920345 867 870 O
patient NCT03920345 871 878 O

- NCT03920345 881 882 O
Breastfeeding NCT03920345 884 897 B-Condition
, NCT03920345 898 899 O
pregnant NCT03920345 900 908 B-Condition
or NCT03920345 909 911 B-Or
patients NCT03920345 912 920 O
who NCT03920345 921 924 O
plan NCT03920345 925 929 B-Assertion___Assertion_Type_Value:intention
a NCT03920345 930 931 O
pregnancy NCT03920345 932 941 B-Condition
while NCT03920345 942 947 B-Temporal_Connection___Temporal_Connection_Type_Value:during
participating NCT03920345 948 961 O
in NCT03920345 962 964 O
the NCT03920345 965 968 O
study NCT03920345 969 974 B-Study

- NCT03920345 977 978 O
Systemic NCT03920345 980 988 B-Modifier
neurological NCT03920345 989 1001 B-Condition
disorders NCT03920345 1002 1011 I-Condition
with NCT03920345 1012 1016 B-And
mobility NCT03920345 1017 1025 B-Condition
limitations NCT03920345 1026 1037 I-Condition
( NCT03920345 1038 1039 O
e NCT03920345 1040 1041 O
. NCT03920345 1042 1043 O
g NCT03920345 1044 1045 O
. NCT03920345 1046 1047 O
advanced NCT03920345 1049 1057 O
Parkinson NCT03920345 1058 1067 B-Condition
's NCT03920345 1067 1069 I-Condition
disease NCT03920345 1070 1077 I-Condition
or NCT03920345 1078 1080 B-Or
multiple NCT03920345 1081 1089 B-Condition
sclerosis NCT03920345 1090 1099 I-Condition
) NCT03920345 1100 1101 O

- NCT03920345 1105 1106 O
Patients NCT03920345 1108 1116 O
with NCT03920345 1117 1121 O
incompatibilities NCT03920345 1122 1139 O
or NCT03920345 1140 1142 O
known NCT03920345 1143 1148 O
limitations NCT03920345 1149 1160 O
that NCT03920345 1161 1165 O
make NCT03920345 1166 1170 O
participation NCT03920345 1171 1184 O
impossible NCT03920345 1185 1195 O

- NCT03920345 1198 1199 O
Patients NCT03920345 1201 1209 O
after NCT03920345 1210 1215 O
stabilization NCT03920345 1216 1229 O
with NCT03920345 1230 1234 O
implants NCT03920345 1235 1243 B-Condition
on NCT03920345 1244 1246 O
thoracic NCT03920345 1247 1255 B-Modifier
or NCT03920345 1256 1258 B-Or
lumbar NCT03920345 1259 1265 B-Modifier
spine NCT03920345 1266 1271 I-Modifier
. NCT03920345 1272 1273 O

- NCT03920345 1277 1278 O
Inability NCT03920345 1280 1289 O
to NCT03920345 1290 1292 O
provide NCT03920345 1293 1300 O
informed NCT03920345 1301 1309 O
consent NCT03920345 1310 1317 O
without NCT03920345 1318 1325 O
a NCT03920345 1326 1327 O
legally NCT03920345 1328 1335 O
authorized NCT03920345 1336 1346 O
representative NCT03920345 1347 1361 O
. NCT03920345 1362 1363 O


Inclusion NCT03920436 0 9 O
Criteria NCT03920436 10 18 O
: NCT03920436 19 20 O

- NCT03920436 24 25 O
19 NCT03920436 27 29 B-Eq_Comparison
years NCT03920436 30 35 I-Eq_Comparison
and NCT03920436 36 39 I-Eq_Comparison
older NCT03920436 40 45 I-Eq_Comparison

Exclusion NCT03920436 46 55 O
Criteria NCT03920436 56 64 O
: NCT03920436 65 66 O

- NCT03920436 70 71 O
aspartate NCT03920436 73 82 B-Observation
aminotransferase NCT03920436 83 99 I-Observation
( NCT03920436 100 101 O
AST NCT03920436 102 105 B-Observation
) NCT03920436 106 107 O
or NCT03920436 108 110 B-Or
alanine NCT03920436 111 118 B-Observation
aminotransferase NCT03920436 119 135 I-Observation
( NCT03920436 136 137 O
ALT NCT03920436 138 141 B-Observation
) NCT03920436 142 143 O
more NCT03920436 144 148 B-Eq_Comparison
than NCT03920436 149 153 I-Eq_Comparison
twice NCT03920436 154 159 I-Eq_Comparison
the NCT03920436 160 163 I-Eq_Comparison
highest NCT03920436 164 171 I-Eq_Comparison
reference NCT03920436 172 181 I-Eq_Comparison
value NCT03920436 182 187 I-Eq_Comparison

- NCT03920436 190 191 O
serum NCT03920436 193 198 B-Observation
creatinine NCT03920436 199 209 I-Observation
≥ NCT03920436 210 211 B-Eq_Comparison
1.5 NCT03920436 212 215 I-Eq_Comparison
mg NCT03920436 216 218 I-Eq_Comparison
/ NCT03920436 219 220 I-Eq_Comparison
dL NCT03920436 221 223 I-Eq_Comparison
) NCT03920436 224 225 O

- NCT03920436 229 230 O
uncontrolled NCT03920436 232 244 B-Modifier
diabetes NCT03920436 245 253 B-Condition
mellitus NCT03920436 254 262 I-Condition
( NCT03920436 263 264 O
a NCT03920436 265 266 O
fasting NCT03920436 267 274 B-Observation
glucose NCT03920436 275 282 I-Observation
of NCT03920436 283 285 O
> NCT03920436 286 287 B-Eq_Comparison
160 NCT03920436 288 291 I-Eq_Comparison
mg NCT03920436 292 294 I-Eq_Comparison
/ NCT03920436 295 296 I-Eq_Comparison
dL NCT03920436 297 299 I-Eq_Comparison
) NCT03920436 300 301 O

- NCT03920436 305 306 O
uncontrolled NCT03920436 308 320 B-Modifier
hypertension NCT03920436 321 333 B-Condition
( NCT03920436 334 335 O
BP NCT03920436 336 338 B-Observation
> NCT03920436 339 340 B-Eq_Comparison
160 NCT03920436 341 344 I-Eq_Comparison
/ NCT03920436 345 346 I-Eq_Comparison
100 NCT03920436 347 350 I-Eq_Comparison
mmHg NCT03920436 351 355 I-Eq_Comparison
) NCT03920436 356 357 O

- NCT03920436 361 362 O
severe NCT03920436 364 370 O
gastrointestinal NCT03920436 371 387 B-Condition
symptoms NCT03920436 388 396 B-Assertion___Assertion_Type_Value:possible

- NCT03920436 399 400 O
alcohol NCT03920436 402 409 B-Observation
abuser NCT03920436 410 416 I-Observation

- NCT03920436 419 420 O
pregnant NCT03920436 422 430 B-Condition
or NCT03920436 431 433 B-Or
lactating NCT03920436 434 443 B-Condition
women NCT03920436 444 449 O

- NCT03920436 452 453 O
allergic NCT03920436 455 463 B-Allergy
to NCT03920436 464 466 O
the NCT03920436 467 470 O
ingredient NCT03920436 471 481 B-Drug
involved NCT03920436 482 490 O

- NCT03920436 493 494 O
cardiocebrovascular NCT03920436 496 515 B-Condition
diseases NCT03920436 516 524 I-Condition
or NCT03920436 525 527 B-Or
any NCT03920436 528 531 O
cancer NCT03920436 532 538 B-Condition
during NCT03920436 539 545 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03920436 546 549 O
six NCT03920436 550 553 B-Eq_Comparison
months NCT03920436 554 560 I-Eq_Comparison
prior NCT03920436 561 566 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03920436 567 569 O
study NCT03920436 570 575 B-Study

- NCT03920436 578 579 O
smoker NCT03920436 581 587 B-Condition

Inclusion NCT03925337 0 9 O
Criteria NCT03925337 10 18 O
: NCT03925337 19 20 O

- NCT03925337 24 25 O
Patients NCT03925337 27 35 O
age NCT03925337 36 39 B-Age
: NCT03925337 40 41 O
≥ NCT03925337 42 43 B-Eq_Comparison
22 NCT03925337 44 46 I-Eq_Comparison
years NCT03925337 47 52 I-Eq_Comparison

- NCT03925337 55 56 O
Patients NCT03925337 58 66 O
presenting NCT03925337 67 77 B-Eq_Comparison
for NCT03925337 78 81 O
routine NCT03925337 82 89 B-Modifier
colonoscopy NCT03925337 90 101 B-Procedure
for NCT03925337 102 105 O
screening NCT03925337 106 115 B-Procedure
and NCT03925337 116 119 B-Or
/ NCT03925337 120 121 I-Or
or NCT03925337 122 124 I-Or
surveillance NCT03925337 125 137 B-Procedure
purposes NCT03925337 138 146 O
. NCT03925337 147 148 O

- NCT03925337 152 153 O
Willingness NCT03925337 155 166 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925337 167 169 O
undergo NCT03925337 170 177 O
two NCT03925337 178 181 B-Eq_Comparison
withdrawals NCT03925337 182 193 B-Condition
with NCT03925337 194 198 O
and NCT03925337 199 202 O
without NCT03925337 203 210 O
the NCT03925337 211 214 O
use NCT03925337 215 218 O
of NCT03925337 219 221 O
computer NCT03925337 222 230 O
- NCT03925337 231 232 O
aided NCT03925337 233 238 O
software NCT03925337 239 247 O
while NCT03925337 248 253 B-Temporal_Connection___Temporal_Connection_Type_Value:during
undergoing NCT03925337 254 264 O
conventional NCT03925337 265 277 B-Modifier
colonoscopy NCT03925337 278 289 B-Procedure
with NCT03925337 290 294 O
sedation NCT03925337 295 303 B-Procedure

- NCT03925337 306 307 O
Ability NCT03925337 309 316 O
to NCT03925337 317 319 O
provide NCT03925337 320 327 O
written NCT03925337 328 335 O
, NCT03925337 336 337 O
informed NCT03925337 338 346 O
consent NCT03925337 347 354 O
and NCT03925337 355 358 O
understand NCT03925337 359 369 O
the NCT03925337 370 373 O
responsibilities NCT03925337 374 390 O
of NCT03925337 391 393 O
trial NCT03925337 394 399 O
participation NCT03925337 400 413 O

Exclusion NCT03925337 414 423 O
Criteria NCT03925337 424 432 O
: NCT03925337 433 434 O

- NCT03925337 438 439 O
Minors NCT03925337 441 447 O
aged NCT03925337 448 452 B-Age
< NCT03925337 453 454 B-Eq_Comparison
22 NCT03925337 455 457 I-Eq_Comparison
years NCT03925337 458 463 I-Eq_Comparison
. NCT03925337 464 465 O

- NCT03925337 469 470 O
People NCT03925337 472 478 O
with NCT03925337 479 483 O
diminished NCT03925337 484 494 B-Condition
cognitive NCT03925337 495 504 I-Condition
capacity NCT03925337 505 513 I-Condition

- NCT03925337 516 517 O
Patients NCT03925337 519 527 O
undergoing NCT03925337 528 538 B-Eq_Comparison
diagnostic NCT03925337 539 549 B-Modifier
colonoscopy NCT03925337 550 561 B-Procedure
( NCT03925337 562 563 O
e NCT03925337 564 565 O
. NCT03925337 566 567 O
g NCT03925337 568 569 O
. NCT03925337 570 571 O
as NCT03925337 573 575 O
an NCT03925337 576 578 O
evaluation NCT03925337 579 589 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03925337 590 593 I-Assertion___Assertion_Type_Value:hypothetical
active NCT03925337 594 600 B-Eq_Comparison
gastrointestinal NCT03925337 601 617 B-Modifier
bleed NCT03925337 618 623 B-Condition
, NCT03925337 624 625 O
referring NCT03925337 626 635 O
collectively NCT03925337 636 648 O
to NCT03925337 649 651 O
the NCT03925337 652 655 O
stomach NCT03925337 656 663 B-Modifier
and NCT03925337 664 667 B-Or
the NCT03925337 668 671 O
small NCT03925337 672 677 B-Modifier
and NCT03925337 678 681 B-Or
large NCT03925337 682 687 B-Modifier
intestine NCT03925337 688 697 I-Modifier
) NCT03925337 698 699 O
. NCT03925337 700 701 O

- NCT03925337 705 706 O
Patients NCT03925337 708 716 O
with NCT03925337 717 721 O
incomplete NCT03925337 722 732 B-Modifier
colonoscopies NCT03925337 733 746 B-Procedure
( NCT03925337 747 748 O
those NCT03925337 749 754 O
where NCT03925337 755 760 O
endoscopists NCT03925337 761 773 O
did NCT03925337 774 777 O
not NCT03925337 778 781 B-Negation
successfully NCT03925337 782 794 O
intubate NCT03925337 795 803 B-Procedure
the NCT03925337 804 807 O
cecum NCT03925337 808 813 B-Modifier
due NCT03925337 814 817 O
to NCT03925337 818 820 O
technical NCT03925337 821 830 O
difficulties NCT03925337 831 843 O
or NCT03925337 844 846 B-Or
poor NCT03925337 847 851 B-Modifier
bowel NCT03925337 852 857 B-Procedure
preparation NCT03925337 858 869 I-Procedure
) NCT03925337 870 871 O

- NCT03925337 875 876 O
Patients NCT03925337 878 886 O
that NCT03925337 887 891 O
have NCT03925337 892 896 O
standard NCT03925337 897 905 O
contraindications NCT03925337 906 923 B-Contraindication
to NCT03925337 924 926 O
colonoscopy NCT03925337 927 938 B-Procedure
in NCT03925337 939 941 O
general NCT03925337 942 949 O
( NCT03925337 950 951 O
e NCT03925337 952 953 O
. NCT03925337 954 955 O
g NCT03925337 956 957 O
. NCT03925337 958 959 O
documented NCT03925337 961 971 O
acute NCT03925337 972 977 O
diverticulitis NCT03925337 978 992 B-Condition
, NCT03925337 993 994 O
fulminant NCT03925337 995 1004 B-Condition
colitis NCT03925337 1005 1012 I-Condition
and NCT03925337 1013 1016 O
known NCT03925337 1017 1022 O
or NCT03925337 1023 1025 O
suspected NCT03925337 1026 1035 B-Assertion___Assertion_Type_Value:possible
perforation NCT03925337 1036 1047 B-Condition
) NCT03925337 1048 1049 O
. NCT03925337 1050 1051 O

- NCT03925337 1055 1056 O
Patients NCT03925337 1058 1066 O
with NCT03925337 1067 1071 O
inflammatory NCT03925337 1072 1084 B-Condition
bowel NCT03925337 1085 1090 I-Condition
disease NCT03925337 1091 1098 I-Condition

- NCT03925337 1101 1102 O
Patients NCT03925337 1104 1112 O
with NCT03925337 1113 1117 O
any NCT03925337 1118 1121 O
polypoid NCT03925337 1122 1130 B-Modifier
/ NCT03925337 1131 1132 B-Or
ulcerated NCT03925337 1133 1142 B-Modifier
lesion NCT03925337 1143 1149 B-Observation
> NCT03925337 1150 1151 B-Eq_Comparison
2 NCT03925337 1152 1153 I-Eq_Comparison
cm NCT03925337 1154 1156 I-Eq_Comparison
concerning NCT03925337 1157 1167 O
for NCT03925337 1168 1171 O
invasive NCT03925337 1172 1180 B-Modifier
cancer NCT03925337 1181 1187 B-Condition
on NCT03925337 1188 1190 O
endoscopy NCT03925337 1191 1200 B-Procedure

- NCT03925337 1203 1204 O
Patients NCT03925337 1206 1214 O
referred NCT03925337 1215 1223 B-Encounter
for NCT03925337 1224 1227 O
endoscopic NCT03925337 1228 1238 B-Procedure
mucosal NCT03925337 1239 1246 I-Procedure
resection NCT03925337 1247 1256 I-Procedure
( NCT03925337 1257 1258 O
EMR NCT03925337 1259 1262 B-Procedure
) NCT03925337 1263 1264 O
, NCT03925337 1265 1266 O
which NCT03925337 1267 1272 O
is NCT03925337 1273 1275 O
a NCT03925337 1276 1277 O
procedure NCT03925337 1278 1287 O
to NCT03925337 1288 1290 O
remove NCT03925337 1291 1297 O
early NCT03925337 1298 1303 O
- NCT03925337 1304 1305 O
stage NCT03925337 1306 1311 O
cancer NCT03925337 1312 1318 O
and NCT03925337 1319 1322 O
precancerous NCT03925337 1323 1335 O
growths NCT03925337 1336 1343 O
from NCT03925337 1344 1348 O
the NCT03925337 1349 1352 O
lining NCT03925337 1353 1359 O
of NCT03925337 1360 1362 O
the NCT03925337 1363 1366 O
digestive NCT03925337 1367 1376 O
tract NCT03925337 1377 1382 O
. NCT03925337 1383 1384 O

Inclusion NCT03925558 0 9 O
Criteria NCT03925558 10 18 O
: NCT03925558 19 20 O

- NCT03925558 23 24 O
Full NCT03925558 25 29 O
term NCT03925558 30 34 O
healthy NCT03925558 35 42 B-Condition
infant NCT03925558 43 49 O
aged NCT03925558 50 54 B-Age
3 NCT03925558 55 56 B-Eq_Comparison
- NCT03925558 57 58 I-Eq_Comparison
95 NCT03925558 59 61 I-Eq_Comparison
days NCT03925558 62 66 I-Eq_Comparison

Exclusion NCT03925558 67 76 O
Criteria NCT03925558 77 85 O
: NCT03925558 86 87 O

- NCT03925558 91 92 O
Prematurity NCT03925558 94 105 B-Condition

- NCT03925558 108 109 O
Low NCT03925558 111 114 O
birth NCT03925558 115 120 B-Observation
weight NCT03925558 121 127 I-Observation

- NCT03925558 130 131 O
Congenital NCT03925558 133 143 B-Condition
anomalies NCT03925558 144 153 I-Condition

- NCT03925558 156 157 O
Chronic NCT03925558 159 166 B-Condition
disease NCT03925558 167 174 I-Condition

- NCT03925558 177 178 O
Failure NCT03925558 180 187 B-Condition
to NCT03925558 188 190 I-Condition
thrive NCT03925558 191 197 I-Condition

- NCT03925558 200 201 O
Allergy NCT03925558 203 210 B-Allergy
or NCT03925558 211 213 B-Or
atopic NCT03925558 214 220 B-Condition
disease NCT03925558 221 228 I-Condition

- NCT03925558 231 232 O
Recent NCT03925558 234 240 B-Eq_Comparison
exposure NCT03925558 241 249 O
to NCT03925558 250 252 O
antibiotics NCT03925558 253 264 B-Drug

Inclusion NCT03864770 0 9 O
Criteria NCT03864770 10 18 O
: NCT03864770 19 20 O

1 NCT03864770 24 25 O
. NCT03864770 25 26 O
≥ NCT03864770 28 29 B-Eq_Comparison
20 NCT03864770 30 32 I-Eq_Comparison
y NCT03864770 33 34 I-Eq_Comparison
/ NCT03864770 35 36 I-Eq_Comparison
o NCT03864770 37 38 I-Eq_Comparison
patients NCT03864770 39 47 O
with NCT03864770 48 52 O
NLCs NCT03864770 53 57 B-Condition
: NCT03864770 58 59 O
( NCT03864770 60 61 O
1 NCT03864770 62 63 O
) NCT03864770 64 65 O
4 NCT03864770 66 67 B-Eq_Comparison
times NCT03864770 68 73 I-Eq_Comparison
/ NCT03864770 74 75 I-Eq_Comparison
week NCT03864770 76 80 I-Eq_Comparison
, NCT03864770 81 82 O
last NCT03864770 83 87 B-Eq_Comparison
2 NCT03864770 88 89 I-Eq_Comparison
weeks NCT03864770 90 95 I-Eq_Comparison
; NCT03864770 95 96 O
( NCT03864770 97 98 O
2 NCT03864770 99 100 O
) NCT03864770 101 102 O
Occurred NCT03864770 103 111 O
in NCT03864770 112 114 O
nighttime NCT03864770 115 124 B-Modifier
or NCT03864770 125 127 B-Or
resting NCT03864770 128 135 B-Modifier
time NCT03864770 136 140 I-Modifier
of NCT03864770 141 143 I-Modifier
daytime NCT03864770 144 151 I-Modifier

2 NCT03864770 154 155 O
. NCT03864770 155 156 O
Patients NCT03864770 158 166 O
with NCT03864770 167 171 O
MTrPs NCT03864770 172 177 B-Condition
on NCT03864770 178 180 B-Eq_Comparison
gastrocnemius NCT03864770 181 194 B-Drug
( NCT03864770 195 196 O
According NCT03864770 197 206 O
to NCT03864770 207 209 O
the NCT03864770 210 213 O
diagnostic NCT03864770 214 224 O
criteria NCT03864770 225 233 O
proposed NCT03864770 234 242 O
by NCT03864770 243 245 O
Simons NCT03864770 246 252 B-Provider
& NCT03864770 253 254 I-Provider
Travell NCT03864770 255 262 I-Provider
) NCT03864770 263 264 O

Exclusion NCT03864770 266 275 O
Criteria NCT03864770 276 284 O
: NCT03864770 285 286 O

1 NCT03864770 290 291 O
. NCT03864770 291 292 O
( NCT03864770 294 295 O
1 NCT03864770 296 297 O
) NCT03864770 298 299 O
Taking NCT03864770 300 306 B-Eq_Comparison
medication NCT03864770 307 317 B-Drug
for NCT03864770 318 321 O
leg NCT03864770 322 325 B-Modifier
cramps NCT03864770 326 332 B-Condition
( NCT03864770 333 334 O
eg NCT03864770 335 337 O
. NCT03864770 338 339 O
Quinine NCT03864770 341 348 B-Drug
, NCT03864770 349 350 O
Magnesium NCT03864770 351 360 B-Drug
oxide NCT03864770 361 366 I-Drug
) NCT03864770 367 368 O
; NCT03864770 369 370 O
( NCT03864770 371 372 O
2 NCT03864770 373 374 O
) NCT03864770 375 376 O
Other NCT03864770 377 382 B-Other
drugs NCT03864770 383 388 B-Drug
that NCT03864770 389 393 O
affect NCT03864770 394 400 O
research NCT03864770 401 409 O
and NCT03864770 410 413 O
evaluation NCT03864770 414 424 B-Study
( NCT03864770 425 426 O
eg NCT03864770 427 429 O
. NCT03864770 430 431 O
diuretics NCT03864770 433 442 B-Drug
, NCT03864770 443 444 O
statins NCT03864770 445 452 B-Drug
, NCT03864770 453 454 O
calcium NCT03864770 455 462 B-Drug
channel NCT03864770 463 470 I-Drug
blockers NCT03864770 471 479 I-Drug
, NCT03864770 480 481 O
anticonvulsants NCT03864770 482 497 B-Drug
) NCT03864770 498 499 O

2 NCT03864770 503 504 O
. NCT03864770 504 505 O
Congenital NCT03864770 507 517 B-Condition
lower NCT03864770 518 523 I-Condition
limb NCT03864770 524 528 I-Condition
musculoskeletal NCT03864770 529 544 I-Condition
diseases NCT03864770 545 553 I-Condition
, NCT03864770 554 555 O
Lower NCT03864770 556 561 B-Modifier
limb NCT03864770 562 566 I-Modifier
or NCT03864770 567 569 B-Or
spine NCT03864770 570 575 B-Modifier
surgery NCT03864770 576 583 B-Procedure

3 NCT03864770 586 587 O
. NCT03864770 587 588 O
Uncommunicated NCT03864770 590 604 B-Condition
or NCT03864770 605 607 B-Or
cognitive NCT03864770 608 617 B-Condition
impaired NCT03864770 618 626 I-Condition

4 NCT03864770 629 630 O
. NCT03864770 630 631 O
Patients NCT03864770 633 641 O
refused NCT03864770 642 649 O
to NCT03864770 650 652 O
be NCT03864770 653 655 O
recruited NCT03864770 656 665 O

Inclusion NCT03867617 0 9 O
Criteria NCT03867617 10 18 O
: NCT03867617 19 20 O

- NCT03867617 24 25 O
Patient NCT03867617 27 34 O
has NCT03867617 35 38 O
provided NCT03867617 39 47 O
written NCT03867617 48 55 O
informed NCT03867617 56 64 O
consent NCT03867617 65 72 O
. NCT03867617 73 74 O

- NCT03867617 78 79 O
Patient NCT03867617 81 88 O
is NCT03867617 89 91 O
18 NCT03867617 92 94 B-Eq_Comparison
years NCT03867617 95 100 I-Eq_Comparison
or NCT03867617 101 103 I-Eq_Comparison
older NCT03867617 104 109 I-Eq_Comparison
. NCT03867617 110 111 O

- NCT03867617 115 116 O
Patient NCT03867617 118 125 O
is NCT03867617 126 128 O
a NCT03867617 129 130 O
planned NCT03867617 131 138 B-Eq_Comparison
recipient NCT03867617 139 148 O
of NCT03867617 149 151 O
a NCT03867617 152 153 O
living NCT03867617 154 160 B-Modifier
donor NCT03867617 161 166 I-Modifier
kidney NCT03867617 167 173 B-Procedure
transplant NCT03867617 174 184 I-Procedure
. NCT03867617 185 186 O

- NCT03867617 190 191 O
Patient NCT03867617 193 200 O
is NCT03867617 201 203 O
a NCT03867617 204 205 O
planned NCT03867617 206 213 B-Eq_Comparison
recipient NCT03867617 214 223 O
of NCT03867617 224 226 O
an NCT03867617 227 229 O
ABO NCT03867617 230 233 B-Modifier
blood NCT03867617 234 239 I-Modifier
group NCT03867617 240 245 I-Modifier
- NCT03867617 246 247 I-Modifier
compatible NCT03867617 248 258 I-Modifier
kidney NCT03867617 259 265 B-Procedure
graft NCT03867617 266 271 I-Procedure
. NCT03867617 272 273 O

- NCT03867617 277 278 O
Patient NCT03867617 280 287 O
is NCT03867617 288 290 O
a NCT03867617 291 292 O
planned NCT03867617 293 300 B-Eq_Comparison
recipient NCT03867617 301 310 O
of NCT03867617 311 313 O
a NCT03867617 314 315 O
kidney NCT03867617 316 322 B-Procedure
graft NCT03867617 323 328 I-Procedure
from NCT03867617 329 333 O
a NCT03867617 334 335 O
donor NCT03867617 336 341 B-Modifier
that NCT03867617 342 346 O
is NCT03867617 347 349 O
not NCT03867617 350 353 B-Negation
HLA NCT03867617 354 357 B-Condition
( NCT03867617 358 359 O
human NCT03867617 360 365 B-Condition
leukocyte NCT03867617 366 375 I-Condition
antigen NCT03867617 376 383 I-Condition
) NCT03867617 384 385 O
- NCT03867617 386 387 O
identical NCT03867617 388 397 B-Modifier
. NCT03867617 398 399 O

- NCT03867617 403 404 O
Patient NCT03867617 406 413 O
is NCT03867617 414 416 O
negative NCT03867617 417 425 O
for NCT03867617 426 429 O
DSA NCT03867617 430 433 B-Condition
( NCT03867617 434 435 O
donor NCT03867617 436 441 B-Condition
- NCT03867617 442 443 I-Condition
specific NCT03867617 444 452 I-Condition
antibodies NCT03867617 453 463 I-Condition
) NCT03867617 464 465 O
. NCT03867617 466 467 O

- NCT03867617 471 472 O
WOCBP NCT03867617 474 479 B-Condition
( NCT03867617 480 481 O
women NCT03867617 482 487 O
of NCT03867617 488 490 B-And
child NCT03867617 491 496 B-Condition
- NCT03867617 497 498 I-Condition
bearing NCT03867617 499 506 I-Condition
potential NCT03867617 507 516 I-Condition
) NCT03867617 517 518 O
must NCT03867617 519 523 O
have NCT03867617 524 528 O
a NCT03867617 529 530 O
negative NCT03867617 531 539 O
pregnancy NCT03867617 540 549 B-Observation
test NCT03867617 550 554 I-Observation
at NCT03867617 555 557 B-Temporal_Connection___Temporal_Connection_Type_Value:during
inclusion NCT03867617 558 567 B-Study
. NCT03867617 568 569 O

- NCT03867617 573 574 O
WOCBP NCT03867617 576 581 B-Condition
must NCT03867617 582 586 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03867617 587 589 I-Assertion___Assertion_Type_Value:hypothetical
using NCT03867617 590 595 B-Eq_Comparison
an NCT03867617 596 598 O
adequate NCT03867617 599 607 O
method NCT03867617 608 614 O
of NCT03867617 615 617 O
contraception NCT03867617 618 631 B-Procedure
to NCT03867617 632 634 O
avoid NCT03867617 635 640 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
pregnancy NCT03867617 641 650 B-Condition
throughout NCT03867617 651 661 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867617 662 665 O
study NCT03867617 666 671 B-Study
and NCT03867617 672 675 B-And
for NCT03867617 676 679 O
up NCT03867617 680 682 B-Eq_Comparison
to NCT03867617 683 685 I-Eq_Comparison
12 NCT03867617 686 688 I-Eq_Comparison
weeks NCT03867617 689 694 I-Eq_Comparison
after NCT03867617 695 700 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03867617 701 704 O
study NCT03867617 705 710 B-Study
in NCT03867617 711 713 O
such NCT03867617 714 718 O
a NCT03867617 719 720 O
manner NCT03867617 721 727 O
that NCT03867617 728 732 O
the NCT03867617 733 736 O
risk NCT03867617 737 741 B-Risk
of NCT03867617 742 744 O
pregnancy NCT03867617 745 754 B-Condition
is NCT03867617 755 757 O
minimized NCT03867617 758 767 O
. NCT03867617 768 769 O

Exclusion NCT03867617 771 780 O
Criteria NCT03867617 781 789 O
: NCT03867617 790 791 O

- NCT03867617 795 796 O
Patient NCT03867617 798 805 O
is NCT03867617 806 808 O
EBV NCT03867617 809 812 B-Condition
( NCT03867617 813 814 O
epstein NCT03867617 815 822 B-Condition
barr NCT03867617 823 827 I-Condition
virus NCT03867617 828 833 I-Condition
) NCT03867617 834 835 O
- NCT03867617 836 837 O
negative NCT03867617 838 846 O
on NCT03867617 847 849 O
serology NCT03867617 850 858 B-Observation
. NCT03867617 859 860 O

- NCT03867617 864 865 O
Patient NCT03867617 867 874 O
is NCT03867617 875 877 O
HIV NCT03867617 878 881 B-Condition
- NCT03867617 882 883 O
positive NCT03867617 884 892 O
or NCT03867617 893 895 B-Or
suffering NCT03867617 896 905 B-Eq_Comparison
from NCT03867617 906 910 O
chronic NCT03867617 911 918 O
viral NCT03867617 919 924 B-Modifier
hepatitis NCT03867617 925 934 B-Condition
. NCT03867617 935 936 O

- NCT03867617 940 941 O
Patient NCT03867617 943 950 O
is NCT03867617 951 953 O
CMV NCT03867617 954 957 B-Condition
( NCT03867617 958 959 O
cytomegalo NCT03867617 960 970 B-Condition
virus NCT03867617 971 976 I-Condition
) NCT03867617 977 978 O
- NCT03867617 979 980 O
negative NCT03867617 981 989 O
and NCT03867617 990 993 B-And
receiving NCT03867617 994 1003 B-Eq_Comparison
a NCT03867617 1004 1005 O
kidney NCT03867617 1006 1012 B-Modifier
from NCT03867617 1013 1017 O
a NCT03867617 1018 1019 O
CMV NCT03867617 1020 1023 B-Condition
- NCT03867617 1024 1025 O
positive NCT03867617 1026 1034 O
donor NCT03867617 1035 1040 B-Modifier
. NCT03867617 1041 1042 O

- NCT03867617 1046 1047 O
Positive NCT03867617 1049 1057 O
T NCT03867617 1058 1059 B-Observation
- NCT03867617 1060 1061 I-Observation
cell NCT03867617 1062 1066 I-Observation
lymphocytotoxic NCT03867617 1067 1082 I-Observation
cross NCT03867617 1083 1088 I-Observation
match NCT03867617 1089 1094 I-Observation
. NCT03867617 1095 1096 O

- NCT03867617 1100 1101 O
Patient NCT03867617 1103 1110 O
with NCT03867617 1111 1115 O
prior NCT03867617 1116 1121 B-Eq_Comparison
kidney NCT03867617 1122 1128 B-Procedure
transplant NCT03867617 1129 1139 I-Procedure
or NCT03867617 1140 1142 B-Or
non NCT03867617 1143 1146 B-Negation
- NCT03867617 1147 1148 O
renal NCT03867617 1149 1154 B-Modifier
solid NCT03867617 1155 1160 B-Procedure
organ NCT03867617 1161 1166 I-Procedure
transplant NCT03867617 1167 1177 I-Procedure
. NCT03867617 1178 1179 O

- NCT03867617 1183 1184 O
Patient NCT03867617 1186 1193 O
has NCT03867617 1194 1197 O
a NCT03867617 1198 1199 O
known NCT03867617 1200 1205 O
contraindication NCT03867617 1206 1222 B-Contraindication
to NCT03867617 1223 1225 O
any NCT03867617 1226 1229 O
of NCT03867617 1230 1232 O
the NCT03867617 1233 1236 O
protocol NCT03867617 1237 1245 B-Study
- NCT03867617 1246 1247 I-Study
specified NCT03867617 1248 1257 I-Study
treatments NCT03867617 1258 1268 B-Procedure
. NCT03867617 1269 1270 O

- NCT03867617 1274 1275 O
Patient NCT03867617 1277 1284 O
had NCT03867617 1285 1288 O
been NCT03867617 1289 1293 O
diagnosed NCT03867617 1294 1303 O
with NCT03867617 1304 1308 O
a NCT03867617 1309 1310 O
malignancy NCT03867617 1311 1321 B-Condition
within NCT03867617 1322 1328 B-Eq_Comparison
5 NCT03867617 1329 1330 I-Eq_Comparison
years NCT03867617 1331 1336 I-Eq_Comparison
prior NCT03867617 1337 1342 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867617 1343 1345 I-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03867617 1346 1351 B-Study
entry NCT03867617 1352 1357 O
, NCT03867617 1358 1359 O
excluding NCT03867617 1360 1369 B-Exception
non NCT03867617 1370 1373 B-Negation
- NCT03867617 1374 1375 O
metastatic NCT03867617 1376 1386 B-Modifier
basal NCT03867617 1387 1392 I-Modifier
or NCT03867617 1393 1395 B-Or
squamous NCT03867617 1396 1404 B-Modifier
cell NCT03867617 1405 1409 I-Modifier
carcinoma NCT03867617 1410 1419 B-Condition
of NCT03867617 1420 1422 O
the NCT03867617 1423 1426 O
skin NCT03867617 1427 1431 B-Modifier
. NCT03867617 1432 1433 O

- NCT03867617 1437 1438 O
Female NCT03867617 1440 1446 O
patients NCT03867617 1447 1455 O
who NCT03867617 1456 1459 B-And
are NCT03867617 1460 1463 O
breast NCT03867617 1464 1470 B-Condition
- NCT03867617 1471 1472 I-Condition
feeding NCT03867617 1473 1480 I-Condition
. NCT03867617 1481 1482 O

- NCT03867617 1486 1487 O
Female NCT03867617 1489 1495 O
patients NCT03867617 1496 1504 O
with NCT03867617 1505 1509 B-And
a NCT03867617 1510 1511 O
positive NCT03867617 1512 1520 O
pregnancy NCT03867617 1521 1530 B-Observation
test NCT03867617 1531 1535 I-Observation
. NCT03867617 1536 1537 O

Inclusion NCT03868826 0 9 O
Criteria NCT03868826 10 18 O
: NCT03868826 19 20 O

- NCT03868826 24 25 O
Patients NCT03868826 27 35 O
eligible NCT03868826 36 44 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03868826 45 48 I-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03868826 49 58 B-Procedure
of NCT03868826 59 61 O
hamstring NCT03868826 62 71 B-Condition
avulsion NCT03868826 72 80 I-Condition

Exclusion NCT03868826 81 90 O
Criteria NCT03868826 91 99 O
: NCT03868826 100 101 O

- NCT03868826 105 106 O
Conditions NCT03868826 108 118 B-Condition
that NCT03868826 119 123 O
contraindicate NCT03868826 124 138 B-Contraindication
muscle NCT03868826 139 145 B-Procedure
strength NCT03868826 146 154 I-Procedure
testing NCT03868826 155 162 I-Procedure
e NCT03868826 163 164 O
. NCT03868826 165 166 O
g NCT03868826 167 168 O
. NCT03868826 169 170 O
cancer NCT03868826 172 178 B-Condition
and NCT03868826 179 182 B-Or
neurological NCT03868826 183 195 B-Condition
conditions NCT03868826 196 206 I-Condition

- NCT03868826 209 210 O
Patients NCT03868826 212 220 O
that NCT03868826 221 225 O
do NCT03868826 226 228 O
not NCT03868826 229 232 B-Negation
speak NCT03868826 233 238 O
or NCT03868826 239 241 O
understand NCT03868826 242 252 O
Danish NCT03868826 253 259 O

Inclusion NCT03921788 0 9 O
Criteria NCT03921788 10 18 O
: NCT03921788 19 20 O

- NCT03921788 24 25 O
The NCT03921788 27 30 O
reproductive NCT03921788 31 43 B-Observation
age NCT03921788 44 47 I-Observation
of NCT03921788 48 50 O
the NCT03921788 51 54 O
woman NCT03921788 55 60 O

- NCT03921788 63 64 O
Blood NCT03921788 66 71 B-Condition
reflux NCT03921788 72 78 I-Condition
in NCT03921788 79 81 O
the NCT03921788 82 85 O
parametric NCT03921788 86 96 B-Modifier
, NCT03921788 97 98 O
uterine NCT03921788 99 106 B-Modifier
, NCT03921788 107 108 O
gonadal NCT03921788 109 116 B-Modifier
veins NCT03921788 117 122 I-Modifier

- NCT03921788 125 126 O
The NCT03921788 128 131 O
absence NCT03921788 132 139 B-Negation
of NCT03921788 140 142 O
any NCT03921788 143 146 O
concomitant NCT03921788 147 158 O
pathology NCT03921788 159 168 B-Condition
, NCT03921788 169 170 O
accompanied NCT03921788 171 182 B-And
by NCT03921788 183 185 O
chronic NCT03921788 186 193 O
pelvic NCT03921788 194 200 B-Condition
pain NCT03921788 201 205 I-Condition

Exclusion NCT03921788 206 215 O
Criteria NCT03921788 216 224 O
: NCT03921788 225 226 O

- NCT03921788 230 231 O
The NCT03921788 233 236 O
absence NCT03921788 237 244 B-Negation
of NCT03921788 245 247 O
blood NCT03921788 248 253 B-Condition
reflux NCT03921788 254 260 I-Condition
in NCT03921788 261 263 O
in NCT03921788 264 266 O
the NCT03921788 267 270 O
parametric NCT03921788 271 281 B-Modifier
, NCT03921788 282 283 O
uterine NCT03921788 284 291 B-Modifier
, NCT03921788 292 293 O
gonadal NCT03921788 294 301 B-Modifier
veins NCT03921788 302 307 I-Modifier

- NCT03921788 310 311 O
The NCT03921788 313 316 O
presence NCT03921788 317 325 O
of NCT03921788 326 328 O
diseases NCT03921788 329 337 B-Condition
, NCT03921788 338 339 O
the NCT03921788 340 343 O
clinical NCT03921788 344 352 O
course NCT03921788 353 359 O
of NCT03921788 360 362 O
which NCT03921788 363 368 O
suggests NCT03921788 369 377 B-Assertion___Assertion_Type_Value:possible
the NCT03921788 378 381 O
presence NCT03921788 382 390 O
of NCT03921788 391 393 O
chronic NCT03921788 394 401 O
pelvic NCT03921788 402 408 B-Condition
pain NCT03921788 409 413 I-Condition
and NCT03921788 414 417 B-And
other NCT03921788 418 423 O
varieties NCT03921788 424 433 O
of NCT03921788 434 436 O
chronic NCT03921788 437 444 O
pain NCT03921788 445 449 B-Condition
, NCT03921788 450 451 O
including NCT03921788 452 461 O
migraine NCT03921788 462 470 B-Condition

- NCT03921788 473 474 O
Pregnancy NCT03921788 476 485 B-Condition

Inclusion NCT03927833 0 9 O
Criteria NCT03927833 10 18 O
: NCT03927833 19 20 O

1 NCT03927833 24 25 O
. NCT03927833 25 26 O
Infants NCT03927833 28 35 B-Family_Member___Family_Member_Type:child
is NCT03927833 36 38 O
inborn NCT03927833 39 45 B-Condition

2 NCT03927833 48 49 O
. NCT03927833 49 50 O
Infant NCT03927833 52 58 B-Family_Member___Family_Member_Type:child
is NCT03927833 59 61 B-Observation
≤ NCT03927833 62 63 B-Eq_Comparison
750 NCT03927833 64 67 I-Eq_Comparison
grams NCT03927833 68 73 I-Eq_Comparison
at NCT03927833 74 76 B-Temporal_Connection___Temporal_Connection_Type_Value:during
birth NCT03927833 77 82 B-Birth
and NCT03927833 83 86 B-Or
/ NCT03927833 87 88 I-Or
or NCT03927833 89 91 I-Or
< NCT03927833 92 93 B-Eq_Comparison
27 NCT03927833 94 96 I-Eq_Comparison
weeks NCT03927833 97 102 I-Eq_Comparison
gestation NCT03927833 103 112 B-Observation
at NCT03927833 113 115 B-Temporal_Connection___Temporal_Connection_Type_Value:during
birth NCT03927833 116 121 B-Birth
by NCT03927833 122 124 O
best NCT03927833 125 129 O
OB NCT03927833 130 132 O
estimate NCT03927833 133 141 O

3 NCT03927833 144 145 O
. NCT03927833 145 146 O
Infant NCT03927833 148 154 B-Family_Member___Family_Member_Type:child
is NCT03927833 155 157 O
12 NCT03927833 158 160 B-Eq_Comparison
- NCT03927833 161 162 I-Eq_Comparison
36 NCT03927833 163 165 I-Eq_Comparison
hours NCT03927833 166 171 I-Eq_Comparison
of NCT03927833 172 174 O
age NCT03927833 175 178 B-Age
. NCT03927833 179 180 O

Exclusion NCT03927833 182 191 O
Criteria NCT03927833 192 200 O
: NCT03927833 201 202 O

1 NCT03927833 206 207 O
. NCT03927833 207 208 O
Unable NCT03927833 210 216 O
to NCT03927833 217 219 O
enroll NCT03927833 220 226 B-Assertion___Assertion_Type_Value:hypothetical
infant NCT03927833 227 233 B-Family_Member___Family_Member_Type:child
by NCT03927833 234 236 B-Eq_Comparison
36 NCT03927833 237 239 I-Eq_Comparison
hours NCT03927833 240 245 I-Eq_Comparison
of NCT03927833 246 248 O
age NCT03927833 249 252 B-Age

2 NCT03927833 255 256 O
. NCT03927833 256 257 O
Previous NCT03927833 259 267 B-Eq_Comparison
phototherapy NCT03927833 268 280 B-Procedure

3 NCT03927833 283 284 O
. NCT03927833 284 285 O
Known NCT03927833 287 292 O
hemolytic NCT03927833 293 302 B-Condition
disease NCT03927833 303 310 I-Condition

4 NCT03927833 313 314 O
. NCT03927833 314 315 O
TSB NCT03927833 317 320 B-Observation
reported NCT03927833 321 329 O
as NCT03927833 330 332 O
> NCT03927833 333 334 B-Eq_Comparison
6.0 NCT03927833 335 338 I-Eq_Comparison
mg NCT03927833 339 341 I-Eq_Comparison
/ NCT03927833 342 343 I-Eq_Comparison
dL NCT03927833 344 346 I-Eq_Comparison
before NCT03927833 347 353 B-Temporal_Connection___Temporal_Connection_Type_Value:before
12 NCT03927833 354 356 B-Eq_Comparison
hours NCT03927833 357 362 I-Eq_Comparison
age NCT03927833 363 366 B-Age

5 NCT03927833 369 370 O
. NCT03927833 370 371 O
Major NCT03927833 373 378 B-Condition
anomaly NCT03927833 379 386 I-Condition

6 NCT03927833 389 390 O
. NCT03927833 390 391 O
Overt NCT03927833 393 398 B-Condition
nonbacterial NCT03927833 399 411 I-Condition
infection NCT03927833 412 421 I-Condition

7 NCT03927833 424 425 O
. NCT03927833 425 426 O
Infant NCT03927833 428 434 B-Family_Member___Family_Member_Type:child
is NCT03927833 435 437 O
likely NCT03927833 438 444 B-Risk
to NCT03927833 445 447 O
expire NCT03927833 448 454 B-Death
soon NCT03927833 455 459 O
: NCT03927833 460 461 O
Limiting NCT03927833 462 470 O
or NCT03927833 471 473 O
withdrawal NCT03927833 474 484 B-Negation
of NCT03927833 485 487 O
intensive NCT03927833 488 497 B-Procedure
care NCT03927833 498 502 I-Procedure
is NCT03927833 503 505 O
being NCT03927833 506 511 O
recommended NCT03927833 512 523 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03927833 524 526 O
the NCT03927833 527 530 O
parents NCT03927833 531 538 O
, NCT03927833 539 540 O
the NCT03927833 541 544 O
parents NCT03927833 545 552 O
are NCT03927833 553 556 O
requesting NCT03927833 557 567 O
withdrawal NCT03927833 568 578 O
of NCT03927833 579 581 O
care NCT03927833 582 586 O
, NCT03927833 587 588 O
or NCT03927833 589 591 O
the NCT03927833 592 595 O
pH NCT03927833 596 598 B-Observation
is NCT03927833 599 601 O
< NCT03927833 602 603 B-Eq_Comparison
6.80 NCT03927833 604 608 I-Eq_Comparison
or NCT03927833 609 611 B-Or
persistent NCT03927833 612 622 B-Condition
bradycardia NCT03927833 623 634 I-Condition
with NCT03927833 635 639 B-And
hypoxemia NCT03927833 640 649 B-Condition
for NCT03927833 650 653 O
> NCT03927833 654 655 B-Eq_Comparison
2 NCT03927833 656 657 I-Eq_Comparison
h NCT03927833 658 659 O
. NCT03927833 660 661 O

Inclusion NCT03925662 0 9 O
Criteria NCT03925662 10 18 O
: NCT03925662 19 20 O

- NCT03925662 24 25 O
Colorectal NCT03925662 27 37 B-Modifier
cancer NCT03925662 38 44 B-Condition
stage NCT03925662 45 50 B-Eq_Comparison
4 NCT03925662 51 52 I-Eq_Comparison
. NCT03925662 52 53 O

Exclusion NCT03925662 55 64 O
Criteria NCT03925662 65 73 O
: NCT03925662 74 75 O

- NCT03925662 79 80 O
Agranulocytosis NCT03925662 82 97 B-Condition

- NCT03925662 100 101 O
Pregnancy NCT03925662 103 112 B-Condition

- NCT03925662 115 116 O
Allergy NCT03925662 118 125 B-Allergy
to NCT03925662 126 128 O
mebendazole NCT03925662 129 140 B-Drug
. NCT03925662 141 142 O

Inclusion NCT03864835 0 9 O
Criteria NCT03864835 10 18 O

•Enrollment NCT03864835 19 30 O
and NCT03864835 31 34 O
completion NCT03864835 35 45 O
of NCT03864835 46 48 O
IRB NCT03864835 49 52 O
study NCT03864835 53 58 O
# NCT03864835 59 60 O
00011797 NCT03864835 61 69 O

Exclusion NCT03864835 71 80 O
Criteria NCT03864835 81 89 O

- NCT03864835 92 93 O
Inability NCT03864835 95 104 O
to NCT03864835 105 107 O
provide NCT03864835 108 115 O
informed NCT03864835 116 124 O
consent NCT03864835 125 132 O

- NCT03864835 135 136 O
Institutionalized NCT03864835 138 155 B-Observation
/ NCT03864835 156 157 B-Or
prisoner NCT03864835 158 166 B-Observation

- NCT03864835 169 170 O
Non NCT03864835 172 175 B-Negation
- NCT03864835 176 177 O
English NCT03864835 178 185 O
- NCT03864835 186 187 O
speaking NCT03864835 188 196 O
patients NCT03864835 197 205 O
due NCT03864835 206 209 O
to NCT03864835 210 212 O
unavailability NCT03864835 213 227 O
of NCT03864835 228 230 O
translators NCT03864835 231 242 O
for NCT03864835 243 246 O
all NCT03864835 247 250 O
visits NCT03864835 251 257 O
/ NCT03864835 258 259 O
sessions NCT03864835 260 268 O

Inclusion NCT03864705 0 9 O
Criteria NCT03864705 10 18 O
: NCT03864705 19 20 O

- NCT03864705 24 25 O
Type NCT03864705 27 31 B-Modifier
2 NCT03864705 32 33 I-Modifier
diabetes NCT03864705 34 42 B-Condition
mellitus NCT03864705 43 51 I-Condition
on NCT03864705 52 54 O
metformin NCT03864705 55 64 B-Drug
therapy NCT03864705 65 72 B-Procedure
for NCT03864705 73 76 O
at NCT03864705 77 79 B-Eq_Comparison
least NCT03864705 80 85 I-Eq_Comparison
3 NCT03864705 86 87 I-Eq_Comparison
months NCT03864705 88 94 I-Eq_Comparison

Exclusion NCT03864705 95 104 O
Criteria NCT03864705 105 113 O
: NCT03864705 114 115 O

- NCT03864705 118 119 O

Inclusion NCT03922425 0 9 O
Criteria NCT03922425 10 18 O
: NCT03922425 19 20 O

- NCT03922425 24 25 O
Age NCT03922425 27 30 B-Age
18 NCT03922425 31 33 B-Eq_Comparison
- NCT03922425 34 35 I-Eq_Comparison
65 NCT03922425 36 38 I-Eq_Comparison

- NCT03922425 42 43 O
Current NCT03922425 45 52 B-Eq_Comparison
service NCT03922425 53 60 B-Encounter
users NCT03922425 61 66 I-Encounter
, NCT03922425 67 68 O
with NCT03922425 69 73 B-And
severe NCT03922425 74 80 O
and NCT03922425 81 84 B-And
enduring NCT03922425 85 93 B-Modifier
mental NCT03922425 94 100 B-Condition
disorder NCT03922425 101 109 I-Condition
, NCT03922425 110 111 O

- NCT03922425 115 116 O
Severe NCT03922425 118 124 O
Mental NCT03922425 125 131 B-Condition
Illnesses NCT03922425 132 141 I-Condition
- NCT03922425 142 143 O
bipolar NCT03922425 144 151 B-Condition
disorder NCT03922425 152 160 I-Condition
, NCT03922425 161 162 O
severe NCT03922425 163 169 B-Condition
depression NCT03922425 170 180 I-Condition
, NCT03922425 181 182 O
or NCT03922425 183 185 B-Or
schizophrenia NCT03922425 186 199 B-Condition

Exclusion NCT03922425 200 209 O
Criteria NCT03922425 210 218 O
: NCT03922425 219 220 O

- NCT03922425 224 225 O
Patients NCT03922425 227 235 O
who NCT03922425 236 239 O
do NCT03922425 240 242 O
not NCT03922425 243 246 O
consent NCT03922425 247 254 O
to NCT03922425 255 257 O
their NCT03922425 258 263 O
data NCT03922425 264 268 O
being NCT03922425 269 274 O
collected NCT03922425 275 284 O

- NCT03922425 287 288 O
Patients NCT03922425 290 298 O
with NCT03922425 299 303 O
acute NCT03922425 304 309 O
somatic NCT03922425 310 317 B-Condition
disorders NCT03922425 318 327 I-Condition

- NCT03922425 330 331 O
Patients NCT03922425 333 341 O
who NCT03922425 342 345 O
are NCT03922425 346 349 O
under NCT03922425 350 355 B-Eq_Comparison
the NCT03922425 356 359 I-Eq_Comparison
age NCT03922425 360 363 I-Eq_Comparison
of NCT03922425 364 366 I-Eq_Comparison
18 NCT03922425 367 369 I-Eq_Comparison
at NCT03922425 370 372 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03922425 373 376 O
start NCT03922425 377 382 O
of NCT03922425 383 385 O
the NCT03922425 386 389 O
study NCT03922425 390 395 B-Study
. NCT03922425 396 397 O

Inclusion NCT03928431 0 9 O
Criteria NCT03928431 10 18 O
: NCT03928431 19 20 O

- NCT03928431 24 25 O
Infants NCT03928431 27 34 B-Family_Member___Family_Member_Type:child
of NCT03928431 35 37 O
healthy NCT03928431 38 45 B-Condition
mothers NCT03928431 46 53 B-Family_Member___Family_Member_Type:mother
with NCT03928431 54 58 B-And
uncomplicated NCT03928431 59 72 B-Modifier
pregnancies NCT03928431 73 84 B-Condition
at NCT03928431 85 87 O
term NCT03928431 88 92 O
, NCT03928431 93 94 O
mothers NCT03928431 95 102 B-Family_Member___Family_Member_Type:mother
of NCT03928431 103 105 O
any NCT03928431 106 109 O
ethnic NCT03928431 110 116 O
or NCT03928431 117 119 O
social NCT03928431 120 126 O
background NCT03928431 127 137 O
that NCT03928431 138 142 O
can NCT03928431 143 146 O
speak NCT03928431 147 152 O
, NCT03928431 153 154 O
read NCT03928431 155 159 O
, NCT03928431 160 161 O
and NCT03928431 162 165 O
understand NCT03928431 166 176 O
Swedish NCT03928431 177 184 O
to NCT03928431 185 187 O
the NCT03928431 188 191 O
extent NCT03928431 192 198 O
that NCT03928431 199 203 O
they NCT03928431 204 208 O
can NCT03928431 209 212 O
consent NCT03928431 213 220 O
in NCT03928431 221 223 O
Swedish NCT03928431 224 231 O
. NCT03928431 232 233 O
An NCT03928431 235 237 O
additional NCT03928431 238 248 O
inclusion NCT03928431 249 258 O
criterion NCT03928431 259 268 O
for NCT03928431 269 272 O
mothers NCT03928431 273 280 O
in NCT03928431 281 283 O
the NCT03928431 284 287 O
CS NCT03928431 288 290 O
groups NCT03928431 291 297 O
is NCT03928431 298 300 O
vaginal NCT03928431 301 308 B-Observation
pH NCT03928431 309 311 I-Observation
≤ NCT03928431 312 313 B-Eq_Comparison
4 NCT03928431 314 315 I-Eq_Comparison
at NCT03928431 316 318 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928431 319 322 O
time NCT03928431 323 327 O
of NCT03928431 328 330 O
birth NCT03928431 331 336 B-Birth
. NCT03928431 337 338 O

Exclusion NCT03928431 340 349 O
Criteria NCT03928431 350 358 O
: NCT03928431 359 360 O

- NCT03928431 364 365 O
Infants NCT03928431 367 374 B-Family_Member___Family_Member_Type:child
of NCT03928431 375 377 O
mothers NCT03928431 378 385 B-Family_Member___Family_Member_Type:mother
with NCT03928431 386 390 O
pre NCT03928431 391 394 B-Condition
- NCT03928431 395 396 I-Condition
eclampsia NCT03928431 397 406 I-Condition
or NCT03928431 407 409 B-Or
complicated NCT03928431 410 421 B-Modifier
pregnancies NCT03928431 422 433 B-Condition
, NCT03928431 434 435 O
mothers NCT03928431 436 443 B-Family_Member___Family_Member_Type:mother
< NCT03928431 444 445 B-Eq_Comparison
18 NCT03928431 446 448 I-Eq_Comparison
years NCT03928431 449 454 I-Eq_Comparison
or NCT03928431 455 457 B-Or
> NCT03928431 458 459 B-Eq_Comparison
40 NCT03928431 460 462 I-Eq_Comparison
years NCT03928431 463 468 I-Eq_Comparison
of NCT03928431 469 471 O
age NCT03928431 472 475 B-Age
, NCT03928431 476 477 O
genital NCT03928431 478 485 B-Condition
herpes NCT03928431 486 492 I-Condition
simplex NCT03928431 493 500 I-Condition
, NCT03928431 501 502 O
genital NCT03928431 503 510 B-Condition
warts NCT03928431 511 516 I-Condition
, NCT03928431 517 518 O
HIV NCT03928431 519 522 B-Condition
, NCT03928431 523 524 O
Hepatitis NCT03928431 525 534 B-Condition
B NCT03928431 535 536 I-Condition
or NCT03928431 537 539 B-Or
complications NCT03928431 540 553 B-Condition
during NCT03928431 554 560 B-Temporal_Connection___Temporal_Connection_Type_Value:during
delivery NCT03928431 561 569 B-Condition
, NCT03928431 570 571 O
infants NCT03928431 572 579 B-Family_Member___Family_Member_Type:child
delivered NCT03928431 580 589 O
prior NCT03928431 590 595 B-Eq_Comparison
to NCT03928431 596 598 I-Eq_Comparison
37 NCT03928431 599 601 I-Eq_Comparison
weeks NCT03928431 602 607 I-Eq_Comparison
of NCT03928431 608 610 O
gestation NCT03928431 611 620 B-Observation
. NCT03928431 621 622 O
Additional NCT03928431 624 634 O
exclusion NCT03928431 635 644 O
criteria NCT03928431 645 653 O
for NCT03928431 654 657 O
mothers NCT03928431 658 665 O
in NCT03928431 666 668 O
the NCT03928431 669 672 O
CS NCT03928431 673 675 O
group NCT03928431 676 681 O
: NCT03928431 682 683 O
Mothers NCT03928431 684 691 B-Family_Member___Family_Member_Type:mother
positive NCT03928431 692 700 O
to NCT03928431 701 703 O
Group NCT03928431 704 709 B-Condition
B NCT03928431 710 711 I-Condition
Streptococcus NCT03928431 712 725 I-Condition
, NCT03928431 726 727 O
Group NCT03928431 728 733 B-Condition
A NCT03928431 734 735 I-Condition
Streptococcus NCT03928431 736 749 I-Condition
, NCT03928431 750 751 O
bacterial NCT03928431 752 761 B-Condition
vaginosis NCT03928431 762 771 I-Condition
, NCT03928431 772 773 O
vaginal NCT03928431 774 781 B-Observation
pH NCT03928431 782 784 I-Observation
> NCT03928431 785 786 B-Eq_Comparison
4 NCT03928431 787 788 I-Eq_Comparison
at NCT03928431 789 791 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03928431 792 795 O
time NCT03928431 796 800 O
of NCT03928431 801 803 O
birth NCT03928431 804 809 B-Birth
. NCT03928431 810 811 O
Mothers NCT03928431 813 820 B-Family_Member___Family_Member_Type:mother
with NCT03928431 821 825 O
fecal NCT03928431 826 831 O
samples NCT03928431 832 839 B-Observation
positive NCT03928431 840 848 O
for NCT03928431 849 852 O
Salmonella NCT03928431 853 863 B-Organism
, NCT03928431 864 865 O
Shigella NCT03928431 866 874 B-Organism
, NCT03928431 875 876 O
Campylobacter NCT03928431 877 890 B-Organism
or NCT03928431 891 893 B-Or
Yersinia NCT03928431 894 902 B-Organism
. NCT03928431 903 904 O

- NCT03928639 1 2 O
INCLUSION NCT03928639 4 13 O
CRITERIA NCT03928639 14 22 O
: NCT03928639 23 24 O

- NCT03928639 28 29 O
Adults NCT03928639 31 37 O
age NCT03928639 38 41 B-Age
greater NCT03928639 42 49 B-Eq_Comparison
than NCT03928639 50 54 I-Eq_Comparison
or NCT03928639 55 57 I-Eq_Comparison
equal NCT03928639 58 63 I-Eq_Comparison
to NCT03928639 64 66 I-Eq_Comparison
18 NCT03928639 67 69 I-Eq_Comparison
years NCT03928639 70 75 I-Eq_Comparison
. NCT03928639 76 77 O

- NCT03928639 81 82 O
Receiving NCT03928639 84 93 B-Eq_Comparison
care NCT03928639 94 98 B-Procedure
from NCT03928639 99 103 O
the NCT03928639 104 107 O
structural NCT03928639 108 118 O
heart NCT03928639 119 124 O
and NCT03928639 125 128 O
valve NCT03928639 129 134 O
program NCT03928639 135 142 O
at NCT03928639 143 145 O
the NCT03928639 146 149 O
participating NCT03928639 150 163 O
NHLBI NCT03928639 164 169 O
structural NCT03928639 170 180 O
heart NCT03928639 181 186 O
disease NCT03928639 187 194 O
network NCT03928639 195 202 O
site NCT03928639 203 207 O
. NCT03928639 208 209 O

- NCT03928639 213 214 O
Consent NCT03928639 216 223 O
to NCT03928639 224 226 O
participate NCT03928639 227 238 O
in NCT03928639 239 241 O
the NCT03928639 242 245 O
protocol NCT03928639 246 254 O
, NCT03928639 255 256 O
directly NCT03928639 257 265 O
, NCT03928639 266 267 O
or NCT03928639 268 270 O
through NCT03928639 271 278 O
legally NCT03928639 279 286 O
authorized NCT03928639 287 297 O
representatives NCT03928639 298 313 O
( NCT03928639 314 315 O
LAR NCT03928639 316 319 O
) NCT03928639 320 321 O
. NCT03928639 322 323 O

EXCLUSION NCT03928639 325 334 O
CRITERIA NCT03928639 335 343 O
: NCT03928639 344 345 O

- NCT03928639 348 349 O
Does NCT03928639 350 354 O
not NCT03928639 355 358 O
consent NCT03928639 359 366 O
to NCT03928639 367 369 O
participate NCT03928639 370 381 O
in NCT03928639 382 384 O
this NCT03928639 385 389 O
protocol NCT03928639 390 398 O
. NCT03928639 399 400 O

Inclusion NCT03927664 0 9 O
Criteria NCT03927664 10 18 O

- NCT03927664 21 22 O
Patients NCT03927664 24 32 O
diagnosed NCT03927664 33 42 O
with NCT03927664 43 47 O
peritoneal NCT03927664 48 58 B-Condition
tuberculosis NCT03927664 59 71 I-Condition

- NCT03927664 74 75 O
Patients NCT03927664 77 85 O
who NCT03927664 86 89 O
have NCT03927664 90 94 O
undergone NCT03927664 95 104 B-Eq_Comparison
a NCT03927664 105 106 O
computed NCT03927664 107 115 B-Procedure
tomographic NCT03927664 116 127 I-Procedure
examination NCT03927664 128 139 I-Procedure

Exclusion NCT03927664 140 149 O
Criteria NCT03927664 150 158 O
: NCT03927664 159 160 O

- NCT03927664 164 165 O
Age NCT03927664 167 170 B-Age
< NCT03927664 171 172 B-Eq_Comparison
12 NCT03927664 173 175 I-Eq_Comparison

- NCT03927664 179 180 O
Unclear NCT03927664 182 189 O
diagnosis NCT03927664 190 199 O

- NCT03927664 202 203 O
More NCT03927664 205 209 B-Eq_Comparison
than NCT03927664 210 214 I-Eq_Comparison
one NCT03927664 215 218 I-Eq_Comparison
etiology NCT03927664 219 227 B-Condition
for NCT03927664 228 231 O
ascites NCT03927664 232 239 B-Condition

- NCT03927664 242 243 O
Not NCT03927664 245 248 O
willing NCT03927664 249 256 O
for NCT03927664 257 260 O
consent NCT03927664 261 268 O

Inclusion NCT03928444 0 9 O
Criteria NCT03928444 10 18 O
: NCT03928444 19 20 O

- NCT03928444 24 25 O
Clinically NCT03928444 27 37 O
diagnosed NCT03928444 38 47 O
facial NCT03928444 48 54 B-Condition
skin NCT03928444 55 59 I-Condition
aging NCT03928444 60 65 I-Condition
. NCT03928444 66 67 O

- NCT03928444 71 72 O
Glogau NCT03928444 74 80 B-Observation
photoaging NCT03928444 81 91 I-Observation
score NCT03928444 92 97 B-Eq_Comparison
II NCT03928444 98 100 I-Eq_Comparison
and NCT03928444 101 104 I-Eq_Comparison
III NCT03928444 105 108 I-Eq_Comparison
. NCT03928444 109 110 O

- NCT03928444 114 115 O
Body NCT03928444 117 121 B-Observation
mass NCT03928444 122 126 I-Observation
index NCT03928444 127 132 I-Observation
≥ NCT03928444 133 134 B-Eq_Comparison
20 NCT03928444 135 137 I-Eq_Comparison
with NCT03928444 138 142 B-And
adequate NCT03928444 143 151 O
abdominal NCT03928444 152 161 B-Modifier
or NCT03928444 162 164 B-Or
other NCT03928444 165 170 O
subcutaneous NCT03928444 171 183 B-Modifier
adipose NCT03928444 184 191 B-Observation
tissue NCT03928444 192 198 I-Observation
accessible NCT03928444 199 209 O
for NCT03928444 210 213 B-Assertion___Assertion_Type_Value:hypothetical
lipoaspiration NCT03928444 214 228 B-Procedure
. NCT03928444 229 230 O

Exclusion NCT03928444 232 241 O
Criteria NCT03928444 242 250 O
: NCT03928444 251 252 O

- NCT03928444 256 257 O
History NCT03928444 259 266 B-Eq_Comparison
of NCT03928444 267 269 O
keloid NCT03928444 270 276 B-Condition
formation NCT03928444 277 286 I-Condition
. NCT03928444 287 288 O

- NCT03928444 292 293 O
Any NCT03928444 295 298 O
coincidental NCT03928444 299 311 O
chronic NCT03928444 312 319 O
illness NCT03928444 320 327 B-Condition
( NCT03928444 328 329 O
e NCT03928444 330 331 O
. NCT03928444 332 333 O
g NCT03928444 334 335 O
. NCT03928444 336 337 O
metabolic NCT03928444 339 348 B-Modifier
, NCT03928444 349 350 O
autoimmune NCT03928444 351 361 B-Modifier
or NCT03928444 362 364 B-Or
endocrinal NCT03928444 365 375 B-Modifier
) NCT03928444 376 377 O
or NCT03928444 378 380 B-Or
malignancy NCT03928444 381 391 B-Condition
. NCT03928444 392 393 O

- NCT03928444 397 398 O
Any NCT03928444 400 403 O
bleeding NCT03928444 404 412 B-Modifier
or NCT03928444 413 415 B-Or
coagulation NCT03928444 416 427 B-Modifier
disorder NCT03928444 428 436 B-Condition
or NCT03928444 437 439 B-Or
recent NCT03928444 440 446 B-Eq_Comparison
use NCT03928444 447 450 O
of NCT03928444 451 453 O
anticoagulant NCT03928444 454 467 B-Drug
therapy NCT03928444 468 475 I-Drug
. NCT03928444 476 477 O

- NCT03928444 481 482 O
Active NCT03928444 484 490 B-Eq_Comparison
infection NCT03928444 491 500 B-Condition
. NCT03928444 501 502 O

- NCT03928444 506 507 O
History NCT03928444 509 516 B-Eq_Comparison
of NCT03928444 517 519 I-Eq_Comparison
any NCT03928444 520 523 I-Eq_Comparison
previous NCT03928444 524 532 I-Eq_Comparison
aesthetic NCT03928444 533 542 B-Procedure
procedure NCT03928444 543 552 I-Procedure
on NCT03928444 553 555 O
the NCT03928444 556 559 O
face NCT03928444 560 564 B-Modifier
within NCT03928444 565 571 B-Eq_Comparison
the NCT03928444 572 575 I-Eq_Comparison
past NCT03928444 576 580 I-Eq_Comparison
6 NCT03928444 581 582 I-Eq_Comparison
months NCT03928444 583 589 I-Eq_Comparison
. NCT03928444 590 591 O

- NCT03928444 595 596 O
History NCT03928444 598 605 B-Eq_Comparison
of NCT03928444 606 608 O
intake NCT03928444 609 615 O
of NCT03928444 616 618 O
anti NCT03928444 619 623 B-Modifier
- NCT03928444 624 625 I-Modifier
aging NCT03928444 626 631 I-Modifier
systemic NCT03928444 632 640 I-Modifier
or NCT03928444 641 643 B-Or
topical NCT03928444 644 651 B-Modifier
medications NCT03928444 652 663 B-Drug
within NCT03928444 664 670 B-Eq_Comparison
the NCT03928444 671 674 I-Eq_Comparison
previous NCT03928444 675 683 I-Eq_Comparison
3 NCT03928444 684 685 I-Eq_Comparison
months NCT03928444 686 692 I-Eq_Comparison
. NCT03928444 693 694 O

Inclusion NCT03865589 0 9 O
Criteria NCT03865589 10 18 O
: NCT03865589 19 20 O

- NCT03865589 24 25 O
Any NCT03865589 27 30 O
patient NCT03865589 31 38 O
undergoing NCT03865589 39 49 B-Eq_Comparison
a NCT03865589 50 51 O
myeloablative NCT03865589 52 65 B-Procedure
conditioning NCT03865589 66 78 I-Procedure
regimen NCT03865589 79 86 O
for NCT03865589 87 90 O
HCT NCT03865589 91 94 B-Condition
between NCT03865589 95 102 B-Eq_Comparison
4 NCT03865589 103 104 I-Eq_Comparison
/ NCT03865589 105 106 I-Eq_Comparison
1 NCT03865589 107 108 I-Eq_Comparison
/ NCT03865589 109 110 I-Eq_Comparison
2019 NCT03865589 111 115 I-Eq_Comparison
and NCT03865589 116 119 I-Eq_Comparison
12 NCT03865589 120 122 I-Eq_Comparison
/ NCT03865589 123 124 I-Eq_Comparison
31 NCT03865589 125 127 I-Eq_Comparison
/ NCT03865589 128 129 I-Eq_Comparison
2120 NCT03865589 130 134 I-Eq_Comparison
defined NCT03865589 135 142 O
as NCT03865589 143 145 O
one NCT03865589 146 149 B-Eq_Comparison
of NCT03865589 150 152 O
the NCT03865589 153 156 B-Criteria_Count
following NCT03865589 157 166 I-Criteria_Count
: NCT03865589 167 168 O

- NCT03865589 177 178 O
TBI NCT03865589 180 183 B-Observation
> NCT03865589 184 185 B-Eq_Comparison
= NCT03865589 186 187 I-Eq_Comparison
1200 NCT03865589 188 192 I-Eq_Comparison
cGy NCT03865589 193 196 I-Eq_Comparison
( NCT03865589 197 198 O
fractionated NCT03865589 199 211 B-Modifier
) NCT03865589 212 213 O

- NCT03865589 222 223 O
Cyclophosphamide NCT03865589 225 241 B-Drug
+ NCT03865589 242 243 B-And
TBI NCT03865589 244 247 B-Observation
( NCT03865589 248 249 O
> NCT03865589 250 251 B-Eq_Comparison
500 NCT03865589 252 255 I-Eq_Comparison
cGy NCT03865589 256 259 I-Eq_Comparison
( NCT03865589 260 261 O
single NCT03865589 262 268 B-Modifier
) NCT03865589 269 270 O
or NCT03865589 271 273 B-Or
> NCT03865589 274 275 B-Eq_Comparison
800 NCT03865589 276 279 I-Eq_Comparison
cGy NCT03865589 280 283 I-Eq_Comparison
( NCT03865589 284 285 O
fractionated NCT03865589 286 298 B-Modifier
) NCT03865589 299 300 O
) NCT03865589 301 302 O

- NCT03865589 311 312 O
Cyclophosphamide NCT03865589 314 330 B-Drug
+ NCT03865589 331 332 B-And
Etoposide NCT03865589 333 342 B-Drug
+ NCT03865589 343 344 B-And
TBI NCT03865589 345 348 B-Observation
( NCT03865589 349 350 O
> NCT03865589 351 352 B-Eq_Comparison
500 NCT03865589 353 356 I-Eq_Comparison
cGy NCT03865589 357 360 I-Eq_Comparison
( NCT03865589 361 362 O
single NCT03865589 363 369 B-Modifier
) NCT03865589 370 371 O
or NCT03865589 372 374 B-Or
> NCT03865589 375 376 B-Eq_Comparison
800 NCT03865589 377 380 I-Eq_Comparison
cGy NCT03865589 381 384 I-Eq_Comparison
( NCT03865589 385 386 O
fractionated NCT03865589 387 399 B-Modifier
) NCT03865589 400 401 O
) NCT03865589 402 403 O

- NCT03865589 412 413 O
Cyclophosphamide NCT03865589 415 431 B-Drug
+ NCT03865589 432 433 B-And
Thiotepa NCT03865589 434 442 B-Drug
+ NCT03865589 443 444 B-And
TBI NCT03865589 445 448 B-Observation
( NCT03865589 449 450 O
> NCT03865589 451 452 B-Eq_Comparison
500 NCT03865589 453 456 I-Eq_Comparison
cGy NCT03865589 457 460 I-Eq_Comparison
( NCT03865589 461 462 O
single NCT03865589 463 469 B-Modifier
) NCT03865589 470 471 O
or NCT03865589 472 474 B-Or
> NCT03865589 475 476 B-Eq_Comparison
800 NCT03865589 477 480 I-Eq_Comparison
cGy NCT03865589 481 484 I-Eq_Comparison
( NCT03865589 485 486 O
fractionated NCT03865589 487 499 B-Modifier
) NCT03865589 500 501 O
) NCT03865589 502 503 O

- NCT03865589 512 513 O
Busulfan NCT03865589 515 523 B-Drug
( NCT03865589 524 525 O
Total NCT03865589 526 531 O
dose NCT03865589 532 536 O
> NCT03865589 537 538 B-Eq_Comparison
7.2 NCT03865589 539 542 I-Eq_Comparison
mg NCT03865589 543 545 I-Eq_Comparison
/ NCT03865589 546 547 I-Eq_Comparison
kg NCT03865589 548 550 I-Eq_Comparison
IV NCT03865589 551 553 B-Modifier
or NCT03865589 554 556 B-Or
> NCT03865589 557 558 B-Eq_Comparison
9.0 NCT03865589 559 562 I-Eq_Comparison
mg NCT03865589 563 565 I-Eq_Comparison
/ NCT03865589 566 567 I-Eq_Comparison
kg NCT03865589 568 570 I-Eq_Comparison
orally NCT03865589 571 577 B-Modifier
) NCT03865589 578 579 O
+ NCT03865589 580 581 B-And
Cyclophosphamide NCT03865589 582 598 B-Drug

- NCT03865589 606 607 O
Busulfan NCT03865589 609 617 B-Drug
( NCT03865589 618 619 O
Total NCT03865589 620 625 O
dose NCT03865589 626 630 O
> NCT03865589 631 632 B-Eq_Comparison
7.2 NCT03865589 633 636 I-Eq_Comparison
mg NCT03865589 637 639 I-Eq_Comparison
/ NCT03865589 640 641 I-Eq_Comparison
kg NCT03865589 642 644 I-Eq_Comparison
IV NCT03865589 645 647 B-Modifier
or NCT03865589 648 650 B-Or
> NCT03865589 651 652 B-Eq_Comparison
9.0 NCT03865589 653 656 I-Eq_Comparison
mg NCT03865589 657 659 I-Eq_Comparison
/ NCT03865589 660 661 I-Eq_Comparison
kg NCT03865589 662 664 I-Eq_Comparison
orally NCT03865589 665 671 B-Modifier
) NCT03865589 672 673 O
+ NCT03865589 674 675 B-And
Melphalan NCT03865589 676 685 B-Drug

- NCT03865589 693 694 O
Busulfan NCT03865589 696 704 B-Drug
( NCT03865589 705 706 O
Total NCT03865589 707 712 O
dose NCT03865589 713 717 O
> NCT03865589 718 719 B-Eq_Comparison
7.2 NCT03865589 720 723 I-Eq_Comparison
mg NCT03865589 724 726 I-Eq_Comparison
/ NCT03865589 727 728 I-Eq_Comparison
kg NCT03865589 729 731 I-Eq_Comparison
IV NCT03865589 732 734 B-Modifier
or NCT03865589 735 737 B-Or
> NCT03865589 738 739 B-Eq_Comparison
9.0 NCT03865589 740 743 I-Eq_Comparison
mg NCT03865589 744 746 I-Eq_Comparison
/ NCT03865589 747 748 I-Eq_Comparison
kg NCT03865589 749 751 I-Eq_Comparison
orally NCT03865589 752 758 B-Modifier
) NCT03865589 759 760 O
+ NCT03865589 761 762 B-And
Thiotepa NCT03865589 763 771 B-Drug

- NCT03865589 779 780 O
NOTE NCT03865589 782 786 O
: NCT03865589 787 788 O
Busulfan NCT03865589 789 797 B-Drug
cumulative NCT03865589 798 808 B-Observation
plasma NCT03865589 809 815 I-Observation
AUC NCT03865589 816 819 I-Observation
of NCT03865589 820 822 O
> NCT03865589 823 824 B-Eq_Comparison
75 NCT03865589 825 827 I-Eq_Comparison
mg NCT03865589 828 830 I-Eq_Comparison
/ NCT03865589 831 832 I-Eq_Comparison
L NCT03865589 833 834 I-Eq_Comparison
per NCT03865589 835 838 I-Eq_Comparison
hour NCT03865589 839 843 I-Eq_Comparison
or NCT03865589 844 846 B-Or
> NCT03865589 847 848 B-Eq_Comparison
18270 NCT03865589 849 854 I-Eq_Comparison
microMolar NCT03865589 855 865 I-Eq_Comparison
per NCT03865589 866 869 I-Eq_Comparison
minute NCT03865589 870 876 I-Eq_Comparison
could NCT03865589 877 882 O
be NCT03865589 883 885 O
used NCT03865589 886 890 O
in NCT03865589 891 893 O
the NCT03865589 894 897 O
preceding NCT03865589 898 907 O
criteria NCT03865589 908 916 O
in NCT03865589 917 919 O
lieu NCT03865589 920 924 O
of NCT03865589 925 927 O
the NCT03865589 928 931 O
mg NCT03865589 932 934 O
/ NCT03865589 935 936 O
kg NCT03865589 937 939 O
doses NCT03865589 940 945 O
. NCT03865589 946 947 O

OR NCT03865589 949 951 B-Or

2 NCT03865589 953 954 O
. NCT03865589 954 955 O
Any NCT03865589 957 960 O
patient NCT03865589 961 968 O
who NCT03865589 969 972 O
has NCT03865589 973 976 O
a NCT03865589 977 978 O
myeloablative NCT03865589 979 992 B-Procedure
conditioning NCT03865589 993 1005 I-Procedure
regimen NCT03865589 1006 1013 O
( NCT03865589 1014 1015 O
as NCT03865589 1016 1018 O
defined NCT03865589 1019 1026 O
by NCT03865589 1027 1029 O
the NCT03865589 1030 1033 O
local NCT03865589 1034 1039 O
HSCT NCT03865589 1040 1044 O
team NCT03865589 1045 1049 O
) NCT03865589 1050 1051 O
that NCT03865589 1052 1056 O
includes NCT03865589 1057 1065 O
sirolimus NCT03865589 1066 1075 B-Drug
and NCT03865589 1076 1079 B-Or
tacrolimus NCT03865589 1080 1090 B-Drug
for NCT03865589 1091 1094 O
GVHD NCT03865589 1095 1099 B-Condition
prophylaxis NCT03865589 1100 1111 B-Procedure
. NCT03865589 1112 1113 O

OR NCT03865589 1115 1117 B-Or

3 NCT03865589 1119 1120 O
. NCT03865589 1120 1121 O
Any NCT03865589 1123 1126 O
patient NCT03865589 1127 1134 O
who NCT03865589 1135 1138 O
is NCT03865589 1139 1141 O
high NCT03865589 1142 1146 O
risk NCT03865589 1147 1151 B-Risk
for NCT03865589 1152 1155 O
SOS NCT03865589 1156 1159 B-Condition
irrespective NCT03865589 1160 1172 O
of NCT03865589 1173 1175 O
conditioning NCT03865589 1176 1188 O
regimen NCT03865589 1189 1196 O
: NCT03865589 1197 1198 O

Neuroblastoma NCT03865589 1200 1213 B-Condition
, NCT03865589 1214 1215 O
HLH NCT03865589 1216 1219 B-Condition
, NCT03865589 1220 1221 O
Osteopetrosis NCT03865589 1222 1235 B-Condition
, NCT03865589 1236 1237 O
Thalassemia NCT03865589 1238 1249 B-Condition
, NCT03865589 1250 1251 O
treatment NCT03865589 1252 1261 B-Procedure
with NCT03865589 1262 1266 O
inotuzumab NCT03865589 1267 1277 B-Drug
or NCT03865589 1278 1280 B-Or
gemtuzumab NCT03865589 1281 1291 B-Drug
within NCT03865589 1292 1298 B-Eq_Comparison
3 NCT03865589 1299 1300 I-Eq_Comparison
months NCT03865589 1301 1307 I-Eq_Comparison
prior NCT03865589 1308 1313 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865589 1314 1316 I-Temporal_Connection___Temporal_Connection_Type_Value:before
HSCT NCT03865589 1317 1321 B-Procedure
admission NCT03865589 1322 1331 B-Encounter
, NCT03865589 1332 1333 O
2 NCT03865589 1334 1335 B-Eq_Comparison
nd NCT03865589 1336 1338 I-Eq_Comparison
HSCT NCT03865589 1339 1343 B-Procedure
if NCT03865589 1344 1346 O
it NCT03865589 1347 1349 O
is NCT03865589 1350 1352 O
myeloablative NCT03865589 1353 1366 B-Modifier
and NCT03865589 1367 1370 O
within NCT03865589 1371 1377 B-Eq_Comparison
6 NCT03865589 1378 1379 I-Eq_Comparison
months NCT03865589 1380 1386 I-Eq_Comparison
of NCT03865589 1387 1389 B-Temporal_Connection___Temporal_Connection_Type_Value:before
prior NCT03865589 1390 1395 O
, NCT03865589 1396 1397 O
iron NCT03865589 1398 1402 B-Condition
overload NCT03865589 1403 1411 I-Condition
, NCT03865589 1412 1413 O
steatohepatitis NCT03865589 1414 1429 B-Condition
, NCT03865589 1430 1431 O
active NCT03865589 1432 1438 B-Eq_Comparison
inflammatory NCT03865589 1439 1451 B-Modifier
or NCT03865589 1452 1454 B-Or
infection NCT03865589 1455 1464 B-Modifier
hepatitis NCT03865589 1465 1474 B-Condition
or NCT03865589 1475 1477 B-Or
any NCT03865589 1478 1481 O
other NCT03865589 1482 1487 B-Other
condition NCT03865589 1488 1497 B-Condition
which NCT03865589 1498 1503 O
puts NCT03865589 1504 1508 O
the NCT03865589 1509 1512 O
patient NCT03865589 1513 1520 O
at NCT03865589 1521 1523 O
a NCT03865589 1524 1525 O
higher NCT03865589 1526 1532 O
risk NCT03865589 1533 1537 B-Risk
of NCT03865589 1538 1540 O
developing NCT03865589 1541 1551 B-Assertion___Assertion_Type_Value:hypothetical
SOS NCT03865589 1552 1555 B-Condition
. NCT03865589 1556 1557 O

Exclusion NCT03865589 1559 1568 O
Criteria NCT03865589 1569 1577 O
: NCT03865589 1578 1579 O

- NCT03865589 1583 1584 O
Any NCT03865589 1586 1589 O
patient NCT03865589 1590 1597 O
who NCT03865589 1598 1601 O
has NCT03865589 1602 1605 O
contraindication NCT03865589 1606 1622 B-Contraindication
to NCT03865589 1623 1625 O
US NCT03865589 1626 1628 B-Procedure
SWE NCT03865589 1629 1632 I-Procedure
( NCT03865589 1633 1634 O
e NCT03865589 1635 1636 O
. NCT03865589 1637 1638 O
g NCT03865589 1639 1640 O
. NCT03865589 1641 1642 O
unable NCT03865589 1644 1650 B-Condition
to NCT03865589 1651 1653 I-Condition
hold NCT03865589 1654 1658 I-Condition
still NCT03865589 1659 1664 I-Condition
) NCT03865589 1665 1666 O


Inclusion NCT03927872 0 9 O
criteria NCT03927872 10 18 O
: NCT03927872 19 20 O

- NCT03927872 24 25 O
CES NCT03927872 27 30 B-Condition
and NCT03927872 31 34 B-Or
non NCT03927872 35 38 B-Negation
- NCT03927872 39 40 O
CES NCT03927872 41 44 B-Condition
diagnosis NCT03927872 45 54 O
was NCT03927872 55 58 O
according NCT03927872 59 68 O
to NCT03927872 69 71 O
Trial NCT03927872 72 77 O
of NCT03927872 78 80 O
Org NCT03927872 81 84 O
10172 NCT03927872 85 90 O
in NCT03927872 91 93 O
Acute NCT03927872 94 99 B-Procedure
Stroke NCT03927872 100 106 I-Procedure
Treatment NCT03927872 107 116 I-Procedure
( NCT03927872 117 118 O
TOAST NCT03927872 119 124 B-Procedure
) NCT03927872 125 126 O
classification NCT03927872 127 141 O
criteria NCT03927872 142 150 O
. NCT03927872 151 152 O

- NCT03927872 156 157 O
non NCT03927872 159 162 B-Negation
- NCT03927872 163 164 O
CES NCT03927872 165 168 B-Condition
were NCT03927872 169 173 O
selected NCT03927872 174 182 O
to NCT03927872 183 185 O
match NCT03927872 186 191 O
patients NCT03927872 192 200 O
with NCT03927872 201 205 O
CES NCT03927872 206 209 B-Condition
regarding NCT03927872 210 219 O
age NCT03927872 220 223 O
and NCT03927872 224 227 O
vascular NCT03927872 228 236 O
risk NCT03927872 237 241 O
factors NCT03927872 242 249 O
as NCT03927872 250 252 O
a NCT03927872 253 254 O
control NCT03927872 255 262 O
group NCT03927872 263 268 O
. NCT03927872 269 270 O

- NCT03927872 274 275 O
Patients NCT03927872 277 285 O
with NCT03927872 286 290 O
National NCT03927872 291 299 B-Condition
Institutes NCT03927872 300 310 I-Condition
of NCT03927872 311 313 I-Condition
Health NCT03927872 314 320 I-Condition
Stroke NCT03927872 321 327 I-Condition
Scale NCT03927872 328 333 I-Condition
( NCT03927872 334 335 O
NIHSS NCT03927872 336 341 B-Condition
) NCT03927872 342 343 O
score NCT03927872 344 349 O
more NCT03927872 350 354 B-Eq_Comparison
than NCT03927872 355 359 I-Eq_Comparison
5 NCT03927872 360 361 I-Eq_Comparison
. NCT03927872 361 362 O

- NCT03927872 366 367 O
Adult NCT03927872 369 374 O
patients NCT03927872 375 383 O
with NCT03927872 384 388 B-And
their NCT03927872 389 394 O
ages NCT03927872 395 399 B-Age
more NCT03927872 400 404 B-Eq_Comparison
than NCT03927872 405 409 I-Eq_Comparison
18 NCT03927872 410 412 I-Eq_Comparison
year NCT03927872 413 417 I-Eq_Comparison
. NCT03927872 418 419 O

Exclusion NCT03927872 421 430 O
criteria NCT03927872 431 439 O
: NCT03927872 440 441 O

- NCT03927872 445 446 O
Lacunar NCT03927872 448 455 B-Modifier
stroke NCT03927872 456 462 B-Condition
and NCT03927872 463 466 O
transient NCT03927872 467 476 B-Condition
ischemic NCT03927872 477 485 I-Condition
attacks NCT03927872 486 493 I-Condition
( NCT03927872 494 495 O
TIAs NCT03927872 496 500 B-Condition
) NCT03927872 501 502 O

- NCT03927872 506 507 O
Haemorrhagic NCT03927872 509 521 B-Modifier
stroke NCT03927872 522 528 B-Condition
. NCT03927872 529 530 O

- NCT03927872 534 535 O
Neurological NCT03927872 537 549 B-Condition
causes NCT03927872 550 556 I-Condition
of NCT03927872 557 559 O
acute NCT03927872 560 565 O
focal NCT03927872 566 571 B-Modifier
cerebral NCT03927872 572 580 B-Condition
dysfunction NCT03927872 581 592 I-Condition
such NCT03927872 593 597 O
as NCT03927872 598 600 O
cerebral NCT03927872 601 609 B-Condition
venous NCT03927872 610 616 I-Condition
sinus NCT03927872 617 622 I-Condition
thrombosis NCT03927872 623 633 I-Condition
, NCT03927872 634 635 O
head NCT03927872 636 640 B-Modifier
trauma NCT03927872 641 647 B-Condition
, NCT03927872 648 649 O
infection NCT03927872 650 659 B-Condition
, NCT03927872 660 661 O
and NCT03927872 662 665 B-Or
auto NCT03927872 666 670 B-Condition
immune NCT03927872 671 677 I-Condition
disorders NCT03927872 678 687 I-Condition

- NCT03927872 690 691 O
Heart NCT03927872 693 698 B-Condition
failure NCT03927872 699 706 I-Condition

- NCT03927872 709 710 O
Liver NCT03927872 712 717 B-Condition
failure NCT03927872 718 725 I-Condition

- NCT03927872 728 729 O
Chronic NCT03927872 731 738 B-Condition
renal NCT03927872 739 744 I-Condition
disease NCT03927872 745 752 I-Condition
. NCT03927872 753 754 O

Inclusion NCT03922334 0 9 O
Criteria NCT03922334 10 18 O
: NCT03922334 19 20 O

- NCT03922334 24 25 O
Pregnant NCT03922334 27 35 B-Condition
( NCT03922334 36 37 O
any NCT03922334 38 41 O
plurality NCT03922334 42 51 O
) NCT03922334 52 53 O
delivering NCT03922334 54 64 B-Eq_Comparison
at NCT03922334 65 67 B-Eq_Comparison
or NCT03922334 68 70 I-Eq_Comparison
after NCT03922334 71 76 I-Eq_Comparison
20 NCT03922334 77 79 I-Eq_Comparison
weeks NCT03922334 80 85 I-Eq_Comparison
of NCT03922334 86 88 O
gestation NCT03922334 89 98 B-Observation
OR NCT03922334 99 101 B-Or
postpartum NCT03922334 102 112 B-Condition
( NCT03922334 113 114 O
during NCT03922334 115 121 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospitalization NCT03922334 122 137 B-Encounter
) NCT03922334 138 139 O
, NCT03922334 140 141 O
regardless NCT03922334 142 152 O
of NCT03922334 153 155 O
perinatal NCT03922334 156 165 O
outcome NCT03922334 166 173 O

- NCT03922334 176 177 O
16 NCT03922334 179 181 B-Eq_Comparison
years NCT03922334 182 187 I-Eq_Comparison
or NCT03922334 188 190 I-Eq_Comparison
older NCT03922334 191 196 I-Eq_Comparison

- NCT03922334 199 200 O
Low NCT03922334 202 205 O
- NCT03922334 206 207 O
income NCT03922334 208 214 O
socioeconomic NCT03922334 215 228 O
status NCT03922334 229 235 O
( NCT03922334 236 237 O
publicly NCT03922334 238 246 O
funded NCT03922334 247 253 O
prenatal NCT03922334 254 262 O
care NCT03922334 263 267 O
) NCT03922334 268 269 O

- NCT03922334 273 274 O
Ability NCT03922334 276 283 O
to NCT03922334 284 286 O
speak NCT03922334 287 292 O
and NCT03922334 293 296 O
read NCT03922334 297 301 O
English NCT03922334 302 309 O
or NCT03922334 310 312 B-Or
Spanish NCT03922334 313 320 O

- NCT03922334 323 324 O
Established NCT03922334 326 337 O
patient NCT03922334 338 345 O
at NCT03922334 346 348 O
the NCT03922334 349 352 O
Northwestern NCT03922334 353 365 O
Medicine NCT03922334 366 374 O
Prentice NCT03922334 375 383 O
Ambulatory NCT03922334 384 394 O
Care NCT03922334 395 399 O
clinical NCT03922334 400 408 O
site NCT03922334 409 413 O
( NCT03922334 414 415 O
at NCT03922334 416 418 B-Eq_Comparison
least NCT03922334 419 424 I-Eq_Comparison
one NCT03922334 425 428 I-Eq_Comparison
antenatal NCT03922334 429 438 O
clinical NCT03922334 439 447 O
visit NCT03922334 448 453 B-Encounter
) NCT03922334 454 455 O
. NCT03922334 456 457 O

Exclusion NCT03922334 459 468 O
Criteria NCT03922334 469 477 O
: NCT03922334 478 479 O

- NCT03922334 483 484 O
Intent NCT03922334 486 492 B-Assertion___Assertion_Type_Value:intention
to NCT03922334 493 495 O
transfer NCT03922334 496 504 B-Encounter
care NCT03922334 505 509 I-Encounter
to NCT03922334 510 512 O
an NCT03922334 513 515 O
outside NCT03922334 516 523 B-Other
institution NCT03922334 524 535 O

- NCT03922334 538 539 O
HIV NCT03922334 541 544 B-Condition
( NCT03922334 545 546 O
as NCT03922334 547 549 O
these NCT03922334 550 555 O
patients NCT03922334 556 564 O
already NCT03922334 565 572 O
receive NCT03922334 573 580 O
intensive NCT03922334 581 590 O
social NCT03922334 591 597 O
support NCT03922334 598 605 O
and NCT03922334 606 609 O
navigation NCT03922334 610 620 O
- NCT03922334 621 622 O
like NCT03922334 623 627 O
services NCT03922334 628 636 O
at NCT03922334 637 639 O
this NCT03922334 640 644 O
institution NCT03922334 645 656 O
) NCT03922334 657 658 O

Inclusion NCT03867227 0 9 O
Criteria NCT03867227 10 18 O
: NCT03867227 19 20 O

- NCT03867227 24 25 O
Patient NCT03867227 27 34 O
with NCT03867227 35 39 O
paroxysmal NCT03867227 40 50 B-Modifier
/ NCT03867227 51 52 B-Or
persistent NCT03867227 53 63 B-Modifier
/ NCT03867227 64 65 B-Or
permanent NCT03867227 66 75 B-Modifier
atrial NCT03867227 76 82 B-Condition
fibrillation NCT03867227 83 95 I-Condition

- NCT03867227 98 99 O
CHA NCT03867227 101 104 B-Observation
2DS NCT03867227 105 108 I-Observation
2VASc NCT03867227 109 114 I-Observation
score NCT03867227 115 120 O
≥ NCT03867227 121 122 B-Eq_Comparison
2 NCT03867227 123 124 I-Eq_Comparison
for NCT03867227 125 128 O
male NCT03867227 129 133 O
and NCT03867227 134 137 B-And
≥ NCT03867227 138 139 B-Eq_Comparison
3 NCT03867227 140 141 I-Eq_Comparison
for NCT03867227 142 145 O
female NCT03867227 146 152 O

- NCT03867227 155 156 O
Without NCT03867227 158 165 B-Negation
contraindications NCT03867227 166 183 B-Contraindication
to NCT03867227 184 186 O
anticoagulation NCT03867227 187 202 B-Procedure
therapy NCT03867227 203 210 I-Procedure

Exclusion NCT03867227 211 220 O
Criteria NCT03867227 221 229 O
: NCT03867227 230 231 O

- NCT03867227 235 236 O
LAA NCT03867227 238 241 B-Modifier
thrombosis NCT03867227 242 252 B-Condition

- NCT03867227 255 256 O
mechanical NCT03867227 258 268 B-Procedure
prosthetic NCT03867227 269 279 I-Procedure
heart NCT03867227 280 285 I-Procedure
valve NCT03867227 286 291 I-Procedure

- NCT03867227 294 295 O
moderate NCT03867227 297 305 O
or NCT03867227 306 308 B-Or
severe NCT03867227 309 315 O
mitral NCT03867227 316 322 B-Condition
valve NCT03867227 323 328 I-Condition
stenosis NCT03867227 329 337 I-Condition

Inclusion NCT03863405 0 9 O
Criteria NCT03863405 10 18 O
: NCT03863405 19 20 O

- NCT03863405 24 25 O
Patients NCT03863405 27 35 O
older NCT03863405 36 41 B-Eq_Comparison
than NCT03863405 42 46 I-Eq_Comparison
18 NCT03863405 47 49 I-Eq_Comparison
years NCT03863405 50 55 I-Eq_Comparison
( NCT03863405 56 57 O
of NCT03863405 58 60 O
both NCT03863405 61 65 O
sexes NCT03863405 66 71 O
) NCT03863405 72 73 O
diagnosed NCT03863405 74 83 O
with NCT03863405 84 88 O
rheumatoid NCT03863405 89 99 B-Condition
arthritis NCT03863405 100 109 I-Condition
according NCT03863405 110 119 O
to NCT03863405 120 122 O
ACR NCT03863405 123 126 O
/ NCT03863405 127 128 O
EULAR NCT03863405 129 134 O
2010 NCT03863405 135 139 O
criteria NCT03863405 140 148 O
. NCT03863405 149 150 O

- NCT03863405 154 155 O
Patients NCT03863405 157 165 O
with NCT03863405 166 170 O
moderate NCT03863405 171 179 B-Eq_Comparison
to NCT03863405 180 182 I-Eq_Comparison
high NCT03863405 183 187 I-Eq_Comparison
disease NCT03863405 188 195 B-Condition
activity NCT03863405 196 204 I-Condition
( NCT03863405 205 206 O
DAS NCT03863405 207 210 B-Observation
- NCT03863405 211 212 I-Observation
28 NCT03863405 213 215 I-Observation
. NCT03863405 216 217 I-Observation
score NCT03863405 219 224 I-Observation
greater NCT03863405 225 232 B-Eq_Comparison
than NCT03863405 233 237 I-Eq_Comparison
3.2 NCT03863405 238 241 I-Eq_Comparison
) NCT03863405 242 243 O

- NCT03863405 247 248 O
Patients NCT03863405 250 258 O
received NCT03863405 259 267 B-Eq_Comparison
the NCT03863405 268 271 O
standard NCT03863405 272 280 B-Procedure
therapy NCT03863405 281 288 I-Procedure
( NCT03863405 289 290 O
i NCT03863405 291 292 O
. NCT03863405 293 294 O
e NCT03863405 295 296 O
. NCT03863405 297 298 O
one NCT03863405 300 303 B-Eq_Comparison
or NCT03863405 304 306 I-Eq_Comparison
more NCT03863405 307 311 I-Eq_Comparison
conventional NCT03863405 312 324 O
DMARDs NCT03863405 325 331 B-Drug
) NCT03863405 332 333 O
for NCT03863405 334 337 O
at NCT03863405 338 340 B-Eq_Comparison
least NCT03863405 341 346 I-Eq_Comparison
three NCT03863405 347 352 I-Eq_Comparison
months NCT03863405 353 359 I-Eq_Comparison
. NCT03863405 360 361 O

Exclusion NCT03863405 363 372 O
Criteria NCT03863405 373 381 O
: NCT03863405 382 383 O

- NCT03863405 387 388 O
Known NCT03863405 390 395 O
hypersensitivity NCT03863405 396 412 B-Condition
to NCT03863405 413 415 O
metformin NCT03863405 416 425 B-Drug
. NCT03863405 426 427 O

- NCT03863405 431 432 O
Patients NCT03863405 434 442 O
who NCT03863405 443 446 O
have NCT03863405 447 451 O
a NCT03863405 452 453 O
prior NCT03863405 454 459 B-Eq_Comparison
diagnosis NCT03863405 460 469 O
with NCT03863405 470 474 O
diabetes NCT03863405 475 483 B-Condition
mellitus NCT03863405 484 492 I-Condition
. NCT03863405 493 494 O

- NCT03863405 498 499 O
Patients NCT03863405 501 509 O
receive NCT03863405 510 517 B-Eq_Comparison
metformin NCT03863405 518 527 B-Drug
for NCT03863405 528 531 O
any NCT03863405 532 535 O
other NCT03863405 536 541 B-Other
indications NCT03863405 542 553 B-Indication
. NCT03863405 554 555 O

- NCT03863405 559 560 O
Patients NCT03863405 562 570 O
with NCT03863405 571 575 O
congestive NCT03863405 576 586 B-Condition
heart NCT03863405 587 592 I-Condition
failure NCT03863405 593 600 I-Condition
. NCT03863405 601 602 O

- NCT03863405 606 607 O
Patients NCT03863405 609 617 O
with NCT03863405 618 622 O
a NCT03863405 623 624 O
history NCT03863405 625 632 B-Eq_Comparison
of NCT03863405 633 635 O
myocardial NCT03863405 636 646 B-Condition
infarction NCT03863405 647 657 I-Condition
. NCT03863405 658 659 O

- NCT03863405 663 664 O
Patients NCT03863405 666 674 O
with NCT03863405 675 679 O
severe NCT03863405 680 686 O
anemia NCT03863405 687 693 B-Condition
. NCT03863405 694 695 O

- NCT03863405 699 700 O
Patients NCT03863405 702 710 O
with NCT03863405 711 715 O
active NCT03863405 716 722 B-Eq_Comparison
infections NCT03863405 723 733 B-Condition
or NCT03863405 734 736 B-Or
other NCT03863405 737 742 B-Other
inflammatory NCT03863405 743 755 B-Condition
diseases NCT03863405 756 764 I-Condition
. NCT03863405 765 766 O

- NCT03863405 770 771 O
Patients NCT03863405 773 781 O
receiving NCT03863405 782 791 B-Eq_Comparison
biological NCT03863405 792 802 B-Procedure
therapy NCT03863405 803 810 I-Procedure
. NCT03863405 811 812 O

- NCT03863405 816 817 O
Pregnancy NCT03863405 819 828 B-Condition
or NCT03863405 829 831 B-Or
lactation NCT03863405 832 841 B-Condition
. NCT03863405 842 843 O

- NCT03863405 847 848 O
Patients NCT03863405 850 858 O
with NCT03863405 859 863 O
impaired NCT03863405 864 872 B-Condition
liver NCT03863405 873 878 I-Condition
functions NCT03863405 879 888 I-Condition
. NCT03863405 889 890 O

- NCT03863405 894 895 O
Patients NCT03863405 897 905 O
with NCT03863405 906 910 O
impaired NCT03863405 911 919 B-Condition
kidney NCT03863405 920 926 I-Condition
functions NCT03863405 927 936 I-Condition
( NCT03863405 937 938 O
serum NCT03863405 939 944 B-Observation
creatinine NCT03863405 945 955 I-Observation
concentrations NCT03863405 956 970 I-Observation
≥ NCT03863405 971 972 B-Eq_Comparison
1.5 NCT03863405 973 976 I-Eq_Comparison
and NCT03863405 977 980 B-Or
≥ NCT03863405 981 982 B-Eq_Comparison
1.4 NCT03863405 983 986 I-Eq_Comparison
mg NCT03863405 987 989 I-Eq_Comparison
/ NCT03863405 990 991 I-Eq_Comparison
dL NCT03863405 992 994 I-Eq_Comparison
in NCT03863405 995 997 O
males NCT03863405 998 1003 O
and NCT03863405 1004 1007 B-Or
females NCT03863405 1008 1015 O
respectively NCT03863405 1016 1028 O
) NCT03863405 1029 1030 O
. NCT03863405 1031 1032 O

- NCT03863405 1036 1037 O
Patients NCT03863405 1039 1047 O
with NCT03863405 1048 1052 O
malignancies NCT03863405 1053 1065 B-Condition
. NCT03863405 1066 1067 O

Inclusion NCT03922347 0 9 O
Criteria NCT03922347 10 18 O
: NCT03922347 19 20 O

- NCT03922347 24 25 O
Inclusion NCT03922347 27 36 O
criteria NCT03922347 37 45 O
were NCT03922347 46 50 O
living NCT03922347 51 57 O
in NCT03922347 58 60 O
one NCT03922347 61 64 O
of NCT03922347 65 67 O
the NCT03922347 68 71 O
non NCT03922347 72 75 O
- NCT03922347 76 77 O
institutionalized NCT03922347 78 95 O
urban NCT03922347 96 101 O
or NCT03922347 102 104 B-Or
rural NCT03922347 105 110 O
residential NCT03922347 111 122 O
areas NCT03922347 123 128 O
in NCT03922347 129 131 O
one NCT03922347 132 135 O
of NCT03922347 136 138 O
the NCT03922347 139 142 O
survey NCT03922347 143 149 O
area NCT03922347 150 154 O
, NCT03922347 155 156 O
being NCT03922347 157 162 O
resident NCT03922347 163 171 O
in NCT03922347 172 174 O
the NCT03922347 175 178 O
same NCT03922347 179 183 O
address NCT03922347 184 191 B-Observation
for NCT03922347 192 195 O
at NCT03922347 196 198 B-Eq_Comparison
least NCT03922347 199 204 I-Eq_Comparison
6 NCT03922347 205 206 I-Eq_Comparison
months NCT03922347 207 213 I-Eq_Comparison
during NCT03922347 214 220 O
the NCT03922347 221 224 O
year NCT03922347 225 229 O
before NCT03922347 230 236 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03922347 237 240 O
enrolment NCT03922347 241 250 B-Study
, NCT03922347 251 252 O
age NCT03922347 253 256 B-Age
50 NCT03922347 257 259 B-Eq_Comparison
and NCT03922347 260 263 I-Eq_Comparison
over NCT03922347 264 268 I-Eq_Comparison
and NCT03922347 269 272 B-And
Iranian NCT03922347 273 280 O
nationality NCT03922347 281 292 O
. NCT03922347 293 294 O

Inclusion NCT03865602 0 9 O
Criteria NCT03865602 10 18 O
: NCT03865602 19 20 O

1 NCT03865602 24 25 O
. NCT03865602 25 26 O
Admitted NCT03865602 28 36 B-Encounter
from NCT03865602 37 41 O
the NCT03865602 42 45 O
emergency NCT03865602 46 55 O
department NCT03865602 56 66 O
to NCT03865602 67 69 B-Temporal_Connection___Temporal_Connection_Type_Value:after
inpatient NCT03865602 70 79 B-Encounter
or NCT03865602 80 82 B-Or
observation NCT03865602 83 94 B-Encounter
status NCT03865602 95 101 O
at NCT03865602 102 104 O
one NCT03865602 105 108 O
of NCT03865602 109 111 O
: NCT03865602 112 113 O

Carolinas NCT03865602 120 129 O
Medical NCT03865602 130 137 O
Center NCT03865602 138 144 O
, NCT03865602 145 146 O
Carolinas NCT03865602 147 156 O
Medical NCT03865602 157 164 O
Center NCT03865602 165 171 O
- NCT03865602 172 173 O
Mercy NCT03865602 174 179 O
, NCT03865602 180 181 O
or NCT03865602 182 184 B-Or
Atrium NCT03865602 185 191 O
Health NCT03865602 192 198 O
Northeast NCT03865602 199 208 O
; NCT03865602 208 209 O

2 NCT03865602 212 213 O
. NCT03865602 213 214 O
≥ NCT03865602 216 217 B-Eq_Comparison
18 NCT03865602 218 220 I-Eq_Comparison
years NCT03865602 221 226 I-Eq_Comparison
of NCT03865602 227 229 O
age NCT03865602 230 233 B-Age
upon NCT03865602 234 238 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03865602 239 248 B-Encounter
; NCT03865602 248 249 O

3 NCT03865602 252 253 O
. NCT03865602 253 254 O
oral NCT03865602 256 260 B-Modifier
/ NCT03865602 261 262 B-Or
parenteral NCT03865602 263 273 B-Modifier
antibiotic NCT03865602 274 284 B-Drug
or NCT03865602 285 287 B-Or
bacterial NCT03865602 288 297 B-Observation
culture NCT03865602 298 305 I-Observation
order NCT03865602 306 311 O
within NCT03865602 312 318 B-Eq_Comparison
24 NCT03865602 319 321 I-Eq_Comparison
hours NCT03865602 322 327 I-Eq_Comparison
of NCT03865602 328 330 B-Temporal_Connection___Temporal_Connection_Type_Value:after
emergency NCT03865602 331 340 B-Encounter
department NCT03865602 341 351 O
presentation NCT03865602 352 364 O
and NCT03865602 365 368 O

1 NCT03865602 376 377 O
. NCT03865602 377 378 O
culture NCT03865602 380 387 B-Observation
drawn NCT03865602 388 393 O
first NCT03865602 394 399 B-Temporal_Connection___Temporal_Connection_Type_Value:before
, NCT03865602 400 401 O
antibiotics NCT03865602 402 413 B-Drug
ordered NCT03865602 414 421 O
within NCT03865602 422 428 B-Eq_Comparison
48 NCT03865602 429 431 I-Eq_Comparison
hours NCT03865602 432 437 I-Eq_Comparison
or NCT03865602 438 440 B-Or

2 NCT03865602 448 449 O
. NCT03865602 449 450 O
antibiotics NCT03865602 452 463 B-Drug
ordered NCT03865602 464 471 O
first NCT03865602 472 477 B-Temporal_Connection___Temporal_Connection_Type_Value:before
, NCT03865602 478 479 O
culture NCT03865602 480 487 B-Observation
ordered NCT03865602 488 495 O
within NCT03865602 496 502 B-Eq_Comparison
48 NCT03865602 503 505 I-Eq_Comparison
hours NCT03865602 506 511 I-Eq_Comparison
( NCT03865602 512 513 O
adapted NCT03865602 514 521 O
from NCT03865602 522 526 O
criteria NCT03865602 527 535 O
applied NCT03865602 536 543 O
in NCT03865602 544 546 O
development NCT03865602 547 558 O
of NCT03865602 559 561 O
the NCT03865602 562 565 O
Third NCT03865602 566 571 O
International NCT03865602 572 585 O
Consensus NCT03865602 586 595 O
Definitions NCT03865602 596 607 O
for NCT03865602 608 611 O
Sepsis NCT03865602 612 618 O
and NCT03865602 619 622 O
Septic NCT03865602 623 629 O
Shock NCT03865602 630 635 O
) NCT03865602 636 637 O

4 NCT03865602 641 642 O
. NCT03865602 642 643 O
deemed NCT03865602 645 651 O
as NCT03865602 652 654 O
high NCT03865602 655 659 B-Modifier
- NCT03865602 660 661 O
risk NCT03865602 662 666 B-Risk
for NCT03865602 667 670 O
30 NCT03865602 671 673 B-Eq_Comparison
- NCT03865602 674 675 I-Eq_Comparison
day NCT03865602 676 679 I-Eq_Comparison
readmission NCT03865602 680 691 B-Encounter
( NCT03865602 692 693 O
i NCT03865602 694 695 O
. NCT03865602 696 697 O
e NCT03865602 698 699 O
. NCT03865602 700 701 O
, NCT03865602 702 703 O
≥ NCT03865602 704 705 B-Eq_Comparison
20 NCT03865602 706 708 I-Eq_Comparison
% NCT03865602 709 710 I-Eq_Comparison
) NCT03865602 711 712 O
or NCT03865602 713 715 B-Or
30 NCT03865602 716 718 B-Eq_Comparison
- NCT03865602 719 720 I-Eq_Comparison
day NCT03865602 721 724 I-Eq_Comparison
mortality NCT03865602 725 734 B-Death
( NCT03865602 735 736 O
i NCT03865602 737 738 O
. NCT03865602 739 740 O
e NCT03865602 741 742 O
. NCT03865602 743 744 O
, NCT03865602 745 746 O
≥ NCT03865602 747 748 B-Eq_Comparison
10 NCT03865602 749 751 I-Eq_Comparison
% NCT03865602 752 753 I-Eq_Comparison
) NCT03865602 754 755 O
using NCT03865602 756 761 B-Eq_Comparison
risk NCT03865602 762 766 B-Observation
- NCT03865602 767 768 I-Observation
scoring NCT03865602 769 776 I-Observation
models NCT03865602 777 783 I-Observation

5 NCT03865602 786 787 O
. NCT03865602 787 788 O
not NCT03865602 790 793 B-Negation
discharged NCT03865602 794 804 B-Encounter
at NCT03865602 805 807 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865602 808 811 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03865602 812 816 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03865602 817 819 I-Temporal_Connection___Temporal_Connection_Type_Value:during
patient NCT03865602 820 827 B-Study
list NCT03865602 828 832 I-Study
generation NCT03865602 833 843 I-Study

Exclusion NCT03865602 844 853 O
Criteria NCT03865602 854 862 O
: NCT03865602 863 864 O

1 NCT03865602 868 869 O
. NCT03865602 869 870 O
prior NCT03865602 872 877 B-Eq_Comparison
randomization NCT03865602 878 891 O
to NCT03865602 892 894 O
either NCT03865602 895 901 O
STAR NCT03865602 902 906 O
or NCT03865602 907 909 O
usual NCT03865602 910 915 O
care NCT03865602 916 920 O
study NCT03865602 921 926 O
arms NCT03865602 927 931 O
; NCT03865602 931 932 O

2 NCT03865602 935 936 O
. NCT03865602 936 937 O
not NCT03865602 939 942 B-Negation
a NCT03865602 943 944 O
North NCT03865602 945 950 O
Carolina NCT03865602 951 959 O
resident NCT03865602 960 968 O
or NCT03865602 969 971 B-Or
residence NCT03865602 972 981 B-Modifier
> NCT03865602 982 983 B-Eq_Comparison
2.5 NCT03865602 984 987 I-Eq_Comparison
- NCT03865602 988 989 I-Eq_Comparison
hour NCT03865602 990 994 I-Eq_Comparison
drive NCT03865602 995 1000 B-Observation
time NCT03865602 1001 1005 I-Observation
from NCT03865602 1006 1010 O
treating NCT03865602 1011 1019 O
hospital NCT03865602 1020 1028 O
; NCT03865602 1028 1029 O

3 NCT03865602 1032 1033 O
. NCT03865602 1033 1034 O
the NCT03865602 1036 1039 O
only NCT03865602 1040 1044 O
antibiotic NCT03865602 1045 1055 B-Drug
associated NCT03865602 1056 1066 O
with NCT03865602 1067 1071 O
patient NCT03865602 1072 1079 O
is NCT03865602 1080 1082 O
administered NCT03865602 1083 1095 B-Eq_Comparison
in NCT03865602 1096 1098 O
the NCT03865602 1099 1102 O
operating NCT03865602 1103 1112 O
room NCT03865602 1113 1117 O
as NCT03865602 1118 1120 O
this NCT03865602 1121 1125 O
likely NCT03865602 1126 1132 B-Assertion___Assertion_Type_Value:possible
represents NCT03865602 1133 1143 O
pre NCT03865602 1144 1147 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03865602 1148 1149 O
operative NCT03865602 1150 1159 B-Procedure
infection NCT03865602 1160 1169 B-Condition
prophylaxis NCT03865602 1170 1181 O
and NCT03865602 1182 1185 B-And
not NCT03865602 1186 1189 B-Negation
presumed NCT03865602 1190 1198 O
infection NCT03865602 1199 1208 B-Condition
; NCT03865602 1208 1209 O

4 NCT03865602 1212 1213 O
. NCT03865602 1213 1214 O
patients NCT03865602 1216 1224 O
transferred NCT03865602 1225 1236 B-Encounter
from NCT03865602 1237 1241 O
other NCT03865602 1242 1247 O
acute NCT03865602 1248 1253 O
care NCT03865602 1254 1258 O
hospitals NCT03865602 1259 1268 O
; NCT03865602 1268 1269 O

5 NCT03865602 1272 1273 O
. NCT03865602 1273 1274 O
patients NCT03865602 1276 1284 O
with NCT03865602 1285 1289 O
a NCT03865602 1290 1291 O
change NCT03865602 1292 1298 O
in NCT03865602 1299 1301 O
code NCT03865602 1302 1306 B-Observation
status NCT03865602 1307 1313 I-Observation
( NCT03865602 1314 1315 O
i NCT03865602 1316 1317 O
. NCT03865602 1318 1319 O
e NCT03865602 1320 1321 O
. NCT03865602 1322 1323 O
, NCT03865602 1324 1325 O
do NCT03865602 1326 1328 B-Observation
not NCT03865602 1329 1332 I-Observation
resuscitate NCT03865602 1333 1344 I-Observation
, NCT03865602 1345 1346 O
do NCT03865602 1347 1349 B-Observation
not NCT03865602 1350 1353 I-Observation
intubate NCT03865602 1354 1362 I-Observation
) NCT03865602 1363 1364 O
within NCT03865602 1365 1371 B-Eq_Comparison
24 NCT03865602 1372 1374 I-Eq_Comparison
hours NCT03865602 1375 1380 I-Eq_Comparison
after NCT03865602 1381 1386 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03865602 1387 1396 B-Encounter
due NCT03865602 1397 1400 O
to NCT03865602 1401 1403 O
the NCT03865602 1404 1407 O
general NCT03865602 1408 1415 O
assumption NCT03865602 1416 1426 O
of NCT03865602 1427 1429 O
increased NCT03865602 1430 1439 O
risk NCT03865602 1440 1444 O
of NCT03865602 1445 1447 O
exposure NCT03865602 1448 1456 O
to NCT03865602 1457 1459 O
less NCT03865602 1460 1464 O
aggressive NCT03865602 1465 1475 O
treatment NCT03865602 1476 1485 O
; NCT03865602 1485 1486 O

6 NCT03865602 1489 1490 O
. NCT03865602 1490 1491 O
patients NCT03865602 1493 1501 O
with NCT03865602 1502 1506 O
infection NCT03865602 1507 1516 B-Condition
ruled NCT03865602 1517 1522 B-Negation
out NCT03865602 1523 1526 I-Negation
during NCT03865602 1527 1533 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865602 1534 1537 O
index NCT03865602 1538 1543 O
hospitalization NCT03865602 1544 1559 B-Encounter
. NCT03865602 1560 1561 O


Inclusion NCT03924687 0 9 O
Criteria NCT03924687 10 18 O
: NCT03924687 19 20 O

- NCT03924687 24 25 O
being NCT03924687 27 32 O
18 NCT03924687 33 35 B-Eq_Comparison
years NCT03924687 36 41 I-Eq_Comparison
of NCT03924687 42 44 I-Eq_Comparison
age NCT03924687 45 48 I-Eq_Comparison
or NCT03924687 49 51 I-Eq_Comparison
older NCT03924687 52 57 I-Eq_Comparison

- NCT03924687 60 61 O
having NCT03924687 63 69 O
suffered NCT03924687 70 78 O
from NCT03924687 79 83 O
daily NCT03924687 84 89 B-Eq_Comparison
pain NCT03924687 90 94 B-Condition
for NCT03924687 95 98 O
more NCT03924687 99 103 B-Eq_Comparison
than NCT03924687 104 108 I-Eq_Comparison
three NCT03924687 109 114 I-Eq_Comparison
months NCT03924687 115 121 I-Eq_Comparison

- NCT03924687 124 125 O
having NCT03924687 127 133 O
reading NCT03924687 134 141 O
and NCT03924687 142 145 O
writing NCT03924687 146 153 O
abilities NCT03924687 154 163 O
in NCT03924687 164 166 O
French NCT03924687 167 173 O
equivalent NCT03924687 174 184 O
or NCT03924687 185 187 O
superior NCT03924687 188 196 O
to NCT03924687 197 199 O
grade NCT03924687 200 205 O
8 NCT03924687 206 207 O

- NCT03924687 211 212 O
having NCT03924687 214 220 O
access NCT03924687 221 227 O
to NCT03924687 228 230 O
Internet NCT03924687 231 239 O
at NCT03924687 240 242 O
home NCT03924687 243 247 O
and NCT03924687 248 251 O
having NCT03924687 252 258 O
a NCT03924687 259 260 O
valid NCT03924687 261 266 O
e NCT03924687 267 268 O
- NCT03924687 269 270 O
mail NCT03924687 271 275 O
address NCT03924687 276 283 O

- NCT03924687 286 287 O
not NCT03924687 289 292 B-Negation
having NCT03924687 293 299 O
previously NCT03924687 300 310 B-Eq_Comparison
completed NCT03924687 311 320 O
an NCT03924687 321 323 O
ACT NCT03924687 324 327 B-Procedure
- NCT03924687 328 329 I-Procedure
type NCT03924687 330 334 I-Procedure
psychotherapy NCT03924687 335 348 I-Procedure
, NCT03924687 349 350 O
not NCT03924687 351 354 B-Negation
having NCT03924687 355 361 O
practiced NCT03924687 362 371 B-Observation
mindfulness NCT03924687 372 383 I-Observation
meditation NCT03924687 384 394 I-Observation
regularly NCT03924687 395 404 O
and NCT03924687 405 408 B-And
not NCT03924687 409 412 B-Negation
having NCT03924687 413 419 O
read NCT03924687 420 424 O
a NCT03924687 425 426 O
bibliotherapy NCT03924687 427 440 B-Procedure
on NCT03924687 441 443 I-Procedure
ACT NCT03924687 444 447 I-Procedure
for NCT03924687 448 451 O
pain NCT03924687 452 456 B-Condition

- NCT03924687 459 460 O
having NCT03924687 462 468 O
stable NCT03924687 469 475 O
medication NCT03924687 476 486 B-Drug
for NCT03924687 487 490 O
at NCT03924687 491 493 B-Eq_Comparison
least NCT03924687 494 499 I-Eq_Comparison
one NCT03924687 500 503 I-Eq_Comparison
month NCT03924687 504 509 I-Eq_Comparison
, NCT03924687 510 511 O
if NCT03924687 512 514 O
applicable NCT03924687 515 525 O
. NCT03924687 526 527 O

Exclusion NCT03924687 529 538 O
Criteria NCT03924687 539 547 O
: NCT03924687 548 549 O

- NCT03924687 552 553 O

Inclusion NCT03925298 0 9 O
Criteria NCT03925298 10 18 O
: NCT03925298 19 20 O

- NCT03925298 24 25 O
Participants NCT03925298 27 39 O
were NCT03925298 40 44 O
eligible NCT03925298 45 53 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03925298 54 57 I-Assertion___Assertion_Type_Value:hypothetical
inclusion NCT03925298 58 67 O
in NCT03925298 68 70 O
the NCT03925298 71 74 O
study NCT03925298 75 80 B-Study
if NCT03925298 81 83 O
they NCT03925298 84 88 O
had NCT03925298 89 92 O
evidence NCT03925298 93 101 O
suggesting NCT03925298 102 112 B-Assertion___Assertion_Type_Value:possible
acute NCT03925298 113 118 O
ischemic NCT03925298 119 127 B-Condition
stroke NCT03925298 128 134 I-Condition
that NCT03925298 135 139 O
lasted NCT03925298 140 146 O
for NCT03925298 147 150 O
≤ NCT03925298 151 152 B-Eq_Comparison
4.5 NCT03925298 153 156 I-Eq_Comparison
hours NCT03925298 157 162 I-Eq_Comparison
. NCT03925298 163 164 O

- NCT03925298 168 169 O
Those NCT03925298 171 176 O
Participants NCT03925298 177 189 O
were NCT03925298 190 194 O
treated NCT03925298 195 202 B-Procedure
with NCT03925298 203 207 O
intravenous NCT03925298 208 219 B-Modifier
thrombolytic NCT03925298 220 232 B-Procedure
therapy NCT03925298 233 240 I-Procedure
( NCT03925298 241 242 O
( NCT03925298 243 244 O
recombinant NCT03925298 245 256 B-Drug
tissue NCT03925298 257 263 I-Drug
plasminogen NCT03925298 264 275 I-Drug
activator NCT03925298 276 285 I-Drug
( NCT03925298 286 287 O
rt NCT03925298 288 290 B-Drug
- NCT03925298 291 292 I-Drug
PA NCT03925298 293 295 I-Drug
) NCT03925298 296 297 O
) NCT03925298 298 299 O
. NCT03925298 300 301 O

Exclusion NCT03925298 303 312 O
Criteria NCT03925298 313 321 O
: NCT03925298 322 323 O

- NCT03925298 327 328 O
Those NCT03925298 330 335 O
who NCT03925298 336 339 O
had NCT03925298 340 343 B-Eq_Comparison
hemorrhagic NCT03925298 344 355 B-Condition
stroke NCT03925298 356 362 I-Condition

- NCT03925298 365 366 O
participants NCT03925298 368 380 O
presented NCT03925298 381 390 O
with NCT03925298 391 395 O
acute NCT03925298 396 401 B-Condition
myocardial NCT03925298 402 412 I-Condition
infarction NCT03925298 413 423 I-Condition
, NCT03925298 424 425 O
cerebrovascular NCT03925298 426 441 B-Condition
stroke NCT03925298 442 448 I-Condition
in NCT03925298 449 451 O
the NCT03925298 452 455 O
previous NCT03925298 456 464 B-Eq_Comparison
three NCT03925298 465 470 I-Eq_Comparison
months NCT03925298 471 477 I-Eq_Comparison
. NCT03925298 478 479 O

- NCT03925298 483 484 O
serious NCT03925298 486 493 O
head NCT03925298 494 498 B-Modifier
trauma NCT03925298 499 505 B-Condition
in NCT03925298 506 508 O
the NCT03925298 509 512 O
previous NCT03925298 513 521 B-Eq_Comparison
three NCT03925298 522 527 I-Eq_Comparison
months NCT03925298 528 534 I-Eq_Comparison
. NCT03925298 535 536 O

- NCT03925298 540 541 O
urinary NCT03925298 543 550 B-Modifier
tract NCT03925298 551 556 I-Modifier
, NCT03925298 557 558 O
lung NCT03925298 559 563 B-Modifier
, NCT03925298 564 565 O
or NCT03925298 566 568 B-Or
gastrointestinal NCT03925298 569 585 B-Modifier
hemorrhage NCT03925298 586 596 B-Condition
within NCT03925298 597 603 B-Eq_Comparison
the NCT03925298 604 607 I-Eq_Comparison
three NCT03925298 608 613 I-Eq_Comparison
weeks NCT03925298 614 619 I-Eq_Comparison
. NCT03925298 620 621 O

- NCT03925298 625 626 O
serious NCT03925298 628 635 O
trauma NCT03925298 636 642 B-Condition
or NCT03925298 643 645 B-Or
major NCT03925298 646 651 B-Modifier
surgery NCT03925298 652 659 B-Procedure
within NCT03925298 660 666 B-Eq_Comparison
the NCT03925298 667 670 I-Eq_Comparison
previous NCT03925298 671 679 I-Eq_Comparison
two NCT03925298 680 683 I-Eq_Comparison
weeks NCT03925298 684 689 I-Eq_Comparison
. NCT03925298 690 691 O

- NCT03925298 695 696 O
lumbar NCT03925298 698 704 B-Modifier
or NCT03925298 705 707 B-Or
arterial NCT03925298 708 716 B-Modifier
puncture NCT03925298 717 725 B-Condition
at NCT03925298 726 728 O
a NCT03925298 729 730 O
non NCT03925298 731 734 B-Modifier
- NCT03925298 735 736 I-Modifier
compressible NCT03925298 737 749 I-Modifier
site NCT03925298 750 754 I-Modifier
within NCT03925298 755 761 B-Eq_Comparison
one NCT03925298 762 765 I-Eq_Comparison
week NCT03925298 766 770 I-Eq_Comparison
. NCT03925298 771 772 O

- NCT03925298 776 777 O
those NCT03925298 779 784 O
received NCT03925298 785 793 B-Eq_Comparison
heparin NCT03925298 794 801 B-Drug
within NCT03925298 802 808 B-Eq_Comparison
48 NCT03925298 809 811 I-Eq_Comparison
hours NCT03925298 812 817 I-Eq_Comparison
, NCT03925298 818 819 O
resulting NCT03925298 820 829 O
in NCT03925298 830 832 O
an NCT03925298 833 835 O
activated NCT03925298 836 845 B-Observation
partial NCT03925298 846 853 I-Observation
thromboplastin NCT03925298 854 868 I-Observation
time NCT03925298 869 873 I-Observation
greater NCT03925298 874 881 B-Eq_Comparison
than NCT03925298 882 886 I-Eq_Comparison
the NCT03925298 887 890 I-Eq_Comparison
upper NCT03925298 891 896 I-Eq_Comparison
limit NCT03925298 897 902 I-Eq_Comparison
of NCT03925298 903 905 I-Eq_Comparison
normal NCT03925298 906 912 I-Eq_Comparison
. NCT03925298 913 914 O

- NCT03925298 918 919 O
systolic NCT03925298 921 929 B-Observation
pressure NCT03925298 930 938 I-Observation
> NCT03925298 939 940 B-Eq_Comparison
185 NCT03925298 941 944 I-Eq_Comparison
mmHg NCT03925298 945 949 I-Eq_Comparison
or NCT03925298 950 952 B-Or
diastolic NCT03925298 953 962 B-Observation
pressure NCT03925298 963 971 I-Observation
> NCT03925298 972 973 B-Eq_Comparison
110 NCT03925298 974 977 I-Eq_Comparison
mmHg NCT03925298 978 982 I-Eq_Comparison
. NCT03925298 983 984 O

- NCT03925298 988 989 O
blood NCT03925298 991 996 B-Observation
glucose NCT03925298 997 1004 I-Observation
< NCT03925298 1005 1006 B-Eq_Comparison
50 NCT03925298 1007 1009 I-Eq_Comparison
or NCT03925298 1010 1012 B-Or
> NCT03925298 1013 1014 B-Eq_Comparison
400 NCT03925298 1015 1018 I-Eq_Comparison
mg NCT03925298 1019 1021 I-Eq_Comparison
/ NCT03925298 1022 1023 I-Eq_Comparison
dL NCT03925298 1024 1026 I-Eq_Comparison
. NCT03925298 1027 1028 O

- NCT03925298 1032 1033 O
current NCT03925298 1035 1042 B-Eq_Comparison
use NCT03925298 1043 1046 I-Eq_Comparison
of NCT03925298 1047 1049 O
anticoagulants NCT03925298 1050 1064 B-Drug
with NCT03925298 1065 1069 B-And
an NCT03925298 1070 1072 O
International NCT03925298 1073 1086 B-Observation
Normalized NCT03925298 1087 1097 I-Observation
Ratio NCT03925298 1098 1103 I-Observation
> NCT03925298 1104 1105 B-Eq_Comparison
1.7 NCT03925298 1106 1109 I-Eq_Comparison
or NCT03925298 1110 1112 B-Or
prothrombin NCT03925298 1113 1124 B-Observation
time NCT03925298 1125 1129 I-Observation
> NCT03925298 1130 1131 B-Eq_Comparison
15 NCT03925298 1132 1134 I-Eq_Comparison
sec NCT03925298 1135 1138 I-Eq_Comparison
; NCT03925298 1138 1139 O
platelet NCT03925298 1140 1148 B-Observation
count NCT03925298 1149 1154 I-Observation
< NCT03925298 1155 1156 B-Eq_Comparison
100 NCT03925298 1157 1160 I-Eq_Comparison
, NCT03925298 1161 1162 I-Eq_Comparison
000 NCT03925298 1163 1166 I-Eq_Comparison
/ NCT03925298 1167 1168 I-Eq_Comparison
mm NCT03925298 1169 1171 I-Eq_Comparison
3 NCT03925298 1172 1173 I-Eq_Comparison
. NCT03925298 1173 1174 O

- NCT03925298 1178 1179 O
pregnancy NCT03925298 1181 1190 B-Condition
; NCT03925298 1190 1191 O
serious NCT03925298 1192 1199 O
heart NCT03925298 1200 1205 B-Modifier
, NCT03925298 1206 1207 O
lung NCT03925298 1208 1212 B-Modifier
, NCT03925298 1213 1214 O
kidney NCT03925298 1215 1221 B-Modifier
or NCT03925298 1222 1224 B-Or
other NCT03925298 1225 1230 B-Other
organ NCT03925298 1231 1236 B-Modifier
dysfunction NCT03925298 1237 1248 B-Condition
. NCT03925298 1249 1250 O

- NCT03925298 1254 1255 O
allergy NCT03925298 1257 1264 B-Allergy
to NCT03925298 1265 1267 O
active NCT03925298 1268 1274 O
ingredients NCT03925298 1275 1286 O
of NCT03925298 1287 1289 O
rt NCT03925298 1290 1292 B-Drug
- NCT03925298 1293 1294 I-Drug
PA NCT03925298 1295 1297 I-Drug
; NCT03925298 1297 1298 O
patients NCT03925298 1299 1307 O
with NCT03925298 1308 1312 O
> NCT03925298 1313 1314 B-Eq_Comparison
4.5 NCT03925298 1315 1318 I-Eq_Comparison
hours NCT03925298 1319 1324 I-Eq_Comparison
from NCT03925298 1325 1329 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03925298 1330 1333 O
last NCT03925298 1334 1338 B-Eq_Comparison
time NCT03925298 1339 1343 I-Eq_Comparison
known NCT03925298 1344 1349 O
to NCT03925298 1350 1352 O
be NCT03925298 1353 1355 O
asymptomatic NCT03925298 1356 1368 B-Condition
. NCT03925298 1369 1370 O

- NCT03925298 1374 1375 O
those NCT03925298 1377 1382 O
in NCT03925298 1383 1385 O
whom NCT03925298 1386 1390 O
troponin NCT03925298 1391 1399 B-Observation
was NCT03925298 1400 1403 O
not NCT03925298 1404 1407 B-Negation
measured NCT03925298 1408 1416 O
at NCT03925298 1417 1419 B-Temporal_Connection___Temporal_Connection_Type_Value:during
admission NCT03925298 1420 1429 B-Encounter
were NCT03925298 1430 1434 O
excluded NCT03925298 1435 1443 B-Negation
from NCT03925298 1444 1448 O
the NCT03925298 1449 1452 O
study NCT03925298 1453 1458 B-Study

Inclusion NCT03869905 0 9 O
Criteria NCT03869905 10 18 O
: NCT03869905 19 20 O

- NCT03869905 24 25 O
Ulcerative NCT03869905 27 37 B-Condition
colitis NCT03869905 38 45 I-Condition
with NCT03869905 46 50 O
confirmed NCT03869905 51 60 O
diagnosis NCT03869905 61 70 O
by NCT03869905 71 73 O
histology NCT03869905 74 83 B-Procedure
and NCT03869905 84 87 B-Or
endoscopy NCT03869905 88 97 B-Procedure
AND NCT03869905 98 101 B-And
in NCT03869905 102 104 O
stable NCT03869905 105 111 O
remission NCT03869905 112 121 B-Condition
for NCT03869905 122 125 O
3 NCT03869905 126 127 B-Eq_Comparison
months NCT03869905 128 134 I-Eq_Comparison
or NCT03869905 135 137 I-Eq_Comparison
more NCT03869905 138 142 I-Eq_Comparison
without NCT03869905 143 150 B-Negation
therapy NCT03869905 151 158 B-Procedure
or NCT03869905 159 161 B-Or
with NCT03869905 162 166 B-And
a NCT03869905 167 168 O
maintenance NCT03869905 169 180 B-Procedure
therapy NCT03869905 181 188 I-Procedure
( NCT03869905 189 190 O
except NCT03869905 191 197 B-Exception
steroids NCT03869905 198 206 B-Drug
and NCT03869905 207 210 B-Or
antibiotics NCT03869905 211 222 B-Drug
for NCT03869905 223 226 O
3 NCT03869905 227 228 B-Eq_Comparison
months NCT03869905 229 235 I-Eq_Comparison
) NCT03869905 236 237 O

- NCT03869905 241 242 O
A NCT03869905 244 245 O
negative NCT03869905 246 254 O
pregnancy NCT03869905 255 264 B-Observation
test NCT03869905 265 269 I-Observation

Exclusion NCT03869905 270 279 O
Criteria NCT03869905 280 288 O
: NCT03869905 289 290 O

- NCT03869905 294 295 O
No NCT03869905 297 299 B-Negation
history NCT03869905 300 307 B-Eq_Comparison
or NCT03869905 308 310 O
diagnosis NCT03869905 311 320 O
of NCT03869905 321 323 O
any NCT03869905 324 327 O
of NCT03869905 328 330 O
the NCT03869905 331 334 O
following NCT03869905 335 344 O
conditions NCT03869905 345 355 B-Condition
: NCT03869905 356 357 O
Chron NCT03869905 358 363 B-Condition
's NCT03869905 363 365 I-Condition
disease NCT03869905 366 373 I-Condition
, NCT03869905 374 375 O
bleeding NCT03869905 376 384 B-Condition
disorders NCT03869905 385 394 I-Condition
, NCT03869905 395 396 O
gastrointestinal NCT03869905 397 413 B-Modifier
or NCT03869905 414 416 B-Or
colonic NCT03869905 417 424 B-Modifier
malignancy NCT03869905 425 435 B-Condition
, NCT03869905 436 437 O
Kidney NCT03869905 438 444 B-Condition
disease NCT03869905 445 452 I-Condition
, NCT03869905 453 454 O
including NCT03869905 455 464 O
kidney NCT03869905 465 471 B-Condition
" NCT03869905 472 473 I-Condition
stones NCT03869905 473 479 I-Condition
" NCT03869905 479 480 I-Condition
or NCT03869905 481 483 B-Or
hypercalcemia NCT03869905 484 497 B-Condition
, NCT03869905 498 499 O
Coagulopathy NCT03869905 500 512 B-Condition
/ NCT03869905 513 514 B-Or
hereditary NCT03869905 515 525 B-Modifier
hemorrhagic NCT03869905 526 537 B-Condition
disorders NCT03869905 538 547 I-Condition
/ NCT03869905 548 549 O
or NCT03869905 550 552 B-Or
receiving NCT03869905 553 562 B-Eq_Comparison
therapeutic NCT03869905 563 574 B-Procedure
doses NCT03869905 575 580 O
of NCT03869905 581 583 O
Coumadin NCT03869905 584 592 B-Drug
or NCT03869905 593 595 B-Or
heparin NCT03869905 596 603 B-Drug
. NCT03869905 604 605 O

- NCT03869905 609 610 O
Ingested NCT03869905 612 620 B-Eq_Comparison
certain NCT03869905 621 628 O
medications NCT03869905 629 640 B-Drug
( NCT03869905 641 642 O
Calcium NCT03869905 643 650 B-Drug
, NCT03869905 651 652 O
Vitamin NCT03869905 653 660 B-Drug
D NCT03869905 661 662 I-Drug
, NCT03869905 663 664 O
fiber NCT03869905 665 670 B-Drug
supplements NCT03869905 671 682 I-Drug
and NCT03869905 683 686 B-Or
Non NCT03869905 687 690 B-Drug
- NCT03869905 691 692 I-Drug
steroidal NCT03869905 693 702 I-Drug
anti NCT03869905 703 707 I-Drug
- NCT03869905 708 709 I-Drug
inflammatory NCT03869905 710 722 I-Drug
drugs NCT03869905 723 728 I-Drug
- NCT03869905 729 730 O
NSAIDs NCT03869905 731 737 B-Drug
) NCT03869905 738 739 O
within NCT03869905 740 746 B-Eq_Comparison
30 NCT03869905 747 749 I-Eq_Comparison
days NCT03869905 750 754 I-Eq_Comparison
of NCT03869905 755 757 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03869905 758 763 B-Study
start NCT03869905 764 769 B-Eq_Comparison
. NCT03869905 770 771 O

Inclusion NCT03868592 0 9 O
Criteria NCT03868592 10 18 O
: NCT03868592 19 20 O

- NCT03868592 24 25 O
BMI NCT03868592 27 30 B-Observation
40 NCT03868592 31 33 B-Eq_Comparison
- NCT03868592 34 35 I-Eq_Comparison
50 NCT03868592 36 38 I-Eq_Comparison
kg NCT03868592 39 41 I-Eq_Comparison
/ NCT03868592 42 43 I-Eq_Comparison
m NCT03868592 44 45 I-Eq_Comparison
2 NCT03868592 46 47 I-Eq_Comparison
. NCT03868592 47 48 O

- NCT03868592 52 53 O
Mo NCT03868592 55 57 O
active NCT03868592 58 64 B-Eq_Comparison
physical NCT03868592 65 73 B-Condition
illness NCT03868592 74 81 I-Condition
that NCT03868592 82 86 O
would NCT03868592 87 92 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03868592 93 102 O
with NCT03868592 103 107 O
mobility NCT03868592 108 116 B-Condition
or NCT03868592 117 119 B-Or
weight NCT03868592 120 126 B-Condition
loss NCT03868592 127 131 I-Condition
after NCT03868592 132 137 B-Temporal_Connection___Temporal_Connection_Type_Value:after
bariatric NCT03868592 138 147 B-Procedure
surgery NCT03868592 148 155 I-Procedure

Exclusion NCT03868592 156 165 O
Criteria NCT03868592 166 174 O
: NCT03868592 175 176 O

- NCT03868592 180 181 O
Type NCT03868592 183 187 B-Modifier
1 NCT03868592 188 189 I-Modifier
or NCT03868592 190 192 B-Or
Type NCT03868592 193 197 B-Modifier
2 NCT03868592 198 199 I-Modifier
Diabetes NCT03868592 200 208 B-Condition
diagnosis NCT03868592 209 218 O
or NCT03868592 219 221 B-Or
fasting NCT03868592 222 229 B-Modifier
plasma NCT03868592 230 236 B-Observation
glucose NCT03868592 237 244 I-Observation
≥ NCT03868592 245 246 B-Eq_Comparison
126 NCT03868592 247 250 I-Eq_Comparison
mg NCT03868592 251 253 I-Eq_Comparison
/ NCT03868592 254 255 I-Eq_Comparison
dL NCT03868592 256 258 I-Eq_Comparison

- NCT03868592 261 262 O
Active NCT03868592 264 270 B-Eq_Comparison
coronary NCT03868592 271 279 B-Condition
artery NCT03868592 280 286 I-Condition
disease NCT03868592 287 294 I-Condition

- NCT03868592 297 298 O
Participation NCT03868592 300 313 O
in NCT03868592 314 316 O
structured NCT03868592 317 327 B-Observation
exercise NCT03868592 328 336 I-Observation
( NCT03868592 337 338 O
> NCT03868592 339 340 B-Eq_Comparison
2 NCT03868592 341 342 I-Eq_Comparison
times NCT03868592 343 348 I-Eq_Comparison
per NCT03868592 349 352 I-Eq_Comparison
week NCT03868592 353 357 I-Eq_Comparison
for NCT03868592 358 361 O
30 NCT03868592 362 364 B-Eq_Comparison
minutes NCT03868592 365 372 I-Eq_Comparison
or NCT03868592 373 375 I-Eq_Comparison
longer NCT03868592 376 382 I-Eq_Comparison
) NCT03868592 383 384 O

- NCT03868592 388 389 O
Smoking NCT03868592 391 398 B-Condition

- NCT03868592 401 402 O
Medications NCT03868592 404 415 B-Drug
known NCT03868592 416 421 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868592 422 424 I-Assertion___Assertion_Type_Value:hypothetical
affect NCT03868592 425 431 O
adipose NCT03868592 432 439 B-Condition
tissue NCT03868592 440 446 I-Condition
metabolism NCT03868592 447 457 I-Condition
( NCT03868592 458 459 O
e NCT03868592 460 461 O
. NCT03868592 462 463 O
g NCT03868592 464 465 O
. NCT03868592 466 467 O
, NCT03868592 468 469 O
beta NCT03868592 470 474 B-Drug
blockers NCT03868592 475 483 I-Drug
, NCT03868592 484 485 O
corticosteroids NCT03868592 486 501 B-Drug
) NCT03868592 502 503 O

- NCT03868592 507 508 O
Renal NCT03868592 510 515 B-Condition
insufficiency NCT03868592 516 529 I-Condition
( NCT03868592 530 531 O
serum NCT03868592 532 537 B-Observation
creatinine NCT03868592 538 548 I-Observation
> NCT03868592 549 550 B-Eq_Comparison
1.5 NCT03868592 551 554 I-Eq_Comparison
mg NCT03868592 555 557 I-Eq_Comparison
/ NCT03868592 558 559 I-Eq_Comparison
dl NCT03868592 560 562 I-Eq_Comparison
) NCT03868592 563 564 O

- NCT03868592 568 569 O
Chronic NCT03868592 571 578 O
active NCT03868592 579 585 B-Eq_Comparison
liver NCT03868592 586 591 B-Condition
disease NCT03868592 592 599 I-Condition
( NCT03868592 600 601 O
Bilirubin NCT03868592 602 611 B-Observation
> NCT03868592 612 613 B-Eq_Comparison
17 NCT03868592 614 616 I-Eq_Comparison
mmol NCT03868592 617 621 I-Eq_Comparison
/ NCT03868592 622 623 I-Eq_Comparison
L NCT03868592 624 625 I-Eq_Comparison
, NCT03868592 626 627 O
AST NCT03868592 628 631 B-Observation
> NCT03868592 632 633 B-Eq_Comparison
144 NCT03868592 634 637 I-Eq_Comparison
IU NCT03868592 638 640 I-Eq_Comparison
/ NCT03868592 641 642 I-Eq_Comparison
L NCT03868592 643 644 I-Eq_Comparison
, NCT03868592 645 646 O
or NCT03868592 647 649 B-Or
ALT NCT03868592 650 653 B-Observation
> NCT03868592 654 655 B-Eq_Comparison
165 NCT03868592 656 659 I-Eq_Comparison
IU NCT03868592 660 662 I-Eq_Comparison
/ NCT03868592 663 664 I-Eq_Comparison
L NCT03868592 665 666 I-Eq_Comparison
) NCT03868592 667 668 O

- NCT03868592 672 673 O
Pregnancy NCT03868592 675 684 B-Condition
or NCT03868592 685 687 B-Or
breastfeeding NCT03868592 688 701 B-Condition
. NCT03868592 702 703 O

Inclusion NCT03925038 0 9 O
Criteria NCT03925038 10 18 O
: NCT03925038 19 20 O

- NCT03925038 24 25 O
Patients NCT03925038 27 35 O
ages NCT03925038 36 40 B-Age
12 NCT03925038 41 43 B-Eq_Comparison
- NCT03925038 44 45 I-Eq_Comparison
100 NCT03925038 46 49 I-Eq_Comparison
years NCT03925038 50 55 I-Eq_Comparison

- NCT03925038 58 59 O
With NCT03925038 61 65 O
any NCT03925038 66 69 O
diagnosis NCT03925038 70 79 O
of NCT03925038 80 82 O
a NCT03925038 83 84 O
mood NCT03925038 85 89 B-Modifier
or NCT03925038 90 92 B-Or
anxiety NCT03925038 93 100 B-Modifier
disorder NCT03925038 101 109 B-Condition

- NCT03925038 112 113 O
Already NCT03925038 115 122 O
established NCT03925038 123 134 O
and NCT03925038 135 138 O
receiving NCT03925038 139 148 B-Eq_Comparison
care NCT03925038 149 153 B-Encounter
in NCT03925038 154 156 O
community NCT03925038 157 166 O
psychiatry NCT03925038 167 177 B-Provider
at NCT03925038 178 180 O
the NCT03925038 181 184 O
Johns NCT03925038 185 190 O
Hopkins NCT03925038 191 198 O
Bayview NCT03925038 199 206 O
Medical NCT03925038 207 214 O
Center NCT03925038 215 221 O
or NCT03925038 222 224 B-Or
at NCT03925038 225 227 O
Johns NCT03925038 228 233 O
Hopkins NCT03925038 234 241 O
Hospital NCT03925038 242 250 O
. NCT03925038 251 252 O

Exclusion NCT03925038 254 263 O
Criteria NCT03925038 264 272 O
: NCT03925038 273 274 O

- NCT03925038 278 279 O
Non NCT03925038 281 284 B-Negation
- NCT03925038 285 286 O
English NCT03925038 287 294 O
speaking NCT03925038 295 303 O

Inclusion NCT03865030 0 9 O
Criteria NCT03865030 10 18 O
: NCT03865030 19 20 O

- NCT03865030 24 25 O
Psoriatic NCT03865030 27 36 B-Condition
patients NCT03865030 37 45 O
that NCT03865030 46 50 O
are NCT03865030 51 54 O
treated NCT03865030 55 62 B-Procedure
in NCT03865030 63 65 O
our NCT03865030 66 69 O
institute NCT03865030 70 79 O
. NCT03865030 80 81 O

Exclusion NCT03865030 83 92 O
Criteria NCT03865030 93 101 O
: NCT03865030 102 103 O

- NCT03865030 107 108 O
Patients NCT03865030 110 118 O
suffering NCT03865030 119 128 O
from NCT03865030 129 133 O
cardiovascular NCT03865030 134 148 B-Condition
diseases NCT03865030 149 157 I-Condition
( NCT03865030 158 159 O
peripheral NCT03865030 160 170 B-Condition
vascular NCT03865030 171 179 I-Condition
disease NCT03865030 180 187 I-Condition
, NCT03865030 188 189 O
congestive NCT03865030 190 200 B-Condition
heart NCT03865030 201 206 I-Condition
failure NCT03865030 207 214 I-Condition
, NCT03865030 215 216 O
status NCT03865030 217 223 O
post NCT03865030 224 228 B-Temporal_Connection___Temporal_Connection_Type_Value:after
cerebrovascular NCT03865030 229 244 B-Condition
accident NCT03865030 245 253 I-Condition
) NCT03865030 254 255 O
. NCT03865030 256 257 O

- NCT03865030 261 262 O
Conditions NCT03865030 264 274 B-Condition
that NCT03865030 275 279 O
are NCT03865030 280 283 O
harmful NCT03865030 284 291 B-Condition
to NCT03865030 292 294 I-Condition
the NCT03865030 295 298 I-Condition
inner NCT03865030 299 304 I-Condition
ear NCT03865030 305 308 I-Condition
( NCT03865030 309 310 O
chronic NCT03865030 311 318 O
renal NCT03865030 319 324 B-Condition
failure NCT03865030 325 332 I-Condition
, NCT03865030 333 334 O
history NCT03865030 335 342 B-Eq_Comparison
of NCT03865030 343 345 O
noise NCT03865030 346 351 B-Condition
exposure NCT03865030 352 360 I-Condition
, NCT03865030 361 362 O
usage NCT03865030 363 368 O
of NCT03865030 369 371 O
ototoxic NCT03865030 372 380 B-Drug
drugs NCT03865030 381 386 I-Drug
, NCT03865030 387 388 O
chronic NCT03865030 389 396 O
otitis NCT03865030 397 403 B-Condition
media NCT03865030 404 409 I-Condition
, NCT03865030 410 411 O
ear NCT03865030 412 415 B-Procedure
surgery NCT03865030 416 423 I-Procedure
in NCT03865030 424 426 O
the NCT03865030 427 430 O
past NCT03865030 431 435 B-Eq_Comparison
, NCT03865030 436 437 O
significant NCT03865030 438 449 O
head NCT03865030 450 454 B-Modifier
trauma NCT03865030 455 461 B-Condition
in NCT03865030 462 464 O
the NCT03865030 465 468 O
past NCT03865030 469 473 B-Eq_Comparison
, NCT03865030 474 475 O
ear NCT03865030 476 479 B-Condition
drum NCT03865030 480 484 I-Condition
perforation NCT03865030 485 496 I-Condition
) NCT03865030 497 498 O
. NCT03865030 499 500 O

- NCT03865030 504 505 O
participant NCT03865030 507 518 O
that NCT03865030 519 523 O
complains NCT03865030 524 533 O
of NCT03865030 534 536 O
vertigo NCT03865030 537 544 B-Condition
/ NCT03865030 545 546 B-Or
dizziness NCT03865030 547 556 B-Condition
/ NCT03865030 557 558 B-Or
unsteadiness NCT03865030 559 571 B-Condition
. NCT03865030 572 573 O

- NCT03865030 577 578 O
Participant NCT03865030 580 591 O
who NCT03865030 592 595 O
is NCT03865030 596 598 O
/ NCT03865030 599 600 O
was NCT03865030 601 604 O
suffering NCT03865030 605 614 O
from NCT03865030 615 619 O
known NCT03865030 620 625 O
inner NCT03865030 626 631 B-Condition
ear NCT03865030 632 635 I-Condition
disease NCT03865030 636 643 I-Condition
: NCT03865030 644 645 O
meniere NCT03865030 646 653 B-Condition
disease NCT03865030 654 661 I-Condition
, NCT03865030 662 663 O
acoustic NCT03865030 664 672 B-Condition
neurinoma NCT03865030 673 682 I-Condition
, NCT03865030 683 684 O
vestibular NCT03865030 685 695 B-Condition
neuronitis NCT03865030 696 706 I-Condition
. NCT03865030 707 708 O

Inclusion NCT03866863 0 9 O
Criteria NCT03866863 10 18 O
: NCT03866863 19 20 O

- NCT03866863 24 25 O
All NCT03866863 27 30 O
birth NCT03866863 31 36 B-Birth
more NCT03866863 37 41 B-Eq_Comparison
than NCT03866863 42 46 I-Eq_Comparison
24 NCT03866863 47 49 I-Eq_Comparison
+ NCT03866863 50 51 I-Eq_Comparison
0 NCT03866863 52 53 I-Eq_Comparison
weeks NCT03866863 54 59 I-Eq_Comparison
of NCT03866863 60 62 B-Temporal_Connection___Temporal_Connection_Type_Value:after
amenorrhea NCT03866863 63 73 B-Condition
at NCT03866863 74 76 O
the NCT03866863 77 80 O
maternity NCT03866863 81 90 O
ward NCT03866863 91 95 O
of NCT03866863 96 98 O
the NCT03866863 99 102 O
hospital NCT03866863 103 111 O
Femme NCT03866863 112 117 O
- NCT03866863 118 119 O
Mère NCT03866863 120 124 O
- NCT03866863 125 126 O
Enfant NCT03866863 127 133 O

- NCT03866863 136 137 O
from NCT03866863 139 143 O
1 NCT03866863 144 145 B-Eq_Comparison
st NCT03866863 146 148 I-Eq_Comparison
of NCT03866863 149 151 I-Eq_Comparison
january NCT03866863 152 159 I-Eq_Comparison
2011 NCT03866863 160 164 I-Eq_Comparison
to NCT03866863 165 167 I-Eq_Comparison
31 NCT03866863 168 170 I-Eq_Comparison
december NCT03866863 171 179 I-Eq_Comparison
2017 NCT03866863 180 184 I-Eq_Comparison
. NCT03866863 184 185 O

Exclusion NCT03866863 187 196 O
Criteria NCT03866863 197 205 O
: NCT03866863 206 207 O

- NCT03866863 211 212 O
Infants NCT03866863 214 221 O
born NCT03866863 222 226 B-Birth
out NCT03866863 227 230 B-Negation
of NCT03866863 231 233 I-Negation
the NCT03866863 234 237 O
hospital NCT03866863 238 246 O
and NCT03866863 247 250 B-And
secondarily NCT03866863 251 262 B-Encounter
hospitalized NCT03866863 263 275 I-Encounter
in NCT03866863 276 278 O
the NCT03866863 279 282 O
hospital NCT03866863 283 291 O
Femme NCT03866863 292 297 O
- NCT03866863 298 299 O
Mère NCT03866863 300 304 O
- NCT03866863 305 306 O
Enfant NCT03866863 307 313 O
. NCT03866863 314 315 O

- NCT03866863 319 320 O
Multiple NCT03866863 322 330 B-Eq_Comparison
pregnancies NCT03866863 331 342 B-Condition
, NCT03866863 343 344 O

- NCT03866863 348 349 O
children NCT03866863 351 359 O
with NCT03866863 360 364 B-And
congenital NCT03866863 365 375 B-Condition
fetal NCT03866863 376 381 I-Condition
anomalies NCT03866863 382 391 I-Condition

- NCT03866863 394 395 O
pregnancies NCT03866863 397 408 B-Condition
without NCT03866863 409 416 B-Negation
first NCT03866863 417 422 B-Modifier
trimester NCT03866863 423 432 I-Modifier
ultrasound NCT03866863 433 443 B-Procedure
( NCT03866863 444 445 O
to NCT03866863 446 448 O
date NCT03866863 449 453 O
the NCT03866863 454 457 O
pregnancy NCT03866863 458 467 B-Condition
) NCT03866863 468 469 O

Inclusion NCT03921918 0 9 O
Criteria NCT03921918 10 18 O
: NCT03921918 19 20 O

1 NCT03921918 24 25 O
. NCT03921918 25 26 O
Subject NCT03921918 28 35 O
≥ NCT03921918 36 37 B-Eq_Comparison
18 NCT03921918 38 40 I-Eq_Comparison
years NCT03921918 41 46 I-Eq_Comparison
old NCT03921918 47 50 B-Age

2 NCT03921918 53 54 O
. NCT03921918 54 55 O
Infant NCT03921918 57 63 O
is NCT03921918 64 66 B-And
≥ NCT03921918 67 68 B-Eq_Comparison
1 NCT03921918 69 70 I-Eq_Comparison
and NCT03921918 71 74 B-And
≤ NCT03921918 75 76 B-Eq_Comparison
6 NCT03921918 77 78 I-Eq_Comparison
month NCT03921918 79 84 I-Eq_Comparison
old NCT03921918 85 88 B-Age

3 NCT03921918 91 92 O
. NCT03921918 92 93 O
Subject NCT03921918 95 102 O
and NCT03921918 103 106 O
baby NCT03921918 107 111 B-Family_Member___Family_Member_Type:child
are NCT03921918 112 115 O
healthy NCT03921918 116 123 B-Condition
according NCT03921918 124 133 O
to NCT03921918 134 136 O
self NCT03921918 137 141 O
- NCT03921918 142 143 O
declaration NCT03921918 144 155 O
in NCT03921918 156 158 O
the NCT03921918 159 162 O
" NCT03921918 163 164 O
Mother NCT03921918 164 170 B-Observation
and NCT03921918 171 174 I-Observation
infant NCT03921918 175 181 I-Observation
health NCT03921918 182 188 I-Observation
questionnaire NCT03921918 189 202 I-Observation
" NCT03921918 202 203 O

4 NCT03921918 206 207 O
. NCT03921918 207 208 O
Subject NCT03921918 210 217 O
is NCT03921918 218 220 O
predominantly NCT03921918 221 234 O
breastfeeding NCT03921918 235 248 B-Condition
( NCT03921918 249 250 O
80 NCT03921918 251 253 B-Eq_Comparison
% NCT03921918 254 255 I-Eq_Comparison
of NCT03921918 256 258 I-Eq_Comparison
all NCT03921918 259 262 I-Eq_Comparison
feeds NCT03921918 263 268 I-Eq_Comparison
, NCT03921918 269 270 O
i NCT03921918 271 272 O
. NCT03921918 273 274 O
e NCT03921918 275 276 O
. NCT03921918 277 278 O
≤ NCT03921918 280 281 B-Eq_Comparison
150 NCT03921918 282 285 I-Eq_Comparison
ml NCT03921918 286 288 I-Eq_Comparison
formula NCT03921918 289 296 I-Eq_Comparison
/ NCT03921918 297 298 I-Eq_Comparison
day NCT03921918 299 302 I-Eq_Comparison
or NCT03921918 303 305 O
equal NCT03921918 306 311 O
representative NCT03921918 312 326 O
amount NCT03921918 327 333 O
of NCT03921918 334 336 O
solid NCT03921918 337 342 O
food NCT03921918 343 347 O
) NCT03921918 348 349 O

5 NCT03921918 353 354 O
. NCT03921918 354 355 O
The NCT03921918 357 360 O
subject NCT03921918 361 368 O
agrees NCT03921918 369 375 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921918 376 378 I-Assertion___Assertion_Type_Value:hypothetical
pump NCT03921918 379 383 B-Observation
or NCT03921918 384 386 B-Or
feed NCT03921918 387 391 B-Observation
the NCT03921918 392 395 O
last NCT03921918 396 400 B-Eq_Comparison
time NCT03921918 401 405 I-Eq_Comparison
a NCT03921918 406 407 O
minimum NCT03921918 408 415 B-Eq_Comparison
of NCT03921918 416 418 I-Eq_Comparison
2 NCT03921918 419 420 I-Eq_Comparison
hours NCT03921918 421 426 I-Eq_Comparison
( NCT03921918 427 428 I-Eq_Comparison
hr NCT03921918 429 431 I-Eq_Comparison
) NCT03921918 432 433 I-Eq_Comparison
before NCT03921918 434 440 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03921918 441 444 O
start NCT03921918 445 450 O
of NCT03921918 451 453 O
the NCT03921918 454 457 O
pumping NCT03921918 458 465 O
session NCT03921918 466 473 O
at NCT03921918 474 476 O
the NCT03921918 477 480 O
study NCT03921918 481 486 B-Study
site NCT03921918 487 491 O

6 NCT03921918 494 495 O
. NCT03921918 495 496 O
The NCT03921918 498 501 O
subject NCT03921918 502 509 O
agrees NCT03921918 510 516 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921918 517 519 I-Assertion___Assertion_Type_Value:hypothetical
photographs NCT03921918 520 531 B-Observation
/ NCT03921918 532 533 I-Observation
3 NCT03921918 534 535 I-Observation
D NCT03921918 536 537 I-Observation
scan NCT03921918 538 542 I-Observation
of NCT03921918 543 545 O
the NCT03921918 546 549 O
breast NCT03921918 550 556 B-Modifier
and NCT03921918 557 560 B-Or
upper NCT03921918 561 566 B-Modifier
body NCT03921918 567 571 I-Modifier
( NCT03921918 572 573 O
no NCT03921918 574 576 B-Exception
face NCT03921918 577 581 B-Modifier
) NCT03921918 582 583 O
, NCT03921918 584 585 O

7 NCT03921918 589 590 O
. NCT03921918 590 591 O
The NCT03921918 593 596 O
subject NCT03921918 597 604 O
agrees NCT03921918 605 611 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921918 612 614 I-Assertion___Assertion_Type_Value:hypothetical
a NCT03921918 615 616 O
video NCT03921918 617 622 B-Observation
while NCT03921918 623 628 B-Temporal_Connection___Temporal_Connection_Type_Value:during
pumping NCT03921918 629 636 B-Observation

8 NCT03921918 639 640 O
. NCT03921918 640 641 O
The NCT03921918 643 646 O
subject NCT03921918 647 654 O
signs NCT03921918 655 660 O
the NCT03921918 661 664 O
informed NCT03921918 665 673 O
consent NCT03921918 674 681 O
documentation NCT03921918 682 695 O

9 NCT03921918 698 699 O
. NCT03921918 699 700 O
Subject NCT03921918 702 709 O
agrees NCT03921918 710 716 B-Assertion___Assertion_Type_Value:hypothetical
that NCT03921918 717 721 I-Assertion___Assertion_Type_Value:hypothetical
a NCT03921918 722 723 O
maximum NCT03921918 724 731 B-Eq_Comparison
of NCT03921918 732 734 I-Eq_Comparison
2 NCT03921918 735 736 I-Eq_Comparison
male NCT03921918 737 741 I-Eq_Comparison
team NCT03921918 742 746 I-Eq_Comparison
members NCT03921918 747 754 I-Eq_Comparison
can NCT03921918 755 758 O
be NCT03921918 759 761 O
present NCT03921918 762 769 B-Observation
in NCT03921918 770 772 I-Observation
the NCT03921918 773 776 I-Observation
room NCT03921918 777 781 I-Observation
to NCT03921918 782 784 O
conduct NCT03921918 785 792 O
the NCT03921918 793 796 O
usability NCT03921918 797 806 O
part NCT03921918 807 811 O
of NCT03921918 812 814 O
the NCT03921918 815 818 O
study NCT03921918 819 824 O

10 NCT03921918 826 828 O
. NCT03921918 828 829 O
The NCT03921918 831 834 O
mother NCT03921918 835 841 O
accepts NCT03921918 842 849 B-Assertion___Assertion_Type_Value:hypothetical
that NCT03921918 850 854 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03921918 855 858 O
pumped NCT03921918 859 865 O
milk NCT03921918 866 870 O
in NCT03921918 871 873 O
visit NCT03921918 874 879 O
2 NCT03921918 880 881 O
must NCT03921918 882 886 O
be NCT03921918 887 889 O
donated NCT03921918 890 897 O
to NCT03921918 898 900 O
the NCT03921918 901 904 O
study NCT03921918 905 910 O
i NCT03921918 911 912 O
. NCT03921918 913 914 O
e NCT03921918 915 916 O
. NCT03921918 917 918 O
can NCT03921918 920 923 O
not NCT03921918 923 926 O
be NCT03921918 927 929 O
fed NCT03921918 930 933 O
to NCT03921918 934 936 O
the NCT03921918 937 940 O
baby NCT03921918 941 945 O

Exclusion NCT03921918 946 955 O
Criteria NCT03921918 956 964 O
: NCT03921918 965 966 O

1 NCT03921918 970 971 O
. NCT03921918 971 972 O
The NCT03921918 974 977 O
subject NCT03921918 978 985 O
has NCT03921918 986 989 O
a NCT03921918 990 991 O
nipple NCT03921918 992 998 B-Observation
size NCT03921918 999 1003 I-Observation
≥ NCT03921918 1004 1005 B-Eq_Comparison
21 NCT03921918 1006 1008 I-Eq_Comparison
mm NCT03921918 1009 1011 I-Eq_Comparison

2 NCT03921918 1014 1015 O
. NCT03921918 1015 1016 O
Mastitis NCT03921918 1018 1026 B-Condition
( NCT03921918 1027 1028 O
any NCT03921918 1029 1032 B-Modifier
breast NCT03921918 1033 1039 I-Modifier
within NCT03921918 1040 1046 B-Eq_Comparison
two NCT03921918 1047 1050 I-Eq_Comparison
weeks NCT03921918 1051 1056 I-Eq_Comparison
prior NCT03921918 1057 1062 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921918 1063 1065 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03921918 1066 1075 B-Study
) NCT03921918 1076 1077 O

3 NCT03921918 1081 1082 O
. NCT03921918 1082 1083 O
Engorgement NCT03921918 1085 1096 B-Condition
( NCT03921918 1097 1098 O
any NCT03921918 1099 1102 B-Modifier
breast NCT03921918 1103 1109 I-Modifier
within NCT03921918 1110 1116 B-Eq_Comparison
two NCT03921918 1117 1120 I-Eq_Comparison
weeks NCT03921918 1121 1126 I-Eq_Comparison
prior NCT03921918 1127 1132 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03921918 1133 1135 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03921918 1136 1145 B-Study
) NCT03921918 1146 1147 O
. NCT03921918 1148 1149 O

4 NCT03921918 1153 1154 O
. NCT03921918 1154 1155 O
Case NCT03921918 1157 1161 O
of NCT03921918 1162 1164 O
current NCT03921918 1165 1172 B-Eq_Comparison
infection NCT03921918 1173 1182 B-Condition
as NCT03921918 1183 1185 O
self NCT03921918 1186 1190 O
- NCT03921918 1191 1192 O
declared NCT03921918 1193 1201 O
in NCT03921918 1202 1204 O
the NCT03921918 1205 1208 O
Mother NCT03921918 1209 1215 B-Observation
and NCT03921918 1216 1219 I-Observation
infant NCT03921918 1220 1226 I-Observation
health NCT03921918 1227 1233 I-Observation
questionnaire NCT03921918 1234 1247 I-Observation

Inclusion NCT03922971 0 9 O
Criteria NCT03922971 10 18 O
: NCT03922971 19 20 O

- NCT03922971 24 25 O
Facilities NCT03922971 27 37 O
that NCT03922971 38 42 O
bill NCT03922971 43 47 O
to NCT03922971 48 50 O
fee NCT03922971 51 54 O
for NCT03922971 55 58 O
service NCT03922971 59 66 O
Medicare NCT03922971 67 75 O
for NCT03922971 76 79 O
gastrointestinal NCT03922971 80 96 B-Procedure
endoscopy NCT03922971 97 106 I-Procedure

Exclusion NCT03922971 107 116 O
Criteria NCT03922971 117 125 O
: NCT03922971 126 127 O

- NCT03922971 130 131 O

Inclusion NCT03868397 0 9 O
Criteria NCT03868397 10 18 O
: NCT03868397 19 20 O

- NCT03868397 24 25 O
older NCT03868397 27 32 B-Eq_Comparison
than NCT03868397 33 37 I-Eq_Comparison
18 NCT03868397 38 40 I-Eq_Comparison
years NCT03868397 41 46 I-Eq_Comparison

- NCT03868397 49 50 O
And NCT03868397 52 55 O
signed NCT03868397 56 62 O
informed NCT03868397 63 71 O
consent NCT03868397 72 79 O

- NCT03868397 82 83 O
And NCT03868397 85 88 O
planned NCT03868397 89 96 B-Eq_Comparison
either NCT03868397 97 103 O
a NCT03868397 104 105 O
) NCT03868397 106 107 O
liver NCT03868397 108 113 B-Procedure
transplantation NCT03868397 114 129 I-Procedure
as NCT03868397 130 132 O
a NCT03868397 133 134 O
recipient NCT03868397 135 144 B-Modifier
; NCT03868397 144 145 O
or NCT03868397 146 148 B-Or
b NCT03868397 149 150 O
) NCT03868397 151 152 O
liver NCT03868397 153 158 B-Procedure
transplantation NCT03868397 159 174 I-Procedure
as NCT03868397 175 177 O
a NCT03868397 178 179 O
donor NCT03868397 180 185 B-Modifier

Exclusion NCT03868397 186 195 O
Criteria NCT03868397 196 204 O
: NCT03868397 205 206 O

- NCT03868397 210 211 O
any NCT03868397 213 216 O
absolute NCT03868397 217 225 O
/ NCT03868397 226 227 O
relative NCT03868397 228 236 O
contraindication NCT03868397 237 253 B-Contraindication
of NCT03868397 254 256 O
contrast NCT03868397 257 265 B-Modifier
- NCT03868397 266 267 I-Modifier
enhanced NCT03868397 268 276 I-Modifier
MRI NCT03868397 277 280 B-Procedure

Inclusion NCT03863067 0 9 O
Criteria NCT03863067 10 18 O
: NCT03863067 19 20 O

- NCT03863067 24 25 O
Patient NCT03863067 27 34 O
with NCT03863067 35 39 O
indication NCT03863067 40 50 B-Indication
for NCT03863067 51 54 O
epiduroscopy NCT03863067 55 67 B-Procedure
in NCT03863067 68 70 O
the NCT03863067 71 74 O
usual NCT03863067 75 80 O
clinical NCT03863067 81 89 O
practice NCT03863067 90 98 O

- NCT03863067 101 102 O
Neurogenic NCT03863067 104 114 B-Condition
claudication NCT03863067 115 127 I-Condition

- NCT03863067 130 131 O
Lumbar NCT03863067 133 139 B-Modifier
pain NCT03863067 140 144 B-Condition
for NCT03863067 145 148 O
more NCT03863067 149 153 B-Eq_Comparison
than NCT03863067 154 158 I-Eq_Comparison
6 NCT03863067 159 160 I-Eq_Comparison
months NCT03863067 161 167 I-Eq_Comparison

- NCT03863067 170 171 O
Numerical NCT03863067 173 182 B-Observation
rating NCT03863067 183 189 I-Observation
scale NCT03863067 190 195 I-Observation
> NCT03863067 196 197 B-Eq_Comparison
6 NCT03863067 198 199 I-Eq_Comparison

- NCT03863067 203 204 O
No NCT03863067 206 208 B-Negation
response NCT03863067 209 217 O
with NCT03863067 218 222 O
medical NCT03863067 223 230 O
treatment NCT03863067 231 240 B-Procedure

- NCT03863067 243 244 O
No NCT03863067 246 248 B-Negation
response NCT03863067 249 257 O
with NCT03863067 258 262 O
other NCT03863067 263 268 B-Other
interventional NCT03863067 269 283 O
treatment NCT03863067 284 293 B-Procedure
: NCT03863067 294 295 O
epidurolysis NCT03863067 296 308 B-Procedure

Exclusion NCT03863067 309 318 O
Criteria NCT03863067 319 327 O
: NCT03863067 328 329 O

- NCT03863067 333 334 O
Psychiatric NCT03863067 336 347 B-Condition
disorders NCT03863067 348 357 I-Condition

- NCT03863067 360 361 O
Opioid NCT03863067 363 369 B-Condition
addiction NCT03863067 370 379 I-Condition

- NCT03863067 382 383 O
Acute NCT03863067 385 390 O
organic NCT03863067 391 398 B-Condition
disease NCT03863067 399 406 I-Condition

- NCT03863067 409 410 O
Severe NCT03863067 412 418 O
chronic NCT03863067 419 426 O
organic NCT03863067 427 434 B-Condition
disease NCT03863067 435 442 I-Condition

- NCT03863067 445 446 O
Vasculo NCT03863067 448 455 B-Condition
- NCT03863067 456 457 I-Condition
cerebral NCT03863067 458 466 I-Condition
disease NCT03863067 467 474 I-Condition

- NCT03863067 477 478 O
Coagulation NCT03863067 480 491 B-Condition
alterations NCT03863067 492 503 I-Condition

- NCT03863067 506 507 O
Ofthalmologic NCT03863067 509 522 B-Condition
disease NCT03863067 523 530 I-Condition

- NCT03863067 533 534 O
Allergic NCT03863067 536 544 B-Allergy

- NCT03863067 547 548 O
Infections NCT03863067 550 560 B-Condition

- NCT03863067 563 564 O
Impossibility NCT03863067 566 579 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03863067 580 582 I-Assertion___Assertion_Type_Value:hypothetical
understand NCT03863067 583 593 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03863067 594 597 O
procedure NCT03863067 598 607 B-Procedure

Inclusion NCT03924713 0 9 O
Criteria NCT03924713 10 18 O
: NCT03924713 19 20 O

- NCT03924713 24 25 O
Either NCT03924713 27 33 O
have NCT03924713 34 38 O
had NCT03924713 39 42 O
more NCT03924713 43 47 B-Eq_Comparison
than NCT03924713 48 52 I-Eq_Comparison
3 NCT03924713 53 54 I-Eq_Comparison
ED NCT03924713 55 57 B-Encounter
visits NCT03924713 58 64 I-Encounter
in NCT03924713 65 67 O
the NCT03924713 68 71 O
prior NCT03924713 72 77 B-Eq_Comparison
12 NCT03924713 78 80 I-Eq_Comparison
months NCT03924713 81 87 I-Eq_Comparison
, NCT03924713 88 89 O
or NCT03924713 90 92 B-Or
at NCT03924713 93 95 B-Eq_Comparison
least NCT03924713 96 101 I-Eq_Comparison
1 NCT03924713 102 103 I-Eq_Comparison
ambulatory NCT03924713 104 114 B-Modifier
care NCT03924713 115 119 I-Modifier
- NCT03924713 120 121 I-Modifier
sensitive NCT03924713 122 131 I-Modifier
hospitalization NCT03924713 132 147 B-Encounter
in NCT03924713 148 150 O
the NCT03924713 151 154 O
prior NCT03924713 155 160 B-Eq_Comparison
12 NCT03924713 161 163 I-Eq_Comparison
months NCT03924713 164 170 I-Eq_Comparison

Exclusion NCT03924713 171 180 O
Criteria NCT03924713 181 189 O
: NCT03924713 190 191 O

- NCT03924713 195 196 O
None NCT03924713 198 202 O
if NCT03924713 203 205 O
they NCT03924713 206 210 O
meet NCT03924713 211 215 O
above NCT03924713 216 221 O
criteria NCT03924713 222 230 O
. NCT03924713 231 232 O

Inclusion NCT03869112 0 9 O
Criteria NCT03869112 10 18 O
: NCT03869112 19 20 O

- NCT03869112 24 25 O
Participant NCT03869112 27 38 O
is NCT03869112 39 41 O
willing NCT03869112 42 49 O
and NCT03869112 50 53 O
able NCT03869112 54 58 O
to NCT03869112 59 61 O
give NCT03869112 62 66 O
informed NCT03869112 67 75 O
consent NCT03869112 76 83 O
for NCT03869112 84 87 O
participation NCT03869112 88 101 O
in NCT03869112 102 104 O
the NCT03869112 105 108 O
study NCT03869112 109 114 B-Study

- NCT03869112 117 118 O
Male NCT03869112 120 124 O
or NCT03869112 125 127 B-Or
Female NCT03869112 128 134 O
, NCT03869112 135 136 O
aged NCT03869112 137 141 B-Age
40 NCT03869112 142 144 B-Eq_Comparison
years NCT03869112 145 150 I-Eq_Comparison
to NCT03869112 151 153 I-Eq_Comparison
85 NCT03869112 154 156 I-Eq_Comparison
years NCT03869112 157 162 I-Eq_Comparison
. NCT03869112 163 164 O

- NCT03869112 168 169 O
Diagnosed NCT03869112 171 180 O
with NCT03869112 181 185 O
COPD NCT03869112 186 190 B-Condition

- NCT03869112 193 194 O
Able NCT03869112 196 200 O
( NCT03869112 201 202 O
in NCT03869112 203 205 O
the NCT03869112 206 209 O
Investigators NCT03869112 210 223 O
opinion NCT03869112 224 231 O
) NCT03869112 232 233 O
and NCT03869112 234 237 O
willing NCT03869112 238 245 O
to NCT03869112 246 248 O
comply NCT03869112 249 255 O
with NCT03869112 256 260 O
all NCT03869112 261 264 O
study NCT03869112 265 270 O
requirements NCT03869112 271 283 O
. NCT03869112 284 285 O

- NCT03869112 289 290 O
Participant NCT03869112 292 303 O
is NCT03869112 304 306 O
willing NCT03869112 307 314 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869112 315 317 I-Assertion___Assertion_Type_Value:hypothetical
attend NCT03869112 318 324 O
visits NCT03869112 325 331 B-Encounter
at NCT03869112 332 334 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03869112 335 343 B-Study
and NCT03869112 344 347 B-And
8 NCT03869112 348 349 B-Eq_Comparison
weeks NCT03869112 350 355 I-Eq_Comparison
( NCT03869112 356 357 O
sub NCT03869112 358 361 O
- NCT03869112 362 363 O
group NCT03869112 364 369 O
: NCT03869112 370 371 O
baseline NCT03869112 372 380 O
, NCT03869112 381 382 O
8 NCT03869112 383 384 O
weeks NCT03869112 385 390 O
) NCT03869112 391 392 O

- NCT03869112 400 401 O
Able NCT03869112 403 407 O
to NCT03869112 408 410 O
read NCT03869112 411 415 O
and NCT03869112 416 419 O
understand NCT03869112 420 430 O
English NCT03869112 431 438 O

Exclusion NCT03869112 439 448 O
Criteria NCT03869112 449 457 O
: NCT03869112 458 459 O

- NCT03869112 463 464 O
Age NCT03869112 466 469 B-Age
< NCT03869112 470 471 B-Eq_Comparison
40 NCT03869112 472 474 I-Eq_Comparison

- NCT03869112 478 479 O
Attended NCT03869112 481 489 O
a NCT03869112 490 491 O
pulmonary NCT03869112 492 501 B-Procedure
rehabilitation NCT03869112 502 516 I-Procedure
programme NCT03869112 517 526 O
or NCT03869112 527 529 B-Or
participating NCT03869112 530 543 O
in NCT03869112 544 546 O
a NCT03869112 547 548 O
physical NCT03869112 549 557 B-Procedure
activity NCT03869112 558 566 I-Procedure
intervention NCT03869112 567 579 I-Procedure
study NCT03869112 580 585 B-Study
in NCT03869112 586 588 O
current NCT03869112 589 596 B-Eq_Comparison
time NCT03869112 597 601 I-Eq_Comparison
or NCT03869112 602 604 B-Or
in NCT03869112 605 607 O
the NCT03869112 608 611 O
last NCT03869112 612 616 B-Eq_Comparison
6 NCT03869112 617 618 I-Eq_Comparison
months NCT03869112 619 625 I-Eq_Comparison
. NCT03869112 626 627 O

- NCT03869112 631 632 O
Any NCT03869112 634 637 O
other NCT03869112 638 643 B-Other
significant NCT03869112 644 655 O
diseases NCT03869112 656 664 B-Condition
or NCT03869112 665 667 B-Or
disorders NCT03869112 668 677 B-Condition
that NCT03869112 678 682 O
are NCT03869112 683 686 O
a NCT03869112 687 688 O
contraindication NCT03869112 689 705 B-Contraindication
to NCT03869112 706 708 O
be NCT03869112 709 711 O
enrolled NCT03869112 712 720 O
in NCT03869112 721 723 O
a NCT03869112 724 725 O
pulmonary NCT03869112 726 735 B-Procedure
rehabilitation NCT03869112 736 750 I-Procedure
programme NCT03869112 751 760 O
. NCT03869112 761 762 O


Inclusion NCT03930108 0 9 O
Criteria NCT03930108 10 18 O
: NCT03930108 19 20 O

- NCT03930108 24 25 O
adult NCT03930108 27 32 O
patients NCT03930108 33 41 O
( NCT03930108 42 43 O
age NCT03930108 44 47 B-Age
18 NCT03930108 48 50 B-Eq_Comparison
and NCT03930108 51 54 I-Eq_Comparison
above NCT03930108 55 60 I-Eq_Comparison
) NCT03930108 61 62 O
who NCT03930108 63 66 O
admitted NCT03930108 67 75 B-Encounter
to NCT03930108 76 78 O
burn NCT03930108 79 83 O
unit NCT03930108 84 88 O
during NCT03930108 89 95 B-Temporal_Connection___Temporal_Connection_Type_Value:during
sampling NCT03930108 96 104 B-Study
period NCT03930108 105 111 O

Exclusion NCT03930108 112 121 O
Criteria NCT03930108 122 130 O
: NCT03930108 131 132 O

- NCT03930108 136 137 O
patients NCT03930108 139 147 O
discharged NCT03930108 148 158 B-Encounter
or NCT03930108 159 161 B-Or
deceased NCT03930108 162 170 B-Death
less NCT03930108 171 175 B-Eq_Comparison
than NCT03930108 176 180 I-Eq_Comparison
24 NCT03930108 181 183 I-Eq_Comparison
hours NCT03930108 184 189 I-Eq_Comparison
of NCT03930108 190 192 B-Temporal_Connection___Temporal_Connection_Type_Value:after
admission NCT03930108 193 202 B-Encounter

- NCT03930108 205 206 O
patients NCT03930108 208 216 O
referred NCT03930108 217 225 B-Encounter
to NCT03930108 226 228 O
other NCT03930108 229 234 B-Other
hospital NCT03930108 235 243 O
within NCT03930108 244 250 B-Eq_Comparison
30 NCT03930108 251 253 I-Eq_Comparison
days NCT03930108 254 258 I-Eq_Comparison
admission NCT03930108 259 268 B-Encounter

Inclusion NCT03922074 0 9 O
Criteria NCT03922074 10 18 O
: NCT03922074 19 20 O

Healthy NCT03922074 22 29 B-Condition
patients NCT03922074 30 38 O
- NCT03922074 39 40 O

Exclusion NCT03922074 42 51 O
Criteria NCT03922074 52 60 O
: NCT03922074 61 62 O

Patients NCT03922074 64 72 O
with NCT03922074 73 77 O
familial NCT03922074 78 86 B-Family_Member
colorectal NCT03922074 87 97 B-Modifier
cancer NCT03922074 98 104 B-Condition
history NCT03922074 105 112 B-Eq_Comparison

- NCT03922074 114 115 O

Inclusion NCT03865056 0 9 O
Criteria NCT03865056 10 18 O
: NCT03865056 19 20 O

1 NCT03865056 24 25 O
. NCT03865056 25 26 O
Hypoxemia NCT03865056 28 37 B-Condition
defined NCT03865056 38 45 O
by NCT03865056 46 48 O
a NCT03865056 49 50 O
ratio NCT03865056 51 56 O
of NCT03865056 57 59 O
the NCT03865056 60 63 O
partial NCT03865056 64 71 B-Observation
pressure NCT03865056 72 80 I-Observation
of NCT03865056 81 83 I-Observation
arterial NCT03865056 84 92 I-Observation
oxygen NCT03865056 93 99 I-Observation
to NCT03865056 100 102 I-Observation
the NCT03865056 103 106 I-Observation
fraction NCT03865056 107 115 I-Observation
of NCT03865056 116 118 I-Observation
inspired NCT03865056 119 127 I-Observation
oxygen NCT03865056 128 134 I-Observation
( NCT03865056 135 136 O
PaO NCT03865056 137 140 B-Observation
2 NCT03865056 141 142 I-Observation
: NCT03865056 143 144 I-Observation
FiO NCT03865056 145 148 I-Observation
2 NCT03865056 149 150 I-Observation
) NCT03865056 151 152 O
≤ NCT03865056 153 154 B-Eq_Comparison
300 NCT03865056 155 158 I-Eq_Comparison
while NCT03865056 159 164 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865056 165 168 O
patient NCT03865056 169 176 O
is NCT03865056 177 179 O
breathing NCT03865056 180 189 B-Observation
oxygen NCT03865056 190 196 I-Observation
through NCT03865056 197 204 O
NHF NCT03865056 205 208 B-Procedure
for NCT03865056 209 212 O
at NCT03865056 213 215 B-Eq_Comparison
least NCT03865056 216 221 I-Eq_Comparison
15 NCT03865056 222 224 I-Eq_Comparison
minutes NCT03865056 225 232 I-Eq_Comparison
; NCT03865056 232 233 O

2 NCT03865056 236 237 O
. NCT03865056 237 238 O
Respiratory NCT03865056 240 251 B-Observation
rate NCT03865056 252 256 I-Observation
> NCT03865056 257 258 B-Eq_Comparison
25 NCT03865056 259 261 I-Eq_Comparison
breaths NCT03865056 262 269 I-Eq_Comparison
/ NCT03865056 270 271 I-Eq_Comparison
minute NCT03865056 272 278 I-Eq_Comparison
; NCT03865056 278 279 O

3 NCT03865056 282 283 O
. NCT03865056 283 284 O
Partial NCT03865056 286 293 B-Observation
pressure NCT03865056 294 302 I-Observation
of NCT03865056 303 305 I-Observation
arterial NCT03865056 306 314 I-Observation
carbon NCT03865056 315 321 I-Observation
dioxide NCT03865056 322 329 I-Observation
( NCT03865056 330 331 O
PaCO NCT03865056 332 336 B-Observation
2 NCT03865056 337 338 I-Observation
) NCT03865056 339 340 O
≤ NCT03865056 341 342 B-Eq_Comparison
45 NCT03865056 343 345 I-Eq_Comparison
mmHg NCT03865056 346 350 I-Eq_Comparison
; NCT03865056 350 351 O

4 NCT03865056 354 355 O
. NCT03865056 355 356 O
Absence NCT03865056 358 365 B-Negation
of NCT03865056 366 368 O
clinical NCT03865056 369 377 O
history NCT03865056 378 385 B-Eq_Comparison
of NCT03865056 386 388 O
underlying NCT03865056 389 399 O
chronic NCT03865056 400 407 O
respiratory NCT03865056 408 419 B-Condition
failure NCT03865056 420 427 I-Condition
. NCT03865056 428 429 O

Exclusion NCT03865056 431 440 O
Criteria NCT03865056 441 449 O
: NCT03865056 450 451 O

1 NCT03865056 455 456 O
. NCT03865056 456 457 O
Lack NCT03865056 459 463 O
of NCT03865056 464 466 O
consent NCT03865056 467 474 O
; NCT03865056 474 475 O

2 NCT03865056 478 479 O
. NCT03865056 479 480 O
Age NCT03865056 482 485 B-Age
< NCT03865056 486 487 B-Eq_Comparison
18 NCT03865056 488 490 I-Eq_Comparison
years NCT03865056 491 496 I-Eq_Comparison
; NCT03865056 496 497 O

3 NCT03865056 500 501 O
. NCT03865056 501 502 O
Invasive NCT03865056 504 512 B-Modifier
mechanical NCT03865056 513 523 B-Procedure
ventilation NCT03865056 524 535 I-Procedure
for NCT03865056 536 539 O
> NCT03865056 540 541 B-Eq_Comparison
48 NCT03865056 542 544 I-Eq_Comparison
hours NCT03865056 545 550 I-Eq_Comparison
in NCT03865056 551 553 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03865056 554 557 I-Temporal_Connection___Temporal_Connection_Type_Value:during
same NCT03865056 558 562 I-Temporal_Connection___Temporal_Connection_Type_Value:during
hospital NCT03865056 563 571 O
admission NCT03865056 572 581 B-Encounter

4 NCT03865056 584 585 O
. NCT03865056 585 586 O
Immediate NCT03865056 588 597 O
need NCT03865056 598 602 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03865056 603 606 I-Assertion___Assertion_Type_Value:hypothetical
intubation NCT03865056 607 617 B-Procedure
; NCT03865056 617 618 O

5 NCT03865056 621 622 O
. NCT03865056 622 623 O
Previous NCT03865056 625 633 B-Eq_Comparison
inclusion NCT03865056 634 643 O
in NCT03865056 644 646 O
the NCT03865056 647 650 O
present NCT03865056 651 658 O
study NCT03865056 659 664 B-Study
; NCT03865056 664 665 O

6 NCT03865056 668 669 O
. NCT03865056 669 670 O
Systolic NCT03865056 672 680 B-Observation
arterial NCT03865056 681 689 I-Observation
pressure NCT03865056 690 698 I-Observation
< NCT03865056 699 700 B-Eq_Comparison
90 NCT03865056 701 703 I-Eq_Comparison
mmHg NCT03865056 704 708 I-Eq_Comparison
after NCT03865056 709 714 B-Temporal_Connection___Temporal_Connection_Type_Value:after
optimal NCT03865056 715 722 B-Modifier
fluid NCT03865056 723 728 B-Procedure
therapy NCT03865056 729 736 I-Procedure
; NCT03865056 736 737 O

7 NCT03865056 740 741 O
. NCT03865056 741 742 O
Cardiogenic NCT03865056 744 755 B-Condition
pulmonary NCT03865056 756 765 I-Condition
edema NCT03865056 766 771 I-Condition
; NCT03865056 771 772 O

8 NCT03865056 775 776 O
. NCT03865056 776 777 O
Glasgow NCT03865056 779 786 B-Observation
Coma NCT03865056 787 791 I-Observation
Scale NCT03865056 792 797 I-Observation
< NCT03865056 798 799 B-Eq_Comparison
12 NCT03865056 800 802 I-Eq_Comparison
; NCT03865056 803 804 O

9 NCT03865056 807 808 O
. NCT03865056 808 809 O
Imminent NCT03865056 811 819 B-Risk
death NCT03865056 820 825 B-Death
; NCT03865056 825 826 O

10 NCT03865056 828 830 O
. NCT03865056 830 831 O
Contraindications NCT03865056 833 850 B-Contraindication
to NCT03865056 851 853 O
noninvasive NCT03865056 854 865 B-Procedure
ventilation NCT03865056 866 877 I-Procedure
; NCT03865056 877 878 O

11 NCT03865056 880 882 O
. NCT03865056 882 883 O
Tracheostomy NCT03865056 885 897 B-Procedure
. NCT03865056 898 899 O

Inclusion NCT03924960 0 9 O
Criteria NCT03924960 10 18 O
: NCT03924960 19 20 O

- NCT03924960 24 25 O
Subjects NCT03924960 27 35 O
diagnosed NCT03924960 36 45 O
according NCT03924960 46 55 O
to NCT03924960 56 58 O
the NCT03924960 59 62 O
American NCT03924960 63 71 O
College NCT03924960 72 79 O
of NCT03924960 80 82 O
Rheumatology NCT03924960 83 95 O
2016 NCT03924960 96 100 O
diagnostic NCT03924960 101 111 O
criteria NCT03924960 112 120 O
for NCT03924960 121 124 O
fibromyalgia NCT03924960 125 137 B-Condition
. NCT03924960 138 139 O

Exclusion NCT03924960 141 150 O
Criteria NCT03924960 151 159 O
: NCT03924960 160 161 O

- NCT03924960 165 166 O
History NCT03924960 168 175 B-Eq_Comparison
of NCT03924960 176 178 O
comorbid NCT03924960 179 187 B-Condition
inflammatory NCT03924960 188 200 I-Condition
rheumatic NCT03924960 201 210 I-Condition
/ NCT03924960 211 212 B-Or
connective NCT03924960 213 223 B-Condition
tissue NCT03924960 224 230 I-Condition
diseases NCT03924960 231 239 I-Condition

- NCT03924960 242 243 O
History NCT03924960 245 252 B-Eq_Comparison
of NCT03924960 253 255 O
cardiovascular NCT03924960 256 270 B-Modifier
or NCT03924960 271 273 B-Or
musculoskeletal NCT03924960 274 289 B-Modifier
problems NCT03924960 290 298 B-Condition
that NCT03924960 299 303 O
could NCT03924960 304 309 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03924960 310 317 B-Negation
them NCT03924960 318 322 O
to NCT03924960 323 325 O
participate NCT03924960 326 337 O
in NCT03924960 338 340 O
an NCT03924960 341 343 O
exercise NCT03924960 344 352 B-Procedure
program NCT03924960 353 360 I-Procedure
. NCT03924960 361 362 O

Inclusion NCT03926000 0 9 O
Criteria NCT03926000 10 18 O
: NCT03926000 19 20 O

- NCT03926000 24 25 O
Patients NCT03926000 27 35 O
scheduled NCT03926000 36 45 B-Eq_Comparison
for NCT03926000 46 49 O
elective NCT03926000 50 58 B-Modifier
knee NCT03926000 59 63 I-Modifier
arthroscopy NCT03926000 64 75 B-Procedure
. NCT03926000 76 77 O

- NCT03926000 81 82 O
Patients NCT03926000 84 92 O
aged NCT03926000 93 97 B-Age
between NCT03926000 98 105 B-Eq_Comparison
21 NCT03926000 106 108 I-Eq_Comparison
and NCT03926000 109 112 I-Eq_Comparison
50 NCT03926000 113 115 I-Eq_Comparison
years NCT03926000 116 121 I-Eq_Comparison
old NCT03926000 122 125 O
. NCT03926000 126 127 O

- NCT03926000 131 132 O
Patients NCT03926000 134 142 O
with NCT03926000 143 147 O
American NCT03926000 148 156 B-Observation
Society NCT03926000 157 164 I-Observation
of NCT03926000 165 167 I-Observation
Anaesthesiologists NCT03926000 168 186 I-Observation
physical NCT03926000 187 195 O
status NCT03926000 196 202 O
I NCT03926000 203 204 B-Eq_Comparison
or NCT03926000 205 207 I-Eq_Comparison
II NCT03926000 208 210 I-Eq_Comparison
. NCT03926000 211 212 O

Exclusion NCT03926000 214 223 O
Criteria NCT03926000 224 232 O
: NCT03926000 233 234 O

- NCT03926000 238 239 O
Patients NCT03926000 241 249 O
with NCT03926000 250 254 O
known NCT03926000 255 260 O
allergy NCT03926000 261 268 B-Allergy
to NCT03926000 269 271 O
any NCT03926000 272 275 O
drug NCT03926000 276 280 B-Drug
used NCT03926000 281 285 O
in NCT03926000 286 288 O
the NCT03926000 289 292 O
study NCT03926000 293 298 B-Study
. NCT03926000 299 300 O

- NCT03926000 304 305 O
Patients NCT03926000 307 315 O
with NCT03926000 316 320 O
chronic NCT03926000 321 328 O
use NCT03926000 329 332 O
of NCT03926000 333 335 O
analgesics NCT03926000 336 346 B-Drug
and NCT03926000 347 350 B-Or
/ NCT03926000 351 352 I-Or
or NCT03926000 353 355 I-Or
sedatives NCT03926000 356 365 B-Drug
. NCT03926000 366 367 O

- NCT03926000 371 372 O
Patients NCT03926000 374 382 O
with NCT03926000 383 387 O
sleep NCT03926000 388 393 B-Condition
apnea NCT03926000 394 399 I-Condition
syndrome NCT03926000 400 408 I-Condition
. NCT03926000 409 410 O

- NCT03926000 414 415 O
Patients NCT03926000 417 425 O
with NCT03926000 426 430 O
renal NCT03926000 431 436 B-Modifier
or NCT03926000 437 439 B-Or
hepatic NCT03926000 440 447 B-Modifier
dysfunction NCT03926000 448 459 B-Condition
. NCT03926000 460 461 O

- NCT03926000 465 466 O
Patients NCT03926000 468 476 O
with NCT03926000 477 481 O
psychiatric NCT03926000 482 493 B-Condition
disorders NCT03926000 494 503 I-Condition
. NCT03926000 504 505 O

Inclusion NCT03863743 0 9 O
Criteria NCT03863743 10 18 O
: NCT03863743 19 20 O

- NCT03863743 24 25 O
ASA NCT03863743 27 30 B-Observation
grade NCT03863743 31 36 B-Eq_Comparison
I NCT03863743 37 38 I-Eq_Comparison
- NCT03863743 39 40 I-Eq_Comparison
III NCT03863743 41 44 I-Eq_Comparison

- NCT03863743 47 48 O
BMI NCT03863743 50 53 B-Observation
under NCT03863743 54 59 B-Eq_Comparison
36 NCT03863743 60 62 I-Eq_Comparison
kg NCT03863743 63 65 I-Eq_Comparison
/ NCT03863743 66 67 I-Eq_Comparison
m^ NCT03863743 68 70 I-Eq_Comparison
2 NCT03863743 71 72 I-Eq_Comparison

- NCT03863743 76 77 O
Scheduled NCT03863743 79 88 B-Eq_Comparison
surgery NCT03863743 89 96 B-Procedure
for NCT03863743 97 100 O
primary NCT03863743 101 108 B-Modifier
total NCT03863743 109 114 B-Modifier
hip NCT03863743 115 118 I-Modifier
or NCT03863743 119 121 B-Or
knee NCT03863743 122 126 B-Modifier
replacement NCT03863743 127 138 B-Procedure

- NCT03863743 141 142 O
Age NCT03863743 144 147 B-Age
18 NCT03863743 148 150 B-Eq_Comparison
+ NCT03863743 151 152 I-Eq_Comparison
years NCT03863743 153 158 I-Eq_Comparison

Exclusion NCT03863743 159 168 O
Criteria NCT03863743 169 177 O
: NCT03863743 178 179 O

- NCT03863743 183 184 O
Contraindications NCT03863743 186 203 B-Contraindication
or NCT03863743 204 206 B-Or
failure NCT03863743 207 214 B-Modifier
of NCT03863743 215 217 O
neuraxial NCT03863743 218 227 B-Procedure
anesthesia NCT03863743 228 238 I-Procedure

- NCT03863743 241 242 O
Patients NCT03863743 244 252 O
must NCT03863743 253 257 O
not NCT03863743 258 261 B-Negation
be NCT03863743 262 264 O
outpatient NCT03863743 265 275 B-Encounter
total NCT03863743 276 281 B-Modifier
hip NCT03863743 282 285 I-Modifier
or NCT03863743 286 288 B-Or
knee NCT03863743 289 293 B-Modifier
procedure NCT03863743 294 303 B-Procedure

- NCT03863743 306 307 O
Known NCT03863743 309 314 O
intercurrent NCT03863743 315 327 B-Modifier
UTI NCT03863743 328 331 B-Condition
, NCT03863743 332 333 O
incontinence NCT03863743 334 346 B-Condition
, NCT03863743 347 348 O
or NCT03863743 349 351 B-Or
urinary NCT03863743 352 359 B-Condition
retention NCT03863743 360 369 I-Condition
not NCT03863743 370 373 B-Negation
addressed NCT03863743 374 383 O
by NCT03863743 384 386 O
pre NCT03863743 387 390 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03863743 391 392 O
operative NCT03863743 393 402 B-Procedure
urologic NCT03863743 403 411 B-Procedure
consultation NCT03863743 412 424 B-Modifier
and NCT03863743 425 428 B-Or
correction NCT03863743 429 439 B-Modifier

- NCT03863743 442 443 O
Pregnancy NCT03863743 445 454 B-Condition

- NCT03863743 457 458 O
Current NCT03863743 460 467 B-Eq_Comparison
nicotine NCT03863743 468 476 B-Drug
, NCT03863743 477 478 O
alcohol NCT03863743 479 486 B-Modifier
or NCT03863743 487 489 B-Or
drug NCT03863743 490 494 B-Modifier
abusers NCT03863743 495 502 B-Condition

- NCT03863743 505 506 O
Pre NCT03863743 508 511 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03863743 512 513 O
operative NCT03863743 514 523 B-Procedure
narcotic NCT03863743 524 532 B-Drug
use NCT03863743 533 536 O
( NCT03863743 537 538 O
any NCT03863743 539 542 O
narcotic NCT03863743 543 551 B-Drug
consumption NCT03863743 552 563 O
within NCT03863743 564 570 B-Eq_Comparison
3 NCT03863743 571 572 I-Eq_Comparison
days NCT03863743 573 577 I-Eq_Comparison
prior NCT03863743 578 583 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863743 584 586 I-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03863743 587 594 B-Procedure
) NCT03863743 595 596 O

- NCT03863743 600 601 O
Post NCT03863743 603 607 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03863743 608 609 O
operative NCT03863743 610 619 B-Procedure
parenteral NCT03863743 620 630 B-Modifier
narcotic NCT03863743 631 639 B-Drug
administration NCT03863743 640 654 O

- NCT03863743 657 658 O
Allergy NCT03863743 660 667 B-Allergy
or NCT03863743 668 670 B-Or
intolerance NCT03863743 671 682 B-Condition
to NCT03863743 683 685 O
liposomal NCT03863743 686 695 B-Drug
bupivacaine NCT03863743 696 707 B-Drug
, NCT03863743 708 709 O
bupivacaine NCT03863743 710 721 B-Drug
, NCT03863743 722 723 O
celecoxib NCT03863743 724 733 B-Drug
, NCT03863743 734 735 O
dexamethasone NCT03863743 736 749 B-Drug
and NCT03863743 750 753 B-Or
/ NCT03863743 754 755 I-Or
or NCT03863743 756 758 I-Or
pregabalin NCT03863743 759 769 B-Drug

Inclusion NCT03860779 0 9 O
Criteria NCT03860779 10 18 O
: NCT03860779 19 20 O

- NCT03860779 24 25 O
Age NCT03860779 27 30 B-Age
above NCT03860779 31 36 B-Eq_Comparison
18 NCT03860779 37 39 I-Eq_Comparison

- NCT03860779 43 44 O
ASA NCT03860779 46 49 B-Observation
classification NCT03860779 50 64 O
I NCT03860779 65 66 B-Eq_Comparison
to NCT03860779 67 69 I-Eq_Comparison
II NCT03860779 70 72 I-Eq_Comparison

- NCT03860779 75 76 O
Indication NCT03860779 78 88 B-Indication
for NCT03860779 89 92 O
colonoscopy NCT03860779 93 104 B-Procedure
with NCT03860779 105 109 O
propofol NCT03860779 110 118 B-Drug
sedation NCT03860779 119 127 B-Procedure

- NCT03860779 130 131 O
Written NCT03860779 133 140 O
informed NCT03860779 141 149 O
consent NCT03860779 150 157 O

Exclusion NCT03860779 158 167 O
Criteria NCT03860779 168 176 O
: NCT03860779 177 178 O

- NCT03860779 182 183 O
Pregnancy NCT03860779 185 194 B-Condition

Inclusion NCT03928951 0 9 O
Criteria NCT03928951 10 18 O
: NCT03928951 19 20 O

- NCT03928951 24 25 O
Every NCT03928951 27 32 O
patient NCT03928951 33 40 O
more NCT03928951 41 45 B-Eq_Comparison
than NCT03928951 46 50 I-Eq_Comparison
18 NCT03928951 51 53 I-Eq_Comparison
years NCT03928951 54 59 I-Eq_Comparison
who NCT03928951 60 63 B-And
was NCT03928951 64 67 O
administered NCT03928951 68 80 B-Eq_Comparison
antibiotherapy NCT03928951 81 95 B-Procedure
for NCT03928951 96 99 O
urinary NCT03928951 100 107 B-Modifier
infection NCT03928951 108 117 B-Condition
in NCT03928951 118 120 O
emergency NCT03928951 121 130 O
department NCT03928951 131 141 O
or NCT03928951 142 144 B-Or
for NCT03928951 145 148 O
whom NCT03928951 149 153 O
urinary NCT03928951 154 161 B-Modifier
infection NCT03928951 162 171 B-Condition
was NCT03928951 172 175 O
diagnosed NCT03928951 176 185 O
in NCT03928951 186 188 O
emergency NCT03928951 189 198 O
department NCT03928951 199 209 O
( NCT03928951 210 211 O
cystitis NCT03928951 212 220 B-Condition
, NCT03928951 221 222 O
acute NCT03928951 223 228 O
pyelonephritis NCT03928951 229 243 B-Condition
, NCT03928951 244 245 O
prostatitis NCT03928951 246 257 B-Condition
) NCT03928951 258 259 O

Exclusion NCT03928951 261 270 O
Criteria NCT03928951 271 279 O
: NCT03928951 280 281 O

- NCT03928951 285 286 O
Patients NCT03928951 288 296 O
less NCT03928951 297 301 B-Eq_Comparison
than NCT03928951 302 306 I-Eq_Comparison
18 NCT03928951 307 309 I-Eq_Comparison
years NCT03928951 310 315 I-Eq_Comparison
old NCT03928951 316 319 B-Age

- NCT03928951 322 323 O
Patients NCT03928951 325 333 O
opposed NCT03928951 334 341 O
to NCT03928951 342 344 O
their NCT03928951 345 350 O
data NCT03928951 351 355 O
use NCT03928951 356 359 O

- NCT03928951 362 363 O
Patients NCT03928951 365 373 O
hospitalized NCT03928951 374 386 B-Encounter
more NCT03928951 387 391 B-Eq_Comparison
than NCT03928951 392 396 I-Eq_Comparison
24 NCT03928951 397 399 I-Eq_Comparison
hours NCT03928951 400 405 I-Eq_Comparison

- NCT03928951 408 409 O
Patients NCT03928951 411 419 O
taking NCT03928951 420 426 B-Eq_Comparison
antibiotherapy NCT03928951 427 441 B-Procedure
already NCT03928951 442 449 O
before NCT03928951 450 456 B-Temporal_Connection___Temporal_Connection_Type_Value:before
their NCT03928951 457 462 O
arrival NCT03928951 463 470 B-Encounter
in NCT03928951 471 473 O
emergency NCT03928951 474 483 O
department NCT03928951 484 494 O

- NCT03928951 497 498 O
Patients NCT03928951 500 508 O
without NCT03928951 509 516 B-Negation
sufficient NCT03928951 517 527 O
reading NCT03928951 528 535 O
capacities NCT03928951 536 546 O
or NCT03928951 547 549 O
understanding NCT03928951 550 563 O
of NCT03928951 564 566 O
french NCT03928951 567 573 O
language NCT03928951 574 582 O
to NCT03928951 583 585 O
express NCT03928951 586 593 O
opposition NCT03928951 594 604 O
to NCT03928951 605 607 O
their NCT03928951 608 613 O
research NCT03928951 614 622 O
participation NCT03928951 623 636 O

- NCT03928951 639 640 O
Any NCT03928951 642 645 O
other NCT03928951 646 651 O
reason NCT03928951 652 658 O
which NCT03928951 659 664 O
, NCT03928951 665 666 O
according NCT03928951 667 676 O
to NCT03928951 677 679 O
investigator NCT03928951 680 692 O
, NCT03928951 693 694 O
might NCT03928951 695 700 O
interfere NCT03928951 701 710 O
with NCT03928951 711 715 O
research NCT03928951 716 724 O
objective NCT03928951 725 734 O
evaluation NCT03928951 735 745 O

Inclusion NCT03924778 0 9 O
Criteria NCT03924778 10 18 O
: NCT03924778 19 20 O

- NCT03924778 24 25 O
female NCT03924778 27 33 O

- NCT03924778 36 37 O
non NCT03924778 39 42 B-Negation
- NCT03924778 43 44 O
Hispanic NCT03924778 45 53 O
, NCT03924778 54 55 O
black NCT03924778 56 61 O
or NCT03924778 62 64 B-Or
white NCT03924778 65 70 O

- NCT03924778 73 74 O
age NCT03924778 76 79 B-Age
19 NCT03924778 80 82 B-Eq_Comparison
- NCT03924778 83 84 I-Eq_Comparison
65 NCT03924778 85 87 I-Eq_Comparison
years NCT03924778 88 93 I-Eq_Comparison

- NCT03924778 96 97 O
BMI NCT03924778 99 102 B-Observation
> NCT03924778 103 104 B-Eq_Comparison
= NCT03924778 105 106 I-Eq_Comparison
30 NCT03924778 107 109 I-Eq_Comparison
kg NCT03924778 110 112 I-Eq_Comparison
/ NCT03924778 113 114 I-Eq_Comparison
m^ NCT03924778 115 117 I-Eq_Comparison
2 NCT03924778 118 119 I-Eq_Comparison

- NCT03924778 123 124 O
able NCT03924778 126 130 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924778 131 133 I-Assertion___Assertion_Type_Value:hypothetical
visit NCT03924778 134 139 B-Encounter
Bionutrition NCT03924778 140 152 O
Unit NCT03924778 153 157 O
daily NCT03924778 158 163 B-Eq_Comparison

Exclusion NCT03924778 164 173 O
Criteria NCT03924778 174 182 O
: NCT03924778 183 184 O

- NCT03924778 188 189 O
gastrointestinal NCT03924778 191 207 B-Modifier
( NCT03924778 208 209 O
GI NCT03924778 210 212 B-Condition
) NCT03924778 213 214 O
conditions NCT03924778 215 225 B-Condition
i NCT03924778 226 227 O
. NCT03924778 228 229 O
e NCT03924778 230 231 O
. NCT03924778 232 233 O
, NCT03924778 234 235 O
irritable NCT03924778 236 245 B-Condition
bowel NCT03924778 246 251 I-Condition
, NCT03924778 252 253 O
diverticulitis NCT03924778 254 268 B-Condition
, NCT03924778 269 270 O
peptic NCT03924778 271 277 B-Condition
ulcers NCT03924778 278 284 I-Condition
, NCT03924778 285 286 O
Crohn NCT03924778 287 292 B-Condition
's NCT03924778 292 294 I-Condition
, NCT03924778 295 296 O
GI NCT03924778 297 299 B-Modifier
cancers NCT03924778 300 307 B-Condition
, NCT03924778 308 309 O
and NCT03924778 310 313 B-Or
adenatomous NCT03924778 314 325 B-Condition
polyps NCT03924778 326 332 I-Condition

- NCT03924778 335 336 O
antibiotic NCT03924778 338 348 B-Drug
or NCT03924778 349 351 B-Or
probiotic NCT03924778 352 361 B-Drug
use NCT03924778 362 365 O
in NCT03924778 366 368 O
the NCT03924778 369 372 O
previous NCT03924778 373 381 B-Eq_Comparison
90 NCT03924778 382 384 I-Eq_Comparison
days NCT03924778 385 389 I-Eq_Comparison

- NCT03924778 392 393 O
tobacco NCT03924778 395 402 B-Condition
use NCT03924778 403 406 I-Condition

- NCT03924778 409 410 O
heavy NCT03924778 412 417 O
alcohol NCT03924778 418 425 B-Condition
consumption NCT03924778 426 437 I-Condition

- NCT03924778 440 441 O
major NCT03924778 443 448 B-Modifier
medical NCT03924778 449 456 B-Condition
conditions NCT03924778 457 467 I-Condition
( NCT03924778 468 469 O
e NCT03924778 470 471 O
. NCT03924778 472 473 O
g NCT03924778 474 475 O
. NCT03924778 476 477 O
, NCT03924778 478 479 O
renal NCT03924778 480 485 B-Condition
disease NCT03924778 486 493 I-Condition
, NCT03924778 494 495 O
diabetes NCT03924778 496 504 B-Condition
, NCT03924778 505 506 O
cancer NCT03924778 507 513 B-Condition
) NCT03924778 514 515 O

Key NCT03866577 0 3 O
Criteria NCT03866577 4 12 O
for NCT03866577 13 16 O
Healthy NCT03866577 17 24 B-Condition
Volunteers NCT03866577 25 35 O
: NCT03866577 36 37 O
Subject NCT03866577 38 45 O
must NCT03866577 46 50 O
be NCT03866577 51 53 O
between NCT03866577 54 61 B-Eq_Comparison
the NCT03866577 62 65 I-Eq_Comparison
ages NCT03866577 66 70 I-Eq_Comparison
of NCT03866577 71 73 I-Eq_Comparison
18 NCT03866577 74 76 I-Eq_Comparison
and NCT03866577 77 80 I-Eq_Comparison
55 NCT03866577 81 83 I-Eq_Comparison
years NCT03866577 84 89 I-Eq_Comparison
; NCT03866577 89 90 O

healthy NCT03866577 91 98 B-Condition
as NCT03866577 99 101 O
indicated NCT03866577 102 111 O
by NCT03866577 112 114 O
medical NCT03866577 115 122 B-Procedure
history NCT03866577 123 130 I-Procedure
, NCT03866577 131 132 O
physical NCT03866577 133 141 B-Procedure
examination NCT03866577 142 153 I-Procedure
, NCT03866577 154 155 O
vital NCT03866577 156 161 B-Observation
signs NCT03866577 162 167 I-Observation
, NCT03866577 168 169 O
clinical NCT03866577 170 178 O
laboratory NCT03866577 179 189 B-Observation
tests NCT03866577 190 195 I-Observation
, NCT03866577 196 197 O
and NCT03866577 198 201 B-Or
12 NCT03866577 202 204 B-Procedure
- NCT03866577 205 206 I-Procedure
lead NCT03866577 207 211 I-Procedure
electrocardiogram NCT03866577 212 229 I-Procedure
, NCT03866577 230 231 O
and NCT03866577 232 235 B-And
all NCT03866577 236 239 O
abnormal NCT03866577 240 248 O
findings NCT03866577 249 257 B-Condition
are NCT03866577 258 261 O
assessed NCT03866577 262 270 O
as NCT03866577 271 273 O
not NCT03866577 274 277 B-Negation
clinically NCT03866577 278 288 O
significant NCT03866577 289 300 O
by NCT03866577 301 303 O
the NCT03866577 304 307 O
Investigator NCT03866577 308 320 O
; NCT03866577 320 321 O
not NCT03866577 322 325 B-Negation
pregnant NCT03866577 326 334 B-Condition
or NCT03866577 335 337 B-Or
breastfeeding NCT03866577 338 351 B-Condition
; NCT03866577 351 352 O
and NCT03866577 353 356 B-And
no NCT03866577 357 359 B-Negation
other NCT03866577 360 365 B-Other
clinically NCT03866577 366 376 O
relevant NCT03866577 377 385 O
abnormalities NCT03866577 386 399 B-Condition
currently NCT03866577 400 409 B-Eq_Comparison
or NCT03866577 410 412 B-Or
in NCT03866577 413 415 O
their NCT03866577 416 421 O
history NCT03866577 422 429 B-Eq_Comparison
that NCT03866577 430 434 O
the NCT03866577 435 438 O
Investigator NCT03866577 439 451 O
would NCT03866577 452 457 O
deem NCT03866577 458 462 O
them NCT03866577 463 467 O
ineligible NCT03866577 468 478 O
to NCT03866577 479 481 O
participate NCT03866577 482 493 O
. NCT03866577 494 495 O

Key NCT03866577 497 500 O
Criteria NCT03866577 501 509 O
for NCT03866577 510 513 O
Immune NCT03866577 514 520 B-Condition
Thrombocytopenic NCT03866577 521 537 I-Condition
Purpura NCT03866577 538 545 I-Condition
( NCT03866577 546 547 O
ITP NCT03866577 548 551 B-Condition
) NCT03866577 552 553 O
Patients NCT03866577 554 562 O
: NCT03866577 563 564 O
Patient NCT03866577 565 572 O
must NCT03866577 573 577 O
be NCT03866577 578 580 O
between NCT03866577 581 588 B-Eq_Comparison
the NCT03866577 589 592 I-Eq_Comparison
ages NCT03866577 593 597 I-Eq_Comparison
of NCT03866577 598 600 I-Eq_Comparison
18 NCT03866577 601 603 I-Eq_Comparison
to NCT03866577 604 606 I-Eq_Comparison
64 NCT03866577 607 609 I-Eq_Comparison
years NCT03866577 610 615 I-Eq_Comparison
and NCT03866577 616 619 B-And
diagnosed NCT03866577 620 629 O
with NCT03866577 630 634 O
ITP NCT03866577 635 638 B-Condition
at NCT03866577 639 641 B-Eq_Comparison
least NCT03866577 642 647 I-Eq_Comparison
3 NCT03866577 648 649 I-Eq_Comparison
months NCT03866577 650 656 I-Eq_Comparison
prior NCT03866577 657 662 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866577 663 665 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03866577 666 675 B-Study
, NCT03866577 676 677 O
stable NCT03866577 678 684 O
maintenance NCT03866577 685 696 B-Procedure
therapy NCT03866577 697 704 I-Procedure
for NCT03866577 705 708 O
at NCT03866577 709 711 B-Eq_Comparison
least NCT03866577 712 717 I-Eq_Comparison
4 NCT03866577 718 719 I-Eq_Comparison
weeks NCT03866577 720 725 I-Eq_Comparison
prior NCT03866577 726 731 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03866577 732 734 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03866577 735 738 O
first NCT03866577 739 744 B-Eq_Comparison
study NCT03866577 745 750 B-Study
visit NCT03866577 751 756 O
, NCT03866577 757 758 O
not NCT03866577 759 762 B-Negation
pregnant NCT03866577 763 771 B-Condition
or NCT03866577 772 774 B-Or
breastfeeding NCT03866577 775 788 B-Condition
, NCT03866577 789 790 O
and NCT03866577 791 794 B-And
no NCT03866577 795 797 B-Negation
other NCT03866577 798 803 B-Other
clinically NCT03866577 804 814 O
relevant NCT03866577 815 823 O
abnormalities NCT03866577 824 837 B-Condition
currently NCT03866577 838 847 B-Eq_Comparison
or NCT03866577 848 850 B-Or
in NCT03866577 851 853 O
their NCT03866577 854 859 O
history NCT03866577 860 867 B-Eq_Comparison
that NCT03866577 868 872 O
the NCT03866577 873 876 O
Investigator NCT03866577 877 889 O
would NCT03866577 890 895 O
deem NCT03866577 896 900 O
them NCT03866577 901 905 O
ineligible NCT03866577 906 916 O
to NCT03866577 917 919 O
participate NCT03866577 920 931 O
. NCT03866577 932 933 O


Inclusion NCT03864952 0 9 O
Criteria NCT03864952 10 18 O
: NCT03864952 19 20 O

- NCT03864952 24 25 O
three NCT03864952 27 32 B-Eq_Comparison
months NCT03864952 33 39 I-Eq_Comparison
before NCT03864952 40 46 I-Eq_Comparison
, NCT03864952 47 48 O
having NCT03864952 49 55 O
been NCT03864952 56 60 O
infected NCT03864952 61 69 B-Condition
with NCT03864952 70 74 O
a NCT03864952 75 76 O
documented NCT03864952 77 87 O
pathogen NCT03864952 88 96 B-Condition

- NCT03864952 99 100 O
this NCT03864952 102 106 O
infection NCT03864952 107 116 O
must NCT03864952 117 121 O
have NCT03864952 122 126 O
been NCT03864952 127 131 O
clinically NCT03864952 132 142 O
obvious NCT03864952 143 150 O

- NCT03864952 153 154 O
the NCT03864952 156 159 O
patient NCT03864952 160 167 O
must NCT03864952 168 172 O
have NCT03864952 173 177 O
dental NCT03864952 178 184 B-Condition
calculus NCT03864952 185 193 I-Condition

Exclusion NCT03864952 194 203 O
Criteria NCT03864952 204 212 O
: NCT03864952 213 214 O

- NCT03864952 218 219 O
to NCT03864952 221 223 O
be NCT03864952 224 226 O
under NCT03864952 227 232 B-Eq_Comparison
18 NCT03864952 233 235 I-Eq_Comparison
years NCT03864952 236 241 I-Eq_Comparison
old NCT03864952 242 245 B-Age

- NCT03864952 248 249 O
to NCT03864952 251 253 O
be NCT03864952 254 256 O
incapable NCT03864952 257 266 O
to NCT03864952 267 269 O
consenting NCT03864952 270 280 O

- NCT03864952 283 284 O
a NCT03864952 286 287 O
tartar NCT03864952 288 294 B-Procedure
removal NCT03864952 295 302 I-Procedure
since NCT03864952 303 308 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03864952 309 312 O
infection NCT03864952 313 322 O

Inclusion NCT03925779 0 9 O
Criteria NCT03925779 10 18 O
: NCT03925779 19 20 O

- NCT03925779 24 25 O
ASA NCT03925779 27 30 B-Observation
I NCT03925779 31 32 B-Eq_Comparison
or NCT03925779 33 35 I-Eq_Comparison
II NCT03925779 36 38 I-Eq_Comparison
physical NCT03925779 39 47 O
status NCT03925779 48 54 O

- NCT03925779 57 58 O
18 NCT03925779 60 62 B-Eq_Comparison
- NCT03925779 63 64 I-Eq_Comparison
65 NCT03925779 65 67 I-Eq_Comparison
years NCT03925779 68 73 I-Eq_Comparison

- NCT03925779 76 77 O
Scheduled NCT03925779 79 88 B-Eq_Comparison
for NCT03925779 89 92 O
elective NCT03925779 93 101 B-Modifier
colonoscopy NCT03925779 102 113 B-Procedure

Exclusion NCT03925779 114 123 O
Criteria NCT03925779 124 132 O
: NCT03925779 133 134 O

- NCT03925779 138 139 O
History NCT03925779 141 148 B-Eq_Comparison
of NCT03925779 149 151 O
allergy NCT03925779 152 159 B-Allergy
to NCT03925779 160 162 O
any NCT03925779 163 166 O
of NCT03925779 167 169 O
the NCT03925779 170 173 O
study NCT03925779 174 179 B-Study
drugs NCT03925779 180 185 B-Drug

- NCT03925779 188 189 O
Alcohol NCT03925779 191 198 B-Modifier
or NCT03925779 199 201 B-Or
drug NCT03925779 202 206 B-Modifier
abuse NCT03925779 207 212 B-Condition
. NCT03925779 213 214 O

- NCT03925779 218 219 O
Second NCT03925779 221 227 B-Eq_Comparison
and NCT03925779 228 231 I-Eq_Comparison
third NCT03925779 232 237 I-Eq_Comparison
- NCT03925779 238 239 I-Eq_Comparison
degree NCT03925779 240 246 I-Eq_Comparison
heart NCT03925779 247 252 B-Condition
block NCT03925779 253 258 I-Condition
. NCT03925779 259 260 O

- NCT03925779 264 265 O
Morbid NCT03925779 267 273 B-Condition
obesity NCT03925779 274 281 I-Condition
. NCT03925779 282 283 O

- NCT03925779 287 288 O
Pregnant NCT03925779 290 298 B-Condition
and NCT03925779 299 302 B-Or
lactating NCT03925779 303 312 B-Condition
women NCT03925779 313 318 O
. NCT03925779 319 320 O

- NCT03925779 324 325 O
Psychiatric NCT03925779 327 338 B-Condition
disorders NCT03925779 339 348 I-Condition
. NCT03925779 349 350 O

- NCT03925779 354 355 O
Severe NCT03925779 357 363 O
cardiac NCT03925779 364 371 B-Modifier
, NCT03925779 372 373 O
respiratory NCT03925779 374 385 B-Modifier
, NCT03925779 386 387 O
renal NCT03925779 388 393 B-Modifier
, NCT03925779 394 395 O
and NCT03925779 396 399 B-Or
liver NCT03925779 400 405 B-Modifier
diseases NCT03925779 406 414 B-Condition

Inclusion NCT03931616 0 9 O
Criteria NCT03931616 10 18 O
: NCT03931616 19 20 O

1 NCT03931616 24 25 O
. NCT03931616 25 26 O
Suspected NCT03931616 28 37 B-Assertion___Assertion_Type_Value:possible
acute NCT03931616 38 43 O
stroke NCT03931616 44 50 B-Condition
according NCT03931616 51 60 O
to NCT03931616 61 63 O
the NCT03931616 64 67 O
dispatcher NCT03931616 68 78 O
stroke NCT03931616 79 85 O
identification NCT03931616 86 100 O
algorithm NCT03931616 101 110 O
during NCT03931616 111 117 O
STEMO NCT03931616 118 123 O
hours NCT03931616 124 129 O
( NCT03931616 130 131 O
7 NCT03931616 132 133 O
am NCT03931616 134 136 O
- NCT03931616 137 138 O
11 NCT03931616 139 141 O
pm NCT03931616 142 144 O
, NCT03931616 145 146 O
Monday NCT03931616 147 153 O
- NCT03931616 154 155 O
Sunday NCT03931616 156 162 O
) NCT03931616 163 164 O
and NCT03931616 165 168 O
within NCT03931616 169 175 O
the NCT03931616 176 179 O
STEMO NCT03931616 180 185 O
catchment NCT03931616 186 195 O
area NCT03931616 196 200 O
Inclusion NCT03931616 201 210 O
criteria NCT03931616 211 219 O
for NCT03931616 220 223 O
primary NCT03931616 224 231 O
study NCT03931616 232 237 O
population NCT03931616 238 248 O
: NCT03931616 249 250 O

2 NCT03931616 254 255 O
. NCT03931616 255 256 O
Final NCT03931616 258 263 O
diagnosis NCT03931616 264 273 O
of NCT03931616 274 276 O
ischemic NCT03931616 277 285 B-Condition
stroke NCT03931616 286 292 I-Condition
( NCT03931616 293 294 O
ICD NCT03931616 295 298 O
10 NCT03931616 299 301 O
: NCT03931616 302 303 O
I NCT03931616 304 305 O
63 NCT03931616 306 308 O
) NCT03931616 309 310 O
or NCT03931616 311 313 B-Or
TIA NCT03931616 314 317 B-Condition
( NCT03931616 318 319 O
Transient NCT03931616 320 329 B-Condition
Ischemic NCT03931616 330 338 I-Condition
Attack NCT03931616 339 345 I-Condition
, NCT03931616 346 347 O
ICD NCT03931616 348 351 O
10 NCT03931616 352 354 O
: NCT03931616 355 356 O
G NCT03931616 357 358 O
45 NCT03931616 359 361 O
except NCT03931616 362 368 B-Exception
G NCT03931616 369 370 B-Condition
45.4 NCT03931616 371 375 I-Condition
) NCT03931616 376 377 O

3 NCT03931616 381 382 O
. NCT03931616 382 383 O
Confirmed NCT03931616 385 394 O
onset NCT03931616 395 400 B-Observation
- NCT03931616 401 402 I-Observation
to NCT03931616 403 405 I-Observation
- NCT03931616 406 407 I-Observation
alarm NCT03931616 408 413 I-Observation
time NCT03931616 414 418 I-Observation
≤ NCT03931616 419 420 B-Eq_Comparison
4 NCT03931616 421 422 I-Eq_Comparison
hours NCT03931616 423 428 I-Eq_Comparison
at NCT03931616 429 431 O
dispatch NCT03931616 432 440 O

4 NCT03931616 443 444 O
. NCT03931616 444 445 O
Pre NCT03931616 447 450 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03931616 451 452 O
stroke NCT03931616 453 459 B-Condition
modified NCT03931616 460 468 B-Observation
Rankin NCT03931616 469 475 I-Observation
scale NCT03931616 476 481 I-Observation
≤ NCT03931616 482 483 B-Eq_Comparison
3 NCT03931616 484 485 I-Eq_Comparison
( NCT03931616 486 487 O
being NCT03931616 488 493 O
able NCT03931616 494 498 B-Condition
to NCT03931616 499 501 I-Condition
ambulate NCT03931616 502 510 I-Condition
, NCT03931616 511 512 O
in NCT03931616 513 515 O
routine NCT03931616 516 523 O
clinical NCT03931616 524 532 O
care NCT03931616 533 537 O
, NCT03931616 538 539 O
patients NCT03931616 540 548 O
with NCT03931616 549 553 O
mRS NCT03931616 554 557 B-Observation
up NCT03931616 558 560 B-Eq_Comparison
to NCT03931616 561 563 I-Eq_Comparison
3 NCT03931616 564 565 I-Eq_Comparison
are NCT03931616 566 569 O
usually NCT03931616 570 577 O
deemed NCT03931616 578 584 O
suitable NCT03931616 585 593 O
for NCT03931616 594 597 O
tissue NCT03931616 598 604 O
plasminogen NCT03931616 605 616 O
activator NCT03931616 617 626 O
treatment NCT03931616 627 636 O
) NCT03931616 637 638 O

Exclusion NCT03931616 640 649 O
Criteria NCT03931616 650 658 O
: NCT03931616 659 660 O

1 NCT03931616 664 665 O
. NCT03931616 665 666 O
Remission NCT03931616 668 677 O
of NCT03931616 678 680 O
disabling NCT03931616 681 690 B-Condition
symptoms NCT03931616 691 699 B-Assertion___Assertion_Type_Value:possible
until NCT03931616 700 705 O
arrival NCT03931616 706 713 O
of NCT03931616 714 716 O
emergency NCT03931616 717 726 O
medical NCT03931616 727 734 O
service NCT03931616 735 742 O

2 NCT03931616 745 746 O
. NCT03931616 746 747 O
Malignant NCT03931616 749 758 B-Modifier
or NCT03931616 759 761 B-Or
other NCT03931616 762 767 B-Modifier
severe NCT03931616 768 774 O
primary NCT03931616 775 782 B-Condition
disease NCT03931616 783 790 I-Condition
with NCT03931616 791 795 B-And
life NCT03931616 796 800 B-Observation
expectancy NCT03931616 801 811 I-Observation
< NCT03931616 812 813 B-Eq_Comparison
1 NCT03931616 814 815 I-Eq_Comparison
year NCT03931616 816 820 I-Eq_Comparison
Additional NCT03931616 821 831 O
exclusion NCT03931616 832 841 O
criteria NCT03931616 842 850 O
for NCT03931616 851 854 O
primary NCT03931616 855 862 O
study NCT03931616 863 868 O
population NCT03931616 869 879 O
: NCT03931616 880 881 O

3 NCT03931616 885 886 O
. NCT03931616 886 887 O
Major NCT03931616 889 894 O
surgery NCT03931616 895 902 B-Procedure
within NCT03931616 903 909 B-Eq_Comparison
4 NCT03931616 910 911 I-Eq_Comparison
weeks NCT03931616 912 917 I-Eq_Comparison
before NCT03931616 918 924 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03931616 925 930 B-Study
inclusion NCT03931616 931 940 O

4 NCT03931616 943 944 O
. NCT03931616 944 945 O
Confirmed NCT03931616 947 956 O
stroke NCT03931616 957 963 B-Condition
within NCT03931616 964 970 B-Eq_Comparison
3 NCT03931616 971 972 I-Eq_Comparison
months NCT03931616 973 979 I-Eq_Comparison
before NCT03931616 980 986 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03931616 987 992 B-Study
inclusion NCT03931616 993 1002 I-Study

5 NCT03931616 1005 1006 O
. NCT03931616 1006 1007 O
Absolute NCT03931616 1009 1017 O
contraindications NCT03931616 1018 1035 B-Contraindication
for NCT03931616 1036 1039 O
thrombolysis NCT03931616 1040 1052 B-Procedure
AND NCT03931616 1053 1056 B-And
thrombectomy NCT03931616 1057 1069 B-Procedure

Inclusion NCT03868332 0 9 O
Criteria NCT03868332 10 18 O
: NCT03868332 19 20 O

Patients NCT03868332 22 30 O
who NCT03868332 31 34 O
are NCT03868332 35 38 O
diagnosed NCT03868332 39 48 O
as NCT03868332 49 51 O
ulcerative NCT03868332 52 62 B-Condition
colitis NCT03868332 63 70 I-Condition
/ NCT03868332 71 72 B-Or
Crhon NCT03868332 73 78 B-Condition
s NCT03868332 79 80 I-Condition
disease NCT03868332 81 88 I-Condition
however NCT03868332 89 96 O
in NCT03868332 97 99 O
activity NCT03868332 100 108 B-Eq_Comparison
or NCT03868332 109 111 B-Or

in NCT03868332 112 114 B-Eq_Comparison
remission NCT03868332 115 124 I-Eq_Comparison
attending NCT03868332 125 134 B-Encounter
the NCT03868332 135 138 O
the NCT03868332 139 142 O
outpatient NCT03868332 143 153 O
clinics NCT03868332 154 161 O
and NCT03868332 162 165 B-Or
inpatient NCT03868332 166 175 B-Encounter
of NCT03868332 176 178 O
gastroenterology NCT03868332 179 195 O
units NCT03868332 196 201 O

of NCT03868332 202 204 O
Internal NCT03868332 205 213 O
medicine NCT03868332 214 222 O
department NCT03868332 223 233 O

Exclusion NCT03868332 234 243 O
Criteria NCT03868332 244 252 O
: NCT03868332 253 254 O

- NCT03868332 258 259 O
Previous NCT03868332 261 269 B-Eq_Comparison
history NCT03868332 270 277 I-Eq_Comparison
of NCT03868332 278 280 O
hypertension NCT03868332 281 293 B-Condition
, NCT03868332 294 295 O
diabetes NCT03868332 296 304 B-Condition
mellitus NCT03868332 305 313 I-Condition
, NCT03868332 314 315 O
Dyslipidemia NCT03868332 316 328 B-Condition

- NCT03868332 331 332 O
Previous NCT03868332 334 342 B-Eq_Comparison
history NCT03868332 343 350 I-Eq_Comparison
of NCT03868332 351 353 O
cardiovascular NCT03868332 354 368 B-Modifier
or NCT03868332 369 371 B-Or
cerebrovascular NCT03868332 372 387 B-Modifier
events NCT03868332 388 394 B-Condition

- NCT03868332 397 398 O
Autoimmune NCT03868332 400 410 B-Modifier
, NCT03868332 411 412 O
Neoplastic NCT03868332 413 423 B-Modifier
diseases NCT03868332 424 432 B-Condition

- NCT03868332 435 436 O
Thromboembolic NCT03868332 438 452 B-Condition
diseases NCT03868332 453 461 I-Condition

Inclusion NCT03929328 0 9 O
Criteria NCT03929328 10 18 O
: NCT03929328 19 20 O

- NCT03929328 24 25 O
Adult NCT03929328 27 32 O
patients NCT03929328 33 41 O
aged NCT03929328 42 46 B-Age
18 NCT03929328 47 49 B-Eq_Comparison
years NCT03929328 50 55 I-Eq_Comparison
or NCT03929328 56 58 I-Eq_Comparison
more NCT03929328 59 63 I-Eq_Comparison
, NCT03929328 64 65 O
both NCT03929328 66 70 O
gender NCT03929328 71 77 O

- NCT03929328 80 81 O
Receiving NCT03929328 83 92 B-Eq_Comparison
endotracheal NCT03929328 93 105 B-Modifier
intubation NCT03929328 106 116 B-Procedure
and NCT03929328 117 120 B-And
mechanical NCT03929328 121 131 B-Modifier
ventilation NCT03929328 132 143 B-Procedure
for NCT03929328 144 147 O
more NCT03929328 148 152 B-Eq_Comparison
than NCT03929328 153 157 I-Eq_Comparison
12 NCT03929328 158 160 I-Eq_Comparison
hours NCT03929328 161 166 I-Eq_Comparison

- NCT03929328 169 170 O
Recovery NCT03929328 172 180 O
from NCT03929328 181 185 O
the NCT03929328 186 189 O
precipitating NCT03929328 190 203 O
illness NCT03929328 204 211 B-Condition

- NCT03929328 214 215 O
Weaning NCT03929328 217 224 O
readiness NCT03929328 225 234 O
according NCT03929328 235 244 O
to NCT03929328 245 247 O
the NCT03929328 248 251 O
following NCT03929328 252 261 O
criteria NCT03929328 262 270 O
: NCT03929328 271 272 O

1 NCT03929328 281 282 O
. NCT03929328 282 283 O
Respiratory NCT03929328 285 296 O
criteria NCT03929328 297 305 O
: NCT03929328 306 307 O

1 NCT03929328 321 322 O
. NCT03929328 322 323 O
PaO NCT03929328 325 328 B-Observation
2 NCT03929328 329 330 I-Observation
: NCT03929328 331 332 O
FIO NCT03929328 333 336 O
2 NCT03929328 337 338 O
> NCT03929328 339 340 B-Eq_Comparison
150 NCT03929328 341 344 I-Eq_Comparison
with NCT03929328 345 349 B-And
FIO NCT03929328 350 353 B-Observation
2 NCT03929328 354 355 I-Observation
≤ NCT03929328 356 357 B-Eq_Comparison
0.4 NCT03929328 358 361 I-Eq_Comparison
, NCT03929328 362 363 O
PEEP NCT03929328 364 368 B-Observation
< NCT03929328 369 370 B-Eq_Comparison
8 NCT03929328 371 372 I-Eq_Comparison
cm NCT03929328 373 375 I-Eq_Comparison
H NCT03929328 376 377 I-Eq_Comparison
2O NCT03929328 378 380 I-Eq_Comparison

2 NCT03929328 393 394 O
. NCT03929328 394 395 O
Arterial NCT03929328 397 405 B-Observation
pH NCT03929328 406 408 I-Observation
> NCT03929328 409 410 B-Eq_Comparison
7.35 NCT03929328 411 415 I-Eq_Comparison

3 NCT03929328 429 430 O
. NCT03929328 430 431 O
Rapid NCT03929328 433 438 B-Observation
shallow NCT03929328 439 446 I-Observation
breathing NCT03929328 447 456 I-Observation
index NCT03929328 457 462 I-Observation
( NCT03929328 463 464 O
RSBI NCT03929328 465 469 B-Observation
) NCT03929328 470 471 O
< NCT03929328 472 473 B-Eq_Comparison
105 NCT03929328 474 477 I-Eq_Comparison

4 NCT03929328 491 492 O
. NCT03929328 492 493 O
Maximum NCT03929328 495 502 B-Observation
inspiratory NCT03929328 503 514 I-Observation
pressure NCT03929328 515 523 I-Observation
( NCT03929328 524 525 O
MIP NCT03929328 526 529 B-Observation
) NCT03929328 530 531 O
< NCT03929328 532 533 B-Eq_Comparison
- NCT03929328 534 535 I-Eq_Comparison
20 NCT03929328 536 538 I-Eq_Comparison
cm NCT03929328 539 541 I-Eq_Comparison
H NCT03929328 542 543 I-Eq_Comparison
20 NCT03929328 544 546 I-Eq_Comparison

2 NCT03929328 555 556 O
. NCT03929328 556 557 O
Clinical NCT03929328 559 567 O
criteria NCT03929328 568 576 O
: NCT03929328 577 578 O

1 NCT03929328 592 593 O
. NCT03929328 593 594 O
Absence NCT03929328 596 603 B-Negation
of NCT03929328 604 606 O
electrocardiographic NCT03929328 607 627 B-Procedure
signs NCT03929328 628 633 B-Assertion___Assertion_Type_Value:possible
of NCT03929328 634 636 O
myocardial NCT03929328 637 647 B-Condition
ischemia NCT03929328 648 656 I-Condition

2 NCT03929328 669 670 O
. NCT03929328 670 671 O
No NCT03929328 673 675 B-Negation
vasoactive NCT03929328 676 686 B-Drug
drugs NCT03929328 687 692 I-Drug
, NCT03929328 693 694 O
or NCT03929328 695 697 B-Or
vital NCT03929328 698 703 B-Observation
signs NCT03929328 704 709 I-Observation
are NCT03929328 710 713 O
stable NCT03929328 714 720 O
with NCT03929328 721 725 B-And
using NCT03929328 726 731 B-Eq_Comparison
vasoactive NCT03929328 732 742 B-Drug
drugs NCT03929328 743 748 I-Drug

3 NCT03929328 761 762 O
. NCT03929328 762 763 O
Heart NCT03929328 765 770 B-Observation
rate NCT03929328 771 775 I-Observation
< NCT03929328 776 777 B-Eq_Comparison
140 NCT03929328 778 781 I-Eq_Comparison
/ NCT03929328 782 783 I-Eq_Comparison
min NCT03929328 784 787 I-Eq_Comparison
, NCT03929328 788 789 O

4 NCT03929328 803 804 O
. NCT03929328 804 805 O
Hemoglobin NCT03929328 807 817 B-Observation
> NCT03929328 818 819 B-Eq_Comparison
8 NCT03929328 820 821 I-Eq_Comparison
g NCT03929328 822 823 I-Eq_Comparison
/ NCT03929328 824 825 I-Eq_Comparison
dL NCT03929328 826 828 I-Eq_Comparison

5 NCT03929328 841 842 O
. NCT03929328 842 843 O
Temperature NCT03929328 845 856 B-Observation
< NCT03929328 857 858 B-Eq_Comparison
38 NCT03929328 859 861 I-Eq_Comparison
° NCT03929328 862 863 I-Eq_Comparison
C NCT03929328 863 864 I-Eq_Comparison

6 NCT03929328 877 878 O
. NCT03929328 878 879 O
No NCT03929328 881 883 B-Negation
need NCT03929328 884 888 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03929328 889 892 O
sedatives NCT03929328 893 902 B-Drug
, NCT03929328 903 904 O
or NCT03929328 905 907 B-Or
mental NCT03929328 908 914 B-Condition
status NCT03929328 915 921 I-Condition
are NCT03929328 922 925 O
stable NCT03929328 926 932 O
with NCT03929328 933 937 B-And
sedatives NCT03929328 938 947 B-Drug

7 NCT03929328 960 961 O
. NCT03929328 961 962 O
Presence NCT03929328 964 972 O
of NCT03929328 973 975 O
respiratory NCT03929328 976 987 B-Condition
stimulus NCT03929328 988 996 I-Condition
, NCT03929328 997 998 O
and NCT03929328 999 1002 B-And
appropriate NCT03929328 1003 1014 O
spontaneous NCT03929328 1015 1026 B-Condition
cough NCT03929328 1027 1032 I-Condition

8 NCT03929328 1045 1046 O
. NCT03929328 1046 1047 O
Absence NCT03929328 1049 1056 B-Negation
of NCT03929328 1057 1059 O
excessive NCT03929328 1060 1069 O
tracheobronchial NCT03929328 1070 1086 B-Condition
secretions NCT03929328 1087 1097 I-Condition

Exclusion NCT03929328 1098 1107 O
Criteria NCT03929328 1108 1116 O
: NCT03929328 1117 1118 O

- NCT03929328 1122 1123 O
Tracheostomy NCT03929328 1125 1137 B-Procedure
status NCT03929328 1138 1144 O

- NCT03929328 1147 1148 O
Decision NCT03929328 1150 1158 O
to NCT03929328 1159 1161 O
stop NCT03929328 1162 1166 B-Negation
life NCT03929328 1167 1171 B-Procedure
- NCT03929328 1172 1173 I-Procedure
supportive NCT03929328 1174 1184 I-Procedure
therapies NCT03929328 1185 1194 I-Procedure
before NCT03929328 1195 1201 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03929328 1202 1212 B-Study

Inclusion NCT03861468 0 9 O
Criteria NCT03861468 10 18 O
: NCT03861468 19 20 O

- NCT03861468 24 25 O
Patients NCT03861468 27 35 O
aged NCT03861468 36 40 B-Age
from NCT03861468 41 45 O
18 NCT03861468 46 48 B-Eq_Comparison
to NCT03861468 49 51 I-Eq_Comparison
80 NCT03861468 52 54 I-Eq_Comparison
years NCT03861468 55 60 I-Eq_Comparison

- NCT03861468 63 64 O
Obese NCT03861468 66 71 B-Condition
( NCT03861468 72 73 O
BMI NCT03861468 74 77 B-Observation
≥ NCT03861468 78 79 B-Eq_Comparison
30 NCT03861468 80 82 I-Eq_Comparison
kg NCT03861468 83 85 I-Eq_Comparison
/ NCT03861468 86 87 I-Eq_Comparison
m² NCT03861468 88 90 I-Eq_Comparison
) NCT03861468 91 92 O

- NCT03861468 96 97 O
Referred NCT03861468 99 107 B-Encounter
by NCT03861468 108 110 O
GPs NCT03861468 111 114 B-Provider
to NCT03861468 115 117 O
the NCT03861468 118 121 O
medical NCT03861468 122 129 O
analysis NCT03861468 130 138 O
laboratory NCT03861468 139 149 O
for NCT03861468 150 153 O
usual NCT03861468 154 159 O
biological NCT03861468 160 170 B-Observation
assessment NCT03861468 171 181 I-Observation

- NCT03861468 184 185 O
Patients NCT03861468 187 195 O
with NCT03861468 196 200 O
no NCT03861468 201 203 B-Negation
respiratory NCT03861468 204 215 B-Condition
follow NCT03861468 216 222 B-Encounter
- NCT03861468 223 224 I-Encounter
up NCT03861468 225 227 I-Encounter
already NCT03861468 228 235 B-Eq_Comparison
in NCT03861468 236 238 O
place NCT03861468 239 244 O

- NCT03861468 247 248 O
Bicarbonate NCT03861468 250 261 B-Observation
- NCT03861468 262 263 I-Observation
Concentration NCT03861468 264 277 I-Observation
≥ NCT03861468 278 279 B-Eq_Comparison
27 NCT03861468 280 282 I-Eq_Comparison
mmol NCT03861468 283 287 I-Eq_Comparison
/ NCT03861468 288 289 I-Eq_Comparison
L NCT03861468 290 291 I-Eq_Comparison

- NCT03861468 294 295 O
STOP NCT03861468 297 301 B-Observation
- NCT03861468 302 303 I-Observation
BANG NCT03861468 304 308 I-Observation
score NCT03861468 309 314 O
≥ NCT03861468 315 316 B-Eq_Comparison
3 NCT03861468 317 318 I-Eq_Comparison

Exclusion NCT03861468 320 329 O
Criteria NCT03861468 330 338 O
: NCT03861468 339 340 O

- NCT03861468 344 345 O
Acute NCT03861468 347 352 O
disease NCT03861468 353 360 B-Condition
or NCT03861468 361 363 B-Or
recently NCT03861468 364 372 B-Eq_Comparison
diagnosed NCT03861468 373 382 O
chronic NCT03861468 383 390 O
disease NCT03861468 391 398 B-Condition
( NCT03861468 399 400 O
< NCT03861468 401 402 B-Eq_Comparison
2 NCT03861468 403 404 I-Eq_Comparison
months NCT03861468 405 411 I-Eq_Comparison
) NCT03861468 412 413 O

- NCT03861468 417 418 O
Hospitalization NCT03861468 420 435 B-Encounter
for NCT03861468 436 439 O
respiratory NCT03861468 440 451 B-Modifier
, NCT03861468 452 453 O
metabolic NCT03861468 454 463 B-Modifier
or NCT03861468 464 466 B-Or
cardiovascular NCT03861468 467 481 B-Modifier
event NCT03861468 482 487 B-Condition
( NCT03861468 488 489 O
< NCT03861468 490 491 B-Eq_Comparison
2 NCT03861468 492 493 I-Eq_Comparison
months NCT03861468 494 500 I-Eq_Comparison
) NCT03861468 501 502 O

- NCT03861468 506 507 O
Renal NCT03861468 509 514 B-Condition
insufficiency NCT03861468 515 528 I-Condition
stage NCT03861468 529 534 B-Eq_Comparison
4 NCT03861468 535 536 I-Eq_Comparison
or NCT03861468 537 539 I-Eq_Comparison
5 NCT03861468 540 541 I-Eq_Comparison
, NCT03861468 542 543 O
or NCT03861468 544 546 B-Or
autoimmune NCT03861468 547 557 B-Condition
disease NCT03861468 558 565 I-Condition
, NCT03861468 566 567 O
or NCT03861468 568 570 B-Or
viral NCT03861468 571 576 B-Condition
hepatitis NCT03861468 577 586 I-Condition
, NCT03861468 587 588 O
or NCT03861468 589 591 B-Or
cirrhosis NCT03861468 592 601 B-Condition

- NCT03861468 604 605 O
Pregnant NCT03861468 607 615 B-Condition
women NCT03861468 616 621 O

- NCT03861468 624 625 O
Patients NCT03861468 627 635 O
already NCT03861468 636 643 O
included NCT03861468 644 652 O
in NCT03861468 653 655 O
an NCT03861468 656 658 O
interventional NCT03861468 659 673 B-Study
study NCT03861468 674 679 I-Study
( NCT03861468 680 681 O
end NCT03861468 682 685 O
of NCT03861468 686 688 O
the NCT03861468 689 692 O
study NCT03861468 693 698 B-Study
< NCT03861468 699 700 B-Eq_Comparison
1 NCT03861468 701 702 I-Eq_Comparison
month NCT03861468 703 708 I-Eq_Comparison
) NCT03861468 709 710 O

Inclusion NCT03922126 0 9 O
Criteria NCT03922126 10 18 O
: NCT03922126 19 20 O

- NCT03922126 24 25 O
male NCT03922126 27 31 O
sex NCT03922126 32 35 O
( NCT03922126 36 37 O
at NCT03922126 38 40 B-Temporal_Connection___Temporal_Connection_Type_Value:during
birth NCT03922126 41 46 B-Birth
) NCT03922126 47 48 O

- NCT03922126 52 53 O
adult NCT03922126 55 60 O
aged NCT03922126 61 65 B-Age
18 NCT03922126 66 68 B-Eq_Comparison
and NCT03922126 69 72 I-Eq_Comparison
older NCT03922126 73 78 I-Eq_Comparison

- NCT03922126 81 82 O
immigrant NCT03922126 84 93 B-Observation
( NCT03922126 94 95 O
not NCT03922126 96 99 B-Negation
born NCT03922126 100 104 B-Birth
in NCT03922126 105 107 O
continental NCT03922126 108 119 O
U NCT03922126 120 121 O
. NCT03922126 122 123 O
S NCT03922126 124 125 O
. NCT03922126 126 127 O
) NCT03922126 128 129 O

- NCT03922126 133 134 O
Latino NCT03922126 136 142 O
( NCT03922126 143 144 O
identifies NCT03922126 145 155 O
as NCT03922126 156 158 O
either NCT03922126 159 165 O
Latinx NCT03922126 166 172 O
or NCT03922126 173 175 B-Or
Hispanic NCT03922126 176 184 O

- NCT03922126 187 188 O
reports NCT03922126 190 197 O
sex NCT03922126 198 201 B-Observation
with NCT03922126 202 206 I-Observation
men NCT03922126 207 210 I-Observation
in NCT03922126 211 213 O
past NCT03922126 214 218 B-Eq_Comparison
12 NCT03922126 219 221 I-Eq_Comparison
months NCT03922126 222 228 I-Eq_Comparison

- NCT03922126 231 232 O
reports NCT03922126 234 241 O
not NCT03922126 242 245 B-Negation
knowing NCT03922126 246 253 B-Assertion___Assertion_Type_Value:hypothetical
their NCT03922126 254 259 O
HIV NCT03922126 260 263 B-Condition
status NCT03922126 264 270 O
or NCT03922126 271 273 B-Or
being NCT03922126 274 279 O
HIV NCT03922126 280 283 B-Condition
negative NCT03922126 284 292 O

Exclusion NCT03922126 293 302 O
Criteria NCT03922126 303 311 O
: NCT03922126 312 313 O

- NCT03922126 317 318 O
Does NCT03922126 320 324 O
not NCT03922126 325 328 B-Negation
identify NCT03922126 329 337 O
as NCT03922126 338 340 O
Latino NCT03922126 341 347 O
/ NCT03922126 348 349 B-Or
Hispanic NCT03922126 350 358 O

- NCT03922126 361 362 O
Born NCT03922126 364 368 B-Birth
in NCT03922126 369 371 O
the NCT03922126 372 375 O
continental NCT03922126 376 387 O
U NCT03922126 388 389 O
. NCT03922126 390 391 O
S NCT03922126 392 393 O
. NCT03922126 394 395 O

- NCT03922126 399 400 O
Female NCT03922126 402 408 O
sex NCT03922126 409 412 O
( NCT03922126 413 414 O
at NCT03922126 415 417 B-Temporal_Connection___Temporal_Connection_Type_Value:during
birth NCT03922126 418 423 B-Birth
) NCT03922126 424 425 O

- NCT03922126 429 430 O
Does NCT03922126 432 436 O
not NCT03922126 437 440 B-Negation
report NCT03922126 441 447 O
sex NCT03922126 448 451 B-Observation
with NCT03922126 452 456 I-Observation
men NCT03922126 457 460 I-Observation
in NCT03922126 461 463 O
the NCT03922126 464 467 O
last NCT03922126 468 472 B-Eq_Comparison
12 NCT03922126 473 475 I-Eq_Comparison
months NCT03922126 476 482 I-Eq_Comparison

- NCT03922126 485 486 O
Reports NCT03922126 488 495 O
being NCT03922126 496 501 O
HIV NCT03922126 502 505 B-Condition
positive NCT03922126 506 514 O

- NCT03922126 517 518 O
Younger NCT03922126 520 527 B-Eq_Comparison
than NCT03922126 528 532 I-Eq_Comparison
18 NCT03922126 533 535 I-Eq_Comparison
years NCT03922126 536 541 I-Eq_Comparison
old NCT03922126 542 545 B-Age

Healthy NCT03924479 0 7 B-Observation
subjects NCT03924479 8 16 O
: NCT03924479 17 18 O
Adults NCT03924479 19 25 O
( NCT03924479 26 27 O
≥ NCT03924479 28 29 B-Eq_Comparison
21 NCT03924479 30 32 I-Eq_Comparison
years NCT03924479 33 38 I-Eq_Comparison
of NCT03924479 39 41 O
age NCT03924479 42 45 B-Age
) NCT03924479 46 47 O
in NCT03924479 48 50 O
the NCT03924479 51 54 O
absence NCT03924479 55 62 B-Negation
of NCT03924479 63 65 O
a NCT03924479 66 67 O
history NCT03924479 68 75 B-Condition
of NCT03924479 76 78 I-Condition
HFpEF NCT03924479 79 84 O
or NCT03924479 85 87 B-Or
HFrEF NCT03924479 88 93 B-Condition
, NCT03924479 94 95 O
pulmonary NCT03924479 96 105 B-Modifier
, NCT03924479 106 107 O
neurologic NCT03924479 108 118 B-Modifier
, NCT03924479 119 120 O
orthopedic NCT03924479 121 131 B-Modifier
, NCT03924479 132 133 O
or NCT03924479 134 136 B-Or
other NCT03924479 137 142 B-Modifier
diseases NCT03924479 143 151 B-Condition
affecting NCT03924479 152 161 I-Condition
the NCT03924479 162 165 I-Condition
neuromuscular NCT03924479 166 179 I-Condition
system NCT03924479 180 186 I-Condition
. NCT03924479 187 188 O

Controls NCT03924479 190 198 O
will NCT03924479 199 203 O
be NCT03924479 204 206 O
matched NCT03924479 207 214 O
for NCT03924479 215 218 O
age NCT03924479 219 222 O
and NCT03924479 223 226 O
sex NCT03924479 227 230 O
. NCT03924479 231 232 O

All NCT03924479 234 237 O
HFpEF NCT03924479 238 243 B-Condition
patients NCT03924479 244 252 O
will NCT03924479 253 257 O
be NCT03924479 258 260 O
managed NCT03924479 261 268 O
by NCT03924479 269 271 O
their NCT03924479 272 277 O
primary NCT03924479 278 285 O
care NCT03924479 286 290 O
physician NCT03924479 291 300 O
or NCT03924479 301 303 O
cardiologist NCT03924479 304 316 O
with NCT03924479 317 321 O
additional NCT03924479 322 332 O
review NCT03924479 333 339 O
and NCT03924479 340 343 O
oversight NCT03924479 344 353 O
by NCT03924479 354 356 O
Dr NCT03924479 357 359 B-Provider
. NCT03924479 360 361 I-Provider
Borlaug NCT03924479 363 370 I-Provider
( NCT03924479 371 372 O
Co NCT03924479 373 375 O
- NCT03924479 376 377 O
Investigator NCT03924479 378 390 O
) NCT03924479 391 392 O
prior NCT03924479 393 398 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03924479 399 401 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03924479 402 412 B-Study
to NCT03924479 413 415 O
ensure NCT03924479 416 422 O
adequacy NCT03924479 423 431 O
of NCT03924479 432 434 O
inclusion NCT03924479 435 444 O
and NCT03924479 445 448 O
exclusion NCT03924479 449 458 O
criteria NCT03924479 459 467 O
and NCT03924479 468 471 O
that NCT03924479 472 476 O
participation NCT03924479 477 490 O
in NCT03924479 491 493 O
exercise NCT03924479 494 502 O
testing NCT03924479 503 510 O
and NCT03924479 511 514 O
resistance NCT03924479 515 525 O
exercise NCT03924479 526 534 O
training NCT03924479 535 543 O
is NCT03924479 544 546 O
safe NCT03924479 547 551 O
. NCT03924479 552 553 O

Inclusion NCT03924479 555 564 O
Criteria NCT03924479 565 573 O
for NCT03924479 574 577 O
HFpEF NCT03924479 578 583 O
, NCT03924479 584 585 O
includes NCT03924479 586 594 O
: NCT03924479 595 596 O

- NCT03924479 600 601 O
Clinical NCT03924479 603 611 O
diagnosis NCT03924479 612 621 O
of NCT03924479 622 624 O
HFpEF NCT03924479 625 630 B-Condition
. NCT03924479 631 632 O

- NCT03924479 636 637 O
Patients NCT03924479 639 647 O
with NCT03924479 648 652 O
a NCT03924479 653 654 O
history NCT03924479 655 662 B-Eq_Comparison
stable NCT03924479 663 669 O
( NCT03924479 670 671 O
no NCT03924479 672 674 B-Negation
medication NCT03924479 675 685 B-Drug
changes NCT03924479 686 693 O
in NCT03924479 694 696 O
past NCT03924479 697 701 B-Eq_Comparison
6 NCT03924479 702 703 I-Eq_Comparison
weeks NCT03924479 704 709 I-Eq_Comparison
( NCT03924479 710 711 O
w NCT03924479 712 713 O
/ NCT03924479 714 715 O
duration NCT03924479 716 724 O
of NCT03924479 725 727 O
diagnosis NCT03924479 728 737 O
> NCT03924479 738 739 B-Eq_Comparison
6 NCT03924479 740 741 I-Eq_Comparison
months NCT03924479 742 748 I-Eq_Comparison
) NCT03924479 749 750 O
. NCT03924479 751 752 O

- NCT03924479 756 757 O
New NCT03924479 759 762 B-Observation
York NCT03924479 763 767 I-Observation
Heart NCT03924479 768 773 I-Observation
Association NCT03924479 774 785 I-Observation
class NCT03924479 786 791 B-Eq_Comparison
I NCT03924479 792 793 I-Eq_Comparison
- NCT03924479 794 795 I-Eq_Comparison
III NCT03924479 796 799 I-Eq_Comparison
. NCT03924479 800 801 O

- NCT03924479 805 806 O
Current NCT03924479 808 815 B-Eq_Comparison
non NCT03924479 816 819 B-Negation
- NCT03924479 820 821 O
smokers NCT03924479 822 829 B-Condition
with NCT03924479 830 834 O
< NCT03924479 835 836 B-Eq_Comparison
15 NCT03924479 837 839 I-Eq_Comparison
pack NCT03924479 840 844 I-Eq_Comparison
year NCT03924479 845 849 I-Eq_Comparison
history NCT03924479 850 857 B-Eq_Comparison
. NCT03924479 858 859 O

- NCT03924479 863 864 O
Non NCT03924479 866 869 B-Negation
- NCT03924479 870 871 O
pregnant NCT03924479 872 880 B-Condition
women NCT03924479 881 886 O
, NCT03924479 887 888 O
and NCT03924479 889 892 B-And
individuals NCT03924479 893 904 O
who NCT03924479 905 908 O
are NCT03924479 909 912 O
able NCT03924479 913 917 B-Observation
to NCT03924479 918 920 I-Observation
exercise NCT03924479 921 929 I-Observation
( NCT03924479 930 931 O
i NCT03924479 932 933 O
. NCT03924479 934 935 O
e NCT03924479 936 937 O
. NCT03924479 938 939 O
without NCT03924479 941 948 B-Negation
orthopedic NCT03924479 949 959 B-Condition
limitations NCT03924479 960 971 I-Condition
or NCT03924479 972 974 B-Or
neuromuscular NCT03924479 975 988 B-Condition
disorders NCT03924479 989 998 I-Condition
) NCT03924479 999 1000 O
. NCT03924479 1001 1002 O

Exclusion NCT03924479 1004 1013 O
Criteria NCT03924479 1014 1022 O
for NCT03924479 1023 1026 O
all NCT03924479 1027 1030 O
subjects NCT03924479 1031 1039 O
, NCT03924479 1040 1041 O
includes NCT03924479 1042 1050 O
: NCT03924479 1051 1052 O

- NCT03924479 1056 1057 O
history NCT03924479 1059 1066 B-Eq_Comparison
of NCT03924479 1067 1069 O
dangerous NCT03924479 1070 1079 O
arrhythmias NCT03924479 1080 1091 B-Condition

- NCT03924479 1094 1095 O
body NCT03924479 1097 1101 B-Observation
mass NCT03924479 1102 1106 I-Observation
index NCT03924479 1107 1112 I-Observation
> NCT03924479 1113 1114 B-Eq_Comparison
35 NCT03924479 1115 1117 I-Eq_Comparison
kg NCT03924479 1118 1120 I-Eq_Comparison
/ NCT03924479 1121 1122 I-Eq_Comparison
m NCT03924479 1123 1124 I-Eq_Comparison
2 NCT03924479 1125 1126 I-Eq_Comparison

- NCT03924479 1129 1130 O
current NCT03924479 1132 1139 B-Eq_Comparison
smokers NCT03924479 1140 1147 B-Condition
and NCT03924479 1148 1151 B-Or
/ NCT03924479 1152 1153 I-Or
or NCT03924479 1154 1156 I-Or
smoking NCT03924479 1157 1164 B-Observation
history NCT03924479 1165 1172 I-Observation
> NCT03924479 1173 1174 B-Eq_Comparison
15 NCT03924479 1175 1177 I-Eq_Comparison
pack NCT03924479 1178 1182 I-Eq_Comparison
years NCT03924479 1183 1188 I-Eq_Comparison

- NCT03924479 1191 1192 O
pregnant NCT03924479 1194 1202 B-Condition
women NCT03924479 1203 1208 O

- NCT03924479 1211 1212 O
uremia NCT03924479 1214 1220 B-Condition
, NCT03924479 1221 1222 O
history NCT03924479 1223 1230 B-Eq_Comparison
of NCT03924479 1231 1233 O
allergy NCT03924479 1234 1241 B-Allergy
to NCT03924479 1242 1244 O
iodides NCT03924479 1245 1252 O

- NCT03924479 1255 1256 O
impaired NCT03924479 1258 1266 B-Condition
renal NCT03924479 1267 1272 I-Condition
function NCT03924479 1273 1281 I-Condition

- NCT03924479 1284 1285 O
creatinine NCT03924479 1287 1297 B-Observation
value NCT03924479 1298 1303 O
greater NCT03924479 1304 1311 B-Eq_Comparison
than NCT03924479 1312 1316 I-Eq_Comparison
or NCT03924479 1317 1319 I-Eq_Comparison
equal NCT03924479 1320 1325 I-Eq_Comparison
to NCT03924479 1326 1328 I-Eq_Comparison
1.3 NCT03924479 1329 1332 I-Eq_Comparison
mg NCT03924479 1333 1335 I-Eq_Comparison
/ NCT03924479 1336 1337 I-Eq_Comparison
dL NCT03924479 1338 1340 I-Eq_Comparison
( NCT03924479 1341 1342 O
via NCT03924479 1343 1346 O
clinical NCT03924479 1347 1355 O
record NCT03924479 1356 1362 O
within NCT03924479 1363 1369 B-Eq_Comparison
the NCT03924479 1370 1373 I-Eq_Comparison
past NCT03924479 1374 1378 I-Eq_Comparison
6 NCT03924479 1379 1380 I-Eq_Comparison
months NCT03924479 1381 1387 I-Eq_Comparison
) NCT03924479 1388 1389 O

- NCT03924479 1393 1394 O
diagnosis NCT03924479 1396 1405 O
of NCT03924479 1406 1408 O
liver NCT03924479 1409 1414 B-Condition
disease NCT03924479 1415 1422 I-Condition

- NCT03924479 1425 1426 O
individuals NCT03924479 1428 1439 O
who NCT03924479 1440 1443 O
are NCT03924479 1444 1447 O
not NCT03924479 1448 1451 B-Negation
able NCT03924479 1452 1456 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03924479 1457 1459 I-Assertion___Assertion_Type_Value:hypothetical
engage NCT03924479 1460 1466 O
in NCT03924479 1467 1469 O
exercise NCT03924479 1470 1478 B-Observation


Inclusion NCT03868644 0 9 O
Criteria NCT03868644 10 18 O
: NCT03868644 19 20 O

- NCT03868644 23 24 O
Youth NCT03868644 25 30 O
previously NCT03868644 31 41 B-Eq_Comparison
participated NCT03868644 42 54 O
in NCT03868644 55 57 O
an NCT03868644 58 60 O
earlier NCT03868644 61 68 O
study NCT03868644 69 74 B-Study
by NCT03868644 75 77 O
Duflo NCT03868644 78 83 O
, NCT03868644 84 85 O
Dupas NCT03868644 86 91 O
and NCT03868644 92 95 O
Kremer NCT03868644 96 102 O
in NCT03868644 103 105 O
328 NCT03868644 106 109 O
primary NCT03868644 110 117 O
schools NCT03868644 118 125 O
in NCT03868644 126 128 O
the NCT03868644 129 132 O
same NCT03868644 133 137 O
study NCT03868644 138 143 O
site NCT03868644 144 148 O
in NCT03868644 149 151 O
Western NCT03868644 152 159 O
Province NCT03868644 160 168 O
, NCT03868644 169 170 O
Kenya NCT03868644 171 176 O
who NCT03868644 177 180 O
consent NCT03868644 181 188 O
to NCT03868644 189 191 O

participate NCT03868644 192 203 O
. NCT03868644 204 205 O

Exclusion NCT03868644 207 216 O
Criteria NCT03868644 217 225 O
: NCT03868644 226 227 O

- NCT03868644 230 231 O
Youth NCT03868644 232 237 O
sampled NCT03868644 238 245 O
for NCT03868644 246 249 O
the NCT03868644 250 253 O
study NCT03868644 254 259 O
who NCT03868644 260 263 O
do NCT03868644 264 266 O
not NCT03868644 267 270 O
consent NCT03868644 271 278 O
to NCT03868644 279 281 O
participate NCT03868644 282 293 O
. NCT03868644 294 295 O

Inclusion NCT03860402 0 9 O
Criteria NCT03860402 10 18 O
: NCT03860402 19 20 O

- NCT03860402 24 25 O
Among NCT03860402 27 32 O
the NCT03860402 33 36 O
pregnant NCT03860402 37 45 B-Condition
women NCT03860402 46 51 O
who NCT03860402 52 55 B-And
were NCT03860402 56 60 O
administered NCT03860402 61 73 B-Eq_Comparison
cesarean NCT03860402 74 82 B-Procedure
section NCT03860402 83 90 I-Procedure
in NCT03860402 91 93 O
this NCT03860402 94 98 O
study NCT03860402 99 104 B-Study
, NCT03860402 105 106 O
those NCT03860402 107 112 O
who NCT03860402 113 116 O
agreed NCT03860402 117 123 O
to NCT03860402 124 126 O
participate NCT03860402 127 138 O
in NCT03860402 139 141 O
this NCT03860402 142 146 O
study NCT03860402 147 152 O
. NCT03860402 153 154 O

Exclusion NCT03860402 156 165 O
Criteria NCT03860402 166 174 O
: NCT03860402 175 176 O

- NCT03860402 180 181 O
Fetal NCT03860402 183 188 B-Condition
distress NCT03860402 189 197 I-Condition
requiring NCT03860402 198 207 B-Assertion___Assertion_Type_Value:hypothetical
fast NCT03860402 208 212 B-Modifier
delivery NCT03860402 213 221 B-Procedure
. NCT03860402 222 223 O

- NCT03860402 227 228 O
Patients NCT03860402 230 238 O
with NCT03860402 239 243 O
hypersensitivity NCT03860402 244 260 B-Condition
, NCT03860402 261 262 O
allergic NCT03860402 263 271 B-Allergy
response NCT03860402 272 280 B-Condition
, NCT03860402 281 282 O
resistance NCT03860402 283 293 B-Condition
to NCT03860402 294 296 O
the NCT03860402 297 300 O
drugs NCT03860402 301 306 B-Drug
used NCT03860402 307 311 O
in NCT03860402 312 314 O
this NCT03860402 315 319 O
study NCT03860402 320 325 B-Study
( NCT03860402 326 327 O
fentanyl NCT03860402 328 336 B-Drug
, NCT03860402 337 338 O
ropivacaine NCT03860402 339 350 B-Drug
, NCT03860402 351 352 O
lidocaine NCT03860402 353 362 B-Drug
) NCT03860402 363 364 O
. NCT03860402 365 366 O

- NCT03860402 370 371 O
Patients NCT03860402 373 381 O
who NCT03860402 382 385 O
is NCT03860402 386 388 O
not NCT03860402 389 392 B-Negation
possible NCT03860402 393 401 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03860402 402 405 O
regional NCT03860402 406 414 B-Procedure
anesthesia NCT03860402 415 425 I-Procedure

- NCT03860402 428 429 O
Patients NCT03860402 431 439 O
who NCT03860402 440 443 O
refused NCT03860402 444 451 O
to NCT03860402 452 454 O
participate NCT03860402 455 466 O
in NCT03860402 467 469 O
this NCT03860402 470 474 O
study NCT03860402 475 480 O
. NCT03860402 481 482 O

- NCT03860402 486 487 O
Patients NCT03860402 489 497 O
who NCT03860402 498 501 O
can NCT03860402 502 505 O
not NCT03860402 505 508 O
read NCT03860402 509 513 O
or NCT03860402 514 516 O
understand NCT03860402 517 527 O
the NCT03860402 528 531 O
agreement NCT03860402 532 541 O
. NCT03860402 542 543 O

- NCT03860402 547 548 O
Patients NCT03860402 550 558 O
whose NCT03860402 559 564 O
weight NCT03860402 565 571 B-Observation
is NCT03860402 572 574 O
less NCT03860402 575 579 B-Eq_Comparison
than NCT03860402 580 584 I-Eq_Comparison
50 NCT03860402 585 587 I-Eq_Comparison
kg NCT03860402 588 590 I-Eq_Comparison
or NCT03860402 591 593 B-Or
exceeds NCT03860402 594 601 B-Eq_Comparison
100 NCT03860402 602 605 I-Eq_Comparison
kg NCT03860402 606 608 I-Eq_Comparison
. NCT03860402 609 610 O

Inclusion NCT03861546 0 9 O
Criteria NCT03861546 10 18 O
: NCT03861546 19 20 O

1 NCT03861546 24 25 O
. NCT03861546 25 26 O
age NCT03861546 28 31 B-Age
> NCT03861546 32 33 B-Eq_Comparison
18 NCT03861546 34 36 I-Eq_Comparison
years NCT03861546 37 42 I-Eq_Comparison
; NCT03861546 42 43 O

2 NCT03861546 46 47 O
. NCT03861546 47 48 O
confirmed NCT03861546 50 59 O
diagnosis NCT03861546 60 69 O
of NCT03861546 70 72 O
prediabetes NCT03861546 73 84 B-Condition
or NCT03861546 85 87 B-Or
T NCT03861546 88 89 B-Condition
2D NCT03861546 90 92 I-Condition
( NCT03861546 93 94 O
documented NCT03861546 95 105 O
A NCT03861546 106 107 B-Observation
1c NCT03861546 108 110 I-Observation
of NCT03861546 111 113 O
≥ NCT03861546 114 115 B-Eq_Comparison
5.7 NCT03861546 116 119 I-Eq_Comparison
% NCT03861546 120 121 I-Eq_Comparison
, NCT03861546 122 123 O
2 NCT03861546 124 125 B-Observation
- NCT03861546 126 127 I-Observation
hour NCT03861546 128 132 I-Observation
post NCT03861546 133 137 I-Observation
- NCT03861546 138 139 I-Observation
load NCT03861546 140 144 I-Observation
glucose NCT03861546 145 152 I-Observation
of NCT03861546 153 155 O
> NCT03861546 156 157 B-Eq_Comparison
140 NCT03861546 158 161 I-Eq_Comparison
, NCT03861546 162 163 O
or NCT03861546 164 166 B-Or
FBG NCT03861546 167 170 B-Observation
of NCT03861546 171 173 O
> NCT03861546 174 175 B-Eq_Comparison
100 NCT03861546 176 179 I-Eq_Comparison
) NCT03861546 180 181 O
; NCT03861546 182 183 O

3 NCT03861546 186 187 O
. NCT03861546 187 188 O
a NCT03861546 190 191 O
family NCT03861546 192 198 B-Family_Member___Family_Member_Type:parent
member NCT03861546 199 205 O
or NCT03861546 206 208 O
peer NCT03861546 209 213 O
willing NCT03861546 214 221 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861546 222 224 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03861546 225 236 O
and NCT03861546 237 240 O
attend NCT03861546 241 247 O
all NCT03861546 248 251 O
sessions NCT03861546 252 260 B-Procedure
as NCT03861546 261 263 O
a NCT03861546 264 265 O
social NCT03861546 266 272 O
influencer NCT03861546 273 283 O
; NCT03861546 283 284 O

4 NCT03861546 287 288 O
. NCT03861546 288 289 O
proficiency NCT03861546 291 302 O
in NCT03861546 303 305 O
English NCT03861546 306 313 O
of NCT03861546 314 316 O
at NCT03861546 317 319 B-Eq_Comparison
least NCT03861546 320 325 I-Eq_Comparison
one NCT03861546 326 329 I-Eq_Comparison
member NCT03861546 330 336 O
of NCT03861546 337 339 O
each NCT03861546 340 344 O
dyad NCT03861546 345 349 O
, NCT03861546 350 351 O

5 NCT03861546 355 356 O
. NCT03861546 356 357 O
willingness NCT03861546 359 370 O
to NCT03861546 371 373 O
provide NCT03861546 374 381 O
written NCT03861546 382 389 O
consent NCT03861546 390 397 O
. NCT03861546 398 399 O

Exclusion NCT03861546 401 410 O
Criteria NCT03861546 411 419 O
: NCT03861546 420 421 O

1 NCT03861546 425 426 O
. NCT03861546 426 427 O
type NCT03861546 429 433 B-Modifier
1 NCT03861546 434 435 I-Modifier
diabetes NCT03861546 436 444 B-Condition
or NCT03861546 445 447 B-Or
diabetes NCT03861546 448 456 B-Condition
secondary NCT03861546 457 466 B-Modifier
to NCT03861546 467 469 O
other NCT03861546 470 475 B-Other
conditions NCT03861546 476 486 B-Condition
( NCT03861546 487 488 O
e NCT03861546 489 490 O
. NCT03861546 491 492 O
g NCT03861546 493 494 O
. NCT03861546 495 496 O
steroid NCT03861546 498 505 B-Drug
- NCT03861546 506 507 O
induced NCT03861546 508 515 B-Modifier
, NCT03861546 516 517 O
pancreatic NCT03861546 518 528 B-Modifier
insufficiency NCT03861546 529 542 B-Condition
, NCT03861546 543 544 O
or NCT03861546 545 547 B-Or
chemotherapy NCT03861546 548 560 B-Procedure
- NCT03861546 561 562 O
induced NCT03861546 563 570 B-Modifier
) NCT03861546 571 572 O
; NCT03861546 573 574 O

2 NCT03861546 577 578 O
. NCT03861546 578 579 O
malignancy NCT03861546 581 591 B-Condition
or NCT03861546 592 594 B-Or
life NCT03861546 595 599 B-Death|B-Risk
- NCT03861546 600 601 I-Death|I-Risk
threatening NCT03861546 602 613 I-Death|I-Risk
illness NCT03861546 614 621 B-Condition
with NCT03861546 622 626 B-And
life NCT03861546 627 631 B-Observation
expectancy NCT03861546 632 642 I-Observation
of NCT03861546 643 645 O
< NCT03861546 646 647 B-Eq_Comparison
5 NCT03861546 648 649 I-Eq_Comparison
years NCT03861546 650 655 I-Eq_Comparison
; NCT03861546 655 656 O

3 NCT03861546 659 660 O
. NCT03861546 660 661 O
end NCT03861546 663 666 B-Modifier
- NCT03861546 667 668 I-Modifier
stage NCT03861546 669 674 I-Modifier
disease NCT03861546 675 682 B-Condition
or NCT03861546 683 685 B-Or
serious NCT03861546 686 693 O
illness NCT03861546 694 701 B-Condition
that NCT03861546 702 706 O
prohibits NCT03861546 707 716 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
participation NCT03861546 717 730 B-Study
( NCT03861546 731 732 O
e NCT03861546 733 734 O
. NCT03861546 735 736 O
g NCT03861546 737 738 O
. NCT03861546 739 740 O
end NCT03861546 742 745 B-Modifier
- NCT03861546 746 747 I-Modifier
stage NCT03861546 748 753 I-Modifier
renal NCT03861546 754 759 B-Condition
disease NCT03861546 760 767 I-Condition
or NCT03861546 768 770 B-Or
class NCT03861546 771 776 B-Eq_Comparison
IV NCT03861546 777 779 I-Eq_Comparison
congestive NCT03861546 780 790 B-Condition
heart NCT03861546 791 796 I-Condition
failure NCT03861546 797 804 I-Condition
) NCT03861546 805 806 O
; NCT03861546 807 808 O

4 NCT03861546 811 812 O
. NCT03861546 812 813 O
inability NCT03861546 815 824 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03861546 825 827 O
perform NCT03861546 828 835 O
unsupervised NCT03861546 836 848 B-Modifier
physical NCT03861546 849 857 B-Observation
activity NCT03861546 858 866 I-Observation
; NCT03861546 866 867 O

5 NCT03861546 870 871 O
. NCT03861546 871 872 O
pregnancy NCT03861546 874 883 B-Condition
; NCT03861546 883 884 O

6 NCT03861546 887 888 O
. NCT03861546 888 889 O
diagnosed NCT03861546 891 900 O
cognitive NCT03861546 901 910 B-Condition
deficits NCT03861546 911 919 I-Condition
or NCT03861546 920 922 B-Or
limited NCT03861546 923 930 O
decision NCT03861546 931 939 B-Condition
- NCT03861546 940 941 I-Condition
making NCT03861546 942 948 I-Condition
capacity NCT03861546 949 957 I-Condition
; NCT03861546 957 958 O

7 NCT03861546 961 962 O
. NCT03861546 962 963 O
alcohol NCT03861546 965 972 B-Modifier
or NCT03861546 973 975 B-Or
substance NCT03861546 976 985 B-Modifier
abuse NCT03861546 986 991 B-Condition
; NCT03861546 991 992 O

8 NCT03861546 995 996 O
. NCT03861546 996 997 O
homelessness NCT03861546 999 1011 B-Condition
or NCT03861546 1012 1014 B-Or
no NCT03861546 1015 1017 B-Negation
fixed NCT03861546 1018 1023 O
address NCT03861546 1024 1031 O
. NCT03861546 1032 1033 O

Inclusion NCT03925727 0 9 O
Criteria NCT03925727 10 18 O
: NCT03925727 19 20 O

- NCT03925727 24 25 O
Subject NCT03925727 27 34 O
- NCT03925727 35 36 O
reported NCT03925727 37 45 O
history NCT03925727 46 53 B-Eq_Comparison
of NCT03925727 54 56 O
dry NCT03925727 57 60 B-Condition
eye NCT03925727 61 64 I-Condition
disease NCT03925727 65 72 I-Condition
in NCT03925727 73 75 O
both NCT03925727 76 80 B-Modifier
eyes NCT03925727 81 85 I-Modifier
for NCT03925727 86 89 O
at NCT03925727 90 92 B-Eq_Comparison
least NCT03925727 93 98 I-Eq_Comparison
6 NCT03925727 99 100 I-Eq_Comparison
months NCT03925727 101 107 I-Eq_Comparison
; NCT03925727 107 108 O

- NCT03925727 111 112 O
History NCT03925727 114 121 B-Eq_Comparison
of NCT03925727 122 124 O
use NCT03925727 125 128 O
of NCT03925727 129 131 O
artificial NCT03925727 132 142 B-Procedure
tear NCT03925727 143 147 I-Procedure
eye NCT03925727 148 151 I-Procedure
drops NCT03925727 152 157 I-Procedure
for NCT03925727 158 161 O
dry NCT03925727 162 165 B-Condition
eye NCT03925727 166 169 I-Condition
symptoms NCT03925727 170 178 B-Assertion___Assertion_Type_Value:possible
; NCT03925727 178 179 O

- NCT03925727 182 183 O
Total NCT03925727 185 190 O
score NCT03925727 191 196 O
of NCT03925727 197 199 O
≥ NCT03925727 200 201 B-Eq_Comparison
40 NCT03925727 202 204 I-Eq_Comparison
on NCT03925727 205 207 O
SANDE NCT03925727 208 213 B-Observation
; NCT03925727 213 214 O

- NCT03925727 217 218 O
TFBUT NCT03925727 220 225 B-Observation
; NCT03925727 225 226 O

- NCT03925727 229 230 O
Corneal NCT03925727 232 239 B-Condition
fluorescein NCT03925727 240 251 I-Condition
staining NCT03925727 252 260 I-Condition
; NCT03925727 260 261 O

- NCT03925727 264 265 O
Lissamine NCT03925727 267 276 B-Modifier
green NCT03925727 277 282 I-Modifier
conjunctival NCT03925727 283 295 B-Condition
staining NCT03925727 296 304 I-Condition
; NCT03925727 304 305 O

- NCT03925727 308 309 O
Schirmer NCT03925727 311 319 B-Observation
's NCT03925727 319 321 I-Observation
test NCT03925727 322 326 I-Observation
score NCT03925727 327 332 O
. NCT03925727 333 334 O

Exclusion NCT03925727 336 345 O
Criteria NCT03925727 346 354 O
: NCT03925727 355 356 O

- NCT03925727 360 361 O
Have NCT03925727 363 367 O
participated NCT03925727 368 380 O
in NCT03925727 381 383 O
a NCT03925727 384 385 O
previous NCT03925727 386 394 B-Eq_Comparison
tavilermide NCT03925727 395 406 B-Drug
( NCT03925727 407 408 O
MIM NCT03925727 409 412 B-Drug
- NCT03925727 413 414 I-Drug
D NCT03925727 415 416 I-Drug
3 NCT03925727 417 418 I-Drug
) NCT03925727 419 420 O
study NCT03925727 421 426 B-Study
; NCT03925727 426 427 O

- NCT03925727 430 431 O
Have NCT03925727 433 437 O
clinically NCT03925727 438 448 O
significant NCT03925727 449 460 O
slit NCT03925727 461 465 B-Condition
lamp NCT03925727 466 470 I-Condition
findings NCT03925727 471 479 I-Condition
at NCT03925727 480 482 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Visit NCT03925727 483 488 B-Study
1 NCT03925727 489 490 O
; NCT03925727 491 492 O

- NCT03925727 495 496 O
Have NCT03925727 498 502 O
a NCT03925727 503 504 O
history NCT03925727 505 512 B-Eq_Comparison
of NCT03925727 513 515 O
lacrimal NCT03925727 516 524 B-Condition
duct NCT03925727 525 529 I-Condition
obstruction NCT03925727 530 541 I-Condition
within NCT03925727 542 548 B-Eq_Comparison
12 NCT03925727 549 551 I-Eq_Comparison
months NCT03925727 552 558 I-Eq_Comparison
of NCT03925727 559 561 B-Temporal_Connection___Temporal_Connection_Type_Value:before
Visit NCT03925727 562 567 B-Study
1 NCT03925727 568 569 O
; NCT03925727 570 571 O

- NCT03925727 574 575 O
Have NCT03925727 577 581 O
an NCT03925727 582 584 O
uncontrolled NCT03925727 585 597 B-Modifier
systemic NCT03925727 598 606 B-Condition
disease NCT03925727 607 614 I-Condition
; NCT03925727 614 615 O

- NCT03925727 618 619 O
Be NCT03925727 621 623 O
a NCT03925727 624 625 O
woman NCT03925727 626 631 O
who NCT03925727 632 635 B-And
is NCT03925727 636 638 O
pregnant NCT03925727 639 647 B-Condition
, NCT03925727 648 649 O
nursing NCT03925727 650 657 B-Condition
or NCT03925727 658 660 B-Or
planning NCT03925727 661 669 B-Assertion___Assertion_Type_Value:intention
a NCT03925727 670 671 O
pregnancy NCT03925727 672 681 B-Condition
; NCT03925727 681 682 O

- NCT03925727 685 686 O
Be NCT03925727 688 690 O
a NCT03925727 691 692 O
woman NCT03925727 693 698 O
of NCT03925727 699 701 B-And
childbearing NCT03925727 702 714 B-Condition
potential NCT03925727 715 724 I-Condition
who NCT03925727 725 728 B-And
is NCT03925727 729 731 O
not NCT03925727 732 735 B-Negation
using NCT03925727 736 741 B-Eq_Comparison
an NCT03925727 742 744 O
acceptable NCT03925727 745 755 O
means NCT03925727 756 761 O
of NCT03925727 762 764 O
birth NCT03925727 765 770 B-Procedure
control NCT03925727 771 778 I-Procedure
; NCT03925727 778 779 O

- NCT03925727 782 783 O
Have NCT03925727 785 789 O
a NCT03925727 790 791 O
condition NCT03925727 792 801 B-Condition
or NCT03925727 802 804 O
be NCT03925727 805 807 O
in NCT03925727 808 810 O
a NCT03925727 811 812 O
situation NCT03925727 813 822 O
which NCT03925727 823 828 O
the NCT03925727 829 832 O
investigator NCT03925727 833 845 O
feels NCT03925727 846 851 O
may NCT03925727 852 855 O
put NCT03925727 856 859 O
the NCT03925727 860 863 O
subject NCT03925727 864 871 O
at NCT03925727 872 874 O
significant NCT03925727 875 886 O
risk NCT03925727 887 891 B-Risk
, NCT03925727 892 893 O
may NCT03925727 894 897 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03925727 898 906 O
the NCT03925727 907 910 O
study NCT03925727 911 916 B-Study
results NCT03925727 917 924 O
, NCT03925727 925 926 O
or NCT03925727 927 929 B-Or
may NCT03925727 930 933 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03925727 934 943 O
significantly NCT03925727 944 957 O
with NCT03925727 958 962 O
the NCT03925727 963 966 O
subject NCT03925727 967 974 O
's NCT03925727 974 976 O
participation NCT03925727 977 990 O
in NCT03925727 991 993 O
the NCT03925727 994 997 O
study NCT03925727 998 1003 B-Study
; NCT03925727 1003 1004 O

- NCT03925727 1007 1008 O
Be NCT03925727 1010 1012 O
currently NCT03925727 1013 1022 B-Eq_Comparison
enrolled NCT03925727 1023 1031 O
in NCT03925727 1032 1034 O
an NCT03925727 1035 1037 O
investigational NCT03925727 1038 1053 O
drug NCT03925727 1054 1058 B-Drug
or NCT03925727 1059 1061 B-Or
device NCT03925727 1062 1068 B-Procedure
study NCT03925727 1069 1074 B-Study
or NCT03925727 1075 1077 B-Or
have NCT03925727 1078 1082 O
used NCT03925727 1083 1087 B-Eq_Comparison
an NCT03925727 1088 1090 O
investigational NCT03925727 1091 1106 B-Study
drug NCT03925727 1107 1111 B-Drug
or NCT03925727 1112 1114 B-Or
device NCT03925727 1115 1121 B-Procedure
within NCT03925727 1122 1128 B-Eq_Comparison
45 NCT03925727 1129 1131 I-Eq_Comparison
days NCT03925727 1132 1136 I-Eq_Comparison
prior NCT03925727 1137 1142 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03925727 1143 1145 O
Visit NCT03925727 1146 1151 B-Study
1 NCT03925727 1152 1153 O
. NCT03925727 1153 1154 O

Inclusion NCT03928223 0 9 O
Criteria NCT03928223 10 18 O
: NCT03928223 19 20 O

- NCT03928223 24 25 O
Dermatology NCT03928223 27 38 B-Provider
in NCT03928223 39 41 B-Encounter
- NCT03928223 42 43 O
and NCT03928223 44 47 B-Or
outpatients NCT03928223 48 59 B-Encounter
with NCT03928223 60 64 B-And
itch NCT03928223 65 69 B-Condition

Exclusion NCT03928223 70 79 O
Criteria NCT03928223 80 88 O
: NCT03928223 89 90 O

- NCT03928223 94 95 O
color NCT03928223 97 102 B-Condition
blindness NCT03928223 103 112 I-Condition

- NCT03928223 115 116 O
lack NCT03928223 118 122 O
of NCT03928223 123 125 O
time NCT03928223 126 130 O

- NCT03928223 133 134 O
lack NCT03928223 136 140 O
of NCT03928223 141 143 O
German NCT03928223 144 150 O
language NCT03928223 151 159 O
. NCT03928223 160 161 O

Inclusion NCT03863197 0 9 O
Criteria NCT03863197 10 18 O
: NCT03863197 19 20 O

- NCT03863197 24 25 O
Confirmed NCT03863197 27 36 O
diagnosis NCT03863197 37 46 O
of NCT03863197 47 49 O
SCP NCT03863197 50 53 B-Condition

- NCT03863197 56 57 O
Aged NCT03863197 59 63 B-Age
5 NCT03863197 64 65 B-Eq_Comparison
- NCT03863197 66 67 I-Eq_Comparison
12 NCT03863197 68 70 I-Eq_Comparison
years NCT03863197 71 76 I-Eq_Comparison

- NCT03863197 79 80 O
GMFCS NCT03863197 82 87 B-Observation
levels NCT03863197 88 94 B-Eq_Comparison
I NCT03863197 95 96 I-Eq_Comparison
- NCT03863197 97 98 I-Eq_Comparison
III NCT03863197 99 102 I-Eq_Comparison
( NCT03863197 103 104 O
GMFCS NCT03863197 105 110 B-Observation
= NCT03863197 111 112 B-Eq_Comparison
Gross NCT03863197 113 118 B-Observation
Motor NCT03863197 119 124 I-Observation
Function NCT03863197 125 133 I-Observation
Classification NCT03863197 134 148 I-Observation
Score NCT03863197 149 154 I-Observation
, NCT03863197 155 156 O
expressing NCT03863197 157 167 O
the NCT03863197 168 171 O
overall NCT03863197 172 179 O
functional NCT03863197 180 190 B-Condition
level NCT03863197 191 196 I-Condition
of NCT03863197 197 199 I-Condition
impairment NCT03863197 200 210 I-Condition
) NCT03863197 211 212 O

- NCT03863197 216 217 O
Sufficient NCT03863197 219 229 B-Assertion___Assertion_Type_Value:hypothetical
cooperation NCT03863197 230 241 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03863197 242 244 O
comprehend NCT03863197 245 255 O
and NCT03863197 256 259 O
complete NCT03863197 260 268 O
the NCT03863197 269 272 O
test NCT03863197 273 277 B-Procedure
procedure NCT03863197 278 287 I-Procedure

Exclusion NCT03863197 288 297 O
Criteria NCT03863197 298 306 O
: NCT03863197 307 308 O

- NCT03863197 312 313 O
Non NCT03863197 315 318 B-Negation
- NCT03863197 319 320 O
ambulatory NCT03863197 321 331 B-Condition

- NCT03863197 334 335 O
Botulinum NCT03863197 337 346 B-Drug
toxin NCT03863197 347 352 I-Drug
A NCT03863197 353 354 I-Drug
injections NCT03863197 355 365 B-Procedure
six NCT03863197 366 369 B-Eq_Comparison
months NCT03863197 370 376 I-Eq_Comparison
prior NCT03863197 377 382 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863197 383 385 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03863197 386 396 B-Study

- NCT03863197 399 400 O
Lower NCT03863197 402 407 B-Modifier
limb NCT03863197 408 412 I-Modifier
surgery NCT03863197 413 420 B-Procedure
two NCT03863197 421 424 B-Eq_Comparison
years NCT03863197 425 430 I-Eq_Comparison
prior NCT03863197 431 436 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863197 437 439 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03863197 440 450 B-Study

- NCT03863197 453 454 O
Presence NCT03863197 456 464 O
of NCT03863197 465 467 O
ataxia NCT03863197 468 474 B-Condition
or NCT03863197 475 477 B-Or
dystonia NCT03863197 478 486 B-Condition

- NCT03863197 489 490 O
Cognitive NCT03863197 492 501 B-Condition
problems NCT03863197 502 510 I-Condition
that NCT03863197 511 515 O
impede NCT03863197 516 522 O
measurements NCT03863197 523 535 B-Observation

- NCT03863197 538 539 O
Severe NCT03863197 541 547 O
co NCT03863197 548 550 B-Condition
- NCT03863197 551 552 I-Condition
morbidities NCT03863197 553 564 I-Condition
( NCT03863197 565 566 O
severe NCT03863197 567 573 O
epilepsy NCT03863197 574 582 B-Condition
, NCT03863197 583 584 O
non NCT03863197 585 588 B-Modifier
- NCT03863197 589 590 I-Modifier
correctable NCT03863197 591 602 I-Modifier
visual NCT03863197 603 609 B-Condition
impairment NCT03863197 610 620 I-Condition
, NCT03863197 621 622 O
autism NCT03863197 623 629 B-Condition
spectrum NCT03863197 630 638 I-Condition
disorders NCT03863197 639 648 I-Condition
, NCT03863197 649 650 O
mental NCT03863197 651 657 B-Condition
problems NCT03863197 658 666 I-Condition
that NCT03863197 667 671 O
prevent NCT03863197 672 679 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
comprehensiveness NCT03863197 680 697 O
of NCT03863197 698 700 O
the NCT03863197 701 704 O
tasks NCT03863197 705 710 B-Procedure
) NCT03863197 711 712 O

Inclusion NCT03920488 0 9 O
Criteria NCT03920488 10 18 O
: NCT03920488 19 20 O

1 NCT03920488 24 25 O
. NCT03920488 25 26 O
age NCT03920488 28 31 B-Age
between NCT03920488 32 39 B-Eq_Comparison
18 NCT03920488 40 42 I-Eq_Comparison
and NCT03920488 43 46 I-Eq_Comparison
60 NCT03920488 47 49 I-Eq_Comparison
years NCT03920488 50 55 I-Eq_Comparison

2 NCT03920488 58 59 O
. NCT03920488 59 60 O
has NCT03920488 62 65 O
signed NCT03920488 66 72 O
informed NCT03920488 73 81 O
consent NCT03920488 82 89 O

3 NCT03920488 92 93 O
. NCT03920488 93 94 O
histologically NCT03920488 96 110 B-Procedure
confirmed NCT03920488 111 120 O
triple NCT03920488 121 127 B-Modifier
negative NCT03920488 128 136 O
breast NCT03920488 137 143 B-Modifier
cancer NCT03920488 144 150 B-Condition
( NCT03920488 151 152 O
ER NCT03920488 153 155 B-Observation
( NCT03920488 156 157 O
Estrogen NCT03920488 158 166 B-Observation
Receptors NCT03920488 167 176 I-Observation
) NCT03920488 177 178 O
< NCT03920488 179 180 B-Eq_Comparison
1 NCT03920488 181 182 I-Eq_Comparison
% NCT03920488 183 184 I-Eq_Comparison
, NCT03920488 185 186 O
PgR NCT03920488 187 190 B-Observation
( NCT03920488 191 192 O
Progesterone NCT03920488 193 205 B-Observation
Receptors NCT03920488 206 215 I-Observation
) NCT03920488 216 217 O
< NCT03920488 218 219 B-Eq_Comparison
1 NCT03920488 220 221 I-Eq_Comparison
% NCT03920488 222 223 I-Eq_Comparison
, NCT03920488 224 225 O
HER NCT03920488 226 229 B-Condition
2 NCT03920488 230 231 I-Condition
/ NCT03920488 232 233 B-Or
neu NCT03920488 234 237 B-Condition
negative NCT03920488 238 246 O
( NCT03920488 247 248 O
IHC NCT03920488 249 252 B-Observation
0 NCT03920488 253 254 B-Eq_Comparison
, NCT03920488 255 256 I-Eq_Comparison
1 NCT03920488 257 258 I-Eq_Comparison
+ NCT03920488 259 260 I-Eq_Comparison
or NCT03920488 261 263 I-Eq_Comparison
2 NCT03920488 264 265 I-Eq_Comparison
+ NCT03920488 266 267 I-Eq_Comparison
FISH NCT03920488 268 272 B-Condition
negative NCT03920488 273 281 O
) NCT03920488 282 283 O
. NCT03920488 284 285 O

4 NCT03920488 289 290 O
. NCT03920488 290 291 O
Stage NCT03920488 293 298 B-Eq_Comparison
I NCT03920488 299 300 I-Eq_Comparison
- NCT03920488 301 302 I-Eq_Comparison
III NCT03920488 303 306 I-Eq_Comparison

5 NCT03920488 309 310 O
. NCT03920488 310 311 O
Able NCT03920488 313 317 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03920488 318 320 I-Assertion___Assertion_Type_Value:hypothetical
undergo NCT03920488 321 328 O
surgery NCT03920488 329 336 B-Procedure
( NCT03920488 337 338 O
primary NCT03920488 339 346 B-Modifier
or NCT03920488 347 349 B-Or
post NCT03920488 350 354 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03920488 355 356 O
neoadjuvant NCT03920488 357 368 B-Procedure
) NCT03920488 369 370 O

6 NCT03920488 374 375 O
. NCT03920488 375 376 O
Availability NCT03920488 378 390 O
of NCT03920488 391 393 O
surgical NCT03920488 394 402 B-Modifier
/ NCT03920488 403 404 B-Or
bioptic NCT03920488 405 412 B-Modifier
material NCT03920488 413 421 B-Observation
within NCT03920488 422 428 B-Eq_Comparison
6 NCT03920488 429 430 I-Eq_Comparison
months NCT03920488 431 437 I-Eq_Comparison
from NCT03920488 438 442 B-Temporal_Connection___Temporal_Connection_Type_Value:after
enrolment NCT03920488 443 452 B-Study

Exclusion NCT03920488 453 462 O
Criteria NCT03920488 463 471 O
: NCT03920488 472 473 O

- NCT03920488 477 478 O
unable NCT03920488 480 486 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
or NCT03920488 487 489 B-Or
unwilling NCT03920488 490 499 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03920488 500 502 O
receive NCT03920488 503 510 O
genetic NCT03920488 511 518 B-Procedure
counselling NCT03920488 519 530 I-Procedure

Inclusion NCT03863977 0 9 O
Criteria NCT03863977 10 18 O
: NCT03863977 19 20 O

- NCT03863977 24 25 O
Patients NCT03863977 27 35 O
' NCT03863977 35 36 O
age NCT03863977 37 40 B-Age
from NCT03863977 41 45 O
18 NCT03863977 46 48 B-Eq_Comparison
to NCT03863977 49 51 I-Eq_Comparison
60 NCT03863977 52 54 I-Eq_Comparison
years NCT03863977 55 60 I-Eq_Comparison
old NCT03863977 61 64 O
, NCT03863977 65 66 O

- NCT03863977 70 71 O
physical NCT03863977 73 81 O
status NCT03863977 82 88 O
ASA NCT03863977 89 92 B-Observation
I NCT03863977 93 94 B-Eq_Comparison
- NCT03863977 95 96 I-Eq_Comparison
II NCT03863977 97 99 I-Eq_Comparison
( NCT03863977 100 101 O
by NCT03863977 102 104 O
the NCT03863977 105 108 O
American NCT03863977 109 117 B-Observation
Society NCT03863977 118 125 I-Observation
of NCT03863977 126 128 I-Observation
Anesthesiologists NCT03863977 129 146 I-Observation
) NCT03863977 147 148 O
, NCT03863977 149 150 O

- NCT03863977 154 155 O
Elective NCT03863977 157 165 B-Modifier
unilateral NCT03863977 166 176 I-Modifier
open NCT03863977 177 181 I-Modifier
inguinal NCT03863977 182 190 B-Procedure
hernia NCT03863977 191 197 I-Procedure
repair NCT03863977 198 204 I-Procedure
, NCT03863977 205 206 O

- NCT03863977 210 211 O
Under NCT03863977 213 218 O
spinal NCT03863977 219 225 B-Procedure
anesthesia NCT03863977 226 236 I-Procedure

Exclusion NCT03863977 237 246 O
Criteria NCT03863977 247 255 O
: NCT03863977 256 257 O

- NCT03863977 261 262 O
age NCT03863977 264 267 B-Age
< NCT03863977 268 269 B-Eq_Comparison
18 NCT03863977 270 272 I-Eq_Comparison
or NCT03863977 273 275 B-Or
> NCT03863977 276 277 B-Eq_Comparison
60 NCT03863977 278 280 I-Eq_Comparison
, NCT03863977 281 282 O

- NCT03863977 286 287 O
American NCT03863977 289 297 B-Observation
society NCT03863977 298 305 I-Observation
of NCT03863977 306 308 I-Observation
anesthesiologist NCT03863977 309 325 I-Observation
( NCT03863977 326 327 O
ASA NCT03863977 328 331 B-Observation
) NCT03863977 332 333 O
class NCT03863977 334 339 B-Eq_Comparison
III NCT03863977 340 343 I-Eq_Comparison
- NCT03863977 344 345 I-Eq_Comparison
IV NCT03863977 346 348 I-Eq_Comparison
, NCT03863977 349 350 O

- NCT03863977 354 355 O
known NCT03863977 357 362 O
allergy NCT03863977 363 370 B-Allergy
to NCT03863977 371 373 O
amino NCT03863977 374 379 B-Drug
amide NCT03863977 380 385 I-Drug
local NCT03863977 386 391 I-Drug
anesthetics NCT03863977 392 403 I-Drug
, NCT03863977 404 405 O

- NCT03863977 409 410 O
skin NCT03863977 412 416 B-Modifier
infection NCT03863977 417 426 B-Condition
and NCT03863977 427 430 B-Or
diseases NCT03863977 431 439 B-Condition
at NCT03863977 440 442 O
site NCT03863977 443 447 B-Modifier
of NCT03863977 448 450 O
injection NCT03863977 451 460 B-Procedure
. NCT03863977 461 462 O

- NCT03863977 466 467 O
coagulation NCT03863977 469 480 B-Condition
disorders NCT03863977 481 490 I-Condition
, NCT03863977 491 492 O

- NCT03863977 496 497 O
patients NCT03863977 499 507 O
with NCT03863977 508 512 O
body NCT03863977 513 517 B-Observation
mass NCT03863977 518 522 I-Observation
index NCT03863977 523 528 I-Observation
( NCT03863977 529 530 O
BMI NCT03863977 531 534 B-Observation
) NCT03863977 535 536 O
> NCT03863977 537 538 B-Eq_Comparison
35 NCT03863977 539 541 I-Eq_Comparison
kg NCT03863977 542 544 I-Eq_Comparison
/ NCT03863977 545 546 I-Eq_Comparison
m NCT03863977 547 548 I-Eq_Comparison
2 NCT03863977 549 550 I-Eq_Comparison
, NCT03863977 551 552 O

- NCT03863977 556 557 O
scrotal NCT03863977 559 566 B-Modifier
hernias NCT03863977 567 574 B-Condition
, NCT03863977 575 576 O

Inclusion NCT03926312 0 9 O
Criteria NCT03926312 10 18 O
: NCT03926312 19 20 O

1 NCT03926312 24 25 O
. NCT03926312 25 26 O
Signed NCT03926312 28 34 O
informed NCT03926312 35 43 O
consent NCT03926312 44 51 O
with NCT03926312 52 56 O
the NCT03926312 57 60 O
study NCT03926312 61 66 O

2 NCT03926312 69 70 O
. NCT03926312 70 71 O
Men NCT03926312 73 76 O
and NCT03926312 77 80 B-Or
women NCT03926312 81 86 O
> NCT03926312 87 88 B-Eq_Comparison
18 NCT03926312 89 91 I-Eq_Comparison
years NCT03926312 92 97 I-Eq_Comparison
of NCT03926312 98 100 O
age NCT03926312 101 104 B-Age

3 NCT03926312 107 108 O
. NCT03926312 108 109 O
Patients NCT03926312 111 119 O
≥ NCT03926312 120 121 B-Eq_Comparison
1 NCT03926312 122 123 I-Eq_Comparison
and NCT03926312 124 127 B-And
≤ NCT03926312 128 129 B-Eq_Comparison
6 NCT03926312 130 131 I-Eq_Comparison
months NCT03926312 132 138 I-Eq_Comparison
after NCT03926312 139 144 B-Temporal_Connection___Temporal_Connection_Type_Value:after
type NCT03926312 145 149 B-Eq_Comparison
I NCT03926312 150 151 I-Eq_Comparison
myocardial NCT03926312 152 162 B-Condition
infarction NCT03926312 163 173 I-Condition

4 NCT03926312 176 177 O
. NCT03926312 177 178 O
Physical NCT03926312 180 188 B-Condition
inactivity NCT03926312 189 199 I-Condition
before NCT03926312 200 206 B-Temporal_Connection___Temporal_Connection_Type_Value:before
MI NCT03926312 207 209 B-Condition
defined NCT03926312 210 217 O
as NCT03926312 218 220 O
the NCT03926312 221 224 O
absence NCT03926312 225 232 B-Negation
of NCT03926312 233 235 O
moderate NCT03926312 236 244 B-Eq_Comparison
to NCT03926312 245 247 I-Eq_Comparison
vigorous NCT03926312 248 256 I-Eq_Comparison
exercise NCT03926312 257 265 B-Observation
for NCT03926312 266 269 O
at NCT03926312 270 272 B-Eq_Comparison
least NCT03926312 273 278 I-Eq_Comparison
30 NCT03926312 279 281 I-Eq_Comparison
minutes NCT03926312 282 289 I-Eq_Comparison
5 NCT03926312 290 291 B-Eq_Comparison
or NCT03926312 292 294 I-Eq_Comparison
more NCT03926312 295 299 I-Eq_Comparison
days NCT03926312 300 304 I-Eq_Comparison
a NCT03926312 305 306 I-Eq_Comparison
week NCT03926312 307 311 I-Eq_Comparison

Exclusion NCT03926312 312 321 O
Criteria NCT03926312 322 330 O
: NCT03926312 331 332 O

1 NCT03926312 336 337 O
. NCT03926312 337 338 O
Heart NCT03926312 340 345 B-Condition
failure NCT03926312 346 353 I-Condition
NYHA NCT03926312 354 358 B-Observation
IIIB NCT03926312 359 363 B-Eq_Comparison
- NCT03926312 364 365 I-Eq_Comparison
IV NCT03926312 366 368 I-Eq_Comparison

2 NCT03926312 371 372 O
. NCT03926312 372 373 O
Planned NCT03926312 375 382 B-Eq_Comparison
coronary NCT03926312 383 391 B-Procedure
revascularization NCT03926312 392 409 I-Procedure

3 NCT03926312 412 413 O
. NCT03926312 413 414 O
Planned NCT03926312 416 423 B-Eq_Comparison
major NCT03926312 424 429 O
surgery NCT03926312 430 437 B-Procedure
within NCT03926312 438 444 B-Eq_Comparison
the NCT03926312 445 448 I-Eq_Comparison
next NCT03926312 449 453 I-Eq_Comparison
12 NCT03926312 454 456 I-Eq_Comparison
months NCT03926312 457 463 I-Eq_Comparison

4 NCT03926312 466 467 O
. NCT03926312 467 468 O
Inability NCT03926312 470 479 B-Condition
to NCT03926312 480 482 I-Condition
walk NCT03926312 483 487 I-Condition
for NCT03926312 488 491 O
any NCT03926312 492 495 O
reason NCT03926312 496 502 O

5 NCT03926312 505 506 O
. NCT03926312 506 507 O
Comorbidities NCT03926312 509 522 B-Condition
that NCT03926312 523 527 O
would NCT03926312 528 533 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03926312 534 542 O
adherence NCT03926312 543 552 O
to NCT03926312 553 555 O
the NCT03926312 556 559 O
rehabilitation NCT03926312 560 574 B-Procedure
program NCT03926312 575 582 I-Procedure
( NCT03926312 583 584 O
e NCT03926312 585 586 O
. NCT03926312 587 588 O
g NCT03926312 589 590 O
. NCT03926312 591 592 O
arthrosis NCT03926312 594 603 B-Condition
, NCT03926312 604 605 O
active NCT03926312 606 612 B-Eq_Comparison
malignancy NCT03926312 613 623 B-Condition
, NCT03926312 624 625 O
major NCT03926312 626 631 B-Condition
depression NCT03926312 632 642 I-Condition
or NCT03926312 643 645 O
other NCT03926312 646 651 B-Other
significant NCT03926312 652 663 O
psychiatric NCT03926312 664 675 B-Condition
disorder NCT03926312 676 684 I-Condition
, NCT03926312 685 686 O
cognitive NCT03926312 687 696 B-Condition
impairment NCT03926312 697 707 I-Condition
) NCT03926312 708 709 O
- NCT03926312 710 711 O
at NCT03926312 712 714 O
the NCT03926312 715 718 O
discretion NCT03926312 719 729 O
of NCT03926312 730 732 O
the NCT03926312 733 736 O
physician NCT03926312 737 746 O

6 NCT03926312 749 750 O
. NCT03926312 750 751 O
Life NCT03926312 753 757 B-Observation
expectancy NCT03926312 758 768 I-Observation
less NCT03926312 769 773 B-Eq_Comparison
than NCT03926312 774 778 I-Eq_Comparison
12 NCT03926312 779 781 I-Eq_Comparison
months NCT03926312 782 788 I-Eq_Comparison

7 NCT03926312 791 792 O
. NCT03926312 792 793 O
Pregnancy NCT03926312 795 804 B-Condition

8 NCT03926312 807 808 O
. NCT03926312 808 809 O
Inability NCT03926312 811 820 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03926312 821 823 O
operate NCT03926312 824 831 B-Observation
the NCT03926312 832 835 I-Observation
smart NCT03926312 836 841 I-Observation
- NCT03926312 842 843 I-Observation
watch NCT03926312 844 849 I-Observation

Inclusion NCT03925649 0 9 O
Criteria NCT03925649 10 18 O
: NCT03925649 19 20 O

- NCT03925649 24 25 O
Cognitively NCT03925649 27 38 O
intact NCT03925649 39 45 O
, NCT03925649 46 47 O
capable NCT03925649 48 55 O
of NCT03925649 56 58 O
giving NCT03925649 59 65 O
informed NCT03925649 66 74 O
consent NCT03925649 75 82 O

- NCT03925649 85 86 O
Clinical NCT03925649 88 96 O
diagnosis NCT03925649 97 106 O
of NCT03925649 107 109 O
a NCT03925649 110 111 O
non NCT03925649 112 115 B-Modifier
- NCT03925649 116 117 I-Modifier
penetrating NCT03925649 118 129 I-Modifier
traumatic NCT03925649 130 139 I-Modifier
SCI NCT03925649 140 143 B-Condition

- NCT03925649 146 147 O
Asia NCT03925649 149 153 B-Condition
Impairment NCT03925649 154 164 I-Condition
Scale NCT03925649 165 170 I-Condition
grade NCT03925649 171 176 B-Eq_Comparison
of NCT03925649 177 179 I-Eq_Comparison
A NCT03925649 180 181 I-Eq_Comparison
, NCT03925649 182 183 I-Eq_Comparison
B NCT03925649 184 185 I-Eq_Comparison
, NCT03925649 186 187 I-Eq_Comparison
or NCT03925649 188 190 I-Eq_Comparison
C NCT03925649 191 192 I-Eq_Comparison

Exclusion NCT03925649 193 202 O
Criteria NCT03925649 203 211 O
: NCT03925649 212 213 O

1 NCT03925649 217 218 O
. NCT03925649 218 219 O
Prior NCT03925649 221 226 B-Eq_Comparison
history NCT03925649 227 234 O
of NCT03925649 235 237 O
: NCT03925649 238 239 O

- NCT03925649 248 249 O
Brain NCT03925649 251 256 B-Modifier
injury NCT03925649 257 263 B-Condition

- NCT03925649 271 272 O
Recent NCT03925649 274 280 B-Eq_Comparison
or NCT03925649 281 283 B-Or
ongoing NCT03925649 284 291 B-Eq_Comparison
infection NCT03925649 292 301 B-Condition

- NCT03925649 309 310 O
Clinically NCT03925649 312 322 O
significant NCT03925649 323 334 O
cardiovascular NCT03925649 335 349 B-Modifier
, NCT03925649 350 351 O
lung NCT03925649 352 356 B-Modifier
, NCT03925649 357 358 O
renal NCT03925649 359 364 B-Modifier
, NCT03925649 365 366 O
hepatic NCT03925649 367 374 B-Modifier
or NCT03925649 375 377 B-Or
endocrine NCT03925649 378 387 B-Modifier
disease NCT03925649 388 395 B-Condition
, NCT03925649 396 397 O

- NCT03925649 406 407 O
Neurodegenerative NCT03925649 409 426 B-Condition
disorders NCT03925649 427 436 I-Condition

- NCT03925649 444 445 O
Cancer NCT03925649 447 453 B-Condition

- NCT03925649 461 462 O
Immunosuppression NCT03925649 464 481 B-Condition
as NCT03925649 482 484 O
defined NCT03925649 485 492 O
by NCT03925649 493 495 O
WBC NCT03925649 496 499 B-Observation
< NCT03925649 500 501 B-Eq_Comparison
3 NCT03925649 502 503 I-Eq_Comparison
, NCT03925649 504 505 I-Eq_Comparison
000 NCT03925649 506 509 I-Eq_Comparison
cells NCT03925649 510 515 I-Eq_Comparison
/ NCT03925649 516 517 I-Eq_Comparison
ml NCT03925649 518 520 I-Eq_Comparison
at NCT03925649 521 523 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03925649 524 532 B-Study
screening NCT03925649 533 542 O
, NCT03925649 543 544 O

- NCT03925649 553 554 O
HIV NCT03925649 556 559 B-Condition
+ NCT03925649 560 561 O

- NCT03925649 570 571 O
Chemical NCT03925649 573 581 B-Modifier
or NCT03925649 582 584 B-Or
ETOH NCT03925649 585 589 B-Modifier
dependency NCT03925649 590 600 B-Condition

2 NCT03925649 603 604 O
. NCT03925649 604 605 O
Having NCT03925649 607 613 O
a NCT03925649 614 615 O
contraindication NCT03925649 616 632 B-Contraindication
to NCT03925649 633 635 O
MRI NCT03925649 636 639 B-Procedure
scans NCT03925649 640 645 O

3 NCT03925649 648 649 O
. NCT03925649 649 650 O
Other NCT03925649 652 657 O
acute NCT03925649 658 663 O
or NCT03925649 664 666 B-Or
chronic NCT03925649 667 674 O
medical NCT03925649 675 682 B-Condition
conditions NCT03925649 683 693 I-Condition
that NCT03925649 694 698 O
, NCT03925649 699 700 O
in NCT03925649 701 703 O
the NCT03925649 704 707 O
opinion NCT03925649 708 715 O
of NCT03925649 716 718 O
the NCT03925649 719 722 O
investigator NCT03925649 723 735 O
, NCT03925649 736 737 O
may NCT03925649 738 741 B-Assertion___Assertion_Type_Value:hypothetical
increase NCT03925649 742 750 O
the NCT03925649 751 754 O
risks NCT03925649 755 760 B-Risk
associated NCT03925649 761 771 O
with NCT03925649 772 776 O
study NCT03925649 777 782 B-Study
participation NCT03925649 783 796 O
or NCT03925649 797 799 B-Or
HB NCT03925649 800 802 B-Drug
- NCT03925649 803 804 I-Drug
adMSC NCT03925649 805 810 I-Drug
administration NCT03925649 811 825 O

4 NCT03925649 828 829 O
. NCT03925649 829 830 O
Participation NCT03925649 832 845 O
in NCT03925649 846 848 O
other NCT03925649 849 854 B-Other
interventional NCT03925649 855 869 O
research NCT03925649 870 878 O
studies NCT03925649 879 886 B-Study

5 NCT03925649 889 890 O
. NCT03925649 890 891 O
Unwillingness NCT03925649 893 906 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03925649 907 909 O
return NCT03925649 910 916 O
for NCT03925649 917 920 O
follow NCT03925649 921 927 B-Encounter
- NCT03925649 928 929 I-Encounter
up NCT03925649 930 932 I-Encounter
visits NCT03925649 933 939 I-Encounter

Inclusion NCT03928509 0 9 O
criteria NCT03928509 10 18 O
: NCT03928509 19 20 O

- NCT03928509 24 25 O
Participants NCT03928509 27 39 O
will NCT03928509 40 44 O
have NCT03928509 45 49 O
been NCT03928509 50 54 O
previously NCT03928509 55 65 B-Eq_Comparison
joined NCT03928509 66 72 O
for NCT03928509 73 76 O
a NCT03928509 77 78 O
public NCT03928509 79 85 O
health NCT03928509 86 92 O
survey NCT03928509 93 99 O
and NCT03928509 100 103 O
have NCT03928509 104 108 O
agreed NCT03928509 109 115 O
to NCT03928509 116 118 O
be NCT03928509 119 121 O
contacted NCT03928509 122 131 O
again NCT03928509 132 137 O
for NCT03928509 138 141 O
this NCT03928509 142 146 O
study NCT03928509 147 152 B-Study
; NCT03928509 153 154 O

- NCT03928509 157 158 O
Age NCT03928509 160 163 B-Age
: NCT03928509 164 165 O
18 NCT03928509 166 168 B-Eq_Comparison
years NCT03928509 169 174 I-Eq_Comparison
or NCT03928509 175 177 I-Eq_Comparison
over NCT03928509 178 182 I-Eq_Comparison
. NCT03928509 183 184 O

- NCT03928509 188 189 O
Place NCT03928509 191 196 O
of NCT03928509 197 199 O
residence NCT03928509 200 209 O
: NCT03928509 210 211 O
Sherbrooke NCT03928509 212 222 O
, NCT03928509 223 224 O
Moncton NCT03928509 225 232 O
or NCT03928509 233 235 B-Or
Saguenay NCT03928509 236 244 O
- NCT03928509 245 246 O
Lac NCT03928509 247 250 O
- NCT03928509 251 252 O
St NCT03928509 253 255 O
- NCT03928509 256 257 O
Jean NCT03928509 258 262 O
. NCT03928509 263 264 O

Inclusion NCT03921034 0 9 O
Criteria NCT03921034 10 18 O
: NCT03921034 19 20 O

- NCT03921034 24 25 O
Unilateral NCT03921034 27 37 B-Modifier
, NCT03921034 38 39 O
primary NCT03921034 40 47 B-Modifier
tricompartment NCT03921034 48 62 I-Modifier
total NCT03921034 63 68 I-Modifier
knee NCT03921034 69 73 I-Modifier
arthroplasty NCT03921034 74 86 B-Procedure

- NCT03921034 89 90 O
Age NCT03921034 92 95 B-Age
18 NCT03921034 96 98 B-Eq_Comparison
years NCT03921034 99 104 I-Eq_Comparison
or NCT03921034 105 107 I-Eq_Comparison
older NCT03921034 108 113 I-Eq_Comparison

- NCT03921034 116 117 O
ASA NCT03921034 119 122 B-Observation
I NCT03921034 123 124 B-Eq_Comparison
- NCT03921034 125 126 I-Eq_Comparison
III NCT03921034 127 130 I-Eq_Comparison

- NCT03921034 133 134 O
Eligible NCT03921034 136 144 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03921034 145 148 I-Assertion___Assertion_Type_Value:hypothetical
spinal NCT03921034 149 155 B-Modifier
or NCT03921034 156 158 B-Or
combined NCT03921034 159 167 B-Modifier
spinal NCT03921034 168 174 I-Modifier
epidural NCT03921034 175 183 B-Procedure
anesthetic NCT03921034 184 194 I-Procedure

- NCT03921034 197 198 O
Able NCT03921034 200 204 O
to NCT03921034 205 207 O
speak NCT03921034 208 213 O
, NCT03921034 214 215 O
read NCT03921034 216 220 O
, NCT03921034 221 222 O
and NCT03921034 223 226 O
understand NCT03921034 227 237 O
English NCT03921034 238 245 O

- NCT03921034 248 249 O
Willing NCT03921034 251 258 O
to NCT03921034 259 261 O
participate NCT03921034 262 273 O
in NCT03921034 274 276 O
the NCT03921034 277 280 O
trial NCT03921034 281 286 B-Study

Exclusion NCT03921034 287 296 O
Criteria NCT03921034 297 305 O
: NCT03921034 306 307 O

- NCT03921034 311 312 O
Contraindication NCT03921034 314 330 B-Contraindication
to NCT03921034 331 333 O
regional NCT03921034 334 342 B-Procedure
anesthesia NCT03921034 343 353 I-Procedure
or NCT03921034 354 356 B-Or
peripheral NCT03921034 357 367 B-Modifier
nerve NCT03921034 368 373 B-Procedure
blocks NCT03921034 374 380 I-Procedure

- NCT03921034 383 384 O
Allergy NCT03921034 386 393 B-Allergy
to NCT03921034 394 396 O
local NCT03921034 397 402 B-Procedure
anesthetics NCT03921034 403 414 I-Procedure

- NCT03921034 417 418 O
Allergy NCT03921034 420 427 B-Allergy
to NCT03921034 428 430 O
NSAIDs NCT03921034 431 437 B-Drug

- NCT03921034 440 441 O
Chronic NCT03921034 443 450 O
renal NCT03921034 451 456 B-Condition
insufficiency NCT03921034 457 470 I-Condition
with NCT03921034 471 475 B-And
Cr NCT03921034 476 478 B-Observation
> NCT03921034 479 480 B-Eq_Comparison
1.4 NCT03921034 481 484 I-Eq_Comparison
or NCT03921034 485 487 B-Or
GFR NCT03921034 488 491 B-Observation
< NCT03921034 492 493 B-Eq_Comparison
60 NCT03921034 494 496 I-Eq_Comparison

- NCT03921034 500 501 O
Have NCT03921034 503 507 O
chronic NCT03921034 508 515 O
pain NCT03921034 516 520 B-Condition
that NCT03921034 521 525 O
is NCT03921034 526 528 O
not NCT03921034 529 532 B-Negation
related NCT03921034 533 540 O
to NCT03921034 541 543 O
their NCT03921034 544 549 O
knee NCT03921034 550 554 B-Modifier
joint NCT03921034 555 560 I-Modifier

- NCT03921034 563 564 O
Have NCT03921034 566 570 O
been NCT03921034 571 575 O
using NCT03921034 576 581 B-Eq_Comparison
opioids NCT03921034 582 589 B-Drug
on NCT03921034 590 592 O
a NCT03921034 593 594 O
chronic NCT03921034 595 602 O
basis NCT03921034 603 608 O
( NCT03921034 609 610 O
daily NCT03921034 611 616 B-Eq_Comparison
or NCT03921034 617 619 B-Or
almost NCT03921034 620 626 O
daily NCT03921034 627 632 B-Eq_Comparison
opioid NCT03921034 633 639 B-Drug
use NCT03921034 640 643 O
for NCT03921034 644 647 O
3 NCT03921034 648 649 B-Eq_Comparison
months NCT03921034 650 656 I-Eq_Comparison
or NCT03921034 657 659 I-Eq_Comparison
longer NCT03921034 660 666 I-Eq_Comparison
) NCT03921034 667 668 O

- NCT03921034 672 673 O
Have NCT03921034 675 679 O
a NCT03921034 680 681 O
pre NCT03921034 682 685 B-Eq_Comparison
- NCT03921034 686 687 I-Eq_Comparison
existing NCT03921034 688 696 I-Eq_Comparison
peripheral NCT03921034 697 707 B-Condition
neuropathy NCT03921034 708 718 I-Condition
involving NCT03921034 719 728 O
the NCT03921034 729 732 O
operative NCT03921034 733 742 B-Modifier
site NCT03921034 743 747 I-Modifier

- NCT03921034 750 751 O
Body NCT03921034 753 757 B-Observation
mass NCT03921034 758 762 I-Observation
index NCT03921034 763 768 I-Observation
greater NCT03921034 769 776 B-Eq_Comparison
than NCT03921034 777 781 I-Eq_Comparison
or NCT03921034 782 784 I-Eq_Comparison
equal NCT03921034 785 790 I-Eq_Comparison
to NCT03921034 791 793 I-Eq_Comparison
40 NCT03921034 794 796 I-Eq_Comparison

Inclusion NCT03860857 0 9 O
Criteria NCT03860857 10 18 O
: NCT03860857 19 20 O

1 NCT03860857 24 25 O
. NCT03860857 25 26 O
Between NCT03860857 28 35 B-Eq_Comparison
the NCT03860857 36 39 I-Eq_Comparison
ages NCT03860857 40 44 I-Eq_Comparison
of NCT03860857 45 47 I-Eq_Comparison
60 NCT03860857 48 50 I-Eq_Comparison
and NCT03860857 51 54 I-Eq_Comparison
85 NCT03860857 55 57 I-Eq_Comparison
; NCT03860857 58 59 O

2 NCT03860857 62 63 O
. NCT03860857 63 64 O
Speaks NCT03860857 66 72 O
fluent NCT03860857 73 79 O
English NCT03860857 80 87 O
; NCT03860857 87 88 O

3 NCT03860857 91 92 O
. NCT03860857 92 93 O
Visual NCT03860857 95 101 B-Modifier
and NCT03860857 102 105 B-And
auditory NCT03860857 106 114 B-Modifier
acuity NCT03860857 115 121 B-Condition
adequate NCT03860857 122 130 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03860857 131 134 I-Assertion___Assertion_Type_Value:hypothetical
neuropsychological NCT03860857 135 153 B-Modifier
and NCT03860857 154 157 B-And
computerized NCT03860857 158 170 B-Modifier
testing NCT03860857 171 178 B-Procedure
; NCT03860857 178 179 O

4 NCT03860857 182 183 O
. NCT03860857 183 184 O
Good NCT03860857 186 190 O
general NCT03860857 191 198 B-Condition
health NCT03860857 199 205 I-Condition
with NCT03860857 206 210 B-And
no NCT03860857 211 213 B-Negation
disease NCT03860857 214 221 B-Condition
( NCT03860857 222 223 O
s NCT03860857 224 225 O
) NCT03860857 226 227 O
expected NCT03860857 228 236 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860857 237 239 I-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03860857 240 249 O
with NCT03860857 250 254 O
the NCT03860857 255 258 O
study NCT03860857 259 264 B-Study
; NCT03860857 264 265 O

5 NCT03860857 268 269 O
. NCT03860857 269 270 O
Willing NCT03860857 272 279 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03860857 280 283 B-And
able NCT03860857 284 288 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03860857 289 291 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03860857 292 303 O
for NCT03860857 304 307 O
the NCT03860857 308 311 O
duration NCT03860857 312 320 O
of NCT03860857 321 323 O
the NCT03860857 324 327 O
study NCT03860857 328 333 B-Study
and NCT03860857 334 337 B-And
in NCT03860857 338 340 O
all NCT03860857 341 344 O
study NCT03860857 345 350 B-Study
procedures NCT03860857 351 361 B-Procedure
including NCT03860857 362 371 O
MRI NCT03860857 372 375 B-Procedure
and NCT03860857 376 379 B-Or
PET NCT03860857 380 383 B-Procedure
; NCT03860857 383 384 O

6 NCT03860857 387 388 O
. NCT03860857 388 389 O
Normal NCT03860857 391 397 O
cognition NCT03860857 398 407 B-Condition
defined NCT03860857 408 415 O
as NCT03860857 416 418 O
a NCT03860857 419 420 O
Clinical NCT03860857 421 429 B-Observation
Dementia NCT03860857 430 438 I-Observation
Rating NCT03860857 439 445 I-Observation
of NCT03860857 446 448 O
0 NCT03860857 449 450 B-Eq_Comparison
and NCT03860857 451 454 B-And
a NCT03860857 455 456 O
Mini NCT03860857 457 461 B-Observation
- NCT03860857 462 463 I-Observation
Mental NCT03860857 464 470 I-Observation
State NCT03860857 471 476 I-Observation
Examination NCT03860857 477 488 I-Observation
score NCT03860857 489 494 B-Eq_Comparison
of NCT03860857 495 497 I-Eq_Comparison
27 NCT03860857 498 500 I-Eq_Comparison
or NCT03860857 501 503 I-Eq_Comparison
higher NCT03860857 504 510 I-Eq_Comparison
. NCT03860857 511 512 O

Exclusion NCT03860857 514 523 O
Criteria NCT03860857 524 532 O
: NCT03860857 533 534 O

1 NCT03860857 538 539 O
. NCT03860857 539 540 O
Significant NCT03860857 542 553 O
co NCT03860857 554 556 B-Modifier
- NCT03860857 557 558 I-Modifier
morbid NCT03860857 559 565 I-Modifier
neurologic NCT03860857 566 576 B-Condition
disease NCT03860857 577 584 I-Condition
such NCT03860857 585 589 O
as NCT03860857 590 592 O
Parkinson NCT03860857 593 602 B-Condition
's NCT03860857 602 604 I-Condition
disease NCT03860857 605 612 I-Condition
, NCT03860857 613 614 O
multiple NCT03860857 615 623 B-Condition
sclerosis NCT03860857 624 633 I-Condition
, NCT03860857 634 635 O
brain NCT03860857 636 641 B-Condition
cyst NCT03860857 642 646 I-Condition
, NCT03860857 647 648 O
tumor NCT03860857 649 654 B-Condition
or NCT03860857 655 657 B-Or
aneurysm NCT03860857 658 666 B-Condition
; NCT03860857 666 667 O

2 NCT03860857 670 671 O
. NCT03860857 671 672 O
Major NCT03860857 674 679 O
health NCT03860857 680 686 B-Condition
conditions NCT03860857 687 697 I-Condition
such NCT03860857 698 702 O
as NCT03860857 703 705 O
uncontrolled NCT03860857 706 718 B-Modifier
diabetes NCT03860857 719 727 B-Condition
mellitus NCT03860857 728 736 I-Condition
, NCT03860857 737 738 O
uncontrolled NCT03860857 739 751 B-Modifier
hypertension NCT03860857 752 764 B-Condition
, NCT03860857 765 766 O
nutritional NCT03860857 767 778 B-Condition
deficiency NCT03860857 779 789 I-Condition
or NCT03860857 790 792 B-Or
uncontrolled NCT03860857 793 805 B-Modifier
thyroid NCT03860857 806 813 B-Condition
disease NCT03860857 814 821 I-Condition
; NCT03860857 821 822 O

3 NCT03860857 825 826 O
. NCT03860857 826 827 O
Significant NCT03860857 829 840 O
psychiatric NCT03860857 841 852 B-Condition
disorders NCT03860857 853 862 I-Condition
such NCT03860857 863 867 O
as NCT03860857 868 870 O
schizophrenia NCT03860857 871 884 B-Condition
, NCT03860857 885 886 O
bipolar NCT03860857 887 894 B-Condition
disorder NCT03860857 895 903 I-Condition
, NCT03860857 904 905 O
anxiety NCT03860857 906 913 B-Condition
disorder NCT03860857 914 922 I-Condition
, NCT03860857 923 924 O
major NCT03860857 925 930 O
depressive NCT03860857 931 941 B-Condition
disorder NCT03860857 942 950 I-Condition
, NCT03860857 951 952 O
or NCT03860857 953 955 B-Or
attention NCT03860857 956 965 B-Condition
- NCT03860857 966 967 I-Condition
deficit NCT03860857 968 975 I-Condition
hyperactivity NCT03860857 976 989 I-Condition
disorder NCT03860857 990 998 I-Condition
; NCT03860857 998 999 O

4 NCT03860857 1002 1003 O
. NCT03860857 1003 1004 O
ADRC NCT03860857 1006 1010 O
consensus NCT03860857 1011 1020 O
diagnosis NCT03860857 1021 1030 O
of NCT03860857 1031 1033 O
dementia NCT03860857 1034 1042 B-Condition
or NCT03860857 1043 1045 B-Or
mild NCT03860857 1046 1050 O
cognitive NCT03860857 1051 1060 B-Condition
impairment NCT03860857 1061 1071 I-Condition
; NCT03860857 1071 1072 O

5 NCT03860857 1075 1076 O
. NCT03860857 1076 1077 O
Cognitive NCT03860857 1079 1088 B-Condition
impairment NCT03860857 1089 1099 I-Condition
when NCT03860857 1100 1104 O
tested NCT03860857 1105 1111 O
at NCT03860857 1112 1114 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03860857 1115 1123 B-Study
( NCT03860857 1124 1125 O
defined NCT03860857 1126 1133 O
as NCT03860857 1134 1136 O
a NCT03860857 1137 1138 O
score NCT03860857 1139 1144 O
on NCT03860857 1145 1147 O
any NCT03860857 1148 1151 O
neuropsychological NCT03860857 1152 1170 B-Observation
test NCT03860857 1171 1175 I-Observation
of NCT03860857 1176 1178 O
1.5 NCT03860857 1179 1182 B-Eq_Comparison
SDs NCT03860857 1183 1186 I-Eq_Comparison
or NCT03860857 1187 1189 I-Eq_Comparison
more NCT03860857 1190 1194 I-Eq_Comparison
outside NCT03860857 1195 1202 B-Modifier
the NCT03860857 1203 1206 I-Modifier
age NCT03860857 1207 1210 I-Modifier
norm NCT03860857 1211 1215 I-Modifier
) NCT03860857 1216 1217 O
; NCT03860857 1218 1219 O

6 NCT03860857 1222 1223 O
. NCT03860857 1223 1224 O
Alcohol NCT03860857 1226 1233 B-Modifier
or NCT03860857 1234 1236 B-Or
substance NCT03860857 1237 1246 B-Modifier
abuse NCT03860857 1247 1252 B-Condition
or NCT03860857 1253 1255 B-Or
dependence NCT03860857 1256 1266 B-Condition
within NCT03860857 1267 1273 B-Eq_Comparison
the NCT03860857 1274 1277 I-Eq_Comparison
past NCT03860857 1278 1282 I-Eq_Comparison
2 NCT03860857 1283 1284 I-Eq_Comparison
years NCT03860857 1285 1290 I-Eq_Comparison
( NCT03860857 1291 1292 O
DSM NCT03860857 1293 1296 O
- NCT03860857 1297 1298 O
IV NCT03860857 1299 1301 O
criteria NCT03860857 1302 1310 O
) NCT03860857 1311 1312 O
; NCT03860857 1313 1314 O

7 NCT03860857 1317 1318 O
. NCT03860857 1318 1319 O
MRI NCT03860857 1321 1324 B-Procedure
contraindications NCT03860857 1325 1342 B-Contraindication
, NCT03860857 1343 1344 O
e NCT03860857 1345 1346 O
. NCT03860857 1347 1348 O
g NCT03860857 1349 1350 O
. NCT03860857 1351 1352 O
pacemakers NCT03860857 1354 1364 B-Procedure
, NCT03860857 1365 1366 O
aneurysm NCT03860857 1367 1375 B-Procedure
clips NCT03860857 1376 1381 I-Procedure
, NCT03860857 1382 1383 O
artificial NCT03860857 1384 1394 B-Procedure
heart NCT03860857 1395 1400 I-Procedure
valves NCT03860857 1401 1407 I-Procedure
, NCT03860857 1408 1409 O
ear NCT03860857 1410 1413 B-Procedure
implants NCT03860857 1414 1422 I-Procedure
, NCT03860857 1423 1424 O
metal NCT03860857 1425 1430 B-Condition
fragments NCT03860857 1431 1440 I-Condition
or NCT03860857 1441 1443 B-Or
foreign NCT03860857 1444 1451 B-Modifier
objects NCT03860857 1452 1459 B-Condition
in NCT03860857 1460 1462 O
the NCT03860857 1463 1466 O
eyes NCT03860857 1467 1471 B-Modifier
, NCT03860857 1472 1473 O
skin NCT03860857 1474 1478 B-Modifier
or NCT03860857 1479 1481 B-Or
body NCT03860857 1482 1486 B-Modifier
. NCT03860857 1487 1488 O
Females NCT03860857 1490 1497 O
who NCT03860857 1498 1501 B-And
are NCT03860857 1502 1505 O
pregnant NCT03860857 1506 1514 B-Condition
or NCT03860857 1515 1517 B-Or
trying NCT03860857 1518 1524 B-Assertion___Assertion_Type_Value:intention
to NCT03860857 1525 1527 I-Assertion___Assertion_Type_Value:intention
get NCT03860857 1528 1531 O
pregnant NCT03860857 1532 1540 B-Condition
are NCT03860857 1541 1544 O
also NCT03860857 1545 1549 O
excluded NCT03860857 1550 1558 B-Negation
; NCT03860857 1558 1559 O

8 NCT03860857 1562 1563 O
. NCT03860857 1563 1564 O
PET NCT03860857 1566 1569 B-Procedure
contraindications NCT03860857 1570 1587 B-Contraindication
, NCT03860857 1588 1589 O
e NCT03860857 1590 1591 O
. NCT03860857 1592 1593 O
g NCT03860857 1594 1595 O
. NCT03860857 1596 1597 O
significant NCT03860857 1599 1610 O
prior NCT03860857 1611 1616 B-Eq_Comparison
radiation NCT03860857 1617 1626 B-Condition
exposure NCT03860857 1627 1635 I-Condition
and NCT03860857 1636 1639 B-Or
pregnancy NCT03860857 1640 1649 B-Condition
. NCT03860857 1650 1651 O

Inclusion NCT03869151 0 9 O
Criteria NCT03869151 10 18 O
: NCT03869151 19 20 O

Patients NCT03869151 22 30 O
with NCT03869151 31 35 O
child NCT03869151 36 41 B-Modifier
A NCT03869151 42 43 I-Modifier
Hepatocellular NCT03869151 44 58 I-Modifier
carcinoma NCT03869151 59 68 B-Condition
. NCT03869151 69 70 O

Exclusion NCT03869151 72 81 O
Criteria NCT03869151 82 90 O
: NCT03869151 91 92 O

- NCT03869151 96 97 O
Patients NCT03869151 99 107 O
with NCT03869151 108 112 O
child NCT03869151 113 118 B-Modifier
C NCT03869151 119 120 I-Modifier
Hepatocellular NCT03869151 121 135 I-Modifier
carcinoma NCT03869151 136 145 B-Condition
. NCT03869151 146 147 O

- NCT03869151 151 152 O
Patients NCT03869151 154 162 O
with NCT03869151 163 167 O
heart NCT03869151 168 173 B-Condition
failure NCT03869151 174 181 I-Condition

Inclusion NCT03862521 0 9 O
criteria NCT03862521 10 18 O

- NCT03862521 21 22 O
Prepubertal NCT03862521 24 35 B-Condition
children NCT03862521 36 44 O
2 NCT03862521 45 46 B-Eq_Comparison
to NCT03862521 47 49 I-Eq_Comparison
< NCT03862521 50 51 I-Eq_Comparison
12 NCT03862521 52 54 I-Eq_Comparison
years NCT03862521 55 60 I-Eq_Comparison
old NCT03862521 61 64 B-Age
( NCT03862521 65 66 O
i NCT03862521 67 68 O
. NCT03862521 69 70 O
e NCT03862521 71 72 O
. NCT03862521 73 74 O
, NCT03862521 75 76 O
before NCT03862521 77 83 O
12 NCT03862521 84 86 O
th NCT03862521 87 89 O
birthday NCT03862521 90 98 O
) NCT03862521 99 100 O

- NCT03862521 104 105 O
Type NCT03862521 107 111 B-Modifier
1 NCT03862521 112 113 I-Modifier
diabetes NCT03862521 114 122 B-Condition
for NCT03862521 123 126 O
at NCT03862521 127 129 B-Eq_Comparison
least NCT03862521 130 135 I-Eq_Comparison
6 NCT03862521 136 137 I-Eq_Comparison
months NCT03862521 138 144 I-Eq_Comparison

- NCT03862521 147 148 O
Patients NCT03862521 150 158 O
must NCT03862521 159 163 O
be NCT03862521 164 166 O
using NCT03862521 167 172 B-Eq_Comparison
insulin NCT03862521 173 180 B-Procedure
pump NCT03862521 181 185 I-Procedure
therapy NCT03862521 186 193 I-Procedure

- NCT03862521 196 197 O
Not NCT03862521 199 202 B-Negation
presently NCT03862521 203 212 B-Eq_Comparison
on NCT03862521 213 215 O
low NCT03862521 216 219 O
carbohydrate NCT03862521 220 232 B-Modifier
diet NCT03862521 233 237 B-Observation

Exclusion NCT03862521 238 247 O
criteria NCT03862521 248 256 O

- NCT03862521 259 260 O
On NCT03862521 262 264 B-Eq_Comparison
low NCT03862521 265 268 O
or NCT03862521 269 271 B-Or
very NCT03862521 272 276 O
low NCT03862521 277 280 O
carbohydrate NCT03862521 281 293 B-Modifier
diet NCT03862521 294 298 B-Observation

- NCT03862521 301 302 O
History NCT03862521 304 311 B-Eq_Comparison
of NCT03862521 312 314 O
endocrine NCT03862521 315 324 B-Modifier
or NCT03862521 325 327 B-Or
metabolic NCT03862521 328 337 B-Modifier
disorder NCT03862521 338 346 B-Condition
that NCT03862521 347 351 O
could NCT03862521 352 357 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03862521 358 364 O
counter NCT03862521 365 372 B-Condition
- NCT03862521 373 374 I-Condition
regulation NCT03862521 375 385 I-Condition
( NCT03862521 386 387 O
well NCT03862521 388 392 O
- NCT03862521 393 394 O
controlled NCT03862521 395 405 O
hypothyroidism NCT03862521 406 420 B-Condition
is NCT03862521 421 423 O
acceptable NCT03862521 424 434 O
if NCT03862521 435 437 O
on NCT03862521 438 440 B-Eq_Comparison
stable NCT03862521 441 447 O
dose NCT03862521 448 452 O
of NCT03862521 453 455 O
l NCT03862521 456 457 B-Drug
- NCT03862521 458 459 I-Drug
thyroxine NCT03862521 460 469 I-Drug
for NCT03862521 470 473 O
≥ NCT03862521 474 475 B-Eq_Comparison
3 NCT03862521 476 477 I-Eq_Comparison
months NCT03862521 478 484 I-Eq_Comparison
) NCT03862521 485 486 O

- NCT03862521 490 491 O
History NCT03862521 493 500 B-Eq_Comparison
of NCT03862521 501 503 O
metabolic NCT03862521 504 513 B-Condition
disorder NCT03862521 514 522 I-Condition
affection NCT03862521 523 532 O
lipid NCT03862521 533 538 B-Condition
metabolism NCT03862521 539 549 I-Condition

- NCT03862521 552 553 O
Severe NCT03862521 555 561 O
hypoglycemic NCT03862521 562 574 B-Condition
event NCT03862521 575 580 I-Condition
in NCT03862521 581 583 O
past NCT03862521 584 588 B-Eq_Comparison
3 NCT03862521 589 590 I-Eq_Comparison
months NCT03862521 591 597 I-Eq_Comparison

Inclusion NCT03862456 0 9 O
Criteria NCT03862456 10 18 O
: NCT03862456 19 20 O

- NCT03862456 24 25 O
Diagnosis NCT03862456 27 36 O
of NCT03862456 37 39 O
periodontitis NCT03862456 40 53 B-Condition
( NCT03862456 54 55 O
stages NCT03862456 56 62 B-Eq_Comparison
III NCT03862456 63 66 I-Eq_Comparison
or NCT03862456 67 69 I-Eq_Comparison
IV NCT03862456 70 72 I-Eq_Comparison
) NCT03862456 73 74 O
that NCT03862456 75 79 O
may NCT03862456 80 83 B-Assertion___Assertion_Type_Value:hypothetical
require NCT03862456 84 91 I-Assertion___Assertion_Type_Value:hypothetical
periodontal NCT03862456 92 103 B-Procedure
surgery NCT03862456 104 111 I-Procedure

- NCT03862456 114 115 O
Have NCT03862456 117 121 O
at NCT03862456 122 124 B-Eq_Comparison
least NCT03862456 125 130 I-Eq_Comparison
10 NCT03862456 131 133 I-Eq_Comparison
teeth NCT03862456 134 139 B-Condition
in NCT03862456 140 142 O
function NCT03862456 143 151 O
, NCT03862456 152 153 O
excluding NCT03862456 154 163 B-Exception
third NCT03862456 164 169 B-Modifier
molars NCT03862456 170 176 I-Modifier
. NCT03862456 177 178 O

- NCT03862456 182 183 O
Present NCT03862456 185 192 O
locations NCT03862456 193 202 O
with NCT03862456 203 207 O
probing NCT03862456 208 215 B-Observation
depth NCT03862456 216 221 I-Observation
( NCT03862456 222 223 O
PS NCT03862456 224 226 B-Observation
) NCT03862456 227 228 O
> NCT03862456 229 230 B-Eq_Comparison
6 NCT03862456 231 232 I-Eq_Comparison
mm NCT03862456 233 235 I-Eq_Comparison
in NCT03862456 236 238 O
at NCT03862456 239 241 B-Eq_Comparison
least NCT03862456 242 247 I-Eq_Comparison
30 NCT03862456 248 250 I-Eq_Comparison
% NCT03862456 251 252 I-Eq_Comparison
of NCT03862456 253 255 O
the NCT03862456 256 259 O
teeth NCT03862456 260 265 B-Condition
. NCT03862456 266 267 O

- NCT03862456 271 272 O
Present NCT03862456 274 281 O
radiographic NCT03862456 282 294 B-Procedure
evidence NCT03862456 295 303 O
of NCT03862456 304 306 O
moderate NCT03862456 307 315 B-Eq_Comparison
- NCT03862456 316 317 I-Eq_Comparison
severe NCT03862456 318 324 I-Eq_Comparison
bone NCT03862456 325 329 B-Condition
loss NCT03862456 330 334 I-Condition
in NCT03862456 335 337 O
at NCT03862456 338 340 B-Eq_Comparison
least NCT03862456 341 346 I-Eq_Comparison
30 NCT03862456 347 349 I-Eq_Comparison
% NCT03862456 350 351 I-Eq_Comparison
of NCT03862456 352 354 O
the NCT03862456 355 358 O
dentition NCT03862456 359 368 B-Modifier
. NCT03862456 369 370 O

- NCT03862456 374 375 O
Detection NCT03862456 377 386 O
of NCT03862456 387 389 O
P NCT03862456 390 391 B-Organism
. NCT03862456 392 393 I-Organism
gingivalis NCT03862456 395 405 I-Organism
in NCT03862456 406 408 O
subgingival NCT03862456 409 420 B-Observation
samples NCT03862456 421 428 I-Observation
taken NCT03862456 429 434 B-Temporal_Connection___Temporal_Connection_Type_Value:during
at NCT03862456 435 437 I-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862456 438 441 O
screening NCT03862456 442 451 B-Study
visit NCT03862456 452 457 O
as NCT03862456 458 460 B-And
well NCT03862456 461 465 I-And
as NCT03862456 466 468 I-And
in NCT03862456 469 471 O
the NCT03862456 472 475 O
post NCT03862456 476 480 B-Modifier
- NCT03862456 481 482 I-Modifier
scaling NCT03862456 483 490 I-Modifier
and NCT03862456 491 494 B-Or
root NCT03862456 495 499 B-Modifier
planning NCT03862456 500 508 I-Modifier
visit NCT03862456 509 514 B-Encounter
and NCT03862456 515 518 O
processed NCT03862456 519 528 O
by NCT03862456 529 531 O
culture NCT03862456 532 539 O
. NCT03862456 540 541 O

- NCT03862456 545 546 O
Systemically NCT03862456 548 560 B-Modifier
healthy NCT03862456 561 568 B-Condition
patients NCT03862456 569 577 O
. NCT03862456 578 579 O

Exclusion NCT03862456 581 590 O
Criteria NCT03862456 591 599 O
: NCT03862456 600 601 O

- NCT03862456 605 606 O
Pregnant NCT03862456 608 616 B-Condition
or NCT03862456 617 619 B-Or
lactating NCT03862456 620 629 B-Condition
women NCT03862456 630 635 O
. NCT03862456 636 637 O

- NCT03862456 641 642 O
Presenting NCT03862456 644 654 O
systemic NCT03862456 655 663 B-Modifier
pathology NCT03862456 664 673 B-Condition
and NCT03862456 674 677 B-Or
/ NCT03862456 678 679 I-Or
or NCT03862456 680 682 I-Or
taking NCT03862456 683 689 B-Eq_Comparison
medication NCT03862456 690 700 B-Drug
that NCT03862456 701 705 O
may NCT03862456 706 709 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03862456 710 716 O
the NCT03862456 717 720 O
periodontal NCT03862456 721 732 B-Condition
situation NCT03862456 733 742 I-Condition
and NCT03862456 743 746 B-Or
/ NCT03862456 747 748 I-Or
or NCT03862456 749 751 I-Or
patients NCT03862456 752 760 O
requiring NCT03862456 761 770 B-Assertion___Assertion_Type_Value:hypothetical
antibiotic NCT03862456 771 781 B-Procedure
prophylaxis NCT03862456 782 793 I-Procedure
. NCT03862456 794 795 O

- NCT03862456 799 800 O
Have NCT03862456 802 806 O
received NCT03862456 807 815 B-Eq_Comparison
systemic NCT03862456 816 824 B-Modifier
antimicrobial NCT03862456 825 838 B-Procedure
treatment NCT03862456 839 848 I-Procedure
in NCT03862456 849 851 O
the NCT03862456 852 855 O
previous NCT03862456 856 864 B-Eq_Comparison
6 NCT03862456 865 866 I-Eq_Comparison
months NCT03862456 867 873 I-Eq_Comparison
. NCT03862456 874 875 O

- NCT03862456 879 880 O
Have NCT03862456 882 886 O
received NCT03862456 887 895 B-Eq_Comparison
periodontal NCT03862456 896 907 B-Procedure
treatment NCT03862456 908 917 I-Procedure
in NCT03862456 918 920 O
the NCT03862456 921 924 O
6 NCT03862456 925 926 B-Eq_Comparison
months NCT03862456 927 933 I-Eq_Comparison
prior NCT03862456 934 939 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862456 940 942 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03862456 943 946 O
beginning NCT03862456 947 956 B-Eq_Comparison
of NCT03862456 957 959 O
the NCT03862456 960 963 O
study NCT03862456 964 969 B-Study
. NCT03862456 970 971 O

- NCT03862456 975 976 O
Patients NCT03862456 978 986 O
allergic NCT03862456 987 995 B-Allergy
to NCT03862456 996 998 O
metronidazole NCT03862456 999 1012 B-Drug
, NCT03862456 1013 1014 O
or NCT03862456 1015 1017 B-Or
to NCT03862456 1018 1020 O
any NCT03862456 1021 1024 O
of NCT03862456 1025 1027 O
the NCT03862456 1028 1031 O
components NCT03862456 1032 1042 O
of NCT03862456 1043 1045 O
commercial NCT03862456 1046 1056 O
formulations NCT03862456 1057 1069 O
thereof NCT03862456 1070 1077 O
( NCT03862456 1078 1079 O
Flagyl NCT03862456 1080 1086 B-Drug
® NCT03862456 1086 1087 O
) NCT03862456 1088 1089 O
. NCT03862456 1090 1091 O

- NCT03862456 1095 1096 O
Patients NCT03862456 1098 1106 O
allergic NCT03862456 1107 1115 B-Allergy
to NCT03862456 1116 1118 O
azithromycin NCT03862456 1119 1131 B-Drug
, NCT03862456 1132 1133 O
or NCT03862456 1134 1136 B-Or
to NCT03862456 1137 1139 O
any NCT03862456 1140 1143 O
of NCT03862456 1144 1146 O
the NCT03862456 1147 1150 O
components NCT03862456 1151 1161 O
of NCT03862456 1162 1164 O
commercial NCT03862456 1165 1175 O
formulations NCT03862456 1176 1188 O
thereof NCT03862456 1189 1196 O
( NCT03862456 1197 1198 O
Zithromax NCT03862456 1199 1208 B-Drug
® NCT03862456 1208 1209 O
) NCT03862456 1210 1211 O
. NCT03862456 1212 1213 O

- NCT03862456 1217 1218 O
Patients NCT03862456 1220 1228 O
who NCT03862456 1229 1232 O
refuse NCT03862456 1233 1239 O
to NCT03862456 1240 1242 O
sign NCT03862456 1243 1247 O
the NCT03862456 1248 1251 O
informed NCT03862456 1252 1260 O
consent NCT03862456 1261 1268 O
. NCT03862456 1269 1270 O

Inclusion NCT03867344 0 9 O
Criteria NCT03867344 10 18 O
: NCT03867344 19 20 O

- NCT03867344 24 25 O
Healthy NCT03867344 27 34 B-Condition
volunteers NCT03867344 35 45 O

- NCT03867344 48 49 O
Males NCT03867344 51 56 O
and NCT03867344 57 60 B-Or
Females NCT03867344 61 68 O
age NCT03867344 69 72 B-Age
18 NCT03867344 73 75 B-Eq_Comparison
to NCT03867344 76 78 I-Eq_Comparison
45 NCT03867344 79 81 I-Eq_Comparison
years NCT03867344 82 87 I-Eq_Comparison

- NCT03867344 90 91 O
BMI NCT03867344 93 96 B-Observation
18 NCT03867344 97 99 B-Eq_Comparison
- NCT03867344 100 101 I-Eq_Comparison
30 NCT03867344 102 104 I-Eq_Comparison
kg NCT03867344 105 107 I-Eq_Comparison
/ NCT03867344 108 109 I-Eq_Comparison
m NCT03867344 110 111 I-Eq_Comparison
2 NCT03867344 112 113 I-Eq_Comparison

Exclusion NCT03867344 114 123 O
Criteria NCT03867344 124 132 O
: NCT03867344 133 134 O

- NCT03867344 138 139 O
Pregnancy NCT03867344 141 150 B-Condition

- NCT03867344 153 154 O
Lactation NCT03867344 156 165 B-Condition

- NCT03867344 168 169 O
Menopause NCT03867344 171 180 B-Condition

- NCT03867344 183 184 O
Any NCT03867344 186 189 O
medical NCT03867344 190 197 B-Condition
condition NCT03867344 198 207 I-Condition

- NCT03867344 210 211 O
Current NCT03867344 213 220 B-Eq_Comparison
or NCT03867344 221 223 B-Or
prior NCT03867344 224 229 B-Eq_Comparison
alcohol NCT03867344 230 237 B-Modifier
or NCT03867344 238 240 B-Or
drug NCT03867344 241 245 B-Modifier
abuse NCT03867344 246 251 B-Condition

- NCT03867344 254 255 O
Active NCT03867344 257 263 B-Eq_Comparison
tobacco NCT03867344 264 271 B-Condition
use NCT03867344 272 275 I-Condition

- NCT03867344 278 279 O
Abnormal NCT03867344 281 289 O
ECG NCT03867344 290 293 B-Procedure

- NCT03867344 296 297 O
In NCT03867344 299 301 O
all NCT03867344 302 305 O
subjects NCT03867344 306 314 O
, NCT03867344 315 316 O
any NCT03867344 317 320 O
individuals NCT03867344 321 332 O
on NCT03867344 333 335 O
oral NCT03867344 336 340 B-Modifier
, NCT03867344 341 342 O
injected NCT03867344 343 351 B-Modifier
, NCT03867344 352 353 O
inhaled NCT03867344 354 361 B-Modifier
or NCT03867344 362 364 B-Or
topical NCT03867344 365 372 B-Modifier
corticosteroids NCT03867344 373 388 B-Drug
within NCT03867344 389 395 B-Eq_Comparison
the NCT03867344 396 399 I-Eq_Comparison
last NCT03867344 400 404 I-Eq_Comparison
year NCT03867344 405 409 I-Eq_Comparison
or NCT03867344 410 412 B-Or
oral NCT03867344 413 417 O
contraceptives NCT03867344 418 432 B-Drug
within NCT03867344 433 439 B-Eq_Comparison
the NCT03867344 440 443 I-Eq_Comparison
past NCT03867344 444 448 I-Eq_Comparison
3 NCT03867344 449 450 I-Eq_Comparison
months NCT03867344 451 457 I-Eq_Comparison
will NCT03867344 458 462 O
be NCT03867344 463 465 O
excluded NCT03867344 466 474 B-Negation
. NCT03867344 475 476 O

- NCT03867344 480 481 O
Use NCT03867344 483 486 O
of NCT03867344 487 489 O
medications NCT03867344 490 501 B-Drug

- NCT03867344 504 505 O
Serum NCT03867344 507 512 B-Observation
potassium NCT03867344 513 522 I-Observation
> NCT03867344 523 524 B-Eq_Comparison
5.0 NCT03867344 525 528 I-Eq_Comparison
mmol NCT03867344 529 533 I-Eq_Comparison
/ NCT03867344 534 535 I-Eq_Comparison
L NCT03867344 536 537 I-Eq_Comparison

- NCT03867344 540 541 O
Estimated NCT03867344 543 552 B-Observation
GFR NCT03867344 553 556 I-Observation
< NCT03867344 557 558 B-Eq_Comparison
60 NCT03867344 559 561 I-Eq_Comparison
mL NCT03867344 562 564 I-Eq_Comparison
/ NCT03867344 565 566 I-Eq_Comparison
min NCT03867344 567 570 I-Eq_Comparison
/ NCT03867344 571 572 I-Eq_Comparison
1.73 NCT03867344 573 577 I-Eq_Comparison
m NCT03867344 578 579 I-Eq_Comparison
2 NCT03867344 580 581 I-Eq_Comparison

- NCT03867344 584 585 O
Hemoglobin NCT03867344 587 597 B-Observation
A NCT03867344 598 599 I-Observation
1c NCT03867344 600 602 I-Observation
≥ NCT03867344 603 604 B-Eq_Comparison
6.5 NCT03867344 605 608 I-Eq_Comparison
% NCT03867344 609 610 I-Eq_Comparison

- NCT03867344 614 615 O
LDL NCT03867344 617 620 B-Observation
> NCT03867344 621 622 B-Eq_Comparison
130 NCT03867344 623 626 I-Eq_Comparison
mg NCT03867344 627 629 I-Eq_Comparison
/ NCT03867344 630 631 I-Eq_Comparison
dL NCT03867344 632 634 I-Eq_Comparison
; NCT03867344 634 635 O
Triglycerides NCT03867344 636 649 B-Observation
> NCT03867344 650 651 B-Eq_Comparison
150 NCT03867344 652 655 I-Eq_Comparison
mg NCT03867344 656 658 I-Eq_Comparison
/ NCT03867344 659 660 I-Eq_Comparison
dL NCT03867344 661 663 I-Eq_Comparison

- NCT03867344 666 667 O
Patient NCT03867344 669 676 B-Observation
Health NCT03867344 677 683 I-Observation
Questionnaire NCT03867344 684 697 I-Observation
( NCT03867344 698 699 O
PHQ NCT03867344 700 703 B-Observation
9 NCT03867344 704 705 I-Observation
) NCT03867344 706 707 O
for NCT03867344 708 711 O
depression NCT03867344 712 722 O
score NCT03867344 723 728 O
≥ NCT03867344 729 730 B-Eq_Comparison
15 NCT03867344 731 733 I-Eq_Comparison

- NCT03867344 737 738 O
GAD NCT03867344 740 743 B-Observation
- NCT03867344 744 745 I-Observation
73 NCT03867344 746 748 I-Observation
Questionnaire NCT03867344 749 762 I-Observation
for NCT03867344 763 766 O
anxiety NCT03867344 767 774 O
score NCT03867344 775 780 O
≥ NCT03867344 781 782 B-Eq_Comparison
10 NCT03867344 783 785 I-Eq_Comparison

- NCT03867344 789 790 O
Primary NCT03867344 792 799 B-Modifier
Care NCT03867344 800 804 I-Modifier
PTSD NCT03867344 805 809 B-Condition
Screen NCT03867344 810 816 B-Procedure
for NCT03867344 817 820 O
DSM NCT03867344 821 824 O
- NCT03867344 825 826 O
5 NCT03867344 827 828 O
for NCT03867344 829 832 O
post NCT03867344 833 837 B-Observation
- NCT03867344 838 839 I-Observation
traumatic NCT03867344 840 849 I-Observation
stress NCT03867344 850 856 I-Observation
disorder NCT03867344 857 865 I-Observation
score NCT03867344 866 871 I-Observation
≥ NCT03867344 872 873 B-Eq_Comparison
10 NCT03867344 874 876 I-Eq_Comparison

- NCT03867344 880 881 O
Blood NCT03867344 883 888 B-Observation
pressure NCT03867344 889 897 I-Observation
systolic NCT03867344 898 906 I-Observation
≥ NCT03867344 907 908 B-Eq_Comparison
140 NCT03867344 909 912 I-Eq_Comparison
or NCT03867344 913 915 B-Or
< NCT03867344 916 917 B-Eq_Comparison
100 NCT03867344 918 921 I-Eq_Comparison
mmHg NCT03867344 922 926 I-Eq_Comparison
; NCT03867344 926 927 O
Blood NCT03867344 928 933 B-Observation
pressure NCT03867344 934 942 I-Observation
diastolic NCT03867344 943 952 I-Observation
> NCT03867344 953 954 B-Eq_Comparison
90 NCT03867344 955 957 I-Eq_Comparison
mmHg NCT03867344 958 962 I-Eq_Comparison

- NCT03867344 965 966 O
Metal NCT03867344 968 973 B-Condition
in NCT03867344 974 976 I-Condition
the NCT03867344 977 980 I-Condition
body NCT03867344 981 985 I-Condition
including NCT03867344 986 995 O
: NCT03867344 996 997 O
cardiac NCT03867344 998 1005 B-Procedure
pacemakers NCT03867344 1006 1016 I-Procedure
, NCT03867344 1017 1018 O
stents NCT03867344 1019 1025 B-Procedure
, NCT03867344 1026 1027 O
artificial NCT03867344 1028 1038 B-Procedure
heart NCT03867344 1039 1044 I-Procedure
valves NCT03867344 1045 1051 I-Procedure
, NCT03867344 1052 1053 O
artificial NCT03867344 1054 1064 B-Procedure
limbs NCT03867344 1065 1070 B-Modifier
or NCT03867344 1071 1073 B-Or
hands NCT03867344 1074 1079 B-Modifier
, NCT03867344 1080 1081 O
brain NCT03867344 1082 1087 B-Procedure
stimulator NCT03867344 1088 1098 I-Procedure
devices NCT03867344 1099 1106 I-Procedure
, NCT03867344 1107 1108 O
implanted NCT03867344 1109 1118 B-Procedure
drug NCT03867344 1119 1123 I-Procedure
pumps NCT03867344 1124 1129 I-Procedure
, NCT03867344 1130 1131 O
ear NCT03867344 1132 1135 B-Procedure
implants NCT03867344 1136 1144 I-Procedure
, NCT03867344 1145 1146 O
eye NCT03867344 1147 1150 B-Procedure
implants NCT03867344 1151 1159 I-Procedure
or NCT03867344 1160 1162 B-Or
known NCT03867344 1163 1168 O
metal NCT03867344 1169 1174 B-Condition
fragments NCT03867344 1175 1184 I-Condition
in NCT03867344 1185 1187 O
eyes NCT03867344 1188 1192 B-Modifier
, NCT03867344 1193 1194 O
exposure NCT03867344 1195 1203 B-Condition
to NCT03867344 1204 1206 O
shrapnel NCT03867344 1207 1215 B-Modifier
or NCT03867344 1216 1218 B-Or
metal NCT03867344 1219 1224 B-Modifier
filings NCT03867344 1225 1232 I-Modifier
( NCT03867344 1233 1234 O
wounded NCT03867344 1235 1242 B-Condition
in NCT03867344 1243 1245 I-Condition
military NCT03867344 1246 1254 I-Condition
combat NCT03867344 1255 1261 I-Condition
, NCT03867344 1262 1263 O
sheet NCT03867344 1264 1269 B-Observation
metal NCT03867344 1270 1275 I-Observation
workers NCT03867344 1276 1283 I-Observation
, NCT03867344 1284 1285 O
welders NCT03867344 1286 1293 B-Observation
, NCT03867344 1294 1295 O
and NCT03867344 1296 1299 O
others NCT03867344 1300 1306 O
) NCT03867344 1307 1308 O
, NCT03867344 1309 1310 O
other NCT03867344 1311 1316 B-Other
metallic NCT03867344 1317 1325 B-Procedure
surgical NCT03867344 1326 1334 I-Procedure
hardware NCT03867344 1335 1343 I-Procedure
in NCT03867344 1344 1346 O
vital NCT03867344 1347 1352 B-Modifier
areas NCT03867344 1353 1358 I-Modifier
, NCT03867344 1359 1360 O
certain NCT03867344 1361 1368 O
tattoos NCT03867344 1369 1376 B-Condition
with NCT03867344 1377 1381 O
metallic NCT03867344 1382 1390 B-Modifier
ink NCT03867344 1391 1394 I-Modifier
, NCT03867344 1395 1396 O
certain NCT03867344 1397 1404 O
transdermal NCT03867344 1405 1416 B-Procedure
medication NCT03867344 1417 1427 I-Procedure
patches NCT03867344 1428 1435 I-Procedure
, NCT03867344 1436 1437 O
and NCT03867344 1438 1441 B-Or
metal NCT03867344 1442 1447 B-Procedure
- NCT03867344 1448 1449 I-Procedure
containing NCT03867344 1450 1460 I-Procedure
IUDs NCT03867344 1461 1465 I-Procedure

Inclusion NCT03863457 0 9 O
Criteria NCT03863457 10 18 O
: NCT03863457 19 20 O

- NCT03863457 24 25 O
Participants NCT03863457 27 39 O
will NCT03863457 40 44 O
be NCT03863457 45 47 O
≥ NCT03863457 48 49 B-Eq_Comparison
18 NCT03863457 50 52 I-Eq_Comparison
years NCT03863457 53 58 I-Eq_Comparison
of NCT03863457 59 61 O
age NCT03863457 62 65 B-Age

- NCT03863457 68 69 O
Known NCT03863457 71 76 B-Modifier
or NCT03863457 77 79 B-Or
suspected NCT03863457 80 89 B-Assertion___Assertion_Type_Value:possible
primary NCT03863457 90 97 B-Modifier
or NCT03863457 98 100 B-Or
metastatic NCT03863457 101 111 B-Modifier
breast NCT03863457 112 118 I-Modifier
cancer NCT03863457 119 125 B-Condition
. NCT03863457 126 127 O

- NCT03863457 131 132 O
At NCT03863457 134 136 B-Eq_Comparison
least NCT03863457 137 142 I-Eq_Comparison
one NCT03863457 143 146 I-Eq_Comparison
lesion NCT03863457 147 153 B-Observation
≥ NCT03863457 154 155 B-Eq_Comparison
1.5 NCT03863457 156 159 I-Eq_Comparison
cm NCT03863457 160 162 I-Eq_Comparison
that NCT03863457 163 167 O
is NCT03863457 168 170 O
seen NCT03863457 171 175 O
on NCT03863457 176 178 O
standard NCT03863457 179 187 B-Procedure
imaging NCT03863457 188 195 I-Procedure
( NCT03863457 196 197 O
e NCT03863457 198 199 O
. NCT03863457 200 201 O
g NCT03863457 202 203 O
. NCT03863457 204 205 O
CT NCT03863457 207 209 B-Procedure
, NCT03863457 210 211 O
MRI NCT03863457 212 215 B-Procedure
, NCT03863457 216 217 O
mammogram NCT03863457 218 227 B-Procedure
, NCT03863457 228 229 O
ultrasound NCT03863457 230 240 B-Procedure
, NCT03863457 241 242 O
FDG NCT03863457 243 246 B-Procedure
- NCT03863457 247 248 I-Procedure
PET NCT03863457 249 252 I-Procedure
/ NCT03863457 253 254 B-Or
CT NCT03863457 255 257 B-Procedure
) NCT03863457 258 259 O
. NCT03863457 260 261 O
Only NCT03863457 263 267 B-Eq_Comparison
one NCT03863457 268 271 I-Eq_Comparison
type NCT03863457 272 276 O
of NCT03863457 277 279 O
imaging NCT03863457 280 287 B-Procedure
is NCT03863457 288 290 O
required NCT03863457 291 299 O
to NCT03863457 300 302 O
show NCT03863457 303 307 O
a NCT03863457 308 309 O
lesion NCT03863457 310 316 B-Condition
. NCT03863457 317 318 O

- NCT03863457 322 323 O
Participants NCT03863457 325 337 O
must NCT03863457 338 342 O
be NCT03863457 343 345 O
informed NCT03863457 346 354 O
of NCT03863457 355 357 O
the NCT03863457 358 361 O
investigational NCT03863457 362 377 O
nature NCT03863457 378 384 O
of NCT03863457 385 387 O
this NCT03863457 388 392 O
study NCT03863457 393 398 O
and NCT03863457 399 402 O
be NCT03863457 403 405 O
willing NCT03863457 406 413 O
to NCT03863457 414 416 O
provide NCT03863457 417 424 O
written NCT03863457 425 432 O
informed NCT03863457 433 441 O
consent NCT03863457 442 449 O
and NCT03863457 450 453 O
participate NCT03863457 454 465 O
in NCT03863457 466 468 O
this NCT03863457 469 473 O
study NCT03863457 474 479 O
in NCT03863457 480 482 O
accordance NCT03863457 483 493 O
with NCT03863457 494 498 O
institutional NCT03863457 499 512 O
and NCT03863457 513 516 O
federal NCT03863457 517 524 O
guidelines NCT03863457 525 535 O
prior NCT03863457 536 541 O
to NCT03863457 542 544 O
study NCT03863457 545 550 O
- NCT03863457 551 552 O
specific NCT03863457 553 561 O
procedures NCT03863457 562 572 O
. NCT03863457 573 574 O

Exclusion NCT03863457 576 585 O
Criteria NCT03863457 586 594 O
: NCT03863457 595 596 O

- NCT03863457 600 601 O
Females NCT03863457 603 610 O
who NCT03863457 611 614 B-And
are NCT03863457 615 618 O
pregnant NCT03863457 619 627 B-Condition
or NCT03863457 628 630 B-Or
breast NCT03863457 631 637 B-Condition
feeding NCT03863457 638 645 I-Condition
at NCT03863457 646 648 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863457 649 652 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03863457 653 657 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03863457 658 660 O
screening NCT03863457 661 670 B-Study
; NCT03863457 670 671 O
a NCT03863457 672 673 O
urine NCT03863457 674 679 B-Observation
pregnancy NCT03863457 680 689 I-Observation
test NCT03863457 690 694 I-Observation
will NCT03863457 695 699 O
be NCT03863457 700 702 O
performed NCT03863457 703 712 O
in NCT03863457 713 715 O
women NCT03863457 716 721 O
of NCT03863457 722 724 B-And
child NCT03863457 725 730 B-Condition
- NCT03863457 731 732 I-Condition
bearing NCT03863457 733 740 I-Condition
potential NCT03863457 741 750 I-Condition
at NCT03863457 751 753 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03863457 754 763 B-Study
. NCT03863457 764 765 O

- NCT03863457 769 770 O
Inability NCT03863457 772 781 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03863457 782 784 O
tolerate NCT03863457 785 793 O
imaging NCT03863457 794 801 B-Procedure
procedures NCT03863457 802 812 I-Procedure
in NCT03863457 813 815 O
the NCT03863457 816 819 O
opinion NCT03863457 820 827 O
of NCT03863457 828 830 O
an NCT03863457 831 833 O
investigator NCT03863457 834 846 O
or NCT03863457 847 849 O
treating NCT03863457 850 858 O
physician NCT03863457 859 868 O
. NCT03863457 869 870 O

- NCT03863457 874 875 O
Any NCT03863457 877 880 O
current NCT03863457 881 888 B-Eq_Comparison
medical NCT03863457 889 896 B-Condition
condition NCT03863457 897 906 I-Condition
, NCT03863457 907 908 O
illness NCT03863457 909 916 B-Condition
, NCT03863457 917 918 O
or NCT03863457 919 921 B-Or
disorder NCT03863457 922 930 B-Condition
, NCT03863457 931 932 O
as NCT03863457 933 935 O
assessed NCT03863457 936 944 O
by NCT03863457 945 947 O
medical NCT03863457 948 955 O
record NCT03863457 956 962 O
review NCT03863457 963 969 O
and NCT03863457 970 973 O
/ NCT03863457 974 975 O
or NCT03863457 976 978 O
self NCT03863457 979 983 O
- NCT03863457 984 985 O
reported NCT03863457 986 994 O
, NCT03863457 995 996 O
that NCT03863457 997 1001 O
is NCT03863457 1002 1004 O
considered NCT03863457 1005 1015 O
by NCT03863457 1016 1018 O
a NCT03863457 1019 1020 O
physician NCT03863457 1021 1030 O
investigator NCT03863457 1031 1043 O
to NCT03863457 1044 1046 O
be NCT03863457 1047 1049 O
a NCT03863457 1050 1051 O
condition NCT03863457 1052 1061 B-Condition
that NCT03863457 1062 1066 O
could NCT03863457 1067 1072 B-Assertion___Assertion_Type_Value:hypothetical
compromise NCT03863457 1073 1083 O
participant NCT03863457 1084 1095 O
safety NCT03863457 1096 1102 O
or NCT03863457 1103 1105 O
successful NCT03863457 1106 1116 O
participation NCT03863457 1117 1130 O
in NCT03863457 1131 1133 O
the NCT03863457 1134 1137 O
study NCT03863457 1138 1143 B-Study
. NCT03863457 1144 1145 O

Inclusion NCT03928119 0 9 O
Criteria NCT03928119 10 18 O
: NCT03928119 19 20 O

- NCT03928119 24 25 O
ST NCT03928119 27 29 B-Condition
- NCT03928119 30 31 I-Condition
Segment NCT03928119 32 39 I-Condition
Elevation NCT03928119 40 49 I-Condition
Myocardial NCT03928119 50 60 I-Condition
Infarction NCT03928119 61 71 I-Condition
patients NCT03928119 72 80 O
within NCT03928119 81 87 B-Eq_Comparison
30 NCT03928119 88 90 I-Eq_Comparison
days NCT03928119 91 95 I-Eq_Comparison
since NCT03928119 96 101 B-Temporal_Connection___Temporal_Connection_Type_Value:after
symptoms NCT03928119 102 110 B-Assertion___Assertion_Type_Value:possible
onset NCT03928119 111 116 B-Eq_Comparison

Exclusion NCT03928119 117 126 O
Criteria NCT03928119 127 135 O
: NCT03928119 136 137 O

- NCT03928119 141 142 O
None NCT03928119 144 148 O

Inclusion NCT03925506 0 9 O
Criteria NCT03925506 10 18 O
: NCT03925506 19 20 O

- NCT03925506 24 25 O
Inpatient NCT03925506 27 36 B-Encounter
≥ NCT03925506 37 38 B-Eq_Comparison
18 NCT03925506 39 41 I-Eq_Comparison
y NCT03925506 42 43 I-Eq_Comparison
. NCT03925506 44 45 I-Eq_Comparison
o NCT03925506 46 47 I-Eq_Comparison
. NCT03925506 48 49 I-Eq_Comparison
who NCT03925506 51 54 B-And
are NCT03925506 55 58 O
scheduled NCT03925506 59 68 B-Eq_Comparison
elective NCT03925506 69 77 O
colonoscopy NCT03925506 78 89 B-Procedure
during NCT03925506 90 96 B-Temporal_Connection___Temporal_Connection_Type_Value:during
hospitalization NCT03925506 97 112 O
irrespective NCT03925506 113 125 O
of NCT03925506 126 128 O
the NCT03925506 129 132 O
indication NCT03925506 133 143 O
. NCT03925506 144 145 O

Exclusion NCT03925506 147 156 O
Criteria NCT03925506 157 165 O
: NCT03925506 166 167 O

- NCT03925506 171 172 O
Urgent NCT03925506 174 180 B-Modifier
colonoscopy NCT03925506 181 192 B-Procedure

- NCT03925506 195 196 O
Patients NCT03925506 198 206 O
who NCT03925506 207 210 O
are NCT03925506 211 214 O
not NCT03925506 215 218 B-Negation
hospitalized NCT03925506 219 231 B-Encounter
when NCT03925506 232 236 B-Temporal_Connection___Temporal_Connection_Type_Value:during
taking NCT03925506 237 243 B-Eq_Comparison
bowel NCT03925506 244 249 B-Procedure
preparation NCT03925506 250 261 I-Procedure
or NCT03925506 262 264 B-Or
when NCT03925506 265 269 O
undergoing NCT03925506 270 280 B-Eq_Comparison
colonoscopy NCT03925506 281 292 B-Procedure

For NCT03924427 0 3 O
more NCT03924427 4 8 O
information NCT03924427 9 20 O
regarding NCT03924427 21 30 O
Bristol NCT03924427 31 38 O
- NCT03924427 39 40 O
Myers NCT03924427 41 46 O
Squibb NCT03924427 47 53 O
Clinical NCT03924427 54 62 O
Trial NCT03924427 63 68 O
participation NCT03924427 69 82 O
, NCT03924427 83 84 O
please NCT03924427 85 91 O

visit NCT03924427 92 97 O
www NCT03924427 98 101 O
. NCT03924427 102 103 O
BMSStudyConnect NCT03924427 104 119 O
. NCT03924427 120 121 O
com NCT03924427 122 125 O

Inclusion NCT03924427 126 135 O
Criteria NCT03924427 136 144 O
: NCT03924427 145 146 O

a NCT03924427 148 149 O
. NCT03924427 150 151 O
For NCT03924427 153 156 O
participants NCT03924427 157 169 O
with NCT03924427 170 174 O
plaque NCT03924427 175 181 B-Condition
psoriasis NCT03924427 182 191 I-Condition
: NCT03924427 192 193 O
i NCT03924427 194 195 O
. NCT03924427 196 197 O
Stable NCT03924427 199 205 O
plaque NCT03924427 206 212 B-Condition
psoriasis NCT03924427 213 222 I-Condition
for NCT03924427 223 226 O
at NCT03924427 227 229 B-Eq_Comparison
least NCT03924427 230 235 I-Eq_Comparison
6 NCT03924427 236 237 I-Eq_Comparison
months NCT03924427 238 244 I-Eq_Comparison

ii NCT03924427 245 247 O
. NCT03924427 248 249 O
Moderate NCT03924427 251 259 B-Eq_Comparison
to NCT03924427 260 262 I-Eq_Comparison
severe NCT03924427 263 269 I-Eq_Comparison
disease NCT03924427 270 277 O
iii NCT03924427 278 281 O
. NCT03924427 282 283 O
Candidate NCT03924427 285 294 B-Indication
for NCT03924427 295 298 O
phototherapy NCT03924427 299 311 B-Procedure
or NCT03924427 312 314 B-Or
systemic NCT03924427 315 323 B-Procedure
therapy NCT03924427 324 331 I-Procedure
b NCT03924427 332 333 O
. NCT03924427 334 335 O

Additional NCT03924427 337 347 O
protocol NCT03924427 348 356 O
- NCT03924427 357 358 O
specified NCT03924427 359 368 O
inclusion NCT03924427 369 378 O
criteria NCT03924427 379 387 O
apply NCT03924427 388 393 O
for NCT03924427 394 397 O
subjects NCT03924427 398 406 O
with NCT03924427 407 411 O
psoriatic NCT03924427 412 421 B-Condition
arthritis NCT03924427 422 431 I-Condition
, NCT03924427 432 433 O
erythrodermic NCT03924427 434 447 B-Condition
psoriasis NCT03924427 448 457 I-Condition
, NCT03924427 458 459 O
or NCT03924427 460 462 B-Or
generalized NCT03924427 463 474 B-Condition
pustular NCT03924427 475 483 I-Condition
psoriasis NCT03924427 484 493 I-Condition

Exclusion NCT03924427 494 503 O
Criteria NCT03924427 504 512 O
: NCT03924427 513 514 O

1 NCT03924427 518 519 O
. NCT03924427 519 520 O
Guttate NCT03924427 522 529 B-Modifier
, NCT03924427 530 531 O
inverse NCT03924427 532 539 B-Modifier
, NCT03924427 540 541 O
or NCT03924427 542 544 B-Or
drug NCT03924427 545 549 B-Drug
- NCT03924427 550 551 O
induced NCT03924427 552 559 O
psoriasis NCT03924427 560 569 B-Condition
at NCT03924427 570 572 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03924427 573 582 B-Study
or NCT03924427 583 585 B-Or
Baseline NCT03924427 586 594 B-Study

2 NCT03924427 597 598 O
. NCT03924427 598 599 O
History NCT03924427 601 608 B-Eq_Comparison
of NCT03924427 609 611 O
recent NCT03924427 612 618 B-Eq_Comparison
infection NCT03924427 619 628 B-Condition

3 NCT03924427 631 632 O
. NCT03924427 632 633 O
Prior NCT03924427 635 640 B-Eq_Comparison
exposure NCT03924427 641 649 O
to NCT03924427 650 652 O
BMS NCT03924427 653 656 B-Drug
- NCT03924427 657 658 I-Drug
986165 NCT03924427 659 665 I-Drug
Other NCT03924427 666 671 O
protocol NCT03924427 672 680 O
defined NCT03924427 681 688 O
inclusion NCT03924427 689 698 O
/ NCT03924427 699 700 O
exclusion NCT03924427 701 710 O
criteria NCT03924427 711 719 O
could NCT03924427 720 725 O
apply NCT03924427 726 731 O


Inclusion NCT03869593 0 9 O
Criteria NCT03869593 10 18 O
: NCT03869593 19 20 O

- NCT03869593 24 25 O
Patient NCT03869593 27 34 O
with NCT03869593 35 39 O
S NCT03869593 40 41 B-Organism
. NCT03869593 42 43 I-Organism
aureus NCT03869593 45 51 I-Organism
or NCT03869593 52 54 B-Or
E NCT03869593 55 56 B-Organism
. NCT03869593 57 58 I-Organism
coli NCT03869593 60 64 I-Organism
bacteriostatic NCT03869593 65 79 B-Condition
bacteremia NCT03869593 80 90 I-Condition
defined NCT03869593 91 98 O
by NCT03869593 99 101 O
at NCT03869593 102 104 B-Eq_Comparison
least NCT03869593 105 110 I-Eq_Comparison
one NCT03869593 111 114 I-Eq_Comparison
positive NCT03869593 115 123 O
blood NCT03869593 124 129 B-Observation
culture NCT03869593 130 137 I-Observation
bottle NCT03869593 138 144 O

- NCT03869593 147 148 O
Patient NCT03869593 150 157 O
requiring NCT03869593 158 167 O
a NCT03869593 168 169 O
blood NCT03869593 170 175 B-Observation
test NCT03869593 176 180 I-Observation
as NCT03869593 181 183 O
part NCT03869593 184 188 O
of NCT03869593 189 191 O
his NCT03869593 192 195 O
bacteremia NCT03869593 196 206 B-Condition

- NCT03869593 209 210 O
not NCT03869593 212 215 B-Negation
subject NCT03869593 216 223 O
to NCT03869593 224 226 O
a NCT03869593 227 228 O
judicial NCT03869593 229 237 B-Observation
protection NCT03869593 238 248 I-Observation
measure NCT03869593 249 256 O

- NCT03869593 259 260 O
Signature NCT03869593 262 271 O
of NCT03869593 272 274 O
the NCT03869593 275 278 O
non NCT03869593 279 282 O
- NCT03869593 283 284 O
opposition NCT03869593 285 295 O
of NCT03869593 296 298 O
consent NCT03869593 299 306 O
( NCT03869593 307 308 O
for NCT03869593 309 312 O
minor NCT03869593 313 318 O
patients NCT03869593 319 327 O
signed NCT03869593 328 334 O
by NCT03869593 335 337 O
one NCT03869593 338 341 O
of NCT03869593 342 344 O
the NCT03869593 345 348 O
parents NCT03869593 349 356 O
or NCT03869593 357 359 O
the NCT03869593 360 363 O
representative NCT03869593 364 378 O
of NCT03869593 379 381 O
the NCT03869593 382 385 O
parental NCT03869593 386 394 O
authority NCT03869593 395 404 O
) NCT03869593 405 406 O

- NCT03869593 410 411 O
Affiliation NCT03869593 413 424 O
to NCT03869593 425 427 O
social NCT03869593 428 434 O
security NCT03869593 435 443 O

Exclusion NCT03869593 444 453 O
Criteria NCT03869593 454 462 O
: NCT03869593 463 464 O

- NCT03869593 468 469 O
Immunocompromised NCT03869593 471 488 B-Condition
patient NCT03869593 489 496 O
defined NCT03869593 497 504 O
by NCT03869593 505 507 O
: NCT03869593 508 509 O

- NCT03869593 518 519 O
current NCT03869593 521 528 B-Eq_Comparison
immunosuppressive NCT03869593 529 546 B-Procedure
therapies NCT03869593 547 556 I-Procedure
: NCT03869593 557 558 O
corticosteroids NCT03869593 559 574 B-Drug
, NCT03869593 575 576 O
chemotherapy NCT03869593 577 589 B-Procedure
, NCT03869593 590 591 O
biotherapy NCT03869593 592 602 B-Procedure

- NCT03869593 610 611 O
solid NCT03869593 613 618 B-Procedure
organ NCT03869593 619 624 I-Procedure
transplant NCT03869593 625 635 I-Procedure
patient NCT03869593 636 643 O
or NCT03869593 644 646 B-Or
hematopoietic NCT03869593 647 660 B-Modifier
stem NCT03869593 661 665 B-Procedure
cell NCT03869593 666 670 I-Procedure
transplant NCT03869593 671 681 I-Procedure

- NCT03869593 689 690 O
chemotherapy NCT03869593 692 704 B-Procedure
- NCT03869593 705 706 O
induced NCT03869593 707 714 O
neutropenia NCT03869593 715 726 B-Condition

- NCT03869593 734 735 O
Congenital NCT03869593 737 747 B-Modifier
immune NCT03869593 748 754 B-Condition
deficiency NCT03869593 755 765 I-Condition

- NCT03869593 768 769 O
bacteremia NCT03869593 771 781 B-Condition
related NCT03869593 782 789 O
to NCT03869593 790 792 O
a NCT03869593 793 794 O
peripheral NCT03869593 795 805 B-Modifier
or NCT03869593 806 808 B-Or
central NCT03869593 809 816 B-Modifier
catheter NCT03869593 817 825 B-Procedure

- NCT03869593 828 829 O
Urinary NCT03869593 831 838 B-Condition
obstruction NCT03869593 839 850 I-Condition
not NCT03869593 851 854 B-Negation
lifted NCT03869593 855 861 B-Procedure
within NCT03869593 862 868 B-Eq_Comparison
the NCT03869593 869 872 I-Eq_Comparison
first NCT03869593 873 878 I-Eq_Comparison
24 NCT03869593 879 881 I-Eq_Comparison
hours NCT03869593 882 887 I-Eq_Comparison
of NCT03869593 888 890 O
management NCT03869593 891 901 O

- NCT03869593 904 905 O
Intra NCT03869593 907 912 B-Modifier
- NCT03869593 913 914 I-Modifier
abdominal NCT03869593 915 924 I-Modifier
infection NCT03869593 925 934 B-Condition
collected NCT03869593 935 944 O
undrained NCT03869593 945 954 B-Procedure
in NCT03869593 955 957 B-Eq_Comparison
the NCT03869593 958 961 I-Eq_Comparison
first NCT03869593 962 967 I-Eq_Comparison
24 NCT03869593 968 970 I-Eq_Comparison
hours NCT03869593 971 976 I-Eq_Comparison
of NCT03869593 977 979 O
management NCT03869593 980 990 O

- NCT03869593 993 994 O
primary NCT03869593 996 1003 B-Modifier
infectious NCT03869593 1004 1014 B-Condition
focus NCT03869593 1015 1020 O
represented NCT03869593 1021 1032 O
by NCT03869593 1033 1035 O
mechanically NCT03869593 1036 1048 B-Procedure
ventilated NCT03869593 1049 1059 I-Procedure
pneumonia NCT03869593 1060 1069 B-Condition

- NCT03869593 1072 1073 O
Pregnant NCT03869593 1075 1083 B-Condition
or NCT03869593 1084 1086 B-Or
lactating NCT03869593 1087 1096 B-Condition
woman NCT03869593 1097 1102 O

Inclusion NCT03862027 0 9 O
Criteria NCT03862027 10 18 O
: NCT03862027 19 20 O

- NCT03862027 24 25 O
Adult NCT03862027 27 32 O
patients NCT03862027 33 41 O
( NCT03862027 42 43 O
age NCT03862027 44 47 B-Age
> NCT03862027 48 49 B-Eq_Comparison
/ NCT03862027 50 51 I-Eq_Comparison
= NCT03862027 52 53 I-Eq_Comparison
18 NCT03862027 54 56 I-Eq_Comparison
) NCT03862027 57 58 O
admitted NCT03862027 59 67 B-Encounter
to NCT03862027 68 70 O
the NCT03862027 71 74 O
Neuro NCT03862027 75 80 O
ICU NCT03862027 81 84 O
of NCT03862027 85 87 O
UNC NCT03862027 88 91 O
Hospital NCT03862027 92 100 O
requiring NCT03862027 101 110 O
mechanical NCT03862027 111 121 B-Procedure
ventilation NCT03862027 122 133 I-Procedure
and NCT03862027 134 137 B-And
with NCT03862027 138 142 O
ICP NCT03862027 143 146 B-Procedure
monitoring NCT03862027 147 157 I-Procedure
in NCT03862027 158 160 O
place NCT03862027 161 166 O
. NCT03862027 167 168 O

Exclusion NCT03862027 170 179 O
Criteria NCT03862027 180 188 O
: NCT03862027 189 190 O

1 NCT03862027 194 195 O
. NCT03862027 195 196 O
Pneumothorax NCT03862027 198 210 B-Condition
or NCT03862027 211 213 B-Or
pneumomediastinum NCT03862027 214 231 B-Condition

2 NCT03862027 234 235 O
. NCT03862027 235 236 O
Life NCT03862027 238 242 B-Observation
expectancy NCT03862027 243 253 I-Observation
< NCT03862027 254 255 B-Eq_Comparison
24 NCT03862027 256 258 I-Eq_Comparison
hours NCT03862027 259 264 I-Eq_Comparison
or NCT03862027 265 267 B-Or
expected NCT03862027 268 276 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862027 277 279 I-Assertion___Assertion_Type_Value:hypothetical
require NCT03862027 280 287 O
mechanical NCT03862027 288 298 B-Procedure
ventilation NCT03862027 299 310 I-Procedure
for NCT03862027 311 314 O
< NCT03862027 315 316 B-Eq_Comparison
24 NCT03862027 317 319 I-Eq_Comparison
hours NCT03862027 320 325 I-Eq_Comparison

3 NCT03862027 328 329 O
. NCT03862027 329 330 O
Condition NCT03862027 332 341 B-Condition
that NCT03862027 342 346 O
precludes NCT03862027 347 356 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
placement NCT03862027 357 366 O
of NCT03862027 367 369 O
an NCT03862027 370 372 O
esophageal NCT03862027 373 383 B-Procedure
balloon NCT03862027 384 391 I-Procedure
[ NCT03862027 392 393 O
esophageal NCT03862027 394 404 B-Modifier
or NCT03862027 405 407 B-Or
nasopharyngeal NCT03862027 408 422 B-Modifier
pathology NCT03862027 423 432 B-Condition
preventing NCT03862027 433 443 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
insertion NCT03862027 444 453 O
of NCT03862027 454 456 O
the NCT03862027 457 460 O
esophageal NCT03862027 461 471 B-Procedure
balloon NCT03862027 472 479 I-Procedure
catheter NCT03862027 480 488 I-Procedure
( NCT03862027 489 490 O
esophageal NCT03862027 491 501 B-Condition
ulcerations NCT03862027 502 513 I-Condition
, NCT03862027 514 515 O
tumors NCT03862027 516 522 B-Condition
, NCT03862027 523 524 O
diverticulitis NCT03862027 525 539 B-Condition
, NCT03862027 540 541 O
bleeding NCT03862027 542 550 B-Condition
varices NCT03862027 551 558 I-Condition
or NCT03862027 559 561 B-Or
in NCT03862027 562 564 O
patients NCT03862027 565 573 O
with NCT03862027 574 578 O
sinusitis NCT03862027 579 588 B-Condition
, NCT03862027 589 590 O
epistaxis NCT03862027 591 600 B-Condition
or NCT03862027 601 603 B-Or
recent NCT03862027 604 610 B-Eq_Comparison
nasopharyngeal NCT03862027 611 625 B-Procedure
surgery NCT03862027 626 633 I-Procedure
) NCT03862027 634 635 O
, NCT03862027 636 637 O
severe NCT03862027 638 644 O
thrombocytopenia NCT03862027 645 661 B-Condition
( NCT03862027 662 663 O
platelet NCT03862027 664 672 B-Observation
count NCT03862027 673 678 I-Observation
< NCT03862027 679 680 B-Eq_Comparison
30 NCT03862027 681 683 I-Eq_Comparison
) NCT03862027 684 685 O
or NCT03862027 686 688 B-Or
coagulopathy NCT03862027 689 701 B-Condition
( NCT03862027 702 703 O
INR NCT03862027 704 707 B-Observation
> NCT03862027 708 709 B-Eq_Comparison
3 NCT03862027 710 711 I-Eq_Comparison
or NCT03862027 712 714 B-Or
on NCT03862027 715 717 B-Eq_Comparison
oral NCT03862027 718 722 B-Drug
anticoagulants NCT03862027 723 737 I-Drug
) NCT03862027 738 739 O
. NCT03862027 740 741 O

4 NCT03862027 745 746 O
. NCT03862027 746 747 O
Pre NCT03862027 749 752 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03862027 753 754 O
enrollment NCT03862027 755 765 B-Study
ICP NCT03862027 766 769 B-Observation
> NCT03862027 770 771 B-Eq_Comparison
20 NCT03862027 772 774 I-Eq_Comparison
mm NCT03862027 775 777 I-Eq_Comparison
Hg NCT03862027 778 780 I-Eq_Comparison

5 NCT03862027 783 784 O
. NCT03862027 784 785 O
Pre NCT03862027 787 790 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03862027 791 792 O
enrollment NCT03862027 793 803 B-Study
CPP NCT03862027 804 807 B-Observation
< NCT03862027 808 809 B-Eq_Comparison
60 NCT03862027 810 812 I-Eq_Comparison
mm NCT03862027 813 815 I-Eq_Comparison
Hg NCT03862027 816 818 I-Eq_Comparison

6 NCT03862027 821 822 O
. NCT03862027 822 823 O
Planned NCT03862027 825 832 B-Eq_Comparison
change NCT03862027 833 839 O
in NCT03862027 840 842 O
the NCT03862027 843 846 O
external NCT03862027 847 855 B-Procedure
ventricular NCT03862027 856 867 I-Procedure
drain NCT03862027 868 873 I-Procedure
set NCT03862027 874 877 B-Modifier
point NCT03862027 878 883 I-Modifier
during NCT03862027 884 890 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862027 891 894 O
pre NCT03862027 895 898 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03862027 899 900 O
intervention NCT03862027 901 913 B-Procedure
, NCT03862027 914 915 O
intervention NCT03862027 916 928 B-Procedure
or NCT03862027 929 931 B-Or
post NCT03862027 932 936 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03862027 937 938 O
intervention NCT03862027 939 951 B-Procedure
periods NCT03862027 952 959 O

7 NCT03862027 962 963 O
. NCT03862027 963 964 O
Incarceration NCT03862027 966 979 B-Observation

8 NCT03862027 982 983 O
. NCT03862027 983 984 O
Variation NCT03862027 986 995 O
in NCT03862027 996 998 O
ICP NCT03862027 999 1002 B-Observation
of NCT03862027 1003 1005 O
> NCT03862027 1006 1007 B-Eq_Comparison
2 NCT03862027 1008 1009 I-Eq_Comparison
cm NCT03862027 1010 1012 I-Eq_Comparison
H NCT03862027 1013 1014 I-Eq_Comparison
2O NCT03862027 1015 1017 I-Eq_Comparison
in NCT03862027 1018 1020 O
the NCT03862027 1021 1024 O
hour NCT03862027 1025 1029 B-Eq_Comparison
prior NCT03862027 1030 1035 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862027 1036 1038 I-Temporal_Connection___Temporal_Connection_Type_Value:before
intervention NCT03862027 1039 1051 B-Procedure
. NCT03862027 1052 1053 O

Inclusion NCT03866668 0 9 O
Criteria NCT03866668 10 18 O
: NCT03866668 19 20 O

- NCT03866668 24 25 O
outpatients NCT03866668 27 38 B-Encounter
2 NCT03866668 39 40 B-Eq_Comparison
to NCT03866668 41 43 I-Eq_Comparison
6 NCT03866668 44 45 I-Eq_Comparison
years NCT03866668 46 51 I-Eq_Comparison
of NCT03866668 52 54 O
age NCT03866668 55 58 B-Age
; NCT03866668 58 59 O

- NCT03866668 62 63 O
males NCT03866668 65 70 O
and NCT03866668 71 74 B-Or
females NCT03866668 75 82 O
who NCT03866668 83 86 B-And
are NCT03866668 87 90 O
physically NCT03866668 91 101 O
healthy NCT03866668 102 109 B-Condition
; NCT03866668 109 110 O

- NCT03866668 113 114 O
diagnosis NCT03866668 116 125 O
of NCT03866668 126 128 O
autism NCT03866668 129 135 B-Condition
spectrum NCT03866668 136 144 I-Condition
disorder NCT03866668 145 153 I-Condition
based NCT03866668 154 159 O
on NCT03866668 160 162 O
clinical NCT03866668 163 171 O
evaluation NCT03866668 172 182 O
and NCT03866668 183 186 O
DSM NCT03866668 187 190 O
- NCT03866668 191 192 O
5 NCT03866668 193 194 O
criteria NCT03866668 195 203 O
, NCT03866668 204 205 O
and NCT03866668 206 209 O
confirmed NCT03866668 210 219 O
using NCT03866668 220 225 O
the NCT03866668 226 229 O
Autism NCT03866668 230 236 O
Diagnostic NCT03866668 237 247 O
Interview NCT03866668 248 257 O
- NCT03866668 258 259 O
Revised NCT03866668 260 267 O
, NCT03866668 268 269 O
and NCT03866668 270 273 O
the NCT03866668 274 277 O
Autism NCT03866668 278 284 O
Diagnostic NCT03866668 285 295 O
Observation NCT03866668 296 307 O
Schedule NCT03866668 308 316 O
; NCT03866668 316 317 O

- NCT03866668 320 321 O
care NCT03866668 323 327 B-Provider
provider NCT03866668 328 336 I-Provider
who NCT03866668 337 340 O
could NCT03866668 341 346 B-Assertion___Assertion_Type_Value:hypothetical
reliably NCT03866668 347 355 O
bring NCT03866668 356 361 O
subject NCT03866668 362 369 O
to NCT03866668 370 372 O
clinic NCT03866668 373 379 O
visits NCT03866668 380 386 B-Encounter
, NCT03866668 387 388 O
could NCT03866668 389 394 B-Assertion___Assertion_Type_Value:hypothetical
provide NCT03866668 395 402 O
trustworthy NCT03866668 403 414 O
ratings NCT03866668 415 422 O
, NCT03866668 423 424 O
and NCT03866668 425 428 O
interacted NCT03866668 429 439 O
with NCT03866668 440 444 O
subject NCT03866668 445 452 O
on NCT03866668 453 455 O
a NCT03866668 456 457 O
regular NCT03866668 458 465 O
basis NCT03866668 466 471 O
; NCT03866668 471 472 O

- NCT03866668 475 476 O
ability NCT03866668 478 485 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03866668 486 488 I-Assertion___Assertion_Type_Value:hypothetical
subject NCT03866668 489 496 O
to NCT03866668 497 499 O
swallow NCT03866668 500 507 O
the NCT03866668 508 511 O
compound NCT03866668 512 520 B-Drug
; NCT03866668 520 521 O

- NCT03866668 524 525 O
stable NCT03866668 527 533 O
concomitant NCT03866668 534 545 B-Modifier
medications NCT03866668 546 557 B-Drug
for NCT03866668 558 561 O
at NCT03866668 562 564 B-Eq_Comparison
least NCT03866668 565 570 I-Eq_Comparison
2 NCT03866668 571 572 I-Eq_Comparison
weeks NCT03866668 573 578 I-Eq_Comparison
( NCT03866668 579 580 O
4 NCT03866668 581 582 B-Eq_Comparison
weeks NCT03866668 583 588 I-Eq_Comparison
if NCT03866668 589 591 O
patient NCT03866668 592 599 O
took NCT03866668 600 604 B-Eq_Comparison
fluoxetine NCT03866668 605 615 B-Drug
) NCT03866668 616 617 O
; NCT03866668 618 619 O

- NCT03866668 622 623 O
no NCT03866668 625 627 B-Negation
planned NCT03866668 628 635 B-Eq_Comparison
changes NCT03866668 636 643 O
in NCT03866668 644 646 O
psychosocial NCT03866668 647 659 B-Procedure
interventions NCT03866668 660 673 I-Procedure
during NCT03866668 674 680 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03866668 681 684 O
open NCT03866668 685 689 B-Modifier
- NCT03866668 690 691 I-Modifier
label NCT03866668 692 697 I-Modifier
trial NCT03866668 698 703 B-Study
. NCT03866668 704 705 O

Exclusion NCT03866668 707 716 O
Criteria NCT03866668 717 725 O
: NCT03866668 726 727 O

- NCT03866668 731 732 O
DSM NCT03866668 734 737 O
- NCT03866668 738 739 O
5 NCT03866668 740 741 O
diagnosis NCT03866668 742 751 O
of NCT03866668 752 754 O
schizophrenia NCT03866668 755 768 B-Condition
, NCT03866668 769 770 O
schizoaffective NCT03866668 771 786 B-Condition
disorder NCT03866668 787 795 I-Condition
, NCT03866668 796 797 O
or NCT03866668 798 800 B-Or
psychotic NCT03866668 801 810 B-Condition
disorder NCT03866668 811 819 I-Condition
not NCT03866668 820 823 O
otherwise NCT03866668 824 833 O
specified NCT03866668 834 843 O
; NCT03866668 843 844 O

- NCT03866668 847 848 O
prior NCT03866668 850 855 B-Eq_Comparison
adequate NCT03866668 856 864 O
trial NCT03866668 865 870 B-Study
of NCT03866668 871 873 O
Esomeprazole NCT03866668 874 886 B-Drug
; NCT03866668 886 887 O

- NCT03866668 890 891 O
active NCT03866668 893 899 B-Eq_Comparison
medical NCT03866668 900 907 B-Condition
problems NCT03866668 908 916 I-Condition
such NCT03866668 917 921 O
as NCT03866668 922 924 O
unstable NCT03866668 925 933 O
seizures NCT03866668 934 942 B-Condition
, NCT03866668 943 944 O
or NCT03866668 945 947 B-Or
significant NCT03866668 948 959 O
physical NCT03866668 960 968 B-Condition
illness NCT03866668 969 976 I-Condition
( NCT03866668 977 978 O
e NCT03866668 979 980 O
. NCT03866668 981 982 O
g NCT03866668 983 984 O
. NCT03866668 985 986 O
, NCT03866668 987 988 O
serious NCT03866668 989 996 O
liver NCT03866668 997 1002 B-Modifier
or NCT03866668 1003 1005 B-Or
renal NCT03866668 1006 1011 B-Modifier
pathology NCT03866668 1012 1021 B-Condition
) NCT03866668 1022 1023 O
. NCT03866668 1024 1025 O

Inclusion NCT03922737 0 9 O
Criteria NCT03922737 10 18 O
: NCT03922737 19 20 O

1 NCT03922737 23 24 O
. NCT03922737 24 25 O
Subjects NCT03922737 27 35 O
over NCT03922737 36 40 B-Eq_Comparison
18 NCT03922737 41 43 I-Eq_Comparison
and NCT03922737 44 47 B-And
under NCT03922737 48 53 B-Eq_Comparison
75 NCT03922737 54 56 I-Eq_Comparison
years NCT03922737 57 62 I-Eq_Comparison
of NCT03922737 63 65 O
age NCT03922737 66 69 B-Age
undergoing NCT03922737 70 80 B-Eq_Comparison
elective NCT03922737 81 89 O
primary NCT03922737 90 97 B-Modifier
orthopaedic NCT03922737 98 109 B-Procedure
surgery NCT03922737 110 117 I-Procedure
at NCT03922737 118 120 O
Thomas NCT03922737 121 127 O
Jefferson NCT03922737 128 137 O
University NCT03922737 138 148 O
Hospital NCT03922737 149 157 O
, NCT03922737 158 159 O
Rothman NCT03922737 160 167 O
Orthopaedic NCT03922737 168 179 O
Specialty NCT03922737 180 189 O
Hospital NCT03922737 190 198 O
or NCT03922737 199 201 B-Or
Methodist NCT03922737 202 211 O
Hospital NCT03922737 212 220 O
who NCT03922737 221 224 O
have NCT03922737 225 229 O
the NCT03922737 230 233 O
capability NCT03922737 234 244 O
to NCT03922737 245 247 O
utilize NCT03922737 248 255 O
a NCT03922737 256 257 O
telecommunications NCT03922737 258 276 O
platform NCT03922737 277 285 O
( NCT03922737 286 287 O
computer NCT03922737 288 296 O
, NCT03922737 297 298 O
tablet NCT03922737 299 305 O
or NCT03922737 306 308 O
similar NCT03922737 309 316 O
device NCT03922737 317 323 O
at NCT03922737 324 326 O
home NCT03922737 327 331 O
with NCT03922737 332 336 O
a NCT03922737 337 338 O
webcam NCT03922737 339 345 O
, NCT03922737 346 347 O
microphone NCT03922737 348 358 O
and NCT03922737 359 362 O
access NCT03922737 363 369 O
to NCT03922737 370 372 O
high NCT03922737 373 377 O
- NCT03922737 378 379 O
speed NCT03922737 380 385 O
internet NCT03922737 386 394 O
) NCT03922737 395 396 O
. NCT03922737 397 398 O

Exclusion NCT03922737 400 409 O
Criteria NCT03922737 410 418 O
: NCT03922737 419 420 O

1 NCT03922737 424 425 O
. NCT03922737 425 426 O
Subjects NCT03922737 428 436 O
who NCT03922737 437 440 O
are NCT03922737 441 444 O
unable NCT03922737 445 451 O
to NCT03922737 452 454 O
access NCT03922737 455 461 O
the NCT03922737 462 465 O
telemedicine NCT03922737 466 478 O
platform NCT03922737 479 487 O
or NCT03922737 488 490 O
who NCT03922737 491 494 O
are NCT03922737 495 498 O
uncomfortable NCT03922737 499 512 O
with NCT03922737 513 517 O
following NCT03922737 518 527 O
up NCT03922737 528 530 O
in NCT03922737 531 533 O
this NCT03922737 534 538 O
fashion NCT03922737 539 546 O

2 NCT03922737 549 550 O
. NCT03922737 550 551 O
Subjects NCT03922737 553 561 O
who NCT03922737 562 565 O
are NCT03922737 566 569 O
unable NCT03922737 570 576 O
or NCT03922737 577 579 O
unwilling NCT03922737 580 589 O
to NCT03922737 590 592 O
provide NCT03922737 593 600 O
post NCT03922737 601 605 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03922737 606 607 O
operative NCT03922737 608 617 B-Procedure
radiographs NCT03922737 618 629 O
electronically NCT03922737 630 644 O
or NCT03922737 645 647 O
who NCT03922737 648 651 O
are NCT03922737 652 655 O
unable NCT03922737 656 662 O
or NCT03922737 663 665 O
unwilling NCT03922737 666 675 O
to NCT03922737 676 678 O
obtain NCT03922737 679 685 O
them NCT03922737 686 690 O

3 NCT03922737 693 694 O
. NCT03922737 694 695 O
Subjects NCT03922737 697 705 O
with NCT03922737 706 710 O
workman NCT03922737 711 718 O
's NCT03922737 718 720 O
compensation NCT03922737 721 733 O
or NCT03922737 734 736 O
automotive NCT03922737 737 747 O
claims NCT03922737 748 754 O
or NCT03922737 755 757 O
other NCT03922737 758 763 O
ongoing NCT03922737 764 771 O
litigation NCT03922737 772 782 O

4 NCT03922737 785 786 O
. NCT03922737 786 787 O
Subjects NCT03922737 789 797 O
that NCT03922737 798 802 O
are NCT03922737 803 806 O
unable NCT03922737 807 813 O
or NCT03922737 814 816 O
unwilling NCT03922737 817 826 O
to NCT03922737 827 829 O
consent NCT03922737 830 837 O
for NCT03922737 838 841 O
enrollment NCT03922737 842 852 O

5 NCT03922737 855 856 O
. NCT03922737 856 857 O
Patients NCT03922737 859 867 O
under NCT03922737 868 873 B-Eq_Comparison
the NCT03922737 874 877 I-Eq_Comparison
age NCT03922737 878 881 I-Eq_Comparison
of NCT03922737 882 884 I-Eq_Comparison
18 NCT03922737 885 887 I-Eq_Comparison
years NCT03922737 888 893 I-Eq_Comparison

6 NCT03922737 896 897 O
. NCT03922737 897 898 O
Pregnant NCT03922737 900 908 B-Condition
or NCT03922737 909 911 B-Or
breastfeeding NCT03922737 912 925 B-Condition
women NCT03922737 926 931 O

7 NCT03922737 934 935 O
. NCT03922737 935 936 O
Patients NCT03922737 938 946 O
undergoing NCT03922737 947 957 B-Eq_Comparison
surgery NCT03922737 958 965 B-Procedure
for NCT03922737 966 969 O
tumor NCT03922737 970 975 B-Condition
, NCT03922737 976 977 O
trauma NCT03922737 978 984 B-Condition
or NCT03922737 985 987 B-Or
infection NCT03922737 988 997 B-Condition
or NCT03922737 998 1000 O
who NCT03922737 1001 1004 O
require NCT03922737 1005 1012 O
revision NCT03922737 1013 1021 O
or NCT03922737 1022 1024 O
staged NCT03922737 1025 1031 O
procedures NCT03922737 1032 1042 O

8 NCT03922737 1045 1046 O
. NCT03922737 1046 1047 O
Patients NCT03922737 1049 1057 O
without NCT03922737 1058 1065 B-Negation
English NCT03922737 1066 1073 O
- NCT03922737 1074 1075 O
language NCT03922737 1076 1084 O
proficiency NCT03922737 1085 1096 O

9 NCT03922737 1099 1100 O
. NCT03922737 1100 1101 O
Patients NCT03922737 1103 1111 O
with NCT03922737 1112 1116 O
unforeseen NCT03922737 1117 1127 B-Assertion___Assertion_Type_Value:hypothetical
intra NCT03922737 1128 1133 B-Temporal_Connection___Temporal_Connection_Type_Value:during
- NCT03922737 1134 1135 O
operative NCT03922737 1136 1145 B-Procedure
or NCT03922737 1146 1148 B-Or
peri NCT03922737 1149 1153 B-Temporal_Connection___Temporal_Connection_Type_Value:during
operative NCT03922737 1154 1163 B-Procedure
complications NCT03922737 1164 1177 B-Condition


Inclusion NCT03869463 0 9 O
Criteria NCT03869463 10 18 O
: NCT03869463 19 20 O

1 NCT03869463 24 25 O
. NCT03869463 25 26 O
Age NCT03869463 28 31 B-Age
18 NCT03869463 32 34 B-Eq_Comparison
- NCT03869463 35 36 I-Eq_Comparison
29 NCT03869463 37 39 I-Eq_Comparison
. NCT03869463 39 40 O

2 NCT03869463 44 45 O
. NCT03869463 45 46 O
Current NCT03869463 48 55 B-Eq_Comparison
diagnosis NCT03869463 56 65 O
of NCT03869463 66 68 O
MDD NCT03869463 69 72 B-Condition
/ NCT03869463 73 74 B-Or
persistent NCT03869463 75 85 B-Modifier
depressive NCT03869463 86 96 B-Condition
disorder NCT03869463 97 105 I-Condition
or NCT03869463 106 108 B-Or
HDRS NCT03869463 109 113 B-Observation
greater NCT03869463 114 121 B-Eq_Comparison
than NCT03869463 122 126 I-Eq_Comparison
or NCT03869463 127 129 I-Eq_Comparison
equal NCT03869463 130 135 I-Eq_Comparison
to NCT03869463 136 138 I-Eq_Comparison
12 NCT03869463 139 141 I-Eq_Comparison
. NCT03869463 141 142 O
3 NCT03869463 144 145 O
. NCT03869463 145 146 O
Daily NCT03869463 148 153 O
access NCT03869463 154 160 O
to NCT03869463 161 163 O
smartphone NCT03869463 164 174 O
or NCT03869463 175 177 O
tablet NCT03869463 178 184 O
with NCT03869463 185 189 O
internet NCT03869463 190 198 O
connection NCT03869463 199 209 O
for NCT03869463 210 213 O
the NCT03869463 214 217 O
study NCT03869463 218 223 O
duration NCT03869463 224 232 O
. NCT03869463 233 234 O

4 NCT03869463 237 238 O
. NCT03869463 238 239 O
Willing NCT03869463 241 248 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03869463 249 252 B-And
able NCT03869463 253 257 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869463 258 260 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03869463 261 269 O
MRI NCT03869463 270 273 B-Procedure
, NCT03869463 274 275 O
mood NCT03869463 276 280 B-Modifier
, NCT03869463 281 282 O
and NCT03869463 283 286 B-Or
neuropsychological NCT03869463 287 305 B-Modifier
testing NCT03869463 306 313 B-Procedure
. NCT03869463 314 315 O
5 NCT03869463 317 318 O
. NCT03869463 318 319 O
IQ NCT03869463 321 323 B-Observation
> NCT03869463 324 325 B-Eq_Comparison
85 NCT03869463 326 328 I-Eq_Comparison
. NCT03869463 328 329 O

Exclusion NCT03869463 331 340 O
Criteria NCT03869463 341 349 O
: NCT03869463 350 351 O

1 NCT03869463 355 356 O
. NCT03869463 356 357 O
Lacks NCT03869463 359 364 O
English NCT03869463 365 372 O
- NCT03869463 373 374 O
speaking NCT03869463 375 383 O
ability NCT03869463 384 391 O
as NCT03869463 392 394 O
determined NCT03869463 395 405 O
by NCT03869463 406 408 O
self NCT03869463 409 413 O
- NCT03869463 414 415 O
report NCT03869463 416 422 O
and NCT03869463 423 426 O
clinical NCT03869463 427 435 O
evaluation NCT03869463 436 446 O
. NCT03869463 447 448 O

2 NCT03869463 452 453 O
. NCT03869463 453 454 O
Evidence NCT03869463 456 464 O
of NCT03869463 465 467 O
schizophrenia NCT03869463 468 481 B-Condition
, NCT03869463 482 483 O
schizoaffective NCT03869463 484 499 B-Condition
disorder NCT03869463 500 508 I-Condition
, NCT03869463 509 510 O
psychosis NCT03869463 511 520 B-Condition
, NCT03869463 521 522 O
bipolar NCT03869463 523 530 B-Condition
I NCT03869463 531 532 B-Eq_Comparison
and NCT03869463 533 536 I-Eq_Comparison
II NCT03869463 537 539 I-Eq_Comparison
disorder NCT03869463 540 548 B-Modifier
. NCT03869463 549 550 O

3 NCT03869463 554 555 O
. NCT03869463 555 556 O
Active NCT03869463 558 564 B-Eq_Comparison
suicidal NCT03869463 565 573 B-Condition
ideation NCT03869463 574 582 I-Condition
, NCT03869463 583 584 O
intent NCT03869463 585 591 B-Assertion___Assertion_Type_Value:intention
, NCT03869463 592 593 O
or NCT03869463 594 596 B-Or
plan NCT03869463 597 601 B-Assertion___Assertion_Type_Value:intention
, NCT03869463 602 603 O
or NCT03869463 604 606 B-Or
past NCT03869463 607 611 B-Eq_Comparison
attempt NCT03869463 612 619 O
within NCT03869463 620 626 B-Eq_Comparison
1 NCT03869463 627 628 I-Eq_Comparison
year NCT03869463 629 633 I-Eq_Comparison
. NCT03869463 634 635 O

4 NCT03869463 639 640 O
. NCT03869463 640 641 O
Severe NCT03869463 643 649 O
depression NCT03869463 650 660 B-Condition
( NCT03869463 661 662 O
HDRS NCT03869463 663 667 B-Observation
> NCT03869463 668 669 B-Eq_Comparison
30 NCT03869463 670 672 I-Eq_Comparison
) NCT03869463 673 674 O
. NCT03869463 675 676 O

5 NCT03869463 680 681 O
. NCT03869463 681 682 O
Neurological NCT03869463 684 696 B-Condition
disorder NCT03869463 697 705 I-Condition
( NCT03869463 706 707 O
epilepsy NCT03869463 708 716 B-Condition
, NCT03869463 717 718 O
multiple NCT03869463 719 727 B-Condition
sclerosis NCT03869463 728 737 I-Condition
, NCT03869463 738 739 O
traumatic NCT03869463 740 749 B-Condition
brain NCT03869463 750 755 I-Condition
injury NCT03869463 756 762 I-Condition
, NCT03869463 763 764 O
clinical NCT03869463 765 773 B-Modifier
stroke NCT03869463 774 780 B-Condition
) NCT03869463 781 782 O
. NCT03869463 783 784 O

6 NCT03869463 788 789 O
. NCT03869463 789 790 O
Use NCT03869463 792 795 B-Eq_Comparison
of NCT03869463 796 798 O
medications NCT03869463 799 810 B-Drug
known NCT03869463 811 816 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03869463 817 819 I-Assertion___Assertion_Type_Value:hypothetical
have NCT03869463 820 824 I-Assertion___Assertion_Type_Value:hypothetical
negative NCT03869463 825 833 O
impact NCT03869463 834 840 O
on NCT03869463 841 843 O
cognition NCT03869463 844 853 B-Condition
( NCT03869463 854 855 O
benzodiazepines NCT03869463 856 871 B-Drug
and NCT03869463 872 875 B-Or
lorazepam NCT03869463 876 885 B-Drug
equivalents NCT03869463 886 897 O
> NCT03869463 898 899 B-Eq_Comparison
1 NCT03869463 900 901 I-Eq_Comparison
mg NCT03869463 902 904 I-Eq_Comparison
daily NCT03869463 905 910 I-Eq_Comparison
, NCT03869463 911 912 O
narcotics NCT03869463 913 922 B-Drug
, NCT03869463 923 924 O
anticholinergics NCT03869463 925 941 B-Drug
) NCT03869463 942 943 O
. NCT03869463 944 945 O

7 NCT03869463 949 950 O
. NCT03869463 950 951 O
History NCT03869463 953 960 B-Eq_Comparison
of NCT03869463 961 963 O
alcohol NCT03869463 964 971 B-Modifier
or NCT03869463 972 974 B-Or
drug NCT03869463 975 979 B-Modifier
abuse NCT03869463 980 985 B-Condition
or NCT03869463 986 988 B-Or
dependence NCT03869463 989 999 B-Modifier
within NCT03869463 1000 1006 B-Eq_Comparison
past NCT03869463 1007 1011 I-Eq_Comparison
year NCT03869463 1012 1016 I-Eq_Comparison
. NCT03869463 1017 1018 O

8 NCT03869463 1022 1023 O
. NCT03869463 1023 1024 O
Acute NCT03869463 1026 1031 O
, NCT03869463 1032 1033 O
severe NCT03869463 1034 1040 O
, NCT03869463 1041 1042 O
unstable NCT03869463 1043 1051 O
medical NCT03869463 1052 1059 B-Condition
illness NCT03869463 1060 1067 I-Condition
. NCT03869463 1068 1069 O
For NCT03869463 1071 1074 O
cancer NCT03869463 1075 1081 B-Condition
, NCT03869463 1082 1083 O
acutely NCT03869463 1084 1091 O
ill NCT03869463 1092 1095 B-Condition
patients NCT03869463 1096 1104 O
( NCT03869463 1105 1106 O
including NCT03869463 1107 1116 O
those NCT03869463 1117 1122 O
with NCT03869463 1123 1127 O
metastases NCT03869463 1128 1138 B-Condition
) NCT03869463 1139 1140 O
are NCT03869463 1141 1144 O
excluded NCT03869463 1145 1153 B-Negation
, NCT03869463 1154 1155 O
but NCT03869463 1156 1159 O
past NCT03869463 1160 1164 B-Eq_Comparison
history NCT03869463 1165 1172 I-Eq_Comparison
of NCT03869463 1173 1175 O
successfully NCT03869463 1176 1188 O
treated NCT03869463 1189 1196 B-Procedure
cancer NCT03869463 1197 1203 B-Condition
does NCT03869463 1204 1208 O
not NCT03869463 1209 1212 B-Negation
result NCT03869463 1213 1219 O
in NCT03869463 1220 1222 O
exclusion NCT03869463 1223 1232 B-Negation
. NCT03869463 1233 1234 O

9 NCT03869463 1238 1239 O
. NCT03869463 1239 1240 O
Regular NCT03869463 1242 1249 O
online NCT03869463 1250 1256 B-Modifier
brain NCT03869463 1257 1262 I-Modifier
training NCT03869463 1263 1271 B-Observation
or NCT03869463 1272 1274 B-Or
regular NCT03869463 1275 1282 O
player NCT03869463 1283 1289 O
of NCT03869463 1290 1292 O
non NCT03869463 1293 1296 B-Negation
- NCT03869463 1297 1298 O
fluency NCT03869463 1299 1306 B-Modifier
verbal NCT03869463 1307 1313 B-Observation
games NCT03869463 1314 1319 I-Observation
, NCT03869463 1320 1321 O
defined NCT03869463 1322 1329 O
as NCT03869463 1330 1332 O
doing NCT03869463 1333 1338 O
these NCT03869463 1339 1344 O
procedures NCT03869463 1345 1355 O
at NCT03869463 1356 1358 O
a NCT03869463 1359 1360 O
frequency NCT03869463 1361 1370 O
of NCT03869463 1371 1373 O
twice NCT03869463 1374 1379 B-Eq_Comparison
weekly NCT03869463 1380 1386 I-Eq_Comparison
or NCT03869463 1387 1389 I-Eq_Comparison
greater NCT03869463 1390 1397 I-Eq_Comparison
during NCT03869463 1398 1404 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03869463 1405 1408 O
year NCT03869463 1409 1413 B-Eq_Comparison
prior NCT03869463 1414 1419 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03869463 1420 1422 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03869463 1423 1432 B-Study
. NCT03869463 1433 1434 O

Inclusion NCT03862976 0 9 O
Criteria NCT03862976 10 18 O
: NCT03862976 19 20 O

- NCT03862976 24 25 O
Women NCT03862976 27 32 O
with NCT03862976 33 37 B-And
singleton NCT03862976 38 47 B-Modifier
gestation NCT03862976 48 57 B-Condition

- NCT03862976 60 61 O
18 NCT03862976 63 65 B-Eq_Comparison
years NCT03862976 66 71 I-Eq_Comparison
to NCT03862976 72 74 I-Eq_Comparison
50 NCT03862976 75 77 I-Eq_Comparison
years NCT03862976 78 83 I-Eq_Comparison

- NCT03862976 86 87 O
High NCT03862976 89 93 O
risk NCT03862976 94 98 B-Risk
pregnancies NCT03862976 99 110 B-Condition
: NCT03862976 111 112 O
DM NCT03862976 113 115 B-Condition
, NCT03862976 116 117 O
or NCT03862976 118 120 B-Or
GDM NCT03862976 121 124 B-Condition
, NCT03862976 125 126 O
or NCT03862976 127 129 B-Or
hypertension NCT03862976 130 142 B-Condition
, NCT03862976 143 144 O
or NCT03862976 145 147 B-Or
preeclampsia NCT03862976 148 160 B-Condition

Exclusion NCT03862976 161 170 O
Criteria NCT03862976 171 179 O
: NCT03862976 180 181 O

- NCT03862976 184 185 O
IUGR NCT03862976 186 190 B-Condition

Inclusion NCT03929705 0 9 O
Criteria NCT03929705 10 18 O
: NCT03929705 19 20 O
Cohort NCT03929705 21 27 O
1 NCT03929705 28 29 O
a NCT03929705 30 31 O
and NCT03929705 32 35 O
1 NCT03929705 36 37 O
b NCT03929705 38 39 O

- NCT03929705 42 43 O
• NCT03929705 45 46 O
Must NCT03929705 47 51 O
be NCT03929705 52 54 O
at NCT03929705 55 57 B-Eq_Comparison
least NCT03929705 58 63 I-Eq_Comparison
18 NCT03929705 64 66 I-Eq_Comparison
years NCT03929705 67 72 I-Eq_Comparison
of NCT03929705 73 75 O
age NCT03929705 76 79 B-Age

- NCT03929705 87 88 O
Must NCT03929705 90 94 O
be NCT03929705 95 97 O
able NCT03929705 98 102 O
to NCT03929705 103 105 O
provide NCT03929705 106 113 O
informed NCT03929705 114 122 O
consent NCT03929705 123 130 O

- NCT03929705 138 139 O
Must NCT03929705 141 145 O
be NCT03929705 146 148 O
able NCT03929705 149 153 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929705 154 156 I-Assertion___Assertion_Type_Value:hypothetical
provide NCT03929705 157 164 O
a NCT03929705 165 166 O
minimum NCT03929705 167 174 B-Eq_Comparison
of NCT03929705 175 177 I-Eq_Comparison
10 NCT03929705 178 180 I-Eq_Comparison
mL NCT03929705 181 183 I-Eq_Comparison
of NCT03929705 184 186 O
whole NCT03929705 187 192 B-Observation
blood NCT03929705 193 198 I-Observation
at NCT03929705 199 201 B-Temporal_Connection___Temporal_Connection_Type_Value:during
each NCT03929705 202 206 O
visit NCT03929705 207 212 B-Encounter
( NCT03929705 213 214 O
16 NCT03929705 215 217 B-Eq_Comparison
mL NCT03929705 218 220 I-Eq_Comparison
for NCT03929705 221 224 O
immunocompromised NCT03929705 225 242 B-Condition
i NCT03929705 243 244 O
. NCT03929705 245 246 O
e NCT03929705 247 248 O
. NCT03929705 249 250 O
HIV NCT03929705 252 255 B-Condition
+ NCT03929705 256 257 O
) NCT03929705 258 259 O

- NCT03929705 268 269 O
Must NCT03929705 271 275 O
be NCT03929705 276 278 O
T NCT03929705 279 280 B-Observation
- NCT03929705 281 282 I-Observation
SPOT NCT03929705 283 287 I-Observation
. NCT03929705 288 289 I-Observation
TB NCT03929705 290 292 I-Observation
positive NCT03929705 293 301 O

- NCT03929705 309 310 O
First NCT03929705 312 317 B-Eq_Comparison
visit NCT03929705 318 323 B-Encounter
suspect NCT03929705 324 331 B-Assertion___Assertion_Type_Value:possible
TB NCT03929705 332 334 B-Condition
subjects NCT03929705 335 343 O
with NCT03929705 344 348 B-And
no NCT03929705 349 351 B-Negation
prior NCT03929705 352 357 B-Eq_Comparison
history NCT03929705 358 365 I-Eq_Comparison
of NCT03929705 366 368 O
TB NCT03929705 369 371 B-Condition
diagnosis NCT03929705 372 381 O
Inclusion NCT03929705 382 391 O
Criteria NCT03929705 392 400 O
: NCT03929705 401 402 O
Cohort NCT03929705 403 409 O
2 NCT03929705 410 411 O
a NCT03929705 412 413 O
and NCT03929705 414 417 O
2 NCT03929705 418 419 O
b NCT03929705 420 421 O

- NCT03929705 429 430 O
Must NCT03929705 432 436 O
be NCT03929705 437 439 O
at NCT03929705 440 442 B-Eq_Comparison
least NCT03929705 443 448 I-Eq_Comparison
18 NCT03929705 449 451 I-Eq_Comparison
years NCT03929705 452 457 I-Eq_Comparison
of NCT03929705 458 460 O
age NCT03929705 461 464 B-Age

- NCT03929705 472 473 O
Must NCT03929705 475 479 O
be NCT03929705 480 482 O
able NCT03929705 483 487 O
to NCT03929705 488 490 O
provide NCT03929705 491 498 O
informed NCT03929705 499 507 O
consent NCT03929705 508 515 O

- NCT03929705 523 524 O
Must NCT03929705 526 530 O
be NCT03929705 531 533 O
able NCT03929705 534 538 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03929705 539 541 I-Assertion___Assertion_Type_Value:hypothetical
provide NCT03929705 542 549 O
a NCT03929705 550 551 O
minimum NCT03929705 552 559 B-Eq_Comparison
of NCT03929705 560 562 I-Eq_Comparison
10 NCT03929705 563 565 I-Eq_Comparison
mL NCT03929705 566 568 I-Eq_Comparison
of NCT03929705 569 571 O
whole NCT03929705 572 577 B-Observation
blood NCT03929705 578 583 I-Observation
at NCT03929705 584 586 B-Temporal_Connection___Temporal_Connection_Type_Value:during
each NCT03929705 587 591 O
visit NCT03929705 592 597 B-Encounter
( NCT03929705 598 599 O
16 NCT03929705 600 602 B-Eq_Comparison
mL NCT03929705 603 605 I-Eq_Comparison
for NCT03929705 606 609 O
immunocompromised NCT03929705 610 627 B-Condition
i NCT03929705 628 629 O
. NCT03929705 630 631 O
e NCT03929705 632 633 O
. NCT03929705 634 635 O
HIV NCT03929705 637 640 B-Condition
+ NCT03929705 641 642 O
) NCT03929705 643 644 O

- NCT03929705 653 654 O
Must NCT03929705 656 660 O
be NCT03929705 661 663 O
T NCT03929705 664 665 B-Condition
- NCT03929705 666 667 I-Condition
SPOT NCT03929705 668 672 I-Condition
. NCT03929705 673 674 I-Condition
TB NCT03929705 675 677 I-Condition
positive NCT03929705 678 686 O

- NCT03929705 694 695 O
No NCT03929705 697 699 B-Negation
prior NCT03929705 700 705 B-Eq_Comparison
history NCT03929705 706 713 I-Eq_Comparison
of NCT03929705 714 716 O
TB NCT03929705 717 719 B-Condition
diagnosis NCT03929705 720 729 O

Exclusion NCT03929705 730 739 O
Criteria NCT03929705 740 748 O
: NCT03929705 749 750 O
Cohort NCT03929705 751 757 O
1 NCT03929705 758 759 O
a NCT03929705 760 761 O
and NCT03929705 762 765 O
1 NCT03929705 766 767 O
b NCT03929705 768 769 O

- NCT03929705 772 773 O
• NCT03929705 775 776 O
Negative NCT03929705 777 785 O
in NCT03929705 786 788 O
the NCT03929705 789 792 O
T NCT03929705 793 794 B-Observation
- NCT03929705 795 796 I-Observation
SPOT NCT03929705 797 801 I-Observation
. NCT03929705 802 803 I-Observation
TB NCT03929705 804 806 I-Observation
test NCT03929705 807 811 I-Observation

- NCT03929705 819 820 O
Previous NCT03929705 822 830 B-Eq_Comparison
or NCT03929705 831 833 B-Or
pre NCT03929705 834 837 B-Eq_Comparison
- NCT03929705 838 839 I-Eq_Comparison
existing NCT03929705 840 848 I-Eq_Comparison
confirmed NCT03929705 849 858 O
TB NCT03929705 859 861 B-Condition
diagnosis NCT03929705 862 871 O

- NCT03929705 879 880 O
On NCT03929705 882 884 B-Eq_Comparison
anti NCT03929705 885 889 O
- NCT03929705 890 891 O
TB NCT03929705 892 894 B-Condition
treatment NCT03929705 895 904 B-Procedure
for NCT03929705 905 908 O
more NCT03929705 909 913 B-Eq_Comparison
than NCT03929705 914 918 I-Eq_Comparison
1 NCT03929705 919 920 I-Eq_Comparison
week NCT03929705 921 925 I-Eq_Comparison
* NCT03929705 926 927 O

- NCT03929705 936 937 O
Not NCT03929705 939 942 O
meeting NCT03929705 943 950 O
inclusion NCT03929705 951 960 O
criteria NCT03929705 961 969 O
Exclusion NCT03929705 970 979 O
Criteria NCT03929705 980 988 O
: NCT03929705 989 990 O
Cohort NCT03929705 991 997 O
2 NCT03929705 998 999 O
a NCT03929705 1000 1001 O
and NCT03929705 1002 1005 O
2 NCT03929705 1006 1007 O
b NCT03929705 1008 1009 O

- NCT03929705 1017 1018 O
Negative NCT03929705 1020 1028 O
T NCT03929705 1029 1030 B-Observation
- NCT03929705 1031 1032 I-Observation
SPOT NCT03929705 1033 1037 I-Observation
. NCT03929705 1038 1039 I-Observation
TB NCT03929705 1040 1042 I-Observation
test NCT03929705 1043 1047 I-Observation

- NCT03929705 1055 1056 O
Previous NCT03929705 1058 1066 B-Eq_Comparison
or NCT03929705 1067 1069 B-Or
pre NCT03929705 1070 1073 B-Eq_Comparison
- NCT03929705 1074 1075 I-Eq_Comparison
existing NCT03929705 1076 1084 I-Eq_Comparison
confirmed NCT03929705 1085 1094 O
TB NCT03929705 1095 1097 B-Condition
diagnosis NCT03929705 1098 1107 O

- NCT03929705 1115 1116 O
On NCT03929705 1118 1120 B-Eq_Comparison
anti NCT03929705 1121 1125 O
- NCT03929705 1126 1127 O
TB NCT03929705 1128 1130 B-Condition
treatment NCT03929705 1131 1140 B-Procedure

- NCT03929705 1148 1149 O
Symptoms NCT03929705 1151 1159 B-Assertion___Assertion_Type_Value:possible
of NCT03929705 1160 1162 O
active NCT03929705 1163 1169 B-Eq_Comparison
TB NCT03929705 1170 1172 B-Condition

- NCT03929705 1180 1181 O
Not NCT03929705 1183 1186 O
meeting NCT03929705 1187 1194 O
inclusion NCT03929705 1195 1204 O
criteria NCT03929705 1205 1213 O

Inclusion NCT03921619 0 9 O
Criteria NCT03921619 10 18 O
: NCT03921619 19 20 O

- NCT03921619 24 25 O
Greater NCT03921619 27 34 B-Eq_Comparison
than NCT03921619 35 39 I-Eq_Comparison
or NCT03921619 40 42 I-Eq_Comparison
equal NCT03921619 43 48 I-Eq_Comparison
to NCT03921619 49 51 I-Eq_Comparison
65 NCT03921619 52 54 I-Eq_Comparison
years NCT03921619 55 60 I-Eq_Comparison
of NCT03921619 61 63 O
age NCT03921619 64 67 B-Age

Exclusion NCT03921619 68 77 O
Criteria NCT03921619 78 86 O
: NCT03921619 87 88 O

- NCT03921619 92 93 O
Younger NCT03921619 95 102 B-Eq_Comparison
than NCT03921619 103 107 I-Eq_Comparison
65 NCT03921619 108 110 I-Eq_Comparison
years NCT03921619 111 116 I-Eq_Comparison
of NCT03921619 117 119 O
age NCT03921619 120 123 B-Age

- NCT03921619 126 127 O
Pre NCT03921619 129 132 B-Eq_Comparison
- NCT03921619 133 134 I-Eq_Comparison
existing NCT03921619 135 143 I-Eq_Comparison
cognitive NCT03921619 144 153 B-Condition
impairment NCT03921619 154 164 I-Condition

- NCT03921619 167 168 O
Pre NCT03921619 170 173 B-Eq_Comparison
- NCT03921619 174 175 I-Eq_Comparison
existing NCT03921619 176 184 I-Eq_Comparison
mobility NCT03921619 185 193 B-Condition
impairment NCT03921619 194 204 I-Condition

- NCT03921619 207 208 O
Pre NCT03921619 210 213 B-Eq_Comparison
- NCT03921619 214 215 I-Eq_Comparison
existing NCT03921619 216 224 I-Eq_Comparison
symptomatic NCT03921619 225 236 B-Assertion___Assertion_Type_Value:possible
upper NCT03921619 237 242 B-Modifier
or NCT03921619 243 245 B-Or
lower NCT03921619 246 251 B-Modifier
extremity NCT03921619 252 261 I-Modifier
disease NCT03921619 262 269 B-Condition

Inclusion NCT03865225 0 9 O
Criteria NCT03865225 10 18 O
: NCT03865225 19 20 O

- NCT03865225 24 25 O
male NCT03865225 27 31 O
and NCT03865225 32 35 B-Or
female NCT03865225 36 42 O
subjects NCT03865225 43 51 O
aged NCT03865225 52 56 B-Age
between NCT03865225 57 64 B-Eq_Comparison
18 NCT03865225 65 67 I-Eq_Comparison
and NCT03865225 68 71 I-Eq_Comparison
90 NCT03865225 72 74 I-Eq_Comparison

- NCT03865225 78 79 O
written NCT03865225 81 88 O
and NCT03865225 89 92 O
oral NCT03865225 93 97 O
informed NCT03865225 98 106 O
consent NCT03865225 107 114 O

- NCT03865225 117 118 O
evidence NCT03865225 120 128 O
of NCT03865225 129 131 O
an NCT03865225 132 134 O
ischaemic NCT03865225 135 144 B-Condition
lesion NCT03865225 145 151 I-Condition
on NCT03865225 152 154 O
cranial NCT03865225 155 162 B-Procedure
computed NCT03865225 163 171 I-Procedure
tomography NCT03865225 172 182 I-Procedure
scan NCT03865225 183 187 I-Procedure
or NCT03865225 188 190 B-Or
magnetic NCT03865225 191 199 B-Procedure
resonance NCT03865225 200 209 I-Procedure
imaging NCT03865225 210 217 I-Procedure

Exclusion NCT03865225 218 227 O
Criteria NCT03865225 228 236 O
: NCT03865225 237 238 O

- NCT03865225 242 243 O
intake NCT03865225 245 251 O
of NCT03865225 252 254 O
any NCT03865225 255 258 O
tricyclic NCT03865225 259 268 B-Drug
antidepressant NCT03865225 269 283 I-Drug
within NCT03865225 284 290 B-Eq_Comparison
the NCT03865225 291 294 I-Eq_Comparison
last NCT03865225 295 299 I-Eq_Comparison
14 NCT03865225 300 302 I-Eq_Comparison
days NCT03865225 303 307 I-Eq_Comparison

- NCT03865225 310 311 O
atrial NCT03865225 313 319 B-Condition
fibrillation NCT03865225 320 332 I-Condition

- NCT03865225 335 336 O
prior NCT03865225 338 343 B-Eq_Comparison
diagnosed NCT03865225 344 353 O
autonomic NCT03865225 354 363 B-Condition
neuropathy NCT03865225 364 374 I-Condition

- NCT03865225 377 378 O
malignant NCT03865225 380 389 B-Condition
cerebral NCT03865225 390 398 I-Condition
infarct NCT03865225 399 406 I-Condition
or NCT03865225 407 409 B-Or
indication NCT03865225 410 420 B-Indication
for NCT03865225 421 424 O
treatment NCT03865225 425 434 B-Procedure
at NCT03865225 435 437 O
intensive NCT03865225 438 447 O
care NCT03865225 448 452 O
unit NCT03865225 453 457 O

- NCT03865225 460 461 O
aphasia NCT03865225 463 470 B-Condition
or NCT03865225 471 473 B-Or
cognitive NCT03865225 474 483 B-Condition
deficit NCT03865225 484 491 I-Condition
with NCT03865225 492 496 O
resulted NCT03865225 497 505 O
inability NCT03865225 506 515 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865225 516 518 O
participate NCT03865225 519 530 O
in NCT03865225 531 533 O
Heart NCT03865225 534 539 B-Modifier
rate NCT03865225 540 544 I-Modifier
variability NCT03865225 545 556 I-Modifier
- NCT03865225 557 558 O
biofeedback NCT03865225 559 570 B-Procedure
training NCT03865225 571 579 I-Procedure

- NCT03865225 582 583 O
respiratory NCT03865225 585 596 B-Condition
insufficiency NCT03865225 597 610 I-Condition

- NCT03865225 613 614 O
blindness NCT03865225 616 625 B-Condition
, NCT03865225 626 627 O
deafness NCT03865225 628 636 B-Condition
or NCT03865225 637 639 B-Or
other NCT03865225 640 645 B-Other
physical NCT03865225 646 654 B-Condition
limitations NCT03865225 655 666 I-Condition
with NCT03865225 667 671 O
resulted NCT03865225 672 680 O
inability NCT03865225 681 690 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865225 691 693 O
participate NCT03865225 694 705 O
in NCT03865225 706 708 O
heart NCT03865225 709 714 B-Modifier
rate NCT03865225 715 719 I-Modifier
variability NCT03865225 720 731 I-Modifier
- NCT03865225 732 733 O
biofeedback NCT03865225 734 745 B-Procedure
training NCT03865225 746 754 I-Procedure

Inclusion NCT03867864 0 9 O
Criteria NCT03867864 10 18 O
: NCT03867864 19 20 O

- NCT03867864 24 25 O
Registered NCT03867864 27 37 O
nurses NCT03867864 38 44 B-Provider
, NCT03867864 45 46 O
working NCT03867864 47 54 O
in NCT03867864 55 57 O
intensive NCT03867864 58 67 O
care NCT03867864 68 72 O
units NCT03867864 73 78 O
( NCT03867864 79 80 O
ICU NCT03867864 81 84 O
) NCT03867864 85 86 O
or NCT03867864 87 89 B-Or
department NCT03867864 90 100 O
of NCT03867864 101 103 O
emergency NCT03867864 104 113 O
( NCT03867864 114 115 O
ED NCT03867864 116 118 O
) NCT03867864 119 120 O
. NCT03867864 121 122 O

- NCT03867864 126 127 O
The NCT03867864 129 132 O
frequency NCT03867864 133 142 O
of NCT03867864 143 145 O
headaches NCT03867864 146 155 B-Condition
more NCT03867864 156 160 B-Eq_Comparison
than NCT03867864 161 165 I-Eq_Comparison
three NCT03867864 166 171 I-Eq_Comparison
times NCT03867864 172 177 I-Eq_Comparison
per NCT03867864 178 181 I-Eq_Comparison
month NCT03867864 182 187 I-Eq_Comparison
. NCT03867864 188 189 O

- NCT03867864 193 194 O
The NCT03867864 196 199 O
type NCT03867864 200 204 O
of NCT03867864 205 207 O
headache NCT03867864 208 216 B-Condition
is NCT03867864 217 219 O
migraine NCT03867864 220 228 B-Condition
or NCT03867864 229 231 B-Or
frequent NCT03867864 232 240 B-Modifier
episodic NCT03867864 241 249 I-Modifier
tension NCT03867864 250 257 I-Modifier
- NCT03867864 258 259 I-Modifier
type NCT03867864 260 264 I-Modifier
headache NCT03867864 265 273 B-Condition
, NCT03867864 274 275 O
which NCT03867864 276 281 O
is NCT03867864 282 284 O
defined NCT03867864 285 292 O
by NCT03867864 293 295 O
the NCT03867864 296 299 O
Headache NCT03867864 300 308 O
Classification NCT03867864 309 323 O
Committee NCT03867864 324 333 O
of NCT03867864 334 336 O
the NCT03867864 337 340 O
International NCT03867864 341 354 O
Headache NCT03867864 355 363 O
Society NCT03867864 364 371 O
. NCT03867864 372 373 O
If NCT03867864 375 377 O
the NCT03867864 378 381 O
symptoms NCT03867864 382 390 B-Assertion___Assertion_Type_Value:possible
of NCT03867864 391 393 O
a NCT03867864 394 395 O
headache NCT03867864 396 404 B-Condition
can NCT03867864 405 408 O
not NCT03867864 408 411 O
be NCT03867864 412 414 O
defined NCT03867864 415 422 O
, NCT03867864 423 424 O
the NCT03867864 425 428 O
investigator NCT03867864 429 441 O
will NCT03867864 442 446 B-Assertion___Assertion_Type_Value:hypothetical
refer NCT03867864 447 452 B-Encounter
the NCT03867864 453 456 O
potential NCT03867864 457 466 O
participant NCT03867864 467 478 O
to NCT03867864 479 481 O
a NCT03867864 482 483 O
neurologist NCT03867864 484 495 B-Provider
for NCT03867864 496 499 O
further NCT03867864 500 507 O
diagnosis NCT03867864 508 517 O
. NCT03867864 518 519 O

Exclusion NCT03867864 521 530 O
Criteria NCT03867864 531 539 O
: NCT03867864 540 541 O

- NCT03867864 545 546 O
Current NCT03867864 548 555 B-Eq_Comparison
user NCT03867864 556 560 O
of NCT03867864 561 563 O
other NCT03867864 564 569 B-Other
kinds NCT03867864 570 575 O
of NCT03867864 576 578 O
essential NCT03867864 579 588 B-Drug
oils NCT03867864 589 593 I-Drug
( NCT03867864 594 595 O
e NCT03867864 596 597 O
. NCT03867864 598 599 O
g NCT03867864 600 601 O
. NCT03867864 602 603 O
, NCT03867864 604 605 O
the NCT03867864 606 609 O
external NCT03867864 610 618 B-Modifier
application NCT03867864 619 630 I-Modifier
on NCT03867864 631 633 I-Modifier
skin NCT03867864 634 638 I-Modifier
, NCT03867864 639 640 O
sniffing NCT03867864 641 649 B-Modifier
) NCT03867864 650 651 O
, NCT03867864 652 653 O
and NCT03867864 654 657 B-And
do NCT03867864 658 660 O
not NCT03867864 661 664 B-Negation
willing NCT03867864 665 672 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867864 673 675 I-Assertion___Assertion_Type_Value:hypothetical
temporarily NCT03867864 676 687 O
suspend NCT03867864 688 695 B-Negation
for NCT03867864 696 699 O
nine NCT03867864 700 704 B-Eq_Comparison
weeks NCT03867864 705 710 I-Eq_Comparison
. NCT03867864 711 712 O

- NCT03867864 716 717 O
Having NCT03867864 719 725 O
sensitive NCT03867864 726 735 B-Condition
responses NCT03867864 736 745 I-Condition
to NCT03867864 746 748 O
the NCT03867864 749 752 O
essential NCT03867864 753 762 B-Drug
oil NCT03867864 763 766 I-Drug
. NCT03867864 767 768 O

- NCT03867864 772 773 O
Pregnancy NCT03867864 775 784 B-Condition
or NCT03867864 785 787 B-Or
preparing NCT03867864 788 797 B-Assertion___Assertion_Type_Value:intention
for NCT03867864 798 801 O
pregnancy NCT03867864 802 811 B-Condition
. NCT03867864 812 813 O

- NCT03867864 817 818 O
Breastfeeding NCT03867864 820 833 B-Condition
. NCT03867864 834 835 O

- NCT03867864 839 840 O
The NCT03867864 842 845 O
type NCT03867864 846 850 O
of NCT03867864 851 853 O
headache NCT03867864 854 862 B-Condition
was NCT03867864 863 866 O
neither NCT03867864 867 874 B-Negation
migraine NCT03867864 875 883 B-Condition
nor NCT03867864 884 887 B-Negation
frequent NCT03867864 888 896 B-Modifier
episodic NCT03867864 897 905 I-Modifier
tension NCT03867864 906 913 I-Modifier
- NCT03867864 914 915 I-Modifier
type NCT03867864 916 920 I-Modifier
headache NCT03867864 921 929 B-Condition
after NCT03867864 930 935 B-Temporal_Connection___Temporal_Connection_Type_Value:after
diagnosed NCT03867864 936 945 O
by NCT03867864 946 948 O
the NCT03867864 949 952 O
neurologist NCT03867864 953 964 B-Provider
. NCT03867864 965 966 O

- NCT03867864 970 971 O
With NCT03867864 973 977 O
hepatic NCT03867864 978 985 B-Modifier
or NCT03867864 986 988 B-Or
renal NCT03867864 989 994 B-Modifier
diseases NCT03867864 995 1003 B-Condition
. NCT03867864 1004 1005 O

- NCT03867864 1009 1010 O
taking NCT03867864 1012 1018 B-Eq_Comparison
medicine NCT03867864 1019 1027 B-Drug
for NCT03867864 1028 1031 O
long NCT03867864 1032 1036 O
- NCT03867864 1037 1038 O
term NCT03867864 1039 1043 O
( NCT03867864 1044 1045 O
such NCT03867864 1046 1050 O
as NCT03867864 1051 1053 O
Aspirin NCT03867864 1054 1061 B-Drug
, NCT03867864 1062 1063 O
anti NCT03867864 1064 1068 B-Drug
- NCT03867864 1069 1070 I-Drug
coagulant NCT03867864 1071 1080 I-Drug
, NCT03867864 1081 1082 O
medication NCT03867864 1083 1093 B-Drug
for NCT03867864 1094 1097 O
mental NCT03867864 1098 1104 B-Condition
disorders NCT03867864 1105 1114 I-Condition
, NCT03867864 1115 1116 O
contraceptives NCT03867864 1117 1131 B-Drug
, NCT03867864 1132 1133 O
etc NCT03867864 1134 1137 O
. NCT03867864 1138 1139 O
) NCT03867864 1140 1141 O
. NCT03867864 1142 1143 O

Inclusion NCT03864120 0 9 O
Criteria NCT03864120 10 18 O
: NCT03864120 19 20 O

1 NCT03864120 24 25 O
. NCT03864120 25 26 O
Age NCT03864120 28 31 B-Age
> NCT03864120 32 33 B-Eq_Comparison
18 NCT03864120 34 36 I-Eq_Comparison
years NCT03864120 37 42 I-Eq_Comparison

2 NCT03864120 45 46 O
. NCT03864120 46 47 O
on NCT03864120 49 51 B-Eq_Comparison
PD NCT03864120 52 54 B-Condition
treatment NCT03864120 55 64 B-Procedure
for NCT03864120 65 68 O
at NCT03864120 69 71 B-Eq_Comparison
least NCT03864120 72 77 I-Eq_Comparison
one NCT03864120 78 81 I-Eq_Comparison
month NCT03864120 82 87 I-Eq_Comparison

3 NCT03864120 90 91 O
. NCT03864120 91 92 O
signed NCT03864120 94 100 O
the NCT03864120 101 104 O
consent NCT03864120 105 112 O

Exclusion NCT03864120 113 122 O
Criteria NCT03864120 123 131 O
: NCT03864120 132 133 O

1 NCT03864120 137 138 O
. NCT03864120 138 139 O
Peritonitis NCT03864120 141 152 B-Condition
or NCT03864120 153 155 B-Or
recovery NCT03864120 156 164 B-Condition
from NCT03864120 165 169 O
peritonitis NCT03864120 170 181 B-Condition
for NCT03864120 182 185 O
less NCT03864120 186 190 B-Eq_Comparison
than NCT03864120 191 195 I-Eq_Comparison
one NCT03864120 196 199 I-Eq_Comparison
month NCT03864120 200 205 I-Eq_Comparison
. NCT03864120 206 207 O

2 NCT03864120 211 212 O
. NCT03864120 212 213 O
On NCT03864120 215 217 B-Eq_Comparison
any NCT03864120 218 221 O
intra NCT03864120 222 227 B-Modifier
peritoneal NCT03864120 228 238 B-Procedure
treatment NCT03864120 239 248 I-Procedure
apart NCT03864120 249 254 B-Exception
from NCT03864120 255 259 O
peritoneal NCT03864120 260 270 B-Procedure
dialysis NCT03864120 271 279 I-Procedure
. NCT03864120 280 281 O

3 NCT03864120 285 286 O
. NCT03864120 286 287 O
Evidence NCT03864120 289 297 O
of NCT03864120 298 300 O
decompensated NCT03864120 301 314 B-Modifier
liver NCT03864120 315 320 I-Modifier
cirrhosis NCT03864120 321 330 B-Condition
or NCT03864120 331 333 B-Or
heart NCT03864120 334 339 B-Condition
failure NCT03864120 340 347 I-Condition
. NCT03864120 348 349 O

4 NCT03864120 353 354 O
. NCT03864120 354 355 O
Evidence NCT03864120 357 365 O
of NCT03864120 366 368 O
extra NCT03864120 369 374 B-Modifier
peritoneal NCT03864120 375 385 B-Condition
leakage NCT03864120 386 393 I-Condition
, NCT03864120 394 395 O
eg NCT03864120 396 398 O
. NCT03864120 399 400 O
leakage NCT03864120 402 409 B-Condition
to NCT03864120 410 412 O
thoracic NCT03864120 413 421 B-Modifier
cavity NCT03864120 422 428 I-Modifier
, NCT03864120 429 430 O
post NCT03864120 431 435 B-Temporal_Connection___Temporal_Connection_Type_Value:after
peritoneal NCT03864120 436 446 B-Procedure
, NCT03864120 447 448 O
hernia NCT03864120 449 455 B-Condition
. NCT03864120 456 457 O

Inclusion NCT03921827 0 9 O
Criteria NCT03921827 10 18 O
: NCT03921827 19 20 O

1 NCT03921827 24 25 O
. NCT03921827 25 26 O
Patients NCT03921827 28 36 O
with NCT03921827 37 41 O
recent NCT03921827 42 48 B-Eq_Comparison
stroke NCT03921827 49 55 B-Condition
/ NCT03921827 56 57 B-Or
TIA NCT03921827 58 61 B-Condition
and NCT03921827 62 65 B-Or
severe NCT03921827 66 72 O
stenosis NCT03921827 73 81 B-Condition
of NCT03921827 82 84 I-Condition
intracranial NCT03921827 85 97 I-Condition
ICA NCT03921827 98 101 B-Modifier
or NCT03921827 102 104 B-Or
MCA NCT03921827 105 108 B-Modifier
and NCT03921827 109 112 B-And
impaired NCT03921827 113 121 B-Condition
CVR NCT03921827 122 125 I-Condition
within NCT03921827 126 132 B-Eq_Comparison
previous NCT03921827 133 141 I-Eq_Comparison
three NCT03921827 142 147 I-Eq_Comparison
months NCT03921827 148 154 I-Eq_Comparison
but NCT03921827 155 158 B-And
not NCT03921827 159 162 B-Negation
before NCT03921827 163 169 B-Temporal_Connection___Temporal_Connection_Type_Value:before
3 NCT03921827 170 171 B-Eq_Comparison
weeks NCT03921827 172 177 I-Eq_Comparison
after NCT03921827 178 183 B-Temporal_Connection___Temporal_Connection_Type_Value:after
acute NCT03921827 184 189 O
stroke NCT03921827 190 196 B-Condition
. NCT03921827 197 198 O
This NCT03921827 200 204 O
is NCT03921827 205 207 O
to NCT03921827 208 210 O
differentiate NCT03921827 211 224 O
between NCT03921827 225 232 O
patients NCT03921827 233 241 O
with NCT03921827 242 246 O
a NCT03921827 247 248 O
long NCT03921827 249 253 B-Condition
- NCT03921827 254 255 I-Condition
standing NCT03921827 256 264 I-Condition
fixed NCT03921827 265 270 I-Condition
- NCT03921827 271 272 I-Condition
stenosis NCT03921827 273 281 I-Condition
from NCT03921827 282 286 O
patients NCT03921827 287 295 O
with NCT03921827 296 300 O
partially NCT03921827 301 310 B-Condition
recanalized NCT03921827 311 322 I-Condition
intracranial NCT03921827 323 335 I-Condition
artery NCT03921827 336 342 I-Condition
( NCT03921827 343 344 O
masquerading NCT03921827 345 357 O
as NCT03921827 358 360 O
severe NCT03921827 361 367 O
stenosis NCT03921827 368 376 B-Condition
) NCT03921827 377 378 O
. NCT03921827 379 380 O

2 NCT03921827 384 385 O
. NCT03921827 385 386 O
Age NCT03921827 388 391 B-Age
> NCT03921827 392 393 B-Eq_Comparison
21 NCT03921827 394 396 I-Eq_Comparison
years NCT03921827 397 402 I-Eq_Comparison

Exclusion NCT03921827 403 412 O
Criteria NCT03921827 413 421 O
: NCT03921827 422 423 O

1 NCT03921827 427 428 O
. NCT03921827 428 429 O
Patients NCT03921827 431 439 O
with NCT03921827 440 444 O
atrial NCT03921827 445 451 B-Condition
fibrillation NCT03921827 452 464 I-Condition
/ NCT03921827 465 466 B-Or
arrhythmias NCT03921827 467 478 B-Condition
. NCT03921827 479 480 O

2 NCT03921827 484 485 O
. NCT03921827 485 486 O
Within NCT03921827 488 494 B-Eq_Comparison
2 NCT03921827 495 496 I-Eq_Comparison
weeks NCT03921827 497 502 I-Eq_Comparison
of NCT03921827 503 505 O
cardiac NCT03921827 506 513 B-Procedure
catheterization NCT03921827 514 529 I-Procedure
or NCT03921827 530 532 B-Or
arterial NCT03921827 533 541 B-Procedure
puncture NCT03921827 542 550 I-Procedure
at NCT03921827 551 553 O
femoral NCT03921827 554 561 B-Modifier
puncture NCT03921827 562 570 I-Modifier
site NCT03921827 571 575 I-Modifier
. NCT03921827 576 577 O

3 NCT03921827 581 582 O
. NCT03921827 582 583 O
Decompensated NCT03921827 585 598 B-Modifier
heart NCT03921827 599 604 B-Condition
failure NCT03921827 605 612 I-Condition
, NCT03921827 613 614 O
usually NCT03921827 615 622 O
class NCT03921827 623 628 O
3 NCT03921827 629 630 B-Eq_Comparison
or NCT03921827 631 633 I-Eq_Comparison
4 NCT03921827 634 635 I-Eq_Comparison

4 NCT03921827 639 640 O
. NCT03921827 640 641 O
LV NCT03921827 643 645 B-Observation
EF NCT03921827 646 648 I-Observation
< NCT03921827 649 650 B-Eq_Comparison
30 NCT03921827 651 653 I-Eq_Comparison
% NCT03921827 654 655 I-Eq_Comparison

5 NCT03921827 659 660 O
. NCT03921827 660 661 O
Moderate NCT03921827 663 671 O
or NCT03921827 672 674 B-Or
severe NCT03921827 675 681 O
AR NCT03921827 682 684 B-Condition

6 NCT03921827 687 688 O
. NCT03921827 688 689 O
Persistent NCT03921827 691 701 O
and NCT03921827 702 705 B-Or
uncontrolled NCT03921827 706 718 B-Modifier
hypertension NCT03921827 719 731 B-Condition
( NCT03921827 732 733 O
BP NCT03921827 734 736 B-Observation
persistently NCT03921827 737 749 O
> NCT03921827 750 751 B-Eq_Comparison
160 NCT03921827 752 755 I-Eq_Comparison
/ NCT03921827 756 757 I-Eq_Comparison
100 NCT03921827 758 761 I-Eq_Comparison
mmHg NCT03921827 762 766 I-Eq_Comparison
) NCT03921827 767 768 O

7 NCT03921827 772 773 O
. NCT03921827 773 774 O
Bleeding NCT03921827 776 784 B-Condition
diathesis NCT03921827 785 794 I-Condition

8 NCT03921827 797 798 O
. NCT03921827 798 799 O
Active NCT03921827 801 807 B-Eq_Comparison
thrombophlebitis NCT03921827 808 824 B-Condition
/ NCT03921827 825 826 B-Or
venous NCT03921827 827 833 B-Condition
disease NCT03921827 834 841 I-Condition
of NCT03921827 842 844 O
lower NCT03921827 845 850 B-Modifier
limbs NCT03921827 851 856 I-Modifier

9 NCT03921827 859 860 O
. NCT03921827 860 861 O
Severe NCT03921827 863 869 O
lower NCT03921827 870 875 B-Modifier
extremity NCT03921827 876 885 I-Modifier
vaso NCT03921827 886 890 B-Condition
- NCT03921827 891 892 I-Condition
occlusive NCT03921827 893 902 I-Condition
disease NCT03921827 903 910 I-Condition

10 NCT03921827 912 914 O
. NCT03921827 914 915 O
Presence NCT03921827 917 925 O
of NCT03921827 926 928 O
a NCT03921827 929 930 O
documented NCT03921827 931 941 O
aortic NCT03921827 942 948 B-Condition
aneurysm NCT03921827 949 957 I-Condition
/ NCT03921827 958 959 B-Or
dissection NCT03921827 960 970 B-Procedure
requiring NCT03921827 971 980 B-Assertion___Assertion_Type_Value:hypothetical
surgical NCT03921827 981 989 B-Procedure
repair NCT03921827 990 996 I-Procedure

11 NCT03921827 998 1000 O
. NCT03921827 1000 1001 O
Pregnancy NCT03921827 1003 1012 B-Condition

Inclusion NCT03868774 0 9 O
Criteria NCT03868774 10 18 O
: NCT03868774 19 20 O

1 NCT03868774 24 25 O
. NCT03868774 25 26 O
Moderate NCT03868774 28 36 B-Eq_Comparison
- NCT03868774 37 38 I-Eq_Comparison
severe NCT03868774 39 45 I-Eq_Comparison
uni NCT03868774 46 49 B-Modifier
- NCT03868774 50 51 I-Modifier
and NCT03868774 52 55 B-Or
bipolar NCT03868774 56 63 B-Modifier
depression NCT03868774 64 74 B-Condition
according NCT03868774 75 84 O
to NCT03868774 85 87 O
the NCT03868774 88 91 O
International NCT03868774 92 105 O
Classification NCT03868774 106 120 O
of NCT03868774 121 123 O
Diseases NCT03868774 124 132 O
( NCT03868774 133 134 O
ICD NCT03868774 135 138 O
- NCT03868774 139 140 O
10 NCT03868774 141 143 O
) NCT03868774 144 145 O

2 NCT03868774 149 150 O
. NCT03868774 150 151 O
A NCT03868774 153 154 O
Hamilton NCT03868774 155 163 B-Observation
scale NCT03868774 164 169 I-Observation
score NCT03868774 170 175 O
( NCT03868774 176 177 O
HDS NCT03868774 178 181 B-Observation
- NCT03868774 182 183 I-Observation
17 NCT03868774 184 186 I-Observation
) NCT03868774 187 188 O
of NCT03868774 189 191 O
≥ NCT03868774 192 193 B-Eq_Comparison
18 NCT03868774 194 196 I-Eq_Comparison
and NCT03868774 197 200 B-Or
/ NCT03868774 201 202 I-Or
or NCT03868774 203 205 I-Or
a NCT03868774 206 207 O
sub NCT03868774 208 211 B-Observation
- NCT03868774 212 213 I-Observation
scale NCT03868774 214 219 I-Observation
( NCT03868774 220 221 O
HDSS NCT03868774 222 226 B-Observation
) NCT03868774 227 228 O
score NCT03868774 229 234 O
of NCT03868774 235 237 O
≥ NCT03868774 238 239 B-Eq_Comparison
9 NCT03868774 240 241 I-Eq_Comparison
within NCT03868774 242 248 B-Eq_Comparison
24 NCT03868774 249 251 I-Eq_Comparison
- NCT03868774 252 253 I-Eq_Comparison
48 NCT03868774 254 256 I-Eq_Comparison
hours NCT03868774 257 262 I-Eq_Comparison
before NCT03868774 263 269 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03868774 270 273 O
first NCT03868774 274 279 B-Eq_Comparison
treatment NCT03868774 280 289 B-Procedure

Exclusion NCT03868774 290 299 O
Criteria NCT03868774 300 308 O
: NCT03868774 309 310 O

1 NCT03868774 314 315 O
. NCT03868774 315 316 O
Organic NCT03868774 318 325 B-Modifier
brain NCT03868774 326 331 B-Condition
disease NCT03868774 332 339 I-Condition
. NCT03868774 340 341 O

2 NCT03868774 345 346 O
. NCT03868774 346 347 O
Epileptic NCT03868774 349 358 B-Condition
seizure NCT03868774 359 366 I-Condition
< NCT03868774 367 368 B-Eq_Comparison
2 NCT03868774 369 370 I-Eq_Comparison
years NCT03868774 371 376 I-Eq_Comparison

3 NCT03868774 379 380 O
. NCT03868774 380 381 O
Patients NCT03868774 383 391 O
with NCT03868774 392 396 O
implanted NCT03868774 397 406 B-Procedure
metal NCT03868774 407 412 I-Procedure
parts NCT03868774 413 418 I-Procedure
in NCT03868774 419 421 O
the NCT03868774 422 425 O
brain NCT03868774 426 431 B-Modifier
or NCT03868774 432 434 B-Or
chest NCT03868774 435 440 B-Modifier

4 NCT03868774 443 444 O
. NCT03868774 444 445 O
Patients NCT03868774 447 455 O
with NCT03868774 456 460 O
pacemaker NCT03868774 461 470 B-Procedure

5 NCT03868774 473 474 O
. NCT03868774 474 475 O
Medical NCT03868774 477 484 O
diseases NCT03868774 485 493 B-Condition
with NCT03868774 494 498 O
cerebral NCT03868774 499 507 B-Condition
impact NCT03868774 508 514 O

6 NCT03868774 517 518 O
. NCT03868774 518 519 O
Serious NCT03868774 521 528 O
suicidal NCT03868774 529 537 B-Condition
danger NCT03868774 538 544 B-Risk


Inclusion NCT03864640 0 9 O
Criteria NCT03864640 10 18 O
: NCT03864640 19 20 O

- NCT03864640 24 25 O
Adult NCT03864640 27 32 O
patients NCT03864640 33 41 O
with NCT03864640 42 46 B-And
colorectal NCT03864640 47 57 B-Modifier
cancer NCT03864640 58 64 B-Condition
. NCT03864640 65 66 O

Exclusion NCT03864640 68 77 O
Criteria NCT03864640 78 86 O
: NCT03864640 87 88 O

- NCT03864640 92 93 O
Patients NCT03864640 95 103 O
reluctant NCT03864640 104 113 O
to NCT03864640 114 116 O
participate NCT03864640 117 128 O
in NCT03864640 129 131 O
the NCT03864640 132 135 O
study NCT03864640 136 141 O
. NCT03864640 142 143 O

Inclusion NCT03928730 0 9 O
Criteria NCT03928730 10 18 O
: NCT03928730 19 20 O

- NCT03928730 24 25 O
All NCT03928730 27 30 O
with NCT03928730 31 35 O
oral NCT03928730 36 40 B-Modifier
and NCT03928730 41 44 B-Or
/ NCT03928730 45 46 I-Or
or NCT03928730 47 49 I-Or
maxillofacial NCT03928730 50 63 B-Modifier
swelling NCT03928730 64 72 B-Condition
, NCT03928730 73 74 O

Exclusion NCT03928730 76 85 O
Criteria NCT03928730 86 94 O
: NCT03928730 95 96 O

- NCT03928730 100 101 O
Any NCT03928730 103 106 O
other NCT03928730 107 112 O
swellings NCT03928730 113 122 B-Condition
that NCT03928730 123 127 O
were NCT03928730 128 132 O
caused NCT03928730 133 139 O
by NCT03928730 140 142 O
trauma NCT03928730 143 149 B-Condition
and NCT03928730 150 153 B-Or
/ NCT03928730 154 155 I-Or
or NCT03928730 156 158 I-Or
fracture NCT03928730 159 167 B-Condition
, NCT03928730 168 169 O
extended NCT03928730 170 178 B-Modifier
below NCT03928730 179 184 I-Modifier
the NCT03928730 185 188 I-Modifier
neck NCT03928730 189 193 I-Modifier
or NCT03928730 194 196 B-Or
patient NCT03928730 197 204 O
reluctant NCT03928730 205 214 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03928730 215 217 I-Assertion___Assertion_Type_Value:hypothetical
undergo NCT03928730 218 225 B-Eq_Comparison
US NCT03928730 226 228 B-Procedure
were NCT03928730 229 233 O
excluded NCT03928730 234 242 B-Negation
from NCT03928730 243 247 O
the NCT03928730 248 251 O
study NCT03928730 252 257 B-Study
. NCT03928730 258 259 O

Inclusion NCT03928054 0 9 O
Criteria NCT03928054 10 18 O
: NCT03928054 19 20 O

- NCT03928054 24 25 O
Patients NCT03928054 27 35 O
with NCT03928054 36 40 O
both NCT03928054 41 45 O
sexes NCT03928054 46 51 O
from NCT03928054 52 56 O
40 NCT03928054 57 59 B-Eq_Comparison
to NCT03928054 60 62 I-Eq_Comparison
80 NCT03928054 63 65 I-Eq_Comparison
years NCT03928054 66 71 I-Eq_Comparison
old NCT03928054 72 75 B-Age

- NCT03928054 78 79 O
who NCT03928054 81 84 O
underwent NCT03928054 85 94 B-Eq_Comparison
imaging NCT03928054 95 102 B-Procedure
examination NCT03928054 103 114 I-Procedure
evidencing NCT03928054 115 125 O
grade NCT03928054 126 131 B-Eq_Comparison
II NCT03928054 132 134 I-Eq_Comparison
or NCT03928054 135 137 I-Eq_Comparison
III NCT03928054 138 141 I-Eq_Comparison
knee NCT03928054 142 146 B-Condition
osteoarthritis NCT03928054 147 161 I-Condition
according NCT03928054 162 171 O
to NCT03928054 172 174 O
the NCT03928054 175 178 O
Kellgren NCT03928054 179 187 O
and NCT03928054 188 191 O
Lawrence NCT03928054 192 200 O
classification NCT03928054 201 215 O

- NCT03928054 218 219 O
who NCT03928054 221 224 O
were NCT03928054 225 229 O
referred NCT03928054 230 238 B-Encounter
to NCT03928054 239 241 O
the NCT03928054 242 245 O
physiotherapy NCT03928054 246 259 B-Provider
service NCT03928054 260 267 I-Provider
by NCT03928054 268 270 O
a NCT03928054 271 272 O
physician NCT03928054 273 282 B-Provider
. NCT03928054 283 284 O

Exclusion NCT03928054 286 295 O
Criteria NCT03928054 296 304 O
: NCT03928054 305 306 O

- NCT03928054 310 311 O
Patients NCT03928054 313 321 O
who NCT03928054 322 325 O
are NCT03928054 326 329 O
unable NCT03928054 330 336 B-Condition
to NCT03928054 337 339 I-Condition
walk NCT03928054 340 344 I-Condition

- NCT03928054 347 348 O
with NCT03928054 350 354 O
a NCT03928054 355 356 O
history NCT03928054 357 364 B-Eq_Comparison
of NCT03928054 365 367 O
cancer NCT03928054 368 374 B-Condition

- NCT03928054 377 378 O
associated NCT03928054 380 390 O
neurological NCT03928054 391 403 B-Condition
diseases NCT03928054 404 412 I-Condition

- NCT03928054 415 416 O
morbid NCT03928054 418 424 B-Condition
obesity NCT03928054 425 432 I-Condition

Inclusion NCT03869645 0 9 O
Criteria NCT03869645 10 18 O
: NCT03869645 19 20 O

- NCT03869645 24 25 O
Patients NCT03869645 27 35 O
who NCT03869645 36 39 O
are NCT03869645 40 43 O
> NCT03869645 44 45 B-Eq_Comparison
18 NCT03869645 46 48 I-Eq_Comparison
years NCT03869645 49 54 I-Eq_Comparison
of NCT03869645 55 57 O
age NCT03869645 58 61 B-Age

- NCT03869645 64 65 O
Patients NCT03869645 67 75 O
with NCT03869645 76 80 O
clinical NCT03869645 81 89 B-Assertion___Assertion_Type_Value:possible
signs NCT03869645 90 95 I-Assertion___Assertion_Type_Value:possible
, NCT03869645 96 97 O
symptoms NCT03869645 98 106 B-Assertion___Assertion_Type_Value:possible
and NCT03869645 107 110 B-And
presentation NCT03869645 111 123 B-Assertion___Assertion_Type_Value:possible
consistent NCT03869645 124 134 O
with NCT03869645 135 139 O
acute NCT03869645 140 145 O
thrombosis NCT03869645 146 156 B-Condition
; NCT03869645 156 157 O
onset NCT03869645 158 163 B-Eq_Comparison
of NCT03869645 164 166 O
symptoms NCT03869645 167 175 O
< NCT03869645 176 177 B-Eq_Comparison
14 NCT03869645 178 180 I-Eq_Comparison
days NCT03869645 181 185 I-Eq_Comparison

- NCT03869645 188 189 O
Patients NCT03869645 191 199 O
cleared NCT03869645 200 207 B-Assertion___Assertion_Type_Value:hypothetical
medically NCT03869645 208 217 I-Assertion___Assertion_Type_Value:hypothetical
for NCT03869645 218 221 I-Assertion___Assertion_Type_Value:hypothetical
invasive NCT03869645 222 230 B-Procedure
endovenous NCT03869645 231 241 I-Procedure
procedures NCT03869645 242 252 I-Procedure

Exclusion NCT03869645 253 262 O
Criteria NCT03869645 263 271 O
: NCT03869645 272 273 O

- NCT03869645 277 278 O
Patients NCT03869645 280 288 O
with NCT03869645 289 293 O
IVC NCT03869645 294 297 B-Procedure
filter NCT03869645 298 304 I-Procedure
in NCT03869645 305 307 O
area NCT03869645 308 312 B-Modifier
to NCT03869645 313 315 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03869645 316 318 I-Assertion___Assertion_Type_Value:hypothetical
treated NCT03869645 319 326 B-Procedure

- NCT03869645 329 330 O
Patients NCT03869645 332 340 O
who NCT03869645 341 344 O
are NCT03869645 345 348 O
< NCT03869645 349 350 B-Eq_Comparison
18 NCT03869645 351 353 I-Eq_Comparison
years NCT03869645 354 359 I-Eq_Comparison
of NCT03869645 360 362 O
age NCT03869645 363 366 B-Age
. NCT03869645 367 368 O

- NCT03869645 372 373 O
Known NCT03869645 375 380 O
anaphylactic NCT03869645 381 393 B-Condition
reaction NCT03869645 394 402 I-Condition
of NCT03869645 403 405 O
radiographic NCT03869645 406 418 B-Drug
contrast NCT03869645 419 427 I-Drug
agents NCT03869645 428 434 I-Drug
that NCT03869645 435 439 O
can NCT03869645 440 443 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03869645 443 446 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
be NCT03869645 447 449 O
pre NCT03869645 450 453 B-Procedure
- NCT03869645 454 455 I-Procedure
treated NCT03869645 456 463 I-Procedure

- NCT03869645 466 467 O
Imaging NCT03869645 469 476 B-Procedure
evidence NCT03869645 477 485 O
or NCT03869645 486 488 B-Or
other NCT03869645 489 494 B-Other
evidence NCT03869645 495 503 O
that NCT03869645 504 508 O
suggests NCT03869645 509 517 O
the NCT03869645 518 521 O
participant NCT03869645 522 533 O
is NCT03869645 534 536 O
not NCT03869645 537 540 B-Negation
appropriate NCT03869645 541 552 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03869645 553 556 O
mechanical NCT03869645 557 567 B-Procedure
thrombectomy NCT03869645 568 580 I-Procedure
intervention NCT03869645 581 593 I-Procedure

- NCT03869645 596 597 O
Female NCT03869645 599 605 O
who NCT03869645 606 609 B-And
is NCT03869645 610 612 O
pregnant NCT03869645 613 621 B-Condition
or NCT03869645 622 624 B-Or
nursing NCT03869645 625 632 B-Condition

- NCT03869645 635 636 O
Concurrent NCT03869645 638 648 B-Modifier
participation NCT03869645 649 662 O
in NCT03869645 663 665 O
another NCT03869645 666 673 B-Other
investigational NCT03869645 674 689 B-Study
drug NCT03869645 690 694 B-Drug
or NCT03869645 695 697 B-Or
device NCT03869645 698 704 B-Procedure
treatment NCT03869645 705 714 I-Procedure
study NCT03869645 715 720 B-Study

Inclusion NCT03924102 0 9 O
Criteria NCT03924102 10 18 O
: NCT03924102 19 20 O

- NCT03924102 24 25 O
At NCT03924102 27 29 B-Eq_Comparison
least NCT03924102 30 35 I-Eq_Comparison
18 NCT03924102 36 38 I-Eq_Comparison
years NCT03924102 39 44 I-Eq_Comparison
of NCT03924102 45 47 O
age NCT03924102 48 51 B-Age
. NCT03924102 52 53 O

- NCT03924102 57 58 O
Enrollment NCT03924102 60 70 O
in NCT03924102 71 73 O
the NCT03924102 74 77 O
UAB NCT03924102 78 81 O
CMC NCT03924102 82 85 O
- NCT03924102 86 87 O
ADHF NCT03924102 88 92 O
study NCT03924102 93 98 O
under NCT03924102 99 104 O
the NCT03924102 105 108 O
separate NCT03924102 109 117 O
UAB NCT03924102 118 121 O
approved NCT03924102 122 130 O
research NCT03924102 131 139 O
protocol NCT03924102 140 148 O
( NCT03924102 149 150 O
IRB NCT03924102 151 154 O
- NCT03924102 155 156 O
300000114 NCT03924102 157 166 O
, NCT03924102 167 168 O
PI NCT03924102 169 171 O
Rajapreyar NCT03924102 172 182 O
) NCT03924102 183 184 O

- NCT03924102 188 189 O
Negative NCT03924102 191 199 O
urine NCT03924102 200 205 O
or NCT03924102 206 208 B-Or
serum NCT03924102 209 214 O
β NCT03924102 215 216 B-Observation
- NCT03924102 217 218 I-Observation
hCG NCT03924102 219 222 I-Observation
test NCT03924102 223 227 I-Observation
within NCT03924102 228 234 B-Eq_Comparison
48 NCT03924102 235 237 I-Eq_Comparison
hours NCT03924102 238 243 I-Eq_Comparison
of NCT03924102 244 246 B-Temporal_Connection___Temporal_Connection_Type_Value:after
[ NCT03924102 247 248 O
11 NCT03924102 249 251 B-Modifier
C NCT03924102 252 253 I-Modifier
] NCT03924102 254 255 O
acetate NCT03924102 256 263 B-Drug
administration NCT03924102 264 278 I-Drug
in NCT03924102 279 281 B-And
women NCT03924102 282 287 O
of NCT03924102 288 290 B-And
child NCT03924102 291 296 B-Condition
bearing NCT03924102 297 304 I-Condition
potential NCT03924102 305 314 I-Condition
. NCT03924102 315 316 O
Women NCT03924102 318 323 O
who NCT03924102 324 327 B-And
are NCT03924102 328 331 O
post NCT03924102 332 336 B-Condition
- NCT03924102 337 338 I-Condition
menopausal NCT03924102 339 349 I-Condition
with NCT03924102 350 354 B-And
at NCT03924102 355 357 B-Eq_Comparison
least NCT03924102 358 363 I-Eq_Comparison
1 NCT03924102 364 365 I-Eq_Comparison
year NCT03924102 366 370 I-Eq_Comparison
since NCT03924102 371 376 B-Temporal_Connection___Temporal_Connection_Type_Value:after
last NCT03924102 377 381 B-Eq_Comparison
menses NCT03924102 382 388 B-Condition
or NCT03924102 389 391 B-Or
documented NCT03924102 392 402 O
surgical NCT03924102 403 411 B-Procedure
sterilization NCT03924102 412 425 I-Procedure
will NCT03924102 426 430 O
not NCT03924102 431 434 B-Negation
require NCT03924102 435 442 B-Assertion___Assertion_Type_Value:hypothetical
pregnancy NCT03924102 443 452 B-Observation
testing NCT03924102 453 460 I-Observation
. NCT03924102 461 462 O

Exclusion NCT03924102 464 473 O
Criteria NCT03924102 474 482 O
: NCT03924102 483 484 O

- NCT03924102 488 489 O
Inability NCT03924102 491 500 O
to NCT03924102 501 503 O
provide NCT03924102 504 511 O
informed NCT03924102 512 520 O
consent NCT03924102 521 528 O

- NCT03924102 531 532 O
Pregnancy NCT03924102 534 543 B-Condition

- NCT03924102 546 547 O
Inability NCT03924102 549 558 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03924102 559 561 O
lie NCT03924102 562 565 O
still NCT03924102 566 571 O
for NCT03924102 572 575 O
the NCT03924102 576 579 O
imaging NCT03924102 580 587 B-Procedure
study NCT03924102 588 593 I-Procedure

- NCT03924102 596 597 O
Weight NCT03924102 599 605 B-Observation
exceeding NCT03924102 606 615 O
the NCT03924102 616 619 O
weight NCT03924102 620 626 O
limit NCT03924102 627 632 O
of NCT03924102 633 635 O
the NCT03924102 636 639 O
PET NCT03924102 640 643 B-Procedure
imaging NCT03924102 644 651 I-Procedure
table NCT03924102 652 657 I-Procedure
( NCT03924102 658 659 O
500 NCT03924102 660 663 B-Eq_Comparison
pounds NCT03924102 664 670 I-Eq_Comparison
) NCT03924102 671 672 O
. NCT03924102 673 674 O

Minimum NCT03862105 0 7 B-Eq_Comparison
Age NCT03862105 8 11 I-Eq_Comparison
: NCT03862105 12 13 I-Eq_Comparison
18 NCT03862105 14 16 I-Eq_Comparison
Years NCT03862105 17 22 I-Eq_Comparison
Maximum NCT03862105 23 30 B-Eq_Comparison
Age NCT03862105 31 34 I-Eq_Comparison
: NCT03862105 35 36 I-Eq_Comparison
99 NCT03862105 37 39 I-Eq_Comparison
Years NCT03862105 40 45 I-Eq_Comparison
Sex NCT03862105 46 49 O
: NCT03862105 50 51 O
All NCT03862105 52 55 O
Gender NCT03862105 56 62 O
Based NCT03862105 63 68 O
: NCT03862105 69 70 O
No NCT03862105 71 73 O

Criteria NCT03862105 74 82 O
: NCT03862105 83 84 O
Inclusion NCT03862105 85 94 O
Criteria NCT03862105 95 103 O
: NCT03862105 104 105 O

- NCT03862105 109 110 O
Male NCT03862105 112 116 O
or NCT03862105 117 119 B-Or
female NCT03862105 120 126 O
patients NCT03862105 127 135 O
with NCT03862105 136 140 B-And
invasive NCT03862105 141 149 B-Modifier
bladder NCT03862105 150 157 I-Modifier
cancer NCT03862105 158 164 B-Condition
scheduled NCT03862105 165 174 B-Eq_Comparison
for NCT03862105 175 178 O
radical NCT03862105 179 186 B-Procedure
cystectomy NCT03862105 187 197 I-Procedure
at NCT03862105 198 200 O
UNC NCT03862105 201 204 O
within NCT03862105 205 211 B-Eq_Comparison
the NCT03862105 212 215 I-Eq_Comparison
next NCT03862105 216 220 I-Eq_Comparison
30 NCT03862105 221 223 I-Eq_Comparison
days NCT03862105 224 228 I-Eq_Comparison

- NCT03862105 231 232 O
English NCT03862105 234 241 O
- NCT03862105 242 243 O
speaking NCT03862105 244 252 O

- NCT03862105 255 256 O
Ability NCT03862105 258 265 O
to NCT03862105 266 268 O
access NCT03862105 269 275 O
the NCT03862105 276 279 O
Internet NCT03862105 280 288 O
( NCT03862105 289 290 O
either NCT03862105 291 297 O
themselves NCT03862105 298 308 O
or NCT03862105 309 311 O
with NCT03862105 312 316 O
assistance NCT03862105 317 327 O
from NCT03862105 328 332 O
their NCT03862105 333 338 O
caregiver NCT03862105 339 348 O
) NCT03862105 349 350 O

- NCT03862105 354 355 O
Ability NCT03862105 357 364 O
to NCT03862105 365 367 O
read NCT03862105 368 372 O

- NCT03862105 375 376 O
Ability NCT03862105 378 385 O
to NCT03862105 386 388 O
provide NCT03862105 389 396 O
informed NCT03862105 397 405 O
consent NCT03862105 406 413 O
. NCT03862105 414 415 O

Exclusion NCT03862105 417 426 O
Criteria NCT03862105 427 435 O
: NCT03862105 436 437 O

- NCT03862105 441 442 O
Inability NCT03862105 444 453 O
to NCT03862105 454 456 O
read NCT03862105 457 461 O

- NCT03862105 464 465 O
Inability NCT03862105 467 476 O
to NCT03862105 477 479 O
provide NCT03862105 480 487 O
informed NCT03862105 488 496 O
consent NCT03862105 497 504 O

- NCT03862105 507 508 O
Severe NCT03862105 510 516 O
psychiatric NCT03862105 517 528 B-Condition
illness NCT03862105 529 536 I-Condition

- NCT03862105 539 540 O
Cystectomy NCT03862105 542 552 B-Procedure
surgery NCT03862105 553 560 I-Procedure
without NCT03862105 561 568 B-Negation
cancer NCT03862105 569 575 B-Condition
diagnosis NCT03862105 576 585 O

- NCT03862105 588 589 O
Non NCT03862105 591 594 B-Negation
- NCT03862105 595 596 O
English NCT03862105 597 604 O
speaking NCT03862105 605 613 O

Inclusion NCT03926403 0 9 O
Criteria NCT03926403 10 18 O
: NCT03926403 19 20 O

- NCT03926403 24 25 O
Patient NCT03926403 27 34 O
treated NCT03926403 35 42 B-Eq_Comparison
under NCT03926403 43 48 O
local NCT03926403 49 54 B-Procedure
anaesthesia NCT03926403 55 66 I-Procedure
in NCT03926403 67 69 O
the NCT03926403 70 73 O
Maxillo NCT03926403 74 81 O
Facial NCT03926403 82 88 O
Surgery NCT03926403 89 96 O
department NCT03926403 97 107 O
with NCT03926403 108 112 O
ultra NCT03926403 113 118 B-Procedure
- NCT03926403 119 120 I-Procedure
short NCT03926403 121 126 I-Procedure
circuit NCT03926403 127 134 I-Procedure

- NCT03926403 137 138 O
Patient NCT03926403 140 147 O
undergoing NCT03926403 148 158 B-Eq_Comparison
face NCT03926403 159 163 B-Modifier
surgery NCT03926403 164 171 B-Procedure

- NCT03926403 174 175 O
Patient NCT03926403 177 184 O
who NCT03926403 185 188 O
has NCT03926403 189 192 O
received NCT03926403 193 201 B-Eq_Comparison
appropriate NCT03926403 202 213 O
information NCT03926403 214 225 O
and NCT03926403 226 229 O
has NCT03926403 230 233 O
provided NCT03926403 234 242 O
informed NCT03926403 243 251 O
consent NCT03926403 252 259 O

- NCT03926403 262 263 O
Adult NCT03926403 265 270 O
patient NCT03926403 271 278 O
≥ NCT03926403 279 280 B-Eq_Comparison
18 NCT03926403 281 283 I-Eq_Comparison
years NCT03926403 284 289 I-Eq_Comparison
old NCT03926403 290 293 B-Age

- NCT03926403 296 297 O
Patient NCT03926403 299 306 O
with NCT03926403 307 311 O
a NCT03926403 312 313 O
score NCT03926403 314 319 O
of NCT03926403 320 322 O
≥ NCT03926403 323 324 B-Eq_Comparison
46 NCT03926403 325 327 I-Eq_Comparison
on NCT03926403 328 330 O
the NCT03926403 331 334 O
initial NCT03926403 335 342 B-Eq_Comparison
anxiety NCT03926403 343 350 B-Observation
self NCT03926403 351 355 I-Observation
- NCT03926403 356 357 I-Observation
assessment NCT03926403 358 368 I-Observation
questionnaire NCT03926403 369 382 I-Observation

Exclusion NCT03926403 383 392 O
Criteria NCT03926403 393 401 O
: NCT03926403 402 403 O

- NCT03926403 407 408 O
Patient NCT03926403 410 417 O
under NCT03926403 418 423 O
general NCT03926403 424 431 B-Procedure
anaesthesia NCT03926403 432 443 I-Procedure

- NCT03926403 446 447 O
Patients NCT03926403 449 457 O
treated NCT03926403 458 465 B-Eq_Comparison
in NCT03926403 466 468 O
conventional NCT03926403 469 481 O
inpatient NCT03926403 482 491 B-Encounter
care NCT03926403 492 496 I-Encounter
or NCT03926403 497 499 B-Or
in NCT03926403 500 502 O
the NCT03926403 503 506 O
traditional NCT03926403 507 518 O
ambulatory NCT03926403 519 529 B-Encounter
circuit NCT03926403 530 537 I-Encounter

- NCT03926403 540 541 O
Patient NCT03926403 543 550 O
under NCT03926403 551 556 B-Observation
guardianship NCT03926403 557 569 I-Observation
or NCT03926403 570 572 B-Or
trusteeship NCT03926403 573 584 B-Observation

- NCT03926403 587 588 O
Minor NCT03926403 590 595 O
patient NCT03926403 596 603 O
< NCT03926403 604 605 B-Eq_Comparison
18 NCT03926403 606 608 I-Eq_Comparison
years NCT03926403 609 614 I-Eq_Comparison
of NCT03926403 615 617 O
age NCT03926403 618 621 B-Age

- NCT03926403 624 625 O
Patient NCT03926403 627 634 O
who NCT03926403 635 638 O
has NCT03926403 639 642 O
not NCT03926403 643 646 O
provided NCT03926403 647 655 O
informed NCT03926403 656 664 O
consent NCT03926403 665 672 O
or NCT03926403 673 675 O
who NCT03926403 676 679 O
can NCT03926403 680 683 O
not NCT03926403 683 686 O
submit NCT03926403 687 693 O
to NCT03926403 694 696 O
the NCT03926403 697 700 O
study NCT03926403 701 706 O
protocol NCT03926403 707 715 O

- NCT03926403 718 719 O
Patient NCT03926403 721 728 O
suffering NCT03926403 729 738 O
from NCT03926403 739 743 O
cognitive NCT03926403 744 753 B-Condition
disorders NCT03926403 754 763 I-Condition
( NCT03926403 764 765 O
ex NCT03926403 766 768 O
: NCT03926403 769 770 O
Alzheimer NCT03926403 771 780 B-Condition
's NCT03926403 780 782 I-Condition
disease NCT03926403 783 790 I-Condition
) NCT03926403 791 792 O

- NCT03926403 796 797 O
Patients NCT03926403 799 807 O
who NCT03926403 808 811 O
are NCT03926403 812 815 O
deaf NCT03926403 816 820 B-Condition
or NCT03926403 821 823 B-Or
hearing NCT03926403 824 831 B-Condition
- NCT03926403 832 833 I-Condition
impaired NCT03926403 834 842 I-Condition

Inclusion NCT03920319 0 9 O
Criteria NCT03920319 10 18 O
: NCT03920319 19 20 O

- NCT03920319 24 25 O
Treatment NCT03920319 27 36 B-Procedure
- NCT03920319 37 38 O
seeking NCT03920319 39 46 B-Assertion___Assertion_Type_Value:intention
cigarette NCT03920319 47 56 B-Condition
smoker NCT03920319 57 63 I-Condition

- NCT03920319 66 67 O
Meet NCT03920319 69 73 O
DSM NCT03920319 74 77 O
- NCT03920319 78 79 O
IV NCT03920319 80 82 O
criteria NCT03920319 83 91 O
for NCT03920319 92 95 O
nicotine NCT03920319 96 104 B-Condition
dependence NCT03920319 105 115 I-Condition

- NCT03920319 118 119 O
Negative NCT03920319 121 129 O
result NCT03920319 130 136 O
on NCT03920319 137 139 O
urine NCT03920319 140 145 B-Observation
test NCT03920319 146 150 I-Observation
for NCT03920319 151 154 I-Observation
drug NCT03920319 155 159 I-Observation
use NCT03920319 160 163 I-Observation
during NCT03920319 164 170 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03920319 171 180 B-Study

Exclusion NCT03920319 181 190 O
Criteria NCT03920319 191 199 O
: NCT03920319 200 201 O

- NCT03920319 205 206 O
History NCT03920319 208 215 B-Eq_Comparison
of NCT03920319 216 218 O
any NCT03920319 219 222 O
Axis NCT03920319 223 227 B-Eq_Comparison
I NCT03920319 228 229 I-Eq_Comparison
psychiatric NCT03920319 230 241 B-Condition
diagnosis NCT03920319 242 251 I-Condition
other NCT03920319 252 257 B-Exception
than NCT03920319 258 262 I-Exception
nicotine NCT03920319 263 271 B-Condition
dependence NCT03920319 272 282 I-Condition

- NCT03920319 285 286 O
Medical NCT03920319 288 295 B-Condition
conditions NCT03920319 296 306 I-Condition
that NCT03920319 307 311 O
might NCT03920319 312 317 B-Assertion___Assertion_Type_Value:possible
affect NCT03920319 318 324 O
brain NCT03920319 325 330 B-Observation
function NCT03920319 331 339 I-Observation

- NCT03920319 342 343 O
Current NCT03920319 345 352 B-Eq_Comparison
use NCT03920319 353 356 O
of NCT03920319 357 359 O
medications NCT03920319 360 371 B-Drug
that NCT03920319 372 376 O
could NCT03920319 377 382 B-Assertion___Assertion_Type_Value:possible
alter NCT03920319 383 388 O
brain NCT03920319 389 394 B-Observation
function NCT03920319 395 403 I-Observation

- NCT03920319 406 407 O
Pregnancy NCT03920319 409 418 B-Condition

- NCT03920319 421 422 O
Current NCT03920319 424 431 B-Eq_Comparison
illicit NCT03920319 432 439 B-Condition
drug NCT03920319 440 444 I-Condition
use NCT03920319 445 448 I-Condition
other NCT03920319 449 454 B-Exception
than NCT03920319 455 459 I-Exception
occasional NCT03920319 460 470 O
use NCT03920319 471 474 O
of NCT03920319 475 477 O
marijuana NCT03920319 478 487 B-Condition

Inclusion NCT03860480 0 9 O
Criteria NCT03860480 10 18 O
: NCT03860480 19 20 O

• NCT03860480 22 23 O
Patients NCT03860480 24 32 O
> NCT03860480 33 34 B-Eq_Comparison
18 NCT03860480 35 37 I-Eq_Comparison
years NCT03860480 38 43 I-Eq_Comparison
old NCT03860480 44 47 B-Age
with NCT03860480 48 52 B-And
to NCT03860480 53 55 O
ASA NCT03860480 56 59 B-Observation
status NCT03860480 60 66 O
I NCT03860480 67 68 B-Eq_Comparison
- NCT03860480 69 70 I-Eq_Comparison
III NCT03860480 71 74 I-Eq_Comparison
, NCT03860480 75 76 O
undergoing NCT03860480 77 87 B-Eq_Comparison
VATS NCT03860480 88 92 B-Procedure
for NCT03860480 93 96 O
lobectomy NCT03860480 97 106 B-Procedure
or NCT03860480 107 109 B-Or
wedge NCT03860480 110 115 B-Procedure
. NCT03860480 116 117 O

Non NCT03860480 119 122 O
- NCT03860480 123 124 O
inclusion NCT03860480 125 134 O
Criteria NCT03860480 135 143 O
: NCT03860480 144 145 O

- NCT03860480 149 150 O
< NCT03860480 152 153 B-Eq_Comparison
18 NCT03860480 154 156 I-Eq_Comparison
years NCT03860480 157 162 I-Eq_Comparison
old NCT03860480 163 166 B-Age

- NCT03860480 169 170 O
BMI NCT03860480 172 175 B-Observation
> NCT03860480 176 177 B-Eq_Comparison
35 NCT03860480 178 180 I-Eq_Comparison

- NCT03860480 184 185 O
Chronic NCT03860480 187 194 O
pain NCT03860480 195 199 B-Condition
history NCT03860480 200 207 B-Eq_Comparison
with NCT03860480 208 212 B-And
regular NCT03860480 213 220 O
opioid NCT03860480 221 227 B-Drug
and NCT03860480 228 231 B-Or
/ NCT03860480 232 233 I-Or
or NCT03860480 234 236 I-Or
gabapentinoids NCT03860480 237 251 B-Drug
use NCT03860480 252 255 O
during NCT03860480 256 262 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860480 263 266 O
2 NCT03860480 267 268 B-Eq_Comparison
weeks NCT03860480 269 274 I-Eq_Comparison
before NCT03860480 275 281 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03860480 282 289 B-Procedure

- NCT03860480 292 293 O
Regular NCT03860480 295 302 B-Eq_Comparison
marijuana NCT03860480 303 312 B-Drug
use NCT03860480 313 316 O

- NCT03860480 319 320 O
History NCT03860480 322 329 B-Eq_Comparison
of NCT03860480 330 332 O
thoracic NCT03860480 333 341 B-Procedure
surgery NCT03860480 342 349 I-Procedure
on NCT03860480 350 352 O
the NCT03860480 353 356 O
operated NCT03860480 357 365 B-Modifier
side NCT03860480 366 370 I-Modifier

- NCT03860480 373 374 O
Epidural NCT03860480 376 384 B-Procedure
analgesia NCT03860480 385 394 I-Procedure
preferred NCT03860480 395 404 B-Assertion___Assertion_Type_Value:hypothetical
due NCT03860480 405 408 O
to NCT03860480 409 411 O
an NCT03860480 412 414 O
anticipated NCT03860480 415 426 B-Assertion___Assertion_Type_Value:hypothetical
high NCT03860480 427 431 O
risk NCT03860480 432 436 B-Risk
of NCT03860480 437 439 O
conversion NCT03860480 440 450 B-Modifier
to NCT03860480 451 453 O
thoracotomy NCT03860480 454 465 B-Procedure

- NCT03860480 468 469 O
Unable NCT03860480 471 477 B-Condition
to NCT03860480 478 480 I-Condition
communicate NCT03860480 481 492 I-Condition
with NCT03860480 493 497 O
the NCT03860480 498 501 O
investigators NCT03860480 502 515 O

- NCT03860480 518 519 O
Receiving NCT03860480 521 530 B-Eq_Comparison
anticoagulation NCT03860480 531 546 B-Procedure
or NCT03860480 547 549 B-Or
experiencing NCT03860480 550 562 B-Eq_Comparison
any NCT03860480 563 566 O
bleeding NCT03860480 567 575 B-Condition
disorder NCT03860480 576 584 I-Condition

- NCT03860480 587 588 O
Surgery NCT03860480 590 597 B-Procedure
for NCT03860480 598 601 O
empyema NCT03860480 602 609 B-Condition
and NCT03860480 610 613 B-Or
sympathectomy NCT03860480 614 627 B-Procedure

- NCT03860480 630 631 O
Known NCT03860480 633 638 O
allergy NCT03860480 639 646 B-Allergy
to NCT03860480 647 649 O
local NCT03860480 650 655 B-Procedure
anesthetics NCT03860480 656 667 I-Procedure
, NCT03860480 668 669 O
fentanyl NCT03860480 670 678 B-Drug
or NCT03860480 679 681 B-Or
hydromorphone NCT03860480 682 695 B-Drug

- NCT03860480 698 699 O
Active NCT03860480 701 707 B-Eq_Comparison
infection NCT03860480 708 717 B-Condition
at NCT03860480 718 720 O
injection NCT03860480 721 730 B-Modifier
sites NCT03860480 731 736 I-Modifier

- NCT03860480 739 740 O
Preexisting NCT03860480 742 753 B-Eq_Comparison
neurological NCT03860480 754 766 B-Condition
deficit NCT03860480 767 774 I-Condition
or NCT03860480 775 777 B-Or
psychiatric NCT03860480 778 789 B-Condition
illness NCT03860480 790 797 I-Condition

- NCT03860480 800 801 O
Severe NCT03860480 803 809 O
cardiovascular NCT03860480 810 824 B-Condition
disease NCT03860480 825 832 I-Condition

- NCT03860480 835 836 O
Liver NCT03860480 838 843 B-Condition
failure NCT03860480 844 851 I-Condition

- NCT03860480 854 855 O
Renal NCT03860480 857 862 B-Condition
failure NCT03860480 863 870 I-Condition
( NCT03860480 871 872 O
estimated NCT03860480 873 882 B-Observation
glomerular NCT03860480 883 893 I-Observation
filtration NCT03860480 894 904 I-Observation
rate NCT03860480 905 909 I-Observation
< NCT03860480 910 911 B-Eq_Comparison
15 NCT03860480 912 914 I-Eq_Comparison
mL NCT03860480 915 917 I-Eq_Comparison
/ NCT03860480 918 919 I-Eq_Comparison
min NCT03860480 920 923 I-Eq_Comparison
/ NCT03860480 924 925 I-Eq_Comparison
1.73 NCT03860480 926 930 I-Eq_Comparison
m NCT03860480 931 932 I-Eq_Comparison
2 NCT03860480 933 934 I-Eq_Comparison
) NCT03860480 935 936 O

- NCT03860480 940 941 O
Pregnancy NCT03860480 943 952 B-Condition

Exclusion NCT03860480 953 962 O
Criteria NCT03860480 963 971 O
: NCT03860480 972 973 O

- NCT03860480 977 978 O
Peri NCT03860480 980 984 B-Temporal_Connection___Temporal_Connection_Type_Value:during
operative NCT03860480 985 994 B-Procedure
conversion NCT03860480 995 1005 B-Modifier
to NCT03860480 1006 1008 O
thoracotomy NCT03860480 1009 1020 B-Procedure

- NCT03860480 1023 1024 O
Severe NCT03860480 1026 1032 O
intra NCT03860480 1033 1038 B-Temporal_Connection___Temporal_Connection_Type_Value:during
- NCT03860480 1039 1040 I-Temporal_Connection___Temporal_Connection_Type_Value:during
or NCT03860480 1041 1043 B-Or
post NCT03860480 1044 1048 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03860480 1049 1058 B-Procedure
bleeding NCT03860480 1059 1067 B-Condition

- NCT03860480 1070 1071 O
Patients NCT03860480 1073 1081 O
requiring NCT03860480 1082 1091 B-Assertion___Assertion_Type_Value:hypothetical
post NCT03860480 1092 1096 B-Temporal_Connection___Temporal_Connection_Type_Value:after
operative NCT03860480 1097 1106 B-Procedure
mechanical NCT03860480 1107 1117 B-Procedure
ventilation NCT03860480 1118 1129 I-Procedure

- NCT03860480 1132 1133 O
Technical NCT03860480 1135 1144 O
inability NCT03860480 1145 1154 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03860480 1155 1157 O
proceed NCT03860480 1158 1165 O
with NCT03860480 1166 1170 O
the NCT03860480 1171 1174 O
blocks NCT03860480 1175 1181 O

Inclusion NCT03869047 0 9 O
Criteria NCT03869047 10 18 O
: NCT03869047 19 20 O

- NCT03869047 24 25 O
physical NCT03869047 27 35 O
status NCT03869047 36 42 O
American NCT03869047 43 51 B-Observation
Society NCT03869047 52 59 I-Observation
of NCT03869047 60 62 I-Observation
Anesthesiologist NCT03869047 63 79 I-Observation
( NCT03869047 80 81 O
ASA NCT03869047 82 85 B-Observation
) NCT03869047 86 87 O
I NCT03869047 88 89 B-Eq_Comparison
or NCT03869047 90 92 I-Eq_Comparison
II NCT03869047 93 95 I-Eq_Comparison

Exclusion NCT03869047 96 105 O
Criteria NCT03869047 106 114 O
: NCT03869047 115 116 O

- NCT03869047 120 121 O
Patients NCT03869047 123 131 O
refusal NCT03869047 132 139 O

- NCT03869047 142 143 O
A NCT03869047 145 146 O
body NCT03869047 147 151 B-Observation
mass NCT03869047 152 156 I-Observation
index NCT03869047 157 162 I-Observation
( NCT03869047 163 164 O
BMI NCT03869047 165 168 B-Observation
) NCT03869047 169 170 O
> NCT03869047 171 172 B-Eq_Comparison
30 NCT03869047 173 175 I-Eq_Comparison
kg NCT03869047 176 178 I-Eq_Comparison
/ NCT03869047 179 180 I-Eq_Comparison
m NCT03869047 181 182 I-Eq_Comparison
2 NCT03869047 183 184 I-Eq_Comparison

- NCT03869047 187 188 O
ASA NCT03869047 190 193 B-Observation
physical NCT03869047 194 202 O
status NCT03869047 203 209 O
> NCT03869047 210 211 B-Eq_Comparison
II NCT03869047 212 214 I-Eq_Comparison

- NCT03869047 217 218 O
major NCT03869047 220 225 O
illnesses NCT03869047 226 235 B-Condition
( NCT03869047 236 237 O
e NCT03869047 238 239 O
. NCT03869047 240 241 O
g NCT03869047 242 243 O
. NCT03869047 244 245 O
, NCT03869047 246 247 O
cardiac NCT03869047 248 255 B-Modifier
, NCT03869047 256 257 O
respiratory NCT03869047 258 269 B-Modifier
, NCT03869047 270 271 O
renal NCT03869047 272 277 B-Modifier
, NCT03869047 278 279 O
hepatic NCT03869047 280 287 B-Modifier
or NCT03869047 288 290 B-Or
neurological NCT03869047 291 303 B-Modifier
) NCT03869047 304 305 O

- NCT03869047 309 310 O
Coagulation NCT03869047 312 323 B-Condition
abnormalities NCT03869047 324 337 O

- NCT03869047 340 341 O
Infection NCT03869047 343 352 B-Condition
at NCT03869047 353 355 O
the NCT03869047 356 359 O
injection NCT03869047 360 369 B-Procedure
site NCT03869047 370 374 B-Modifier

- NCT03869047 377 378 O
Allergy NCT03869047 380 387 B-Allergy
or NCT03869047 388 390 B-Or
contraindications NCT03869047 391 408 B-Contraindication
to NCT03869047 409 411 O
the NCT03869047 412 415 O
drugs NCT03869047 416 421 B-Drug
used NCT03869047 422 426 O
in NCT03869047 427 429 O
the NCT03869047 430 433 O
study NCT03869047 434 439 B-Study

- NCT03869047 442 443 O
History NCT03869047 445 452 B-Eq_Comparison
of NCT03869047 453 455 O
drug NCT03869047 456 460 B-Condition
addiction NCT03869047 461 470 I-Condition
or NCT03869047 471 473 B-Or
alcohol NCT03869047 474 481 B-Condition
abuse NCT03869047 482 487 I-Condition

- NCT03869047 490 491 O
A NCT03869047 493 494 O
psychiatric NCT03869047 495 506 B-Condition
illness NCT03869047 507 514 I-Condition
, NCT03869047 515 516 O
or NCT03869047 517 519 B-Or
mental NCT03869047 520 526 B-Condition
retardation NCT03869047 527 538 I-Condition
interfering NCT03869047 539 550 B-Assertion___Assertion_Type_Value:hypothetical
with NCT03869047 551 555 O
the NCT03869047 556 559 O
evaluation NCT03869047 560 570 O
of NCT03869047 571 573 O
pain NCT03869047 574 578 B-Observation
scores NCT03869047 579 585 I-Observation
or NCT03869047 586 588 B-Or
PCA NCT03869047 589 592 B-Procedure
programs NCT03869047 593 601 I-Procedure
. NCT03869047 602 603 O

Inclusion NCT03928652 0 9 O
Criteria NCT03928652 10 18 O
: NCT03928652 19 20 O

1 NCT03928652 24 25 O
. NCT03928652 25 26 O
Colon NCT03928652 28 33 B-Modifier
or NCT03928652 34 36 B-Or
rectal NCT03928652 37 43 B-Modifier
cancer NCT03928652 44 50 B-Condition
diagnosed NCT03928652 51 60 O
by NCT03928652 61 63 O
endoscopic NCT03928652 64 74 B-Procedure
biopsy NCT03928652 75 81 I-Procedure
histopathology NCT03928652 82 96 I-Procedure
; NCT03928652 96 97 O

2 NCT03928652 100 101 O
. NCT03928652 101 102 O
Complete NCT03928652 104 112 O
sample NCT03928652 113 119 B-Observation
information NCT03928652 120 131 O
, NCT03928652 132 133 O
including NCT03928652 134 143 O
sample NCT03928652 144 150 O
number NCT03928652 151 157 O
, NCT03928652 158 159 O
gender NCT03928652 160 166 O
, NCT03928652 167 168 O
age NCT03928652 169 172 O
and NCT03928652 173 176 O
clinical NCT03928652 177 185 O
molecular NCT03928652 186 195 O
diagnostic NCT03928652 196 206 O
information NCT03928652 207 218 O
, NCT03928652 219 220 O
etc NCT03928652 221 224 O
. NCT03928652 225 226 O
; NCT03928652 227 228 O

3 NCT03928652 231 232 O
. NCT03928652 232 233 O
Sufficient NCT03928652 235 245 O
surgical NCT03928652 246 254 B-Observation
tissue NCT03928652 255 261 I-Observation
samples NCT03928652 262 269 O
are NCT03928652 270 273 O
available NCT03928652 274 283 O
for NCT03928652 284 287 B-Assertion___Assertion_Type_Value:hypothetical
testing NCT03928652 288 295 B-Observation
; NCT03928652 295 296 O

4 NCT03928652 299 300 O
. NCT03928652 300 301 O
untreated NCT03928652 303 312 B-Negation|B-Procedure
colon NCT03928652 313 318 B-Modifier
or NCT03928652 319 321 B-Or
rectal NCT03928652 322 328 B-Modifier
cancer NCT03928652 329 335 B-Condition
patients NCT03928652 336 344 O
; NCT03928652 344 345 O

5 NCT03928652 348 349 O
. NCT03928652 349 350 O
Patient NCT03928652 352 359 O
able NCT03928652 360 364 O
to NCT03928652 365 367 O
understand NCT03928652 368 378 O
and NCT03928652 379 382 O
sign NCT03928652 383 387 O
written NCT03928652 388 395 O
informed NCT03928652 396 404 O
consent NCT03928652 405 412 O

6 NCT03928652 415 416 O
. NCT03928652 416 417 O
No NCT03928652 419 421 B-Negation
evidence NCT03928652 422 430 O
of NCT03928652 431 433 O
distant NCT03928652 434 441 B-Condition
metastasis NCT03928652 442 452 I-Condition
( NCT03928652 453 454 O
M NCT03928652 455 456 O
0 NCT03928652 457 458 O
) NCT03928652 459 460 O

Exclusion NCT03928652 462 471 O
Criteria NCT03928652 472 480 O
: NCT03928652 481 482 O

1 NCT03928652 486 487 O
. NCT03928652 487 488 O
Previously NCT03928652 490 500 B-Eq_Comparison
treated NCT03928652 501 508 B-Procedure
CRC NCT03928652 509 512 B-Condition
, NCT03928652 513 514 O
including NCT03928652 515 524 O
cytotoxic NCT03928652 525 534 B-Drug
drug NCT03928652 535 539 I-Drug
therapy NCT03928652 540 547 I-Drug
, NCT03928652 548 549 O
targeted NCT03928652 550 558 B-Procedure
drug NCT03928652 559 563 I-Procedure
therapy NCT03928652 564 571 I-Procedure
, NCT03928652 572 573 O
etc NCT03928652 574 577 O
. NCT03928652 578 579 O
; NCT03928652 580 581 O

2 NCT03928652 584 585 O
. NCT03928652 585 586 O
Other NCT03928652 588 593 B-Other
malignant NCT03928652 594 603 B-Condition
tumors NCT03928652 604 610 I-Condition
; NCT03928652 610 611 O

3 NCT03928652 614 615 O
. NCT03928652 615 616 O
Pregnant NCT03928652 618 626 B-Condition
women NCT03928652 627 632 O
; NCT03928652 632 633 O

4 NCT03928652 636 637 O
. NCT03928652 637 638 O
Hereditary NCT03928652 640 650 B-Family_Member
colorectal NCT03928652 651 661 B-Modifier
cancer NCT03928652 662 668 B-Condition
linked NCT03928652 669 675 O
to NCT03928652 676 678 O
familial NCT03928652 679 687 B-Condition
colonic NCT03928652 688 695 I-Condition
polyposis NCT03928652 696 705 I-Condition
or NCT03928652 706 708 B-Or
Lynch NCT03928652 709 714 B-Condition
syndrome NCT03928652 715 723 I-Condition

Inclusion NCT03925883 0 9 O
Criteria NCT03925883 10 18 O
: NCT03925883 19 20 O

- NCT03925883 24 25 O
Positive NCT03925883 27 35 O
FIT NCT03925883 36 39 B-Observation
test NCT03925883 40 44 I-Observation

Exclusion NCT03925883 45 54 O
Criteria NCT03925883 55 63 O
: NCT03925883 64 65 O

- NCT03925883 69 70 O
Prior NCT03925883 72 77 B-Eq_Comparison
colorectal NCT03925883 78 88 B-Modifier
cancer NCT03925883 89 95 B-Condition

- NCT03925883 98 99 O
Dialysis NCT03925883 101 109 B-Procedure
patient NCT03925883 110 117 O

Inclusion NCT03863366 0 9 O
Criteria NCT03863366 10 18 O
: NCT03863366 19 20 O

- NCT03863366 24 25 O
Male NCT03863366 27 31 O
or NCT03863366 32 34 B-Or
female NCT03863366 35 41 O

- NCT03863366 44 45 O
Aged NCT03863366 47 51 B-Age
18 NCT03863366 52 54 B-Eq_Comparison
- NCT03863366 55 56 I-Eq_Comparison
40 NCT03863366 57 59 I-Eq_Comparison
years NCT03863366 60 65 I-Eq_Comparison

- NCT03863366 68 69 O
Willing NCT03863366 71 78 O
and NCT03863366 79 82 O
able NCT03863366 83 87 O
to NCT03863366 88 90 O
give NCT03863366 91 95 O
informed NCT03863366 96 104 O
consent NCT03863366 105 112 O
for NCT03863366 113 116 O
participation NCT03863366 117 130 O
in NCT03863366 131 133 O
the NCT03863366 134 137 O
study NCT03863366 138 143 O

- NCT03863366 146 147 O
Sufficiently NCT03863366 149 161 O
fluent NCT03863366 162 168 O
English NCT03863366 169 176 O
to NCT03863366 177 179 O
understand NCT03863366 180 190 O
and NCT03863366 191 194 O
complete NCT03863366 195 203 O
the NCT03863366 204 207 O
task NCT03863366 208 212 O

Exclusion NCT03863366 213 222 O
Criteria NCT03863366 223 231 O
: NCT03863366 232 233 O

- NCT03863366 237 238 O
Current NCT03863366 240 247 B-Eq_Comparison
usage NCT03863366 248 253 O
of NCT03863366 254 256 O
psychoactive NCT03863366 257 269 B-Drug
medication NCT03863366 270 280 I-Drug
( NCT03863366 281 282 O
except NCT03863366 283 289 B-Exception
the NCT03863366 290 293 O
contraceptive NCT03863366 294 307 B-Drug
pill NCT03863366 308 312 I-Drug
, NCT03863366 313 314 O
the NCT03863366 315 318 O
Depo NCT03863366 319 323 B-Drug
- NCT03863366 324 325 I-Drug
Provera NCT03863366 326 333 I-Drug
injection NCT03863366 334 343 O
or NCT03863366 344 346 B-Or
the NCT03863366 347 350 O
progesterone NCT03863366 351 363 B-Procedure
implant NCT03863366 364 371 I-Procedure
) NCT03863366 372 373 O

- NCT03863366 377 378 O
Any NCT03863366 380 383 O
past NCT03863366 384 388 B-Eq_Comparison
or NCT03863366 389 391 B-Or
current NCT03863366 392 399 B-Eq_Comparison
Axis NCT03863366 400 404 B-Modifier
1 NCT03863366 405 406 I-Modifier
DSM NCT03863366 407 410 I-Modifier
- NCT03863366 411 412 I-Modifier
IV NCT03863366 413 415 I-Modifier
psychiatric NCT03863366 416 427 B-Condition
disorder NCT03863366 428 436 I-Condition

- NCT03863366 439 440 O
Significant NCT03863366 442 453 O
medical NCT03863366 454 461 B-Condition
condition NCT03863366 462 471 I-Condition

- NCT03863366 474 475 O
Current NCT03863366 477 484 B-Eq_Comparison
or NCT03863366 485 487 B-Or
past NCT03863366 488 492 B-Eq_Comparison
gastro NCT03863366 493 499 B-Modifier
- NCT03863366 500 501 I-Modifier
intestinal NCT03863366 502 512 I-Modifier
disorder NCT03863366 513 521 B-Condition
or NCT03863366 522 524 B-Or
irritable NCT03863366 525 534 B-Condition
bowel NCT03863366 535 540 I-Condition
syndrome NCT03863366 541 549 I-Condition

- NCT03863366 552 553 O
Current NCT03863366 555 562 B-Eq_Comparison
pregnancy NCT03863366 563 572 B-Condition
or NCT03863366 573 575 B-Or
breastfeeding NCT03863366 576 589 B-Condition

- NCT03863366 592 593 O
Known NCT03863366 595 600 O
lactate NCT03863366 601 608 B-Condition
deficiency NCT03863366 609 619 I-Condition
or NCT03863366 620 622 B-Or
any NCT03863366 623 626 O
other NCT03863366 627 632 B-Other
problem NCT03863366 633 640 B-Condition
absorbing NCT03863366 641 650 I-Condition
lactose NCT03863366 651 658 B-Modifier
, NCT03863366 659 660 O
galactose NCT03863366 661 670 B-Modifier
or NCT03863366 671 673 B-Or
glucose NCT03863366 674 681 B-Modifier

- NCT03863366 684 685 O
Current NCT03863366 687 694 B-Eq_Comparison
or NCT03863366 695 697 B-Or
past NCT03863366 698 702 B-Eq_Comparison
history NCT03863366 703 710 I-Eq_Comparison
of NCT03863366 711 713 O
drug NCT03863366 714 718 B-Modifier
or NCT03863366 719 721 B-Or
alcohol NCT03863366 722 729 B-Modifier
dependency NCT03863366 730 740 B-Condition

- NCT03863366 743 744 O
Participation NCT03863366 746 759 O
in NCT03863366 760 762 O
a NCT03863366 763 764 O
psychological NCT03863366 765 778 B-Modifier
or NCT03863366 779 781 B-Or
medical NCT03863366 782 789 B-Modifier
study NCT03863366 790 795 B-Study
involving NCT03863366 796 805 O
the NCT03863366 806 809 O
use NCT03863366 810 813 O
of NCT03863366 814 816 O
medication NCT03863366 817 827 B-Drug
within NCT03863366 828 834 B-Eq_Comparison
the NCT03863366 835 838 I-Eq_Comparison
last NCT03863366 839 843 I-Eq_Comparison
3 NCT03863366 844 845 I-Eq_Comparison
months NCT03863366 846 852 I-Eq_Comparison

- NCT03863366 855 856 O
Previous NCT03863366 858 866 B-Eq_Comparison
participation NCT03863366 867 880 O
in NCT03863366 881 883 O
a NCT03863366 884 885 O
study NCT03863366 886 891 B-Study
using NCT03863366 892 897 O
the NCT03863366 898 901 O
same NCT03863366 902 906 B-Modifier
, NCT03863366 907 908 O
or NCT03863366 909 911 B-Or
similar NCT03863366 912 919 B-Modifier
, NCT03863366 920 921 O
emotional NCT03863366 922 931 B-Procedure
processing NCT03863366 932 942 I-Procedure
tasks NCT03863366 943 948 I-Procedure

- NCT03863366 951 952 O
Smoker NCT03863366 954 960 B-Observation
> NCT03863366 961 962 B-Eq_Comparison
5 NCT03863366 963 964 I-Eq_Comparison
cigarettes NCT03863366 965 975 I-Eq_Comparison
per NCT03863366 976 979 I-Eq_Comparison
day NCT03863366 980 983 I-Eq_Comparison

- NCT03863366 986 987 O
Typically NCT03863366 989 998 O
drinks NCT03863366 999 1005 B-Observation
> NCT03863366 1006 1007 B-Eq_Comparison
6 NCT03863366 1008 1009 I-Eq_Comparison
caffeinated NCT03863366 1010 1021 I-Eq_Comparison
drinks NCT03863366 1022 1028 I-Eq_Comparison
per NCT03863366 1029 1032 I-Eq_Comparison
day NCT03863366 1033 1036 I-Eq_Comparison

Inclusion NCT03921970 0 9 O
Criteria NCT03921970 10 18 O
: NCT03921970 19 20 O

- NCT03921970 24 25 O
American NCT03921970 27 35 B-Observation
Society NCT03921970 36 43 I-Observation
of NCT03921970 44 46 I-Observation
Anesthesiologists NCT03921970 47 64 I-Observation
( NCT03921970 65 66 O
ASA NCT03921970 67 70 B-Observation
) NCT03921970 71 72 O
classification NCT03921970 73 87 B-Eq_Comparison
I NCT03921970 88 89 I-Eq_Comparison
- NCT03921970 90 91 I-Eq_Comparison
II NCT03921970 92 94 I-Eq_Comparison

- NCT03921970 97 98 O
Scheduled NCT03921970 100 109 B-Eq_Comparison
for NCT03921970 110 113 O
laparoscopic NCT03921970 114 126 B-Procedure
sleeve NCT03921970 127 133 I-Procedure
gastrectomy NCT03921970 134 145 I-Procedure
under NCT03921970 146 151 O
general NCT03921970 152 159 B-Procedure
anesthesia NCT03921970 160 170 I-Procedure

Exclusion NCT03921970 171 180 O
Criteria NCT03921970 181 189 O
: NCT03921970 190 191 O

- NCT03921970 195 196 O
Bleeding NCT03921970 198 206 B-Condition
diathesis NCT03921970 207 216 I-Condition

- NCT03921970 219 220 O
Receiving NCT03921970 222 231 B-Eq_Comparison
anticoagulant NCT03921970 232 245 B-Drug
treatment NCT03921970 246 255 B-Procedure

- NCT03921970 258 259 O
Known NCT03921970 261 266 O
local NCT03921970 267 272 O
anesthetics NCT03921970 273 284 O
and NCT03921970 285 288 B-Or
opioid NCT03921970 289 295 B-Drug
allergy NCT03921970 296 303 B-Allergy

- NCT03921970 306 307 O
Infection NCT03921970 309 318 B-Condition
of NCT03921970 319 321 O
the NCT03921970 322 325 O
skin NCT03921970 326 330 B-Modifier
at NCT03921970 331 333 I-Modifier
the NCT03921970 334 337 I-Modifier
site NCT03921970 338 342 I-Modifier
of NCT03921970 343 345 I-Modifier
the NCT03921970 346 349 I-Modifier
needle NCT03921970 350 356 I-Modifier
puncture NCT03921970 357 365 I-Modifier

- NCT03921970 368 369 O
Pregnancy NCT03921970 371 380 B-Condition
or NCT03921970 381 383 B-Or
lactation NCT03921970 384 393 B-Condition

- NCT03921970 396 397 O
Patients NCT03921970 399 407 O
who NCT03921970 408 411 O
do NCT03921970 412 414 O
not NCT03921970 415 418 B-Negation
accept NCT03921970 419 425 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03921970 426 429 O
procedure NCT03921970 430 439 B-Procedure

Inclusion NCT03865433 0 9 O
Criteria NCT03865433 10 18 O
: NCT03865433 19 20 O

1 NCT03865433 24 25 O
. NCT03865433 25 26 O
are NCT03865433 28 31 O
aged NCT03865433 32 36 B-Age
13 NCT03865433 37 39 B-Eq_Comparison
- NCT03865433 40 41 I-Eq_Comparison
17 NCT03865433 42 44 I-Eq_Comparison
, NCT03865433 45 46 I-Eq_Comparison
years NCT03865433 47 52 I-Eq_Comparison
and NCT03865433 53 56 B-And
a NCT03865433 57 58 O
high NCT03865433 59 63 O
school NCT03865433 64 70 O
student NCT03865433 71 78 O
- NCT03865433 79 80 O
athlete NCT03865433 81 88 O
who NCT03865433 89 92 O
attends NCT03865433 93 100 O
school NCT03865433 101 107 O
where NCT03865433 108 113 O
an NCT03865433 114 116 O
athletic NCT03865433 117 125 O
trainer NCT03865433 126 133 O
can NCT03865433 134 137 O
supervise NCT03865433 138 147 O
the NCT03865433 148 151 O
exercise NCT03865433 152 160 O
protocol NCT03865433 161 169 O
; NCT03865433 169 170 O

2 NCT03865433 173 174 O
. NCT03865433 174 175 O
have NCT03865433 177 181 O
sustained NCT03865433 182 191 O
a NCT03865433 192 193 O
concussion NCT03865433 194 204 B-Condition
within NCT03865433 205 211 B-Eq_Comparison
2 NCT03865433 212 213 I-Eq_Comparison
- NCT03865433 214 215 I-Eq_Comparison
7 NCT03865433 216 217 I-Eq_Comparison
days NCT03865433 218 222 I-Eq_Comparison
of NCT03865433 223 225 B-Temporal_Connection___Temporal_Connection_Type_Value:before
clinic NCT03865433 226 232 B-Encounter
presentation NCT03865433 233 245 I-Encounter
and NCT03865433 246 249 O
diagnosed NCT03865433 250 259 O
by NCT03865433 260 262 O
a NCT03865433 263 264 O
study NCT03865433 265 270 B-Study
physician NCT03865433 271 280 B-Provider
; NCT03865433 280 281 O

3 NCT03865433 284 285 O
. NCT03865433 285 286 O
demonstrate NCT03865433 288 299 O
symptom NCT03865433 300 307 O
exacerbation NCT03865433 308 320 O
during NCT03865433 321 327 O
a NCT03865433 328 329 O
graded NCT03865433 330 336 O
treadmill NCT03865433 337 346 O
exercise NCT03865433 347 355 O
test NCT03865433 356 360 O
and NCT03865433 361 364 O
can NCT03865433 365 368 O
not NCT03865433 368 371 O
complete NCT03865433 372 380 O
the NCT03865433 381 384 O
test NCT03865433 385 389 O
; NCT03865433 389 390 O

4 NCT03865433 393 394 O
. NCT03865433 394 395 O
are NCT03865433 397 400 O
currently NCT03865433 401 410 O
participating NCT03865433 411 424 O
in NCT03865433 425 427 O
a NCT03865433 428 429 O
school NCT03865433 430 436 O
or NCT03865433 437 439 O
club NCT03865433 440 444 O
sport NCT03865433 445 450 O
; NCT03865433 450 451 O

5 NCT03865433 454 455 O
. NCT03865433 455 456 O
are NCT03865433 458 461 O
English NCT03865433 462 469 O
speaking NCT03865433 470 478 O
and NCT03865433 479 482 O
capable NCT03865433 483 490 O
of NCT03865433 491 493 O
giving NCT03865433 494 500 O
assent NCT03865433 501 507 O

Exclusion NCT03865433 508 517 O
Criteria NCT03865433 518 526 O
: NCT03865433 527 528 O

1 NCT03865433 532 533 O
. NCT03865433 533 534 O
have NCT03865433 536 540 O
a NCT03865433 541 542 O
reported NCT03865433 543 551 O
history NCT03865433 552 559 B-Eq_Comparison
of NCT03865433 560 562 O
neurological NCT03865433 563 575 B-Condition
condition NCT03865433 576 585 I-Condition
or NCT03865433 586 588 B-Or
disorder NCT03865433 589 597 B-Condition
including NCT03865433 598 607 O
but NCT03865433 608 611 O
not NCT03865433 612 615 O
limited NCT03865433 616 623 O
to NCT03865433 624 626 O
brain NCT03865433 627 632 B-Procedure
surgery NCT03865433 633 640 I-Procedure
, NCT03865433 641 642 O
special NCT03865433 643 650 B-Procedure
education NCT03865433 651 660 I-Procedure
, NCT03865433 661 662 O
seizure NCT03865433 663 670 B-Condition
disorder NCT03865433 671 679 I-Condition
, NCT03865433 680 681 O
speech NCT03865433 682 688 B-Condition
pathology NCT03865433 689 698 I-Condition
, NCT03865433 699 700 O
previous NCT03865433 701 709 B-Eq_Comparison
diagnosis NCT03865433 710 719 O
of NCT03865433 720 722 O
Post NCT03865433 723 727 B-Condition
- NCT03865433 728 729 I-Condition
Concussion NCT03865433 730 740 I-Condition
Syndrome NCT03865433 741 749 I-Condition
( NCT03865433 750 751 O
PCS NCT03865433 752 755 B-Condition
) NCT03865433 756 757 O
, NCT03865433 758 759 O

2 NCT03865433 763 764 O
. NCT03865433 764 765 O
are NCT03865433 767 770 O
unwilling NCT03865433 771 780 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865433 781 783 O
exercise NCT03865433 784 792 B-Observation
, NCT03865433 793 794 O

3 NCT03865433 798 799 O
. NCT03865433 799 800 O
have NCT03865433 802 806 O
focal NCT03865433 807 812 B-Condition
neurologic NCT03865433 813 823 I-Condition
deficit NCT03865433 824 831 I-Condition
that NCT03865433 832 836 O
would NCT03865433 837 842 O
represent NCT03865433 843 852 O
risk NCT03865433 853 857 B-Risk
for NCT03865433 858 861 O
walking NCT03865433 862 869 B-Observation
/ NCT03865433 870 871 B-Or
running NCT03865433 872 879 B-Observation
on NCT03865433 880 882 O
treadmill NCT03865433 883 892 B-Modifier
, NCT03865433 893 894 O

4 NCT03865433 898 899 O
. NCT03865433 899 900 O
exhibit NCT03865433 902 909 O
an NCT03865433 910 912 O
inability NCT03865433 913 922 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865433 923 925 O
exercise NCT03865433 926 934 B-Observation
due NCT03865433 935 938 O
to NCT03865433 939 941 O
injury NCT03865433 942 948 B-Condition
, NCT03865433 949 950 O
known NCT03865433 951 956 O
heart NCT03865433 957 962 B-Condition
disease NCT03865433 963 970 I-Condition
, NCT03865433 971 972 O
or NCT03865433 973 975 B-Or
increased NCT03865433 976 985 O
cardiac NCT03865433 986 993 B-Condition
risk NCT03865433 994 998 B-Risk
, NCT03865433 999 1000 O

5 NCT03865433 1004 1005 O
. NCT03865433 1005 1006 O
have NCT03865433 1008 1012 O
experienced NCT03865433 1013 1024 O
more NCT03865433 1025 1029 B-Eq_Comparison
than NCT03865433 1030 1034 I-Eq_Comparison
3 NCT03865433 1035 1036 I-Eq_Comparison
previous NCT03865433 1037 1045 B-Eq_Comparison
concussions NCT03865433 1046 1057 B-Condition
, NCT03865433 1058 1059 O

6 NCT03865433 1063 1064 O
. NCT03865433 1064 1065 O
have NCT03865433 1067 1071 O
suffered NCT03865433 1072 1080 B-Eq_Comparison
a NCT03865433 1081 1082 O
substantial NCT03865433 1083 1094 O
comorbidity NCT03865433 1095 1106 B-Condition
( NCT03865433 1107 1108 O
eg NCT03865433 1109 1111 O
, NCT03865433 1112 1113 O
cervical NCT03865433 1114 1122 B-Condition
injury NCT03865433 1123 1129 I-Condition
) NCT03865433 1130 1131 O
, NCT03865433 1132 1133 O

7 NCT03865433 1137 1138 O
. NCT03865433 1138 1139 O
currently NCT03865433 1141 1150 B-Eq_Comparison
taking NCT03865433 1151 1157 I-Eq_Comparison
β NCT03865433 1158 1159 B-Drug
- NCT03865433 1160 1161 I-Drug
blockers NCT03865433 1162 1170 I-Drug
, NCT03865433 1171 1172 O
calcium NCT03865433 1173 1180 B-Drug
channel NCT03865433 1181 1188 I-Drug
blockers NCT03865433 1189 1197 I-Drug
, NCT03865433 1198 1199 O
or NCT03865433 1200 1202 B-Or
prophylactic NCT03865433 1203 1215 B-Drug
headache NCT03865433 1216 1224 I-Drug
medications NCT03865433 1225 1236 I-Drug
( NCT03865433 1237 1238 O
e NCT03865433 1239 1240 O
. NCT03865433 1241 1242 O
g NCT03865433 1243 1244 O
. NCT03865433 1245 1246 O
, NCT03865433 1247 1248 O
amitriptyline NCT03865433 1249 1262 B-Drug
, NCT03865433 1263 1264 O
topiramate NCT03865433 1265 1275 B-Drug
) NCT03865433 1276 1277 O
, NCT03865433 1278 1279 O
or NCT03865433 1280 1282 B-Or

8 NCT03865433 1285 1286 O
. NCT03865433 1286 1287 O
have NCT03865433 1289 1293 O
a NCT03865433 1294 1295 O
resting NCT03865433 1296 1303 B-Modifier
blood NCT03865433 1304 1309 B-Observation
pressure NCT03865433 1310 1318 I-Observation
of NCT03865433 1319 1321 O
> NCT03865433 1322 1323 B-Eq_Comparison
140 NCT03865433 1324 1327 I-Eq_Comparison
/ NCT03865433 1328 1329 I-Eq_Comparison
90 NCT03865433 1330 1332 I-Eq_Comparison
. NCT03865433 1332 1333 O

9 NCT03865433 1337 1338 O
. NCT03865433 1338 1339 O
If NCT03865433 1341 1343 O
the NCT03865433 1344 1347 O
potential NCT03865433 1348 1357 O
participant NCT03865433 1358 1369 O
or NCT03865433 1370 1372 O
parent NCT03865433 1373 1379 O
/ NCT03865433 1380 1381 O
guardian NCT03865433 1382 1390 O
is NCT03865433 1391 1393 O
unable NCT03865433 1394 1400 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03865433 1401 1403 O
fully NCT03865433 1404 1409 O
understand NCT03865433 1410 1420 O
the NCT03865433 1421 1424 O
study NCT03865433 1425 1430 B-Study
protocol NCT03865433 1431 1439 O
or NCT03865433 1440 1442 B-Or
study NCT03865433 1443 1448 B-Study
risks NCT03865433 1449 1454 B-Risk
due NCT03865433 1455 1458 O
to NCT03865433 1459 1461 O
injury NCT03865433 1462 1468 B-Condition
or NCT03865433 1469 1471 B-Or
developmental NCT03865433 1472 1485 B-Condition
delay NCT03865433 1486 1491 I-Condition
, NCT03865433 1492 1493 O
the NCT03865433 1494 1497 O
potential NCT03865433 1498 1507 O
participant NCT03865433 1508 1519 O
will NCT03865433 1520 1524 O
be NCT03865433 1525 1527 O
excluded NCT03865433 1528 1536 B-Negation
from NCT03865433 1537 1541 O
the NCT03865433 1542 1545 O
study NCT03865433 1546 1551 B-Study
. NCT03865433 1552 1553 O

Inclusion NCT03920475 0 9 O
Criteria NCT03920475 10 18 O
: NCT03920475 19 20 O

- NCT03920475 24 25 O
Patients NCT03920475 27 35 O
with NCT03920475 36 40 O
uni NCT03920475 41 44 B-Modifier
- NCT03920475 45 46 O
or NCT03920475 47 49 B-Or
bipolar NCT03920475 50 57 B-Modifier
depression NCT03920475 58 68 B-Condition
, NCT03920475 69 70 O
diagnosed NCT03920475 71 80 O
according NCT03920475 81 90 O
to NCT03920475 91 93 O
the NCT03920475 94 97 O
criteria NCT03920475 98 106 O
of NCT03920475 107 109 O
the NCT03920475 110 113 O
DSM NCT03920475 114 117 O
- NCT03920475 118 119 O
IV NCT03920475 120 122 O
via NCT03920475 123 126 O
MINI NCT03920475 127 131 O
6.0 NCT03920475 132 135 O
diagnostic NCT03920475 136 146 O
tool NCT03920475 147 151 O
. NCT03920475 152 153 O

- NCT03920475 157 158 O
At NCT03920475 160 162 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03920475 163 166 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03920475 167 171 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03920475 172 174 O
inclusion NCT03920475 175 184 O
in NCT03920475 185 187 O
the NCT03920475 188 191 O
study NCT03920475 192 197 B-Study
, NCT03920475 198 199 O
the NCT03920475 200 203 O
symptoms NCT03920475 204 212 O
must NCT03920475 213 217 O
meet NCT03920475 218 222 O
at NCT03920475 223 225 O
least NCT03920475 226 231 O
the NCT03920475 232 235 O
requirements NCT03920475 236 248 O
of NCT03920475 249 251 O
a NCT03920475 252 253 O
moderately NCT03920475 254 264 O
severe NCT03920475 265 271 O
depression NCT03920475 272 282 B-Condition
, NCT03920475 283 284 O
defined NCT03920475 285 292 O
by NCT03920475 293 295 O
a NCT03920475 296 297 O
minimum NCT03920475 298 305 O
score NCT03920475 306 311 O
of NCT03920475 312 314 O
≥ NCT03920475 315 316 B-Eq_Comparison
22 NCT03920475 317 319 I-Eq_Comparison
on NCT03920475 320 322 O
the NCT03920475 323 326 O
Montgomery NCT03920475 327 337 B-Observation
- NCT03920475 338 339 I-Observation
Åsberg NCT03920475 340 346 I-Observation
Depression NCT03920475 347 357 I-Observation
Scale NCT03920475 358 363 I-Observation
. NCT03920475 364 365 O

Exclusion NCT03920475 367 376 O
Criteria NCT03920475 377 385 O
: NCT03920475 386 387 O

- NCT03920475 391 392 O
Patients NCT03920475 394 402 O
with NCT03920475 403 407 O
severe NCT03920475 408 414 O
somatic NCT03920475 415 422 B-Modifier
, NCT03920475 423 424 O
rheumatic NCT03920475 425 434 B-Modifier
, NCT03920475 435 436 O
endocrine NCT03920475 437 446 B-Modifier
or NCT03920475 447 449 B-Or
neurological NCT03920475 450 462 B-Modifier
comorbidities NCT03920475 463 476 B-Condition
. NCT03920475 477 478 O
This NCT03920475 480 484 O
includes NCT03920475 485 493 O
in NCT03920475 494 496 O
particular NCT03920475 497 507 O
neurological NCT03920475 508 520 B-Condition
disorders NCT03920475 521 530 I-Condition
associated NCT03920475 531 541 O
with NCT03920475 542 546 O
cognitive NCT03920475 547 556 B-Condition
disorder NCT03920475 557 565 I-Condition
, NCT03920475 566 567 O
severe NCT03920475 568 574 O
liver NCT03920475 575 580 B-Modifier
, NCT03920475 581 582 O
kidney NCT03920475 583 589 B-Modifier
and NCT03920475 590 593 B-Or
cardiac NCT03920475 594 601 B-Modifier
diseases NCT03920475 602 610 B-Condition
. NCT03920475 611 612 O

- NCT03920475 616 617 O
Patients NCT03920475 619 627 O
, NCT03920475 628 629 O
who NCT03920475 630 633 O
are NCT03920475 634 637 O
being NCT03920475 638 643 B-Eq_Comparison
treated NCT03920475 644 651 I-Eq_Comparison
permanently NCT03920475 652 663 O
with NCT03920475 664 668 O
anti NCT03920475 669 673 B-Drug
- NCT03920475 674 675 I-Drug
inflammatory NCT03920475 676 688 I-Drug
or NCT03920475 689 691 B-Or
immunosuppressive NCT03920475 692 709 B-Drug
drugs NCT03920475 710 715 I-Drug
( NCT03920475 716 717 O
e NCT03920475 718 719 O
. NCT03920475 720 721 O
g NCT03920475 722 723 O
. NCT03920475 724 725 O
corticosteroids NCT03920475 727 742 B-Drug
or NCT03920475 743 745 O
alpha NCT03920475 746 751 B-Modifier
/ NCT03920475 752 753 B-Or
beta NCT03920475 754 758 B-Modifier
- NCT03920475 759 760 O
a NCT03920475 761 762 B-Drug
( NCT03920475 763 764 I-Drug
nta NCT03920475 765 768 I-Drug
) NCT03920475 769 770 I-Drug
gonists NCT03920475 771 778 I-Drug
, NCT03920475 779 780 O
immuno NCT03920475 781 787 B-Drug
suppressant NCT03920475 788 799 I-Drug
drugs NCT03920475 800 805 I-Drug
) NCT03920475 806 807 O
. NCT03920475 808 809 O

- NCT03920475 813 814 O
Patients NCT03920475 816 824 O
with NCT03920475 825 829 O
severe NCT03920475 830 836 O
psychiatric NCT03920475 837 848 B-Condition
disorders NCT03920475 849 858 I-Condition
( NCT03920475 859 860 O
Axis NCT03920475 861 865 B-Eq_Comparison
I NCT03920475 866 867 I-Eq_Comparison
) NCT03920475 868 869 O
such NCT03920475 870 874 O
as NCT03920475 875 877 O
schizophrenia NCT03920475 878 891 B-Condition
, NCT03920475 892 893 O
dementia NCT03920475 894 902 B-Condition
, NCT03920475 903 904 O
ADHD NCT03920475 905 909 B-Condition
, NCT03920475 910 911 O
obsessive NCT03920475 912 921 B-Condition
- NCT03920475 922 923 I-Condition
compulsive NCT03920475 924 934 I-Condition
disorder NCT03920475 935 943 I-Condition
, NCT03920475 944 945 O
current NCT03920475 946 953 B-Eq_Comparison
alcohol NCT03920475 954 961 B-Modifier
, NCT03920475 962 963 O
drugs NCT03920475 964 969 B-Modifier
or NCT03920475 970 972 B-Or
drug NCT03920475 973 977 B-Modifier
addiction NCT03920475 978 987 B-Condition
. NCT03920475 988 989 O

- NCT03920475 993 994 O
Patients NCT03920475 996 1004 O
who NCT03920475 1005 1008 O
have NCT03920475 1009 1013 O
already NCT03920475 1014 1021 B-Eq_Comparison
been NCT03920475 1022 1026 O
treated NCT03920475 1027 1034 B-Procedure
unsuccessfully NCT03920475 1035 1049 O
with NCT03920475 1050 1054 O
sertraline NCT03920475 1055 1065 B-Drug
and NCT03920475 1066 1069 B-Or
all NCT03920475 1070 1073 O
alternate NCT03920475 1074 1083 B-Drug
medications NCT03920475 1084 1095 I-Drug
allowed NCT03920475 1096 1103 O
in NCT03920475 1104 1106 O
the NCT03920475 1107 1110 O
study NCT03920475 1111 1116 B-Study
. NCT03920475 1117 1118 O

- NCT03920475 1122 1123 O
Pregnant NCT03920475 1125 1133 B-Condition
or NCT03920475 1134 1136 B-Or
lactating NCT03920475 1137 1146 B-Condition
( NCT03920475 1147 1148 O
breast NCT03920475 1149 1155 B-Condition
feeding NCT03920475 1156 1163 I-Condition
) NCT03920475 1164 1165 O
women NCT03920475 1166 1171 O
. NCT03920475 1172 1173 O

Inclusion NCT03865342 0 9 O
criteria NCT03865342 10 18 O
: NCT03865342 19 20 O

- NCT03865342 24 25 O
English NCT03865342 27 34 O
- NCT03865342 35 36 O
speaking NCT03865342 37 45 O

- NCT03865342 48 49 O
18 NCT03865342 51 53 B-Eq_Comparison
years NCT03865342 54 59 I-Eq_Comparison
of NCT03865342 60 62 I-Eq_Comparison
age NCT03865342 63 66 I-Eq_Comparison
and NCT03865342 67 70 I-Eq_Comparison
older NCT03865342 71 76 I-Eq_Comparison

- NCT03865342 79 80 O
Referral NCT03865342 82 90 B-Encounter
from NCT03865342 91 95 O
the NCT03865342 96 99 O
patient NCT03865342 100 107 O
's NCT03865342 107 109 O
physician NCT03865342 110 119 B-Provider

- NCT03865342 122 123 O
Hemoglobin NCT03865342 125 135 B-Observation
A NCT03865342 136 137 I-Observation
1C NCT03865342 138 140 I-Observation
: NCT03865342 141 142 O
5.7 NCT03865342 143 146 B-Eq_Comparison
- NCT03865342 147 148 I-Eq_Comparison
6.4 NCT03865342 149 152 I-Eq_Comparison
within NCT03865342 153 159 B-Eq_Comparison
the NCT03865342 160 163 I-Eq_Comparison
3 NCT03865342 164 165 I-Eq_Comparison
months NCT03865342 166 172 I-Eq_Comparison
prior NCT03865342 173 178 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03865342 179 181 O
enrollment NCT03865342 182 192 B-Study

- NCT03865342 195 196 O
Own NCT03865342 198 201 O
a NCT03865342 202 203 O
smartphone NCT03865342 204 214 O
( NCT03865342 215 216 O
Apple NCT03865342 217 222 O
or NCT03865342 223 225 O
Android NCT03865342 226 233 O
) NCT03865342 234 235 O

Exclusion NCT03865342 237 246 O
criteria NCT03865342 247 255 O
: NCT03865342 256 257 O

- NCT03865342 261 262 O
Recent NCT03865342 264 270 B-Eq_Comparison
weight NCT03865342 271 277 B-Observation
loss NCT03865342 278 282 I-Observation
( NCT03865342 283 284 O
by NCT03865342 285 287 O
patient NCT03865342 288 295 O
report NCT03865342 296 302 O
, NCT03865342 303 304 O
> NCT03865342 305 306 B-Eq_Comparison
5 NCT03865342 307 308 I-Eq_Comparison
lbs NCT03865342 309 312 I-Eq_Comparison
in NCT03865342 313 315 B-Eq_Comparison
the NCT03865342 316 319 I-Eq_Comparison
6 NCT03865342 320 321 I-Eq_Comparison
months NCT03865342 322 328 I-Eq_Comparison
preceding NCT03865342 329 338 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03865342 339 349 B-Study
visit NCT03865342 350 355 O
) NCT03865342 356 357 O

- NCT03865342 361 362 O
previous NCT03865342 364 372 B-Eq_Comparison
diagnosis NCT03865342 373 382 O
of NCT03865342 383 385 O
type NCT03865342 386 390 B-Modifier
1 NCT03865342 391 392 I-Modifier
or NCT03865342 393 395 B-Or
type NCT03865342 396 400 B-Modifier
2 NCT03865342 401 402 I-Modifier
diabetes NCT03865342 403 411 B-Condition

- NCT03865342 414 415 O
serious NCT03865342 417 424 O
or NCT03865342 425 427 B-Or
persistent NCT03865342 428 438 B-Modifier
mental NCT03865342 439 445 B-Condition
illnesses NCT03865342 446 455 I-Condition

- NCT03865342 458 459 O
more NCT03865342 461 465 B-Eq_Comparison
than NCT03865342 466 470 I-Eq_Comparison
72 NCT03865342 471 473 I-Eq_Comparison
hours NCT03865342 474 479 I-Eq_Comparison
of NCT03865342 480 482 O
hospitalization NCT03865342 483 498 B-Encounter
in NCT03865342 499 501 B-Eq_Comparison
the NCT03865342 502 505 I-Eq_Comparison
last NCT03865342 506 510 I-Eq_Comparison
30 NCT03865342 511 513 I-Eq_Comparison
days NCT03865342 514 518 I-Eq_Comparison

- NCT03865342 521 522 O
Enrollment NCT03865342 524 534 O
in NCT03865342 535 537 O
a NCT03865342 538 539 O
structured NCT03865342 540 550 O
weight NCT03865342 551 557 B-Procedure
- NCT03865342 558 559 I-Procedure
loss NCT03865342 560 564 I-Procedure
program NCT03865342 565 572 I-Procedure
currently NCT03865342 573 582 B-Eq_Comparison
or NCT03865342 583 585 B-Or
within NCT03865342 586 592 B-Eq_Comparison
the NCT03865342 593 596 I-Eq_Comparison
1 NCT03865342 597 598 I-Eq_Comparison
month NCT03865342 599 604 I-Eq_Comparison
preceding NCT03865342 605 614 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03865342 615 620 B-Study
enrollment NCT03865342 621 631 O

- NCT03865342 634 635 O
Pregnant NCT03865342 637 645 B-Condition

- NCT03865342 648 649 O
Currently NCT03865342 651 660 B-Eq_Comparison
nursing NCT03865342 661 668 B-Condition

- NCT03865342 671 672 O
Have NCT03865342 674 678 O
given NCT03865342 679 684 B-Condition
birth NCT03865342 685 690 I-Condition
within NCT03865342 691 697 B-Eq_Comparison
the NCT03865342 698 701 I-Eq_Comparison
past NCT03865342 702 706 I-Eq_Comparison
3 NCT03865342 707 708 I-Eq_Comparison
months NCT03865342 709 715 I-Eq_Comparison

- NCT03865342 718 719 O
Has NCT03865342 721 724 O
been NCT03865342 725 729 O
discouraged NCT03865342 730 741 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
by NCT03865342 742 744 O
a NCT03865342 745 746 O
physician NCT03865342 747 756 B-Provider
to NCT03865342 757 759 O
enroll NCT03865342 760 766 O
in NCT03865342 767 769 O
a NCT03865342 770 771 O
DPP NCT03865342 772 775 B-Procedure
program NCT03865342 776 783 I-Procedure

Inclusion NCT03920618 0 9 O
Criteria NCT03920618 10 18 O
: NCT03920618 19 20 O

1 NCT03920618 24 25 O
. NCT03920618 25 26 O
Positive NCT03920618 28 36 O
hepatitis NCT03920618 37 46 B-Observation
b NCT03920618 47 48 I-Observation
surface NCT03920618 49 56 I-Observation
antigen NCT03920618 57 64 I-Observation
or NCT03920618 65 67 B-Or
hepatitis NCT03920618 68 77 B-Observation
b NCT03920618 78 79 I-Observation
virus NCT03920618 80 85 I-Observation
DNA NCT03920618 86 89 I-Observation
> NCT03920618 90 91 B-Eq_Comparison
0.5 NCT03920618 92 95 I-Eq_Comparison
year NCT03920618 96 100 I-Eq_Comparison
; NCT03920618 100 101 O

2 NCT03920618 104 105 O
. NCT03920618 105 106 O
Age NCT03920618 108 111 B-Age
from NCT03920618 112 116 O
18 NCT03920618 117 119 B-Eq_Comparison
to NCT03920618 120 122 I-Eq_Comparison
55 NCT03920618 123 125 I-Eq_Comparison
years NCT03920618 126 131 I-Eq_Comparison
old NCT03920618 132 135 O
; NCT03920618 135 136 O

3 NCT03920618 139 140 O
. NCT03920618 140 141 O
Serum NCT03920618 143 148 B-Observation
total NCT03920618 149 154 I-Observation
bilirubin NCT03920618 155 164 I-Observation
level NCT03920618 165 170 I-Observation
> NCT03920618 171 172 B-Eq_Comparison
10 NCT03920618 173 175 I-Eq_Comparison
times NCT03920618 176 181 I-Eq_Comparison
upper NCT03920618 182 187 I-Eq_Comparison
limit NCT03920618 188 193 I-Eq_Comparison
of NCT03920618 194 196 I-Eq_Comparison
normal NCT03920618 197 203 I-Eq_Comparison
; NCT03920618 203 204 O

4 NCT03920618 207 208 O
. NCT03920618 208 209 O
Prothrombin NCT03920618 211 222 B-Observation
time NCT03920618 223 227 I-Observation
activity NCT03920618 228 236 I-Observation
< NCT03920618 237 238 B-Eq_Comparison
40 NCT03920618 239 241 I-Eq_Comparison
% NCT03920618 242 243 I-Eq_Comparison
or NCT03920618 244 246 B-Or
prothrombin NCT03920618 247 258 B-Observation
time NCT03920618 259 263 I-Observation
international NCT03920618 264 277 I-Observation
ratio NCT03920618 278 283 I-Observation
> NCT03920618 284 285 B-Eq_Comparison
1.5 NCT03920618 286 289 I-Eq_Comparison
； NCT03920618 290 291 O

5 NCT03920618 294 295 O
. NCT03920618 295 296 O
Do NCT03920618 298 300 O
not NCT03920618 301 304 B-Negation
receive NCT03920618 305 312 O
nucleotide NCT03920618 313 323 B-Modifier
/ NCT03920618 324 325 B-Or
nucleoside NCT03920618 326 336 B-Modifier
analogues NCT03920618 337 346 B-Procedure
treatment NCT03920618 347 356 I-Procedure
in NCT03920618 357 359 O
the NCT03920618 360 363 O
past NCT03920618 364 368 B-Eq_Comparison
half NCT03920618 369 373 I-Eq_Comparison
year NCT03920618 374 378 I-Eq_Comparison
. NCT03920618 379 380 O

Exclusion NCT03920618 382 391 O
Criteria NCT03920618 392 400 O
: NCT03920618 401 402 O

1 NCT03920618 406 407 O
. NCT03920618 407 408 O
Other NCT03920618 410 415 B-Other
active NCT03920618 416 422 B-Eq_Comparison
liver NCT03920618 423 428 B-Condition
diseases NCT03920618 429 437 I-Condition
; NCT03920618 437 438 O

2 NCT03920618 441 442 O
. NCT03920618 442 443 O
Hepatocellular NCT03920618 445 459 B-Condition
carcinoma NCT03920618 460 469 I-Condition
or NCT03920618 470 472 B-Or
other NCT03920618 473 478 B-Other
malignancy NCT03920618 479 489 B-Condition
; NCT03920618 489 490 O

3 NCT03920618 493 494 O
. NCT03920618 494 495 O
Pregnancy NCT03920618 497 506 B-Condition
or NCT03920618 507 509 B-Or
lactation NCT03920618 510 519 B-Condition
; NCT03920618 519 520 O

4 NCT03920618 523 524 O
. NCT03920618 524 525 O
Human NCT03920618 527 532 B-Condition
immunodeficiency NCT03920618 533 549 I-Condition
virus NCT03920618 550 555 I-Condition
infection NCT03920618 556 565 I-Condition
or NCT03920618 566 568 B-Or
congenital NCT03920618 569 579 B-Condition
immune NCT03920618 580 586 I-Condition
deficiency NCT03920618 587 597 I-Condition
diseases NCT03920618 598 606 I-Condition
; NCT03920618 606 607 O

5 NCT03920618 610 611 O
. NCT03920618 611 612 O
Severe NCT03920618 614 620 O
diabetes NCT03920618 621 629 B-Condition
, NCT03920618 630 631 O
autoimmune NCT03920618 632 642 B-Condition
diseases NCT03920618 643 651 I-Condition
; NCT03920618 651 652 O

6 NCT03920618 655 656 O
. NCT03920618 656 657 O
Other NCT03920618 659 664 B-Other
important NCT03920618 665 674 O
organ NCT03920618 675 680 B-Condition
dysfunctions NCT03920618 681 693 I-Condition
; NCT03920618 693 694 O

7 NCT03920618 697 698 O
. NCT03920618 698 699 O
Using NCT03920618 701 706 B-Eq_Comparison
glucocorticoid NCT03920618 707 721 B-Drug
; NCT03920618 721 722 O

8 NCT03920618 725 726 O
. NCT03920618 726 727 O
Patients NCT03920618 729 737 O
can NCT03920618 738 741 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03920618 742 745 B-Negation
follow NCT03920618 746 752 B-Encounter
- NCT03920618 753 754 I-Encounter
up NCT03920618 755 757 I-Encounter
; NCT03920618 757 758 O

9 NCT03920618 761 762 O
. NCT03920618 762 763 O
Investigator NCT03920618 765 777 O
considering NCT03920618 778 789 O
inappropriate NCT03920618 790 803 O
. NCT03920618 804 805 O

Inclusion NCT03924141 0 9 O
Criteria NCT03924141 10 18 O
: NCT03924141 19 20 O

- NCT03924141 24 25 O
Third NCT03924141 27 32 O
year NCT03924141 33 37 O
nursing NCT03924141 38 45 O
student NCT03924141 46 53 O

Exclusion NCT03924141 54 63 O
Criteria NCT03924141 64 72 O
: NCT03924141 73 74 O

- NCT03924141 78 79 O
Has NCT03924141 81 84 O
to NCT03924141 85 87 O
talk NCT03924141 88 92 O
and NCT03924141 93 96 O
understand NCT03924141 97 107 O
Norwegian NCT03924141 108 117 O

Inclusion NCT03863080 0 9 O
Criteria NCT03863080 10 18 O
: NCT03863080 19 20 O

1 NCT03863080 24 25 O
. NCT03863080 25 26 O
Male NCT03863080 28 32 O
or NCT03863080 33 35 B-Or
female NCT03863080 36 42 O
≥ NCT03863080 43 44 B-Eq_Comparison
18 NCT03863080 45 47 I-Eq_Comparison
years NCT03863080 48 53 I-Eq_Comparison
of NCT03863080 54 56 O
age NCT03863080 57 60 B-Age
. NCT03863080 61 62 O

2 NCT03863080 66 67 O
. NCT03863080 67 68 O
Myasthenia NCT03863080 70 80 B-Condition
Gravis NCT03863080 81 87 I-Condition
Foundation NCT03863080 88 98 I-Condition
of NCT03863080 99 101 I-Condition
America NCT03863080 102 109 I-Condition
( NCT03863080 110 111 O
MGFA NCT03863080 112 116 B-Condition
) NCT03863080 117 118 O
Class NCT03863080 119 124 B-Eq_Comparison
II NCT03863080 125 127 I-Eq_Comparison
- NCT03863080 128 129 I-Eq_Comparison
IVa NCT03863080 130 133 I-Eq_Comparison
and NCT03863080 134 137 B-And
likely NCT03863080 138 144 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03863080 145 148 B-Negation
in NCT03863080 149 151 O
need NCT03863080 152 156 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03863080 157 159 I-Assertion___Assertion_Type_Value:hypothetical
a NCT03863080 160 161 O
respirator NCT03863080 162 172 B-Procedure
for NCT03863080 173 176 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863080 177 180 I-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03863080 181 189 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03863080 190 192 O
the NCT03863080 193 196 O
study NCT03863080 197 202 B-Study
as NCT03863080 203 205 O
judged NCT03863080 206 212 O
by NCT03863080 213 215 O
the NCT03863080 216 219 O
Investigator NCT03863080 220 232 O
. NCT03863080 233 234 O

3 NCT03863080 238 239 O
. NCT03863080 239 240 O
QMG NCT03863080 242 245 B-Observation
score NCT03863080 246 251 O
≥ NCT03863080 252 253 B-Eq_Comparison
12 NCT03863080 254 256 I-Eq_Comparison
at NCT03863080 257 259 B-Temporal_Connection___Temporal_Connection_Type_Value:during
Screening NCT03863080 260 269 B-Study
and NCT03863080 270 273 B-And
Baseline NCT03863080 274 282 B-Study
. NCT03863080 283 284 O

Other NCT03863080 286 291 O
, NCT03863080 292 293 O
more NCT03863080 294 298 O
specific NCT03863080 299 307 O
inclusion NCT03863080 308 317 O
criteria NCT03863080 318 326 O
are NCT03863080 327 330 O
defined NCT03863080 331 338 O
in NCT03863080 339 341 O
the NCT03863080 342 345 O
protocol NCT03863080 346 354 O
. NCT03863080 355 356 O

Exclusion NCT03863080 358 367 O
Criteria NCT03863080 368 376 O
: NCT03863080 377 378 O

1 NCT03863080 382 383 O
. NCT03863080 383 384 O
Use NCT03863080 386 389 O
of NCT03863080 390 392 O
rituximab NCT03863080 393 402 B-Drug
, NCT03863080 403 404 O
belimumab NCT03863080 405 414 B-Drug
, NCT03863080 415 416 O
eculizumab NCT03863080 417 427 B-Drug
or NCT03863080 428 430 B-Or
any NCT03863080 431 434 O
monoclonal NCT03863080 435 445 B-Drug
antibody NCT03863080 446 454 I-Drug
for NCT03863080 455 458 O
immunomodulation NCT03863080 459 475 B-Procedure
within NCT03863080 476 482 B-Eq_Comparison
6 NCT03863080 483 484 I-Eq_Comparison
months NCT03863080 485 491 I-Eq_Comparison
prior NCT03863080 492 497 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863080 498 500 O
first NCT03863080 501 506 B-Eq_Comparison
dosing NCT03863080 507 513 B-Procedure
. NCT03863080 514 515 O

2 NCT03863080 519 520 O
. NCT03863080 520 521 O
Immunoglobulins NCT03863080 523 538 B-Drug
given NCT03863080 539 544 O
by NCT03863080 545 547 O
SC NCT03863080 548 550 B-Modifier
, NCT03863080 551 552 O
IV NCT03863080 553 555 B-Modifier
( NCT03863080 556 557 O
IVIG NCT03863080 558 562 B-Modifier
) NCT03863080 563 564 O
, NCT03863080 565 566 O
or NCT03863080 567 569 B-Or
intramuscular NCT03863080 570 583 B-Modifier
route NCT03863080 584 589 I-Modifier
, NCT03863080 590 591 O
or NCT03863080 592 594 B-Or
plasmapheresis NCT03863080 595 609 B-Procedure
/ NCT03863080 610 611 O
plasma NCT03863080 612 618 B-Procedure
exchange NCT03863080 619 627 I-Procedure
( NCT03863080 628 629 O
PE NCT03863080 630 632 B-Procedure
) NCT03863080 633 634 O
within NCT03863080 635 641 B-Eq_Comparison
4 NCT03863080 642 643 I-Eq_Comparison
weeks NCT03863080 644 649 I-Eq_Comparison
before NCT03863080 650 656 B-Temporal_Connection___Temporal_Connection_Type_Value:before
Screening NCT03863080 657 666 B-Study
. NCT03863080 667 668 O

3 NCT03863080 672 673 O
. NCT03863080 673 674 O
Thymectomy NCT03863080 676 686 B-Procedure
performed NCT03863080 687 696 O
< NCT03863080 697 698 B-Eq_Comparison
12 NCT03863080 699 701 I-Eq_Comparison
months NCT03863080 702 708 I-Eq_Comparison
prior NCT03863080 709 714 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863080 715 717 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03863080 718 727 B-Study
. NCT03863080 728 729 O

4 NCT03863080 733 734 O
. NCT03863080 734 735 O
Total NCT03863080 737 742 B-Observation
IgG NCT03863080 743 746 I-Observation
level NCT03863080 747 752 O
< NCT03863080 753 754 B-Eq_Comparison
6 NCT03863080 755 756 I-Eq_Comparison
g NCT03863080 757 758 I-Eq_Comparison
/ NCT03863080 759 760 I-Eq_Comparison
L NCT03863080 761 762 I-Eq_Comparison
( NCT03863080 763 764 O
at NCT03863080 765 767 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03863080 768 777 B-Study
) NCT03863080 778 779 O
. NCT03863080 780 781 O

5 NCT03863080 785 786 O
. NCT03863080 786 787 O
Absolute NCT03863080 789 797 B-Observation
neutrophil NCT03863080 798 808 I-Observation
count NCT03863080 809 814 I-Observation
< NCT03863080 815 816 B-Eq_Comparison
1500 NCT03863080 817 821 I-Eq_Comparison
cells NCT03863080 822 827 I-Eq_Comparison
/ NCT03863080 828 829 I-Eq_Comparison
mm NCT03863080 830 832 I-Eq_Comparison
3 NCT03863080 833 834 I-Eq_Comparison
( NCT03863080 835 836 O
at NCT03863080 837 839 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03863080 840 849 B-Study
) NCT03863080 850 851 O
. NCT03863080 852 853 O

Other NCT03863080 855 860 O
, NCT03863080 861 862 O
more NCT03863080 863 867 O
specific NCT03863080 868 876 O
exclusion NCT03863080 877 886 O
criteria NCT03863080 887 895 O
are NCT03863080 896 899 O
defined NCT03863080 900 907 O
in NCT03863080 908 910 O
the NCT03863080 911 914 O
protocol NCT03863080 915 923 O

Inclusion NCT03934385 0 9 O
Criteria NCT03934385 10 18 O
: NCT03934385 19 20 O

- NCT03934385 24 25 O
English NCT03934385 27 34 O
- NCT03934385 35 36 O
speaking NCT03934385 37 45 O

- NCT03934385 48 49 O
Elevated NCT03934385 51 59 O
score NCT03934385 60 65 O
on NCT03934385 66 68 O
Spider NCT03934385 69 75 B-Observation
Phobia NCT03934385 76 82 I-Observation
Questionnaire NCT03934385 83 96 I-Observation
( NCT03934385 97 98 O
SPQ NCT03934385 99 102 B-Observation
) NCT03934385 103 104 O

Exclusion NCT03934385 106 115 O
Criteria NCT03934385 116 124 O
: NCT03934385 125 126 O

- NCT03934385 130 131 O
Severe NCT03934385 133 139 O
allergies NCT03934385 140 149 B-Allergy
to NCT03934385 150 152 O
bees NCT03934385 153 157 O
/ NCT03934385 158 159 B-Or
spiders NCT03934385 160 167 O
/ NCT03934385 168 169 B-Or
insects NCT03934385 170 177 O

Inclusion NCT03927742 0 9 O
Criteria NCT03927742 10 18 O
: NCT03927742 19 20 O

- NCT03927742 24 25 O
18 NCT03927742 27 29 B-Eq_Comparison
- NCT03927742 30 31 I-Eq_Comparison
75 NCT03927742 32 34 I-Eq_Comparison
years NCT03927742 35 40 I-Eq_Comparison
old NCT03927742 41 44 B-Age

- NCT03927742 47 48 O
Diagnosed NCT03927742 50 59 O
with NCT03927742 60 64 O
cutaneous NCT03927742 65 74 B-Condition
invasive NCT03927742 75 83 I-Condition
melanoma NCT03927742 84 92 I-Condition
within NCT03927742 93 99 O
HealthPartners NCT03927742 100 114 O
system NCT03927742 115 121 O
since NCT03927742 122 127 B-Eq_Comparison
2010 NCT03927742 128 132 I-Eq_Comparison

- NCT03927742 136 137 O
Able NCT03927742 139 143 O
to NCT03927742 144 146 O
read NCT03927742 147 151 O
/ NCT03927742 152 153 O
write NCT03927742 154 159 O
in NCT03927742 160 162 O
English NCT03927742 163 170 O

- NCT03927742 173 174 O
Own NCT03927742 176 179 O
a NCT03927742 180 181 O
smartphone NCT03927742 182 192 O

- NCT03927742 195 196 O
Able NCT03927742 198 202 O
to NCT03927742 203 205 O
provide NCT03927742 206 213 O
voluntary NCT03927742 214 223 O
informed NCT03927742 224 232 O
consent NCT03927742 233 240 O

Exclusion NCT03927742 241 250 O
Criteria NCT03927742 251 259 O
: NCT03927742 260 261 O

- NCT03927742 265 266 O
Inability NCT03927742 268 277 O
to NCT03927742 278 280 O
provide NCT03927742 281 288 O
informed NCT03927742 289 297 O
written NCT03927742 298 305 O
consent NCT03927742 306 313 O

- NCT03927742 316 317 O
Pregnancy NCT03927742 319 328 B-Condition

Inclusion NCT03924544 0 9 O
Criteria NCT03924544 10 18 O
: NCT03924544 19 20 O

- NCT03924544 24 25 O
Primary NCT03924544 27 34 B-Modifier
Open NCT03924544 35 39 I-Modifier
Angle NCT03924544 40 45 I-Modifier
Glaucoma NCT03924544 46 54 B-Condition

Exclusion NCT03924544 55 64 O
Criteria NCT03924544 65 73 O
: NCT03924544 74 75 O

- NCT03924544 79 80 O
Secondary NCT03924544 82 91 B-Modifier
Glaucoma NCT03924544 92 100 B-Condition
, NCT03924544 101 102 O
Closed NCT03924544 103 109 B-Modifier
angle NCT03924544 110 115 I-Modifier
glaucoma NCT03924544 116 124 B-Condition

Inclusion NCT03866148 0 9 O
Criteria NCT03866148 10 18 O
: NCT03866148 19 20 O

- NCT03866148 24 25 O
Patients NCT03866148 27 35 O
with NCT03866148 36 40 O
moderate NCT03866148 41 49 B-Eq_Comparison
to NCT03866148 50 52 I-Eq_Comparison
severe NCT03866148 53 59 I-Eq_Comparison
sleep NCT03866148 60 65 B-Condition
apnoea NCT03866148 66 72 I-Condition
who NCT03866148 73 76 B-And
require NCT03866148 77 84 B-Assertion___Assertion_Type_Value:hypothetical
CPAP NCT03866148 85 89 B-Procedure
as NCT03866148 90 92 O
standard NCT03866148 93 101 B-Procedure
care NCT03866148 102 106 I-Procedure
( NCT03866148 107 108 O
AHI NCT03866148 109 112 B-Observation
> NCT03866148 113 114 B-Eq_Comparison
15 NCT03866148 115 117 I-Eq_Comparison
) NCT03866148 118 119 O

- NCT03866148 123 124 O
Patients NCT03866148 126 134 O
between NCT03866148 135 142 B-Eq_Comparison
the NCT03866148 143 146 I-Eq_Comparison
age NCT03866148 147 150 I-Eq_Comparison
of NCT03866148 151 153 I-Eq_Comparison
18 NCT03866148 154 156 I-Eq_Comparison
and NCT03866148 157 160 I-Eq_Comparison
75 NCT03866148 161 163 I-Eq_Comparison

Exclusion NCT03866148 165 174 O
Criteria NCT03866148 175 183 O
: NCT03866148 184 185 O

- NCT03866148 189 190 O
Patients NCT03866148 192 200 O
with NCT03866148 201 205 O
a NCT03866148 206 207 O
diagnosis NCT03866148 208 217 O
of NCT03866148 218 220 O
atrial NCT03866148 221 227 B-Condition
fibrillation NCT03866148 228 240 I-Condition
( NCT03866148 241 242 O
AF NCT03866148 243 245 B-Condition
) NCT03866148 246 247 O
, NCT03866148 248 249 O
atrial NCT03866148 250 256 B-Condition
flutter NCT03866148 257 264 I-Condition
and NCT03866148 265 268 B-Or
/ NCT03866148 269 270 I-Or
or NCT03866148 271 273 I-Or
ventricular NCT03866148 274 285 B-Condition
tachycardia NCT03866148 286 297 I-Condition
( NCT03866148 298 299 O
VT NCT03866148 300 302 B-Condition
) NCT03866148 303 304 O

- NCT03866148 308 309 O
Patients NCT03866148 311 319 O
with NCT03866148 320 324 O
an NCT03866148 325 327 O
ILR NCT03866148 328 331 B-Procedure
already NCT03866148 332 339 B-Eq_Comparison
in NCT03866148 340 342 B-Modifier
- NCT03866148 343 344 I-Modifier
situ NCT03866148 345 349 I-Modifier
or NCT03866148 350 352 B-Or
an NCT03866148 353 355 O
established NCT03866148 356 367 O
indication NCT03866148 368 378 B-Indication
for NCT03866148 379 382 O
ILR NCT03866148 383 386 B-Procedure

- NCT03866148 389 390 O
Patients NCT03866148 392 400 O
with NCT03866148 401 405 O
a NCT03866148 406 407 O
palliative NCT03866148 408 418 B-Condition
diagnosis NCT03866148 419 428 O
i NCT03866148 429 430 O
. NCT03866148 431 432 O
e NCT03866148 433 434 O
. NCT03866148 435 436 O
life NCT03866148 438 442 B-Observation
expectancy NCT03866148 443 453 I-Observation
less NCT03866148 454 458 B-Eq_Comparison
than NCT03866148 459 463 I-Eq_Comparison
3 NCT03866148 464 465 I-Eq_Comparison
years NCT03866148 466 471 I-Eq_Comparison

- NCT03866148 474 475 O
Patients NCT03866148 477 485 O
who NCT03866148 486 489 O
lack NCT03866148 490 494 B-Condition
capacity NCT03866148 495 503 I-Condition

Inclusion NCT03926078 0 9 O
criteria NCT03926078 10 18 O
: NCT03926078 19 20 O

- NCT03926078 24 25 O
All NCT03926078 27 30 O
patients NCT03926078 31 39 O
that NCT03926078 40 44 O
visit NCT03926078 45 50 B-Encounter
the NCT03926078 51 54 O
Zuyderland NCT03926078 55 65 O
Medical NCT03926078 66 73 O
Centre NCT03926078 74 80 O
outpatient NCT03926078 81 91 O
clinic NCT03926078 92 98 O
for NCT03926078 99 102 B-Temporal_Connection___Temporal_Connection_Type_Value:during
evaluation NCT03926078 103 113 B-Procedure
of NCT03926078 114 116 O
their NCT03926078 117 122 O
pectus NCT03926078 123 129 B-Condition
excavatum NCT03926078 130 139 I-Condition
. NCT03926078 140 141 O

- NCT03926078 145 146 O
No NCT03926078 148 150 O
age NCT03926078 151 154 O
restrictions NCT03926078 155 167 O
were NCT03926078 168 172 O
imposed NCT03926078 173 180 O
, NCT03926078 181 182 O
however NCT03926078 183 190 O
, NCT03926078 191 192 O
to NCT03926078 193 195 O
be NCT03926078 196 198 O
eligible NCT03926078 199 207 O
, NCT03926078 208 209 O
it NCT03926078 210 212 O
was NCT03926078 213 216 O
mandatory NCT03926078 217 226 O
to NCT03926078 227 229 O
be NCT03926078 230 232 O
able NCT03926078 233 237 O
to NCT03926078 238 240 O
stand NCT03926078 241 246 O
still NCT03926078 247 252 O
in NCT03926078 253 255 O
and NCT03926078 256 259 O
upright NCT03926078 260 267 O
position NCT03926078 268 276 O
for NCT03926078 277 280 O
60 NCT03926078 281 283 O
seconds NCT03926078 284 291 O
. NCT03926078 292 293 O

Exclusion NCT03926078 295 304 O
criteria NCT03926078 305 313 O
: NCT03926078 314 315 O

- NCT03926078 318 319 O
Patients NCT03926078 320 328 O
that NCT03926078 329 333 O
suffer NCT03926078 334 340 O
from NCT03926078 341 345 O
any NCT03926078 346 349 O
form NCT03926078 350 354 O
of NCT03926078 355 357 O
light NCT03926078 358 363 B-Condition
hypersensitivity NCT03926078 364 380 I-Condition
or NCT03926078 381 383 B-Or
epilepsy NCT03926078 384 392 B-Condition
were NCT03926078 393 397 O
not NCT03926078 398 401 O
considered NCT03926078 402 412 O
while NCT03926078 413 418 O
3 NCT03926078 419 420 O
D NCT03926078 421 422 O
optical NCT03926078 423 430 O
surface NCT03926078 431 438 O
images NCT03926078 439 445 O
were NCT03926078 446 450 O
acquired NCT03926078 451 459 O
with NCT03926078 460 464 O
the NCT03926078 465 468 O
use NCT03926078 469 472 O
of NCT03926078 473 475 O
structured NCT03926078 476 486 O
, NCT03926078 487 488 O
flashing NCT03926078 489 497 O
light NCT03926078 498 503 O
. NCT03926078 504 505 O


Inclusion NCT03921463 0 9 O
Criteria NCT03921463 10 18 O
: NCT03921463 19 20 O

- NCT03921463 24 25 O
1 NCT03921463 27 28 O
) NCT03921463 29 30 O
Age NCT03921463 31 34 B-Age
: NCT03921463 35 36 O
20 NCT03921463 37 39 B-Eq_Comparison
~ NCT03921463 40 41 I-Eq_Comparison
35 NCT03921463 42 44 I-Eq_Comparison
years NCT03921463 45 50 I-Eq_Comparison
old NCT03921463 51 54 O
; NCT03921463 54 55 O
2 NCT03921463 56 57 O
) NCT03921463 58 59 O
first NCT03921463 60 65 B-Eq_Comparison
parturients NCT03921463 66 77 B-Condition
registered NCT03921463 78 88 O
in NCT03921463 89 91 O
the NCT03921463 92 95 O
obstetrics NCT03921463 96 106 O
department NCT03921463 107 117 O
of NCT03921463 118 120 O
our NCT03921463 121 124 O
hospital NCT03921463 125 133 O
; NCT03921463 133 134 O
3 NCT03921463 135 136 O
) NCT03921463 137 138 O
no NCT03921463 139 141 B-Negation
medical NCT03921463 142 149 B-Condition
complications NCT03921463 150 163 I-Condition
before NCT03921463 164 170 B-Temporal_Connection___Temporal_Connection_Type_Value:before
pregnancy NCT03921463 171 180 B-Condition
, NCT03921463 181 182 O
no NCT03921463 183 185 B-Negation
UI NCT03921463 186 188 B-Condition
and NCT03921463 189 192 B-Or
POP NCT03921463 193 196 B-Condition
( NCT03921463 197 198 O
according NCT03921463 199 208 O
to NCT03921463 209 211 O
the NCT03921463 212 215 O
standard NCT03921463 216 224 B-Observation
of NCT03921463 225 227 I-Observation
POP NCT03921463 228 231 I-Observation
- NCT03921463 232 233 I-Observation
Q NCT03921463 234 235 I-Observation
stage NCT03921463 236 241 I-Observation
) NCT03921463 242 243 O
; NCT03921463 244 245 O
4 NCT03921463 246 247 O
) NCT03921463 248 249 O
no NCT03921463 250 252 B-Negation
obstetric NCT03921463 253 262 B-Condition
complications NCT03921463 263 276 I-Condition
; NCT03921463 276 277 O
5 NCT03921463 278 279 O
) NCT03921463 280 281 O
the NCT03921463 282 285 O
patients NCT03921463 286 294 O
agreed NCT03921463 295 301 O
to NCT03921463 302 304 O
conduct NCT03921463 305 312 O
the NCT03921463 313 316 O
study NCT03921463 317 322 O
and NCT03921463 323 326 O
signed NCT03921463 327 333 O
the NCT03921463 334 337 O
informed NCT03921463 338 346 O
consent NCT03921463 347 354 O
. NCT03921463 355 356 O

Exclusion NCT03921463 358 367 O
Criteria NCT03921463 368 376 O
: NCT03921463 377 378 O

- NCT03921463 382 383 O
1 NCT03921463 385 386 O
) NCT03921463 387 388 O
patients NCT03921463 389 397 O
with NCT03921463 398 402 O
uncontrolled NCT03921463 403 415 B-Modifier
epilepsy NCT03921463 416 424 B-Condition
, NCT03921463 425 426 O
central NCT03921463 427 434 B-Condition
nervous NCT03921463 435 442 I-Condition
system NCT03921463 443 449 I-Condition
diseases NCT03921463 450 458 I-Condition
or NCT03921463 459 461 B-Or
mental NCT03921463 462 468 B-Condition
disorders NCT03921463 469 478 I-Condition
, NCT03921463 479 480 O
whose NCT03921463 481 486 O
clinical NCT03921463 487 495 O
severity NCT03921463 496 504 O
shall NCT03921463 505 510 O
be NCT03921463 511 513 O
determined NCT03921463 514 524 O
by NCT03921463 525 527 O
the NCT03921463 528 531 O
researcher NCT03921463 532 542 O
to NCT03921463 543 545 O
affect NCT03921463 546 552 O
clinical NCT03921463 553 561 O
research NCT03921463 562 570 O
compliance NCT03921463 571 581 O
; NCT03921463 581 582 O
2 NCT03921463 583 584 O
) NCT03921463 585 586 O
follow NCT03921463 587 593 B-Encounter
up NCT03921463 594 596 I-Encounter
the NCT03921463 597 600 O
patients NCT03921463 601 609 O
with NCT03921463 610 614 B-Assertion___Assertion_Type_Value:hypothetical
difficulty NCT03921463 615 625 B-Negation
. NCT03921463 626 627 O

Inclusion NCT03861858 0 9 O
Criteria NCT03861858 10 18 O
: NCT03861858 19 20 O

- NCT03861858 24 25 O
Age NCT03861858 27 30 B-Age
13 NCT03861858 31 33 B-Eq_Comparison
- NCT03861858 34 35 I-Eq_Comparison
17 NCT03861858 36 38 I-Eq_Comparison
years NCT03861858 39 44 I-Eq_Comparison
or NCT03861858 45 47 B-Or
18 NCT03861858 48 50 B-Eq_Comparison
- NCT03861858 51 52 I-Eq_Comparison
20 NCT03861858 53 55 I-Eq_Comparison
if NCT03861858 56 58 O
still NCT03861858 59 64 O
living NCT03861858 65 71 O
at NCT03861858 72 74 O
home NCT03861858 75 79 O
with NCT03861858 80 84 O
parent NCT03861858 85 91 O
. NCT03861858 92 93 O

- NCT03861858 97 98 O
Agreement NCT03861858 100 109 O
of NCT03861858 110 112 O
at NCT03861858 113 115 B-Eq_Comparison
least NCT03861858 116 121 I-Eq_Comparison
one NCT03861858 122 125 I-Eq_Comparison
responsible NCT03861858 126 137 O
adult NCT03861858 138 143 O
parent NCT03861858 144 150 B-Family_Member___Family_Member_Type:parent
/ NCT03861858 151 152 O
caregiver NCT03861858 153 162 O
to NCT03861858 163 165 O
participate NCT03861858 166 177 O
in NCT03861858 178 180 O
treatment NCT03861858 181 190 B-Procedure
. NCT03861858 191 192 O

- NCT03861858 196 197 O
Agreement NCT03861858 199 208 O
to NCT03861858 209 211 O
take NCT03861858 212 216 O
part NCT03861858 217 221 O
in NCT03861858 222 224 O
assessments NCT03861858 225 236 O
, NCT03861858 237 238 O
videotaping NCT03861858 239 250 O
/ NCT03861858 251 252 O
audiotaping NCT03861858 253 264 O
and NCT03861858 265 268 O
coding NCT03861858 269 275 O
of NCT03861858 276 278 O
their NCT03861858 279 284 O
sessions NCT03861858 285 293 O
by NCT03861858 294 296 O
research NCT03861858 297 305 O
personnel NCT03861858 306 315 O
. NCT03861858 316 317 O

- NCT03861858 321 322 O
Agreement NCT03861858 324 333 O
to NCT03861858 334 336 O
pay NCT03861858 337 340 O
for NCT03861858 341 344 O
mental NCT03861858 345 351 O
health NCT03861858 352 358 O
services NCT03861858 359 367 O
at NCT03861858 368 370 O
the NCT03861858 371 374 O
DBT NCT03861858 375 378 O
- NCT03861858 379 380 O
RU NCT03861858 381 383 O
on NCT03861858 384 386 O
a NCT03861858 387 388 O
sliding NCT03861858 389 396 O
scale NCT03861858 397 402 O
, NCT03861858 403 404 O
and NCT03861858 405 408 O
to NCT03861858 409 411 O
participate NCT03861858 412 423 O
in NCT03861858 424 426 O
research NCT03861858 427 435 O
assessments NCT03861858 436 447 O
as NCT03861858 448 450 O
volunteers NCT03861858 451 461 O
. NCT03861858 462 463 O

- NCT03861858 467 468 O
Residence NCT03861858 470 479 O
within NCT03861858 480 486 O
commuting NCT03861858 487 496 B-Observation
distance NCT03861858 497 505 I-Observation
of NCT03861858 506 508 O
clinic NCT03861858 509 515 O
( NCT03861858 516 517 O
< NCT03861858 518 519 B-Eq_Comparison
45 NCT03861858 520 522 I-Eq_Comparison
minutes NCT03861858 523 530 I-Eq_Comparison
) NCT03861858 531 532 O
. NCT03861858 533 534 O

- NCT03861858 538 539 O
Agreement NCT03861858 541 550 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03861858 551 553 O
discontinue NCT03861858 554 565 B-Negation
other NCT03861858 566 571 O
forms NCT03861858 572 577 O
of NCT03861858 578 580 O
talk NCT03861858 581 585 B-Procedure
therapy NCT03861858 586 593 I-Procedure
for NCT03861858 594 597 B-Temporal_Connection___Temporal_Connection_Type_Value:during
duration NCT03861858 598 606 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03861858 607 609 O
DBT NCT03861858 610 613 B-Procedure
program NCT03861858 614 621 I-Procedure
( NCT03861858 622 623 O
does NCT03861858 624 628 B-Exception
not NCT03861858 629 632 I-Exception
refer NCT03861858 633 638 I-Exception
to NCT03861858 639 641 I-Exception
AA NCT03861858 642 644 B-Modifier
/ NCT03861858 645 646 B-Or
NA NCT03861858 647 649 B-Modifier
programs NCT03861858 650 658 B-Procedure
or NCT03861858 659 661 B-Or
psychotropic NCT03861858 662 674 B-Drug
medication NCT03861858 675 685 I-Drug
management NCT03861858 686 696 B-Procedure
) NCT03861858 697 698 O
. NCT03861858 699 700 O

- NCT03861858 704 705 O
Exhibits NCT03861858 707 715 O
dysregulation NCT03861858 716 729 B-Condition
within NCT03861858 730 736 B-Eq_Comparison
the NCT03861858 737 740 I-Eq_Comparison
past NCT03861858 741 745 I-Eq_Comparison
six NCT03861858 746 749 I-Eq_Comparison
months NCT03861858 750 756 I-Eq_Comparison
as NCT03861858 757 759 O
evidenced NCT03861858 760 769 O
by NCT03861858 770 772 O
1 NCT03861858 773 774 O
) NCT03861858 775 776 O
intentional NCT03861858 777 788 B-Modifier
self NCT03861858 789 793 B-Condition
- NCT03861858 794 795 I-Condition
injury NCT03861858 796 802 I-Condition
and NCT03861858 803 806 B-Or
/ NCT03861858 807 808 I-Or
or NCT03861858 809 811 I-Or
suicide NCT03861858 812 819 B-Condition
attempt NCT03861858 820 827 I-Condition
and NCT03861858 828 831 B-Or
/ NCT03861858 832 833 I-Or
or NCT03861858 834 836 I-Or
2 NCT03861858 837 838 O
) NCT03861858 839 840 O
substance NCT03861858 841 850 B-Condition
use NCT03861858 851 854 I-Condition
disorder NCT03861858 855 863 I-Condition
. NCT03861858 864 865 O

- NCT03861858 869 870 O
Meets NCT03861858 872 877 O
two NCT03861858 878 881 B-Eq_Comparison
additional NCT03861858 882 892 O
criteria NCT03861858 893 901 O
for NCT03861858 902 905 O
borderline NCT03861858 906 916 B-Condition
personality NCT03861858 917 928 I-Condition
disorder NCT03861858 929 937 I-Condition
( NCT03861858 938 939 O
BPD NCT03861858 940 943 B-Condition
) NCT03861858 944 945 O
. NCT03861858 946 947 O

Exclusion NCT03861858 949 958 O
Criteria NCT03861858 959 967 O
: NCT03861858 968 969 O

- NCT03861858 973 974 O
Clients NCT03861858 976 983 O
who NCT03861858 984 987 O
need NCT03861858 988 992 B-Assertion___Assertion_Type_Value:hypothetical
mental NCT03861858 993 999 B-Procedure
health NCT03861858 1000 1006 I-Procedure
services NCT03861858 1007 1015 I-Procedure
not NCT03861858 1016 1019 B-Negation
available NCT03861858 1020 1029 O
at NCT03861858 1030 1032 O
the NCT03861858 1033 1036 O
DBT NCT03861858 1037 1040 O
- NCT03861858 1041 1042 O
RU NCT03861858 1043 1045 O
, NCT03861858 1046 1047 O
such NCT03861858 1048 1052 O
as NCT03861858 1053 1055 O
treatment NCT03861858 1056 1065 B-Procedure
for NCT03861858 1066 1069 O
schizophrenia NCT03861858 1070 1083 B-Condition
or NCT03861858 1084 1086 B-Or
life NCT03861858 1087 1091 B-Death|B-Risk
- NCT03861858 1092 1093 I-Death|I-Risk
threatening NCT03861858 1094 1105 I-Death|I-Risk
anorexia NCT03861858 1106 1114 B-Condition
, NCT03861858 1115 1116 O
or NCT03861858 1117 1119 B-Or
who NCT03861858 1120 1123 O
are NCT03861858 1124 1127 O
currently NCT03861858 1128 1137 B-Eq_Comparison
obtaining NCT03861858 1138 1147 O
optimum NCT03861858 1148 1155 O
professional NCT03861858 1156 1168 B-Procedure
treatment NCT03861858 1169 1178 I-Procedure
that NCT03861858 1179 1183 O
should NCT03861858 1184 1190 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03861858 1191 1194 B-Negation
be NCT03861858 1195 1197 O
ended NCT03861858 1198 1203 B-Negation
. NCT03861858 1204 1205 O

- NCT03861858 1209 1210 O
Non NCT03861858 1212 1215 B-Negation
- NCT03861858 1216 1217 O
English NCT03861858 1218 1225 O
speaking NCT03861858 1226 1234 O
. NCT03861858 1235 1236 O

- NCT03861858 1240 1241 O
IQ NCT03861858 1243 1245 B-Observation
< NCT03861858 1246 1247 B-Eq_Comparison
70 NCT03861858 1248 1250 I-Eq_Comparison
. NCT03861858 1250 1251 O

- NCT03861858 1255 1256 O
Unable NCT03861858 1258 1264 O
to NCT03861858 1265 1267 O
understand NCT03861858 1268 1278 O
research NCT03861858 1279 1287 O
consent NCT03861858 1288 1295 O
forms NCT03861858 1296 1301 O
. NCT03861858 1302 1303 O

- NCT03861858 1307 1308 O
Court NCT03861858 1310 1315 B-Observation
- NCT03861858 1316 1317 I-Observation
ordered NCT03861858 1318 1325 I-Observation
to NCT03861858 1326 1328 O
participate NCT03861858 1329 1340 O
in NCT03861858 1341 1343 O
treatment NCT03861858 1344 1353 B-Procedure
. NCT03861858 1354 1355 O

Inclusion NCT03863171 0 9 O
Criteria NCT03863171 10 18 O
: NCT03863171 19 20 O

- NCT03863171 24 25 O
Ocular NCT03863171 27 33 B-Condition
ischemia NCT03863171 34 42 I-Condition
syndrome NCT03863171 43 51 I-Condition
group NCT03863171 52 57 O
: NCT03863171 58 59 O
Patients NCT03863171 60 68 O
diagnosed NCT03863171 69 78 O
with NCT03863171 79 83 O
ocular NCT03863171 84 90 B-Condition
ischemia NCT03863171 91 99 I-Condition
syndrome NCT03863171 100 108 I-Condition
; NCT03863171 108 109 O

- NCT03863171 112 113 O
Age NCT03863171 115 118 B-Modifier
- NCT03863171 119 120 I-Modifier
related NCT03863171 121 128 I-Modifier
macular NCT03863171 129 136 B-Condition
degeneration NCT03863171 137 149 I-Condition
group NCT03863171 150 155 O
( NCT03863171 156 157 O
Control NCT03863171 158 165 O
group NCT03863171 166 171 O
) NCT03863171 172 173 O
: NCT03863171 174 175 O
Patients NCT03863171 176 184 O
diagnosed NCT03863171 185 194 O
with NCT03863171 195 199 O
age NCT03863171 200 203 B-Modifier
- NCT03863171 204 205 I-Modifier
related NCT03863171 206 213 I-Modifier
macular NCT03863171 214 221 B-Condition
degeneration NCT03863171 222 234 I-Condition
; NCT03863171 234 235 O

- NCT03863171 238 239 O
Age NCT03863171 241 244 B-Age
: NCT03863171 245 246 O
50 NCT03863171 247 249 B-Eq_Comparison
- NCT03863171 250 251 I-Eq_Comparison
80 NCT03863171 252 254 I-Eq_Comparison
years NCT03863171 255 260 I-Eq_Comparison
; NCT03863171 260 261 O

- NCT03863171 264 265 O
Sex NCT03863171 267 270 O
: NCT03863171 271 272 O
all NCT03863171 273 276 O
; NCT03863171 276 277 O

- NCT03863171 280 281 O
Patients NCT03863171 283 291 O
signed NCT03863171 292 298 O
written NCT03863171 299 306 O
informed NCT03863171 307 315 O
consent NCT03863171 316 323 O
. NCT03863171 324 325 O

Exclusion NCT03863171 327 336 O
Criteria NCT03863171 337 345 O
: NCT03863171 346 347 O

- NCT03863171 351 352 O
Fundus NCT03863171 354 360 B-Procedure
fluorescein NCT03863171 361 372 I-Procedure
angiography NCT03863171 373 384 I-Procedure
( NCT03863171 385 386 O
FFA NCT03863171 387 390 B-Procedure
) NCT03863171 391 392 O
clear NCT03863171 393 398 O
images NCT03863171 399 405 O
can NCT03863171 406 409 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
not NCT03863171 409 412 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
be NCT03863171 413 415 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
obtained NCT03863171 416 424 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
due NCT03863171 425 428 O
to NCT03863171 429 431 O
refractive NCT03863171 432 442 B-Condition
media NCT03863171 443 448 I-Condition
problems NCT03863171 449 457 I-Condition
( NCT03863171 458 459 O
such NCT03863171 460 464 O
as NCT03863171 465 467 O
corneal NCT03863171 468 475 B-Condition
leukoplakia NCT03863171 476 487 I-Condition
, NCT03863171 488 489 O
severe NCT03863171 490 496 O
cataract NCT03863171 497 505 B-Condition
, NCT03863171 506 507 O
vitreous NCT03863171 508 516 B-Condition
hemorrhage NCT03863171 517 527 I-Condition
, NCT03863171 528 529 O
etc NCT03863171 530 533 O
. NCT03863171 534 535 O
) NCT03863171 536 537 O
; NCT03863171 538 539 O

- NCT03863171 542 543 O
Patients NCT03863171 545 553 O
with NCT03863171 554 558 O
contraindications NCT03863171 559 576 B-Contraindication
for NCT03863171 577 580 O
FFA NCT03863171 581 584 B-Procedure
; NCT03863171 584 585 O

- NCT03863171 588 589 O
Patients NCT03863171 591 599 O
was NCT03863171 600 603 O
unable NCT03863171 604 610 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03863171 611 613 O
perform NCT03863171 614 621 O
magnetic NCT03863171 622 630 B-Procedure
resonance NCT03863171 631 640 I-Procedure
rmaging NCT03863171 641 648 I-Procedure
( NCT03863171 649 650 O
MRI NCT03863171 651 654 B-Procedure
) NCT03863171 655 656 O
test NCT03863171 657 661 O
; NCT03863171 661 662 O

- NCT03863171 665 666 O
Patients NCT03863171 668 676 O
with NCT03863171 677 681 O
history NCT03863171 682 689 B-Eq_Comparison
of NCT03863171 690 692 O
bleeding NCT03863171 693 701 B-Condition
and NCT03863171 702 705 B-Or
cerebral NCT03863171 706 714 B-Condition
infarction NCT03863171 715 725 I-Condition
; NCT03863171 725 726 O

- NCT03863171 729 730 O
Patients NCT03863171 732 740 O
with NCT03863171 741 745 O
a NCT03863171 746 747 O
history NCT03863171 748 755 B-Eq_Comparison
of NCT03863171 756 758 O
surgery NCT03863171 759 766 B-Procedure
within NCT03863171 767 773 B-Eq_Comparison
3 NCT03863171 774 775 I-Eq_Comparison
months NCT03863171 776 782 I-Eq_Comparison
; NCT03863171 782 783 O

- NCT03863171 786 787 O
Patients NCT03863171 789 797 O
who NCT03863171 798 801 O
had NCT03863171 802 805 O
participated NCT03863171 806 818 O
in NCT03863171 819 821 O
other NCT03863171 822 827 B-Other
clinical NCT03863171 828 836 B-Study
trials NCT03863171 837 843 I-Study
within NCT03863171 844 850 B-Eq_Comparison
3 NCT03863171 851 852 I-Eq_Comparison
months NCT03863171 853 859 I-Eq_Comparison
; NCT03863171 859 860 O

- NCT03863171 863 864 O
Patients NCT03863171 866 874 O
who NCT03863171 875 878 O
disagree NCT03863171 879 887 O
and NCT03863171 888 891 O
refuse NCT03863171 892 898 O
to NCT03863171 899 901 O
participate NCT03863171 902 913 O
in NCT03863171 914 916 O
the NCT03863171 917 920 O
trial NCT03863171 921 926 O
. NCT03863171 927 928 O

Inclusion NCT03929692 0 9 O
Criteria NCT03929692 10 18 O
: NCT03929692 19 20 O

- NCT03929692 24 25 O
Intervention NCT03929692 27 39 O
group NCT03929692 40 45 O
: NCT03929692 46 47 O
Participants NCT03929692 48 60 O
must NCT03929692 61 65 O
be NCT03929692 66 68 O
in NCT03929692 69 71 O
10 NCT03929692 72 74 O
th NCT03929692 75 77 O
school NCT03929692 78 84 O
grade NCT03929692 85 90 O
or NCT03929692 91 93 O
aged NCT03929692 94 98 B-Age
15 NCT03929692 99 101 B-Eq_Comparison
to NCT03929692 102 104 I-Eq_Comparison
16 NCT03929692 105 107 I-Eq_Comparison
years NCT03929692 108 113 I-Eq_Comparison
when NCT03929692 114 118 O
recruited NCT03929692 119 128 O
in NCT03929692 129 131 O
training NCT03929692 132 140 O
companies NCT03929692 141 150 O
. NCT03929692 151 152 O

- NCT03929692 156 157 O
Control NCT03929692 159 166 O
Group NCT03929692 167 172 O
: NCT03929692 173 174 O
Participants NCT03929692 175 187 O
must NCT03929692 188 192 O
be NCT03929692 193 195 O
in NCT03929692 196 198 O
12 NCT03929692 199 201 O
th NCT03929692 202 204 O
school NCT03929692 205 211 O
grade NCT03929692 212 217 O
or NCT03929692 218 220 O
aged NCT03929692 221 225 B-Age
17 NCT03929692 226 228 B-Eq_Comparison
to NCT03929692 229 231 I-Eq_Comparison
18 NCT03929692 232 234 I-Eq_Comparison
years NCT03929692 235 240 I-Eq_Comparison
when NCT03929692 241 245 O
recruited NCT03929692 246 255 O
in NCT03929692 256 258 O
training NCT03929692 259 267 O
companies NCT03929692 268 277 O
. NCT03929692 278 279 O

Exclusion NCT03929692 281 290 O
Criteria NCT03929692 291 299 O
: NCT03929692 300 301 O

- NCT03929692 304 305 O
none NCT03929692 306 310 O

Inclusion NCT03865680 0 9 O
Criteria NCT03865680 10 18 O
: NCT03865680 19 20 O

- NCT03865680 24 25 O
Healthy NCT03865680 27 34 B-Condition
children NCT03865680 35 43 O
with NCT03865680 44 48 B-And
no NCT03865680 49 51 B-Negation
systemic NCT03865680 52 60 B-Modifier
diseases NCT03865680 61 69 B-Condition
. NCT03865680 70 71 O

- NCT03865680 75 76 O
High NCT03865680 78 82 O
caries NCT03865680 83 89 B-Condition
risk NCT03865680 90 94 B-Risk
children NCT03865680 95 103 O
with NCT03865680 104 108 B-And
the NCT03865680 109 112 O
presence NCT03865680 113 121 O
of NCT03865680 122 124 O
at NCT03865680 125 127 B-Eq_Comparison
least NCT03865680 128 133 I-Eq_Comparison
one NCT03865680 134 137 I-Eq_Comparison
visible NCT03865680 138 145 B-Modifier
active NCT03865680 146 152 B-Eq_Comparison
WSL NCT03865680 153 156 B-Condition
in NCT03865680 157 159 O
primary NCT03865680 160 167 B-Modifier
teeth NCT03865680 168 173 I-Modifier
with NCT03865680 174 178 B-And
ICDAS NCT03865680 179 184 B-Observation
II NCT03865680 185 187 I-Observation
score NCT03865680 188 193 I-Observation
of NCT03865680 194 196 O
1 NCT03865680 197 198 B-Eq_Comparison
, NCT03865680 199 200 I-Eq_Comparison
2 NCT03865680 201 202 I-Eq_Comparison
or NCT03865680 203 205 I-Eq_Comparison
3 NCT03865680 206 207 I-Eq_Comparison

- NCT03865680 211 212 O
Completion NCT03865680 214 224 O
of NCT03865680 225 227 O
a NCT03865680 228 229 O
parental NCT03865680 230 238 O
consent NCT03865680 239 246 O
to NCT03865680 247 249 O
participate NCT03865680 250 261 O
in NCT03865680 262 264 O
the NCT03865680 265 268 O
study NCT03865680 269 274 O
. NCT03865680 275 276 O

Exclusion NCT03865680 278 287 O
Criteria NCT03865680 288 296 O
: NCT03865680 297 298 O

- NCT03865680 302 303 O
Selected NCT03865680 305 313 B-Modifier
tooth NCT03865680 314 319 I-Modifier
with NCT03865680 320 324 O
cavitated NCT03865680 325 334 B-Condition
lesion NCT03865680 335 341 I-Condition
. NCT03865680 342 343 O

- NCT03865680 347 348 O
Selected NCT03865680 350 358 B-Modifier
tooth NCT03865680 359 364 I-Modifier
with NCT03865680 365 369 O
enamel NCT03865680 370 376 B-Condition
defects NCT03865680 377 384 I-Condition
. NCT03865680 385 386 O

- NCT03865680 390 391 O
Participants NCT03865680 393 405 O
allergic NCT03865680 406 414 B-Allergy
to NCT03865680 415 417 O
milk NCT03865680 418 422 O
products NCT03865680 423 431 O
. NCT03865680 432 433 O

Inclusion NCT03863392 0 9 O
Criteria NCT03863392 10 18 O
: NCT03863392 19 20 O

- NCT03863392 24 25 O
Primigravida NCT03863392 27 39 B-Condition
or NCT03863392 40 42 B-Or
Primipara NCT03863392 43 52 B-Condition

- NCT03863392 55 56 O
Pregnancy NCT03863392 58 67 B-Condition
between NCT03863392 68 75 B-Eq_Comparison
36 NCT03863392 76 78 I-Eq_Comparison
and NCT03863392 79 82 I-Eq_Comparison
42 NCT03863392 83 85 I-Eq_Comparison
weeks NCT03863392 86 91 I-Eq_Comparison
of NCT03863392 92 94 O
gestation NCT03863392 95 104 B-Observation
. NCT03863392 105 106 O

- NCT03863392 110 111 O
A NCT03863392 113 114 O
live NCT03863392 115 119 B-Modifier
singleton NCT03863392 120 129 B-Condition
fetus NCT03863392 130 135 I-Condition
in NCT03863392 136 138 O
cephalic NCT03863392 139 147 B-Modifier
presentation NCT03863392 148 160 I-Modifier
. NCT03863392 161 162 O

- NCT03863392 166 167 O
No NCT03863392 169 171 B-Negation
history NCT03863392 172 179 B-Eq_Comparison
of NCT03863392 180 182 O
uterine NCT03863392 183 190 B-Procedure
surgery NCT03863392 191 198 I-Procedure
. NCT03863392 199 200 O

- NCT03863392 204 205 O
Clinically NCT03863392 207 217 O
adequate NCT03863392 218 226 O
pelvis NCT03863392 227 233 B-Condition
. NCT03863392 234 235 O

- NCT03863392 239 240 O
Modified NCT03863392 242 250 B-Modifier
Bishop NCT03863392 251 257 B-Observation
's NCT03863392 257 259 I-Observation
score NCT03863392 260 265 I-Observation
< NCT03863392 266 267 B-Eq_Comparison
5 NCT03863392 268 269 I-Eq_Comparison
. NCT03863392 269 270 O

- NCT03863392 274 275 O
Reactive NCT03863392 277 285 O
Non NCT03863392 286 289 B-Procedure
stress NCT03863392 290 296 I-Procedure
test NCT03863392 297 301 I-Procedure
( NCT03863392 302 303 O
NST NCT03863392 304 307 B-Procedure
) NCT03863392 308 309 O
. NCT03863392 310 311 O

Exclusion NCT03863392 313 322 O
Criteria NCT03863392 323 331 O
: NCT03863392 332 333 O

- NCT03863392 337 338 O
•Known NCT03863392 340 346 O
hypersensitivity NCT03863392 347 363 B-Condition
or NCT03863392 364 366 B-Or
contraindications NCT03863392 367 384 B-Contraindication
to NCT03863392 385 387 O
oral NCT03863392 388 392 B-Modifier
misoprostol NCT03863392 393 404 B-Drug
( NCT03863392 405 406 O
uterine NCT03863392 407 414 B-Procedure
surgery NCT03863392 415 422 I-Procedure
) NCT03863392 423 424 O
. NCT03863392 425 426 O

- NCT03863392 435 436 O
Any NCT03863392 438 441 O
antenatal NCT03863392 442 451 B-Modifier
medical NCT03863392 452 459 O
complications NCT03863392 460 473 B-Condition
. NCT03863392 474 475 O

- NCT03863392 484 485 O
A NCT03863392 487 488 O
situation NCT03863392 489 498 B-Condition
requiring NCT03863392 499 508 B-Assertion___Assertion_Type_Value:hypothetical
LSCS NCT03863392 509 513 B-Procedure
( NCT03863392 514 515 O
Maternal NCT03863392 516 524 B-Modifier
or NCT03863392 525 527 B-Or
Fetal NCT03863392 528 533 B-Modifier
) NCT03863392 534 535 O
e NCT03863392 536 537 O
. NCT03863392 538 539 O
g NCT03863392 540 541 O
: NCT03863392 542 543 O
fetal NCT03863392 544 549 B-Condition
distress NCT03863392 550 558 I-Condition

- NCT03863392 566 567 O
Non NCT03863392 569 572 O
- NCT03863392 573 574 O
reactive NCT03863392 575 583 O
NST NCT03863392 584 587 B-Procedure
. NCT03863392 588 589 O

- NCT03863392 598 599 O
Patient NCT03863392 601 608 O
's NCT03863392 608 610 O
refusal NCT03863392 611 618 O
to NCT03863392 619 621 O
give NCT03863392 622 626 O
consent NCT03863392 627 634 O

Inclusion NCT03868189 0 9 O
Criteria NCT03868189 10 18 O
: NCT03868189 19 20 O

- NCT03868189 24 25 O
Patient NCT03868189 27 34 O
requiring NCT03868189 35 44 B-Assertion___Assertion_Type_Value:hypothetical
an NCT03868189 45 47 O
electroneuromyogram NCT03868189 48 67 B-Procedure
whose NCT03868189 68 73 O
indication NCT03868189 74 84 B-Indication
allows NCT03868189 85 91 O
the NCT03868189 92 95 O
application NCT03868189 96 107 O
of NCT03868189 108 110 O
a NCT03868189 111 112 O
standard NCT03868189 113 121 B-Modifier
protocol NCT03868189 122 130 I-Modifier
of NCT03868189 131 133 O
examination NCT03868189 134 145 B-Procedure
. NCT03868189 146 147 O

- NCT03868189 151 152 O
Patient NCT03868189 154 161 O
that NCT03868189 162 166 O
has NCT03868189 167 170 O
given NCT03868189 171 176 O
his NCT03868189 177 180 O
/ NCT03868189 181 182 O
her NCT03868189 183 186 O
free NCT03868189 187 191 O
and NCT03868189 192 195 O
informed NCT03868189 196 204 O
consent NCT03868189 205 212 O
. NCT03868189 213 214 O

- NCT03868189 218 219 O
Patient NCT03868189 221 228 O
that NCT03868189 229 233 O
signed NCT03868189 234 240 O
the NCT03868189 241 244 O
consent NCT03868189 245 252 O
form NCT03868189 253 257 O
. NCT03868189 258 259 O

- NCT03868189 263 264 O
Patient NCT03868189 266 273 O
with NCT03868189 274 278 O
an NCT03868189 279 281 O
health NCT03868189 282 288 O
insurance NCT03868189 289 298 O
plan NCT03868189 299 303 O
. NCT03868189 304 305 O

- NCT03868189 309 310 O
The NCT03868189 312 315 O
patient NCT03868189 316 323 O
is NCT03868189 324 326 O
at NCT03868189 327 329 B-Eq_Comparison
least NCT03868189 330 335 I-Eq_Comparison
18 NCT03868189 336 338 I-Eq_Comparison
years NCT03868189 339 344 I-Eq_Comparison
old NCT03868189 345 348 B-Age
( NCT03868189 349 350 O
≥ NCT03868189 351 352 O
) NCT03868189 353 354 O
. NCT03868189 355 356 O

- NCT03868189 360 361 O
he NCT03868189 363 365 O
patient NCT03868189 366 373 O
is NCT03868189 374 376 O
under NCT03868189 377 382 B-Eq_Comparison
80 NCT03868189 383 385 I-Eq_Comparison
years NCT03868189 386 391 I-Eq_Comparison
old NCT03868189 392 395 B-Age
( NCT03868189 396 397 O
≤ NCT03868189 398 399 O
) NCT03868189 400 401 O
. NCT03868189 402 403 O

Exclusion NCT03868189 405 414 O
Criteria NCT03868189 415 423 O
: NCT03868189 424 425 O

- NCT03868189 429 430 O
Patient NCT03868189 432 439 O
with NCT03868189 440 444 O
symptoms NCT03868189 445 453 B-Assertion___Assertion_Type_Value:possible
of NCT03868189 454 456 O
neuropathy NCT03868189 457 467 B-Condition
during NCT03868189 468 474 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03868189 475 478 O
screening NCT03868189 479 488 B-Study
. NCT03868189 489 490 O

- NCT03868189 494 495 O
Patient NCT03868189 497 504 O
whose NCT03868189 505 510 O
Neurological NCT03868189 511 523 B-Observation
severity NCT03868189 524 532 I-Observation
score NCT03868189 533 538 I-Observation
( NCT03868189 539 540 O
NSS NCT03868189 541 544 B-Observation
) NCT03868189 545 546 O
score NCT03868189 547 552 O
is NCT03868189 553 555 O
≥ NCT03868189 556 557 B-Eq_Comparison
3 NCT03868189 558 559 I-Eq_Comparison
. NCT03868189 559 560 O

- NCT03868189 564 565 O
Patient NCT03868189 567 574 O
whose NCT03868189 575 580 O
neurological NCT03868189 581 593 B-Procedure
examination NCT03868189 594 605 I-Procedure
is NCT03868189 606 608 O
abnormal NCT03868189 609 617 O
and NCT03868189 618 621 B-Or
suggestive NCT03868189 622 632 B-Assertion___Assertion_Type_Value:possible
of NCT03868189 633 635 O
neuropathy NCT03868189 636 646 B-Condition
. NCT03868189 647 648 O

- NCT03868189 652 653 O
Patient NCT03868189 655 662 O
presenting NCT03868189 663 673 O
a NCT03868189 674 675 O
pathology NCT03868189 676 685 B-Condition
that NCT03868189 686 690 O
could NCT03868189 691 696 B-Assertion___Assertion_Type_Value:hypothetical
cause NCT03868189 697 702 O
neuropathy NCT03868189 703 713 B-Condition
( NCT03868189 714 715 O
e NCT03868189 716 717 O
. NCT03868189 718 719 O
g NCT03868189 720 721 O
. NCT03868189 722 723 O
diabetes NCT03868189 725 733 B-Condition
, NCT03868189 734 735 O
renal NCT03868189 736 741 B-Condition
failure NCT03868189 742 749 I-Condition
, NCT03868189 750 751 O
etc NCT03868189 752 755 O
. NCT03868189 756 757 O
) NCT03868189 758 759 O
. NCT03868189 760 761 O

- NCT03868189 765 766 O
Patient NCT03868189 768 775 O
already NCT03868189 776 783 O
participating NCT03868189 784 797 O
in NCT03868189 798 800 O
a NCT03868189 801 802 O
category NCT03868189 803 811 O
1 NCT03868189 812 813 O
research NCT03868189 814 822 O
study NCT03868189 823 828 O
( NCT03868189 829 830 O
Jardé NCT03868189 831 836 O
law NCT03868189 837 840 O
) NCT03868189 841 842 O
. NCT03868189 843 844 O

- NCT03868189 848 849 O
Patient NCT03868189 851 858 O
in NCT03868189 859 861 O
an NCT03868189 862 864 O
exclusion NCT03868189 865 874 O
period NCT03868189 875 881 O
determined NCT03868189 882 892 O
by NCT03868189 893 895 O
another NCT03868189 896 903 B-Other
study NCT03868189 904 909 B-Study
. NCT03868189 910 911 O

- NCT03868189 915 916 O
Patient NCT03868189 918 925 O
under NCT03868189 926 931 O
the NCT03868189 932 935 O
protection NCT03868189 936 946 B-Observation
of NCT03868189 947 949 I-Observation
justice NCT03868189 950 957 I-Observation
, NCT03868189 958 959 O
under NCT03868189 960 965 B-Observation
guardianship NCT03868189 966 978 I-Observation
or NCT03868189 979 981 B-Or
under NCT03868189 982 987 O
curatorship NCT03868189 988 999 B-Observation
. NCT03868189 1000 1001 O

- NCT03868189 1005 1006 O
Patient NCT03868189 1008 1015 O
refusing NCT03868189 1016 1024 O
to NCT03868189 1025 1027 O
sign NCT03868189 1028 1032 O
the NCT03868189 1033 1036 O
consent NCT03868189 1037 1044 O
form NCT03868189 1045 1049 O
. NCT03868189 1050 1051 O

- NCT03868189 1055 1056 O
Patient NCT03868189 1058 1065 O
for NCT03868189 1066 1069 O
which NCT03868189 1070 1075 O
it NCT03868189 1076 1078 O
is NCT03868189 1079 1081 O
impossible NCT03868189 1082 1092 O
to NCT03868189 1093 1095 O
provide NCT03868189 1096 1103 O
information NCT03868189 1104 1115 O
about NCT03868189 1116 1121 O
the NCT03868189 1122 1125 O
study NCT03868189 1126 1131 B-Study
. NCT03868189 1132 1133 O

- NCT03868189 1137 1138 O
Pregnant NCT03868189 1140 1148 B-Condition
patient NCT03868189 1149 1156 O
, NCT03868189 1157 1158 O
parturient NCT03868189 1159 1169 B-Condition
, NCT03868189 1170 1171 O
or NCT03868189 1172 1174 B-Or
breastfeeding NCT03868189 1175 1188 B-Condition
. NCT03868189 1189 1190 O

Inclusion NCT03860584 0 9 O
Criteria NCT03860584 10 18 O
: NCT03860584 19 20 O

- NCT03860584 24 25 O
Serum NCT03860584 27 32 B-Observation
Glucose NCT03860584 33 40 I-Observation
100 NCT03860584 41 44 B-Eq_Comparison
- NCT03860584 45 46 I-Eq_Comparison
126 NCT03860584 47 50 I-Eq_Comparison
mg NCT03860584 51 53 I-Eq_Comparison
/ NCT03860584 54 55 I-Eq_Comparison
dl NCT03860584 56 58 I-Eq_Comparison

- NCT03860584 61 62 O
Waist NCT03860584 64 69 B-Observation
C NCT03860584 70 71 I-Observation
> NCT03860584 72 73 B-Eq_Comparison
89 NCT03860584 74 76 I-Eq_Comparison
/ NCT03860584 77 78 I-Eq_Comparison
102 NCT03860584 79 82 I-Eq_Comparison
cm NCT03860584 83 85 I-Eq_Comparison
; NCT03860584 85 86 O
F NCT03860584 87 88 O
/ NCT03860584 89 90 B-Or
M NCT03860584 91 92 O

- NCT03860584 95 96 O
Serum NCT03860584 98 103 B-Observation
HDL NCT03860584 104 107 I-Observation
- NCT03860584 108 109 I-Observation
C NCT03860584 110 111 I-Observation
: NCT03860584 112 113 O
< NCT03860584 114 115 B-Eq_Comparison
50 NCT03860584 116 118 I-Eq_Comparison
/ NCT03860584 119 120 I-Eq_Comparison
40 NCT03860584 121 123 I-Eq_Comparison
mg NCT03860584 124 126 I-Eq_Comparison
/ NCT03860584 127 128 I-Eq_Comparison
dl NCT03860584 129 131 I-Eq_Comparison
; NCT03860584 131 132 O
F NCT03860584 133 134 O
/ NCT03860584 135 136 B-Or
M NCT03860584 137 138 O

- NCT03860584 141 142 O
Serum NCT03860584 144 149 B-Observation
TG NCT03860584 150 152 I-Observation
: NCT03860584 153 154 O
> NCT03860584 155 156 B-Eq_Comparison
150 NCT03860584 157 160 I-Eq_Comparison
mg NCT03860584 161 163 I-Eq_Comparison
/ NCT03860584 164 165 I-Eq_Comparison
dl NCT03860584 166 168 I-Eq_Comparison

- NCT03860584 171 172 O
BP NCT03860584 174 176 B-Observation
> NCT03860584 177 178 B-Eq_Comparison
130 NCT03860584 179 182 I-Eq_Comparison
/ NCT03860584 183 184 I-Eq_Comparison
85 NCT03860584 185 187 I-Eq_Comparison
mmHg NCT03860584 188 192 I-Eq_Comparison

- NCT03860584 195 196 O
Serum NCT03860584 198 203 B-Observation
Endotoxin NCT03860584 204 213 I-Observation
> NCT03860584 214 215 B-Eq_Comparison
25 NCT03860584 216 218 I-Eq_Comparison
EU NCT03860584 219 221 I-Eq_Comparison
/ NCT03860584 222 223 I-Eq_Comparison
ml NCT03860584 224 226 I-Eq_Comparison

Exclusion NCT03860584 227 236 O
Criteria NCT03860584 237 245 O
: NCT03860584 246 247 O

- NCT03860584 251 252 O
Unstable NCT03860584 254 262 O
body NCT03860584 263 267 B-Observation
mass NCT03860584 268 272 I-Observation
( NCT03860584 273 274 O
± NCT03860584 275 276 B-Eq_Comparison
2 NCT03860584 277 278 I-Eq_Comparison
kg NCT03860584 279 281 I-Eq_Comparison
over NCT03860584 282 286 O
prior NCT03860584 287 292 B-Eq_Comparison
3 NCT03860584 293 294 I-Eq_Comparison
- NCT03860584 295 296 I-Eq_Comparison
mo NCT03860584 297 299 I-Eq_Comparison
) NCT03860584 300 301 O

- NCT03860584 305 306 O
Vegetarian NCT03860584 308 318 B-Condition

- NCT03860584 321 322 O
Food NCT03860584 324 328 O
allergies NCT03860584 329 338 B-Allergy
or NCT03860584 339 341 B-Or
lactose NCT03860584 342 349 B-Condition
intolerance NCT03860584 350 361 I-Condition

- NCT03860584 364 365 O
User NCT03860584 367 371 B-Eq_Comparison
of NCT03860584 372 374 O
dietary NCT03860584 375 382 B-Drug
supplements NCT03860584 383 394 I-Drug
or NCT03860584 395 397 B-Or
probiotics NCT03860584 398 408 B-Drug
( NCT03860584 409 410 O
within NCT03860584 411 417 B-Eq_Comparison
past NCT03860584 418 422 I-Eq_Comparison
1 NCT03860584 423 424 I-Eq_Comparison
- NCT03860584 425 426 I-Eq_Comparison
mo NCT03860584 427 429 I-Eq_Comparison
) NCT03860584 430 431 O

- NCT03860584 435 436 O
Pregnancy NCT03860584 438 447 B-Condition
, NCT03860584 448 449 O
lactation NCT03860584 450 459 B-Condition
, NCT03860584 460 461 O
changes NCT03860584 462 469 O
in NCT03860584 470 472 O
birth NCT03860584 473 478 B-Procedure
control NCT03860584 479 486 I-Procedure
( NCT03860584 487 488 O
within NCT03860584 489 495 B-Eq_Comparison
6 NCT03860584 496 497 I-Eq_Comparison
- NCT03860584 498 499 I-Eq_Comparison
mo NCT03860584 500 502 I-Eq_Comparison
) NCT03860584 503 504 O

- NCT03860584 508 509 O
Any NCT03860584 511 514 O
gastrointestinal NCT03860584 515 531 B-Condition
disorders NCT03860584 532 541 I-Condition

- NCT03860584 544 545 O
Chronic NCT03860584 547 554 O
diarrhea NCT03860584 555 563 B-Condition

- NCT03860584 566 567 O
Smoker NCT03860584 569 575 B-Condition

- NCT03860584 578 579 O
Excess NCT03860584 581 587 O
alcohol NCT03860584 588 595 B-Observation
( NCT03860584 596 597 O
> NCT03860584 598 599 B-Eq_Comparison
2 NCT03860584 600 601 I-Eq_Comparison
drinks NCT03860584 602 608 I-Eq_Comparison
/ NCT03860584 609 610 I-Eq_Comparison
d NCT03860584 611 612 I-Eq_Comparison
) NCT03860584 613 614 O

- NCT03860584 618 619 O
Excess NCT03860584 621 627 O
aerobic NCT03860584 628 635 B-Observation
exercise NCT03860584 636 644 I-Observation
( NCT03860584 645 646 O
> NCT03860584 647 648 B-Eq_Comparison
5 NCT03860584 649 650 I-Eq_Comparison
h NCT03860584 651 652 I-Eq_Comparison
/ NCT03860584 653 654 I-Eq_Comparison
wk NCT03860584 655 657 I-Eq_Comparison
) NCT03860584 658 659 O

- NCT03860584 663 664 O
Recent NCT03860584 666 672 B-Eq_Comparison
antibiotic NCT03860584 673 683 B-Drug
or NCT03860584 684 686 B-Or
anti NCT03860584 687 691 B-Drug
- NCT03860584 692 693 I-Drug
inflammatory NCT03860584 694 706 I-Drug
agent NCT03860584 707 712 I-Drug
use NCT03860584 713 716 O

- NCT03860584 719 720 O
BP NCT03860584 722 724 B-Observation
> NCT03860584 725 726 B-Eq_Comparison
140 NCT03860584 727 730 I-Eq_Comparison
/ NCT03860584 731 732 I-Eq_Comparison
90 NCT03860584 733 735 I-Eq_Comparison
mmHg NCT03860584 736 740 I-Eq_Comparison

Inclusion NCT03929809 0 9 O
Criteria NCT03929809 10 18 O
: NCT03929809 19 20 O

1 NCT03929809 24 25 O
. NCT03929809 25 26 O
Participants NCT03929809 28 40 O
will NCT03929809 41 45 O
be NCT03929809 46 48 O
adults NCT03929809 49 55 O
who NCT03929809 56 59 B-And
utilize NCT03929809 60 67 O
English NCT03929809 68 75 O
as NCT03929809 76 78 O
their NCT03929809 79 84 O
primary NCT03929809 85 92 O
language NCT03929809 93 101 O
. NCT03929809 102 103 O

2 NCT03929809 107 108 O
. NCT03929809 108 109 O
Unilateral NCT03929809 111 121 O
severe NCT03929809 122 128 O
to NCT03929809 129 131 O
profound NCT03929809 132 140 B-Condition
sensorineural NCT03929809 141 154 I-Condition
hearing NCT03929809 155 162 I-Condition
loss NCT03929809 163 167 I-Condition
for NCT03929809 168 171 O
a NCT03929809 172 173 O
duration NCT03929809 174 182 O
of NCT03929809 183 185 O
at NCT03929809 186 188 B-Eq_Comparison
least NCT03929809 189 194 I-Eq_Comparison
6 NCT03929809 195 196 I-Eq_Comparison
months NCT03929809 197 203 I-Eq_Comparison
( NCT03929809 204 205 O
to NCT03929809 206 208 B-Assertion___Assertion_Type_Value:hypothetical
ensure NCT03929809 209 215 I-Assertion___Assertion_Type_Value:hypothetical
stability NCT03929809 216 225 I-Assertion___Assertion_Type_Value:hypothetical
of NCT03929809 226 228 O
hearing NCT03929809 229 236 B-Condition
loss NCT03929809 237 241 I-Condition
) NCT03929809 242 243 O
, NCT03929809 244 245 O
but NCT03929809 246 249 O
no NCT03929809 250 252 B-Eq_Comparison
greater NCT03929809 253 260 I-Eq_Comparison
than NCT03929809 261 265 I-Eq_Comparison
10 NCT03929809 266 268 I-Eq_Comparison
years NCT03929809 269 274 I-Eq_Comparison
. NCT03929809 275 276 O

3 NCT03929809 280 281 O
. NCT03929809 281 282 O
Contralateral NCT03929809 284 297 B-Condition
ear NCT03929809 298 301 I-Condition
with NCT03929809 302 306 B-And
normal NCT03929809 307 313 O
, NCT03929809 314 315 O
or NCT03929809 316 318 B-Or
near NCT03929809 319 323 O
- NCT03929809 324 325 O
normal NCT03929809 326 332 O
, NCT03929809 333 334 O
hearing NCT03929809 335 342 B-Condition
. NCT03929809 343 344 O

4 NCT03929809 348 349 O
. NCT03929809 349 350 O
Poorer NCT03929809 352 358 B-Condition
ear NCT03929809 359 362 I-Condition
( NCT03929809 363 364 O
ear NCT03929809 365 368 B-Modifier
to NCT03929809 369 371 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03929809 372 374 I-Assertion___Assertion_Type_Value:hypothetical
implanted NCT03929809 375 384 B-Procedure
) NCT03929809 385 386 O
: NCT03929809 387 388 O
severe NCT03929809 389 395 O
to NCT03929809 396 398 O
profound NCT03929809 399 407 B-Condition
sensorineural NCT03929809 408 421 I-Condition
hearing NCT03929809 422 429 I-Condition
loss NCT03929809 430 434 I-Condition
, NCT03929809 435 436 O
defined NCT03929809 437 444 O
as NCT03929809 445 447 O
pure NCT03929809 448 452 B-Observation
- NCT03929809 453 454 I-Observation
tone NCT03929809 455 459 I-Observation
thresholds NCT03929809 460 470 I-Observation
70 NCT03929809 471 473 B-Eq_Comparison
dB NCT03929809 474 476 I-Eq_Comparison
HL NCT03929809 477 479 I-Eq_Comparison
or NCT03929809 480 482 I-Eq_Comparison
greater NCT03929809 483 490 I-Eq_Comparison
for NCT03929809 491 494 O
the NCT03929809 495 498 O
frequencies NCT03929809 499 510 O
500 NCT03929809 511 514 O
, NCT03929809 515 516 O
1000 NCT03929809 517 521 O
, NCT03929809 522 523 O

2000 NCT03929809 530 534 O
, NCT03929809 535 536 O
3000 NCT03929809 537 541 O
, NCT03929809 542 543 O
and NCT03929809 544 547 O
4000 NCT03929809 548 552 O
Hz NCT03929809 553 555 O
with NCT03929809 556 560 B-And
monosyllabic NCT03929809 561 573 B-Condition
word NCT03929809 574 578 I-Condition
understanding NCT03929809 579 592 I-Condition
, NCT03929809 593 594 O
as NCT03929809 595 597 O
measured NCT03929809 598 606 O
using NCT03929809 607 612 B-Eq_Comparison
the NCT03929809 613 616 O
CNC NCT03929809 617 620 B-Observation
Word NCT03929809 621 625 I-Observation
Test NCT03929809 626 630 I-Observation
at NCT03929809 631 633 O
60 NCT03929809 634 636 B-Eq_Comparison
dBA NCT03929809 637 640 I-Eq_Comparison
under NCT03929809 641 646 O
earphones NCT03929809 647 656 O
, NCT03929809 657 658 O
less NCT03929809 659 663 B-Eq_Comparison
than NCT03929809 664 668 I-Eq_Comparison
or NCT03929809 669 671 I-Eq_Comparison
equal NCT03929809 672 677 I-Eq_Comparison
to NCT03929809 678 680 I-Eq_Comparison
20 NCT03929809 681 683 I-Eq_Comparison
% NCT03929809 684 685 I-Eq_Comparison

5 NCT03929809 689 690 O
. NCT03929809 690 691 O
Better NCT03929809 693 699 B-Condition
ear NCT03929809 700 703 I-Condition
( NCT03929809 704 705 O
contralateral NCT03929809 706 719 B-Condition
ear NCT03929809 720 723 I-Condition
) NCT03929809 724 725 O
: NCT03929809 726 727 O
normal NCT03929809 728 734 O
or NCT03929809 735 737 B-Or
near NCT03929809 738 742 O
- NCT03929809 743 744 O
normal NCT03929809 745 751 O
hearing NCT03929809 752 759 B-Condition
defined NCT03929809 760 767 O
as NCT03929809 768 770 O
pure NCT03929809 771 775 B-Observation
- NCT03929809 776 777 I-Observation
tone NCT03929809 778 782 I-Observation
thresholds NCT03929809 783 793 I-Observation
no NCT03929809 794 796 B-Negation
poorer NCT03929809 797 803 B-Eq_Comparison
than NCT03929809 804 808 I-Eq_Comparison
30 NCT03929809 809 811 I-Eq_Comparison
dB NCT03929809 812 814 I-Eq_Comparison
HL NCT03929809 815 817 I-Eq_Comparison
at NCT03929809 818 820 O
250 NCT03929809 821 824 O
, NCT03929809 825 826 O
500 NCT03929809 827 830 O
, NCT03929809 831 832 O
1000 NCT03929809 833 837 O
, NCT03929809 838 839 O
2000 NCT03929809 840 844 O
, NCT03929809 845 846 O
and NCT03929809 847 850 O
3000 NCT03929809 851 855 O
Hz NCT03929809 856 858 O
and NCT03929809 859 862 B-And
no NCT03929809 863 865 B-Negation
poorer NCT03929809 866 872 B-Eq_Comparison
than NCT03929809 873 877 I-Eq_Comparison
40 NCT03929809 878 880 I-Eq_Comparison
dB NCT03929809 881 883 I-Eq_Comparison
HL NCT03929809 884 886 I-Eq_Comparison
at NCT03929809 887 889 O
4000 NCT03929809 890 894 O
Hz NCT03929809 895 897 O
with NCT03929809 898 902 B-And
monosyllabic NCT03929809 903 915 B-Condition
word NCT03929809 916 920 I-Condition
understanding NCT03929809 921 934 I-Condition
, NCT03929809 935 936 O
as NCT03929809 937 939 O
measured NCT03929809 940 948 O
using NCT03929809 949 954 B-Eq_Comparison
the NCT03929809 955 958 O
CNC NCT03929809 959 962 B-Observation
Word NCT03929809 963 967 I-Observation
Test NCT03929809 968 972 I-Observation
at NCT03929809 973 975 O
60 NCT03929809 976 978 B-Eq_Comparison
dBA NCT03929809 979 982 I-Eq_Comparison
under NCT03929809 983 988 O
earphones NCT03929809 989 998 O
, NCT03929809 999 1000 O
of NCT03929809 1001 1003 O
greater NCT03929809 1004 1011 B-Eq_Comparison
than NCT03929809 1012 1016 I-Eq_Comparison
or NCT03929809 1017 1019 I-Eq_Comparison
equal NCT03929809 1020 1025 I-Eq_Comparison
to NCT03929809 1026 1028 I-Eq_Comparison
85 NCT03929809 1029 1031 I-Eq_Comparison
% NCT03929809 1032 1033 I-Eq_Comparison
. NCT03929809 1034 1035 O

6 NCT03929809 1039 1040 O
. NCT03929809 1040 1041 O
Willingness NCT03929809 1043 1054 O
to NCT03929809 1055 1057 O
comply NCT03929809 1058 1064 O
with NCT03929809 1065 1069 O
all NCT03929809 1070 1073 O
study NCT03929809 1074 1079 O
requirements NCT03929809 1080 1092 O
. NCT03929809 1093 1094 O

7 NCT03929809 1098 1099 O
. NCT03929809 1099 1100 O
Patent NCT03929809 1102 1108 B-Condition
cochlea NCT03929809 1109 1116 I-Condition
and NCT03929809 1117 1120 B-And
normal NCT03929809 1121 1127 O
cochlear NCT03929809 1128 1136 B-Condition
anatomy NCT03929809 1137 1144 I-Condition
. NCT03929809 1145 1146 O

Exclusion NCT03929809 1148 1157 O
Criteria NCT03929809 1158 1166 O
: NCT03929809 1167 1168 O

1 NCT03929809 1172 1173 O
. NCT03929809 1173 1174 O
Medical NCT03929809 1176 1183 B-Modifier
or NCT03929809 1184 1186 B-Or
psychological NCT03929809 1187 1200 B-Modifier
conditions NCT03929809 1201 1211 B-Condition
that NCT03929809 1212 1216 O
contraindicate NCT03929809 1217 1231 B-Contraindication
undergoing NCT03929809 1232 1242 O
surgery NCT03929809 1243 1250 B-Procedure
. NCT03929809 1251 1252 O

2 NCT03929809 1256 1257 O
. NCT03929809 1257 1258 O
Ossification NCT03929809 1260 1272 B-Condition
or NCT03929809 1273 1275 B-Or
any NCT03929809 1276 1279 O
other NCT03929809 1280 1285 O
cochlear NCT03929809 1286 1294 B-Condition
anomaly NCT03929809 1295 1302 I-Condition
that NCT03929809 1303 1307 O
might NCT03929809 1308 1313 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03929809 1314 1321 B-Negation
complete NCT03929809 1322 1330 O
insertion NCT03929809 1331 1340 B-Procedure
of NCT03929809 1341 1343 I-Procedure
the NCT03929809 1344 1347 I-Procedure
electrode NCT03929809 1348 1357 I-Procedure
array NCT03929809 1358 1363 I-Procedure
. NCT03929809 1364 1365 O

3 NCT03929809 1369 1370 O
. NCT03929809 1370 1371 O
Unrealistic NCT03929809 1373 1384 O
expectations NCT03929809 1385 1397 B-Assertion___Assertion_Type_Value:hypothetical
on NCT03929809 1398 1400 O
the NCT03929809 1401 1404 O
part NCT03929809 1405 1409 O
of NCT03929809 1410 1412 O
the NCT03929809 1413 1416 O
candidate NCT03929809 1417 1426 O
and NCT03929809 1427 1430 O
/ NCT03929809 1431 1432 O
or NCT03929809 1433 1435 O
candidate NCT03929809 1436 1445 O
's NCT03929809 1445 1447 O
family NCT03929809 1448 1454 O
, NCT03929809 1455 1456 O
regarding NCT03929809 1457 1466 O
the NCT03929809 1467 1470 O
possible NCT03929809 1471 1479 O
benefits NCT03929809 1480 1488 O
, NCT03929809 1489 1490 O
risks NCT03929809 1491 1496 O
, NCT03929809 1497 1498 O
and NCT03929809 1499 1502 O
limitations NCT03929809 1503 1514 O
that NCT03929809 1515 1519 O
are NCT03929809 1520 1523 O
inherent NCT03929809 1524 1532 O
to NCT03929809 1533 1535 O
the NCT03929809 1536 1539 O
surgical NCT03929809 1540 1548 B-Procedure
procedure NCT03929809 1549 1558 I-Procedure
( NCT03929809 1559 1560 O
s NCT03929809 1561 1562 O
) NCT03929809 1563 1564 O
and NCT03929809 1565 1568 B-Or
prosthetic NCT03929809 1569 1579 B-Condition
devices NCT03929809 1580 1587 I-Condition
. NCT03929809 1588 1589 O

4 NCT03929809 1593 1594 O
. NCT03929809 1594 1595 O
Unwillingness NCT03929809 1597 1610 O
or NCT03929809 1611 1613 O
inability NCT03929809 1614 1623 O
of NCT03929809 1624 1626 O
the NCT03929809 1627 1630 O
candidate NCT03929809 1631 1640 O
to NCT03929809 1641 1643 O
comply NCT03929809 1644 1650 O
with NCT03929809 1651 1655 O
all NCT03929809 1656 1659 O
investigational NCT03929809 1660 1675 O
requirements NCT03929809 1676 1688 O
. NCT03929809 1689 1690 O

5 NCT03929809 1694 1695 O
. NCT03929809 1695 1696 O
Active NCT03929809 1698 1704 B-Eq_Comparison
middle NCT03929809 1705 1711 B-Modifier
ear NCT03929809 1712 1715 I-Modifier
infection NCT03929809 1716 1725 B-Condition
. NCT03929809 1726 1727 O

6 NCT03929809 1731 1732 O
. NCT03929809 1732 1733 O
Tinnitus NCT03929809 1735 1743 B-Condition
primary NCT03929809 1744 1751 O
motivation NCT03929809 1752 1762 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03929809 1763 1766 I-Assertion___Assertion_Type_Value:hypothetical
implantation NCT03929809 1767 1779 B-Procedure
. NCT03929809 1780 1781 O

Inclusion NCT03862625 0 9 O
Criteria NCT03862625 10 18 O
: NCT03862625 19 20 O

- NCT03862625 24 25 O
the NCT03862625 27 30 O
participant NCT03862625 31 42 O
6 NCT03862625 43 44 B-Eq_Comparison
to NCT03862625 45 47 I-Eq_Comparison
15 NCT03862625 48 50 I-Eq_Comparison
years NCT03862625 51 56 I-Eq_Comparison
of NCT03862625 57 59 O
age NCT03862625 60 63 B-Age
during NCT03862625 64 70 B-Temporal_Connection___Temporal_Connection_Type_Value:during
inclusion NCT03862625 71 80 B-Study

- NCT03862625 83 84 O
the NCT03862625 86 89 O
participant NCT03862625 90 101 O
is NCT03862625 102 104 O
diagnosed NCT03862625 105 114 O
as NCT03862625 115 117 O
cerebral NCT03862625 118 126 B-Condition
palsy NCT03862625 127 132 I-Condition
by NCT03862625 133 135 O
a NCT03862625 136 137 O
specialist NCT03862625 138 148 B-Provider

- NCT03862625 151 152 O
the NCT03862625 154 157 O
participant NCT03862625 158 169 O
's NCT03862625 169 171 O
Cobb NCT03862625 172 176 B-Observation
angle NCT03862625 177 182 I-Observation
is NCT03862625 183 185 O
between NCT03862625 186 193 B-Eq_Comparison
10 NCT03862625 194 196 I-Eq_Comparison
- NCT03862625 197 198 I-Eq_Comparison
40 NCT03862625 199 201 I-Eq_Comparison
degrees NCT03862625 202 209 I-Eq_Comparison
. NCT03862625 210 211 O
( NCT03862625 213 214 O
Cobb NCT03862625 215 219 B-Observation
angle NCT03862625 220 225 I-Observation
above NCT03862625 226 231 B-Eq_Comparison
40 NCT03862625 232 234 I-Eq_Comparison
degrees NCT03862625 235 242 I-Eq_Comparison
and NCT03862625 243 246 B-Or
patients NCT03862625 247 255 O
whose NCT03862625 256 261 O
parents NCT03862625 262 269 B-Family_Member___Family_Member_Type:parent
have NCT03862625 270 274 O
not NCT03862625 275 278 B-Negation
accepted NCT03862625 279 287 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03862625 288 291 O
operation NCT03862625 292 301 B-Procedure
) NCT03862625 302 303 O

- NCT03862625 307 308 O
There NCT03862625 310 315 O
is NCT03862625 316 318 O
no NCT03862625 319 321 B-Negation
history NCT03862625 322 329 B-Eq_Comparison
of NCT03862625 330 332 O
operation NCT03862625 333 342 B-Procedure
due NCT03862625 343 346 O
to NCT03862625 347 349 O
scoliosis NCT03862625 350 359 B-Condition
or NCT03862625 360 362 B-Or
the NCT03862625 363 366 O
decision NCT03862625 367 375 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03862625 376 378 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03862625 379 382 O
operation NCT03862625 383 392 B-Procedure
has NCT03862625 393 396 O
not NCT03862625 397 400 B-Negation
been NCT03862625 401 405 O
accepted NCT03862625 406 414 B-Assertion___Assertion_Type_Value:hypothetical
by NCT03862625 415 417 O
the NCT03862625 418 421 O
patients NCT03862625 422 430 O
and NCT03862625 431 434 O
their NCT03862625 435 440 O
parents NCT03862625 441 448 B-Family_Member___Family_Member_Type:parent

- NCT03862625 451 452 O
the NCT03862625 454 457 O
participant NCT03862625 458 469 O
is NCT03862625 470 472 O
Gross NCT03862625 473 478 B-Observation
Motor NCT03862625 479 484 I-Observation
Function NCT03862625 485 493 I-Observation
Classification NCT03862625 494 508 I-Observation
System NCT03862625 509 515 I-Observation
Level NCT03862625 516 521 O
4 NCT03862625 522 523 B-Eq_Comparison
or NCT03862625 524 526 I-Eq_Comparison
5 NCT03862625 527 528 I-Eq_Comparison

- NCT03862625 532 533 O
Lack NCT03862625 535 539 B-Condition
of NCT03862625 540 542 I-Condition
contracture NCT03862625 543 554 I-Condition
to NCT03862625 555 557 O
prevent NCT03862625 558 565 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
sitting NCT03862625 566 573 B-Observation
in NCT03862625 574 576 O
the NCT03862625 577 580 O
lower NCT03862625 581 586 B-Modifier
extremity NCT03862625 587 596 I-Modifier

- NCT03862625 599 600 O
Parents NCT03862625 602 609 O
agree NCT03862625 610 615 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862625 616 618 I-Assertion___Assertion_Type_Value:hypothetical
participate NCT03862625 619 630 O
in NCT03862625 631 633 O
the NCT03862625 634 637 O
intensive NCT03862625 638 647 B-Modifier
therapy NCT03862625 648 655 B-Procedure
program NCT03862625 656 663 O
and NCT03862625 664 667 B-And
stop NCT03862625 668 672 B-Negation
the NCT03862625 673 676 O
therapeutic NCT03862625 677 688 B-Procedure
interventions NCT03862625 689 702 I-Procedure
for NCT03862625 703 706 O
scoliosis NCT03862625 707 716 B-Condition
and NCT03862625 717 720 B-Or
lower NCT03862625 721 726 B-Modifier
extremities NCT03862625 727 738 I-Modifier
during NCT03862625 739 745 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03862625 746 749 O
3 NCT03862625 750 751 B-Eq_Comparison
- NCT03862625 752 753 I-Eq_Comparison
month NCT03862625 754 759 I-Eq_Comparison
follow NCT03862625 760 766 B-Encounter
- NCT03862625 767 768 I-Encounter
up NCT03862625 769 771 I-Encounter
period NCT03862625 772 778 O

Exclusion NCT03862625 779 788 O
Criteria NCT03862625 789 797 O
: NCT03862625 798 799 O

- NCT03862625 803 804 O
Having NCT03862625 806 812 O
a NCT03862625 813 814 O
history NCT03862625 815 822 B-Eq_Comparison
of NCT03862625 823 825 O
operation NCT03862625 826 835 B-Procedure
due NCT03862625 836 839 O
to NCT03862625 840 842 O
scoliosis NCT03862625 843 852 B-Condition

- NCT03862625 855 856 O
The NCT03862625 858 861 O
deformity NCT03862625 862 871 B-Condition
in NCT03862625 872 874 O
the NCT03862625 875 878 O
spine NCT03862625 879 884 B-Modifier
is NCT03862625 885 887 I-Modifier
rigid NCT03862625 888 893 I-Modifier

- NCT03862625 896 897 O
If NCT03862625 899 901 O
the NCT03862625 902 905 O
curvature NCT03862625 906 915 B-Observation
measured NCT03862625 916 924 O
in NCT03862625 925 927 O
the NCT03862625 928 931 O
spine NCT03862625 932 937 B-Modifier
is NCT03862625 938 940 O
less NCT03862625 941 945 B-Eq_Comparison
than NCT03862625 946 950 I-Eq_Comparison
10 NCT03862625 951 953 I-Eq_Comparison
degrees NCT03862625 954 961 I-Eq_Comparison
or NCT03862625 962 964 B-Or
more NCT03862625 965 969 B-Eq_Comparison
than NCT03862625 970 974 I-Eq_Comparison
40 NCT03862625 975 977 I-Eq_Comparison
degrees NCT03862625 978 985 I-Eq_Comparison
in NCT03862625 986 988 O
the NCT03862625 989 992 O
patients NCT03862625 993 1001 B-And
whose NCT03862625 1002 1007 I-And
operation NCT03862625 1008 1017 B-Procedure
decision NCT03862625 1018 1026 B-Assertion___Assertion_Type_Value:hypothetical
is NCT03862625 1027 1029 I-Assertion___Assertion_Type_Value:hypothetical
accepted NCT03862625 1030 1038 I-Assertion___Assertion_Type_Value:hypothetical
by NCT03862625 1039 1041 O
the NCT03862625 1042 1045 O
family NCT03862625 1046 1052 B-Family_Member

- NCT03862625 1055 1056 O
Having NCT03862625 1058 1064 O
a NCT03862625 1065 1066 O
seating NCT03862625 1067 1074 B-Condition
modification NCT03862625 1075 1087 I-Condition
applied NCT03862625 1088 1095 O
at NCT03862625 1096 1098 B-Eq_Comparison
least NCT03862625 1099 1104 I-Eq_Comparison
1 NCT03862625 1105 1106 I-Eq_Comparison
year NCT03862625 1107 1111 I-Eq_Comparison
before NCT03862625 1112 1118 B-Temporal_Connection___Temporal_Connection_Type_Value:before
being NCT03862625 1119 1124 O
included NCT03862625 1125 1133 O
in NCT03862625 1134 1136 O
the NCT03862625 1137 1140 O
study NCT03862625 1141 1146 B-Study

- NCT03862625 1149 1150 O
Having NCT03862625 1152 1158 O
a NCT03862625 1159 1160 O
spasticity NCT03862625 1161 1171 B-Condition
and NCT03862625 1172 1175 B-Or
contracture NCT03862625 1176 1187 B-Condition
to NCT03862625 1188 1190 O
prevent NCT03862625 1191 1198 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
sitting NCT03862625 1199 1206 B-Observation
in NCT03862625 1207 1209 O
the NCT03862625 1210 1213 O
hip NCT03862625 1214 1217 B-Modifier
and NCT03862625 1218 1221 B-And
knee NCT03862625 1222 1226 B-Modifier
joint NCT03862625 1227 1232 I-Modifier

- NCT03862625 1235 1236 O
Having NCT03862625 1238 1244 O
a NCT03862625 1245 1246 O
pressure NCT03862625 1247 1255 B-Condition
ulcer NCT03862625 1256 1261 I-Condition
to NCT03862625 1262 1264 O
prevent NCT03862625 1265 1272 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
the NCT03862625 1273 1276 O
patient NCT03862625 1277 1284 O
from NCT03862625 1285 1289 O
sitting NCT03862625 1290 1297 B-Observation

- NCT03862625 1300 1301 O
the NCT03862625 1303 1306 O
participant NCT03862625 1307 1318 O
has NCT03862625 1319 1322 O
comorbidity NCT03862625 1323 1334 B-Condition
that NCT03862625 1335 1339 O
is NCT03862625 1340 1342 O
not NCT03862625 1343 1346 B-Negation
related NCT03862625 1347 1354 O
about NCT03862625 1355 1360 O
cerebral NCT03862625 1361 1369 B-Condition
palsy NCT03862625 1370 1375 I-Condition

- NCT03862625 1378 1379 O
Having NCT03862625 1381 1387 O
epileptic NCT03862625 1388 1397 B-Condition
seizures NCT03862625 1398 1406 I-Condition
not NCT03862625 1407 1410 B-Negation
controlled NCT03862625 1411 1421 O

- NCT03862625 1424 1425 O
Having NCT03862625 1427 1433 O
bone NCT03862625 1434 1438 B-Procedure
operations NCT03862625 1439 1449 I-Procedure
for NCT03862625 1450 1453 O
hip NCT03862625 1454 1457 B-Modifier
joints NCT03862625 1458 1464 I-Modifier

Inclusion NCT03926585 0 9 O
Criteria NCT03926585 10 18 O
: NCT03926585 19 20 O

- NCT03926585 24 25 O
Patients NCT03926585 27 35 O
admitted NCT03926585 36 44 B-Encounter
to NCT03926585 45 47 O
the NCT03926585 48 51 O
department NCT03926585 52 62 O
of NCT03926585 63 65 O
endocrinology NCT03926585 66 79 B-Provider
with NCT03926585 80 84 B-And
the NCT03926585 85 88 O
diagnose NCT03926585 89 97 O
hypothyroidism NCT03926585 98 112 B-Condition
because NCT03926585 113 120 O
of NCT03926585 121 123 O
persistent NCT03926585 124 134 B-Modifier
hypothyroid NCT03926585 135 146 B-Condition
symptoms NCT03926585 147 155 B-Assertion___Assertion_Type_Value:possible
despite NCT03926585 156 163 B-And
treatment NCT03926585 164 173 B-Procedure
with NCT03926585 174 178 O
L NCT03926585 179 180 B-Drug
- NCT03926585 181 182 I-Drug
thyroxine NCT03926585 183 192 I-Drug
mono NCT03926585 193 197 B-Procedure
- NCT03926585 198 199 I-Procedure
therapy NCT03926585 200 207 I-Procedure
and NCT03926585 208 211 B-And
normal NCT03926585 212 218 O
and NCT03926585 219 222 B-And
stable NCT03926585 223 229 O
TSH NCT03926585 230 233 B-Observation
( NCT03926585 234 235 O
for NCT03926585 236 239 O
at NCT03926585 240 242 B-Eq_Comparison
least NCT03926585 243 248 I-Eq_Comparison
6 NCT03926585 249 250 I-Eq_Comparison
months NCT03926585 251 257 I-Eq_Comparison
) NCT03926585 258 259 O
. NCT03926585 260 261 O

- NCT03926585 265 266 O
Started NCT03926585 268 275 O
in NCT03926585 276 278 O
combination NCT03926585 279 290 B-Procedure
therapy NCT03926585 291 298 I-Procedure
with NCT03926585 299 303 O
L NCT03926585 304 305 B-Drug
- NCT03926585 306 307 I-Drug
thyroxine NCT03926585 308 317 I-Drug
and NCT03926585 318 321 B-And
Liothyronine NCT03926585 322 334 B-Drug
in NCT03926585 335 337 O
an NCT03926585 338 340 O
approximately NCT03926585 341 354 O
17 NCT03926585 355 357 B-Eq_Comparison
/ NCT03926585 358 359 I-Eq_Comparison
1 NCT03926585 360 361 I-Eq_Comparison
ratio NCT03926585 362 367 I-Eq_Comparison

- NCT03926585 370 371 O
Exclusion NCT03926585 373 382 B-Negation
of NCT03926585 383 385 O
an NCT03926585 386 388 O
alternative NCT03926585 389 400 B-Other
explanation NCT03926585 401 412 B-Condition
for NCT03926585 413 416 O
persistent NCT03926585 417 427 B-Modifier
hypothyroid NCT03926585 428 439 B-Condition
symptoms NCT03926585 440 448 B-Assertion___Assertion_Type_Value:possible

Exclusion NCT03926585 449 458 O
Criteria NCT03926585 459 467 O
: NCT03926585 468 469 O

- NCT03926585 473 474 O
Initiation NCT03926585 476 486 B-Eq_Comparison
of NCT03926585 487 489 O
L NCT03926585 490 491 B-Drug
- NCT03926585 492 493 I-Drug
thyroxine NCT03926585 494 503 I-Drug
treatment NCT03926585 504 513 B-Procedure
in NCT03926585 514 516 O
patients NCT03926585 517 525 O
with NCT03926585 526 530 B-And
s NCT03926585 531 532 B-Observation
- NCT03926585 533 534 I-Observation
TSH NCT03926585 535 538 I-Observation
below NCT03926585 539 544 B-Eq_Comparison
upper NCT03926585 545 550 I-Eq_Comparison
normal NCT03926585 551 557 I-Eq_Comparison
limit NCT03926585 558 563 I-Eq_Comparison
( NCT03926585 564 565 O
with NCT03926585 566 570 O
assay NCT03926585 571 576 O
in NCT03926585 577 579 O
current NCT03926585 580 587 O
use NCT03926585 588 591 O
, NCT03926585 592 593 O
that NCT03926585 594 598 O
is NCT03926585 599 601 O
TSH NCT03926585 602 605 B-Observation
< NCT03926585 606 607 B-Eq_Comparison
4 NCT03926585 608 609 I-Eq_Comparison
mU NCT03926585 610 612 I-Eq_Comparison
/ NCT03926585 613 614 I-Eq_Comparison
L NCT03926585 615 616 I-Eq_Comparison
) NCT03926585 617 618 O

- NCT03926585 622 623 O
Ongoing NCT03926585 625 632 B-Eq_Comparison
pregnancy NCT03926585 633 642 B-Condition

- NCT03926585 645 646 O
Age NCT03926585 648 651 B-Age
below NCT03926585 652 657 B-Eq_Comparison
18 NCT03926585 658 660 I-Eq_Comparison
years NCT03926585 661 666 I-Eq_Comparison
or NCT03926585 667 669 B-Or
above NCT03926585 670 675 B-Eq_Comparison
80 NCT03926585 676 678 I-Eq_Comparison
years NCT03926585 679 684 I-Eq_Comparison
. NCT03926585 685 686 O

- NCT03926585 690 691 O
Patients NCT03926585 693 701 O
who NCT03926585 702 705 O
do NCT03926585 706 708 O
not NCT03926585 709 712 O
read NCT03926585 713 717 O
and NCT03926585 718 721 O
understand NCT03926585 722 732 O
information NCT03926585 733 744 O
material NCT03926585 745 753 O
given NCT03926585 754 759 O

- NCT03926585 762 763 O
Patients NCT03926585 765 773 O
who NCT03926585 774 777 O
are NCT03926585 778 781 O
not NCT03926585 782 785 O
competent NCT03926585 786 795 O
to NCT03926585 796 798 O
give NCT03926585 799 803 O
informed NCT03926585 804 812 O
consent NCT03926585 813 820 O


Inclusion NCT03927391 0 9 O
Criteria NCT03927391 10 18 O
: NCT03927391 19 20 O

- NCT03927391 24 25 O
Frail NCT03927391 27 32 B-Condition
ᵃ NCT03927391 33 34 O
male NCT03927391 35 39 O
patients NCT03927391 40 48 O
with NCT03927391 49 53 B-And
prostate NCT03927391 54 62 B-Modifier
cancer NCT03927391 63 69 B-Condition
who NCT03927391 70 73 B-And
will NCT03927391 74 78 B-Eq_Comparison
start NCT03927391 79 84 B-Eq_Comparison
treatment NCT03927391 85 94 B-Procedure
with NCT03927391 95 99 O
enzalutamide NCT03927391 100 112 B-Drug
within NCT03927391 113 119 B-Modifier
label NCT03927391 120 125 I-Modifier

- NCT03927391 128 129 O
Age NCT03927391 131 134 B-Age
at NCT03927391 135 137 B-Eq_Comparison
least NCT03927391 138 143 I-Eq_Comparison
18 NCT03927391 144 146 I-Eq_Comparison
years NCT03927391 147 152 I-Eq_Comparison

- NCT03927391 155 156 O
Patient NCT03927391 158 165 O
who NCT03927391 166 169 O
are NCT03927391 170 173 O
able NCT03927391 174 178 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03927391 179 182 I-Assertion___Assertion_Type_Value:hypothetical
willing NCT03927391 183 190 I-Assertion___Assertion_Type_Value:hypothetical
to NCT03927391 191 193 O
give NCT03927391 194 198 O
written NCT03927391 199 206 O
informed NCT03927391 207 215 O
consent NCT03927391 216 223 O
prior NCT03927391 224 229 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03927391 230 232 I-Temporal_Connection___Temporal_Connection_Type_Value:before
screening NCT03927391 233 242 B-Study

- NCT03927391 245 246 O
Patients NCT03927391 248 256 O
from NCT03927391 257 261 O
whom NCT03927391 262 266 O
it NCT03927391 267 269 O
is NCT03927391 270 272 O
possible NCT03927391 273 281 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03927391 282 284 I-Assertion___Assertion_Type_Value:hypothetical
collect NCT03927391 285 292 I-Assertion___Assertion_Type_Value:hypothetical
blood NCT03927391 293 298 B-Observation
samples NCT03927391 299 306 I-Observation

- NCT03927391 309 310 O
Patients NCT03927391 312 320 O
who NCT03927391 321 324 O
are NCT03927391 325 328 O
willing NCT03927391 329 336 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03927391 337 339 I-Assertion___Assertion_Type_Value:hypothetical
answer NCT03927391 340 346 O
the NCT03927391 347 350 O
questionnaires NCT03927391 351 365 B-Observation
and NCT03927391 366 369 B-And
test NCT03927391 370 374 B-Observation

- NCT03927391 377 378 O
Life NCT03927391 380 384 B-Observation
expectancy NCT03927391 385 395 I-Observation
of NCT03927391 396 398 O
> NCT03927391 399 400 B-Eq_Comparison
6 NCT03927391 401 402 I-Eq_Comparison
months NCT03927391 403 409 I-Eq_Comparison

- NCT03927391 412 413 O
Capable NCT03927391 415 422 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03927391 423 425 I-Assertion___Assertion_Type_Value:hypothetical
understanding NCT03927391 426 439 O
and NCT03927391 440 443 O
answering NCT03927391 444 453 O
Dutch NCT03927391 454 459 O
tests NCT03927391 460 465 B-Observation
and NCT03927391 466 469 B-And
questionnaires NCT03927391 470 484 B-Observation
, NCT03927391 485 486 O
as NCT03927391 487 489 O
determined NCT03927391 490 500 O
by NCT03927391 501 503 O
the NCT03927391 504 507 O
investigator NCT03927391 508 520 O

ᵃ NCT03927391 522 523 O
Frail NCT03927391 524 529 B-Condition
is NCT03927391 530 532 O
defined NCT03927391 533 540 O
as NCT03927391 541 543 O
: NCT03927391 544 545 O

- NCT03927391 549 550 O
a NCT03927391 552 553 O
score NCT03927391 554 559 O
on NCT03927391 560 562 O
the NCT03927391 563 566 O
comprehensive NCT03927391 567 580 O
G NCT03927391 581 582 B-Observation
8 NCT03927391 583 584 I-Observation
assessment NCT03927391 585 595 I-Observation
with NCT03927391 596 600 O
cut NCT03927391 601 604 O
- NCT03927391 605 606 O
off NCT03927391 607 610 O
≤ NCT03927391 611 612 B-Eq_Comparison
14 NCT03927391 613 615 I-Eq_Comparison
points NCT03927391 616 622 O
and NCT03927391 623 626 O

- NCT03927391 629 630 O
score NCT03927391 632 637 O
≥ NCT03927391 638 639 B-Eq_Comparison
grade NCT03927391 640 645 I-Eq_Comparison
1 NCT03927391 646 647 I-Eq_Comparison
for NCT03927391 648 651 O
Central NCT03927391 652 659 B-Condition
Nervous NCT03927391 660 667 I-Condition
Disorders NCT03927391 668 677 I-Condition
according NCT03927391 678 687 O
to NCT03927391 688 690 O
the NCT03927391 691 694 O
Common NCT03927391 695 701 O
Toxicity NCT03927391 702 710 O
Criteria NCT03927391 711 719 O
Adverse NCT03927391 720 727 O
Event NCT03927391 728 733 O
( NCT03927391 734 735 O
CTCAE NCT03927391 736 741 O
) NCT03927391 742 743 O
criteria NCT03927391 744 752 O
, NCT03927391 753 754 O
of NCT03927391 755 757 O
one NCT03927391 758 761 B-Eq_Comparison
of NCT03927391 762 764 O
the NCT03927391 765 768 B-Criteria_Count
following NCT03927391 769 778 I-Criteria_Count
: NCT03927391 779 780 O
Fatigue NCT03927391 781 788 B-Condition
, NCT03927391 789 790 O
Concentration NCT03927391 791 804 B-Condition
impairment NCT03927391 805 815 I-Condition
, NCT03927391 816 817 O
cognitive NCT03927391 818 827 B-Condition
disturbance NCT03927391 828 839 I-Condition
, NCT03927391 840 841 O
amnesia NCT03927391 842 849 B-Condition
, NCT03927391 850 851 O
depressed NCT03927391 852 861 B-Condition
level NCT03927391 862 867 I-Condition
of NCT03927391 868 870 I-Condition
consciousness NCT03927391 871 884 I-Condition
, NCT03927391 885 886 O
memory NCT03927391 887 893 B-Condition
impairment NCT03927391 894 904 I-Condition
, NCT03927391 905 906 O
hypersomnia NCT03927391 907 918 B-Condition
. NCT03927391 919 920 O

Exclusion NCT03927391 922 931 O
Criteria NCT03927391 932 940 O
: NCT03927391 941 942 O

- NCT03927391 946 947 O
change NCT03927391 949 955 O
in NCT03927391 956 958 O
dose NCT03927391 959 963 O
of NCT03927391 964 966 O
opioids NCT03927391 967 974 B-Drug
/ NCT03927391 975 976 B-Or
sedatives NCT03927391 977 986 B-Drug
/ NCT03927391 987 988 B-Or
benzodiazepines NCT03927391 989 1004 B-Drug
during NCT03927391 1005 1011 B-Temporal_Connection___Temporal_Connection_Type_Value:during
last NCT03927391 1012 1016 B-Eq_Comparison
2 NCT03927391 1017 1018 I-Eq_Comparison
weeks NCT03927391 1019 1024 I-Eq_Comparison
before NCT03927391 1025 1031 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03927391 1032 1037 B-Study
) NCT03927391 1038 1039 O

- NCT03927391 1043 1044 O
Use NCT03927391 1046 1049 O
of NCT03927391 1050 1052 O
psychostimulants NCT03927391 1053 1069 B-Drug
such NCT03927391 1070 1074 O
as NCT03927391 1075 1077 O
methylphenidate NCT03927391 1078 1093 B-Drug
within NCT03927391 1094 1100 B-Eq_Comparison
1 NCT03927391 1101 1102 I-Eq_Comparison
week NCT03927391 1103 1107 I-Eq_Comparison
of NCT03927391 1108 1110 B-Temporal_Connection___Temporal_Connection_Type_Value:before
start NCT03927391 1111 1116 B-Eq_Comparison
of NCT03927391 1117 1119 O
study NCT03927391 1120 1125 B-Study

- NCT03927391 1128 1129 O
Diagnosed NCT03927391 1131 1140 O
with NCT03927391 1141 1145 O
medical NCT03927391 1146 1153 B-Condition
conditions NCT03927391 1154 1164 I-Condition
that NCT03927391 1165 1169 O
affect NCT03927391 1170 1176 O
cognition NCT03927391 1177 1186 B-Condition
: NCT03927391 1187 1188 O
Dementia NCT03927391 1189 1197 B-Condition
, NCT03927391 1198 1199 O
Alzheimer NCT03927391 1200 1209 B-Condition
disease NCT03927391 1210 1217 I-Condition
, NCT03927391 1218 1219 O
Parkinson NCT03927391 1220 1229 B-Condition
's NCT03927391 1229 1231 I-Condition
disease NCT03927391 1232 1239 I-Condition
, NCT03927391 1240 1241 O
psychiatric NCT03927391 1242 1253 B-Condition
disorders NCT03927391 1254 1263 I-Condition
that NCT03927391 1264 1268 O
affect NCT03927391 1269 1275 O
cognition NCT03927391 1276 1285 B-Condition
other NCT03927391 1286 1291 B-Exception
than NCT03927391 1292 1296 I-Exception
depression NCT03927391 1297 1307 B-Condition
or NCT03927391 1308 1310 B-Or
anxiety NCT03927391 1311 1318 B-Condition
complaints NCT03927391 1319 1329 O
related NCT03927391 1330 1337 O
to NCT03927391 1338 1340 O
the NCT03927391 1341 1344 O
disease NCT03927391 1345 1352 O

- NCT03927391 1355 1356 O
Active NCT03927391 1358 1364 B-Eq_Comparison
infection NCT03927391 1365 1374 B-Condition
or NCT03927391 1375 1377 B-Or
other NCT03927391 1378 1383 B-Other
comorbidities NCT03927391 1384 1397 B-Condition
that NCT03927391 1398 1402 O
may NCT03927391 1403 1406 O
contribute NCT03927391 1407 1417 O
to NCT03927391 1418 1420 O
REDOSE NCT03927391 1421 1427 O
, NCT03927391 1428 1429 O
February NCT03927391 1430 1438 O
2019 NCT03927391 1439 1443 O
Page NCT03927391 1444 1448 O
7 NCT03927391 1449 1450 O
of NCT03927391 1451 1453 O
53 NCT03927391 1454 1456 O
fatigue NCT03927391 1457 1464 B-Condition
or NCT03927391 1465 1467 B-Or
cognition NCT03927391 1468 1477 B-Condition
change NCT03927391 1478 1484 O
within NCT03927391 1485 1491 B-Eq_Comparison
4 NCT03927391 1492 1493 I-Eq_Comparison
weeks NCT03927391 1494 1499 I-Eq_Comparison
of NCT03927391 1500 1502 B-Temporal_Connection___Temporal_Connection_Type_Value:before
study NCT03927391 1503 1508 B-Study
entry NCT03927391 1509 1514 O

- NCT03927391 1517 1518 O
Clinical NCT03927391 1520 1528 O
relevant NCT03927391 1529 1537 O
anaemia NCT03927391 1538 1545 B-Condition

- NCT03927391 1548 1549 O
MoCa NCT03927391 1551 1555 B-Observation
score NCT03927391 1556 1561 I-Observation
< NCT03927391 1562 1563 B-Eq_Comparison
20 NCT03927391 1564 1566 I-Eq_Comparison

- NCT03927391 1570 1571 O
Hypersensitivity NCT03927391 1573 1589 B-Condition
to NCT03927391 1590 1592 O
the NCT03927391 1593 1596 O
active NCT03927391 1597 1603 B-Drug
substance NCT03927391 1604 1613 I-Drug
or NCT03927391 1614 1616 B-Or
to NCT03927391 1617 1619 O
any NCT03927391 1620 1623 B-Modifier
of NCT03927391 1624 1626 I-Modifier
the NCT03927391 1627 1630 I-Modifier
excipients NCT03927391 1631 1641 I-Modifier
. NCT03927391 1642 1643 O

Inclusion NCT03925922 0 9 O
Criteria NCT03925922 10 18 O
: NCT03925922 19 20 O

- NCT03925922 24 25 O
Nulliparous NCT03925922 27 38 B-Modifier
singleton NCT03925922 39 48 I-Modifier
pregnancy NCT03925922 49 58 B-Condition

- NCT03925922 61 62 O
gestational NCT03925922 64 75 B-Observation
age NCT03925922 76 79 I-Observation
between NCT03925922 80 87 B-Eq_Comparison
37 NCT03925922 88 90 I-Eq_Comparison
week NCT03925922 91 95 I-Eq_Comparison
and NCT03925922 96 99 I-Eq_Comparison
42 NCT03925922 100 102 I-Eq_Comparison
weeks NCT03925922 103 108 I-Eq_Comparison

- NCT03925922 111 112 O
Cephalic NCT03925922 114 122 B-Condition
presentation NCT03925922 123 135 I-Condition

- NCT03925922 138 139 O
Bishop NCT03925922 141 147 B-Observation
score NCT03925922 148 153 I-Observation
of NCT03925922 154 156 O
5 NCT03925922 157 158 B-Eq_Comparison
or NCT03925922 159 161 I-Eq_Comparison
less NCT03925922 162 166 I-Eq_Comparison

- NCT03925922 169 170 O
No NCT03925922 172 174 B-Negation
clinical NCT03925922 175 183 O
evidence NCT03925922 184 192 O
of NCT03925922 193 195 O
regular NCT03925922 196 203 B-Condition
contraction NCT03925922 204 215 I-Condition

Exclusion NCT03925922 216 225 O
Criteria NCT03925922 226 234 O
: NCT03925922 235 236 O

- NCT03925922 240 241 O
Rupture NCT03925922 243 250 B-Condition
of NCT03925922 251 253 I-Condition
membrane NCT03925922 254 262 I-Condition

- NCT03925922 265 266 O
Vaginal NCT03925922 268 275 B-Condition
bleeding NCT03925922 276 284 I-Condition

- NCT03925922 287 288 O
Any NCT03925922 290 293 O
contraindication NCT03925922 294 310 B-Contraindication
to NCT03925922 311 313 O
vaginal NCT03925922 314 321 B-Modifier
delivery NCT03925922 322 330 B-Procedure

Inclusion NCT03926013 0 9 O
Criteria NCT03926013 10 18 O
: NCT03926013 19 20 O

- NCT03926013 24 25 O
Histology NCT03926013 27 36 O
: NCT03926013 37 38 O
Part NCT03926013 39 43 O
1 NCT03926013 44 45 O
: NCT03926013 46 47 O
Metastatic NCT03926013 48 58 B-Modifier
castration NCT03926013 59 69 I-Modifier
- NCT03926013 70 71 I-Modifier
resistant NCT03926013 72 81 I-Modifier
prostate NCT03926013 82 90 I-Modifier
cancer NCT03926013 91 97 B-Condition
( NCT03926013 98 99 O
mCRPC NCT03926013 100 105 B-Condition
) NCT03926013 106 107 O
with NCT03926013 108 112 B-And
histologic NCT03926013 113 123 B-Procedure
confirmation NCT03926013 124 136 O
of NCT03926013 137 139 O
adenocarcinoma NCT03926013 140 154 B-Condition
. NCT03926013 155 156 O
Adenocarcinoma NCT03926013 158 172 B-Condition
with NCT03926013 173 177 O
small NCT03926013 178 183 B-Modifier
- NCT03926013 184 185 I-Modifier
cell NCT03926013 186 190 I-Modifier
or NCT03926013 191 193 B-Or
neuroendocrine NCT03926013 194 208 B-Modifier
features NCT03926013 209 217 O
is NCT03926013 218 220 O
allowed NCT03926013 221 228 O
. NCT03926013 229 230 O
mCRPC NCT03926013 232 237 B-Condition
is NCT03926013 238 240 O
defined NCT03926013 241 248 O
by NCT03926013 249 251 O
prostate NCT03926013 252 260 O
Cancer NCT03926013 261 267 O
Working NCT03926013 268 275 O
Group NCT03926013 276 281 O
( NCT03926013 282 283 O
PCWG NCT03926013 284 288 O
) NCT03926013 289 290 O
3 NCT03926013 291 292 O
criteria NCT03926013 293 301 O
. NCT03926013 302 303 O
Part NCT03926013 305 309 O
2 NCT03926013 310 311 O
: NCT03926013 312 313 O
mCRPC NCT03926013 314 319 B-Condition
as NCT03926013 320 322 O
defined NCT03926013 323 330 O
above NCT03926013 331 336 O
or NCT03926013 337 339 B-Or
pathologically NCT03926013 340 354 B-Procedure
confirmed NCT03926013 355 364 O
metastatic NCT03926013 365 375 B-Modifier
renal NCT03926013 376 381 I-Modifier
cell NCT03926013 382 386 I-Modifier
carcinoma NCT03926013 387 396 B-Condition
( NCT03926013 397 398 O
RCC NCT03926013 399 402 B-Condition
) NCT03926013 403 404 O
as NCT03926013 405 407 O
defined NCT03926013 408 415 O
by NCT03926013 416 418 O
world NCT03926013 419 424 O
health NCT03926013 425 431 O
organization NCT03926013 432 444 O
( NCT03926013 445 446 O
WHO NCT03926013 447 450 O
) NCT03926013 451 452 O

2016 NCT03926013 459 463 O
Classifications NCT03926013 464 479 O

- NCT03926013 482 483 O
Measurable NCT03926013 485 495 B-Modifier
or NCT03926013 496 498 B-Or
evaluable NCT03926013 499 508 B-Modifier
disease NCT03926013 509 516 B-Condition
: NCT03926013 517 518 O
Part NCT03926013 519 523 O
1 NCT03926013 524 525 O
: NCT03926013 526 527 O
Either NCT03926013 528 534 O
measurable NCT03926013 535 545 B-Modifier
or NCT03926013 546 548 B-Or
evaluable NCT03926013 549 558 B-Modifier
disease NCT03926013 559 566 B-Condition
for NCT03926013 567 570 O
prostate NCT03926013 571 579 B-Modifier
cancer NCT03926013 580 586 B-Condition
. NCT03926013 587 588 O
Part NCT03926013 590 594 O
2 NCT03926013 595 596 O
: NCT03926013 597 598 O
At NCT03926013 599 601 B-Eq_Comparison
least NCT03926013 602 607 I-Eq_Comparison
one NCT03926013 608 611 I-Eq_Comparison
measurable NCT03926013 612 622 O
lesion NCT03926013 623 629 B-Condition
as NCT03926013 630 632 O
per NCT03926013 633 636 O
RECIST NCT03926013 637 643 O
v NCT03926013 644 645 O
1.1 NCT03926013 646 649 O
. NCT03926013 649 650 O

- NCT03926013 654 655 O
Evidence NCT03926013 657 665 O
of NCT03926013 666 668 O
disease NCT03926013 669 676 B-Condition
progression NCT03926013 677 688 I-Condition
on NCT03926013 689 691 O
prior NCT03926013 692 697 B-Eq_Comparison
therapy NCT03926013 698 705 B-Procedure
that NCT03926013 706 710 O
requires NCT03926013 711 719 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03926013 720 721 O
new NCT03926013 722 725 O
line NCT03926013 726 730 O
of NCT03926013 731 733 O
treatment NCT03926013 734 743 B-Procedure

- NCT03926013 746 747 O
Participants NCT03926013 749 761 O
with NCT03926013 762 766 O
accessible NCT03926013 767 777 O
lesions NCT03926013 778 785 B-Condition
enrolled NCT03926013 786 794 O
in NCT03926013 795 797 O
selected NCT03926013 798 806 O
pharmacokinetic NCT03926013 807 822 O
( NCT03926013 823 824 O
PK NCT03926013 825 827 O
) NCT03926013 828 829 O
/ NCT03926013 830 831 O
pharmacodynamics NCT03926013 832 848 O
( NCT03926013 849 850 O
PD NCT03926013 851 853 O
) NCT03926013 854 855 O
cohorts NCT03926013 856 863 O
and NCT03926013 864 867 O
in NCT03926013 868 870 O
Part NCT03926013 871 875 O
2 NCT03926013 876 877 O
must NCT03926013 878 882 O
agree NCT03926013 883 888 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03926013 889 891 I-Assertion___Assertion_Type_Value:hypothetical
undergo NCT03926013 892 899 O
the NCT03926013 900 903 O
mandatory NCT03926013 904 913 O
fresh NCT03926013 914 919 B-Modifier
tumor NCT03926013 920 925 I-Modifier
biopsies NCT03926013 926 934 B-Procedure
, NCT03926013 935 936 O
unless NCT03926013 937 943 B-Exception
collection NCT03926013 944 954 O
of NCT03926013 955 957 O
the NCT03926013 958 961 O
biopsy NCT03926013 962 968 B-Procedure
presents NCT03926013 969 977 O
a NCT03926013 978 979 O
safety NCT03926013 980 986 O
risk NCT03926013 987 991 B-Risk

Exclusion NCT03926013 992 1001 O
Criteria NCT03926013 1002 1010 O
: NCT03926013 1011 1012 O

- NCT03926013 1016 1017 O
At NCT03926013 1019 1021 B-Eq_Comparison
least NCT03926013 1022 1027 I-Eq_Comparison
2 NCT03926013 1028 1029 I-Eq_Comparison
weeks NCT03926013 1030 1035 I-Eq_Comparison
between NCT03926013 1036 1043 B-Temporal_Connection___Temporal_Connection_Type_Value:after
prior NCT03926013 1044 1049 B-Eq_Comparison
anticancer NCT03926013 1050 1060 B-Procedure
treatment NCT03926013 1061 1070 I-Procedure
( NCT03926013 1071 1072 O
including NCT03926013 1073 1082 O
radiotherapy NCT03926013 1083 1095 B-Procedure
) NCT03926013 1096 1097 O
discontinuation NCT03926013 1098 1113 O
and NCT03926013 1114 1117 O
the NCT03926013 1118 1121 O
first NCT03926013 1122 1127 B-Eq_Comparison
dose NCT03926013 1128 1132 O
of NCT03926013 1133 1135 O
study NCT03926013 1136 1141 B-Study
drug NCT03926013 1142 1146 B-Drug
, NCT03926013 1147 1148 O
and NCT03926013 1149 1152 O
toxicities NCT03926013 1153 1163 B-Observation
have NCT03926013 1164 1168 O
returned NCT03926013 1169 1177 O
to NCT03926013 1178 1180 O
Grade NCT03926013 1181 1186 B-Eq_Comparison
less NCT03926013 1187 1191 I-Eq_Comparison
than NCT03926013 1192 1196 I-Eq_Comparison
or NCT03926013 1197 1199 I-Eq_Comparison
equal NCT03926013 1200 1205 I-Eq_Comparison
to NCT03926013 1206 1208 I-Eq_Comparison
( NCT03926013 1209 1210 I-Eq_Comparison
< NCT03926013 1211 1212 I-Eq_Comparison
= NCT03926013 1213 1214 I-Eq_Comparison
) NCT03926013 1215 1216 I-Eq_Comparison
1 NCT03926013 1217 1218 I-Eq_Comparison
or NCT03926013 1219 1221 B-Or
baseline NCT03926013 1222 1230 B-Study

- NCT03926013 1233 1234 O
Prior NCT03926013 1236 1241 B-Eq_Comparison
treatment NCT03926013 1242 1251 B-Procedure
with NCT03926013 1252 1256 O
prostate NCT03926013 1257 1265 B-Drug
- NCT03926013 1266 1267 I-Drug
specific NCT03926013 1268 1276 I-Drug
membrane NCT03926013 1277 1285 I-Drug
antigen NCT03926013 1286 1293 I-Drug
( NCT03926013 1294 1295 O
PSMA NCT03926013 1296 1300 B-Drug
) NCT03926013 1301 1302 O
- NCT03926013 1303 1304 O
targeted NCT03926013 1305 1313 O
therapy NCT03926013 1314 1321 O
except NCT03926013 1322 1328 B-Exception
for NCT03926013 1329 1332 O
PSMA NCT03926013 1333 1337 B-Immunization
- NCT03926013 1338 1339 I-Immunization
targeted NCT03926013 1340 1348 I-Immunization
vaccine NCT03926013 1349 1356 I-Immunization
is NCT03926013 1357 1359 O
permitted NCT03926013 1360 1369 O

- NCT03926013 1372 1373 O
Solid NCT03926013 1375 1380 B-Modifier
organ NCT03926013 1381 1386 I-Modifier
or NCT03926013 1387 1389 B-Or
bone NCT03926013 1390 1394 B-Modifier
marrow NCT03926013 1395 1401 I-Modifier
transplantation NCT03926013 1402 1417 B-Procedure

- NCT03926013 1420 1421 O
Seizure NCT03926013 1423 1430 B-Condition
or NCT03926013 1431 1433 B-Or
known NCT03926013 1434 1439 O
condition NCT03926013 1440 1449 B-Condition
that NCT03926013 1450 1454 O
may NCT03926013 1455 1458 B-Assertion___Assertion_Type_Value:hypothetical
predispose NCT03926013 1459 1469 O
to NCT03926013 1470 1472 O
seizure NCT03926013 1473 1480 B-Condition
or NCT03926013 1481 1483 B-Or
intracranial NCT03926013 1484 1496 B-Condition
masses NCT03926013 1497 1503 I-Condition

- NCT03926013 1506 1507 O
Other NCT03926013 1509 1514 B-Other
active NCT03926013 1515 1521 B-Eq_Comparison
malignancy NCT03926013 1522 1532 B-Condition
requiring NCT03926013 1533 1542 B-Assertion___Assertion_Type_Value:hypothetical
systemic NCT03926013 1543 1551 B-Modifier
treatment NCT03926013 1552 1561 B-Procedure
< NCT03926013 1562 1563 B-Eq_Comparison
= NCT03926013 1564 1565 I-Eq_Comparison
12 NCT03926013 1566 1568 I-Eq_Comparison
months NCT03926013 1569 1575 I-Eq_Comparison
prior NCT03926013 1576 1581 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03926013 1582 1584 I-Temporal_Connection___Temporal_Connection_Type_Value:before
enrollment NCT03926013 1585 1595 B-Study

Inclusion NCT03862690 0 9 O
Criteria NCT03862690 10 18 O
: NCT03862690 19 20 O

- NCT03862690 24 25 O
Signed NCT03862690 27 33 O
consent NCT03862690 34 41 O
obtained NCT03862690 42 50 O
before NCT03862690 51 57 O
any NCT03862690 58 61 O
study NCT03862690 62 67 O
- NCT03862690 68 69 O
related NCT03862690 70 77 O
activities NCT03862690 78 88 O
( NCT03862690 89 90 O
study NCT03862690 91 96 O
- NCT03862690 97 98 O
related NCT03862690 99 106 O
activities NCT03862690 107 117 O
are NCT03862690 118 121 O
any NCT03862690 122 125 O
procedure NCT03862690 126 135 O
related NCT03862690 136 143 O
to NCT03862690 144 146 O
recording NCT03862690 147 156 O
of NCT03862690 157 159 O
data NCT03862690 160 164 O
according NCT03862690 165 174 O
to NCT03862690 175 177 O
the NCT03862690 178 181 O
protocol NCT03862690 182 190 O
) NCT03862690 191 192 O

- NCT03862690 196 197 O
The NCT03862690 199 202 O
decision NCT03862690 203 211 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03862690 212 214 I-Assertion___Assertion_Type_Value:hypothetical
initiate NCT03862690 215 223 I-Assertion___Assertion_Type_Value:hypothetical
treatment NCT03862690 224 233 B-Procedure
with NCT03862690 234 238 O
commercially NCT03862690 239 251 O
available NCT03862690 252 261 O
NovoMix NCT03862690 262 269 B-Drug
® NCT03862690 269 270 I-Drug
30 NCT03862690 271 273 I-Drug
has NCT03862690 274 277 O
been NCT03862690 278 282 O
made NCT03862690 283 287 O
by NCT03862690 288 290 O
the NCT03862690 291 294 O
patient NCT03862690 295 302 O
and NCT03862690 303 306 O
the NCT03862690 307 310 O
treating NCT03862690 311 319 O
physician NCT03862690 320 329 O
before NCT03862690 330 336 O
and NCT03862690 337 340 O
independently NCT03862690 341 354 O
from NCT03862690 355 359 O
the NCT03862690 360 363 O
decision NCT03862690 364 372 O
to NCT03862690 373 375 O
include NCT03862690 376 383 O
the NCT03862690 384 387 O
patient NCT03862690 388 395 O
in NCT03862690 396 398 O
this NCT03862690 399 403 O
study NCT03862690 404 409 O

- NCT03862690 412 413 O
Male NCT03862690 415 419 O
or NCT03862690 420 422 B-Or
female NCT03862690 423 429 O
, NCT03862690 430 431 O
greater NCT03862690 432 439 B-Eq_Comparison
than NCT03862690 440 444 I-Eq_Comparison
or NCT03862690 445 447 I-Eq_Comparison
equal NCT03862690 448 453 I-Eq_Comparison
to NCT03862690 454 456 I-Eq_Comparison
19 NCT03862690 457 459 I-Eq_Comparison
years NCT03862690 460 465 I-Eq_Comparison
at NCT03862690 466 468 O
the NCT03862690 469 472 O
time NCT03862690 473 477 O
of NCT03862690 478 480 O
signing NCT03862690 481 488 O
informed NCT03862690 489 497 O
consent NCT03862690 498 505 O

- NCT03862690 508 509 O
Diagnosed NCT03862690 511 520 O
with NCT03862690 521 525 O
type NCT03862690 526 530 B-Modifier
2 NCT03862690 531 532 I-Modifier
diabetes NCT03862690 533 541 B-Condition
and NCT03862690 542 545 B-And
treated NCT03862690 546 553 B-Procedure
with NCT03862690 554 558 O
basal NCT03862690 559 564 B-Drug
insulin NCT03862690 565 572 I-Drug
plus NCT03862690 573 577 O
1 NCT03862690 578 579 B-Eq_Comparison
- NCT03862690 580 581 I-Eq_Comparison
3 NCT03862690 582 583 I-Eq_Comparison
bolus NCT03862690 584 589 I-Eq_Comparison
insulin NCT03862690 590 597 I-Eq_Comparison
injections NCT03862690 598 608 I-Eq_Comparison
per NCT03862690 609 612 I-Eq_Comparison
day NCT03862690 613 616 I-Eq_Comparison
for NCT03862690 617 620 O
at NCT03862690 621 623 B-Eq_Comparison
least NCT03862690 624 629 I-Eq_Comparison
24 NCT03862690 630 632 I-Eq_Comparison
weeks NCT03862690 633 638 I-Eq_Comparison
prior NCT03862690 639 644 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862690 645 647 I-Temporal_Connection___Temporal_Connection_Type_Value:before
informed NCT03862690 648 656 O
consent NCT03862690 657 664 O

- NCT03862690 667 668 O
Available NCT03862690 670 679 O
and NCT03862690 680 683 O
documented NCT03862690 684 694 O
HbA NCT03862690 695 698 B-Observation
1c NCT03862690 699 701 I-Observation
value NCT03862690 702 707 O
less NCT03862690 708 712 B-Eq_Comparison
than NCT03862690 713 717 I-Eq_Comparison
or NCT03862690 718 720 I-Eq_Comparison
equal NCT03862690 721 726 I-Eq_Comparison
to NCT03862690 727 729 I-Eq_Comparison
12 NCT03862690 730 732 I-Eq_Comparison
weeks NCT03862690 733 738 I-Eq_Comparison
prior NCT03862690 739 744 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862690 745 747 I-Temporal_Connection___Temporal_Connection_Type_Value:before
initiation NCT03862690 748 758 B-Eq_Comparison
of NCT03862690 759 761 O
NovoMix NCT03862690 762 769 B-Drug
® NCT03862690 769 770 I-Drug
30 NCT03862690 771 773 I-Drug
treatment NCT03862690 774 783 B-Procedure

Exclusion NCT03862690 784 793 O
Criteria NCT03862690 794 802 O
: NCT03862690 803 804 O

- NCT03862690 808 809 O
Previous NCT03862690 811 819 B-Eq_Comparison
participation NCT03862690 820 833 O
in NCT03862690 834 836 O
this NCT03862690 837 841 O
study NCT03862690 842 847 B-Study
. NCT03862690 848 849 O
Participation NCT03862690 851 864 O
is NCT03862690 865 867 O
defined NCT03862690 868 875 O
as NCT03862690 876 878 O
having NCT03862690 879 885 O
given NCT03862690 886 891 O
informed NCT03862690 892 900 O
consent NCT03862690 901 908 O
in NCT03862690 909 911 O
this NCT03862690 912 916 O
study NCT03862690 917 922 O

- NCT03862690 925 926 O
Mental NCT03862690 928 934 B-Condition
incapacity NCT03862690 935 945 I-Condition
, NCT03862690 946 947 O
unwillingness NCT03862690 948 961 B-Modifier
or NCT03862690 962 964 B-Or
language NCT03862690 965 973 B-Condition
barriers NCT03862690 974 982 I-Condition
precluding NCT03862690 983 993 O
adequate NCT03862690 994 1002 O
understanding NCT03862690 1003 1016 O
or NCT03862690 1017 1019 O
cooperation NCT03862690 1020 1031 O

- NCT03862690 1034 1035 O
Participation NCT03862690 1037 1050 O
in NCT03862690 1051 1053 O
any NCT03862690 1054 1057 O
clinical NCT03862690 1058 1066 B-Study
trial NCT03862690 1067 1072 I-Study
of NCT03862690 1073 1075 O
an NCT03862690 1076 1078 O
approved NCT03862690 1079 1087 O
or NCT03862690 1088 1090 B-Or
non NCT03862690 1091 1094 O
- NCT03862690 1095 1096 O
approved NCT03862690 1097 1105 O
investigational NCT03862690 1106 1121 B-Study
medicinal NCT03862690 1122 1131 B-Drug
product NCT03862690 1132 1139 I-Drug
within NCT03862690 1140 1146 B-Eq_Comparison
24 NCT03862690 1147 1149 I-Eq_Comparison
weeks NCT03862690 1150 1155 I-Eq_Comparison
prior NCT03862690 1156 1161 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03862690 1162 1164 I-Temporal_Connection___Temporal_Connection_Type_Value:before
initiation NCT03862690 1165 1175 B-Eq_Comparison
of NCT03862690 1176 1178 O
NovoMix NCT03862690 1179 1186 B-Drug
® NCT03862690 1186 1187 I-Drug
30 NCT03862690 1188 1190 I-Drug
treatment NCT03862690 1191 1200 B-Procedure
. NCT03862690 1201 1202 O
Clinical NCT03862690 1204 1212 O
trials NCT03862690 1213 1219 O
do NCT03862690 1220 1222 O
not NCT03862690 1223 1226 O
include NCT03862690 1227 1234 O
non NCT03862690 1235 1238 O
- NCT03862690 1239 1240 O
interventional NCT03862690 1241 1255 O
studies NCT03862690 1256 1263 O

- NCT03862690 1266 1267 O
Hypersensitivity NCT03862690 1269 1285 B-Condition
to NCT03862690 1286 1288 O
NovoMix NCT03862690 1289 1296 B-Drug
® NCT03862690 1296 1297 I-Drug
30 NCT03862690 1298 1300 I-Drug
or NCT03862690 1301 1303 B-Or
to NCT03862690 1304 1306 O
any NCT03862690 1307 1310 O
of NCT03862690 1311 1313 O
the NCT03862690 1314 1317 O
excipients NCT03862690 1318 1328 O

- NCT03862690 1331 1332 O
Pregnancy NCT03862690 1334 1343 B-Condition
or NCT03862690 1344 1346 B-Or
intention NCT03862690 1347 1356 B-Assertion___Assertion_Type_Value:intention
of NCT03862690 1357 1359 O
becoming NCT03862690 1360 1368 O
pregnant NCT03862690 1369 1377 B-Condition

Inclusion NCT03929263 0 9 O
Criteria NCT03929263 10 18 O
: NCT03929263 19 20 O

- NCT03929263 24 25 O
Eligible NCT03929263 27 35 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03929263 36 39 O
fMRI NCT03929263 40 44 B-Procedure

- NCT03929263 47 48 O
Sufficient NCT03929263 50 60 O
English NCT03929263 61 68 O
fluency NCT03929263 69 76 O
to NCT03929263 77 79 O
complete NCT03929263 80 88 O
tasks NCT03929263 89 94 O

- NCT03929263 97 98 O
BMI NCT03929263 100 103 B-Observation
≤ NCT03929263 104 105 B-Eq_Comparison
40.0 NCT03929263 106 110 I-Eq_Comparison

- NCT03929263 114 115 O
Right NCT03929263 117 122 B-Condition
- NCT03929263 123 124 I-Condition
handed NCT03929263 125 131 I-Condition

- NCT03929263 134 135 O
Biological NCT03929263 137 147 B-Modifier
female NCT03929263 148 154 O

- NCT03929263 157 158 O
Co NCT03929263 160 162 B-Observation
- NCT03929263 163 164 I-Observation
residing NCT03929263 165 173 I-Observation
at NCT03929263 174 176 B-Eq_Comparison
least NCT03929263 177 182 I-Eq_Comparison
4 NCT03929263 183 184 I-Eq_Comparison
days NCT03929263 185 189 I-Eq_Comparison
/ NCT03929263 190 191 I-Eq_Comparison
week NCT03929263 192 196 I-Eq_Comparison

- NCT03929263 199 200 O
Adult NCT03929263 202 207 O
participants NCT03929263 208 220 O
: NCT03929263 221 222 O
Biological NCT03929263 223 233 O
mother NCT03929263 234 240 B-Family_Member___Family_Member_Type:mother
of NCT03929263 241 243 O
adolescent NCT03929263 244 254 O
participant NCT03929263 255 266 O

- NCT03929263 269 270 O
Adult NCT03929263 272 277 O
participants NCT03929263 278 290 O
: NCT03929263 291 292 O
Primary NCT03929263 293 300 B-Family_Member___Family_Member_Type:parent
caregiver NCT03929263 301 310 I-Family_Member___Family_Member_Type:parent
> NCT03929263 311 312 B-Eq_Comparison
50 NCT03929263 313 315 I-Eq_Comparison
% NCT03929263 316 317 I-Eq_Comparison
of NCT03929263 318 320 O
child NCT03929263 321 326 B-Family_Member___Family_Member_Type:child
's NCT03929263 326 328 O
lifespan NCT03929263 329 337 B-Observation

- NCT03929263 340 341 O
Adult NCT03929263 343 348 O
participants NCT03929263 349 361 O
: NCT03929263 362 363 O
BMI NCT03929263 364 367 B-Observation
≥ NCT03929263 368 369 B-Eq_Comparison
18.0 NCT03929263 370 374 I-Eq_Comparison

- NCT03929263 378 379 O
Adolescent NCT03929263 381 391 O
participants NCT03929263 392 404 O
: NCT03929263 405 406 O
Age NCT03929263 407 410 B-Age
13 NCT03929263 411 413 B-Eq_Comparison
- NCT03929263 414 415 I-Eq_Comparison
17 NCT03929263 416 418 I-Eq_Comparison
years NCT03929263 419 424 I-Eq_Comparison

- NCT03929263 427 428 O
Adolescent NCT03929263 430 440 O
participants NCT03929263 441 453 O
: NCT03929263 454 455 O
BMI NCT03929263 456 459 B-Observation
≥ NCT03929263 460 461 B-Eq_Comparison
16.0 NCT03929263 462 466 I-Eq_Comparison

Exclusion NCT03929263 468 477 O
Criteria NCT03929263 478 486 O
: NCT03929263 487 488 O

- NCT03929263 492 493 O
Current NCT03929263 495 502 B-Eq_Comparison
psychiatric NCT03929263 503 514 B-Condition
diagnosis NCT03929263 515 524 I-Condition

- NCT03929263 527 528 O
Medications NCT03929263 530 541 B-Drug
influencing NCT03929263 542 553 O
fMRI NCT03929263 554 558 B-Procedure

- NCT03929263 561 562 O
Medical NCT03929263 564 571 B-Condition
conditions NCT03929263 572 582 I-Condition
influencing NCT03929263 583 594 O
fMRI NCT03929263 595 599 B-Procedure

- NCT03929263 602 603 O
Alcohol NCT03929263 605 612 B-Drug
or NCT03929263 613 615 B-Or
psychoactive NCT03929263 616 628 B-Drug
drug NCT03929263 629 633 I-Drug
on NCT03929263 634 636 B-Temporal_Connection___Temporal_Connection_Type_Value:during
scan NCT03929263 637 641 B-Study
day NCT03929263 642 645 O

- NCT03929263 648 649 O
Adolescent NCT03929263 651 661 O
participants NCT03929263 662 674 O
: NCT03929263 675 676 O
Neurodevelopmental NCT03929263 677 695 B-Condition
delay NCT03929263 696 701 I-Condition

- NCT03929263 704 705 O
Adolescent NCT03929263 707 717 O
participants NCT03929263 718 730 O
: NCT03929263 731 732 O
History NCT03929263 733 740 B-Eq_Comparison
of NCT03929263 741 743 O
mood NCT03929263 744 748 B-Modifier
or NCT03929263 749 751 B-Or
psychotic NCT03929263 752 761 B-Modifier
disorder NCT03929263 762 770 B-Condition

- NCT03929263 773 774 O
Adolescent NCT03929263 776 786 O
participants NCT03929263 787 799 O
: NCT03929263 800 801 O
History NCT03929263 802 809 B-Eq_Comparison
of NCT03929263 810 812 O
obsessive NCT03929263 813 822 B-Condition
- NCT03929263 823 824 I-Condition
compulsive NCT03929263 825 835 I-Condition
disorder NCT03929263 836 844 I-Condition
( NCT03929263 845 846 O
OCD NCT03929263 847 850 B-Condition
) NCT03929263 851 852 O
or NCT03929263 853 855 B-Or
attention NCT03929263 856 865 B-Condition
- NCT03929263 866 867 I-Condition
deficit NCT03929263 868 875 I-Condition
/ NCT03929263 876 877 I-Condition
hyperactivity NCT03929263 878 891 I-Condition
disorder NCT03929263 892 900 I-Condition
( NCT03929263 901 902 O
ADHD NCT03929263 903 907 B-Condition
) NCT03929263 908 909 O


Inclusion NCT03863223 0 9 O
Criteria NCT03863223 10 18 O
: NCT03863223 19 20 O

1 NCT03863223 24 25 O
. NCT03863223 25 26 O
HER NCT03863223 28 31 B-Modifier
2 NCT03863223 32 33 I-Modifier
positive NCT03863223 34 42 O
recurrent NCT03863223 43 52 B-Modifier
or NCT03863223 53 55 B-Or
metastasis NCT03863223 56 66 B-Modifier
breast NCT03863223 67 73 I-Modifier
cancer NCT03863223 74 80 B-Condition
. NCT03863223 81 82 O

2 NCT03863223 86 87 O
. NCT03863223 87 88 O
Patients NCT03863223 90 98 O
with NCT03863223 99 103 O
measurable NCT03863223 104 114 B-Modifier
disease NCT03863223 115 122 B-Condition
are NCT03863223 123 126 O
eligible NCT03863223 127 135 O
. NCT03863223 136 137 O

3 NCT03863223 141 142 O
. NCT03863223 142 143 O
Eastern NCT03863223 145 152 B-Observation
Cooperative NCT03863223 153 164 I-Observation
Oncology NCT03863223 165 173 I-Observation
Group NCT03863223 174 179 I-Observation
( NCT03863223 180 181 O
ECOG NCT03863223 182 186 B-Observation
) NCT03863223 187 188 O
performance NCT03863223 189 200 O
status NCT03863223 201 207 O
0 NCT03863223 208 209 B-Eq_Comparison
or NCT03863223 210 212 I-Eq_Comparison
1 NCT03863223 213 214 I-Eq_Comparison
. NCT03863223 214 215 O

4 NCT03863223 219 220 O
. NCT03863223 220 221 O
Adequate NCT03863223 223 231 O
organ NCT03863223 232 237 B-Condition
function NCT03863223 238 246 I-Condition
. NCT03863223 247 248 O

5 NCT03863223 252 253 O
. NCT03863223 253 254 O
Signed NCT03863223 256 262 O
, NCT03863223 263 264 O
written NCT03863223 265 272 O
inform NCT03863223 273 279 O
consent NCT03863223 280 287 O
obtained NCT03863223 288 296 O
prior NCT03863223 297 302 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03863223 303 305 I-Temporal_Connection___Temporal_Connection_Type_Value:before
any NCT03863223 306 309 O
study NCT03863223 310 315 B-Study
procedure NCT03863223 316 325 O
. NCT03863223 326 327 O

Exclusion NCT03863223 329 338 O
Criteria NCT03863223 339 347 O
: NCT03863223 348 349 O

1 NCT03863223 353 354 O
. NCT03863223 354 355 O
History NCT03863223 357 364 B-Eq_Comparison
of NCT03863223 365 367 O
anti NCT03863223 368 372 O
- NCT03863223 373 374 O
cancer NCT03863223 375 381 B-Condition
therapy NCT03863223 382 389 B-Procedure
for NCT03863223 390 393 O
MBC NCT03863223 394 397 B-Condition
( NCT03863223 398 399 O
with NCT03863223 400 404 O
the NCT03863223 405 408 O
exception NCT03863223 409 418 B-Exception
of NCT03863223 419 421 O
one NCT03863223 422 425 B-Eq_Comparison
prior NCT03863223 426 431 B-Eq_Comparison
hormonal NCT03863223 432 440 B-Procedure
regimen NCT03863223 441 448 I-Procedure
for NCT03863223 449 452 O
MBC NCT03863223 453 456 B-Condition
） NCT03863223 456 457 O
. NCT03863223 458 459 O

2 NCT03863223 463 464 O
. NCT03863223 464 465 O
History NCT03863223 467 474 B-Eq_Comparison
of NCT03863223 475 477 O
HER NCT03863223 478 481 B-Modifier
tyrosine NCT03863223 482 490 B-Drug
kinase NCT03863223 491 497 I-Drug
inhibitors NCT03863223 498 508 I-Drug
or NCT03863223 509 511 B-Or
monoclonal NCT03863223 512 522 B-Drug
antibody NCT03863223 523 531 I-Drug
for NCT03863223 532 535 O
breast NCT03863223 536 542 B-Modifier
cancer NCT03863223 543 549 B-Condition
in NCT03863223 550 552 O
any NCT03863223 553 556 O
treatment NCT03863223 557 566 B-Procedure
setting NCT03863223 567 574 O
, NCT03863223 575 576 O
except NCT03863223 577 583 B-Exception
trastuzumab NCT03863223 584 595 B-Drug
used NCT03863223 596 600 O
in NCT03863223 601 603 O
the NCT03863223 604 607 O
neo NCT03863223 608 611 B-Modifier
- NCT03863223 612 613 I-Modifier
adjuvant NCT03863223 614 622 I-Modifier
or NCT03863223 623 625 B-Or
adjuvant NCT03863223 626 634 B-Modifier
setting NCT03863223 635 642 O
. NCT03863223 643 644 O

3 NCT03863223 648 649 O
. NCT03863223 649 650 O
Assessed NCT03863223 652 660 O
by NCT03863223 661 663 O
the NCT03863223 664 667 O
investigator NCT03863223 668 680 O
to NCT03863223 681 683 O
be NCT03863223 684 686 O
unable NCT03863223 687 693 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
receive NCT03863223 694 701 O
systemic NCT03863223 702 710 B-Modifier
chemotherapy NCT03863223 711 723 B-Procedure
. NCT03863223 724 725 O

4 NCT03863223 729 730 O
. NCT03863223 730 731 O
History NCT03863223 733 740 B-Eq_Comparison
of NCT03863223 741 743 O
other NCT03863223 744 749 B-Other
malignancy NCT03863223 750 760 B-Condition
within NCT03863223 761 767 B-Eq_Comparison
the NCT03863223 768 771 I-Eq_Comparison
last NCT03863223 772 776 I-Eq_Comparison
5 NCT03863223 777 778 I-Eq_Comparison
years NCT03863223 779 784 I-Eq_Comparison
, NCT03863223 785 786 O
except NCT03863223 787 793 B-Exception
for NCT03863223 794 797 O
carcinoma NCT03863223 798 807 B-Condition
in NCT03863223 808 810 O
situ NCT03863223 811 815 B-Modifier
of NCT03863223 816 818 I-Modifier
cervix NCT03863223 819 825 I-Modifier
, NCT03863223 826 827 O
basal NCT03863223 828 833 B-Modifier
cell NCT03863223 834 838 I-Modifier
carcinoma NCT03863223 839 848 I-Modifier
or NCT03863223 849 851 B-Or
squamous NCT03863223 852 860 B-Modifier
cell NCT03863223 861 865 I-Modifier
carcinoma NCT03863223 866 875 B-Condition
of NCT03863223 876 878 O
the NCT03863223 879 882 O
skin NCT03863223 883 887 B-Modifier
that NCT03863223 888 892 O
has NCT03863223 893 896 O
been NCT03863223 897 901 O
previously NCT03863223 902 912 B-Eq_Comparison
treated NCT03863223 913 920 B-Procedure
with NCT03863223 921 925 O
curative NCT03863223 926 934 B-Modifier
intent NCT03863223 935 941 I-Modifier
. NCT03863223 942 943 O

5 NCT03863223 947 948 O
. NCT03863223 948 949 O
Pregnant NCT03863223 951 959 B-Condition
or NCT03863223 960 962 B-Or
lactating NCT03863223 963 972 B-Condition
women NCT03863223 973 978 O
, NCT03863223 979 980 O
or NCT03863223 981 983 B-Or
for NCT03863223 984 987 O
women NCT03863223 988 993 O
of NCT03863223 994 996 O
childbearing NCT03863223 997 1009 B-Condition
potential NCT03863223 1010 1019 B-Assertion___Assertion_Type_Value:hypothetical
unwilling NCT03863223 1020 1029 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03863223 1030 1032 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
use NCT03863223 1033 1036 O
a NCT03863223 1037 1038 O
highly NCT03863223 1039 1045 B-Modifier
- NCT03863223 1046 1047 I-Modifier
effective NCT03863223 1048 1057 I-Modifier
contraception NCT03863223 1058 1071 B-Procedure
during NCT03863223 1072 1078 B-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03863223 1079 1081 O
the NCT03863223 1082 1085 O
study NCT03863223 1086 1091 B-Study
treatment NCT03863223 1092 1101 B-Procedure
and NCT03863223 1102 1105 B-And
for NCT03863223 1106 1109 O
at NCT03863223 1110 1112 B-Eq_Comparison
least NCT03863223 1113 1118 I-Eq_Comparison
7 NCT03863223 1119 1120 I-Eq_Comparison
months NCT03863223 1121 1127 I-Eq_Comparison
after NCT03863223 1128 1133 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03863223 1134 1137 O
last NCT03863223 1138 1142 B-Eq_Comparison
dose NCT03863223 1143 1147 O
of NCT03863223 1148 1150 O
study NCT03863223 1151 1156 B-Study
treatment NCT03863223 1157 1166 B-Procedure
. NCT03863223 1167 1168 O

Inclusion NCT03920800 0 9 O
Criteria NCT03920800 10 18 O
: NCT03920800 19 20 O

- NCT03920800 24 25 O
Patients NCT03920800 27 35 O
followed NCT03920800 36 44 B-Encounter
within NCT03920800 45 51 O
the NCT03920800 52 55 O
CHU NCT03920800 56 59 O
Brugmann NCT03920800 60 68 O
Hospital NCT03920800 69 77 O
( NCT03920800 78 79 O
no NCT03920800 80 82 B-Negation
private NCT03920800 83 90 O
practices NCT03920800 91 100 O
) NCT03920800 101 102 O
. NCT03920800 103 104 O

- NCT03920800 108 109 O
HSIL NCT03920800 111 115 B-Condition
lesions NCT03920800 116 123 I-Condition
confirmed NCT03920800 124 133 O
by NCT03920800 134 136 O
anatomopathologic NCT03920800 137 154 O
analysis NCT03920800 155 163 O
on NCT03920800 164 166 O
cervical NCT03920800 167 175 B-Procedure
biopsies NCT03920800 176 184 I-Procedure
or NCT03920800 185 187 B-Or
cone NCT03920800 188 192 B-Observation
specimen NCT03920800 193 201 I-Observation
without NCT03920800 202 209 B-Negation
evidence NCT03920800 210 218 O
of NCT03920800 219 221 O
invasive NCT03920800 222 230 B-Condition
lesions NCT03920800 231 238 I-Condition

Exclusion NCT03920800 239 248 O
Criteria NCT03920800 249 257 O
: NCT03920800 258 259 O

- NCT03920800 263 264 O
Invasive NCT03920800 266 274 B-Condition
lesions NCT03920800 275 282 I-Condition

Inclusion NCT03923972 0 9 O
Criteria NCT03923972 10 18 O
: NCT03923972 19 20 O

- NCT03923972 24 25 O
all NCT03923972 27 30 O
adult NCT03923972 31 36 O
patients NCT03923972 37 45 O
with NCT03923972 46 50 O
non NCT03923972 51 54 B-Modifier
- NCT03923972 55 56 I-Modifier
dialysis NCT03923972 57 65 I-Modifier
dependent NCT03923972 66 75 I-Modifier
chronic NCT03923972 76 83 B-Condition
kidney NCT03923972 84 90 I-Condition
disease NCT03923972 91 98 I-Condition
, NCT03923972 99 100 O
peritoneal NCT03923972 101 111 B-Procedure
dialysis NCT03923972 112 120 I-Procedure
, NCT03923972 121 122 O
hemodialysis NCT03923972 123 135 B-Procedure
, NCT03923972 136 137 O
renal NCT03923972 138 143 B-Procedure
transplantation NCT03923972 144 159 I-Procedure

- NCT03923972 162 163 O
all NCT03923972 165 168 O
active NCT03923972 169 175 B-Eq_Comparison
physicians NCT03923972 176 186 O
in NCT03923972 187 189 O
the NCT03923972 190 193 O
department NCT03923972 194 204 O
of NCT03923972 205 207 O
nephrology NCT03923972 208 218 B-Provider
involved NCT03923972 219 227 O
in NCT03923972 228 230 O
patient NCT03923972 231 238 O
care NCT03923972 239 243 O

- NCT03923972 246 247 O
all NCT03923972 249 252 O
active NCT03923972 253 259 B-Eq_Comparison
nurses NCT03923972 260 266 O
in NCT03923972 267 269 O
the NCT03923972 270 273 O
department NCT03923972 274 284 O
of NCT03923972 285 287 O
nephrology NCT03923972 288 298 B-Provider
involved NCT03923972 299 307 O
in NCT03923972 308 310 O
patient NCT03923972 311 318 O
care NCT03923972 319 323 O

- NCT03923972 326 327 O
all NCT03923972 329 332 O
heads NCT03923972 333 338 O
of NCT03923972 339 341 O
nephrology NCT03923972 342 352 B-Provider
departments NCT03923972 353 364 O

Exclusion NCT03923972 365 374 O
Criteria NCT03923972 375 383 O
: NCT03923972 384 385 O

- NCT03923972 389 390 O
children NCT03923972 392 400 O

- NCT03923972 403 404 O
no NCT03923972 406 408 B-Negation
physical NCT03923972 409 417 B-Condition
disability NCT03923972 418 428 I-Condition
making NCT03923972 429 435 O
it NCT03923972 436 438 O
impossible NCT03923972 439 449 B-Negation
to NCT03923972 450 452 B-Assertion___Assertion_Type_Value:hypothetical
conduct NCT03923972 453 460 I-Assertion___Assertion_Type_Value:hypothetical
exercise NCT03923972 461 469 B-Procedure
training NCT03923972 470 478 I-Procedure

- NCT03923972 481 482 O
no NCT03923972 484 486 B-Negation
mental NCT03923972 487 493 B-Condition
disability NCT03923972 494 504 I-Condition
or NCT03923972 505 507 B-Or
language NCT03923972 508 516 B-Condition
problem NCT03923972 517 524 I-Condition
making NCT03923972 525 531 O
it NCT03923972 532 534 O
impossible NCT03923972 535 545 B-Negation
to NCT03923972 546 548 O
understand NCT03923972 549 559 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03923972 560 563 I-Assertion___Assertion_Type_Value:hypothetical
fill NCT03923972 564 568 I-Assertion___Assertion_Type_Value:hypothetical
in NCT03923972 569 571 I-Assertion___Assertion_Type_Value:hypothetical
a NCT03923972 572 573 O
questionnaire NCT03923972 574 587 B-Observation

Inclusion NCT03926208 0 9 O
Criteria NCT03926208 10 18 O
: NCT03926208 19 20 O

1 NCT03926208 24 25 O
. NCT03926208 25 26 O
≥ NCT03926208 28 29 B-Eq_Comparison
18 NCT03926208 30 32 I-Eq_Comparison
years NCT03926208 33 38 I-Eq_Comparison
of NCT03926208 39 41 O
age NCT03926208 42 45 B-Age

2 NCT03926208 48 49 O
. NCT03926208 49 50 O
Patient NCT03926208 52 59 O
requires NCT03926208 60 68 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03926208 69 70 O
foot NCT03926208 71 75 B-Modifier
or NCT03926208 76 78 B-Or
ankle NCT03926208 79 84 B-Modifier
operative NCT03926208 85 94 B-Procedure
procedure NCT03926208 95 104 I-Procedure

3 NCT03926208 107 108 O
. NCT03926208 108 109 O
Patient NCT03926208 111 118 O
provides NCT03926208 119 127 O
informed NCT03926208 128 136 O
consent NCT03926208 137 144 O

Exclusion NCT03926208 145 154 O
Criteria NCT03926208 155 163 O
: NCT03926208 164 165 O

1 NCT03926208 169 170 O
. NCT03926208 170 171 O
Patient NCT03926208 173 180 O
refuses NCT03926208 181 188 O

2 NCT03926208 191 192 O
. NCT03926208 192 193 O
Patient NCT03926208 195 202 O
is NCT03926208 203 205 O
incarcerated NCT03926208 206 218 B-Observation
, NCT03926208 219 220 O
incapacitated NCT03926208 221 234 B-Condition
, NCT03926208 235 236 O
or NCT03926208 237 239 O
otherwise NCT03926208 240 249 O
unable NCT03926208 250 256 O
to NCT03926208 257 259 O
provide NCT03926208 260 267 O
appropriate NCT03926208 268 279 O
informed NCT03926208 280 288 O
consent NCT03926208 289 296 O

Inclusion NCT03927092 0 9 O
Criteria NCT03927092 10 18 O
: NCT03927092 19 20 O

- NCT03927092 24 25 O
Diagnosed NCT03927092 27 36 O
as NCT03927092 37 39 O
having NCT03927092 40 46 O
Multiple NCT03927092 47 55 B-Condition
Sclerosis NCT03927092 56 65 I-Condition

- NCT03927092 68 69 O
Attends NCT03927092 71 78 O
the NCT03927092 79 82 O
annual NCT03927092 83 89 O
patient NCT03927092 90 97 O
education NCT03927092 98 107 O
seminar NCT03927092 108 115 O
at NCT03927092 116 118 O
the NCT03927092 119 122 O
investigators NCT03927092 123 136 O
' NCT03927092 136 137 O
university NCT03927092 138 148 O
hospital NCT03927092 149 157 O

- NCT03927092 160 161 O
Older NCT03927092 163 168 B-Eq_Comparison
than NCT03927092 169 173 I-Eq_Comparison
18 NCT03927092 174 176 I-Eq_Comparison
years NCT03927092 177 182 I-Eq_Comparison
of NCT03927092 183 185 O
age NCT03927092 186 189 B-Age

- NCT03927092 192 193 O
Can NCT03927092 195 198 O
read NCT03927092 199 203 O
and NCT03927092 204 207 O
write NCT03927092 208 213 O

Exclusion NCT03927092 214 223 O
Criteria NCT03927092 224 232 O
: NCT03927092 233 234 O

- NCT03927092 238 239 O
Does NCT03927092 241 245 O
not NCT03927092 246 249 B-Negation
accept NCT03927092 250 256 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03927092 257 259 O
answer NCT03927092 260 266 O
the NCT03927092 267 270 O
questionnaire NCT03927092 271 284 B-Observation

- NCT03927092 287 288 O
Unable NCT03927092 290 296 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03927092 297 299 O
answer NCT03927092 300 306 O
the NCT03927092 307 310 O
questions NCT03927092 311 320 B-Procedure
due NCT03927092 321 324 O
to NCT03927092 325 327 O
a NCT03927092 328 329 O
cognitive NCT03927092 330 339 B-Condition
impairment NCT03927092 340 350 I-Condition

Inclusion NCT03861715 0 9 O
Criteria NCT03861715 10 18 O
: NCT03861715 19 20 O

- NCT03861715 24 25 O
age NCT03861715 27 30 B-Age
20 NCT03861715 31 33 B-Eq_Comparison
- NCT03861715 34 35 I-Eq_Comparison
34 NCT03861715 36 38 I-Eq_Comparison
years NCT03861715 39 44 I-Eq_Comparison
; NCT03861715 44 45 O

- NCT03861715 48 49 O
body NCT03861715 51 55 B-Observation
mass NCT03861715 56 60 I-Observation
index NCT03861715 61 66 I-Observation
( NCT03861715 67 68 O
BMI NCT03861715 69 72 B-Observation
) NCT03861715 73 74 O
18 NCT03861715 75 77 B-Eq_Comparison
- NCT03861715 78 79 I-Eq_Comparison
29 NCT03861715 80 82 I-Eq_Comparison
kg NCT03861715 83 85 I-Eq_Comparison
/ NCT03861715 86 87 I-Eq_Comparison
m NCT03861715 88 89 I-Eq_Comparison
2 NCT03861715 90 91 I-Eq_Comparison
; NCT03861715 91 92 O

- NCT03861715 95 96 O
regular NCT03861715 98 105 O
menstrual NCT03861715 106 115 B-Condition
cycle NCT03861715 116 121 I-Condition
of NCT03861715 122 124 O
26 NCT03861715 125 127 B-Eq_Comparison
- NCT03861715 128 129 I-Eq_Comparison
35 NCT03861715 130 132 I-Eq_Comparison
days NCT03861715 133 137 I-Eq_Comparison
, NCT03861715 138 139 O

- NCT03861715 143 144 O
AMH NCT03861715 146 149 B-Observation
levels NCT03861715 150 156 O
age NCT03861715 157 160 O
appropriate NCT03861715 161 172 O
( NCT03861715 173 174 O
≥ NCT03861715 175 176 B-Eq_Comparison
2.3 NCT03861715 177 180 I-Eq_Comparison
ng NCT03861715 181 183 I-Eq_Comparison
/ NCT03861715 184 185 I-Eq_Comparison
ml NCT03861715 186 188 I-Eq_Comparison
) NCT03861715 189 190 O

- NCT03861715 194 195 O
early NCT03861715 197 202 B-Modifier
follicular NCT03861715 203 213 I-Modifier
- NCT03861715 214 215 I-Modifier
phase NCT03861715 216 221 I-Modifier
serum NCT03861715 222 227 B-Observation
concentration NCT03861715 228 241 I-Observation
of NCT03861715 242 244 I-Observation
FSH NCT03861715 245 248 I-Observation
within NCT03861715 249 255 B-Eq_Comparison
normal NCT03861715 256 262 I-Eq_Comparison
limits NCT03861715 263 269 I-Eq_Comparison
( NCT03861715 270 271 O
1 NCT03861715 272 273 B-Eq_Comparison
- NCT03861715 274 275 I-Eq_Comparison
12 NCT03861715 276 278 I-Eq_Comparison
IU NCT03861715 279 281 I-Eq_Comparison
/ NCT03861715 282 283 I-Eq_Comparison
l NCT03861715 284 285 I-Eq_Comparison
) NCT03861715 286 287 O
. NCT03861715 288 289 O

Exclusion NCT03861715 291 300 O
Criteria NCT03861715 301 309 O
: NCT03861715 310 311 O

- NCT03861715 315 316 O
women NCT03861715 318 323 O
with NCT03861715 324 328 B-And
diabetes NCT03861715 329 337 B-Condition
and NCT03861715 338 341 B-Or
other NCT03861715 342 347 B-Other
metabolic NCT03861715 348 357 B-Condition
disease NCT03861715 358 365 I-Condition

- NCT03861715 368 369 O
women NCT03861715 371 376 O
with NCT03861715 377 381 B-And
hereditary NCT03861715 382 392 B-Modifier
genetic NCT03861715 393 400 B-Condition
diseases NCT03861715 401 409 I-Condition
; NCT03861715 409 410 O

- NCT03861715 413 414 O
women NCT03861715 416 421 O
with NCT03861715 422 426 B-And
heart NCT03861715 427 432 B-Condition
disease NCT03861715 433 440 I-Condition
, NCT03861715 441 442 O
QT NCT03861715 443 445 B-Condition
prolongation NCT03861715 446 458 I-Condition
, NCT03861715 459 460 O
heart NCT03861715 461 466 B-Condition
failure NCT03861715 467 474 I-Condition

- NCT03861715 477 478 O
elevated NCT03861715 480 488 O
liver NCT03861715 489 494 B-Condition
enzymes NCT03861715 495 502 I-Condition
, NCT03861715 503 504 O
liver NCT03861715 505 510 B-Condition
failure NCT03861715 511 518 I-Condition
, NCT03861715 519 520 O
hepatitis NCT03861715 521 530 B-Condition

- NCT03861715 533 534 O
women NCT03861715 536 541 O
with NCT03861715 542 546 B-And
inflammatory NCT03861715 547 559 B-Modifier
or NCT03861715 560 562 B-Or
autoimmune NCT03861715 563 573 B-Modifier
disease NCT03861715 574 581 B-Condition

- NCT03861715 584 585 O
abnormal NCT03861715 587 595 O
karyotype NCT03861715 596 605 B-Condition
; NCT03861715 605 606 O

- NCT03861715 609 610 O
endometriosis NCT03861715 612 625 B-Condition
stage NCT03861715 626 631 B-Eq_Comparison
III NCT03861715 632 635 I-Eq_Comparison
/ NCT03861715 636 637 I-Eq_Comparison
IV NCT03861715 638 640 I-Eq_Comparison
; NCT03861715 640 641 O

- NCT03861715 644 645 O
history NCT03861715 647 654 B-Eq_Comparison
of NCT03861715 655 657 O
recurrent NCT03861715 658 667 B-Condition
miscarriage NCT03861715 668 679 I-Condition
; NCT03861715 679 680 O

- NCT03861715 683 684 O
severe NCT03861715 686 692 O
OHSS NCT03861715 693 697 B-Condition
in NCT03861715 698 700 B-Temporal_Connection___Temporal_Connection_Type_Value:during
a NCT03861715 701 702 O
previous NCT03861715 703 711 B-Eq_Comparison
stimulation NCT03861715 712 723 B-Procedure
cycle NCT03861715 724 729 I-Procedure
or NCT03861715 730 732 B-Or
any NCT03861715 733 736 O
contraindication NCT03861715 737 753 B-Contraindication
for NCT03861715 754 757 O
the NCT03861715 758 761 O
use NCT03861715 762 765 O
of NCT03861715 766 768 O
gonadotrophins NCT03861715 769 783 B-Drug
. NCT03861715 784 785 O

Inclusion NCT03922542 0 9 O
Criteria NCT03922542 10 18 O
: NCT03922542 19 20 O

- NCT03922542 24 25 O
Documented NCT03922542 27 37 O
keratoconus NCT03922542 38 49 B-Condition
or NCT03922542 50 52 B-Or
ectasia NCT03922542 53 60 B-Condition
after NCT03922542 61 66 B-Temporal_Connection___Temporal_Connection_Type_Value:after
refractive NCT03922542 67 77 B-Procedure
surgery NCT03922542 78 85 I-Procedure

Exclusion NCT03922542 86 95 O
Criteria NCT03922542 96 104 O
: NCT03922542 105 106 O

- NCT03922542 110 111 O
Insufficient NCT03922542 113 125 B-Condition
corneal NCT03922542 126 133 I-Condition
thickness NCT03922542 134 143 I-Condition

- NCT03922542 146 147 O
Ocular NCT03922542 149 155 B-Condition
condition NCT03922542 156 165 I-Condition
that NCT03922542 166 170 O
may NCT03922542 171 174 B-Assertion___Assertion_Type_Value:possible
predispose NCT03922542 175 185 B-Risk
the NCT03922542 186 189 O
eye NCT03922542 190 193 B-Condition
to NCT03922542 194 196 I-Condition
complications NCT03922542 197 210 I-Condition

- NCT03922542 213 214 O
History NCT03922542 216 223 B-Eq_Comparison
of NCT03922542 224 226 O
chemical NCT03922542 227 235 B-Condition
injury NCT03922542 236 242 I-Condition
or NCT03922542 243 245 B-Or
delayed NCT03922542 246 253 B-Condition
epithelial NCT03922542 254 264 I-Condition
healing NCT03922542 265 272 I-Condition

- NCT03922542 275 276 O
Condition NCT03922542 278 287 B-Condition
that NCT03922542 288 292 O
would NCT03922542 293 298 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03922542 299 308 O
with NCT03922542 309 313 O
or NCT03922542 314 316 B-Or
prolong NCT03922542 317 324 O
epithelial NCT03922542 325 335 B-Condition
healing NCT03922542 336 343 I-Condition

- NCT03922542 346 347 O
Known NCT03922542 349 354 O
sensitivity NCT03922542 355 366 B-Condition
to NCT03922542 367 369 O
treatment NCT03922542 370 379 B-Procedure
medications NCT03922542 380 391 B-Drug

- NCT03922542 394 395 O
Pregnancy NCT03922542 397 406 B-Condition

Inclusion NCT03860753 0 9 O
Criteria NCT03860753 10 18 O
: NCT03860753 19 20 O

- NCT03860753 24 25 O
treatment NCT03860753 27 36 B-Procedure
- NCT03860753 37 38 O
seeking NCT03860753 39 46 B-Assertion___Assertion_Type_Value:intention
individuals NCT03860753 47 58 O
diagnosed NCT03860753 59 68 O
with NCT03860753 69 73 O
AUD NCT03860753 74 77 B-Condition
diagnostic NCT03860753 78 88 O
statistical NCT03860753 89 100 O
manual NCT03860753 101 107 O
5 NCT03860753 108 109 O
( NCT03860753 110 111 O
DSM NCT03860753 112 115 O
- NCT03860753 116 117 O
5 NCT03860753 118 119 O
) NCT03860753 120 121 O

- NCT03860753 125 126 O
fluent NCT03860753 128 134 O
in NCT03860753 135 137 O
English NCT03860753 138 145 O

- NCT03860753 148 149 O
past NCT03860753 151 155 B-Eq_Comparison
month NCT03860753 156 161 I-Eq_Comparison
excessive NCT03860753 162 171 O
alcohol NCT03860753 172 179 B-Observation
use NCT03860753 180 183 I-Observation
( NCT03860753 184 185 O
> NCT03860753 186 187 B-Eq_Comparison
7 NCT03860753 188 189 I-Eq_Comparison
drinks NCT03860753 190 196 I-Eq_Comparison
/ NCT03860753 197 198 I-Eq_Comparison
week NCT03860753 199 203 I-Eq_Comparison
for NCT03860753 204 207 O
woman NCT03860753 208 213 O
, NCT03860753 214 215 O
> NCT03860753 216 217 B-Eq_Comparison
14 NCT03860753 218 220 I-Eq_Comparison
drinks NCT03860753 221 227 I-Eq_Comparison
/ NCT03860753 228 229 I-Eq_Comparison
week NCT03860753 230 234 I-Eq_Comparison
for NCT03860753 235 238 O
men NCT03860753 239 242 O
, NCT03860753 243 244 O
> NCT03860753 245 246 O
3 NCT03860753 247 248 B-Eq_Comparison
drinks NCT03860753 249 255 I-Eq_Comparison
/ NCT03860753 256 257 I-Eq_Comparison
occasion NCT03860753 258 266 I-Eq_Comparison
for NCT03860753 267 270 O
women NCT03860753 271 276 O
> NCT03860753 277 278 B-Eq_Comparison
4 NCT03860753 279 280 I-Eq_Comparison
drinks NCT03860753 281 287 I-Eq_Comparison
/ NCT03860753 288 289 I-Eq_Comparison
occasion NCT03860753 290 298 I-Eq_Comparison
for NCT03860753 299 302 O
men NCT03860753 303 306 O
) NCT03860753 307 308 O
14 NCT03860753 309 311 O

- NCT03860753 315 316 O
baseline NCT03860753 318 326 O
Hamilton NCT03860753 327 335 B-Observation
Anxiety NCT03860753 336 343 I-Observation
Rating NCT03860753 344 350 I-Observation
Scale NCT03860753 351 356 I-Observation
( NCT03860753 357 358 O
HAM NCT03860753 359 362 B-Observation
- NCT03860753 363 364 I-Observation
A NCT03860753 365 366 I-Observation
) NCT03860753 367 368 O
or NCT03860753 369 371 B-Or
Perceived NCT03860753 372 381 B-Observation
Stress NCT03860753 382 388 I-Observation
Scale NCT03860753 389 394 I-Observation
( NCT03860753 395 396 O
PSS NCT03860753 397 400 B-Observation
) NCT03860753 401 402 O
core NCT03860753 403 407 O
indicative NCT03860753 408 418 O
of NCT03860753 419 421 O
mild NCT03860753 422 426 O
to NCT03860753 427 429 B-Or
moderate NCT03860753 430 438 O
anxiety NCT03860753 439 446 B-Condition
( NCT03860753 447 448 O
score NCT03860753 449 454 B-Eq_Comparison
8 NCT03860753 455 456 I-Eq_Comparison
to NCT03860753 457 459 I-Eq_Comparison
23 NCT03860753 460 462 I-Eq_Comparison
) NCT03860753 463 464 O
or NCT03860753 465 467 B-Or
moderate NCT03860753 468 476 O
stress NCT03860753 477 483 B-Condition
( NCT03860753 484 485 O
score NCT03860753 486 491 B-Eq_Comparison
14 NCT03860753 492 494 I-Eq_Comparison
to NCT03860753 495 497 I-Eq_Comparison
26 NCT03860753 498 500 I-Eq_Comparison
) NCT03860753 501 502 O
, NCT03860753 503 504 O
respectively NCT03860753 505 517 O

- NCT03860753 520 521 O
increase NCT03860753 523 531 O
in NCT03860753 532 534 O
alcohol NCT03860753 535 542 B-Condition
craving NCT03860753 543 550 I-Condition
following NCT03860753 551 560 B-Temporal_Connection___Temporal_Connection_Type_Value:after
the NCT03860753 561 564 O
baseline NCT03860753 565 573 B-Study
stress NCT03860753 574 580 O
reactivity NCT03860753 581 591 O
assessment NCT03860753 592 602 O
. NCT03860753 603 604 O

Exclusion NCT03860753 606 615 O
Criteria NCT03860753 616 624 O
: NCT03860753 625 626 O

- NCT03860753 630 631 O
Individuals NCT03860753 633 644 O
will NCT03860753 645 649 O
be NCT03860753 650 652 O
excluded NCT03860753 653 661 O
for NCT03860753 662 665 O
exhibiting NCT03860753 666 676 O
severe NCT03860753 677 683 O
scores NCT03860753 684 690 O
on NCT03860753 691 693 O
the NCT03860753 694 697 O
HAM NCT03860753 698 701 B-Observation
- NCT03860753 702 703 I-Observation
A NCT03860753 704 705 I-Observation
, NCT03860753 706 707 O
PSS NCT03860753 708 711 B-Observation
, NCT03860753 712 713 O
or NCT03860753 714 716 B-Or
post NCT03860753 717 721 B-Condition
- NCT03860753 722 723 I-Condition
traumatic NCT03860753 724 733 I-Condition
( NCT03860753 734 735 O
PTSD NCT03860753 736 740 B-Condition
) NCT03860753 741 742 O
checklist NCT03860753 743 752 B-Observation
( NCT03860753 753 754 O
PCL NCT03860753 755 758 B-Observation
- NCT03860753 759 760 I-Observation
5 NCT03860753 761 762 I-Observation
) NCT03860753 763 764 O
at NCT03860753 765 767 O
the NCT03860753 768 771 O
discretion NCT03860753 772 782 O
of NCT03860753 783 785 O
the NCT03860753 786 789 O
admitting NCT03860753 790 799 O
physician NCT03860753 800 809 O

- NCT03860753 812 813 O
physical NCT03860753 815 823 O
dependence NCT03860753 824 834 B-Condition
on NCT03860753 835 837 I-Condition
alcohol NCT03860753 838 845 I-Condition
Alcohol NCT03860753 846 853 B-Observation
Use NCT03860753 854 857 I-Observation
Disorders NCT03860753 858 867 I-Observation
Inventory NCT03860753 868 877 I-Observation
( NCT03860753 878 879 O
AUDIT NCT03860753 880 885 B-Observation
) NCT03860753 886 887 O
score NCT03860753 888 893 O
indicative NCT03860753 894 904 O
of NCT03860753 905 907 O
severe NCT03860753 908 914 O
alcohol NCT03860753 915 922 B-Condition
dependence NCT03860753 923 933 I-Condition
( NCT03860753 934 935 O
≥ NCT03860753 936 937 B-Eq_Comparison
13 NCT03860753 938 940 I-Eq_Comparison
for NCT03860753 941 944 O
women NCT03860753 945 950 O
, NCT03860753 951 952 O
≥ NCT03860753 953 954 B-Eq_Comparison
15 NCT03860753 955 957 I-Eq_Comparison
for NCT03860753 958 961 O
men NCT03860753 962 965 O
) NCT03860753 966 967 O

- NCT03860753 971 972 O
greater NCT03860753 974 981 B-Eq_Comparison
than NCT03860753 982 986 I-Eq_Comparison
mild NCT03860753 987 991 O
substance NCT03860753 992 1001 B-Condition
use NCT03860753 1002 1005 I-Condition
disorder NCT03860753 1006 1014 I-Condition
on NCT03860753 1015 1017 O
drugs NCT03860753 1018 1023 B-Drug
other NCT03860753 1024 1029 B-Exception
than NCT03860753 1030 1034 I-Exception
alcohol NCT03860753 1035 1042 B-Drug
, NCT03860753 1043 1044 O
nicotine NCT03860753 1045 1053 B-Drug
, NCT03860753 1054 1055 O
and NCT03860753 1056 1059 B-And
marijuana NCT03860753 1060 1069 B-Drug

- NCT03860753 1072 1073 O
contraindications NCT03860753 1075 1092 B-Contraindication
for NCT03860753 1093 1096 O
taking NCT03860753 1097 1103 B-Eq_Comparison
pioglitazone NCT03860753 1104 1116 B-Drug
; NCT03860753 1116 1117 O
medical NCT03860753 1118 1125 O
conditions NCT03860753 1126 1136 B-Condition
contraindicating NCT03860753 1137 1153 B-Contraindication
pioglitazone NCT03860753 1154 1166 B-Drug
pharmacotherapy NCT03860753 1167 1182 O
or NCT03860753 1183 1185 B-Or
taking NCT03860753 1186 1192 B-Eq_Comparison
contraindicated NCT03860753 1193 1208 B-Contraindication
medications NCT03860753 1209 1220 B-Drug

- NCT03860753 1223 1224 O
be NCT03860753 1226 1228 O
pregnant NCT03860753 1229 1237 B-Condition
, NCT03860753 1238 1239 O
nursing NCT03860753 1240 1247 B-Condition
, NCT03860753 1248 1249 O
or NCT03860753 1250 1252 B-Or
planning NCT03860753 1253 1261 B-Assertion___Assertion_Type_Value:intention
on NCT03860753 1262 1264 O
becoming NCT03860753 1265 1273 O
pregnant NCT03860753 1274 1282 B-Condition
during NCT03860753 1283 1289 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03860753 1290 1293 O
course NCT03860753 1294 1300 O
of NCT03860753 1301 1303 O
the NCT03860753 1304 1307 O
study NCT03860753 1308 1313 B-Study

- NCT03860753 1316 1317 O
have NCT03860753 1319 1323 O
any NCT03860753 1324 1327 O
other NCT03860753 1328 1333 O
illness NCT03860753 1334 1341 B-Condition
, NCT03860753 1342 1343 O
condition NCT03860753 1344 1353 B-Condition
, NCT03860753 1354 1355 O
or NCT03860753 1356 1358 B-Or
use NCT03860753 1359 1362 O
of NCT03860753 1363 1365 O
medications NCT03860753 1366 1377 B-Drug
, NCT03860753 1378 1379 O
which NCT03860753 1380 1385 O
in NCT03860753 1386 1388 O
the NCT03860753 1389 1392 O
opinion NCT03860753 1393 1400 O
of NCT03860753 1401 1403 O
the NCT03860753 1404 1407 O
PI NCT03860753 1408 1410 O
and NCT03860753 1411 1414 O
/ NCT03860753 1415 1416 O
or NCT03860753 1417 1419 O
admitting NCT03860753 1420 1429 O
physician NCT03860753 1430 1439 O
would NCT03860753 1440 1445 B-Assertion___Assertion_Type_Value:hypothetical
preclude NCT03860753 1446 1454 B-Negation
safe NCT03860753 1455 1459 B-Modifier
and NCT03860753 1460 1463 B-Or
/ NCT03860753 1464 1465 I-Or
or NCT03860753 1466 1468 I-Or
successful NCT03860753 1469 1479 B-Modifier
completion NCT03860753 1480 1490 O
of NCT03860753 1491 1493 O
the NCT03860753 1494 1497 O
study NCT03860753 1498 1503 B-Study
. NCT03860753 1504 1505 O


Inclusion NCT03926039 0 9 O
Criteria NCT03926039 10 18 O
: NCT03926039 19 20 O

1 NCT03926039 24 25 O
. NCT03926039 25 26 O
Primary NCT03926039 28 35 B-Modifier
liver NCT03926039 36 41 I-Modifier
cancer NCT03926039 42 48 B-Condition
patients NCT03926039 49 57 O
( NCT03926039 58 59 O
ICD NCT03926039 60 63 O
10 NCT03926039 64 66 O
is NCT03926039 67 69 O
C NCT03926039 70 71 O
22.0 NCT03926039 72 76 O
) NCT03926039 77 78 O
and NCT03926039 79 82 B-And
Barcelona NCT03926039 83 92 B-Condition
stage NCT03926039 93 98 I-Condition
( NCT03926039 99 100 O
BCLC NCT03926039 101 105 B-Condition
stage NCT03926039 106 111 I-Condition
) NCT03926039 112 113 O
0 NCT03926039 114 115 B-Eq_Comparison
- NCT03926039 116 117 I-Eq_Comparison
A NCT03926039 118 119 I-Eq_Comparison
. NCT03926039 120 121 O

2 NCT03926039 125 126 O
. NCT03926039 126 127 O
At NCT03926039 129 131 B-Eq_Comparison
least NCT03926039 132 137 I-Eq_Comparison
20 NCT03926039 138 140 I-Eq_Comparison
years NCT03926039 141 146 I-Eq_Comparison
of NCT03926039 147 149 O
age NCT03926039 150 153 B-Age
. NCT03926039 154 155 O

3 NCT03926039 159 160 O
. NCT03926039 160 161 O
No NCT03926039 163 165 B-Negation
mental NCT03926039 166 172 B-Condition
illness NCT03926039 173 180 I-Condition
. NCT03926039 181 182 O

4 NCT03926039 186 187 O
. NCT03926039 187 188 O
Patients NCT03926039 190 198 O
who NCT03926039 199 202 O
can NCT03926039 203 206 O
communicate NCT03926039 207 218 O
in NCT03926039 219 221 O
Mandarin NCT03926039 222 230 O
or NCT03926039 231 233 B-Or
Taiwanese NCT03926039 234 243 O
. NCT03926039 244 245 O

Exclusion NCT03926039 247 256 O
Criteria NCT03926039 257 265 O
: NCT03926039 266 267 O

1 NCT03926039 271 272 O
. NCT03926039 272 273 O
Do NCT03926039 275 277 O
n't NCT03926039 277 280 O
know NCT03926039 281 285 O
himself NCT03926039 286 293 O
condition NCT03926039 294 303 B-Condition
. NCT03926039 304 305 O

2 NCT03926039 309 310 O
. NCT03926039 310 311 O
Unconscious NCT03926039 313 324 B-Condition
patients NCT03926039 325 333 O
. NCT03926039 334 335 O

3 NCT03926039 339 340 O
. NCT03926039 340 341 O
Patients NCT03926039 343 351 O
with NCT03926039 352 356 O
liver NCT03926039 357 362 B-Modifier
cancer NCT03926039 363 369 B-Procedure
resection NCT03926039 370 379 I-Procedure
or NCT03926039 380 382 B-Or
partial NCT03926039 383 390 B-Modifier
liver NCT03926039 391 396 I-Modifier
resection NCT03926039 397 406 B-Procedure
were NCT03926039 407 411 O
performed NCT03926039 412 421 B-Eq_Comparison
within NCT03926039 422 428 B-Eq_Comparison
3 NCT03926039 429 430 I-Eq_Comparison
months NCT03926039 431 437 I-Eq_Comparison
. NCT03926039 438 439 O


Inclusion NCT03868228 0 9 O
Criteria NCT03868228 10 18 O
: NCT03868228 19 20 O

1 NCT03868228 24 25 O
. NCT03868228 25 26 O
Patients NCT03868228 28 36 O
with NCT03868228 37 41 O
CPM NCT03868228 42 45 B-Condition
with NCT03868228 46 50 B-And
expected NCT03868228 51 59 B-Modifier
life NCT03868228 60 64 B-Observation
expectancy NCT03868228 65 75 I-Observation
of NCT03868228 76 78 O
> NCT03868228 79 80 B-Eq_Comparison
6 NCT03868228 81 82 I-Eq_Comparison
months NCT03868228 83 89 I-Eq_Comparison
. NCT03868228 90 91 O

2 NCT03868228 95 96 O
. NCT03868228 96 97 O
ECOG NCT03868228 99 103 B-Observation
Scale NCT03868228 104 109 I-Observation
of NCT03868228 110 112 I-Observation
Performance NCT03868228 113 124 I-Observation
Status NCT03868228 125 131 I-Observation
( NCT03868228 132 133 O
PS NCT03868228 134 136 B-Observation
) NCT03868228 137 138 O
scores NCT03868228 139 145 B-Eq_Comparison
0 NCT03868228 146 147 I-Eq_Comparison
or NCT03868228 148 150 I-Eq_Comparison
1 NCT03868228 151 152 I-Eq_Comparison
. NCT03868228 152 153 O

3 NCT03868228 157 158 O
. NCT03868228 158 159 O
15 NCT03868228 161 163 O
mile NCT03868228 164 168 O
catchment NCT03868228 169 178 O
area NCT03868228 179 183 O
to NCT03868228 184 186 B-Assertion___Assertion_Type_Value:hypothetical
facilitate NCT03868228 187 197 I-Assertion___Assertion_Type_Value:hypothetical
overseeing NCT03868228 198 208 O
systemic NCT03868228 209 217 B-Modifier
chemotherapy NCT03868228 218 230 B-Procedure
administration NCT03868228 231 245 O

4 NCT03868228 248 249 O
. NCT03868228 249 250 O
Concomitant NCT03868228 252 263 B-Modifier
systemic NCT03868228 264 272 I-Modifier
chemotherapy NCT03868228 273 285 B-Procedure
regimens NCT03868228 286 294 O
with NCT03868228 295 299 O
FOLFIRI NCT03868228 300 307 B-Drug
, NCT03868228 308 309 O
FOLFOX NCT03868228 310 316 B-Drug
, NCT03868228 317 318 O
Mitomycin NCT03868228 319 328 B-Drug
C NCT03868228 329 330 I-Drug
& NCT03868228 331 332 B-Or

Fluorouracil NCT03868228 338 350 B-Drug
, NCT03868228 351 352 O
Capecitabine NCT03868228 353 365 B-Drug
( NCT03868228 366 367 O
excluding NCT03868228 368 377 B-Exception
Lonsurf NCT03868228 378 385 B-Drug
) NCT03868228 386 387 O
or NCT03868228 388 390 B-Or
without NCT03868228 391 398 B-Negation
systemic NCT03868228 399 407 B-Modifier
chemotherapy NCT03868228 408 420 B-Procedure
if NCT03868228 421 423 O
no NCT03868228 424 426 B-Negation
systemic NCT03868228 427 435 B-Modifier
options NCT03868228 436 443 O
available NCT03868228 444 453 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868228 454 456 O
patient NCT03868228 457 464 O

5 NCT03868228 467 468 O
. NCT03868228 468 469 O
Neutrophil NCT03868228 471 481 B-Observation
count NCT03868228 482 487 I-Observation
on NCT03868228 488 490 B-Temporal_Connection___Temporal_Connection_Type_Value:during
or NCT03868228 491 493 B-Or
just NCT03868228 494 498 O
before NCT03868228 499 505 B-Temporal_Connection___Temporal_Connection_Type_Value:before
chemotherapy NCT03868228 506 518 B-Procedure
due NCT03868228 519 522 O
date NCT03868228 523 527 O
of NCT03868228 528 530 O
> NCT03868228 531 532 B-Eq_Comparison
1.5 NCT03868228 533 536 I-Eq_Comparison

Exclusion NCT03868228 538 547 O
Criteria NCT03868228 548 556 O
: NCT03868228 557 558 O

1 NCT03868228 562 563 O
. NCT03868228 563 564 O
Age NCT03868228 566 569 B-Age
< NCT03868228 570 571 B-Eq_Comparison
18 NCT03868228 572 574 I-Eq_Comparison

2 NCT03868228 578 579 O
. NCT03868228 579 580 O
MDT NCT03868228 582 585 B-Condition
decision NCT03868228 586 594 O
that NCT03868228 595 599 O
patient NCT03868228 600 607 O
not NCT03868228 608 611 B-Negation
suitable NCT03868228 612 620 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03868228 621 624 O
PIPAC NCT03868228 625 630 B-Procedure

3 NCT03868228 633 634 O
. NCT03868228 634 635 O
Decision NCT03868228 637 645 O
by NCT03868228 646 648 O
Pre NCT03868228 649 652 B-Procedure
operative NCT03868228 653 662 I-Procedure
Assessment NCT03868228 663 673 I-Procedure
Department NCT03868228 674 684 O
or NCT03868228 685 687 B-Or
Consultant NCT03868228 688 698 B-Modifier
Anaesthetist NCT03868228 699 711 B-Provider
that NCT03868228 712 716 O
patient NCT03868228 717 724 O
not NCT03868228 725 728 B-Negation
fit NCT03868228 729 732 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03868228 733 736 I-Assertion___Assertion_Type_Value:hypothetical
general NCT03868228 737 744 B-Procedure
anaesthesia NCT03868228 745 756 I-Procedure
and NCT03868228 757 760 B-Or
/ NCT03868228 761 762 I-Or
or NCT03868228 763 765 I-Or
laparoscopy NCT03868228 766 777 B-Procedure

4 NCT03868228 780 781 O
. NCT03868228 781 782 O
Clinically NCT03868228 784 794 O
evident NCT03868228 795 802 B-Condition
gross NCT03868228 803 808 I-Condition
ascites NCT03868228 809 816 I-Condition

5 NCT03868228 819 820 O
. NCT03868228 820 821 O
Bowel NCT03868228 823 828 B-Condition
obstruction NCT03868228 829 840 I-Condition

6 NCT03868228 843 844 O
. NCT03868228 844 845 O
Bevacizumab NCT03868228 847 858 B-Drug
as NCT03868228 859 861 O
part NCT03868228 862 866 O
of NCT03868228 867 869 O
systemic NCT03868228 870 878 B-Modifier
chemotherapy NCT03868228 879 891 B-Procedure
regime NCT03868228 892 898 O
- NCT03868228 899 900 O
time NCT03868228 901 905 O
from NCT03868228 906 910 O
chemotherapy NCT03868228 911 923 B-Procedure
to NCT03868228 924 926 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03868228 927 934 B-Procedure
would NCT03868228 935 940 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03868228 941 943 I-Assertion___Assertion_Type_Value:hypothetical
too NCT03868228 944 947 O
long NCT03868228 948 952 O
for NCT03868228 953 956 O
PIPAC NCT03868228 957 962 B-Procedure
to NCT03868228 963 965 O
be NCT03868228 966 968 O
feasible NCT03868228 969 977 O

7 NCT03868228 980 981 O
. NCT03868228 981 982 O
Previous NCT03868228 984 992 B-Eq_Comparison
bone NCT03868228 993 997 B-Condition
marrow NCT03868228 998 1004 I-Condition
suppression NCT03868228 1005 1016 I-Condition
due NCT03868228 1017 1020 O
to NCT03868228 1021 1023 O
chemotherapy NCT03868228 1024 1036 B-Procedure
given NCT03868228 1037 1042 O
risk NCT03868228 1043 1047 B-Risk
of NCT03868228 1048 1050 O
post NCT03868228 1051 1055 B-Temporal_Connection___Temporal_Connection_Type_Value:after
- NCT03868228 1056 1057 O
operative NCT03868228 1058 1067 B-Procedure
neutropenia NCT03868228 1068 1079 B-Condition

- NCT03921515 1 2 O
INCLUSION NCT03921515 4 13 O
CRITERIA NCT03921515 14 22 O
: NCT03921515 23 24 O

1 NCT03921515 33 34 O
. NCT03921515 34 35 O
Meets NCT03921515 37 42 O
one NCT03921515 43 46 B-Eq_Comparison
of NCT03921515 47 49 O
the NCT03921515 50 53 B-Criteria_Count
following NCT03921515 54 63 I-Criteria_Count
: NCT03921515 64 65 O

1 NCT03921515 79 80 O
. NCT03921515 80 81 O
has NCT03921515 83 86 O
documentation NCT03921515 87 100 O
of NCT03921515 101 103 O
HIES NCT03921515 104 108 B-Condition
or NCT03921515 109 111 B-Or
CGD NCT03921515 112 115 B-Condition
( NCT03921515 116 117 O
patient NCT03921515 118 125 O
populations NCT03921515 126 137 O
) NCT03921515 138 139 O
; NCT03921515 140 141 O
or NCT03921515 142 144 B-Or

2 NCT03921515 157 158 O
. NCT03921515 158 159 O
does NCT03921515 161 165 O
not NCT03921515 166 169 B-Negation
have NCT03921515 170 174 O
clinically NCT03921515 175 185 O
apparent NCT03921515 186 194 O
evidence NCT03921515 195 203 O
of NCT03921515 204 206 O
an NCT03921515 207 209 O
immune NCT03921515 210 216 B-Condition
defect NCT03921515 217 223 I-Condition
or NCT03921515 224 226 B-Or
history NCT03921515 227 234 B-Eq_Comparison
of NCT03921515 235 237 O
invasive NCT03921515 238 246 B-Modifier
or NCT03921515 247 249 B-Or
recurrent NCT03921515 250 259 B-Modifier
S NCT03921515 260 261 B-Organism
. NCT03921515 262 263 I-Organism
aureus NCT03921515 265 271 I-Organism
infections NCT03921515 272 282 B-Condition
( NCT03921515 283 284 O
healthy NCT03921515 285 292 B-Condition
volunteers NCT03921515 293 303 O
) NCT03921515 304 305 O
. NCT03921515 306 307 O

2 NCT03921515 316 317 O
. NCT03921515 317 318 O
Between NCT03921515 320 327 O
the NCT03921515 328 331 O
following NCT03921515 332 341 O
age NCT03921515 342 345 O
limits NCT03921515 346 352 O
( NCT03921515 353 354 O
inclusive NCT03921515 355 364 O
) NCT03921515 365 366 O
: NCT03921515 367 368 O

1 NCT03921515 382 383 O
. NCT03921515 383 384 O
18 NCT03921515 386 388 B-Eq_Comparison
and NCT03921515 389 392 I-Eq_Comparison
65 NCT03921515 393 395 I-Eq_Comparison
years NCT03921515 396 401 I-Eq_Comparison
old NCT03921515 402 405 B-Age
for NCT03921515 406 409 O
healthy NCT03921515 410 417 B-Condition
volunteers NCT03921515 418 428 O
; NCT03921515 428 429 O

2 NCT03921515 442 443 O
. NCT03921515 443 444 O
7 NCT03921515 446 447 B-Eq_Comparison
and NCT03921515 448 451 I-Eq_Comparison
65 NCT03921515 452 454 I-Eq_Comparison
years NCT03921515 455 460 I-Eq_Comparison
old NCT03921515 461 464 B-Age
for NCT03921515 465 468 O
patients NCT03921515 469 477 O
with NCT03921515 478 482 O
CGD NCT03921515 483 486 B-Condition
; NCT03921515 486 487 O

3 NCT03921515 500 501 O
. NCT03921515 501 502 O
18 NCT03921515 504 506 B-Eq_Comparison
and NCT03921515 507 510 I-Eq_Comparison
65 NCT03921515 511 513 I-Eq_Comparison
years NCT03921515 514 519 I-Eq_Comparison
old NCT03921515 520 523 B-Age
for NCT03921515 524 527 O
patients NCT03921515 528 536 O
with NCT03921515 537 541 O
HIES NCT03921515 542 546 B-Condition
. NCT03921515 547 548 O

3 NCT03921515 557 558 O
. NCT03921515 558 559 O
Willing NCT03921515 561 568 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03921515 569 571 I-Assertion___Assertion_Type_Value:hypothetical
allow NCT03921515 572 577 B-Observation
storage NCT03921515 578 585 I-Observation
of NCT03921515 586 588 O
blood NCT03921515 589 594 B-Modifier
, NCT03921515 595 596 O
RNA NCT03921515 597 600 B-Modifier
, NCT03921515 601 602 O
bacterial NCT03921515 603 612 B-Modifier
and NCT03921515 613 616 B-Or
fungal NCT03921515 617 623 B-Modifier
cultures NCT03921515 624 632 I-Modifier
, NCT03921515 633 634 O
and NCT03921515 635 638 B-Or
other NCT03921515 639 644 O
tissue NCT03921515 645 651 B-Modifier
samples NCT03921515 652 659 I-Modifier
for NCT03921515 660 663 O
future NCT03921515 664 670 O
research NCT03921515 671 679 O
. NCT03921515 680 681 O

4 NCT03921515 690 691 O
. NCT03921515 691 692 O
Able NCT03921515 694 698 O
to NCT03921515 699 701 O
provide NCT03921515 702 709 O
informed NCT03921515 710 718 O
consent NCT03921515 719 726 O
. NCT03921515 727 728 O

EXCLUSION NCT03921515 730 739 O
CRITERIA NCT03921515 740 748 O
: NCT03921515 749 750 O

The NCT03921515 752 755 O
following NCT03921515 756 765 O
exclusion NCT03921515 766 775 O
criteria NCT03921515 776 784 O
apply NCT03921515 785 790 O
to NCT03921515 791 793 O
all NCT03921515 794 797 O
subjects NCT03921515 798 806 O
: NCT03921515 807 808 O

1 NCT03921515 812 813 O
. NCT03921515 813 814 O
For NCT03921515 816 819 O
individuals NCT03921515 820 831 O
undergoing NCT03921515 832 842 B-Eq_Comparison
blister NCT03921515 843 850 B-Modifier
or NCT03921515 851 853 B-Or
skin NCT03921515 854 858 B-Modifier
biopsy NCT03921515 859 865 B-Procedure
procedures NCT03921515 866 876 I-Procedure
, NCT03921515 877 878 O
history NCT03921515 879 886 B-Eq_Comparison
of NCT03921515 887 889 O
keloid NCT03921515 890 896 B-Condition
formation NCT03921515 897 906 I-Condition
. NCT03921515 907 908 O

2 NCT03921515 912 913 O
. NCT03921515 913 914 O
Current NCT03921515 916 923 B-Eq_Comparison
or NCT03921515 924 926 B-Or
prior NCT03921515 927 932 B-Eq_Comparison
( NCT03921515 933 934 O
within NCT03921515 935 941 B-Eq_Comparison
3 NCT03921515 942 943 I-Eq_Comparison
months NCT03921515 944 950 I-Eq_Comparison
) NCT03921515 951 952 O
anticoagulant NCT03921515 953 966 B-Modifier
or NCT03921515 967 969 B-Or
anti NCT03921515 970 974 B-Modifier
- NCT03921515 975 976 I-Modifier
platelet NCT03921515 977 985 I-Modifier
therapy NCT03921515 986 993 B-Procedure
( NCT03921515 994 995 O
other NCT03921515 996 1001 B-Exception
than NCT03921515 1002 1006 I-Exception
aspirin NCT03921515 1007 1014 B-Drug
or NCT03921515 1015 1017 B-Or
non NCT03921515 1018 1021 B-Drug
- NCT03921515 1022 1023 I-Drug
steroidal NCT03921515 1024 1033 I-Drug
anti NCT03921515 1034 1038 I-Drug
- NCT03921515 1039 1040 I-Drug
inflammatory NCT03921515 1041 1053 I-Drug
drugs NCT03921515 1054 1059 I-Drug
[ NCT03921515 1060 1061 O
NSAIDs NCT03921515 1062 1068 B-Drug
] NCT03921515 1069 1070 O
) NCT03921515 1071 1072 O
. NCT03921515 1073 1074 O

3 NCT03921515 1078 1079 O
. NCT03921515 1079 1080 O
Current NCT03921515 1082 1089 B-Eq_Comparison
or NCT03921515 1090 1092 B-Or
prior NCT03921515 1093 1098 B-Eq_Comparison
( NCT03921515 1099 1100 O
within NCT03921515 1101 1107 B-Eq_Comparison
3 NCT03921515 1108 1109 I-Eq_Comparison
months NCT03921515 1110 1116 I-Eq_Comparison
) NCT03921515 1117 1118 O
use NCT03921515 1119 1122 O
of NCT03921515 1123 1125 O
immunomodulatory NCT03921515 1126 1142 B-Drug
drugs NCT03921515 1143 1148 I-Drug
( NCT03921515 1149 1150 O
e NCT03921515 1151 1152 O
. NCT03921515 1153 1154 O
g NCT03921515 1155 1156 O
. NCT03921515 1157 1158 O
, NCT03921515 1159 1160 O
chemotherapy NCT03921515 1161 1173 B-Procedure
, NCT03921515 1174 1175 O
steroids NCT03921515 1176 1184 B-Drug
) NCT03921515 1185 1186 O
, NCT03921515 1187 1188 O
except NCT03921515 1189 1195 B-Exception
if NCT03921515 1196 1198 O
approved NCT03921515 1199 1207 O
by NCT03921515 1208 1210 O
the NCT03921515 1211 1214 O
principal NCT03921515 1215 1224 O
investigator NCT03921515 1225 1237 O
. NCT03921515 1238 1239 O

4 NCT03921515 1243 1244 O
. NCT03921515 1244 1245 O
Pregnancy NCT03921515 1247 1256 B-Condition
. NCT03921515 1257 1258 O

5 NCT03921515 1262 1263 O
. NCT03921515 1263 1264 O
Any NCT03921515 1266 1269 O
condition NCT03921515 1270 1279 B-Condition
that NCT03921515 1280 1284 O
, NCT03921515 1285 1286 O
in NCT03921515 1287 1289 O
the NCT03921515 1290 1293 O
opinion NCT03921515 1294 1301 O
of NCT03921515 1302 1304 O
the NCT03921515 1305 1308 O
investigator NCT03921515 1309 1321 O
, NCT03921515 1322 1323 O
contraindicates NCT03921515 1324 1339 B-Contraindication
participation NCT03921515 1340 1353 O
in NCT03921515 1354 1356 O
the NCT03921515 1357 1360 O
study NCT03921515 1361 1366 B-Study
. NCT03921515 1367 1368 O

Inclusion NCT03865576 0 9 O
Criteria NCT03865576 10 18 O
: NCT03865576 19 20 O

- NCT03865576 24 25 O
ICU NCT03865576 27 30 B-Encounter
patients NCT03865576 31 39 O
suspected NCT03865576 40 49 B-Assertion___Assertion_Type_Value:possible
of NCT03865576 50 52 O
having NCT03865576 53 59 O
an NCT03865576 60 62 O
abnormality NCT03865576 63 74 O
of NCT03865576 75 77 O
ICP NCT03865576 78 81 B-Condition
undergoing NCT03865576 82 92 B-Eq_Comparison
monitoring NCT03865576 93 103 B-Procedure
with NCT03865576 104 108 O
commercially NCT03865576 109 121 O
- NCT03865576 122 123 O
available NCT03865576 124 133 O
, NCT03865576 134 135 O
FDA NCT03865576 136 139 O
- NCT03865576 140 141 O
approved NCT03865576 142 150 O
instrumentation NCT03865576 151 166 O
. NCT03865576 167 168 O

Exclusion NCT03865576 170 179 O
Criteria NCT03865576 180 188 O
: NCT03865576 189 190 O

History NCT03865576 192 199 B-Eq_Comparison
of NCT03865576 200 202 O
: NCT03865576 203 204 O

- NCT03865576 208 209 O
Glaucoma NCT03865576 211 219 B-Condition
or NCT03865576 220 222 B-Or
optic NCT03865576 223 228 B-Modifier
hypertension NCT03865576 229 241 B-Condition

- NCT03865576 244 245 O
Severe NCT03865576 247 253 O
orbital NCT03865576 254 261 B-Modifier
or NCT03865576 262 264 B-Or
ophthalmic NCT03865576 265 275 B-Modifier
injury NCT03865576 276 282 B-Condition

- NCT03865576 285 286 O
Orbital NCT03865576 288 295 B-Modifier
or NCT03865576 296 298 B-Or
intraocular NCT03865576 299 310 B-Modifier
surgery NCT03865576 311 318 B-Procedure
that NCT03865576 319 323 O
might NCT03865576 324 329 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03865576 330 339 O
with NCT03865576 340 344 O
orbital NCT03865576 345 352 B-Condition
compliance NCT03865576 353 363 I-Condition

- NCT03865576 366 367 O
Congenital NCT03865576 369 379 B-Condition
malformations NCT03865576 380 393 I-Condition
of NCT03865576 394 396 O
the NCT03865576 397 400 O
eye NCT03865576 401 404 B-Modifier
and NCT03865576 405 408 B-Or
/ NCT03865576 409 410 I-Or
or NCT03865576 411 413 I-Or
orbit NCT03865576 414 419 B-Modifier
that NCT03865576 420 424 O
might NCT03865576 425 430 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03865576 431 440 O
with NCT03865576 441 445 O
orbital NCT03865576 446 453 B-Condition
compliance NCT03865576 454 464 I-Condition
or NCT03865576 465 467 B-Or
orbital NCT03865576 468 475 B-Condition
vascular NCT03865576 476 484 I-Condition
anatomy NCT03865576 485 492 I-Condition

Inclusion NCT03927066 0 9 O
Criteria NCT03927066 10 18 O
: NCT03927066 19 20 O

- NCT03927066 24 25 O
Non NCT03927066 27 30 B-Negation
- NCT03927066 31 32 O
obese NCT03927066 33 38 B-Condition
( NCT03927066 39 40 O
BMI NCT03927066 41 44 B-Observation
< NCT03927066 45 46 B-Eq_Comparison
30 NCT03927066 47 49 I-Eq_Comparison
) NCT03927066 50 51 O

- NCT03927066 55 56 O
Non NCT03927066 58 61 O
- NCT03927066 62 63 O
smokers NCT03927066 64 71 O

- NCT03927066 74 75 O
Free NCT03927066 77 81 B-Negation
of NCT03927066 82 84 I-Negation
any NCT03927066 85 88 O
systemic NCT03927066 89 97 B-Modifier
diseases NCT03927066 98 106 B-Condition
including NCT03927066 107 116 O
hypertension NCT03927066 117 129 B-Condition
, NCT03927066 130 131 O
diabetes NCT03927066 132 140 B-Condition
, NCT03927066 141 142 O
coronary NCT03927066 143 151 B-Condition
artery NCT03927066 152 158 I-Condition
disease NCT03927066 159 166 I-Condition
, NCT03927066 167 168 O
neurologic NCT03927066 169 179 B-Condition
disease NCT03927066 180 187 I-Condition
, NCT03927066 188 189 O
or NCT03927066 190 192 B-Or
any NCT03927066 193 196 O
other NCT03927066 197 202 B-Other
major NCT03927066 203 208 O
medical NCT03927066 209 216 B-Condition
co NCT03927066 217 219 I-Condition
- NCT03927066 220 221 I-Condition
morbidity NCT03927066 222 231 I-Condition

- NCT03927066 234 235 O
Women NCT03927066 237 242 O
will NCT03927066 243 247 B-Eq_Comparison
be NCT03927066 248 250 I-Eq_Comparison
either NCT03927066 251 257 O
surgically NCT03927066 258 268 B-Procedure
sterilized NCT03927066 269 279 I-Procedure
or NCT03927066 280 282 B-Or
non NCT03927066 283 286 B-Negation
- NCT03927066 287 288 O
pregnant NCT03927066 289 297 B-Condition
as NCT03927066 298 300 O
determined NCT03927066 301 311 O
by NCT03927066 312 314 O
a NCT03927066 315 316 O
urine NCT03927066 317 322 B-Observation
pregnancy NCT03927066 323 332 I-Observation
test NCT03927066 333 337 I-Observation

Inclusion NCT03868995 0 9 O
Criteria NCT03868995 10 18 O
: NCT03868995 19 20 O

1 NCT03868995 24 25 O
. NCT03868995 25 26 O
20 NCT03868995 28 30 B-Eq_Comparison
- NCT03868995 31 32 I-Eq_Comparison
70 NCT03868995 33 35 I-Eq_Comparison
age NCT03868995 36 39 B-Age

2 NCT03868995 42 43 O
. NCT03868995 43 44 O
Chronic NCT03868995 46 53 O
ankle NCT03868995 54 59 B-Modifier
sprain NCT03868995 60 66 B-Condition
more NCT03868995 67 71 B-Eq_Comparison
than NCT03868995 72 76 I-Eq_Comparison
3 NCT03868995 77 78 I-Eq_Comparison
months NCT03868995 79 85 I-Eq_Comparison
with NCT03868995 86 90 B-And
chronic NCT03868995 91 98 O
ankle NCT03868995 99 104 B-Modifier
pain NCT03868995 105 109 B-Condition
or NCT03868995 110 112 B-Or
instability NCT03868995 113 124 B-Modifier
sensation NCT03868995 125 134 B-Condition

3 NCT03868995 137 138 O
. NCT03868995 138 139 O
Ultrasound NCT03868995 141 151 B-Procedure
diagnosed NCT03868995 152 161 O
anterior NCT03868995 162 170 B-Modifier
talofibular NCT03868995 171 182 I-Modifier
ligament NCT03868995 183 191 B-Condition
sprain NCT03868995 192 198 I-Condition

Exclusion NCT03868995 199 208 O
Criteria NCT03868995 209 217 O
: NCT03868995 218 219 O

1 NCT03868995 223 224 O
. NCT03868995 224 225 O
Acute NCT03868995 227 232 O
ankle NCT03868995 233 238 B-Modifier
sprain NCT03868995 239 245 B-Condition
less NCT03868995 246 250 B-Eq_Comparison
than NCT03868995 251 255 I-Eq_Comparison
3 NCT03868995 256 257 I-Eq_Comparison
months NCT03868995 258 264 I-Eq_Comparison

2 NCT03868995 267 268 O
. NCT03868995 268 269 O
Lower NCT03868995 271 276 B-Modifier
limb NCT03868995 277 281 I-Modifier
fracture NCT03868995 282 290 B-Condition
history NCT03868995 291 298 B-Eq_Comparison

3 NCT03868995 301 302 O
. NCT03868995 302 303 O
Cognitive NCT03868995 305 314 B-Condition
impairment NCT03868995 315 325 I-Condition

4 NCT03868995 328 329 O
. NCT03868995 329 330 O
Other NCT03868995 332 337 B-Other
neurological NCT03868995 338 350 B-Modifier
or NCT03868995 351 353 B-Or
muscular NCT03868995 354 362 B-Modifier
disorders NCT03868995 363 372 B-Condition

5 NCT03868995 375 376 O
. NCT03868995 376 377 O
Sever NCT03868995 379 384 O
pain NCT03868995 385 389 B-Condition
could NCT03868995 390 395 B-Assertion___Assertion_Type_Value:hypothetical
not NCT03868995 396 399 B-Negation
tolerate NCT03868995 400 408 B-Assertion___Assertion_Type_Value:hypothetical
examination NCT03868995 409 420 B-Procedure

Inclusion NCT03864822 0 9 O
Criteria NCT03864822 10 18 O
: NCT03864822 19 20 O

- NCT03864822 24 25 O
Otherwise NCT03864822 27 36 O
healthy NCT03864822 37 44 B-Condition
men NCT03864822 45 48 O
and NCT03864822 49 52 B-Or
women NCT03864822 53 58 O

- NCT03864822 61 62 O
Aged NCT03864822 64 68 B-Age
18 NCT03864822 69 71 B-Eq_Comparison
- NCT03864822 72 73 I-Eq_Comparison
60 NCT03864822 74 76 I-Eq_Comparison
years NCT03864822 77 82 I-Eq_Comparison

- NCT03864822 85 86 O
Continuous NCT03864822 88 98 B-Eq_Comparison
pain NCT03864822 99 103 B-Condition
( NCT03864822 104 105 O
> NCT03864822 106 107 B-Eq_Comparison
3 NCT03864822 108 109 I-Eq_Comparison
days NCT03864822 110 114 I-Eq_Comparison
pain NCT03864822 115 119 I-Eq_Comparison
/ NCT03864822 120 121 I-Eq_Comparison
week NCT03864822 122 126 I-Eq_Comparison
) NCT03864822 127 128 O
episode NCT03864822 129 136 O
lasting NCT03864822 137 144 O
at NCT03864822 145 147 B-Eq_Comparison
least NCT03864822 148 153 I-Eq_Comparison
3 NCT03864822 154 155 I-Eq_Comparison
months NCT03864822 156 162 I-Eq_Comparison
, NCT03864822 163 164 O
sufficient NCT03864822 165 175 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03864822 176 178 I-Assertion___Assertion_Type_Value:hypothetical
limit NCT03864822 179 184 O
daily NCT03864822 185 190 B-Eq_Comparison
activities NCT03864822 191 201 B-Observation

- NCT03864822 204 205 O
Pain NCT03864822 207 211 B-Condition
in NCT03864822 212 214 O
the NCT03864822 215 218 O
region NCT03864822 219 225 B-Modifier
posteriorly NCT03864822 226 237 I-Modifier
between NCT03864822 238 245 I-Modifier
the NCT03864822 246 249 I-Modifier
inferior NCT03864822 250 258 I-Modifier
border NCT03864822 259 265 I-Modifier
of NCT03864822 266 268 I-Modifier
the NCT03864822 269 272 I-Modifier
12 NCT03864822 273 275 I-Modifier
th NCT03864822 276 278 I-Modifier
rib NCT03864822 279 282 I-Modifier
and NCT03864822 283 286 B-And
the NCT03864822 287 290 O
lower NCT03864822 291 296 B-Modifier
gluteal NCT03864822 297 304 I-Modifier
fold NCT03864822 305 309 I-Modifier
( NCT03864822 310 311 O
low NCT03864822 312 315 B-Modifier
back NCT03864822 316 320 I-Modifier
pain NCT03864822 321 325 B-Condition
) NCT03864822 326 327 O
at NCT03864822 328 330 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03864822 331 334 I-Temporal_Connection___Temporal_Connection_Type_Value:during
time NCT03864822 335 339 I-Temporal_Connection___Temporal_Connection_Type_Value:during
of NCT03864822 340 342 O
recruitment NCT03864822 343 354 B-Study

- NCT03864822 357 358 O
Able NCT03864822 360 364 O
to NCT03864822 365 367 O
speak NCT03864822 368 373 O
, NCT03864822 374 375 O
read NCT03864822 376 380 O
and NCT03864822 381 384 O
understand NCT03864822 385 395 O
English NCT03864822 396 403 O

Exclusion NCT03864822 404 413 O
Criteria NCT03864822 414 422 O
: NCT03864822 423 424 O

- NCT03864822 428 429 O
Pregnancy NCT03864822 431 440 B-Condition

- NCT03864822 443 444 O
Low NCT03864822 446 449 B-Modifier
back NCT03864822 450 454 I-Modifier
pain NCT03864822 455 459 B-Condition
associated NCT03864822 460 470 O
with NCT03864822 471 475 O
menstruation NCT03864822 476 488 B-Condition

- NCT03864822 491 492 O
Currently NCT03864822 494 503 B-Eq_Comparison
seeking NCT03864822 504 511 B-Assertion___Assertion_Type_Value:intention
active NCT03864822 512 518 B-Eq_Comparison
treatment NCT03864822 519 528 B-Procedure
for NCT03864822 529 532 O
low NCT03864822 533 536 B-Modifier
back NCT03864822 537 541 I-Modifier
pain NCT03864822 542 546 B-Condition

- NCT03864822 549 550 O
Red NCT03864822 552 555 B-Condition
flags NCT03864822 556 561 I-Condition
symptoms NCT03864822 562 570 B-Assertion___Assertion_Type_Value:possible
( NCT03864822 571 572 O
i NCT03864822 573 574 O
. NCT03864822 575 576 O
e NCT03864822 577 578 O
. NCT03864822 579 580 O
fever NCT03864822 582 587 B-Condition
, NCT03864822 588 589 O
malaise NCT03864822 590 597 B-Condition
, NCT03864822 598 599 O
progressive NCT03864822 600 611 B-Modifier
neurologic NCT03864822 612 622 B-Condition
deficit NCT03864822 623 630 I-Condition
, NCT03864822 631 632 O
significant NCT03864822 633 644 O
trauma NCT03864822 645 651 B-Condition
, NCT03864822 652 653 O
prolonged NCT03864822 654 663 B-Modifier
corticosteroid NCT03864822 664 678 B-Drug
use NCT03864822 679 682 O
or NCT03864822 683 685 B-Or
osteoporosis NCT03864822 686 698 B-Condition
, NCT03864822 699 700 O
pain NCT03864822 701 705 B-Condition
worst NCT03864822 706 711 O
at NCT03864822 712 714 O
night NCT03864822 715 720 B-Modifier
, NCT03864822 721 722 O
urinary NCT03864822 723 730 B-Modifier
or NCT03864822 731 733 B-Or
faecal NCT03864822 734 740 B-Modifier
incontinence NCT03864822 741 753 B-Condition
, NCT03864822 754 755 O
or NCT03864822 756 758 B-Or
unintended NCT03864822 759 769 B-Modifier
weight NCT03864822 770 776 B-Condition
loss NCT03864822 777 781 I-Condition
) NCT03864822 782 783 O

- NCT03864822 787 788 O
Drug NCT03864822 790 794 B-Condition
addiction NCT03864822 795 804 I-Condition
defined NCT03864822 805 812 O
as NCT03864822 813 815 O
the NCT03864822 816 819 O
use NCT03864822 820 823 O
of NCT03864822 824 826 O
cannabis NCT03864822 827 835 B-Drug
, NCT03864822 836 837 O
opioids NCT03864822 838 845 B-Drug
or NCT03864822 846 848 B-Or
other NCT03864822 849 854 B-Other
drugs NCT03864822 855 860 B-Drug

- NCT03864822 863 864 O
Current NCT03864822 866 873 B-Eq_Comparison
or NCT03864822 874 876 B-Or
previous NCT03864822 877 885 B-Eq_Comparison
neurologic NCT03864822 886 896 B-Modifier
, NCT03864822 897 898 O
musculoskeletal NCT03864822 899 914 B-Modifier
, NCT03864822 915 916 O
mental NCT03864822 917 923 B-Modifier
, NCT03864822 924 925 O
or NCT03864822 926 928 B-Or
other NCT03864822 929 934 B-Other
illnesses NCT03864822 935 944 B-Condition
which NCT03864822 945 950 O
may NCT03864822 951 954 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03864822 955 961 O
the NCT03864822 962 965 O
trial NCT03864822 966 971 B-Study

- NCT03864822 974 975 O
Current NCT03864822 977 984 B-Eq_Comparison
or NCT03864822 985 987 B-Or
previous NCT03864822 988 996 B-Eq_Comparison
chronic NCT03864822 997 1004 O
or NCT03864822 1005 1007 B-Or
recurrent NCT03864822 1008 1017 B-Modifier
pain NCT03864822 1018 1022 B-Condition
condition NCT03864822 1023 1032 I-Condition
other NCT03864822 1033 1038 B-Exception
than NCT03864822 1039 1043 I-Exception
low NCT03864822 1044 1047 B-Modifier
back NCT03864822 1048 1052 I-Modifier
pain NCT03864822 1053 1057 B-Condition

- NCT03864822 1060 1061 O
Current NCT03864822 1063 1070 B-Eq_Comparison
regular NCT03864822 1071 1078 O
use NCT03864822 1079 1082 O
of NCT03864822 1083 1085 O
analgesic NCT03864822 1086 1095 B-Drug
medication NCT03864822 1096 1106 I-Drug
or NCT03864822 1107 1109 B-Or
other NCT03864822 1110 1115 B-Other
medication NCT03864822 1116 1126 B-Drug
which NCT03864822 1127 1132 O
may NCT03864822 1133 1136 B-Assertion___Assertion_Type_Value:hypothetical
affect NCT03864822 1137 1143 O
the NCT03864822 1144 1147 O
trial NCT03864822 1148 1153 B-Study

- NCT03864822 1156 1157 O
Lack NCT03864822 1159 1163 O
of NCT03864822 1164 1166 O
ability NCT03864822 1167 1174 O
to NCT03864822 1175 1177 O
cooperate NCT03864822 1178 1187 O

Inclusion NCT03862781 0 9 O
Criteria NCT03862781 10 18 O
: NCT03862781 19 20 O

- NCT03862781 24 25 O
Eligible NCT03862781 27 35 O
patients NCT03862781 36 44 O
are NCT03862781 45 48 O
those NCT03862781 49 54 O
over NCT03862781 55 59 B-Eq_Comparison
18 NCT03862781 60 62 I-Eq_Comparison
years NCT03862781 63 68 I-Eq_Comparison
of NCT03862781 69 71 O
age NCT03862781 72 75 B-Age
who NCT03862781 76 79 B-And
are NCT03862781 80 83 O
regularly NCT03862781 84 93 O
scheduled NCT03862781 94 103 B-Eq_Comparison
to NCT03862781 104 106 O
undergo NCT03862781 107 114 O
a NCT03862781 115 116 O
right NCT03862781 117 122 B-Procedure
hemicolectomy NCT03862781 123 136 I-Procedure
via NCT03862781 137 140 O
a NCT03862781 141 142 O
minimally NCT03862781 143 152 B-Procedure
invasive NCT03862781 153 161 I-Procedure
approach NCT03862781 162 170 I-Procedure
( NCT03862781 171 172 O
robotic NCT03862781 173 180 B-Modifier
or NCT03862781 181 183 B-Or
laparoscopic NCT03862781 184 196 B-Modifier
) NCT03862781 197 198 O
with NCT03862781 199 203 B-And
the NCT03862781 204 207 O
creation NCT03862781 208 216 O
of NCT03862781 217 219 O
an NCT03862781 220 222 O
anastomosis NCT03862781 223 234 B-Procedure
. NCT03862781 235 236 O
Right NCT03862781 238 243 B-Procedure
colectomy NCT03862781 244 253 I-Procedure
will NCT03862781 254 258 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03862781 259 261 I-Assertion___Assertion_Type_Value:hypothetical
defined NCT03862781 262 269 O
as NCT03862781 270 272 O
removal NCT03862781 273 280 B-Procedure
of NCT03862781 281 283 I-Procedure
the NCT03862781 284 287 I-Procedure
ascending NCT03862781 288 297 I-Procedure
colon NCT03862781 298 303 I-Procedure
, NCT03862781 304 305 O
ligation NCT03862781 306 314 B-Procedure
of NCT03862781 315 317 I-Procedure
the NCT03862781 318 321 I-Procedure
ileocolic NCT03862781 322 331 I-Procedure
artery NCT03862781 332 338 I-Procedure
and NCT03862781 339 342 I-Procedure
vein NCT03862781 343 347 I-Procedure
, NCT03862781 348 349 O
+ NCT03862781 350 351 O
/ NCT03862781 352 353 O
- NCT03862781 354 355 O
removal NCT03862781 356 363 B-Procedure
of NCT03862781 364 366 I-Procedure
the NCT03862781 367 370 I-Procedure
terminal NCT03862781 371 379 I-Procedure
ileum NCT03862781 380 385 I-Procedure
, NCT03862781 386 387 O
+ NCT03862781 388 389 O
/ NCT03862781 390 391 O
- NCT03862781 392 393 O
removal NCT03862781 394 401 B-Procedure
of NCT03862781 402 404 I-Procedure
the NCT03862781 405 408 I-Procedure
proximal NCT03862781 409 417 I-Procedure
transverse NCT03862781 418 428 I-Procedure
colon NCT03862781 429 434 I-Procedure
, NCT03862781 435 436 O
and NCT03862781 437 440 O
+ NCT03862781 441 442 O
/ NCT03862781 443 444 O
- NCT03862781 445 446 O
removal NCT03862781 447 454 B-Procedure
of NCT03862781 455 457 I-Procedure
the NCT03862781 458 461 I-Procedure
right NCT03862781 462 467 I-Procedure
branch NCT03862781 468 474 I-Procedure
of NCT03862781 475 477 I-Procedure
the NCT03862781 478 481 I-Procedure
middle NCT03862781 482 488 I-Procedure
colic NCT03862781 489 494 I-Procedure
artery NCT03862781 495 501 I-Procedure
and NCT03862781 502 505 I-Procedure
vein NCT03862781 506 510 I-Procedure
. NCT03862781 511 512 O

Exclusion NCT03862781 514 523 O
Criteria NCT03862781 524 532 O
: NCT03862781 533 534 O

- NCT03862781 538 539 O
Pregnant NCT03862781 541 549 B-Condition
women NCT03862781 550 555 O

- NCT03862781 558 559 O
Additional NCT03862781 561 571 O
colon NCT03862781 572 577 B-Procedure
resection NCT03862781 578 587 I-Procedure
is NCT03862781 588 590 O
planned NCT03862781 591 598 B-Eq_Comparison
( NCT03862781 599 600 O
i NCT03862781 601 602 O
. NCT03862781 603 604 O
e NCT03862781 605 606 O
. NCT03862781 607 608 O
left NCT03862781 610 614 B-Procedure
colectomy NCT03862781 615 624 I-Procedure
or NCT03862781 625 627 B-Or
proctectomy NCT03862781 628 639 B-Procedure
) NCT03862781 640 641 O

- NCT03862781 645 646 O
Vulnerable NCT03862781 648 658 B-Observation
populations NCT03862781 659 670 I-Observation
such NCT03862781 671 675 O
as NCT03862781 676 678 O
prisoners NCT03862781 679 688 B-Observation
or NCT03862781 689 691 O
adults NCT03862781 692 698 O
unable NCT03862781 699 705 O
to NCT03862781 706 708 O
give NCT03862781 709 713 O
consent NCT03862781 714 721 O

- NCT03862781 724 725 O
If NCT03862781 727 729 O
the NCT03862781 730 733 O
scheduled NCT03862781 734 743 O
surgery NCT03862781 744 751 B-Procedure
is NCT03862781 752 754 O
planned NCT03862781 755 762 B-Eq_Comparison
at NCT03862781 763 765 O
Butterworth NCT03862781 766 777 O
hospital NCT03862781 778 786 O
( NCT03862781 787 788 O
as NCT03862781 789 791 O
to NCT03862781 792 794 O
standardize NCT03862781 795 806 O
the NCT03862781 807 810 O
nursing NCT03862781 811 818 O
care NCT03862781 819 823 O
received NCT03862781 824 832 B-Eq_Comparison
post NCT03862781 833 837 O
operatively NCT03862781 838 849 O
) NCT03862781 850 851 O

- NCT03862781 855 856 O
Emergent NCT03862781 858 866 O
cases NCT03862781 867 872 O

Patients NCT03862781 873 881 O
will NCT03862781 882 886 O
be NCT03862781 887 889 O
excluded NCT03862781 890 898 O
from NCT03862781 899 903 O
the NCT03862781 904 907 O
study NCT03862781 908 913 O
intra NCT03862781 914 919 O
- NCT03862781 920 921 O
operatively NCT03862781 922 933 O
if NCT03862781 934 936 B-Assertion___Assertion_Type_Value:hypothetical
: NCT03862781 937 938 O

- NCT03862781 942 943 O
The NCT03862781 945 948 O
procedure NCT03862781 949 958 O
is NCT03862781 959 961 O
converted NCT03862781 962 971 O
to NCT03862781 972 974 O
an NCT03862781 975 977 O
open NCT03862781 978 982 B-Procedure
resection NCT03862781 983 992 I-Procedure

- NCT03862781 995 996 O
If NCT03862781 998 1000 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03862781 1001 1002 O
loop NCT03862781 1003 1007 B-Procedure
ileostomy NCT03862781 1008 1017 I-Procedure
is NCT03862781 1018 1020 O
performed NCT03862781 1021 1030 O
in NCT03862781 1031 1033 B-And
addition NCT03862781 1034 1042 I-And
to NCT03862781 1043 1045 O
the NCT03862781 1046 1049 O
right NCT03862781 1050 1055 B-Procedure
colectomy NCT03862781 1056 1065 I-Procedure

Inclusion NCT03868670 0 9 O
Criteria NCT03868670 10 18 O
: NCT03868670 19 20 O

- NCT03868670 24 25 O
BMI NCT03868670 27 30 B-Observation
45 NCT03868670 31 33 B-Eq_Comparison
- NCT03868670 34 35 I-Eq_Comparison
60 NCT03868670 36 38 I-Eq_Comparison
kg NCT03868670 39 41 I-Eq_Comparison
/ NCT03868670 42 43 I-Eq_Comparison
m NCT03868670 44 45 I-Eq_Comparison
2 NCT03868670 46 47 I-Eq_Comparison

- NCT03868670 50 51 O
Failure NCT03868670 53 60 O
of NCT03868670 61 63 O
at NCT03868670 64 66 B-Eq_Comparison
least NCT03868670 67 72 I-Eq_Comparison
one NCT03868670 73 76 I-Eq_Comparison
weight NCT03868670 77 83 B-Drug
loss NCT03868670 84 88 I-Drug
medication NCT03868670 89 99 I-Drug

- NCT03868670 102 103 O
Previous NCT03868670 105 113 B-Eq_Comparison
Gastric NCT03868670 114 121 B-Procedure
Bypass NCT03868670 122 128 I-Procedure
Surgery NCT03868670 129 136 I-Procedure
lead NCT03868670 137 141 O
to NCT03868670 142 144 O
less NCT03868670 145 149 B-Eq_Comparison
than NCT03868670 150 154 I-Eq_Comparison
50 NCT03868670 155 157 I-Eq_Comparison
% NCT03868670 158 159 I-Eq_Comparison
of NCT03868670 160 162 O
excess NCT03868670 163 169 B-Observation
weight NCT03868670 170 176 I-Observation
lost NCT03868670 177 181 O
by NCT03868670 182 184 O
2 NCT03868670 185 186 B-Eq_Comparison
years NCT03868670 187 192 I-Eq_Comparison
after NCT03868670 193 198 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03868670 199 206 O

- NCT03868670 209 210 O
Significant NCT03868670 212 223 O
Loss NCT03868670 224 228 B-Condition
of NCT03868670 229 231 I-Condition
Control NCT03868670 232 239 I-Condition
over NCT03868670 240 244 O
eating NCT03868670 245 251 B-Modifier

- NCT03868670 254 255 O
Subject NCT03868670 257 264 O
is NCT03868670 265 267 O
able NCT03868670 268 272 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868670 273 275 I-Assertion___Assertion_Type_Value:hypothetical
attend NCT03868670 276 282 O
all NCT03868670 283 286 O
scheduled NCT03868670 287 296 B-Eq_Comparison
clinic NCT03868670 297 303 B-Encounter
appointments NCT03868670 304 316 I-Encounter
on NCT03868670 317 319 O
their NCT03868670 320 325 O
own NCT03868670 326 329 O
or NCT03868670 330 332 O
with NCT03868670 333 337 O
a NCT03868670 338 339 O
caregiver NCT03868670 340 349 O
. NCT03868670 350 351 O

- NCT03868670 355 356 O
Premenopausal NCT03868670 358 371 B-Condition
women NCT03868670 372 377 O
must NCT03868670 378 382 O
agree NCT03868670 383 388 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868670 389 391 I-Assertion___Assertion_Type_Value:hypothetical
use NCT03868670 392 395 O
acceptable NCT03868670 396 406 O
methods NCT03868670 407 414 O
of NCT03868670 415 417 O
birth NCT03868670 418 423 B-Procedure
control NCT03868670 424 431 I-Procedure
. NCT03868670 432 433 O

- NCT03868670 437 438 O
Participants NCT03868670 440 452 O
provide NCT03868670 453 460 O
voluntary NCT03868670 461 470 O
, NCT03868670 471 472 O
decisionally NCT03868670 473 485 O
capable NCT03868670 486 493 O
, NCT03868670 494 495 O
and NCT03868670 496 499 O
appropriately NCT03868670 500 513 O
informed NCT03868670 514 522 O
consent NCT03868670 523 530 O
. NCT03868670 531 532 O

- NCT03868670 536 537 O
Subject NCT03868670 539 546 O
is NCT03868670 547 549 O
able NCT03868670 550 554 O
to NCT03868670 555 557 O
comply NCT03868670 558 564 O
w NCT03868670 565 566 O
/ NCT03868670 567 568 O
all NCT03868670 569 572 O
testing NCT03868670 573 580 O
and NCT03868670 581 584 O
follow NCT03868670 585 591 O
- NCT03868670 592 593 O
up NCT03868670 594 596 O
requirements NCT03868670 597 609 O
defined NCT03868670 610 617 O
by NCT03868670 618 620 O
the NCT03868670 621 624 O
study NCT03868670 625 630 O
protocol NCT03868670 631 639 O
. NCT03868670 640 641 O

- NCT03868670 645 646 O
Participant NCT03868670 648 659 O
has NCT03868670 660 663 O
no NCT03868670 664 666 B-Negation
immediate NCT03868670 667 676 O
plan NCT03868670 677 681 B-Assertion___Assertion_Type_Value:intention
for NCT03868670 682 685 O
relocation NCT03868670 686 696 B-Observation
beyond NCT03868670 697 703 B-Eq_Comparison
6 NCT03868670 704 705 I-Eq_Comparison
hours NCT03868670 706 711 I-Eq_Comparison
of NCT03868670 712 714 O
the NCT03868670 715 718 O
study NCT03868670 719 724 B-Study
site NCT03868670 725 729 O
. NCT03868670 730 731 O

- NCT03868670 735 736 O
Proficiency NCT03868670 738 749 O
with NCT03868670 750 754 O
the NCT03868670 755 758 O
English NCT03868670 759 766 O
language NCT03868670 767 775 O
. NCT03868670 776 777 O

Exclusion NCT03868670 779 788 O
Criteria NCT03868670 789 797 O
: NCT03868670 798 799 O

- NCT03868670 803 804 O
Subject NCT03868670 806 813 O
has NCT03868670 814 817 O
an NCT03868670 818 820 O
implanted NCT03868670 821 830 B-Procedure
medical NCT03868670 831 838 I-Procedure
device NCT03868670 839 845 I-Procedure
that NCT03868670 846 850 O
delivers NCT03868670 851 859 O
electrical NCT03868670 860 870 B-Procedure
energy NCT03868670 871 877 I-Procedure
to NCT03868670 878 880 O
the NCT03868670 881 884 O
brain NCT03868670 885 890 B-Modifier
. NCT03868670 891 892 O

- NCT03868670 896 897 O
Subject NCT03868670 899 906 O
has NCT03868670 907 910 O
an NCT03868670 911 913 O
implantable NCT03868670 914 925 B-Procedure
cardiac NCT03868670 926 933 I-Procedure
pacemaker NCT03868670 934 943 I-Procedure
, NCT03868670 944 945 O
defibrillator NCT03868670 946 959 B-Procedure
, NCT03868670 960 961 O
or NCT03868670 962 964 B-Or
neurostimulator NCT03868670 965 980 B-Procedure
. NCT03868670 981 982 O

- NCT03868670 986 987 O
Subject NCT03868670 989 996 O
is NCT03868670 997 999 O
likely NCT03868670 1000 1006 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03868670 1007 1009 I-Assertion___Assertion_Type_Value:hypothetical
require NCT03868670 1010 1017 O
repeat NCT03868670 1018 1024 B-Modifier
MR NCT03868670 1025 1027 B-Procedure
imaging NCT03868670 1028 1035 I-Procedure
after NCT03868670 1036 1041 B-Temporal_Connection___Temporal_Connection_Type_Value:after
implant NCT03868670 1042 1049 B-Procedure
of NCT03868670 1050 1052 I-Procedure
the NCT03868670 1053 1056 I-Procedure
RNS NCT03868670 1057 1060 I-Procedure
Neurostimulator NCT03868670 1061 1076 B-Modifier
and NCT03868670 1077 1080 B-Or
Leads NCT03868670 1081 1086 B-Modifier
. NCT03868670 1087 1088 O

- NCT03868670 1092 1093 O
Subject NCT03868670 1095 1102 O
is NCT03868670 1103 1105 O
unable NCT03868670 1106 1112 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03868670 1113 1115 O
fit NCT03868670 1116 1119 O
into NCT03868670 1120 1124 O
CT NCT03868670 1125 1127 B-Procedure
scanner NCT03868670 1128 1135 I-Procedure
( NCT03868670 1136 1137 O
500 NCT03868670 1138 1141 B-Eq_Comparison
lb NCT03868670 1142 1144 I-Eq_Comparison
upper NCT03868670 1145 1150 I-Eq_Comparison
weight NCT03868670 1151 1157 B-Observation
limit NCT03868670 1158 1163 O
for NCT03868670 1164 1167 O
CT NCT03868670 1168 1170 B-Procedure
scanner NCT03868670 1171 1178 I-Procedure
) NCT03868670 1179 1180 O
. NCT03868670 1181 1182 O

- NCT03868670 1186 1187 O
Inability NCT03868670 1189 1198 O
to NCT03868670 1199 1201 O
provide NCT03868670 1202 1209 O
informed NCT03868670 1210 1218 O
consent NCT03868670 1219 1226 O
to NCT03868670 1227 1229 O
treatment NCT03868670 1230 1239 O
. NCT03868670 1240 1241 O

Inclusion NCT03869775 0 9 O
Criteria NCT03869775 10 18 O
: NCT03869775 19 20 O

- NCT03869775 24 25 O
the NCT03869775 27 30 O
patient NCT03869775 31 38 O
will NCT03869775 39 43 B-Eq_Comparison
be NCT03869775 44 46 I-Eq_Comparison
operated NCT03869775 47 55 B-Procedure
with NCT03869775 56 60 O
spinal NCT03869775 61 67 B-Procedure
anesthesia NCT03869775 68 78 I-Procedure

- NCT03869775 81 82 O
over NCT03869775 84 88 B-Eq_Comparison
18 NCT03869775 89 91 I-Eq_Comparison
years NCT03869775 92 97 I-Eq_Comparison

- NCT03869775 100 101 O
no NCT03869775 103 105 B-Negation
additional NCT03869775 106 116 O
disease NCT03869775 117 124 B-Condition
and NCT03869775 125 128 O
only NCT03869775 129 133 B-Exception
DM NCT03869775 134 136 B-Condition

Exclusion NCT03869775 137 146 O
Criteria NCT03869775 147 155 O
: NCT03869775 156 157 O

- NCT03869775 161 162 O
patients NCT03869775 164 172 O
with NCT03869775 173 177 O
additional NCT03869775 178 188 O
disease NCT03869775 189 196 B-Condition

- NCT03869775 199 200 O
patients NCT03869775 202 210 O
under NCT03869775 211 216 B-Eq_Comparison
18 NCT03869775 217 219 I-Eq_Comparison
years NCT03869775 220 225 I-Eq_Comparison
of NCT03869775 226 228 O
age NCT03869775 229 232 B-Age

- NCT03869775 235 236 O
patients NCT03869775 238 246 O
contraindicated NCT03869775 247 262 B-Contraindication
in NCT03869775 263 265 O
spinal NCT03869775 266 272 B-Procedure
anesthesia NCT03869775 273 283 I-Procedure

Inclusion NCT03921164 0 9 O
Criteria NCT03921164 10 18 O
: NCT03921164 19 20 O

- NCT03921164 24 25 O
Patients NCT03921164 27 35 O
> NCT03921164 36 37 B-Eq_Comparison
18 NCT03921164 38 40 I-Eq_Comparison
years NCT03921164 41 46 I-Eq_Comparison
, NCT03921164 47 48 O
scheduled NCT03921164 49 58 B-Eq_Comparison
for NCT03921164 59 62 O
an NCT03921164 63 65 O
elective NCT03921164 66 74 B-Procedure
interventional NCT03921164 75 89 B-Procedure
neuroradiology NCT03921164 90 104 I-Procedure
procedure NCT03921164 105 114 I-Procedure
under NCT03921164 115 120 O
general NCT03921164 121 128 B-Procedure
anesthesia NCT03921164 129 139 I-Procedure
requiring NCT03921164 140 149 B-Assertion___Assertion_Type_Value:hypothetical
a NCT03921164 150 151 O
continuous NCT03921164 152 162 O
monitoring NCT03921164 163 173 O
of NCT03921164 174 176 O
mean NCT03921164 177 181 B-Observation
arterial NCT03921164 182 190 I-Observation
pressure NCT03921164 191 199 I-Observation
and NCT03921164 200 203 B-And
cardiac NCT03921164 204 211 B-Observation
output NCT03921164 212 218 I-Observation
. NCT03921164 219 220 O

Exclusion NCT03921164 222 231 O
Criteria NCT03921164 232 240 O
: NCT03921164 241 242 O

- NCT03921164 246 247 O
age NCT03921164 249 252 B-Age
< NCT03921164 253 254 B-Eq_Comparison
18 NCT03921164 255 257 I-Eq_Comparison
years NCT03921164 258 263 I-Eq_Comparison

- NCT03921164 266 267 O
Patient NCT03921164 269 276 O
who NCT03921164 277 280 O
has NCT03921164 281 284 O
not NCT03921164 285 288 O
signed NCT03921164 289 295 O
the NCT03921164 296 299 O
consent NCT03921164 300 307 O

- NCT03921164 310 311 O
Pregnant NCT03921164 313 321 B-Condition
woman NCT03921164 322 327 O

- NCT03921164 330 331 O
Patient NCT03921164 333 340 O
under NCT03921164 341 346 O
judicial NCT03921164 347 355 B-Observation
protection NCT03921164 356 366 I-Observation

- NCT03921164 369 370 O
Patient NCT03921164 372 379 O
without NCT03921164 380 387 O
affiliation NCT03921164 388 399 O
to NCT03921164 400 402 O
a NCT03921164 403 404 O
social NCT03921164 405 411 O
security NCT03921164 412 420 O
scheme NCT03921164 421 427 O

Inclusion NCT03867591 0 9 O
Criteria NCT03867591 10 18 O
: NCT03867591 19 20 O

- NCT03867591 24 25 O
Able NCT03867591 27 31 O
to NCT03867591 32 34 O
provide NCT03867591 35 42 O
written NCT03867591 43 50 O
informed NCT03867591 51 59 O
consent NCT03867591 60 67 O
in NCT03867591 68 70 O
English NCT03867591 71 78 O
. NCT03867591 79 80 O

- NCT03867591 84 85 O
Willing NCT03867591 87 94 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867591 95 97 I-Assertion___Assertion_Type_Value:hypothetical
have NCT03867591 98 102 O
height NCT03867591 103 109 B-Observation
and NCT03867591 110 113 B-Or
weight NCT03867591 114 120 B-Observation
measured NCT03867591 121 129 O
and NCT03867591 130 133 O
provide NCT03867591 134 141 O
demographic NCT03867591 142 153 O
information NCT03867591 154 165 O
( NCT03867591 166 167 O
e NCT03867591 168 169 O
. NCT03867591 170 171 O
g NCT03867591 172 173 O
. NCT03867591 174 175 O
age NCT03867591 177 180 O
, NCT03867591 181 182 O
race NCT03867591 183 187 O
, NCT03867591 188 189 O
sex NCT03867591 190 193 O
) NCT03867591 194 195 O

- NCT03867591 199 200 O
Experience NCT03867591 202 212 O
heartburn NCT03867591 213 222 B-Condition
symptoms NCT03867591 223 231 B-Assertion___Assertion_Type_Value:possible
at NCT03867591 232 234 B-Eq_Comparison
least NCT03867591 235 240 I-Eq_Comparison
2 NCT03867591 241 242 I-Eq_Comparison
days NCT03867591 243 247 I-Eq_Comparison
a NCT03867591 248 249 I-Eq_Comparison
week NCT03867591 250 254 I-Eq_Comparison
during NCT03867591 255 261 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867591 262 265 O
past NCT03867591 266 270 B-Eq_Comparison
3 NCT03867591 271 272 I-Eq_Comparison
months NCT03867591 273 279 I-Eq_Comparison
. NCT03867591 280 281 O

- NCT03867591 285 286 O
Use NCT03867591 288 291 B-Eq_Comparison
OTC NCT03867591 292 295 B-Drug
product NCT03867591 296 303 I-Drug
( NCT03867591 304 305 O
s NCT03867591 306 307 O
) NCT03867591 308 309 O
, NCT03867591 310 311 O
supplements NCT03867591 312 323 B-Drug
, NCT03867591 324 325 O
or NCT03867591 326 328 B-Or
dietary NCT03867591 329 336 B-Drug
manipulation NCT03867591 337 349 I-Drug
to NCT03867591 350 352 O
relieve NCT03867591 353 360 O
heartburn NCT03867591 361 370 B-Condition
symptoms NCT03867591 371 379 B-Assertion___Assertion_Type_Value:possible
in NCT03867591 380 382 O
the NCT03867591 383 386 O
last NCT03867591 387 391 B-Eq_Comparison
3 NCT03867591 392 393 I-Eq_Comparison
months NCT03867591 394 400 I-Eq_Comparison
. NCT03867591 401 402 O

- NCT03867591 406 407 O
Willing NCT03867591 409 416 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867591 417 419 I-Assertion___Assertion_Type_Value:hypothetical
take NCT03867591 420 424 O
the NCT03867591 425 428 O
study NCT03867591 429 434 B-Study
soy NCT03867591 435 438 B-Drug
supplement NCT03867591 439 449 I-Drug
before NCT03867591 450 456 B-Temporal_Connection___Temporal_Connection_Type_Value:before
resorting NCT03867591 457 466 O
to NCT03867591 467 469 O
OTC NCT03867591 470 473 B-Drug
product NCT03867591 474 481 I-Drug
( NCT03867591 482 483 O
s NCT03867591 484 485 O
) NCT03867591 486 487 O
to NCT03867591 488 490 O
control NCT03867591 491 498 O
heartburn NCT03867591 499 508 B-Condition
symptoms NCT03867591 509 517 B-Assertion___Assertion_Type_Value:possible
. NCT03867591 518 519 O

- NCT03867591 523 524 O
Willing NCT03867591 526 533 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867591 534 536 I-Assertion___Assertion_Type_Value:hypothetical
complete NCT03867591 537 545 O
questionnaires NCT03867591 546 560 B-Observation
, NCT03867591 561 562 O
records NCT03867591 563 570 B-Observation
, NCT03867591 571 572 O
and NCT03867591 573 576 B-Or
diaries NCT03867591 577 584 B-Observation
associated NCT03867591 585 595 O
with NCT03867591 596 600 O
the NCT03867591 601 604 O
study NCT03867591 605 610 B-Study
and NCT03867591 611 614 O
to NCT03867591 615 617 O
complete NCT03867591 618 626 O
all NCT03867591 627 630 O
clinical NCT03867591 631 639 B-Encounter
visits NCT03867591 640 646 I-Encounter
. NCT03867591 647 648 O

- NCT03867591 652 653 O
Willing NCT03867591 655 662 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03867591 663 665 I-Assertion___Assertion_Type_Value:hypothetical
provide NCT03867591 666 673 O
information NCT03867591 674 685 O
about NCT03867591 686 691 O
dietary NCT03867591 692 699 B-Observation
intake NCT03867591 700 706 I-Observation
; NCT03867591 706 707 O
3 NCT03867591 708 709 B-Eq_Comparison
- NCT03867591 710 711 I-Eq_Comparison
day NCT03867591 712 715 I-Eq_Comparison
online NCT03867591 716 722 I-Eq_Comparison
24 NCT03867591 723 725 I-Eq_Comparison
- NCT03867591 726 727 I-Eq_Comparison
hr NCT03867591 728 730 I-Eq_Comparison
recalls NCT03867591 731 738 B-Observation
during NCT03867591 739 745 B-Temporal_Connection___Temporal_Connection_Type_Value:during
baseline NCT03867591 746 754 B-Study
, NCT03867591 755 756 O
intervention NCT03867591 757 769 B-Procedure
, NCT03867591 770 771 O
and NCT03867591 772 775 B-And
washout NCT03867591 776 783 B-Procedure
. NCT03867591 784 785 O

- NCT03867591 789 790 O
Willing NCT03867591 792 799 O
and NCT03867591 800 803 O
able NCT03867591 804 808 O
to NCT03867591 809 811 O
provide NCT03867591 812 819 O
a NCT03867591 820 821 O
valid NCT03867591 822 827 O
social NCT03867591 828 834 O
security NCT03867591 835 843 O
for NCT03867591 844 847 O
study NCT03867591 848 853 O
payment NCT03867591 854 861 O
purposes NCT03867591 862 870 O
. NCT03867591 871 872 O

Exclusion NCT03867591 874 883 O
Criteria NCT03867591 884 892 O
: NCT03867591 893 894 O

- NCT03867591 898 899 O
Do NCT03867591 901 903 O
not NCT03867591 904 907 O
meet NCT03867591 908 912 O
the NCT03867591 913 916 O
above NCT03867591 917 922 O
criteria NCT03867591 923 931 O
. NCT03867591 932 933 O

- NCT03867591 937 938 O
Soy NCT03867591 940 943 O
allergy NCT03867591 944 951 B-Allergy

- NCT03867591 954 955 O
Severe NCT03867591 957 963 O
heartburn NCT03867591 964 973 B-Condition
problem NCT03867591 974 981 I-Condition
( NCT03867591 982 983 O
can NCT03867591 984 987 O
not NCT03867591 987 990 O
be NCT03867591 991 993 O
ignored NCT03867591 994 1001 O
and NCT03867591 1002 1005 O
often NCT03867591 1006 1011 B-Assertion___Assertion_Type_Value:hypothetical
limits NCT03867591 1012 1018 O
your NCT03867591 1019 1023 O
concentration NCT03867591 1024 1037 B-Condition
on NCT03867591 1038 1040 O
daily NCT03867591 1041 1046 B-Eq_Comparison
activities NCT03867591 1047 1057 O
) NCT03867591 1058 1059 O
during NCT03867591 1060 1066 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867591 1067 1070 O
last NCT03867591 1071 1075 B-Eq_Comparison
week NCT03867591 1076 1080 I-Eq_Comparison

- NCT03867591 1083 1084 O
Diagnosed NCT03867591 1086 1095 O
or NCT03867591 1096 1098 B-Or
currently NCT03867591 1099 1108 B-Eq_Comparison
being NCT03867591 1109 1114 I-Eq_Comparison
treated NCT03867591 1115 1122 B-Procedure
for NCT03867591 1123 1126 O
any NCT03867591 1127 1130 O
gastrointestinal NCT03867591 1131 1147 B-Condition
diseases NCT03867591 1148 1156 I-Condition
including NCT03867591 1157 1166 O
GERD NCT03867591 1167 1171 B-Condition
, NCT03867591 1172 1173 O
gastric NCT03867591 1174 1181 B-Condition
ulcers NCT03867591 1182 1188 I-Condition
, NCT03867591 1189 1190 O
Crohn NCT03867591 1191 1196 B-Condition
's NCT03867591 1196 1198 I-Condition
, NCT03867591 1199 1200 O
celiac NCT03867591 1201 1207 B-Condition
, NCT03867591 1208 1209 O
ulcerative NCT03867591 1210 1220 B-Condition
colitis NCT03867591 1221 1228 I-Condition
, NCT03867591 1229 1230 O
etc NCT03867591 1231 1234 O
. NCT03867591 1235 1236 O

- NCT03867591 1240 1241 O
Self NCT03867591 1243 1247 O
- NCT03867591 1248 1249 O
disclosed NCT03867591 1250 1259 O
as NCT03867591 1260 1262 O
pregnant NCT03867591 1263 1271 B-Condition
or NCT03867591 1272 1274 B-Or
breast NCT03867591 1275 1281 B-Condition
- NCT03867591 1282 1283 I-Condition
feeding NCT03867591 1284 1291 I-Condition
or NCT03867591 1292 1294 B-Or
planning NCT03867591 1295 1303 B-Assertion___Assertion_Type_Value:intention
on NCT03867591 1304 1306 O
becoming NCT03867591 1307 1315 O
pregnant NCT03867591 1316 1324 B-Condition
during NCT03867591 1325 1331 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03867591 1332 1335 O
study NCT03867591 1336 1341 B-Study
duration NCT03867591 1342 1350 O
. NCT03867591 1351 1352 O

- NCT03867591 1356 1357 O
Currently NCT03867591 1359 1368 B-Eq_Comparison
participating NCT03867591 1369 1382 O
in NCT03867591 1383 1385 O
another NCT03867591 1386 1393 B-Other
clinical NCT03867591 1394 1402 O
study NCT03867591 1403 1408 B-Study
. NCT03867591 1409 1410 O

Inclusion NCT03923621 0 9 O
Criteria NCT03923621 10 18 O
: NCT03923621 19 20 O

- NCT03923621 24 25 O
ASA NCT03923621 27 30 B-Observation
I NCT03923621 31 32 B-Eq_Comparison
or NCT03923621 33 35 I-Eq_Comparison
II NCT03923621 36 38 I-Eq_Comparison

- NCT03923621 41 42 O
Pilonidal NCT03923621 44 53 B-Condition
disease NCT03923621 54 61 I-Condition
< NCT03923621 62 63 B-Eq_Comparison
3 NCT03923621 64 65 I-Eq_Comparison
previous NCT03923621 66 74 B-Eq_Comparison
treatments NCT03923621 75 85 B-Procedure

- NCT03923621 88 89 O
Previous NCT03923621 91 99 B-Eq_Comparison
incision NCT03923621 100 108 B-Procedure
and NCT03923621 109 112 B-Or
drainage NCT03923621 113 121 B-Procedure
allowed NCT03923621 122 129 O

- NCT03923621 132 133 O
Over NCT03923621 135 139 B-Eq_Comparison
16 NCT03923621 140 142 I-Eq_Comparison
years NCT03923621 143 148 I-Eq_Comparison

Exclusion NCT03923621 149 158 O
Criteria NCT03923621 159 167 O
: NCT03923621 168 169 O

- NCT03923621 173 174 O
Co NCT03923621 176 178 B-Condition
- NCT03923621 179 180 I-Condition
morbidity NCT03923621 181 190 I-Condition
> NCT03923621 191 192 O
ASA NCT03923621 193 196 B-Observation
II NCT03923621 197 199 B-Eq_Comparison

- NCT03923621 202 203 O
Unable NCT03923621 205 211 O
to NCT03923621 212 214 O
consent NCT03923621 215 222 O
themselves NCT03923621 223 233 O

- NCT03923621 236 237 O
Under NCT03923621 239 244 B-Eq_Comparison
16 NCT03923621 245 247 I-Eq_Comparison
years NCT03923621 248 253 I-Eq_Comparison

- NCT03923621 256 257 O
Vulnerable NCT03923621 259 269 B-Condition
adults NCT03923621 270 276 O

Inclusion NCT03922698 0 9 O
Criteria NCT03922698 10 18 O
: NCT03922698 19 20 O

- NCT03922698 24 25 O
age NCT03922698 27 30 B-Age
≥ NCT03922698 31 32 B-Eq_Comparison
45 NCT03922698 33 35 I-Eq_Comparison
and NCT03922698 36 39 B-And
≤ NCT03922698 40 41 B-Eq_Comparison
90 NCT03922698 42 44 I-Eq_Comparison
years NCT03922698 45 50 I-Eq_Comparison
; NCT03922698 50 51 O

- NCT03922698 54 55 O
patients NCT03922698 57 65 O
with NCT03922698 66 70 O
severe NCT03922698 71 77 O
( NCT03922698 78 79 O
70 NCT03922698 80 82 B-Eq_Comparison
- NCT03922698 83 84 I-Eq_Comparison
99 NCT03922698 85 87 I-Eq_Comparison
% NCT03922698 88 89 I-Eq_Comparison
) NCT03922698 90 91 O
carotid NCT03922698 92 99 B-Observation
stenosis NCT03922698 100 108 I-Observation
, NCT03922698 109 110 O
diagnosed NCT03922698 111 120 O
with NCT03922698 121 125 O
color NCT03922698 126 131 B-Procedure
doppler NCT03922698 132 139 I-Procedure
echography NCT03922698 140 150 I-Procedure
or NCT03922698 151 153 B-Or
angio NCT03922698 154 159 B-Modifier
- NCT03922698 160 161 O
MRI NCT03922698 162 165 B-Procedure
or NCT03922698 166 168 B-Or
angiography NCT03922698 169 180 B-Procedure
; NCT03922698 180 181 O

- NCT03922698 184 185 O
written NCT03922698 187 194 O
informed NCT03922698 195 203 O
consent NCT03922698 204 211 O
. NCT03922698 212 213 O

Exclusion NCT03922698 215 224 O
Criteria NCT03922698 225 233 O
: NCT03922698 234 235 O

- NCT03922698 239 240 O
carotid NCT03922698 242 249 B-Observation
stenosis NCT03922698 250 258 I-Observation
< NCT03922698 259 260 B-Eq_Comparison
70 NCT03922698 261 263 I-Eq_Comparison
% NCT03922698 264 265 I-Eq_Comparison
at NCT03922698 266 268 O
carotid NCT03922698 269 276 B-Modifier
bifurcation NCT03922698 277 288 I-Modifier
or NCT03922698 289 291 B-Or
diagnosed NCT03922698 292 301 O
with NCT03922698 302 306 O
color NCT03922698 307 312 B-Procedure
doppler NCT03922698 313 320 I-Procedure
echography NCT03922698 321 331 I-Procedure
or NCT03922698 332 334 B-Or
angio NCT03922698 335 340 B-Modifier
- NCT03922698 341 342 O
MRI NCT03922698 343 346 B-Procedure
or NCT03922698 347 349 B-Or
angiography NCT03922698 350 361 B-Procedure
; NCT03922698 361 362 O

- NCT03922698 365 366 O
severe NCT03922698 368 374 O
neoplasia NCT03922698 375 384 B-Condition
; NCT03922698 384 385 O

- NCT03922698 388 389 O
participation NCT03922698 391 404 O
to NCT03922698 405 407 O
other NCT03922698 408 413 B-Other
clinical NCT03922698 414 422 B-Study
trial NCT03922698 423 428 I-Study
, NCT03922698 429 430 O
ongoing NCT03922698 431 438 B-Eq_Comparison
or NCT03922698 439 441 B-Or
terminated NCT03922698 442 452 O
less NCT03922698 453 457 B-Eq_Comparison
than NCT03922698 458 462 I-Eq_Comparison
one NCT03922698 463 466 I-Eq_Comparison
month NCT03922698 467 472 I-Eq_Comparison
before NCT03922698 473 479 B-Temporal_Connection___Temporal_Connection_Type_Value:before
enrolment NCT03922698 480 489 O
in NCT03922698 490 492 O
this NCT03922698 493 497 O
study NCT03922698 498 503 B-Study
. NCT03922698 504 505 O

Inclusion NCT03867903 0 9 O
Criteria NCT03867903 10 18 O
: NCT03867903 19 20 O

- NCT03867903 24 25 O
Study NCT03867903 27 32 O
participants NCT03867903 33 45 O
will NCT03867903 46 50 O
be NCT03867903 51 53 O
infants NCT03867903 54 61 B-Family_Member___Family_Member_Type:child
( NCT03867903 62 63 O
and NCT03867903 64 67 B-Or
their NCT03867903 68 73 O
parents NCT03867903 74 81 B-Family_Member___Family_Member_Type:parent
) NCT03867903 82 83 O
who NCT03867903 84 87 O
have NCT03867903 88 92 O
undergone NCT03867903 93 102 B-Eq_Comparison
cardiac NCT03867903 103 110 B-Procedure
surgery NCT03867903 111 118 I-Procedure
at NCT03867903 119 121 O
Children NCT03867903 122 130 O
's NCT03867903 130 132 O
Mercy NCT03867903 133 138 O
Kansas NCT03867903 139 145 O
City NCT03867903 146 150 O
in NCT03867903 151 153 O
the NCT03867903 154 157 O
first NCT03867903 158 163 B-Eq_Comparison
six NCT03867903 164 167 I-Eq_Comparison
weeks NCT03867903 168 173 I-Eq_Comparison
of NCT03867903 174 176 B-Temporal_Connection___Temporal_Connection_Type_Value:after
life NCT03867903 177 181 B-Birth
and NCT03867903 182 185 B-And
are NCT03867903 186 189 O
currently NCT03867903 190 199 B-Eq_Comparison
less NCT03867903 200 204 B-Eq_Comparison
than NCT03867903 205 209 I-Eq_Comparison
18 NCT03867903 210 212 I-Eq_Comparison
months NCT03867903 213 219 I-Eq_Comparison
of NCT03867903 220 222 O
age NCT03867903 223 226 B-Age
at NCT03867903 227 229 O
the NCT03867903 230 233 O
time NCT03867903 234 238 O
of NCT03867903 239 241 O
being NCT03867903 242 247 O
approached NCT03867903 248 258 O
for NCT03867903 259 262 O
participation NCT03867903 263 276 O
in NCT03867903 277 279 O
this NCT03867903 280 284 O
study NCT03867903 285 290 B-Study
. NCT03867903 291 292 O

Exclusion NCT03867903 294 303 O
Criteria NCT03867903 304 312 O
: NCT03867903 313 314 O

- NCT03867903 318 319 O
• NCT03867903 321 322 O
Families NCT03867903 323 331 O
without NCT03867903 332 339 O
access NCT03867903 340 346 O
to NCT03867903 347 349 O
a NCT03867903 350 351 O
personal NCT03867903 352 360 O
device NCT03867903 361 367 O
for NCT03867903 368 371 O
download NCT03867903 372 380 O
( NCT03867903 381 382 O
no NCT03867903 383 385 O
devices NCT03867903 386 393 O
will NCT03867903 394 398 O
be NCT03867903 399 401 O
provided NCT03867903 402 410 O
) NCT03867903 411 412 O

- NCT03867903 421 422 O
Children NCT03867903 424 432 B-Family_Member___Family_Member_Type:child
who NCT03867903 433 436 O
are NCT03867903 437 440 O
deceased NCT03867903 441 449 B-Death
prior NCT03867903 450 455 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03867903 456 458 I-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03867903 459 462 O
family NCT03867903 463 469 O
being NCT03867903 470 475 O
approached NCT03867903 476 486 O
for NCT03867903 487 490 O
study NCT03867903 491 496 B-Study
participation NCT03867903 497 510 O

- NCT03867903 518 519 O
Neonates NCT03867903 521 529 B-Family_Member___Family_Member_Type:child
that NCT03867903 530 534 O
are NCT03867903 535 538 O
considered NCT03867903 539 549 O
non NCT03867903 550 553 B-Condition
- NCT03867903 554 555 I-Condition
viable NCT03867903 556 562 I-Condition
, NCT03867903 563 564 O
or NCT03867903 565 567 B-Or
have NCT03867903 568 572 O
the NCT03867903 573 576 O
potential NCT03867903 577 586 B-Risk
to NCT03867903 587 589 O
be NCT03867903 590 592 O
non NCT03867903 593 596 B-Condition
- NCT03867903 597 598 I-Condition
viable NCT03867903 599 605 I-Condition

- NCT03867903 613 614 O
Spanish NCT03867903 616 623 O
- NCT03867903 624 625 O
only NCT03867903 626 630 O
speaking NCT03867903 631 639 O
families NCT03867903 640 648 O

Exclude NCT03867903 649 656 O
special NCT03867903 657 664 O
populations NCT03867903 665 676 O
: NCT03867903 677 678 O

• NCT03867903 680 681 O
Wards NCT03867903 682 687 B-Observation
of NCT03867903 688 690 I-Observation
the NCT03867903 691 694 I-Observation
state NCT03867903 695 700 I-Observation

Inclusion NCT03861130 0 9 O
Criteria NCT03861130 10 18 O
: NCT03861130 19 20 O

- NCT03861130 24 25 O
Affected NCT03861130 27 35 O
children NCT03861130 36 44 O
will NCT03861130 45 49 O
be NCT03861130 50 52 O
recruited NCT03861130 53 62 O
if NCT03861130 63 65 O
the NCT03861130 66 69 O
treating NCT03861130 70 78 B-Procedure
clinician NCT03861130 79 88 B-Provider
has NCT03861130 89 92 O
made NCT03861130 93 97 O
a NCT03861130 98 99 O
diagnosis NCT03861130 100 109 O
of NCT03861130 110 112 O
possible NCT03861130 113 121 B-Assertion___Assertion_Type_Value:possible
Kawasaki NCT03861130 122 130 B-Condition
disease NCT03861130 131 138 I-Condition
( NCT03861130 139 140 O
even NCT03861130 141 145 O
if NCT03861130 146 148 O
they NCT03861130 149 153 O
do NCT03861130 154 156 O
not NCT03861130 157 160 O
fulfil NCT03861130 161 167 O
the NCT03861130 168 171 O
criteria NCT03861130 172 180 O
below NCT03861130 181 186 O
for NCT03861130 187 190 O
Kawasaki NCT03861130 191 199 B-Condition
disease NCT03861130 200 207 I-Condition
) NCT03861130 208 209 O
. NCT03861130 210 211 O

The NCT03861130 213 216 O
current NCT03861130 217 224 O
standard NCT03861130 225 233 O
diagnostic NCT03861130 234 244 O
criteria NCT03861130 245 253 O
for NCT03861130 254 257 O
KD NCT03861130 258 260 B-Condition
( NCT03861130 261 262 O
Circulation NCT03861130 263 274 O
2001 NCT03861130 275 279 O
103 NCT03861130 280 283 O
335 NCT03861130 284 287 O
- NCT03861130 288 289 O
336 NCT03861130 290 293 O
doi NCT03861130 294 297 O
: NCT03861130 298 299 O
10.1161 NCT03861130 300 307 O
/ NCT03861130 308 309 O
01 NCT03861130 310 312 O
. NCT03861130 312 313 O
CIR NCT03861130 314 317 O
103.2.335 NCT03861130 318 327 O
) NCT03861130 328 329 O
are NCT03861130 330 333 O
: NCT03861130 334 335 O

The NCT03861130 337 340 O
presence NCT03861130 341 349 O
of NCT03861130 350 352 O
fever NCT03861130 353 358 B-Condition
for NCT03861130 359 362 O
at NCT03861130 363 365 B-Eq_Comparison
least NCT03861130 366 371 I-Eq_Comparison
five NCT03861130 372 376 I-Eq_Comparison
days NCT03861130 377 381 I-Eq_Comparison
plus NCT03861130 382 386 B-And
four NCT03861130 387 391 B-Eq_Comparison
of NCT03861130 392 394 O
the NCT03861130 395 398 B-Criteria_Count
following NCT03861130 399 408 I-Criteria_Count
criteria NCT03861130 409 417 I-Criteria_Count
: NCT03861130 418 419 O

1 NCT03861130 423 424 O
. NCT03861130 424 425 O
Changes NCT03861130 427 434 O
in NCT03861130 435 437 O
the NCT03861130 438 441 O
peripheral NCT03861130 442 452 B-Condition
extremities NCT03861130 453 464 I-Condition
Acute NCT03861130 465 470 O
: NCT03861130 471 472 O
erythema NCT03861130 473 481 B-Condition
and NCT03861130 482 485 B-Or
oedema NCT03861130 486 492 B-Condition
of NCT03861130 493 495 O
hands NCT03861130 496 501 B-Modifier
and NCT03861130 502 505 B-Or
feet NCT03861130 506 510 B-Modifier
Convalescent NCT03861130 511 523 B-Modifier
: NCT03861130 524 525 O
membranous NCT03861130 526 536 B-Condition
desquamation NCT03861130 537 549 I-Condition
of NCT03861130 550 552 O
fingertips NCT03861130 553 563 B-Modifier

2 NCT03861130 566 567 O
. NCT03861130 567 568 O
Polymorphous NCT03861130 570 582 B-Condition
exanthema NCT03861130 583 592 I-Condition

3 NCT03861130 595 596 O
. NCT03861130 596 597 O
Bilateral NCT03861130 599 608 B-Modifier
painless NCT03861130 609 617 I-Modifier
bulbar NCT03861130 618 624 B-Condition
conjunctival NCT03861130 625 637 I-Condition
injection NCT03861130 638 647 I-Condition
without NCT03861130 648 655 B-Negation
exudate NCT03861130 656 663 B-Modifier

4 NCT03861130 666 667 O
. NCT03861130 667 668 O
Changes NCT03861130 670 677 O
in NCT03861130 678 680 O
lips NCT03861130 681 685 B-Modifier
and NCT03861130 686 689 B-Or
oral NCT03861130 690 694 B-Modifier
cavity NCT03861130 695 701 B-Condition
: NCT03861130 702 703 O
erythema NCT03861130 704 712 B-Condition
and NCT03861130 713 716 B-Or
cracking NCT03861130 717 725 B-Condition
of NCT03861130 726 728 I-Condition
lips NCT03861130 729 733 I-Condition
, NCT03861130 734 735 O
strawberry NCT03861130 736 746 B-Condition
tongue NCT03861130 747 753 I-Condition
, NCT03861130 754 755 O
diffuse NCT03861130 756 763 B-Condition
injection NCT03861130 764 773 I-Condition
of NCT03861130 774 776 O
oral NCT03861130 777 781 B-Modifier
and NCT03861130 782 785 B-Or
pharyngeal NCT03861130 786 796 B-Modifier
mucosae NCT03861130 797 804 I-Modifier

5 NCT03861130 807 808 O
. NCT03861130 808 809 O
Cervical NCT03861130 811 819 B-Condition
lymphadenopathy NCT03861130 820 835 I-Condition
( NCT03861130 836 837 O
> NCT03861130 838 839 B-Eq_Comparison
1.5 NCT03861130 840 843 I-Eq_Comparison
cm NCT03861130 844 846 I-Eq_Comparison
diameter NCT03861130 847 855 B-Observation
) NCT03861130 856 857 O
, NCT03861130 858 859 O
usually NCT03861130 860 867 O
unilateral NCT03861130 868 878 O
Patients NCT03861130 879 887 O
meeting NCT03861130 888 895 O
not NCT03861130 896 899 O
all NCT03861130 900 903 O
of NCT03861130 904 906 O
these NCT03861130 907 912 O
criteria NCT03861130 913 921 O
may NCT03861130 922 925 O
meet NCT03861130 926 930 O
the NCT03861130 931 934 O
criteria NCT03861130 935 943 O
for NCT03861130 944 947 O
atypical NCT03861130 948 956 O
Kawasaki NCT03861130 957 965 B-Condition
disease NCT03861130 966 973 I-Condition
, NCT03861130 974 975 O
ie NCT03861130 976 978 O
. NCT03861130 979 980 O
if NCT03861130 982 984 O
they NCT03861130 985 989 O
have NCT03861130 990 994 O
fever NCT03861130 995 1000 B-Condition
and NCT03861130 1001 1004 B-And
two NCT03861130 1005 1008 O
or NCT03861130 1009 1011 O
three NCT03861130 1012 1017 O
of NCT03861130 1018 1020 O
the NCT03861130 1021 1024 O
above NCT03861130 1025 1030 O
criteria NCT03861130 1031 1039 O
and NCT03861130 1040 1043 O
elevation NCT03861130 1044 1053 O
of NCT03861130 1054 1056 O
CRP NCT03861130 1057 1060 B-Condition
or NCT03861130 1061 1063 B-Or
echocardiographic NCT03861130 1064 1081 B-Observation
evidence NCT03861130 1082 1090 I-Observation
of NCT03861130 1091 1093 O
coronary NCT03861130 1094 1102 B-Condition
artery NCT03861130 1103 1109 I-Condition
dilatation NCT03861130 1110 1120 I-Condition
. NCT03861130 1121 1122 O

Parents NCT03861130 1124 1131 B-Family_Member___Family_Member_Type:parent
of NCT03861130 1132 1134 O
affected NCT03861130 1135 1143 O
child NCT03861130 1144 1149 O
must NCT03861130 1150 1154 O
be NCT03861130 1155 1157 O
biological NCT03861130 1158 1168 O
parents NCT03861130 1169 1176 O
. NCT03861130 1177 1178 O

Exclusion NCT03861130 1180 1189 O
Criteria NCT03861130 1190 1198 O
: NCT03861130 1199 1200 O

- NCT03861130 1204 1205 O
children NCT03861130 1207 1215 B-Family_Member___Family_Member_Type:child
who NCT03861130 1216 1219 O
do NCT03861130 1220 1222 O
not NCT03861130 1223 1226 B-Negation
have NCT03861130 1227 1231 O
a NCT03861130 1232 1233 O
diagnosis NCT03861130 1234 1243 O
of NCT03861130 1244 1246 O
possible NCT03861130 1247 1255 B-Assertion___Assertion_Type_Value:possible
Kawasaki NCT03861130 1256 1264 B-Condition
disease NCT03861130 1265 1272 I-Condition


Inclusion NCT03868371 0 9 O
Criteria NCT03868371 10 18 O
: NCT03868371 19 20 O

- NCT03868371 24 25 O
≥ NCT03868371 27 28 B-Eq_Comparison
18 NCT03868371 29 31 I-Eq_Comparison
years NCT03868371 32 37 I-Eq_Comparison
of NCT03868371 38 40 O
age NCT03868371 41 44 B-Age

- NCT03868371 47 48 O
Currently NCT03868371 50 59 B-Eq_Comparison
treated NCT03868371 60 67 B-Procedure
with NCT03868371 68 72 O
peritoneal NCT03868371 73 83 B-Procedure
dialysis NCT03868371 84 92 I-Procedure
( NCT03868371 93 94 O
APD NCT03868371 95 98 B-Procedure
or NCT03868371 99 101 B-Or
CAPD NCT03868371 102 106 B-Procedure
) NCT03868371 107 108 O

- NCT03868371 112 113 O
Serum NCT03868371 115 120 B-Observation
ionized NCT03868371 121 128 I-Observation
calcium NCT03868371 129 136 I-Observation
between NCT03868371 137 144 B-Eq_Comparison
1.10 NCT03868371 145 149 I-Eq_Comparison
and NCT03868371 150 153 I-Eq_Comparison
1.40 NCT03868371 154 158 I-Eq_Comparison
mmol NCT03868371 159 163 I-Eq_Comparison
/ NCT03868371 164 165 I-Eq_Comparison
L NCT03868371 166 167 I-Eq_Comparison
for NCT03868371 168 171 O
> NCT03868371 172 173 B-Eq_Comparison
3 NCT03868371 174 175 I-Eq_Comparison
months NCT03868371 176 182 I-Eq_Comparison

- NCT03868371 185 186 O
Plasma NCT03868371 188 194 B-Observation
phosphate NCT03868371 195 204 I-Observation
between NCT03868371 205 212 B-Eq_Comparison
0.7 NCT03868371 213 216 I-Eq_Comparison
and NCT03868371 217 220 I-Eq_Comparison
3.0 NCT03868371 221 224 I-Eq_Comparison
mmol NCT03868371 225 229 I-Eq_Comparison
/ NCT03868371 230 231 I-Eq_Comparison
L NCT03868371 232 233 I-Eq_Comparison
for NCT03868371 234 237 O
> NCT03868371 238 239 B-Eq_Comparison
3 NCT03868371 240 241 I-Eq_Comparison
months NCT03868371 242 248 I-Eq_Comparison

Exclusion NCT03868371 249 258 O
Criteria NCT03868371 259 267 O
: NCT03868371 268 269 O

- NCT03868371 273 274 O
Earlier NCT03868371 276 283 B-Eq_Comparison
parathyroidectomized NCT03868371 284 304 B-Condition

- NCT03868371 307 308 O
Other NCT03868371 310 315 B-Other
conditions NCT03868371 316 326 B-Condition
, NCT03868371 327 328 O
which NCT03868371 329 334 O
hinders NCT03868371 335 342 O
the NCT03868371 343 346 O
participation NCT03868371 347 360 O
in NCT03868371 361 363 O
the NCT03868371 364 367 O
trial NCT03868371 368 373 B-Study

Inclusion NCT03865316 0 9 O
Criteria NCT03865316 10 18 O
: NCT03865316 19 20 O

- NCT03865316 24 25 O
Patients NCT03865316 27 35 O
18 NCT03865316 36 38 B-Eq_Comparison
years NCT03865316 39 44 I-Eq_Comparison
old NCT03865316 45 48 I-Eq_Comparison
and NCT03865316 49 52 I-Eq_Comparison
older NCT03865316 53 58 I-Eq_Comparison
at NCT03865316 59 61 O
the NCT03865316 62 65 O
time NCT03865316 66 70 O
of NCT03865316 71 73 O
consent NCT03865316 74 81 O
. NCT03865316 82 83 O

- NCT03865316 87 88 O
ASA NCT03865316 90 93 B-Observation
status NCT03865316 94 100 O
I NCT03865316 101 102 B-Eq_Comparison
, NCT03865316 103 104 I-Eq_Comparison
II NCT03865316 105 107 I-Eq_Comparison
, NCT03865316 108 109 I-Eq_Comparison
or NCT03865316 110 112 I-Eq_Comparison
III NCT03865316 113 116 I-Eq_Comparison
. NCT03865316 117 118 O

- NCT03865316 122 123 O
English NCT03865316 125 132 O
- NCT03865316 133 134 O
speaking NCT03865316 135 143 O
subjects NCT03865316 144 152 O
. NCT03865316 153 154 O

- NCT03865316 158 159 O
Scheduled NCT03865316 161 170 B-Eq_Comparison
for NCT03865316 171 174 O
surgical NCT03865316 175 183 B-Modifier
and NCT03865316 184 187 B-Or
non NCT03865316 188 191 B-Negation
- NCT03865316 192 193 O
surgical NCT03865316 194 202 B-Modifier
procedures NCT03865316 203 213 B-Procedure
scheduled NCT03865316 214 223 B-Eq_Comparison
under NCT03865316 224 229 O
general NCT03865316 230 237 B-Procedure
anesthesia NCT03865316 238 248 I-Procedure
( NCT03865316 249 250 O
Common NCT03865316 251 257 O
procedures NCT03865316 258 268 O
include NCT03865316 269 276 O
but NCT03865316 277 280 O
are NCT03865316 281 284 O
not NCT03865316 285 288 O
restricted NCT03865316 289 299 O
to NCT03865316 300 302 O
tonsillectomy NCT03865316 303 316 B-Procedure
, NCT03865316 317 318 O
adenoidectomy NCT03865316 319 332 B-Procedure
, NCT03865316 333 334 O
urological NCT03865316 335 345 B-Procedure
procedures NCT03865316 346 356 I-Procedure
, NCT03865316 357 358 O
dental NCT03865316 359 365 B-Procedure
rehabilitation NCT03865316 366 380 I-Procedure
, NCT03865316 381 382 O
orthopedic NCT03865316 383 393 B-Procedure
procedures NCT03865316 394 404 I-Procedure
, NCT03865316 405 406 O
biopsies NCT03865316 407 415 B-Procedure
, NCT03865316 416 417 O
audiogram NCT03865316 418 427 B-Procedure
, NCT03865316 428 429 O
nuclear NCT03865316 430 437 B-Procedure
scans NCT03865316 438 443 I-Procedure
, NCT03865316 444 445 O
gastroscopy NCT03865316 446 457 B-Procedure
, NCT03865316 458 459 O
colonoscopy NCT03865316 460 471 B-Procedure
, NCT03865316 472 473 O
etc NCT03865316 474 477 O
. NCT03865316 478 479 O
) NCT03865316 480 481 O
. NCT03865316 482 483 O

Exclusion NCT03865316 485 494 O
Criteria NCT03865316 495 503 O
: NCT03865316 504 505 O

- NCT03865316 509 510 O
Any NCT03865316 512 515 O
deformities NCT03865316 516 527 B-Condition
or NCT03865316 528 530 B-Or
devices NCT03865316 531 538 B-Procedure
that NCT03865316 539 543 O
may NCT03865316 544 547 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03865316 548 555 B-Negation
application NCT03865316 556 567 O
of NCT03865316 568 570 O
EEG NCT03865316 571 574 B-Procedure
Sensor NCT03865316 575 581 I-Procedure
to NCT03865316 582 584 O
forehead NCT03865316 585 593 B-Modifier
with NCT03865316 594 598 O
a NCT03865316 599 600 O
proper NCT03865316 601 607 O
fit NCT03865316 608 611 O
. NCT03865316 612 613 O

- NCT03865316 617 618 O
Subjects NCT03865316 620 628 O
who NCT03865316 629 632 O
are NCT03865316 633 636 O
developmentally NCT03865316 637 652 B-Condition
delayed NCT03865316 653 660 I-Condition
. NCT03865316 661 662 O

- NCT03865316 666 667 O
Subjects NCT03865316 669 677 O
deemed NCT03865316 678 684 O
not NCT03865316 685 688 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
suitable NCT03865316 689 697 I-Assertion___Assertion_Type_Value:hypothetical|I-Negation
for NCT03865316 698 701 O
study NCT03865316 702 707 B-Study
at NCT03865316 708 710 O
the NCT03865316 711 714 O
discretion NCT03865316 715 725 O
of NCT03865316 726 728 O
the NCT03865316 729 732 O
investigator NCT03865316 733 745 O
. NCT03865316 746 747 O

Inclusion NCT03865160 0 9 O
Criteria NCT03865160 10 18 O
: NCT03865160 19 20 O

- NCT03865160 24 25 O
Children NCT03865160 27 35 O
aged NCT03865160 36 40 B-Age
6 NCT03865160 41 42 B-Eq_Comparison
- NCT03865160 43 44 I-Eq_Comparison
11 NCT03865160 45 47 I-Eq_Comparison
years NCT03865160 48 53 I-Eq_Comparison
with NCT03865160 54 58 B-And
- NCT03865160 59 60 B-Eq_Comparison
1 NCT03865160 61 62 I-Eq_Comparison
- NCT03865160 63 64 I-Eq_Comparison
to NCT03865160 65 67 I-Eq_Comparison
- NCT03865160 68 69 I-Eq_Comparison
10 NCT03865160 70 72 I-Eq_Comparison
diopters NCT03865160 73 81 I-Eq_Comparison
( NCT03865160 82 83 I-Eq_Comparison
D NCT03865160 84 85 I-Eq_Comparison
) NCT03865160 86 87 I-Eq_Comparison
myopia NCT03865160 88 94 B-Observation

Exclusion NCT03865160 95 104 O
Criteria NCT03865160 105 113 O
: NCT03865160 114 115 O

- NCT03865160 119 120 O
Any NCT03865160 122 125 O
organic NCT03865160 126 133 B-Condition
eye NCT03865160 134 137 I-Condition
disease NCT03865160 138 145 I-Condition
, NCT03865160 146 147 O
strabismus NCT03865160 148 158 B-Condition
, NCT03865160 159 160 O
astigmatism NCT03865160 161 172 B-Condition
and NCT03865160 173 176 B-Or
/ NCT03865160 177 178 I-Or
or NCT03865160 179 181 I-Or
anisometropia NCT03865160 182 195 B-Observation
> NCT03865160 196 197 B-Eq_Comparison
1.5 NCT03865160 198 201 I-Eq_Comparison
D NCT03865160 202 203 I-Eq_Comparison
, NCT03865160 204 205 O
prematurity NCT03865160 206 217 B-Condition
, NCT03865160 218 219 O
use NCT03865160 220 223 B-Eq_Comparison
of NCT03865160 224 226 O
mono NCT03865160 227 231 B-Modifier
- NCT03865160 232 233 I-Modifier
/ NCT03865160 234 235 B-Or
multifocal NCT03865160 236 246 B-Modifier
contact NCT03865160 247 254 B-Procedure
lenses NCT03865160 255 261 I-Procedure
, NCT03865160 262 263 O
pre NCT03865160 264 267 B-Temporal_Connection___Temporal_Connection_Type_Value:before
- NCT03865160 268 269 O
treatment NCT03865160 270 279 B-Procedure
with NCT03865160 280 284 O
atropine NCT03865160 285 293 B-Drug

Inclusion NCT03920241 0 9 O
Criteria NCT03920241 10 18 O
: NCT03920241 19 20 O

- NCT03920241 24 25 O
18 NCT03920241 27 29 B-Eq_Comparison
years NCT03920241 30 35 I-Eq_Comparison
of NCT03920241 36 38 I-Eq_Comparison
age NCT03920241 39 42 I-Eq_Comparison
or NCT03920241 43 45 I-Eq_Comparison
more NCT03920241 46 50 I-Eq_Comparison

- NCT03920241 53 54 O
Fluency NCT03920241 56 63 O
in NCT03920241 64 66 O
oral NCT03920241 67 71 O
and NCT03920241 72 75 O
written NCT03920241 76 83 O
Spanish NCT03920241 84 91 O

Exclusion NCT03920241 92 101 O
Criteria NCT03920241 102 110 O
: NCT03920241 111 112 O

- NCT03920241 116 117 O
Having NCT03920241 119 125 O
any NCT03920241 126 129 O
current NCT03920241 130 137 B-Eq_Comparison
of NCT03920241 138 140 O
serious NCT03920241 141 148 O
psychological NCT03920241 149 162 B-Condition
disorder NCT03920241 163 171 I-Condition
or NCT03920241 172 174 B-Or
substance NCT03920241 175 184 B-Condition
abuse NCT03920241 185 190 B-Modifier
/ NCT03920241 191 192 B-Or
dependence NCT03920241 193 203 B-Modifier
. NCT03920241 204 205 O

- NCT03920241 209 210 O
Being NCT03920241 212 217 O
currently NCT03920241 218 227 B-Eq_Comparison
enrolled NCT03920241 228 236 O
in NCT03920241 237 239 O
another NCT03920241 240 247 O
standardized NCT03920241 248 260 O
meditation NCT03920241 261 271 B-Procedure
program NCT03920241 272 279 I-Procedure

Inclusion NCT03934424 0 9 O
Criteria NCT03934424 10 18 O
: NCT03934424 19 20 O

- NCT03934424 24 25 O
Generally NCT03934424 27 36 O
healthy NCT03934424 37 44 B-Condition
individuals NCT03934424 45 56 O
aged NCT03934424 57 61 B-Age
from NCT03934424 62 66 O
18 NCT03934424 67 69 B-Eq_Comparison
to NCT03934424 70 72 I-Eq_Comparison
55 NCT03934424 73 75 I-Eq_Comparison
years NCT03934424 76 81 I-Eq_Comparison

- NCT03934424 84 85 O
BMI NCT03934424 87 90 B-Observation
25 NCT03934424 91 93 B-Eq_Comparison
- NCT03934424 94 95 I-Eq_Comparison
35 NCT03934424 96 98 I-Eq_Comparison
kg NCT03934424 99 101 I-Eq_Comparison
/ NCT03934424 102 103 I-Eq_Comparison
m NCT03934424 104 105 I-Eq_Comparison
2 NCT03934424 106 107 I-Eq_Comparison
will NCT03934424 108 112 O
be NCT03934424 113 115 O
recruited NCT03934424 116 125 O

Exclusion NCT03934424 126 135 O
Criteria NCT03934424 136 144 O
: NCT03934424 145 146 O

- NCT03934424 150 151 O
Being NCT03934424 153 158 B-Eq_Comparison
on NCT03934424 159 161 O
a NCT03934424 162 163 O
weight NCT03934424 164 170 B-Modifier
- NCT03934424 171 172 I-Modifier
loss NCT03934424 173 177 I-Modifier
or NCT03934424 178 180 B-Or
special NCT03934424 181 188 B-Modifier
diet NCT03934424 189 193 B-Procedure

- NCT03934424 196 197 O
Taking NCT03934424 199 205 B-Eq_Comparison
any NCT03934424 206 209 O
medications NCT03934424 210 221 B-Drug
or NCT03934424 222 224 B-Or
drugs NCT03934424 225 230 B-Drug
known NCT03934424 231 236 O
to NCT03934424 237 239 O
affect NCT03934424 240 246 O
appetite NCT03934424 247 255 B-Condition

- NCT03934424 258 259 O
Have NCT03934424 261 265 O
serious NCT03934424 266 273 O
claustrophobia NCT03934424 274 288 B-Condition
. NCT03934424 289 290 O

- NCT03934424 294 295 O
Individuals NCT03934424 297 308 O
with NCT03934424 309 313 O
mental NCT03934424 314 320 B-Condition
disorders NCT03934424 321 330 I-Condition
( NCT03934424 331 332 O
self NCT03934424 333 337 B-Assertion___Assertion_Type_Value:possible
- NCT03934424 338 339 I-Assertion___Assertion_Type_Value:possible
report NCT03934424 340 346 I-Assertion___Assertion_Type_Value:possible
) NCT03934424 347 348 O
will NCT03934424 349 353 O
be NCT03934424 354 356 O
excluded NCT03934424 357 365 B-Negation
. NCT03934424 366 367 O

- NCT03934424 371 372 O
Due NCT03934424 374 377 O
to NCT03934424 378 380 O
MRI NCT03934424 381 384 B-Procedure
, NCT03934424 385 386 O
any NCT03934424 387 390 O
individuals NCT03934424 391 402 O
with NCT03934424 403 407 O
metallic NCT03934424 408 416 B-Condition
objects NCT03934424 417 424 I-Condition
in NCT03934424 425 427 I-Condition
their NCT03934424 428 433 I-Condition
body NCT03934424 434 438 I-Condition
, NCT03934424 439 440 O
including NCT03934424 441 450 O
surgical NCT03934424 451 459 B-Condition
staples NCT03934424 460 467 I-Condition
left NCT03934424 468 472 I-Condition
in NCT03934424 473 475 I-Condition
the NCT03934424 476 479 I-Condition
body NCT03934424 480 484 I-Condition
following NCT03934424 485 494 B-Temporal_Connection___Temporal_Connection_Type_Value:after
surgery NCT03934424 495 502 B-Procedure
, NCT03934424 503 504 O
middle NCT03934424 505 511 B-Condition
ear NCT03934424 512 515 I-Condition
prosthesis NCT03934424 516 526 I-Condition
, NCT03934424 527 528 O
permanent NCT03934424 529 538 B-Condition
eye NCT03934424 539 542 I-Condition
liner NCT03934424 543 548 I-Condition
, NCT03934424 549 550 O
metal NCT03934424 551 556 B-Condition
foreign NCT03934424 557 564 I-Condition
objects NCT03934424 565 572 I-Condition
lodged NCT03934424 573 579 I-Condition
inside NCT03934424 580 586 I-Condition
the NCT03934424 587 590 I-Condition
eye NCT03934424 591 594 I-Condition
, NCT03934424 595 596 O
heart NCT03934424 597 602 B-Condition
pacemakers NCT03934424 603 613 I-Condition
, NCT03934424 614 615 O
and NCT03934424 616 619 B-Or
/ NCT03934424 620 621 I-Or
or NCT03934424 622 624 I-Or
pins NCT03934424 625 629 B-Condition
inside NCT03934424 630 636 I-Condition
the NCT03934424 637 640 O
knee NCT03934424 641 645 B-Modifier
or NCT03934424 646 648 B-Or
other NCT03934424 649 654 B-Modifier
joints NCT03934424 655 661 I-Modifier
or NCT03934424 662 664 B-Or
who NCT03934424 665 668 O
are NCT03934424 669 672 O
pregnant NCT03934424 673 681 B-Condition
or NCT03934424 682 684 B-Or
could NCT03934424 685 690 B-Assertion___Assertion_Type_Value:possible
be NCT03934424 691 693 I-Assertion___Assertion_Type_Value:possible
pregnant NCT03934424 694 702 B-Condition
( NCT03934424 703 704 O
assessed NCT03934424 705 713 O
through NCT03934424 714 721 O
a NCT03934424 722 723 O
urine NCT03934424 724 729 B-Observation
pregnancy NCT03934424 730 739 I-Observation
test NCT03934424 740 744 I-Observation
for NCT03934424 745 748 O
women NCT03934424 749 754 O
) NCT03934424 755 756 O
will NCT03934424 757 761 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03934424 762 764 I-Assertion___Assertion_Type_Value:hypothetical
excluded NCT03934424 765 773 B-Negation
from NCT03934424 774 778 O
this NCT03934424 779 783 O
study NCT03934424 784 789 B-Study
because NCT03934424 790 797 O
of NCT03934424 798 800 O
the NCT03934424 801 804 O
risk NCT03934424 805 809 B-Risk
associated NCT03934424 810 820 B-Assertion___Assertion_Type_Value:hypothetical
with NCT03934424 821 825 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03934424 826 829 O
MRI NCT03934424 830 833 B-Procedure
scanner NCT03934424 834 841 O
. NCT03934424 842 843 O

Inclusion NCT03867214 0 9 O
Criteria NCT03867214 10 18 O
: NCT03867214 19 20 O

- NCT03867214 24 25 O
Adult NCT03867214 27 32 O
patients NCT03867214 33 41 O
who NCT03867214 42 45 B-And
plan NCT03867214 46 50 B-Assertion___Assertion_Type_Value:intention
to NCT03867214 51 53 I-Assertion___Assertion_Type_Value:intention
undergo NCT03867214 54 61 O
simultaneous NCT03867214 62 74 B-Modifier
primary NCT03867214 75 82 I-Modifier
total NCT03867214 83 88 B-Procedure
knee NCT03867214 89 93 I-Procedure
arthroplasty NCT03867214 94 106 I-Procedure
on NCT03867214 107 109 O
bilateral NCT03867214 110 119 B-Modifier
knee NCT03867214 120 124 I-Modifier
joint NCT03867214 125 130 I-Modifier
with NCT03867214 131 135 B-And
a NCT03867214 136 137 O
diagnosis NCT03867214 138 147 O
of NCT03867214 148 150 O
osteoarthritis NCT03867214 151 165 B-Condition
or NCT03867214 166 168 B-Or
aseptic NCT03867214 169 176 B-Condition
bone NCT03867214 177 181 I-Condition
necrosis NCT03867214 182 190 I-Condition
, NCT03867214 191 192 O
but NCT03867214 193 196 B-And
not NCT03867214 197 200 B-Negation
of NCT03867214 201 203 O
rheumatoid NCT03867214 204 214 B-Condition
arthritis NCT03867214 215 224 I-Condition
; NCT03867214 224 225 O

- NCT03867214 228 229 O
All NCT03867214 231 234 O
patients NCT03867214 235 243 O
who NCT03867214 244 247 O
have NCT03867214 248 252 O
normal NCT03867214 253 259 O
pre NCT03867214 260 263 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03867214 264 273 B-Procedure
platelet NCT03867214 274 282 B-Observation
count NCT03867214 283 288 I-Observation
, NCT03867214 289 290 O
normal NCT03867214 291 297 O
prothrombin NCT03867214 298 309 B-Observation
time NCT03867214 310 314 I-Observation
, NCT03867214 315 316 O
normal NCT03867214 317 323 O
partial NCT03867214 324 331 B-Observation
thromboplastin NCT03867214 332 346 I-Observation
time NCT03867214 347 351 I-Observation
, NCT03867214 352 353 O
and NCT03867214 354 357 B-And
normal NCT03867214 358 364 O
international NCT03867214 365 378 B-Observation
normalized NCT03867214 379 389 I-Observation
ratio NCT03867214 390 395 I-Observation
; NCT03867214 395 396 O

- NCT03867214 399 400 O
The NCT03867214 402 405 O
use NCT03867214 406 409 O
of NCT03867214 410 412 O
only NCT03867214 413 417 O
balanced NCT03867214 418 426 B-Drug
electrolyte NCT03867214 427 438 I-Drug
solutions NCT03867214 439 448 I-Drug
and NCT03867214 449 452 B-Or
/ NCT03867214 453 454 I-Or
or NCT03867214 455 457 I-Or
albumin NCT03867214 458 465 B-Observation
for NCT03867214 466 469 O
plasma NCT03867214 470 476 B-Procedure
volume NCT03867214 477 483 I-Procedure
restitution NCT03867214 484 495 I-Procedure
. NCT03867214 496 497 O

Exclusion NCT03867214 499 508 O
Criteria NCT03867214 509 517 O
: NCT03867214 518 519 O

- NCT03867214 523 524 O
Allergy NCT03867214 526 533 B-Allergy
to NCT03867214 534 536 O
tranexamic NCT03867214 537 547 B-Drug
acid NCT03867214 548 552 I-Drug
; NCT03867214 552 553 O

- NCT03867214 556 557 O
Receiving NCT03867214 559 568 B-Eq_Comparison
warfarin NCT03867214 569 577 B-Drug
or NCT03867214 578 580 B-Or
heparin NCT03867214 581 588 B-Drug
; NCT03867214 588 589 O
had NCT03867214 590 593 O
a NCT03867214 594 595 O
history NCT03867214 596 603 B-Eq_Comparison
of NCT03867214 604 606 O
hemophilia NCT03867214 607 617 B-Condition
, NCT03867214 618 619 O
deep NCT03867214 620 624 B-Condition
venous NCT03867214 625 631 I-Condition
thrombosis NCT03867214 632 642 I-Condition
, NCT03867214 643 644 O
pulmonary NCT03867214 645 654 B-Condition
embolism NCT03867214 655 663 I-Condition
, NCT03867214 664 665 O
or NCT03867214 666 668 B-Or
renal NCT03867214 669 674 B-Condition
impairment NCT03867214 675 685 I-Condition
; NCT03867214 685 686 O
or NCT03867214 687 689 B-Or
were NCT03867214 690 694 B-Eq_Comparison
pregnant NCT03867214 695 703 B-Condition
; NCT03867214 703 704 O

- NCT03867214 707 708 O
Patients NCT03867214 710 718 O
with NCT03867214 719 723 O
any NCT03867214 724 727 O
cardiovascular NCT03867214 728 742 B-Condition
problems NCT03867214 743 751 I-Condition
( NCT03867214 752 753 O
such NCT03867214 754 758 O
as NCT03867214 759 761 O
myocardiac NCT03867214 762 772 B-Condition
infarction NCT03867214 773 783 I-Condition
history NCT03867214 784 791 B-Eq_Comparison
, NCT03867214 792 793 O
atrial NCT03867214 794 800 B-Condition
fibrillation NCT03867214 801 813 I-Condition
, NCT03867214 814 815 O
angina NCT03867214 816 822 B-Condition
) NCT03867214 823 824 O
; NCT03867214 825 826 O

- NCT03867214 829 830 O
Patients NCT03867214 832 840 O
with NCT03867214 841 845 O
thromboembolic NCT03867214 846 860 B-Condition
disorders NCT03867214 861 870 I-Condition
, NCT03867214 871 872 O
or NCT03867214 873 875 B-Or
those NCT03867214 876 881 O
exhibiting NCT03867214 882 892 O
a NCT03867214 893 894 O
deteriorating NCT03867214 895 908 O
general NCT03867214 909 916 B-Condition
condition NCT03867214 917 926 I-Condition
; NCT03867214 926 927 O

- NCT03867214 930 931 O
Pre NCT03867214 933 936 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03867214 937 946 B-Procedure
anemia NCT03867214 947 953 B-Condition
( NCT03867214 954 955 O
a NCT03867214 956 957 O
hemoglobin NCT03867214 958 968 B-Observation
value NCT03867214 969 974 O
of NCT03867214 975 977 O
< NCT03867214 978 979 B-Eq_Comparison
11 NCT03867214 980 982 I-Eq_Comparison
g NCT03867214 983 984 I-Eq_Comparison
/ NCT03867214 985 986 I-Eq_Comparison
dL NCT03867214 987 989 I-Eq_Comparison
in NCT03867214 990 992 O
females NCT03867214 993 1000 O
and NCT03867214 1001 1004 B-Or
< NCT03867214 1005 1006 B-Eq_Comparison
12 NCT03867214 1007 1009 I-Eq_Comparison
g NCT03867214 1010 1011 I-Eq_Comparison
/ NCT03867214 1012 1013 I-Eq_Comparison
dL NCT03867214 1014 1016 I-Eq_Comparison
in NCT03867214 1017 1019 O
males NCT03867214 1020 1025 O
) NCT03867214 1026 1027 O
, NCT03867214 1028 1029 O
refusal NCT03867214 1030 1037 B-Assertion___Assertion_Type_Value:hypothetical
of NCT03867214 1038 1040 O
blood NCT03867214 1041 1046 B-Procedure
products NCT03867214 1047 1055 I-Procedure
; NCT03867214 1055 1056 O

- NCT03867214 1059 1060 O
Pre NCT03867214 1062 1065 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03867214 1066 1075 B-Procedure
use NCT03867214 1076 1079 O
of NCT03867214 1080 1082 O
anticoagulant NCT03867214 1083 1096 B-Procedure
therapy NCT03867214 1097 1104 I-Procedure
within NCT03867214 1105 1111 B-Eq_Comparison
five NCT03867214 1112 1116 I-Eq_Comparison
days NCT03867214 1117 1121 I-Eq_Comparison
before NCT03867214 1122 1128 B-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03867214 1129 1136 B-Procedure
, NCT03867214 1137 1138 O
fibrinolytic NCT03867214 1139 1151 B-Condition
disorders NCT03867214 1152 1161 I-Condition
requiring NCT03867214 1162 1171 B-Assertion___Assertion_Type_Value:hypothetical
intraoperative NCT03867214 1172 1186 O
antifibrinolytic NCT03867214 1187 1203 B-Procedure
treatment NCT03867214 1204 1213 I-Procedure
, NCT03867214 1214 1215 O
coagulopathy NCT03867214 1216 1228 B-Condition
( NCT03867214 1229 1230 O
as NCT03867214 1231 1233 O
identified NCT03867214 1234 1244 O
by NCT03867214 1245 1247 O
a NCT03867214 1248 1249 O
pre NCT03867214 1250 1253 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03867214 1254 1263 B-Procedure
platelet NCT03867214 1264 1272 B-Observation
count NCT03867214 1273 1278 I-Observation
of NCT03867214 1279 1281 O
< NCT03867214 1282 1283 B-Eq_Comparison
150 NCT03867214 1284 1287 I-Eq_Comparison
, NCT03867214 1288 1289 I-Eq_Comparison
000 NCT03867214 1290 1293 I-Eq_Comparison
/ NCT03867214 1294 1295 I-Eq_Comparison
mm NCT03867214 1296 1298 I-Eq_Comparison
3 NCT03867214 1299 1300 I-Eq_Comparison
, NCT03867214 1301 1302 O
an NCT03867214 1303 1305 O
international NCT03867214 1306 1319 B-Observation
normalized NCT03867214 1320 1330 I-Observation
ratio NCT03867214 1331 1336 I-Observation
of NCT03867214 1337 1339 O
> NCT03867214 1340 1341 B-Eq_Comparison
1.4 NCT03867214 1342 1345 I-Eq_Comparison
, NCT03867214 1346 1347 O
or NCT03867214 1348 1350 O
a NCT03867214 1351 1352 O
prolonged NCT03867214 1353 1362 O
partial NCT03867214 1363 1370 B-Observation
thromboplastin NCT03867214 1371 1385 I-Observation
time NCT03867214 1386 1390 I-Observation
[ NCT03867214 1391 1392 O
> NCT03867214 1393 1394 B-Eq_Comparison
1.4 NCT03867214 1395 1398 I-Eq_Comparison
times NCT03867214 1399 1404 I-Eq_Comparison
normal NCT03867214 1405 1411 I-Eq_Comparison
] NCT03867214 1412 1413 O
) NCT03867214 1414 1415 O
. NCT03867214 1416 1417 O

Inclusion NCT03863548 0 9 O
Criteria NCT03863548 10 18 O
: NCT03863548 19 20 O

- NCT03863548 24 25 O
person NCT03863548 27 33 O
who NCT03863548 34 37 O
has NCT03863548 38 41 O
expressed NCT03863548 42 51 O
willingness NCT03863548 52 63 O
to NCT03863548 64 66 O
participate NCT03863548 67 78 O

- NCT03863548 81 82 O
person NCT03863548 84 90 O
over NCT03863548 91 95 B-Eq_Comparison
18 NCT03863548 96 98 I-Eq_Comparison
years NCT03863548 99 104 I-Eq_Comparison
of NCT03863548 105 107 O
age NCT03863548 108 111 B-Age

- NCT03863548 114 115 O
person NCT03863548 117 123 O
with NCT03863548 124 128 O
a NCT03863548 129 130 O
retinal NCT03863548 131 138 B-Condition
- NCT03863548 139 140 I-Condition
vitreous NCT03863548 141 149 I-Condition
condition NCT03863548 150 159 I-Condition
requiring NCT03863548 160 169 B-Assertion___Assertion_Type_Value:hypothetical
scheduled NCT03863548 170 179 B-Eq_Comparison
surgery NCT03863548 180 187 B-Procedure
( NCT03863548 188 189 O
epi NCT03863548 190 193 B-Procedure
- NCT03863548 194 195 I-Procedure
retinal NCT03863548 196 203 I-Procedure
membrane NCT03863548 204 212 I-Procedure
surgery NCT03863548 213 220 I-Procedure
, NCT03863548 221 222 O
vitreous NCT03863548 223 231 B-Procedure
traction NCT03863548 232 240 I-Procedure
surgery NCT03863548 241 248 I-Procedure
, NCT03863548 249 250 O
macular NCT03863548 251 258 B-Procedure
hole NCT03863548 259 263 I-Procedure
surgery NCT03863548 264 271 I-Procedure
) NCT03863548 272 273 O
. NCT03863548 274 275 O

Exclusion NCT03863548 277 286 O
Criteria NCT03863548 287 295 O
: NCT03863548 296 297 O

- NCT03863548 301 302 O
person NCT03863548 304 310 O
subject NCT03863548 311 318 O
to NCT03863548 319 321 O
legal NCT03863548 322 327 B-Observation
protection NCT03863548 328 338 I-Observation
( NCT03863548 339 340 O
curatorship NCT03863548 341 352 O
, NCT03863548 353 354 O
guardianship NCT03863548 355 367 O
) NCT03863548 368 369 O

- NCT03863548 373 374 O
person NCT03863548 376 382 O
deemed NCT03863548 383 389 O
mentally NCT03863548 390 398 B-Condition
incompetent NCT03863548 399 410 I-Condition

- NCT03863548 413 414 O
pregnant NCT03863548 416 424 B-Condition
, NCT03863548 425 426 O
parturient NCT03863548 427 437 B-Condition
or NCT03863548 438 440 B-Or
breastfeeding NCT03863548 441 454 B-Condition
woman NCT03863548 455 460 O

- NCT03863548 463 464 O
adult NCT03863548 466 471 O
unwilling NCT03863548 472 481 O
or NCT03863548 482 484 O
unable NCT03863548 485 491 O
to NCT03863548 492 494 O
consent NCT03863548 495 502 O

- NCT03863548 505 506 O
patient NCT03863548 508 515 O
who NCT03863548 516 519 O
has NCT03863548 520 523 O
already NCT03863548 524 531 B-Eq_Comparison
participated NCT03863548 532 544 I-Eq_Comparison
in NCT03863548 545 547 O
the NCT03863548 548 551 O
study NCT03863548 552 557 B-Study

- NCT03863548 560 561 O
person NCT03863548 563 569 O
with NCT03863548 570 574 O
a NCT03863548 575 576 O
physical NCT03863548 577 585 B-Modifier
or NCT03863548 586 588 B-Or
mental NCT03863548 589 595 B-Modifier
disability NCT03863548 596 606 B-Condition
that NCT03863548 607 611 O
does NCT03863548 612 616 O
not NCT03863548 617 620 B-Negation
allow NCT03863548 621 626 O
participation NCT03863548 627 640 O
. NCT03863548 641 642 O

- NCT03863548 646 647 O
a NCT03863548 649 650 O
person NCT03863548 651 657 O
who NCT03863548 658 661 O
has NCT03863548 662 665 O
participated NCT03863548 666 678 O
in NCT03863548 679 681 O
any NCT03863548 682 685 O
study NCT03863548 686 691 B-Study
of NCT03863548 692 694 O
an NCT03863548 695 697 O
experimental NCT03863548 698 710 O
medical NCT03863548 711 718 O
product NCT03863548 719 726 B-Drug
within NCT03863548 727 733 B-Eq_Comparison
the NCT03863548 734 737 I-Eq_Comparison
previous NCT03863548 738 746 I-Eq_Comparison
3 NCT03863548 747 748 I-Eq_Comparison
months NCT03863548 749 755 I-Eq_Comparison

- NCT03863548 758 759 O
person NCT03863548 761 767 O
who NCT03863548 768 771 O
experiences NCT03863548 772 783 O
any NCT03863548 784 787 O
of NCT03863548 788 790 O
the NCT03863548 791 794 B-Criteria_Count
following NCT03863548 795 804 I-Criteria_Count
during NCT03863548 805 811 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03863548 812 815 O
ophthalmological NCT03863548 816 832 B-Procedure
examination NCT03863548 833 844 I-Procedure
: NCT03863548 845 846 O

- NCT03863548 855 856 O
severe NCT03863548 858 864 O
or NCT03863548 865 867 B-Or
proliferating NCT03863548 868 881 B-Modifier
diabetic NCT03863548 882 890 B-Condition
retinopathy NCT03863548 891 902 I-Condition

- NCT03863548 910 911 O
intra NCT03863548 913 918 B-Modifier
- NCT03863548 919 920 I-Modifier
vitreal NCT03863548 921 928 I-Modifier
hemorrhage NCT03863548 929 939 B-Condition

- NCT03863548 947 948 O
tractional NCT03863548 950 960 B-Condition
retinal NCT03863548 961 968 I-Condition
detachment NCT03863548 969 979 I-Condition

- NCT03863548 987 988 O
subretinal NCT03863548 990 1000 B-Modifier
or NCT03863548 1001 1003 B-Or
retrohyaloidal NCT03863548 1004 1018 B-Modifier
hematoma NCT03863548 1019 1027 B-Condition
. NCT03863548 1028 1029 O

Inclusion NCT03928678 0 9 O
Criteria NCT03928678 10 18 O
: NCT03928678 19 20 O

- NCT03928678 24 25 O
Age NCT03928678 27 30 B-Age
≤ NCT03928678 31 32 B-Eq_Comparison
60 NCT03928678 33 35 I-Eq_Comparison
years NCT03928678 36 41 I-Eq_Comparison
, NCT03928678 42 43 O

- NCT03928678 47 48 O
Good NCT03928678 50 54 O
nutrition NCT03928678 55 64 O
, NCT03928678 65 66 O

- NCT03928678 70 71 O
No NCT03928678 73 75 B-Negation
systemic NCT03928678 76 84 B-Condition
infection NCT03928678 85 94 I-Condition
and NCT03928678 95 98 B-And

- NCT03928678 101 102 O
Elective NCT03928678 104 112 O
laparoscopic NCT03928678 113 125 B-Procedure
surgery NCT03928678 126 133 I-Procedure

Exclusion NCT03928678 134 143 O
Criteria NCT03928678 144 152 O
: NCT03928678 153 154 O

- NCT03928678 158 159 O
Age NCT03928678 161 164 B-Age
> NCT03928678 165 166 B-Eq_Comparison
75 NCT03928678 167 169 I-Eq_Comparison
years NCT03928678 170 175 I-Eq_Comparison
, NCT03928678 176 177 O

- NCT03928678 181 182 O
Malnutrition NCT03928678 184 196 B-Condition
or NCT03928678 197 199 B-Or
an NCT03928678 200 202 O
organ NCT03928678 203 208 B-Condition
system NCT03928678 209 215 I-Condition
infection NCT03928678 216 225 I-Condition

- NCT03928678 228 229 O
Associated NCT03928678 231 241 O
with NCT03928678 242 246 O
obstruction NCT03928678 247 258 B-Condition
, NCT03928678 259 260 O
bleeding NCT03928678 261 269 B-Condition
, NCT03928678 270 271 O
emergency NCT03928678 272 281 B-Procedure
surgery NCT03928678 282 289 I-Procedure
or NCT03928678 290 292 B-Or
other NCT03928678 293 298 O
surgical NCT03928678 299 307 B-Procedure
intervention NCT03928678 308 320 I-Procedure

- NCT03928678 323 324 O
Tumor NCT03928678 326 331 B-Condition
with NCT03928678 332 336 I-Condition
extensive NCT03928678 337 346 I-Condition
metastasis NCT03928678 347 357 I-Condition

- NCT03928678 360 361 O
Prior NCT03928678 363 368 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03928678 369 371 I-Temporal_Connection___Temporal_Connection_Type_Value:before
surgery NCT03928678 372 379 B-Procedure
, NCT03928678 380 381 O
patient NCT03928678 382 389 O
was NCT03928678 390 393 O
fasting NCT03928678 394 401 B-Observation
, NCT03928678 402 403 O
underwent NCT03928678 404 413 B-Eq_Comparison
gastrointestinal NCT03928678 414 430 B-Procedure
decompression NCT03928678 431 444 I-Procedure
and NCT03928678 445 448 B-And
received NCT03928678 449 457 B-Eq_Comparison
nutritional NCT03928678 458 469 B-Procedure
support NCT03928678 470 477 I-Procedure

- NCT03928678 480 481 O
Previous NCT03928678 483 491 B-Eq_Comparison
history NCT03928678 492 499 I-Eq_Comparison
of NCT03928678 500 502 O
abdominal NCT03928678 503 512 B-Procedure
surgery NCT03928678 513 520 I-Procedure

- NCT03928678 523 524 O
Patient NCT03928678 526 533 O
have NCT03928678 534 538 O
previously NCT03928678 539 549 B-Eq_Comparison
undergone NCT03928678 550 559 I-Eq_Comparison
gastrostomy NCT03928678 560 571 B-Procedure

Inclusion NCT03931772 0 9 O
Criteria NCT03931772 10 18 O
: NCT03931772 19 20 O

- NCT03931772 24 25 O
18 NCT03931772 27 29 B-Eq_Comparison
years NCT03931772 30 35 I-Eq_Comparison
or NCT03931772 36 38 I-Eq_Comparison
older NCT03931772 39 44 I-Eq_Comparison

- NCT03931772 47 48 O
Able NCT03931772 50 54 O
to NCT03931772 55 57 O
read NCT03931772 58 62 O
and NCT03931772 63 66 O
understand NCT03931772 67 77 O
English NCT03931772 78 85 O

- NCT03931772 88 89 O
Desire NCT03931772 91 97 B-Assertion___Assertion_Type_Value:intention
to NCT03931772 98 100 I-Assertion___Assertion_Type_Value:intention
quit NCT03931772 101 105 B-Condition
smoking NCT03931772 106 113 I-Condition
( NCT03931772 114 115 O
specifically NCT03931772 116 128 O
, NCT03931772 129 130 O
report NCT03931772 131 137 O
a NCT03931772 138 139 O
motivation NCT03931772 140 150 B-Modifier
of NCT03931772 151 153 O
≥ NCT03931772 154 155 B-Eq_Comparison
5 NCT03931772 156 157 I-Eq_Comparison
out NCT03931772 158 161 I-Eq_Comparison
of NCT03931772 162 164 I-Eq_Comparison
10 NCT03931772 165 167 I-Eq_Comparison
to NCT03931772 168 170 O
quit NCT03931772 171 175 B-Observation
smoking NCT03931772 176 183 I-Observation
on NCT03931772 184 186 O
a NCT03931772 187 188 O
10 NCT03931772 189 191 B-Modifier
- NCT03931772 192 193 I-Modifier
point NCT03931772 194 199 I-Modifier
Likert NCT03931772 200 206 I-Modifier
- NCT03931772 207 208 I-Modifier
type NCT03931772 209 213 I-Modifier
scale NCT03931772 214 219 I-Modifier
) NCT03931772 220 221 O

- NCT03931772 225 226 O
Having NCT03931772 228 234 O
access NCT03931772 235 241 O
to NCT03931772 242 244 O
wireless NCT03931772 245 253 O
internet NCT03931772 254 262 O
connection NCT03931772 263 273 O
or NCT03931772 274 276 O
mobile NCT03931772 277 283 O
data NCT03931772 284 288 O

- NCT03931772 291 292 O
Reporting NCT03931772 294 303 O
being NCT03931772 304 309 O
a NCT03931772 310 311 O
daily NCT03931772 312 317 B-Eq_Comparison
smoker NCT03931772 318 324 B-Condition
for NCT03931772 325 328 O
at NCT03931772 329 331 B-Eq_Comparison
least NCT03931772 332 337 I-Eq_Comparison
one NCT03931772 338 341 I-Eq_Comparison
year NCT03931772 342 346 I-Eq_Comparison
, NCT03931772 347 348 O
smoking NCT03931772 349 356 B-Observation
an NCT03931772 357 359 O
average NCT03931772 360 367 B-Eq_Comparison
≥ NCT03931772 368 369 I-Eq_Comparison
5 NCT03931772 370 371 I-Eq_Comparison
cigarettes NCT03931772 372 382 I-Eq_Comparison
per NCT03931772 383 386 I-Eq_Comparison
day NCT03931772 387 390 I-Eq_Comparison

Exclusion NCT03931772 391 400 O
Criteria NCT03931772 401 409 O
: NCT03931772 410 411 O

- NCT03931772 415 416 O
Meeting NCT03931772 418 425 O
criteria NCT03931772 426 434 O
for NCT03931772 435 438 O
drug NCT03931772 439 443 B-Condition
abuse NCT03931772 444 449 I-Condition
of NCT03931772 450 452 O
depressants NCT03931772 453 464 B-Drug
, NCT03931772 465 466 O
dissociative NCT03931772 467 479 B-Drug
anesthetics NCT03931772 480 491 I-Drug
, NCT03931772 492 493 O
hallucinogens NCT03931772 494 507 B-Drug
, NCT03931772 508 509 O
opioids NCT03931772 510 517 B-Drug
, NCT03931772 518 519 O
cocaine NCT03931772 520 527 B-Drug
, NCT03931772 528 529 O
or NCT03931772 530 532 O
amphetamine NCT03931772 533 544 B-Drug
within NCT03931772 545 551 B-Eq_Comparison
the NCT03931772 552 555 I-Eq_Comparison
last NCT03931772 556 560 I-Eq_Comparison
3 NCT03931772 561 562 I-Eq_Comparison
months NCT03931772 563 569 I-Eq_Comparison
. NCT03931772 570 571 O

- NCT03931772 575 576 O
Severe NCT03931772 578 584 O
psychiatric NCT03931772 585 596 B-Modifier
or NCT03931772 597 599 B-Or
structural NCT03931772 600 610 B-Modifier
brain NCT03931772 611 616 B-Condition
disease NCT03931772 617 624 I-Condition
( NCT03931772 625 626 O
i NCT03931772 627 628 O
. NCT03931772 629 630 O
e NCT03931772 631 632 O
. NCT03931772 633 634 O
psychosis NCT03931772 636 645 B-Condition
, NCT03931772 646 647 O
stroke NCT03931772 648 654 B-Condition
with NCT03931772 655 659 B-And
functional NCT03931772 660 670 B-Condition
impairment NCT03931772 671 681 I-Condition
, NCT03931772 682 683 O
dementia NCT03931772 684 692 B-Condition
) NCT03931772 693 694 O
or NCT03931772 695 697 B-Or
[ NCT03931772 698 699 O
current NCT03931772 700 707 B-Eq_Comparison
/ NCT03931772 708 709 B-Or
recent NCT03931772 710 716 B-Eq_Comparison
risk NCT03931772 717 721 B-Condition
to NCT03931772 722 724 I-Condition
self NCT03931772 725 729 I-Condition
. NCT03931772 730 731 O
Indicated NCT03931772 733 742 O
by NCT03931772 743 745 O
denial NCT03931772 746 752 O
of NCT03931772 753 755 O
question NCT03931772 756 764 O
pertaining NCT03931772 765 775 O
to NCT03931772 776 778 O
inpatient NCT03931772 779 788 B-Encounter
hospitalization NCT03931772 789 804 I-Encounter

- NCT03931772 807 808 O
Hearing NCT03931772 810 817 B-Condition
impairment NCT03931772 818 828 I-Condition
that NCT03931772 829 833 O
would NCT03931772 834 839 B-Assertion___Assertion_Type_Value:hypothetical
impede NCT03931772 840 846 O
ability NCT03931772 847 854 O
to NCT03931772 855 857 O
listen NCT03931772 858 864 O
the NCT03931772 865 868 O
auditory NCT03931772 869 877 B-Modifier
intervention NCT03931772 878 890 B-Study

- NCT03931772 893 894 O
Major NCT03931772 896 901 O
illnesses NCT03931772 902 911 B-Condition
impacting NCT03931772 912 921 B-Assertion___Assertion_Type_Value:hypothetical
the NCT03931772 922 925 O
study NCT03931772 926 931 B-Study
results NCT03931772 932 939 O

- NCT03931772 942 943 O
Currently NCT03931772 945 954 B-Eq_Comparison
taking NCT03931772 955 961 I-Eq_Comparison
Wellbutrin NCT03931772 962 972 B-Drug
, NCT03931772 973 974 O
Chantix NCT03931772 975 982 B-Drug
, NCT03931772 983 984 O
or NCT03931772 985 987 B-Or
other NCT03931772 988 993 O
pharmacological NCT03931772 994 1009 O
smoking NCT03931772 1010 1017 B-Drug
cessation NCT03931772 1018 1027 I-Drug
aids NCT03931772 1028 1032 I-Drug
that NCT03931772 1033 1037 O
could NCT03931772 1038 1043 B-Assertion___Assertion_Type_Value:hypothetical
confound NCT03931772 1044 1052 O
results NCT03931772 1053 1060 O
of NCT03931772 1061 1063 O
the NCT03931772 1064 1067 O
study NCT03931772 1068 1073 B-Study

Inclusion NCT03869788 0 9 O
Criteria NCT03869788 10 18 O
: NCT03869788 19 20 O

- NCT03869788 24 25 O
vague NCT03869788 27 32 B-Modifier
gastrointestinal NCT03869788 33 49 B-Condition
disturbances NCT03869788 50 62 I-Condition
. NCT03869788 63 64 O

- NCT03869788 68 69 O
intermittent NCT03869788 71 83 B-Modifier
eosinophilia NCT03869788 84 96 B-Condition
. NCT03869788 97 98 O

- NCT03869788 102 103 O
biliary NCT03869788 105 112 B-Condition
obstruction NCT03869788 113 124 I-Condition
. NCT03869788 125 126 O

- NCT03869788 130 131 O
biliary NCT03869788 133 140 B-Condition
colic NCT03869788 141 146 I-Condition
pain NCT03869788 147 151 I-Condition
. NCT03869788 152 153 O

- NCT03869788 157 158 O
intermittent NCT03869788 160 172 B-Modifier
jaundice NCT03869788 173 181 B-Condition
. NCT03869788 182 183 O

- NCT03869788 187 188 O
right NCT03869788 190 195 B-Modifier
upper NCT03869788 196 201 I-Modifier
- NCT03869788 202 203 I-Modifier
quadrant NCT03869788 204 212 I-Modifier
abdominal NCT03869788 213 222 B-Condition
tenderness NCT03869788 223 233 I-Condition
. NCT03869788 234 235 O

Exclusion NCT03869788 237 246 O
Criteria NCT03869788 247 255 O
: NCT03869788 256 257 O

- NCT03869788 261 262 O
no NCT03869788 264 266 O
exclusion NCT03869788 267 276 O
Criteria NCT03869788 277 285 O

Inclusion NCT03866486 0 9 O
Criteria NCT03866486 10 18 O
: NCT03866486 19 20 O

- NCT03866486 24 25 O
1 NCT03866486 27 28 O
. NCT03866486 28 29 O
The NCT03866486 31 34 O
patients NCT03866486 35 43 O
who NCT03866486 44 47 O
enrolled NCT03866486 48 56 O
in NCT03866486 57 59 O
the NCT03866486 60 63 O
XPL NCT03866486 64 67 O
- NCT03866486 68 69 O
IVUS NCT03866486 70 74 O
study NCT03866486 75 80 B-Study
. NCT03866486 81 82 O

- NCT03866486 86 87 O
2 NCT03866486 89 90 O
. NCT03866486 90 91 O
Provision NCT03866486 93 102 O
of NCT03866486 103 105 O
informed NCT03866486 106 114 O
consent NCT03866486 115 122 O

Exclusion NCT03866486 123 132 O
Criteria NCT03866486 133 141 O
: NCT03866486 142 143 O

- NCT03866486 147 148 O
1 NCT03866486 150 151 O
. NCT03866486 151 152 O
This NCT03866486 154 158 O
observational NCT03866486 159 172 O
study NCT03866486 173 178 B-Study
does NCT03866486 179 183 O
not NCT03866486 184 187 O
have NCT03866486 188 192 O
any NCT03866486 193 196 O
specific NCT03866486 197 205 O
exclusion NCT03866486 206 215 O
criteria NCT03866486 216 224 O
. NCT03866486 225 226 O

Inclusion NCT03860389 0 9 O
Criteria NCT03860389 10 18 O
: NCT03860389 19 20 O

- NCT03860389 24 25 O
Diagnosis NCT03860389 27 36 O
of NCT03860389 37 39 O
autism NCT03860389 40 46 B-Condition
spectrum NCT03860389 47 55 I-Condition
disorder NCT03860389 56 64 I-Condition

Exclusion NCT03860389 65 74 O
Criteria NCT03860389 75 83 O
: NCT03860389 84 85 O

- NCT03860389 89 90 O
Any NCT03860389 92 95 O
medical NCT03860389 96 103 B-Condition
condition NCT03860389 104 113 I-Condition
which NCT03860389 114 119 O
excludes NCT03860389 120 128 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
the NCT03860389 129 132 O
child NCT03860389 133 138 B-Family_Member___Family_Member_Type:child
from NCT03860389 139 143 O
partaking NCT03860389 144 153 O
in NCT03860389 154 156 O
exercise NCT03860389 157 165 B-Observation

Inclusion NCT03923946 0 9 O
Criteria NCT03923946 10 18 O
: NCT03923946 19 20 O

- NCT03923946 24 25 O
Eligible NCT03923946 27 35 B-Assertion___Assertion_Type_Value:hypothetical
for NCT03923946 36 39 I-Assertion___Assertion_Type_Value:hypothetical
the NCT03923946 40 43 O
early NCT03923946 44 49 B-Modifier
supported NCT03923946 50 59 I-Modifier
discharge NCT03923946 60 69 B-Encounter
pathway NCT03923946 70 77 O
this NCT03923946 78 82 O
includes NCT03923946 83 91 O
: NCT03923946 92 93 O

- NCT03923946 102 103 O
Confirmed NCT03923946 105 114 O
diagnosis NCT03923946 115 124 O
of NCT03923946 125 127 O
a NCT03923946 128 129 O
new NCT03923946 130 133 B-Eq_Comparison
stroke NCT03923946 134 140 B-Condition
. NCT03923946 141 142 O

- NCT03923946 151 152 O
Over NCT03923946 154 158 B-Eq_Comparison
18 NCT03923946 159 161 I-Eq_Comparison
Years NCT03923946 162 167 I-Eq_Comparison
old NCT03923946 168 171 B-Age
. NCT03923946 172 173 O

- NCT03923946 182 183 O
Able NCT03923946 185 189 O
to NCT03923946 190 192 O
consent NCT03923946 193 200 O
to NCT03923946 201 203 O
being NCT03923946 204 209 O
in NCT03923946 210 212 O
the NCT03923946 213 216 O
study NCT03923946 217 222 B-Study
. NCT03923946 223 224 O

- NCT03923946 233 234 O
The NCT03923946 236 239 O
patient NCT03923946 240 247 B-Family_Member___Family_Member_Type:patient
and NCT03923946 248 251 B-And
their NCT03923946 252 257 O
family NCT03923946 258 264 B-Family_Member
/ NCT03923946 265 266 O
carer NCT03923946 267 272 O
agree NCT03923946 273 278 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03923946 279 281 I-Assertion___Assertion_Type_Value:hypothetical
rehabilitation NCT03923946 282 296 B-Procedure
process NCT03923946 297 304 O
continuing NCT03923946 305 315 O
at NCT03923946 316 318 O
home NCT03923946 319 323 O
. NCT03923946 324 325 O

- NCT03923946 334 335 O
The NCT03923946 337 340 O
home NCT03923946 341 345 O
environment NCT03923946 346 357 O
is NCT03923946 358 360 O
conducive NCT03923946 361 370 O
to NCT03923946 371 373 O
the NCT03923946 374 377 O
community NCT03923946 378 387 O
- NCT03923946 388 389 O
based NCT03923946 390 395 O
rehabilitation NCT03923946 396 410 O
. NCT03923946 411 412 O

- NCT03923946 421 422 O
Achievable NCT03923946 424 434 O
rehabilitation NCT03923946 435 449 B-Procedure
goals NCT03923946 450 455 O
can NCT03923946 456 459 B-Assertion___Assertion_Type_Value:hypothetical
be NCT03923946 460 462 I-Assertion___Assertion_Type_Value:hypothetical
identified NCT03923946 463 473 O
. NCT03923946 474 475 O

- NCT03923946 484 485 O
Document NCT03923946 487 495 O
acknowledgement NCT03923946 496 511 O
that NCT03923946 512 516 O
the NCT03923946 517 520 O
patient NCT03923946 521 528 O
is NCT03923946 529 531 O
sufficiently NCT03923946 532 544 O
well NCT03923946 545 549 O
enough NCT03923946 550 556 O
from NCT03923946 557 561 O
a NCT03923946 562 563 O
medical NCT03923946 564 571 O
perspective NCT03923946 572 583 O
to NCT03923946 584 586 O
be NCT03923946 587 589 O
managed NCT03923946 590 597 O
in NCT03923946 598 600 O
the NCT03923946 601 604 O
community NCT03923946 605 614 O
. NCT03923946 615 616 O

- NCT03923946 625 626 O
The NCT03923946 628 631 O
patient NCT03923946 632 639 O
's NCT03923946 639 641 O
language NCT03923946 642 650 O
and NCT03923946 651 654 O
/ NCT03923946 655 656 O
or NCT03923946 657 659 O
cognitive NCT03923946 660 669 O
skills NCT03923946 670 676 O
are NCT03923946 677 680 O
at NCT03923946 681 683 O
a NCT03923946 684 685 O
level NCT03923946 686 691 O
for NCT03923946 692 695 O
them NCT03923946 696 700 O
to NCT03923946 701 703 O
manage NCT03923946 704 710 O
on NCT03923946 711 713 O
their NCT03923946 714 719 O
own NCT03923946 720 723 O
for NCT03923946 724 727 O
periods NCT03923946 728 735 O
as NCT03923946 736 738 O
is NCT03923946 739 741 O
necessary NCT03923946 742 751 O
. NCT03923946 752 753 O

In NCT03923946 755 757 O
addition NCT03923946 758 766 O
to NCT03923946 767 769 O
ESSD NCT03923946 770 774 B-Condition
criteria NCT03923946 775 783 O
participants NCT03923946 784 796 O
must NCT03923946 797 801 O
; NCT03923946 801 802 O

- NCT03923946 805 806 O
Have NCT03923946 808 812 O
a NCT03923946 813 814 O
good NCT03923946 815 819 O
grasp NCT03923946 820 825 O
of NCT03923946 826 828 O
the NCT03923946 829 832 O
English NCT03923946 833 840 O
language NCT03923946 841 849 O

- NCT03923946 852 853 O
Have NCT03923946 855 859 O
been NCT03923946 860 864 B-Eq_Comparison
discharged NCT03923946 865 875 B-Encounter
from NCT03923946 876 880 O
the NCT03923946 881 884 O
ESSD NCT03923946 885 889 B-Condition
pathway NCT03923946 890 897 O

Exclusion NCT03923946 898 907 O
Criteria NCT03923946 908 916 O
: NCT03923946 917 918 O

- NCT03923946 922 923 O
Participants NCT03923946 925 937 O
will NCT03923946 938 942 O
be NCT03923946 943 945 O
excluded NCT03923946 946 954 O
if NCT03923946 955 957 O
they NCT03923946 958 962 O
: NCT03923946 963 964 O

- NCT03923946 973 974 O
Have NCT03923946 976 980 O
any NCT03923946 981 984 O
communication NCT03923946 985 998 B-Condition
difficulties NCT03923946 999 1011 I-Condition
that NCT03923946 1012 1016 O
would NCT03923946 1017 1022 B-Assertion___Assertion_Type_Value:hypothetical
prevent NCT03923946 1023 1030 B-Negation
them NCT03923946 1031 1035 O
from NCT03923946 1036 1040 O
engaging NCT03923946 1041 1049 O
in NCT03923946 1050 1052 O
the NCT03923946 1053 1056 O
intervention NCT03923946 1057 1069 B-Procedure
( NCT03923946 1070 1071 O
including NCT03923946 1072 1081 O
hearing NCT03923946 1082 1089 B-Condition
impairments NCT03923946 1090 1101 I-Condition
, NCT03923946 1102 1103 O
visual NCT03923946 1104 1110 B-Condition
impairments NCT03923946 1111 1122 I-Condition
, NCT03923946 1123 1124 O
inability NCT03923946 1125 1134 B-Negation
to NCT03923946 1135 1137 O
understand NCT03923946 1138 1148 O
English NCT03923946 1149 1156 O
) NCT03923946 1157 1158 O
. NCT03923946 1159 1160 O
These NCT03923946 1162 1167 O
will NCT03923946 1168 1172 O
be NCT03923946 1173 1175 O
assessed NCT03923946 1176 1184 O
at NCT03923946 1185 1187 O
researcher NCT03923946 1188 1198 O
's NCT03923946 1198 1200 O
discretion NCT03923946 1201 1211 O
during NCT03923946 1212 1218 O
baseline NCT03923946 1219 1227 O
assessments NCT03923946 1228 1239 O
. NCT03923946 1240 1241 O

- NCT03923946 1250 1251 O
Had NCT03923946 1253 1256 O
a NCT03923946 1257 1258 O
diagnosis NCT03923946 1259 1268 O
of NCT03923946 1269 1271 O
dementia NCT03923946 1272 1280 B-Condition
prior NCT03923946 1281 1286 B-Temporal_Connection___Temporal_Connection_Type_Value:before
to NCT03923946 1287 1289 O
the NCT03923946 1290 1293 O
stroke NCT03923946 1294 1300 B-Condition
. NCT03923946 1301 1302 O

- NCT03923946 1311 1312 O
Are NCT03923946 1314 1317 O
deemed NCT03923946 1318 1324 O
to NCT03923946 1325 1327 O
lack NCT03923946 1328 1332 O
capacity NCT03923946 1333 1341 O
to NCT03923946 1342 1344 O
give NCT03923946 1345 1349 O
informed NCT03923946 1350 1358 O
consent NCT03923946 1359 1366 O
. NCT03923946 1367 1368 O
This NCT03923946 1370 1374 O
will NCT03923946 1375 1379 O
be NCT03923946 1380 1382 O
judged NCT03923946 1383 1389 O
via NCT03923946 1390 1393 O
a NCT03923946 1394 1395 O
qualified NCT03923946 1396 1405 O
clinician NCT03923946 1406 1415 O
. NCT03923946 1416 1417 O

- NCT03923946 1426 1427 O
Have NCT03923946 1429 1433 O
had NCT03923946 1434 1437 O
previous NCT03923946 1438 1446 B-Eq_Comparison
experience NCT03923946 1447 1457 O
of NCT03923946 1458 1460 O
CFT NCT03923946 1461 1464 B-Procedure

- NCT03923946 1472 1473 O
Were NCT03923946 1475 1479 B-Eq_Comparison
receiving NCT03923946 1480 1489 I-Eq_Comparison
medical NCT03923946 1490 1497 B-Modifier
or NCT03923946 1498 1500 B-Or
psychological NCT03923946 1501 1514 B-Modifier
treatment NCT03923946 1515 1524 B-Procedure
for NCT03923946 1525 1528 O
a NCT03923946 1529 1530 O
mental NCT03923946 1531 1537 B-Condition
illness NCT03923946 1538 1545 I-Condition
at NCT03923946 1546 1548 B-Temporal_Connection___Temporal_Connection_Type_Value:during
the NCT03923946 1549 1552 O
time NCT03923946 1553 1557 O
of NCT03923946 1558 1560 O
their NCT03923946 1561 1566 O
stroke NCT03923946 1567 1573 B-Condition
. NCT03923946 1574 1575 O

Inclusion NCT03860623 0 9 O
Criteria NCT03860623 10 18 O
: NCT03860623 19 20 O

- NCT03860623 24 25 O
BMI NCT03860623 27 30 B-Observation
30 NCT03860623 31 33 B-Eq_Comparison
- NCT03860623 34 35 I-Eq_Comparison
40 NCT03860623 36 38 I-Eq_Comparison
kg NCT03860623 39 41 I-Eq_Comparison
/ NCT03860623 42 43 I-Eq_Comparison
m NCT03860623 44 45 I-Eq_Comparison
2 NCT03860623 46 47 I-Eq_Comparison

- NCT03860623 50 51 O
BMI NCT03860623 53 56 B-Observation
18 NCT03860623 57 59 B-Eq_Comparison
- NCT03860623 60 61 I-Eq_Comparison
25 NCT03860623 62 64 I-Eq_Comparison
kg NCT03860623 65 67 I-Eq_Comparison
/ NCT03860623 68 69 I-Eq_Comparison
m NCT03860623 70 71 I-Eq_Comparison
2 NCT03860623 72 73 I-Eq_Comparison
; NCT03860623 73 74 O
those NCT03860623 75 80 O
with NCT03860623 81 85 O
BMI NCT03860623 86 89 B-Observation
up NCT03860623 90 92 B-Eq_Comparison
to NCT03860623 93 95 I-Eq_Comparison
28 NCT03860623 96 98 I-Eq_Comparison
kg NCT03860623 99 101 I-Eq_Comparison
/ NCT03860623 102 103 I-Eq_Comparison
m NCT03860623 104 105 I-Eq_Comparison
2 NCT03860623 106 107 I-Eq_Comparison
will NCT03860623 108 112 O
be NCT03860623 113 115 O
included NCT03860623 116 124 O
if NCT03860623 125 127 O
waist NCT03860623 128 133 B-Observation
circumference NCT03860623 134 147 I-Observation
is NCT03860623 148 150 O
< NCT03860623 151 152 B-Eq_Comparison
96 NCT03860623 153 155 I-Eq_Comparison
cm NCT03860623 156 158 I-Eq_Comparison
. NCT03860623 159 160 O

- NCT03860623 164 165 O
Males NCT03860623 167 172 O

- NCT03860623 175 176 O
Aged NCT03860623 178 182 B-Age
18 NCT03860623 183 185 B-Eq_Comparison
- NCT03860623 186 187 I-Eq_Comparison
60 NCT03860623 188 190 I-Eq_Comparison
yrs NCT03860623 191 194 I-Eq_Comparison

Exclusion NCT03860623 195 204 O
Criteria NCT03860623 205 213 O
: NCT03860623 214 215 O

- NCT03860623 219 220 O
Acute NCT03860623 222 227 O
illness NCT03860623 228 235 B-Condition
in NCT03860623 236 238 O
the NCT03860623 239 242 O
preceding NCT03860623 243 252 B-Eq_Comparison
6 NCT03860623 253 254 I-Eq_Comparison
weeks NCT03860623 255 260 I-Eq_Comparison

- NCT03860623 263 264 O
Taking NCT03860623 266 272 B-Eq_Comparison
regular NCT03860623 273 280 O
medication NCT03860623 281 291 B-Drug

- NCT03860623 294 295 O
History NCT03860623 297 304 B-Eq_Comparison
of NCT03860623 305 307 O
deep NCT03860623 308 312 B-Condition
vein NCT03860623 313 317 I-Condition
thrombosis NCT03860623 318 328 I-Condition
or NCT03860623 329 331 B-Or
clotting NCT03860623 332 340 B-Condition
disorders NCT03860623 341 350 I-Condition

- NCT03860623 353 354 O
Hypertension NCT03860623 356 368 B-Condition

- NCT03860623 371 372 O
Diabetes NCT03860623 374 382 B-Condition

- NCT03860623 385 386 O
Any NCT03860623 388 391 O
clinically NCT03860623 392 402 O
significant NCT03860623 403 414 O
findings NCT03860623 415 423 B-Condition
at NCT03860623 424 426 B-Temporal_Connection___Temporal_Connection_Type_Value:during
screening NCT03860623 427 436 B-Study

- NCT03860623 439 440 O
History NCT03860623 442 449 B-Eq_Comparison
of NCT03860623 450 452 O
substance NCT03860623 453 462 B-Condition
abuse NCT03860623 463 468 I-Condition

- NCT03860623 471 472 O
Demonstrating NCT03860623 474 487 O
factors NCT03860623 488 495 B-Condition
precluding NCT03860623 496 506 B-Contraindication
safe NCT03860623 507 511 O
MRI NCT03860623 512 515 B-Procedure

- NCT03860623 518 519 O
History NCT03860623 521 528 B-Eq_Comparison
of NCT03860623 529 531 O
gastrointestinal NCT03860623 532 548 B-Condition
motility NCT03860623 549 557 I-Condition
disorders NCT03860623 558 567 I-Condition
( NCT03860623 568 569 O
e NCT03860623 570 571 O
. NCT03860623 572 573 O
g NCT03860623 574 575 O
. NCT03860623 576 577 O
gastroesophageal NCT03860623 579 595 B-Condition
reflux NCT03860623 596 602 I-Condition
disease NCT03860623 603 610 I-Condition
- NCT03860623 611 612 O
irritable NCT03860623 613 622 B-Condition
bowel NCT03860623 623 628 I-Condition
syndrome NCT03860623 629 637 I-Condition
, NCT03860623 638 639 O
gastroparesis NCT03860623 640 653 B-Condition
, NCT03860623 654 655 O
sphincter NCT03860623 656 665 B-Condition
of NCT03860623 666 668 I-Condition
Oddi NCT03860623 669 673 I-Condition
dysfunction NCT03860623 674 685 I-Condition
, NCT03860623 686 687 O
etc NCT03860623 688 691 O
. NCT03860623 692 693 O
) NCT03860623 694 695 O

- NCT03860623 699 700 O
Previous NCT03860623 702 710 B-Eq_Comparison
thoracic NCT03860623 711 719 B-Modifier
or NCT03860623 720 722 B-Or
abdominal NCT03860623 723 732 B-Modifier
surgery NCT03860623 733 740 B-Procedure
. NCT03860623 741 742 O

- NCT03860623 746 747 O
Those NCT03860623 749 754 O
who NCT03860623 755 758 O
report NCT03860623 759 765 O
having NCT03860623 766 772 O
≤ NCT03860623 773 774 B-Eq_Comparison
3 NCT03860623 775 776 I-Eq_Comparison
bowel NCT03860623 777 782 B-Observation
movements NCT03860623 783 792 I-Observation
/ NCT03860623 793 794 O
week NCT03860623 795 799 O
or NCT03860623 800 802 B-Or
> NCT03860623 803 804 B-Eq_Comparison
2 NCT03860623 805 806 I-Eq_Comparison
/ NCT03860623 807 808 I-Eq_Comparison
day NCT03860623 809 812 I-Eq_Comparison
. NCT03860623 813 814 O

Inclusion NCT03921437 0 9 O
conditions NCT03921437 10 20 O
: NCT03921437 21 22 O

1 NCT03921437 26 27 O
. NCT03921437 27 28 O
The NCT03921437 30 33 O
fifth NCT03921437 34 39 B-Eq_Comparison
stage NCT03921437 40 45 I-Eq_Comparison
of NCT03921437 46 48 O
chronic NCT03921437 49 56 O
renal NCT03921437 57 62 B-Condition
failure NCT03921437 63 70 I-Condition
diagnosed NCT03921437 71 80 O
by NCT03921437 81 83 O
a NCT03921437 84 85 O
physician NCT03921437 86 95 O
. NCT03921437 96 97 O

2 NCT03921437 101 102 O
. NCT03921437 102 103 O
The NCT03921437 105 108 O
physician NCT03921437 109 118 O
advises NCT03921437 119 126 O
and NCT03921437 127 130 O
informs NCT03921437 131 138 O
the NCT03921437 139 142 O
patient NCT03921437 143 150 O
who NCT03921437 151 154 O
has NCT03921437 155 158 O
to NCT03921437 159 161 O
undergo NCT03921437 162 169 B-Eq_Comparison
renal NCT03921437 170 175 B-Procedure
replacement NCT03921437 176 187 I-Procedure
therapy NCT03921437 188 195 I-Procedure
but NCT03921437 196 199 B-And
has NCT03921437 200 203 O
not NCT03921437 204 207 B-Negation
yet NCT03921437 208 211 O
decided NCT03921437 212 219 O
what NCT03921437 220 224 O
treatment NCT03921437 225 234 B-Procedure
to NCT03921437 235 237 O
take NCT03921437 238 242 O
. NCT03921437 243 244 O

3 NCT03921437 248 249 O
. NCT03921437 249 250 O
Being NCT03921437 252 257 O
able NCT03921437 258 262 O
to NCT03921437 263 265 O
communicate NCT03921437 266 277 O
in NCT03921437 278 280 O
Mandarin NCT03921437 281 289 O
and NCT03921437 290 293 B-And
Taiwan NCT03921437 294 300 O
. NCT03921437 301 302 O

4 NCT03921437 306 307 O
. NCT03921437 307 308 O
Ages NCT03921437 310 314 B-Age
over NCT03921437 315 319 O
20 NCT03921437 320 322 B-Eq_Comparison
years NCT03921437 323 328 I-Eq_Comparison
old NCT03921437 329 332 O
. NCT03921437 333 334 O

Exclusion NCT03921437 336 345 O
conditions NCT03921437 346 356 O
: NCT03921437 357 358 O

1 NCT03921437 362 363 O
. NCT03921437 363 364 O
Cognitive NCT03921437 366 375 B-Condition
impairment NCT03921437 376 386 I-Condition
: NCT03921437 387 388 O
The NCT03921437 389 392 O
MMSE NCT03921437 393 397 B-Observation
of NCT03921437 398 400 O
the NCT03921437 401 404 O
above NCT03921437 405 410 O
- NCT03921437 411 412 O
mentioned NCT03921437 413 422 O
educators NCT03921437 423 432 O
was NCT03921437 433 436 O
26 NCT03921437 437 439 B-Eq_Comparison
points NCT03921437 440 446 I-Eq_Comparison
, NCT03921437 447 448 O
and NCT03921437 449 452 B-And
the NCT03921437 453 456 O
national NCT03921437 457 465 B-Observation
minimum NCT03921437 466 473 I-Observation
was NCT03921437 474 477 O
< NCT03921437 478 479 B-Eq_Comparison
21 NCT03921437 480 482 I-Eq_Comparison
points NCT03921437 483 489 I-Eq_Comparison
, NCT03921437 490 491 O
those NCT03921437 492 497 O
who NCT03921437 498 501 O
are NCT03921437 502 505 O
not NCT03921437 506 509 B-Negation
educated NCT03921437 510 518 B-Condition
are NCT03921437 519 522 O
< NCT03921437 523 524 B-Eq_Comparison
16 NCT03921437 525 527 I-Eq_Comparison
points NCT03921437 528 534 I-Eq_Comparison
, NCT03921437 535 536 O
and NCT03921437 537 540 O
the NCT03921437 541 544 O
case NCT03921437 545 549 O
is NCT03921437 550 552 O
excluded NCT03921437 553 561 O
. NCT03921437 562 563 O

2 NCT03921437 567 568 O
. NCT03921437 568 569 O
Patients NCT03921437 571 579 O
who NCT03921437 580 583 O
have NCT03921437 584 588 O
received NCT03921437 589 597 B-Eq_Comparison
non NCT03921437 598 601 B-Negation
- NCT03921437 602 603 O
emergency NCT03921437 604 613 B-Modifier
dialysis NCT03921437 614 622 B-Procedure
treatment NCT03921437 623 632 I-Procedure
. NCT03921437 633 634 O

3 NCT03921437 638 639 O
. NCT03921437 639 640 O
Patients NCT03921437 642 650 O
with NCT03921437 651 655 O
severe NCT03921437 656 662 O
cardiopulmonary NCT03921437 663 678 B-Modifier
dysfunction NCT03921437 679 690 B-Condition
, NCT03921437 691 692 O
severe NCT03921437 693 699 O
shock NCT03921437 700 705 B-Condition
, NCT03921437 706 707 O
low NCT03921437 708 711 B-Condition
blood NCT03921437 712 717 I-Condition
pressure NCT03921437 718 726 I-Condition
, NCT03921437 727 728 O
and NCT03921437 729 732 O
large NCT03921437 733 738 O
bleeding NCT03921437 739 747 B-Condition
are NCT03921437 748 751 O
not NCT03921437 752 755 O
controlled NCT03921437 756 766 O
. NCT03921437 767 768 O

4 NCT03921437 772 773 O
. NCT03921437 773 774 O
Patients NCT03921437 776 784 O
with NCT03921437 785 789 O
chronic NCT03921437 790 797 O
active NCT03921437 798 804 B-Eq_Comparison
hepatitis NCT03921437 805 814 B-Condition
, NCT03921437 815 816 O
cirrhosis NCT03921437 817 826 B-Condition
or NCT03921437 827 829 B-Or
liver NCT03921437 830 835 B-Condition
failure NCT03921437 836 843 I-Condition
. NCT03921437 844 845 O

5 NCT03921437 849 850 O
. NCT03921437 850 851 O
A NCT03921437 853 854 O
history NCT03921437 855 862 B-Eq_Comparison
of NCT03921437 863 865 O
cancer NCT03921437 866 872 B-Condition
that NCT03921437 873 877 O
may NCT03921437 878 881 O
be NCT03921437 882 884 O
transferred NCT03921437 885 896 O
. NCT03921437 897 898 O

6 NCT03921437 902 903 O
. NCT03921437 903 904 O
Severe NCT03921437 906 912 O
bleeding NCT03921437 913 921 B-Condition
tendency NCT03921437 922 930 O
. NCT03921437 931 932 O

7 NCT03921437 936 937 O
. NCT03921437 937 938 O
Loss NCT03921437 940 944 O
of NCT03921437 945 947 O
peritoneal NCT03921437 948 958 B-Condition
function NCT03921437 959 967 I-Condition
or NCT03921437 968 970 B-Or
extensive NCT03921437 971 980 O
peritoneal NCT03921437 981 991 B-Condition
adhesion NCT03921437 992 1000 I-Condition
, NCT03921437 1001 1002 O
unable NCT03921437 1003 1009 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03921437 1010 1012 O
use NCT03921437 1013 1016 O
peritoneal NCT03921437 1017 1027 B-Procedure
dialysis NCT03921437 1028 1036 I-Procedure
. NCT03921437 1037 1038 O

8 NCT03921437 1042 1043 O
. NCT03921437 1043 1044 O
Unable NCT03921437 1046 1052 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03921437 1053 1055 O
correct NCT03921437 1056 1063 B-Procedure
physiological NCT03921437 1064 1077 B-Condition
defects NCT03921437 1078 1085 I-Condition
, NCT03921437 1086 1087 O
may NCT03921437 1088 1091 B-Assertion___Assertion_Type_Value:hypothetical
interfere NCT03921437 1092 1101 O
with NCT03921437 1102 1106 O
peritoneal NCT03921437 1107 1117 B-Procedure
dialysis NCT03921437 1118 1126 I-Procedure
, NCT03921437 1127 1128 O
or NCT03921437 1129 1131 B-Or
increase NCT03921437 1132 1140 O
the NCT03921437 1141 1144 O
chance NCT03921437 1145 1151 B-Risk
of NCT03921437 1152 1154 I-Risk
infection NCT03921437 1155 1164 B-Condition
, NCT03921437 1165 1166 O
such NCT03921437 1167 1171 O
as NCT03921437 1172 1174 O
umbilical NCT03921437 1175 1184 B-Condition
hernia NCT03921437 1185 1191 I-Condition
. NCT03921437 1192 1193 O

9 NCT03921437 1197 1198 O
. NCT03921437 1198 1199 O
The NCT03921437 1201 1204 O
patient NCT03921437 1205 1212 O
is NCT03921437 1213 1215 O
unable NCT03921437 1216 1222 B-Assertion___Assertion_Type_Value:hypothetical|B-Negation
to NCT03921437 1223 1225 O
operate NCT03921437 1226 1233 O
the NCT03921437 1234 1237 O
fluid NCT03921437 1238 1243 B-Procedure
change NCT03921437 1244 1250 I-Procedure
, NCT03921437 1251 1252 O
hand NCT03921437 1253 1257 O
shake NCT03921437 1258 1263 O
, NCT03921437 1264 1265 O
and NCT03921437 1266 1269 O
no NCT03921437 1270 1272 B-Negation
family NCT03921437 1273 1279 B-Family_Member
members NCT03921437 1280 1287 I-Family_Member
can NCT03921437 1288 1291 O
assist NCT03921437 1292 1298 O
. NCT03921437 1299 1300 O

10 NCT03921437 1303 1305 O
. NCT03921437 1305 1306 O
Patients NCT03921437 1308 1316 O
who NCT03921437 1317 1320 O
are NCT03921437 1321 1324 O
blind NCT03921437 1325 1330 B-Condition
, NCT03921437 1331 1332 O
have NCT03921437 1333 1337 O
poor NCT03921437 1338 1342 B-Condition
eyesight NCT03921437 1343 1351 I-Condition
, NCT03921437 1352 1353 O
and NCT03921437 1354 1357 B-Or
have NCT03921437 1358 1362 O
difficulty NCT03921437 1363 1373 B-Condition
operating NCT03921437 1374 1383 I-Condition
. NCT03921437 1384 1385 O

Inclusion NCT03926702 0 9 O
Criteria NCT03926702 10 18 O
: NCT03926702 19 20 O

- NCT03926702 24 25 O
Healthy NCT03926702 27 34 O
Volunteers NCT03926702 35 45 O
: NCT03926702 46 47 O
Subjects NCT03926702 48 56 O
must NCT03926702 57 61 O
be NCT03926702 62 64 O
aged NCT03926702 65 69 B-Age
50 NCT03926702 70 72 B-Eq_Comparison
and NCT03926702 73 76 I-Eq_Comparison
over NCT03926702 77 81 I-Eq_Comparison
. NCT03926702 82 83 O
These NCT03926702 85 90 O
individuals NCT03926702 91 102 O
will NCT03926702 103 107 O
all NCT03926702 108 111 O
be NCT03926702 112 114 O
of NCT03926702 115 117 O
good NCT03926702 118 122 O
general NCT03926702 123 130 B-Condition
medical NCT03926702 131 138 I-Condition
health NCT03926702 139 145 I-Condition
with NCT03926702 146 150 B-And
no NCT03926702 151 153 B-Negation
neurological NCT03926702 154 166 B-Condition
diseases NCT03926702 167 175 I-Condition
and NCT03926702 176 179 O
capable NCT03926702 180 187 O
of NCT03926702 188 190 O
providing NCT03926702 191 200 O
informed NCT03926702 201 209 O
consent NCT03926702 210 217 O
. NCT03926702 218 219 O

- NCT03926702 223 224 O
Patients NCT03926702 226 234 O
: NCT03926702 235 236 O
Subjects NCT03926702 237 245 O
must NCT03926702 246 250 O
be NCT03926702 251 253 O
aged NCT03926702 254 258 B-Age
50 NCT03926702 259 261 B-Eq_Comparison
and NCT03926702 262 265 I-Eq_Comparison
over NCT03926702 266 270 I-Eq_Comparison
. NCT03926702 271 272 O
Patients NCT03926702 274 282 O
will NCT03926702 283 287 O
meet NCT03926702 288 292 O
diagnostic NCT03926702 293 303 O
criteria NCT03926702 304 312 O
at NCT03926702 313 315 O
UCSF NCT03926702 316 320 O
for NCT03926702 321 324 O
Alzheimer NCT03926702 325 334 B-Condition
's NCT03926702 334 336 I-Condition
disease NCT03926702 337 344 I-Condition
( NCT03926702 345 346 O
AD NCT03926702 347 349 B-Condition
) NCT03926702 350 351 O
, NCT03926702 352 353 O
mild NCT03926702 354 358 O
cognitive NCT03926702 359 368 B-Condition
impairment NCT03926702 369 379 I-Condition
( NCT03926702 380 381 O
MCI NCT03926702 382 385 B-Condition
) NCT03926702 386 387 O
, NCT03926702 388 389 O
or NCT03926702 390 392 B-Or
progressive NCT03926702 393 404 B-Condition
supranuclear NCT03926702 405 417 I-Condition
palsy NCT03926702 418 423 I-Condition
( NCT03926702 424 425 O
PSP NCT03926702 426 429 B-Condition
) NCT03926702 430 431 O
. NCT03926702 432 433 O

Exclusion NCT03926702 435 444 O
Criteria NCT03926702 445 453 O
: NCT03926702 454 455 O

- NCT03926702 459 460 O
Any NCT03926702 462 465 O
medical NCT03926702 466 473 O
contraindications NCT03926702 474 491 B-Contraindication
to NCT03926702 492 494 O
an NCT03926702 495 497 O
MRI NCT03926702 498 501 B-Procedure
scan NCT03926702 502 506 I-Procedure

- NCT03926702 509 510 O
A NCT03926702 512 513 O
pacemaker NCT03926702 514 523 B-Procedure

- NCT03926702 526 527 O
Metal NCT03926702 529 534 B-Condition
clips NCT03926702 535 540 I-Condition
in NCT03926702 541 543 O
brain NCT03926702 544 549 B-Modifier
or NCT03926702 550 552 B-Or
tattoos NCT03926702 553 560 B-Observation
above NCT03926702 561 566 B-Modifier
neck NCT03926702 567 571 I-Modifier

- NCT03926702 574 575 O
Metallic NCT03926702 577 585 B-Condition
implants NCT03926702 586 594 I-Condition
or NCT03926702 595 597 B-Or
shrapnel NCT03926702 598 606 B-Condition
in NCT03926702 607 609 O
body NCT03926702 610 614 B-Modifier

- NCT03926702 617 618 O
Any NCT03926702 620 623 O
body NCT03926702 624 628 B-Modifier
jewelry NCT03926702 629 636 B-Observation
or NCT03926702 637 639 B-Or
piercings NCT03926702 640 649 B-Observation
that NCT03926702 650 654 O
are NCT03926702 655 658 O
not NCT03926702 659 662 B-Modifier
removable NCT03926702 663 672 I-Modifier

- NCT03926702 675 676 O
A NCT03926702 678 679 O
history NCT03926702 680 687 B-Eq_Comparison
of NCT03926702 688 690 O
claustrophobia NCT03926702 691 705 B-Condition

- NCT03926702 708 709 O
A NCT03926702 711 712 O
known NCT03926702 713 718 O
major NCT03926702 719 724 O
systemic NCT03926702 725 733 B-Condition
disease NCT03926702 734 741 I-Condition

- NCT03926702 744 745 O
A NCT03926702 747 748 O
history NCT03926702 749 756 B-Eq_Comparison
of NCT03926702 757 759 O
a NCT03926702 760 761 O
psychiatric NCT03926702 762 773 B-Condition
disorder NCT03926702 774 782 I-Condition

- NCT03926702 785 786 O
A NCT03926702 788 789 O
history NCT03926702 790 797 B-Eq_Comparison
of NCT03926702 798 800 O
substance NCT03926702 801 810 B-Condition
abuse NCT03926702 811 816 I-Condition
( NCT03926702 817 818 O
prescription NCT03926702 819 831 B-Modifier
or NCT03926702 832 834 B-Or
non NCT03926702 835 838 B-Modifier
- NCT03926702 839 840 I-Modifier
prescription NCT03926702 841 853 I-Modifier
) NCT03926702 854 855 O
within NCT03926702 856 862 B-Eq_Comparison
the NCT03926702 863 866 I-Eq_Comparison
past NCT03926702 867 871 I-Eq_Comparison
5 NCT03926702 872 873 I-Eq_Comparison
years NCT03926702 874 879 I-Eq_Comparison

- NCT03926702 882 883 O
A NCT03926702 885 886 O
current NCT03926702 887 894 B-Eq_Comparison
weight NCT03926702 895 901 B-Observation
of NCT03926702 902 904 O
less NCT03926702 905 909 B-Eq_Comparison
than NCT03926702 910 914 I-Eq_Comparison
45 NCT03926702 915 917 I-Eq_Comparison
kilograms NCT03926702 918 927 I-Eq_Comparison
( NCT03926702 928 929 O
100 NCT03926702 930 933 B-Eq_Comparison
pounds NCT03926702 934 940 I-Eq_Comparison
) NCT03926702 941 942 O

- NCT03926702 946 947 O
Difficulty NCT03926702 949 959 B-Condition
in NCT03926702 960 962 I-Condition
urinating NCT03926702 963 972 I-Condition
or NCT03926702 973 975 B-Or
emptying NCT03926702 976 984 B-Condition
the NCT03926702 985 988 I-Condition
bladder NCT03926702 989 996 I-Condition

- NCT03926702 999 1000 O
Under NCT03926702 1002 1007 B-Eq_Comparison
age NCT03926702 1008 1011 I-Eq_Comparison
50 NCT03926702 1012 1014 I-Eq_Comparison

- NCT03926702 1018 1019 O
Participating NCT03926702 1021 1034 B-Eq_Comparison
in NCT03926702 1035 1037 O
an NCT03926702 1038 1040 O
experimental NCT03926702 1041 1053 B-Modifier
radiotracer NCT03926702 1054 1065 B-Procedure
study NCT03926702 1066 1071 B-Study

- NCT03926702 1074 1075 O
Subjects NCT03926702 1077 1085 O
must NCT03926702 1086 1090 O
be NCT03926702 1091 1093 O
fluent NCT03926702 1094 1100 O
English NCT03926702 1101 1108 O
speakers NCT03926702 1109 1117 O

Inclusion NCT03925454 0 9 O
Criteria NCT03925454 10 18 O
: NCT03925454 19 20 O

- NCT03925454 24 25 O
Receiving NCT03925454 27 36 B-Eq_Comparison
HHD NCT03925454 37 40 B-Procedure
or NCT03925454 41 43 B-Or
ICHDF NCT03925454 44 49 B-Procedure
for NCT03925454 50 53 O
more NCT03925454 54 58 B-Eq_Comparison
than NCT03925454 59 63 I-Eq_Comparison
3 NCT03925454 64 65 I-Eq_Comparison
months NCT03925454 66 72 I-Eq_Comparison
and NCT03925454 73 76 B-And
less NCT03925454 77 81 B-Eq_Comparison
than NCT03925454 82 86 I-Eq_Comparison
36 NCT03925454 87 89 I-Eq_Comparison
months NCT03925454 90 96 I-Eq_Comparison
. NCT03925454 97 98 O

- NCT03925454 102 103 O
Haemoglobin NCT03925454 105 116 B-Observation
equal NCT03925454 117 122 B-Eq_Comparison
to NCT03925454 123 125 I-Eq_Comparison
or NCT03925454 126 128 I-Eq_Comparison
greater NCT03925454 129 136 I-Eq_Comparison
than NCT03925454 137 141 I-Eq_Comparison
100 NCT03925454 142 145 I-Eq_Comparison
g NCT03925454 146 147 I-Eq_Comparison
/ NCT03925454 148 149 I-Eq_Comparison
L NCT03925454 150 151 I-Eq_Comparison
at NCT03925454 152 154 B-Temporal_Connection___Temporal_Connection_Type_Value:during
enrolment NCT03925454 155 164 B-Study
. NCT03925454 165 166 O

- NCT03925454 170 171 O
Willing NCT03925454 173 180 B-Assertion___Assertion_Type_Value:hypothetical
and NCT03925454 181 184 B-And
physically NCT03925454 185 195 O
able NCT03925454 196 200 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925454 201 203 O
undertake NCT03925454 204 213 O
the NCT03925454 214 217 O
study NCT03925454 218 223 B-Study
assessments NCT03925454 224 235 B-Procedure
/ NCT03925454 236 237 B-Or
tests NCT03925454 238 243 B-Procedure

- NCT03925454 246 247 O
Willing NCT03925454 249 256 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03925454 257 259 O
provide NCT03925454 260 267 O
blood NCT03925454 268 273 B-Observation
for NCT03925454 274 277 O
storage NCT03925454 278 285 O
and NCT03925454 286 289 O
future NCT03925454 290 296 O
analysis NCT03925454 297 305 O

- NCT03925454 308 309 O
Able NCT03925454 311 315 O
to NCT03925454 316 318 O
give NCT03925454 319 323 O
informed NCT03925454 324 332 O
consent NCT03925454 333 340 O

Exclusion NCT03925454 341 350 O
Criteria NCT03925454 351 359 O
: NCT03925454 360 361 O

- NCT03925454 365 366 O
Living NCT03925454 368 374 B-Procedure
donor NCT03925454 375 380 I-Procedure
transplant NCT03925454 381 391 I-Procedure
or NCT03925454 392 394 B-Or
change NCT03925454 395 401 O
to NCT03925454 402 404 O
peritoneal NCT03925454 405 415 B-Procedure
dialysis NCT03925454 416 424 I-Procedure
planned NCT03925454 425 432 B-Eq_Comparison

- NCT03925454 435 436 O
Physical NCT03925454 438 446 B-Procedure
assessments NCT03925454 447 458 I-Procedure
contraindicated NCT03925454 459 474 B-Contraindication
for NCT03925454 475 478 O
the NCT03925454 479 482 O
following NCT03925454 483 492 O
clinical NCT03925454 493 501 O
reasons NCT03925454 502 509 O

- NCT03925454 517 518 O
Acute NCT03925454 520 525 B-Condition
Coronary NCT03925454 526 534 I-Condition
Syndrome NCT03925454 535 543 I-Condition
( NCT03925454 544 545 O
ACS NCT03925454 546 549 B-Condition
) NCT03925454 550 551 O
within NCT03925454 552 558 B-Eq_Comparison
the NCT03925454 559 562 I-Eq_Comparison
last NCT03925454 563 567 I-Eq_Comparison
3 NCT03925454 568 569 I-Eq_Comparison
months NCT03925454 570 576 I-Eq_Comparison
( NCT03925454 577 578 O
chest NCT03925454 579 584 B-Modifier
pain NCT03925454 585 589 B-Condition
, NCT03925454 590 591 O
ECG NCT03925454 592 595 B-Procedure
changes NCT03925454 596 603 O
or NCT03925454 604 606 B-Or
typical NCT03925454 607 614 O
biomarker NCT03925454 615 624 B-Observation
elevation NCT03925454 625 634 O
) NCT03925454 635 636 O
. NCT03925454 637 638 O

- NCT03925454 647 648 O
Any NCT03925454 650 653 O
current NCT03925454 654 661 B-Eq_Comparison
uncontrolled NCT03925454 662 674 B-Modifier
cardiac NCT03925454 675 682 B-Condition
dysrhythmias NCT03925454 683 695 I-Condition
causing NCT03925454 696 703 O
symptoms NCT03925454 704 712 B-Assertion___Assertion_Type_Value:possible
( NCT03925454 713 714 O
chest NCT03925454 715 720 B-Modifier
pain NCT03925454 721 725 B-Condition
, NCT03925454 726 727 O
palpitations NCT03925454 728 740 B-Condition
, NCT03925454 741 742 O
syncope NCT03925454 743 750 B-Condition
or NCT03925454 751 753 B-Or
dizziness NCT03925454 754 763 B-Condition
) NCT03925454 764 765 O

- NCT03925454 774 775 O
Symptomatic NCT03925454 777 788 B-Condition
aortic NCT03925454 789 795 I-Condition
stenosis NCT03925454 796 804 I-Condition

- NCT03925454 812 813 O
New NCT03925454 815 818 B-Observation
York NCT03925454 819 823 I-Observation
Heart NCT03925454 824 829 I-Observation
Association NCT03925454 830 841 I-Observation
grade NCT03925454 842 847 B-Eq_Comparison
IV NCT03925454 848 850 I-Eq_Comparison
Heart NCT03925454 851 856 B-Condition
failure NCT03925454 857 864 I-Condition

- NCT03925454 872 873 O
Severe NCT03925454 875 881 O
chronic NCT03925454 882 889 O
obstructive NCT03925454 890 901 B-Condition
pulmonary NCT03925454 902 911 I-Condition
disease NCT03925454 912 919 I-Condition

- NCT03925454 927 928 O
Acute NCT03925454 930 935 O
pulmonary NCT03925454 936 945 B-Condition
embolus NCT03925454 946 953 I-Condition
or NCT03925454 954 956 B-Or
pulmonary NCT03925454 957 966 B-Condition
infarction NCT03925454 967 977 I-Condition
in NCT03925454 978 980 O
the NCT03925454 981 984 O
last NCT03925454 985 989 B-Eq_Comparison
3 NCT03925454 990 991 I-Eq_Comparison
months NCT03925454 992 998 I-Eq_Comparison

- NCT03925454 1006 1007 O
Current NCT03925454 1009 1016 B-Eq_Comparison
acute NCT03925454 1017 1022 B-Condition
myocarditis NCT03925454 1023 1034 I-Condition
or NCT03925454 1035 1037 B-Or
pericarditis NCT03925454 1038 1050 B-Condition

- NCT03925454 1058 1059 O
Suspected NCT03925454 1061 1070 B-Assertion___Assertion_Type_Value:possible
or NCT03925454 1071 1073 B-Or
known NCT03925454 1074 1079 B-Modifier
dissecting NCT03925454 1080 1090 B-Condition
aneurysm NCT03925454 1091 1099 I-Condition

- NCT03925454 1107 1108 O
Acute NCT03925454 1110 1115 O
systemic NCT03925454 1116 1124 B-Modifier
infection NCT03925454 1125 1134 B-Condition
, NCT03925454 1135 1136 O
accompanied NCT03925454 1137 1148 B-And
by NCT03925454 1149 1151 I-And
fever NCT03925454 1152 1157 B-Condition
, NCT03925454 1158 1159 O
body NCT03925454 1160 1164 B-Condition
aches NCT03925454 1165 1170 I-Condition
or NCT03925454 1171 1173 B-Or
swollen NCT03925454 1174 1181 B-Condition
lymph NCT03925454 1182 1187 I-Condition
glands NCT03925454 1188 1194 I-Condition

- NCT03925454 1197 1198 O
Pregnancy NCT03925454 1200 1209 B-Condition

- NCT03925454 1212 1213 O
Life NCT03925454 1215 1219 B-Observation
expectancy NCT03925454 1220 1230 I-Observation
of NCT03925454 1231 1233 O
less NCT03925454 1234 1238 B-Eq_Comparison
than NCT03925454 1239 1243 I-Eq_Comparison
twelve NCT03925454 1244 1250 I-Eq_Comparison
months NCT03925454 1251 1257 I-Eq_Comparison

Inclusion NCT03923205 0 9 O
Criteria NCT03923205 10 18 O
: NCT03923205 19 20 O

Healthy NCT03923205 22 29 B-Condition
and NCT03923205 30 33 B-And
T NCT03923205 34 35 B-Condition
2D NCT03923205 36 38 I-Condition
( NCT03923205 39 40 O
controlled NCT03923205 41 51 O
by NCT03923205 52 54 O
diet NCT03923205 55 59 B-Procedure
and NCT03923205 60 63 B-And
lifestyle NCT03923205 64 73 B-Observation
or NCT03923205 74 76 B-Or
metformin NCT03923205 77 86 B-Drug
) NCT03923205 87 88 O
volunteers NCT03923205 89 99 O
; NCT03923205 99 100 O
Age NCT03923205 101 104 B-Age
18 NCT03923205 105 107 B-Eq_Comparison
+ NCT03923205 108 109 I-Eq_Comparison
; NCT03923205 110 111 O
males NCT03923205 112 117 O
and NCT03923205 118 121 B-Or
females NCT03923205 122 129 O
. NCT03923205 130 131 O

Exclusion NCT03923205 134 143 O
Criteria NCT03923205 144 152 O
: NCT03923205 153 154 O

For NCT03923205 156 159 O
the NCT03923205 160 163 O
healthy NCT03923205 164 171 B-Condition
group NCT03923205 172 177 O
: NCT03923205 178 179 O

- NCT03923205 183 184 O
taking NCT03923205 186 192 B-Eq_Comparison
prescribed NCT03923205 193 203 O
medication NCT03923205 204 214 B-Drug

- NCT03923205 217 218 O
HbA NCT03923205 220 223 B-Observation
1c NCT03923205 224 226 I-Observation
above NCT03923205 227 232 B-Eq_Comparison
48 NCT03923205 233 235 I-Eq_Comparison
mmol NCT03923205 236 240 I-Eq_Comparison
/ NCT03923205 241 242 I-Eq_Comparison
mol NCT03923205 243 246 I-Eq_Comparison
( NCT03923205 247 248 O
or NCT03923205 249 251 B-Or
6.5 NCT03923205 252 255 B-Eq_Comparison
% NCT03923205 256 257 I-Eq_Comparison
) NCT03923205 258 259 O

- NCT03923205 263 264 O
pregnant NCT03923205 266 274 B-Condition
or NCT03923205 275 277 B-Or
breastfeeding NCT03923205 278 291 B-Condition

- NCT03923205 294 295 O
blood NCT03923205 297 302 B-Observation
donation NCT03923205 303 311 I-Observation
in NCT03923205 312 314 O
the NCT03923205 315 318 O
last NCT03923205 319 323 B-Eq_Comparison
three NCT03923205 324 329 I-Eq_Comparison
months NCT03923205 330 336 I-Eq_Comparison

- NCT03923205 339 340 O
unable NCT03923205 342 348 O
to NCT03923205 349 351 O
give NCT03923205 352 356 O
written NCT03923205 357 364 O
informed NCT03923205 365 373 O
consent NCT03923205 374 381 O

- NCT03923205 384 385 O
eating NCT03923205 387 393 B-Condition
disorders NCT03923205 394 403 I-Condition
such NCT03923205 404 408 O
as NCT03923205 409 411 O
anorexia NCT03923205 412 420 B-Condition
, NCT03923205 421 422 O
bulimia NCT03923205 423 430 B-Condition
, NCT03923205 431 432 O
binge NCT03923205 433 438 B-Condition
eating NCT03923205 439 445 I-Condition
or NCT03923205 446 448 B-Or
night NCT03923205 449 454 B-Condition
eating NCT03923205 455 461 I-Condition
syndrome NCT03923205 462 470 I-Condition
. NCT03923205 471 472 O

- NCT03923205 476 477 O
significant NCT03923205 479 490 O
health NCT03923205 491 497 B-Condition
issue NCT03923205 498 503 I-Condition

- NCT03923205 506 507 O
taking NCT03923205 509 515 B-Eq_Comparison
vitamin NCT03923205 516 523 B-Drug
or NCT03923205 524 526 B-Or
mineral NCT03923205 527 534 B-Drug
supplements NCT03923205 535 546 I-Drug
( NCT03923205 547 548 O
unless NCT03923205 549 555 B-Exception
they NCT03923205 556 560 O
agree NCT03923205 561 566 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03923205 567 569 I-Assertion___Assertion_Type_Value:hypothetical
discontinue NCT03923205 570 581 B-Negation
supplementation NCT03923205 582 597 B-Drug
2 NCT03923205 598 599 B-Eq_Comparison
weeks NCT03923205 600 605 I-Eq_Comparison
or NCT03923205 606 608 I-Eq_Comparison
more NCT03923205 609 613 I-Eq_Comparison
before NCT03923205 614 620 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923205 621 624 O
start NCT03923205 625 630 O
of NCT03923205 631 633 O
the NCT03923205 634 637 O
study NCT03923205 638 643 B-Study
) NCT03923205 644 645 O

- NCT03923205 649 650 O
Food NCT03923205 652 656 O
allergies NCT03923205 657 666 B-Allergy
/ NCT03923205 667 668 B-Or
intolerances NCT03923205 669 681 B-Condition

For NCT03923205 682 685 O
the NCT03923205 686 689 O
T NCT03923205 690 691 B-Condition
2D NCT03923205 692 694 I-Condition
groups NCT03923205 695 701 O
: NCT03923205 702 703 O

- NCT03923205 707 708 O
T NCT03923205 710 711 B-Condition
2D NCT03923205 712 714 I-Condition
controlled NCT03923205 715 725 O
by NCT03923205 726 728 O
medication NCT03923205 729 739 B-Drug
other NCT03923205 740 745 B-Exception
than NCT03923205 746 750 I-Exception
metformin NCT03923205 751 760 B-Drug

- NCT03923205 763 764 O
pregnant NCT03923205 766 774 B-Condition
or NCT03923205 775 777 B-Or
breastfeeding NCT03923205 778 791 B-Condition

- NCT03923205 794 795 O
blood NCT03923205 797 802 B-Observation
donation NCT03923205 803 811 I-Observation
in NCT03923205 812 814 O
the NCT03923205 815 818 O
last NCT03923205 819 823 B-Eq_Comparison
three NCT03923205 824 829 I-Eq_Comparison
months NCT03923205 830 836 I-Eq_Comparison

- NCT03923205 839 840 O
unable NCT03923205 842 848 O
to NCT03923205 849 851 O
give NCT03923205 852 856 O
written NCT03923205 857 864 O
informed NCT03923205 865 873 O
consent NCT03923205 874 881 O

- NCT03923205 884 885 O
eating NCT03923205 887 893 B-Condition
disorders NCT03923205 894 903 I-Condition
such NCT03923205 904 908 O
as NCT03923205 909 911 O
anorexia NCT03923205 912 920 B-Condition
, NCT03923205 921 922 O
bulimia NCT03923205 923 930 B-Condition
, NCT03923205 931 932 O
binge NCT03923205 933 938 B-Condition
eating NCT03923205 939 945 I-Condition
or NCT03923205 946 948 B-Or
night NCT03923205 949 954 B-Condition
eating NCT03923205 955 961 I-Condition
syndrome NCT03923205 962 970 I-Condition
. NCT03923205 971 972 O

- NCT03923205 976 977 O
any NCT03923205 979 982 O
other NCT03923205 983 988 O
significant NCT03923205 989 1000 O
health NCT03923205 1001 1007 B-Condition
issue NCT03923205 1008 1013 I-Condition
other NCT03923205 1014 1019 B-Exception
than NCT03923205 1020 1024 I-Exception
T NCT03923205 1025 1026 B-Condition
2D NCT03923205 1027 1029 I-Condition

- NCT03923205 1032 1033 O
taking NCT03923205 1035 1041 B-Eq_Comparison
vitamin NCT03923205 1042 1049 B-Drug
or NCT03923205 1050 1052 B-Or
mineral NCT03923205 1053 1060 B-Drug
supplements NCT03923205 1061 1072 I-Drug
( NCT03923205 1073 1074 O
unless NCT03923205 1075 1081 B-Exception
they NCT03923205 1082 1086 I-Exception
agree NCT03923205 1087 1092 B-Assertion___Assertion_Type_Value:hypothetical
to NCT03923205 1093 1095 I-Assertion___Assertion_Type_Value:hypothetical
discontinue NCT03923205 1096 1107 B-Negation
supplementation NCT03923205 1108 1123 B-Drug
2 NCT03923205 1124 1125 B-Eq_Comparison
weeks NCT03923205 1126 1131 I-Eq_Comparison
before NCT03923205 1132 1138 B-Temporal_Connection___Temporal_Connection_Type_Value:before
the NCT03923205 1139 1142 O
start NCT03923205 1143 1148 O
of NCT03923205 1149 1151 O
the NCT03923205 1152 1155 O
study NCT03923205 1156 1161 B-Study
) NCT03923205 1162 1163 O

- NCT03923205 1167 1168 O
food NCT03923205 1170 1174 O
allergies NCT03923205 1175 1184 B-Allergy
/ NCT03923205 1185 1186 B-Or
intolerances NCT03923205 1187 1199 B-Condition


Inclusion NCT03923335 0 9 O
Criteria NCT03923335 10 18 O
: NCT03923335 19 20 O

1 NCT03923335 24 25 O
. NCT03923335 25 26 O
TNM NCT03923335 28 31 O
stage NCT03923335 32 37 O
I NCT03923335 38 39 O
- NCT03923335 40 41 O
II NCT03923335 42 44 O
( NCT03923335 45 46 O
T NCT03923335 47 48 O
1 NCT03923335 49 50 O
- NCT03923335 51 52 B-Eq_Comparison
4 NCT03923335 53 54 I-Eq_Comparison
N NCT03923335 55 56 O
0 NCT03923335 57 58 O
M NCT03923335 58 59 O
0 NCT03923335 60 61 O
) NCT03923335 62 63 O
colorectal NCT03923335 64 74 B-Modifier
cancer NCT03923335 75 81 B-Condition
cases NCT03923335 82 87 O

2 NCT03923335 90 91 O
. NCT03923335 91 92 O
receive NCT03923335 94 101 O
radical NCT03923335 102 109 B-Modifier
surgical NCT03923335 110 118 B-Procedure
resection NCT03923335 119 128 I-Procedure

3 NCT03923335 131 132 O
. NCT03923335 132 133 O
have NCT03923335 135 139 O
completed NCT03923335 140 149 O
data NCT03923335 150 154 O
of NCT03923335 155 157 O
tumor NCT03923335 158 163 B-Condition
location NCT03923335 164 172 B-Modifier
, NCT03923335 173 174 O
histological NCT03923335 175 187 B-Modifier
type NCT03923335 188 192 I-Modifier
, NCT03923335 193 194 O
behavioral NCT03923335 195 205 B-Modifier
characteristics NCT03923335 206 221 I-Modifier
or NCT03923335 222 224 B-Or
TNM NCT03923335 225 228 B-Modifier
staging NCT03923335 229 236 I-Modifier

4 NCT03923335 239 240 O
. NCT03923335 240 241 O
have NCT03923335 243 247 O
tumor NCT03923335 248 253 B-Observation
specimens NCT03923335 254 263 I-Observation
and NCT03923335 264 267 B-And
either NCT03923335 268 274 O
a NCT03923335 275 276 O
valid NCT03923335 277 282 O
microsatellite NCT03923335 283 297 B-Observation
instability NCT03923335 298 309 I-Observation
( NCT03923335 310 311 O
MSI NCT03923335 312 315 B-Observation
) NCT03923335 316 317 O
or NCT03923335 318 320 B-Or
immuno NCT03923335 321 327 B-Observation
- NCT03923335 328 329 I-Observation
histochemistry NCT03923335 330 344 I-Observation
( NCT03923335 345 346 O
IHC NCT03923335 347 350 B-Observation
) NCT03923335 351 352 O
data NCT03923335 353 357 O

5 NCT03923335 360 361 O
. NCT03923335 361 362 O
have NCT03923335 364 368 O
valid NCT03923335 369 374 O
V NCT03923335 375 376 B-Observation
- NCT03923335 377 378 I-Observation
raf NCT03923335 379 382 I-Observation
murine NCT03923335 383 389 I-Observation
sarcoma NCT03923335 390 397 I-Observation
viral NCT03923335 398 403 I-Observation
oncogene NCT03923335 404 412 I-Observation
homolog NCT03923335 413 420 I-Observation
B NCT03923335 421 422 I-Observation
1 NCT03923335 423 424 I-Observation
( NCT03923335 425 426 O
BRAF NCT03923335 427 431 B-Observation
) NCT03923335 432 433 O
, NCT03923335 434 435 O
kirsten NCT03923335 436 443 B-Observation
rat NCT03923335 444 447 I-Observation
sarcoma NCT03923335 448 455 I-Observation
viral NCT03923335 456 461 I-Observation
oncogene NCT03923335 462 470 I-Observation
( NCT03923335 471 472 O
KRAS NCT03923335 473 477 B-Observation
) NCT03923335 478 479 O
, NCT03923335 480 481 O
CpG NCT03923335 482 485 B-Observation
island NCT03923335 486 492 I-Observation
methylator NCT03923335 493 503 I-Observation
phenotype NCT03923335 504 513 I-Observation
( NCT03923335 514 515 O
CIMP NCT03923335 516 520 B-Observation
) NCT03923335 521 522 O
results NCT03923335 523 530 O

6 NCT03923335 533 534 O
. NCT03923335 534 535 O
have NCT03923335 537 541 O
at NCT03923335 542 544 B-Eq_Comparison
least NCT03923335 545 550 I-Eq_Comparison
4 NCT03923335 551 552 I-Eq_Comparison
years NCT03923335 553 558 I-Eq_Comparison
of NCT03923335 559 561 O
follow NCT03923335 562 568 B-Encounter
- NCT03923335 569 570 I-Encounter
up NCT03923335 571 573 I-Encounter

7 NCT03923335 576 577 O
. NCT03923335 577 578 O
have NCT03923335 580 584 O
valid NCT03923335 585 590 O
time NCT03923335 591 595 B-Modifier
to NCT03923335 596 598 I-Modifier
local NCT03923335 599 604 I-Modifier
recurrence NCT03923335 605 615 B-Condition
/ NCT03923335 616 617 B-Or
metastasis NCT03923335 618 628 B-Condition
in NCT03923335 629 631 B-Temporal_Connection___Temporal_Connection_Type_Value:during
follow NCT03923335 632 638 B-Encounter
- NCT03923335 639 640 I-Encounter
up NCT03923335 641 643 I-Encounter

8 NCT03923335 646 647 O
. NCT03923335 647 648 O
have NCT03923335 650 654 O
clinical NCT03923335 655 663 O
/ NCT03923335 664 665 O
treatment NCT03923335 666 675 B-Procedure
record NCT03923335 676 682 O
data NCT03923335 683 687 O
and NCT03923335 688 691 B-And
valid NCT03923335 692 697 O
pre NCT03923335 698 701 B-Temporal_Connection___Temporal_Connection_Type_Value:before
operative NCT03923335 702 711 B-Procedure
status NCT03923335 712 718 O
of NCT03923335 719 721 O
intestinal NCT03923335 722 732 B-Condition
obstruction NCT03923335 733 744 I-Condition
or NCT03923335 745 747 I-Condition
perforation NCT03923335 748 759 I-Condition
( NCT03923335 760 761 O
IOP NCT03923335 762 765 B-Condition
) NCT03923335 766 767 O
, NCT03923335 768 769 O
counts NCT03923335 770 776 B-Eq_Comparison
of NCT03923335 777 779 O
lymph NCT03923335 780 785 B-Procedure
node NCT03923335 786 790 I-Procedure
removed NCT03923335 791 798 I-Procedure
in NCT03923335 799 801 B-Temporal_Connection___Temporal_Connection_Type_Value:during
surgical NCT03923335 802 810 B-Procedure
resection NCT03923335 811 820 I-Procedure
. NCT03923335 821 822 O

Exclusion NCT03923335 824 833 O
Criteria NCT03923335 834 842 O
: NCT03923335 843 844 O

1 NCT03923335 848 849 O
. NCT03923335 849 850 O
have NCT03923335 852 856 O
had NCT03923335 857 860 O
a NCT03923335 861 862 O
previous NCT03923335 863 871 B-Eq_Comparison
diagnosis NCT03923335 872 881 O
of NCT03923335 882 884 O
any NCT03923335 885 888 O
cancer NCT03923335 889 895 B-Condition
or NCT03923335 896 898 B-Or
presence NCT03923335 899 907 O
of NCT03923335 908 910 O
any NCT03923335 911 914 O
tumor NCT03923335 915 920 B-Condition
other NCT03923335 921 926 B-Exception
than NCT03923335 927 931 I-Exception
the NCT03923335 932 935 O
CRC NCT03923335 936 939 B-Condition

2 NCT03923335 942 943 O
. NCT03923335 943 944 O
have NCT03923335 946 950 O
had NCT03923335 951 954 O
inflammatory NCT03923335 955 967 B-Condition
bowel NCT03923335 968 973 I-Condition
disease NCT03923335 974 981 I-Condition

3 NCT03923335 984 985 O
. NCT03923335 985 986 O
have NCT03923335 988 992 O
had NCT03923335 993 996 O
hereditary NCT03923335 997 1007 B-Modifier
colorectal NCT03923335 1008 1018 I-Modifier
cancer NCT03923335 1019 1025 B-Condition
syndromes NCT03923335 1026 1035 I-Condition
, NCT03923335 1036 1037 O
including NCT03923335 1038 1047 O
Familial NCT03923335 1048 1056 B-Condition
adenomatous NCT03923335 1057 1068 I-Condition
polyposis NCT03923335 1069 1078 I-Condition
, NCT03923335 1079 1080 O
mutyh NCT03923335 1081 1086 B-Modifier
( NCT03923335 1087 1088 O
MYH NCT03923335 1089 1092 B-Modifier
) NCT03923335 1093 1094 O
- NCT03923335 1095 1096 O
associated NCT03923335 1097 1107 O
polyposis NCT03923335 1108 1117 B-Condition
, NCT03923335 1118 1119 O
Peutz NCT03923335 1120 1125 B-Condition
- NCT03923335 1126 1127 I-Condition
Jeghers NCT03923335 1128 1135 I-Condition
syndrome NCT03923335 1136 1144 I-Condition
, NCT03923335 1145 1146 O
Juvenile NCT03923335 1147 1155 B-Condition
polyposis NCT03923335 1156 1165 I-Condition
coli NCT03923335 1166 1170 I-Condition
, NCT03923335 1171 1172 O
phosphate NCT03923335 1173 1182 B-Condition
and NCT03923335 1183 1186 I-Condition
tension NCT03923335 1187 1194 I-Condition
homology NCT03923335 1195 1203 I-Condition
deleted NCT03923335 1204 1211 I-Condition
on NCT03923335 1212 1214 I-Condition
chromosome NCT03923335 1215 1225 I-Condition
ten NCT03923335 1226 1229 I-Condition
( NCT03923335 1230 1231 O
PTEN NCT03923335 1232 1236 B-Condition
) NCT03923335 1237 1238 O
tumor NCT03923335 1239 1244 B-Condition
- NCT03923335 1245 1246 I-Condition
hamartoma NCT03923335 1247 1256 I-Condition
syndromes NCT03923335 1257 1266 I-Condition
, NCT03923335 1267 1268 O
Lynch NCT03923335 1269 1274 B-Condition
Syndrome NCT03923335 1275 1283 I-Condition
, NCT03923335 1284 1285 O
and NCT03923335 1286 1289 B-Or
Familial NCT03923335 1290 1298 B-Modifier
Colorectal NCT03923335 1299 1309 I-Modifier
Cancer NCT03923335 1310 1316 B-Condition
Type NCT03923335 1317 1321 B-Modifier
X NCT03923335 1322 1323 I-Modifier
. NCT03923335 1324 1325 O

Inclusion NCT03868579 0 9 O
Criteria NCT03868579 10 18 O
: NCT03868579 19 20 O

- NCT03868579 24 25 O
Patients NCT03868579 27 35 O
who NCT03868579 36 39 O
will NCT03868579 40 44 B-Eq_Comparison
undergo NCT03868579 45 52 I-Eq_Comparison
pleuroscopy NCT03868579 53 64 B-Procedure
with NCT03868579 65 69 O
biopsy NCT03868579 70 76 B-Procedure

Exclusion NCT03868579 77 86 O
Criteria NCT03868579 87 95 O
: NCT03868579 96 97 O

- NCT03868579 101 102 O
Patients NCT03868579 104 112 O
with NCT03868579 113 117 O
known NCT03868579 118 123 O
malignant NCT03868579 124 133 B-Modifier
pleural NCT03868579 134 141 B-Condition
effusion NCT03868579 142 150 I-Condition

- NCT03868579 153 154 O
Inability NCT03868579 156 165 O
or NCT03868579 166 168 O
unwillingness NCT03868579 169 182 O
to NCT03868579 183 185 O
give NCT03868579 186 190 O
informed NCT03868579 191 199 O
consent NCT03868579 200 207 O

Inclusion NCT03928132 0 9 O
Criteria NCT03928132 10 18 O
: NCT03928132 19 20 O

- NCT03928132 24 25 O
French NCT03928132 27 33 O
- NCT03928132 34 35 O
speaking NCT03928132 36 44 O
health NCT03928132 45 51 O
professionals NCT03928132 52 65 O
( NCT03928132 66 67 O
in NCT03928132 68 70 O
practice NCT03928132 71 79 O
and NCT03928132 80 83 O
in NCT03928132 84 86 O
training NCT03928132 87 95 O
) NCT03928132 96 97 O
. NCT03928132 98 99 O

Inclusion NCT03862560 0 9 O
Criteria NCT03862560 10 18 O
: NCT03862560 19 20 O

- NCT03862560 24 25 O
Caucasian NCT03862560 27 36 O
, NCT03862560 37 38 O
Healthy NCT03862560 39 46 B-Condition
participant NCT03862560 47 58 O
, NCT03862560 59 60 O
from NCT03862560 61 65 O
12 NCT03862560 66 68 B-Eq_Comparison
to NCT03862560 69 71 I-Eq_Comparison
20 NCT03862560 72 74 I-Eq_Comparison
years NCT03862560 75 80 I-Eq_Comparison
old NCT03862560 81 84 B-Age
, NCT03862560 85 86 O
with NCT03862560 87 91 B-And
a NCT03862560 92 93 O
history NCT03862560 94 101 B-Eq_Comparison
of NCT03862560 102 104 O
training NCT03862560 105 113 B-Observation
at NCT03862560 114 116 B-Eq_Comparison
least NCT03862560 117 122 I-Eq_Comparison
3 NCT03862560 123 124 I-Eq_Comparison
years NCT03862560 125 130 I-Eq_Comparison
. NCT03862560 131 132 O

Exclusion NCT03862560 134 143 O
Criteria NCT03862560 144 152 O
: NCT03862560 153 154 O

- NCT03862560 158 159 O
Non NCT03862560 161 164 B-Negation
- NCT03862560 165 166 O
caucasian NCT03862560 167 176 O
, NCT03862560 177 178 O
injury NCT03862560 179 185 B-Condition
. NCT03862560 186 187 O

Inclusion NCT03928691 0 9 O
criteria NCT03928691 10 18 O
: NCT03928691 19 20 O

pregnant NCT03928691 22 30 B-Condition
women NCT03928691 31 36 O
34 NCT03928691 37 39 B-Eq_Comparison
weeks NCT03928691 40 45 I-Eq_Comparison
or NCT03928691 46 48 I-Eq_Comparison
less NCT03928691 49 53 I-Eq_Comparison
admitted NCT03928691 54 62 B-Encounter
to NCT03928691 63 65 O
Women NCT03928691 66 71 O
's NCT03928691 71 73 O
Health NCT03928691 74 80 O
Hospital NCT03928691 81 89 O
with NCT03928691 90 94 O
a NCT03928691 95 96 O
diagnosis NCT03928691 97 106 O
of NCT03928691 107 109 O
: NCT03928691 110 111 O

- NCT03928691 115 116 O
sever NCT03928691 118 123 O
preeclampsia NCT03928691 124 136 B-Condition
. NCT03928691 137 138 O
It NCT03928691 140 142 O
is NCT03928691 143 145 O
defined NCT03928691 146 153 O
as NCT03928691 154 156 O
1 NCT03928691 157 158 O
- NCT03928691 159 160 O
blood NCT03928691 161 166 B-Observation
pressure NCT03928691 167 175 I-Observation
160 NCT03928691 176 179 B-Eq_Comparison
/ NCT03928691 180 181 I-Eq_Comparison
110 NCT03928691 182 185 I-Eq_Comparison
mmHg NCT03928691 186 190 I-Eq_Comparison
or NCT03928691 191 193 I-Eq_Comparison
more NCT03928691 194 198 I-Eq_Comparison
2 NCT03928691 199 200 O
- NCT03928691 201 202 O
proteinurea NCT03928691 203 214 B-Observation
( NCT03928691 215 216 O
+ NCT03928691 217 218 B-Eq_Comparison
3 NCT03928691 219 220 I-Eq_Comparison
or NCT03928691 221 223 I-Eq_Comparison
more NCT03928691 224 228 I-Eq_Comparison
by NCT03928691 229 231 B-Modifier
dipstick NCT03928691 232 240 I-Modifier
) NCT03928691 241 242 O
3 NCT03928691 243 244 B-Condition
- NCT03928691 245 246 I-Condition
HELLP NCT03928691 247 252 I-Condition
syndrome NCT03928691 253 261 I-Condition

- NCT03928691 264 265 O
threatened NCT03928691 267 277 B-Assertion___Assertion_Type_Value:possible
preterm NCT03928691 278 285 B-Condition
labour NCT03928691 286 292 I-Condition
that NCT03928691 293 297 O
will NCT03928691 298 302 B-Assertion___Assertion_Type_Value:hypothetical
receive NCT03928691 303 310 O
Magnesium NCT03928691 311 320 B-Drug
Sulphate NCT03928691 321 329 I-Drug
either NCT03928691 330 336 O
for NCT03928691 337 340 O
tocolysis NCT03928691 341 350 O
or NCT03928691 351 353 O
neuroprotection NCT03928691 354 369 O
. NCT03928691 370 371 O

Exclusion NCT03928691 373 382 O
criteria NCT03928691 383 391 O
: NCT03928691 392 393 O

- NCT03928691 396 397 O
women NCT03928691 398 403 O
with NCT03928691 404 408 B-And
more NCT03928691 409 413 B-Eq_Comparison
than NCT03928691 414 418 I-Eq_Comparison
34 NCT03928691 419 421 I-Eq_Comparison
weeks NCT03928691 422 427 I-Eq_Comparison
gestation NCT03928691 428 437 B-Observation
and NCT03928691 438 441 B-And
with NCT03928691 442 446 O
any NCT03928691 447 450 O
contraindication NCT03928691 451 467 B-Contraindication
for NCT03928691 468 471 O
Magnesium NCT03928691 472 481 B-Drug
Sulphate NCT03928691 482 490 I-Drug
intake NCT03928691 491 497 O
like NCT03928691 498 502 O
severe NCT03928691 503 509 O
renal NCT03928691 510 515 B-Condition
impairment NCT03928691 516 526 I-Condition
or NCT03928691 527 529 B-Or
myasthenia NCT03928691 530 540 B-Condition
gravis NCT03928691 541 547 I-Condition
. NCT03928691 548 549 O


Inclusion NCT03867695 0 9 O
criteria NCT03867695 10 18 O
: NCT03867695 19 20 O

- NCT03867695 24 25 O
All NCT03867695 27 30 O
patients NCT03867695 31 39 O
undergoing NCT03867695 40 50 B-Eq_Comparison
lobectomy NCT03867695 51 60 B-Procedure
VATS NCT03867695 61 65 I-Procedure

- NCT03867695 68 69 O
Older NCT03867695 71 76 B-Age
> NCT03867695 77 78 B-Eq_Comparison
18 NCT03867695 79 81 I-Eq_Comparison
years NCT03867695 82 87 I-Eq_Comparison

- NCT03867695 90 91 O
Patients NCT03867695 93 101 O
who NCT03867695 102 105 O
meet NCT03867695 106 110 O
criteria NCT03867695 111 119 O
of NCT03867695 120 122 O
ASA NCT03867695 123 126 B-Observation
1 NCT03867695 127 128 B-Eq_Comparison
to NCT03867695 129 131 I-Eq_Comparison
3 NCT03867695 132 133 I-Eq_Comparison
class NCT03867695 134 139 I-Eq_Comparison

Exclusion NCT03867695 140 149 O
criteria NCT03867695 150 158 O
: NCT03867695 159 160 O

- NCT03867695 164 165 O
Patient NCT03867695 167 174 O
's NCT03867695 174 176 O
refusal NCT03867695 177 184 O
to NCT03867695 185 187 O
participate NCT03867695 188 199 O
in NCT03867695 200 202 O
the NCT03867695 203 206 O
study NCT03867695 207 212 O

- NCT03867695 215 216 O
Psychiatric NCT03867695 218 229 B-Condition
disorder NCT03867695 230 238 I-Condition
( NCT03867695 239 240 O
impossibility NCT03867695 241 254 O
to NCT03867695 255 257 O
collect NCT03867695 258 265 O
the NCT03867695 266 269 O
informed NCT03867695 270 278 O
consent NCT03867695 279 286 O
) NCT03867695 287 288 O

- NCT03867695 292 293 O
Patient NCT03867695 295 302 O
under NCT03867695 303 308 O
juridical NCT03867695 309 318 B-Observation
protection NCT03867695 319 329 I-Observation

- NCT03867695 332 333 O
On NCT03867695 335 337 O
going NCT03867695 338 343 O
an NCT03867695 344 346 O
other NCT03867695 347 352 B-Other
study NCT03867695 353 358 B-Study

- NCT03867695 361 362 O
Non NCT03867695 364 367 B-Negation
balanced NCT03867695 368 376 B-Modifier
epilepsy NCT03867695 377 385 B-Condition

- NCT03867695 388 389 O
3 NCT03867695 391 392 B-Eq_Comparison
grade NCT03867695 393 398 I-Eq_Comparison
auriculo NCT03867695 399 407 B-Modifier
- NCT03867695 408 409 I-Modifier
ventricular NCT03867695 410 421 I-Modifier
heart NCT03867695 422 427 B-Condition
block NCT03867695 428 433 I-Condition
without NCT03867695 434 441 B-Negation
pacing NCT03867695 442 448 B-Modifier

- NCT03867695 451 452 O
Severe NCT03867695 454 460 O
hepatocellular NCT03867695 461 475 B-Condition
insufficiency NCT03867695 476 489 I-Condition

- NCT03867695 492 493 O
Anti NCT03867695 495 499 B-Procedure
arrhythmic NCT03867695 500 510 I-Procedure
treatment NCT03867695 511 520 I-Procedure
: NCT03867695 521 522 O
class NCT03867695 523 528 B-Eq_Comparison
III NCT03867695 529 532 I-Eq_Comparison
of NCT03867695 533 535 O
the NCT03867695 536 539 O
Vaughan NCT03867695 540 547 B-Modifier
William NCT03867695 548 555 I-Modifier
's NCT03867695 555 557 I-Modifier
classification NCT03867695 558 572 I-Modifier

- NCT03867695 575 576 O
Pregnant NCT03867695 578 586 B-Condition
patient NCT03867695 587 594 O
or NCT03867695 595 597 B-Or
/ NCT03867695 598 599 I-Or
and NCT03867695 600 603 I-Or
breastfeeding NCT03867695 604 617 B-Condition

- NCT03867695 620 621 O
History NCT03867695 623 630 B-Eq_Comparison
of NCT03867695 631 633 O
opioid NCT03867695 634 640 B-Condition
abuse NCT03867695 641 646 I-Condition

- NCT03867695 649 650 O
Allergy NCT03867695 652 659 B-Allergy
to NCT03867695 660 662 O
local NCT03867695 663 668 B-Drug
anesthetic NCT03867695 669 679 I-Drug
drug NCT03867695 680 684 I-Drug
or NCT03867695 685 687 B-Or
opioids NCT03867695 688 695 B-Drug
